<SEC-DOCUMENT>0001292814-26-002013.txt : 20260331
<SEC-HEADER>0001292814-26-002013.hdr.sgml : 20260331
<ACCEPTANCE-DATETIME>20260331173113
ACCESSION NUMBER:		0001292814-26-002013
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		159
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260331
DATE AS OF CHANGE:		20260331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Afya Ltd
		CENTRAL INDEX KEY:			0001771007
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-EDUCATIONAL SERVICES [8200]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38992
		FILM NUMBER:		26823760

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		PARAIBA, NO. 330
		STREET 2:		17TH FLOOR, FUNCIONARIOS
		CITY:			BELO HORIZONTE, MINAS GERAIS
		PROVINCE COUNTRY:   	D5
		BUSINESS PHONE:		553135157550

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		PARAIBA, NO. 330
		STREET 2:		17TH FLOOR, FUNCIONARIOS
		CITY:			BELO HORIZONTE, MINAS GERAIS
		PROVINCE COUNTRY:   	D5
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>afyaform20f_2025.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:afya="http://afya.com.br/20251231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_027_IFRS%2D2024%2D(with%2DECD%2DCYD) -->
<!-- Field: Set; Name: xdx; ID: xdx_037_afya_afya.com.br_20251231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20250101_20251231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DDocumentFiscalYearFocus_2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001771007 -->
<!-- Field: Set; Name: xdx; ID: xdx_073_SO_afyaform20f__2025.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_065_USD_0_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_060_USDPShares_0_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_061_BRL_1_iso4217%2D%2DBRL -->
<!-- Field: Set; Name: xdx; ID: xdx_062_BRLPShares_3_iso4217%2D%2DBRL_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06C_N_5_Number -->
<!-- Field: Set; Name: xdx; ID: xdx_065_EUR_0_iso4217%2D%2DEUR -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000004" name="dei:DocumentFiscalYearFocus">2025</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000005" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000006" name="dei:EntityCentralIndexKey">0001771007</ix:nonNumeric>
  <ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="AsOf2024-12-31" id="xdx2ixbrl0135" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPayable" contextRef="AsOf2024-12-31" id="xdx2ixbrl0180" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DeferredTaxLiabilities" contextRef="AsOf2025-12-31" id="xdx2ixbrl0212" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl0325" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl0326" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0327" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0366" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0367" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0368" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0369" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0375" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0376" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0377" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0378" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0384" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0385" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0386" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0388" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0390" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0393" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0394" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0396" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0397" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0399" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0402" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0403" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0404" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0405" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0411" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0414" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0415" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0417" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0420" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0423" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0424" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0426" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0429" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0430" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0431" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0432" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0433" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="xdx2ixbrl0434" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0447" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0448" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0449" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0450" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0456" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0457" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0458" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0459" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0465" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0466" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0467" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0469" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0471" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0474" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0477" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0478" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0480" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0483" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0486" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0487" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0489" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0492" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0493" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0494" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0495" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0496" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="xdx2ixbrl0497" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0510" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0511" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0512" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0513" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0519" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0520" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0521" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0522" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0528" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0529" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0530" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0532" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0534" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0537" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0538" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0540" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0541" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0543" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0546" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0549" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0550" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0552" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0555" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0558" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0559" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0561" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0564" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0565" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0566" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0567" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PurchaseOfAcquisitionOfNoncontrollingInterests" contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl0702" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PurchaseOfAcquisitionOfNoncontrollingInterests" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl0703" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl0743" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="xdx2ixbrl1302" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="xdx2ixbrl1338" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="xdx2ixbrl1350" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1356" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="xdx2ixbrl1358" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="xdx2ixbrl1362" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="xdx2ixbrl1374" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="xdx2ixbrl1410" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="xdx2ixbrl1446" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="xdx2ixbrl1458" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1464" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="xdx2ixbrl1466" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="xdx2ixbrl1470" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="xdx2ixbrl1482" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1498" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="xdx2ixbrl1502" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="xdx2ixbrl1512" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1546" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1580" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="xdx2ixbrl1584" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="xdx2ixbrl1594" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1628" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1663" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="xdx2ixbrl1667" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="xdx2ixbrl1677" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1711" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherAssetsRelatedPartyTransactions" contextRef="AsOf2025-12-31" id="xdx2ixbrl1944" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TradeAndOtherCurrentPayablesToRelatedParties1" contextRef="AsOf2025-12-31" id="xdx2ixbrl1952" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2267" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2276" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2278" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2279" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2287" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2289" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2295" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2300" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2301" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="xdx2ixbrl2304" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl2307" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2322" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2333" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2334" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2339" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2342" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2344" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="xdx2ixbrl2348" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="xdx2ixbrl2349" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2350" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2355" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2356" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="xdx2ixbrl2359" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl2362" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2377" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2378" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2386" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="xdx2ixbrl2387" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2388" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2399" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2400" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="xdx2ixbrl2403" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl2406" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2421" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2427" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2432" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2438" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2443" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2449" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2454" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2455" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="xdx2ixbrl2456" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="xdx2ixbrl2458" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2460" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2461" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2465" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2471" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2476" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2482" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2485" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2487" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="xdx2ixbrl2491" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2493" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2498" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2499" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="xdx2ixbrl2502" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2504" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2505" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2509" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2515" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2520" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2526" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2529" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2531" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2537" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2542" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2548" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl2617" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2797" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2799" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2813" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2819" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2820" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2829" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2843" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2845" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2859" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2865" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2866" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2874" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2890" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2892" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2906" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2912" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2913" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2921" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2929" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2931" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2945" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="xdx2ixbrl3069" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="xdx2ixbrl3071" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember" id="xdx2ixbrl3129" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember" id="xdx2ixbrl3131" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember" id="xdx2ixbrl3145" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember" id="xdx2ixbrl3147" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember" id="xdx2ixbrl3157" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember" id="xdx2ixbrl3159" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FUNICMember" id="xdx2ixbrl3213" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FUNICMember" id="xdx2ixbrl3215" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FUNICMember" id="xdx2ixbrl3219" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FUNICMember" id="xdx2ixbrl3223" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPayable" contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="xdx2ixbrl3324" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_custom_OctoberTwentyTwentyFiveMember" id="xdx2ixbrl3368" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_custom_AprilTwentyTwentySixMember" id="xdx2ixbrl3388" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_custom_JanuaryTwentyTwentyEightMember" id="xdx2ixbrl3398" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_custom_OctoberTwentyTwentyEightMember" id="xdx2ixbrl3420" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_custom_OctoberTwentyThirtyMember" id="xdx2ixbrl3430" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsBusinessCombinations" contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl3500" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:BusinessCombinationsLeaseLiabilities" contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl3506" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DepreciationExpenseLeaseLiabilities" contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl3518" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DepreciationExpenseLeaseLiabilities" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl3520" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DepreciationExpenseLeaseLiabilities" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3522" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsInterestExpense" contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl3524" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsInterestExpense" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl3526" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsInterestExpense" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3528" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfPrincipal" contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl3536" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfPrincipal" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl3538" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfPrincipal" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3540" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfInterest" contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl3548" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfInterest" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl3550" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfInterest" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3552" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsCurrent" contextRef="AsOf2025-12-31" id="xdx2ixbrl3584" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsCurrent" contextRef="AsOf2024-12-31" id="xdx2ixbrl3586" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl3588" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_custom_UnigranrioMember" id="xdx2ixbrl3618" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_custom_FUNICMember" id="xdx2ixbrl3632" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_custom_AlemDaMedicinaMember" id="xdx2ixbrl3638" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember" id="xdx2ixbrl3742" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember" id="xdx2ixbrl3744" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl3832" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl3834" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl3836" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl3846" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl3882" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl3884" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="xdx2ixbrl3886" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2025-01-012025-12-31_custom_DividendsPayableMember" id="xdx2ixbrl3964" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" contextRef="AsOf2025-12-31_ifrs-full_ShareOptionsMember" id="xdx2ixbrl4273" unitRef="BRLPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember" id="xdx2ixbrl4275" unitRef="N" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" contextRef="From2024-01-012024-12-31_ifrs-full_ShareOptionsMember" id="xdx2ixbrl4277" unitRef="N" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember" id="xdx2ixbrl4409" unitRef="N" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" contextRef="From2024-01-012024-12-31_custom_RestrictedStockUnitsMember" id="xdx2ixbrl4411" unitRef="N" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember" id="xdx2ixbrl4640" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember" id="xdx2ixbrl4642" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember" id="xdx2ixbrl4682" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember" id="xdx2ixbrl4700" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember" id="xdx2ixbrl4702" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember" id="xdx2ixbrl4742" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember" id="xdx2ixbrl4762" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember" id="xdx2ixbrl4764" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember" id="xdx2ixbrl4804" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RecognisedDeferredTaxAssets" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl4969" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PermanentAdjustmentsManagementBonuses" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl4982" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PermanentAdjustmentsPillarTwo" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl4997" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PermanentAdjustmentsPillarTwo" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl4998" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DeferredTaxAssetsLossCarryforwards" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl5026" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AllowanceForExpectedCreditLoss" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl5035" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAsset" contextRef="AsOf2024-12-31" id="xdx2ixbrl5044" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LeaseLiability" contextRef="AsOf2024-12-31" id="xdx2ixbrl5050" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ProvisionForProfitSharing" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl5056" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:LegalProceedingsProvision" contextRef="AsOf2024-12-31" id="xdx2ixbrl5062" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AmortizationOfIntangibleAsset" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl5068" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Other" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl5074" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DeferredTaxAsset" contextRef="AsOf2024-12-31" id="xdx2ixbrl5080" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl5089" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AdditionsFairValueRemeasurementsOnBusinessCombinations" contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl5097" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="xdx2ixbrl5135" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="xdx2ixbrl5223" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RemeasurementOfEarnOut" contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl5269" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RemeasurementOfEarnOut" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl5271" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsPayables" contextRef="From2024-01-012024-12-31" id="xdx2ixbrl5295" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsPayables" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl5297" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="afya-20251231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2025-01-01to2025-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_ClassACommonSharesHeldInTreasuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesHeldInTreasuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_ClassBOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-05-07_custom_FaculdadeMasterclassLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeMasterclassLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-05-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeMasterclassLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-05-062025-05-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-06</xbrli:startDate>
        <xbrli:endDate>2025-05-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesS.A.Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-05-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_AfyaParticipacoesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AfyaParticipacoesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoS.A.FASAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoS.A.FASAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaenseDeEducacaoECulturaLtda.IPECMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaenseDeEducacaoECulturaLtda.IPECMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorS.A.UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorS.A.UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeEnsinoSaoLucasLtda.UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeEnsinoSaoLucasLtda.UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeSolutionsS.A.MedicinaeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeSolutionsS.A.MedicinaeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtda.CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtda.CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiaDaInformacaoLtda.ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiaDaInformacaoLtda.ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesDeTecnologiaLtda.RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesDeTecnologiaLtda.RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_UnidomParticipacoesS.A.UnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomParticipacoesS.A.UnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_UnidomParticipacoesS.A.UnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomParticipacoesS.A.UnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaFUNICMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeMasterclassLtdaFUNICMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_FVTPLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">afya:FVTPLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_FinancialAssetsAtAmortizedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">afya:FinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_FVOCIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">afya:FVOCIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_FVOCI1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">afya:FVOCI1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_CustomerRelationshipsOtherCoursesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">afya:CustomerRelationshipsOtherCoursesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_BrandNamesMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_BrandNamesMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_EducationContentDevelopedTechnologyAndEducationalPlatformMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">afya:EducationContentDevelopedTechnologyAndEducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_EducationContentDevelopedTechnologyAndEducationalPlatformMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">afya:EducationContentDevelopedTechnologyAndEducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ProgramOfSocialIntegrationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:TeachingActivitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_TeachingActivitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ContributionForTheFinancingOfSocialSecurityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:TeachingActivitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_ProgramOfSocialIntegrationMember_custom_NonTeachingActivitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ProgramOfSocialIntegrationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:NonTeachingActivitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_NonTeachingActivitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ContributionForTheFinancingOfSocialSecurityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:NonTeachingActivitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-262024-12-27_custom_OrganizationForEconomicCooperationAndDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:OrganizationForEconomicCooperationAndDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-26</xbrli:startDate>
        <xbrli:endDate>2024-12-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_OrganizationForEconomicCooperationAndDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:OrganizationForEconomicCooperationAndDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_AmendmentsToIAS21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_LackOfExchangeabilityAmendmentsToIAS21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:LackOfExchangeabilityAmendmentsToIAS21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_AnnualImprovementsToIFRSAccountingStandardsVolume11Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AnnualImprovementsToIFRSAccountingStandardsVolume11Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_IFRS18PresentationAndDisclosureInFinancialStatementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:IFRS18PresentationAndDisclosureInFinancialStatementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentBalancesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentBalancesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-01_custom_UnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-292024-07-01_custom_UnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-29</xbrli:startDate>
        <xbrli:endDate>2024-07-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-292024-07-01_custom_AcquisitionOfUnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfUnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-29</xbrli:startDate>
        <xbrli:endDate>2024-07-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfUnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AcquisitionOfUnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfUnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-292024-07-01_ifrs-full_LicencesAndFranchisesMember_custom_AcquisitionOfUnidomMember_custom_WithAndWithoutMethodMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfUnidomMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:WithAndWithoutMethodMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-29</xbrli:startDate>
        <xbrli:endDate>2024-07-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-292024-07-01_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfUnidomMember_ifrs-full_MultiperiodExcessEarningsMethodMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfUnidomMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">ifrs-full:MultiperiodExcessEarningsMethodMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-29</xbrli:startDate>
        <xbrli:endDate>2024-07-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_BankCertificatesOfDepositMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:BankCertificatesOfDepositMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_BankCertificatesOfDepositMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:BankCertificatesOfDepositMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_USDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">afya:USDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_USDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">afya:USDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_TuitionFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:TuitionFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_TuitionFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:TuitionFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_EducationalContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_EducationalContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_FIESMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:FIESMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_FIESMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:FIESMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_EducationalCreditsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalCreditsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_EducationalCreditsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalCreditsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_MobileAppSubscriptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:MobileAppSubscriptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_MobileAppSubscriptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:MobileAppSubscriptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_OthersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:OthersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_OthersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:OthersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsNeitherPastDueNorImpairedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsNeitherPastDueNorImpairedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_NotLaterThanOneMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_NotLaterThanOneMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LaterThanSixMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanSixMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LaterThanSixMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanSixMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_EMIVEPatrulha24HorasLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:EMIVEPatrulha24HorasLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_EMIVEPatrulha24HorasLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:EMIVEPatrulha24HorasLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EMIVEPatrulha24HorasLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:EMIVEPatrulha24HorasLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_DepreciationRightofuseAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:DepreciationRightofuseAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_DepreciationRightofuseAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:DepreciationRightofuseAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DepreciationRightofuseAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:DepreciationRightofuseAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_LeaseLiabilitiesInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseLiabilitiesInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_LeaseLiabilitiesInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseLiabilitiesInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LeaseLiabilitiesInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseLiabilitiesInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_LeaseAgreements1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-052018-09-06_custom_LeaseAgreements1Member_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-05</xbrli:startDate>
        <xbrli:endDate>2018-09-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-052018-09-06_custom_LeaseAgreements1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-05</xbrli:startDate>
        <xbrli:endDate>2018-09-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-28</xbrli:startDate>
        <xbrli:endDate>2019-10-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-28</xbrli:startDate>
        <xbrli:endDate>2019-10-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-08-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-28</xbrli:startDate>
        <xbrli:endDate>2021-08-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements4Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements4Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements4Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-012024-05-02_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-01</xbrli:startDate>
        <xbrli:endDate>2024-05-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-132024-07-14_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-13</xbrli:startDate>
        <xbrli:endDate>2024-07-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements5Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements5Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements5Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements5Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_LeaseAgreements5Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements5Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_LeaseAgreements5Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements5Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-23</xbrli:startDate>
        <xbrli:endDate>2018-04-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_LeaseAgreements5Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements5Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_LeaseAgreements5Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements5Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LicencesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_EducationContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_EducationalPlatformMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_SoftwareInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LicencesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_EducationContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_EducationalPlatformMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_SoftwareInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ITPACGaranhunsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ITPACGaranhunsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnifipMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnifipMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FUNICMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FUNICMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CarryingAmountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CarryingAmountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_DiscountRatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:DiscountRatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_PerpetuityGrowthRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:PerpetuityGrowthRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_EBITDAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EBITDAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersEarnOutsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersEarnOutsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersEarnOutsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersEarnOutsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersUnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersUnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersUnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersUnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_OctoberTwentyTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_OctoberTwentyTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_OctoberTwentyTwentyFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyTwentyFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_JulyTwentyTwentySevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:JulyTwentyTwentySevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_JulyTwentyTwentySevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:JulyTwentyTwentySevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_JulyTwentyTwentySevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:JulyTwentyTwentySevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_AprilTwentyTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:AprilTwentyTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_AprilTwentyTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:AprilTwentyTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_AprilTwentyTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:AprilTwentyTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_JanuaryTwentyTwentyEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:JanuaryTwentyTwentyEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_JanuaryTwentyTwentyEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:JanuaryTwentyTwentyEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_JanuaryTwentyTwentyEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:JanuaryTwentyTwentyEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_AprilTwentyThirtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:AprilTwentyThirtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_AprilTwentyThirtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:AprilTwentyThirtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_AprilTwentyThirtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:AprilTwentyThirtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_OctoberTwentyTwentyEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyTwentyEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_OctoberTwentyTwentyEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyTwentyEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_OctoberTwentyTwentyEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyTwentyEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_OctoberTwentyThirtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyThirtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_OctoberTwentyThirtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyThirtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_OctoberTwentyThirtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyThirtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-07_custom_InternationalFinanceCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:InternationalFinanceCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-012024-08-07_custom_InternationalFinanceCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:InternationalFinanceCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-01</xbrli:startDate>
        <xbrli:endDate>2024-08-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-10-15_custom_TwoSeriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:TwoSeriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-10-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-10-15_custom_FirstSeriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:FirstSeriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-10-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-10-15_custom_SecondSeriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:SecondSeriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-10-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-10-012025-10-15_custom_InternationalFinanceCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:InternationalFinanceCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-01</xbrli:startDate>
        <xbrli:endDate>2025-10-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-032021-08-04_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-03</xbrli:startDate>
        <xbrli:endDate>2021-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-04_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-292023-01-02_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-29</xbrli:startDate>
        <xbrli:endDate>2023-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-02_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-05-052025-05-07_custom_FUNICMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-05</xbrli:startDate>
        <xbrli:endDate>2025-05-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-05-07_custom_FUNICMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-05-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-122021-05-13_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-12</xbrli:startDate>
        <xbrli:endDate>2021-05-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-13_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-032022-03-04_custom_AlemDaMedicinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-03</xbrli:startDate>
        <xbrli:endDate>2022-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-04_custom_AlemDaMedicinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-042022-04-05_custom_CardioPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardioPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-04</xbrli:startDate>
        <xbrli:endDate>2022-04-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-05_custom_CardioPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardioPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-302024-07-01_custom_UnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-30</xbrli:startDate>
        <xbrli:endDate>2024-07-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_currency_EUR_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">currency:EUR</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_DelReyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_FUNICMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_FUNICMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_FUNICMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_AlemDaMedicinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_AlemDaMedicinaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CardiPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardiPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_CardiPapersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardiPapersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_UnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_UnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_UnidomMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_ForeignCurrencyExposuresMember_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:ForeignCurrencyExposuresMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_IncreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:IncreaseForeignCurrencyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_DecreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:DecreaseForeignCurrencyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_LoansAndFinancingMember197490421">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_LoansAndFinancingMember197490453">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_ShareBasedCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_ShareBasedCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ShareBasedCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_RestrictedStockUnits1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnits1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_RestrictedStockUnits2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnits2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_RestrictedStockUnits3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnits3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-01</xbrli:startDate>
        <xbrli:endDate>2025-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-01</xbrli:startDate>
        <xbrli:endDate>2025-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-01</xbrli:startDate>
        <xbrli:endDate>2025-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-01</xbrli:startDate>
        <xbrli:endDate>2025-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-01</xbrli:startDate>
        <xbrli:endDate>2025-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-01</xbrli:startDate>
        <xbrli:endDate>2025-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_ShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_November2025Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:November2025Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_April2025Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:April2025Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_October2024Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:October2024Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_December2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:December2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_October2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:October2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_August2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:August2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_April2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:April2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_February2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:February2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember_custom_November2025Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:November2025Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember_custom_November2025Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:November2025Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember_custom_April2025Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:April2025Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember_custom_April2025Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:April2025Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_BottomOfRangeMember_custom_October2024Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:October2024Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_TopOfRangeMember_custom_October2024Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:October2024Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_December2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:December2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_December2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:December2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_October2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:October2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_October2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:October2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_August2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:August2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_August2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:August2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_April2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:April2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_April2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:April2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_February2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:February2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_February2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:February2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_ClassBOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-03-112025-03-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-11</xbrli:startDate>
        <xbrli:endDate>2025-03-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-032025-04-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-03</xbrli:startDate>
        <xbrli:endDate>2025-04-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-08-13_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-08-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_UndergraduateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentTransactionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_UndergraduateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentTransactionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentTransactionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-12-31_custom_OtherAssetsNonCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">afya:OtherAssetsNonCurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_OtherAssetsNonCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">afya:OtherAssetsNonCurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2026-03-112026-03-12_custom_NonadjustingEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">afya:NonadjustingEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-03-11</xbrli:startDate>
        <xbrli:endDate>2026-03-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2026-04-052026-04-06_custom_NonadjustingEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">afya:NonadjustingEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-04-05</xbrli:startDate>
        <xbrli:endDate>2026-04-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="BRL">
      <xbrli:measure>iso4217:BRL</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="BRLPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:BRL</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="N">
      <xbrli:measure>afya:Number</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="EUR">
      <xbrli:measure>iso4217:EUR</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 3.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->


<p style="font: 14pt Times New Roman, Times, Serif; margin: 0 0 3pt; text-align: center">UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 3pt; text-align: center">Washington, D.C. 20549</p>

<!-- Field: Rule-Page --><div style="margin: 1pt 3in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>FORM <span id="xdx_902_edei--DocumentType_c20250101__20251231_zX1PxpeZHmhh"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000017" name="dei:DocumentType">20-F</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">(Mark One)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.5in"><span id="xdx_90F_edei--DocumentRegistrationStatement_c20250101__20251231_z761JvcQfNlj"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleanfalse" id="Fact000018" name="dei:DocumentRegistrationStatement">&#9744;</ix:nonNumeric></span></td><td><b>REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>OR</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.5in"><span id="xdx_904_edei--DocumentAnnualReport_c20250101__20251231_zHInFeMWR94i"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleantrue" id="Fact000019" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></td><td><b>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE<br/>
ACT OF 1934<br/>
For the fiscal year ended <span id="xdx_90B_edei--DocumentPeriodEndDate_c20250101__20251231_zgcJ6uJK9zSj"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:datemonthdayyearen" id="Fact000020" name="dei:DocumentPeriodEndDate"><span id="xdx_90D_edei--CurrentFiscalYearEndDate_c20250101__20251231_zyd6MWCMNNJa"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:datemonthdayen" id="Fact000021" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric></span>, 2025</ix:nonNumeric></span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>OR</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.5in"><span id="xdx_90C_edei--DocumentTransitionReport_c20250101__20251231_z5Sxn8HAL3z"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleanfalse" id="Fact000022" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></td><td><b>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE<br/>
ACT OF 1934</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>OR</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.5in"><span id="xdx_90C_edei--DocumentShellCompanyReport_c20250101__20251231_zDnOMujZ03F8"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleanfalse" id="Fact000023" name="dei:DocumentShellCompanyReport">&#9744;</ix:nonNumeric></span></td><td><b>SHELL
                                            COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934<br/>
                                            Date of event requiring this shell company report<br/>
                                            For the transition period from <span style="text-decoration: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>to&#160;<span style="text-decoration: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                                            </span>.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Commission file number: <span id="xdx_900_edei--EntityFileNumber_c20250101__20251231_zAQQzvSFFi0c"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000024" name="dei:EntityFileNumber">001-38992</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span style="font-size: 14pt"><b><span id="xdx_905_edei--EntityRegistrantName_c20250101__20251231_zk0usCkDk856"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000025" name="dei:EntityRegistrantName">AFYA LIMITED</ix:nonNumeric></span><br/>
</b></span><span style="font-size: 9pt">(Exact name of Registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-align: center"><span style="font-size: 12pt">N/A<br/>
<span style="font-size: 9pt">(Translation of Registrant&#8217;s name into English)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-align: center"><span style="font-size: 11pt"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20250101__20251231_zZgJqUAWawul"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt-sec:edgarprovcountryen" id="Fact000026" name="dei:EntityIncorporationStateCountryCode">Cayman Islands</ix:nonNumeric></span></b><br/>
</span><span style="font-size: 9pt">(Jurisdiction of incorporation or organization)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-align: center"><span id="xdx_902_edei--EntityAddressAddressLine1_c20250101__20251231_zyaDxZ3u08Hl" style="font-size: 11pt"><b><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000027" name="dei:EntityAddressAddressLine1">Rua
Paraiba</ix:nonNumeric></b></span><b><span style="font-size: 11pt">, <span id="xdx_905_edei--EntityAddressAddressLine2_c20250101__20251231_zDKtmDn3wxbl"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000028" name="dei:EntityAddressAddressLine2">No.
330</ix:nonNumeric></span></span></b><b><span style="font-size: 11pt">, <span id="xdx_90F_edei--EntityAddressAddressLine3_c20250101__20251231_zdeJrNUtgtIh"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000029" name="dei:EntityAddressAddressLine3">17th
floor</ix:nonNumeric></span></span></b><span style="font-size: 11pt"><br/>
Funcion&#225;rios, Belo Horizonte</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-align: center"><span style="font-size: 11pt"><br/> <span id="xdx_90C_edei--EntityAddressCityOrTown_c20250101__20251231_zFYiy4X0xZI6"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000030" name="dei:EntityAddressCityOrTown">Minas Gerais</ix:nonNumeric></span> &#8212; MG, <span id="xdx_903_edei--EntityAddressCountry_c20250101__20251231_z04oVvh8qXZ8"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt-sec:countrynameen" id="Fact000031" name="dei:EntityAddressCountry">Brazil</ix:nonNumeric></span><br/>
<span style="font-size: 9pt">(Address of principal executive offices)</span> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-align: center"><span style="font-size: 11pt"><b><span id="xdx_909_edei--ContactPersonnelName_c20250101__20251231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zKiEXPO80x0f" title="Contact Personnel Name"><ix:nonNumeric contextRef="From2025-01-012025-12-31_dei_BusinessContactMember" id="Fact000033" name="dei:ContactPersonnelName">Virgilio Deloy Capobianco Gibbon</ix:nonNumeric></span><br/>
Chief Executive Officer<br/>
Tel.: +<span id="xdx_903_edei--CityAreaCode_c20250101__20251231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z04KKSiSsHu4" title="City Area Code"><ix:nonNumeric contextRef="From2025-01-012025-12-31_dei_BusinessContactMember" id="Fact000035" name="dei:CityAreaCode">55</ix:nonNumeric></span> (31) <span id="xdx_900_edei--LocalPhoneNumber_c20250101__20251231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zc2GuvlUiyVe" title="Local Phone Number"><ix:nonNumeric contextRef="From2025-01-012025-12-31_dei_BusinessContactMember" id="Fact000037" name="dei:LocalPhoneNumber">3515-7550</ix:nonNumeric></span> Email: <span id="xdx_907_edei--ContactPersonnelEmailAddress_c20250101__20251231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zQ8dM2pkBzh1" title="Contact Personnel Email Address"><ix:nonNumeric contextRef="From2025-01-012025-12-31_dei_BusinessContactMember" id="Fact000039" name="dei:ContactPersonnelEmailAddress">ir@afya.com.br</ix:nonNumeric></span><br/>
<span id="xdx_904_edei--EntityAddressAddressLine1_c20250101__20251231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zKpSxDRNDOfg" title="Entity Address, Address Line One"><ix:nonNumeric contextRef="From2025-01-012025-12-31_dei_BusinessContactMember" id="Fact000041" name="dei:EntityAddressAddressLine1">Rua Paraiba</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20250101__20251231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zXdvNBOwolQ3" title="Entity Address, Address Line Two"><ix:nonNumeric contextRef="From2025-01-012025-12-31_dei_BusinessContactMember" id="Fact000043" name="dei:EntityAddressAddressLine2">No. 330</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressAddressLine3_c20250101__20251231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zp8m6n9dKI6d"><ix:nonNumeric contextRef="From2025-01-012025-12-31_dei_BusinessContactMember" id="Fact000044" name="dei:EntityAddressAddressLine3">17th floor</ix:nonNumeric></span><br/>
Funcion&#225;rios, Belo Horizonte, <span id="xdx_90D_edei--EntityAddressCityOrTown_c20250101__20251231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zvAek8mdT7kl" title="Entity Address, City or Town"><ix:nonNumeric contextRef="From2025-01-012025-12-31_dei_BusinessContactMember" id="Fact000046" name="dei:EntityAddressCityOrTown">Minas Gerais</ix:nonNumeric></span><br/>
<span id="xdx_906_edei--EntityAddressCountry_c20250101__20251231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zKsvwUHVzTQd" title="Entity Address, Country"><ix:nonNumeric contextRef="From2025-01-012025-12-31_dei_BusinessContactMember" format="ixt-sec:countrynameen" id="Fact000048" name="dei:EntityAddressCountry">Brazil</ix:nonNumeric></span><br/>
</b></span><span style="font-size: 9pt">(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Securities registered or to be registered pursuant to Section 12(b)
of the Act:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 38%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"><b>Title
    of each class</b></p></td>
    <td style="width: 31%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"><b>Trading
    Symbol(s)</b></p></td>
    <td style="width: 31%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center"><b>Name
    of each exchange on which registered</b></p></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-bottom: 5pt; padding-left: 2.9pt; text-align: center"><span style="font-size: 8pt"><span id="xdx_905_edei--Security12bTitle_c20250101__20251231_zVxkOgNrnbfj"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000049" name="dei:Security12bTitle">Class A common shares, par value US$0.00005 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-bottom: 5pt; padding-left: 2.9pt; text-align: center"><span style="font-size: 8pt"><span id="xdx_905_edei--TradingSymbol_c20250101__20251231_zfw8MKT9PDll"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000050" name="dei:TradingSymbol">AFYA</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-bottom: 5pt; padding-left: 2.9pt; text-align: center"><span style="font-size: 8pt"><span id="xdx_909_edei--SecurityExchangeName_c20250101__20251231_z62uMGItnpkl"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt-sec:exchnameen" id="Fact000051" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Global Select Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Securities registered or to be registered pursuant to Section 12(g)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>None</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Securities for which there is a reporting obligation pursuant to
Section 15(d) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>None</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Indicate the number of outstanding shares of each of the issuer&#8217;s
classes of capital or common stock as of the close of the period covered by the annual report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The number of outstanding shares as of December 31, 2025 was <span id="xdx_903_edei--EntityCommonStockSharesOutstanding_iI_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zC41wGf3psCi"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-12-31_custom_ClassAOrdinarySharesMember" id="Fact000052" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">55,148,697</ix:nonFraction></span>
Class A common shares (including <span id="xdx_90F_edei--EntityCommonStockSharesOutstanding_iI_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesHeldInTreasuryMember_zmvaouKpUDq8"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-12-31_custom_ClassACommonSharesHeldInTreasuryMember" id="Fact000053" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,855,150</ix:nonFraction></span> Class A common shares held in treasury) and <span id="xdx_904_edei--EntityCommonStockSharesOutstanding_iI_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zyQitCgu1CIf"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-12-31_custom_ClassBOrdinarySharesMember" id="Fact000054" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,574,134</ix:nonFraction></span>
Class B common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Indicate by check mark if the registrant is a well-known seasoned
issuer, as defined in Rule 405 of the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt; text-align: center">Yes <span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt">&#9744;</span>	<span id="xdx_908_edei--EntityWellKnownSeasonedIssuer_c20250101__20251231_zVHouriMvI5f"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000055" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span>
<span style="font-size: 10pt">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">If this report is an annual or transition report, indicate by check
mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt; text-align: center">Yes <span style="font-size: 10pt">&#9744;</span>	<span id="xdx_908_edei--EntityVoluntaryFilers_c20250101__20251231_zpaolRkfJ489"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000056" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>
<span style="font-size: 10pt">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt"><b>Note</b> &#8212; Checking the box above will not relieve any registrant
required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">Indicate by check mark whether the registrant (1)&#160;has filed
all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements
for the past 90 days.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt; text-align: center"><span id="xdx_909_edei--EntityCurrentReportingStatus_c20250101__20251231_zi4Go7WEJqjd"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000057" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> <span style="font-size: 10pt">&#9746;</span>	No
<span style="font-size: 10pt">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">Indicate by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt; text-align: center"><span id="xdx_90A_edei--EntityInteractiveDataCurrent_c20250101__20251231_zCGUDXWXOTu9"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000058" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> <span style="font-size: 10pt">&#9746;</span>	No
<span style="font-size: 10pt">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221;
&#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="display: none">&#9744;</span></p>

<p style="font: 10pt/90% Times New Roman, Times, Serif; margin: 0 0 4pt; text-indent: 0.25in"><span id="xdx_907_edei--EntityFilerCategory_c20250101__20251231_zE2aAgUqfXU6"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt-sec:entityfilercategoryen" id="Fact000059" name="dei:EntityFilerCategory">Large Accelerated Filer</ix:nonNumeric></span> &#9746;	Accelerated
Filer &#9744;</p>

<p style="font: 10pt/90% Times New Roman, Times, Serif; margin: 0 0 4pt; text-indent: 0.25in">Non-accelerated Filer &#9744;	Emerging
growth company <span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20250101__20251231_zWhr6SfeCVXk" title="Entity Emerging Growth Company"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleanfalse" id="Fact000061" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">If an emerging growth company that prepares its financial statements
in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards&#8224; provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">&#8224; The term &#8220;new or revised financial accounting standard&#8221;
refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">If securities are registered pursuant to Section 12(b) of the Act,
indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to
previously issued financial statements. <span id="xdx_906_edei--DocumentFinStmtErrorCorrectionFlag_c20250101__20251231_zdboz1zNVpUb" title="Document Financial Statement Error Correction [Flag]"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleanfalse" id="Fact000063" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">Indicate by check mark whether any of those error corrections are
restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers
during the relevant recovery period pursuant to &#167; 240.10D-1(b). &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">Indicate by check mark whether the registrant has filed a report
on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section
404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
<span id="xdx_900_edei--IcfrAuditorAttestationFlag_c20250101__20251231_zjunXLfQVEeg"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleantrue" id="Fact000064" name="dei:IcfrAuditorAttestationFlag">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">Indicate by check mark which basis of accounting the registrant has
used to prepare the financial statements included in this filing:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt 0.5in">&#9744;	U.S. GAAP</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt 0.5in">&#9746;	<span id="xdx_900_edei--DocumentAccountingStandard_c20250101__20251231_zfs97TGtz824" title="Document Accounting Standard"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000066" name="dei:DocumentAccountingStandard">International Financial Reporting Standards</ix:nonNumeric></span> as issued
by the International Accounting Standards Board</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt 0.5in">&#9744;	Other</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">If &#8220;Other&#8221; has been checked in response to the previous
question, indicate by check mark which financial statement item the registrant has elected to follow.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt; text-align: center">&#9744; Item 17	&#9744; Item 18</p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt">If this is an annual report, indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 4pt; text-align: center">Yes <span style="font-size: 10pt">&#9744;</span>	No
<span style="font-size: 10pt"><span id="xdx_902_edei--EntityShellCompany_dbF_c20250101__20251231_zkG4pf71FcJ7" title="Entity Shell Company"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleanfalse" id="Fact000068" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 3.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>



<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><span style="text-transform: uppercase"><b><span id="TableOfContents001"></span>table of contents</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 2.6in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right"><span style="text-decoration: underline">Page</span></p>



<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; text-transform: uppercase">
    <td style="width: 90%; text-align: left; text-indent: -22.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 22.5pt"><a href="#a_Toc225309223">PART I INTRODUCTION</a></td>
    <td style="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309223">1</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309224">ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309224">4</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309225">ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309225">4</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309226">ITEM 3. KEY INFORMATION</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309226">4</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309227">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Reserved</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309227">4</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309228">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Capitalization and Indebtedness</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309228">4</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309229">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Reasons for the Offer and Use of Proceeds</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309229">4</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309230">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Risk Factors</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309230">5</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309231">ITEM 4. INFORMATION ON THE COMPANY</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309231">47</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309232">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;History and Development of the Company</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309232">47</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309233">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Business Overview</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309233">52</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309234">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Organizational Structure</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309234">89</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309235">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Property, Plant and Equipment</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309235">90</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309236">ITEM 4A. UNRESOLVED STAFF COMMENTS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309236">90</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309237">ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309237">90</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309238">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating Results</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309238">90</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309239">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Liquidity and Capital Resources</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309239">108</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309240">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Research and Development, Patents and Licenses</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309240">112</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309241">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trend Information</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309241">113</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309242">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Critical Accounting Estimates</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309242">113</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309243">ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309243">113</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309244">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Directors and Senior Management</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309244">113</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309245">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Compensation</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309245">116</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309246">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Board Practices</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309246">117</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309247">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employees</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309247">121</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309248">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Ownership</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309248">122</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309249">F. &#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosure of a Registrant&#8217;s Action to Recover Erroneously
Awarded Compensation</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309249">122</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309250">ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309250">122</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309251">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Major Shareholders</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309251">122</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309252">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Related Party Transactions</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309252">125</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309253">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interests of Experts and Counsel</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309253">127</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309254">ITEM 8. FINANCIAL INFORMATION</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309254">127</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309255">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Consolidated Statements and Other Financial Information</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309255">127</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309256">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Significant Changes</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309256">131</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309257">ITEM 9. THE OFFER AND LISTING</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309257">131</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309258">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Offer and Listing Details</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309258">131</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309259">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plan of Distribution</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309259">132</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309260">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Markets</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309260">132</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309261">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Selling Shareholders</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309261">132</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309262">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dilution</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309262">132</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309263">F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Expenses of the Issue</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309263">132</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309264">ITEM 10. ADDITIONAL INFORMATION</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309264">132</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309265">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Capital</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309265">132</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309266">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Memorandum and Articles of Association</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309266">132</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309267">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material Contracts</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309267">149</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309268">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exchange Controls</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309268">149</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309269">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Taxation</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309269">149</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309270">F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dividends and Paying Agents</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309270">153</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309271">G.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Statement by Experts</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309271">153</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309272">H.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Documents on Display</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309272">153</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309273">I.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsidiary Information</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309273">153</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309274">J.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Annual Report to Security Holders</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309274">154</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309275">ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309275">154</a></td></tr>
</table>
<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="width: 90%; text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309276">ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</a></td>
    <td style="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309276">155</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309277">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Debt Securities</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309277">155</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309278">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Warrants and Rights</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309278">155</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309279">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Securities</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309279">155</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309280">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;American Depositary Shares</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309280">155</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309281">ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309281">156</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309282">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defaults</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309282">156</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309283">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Arrears and delinquencies</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309283">156</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309284">ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309284">156</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309285">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material modifications to instruments</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309285">156</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309286">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material modifications to rights</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309286">156</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309287">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Withdrawal or substitution of assets</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309287">156</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309288">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Change in trustees or paying agents</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309288">156</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309289">E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Use of proceeds</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309289">156</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309290">ITEM 15. CONTROLS AND PROCEDURES</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309290">156</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309291">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosure Controls and Procedures</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309291">156</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309292">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Management&#8217;s Annual Report on Internal Control Over Financial
Reporting</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309292">156</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309293">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attestation Report of the Registered Public Accounting Firm</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309293">157</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 23.75pt"><a href="#a_Toc225309294">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Changes in Internal Control Over Financial Reporting</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309294">157</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309295">ITEM 16. RESERVED</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309295">157</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309296">ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309296">157</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309297">ITEM 16B. CODE OF ETHICS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309297">157</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309298">ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309298">158</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309299">ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309299">158</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309300">ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309300">158</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309301">ITEM 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309301">160</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309302">ITEM 16G. CORPORATE GOVERNANCE</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309302">160</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309303">ITEM 16H. MINE SAFETY DISCLOSURE</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309303">161</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309304">ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309304">161</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309305">ITEM 16J. INSIDER TRADING POLICIES</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309305">161</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309306">ITEM 16K. CYBERSECURITY</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309306">162</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; text-transform: uppercase">
    <td style="text-align: left; text-indent: -22.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 22.5pt"><a href="#a_Toc225309307">PART III</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309307">164</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309308">ITEM 17. FINANCIAL STATEMENTS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309308">164</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309309">ITEM 18. FINANCIAL STATEMENTS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309309">164</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -23.75pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.5in"><a href="#a_Toc225309310">ITEM 19. EXHIBITS</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc225309310">164</a></td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; text-transform: uppercase">
    <td style="text-align: left; text-indent: -22.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 22.5pt"><a href="#a_Toc131581046">Index to Financial Statements</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><a href="#a_Toc131581046">F-1</a></td></tr>
</table>
<p style="font: 10pt Times New Roman,serif; margin: 0 0 0 22.5pt; text-transform: uppercase; text-indent: -22.5pt">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 20pt 0 10pt; text-transform: uppercase; text-align: center"><span id="a_Toc215609471"></span><span id="a_Toc225309223"></span><span id="a_Toc196072464"></span><span id="a_Toc164277164"></span><span id="a_Toc194891100"></span><span id="a_Toc190934937"></span><span id="a_Toc133237637"></span><span id="a_Toc163120231"></span><span id="a_Toc131580958"></span>
PART I<br/>
INTRODUCTION</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Certain Definitions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Unless otherwise indicated or the context otherwise
requires, all references in this annual report to &#8220;Afya&#8221; or the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221;
&#8220;ours,&#8221; &#8220;us&#8221; or similar terms refer to Afya Limited, together with its subsidiaries; all references in this annual
report to &#8220;Afya Brazil&#8221; refer to Afya Participa&#231;&#245;es S.A.; all references in this annual report to &#8220;Medcel&#8221;
refer to Medcel Editora e Eventos S.A. (merged by Afya Brazil in 2024); and all references in this annual report to &#8220;IPTAN&#8221;
refer to IPTAN&#8212;Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A., &#8220;IESVAP&#8221; refer to Instituto de
Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A., &#8220;CCSI&#8221; refer to Centro de Ci&#234;ncias em Sa&#250;de
de Itajub&#225; S.A., &#8220;IESP&#8221; refer to Instituto de Ensino Superior do Piau&#237; S.A., &#8220;FADEP&#8221; refer to FADEP&#8212;Faculdade
Educacional de Pato Branco Ltda., &#8220;FASA&#8221; refer to Instituto Educacional Santo Agostinho S.A., &#8220;IPEMED&#8221; refer to
Instituto de Pesquisa e Ensino M&#233;dico do Estado de Minas Gerais Ltda. (merged by Afya Brazil in 2024), &#8220;IPEC&#8221; refer
to Instituto Paraense de Educa&#231;&#227;o e Cultura Ltda., &#8220;UniRedentor&#8221; refer to Sociedade Universit&#225;ria Redentor
S.A., &#8220;UniSL&#8221; refer to Centro Universit&#225;rio S&#227;o Lucas Ltda., &#8220;PEBMED&#8221; refer to PEBMED Institui&#231;&#227;o
de Pesquisa M&#233;dica e Servi&#231;os Tecnol&#243;gicos da &#193;rea da Sa&#250;de S.A. (merged by Afya Brazil in 2024), &#8220;FESAR&#8221;
refer to Sociedade de Educa&#231;&#227;o, Cultura e Tecnologia da Amaz&#244;nia S.A., &#8220;MedPhone&#8221; refer to MedPhone Tecnologia
em Sa&#250;de Ltda. (merged by Afya Brazil in 2022), &#8220;FCMPB&#8221; refer to Centro Superior de Ci&#234;ncias da Sa&#250;de
Ltda., &#8220;UnifipMoc&#8221; refer to Sociedade Padr&#227;o de Educa&#231;&#227;o Superior Ltda., &#8220;iClinic&#8221; refer
to iClinic Desenvolvimento de Software S.A. (merged by Afya Brazil in 2025), &#8220;Medicinae&#8221; refer to Medicinae Solutions S.A.
(merged by Afya Brazil in 2025), &#8220;Medical Harbour&#8221; refer to Medical Harbour Aparelhos M&#233;dico-Hospitalares e Servi&#231;os
em Tecnologia Ltda., &#8220;Cliquefarma&#8221; refer to Cliquefarma Drogarias Online Ltda. (merged by Afya Brazil in 2025), &#8220;Shosp&#8221;
refer to Shosp Tecnologia da Informa&#231;&#227;o Ltda. (merged by Afya Brazil in 2025), &#8220;Unigranrio&#8221; refer to Companhia
Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura, &#8220;RX PRO&#8221; refer to RX PRO Solu&#231;&#245;es de Tecnologia Ltda.
(merged by Afya Brazil in 2025), &#8220;Garanhuns&#8221; refer to Faculdade ITPAC Garanhuns - Instituto Tocantinense Presidente Antonio
Carlos Ltda., &#8220;Al&#233;m da Medicina&#8221; refer to <span id="a_Hlk194685356"></span>BMV Atividades M&#233;dicas Ltda. (merged
by Afya Brazil in 2024), &#8220;CardioPapers&#8221; refer to Cardiopapers Solu&#231;&#245;es Digitais Ltda. (merged by Afya Brazil
in 2024), &#8220;Glic&#8221; refer to Quasar Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (merged by Afya Brazil in 2025),
&#8220;DelRey&#8221; refer to Sociedade Educacional e Cultural Sergipe DelRey Ltda., &#8220;UNIVA&#199;O&#8221; refer Uni&#227;o Educacional
do Vale do A&#231;o S.A., &#8220;ITPAC Aragua&#237;na&#8221; refer to ITPAC - Instituto Tocantinense Presidente Ant&#244;nio Carlos
S.A., &#8220;ITPAC Porto&#8221; refer to ITPAC Porto - Instituto Tocantinense Presidente Ant&#244;nio Carlos Porto S.A., &#8220;UEPC&#8221;
refer to Uni&#227;o Educacional do Planalto Central S.A., &#8220;Unidom&#8221; refer to Unidom Participa&#231;&#245;es S.A. (merged
by Afya Brazil in 2025), &#8220;IBES&#8221; refer to Institui&#231;&#227;o Baiana de Ensino Superior Ltda., &#8220;Sessa&#8221; refer
to SESSA &#8212; Sociedade de Educa&#231;&#227;o Superior do Semi-&#193;rido Ltda., and &#8220;FUNIC&#8221; refer to Faculdade Masterclass
Ltda.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The term &#8220;Esteves Family&#8221; refers to Nicolau
Carvalho Esteves, Ros&#226;ngela de Oliveira Tavares Esteves, NRE Capital Ventures Ltd. and NRE B Ventures Ltd., collectively, our former
controlling shareholders. The term &#8220;Bertelsmann&#8221; refers to Bertelsmann SE &amp; Co. KGaA and Erste WV G&#252;tersloh GmbH,
collectively, our current controlling shareholder.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The term &#8220;Brazil&#8221; refers to the Federative
Republic of Brazil, and the phrase &#8220;Brazilian government&#8221; refers to the federal government of Brazil. &#8220;Central Bank&#8221;
refers to the Brazilian Central Bank <i>(Banco Central do Brasil).</i> References in the annual report to &#8220;<i>real,</i>&#8221; &#8220;<i>reais</i>&#8221;
or &#8220;R$&#8221; refer to the Brazilian <i>real,</i> the official currency of Brazil, and references to &#8220;U.S. dollar,&#8221;
&#8220;U.S. dollars&#8221; or &#8220;US$&#8221; refer to U.S. dollars, the official currency of the United States.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Financial Information</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is a Cayman Islands exempted company with limited
liability duly registered with the Cayman Islands Registrar of Companies and was incorporated on March 22, 2019.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The consolidated financial information of Afya
contained in this annual report is derived from our audited consolidated financial statements as of December 31, 2025 and 2024 and
for each of the years in the three-year period ended December 31, 2025, together with the notes thereto. All references herein to
&#8220;our consolidated financial statements&#8221; are to Afya&#8217;s audited consolidated financial
statements included elsewhere in this annual report.</p>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is a holding company, and as such, the primary
source of revenue derives from its interest in its operational companies in Brazil. Afya&#8217;s functional currency as well as that of
its subsidiaries is the Brazilian <i>real</i>. We prepare our consolidated financial statements in accordance with IFRS Accounting Standards
as issued by the International Accounting Standards Board (&#8220;IFRS Accounting Standards&#8221;).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our fiscal year ends on December 31 of each year, so
all references to a particular fiscal year are to the applicable year ended December 31.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk127453259"></span>Convenience Translation</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The reporting currency for our consolidated financial
statements is the Brazilian <i>real</i> and, solely for the convenience of the reader, we have provided convenience translations into
U.S. dollars using the selling exchange rates published by the Central Bank on its website. Unless otherwise indicated, convenience translations
from <i>reais</i> into U.S. dollars in this annual report use the Central Bank offer exchange rate published on December 31, 2025, which
was R$5.5024 per US$1.00. No representation is made that the Brazilian <i>reais</i> amounts referred to could have been, or could be,
converted into U.S. dollars at any particular rate.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Market Data</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">This annual report contains data related to economic
conditions in the market in which we operate. The information contained in this annual report concerning economic conditions is based
on publicly available information from third-party sources that we believe to be reasonable. Market data and certain industry forecast
data used in this annual report were obtained from internal reports and studies, where appropriate, as well as estimates, market research,
publicly available information (including information available from the United States Securities and Exchange Commission website) and
industry publications. We obtained the information included in this annual report relating to the industry in which we operate, as well
as the estimates concerning market shares, through internal research, a report by a third-party consulting firm commissioned by us, public
information and publications on the industry prepared by official public sources, such as the Central Bank, the Brazilian Institute of
Geography and Statistics <i>(Instituto Brasileiro de Geografia e Estat&#237;stica),</i> or the IBGE, the Organisation for Economic Co-operation
and Development, or OECD, the Brazilian Ministry of Education <i>(Minist&#233;rio da Educa&#231;&#227;o),</i> or MEC, the An&#237;sio
Teixeira National Institute of Educational Studies and Research <i>(Instituto Nacional de Estudos e Pesquisas Educacionais An&#237;sio
Teixeira),</i> or the INEP, the Institute of Applied Economic Research <i>(Instituto de Pesquisa Econ&#244;mica Aplicada),</i> or the
IPEA, the Brazilian Medical Association (<i>Associa&#231;&#227;o M&#233;dica Brasileira)</i>, or AMB as well as private sources,
such as Bloomberg, consulting and research companies in the Brazilian and international education industry, the Brazilian Economic Institute
of Funda&#231;&#227;o Getulio Vargas <i>(Instituto Brasileiro de Economia da Funda&#231;&#227;o Getulio Vargas),</i> or FGV/IBRE,
the Association of American Medical Colleges, or AAMC among others.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Industry publications, governmental publications and
other market sources, including those referred to above, generally state that the information they include has been obtained from sources
believed to be reliable, but that the accuracy and completeness of such information is not guaranteed. While we are not aware of any misstatements
regarding the market and industry data presented herein, our estimates involve risks and uncertainties and are subject to change based
on various factors, including those discussed in the section entitled &#8220;Item 3. Key Information&#8212;D. Risk Factors.&#8221; Except
as disclosed in this annual report, none of the publications, reports or other published industry sources referred to in this annual report
were commissioned by us or prepared at our request. Except as disclosed in this annual report, we have not sought or obtained the consent
of any of these sources to include such market data in this annual report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Rounding</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have made rounding adjustments to some of the figures
included in this annual report. Accordingly, numerical figures shown as totals in some tables may not be an arithmetic aggregation of
the figures that preceded them.</p>


<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Forward-Looking Statements</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">This annual report on Form 20-F contains information
that constitutes forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities
Exchange Act of 1934, as amended, or Exchange Act, that are not based on historical facts and are not assurances of future results. The
forward-looking statements contained in this annual report, which address our expected business and financial performance, among other
matters, contain words such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221;
&#8220;plan,&#8221; &#8220;aim,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221;
&#8220;likely,&#8221; &#8220;potential&#8221; and similar expressions. We have made forward-looking statements that address, among other
things, our current expectations, plans, forecasts, projections and strategies about future events and financial trends that affect, or
may affect, our business, industry, market share, reputation, financial condition, results of operations, margins, cash flow and/or the
market price of our common shares, all of which are subject to known and unknown risks and uncertainties. Our actual results may differ
materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those
identified under the section entitled &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8221; in this annual report. These risks and
uncertainties include factors relating to:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to implement our business strategy;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in government regulations and legislation applicable to the education industry in Brazil, both in the traditional and distance
learning segments, including tax regulations and/or legislation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>government interventions, including changes in, or termination of, education industry programs such as the Higher Education Student
Financing Fund (<i>Fundo de Financiamento ao Estudante do Ensino Superior</i>), or FIES, and/or the University for All Program (<i>Programa
Universidade para Todos</i>), or PROUNI, both in the traditional and distance learning segments, that affect the economic or tax regime,
the collection of tuition fees or the regulatory framework applicable to educational institutions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in the financial condition of the students enrolling in our institutions in general and in the competitive conditions in the
education industry, both in the traditional and distance learning segments, or changes in the financial condition of our institutions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to adapt to technological changes in the educational sector, including in relation to distance learning programs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the availability of government authorizations on terms and conditions and within periods acceptable to us;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>developments with respect to actual or potential epidemics, pandemics, outbreaks or other public health crises in Brazil and globally;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to continue attracting and retaining new students;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to maintain the academic quality of our programs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to compete and conduct our business in the future;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the success of operating initiatives, including advertising and promotional efforts and new product, service and concept development
by us and our competitors;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in consumer demands and preferences and technological advances, and our ability to innovate to respond to such changes;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the availability of qualified personnel and the ability to retain such personnel;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our capitalization and level of indebtedness;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the interests of our controlling shareholder;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a decline in the number of students enrolled in our programs or the amount of tuition we can charge;</td></tr></table>


<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in labor, distribution and other operating costs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our compliance with, and changes to, government laws, regulations and tax matters that currently apply to us;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>general economic, financial, political, demographic and business conditions in Brazil, including the impact of the current international
economic environment and the macroeconomic conditions in Brazil, the impact of the Brazilian presidential elections to be held in October
2026, as well as any other countries we may serve in the future and their impact on our business;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the effects of the ongoing conflicts in Europe and the Middle East and related disruptions on the general economic and business conditions
in Brazil, Latin America and globally;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>fluctuations in interest, inflation and exchange rates in Brazil and any other countries we may serve in the future;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>other factors that may affect our financial condition, liquidity and results of operations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the effectiveness of our risk management policies and procedures, including our internal control over financial reporting; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the other factors discussed under the section &#8220;Risk Factors&#8221; in this annual report on Form 20-F.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Prospective investors are cautioned that any such forward-looking
statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially
from those in the forward-looking statements. The accompanying information contained in this annual report on Form 20-F, including without
limitation the information set forth under the heading &#8220;Item 5. Operating and Financial Review and Prospects&#8221; identifies important
factors that could cause such differences. In light of the risks, uncertainties and assumptions associated with forward-looking statements,
you should not place undue reliance on any forward-looking statements. Additional risks that we may currently deem immaterial or that
are not presently known to us could also cause the forward-looking events discussed in this annual report on Form 20-F not to occur.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our forward-looking statements speak only as of the
date of this annual report on Form 20-F, and we do not undertake any obligation to update them in light of new information or future developments
or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence
of unanticipated events.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609472"></span><span id="a_Toc225309224"></span><span id="a_Toc196072465"></span><span id="a_Toc164277165"></span><span id="a_Toc194891101"></span><span id="a_Toc190934938"></span><span id="a_Toc133237638"></span><span id="a_Toc163120232"></span><span id="a_Toc131580959"></span>ITEM
1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609473"></span><span id="a_Toc225309225"></span><span id="a_Toc196072466"></span><span id="a_Toc164277166"></span><span id="a_Toc194891102"></span><span id="a_Toc190934939"></span><span id="a_Toc133237639"></span><span id="a_Toc163120233"></span><span id="a_Toc131580960"></span>ITEM
2. OFFER STATISTICS AND EXPECTED TIMETABLE</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609474"></span><span id="a_Toc225309226"></span><span id="a_Toc196072467"></span><span id="a_Toc164277167"></span><span id="a_Toc194891103"></span><span id="a_Toc190934940"></span><span id="a_Toc133237640"></span><span id="a_Toc163120234"></span><span id="a_Toc131580961"></span>ITEM
3. KEY INFORMATION</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609475"></span><span id="a_Toc225309227"></span><span id="a_Toc196072468"></span><span id="a_Toc164277168"></span><span id="a_Toc194891104"></span><span id="a_Toc190934941"></span><span id="a_Toc163120235"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Reserved</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609476"></span><span id="a_Toc225309228"></span><span id="a_Toc196072469"></span><span id="a_Toc164277169"></span><span id="a_Toc194891105"></span><span id="a_Toc190934942"></span><span id="a_Toc133237642"></span><span id="a_Toc163120236"></span><span id="a_Toc131580963"></span><span id="a_cp_change_78"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Capitalization
and Indebtedness</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609477"></span><span id="a_Toc225309229"></span><span id="a_Toc196072470"></span><span id="a_Toc164277170"></span><span id="a_Toc194891106"></span><span id="a_Toc190934943"></span><span id="a_Toc133237643"></span><span id="a_Toc163120237"></span><span id="a_Toc131580964"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Reasons
for the Offer and Use of Proceeds</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>


<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609478"></span><span id="a_Toc225309230"></span><span id="a_Toc196072471"></span><span id="a_Toc164277171"></span><span id="a_Toc194891107"></span><span id="a_Toc190934944"></span><span id="a_Toc133237644"></span><span id="a_Toc163120238"></span><span id="a_Toc131580965"></span>
D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Risk Factors</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc131580966"></span><span id="a_Toc132366930"></span>Summary of
Risk Factors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">An investment in our Class A common shares is subject
to several risks, including risks relating to our business and industry, risks relating to Brazil and risks relating to our Class A common
shares. The following list summarizes some, but not all, of these risks. Please read the information in the section entitled &#8220;Risk
Factors&#8221; for a more thorough description of these and other risks.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Certain Risks Relating to Our Business and Industry</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>We face significant competition in the provision of our educational services. If our competition increases or if we fail to compete
efficiently, we may lose market share, and our profitability may be adversely affected</i>. We compete with various public and private
post-secondary education institutions, including distance learning institutions and remote locations. If our competition increases due
to lighter regulatory constraints or otherwise, or if we fail to compete effectively, our business, results of operations and financial
condition could be materially affected.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Changes to the rules, judicial interpretations, administrative decisions or delays or suspension of tuition payments made through
FIES may adversely affect our cash flows and our business.</i></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="a_Hlk163500994"></span><span style="font-family: Symbol">&#183;</span></td><td><i>If we lose the benefits of federal tax exemptions provided under the PROUNI program, our business, financial condition and results
of operations may be materially adversely affected. </i>We may be disqualified from the PROUNI program and lose our tax exemptions if
we do not comply with certain requirements.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>An increase in delays and/or defaults in the payment of tuition fees or license subscription fees of medical practice solutions
may adversely affect our income and cash flows.</i></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>We may face challenges in identifying and acquiring new medical higher education institutions, which could hinder our strategic
and financial goals. Additionally, difficulties in effectively integrating and managing an increasing number of acquisitions may adversely
affect our strategic objectives.</i> We aim to expand our operations by acquiring medical higher education institutions and health tech
companies, including potentially significant and strategically relevant acquisitions. However, we cannot guarantee the identification
or acquisition of suitable medical education institutions on favorable terms or at all. Additionally, integrating acquired companies may
present challenges, such as managing a larger, geographically dispersed workforce, implementing uniform controls, procedures, and policies,
and incurring high or unexpected integration costs.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>We may require additional funds to continue our expansion strategy. If we are unable to obtain adequate financing on favorable
terms to complete any potential acquisition and implement our expansion plans, our growth strategy may be materially and adversely affected.</i>
If adequate funds are unavailable or are not available on acceptable terms, we may be unable to fund our expansion, capitalize on acquisition
opportunities, develop or enhance our product and service portfolio, or respond to competitive pressures, which could have a material
adverse effect on our business, results of operations and financial condition.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Our revenues are
                                            highly concentrated in the tuition fees we charge for our medical courses. Any adverse economic,
                                            market or regulatory factors affecting such medical courses could decrease demand, which
                                            could materially adversely affect us. </i>Economic, market or regulatory factors affecting
                                            either the amount of tuition fees we are able to charge for the medical courses we offer
                                            or the ability of our students to pay such tuition fees could result in significantly decreased
                                            demand for our services.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk127196586"></span>Certain Risks Relating to
Brazil</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>The Brazilian federal government has exercised, and continues to exercise, significant influence over the Brazilian economy. This
involvement as well as Brazil&#8217;s political and economic conditions could harm us and the price of our Class A common shares. </i>The
Brazilian government&#8217;s actions to control inflation and other policies and regulations have often involved increases or decreases
in interest rates, changes in fiscal policies, wage and price controls, currency devaluations, capital
controls, import and export restrictions, among others. Uncertainty over whether the Brazilian federal government will implement reforms
or changes in policy or regulation affecting these or the Brazilian presidential elections scheduled for October 2026 or other factors
in the future may affect economic performance and contribute to economic uncertainty in Brazil.</td></tr></table>


<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Economic uncertainty and political instability in Brazil may harm our business and the price of our Class A common shares. </i>Political
crises have affected and continue to affect the confidence of investors and the general public, which has historically resulted in economic
deceleration and heightened volatility in the securities offered by companies with significant operations in Brazil.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Exchange rate instability may have adverse effects on the Brazilian economy, us and the price of our Class A common shares. </i>The
Brazilian government has implemented various economic plans and used various exchange rate policies, including sudden devaluations, periodic
mini devaluations (during which the frequency of adjustments has ranged from daily to monthly), exchange controls, dual exchange rate
markets and a floating exchange rate system. In addition, domestic and international reactions to restrictive economic policies could
have a negative impact on the Brazilian economy.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Infrastructure and workforce deficiency in Brazil may impact economic growth and have a material adverse effect on us. </i>Growth
is limited by inadequate infrastructure, including potential energy shortages and deficient transportation, logistics and telecommunication
sectors, general strikes, the lack of a qualified labor force, and the lack of private and public investments in these areas, which limit
productivity and efficiency.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Certain Risks Relating to Our Class A Common Shares</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>An active trading market for our Class A common shares may not be sustainable. If an active trading market is not maintained, investors
may not be able to resell their shares and our ability to raise capital in the future may be impaired. </i>Although our Class A common
shares are listed and being traded on the Nasdaq Global Select Market, an active trading market for our shares may not be maintained.
The stock market in general has experienced substantial price and volume fluctuations that have often been unrelated or disproportionate
to the operating performance of particular companies affected.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>The concentration of ownership and voting power in Bertelsmann, our controlling shareholder, limits your ability to influence corporate
matters.</i> Bertelsmann, our controlling shareholder, owns 88.3% of our outstanding Class B common shares as of the date of this annual
report, which, together with its ownership of 51.8% of our outstanding Class A common shares, represent approximately 64.7% of our outstanding
share capital and 84.0% of the voting power of our outstanding share capital, and, together with the Esteves Family, controls all matters
requiring shareholder approval. This concentration of ownership and voting power limits your ability to influence corporate matters. The
decisions of Bertelsmann and the Esteves Family on these matters may be contrary to your expectations or preferences, and they may take
actions that could be contrary to your interests. So long as Bertelsmann and the Esteves Family continue to beneficially own a sufficient
number of Class B common shares, even if they beneficially own significantly less than 50% of our outstanding share capital, acting together,
they will be able to effectively control the outcome of all decisions at our shareholders&#8217; meetings.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Class A common shares eligible for future sale may cause the market price of our Class A common shares to drop significantly. </i>The
market price of our Class A common shares may decline as a result of sales of a large number of our Class A common shares in the market
(including Class A common shares issuable upon conversion of Class B common shares) or the perception that these sales may occur, including
by our controlling shareholder.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>There can be no assurance that we will not be a passive foreign investment company, or PFIC, for any taxable year, which could
subject United States investors in our Class A common shares to significant adverse U.S. federal income tax consequences. </i>Based on
the composition of our income and assets and the value of our assets, including goodwill (the implied value of which we estimate based
on the price of our Class A common shares), we believe that we were not a PFIC for the taxable year of 2025. However, because we hold
a substantial amount of cash (relative to the assets shown on our balance sheet) and because our PFIC status for any taxable year will depend on the composition
of our income and assets and the value of our assets from time to time (which may be determined, in part, by reference to the market price
of our Class A common shares, which could be volatile), there can be no assurance that we will not be a PFIC for any taxable year.</td></tr></table>


<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Certain Risks Relating to Our Business and Industry</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk133227670"></span><span id="a_Hlk159335414"></span><span id="a_Hlk161835801"></span><span id="a_Hlk159432557"></span>We
face significant competition in the provision of our educational services. If our competition increases or if we fail to compete efficiently,
we may lose market share, and our profitability may be adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk159432536"></span>We compete with various
public and private post-secondary education institutions, including distance learning institutions, and we expect existing competitors
and new entrants to revise and improve their business models constantly in response to challenges from competing businesses, including
ours. Our competitors may offer programs or courses similar to or better than those offered by us, have access to more funds, be more
prestigious or well-regarded within the academic community, have more conveniently located campuses with better infrastructure, introduce
new or improved delivery of online education and technology-enabled services that we cannot match or exceed in a timely or cost-effective
manner, or charge lower tuition. In any of these cases, our ability to grow our revenue and achieve profitability could be compromised.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Particularly with our Continuing Education segment,
we have recently experienced increasing competition from traditional education institutions that previously had been limited to providing
undergraduate courses and have since begun to offer graduate programs. Increased competition in the graduate program landscape within
our Continuing Education segment may result in pricing pressure for us in terms of the percentage of tuition and fees we are able to negotiate.
The competitive landscape may also result in longer and more complex sales cycles with prospective students or a decrease in our market
share, any of which could negatively affect our revenue and future operating results and our ability to grow our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For our Undergraduate segment, the expansion of medicine
courses in Brazil is subject to restrictive requirements under the <i>Mais M&#233;dicos</i> program. Among the criteria considered in
the authorization process, two relevant aspects are (i) the social need of these new openings in a specified medical region, and (ii)
the sufficiency of the current medical infrastructure in both public regional hospitals and in the applicant medical institution in order
to obtain government authorization, particularly with respect to the availability of public hospital beds within Brazil&#8217;s Unified
Health System (<i>Sistema &#218;nico de Sa&#250;de</i>, or SUS) for medical practice scenarios.<span id="a_Hlk156484495"></span> MEC has,
from time to time, restricted, suspended and revised the authorization of new medical education courses, and the regulatory framework
governing the opening of new medical courses has also been subject to constitutional review before the Brazilian Supreme Court, underscoring
the evolving and uncertain nature of the applicable regulatory framework.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Although the Brazilian Supreme Court has upheld the
core requirements of the <i>Mais M&#233;dicos</i> program, certain market participants have challenged these restrictions before Brazilian
courts and have sought court orders compelling MEC to receive and administratively review applications for new medical courses and increases
in medical school seats. Such applications continue to be considered within a regulatory framework that remains subject to administrative
discretion, judicial interpretation and future regulatory change.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, notwithstanding the restrictive federal
regulatory framework applicable to the authorization of new medical programs and the expansion of student seats, certain municipal higher
education institutions have, in practice, created and expanded medical courses outside of this framework. In particular, some municipal
institutions have offered medical programs without complying with the authorization procedures of MEC, including the federal public call
process required under applicable law, and have unilaterally determined the number of seats offered. In certain cases, these institutions
have also expanded their operations beyond the territorial limits of their founding municipalities and have charged tuition fees, effectively
operating in a manner similar to private institutions while remaining subject to a different regulatory regime. This practice has been
challenged in Brazilian courts on the grounds that it may undermine the coordinated federal system for medical education and the allocation
of healthcare resources under SUS, as well as create competitive distortions in relation to private institutions subject to federal oversight.
As a result, these dynamics may allow certain market participants to expand more rapidly or at lower regulatory cost than institutions
subject to the federal framework, potentially placing us at a competitive disadvantage in affected regions and segments.</p>


<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, with the publication on September 26,
2025 of MEC Notice No. 15/2025 (&#8220;Notice 15/2025&#8221;), which amended MEC Notice No. 5/2024 and is aimed at the accreditation of
higher education institutions maintained by hospital units, hospitals and community based higher education institutions became eligible
to apply for accreditation to open medical degree programs under more flexible criteria than those traditionally applicable to private
educational institutions, including with respect to medical residency requirements and minimum public health system bed ratios per student
seat.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">This judicial or regulatory flexibility may result
in competitive disparities and give rise to legal challenges based on unequal regulatory treatment in the authorization process for new
medical degree programs. While most private institutions remain subject to stringent requirements, hospitals and community-based institutions
are subject to more lenient criteria, which may facilitate their entry into and accelerated expansion within the educational market.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 21.3pt">As a result, we may face increased competitive pressure,
which could directly affect our ability to attract students, maintain operating margins, and sustain our competitive position in the sector.
We cannot assure you that we will be able to compete successfully against our current or future competitors. If we are unable to maintain
our competitive position or otherwise respond to competitive pressures effectively, we may lose our market share, our profits may decrease
and we may be adversely affected. Given that a substantial portion of our revenues derives from tuition fees of medical education programs,
increased competition in these programs could materially impact our revenue growth and margins.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For more information, see &#8220;Item 4. Information
on the Company&#8212;Business Overview&#8212;Regulatory Overview.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may not be able to update, improve or offer our educational
content, digital products and services in a timely or cost-effective manner, including in response to rapid technological changes such
as the increasing adoption of artificial intelligence, which may materially and adversely affect our ability to attract and retain students,
users and customers.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">To differentiate ourselves and remain competitive,
we must continually update our courses, medical education content, digital platforms and technology-enabled solutions and develop new
educational programs, products and services across our Undergraduate, Continuing Education and Medical Practice Solutions segments. This
includes incorporating new technologies and delivery models, such as artificial intelligence-enabled tools, digital learning platforms
and data-driven clinical solutions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Technological innovation in education and healthcare,
including the rapid development and adoption of artificial intelligence and generative AI technologies, is evolving quickly and may significantly
change how medical knowledge is created, accessed, delivered and applied. If we fail to anticipate, adapt to or effectively integrate
these technological developments into our offerings, our programs, content, products and services may become less competitive, less relevant
or obsolete. In addition, our competitors or new market entrants, including large technology companies or specialized AI providers, may
develop or deploy more advanced or cost-effective solutions that diminish the value of our offerings.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Furthermore, artificial intelligence technologies may
enable students, physicians and healthcare professionals to obtain educational content, clinical knowledge or professional support through
alternative platforms, tools or automated systems that do not rely on our educational programs or digital solutions. As a result, demand
for certain of our courses, content libraries, clinical decision tools or other products and services could decline.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, updates to our current programs or the
development of new products and services may not be readily accepted by our students, users or customers, or by the market. If we do not
adequately modify our offerings in response to technological developments or evolving market demand, whether due to financial restrictions,
unusual technological changes or other factors, or if our target audiences do not respond positively to our innovations, our ability to
attract and retain students, users and customers may be impaired, which could materially and adversely affect our business, financial
condition, results of operations and prospects.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">If we are not able to attract and retain students, users
and customers across our ecosystem, or are unable to do so without decreasing our tuition fees or pricing of our products and services,
our revenues may decline.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The success of our business depends primarily on our
ability to attract, engage and retain learners, users and customers across our ecosystem, including students enrolled in our undergraduate
and continuing education programs, as well as physicians and other healthcare professionals who use
or subscribe to our medical practice solutions. Our ability to do so depends mainly on the tuition fees we charge for our educational
programs, the pricing and perceived value of our digital products and services, the quality and reputation of our offerings, the effectiveness
of our technology platforms, and the convenience and accessibility of our physical and digital infrastructure. These factors are affected
by, among other things, our ability to (i)&#160;respond to increasing competitive pressures, (ii)&#160;develop our educational systems
and technology platforms to address evolving market trends and the needs of students, physicians and healthcare stakeholders, (iii)&#160;develop
new programs, content, and digital solutions and enhance existing offerings, (iv)&#160;adequately prepare our students for careers in
their chosen professional occupations and provide relevant tools and content that support physicians and healthcare professionals in their
clinical and professional activities, (v)&#160;successfully implement our expansion strategy, (vi)&#160;manage our growth while maintaining
the quality, reliability and relevance of our products and services, and (vii)&#160;effectively market and distribute our offerings to
a broader base of prospective students, physicians and institutional partners.</p>


<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If we are unable to continue to attract new students
to enroll in our programs, retain our current students, expand and maintain our base of physician users and subscribers, or sustain demand
for our products and services without significantly decreasing tuition fees or pricing, for example as a result of changes in student
or user preferences, technological shifts, increased competition, or economic uncertainty or volatility, our revenues and our business
may decline and we may be adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If we fail to maintain the quality of our educational
programs or digital medical solutions, our reputation, student enrollment, user engagement, and financial performance may suffer. The
perceived quality of our medical education programs, including residency preparation, specialization test preparation and graduate courses
within our Continuing Education segment, as well as the quality, accuracy and usefulness of our medical practice solutions, is critical
to attracting and retaining students and physician users. Any decline in academic standards, deficiencies in faculty expertise, ineffective
curriculum design, technological limitations, inaccurate or outdated medical content, inadequate infrastructure, or failure to adapt to
evolving industry and regulatory requirements could diminish our competitive position. Additionally, as we expand our offerings and delivery
methods, including digital and in-person content and technology-enabled solutions for healthcare professionals, ensuring consistency,
reliability and effectiveness across platforms is essential. Negative student and user outcomes, such as lower test pass rates or dissatisfaction
with educational quality, reduced clinical utility of our digital tools or decreased engagement from physicians and healthcare partners,
could also harm our reputation and reduce demand for our offerings. If we are unable to sustain high-quality products and services across
our ecosystem, demand may decline, adversely impacting our revenues, growth prospects, and overall business.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may be adversely affected if the government changes
its investment strategy in education.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">According to Brazilian Federal Law No. 9,394/1996,
as amended, providing education is a duty of the government and of the family, and private education is permitted subject to the terms
set forth by the Brazilian Constitution and applicable laws and regulations. Certain public institutions may have certain competitive
advantages over us in the admissions process, as they do not charge tuition fees and may be perceived as more prestigious than private
institutions. However, the highly limited number of available positions and the intensely competitive nature of the admission process
to public institutions significantly restrict student access to these institutions. Nevertheless, the Brazilian government may implement
policy changes that heighten the competition by (i)&#160;increasing public investment in primary and post-secondary education, expanding
the number of federal institutions, expanding available positions and enhancing the quality of education provided by public institutions;
and (ii)&#160;reallocating resources from centers of excellence and research to public post-secondary education institutions. Additionally,
the introduction or expansion of affirmative action admission policies by federal and state institutions, based on socioeconomic status,
race or ethnicity, could also further intensify competition in the industry. While, as of the date of this annual report, we are not aware
of any enacted legislation or consolidated policy changes that would significantly reduce the competitiveness of private education institutions,
discussions regarding public budgets, funding mechanisms and long-term investment plans for the education sector are ongoing and could
be implemented in the future. Any significant policy change that increases the level of public investment in education, expands the availability
of tuition-free school positions, or otherwise enhances the competitiveness of public education institutions could adversely affect us.</p>


<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk221125387"></span> Changes to the rules, judicial
interpretations, administrative decisions or delays or suspension of tuition payments made through FIES may adversely affect our cash
flows and our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Some of our students finance their tuition fees through
the Higher Education Student Financing Fund (<i>Fundo de Financiamento ao Estudante do Ensino Superior</i>, or FIES) created by the Brazilian
federal government and currently operated by Caixa Econ&#244;mica Federal, a government controlled financial institution with administrative
and operational autonomy, in coordination with the National Fund for Educational Development (<i>Fundo Nacional de Desenvolvimento da
Educa&#231;&#227;o</i>, or FNDE), which offers financing to low-income students enrolled in undergraduate programs in private higher
education institutions. As of the date of this annual report, we have adhered to FIES as most recently amended by the Brazilian federal
government. As revised, FIES provides financial support for low-income students throughout Brazil, in particular in the North, Northeast
and Midwest regions. As a result, we have exposure to risks associated with delays in the transfer of monthly tuition payments from the
FIES program, and with potential default or nonpayment by the Brazilian federal government.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The financing is provided by federal government funds
and contributions from Higher Education Institutions, or HEIs, through the Fundo Garantidor do FIES, or FG-FIES fund. If the FG-FIES fund
becomes insufficiently funded, the federal government may implement measures to preserve its solvency, including increasing the retention
of tuition receivables from participating institutions, reducing the availability of FIES financing, or limiting the scope or timing of
guarantee payments. Any increase in retention levels would reduce our operating cash flows and liquidity, any reduction in FIES availability
could limit student enrollment and growth, and any limitations or delays in FG-FIES guarantee payments would increase our exposure to
student default, each of which could adversely affect our financial condition and results of operations. Should (i) the Brazilian federal
government terminate, suspend, reduce, delay the transfer of monthly payments to our institutions that participate in FIES, or fail to
honor its payment obligations under FIES or other public student financing programs, (ii) we fail to meet the requirements for participation
in the program, or our students benefiting from FIES fail to meet the requirements for enrollment in the program, (iii) the Brazilian
federal government extend the term to make reimbursements under FIES or adversely change its rules, (iv) administrative decisions by Caixa
Econ&#244;mica Federal in the exercise of its operational autonomy result in stricter interpretations, processing delays or changes in
operational procedures, or (v) judicial proceedings, court rulings or other judicial interpretations affect the application of FIES rules,
eligibility criteria, reimbursement mechanisms or the interpretation of regulatory requirements, our results of operations, cash flow
and liquidity may be materially adversely affected. We may also experience a decline in revenues, an increase in accounts receivable,
and a reduction in the number of students at our campuses from the FIES program.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, future changes to the rules to renew FIES
contracts, as well as the shutdown of the system to enter into new student financing agreements, adverse judicial or administrative developments
relating to the program, or delays and defaults in government payments may negatively affect the number of students enrolled in our courses,
the timing and certainty of tuition fee collections, and consequently cause a material reduction in our revenues and cash flow. For more
information regarding the changes to FIES contracts, see &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Regulatory
Overview.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk222266437"></span>The taxation system in Brazil
may undergo significant changes, including as a result of the upcoming tax reform bill, potentially leading to material changes in the
taxation of our products and services that could adversely affect our results of operations and financial condition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Taxation in Brazil is complex, with a myriad of regulations,
exemptions, and amendments, that make it challenging for businesses to navigate and anticipate their tax obligations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As part of a broad tax reform effort, Constitutional
Amendment Proposal No. 45/2020 was approved and subsequently promulgated in Constitutional Amendment No. 132, on December 20, 2023, which
proposes a new tax to substitute the Social Contribution Tax on Gross Revenue (<i>Programa de Integra&#231;&#227;o Social</i>, or
PIS), and the Social Security Financing Tax on Gross Revenue (<i>Contribui&#231;&#227;o para o Financiamento da Seguridade Social</i>,
or COFINS), (and other state and municipal taxes). In an effort to implement Constitutional Amendment No. 132, the Brazilian government
enacted Complementary Law No. 214/2025 on January 16, 2025, sanctioning Complementary Bill No. 68/2024. This law introduced the Goods
and Services Tax (<i>Imposto sobre Bens e Servi&#231;os</i>, or IBS), the Social Contribution on Goods and Services (<i>Contribui&#231;&#227;o
Social sobre Bens e Servi&#231;os</i>, or CBS), and the Selective Tax (<i>Imposto Seletivo</i>, or IS).</p>


<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The CBS replaces PIS and COFINS as part of a broader
tax reform. Notably, the CBS maintains a zero rate for educational institutions participating in the PROUNI program, preserving the related
tax benefits.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, regarding the IBS, which replaces the
current Service Tax (ISS), a 60% reduction in the applicable rate for the education sector has been granted. However, the final rate still
depends on regulation by the States and Municipalities, with a reference percentage estimated at 17.7%. It is worth noting that the current
average ISS rate is 3%, which could impact the institution&#8217;s overall tax burden.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Any increase in tax rates could elevate the cost of
our products and services, thereby reducing profitability if we could not timely pass these adjustments on to consumers. On the other
hand, a decrease in tax rates might positively impact margins, but could also lead to intensified competition as other market players
might adjust their own pricing strategies. The effects of these proposed tax reform and any other changes that result from the enactment
of additional tax reforms have not been, and cannot be, quantified. However, some of these measures, if enacted, may result in increases
in our overall tax burden, which could negatively affect our overall financial performance.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, Brazil has implemented the OECD Pillar Two
global minimum tax regime through the enactment of Law No. 15,079/2024, which became effective in 2025. This regime introduces further
uncertainty regarding our future effective tax rate and tax cash outflows. In particular, the treatment of PROUNI-related tax benefits
under Pillar Two rules may materially affect us. During 2025, we pursued judicial measures and engaged in discussions with the Brazilian
Federal Revenue Service (<i>Receita Federal do Brasil</i>), members of Congress, and relevant parliamentary bodies to support legislative
initiatives that would allow PROUNI-related tax benefits to be treated as qualified refundable tax credits for Pillar Two purposes. If
these efforts are unsuccessful, we may remain subject to the additional Social Contribution on Net Income Tax (<i>Contribui&#231;&#227;o
Social sobre o Lucro L&#237;quido</i>, or CSLL), which could materially and adversely impact our business, results of operations, and
financial condition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Furthermore, because the Pillar Two regime applies
only to multinational enterprise groups that meet certain revenue thresholds and other eligibility criteria under the OECD framework,
it does not apply uniformly to all higher education institutions operating in Brazil. As a result, certain institutions, particularly
those that are not subject to Pillar Two rules due to their size, ownership structure or tax profile, may continue to benefit from tax
incentives, including those related to PROUNI, without being subject to the same minimum tax constraints. Consequently, such institutions
may operate with lower effective tax burdens than ours, which may enable them to allocate greater resources to pricing strategies, marketing
initiatives, infrastructure expansion or other investments. This regulatory asymmetry could adversely affect our competitive position,
margins and ability to invest in growth.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">At the end of 2025, Brazil approved changes to its
income tax legislation to introduce withholding income tax on dividends distributed by Brazilian companies to individual shareholders
and to reinstate taxation on dividends remitted to non-resident entities abroad, in each case effective as of January 1, 2026. A 10% withholding
tax will apply to cross-border dividends, regardless of the amount<span style="color: #0A0A0A">.</span> Although this withholding tax
does not currently apply to dividends paid to legal entities in Brazil, the introduction of dividend taxation represents a material change
to Brazil&#8217;s prior tax framework and may reduce the net returns received by us from our Brazilian subsidiaries and consequently by
our shareholders, which could influence corporate distribution practices and capital allocation decisions and may expose us to additional
tax burdens or adverse impacts on our financial condition should further changes to the dividend tax regime be enacted.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">If we lose the benefits of federal tax exemptions provided
under the PROUNI program, our business, financial condition and results of operations may be materially adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Some of our students participate in the University
for All Program <i>(Programa Universidade para Todos,</i> or PROUNI program). Through the PROUNI program, the Brazilian federal government
grants a number of full and partial scholarships to low-income undergraduate students in private higher education institutions. As a result
of our participation in the PROUNI program, we benefit from certain federal tax exemptions relating to undergraduate&#8217;s and associate&#8217;s
degree programs, such as (i)&#160;income tax, (ii)&#160;PIS, (iii)&#160;COFINS, and (iv) CSLL, regarding our revenues from undergraduate
and associate programs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We may be disqualified from the PROUNI program and
lose our tax exemptions if we do not comply with certain requirements, such as providing total or partial scholarships for low-income
students eligible for the program, and submitting to MEC semi-annual records of attendance, achievement and dropout of students receiving
scholarships, among others. See &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Regulatory Overview.&#8221; If we lose our tax exemptions or are unable to comply with
other, more stringent requirements that may be introduced in the future, our business, financial condition and results of operations could
be materially adversely affected.</p>


<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">There is a risk that additional changes in tax laws
may prohibit, interrupt or modify the use of existing tax exemptions, and we cannot assure you that we will fully maintain such tax and
other benefits related to PROUNI in the event the tax laws are amended further. Future regulatory developments or additional legislative
changes could still impact the tax benefits available to us under the PROUNI program. Any suspension, accelerated default, repayment or
inability to renew our tax exemptions may have an adverse effect on our results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If we lose our tax exemptions, have our tax incentives
significantly reduced, become unable to comply with future requirements, or if changes in law limit our ability to maintain these tax
benefits, our business, financial condition and results of operations may be significantly and adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Any change or review of the tax treatment of our activities,
or the loss or reduction in tax benefits on the sale of books (including digital content) may materially adversely affect us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian Federal Constitution, in Article 150,
grants tax immunity for activities related to the production, sale, and resale of books. In this sense, this activity performed within
our Continuing Education segment is not taxed by the federal VAT (tax on industrial activity, or &#8220;IPI&#8221;), the state VAT (tax
on sale or resale of products, or &#8220;ICMS&#8221;) and the municipal VAT (tax on services, or &#8220;ISS&#8221;). According to Brazilian
federal law No. 10,865/2004, the Company also benefited from a zero-tax rate on Federal Social Contributions, PIS and COFINS, which are
calculated on gross revenue.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The tax reform ensured tax immunity for the taxes provided
for in Article 150 of the Federal Constitution, applying exclusively to the IBS. However, no differentiated provisions were established
regarding the CBS. Nevertheless, infra-constitutional legislation, particularly Complementary Law No. 214/2025, included the CBS within
the scope of the immunity granted by Article 150 of the Federal Constitution, as stated in its Article 9.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If the Brazilian government or tax authority or the
Brazilian superior courts decide to change or review the tax treatment for the production or sales of books (including digital books and
e-readers), and we are unable to pass any cost increase onto our students, our results may be materially adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk221101970"></span>We may be held liable for
extraordinary events that may occur at our campuses, which may have an adverse effect on our image and, consequently, our results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We may be held liable for the actions or omissions
of officers, directors, professors or other employees at our campuses, including allegations of non-compliance with MEC legislation and
regulations. Accidents, injuries or other damages, affecting students, professors, other employees, or third parties at our campuses could
lead to claims of negligence, inadequate supervision, or other liability. Injuries could be caused by or arise from the actions or negligence
of our students, employees, contractors or visitors on our premises, including due to failures in our access control and security systems
or infrastructure issues. If any such event occurs, our facilities may be perceived as unsafe, potentially deterring students from enrolling
or attending our schools. We may also face claims alleging that officers, directors, professors or other employees committed moral or
sexual harassment or other unlawful acts, and we may be subject to legal proceedings by current and/or former employees alleging breaches
of applicable labor laws. Even if unsuccessful, these claims may cause negative publicity, reduce enrollment numbers, increase student
attrition rates, entail substantial expenses and divert the time and attention of our management, materially adversely affecting our results
of operations and financial condition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, we operate clinics, outpatient facilities,
and laboratories where physicians and students perform procedures. Non-compliance with health and safety standards, regulations, and laws
can result in serious consequences, including death or physical injury to physicians, students, patients and other persons on our premises.
We cannot assure you that we will be at all times able to comply with all such regulations or guarantee the safety of all persons on our
premises, including patients.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, infrastructure vulnerabilities can
lead to adverse events with significant impacts on our reputation to the extent that they may expose students, staff and faculty to
physical injury. As of the date of this annual report, we operate a large number of campuses and facilities across multiple regions
in Brazil. The operation and maintenance of a geographically dispersed network of physical facilities present ongoing operational
challenges. Although we have procedures designed to promote the proper maintenance,
conservation and safety of our facilities, and we conduct periodic inspections and maintenance activities, we cannot assure you that all
facilities will at all times be maintained in optimal condition or that safety practices will always be fully observed. From time to time,
certain facilities or specific areas within our campuses may require repairs, maintenance, temporary closure or other remedial actions
to address conservation or safety-related matters. Any failure to adequately maintain our facilities or comply with applicable safety
standards could result in operational disruptions, additional costs, regulatory scrutiny, reputational harm or potential liability.</p>


<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Extraordinary events may also temporarily disrupt the
operation of our campuses or limit the availability or use of classrooms, laboratories or other campus infrastructure. Such events may
include, for example, structural incidents affecting our facilities, fires, power outages, flooding or other infrastructure failures.
If any such events were to occur, we may be required to temporarily close classrooms or campus buildings, reduce our available physical
capacity, or reallocate students, classes and academic activities, particularly those requiring in person instruction such as laboratory
or practical training. These operational adjustments could disrupt the delivery of our programs and adversely affect our results of operations
and financial condition. See also &#8220;&#8212;Public health outbreaks, epidemics or pandemics have adversely affected and may continue
to adversely affect our business.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Certain of our campuses operate in properties that
are shared with or adjacent to facilities operated by independent third parties, including commercial establishments that share common
areas or infrastructure with our campuses. In some cases, these third-party operated facilities use names or branding that are associated
with our institutions. As a result, incidents, accidents or other adverse events occurring in such facilities, even if not operated or
controlled by us, may nevertheless be perceived by students, employees, regulators and the public as being connected to us, which could
materially harm our brand and reputation. In addition, engineering assessments relating to properties in which our campuses operate have
identified, or may in the future identify, structural risks affecting shared premises or infrastructure. Although we do not control all
portions of such properties, any structural failures, safety incidents or disruptions in shared or adjacent facilities could result in
operational interruptions, expose individuals to physical injury and adversely affect our reputation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If any such events were to occur, our reputation could
be materially and adversely affected, which could in turn have significant adverse effects on our results of operations and financial
condition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our insurance coverage may not cover certain indemnifications
we may be required to pay, be insufficient to cover these types of claims, or may not cover certain acts or events. We may also not be
able to renew our current insurance policies under the same terms. Such liability claims may affect our reputation and harm our financial
results. See &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Insurance.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We cannot guarantee that our suppliers will not engage
in improper practices, including inappropriate labor practices.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">To meet the needs of our students and offer greater
comfort and quality in all areas and aspects of our activities, we depend on service providers and suppliers for services such as cleaning,
surveillance, telemarketing and security. In the event that our service providers engage in such improper business practices, our customers&#8217;
perception of our business may be adversely affected, which may adversely affect our business, results of operations and our reputation.
For example, we may be adversely affected if these third-party service providers and suppliers do not meet their obligations under Brazilian
labor laws and with the obligations and guidelines established in our Code of Ethics and Conduct and also in our services agreements for
providers and suppliers, including with respect to supplying appropriate protective equipment or training to employees that are designated
to work on our premises. According to Brazilian labor law, we may be liable to the employees of these service providers and suppliers
for labor obligations of these service providers and suppliers to the extent such service providers and suppliers fail to indemnify such
employees pursuant to court orders, and we may also be fined by the relevant authorities. This risk is particularly relevant if these
suppliers are involved in sensitive labor issues, such as violations of human rights, discriminatory acts, child labor and direct or indirect
use of forced labor or modern slavery and for which we may be held liable in civil, labor, criminal and administrative proceedings, including
for damages and remediation costs. As a result, we may face difficulties in obtaining or maintaining operating licenses. Any such litigation
could impact our customers&#8217; perception of our business, and adverse decisions may compel us to disburse material amounts in connection
therewith, which may adversely affect our business, results of operations and our reputation.</p>


<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We are subject to anti-corruption, anti-bribery and anti-money
laundering laws and regulations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We operate in jurisdictions that have a high risk for
corruption and we are subject to various anti-corruption, anti-bribery and anti-money laundering laws and regulations, including the Brazilian
Federal Law No. 12,846/2013, also known as the Clean Company Act (and Decree No. 11,129/2022 that regulates the Clean Company Act), Brazilian
Federal Law No. 9,613/1998, as amended by Brazilian Federal Law No. 12,683/2012, and Brazilian Federal Law No. 8,429/1992, as amended
by Brazilian Federal Law No. 14,230/2022, in addition to the United States Foreign Corrupt Practices Act of 1977, as amended, or the FCPA.
Both the Clean Company Act and the FCPA impose liability against companies that engage in bribery of government officials, either directly
or through intermediaries.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Anti-corruption laws are interpreted broadly and prohibit
us and our collaborators from authorizing, offering, or directly or indirectly providing improper payments or benefits to recipients in
the public or private sector. Although we strongly condemn the practice of corruption and bribery by promoting a culture of ethics and
through our integrity program as provided for in our Code of Ethics and Conduct and Compliance, Anti-Corruption and Fraud Policy and in
the whistleblowing channel, we or our collaborators may have direct and indirect interactions with government agencies and state-affiliated
entities and universities in the course of our business. We use third-party collaborators, and strategic partners, law firms, and other
representatives for regulatory compliance, patent registration, deregulation advocacy, field testing, and other purposes. We can be held
liable for the corrupt or other illegal activities of these third-party collaborators, our employees, representatives, contractors, partners,
and agents, even if we do not explicitly authorize such activities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Anti-money laundering, anti-bribery, anti-corruption
and sanctions laws and regulations to which we are subject require us, among other things, to conduct full customer due diligence (including
sanctions and politically exposed person screening) and to keep our customer, account and transaction information up to date. We have
implemented and are in the process of reviewing our policies and procedures detailing what is required from those responsible, but all
such policies may not be completed or may not be fully in effect as of the date of this annual report (in particular, our policies relating
to sanctions laws and regulations). In addition, we rely heavily on our employees to assist us by spotting such illegal and improper activities
and reporting them, and our employees have varying degrees of experience in recognizing criminal tactics and understanding the level of
sophistication of criminal organizations. In addition, we rely upon our relevant counterparties to a large degree to maintain and appropriately
apply their own appropriate compliance measures, procedures and internal policies. Accordingly, there can be no assurance that all of
our employees, representatives, contractors, partners, or agents will comply with these laws at all times. If we are unable to apply the
necessary scrutiny and oversight of employees, third parties to whom we outsource certain tasks and processes or counterparties, we increase
the risk of regulatory breach.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Violations of, or even accusations of or associations
with violations of, anti-corruption, anti-bribery and anti-money laundering laws and regulations could result in criminal liability, administrative
and civil lawsuits, significant fines and penalties (including being added to &#8220;blacklists&#8221; that would prohibit certain parties
from engaging in transactions with us), forfeiture of significant assets and reputational harm. Non-compliance with these laws could subject
us to whistleblower complaints, investigations, sanctions, settlements, prosecution, injunctions, suspension and debarment from contracting
with certain governments or other persons, the loss of export privileges, reputational harm, adverse media coverage, and other collateral
consequences. If any subpoenas or investigations are launched, or governmental or other sanctions are imposed, or if we do not prevail
in any possible civil or criminal litigation, our business, results of operations, and financial condition could be materially harmed.
Such violations could also constitute an event of default under certain of our financing arrangements, including the loan agreement executed
with the International Finance Corporation (IFC) and instruments governing our book-entry commercial notes, which could result in the
acceleration of outstanding indebtedness and the obligation to immediately repay such amounts. Any such acceleration could materially
and adversely affect our liquidity, financial condition and results of operations. In addition, responding to any action will likely result
in a materially significant diversion of management&#8217;s attention and resources and significant defense costs and other professional
fees. Enforcement actions and sanctions could further harm our reputation, business, results of operations, and financial condition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If any person in the Cayman Islands knows or suspects,
or has reasonable grounds for knowing or suspecting that another person is engaged in criminal conduct or money laundering, or is involved
with terrorism or terrorist financing and property, and the information for that knowledge or suspicion came to their attention in the
course of business in the regulated sector, or other trade, profession, business or employment, the person will be required to report
such knowledge or suspicion to (i)&#160;the Financial Reporting Authority (&#8220;FRA&#8221;) of the Cayman Islands, pursuant to the Proceeds of Crime Act (As Revised) of the Cayman Islands,
if the disclosure relates to criminal conduct or money laundering, or (ii)&#160;a police officer of the rank of constable or higher, or
the FRA, pursuant to the Terrorism Act (As Revised) of the Cayman Islands, if the disclosure relates to involvement with terrorism or
terrorist financing and property. Such a report shall not be treated as a breach of confidence or of any restriction upon the disclosure
of information imposed by any enactment or otherwise.</p>


<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We are subject to the Economic Substance Regime in the
Cayman Islands.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Cayman Islands enacted the International Tax Co-operation
(Economic Substance) Act (As Revised) (the &#8220;Economic Substance Act&#8221;). The Economic Substance Act is supplemented by the issuance
of related Guidance on Economic Substance for Geographically Mobile Activities, version 3.2 of which was issued in July 2022. We are currently
subject to the Economic Substance Act. As we are a Cayman Islands exempted company, compliance obligations include filing annual notifications
for us, which need to state whether we are carrying out any relevant activities and, if so, whether we have satisfied economic substance
tests to the extent required under the Cayman Economic Substance Act. Given our business activities and operations may change from time
to time, it is difficult to predict if we will continue to be subject to the Economic Substance Act and the impact that the Economic Substance
Act could have on us and our subsidiaries. For example, compliance with any applicable obligations may create significant additional costs
that may be borne by us or otherwise affect our management and operation. We will continue to consider the implications of the Economic
Substance Act on our business activities and operations and reserve the right to adopt such arrangements as we deem necessary or desirable
to comply with any applicable requirements. Failure to satisfy these requirements may subject us to penalties under the Cayman Economic
Substance Act.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We are subject to environmental laws and regulations,
which may become more stringent in the future and increase our obligations and capital expenditures with respect to their compliance.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to several environmental laws and regulations
at the municipal, state and federal levels, and noncompliance may result in significant penalties and liabilities. Our operations are
subject to extensive environmental laws and regulations enforced by governmental agencies and regulatory bodies, which have the authority
to impose administrative, civil and criminal sanctions. Any violations of these laws and regulations could result in the imposition of
criminal and administrative sanctions, as well as civil liability, seeking redress for alleged environmental damages and damages to third
parties.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Environmental infractions may lead to administrative
sanctions, including, among other consequences, fines ranging from R$50 to R$50 million, the revocation of our licenses and authorizations,
or the temporary or permanent suspension of our activities. There is no statutory limit to the amount courts may award to cover the costs
of remediation in the case of civil liability or, if the environmental damage cannot be repaired, the payment of an indemnity. Additionally,
claims for environmental damages are not subject to a statute of limitations. The enactment of more stringent laws and regulations or
more stringent interpretations of existing laws and regulations may force us to increase our capital expenditures relating to environmental
compliance, therefore diverting funds from previously planned investments. These changes could have a material adverse effect on us. Governmental
agencies or other authorities may also significantly delay or deny the issuance of permits and authorizations required for our operations,
preventing us from making constructions and improvements at our campuses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, we have environmental compliance obligations
under the loan agreement executed with the International Finance Corporation (IFC) and under the issuance of book-entry commercial notes.
Any failure to comply with these obligations could trigger events of default, which may result in the acceleration of these financial
agreements, requiring us to make immediate repayments that could materially impact our financial condition. See &#8220;Item 5. Operating
and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8212;Indebtedness.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the improper disposal of solid waste,
as well as accidents during waste transportation could also result in administrative, civil and criminal penalties. Under the strict and
joint environmental liability framework, we may be held responsible for environmental damages caused by third parties hired for waste
collection, transportation and final disposal, even if we comply with contractual and regulatory obligations in outsourcing such services.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Furthermore, Brazilian Federal Law No. 8,501, enacted
on November 30, 1992, establishes regulations for the use of unclaimed cadavers for educational and scientific purposes by medical institutions.
Institutions must comply with the documentation and requirements established by the referred law.
Noncompliance with these regulations may result in administrative, civil, and criminal penalties, and reputational damage.</p>


<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We are subject to supervision by MEC and, consequently,
may suffer sanctions as a result of non-compliance with any regulatory requirements.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Brazilian Federal Law No. 10,861/2004, as regulated
by Decree No. 9,235/2017 and MEC Ordinance No. 378/2025 (New Regulatory Framework for Higher Education), implemented the activities of
supervision of post-secondary education entities and courses in the Brazilian federal education system, including distance learning programs.
MEC&#8217;s SERES is responsible for the regular and special supervision of the corresponding courses and programs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Regular supervision derives from complaints and allegations
by students, parents and faculty members, as well as by public entities and the press. These complaints and allegations involve specific
cases of entities with courses showing evidence of irregularities or deficiencies. We are subject to those complaints and representations.
Special supervision, on the other hand, may be commenced by MEC itself, based on its post-secondary education regularity and quality standards,
and involves more than one course or entity, grouped according to the criteria chosen for the special supervision.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Following the establishment of the National Medical
Education Assessment Examination (<i>Exame Nacional de Avalia&#231;&#227;o da Forma&#231;&#227;o M&#233;dica</i>, or &#8220;ENAMED&#8221;)
by MEC Ordinance No. 330/2025 and its regulation by INEP Ordinance No. 413/2025, the performance of medical degree programs has become
subject to monitoring based on students&#8217; results. Medical programs that demonstrate unsatisfactory performance may be subject to
special supervision by MEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, we are also subject to special supervision
in case of unsatisfactory results in the National Student Performance Exam (<i>Exame Nacional de Desempenho de Estudantes</i>, or ENADE)
and the Difference Indicator between Expected and Actual Performance <i>(Indicador de Diferen&#231;a entre os Desempenhos Observado
e Esperado),</i> among other quality indicators, the history of course evaluations by INEP, as well as compliance with specific legal
requirements as, for example, the minimum ratio between faculty members with master&#8217;s or doctorate degrees or certain mandatory
digitization requirements with respect to academic documents for our students under MEC&#8217;s recent digital academic collection rules.
Administrative irregularities can include, among others: (i)&#160;unlicensed or irregular post-secondary courses; (ii)&#160;any outsourcing
of post-secondary education activities; (iii)&#160;the failure to file a re-accreditation or recognition or renewal request with respect
to post-secondary education courses within the time periods enacted by MEC pursuant to Decree No. 9,235/2017; (iv)&#160;failure to comply
with the rules and requirements for maximum occupancy of authorized vacancies approved by MEC; and (v) failure to comply with any penalties
imposed by MEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If MEC concludes, as part of its supervisory activities,
that an irregularity constitutes an imminent risk or threat to students or the public interest, it may impose the following measures on
the relevant educational institution for a period to be determined by SERES: (i)&#160;suspend the admission of new students; (ii)&#160;suspend
the offering of undergraduate or graduate <i>lato sensu </i>courses; (iii)&#160;suspend the institution&#8217;s discretionary ability
to, among other things, create new post-secondary courses and establish course curricula, if applicable; (iv)&#160;suspend the license
to establish new distance learning programs; (v)&#160;override any ongoing regulatory requests filed by the institution and prohibit new
regulatory requests; (vi)&#160;suspend participation in FIES; (vii)&#160;suspend participation in PROUNI; and (viii)&#160;suspend or restrict
participation in other federal education programs. The educational institution can contest MEC&#8217;s findings by filing motions with
MEC or with Brazilian courts.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Upon completion of the supervisory process and to the
extent MEC concludes that there are administrative irregularities, SERES may apply the penalties provided for by Law No. 9,394/1996, namely
(i)&#160;discontinue courses; (ii)&#160;directly intervene in the educational institution; (iii)&#160;temporarily suspend the institution&#8217;s
discretionary ability to, among other things, create new post-secondary courses and establish course curricula, if applicable; (iv)&#160;disqualify
the institution as an educational institution; (v)&#160;reduce the number of student vacancies; (vi)&#160;temporarily suspend new student
enrollments; or (vii)&#160;temporarily suspend courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, we and our subsidiaries face the risk of
unintentionally surpassing MEC&#8217;s authorized medical or other enrollment limits due to court-mandated student enrollments, which
do not count towards our allocated enrollment limit. Inaccurate assessment of these judicial demands, such as misinterpreting obligations
like discounts as enrollments under litigation, may result in exceeding our authorized
enrollment limits. This breach by us, or by any of the companies that we have acquired or may acquire, could lead to regulatory penalties,
reputational harm, and strain our resources, compromising our educational quality.</p>


<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk221103842"></span>The post-secondary education
sector is highly regulated, and our failure to comply with existing or future laws and regulations could limit our ability to operate
medical programs, obtain new authorizations or accreditations, maintain our regulatory approvals, or obtain re-accreditations, which could
materially impact our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to various federal laws and extensive
government regulations by MEC, <i>Conselho Nacional de Educa&#231;&#227;o</i> (National Education Council, or CNE), INEP, FIES and
the National Post-secondary Education Assessment Commission <i>(Comiss&#227;o Nacional de Avalia&#231;&#227;o da Educa&#231;&#227;o
Superior,</i> or CONAES), among others, including, but not limited to the <i>Mais M&#233;dicos Law</i>, which created the <i>Mais M&#233;dicos</i>
program.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Regulatory requirements applicable to different types
of post-secondary education institutions affect our ability to create or expand programs, particularly in medicine and other health sciences,
which require prior MEC approval.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">All accredited educational institutions require the
prior approval of MEC to create campuses outside their headquarters. All post-secondary education programs must be recognized by MEC as
a requirement, together with registration of the program, to validate the diplomas issued by them. However, pursuant to Article 101 of
Ordinance No. 23/2017 of MEC, issued diplomas may be valid even if the program is not formally recognized by MEC, so long as the educational
institution has filed the request with MEC to certify the program, and the request is pending formal review and approval by MEC. As a
result, any failure to comply with legal and regulatory requirements by post-secondary education entities may result in the imposition
of sanctions by MEC, as well as damage to the program&#8217;s reputation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">MEC must authorize our campuses located outside our
headquarters before they can start their operations and programs. For further information, see &#8220;Item 4. Information on the Company&#8212;Business
Overview&#8212;Regulatory Overview.&#8221; Distance learning programs, as well as on-campus learning, are also subject to strict accreditation
requirements for their implementation and operation. We must comply with all such requirements in order to obtain and renew all authorizations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We cannot assure you we will be able to comply with
these regulations and maintain the validity of our authorizations, enrollments and accreditations in the future. If we fail to comply
with these regulatory requirements, MEC could place limitations on our operations, including cancellation of programs, reduction in the
number of positions we offer to students, termination of our ability to issue degrees and certificates and revocation of our accreditation.
Given that a substantial portion of our revenues derives from regulated medical programs, any MEC-imposed restriction could materially
impact our financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We cannot assure you that we will obtain accreditation
or re-accreditation of our post-secondary education institutions, or that our courses will receive authorization or the renewal of prior
authorizations as scheduled, or that they will have all of the accreditations, re-accreditations, authorizations and the renewal of prior
authorizations required by MEC. The absence of such accreditations and authorizations from MEC or any delays in obtaining them could adversely
affect our financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, we may also be adversely affected by any
changes in the laws and regulations applicable to post-secondary education institutions, particularly by changes related to: (i)&#160;any
revocation of accreditation of private educational institutions; (ii)&#160;the imposition of controls on monthly tuition payments or restrictions
on the profitability of private educational institutions; (iii)&#160;faculty credentials; (iv)&#160;academic requirements for courses
and curricula; (v)&#160;infrastructure requirements of campuses, such as libraries, laboratories and administrative support; (vi)&#160;the
<i>Mais M&#233;dicos</i> program; (vii) the imposition of new regulatory controls applicable to postgraduate programs, including the
imposition of enrollment caps; and (viii)&#160;the promulgation by MEC of new rules and regulations affecting post-secondary education,
including with respect to distance learning programs. For example, Technical Note No. 5/2025 issued by MEC in August 2025 restricts the
use of remaining or unfilled seats for first-year undergraduate admissions, limiting our ability to offset student attrition through additional
freshman enrollment. As a result, we may experience reduced enrollment levels and tuition revenues, which could materially and adversely
affect our business, financial condition and results of operations.</p>


<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We may be materially adversely affected if we are unable
to obtain these authorizations, accreditations, course recognitions, or to comply with changes in the laws and regulations in a timely
manner, if we cannot introduce new courses as quickly as our competitors, if we are not able to or do not comply with any new rules or
regulations promulgated by MEC, or if laws and regulations are passed adverse to the business and operations of post-secondary education
institutions.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk221142156"></span>If we or our students are
not able to maintain satisfactory MEC evaluation ratings, we may be adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We and our students are regularly evaluated and rated
by MEC. If our campuses, programs or students receive unsatisfactory scores in any of their evaluations, including the IGC <i>(&#205;ndice
Geral de Cursos),</i> the ENADE and the ENAMED, we may be subject not only to a reduction in enrollments and adverse perceptions regarding
the quality of our educational services, but also to supervisory measures and progressive regulatory sanctions imposed by MEC and SERES.
Such measures may include, among others, restrictions on the expansion of authorized enrollment capacity, limitations on the opening of
new courses or campuses, suspension of new FIES contracts, suspension or restriction of participation in the PROUNI program, the reduction
in the number of approved seats, as well as suspension or limitation of access to other federal educational programs and incentives. Any
of these measures, individually or in the aggregate, could materially and adversely affect our reputation and, consequently, our results
of operations and financial condition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">ENAMED results are used as a reference for public policy
initiatives and for medical residency selection processes, such as the National Medical Residency Examination (<i>Exame Nacional de Resid&#234;ncia</i>,
or ENARE). Unsatisfactory performance, defined as scores of 1 or 2 on a scale of 1 to 5, may harm the academic reputation of our medical
programs, reduce their attractiveness to prospective students, and adversely affect the placement of our graduates in competitive medical
residency programs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In the event that any of our programs receive unsatisfactory
evaluations, the post-secondary education institution offering the programs may be subject to an administrative supervisory proceeding
by MEC. Depending on the level of student proficiency and the outcome of such proceedings, precautionary measures may be imposed, including,
among others, suspension of new student admissions, reduction in the number of approved seats, prohibition on increasing the number of
seats, suspension of participation in FIES and in PROUNI, and additional evaluations under other federal education programs. For example,
in the first cycle of the ENAMED, conducted in 2025, certain of our medical programs received a score of 2, which is considered below
average under the MEC evaluation scale. The results of this first ENAMED cycle were publicly released by MEC on January 19, 2026, and
on March 16, 2026, through SERES, MEC issued administrative orders initiating supervisory proceedings against medical programs that received
such scores.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a result, certain of our medical programs became
subject to supervisory proceedings and, in certain cases, precautionary measures. Such measures were implemented after the enrollment
period for the first academic semester of 2026, and, therefore, are not expected to have a material impact on our 2026 results. If we
are unable to improve the performance of our programs in future ENAMED evaluation cycles or to reverse or mitigate these measures, we
may become subject to more severe regulatory sanctions or to the continued application of existing measures, which, in each case, could
materially and adversely affect our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Furthermore, negative perceptions regarding the quality
of our programs could adversely affect our position in the educational market, reduce enrollment demand, and impair our financial sustainability.
The quality of our academic curricula is a key element of the education we provide. We cannot assure you that the academic curricula developed
for new programs will meet the standards established by the MEC, and any failure to meet such standards could adversely affect our reputation,
student demand, and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, legislative initiatives may introduce
further performance-based mechanisms affecting medical education providers. For example, Bill No. 2,294/2024, proposes the creation of
a mandatory National Medical Proficiency Examination (&#8220;PROFIMED&#8221;) as a condition for newly graduated physicians to obtain
professional registration in Brazil. The bill remains under review by the Brazilian Federal Senate, and its final approval, implementation
timeline and regulatory framework remain uncertain. If enacted, the proposed examination would establish a standardized nationwide assessment
of medical graduates and could become an additional public metric of academic quality and institutional performance.</p>


<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If PROFIMED is implemented, institutions whose students
demonstrate lower approval rates may experience reputational harm, reduced demand from prospective students, increased attrition, or enhanced
regulatory scrutiny. Moreover, lower graduate approval rates could negatively affect perceptions regarding employability and professional
readiness, which are key determinants of enrollment decisions. Any of these developments could adversely affect our student enrollment
levels, competitive position, results of operations and financial condition.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may face restrictions and penalties under the Brazilian
Consumer Protection Code in the future.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil has a series of strict consumer protection laws,
referred to as the Consumer Protection Code <i>(C&#243;digo de Defesa do Consumidor).</i> These laws apply to all companies in Brazil
that supply products or services to Brazilian consumers, including us. They include protection against misleading and deceptive advertising,
coercive or unfair business practices and issues in the formation and interpretation of contracts, usually in the form of civil liabilities
and administrative penalties for violations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">These penalties are often levied by the Brazilian Consumer
Protection Agencies <i>(Funda&#231;&#227;o de Prote&#231;&#227;o e Defesa do Consumidor,</i> or PROCONs), which oversee consumer
issues on a district-by-district basis. Companies operating across Brazil may face penalties from multiple PROCONs, as well as from the
National Secretariat for Consumers <i>(Secretaria Nacional do Consumidor</i>, or SENACON). Companies may settle claims made by consumers
via PROCONs by paying compensation for violations directly to consumers and through a conduct adjustment agreement <i>(Termo de Ajustamento
de Conduta,</i> or TAC).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Brazilian public prosecutors may also commence investigations
of alleged violations of consumer rights and require companies to enter into TACs. Companies that violate TACs face potential enforcement
proceedings and other potential penalties such as fines, as set forth in the relevant TAC. Brazilian public prosecutors may also file
public civil actions against companies who violate consumer rights or competition rules, seeking strict adherence to consumer protection
laws and compensation for any damages to consumers. In certain cases, we may also face investigations and/or sanctions by the CADE, in
the event our business practices are found to affect the competitiveness of the markets in which we operate or the consumers in such markets.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We may also be subject to legal proceedings by current
and/or former students alleging breaches of rights granted by the Brazilian Consumer Protection Code that<i>, </i>even if unsuccessful,
may cause negative publicity, reduce enrollment numbers, increase student attrition rates, entail substantial expenses and divert the
time and attention of our management, materially adversely affecting our results of operations and financial condition.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Government agencies, MEC, ANVISA (Brazilian Health Agency),
and third parties may conduct inspections, file administrative proceedings or initiate litigation against us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Because we operate in a highly regulated industry,
government agencies, MEC, ANVISA (Brazilian Health Agency)&#160;or third parties may conduct inspections, file administrative proceedings
or initiate litigation for non-compliance with regulations against us or the institutions we purchase. If the results of these proceedings
or litigations are unfavorable to us, or if we are unable to successfully defend our cases, we may be required to pay monetary damages
or be subject to fines, limitations, injunctions or other penalties. Even if we adequately address issues raised by an inspection conducted
by an agency or successfully defend our case in an administrative proceeding or court action, we may have to set aside significant financial
and management resources to settle issues raised by these proceedings or to those lawsuits or claims. Administrative proceedings or court
actions brought against us may damage our reputation, even if such lawsuits or claims are without merit.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Failure to obtain or maintain licenses and permits with
respect to our real estate or construction projects in a timely manner may result in penalties, including closures of some of our campuses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The use of all our buildings, including operational
and administrative facilities, is contingent upon the successful issuance of an occupancy permit <i>(Habite-se)</i> or an equivalent certificate
issued by the municipality where the property is located, certifying that the building was constructed in compliance with applicable zoning
and municipal regulations. Additionally, non-residential properties must obtain a use and operations license and/or permit from the relevant
municipality, as well as a fire department inspection certificate, issued by the fire department, before regular use.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are currently in the process of obtaining and/or
renewing these licenses for some of the real estate we use. The absence of such licenses may result in penalties ranging from fines to
the forced demolition of non-compliant areas or, in the worst-case scenario, the temporary or permanent closure
of the campus or branch lacking the licenses and permits. This could occur if the relevant penalties and fines are not paid, and the licenses
and permits are not obtained following notifications from the relevant authorities. Any imposed penalties, particularly the forced closure
of any of our campuses or branches, could have a material adverse effect on our business. Furthermore, in the event of any accident at
our campuses or branches, the lack of such licenses could result in civil and criminal liability, and the cancellation of insurance policies,
if any for the respective campus or branch and could damage our reputation.</p>


<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, we routinely undertake complex construction,
expansion and renovation projects at our campuses, which require additional construction licenses and permits, including environmental
licenses for such projects. Failure to obtain or maintain these licenses or permits during these projects may lead to delays to or additional
costs (including fines or other penalties imposed by governmental authorities), as well as material adverse effects on our results of
operations, financial condition, and reputation.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span style="background-color: white">Failure to provide
a high-quality customer experience may adversely affect us.</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Customer experience is fundamental to our success.
Meeting high-quality standards in both in-person and virtual learning is a constant challenge, as customers&#8217; expectations continue
to rise. Failure to deliver a valuable learning experience, whether in physical classrooms or online, can lead to student dissatisfaction,
ultimately adversely affecting our reputation and our ability to attract and retain students. Factors such as the perceived quality of
teaching, institutional credibility, and overall student support play crucial roles in fostering satisfaction and long-term engagement.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Delivering a consistently valuable experience requires
overcoming several obstacles. In in-person programs, maintaining qualified faculty, ensuring well-equipped facilities, and providing satisfactory
administrative support are key concerns. Students expect engaging, practical, and hands-on learning, particularly where clinical training
and laboratory access are required. Any shortcomings in these areas can lead to frustration and impact the perceived value of our programs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In virtual programs and digital content, the challenges
are different but equally significant. Students depend on user-friendly, reliable digital platforms to access course materials, attend
live sessions, and engage with instructors. Technical failures, poor user experience, or insufficient student support can result in disengagement
and lower retention rates. Additionally, delivering virtual learning programs with the same depth and effectiveness as face-to-face instruction
requires continuous innovation in teaching methodologies.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil&#8217;s geographic and economic diversity adds
another layer of complexity. While in some regions, students benefit from robust infrastructure and access to resources, others may struggle
with unreliable internet connections, limited access to technology, or logistical barriers to attending in-person classes. These disparities
make it difficult to provide a uniform student experience across different locations. Any of these factors could materially affect our
business, financial condition, and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">If we continue to grow, we may be unable to effectively
manage operational expansion, increased platform complexity, or talent needs, which could adversely affect our business and financial
performance.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are currently experiencing significant expansion
and facing numerous related issues, such as the acquisition and retention of experienced and talented personnel, cash flow management,
corporate culture and effectiveness of internal controls. These challenges, along with the significant time spent addressing them may
divert our management&#8217;s attention from other business issues and opportunities. Additionally, our current and planned platform and
systems, procedures and controls, personnel and third-party relationships may not be adequate to support our future operations. The strain
on management and our operational and financial resources is expected to continue, and failure to manage growth effectively could seriously
harm our business, results of operations and financial condition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are also dependent upon the ability and experience
of key personnel. Failure to retain or attract senior executives, board members (including those with M&amp;A experience related to our
industry), or key managers, could have a material adverse effect on our business, financial condition and results of operations. Our teaching
faculty, including teachers and professors at our post-secondary education institutions, is essential for maintaining the quality of our
programs and the strength of our brand and reputation. We promote training to ensure our faculty attains and maintains the qualifications
we require and stays updated on trends and changes in their areas. Due to shortages in the supply of qualified professors, competition for hiring
and retaining qualified professionals has increased substantially. We cannot assure you that we will succeed in retaining our current
professors or recruiting or training new professors who meet our quality standards, particularly as we continue to expand our operations.
In addition, given the regulatory requirements applicable to medical programs, the loss of senior academic leaders or specialized faculty
could disrupt our ability to meet accreditation standards or maintain program quality, which could materially affect our business and
results of operations.</p>


<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our corporate culture and values are critical to our
success, and failure to preserve them could harm our ability to recruit, retain and develop personnel and implement our strategic plans
effectively. We are advancing culture change through the implementation of diversity, equity and inclusion, or DEI initiatives. For example,
in 2021, we undertook a public commitment by signing onto the United Nations Global Compact and committing to achieve gender equity by
having women occupy half of our managerial positions by 2030. In addition, in 2024, we made a public commitment aligned with the targets
of SDG 3 (Good Health and Well-Being), pledging that by 2030 we will deliver an additional five million free healthcare consultations.
Failure to implement these initiatives successfully could adversely impact our ability to recruit, attract and retain talent, and perceived
insufficient commitment to DEI or environmental, social, and governance initiatives, which may adversely affect our reputation and, consequently,
our results of operations and financial condition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">To successfully compete and grow, we must attract,
recruit, retain and develop personnel with the necessary expertise. The competitive market for qualified personnel may hinder our ability
to recruit additional personnel or replace key personnel who depart. Our efforts to retain and develop personnel may also result in significant
additional expenses, adversely affecting our profitability. We cannot assure you that qualified employees will continue to be employed,
that we will manage them successfully, or that, in the future, we will be able to attract qualified personnel with similar skills and
expertise at an equivalent cost in the future.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">To remain competitive, we must constantly update our
software, enhance and improve our billing, transaction and other business systems, and add and train new software designers and engineers,
as well as other personnel. This process is time-intensive and expensive and may lead to higher costs in the future. Furthermore, managing
multiple commercial relationships with strategic partners, online service providers, and other third parties could lead to execution problems
affecting current and future revenues and operating margins.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may face challenges in identifying and acquiring new
medical higher education institutions, which could hinder our strategic and financial goals. Additionally, difficulties in effectively
integrating and managing an increasing number of acquisitions may adversely affect our strategic objectives.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.25in">We aim to expand our operations
by acquiring medical higher education institutions and health tech companies, including potentially significant and strategically relevant
acquisitions. However, we cannot guarantee the identification or acquisition of suitable medical education institutions on favorable terms
or at all.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, our previous and any future acquisitions
involve several risks and challenges that may have a material adverse effect on our business and results, including the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the acquisition may not align with our commercial strategy or institutional image;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>future acquisitions may be subject to approval by Brazil&#8217;s Administrative Council for Economic Defense <i>(Conselho Administrativo
de Defesa Econ&#244;mica,</i> or CADE) or other regulatory authorities, which may deny approval, or impose conditions or restrictions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>we may face contingent and/or successor liabilities (either currently known or unknown to us) related to&#160;judicial and administrative
proceedings,&#160;financial, reputational and technical issues, including regulatory, tax, labor, social security, environmental, intellectual
property, accounting practices, financial disclosures, internal controls, anti-corruption, anti-bribery or anti-money laundering issues,
which may not be fully indemnifiable under the relevant acquisition agreement;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the acquisition process may require additional funds and/or may be time-consuming, diverting management&#8217;s attention from daily
operations;</td></tr></table>


<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our investments in acquisitions may not yield expected returns, and we may mismanage administrative and financial resources during
integration;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the business model of acquired institutions may differ from ours, and we may be unable to adapt them to our business model or do so
efficiently;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>we may not be able to integrate efficiently and successfully the operations of the institutions we acquire, including their personnel,
financial systems, distribution or operating procedures;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>certain acquisitions may impact our financial reporting obligations and delay the preparation of our consolidated financial statements;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the acquisitions may generate goodwill, the impairment of which could increase our expenses, negatively affecting our results of operations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the transfer of management of the target institution due to a change of control or corporate restructuring must be notified to MEC
within 60 days from the consummation of the acquisition, and MEC may impose additional restrictions on its reaccreditation; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>we may be unable to provide the necessary resources to support the acquired company&#8217;s operations and failure to meet any applicable
reaccreditation requirements may result in additional restrictions or conditions on the reaccreditation imposed by MEC.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, we may face significant challenges in
the process of integrating the operations of any acquired company with our existing business, such as managing a larger, geographically
dispersed workforce, and implementing efficient uniform controls, procedures and policies, along with incurring high or unexpected integration
costs. As of the date of this annual report, we have fully integrated the operations of all acquired companies into our existing business,
except for Medical Harbour, whose integration is ongoing. The anticipated benefits of the acquisitions we may pursue will not be achieved
unless we successfully and efficiently integrate the acquired companies into our operations and effectively manage, market and apply our
business strategy to them. Additionally, we may be unable to integrate faculty and personnel with diverse professional experiences and
corporate cultures, potentially impairing our relationship with current and new employees, including professors.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Failure to prevent or detect a malicious cyber-attack
on our systems and databases could result in a misappropriation of confidential information or access to highly sensitive information.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Cyber-attacks are becoming more sophisticated and pervasive.
Across our business, we hold large volumes of personally identifiable information, including that of employees, institutions, customers,
students and parents, legal guardians, patients, physicians and clients (B2B and B2C). Individuals have tried and may continue to try
to gain unauthorized access to our data in order to misappropriate such information for potentially fraudulent purposes, and our security
measures may fail to prevent such unauthorized access. A breach of our systems could result in a devastating impact on our reputation,
financial condition or student experience. In addition, if we were unable to prove that our systems are properly designed to detect an
intrusion, we could be subject to severe penalties and loss of existing or future business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In particular, data protection and privacy laws are
developing rapidly to take into account the changes in cultural and consumer attitudes towards the protection of personal data. In operating
our business and selling our products and services to customers, we and our subsidiaries collect, use, store, transmit and otherwise process
employee and customer data, including sensitive personal data. As a result, we and our subsidiaries are subject to a variety of laws and
regulations in Brazil, as well as contractual obligations, regarding data privacy, security and protection. In many cases, these laws
and regulations apply not only to third-party transactions, but also to transfers of information between or among us, our subsidiaries
and other parties with which we have commercial relationships. We also engage third-party service providers that process certain data
on our behalf, and although we have processes designed to promote compliance with applicable data protection and privacy laws, we cannot
assure you that such third parties will comply with all applicable legal requirements or that their processing activities will not result
in data breaches or other violations, which could subject us to regulatory scrutiny, liability and reputational harm and materially adversely
affect our business, financial condition and results of operations.</p>


<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Privacy, information security, and data protection
are significant issues globally. The regulatory framework governing the collection, processing, storage, use and sharing of certain information,
particularly financial and other personal data, is rapidly evolving and is likely to continue to be subject to uncertainty and varying
interpretations. The occurrence of unanticipated events and the development of evolving technologies often rapidly drive the adoption
of legislation or regulation affecting the use, collection or other processing of data and the manner in which we conduct our business.
Any failure or perceived failure by us to comply with our privacy policies or any applicable privacy, security or data protection, information
security or consumer protection-related laws, regulations, orders or industry standards in one or more jurisdictions could expose us to
costly litigation, significant awards, fines or judgments, civil and criminal penalties or negative publicity, and could materially and
adversely affect our business, financial condition and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our success depends on our ability to monitor and adapt
to technological changes and maintain a technological infrastructure that works adequately and without interruption.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Information technology is an essential factor for our
growth. Our information technology systems and tools may become obsolete or insufficient, or we may have difficulties in following and
adapting to technological changes in the education sector, particularly in the distance learning segment where the technological needs
and expectations of our customers and market standards change rapidly, especially with the increasing adoption of AI technologies, and
we must quickly adapt to new distance learning technology, practices and standards. Moreover, our competitors may introduce better products
or service platforms. Our success depends on our ability to efficiently improve our current products while developing and introducing
new products that are accepted in the marketplace. Additionally, a failure to upgrade our technology, features, content, security infrastructure,
network infrastructure, or other infrastructure associated with our platform could harm our business. Adverse consequences could include
unanticipated disruptions, slower response times, bugs, degradation in levels of customer support, impaired quality of users&#8217; experiences
of our educational platform and delays in reporting accurate financial information.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The efficient operation of our business depends on
our information technology systems, particularly our Continuing Education and Medical Practice Solutions segments. If our information
technology systems fail to operate as anticipated and without interruptions or do not perform as specified, our services may be interrupted,
patient care may be affected, and we may be subject to legal claims, regulatory compliance issues and our reputation may be harmed. Several
problems regarding our information technology structure, such as viruses, hackers, system interruptions and technical difficulties regarding
our transmissions of data, sound and image, may have a material adverse effect on us and our business. Our information technology systems
are also vulnerable to damage or interruption including from fires, floods and other natural disasters; terrorist attacks and attacks
by computer viruses or hackers; power losses; and computer systems, or Internet, telecommunications or data network failures and our disaster
recovery plans may not be effective. The failure of our information technology systems to perform as we anticipate or our failure to effectively
implement new systems could disrupt our entire operation and could result in decreased sales, increased overhead costs, legal and regulatory
liability and reputational harm, all of which could have a material adverse effect on our reputation, business, results of operations
and financial condition. In addition, we face risks associated with unauthorized access to our systems, including by hackers and due to
failures of our security measures. These unauthorized entries into our systems can result in the theft of proprietary or sensitive information,
including student information, intellectual property and sensitive data, cause interruptions in the operation of our systems, or hinder
our ability to innovate. As a result, we may be forced to incur considerable expenses to protect our systems from security breaches and
to mitigate our exposure to technological problems and interruptions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Internet Act (Law No. 12,965/2014) applies only
to personal data collected through the internet, and establishes other principles and rules with respect to the privacy and protection
of the personal and behavioral data of internet users. The Internet Act guarantees, among others, the privacy of internet and privately
stored communications. Any data processing activity is subject to the data subject&#8217;s informed, free and express consent. Decree
No. 8,771/2016, which regulates the Internet Act, requires internet app providers to maintain certain security measures in connection
with the storage of personal data, including: (i)&#160;strict controls on access to personal data; (ii)&#160;authentication safeguards;
(iii)&#160;detailed data inventories (e.g., date, time and duration of access to the data, identity of the employee that accessed the
data and the actions taken), and (iv)&#160;use of IT solutions to ensure the data is protected (for example, data encryption or other
equivalent protective measures). If we fail to comply with the provisions of the Internet Act, we may be subject to sanctions and penalties,
including damages, which will be assessed based on the nature and degree of our non-compliance, among other factors.</p>


<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We rely upon a third-party data center service provider
to host certain aspects of our platform and content and any disruption to, or interference with, our unauthorized or improper use of such
services could impair our ability to deliver our platform, resulting in customer dissatisfaction, damaging our reputation, and harming
our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We utilize data center hosting facilities from a global
third-party service provider to make certain content available on our platform. Our operations depend, in part, on our provider&#8217;s
ability to protect its facilities against damage or interruption from natural disasters, power or telecommunications failures, criminal
acts and similar events. The occurrence of spikes in user volume, traffic, natural disasters, acts of terrorism, vandalism or sabotage,
or a decision to close a facility without adequate notice, or other unanticipated problems at our provider&#8217;s facilities could result
in lengthy interruptions in the availability of our platform, which would adversely affect our business. Some of our systems are not fully
redundant, and our&#160;disaster recovery&#160;planning cannot account for all eventualities. Any problems at our data centers could result
in lengthy interruptions in our service. In addition, our products and services are highly technical and complex and may contain errors
or vulnerabilities, which could result in interruptions in our services or the failure of our systems.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Failure to comply with data privacy regulations could
result in reputational damage to our brands and adversely affect our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk159493749"></span>Any perceived or actual
unauthorized disclosure of personally identifiable information, whether through a breach of our network by an unauthorized party, employee
theft, misuse or error or otherwise, could harm our reputation, impair our ability to attract and retain our customers, or subject us
to claims or litigation arising from damages suffered by individuals. Failure to adequately protect personally identifiable information
could potentially lead to penalties, significant remediation costs, reputational damage, the cancellation of existing contracts and difficulty
in competing for future business. In addition, we could incur significant costs in complying with relevant laws and regulations regarding
the unauthorized disclosure of personal information, which may be affected by any changes to data privacy legislation at both the federal
and state levels.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In particular, on August 14, 2018, the President of
Brazil approved the General Personal Data Protection Law (<i>Lei Geral de Prote&#231;&#227;o de Dados Pessoais</i>, &#8220;LGPD&#8221;),
which came completely into force on August 1, 2021. The LGPD is a comprehensive data protection law establishing general principles and
obligations that apply across multiple economic sectors and contractual relationships. The LGPD applies to individuals or legal, private
or government entities, that process personal data in Brazil or collect personal data in Brazil or, further, when the processing activities
have the purpose of offering or supplying goods or services to data subjects located in Brazil. The LGPD establishes detailed rules for
the collection, use, processing, storage and any operation carried out with personal data (including personal data of clients, suppliers,
employees and patients of our medical schools), and affects all economic sectors, including the relationship between customers and suppliers
of goods and services, employees and employers and other relationships in which personal data is collected, whether in a digital or physical
environment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Specifically, the LGPD establishes, among other things,
data subjects&#8217; rights, the legal basis for personal data protection, requirements for obtaining consent from data owners, obligations
and requirements related to security incidents, data leaks and international data transfers, as well as the creation of the National Data
Protection Authority (<i>Ag&#234;ncia Nacional de Prote&#231;&#227;o de Dados</i>, &#8220;ANPD&#8221;), for the purposes of monitoring,
implementing and supervising compliance with the LGPD in Brazil. In the event of non-compliance with the LGPD, we may be subject to penalties,
including (1)&#160;warnings, with the impositions of a deadline for the adoption of corrective measures; (2)&#160;a one-time fine for
each violation of up to 2% (subject to an upper limit of R$50,000,000) of our revenue; (3)&#160;a daily fine (subject to an upper limit
of R$50,000,000); (4)&#160;public disclosure of the violation after due investigation and confirmation of its occurrence; (5)&#160;the
restriction of access to the personal data to which the violation relates, until corrective measures are implemented; (6)&#160;deletion
of the personal data to which the violation relates; (7)&#160;partial suspension of the databases to which the violation relates for up
to six months, which can be extended for an equal period until corrective measures are implemented; (8)&#160;suspension of the personal
data processing activities to which the violation relates for up to 12 months; and (9)&#160;partial or full prohibition on personal data
processing activities. In addition, the LGPD creates a private cause of action, which means we are subject to both class-based and individual
claims for violations of the LGPD. The application of sanctions by the ANPD has been further regulated by the Regulations on the Application
of Administrative Sanctions, dated February 27, 2023, as a result of which the ANPD will now be able to apply administrative sanctions
based on clearer and more established guidelines and requirements.</p>


<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk160120154"></span> Data protection is an
important issue for us. We consider the LGPD as an opportunity to further develop and continuously improve our data protection processes.
Since 2021, we have been offering training on the LGPD on our e-learning platform to teach our employees the principles of data protection.
This training is mandatory for all employees, including our management. As part of this development and improvement process, we have also
introduced governance models and technical improvements to comply with legal requirements, reduce the risk of data breaches and guarantee
the rights of stakeholders with regard to their data security and privacy.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Although we have substantially implemented systems
and processes designed to comply with the LGPD across our operations, and have integrated such a framework within the Company and most
of its subsidiaries, our data protection compliance efforts remain an ongoing and evolving process. We cannot assure you that our LGPD
compliance efforts will be deemed appropriate or sufficient by regulatory authorities, in particular ANPD, or by courts, such as the Brazilian
Public Prosecution Office (<i>Minist&#233;rio P&#250;blico</i>). Moreover, as the LGPD requires further regulation from the ANPD regarding
several aspects of the law, which are yet unknown, we may have difficulty adapting our systems and processes to the new legislation due
to the legislation&#8217;s complexity. The changes have impacted, and could further adversely impact, our business by increasing our operational
and compliance costs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Any additional privacy laws, rules or regulations enacted
or approved in Brazil or in other jurisdictions in which we operate could cause us to incur costs to correct the breaches or failures,
expose us to uninsured liability, increase our risk of regulatory scrutiny, subject us to lawsuits and administrative procedures, and
result in the imposition of material penalties and fines under state and federal laws or regulations, which could seriously harm our business,
financial condition or results of operations. Any failure, real or perceived, by us to comply with our privacy policies or with any regulatory
requirements or orders or other local, state, federal or international privacy or consumer protection-related laws and regulations could
cause customers to reduce their purchases of our products and services and could materially and adversely affect our business.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk221142042"></span>We face risks relating to
our Medical Practice Solutions segment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We may face risks relating to the expansion, including
through acquisitions, of our Medical Practice Solutions segment, which provides clinical decisions software, practice management tools
and electronic medical records, doctor-patient relationship, telemedicine and digital prescriptions. We are subject to significant execution
risk since we are providing new digital features and developing a new market, where the technological needs, the expectations of our customers
and market standards change rapidly, especially with the increasing adoption of AI technologies. The increasing use of generative AI tools
as a primary source of information, rather than traditional search engines and digital platforms such as Google, may also adversely affect
our customer acquisition strategies, visibility and digital positioning, requiring us to continually reassess how we reach, engage and
retain users. Our competitors may offer solutions that are similar to or better than those offered by us, have access to more funds, and
be more prestigious or well-regarded within the medical community. As such, we may have to quickly modify our products and services to
adapt to new digital education technologies, practices and standards. In addition, an error in the design, programming or validation of
clinical decisions software could lead to inappropriate assignment or dosing of patients, which could give rise to patient safety issues
and/or liability claims against us, amongst other things, any of which could have a material adverse effect on our financial condition,
results of operations and reputation. See also &#8220;&#8212;Our success depends on our ability to monitor and adapt to technological
changes and maintain a technological infrastructure that works adequately and without interruption.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the success of our digital solutions depends
on the general population having easy and affordable access to the internet, as well as on other technological factors that are outside
of our control. If the internet becomes inaccessible or access costs increase to levels higher than current prices, we may be unable to
successfully implement our digital solutions strategy, which would have an adverse effect on our growth strategy.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, we may face regulatory risks related
to the approval, certification, and compliance requirements applicable to our Medical Practice Solutions segment. Failure to comply with
healthcare, medical device, or digital health regulations, including ANVISA requirements, or to timely adapt to changes in the regulatory
environment or new or evolving regulatory requirements, could limit our ability to offer certain products, require modifications to our
products or business practices, increase compliance costs, or result in sanctions, fines, or other penalties, any of which could adversely
affect our operations and reputation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Finally, we also face operational risks relating to
the integration of any acquired companies to build our ecosystem, including userbase and platform integration risks, among other risks.
As a result, any acquisition we may make in this segment involve several uncertainties, risks and challenges
that may have a material adverse effect on our business and results of operations, and result in the risk of impairment. See also &#8220;&#8212;We
may face challenges in identifying and acquiring new medical higher education institutions, which could hinder our strategic and financial
goals. Additionally, difficulties in effectively integrating and managing an increasing number of acquisitions may adversely affect our
strategic objectives.&#8221;</p>


<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt"></p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk221100523"></span>Our business depends on
the continued success of the brands of each of our institutions, as well as the &#8220;Afya&#8221; brand, and if we fail to maintain and
enhance the recognition of our brands, we may face difficulty enrolling new students and selling educational content and medical practice
solutions to new clients, and our reputation and operating results may be harmed.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe that market awareness of our brands has
contributed significantly to the success of our business. Maintaining and enhancing our brands is critical to our efforts to increase
student enrollments and expand the selling of educational content and medical practice solutions for new clients. In addition, we have
licensed the brand &#8220;Afya&#8221; to Instituto Afya, which is an independent non-profit organization that aims to promote solutions
to chronic non-communicable conditions (CNCCs) through research, cross-sector collaboration, and engagement with diverse segments of society.
Any failure by us or by any licensee, including Instituto Afya, to maintain and enhance our brand recognition could have a material and
adverse effect on our business, operating results and financial condition. We have devoted significant resources to our brand promotion,
but we cannot assure you that these efforts will be successful. If we are unable to further enhance our brand recognition, or if we incur
excessive marketing and promotion expenses, or if our brand image is negatively impacted by any negative publicity, our business and results
of operations may be materially and adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk127545267"></span>If we are unable to maintain
effective disclosure controls and procedures and internal controls over financial reporting, we may be unable to accurately report our
results of operations, meet our reporting obligations or prevent fraud.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk133233432"></span>Disclosure controls and
procedures are designed to provide reasonable assurance that information required to be disclosed by us under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is
accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure. Internal control over
financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements in accordance with IFRS Accounting Standards. For details of the controls mentioned above, see the section of this
annual report entitled &#8220;Item 15. Controls and Procedures&#8212;B. Management&#8217;s Annual Report on Internal Control Over Financial
Reporting.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">However, these controls have inherent limitations,
including the possibility of human error, faulty judgments, and circumvention or unauthorized override. In addition, as we complete acquisitions,
we may not be able to integrate the acquired entities&#8217; control environment and procedures on a timely basis. As a result, misstatements
due to error or fraud may occur and may not be detected on a timely basis. We cannot assure you that significant deficiencies or material
weaknesses in our internal control over financial reporting will not be identified in the future. If we fail to maintain an effective
control environment, we could suffer material misstatements, fail to meet our reporting obligations, or become subject to regulatory scrutiny,
which could adversely affect investor confidence and the trading price of our Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span style="background-color: white">Any decrease in
the number of students, learners, users or customers across our education programs and medical practice solutions may adversely affect
our results of operations.</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: white">We believe that
our attrition rates and engagement levels are primarily </span>influenced by <span style="background-color: white">the personal motivation
and financial </span>circumstances <span style="background-color: white">of our current and </span>prospective <span style="background-color: white">customers,
as well as </span>by <span style="background-color: white">socioeconomic conditions in Brazil. Significant changes in future attrition
rates or engagement levels, failure to re-enroll, re-engage, or renew subscriptions may reduce the number of new and returning customers,
</span>particularly in the context of economic uncertainty or volatility, <span style="background-color: white">and may have a material
adverse effect on our revenues and our results of operations.</span></p>


<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">An increase in delays and/or defaults in the payment
of tuition fees or license subscription fees of medical practice solutions may adversely affect our income and cash flows.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We depend on the full and timely payment of (i) the
tuition we charge our students, including tuition payments we receive through FIES; and (ii) the subscription fees we charge our clients.
Adverse changes in the macroeconomic environment and the earnings capacity of our customers, may lead to an increase in payment delinquency
or default and negatively impact our ability to collect our accounts receivable. An increase in payment delinquency or default by our
customers may have a material adverse effect on our cash flows and our business, including our ability to meet our obligations. Our allowance
for expected credit losses expenses as a percentage of our revenue was 1.5%, 1.8% and 2.6% for the years ended December 31, 2025, 2024
and 2023, respectively. There is no guarantee that our allowance for expected credit losses expenses will not increase in the following
years. Our inability to collect our accounts receivable on a timely basis, if at all, could cause our allowance for expected credit losses
expenses to increase in the future, and materially and adversely affect our financial condition, liquidity and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Unfavorable decisions in our legal, arbitration or administrative
proceedings may result in financial losses, reputational harm, or operational restrictions that could adversely affect our business and
the trading price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are, and we, our controlling shareholder, directors
or officers may be in the future, party to legal, arbitration and administrative investigations, inspections and proceedings arising from
the ordinary course of our business or from nonrecurring corporate, tax, criminal or regulatory events, involving our suppliers, students,
staff, faculty members, as well as environmental, competition and tax authorities, especially with respect to civil, tax, criminal and
labor claims. We cannot guarantee that the results of these proceedings will be favorable to us or that we have made sufficient provisions
for liabilities that may arise as a result of these or other proceedings. Adverse decisions on material legal, arbitration or administrative
proceedings may damage our reputation and may adversely affect our results of operations and the price of our Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Difficulties in identifying, opening and efficiently
managing new campuses or in obtaining regulatory authorizations and accreditations on a timely basis as part of our organic growth strategy
may adversely affect our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our organic growth strategy includes expanding by opening
new campuses and integrating them into our educational network. This growth plan presents significant challenges in terms of maintaining
our teaching quality and culture due to the complexity and difficulty of effectively managing a greater number of campuses and programs.
If we are unable to maintain our current quality standards, we may lose market share and be adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Establishing new campuses poses significant challenges
and requires substantial investments in infrastructure, marketing, personnel and other pre-operational expenses, primarily in identifying
new sites for lease or purchase. We prioritize identifying strategic sites, negotiating the purchase or lease of properties, building
or refurbishing facilities (including libraries, laboratories and classrooms), obtaining local permits, hiring and training faculty and
staff, and investing in administration and support. We cannot assure you that we will succeed in identifying facilities with adequate
infrastructure for our new campuses, develop adequate infrastructure in properties we acquire, or have enough resources to continue expanding
through acquisitions or development of new projects.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are also required to register our new campuses with
MEC, before opening and operating them, as well as having our new programs accredited by MEC in order to issue official degrees and certificates
to our students. If we do not succeed in identifying and establishing our campuses in a cost-effective manner or in obtaining such authorizations
or accreditations on a timely basis, or if MEC imposes restrictions or conditions on our accreditation requests for new campuses, our
business may be adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If we fail to develop adequate infrastructure for new
programs that meet the requirements imposed by MEC or the standards set forth in our business plan, our ability to offer such programs
and expand our business may be limited and our financial condition and results of operations may be adversely impacted.</p>


<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may not be successful in meeting our environmental,
social and corporate governance, or ESG, commitments, which may have a material adverse effect on our business, financial condition, reputation
and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The market is increasingly concerned with how companies
assess and manage ESG risks to protect themselves and create opportunities to generate value. As part of this trend, we have made certain
ESG commitments, and we strive to maintain socially responsible business practices, including fostering social investments and structuring
programs to generate a positive social impact in areas related to our business, such as access to medical care and improvement of health
indicators in surrounding communities, employability, education and culture. Failure to meet our ESG commitments or to pursue these socially
responsible business practices, partially or at all, may have a material adverse effect on our business, reputation, financial condition
and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">There has been an increase in ESG rules and regulations
applicable to our business. Given the pace of legislative developments in this area, although we make efforts to follow the best practices,
we may not be able to comply with the new regulations in their totality. We are also exposed to the risk that future ESG rules and regulations
may adversely affect our ability to conduct our business by requiring us to reduce the value of our assets or reduce their useful life,
face increased compliance costs or take other actions that may be adverse to us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our activities may also impact the lives and socioeconomic
dynamics of communities, especially those neighboring our campuses. These impacts may include truck, vehicle and pedestrian traffic, construction,
noise and waste generation, and the effects of lower-quality, free services that we may provide to such communities. As a result, there
may be stoppages in our operations due to demonstrations in surrounding communities, as well. If we do not establish effective communication
channels with such communities, we may face challenges in the operation of educational institutions and project execution, which could
jeopardize our reputation and impede the attainment of our strategic objectives.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our holding company structure makes us dependent on the
operations of our subsidiaries. We depend on dividend distributions by our subsidiaries, and we may be adversely affected if the performance
of our subsidiaries is not positive.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are a Cayman Islands exempted company with limited
liability. Our material assets are our direct and indirect equity interests in our subsidiaries. We control a number of subsidiary companies
that carry out the business activities of our corporate group. Our ability to comply with our financial obligations and to pay dividends
to our shareholders depends on our ability to receive distributions from the companies we control, which in turn depends on the cash flow
and profits of those companies. There is no guarantee that the cash flow and profits of our controlled companies will be sufficient for
us to comply with our financial obligations and pay dividends to our shareholders. Furthermore, exchange rate fluctuation will affect
the U.S. dollar value of any distributions our subsidiaries make with respect to our equity interests in those subsidiaries.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, at the end of 2025, the Brazilian government
approved changes to its income tax legislation to introduce withholding income tax on dividends distributed by Brazilian companies to
individual shareholders and to reinstate taxation on dividends remitted to non-resident entities abroad, in each case effective as of
January 1, 2026. Under the new rules, a 10% withholding tax applies to the portion of dividends exceeding R$50,000 received in a calendar
year by the same individual shareholder from the same distributing entity, and a 10% withholding tax will apply to cross-border dividends,
regardless of the amount. Although this withholding tax does not currently apply to dividends paid to legal entities in Brazil, the introduction
of dividend taxation represents a material change to Brazil&#8217;s prior tax framework and may reduce the net returns received by us
from our Brazilian subsidiaries and consequently by our shareholders, which could influence corporate distribution practices and capital
allocation decisions and may expose us to additional tax burdens or adverse impacts on our financial condition should further changes
to the dividend tax regime be enacted.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In this context, in December 2025, we approved the
distribution of accumulated profit reserves by certain of our Brazilian subsidiaries, with payments expected to be made to us through
2028. This decision was made in light of the changes in Brazilian tax legislation and to mitigate the risk of additional tax burdens should
further changes to the dividend tax regime be introduced. The distribution was intended to allow for the orderly repatriation of profits
generated under the prior tax framework, while preserving flexibility in our capital allocation planning.</p>


<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Any additional taxation on the distribution of dividends
and any increase in applicable taxes on the payment of interest on shareholders&#8217; equity may adversely affect us and our financial
condition to distribute dividends</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Failure to protect or enforce our intellectual property
and other proprietary rights could adversely affect our business and financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We rely and expect to continue to rely on a combination
of trademark, copyright, patent and trade secret protection laws, as well as confidentiality and license agreements with our employees,
consultants and third parties with whom we have relationships to protect our intellectual property and proprietary rights.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">From time to time, we expect to file patent, copyright
and trademark applications in Brazil and abroad. Nevertheless, these applications may not be approved or otherwise provide the full protection
we seek. Any dismissal of our trademark applications may impact our business. Third parties may challenge any patents, copyrights, trademarks
and other intellectual property and proprietary rights owned or held by us. Third parties may knowingly or unknowingly infringe, misappropriate
or otherwise violate our patents, copyrights, trademarks and other proprietary rights, and we may not be able to prevent infringement,
misappropriation or other violation without substantial expense to us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Furthermore, we cannot guarantee that:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our intellectual property and proprietary rights will provide competitive advantages to us;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our competitors or others will not design around our intellectual property or proprietary rights;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our ability to assert or enforce our intellectual property or proprietary rights against potential competitors or to settle current
or future disputes will not be limited by our agreements with third parties;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>our intellectual property and proprietary rights will be enforced in jurisdictions where competition may be intense or where legal
protection may be weak;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>any of the patents, trademarks, copyrights, trade secrets or other intellectual property or proprietary rights that we presently employ
in our business will not lapse or be invalidated, circumvented, challenged or abandoned; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>we will not lose the ability to assert or enforce our intellectual property or proprietary rights against or to license our intellectual
property or proprietary rights to others and collect royalties or other payments.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If we pursue litigation to assert or enforce our intellectual
property or proprietary rights, an adverse decision in any of these legal actions could limit our ability to assert our intellectual property
or proprietary rights, limit the value of our intellectual property or proprietary rights or otherwise negatively impact our business,
financial condition and results of operations. If the protection of our intellectual property and proprietary rights is inadequate to
prevent use or misappropriation by third parties, the value of our brand and other intangible assets may be diminished, competitors may
be able to more effectively mimic our service and methods of operations, the perception of our business and service to customers and potential
customers may become confused in the marketplace and our ability to attract customers may be adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may in the future be subject to intellectual property
claims, which are costly to defend and, if we do not succeed in defending such claims, could harm our business, financial condition and
operating results.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">From time to time, third parties may allege in the
future that we or our business infringes, misappropriates or otherwise violates their intellectual property or proprietary rights, including
with respect to our publications. Many companies, including various &#8220;non-practicing entities&#8221; or &#8220;patent trolls,&#8221;
are devoting significant resources to developing or acquiring patents that could potentially affect many aspects of our business. We have
not exhaustively searched patents related to our technology. In addition, the publishing industry has been, and we expect in the future
will continue to be, the target of counterfeiting and piracy. We may implement measures in an effort to protect against these potential
liabilities that could require us to spend substantial resources. Any costs incurred as a result of liability or asserted liability relating
to sales of unauthorized or counterfeit educational materials could harm our business, reputation and financial condition.</p>


<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Third parties may initiate litigation against us without
warning. Others may send us letters or other communications that make allegations without initiating litigation. We may in the future
receive such communications, which we assess on a case-by-case basis. We may elect not to respond to the communication if we believe it
is without merit or we may attempt to resolve disputes out of court by electing to pay royalties or other fees for licenses. If we are
forced to defend ourselves against intellectual property claims, whether they are with or without merit or are determined in our favor,
we may face costly litigation, diversion of technical and management personnel, inability to use our current website or inability to market
our service or merchandise our products. As a result of a dispute, we may have to develop non-infringing technology, including partially
or fully revising any publication that infringes intellectual property rights, enter into licensing agreements, adjust our merchandising
or marketing activities or take other action to resolve the claims. These actions, if required, may be unavailable on terms acceptable
to us or may be costly or unavailable. If we are unable to obtain sufficient rights or develop non-infringing intellectual property or
otherwise alter our business practices, as appropriate, on a timely basis, our reputation or brand, our business and our competitive position
may be affected adversely and we may be subject to an injunction or be required to pay or incur substantial damages and/or fees and/or
royalties.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Some of our services are provided using proprietary
software and our software is mainly developed by our employees, who assign to us their copyrights over the software. In this regard, though
applicable law establishes that employers shall have full title over rights relating to software developed by their employees, we could
be subject to lawsuits by former employees claiming ownership of such software. As a result, we may be required to obtain licenses of
such software, incurring costs relating to payments of royalties and/or damages and we may be forced to cease the use of such software.
If we are unable to use certain of our proprietary software as a result of any of the foregoing or otherwise, this could have a material
adverse effect on our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, we use open source software in connection
with certain of our products and services. Companies that incorporate open source software into their products have, from time to time,
faced claims challenging the ownership of open source software and/or compliance with open source license terms. As a result, we could
be subject to suits by parties claiming ownership of what we believe to be open source software or non-compliance with open source licensing
terms. Some open source software licenses require users who distribute or use open source software as part of their software to publicly
disclose all or part of the source code to such software and/or make available any derivative works of the open source code on unfavorable
terms or at no cost. Any requirement to disclose our proprietary source code or pay damages for breach of contract could have a material
adverse effect on our business, financial condition and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Some of the properties that we occupy are owned by companies
controlled by one of our significant shareholders. Therefore, we are exposed to conflicts of interest, since the administration of such
properties may conflict with our interests, those of such significant shareholder and those of our other shareholders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Some of the properties we occupy, including properties
where some of our campuses are located, are owned by companies controlled by one of our significant shareholders. Therefore, the interests
of our significant shareholder in the administration of such property may conflict with our interests and those of our other shareholders.
For further information, see &#8220;Item 7. Major Shareholders and Related Party Transactions&#8212;Related Party Transactions&#8221;
and note 7 to our consolidated financial statements.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk221142454"></span>We could be adversely affected
if we are unable to pass on increases in our costs and expenses to our students, users and customers by adjusting our monthly tuition
fees or the pricing of our products and services.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our primary source of income is the monthly tuition
payments we charge to our students enrolled in our undergraduate and continuing education programs, as well as revenues derived from the
pricing of our digital products and services used by physicians and other healthcare professionals. Our payroll costs and expenses account
for the majority of the costs of services and selling, general and administrative expenses, or 56.5%, 55.6% and 56.1% of such costs and
expenses for the years ended December 31, 2025, 2024 and 2023, respectively. Our faculty and administrative employees are represented
by labor unions in the higher education sector and are covered by collective bargaining agreements or similar arrangements determining
the number of working hours, minimum compensation, vacations and fringe benefits, among other terms. These agreements are subject to annual
renegotiation and may be so modified. We could also be adversely affected if we fail to achieve and maintain cooperative relationships
with our professors&#8217; or administrative employees&#8217; unions or face strikes, stoppages or other labor disruptions by our professors
or employees, or if we are unable to pass on any increase in costs arising from the renegotiation of collective bargaining agreements through adjustments
to the monthly tuition fees paid by students or the pricing of our products and services, which may have a material adverse effect on
our business.</p>


<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, our maintenance expenses and utilities
expenses (comprised mainly of water, electricity and telephone expenses) represent 6.5%, 6.8% and 6.2% of our costs of services and selling,
general and administrative expenses for the years ended December 31, 2025, 2024 and 2023, respectively. Personnel costs and expenses,
lease values and the cost of electricity are adjusted regularly using indices that reflect changes in inflation levels. If we are not
able to transfer any increases in our costs and expenses to students, users or customers by increasing the amounts of their monthly tuition
fees or the pricing of our products and services, for example as a result of ongoing political and economic instability in Brazil or globally,
our operating results may be adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Climate change can create transition risks, physical
risks and other risks that could adversely affect us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Climate risk is a transversal risk that can be an aggravating
factor for the types of traditional risks that we manage in the ordinary course of business, including, without limitation, the risks
described in this &#8220;Risk Factors&#8221; section. Based on the classifications used by the Taskforce on Climate-Related Financial
Disclosures, we consider that there are two primary sources of climate change-related financial risks: physical and transition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Physical risks resulting from climate change can be
event-driven (acute) or long-term shifts (chronic) in climate patterns:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Acute physical risks include increased severity of extreme weather events, such as drought, hurricanes, or floods;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Chronic physical risks include changes in precipitation patterns and extreme variability in weather patterns, rising mean temperatures,
chronic heat waves or rising sea levels;</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The main physical risks that can impact us are acute
physical risks that can disrupt our supply chain, affect the operation of our campuses, clinics or other facilities, or otherwise impair
the availability or reliability of our physical or digital infrastructure.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Transition risks refer to actions to address mitigation
and adaptation requirements related to climate change, and they can fall into various categories such as market and technology changes:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Market risk may manifest through shifts in supply and demand for certain commodities, products, and services, as climate-related risks
and opportunities are increasingly considered.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Technology risk arises from improvements or innovations to support the transition to a lower-carbon, energy-efficient economic system
that can have a significant impact on companies to the extent that new technology displaces old systems and disrupts some parts of the
existing economic system. One of our strategies to minimize our carbon footprint <span style="background-color: white">is to reduce the
number of physical pages we print as part </span>of <span style="background-color: white">our printed educational materials by making
those educational materials available to students digitally on our online platform.</span></td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Policy actions generally fall into two categories:
those that attempt to constrain actions that contribute to the adverse effects of climate change and those that seek to promote adaptation
to climate change. The risk associated with, and the financial impact of policy changes depends on the nature and timing of the policy
change.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our campuses, operations and digital infrastructure
may be adversely affected by increased regulatory requirements or policy developments relating to environmental and climate related matters
as their importance continues to grow. These and other changes in regulations in Brazil and international markets may expose us to increased
compliance costs, require investments in facilities, operations or technology, limit our ability to pursue certain business opportunities
or provide certain educational programs, digital products and services, or otherwise affect how we operate across our ecosystem. Any such
developments could adversely affect our business, financial condition and results of operations.</p>



<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->
<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">The interests of our management team may be focused
on the short-term market price of our Class A common shares, which may not align with your interests. Additionally, our shareholders
may experience dilution of their interests in our share capital and in the value of their investments due to the issuance of new shares
for settlement of our share-based incentive plans.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our directors and officers, among others, own shares
issued by us and are beneficiaries under our share-based incentive plans. Our current stock option plan for our managers and employees,
approved in August 2019 (and amended in July 2020, July 2022, July 2023 and October 2025), authorizes up to 4.0% of our common shares
at any time (excluding treasury shares) for issuance under this equity incentive plan. In addition, on July 8, 2022, we established a
restricted stock units (RSUs) program, authorizing up to 1.2% of our common shares (excluding treasury shares) at any time for issuance
under this plan.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Due to the issuance of stock options or RSUs, to members
of our management team, a significant portion of their compensation is closely tied to our results of operations and, more specifically
to the trading price of our Class A common shares. This may lead such individuals to direct our business and conduct our activities with
an emphasis on short-term profit generation. Consequently, the interests of our management team may not align with the interests of our
other shareholders that have longer-term investment objectives.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Once options have been exercised by the participants
and/or the common shares to be issued under the RSUs program have vested, our board of directors will determine whether our share capital
should be increased through the issuance of new shares to be subscribed by participants, or if they will be settled through shares held
in treasury. If settlement occurs through the issuance of new shares, our shareholders will experience dilution, of their interests in
our share capital and in the value of their investments, up to a maximum of 5.2% of our common shares at any time. Should new stock options
or RSUs be granted, whether under existing plans or new plans, our shareholders will be subject to additional dilution.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For additional information on our share-based incentive
plans, see &#8220;Item 6. Directors, Senior Management and Employees&#8212;B. Compensation&#8212;Long-Term Incentive Plans.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may not be able to maintain or renew our existing
leases.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We lease substantially all of the properties in which
we conduct our operations. According to Brazilian lease laws, a lessee has the right to request judicial renewal of existing non-residential
leases for subsequent terms equal to the original term of the lease. In order for a lessee to enforce this right, the following criteria
must be met (i)&#160;the non-residential lease agreement must have a fixed term equal to or greater than five consecutive years, or, in
the event there is more than one agreement or amendment thereto regarding the same real estate, the aggregate term in such agreement or
amendment must be greater than five consecutive years (ii)&#160;the lessee must have been using the property for the same purpose for
a minimum and continuous period of three years and (iii)&#160;the lessee must claim the right to judicial renewal at least one year and
at most six months prior to the end of the term of the lease agreement.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Lease agreements with terms lasting less than five
years are not entitled to a right of compulsory renewal and, as a result, the lessor has the right to refuse renewal of the lease upon
expiration of its term. Even for lease agreements with terms of five years or more, renewal is not automatic and depends on compliance
with the legal requirements for judicial renewal. The lease agreements relating to our campuses generally have terms lasting from five
to 30 years and are renewable in accordance with applicable Brazilian lease laws. If we are forced to close any of our campuses due to
the termination of a lease agreement and our inability to renew the lease, our business and results of operations may be adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, most of our lease agreements are not registered
with the relevant real estate registries. Although we have a statutory right of first refusal under Brazilian lease laws, the absence
of registration prevents us from enforcing this right against third parties. A subsequent purchaser who was not formally notified of our
lease and consequent right of first refusal may require that we vacate the property.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our success depends on our ability to operate in strategically
located property that is easily accessible by public transportation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe that urban mobility, inadequate public transportation
systems and high transportation costs in many Brazilian cities make the location and accessibility of campuses a decisive factor for students
choosing an educational institution. Therefore, a key component of the success of our business consists in finding, renting and/or buying
strategically located property that meets the needs of our students. We cannot guarantee that we will be able to keep our current property
or acquire new property that is strategically located in the future. In addition, acquisition costs, costs associated with improvements, construction, and
repairs of existing properties, and rental values for the properties we use might increase in the future and could have a material adverse
effect on our business. Finally, due to demographic and socioeconomic changes in the regions in which we operate, we cannot guarantee
that the location of our campuses will continue to be attractive and convenient to students.</p>


<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our operations and projects are exposed to occupational
health and safety and accident risks.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to laws and regulations governing health
and safety matters, protecting both members of the public and their employees and contractors. Some of the tasks undertaken by our employees
and contractors, including our maintenance employees, can be inherently dangerous and have the potential to result in serious injury or
death. Moreover, in the ordinary course of our business, we undertake complex construction, expansion and renovation projects that may
subject our employees or contractors to the risk of harm. Any breach of these obligations, or serious accidents involving our employees,
contractors or members of the public could expose us to adverse regulatory consequences, including the forfeit or suspension of operating
licenses, potential litigation, claims for material financial compensation, reputational damage, fines or other legislative sanction,
all of which have the potential to impact the results of our operating entities and our ability to make distributions. In addition, any
insurance coverage that we may have obtained with respect to such obligations may not cover certain indemnifications we may be required
to pay, be insufficient to cover these types of claims, or may not cover certain acts or events.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may require additional funds to continue our expansion
strategy. If we are unable to obtain adequate financing on favorable terms to complete any potential acquisition and implement our expansion
plans, our growth strategy may be materially and adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In the future, we may need to raise additional capital
to fund our expansion (organically or through strategic acquisitions), obtain new licenses, develop or enhance products and services,
or respond to competitive pressures. Our ability to raise additional funds will depend on financial, economic and other factors, many
of which are beyond our control. For example, financial markets can be negatively impacted by macroeconomic trends, including high interest
rates and rising inflation. Adequate funding may not be available on favorable terms to us or at all, particularly under these conditions.
If adequate funds are unavailable or are not available on acceptable terms, we may be unable to fund our expansion, capitalize on acquisition
opportunities, develop or enhance our product and service portfolio, or respond to competitive pressures, which could have a material
adverse effect on our business, results of operations and financial condition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Raising additional funds through the issuance of equity
or convertible debt securities may dilute our shareholders&#8217; interests, and the issued securities may have rights, preferences and
privileges senior to those of our shares. Additionally, debt financing may impose restrictive covenants that limit our operational and
financial flexibility, including by imposing restrictions on our ability to incur additional indebtedness, create liens, make acquisitions,
dispose of assets and make restricted payments, among others. Such indebtedness may also require us to maintain certain financial ratios,
potentially limiting our ability to secure future financing, withstand future economic downturns, or conduct necessary corporate activities.
A breach of any such covenant would likely result in a default, leading to acceleration of the outstanding indebtedness if not waived.
For more information, see &#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8212;Indebtedness.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk126855321"></span>Our revenues are highly
concentrated in the tuition fees we charge for our medical courses. Any adverse economic, market or regulatory factors affecting such
medical courses could decrease demand, which could materially adversely affect us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A significant portion of our revenue relating to our
Undergraduate segment is currently concentrated in the tuition fees we charge for our medical courses across our network. For the years
ended December 31, 2025, 2024 and 2023, 85.7%, 85.6% and 85.5%, respectively, of our Undergraduate segment revenue were derived from undergraduate
tuition fees we or our subsidiaries charged for medical courses. Therefore, economic, market or regulatory factors affecting either the
amount of tuition fees we are able to charge for the medical courses we offer or the ability of our students to pay such tuition fees
could result in significantly decreased demand for our services, which could materially adversely affect us.</p>


<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may not be able to successfully expand our presence
and performance in the distance learning business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We may face difficulties in successfully operating
and expanding our distance learning program, as well as in implementing and investing in the necessary technologies. The technological
needs, the customer expectations and market standards in this sector change rapidly. We must quickly modify our products and services
to adapt to new distance learning technologies, practices, rules and regulatory standards. Our competitive position may be adversely affected
if current or future competitors introduce superior products or service platforms, or if our resources are insufficient to develop our
technological capabilities and adapt them to regulatory standards swiftly enough to maintain our competitive position.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, the success of our distance learning
programs depends on the general population having easy and affordable access to the internet, as well as on other technological factors
that are beyond our control. If internet access becomes unavailable, access costs increase to levels significantly higher than current
prices, or if the number of students interested in distance learning educational methods does not increase, we may be unable to successfully
implement our distance learning strategy, which would adversely affect our growth strategy.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Acquisitions of educational institutions, in certain
circumstances, must be approved by the Administrative Council for Economic Defense.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Brazilian legislation provides that acquisitions of
educational institutions meeting certain requirements must be approved by Brazil&#8217;s Administrative Council for Economic Defense <i>(Conselho
Administrativo de Defesa Econ&#244;mica,</i> or CADE) prior to the completion of the acquisition if one of the companies or group of
companies involved has gross annual revenues in Brazil of at least R$750.0 million in the year immediately prior to the acquisition and
any other party or group of companies involved has gross income of at least R$75.0 million in that same period. As part of this process,
CADE analyzes whether the transaction may substantially lessen competition in the relevant market, create or strengthen a dominant position,
or result in the elimination of a significant portion of competition. If CADE determines that the transaction raises competitive concerns,
it may impose structural or behavioral remedies, such as requiring the divestiture of assets, imposing restrictions on certain commercial
practices, or setting conditions for market access. Failure to obtain approval for future acquisitions or to comply with any remedies
imposed as a condition for approval may result in fines or the annulment of the transaction which could adversely affect our results of
operations and financial condition. As a result of our growth strategy through acquisitions of new entities, we may need additional funds
to implement our strategy. Therefore, if we cannot obtain adequate financing to conclude any potential acquisition and implement our expansion
plans, our growth strategy will be affected. See &#8220;&#8212;We may require additional funds to continue our expansion strategy. If
we are unable to obtain adequate financing on favorable terms to complete any potential acquisition and implement our expansion plans,
our growth strategy may be materially and adversely affected.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk127535031"></span>Our Continuing Education
segment is subject to seasonal fluctuations, which may cause our operating results to fluctuate from quarter-to-quarter and adversely
impact our working capital and liquidity throughout the year, adversely affecting our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk194685996"></span>Continuing Education revenues
are mostly related to: (i) monthly intakes and tuition fees on medical education and (ii) revenue derived from the sales of e-books which
are recognized at the point in time when control is transferred to the customer, which is generally concentrated in the first and last
quarter of the year due to the period of enrollments.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Accordingly, we expect quarterly fluctuations in our
revenues and operating results may continue to occur. These fluctuations could result in volatility and adversely affect our liquidity
and cash flows. As our business grows, these seasonal fluctuations may become more relevant. As a result, we believe that sequential quarterly
comparisons of our financial results may not provide an accurate assessment of our financial position.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, the overall macroeconomic environment
in Brazil has undergone significant volatility as a result of adverse political and economic pressures. Adverse macroeconomic conditions
have led to a contraction in the disposable income of both existing and potential clientele within our Continuing Education segment, prompting
a deferral of their intentions to pursue residency and graduate endeavors. Consequently, this resulted in diminished demand for our residency
preparatory courses and medical graduate courses during that timeframe and may result in the risk of reduced financial results and the
impairment of goodwill recorded from the acquired companies in our Continuing Education segment.</p>


<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Recent developments in artificial intelligence regulation
in Brazil may impose additional compliance costs and operational challenges that could adversely affect our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In December 2024, the Brazilian Senate approved the
regulatory framework for artificial intelligence (AI), known as the &#8220;<i>Marco Regulat&#243;rio da Intelig&#234;ncia Artificial</i>,&#8221;
which is currently under consideration by the Brazilian House of Representatives. This proposed legislation, if definitively approved,
would establish comprehensive rules for the development and use of AI systems across various sectors, including education and healthcare.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If enacted, the new regulations may require us to implement
additional compliance measures, such as conducting AI impact assessments, enhancing data security and privacy protocols, and strengthening
corporate risk management frameworks in accordance with regulatory guidelines. Given our reliance on technology-driven solutions for medical
education and digital healthcare services, increased regulatory scrutiny on AI applications could impact our ability to develop, deploy,
or improve AI-based tools.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Compliance with evolving AI regulations may lead to
higher operational costs, delays in innovation, and potential restrictions on certain AI-driven functionalities, which could adversely
affect our business, financial condition, and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Disruption or volatility in global financial and credit
markets could adversely affect the financial and economic environment in Brazil, which could materially and adversely affect our business,
financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our operations are closely tied to the performance
of the Brazilian economy. Volatility in global financial and credit markets, driven by geopolitical conflicts, inflationary pressures,
rising interest rates, and protectionist trade policies, can affect investor confidence, capital flows, commodity prices, and exchange
rates. These dynamics influence Brazil&#8217;s economic stability and, in turn, the financial condition of our customers and counterparties.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Geopolitical instability, including the ongoing conflict
between Russia and Ukraine, the uncertainty following the ceasefire in the Gaza Strip, the recent U.S. and Israeli airstrikes in Iran,
increasing tensions among Middle Eastern countries, the instability in Venezuela after the arrest of President Nicolas Maduro by United
States forces, and tensions between China and the United States, has led to increased volatility in global financial and commodity markets.
These conflicts have contributed to higher fuel and energy and food prices, increased maritime shipping costs, and disrupted global supply
chains. Such developments place inflationary pressure on the Brazilian economy, raise import costs, and may compel monetary authorities
to adopt tighter policies, which could slow economic growth. In addition, the resulting macroeconomic uncertainty may reduce investor
appetite for emerging markets, leading to currency depreciation, lower levels of foreign direct investment, and diminished access to international
capital markets for Brazilian companies, including us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Further contributing to global economic uncertainty,
growing protectionism and trade tensions could intensify and negatively impact the Brazilian economy. The U.S. presidential administration
has increased tariffs, and the possibility of new or higher trade tariffs remains. Certain U.S. trading partners have announced retaliatory
actions, including tariffs, in response. The continuation, pause or escalation of tariffs and other trade restrictions, the continued
depreciation of the U.S. dollar and other non-trade-related measures or policies of the U.S. presidential administration, including immigration
reforms, could further transform international trade relations, investment flows and supply chains significantly, resulting in continued
market volatility and lower global growth, intensifying concerns over the global macroeconomic environment, inflation and the potential
for a recession. Any of the foregoing could have a material adverse effect on our business, results of operations, financial condition
and prospects.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">These external pressures may reduce liquidity and increase
the cost of funding for Brazilian issuers and borrowers, including us. A deterioration in economic conditions could also impair the financial
capacity of our students and adversely affect demand for our programs, products and services. Reduced access to capital may limit our
ability to pursue growth initiatives or respond effectively to changing market conditions, which could negatively affect our results of
operations.</p>


<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk132803645"></span><span id="a_Hlk132138206"></span>
Public health outbreaks, epidemics or pandemics have adversely affected and may continue to adversely affect our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Public health outbreaks, epidemics or pandemics could
materially adversely impact our business. Such public health crises may negatively impact the global economy, disrupt supply chains, and
create significant volatility in global financial markets. They could also lead to interruptions of our on-campus activities to varying
degrees, especially affecting our practical educational activities. The ultimate extent of any such epidemics, pandemics, outbreaks or
other public health crises on our business, financial condition and results of operations would depend on future developments, which are
highly uncertain and cannot be predicted with any certainty. Such developments could therefore have a material adverse effect on our business,
financial condition and results of operations, and it may also have the effect of heightening many of the other risks described in this
&#8220;Risk Factors&#8221; section.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our business continuity and disaster recovery plans may
not adequately protect us from a serious disaster.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Failure to maintain effective business continuity and
disaster recovery plans could materially disrupt our operations and negatively impact our financial performance, reputation, and stakeholder
relationships. Our ability to deliver high-quality educational and medical services across our core segments&#8212;Undergraduate, Continuing
Education, and Medical Practice Services&#8212;relies on uninterrupted operations. Unexpected events, such as natural disasters, wildfires,
public health crises, cyberattacks, technology failures, power outages, or other emergencies, could impair our ability to offer courses,
delay student progression and graduation, and lead to financial losses. The continuity of our Undergraduate and Continuing Education programs
is critical to preserving student trust and academic partnerships, while any disruption to our Medical Practice Services could directly
affect patient care, physician engagement, and relationships with B2B clients, including pharmaceutical companies. If we fail to effectively
mitigate or recover from such disruptions, we could face legal liabilities, financial setbacks, and reputational harm that adversely impact
our business and growth prospects.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Certain Risks Relating to Brazil</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">The Brazilian federal government has exercised, and continues
to exercise, significant influence over the Brazilian economy. This involvement as well as Brazil&#8217;s political and economic conditions
could harm us and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian federal government frequently exercises
significant influence over the Brazilian economy and occasionally makes significant changes in policy and regulations. The Brazilian government&#8217;s
actions to control inflation and other policies and regulations have often involved, among other measures, increases or decreases in interest
rates, changes in fiscal policies, wage and price controls, foreign exchange rate controls, blocking access to bank accounts, currency
devaluations, capital controls and import and export restrictions. We have no control over and cannot predict what measures or policies
the Brazilian government may take in the future. We and the market price of our securities may be harmed by changes in Brazilian government
policies, as well as general economic factors, including, without limitation:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>growth or downturn of the Brazilian economy;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>interest rates and monetary policies;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>exchange rates and currency fluctuations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>inflation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>liquidity of the domestic capital and lending markets;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>import and export controls;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>exchange controls and restrictions on remittances abroad and payments of dividends;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>modifications to laws and regulations according to political, social and economic interests;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>fiscal policy and changes in tax laws;</td></tr></table>


<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>economic, political and social instability, including general strikes and mass demonstrations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the regulatory framework governing the educational industry;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>labor and social security regulations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>energy and water shortages and rationing;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>commodity prices;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in demographics, in particular declining birth rates, which will result in a decrease in the number of enrolled students in
education in the future; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>other political, diplomatic, social and economic developments in or affecting Brazil.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Uncertainty over whether the Brazilian federal government
will implement reforms or changes in policy or regulation affecting these or other factors in the future may affect economic performance
and contribute to economic uncertainty in Brazil, which may have an adverse effect on our activities and consequently our operating results,
and may also adversely affect the trading price of our Class A common shares. Recent economic and political instability has led to a negative
perception of the Brazilian economy and higher volatility in the Brazilian securities markets, which also may adversely affect us and
our Class A common shares. See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;Significant Factors Affecting Our Results
of Operations&#8212;Brazilian Macroeconomic Environment.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Economic uncertainty and political instability in Brazil
may harm our business and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil&#8217;s political environment has historically
influenced, and continues to influence, the performance of the country&#8217;s economy. Periods of political instability and uncertainty
have affected, and may continue to affect, investor and consumer confidence, which has historically resulted in economic deceleration
and heightened volatility in the securities of companies with significant operations in Brazil, including our securities. Recent economic
instability has contributed to reduced market confidence in the Brazilian economy and a challenging political environment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Between 2014 and 2021, the federal government recorded
consecutive fiscal deficits. Although a temporary budget surplus was achieved in 2022, supported in part by rising commodity prices and
higher inflation, fiscal deficits returned in 2023 and 2024 as revenues weakened and expenditures continued to expand, despite ad hoc
fiscal measures enacted at the end of 2023. In 2025, weaker demand and the diminishing effects of prior fiscal stimulus contributed to
slower economic growth. Inflation remained moderate but above target, while fiscal accounts again reflected a primary deficit driven by
rising mandatory expenditures and limited revenue growth. Brazil&#8217;s state governments also continue to face fiscal pressures due
to high debt levels, declining revenues, rigid expenditure structures and extensive federal economic relief programs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As Brazil approaches presidential elections scheduled
for October 2026, uncertainty regarding the outcome of the elections and the direction of future economic, fiscal and regulatory policies
may further exacerbate political and economic uncertainty. This uncertainty could increase volatility in the Brazilian financial markets
and in the market price of securities issued by Brazilian companies, including our Class A common shares, and may adversely affect our
business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Although Brazil&#8217;s tax reform related to consumption-based
taxes was approved by the Brazilian Congress in 2023, its full implementation remains subject to additional complementary legislation,
regulatory guidance and administrative measures through 2026. Uncertainty regarding the scope, timing and practical application of this
reform, together with potential changes to monetary, fiscal and social security policies and related legislation, may further contribute
to economic uncertainty and volatility in Brazil, adversely affecting business confidence, investment levels and overall economic stability.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">These uncertainties and policy developments may increase
volatility in the Brazilian capital markets. A failure by the Brazilian government to implement necessary reforms, or perceptions of fiscal
deterioration or policy instability, could weaken confidence in Brazil&#8217;s fiscal outlook, lead to downgrades of Brazil&#8217;s sovereign
foreign credit ratings, further depreciation of the real and increases in inflation
and interest rates, any of which could materially and adversely affect our business and the trading price of our Class A common shares.</p>


<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk127547312"></span>Inflation and certain measures
by the Brazilian government to curb inflation have historically harmed the Brazilian economy and Brazilian capital markets, and high levels
of inflation in the future would harm our business and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In the past, Brazil has experienced extremely high
rates of inflation. Inflation and some of the measures taken by the Brazilian government in an attempt to curb inflation have had significant
negative effects on the Brazilian economy generally. Inflation, policies adopted to curb inflationary pressures and uncertainties regarding
possible future governmental intervention have contributed to economic uncertainty and heightened volatility in the Brazilian capital
markets.</p>

<p style="font: 10pt/107% Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk131177817"></span>According to the
National Consumer Price Index (<i>&#205;ndice Nacional de Pre&#231;os ao Consumidor Amplo</i>, or IPCA), which is published by the
Brazilian Institute for Geography and Statistics (<i>Instituto Brasileiro de Geografia e Estat&#237;stica</i>, or IBGE), <span id="a_Hlk131177543"></span>Brazilian
inflation rates were 4.3%, 4.8% and 4.6% as of December&#160;31, 2025, 2024 and 2023, respectively. Brazil may experience high levels
of inflation in the future and inflationary pressures may lead to the Brazilian government intervening in the economy and introducing
policies that could harm our business and the trading price of our Class&#160;A common shares. In the past, the Brazilian government&#8217;s
interventions included the maintenance of a restrictive monetary policy with high interest rates that restricted credit availability and
reduced economic growth, causing volatility in interest rates. For example, the Monetary Policy Committee (<i>Comit&#234; de Pol&#237;tica
Monet&#225;ria do Banco Central do Brasil</i>), or COPOM, started raising the official base interest rate (<i>Sistema Especial de Liquida&#231;&#227;o
e Cust&#243;dia</i>) or the SELIC rate, in mid-March 2021, ultimately reaching 9.25% by the end of 2021. Following successive tightening
and easing cycles in response to evolving inflationary and fiscal conditions, the SELIC rate varied significantly over this period and
reached 15% by June 2025. As of the date of this annual report, the SELIC rate stands at 15% per annum, reflecting the challenges of controlling
inflation amid a strong economy, historically low unemployment levels, and fiscal imbalances requiring tighter monetary policy to maintain
economic stability.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk127547633"></span>Exchange rate instability
may have adverse effects on the Brazilian economy, us and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian currency has been historically volatile
and has been devalued frequently over the past three decades. Throughout this period, the Brazilian government has implemented various
economic plans and used various exchange rate policies, including sudden devaluations, periodic mini devaluations (during which the frequency
of adjustments has ranged from daily to monthly), exchange controls, dual exchange rate markets and a floating exchange rate system. Although
long-term depreciation of the real is generally linked to the rate of inflation in Brazil, depreciation of the real occurring over shorter
periods of time has resulted in significant variations in the exchange rate between the real, the U.S. dollar and other currencies.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk127547620"></span>The real/U.S. dollar exchange
rate reported by the Central Bank was R$4.8413 per US$1.00 on December 31, 2023, which reflected a 7.2% appreciation in the real against
the U.S. dollar during 2023. The real/U.S. dollar exchange rate reported by the Central Bank was R$6.1923 per US$1.00 on December 31,
2024, which reflected a 27.9% depreciation in the real against the U.S. dollar during 2024. The real/U.S. dollar exchange rate reported
by the Central Bank was R$5.5024 per US$1.00 on December 31, 2025, which reflected a 11.1% appreciation in the real against the U.S. dollar
during 2025. As of March 23, 2026, the exchange rate for the sale of U.S. dollars as reported by the Central Bank was R$5.2440 per US$1.00,
which reflected an appreciation of 4.7% in the real against the U.S. dollar since December 31, 2025. There can be no assurance that the
real will not again depreciate or appreciate against the U.S. dollar or other currencies in the future.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A devaluation of the <i>real</i> relative to the U.S.
dollar could create inflationary pressures in Brazil and cause the Brazilian government to, among other measures, increase interest rates.
Any depreciation of the <i>real</i> may generally restrict access to the international capital markets. It would also reduce the U.S.
dollar value of our results of operations. Restrictive macroeconomic policies could reduce the stability of the Brazilian economy and
harm our results of operations and profitability. In addition, domestic and international reactions to restrictive economic policies could
have a negative impact on the Brazilian economy. These policies and any reactions to them may harm us by curtailing access to foreign
financial markets and prompting further government intervention. A devaluation of the <i>real</i> relative to the U.S. dollar may also, as in the context
of the current economic slowdown, decrease consumer spending, increase deflationary pressures and reduce economic growth.</p>


<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On the other hand, an appreciation of the real relative
to the U.S. dollar and other foreign currencies may deteriorate the Brazilian foreign exchange current accounts. Depending on the circumstances,
either devaluation or appreciation of the <i>real</i> relative to the U.S. dollar and other foreign currencies could restrict the growth
of the Brazilian economy, as well as our business, results of operations and profitability.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk127548048"></span><span id="a_Hlk131177983"></span>Infrastructure
and workforce deficiency in Brazil may impact economic growth and have a material adverse effect on us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our performance depends on the overall health and growth
of the Brazilian economy. Brazilian GDP growth has fluctuated over the past few years, notwithstanding a growth of 2.9% in 2023, a growth
of 3.4% in 2024, and a growth of 2.3% in 2025. Growth is limited by inadequate infrastructure, including potential energy shortages and
deficient transportation, logistics and telecommunication sectors, general strikes, the lack of a qualified labor force, and the lack
of private and public investments in these areas, which limit productivity and efficiency. Any of these factors could lead to labor market
volatility and generally impact income, purchasing power and consumption levels, which could limit growth and ultimately have a material
adverse effect on us.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Developments and the perceptions of risks in other countries,
including other emerging markets, the United States and Europe, may harm the Brazilian economy and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The market for securities offered by companies with
significant operations in Brazil is influenced by economic and market conditions in Brazil and, to varying degrees, market conditions
in other Latin American and emerging markets, as well as the United States, Europe and other countries. There have been concerns over
conflicts, unrest and terrorist threats in the Middle East, Europe and Africa, which have resulted in volatility in oil and other markets.
Furthermore, since returning to office, President Trump&#8217;s administration been implementing protectionist policies, including the
expansion of tariffs on a range of goods from key trading partners such as China, the European Union and Brazil. Among others, in 2025,
the U.S. government announced an increase in tariffs on Brazilian imports, including industrial goods, commodities and agricultural products,
which took effect, subject to certain exceptions. Subsequently, on February 20, 2026, the U.S. Supreme Court ruled that certain broad
tariffs imposed under the International Emergency Economic Power Act (IEEPA) were unlawful for lack of presidential authority. However,
other tariff measures remain in effect and may be subject to further policy developments. Increased tariffs and the potential for further
trade restrictions may lead to a slowdown in global trade and economic activity, with disproportionate effects on emerging markets like
Brazil. Such developments could result in greater currency volatility, reduced foreign investment flows, higher inflation, and increased
interest rates in affected jurisdictions, including Brazil, all of which can negatively impact <span style="background-color: white">our
</span>business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">To the extent the conditions of the global markets
or economy deteriorate, the business of companies with significant operations in Brazil may be harmed. The weakness in the global economy
has been marked by, among other adverse factors, lower levels of consumer and corporate confidence, decreased business investment and
consumer spending, increased unemployment, reduced income and asset values in many areas, currency volatility and limited availability
of credit and access to capital. Developments or economic conditions in other emerging market countries have at times significantly affected
the availability of credit to companies with significant operations in Brazil and resulted in considerable outflows of funds from Brazil,
decreasing the amount of foreign investments in Brazil. These developments, as well as potential crises and forms of political instability
arising therefrom or any other as of yet unforeseen development, may harm our business and the price of our Class&#160;A common shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk127548141"></span>Any further downgrading
of Brazil&#8217;s credit rating could reduce the trading price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We and the trading price of our Class A common shares
may be harmed by investors&#8217; perceptions of risks related to Brazil&#8217;s sovereign debt credit rating. Rating agencies regularly
evaluate Brazil and its sovereign credit ratings, which are based on a number of factors, including macroeconomic trends, fiscal and budgetary
conditions, indebtedness metrics and the perspective of changes in any of these factors.</p>


<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk127548205"></span> Beginning in 2015, rating
agencies initiated a series of reviews of Brazil&#8217;s sovereign credit rating, which resulted in the loss of Brazil&#8217;s investment
grade status and multiple downgrades across the major agencies. Since then, Brazil&#8217;s sovereign credit ratings have remained below
investment grade, despite periods of stabilization and selective upgrades that reflected, among other factors, Brazil&#8217;s external
position, monetary policy credibility and expectations of gradual fiscal adjustment:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span id="a_Hlk131178179"></span><span style="font-family: Symbol">&#183;</span></td><td>Standard &amp; Poor&#8217;s downgraded Brazil to below investment grade beginning in 2015. The agency has since taken rating actions
reflecting changes in macroeconomic and fiscal conditions, and as of June 5, 2025, Brazil was rated BB with a stable outlook.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Moody&#8217;s downgraded Brazil to below investment grade beginning in 2015. While Moody&#8217;s has implemented rating and outlook
actions over time, Brazil remains below investment grade and, as of May 30, 2025, Brazil was rated Ba1 with a stable outlook.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Fitch downgraded Brazil to below investment grade beginning in 2015, reflecting in part fiscal and macroeconomic conditions. Fitch
has since taken actions reflecting changes in economic and policy conditions, and as of June 25, 2025, Brazil was rated BB with a stable
outlook.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil&#8217;s sovereign credit rating is currently
rated below investment grade by the three main credit rating agencies. Consequently, the prices of securities offered by companies with
significant operations in Brazil have been negatively affected. A prolongation or worsening of the challenging economic conditions currently
facing Brazil, along with continued political uncertainty, among other factors, could lead to further ratings downgrades. Any further
downgrade of Brazil&#8217;s sovereign foreign credit ratings could heighten investors&#8217; perception of risk and, as a result, cause
the trading price of our Class A common shares to decline.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Certain Risks Relating to Our Class A Common Shares</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">An active trading market for our Class A common shares
may not be sustainable. If an active trading market is not maintained, investors may not be able to resell their shares and our ability
to raise capital in the future may be impaired.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Although our Class A common shares are listed and being
traded on the Nasdaq Global Select Market, an active trading market for our shares may not be maintained. The existence of our dual-class
share structure could also result in less liquidity for our Class A common shares than if there were only one class of our common shares.
If an active market for our Class A common shares is not maintained, it may be difficult for you to sell shares without depressing the
market price for the shares or at all. An inactive trading market may also impair our ability to raise capital to continue to fund operations
by selling shares and may impair our ability to acquire other companies or technologies by using our shares as consideration. In addition
to the risks described above, the market price of our Class A common shares may be influenced by many factors, some of which are beyond
our control, including:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>announcements by us or our competitors of significant contracts or acquisitions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>technological innovations by us or competitors;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the failure of financial analysts to cover our Class A common shares or changes in financial estimates by analysts;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>actual or anticipated variations in our operating results;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in financial estimates by financial analysts, or any failure by us to meet or exceed any of these estimates, or changes in
the recommendations of any financial analysts that elect to follow our Class A common shares or the shares of our competitors;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>future sales of our shares; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>investor perceptions of us and the industries in which we operate.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the stock market in general has experienced
substantial price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of particular
companies affected. These broad market and industry factors may materially harm the market price of our
Class A common shares, regardless of our operating performance. In the past, following periods of volatility in the market price of certain
companies&#8217; securities, securities class action litigation has been instituted against these companies. This litigation, if instituted
against us, could adversely affect our financial condition or results of operations. If a market is not maintained, the liquidity and
price of our Class A common shares could be seriously harmed.</p>


<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk127549166"></span><span id="a_Hlk131610272"></span>The
concentration of ownership and voting power in Bertelsmann, our controlling shareholder, limits your ability to influence corporate matters.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Bertelsmann, our controlling shareholder, owns 88.3%
of our outstanding Class B common shares, which, together with its ownership of 51.8% of our outstanding Class A common shares, represent
approximately 64.7% of our outstanding share capital and 84.0% of the voting power of our outstanding share capital, and, together with
the Esteves Family, controls all matters requiring shareholder approval. Our Class B common shares are entitled to 10 votes per share
and our Class A common shares, which are the common shares trading on the Nasdaq, are entitled to one vote per share. Our Class B common
shares are convertible into an equivalent number of Class A common shares and generally convert into Class A common shares upon transfer
subject to limited exceptions. As a result, Bertelsmann and the Esteves Family will control the outcome of all of our decisions at our
shareholders&#8217; meetings, and Bertelsmann alone is able to elect a majority of the members of our board of directors. <span id="a_cp_change_251"></span>The
decisions of Bertelsmann and the Esteves Family on these matters may be contrary to your expectations or preferences, and they may take
actions that could be contrary to your interests. They are able to prevent any other shareholders, including you, from blocking these
actions. For further information regarding shareholdings in our company, see &#8220;Item 7. Major Shareholders and Related Party Transactions&#8212;A.
Major Shareholders.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">So long as Bertelsmann and the Esteves Family continue
to beneficially own a sufficient number of Class B common shares, even if they beneficially own significantly less than 50% of our outstanding
share capital, acting together, they will be able to effectively control the outcome of all decisions at our shareholders&#8217; meetings.
For example, if our Class B common shares amounted to 15% of our outstanding common shares, beneficial owners of our Class B common shares
(consisting of the Esteves Family and Bertelsmann), would collectively control 63.8% of the voting power of our outstanding common shares.
If Bertelsmann sells or transfers any of its Class B common shares, they will generally convert automatically into Class A common shares,
subject to limited exceptions, such as transfers to affiliates, to trustees for the holder or its affiliates and certain transfers to
U.S. tax exempt organizations. The fact that any Class B common shares convert into Class A common shares if Bertelsmann sells or transfers
them means that Bertelsmann will in many situations continue to control a majority of the combined voting power of our outstanding share
capital, due to the voting rights of any Class B common shares that it will retain. However, if our Class B common shares at any time
represent less than 10% of the total number of shares in the capital of the Company outstanding, the Class B common shares then outstanding
will automatically convert into Class A common shares. For a description of our dual class equity structure, see &#8220;Item 10. Additional
Information&#8212;B. Memorandum and Articles of Association&#8212;Description of Share Capital.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Class A common shares eligible for future sale may cause
the market price of our Class A common shares to drop significantly.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The market price of our Class A common shares may decline
as a result of sales of a large number of our Class A common shares in the market (including Class A common shares issuable upon conversion
of Class B common shares) or the perception that these sales may occur. These sales, or the possibility that these sales may occur, also
might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The number of total shares as of December 31, 2025
was 55,148,697 Class A common shares and 38,574,134 Class B common shares, which, except as set forth below, are freely tradable without
restriction or further registration under the Securities Act by persons other than our affiliates within the meaning of Rule 144 of the
Securities Act.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our shareholders or entities controlled by them or
their permitted transferees will be able to sell their shares in the public market from time to time without registering them, subject
to certain limitations on the timing, amount and method of those sales imposed by regulations promulgated by the SEC.</p>


<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If any of our shareholders, the affiliated entities
controlled by them or their respective permitted transferees were to sell a large number of their shares, the market price of our Class
A common shares may decline significantly. In addition, the perception in the public markets that sales by them might occur may also adversely
affect the market price of our Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our Articles of Association contain anti-takeover provisions
that may discourage a third party from acquiring us and adversely affect the rights of holders of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association contain certain provisions
that could limit the ability of others to acquire our control, including a provision that grants authority to our board of directors to
establish and issue from time to time one or more series of preferred shares without action by our shareholders and to determine, with
respect to any series of preferred shares, the terms and rights of that series. These provisions could have the effect of depriving our
shareholders of the opportunity to sell their shares at a premium over the prevailing market price by discouraging third parties from
seeking to obtain our control in a tender offer or similar transactions.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">If securities or industry analysts publish inaccurate
or unfavorable research, about our business, the price of our Class A common shares and our trading volume could decline.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The trading market for our Class A common shares will
depend in part on the research and reports that securities or industry analysts publish about us, our business, our market or our competitors.
In the event one or more of the analysts who cover us downgrades us or releases negative publicity about our Class A common shares, our
share price would likely decline.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Further, as we are not required to publish quarterly
financial information, if we cease to publish that information, any analysts covering us may not have enough information to compare us
to our peers on a regular basis and may choose to cease coverage. If one or more of these analysts ceases to cover us or fails to regularly
publish reports on us, interest in our Class A common shares may decrease, which may cause our share price or trading volume to decline.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">There can be no assurance that we will continue to declare
dividends.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On March 12, 2026, our Board of Directors approved
dividend distribution in the amount of R$307.4 million, payable in U.S. dollars on April 6, 2026, to&#160;the shareholders on record as
of the close of business on March 25, 2026. For additional information, see &#8220;Item 8. Financial Information&#8212;A. Consolidated
Statements and Other Financial Information&#8212;Dividends and Dividend Policy.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The payment of any dividends in the future is subject
to continued capital availability, market conditions, applicable laws and agreements, and our board of directors continuing to determine
that the declaration of dividends is in the best interests of the Company. The declaration and payment of any dividend may be re-evaluated
at any time, and there can be no assurance that we will declare dividends in the future in any particular amounts, or at all.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our dual class equity structure means our shares will
not be included in certain indices. We cannot predict the impact this may have on our share price.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In 2017, FTSE Russell, S&amp;P Dow Jones and MSCI announced
changes to their eligibility criteria for inclusion of shares of public companies on certain indices to exclude companies with multiple
classes of shares of common stock from being added to such indices. FTSE Russell announced plans to require new constituents of its indices
to have at least five percent of their voting rights in the hands of public stockholders, whereas S&amp;P Dow Jones announced that companies
with multiple share classes, such as ours, will not be eligible for inclusion in the S&amp;P 500, S&amp;P MidCap 400 and S&amp;P SmallCap
600, which together make up the S&amp;P Composite 1500. MSCI also opened public consultations on their treatment of no-vote and multi-class
structures and temporarily barred new multi-class listings from its ACWI Investable Market Index and U.S. Investable Market 2500 Index;
however, in October 2018, MSCI announced its decision to include equity securities &#8220;with unequal voting structures&#8221; in its
indices and to launch a new index that specifically includes voting rights in its eligibility criteria.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We cannot assure you that other stock indices will
not take a similar approach to FTSE Russell, S&amp;P Dow Jones and MSCI in the future. Under the announced policies, our dual class equity
structure would make us ineligible for inclusion in any of these indices and, as a result, mutual funds, exchange-traded funds and other
investment vehicles that attempt to passively track these indices will not invest in our stock. It continues to be somewhat unclear what effect, if any, these policies will have on the valuations
of publicly traded companies excluded from the indices, but in certain situations they may depress these valuations compared to those
of other similar companies that are included. Exclusion from indices could make our Class A common shares less attractive to investors
and, as a result, the market price of our Class A common shares could be adversely affected.</p>


<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our dual class equity structure concentrates voting control
with the holders of our Class B common shares, which may limit your ability to influence corporate matters.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Each Class A common share entitles its holder to one
vote per share, and each Class B common share entitles its holder to 10 votes per share. Due to the 10-to-one voting ratio between our
Class B and Class A common shares, the beneficial owners of our Class B common shares (composed of the Esteves Family and Bertelsmann)
collectively will continue to control a majority of the combined voting power of our common shares and therefore be able to control all
matters submitted to our shareholders so long as the total number of the issued and outstanding Class B common shares is at least 16.67%
of the total number of shares outstanding. However, if our Class B common shares at any time represent less than 10% of the total number
of shares in the capital of the Company outstanding, the Class B common shares then outstanding will automatically convert into Class
A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, our Articles of Association provide that
at any time when there are Class A common shares in issue, additional Class B common shares may only be issued pursuant to (1)&#160;a
share split, subdivision of shares or similar transaction or where a dividend or other distribution is paid by the issue of shares or
rights to acquire shares or following capitalization of profits, (2)&#160;a merger, consolidation, or other business combination involving
the issuance of Class B common shares as full or partial consideration, or (3)&#160;an issuance of Class A common shares, whereby holders
of the Class B common shares are entitled to purchase a number of Class B common shares that would allow them to maintain their proportional
ownership interests in Afya (following an offer by us to each holder of Class B common shares to issue to such holder, upon the same economic
terms and at the same price, such number of Class B common shares as would ensure such holder may maintain a proportional ownership interest
in Afya pursuant to our Articles of Association).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Future transfers by holders of Class B common shares
will generally result in those shares converting to Class A common shares, subject to limited exceptions, such as certain transfers effected
to permitted transferees or for estate planning or charitable purposes. The conversion of Class B common shares to Class A common shares
will have the effect, over time, of increasing the relative voting power of those holders of Class B common shares who retain their shares
in the long term.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In light of the above provisions relating to the issuance
of additional Class B common shares, the fact that future transfers by holders of Class B common shares will generally result in those
shares converting to Class A common shares, subject to limited exceptions as provided in the Articles of Association; as well as the 10-to-one
voting ratio of our Class B common shares and Class A common shares, holders of our Class B common shares will in many situations continue
to maintain control of all matters requiring shareholder approval. This concentrated control will limit or preclude your ability to influence
corporate matters for the foreseeable future. For a description of our dual class equity structure, see &#8220;Item 10. Additional Information&#8212;B.
Memorandum and Articles of Association&#8212;Description of Share Capital&#8212;Voting Rights.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We are a Cayman Islands exempted company with limited
liability. The rights of our shareholders, including with respect to fiduciary duties and corporate opportunities, may be different from
the rights of shareholders governed by the laws of U.S. jurisdictions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are a Cayman Islands exempted company with limited
liability. Our corporate affairs are governed by our Articles of Association and by the laws of the Cayman Islands. The rights of shareholders
and the responsibilities of members of our board of directors may be different from the rights of shareholders and responsibilities of
directors in companies governed by the laws of U.S. jurisdictions. In particular, as a matter of Cayman Islands law, directors of a Cayman
Islands company owe fiduciary duties to the company and separately a duty of care, diligence and skill to the company.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, directors and officers owe
the following fiduciary duties: (i)&#160;duty to act in good faith in what the director or officer believes to be in the best interests
of the company as a whole; (ii)&#160;duty to exercise powers for the purposes for which those powers were conferred and not for a collateral
purpose; (iii)&#160;directors should not improperly fetter the exercise of future discretion; (iv)&#160;duty to exercise powers fairly
as between different sections of shareholders; (v)&#160;duty to exercise independent
judgment; and (vi)&#160;duty not to put themselves in a position in which there is a conflict between their duty to the company and their
personal interests. Our Articles of Association have varied this last obligation by providing that a director must disclose the nature
and extent of his or her interest in any contract or arrangement, and following such disclosure and subject to any separate requirement
under applicable law or the listing rules of the Nasdaq, and unless disqualified by the chairman of the relevant meeting, such director
may vote in respect of any transaction or arrangement in which he or she is interested and may be counted in the quorum at the meeting.
Conversely, under Delaware corporate law, a director has a fiduciary duty to the corporation and its stockholders (made up of two components)
and the director&#8217;s duties prohibit self-dealing by a director and mandate that the best interest of the corporation and its shareholders
take precedence over any interest possessed by a director, officer or controlling shareholder and not shared by the shareholders generally.
See &#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles of Association&#8212;Description of Share Capital&#8212;Principal
Differences between Cayman Islands and U.S. Corporate Law.&#8221;</p>


<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may need to raise additional capital in the future
by issuing securities, use our Class A common shares as acquisition consideration or enter into corporate transactions with an effect
similar to a merger, which may dilute your interest in our share capital and affect the trading price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We may need to raise additional funds to grow our business
and implement our growth strategy going forward through public or private issuances of common shares or securities convertible into, or
exchangeable for, our common shares, which may dilute your interest in our share capital or result in a decrease in the market price of
our common shares. In addition, we may also use our Class A common shares as acquisition consideration or enter into mergers or other
similar transactions in the future, which may dilute your interest in our share capital or result in a decrease in the market price of
our Class A common shares. Any fundraising through the issuance of shares or securities convertible into or exchangeable for shares, the
use of our Class A common shares as acquisition consideration, or the participation in corporate transactions with an effect similar to
a merger, may dilute your interest in our share capital or result in a decrease in the market price of our Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">As a foreign private issuer, we have different disclosure
and other requirements than U.S. domestic registrants.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a foreign private issuer, we are subject to different
disclosure and other requirements than domestic U.S. registrants. For example, as a foreign private issuer, in the United States, we are
not subject to the same disclosure requirements as a domestic U.S. registrant under the Exchange Act, including the requirements to prepare
and issue quarterly reports on Form 10-Q or to file current reports on Form 8-K upon the occurrence of specified significant events, the
proxy rules applicable to domestic U.S. registrants under Section 14 of the Exchange Act or the insider reporting and short-swing profit
rules applicable to domestic U.S. registrants under Section 16 of the Exchange Act. In addition, we rely on exemptions from certain U.S.
rules which permit us to follow Cayman Islands legal requirements rather than certain of the requirements that are applicable to U.S.
domestic registrants.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We follow Cayman Islands laws and regulations that
are applicable to Cayman Islands companies. However, Cayman Islands laws and regulations applicable to Cayman Islands companies do not
contain any provisions comparable to the U.S. proxy rules, the U.S. rules relating to the filing of reports on Form 10-Q or 8-K or the
U.S. rules relating to liability for insiders who profit from trades made in a short period of time, as referred to above.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Furthermore, foreign private issuers are required to
file their annual report on Form 20-F within 120 days after the end of each fiscal year, while U.S. domestic issuers that are accelerated
filers are required to file their annual report on Form 10-K within 75 days after the end of each fiscal year. Foreign private issuers
are also exempt from Regulation Fair Disclosure, aimed at preventing issuers from making selective disclosures of material information,
although we will be subject to Cayman Islands laws and regulations having substantially the same effect as Regulation Fair Disclosure.
As a result of the above, even though we are required to file reports on Form 6-K disclosing the limited information which we have made
or are required to make public pursuant to Cayman Islands law, or are required to distribute to shareholders generally, and that is material
to us, you may not receive information of the same type or amount that is required to be disclosed to shareholders of a U.S. company.</p>


<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">As a foreign private issuer, we rely on permitted exemptions
from certain Nasdaq corporate governance standards applicable to U.S. issuers, including the requirement that a majority of an issuer&#8217;s
directors consist of independent directors. This may afford less protection to holders of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Section 5605 of the Nasdaq equity rules requires listed
companies to have, among other things, a majority of their board members be independent, and to have independent director oversight of
executive compensation, nomination of directors and corporate governance matters. As a foreign private issuer, however, we are permitted
to, and we have, and will continue to, follow home country practice in lieu of the above requirements. See &#8220;Item 10. Additional
Information&#8212;B. Memorandum and Articles of Association&#8212;Description of Share Capital&#8212;Principal Differences between Cayman
Islands and U.S. Corporate Law.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may lose our foreign private issuer status, which
would then require us to comply with the Exchange Act&#8217;s domestic reporting regime and cause us to incur significant legal, accounting
and other expenses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In order to maintain our current status as a foreign
private issuer, either (a)&#160;more than 50% of our Class A common shares must be either directly or indirectly owned of record by non-residents
of the United States or (b)(i)&#160;a majority of our executive officers or directors may not be U.S. citizens or residents, (ii)&#160;more
than 50% of our assets cannot be located in the United States and (iii)&#160;our business must be administered principally outside the
United States. If we lose this status, we would be required to comply with the Exchange Act reporting and other requirements applicable
to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We may also be required
to make changes in our corporate governance practices in accordance with various SEC and Nasdaq rules. The regulatory and compliance costs
to us under U.S. securities laws if we are required to comply with the reporting requirements applicable to a U.S. domestic issuer may
be significantly higher than the costs we will incur as a foreign private issuer.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our shareholders may face difficulties in protecting
their interests because we are a Cayman Islands exempted company.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our corporate affairs are governed by our Articles
of Association, by the Companies Act (As Revised) of the Cayman Islands and the common law of the Cayman Islands. The rights of shareholders
to take action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under
Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived
in part from comparatively limited judicial precedent in the Cayman Islands as well as that from English common law, which has persuasive,
but not binding, authority on a court in the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our
directors under Cayman Islands law are different from what they would be under statutes or judicial precedent in some jurisdictions in
the United States. In particular, the Cayman Islands has a less exhaustive body of securities laws than the United States. In addition,
some U.S. states, such as Delaware, have more fully developed and judicially interpreted bodies of corporate law.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a result of all of the above, public shareholders
may have more difficulty in protecting their interests in the face of actions taken by management, members of the board of directors or
controlling shareholder than they would as shareholders of a corporation incorporated in a jurisdiction in the United States.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">While Cayman Islands law allows a dissenting shareholder
to express the shareholder&#8217;s view that a court-sanctioned reorganization by way of a scheme of arrangement of a Cayman Islands company
would not provide fair value for the shareholder&#8217;s shares, Cayman Islands statutory law does not specifically provide for shareholder
appraisal rights in connection with a court sanctioned reorganization by way of a scheme of arrangement. This may make it more difficult
for you to assess the value of any consideration you may receive in a merger or consolidation by way of a scheme of arrangement or to
require that the acquirer gives you additional consideration if you believe the consideration offered is insufficient. However, Cayman
Islands statutory law provides a mechanism for a dissenting shareholder in a statutory merger or consolidation to apply to the Grand Court
of the Cayman Islands for a determination of the fair value of the dissenter&#8217;s shares if it is not possible for the company and
the dissenter to agree on a fair price within the time limits prescribed.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Shareholders of Cayman Islands exempted companies (such
as us) have no general rights under Cayman Islands law to inspect corporate records and accounts or to obtain copies of lists of shareholders.
Our directors have discretion under our Articles of Association to determine whether or not, and under what conditions, our corporate
records may be inspected by our shareholders, but are not obliged to make them available to our shareholders. This may make it more difficult for you to obtain information needed to establish
any facts necessary for a shareholder motion or to solicit proxies from other shareholders in connection with a proxy contest.</p>


<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">United States civil liabilities and certain judgments
obtained against us by our shareholders may not be enforceable.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are a Cayman Islands exempted company and substantially
all of our assets are located outside of the United States. In addition, the majority of our directors and officers are nationals and
residents of countries other than the United States. A substantial portion of the assets of these persons is located outside of the United
States. As a result, it may be difficult to effect service of process within the United States upon these persons. It may also be difficult
to enforce in U.S. courts judgments obtained in U.S. courts based on the civil liability provisions of the U.S. federal securities laws
against us and our officers and directors who are not resident in the United States and the substantial majority of whose assets are located
outside of the United States.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Further, it is unclear if original actions predicated
on civil liabilities based solely upon U.S. federal securities laws are enforceable in courts outside the United States, including in
the Cayman Islands and Brazil. Courts of the Cayman Islands are unlikely (i) to recognize or enforce against us judgments of courts of
the United States predicated upon the civil liability provisions of the federal securities laws of the United States or any state; and
(ii) in original actions brought in the Cayman Islands, to impose liabilities against us predicated upon the civil liability provisions
of the federal securities laws of the United States or any state, so far as the liabilities imposed by those provisions are penal in nature.
In those circumstances, although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the
courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without
retrial on the merits based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation
to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman
Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty,
inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner,
or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive
or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court may stay enforcement proceedings if concurrent
proceedings are being brought elsewhere.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Judgments of Brazilian courts to enforce our obligations
with respect to our Class A common shares may be payable only in <span style="font-style: normal">reais</span>.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Most of our assets are located in Brazil. If proceedings
are brought in the courts of Brazil seeking to enforce our obligations in respect of our Class A common shares, we may not be required
to discharge our obligations in a currency other than the <i>real.</i> Under Brazilian exchange control laws, an obligation in Brazil
to pay amounts denominated in a currency other than the <i>real </i>may only be satisfied in Brazilian currency at the exchange rate,
as determined by the Central Bank, in effect on the date the judgment is obtained, and such amounts are then adjusted to reflect exchange
rate variations through the effective payment date. The then-prevailing exchange rate may not afford non-Brazilian investors with full
compensation for any claim arising out of or related to our obligations under the Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our Class A common shares may not be a suitable investment
for all investors, as an investment in our Class A common shares presents risks and the possibility of financial losses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The investment in our Class A common shares is subject
to risks. Investors who wish to invest in our Class A common shares are thus subject to asset losses, including loss of the entire value
of their investment, as well as other risks, including those related to our Class A common shares, us, the sector in which we operate,
our shareholders and the general macroeconomic environment in Brazil, among other risks.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Each potential investor in our Class A common shares
must therefore determine the suitability of that investment in light of its own circumstances. In particular, each potential investor
should:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>have sufficient knowledge and experience to make a meaningful evaluation of our Class A common shares, the merits and risks of investing
in our Class A common shares and the information contained in this annual report;</td></tr></table>


<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>have access to, and knowledge of, appropriate analytical tools to evaluate, in the context of its particular financial situation,
an investment in our Class A common shares and the impact our Class A common shares will have on its overall investment portfolio;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>have sufficient financial resources and liquidity to bear all of the risks of an investment in our Class A common shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>understand thoroughly the terms of our Class A common shares and be familiar with the behavior of any relevant indices and financial
markets; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>be able to evaluate (either alone or with the help of a financial adviser) possible scenarios for economic, interest rate and other
factors that may affect its investment and its ability to bear the applicable risks.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">There can be no assurance that we will not be a passive
foreign investment company, or PFIC, for any taxable year, which could subject United States investors in our Class A common shares to
significant adverse U.S. federal income tax consequences.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Internal Revenue Code of 1986, as amended
(the &#8220;Code&#8221;), we will be a PFIC for any taxable year in which, after the application of certain look-through rules with respect
to subsidiaries, either (i) 75% or more of our gross income consists of &#8220;passive income,&#8221; or (ii) 50% or more of the average
quarterly value of our assets consists of assets that produce, or are held for the production of, &#8220;passive income.&#8221; Passive
income generally includes dividends, interest, certain non-active rents and royalties, and capital gains. Cash is generally a passive
asset for these purposes. Goodwill is an active asset to the extent attributable to activities that produce active income.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Based on the composition of our income and assets and
the value of our assets, including goodwill (the implied value of which we estimate based on the price of our Class A common shares),
we believe that we were not a PFIC for the taxable year of 2025. However, because we hold a substantial amount of cash (relative to the
assets shown on our balance sheet) and because our PFIC status for any taxable year will depend on the composition of our income and assets
and the value of our assets from time to time (which may be determined, in part, by reference to the market price of our Class A common
shares, which could be volatile), there can be no assurance that we will not be a PFIC for any taxable year. If our Class A common share
price declines while we continue to hold a substantial amount of cash for any taxable year, our risk of being or becoming a PFIC will
increase. In addition, as we continue to expand our business through acquisitions and organically, our risk of becoming a PFIC will increase
if we engage in activities that generate substantial passive income. Moreover, the extent to which our goodwill will be treated as an
active asset is not entirely clear. If we are a PFIC for any taxable year during which a U.S. investor holds Class A common shares, we
generally will continue to be treated as a PFIC with respect to that U.S. investor for all succeeding years during which the U.S. investor
holds Class A common shares, even if we ceased to meet the threshold requirement for PFIC status. Such a U.S. investor may be subject
to certain adverse U.S. federal income tax consequences. See &#8220;Item 10. Additional Information&#8212;10.E. Taxation&#8212;U.S. Federal
Income Tax Considerations&#8212;Passive Foreign Investment Company Rules.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609479"></span><span id="a_Toc225309231"></span><span id="a_Toc196072472"></span><span id="a_Toc164277172"></span><span id="a_Toc194891108"></span><span id="a_Toc190934945"></span><span id="a_Toc133237645"></span><span id="a_Toc163120239"></span><span id="a_Toc131580967"></span>ITEM
4. INFORMATION ON THE COMPANY</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609480"></span><span id="a_Toc225309232"></span><span id="a_Toc196072473"></span><span id="a_Toc164277173"></span><span id="a_Toc194891109"></span><span id="a_Toc190934946"></span><span id="a_Toc133237646"></span><span id="a_Toc163120240"></span><span id="a_Toc131580968"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;History
and Development of the Company</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya Limited is a publicly held company listed on the
Nasdaq since July 2019, and therefore subject to certain reporting requirements of the Exchange Act.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We were incorporated on March 22, 2019, as a Cayman
Islands exempted company with limited liability duly registered with the Cayman Islands Registrar of Companies. Our corporate purposes
are unrestricted, and we have the authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies
Act (As Revised) of the Cayman Islands, or the Companies Act.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our affairs are governed principally by (i)&#160;our
Amended and Restated Memorandum and Articles of Association; (ii)&#160;the Companies Act; and (iii)&#160;the common law of the Cayman
Islands. As provided in our Amended and Restated Memorandum and Articles of Association, subject to Cayman Islands law, we have full capacity
to carry on or undertake any business or activity, do any act or enter into any transaction, and, for such purposes, full rights, powers and privileges. Our registered office is c/o Maples Corporate
Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.</p>


<!-- Field: Page; Sequence: 52 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The SEC maintains an internet site (http://www.sec.gov)
that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our internet address is https://ir.afya.com.br/.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our History</p>

<p style="font: bold 10pt Times New Roman,serif; text-align: center; margin-top: 0; margin-bottom: 10pt"><img src="image_001.jpg" alt="" style="height: 218px; width: 975px"/>&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya Brazil was established with the objective of offering
medical education programs supported by a standardized academic and operational model. In order to achieve that, we have assembled institutions
that collectively will help us fulfill our mission. The combination of Afya Brazil, the largest medical education group in Brazil on a
per-seat basis, according to MEC, and Medcel, one of the leaders in residency exams preparatory courses, was the first step toward achieving
our goal.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya benefits from over 26 years of medical education
experience through Afya Brazil and Medcel, both of which were founded and managed by physicians, with a focus on academic excellence and
deep roots in technology and innovation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We were founded in 1999 with the opening of our first
medical school, Centro Universit&#225;rio ITPAC, by the Esteves Family, a family of medical professionals with a passion for medical
education. Since its inception, our focus has been on medical and related health courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Medcel was founded by Dr. Atilio Barbosa in 2004, a
pioneer in online medical preparatory courses. In 2007, Medcel launched a proprietary platform to broadcast online classes. Over the years,
Medcel evolved from its online platform into an adaptive digital learning environment where students can access digital media, watch medical
case studies, listen to podcasts and answer personalized quizzes. In 2018, Medcel began offering its high-quality tech-enabled content
in different formats and to other academic institutions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In 2016, the private equity group Crescera Investimentos
(formerly Bozano Investimentos) joined forces with Afya Brazil and Medcel, laying out the foundations for the creation of the largest
medical education group in Brazil. Crescera has since sold its interest in Afya to Bertelsmann in 2021. See &#8220;&#8212; Acquisition
of Crescera Shares by Bertelsmann&#8221; below. Medcel was merged into Afya Brazil in 2024.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The industry expertise of our founders combined with
the governance and financial support of Crescera Investimentos allowed the group to dive deeper into its mission as a thematic educational
service provider focused on the lifelong learning career of physicians in Brazil. We achieve this through the production and distribution
of high-quality content through technology.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, 26,313 physicians had graduated
with us since the founding of our predecessor companies. Over the last decade, Afya Brazil grew into a large medical education group,
with several campuses and as of December 31, 2025, had 86,025 undergraduate students, of which 52,101 were health-related students and
33,924 were non-health-related students. We also had 55,039 students in the Continuing Education segment and 195,504 active payers in
the Medical Practice Solutions segment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In order to achieve our goals, we have laid the foundations
of Afya focusing on a four-step process:</p>


<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Management Professionalization</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our highly skilled and experienced management team
has extensive experience in the education industry and was hired from some of the best health, education and technology institutions in
Brazil. Our management team is part of a company-wide strategy to attract and retain the best talent. Our CEO, Virgilio Deloy Capobianco
Gibbon, has over 17 years of experience in education. Our CFO, Luis Andr&#233; Blanco, has over 16 years of experience as CFO, and L&#233;lio
de Souza Junior, our Vice President of Medical Practice Solutions, has more than 26 years of experience in technology companies.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Integration of Processes &amp; Services</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In order to create synergies, we have developed several
initiatives to improve operational efficiency and to integrate processes across all our campuses and operations. A central element of
this strategy is our high standard Shared Services Center, which centralizes a wide range of administrative and operational functions,
including finance, accounting, procurement, human resources and other back-office activities, allowing our academic institutions to focus
primarily on educational and clinical excellence. These initiatives are designed to support scale and operational efficiency, contributing
to lower marginal costs as we expand our academic footprint.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Shared Services Center operates in conjunction
with our integrated technology infrastructure, which includes our Enterprise Resource Planning (ERP), Academic System and Learning Management
System (LMS). These systems were implemented in the beginning in 2017, and provide a unified technological environment that supports the
integration and standardization of administrative, financial and academic processes across our operations, and of the educational curriculum
across our undergraduate medical programs. New entrants, including those at acquired institutions, are enrolled under Afya&#8217;s standardized
curricular matrix and, since the second half of 2019, have had access to our fully integrated Educational Curriculum.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Continuing Innovation</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We take a blended approach to our methodology, integrating
in-person teaching with digital learning tools and features. By integrating face-to-face and online features through data collection and
analysis, we are able to individualize the student experience at all times. Through seven key initiatives, we create a 100% student-centric
ecosystem. These initiatives include: (i) medical content mapping, (ii) proprietary methodological assembly, (iii) significant learning
experiences, (iv) comprehensive adaptive learning, (v) daily learning process evaluation, (vi) practical learning and (vii) knowledge
development.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In recent years, we have also expanded the use of artificial
intelligence across our ecosystem to enhance both our digital products and our internal operations. We incorporate artificial intelligence
capabilities into certain of our healthcare technology platforms, including clinical decision support and workflow tools embedded in products
such as Afya iClinic and Afya Whitebook. These solutions support physicians and medical students in their daily clinical practice by facilitating
access to medical content, assisting with documentation and enabling real-time information capture and analysis.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are also implementing artificial intelligence tools
within our Shared Services Center and corporate functions to improve operational efficiency, automate processes and enhance internal decision-making.
We believe that the responsible adoption of artificial intelligence across our ecosystem strengthens our ability to deliver innovative
educational experiences, support physicians in clinical practice and improve the scalability and efficiency of our operations.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk131603241"></span>Organic Growth</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk164689698"></span>In 2018, MEC awarded new
licenses to Afya Brazil, allowing it, subject to the verification by MEC of the satisfactory implementation of all regulatory requirements,
to operate seven new medical schools through the <i>Mais M&#233;dicos II</i> program, with an aggregate amount of 350 new medical school
seats per year. As of December 31, 2025, six of these campuses are already operating, as described below. The remaining campus, Afya Camet&#225;,
is approved but non-operating and will not become operational, as it is located within the same federally designated healthcare planning
region as Afya Abaetetuba, allowing, under applicable regulatory rules, the authorization of additional medical school seats at Afya Abaetetuba.</p>


<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk165026890"></span> On October 2, 2020, MEC
authorized Afya to operate the undergraduate medicine course in Santa In&#234;s, in the State of Maranh&#227;o, under the&#160;<i>Mais
M&#233;dicos II</i>&#160;program. This was the first of Afya&#8217;s seven&#160;<i>Mais M&#233;dicos II</i>&#160;campuses to receive
authorization, and Afya was the education group awarded the largest number of licenses under the program. This campus contributed 50 seats
to our operating seat base and has been operational since October 2020.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On December 30, 2020, MEC authorized Afya to operate
the undergraduate medicine course in Cruzeiro do Sul, in the State of Acre, under the&#160;<i>Mais M&#233;dicos II</i>&#160;program.
This campus contributed 50 seats to our operating seat base and has been operational since the first semester of 2021.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On November 5, 2021, MEC authorized Afya to operate
the undergraduate medicine course in Garanhuns, in the State of Pernambuco, under the&#160;<i>Mais M&#233;dicos II</i>&#160;program.
This campus contributed 120 seats to our operating seat base and has been operational since the second semester of 2022.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On February 23, 2022, MEC authorized Afya to operate
the undergraduate medicine courses at Afya Abaetetuba, in the State of Par&#225;, and in Itacoatiara, in the State of Amazonas, both
under the&#160;<i>Mais M&#233;dicos II</i>&#160;program. Each campus contributed 50 seats to our operating seat base and has been operational
since February 2022.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On March 16, 2022, MEC authorized Afya to operate the
undergraduate medicine courses in Bragan&#231;a, in the State of Par&#225;, and in Manacapuru, in the State of Amazonas, both under
the&#160;<i>Mais M&#233;dicos II</i>&#160;program. Each campus contributed 50 seats to our operating seat base and has been operational
since March 2022.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On March 18, 2022, MEC authorized 28 additional medical
school seats at Centro Universit&#225;rio S&#227;o Lucas Ji-Paran&#225;, in the city of Ji-Paran&#225;, in the State of Rond&#244;nia.
Under the terms of the UniSL acquisition, the authorization of these additional seats triggered an earn-out payment to the sellers in
the amount of R$800,000 per seat, adjusted by the Brazilian interbank interest rate (&#8220;CDI&#8221;) from the closing until the payment
date, of which 50% was paid in April 2022, and the remaining amount was paid in March 2024. These additional seats became operational
in June 2022.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On December 29, 2022, MEC authorized an increase of
64 medical school seats at Faculdade Santo Agostinho, in the city of Itabuna, in the State of Bahia, with no additional financial commitment
required. These additional seats became operational in the first semester of 2023.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On January 24, 2024, MEC authorized an increase of
40 medical school seats at Faculdades Integradas Padr&#227;o (FIP Guanambi), in the city of Guanambi, in the State of Bahia, resulting
in an additional payment of R$49.6 million in February 2024. With this authorization, the campus reached 100 medical school seats.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On July 12, 2024, MEC authorized an increase of 80
medical school seats at Centro Universit&#225;rio Tiradentes Alagoas (UNIMA), in the city of Macei&#243;, in the State of Alagoas,
resulting in an additional payment of R$107.6 million in August 2024 under the DelRey acquisition. With this authorization, the campus
reached 220 medical school seats.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On September 6, 2024, following the conclusion of an
administrative procedure, MEC granted the request for reconsideration submitted by Unigranrio, reestablishing 10 medical school seats
in the city of Rio de Janeiro. With this authorization, Unigranrio reached 318 medical school seats across both of its campuses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On November 7, 2025, MEC authorized an increase of
100 medical school seats at ITPAC Porto, in the city of Bragan&#231;a, in the State of Par&#225;. With this authorization, the campus
reached 150 medical school seats, and Afya reached 3,753 total approved medical school seats.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On December 19, 2025, MEC authorized an increase of
2 medical school seats at Afya Pato Branco, in the city of Pato Branco, in the State of Paran&#225;. With this authorization, the campus
reached 112 medical school seats, and Afya reached 3,755 total approved medical school seats.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On February 6, 2026, MEC authorized an increase of
63 medical school seats for Afya Abaetetuba (ITPAC &#8211; Instituto Tocantinense Presidente Antonio Carlos Porto S.A.), in the city of
Abaetetuba, in the State of Par&#225;. Because Afya Camet&#225; and Afya Abaetetuba are located within the same federally designated
healthcare planning region, Afya Camet&#225; will not become operational, which allowed the
authorization of these 63 additional seats at Afya Abaetetuba.</p>


<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">With this authorization, the campus reached 113 medical
school seats, and, as of the date of this annual report, Afya has a total of 3,768 approved medical school seats across its portfolio,
including 175 seats from Unidom which are subject to a final conclusion of the court proceedings. The continued operation of certain of
these campuses was subject to the verification by MEC of the satisfactory implementation by Afya Brazil of all regulatory requirements.
See &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Our Geographic Presence.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Initial Public Offering and Equity Follow-on Offering</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In July 2019, we completed our initial public offering,
in which we sold an aggregate of 15,805,841 of our Class A common shares at a public offering price of US$19.00 per common share. We received
approximately US$242.7 million of net proceeds from our initial public offering (i.e., after deducting underwriting discounts, commissions
and offering expenses). Our shares began trading on the Nasdaq Global Select Market on July 19, 2019, under the symbol &#8220;AFYA.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In February 2020, we completed an equity follow-on
offering, in which we sold an aggregate of 3,260,480 of our Class A common shares at a public offering price of US$27.50 per common share.
We received approximately US$86.6 million of net proceeds from our follow-on offering (i.e., after deducting underwriting discounts, commissions
and offering expenses).</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">SoftBank Investment</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In April 2021, we issued R$822 million (equivalent
to US$150 million) of Series A perpetual convertible preferred shares to SBLA Holdco LLC, an affiliate of Softbank. On November 3, 2025,
we repurchased all outstanding Series A perpetual convertible preferred shares from SoftBank for an aggregate purchase price of R$831.6
million, and such shares were subsequently cancelled. In connection with the repurchase, Maria Tereza Azevedo resigned from our board
of directors, effective December 31, 2025.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk164673506"></span>Acquisition of Crescera Shares by Bertelsmann</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On June 7, 2021, an affiliate of Bertelsmann acquired
the entirety of the 23,074,134 Class B Afya&#8217;s common shares held by the private equity group Crescera Investimentos through Crescera
Educacional II Fundo de Investimento em Participa&#231;&#245;es Multiestrategia, or &#8220;Crescera Educacional,&#8221; pursuant to
a provision in Afya&#8217;s amended and restated memorandum and articles of association then in effect and in the shareholders&#8217;
agreement between certain members of the Esteves family and Crescera Educacional, which granted Bertelsmann the right to acquire Crescera
Educacional&#8217;s Class B common shares and become a party to the shareholders&#8217; agreement.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Bertelsmann is a media, services and education company
that operates in about 50 countries around the world. It includes the entertainment group RTL Group, the trade book publisher Penguin
Random House, the music company BMG, the service provider Arvato, the Bertelsmann Printing Group, the Bertelsmann Education Group and
Bertelsmann Investments, an international network of funds. Since Afya&#8217;s inception, Bertelsmann has indirectly held a stake in Afya
through its investment in Crescera Educacional. In connection with and following such transaction, Bertelsmann appointed Kay Krafft, Shobhna
Mohn, Christina Krebs and Benedikt Dalkmann as members of our board of directors. Shobhna Mohn later resigned from our board of directors,
effective as of June 30, 2024. For more information, see &#8220;Item 6. Directors, Senior Management and Employees&#8221;.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Acquisition of Our Corporate Control by Bertelsmann</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On May 4, 2022, Bertelsmann acquired 6,000,000 of our
Class B common shares from the Esteves Family at a purchase price of US$26.90 per share. As a result of the closing of the transaction,
Bertelsmann came to beneficially own approximately a 57.5% voting interest in Afya. We also entered into a new CEO executive employment
agreement with Virgilio Deloy Capobianco Gibbon, extending its period through May 2027. The extension was made in connection with the
increase of Bertelsmann&#8217;s stake in Afya to continue to execute the expansion in the medical education business and the deployment
of our digital health services strategy.</p>


<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609481"></span><span id="a_Toc225309233"></span><span id="a_Toc196072474"></span><span id="a_Toc164277174"></span><span id="a_Toc194891110"></span><span id="a_Toc190934947"></span><span id="a_Toc133237647"></span><span id="a_Toc163120241"></span><span id="a_Toc131580969"></span>
B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Business Overview</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are a medical education and technology company in
Brazil focused on supporting physicians throughout their professional lifecycle, from medical school enrollment through residency preparation,
graduate and specialization programs and continuing medical education, or CME, as well as throughout their clinical practice. Based on
the number of medical school seats approved by MEC, we have the largest medical education footprint in Brazil.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our Scale in Brazil</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Largest medical education footprint in Brazil based on MEC-approved medical school seats</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Presence across 21 Brazilian states through our undergraduate and graduate campuses</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>62 undergraduate and graduate medical school campuses</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>3,768 operating medical school seats, as of the date of this annual report.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>300,646 users positively impacted by Afya across our education ecosystem</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our operations combine traditional medical education
with digital solutions designed to support physicians throughout their careers. Through this integrated platform, we aim to deliver an
end-to-end physician-centric ecosystem that serves and empowers students and physicians from the moment they enter medical school through
residency preparation, graduate and specialization programs and continuing medical education, enabling them to engage in lifelong medical
learning throughout their professional careers.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We operate our business through three segments: Undergraduate,
Continuing Education and Medical Practice Solutions. These segments reflect our strategy of supporting physicians throughout their professional
lifecycle, from medical education through clinical practice. For additional information regarding the performance of these segments, see
&#8220;Item 5. Operating and Financial Review and Prospects.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Undergraduate</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Undergraduate segment which provides educational
services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs.
These programs are delivered through our network of higher education institutions located across Brazil and are regulated by the MEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition to health sciences courses, which include
medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine, we also
offer degree programs and courses in other disciplines across several of our campuses. These include undergraduate and graduate programs
in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. These non-health courses are not
part of our core business, although the number of non-health sciences courses we offer has increased as a consequence of our strategic
acquisitions of multi-disciplinary schools with strong health sciences programs, which are the primary focus of our acquisition strategy.
Although non-health courses are not part of our long-term growth strategy, we expect to continue offering them to the extent they generate
local demand.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Continuing Education</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Continuing Education segment, which provides medical
education (including residency preparation programs, specialization test preparation and other medical capabilities), specialization and
graduate courses in medicine, delivered through digital and in-person content, designed primarily for physicians and medical students
who seek professional development beyond undergraduate medical education.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We operate a portfolio of digital platforms that provide
technical medical content, professional development tools and specialized training resources for physicians and medical students. These
platforms offer a broad range of educational materials, including structured courses, mentoring programs for medical residency preparation,
specialty training programs and professional development content. Our platforms also include educational resources designed to support
physicians&#8217; broader professional development, including soft skills training and educational materials covering financial literacy,
accounting and investment fundamentals tailored for physicians.</p>


<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our educational content spans multiple medical specialties
and includes courses, books and technical materials developed by physicians and medical experts. These resources cover a variety of medical
disciplines, including cardiology, endocrinology, dermatology, gynecology and obstetrics, pediatrics and psychiatry, among others. Our
platforms provide continuing education opportunities through medical update courses, specialization preparation programs and technical
training modules designed to support physicians in maintaining and expanding their clinical knowledge.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, we provide interactive digital learning
tools designed to support medical education and professional training, including solutions focused on anatomy education and medical imaging.
These platforms enable physicians, professors and medical students to explore anatomical structures and medical imaging through advanced
digital visualization technologies. For example, our digital anatomy platform allows users to interact with photorealistic representations
of the human body through virtual dissection and anatomy modules, providing an alternative educational resource for anatomy training.
We also provide medical imaging solutions that allow physicians to visualize, manipulate, store and share diagnostic imaging data, supporting
radiology and teleradiology workflows.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Through this segment, we seek to provide physicians
with continuous access to educational content, specialized medical knowledge and digital learning tools that support their ongoing professional
development throughout their careers.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Medical Practice Solutions</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Medical Practice Solutions segment provides clinical
decision, clinical management and doctor-patient relationships for physicians and provides access, demand and efficiency for the healthcare
players.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Medical Practice Solutions portfolio includes four
main categories of products and services: (i) Clinical Decision Support Platforms, (ii) Medical Practice Management Software, (iii) Healthcare
Financial Services, and (iv) Digital Healthcare Ecosystem Solutions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Clinical Decision Support Platforms.</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We offer mobile and web-based applications that provide
physicians and healthcare professionals with access to clinical references, treatment protocols, medical guidelines and other evidence-based
resources used in daily clinical decision-making. Our platforms also provide medical content, expert commentary and scientific updates
related to clinical practice.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Medical Practice Management Software.</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We provide physician-focused software solutions designed
to help healthcare professionals manage and operate their medical practices. These include electronic medical record systems delivered
through a software-as-a-service (SaaS) model, clinical management platforms that support appointment scheduling, patient management and
financial administration, telemedicine solutions for remote consultations and digital platforms that enable patients to identify physicians
and schedule medical consultations online.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Healthcare Financial Services.</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We also provide financial technology solutions designed
to support physicians and healthcare providers in managing receivables and financial operations. Our platform enables healthcare professionals
to manage receivable flows through financial structures such as FIDC (Receivables Investment Funds), helping address challenges associated
with healthcare payment cycles.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Digital Healthcare Ecosystem Solutions.</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our technology portfolio also includes digital platforms
that support electronic prescription workflows, provide information related to pharmaceutical products and pricing, facilitate communication
between physicians and pharmaceutical companies and connect physicians, patients and healthcare devices through digital disease management
and monitoring tools.</p>


<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Together with our Undergraduate and Continuing Education
segments, our Medical Practice Solutions segment completes our end-to-end, physician-centric ecosystem, supporting lifelong medical learning
and enabling us to offer a broad portfolio of education, technology and professional solutions, while creating cross-selling and upselling
opportunities across our physician user base.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Operating Scale and Capacity</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, we had 86,025 enrolled students,
compared to 76,988 enrolled students as of December 31, 2024, representing an increase of 11.7% in 2025, and 66,034 enrolled students
as of December 31, 2023, representing an increase of 16.6% in 2024.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Based on our number of MEC&#8217;s approved medical
seats, as compared to our main competitors, we have the largest medical education footprint in Brazil. Our undergraduate and graduate
campuses are spread across 21 Brazilian states, and our digital medical platform is available nationwide.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, our network of 62 undergraduate
and graduate medical school campuses consisted of 25 graduate facilities, 37 undergraduate operating units (i.e., units that have been
approved by MEC and that have commenced operations) and 1 approved unit (i.e., a unit that has been approved by MEC but that has not yet
commenced operations), compared to 57 campuses as of December 31, 2024 and 32 campuses as of December 31, 2023.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, our network of medical school
seats consisted of 3,705 operating seats (seats that have been approved by MEC and that have commenced operations), compared to 3,543
operating seats as of December 31, 2024 and 3,113 operating seats as of December 31, 2023.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our business model is characterized by high revenue
visibility and operating leverage. For the years ended December 31, 2025, 2024 and 2023, 95.7%, 95.4% and 95.5%, respectively, of our
revenue was generated by our Undergraduate and Continuing Education segment, which are primarily driven by the monthly tuition fees charged
to enrolled students.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The average monthly net ticket for medical school tuition
fees was R$9,060 for the year ended December 31, 2025, which represented an increase of 2.8% from R$8,809 for the year ended December
31, 2024, which, in turn, represented an increase of 4.1% from R$8,460 for the year ended December 31, 2023.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our strategy of combining organic expansion and selective
acquisitions has supported consistent growth and profitability over recent years, as further discussed in &#8220;Item 5. Operating and
Financial Review and Prospects.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Recent Developments</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On February 10, 2026, MEC formally cancelled the public
call relating to the <i>Mais M&#233;dicos III</i> program, The program provided for the potential opening of up to approximately 5,700
new undergraduate seats, to be distributed across 95 cities with a limit of 60 seats per institution. As a result of the cancellation,
our expected allocation of new medical school seats under this program will no longer occur under the previously announced timeline, potentially
limiting near-term opportunities for organic expansion through the opening of new medical school seats.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The cancellation may also affect industry growth dynamics
by slowing the pace of new seat additions, which could impact future revenue expansion prospects for operators seeking to grow through
new authorizations. In this context, education groups may increasingly pursue alternative expansion strategies, including acquisitions
of existing medical schools or approved seats, which could intensify competition for M&amp;A opportunities and influence asset valuations,
while also affecting the pace of market saturation in certain regions.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Recent Acquisitions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The entry point to a medical career begins in undergraduate
institutions, so part of our mission is to consolidate this market. Accordingly, expanding our operations through acquisitions has been
a key component of our growth strategy. We have been able to apply our operating business model to our acquisitions, allowing us to add
quality, value and increase profitability.</p>


<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, we have equipped ourselves through key
initiatives for strategic and relevant acquisitions to our portfolio, including: the creation of our Shared Services Center dedicated
to serving our business units and running our integration processes, the centralization of content creation and the creation of a dedicated
sales team for each market we operate in.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our recent acquisitions, which were all made through
Afya Brazil, include:</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">DelRey</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On January 2, 2023, we acquired 100% of the total share
capital of DelRey, which acquisition encompasses the operations of Centro Universit&#225;rio Tiradentes Alagoas, or UNIMA, and Faculdade
Tiradentes Jaboat&#227;o dos Guararapes, or FCM Jaboat&#227;o. The transaction does not include the &#8220;UNIMA&#8221; and &#8220;FCM
Jaboat&#227;o&#8221; trademarks, which were licensed to Afya during the first year of operation. The aggregate purchase price of R$816.2
million is comprised of: (i) R$575.0 million paid in cash on the transaction&#8217;s closing date; and (ii) R$234.0 million to be paid
in three annual installments of R$134.0 million in January 2024, R$50.0 million in January 2025 and R$50.0 million in January 2026, as
adjusted by the SELIC rate, none of which remains outstanding. The aggregate purchase also includes R$7.2 million estimated at fair value
as of the date of acquisition relating to an offer of our digital solutions free of charge until December 31, 2030 for medical students
of universities owned by the sellers but which were not a part of this transaction. On July 12, 2024, MEC authorized the increase of 80
medical school seats of UNIMA, which resulted in an additional payment of R$107.6 million to the former shareholders of UNIMA.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Unidom</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On July 1, 2024, we acquired 100% of the total share
capital of Unidom Participa&#231;&#245;es S.A., which acquisition encompasses the operations of Unidompedro and Faculdade Dom Luiz,
or &#8220;Unidom,&#8221; Institui&#231;&#227;o Baiana de Ensino Superior Ltda., or &#8220;IBES,&#8221; and SESSA &#8212; Sociedade
de Educa&#231;&#227;o Superior do Semi-&#193;rido Ltda., or &#8220;Sessa.&#8221; The aggregate purchase price of R$620.8 million
is comprised of: (i) R$340.8 million paid in cash on the transaction&#8217;s closing date; and (ii) R$280.0 million to be paid in ten
annual installments, adjusted by the CDI rate, and it is conditioned upon the maintenance of the authorization of the 175 medical school
seats in each year immediately before payment. The remaining balance will be accelerated if a final and non-appealable ruling of certain
court proceedings confirms the authorization for all 175 medical school seats. In turn, if a final ruling does not confirm the authorization
for such 175 medical school seats, the outstanding balance will no longer be due.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">FUNIC</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On May 7, 2025, we closed the acquisition 100% of the
total share capital of Faculdade Masterclass Ltda., or &#8220;FUNIC,&#8221; which has added 60 medical school seats to Afya in Contagem,
a city in the metropolitan area of Belo Horizonte, the capital of the state of Minas Gerais. The aggregate purchase price was R$100 million,
of which R$60 million was paid in cash on the closing date, and R$40 million will be paid in three annual installments adjusted by the
CDI rate. Additionally, the acquisition includes a potential additional payment for up to 60 medical school seats. If approved by MEC
within 36 months of the closing date, we will be required to make an additional payment of R$1 million per approved seat, up to a maximum
of 60 medical school seats. We do not have a legal or constructive obligation at the acquisition date and as of December 31, 2025. For
more information, see note 1 in our audited financial statements included elsewhere in this annual report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk133252306"></span>Our Competitive Strengths</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Continuous focus on disrupting traditional medical education</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We have an in-depth understanding of medical education and the related issues faced by students in Brazil. As the largest medical
education group in Brazil on a per-seat basis, according to MEC, we are able to identify trends and adapt our services accordingly;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We have developed a methodological approach to learning that incorporates individualization and technology in both digital and physical
format;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We currently produce content that is centralized, continuously updated and available to all our institutions and students;</td></tr></table>


<!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We believe we have the largest end-to-end physician-centric ecosystem in medical education in Brazil, with 62 undergraduate and graduate
medical school campuses, and 300,646 users in Afya&#8217;s ecosystem;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We believe we have developed the first instructional medical web series created globally, and we have completed two seasons;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We believe we are the first education group in Brazil to offer a fully digital and customized service for medical residency exam preparation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We believe we are the first player to offer supplemental medical education content to third-party institutions through a business-to-business
model; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We started offering content and clinical tools for healthcare professionals, including mobile and web apps.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">High-quality standards</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Quality is a cornerstone of our value proposition.
Our operating infrastructure and innovative methodological approach have achieved high levels of satisfaction across our medical schools.
Through our digital platforms, we monitor our students&#8217; learning experience using several criteria and variables. Our NPS, a widely
known survey methodology that measures the willingness of customers to recommend a company&#8217;s products and services, showed a consistent
improvement across all groups of medical students in 2025 compared to 2024. Among students from the 1<sup>st</sup> to the 4<sup>th</sup>
semester, the NPS decreased from 46 in 2024 to 43 in 2025. For those in the 5<sup>th</sup> to the 10<sup>th</sup> semester, it increased
from 29 to 35. Finally, among students in the last two semesters of the program, the score went up from 31 to 38. This gradual improvement
in our NPS score shows our continuing commitment to high-quality education and the medical careers of our students. Additionally, according
to the latest results released by the Brazilian government in 2023, our average General Course Index, which is measured and published
by MEC, and is based on certain institutional planning and development, academic and management criteria, was 2.60 on a scale of 1 to
5, in line with the Brazilian average of 2.62. See &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Regulatory
Overview&#8212;Regulatory Processes of Post-secondary Education Institutions&#8212;Accreditation of Post-secondary Education Institutions
and Authorization and Recognition of Courses&#8221; for further information on the <i>General Course Index.</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, through our online medical education platform
that offers distance learning residency preparatory courses, we are able to monitor our students&#8217; learning experience using several
criteria and variables, including the educational materials they access and use, frequently asked questions, their study hours and schedule,
and their attendance record. Furthermore, as a result of the quality of the content and methodology and the differentiated services we
offer, third-party medical schools proactively contact us seeking to adopt our medical education content to improve their medical students&#8217;
learning experience and academic scores<span id="a_Hlk130286628"></span>. As of December 31, 2025, 14 third-party schools had adopted our
medical education content compared to 17 as of December 31, 2024.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">The nature of our business model</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Attractive financial model:</i> We have a strong
combination of significantly low customer acquisition costs, calculated as the sum of sales and marketing and personnel expenses divided
by student additions, which were approximately R$1,190, R$1,576 and R$1,415 per student as of December 31, 2025, 2024 and 2023, respectively,
high occupancy rates of approximately 100% of medical school seats in our medical schools as of December 31, 2025, 2024 and 2023, strong
net cash flows from operating activities which was R$1,531.6 million, R$1,432.7 million and R$1,043.6 million for the years ended December
31, 2025, 2024 and 2023, respectively, and Operating Cash Conversion Ratio which was 93.7%, 102.2% and 97.1% as of December 31, 2025,
2024 and 2023, respectively. As of December 31, 2025, our Lifetime Value (LTV) was R$488,020, calculated as the gross profit per student
of R$81,337 divided by 17% (to account for one-sixth of the student base graduating every year). As of December 31, 2024, our LTV was
R$447,647, calculated as the gross profit per student of R$74,602 divided by 17%. As of December 31, 2023, our LTV was R$423,308, calculated
as the gross profit per student of R$70,551 divided by 17%.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Contracted growth:</i> We have contracted growth
visibility into medical schools that are in the initial six years of operations as a result of the six-year maturation cycle of our medical
school seats. This cycle begins when a medical school becomes operational, with a first-year medical school class that progresses through
the required six years as the next classes begin behind it, and ends when the medical school has six
school years of medical students and has therefore reached capacity at maturation (i.e., the maximum number of approved seats). Since
the maximum number of medical seats per medical school is set by regulation, the only way to grow our medical school seats, and thus our
numbers of enrollments, is through acquisitions or starting new medical schools. As of December 31, 2025, we had 3,755 approved medical
school seats, including 175 seats from Unidom which are subject to a final conclusion of the court proceedings, out of an expected total
capacity of 27,036 medical school enrollments by 2031, which gives us visibility as to the growth potential of our revenues over the period.
See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;Medical School Regulatory Capacity and Capacity at Maturation.&#8221;</p>


<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>End-to-end ecosystem:</i> Successfully integrating
the businesses we invest in or acquire, allows us to offer an end-to-end physician-centric ecosystem. The point of entry of one business
unit is the point of exit from another, which increases cross-selling and upselling opportunities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Difficult to replicate:</i> We believe the combination
of regulatory barriers, demand and supply imbalance and our end-to-end physician-centric ecosystem are difficult to replicate and that
it would take a significant amount of time for competitors to reach the scale of our operation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Self-reinforcing network effects of our education
cycle:</i> As we aim to be the trusted content and knowledge partner for lifelong medical learners in Brazil, we have created and have
been nurturing an education cycle that entails differentiation, talented stakeholders and recognition. Our continuous focus on implementing
all stages of our cycle has allowed us to continuously expand our footprint.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: center"><img src="image_002.jpg" alt=""/><span style="background-color: #E4E4E5"></span></p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Extensive M&amp;A track record</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have extensive capabilities in, and a strong track
record of, identifying, negotiating and successfully integrating acquisitions. We have developed an integration model, operated by a dedicated
team responsible for analyzing, mapping and integrating the systems of our acquired businesses, that we believe enables us to fully integrate
the businesses we acquire in an efficient manner and usually within 12 months of their acquisition.</p>


<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our integration model is composed of four stages:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Stage 1 (Preliminary Analysis): Preliminary analysis of the available infrastructure, organizational structure and teaching model
of the acquired business to identify potential integration issues.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Stage 2 (Detailed Mapping): Detailed migration diagnosis and mapping of the systems, processes and teaching model of the acquired
business to be integrated into our centralized shared-services center and academic model.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Stage 3 (Integration/Migration): Centralization and migration of the systems and processes into our shared services center and standardization
of the teaching model of the acquired business.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Stage 4 (Ongoing Support): Post migration/integration remote and on-site support and monitoring to stabilize the integrated operations
of the acquired business.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our consolidated operating history and our recent acquisitions
entail a number of challenges, such as effectively integrating the operations of any acquired company with our existing business and managing
a growing number of campuses. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and
Industry&#8212;We may face challenges in identifying and acquiring new medical higher education institutions, which could hinder our strategic
and financial goals. Additionally, difficulties in effectively integrating and managing an increasing number of acquisitions may adversely
affect our strategic objectives.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Purpose driven culture</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk130286721"></span>Medical education requires
a core human value: compassion. As we endeavor to revolutionize medical education in Brazil, we believe that by training and educating
better physicians we are helping people and their communities across Brazil. This mission has united families and entrepreneurs, executives
and sponsors with over 20 years of know-how and expertise in the education sector. Our internal satisfaction survey conducted in 2025
showed employee satisfaction levels of 90 out of a possible 100, based on several criteria, such as trust in, and a commitment to, our
values, leadership satisfaction, work satisfaction, learning and development, and active participation in our activities, reinforcing
our strong commitment to our mission and purpose.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><b><i>Instituto Afya</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On October 31, 2025 Afya Brazil and Unigranrio established
a partnership and incorporated the Instituto Afya, which is an independent non-profit organization that aims to promote solutions to chronic
non-communicable conditions (CNCCs) through research, cross-sector collaboration, and engagement with diverse segments of society. Its
activities are aimed at improving the quality of life of the Brazilian population through research, innovation, stakeholder engagement,
and cross-sector collaboration. The Institute operates through partnerships with public and private sector entities to generate knowledge
and develop initiatives designed to expand access to healthcare, with an emphasis on prevention and care delivery. Its activities are
intended to support the development of sustainable solutions that contribute to a more efficient and inclusive healthcare system.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Growth Strategies</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We aim to continue to grow organically and through
acquisitions and to generate greater shareholder value by implementing the following strategic initiatives:</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Maturation of current number of authorized medical school
seats</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We benefit from contracted growth visibility in our
medical schools that are in the initial six years of operations, which we derive the six-year maturation cycle of our medical school seats,
which begins when a medical school becomes operational, with a first year medical school class which progresses through the required six
years as the next classes begin behind it, and which ends when the medical school has six school years of medical students and has therefore
reached capacity at maturation (i.e., the maximum number of approved seats).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Since the maximum number of medical seats per medical
school is set by applicable regulations, the only way to grow our medical school seats, and thus our number of enrollments, is through
acquisitions or starting new medical schools. As of the date of this annual report, assuming full compliance with applicable regulations
and that our campuses mature as expected, we estimate reaching a total medical student
base of 27,130 students by 2031. See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;Medical School Regulatory Capacity
and Capacity at Maturation&#8221; and &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212; Certain Risks Relating to Our Business
and Industry&#8212;The post-secondary education sector is highly regulated, and our failure to comply with existing or future laws and
regulations could limit our ability to operate medical programs, obtain new authorizations or accreditations, maintain our regulatory
approvals, or obtain re-accreditations, which could materially impact our business.&#8221;</p>


<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Expand our medical residency preparation enrollments
base</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We expect that competition for medical residencies
will increase as the number of graduating physicians grows and the number of available residency seats remains static. We plan to continue
to grow our medical residency exam preparation student enrollments, leveraging the academic outcome, scalability and learning experience
of our digital platform.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Expand our graduate programs enrollments base</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Due to the shortage of medical residency seats and
the growing demand for medical undergraduate courses, we believe we will be able to expand our current offering in the Undergraduate segment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We intend to continue developing our business-to-business
strategy by increasing the number of partners and student enrollments through increased marketing and sales efforts.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Cross-sell across our existing medical student base</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Because our solutions target the lifelong education
journey of medical students, we have identified an opportunity to increase student enrollments at a low marginal cost driven by cross-selling
opportunities, such as increasing the number of former undergraduate students subscribing to our medical residency exam solutions and
the number of former undergraduate and/or medical residency students applying to our graduate and/or other continuing medical education
offerings, such as hard and soft skills courses.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Expand our B2B capabilities</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">B2B contracts are effective customer entry points to
our products and services. Students are familiar with our platforms, increasing our brand equity and helping us attract more physicians
to enroll in preparatory courses, graduate programs, hard and soft skills courses.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Expand our distribution channels</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We plan to continuously expand our distribution network
by increasing our presence in direct and third-party channels, launching graduate courses or CME for third-party continuing medical education
hubs (including, but not limited to, hospitals, clinics and other medical schools) to grow our graduate medical footprint, through partnerships
with such third-party continuing medical education hubs.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Leverage infrastructure and extract synergies from acquisitions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe we have been able to successfully integrate
our acquisitions into our ecosystem. We plan to implement several measures to improve the profitability of recent acquisitions, including
but not limited to:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Streamlining fee discounts and scholarship policies;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Integrating operations with our shared-services center;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Streamlining faculty training in line with our career plan; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Integrating teaching models into our academic model.</td></tr></table>


<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk130999560"></span> Continue to selectively
pursue M&amp;A opportunities</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our acquisition strategy is primarily focused on expanding
our medical school footprint by adding new institutions to our existing portfolio, which we believe supports our long-term growth and
reinforces our position as a leading medical education provider in Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We also plan to selectively pursue acquisitions that
will complement our current medical education services offering and/or enhance our product portfolio, such as digital content platforms,
continuing medical education institutions and other medical certification companies, among others. We are currently evaluating possible
acquisition opportunities and submit non-binding proposals from time to time.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe that we have developed a strong capability
and track record of acquisitions. In 2025, we acquired FUNIC, which increased our number of approved medical school seats by 60 approved
seats. In 2024, we acquired Unidom, which increased our number of approved medical school seats by 300 seats authorized, of which 125
are final and 175 are subject to a final conclusion of the court proceedings. In 2023, we acquired DelRey, which encompasses the operations
of UNIMA and FCM Jaboat&#227;o. Our acquisition strategy is mainly focused on expanding our medical school footprint by adding new institutions
to our existing portfolio.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Enter into new markets</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe our end-to-end physician-centric ecosystem
is equipped to serve medical students in complementary segments where our innovative, methodological, data-driven approach can continue
to disrupt traditional vendors and legacy business models. We believe opportunities exist in new sectors and regions of Brazil. In the
future, we intend to focus on expanding further into continuing medical education. We may also seek to grow our business by selectively
expanding into international markets with similar fundamentals.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Develop new products</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We plan to continuously evolve our platform and offer
solutions that keep up with the growing demands of our students. We have a planned pipeline of new products, including new medical web-series
seasons, corporate medical training, new extension health programs, a tutoring suite, a peer-to-peer suite and a virtual reality product.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk132205221"></span>Our Geographic Presence</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our headquarters and most of our shared services operations
are located in Belo Horizonte in the State of Minas Gerais. Our content creation and dedicated sales team is located in S&#227;o Paulo,
in the State of S&#227;o Paulo.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, our network consisted of a
total of 62 undergraduate and graduate campuses: (i) 37 undergraduate campuses, out of which 32 offer a medical course and (ii) 25 graduate
campuses that offer medicine- and health-related courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The chart and table below illustrate our current footprint
of undergraduate medical schools, as of the date of this annual report.</p>


<!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; width: 28%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Campus</p></td>
    <td style="white-space: nowrap; width: 6%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">State</p></td>
    <td style="white-space: nowrap; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Brand</p></td>
    <td style="white-space: nowrap; width: 14%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Year of Acquisition</p></td>
    <td style="white-space: nowrap; width: 14%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Approved
    Medical School Seats(1)</p></td>
    <td style="white-space: nowrap; width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Semester(2)</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Porto	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">TO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">ITPAC Porto</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Before 2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">120</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.04</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Pato Branco	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PR</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FADEP</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.17</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Pato Branco	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PR</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FADEP</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">60</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.19</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Pato Branco	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PR</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FADEP</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.26</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Itajub&#225;	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">MG</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">CCSI</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">87</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.68</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Parna&#237;ba	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PI</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">IESVAP</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">80</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.15</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Palmas	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">TO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">ITPAC</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">120</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.17</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Teresina	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PI</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">IESP</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">110</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.04</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Teresina	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PI</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">IESP</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">61</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.17</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">S&#227;o Jo&#227;o Del Rei	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">MG</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">IPTAN</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">38</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.15</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">S&#227;o Jo&#227;o Del Rei	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">MG</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">IPTAN</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">11</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.16</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Aragua&#237;na	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">TO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UNITPAC</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">80</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.06</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Ipatinga	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">MG</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UNIVA&#199;O</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2018</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.99</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Marab&#225;	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FACIMPA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">120</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.19</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Vit&#243;ria da Conquista	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">BA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FASA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.15</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Itabuna	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">BA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FASA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">85</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.18</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Itabuna	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">BA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FASA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">64</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.23</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Cruzeiro do Sul	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">AC</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.21</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Santa In&#234;s	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">MA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.20</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Manacapuru	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">AM</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.22</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Itacoatiara	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">AM</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.22</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Abaetetuba	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.22</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Abaetetuba	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">63</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.26</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Bragan&#231;a	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">50</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.22</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Bragan&#231;a	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">ITPAC - <i>Mais M&#233;dicos</i></td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.26</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Itaperuna	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">RJ</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UniRedentor</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2019</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">112</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.15</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Jo&#227;o Pessoa	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FCMPB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">24</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.17</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Jo&#227;o Pessoa	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FCMPB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">33</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.18</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Jo&#227;o Pessoa	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FCMPB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">80</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.16</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Jo&#227;o Pessoa	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FCMPB</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">20</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.18</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Reden&#231;&#227;o	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FESAR</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">120</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.18</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Porto Velho	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">RO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UniSL</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">52</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.19</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Porto Velho	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">RO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UniSL</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">130</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.05</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Ji-Paran&#225;	</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">RO</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UniSL</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2020</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">28</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.21</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Guanambi	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">BA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FIP Guanambi</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">60</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.18</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Guanambi	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">BA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FIP Guanambi</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">40</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.24</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Garanhuns	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PE</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">ITPAC</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">120</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.21</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Montes Claros	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">MG</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UNIFIPMOC</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.07</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Duque de Caxias	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">RJ</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UNIGRANRIO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">110</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.97</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Duque de Caxias	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">RJ</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UNIGRANRIO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">88</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.17</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Rio de Janeiro	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">RJ</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UNIGRANRIO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">110</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.04</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Rio de Janeiro	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">RJ</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UNIGRANRIO</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2021</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">10</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.24</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Alagoas	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">AL</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UNIMA</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2023</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.14</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Alagoas	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">AL</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UNIMA </td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2023</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">40</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.16</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Alagoas	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">AL</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UNIMA </td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2023</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">80</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.24</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Jaboat&#227;o	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PE</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FCM Jaboat&#227;o </td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2023</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.18</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Jaboat&#227;o	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">PE</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FCM Jaboat&#227;o </td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2023</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">100</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.19</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Unidompedro (3)	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">BA</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">UNIDOM</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2024</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">300</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">01.21</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">FCM Contagem	</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">MG</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">FUNIC</td>
    <td style="white-space: nowrap; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">2025</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">60</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">02.25</td></tr>
  </table>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Number of medical school seats presented are estimated.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Schools with six or more years of operations are considered fully matured.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>300 seats authorized, of which 125 are final and 175 are subject to a final conclusion of court proceedings.</td></tr></table>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Industry Overview</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Introduction to Brazil&#8217;s Education Environment</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil&#8217;s education environment has become increasingly
open to private capital. At the same time, the government has continued to play an important role through the municipalities, states,
and federal government.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Post-Secondary Education</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Higher education in Brazil differs significantly from
pre-secondary education. According to the most recent data from the <i>Censo da Educa&#231;&#227;o Superior</i> published by the INEP,
the vast majority of higher education schools are under private management. As of the 2024 census, Brazil had approximately 2,561 higher
education institutions, of which 2,244 were private and 317 were public, meaning that approximately
87.6% of all higher education institutions were privately operated.</p>


<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Higher education institutions are divided into three
categories depending on the number of courses they offer, seniority of the teaching staff, and amount of research they conduct: they can
be classified as colleges, university centers or universities. Typical post-secondary programs take between four to six years to complete.
While some courses in these programs only occur during a certain period of the day (i.e., morning, afternoon, or evening), others are
offered as full day courses. Tuition is paid on a monthly basis, primarily out of pocket by students and their families. Government financing
is available, but not easily accessible. The main programs are FIES and PROUNI, which have historically represented a relevant source
of student financing in Brazil, according to <i>Sinopse Estat&#237;stica da Educa&#231;&#227;o Superior</i>.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Introduction to Brazil&#8217;s Medical Education Industry</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In Brazil, aspiring physicians apply to medical school
following graduation from secondary education. Medical school in Brazil is a six-year undergraduate program. Upon graduation, medical
students gain a license and can start working as generalist physicians. At this point, they usually consider alternatives to gain a certification
for one or more medical specialties.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The first and most common path to obtaining a medical
specialty certification is through a medical residency program. Candidates seeking admission to a residency program must pass a competitive
entrance examination administered by the institution offering the program. Once admitted, physicians begin their residency training and
generally receive a government-funded stipend during the specialization period. If the physician wants to pursue a subspecialty, he or
she will need additional years of study, which may require a separate competitive admission process.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Medical professionals who do not pursue or are not
admitted to a residency program may still obtain a medical specialty certification through alternative pathways. In Brazil, specialty
titles are generally granted by medical specialty societies affiliated with the AMB, and typically require candidates to meet certain
eligibility criteria and pass a certification examination. These criteria may include a minimum period of professional practice, supervised
clinical experience, or completion of recognized postgraduate training programs, among other requirements. Depending on the specialty
and the candidate&#8217;s professional experience, it may take several years for a generalist to meet the criteria and, in this context,
graduate courses can be a shorter path to reach eligibility sooner.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As medical science continues to evolve very rapidly,
physicians must seek ways to stay up to date on those developments. For that purpose, physicians and other medical professionals tend
to use numerous sources of continuing medical education, or CME, including short-term programs, scientific paper digests, and medical
congresses, among others.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk164255669"></span>Regulatory Overview and <i>Mais M&#233;dicos</i>
Program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Medical education in Brazil is subject to regulatory
terms that aim to guide the geographic distribution and expansion of medical school seats across the country. Since 2013, the Brazilian
government has implemented initiatives to increase the number of annual medical school and residency positions, including the <i>Mais
M&#233;dicos</i> program, a strategic initiative designed to expand access to primary healthcare services in underserved municipalities,
strengthen healthcare infrastructure, and promote a more balanced distribution of medical professionals nationwide.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The legal framework for this initiative was established
by the <i>Mais M&#233;dicos</i> Law, which set forth rules governing the authorization of new medical courses in Brazil and introduced
regulatory criteria to guide the expansion and geographic allocation of medical school seats across the country. Among the criteria considered
in the authorization process, two relevant aspects are (i) the importance of these new openings in a specified region and (ii) the sufficiency
of the current medical infrastructure in both public regional hospitals and in the applicant medical institution in order to obtain government
authorization, particularly with respect to the availability of public hospital beds within Brazil&#8217;s Unified Health System (SUS)
for medical practice scenarios.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">From its creation in 2013 until the date of this annual
report, MEC, through SERES, has announced three public calls for the selection of proposals for the authorization of medical courses on
a national scale, although the most recent public call was subsequently cancelled: the <i>Mais M&#233;dicos
I</i> program in 2013, the <i>Mais M&#233;dicos II</i> program in 2018, and the <i>Mais M&#233;dicos III</i> program in 2023, although
the most recent public call was subsequently cancelled.</p>


<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk164183631"></span><i>Mais M&#233;dicos
I</i> and <i>Mais M&#233;dicos II</i> jointly authorized the opening of 58 new medicine courses and, initially, 4,971 new seats in medical
schools, which may be increased by up to 100 seats each in accordance with the <i>Mais M&#233;dicos</i> regulation. Following the increase
in annual offerings through <i>Mais M&#233;dicos</i>, on April 5, 2018, MEC announced that the government had decided to freeze the
new offering of medical school seats for a period of five years pursuant to Ordinance No. 328/2018. The decision was based on the need
to evaluate the impact of opening new medicine courses in Brazil. On April 5, 2023, MEC issued Ordinance No. 650/2023, which revoked the
suspension under Ordinance No. 328/2018 and set new rules for the opening of new medicine courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Following the issuance of Ordinance No. 650/2023, on
October 4, 2023, MEC, through SERES, announced a public call for the selection of proposals for the authorization of medical courses on
a national scale under the <i>Mais M&#233;dicos III</i> program. The rules for the program set forth the criteria for new undergraduate
medical school seats and provided for the potential opening of up to approximately 5,700 new undergraduate seats, to be distributed across
95 cities with a limit of 60 seats per institution. However, on February 10, 2026, MEC formally cancelled the public call relating to
the <i>Mais M&#233;dicos III</i> program, with immediate effect. As a result, the authorization process contemplated under that public
call was discontinued.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Although the <i>Mais M&#233;dicos</i> program requires
a public call prior to the authorization of a new medicine course, some educational institutions have been judicially challenging this
restriction before Brazilian courts to compel MEC to receive and review requests for new medicine courses outside the <i>Mais M&#233;dicos</i>
program rules, alleging that these rules constitute an undue restriction on freedom of competition. Certain courts may ultimately compel
MEC to receive and review these requests. For more information, see &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain
Risks Relating to Our Business and Industry&#8212;We face significant competition in the provision of our educational services. If our
competition increases or if we fail to compete efficiently, we may lose market share, and our profitability may be adversely affected.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the increase in medical school seats in
existing undergraduate courses is regulated by specific rules, including, but not limiting to Ordinance No. 1,771, dated September 1,
2023, which allowed educational institutions that already operate authorized undergraduate medical programs to request an increase in
medical school seats by submitting a request to MEC and is subject to compliance with applicable regulatory criteria, including academic
quality indicators, limits on the percentage of seat expansion permitted for each program, and the availability of adequate healthcare
infrastructure and clinical training capacity within SUS.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk131603616"></span>Brazilian Medical Education Quantitative
Assessment</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Given the national regulatory framework, expanding
medical school seats depends mostly on quality attributes and the need for additional doctors in the given geography. While the number
of medical school seats remained approximately unchanged between 2005 and 2012, the federal government introduced public policy initiatives
aimed at addressing the shortage of physicians, including the Mais M&#233;dicos program, which accelerated the expansion of medical
education capacity beginning in 2013.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Mais M&#233;dicos I</i> and <i>Mais M&#233;dicos
II</i> jointly authorized the opening of 58 new medicine courses and, initially, 4,971 new seats in medical schools, which may be subject
to an increase of up to 100 seats, each in accordance with the <i>Mais M&#233;dicos</i> regulation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">According to the <i>Demografia M&#233;dica do Brasil</i>
report&#8212;which is co-produced by the Brazilian Medical Association (<i>Associa&#231;&#227;o M&#233;dica Brasileira, or AMB</i>)
and the University of S&#227;o Paulo, Brazil, or Demografia M&#233;dica&#8212;the number of physicians in Brazil increased from 310,800
to 635,706 from 2010 to 2025, representing an 104.5% increase. With that demand in place, a supply of new healthcare professionals is
expected to keep growing to keep up with the increased demand for public and private health services.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">By 2025, the total number of physicians in Brazil increased
to 635,706 professionals, implying 2.98 doctors per 1,000 inhabitants.</p>


<!-- Field: Page; Sequence: 68 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Projection of the Number of Physicians in Brazil
(2023 to 2035)</p>

<p style="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><img src="image_003.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: Demografia M&#233;dica, 2025. 2024-2035
figures are projections </i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Fundamentals of Medical Education in Brazil</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The medical education market in Brazil is supported
mainly by the higher demand for medical courses than the actual seats offering, the low and uneven medical density when compared to the
Organization of Economic Cooperation and Development, or OECD average, Brazil&#8217;s fast aging population, and compelling financial
rewards for those seeking to pursue a medical career.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Brazil&#8217;s Aging Population</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil&#8217;s aging population is expected to drive
an increase in demand for physicians and other healthcare service providers. Although Brazil currently has a younger population than most
developed countries, demographic projections indicate that the country will experience a rapid aging process in the coming decades. The
share of the population aged 65 and over is projected to increase significantly, reaching nearly 22% by 2050, according to projections
from the Organisation for Economic Co-operation and Development, Health at a Glance 2025: OECD Indicators (OECD Publishing, 2025). Compared
to 1995, life expectancy at birth is up from 66 years to 76 years in 2023, according to the <i>Instituto Brasileiro de Geografia e Estat&#237;stica</i>,
or IBGE, driven primarily by medical and health improvements.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">By 2030, 13.5% of the Brazilian population is expected
to be older than 65 years, compared to 7.3% in 2010. Furthermore, in 2060, the percentage of the population of 60 years and older is expected
to exceed the number of people 19 years and under, according to the <i>Instituto Brasileiro de Geografia e Estat&#237;stica</i>, or
IBGE.</p>


<!-- Field: Page; Sequence: 69 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Population Distribution by Age Group&#8212;Brazil</p>

<p style="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><img src="image_004.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman,serif; margin: 0; text-align: center">&#160;</p>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 12pt 0.25in; text-indent: -0.25in"><i>Source: </i>IBGE, 2024.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Increase in Medical Services Demand</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The long-suppressed demand for health services in Brazil
is expected to continue to increase given demographic changes in Brazil as well as a larger portion of the population being able to access
private healthcare services. As of December 31, 2025, Private Health Insurance penetration in Brazil reached 24.4%, according to data
from ANS. This level is lower than that observed in other countries. Even with the expected increase in medical graduation, the demand
for healthcare services is expected to surpass the current supply of physicians by medical schools creating a continued demand for medical
courses and graduate education.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">According to Demografia M&#233;dica, Brazil had 2.98
doctors per 1,000 inhabitants in 2023, which is considerably below the international average and the average of developed countries, which
have been through the demographic changes that are expected to happen in Brazil. For example, according to Demografia M&#233;dica, Italy
had an average of 4.24 doctors per 1,000 inhabitants in 2023. Considering the projections of a total of 635,706 physicians in 2025 versus
Brazil&#8217;s population growth over the same period, Brazil would still have approximately 2.98 doctors per 1,000 inhabitants, which
is still below the OECD average.</p>


<!-- Field: Page; Sequence: 70 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Doctors per Thousand Inhabitants, According to Selected
OECD Countries (2023).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><img src="image_005.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source: </i>OECD, 2023.</p>


<!-- Field: Page; Sequence: 71 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Shortage and Distribution of Medical Professionals in
Brazil</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil&#8217;s low medical density and inequality in
physician distribution is illustrated in the figure below. As of 2024, S&#227;o Paulo and Rio de Janeiro had 3.8 and 4.2 doctors per
1,000 inhabitants, respectively, while the states of Maranh&#227;o and Par&#225; had 1.3 and 1.4 doctors per inhabitant, respectively.
The north and northeast regions are Brazil&#8217;s most underserved areas and have been the focus of governmental physician assignment
programs.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Distribution of Doctors According to Brazilian States&#8212;2024</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="image_006.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 12pt 0.25in; text-indent: -0.25in"><i>Source: </i>Demografia M&#233;dica, 2024</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Compelling Financial Rewards for Pursuing a Medical Career</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">One of the notable arguments for pursuing a medical
career in Brazil is the potential financial outcome for the future physician, with higher salaries and fast payback. The main points of
view that support the increasing demand for medical education analysis are: (i) a reported employability rate of approximately 92% for
medical school graduates in Brazil, based on available data from Instituto Semesp, 2024; (ii) salaries for medical school graduates that
are significantly higher than those of graduates from other fields, and (iii) its above-average income after graduation results in a relatively
short payback period compared to other undergraduate programs, even when accounting for the comparatively high tuition associated with
the six-year medical undergraduate program.</p>


<!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: center; text-indent: 0.25in"><img src="image_007.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: center; text-indent: 0.25in"><img src="image_008.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source:</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>(1) Instituto Semesp, 2024</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>(2) Demografia M&#233;dica 2025, </i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 12pt 0.25in; text-indent: -0.25in"><i>(3) Afya&#8217;s Research Center, </i></p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Expansion in Graduate Programs and CME</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The number of public and private medical graduate courses
is not measured by any institution, as it is developing and growing as residency slots become increasingly restricted. Typically, educational
institutions partner with hospitals to provide an adequate infrastructure for teaching students. Unlike residencies, students pay out-of-pocket
monthly tuition of around R$4,000, according to a third-party consulting firm. These are usually one to two-year courses and there is
currently no government student financing for this segment.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Underlying Trends of Medical Education in Brazil</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition to a large and underpenetrated total addressable
market, we have identified other trends that contribute to the strength of the markets we serve:</p>


<!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Increased life expectancy and demand for medical services:</i></b> The Brazilian population is aging at the fastest rate in
its recent history. Average life expectancy is currently 76.2 years, and the number of people over 65 should double from 7% of the total
population in 2012 to 14% of the total population in 2033. This has led to, and is expected to continue to drive, increased demand for
healthcare professionals. In addition, private healthcare spending and public healthcare spending in Brazil grew at a CAGR of 14.0% and
11.8%, respectively, from 2010 to 2015, primarily due to an increase in demand for medical services as a result of an aging population
and an increase in average household income. These trends have continued since 2015 to date.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Shortage of medical professionals in Brazil:</i></b> There is a shortage of medical professionals in Brazil, primarily due to
the uneven socio-economic environment. On average, Brazilian cities with less than 50,000 inhabitants, which corresponds to approximately
90% of all cities in Brazil, have less than one physician per 1,000 residents. Brazil is expected to have an average of 3.07 physicians
per 1,000 inhabitants by 2028, below the average of 3.4 for 2018 Organization for Economic Cooperation and Development, or OECD, countries.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Attractive financial incentives:</i></b> The medical profession is lucrative. Medical professionals are highly employable, with
salaries that are on average more than three times higher than the average salary for other professions such as engineering, nursing and
law, and 1.9 to 3.8 times higher than the net present value of engineering, nursing or law programs in Brazil.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Supply and demand imbalance for medical education:</i></b> The number of available medical course seats in Brazil is controlled
by MEC, which has limited medical school intakes to current levels until 2023, resulting in a significant imbalance between supply and
demand. In the last three years, medical schools have on average received five applications per available medical course seat, and four
applications per available residency program vacancy, and the number of applications are expected to increase. We believe that graduate
courses will gradually become a more popular, high-demand destination for physicians that are not admitted into residency programs.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>CME expansion:</i></b> The growing number of physicians in Brazil and the demand for ongoing education on new medical procedures,
drugs, technologies and developments will continue to drive demand for CME.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Technological innovation is driving medical education:</i></b> The current generation of medical students and professionals
requires instantly accessible digital content. Over 600,000 biomedical articles have been published globally every year since 2005, and
it is critical for lifelong learners to be able to access information and learning methodologies regardless of location and physical availability.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Limited scope of existing product offerings:</i></b> By generally limiting their focus on individual aspects of a student&#8217;s
education cycle, traditional education providers have struggled to build comprehensive student track records and profile databases. Consequently,
there is a general lack of integrated platforms that apply accumulated student information to efficiently tailor experiences to, or produce
bespoke materials for, the particular needs of each student.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe we are well-positioned to take advantage
of this market and its trends, bringing a more effective, personal and diversified service to our students, which will enable us to continue
to grow our market share.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Competition</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe we are the only company in Brazil with a
focus on the entire learning career of a physician. However, several companies provide solutions that compete in some of the markets in
which we operate.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We compete directly or indirectly with other post-secondary
institutions that offer medical courses or any of the other higher education courses in our portfolio. This market is very fragmented
and currently, there are more than 300 other institutions that offer medical courses in Brazil. The following table sets forth our main
competitors and the number of approved medical school seats they had as of December 31, 2025:</p>


<!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Number of
    Approved Medical School Seats</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 85%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Company</p></td>
    <td style="width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">As of<br/>
    December 31, 2025</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Afya Brazil	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3,755</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Player 1	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2,060</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Player 2	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,867</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Player 3	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,069</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Player 4	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,001</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk193368877"></span>The market for graduate
medical courses has been growing rapidly and we have recently experienced increasing competition from traditional education institutions
that previously had been limited to providing undergraduate courses and have since begun to offer graduate programs.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Products and Services</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We report our results of operations for each of the
following three operating segments:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Undergraduate, which provides educational services through undergraduate courses related to medical school, undergraduate health science
and other ex-health undergraduate programs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Continuing Education, which provides medical education (including residency preparation programs, specialization test preparation
and other medical capabilities), specialization and graduate courses in medicine, delivered through digital and in-person content; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Medical Practice Solutions, which provides clinical decision, clinical management and doctor-patient relationships for physicians
and provide access, demand and efficiency for the healthcare players.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We offer the following educational products and services
to lifelong medical learners enrolled across our evolving distribution network, as well as to third-party medical schools.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Undergraduate</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Medical Schools</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>A fully integrated core curriculum is offered to our medical school students across all our campuses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>All our medical students have access to our supplemental instructional platforms as part of the internship module of their medical
course, which we implemented for all incoming medical students of the fifth and sixth academic year.</td></tr></table>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Other Programs</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Other national core curriculum is offered to all students across all of our undergraduate campuses: healthcare degrees and a subset
of non-healthcare degrees, including business and engineering degrees offered by the companies we invested in or acquired.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Continuing Education</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Residency Journey</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Instructional content in digital format is offered to medical students and newly graduated physicians to prepare them for medical
residency exams.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Supplementary instructional content in digital format is offered to third-party medical schools that adopt our services.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2025, 2024 and 2023, we had 12,990, 16,381 and 12,170, respectively, enrolled students in our medical residency
preparatory courses.</td></tr></table>


<!-- Field: Page; Sequence: 75 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Graduate Journey</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We offer a wide array of options for doctors pursuing specialization, whether through graduate medical courses or preparatory programs
for specialist title exams. These students also have access to some of our supplemental instructional platforms.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Supplemental instructional content for different medical specializations is offered to individual lifelong medical learners in our
graduate courses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2025, 2024 and 2023, we had 10,234, 8,527 and 7,722 enrolled students in our graduate courses, respectively.</td></tr></table>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Other Courses &#8212; B2P and Business to Business Offerings</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>We provide courses that extend beyond medical practice, focusing on lifelong learning and the development of both technical and interpersonal
skills essential for well-rounded medical professionals.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>These programs cater to physicians seeking to stay current throughout their careers while enhancing their technical expertise.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2025, 2024 and 2023, we had 31,815, 25,613 and 27,188 enrolled students in our other courses, respectively.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Medical Practice Solutions</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Subscription-based mobile app and website portal focused on assisting health professionals and students with clinical decision-making
for 30 medical specializations through tools such as medical calculators, charts and updated content, including prescriptions, clinical
scores, medical procedures and laboratory exams, among others.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Free instructional content we offer to physicians, healthcare professionals and students.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2025, we had approximately 195,504 active paying users, consisting of approximately 156,598 in Clinical Decision
and 38,906 in Clinical Management. As of December 31, 2024, we had approximately 195,018 active paying users, consisting of approximately
161,283 in Clinical Decision and 33,735 in Clinical Management. As of December 31, 2023, we had approximately 183,602 active paying users,
consisting of approximately 153,541 in Clinical Decision and 30,061 in Clinical Management.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following chart sets forth our market share by
career aging cohort as of December 31, 2025:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: center; text-indent: 0.25in"><img src="image_009.jpg" alt=""/></p>


<!-- Field: Page; Sequence: 76 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Lifelong Medical Learner Clients</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, we had a total of 141,064
students across all our segments, including 25,556 enrolled in our undergraduate medical programs, 12,990 enrolled students in our medical
residency preparatory courses, 10,234 enrolled students in our medical graduate courses, and 31,815 enrolled students using our other
B2B and B2P offerings.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition to health sciences courses, which comprise
medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine, we also offer
degree programs and courses in other non-health sciences subjects and disciplines across several of our campuses, including undergraduate
and graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. These non-health
sciences courses are not part of our core business&#8212;the number we offer has increased as a consequence of our strategic acquisitions
of multi-disciplinary schools with strong health sciences programs, which are our principal focus. Although non-health courses are not
part of our growth strategy, we expect to continue to offer them to the extent they generate local demand. These non-health sciences programs
represented 6.3%, 6.3% and 6.5% of the total revenues of our Undergraduate segment in 2025, 2024 and 2023, respectively.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The attractive dynamics for medical education in Brazil,
including high demand for medical services and low medical density, combined with the exceptional rewards a physician receives (e.g.,
high wages, fast payback), create the perfect environment for us, with high demand for health sciences programs throughout the entire
medical career. This scenario enables us to target a unique student profile during our selection process, capturing the most capable individuals
in Brazil<span id="a_Hlk130287147"></span>.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk163715262"></span>Student Financing and Incentive
Programs</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Student Financing Program&#8212;Fundo de Financiamento
Estudantil (</i>&#8220;<i>FIES</i>&#8221;<i>)</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk163498549"></span>FIES is a MEC program
created by Law No. 10,260/2001 to provide financing to undergraduate students who are unable to finance their own education. After going
through several reforms from 2015 onwards, as of the date of this annual report, the FIES program is provided in the following categories:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Public FIES (2018)&#8212;Extended to persons with a per capita income of up to three minimum wages, with zero interest rate, with
the credit risk being divided between the government and the private Higher Education Institutions, or HEIs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Private FIES (2018)&#8212;Extended to persons with a per capital income of up to five minimum wages, with low interest rates. Regional
funds and private financial institutions, provide the financing; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Social FIES (2024)&#8212;Reserves at least 50% of FIES vacancies in each selection process for students with a per capita family income
of up to half a minimum wage, with zero interest rate.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk130579741"></span><span id="a_Hlk163715216"></span>Under
the Public FIES and the Social FIES modalities, financing is provided by federal government resources and contributions from Higher Education
Institutions, or HEIs through the <i>Fundo Garantidor do FIES</i>, the FG-FIES fund. Under this framework, participating HEIs contribute
to the fund through the retention of a percentage of financed tuition receivables, which is allocated to the FG-FIES to form a reserve
designed to mitigate the risk of default in FIES financing operations. This structure supports the operation of the FIES program by providing
a credit risk mitigation mechanism for participating institutions and financial agents. With respect to this fund, on November 1, 2023,
Law No. 14,719 was enacted and set a maximum contribution limit to the FG-FIES at 27.5%. This limit applies to contributions made by maintaining
entities voluntarily joining the program after the fifth year of their participation. In addition, as part of the conditions and rules
of the FIES program, private higher education institutions that apply for the program can immediately increase up to 10% of their authorized
vacancies annually.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For more information, see &#8220;Item 3. Key Information&#8212;D.
Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212; Changes to the rules, judicial interpretations, administrative
decisions or delays or suspension of tuition payments made through FIES may adversely affect our cash flows and our business&#8221; for
further information.</p>


<!-- Field: Page; Sequence: 77 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Incentive Program&#8212;Programa Universidade Para Todos</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Programa Universidade Para Todos,</i> or PROUNI,
was established in 2005 through Law No. 10,096/2005, which offers full and partial scholarships (50%), in private HEIs for undergraduate
and subsequent courses of specific training, to Brazilian students without a higher education diploma. Additionally, the Government offers
federal tax exemptions to higher education institutions adhering to PROUNI.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Private higher education institutions, whether for
profit or not, may join PROUNI by signing a term of adhesion (valid for 10 years), and at least (i)&#160;offer a full scholarship for
every 10.7 students who pay a regular monthly fee and are regularly enrolled at the end of the previous school year; or (ii)&#160;an integral
scholarship for every 22 students who pay the regular monthly tuition fees in specific undergraduate and subsequent courses, provided
they also offer scholarships of 50%, in amounts necessary so that the sum of the benefits granted is equivalent to 8.5% of its annual
revenue.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The tax exemptions (in whole or in part) for HEIs that
participate in this program are the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>IRPJ (income tax) and CSLL (social contribution), with respect to the portion of net income in proportion to revenues from traditional
and technology undergraduate programs; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>COFINS (Contribution for the Financing of Social Security) and PIS (Program of Social Integration), concerning revenues from traditional
and technology undergraduate programs.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, as part of the conditions and rules of
the PROUNI program, private higher education institutions that apply for the program can immediately increase up to 10% of their authorized
vacancies annually, except for law and medicine courses, which are subject to annual approvals by MEC.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Other Private Financing Program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition to PROUNI and FIES, Afya participates in
private financing programs through external partners (Pravaler, Bradesco, Sicoob, CashMe, BNB, Emcash and Alume) for undergraduate students.
Moreover, in 2024 we launched our own financing program for some of its units to support medical students who were not eligible for other
types of financing.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Key Benefits for Our Lifelong Medical Learners</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe the end-to-end physician-centric ecosystem
we have been developing for our students sets us apart from our peers, as we deliver content and learning activities that are tailored
to each student&#8217;s needs. This contributes to a more interactive and enjoyable learning process for our students, breaking away from
a teaching system that we perceive as presenting students with an overwhelming amount of content, unengaging classes and scattered information.
We achieve this based on three main pillars: innovative data-oriented methodology, a cutting-edge platform and state-of-the-art operating
environment.</p>


<!-- Field: Page; Sequence: 78 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: center"><img src="image_010.jpg" alt=""/></p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Innovative, Data-oriented Methodology</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our proprietary methodology to support our students&#8217;
lifelong medical education is based on the following concepts:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Standardized medical curricula:</i> The organization
of our medical curricula around interdisciplinary macro-medical topics to guide the development of in-person teaching plans and online
learning tools, offering a scalable solution for schools through weekly synchronized content;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Active learning:</i> Educational strategy to foster
independent, critical and creative student thinking, as well as encourage effective teamwork through case-based problem-solving exercises,
debates and small-group discussions;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Blended learning:</i> Balanced in-person teaching
with technology-assisted activities to improve student and teacher efficiency and results; and</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Adaptive learning:</i> A personalized instruction
and assessment tool that provides training and content tailor-made to each student&#8217;s individual profile. Students can access real-time
feedback on areas in which they can improve, effective learning methods and teaching/study plans that are most suitable for them.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Cutting-Edge Digital Platform</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe we deliver modern, bespoke verbal and practical
teaching. We continuously invest in creating innovative, technology-enabled activities and features to enhance our platform. We offer
our medical school students doing internships or studying for residency exams the following features through our digital platform:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Web portal and in-app communication:</i> Online
platform combining supplementary instructional content and a personalized communication tool for students, through which they can also
access our content offline;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Assessment tool</i>: Broad database suite composed
of quizzes and problem-solving activities, through which students can choose the subjects they would like to focus on, with additional
teacher-led instructional content;</p>


<!-- Field: Page; Sequence: 79 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Tutoring/mentoring platform</i>: An online monitoring
and support platform for both undergraduate and graduate medical students. The platform allows tutors to interact with students through
emails, video calls, voice calls and push notifications, and keeps records of such interactions. It also allows students to ask the tutors
questions and schedule appointments. The platform also tracks individual student performance and progress; and</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Digital health services platform</i>: A combination
of mobile and web applications focused on helping physicians, nurses, healthcare professionals and medical students in their clinical
decision-making and providing medical references and updates for the medical community.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">State-of-the-Art Operating Environment</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For us, individualized learning should be used not
just when offering content or technology-supported activities, but also during in-person encounters. Our professors can use our resources
to approach lessons more objectively, focusing on each student&#8217;s needs:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Modern teaching facilities:</i> We have designed
our classrooms to engage students in active learning. We rely on cutting-edge didactical equipment and simulation labs and state-of-the-art
realistic simulation technologies;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Medical specializations centers:</i> Our campuses
offer simulation centers and clinics where students can practice primary and secondary care, leveraging the learning process and providing
medical assistance to the local population; and</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Practical learning network:</i> Throughout the internship
cycle, our students can access over 596 partner teaching hospitals and clinics, the largest network of any education group in Brazil.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Evolving Distribution Network</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe that an effective end-to-end physician-centric
ecosystem goes beyond offering the largest and most complete operating infrastructure to the students enrolled at our campuses and with
access to our digital platforms. Through our evolving distribution model, we also expect to empower lifelong medical learners across our
growing network of diversified partner teaching hospitals, clinics and third-party medical schools by increasing our products and services
offerings as we continue to expand our business-to-business, or B2B capabilities.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Seasonality of Operations</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Undergraduate segment revenues are related to the intake
process and monthly tuition fees charged to students, and do not significantly fluctuate from quarter to quarter. Continuing Education
revenues are mostly related to: (i) monthly intakes and tuition fees on medical education, which generally do not experience significant
fluctuations resulting from seasonality and (ii) revenue derived from the sales of e-books which are recognized at the point in time when
control is transferred to the customer, which is generally concentrated in the first and last quarter of the year due to the period of
enrollments. Consequently, the Continuing Education segment generally has higher revenues and results of operations in the first and last
quarters of the fiscal year than in the second and third quarters of the fiscal year. Medical Practice Solutions revenues derive mainly
from Whitebook and iClinic, which do not experience significant fluctuations resulting from seasonality.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Marketing and Sales</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our marketing strategy is designed to efficiently identify,
qualify and convert prospective students and physicians into enrollments and product adoption across our educational and digital solutions
portfolio, while maximizing lifetime value within our physician ecosystem.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We execute this strategy through three integrated and
continuously optimized stages:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Identification:</i></b> We deploy a diversified mix of digital and offline channels, amplified by our owned media and social
platforms, to distribute relevant, educational content tailored to each stage of the physician journey, from undergraduate students to
practicing physicians. This approach supports continuous engagement with our solutions across both academic and professional milestones,
including our educational programs, mobile applications, and practice management software.</td></tr></table>


<!-- Field: Page; Sequence: 80 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Qualification:</i></b> Upon lead capture, we segment and nurture prospective students and physicians through personalized content
aligned with their academic stage, clinical practice needs, and professional goals. Concurrently, we apply data-driven scoring models
to prioritize high-intent leads, improving resource allocation and increasing downstream conversion efficiency across both educational
offerings and digital products.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Conversion:</i></b> Sales-qualified leads are routed to dedicated commercial teams that execute structured, performance-driven
campaigns. Conversion is actively managed through rigorous monitoring of funnel metrics, enabling continuous optimization of both sales
productivity and customer experience, across enrollments as well as adoption of our digital solutions.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Given our end-to-end and physician-centric model, we
support learners and professionals throughout their entire lifecycle. As a result, our funnels are dynamically calibrated based on supply-demand
dynamics across segments (including undergraduate medical education, preparatory courses, postgraduate programs, and digital practice
solutions), competitive intensity, and broader market conditions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our primary strategic focus is attracting and enrolling
top-tier students into our medical schools. In preparatory and postgraduate segments, as well as in our digital solutions for physicians,
we emphasize clear communication of learning outcomes, clinical and operational value, and overall cost-benefit proposition, reinforcing
a strong value proposition that drives both enrollment and product adoption.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our marketing and sales operations are supported by
a robust technology stack, including Salesforce, Marketing Cloud, Insider, Braze, ActiveCampaign, HubSpot, and advanced analytics and
performance measurement tools, enabling end-to-end tracking, personalization, and optimization across the full physician lifecycle.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe that our vertically integrated business
model, combined with the extensive and effective use of CRM and data analytics capabilities, provides us with a significant competitive
advantage&#8212;namely, the ability to identify, engage, and offer tailored educational and digital solutions, including applications
and practice management software, to a substantial share of medical students and physicians across Brazil.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Technology and Intellectual Property</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Technology</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have implemented several initiatives to improve
operational efficiency and to integrate processes across several campuses and operations. We plan to continue this process in the future
to fully consolidate Afya Brazil&#8217;s integrated systems with those of our recent acquisitions.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Shared Services Center</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have invested in a modern Shared Services Center,
or SSC, to process back-office and non-student-facing transactions. The SSC centralizes a broad range of administrative functions, including
finance, accounting, procurement and human resources, and operates with standardized processes and dedicated teams. It currently has idle
capacity and is expected to enable student-base growth with low marginal costs.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk162009774"></span>Integrated Systems</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have adopted third-party systems to handle our internal
systems in a fully integrated manner:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Enterprise Resource Planning, or ERP:</i></b> TOTVS ERP RM is the leading solution in the Education Industry in Brazil and delivers
a flexible systemic solution that fits our companies&#8217; processes to improve management and organization. At the same time, it allows
high governance of the processes, with complete control of all back-office activities, preventing operational errors and allowing efficient
tax-related calculations and control of government obligations. Salesforce optimizes our sales and customer relationship management processes,
facilitating streamlined lead management, sales forecasting, and customer engagement. Its robust analytics capabilities offer valuable
insights into sales performance and customer behavior, enabling data-driven decision-making and strategic planning. Additionally, ServiceNow
enhances internal workflows and IT service management, empowering teams to efficiently handle incidents, changes, and service requests.
Its intuitive interface and automation bolster productivity and customer satisfaction. Moreover, ServiceNow&#8217;s robust reporting
and analytics offer valuable insights, facilitating data-driven decision-making and continuous improvement.</td></tr></table>


<!-- Field: Page; Sequence: 81 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Academic System:</i></b> TOTVS RM Educacional is a mature platform that allows the configuration of the student payment plan
attached to the disciplines enrolled and processes preventing manual financial transactions and making the process more flexible and efficient.
This system includes both Student and Faculty Portals, with features that allow mobile frequency monitoring and provide payment solutions
to students and also manages the faculties&#8217; timesheet and payroll.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Learning Management System, or LMS:</i></b> Canvas LMS is a cloud-native, highly scalable system that connects all digital learning
tools and evaluation resources accessed nationally by our faculties and students.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk130287214"></span>As of the date of this
annual report, Medical Harbour, independently operates its own ERP system and has not yet migrated to the TOTVS RM platform. Its operations
are conducted in coordination with our standards and are integrated into the Canvas LMS ecosystem. We are working to migrate the systems
from Medical Harbour in order to fully incorporate it into our integrated systems.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Intellectual Property</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We rely on a combination of copyright, trademark and
trade secret laws, as well as employee and third-party non-disclosure, confidentiality and other types of contractual arrangements to
establish, maintain and enforce our intellectual property rights, including with respect to our proprietary rights related to our products
and services. In addition, we license technology from third parties.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk130287230"></span>As of the date of this
annual report, we had no issued patents and one patent application pending in Brazil. <span id="a_Hlk159340775"></span>As of December 31,
2025, we owned 415 trademark registrations in Brazil and 8 abroad, and we have also sought to register other trademarks in the United
States, in the European Union, Portugal, Mexico, China and Colombia. As of the date of this annual report, we have 405 pending trademark
applications in Brazil and unregistered trademarks that we use to promote our brand, and also own 381 registered domain names in Brazil
and 60 registered international domain names, and have registered four software programs in Brazil.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk163038789"></span>Insurance</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have insurance policies with reputable insurers
in amounts considered sufficient by our management to cover potential losses arising from indemnities that we may have to pay to third
parties as a result of our operations. The policies for our operating units have an aggregate coverage limit of up to approximately R$395.4
million. The Company and its subsidiaries have a risk management program with the purpose of delimiting the risks, seeking coverage compatible
with its size and operations in the market. We seek coverage against risks that are compatible with our scale and type of operations,
considering the nature of our activities, the risks we are exposed to, market practices in our industry, and the advice of our insurance
consultants.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">While we believe our insurance contracts reflect standard
market practices, there are certain types of risks that may not be covered by the policies (such as war, terrorism, acts of God and force
majeure, liability for certain harm or interruption of certain activities). Therefore, if any of these uncovered events occur, we may
be obliged to incur additional costs to remedy the situation, reconstitute our assets and/or indemnify our customers, which may adversely
affect us. Furthermore, even in the event that we incur a loss that is covered by our policies, we cannot assure that damages awarded
by our insurers will be sufficient to cover the losses arising from the insured event. See &#8220;Item 3. Key Information&#8212;D. Risk
Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;We may be held liable for extraordinary events that may occur
at our campuses, which may have an adverse effect on our image and, consequently, our results of operations.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk163038815"></span>Regulatory Overview</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian Constitution establishes education as
a right for all citizens and a duty of the State and the family. Accordingly, the government is required to provide all Brazilian citizens
with access to free primary education with compulsory attendance. Private investment in education is permitted as long as entities providing
education services comply with the applicable rules and regulations.</p>


<!-- Field: Page; Sequence: 82 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian education system is organized under a
cooperative management among federal, state and municipal governments. The federal branch is required to organize and coordinate the federal
educational system in order to guarantee equal opportunity and quality of education throughout Brazil. The states and the Federal District
are required to focus on secondary education, while municipalities are responsible for providing pre-primary school and primary education.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Private Higher Education Institutions are part of the
federal educational system and their activities are regulated by the federal government, and universities have didactic, scientific and
administrative autonomy as provided by the Brazilian Constitution.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, Law No. 9,394 of December 20, 1996, named
by National Education Guidelines Law <i>(Lei de Diretrizes e Bases da Educa&#231;&#227;o,</i> or LDB) provides the guidelines for
the provision of educational services in Brazil and sets forth the federal government&#8217;s duty to, among others: (i)&#160;coordinate
the national education system; (ii)&#160;prepare the National Education Plan; (iii)&#160;provide technical and financial assistance to
the states, the Federal District and municipalities; and (iv)&#160;define, in cooperation with other federal entities, the responsibilities
and guidelines for primary and secondary education, with the federal government&#8217;s priority in post-secondary education, issuing
rules and regulations regarding undergraduate and graduate programs, and carrying out the activities relating to the accreditation of
institutions, authorization and recognition of courses and monitoring and evaluation of the educational system as a whole.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the Brazilian federal government has historically
established decennial National Education Plans (Plano Nacional de Educa&#231;&#227;o, or &#8220;PNE&#8221;) to define strategic guidelines
for the education sector. The first PNE was enacted by Law No. 10,172, of January 9, 2001, followed by a subsequent plan for the 2014&#8211;2024
period, instituted by Law No. 13,005, of June 25, 2014.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In 2026, a new PNE was approved by the National Congress
and is pending presidential sanction. Once enacted, it is expected to establish a ten-year framework (2026&#8211;2036) focused on expanding
access to education, improving learning outcomes and reducing regional and socioeconomic disparities, with increased emphasis on territorial
equity and alignment with labor market needs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">With respect to higher education, the proposed framework
is expected to support enrollment growth, particularly in underserved and underpenetrated regions, and to promote the expansion of education
beyond major urban centers. The plan also includes initiatives aimed at improving educational infrastructure and connectivity, which may
enhance operating conditions and support scalable and technology-enabled learning models.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, the increased emphasis on quality, employability
and alignment with essential public services, including healthcare, is expected to favor institutions with strong academic standards,
governance and focus on professional training, while supporting the continued development and consolidation of the sector.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The goals and strategies set forth in the proposed
PNE are expected to apply across all federative entities and to serve as a key policy reference for both public and private education
institutions operating in Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Finally, each of the federal, state and municipal governments
are required to prepare a 10-year education plan and to establish policies, guidelines and objectives applicable to the segment of the
Brazilian education system over which it has responsibility.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Post-Secondary Education</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The post-secondary education sector is subject to comprehensive
government regulation. Its purpose is to ensure the quality of educational services, through evaluations of the ability of educational
institutions to meet minimum standards established by CNE and approved by MEC. This evaluation includes the analysis of pedagogical projects,
the infrastructure of Higher Educational Institutions, or HEIs, and their academic staff, and the results of such evaluations are considered
in the proceedings for opening new units and new courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Therefore, activities and courses offered by HEIs in
Brazil depend on authorizations and are subject to ongoing regulation, guided by the results of quality assessments. The federal responsibility
to regulate, monitor and evaluate post-secondary education institutions and programs is exercised by MEC, CNE, INEP and CONAES.</p>


<!-- Field: Page; Sequence: 83 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Ministry of Education</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Ministry of Education, or MEC, is the highest authority
for post-secondary education within the Brazilian national education system, whose competence consists, among other prerogatives, of the
following: (1)&#160;confirming CNE&#8217;s accreditation decisions for post-secondary education institutions; (2)&#160;confirming evaluation
systems and criteria adopted by the INEP; (3)&#160;confirming opinions and regulation proposals from CNE; (4)&#160;issuing rules and instructions
for compliance with laws, decrees and regulations pertaining to education issues; and (5)&#160;regulating and monitoring the post-secondary
education system through its secretariats.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">National Education Council</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The National Education Council, or CNE, is a consulting
and decision-making body monitored by MEC, collectively comprised of the Chamber of Primary and Secondary Education, or CEB, and the Chamber
of Post-secondary Education, or CES, each composed of 12 members appointed by the President of Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">CNE is required, among other responsibilities, to:
(i)&#160;issue regulations to implement MEC&#8217;s guidelines, as well as advise and support MEC in its activities and decisions; (ii)&#160;decide
on accreditation applications and renewals from post-secondary education institutions engaged in distance learning, based on the opinion
of the relevant secretariats; (iii)&#160;propose guidelines and deliberate on the preparation of the evaluation instruments for accreditation
and re-accreditation of institutions to be elaborated by INEP; (iv)&#160;issue guidelines to be observed by SERES for accreditation and
re-accreditation of universities, university centers and colleges; (v)&#160;determine, through CES, the inclusion and exclusion of course
designation from the catalog of advanced technology courses; (vi)&#160;rule on appeals of decisions issued by SERES, CEB or CES; and (vii)&#160;analyze
and propose questions regarding the application of post-secondary education legislation to MEC.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">An&#237;sio Teixeira National Institute for Educational
Research</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The An&#237;sio Teixeira National Institute for Educational
Research, or INEP, is a federal body linked to MEC whose main responsibilities are, among others, to: (i)&#160;design, plan, coordinate
and operationalize actions for the evaluation of HEIs, undergraduate courses and government schools, as well as the National Student Performance
Examination, or ENADE, the examinations and assessments of undergraduate students; (ii)&#160;design, plan, coordinate, operationalize
and evaluate indicators related to post-secondary education resulting from examinations and inputs from official databases, the establishment
and maintenance of databases of specialized evaluators and collaborators, including the appointment of evaluation committees; (iii)&#160;prepare
and submit to MEC the instruments for external evaluation <i>(in loco),</i> in accordance with the guidelines proposed by the SERES and
by other competent bodies; (iv)&#160;design, plan, evaluate and update the indicators for the external evaluation instruments in place,
in accordance with the guidelines proposed by CONAES; (v)&#160;chair the Technical Committee for Evaluation Monitoring; and (vi)&#160;plan,
coordinate, operationalize and evaluate the actions necessary to achieve its objectives.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">National Higher Education Evaluation Commission</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The National Higher Education Evaluation Commission,
or CONAES, is a coordination and monitoring body of the National Higher Education Evaluation System, or SINAES, monitored by MEC, composed
of a President and 13 members, including one representative of the INEP, one representative of the <i>Funda&#231;&#227;o de Coordena&#231;&#227;o
de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior</i> (Foundation for the Coordination of Improvement of Post-secondary Education
Personnel, or CAPES), three representatives of MEC (one of which must come from the body responsible for the regulation and monitoring
of post-secondary education), one representative of the student body of post-secondary education institutions, one representative of the
academic staff of post-secondary education institutions, one representative of the administrative body of post-secondary education institutions,
and five members appointed by the Minister of Education, with distinguished scientific, philosophic and artistic knowledge and proven
expertise in post-secondary evaluation or management.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Among other activities CONAES is required to: (i)&#160;propose
and evaluate the dynamics, procedures and mechanisms for institutional evaluation, courses and student performance; (ii)&#160;establish
guidelines for the organization of evaluation committees, analyze reports, prepare opinions and submit recommendations to the competent
bodies; (iii)&#160;formulate proposals for the development of HEIs, based on the analysis and recommendations produced in the evaluation
processes; (iv)&#160;communicate with the state educational systems, with the aim to establish common actions and criteria for the evaluation
and supervision of post-secondary education; and (v)&#160;annually submit for approval by the Minister of Education the list
of courses for which students will apply for the ENADE.</p>


<!-- Field: Page; Sequence: 84 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Conselho Federal de Medicina (&#8220;CFM&#8221;)</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Conselho Federal de Medicina, or CFM, is the federal
professional regulatory body responsible for overseeing the ethical and professional standards governing the practice of medicine in Brazil.
The CFM operates in conjunction with the Regional Medical Councils (Conselhos Regionais de Medicina, or &#8220;CRMs&#8221;), which together
form the Brazilian Medical Councils System. While the CFM establishes general rules, ethical standards and professional guidelines applicable
to physicians nationwide, the CRMs are responsible for the registration of physicians and the supervision and enforcement of professional
conduct at the state level.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In order to practice medicine in Brazil, physicians
must hold a medical degree issued by a higher education institution duly accredited by the MEC and must also obtain registration with
the CRM of the jurisdiction in which they intend to practice. The medical councils are also responsible for monitoring compliance with
the Medical Code of Ethics and other professional regulations applicable to physicians.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Although the CFM does not regulate higher education
institutions or authorize the operation of medical schools, it plays an institutional role in the broader healthcare and medical education
environment in Brazil. The CFM frequently participates in public policy discussions and debates relating to the quality of medical education,
the expansion of medical school seats and other matters related to the training and qualification of physicians. In this capacity, the
CFM may issue technical opinions, studies and public statements that may influence legislative or regulatory initiatives concerning medical
education.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Brazilian Health Regulatory Agency (Ag&#234;ncia Nacional
de Vigil&#226;ncia Sanit&#225;ria, or &#8220;ANVISA&#8221;)</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The ANVISA is the federal authority responsible for
regulating and supervising health-related products and services in Brazil, including healthcare facilities, medical devices and digital
health solutions. Although ANVISA does not directly regulate higher education institutions, sanitary regulations may apply to healthcare-related
facilities and activities used in practical training for healthcare programs, such as teaching hospitals, clinics and laboratories, as
well as to activities and infrastructure associated with our Medical Practice Solutions segment, to the extent they involve regulated
healthcare services, medical devices or software qualifying as Software as a Medical Device under applicable Brazilian regulations. Accordingly,
we must comply with applicable sanitary regulations, including approval, certification, licensing and inspection requirements. Failure
to comply with, or to adapt to evolving regulatory standards may result in operational restrictions, required modifications to our products
or services, increased compliance costs or administrative penalties, which could adversely affect our ability to offer certain solutions
and impact our operations.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Organization of Post-Secondary Education Institutions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In order to allow post-secondary education institutions
to fulfill their objectives, the LDB also provides that post-secondary education includes the following programs:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Undergraduate courses,</i> including traditional and technological undergraduate courses, offering specific training and diplomas
to students, open to candidates who have completed high school or equivalent and who have been approved in the respective selection or
entrance examinations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Graduate courses,</i> including master&#8217;s and doctoral degrees, specialization courses, further training courses and others,
open to candidates who hold a diploma in an undergraduate course and who meet the requirements laid down by educational institutions;
and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Extension courses,</i> understood as any academic, technical or cultural activity that is not included as an integral and compulsory
part of the undergraduate and graduate curriculum, in which the students receive certificates. Such courses are open to candidates who
meet the requirements established in each case by educational institutions.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">According to the LDB, post-secondary education can
be provided by public or private institutions. A private post-secondary education institution must be controlled, managed and supported
by an individual or a legal entity with responsibility for financing its supported entities. Post-secondary
education institutions may be supported by for-profit or not-for-profit private institutions, or supporting entities, as follows:</p>


<!-- Field: Page; Sequence: 85 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Private in the strict sense:</i> private for-profit institutions created and maintained by one or more private individuals or legal
entities;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Community:</i> incorporated by groups of individuals or by one or more legal entities and that include representatives of the community
in their organizational structure;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Confessional:</i> incorporated by groups of individuals or by one or more legal entities that meet the specific confessional and
ideological orientation and that include representatives of the community in their organizational structure; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Philanthropic,</i> in the form of the applicable regulations.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">According to their organization and academic prerogatives,
post-secondary education institutions can be:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Colleges:</i> colleges are public or private HEIs offering post-secondary programs in one or more areas, maintained by a single
supporting entity and with isolated management and direction. Colleges are allowed to offer programs along several levels, namely bachelor&#8217;s,
associate&#8217;s, specialization and graduate programs (master&#8217;s and doctorate degrees). Colleges have minimum requirements with
regard to the qualification of faculty members and their labor practices, and cannot establish new campuses, courses, or spots without
prior authorization from MEC;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>University Centers:</i> university centers are public or private education institutions offering several bachelor&#8217;s, associate&#8217;s
and graduate programs, and are expected to provide appropriate work conditions, education and qualification opportunities for their professors.
To be considered a university center, the institution shall comply with such requirements: (i)&#160;at least one-fifth of the faculty
members of a university center must hold a master&#8217;s or doctorate degree; (ii)&#160;at least 20% of the faculty members must work
on a full-time basis; (iii)&#160;at least eight undergraduate courses shall be recognized and have obtained a satisfactory concept in
the on-site external evaluation carried out by INEP; (iv)&#160;have an institutionalized extension program in the areas of knowledge covered
by their undergraduate courses; (v)&#160;have a scientific initiation program with a project supervised by doctoral or masters professors,
which may include programs of professional or technological initiation and initiation to teaching; (vi)&#160;have obtained an Institutional
Concept, or CI, greater than or equal to four in the on-site external evaluation performed by INEP; and (vii)&#160;have not been penalized
as a result of an administrative supervision process in the last two years; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Universities:</i> universities are public or private education institutions offering several post-secondary programs, continuing
education and research development. Like University Centers, certain requirements for university re-accreditation must be observed, namely:
(i)&#160;one-third of the academic staff is hired on a full-time basis; (ii)&#160;one-third of the faculty members must have a master&#8217;s
or doctoral degree; (iii)&#160;at least 60.0% of the undergraduate courses shall be recognized and have a satisfactory concept obtained
in the evaluation proceedings carried out by INEP; (iv)&#160;have an institutionalized extension program in the areas of knowledge covered
by their undergraduate courses; (v)&#160;have a scientific initiation program with a project supervised by master&#8217;s or doctoral
professors, which may include programs of professional or technological initiation and initiation to teaching; (vi)&#160;have obtained
CI greater than or equal to four in the external evaluation carried out by INEP; (vii)&#160;regularly offer four master&#8217;s degree
courses and two PhD courses recognized by MEC; and (viii)&#160;have not been penalized as a result of an administrative supervision process
in the last two years.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The LDB provides that the following powers are granted
to universities and university centers in the exercise of their autonomy, amongst others: (i)&#160;to create, organize and discontinue
post-secondary education programs on their premises, subject to the applicable regulation; (ii)&#160;to establish the curricula for programs,
subject to the applicable general guidelines; (iii)&#160;to establish plans, programs and projects in connection with scientific research,
artistic production and extra-curricular activities; (iv)&#160;to establish the number of student offerings available; and (v)&#160;to
create and change their bylaws in accordance with the applicable general rules, as well as to award degrees, diplomas and other certificates.</p>


<!-- Field: Page; Sequence: 86 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Distance Learning</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Distance learning in Brazil is regulated by article
80 of the LDB, by Decrees 9,057 and 9,235, both of 2017, by Ordinances No. 11 and 23, both of 2017, and CNE&#8217;s Resolution No. 1,
of 2016, as amended by Ordinance No. 528 of June 6, 2024, and by Decree No. 12,456 of May 19, 2025.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Distance learning is defined as the educational method
in which didactic and pedagogic processes are conducted through information and communication media and technologies, with students and
teachers interacting in educational activities while located in different locations or at different times.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to the applicable regulations, distance learning
is subject to different factors compared to traditional methods, including: (i)&#160;reduced transmission costs in commercial channels
of sound and audiovisual broadcasting; (ii)&#160;concession of channels with exclusive educational purposes; and (iii)&#160;minimal time
reservation, with no onus on the public authorities, by the concessionaries of commercial channels.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Distance learning can be offered at the following levels
and as part of the following educational methods: (i)&#160;primary and secondary education, as long as it is used only to supplement learning
processes or in emergency situations; (ii)&#160;education for young people and adults, according to specific legal criteria; (iii)&#160;special
education, according to specific legal criteria; (iv)&#160;professional education, covering technical programs at the secondary level
and technological programs at the post-secondary level; and (v)&#160;post-secondary education, covering graduate, master&#8217;s programs,
specializations, and doctorate studies.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Undergraduate courses (bachelor&#8217;s, licentiate
and technological) may be offered using distance learning methods whenever a post-secondary institution is regularly accredited by MEC
for this purpose.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to Decree No. 9,057, 2017, institutional accreditation
and reaccreditation, as well as the authorization and recognition of courses and their renewal will be subject to on-site evaluation,
with the aim to verify the existence and suitability of the method, infrastructure, technology and personnel that may enable the execution
of the activities provided in the Institutional Development Plan or PDI and the Pedagogical Project of the Course, or PPC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">HEIs accredited for the offering of post-secondary
education in the distance modality that hold autonomy prerogatives (universities and university centers) do not require authorization
for operation of the post-secondary course in the distance modality, but shall inform MEC about the offering of the course within 60 days
of the date of creation of such course, for the purposes of supervision, evaluation and recognition. Also, accredited HEIs must inform
MEC about the creation of distance learning supporting units and the alteration of their addresses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Although distance learning is defined by the absence
of direct contact between students and teachers, there are activities that must be conducted on-site, such as tutorials, evaluations,
internships, professional practice, laboratory and dissertation defense, which are to be provided in the educational and development projects
of the institution and the course. Accordingly, distance learning institutions must provide the necessary infrastructure for the students
to conduct those activities, using the headquarters of the education institution or smaller supporting units throughout the country. Distance
learning supporting units are no longer subject to on-site evaluation or required to obtain prior authorization from MEC in order to be
set up or operated. Pursuant to Ordinance No. 11/2017, such units can be created by a unilateral decision of the institution itself. Nevertheless,
such units remain subject to MEC&#8217;s supervisory authority, including documentary review, monitoring and inspection procedures, in
accordance with the post-authorization oversight framework strengthened by Decree No. 12,456/2025.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Distance courses and programs must be projected with
the same defined duration as the respective on-site courses. The evaluation of the performance of students for promotion, conclusion of
the course and obtainment of diplomas and certificates must be conducted through the conclusion of the programmed activities and on-site
exams by the accredited HEIs, following procedures and criteria defined in the respective PPC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The evaluation of the distance learning courses
is performed in a very similar manner as the evaluation of on-site courses, and is conducted within the scope of SINAES. In the
event of any irregularity or non-compliance to any of the previously established conditions set by MEC, the competent body may
initiate an administrative proceeding that may result in one or more penalties, such as: (i)&#160;forfeiture of accreditation or
reaccreditation to operate as a distance learning institution; (ii)&#160;intervention; (iii)&#160;temporary suspension of autonomy
prerogatives; (iv)&#160;initiate reaccreditation proceedings; (v)&#160;reduction of available vacancies within
courses; (vi)&#160;temporary suspension of new students admissions; and (vii)&#160;temporary suspension of courses offered.</p>


<!-- Field: Page; Sequence: 87 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Diplomas and certificates for distance learning courses
and programs from accredited institutions are valid throughout the national territory and institutions are not entitled to set different
criteria for diplomas issued for distance learning courses and those issued for on-site courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Distance learning courses may be offered only by HEIs
that hold specific accreditations for this purpose. It is MEC&#8217;s responsibility to promote the accreditation acts of post-secondary
institutions. To act outside the institution&#8217;s local geographic reach, the institution shall require an extraterritorial accreditation
to MEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Distance learning courses or programs require periodic
renewal. Also, the accredited institution must initiate the authorized coursework within 24 months from the accreditation, and if the
institution does not implement the authorized activities in such time frame, it will be subject to an administrative proceeding that may
result in the cancellation of the given authorization.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to Decree No. 9,057/2017, post-secondary courses
may be offered in the distance learning modality through a partnership between an accredited distance HEI and another company. In this
case, applicable regulations establish that educational activities must be conducted in the facilities of the accredited HEI, which will
be responsible before MEC for the regularity of the teaching and learning processes. Accordingly, the HEI must inform MEC of its partnerships,
describing their purpose and most relevant aspects, in order for MEC to be able to assess eventual irregularities.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Regulatory Processes of Post-Secondary Education Institutions</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Accreditation of Post-Secondary Education Institutions
and Authorization and Recognition of Courses</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A post-secondary education institution is initially
accredited as a college. The accreditation as a university or university center is only granted after the institution has operated as
a college and met satisfactory quality standards, including positive assessments in the SINAES. In addition, the HEI must fulfill other
legal requirements that could vary according to the respective category, such as the requirement that a certain percentage of faculty
members meet minimum graduation standards (i.e., a doctorate or master&#8217;s degree), and specific types of labor regimes.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The application for qualification of a post-secondary
education institution must be supported by various documents, including:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Supporting entity:</i> (i)&#160;incorporation documents, duly registered with the competent body, evidencing its existence and
legal capacity, in accordance with civil legislation; (ii)&#160;proof of registration in the National Taxpayer&#8217;s Registry or, CNPJ;
(iii)&#160;certificates of tax and social security compliance; (iv)&#160;proof of ownership of assets capable of supporting the education
institution; (v)&#160;financial statements; and (vi)&#160;consent form executed by the supporting entity&#8217;s legal representative,
vouching for the veracity and regularity of the provided information and the financial capability of the supporting entity; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Post-secondary education institution:</i> (i)&#160;proof of payment of the on-site evaluation fee related to the external evaluation
to be performed by INEP; (ii)&#160;PDI; (iii)&#160;bylaws and internal regulations; (iv)&#160;identification and qualification of managers,
with a description of their academic and administrative experience; (v)&#160;receipt of regularity and availability of the teaching facilities;
(vi)&#160;plan of accessibility assurance, pursuant to the regulation and followed by a technical report by a competent professional or
public body; and (vii)&#160;compliance with the legal requirements related to the safety of the building, including having an escape route
in case of fire, proved by a specific report issued by the competent public body.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In relation to the accreditation process of a new post-secondary
educational institution and linked course authorizations, MEC may issue a temporary accreditation act to expedite the operation, pursuant
to Article 24 of Decree No. 9,235/2017, as amended by Decree No. 12,456 of 2025. The granting of such temporary accreditation is conditional
upon the supporting entity cumulatively meeting all the following requirements:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>all self-supporting post-secondary education institutions have been reaccredited within the previous five years, obtaining an average
Institutional Score <i>(Conceito Institucional)</i> equal to or greater than &#8220;4&#8221;;</td></tr></table>


<!-- Field: Page; Sequence: 88 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>none of the institutions maintained by the supporting entity may have been subject to administrative penalties by MEC within the two
years preceding the accreditation request; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the courses to be offered by the new post-secondary institution, which are limited to a maximum of five courses, must be equivalent
to courses already offered by other institutions supported by the same supporting entity, duly recognized by MEC within the previous five
years, with a Program Score <i>(Conceito de Curso)</i> equal to or greater than &#8220;4.&#8221;</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Following the initial accreditation as a post-secondary
education institution, colleges depend on an authorization issued by MEC to offer post-secondary education courses. Within their autonomy,
universities and university centers do not depend on authorization by MEC to create the majority of post-secondary education courses and
campuses in the same city as its headquarters, except for medicine, dentistry, psychology, nursery and law courses, which necessarily
must be previously authorized by MEC. In any other cases, institutions are required to inform MEC about the programs they offer for purposes
of monitoring, evaluation and further recognition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In the authorization for post-secondary on-site courses
of the federal education system, the external in loco evaluation can be waived after documentary analysis if the following requirements
are met: (i)&#160;having an Institutional Score <i>(Conceito Institucional)</i> greater than or equal to &#8220;3&#8221;; (ii)&#160;absence
of a supervision process; and (iii)&#160;the institution offers other courses in the same area of knowledge which meet the minimum evaluation
standards.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Requesting authorization for a course must be supported
by the following documents, among others: (i)&#160;proof of payment of the on-site evaluation fee; (ii)&#160;the PPC, outlining the number
of students, classes, description of the program and other relevant academic elements, and describing the facilities, technology and staff
for the distance learning support units, if applicable; (iii)&#160;list of faculty members, together with the relevant agreements entered
into with the education institution, together with their respective titles, working hours and work regime; and (iv)&#160;proof of availability
of the teaching facilities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Universities and university centers may also apply
for the accreditation of a campus not located in the same city as its headquarters, provided that it is located in the same state. Such
campuses and programs must integrate the same set of universities or university centers and will only enjoy autonomous prerogatives if
there is compliance with the same headquarters requirements and if a high-quality degree is shown, through an average Institutional Score
<i>(Conceito Institucional)</i> greater or equal to &#8220;4.&#8221; Therefore, even in the case of universities or university centers,
prior authorization from MEC is necessary to create any courses on campuses not located in the same city as the university&#8217;s headquarters.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Once authorization for a given program has been issued,
post-secondary education institutions, including university centers and universities, must also file a request for the recognition of
the program as a condition for the national validation of the respective diploma. The requirement must be filed with MEC after the midway
point of the term established for the completion of the corresponding program and three-quarters completion of such term, and must include
the following documents, among others: (i)&#160;PPC, including the number of students, schedules and other pertinent academic information,
(ii)&#160;list of faculty members, listed in the national registry of instructors, and (iii)&#160;proof of availability of the teaching
facilities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Authorization and recognition of courses, as well as
accreditation of post-secondary education institutions must have a limited term and be renewed periodically following the regular evaluation
process, currently established according to the evaluation cycles of the SINAES.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our post-secondary education institutions are accredited
by MEC and their courses are duly authorized. We also make every effort to comply with all applicable regulations to maintain our institutions
and courses compliant with MEC regulations.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Additional Guidance on Admissions Management &#8211;
Medical Programs</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In August 2025, the MEC issued Technical Note No. 5/2025,
providing interpretative guidance on certain aspects of admissions management in undergraduate medical programs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In this context, Technical Note No. 5/2025 clarifies
that vacancies arising from student attrition during the course may not be offered as new first-year admission seats, as this could result
in cohorts exceeding the originally authorized annual capacity and, consequently, lead to a number of students
during the internship phase that exceeds the capacity of the public healthcare facilities available as practical training settings.</p>


<!-- Field: Page; Sequence: 89 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">According to the Technical Note, such practice may
be deemed an administrative irregularity under applicable regulations.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk163038869"></span>Modification of Supporting Entity</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to Decree No. 9,235/2017 and Ordinance No.
23/2017, as amended by Decree No. 12,456/2025, a modification of a supporting entity occurs whenever there is a change in the supporting
entity itself or in its controlling shareholder, provided that such change affects the institution&#8217;s decision-making process. Following
the enactment of Decree No. 12,456/2025, the modification of the supporting entity is no longer subject to approval of MEC. However, the
educational institution is required to notify MEC within 60 days of the consummation of the relevant event, for purposes of updating its
registration in the e-MEC. Such notice must be accompanied by all relevant and duly registered legal documentation evidencing the change,
as well as a term of commitment executed by the legal representatives of both the current and new supporting entities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The new supporting entity or controlling shareholder
must meet the requirements necessary for the accreditation of a post-secondary education institution, which will be assessed by MEC in
the context of the institution&#8217;s reaccreditation proceedings. Additionally, the LDB also provides that educational institutions
must inform MEC of any change in their bylaws, which must be registered with competent bodies.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The transfer of programs or courses between HEIs is
strictly prohibited and may subject the involved entities to penalties such as: (i)&#160;suspension of new students&#8217; admission;
(ii)&#160;suspension of the offering of undergraduate or graduate <i>lato sensu</i> courses; (iii)&#160;suspension of the institution&#8217;s
autonomy to, among others, create new post-secondary courses and establish course curricula, if applicable; (iv)&#160;suspension of the
license to establish new distance-learning programs; (v)&#160;override any ongoing regulatory requests filed by the institution and prohibit
the filing of any new regulatory requests; (vi)&#160;suspension of the participation in the FIES; (vii)&#160;suspension of the participation
in PROUNI; and (viii)&#160;suspension or restriction to participate in other federal educational programs.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk163039483"></span><span id="a_Hlk163038905"></span><span id="a_Hlk163498488"></span>Financing
Alternatives for Students: Incentive Programs</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Programs providing public funding to students enrolled
in private higher education institutions have been a major public policy to expand access to post-secondary education in Brazil, especially
for the low-income segment of the population. The most important programs are the following.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">University for All Program, or PROUNI</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The University for All Program, or PROUNI is a tax
incentive program created through the Provisional Measure No. 213, of September 10, 2004, later converted into Law No. 11,096, of January
13, 2005, that addresses the exemption of certain federal taxes imposed to post-secondary institutions that grant scholarships to low-income
students enrolled in undergraduate courses and technology graduate courses. By granting tax incentives to IES, PROUNI has played an important
role in inciting growth and private investment in the post-secondary education sector.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Private post-secondary institutions may adhere to PROUNI
by the execution of a specific agreement with MEC, valid for 10 years and renewable for the same period. Such agreement must be emended
every semester with an additional term establishing the number of scholarships to be offered in each course, unit and class, and what
percentage of scholarships shall be granted to indigenous and afro-Brazilians. In order to participate in PROUNI, an educational institution
must:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>be up to date with its tax obligations; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>comply with the following requirements: (1)&#160;offer at least one full-time scholarship to every 10.7 regularly paying students
enrolled at the end of the past school year, excluding the full-time scholarships granted through PROUNI or by the institution; or (2)&#160;offer
one full-time scholarship to every 22 regularly paying students enrolled in traditional and technological graduation courses, provided
that it also offers scholarships (50% of the tuition) with a value equal to 8.5% of the paying students&#8217; annual revenue, available
to students enrolled in traditional and technological graduation courses at the school year.</td></tr></table>


<!-- Field: Page; Sequence: 90 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The ratio between the number of scholarships and the
number of regularly paying students must be complied with annually. If the entity does not comply with the ratio during a school year
because of the withdrawal of students, the institution must adjust the number of scholarships in a proportionate matter for the subsequent
school year.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to Normative Ruling No. 1,394, of September
12, 2013, issued by the Brazilian Federal Revenue Office, a post-secondary education institution that has adhered to the PROUNI is exempt,
totally or partly, from the following taxes for the duration of the adherence period:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Income Tax (&#8220;IRPJ&#8221;) and Social Contribution on Net Income (&#8220;CSLL&#8221;), with respect to the net income proportionate
to the revenue derived from the Undergraduate Degree Programs and Extension courses; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Contribution for Social Security Financing (&#8220;Cofins&#8221;) and Contribution to the Social Integration Plan (&#8220;PIS&#8221;),
with respect to the revenue derived from the traditional and technological graduation courses.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In case a post-secondary education institution requires
its exclusion from the PROUNI, its tax incentives will be suspended from the date of the solicitation and will not be applicable for the
entire period of the basis of calculation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The calculation of such tax benefits follows the regulatory
criteria established by the Brazilian Federal Revenue Service (<i>Receita Federal do Brasil</i>), including the Proportion of Effective
Occupation of the Scholarships, or POEB, which directly affects the amount of the tax exemption.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Student Financing Program, or FIES</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Student Financing Program (<i>Fundo de Financiamento
ao Estudante do Ensino Superior</i>, or FIES), created by Law No. 10,260, of July 12, 2001, is a MEC program to finance students who cannot
bear the total costs of their education. FIES has been the most important program for the expansion of access to higher education in Brazil
during the last decade, and it is currently responsible for a significant part of the revenues of the majority of private higher education
institutions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">FIES consists of funding granted by the National Fund
for Educational Development, or FNDE to students regularly enrolled in an on-site course of a post-secondary private HEI registered in
the FIES that has been positively evaluated by MEC. After a specific selection process, students may be partially or wholly funded by
FIES and, in that case, FNDE will be responsible for crediting the corresponding amount due by the student to the private higher education
institution.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Payments are made with government bonds whose primary
purpose is to compensate tax debts from the private higher education institution. In case there are no debts to be compensated, the institution
can resell the bonds to the government by means of a specific proceeding that currently occurs on a monthly basis. The frequency of these
proceedings could vary according to public financial constraints and the discretion of FNDE.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk163495256"></span>FIES has been substantially
reshaped by Law No 13,530, dated December 7, 2017, and currently the program is not as broad as it used to be. According to applicable
regulations, in order to enroll students who have been selected by FIES, private higher education institutions are required to contribute
to the fund 13% of the amount due by the student to the institution as consideration for the educational services rendered in the first
year of studies. This amount is subject to change in the following years and could vary between 10% and 25% of the consideration due,
depending on specific circumstances.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk163495615"></span>On March 1, 2024, MEC
issued Ordinance No. 167/2024, establishing the Social FIES program. This program reserves at least 50% of FIES vacancies in each selection
process for students with a per capita family income of up to half a minimum wage, registered in the Central Registry of Social Programs
of the Federal Government (Cad&#218;nico). These eligible students can receive 100% financing for tuition fees at universities, subject
to the availability of the FIES budget.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk223088931"></span>National Higher Education Evaluation System</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The National Higher Education Evaluation System, or
SINAES was created by Law No. 10,861 of April 14, 2004, with the purpose of evaluating post-secondary education institutions, undergraduate
courses and measuring student academic performance. The main objective of this evaluation system is to assess the quality of education
in the country, providing guidelines for MEC to decide upon institutional reaccreditation,
recognition and renewal of recognition of courses. Additionally, SINAES is responsible for improving the quality of post-secondary education
in Brazil given that MEC can identify deficiencies and establish specific conditions for institutions to remedy their issues and resume
their operations.</p>


<!-- Field: Page; Sequence: 91 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The SINAES is monitored and coordinated by the CONAES
and INEP has a very important role in all processes. The results of the evaluation of post-secondary education institutions and their
programs are public and represented on a five-level scale as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Level 5 indicates excellent conditions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Level 4 indicates more than satisfactory conditions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Level 3 indicates satisfactory conditions; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Levels 1 and 2 indicate unsatisfactory conditions.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to applicable regulations, evaluation processes
consist of a preliminary assessment of several conditions relating to the institution and its courses, such as infrastructure, titles
of faculty members, work schedule of faculty members and student performance. Every year INEP establishes a method to evaluate those elements
and for them to correspond to a number in the five level scale.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The preliminary assessment is a complex process based
on quality indicators as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(a)</td><td>National Student Performance Examination</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The National Student Performance Examination, or ENADE,
is a test applied to a number of students that are completing courses. It evaluates students&#8217; knowledge regarding the content provided
in the curricular guidelines of the respective undergraduate course, their skills and competencies. ENADE&#8217;s results are considered
in the composition of quality indexes for courses and institutions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Since 2025, ENAMED, a modality of ENADE applicable
to medical programs, has been implemented pursuant to MEC Ordinance No. 330/2025 and further regulated by INEP Ordinance No. 413/2025.
ENAMED is a mandatory annual examination for students in the final year of the program (internship), and participation is required for
the student&#8217;s academic regularity and for institutional evaluation purposes. As of&#160;2026, ENAMED has also been extended to students
in the fourth year (pre-internship) to monitor the progression of academic training. ENAMED assigns a concept rating on a scale from 1
to 5 to each medical program, and its results are incorporated into the calculation of quality indicators for such programs and their
respective institutions in the same manner as ENADE.</p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(b)</td><td>Preliminary Course Concept</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Preliminary Course Concept, or CPC, is a compound
of the ENADE score, the Difference Indicator between Observed and Expected Performance, or IDD, and factors that include teacher titles,
the work schedule of faculty staff and infrastructure of the institution. It is an indicator of the state of undergraduate courses in
the country. CPC 1 and 2 courses are automatically included in the INEP examiner&#8217;s visit schedule for on-site verification of teaching
conditions. Courses with a concept equal to or greater than 3 can choose not to receive the visit of the evaluators and, thus, transform
the CPC into a permanent concept (the Course Concept). The CPC is released every year for a specific group of courses along with the results
of ENADE.</p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(c)</td><td>General Course Index</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The General Course Index, or IGC, of the institution
summarizes in a single indicator the results of CPC and the evaluation of master&#8217;s and doctorate courses of each educational institution.
With regard to undergraduate courses, CAPES indexes are used and adapted to the scale according to a methodology provided by INEP, given
that they are organized in a different manner. IGC also goes from 1 to 5 and is published by INEP/MEC, after the release of the results
of ENADE and CPC. The IGC is a criterion in the accreditation and re-accreditation processes of institutions and also in the authorization
process for new courses: institutions with IGCs less than 3, for example, may have their applications for new courses rejected by MEC.
Similarly, the indicator is used to guide the expansion of quality education: institutions with good performance are exempted from the
authorization of MEC to open courses.</p>


<!-- Field: Page; Sequence: 92 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><i>(d)</i></td><td><i>Indicator of Difference Between Observed and Expected Performance</i></td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Indicator of Difference Between Observed and Expected
Performance, or IDD, is aimed at providing a reference of the contribution of the course to the learning of each student. For that purpose,
it compares the results of the ENADE with the performance of the same student in the ENEM. The indicator has a scale of 1 to 5.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Following preliminary assessments, all institutions
are typically subject to an on-site evaluation to confirm the results. However, given the size of the system, MEC gives institutions the
option to convert the results of the preliminary assessments into final results and, therefore, forgo on-site evaluations. For institutions
that obtain unsatisfactory levels, MEC on-site evaluations are mandatory.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Even before the on-site evaluation, MEC is entitled
to apply precautionary measures when preliminary assessments of the institution or course are not considered satisfactory, such as: (i)&#160;suspension
of new enrollments within the respective course or the entire institution; (ii)&#160;reduction of vacancies; and (iii)&#160;suspension
of all regulatory proceedings for institutional reaccreditation, new authorizations, recognitions or renewals of recognitions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Should the level be confirmed as less than three by
the on-site evaluation, MEC may propose a term of commitment to the institution, in order for it to correct the unsatisfactory conditions
within a specific deadline. Failure to uphold, in full or in part, the conditions established in the term of commitment may result in
one or more penalties to be applied by MEC, such as: (i)&#160;temporary suspension of the opening of a selection process of graduation
courses; (ii)&#160;disqualification from the operating authorization of the higher education institution or recognition of courses offered;
and (iii)&#160;warning, suspension or cancellation of the mandate of the officer responsible for the action not executed, in the case
of public HEI.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">After the on-site evaluations, institutions and courses
obtain definitive quality concepts, as follows:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Institutional
Concept, which is the result of the on-site evaluation of the institution performed by INEP; and</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Course
Concept, which is the result of the on-site evaluation of the course performed by INEP.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk163038922"></span>Accreditation for Graduate Programs</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Lato Sensu</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Post-secondary HEIs accredited for offering undergraduate
courses and that have at least one regular undergraduate course or a <i>stricto sensu</i> graduate course can offer <i>lato sensu </i>graduate
courses in the subjects in which they are accredited, either on-site or through distance learning.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The offering of graduate programs does not require
an authorization to operate, even if it is offered by a college. However, it must be notified to MEC, through MEC&#8217;s system (e-MEC),
within 60 days of the date of creation of such course.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The <i>lato sensu</i> graduate courses are aimed at
students who hold a diploma in an undergraduate course and satisfy the criteria of the institution that is offering the graduate course.
The graduate courses must meet the following requirements: (i)&#160;curriculum with a minimum study load of 360 hours; and (ii)&#160;a
teaching staff composed of at least 50% masters- or doctorate-level graduates of <i>stricto sensu</i> graduate courses.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Stricto Sensu</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The authorization and recognition of <i>stricto sensu</i>
graduate courses (masters and doctorates) must be evaluated by CAPES, submitted to CNE&#8217;s deliberation and approved by MEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The HEIs can only initiate masters and doctorate courses
activities following the publication of the homologation of CNE&#8217;s favorable opinion by MEC in the Official Gazette.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As part of its analysis, CAPES must consider the
general requirements and the specific parameters of the subject area to which each course is linked. The general requirements are:
(i)&#160;alignment of the proposal with the graduate planning of the institution; (ii)&#160;suitability and justification of the
proposal for the regional or national development and its economic and social importance; (iii)&#160;clarity and consistency of the
proposal with detailed information on its objectives, area of concentration, lines of research,
curricular structure, discipline and bibliographic references; (iv)&#160;clarity of the criteria adopted to select the students, justifications
for the profile of the aimed formation and profile of the egress; (v)&#160;proof that the teaching staff has academic, didactic, technical
and scientific competence and qualifications related to the purpose of the course; (vi)&#160;a permanent teaching staff to ensure the
regularity and quality of teaching, research and orientation activities; (vii)&#160;indication of up to five intellectual productions
of each permanent teacher; and (viii)&#160;physical and technological infrastructure of teaching and research adequate for the development
of the proposed activities.</p>


<!-- Field: Page; Sequence: 93 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Authorizations of new <i>stricto sensu</i> graduate
courses must be requested at specific dates, as defined by CAPES and published in the Official Gazette.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">The Mais M&#233;dicos Program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The <i>Mais M&#233;dicos Law</i> established the
<i>Mais M&#233;dicos</i> program, an initiative designed to address medical professional shortages in certain municipalities and underserved
regions of Brazil and improve healthcare infrastructure and services, implementing short- and long-term measures to improve the Brazilian
medical training system in both quantitative and qualitative ways. This law establishes specific regulations for medical courses, including
criteria for approving the creation of new courses in Brazil involving the definition of its location, the mandatory contribution to the
public health infrastructure according to the specific categories established by Ordinance No. 16/2014 issued by MEC (i.e., training of
health professionals, building or reforming of health service structure, purchasing of medical equipment and supplies and study grant
to the medical residency program) and also the conditions for public-private partnerships to implement the course.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Within the <i>Mais M&#233;dicos</i> program, supporting
entities are no longer able to choose the location of their courses or establish all conditions of supply, which have been transferred
to MEC. The proceedings to implement a medical course, therefore, are more bureaucratic and time-consuming. MEC publishes a public auction
notice to select municipalities that will receive medical courses. After this selection, it issues another public auction notice with
the criteria for private higher institutions to compete for the right to implement courses in the municipalities previously selected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk132882830"></span>From its creation in 2013
until the date of this annual report, MEC, through SERES, has announced three public calls for the selection of proposals for the authorization
of medical courses on a national scale, although the most recent public call was subsequently cancelled: the <i>Mais M&#233;dicos I</i>
program in 2013, the <i>Mais M&#233;dicos II</i> program in 2018, and the <i>Mais M&#233;dicos III</i> program in 2023.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Mais M&#233;dicos I</i> and <i>Mais M&#233;dicos
II</i> jointly authorized the opening of 58 new medicine courses and, initially, 4,971 new seats in medical schools, which may be increased
by up to 100 seats each in accordance with the <i>Mais M&#233;dicos</i> regulation. Following the increase in annual offerings through
<i>Mais M&#233;dicos</i>, on April 5, 2018, MEC announced that the government had decided to freeze the new offering of medical school
seats for a period of five years pursuant to Ordinance No. 328/2018. The decision was based on the need to evaluate the impact of opening
new medicine courses in Brazil. On April 5, 2023, MEC issued Ordinance No. 650/2023, which revoked the suspension under Ordinance No.
328/2018 and set new rules for the opening of new medicine courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Following the issuance of Ordinance No. 650/2023, on
October 4, 2023, MEC, through SERES, announced a public call for the selection of proposals for the authorization of medical courses on
a national scale under the <i>Mais M&#233;dicos III</i> program. The rules for the program set forth the criteria for new undergraduate
medical school seats and provided for the potential opening of up to approximately 5,700 new undergraduate seats, to be distributed across
95 cities with a limit of 60 seats per institution. However, on February 10, 2026, MEC formally cancelled the public call relating to
the <i>Mais M&#233;dicos III</i> program, with immediate effect. As a result, the authorization process contemplated under that public
call was discontinued.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609482"></span><span id="a_Toc225309234"></span><span id="a_Toc196072475"></span><span id="a_Toc164277175"></span><span id="a_Toc194891111"></span><span id="a_Toc190934948"></span><span id="a_Toc133237648"></span><span id="a_Toc163120242"></span><span id="a_Toc131580970"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Organizational
Structure</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">All of our subsidiaries are incorporated in Brazil.
The following is a chart of our current corporate structure as of the date of this annual report:</p>


<!-- Field: Page; Sequence: 94 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; text-align: center; margin-top: 0; margin-bottom: 10pt"><img src="image_011.jpg" alt=""/></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Medcel, IPEMED, PEBMED, CardioPapers and Al&#233;m
da Medicina were merged into Afya Brazil in 2024 and Unidom, iClinic, Medicinae, Cliquefarma, Shosp, RX PRO and Glic were merged into
Afya Brazil in 2025 and therefore they do not appear in our current corporate structure chart.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk163039555"></span><span id="a_Hlk130828961"></span><span id="a_Toc215609483"></span><span id="a_Toc225309235"></span><span id="a_Toc196072476"></span><span id="a_Toc164277176"></span><span id="a_Toc194891112"></span><span id="a_Toc190934949"></span><span id="a_Toc133237649"></span><span id="a_Toc163120243"></span><span id="a_Toc131580971"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Property,
Plant and Equipment</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk163552251"></span>As of the date of this
annual report, our corporate headquarters are located in Belo Horizonte, State of Minas Gerais. We also have branches of the headquarters
located in Belo Horizonte, State of Minas Gerais, S&#227;o Paulo, State of S&#227;o Paulo and Rio de Janeiro, State of Rio de Janeiro.
All of the corporate headquarters are under lease agreements.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition to our corporate headquarters and as of
December 31, 2025, we leased almost all of our operational, sales, and administrative facilities. We believe that our facilities are suitable
and adequate for our business as presently conducted, however, we periodically review our facility requirements and may acquire new space
to meet the needs of our business or consolidate and dispose of facilities that are no longer required.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609484"></span><span id="a_Toc225309236"></span><span id="a_Toc196072477"></span><span id="a_Toc164277177"></span><span id="a_Toc194891113"></span><span id="a_Toc190934950"></span><span id="a_Toc133237650"></span><span id="a_Toc163120244"></span><span id="a_Toc131580972"></span><span style="color: #0D0E00">ITEM
4A. </span>UNRESOLVED STAFF COMMENTS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">None.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609485"></span><span id="a_Toc225309237"></span><span id="a_Toc196072478"></span><span id="a_Toc164277178"></span><span id="a_Toc194891114"></span><span id="a_Toc190934951"></span><span id="a_Toc133237651"></span><span id="a_Toc163120245"></span><span id="a_Toc131580973"></span>ITEM
5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609486"></span><span id="a_Toc225309238"></span><span id="a_Toc196072479"></span><span id="a_Toc164277179"></span><span id="a_Toc194891115"></span><span id="a_Toc190934952"></span><span id="a_Toc133237652"></span><span id="a_Toc163120246"></span><span id="a_Toc131580974"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Operating
Results</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Overview</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are the largest medical education group in Brazil
on a per-seat basis, according to MEC, delivering an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong
medical learners from the moment they join us as medical students through their medical residency preparation, graduation program, and
CME.</p>


<!-- Field: Page; Sequence: 95 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our innovative methodological approach combines integrated
content, interactive learning, and an adaptive experience for lifelong medical learners. Through our educational content and technology-enabled
activities, we focus on effective, personalized learning that mirrors one-on-one tutoring.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, we had 86,025 enrolled students,
compared to 76,988 enrolled students as of December 31, 2024, representing an increase of 11.7% in 2025, and compared to 66,034 enrolled
students as of December 31, 2023, representing an increase of 16.6% in 2024.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Growth</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our revenue growth and increased profitability have
been driven by:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Maturation of current number of authorized medical school seats</i></b> &#8212; Anticipated and contracted growth visibility
until 2031 from new medical school seats awarded to our schools, that are in the process of maturing, and new seats from our awarded campuses
in connection with the <i>Mais M&#233;dicos</i> program and which became operational in 2022;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Expansion of medical residency preparation and graduate programs enrollments</i></b> &#8212; Increase in the number of students
adopting our digital platform, as well as partners and students enrolling in our medical graduate courses;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Deepening of relationships across lifelong medical learners base</i></b> &#8212; Cross-selling opportunities such as increasing
the number of former undergraduate students subscribing to our medical residency preparation solutions and the number of former undergraduate
and/or medical residency preparation students applying to our graduate and CME courses;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>M&amp;A</i></b> &#8212; Business combinations and asset acquisitions or investment in businesses that complement our medical
education services offering. In 2025, we acquired FUNIC. In 2024, we acquired Unidom. In 2023, we acquired DelRey, which encompasses the
operations of UNIMA and FCM Jaboat&#227;o and an additional 15% of CCSI, consolidating our ownership of 75% of its total share capital;
and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b><i>Synergies extraction</i></b> &#8212; Successful implementation of several measures to improve the profitability of recent acquisitions,
such as streamlining fee discounts and scholarship policies, integrating operations with our shared-services center; and aligning newly
acquired faculty teams with our career plan.</td></tr></table>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Key Business Metrics</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We review the following key metrics to evaluate our
business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions:</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Medicine as a Percentage of Our Total Undergraduate Segment
Revenue</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe the metric that best demonstrates our focus
on medical education and its relevance to our products and services offering is the contribution of undergraduate medical school programs
(&#8220;Medicine&#8221;) to our total Undergraduate segment revenue.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For the years ended December 31, 2025, 2024 and 2023,
revenue from Medicine was 85.7%, 85.6% and 85.5% respectively, of our total Undergraduate segment revenue. The following table sets forth
the detailed information of our revenue derived from the different programs within our Undergraduate segment:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; vertical-align: bottom; width: 55%; text-align: center">&#160;</td>
    <td style="text-align: center; vertical-align: top; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; vertical-align: bottom; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2024</p></td>
    <td style="text-align: center; vertical-align: bottom; width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2023</p></td></tr>
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; vertical-align: top; text-align: center">(in US$ millions (1))</td>
    <td colspan="3" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; vertical-align: bottom; text-align: center">(in R$ millions)</td></tr>
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="4" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; vertical-align: top; text-align: center">(except percentages)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Medicine	</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">506.9</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,789.2</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,477.9</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,147.4</td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Other undergraduate health sciences programs	</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">47.6</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">261.7</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">236.8</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">200.6</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Other undergraduate programs(2)	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0">37.2</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0">204.5</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0">181.0</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0">163.0</p></td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Undergraduate segment revenue</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0"><b>591.6</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0"><b>3,255.4</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0"><b>2,895.7</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0"><b>2,511.0</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Medical School programs % (3)	</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: -6pt; padding-left: 2.9pt; text-align: right">85.7%</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: -6pt; padding-left: 2.9pt; text-align: right">85.7%</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: -6pt; padding-left: 2.9pt; text-align: right">85.6%</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">85.5%</td></tr>
  </table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For convenience purposes only, amounts in <i>reais</i> for the year ended December 31, 2025 have been translated to U.S. dollars using
an exchange rate of R$5.5024 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2025, as reported by the Central
Bank. These translations should not be considered representations that any such amounts have been, could have been or could be converted
at that or any other exchange rate.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Represents all non-health sciences undergraduate programs.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>Calculated as Medical School programs divided by the Undergraduate segment revenue.</td></tr></table>

<!-- Field: Page; Sequence: 96 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Medical School Regulatory Capacity and Capacity at Maturation</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Medical school regulatory capacity and capacity at
maturation are operating metrics that provide visibility into our medical school enrollments contracted growth given the supply and demand
imbalance in the medical school market and the fact that our medical schools have historically operated very close to their regulatory
capacity. Accordingly, the gradual increase in our capacity helps explain the increase in our medical school enrollments, which in turn
helps explain our medical school enrollments contracted growth. Contracted growth refers only to schools that are in the initial six years
of operation. In addition, since the maximum number of medical seats per medical school is set by applicable regulations, the only way
to grow our medical school seats, and therefore our number of enrollments, is through acquisitions or starting new medical schools.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Medical school regulatory capacity is defined by the
number of medical school seats available per year awarded by MEC <i>plus</i> the additional seats associated with PROUNI and FIES, <i>multiplied
by</i> the number of years of operations since the seats were awarded, up to the sixth year of operations (maturation). Capacity at maturation
represents the maximum number of approved seats at a medical school six years after becoming operational. Our medical schools have a six-year
maturation cycle because medical school programs in Brazil are for a duration of six years. A maturation cycle represents the period starting
when a medical school commences its operations with a first year medical school class of students which progresses through the required
six years as the next classes begin behind it, and ends when the medical school has six school years of medical students and has therefore
reached capacity at maturation (i.e., the maximum number of approved seats).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For illustration, a medical school that is awarded
100 seats from MEC has the opportunity to add up to 20 additional seats:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>10 more seats by adhering to PROUNI (one seat for every 10.7 seats awarded by MEC); and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>10 more seats by adhering to FIES (10% of the seats awarded by MEC).</td></tr></table>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Illustrative Evolution of Regulatory Capacity per
Medical School</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="image_012.jpg" alt=""/></p>


<!-- Field: Page; Sequence: 97 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our medical school regulatory capacity by seats was
3,755, 3,593 and 3,163 seats and our capacity at maturation was 27,036, 25,870 and 22,774, as of December 31, 2025, 2024 and 2023, respectively.
Assuming our medical schools continue to operate at full capacity, we estimate reaching a total medical student base of 27,130 students
by 2031.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Medical School Occupancy Rate</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The occupancy rate of our medical schools is the ratio
of the number of students effectively enrolled divided by the regulatory capacity in a given period. While we believe retention rates
are an important measure of quality and customer satisfaction, we believe that occupancy rate is a more meaningful metric as it captures
not only our ability to retain students but also to find new students to compensate for eventual dropouts. Our management does not separately
measure retention rates to make decisions about our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following table sets forth our medical seats occupancy
rate as of the dates indicated.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">As of December
    31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; width: 61%; text-align: center">&#160;</td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2025</p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2024</p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2023</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Occupancy rate	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">~100.0%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">~100.0%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">~100.0%</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Non-GAAP Financial Measures</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">This annual report presents our Revenue (ex-Acquisitions),
Adjusted EBITDA and Operating Cash Conversion Ratio information for the convenience of investors, which are non-GAAP financial measures.
A non-GAAP financial measure is generally defined as one that purports to measure financial performance but excludes or includes amounts
that would not be so adjusted in the most comparable GAAP measure. Although Revenue (ex-Acquisitions), Adjusted EBITDA and Operating Cash
Conversion Ratio may be used by the Company&#8217;s management, investors and securities analysts in their evaluation of companies, these
measures have limitations as analytical tools, and you should not consider them in isolation or as substitutes for the IFRS Accounting
Standards measures of earnings. Additionally, our calculations of Revenue (ex-Acquisitions), Adjusted EBITDA and Operating Cash Conversion
Ratio may be different from the calculations used by other companies, including our competitors in the education services industry, and
therefore, our measures may not be comparable to those of other companies.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We present Revenue (ex-Acquisitions) because we believe
this measure provides investors with a supplemental measure of the financial performance of our operations without the impact of the acquisition
occurred in the last fiscal year, which facilitates comparisons with the previous periods presented considering the organizational structure
as of the beginning of the year ended December 31, 2025. We calculate our Revenue (ex-Acquisitions) as revenue <i>less</i> the revenue
recognized by our acquired companies after the date of their acquisition, i.e. for a period of less than 12 months. The comparability
of our Revenue (ex-Acquisitions) between periods was impacted by acquisitions of FUNIC in 2025 and Unidom in 2024 described under &#8220;Item
4B Business Overview&#8212;Our Recent Acquisitions&#8221; above.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We present Adjusted EBITDA because we believe this
measure provides investors with a supplemental measure of the financial performance of our operations that facilitates period-to-period
comparisons on a consistent basis. We calculate our Adjusted EBITDA as net income <i>plus/minus</i> finance result <i>plus</i> income
taxes expense <i>plus</i> depreciation and amortization <i>plus</i> interest earned (interest received on late payments of monthly tuition
fees), <i>minus</i> share of profit of equity-accounted investee, net of tax, <i>plus</i> share-based compensation expense <i>plus/minus</i>
the following items, as applicable: (i) integration of new companies, (ii) M&amp;A advisory and due diligence, (iii) gain on tax amnesty,
(iv) expansion projects, (v) restructuring expenses, and (vi) mandatory discounts in tuition fees.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We also present Operating Cash Conversion Ratio because
we believe this measure provides investors with a measure of how efficiently we convert our operating results into cash. We calculate
our Operating Cash Conversion Ratio as (i) net cash flows from operating activities, adjusted to exclude income taxes paid, divided by
(ii) Adjusted EBITDA, excluding certain items that are included in the calculation of Adjusted EBITDA but whose cash effects are reflected
in operating cash flows. For purposes of this measure, we exclude from Adjusted EBITDA the add-backs related to (i) integration of new
companies, (ii) M&amp;A advisory and due diligence, (iii) gain on tax amnesty, (iv) expansion projects, (v) restructuring expenses, and
(vi) mandatory discounts in tuition fees. Although such items are added back in the calculation of Adjusted EBITDA, their cash effects
are reflected in operating cash flows. Excluding these items from Adjusted EBITDA for purposes of this ratio is
intended to improve comparability between the numerator and denominator and to provide a more meaningful measure of cash conversion.</p>


<!-- Field: Page; Sequence: 98 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following tables set forth the reconciliations
between (i) Revenue (ex-Acquisition) to our revenue, (ii) Adjusted EBITDA to our net income and (iii) Operating Cash Conversion Ratio
to our cash flow from operations for the years ended December 31, 2025, 2024 and 2023, in each case, our most recent directly comparable
financial measures calculated and presented in accordance with IFRS Accounting Standards.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Reconciliation between Revenue and Revenue (ex-Acquisition)</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="4" style="text-align: center; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">For the Year
    Ended December 31,</p></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2024</p></td>
    <td style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2023</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">(in US$ millions (1))</td>
    <td colspan="3" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">(in R$ millions)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Revenue	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">671.9</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3,697.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3,304.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2,875.9</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Acquired companies&#8217; revenue after acquisition	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0">16.3</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0">89.7</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0">&#8211;</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0">&#8211;</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Revenue (ex-Acquisition)(2)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0"><b>655.6</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0"><b>3,607.5</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0"><b>3,304.3</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; text-align: right; margin-top: 0; margin-bottom: 0"><b>2,875.9</b></p></td></tr>
  <tr style="background-color: White">
    <td style="width: 52%">&#160;</td>
    <td style="text-align: right; width: 12%">&#160;</td>
    <td style="text-align: right; width: 12%">&#160;</td>
    <td style="text-align: right; width: 12%">&#160;</td>
    <td style="text-align: right; width: 12%">&#160;</td>
    </tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For convenience purposes only, amounts in reais for the year ended December 31, 2025 have been translated to U.S. dollars using an
exchange rate of R$5.5024 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2025, as reported by the Central
Bank. These translations should not be considered representations that any such amounts have been, could have been or could be converted
at that or any other exchange rate. See &#8220;&#8212;Exchange Rates&#8221; for further information about recent fluctuations in exchange
rates.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>&#8220;Ex-Acquisitions&#8221; figures account for revenue recorded by our acquired companies in the last financial period presented
(i.e., December 31, 2025) after the date of their acquisitions. For the year ended December 31, 2025, &#8220;ex-Acquisitions&#8221; excludes
revenues from FUNIC, (May to December 2025) which was acquired on May 7, 2025 and Unidom (January to June 2025) which was acquired on
July 1, 2024.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Reconciliation between Net Income and Adjusted EBITDA</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="4" style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2024</p></td>
    <td style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2023</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">(in US$ millions (1))</td>
    <td colspan="3" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">(in R$ millions)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Net income	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">139.7</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">768.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">648.9</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">405.4</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Net finance result	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">66.5</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">366.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">347.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">347.0</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Income taxes expense	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">16.8</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">92.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">27.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">24.2</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Depreciation and amortization	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">67.9</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">373.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">333.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">289.5</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Interest earned(2)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">9.0</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">49.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">43.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">33.5</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Share of profit of equity-accounted investee, net of tax	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(2.5)</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(13.9)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(11.7)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(9.5)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Share-based compensation expense	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2.8</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">15.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">32.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">31.5</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 8.65pt; padding-left: 22.5pt; font-family: Times New Roman,serif; text-indent: -8.65pt">Integration of new companies(3)(9)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.6</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">25.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">25.7</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">28.1</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 8.65pt; padding-left: 22.5pt; font-family: Times New Roman,serif; text-indent: -8.65pt">M&amp;A advisory and due diligence(4)(9)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.1</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">12.6</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 8.65pt; padding-left: 22.5pt; font-family: Times New Roman,serif; text-indent: -8.65pt">Gain on tax amnesty(5)(9)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(16.8)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 8.65pt; padding-left: 22.5pt; font-family: Times New Roman,serif; text-indent: -8.65pt">Expansion projects(6)(9)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.4</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.7</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.4</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 8.65pt; padding-left: 22.5pt; font-family: Times New Roman,serif; text-indent: -8.65pt">Restructuring expenses(7)(9)	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.1</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2.2</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">12.0</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 8.65pt; padding-left: 22.5pt; font-family: Times New Roman,serif; text-indent: -8.65pt">Mandatory discounts in tuition fees(8)(9)	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8211;</p></td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8211;</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8211;</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">3.8</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Adjusted EBITDA</b>	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>305.4</b></p></td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,680.3</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,455.6</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,165.7</b></p></td></tr>
  <tr>
    <td style="width: 52%">&#160;</td>
    <td style="text-align: right; width: 12%">&#160;</td>
    <td style="text-align: right; width: 12%">&#160;</td>
    <td style="text-align: right; width: 12%">&#160;</td>
    <td style="text-align: right; width: 12%">&#160;</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For convenience purposes only, amounts in <i>reais</i> for the year ended December 31, 2025 have been translated to U.S. dollars using
an exchange rate of R$5.5024 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2025, as reported by the Central
Bank. These translations should not be considered representations that any such amounts have been, could have been or could be converted
at that or any other exchange rate. See &#8220;&#8212;Exchange Rates&#8221; for further information about recent fluctuations in exchange
rates.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Consists of interest received on late payments of monthly tuition fees.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>Consists of expenses related to the integration of recently acquired companies, such as expenses with personnel and third-party consulting
firms.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(4)</td><td>Consists of expenses related to professional and consultant fees in connection with due diligence services for our M&amp;A transactions.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(5)</td><td>On August 10, 2023, Unigranrio entered into a tax amnesty program on interest and penalties to settle a tax proceeding with respect
to ISS (tax on services) with the municipality of Rio de Janeiro, which resulted in a payment of R$14.9 million to settle the claim. The
selling shareholders of Unigranrio agreed to pay R$5.4 million regarding this matter. We had a provision of R$53.3 million and an indemnification
asset from the selling shareholders of R$20.0 million (in light of the indemnification clauses as defined at the acquisition of Unigranrio),
with respect to such tax proceeding. The difference between the provision, indemnification asset and the actual paid amount was recorded
in Other income on the consolidated statement of income and comprehensive income.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(6)</td><td>Consists of expenses related to professional and consultant fees in connection with the opening of new campuses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(7)</td><td>Consists of expenses related to employee redundancies in connection with the organizational restructuring of our acquired companies.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(8)</td><td>Consists of mandatory discounts in tuition fees granted by state decrees and individual/collective legal proceedings and public civil
proceedings due to COVID-19 on-site class restriction, and excludes any recovery of these discounts that were invoiced based on a decision
by the Brazilian Supreme Court with respect to this matter that deemed such discounts to be unconstitutional.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(9)</td><td>We believe these adjustments are appropriate to provide investors with additional information about certain expenses that we do not
expect to continue at the same level in the future.</td></tr></table>


<!-- Field: Page; Sequence: 99 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Reconciliation between Cash Flow from Operations and
Operating Cash Conversion Ratio</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="4" style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; width: 52%; text-align: center">&#160;</td>
    <td style="text-align: center; width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2024</p></td>
    <td style="text-align: center; width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2023</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">(in US$ millions (1))</td>
    <td colspan="3" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">(in R$ millions)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="4" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">(except percentages)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Net cash flows from operating activities	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">278.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,531.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,432.7</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,043.6</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Income taxes paid	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2.9</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">16.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">20.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">45.1</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Net cash flows from operating activities, before income taxes paid (A)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">281.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,547.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,453.2</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,088.8</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Adjusted EBITDA(2)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">305.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,680.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,455.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,165.7</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 19.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Integration of new companies(3)(9)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">25.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">25.7</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">28.1</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 19.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">M&amp;A advisory and due diligence(4)(9)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">12.6</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 19.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Gain on tax amnesty(5)(9)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(16.8)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 19.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Expansion projects(6)(9)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.7</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.4</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 19.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Restructuring expenses(7)(9)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2.2</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2.1</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">12.0</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 19.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Mandatory discounts in tuition fees(8)(9)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3.8</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Adjusted EBITDA ex cash effects reflected in operating cash flows (B)	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">300.1</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">1,651.3</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">1,421.3</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">1,121.6</p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Operating Cash Conversion Ratio (A/B)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>93.7%</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>93.7%</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>102.2%</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>97.1%</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For convenience purposes only, amounts in <i>reais</i> for the year ended December 31, 2025 have been translated to U.S. dollars using
an exchange rate of R$5.5024 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2025, as reported by the Central
Bank. These translations should not be considered representations that any such amounts have been, could have been or could be converted
at that or any other exchange rate. See &#8220;&#8212;Exchange Rates&#8221; for further information about recent fluctuations in exchange
rates.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>See &#8220;&#8212;Reconciliation between Net Income and Adjusted EBITDA&#8221; above.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>Consists of expenses related to the integration of recently acquired companies, such as expenses with personnel and third-party consulting
firms.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(4)</td><td>Consists of expenses related to professional and consultant fees in connection with due diligence services for our M&amp;A transactions.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(5)</td><td><span id="a_Hlk164349477"></span>On August 10, 2023, Unigranrio entered into a tax amnesty program on interest and penalties to settle
a tax proceeding with respect to ISS (tax on services) with the municipality of Rio de Janeiro, which resulted in a payment of R$14.9
million to settle the claim. The selling shareholders of Unigranrio agreed to pay R$5.4 million regarding this matter. We had a provision
of R$53.3 million and an indemnification asset from the selling shareholders of R$20.0 million (in light of the indemnification clauses
as defined at the acquisition of Unigranrio), with respect to such tax proceeding. The difference between the provision, indemnification
asset and the actual paid amount was recorded in Other income on the consolidated statement of income and comprehensive income.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(6)</td><td>Consists of expenses related to professional and consultant fees in connection with the opening of new campuses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(7)</td><td>Consists of expenses related to employee redundancies in connection with the organizational restructuring of our acquired companies.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(8)</td><td>Consists of mandatory discounts in tuition fees granted by state decrees and individual/collective legal proceedings and public civil
proceedings due to COVID-19 on-site class restriction, and excludes any recovery of these discounts that were invoiced based on a decision
by the Brazilian Supreme Court with respect to this matter that deemed such discounts to be unconstitutional.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(9)</td><td>We believe these adjustments are appropriate to provide investors with additional information about certain expenses that we do not
expect to continue at the same level in the future</td></tr></table>


<!-- Field: Page; Sequence: 100 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Operating Data</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Key Revenue Drivers &#8211;&#8211; Undergraduate Segment</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="3" style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">As of and
    For the Year Ended<br/>
    December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; width: 60%; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="text-align: center; width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; width: 14%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2024</p></td>
    <td style="text-align: center; width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2023</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>UNDERGRADUATE PROGRAMS</b></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b><i>Medical School</i></b></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Approved Seats	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3,755</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;3,593 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3,163</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Operating Seats	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3,705</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;3,543 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3,113</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Total Students (end of period)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">25,556</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;24,255 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">21,446</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Average Total Students	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">25,719</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;23,440 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">21,154</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 8.65pt; padding-left: 17.3pt; text-indent: -8.65pt; font-family: Times New Roman,serif">Average Total Students (ex-Acquisitions)(1)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">24,881</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;23,440 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">21,154</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>Revenue (Total) (in R$ thousands)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,789,170</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,477,906</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,147,448</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>Revenue (ex-Acquisitions) (in R$ thousands)(1)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,705,045 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,477,906</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,147,448</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>Medical School Net Avg. Ticket (ex-Acquisitions) (R$/month)(1)(2)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>9,060 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>8,809 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>8,460</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b><i>Undergraduate Health Science</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Total Students (end of period)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">26,545</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;25,570 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">21,117</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Average Total Students	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">26,344</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;25,154 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">21,365</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 8.65pt; padding-left: 17.3pt; text-indent: -8.65pt; font-family: Times New Roman,serif">Average Total Students (ex-Acquisitions)(1)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">25,954</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;25,154</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">21,365</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>Revenue (Total) (in R$ thousands)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>261,724</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>236,791</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>200,613 </b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>Revenue (ex-Acquisitions) (in R$ thousands)(1)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>257,075</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>236,791</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>200,613 </b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b><i>Other Ex-Health Undergraduate</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Total Students (end of period)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">33,924</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;27,163 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">23,471</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Average Total Students	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">34,271</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;27,542 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">24,336</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 8.65pt; padding-left: 17.3pt; text-indent: -8.65pt; font-family: Times New Roman,serif">Average Total Students (ex-Acquisitions)(1)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">33,538</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;27,542</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">24,336</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>Revenue (Total)(in R$ thousands)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>204,533</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>180,994</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>162,957 </b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>Revenue (ex-Acquisitions) (in R$ thousands)(1)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>203,600</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>180,994</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>162,957</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b><i>Revenue</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>Undergraduate Segment Revenue (Total) (in R$ thousands)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>3,255,426</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,895,692 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,511,018</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>Undergraduate Segment Revenue (ex-Acquisitions) (in R$ thousands)(1)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>3,165,720</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,895,692</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,511,018</b></p></td></tr>
  </table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>&#8220;Ex-Acquisitions&#8221; figures account for revenue recorded by our acquired companies in the last financial period presented
(i.e., December 31, 2025) after the date of their acquisitions. For the year ended December 31, 2025, &#8220;ex-Acquisitions&#8221; excludes
revenues from FUNIC (May to December 2025) which was acquired on May 7, 2025 and Unidom (January to June 2025) which was acquired on July
1, 2024. For more information See &#8220;&#8212;Non-GAAP Financial Measures.&#8221;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Medical School Net Average Ticket (ex-Acquisitions) is calculated as Revenue (ex-Acquisitions) divided by the Average Total Students
(ex-Acquisitions), divided by the number of months in a given period.</td></tr></table>


<!-- Field: Page; Sequence: 101 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Key Revenue Drivers &#8212; Continuing Education Segment</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="3" style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">As of and
    For the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; width: 60%; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="text-align: center; width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2024</p></td>
    <td style="text-align: center; width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2023</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>CONTINUING EDUCATION </b></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b><i>Total Students (end of period) </i></b></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Residency Journey - Business to Physicians B2P	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">12,990</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">16,381</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">12,170</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Graduate Journey - Business to Physicians B2P	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">10,234</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">8,527</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">7,722</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Other Courses - B2P and Business to Business Offerings 	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">31,815</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">25,613</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">27,188</p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Total Students</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>55,039</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>50,521</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>47,080</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b><i>Revenue</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 8.65pt; padding-left: 17.3pt; font-family: Times New Roman,serif; text-indent: -8.65pt">Business to Physician - B2P (in R$ thousands)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">257,706</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">237,379</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">215,504</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 8.65pt; padding-left: 17.3pt; font-family: Times New Roman,serif; text-indent: -8.65pt">Business to Business - B2B (in R$ thousands)	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">26,765</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">18,060</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">20,325</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Continuing Education Segment Revenue (Total) (in R$ thousands)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>284,471</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>255,438</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>235,830</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Key Revenue Drivers &#8212; Medical Practice Solutions
Segment</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="3" style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">As of and
    For the Year Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; width: 61%; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="text-align: center; width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2024</p></td>
    <td style="text-align: center; width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2023</p></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>MEDICAL PRACTICE SOLUTIONS(1)</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b><i>Active Paying Users (end of period)</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Clinical Decision	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">156,598</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">161,283</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">153,541</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Clinical Management	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">38,906</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">33,735</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">30,061</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Total Active Paying Users (end of period)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>195,504</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>195,018</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>183,602</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b><i>Monthly Active Users (MAU)</i></b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Total Monthly Active Users (MaU) - Medical Practice Solutions (1)	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>220,051</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>238,343</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>247,702</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 8.65pt; padding-left: 17.3pt; font-family: Times New Roman,serif; text-indent: -8.65pt">Revenue - B2P (in R$ thousands)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">152,643</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">139,534</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">122,983</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 8.65pt; padding-left: 17.3pt; font-family: Times New Roman,serif; text-indent: -8.65pt">Revenue - B2B (in R$ thousands)	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">18,680</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">22,252</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">17,299</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 8.65pt; padding-left: 17.3pt; font-family: Times New Roman,serif; text-indent: -8.65pt"><b>Medical Practice Solutions Segment Revenue (Total) (in R$ thousands) (2)</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>171,323</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>161,787 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>140,282 </b></p></td></tr>
  </table>
<p style="font: 5pt Times New Roman,serif; margin: 0 0 2.5pt">&#160;</p>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>&#8220;Monthly Active Users (MaU)&#8221; represents the number of unique individuals that consumed digital services content in each
one of our products in the last 30 days of a specific period.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Revenue from Shosp, our clinical management software, was reclassified from B2B to B2P in 2025 and was applied retroactively for comparative
purposes.</td></tr></table>

<!-- Field: Page; Sequence: 102 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Revenue and Revenue (ex-Acquisitions)</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif">&#160;</td>
    <td colspan="5" style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; width: 42%; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="text-align: center; width: 14%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025 Ex-Acquisitions(1)</p></td>
    <td style="text-align: center; width: 9%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2024</p></td>
    <td style="text-align: center; width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">% Change</p></td>
    <td style="text-align: center; width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">% Change
    Ex-Acquisitions(1)</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif">&#160;</td>
    <td colspan="5" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">(in R$ millions)</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Revenue</b></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Undergraduate	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3,255.4</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3,165.7</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2,895.7</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">12.4%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">9.3%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Continuing Education	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">284.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">284.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;255.4 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">11.4%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">11.4%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Medical Practice Solutions	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">171.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">171.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">161.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.9%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.9%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Inter-segment eliminations	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(14.0)</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(14.0)</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(8.6)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">62.6%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">62.6%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Total</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>3,697.3</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>3,607.5</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>3,304.3</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>11.9%</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>9.2%</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For the year ended December 31, 2025, &#8220;ex-Acquisitions&#8221; excludes revenues from FUNIC, (May to December 2025) which was
acquired on May 7, 2025 and Unidom (January to June 2025) which was acquired on July 1, 2024. For more information See &#8220;&#8212;Non-GAAP
Financial Measures.&#8221;</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The comparability of our revenues between periods was
impacted by the acquisitions of Unidom in 2024 and FUNIC in 2025 described under &#8220;Item 4B Business Overview&#8212;Our Recent Acquisitions.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Exchange Rates</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Brazilian foreign exchange system allows the purchase
and sale of foreign currency and the international transfer of <i>reais</i> by any person or legal entity, regardless of the amount, subject
to certain regulatory procedures.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The real/U.S. dollar exchange rate reported by the
Central Bank was R$4.8413 per US$1.00 on December 31, 2023, which reflected a 7.2% appreciation in the real against the U.S. dollar during
2023. On December 31, 2024, the exchange rate for the sale of U.S. dollars reported by the Central Bank was R$6.1923 per US$1.00, which
reflected a 27.9% depreciation in the real against the U.S. dollar during 2024. On December 31, 2025, the exchange rate for the sale of
U.S. dollars reported by the Central Bank was R$$5.5024 per US$1.00, which reflected a 11.1% appreciation in the real against the U.S.
dollar during 2025. As of March 23, 2026, the exchange rate for the sale of U.S. dollars as reported by the Central Bank was R$5.2440
per US$1.00, which reflected an appreciation of 4.7% in the real against the U.S. dollar since December 31, 2025. There can be no assurance
that the real will not again depreciate or appreciate against the U.S. dollar or other currencies in the future.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Central Bank has intervened occasionally in the
foreign exchange market to attempt to control instability in foreign exchange rates. We cannot predict whether the Central Bank or the
Brazilian government will continue to allow the <i>real</i> to float freely or will intervene in the exchange rate market by re-implementing
a currency band system or otherwise. The <i>real</i> may depreciate or appreciate substantially against the U.S. dollar in the future.
Furthermore, Brazilian law provides that, whenever there is a serious imbalance in Brazil&#8217;s balance of payments or there are serious
reasons to foresee a serious imbalance, temporary restrictions may be imposed on remittances of foreign capital abroad. We cannot assure
you that the Brazilian government will not place restrictions on remittances of foreign capital abroad in the future.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following table sets forth, for the periods indicated,
the high, low, average and period-end exchange rates for the purchase of U.S. dollars expressed in Brazilian <i>reais</i> per U.S. dollar.
The monthly and annual average rates are calculated by using the average of reported exchange rates by the Central Bank on each day during
a monthly period and on the last day of each month during an annual period, respectively.</p>


<!-- Field: Page; Sequence: 103 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 60%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Year</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Period-End</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Average(1)</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Low(2)</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">High(3)</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">2021	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.580</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.395</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.920</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.839</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">2022	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.218</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.165</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.618</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.704</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">2023	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.841</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.995</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.720</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.446</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">2024	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">6.192</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.392</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.854</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">6.199</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">2025	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.502</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.586</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.273</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">6.209</td></tr>
  </table>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source:</i> Central Bank.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Represents the average of the exchange rates on the closing of each day during the year.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Represents the minimum of the exchange rates on the closing of each day during the year.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>Represents the maximum of the exchange rates on the closing of each day during the year.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 60%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center"><span id="a_Hlk225288794"></span><span id="a_Hlk195858326"></span>Month</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Period-end</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Average(1)</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Low(2)</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">High(3)</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">September 2025	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.3186</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.3674</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.3010</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.4680</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">October 2025	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.3843</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.3855</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.3208</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.4982</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">November 2025	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.3338</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.3409</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.2729</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.3948</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">December 2025	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.5024</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.4531</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.2952</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.5739</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">January 2026	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.2301</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.3380</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.1838</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.4372</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">February 2026	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.1495</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.2006</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.1382</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.2587</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">March 2026 (through March 23, 2026)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.2440</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.2303</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.1596</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.2878</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source:</i> Central Bank.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Represents the average of the exchange rates on the closing of each day during the month.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Represents the minimum of the exchange rates on the closing of each day during the month.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>Represents the maximum of the exchange rates on the closing of each day during the month.</td></tr></table>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Significant Factors Affecting Our Results of Operations</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe that our results of operations and financial
performance will be driven by the following trends and factors:</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Regulatory Environment and Mais M&#233;dicos Program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our business is significantly influenced by the regulatory
environment of the educational industry in Brazil. We are subject to various federal laws and extensive government regulations by MEC,
CNE, INEP, FIES and CONAES, among others. In particular, medical education in Brazil is subject to regulations that aim to control the
supply of medical school seats across Brazil and their geographic allocation including, but not limited to the <i>Mais M&#233;dicos
Law</i>, which created the <i>Mais M&#233;dicos</i> program, whose main objectives include addressing the provision of doctors for primary
care in municipalities, strengthen health care infrastructure and allocate medical workforce to vulnerable areas.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">With the increase in annual offerings through <i>Mais
M&#233;dicos, </i>on April 5, 2018, MEC issued Ordinance No. 328/2018, pursuant to which, among other measures, MEC imposed a five-year
suspension on the granting of authorizations for the creation of new medical education courses. However, on April 5, 2023, MEC issued
Ordinance No. 650/2023, which revoked the suspension under Ordinance No. 328/18 and set new rules for the opening of new medicine courses.
In particular, MEC will be required to conduct a public call for new courses, i.e., through the <i>Mais M&#233;dicos</i> program pursuant
to the <i>Mais M&#233;dicos Law</i>.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In this context, on October 4, 2023, MEC, through SERES,
exercising its legal powers and based on Article 3 of the <i>Mais M&#233;dicos Law</i>, announced a public call for the selection of
proposals for the authorization of new undergraduate medical courses nationwide under the Mais M&#233;dicos III program. The public
call established the rules, procedures, decision-making standards and timeline applicable to the selection process and contemplated the
potential creation of new medical school seats across several municipalities in Brazil. However, on February 10, 2026, MEC formally cancelled
the public call relating to the Mais M&#233;dicos III program, with immediate effect, and the authorization process contemplated under
that public call was discontinued. Although the cancellation eliminated the specific expansion process initiated in 2023, future regulatory
initiatives or public calls for the authorization of new medical courses may increase the number of medical school seats in Brazil and,
consequently, intensify competition in the sector. If competition increases, we may be required to reduce our tuition fees or increase
our operating expenses (including our costs per student) in order to retain or attract students or to pursue new market opportunities
and reduce our ability to fill all our medical school seats capacity.</p>


<!-- Field: Page; Sequence: 104 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For further information, see &#8220;Item 4. Information
on the Company&#8212;Business Overview&#8212;Regulatory Overview,&#8221; &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain
Risks Relating to Our Business and Industry&#8212; The post-secondary education sector is highly regulated, and our failure to comply
with existing or future laws and regulations could limit our ability to operate medical programs, obtain new authorizations or accreditations,
maintain our regulatory approvals, or obtain re-accreditations, which could materially impact our business,&#8221; &#8220;Item 3. Key
Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;We are subject to supervision by MEC
and, consequently, may suffer sanctions as a result of non-compliance with any regulatory requirements&#8221; and &#8220;Item 3. Key Information&#8212;D.
Risk Factors&#8212;We face significant competition in the provision of our educational services. If our competition increases or if we
fail to compete efficiently, we may lose market share, and our profitability may be adversely affected.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Scholarships, Student Financing and Tax Benefits</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A large number of our students fund their tuition fees
through financing from FIES. In addition, we participate in the PROUNI scholarship program, and we benefit from tax benefits in return.
For more information on our students enrolled in these programs, see &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Regulatory
Overview&#8212;Financing Alternatives for Students: Incentive Programs&#8212;University for All Program&#8221; &#8220;Regulatory Overview&#8212;Financing
Alternatives for Students: Incentive Programs&#8212;Student Financing Program (FIES),&#8221; &#8220;Item 3. Key Information&#8212;D. Risk
Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212; Changes to the rules, judicial interpretations, administrative
decisions or delays or suspension of tuition payments made through FIES may adversely affect our cash flows and our business,&#8221; and
&#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;If we lose the benefits
of federal tax exemptions provided under the PROUNI program, our business, financial condition and results of operations may be materially
adversely affected.&#8221; In addition to PROUNI and FIES, we participate in private financing programs through external partners (Pravaler,
Bradesco, BNB, Sicoob, CashMe, Alume and Emcash) for undergraduate students.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Brazilian Macroeconomic Environment</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">All of our operations are located in Brazil. As a result,
our revenues and profitability are affected by political and economic developments in Brazil and the effect that these factors have on
the availability of credit, disposable income, employment rates and average wages in Brazil. Our operations, and the industry in general,
may be affected changes in economic conditions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Brazil is the largest economy in Latin America, as
measured by gross domestic product, or GDP. The following table shows data for real GDP, inflation and interest rates in Brazil and the
U.S. dollar/<i>real</i> exchange rate at the dates and for the periods indicated.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; width: 70%; text-align: center">&#160;</td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2025</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2024</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2023</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Real growth (contraction) in gross domestic product	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2.3%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3.4%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2.9%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Inflation (IGP-M)(1)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(1.1)%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">6.5%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(3.2)%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Inflation (IPCA)(2)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.3%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.8%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.6%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Long-term interest rates&#8212;TJLP (average)(3)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">9.1%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">7.4%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.7%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">CDI rate(4)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">14.9%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">12.15%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">13.2%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Period-end exchange rate&#8212;<i>reais</i> per US$1.00	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.502</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">6.192</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.841</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Average exchange rate&#8212;<i>reais</i> per US$1.00(5)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.586</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.392</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4.995</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Appreciation (depreciation) of the <i>real</i> vs. US$ in the period(6)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">11.1%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(27.9)%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">7.2%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Unemployment rate(7)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.1%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;6.2%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">7.4%</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><i>Source:</i> FGV, IBGE, Central Bank and Bloomberg.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Inflation (IGP-M) is the general market price index measured by the FGV.</td></tr></table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Inflation (IPCA) is a broad consumer price index measured by the IBGE.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>TJLP is the Brazilian long-term interest rate (average of monthly rates for the period).</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(4)</td><td>The CDI rate <i>(Certificado de Dep&#243;sito Interbanc&#225;rio)</i> interest rate is an average of interbank overnight rates
in Brazil.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(5)</td><td>Average of the exchange rate on each business day of the year.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(6)</td><td>Comparing the US$ closing selling exchange rate as reported by the Central Bank at the end of the period&#8217;s last day with the
day immediately prior to the first day of the period discussed.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(7)</td><td>Average unemployment rate for the year as measured by the IBGE.</td></tr></table>


<!-- Field: Page; Sequence: 105 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Inflation directly affects our current operating costs
and expenses, adjusted by reference to indexes that reflect the inflation rate such as the IGP-M or IPCA, primarily as a result of annual
adjustments to faculty member and employee salaries. Historically, inflation has been more than offset by the tuition fees we charge our
students.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our financial performance is also marginally tied to
fluctuations in interest rates, such as the CDI rate, because such fluctuations affect the value of our financial investments. We are
also exposed to fluctuations in interest rates on our accounts payable to selling shareholders and loans and financing which are indexed
to the CDI, IPCA and SELIC.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Pillar Two Global Minimum Tax</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On December 27, 2024, Law 15,079/2024 was enacted,
establishing the implementation of the OECD&#8217;s Pillar Two global minimum tax in Brazil, effective as of January 1, 2025.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Law 15,079/2024 aligns the Brazilian tax legislation
to the OECD&#8217;s Global Anti-Base Erosion (GloBE) rules by introducing a minimum effective taxation of 15% through an additional Social
Contribution tax on Net Profit (<i>Contribui&#231;&#227;o Social sobre o Lucro L&#237;quido</i>, or &#8220;CSLL&#8221;). This regulation
applies to multinational groups within the scope of the OECD&#8217;s GloBE rules, specifically those whose ultimate parent entity reported
annual consolidated revenues of at least &#8364;750 million in at least two of the four fiscal years immediately preceding the year under
review.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The rules are designed to ensure that the additional
CSLL qualifies as a Qualified Domestic Minimum Top-up Tax (QDMTT) under the OECD Inclusive Framework, subjecting Brazilian entities to
a minimum tax rate of 15%.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On March 28, 2025, we filed a writ of mandamus with
the Brazilian Federal Court challenging the enforceability of the newly enacted additional CSLL. The legal proceeding is grounded on constitutional
and statutory arguments, and is waiting for court decision to prevent the collection of the additional CSLL, which is scheduled to be
disbursed in 2026 with respect to the 2025 fiscal year. As of the date of this annual report, no favorable preliminary relief has been
granted, and the judicial discussion remains pending.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As no court decision has been issued to date, we have
recorded a provision based on the amounts calculated in accordance with the applicable legislation. For the year ended December 31, 2025,
the additional income tax expense arising from Law No. 15,079/2024 totaled R$109.5 million and was recognized as income taxes payable
within current liabilities. We have applied the exception to the recognition and disclosure of deferred tax assets and liabilities related
to Pillar Two income taxes.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In parallel with the judicial proceedings, we continue
to evaluate and pursue additional strategies to mitigate the potential impacts of the application of the Pillar Two rules to our operations,
including the assessment of further judicial measures and ongoing engagement with members of the Brazilian Congress and relevant parliamentary
bodies in connection with legislative initiatives aimed at allowing such PROUNI-related tax benefits to be treated as qualified refundable
tax credits for purposes of the Pillar Two global minimum tax rules.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Acquisitions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We may face significant challenges in the process
of integrating the operations of our acquired companies. If we are not able to manage these integrations effectively, our results of
operations may be affected. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business
and Industry&#8212;We may face challenges in identifying and acquiring new medical higher education institutions, which could hinder
our strategic and financial goals. Additionally, difficulties in effectively integrating and managing
an increasing number of acquisitions may adversely affect our strategic objectives&#8221; and &#8220;Item 4. Information on the Company&#8212;B.
Business Overview&#8212;Our Recent Acquisitions.&#8221;</p>


<!-- Field: Page; Sequence: 106 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Business Segments</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our three operating segments are as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Undergraduate, which provides educational services through undergraduate courses related to medical school, undergraduate health science
and other ex-health undergraduate programs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Continuing Education, which provides medical education (including residency preparation programs, specialization test preparation
and other medical capabilities), specialization and graduate courses in medicine, delivered through digital and in-person content; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Medical Practice Solutions, which provides clinical decision, clinical management and doctor-patient relationships for physicians
and provide access, demand and efficiency for the healthcare players.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Segment information is presented consistently with
the internal reports provided to our chief executive officer, who is our chief operating decision maker (CODM) and is responsible for
allocating resources, assessing the performance of our operating segments, and making our strategic decisions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">No operating segments have been aggregated to form
the above reportable operating segments. There is only one geographic region and the results are monitored and evaluated based on the
three reportable segments.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Description of Principal Line Items</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Revenue</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our revenue consists primarily of tuition fees charged
for medical courses. We also generate revenue from tuition fees for other undergraduate and graduate courses, student fees, certain education-related
activities, digital education content and subscription of digital services.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Cost of Services</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Cost of services includes expenses related to payroll,
rent, hospital agreements, utilities and depreciation and amortization. Cost of services amounted to 35.5%, 36.8% and 38.6% of our revenue
in the years ended December 31, 2025, 2024 and 2023, respectively.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Selling, General and Administrative Expenses and Other
Expenses</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our operating expenses includes expenses for personnel,
general and administrative, management and officer compensation, marketing and other income and expenses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Personnel.</i> Personnel expenses consist of wages,
overtime, benefits (meal vouchers, transportation vouchers and medical and dental insurance, among others), profit sharing, social contribution
and payroll taxes. In Brazil, social contribution and payroll taxes consist of the Brazilian Social Security Institute <i>(Instituto Nacional
do Seguro Social)</i> contribution, or INSS, and the Brazilian Unemployment Severance Fund <i>(Fundo de Garantia do Tempo de Servi&#231;o)</i>
contribution, or FGTS.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Selling, general and administrative.</i> Selling,
general and administrative expenses mainly consist of: (i)&#160;building infrastructure expenses, such as leases and property maintenance;
(ii)&#160;utilities expenses; (iii)&#160;expenses for computer system maintenance and office automation, such as software licenses, as
well as for integrated accounting, treasury, financial planning and cost management systems; (iv)&#160;sales and marketing expenses; and
(v)&#160;amounts paid for professional services, such as consultants, auditors and outside counsel.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Other income and expenses.</i> Other income and
expenses, consists mainly of miscellaneous income and/or expense items.</p>


<!-- Field: Page; Sequence: 107 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Finance Result</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our finance result includes finance income and finance
expenses. Our finance income consists mainly of income from interest earned on financial investments and interest received on late payments
from students. Our finance expenses consist mainly of interest expenses from accounts payable to selling shareholders, loans and financing
and lease liabilities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We also have cash and cash equivalents denominated
in U.S. dollars, and accordingly, we have foreign exchange gain or losses from the changes in U.S. dollars against the Brazilian <i>real.</i></p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Income Taxes Expenses</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Income taxes expenses includes current income taxes
and social contribution.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Consolidated Results of Operations</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Year Ended December 31, 2025 Compared to the Year Ended
December 31, 2024</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following table sets forth our consolidated income
statement data for the years ended December&#160;31, 2025 and 2024:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="3" style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; width: 65%; text-align: center">&#160;</td>
    <td style="text-align: center; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2025</p></td>
    <td style="text-align: center; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2024</p></td>
    <td style="text-align: center; width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Change (%)</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="3" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">(in R$ millions, except for percentages)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Revenue	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3,697.3 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3,304.3 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">11.9%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Cost of services	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(1,313.9)</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(1,215.6)</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">8.1%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Gross profit</b>	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,383.4 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,088.7 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>14.1%</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Selling, general and administrative expenses	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(1,113.1) </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(1,008.4)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">10.4%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Allowance for expected credit losses	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(57.1)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(60.9)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(6.2%)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Other income	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">18.8</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">13.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">41.4%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Other expenses	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(18.9)</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(20.6)</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(8.3%)</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Operating income</b>	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,213.1 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,012.1 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>19.9%</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Finance income	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">194.9 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">111.3 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">75.1%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Finance expenses	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(561.0)</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(458.7)</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">22.3%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Net Finance Result</b>	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>(366.1) </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>(347.5)</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>5.4%</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Share of profit of equity-accounted investee, net of tax	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">13.9</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">11.7</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">18.8%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Income before income taxes</b>	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>860.9 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>676.4 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>27.3%</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Income taxes expenses</b>	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Current	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(133.3) </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(24.2)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">n.m.</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Deferred	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">40.8</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(3.2)</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">n.m.</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Net income</b>	</td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>768.4 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>648.9 </b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>18.4%</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 0 0.25in; text-indent: -0.25in">n.m. = not meaningful</p>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Revenue</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Revenue for the year ended December 31, 2025 was R$3,697.3
million, an increase of R$393.0 million, or 11.9%, from R$3,304.3 million for the year ended December 31, 2024. The increase in our revenue
was primarily affected by the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Undergraduate segment, revenue for the year ended December 31, 2025 was R$3,255.4 million, an increase of 12.4%, or R$359.7
million, from R$2,895.7 million for the year ended December 31, 2024. This increase was primarily attributable to: (i) organic revenue
growth from the maturation of medical school seats and an increase of medical school net average ticket from an average ticket per month
of R$8,809 in 2024 to R$9,060 in 2025, resulting in an increase of R$173.0 million in our Undergraduate segment&#8217;s net revenue; and (ii) consolidation of the results
of operations of Unidom beginning in July 2024, resulting in an increase of R$109.1 million in our Undergraduate segment&#8217;s net revenue;</td></tr></table>


<!-- Field: Page; Sequence: 108 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Continuing Education segment, revenue for the year ended December 31, 2025 was R$284.5 million, an increase of 11.4%, or R$29.1
million, from R$255.4 million for the year ended December 31, 2024. This increase was primarily attributable to a 8.9% increase in average
total students from 50,521 paying students in 2024 to 55,039 paying students in 2025; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Medical Practice Solutions segment, revenue for the year ended December 31, 2025 was R$171.3 million, an increase of 5.9%,
or R$9.5 million, from R$161.8 million for the year ended December 31, 2024. This increase was primarily attributable to an increase of
total active paying users from 195,018 active paying users in 2024 to 195,504 active paying users in 2025, and as a result of price adjustments.</td></tr></table>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Cost of Services</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Cost of services for the year ended December 31, 2025
was R$1,313.9 million, an increase of R$98.3 million, or 8.1%, from R$1,215.6 million for the year ended December 31, 2024. As a percentage
of revenue, our cost of services decreased to 35.5% for the year ended December 31, 2025, compared to 36.8% for the year ended December
31, 2024. The increase in our cost of services was primarily affected by the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Undergraduate segment, cost of services for the year ended December 31, 2025 was R$1,176.8 million, an increase of R$90.7 million,
or 8.4%, from R$1,086.1 million for the year ended December 31, 2024. This increase was primarily attributable to an increase of R$87.5
million applied to salaries and wages, both related to an increase in the number of personnel and yearly readjustment of wages;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Continuing Education segment, cost of services for the year ended December 31, 2025 was R$96.4 million, an increase of R$0.2
million, or 0.2%, from R$96.2 million for the year ended December 31, 2024. This increase was primarily attributable to a general increase
in costs with salaries across our operating units as a result of annual readjustment of wages;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Medical Practice Solutions segment, cost of services for the year ended December 31, 2025 was R$54.7 million, an increase of
R$12.8 million, or 30.5%, from R$41.9 million for the year ended December 31, 2024. This increase was primarily to a general increase
in costs with salaries across our operating units as a result of an increase in the number of personnel and annual readjustment of wages.</td></tr></table>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Gross Profit</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a result of the foregoing, gross profit for the
year ended December 31, 2025 was R$2,383.4 million, an increase of R$294.7 million, or 14.1%, from R$2,088.7 million for the year ended
December 31, 2024. Our gross profit by segment was the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Undergraduate segment, gross profit for the year ended December 31, 2025 was R$2,078.6 million, an increase of R$269.0 million,
or 14.9%, from R$1,809.6 million for the year ended December 31, 2024;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Continuing Education segment, gross profit for the year ended December 31, 2025 was R$188.1 million, an increase of R$28.8
million, or 18.1%, from R$159.3 million for the year ended December 31, 2024; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Medical Practice Solutions segment, gross profit for the year ended December 31, 2025 was R$116.6 million, a decrease of R$3.3
million, or 2.7%, from R$119.9 million for the year ended December 31, 2024.</td></tr></table>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Selling, General and Administrative Expenses</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Selling, general and administrative expenses for the
year ended December 31, 2025 was R$1,113.1 million, an increase of R$104.7 million, or 10.4%, from R$1,008.4 million for the year ended
December 31, 2024. This increase was primarily attributable to: (i) an increase of R$46.2 million in payroll expenses as a result of an
increase in the total number of personnel and yearly readjustment of wages, (ii) an increase of R$29.9 million in sales and marketing
expenses, mostly related to rebranding efforts, marketing campaigns and advertising expenses; and (iii) an increase of R$22.7 million
in depreciation and amortization expenses as a result of capital expenditures in 2025.</p>


<!-- Field: Page; Sequence: 109 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Operating Income</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For the reasons discussed above, operating income for
the year ended December 31, 2025 was R$1,213.1 million, an increase of R$201.0 million, or 19.9%, from R$1,012.1 million for the year
ended December 31, 2024.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Net Finance Result</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Net Finance result for the year ended December 31,
2025 was an expense of R$366.1 million, compared to an expense of R$347.5 million for the year ended December 31, 2024, for the reasons
described below.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Finance income.</i> Finance income for the
year ended December 31, 2025 was R$194.9 million, an increase of R$83.6 million, or 75.1%, from R$111.3 million for the year ended
December 31, 2024. This increase was primarily attributable to an increase in financial income from cash equivalents due to: (i) a
higher amount in cash equivalents during 2025 when compared to 2024; and (ii) a higher average interest on these investments (101.2%
of the CDI rate for 2025 compared to 99.1% of the CDI rate for 2024).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Finance expenses.</i> Finance expenses for the year
ended December 31, 2025 was R$561.0 million, an increase of R$102.3 million, or 22.3%, from R$458.7 million for the year ended December
31, 2024. This increase was primarily attributable to: (i) higher interest expense, which increased by R$62.0 million year-over-year;
(ii) higher financial discounts, which increased by R$21.0 million; (iii) higher interest expense on lease liabilities, which increased
by R$11.1 million.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Income before Income Taxes</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a result of the foregoing, income before income
taxes for the year ended December 31, 2025 was R$860.9 million, an increase of R$184.5 million, or 27.3%, from R$676.4 million for the
year ended December 31, 2024.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Income Taxes Expenses</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Current income taxes expenses for the year ended December
31, 2025 was R$133.3 million, an increase of R$83.6 million, or 75.1%, from R$24.2 million for the year ended December 31, 2024. Deferred
income taxes for the year ended December 31, 2025 was a benefit of R$40.8 million, a change of R$44.0 million from an expense of R$3.2
million for the year ended December 31, 2024. The effective tax rate increased to 10.7% for the year ended December 31, 2025 from 4.1%
for the year ended December 31, 2024. This increase in our effective tax rate was primarily attributable to the effects of Pillar Two
- for more information refer to &#8216;Pillar Two Global Minimum Tax&#8217; topic.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Net Income</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a result of the foregoing, our net income for the
year ended December 31, 2025 was R$768.4 million, an increase of R$119.5 million, or 18.4%, from R$648.9 million for the year ended December
31, 2024.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Year Ended December 31, 2024 Compared to the Year Ended
December 31, 2023</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following table sets forth our consolidated income
statement data for the years ended December&#160;31, 2024 and 2023:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt/9pt Times New Roman,serif; padding-top: 1pt; padding-bottom: 2pt; text-align: center">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center"><b>For the Year
    Ended December 31,</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt/9pt Times New Roman,serif; width: 65%; padding-top: 1pt; padding-bottom: 2pt; text-align: center">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center"><b>2024</b></p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center"><b>2023</b></p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center"><b>Change (%)</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt/9pt Times New Roman,serif; padding-top: 1pt; padding-bottom: 2pt">&#160;</td>
    <td colspan="3" style="font: 10pt/9pt Times New Roman,serif; padding-top: 1pt; padding-bottom: 2pt; text-align: center"><b>(in R$ millions, except for percentages)</b></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Revenue	</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">3,304.3 </td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">2,875.9</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">14.9%</td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Cost of services	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(1,215.6)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(1,109.8)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">9.5%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Gross profit</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,088.7 </b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,766.1</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>18.3%</b></p></td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Selling, general and administrative expenses	</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(1,008.4)</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(940.1)</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">7.3%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Allowance for expected credit losses	</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(60.9)</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(74.5)</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(18.3%)</td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Other income	</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">13.3</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">53.2</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(75.0%)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Other expenses	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(20.6)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(37.6)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(45.2%)</p></td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Operating income</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,012.1 </b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>767.1</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>31.9%</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Finance income	</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">111.3 </td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">110.6</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">0.6%</td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Finance expenses	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(458.7)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(457.6)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">0.2%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Finance result</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>(347.5)</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>(347.0)</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>0.1%</b></p></td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Share of income of associate	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">11.7</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">9.5</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">23.5%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Income before income taxes</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>676.4 </b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>429.6</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>57.4%</b></p></td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Income taxes expenses	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(27.5)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(24.2)</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">13.6%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Net income</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>648.9 </b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>405.4</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>60.1%</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<!-- Field: Page; Sequence: 110 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Revenue</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Revenue for the year ended December 31, 2024 was R$3,304.3
million, an increase of R$428.4 million, or 14.9%, from R$2,875.9 million for the year ended December 31, 2023. The increase in our revenue
was primarily affected by the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Undergraduate segment, revenue for the year ended December 31, 2024 was R$2,895.7 million, an increase of 15.3%, or R$384.7
million, from R$2,511.0 million for the year ended December 31, 2023. This increase was primarily attributable to: (i) an increase of
13.8% in our total number of operating seats, from 3,113 seats in 2023 to 3,543 seats in 2024, as a result of the Unidom acquisition;
and (ii) increase of 4.1% in the medical school net average ticket, from an average ticket of R$8,460 in 2023 to R$8,809 in 2024;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Continuing Education segment, revenue for the year ended December 31, 2024 was R$255.4 million, an increase of 8.3%, or R$19.6
million, from R$235.8 million for the year ended December 31, 2023. This increase was primarily attributable to a 7.3% increase in average
total students from 47,080 paying students in 2023 to 50,521 paying students in 2024; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Medical Practice Solutions segment, revenue for the year ended December 31, 2024 was R$161.8 million, an increase of 15.3%,
or R$21.5 million, from R$140.3 million for the year ended December 31, 2023. This increase was primarily attributable to an increase
of 6.2% in Medical Practice Solutions total active paying users from 183,602 active paying users in 2023 to 195,018 active paying users
in 2024, and as a result of price adjustments.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Cost of services</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Cost of services for the year ended December 31, 2024
was R$1,215.6 million, an increase of R$105.8 million, or 9.5%, from R$1,109.8 million for the year ended December 31, 2023. As a percentage
of revenue, our cost of services decreased to 36.8% for the year ended December 31, 2024, compared to 38.6% for the year ended December
31, 2023. The increase in our cost of services was primarily affected by the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Undergraduate segment, cost of services for the year ended December 31, 2024 was R$1,086.1 million, an increase of R$88.1 million,
or 8.8%, from R$998.0 million for the year ended December 31, 2023. This increase was primarily attributable to: (i) the consolidation
of the results of operations for the year ended December 31, 2024 of Unidom in 2024, resulting in an increase of R$16 million in our Undergraduate
segment&#8217;s cost of services; (ii) an increase of R$6.8 million applied to salaries and wages, both related to increase in the number
of personnel and yearly readjustment of wages; and (iii) other cost-related effects, such as an increase in costs from hospital and medical
agreements and facilities and utilities;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Continuing Education segment, cost of services for the year ended December 31, 2024 was R$96.2 million, an increase of R$4.3
million, or 4.6%, from R$91.9 million for the year ended December 31, 2023. This increase was primarily attributable to (i) an increase
in costs associated with the opening of new IPEMED units in 2024, and (ii) a general increase in expenses with
salaries across our operating units as a result of an increase in the number of personnel and annual readjustment of wages; and</td></tr></table>


<!-- Field: Page; Sequence: 111 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Medical Practice Solutions segment, cost of services for the year ended December 31, 2024 was R$41.9 million, an increase of
R$10.8 million, or 34.6%, from R$31.1 million for the year ended December 31, 2023. This increase was primarily attributable to an increase
in costs with consultancy and third-party services in the amount of R$7.8 million, mostly as a result of the hiring of consultancy services
for projects aiming to increase the efficiency of operations of companies in our Medical Practice Solutions segment.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Gross profit</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a result of the foregoing, gross profit for the
year ended December 31, 2024 was R$2,088.7 million, an increase of R$322.6 million, or 18.3%, from R$1,766.1 million for the year ended
December 31, 2023. Our gross profit by segment was the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Undergraduate segment, gross profit for the year ended December 31, 2024 was R$1,809.6 million, an increase of R$296.6 million,
or 19.6%, from R$1,513.0 million for the year ended December 31, 2023;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Continuing Education segment, gross profit for the year ended December 31, 2024 was R$159.3 million, an increase of R$15.3
million, or 10.7%, from R$143.9 million for the year ended December 31, 2023; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In our Medical Practice Solutions segment, gross profit for the year ended December 31, 2024 was R$119.9 million, an increase of R$10.7
million, or 9.8%, from R$109.1 million for the year ended December 31, 2023.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Selling, general and administrative expenses</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Selling, general and administrative expenses for the
year ended December 31, 2024 was R$1,008.4 million, an increase of R$68.3 million, or 7.3%, from R$940.1 million for the year ended December
31, 2023. This increase was primarily attributable to: (i) an increase of R$28.5 million in payroll expenses as a result of an increase
in the total number of personnel and yearly readjustment of wages, (ii) an increase of R$23.6 million in maintenance expenses, mostly
related to periodic conservation procedures on equipment and furniture of educational institutions, and (iii) an increase of R$13.7 million
in sales and marketing expenses, mostly related to rebranding efforts, marketing campaigns and advertising expenses, which was partially
offset by a reduction of R$16.6 million in consulting fees.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Other income and other expenses</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Other income for the year ended December 31, 2024 was
R$13.3 million, a reduction of R$39.9 million from R$53.2 million in the year ended December 31, 2023, which was primarily due to the
settlement in 2023 of Unigranrio&#8217;s tax proceeding in respect to ISS (tax on services) with the municipality of Rio de Janeiro.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Other expenses for the year ended December 31, 2024
was R$20.6 million, a reduction of R$17.0 million from R$37.6 million in the year ended December 31, 2023, which was primarily due to
FIES charges in 2023 in the amount of R$18.7 million.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Operating income</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For the reasons discussed above, operating income for
the year ended December 31, 2024 was R$1,012.1 million, an increase of R$245.0 million, or 31.9%, from R$767.1 million for the year ended
December 31, 2023.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Finance result</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Finance result for the year ended December 31, 2024
was a net finance expense of R$347.5 million, compared to a net finance expense of R$347.0 million for the year ended December 31, 2023,
for the reasons described below.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Finance income.</i> Finance income for the year
ended December 31, 2024 was R$111.3 million, remaining stable year over year when compared to R$110.6 million for the year ended December
31, 2023.</p>


<!-- Field: Page; Sequence: 112 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Finance expenses.</i> Finance expenses for the year
ended December 31, 2024 was R$458.7 million, remaining stable year over year when compared to R$457.6 million for the year ended December
31, 2023.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Income before income taxes</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a result of the foregoing, income before income
taxes for the year ended December 31, 2024 was R$676.4 million, an increase of R$246.8 million, or 57.4%, from R$429.6 million for the
year ended December 31, 2023.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Income taxes expenses</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Income taxes expenses for the year ended December 31,
2024 was R$27.5 million, remaining stable year over year when compared to R$24.2 million for the year ended December 31, 2023, and the
effective tax rate decreased from 5.62% for the year ended December 31, 2023, to 4.10% for the year ended December 31, 2024. This decrease
in our effective tax rate was primarily attributable to the effects of: (i) an increase in the amount of PROUNI fiscal incentives received,
from R$310.0 million in 2023 to R$379.7 million in 2024.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in"><i>Net income</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0">As a result of the foregoing, our net income for the year ended December 31, 2024
was R$648.9 million, an increase of R$243.5 million, or 60.1%, from R$405.4 million for the year ended December 31, 2023.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">&#160;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Critical Accounting Estimates and Assumptions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our consolidated financial statements are prepared
in conformity with IFRS Accounting Standards. In preparing our consolidated financial statements, we make assumptions, judgments and estimates
that can have a significant impact on amounts reported in our consolidated financial statements. We base our assumptions, judgments and
estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results
could differ materially from these estimates under different assumptions or conditions. We regularly reevaluate our assumptions, judgments
and estimates. Our material accounting policies are described in note 2 and our critical accounting estimates and assumptions are described
in note 2.5 to our consolidated financial statements included elsewhere in this annual report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Recent Accounting Pronouncements</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The new and amended standards and interpretations that
were applied for the first time in 2025 did not have a significant impact on our consolidated financial statements. We have not adopted
new and amended standards and interpretations that are not yet effective.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609487"></span><span id="a_Toc225309239"></span><span id="a_Toc196072480"></span><span id="a_Toc164277180"></span><span id="a_Toc194891116"></span><span id="a_Toc190934953"></span><span id="a_Toc133237653"></span><span id="a_Toc163120247"></span><span id="a_Toc131580975"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Liquidity
and Capital Resources</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following table shows the cash flows for the years
ended December 31, 2025, 2024 and 2023:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; width: 66%; text-align: center">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: black 1pt solid; font: 8pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center"><b>2025</b></p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: black 1pt solid; font: 8pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center"><b>2024</b></p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: black 1pt solid; font: 8pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center"><b>2023</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="3" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">(in R$ millions)</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Cash Flow Data</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Net cash flows from operating activities	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,531.6</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;1,432.7</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,043.6</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Net cash flows used in investing activities	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(507.1)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(1,091.6)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(1,143.0)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Net cash flows from (used in) financing activities	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(808.3)</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">24.0</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">(439.9)</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Operating Activities</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We had net cash flows from operating activities of
R$1,531.6 million in 2025 as compared to R$1,432.7 million in 2024 (an increase of R$98.9 million, or 6.9%). The increase primarily reflects
higher operating profitability, with an increase in our income before income taxes of R$184.5 million in 2025 compared to 2024. This was
mainly driven by an increase in trade receivables which showed an increase in the cash outflow of R$80.2 million in 2025 compared to 2024,
and the recoverable taxes, which showed an increase in the cash outflow of R$28.8 million in 2025 compared to 2024.</p>


<!-- Field: Page; Sequence: 113 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Investing Activities</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We had net cash flows used in investing activities
of R$507.1 million in 2025, as compared to net cash flows used in investing activities of R$1,091.6 million in 2024 mainly as a result
of a decrease of R$483.5 million in the acquisition of assets and subsidiaries, net of cash acquired, from R$627.6 million in 2024 to
R$144.1 million in 2025.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Financing Activities</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We had net cash flows used in financing activities
of R$808.3 million in 2025, as compared to a net cash from financing activities of R$24.0 million in 2024, mainly as a result of: (i)
an increase of R$1,496.2 million in the payments of principal of loans and financing, due to the repurchase of all outstanding Series
A perpetual convertible preferred shares from Softbank and the repayment of debentures on the fourth quarter of 2025, which was partially
offset by, an increase of R$1,003.3 million in the proceeds from loans and financing; (ii) an amount of R$77.0 million in treasury shares
repurchased; and (iii) dividends payment in the amount of R$128.5 million.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For a discussion of changes in our consolidated cash
flows in the year ended December 31, 2024 compared to the year ended December 31, 2023, see our annual report on Form 20-F for the fiscal
year ended December 31, 2024, filed with the SEC on April 29, 2025.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Liquidity</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our primary sources of liquidity consist of (i) cash
and cash equivalents, (ii) cash generated from our operations and (iii) borrowings under financing arrangements with financial institutions
and proceeds from the issuance of debt securities. We have historically generated significant cash flows from operating activities, which
represent our main source of liquidity.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We believe that our current available cash and cash
equivalents and the cash flows from our operating activities will be sufficient to meet our working capital requirements and capital expenditures
in the ordinary course of business for the next 12 months, including our material cash requirements, which consist primarily of working
capital needs, capital expenditures, acquisitions, payments related to business combinations, including contingent consideration and deferred
payments, lease liabilities, interest and principal payments on our total loans and financing and other contractual commitments. These
requirements are expected to be funded primarily through cash generated from operations, existing cash balances and available financing
sources.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, our financial liabilities
consisted primarily of loans and financing, lease liabilities and accounts payable to selling shareholders related to prior acquisitions,
in addition to trade payables. Our indebtedness includes obligations with financial institutions and debt securities, with a maturity
profile that extends over multiple years. We also have obligations arising from contingent consideration arrangements and deferred payments
in connection with business combinations, which represent a recurring use of liquidity as part of our growth strategy.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We actively manage our liquidity and capital structure
by monitoring our cash position, level of indebtedness, cost of funding and maturity profile of our obligations. Our management regularly
reviews projected and actual cash flows, taking into account our operating performance, planned capital expenditures, acquisition pipeline,
debt servicing requirements, covenant compliance and internal liquidity targets. We may access capital markets or alternative sources
of financing as needed to support our operations and strategic initiatives.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Cash generated from operations is driven primarily
by tuition payments from our undergraduate and continuing education programs, as well as revenues from our digital products and services
offered to physicians and healthcare professionals. Our ability to generate operating cash flows depends on, among other factors, enrollment
levels, pricing of our programs and solutions, operating performance, cost structure and working capital management.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, we had cash and cash equivalents
of R$1,125.4 million, compared to R$911.0 million as of December 31, 2024. As of December 31, 2025, we had working capital, defined as
total current assets less total current liabilities, of R$ 1,058.1 million, compared to working capital of R$ 449.6 million as of December
31, 2024.</p>


<!-- Field: Page; Sequence: 114 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Indebtedness</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, we had outstanding debt, comprised
of our loans and financings, in the aggregate amount of R$2,054.3 million. The following table summarizes our loans and financings as of
December 31, 2025 and 2024:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 32%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Financial
    institution</p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Currency</p></td>
    <td style="width: 17%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Interest
    rate</p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Maturity</p></td>
    <td style="width: 12%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2025</p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2024</p></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">(in R$ thousands)</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Banco Ita&#250; Unibanco S.A. (a)	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">Brazilian real</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">CDI + 1.90% p.y.</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">October 2025</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">-</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">309,496</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">FINEP (b)	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">Brazilian real</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">TJLP p.y.</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">July 2027</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5,262</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">8,209</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Softbank (c)	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">Brazilian real</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">6.5% p.y.</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">April 2026</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">-</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">845,492</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Debentures (d)	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">Brazilian real</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">CDI + 1.80% p.y.</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">January 2028</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">-</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">526,946</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">IFC (e)	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">Brazilian real</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">CDI + 1.05% p.y.</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">April 2030</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">510,672</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">505,018</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Commercial notes (f)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">Brazilian real</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">CDI + 0.70% p.y.</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">October 2028</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">512,678 </td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">-</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Commercial notes (f)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">Brazilian real</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">CDI + 0.85% p.y.</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">October 2030</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">1,025,655</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">-</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Total Loans and Financing</b>	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,054,267</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,195,161</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Current	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">60,668</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">363,554 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Non-current	</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,993,599</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,831,607</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(a)</td><td>On October 1, 2020, Afya Brazil entered into a loan with Banco Ita&#250; Unibanco S.A. in the amount of R$500.0 million, bearing
interest at the CDI rate plus 1.62% per year, originally repayable in three installments in October 2022, April 2023 and October 2023.
On September 28, 2022, Afya Brazil amended the agreement to extend its debt profile, postponing the original repayment dates to 2023,
2024 and 2025, with the spread over the CDI rate increasing from 1.62% to 1.90% per year. The aggregate outstanding amount was fully repaid
on September 30, 2025.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(b)</td><td>On July 23, 2019, Medcel entered into a loan of R$16.2 million with Financiadora de Estudos e Projetos (&#8220;FINEP&#8221;), a governmental
agency focused on financing investments in research and development, bearing interest at a rate based on the TJLP (Long-Term Interest
Rate), with maturity in 2027. The first tranche of R$6.7 million and the second tranche of R$4.1 million were drawn down in October 2019
and December 2020, respectively, to develop the Medical web series and other digital content. Additional tranches totaling R$5.3 million
were drawn down in March and June 2023. The agreement contains no financial covenants, and the total loan balance is guaranteed by a bank
warranty.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(c)</td><td>In April 2021, we issued R$822 million (equivalent to US$150 million) of Series A perpetual convertible preferred shares to SBLA Holdco
LLC, an affiliate of Softbank. On November 3, 2025, we repurchased all outstanding Series A perpetual convertible preferred shares from
Softbank for an aggregate purchase price of R$831.6 million, and such shares were subsequently cancelled.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(d)</td><td>On December 16, 2022, Afya Brazil issued 500,000 simple, non-convertible, unsecured debentures in a single series, each with a par
value of R$1.00, totaling an aggregate amount of R$500.0 million, in a public distribution with restricted placement efforts in the Brazilian
market, under the terms of the Brazilian Securities Commission (<i>Comiss&#227;o de Valores Mobili&#225;rios</i>) Rule No. 476. The
proceeds of the offering were intended for general corporate purposes, strengthening our cash position and extending our debt maturity
profile. The debentures were issued with a maturity date of January 15, 2028, with the principal to be amortized in two equal installments
payable on January 15, 2027 and January 15, 2028, corresponding to the fourth and fifth years of the transaction, respectively. The debentures
bear interest at 100% of the CDI rate plus 1.80% per year, payable semi-annually on January 15 and July 15 of each year until the maturity
date. The aggregate outstanding amount was fully repaid on October 22, 2025.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(e)</td><td>On August 7, 2024, Afya Brazil and certain other guarantors party thereto, including Afya Limited, as Parent Company Guarantor, entered
into a loan agreement with International Finance Corporation (&#8220;IFC&#8221;) in the principal amount of R$500.0 million to support
its expansion program through acquisitions. This financing represented IFC&#8217;s first sustainability-linked loan based on social targets
in the education sector, providing for a potential interest rate reduction as Afya Brazil meets predefined performance targets in selected
social key performance indicators (&#8220;Sustainability Performance Targets&#8221;). The loan bears interest at the CDI rate plus a spread
of 1.20% per year, which may be reduced by up to 0.15% per year if the Sustainability Performance Targets are achieved, and is repayable
in seven equal semi-annual installments beginning in April 2027.</td></tr></table>


<!-- Field: Page; Sequence: 115 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.5in; text-indent: 0in">The Sustainability Performance Targets are defined
based on two key performance indicators, each capable of reducing the applicable spread by 0.075% per year if met. The first relates to
the number of free medical consultations delivered by students, reinforcing Afya Brazil&#8217;s commitment to expanding access to healthcare
in underserved communities. The second is linked to the academic quality of Afya Brazil&#8217;s medical courses and is measured by the
percentage of courses that achieve a quality grade of 4 or 5 in Brazil&#8217;s Ministry of Education evaluation system.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.5in; text-indent: 0in">Pursuant to this agreement, Afya Brazil, as borrower,
and the Company, in its capacity as Parent Company Guarantor, are subject to certain financial covenants under this agreement, including
a requirement to:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.75in; text-indent: 0in">(i) maintain an Adjusted Net Debt to EBITDA ratio
of no more than 3.0x, on a consolidated basis at the level of the Company, as of the last day of each quarter until maturity. For purposes
of this agreement, Adjusted Net Debt means, as of any date of calculation, (a) the aggregate amount of the Company&#8217;s consolidated
financial debt (whether classified as current or non-current liabilities), including accounts payable with respect to acquisitions in
which the seller finances a portion of the sale price, excluding lease liabilities and, without double counting, any financial debt with
affiliates, minus (b) the Company&#8217;s cash and cash equivalents (including earnings thereon) and the aggregate outstanding balance
of the Series A perpetual convertible preferred shares, calculated on the basis of the most recently available quarterly financial statements.
For purposes of this agreement, &#8220;EBITDA&#8221; means, for the relevant calculation period and for any person or specified group
of persons, net income for such period, plus, without duplication, (i) income tax expenses, (ii) net financial result (excluding interest
expenses on lease liabilities), (iii) depreciation and amortization expenses (excluding depreciation of right-of-use assets), (iv) share-based
compensation expenses, (v) share of income of associates from equity method investments, (vi) interest and fines received on past-due
student tuition fees paid to schools and educational systems and (vii) non-recurring expenses, in each case, of such person or specified
group of persons, determined on a consolidated basis (unless otherwise specified); and</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.75in; text-indent: 0in">(ii) ensure that, as of June 30 and December 31
of each financial year, the Aggregate EBITDA Amount for the relevant period is at least equal to 60% of the Company&#8217;s consolidated
EBITDA. For purposes of this agreement, Aggregate EBITDA Amount means the sum of (a) Afya Brazil&#8217;s unconsolidated EBITDA for the
relevant period, plus (b) the unconsolidated EBITDA of each of the guarantors under the agreement for the relevant period, plus (c) any
cash received by Afya Brazil during the relevant period as a cash dividend or capital reduction from any entity other than the guarantors.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(f)</td><td>On October 15, 2025, Afya Brazil issued commercial notes for private placement (&#8220;Commercial Notes&#8221;), sold to Opea Securitizadora
S.A. (&#8220;Opea&#8221;), a Brazilian securitization corporation pursuant to Section 45 of Brazilian Law No. 14,195/2021, as amended.
Opea issued a debenture backed by the Commercial Notes on the same terms and conditions.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.5in; text-indent: 0in">The aggregate principal amount of the Commercial
Notes is R$1,500 million, divided into two series, the first in the aggregate amount of R$500 million (&#8220;First Series&#8221;) and
the second in the aggregate amount of R$1,000 million (&#8220;Second Series&#8221;). The First Series will mature on October 15, 2028
and the Second Series will mature on October 15, 2030. The interest rate applicable to the First Series and Second Series is equal to
the CDI rate plus a spread of 0.70% and 0.85% per year, respectively, based on 252 business days.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 0.5in; text-indent: 0in">Afya Brazil is subject to certain obligations including
financial covenants, and the Company shall maintain Net Debt (excluding lease liabilities) to Adjusted EBITDA ratio below or equal to
3.0x, at the end of each fiscal year, until maturity date, applicable from December 31, 2025 and thereafter. For purposes of this agreement,
Adjusted EBITDA means, based on the consolidated financial statements of the Company for the twelve-month period immediately preceding
each calculation date, net income for such period, plus (i) income taxes expenses, (ii) net financial result (excluding interest expenses
on lease liabilities), (iii) depreciation and amortization expenses (excluding right-of-use assets depreciation expenses), (iv) share-based
compensation expenses, (v) share of income of associate, (vi) interest received and (vii) non-recurring expenses.</p>


<!-- Field: Page; Sequence: 116 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Share Buyback Program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For further information on our share buyback program,
see note 15 to the consolidated financial statements, included elsewhere in this annual report, Exhibit 2.1, &#8220;Description of Securities
Registered Under Section 12 of the Exchange Act - Share Repurchases&#8221; and &#8220;Item 16E. Purchases Of Equity Securities By The
Issuer And Affiliated Purchasers.&#8221;</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Tabular Disclosure of Contractual Obligations</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a summary of our contractual obligations,
based on contractual undiscounted amounts, as of December 31, 2025:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="5" style="text-align: center; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Payments
    Due by Period as of December 31, 2025</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; width: 45%; text-align: center">&#160;</td>
    <td style="text-align: center; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Less than<br/>
    1 year</p></td>
    <td style="text-align: center; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">1 &#8212;
    3 years</p></td>
    <td style="text-align: center; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">3 &#8212;
    5 years</p></td>
    <td style="text-align: center; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">More than<br/>
    5 years</p></td>
    <td style="text-align: center; width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Total</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="5" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">(in R$ thousands)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Trade payables	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">123,581</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">123,581</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Loans and financing 	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">308,292</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,360,411</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,473,733</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3,142,436</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Lease liabilities	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">178,638</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">347,847</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">331,019</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,342,713</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2,200,217</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Accounts payable to selling shareholders	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">126,307</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">131,446</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">185,821</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">502,355</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">945,929</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Total</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>736,818</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,839,704</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,990,573</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,845,068</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>6,412,163</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Future cash needs in the&#160;short and long term will
be funded by our operating cash flows and from proceeds raised in the debt or equity capital markets.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, we did not have any off-balance
sheet arrangements.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 0.25in">Principal Capital Expenditures</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We made capital expenditures (consisting of the acquisition
of property and equipment and intangible assets) of R$364.0 million, R$392.6 million and R$218.4 million in 2025, 2024 and 2023, respectively.
During these years, our capital expenditures mainly included expenditures related to: (i) R$100.0 million regarding the FUNIC&#8217;s
acquisition, mostly from Licenses with indefinite useful life; (ii) the expansion and maintenance of our campuses and headquarters, including
leasehold improvements; (iii) the expansion and maintenance of our shared services center; and (iv) the development of new solutions in
the Medical Practice Solutions segment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For 2026, we have budgeted capital expenditures of
R$360.8 million, mostly to support the growth in our business and operations. We expect to meet our capital expenditure needs for the
foreseeable future from our operating cash flow and our existing cash and cash equivalents. Our future capital requirements may be adjusted
from time to time as they depend on several factors, including our growth rate, the expansion of our research and development efforts,
employee headcount, marketing and sales activities, the introduction of new features to our existing products, the continued market acceptance
of our products.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609488"></span><span id="a_Toc225309240"></span><span id="a_Toc196072481"></span><span id="a_Toc164277181"></span><span id="a_Toc194891117"></span><span id="a_Toc190934954"></span><span id="a_Toc133237654"></span><span id="a_Toc163120248"></span><span id="a_Toc131580976"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Research
and Development, Patents and Licenses</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, we owned 415 trademark registrations
in Brazil and 8 trademark registrations abroad. We have also filed 6 international trademark applications, covering a total of 7 classes.
Out of these, three applications are still under examination &#8212; namely, the Afya application in the United States, the BioAtlas applications
in the United States and the Whitebook application in Mexico.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have two pending registration requests for the Afya
trademark in the United States. We have registered the BioAtlas trademark (a Medical Harbour product) in the European Union and have a
pending registration application for such trademark in the United States. We have registered the Whitebook trademark (a PEBMED product)
in Mexico and Colombia, and a variation of the Whitebook trademark in Portugal. We also have a pending registration application for the
Whitebook trademark in Mexico.</p>


<!-- Field: Page; Sequence: 117 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of the date of this annual report, we have 405 pending
trademark applications in Brazil and unregistered trademarks that we use to promote our brand, and also own 381 registered domain names
in Brazil and 60 registered international domain names, and have registered four software programs in Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">See &#8220;Item 4. Information on the Company&#8212;Technology
and Intellectual Property.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609489"></span><span id="a_Toc225309241"></span><span id="a_Toc196072482"></span><span id="a_Toc164277182"></span><span id="a_Toc194891118"></span><span id="a_Toc190934955"></span><span id="a_Toc133237655"></span><span id="a_Toc163120249"></span><span id="a_Toc131580977"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trend
Information</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Other than as disclosed elsewhere in this annual report,
we are not aware of any other trends, uncertainties, demands, commitments or events for the year ended December 31, 2025 that are reasonably
likely to have a material and adverse effect on our revenues, income, profitability, liquidity or capital resources, or that would cause
the disclosed financial information to be not necessarily indicative of future results of operations or financial conditions.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609490"></span><span id="a_Toc225309242"></span><span id="a_Toc196072483"></span><span id="a_Toc164277183"></span><span id="a_Toc194891119"></span><span id="a_Toc190934956"></span><span id="a_Toc133237656"></span><span id="a_Toc163120250"></span><span id="a_Toc131580978"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Critical
Accounting Estimates</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our consolidated financial statements have been prepared
in accordance with IFRS Accounting Standards. In preparing our consolidated financial statements, we make assumptions, judgments and estimates
that can have a significant impact on amounts reported in our consolidated financial statements. We base our assumptions, judgments and
estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results
could differ materially from these estimates under different assumptions or conditions. We regularly reevaluate our assumptions, judgments
and estimates, presenting our critical accounting estimates in note 2.5 of our consolidated financial statements included elsewhere in
this annual report.<span id="a_Toc133237657"></span><span id="a_Toc131580979"></span></p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609491"></span><span id="a_Toc225309243"></span><span id="a_Toc196072484"></span><span id="a_Toc164277184"></span><span id="a_Toc194891120"></span><span id="a_Toc190934957"></span><span id="a_Toc163120251"></span>ITEM
6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609492"></span><span id="a_Toc225309244"></span><span id="a_Toc196072485"></span><span id="a_Toc164277185"></span><span id="a_Toc194891121"></span><span id="a_Toc190934958"></span><span id="a_Toc133237658"></span><span id="a_Toc163120252"></span><span id="a_Toc131580980"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Directors
and Senior Management</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are managed by our board of directors and by our
senior management, pursuant to our Amended and Restated Memorandum and Articles of Association and the Cayman Islands Companies Act (As
Revised).</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Board of Directors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors is currently composed of 9 members.
Each of our directors shall hold office for a two (2) year term and are eligible for re-election. Under our Amended and Restated Memorandum
and Articles of Association: (i) Bertelsmann, for so long as it holds a number of our Class B common shares in excess of 10% of the total
number of outstanding Class B common shares (referred to herein as the &#8220;Ownership Threshold&#8221;), shall be entitled to appoint,
at its sole discretion, up to seven of our directors, and shall be entitled at any time to remove, substitute or replace any of its appointed
directors for any reason in its sole discretion; (ii) the Esteves Family, for so long as it holds our Class B common shares in excess
of the Ownership Threshold, shall be entitled to appoint, at its sole discretion, up to two of our directors, and shall be entitled at
any time to remove, substitute or replace any of its appointed directors for any reason in its sole discretion; and (iii) Bertelsmann
and the Esteves Family, for so long as they hold our Class B common shares in excess of the Ownership Threshold shall be entitled to jointly
appoint, at their sole discretion, up to one (1) director and shall be entitled at any time to remove, substitute or replace their appointed
director for any reason in their sole discretion (provided that if only one of Bertelsmann and the Esteves Family holds Class B common
shares in excess of the Ownership Threshold, then only Bertelsmann or the Esteves Family, as applicable, shall have these rights). Directors
appointed by the board of directors hold office until the next annual general meeting. Our directors do not have a retirement age requirement
under our Articles of Association. Subject to the foregoing, the directors shall be elected by an ordinary resolution of our shareholders,
which requires the affirmative vote of a simple majority of the votes cast on the resolution by the shareholders entitled to vote who
are present, in person or by proxy, at the meeting.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following table lists the current members of our
board of directors:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 45%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Name</p></td>
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Age</p></td>
    <td style="width: 45%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Position</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Kay Krafft	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">55</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-family: Times New Roman,serif; text-indent: -9.35pt">Co-Chairman</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Nicolau Carvalho Esteves	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">73</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-family: Times New Roman,serif; text-indent: -9.35pt">Co-Chairman</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Benedikt Dalkmann	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">41</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-family: Times New Roman,serif; text-indent: -9.35pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Christina Krebs	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">52</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-family: Times New Roman,serif; text-indent: -9.35pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Renato Tavares Esteves	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">38</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-family: Times New Roman,serif; text-indent: -9.35pt">Director</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Jo&#227;o Paulo Seibel de Faria	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">50</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-family: Times New Roman,serif; text-indent: -9.35pt">Independent Director*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Vanessa Claro Lopes	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">50</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-family: Times New Roman,serif; text-indent: -9.35pt">Independent Director*</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Miguel Filisbino Pereira de Paula	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">64</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-family: Times New Roman,serif; text-indent: -9.35pt">Independent Director*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Marcelo Ken Suhara	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">52</td>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-family: Times New Roman,serif; text-indent: -9.35pt">Independent Director*</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">*</td><td>Member of our Audit Committee. At our annual shareholders&#8217; meeting held on June 24, 2025, Jo&#227;o Paulo Seibel de Faria,
Vanessa Claro Lopes, Miguel Filisbino Pereira de Paula, and Marcelo Ken Suhara were re-elected as independent directors of the Company,
each to serve for a two-year term. <span id="a_cp_change_1063"></span><span id="a_cp_change_1065"></span><span id="a_M588"></span></td></tr></table>

<!-- Field: Page; Sequence: 118 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a brief summary of the business experience
of our directors. Unless otherwise indicated, the current business addresses for our directors is Rua Paraiba, No. 330, 17th floor, Funcion&#225;rios,
Belo Horizonte, Minas Gerais, Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk164851834"></span><i>Kay Krafft</i>. Kay
Krafft is co-chairman of our board of directors, a position he has held since May 2022 after having held the position of director since
August 2021. He is the founding CEO of Bertelsmann Education Group. Until 2014, he was an Executive Board member of the of music rights
management company BMG. Before joining BMG, he served as EVP and global head of M&amp;A at Bertelsmann while implementing major portfolio
adjustments during this time. Prior to joining Bertelsmann, Kay Krafft was a partner at professional services firm Deloitte.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Nicolau Carvalho Esteves</i>. Nicolau Carvalho Esteves
is co-chairman of our board of directors, a position he has held since May 2022 after having held the position of chairman since July
2019. He is a qualified orthopedist and has over 25 years of experience in the education industry. He was the chairman of the board of
directors of Afya Brazil from August 2016 to December 2019, when the board of directors of Afya Brazil was extinguished. He is the founding
shareholder of the following companies, for which he served as Chief Executive Officer for the periods indicated (i)&#160;ITPAC&#8212;Instituto
Tocantinense Presidente Ant&#244;nio Carlos S.A. (1999-2016); (ii)&#160;ITPAC Porto&#8212;Instituto Tocantinense Presidente Ant&#244;nio
Carlos Porto S.A. (2008-2016); (iii)&#160;IPTAN&#8212;Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (2003-2016)
and (iv)&#160;Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A. (2016-2018). He is also a member of the board
of directors of Emive Participa&#231;&#245;es S.A, a position he has held since January 2024. He holds a Medicine degree from Faculdade
de Medicina de Barbacena, a master&#8217;s degree in business administration from FGV, a master&#8217;s degree in Corporate Finance from
Funda&#231;&#227;o Dom Cabral, a master&#8217;s degree in business administration from FEAD and a Business Administration degree from
AIEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Benedikt Dalkmann</i>. Benedikt Dalkmann is a member
of our board of directors, a position he has held since May 2022, in addition to being Chief Financial Officer of Bertelsmann Education
Group. He has played a formative role in developing the Group since its foundation in 2015, including the expansion of Relias into a major
player in U.S. healthcare education through acquisitions, as well as the establishment of an international presence. Before joining the
Education Group, Benedikt worked as Director of Strategy &amp; Investments at Bertelsmann Group. Other experiences include a period in
Venture Capital at Holtzbrinck, and in management consulting.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Christina Krebs</i>. Christina Krebs is a member
of our board of directors, a position she has held since December&#160;2022, in addition to being the Chief People Officer of Bertelsmann
Education Group and the Chief People Officer at Relias, a Bertelsmann Education Group company. Prior to 2020, Christina held multiple
roles at Relias including VP, Client Care and VP, Integration, where she helped integrate multiple healthcare technology companies into
the Relias portfolio. Before joining Relias, Christina was a partner at the professional services firm, ScottMadden Management Consultants.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk164851811"></span><i>Renato Tavares Esteves.</i>
Renato Tavares Esteves is a member of our board of directors, a position he has held since July 2019. He was a member of the board of
directors of Afya Brazil from August 2016 to December 2019, when the board of directors of Afya Brazil was extinguished. He served as
executive officer of the following companies: <i>Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A., UNIVA&#199;O&#8212;Uni&#227;o
Educacional do Vale do A&#231;o S.A., IPTAN&#8212;Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A., ITPAC&#8212;Instituto
Tocantinense Presidente Ant&#244;nio Carlos S.A.,</i> and <i>Instituto de Ensino Superior do Piau&#237; S.A.&#8212;IESP. </i>He is
also a member of the board of directors of Emive Participa&#231;&#245;es S.A., a position he has held since January 2024. He holds
a degree in medicine from Faculdade de Medicina de Barbacena, and a master&#8217;s degree in business administration and Corporate Finance
from FGV.</p>


<!-- Field: Page; Sequence: 119 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Jo&#227;o Paulo Seibel de Faria</i>. Jo&#227;o
Paulo Seibel de Faria is a member of our board of directors and an independent member of our audit, risks and ethics committee, positions
he has held since August 2020. He is currently the CFO of Ericsson Latin America since 2024. He has 30 years of experience in companies
like Arthur Andersen S/C, Ericsson Telecomunica&#231;&#245;es, Microsoft, Didi Chuxing, OLX and Patria Investments. He spent 18 years
at Microsoft in different leadership roles in Latin America and the U.S. in sales, marketing and in finance, including his last role as
chief financial officer in Brazil. Mr. Faria holds a bachelor&#8217;s degree in business management from FAAP and an Executive MBA from
Insper (both in S&#227;o Paulo). Additionally, he holds several executive sessions in leadership, strategy and global business environment
from Funda&#231;&#227;o Dom Cabral, INSEAD and Devry.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Vanessa Claro Lopes</i>. Vanessa Claro Lopes is
a member of our board of directors and an independent member of our audit, risks and ethics committee, positions she has held since July
2019. She currently serves as an independent member of the board of directors and chair of both the audit committee and the related parties
committee at Rumo S.A. Additionally, Ms. Lopes is an independent director and chair of the audit committee at Americanas S.A., where she
also serves as a member of the nominating committee. Her current governance portfolio includes serving as chair of the audit committee
at Tegma Gest&#227;o Log&#237;stica S.A., and as a member of the audit and ethics committee at AXIA Energia (Eletrobras Group). Prior
to her current roles, Ms. Lopes served on the audit, risks, and ethics Committee of Embraer S.A. and chaired the fiscal council of Via
Varejo S.A. Her extensive background in oversight includes memberships on the fiscal councils of prominent organizations such as Gerdau
S.A., Terra Santa Agro S.A., Est&#225;cio Participa&#231;&#245;es S.A., Renova Energia S.A., Cosan S.A., Cosan S.A., Log&#237;stica
S.A. and Comg&#225;s S.A. With over 30 years of experience in corporate governance, internal controls and auditing, Ms. Lopes held key
executive positions earlier in her career, including Head of Internal Audit at TAM S.A. and Globex Utilidades S.A. (Grupo P&#227;o de
A&#231;&#250;car), and Audit Manager at Grupo Telef&#244;nica. She began her professional trajectory at PricewaterhouseCoopers (PwC)
in 1995, where she spearheaded the creation of the revenue assurance department for the Telecommunications sector in Brazil. Ms. Lopes
holds an MBA from EAESP/FGV, a master&#8217;s degree in management systems from Universidade Federal Fluminense (UFF), and a Postgraduate
Diploma in Computer Networks from Universidade S&#227;o Judas. She also earned degrees in accounting from Universidade Federal Fluminense
(UFF) and systems analysis from FATEC/BS.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Miguel Filisbino Pereira de Paula</i>. Miguel Filisbino
Pereira de Paula is a member of our board of directors and an independent member of our audit, risks and ethics committee and People &amp;
ESG Committee, which positions he has held since August 2020. He has over 30 years&#8217; experience in C-level positions and serving
on the advisory boards and boards of directors of large companies, such as Gerdau S.A., Votorantim Cimentos S.A., Yduqs S.A. and Companhia
Brasileira de Distribui&#231;&#227;o GPA. Miguel is an expert in the education industry, where he was Vice President of People, Management,
and Services for nine years at the education company Est&#225;cio Participa&#231;&#245;es S.A. and he also serves as an operating
partner of People Management and Governance areas for private equity funds, including portfolio companies of Crescera Capital and EB Capital
and was also appointed as independent member of advisory boards and boards of directors of these mentioned companies. Currently, Miguel
is a member of the Board of Directors of Gurgel Mix (Loja do Mec&#226;nico), Salus Group and Hospital CARE as observer of the Board.
During his executive career, he has led major turnaround projects in companies and/or business units of these groups, always focusing
on processes, people, new organizational concepts and governance models, and he has been directly and/or indirectly responsible for hiring
and developing many executives for management positions in these organizations. He holds a degree in business administration from Universidade
Luterana do Brasil, an MBA in retail management from the University of S&#227;o Paulo and an MBA in human resources management from
Pontif&#237;cia Universidade Cat&#243;lica do Rio Grande do Sul. He completed several courses in leadership and business management
in Brazil, at the Kellogg School of Management: in the United States and at the Union of Japanese Scientists and Engineers (JUSE).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Marcelo Ken Suhara</i>. Marcelo Ken Suhara is a
member of our board of directors and an independent member of our audit, risks and ethics committee which positions he has held since
June 2023. He has a combined 26 years of experience in initial public offering advisory services, financial reporting, accounting and
audit. He was a partner in the capital markets center at Ernst &amp; Young in S&#227;o Paulo from 2011 to March 2022. He also worked
in the capital markets group at PricewaterhouseCoopers from 2001 to 2010, and in audit at Arthur Andersen from 1998 to 2000 and Coopers
&amp; Lybrand from 1996 to 1998. He has extensive experience in initial public offerings, equity and debt offerings in the Brazilian
and international capital markets, and advised companies on financial reporting and regulatory matters on capital markets transactions,
and on SEC rules and regulations. He holds a bachelor&#8217;s degree in business management from <i>Pontificia Universidade Cat&#243;lica
</i>and a bachelor&#8217;s degree in accounting from <i>Universidade Paulista</i> and is a Brazilian Certified Accountant registered
at CRC &#8212; <i>Conselho Regional de Contabilidade</i> (Brazilian Regional Accounting Council).</p>

<!-- Field: Page; Sequence: 120 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Executive Officers</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our executive officers are responsible for the management
and representation of our company. We have a strong centralized team led by Virgilio Deloy Capobianco Gibbon, our CEO, with broad experience
in the education industry.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following table lists our current executive officers.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 49%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center"><span id="a_Hlk164763705"></span>Name</p></td>
    <td style="width: 6%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Age</p></td>
    <td style="width: 45%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Position</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Virgilio Deloy Capobianco Gibbon	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">51</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">Chief Executive Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Luis Andr&#233; Carpintero Blanco	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">52</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">Chief Financial Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">L&#233;lio de Souza Junior	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">52</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif">Vice President of Medical Practice Solutions</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a brief summary of the business experience
of our executive officers. Unless otherwise indicated, the current business addresses for our executive officers is Rua Paraiba, No 330,
17th Floor, Funcion&#225;rios, Belo Horizonte, Minas Gerais, Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk164763655"></span><i>Virgilio Deloy Capobianco
Gibbon.</i> Virgilio Deloy Capobianco Gibbon serves as the Chief Executive Officer of Afya, a position he has held since 2016. Under his
leadership, Afya successfully executed its Initial Public Offering on the Nasdaq in 2019. Since our IPO, Afya has experienced significant
growth, expanding its operations and solidifying its position as a leader in medical education in Brazil. In recognition of his contributions
to sustainable development, Virgilio was honored by the United Nations as an Impact Leader for the Sustainable Development Goals (SDGs).
In 2023, he was named the Best Executive in the Education Sector in Brazil by Valor 1000. Prior to his tenure at Afya, Virgilio held several
key positions such as Chief Operating Officer at YDUQS (formerly Est&#225;cio Participa&#231;&#245;es S.A.) from March 2010 to March
2012, Chief Financial Officer at YDUQS from March 2012 to June 2016, Executive Director of Business Consulting and Education Industry
at TOTVS from October 2007 to December 2009 and Senior Manager of Business Consulting at Accenture from 2000 to 2007. Virgilio holds a
degree in Economics from Pontif&#237;cia Universidade Cat&#243;lica do Rio de Janeiro (PUC-RJ) and has completed executive management
programs at Funda&#231;&#227;o Getulio Vargas (FGV), Stanford University, and Harvard University.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>Luis Andr&#233; Blanco.</i> Luis Andr&#233;
Blanco is our Chief Financial Officer, a position he has held since May 2020. Prior to joining us, he served as CFO for OdontoPrev for
10 years, where he oversaw corporate finance &#8212; treasury, financial planning, M&amp;A, tax and accounting operations, legal and compliance.
Prior to that, Luis served as a Financial Officer at Vivo S.A. from 2003 to 2009 and also as CFO at <i>Tele Centro &#8212; Oeste Celular
Participa&#231;&#245;es</i> from 2000 to 2003. Luis holds a bachelor&#8217;s degree in engineering from the Federal University of
Rio de Janeiro and an executive program degree from University of Westminster, London, England.</p>

<p style="font: 10pt/107% Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><i>L&#233;lio de Souza Junior.</i>
L&#233;lio de Souza Junior is our Vice President of Medical Practice Solutions, a position he has held since January 2022. Prior to
joining us, he served as CEO for Intelie for five years, where he had the chance to support the internationalization of the company,
the acquisition process by RigNet (later on acquired by Viasat, NASDAQ: VSAT) and to experience a very well succeeded growth
history. Prior to that, Lelio served as a Corporate Officer at TOTVS from 2008 &#8212; 2016 and also as Senior Manager in Accenture
from 2000-2008. Lelio holds a bachelor&#8217;s degree in Mechanical Engineering from the Federal University of Minas Gerais (UFMG)
and executive programs degrees from University of Wharton, Pennsylvania, USA and Insper, S&#227;o Paulo, Brazil.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Family Relationships</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Nicolau Carvalho Esteves, the co-chairman of our board
of directors, is the father of Renato Tavares Esteves, one of our directors.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk162015298"></span><span id="a_Toc215609493"></span><span id="a_Toc225309245"></span><span id="a_Toc196072486"></span><span id="a_Toc164277186"></span><span id="a_Toc194891122"></span><span id="a_Toc190934959"></span><span id="a_Toc133237659"></span><span id="a_Toc163120253"></span><span id="a_Toc131580981"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Compensation</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, we are not required to disclose
compensation paid to our senior management on an individual basis and we have not otherwise publicly disclosed this information elsewhere.</p>


<!-- Field: Page; Sequence: 121 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our executive officers, directors and management receive
fixed and variable compensation. They also receive benefits in line with market practice in Brazil. The fixed component of their compensation
is set on market terms and adjusted annually.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The variable component consists of cash bonuses and
awards of shares (or the cash equivalent). Cash bonuses or paid to executive officers and members of our management based on previously
agreed targets for the business. Shares (or the cash equivalent) are awarded under our share-based long-term incentive plans, as discussed
below.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following table sets forth the fixed and variable
compensation of our key management personnel for the periods indicated:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; width: 61%; text-align: center">&#160;</td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2025</p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2024</p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2023</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 1pt; padding-bottom: 2pt; font-family: Times New Roman,serif; text-align: center; line-height: 9pt">&#160;</td>
    <td colspan="3" style="padding-top: 1pt; padding-bottom: 2pt; font-family: Times New Roman,serif; text-align: center; line-height: 9pt"><span style="font-size: 8pt"><b>(in R$ millions)</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Short-term employee benefits	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">27.2</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">21.2</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">17.0</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Share-based compensation plans	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">16.2</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">19.9</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">21.4</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Total compensation</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>43.4</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>41.1</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>38.4</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt">&#160;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Long-Term Incentive Plans</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Afya Stock Options Plan</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On August 30, 2019, our board of directors approved
the establishment of the new equity incentive plan, or the stock option plan, as amended, with the purpose of advancing the interests
of our shareholders by enhancing our ability to attract, retain and motivate individuals to perform at the highest level.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The stock option plan and the applicable option agreement
to be entered into between us and the beneficiary, or the Option Agreement, governs the issuance of equity incentive awards with respect
to our Class A common shares, or the Options. The calculation of the strike price of the Option will be set forth in the applicable Option
Agreement, as approved by the board of directors, upon the granting of the Option to the beneficiary. If a beneficiary is dismissed by
us, resigns, retires or dies, the portion of his or her Options under the stock option plan that has vested at that date will be satisfied,
but the non-vested portion will be canceled. If a beneficiary is terminated for cause, all of his or her Options under the stock option
plan will be canceled. The maximum aggregate number of shares that can be issued to beneficiaries under the stock option plan may not
exceed 4% of our share capital at any time, excluding treasury shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In 2025 and 2024, we&#160;granted 752,000 and 113,900
stock&#160;options to our executives, respectively. As of December 31, 2025, a total of 1,843,369 stock options were outstanding under
the stock option plan. For further information about vesting periods and strike price, see note 14.b.1&#160;to our consolidated&#160;financial
statements.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Restricted Stock Units Program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On July 8, 2022, our board of directors approved our
restricted stock units program, or the RSU program, for employees. The participant&#8217;s right to effectively receive ownership of RSUs
will be conditioned on the participant&#8217;s continuance as an employee or director in the business group from the grant date until
vesting. Employees will be entitled to these shares in a proportion of 10%, 20%, 30% and 40% each year. The maximum aggregate number of
shares that can be issued to beneficiaries under the RSU program may not exceed 1.2% of our share capital at any time, excluding treasury
shares. In 2025 and 2024, we granted 381,000 and 44,500 RSUs to our executives, respectively. As of December 31, 2025, a total of 719,718
restricted shares were outstanding under the RSU program. For further information about vesting periods and our RSU program, see note
14.b.2 to our consolidated financial statements.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609494"></span><span id="a_Toc225309246"></span><span id="a_Toc196072487"></span><span id="a_Toc164277187"></span><span id="a_Toc194891123"></span><span id="a_Toc190934960"></span><span id="a_Toc133237660"></span><span id="a_Toc163120254"></span><span id="a_Toc131580982"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Board
Practices</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Duties of Directors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, directors of a Cayman Islands
company are considered fiduciaries of the company. As such, directors owe fiduciary duties to the company, which include acting in the
best interests of the company, exercising their powers for the purposes for which they were conferred,
and avoiding situations where their personal interests may conflict with their duty to the company. Consequently, a director has a duty
not to profit from their position as director, unless the company expressly permits such profits. Additionally, a director must not place
themselves in a position where their personal interests or obligations to third parties conflict with the interests of the company. However,
a company&#8217;s articles of association may allow a director to vote on a matter in which they have a personal interest, provided the
nature of the interest is disclosed to the board of directors. Our Articles of Association require that a director disclose the nature
and extent of any material interests in any contract or arrangement. Furthermore, a director may vote on any resolution concerning an
interested matter, provided the director has disclosed the nature of their interest, subject to any separate requirement under applicable
law or the listing rules of the Nasdaq and unless such director has been disqualified by the chairman.</p>


<!-- Field: Page; Sequence: 122 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A director of a Cayman Islands company is also obligated
to exercise independent judgment in performing their duties and to act with reasonable skill, care and diligence. This standard of care
has both objective and subjective components. Recent Cayman Islands case law confirmed that directors must exercise the care, skill and
diligence that would be expected of a reasonably diligent person with the general knowledge, skill and experience typically possessed
by someone acting as a director. Additionally, a director is required to apply the knowledge, skill and experience they actually possesses
in carrying out their functions.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Risk Management</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya&#8217;s integrated Risk Management is aligned
with Bertelsmann&#8217;s Risk Management and Internal Controls Policy, which defines the methodologies, guidelines, response strategy,
governance and responsibilities to guide the processes of identifying, assessing, treating, monitoring and communicating risks distributed
across of the following categories: Operational, financial, compliance and strategic including ESG (environmental, social and governance),
aligned with industry best practices.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our integrated risk governance practice is founded
on the lines of defense model and based on globally recognized standards for risk management, including ISO 31000 and COSO-ERM:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>First Line</i>: This comprises risk owners who are responsible for executing processes, identifying risks, and implementing action
plans. Working closely with the Risk and Controls department, they proactively identify potential risks in their operations.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Second Line</i>: Risk Management, Internal Controls and other specialized areas that collaborate with risk owners to monitor risks
and action plans. The Risk and Controls department coordinates progress and action plans in partnership with the internal audit teams
and other Afya units. They report their findings to the executive officers, the Audit, Risk and Ethics Committee and the board of directors.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Third Line</i>: Represented by the Internal Audit team, this line conducts independent evaluations for management. They perform
substantive tests of internal controls to detect operational and financial deviations resulting from failures or fraudulent activities.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Whistleblowing Channel</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya provides to internal and external public a whistleblowing
channel hosted outside Afya&#8217;s systems and managed by a third party named ICTS Global do Brasil - Aliant, that is an independent,
confidential and impartial tool for reporting of accusations or evidence of illicit conducts that violates Afya&#8217;s Code of Ethics
and also its integrity program and the current legislation. For more information regarding the whistleblowing channel please enter <span style="color: Blue"><span style="text-decoration: underline">www.canaldeetica.com.br/afya</span></span>.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Governance</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Toc190934961"></span>Below, we list our main
structures with a role in Risk Governance. For more information, see &#8220;Item 6. Directors, Senior Management and Employees&#8212;A.
Directors and Senior Management&#8212;Board of Directors.&#8221;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="text-decoration: underline">Board of Directors:</span>&#160;Responsible for overseeing the company&#8217;s risk management, through regular reports from our executive
officers together with the support of the audit, risks and ethics committee, ensuring that it is aligned with our strategic objectives
and values.</td></tr></table>


<!-- Field: Page; Sequence: 123 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="text-decoration: underline">Audit, Risks and Ethics Committee:</span>&#160;Comprised by independent members of our board of directors, it is in charge of monitoring
and reviewing the company&#8217;s main risks, as well as supervising that mitigating actions are being effectively implemented.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="text-decoration: underline">People and ESG Committee:</span> Responsible for having decision-making power, by delegation of our board of directors, with respect
to executives&#8217; compensation, management succession, compensation plans and policies, director and committee member compensation
and sustainability and social responsibility matters.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="text-decoration: underline">Executive Officers:</span>&#160;Propose methodologies, guidelines, risk response strategies, governance, and responsibilities to guide
the process, as well as ensure the proper allocation of resources for risk mitigation. Evaluate the robustness of risk management through
periodic reports, discussing and validating the risk matrix, considering the impact and probability assessments from the responsible areas,
and defining the risk control panel, forwarding it for the audit, risks and ethics committee and the board of directors&#8217; approval.</td></tr></table>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Election and Terms of Directors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">See &#8220;Item 10. Additional Information.&#8212;B.
Memorandum and Articles of Association&#8212;Appointment, Disqualification and Removal of Directors.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Board Committees</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors has established an audit, risks
and ethics committee and a people and ESG committee. In the future, our board of directors may establish other committees, as it deems
appropriate, to assist with its responsibilities.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk164263373"></span>Audit, Risks and Ethics
Committee</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The audit, risks and ethics committee, or the audit
committee, which consists of Vanessa Claro Lopes (elected to the committee on July 8, 2019), Jo&#227;o Paulo Seibel de Faria (elected
to the committee on August 26, 2020), Miguel Filisbino Pereira de Paula (elected to the committee on August 26, 2020), and Marcelo Ken
Suhara (elected to the committee on June 22, 2023) assists our board of directors in overseeing our accounting and financial reporting
processes and the audits of our consolidated financial statements. In addition, the audit committee is directly responsible for the recommendation
for approval by the board of directors of the appointment and compensation of our independent registered public accounting firm. Jo&#227;o
Paulo Seibel de Faria serves as chairman of the audit committee. The audit committee consists exclusively of members of our board of directors
who are financially literate, and Marcelo Ken Suhara is considered an &#8220;audit committee financial expert&#8221; as defined by the
SEC. Our board of directors has determined that Vanessa Claro Lopes, Jo&#227;o Paulo Seibel de Faria, Miguel Filisbino Pereira de Paula,
and Marcelo Ken Suhara satisfy the &#8220;independence&#8221; requirements set forth in Rule 10A-3 under the Exchange Act.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk164354971"></span>The audit committee complies
with applicable SEC and Nasdaq rules. Notwithstanding anything to the contrary established in the audit committee charter, the audit committee
is responsible for, among other things:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>give its opinion in the selection, hiring, monitoring and removal of the independent registered public accounting firm, for the preparation
of an external audit or for any other service; pre-approval of the audit services and non-audit services to be provided by our independent
registered public accounting firm before the auditor is engaged to render such services;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>discuss with the independent registered public accounting firm its responsibilities under PCAOB auditing standards, review and approve
the planned scope and timing of the annual audit plan(s) and discuss significant findings from the audit;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>become aware and evaluate the report from the independent registered public accounting firm describing all relationships between the
independent registered public accounting firm and the Company consistent with the applicable PCAOB requirements regarding the independent
registered public accounting firm&#8217;s communications with the audit committee concerning independence;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>confirming and evaluating the rotation of the audit partners on the audit engagement team as required by law;</td></tr></table>


<!-- Field: Page; Sequence: 124 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>review with management and the independent registered public accounting firm, in separate meetings whenever the audit committee deems
appropriate, any analyses or other written communications prepared by the management and/or the independent registered public accounting
firm setting forth significant financial reporting issues and judgments made in connection with the preparation of the financial statements,
including analyses of the effects of alternative IFRS Accounting Standards methods on the financial statements; and other critical accounting
policies and practices of the Company;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>review, in conjunction with the Chief Executive Officer and Chief Financial Officer of the Company, the Company&#8217;s disclosure
controls and procedures and internal control over financial reporting;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>establish procedures for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal
accounting controls or auditing matters, and the confidential, anonymous submission by employees of the Company of concerns regarding
questionable accounting or auditing matters;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>monitor the processes implemented by the executives regarding related person transactions (as defined in our related person transaction
policy) in accordance with our related person transaction policy;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>overseeing the effectiveness of our cybersecurity program; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>periodically monitor the prevention, detection, mitigation, and remediation of general risks, cybersecurity threats and incidents
and report its findings to our board of directors.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The audit committee meets as often as it determines
is appropriate to carry out its responsibilities, but in any event, pursuant to its charter, the audit committee ordinarily meets at least
six times per year.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Information contained on our website shall not constitute,
or be deemed incorporated as, a part of this annual report.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, our audit committee monitors ongoing compliance
with our code of ethics and related compliance policies.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk164432703"></span>People and ESG Committee</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The People and ESG Committee assists our board of directors
in reviewing and approving the compensation structure, including all forms of compensation relating to our directors and executive officers.
As permitted by the listing requirements of Nasdaq, we have opted out of Nasdaq Listing Rule 5605(d), which requires that a compensation
committee consist entirely of independent directors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The People and ESG Committee has authority over key
decisions related to compensation, succession, organizational development, and sustainability. Its responsibilities include setting and
reviewing our overall compensation policies, including for directors, executive officers, and committee members; evaluating executive
performance and incentive plans; overseeing succession planning for key roles; and approving material employment or termination agreements
and non-standard compensation arrangements.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The People and ESG Committee also monitors leadership
development, organizational culture, and performance evaluation outcomes, and is responsible for managing our stock option plan. On the
ESG front, it advises the board on the integration of sustainability into our long-term strategy, evaluates progress toward ESG goals,
and reviews our ESG disclosures and participation in relevant external frameworks and commitments.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Executives may be invited to provide information to
the People and ESG Committee but do not participate in discussions regarding their own compensation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of the date of this annual report, our People and
ESG Committee consists of Rafael Munerato de Almeida, Renato Tavares Esteves, Miguel Filisbino Pereira de Paula, Kay Krafft and Christina
Krebs. Miguel Filisbino Pereira de Paula serves as chairman of the People and ESG Committee.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">See &#8220;Item 6. Directors, Senior Management and
Employees&#8212;F. Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation.&#8221;</p>


<!-- Field: Page; Sequence: 125 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Controlled Company Exception</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Bertelsmann beneficially owns the majority of our Class
B common shares, representing 84.0% of the voting power of our outstanding share capital. As a result, we are a &#8220;controlled company&#8221;
within the meaning of the corporate governance standards of the Nasdaq corporate governance rules. Under these rules, a company of which
more than 50% of the voting power in the election of directors is held by an individual, group or another company is a &#8220;controlled
company&#8221; and may elect not to comply with certain corporate governance requirements.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a &#8220;controlled company,&#8221; we may elect
not to comply with certain corporate governance standards, including the requirements (1) that a majority of our board of directors consist
of independent directors; (2) that our board of directors have a compensation committee that is comprised entirely of independent directors
with a written charter addressing the committee&#8217;s purpose and responsibilities; and (3) that our board of directors have a nominating
and corporate governance committee that is comprised entirely of independent directors with a written charter addressing the committee&#8217;s
purpose and responsibilities. For so long as we qualify as a controlled company, we may take advantage of these exemptions. Accordingly,
our shareholders may not have the same protections afforded to shareholders of companies that are subject to all of these corporate governance
requirements. In the event that we cease to be a &#8220;controlled company&#8221; and our common shares continue to be listed on the Nasdaq,
we will be required to comply with the corporate governance standards within the applicable transition periods.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk163715495"></span><span id="a_Hlk164267479"></span>Board Diversity
Matrix</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Board Diversity
    Matrix (as of December 31, 2025)</p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif">Country of Principal Executive Offices:</td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif">Brazil</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif">Foreign Private Issuer:</td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif">Yes (the Cayman Islands)</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif">Disclosure Prohibited under Home Country Law:</td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif">No</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif">Total Number of Directors:</td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; line-height: 107%">9</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 10pt 5.4pt 2pt; text-align: center; width: 56%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 11%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 11%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 11%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 11%">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 10pt 5.4pt 2pt; width: 56%; text-align: center">&#160;</td>
    <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 10pt 0 2pt; text-align: center">Female</p></td>
    <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 10pt 0 2pt; text-align: center">Male</p></td>
    <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 10pt 0 2pt; text-align: center">Non-Binary</p></td>
    <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 10pt 0 2pt; text-align: center">Did Not
    Disclose Gender</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif"><b>Part I: Gender Identity</b></td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif">Directors:</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right">2</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right">7</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif"><b>Part II: Demographic Background</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif">Underrepresented Individual in Home Country Jurisdiction:</td>
    <td colspan="4" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right">2</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif">LGBTQ+:</td>
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif">Did not Disclose Demographic Background:</td>
    <td colspan="4" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right">7</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk130833558"></span><span id="a_Toc215609495"></span><span id="a_Toc225309247"></span><span id="a_Toc196072488"></span><span id="a_Toc164277188"></span><span id="a_Toc194891124"></span><span id="a_Toc190934962"></span><span id="a_Toc133237661"></span><span id="a_Toc163120255"></span><span id="a_Toc131580983"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employees</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, we had 9,395 employees, 9%
of whom were based in our offices in Belo Horizonte and 91% of whom were based in other cities elsewhere in Brazil. We also engage temporary
employees and consultants as needed to support our operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The table below breaks down our full-time personnel
by function as of December 31, 2025:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; width: 70%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Function</p></td>
    <td style="text-align: center; width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Number of
    Employees</p></td>
    <td style="text-align: center; width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">% of Total</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Management	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right; line-height: 107%">54</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.6%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Shared Services Center and IT, Sales and Marketing	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,081</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">11.5%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Faculties	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,066</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">43.3%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">General and Administrative	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">4,194</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">44.6%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Total</b>	</td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>9,395</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>100.0%</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our employees in Brazil are represented by the labor
unions of independent sales agents and of consulting, information, research and accounting firms for the geographic area in which they
render services. We believe we have a constructive relationship with these unions, as we have never experienced strikes, work stoppages
or disputes leading to any form of downtime.</p>


<!-- Field: Page; Sequence: 126 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609496"></span><span id="a_Toc225309248"></span><span id="a_Toc196072489"></span><span id="a_Toc164277189"></span><span id="a_Toc194891125"></span><span id="a_Toc190934963"></span><span id="a_Toc133237662"></span><span id="a_Toc163120256"></span><span id="a_Toc131580984"></span>
E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Ownership</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For information regarding the share ownership of our
directors and senior management, see &#8220;Item 7. Major Shareholders and Related Party Transactions&#8212;A. Major Shareholders.&#8221;
For information as to stock options or RSUs granted to our directors, executive officers and other employees, see &#8220;Item 6. Directors,
Senior Management and Employees&#8212;B. Compensation&#8212;Long-Term Incentive Plans.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk163503160"></span><span id="a_Toc215609497"></span><span id="a_Toc225309249"></span><span id="a_Toc196072490"></span><span id="a_Toc164277190"></span><span id="a_Toc194891126"></span><span id="a_Toc190934964"></span><span id="a_Toc133237663"></span><span id="a_Toc163120257"></span><span id="a_Toc131580985"></span>F.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have adopted a compensation recoupment policy on
November 30, 2023. See Exhibit 97.1 incorporated by reference to this annual report.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have not been required to prepare an accounting
restatement at any time during or after our last completed fiscal year and no recovery of awarded compensation is required pursuant to
our compensation recoupment policy.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609498"></span><span id="a_Toc225309250"></span><span id="a_Toc196072491"></span><span id="a_Toc164277191"></span><span id="a_Toc194891127"></span><span id="a_Toc190934965"></span><span id="a_Toc133237664"></span><span id="a_Toc163120258"></span><span id="a_Toc131580986"></span>ITEM
7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609499"></span><span id="a_Toc225309251"></span><span id="a_Toc196072492"></span><span id="a_Toc164277192"></span><span id="a_Toc194891128"></span><span id="a_Toc190934966"></span><span id="a_Toc133237665"></span><span id="a_Toc163120259"></span><span id="a_Toc131580987"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Major
Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following table and accompanying footnotes presents
information relating to the beneficial ownership of our Class A common shares and our Class B common shares as of the date of this annual
report:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>each person or group of affiliated persons, known by us to own beneficially 5% or more of our outstanding shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>each of our executive officers and directors individually; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>all executive officers and directors as a group.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The number of common shares beneficially owned by each
entity, person, executive officer or director is determined in accordance with the rules of the SEC, and the information is not necessarily
indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares over which the individual
has sole or shared voting power or investment power as well as any shares that the individual has the right to acquire within 60 days
through the exercise of any option, warrant or other right. Except as otherwise indicated, and subject to applicable community property
laws, the persons named in the table have sole voting and investment power with respect to all common shares held by that person.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Unless otherwise indicated below, the business address
for each beneficial owner is c/o Afya, Rua Paraiba, No. 330, 17th floor, Funcion&#225;rios, Belo Horizonte, Minas Gerais, Brazil.</p>


<!-- Field: Page; Sequence: 127 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="4" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Shares Beneficially
    Owned</p></td>
    <td rowspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">% of Total
    Voting Power(2)</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="4" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Common Shares</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Class A</p></td>
    <td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Class B</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 35%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Shareholders
    (1)</p></td>
    <td style="width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Shares</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">%</p></td>
    <td style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Shares</p></td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">%</p></td>
    <td style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">%</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 0.1in; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>5% Shareholders Party to our Shareholders&#8217; Agreement</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Bertelsmann SE &amp; Co. <br/>
KGaA (3)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">26,576,579</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">51.8%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">34,074,134</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">88.3%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">84.0%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Nicolau Carvalho Esteves (4)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5,335,295</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">10.4%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4,500,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">11.7%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">11.5%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Ros&#226;ngela de Oliveira Tavares Esteves (5) 	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5,321,379</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">10.4%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">4,500,000</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">11.7%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">11.5%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Renato Tavares Esteves (6)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,263,613</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2.5%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.3%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Vanessa Tavares Esteves (7)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,435,440</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2.8%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.3%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">L&#237;lian Tavares Esteves de Carvalho (8)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,531,909</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">3.0%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.4%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.1in; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>Other 5% Shareholders</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">FMR LLC (9)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">2,734,455</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.3%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.6%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.1in; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif"><b>Other Executive Officers and Directors (10)</b></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Kay Krafft (11)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Benedikt Dalkmann(12)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Christina Krebs(13)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Jo&#227;o Paulo Seibel de Faria	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Miguel Filisbino Pereira de Paula	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Vanessa Claro Lopes	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1,315</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">*</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">*</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Marcelo Ken Suhara		</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">L&#233;lio de Souza Junior(14)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">211,232</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.4%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">*</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Luis Andr&#233; Carpintero Blanco(15)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">122,103</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.2%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.1in; padding-left: 16.55pt; text-indent: -9.35pt; font-family: Times New Roman,serif">Virgilio Deloy Capobianco Gibbon(16)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">496,938</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">1.0%</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8212;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.1%</td></tr>
  </table>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">*</td><td>Represents beneficial ownership of less than 0.1% of the respective class of our outstanding shares.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>As of the date of this annual report, we have 51,293,547 outstanding Class A common shares (55,148,697 total Class A common shares,
of which 3,855,150, as of December 31, 2025, are common shares held in treasury) and 38,574,134 Class B common shares of our authorized
share capital issued and outstanding.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Percentage of total voting power represents voting power with respect to all of our Class A common shares and Class B common shares,
as a single class. Holders of our Class B common shares are entitled to 10 votes per share, whereas holders of our Class A common shares
are entitled to one vote per share. For more information about the voting rights of our Class A common shares and Class B common shares,
see &#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles of Association&#8212;Description of Share Capital.&#8221;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(3)</td><td>Based on a statement by Bertelsmann SE &amp; Co. KGaA and Erste WV G&#252;tersloh GmbH on Schedule 13D/A filed on March 4, 2025. Such
person&#8217;s business address is at Carl-Bertelsmann-Strasse 270, 33311 G&#252;tersloh, Germany.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(4)</td><td>Based on a statement by Nicolau Carvalho Esteves on Form 3 filed on March 18, 2026, as amended by Form 3/A filed on March 23, 2026.
Nicolau Carvalho Esteves is a member of our board of directors. Includes 5,321,379 Class A common shares and 4,500,000 Class B common
shares held of record by NRE Capital Ventures Limited, a company controlled by Nicolau Carvalho Esteves and his wife, Ros&#226;ngela
de Oliveira Tavares Esteves, who hold 100% of the shares in joint tenancy, and 13,916 Class A common shares held of record by Nicolau
Carvalho Esteves.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(5)</td><td>Based on a statement by Nicolau Carvalho Esteves on Form 3 filed on March 18, 2026, as amended by Form 3/A filed on March 23, 2026.
Nicolau Carvalho Esteves is a member of our board of directors. Includes 5,321,379 Class A common shares and 4,500,000 Class B common
shares held of record by N<span id="a_Hlk163118341"></span>RE Capital Ventures Limited, a company controlled by Nicolau Carvalho Esteves and
his wife, Ros&#226;ngela de Oliveira Tavares Esteves, who hold 100% of the shares in joint tenancy.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(6)</td><td>Based on a statement by Renato Tavares Esteves on Form 3 filed on March 18, 2026. Renato Tavares Esteves is a member of our board
of directors. Consists of 1,263,613 Class A common shares held of record by RTE B Ventures Ltd., which is solely owned and controlled
by Renato Tavares Esteves.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(7)</td><td>Based on a statement by Vanessa Tavares Esteves, VTE Capital Ventures Ltd. and VTE B Ventures Ltd. on Schedule 13G/A filed on November
14, 2024. Consists of 1,435,440 Class A common shares held of record by VTE B Ventures Ltd., which is wholly-owned by VTE Capital Ventures
Ltd which is, in turn, wholly-owned by Vanessa Tavares Esteves.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(8)</td><td>Based on a statement by Lilian Tavares Esteves de Carvalho, LTE Capital Ventures Ltd. and LTE B Ventures Ltd. on Schedule 13G/A filed
on November 14, 2024. Consists of 1,848 Class A common shares held of record by L&#237;lian Tavares Esteves de Carvalho and 1,530,061 Class A
common shares held of record by LTE B Ventures Ltd., which is wholly-owned by LTE Capital Ventures Ltd.</td></tr></table>


<!-- Field: Page; Sequence: 128 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(9)</td><td>Based on a statement on Schedule 13-F filed on February 17, 2026, by FMR LLC. Such person&#8217;s business address is 245 Summer Street,
Boston, MA 02210.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(10)</td><td>Disclosure regarding the equity interest held by Messrs. Nicolau Carvalho Esteves and Renato Tavares Esteves, both members of our
board of directors, in us, is above.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(11)</td><td>Mr. Kay Krafft, a member of our board of directors, is the founding CEO of Bertelsmann Education Group. Mr. Krafft disclaims beneficial
ownership of the shares held by Bertelsmann except to the extent, if any, of his pecuniary interest therein.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(12)</td><td>Mr. Benedikt Dalkmann, a member of our board of directors, is the Chief Financial Officer at Bertelsmann Education Group. Mr. Dalkmann
disclaims beneficial ownership of the shares held by Bertelsmann except to the extent, if any, of his pecuniary interest therein.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in">(13) Ms. Christina Krebs, a member of our board
of directors, is the Chief People Officer at Bertelsmann Investments. Ms. Krebs disclaims beneficial ownership of the shares held by Bertelsmann
except to the extent, if any, of her pecuniary interest therein.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(14)</td><td>Based on a statement by L&#233;lio de Souza Junior on Form 3 filed on March 18, 2026. Includes 43,032 Class A common shares held
of record by L&#233;lio de Souza Junior, 16,200 RSUs vesting within 60 days from the date of this annual report and 152,000 stock options
exercisable within 60 days from the date of this annual report.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(15)</td><td>Based on a statement by Luis Andr&#233; Carpintero Blanco on Form 3 filed on March 18, 2026. Includes 61,103 Class A common shares
held of record by Luis Andr&#233; Carpintero Blanco, 23,500 RSUs vesting within 60 days from the date of this annual report and 37,500
stock options exercisable within 60 days from the date of this annual report.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(16)</td><td>Based on a statements by Virgilio Deloy Capobianco Gibbon on Form 3 filed on March 18, 2026 and on Form 4 filed on March 31, 2026. Includes 151,938 Class A common
                                                             shares held of record by Virgilio Deloy Capobianco Gibbon and 200,000 Class A common shares held of record by Gibboat Overseas Ltd,
                                                             which is solely owned and controlled by Virgilio Deloy Capobianco Gibbon, as well as 59,000 RSUs vesting within 60 days from the
                                                             date of this annual report and 86,000 stock options exercisable within 60 days from the date of this annual report.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 12pt 0 10pt; text-indent: 0.25in">The holders of our Class A common shares and Class
B common shares have identical rights, except that the Esteves Family and Bertelsmann as holders of Class B common shares (i)&#160;are
entitled to 10 votes per share, whereas holders of our Class A common shares are entitled to one vote per share, (ii)&#160;have certain
conversion rights and (iii)&#160;are entitled to maintain a proportional ownership interest by purchasing additional Class B common shares
in the event that additional Class A common shares are issued. For more information see &#8220;Item 10. Additional Information&#8212;B.
Memorandum and Articles of Association&#8212;Description of Share Capital&#8212;Preemptive or Similar Rights&#8221; and &#8220;Item 10.
Additional Information&#8212;B. Memorandum and Articles of Association&#8212;Description of Share Capital&#8212;Conversion.&#8221; Each
Class B common share is convertible into one Class A common share.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are not aware of any other shareholder that beneficially
owns more than 5% of our common shares nor of any arrangements the operation of which may at a subsequent date result in a change of control
of the company.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Shareholders&#8217; Agreement</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On June 7, 2021, in connection with the acquisition
by Bertelsmann of all Afya shares held by Crescera as of such date pursuant to a share purchase agreement also entered into on such date,
certain members of the Esteves family and Bertelsmann determined to enter into an amended and restated shareholders&#8217; agreement,
or the A&amp;R Shareholders&#8217; Agreement.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The A&amp;R Shareholders&#8217; Agreement provides
that the parties shall cooperate to ensure that Afya enters into a customary registration rights agreement with the parties. Further,
(i) while Bertelsmann holds an interest in Afya, or (ii) for a period of five years from the moment the Original Shareholder ceases to
hold an interest in the Company (whichever occurs earlier), certain members of the Esteves family are bound by a non-compete obligation
preventing them from directly or indirectly carrying on a competing business that is in direct competition with us, subject to certain
limited exceptions.</p>


<!-- Field: Page; Sequence: 129 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609500"></span><span id="a_Toc225309252"></span><span id="a_Toc196072493"></span><span id="a_Toc164277193"></span><span id="a_Toc194891129"></span><span id="a_Toc190934967"></span><span id="a_Toc133237666"></span><span id="a_Toc163120260"></span><span id="a_Toc131580988"></span>
B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Related Party Transactions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition to the compensation arrangements with directors
and executive officers described under &#8220;Item 6. Directors, Senior Management and Employees&#8212;B. Compensation&#8221; and certain
other rights of certain of the holders of our common shares as described under &#8220;&#8212;A. Major Shareholders&#8212;Shareholders&#8217;
Agreement,&#8221; the following is a description of material transactions since January 1, 2025 and each currently proposed transaction
in which the amount involved in the transactions is material to us and any related party.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Lease Agreements</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Lease Agreements with RVL Esteves Gest&#227;o Imobili&#225;ria
S.A.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya Brazil and its subsidiaries have entered into
lease agreements with RVL Esteves Gest&#227;o Imobili&#225;ria S.A. (&#8220;RVL&#8221;), an entity controlled by the shareholder Nicolau
Carvalho Esteves and of which Mr. Renato Tavares Esteves is an executive officer. The main lease agreements with RVL are described below:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On June 21, 2016, RVL entered into lease agreements,
as amended on April 26, 2018, with ITPAC Aragua&#237;na and ITPAC Porto, pursuant to which RVL agreed to lease campuses to those entities
in the cities of Aragua&#237;na and Porto Nacional, both located in the State of Tocantins. The lease agreements are adjustable in accordance
with the provisions of each lease agreement. The lease agreements are for an initial term of 20 years and are renewable for an additional
20 years subject to the provisions of each lease agreement. The balance of lease liabilities as of December 31, 2025 was R$84.0 million
(December 31, 2024: R$84.1 million) and the amount paid during the year ended December 31, 2025 was R$13.9 million (2024 and 2023: R$13.5
million and R$13.3 million, respectively).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On September 6, 2018, RVL entered into a lease agreement
with ITPAC Aragua&#237;na, pursuant to which RVL agreed to lease to ITPAC Aragua&#237;na the new campus built by RVL in the city of
Palmas, State of Tocantins. The lease agreement is for an amount equal to 7.5% of the monthly revenue of ITPAC until July 2024. From August
2024, the monthly amount should be equal to the amount paid in the first semester of 2024 and thereafter adjusted annually by the inflation
rate (IGP M). The lease agreement is for an initial term of 20 years and is renewable for an additional 20 years. The balance of lease
liabilities as of December 31, 2025 was R$65.3 million (December 31, 2024: R$64.0 million) and the amount paid during the year ended December
31, 2025 was R$8.9 million (2024 and 2023: R$8.6 million and R$7.6 million, respectively).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On October 30, 2019, RVL entered into a lease agreement
with IPTAN, pursuant to which RVL agreed to lease to IPTAN the medical campus in the city of Santa In&#234;s, State of Maranh&#227;o.
The lease agreement, as amended on February 27, 2025, is for a monthly amount adjusted in accordance with the provisions of the lease
agreement of: (i) R$12.0 thousand until December 2020; (ii) from January 2021 to December 2025, 6.5% of the monthly revenue of IPTAN during
the prior semester; (iii) from January 2026, the monthly amount should be equal to the amount paid in the second semester of 2025; and
(iv) from January 2027 thereon, the monthly amount should be adjusted annually by the inflation rate (IPCA). The lease agreement is for
a term of 20 years and is renewable for an additional 20 years. The balance of lease liabilities as of December 31, 2025 was R$16.0 million
(December 31, 2024: R$9.7 million) and the amount paid during the year ended December 31, 2025 was R$2.1 million (2024 and 2023: R$1.3
million and R$1.1 million, respectively).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On August 2, 2021, RVL entered into a lease agreement
with ITPAC Aragua&#237;na, pursuant to which RVL agreed to lease to ITPAC the new ITPAC Garanhuns medical campus, in the city of Garanhuns,
State of Pernambuco. The lease agreement is for a monthly amount equal to: (i) up to June 2022, R$40.0 thousand; (ii) from July 2022 until
December 2028, 6.5% of the monthly revenue of ITPAC Garanhuns during the prior semester, adjusted in accordance with the provisions of
the lease agreement; and (iii) from January 2029 on, the monthly amount should be adjusted annually by the inflation rate (IPCA). The
lease agreement is for a term of 20 years. The balance of lease liabilities as of December 31, 2025 was R$26.3 million (December 31, 2024:
R$17.6 million) and the amount paid during the year ended December 31, 2025 was R$3.7 million (2024 and 2023: R$2.2 million and R$1.2
million, respectively).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On May 2, 2024, RVL entered into a rent agreement with
IPTAN, pursuant to which RVL agreed to rent to IPTAN a property for the campus in the city of S&#227;o Jo&#227;o del Rei, State of
Minas Gerais. The rent agreement is for a monthly amount payable equal to R$4.0 thousand, adjusted annually by the inflation rate (IGP
M). The rent agreement is for a term of one year and is renewable for an additional term of three years.</p>


<!-- Field: Page; Sequence: 130 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On June 14, 2024, RVL entered into a lease agreement
with DelRey, pursuant to which RVL agreed to lease to DelRey a property for the campus in the city of Jaboat&#227;o dos Guararapes,
State of Pernambuco. The lease agreement is for a monthly amount payable equal to R$0.1 million, with a grace period of 12 months, extended
by an additional six months. The monthly amount payable should be adjusted annually by the inflation rate (IPCA). The lease agreement
is for a term of 20 years. The balance of lease liabilities as of December 31, 2025 was R$10.9 million (December 31, 2024: R$9.4 million)
and, due to the grace period, no payments were made during the years ended December 31, 2025 and 2024.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Lease Agreement with UNIVA&#199;O Patrimonial Ltda.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On July 14, 2016, UNIVA&#199;O Patrimonial Ltda.,
an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Ms. Ros&#226;ngela de Oliveira Tavares Esteves is the chief
executive officer, entered into a lease agreement with UNIVA&#199;O, a subsidiary of Afya Brazil, pursuant to which UNIVA&#199;O Patrimonial
Ltda. agreed to lease UNIVA&#199;O&#8217;s campus to UNIVA&#199;O, located in the city of Ipatinga, State of Minas Gerais. The lease
agreement is adjustable in accordance with the provisions of the lease agreement. The lease agreement is for an initial term of 20 years
and is renewable for an additional 20 years subject to the provisions of the lease agreement. The balance of lease liabilities as of December
31, 2025 was R$22.8 million (December 31, 2024: R$22.8 million) and the amount paid during the year ended December 31, 2025 was R$3.8
million (2024 and 2023: R$3.6 million and R$3.6 million, respectively).</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Lease Agreement with IESVAP Patrimonial Ltda.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On April 25, 2018, IESVAP Patrimonial Ltda., an entity
controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato Tavares Esteves is an executive officer, entered into a
lease agreement with IESVAP, a subsidiary of Afya Brazil, pursuant to which IESVAP Patrimonial Ltda. agreed to lease IESVAP&#8217;s campus
to IESVAP located in the city of Parna&#237;ba, State of Piau&#237;. The lease agreement is for an amount equal to 7.5% of the monthly
revenue of IESVAP until June 2021. From July 2021, the monthly amount should be equal to the amount paid in the first semester of 2021
and thereafter adjusted annually by the inflation rate (IGP-M). The lease agreement is for an initial term of 20 years and is renewable
for an additional 20 years subject to the provisions of the lease agreement. The balance of lease liabilities as of December 31, 2025
was R$35.5 million (December 31, 2024: R$35.1 million) and the amount paid during the year ended December 31, 2025 was R$5.4 million (2024
and 2023: R$5.2 million and R$5.2 million, respectively).</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Security-Related Arrangements</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya Brazil has incurred expenses with EMIVE Patrulha
24 Horas Ltda., a company in which one of our principal shareholders has significant influence, in connection with security-related services
and/or products provided to certain of our facilities. The amounts expensed in connection with these arrangements totaled R$7 thousand,
R$7 thousand, and R$6 thousand in 2025, 2024, and 2023, respectively. The agreement governing these arrangements sets forth the terms
and conditions, including specifications, service locations, and payment terms.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Sales of Educational Content</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya Brazil has generated revenue from the sale of
educational content to UEPC, a company in which Afya Brazil has a minority interest of 30%. These transactions relate to the provision
of specialized academic materials and digital content used in their educational programs. The revenue recognized in connection with these
arrangements totaled R$0.5 million each year in 2025, 2024 and 2023. The agreements governing these sales establish the specific delivery
terms, intellectual property rights, and payment conditions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For more information, see note 7 to our consolidated
financial statements.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Related Person Transaction Policy</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On January 29, 2021, our board of directors approved
the related party transactions and conflicts of interest policy that set forth our guidelines and procedures regarding agreements with
related parties. On December 19, 2022, our board of directors approved an amendment to our policy in order to reflect certain revised
approval thresholds.</p>


<!-- Field: Page; Sequence: 131 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our related person transaction policy states that related
person transactions must be approved or ratified by our executive officers and board of directors. In determining whether to approve or
ratify a transaction with a related person, our executive officers or board of directors will consider all relevant facts and circumstances,
including without limitation the commercial reasonableness of the terms, of the transaction the benefit and perceived benefit, or lack
thereof, to us, opportunity costs of alternate transaction, the materiality and character of the related person&#8217;s direct or indirect
interest and the actual or apparent conflict of interest of the related person.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to the related transaction policy, our executive
officers or board of directors will not approve or ratify a related person transaction unless it has determined that, upon consideration
of all relevant information, such transaction is in, or not inconsistent with, our best interests and the best interests of our shareholders.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Indemnification Agreements</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have executed indemnification agreements with our
directors and executive officers. The indemnification agreements and our Articles of Association require us to indemnify our directors
and executive officers to the fullest extent permitted by law.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Employment Agreements</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Virgilio Deloy Capobianco Gibbon, L&#233;lio de Souza
Junior and Luis Andr&#233; Carpintero Blanco entered into employment agreements with the Company. The independent directors have also
entered into service agreements with the Company.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For a description of the compensation paid to our directors
and executive officers, see &#8220;Item 6. Directors, Senior Management and Employees&#8212;B. Compensation.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Long-Term Incentive Plans</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">See &#8220;Item 6. Directors, Senior Management and
Employees&#8212;B. Compensation&#8212;Long-Term Incentive Plans.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609501"></span><span id="a_Toc225309253"></span><span id="a_Toc196072494"></span><span id="a_Toc164277194"></span><span id="a_Toc194891130"></span><span id="a_Toc190934968"></span><span id="a_Toc133237667"></span><span id="a_Toc163120261"></span><span id="a_Toc131580989"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interests
of Experts and Counsel</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609502"></span><span id="a_Toc225309254"></span><span id="a_Toc196072495"></span><span id="a_Toc164277195"></span><span id="a_Toc194891131"></span><span id="a_Toc190934969"></span><span id="a_Toc133237668"></span><span id="a_Toc163120262"></span><span id="a_Toc131580990"></span>ITEM
8. FINANCIAL INFORMATION</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609503"></span><span id="a_Toc225309255"></span><span id="a_Toc196072496"></span><span id="a_Toc164277196"></span><span id="a_Toc194891132"></span><span id="a_Toc190934970"></span><span id="a_Toc133237669"></span><span id="a_Toc163120263"></span><span id="a_Toc131580991"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Consolidated
Statements and Other Financial Information</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">See Exhibits.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: justify"><span id="a_Hlk163047499"></span>Legal and Administrative
Proceedings</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">From time to time, we are involved in disputes that
arise in the ordinary course of our business. Any claims against us, whether meritorious or not, can be time consuming, result in costly
litigation, require significant management time and result in the diversion of significant operational resources.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We and our subsidiaries are subject to a number of
judicial and administrative proceedings in the Brazilian court systems, including civil, labor and tax law and social security claims
and other proceedings, which we believe are common and incidental to business operations in Brazil, in general. We recognize provisions
for legal proceedings in our consolidated financial statements, when we are advised by independent outside counsel that (i)&#160;it is
probable that an outflow of resources will be required to settle the obligation, and (ii)&#160;a reliable estimate can be made of the
amount of the obligation. The assessment of the likelihood of loss includes analysis by outside counsel of available evidence, the hierarchy
of laws, available case law, recent court rulings and their relevance in the legal system. Our provisions for probable losses arising
from these matters are estimated and periodically adjusted by management. In making these adjustments our management relies on the opinions
of our external legal advisors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, we had provisions
recorded in our consolidated financial statements in connection with legal proceedings for which we believe a loss is probable, in
an aggregate amount of R$ 128.2 million, and had made judicial deposits in an aggregate amount of R$19.3 million. However, legal
proceedings are inherently unpredictable and subject to significant uncertainties. If one or more cases were to result in a judgment against us in any reporting
period for amounts that exceeded our management's expectations, the impact on our operating results or financial condition for that reporting
period could be material.</p>


<!-- Field: Page; Sequence: 132 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, under the terms of the share purchase
and sale agreements between us and the selling shareholders of certain subsidiaries acquired by us, such selling shareholders are exclusively
responsible for any liabilities (including labor, tax and civil liabilities), which are or will be the subject of a claim by any third
party, arising from an act or fact that occurred, whether by action or inaction, prior to or on the closing dates of the respective acquisitions,
and such selling shareholders have agreed to indemnify us and our subsidiaries in the event of any losses relating to any such contingent
liabilities. Accordingly, the provisions in respect to such contingent liabilities are recorded as non-current liabilities, with a corresponding
amount recorded as non-current other assets; as of December 31, 2025, we have recorded R$80.4 million as other non-current assets with
respect to provisioned amounts relating to such contingent liabilities.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: justify">Civil Matters</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk132299632"></span>As of December 31, 2025,
we and our subsidiaries were party to approximately 10,672 civil proceedings, including 5,021 collection proceedings in which we are plaintiffs
and 5,651 other judicial proceedings. In addition, we were subject to 448 administrative proceedings. The civil claims to which we are
a party generally relate to consumer claims, including those related to student complaints. We believe these proceedings are unlikely
to have a material adverse impact, individually, or in the aggregate, on our results of operations or financial condition.</p>

<p style="font: 10pt/107% Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On October 9, 2012, a civil suit was filed by
Marly Luzia Bernardes Rocha against ITPAC Porto and others, alleging (i)&#160;that Municipal Law No. 1780/03 in connection with the creation
of the <i>Instituto de Ensino Superior de Porto Nacional </i>(IESPEN) is unconstitutional, and therefore that IESPEN&#8217;s dissolution
and assignment of all its contingencies to ITPAC Porto should be voided; (ii)&#160;that ITPAC Porto acted in bad faith and failed in its
duties to pay for corresponding material damages, loss of profits, loss of opportunity and moral damages; (iii)&#160;that Maria Aurora
Pinto Leite e Silva and Celso Eduardo Avelar Freire, shareholders of IESPEN, did not pay up corporate capital; and (iv)&#160;that ITPAC
Porto should compensate the plaintiffs for alleged illicit enrichment in connection with the dissolution. On January 12, 2014, ITPAC Porto
filed its defense. On November 13, 2016, the lower court froze 8% of ITPAC Porto&#8217;s monthly revenues in favor of the plaintiffs,
and the freeze order was overturned on January 12, 2017. On October 20, 2025, the lower court rendered a decision partially granting the
plaintiff&#8217;s claims. The court declared the nullity of certain shareholders&#8217; meeting resolutions and converted the plaintiff&#8217;s
alleged rights into losses and damages, condemning ITPAC Porto, jointly with other defendants, to pay material damages, loss of profits
and loss of opportunity, to be determined in liquidation of judgment, as well as moral damages in the amount of R$30,000.00, subject to
monetary adjustment and interest. Motions for clarification have been filed, and the decision has not yet become final. As of the date
of this annual report, we intend to file an appeal. We estimate the amount of any claim for damages that may be imposed on us as a result
of these proceedings to be approximately R$27.9 million, with the likelihood of loss is possible.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In 2008, two public civil proceedings were filed by
the Brazilian federal government and the federal public prosecutor for the suspension of the activities of the Garanhuns Greenfield unit,
claiming that the status of the Garanhuns Greenfield unit with MEC was irregular. The suspension was judicially granted. Despite the suspension,
Afya Brazil initiated an administrative proceeding requesting that MEC reconsider its previous decision, which had denied a request to
transfer the administrative proceeding related to the authorization of the medical program&#8212;originally submitted in 2011&#8212;from
the state education system to the federal education system, in accordance with applicable regulations. On September 2, 2020, MEC published
Ordinance No. 722/2020 recognizing the right of ITPAC and determining the review of the regularization request formulated in 2011 by the
institution. On November 5, 2021, the instruction authorizing the start of educational activities was published. As of the date of this
annual report, the first public civil proceeding has reached a final decision and is pending enforcement by the Federal Public Prosecutor&#8217;s
Office and the other remains pending, awaiting a decision on appeal.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On November 30, 2019, a public proceeding was filed
by Domingos Borges da Silva against Centro de Ensino S&#227;o Lucas, other educational institutions and the city hall of Porto Velho,
alleging (i) that the defendants were purportedly not granting all the full scholarships to undergraduate students from &#8220;<i>Programa
de Inclus&#227;o Social Universidade Para Todos &#8212; Faculdade da Prefeitura</i>,&#8221; provided by Municipal Law No. 1,887/10 and
modified by Municipal Law No. 2,284/16; (ii) that due to the lack of full scholarships, the Treasury was being jeopardized because the agreement was for tax waive in exchange to the full scholarships
for the beneficiary from the referred Program; (iii) therefore, the plaintiff requires to be awarded a preliminary injunction to revoke
Municipal Laws Nos. 1,887/10 and 2,284/16 and the suspension of the adhesion contracts to the Program signed by the defendants; and (iv)
that the defendants should be liable for alleged material damages and loss of profits. On January 13, 2020, the lower court denied the
preliminary injunction. On March 3, 2020, UniSL was served. On August 22, 2025, the court rendered a final decision dismissing the claims.
The decision denying the mandatory appellate review was published on December 5, 2025. As of the date of this annual report, this proceeding
is complete and is awaiting final certification. Based on this decision, the likelihood of loss is considered remote, and no material
adverse impact is expected.</p>


<!-- Field: Page; Sequence: 133 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The provisions related to civil proceedings whose likelihood
of loss is assessed as probable are R$28.0 million as of December 31, 2025. There are other civil proceedings assessed by management and
our legal counsels as having a possible risk of loss, for which no provisions are recognized, in the amount of R$59.1 million as of December
31, 2025.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt; text-align: justify"><span id="a_Hlk131695413"></span>Labor
Matters</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, we and our subsidiaries were
party to approximately 397 labor proceedings, 320 of which are judicial proceedings and 77 of which are administrative proceedings. The
principal labor proceedings to which we are a party were filed by former employees or service providers seeking enforcement of labor rights
allegedly not provided by us. The judicial proceedings relate to employment bonds (judicial proceedings filed by former service providers),
overtime, premiums for hazardous workplace conditions, statutory severance, fines for severance payment delays, and compensation for workplace-related
accidents. The administrative proceedings relate to the alleged failure by us to comply with certain labor laws, including with respect
to working hours, the registration of employment agreements, disabled workers&#8217; hiring quotas and the protection of underage workers
and apprentices.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The provisions related to labor proceedings whose likelihood
of loss is assessed as probable are R$43.7 million as of December 31, 2025. There are other labor proceedings assessed by management and
our legal counsels as having a possible risk of loss, for which no provisions are recognized, in the amount of R$36.8 million as of December
31, 2025.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt; text-align: justify"><span id="a_Hlk131695485"></span><span id="a_Hlk164267619"></span>Tax
and Social Security Matters</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, certain of our subsidiaries
were party to 149 tax and social security proceedings, 84 of which are judicial proceedings and 65 of which are administrative proceedings,
for which we did not record any provisions based on the advice of our external legal counsel that the likelihood of loss is possible.
The tax claims to which these subsidiaries are party are mostly tax foreclosures filed by Brazilian federal and municipal tax authorities.</p>

<p style="font: 10pt/107% Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">ITPAC Porto is party to a tax enforcement proceeding
filed by the Brazilian federal government on July 12, 2010, seeking the collection of social security contributions on payroll, in the
total historical amount of R$ 1.5 million. In 2016, the enforcement proceeding was redirected to ITPAC Porto based on allegations of corporate
succession, which are contested by us. The debt is fully secured by a bank guarantee letter accepted by the federal government. We filed
objections to the tax enforcement, which were dismissed at the first instance, and an appeal is currently pending before the Brazilian
Federal Regional Court of the 1st Region. Based on the assessment of our external legal counsel, the likelihood of loss is possible, and
therefore no provision has been recorded. As of the date of this annual report, the amount involved in this proceeding is approximately
R$ 3.6 million.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk163499425"></span>UniSL is party to an administrative
tax proceeding initiated by the Municipality of Porto Velho in July 2017, arising from a tax assessment alleging insufficient payment
of ISS (service tax) on tuition fees and other revenues, in the total historical amount of R$ 6.0 million. In March 2023, a first-instance
administrative decision rejected the defense presented by us and reduced the applicable penalty from 150% to 80%, following the enactment
of more favorable legislation. We filed an administrative appeal, which is currently under review by the Municipal Tax Appeals Council
of Porto Velho. The reporting judge has issued a vote to uphold the challenged decision, and the proceeding is currently suspended due
to a request for review by another council member. Based on the assessment of our external legal counsel, the likelihood of loss is possible.
As of the date of this annual report, the amount involved in this proceeding is approximately R$ 8.2 million.</p>


<!-- Field: Page; Sequence: 134 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In 2021, Unigranrio filed a lawsuit seeking the annulment
of three tax assessments related to the imposition of ISS (a municipal tax on services), based on the alleged applicability of tax immunity.
On August 10, 2023, Unigranrio joined a tax amnesty program established by the Municipality of Rio de Janeiro, which aimed to address
interest and penalties related to a tax proceeding concerning ISS (city tax on services) with the municipality of Rio de Janeiro. As a
result, Unigranrio made a payment of R$14.9 million to settle the claim. Following this payment, the merits of the case were deemed resolved.
However, the dispute regarding the attorneys&#8217; fees awarded to the Municipal Attorney&#8217;s Office remains pending, as it is still
under evaluation whether such amounts were encompassed within the settlement made under the amnesty program. Based on the assessment of
our external legal counsel, the likelihood of loss related exclusively to this residual matter is possible. As of the date of this annual
report, the amount still under dispute is approximately R$ 2.5 million.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">FCMPB is a party to an administrative tax proceeding
initiated in September 2024, related to the assessment of potential ISS liability on revenues derived from student tuition, involving
an estimated historical amount of R$ 10.8 million. We filed an administrative challenge, and the proceeding remains pending judgment.
Based on the assessment of our external legal counsel, the likelihood of loss is possible. As of the date of this annual report, the amount
involved in this proceeding is approximately R$12.2 million.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.25in">The provisions related to tax
proceedings whose likelihood of loss is assessed as probable are R$56.4 million as of December 31, 2025. There are other tax proceedings
assessed by management and our legal counsels as having a possible risk of loss, for which no provisions are recognized, in the amount
of R$30.5 million as of December 31, 2025.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk161993642"></span>Mais M&#233;dicos Proceedings</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On January 31, 2019, Brasil Educa&#231;&#227;o
S.A., or BR Educa&#231;&#227;o, filed legal proceedings against SERES before the 2nd Federal Court of the Federal District seeking
judicial review of SERES&#8217;s decision to disqualify the BR Educa&#231;&#227;o&#8217;s bid to open a medical school in the city
of Abaetetuba, in the State of Par&#225;, as part of the public call for the Mais M&#233;dicos II program, and to authorize ITPAC
Porto to operate the new undergraduate medical program. ITPAC Porto joined these proceedings as a co-defendant. The lower court granted
a preventive injunction in favor of BR Educa&#231;&#227;o, suspending SERES&#8217;s award of the medical school to ITPAC Porto. This
injunction was subsequently repealed by the Federal Court of Appeals upon preliminary review. The Federal Court of Appeals granted ITPAC
Porto&#8217;s request for a stay, thereby suspending the effects of the lower court&#8217;s preliminary injunction. BR Educa&#231;&#227;o
subsequently filed an interlocutory appeal against this decision. As of the date of this annual report, there was no final ruling on the
interlocutory appeal that suspended the effects of the lower court&#8217;s preliminary injunction, nor on the merits of the lawsuit by
the lower court, and the likelihood of loss in this proceeding is considered to be possible.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Dividends and Dividend Policy</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Prior to 2025, we had never declared or paid any dividend
on our common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On March 12, 2025, our board of directors approved
our first ever distribution of dividend. This dividend of R$129.8 million, equivalent to R$1.348923 per share was paid on April 4, 2025
to all shareholders of record as of the close of business on March 26, 2025. The payment was made in U.S. dollars at the exchange rate
(PTAX) published on March 13, 2025 by the Brazilian Central Bank, which was R$/USD5.8131.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On March 12, 2026, our board of directors approved
a dividend distribution in the amount of R$307.4 million, representing 40% of our consolidated net income for the year ended December
31, 2025 and a dividend per share of R$3.446838, payable in U.S. dollars on April 6, 2026, to&#160;the shareholders on record as of the
close of business on March 25, 2026. The payment will be made at the exchange rate (PTAX) published by the Brazilian Central Bank on March
13, 2026, which was R$/USD5.2541.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The payment of future dividends is subject to future
declaration by our board of directors, which will be based in part on continued capital availability, market conditions, applicable laws
and agreements, and our board of directors continuing to determine that the declaration of dividends is in the best interests of our shareholders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We may also make any future determination to pay dividends
based on an ordinary shareholder resolution, but no dividend may exceed the amount recommended by our board of directors. Even if our
board of directors recommends a dividend payment, the form, frequency and amount will depend on a number of factors, including our future
operations and earnings, our capital requirements and surplus, our general financial condition, impositions of restrictions on conversions and remittances of funds abroad in the jurisdictions
where we operate, contractual restrictions and other factors that the board of directors may deem relevant. Dividends on our common shares,
if any, will be paid in U.S. dollars.</p>


<!-- Field: Page; Sequence: 135 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are a holding company incorporated in the Cayman
Islands. We rely on dividends and distributions from our subsidiaries in Brazil for our cash requirements, including funds to pay our
operating expenses, service any debt we may incur and pay dividends and other cash distributions to our shareholders. Also, payments of
dividends from Afya Brazil to Afya Limited may be made according to cash requirements. Our holding company structure makes us dependent
on the operations of our subsidiaries and therefore, any determination to pay dividends in the future will depend on our ability to receive
distributions from them. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Our
holding company structure makes us dependent on the operations of our subsidiaries. We depend on dividend distributions by our subsidiaries,
and we may be adversely affected if the performance of our subsidiaries is not positive.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Certain Cayman Islands Legal Requirements Related to Dividends</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Companies Act and our Articles of Association,
a Cayman Islands company may pay a dividend out of either its profit or share premium account, but a dividend may not be paid if this
would result in the company being unable to pay its debts as they fall due in the ordinary course of business. According to our Articles
of Association, dividends can be declared and paid out of funds lawfully available to us, which include the share premium account. Dividends,
if any, would be paid in proportion to the number of common shares a shareholder holds. For further information, see &#8220;Item 10. Additional
Information&#8212;E. Taxation&#8212;Cayman Islands Tax Considerations.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Certain Brazilian Legal Requirements Related to Dividends</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our ability to pay dividends is directly related to
positive and distributable net results from our Brazilian subsidiaries. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain
Risks Relating to Our Business and Industry&#8212;Our holding company structure makes us dependent on the operations of our subsidiaries.
We depend on dividend distributions by our subsidiaries, and we may be adversely affected if the performance of our subsidiaries is not
positive.&#8221; Our Brazilian subsidiaries are required under Federal Law No. 6,404 dated December 15, 1976, as amended, to distribute
a mandatory minimum dividend to shareholders each year, which cannot be lower than 50% of their income for the prior year, unless a lower
mandatory minimum dividend is provided for in such subsidiary by-laws or such distribution is suspended by a decision of such subsidiary&#8217;s
shareholders at its annual shareholders&#8217; meeting based on a report by its board of directors that such distribution would be incompatible
with its financial condition at that time.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, if, for any legal reasons due to new laws
or bilateral agreements between countries, our Brazilian subsidiaries are unable to pay dividends to Cayman Islands companies, or if a
Cayman Islands company becomes incapable of receiving them, we may not be able to make any dividend payments in the future.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Hlk161993116"></span>As of the date of this
annual report, Afya Brazil and certain of our subsidiaries are required by their respective bylaws to distribute the following minimum
dividends to shareholders: (i)&#160;Afya Brazil, ITPAC Aragua&#237;na, ITPAC Porto, IESP, IPTAN, UEPC, FASA, UniRedentor, FESAR, IESVAP,
UNIVA&#199;O, and Unigranrio&#8212;at least 25% of adjusted net profit in each fiscal year; and (ii)&#160;CCSI&#8212;at least 2% of
net profit in each fiscal year. FADEP, IPEC, UniSL, FCMPB, Medical Harbour, IBES, SESSA, DelRey and FUNIC are limited liability companies
and their articles of association do not stipulate a mandatory minimum dividend.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609504"></span><span id="a_Toc225309256"></span><span id="a_Toc196072497"></span><span id="a_Toc194891133"></span><span id="a_Toc164277197"></span><span id="a_Toc190934971"></span><span id="a_Toc133237670"></span><span id="a_Toc163120264"></span><span id="a_Toc131580992"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Significant
Changes</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Except as disclosed elsewhere in this annual report,
we have not experienced any significant changes since the date of our consolidated financial statements included in this annual report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609505"></span><span id="a_Toc225309257"></span><span id="a_Toc196072498"></span><span id="a_Toc164277198"></span><span id="a_Toc194891134"></span><span id="a_Toc190934972"></span><span id="a_Toc133237671"></span><span id="a_Toc163120265"></span><span id="a_Toc131580993"></span>ITEM
9. THE OFFER AND LISTING</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609506"></span><span id="a_Toc225309258"></span><span id="a_Toc196072499"></span><span id="a_Toc164277199"></span><span id="a_Toc194891135"></span><span id="a_Toc190934973"></span><span id="a_Toc133237672"></span><span id="a_Toc163120266"></span><span id="a_Toc131580994"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Offer
and Listing Details</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On July 19, 2019, we completed our initial public offering.
On February 7, 2020, we completed a follow-on offering. Our common shares have been listed on the Nasdaq since July 19, 2019 under the
symbol &#8220;AFYA.&#8221; Prior to that date, there was no public trading market for our common shares.
In Brazil, Brazilian Depositary Receipts, or BDRs, representing our common shares are traded on the B3 S.A. &#8211; Brasil, Bolsa, Balc&#227;o
under the symbol &#8220;A2FY34.&#8221;</p>


<!-- Field: Page; Sequence: 136 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609507"></span><span id="a_Toc225309259"></span><span id="a_Toc196072500"></span><span id="a_Toc164277200"></span><span id="a_Toc194891136"></span><span id="a_Toc190934974"></span><span id="a_Toc133237673"></span><span id="a_Toc163120267"></span><span id="a_Toc131580995"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plan
of Distribution</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609508"></span><span id="a_Toc225309260"></span><span id="a_Toc196072501"></span><span id="a_Toc164277201"></span><span id="a_Toc194891137"></span><span id="a_Toc190934975"></span><span id="a_Toc133237674"></span><span id="a_Toc163120268"></span><span id="a_Toc131580996"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Markets</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">See &#8220;&#8212;A. Offer and Listing Details&#8221;
above.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609509"></span><span id="a_Toc225309261"></span><span id="a_Toc196072502"></span><span id="a_Toc164277202"></span><span id="a_Toc194891138"></span><span id="a_Toc190934976"></span><span id="a_Toc133237675"></span><span id="a_Toc163120269"></span><span id="a_Toc131580997"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Selling
Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609510"></span><span id="a_Toc225309262"></span><span id="a_Toc196072503"></span><span id="a_Toc164277203"></span><span id="a_Toc194891139"></span><span id="a_Toc190934977"></span><span id="a_Toc133237676"></span><span id="a_Toc163120270"></span><span id="a_Toc131580998"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dilution</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609511"></span><span id="a_Toc225309263"></span><span id="a_Toc196072504"></span><span id="a_Toc164277204"></span><span id="a_Toc194891140"></span><span id="a_Toc190934978"></span><span id="a_Toc133237677"></span><span id="a_Toc163120271"></span><span id="a_Toc131580999"></span>F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Expenses
of the Issue</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609512"></span><span id="a_Toc225309264"></span><span id="a_Toc196072505"></span><span id="a_Toc164277205"></span><span id="a_Toc194891141"></span><span id="a_Toc190934979"></span><span id="a_Toc133237678"></span><span id="a_Toc163120272"></span><span id="a_Toc131581000"></span>ITEM
10. ADDITIONAL INFORMATION</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609513"></span><span id="a_Toc225309265"></span><span id="a_Toc196072506"></span><span id="a_Toc164277206"></span><span id="a_Toc194891142"></span><span id="a_Toc190934980"></span><span id="a_Toc133237679"></span><span id="a_Toc163120273"></span><span id="a_Toc131581001"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share
Capital</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609514"></span><span id="a_Toc225309266"></span><span id="a_Toc196072507"></span><span id="a_Toc164277207"></span><span id="a_Toc194891143"></span><span id="a_Toc190934981"></span><span id="a_Toc163120274"></span><span id="a_Toc133237680"></span><span id="a_Toc131581002"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Memorandum
and Articles of Association</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Description of Share Capital</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We were incorporated on March 22, 2019, as a Cayman
Islands exempted company with limited liability duly registered with the Cayman Islands Registrar of Companies. Our corporate purposes
are unrestricted, and we have the authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies
Act.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our affairs are governed principally by (i)&#160;our
Amended and Restated Memorandum and Articles of Association; (ii)&#160;the Companies Act; and (iii)&#160;the common law of the Cayman
Islands. As provided in our Amended and Restated Memorandum and Articles of Association, subject to Cayman Islands law, we have full capacity
to carry on or undertake any business or activity, do any act or enter into any transaction, and, for such purposes, full rights, powers
and privileges. Our registered office is c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman
Islands.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association authorize the issuance
of share capital of up to 1,000,000,000 shares of a nominal or par value of US$0.00005 each, which, at the date of this annual report,
comprise 500,000,000 Class A common shares, 250,000,000 Class B common shares (which may be converted into Class A common shares in the
manner contemplated in our Articles of Association), and 250,000,000 shares of such class or classes (howsoever designated) and having
the rights that our board of directors may determine. As of the date of this annual report, we have 55,148,697 Class A common shares (including
3,855,150 Class A common shares held in treasury) and 38,574,134 Class B common shares of our authorized share capital issued and outstanding.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a summary of the material provisions
of our authorized share capital and our Articles of Association.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Share Capital</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Amended and Restated Memorandum and Articles of
Association currently authorize two classes of common shares: Class A common shares, which are entitled to one (1) vote per share, and
Class B common shares, which are entitled to ten (10) votes per share and to maintain a proportional
ownership interest in the event that additional Class A common shares, or any other class of share designated as a common share are issued.
Any holder of Class B common shares may convert his or her shares at any time into Class A common shares on a share-for-share basis. The
rights of the two classes of common shares are otherwise identical, except as described in our Amended and Restated Memorandum and Articles
of Association. The implementation of this dual class equity structure was required by the Esteves Family and Crescera, our principal
shareholders in the year of 2019, as a condition of undertaking the initial public offering of our common shares. See &#8220;&#8212;Anti-Takeover
Provisions in Our Articles of Association&#8212;Two Classes of Common Shares.&#8221;</p>


<!-- Field: Page; Sequence: 137 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, our total authorized share
capital was US$50,000, divided into 1,000,000,000 shares par value US$0.00005 each, of which:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>500,000,000 shares are designated as Class A common shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>250,000,000 shares are designated as Class B common shares; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>250,000,000 shares of such class or classes (howsoever designated) and having the rights as the Board may determine.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, the Company&#8217;s share
capital was R$17,000 represented by 93,722,831 shares comprised by 55,148,697 Class A common shares and 38,574,134 class B common shares.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk130377670"></span>Treasury Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, Afya had 3,855,150 common
shares in treasury.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Issuance of Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Except as expressly provided in our Articles of Association,
our board of directors has general and unconditional authority to allot, grant options over, offer or otherwise deal with or dispose of
any unissued shares in the company&#8217;s capital without the approval of our shareholders (whether forming part of the original or any
increased share capital), either at a premium or at par, with or without preferred, deferred or other special rights or restrictions,
whether in regard to dividend, voting, return of capital or otherwise and to such persons, on such terms and conditions, and at such times
as the directors may decide, but so that no share shall be issued at a discount, except in accordance with the provisions of the Companies
Act. In accordance with its Articles of Association, Afya shall not issue bearer shares or warrants.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association provide that at any time
that there are Class A common shares in issue, additional Class B common shares may only be issued pursuant to (i)&#160;a share split,
subdivision of shares or similar transaction or where a dividend or other distribution is effected through the issue of shares, debentures,
or rights to acquire shares, or through the capitalization of profits, ensuring proportional allocation and class consistency, (ii)&#160;a
merger, consolidation, or other business combination, or (iii)&#160;an issuance of shares including Class A common shares or any other
class of share designated as a common share pursuant to the Articles of Association, whereby each holder of the Class B common shares
is entitled to purchase a number of Class B common shares that would allow such holder to maintain its proportional ownership interests
in Afya.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under our Articles of Association, we may not issue
Common Shares and/or preferred shares to any person on any terms unless we first offer each holder of Class B common shares the opportunity
to subscribe for such number of Class B common shares, on the same economic terms and at the same price, as would allow such holder to
maintain its proportional ownership interest in Afya. In light of: (a)&#160;the above provisions; (b)&#160;the fact that future transfers
of Class B common shares will generally result in their conversion into Class A common shares, subject to limited exceptions set forth
in our Articles of Association; and (c)&#160;the ten-to-one voting ratio between our Class B common shares and Class A common shares,
holders of our Class B common shares will, in many circumstances, continue to maintain control of all matters requiring shareholder approval.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">This concentration of ownership and voting power will
limit or preclude your ability to influence corporate matters for the foreseeable future.</p>


<!-- Field: Page; Sequence: 138 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->133<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association also provide that the issuance
of non-voting common shares requires the affirmative vote of a majority of the then-outstanding Class A common shares, approval by ordinary
resolution of our shareholders, which requires the affirmative vote of a simple majority of the votes cast on the resolution by the shareholders
entitled to vote who are present, in person or by proxy, at the meeting and the prior written consent of a Bertelsmann Director and Esteves
Family Director as set out below in &#8220;&#8212;Proceedings of the Board of Directors.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Fiscal Year</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our fiscal year begins on January 1 of each year and
ends on December 31 of the same year.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Voting Rights</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The holders of the Class A common shares and Class
B common shares have identical rights, except that (i)&#160;the holder of Class B common shares is entitled to ten (10) votes per share,
whereas holders of Class A common shares are entitled to one (1) vote per share, (ii)&#160;Class B common shares have certain conversion
rights, and (iii)&#160;the holders of Class B common shares are entitled to maintain their proportional ownership interest in the event
that common shares and/or preferred shares are proposed to be issued. For more information see below &#8220;&#8212;Preemptive or Similar
Rights&#8221; and &#8220;&#8212;Conversion.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The holders of Class A common shares and Class B common
shares vote together as a single class on all matters (including the election of directors) submitted to a vote of shareholders, except
as provided below and as otherwise required by law.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association provide as follows regarding
the respective rights of holders of Class A common shares and Class B common shares:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.3in"><span style="background-color: white">(i)</span></td><td>Class consents from the holders of Class A common shares or Class B common shares, as applicable, shall be required for any variation
to the rights attached to their respective class of shares, however, the directors may treat any two or more classes of shares as forming
one class if they consider that all such classes would be affected in the same way by the proposal;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.3in">(ii)</td><td>The rights conferred on holders of Class A common shares shall not be deemed to be varied by the creation or issue of further Class
B common shares and vice versa; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.3in">(iii)</td><td>The rights attaching to the Class A common shares and the Class B common shares shall not be deemed to be varied by the creation or
issue of further shares ranking pari passu therewith, the redemption or purchase of any shares of any class by the Company, the cancellation
of authorized but unissued shares of that class or the creation or issue of shares with preferred or other rights, including, without
limitation, shares with enhanced or weighted voting rights.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As set forth in the Articles of Association, the holders
of Class A common shares and Class B common shares, respectively, do not have the right to vote separately if the number of authorized
shares of such class is increased or decreased. Rather, the number of authorized Class A common shares and Class B common shares may be
increased or decreased (but not below the number of shares of such class then outstanding) by the affirmative vote of the holders of a
majority of the voting power of the issued and outstanding Class A common shares and Class B common shares, voting together in a general
meeting.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Preemptive or Similar Rights</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares and Class B common shares
are not entitled to preemptive rights upon transfer and are not subject to conversion (except as described below under &#8220;&#8212;Conversion&#8221;),
redemption or sinking fund provisions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Class B common shares are entitled to maintain
a proportional ownership interest in the event that additional common and/or preferred shares are issued. As such, if Afya issues common
and/or preferred shares, it must first make an offer to each holder of Class B common shares to issue to such holder on the same economic
terms such number of Class B common shares as would ensure such holder may maintain a proportional ownership interest in Afya. This right
to maintain a proportional ownership interest may be waived by all of the holders of Class B common shares, such waiver to remain effective until the date specified
therein or twelve (12) months from the date of the waiver. For more information see &#8220;&#8212; Issuance of Shares.&#8221;</p>


<!-- Field: Page; Sequence: 139 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->134<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Conversion</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The outstanding Class B common shares are convertible
into Class A Common Shares, on a share-to-share basis, at any time after issue and without payment of any additional sum, as follows:
(i)&#160;at the discretion of a holder of Class B common shares, a Class B common share may be converted into one Class A common share,
or (ii)&#160;upon the request of the holders of all the then issued and outstanding Class B common shares, all outstanding Class B common
shares may be converted into a like number of Class A common shares. In addition, each Class B common share will convert automatically
into one Class A common share upon any transfer, whether or not for value, except for certain transfers described in the Articles of Association,
including transfers to holders of Class B common shares, to affiliates, to and between the Esteves Family, Bertelsmann, their family members
and their respective children, heirs and successors, trusts solely for the benefit of the shareholder or their affiliates, and to partnerships,
corporations and other entities exclusively owned or controlled by the Class B shareholder or their affiliates and certain transfers to
organizations that are exempt from taxation under Section 501(c)(3) of the Internal Revenue Code of 1986, as amended. Furthermore, each
Class B common share will convert automatically into one Class A common share and no Class B common shares will be issued thereafter if,
at any time, the total number of the issued and outstanding Class B common shares is less than 10% of the total number of shares outstanding.
To the extent that Bertelsmann or the Esteves Family cease to be a Class B common shareholder, the rights nominally vested to each shall
vest in their permitted transferee within the meaning of our Articles of Association.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">No class of our common shares may be subdivided or
combined unless the other class of common shares is concurrently subdivided or combined in the same proportion and in the same manner.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Equal Status</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Except as expressly provided in our Articles of Association,
Class A common shares and Class B common shares have the same rights and privileges and rank equally, share ratably and are identical
in all respects as to all matters.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In the event of any merger, consolidation, scheme,
arrangement or other business combination requiring the approval of our shareholders entitled to vote thereon (whether or not Afya is
the surviving entity), the holders of Class A common shares shall have the right to receive, or the right to elect to receive, the same
form of consideration as the holders of Class B common shares, and the holders of Class A common shares shall have the right to receive,
or the right to elect to receive, at least the same amount of consideration on a per share basis as the holders of Class B common shares.
In the event of any (i)&#160;tender or exchange offer to acquire any Class A common shares or Class B common shares by any third-party
pursuant to an agreement to which Afya is a party, or (ii)&#160;any tender or exchange offer by Afya to acquire any Class A common shares
or Class B common shares, the holders of Class A common shares shall have the right to receive, or the right to elect to receive, the
same form of consideration as the holders of Class B common shares, and the holders of Class A common shares shall have the right to receive,
or the right to elect to receive, at least the same amount of consideration on a per share basis as the holders of Class B common shares.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Record Dates</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For the purpose of determining shareholders entitled
to notice of, or to vote at any general meeting of shareholders or any adjournment thereof, or shareholders entitled to receive dividend
or other distribution payments, or in order to make a determination of shareholders for any other purpose, Our board of directors may
set a record date which shall not exceed 40 clear days prior to the date where the determination will be made.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">General Meetings of Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a condition of admission to a shareholders&#8217;
meeting, a shareholder must be duly registered as a shareholder of Afya at the applicable record date for that meeting and, in order to
vote, all calls or installments then payable by such shareholder to Afya in respect of the shares that such shareholder holds must have
been paid.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to any special rights or restrictions as to
voting then attached to any shares, at any general meeting every shareholder who is present in person or by proxy (or, in the case of
a shareholder being a corporation, by its duly authorized representative not being himself or herself a shareholder
entitled to vote) shall have one vote per Class A common share and 10 votes per Class B common share.</p>


<!-- Field: Page; Sequence: 140 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->135<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a Cayman Islands exempted company, Afya is not obliged
by the Companies Act to call annual general meetings; however, the Articles of Association provide that in each year the company will
hold an annual general meeting of shareholders, at a time determined by the board of directors. For the annual general meeting of shareholders
the agenda will include, among other things, the presentation of the annual accounts and the report of the directors (if any). In addition,
the agenda for an annual general meeting of shareholders will only include such items as have been included therein by the board of directors.
Also, Afya may, but is not required to (unless required by the laws of the Cayman Islands), hold other extraordinary general meetings
during the year.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">General meetings of shareholders are generally expected
to take place in Belo Horizonte, Brazil, but may be held elsewhere if the directors so decide.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act provides shareholders a limited right
to request a general meeting and does not provide shareholders with any right to put any proposal before a general meeting in default
of a company&#8217;s Articles of Association. However, these rights may be provided in a company&#8217;s Articles of Association. Our
Articles of Association provide that upon the requisition of one or more shareholders representing not less than one-third of the voting
rights entitled to vote at general meetings, the board will convene an extraordinary general meeting and put the resolutions so requisitioned
to a vote at such meeting. The Articles of Association provide no other right to put any proposals before annual general meetings or extraordinary
general meetings.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to regulatory requirements, the annual general
meeting and any extraordinary general meetings must be called with at least ten (10) clear calendar days&#8217; notice prior to the relevant
shareholders meeting and convened by a notice discussed below. Alternatively, upon the prior consent of all holders entitled to receive
notice, with regards to the annual general meeting, and upon the prior consent of a majority in number of the members (which shall include
Bertelsmann and the Esteves Family) together holding at least 95% in par value of the shares entitled to attend and vote, with regards
to an extraordinary general meeting, that meeting may be convened by a shorter notice and in a manner deemed appropriate by those holders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya will give notice of each general meeting of shareholders
by publication on its website and in any other manner that it may be required to follow in order to comply with Cayman Islands law, Nasdaq
and SEC requirements. The holders of registered shares may be given notice of a shareholders&#8217; meeting by means of letters sent to
the addresses of those shareholders as registered in our shareholders&#8217; register, or, subject to certain statutory requirements,
by electronic means.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><b>Holders whose shares are registered in the name
of DTC or its nominee, which we expect will be the case for all holders of Class A common shares, will not be a shareholder or member
of the company and must rely on the procedures of DTC regarding notice of shareholders&#8217; meetings and the exercise of rights of a
holder of the Class A common shares.</b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A quorum for a general meeting consists of any one
or more persons holding or representing by proxy not less than one-third of the aggregate voting power of all shares in issue and entitled
to vote upon the business to be transacted.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A resolution put to a vote at a general meeting shall
be decided on a poll. An ordinary resolution to be passed by the shareholders at a general meeting requires the affirmative vote of a
simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote, present in person or by proxy and voting at
the meeting. A special resolution requires the affirmative vote on a poll of no less than two-thirds of the votes cast by the shareholders
entitled to vote who are present in person or by proxy at a general meeting. Both ordinary resolutions and special resolutions may also
be passed by a unanimous written resolution signed by all the shareholders of our Company, as permitted by the Companies Act and our Articles
of Association.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to our Articles of Association, general meetings
of shareholders are to be chaired by the co-chairman of our board of directors appointed by Bertelsmann or in his absence, the co-chairman
of the board of directors appointed by the Esteves Family. If both such co-chairmen are absent, the directors present at the meeting shall
appoint one of them to be chairman of the general meeting. If neither the chairmen nor another director is present at the general meeting
within 15 minutes after the time appointed for holding the meeting, the shareholders present in person or by proxy and entitled to vote may elect any one of the shareholders
to be chairman. The order of business at each meeting shall be determined by the chairman of the meeting and he or she shall have the
right and authority to prescribe such rules, regulations and procedures and to do all such acts and things as are necessary or desirable
for the proper conduct of the meeting, including, without limitation, the establishment of procedures for the maintenance of order and
safety, limitations on the time allotted to questions or comments on the affairs of the Company, restrictions on entry to such meeting
after the time prescribed for the commencement thereof, and the opening and closing of the polls. The chairman shall not have the right
to vote in his capacity as chairman and shall not have a casting vote.</p>


<!-- Field: Page; Sequence: 141 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->136<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Liquidation Rights</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If Afya is voluntarily wound up, the liquidator shall,
after taking into account and giving effect to:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.5in">(i)</td><td>the rights of preferred and secured creditors and to</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.5in">(ii)</td><td>any agreement between Afya and any creditors that the claims of such creditors shall be subordinated or otherwise deferred to the
claims of any other creditors and to</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.5in">(iii)</td><td>any contractual rights of set-off or netting of claims between Afya and any person or persons (including without limitation any bilateral
or any multi-lateral set-off or netting arrangements between the company and any person or persons) and subject to</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.5in">(iv)</td><td>any agreement between Afya and any person or persons to waive or limit the same,</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0in">apply our property in satisfaction of its liabilities
<i>pari passu</i>. Any remaining assets shall then be distributed among shareholders in accordance with their rights and interests in
Afya.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Special Matters</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya may not without the prior written consent of (i)&#160;Bertelsmann
for so long as it holds Class B common shares in excess of the Ownership Threshold and (ii)&#160;the Esteves Family for so long as it
holds Class B common shares in excess of the Ownership Threshold: change the number of directors; amend its Memorandum and Articles of
Association; vary the rights attaching to shares; approve the winding-up, liquidation or dissolution of Afya; or take certain actions
in respect of its share capital as set out in the Articles of Association; register as an exempted limited duration company; or approve
the transfer by way of continuation of Afya to a jurisdiction outside the Cayman Islands.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Anti-Corruption and Anti-Money Laundering</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association contain stringent anti-corruption,
anti-money laundering and certain other related measures applicable to us, our officers and directors, and service providers. The Articles
of Association provide that if one of our shareholders is found to have been involved in an act of corruption, money laundering or other
related irregular act, the directors shall convene a meeting to consider the circumstances of such incident, and establish a course of
action to be taken against such shareholder. The actions range from (i)&#160;suspending such shareholder from his/her duties as a director,
officer and/or employee (if applicable) of the Company; (ii)&#160;terminating such duties; (iii)&#160;directing such shareholder to transfer
the entirety of his/her shareholding in the Company to his/her children and/or heirs; or (iv)&#160;if such transfer is not possible, resolve
that the shares in the Company owned by such shareholder be mandatorily redeemed by us. Further, our Articles of Association provide that
we shall not engage the services of any provider that has been found to violate applicable anti-corruption laws, and further provide that
we and our shareholders shall not violate applicable anti-corruption laws or laws related to acts or improbity.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Changes to Capital</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the restrictions contained in the Articles
of Association and summarized above in &#8220;&#8212;Special Matters,&#8221; Afya may from time to time by ordinary resolution:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>increase its share capital by such sum, to be divided into shares of such amount, as the resolution shall prescribe;</td></tr></table>


<!-- Field: Page; Sequence: 142 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->137<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>consolidate and divide all or any of its share capital into shares of a larger amount than its existing shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>convert all or any of its paid-up shares into stock and reconvert that stock into paid up shares of any denomination;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>subdivide its existing shares or any of them into shares of a smaller amount, provided that in the subdivision the proportion between
the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in the case of the share from which the
reduced share is derived; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and
diminish the amount of its share capital by the amount of the shares so canceled.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our shareholders may by special resolution, subject
to confirmation by the Grand Court of the Cayman Islands on an application by the Company for an order confirming such reduction, reduce
its share capital or any capital redemption reserve in any manner permitted by law.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, subject to the provisions of the Companies
Act and our Articles of Association, Afya may:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>issue shares on terms that they are to be redeemed or are liable to be redeemed;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>purchase its own shares (including any redeemable shares); and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>make a payment in respect of the redemption or purchase of its own shares in any manner authorized by the Companies Act, including
out of its own capital.</td></tr></table>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Transfer of Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to any applicable restrictions set forth in
the Articles of Association, any shareholder of Afya may transfer all or any of his or her common shares by an instrument of transfer
in the usual or common form or in the form prescribed by the Nasdaq or any other form approved by the Company&#8217;s board of directors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares are traded on the Nasdaq
in book-entry form and may be transferred in accordance with our Articles of Association and Nasdaq&#8217;s rules and regulations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">However, our board of directors may, in its absolute
discretion, decline to register any transfer of any common share which is either not fully paid up to a person of whom it does not approve
or is issued under any share incentive scheme for employees which contains a transfer restriction that is still applicable to such common
share. The board of directors may also decline to register any transfer of any common share unless:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the instrument of transfer is lodged with Afya, accompanied by the certificate (if any) for the common shares to which it relates
and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the instrument of transfer is in respect of only one class of shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the instrument of transfer is properly stamped, if required;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the common shares transferred are free of any lien in favor of Afya; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>in the case of a transfer to joint holders, the transfer is not to more than four joint holders.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If the directors refuse to register a transfer they
are required, within 15 business days after the date on which the instrument of transfer was lodged, to send to the transferee notice
of such refusal.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Share Repurchases</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act and the Articles of Association permit
Afya to purchase its own shares, subject to certain restrictions. The board of directors may only exercise this power on behalf of Afya,
and subject to the Companies Act, the Articles of Association and to any applicable requirements imposed from time to time by the SEC,
the Nasdaq, or by any recognized stock exchange on which our securities are
listed. Set forth below is a description of our share repurchase programs.</p>


<!-- Field: Page; Sequence: 143 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->138<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><b><i>1<sup>st</sup> Share Repurchase Program</i>.</b>
Our Board of Directors approved a share buyback program on December 23, 2020. Under the share buyback program, Afya may repurchase up
to 1,015,844 of its outstanding Class A common shares in the open market, based on prevailing market prices, or in privately negotiated
transactions, over a period beginning on December 24, 2020 continuing until the earlier of the completion of the repurchase or December
31, 2021, depending upon market conditions. We repurchased the shares to execute the stock option program for the executives of the Company
and utilized our existing funds to fund repurchases made under this program. Our Board of Directors also authorized management to appoint
BofA Securities, Inc. as our agent to purchase the shares on our behalf in the open market. It is our intention such purchases benefit
from the safe harbor provided by Rule 10b-18 (&#8220;Rule 10b-18&#8221;) promulgated by the SEC under the Exchange Act. Accordingly, we
shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rule 10b-18
for purchases of our common shares under the program. The share buyback program was completed on October 21, 2021, upon the completion
of the purchase of the full amount of Class A common shares permitted under the program.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><b><i>2<sup>nd</sup> Share Repurchase Program</i>.</b>
After the completion of our first share repurchase program on October 21, 2021 that resulted in the purchase of 1,015,844 Class A common
shares, our Board of Directors approved a new share repurchase program on October 27, 2021, or the second share repurchase program. Under
the second share repurchase program, Afya may repurchase up to 1,383,108 of its outstanding Class A common shares in the open market,
based on prevailing market prices, or in privately negotiated transactions, beginning on October 28, 2021 until the earlier of the completion
of the repurchase or December 31, 2022, depending upon market conditions. We repurchased the shares to execute the stock option program
for the executives of the Company and utilized our existing funds to fund repurchases made under this program. The Board of Directors
of Afya also authorized management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market.
It is Afya&#8217;s intention that such purchases benefit from the safe harbor provided by Rule 10b-18 promulgated by the SEC under the
Exchange Act. Accordingly, Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize
the availability of Rule 10b-18 for purchases under the program. The second share repurchase program was completed on January 14, 2022,
upon the purchase of the full amount of Class A common shares permitted under the second share repurchase program.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><b><i>3<sup>rd</sup> Share Repurchase Program</i>.</b>
After the completion of our second share repurchase program, which resulted in the purchase of 1,383,108 Class A common shares, our Board
of Directors approved a new share repurchase program on January 27, 2022, or the third share repurchase program. Under the third share
repurchase program, Afya may repurchase up to 1,874,457 of its outstanding Class A common shares which represents 4% of its free float,
in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on January 27, 2022, until the
earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions. We repurchased the shares for use
in our stock option program, as consideration in business combination transactions and for general corporate purposes and utilized our
existing funds and dividends received from Afya Brazil to fund repurchases made under this program. The Board of Directors of Afya also
authorized management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market. It is Afya&#8217;s
intention that such purchases benefit from the safe harbor provided by Rule 10b-18 promulgated by the SEC under the Exchange Act. Accordingly,
Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rule
10b-18 for purchases under the program. The third share repurchase program was completed on May 4, 2022, upon the purchase of the full
amount of Class A common shares permitted under the third share repurchase program.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><b><i>4th Share Repurchase Program</i>.</b> After the
completion of our third share repurchase program, which resulted in the purchase of 1,874,457 Class A common shares, our board of directors
approved a new share repurchase program on March 24, 2023, or the fourth share repurchase program. Under the fourth share repurchase program,
Afya may repurchase up to 2,000,000 of its outstanding Class A common shares, in the open market, based on prevailing market prices, or
in privately negotiated transactions, beginning on March 24, 2023 until the earlier of the completion of the repurchase or December 31,
2024, depending upon market conditions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><b><i>5th Share Repurchase Program</i>.</b> After the
completion of our fourth share repurchase program, which resulted in the purchase of 216,339 Class A common shares, our board of directors
approved a new share repurchase program on August 13, 2025, or the fifth share repurchase program. Under the fifth share repurchase program,
Afya may repurchase up to 4,000,000 of its outstanding Class A common shares,
in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on August 15, 2025 until the
earlier of the completion of the repurchase or December 31, 2026, depending upon market conditions.</p>


<!-- Field: Page; Sequence: 144 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->139<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For the year ended December 31, 2024, there were no
Class A common shares repurchased by us. For the year ended December 31, 2025, we repurchased 966,541 Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The share repurchases may be made from time to time
through open market transactions and are subject to market and business conditions, levels of available liquidity, cash requirements for
other purposes, regulatory, and other relevant factors. Afya intends to repurchase the shares for use in its stock option and RSU programs,
as consideration in future business combination transactions and for general corporate purposes. Afya expects to utilize its existing
funds and future dividends to be received from Afya Brazil and/or strike price funds to be received in connection with any option exercises
under its stock option program, to fund repurchases made under this program. Afya&#8217;s Board of Directors will review the share repurchase
program periodically and may authorize adjustments to its terms and size or suspend or discontinue the program.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Board of Directors of Afya also authorized management
to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market. It is Afya&#8217;s intention that
such purchases benefit from the safe harbors provided by Rules 10b-18 and 10b5-1 promulgated by the SEC under the Exchange Act. Accordingly,
Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rules
10b-18 or 10b5-1 for purchases under the program.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Dividends and Capitalization of Profits</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have not adopted a dividend policy with respect
to payments of any future dividends by Afya. Subject to the Companies Act, our shareholders may, by resolution passed by a simple majority
of the voting rights entitled to vote at a general meeting, declare dividends (including interim dividends) to be paid to shareholders
but no dividend shall be declared in excess of the amount recommended by the board of directors. The board of directors may also declare
dividends. Dividends may be declared and paid out of funds lawfully available to Afya. Except as otherwise provided by the rights attached
to shares and the Articles of Association of Afya, all dividends shall be paid in proportion to the number of Class A common shares or
Class B common shares a shareholder holds at the date the dividend is declared (or such other date as may be set as a record date); but,
(i)&#160;if any share is issued on terms providing that it shall rank for dividend as from a particular date, that share shall rank for
dividend accordingly, and (ii)&#160;where we have shares in issue which are not fully paid up (as to par value) we may pay dividends in
proportion to the amounts paid up on each share.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The holders of Class A common shares and Class B common
shares shall be entitled to share equally in any dividends that may be declared in respect of our common shares from time to time. In
the event that a dividend is paid in the form of Class A common shares or Class B common shares, or rights to acquire Class A common shares
or Class B common shares, (i)&#160;the holders of Class A common shares shall receive Class A common shares, or rights to acquire Class
A common shares, as the case may be; and (ii)&#160;the holders of Class B common shares shall receive Class B common shares, or rights
to acquire Class B common shares, as the case may be.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Appointment, Disqualification and Removal of Directors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is managed by its board of directors. The Articles
of Association provide that, unless otherwise determined by a special resolution of shareholders, the board of directors will be composed
of four to 14 directors, with the number being determined by a majority of the directors then in office. There are no provisions relating
to the retirement of directors upon reaching any age limit. The Articles of Association also provide that, while our shares are admitted
to trading on Nasdaq, the board of directors must always comply with the residency and citizenship requirements of the U.S. securities
laws applicable to foreign private issuers. Bertelsmann for so long as it holds Class B common shares in excess of the Ownership Threshold
may appoint up to seven directors at its discretion (and is entitled at any time to remove substitute or replace such directors) (&#8220;Bertelsmann
Directors&#8221;), and the Esteves Family for so long as it holds Class B common shares in excess of the Ownership Threshold may appoint
up to two directors at its discretion (and is entitled at any time to remove substitute or replace such directors) (&#8220;Esteves Family
Directors&#8221;). In addition for so long as both hold Class B common shares in excess of the Ownership Threshold, they may appoint a
further director (the &#8220;Joint Director&#8221;) and are entitled at any time to remove, substitute or replace the Joint Director (provided
that if only one of Bertelsmann and the Esteves Family holds Class B Common Shares in excess of the Ownership Threshold, then only
Bertelsmann or the Esteves Family, as applicable, shall have such right). The Board of Directors shall have one (1) co-chairman appointed
by Bertelsmann, for so long as it holds Class B Common Shares in excess of the Ownership Threshold and one (1) co-chairman appointed by
the Esteves Family, for so long as it holds Class B Common Shares in excess of the Ownership Threshold, thereafter, the chairman of the
Board of Directors shall be appointed by a majority of the Directors then in office.</p>


<!-- Field: Page; Sequence: 145 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->140<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing, the Articles of Association
provide that directors shall be elected by an ordinary resolution of our shareholders, which requires the affirmative vote of a simple
majority of the votes cast on the resolution by the shareholders entitled to vote who are present, in person or by proxy, at the meeting.
Each director shall be appointed and elected for a two-year term or until his or her death, resignation or removal, and is eligible for
re-election.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For the names of our directors, see &#8220;Item 6.
Directors, Senior Management and Employees&#8212;A. Directors and Senior Management&#8212;Board of Directors.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Any vacancies on the board of directors that arise
other than in respect of the Bertelsmann and/or Esteves Family director appointments set out above or upon the removal of a director by
resolution passed at a general meeting can be filled by the remaining directors (notwithstanding that they may constitute less than a
quorum). Any such appointment shall be as an interim director to fill such vacancy until the next annual general meeting of shareholders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing, additions to the existing
board (within the limits set pursuant to the Articles of Association) may be made by ordinary resolution of the shareholders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors has an audit committee in place.
See &#8220;Item 6. Directors, Senior Management and Employees&#8212;A. Directors and Senior Management&#8212;Audit Committee.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Grounds for Removing a Director</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A director may be removed with or without cause by
ordinary resolution, save that each Bertelsmann Director may only be removed by Bertelsmann at its discretion and each Esteves Family
Director may only be removed by the Esteves Family at its discretion.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The notice of general meeting must contain a statement
of the intention to remove the director and must be served on the director not less than 10 calendar days before the meeting. The director
is entitled to attend the meeting and be heard on the motion for his removal.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The office of a director will be vacated automatically
if he or she (i)&#160;becomes prohibited by law from being a director, (ii)&#160;becomes bankrupt or makes an arrangement or composition
with his creditors, (iii)&#160;dies or is in the opinion of all his co-directors, incapable by reason of mental disorder of discharging
his duties as director, (iv)&#160;resigns his office by notice to us or (v)&#160;has for more than six months been absent without permission
of the directors from meetings of the board of directors held during that period, and the remaining directors resolve that his or her
office be vacated. Further, the Directors may remove a Director as set out above in &#8220;&#8212;Anti-Corruption and Anti-Money Laundering.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Proceedings of the Board of Directors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Articles of Association provide that our
business is to be managed and conducted by the board of directors, save that Afya may not without (i)&#160;the consent of a
Bertelsmann Director while there is a Bertelsmann Director and (ii)&#160;the consent of an Esteves Family Director while there is an
Esteves Family Director: create new classes of shares, issue new shares, options, warrants or convertible securities of similar
nature conferring the right upon the holders thereof to subscribe for purchase or receive any class of shares or securities in the
capital of Afya; repurchase or redeem any shares; execute and/or terminate any shareholders&#8217; agreement, quotaholders&#8217;
agreement, or any other agreements related to our interest in any subsidiary; approve our consolidated financial statements; effect
any follow-on offerings of Afya; approve the listing and/or the delisting of our securities with any designated stock exchange;
conduct, negotiate, terminate and/or amend any business, agreement, or transaction between Afya and any related party valued in
excess of R$0.5 million; approve any sale or encumbrance, for the benefit of a person of shares issued by any subsidiary, or the
admission of any new partner or shareholder in such subsidiaries; carry out any investments outside the scope of the core business of Afya
(as set out in the Articles of Association); incorporate any entity; appoint or terminate the engagement of any auditor that is not an
Authorized Auditor as set out in the Articles of Association; provide any guarantee in respect of any person or related person of any
of our shareholders, director and/or officers inter alia; or take actions in connection with the Company&#8217;s Anti-Corruption measures,
provided that if the Anti-Corruption measures relate to either Bertelsmann or the Esteves Family, then the consent of the Esteves Family
Director or the Bertelsmann Director respectively shall not be required.</p>


<!-- Field: Page; Sequence: 146 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->141<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The quorum necessary for the board meeting shall be
a simple majority of the directors then in office (subject to there being a minimum of two directors present), and business at any meeting
shall be decided by a majority of votes. None of the Bertelsmann Chairman, the Esteves Family Chairman and the chairman of the meeting
will have a second or casting vote; provided that if the votes are evenly split, a Bertelsmann Director (or Bertelsmann Chairman) shall
have a casting vote.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing and the provisions of the
Articles of Association, the board of directors may regulate its proceedings as they determine it is appropriate. Board meetings shall
be held bi-monthly and shall take place either in Belo Horizonte, Brazil, or at such other place as the directors may determine.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the provisions of the Articles of Association,
to any directions given by ordinary resolution of the shareholders and the listing rules of the Nasdaq, the board of directors may from
time to time at its discretion exercise all powers of Afya, including, subject to the Companies Act, the power to issue debentures, bonds
and other securities of the company, whether outright or as collateral security for any debt, liability or obligation of our company or
of any third-party.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Inspection of Books and Records</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Holders of Afya shares have no general right under
Cayman Islands law to inspect or obtain copies of the list of shareholders or corporate records of the Company. However, the board of
directors may determine from time to time whether and to what extent our accounting records and books shall be open to inspection by shareholders
who are not members of the board of directors. Notwithstanding the above, the Articles of Association provide shareholders with the right
to receive annual financial statements and upon request agreements executed by the Company and its Related Parties (as defined in the
Articles of Association), shareholder agreements to which the Company is a party and details of any incentive plan. Such right to receive
annual financial statements may be satisfied by publishing the same on the company&#8217;s website or filing such annual reports as we
are required to file with the SEC.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Register of Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares are held through DTC, and
DTC or Cede &amp; Co., as nominee for DTC, and recorded in the shareholders&#8217; register as the holder of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, Afya must keep a register
of shareholders that includes:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the names and addresses of the shareholders, a statement of the shares held by each member and of the amount paid or agreed to be
considered as paid, on the shares of each member;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>whether voting rights attach to the shares in issue;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the date on which the name of any person was entered on the register as a member; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the date on which any person ceased to be a member.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, the register of shareholders
of Afya is prima facie evidence of the matters set out therein (i.e., the register of shareholders will raise a presumption of fact on
the matters referred to above unless rebutted) and a shareholder registered in the register of shareholders is deemed as a matter of Cayman
Islands law to have <i>prima facie</i> legal title to the shares as set against his or her name in the register of shareholders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">However, there are certain limited circumstances
where an application may be made to a Cayman Islands court for a determination on whether the register of members reflects the
correct legal position. Further, the Cayman Islands court has the power to order that the register of members maintained by a
company should be rectified where it considers that the register of members does not reflect the correct legal position. If an
application for an order for rectification of the register of members were made in respect of our ordinary
shares, then the validity of such shares may be subject to re-examination by a Cayman Islands court.</p>


<!-- Field: Page; Sequence: 147 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->142<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Exempted Company</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is an exempted company with limited liability
under the Companies Act. The Companies Act distinguishes between ordinary resident companies and exempted companies. Any company that
is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted
company. The requirements for an exempted company are essentially the same as for an ordinary company except for the exemptions and privileges
listed below:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company does not have to file an annual return of its shareholders with the Registrar of Companies;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company&#8217;s register of shareholders is not open to inspection;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company does not have to hold an annual general meeting;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may issue shares with no par value;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for
20 years in the first instance);</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may register as a limited duration company; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may register as a segregated portfolio company.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">&#8220;Limited liability&#8221; means that the liability
of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional circumstances,
such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which
a court may be prepared to pierce or lift the corporate veil).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to reporting and other informational
requirements of the Exchange Act, as applicable to foreign private issuers. Except as otherwise disclosed in this annual report, we comply
with the Nasdaq rules in lieu of following home country practice.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Anti-Takeover Provisions in Our Articles of Association</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Some provisions of the Articles of Association may
discourage, delay or prevent a change in control of Afya or management that shareholders may consider favorable. In particular, the capital
structure of Afya concentrates ownership of voting rights in the hands of the Esteves Family and Bertelsmann. These provisions, which
are summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed
to encourage persons seeking to acquire control of Afya to first negotiate with the board of directors. However, these provisions could
also have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations
in the market price of the Class A common shares that often result from actual or rumored hostile takeover attempts. These provisions
may also have the effect of preventing changes in the management of Afya. It is possible that these provisions could make it more difficult
to accomplish transactions that shareholders may otherwise deem to be in their best interests.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Two Classes of Common Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Class B common shares of Afya are entitled to 10
votes per share, while the Class A common shares are entitled to one vote per share. Since they own of all of the Class B common shares
of Afya, the Esteves Family and Bertelsmann currently have the ability to elect all directors and to determine the outcome of all matters
submitted for a vote of shareholders. This concentrated voting control could discourage others from initiating any potential merger, takeover,
or other change of control transaction that other shareholders may view as beneficial.</p>


<!-- Field: Page; Sequence: 148 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->143<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">So long as the Esteves Family and Bertelsmann have
the ability to determine the outcome of all matters submitted to a vote of shareholders, third parties may be deterred in their willingness
to make an unsolicited merger, takeover, or other change of control proposal, or to engage in a proxy contest for the election of directors.
As a result, the fact that Afya has two classes of common shares may have the effect of depriving you as a holder of Class A common shares
of an opportunity to sell your Class A common shares at a premium over prevailing market prices and make it more difficult to replace
the directors and management of Afya.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Preferred Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors is given wide powers to issue
one or more classes or series of shares with preferred rights. Such preferences may include, for example, dividend rights, conversion
rights, redemption privileges, enhanced voting powers and liquidation preferences.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Despite the anti-takeover provisions described above,
under Cayman Islands law, our board of directors may only exercise the rights and powers granted to them under the Articles of Association,
for what they believe in good faith to be in the best interests of Afya and for a proper corporate purpose.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Protection of Non-Controlling Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Grand Court of the Cayman Islands may, on the application
of shareholders holding not less than one fifth of the shares of Afya in issue, appoint an inspector to examine the Company&#8217;s affairs
and report thereon in a manner as the Grand Court shall direct.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the provisions of the Companies Act, any
shareholder may petition the Grand Court of the Cayman Islands which may make a winding up order, if the court is of the opinion that
this winding up is just and equitable.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Notwithstanding the U.S. securities laws and regulations
that are applicable to Afya, general corporate claims against Afya by its shareholders must, as a general rule, be based on the general
laws of contract or tort applicable in the Cayman Islands or their individual rights as shareholders as established by our Articles of
Association.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Cayman Islands courts ordinarily would be expected
to follow English case law precedents, which permit a minority shareholder to commence a representative action against Afya, or derivative
actions in our name, to challenge (i)&#160;an act which is ultra vires or illegal, (ii)&#160;an act which constitutes a fraud against
the minority and the wrongdoers themselves control Afya, and (iii)&#160;an irregularity in the passing of a resolution that requires a
qualified (or special) majority.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Registration Rights and Restricted Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Although no shareholders of Afya have formal registration
rights, they or entities controlled by them or their permitted transferees will be able to sell their shares in the public market from
time to time without registering them, subject to certain limitations on the timing, amount and method of those sales imposed by regulations
promulgated by the SEC.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Principal Differences between Cayman Islands and U.S. Corporate Law</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act was modeled originally after similar
laws in England and Wales but does not follow subsequent statutory enactments in England and Wales. In addition, the Companies Act differs
from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of the significant differences between
the provisions of the Companies Act applicable to Afya and the laws applicable to companies incorporated in the United States and their
shareholders.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Mergers and Similar Arrangements</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act permits mergers or consolidations
between two Cayman Islands companies, or between a Cayman Islands company and a company incorporated in another jurisdiction (provided
that is facilitated by the laws of that other jurisdiction).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Where the merger or consolidation is between two Cayman
Islands companies the directors of each company must approve a written plan of merger or consolidation, which must then be authorized
by (a)&#160;a special resolution (usually a majority of 66 2/3 % in value) of the shareholders of each company;
and (b)&#160;such other authorization, if any, as may be specified in such constituent company&#8217;s articles of association. No shareholder
resolution is required for a merger between a parent company (i.e., a company that owns at least 90% of the issued shares of each class
in a subsidiary company) and its subsidiary company. The consent of each holder of a fixed or floating security interest of a constituent
company must be obtained, unless the court waives such requirement. If the Cayman Islands Registrar of Companies is satisfied that the
requirements of the Companies Act (which includes certain other formalities) have been complied with, the Registrar of Companies will
register the plan of merger or consolidation. Where the merger or consolidation involves a foreign company, the procedure is similar,
save that with respect to the foreign company, the director of the Cayman Islands company is required to make a declaration to the effect
that, having made due enquiry, he is of the opinion that the requirements set out below have been met: (i) that the merger or consolidation
is permitted or not prohibited by the constitutional documents of the foreign company and by the laws of the jurisdiction in which the
foreign company is incorporated, and that those laws and any requirements of those constitutional documents have been or will be complied
with; (ii)&#160;that no petition or other similar proceeding has been filed and remains outstanding or order made or resolution adopted
to wind up or liquidate the company in any foreign jurisdictions; (iii)&#160;that no receiver, trustee, administrator or other similar
person has been appointed in any jurisdiction and is acting in respect of the foreign company, its affairs or property or any part thereof;
(iv)&#160;that no scheme, order, compromise or similar arrangement has been entered into or made in any jurisdiction whereby the rights
of creditors of the foreign company are and continue to be suspended or restricted.</p>


<!-- Field: Page; Sequence: 149 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->144<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Moreover, Cayman Islands law also has separate statutory
provisions that facilitate the reconstruction or amalgamation of companies, in certain circumstances, which will generally be more suited
for complex mergers or other transactions involving widely held companies, commonly referred to in the Cayman Islands as a &#8220;scheme
of arrangement&#8221; which may be tantamount to a merger. In the event that a merger was sought pursuant to a scheme of arrangement (the
procedure of which are more rigorous and take longer to complete than the procedures typically required to consummate a merger in the
United States), the arrangement in question must be approved by, if a shareholder scheme, shareholders representing three-fourths in value
of each class of shareholders with whom the arrangement is to be made or, if a creditor scheme, a majority in number of each class of
creditors with whom the arrangement is to be made, and who must in addition represent three-fourths in value of each such class of creditors,
as the case may be, that are present and voting either in person or by proxy at a meeting or meetings summoned for that purpose. The convening
of the meetings and subsequently the terms of the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting
shareholder would have the right to express to the court the view that the transaction should not be approved, the court can be expected
to approve the arrangement if it satisfies itself that:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Afya is not proposing to act illegally or beyond the scope of its corporate authority and the statutory provisions as to majority
vote have been complied with;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the shareholders have been fairly represented at the meeting in question;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the arrangement is such as a businessman would reasonably approve; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act or that would amount
to a &#8220;fraud on the minority.&#8221;</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If a scheme of arrangement or takeover offer (as described
below) is approved, any dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be
available to dissenting shareholders of United States corporations, providing rights to receive payment in cash for the judicially determined
value of the shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Squeeze-out Provisions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">When a takeover offer is made and accepted by holders
of 90.0% of the shares to whom the offer is made within four months, the offeror may, within a two-month period, require the holders of
the remaining shares to transfer such shares on the terms of the offer. An objection may be made to the Grand Court of the Cayman Islands
but is unlikely to succeed unless there is evidence of fraud, bad faith, collusion or inequitable treatment of the shareholders.</p>


<!-- Field: Page; Sequence: 150 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->145<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Further, transactions similar to a merger, reconstruction
and/or an amalgamation may in some circumstances be achieved through other means to these statutory provisions, such as a share capital
exchange, asset acquisition or control, through contractual arrangements, of an operating business.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Shareholders&#8217; Suits</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Maples and Calder (Cayman) LLP, our Cayman Islands
counsel is not aware of any reported class action having been brought in a Cayman Islands court. Derivative actions have been brought
in the Cayman Islands courts, and the Cayman Islands courts have confirmed the availability for such actions. In most cases, we will be
the proper plaintiff in any claim based on a breach of duty owed to us, and a claim against (for example) our officers or directors usually
may not be brought by a shareholder. However, based on English authorities, which would in all likelihood be of persuasive authority and
be applied by a court in the Cayman Islands, exceptions to the foregoing principle apply in circumstances in which:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a company is acting or proposing to act illegally or beyond the scope of its authority;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the act complained of, although not beyond the scope of the authority, could be effected if duly authorized by more than the number
of votes which have actually been obtained; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>those who control the company are perpetrating a &#8220;fraud on the minority.&#8221;</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A shareholder may have a direct right of action against
us where the individual rights of that shareholder have been infringed or are about to be infringed.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Borrowing Powers</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the provisions of the Articles of Association,
our directors may exercise all the powers of Afya to borrow money and to mortgage or charge its undertaking, property and assets (present
and future) and uncalled capital or any part thereof and to issue debentures, debenture stock, mortgages, bonds and other such securities
whether outright or as security for any debt, liability or obligation of Afya or of any third party. Such powers may be varied by a special
resolution of shareholders (requiring a two-thirds majority vote).</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Indemnification of Directors and Executive Officers and
Limitation of Liability</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act does not limit the extent to which
a company&#8217;s articles of association may provide for indemnification of directors and officers, except to the extent that it may
be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences
of committing a crime. Our Articles of Association provide that we shall indemnify and hold harmless our directors and officers against
all actions, proceedings, costs, charges, expenses, losses, damages, liabilities, judgments, fines, settlements and other amounts incurred
or sustained by such directors or officers, other than by reason of such person&#8217;s dishonesty, willful default or fraud, in or about
the conduct of our company&#8217;s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge
of his duties, powers, authorities or discretions, including without prejudice to the generality of the foregoing, any costs, expenses,
losses or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil, criminal or other
proceedings concerning Afya or our affairs in any court whether in the Cayman Islands or elsewhere. This standard of conduct is generally
the same as permitted under the Delaware General Corporation Law for a Delaware corporation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to Our directors, officers or persons controlling the Company under the foregoing provisions,
we have been informed that, in the opinion of the SEC, this indemnification is against public policy as expressed in the Securities Act
and is therefore unenforceable.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Directors&#8217; and Controlling Shareholders&#8217;
Fiduciary Duties</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a matter of Cayman Islands law, a director of a
Cayman Islands company is in the position of a fiduciary with respect to the company. Accordingly, directors and officers owe the following
fiduciary duties: (1) duty to act in good faith in what the director or officer believes to be in the best interests of the company as
a whole; (2) duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; (3) directors
should not improperly fetter the exercise of future discretion; (4) duty to exercise powers fairly as between different sections of shareholders; (5) duty to exercise independent judgment;
and (6) duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests.
However, this obligation may be varied by the company&#8217;s articles of association, which may permit a director to vote on a matter
in which he has a personal interest provided that he has disclosed that nature of his interest to the board of directors. With respect
to the duty of directors to avoid conflicts of interest, our Articles of Association vary from the applicable provisions of Cayman Islands
law mentioned above by providing that a director must disclose the nature and extent of his or her interest in any contract or arrangement,
and following such disclosure and subject to any separate requirement under applicable law or the listing rules of the Nasdaq, and unless
disqualified by the chairman of the relevant meeting, such director may vote in respect of any transaction or arrangement in which he
or she is interested and may be counted in the quorum at the meeting.</p>


<!-- Field: Page; Sequence: 151 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->146<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A director of a Cayman Islands company also owes to
the company duties to exercise independent judgment in carrying out his functions and to exercise reasonable skill, care and diligence,
which has both objective and subjective elements. Recent Cayman Islands case law confirmed that directors must exercise the care, skill
and diligence that would be exercised by a reasonably diligent person having the general knowledge, skill and experience reasonably to
be expected of a person acting as a director.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Additionally, a director must exercise the knowledge,
skill and experience which he or she actually possesses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A general notice may be given to the board of directors
to the effect that (i)&#160;the director is a member or officer of a specified company or firm and is to be regarded as interested in
any contract or arrangement which may after the date of the notice be made with that company or firm; or (ii)&#160;he or she is to be
regarded as interested in any contract or arrangement which may after the date of the notice to the board of directors be made with a
specified person who is connected with him or her, will be deemed sufficient declaration of interest. This notice shall specify the nature
of the interest in question. Following the disclosure being made pursuant to our Articles of Association and subject to any separate requirement
under applicable law or the listing rules of the Nasdaq, and unless disqualified by the chairman of the relevant meeting, a director may
vote in respect of any transaction or arrangement in which he or she is interested and may be counted in the quorum at the meeting.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In comparison, under Delaware corporate law, a director
of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components: the duty of care
and the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person
would exercise under similar circumstances. Under this duty, a director must inform himself or herself of, and disclose to shareholders,
all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director act in
a manner he or she reasonably believes to be in the best interests of the corporation. He or she must not use his or her corporate position
for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interest of the corporation
and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder and not shared by the
shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the
honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence
of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, a director must
prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Furthermore, as a matter of Cayman Islands law and
in contrast to the position under Delaware corporate law, controlling shareholders of Cayman Islands companies do not owe fiduciary duties
to those companies, other than the limited duty that applies to all shareholders to exercise their votes to amend a company&#8217;s articles
of association in good faith in the interests of the company. The absence of this minority shareholder protection might impact the ability
of minority shareholders to protect their interests.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Shareholder Proposals</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Delaware General Corporation Law, a shareholder
has the right to put any proposal before the annual meeting of shareholders, provided it complies with the notice provisions in the governing
documents. The Delaware General Corporation Law does not provide shareholders an express right to put any proposal before the annual meeting
of shareholders, but Delaware corporations generally afford shareholders an opportunity to make proposals and nominations provided that
they comply with the notice provisions in the certificate of incorporation or bylaws. A special meeting may be called by the board of directors or any other person
authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings.</p>


<!-- Field: Page; Sequence: 152 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->147<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act provides shareholders with only limited
rights to requisition a general meeting and does not provide shareholders with any right to put any proposal before a general meeting.
However, these rights may be provided in a company&#8217;s articles of association. Our Articles of Association provide that upon the
requisition of one or more shareholders representing not less than one-third of the voting rights entitled to vote at general meetings,
the board will convene an extraordinary general meeting and put the resolutions so requisitioned to a vote at such meeting. The Articles
of Association provide no other right to put any proposals before annual general meetings or extraordinary general meetings.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Cumulative Voting</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Delaware General Corporation Law, cumulative
voting for elections of directors is not permitted unless the corporation&#8217;s certificate of incorporation specifically provides for
it.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Cumulative voting potentially facilitates the representation
of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder
is entitled on a single director, which increases the shareholder&#8217;s voting power with respect to electing such director. As permitted
under Cayman Islands law, our Articles of Association do not provide for cumulative voting. As a result, the shareholders of Afya are
not afforded any less protections or rights on this issue than shareholders of a Delaware corporation.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Removal of Directors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The office of a director shall be vacated automatically
if, among other things, he or she (i)&#160;becomes prohibited by law from being a director, (ii)&#160;becomes bankrupt or makes an arrangement
or composition with his creditors, (iii)&#160;dies or is in the opinion of all his co-directors, incapable by reason of mental disorder
of discharging his duties as director, (iv)&#160;resigns his office by notice to us or (v)&#160;has for more than six months been absent
without permission of the directors from meetings of the board of directors held during that period, and the remaining directors resolve
that his/her office be vacated.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Transaction with Interested Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Delaware General Corporation Law provides that,
unless the corporation has specifically elected not to be governed by this statute, it is prohibited from engaging in certain business
combinations with an &#8220;interested shareholder&#8221; for three years following the date that this person becomes an interested shareholder.
An interested shareholder generally is a person or a group who or which owns or owned 15% or more of the target&#8217;s outstanding voting
shares or who or which is an affiliate or associate of the corporation and owned 15% or more of the corporation&#8217;s outstanding voting
shares within the past three years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the
target in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on
which the shareholder becomes an interested shareholder, the board of directors approves either the business combination or the transaction
which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware corporation to negotiate
the terms of any acquisition transaction with the target&#8217;s board of directors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Cayman Islands law has no comparable statute. As a
result, Afya cannot avail itself of the types of protections afforded by the Delaware business combination statute. However, although
Cayman Islands law does not regulate transactions between a company and its significant shareholders, it does provide that the board of
directors owe duties to ensure that these transactions are entered into bona fide in the best interests of the company and for a proper
corporate purpose and, as noted above, a transaction may be subject to challenge if it has the effect of constituting a fraud on the minority
shareholders.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Dissolution; Winding Up</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Delaware General Corporation Law, unless
the board of directors approves the proposal to dissolve, dissolution must be approved by shareholders holding 100% of the total voting
power of the corporation. If the dissolution is initiated by the board of directors it may be approved by a simple majority of the corporation&#8217;s
outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement
in connection with dissolutions initiated by the board. Under Cayman Islands law, a company may be wound up by either an order of the courts of the Cayman
Islands or by a special resolution of its members or, if the company resolves by ordinary resolution that it be wound up because it is
unable to pay its debts as they fall due. The court has authority to order winding up in a number of specified circumstances including
where it is, in the opinion of the court, just and equitable to do so.</p>


<!-- Field: Page; Sequence: 153 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->148<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Companies Act, Afya may be dissolved, liquidated
or wound up by a special resolution of shareholders (requiring a two-thirds majority vote). Our Articles of Association also give its
board of directors authority to petition the Cayman Islands Court to wind up Afya.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Variation of Rights of Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Delaware General Corporation Law, a corporation
may vary the rights of a class of shares with the approval of a majority of the outstanding shares of that class, unless the certificate
of incorporation provides otherwise. Under our Articles of Association, if the share capital is divided into more than one class of shares,
the rights attached to any class may only be varied with the written consent of the holders of two-thirds of the shares of that class
or the sanction of a special resolution passed at a separate meeting of the holders of the shares of that class.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Also, except with respect to share capital (as described
above), alterations to our Articles of Association may only be made by special resolution of shareholders (requiring a two-thirds majority
vote).</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Amendment of Governing Documents</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Delaware General Corporation Law, a corporation&#8217;s
certificate of incorporation may be amended only if adopted and declared advisable by the board of directors and approved by a majority
of the outstanding shares entitled to vote, and the bylaws may be amended with the approval of a majority of the outstanding shares entitled
to vote and may, if so provided in the certificate of incorporation, also be amended by the board of directors. Under Cayman Islands law,
our Articles of Association generally (and save for certain amendments to share capital described in this section) may only be amended
by special resolution of shareholders (requiring a two-thirds majority vote).</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Rights of Non-Resident or Foreign Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">There are no limitations imposed by our Articles of
Association on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition, there
are no provisions in the Articles of Association governing the ownership threshold above which shareholder ownership must be disclosed.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609515"></span><span id="a_Toc225309267"></span><span id="a_Toc196072508"></span><span id="a_Toc164277208"></span><span id="a_Toc194891144"></span><span id="a_Toc190934982"></span><span id="a_Toc133237681"></span><span id="a_Toc163120275"></span><span id="a_Toc131581003"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material
Contracts</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For information concerning certain contracts important
to our business, see &#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8221; and &#8220;Item
4. Information on the Company&#8212; Our Recent Acquisitions.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Except as otherwise described in this annual report
on Form 20-F, we have not entered into any material contracts other than in the ordinary course of business.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609516"></span><span id="a_Toc225309268"></span><span id="a_Toc196072509"></span><span id="a_Toc164277209"></span><span id="a_Toc194891145"></span><span id="a_Toc190934983"></span><span id="a_Toc133237682"></span><span id="a_Toc163120276"></span><span id="a_Toc131581004"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exchange
Controls</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Cayman Islands currently has no exchange control
restrictions.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609517"></span><span id="a_Toc225309269"></span><span id="a_Toc196072510"></span><span id="a_Toc164277210"></span><span id="a_Toc194891146"></span><span id="a_Toc190934984"></span><span id="a_Toc133237683"></span><span id="a_Toc163120277"></span><span id="a_Toc131581005"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Taxation</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Cayman Islands Tax Considerations</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Cayman Islands laws currently levy no taxes on
individuals or corporations based upon profits, income, gains or appreciation and there is no taxation in the nature of inheritance tax
or estate duty or withholding tax applicable to us or to any holder of Class A common shares. There are no other taxes likely to be material
to us levied by the government of the Cayman Islands except for stamp duties which may be applicable on instruments executed in, or after
execution brought within the jurisdiction of the Cayman Islands. No stamp duty is payable in the Cayman Islands on transfers of shares
of Cayman Islands companies except those which hold interests in land in the Cayman Islands. The Cayman Islands is not party to any double tax treaties
which are applicable to any payments made by or to our company. There are no exchange control regulations or currency restrictions in
the Cayman Islands.</p>


<!-- Field: Page; Sequence: 154 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->149<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a Cayman Islands exempted company with limited liability,
we have applied for and received an undertaking as to tax concessions pursuant to Section 6 of the Tax Concessions Act (As Revised). This
undertaking provides that, for a period of 20 years from the date of issue of the undertaking, no law thereafter enacted in the Cayman
Islands imposing any taxes to be levied on profits, income, gains or appreciation will apply to us or our operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Payments of dividends and capital in respect of our
Class A common shares will not be subject to taxation in the Cayman Islands and no withholding will be required on the payment of a dividend
or capital to any holder of our Class A common shares, nor will gains derived from the disposal of our Class A common shares be subject
to Cayman Islands income or corporation tax.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">There is no income tax treaty or convention currently
in effect between the United States and the Cayman Islands.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">U.S. Federal Income Tax Considerations</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a description of the material U.S.
federal income tax consequences to the U.S. Holders described below of owning and disposing of Class A common shares, but it does not
purport to be a comprehensive description of all tax considerations that may be relevant to a particular person&#8217;s decision to own
the securities. This discussion applies to you only if you hold Class A common shares as capital assets for U.S. federal income tax purposes.
In addition, it does not describe any state, local or non-U.S. tax consequences or all of the tax consequences that may be relevant in
light of your particular circumstances, including any minimum tax consequences, the potential application of the provisions of the Code
known as the Medicare contribution tax and differing tax consequences applicable to you if you are subject to special rules, such as:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>one of certain financial institutions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a dealer or trader in securities who uses a mark-to-market method of tax accounting;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a person holding a Class A common share as part of a straddle, wash sale, conversion transaction or integrated transaction or entering
into a constructive sale with respect to a Class A common share;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a person whose functional currency for U.S. federal income tax purposes is not the U.S. dollar;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an entity or arrangement classified as a partnership for U.S. federal income tax purposes;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a tax-exempt entity, an &#8220;individual retirement account&#8221; or a &#8220;Roth IRA&#8221;;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a person who acquired our Class A common shares pursuant to the exercise of an employee stock option or otherwise as compensation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a U.S. expatriate or certain former citizen of the United States;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a person that owns or is deemed to own ten percent or more of our stock (by vote or value); or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a person holding shares in connection with a trade or business conducted outside of the United States.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If you are an entity or arrangement classified as a
partnership for U.S. federal income tax purposes, the U.S. federal income tax treatment of a partner will generally depend on the status
of the partner and your activities. Partnerships holding Class A common shares and partners in such partnerships should consult their
tax advisers as to the particular U.S. federal income tax consequences of holding and disposing of the Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">This discussion is based on the Internal Revenue Code
of 1986, as amended (the &#8220;Code&#8221;), administrative pronouncements, judicial decisions, and final, temporary and proposed Treasury
regulations all as of the date hereof, any of which is subject to change, possibly with retroactive effect.</p>


<!-- Field: Page; Sequence: 155 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->150<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">You are a &#8220;U.S. Holder&#8221; if for U.S. federal
income tax purposes you are a beneficial owner of Class A common shares and:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a citizen or individual resident of the United States;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a corporation created or organized in or under the laws of the United States, any state therein or the District of Columbia; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an estate or trust the income of which is subject to U.S. federal income taxation regardless of its source.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Taxation of Distributions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following is subject to the discussion in &#8220;&#8212;Passive
Foreign Investment Company Rules&#8221; below.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Distributions paid on our Class A common shares, other
than certain <i>pro rata</i> distributions of Class A common shares, will be treated as dividends for U.S. federal income tax purposes
to the extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles). Because
we do not maintain calculations of our earnings and profits under U.S. federal income tax principles, it is expected that distributions
generally will be reported to you as dividends. Subject to applicable limitations, dividends paid to certain non-corporate U.S. Holders
may be eligible for taxation as &#8220;qualified dividend income&#8221; and therefore may be taxable at rates applicable to long-term
capital gains, provided the Class A common shares are treated as readily tradeable on an established securities market in the United States.
You should consult your tax adviser regarding the availability of the reduced tax rate on dividends in your particular circumstances.
The amount of any dividend will be treated as foreign-source dividend income and will not be eligible for the dividends-received deduction
generally available to U.S. corporations under the Code. Dividends will be included in your income on the date of receipt.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As discussed in &#8220;&#8212;Cayman Islands Tax Considerations,&#8221;
there are currently no applicable withholding taxes under Cayman Island law. However, if any non-U.S. income taxes were withheld from
distributions on your Class A common shares, the amount of the withheld tax would be includible in your income as a dividend. Subject
to applicable limitations, some of which vary depending upon your circumstances, the non-U.S. withholding tax may be potentially creditable
against your U.S. federal income tax liability. Certain Treasury regulations impose additional requirements for non-U.S. taxes to be eligible
for foreign tax credit, which applicability are further modified by notices from the IRS, and we cannot assure you that any non-U.S. income
taxes would be creditable against your U.S. federal income tax liability. Subject to generally applicable limitations under U.S. law,
you may be able to elect to deduct otherwise creditable withholding taxes. Even if the non-U.S. withholding taxes are not creditable,
you may be entitled to deduct such taxes, subject to applicable limitations under the Code. The rules governing foreign tax credits are
complex, and you should consult your tax adviser regarding the creditability or deductibility of non-U.S. taxes, if any, in your particular
circumstances (including any applicable limitations).</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Sale or Other Disposition of Class A Common Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following is subject to the discussion in &#8220;&#8212;<i>Passive
Foreign Investment Company Rules</i>&#8221; below.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For U.S. federal income tax purposes, gain or loss
realized on the sale or other disposition of a Class A common share will be capital gain or loss, and will be long-term capital gain or
loss if you have held the Class A common share for more than one year. The amount of the gain or loss will equal the difference between
your tax basis in the Class A common share disposed of and the amount realized on the disposition, in each case as determined in U.S.
dollars. This gain or loss will generally be U.S.-source gain or loss for foreign tax credit purposes. Long-term capital gains of non-corporate
U.S. Holders are eligible for reduced rates of taxation. The deductibility of capital losses is subject to limitations. If any non-U.S.
taxes were imposed on gains from dispositions of the Class A common shares, it is expected that those taxes would not be creditable against
your U.S. federal income tax liability. You should consult your tax adviser regarding the U.S. federal income tax consequences if any
non-U.S. income taxes were imposed on disposition gains.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Passive Foreign Investment Company Rules</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under the Code, we will be a PFIC for any taxable year
in which, after the application of certain &#8220;look-through&#8221; rules with respect to subsidiaries, either (i) 75% or more of our
gross income consists of &#8220;passive income,&#8221; or (ii) 50% or more of the average quarterly value of our assets consists of assets
that produce, or are held for the production of, &#8220;passive income.&#8221; For purposes of the above calculations,
we will be treated as if we hold our proportionate share of the assets of, and receive directly our proportionate share of the income
of, any other corporation in which we directly or indirectly own at least 25%, by value, of the shares of such corporation. Passive income
generally includes dividends, interest, certain non-active rents or royalties and investment gains. Cash is generally a passive asset
for these purposes. Goodwill is an active asset to the extent attributable to activities that produce active income.</p>


<!-- Field: Page; Sequence: 156 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->151<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Based on the composition of our income and assets and
the value of our assets, including goodwill (the implied value of which we estimate based on the price of our Class A common shares),
we believe that we were not a PFIC for the taxable year of 2025. However, because we hold a substantial amount of cash (relative to the
assets shown on our balance sheet) and because our PFIC status for any taxable year will depend on the composition of our income and assets
and the value of our assets from time to time (which may be determined, in part, by reference to the market price of our Class A common
shares, which could be volatile), there can be no assurance that we will not be a PFIC for any taxable year. If our Class A common share
price declines while we continue to hold a substantial amount of cash for any taxable year, our risk of being or becoming a PFIC will
increase. In addition, as we continue to expand our business through acquisitions and organically, our risk of becoming a PFIC will increase
if we engage in activities that generate substantial passive income. Moreover, the extent to which our goodwill will be treated as an
active asset is not entirely clear. If we were a PFIC for any taxable year during which you hold Class A common shares, we generally would
continue to be treated as a PFIC with respect to you for all succeeding years during which you hold Class A common shares, even if we
ceased to meet the threshold requirements for PFIC status.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If we were a PFIC for any taxable year and any of our
subsidiaries or other companies in which we owned or were treated as owning equity interests were also a PFIC (any such entity, a &#8220;Lower-tier
PFIC&#8221;), you would be deemed to own a proportionate amount (by value) of the shares of each Lower-tier PFIC and would be subject
to U.S. federal income tax according to the rules described in the subsequent paragraph on (i) certain distributions by a Lower-tier PFIC
and (ii) dispositions of shares of Lower-tier PFICs, in each case as if you held such shares directly, even though you would not receive
the proceeds of those distributions or dispositions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If we were a PFIC for any taxable year during which
you held any of our Class A common shares, you could be subject to adverse tax consequences. Generally, gain recognized upon a disposition
(including, under certain circumstances, a pledge) of Class A common shares would be allocated ratably over your holding period for the
shares. The amounts allocated to the taxable year of disposition and to years before we became a PFIC would be taxed as ordinary income.
The amount allocated to each other taxable year would be subject to tax at the highest rate in effect for that taxable year for individuals
or corporations, as appropriate, and an interest charge would be imposed on the tax on such amount. Further, to the extent that distributions
received on your Class A common shares in a taxable year exceeded 125% of the average of the annual distributions on those shares during
the preceding three taxable years or your holding period, whichever was shorter, the excess distributions would be subject to taxation
in the same manner as gain, described immediately above.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Alternatively, if we were a PFIC and if the Class A
common shares were &#8220;regularly traded&#8221; on a &#8220;qualified exchange,&#8221; you could be eligible to make a mark-to-market
election that would result in tax treatment different from the general tax treatment for PFICs described above. The Class A common shares
would be treated as &#8220;regularly traded&#8221; in any calendar year in which more than a <i>de minimis </i>quantity of the Class A
common shares were traded on a qualified exchange on at least 15 days during each calendar quarter. The Nasdaq, on which the Class A common
shares are listed, is a qualified exchange for this purpose. Once made, the election cannot be revoked without the consent of the IRS
unless the shares cease to be marketable.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If you make the mark-to-market election, you
generally will recognize as ordinary income any excess of the fair market value of your Class A common shares at the end of each
taxable year over their adjusted tax basis, and will recognize an ordinary loss in respect of any excess of the adjusted tax basis
of the Class A common shares over their fair market value at the end of the taxable year (but only to the extent of the net amount
of income previously included as a result of the mark-to-market election). If you make the election, your tax basis in your Class A
common shares will be adjusted to reflect these income or loss amounts. Any gain recognized on the sale or other disposition of
Class A common shares in a year when we are a PFIC will be treated as ordinary income and any loss will be treated as an ordinary
loss (but only to the extent of the net amount of income previously included as a result of the mark-to-market election, with any
excess treated as a capital loss). This election cannot be made with respect to any of our subsidiaries the shares of which are not
regularly traded. Accordingly, you may continue to be subject to tax under the PFIC excess distribution regime with respect to any lower-tier
PFICs notwithstanding your mark-to-market election for the Class A common shares.</p>


<!-- Field: Page; Sequence: 157 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->152<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We do not intend to provide information necessary for
you to make a qualifying electing fund election which would result in alternative treatment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, if we were a PFIC for any taxable year
in which we paid a dividend or for the prior taxable year, the preferential dividend rates discussed above with respect to dividends paid
to certain non-corporate U.S. Holders would not apply.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If you own Class A common shares during any year in
which we are a PFIC, you generally must file annual reports on IRS Form 8621 (or any successor form) with respect to us, generally with
your federal income tax return for that year. A failure to file one or more of these forms as required may toll the running of the statute
of limitations in respect of each of your taxable years for which such form is required to be filed. As a result, the taxable years with
respect to which you fail to file the form may remain open to assessment by the IRS.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">You should consult your tax adviser regarding whether
we are a PFIC and the potential application of the PFIC rules.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Information Reporting and Backup Withholding</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Payments of dividends and sales proceeds that are made
within the United States or through certain U.S.-related financial intermediaries generally are subject to information reporting, and
may be subject to backup withholding, unless (i) you are a corporation or other exempt recipient or (ii) in the case of backup withholding,
you provide a correct taxpayer identification number and certify that you are not subject to backup withholding.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Backup withholding is not an additional tax. The amount
of any backup withholding from a payment to you will be allowed as a refund or credit against your U.S. federal income tax liability and
may entitle you to a refund, provided that the required information is timely furnished to the IRS.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Foreign Financial Asset Reporting</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Certain U.S. Holders who are individuals (and certain
specified entities) may be required to report information relating to their ownership of Class A common shares, or non-U.S. accounts through
which Class A common shares are held. You should consult your tax adviser regarding your reporting obligations with respect to the Class
A common shares.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609518"></span><span id="a_Toc225309270"></span><span id="a_Toc196072511"></span><span id="a_Toc164277211"></span><span id="a_Toc194891147"></span><span id="a_Toc190934985"></span><span id="a_Toc133237684"></span><span id="a_Toc163120278"></span><span id="a_Toc131581006"></span>F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dividends
and Paying Agents</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609519"></span><span id="a_Toc225309271"></span><span id="a_Toc196072512"></span><span id="a_Toc164277212"></span><span id="a_Toc194891148"></span><span id="a_Toc190934986"></span><span id="a_Toc133237685"></span><span id="a_Toc163120279"></span><span id="a_Toc131581007"></span>G.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Statement
by Experts</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609520"></span><span id="a_Toc225309272"></span><span id="a_Toc196072513"></span><span id="a_Toc164277213"></span><span id="a_Toc194891149"></span><span id="a_Toc190934987"></span><span id="a_Toc133237686"></span><span id="a_Toc163120280"></span><span id="a_Toc131581008"></span>H.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Documents
on Display</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to the informational requirements of
the Exchange Act applicable to foreign private issuers. Accordingly, we are required to file reports and other information with the SEC,
including annual reports on Form 20-F within four months from the end of each of our fiscal years, and reports on Form 6-K. You can read
our SEC filings over the Internet at the SEC&#8217;s website at www.sec.gov. You may also read and copy any document we file with the
SEC at its public reference room at 100 F. Street, N.E., Washington, D.C. 20549. You may obtain copies of these documents upon the payment
of the fees prescribed by the SEC. Please call the SEC at 1-800-SEC-0330 for further information about the public reference room.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609521"></span><span id="a_Toc225309273"></span><span id="a_Toc196072514"></span><span id="a_Toc164277214"></span><span id="a_Toc194891150"></span><span id="a_Toc190934988"></span><span id="a_Toc133237687"></span><span id="a_Toc163120281"></span><span id="a_Toc131581009"></span>I.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsidiary
Information</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">See note 2.2 to our consolidated financial statements
for a description of the Company&#8217;s subsidiaries.</p>


<!-- Field: Page; Sequence: 158 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->153<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609522"></span><span id="a_Toc225309274"></span><span id="a_Toc196072515"></span><span id="a_Toc164277215"></span><span id="a_Toc194891151"></span><span id="a_Toc190934989"></span><span id="a_Toc133237688"></span><span id="a_Toc163120282"></span><span id="a_Toc131581010"></span>
J.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Annual Report to Security Holders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If we are required to provide an annual report to security
holders in response to the requirements of Form 6-K, we will submit the annual report to security holders in electronic format in accordance
with the EDGAR Filer Manual.<span id="a_Toc133237689"></span><span id="a_Toc131581011"></span></p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609523"></span><span id="a_Toc225309275"></span><span id="a_Toc196072516"></span><span id="a_Toc164277216"></span><span id="a_Toc194891152"></span><span id="a_Toc190934990"></span><span id="a_Toc163120283"></span>ITEM
11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are exposed to market risks in the ordinary course
of our business, including the effects of interest rate changes and foreign currency fluctuations. We monitor market, credit and operational
risks in line with the objectives in capital management, supported by the oversight of our Board of Directors, in decisions related to
capital management and to ensure their consistency with our objectives and assessment of risks. Information relating to quantitative and
qualitative disclosures about these market risks is described below.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Interest Rate Risk</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Interest rate risk is the risk that the fair value
or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. Our exposure to the risk of
changes in market interest rates relates primarily to cash equivalents, loans and financing and accounts payable to selling shareholders
with floating interest rates.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following table demonstrates the sensitivity to
a reasonably possible change in the current interest rates on cash equivalents, loans and financing and accounts payable to selling shareholders.
With all variables held constant, our income before income taxes is affected through the impact on floating interest rate, as follows:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 5pt 2pt 3pt; width: 46%; text-align: center">&#160;</td>
    <td style="width: 18%; padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Balance as
    of December 31, 2025</p></td>
    <td style="width: 18%; padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Index</p></td>
    <td style="width: 18%; padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Base rate</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 5pt 2pt 3pt; text-align: center">&#160;</td>
    <td colspan="3" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 5pt 2pt 3pt; text-align: center">(amounts in R$ thousands, unless otherwise stated)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Cash equivalents	</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: right">1,086,489</td>
    <td style="padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: center">CDI</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: right">163,781</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5pt; padding-left: 3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt">&#160;</td>
    <td style="padding-right: 5pt; padding-left: 3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Loans and financing	</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: right">(2,049,005)</td>
    <td style="padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: center">CDI</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: right">(323,480)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Loans and financing	</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: right">(5,262)</td>
    <td style="padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: center">TJLP</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: right">(477)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 5pt; padding-left: 3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt">&#160;</td>
    <td style="padding-right: 5pt; padding-left: 3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Accounts payable to selling shareholders	</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: right">(365,656)</td>
    <td style="padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: center">CDI</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: right">(54,483)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Accounts payable to selling shareholders	</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: right">(71,604)</td>
    <td style="padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: center">SELIC</td>
    <td style="vertical-align: top; padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(10,669)</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Net exposure</b>	</td>
    <td style="padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: right">&#160;</td>
    <td style="padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(225,328)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 5pt 2pt 3pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Increase
    in basis points</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 5pt 2pt 3pt; width: 60%; text-align: center">&#160;</td>
    <td style="width: 25%; padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">+75</p></td>
    <td style="width: 25%; padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">+150</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 5pt 2pt 3pt; text-align: center">&#160;</td>
    <td colspan="2" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 5pt 2pt 3pt; text-align: center">(amounts in R$ thousands, unless otherwise stated)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Net effect on profit before tax	</td>
    <td style="padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: right">(10,538)</td>
    <td style="padding-right: 5pt; padding-left: 3pt; font-family: Times New Roman,serif; text-align: right">(21,076)</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For further information, see note 12.4.1 to our consolidated
financial statements included elsewhere in this annual report.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Foreign Currency Risk</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Foreign currency risk is the risk that the fair value
or future cash flows of an exposure will fluctuate because of changes in foreign exchange rates. Our exposure to the risk of changes in
foreign exchange rates relates to cash and cash equivalents denominated in U.S. dollars in the amount of R$23.4 million as of December
31, 2025. See note 12.4.1 to our consolidated financial statements for a sensitivity analysis of the impact of a hypothetical 10% change
in the exchange rate variation on our cash and cash equivalents as of December 31, 2025.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Credit Risk</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Credit risk is the risk that a counterparty will not
meet its obligations under a financial instrument or customer contract, leading to a financial loss. We are exposed to credit risk from
its operating activities (primarily trade receivables) and from its financing activities, including cash and cash equivalents.</p>


<!-- Field: Page; Sequence: 159 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->154<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Customer credit risk is managed by us based on the
established policy, procedures and control relating to customer credit risk management. Outstanding customer receivables are regularly
monitored.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Credit risk from balances with banks and financial
institutions is managed by the treasury department in accordance with our policy. Investments of surplus funds are made only with approved
counterparties and within limits assigned to each counterparty.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The carrying amounts of financial assets are the maximum
exposure to credit risk for the components of the statements of financial position on December 31, 2025 and 2024.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Liquidity Risk</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Management has responsibility for monitoring liquidity
risk. In order to achieve our objective, Management regularly reviews the risk and maintains appropriate reserves, including bank credit
facilities with first tier financial institutions. Management also continuously monitors projected and actual cash flows and the combination
of the maturity profiles of the financial assets and liabilities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The main requirements for financial resources used
by us arise from the need to make payments for suppliers, operating expenses, labor and social obligations, loans and financing and accounts
payable to selling shareholders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For more information, see &#8220;Item 5. Operating
and Financial Review and Prospects&#8212;B. Tabular Disclosure of Contractual Obligations.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609524"></span><span id="a_Toc225309276"></span><span id="a_Toc196072517"></span><span id="a_Toc164277217"></span><span id="a_Toc194891153"></span><span id="a_Toc190934991"></span><span id="a_Toc133237690"></span><span id="a_Toc163120284"></span><span id="a_Toc131581012"></span>ITEM
12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609525"></span><span id="a_Toc225309277"></span><span id="a_Toc196072518"></span><span id="a_Toc164277218"></span><span id="a_Toc194891154"></span><span id="a_Toc190934992"></span><span id="a_Toc133237691"></span><span id="a_Toc163120285"></span><span id="a_Toc131581013"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Debt
Securities</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609526"></span><span id="a_Toc225309278"></span><span id="a_Toc196072519"></span><span id="a_Toc164277219"></span><span id="a_Toc194891155"></span><span id="a_Toc190934993"></span><span id="a_Toc133237692"></span><span id="a_Toc163120286"></span><span id="a_Toc131581014"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Warrants
and Rights</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609527"></span><span id="a_Toc225309279"></span><span id="a_Toc196072520"></span><span id="a_Toc164277220"></span><span id="a_Toc194891156"></span><span id="a_Toc190934994"></span><span id="a_Toc133237693"></span><span id="a_Toc163120287"></span><span id="a_Toc131581015"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other
Securities</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609528"></span><span id="a_Toc225309280"></span><span id="a_Toc196072521"></span><span id="a_Toc164277221"></span><span id="a_Toc194891157"></span><span id="a_Toc190934995"></span><span id="a_Toc133237694"></span><span id="a_Toc163120288"></span><span id="a_Toc131581016"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;American
Depositary Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>


<!-- Field: Page; Sequence: 160 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->155<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 20pt 0 10pt; text-align: center"><span id="a_Toc164277222"></span><span id="a_Toc190934996"></span><span id="a_Toc133237695"></span><span id="a_Toc163120289"></span><span id="a_Toc131581017"></span>
PART II</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609529"></span><span id="a_Toc225309281"></span><span id="a_Toc196072522"></span><span id="a_Toc164277223"></span><span id="a_Toc194891158"></span><span id="a_Toc190934997"></span><span id="a_Toc133237696"></span><span id="a_Toc163120290"></span><span id="a_Toc131581018"></span>ITEM
13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609530"></span><span id="a_Toc225309282"></span><span id="a_Toc196072523"></span><span id="a_Toc164277224"></span><span id="a_Toc194891159"></span><span id="a_Toc190934998"></span><span id="a_Toc133237697"></span><span id="a_Toc163120291"></span><span id="a_Toc131581019"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defaults</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">No matters to report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609531"></span><span id="a_Toc225309283"></span><span id="a_Toc196072524"></span><span id="a_Toc164277225"></span><span id="a_Toc194891160"></span><span id="a_Toc190934999"></span><span id="a_Toc133237698"></span><span id="a_Toc163120292"></span><span id="a_Toc131581020"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Arrears
and delinquencies</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">No matters to report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609532"></span><span id="a_Toc225309284"></span><span id="a_Toc196072525"></span><span id="a_Toc164277226"></span><span id="a_Toc194891161"></span><span id="a_Toc190935000"></span><span id="a_Toc133237699"></span><span id="a_Toc163120293"></span><span id="a_Toc131581021"></span>ITEM
14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609533"></span><span id="a_Toc225309285"></span><span id="a_Toc196072526"></span><span id="a_Toc164277227"></span><span id="a_Toc194891162"></span><span id="a_Toc190935001"></span><span id="a_Toc133237700"></span><span id="a_Toc163120294"></span><span id="a_Toc131581022"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material
modifications to instruments</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">No matters to report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609534"></span><span id="a_Toc225309286"></span><span id="a_Toc196072527"></span><span id="a_Toc164277228"></span><span id="a_Toc194891163"></span><span id="a_Toc190935002"></span><span id="a_Toc133237701"></span><span id="a_Toc163120295"></span><span id="a_Toc131581023"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material
modifications to rights</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">No matters to report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609535"></span><span id="a_Toc225309287"></span><span id="a_Toc196072528"></span><span id="a_Toc164277229"></span><span id="a_Toc194891164"></span><span id="a_Toc190935003"></span><span id="a_Toc133237702"></span><span id="a_Toc163120296"></span><span id="a_Toc131581024"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Withdrawal
or substitution of assets</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">No matters to report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609536"></span><span id="a_Toc225309288"></span><span id="a_Toc196072529"></span><span id="a_Toc164277230"></span><span id="a_Toc194891165"></span><span id="a_Toc190935004"></span><span id="a_Toc133237703"></span><span id="a_Toc163120297"></span><span id="a_Toc131581025"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Change
in trustees or paying agents</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">No matters to report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609537"></span><span id="a_Toc225309289"></span><span id="a_Toc196072530"></span><span id="a_Toc164277231"></span><span id="a_Toc194891166"></span><span id="a_Toc190935005"></span><span id="a_Toc133237704"></span><span id="a_Toc163120298"></span><span id="a_Toc131581026"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Use
of proceeds</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">No matters to report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609538"></span><span id="a_Toc225309290"></span><span id="a_Toc196072531"></span><span id="a_Toc164277232"></span><span id="a_Toc194891167"></span><span id="a_Toc190935006"></span><span id="a_Toc133237705"></span><span id="a_Toc163120299"></span><span id="a_Toc131581027"></span>ITEM
15. CONTROLS AND PROCEDURES</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609539"></span><span id="a_Toc225309291"></span><span id="a_Toc196072532"></span><span id="a_Toc164277233"></span><span id="a_Toc194891168"></span><span id="a_Toc190935007"></span><span id="a_Toc133237706"></span><span id="a_Toc163120300"></span><span id="a_Toc131581028"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosure
Controls and Procedures</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have evaluated, with the participation of our Chief
Executive Officer and Chief Financial Officer, the effectiveness of our &#8220;disclosure controls and procedures,&#8221; as such term
is defined in Rule 13a-15(e) and 15d-15(e) of the Exchange Act, as of December 31, 2025. There are inherent limitations to the effectiveness
of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the
controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving
their control objectives. Based upon our evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure
controls and procedures were effective as of December 31, 2025 to provide reasonable assurance that information required to be disclosed
by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods
specified in the applicable rules and forms, and that it is accumulated and communicated to our management, including our Chief Executive
Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609540"></span><span id="a_Toc225309292"></span><span id="a_Toc196072533"></span><span id="a_Toc164277234"></span><span id="a_Toc194891169"></span><span id="a_Toc190935008"></span><span id="a_Toc133237707"></span><span id="a_Toc163120301"></span><span id="a_Toc131581029"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Management&#8217;s
Annual Report on Internal Control Over Financial Reporting</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our management is responsible for establishing and
maintaining effective internal control over financial reporting as defined in Rule 13a-15(f) of the Exchange Act. Our internal control
over financial reporting is designed to provide reasonable assurance to our management and board of directors regarding the preparation
and fair presentation of published financial statements. Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because
of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p>


<!-- Field: Page; Sequence: 161 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->156<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our management, with the participation of the Chief
Executive Officer and Chief Financial Officer, under the oversight of our board of directors, evaluated the effectiveness of the Company&#8217;s
internal control over financial reporting as of December 31, 2025. In making this assessment, management used the criteria set forth by
the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control &#8212; Integrated Framework (2013), or COSO
2013. Based on this assessment, management believes that, as of December 31, 2025, our internal control over financial reporting was effective,
based on those criteria.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609541"></span><span id="a_Toc225309293"></span><span id="a_Toc196072534"></span><span id="a_Toc164277235"></span><span id="a_Toc194891170"></span><span id="a_Toc190935009"></span><span id="a_Toc133237708"></span><span id="a_Toc163120302"></span><span id="a_Toc131581030"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attestation
Report of the Registered Public Accounting Firm</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The effectiveness of internal control over financial
reporting as of December 31, 2025 has been audited by KPMG Auditores Independentes Ltda., or &#8220;KPMG,&#8221;, the independent registered
public accounting firm that also audited our consolidated financial statements as of and for the year then ended December 31, 2025. The
report dated March 31, 2026, issued by KPMG regarding effectiveness of the internal control over financial reporting as of December 31,
2025, is included herein.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609542"></span><span id="a_Toc225309294"></span><span id="a_Toc196072535"></span><span id="a_Toc164277236"></span><span id="a_Toc194891171"></span><span id="a_Toc190935010"></span><span id="a_Toc133237709"></span><span id="a_Toc163120303"></span><span id="a_Toc131581031"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Changes
in Internal Control Over Financial Reporting</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.25in">There were no significant changes
in our internal control over financial reporting that occurred during the year ended December 31, 2025 that materially affected or are
reasonably likely to materially affect our internal control over financial reporting.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609543"></span><span id="a_Toc225309295"></span><span id="a_Toc196072536"></span><span id="a_Toc164277237"></span><span id="a_Toc194891172"></span><span id="a_Toc190935011"></span><span id="a_Toc133237710"></span><span id="a_Toc163120304"></span><span id="a_Toc131581032"></span>ITEM
16. RESERVED</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609544"></span><span id="a_Toc225309296"></span><span id="a_Toc196072537"></span><span id="a_Toc164277238"></span><span id="a_Toc194891173"></span><span id="a_Toc190935012"></span><span id="a_Toc133237711"></span><span id="a_Toc163120305"></span><span id="a_Toc131581033"></span>ITEM
16A. AUDIT COMMITTEE FINANCIAL EXPERT</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The audit committee, which currently consists of Vanessa
Claro Lopes, Jo&#227;o Paulo Seibel de Faria, Miguel Filisbino Pereira de Paula and Marcelo Ken Suhara, assists our board of directors
in overseeing our accounting and financial reporting processes and the audits of our consolidated financial statements. In addition, the
audit committee is directly responsible for the recommendation for approval by the board of directors of the appointment and compensation,
of our independent registered public accounting firm. Jo&#227;o Paulo Seibel de Faria serves as Chair of the audit committee. The audit
committee consists exclusively of members of our board of directors who are financially literate, and Marcelo Ken Suhara qualifies as
&#8220;audit committee financial expert&#8221; as defined in Item 16A of Form 20-F. Our board of directors has determined that Vanessa
Claro Lopes, Jo&#227;o Paulo Seibel de Faria, Miguel Filisbino Pereira de Paula and Marcelo Ken Suhara satisfy the &#8220;independence&#8221;
requirements set forth in Rule 10A-3 under the Exchange Act. For more information, see &#8220;Item 6. Directors, Senior Management and
Employees&#8212;C. Board Practices&#8212;Board Committees&#8212;Audit Committee.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609545"></span><span id="a_Toc225309297"></span><span id="a_Toc196072538"></span><span id="a_Toc164277239"></span><span id="a_Toc194891174"></span><span id="a_Toc190935013"></span><span id="a_Toc133237712"></span><span id="a_Toc163120306"></span><span id="a_Toc131581034"></span>ITEM
16B. CODE OF ETHICS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our activities are subject to a code of ethics, which
is applicable to all our members and entities, including our directors, officers, managers, teachers and other staff (including interns).
Our code of ethics is also applicable to relevant third parties involved in our activities, such as suppliers, consultants and other service
providers. Our code of ethics describes our mission, vision and values and provides the relevant conduct standards that must be followed
by our members and entities. It regulates our interactions with our suppliers, students, clients, competitors and governmental entities
and agents. Our code of ethics also sets forth fundamental rules of conduct related to the safeguarding of our financial books and records,
conflict of interest situations, the protection of our confidential information and assets and our compliance with applicable laws as
well as relevant information on whistleblowing procedures. All reports are assessed by the Company&#8217;s internal compliance bodies
in accordance with its internal compliance policies, and their conclusions are evaluated by the Internal Ethics and Conduct Commission,
which decides on the actions to be adopted. The Code of Ethics is included as an exhibit to this annual report. We have also posted a
copy of our code of business conduct and ethics on our website at https://ir.afya.com.br/corporate-governance/governance-structure-documents/.</p>


<!-- Field: Page; Sequence: 162 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->157<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609546"></span><span id="a_Toc225309298"></span><span id="a_Toc196072539"></span><span id="a_Toc164277240"></span><span id="a_Toc194891175"></span><span id="a_Toc190935014"></span><span id="a_Toc133237713"></span><span id="a_Toc163120307"></span><span id="a_Toc131581035"></span>
ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span id="a_Hlk164705354"></span>Audit and Non-Audit Fees</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our independent registered public accounting firm was
KPMG for the year ended December 31, 2025 and our independent registered public accounting firm was Ernst &amp; Young Auditores Independentes
S/S Ltda., or EY, for the year ended December 31, 2024. The following table sets forth the aggregate fees by categories specified below
in connection with certain professional services rendered by KPMG or EY, our principal accountants, for the periods indicated.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Year Ended
    December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; width: 70%; text-align: center">&#160;</td>
    <td style="width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2025</p></td>
    <td style="width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2024</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">&#160;</td>
    <td colspan="2" style="font: bold 8pt/9pt Times New Roman,serif; padding: 1pt 2.9pt 2pt; text-align: center">(in R$ millions)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Audit fees (1)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">5.3</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">8.7</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Tax fees (2)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.5</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">0.4</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">All other fees (3)	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">0.3</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">-</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><b>Total fees</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>6.1</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>9.1</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>Audit fees include fees of R$4.2 million for the audit of our consolidated financial
statements; audit of the internal control over financial reporting, audit of statutory financial statements of subsidiaries; review of
our interim financial statements, and, when applicable, audit of financial statements of acquired businesses. From the total amount, R$1.1
million relates to predecessor auditor.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>Tax fees consist of fees for services rendered in connection with the review of our ECF (Escritura&#231;&#227;o Cont&#225;bil
Fiscal) Brazilian tax reporting performed by the predecessor auditor.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0; text-align: right"/><td style="width: 0.25in">(3)</td><td>Consists of fees of R$0.3 million related to limited assurance services rendered in connection with the review of our
                                                                               sustainability annual report, performed in accordance with ISAE 3000.</td>
</tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The policy of our audit committee is to pre-approve
all audit and non-audit services provided by our independent registered public accounting firm, including audit services, audit-related
services, tax services and other services as described above, other than those for <i>de minimus</i> services that are approved by the
audit committee prior to the completion of the audit.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609547"></span><span id="a_Toc225309299"></span><span id="a_Toc196072540"></span><span id="a_Toc164277241"></span><span id="a_Toc194891176"></span><span id="a_Toc190935015"></span><span id="a_Toc133237714"></span><span id="a_Toc163120308"></span><span id="a_Toc131581036"></span>ITEM
16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Company does not rely on any exemptions from the
listing standards for audit committees. See &#8220;Item 6. Directors, Senior Management and Employees&#8212;A. Directors and Senior Management&#8212;Audit
Committee&#8221; for details regarding our board of directors and audit committee.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609548"></span><span id="a_Toc225309300"></span><span id="a_Toc196072541"></span><span id="a_Toc164277242"></span><span id="a_Toc194891177"></span><span id="a_Toc190935016"></span><span id="a_Toc133237715"></span><span id="a_Toc163120309"></span><span id="a_Toc131581037"></span>ITEM
16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Set forth below, in tabular format, is disclosure on
the repurchase of our Class A common shares by us or on our behalf, or by or on behalf of an &#8220;affiliated purchaser&#8221; (as defined
under Rule 10b-18(a)(3) under the Exchange Act), for the year ended December 31, 2025:</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Shares Purchased by the Company</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 39%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Period</p></td>
    <td style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Total Number
    of Shares Purchased(1)</p></td>
    <td style="width: 13%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Average Price
    Paid per Share (2)</p></td>
    <td style="width: 16%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Total Number
    of Shares Purchased as Part of Publicly Announced Plans or Programs (3)</p></td>
    <td style="width: 18%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Maximum Number
    (or Approximate Dollar Value) of Shares that May Yet Be Purchased under the Plans or Programs (2)</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">January 1 to January 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">February 1 to February 28, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">March 1 to March 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">April 1 to April 30, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">May 1 to May 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">June 1 to June 30, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">July 1 to July 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">August 1 to August 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">83,824</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 81.46</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">83,824</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 3,916,176</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">September 1 to September 30, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">52,683</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 81.35</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">52,683</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 3,863,493</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">October 1 to October 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">267,198</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 80.10</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">267,198</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 3,596,295</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">November 1 to November 30, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">207,595</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 79.05</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">207,595</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 3,388,700</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt; font-family: Times New Roman,serif">December 1 to December 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">355,241</p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">R$ 80.19</p></td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">355,241</p></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 3,033,459</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 8.65pt; padding-left: 17.3pt; text-indent: -8.65pt; font-family: Times New Roman,serif"><b>Total</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>966,541</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>R$ 80.09</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>966,541</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For more information on our share repurchase programs, see &#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles
of Association&#8212;Share Repurchases.&#8221;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(2)</td><td>For convenience purposes only, amounts in <i>reais</i> in this column have been converted from U.S. dollars using an exchange rate
of R$5.5024 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2025, as reported by the Central Bank. These translations
should not be considered representations that any such amounts have been, could have been or could be converted at that or any other exchange
rate.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="background-color: white">(3)</span></td><td><span style="background-color: white">Our board of directors has approved our fifth share repurchase program on August 13, 2025. Under
the fifth share repurchase program, Afya may repurchase up to 4,000,000 of its outstanding Class A common shares, in the open market,
based on prevailing market prices, or in privately negotiated transactions, beginning on August 15, 2025 until the earlier of the completion
of the repurchase or December 31, 2026, depending upon market conditions.</span></td></tr></table>


<!-- Field: Page; Sequence: 163 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->158<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center"><span id="a_Hlk164705383"></span>Shares Purchased by
Bertelsmann</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 39%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Period</p></td>
    <td style="width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Total Number
    of Shares Purchased</p></td>
    <td style="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Average Price
    Paid per Share (1)</p></td>
    <td style="width: 15%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Total Number
    of Shares Purchased as Part of Publicly Announced Plans or Programs (2)</p></td>
    <td style="width: 17%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Maximum Number
    (or Approximate Dollar Value) of Shares that May Yet Be Purchased under the Plans or Programs (1)</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">January 1 to January 31, 2025	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">308,414</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 86.99</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">308,414</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 15,365,193.09</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">February 1 to February 28, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">412,952</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 93.57</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">412,952</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">R$ 8,342,442.87</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">March 1 to March 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">April 1 to April 30, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">May 1 to May 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">June 1 to June 30, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">July 1 to July 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">August 1 to August 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">September 1 to September 30, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">October 1 to October 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">November 1 to November 30, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">December 1 to December 31, 2025	</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8211;</p></td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8211;</p></td>
    <td style="text-align: right; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8211;</p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#8211;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-right: 8.65pt; padding-left: 17.3pt; font-family: Times New Roman,serif; text-indent: -8.65pt"><b>Total</b>	</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>721,366</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>R$90.28</b></p></td>
    <td style="text-align: right; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>721,366</b></p></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: right">&#160;</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">(1)</td><td>For convenience purposes only, amounts in <i>reais</i> in this column have been converted from U.S. dollars using an exchange rate
of R$5.5024 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2025, as reported by the Central Bank. These translations
should not be considered representations that any such amounts have been, could have been or could be converted at that or any other exchange
rate.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="background-color: white">(2)</span></td><td><span style="background-color: white">On May 26, 2022, Bertelsmann entered into a trading plan pursuant to Rule 10b5-1 under the
                                                                                                         Exchange Act with an unaffiliated third-party broker (the &#8220;Bertelsmann Existing Trading Plan&#8221;)</span>, which was
                                                                                                         publicly announced on May 27, 2022<span style="background-color: white">. Under the Bertelsmann Existing Trading Plan, the broker is
                                                                                                         authorized and directed to purchase Class A common shares of the Company in open
market transactions on behalf of Bertelsmann, subject to certain conditions, with an aggregate purchase price of up to US$129.0 million,
beginning on June 27, 2022, until the earlier of the completion of the repurchase or September 25, 2023, unless terminated earlier in
accordance with its terms<span style="background-color: white">. See Amendment No. 6 to the report on Schedule 13D filed by Bertelsmann
with the SEC on May 27, 2022. On December 15, 2022, Bertelsmann entered into an amendment to the Bertelsmann Existing Trading Plan (the
&#8220;Bertelsmann Trading Plan Amendment&#8221;)</span>, which was publicly announced on December 16, 2022<span style="background-color: white">.
Under the Bertelsmann Trading Plan Amendment, the broker is authorized and directed to purchase an additional number of Class A common
shares of the Company in open market transactions on behalf of Bertelsmann, subject to certain conditions, with an aggregate purchase
price of up to US$200.0 million. Such additional purchases may only commence once the purchases under the Bertelsmann Existing Trading
Plan have been completed but in no event before January 16, 2023. In addition, the Bertelsmann Trading Plan Amendment extended the term
of the Bertelsmann Existing Trading Plan to May 31, 2024, unless terminated earlier in accordance with its terms. See Amendment No. 13
to the report on Schedule 13D filed by Bertelsmann with the SEC on December 16, 2022. On May 21, 2024, Bertelsmann entered into an amendment
to the Trading Plan (the &#8220;Trading Plan Amendment&#8221;). Under the Trading Plan Amendment, the term of the Existing Trading Plan
was extended until May 31, 2026 (unless terminated earlier in accordance with its terms), and in addition the purchasing guidelines for
the Broker for purchases under the Existing Trading Plan were modified. Purchases under the Trading Plan Amendment may only commence thirty
days after the date of the Trading Plan Amendment. There can be no certainty that any Class A common shares will be purchased under the
Trading Plan Amendment.</span></span></td></tr></table>


<!-- Field: Page; Sequence: 164 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->159<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609549"></span><span id="a_Toc225309301"></span><span id="a_Toc196072542"></span><span id="a_Toc164277243"></span><span id="a_Toc194891178"></span><span id="a_Toc190935017"></span><span id="a_Toc133237716"></span><span id="a_Toc163120310"></span><span id="a_Toc131581038"></span>ITEM
16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">EY was appointed to act as our independent registered
public accounting firm to audit our consolidated financial statements as of and for the years ended December&#160;31, 2024 and 2023. On
June 2, 2025, our board of directors, following the recommendation of our audit committee, approved the engagement of KPMG to provide
independent auditing services for the Company, replacing EY as our independent registered public accounting firm.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">EY&#8217;s reports on our consolidated financial statements
for the years ended December&#160;31, 2024 and 2023 did not contain an adverse opinion or disclaimer of opinion, nor was any report qualified
or modified as to uncertainty, audit scope or accounting principles.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">During the Company&#8217;s fiscal years ended December&#160;31,
2024 and 2023 and the subsequent interim period through June 2, 2025, there were no disagreements with EY, whether or not resolved, on
any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedures, which disagreement,
if not resolved to the satisfaction of EY, would have caused EY to make a reference to the subject matter of the disagreement in connection
with any reports it would have issued, and there were no &#8220;reportable events&#8221; as that term is defined in Item 16F(a)(1)(v)
of Form&#160;20-F.&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have provided EY with a copy of the foregoing disclosure,
and we have requested that it furnish us with a letter addressed to the SEC stating whether or not it agrees with the above disclosures.
A copy of this letter is filed as Exhibit 16.1 to this Form&#160;20-F.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We did not consult KPMG during the Company&#8217;s
fiscal years ended December&#160;31, 2024 and 2023 and the subsequent interim period through June 2, 2025 regarding the application of
accounting principles to a specific transaction, either completed or proposed, or regarding the type of audit opinion that might be rendered
by KPMG on our consolidated financial statements. Furthermore, KPMG did not provide any written report or oral advice that KPMG concluded
was an important factor considered by us in reaching a decision as to any such accounting, auditing or financial reporting.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609550"></span><span id="a_Toc225309302"></span><span id="a_Toc196072543"></span><span id="a_Toc164277244"></span><span id="a_Toc194891179"></span><span id="a_Toc190935018"></span><span id="a_Toc133237717"></span><span id="a_Toc163120311"></span><span id="a_Toc131581039"></span>ITEM
16G. CORPORATE GOVERNANCE</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Cayman Islands law restricts transactions between a
company and its directors unless there are provisions in the Articles of Association which provide a mechanism to alleviate possible conflicts
of interest. Additionally, Cayman Islands law imposes on directors&#8217; duties of care and skill and fiduciary duties to the companies
which they serve. Under our Articles of Association, a director must disclose the nature and extent of his interest in any contract or
arrangement, and following such disclosure and subject to any separate requirement under applicable law or the listing rules of the Nasdaq,
and unless disqualified by the chairman of the relevant meeting, the interested director may vote in respect of any transaction or arrangement in which he or she
is interested. The interested director shall be counted in the quorum at such meeting and the resolution may be passed by a majority of
the directors present at the meeting.</p>


<!-- Field: Page; Sequence: 165 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->160<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Foreign Private Issuer Status</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing and our Articles of Association,
our directors may exercise all the powers of Afya to vote compensation to themselves or any member of their body in the absence of an
independent quorum. Our Articles of Association provide that, in the event a Compensation Committee is established, it shall be made up
of such number of independent directors as is required from time to time by the Nasdaq rules (or as otherwise may be required by law).
We currently have no intention to establish a Compensation Committee.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a foreign private issuer, we are permitted to follow
home country practice in lieu of certain Nasdaq corporate governance rules, subject to certain requirements. We currently rely, and will
continue to rely, on the foreign private issuer exemption with respect to the following rules:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5605(b), which requires that independent directors comprise a majority of a company&#8217;s board of directors. As allowed
by the laws of the Cayman Islands, independent directors do not comprise a majority of our board of directors.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5605(e)(1), which requires that a company have a nominations committee comprised solely of &#8220;independent directors&#8221;
as defined by Nasdaq. As allowed by the laws of the Cayman Islands, we do not have a nominations committee nor do we have any current
intention to establish one.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5605(d) &amp; (e), which require that compensation for our executive officers and selection of our director nominees be
determined by a majority of independent directors. As allowed by the laws of the Cayman Islands, we do not have a nomination and corporate
governance committee or remuneration committee nor do we have any current intention to establish either.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5635, which requires an issuer to obtain shareholder approval prior to an issuance of securities (in certain circumstances)
in connection with certain events, including: (i) the acquisition of the stock or assets of another company; (ii) equity-based compensation
of officers, directors, employees or consultants; (iii) a change of control; and (iv) private placements. Cayman Islands law does not
require shareholder approval prior to an issuance of securities to the extent the securities are authorized.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5250(b)(3) and Rule 5250(d), which require certain disclosures of third party director and nominee compensation and distribution
of annual and interim reports, respectively. As allowed by the laws of the Cayman Islands, we are not required to disclose such compensation
or distribute reports in the manner specified by such rule.</td></tr></table>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609551"></span><span id="a_Toc225309303"></span><span id="a_Toc196072544"></span><span id="a_Toc164277245"></span><span id="a_Toc194891180"></span><span id="a_Toc190935019"></span><span id="a_Toc133237718"></span><span id="a_Toc163120312"></span><span id="a_Toc131581040"></span>ITEM
16H. MINE SAFETY DISCLOSURE</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609552"></span><span id="a_Toc225309304"></span><span id="a_Toc196072545"></span><span id="a_Toc164277246"></span><span id="a_Toc194891181"></span><span id="a_Toc190935020"></span><span id="a_Toc133237719"></span><span id="a_Toc163120313"></span><span id="a_Toc131581041"></span>ITEM
16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609553"></span><span id="a_Toc225309305"></span><span id="a_Toc196072546"></span><span id="a_Toc164277247"></span><span id="a_Toc194891182"></span><span id="a_Toc190935021"></span><span id="a_Toc163120314"></span>ITEM
16J. INSIDER TRADING POLICIES</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="a_Toc164277248"></span>We maintain <span id="xdx_904_eecd--InsiderTrdPoliciesProcAdoptedFlag_dbT_c20250101__20251231_zlCCW619kxF3" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBQb2xpY2llcyBhbmQgUHJvY2VkdXJlcwA_"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleantrue" id="Fact000069" name="ecd:InsiderTrdPoliciesProcAdoptedFlag">insider trading
policies</ix:nonNumeric></span> and procedures governing the purchase, sale, and/or other dispositions of our Company&#8217;s Class A common shares by directors,
officers, and employees, as well as the Company itself, that we believe are reasonably designed to promote compliance with insider trading
laws, rules, and regulations, as well as Nasdaq listing standards. A copy of our insider trading policy was filed as Exhibit 11.2 to our
annual report on Form 20-F.</p>


<!-- Field: Page; Sequence: 166 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->161<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Hlk161990523"></span><span id="a_Hlk161990408"></span><span id="a_Hlk164268893"></span><span id="a_Toc215609554"></span><span id="a_Toc225309306"></span><span id="a_Toc196072547"></span><span id="a_Toc194891183"></span><span id="a_Toc163120315"></span><span id="a_Toc152201358"></span><span id="a_Toc190935022"></span>
ITEM 16K. CYBERSECURITY</p>

<p id="xdx_98A_ecyd--CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_iB_c20250101__20251231_gBFCRMPFAIAMT-NLZAK_zLpb9pnjMON1" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" continuedAt="ConU000078-01" escape="true" id="Fact000078" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"><b style="display: none">Risk Management and Strategy</b></ix:nonNumeric></p>

<div id="xdx_C01_gBFCRMPFAIAMT-NLZAK_zKSMlDISzkp5"><ix:continuation continuedAt="ConU000078-02" id="ConU000078-01"><p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Overview</p></ix:continuation></div>

<div id="xdx_C0A_gBFCRMPFAIAMT-NLZAK_zw8CSF0RHS9b"><ix:continuation continuedAt="ConU000078-03" id="ConU000078-02"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Company has policies and procedures in place to
address information technology and cybersecurity risks as part of its corporate risk management process. These processes are integrated
into Afya&#8217;s enterprise risk management (ERM) framework to ensure alignment with our overall approach to corporate risk. This includes
activities such as risk identification, classification, and mitigation, as well as the development of action plans aligned with industry
best practices.</p></ix:continuation></div>

<div id="xdx_C04_gBFCRMPFAIAMT-NLZAK_zm6zdEdQilU9"><ix:continuation continuedAt="ConU000078-04" id="ConU000078-03"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Cybersecurity initiatives at Afya are overseen by our
Chief Information Security Office, or CISO. The CISO&#8217;s responsibilities include defining and aligning action plans with Afya&#8217;s
corporate risk management team. Additionally, the CISO serves as the Data Protection Officer, handling privacy and data protection matters
and defining cybersecurity strategies for the entire company. This includes ensuring effective monitoring, threat detection, response
to events and incidents, and overall cybersecurity management. Cybersecurity monitoring with respect to our newly acquired companies is
managed from the outset by our IT technical team. Exposure to risk during this period is naturally greater as such acquired company is
not always mature in terms of cybersecurity risk management, but we seek to mitigate these risks by making adjustments to their practices
and applying our policies.</p></ix:continuation></div>

<div id="xdx_C06_gBFCRMPFAIAMT-NLZAK_zjDqNzg4X8d9"><ix:continuation continuedAt="ConU000078-05" id="ConU000078-04"><p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Risk Management and Strategy</p></ix:continuation></div>

<div id="xdx_C04_gBFCRMPFAIAMT-NLZAK_zkcQ3i7h5Fs1"><ix:continuation continuedAt="ConU000078-06" id="ConU000078-05"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya has comprehensive policies, procedures, and a
dedicated risk management team responsible for addressing corporate risks across various themes, including strategic, operational, financial,
and compliance areas. Within each theme, Afya identifies and manages risks related to quality, procurement, cybersecurity, privacy and
data protection, financial reporting, legal compliance, regulatory matters, as well as risks related to ESG.</p></ix:continuation></div>

<div id="xdx_C0D_gBFCRMPFAIAMT-NLZAK_z0jBs1FtLS6b"><ix:continuation continuedAt="ConU000078-07" id="ConU000078-06"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Company follows a structured approach, including
a risk matrix with defined risk levels and criticality, which guides the need for risk treatment and the development of action plans.
<span id="xdx_90E_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20250101__20251231_zJIUVjcAO06h" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleantrue" id="Fact000079" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">These plans are monitored by the responsible parties for each theme under the oversight of the risk and controls department.</ix:nonNumeric></span> <span id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20250101__20251231_zjqhMoD1cRii" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000080" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock">Furthermore,
Afya has an assessment process that evaluates cybersecurity, privacy, and data protection policies of critical suppliers before onboarding.
This process aligns with frameworks such as COSO-ERM and COSO Internal Control - <span id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20250101__20251231_zMaUWL0wXdM5" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleantrue" id="Fact000081" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag">Integrated</ix:nonNumeric></span> Framework.</ix:nonNumeric></span> To ensure compliance with industry
standards and enhance cybersecurity maturity levels, Afya engages specialized companies to review its plans and procedures, aiming to
adopt market best practices.</p></ix:continuation></div>

<div id="xdx_C09_gBFCRMPFAIAMT-NLZAK_zDvt2w9bTvdf"><ix:continuation continuedAt="ConU000078-08" id="ConU000078-07"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Within the further detailed governance scheme, the
Company has established the audit, risk, and ethics committee to oversee risk management guidelines through a structured approach known
as the three lines of defense:</p></ix:continuation></div>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>First Line of Defense</i>: This comprises risk owners who are responsible for executing processes, identifying risks, and implementing
action plans. Working closely with the risk and controls department, they proactively identify potential risks within their operations,
including financial, operational, and cybersecurity aspects. This includes analyzing activities and relationships with suppliers and third
parties.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Second Line of Defense</i>: The compliance, corporate risks, and internal controls area collaborates with risk owners to monitor
risks and action plans. The risk and controls department coordinates progress and action plans in partnership with internal audit teams
and other Afya units such as the technology team, the information security team, and the privacy team. They report their findings to the
audit, risk, and ethics committee.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Third Line of Defense</i>: Represented by the internal audit team, this line conducts independent evaluations for management. They
perform substantive tests of internal controls to detect operational and financial deviations resulting from failures or fraudulent activities.</td></tr></table>

<div id="xdx_C07_gBFCRMPFAIAMT-NLZAK_zWxit9VzbXn"><ix:continuation id="ConU000078-08"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For the monitoring and response to cyber incidents,
Afya has teams responsible for detecting and monitoring the Company&#8217;s environment, performing threat intelligence analysis, conducting
intrusion testing, and verifying the coverage and effectiveness of its detection and monitoring tools.</p></ix:continuation></div>


<!-- Field: Page; Sequence: 167 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->162<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p id="xdx_989_ecyd--CybersecurityRiskBoardOfDirectorsOversightTextBlock_c20250101__20251231_gBFCRBODOTB-XZ_zVi1hdBFpp3d" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" continuedAt="ConU000089-01" escape="true" id="Fact000089" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock">Governance</ix:nonNumeric></p>

<div id="xdx_C06_gBFCRBODOTB-XZ_zw9uBrrwekik"><ix:continuation continuedAt="ConU000089-02" id="ConU000089-01"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya places significant emphasis on cybersecurity within
its information technology area, covering areas such as incident management, information technology governance, privacy and data protection,
cybersecurity, infrastructure, and systems management. <span id="xdx_909_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_c20250101__20251231_zVkFW06F3D2l" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000090" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">These efforts are led by <span id="xdx_908_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20250101__20251231_zUjZtfj6cte4" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleantrue" id="Fact000091" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">our chief information officer, or CIO</ix:nonNumeric></span>, and our CISO. The
CISO, drawing from extensive experience in leading technology and information security departments in large companies, is responsible
for developing a proactive security strategy capable of continuous threat exposure management, in balance with the organization&#8217;s
business goals.</ix:nonNumeric></span> This includes ensuring compliance with relevant information security and data privacy regulations, conducting training
for the security team and promoting user awareness to keep stakeholders informed about emerging technologies and threats.</p></ix:continuation></div>

<div id="xdx_C09_gBFCRBODOTB-XZ_zwt1RVGic11i"><ix:continuation continuedAt="ConU000089-03" id="ConU000089-02"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="xdx_900_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250101__20251231_zwvX3hCilYj2" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000092" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">Afya&#8217;s governance structure includes the audit,
risk, and ethics committee, which oversees risks identified by the risk and controls department, including cyber risks.</ix:nonNumeric></span> <span id="xdx_90A_ecyd--CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_c20250101__20251231_zpKhXmXTeEjk" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000093" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">The audit, risk,
and ethics committee reports to our <span id="xdx_90F_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_dbT_c20250101__20251231_zuUcoGh3ttP" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleantrue" id="Fact000094" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">board of directors</ix:nonNumeric></span> on a quarterly basis and, where applicable, review of specific incident responses.</ix:nonNumeric></span>
<span id="xdx_90B_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250101__20251231_zY3dFlRPx7Bf" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000095" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">Our board of directors then sets strategic objectives and monitors the company&#8217;s risk landscape and corresponding action plans.</ix:nonNumeric></span></p></ix:continuation></div>

<div id="xdx_C05_gBFCRBODOTB-XZ_zuvzazYv2M19"><ix:continuation continuedAt="ConU000089-04" id="ConU000089-03"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="xdx_905_ecyd--CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_c20250101__20251231_zrREuBV8rDAb" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000096" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">Afya&#8217;s cybersecurity team holds regular meetings
to ensure continuous alignment and enhancement of the infrastructure and technology supporting the organization&#8217;s cybersecurity
strategy.</ix:nonNumeric></span> Potential improvements are identified and evaluated for feasibility and implementation in accordance with internal governance
processes. Afya continuously adopts and invests in technological solutions to strengthen its cybersecurity posture, enhancing monitoring,
threat detection, incident response, recovery, and protection capabilities across the organization.</p></ix:continuation></div>

<div id="xdx_C0C_gBFCRBODOTB-XZ_zL4LoeMFiG34"><ix:continuation continuedAt="ConU000089-05" id="ConU000089-04"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span id="xdx_90C_ecyd--CybersecurityRiskRoleOfManagementTextBlock_c20250101__20251231_zvCDNHKXqHJ" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000097" name="cyd:CybersecurityRiskRoleOfManagementTextBlock">In terms of disaster preparedness, Afya has a comprehensive
disaster recovery plan that includes a dedicated committee, trigger mechanisms, and defined recovery points focused on the Company&#8217;s
infrastructure. Additionally, Afya maintains a robust business continuity plan involving key teams and critical service mapping, with
criteria for defining criticality, financial impact, and brand reputation.</ix:nonNumeric></span></p></ix:continuation></div>

<div id="xdx_C00_gBFCRBODOTB-XZ_zvlovbuO2rvj"><ix:continuation continuedAt="ConU000089-06" id="ConU000089-05"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya&#8217;s privacy team is responsible for addressing
risks and controls related to personal data. They adhere to industry best practices such as ISO27000, LGPD, GDPR, and the NIST Cybersecurity
Framework, leveraging governance, risk management and compliance solutions to support their risk management processes.</p></ix:continuation></div>

<div id="xdx_C07_gBFCRBODOTB-XZ_zwqeIwR5amE1"><ix:continuation continuedAt="ConU000089-07" id="ConU000089-06"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">According to processes and controls established by
Afya, as of December 31, 2025, <span id="xdx_902_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20250101__20251231_zNemqp6VQP6a" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000098" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">no events were identified that could indicate the materialization of risks or the identification of material
incidents under the cybersecurity aspect that <span id="xdx_904_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbT_c20250101__20251231_zAEWZ3w1Nql8" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" format="ixt:booleantrue" id="Fact000099" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">affected or could affect</ix:nonNumeric></span> the business strategy, results of operations, or financial condition
of the company.</ix:nonNumeric></span> Minor incidents that occurred during the period were identified, treated, and communicated in accordance with the protocols,
policies, and procedures established for response. However, despite our efforts, we cannot eliminate all risks from cybersecurity threats,
or provide assurances that we have not experienced an undetected cybersecurity incident.</p></ix:continuation></div>

<div id="xdx_C0C_gBFCRBODOTB-XZ_zZwXfAFvktA5"><ix:continuation id="ConU000089-07"><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For more information about these risks, please see
&#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks Relating to Our Business and Industry&#8212; Failure to prevent or detect
a malicious cyber-attack on our systems and databases could result in a misappropriation of confidential information or access to highly
sensitive information&#8221; and &#8220;&#8212;Our success depends on our ability to monitor and adapt to technological changes and maintain
a technological infrastructure that works adequately and without interruption&#8221; in this annual report.</p></ix:continuation></div>


<!-- Field: Page; Sequence: 168 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->163<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: bold 10pt Times New Roman,serif; margin: 20pt 0 10pt; text-transform: uppercase; text-align: center"><span id="a_Toc215609555"></span><span id="a_Toc225309307"></span><span id="a_Toc196072548"></span><span id="a_Toc164277249"></span><span id="a_Toc194891184"></span><span id="a_Toc190935023"></span><span id="a_Toc133237720"></span><span id="a_Toc163120316"></span><span id="a_Toc131581042"></span>
PART III</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609556"></span><span id="a_Toc225309308"></span><span id="a_Toc196072549"></span><span id="a_Toc164277250"></span><span id="a_Toc194891185"></span><span id="a_Toc190935024"></span><span id="a_Toc133237721"></span><span id="a_Toc163120317"></span><span id="a_Toc131581043"></span>ITEM
17. FINANCIAL STATEMENTS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have responded to Item 18 in lieu of this item.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609557"></span><span id="a_Toc225309309"></span><span id="a_Toc196072550"></span><span id="a_Toc164277251"></span><span id="a_Toc194891186"></span><span id="a_Toc190935025"></span><span id="a_Toc133237722"></span><span id="a_Toc163120318"></span><span id="a_Toc131581044"></span>ITEM
18. FINANCIAL STATEMENTS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">See our consolidated financial statements beginning
on page F-1.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_Toc215609558"></span><span id="a_Toc225309310"></span><span id="a_Toc196072551"></span><span id="a_Toc164277252"></span><span id="a_Toc194891187"></span><span id="a_Toc190935026"></span><span id="a_Toc163120319"></span><span id="a_Toc133237723"></span><span id="a_Toc131581045"></span>ITEM
19. EXHIBITS</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 10%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Exhibit<br/>
    No.</p></td>
    <td style="width: 90%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Description</p></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281423001938/ex01-4.htm"><span style="font-size: 10pt">1.1</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281423001938/ex01-4.htm"><span style="font-size: 10pt">Amended and Restated Memorandum and Articles of Association of Afya adopted on April 29, 2022, effective as of May 4, 2022 (incorporated by reference to Exhibit 1.4 of the Registrant&#8217;s Annual Report on Form 20-F filed with the SEC on April 28, 2023).</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="ex02-1.htm"><span style="font-size: 10pt">2.1*</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="ex02-1.htm"><span style="font-size: 10pt; background-color: white">Description of Securities registered under Section 12 of the Exchange Act.</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_3.htm"><span style="font-size: 10pt">4.1 &#8224;</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_3.htm"><span style="font-size: 10pt">English translation of Purchase Agreement dated as of November 27, 2018, among NRE Participa&#231;&#245;es S.A., JC JOINT Fundo de Investimento em Participa&#231;&#245;es Multiestrat&#233;gia, Breno Miranda Trabulo Pinheiro Correia and Cristina Maria Miranda de Sousa (incorporated herein by reference to Exhibit 10.3 to the Registration Statement on Form F-1 filed with the SEC on July 9, 2019, File No. 333-232309).</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_4.htm"><span style="font-size: 10pt">4.2 &#8224;</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_4.htm"><span style="font-size: 10pt">English translation of Purchase Agreement dated as of December 5, 2018, among NRE Participa&#231;&#245;es S.A., Jo&#227;o Carlos Ribeiro Pedroso, Leoni Margarida Bertolin, Jos&#233; Carlos Janu&#225;rio, Ricardo Pedroso, Daiane Pedroso Canto and RD Administra&#231;&#227;o e Participa&#231;&#227;o Ltda. (incorporated herein by reference to Exhibit 10.4 to the Registration Statement on Form F-1 filed with the SEC on July 9, 2019, File No. 333-232309).</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="ex04-3.htm"><span style="font-size: 10pt">4.3*&#8224;</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="ex04-3.htm">
   Loan Agreement between Afya Participa&#231;&#245;es
S.A. and International Finance Corporation dated as of July 22, 2024.</a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="ex04-4.htm"><span style="font-size: 10pt">4.4*&#8224;</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="ex04-4.htm"><span style="font-size: 10pt">English translation of the First Issue of Registered Commercial Notes, in Two Series, for Private Placement, issued by Afya Participa&#231;&#245;es S.A. dated as of October 8, 2025.</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="ex08-1.htm"><span style="font-size: 10pt">8.1*</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="ex08-1.htm"><span style="font-size: 10pt">List of Subsidiaries.</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="ex11-1.htm"><span style="font-size: 10pt">11.1*</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="ex11-1.htm"><span style="font-size: 10pt">Code of Ethics and Conduct</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281425001707/ex11-2.htm"><span style="font-size: 10pt">11.2</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281425001707/ex11-2.htm"><span style="font-size: 10pt">Insider Trading Policy&#160;(incorporated by reference to Exhibit 11.2 of the Registrant&#8217;s Annual Report on Form 20-F filed with the SEC on April 28, 2025). </span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="ex12-1.htm"><span style="font-size: 10pt">12.1*</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="ex12-1.htm"><span style="font-size: 10pt">Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act.</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="ex12-2.htm"><span style="font-size: 10pt">12.2*</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="ex12-2.htm"><span style="font-size: 10pt">Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act.</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="ex13-1.htm"><span style="font-size: 10pt">13.1*</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="ex13-1.htm"><span style="font-size: 10pt">Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act.</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="ex13-2.htm"><span style="font-size: 10pt">13.2*</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="ex13-2.htm"><span style="font-size: 10pt">Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act.</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="ex16-1.htm"><span style="font-size: 10pt">16.1*</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="ex16-1.htm"><span style="font-size: 10pt">Letter regarding change in certifying accountant.</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="ex23-1.htm"><span style="font-size: 10pt">23.1*</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="ex23-1.htm"><span style="font-size: 10pt">Consent of Ernst &amp; Young Auditores Independentes S.S. Ltda.</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="ex23-2.htm"><span style="font-size: 10pt">23.2*</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="ex23-2.htm"><span style="font-size: 10pt">Consent of </span>KPMG Auditores Independentes Ltda.</a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281424001607/ex97-1.htm"><span style="font-size: 10pt">97.1</span></a></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><a href="https://www.sec.gov/Archives/edgar/data/1771007/000129281424001607/ex97-1.htm"><span style="font-size: 10pt">Compensation recoupment policy, dated November 30, 2023 (incorporated herein by reference to Exhibit 97.1 to the annual report on Form 20-F for the year ended December 31, 2023, filed with the SEC on April 26, 2024).</span></a></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><span style="font-size: 10pt">101.INS*</span></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><span style="font-size: 10pt">Inline XBRL Instance Document</span></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><span style="font-size: 10pt">101.SCH*</span></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Schema Document</span></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><span style="font-size: 10pt">101.CAL*</span></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><span style="font-size: 10pt">101.DEF*</span></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><span style="font-size: 10pt">101.LAB*</span></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><span style="font-size: 10pt">101.PRE*</span></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr>
  <tr>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif"><span style="font-size: 10pt">104*</span></td>
    <td style="padding-right: 9.35pt; text-indent: 0in; font-family: Times New Roman,serif"><span style="font-size: 10pt">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).</span></td></tr>
  </table>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 20%"><div style="border-top: Gray 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 2%">*</td><td>Filed herewith.</td></tr></table>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0pt; margin-bottom: 4.5pt">
<tr style="vertical-align: top">
  <td style="width: 2%">&#8224;</td>
  <td style="width: 98%">Certain provisions, exhibits and schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K.</td></tr>
</table>



<!-- Field: Page; Sequence: 169 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->164<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">SIGNATURES</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The registrant hereby certifies that it meets all of
the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on Form
20-F on its behalf.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="padding-right: 5.75pt; padding-bottom: 24pt; font-family: Times New Roman,serif"><b>AFYA LIMITED</b></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 3%; padding-right: 5.75pt; font-family: Times New Roman,serif">By:</td>
    <td style="border-bottom: Black 1pt solid; width: 37%; padding-right: 5.75pt; font-family: Times New Roman,serif">/s/ Virgilio Deloy Capobianco Gibbon</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding-right: 5.75pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-right: 5.75pt; font-family: Times New Roman,serif">Name:	Virgilio Deloy Capobianco Gibbon</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding-right: 5.75pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-right: 5.75pt; font-family: Times New Roman,serif">Title:	Chief Executive Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="padding-right: 5.75pt; padding-bottom: 24pt; font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 3%; padding-right: 5.75pt; font-family: Times New Roman,serif">By:</td>
    <td style="border-bottom: Black 1pt solid; width: 37%; padding-right: 5.75pt; font-family: Times New Roman,serif">/s/ Luis Andr&#233; Carpintero Blanco</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding-right: 5.75pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-right: 5.75pt; font-family: Times New Roman,serif">Name:	Luis Andr&#233; Carpintero Blanco</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="padding-right: 5.75pt; font-family: Times New Roman,serif">&#160;</td>
    <td style="padding-right: 5.75pt; font-family: Times New Roman,serif">Title:	Chief Financial Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Date: March 31 2026</p>

<p style="font: 10pt Times New Roman,serif; margin: 0"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 170 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->165<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 20pt 0 10pt; text-transform: uppercase; text-align: center"><span id="a_Toc215609559"></span><span id="a_Toc225309311"></span><span id="a_Toc196072552"></span><span id="a_Toc164277253"></span><span id="a_Toc194891188"></span><span id="a_Toc190935027"></span><span id="a_Toc133237724"></span><span id="a_Toc163120320"></span><span id="a_Toc131581046"></span>
Index to Financial Statements</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Audited Consolidated Statements&#8212;Afya Limited</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right"><span style="text-decoration: underline">Page</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 90%; padding-right: 0.1in; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><a href="#a_007">Report of Independent Registered Public Accounting Firm (PCAOB ID: <span id="xdx_902_edei--AuditorFirmId_c20250101__20251231_zYV8mFnKZLIi"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000100" name="dei:AuditorFirmId">1124</ix:nonNumeric></span>)	</a></td>
    <td style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right"><a href="#a_007">F-1</a></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 0.1in; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><a href="#a_006">Report of Independent Registered Public Accounting Firm (PCAOB ID: 1448)	</a></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right"><a href="#a_006">F-4</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.1in; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><a href="#a_0001">Consolidated Statements of Financial Position as of December 31, 2025 and 2024	</a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right"><a href="#a_0001">F-5</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.1in; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><a href="#a_0002">Consolidated Statements of Income and Other Comprehensive Income for the years ended December 31, 2025, 2024 and 2023	</a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right"><a href="#a_0002">F-6</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.1in; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><a href="#a_0003">Consolidated Statements of Changes in Equity for the years ended December 31, 2025, 2024 and 2023	</a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right"><a href="#a_0003">F-7</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.1in; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><a href="#a_0004">Consolidated Statements of Cash Flows for the years ended December 31, 2025, 2024 and 2023	</a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right"><a href="#a_0004">F-8</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.1in; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt"><a href="#a_0005">Notes to the Consolidated Financial Statements for the years ended December 31, 2025, 2024 and 2023	</a></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman,serif; text-align: right"><a href="#a_0005">F-9</a></td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">&#160;</p>


<!-- Field: Page; Sequence: 171 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center">&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->166<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents001">Table of Contents</a>&#160;</td></tr><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">&#160;</p>

<p style="font: 19.5pt Nunito Sans; margin: 0; color: #C00000"><b></b></p>

<p style="font: 19.5pt Nunito Sans; margin: 0; color: #C00000"><b>&#160;Afya Limited</b></p>

<p style="font: 19.5pt Nunito Sans; margin: 0; color: #C00000"><b>&#160;&#160;</b></p>

<p style="font: 19.5pt Nunito Sans; margin: 0; color: #C00000"><b>&#160;</b></p>

<p style="font: 14.5pt Nunito Sans; margin: 0; color: #C00000"><b>Consolidated financial statements</b></p>

<p style="font: 14.5pt Nunito Sans; margin: 0; color: #C00000"><b>as of December 31, 2025 and 2024 and</b></p>

<p style="font: 14.5pt Nunito Sans; margin: 0; color: #C00000"><b>for the years ended December 31, 2025, 2024 and 2023</b></p>

<p style="font: 14.5pt Nunito Sans; margin: 0; color: #C00000"><b>&#160;</b></p>

<p style="font: 14.5pt Nunito Sans; margin: 0; color: #C00000"><b></b></p>

<!-- Field: Page; Sequence: 172; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt">&#160;</div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: left; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 14.5pt Nunito Sans; margin: 0; color: #C00000"><b>&#160;</b></p>
<p style="font: bold 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 20pt; text-align: center"><span id="a_007"></span>Report of Independent Registered Public
Accounting Firm</p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">To the Stockholders and Board of Directors<br/>
Afya Limited</p>

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt">Opinion on the <span style="font-style: normal">Consolidated
</span>Financial Statements</p>

<p style="font: 8.5pt Nunito Sans; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">We have audited
the accompanying consolidated statement of financial position of Afya Limited. and&#160;subsidiaries (the Company) as of December&#160;31,
2025, the related consolidated statements of income and other comprehensive income, changes in equity, and cash flows for the year ended
December&#160;31, 2025, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated
financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2025, and
the results of its operations and its cash flows for the year ended December&#160;31, 2025, in conformity with IFRS Accounting Standards
as issued by the International Accounting Standards Boards (&#8220;IFRS Accounting Standards&#8221;).</span> 	</p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of
December&#160;31, 2025, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee
of Sponsoring Organizations of the Treadway Commission, and our report dated March&#160;31, 2026 expressed an unqualified opinion on the
effectiveness of the Company&#8217;s internal control over financial reporting .</p>

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt">Basis for Opinion</p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">These consolidated financial statements are the responsibility
of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our
audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance
with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">We conducted our audits in accordance with the standards of
the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial
statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the
risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated
financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management,
as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable
basis for our opinion.</p>

<!-- Field: Page; Sequence: 173; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: left; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt"></p>

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt">Critical Audit Matters</p>

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt"><span style="font-style: normal">The critical audit matters
communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or
required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated
financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit
matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating
the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which
they relate.</span></p>

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt"><span style="font-style: normal"><span style="text-decoration: underline">Evaluation of goodwill
and licenses with indefinite useful lives for impairment</span></span></p>

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt"><span style="font-style: normal">As discussed in Notes
2.5 and 11 to the consolidated financial statements, the Company&#8217;s goodwill and licenses with indefinite useful lives as of December
31, 2025, were R$1,526,733 thousand and R$3,460,415 thousand, respectively. Goodwill and intangible assets with indefinite useful lives
are tested for impairment annually and when circumstances indicate that the carrying amount may be impaired. Impairment is determined
for goodwill and intangible assets with indefinite useful lives by assessing the recoverable amount of each CGU to which the goodwill
and intangible assets with indefinite useful lives relate. The recoverable amount for each CGU is the higher of the CGU&#8217;s fair value
less costs of disposal and its value in use (VIU). In assessing VIU, the estimated future cash flows are discounted to their present value
using a pre-tax discount rate. When the carrying amount of a CGU exceeds its recoverable amount, the CGU is considered impaired and the
goodwill and intangible assets with indefinite useful lives are written down to their recoverable amounts.&#160;The VIU was calculated
using the discounted cash flow model for each CGU. Based on these assessments, no impairment loss was recognized as of December 31, 2025.</span></p>

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt"><span style="font-style: normal">We identified the evaluation
of goodwill and licenses with indefinite useful lives associated with certain CGUs for impairment as a critical audit matter. Challenging
auditor judgment was required to evaluate key assumptions used to determine the VIU of certain CGUs. Key assumptions included the forecasted
revenue growth rates, the forecasted EBITDA growth rates, the long-term growth rates, and the discount rates. Minor changes in these key
assumptions could have had a significant effect on the VIU of certain CGUs. In addition, the audit effort associated with the VIU estimate
for certain CGUs required specialized skills and knowledge.</span></p>

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt"><span style="font-style: normal">The following are the primary audit procedures we performed to address
this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the
Company&#8217;s impairment evaluation of goodwill and licenses with indefinite useful lives. This included controls related to the Company&#8217;s
development of the key assumptions used in estimating the VIU for certain CGUs. We evaluated the Company&#8217;s forecasted revenue growth
rates and forecasted EBITDA growth rates for certain CGUs by comparing them to historical revenue growth rates and historical EBITDA growth
rates performance for the respective CGUs. For certain CGUs, we compared the Company&#8217;s historical revenue and EBITDA growth rates
to actual results to assess the Company&#8217;s ability to accurately forecast. In addition, we involved valuation professionals with
specialized skills and knowledge, who assisted in:</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0pt"/><td style="width: 14.2pt"><span style="font-family: Symbol; font-style: normal">&#183;</span></td><td><span style="font-style: normal">evaluating the reasonableness of the discount rates for certain CGUs by comparing the inputs used
by the Company to develop the discount rates to publicly available market data for comparable entities;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0pt"/><td style="width: 14.2pt"><span style="font-family: Symbol; font-style: normal">&#183;</span></td><td><span style="font-style: normal">evaluating the forecasted revenue growth rates and forecasted EBITDA growth rates for certain CGUs
by comparing them to revenue growth rates and margin outcomes for comparable companies.</span></td></tr></table>

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt"><span style="font-style: normal"></span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0pt"/><td style="width: 14.2pt"><span style="font-family: Symbol; font-style: normal">&#183;</span></td><td><span style="font-style: normal">evaluating the long-term growth rate for certain CGUs by comparing them to economic growth expectations
using publicly available market data.</span></td></tr></table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">/s/ <span id="xdx_907_edei--AuditorName_c20250101__20251231_zOCpB2aNop79"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000101" name="dei:AuditorName">KPMG Auditores Independentes Ltda.</ix:nonNumeric></span></p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">&#160;</p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">We have served as the Company&#8217;s auditor since 2025.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_909_edei--AuditorLocation_c20250101__20251231_zpfjvDy6VBv9"><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" id="Fact000102" name="dei:AuditorLocation">Belo
Horizonte</ix:nonNumeric></span>, Brazil<br/>
March 31, 2026</p>


<p style="font: 19.5pt Nunito Sans; margin: 0; color: #C00000"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 174; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: left; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 19.5pt Nunito Sans; margin: 0; color: #C00000"><b></b></p>
<p style="font: 14.5pt Nunito Sans; margin: 0; color: #C00000"><b></b></p>

<p style="font: bold 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 20pt; text-align: center">Report of Independent Registered Public
Accounting Firm</p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">To the Stockholders and Board of Directors<br/>
<b>Afya Limited </b></p>

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt"><b>Opinion on Internal Control Over Financial Reporting
</b></p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">We have audited Afya Limited and subsidiaries (the Company)
internal control over financial reporting as of December&#160;31, 2025, based on criteria established in <i>Internal Control &#8211; Integrated
Framework (2013)</i> issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained,
in all material respects, effective internal control over financial reporting as of December&#160;31, 2025, based on criteria established
in <i>Internal Control &#8211; Integrated Framework (2013)</i> issued by the Committee of Sponsoring Organizations of the Treadway Commission.</p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statements of financial position of the Company as
of December&#160;31, 2025, the consolidated statements of income and other comprehensive income, changes in equity, and cash flows for
the year ended December&#160;31, 2025 and the related notes (collectively, the consolidated financial statements), and our report dated
March 31, 2026 expressed an unqualified opinion on those consolidated financial statements.</p>

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt"><b>Basis for Opinion </b></p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">The Company&#8217;s management is responsible for maintaining
effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting,
included in the accompanying Management&#8217;s Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express
an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered
with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and
the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">We conducted our audit in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control
over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining
an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating
the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures
as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</p>

<p style="font: italic 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt"><b>Definition and Limitations of Internal Control Over
Financial Reporting </b></p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">A company&#8217;s internal control over financial reporting
is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over
financial reporting includes those policies and procedures that (1)&#160;pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of the company; (2)&#160;provide reasonable assurance that
transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and
directors of the company; and (3)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition,
use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject
to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or
procedures may deteriorate.</p>

<p style="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">/s/ KPMG Auditores Independentes Ltda.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Belo Horizonte- Minas Gerais, Brazil</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">March 31, 2026<br/>
<br/>
</p>
<p style="font: 14.5pt Nunito Sans; margin: 0; color: #C00000"><b></b></p>

<p style="font: 14.5pt Nunito Sans; margin: 0; color: #C00000"><b>&#160;</b></p>

<p style="font: 14.5pt Nunito Sans; margin: 0; color: #C00000"><b></b></p>

<!-- Field: Page; Sequence: 175; Options: NewSection; Value: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: left; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 14.5pt Nunito Sans; margin: 0; color: #C00000"><b></b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"><b>&#160;</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"><b><span id="a_006"></span>Report of Independent Registered
Public Accounting Firm</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">To the Shareholders and the Board of Directors of</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Afya Limited</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><b>Opinion on the Financial Statements</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">We have audited the accompanying consolidated statement
of financial position of Afya Limited (the Company) as of December 31, 2024, the related consolidated statements of income and other comprehensive
income, changes in equity and cash flows for each of the two years in the period ended December 31, 2024, and the related notes (collectively
referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly,
in all material respects, the financial position of the Company at December 31, 2024, and the results of its operations and its cash flows
for each of the two years in the period ended December 31, 2024, in conformity with IFRS Accounting Standards as issued by the International
Accounting Standards Board (IASB).</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><b>Basis for Opinion</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We
are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to
be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations
of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">We conducted our audits in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation
of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">/s/ ERNST &amp; YOUNG</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">Auditores Independentes S/S Ltda.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">We&#160;have&#160;served&#160;as&#160;the&#160;Company's&#160;auditor&#160;from&#160;2016
to 2025.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">Belo Horizonte, Brazil</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">March 13, 2025<b>&#160;</b></p>


<!-- Field: Page; Sequence: 176; Options: NewSection; Value: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%"/><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12.5pt Nunito Sans; margin: 0; color: #C0504D"><b>Afya Limited</b></p>

<p style="font: 9.5pt Nunito Sans; margin: 0"><span id="a_0001"></span>Consolidated statement of financial position</p>

<p style="font: 9.5pt Nunito Sans; margin: 0">As of December 31, 2025 and 2024</p>

<p style="border-bottom: Black 0.5pt solid; font: 9.5pt Nunito Sans; margin: 0"><i>(In thousands of Brazilian reais)</i></p>

<p style="font: 2pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" id="xdx_302_111_pn3n3_zfqT3TxjHsC9" summary="xdx: Statement - Consolidated statement of financial position" style="font: 8.5pt Nunito Sans; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: -3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_49B_20251231_z3r12TFDtSRb" style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_494_20241231_zhbvQdXLKyHk" style="text-align: center; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 57%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Notes</b></td>
    <td style="white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="width: 1%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr id="xdx_40E_eifrs-full--AssetsAbstract_iB_zqeMsv76Q6A2">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: -3.5pt"><b>Assets</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="border-top: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-top: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentAssetsAbstract_iB_zuTvOflHPIje">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: -3.5pt"><b>Current assets</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CashAndCashEquivalents_i01I_pn3n3_maCAziMt_zJzYxAyOjLu7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Cash and cash equivalents</td>
    <td style="white-space: nowrap; text-align: center">5</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2025-12-31" id="Fact000110" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,125,381</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2024-12-31" id="Fact000111" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">911,015</ix:nonFraction> </td></tr>
  <tr id="xdx_40C_eifrs-full--CurrentTradeReceivables_i01I_pn3n3_maCAziMt_zlSlBCD6lQhj" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Trade receivables</td>
    <td style="white-space: nowrap; text-align: center">6</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="AsOf2025-12-31" id="Fact000113" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">717,373</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="AsOf2024-12-31" id="Fact000114" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">595,898</ix:nonFraction> </td></tr>
  <tr id="xdx_40C_eifrs-full--CurrentTaxAssets_i01I_pn3n3_maCAziMt_zuzYoGfWDpqh" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Recoverable taxes</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentTaxAssets" contextRef="AsOf2025-12-31" id="Fact000116" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,429</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentTaxAssets" contextRef="AsOf2024-12-31" id="Fact000117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,139</ix:nonFraction> </td></tr>
  <tr id="xdx_400_ecustom--IncomeTaxesRecoverable_i01I_pn3n3_maCAziMt_zVBXUlfdwgNf" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Income taxes recoverable</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="afya:IncomeTaxesRecoverable" contextRef="AsOf2025-12-31" id="Fact000119" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,046</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="afya:IncomeTaxesRecoverable" contextRef="AsOf2024-12-31" id="Fact000120" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,587</ix:nonFraction></td></tr>
  <tr id="xdx_400_eifrs-full--OtherCurrentAssets_i01I_pn3n3_maCAziMt_ziFx14cqZrkb" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Other assets</td>
    <td style="white-space: nowrap; text-align: center">8</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf2025-12-31" id="Fact000122" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,947</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf2024-12-31" id="Fact000123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,145</ix:nonFraction> </td></tr>
  <tr id="xdx_40A_eifrs-full--CurrentAssets_i01TI_pn3n3_mtCAziMt_maAzBIg_zQtNqauzNF6b" style="background-color: White">
    <td style="white-space: nowrap"><b>Total current assets</b></td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><b><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2025-12-31" id="Fact000125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,942,176</ix:nonFraction> </b></td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><b><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2024-12-31" id="Fact000126" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,589,784</ix:nonFraction> </b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--NoncurrentAssetsAbstract_i01B" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: -3.5pt"><b>Non-current assets</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_404_ecustom--NoncurrentTradeReceivable_i02I_pn3n3_maNAzbfa_z4RXOxT4Jywc" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Trade receivables</td>
    <td style="white-space: nowrap; text-align: center">6</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="afya:NoncurrentTradeReceivable" contextRef="AsOf2025-12-31" id="Fact000131" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,985</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="afya:NoncurrentTradeReceivable" contextRef="AsOf2024-12-31" id="Fact000132" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,948</ix:nonFraction> </td></tr>
  <tr id="xdx_40E_eifrs-full--DeferredTaxAssets_i02I_pn3n3_maNAzbfa_zqRwoaSabdKf" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Deferred tax assets</td>
    <td style="white-space: nowrap; text-align: center">20</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="AsOf2025-12-31" id="Fact000134" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,552</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0135">-</span></td></tr>
  <tr id="xdx_404_eifrs-full--OtherNoncurrentAssets_i02I_pn3n3_maNAzbfa_zoNRxEGUdqH8" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Other assets</td>
    <td style="white-space: nowrap; text-align: center">8</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf2025-12-31" id="Fact000137" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">125,480</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf2024-12-31" id="Fact000138" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">115,875</ix:nonFraction> </td></tr>
  <tr id="xdx_40B_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_i02I_pn3n3_maNAzbfa_zsbnk8a4Nh9e" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Investment in associate</td>
    <td style="white-space: nowrap; text-align: center">9</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="AsOf2025-12-31" id="Fact000140" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,518</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="AsOf2024-12-31" id="Fact000141" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,442</ix:nonFraction> </td></tr>
  <tr id="xdx_400_eifrs-full--PropertyPlantAndEquipment_i02I_pn3n3_maNAzbfa_zCBBD0qd14Sd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Property and equipment</td>
    <td style="white-space: nowrap; text-align: center">10</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2025-12-31" id="Fact000143" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">711,485</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2024-12-31" id="Fact000144" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">658,482</ix:nonFraction> </td></tr>
  <tr id="xdx_409_eifrs-full--RightofuseAssets_i02I_pn3n3_maNAzbfa_zUNYKD7ys0se" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Right-of-use assets</td>
    <td style="white-space: nowrap; text-align: center">12.2.2</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2025-12-31" id="Fact000146" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">896,758</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2024-12-31" id="Fact000147" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">842,219</ix:nonFraction> </td></tr>
  <tr id="xdx_402_eifrs-full--IntangibleAssetsOtherThanGoodwill_i02I_pn3n3_maNAzbfa_zW1twqi2aR2" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Intangible assets</td>
    <td style="white-space: nowrap; text-align: center">11</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2025-12-31" id="Fact000149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,587,980</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2024-12-31" id="Fact000150" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,532,789</ix:nonFraction> </td></tr>
  <tr id="xdx_40F_eifrs-full--NoncurrentAssets_i02TI_pn3n3_mtNAzbfa_maAzBIg_zCn21af6nFN6" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 4.4pt"><b>Total non-current assets</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2025-12-31" id="Fact000152" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,415,758</ix:nonFraction> </b></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2024-12-31" id="Fact000153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,239,755</ix:nonFraction> </b></td></tr>
  <tr id="xdx_400_eifrs-full--Assets_iTI_pn3n3_mtAzBIg_z75ms05n1ZV2" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: -3.5pt"><b>Total assets</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2025-12-31" id="Fact000155" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,357,934</ix:nonFraction> </b></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2024-12-31" id="Fact000156" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,829,539</ix:nonFraction> </b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--LiabilitiesAbstract_iB" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: -3.5pt"><b>Liabilities</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--CurrentLiabilitiesAbstract_i01B" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: -3.5pt"><b>Current liabilities</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--TradeAndOtherCurrentPayables_i02I_pn3n3_maCLzt3C_zPELY0MgEnji" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Trade payables</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="AsOf2025-12-31" id="Fact000164" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123,581</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="AsOf2024-12-31" id="Fact000165" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,080</ix:nonFraction> </td></tr>
  <tr id="xdx_405_eifrs-full--ShorttermBorrowings_i02I_pn3n3_maCLzt3C_zsQ9ioqpkfM6" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Loans and financing</td>
    <td style="white-space: nowrap; text-align: center">12.2.1</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:ShorttermBorrowings" contextRef="AsOf2025-12-31" id="Fact000167" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,668</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:ShorttermBorrowings" contextRef="AsOf2024-12-31" id="Fact000168" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">363,554</ix:nonFraction> </td></tr>
  <tr id="xdx_407_eifrs-full--CurrentLeaseLiabilities_i02I_pn3n3_maCLzt3C_z0sqDwVToZWe" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Lease liabilities</td>
    <td style="white-space: nowrap; text-align: center">12.2.2</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2025-12-31" id="Fact000170" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,772</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2024-12-31" id="Fact000171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,580</ix:nonFraction> </td></tr>
  <tr id="xdx_40A_eifrs-full--TradeAndOtherCurrentPayablesToRelatedParties_i02I_pn3n3_maCLzt3C_zWW56Yt9UAf2" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Accounts payable to selling shareholders</td>
    <td style="white-space: nowrap; text-align: center">12.2.3</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" contextRef="AsOf2025-12-31" id="Fact000173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,640</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" contextRef="AsOf2024-12-31" id="Fact000174" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">185,318</ix:nonFraction> </td></tr>
  <tr id="xdx_40A_eifrs-full--CurrentDepositsFromCustomers_i02I_pn3n3_maCLzt3C_zlpkG4lzkIp1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Advances from customers</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentDepositsFromCustomers" contextRef="AsOf2025-12-31" id="Fact000176" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">158,035</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentDepositsFromCustomers" contextRef="AsOf2024-12-31" id="Fact000177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">161,048</ix:nonFraction> </td></tr>
  <tr id="xdx_40A_eifrs-full--DividendsPayable_i02I_pn3n3_maCLzt3C_zhN0rYbr1oXc" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Dividends payable</td>
    <td style="white-space: nowrap; text-align: center">15</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:DividendsPayable" contextRef="AsOf2025-12-31" id="Fact000179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">192</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0180">-</span></td></tr>
  <tr id="xdx_405_eifrs-full--CurrentRecognisedLiabilitiesDefinedBenefitPlan_i02I_pn3n3_maCLzt3C_zhvFqo5ukR3f" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Labor and social obligations</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="AsOf2025-12-31" id="Fact000182" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">217,526</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="AsOf2024-12-31" id="Fact000183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">208,076</ix:nonFraction> </td></tr>
  <tr id="xdx_409_ecustom--CurrentTaxesPayable_i02I_pn3n3_maCLzt3C_zbPoqrpAtUne" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Taxes payable</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="afya:CurrentTaxesPayable" contextRef="AsOf2025-12-31" id="Fact000185" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,043</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="afya:CurrentTaxesPayable" contextRef="AsOf2024-12-31" id="Fact000186" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,456</ix:nonFraction> </td></tr>
  <tr id="xdx_403_eifrs-full--CurrentTaxLiabilitiesCurrent_i02I_pn3n3_maCLzt3C_zDqodeY6kRz9" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Income taxes payable</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="AsOf2025-12-31" id="Fact000188" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">112,638</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact000189" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,247</ix:nonFraction> </td></tr>
  <tr id="xdx_40D_eifrs-full--OtherCurrentLiabilities_i02I_pn3n3_maCLzt3C_zSqrBI7PRWz4" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Other liabilities</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-right: -3.85pt; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf2025-12-31" id="Fact000191" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,946</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -3.4pt; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf2024-12-31" id="Fact000192" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,836</ix:nonFraction> </td></tr>
  <tr id="xdx_40D_eifrs-full--CurrentLiabilities_i02TI_pn3n3_mtCLzt3C_maLzhbz_zDXpjsLVUgmi" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 4.4pt"><b>Total current liabilities</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2025-12-31" id="Fact000194" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">884,041</ix:nonFraction> </b></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2024-12-31" id="Fact000195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,140,195</ix:nonFraction> </b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--NoncurrentLiabilitiesAbstract_i01B" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: -3.5pt"><b>Non-current liabilities</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--LongtermBorrowings_i02I_pn3n3_maNLznQV_ztcSQMSBnHch" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Loans and financing</td>
    <td style="white-space: nowrap; text-align: center">12.2.1</td>
    <td style="white-space: nowrap; text-align: right"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="AsOf2025-12-31" id="Fact000200" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,993,599</ix:nonFraction> </td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="AsOf2024-12-31" id="Fact000201" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,831,607</ix:nonFraction> </td></tr>
  <tr id="xdx_40E_eifrs-full--NoncurrentLeaseLiabilities_i02I_pn3n3_maNLznQV_zAM9wwQ5oLQc" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Lease liabilities</td>
    <td style="white-space: nowrap; text-align: center">12.2.2</td>
    <td style="white-space: nowrap; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2025-12-31" id="Fact000203" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,009,974</ix:nonFraction> </td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2024-12-31" id="Fact000204" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">932,756</ix:nonFraction> </td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentPayablesToRelatedParties_i02I_pn3n3_maNLznQV_zOou9Y2AiEGj" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Accounts payable to selling shareholders</td>
    <td style="white-space: nowrap; text-align: center">12.2.3</td>
    <td style="white-space: nowrap; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentPayablesToRelatedParties" contextRef="AsOf2025-12-31" id="Fact000206" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">329,957</ix:nonFraction> </td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentPayablesToRelatedParties" contextRef="AsOf2024-12-31" id="Fact000207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">345,454</ix:nonFraction> </td></tr>
  <tr id="xdx_405_ecustom--NoncurrentTaxesPayable_i02I_pn3n3_maNLznQV_zARBdgNgl6ai" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Taxes payable</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><ix:nonFraction name="afya:NoncurrentTaxesPayable" contextRef="AsOf2025-12-31" id="Fact000209" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,487</ix:nonFraction> </td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><ix:nonFraction name="afya:NoncurrentTaxesPayable" contextRef="AsOf2024-12-31" id="Fact000210" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">84,407</ix:nonFraction> </td></tr>
  <tr id="xdx_407_eifrs-full--DeferredTaxLiabilities_i02I_pn3n3_maNLznQV_zfNMDvcfmK45" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Deferred tax liabilities</td>
    <td style="white-space: nowrap; text-align: center">20</td>
    <td style="white-space: nowrap; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0212">-</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><ix:nonFraction name="ifrs-full:DeferredTaxLiabilities" contextRef="AsOf2024-12-31" id="Fact000213" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,274</ix:nonFraction></td></tr>
  <tr id="xdx_403_eifrs-full--LongtermLegalProceedingsProvision_i02I_pn3n3_maNLznQV_zR5K2mXQhExa" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Provision for legal proceedings</td>
    <td style="white-space: nowrap; text-align: center">21</td>
    <td style="white-space: nowrap; text-align: right"><ix:nonFraction name="ifrs-full:LongtermLegalProceedingsProvision" contextRef="AsOf2025-12-31" id="Fact000215" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,220</ix:nonFraction> </td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; text-align: right"><ix:nonFraction name="ifrs-full:LongtermLegalProceedingsProvision" contextRef="AsOf2024-12-31" id="Fact000216" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">113,521</ix:nonFraction> </td></tr>
  <tr id="xdx_40A_eifrs-full--OtherNoncurrentLiabilities_i02I_pn3n3_maNLznQV_zZ2Acvujzesj" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Other liabilities</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-right: -3.85pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf2025-12-31" id="Fact000218" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,471</ix:nonFraction> </td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -3.4pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf2024-12-31" id="Fact000219" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,742</ix:nonFraction> </td></tr>
  <tr id="xdx_40F_eifrs-full--NoncurrentLiabilities_i02TI_pn3n3_mtNLznQV_maLzhbz_zFyZDU1GkaT3" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><b>Total non-current liabilities</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2025-12-31" id="Fact000221" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,582,708</ix:nonFraction> </b></td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2024-12-31" id="Fact000222" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,378,761</ix:nonFraction> </b></td></tr>
  <tr id="xdx_408_eifrs-full--Liabilities_iTI_pn3n3_mtLzhbz_maEALzSEY_z6KzgJMDaUUa" style="background-color: White">
    <td style="white-space: nowrap"><b>Total liabilities</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><b><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf2025-12-31" id="Fact000224" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,466,749</ix:nonFraction> </b></td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><b><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf2024-12-31" id="Fact000225" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,518,956</ix:nonFraction></b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--EquityAbstract_iB" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: -3.5pt"><b>Equity</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">15</td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--IssuedCapital_i01I_pn3n3_maEATOOzt9Y_z1RAybZ4NzA7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Share capital</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2025-12-31" id="Fact000230" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2024-12-31" id="Fact000231" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction> </td></tr>
  <tr id="xdx_403_eifrs-full--AdditionalPaidinCapital_i01I_pn3n3_maEATOOzt9Y_z9mQRFu84J8e" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Additional paid-in capital</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalPaidinCapital" contextRef="AsOf2025-12-31" id="Fact000233" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,320,422</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalPaidinCapital" contextRef="AsOf2024-12-31" id="Fact000234" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,344,521</ix:nonFraction> </td></tr>
  <tr id="xdx_40A_eifrs-full--TreasuryShares_i01NI_pn3n3_di_msEATOOzt9Y_zafTdm7rnFL8" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Treasury shares</td>
    <td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right">(<ix:nonFraction name="ifrs-full:TreasuryShares" contextRef="AsOf2025-12-31" id="Fact000236" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">306,010</ix:nonFraction>)</td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right">(<ix:nonFraction name="ifrs-full:TreasuryShares" contextRef="AsOf2024-12-31" id="Fact000237" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">273,955</ix:nonFraction>)</td></tr>
  <tr id="xdx_401_eifrs-full--ReserveOfSharebasedPayments_i01I_pn3n3_maEATOOzt9Y_zyPB0dKqOB13" style="background-color: White">
    <td style="white-space: nowrap; padding-left: 7.1pt">Share-based compensation reserve</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:ReserveOfSharebasedPayments" contextRef="AsOf2025-12-31" id="Fact000239" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">202,815</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:ReserveOfSharebasedPayments" contextRef="AsOf2024-12-31" id="Fact000240" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">187,497</ix:nonFraction> </td></tr>
  <tr id="xdx_40C_eifrs-full--RetainedEarnings_i01I_pn3n3_maEATOOzt9Y_zKUAkgLRkyS7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Retained earnings</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf2025-12-31" id="Fact000242" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,634,552</ix:nonFraction> </td>
    <td style="padding-left: 14.2pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 14.2pt; text-align: right"><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf2024-12-31" id="Fact000243" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,011,875</ix:nonFraction> </td></tr>
  <tr id="xdx_40D_eifrs-full--EquityAttributableToOwnersOfParent_i01TI_pn3n3_mtEATOOzt9Y_maEz587_zm8tOEuj2Nfb" style="background-color: White">
    <td style="white-space: nowrap"><b>Equity attributable to the owners of the Company</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf2025-12-31" id="Fact000245" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,851,796</ix:nonFraction> </b></td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf2024-12-31" id="Fact000246" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,269,955</ix:nonFraction> </b></td></tr>
  <tr id="xdx_40B_eifrs-full--NoncontrollingInterests_i01I_pn3n3_maEz587_zGKOXrIcRE9i" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 7.1pt">Non-controlling interests</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf2025-12-31" id="Fact000248" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,389</ix:nonFraction> </td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf2024-12-31" id="Fact000249" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,628</ix:nonFraction> </td></tr>
  <tr id="xdx_40C_eifrs-full--Equity_i01TI_pn3n3_mtEz587_maEALzSEY_zpiy6h76Le2e" style="background-color: White">
    <td style="white-space: nowrap"><b>Total equity</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31" id="Fact000251" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,891,185</ix:nonFraction> </b></td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31" id="Fact000252" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,310,583</ix:nonFraction> </b></td></tr>
  <tr id="xdx_400_eifrs-full--EquityAndLiabilities_iTI_pn3n3_mtEALzSEY_z3jC8NiKDf6i" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><b>Total liabilities and equity</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2025-12-31" id="Fact000254" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,357,934</ix:nonFraction> </b></td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2024-12-31" id="Fact000255" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,829,539</ix:nonFraction></b></td></tr>
  </table>
<p style="font: 9pt Nunito Sans; margin: 3pt 0 0">The accompanying notes are an integral part of these  consolidated financial
statements.</p>


<!-- Field: Page; Sequence: 177; Options: NewSection; Value: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12.5pt Nunito Sans; margin: 0; color: #C0504D"><b>Afya Limited</b></p>

<p style="font: 9.5pt Nunito Sans; margin: 0"><span id="a_0002"></span>Consolidated statement of income and other comprehensive income</p>

<p style="font: 9.5pt Nunito Sans; margin: 0">For the years ended December 31, 2025, 2024 and 2023</p>

<p style="border-bottom: Black 0.5pt solid; font: 9.5pt Nunito Sans; margin: 0"><i>(In thousands of Brazilian reais, except for earnings
per share information)</i></p>

<p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" id="xdx_307_113_pn3n3_zoNYaWxyUDzc" summary="xdx: Statement - Consolidated statement of income and other comprehensive income" style="font: 8.5pt Nunito Sans; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; text-indent: 0.3pt">&#160;</td>
    <td id="xdx_49F_20250101__20251231_zhnGkhZ0rym4" style="padding-right: 7.05pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td id="xdx_49C_20240101__20241231_zlm4m9J0WY84" style="padding-right: 7.05pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td id="xdx_499_20230101__20231231_ze7NYWH2Fui" style="padding-right: 7.05pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 51%; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; text-indent: 0.3pt"><b>Notes</b></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b>2025</b></td>
    <td style="vertical-align: top; width: 1%; padding-right: 6.9pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 6.9pt; text-align: right; text-indent: 0.3pt"><b>2024</b></td>
    <td style="vertical-align: top; width: 1%; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b>2023</b></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"/>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--Revenue_maGPzyip_z2gIZ377TPG6" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">Revenue</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">17</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2025-01-01to2025-12-31" id="Fact000257" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,697,255</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2024-01-012024-12-31" id="Fact000258" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,304,329</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31" id="Fact000259" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></td></tr>
  <tr id="xdx_409_eifrs-full--CostOfSales_iN_pn3n3_di_msGPzyip_zbg7GVIZQGA4" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt">Cost of services</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">18</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2025-01-01to2025-12-31" id="Fact000261" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,313,895</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2024-01-012024-12-31" id="Fact000262" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,215,603</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2023-01-012023-12-31" id="Fact000263" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,109,813</ix:nonFraction>)</td></tr>
  <tr id="xdx_408_eifrs-full--GrossProfit_iT_pn3n3_mtGPzyip_maPLFOAziWO_zUedBr65eEnc" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt"><b>Gross profit</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2025-01-01to2025-12-31" id="Fact000265" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,383,360</ix:nonFraction> </b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2024-01-012024-12-31" id="Fact000266" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,088,726</ix:nonFraction> </b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31" id="Fact000267" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,766,100</ix:nonFraction></b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--GeneralAndAdministrativeExpense_iN_pn3n3_di_msPLFOAziWO_zTYcyr15JXJd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">Selling, general and administrative expenses</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">18</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2025-01-01to2025-12-31" id="Fact000269" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,113,065</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2024-01-012024-12-31" id="Fact000270" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,008,427</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31" id="Fact000271" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">940,132</ix:nonFraction>)</td></tr>
  <tr id="xdx_402_ecustom--AllowanceForExpectedCreditLosses_iN_pn3n3_di_msPLFOAziWO_zS3wqZ4AKQn5" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt">Allowance for expected credit losses</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">18</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2025-01-01to2025-12-31" id="Fact000273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,090</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2024-01-012024-12-31" id="Fact000274" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,894</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2023-01-012023-12-31" id="Fact000275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,552</ix:nonFraction>)</td></tr>
  <tr id="xdx_400_eifrs-full--OtherOperatingIncomeExpense_maPLFOAziWO_zTdYIvncV91a" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">Other income</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:OtherOperatingIncomeExpense" contextRef="From2025-01-01to2025-12-31" id="Fact000277" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,762</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:OtherOperatingIncomeExpense" contextRef="From2024-01-012024-12-31" id="Fact000278" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,299</ix:nonFraction></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:OtherOperatingIncomeExpense" contextRef="From2023-01-012023-12-31" id="Fact000279" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,206</ix:nonFraction></td></tr>
  <tr id="xdx_40C_eifrs-full--OtherExpenseByNature_iN_pn3n3_di_msPLFOAziWO_zgD3dPpURbFe" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt">Other expenses</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="ifrs-full:OtherExpenseByNature" contextRef="From2025-01-01to2025-12-31" id="Fact000281" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,857</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="ifrs-full:OtherExpenseByNature" contextRef="From2024-01-012024-12-31" id="Fact000282" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,591</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="ifrs-full:OtherExpenseByNature" contextRef="From2023-01-012023-12-31" id="Fact000283" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,561</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--ProfitLossFromOperatingActivities_iT_pn3n3_mtPLFOAziWO_maPLBTzdiV_zfOTcbUMyXne" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt"><b>Operating income</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,213,110</ix:nonFraction> </b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2024-01-012024-12-31" id="Fact000286" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,012,113</ix:nonFraction> </b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2023-01-012023-12-31" id="Fact000287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">767,061</ix:nonFraction></b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--FinanceIncome_maFICzW1W_zrMHjWn3XxR4" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt">Finance income</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">19</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2025-01-01to2025-12-31" id="Fact000289" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">194,943</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2024-01-012024-12-31" id="Fact000290" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">111,283</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2023-01-012023-12-31" id="Fact000291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,642</ix:nonFraction></td></tr>
  <tr id="xdx_40B_eifrs-full--FinanceCosts_iN_pn3n3_di_msFICzW1W_zG0eJQj6gx46" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">Finance expenses</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">19</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2025-01-01to2025-12-31" id="Fact000293" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">561,024</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2024-01-012024-12-31" id="Fact000294" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">458,742</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2023-01-012023-12-31" id="Fact000295" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">457,616</ix:nonFraction>)</td></tr>
  <tr id="xdx_405_eifrs-full--FinanceIncomeCost_iT_pn3n3_mtFICzW1W_maPLBTzdiV_zg1hsysrxUNd" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt"><b>Net finance result</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b>(<ix:nonFraction name="ifrs-full:FinanceIncomeCost" contextRef="From2025-01-01to2025-12-31" id="Fact000297" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">366,081</ix:nonFraction>)</b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b>(<ix:nonFraction name="ifrs-full:FinanceIncomeCost" contextRef="From2024-01-012024-12-31" id="Fact000298" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">347,459</ix:nonFraction>)</b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b>(<ix:nonFraction name="ifrs-full:FinanceIncomeCost" contextRef="From2023-01-012023-12-31" id="Fact000299" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">346,974</ix:nonFraction>)</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_maPLBTzdiV_zsDhSWEMkrYh" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt">Share of profit of equity-accounted investee, net of tax</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">9</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From2025-01-01to2025-12-31" id="Fact000301" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,916</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From2024-01-012024-12-31" id="Fact000302" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,737</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From2023-01-012023-12-31" id="Fact000303" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,495</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--ProfitLossBeforeTax_iT_pn3n3_mtPLBTzdiV_maPLzBpM_znpddtdTlZ5c" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt"><b>Income before income taxes</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2025-01-01to2025-12-31" id="Fact000305" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">860,945</ix:nonFraction> </b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2024-01-012024-12-31" id="Fact000306" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">676,391</ix:nonFraction> </b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2023-01-012023-12-31" id="Fact000307" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">429,582</ix:nonFraction></b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncomeTaxesExpensesAbstract_iB_zowM9zBNeOMe" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt"><b>Income taxes expenses</b></td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt"><b>20</b></td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--IncomeTaxesExpensesCurrent_iN_di_msPLzBpM_zYG88omot5D8" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">Current</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="afya:IncomeTaxesExpensesCurrent" contextRef="From2025-01-01to2025-12-31" id="Fact000313" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">133,328</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="afya:IncomeTaxesExpensesCurrent" contextRef="From2024-01-012024-12-31" id="Fact000314" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,238</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="afya:IncomeTaxesExpensesCurrent" contextRef="From2023-01-012023-12-31" id="Fact000315" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,399</ix:nonFraction>)</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxes_maPLzBpM_zBzkwzXsry3g" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt">Deferred</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="afya:DeferredTaxes" contextRef="From2025-01-01to2025-12-31" id="Fact000317" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,826</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">(<ix:nonFraction name="afya:DeferredTaxes" contextRef="From2024-01-012024-12-31" id="Fact000318" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,233</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="afya:DeferredTaxes" contextRef="From2023-01-012023-12-31" id="Fact000319" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,233</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--ProfitLoss_iT_pn3n3_mtPLzBpM_maCIzVzV_zkrrj66Ck6Z3" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt"><b>Net income</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2025-01-01to2025-12-31" id="Fact000321" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">768,443</ix:nonFraction> </b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2024-01-012024-12-31" id="Fact000322" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">648,920</ix:nonFraction></b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31" id="Fact000323" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,416</ix:nonFraction></b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--OtherComprehensiveIncome_maCIzVzV_zKZWNcnwSwZb" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt">Other comprehensive income</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><span style="-sec-ix-hidden: xdx2ixbrl0325">-</span></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><span style="-sec-ix-hidden: xdx2ixbrl0326">-</span></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><span style="-sec-ix-hidden: xdx2ixbrl0327">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_406_eifrs-full--ComprehensiveIncome_iT_pn3n3_mtCIzVzV_zTNcrZz7xAJl" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt"><b>Total comprehensive income</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2025-01-01to2025-12-31" id="Fact000329" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">768,443</ix:nonFraction> </b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2024-01-012024-12-31" id="Fact000330" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">648,920</ix:nonFraction> </b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31" id="Fact000331" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,416</ix:nonFraction></b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--ProfitLossAttributableToAbstract_iB" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt"><b>Net income / total comprehensive income attributable to:</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_409_eifrs-full--ProfitLossAttributableToOwnersOfParent_i01_pn3n3_maCILzVFt_znRRPx6DHjv7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">Owners of the Company</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From2025-01-01to2025-12-31" id="Fact000337" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">752,461</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From2024-01-012024-12-31" id="Fact000338" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">631,510</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From2023-01-012023-12-31" id="Fact000339" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,324</ix:nonFraction></td></tr>
  <tr id="xdx_401_eifrs-full--ProfitLossAttributableToNoncontrollingInterests_i01_pn3n3_maCILzVFt_zBINbRAg90ki" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt">Non-controlling interests</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From2025-01-01to2025-12-31" id="Fact000341" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,982</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From2024-01-012024-12-31" id="Fact000342" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,410</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From2023-01-012023-12-31" id="Fact000343" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,092</ix:nonFraction></td></tr>
  <tr id="xdx_403_ecustom--ComprehensiveIncomeLoss_iT_mtCILzVFt_z1XQzz8lYP3c" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt"><b style="display: none">Total comprehensive income</b></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="afya:ComprehensiveIncomeLoss" contextRef="From2025-01-01to2025-12-31" id="Fact000345" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">768,443</ix:nonFraction> </b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="afya:ComprehensiveIncomeLoss" contextRef="From2024-01-012024-12-31" id="Fact000346" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">648,920</ix:nonFraction> </b></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><b><ix:nonFraction name="afya:ComprehensiveIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000347" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,416</ix:nonFraction></b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td></tr>
  <tr id="xdx_40A_eifrs-full--BasicEarningsLossPerShare_pip0_zvAR1DwMQO75" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 0.3pt">Basic earnings per common share</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">16</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2025-01-01to2025-12-31" id="Fact000349" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">8.32</ix:nonFraction></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2024-01-012024-12-31" id="Fact000350" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">7.01</ix:nonFraction></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2023-01-012023-12-31" id="Fact000351" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">4.30</ix:nonFraction></td></tr>
  <tr id="xdx_405_eifrs-full--DilutedEarningsLossPerShare_pip0_ziYO7JeBAUnc" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 0.3pt">Diluted earnings per common share</td>
    <td style="white-space: nowrap; text-align: center; text-indent: 0.3pt">16</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2025-01-01to2025-12-31" id="Fact000353" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">8.24</ix:nonFraction></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2024-01-012024-12-31" id="Fact000354" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">6.93</ix:nonFraction></td>
    <td style="vertical-align: top; padding-right: 7.05pt; text-align: right; text-indent: 0.3pt">&#160;</td>
    <td style="padding-right: 7.05pt; text-align: right; text-indent: 0.3pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2023-01-012023-12-31" id="Fact000355" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">4.27</ix:nonFraction></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">The accompanying notes are an integral part of these  consolidated financial statements.</p>


<!-- Field: Page; Sequence: 178 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12.5pt Nunito Sans; margin: 0; color: #C0504D"><b>Afya Limited</b></p>

<p style="font: 9.5pt Nunito Sans; margin: 0"><span id="a_0003"></span>Consolidated statement of changes in equity</p>

<p style="font: 9.5pt Nunito Sans; margin: 0">For the years ended December 31, 2025, 2024 and 2023</p>

<p style="border-bottom: Black 0.5pt solid; font: 9.5pt Nunito Sans; margin: 0"><i>(In thousands of Brazilian reais)</i></p>

<p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" id="xdx_308_114_pn3n3_zWrqxWYlJVqg" summary="xdx: Statement - Consolidated statement of changes in equity" style="font: 8.5pt Nunito Sans; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B9_ifrs-full--ComponentsOfEquityAxis_ifrs-full--IssuedCapitalMember_zJYQuTT8iag6" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B6_ifrs-full--ComponentsOfEquityAxis_ifrs-full--AdditionalPaidinCapitalMember_zNnJ42uheVsl" style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BC_ifrs-full--ComponentsOfEquityAxis_ifrs-full--TreasurySharesMember_zvCMim1lyRyd" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BA_ifrs-full--ComponentsOfEquityAxis_ifrs-full--ReserveOfSharebasedPaymentsMember_zVJTajWc7xV7" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B4_ifrs-full--ComponentsOfEquityAxis_ifrs-full--RetainedEarningsMember_zeh7Zo8I4LF4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B5_ifrs-full--ComponentsOfEquityAxis_ifrs-full--EquityAttributableToOwnersOfParentMember_ztJUoc84kI29" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B9_ifrs-full--ComponentsOfEquityAxis_ifrs-full--NoncontrollingInterestsMember_zpPo9s9OAlU6" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BF_zXbAsRPszek9" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt"><b>Equity attributable to the owners of the Company</b></span></td>
    <td colspan="2" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; width: 43%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="width: 4%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt"><b>Notes</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt"><b>Share capital</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 6%; padding-right: 0.25pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt"><b>Additional paid-in capital</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt"><b>Treasury shares</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt"><b>Share-based compensation reserve</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt"><b>Retained earnings</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt"><b>Non-controlling interests</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt"><b>Total equity</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_434_c20230101__20231231_eifrs-full--Equity_iS_z1aJYJDzdwgb" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt"><b>Balances at January 1, 2023</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_IssuedCapitalMember" id="Fact000357" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000358" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,375,344</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_TreasurySharesMember" id="Fact000359" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">304,947</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000360" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123,538</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_RetainedEarningsMember" id="Fact000361" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,004,886</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000362" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,198,838</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000363" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,320</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2022-12-31" id="Fact000364" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,250,158</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_403_eifrs-full--ProfitLoss_zBuUBoROUmbh" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Net income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0366">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0367">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0368">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0369">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="Fact000370" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,324</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000371" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,324</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000372" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,092</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31" id="Fact000373" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,416</ix:nonFraction></span></td></tr>
  <tr id="xdx_404_eifrs-full--ComprehensiveIncome_z2LR2PlHPTjb" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Total comprehensive income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0375">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0376">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0377">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0378">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="Fact000379" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,324</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000380" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,324</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000381" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,092</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2023-01-012023-12-31" id="Fact000382" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,416</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_zyDdEMdWqgI2" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Share-based compensation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt">18</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0384">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0385">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0386">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000387" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,535</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0388">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000389" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,535</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0390">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2023-01-012023-12-31" id="Fact000391" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,535</ix:nonFraction></span></td></tr>
  <tr id="xdx_408_ecustom--TreasurySharesRepurchase_zhJZ6vRaPdw" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Treasury shares repurchase</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt">15</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0393">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0394">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="Fact000395" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,369</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0396">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0397">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000398" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,369</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0399">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2023-01-012023-12-31" id="Fact000400" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,369</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40A_ecustom--AcquisitionOfNoncontrollingInterests_zMNjzUmqUo5i" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Acquisition of non-controlling interests</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0402">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0403">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0404">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0405">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember" id="Fact000406" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,845</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000407" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,845</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000408" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,155</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:AcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31" id="Fact000409" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">21,000</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_401_ecustom--RestrictedSharesTransferredToExecutives_zH0txv2eAC3j" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Restricted stock units transferred under the share-based compensation plan</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0411">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000412" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,491</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="Fact000413" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,722</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0414">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0415">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000416" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,769</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0417">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2023-01-012023-12-31" id="Fact000418" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,769</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_401_ecustom--TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions_zNW6B9QC5KO" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Treasury shares transferred to executives from exercise of stock options</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0420">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000421" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,653</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember" id="Fact000422" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,444</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0423">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0424">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000425" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,791</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0426">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2023-01-012023-12-31" id="Fact000427" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,791</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_eifrs-full--DividendsPaid_iN_di_zifTEOM2QfW1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Dividends declared </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt">15</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0429">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0430">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0431">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0432">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0433">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0434">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000435" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,750</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2023-01-012023-12-31" id="Fact000436" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,750</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_432_c20240101__20241231_eifrs-full--Equity_iS_zaQv4BhZUY82" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt"><b>Balances at December 31, 2023</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_IssuedCapitalMember" id="Fact000438" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000439" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,365,200</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_TreasurySharesMember" id="Fact000440" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">299,150</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000441" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">155,073</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_RetainedEarningsMember" id="Fact000442" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,380,365</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000443" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,601,505</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000444" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,507</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2023-12-31" id="Fact000445" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,643,012</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--ProfitLoss_zEvrQpCT3bf2" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Net income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0447">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0448">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0449">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0450">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember" id="Fact000451" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">631,510</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000452" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">631,510</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000453" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,410</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2024-01-012024-12-31" id="Fact000454" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">648,920</ix:nonFraction> </span></td></tr>
  <tr id="xdx_404_eifrs-full--ComprehensiveIncome_zIILAlEHJpYa" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Total comprehensive income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0456">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0458">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0459">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember" id="Fact000460" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">631,510</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000461" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">631,510</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000462" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,410</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2024-01-012024-12-31" id="Fact000463" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">648,920</ix:nonFraction> </span></td></tr>
  <tr id="xdx_405_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_zp4In2SiOBl9" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Share-based compensation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt">18</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0465">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0466">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0467">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000468" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,424</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0469">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000470" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,424</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0471">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2024-01-012024-12-31" id="Fact000472" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,424</ix:nonFraction> </span></td></tr>
  <tr id="xdx_401_ecustom--RestrictedSharesTransferredToExecutives_zulcWGinPtF9" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Restricted stock units transferred under the share-based compensation plan</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0474">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000475" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,672</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember" id="Fact000476" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,812</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0477">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0478">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000479" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,860</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0480">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2024-01-012024-12-31" id="Fact000481" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,860</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_401_ecustom--TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions_zjz8m5VCdid1" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Treasury shares transferred to executives from exercise of stock options</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000484" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,007</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember" id="Fact000485" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,383</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0486">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0487">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,376</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0489">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2024-01-012024-12-31" id="Fact000490" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,376</ix:nonFraction> </span></td></tr>
  <tr id="xdx_409_eifrs-full--DividendsPaid_iN_di_z5n14Krlakhl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Dividends declared </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt">15</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0492">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0493">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0494">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0495">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0496">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0497">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000498" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,289</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2024-01-012024-12-31" id="Fact000499" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,289</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43F_c20250101__20251231_eifrs-full--Equity_iS_zZHPdhD6CGsc" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt"><b>Balances at December 31, 2024</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_IssuedCapitalMember" id="Fact000501" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000502" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,344,521</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_TreasurySharesMember" id="Fact000503" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">273,955</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000504" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">187,497</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_RetainedEarningsMember" id="Fact000505" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,011,875</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000506" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,269,955</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000507" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,628</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31" id="Fact000508" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,310,583</ix:nonFraction> </b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 3.8pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt">&#160;</td>
    <td style="padding-right: 0.25pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt">&#160;</td></tr>
  <tr id="xdx_403_eifrs-full--ProfitLoss_zpbkxwb1oJYe" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Net income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0510">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0512">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0513">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember" id="Fact000514" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">752,461</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000515" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">752,461</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000516" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,982</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2025-01-01to2025-12-31" id="Fact000517" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">768,443</ix:nonFraction> </span></td></tr>
  <tr id="xdx_404_eifrs-full--ComprehensiveIncome_zCrKLmv5lwhd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Total comprehensive income</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0519">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0520">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0521">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0522">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember" id="Fact000523" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">752,461</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000524" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">752,461</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000525" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,982</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2025-01-01to2025-12-31" id="Fact000526" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">768,443</ix:nonFraction> </span></td></tr>
  <tr id="xdx_405_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_zsay7F73Hgma" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Share-based compensation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt">18</span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0528">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0529">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0530">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000531" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,318</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0532">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000533" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,318</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0534">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2025-01-01to2025-12-31" id="Fact000535" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,318</ix:nonFraction> </span></td></tr>
  <tr id="xdx_408_ecustom--TreasurySharesRepurchase_z6yTeCQ80MLl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Treasury shares repurchase</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt">15</span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0538">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt">(<ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember" id="Fact000539" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">77,002</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0540">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0541">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt">(<ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000542" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">77,002</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0543">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt">(<ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2025-01-01to2025-12-31" id="Fact000544" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">77,002</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_401_ecustom--RestrictedSharesTransferredToExecutives_zZlSlIQO3M4" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Restricted stock units transferred under the share-based compensation plan</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0546">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt">(<ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000547" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,764</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember" id="Fact000548" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,879</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0549">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0550">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt">(<ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000551" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,885</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0552">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt">(<ix:nonFraction name="afya:RestrictedSharesTransferredToExecutives" contextRef="From2025-01-01to2025-12-31" id="Fact000553" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,885</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_401_ecustom--TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions_zT6nT8O3qWvg" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Treasury shares transferred to executives from exercise of stock options</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0555">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt">(<ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000556" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,335</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember" id="Fact000557" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,068</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0558">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0559">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000560" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,733</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0561">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" contextRef="From2025-01-01to2025-12-31" id="Fact000562" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,733</ix:nonFraction> </span></td></tr>
  <tr id="xdx_409_eifrs-full--DividendsPaid_iN_di_zFRSwEi3AXij" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt">Dividends declared </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 8pt">15</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0564">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0565">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0566">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0567">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember" id="Fact000568" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">129,784</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000569" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">129,784</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000570" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,221</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 39.4pt; text-align: right; text-indent: -39.4pt"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2025-01-01to2025-12-31" id="Fact000571" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">147,005</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43C_c20250101__20251231_eifrs-full--Equity_iE_z4QQFGJuXio9" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 8pt"><b>Balances at December 31, 2025</b> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31_ifrs-full_IssuedCapitalMember" id="Fact000573" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="Fact000574" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,320,422</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31_ifrs-full_TreasurySharesMember" id="Fact000575" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">306,010</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="Fact000576" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">202,815</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31_ifrs-full_RetainedEarningsMember" id="Fact000577" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,634,552</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="Fact000578" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,851,796</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31_ifrs-full_NoncontrollingInterestsMember" id="Fact000579" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,389</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31" id="Fact000580" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,891,185</ix:nonFraction> </b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">The accompanying notes are an integral part of these  consolidated financial statements.</p>


<!-- Field: Page; Sequence: 179 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12.5pt Nunito Sans; margin: 0; color: #C0504D"><b>Afya Limited</b></p>

<p style="font: 9.5pt Nunito Sans; margin: 0"><span id="a_0004"></span>Consolidated statement of cash flows</p>

<p style="font: 9.5pt Nunito Sans; margin: 0">For the years ended December 31, 2025, 2024 and 2023</p>

<p style="border-bottom: Black 0.5pt solid; font: 9.5pt Nunito Sans; margin: 0"><i>(In thousands of Brazilian reais)</i></p>

<p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" id="xdx_306_112_pn3n3_zV8gHxKrX7G7" summary="xdx: Statement - Consolidated statement of cash flows" style="font: 8.5pt Nunito Sans; width: 100%; border-collapse: collapse">
  <tr>
    <td style="line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">&#160;</td>
    <td id="xdx_49A_20250101__20251231_zAHJKv0QOzAk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 9.5pt"/>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td id="xdx_49D_20240101__20241231_zFdY7bwd8UWd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td id="xdx_492_20230101__20231231_zQUYzrPnCV8c" style="vertical-align: top; text-align: center; line-height: 9.5pt">&#160;</td></tr>
<tr>
    <td style="width: 53%; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; width: 12%; text-align: center; line-height: 9.5pt"><b>Notes</b></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><b>2025</b></td>
    <td style="vertical-align: top; width: 1%; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><b>2024</b></td>
    <td style="vertical-align: top; width: 1%; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; text-align: right; line-height: 9.5pt"><b>2023</b></td></tr>
  <tr>
    <td style="line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"/>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--CashFlowsFromUsedInOperatingActivitiesAbstract_iB">
    <td style="line-height: 9.5pt"><b>Operating activities</b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_404_ecustom--IncomeLossBeforeIncomeTaxes_i01N_pn3n3_di_msAFRPLzvdO_z7R4Z4qvGYkd" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Income before income taxes</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:IncomeLossBeforeIncomeTaxes" contextRef="From2025-01-01to2025-12-31" id="Fact000586" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">860,945</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:IncomeLossBeforeIncomeTaxes" contextRef="From2024-01-012024-12-31" id="Fact000587" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">676,391</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:IncomeLossBeforeIncomeTaxes" contextRef="From2023-01-012023-12-31" id="Fact000588" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">429,582</ix:nonFraction></td></tr>
  <tr id="xdx_404_eifrs-full--AdjustmentsForReconcileProfitLossAbstract_i01B" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 14.2pt">Adjustments to reconcile income before income taxes</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--AdjustmentsForDepreciationAndAmortisationExpense_i02_pn3n3_maAFRPLzvdO_zoCV6YVi8Bbi" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 21.3pt">Depreciation and amortization expenses</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">18</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="From2025-01-01to2025-12-31" id="Fact000594" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">373,344</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="From2024-01-012024-12-31" id="Fact000595" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">333,341</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="From2023-01-012023-12-31" id="Fact000596" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">289,511</ix:nonFraction></td></tr>
  <tr id="xdx_40C_ecustom--WriteoffOfPropertyAndEquipment_i02_pn3n3_maAFRPLzvdO_zAjIaU2fo7l6" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 21.3pt">Write-off of property and equipment</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">10</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:WriteoffOfPropertyAndEquipment" contextRef="From2025-01-01to2025-12-31" id="Fact000598" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,062</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:WriteoffOfPropertyAndEquipment" contextRef="From2024-01-012024-12-31" id="Fact000599" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,539</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:WriteoffOfPropertyAndEquipment" contextRef="From2023-01-012023-12-31" id="Fact000600" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,910</ix:nonFraction></td></tr>
  <tr id="xdx_409_ecustom--WriteoffOfIntangibleAssets_i02_pn3n3_maAFRPLzvdO_zLl1E8HtWioi" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 21.3pt">Write-off of intangible assets</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">11</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2025-01-01to2025-12-31" id="Fact000602" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">275</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2024-01-012024-12-31" id="Fact000603" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">244</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31" id="Fact000604" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">413</ix:nonFraction></td></tr>
  <tr id="xdx_401_ecustom--AllowanceForDoubtfulAccountsOfOpeartingActivities_i02_pn3n3_maAFRPLzvdO_z87nrNxdc9o5" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 21.3pt">Allowance for expected credit losses</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">6, 18</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:AllowanceForDoubtfulAccountsOfOpeartingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000606" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,090</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:AllowanceForDoubtfulAccountsOfOpeartingActivities" contextRef="From2024-01-012024-12-31" id="Fact000607" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,894</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:AllowanceForDoubtfulAccountsOfOpeartingActivities" contextRef="From2023-01-012023-12-31" id="Fact000608" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,552</ix:nonFraction></td></tr>
  <tr id="xdx_402_eifrs-full--AdjustmentsForSharebasedPayments_i02_pn3n3_maAFRPLzvdO_zD6JRq0kq5y" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 21.3pt">Share-based compensation expense</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">18</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From2025-01-01to2025-12-31" id="Fact000610" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,318</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From2024-01-012024-12-31" id="Fact000611" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,424</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From2023-01-012023-12-31" id="Fact000612" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,535</ix:nonFraction></td></tr>
  <tr id="xdx_401_eifrs-full--AdjustmentsForUnrealisedForeignExchangeLossesGains_i02_pn3n3_maAFRPLzvdO_ztfF86UCMSAh" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 21.3pt">Net foreign exchange differences</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" contextRef="From2025-01-01to2025-12-31" id="Fact000614" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,816</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" contextRef="From2024-01-012024-12-31" id="Fact000615" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,027</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" contextRef="From2023-01-012023-12-31" id="Fact000616" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">681</ix:nonFraction></td></tr>
  <tr id="xdx_400_ecustom--AccruedInterestOfOpeartingActivities_i02_pn3n3_maAFRPLzvdO_zQ2WeXSUPg76" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 21.3pt">Accrued interest</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">19</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:AccruedInterestOfOpeartingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000618" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">316,379</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:AccruedInterestOfOpeartingActivities" contextRef="From2024-01-012024-12-31" id="Fact000619" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">254,386</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:AccruedInterestOfOpeartingActivities" contextRef="From2023-01-012023-12-31" id="Fact000620" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">285,447</ix:nonFraction></td></tr>
  <tr id="xdx_40E_eifrs-full--InterestExpenseOnLeaseLiabilities_i02_pn3n3_maAFRPLzvdO_zek5oc3nVjC7" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 21.3pt">Accrued interest on lease liabilities</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">12.2.2, 12.5, 19</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2025-01-01to2025-12-31" id="Fact000622" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123,067</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2024-01-012024-12-31" id="Fact000623" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">111,966</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2023-01-012023-12-31" id="Fact000624" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,849</ix:nonFraction></td></tr>
  <tr id="xdx_404_ecustom--ShareOfProfitOfEquityaccountedInvesteeNetOfTax_i02N_pn3n3_di_msAFRPLzvdO_zzAQ0oWR5V9a" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 21.3pt">Share of profit of equity-accounted investee, net of tax</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">9</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:ShareOfProfitOfEquityaccountedInvesteeNetOfTax" contextRef="From2025-01-01to2025-12-31" id="Fact000626" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,916</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:ShareOfProfitOfEquityaccountedInvesteeNetOfTax" contextRef="From2024-01-012024-12-31" id="Fact000627" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,737</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:ShareOfProfitOfEquityaccountedInvesteeNetOfTax" contextRef="From2023-01-012023-12-31" id="Fact000628" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,495</ix:nonFraction>)</td></tr>
  <tr id="xdx_40A_eifrs-full--AdjustmentsForProvisions_i02_pn3n3_maAFRPLzvdO_zoTN3nWbVmJ6" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 21.3pt">Provision (reversal) for legal proceedings</td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForProvisions" contextRef="From2025-01-01to2025-12-31" id="Fact000630" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,250</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForProvisions" contextRef="From2024-01-012024-12-31" id="Fact000631" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,705</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForProvisions" contextRef="From2023-01-012023-12-31" id="Fact000632" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">40,044</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt">&#160;</td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_406_ecustom--IncreaseDecreaseInOperatingLiabilities1Abstract_i02B_z6wcEGpwcgjk" style="background-color: White">
    <td style="line-height: 9.5pt"><b>Changes in assets and liabilities</b></td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_i03_pn3n3_maAFRPLzvdO_zPny3oV8N0A4" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Trade receivables</td>
    <td style="text-align: center; line-height: 9.5pt">6</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="From2025-01-01to2025-12-31" id="Fact000638" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">177,602</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="From2024-01-012024-12-31" id="Fact000639" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">97,449</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="From2023-01-012023-12-31" id="Fact000640" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">131,336</ix:nonFraction>)</td></tr>
  <tr id="xdx_405_ecustom--IncreaseDecreaseInRecoverableTaxes_i03N_pn3n3_di_msAFRPLzvdO_zba0Ve2mQQyc" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Recoverable taxes</td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:IncreaseDecreaseInRecoverableTaxes" contextRef="From2025-01-01to2025-12-31" id="Fact000642" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,749</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="afya:IncreaseDecreaseInRecoverableTaxes" contextRef="From2024-01-012024-12-31" id="Fact000643" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,107</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:IncreaseDecreaseInRecoverableTaxes" contextRef="From2023-01-012023-12-31" id="Fact000644" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,353</ix:nonFraction>)</td></tr>
  <tr id="xdx_407_eifrs-full--AdjustmentsForDecreaseIncreaseInOtherAssets_i03_pn3n3_maAFRPLzvdO_zeKfrQIR3wz" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Other assets</td>
    <td style="text-align: center; line-height: 9.5pt">8</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" contextRef="From2025-01-01to2025-12-31" id="Fact000646" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,798</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" contextRef="From2024-01-012024-12-31" id="Fact000647" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,220</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" contextRef="From2023-01-012023-12-31" id="Fact000648" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88,427</ix:nonFraction></td></tr>
  <tr id="xdx_409_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_i03_pn3n3_maAFRPLzvdO_zthJZ87G2yWi" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Trade payables</td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2025-01-01to2025-12-31" id="Fact000650" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,499</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2024-01-012024-12-31" id="Fact000651" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,126</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2023-01-012023-12-31" id="Fact000652" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,500</ix:nonFraction></td></tr>
  <tr id="xdx_405_eifrs-full--AdjustmentsForIncomeTaxExpense_i03_pn3n3_maAFRPLzvdO_ziqHVOunbwzf" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Taxes payable</td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncomeTaxExpense" contextRef="From2025-01-01to2025-12-31" id="Fact000654" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,109</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncomeTaxExpense" contextRef="From2024-01-012024-12-31" id="Fact000655" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,798</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncomeTaxExpense" contextRef="From2023-01-012023-12-31" id="Fact000656" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,278</ix:nonFraction></td></tr>
  <tr id="xdx_406_eifrs-full--AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_i03_pn3n3_maAFRPLzvdO_z7JmrNHBSmFc" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Advances from customers</td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" contextRef="From2025-01-01to2025-12-31" id="Fact000658" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,013</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" contextRef="From2024-01-012024-12-31" id="Fact000659" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,329</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" contextRef="From2023-01-012023-12-31" id="Fact000660" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,892</ix:nonFraction>)</td></tr>
  <tr id="xdx_40B_eifrs-full--OtherAdjustmentsForNoncashItems_i03_pn3n3_maAFRPLzvdO_zstZhprS8n8j" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Labor and social obligations</td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:OtherAdjustmentsForNoncashItems" contextRef="From2025-01-01to2025-12-31" id="Fact000662" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,450</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:OtherAdjustmentsForNoncashItems" contextRef="From2024-01-012024-12-31" id="Fact000663" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,414</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:OtherAdjustmentsForNoncashItems" contextRef="From2023-01-012023-12-31" id="Fact000664" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,525</ix:nonFraction></td></tr>
  <tr id="xdx_40E_ecustom--IncreaseDecreaseInPaymentsOfLegalProceedings_i03N_pn3n3_di_msAFRPLzvdO_zCidcglrjTId" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Payments of legal proceedings</td>
    <td style="text-align: center; line-height: 9.5pt">21</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:IncreaseDecreaseInPaymentsOfLegalProceedings" contextRef="From2025-01-01to2025-12-31" id="Fact000666" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,873</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:IncreaseDecreaseInPaymentsOfLegalProceedings" contextRef="From2024-01-012024-12-31" id="Fact000667" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,637</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:IncreaseDecreaseInPaymentsOfLegalProceedings" contextRef="From2023-01-012023-12-31" id="Fact000668" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,781</ix:nonFraction>)</td></tr>
  <tr id="xdx_40E_eifrs-full--AdjustmentsForIncreaseDecreaseInOtherLiabilities_i03_pn3n3_maAFRPLzvdO_zW1x723naNg" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Other liabilities</td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities" contextRef="From2025-01-01to2025-12-31" id="Fact000670" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,196</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities" contextRef="From2024-01-012024-12-31" id="Fact000671" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,687</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities" contextRef="From2023-01-012023-12-31" id="Fact000672" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">42,542</ix:nonFraction>)</td></tr>
  <tr id="xdx_404_eifrs-full--AdjustmentsForReconcileProfitLoss_i03T_pn3n3_mtAFRPLzvdO_maCFFUIzbWe_zA6MwjezclXj" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt"><b style="display: none">Net cash flows from operating activities before income taxes</b></td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><b><ix:nonFraction name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="From2025-01-01to2025-12-31" id="Fact000674" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,547,633</ix:nonFraction></b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><b><ix:nonFraction name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="From2024-01-012024-12-31" id="Fact000675" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,453,179</ix:nonFraction></b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 9.5pt"><b><ix:nonFraction name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="From2023-01-012023-12-31" id="Fact000676" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,088,767</ix:nonFraction></b></td></tr>
  <tr id="xdx_40B_eifrs-full--IncomeTaxesPaidRefundClassifiedAsOperatingActivities_i02N_pn3n3_di_msCFFUIzbWe_zCBVPNVhYcm4" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Income taxes paid</td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000678" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,046</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From2024-01-012024-12-31" id="Fact000679" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,520</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From2023-01-012023-12-31" id="Fact000680" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,144</ix:nonFraction>)</td></tr>
  <tr id="xdx_407_eifrs-full--CashFlowsFromUsedInOperatingActivities_iT_pn3n3_mtCFFUIzbWe_maIDICAzKQW_zWvDqzvlufn6" style="background-color: White">
    <td style="line-height: 9.5pt"><b>Net cash flows from operating activities</b></td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000682" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,531,587</ix:nonFraction></b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2024-01-012024-12-31" id="Fact000683" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,432,659</ix:nonFraction></b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; line-height: 9.5pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2023-01-012023-12-31" id="Fact000684" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,043,623</ix:nonFraction></b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt">&#160;</td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--CashFlowsFromUsedInInvestingActivitiesAbstract_iB" style="background-color: White">
    <td style="line-height: 9.5pt"><b>Investing activities</b></td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_i01N_pn3n3_di_msCFFUIzK4L_z9bXcbUOuAq" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Acquisition of property and equipment</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">10</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000690" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">166,014</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From2024-01-012024-12-31" id="Fact000691" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">136,924</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From2023-01-012023-12-31" id="Fact000692" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">118,435</ix:nonFraction>)</td></tr>
  <tr id="xdx_40F_ecustom--PurchaseOfIntangibleAssetClassifiedAsInvestingActivities_i01N_pn3n3_di_msCFFUIzK4L_zHidNoPXtud1" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Acquisition of intangibles assets</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">11</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000694" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">197,997</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" contextRef="From2024-01-012024-12-31" id="Fact000695" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">255,691</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" contextRef="From2023-01-012023-12-31" id="Fact000696" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">126,993</ix:nonFraction>)</td></tr>
  <tr id="xdx_40F_eifrs-full--DividendsReceived_i01_pn3n3_maCFFUIzK4L_z15B18RmYvH2" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Dividends received</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">9</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2025-01-01to2025-12-31" id="Fact000698" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,553</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2024-01-012024-12-31" id="Fact000699" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,501</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2023-01-012023-12-31" id="Fact000700" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,900</ix:nonFraction></td></tr>
  <tr id="xdx_404_ecustom--PurchaseOfAcquisitionOfNoncontrollingInterests_i01N_pn3n3_di_msCFFUIzK4L_zsj8zstjzF8f" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Acquisition of non-controlling interest</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0702">-</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0703">-</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:PurchaseOfAcquisitionOfNoncontrollingInterests" contextRef="From2023-01-012023-12-31" id="Fact000704" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,000</ix:nonFraction>)</td></tr>
  <tr id="xdx_40A_eifrs-full--PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_i01N_pn3n3_di_msCFFUIzK4L_zH1y6x0gJvk7" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Acquisition of assets and subsidiaries, net of cash acquired</td>
    <td style="text-align: center; line-height: 9.5pt">12.2.3</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000706" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">144,076</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" contextRef="From2024-01-012024-12-31" id="Fact000707" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">627,568</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" contextRef="From2023-01-012023-12-31" id="Fact000708" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">815,005</ix:nonFraction>)</td></tr>
  <tr id="xdx_401_ecustom--PaymentsOfInterest_i01N_pn3n3_di_msCFFUIzK4L_zZvegIxhU83f" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Payments of interest</td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:PaymentsOfInterest" contextRef="From2025-01-01to2025-12-31" id="Fact000710" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,536</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:PaymentsOfInterest" contextRef="From2024-01-012024-12-31" id="Fact000711" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">78,931</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:PaymentsOfInterest" contextRef="From2023-01-012023-12-31" id="Fact000712" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,518</ix:nonFraction>)</td></tr>
  <tr id="xdx_40B_eifrs-full--CashFlowsFromUsedInInvestingActivities_i01T_pn3n3_mtCFFUIzK4L_maIDICAzKQW_zt4xZ30qKZe8" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt"><b>Net cash flows used in investing activities</b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><b>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000714" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">507,070</ix:nonFraction>)</b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><b>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="From2024-01-012024-12-31" id="Fact000715" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,091,613</ix:nonFraction>)</b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; line-height: 9.5pt"><b>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="From2023-01-012023-12-31" id="Fact000716" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,143,051</ix:nonFraction>)</b></td></tr>
  <tr style="background-color: White">
    <td style="line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 2.8pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_40E_eifrs-full--CashFlowsFromUsedInFinancingActivitiesAbstract_iB" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt"><b>Financing activities</b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 2.8pt; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td></tr>
  <tr id="xdx_401_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_i01N_pn3n3_di_msCFFUIzvKL_z1TQfL0lnrl9" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Payments of principal of loans and financing</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">12.5</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000722" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,624,911</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="From2024-01-012024-12-31" id="Fact000723" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,696</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact000724" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">112,630</ix:nonFraction>)</td></tr>
  <tr id="xdx_40C_ecustom--RepaymentsOfInterest_i01N_pn3n3_di_msCFFUIzvKL_zh0tDrhr4Vn4" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Payments of interest</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:RepaymentsOfInterest" contextRef="From2025-01-01to2025-12-31" id="Fact000726" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">309,337</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:RepaymentsOfInterest" contextRef="From2024-01-012024-12-31" id="Fact000727" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">177,192</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:RepaymentsOfInterest" contextRef="From2023-01-012023-12-31" id="Fact000728" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">175,889</ix:nonFraction>)</td></tr>
  <tr id="xdx_40B_eifrs-full--ProceedsFromBorrowingsClassifiedAsFinancingActivities_i01_pn3n3_maCFFUIzvKL_z1xmjWbHLkKf" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Proceeds from loans and financing</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">12.5</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000730" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,494,881</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="From2024-01-012024-12-31" id="Fact000731" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">491,593</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact000732" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,288</ix:nonFraction></td></tr>
  <tr id="xdx_400_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_i01N_pn3n3_di_msCFFUIzvKL_zM9G1sczov0j" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Payments of principal of lease liabilities</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">12.2.2, 12.5</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,411</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2024-01-012024-12-31" id="Fact000735" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,221</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact000736" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,473</ix:nonFraction>)</td></tr>
  <tr id="xdx_40B_ecustom--PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities_i01N_pn3n3_di_msCFFUIzvKL_z9icyVQ6Gps9" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Payments of interest of lease liabilities</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">12.2.2, 12.5</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000738" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">121,475</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2024-01-012024-12-31" id="Fact000739" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">111,605</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact000740" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">103,911</ix:nonFraction>)</td></tr>
  <tr id="xdx_40F_ecustom--TreasurySharesRepurchase_i01_maCFFUIzvKL_zAjSBk4ft7j8" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Treasury shares repurchase</td>
    <td style="text-align: center; line-height: 9.5pt">15</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2025-01-01to2025-12-31" id="Fact000742" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">77,002</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="-sec-ix-hidden: xdx2ixbrl0743">-</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt">(<ix:nonFraction name="afya:TreasurySharesRepurchase" contextRef="From2023-01-012023-12-31" id="Fact000744" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,369</ix:nonFraction>)</td></tr>
  <tr id="xdx_40C_eifrs-full--ProceedsFromExerciseOfOptions_i01_maCFFUIzvKL_zy4fFnvRERk" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Proceeds from exercise of stock options</td>
    <td style="text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="From2025-01-01to2025-12-31" id="Fact000746" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,733</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="From2024-01-012024-12-31" id="Fact000747" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,376</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="From2023-01-012023-12-31" id="Fact000748" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,791</ix:nonFraction></td></tr>
  <tr id="xdx_404_eifrs-full--DividendsPaidClassifiedAsFinancingActivities_i01N_di_msCFFUIzvKL_zHmXbVWS90p3" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Dividends paid</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">12.5, 15</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000750" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">146,813</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From2024-01-012024-12-31" id="Fact000751" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,289</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact000752" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,750</ix:nonFraction>)</td></tr>
  <tr id="xdx_40B_eifrs-full--CashFlowsFromUsedInFinancingActivities_i01T_mtCFFUIzvKL_maIDICAzKQW_ze0oKSfLLJU7" style="background-color: White">
    <td style="line-height: 9.5pt"><b>Net cash flows from (used in) financing activities</b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><b>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact000754" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">808,335</ix:nonFraction>)</b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="From2024-01-012024-12-31" id="Fact000755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,966</ix:nonFraction></b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 9.5pt"><b>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact000756" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">439,943</ix:nonFraction>)</b></td></tr>
  <tr id="xdx_40E_eifrs-full--EffectOfExchangeRateChangesOnCashAndCashEquivalents_i01_maIDICAzKQW_z4XMnGedcOdg" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Net foreign exchange differences</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From2025-01-01to2025-12-31" id="Fact000758" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,816</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From2024-01-012024-12-31" id="Fact000759" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,027</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 9.5pt">(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From2023-01-012023-12-31" id="Fact000760" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">681</ix:nonFraction>)</td></tr>
  <tr id="xdx_400_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_iT_mtIDICAzKQW_zRwaRO8PSSpb" style="background-color: White">
    <td style="line-height: 9.5pt"><b>Net increase (decrease) in cash and cash equivalents</b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2025-01-01to2025-12-31" id="Fact000762" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">214,366</ix:nonFraction></b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2024-01-012024-12-31" id="Fact000763" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">357,985</ix:nonFraction></b></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt double; text-align: right; line-height: 9.5pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2023-01-012023-12-31" id="Fact000764" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">540,052</ix:nonFraction>)</b></td></tr>
  <tr id="xdx_40B_eifrs-full--RestrictedCashAndCashEquivalents_iS_zSOlo3XU1b7g" style="background-color: rgb(213,234,234)">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Cash and cash equivalents at the beginning of the year</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">5</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2024-12-31" id="Fact000766" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">911,015</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2023-12-31" id="Fact000767" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">553,030</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2022-12-31" id="Fact000768" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,093,082</ix:nonFraction></td></tr>
  <tr id="xdx_402_eifrs-full--RestrictedCashAndCashEquivalents_iE_zn4pRUHZXrpe" style="background-color: White">
    <td style="line-height: 9.5pt; text-indent: 7.1pt">Cash and cash equivalents at the end of the year</td>
    <td style="vertical-align: top; text-align: center; line-height: 9.5pt">5</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2025-12-31" id="Fact000770" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,125,381</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2024-12-31" id="Fact000771" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">911,015</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt">&#160;</td>
    <td style="text-align: right; line-height: 9.5pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2023-12-31" id="Fact000772" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">553,030</ix:nonFraction></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">The accompanying notes are an integral part of these  consolidated financial statements.</p>


<!-- Field: Page; Sequence: 180; Options: NewSection; Value: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000774" name="afya:DisclosureOfGeneralInformationAboutFinancialStatementExplanatory"><p id="xdx_808_ecustom--DisclosureOfGeneralInformationAboutFinancialStatementExplanatory_znzvRxEeyWbg" style="margin-top: 0; margin-bottom: 0"><span id="a_0005"></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">1</td><td><span id="xdx_82E_zLcNmNOSZjee">Corporate information</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0pt 0pt 0pt 3%">Afya Limited (&#8220;Afya&#8221;), collectively with its subsidiaries referred to as the
&#8220;Company&#8221;, is a holding company incorporated under the laws of the Cayman Islands on March 22, 2019. Afya completed its initial
public offering (IPO) on July 19, 2019, and its shares are listed on the Nasdaq under the symbol &#8220;AFYA&#8221;. The Company&#8217;s
ultimate parent company is Bertelsmann SE&amp; Co. KGaA (&#8220;Bertelsmann&#8221;).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0pt 0pt 0pt 3%">The Company is formed by a network of higher education and post-graduate institutions,
focused on medical schools, under the regulations of the Ministry of Education (&#8220;MEC&#8221;). The Company also provides other educational
services that comprise the development and sale of electronically distributed educational courses on medicine science and soft skills
educational content. The Company also offers solutions to empower the physicians in their daily routine including supporting clinic decisions
through mobile app subscription, delivering practice management tools through a SaaS (Software as a Service) model and supporting the
patient-physician relationship.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0pt 0pt 0pt 3%; color: #C00000"><span style="text-decoration: underline">Acquisition in 2025</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On May 7, 2025, Afya Participa&#231;&#245;es S.A. (&#8220;Afya Brazil&#8221;) acquired
<span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_c20250507__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeMasterclassLtdaMember_z0zy4jJ7h9R4" title="Acquired percenatge"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2025-05-07_custom_FaculdadeMasterclassLtdaMember" id="Fact000776" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of Faculdade Masterclass Ltda. (&#8220;FUNIC&#8221;), located in the city of Contagem, a city in the metropolitan
area of Belo Horizonte, the capital of the State of Minas Gerais. The acquisition contributed 60 medical school seats to Afya. FUNIC started
its operations in the second semester of 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span id="xdx_90A_eifrs-full--DescriptionOfAcquiree_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeMasterclassLtdaMember_zieAbuTcqVgj" title="Acquired purchase price"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaMember" id="Fact000778" name="ifrs-full:DescriptionOfAcquiree">The aggregate purchase price is R$100,000. The price and payment conditions are: (i) R$60,000,
net of the estimated Net Debt, paid in cash on May 7, 2025 and presented in &#8220;Acquisition of assets and subsidiaries, net of cash
acquired&#8221; in the consolidated statement of cash flows; and (ii) R$40,000 payable in three equal annual installments adjusted by
100% of the Brazilian interbank interest rate (&#8220;CDI&#8221;) - see Note 22. FUNIC&#8217;s installments are not contingent consideration
and therefore are not included in the fair value disclosure in Note 2.3(b). The time value on the deferred installments is recognized
as finance expense using the effective interest rate method.</ix:nonNumeric></span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The acquisition includes a potential additional payment for up to 60 medical school seats,
contingent upon regulatory approval. If approved by MEC within 36 months from the closing date, an additional payment of R$<span id="xdx_90E_ecustom--AdditionalPaymentToShareholder_pn3n3_c20250506__20250507_zSlxzI1UiYei" title="Additional payment to shareholders"><ix:nonFraction name="afya:AdditionalPaymentToShareholder" contextRef="From2025-05-062025-05-07" id="Fact000780" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,000</ix:nonFraction></span> per approved
seat will become payable. Afya Brazil does not have a legal or constructive obligation at the acquisition date or at any reporting date.
Upon approval, the additional seats will give rise to additional licenses, which will be recognized and measured at that time, together
with the recognition of the related liability.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Management assessed the aspects of such transaction in accordance with IFRS 3 - Business
Combinations and applied the optional &#8216;concentration test&#8217;, designed to simplify the evaluation of whether an acquired set
of activities and assets is not a business. Since substantially all of the fair value of the gross assets acquired is concentrated in
a single identifiable asset, Management concluded that the transaction does not fall under the definition of a business, but an acquisition
of assets, which were measured on initial recognition at cost allocated to identifiable assets and liabilities on a relative fair value
basis.</p>

<ix:exclude><p id="xdx_23C_ziSszpGzAcsg" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 181 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zffyUtMTt7Rj" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000784" name="afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_884_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_pn3n3_zcYr6u6Ajd7e" summary="xdx: Disclosure - Corporate information (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BE_zb9ZC67chhye" style="display: none">Schedule of identifiable assets and liabilities</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 83%; padding-right: 3.5pt; padding-left: 3.5pt"><b>Assets</b></td>
    <td style="white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cash and cash equivalents</td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zMBwY30cG01d" title="Cash and cash and equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member" id="Fact000786" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Property and equipment</td>
    <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zKzqNGtR8Svb" title="Property and equipment" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member" id="Fact000788" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,683</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Intangible assets - Licenses with indefinite useful life</td>
    <td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zFDVFctUyYC" title="Intangible assets" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member" id="Fact000790" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,628</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zTRAGlXx52D" title="Total" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member" id="Fact000792" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">102,314</ix:nonFraction></b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Liabilities</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Trade payables</td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zghtsN3MIQGj" title="Trade payables" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member" id="Fact000794" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Loans and financing</td>
    <td id="xdx_98A_ecustom--LoansAndFinancingAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zUSmDaDYT1n" title="Loans and financing" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancingAsOfAcquisitionDate" contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member" id="Fact000796" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,243</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_981_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zTD15KcIWIZj" title="Financial liabilities recognised as of acquisition date" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member" id="Fact000798" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,314</ix:nonFraction></b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Total net assets</b></td>
    <td id="xdx_981_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zb7lxY6QyGvh" title="Total net assets" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member" id="Fact000800" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,000</ix:nonFraction></b></td></tr>
  </table></ix:nonNumeric>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The valuation techniques used to licenses with indefinite useful life, which is the most
representative asset acquired, were the With-and-without method, which consists of estimating the fair value of an asset by the difference
between the value of this asset in two scenarios: a scenario considering the existence of the asset in question and another considering
its non-existence.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><span style="text-decoration: underline">Acquisition in 2024</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On July 1, 2024, Afya Brazil acquired Unidom Participa&#231;&#245;es S.A. (&#8220;Unidom&#8221;).
Unidom is a post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate
programs in medicine and health, as well as other courses. It encompasses &#8220;Unidompedro&#8221; and &#8220;Faculdade Dom Luiz&#8221;,
both located in the State of Bahia with operations in the cities of Salvador, Luis Eduardo Magalh&#227;es, Barreiras and Ribeira do
Pombal. See Note 4.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000802" name="afya:DisclosureOfMaterialAccountingPoliciesExplanatory"><p id="xdx_803_ecustom--DisclosureOfMaterialAccountingPoliciesExplanatory_zGjNOx92TI29" style="font: 10.5pt Nunito Sans; margin: 0; color: #C00000">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">2</td><td><span id="xdx_822_zfp2L1I6Lw4j">Material accounting policies</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: bold 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">2.1 Basis of preparation</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">These consolidated financial statements have been prepared in accordance with IFRS Accounting
Standards as issued by the International Accounting Standards Board (IFRS Accounting Standards).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In preparing these consolidated financial statements, Management has assessed the Company&#8217;s
ability to continue as a going concern and concluded that the going concern basis of accounting is appropriate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">These consolidated financial statements have been prepared on a historical cost
basis, except for the following items measured at fair value: (i) certain financial instruments - including the contingent consideration
payable to selling shareholders - measured at fair value through profit or loss (Notes 2.3(b) and 12.2.3); (ii) the initial recognition
of identifiable assets and liabilities acquired in business combinations, which are measured at fair value at the acquisition date (Note
4); and (iii) equity-settled share-based payment awards, which are measured at grant-date fair value (Note 14). Disclosures about fair
value hierarchy and valuation techniques for recurring measurements are provided in Note 2.3(b).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Substantially all operations are conducted in Brazil. Accordingly, Management determined
the functional currency of the Company to be the Brazilian real (&#8220;R$&#8221;). These   consolidated financial statements
are presented in R$, and amounts are rounded to the nearest thousand, unless otherwise stated.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company improved the presentation of some items in the consolidated statement of income
and other comprehensive income for the current year, by segregating the &#8216;Allowance for expected credit losses&#8217; expenses from
the &#8216;Selling, general and administrative expenses&#8217; and the &#8216;Other income&#8217; and &#8216;Other expenses&#8217; from
the &#8216;Other income (expenses), net&#8217;. To ensure comparability, the Company reflected these changes in the previous years.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">These  consolidated financial statements were authorized for issue by the Board
of Directors on March 12, 2026.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>2.2 Basis of consolidation</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The table below presents a list of the Company&#8217;s subsidiaries and associate:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 182 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zxQvdRKCxAvg" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact000805" name="afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_893_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zcj6lFUACLga" summary="xdx: Disclosure - Material accounting policies (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B5_zynWLHfQVvif" style="display: none">Schedule of company&#8217;s subsidiaries and associate</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Direct and indirect interest</b></span></td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; width: 260px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Name</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 165px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Main activities</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 106px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Location</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Investment type</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 94px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2025</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 95px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2024</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Afya Participa&#231;&#245;es S.A. (&#8220;Afya Brazil&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90F_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zv5MTqPDekz" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AfyaParticipacoesSAMember" id="Fact000807" name="afya:PrincipalActivities">Holding</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zPQvVIsNbXAl" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AfyaParticipacoesSAMember" id="Fact000809" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Nova Lima - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zPhxWSLNNFYb" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AfyaParticipacoesSAMember" id="Fact000811" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z3dUyGsNEGAj" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_AfyaParticipacoesSAMember" id="Fact000813" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zykxwE9jljwb" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_AfyaParticipacoesSAMember" id="Fact000815" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto Tocantinense Presidente Ant&#244;nio Carlos Porto S.A. - (&#8220;ITPAC Porto&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zN6FDhFYiu8g" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" id="Fact000817" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_z6JBWPXjcXY9" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" id="Fact000819" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Porto Nacional - TO</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zHBIi1cxo8R2" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" id="Fact000821" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zIegwX923u7h" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" id="Fact000823" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_z9fDNnTtrmke" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" id="Fact000825" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto Tocantinense Presidente Ant&#244;nio Carlos S.A. - (&#8220;ITPAC Aragua&#237;na&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zeVY7TuruoTj" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" id="Fact000827" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zmJbPAAr1cw2" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" id="Fact000829" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Aragua&#237;na - TO</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zDNrwBhUTADl" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" id="Fact000831" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zBxnAE9RObwa" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" id="Fact000833" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_z7lLtAtqjHJ5" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" id="Fact000835" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Uni&#227;o Educacional do Vale do A&#231;o S.A. - (&#8220;UNIVA&#199;O&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zb1MPrkWtBj7" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" id="Fact000837" name="afya:PrincipalActivities">Medicine undergraduate degree program</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zkBKk14iQtJ3" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" id="Fact000839" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Ipatinga - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_ztAaXWaBOmXk" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" id="Fact000841" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zq7PR9YcZf4l" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" id="Fact000843" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z3hzjt4buVzc" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" id="Fact000845" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#8220;IPTAN&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zKEFurG6PIJk" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" id="Fact000847" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_z34RwQCvWmkg" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" id="Fact000849" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o Jo&#227;o Del Rei - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zC6MdwGisMA3" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" id="Fact000851" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zYYLghJr7UPh" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" id="Fact000853" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_z3Vs4M6uzCu8" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" id="Fact000855" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A. (&#8220;IESVAP&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zxk0We0LsPTa" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" id="Fact000857" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zIGxc588gUV3" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" id="Fact000859" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Parna&#237;ba - PI</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_909_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zP79vi4r5u25" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" id="Fact000861" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zLKyjBMsY4q" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" id="Fact000863" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zqRuGSlSR3c5" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" id="Fact000865" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Centro de Ci&#234;ncias em Sa&#250;de de Itajub&#225; S.A. (&#8220;CCSI&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90C_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_znpmsbq0xH48" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" id="Fact000867" name="afya:PrincipalActivities">Medicine undergraduate degree program</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zRwHby9YAzig" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" id="Fact000869" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Itajub&#225; - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z4hzcx6IE5V5" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" id="Fact000871" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zQRvYSVGO8l1" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" id="Fact000873" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zqvLSDfXd139" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" id="Fact000875" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto de Ensino Superior do Piau&#237; S.A. (&#8220;IESP&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zj3jTfZwlLji" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" id="Fact000877" name="afya:PrincipalActivities">Undergraduate and graduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_ztDnmW1MZkv1" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" id="Fact000879" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Teresina - PI</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zdGWxYEdRXe1" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" id="Fact000881" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_znSqGAUxHmSh" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" id="Fact000883" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zSkFjQ6kWxcj" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" id="Fact000885" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">FADEP - Faculdade Educacional de Pato Branco Ltda. (&#8220;FADEP&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zHlgWNtXlL1i" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" id="Fact000887" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_z56ixa0OF8z1" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" id="Fact000889" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Pato Branco - PR</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zngY2U4fEaAc" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" id="Fact000891" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zSdYtCrll9g3" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" id="Fact000893" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zmiMsMyM8Z15" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" id="Fact000895" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto Educacional Santo Agostinho S.A. (&#8220;FASA&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zEGxfStAXTxh" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" id="Fact000897" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zj2TQxkuupd1" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" id="Fact000899" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Montes Claros - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zItnb4CAdbX7" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" id="Fact000901" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zyjNud4yCVT9" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" id="Fact000903" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zjp7cIlEofq4" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" id="Fact000905" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto Paraense de Educa&#231;&#227;o e Cultura Ltda. (&#8220;IPEC&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zdUIpIjzmRrf" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" id="Fact000907" name="afya:PrincipalActivities">Medicine undergraduate degree program</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_900_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_z6DdHhd4Xmza" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" id="Fact000909" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Marab&#225; - PA</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zr87jn2JTCXc" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" id="Fact000911" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zcjdzX044wOl" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" id="Fact000913" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zqUtS4RqBPee" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" id="Fact000915" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Sociedade Universit&#225;ria Redentor S.A. (&#8220;UniRedentor&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_909_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_za0Q6jdh9pak" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember" id="Fact000917" name="afya:PrincipalActivities">Undergraduate and graduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z6VCJPMUsi1f" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember" id="Fact000919" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Itaperuna - RJ</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zD4jfTDq71j6" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember" id="Fact000921" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zIVijpv6VO43" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember" id="Fact000923" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z07aHHXjuuVe" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember" id="Fact000925" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Centro de Ensino S&#227;o Lucas Ltda. (&#8220;UniSL&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zIhMyuuAKua2" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember" id="Fact000927" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zhZhAnIDU9E1" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember" id="Fact000929" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Porto Velho - RO</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zQRwvub5eTIa" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember" id="Fact000931" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zgs2o9pY6Cmh" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember" id="Fact000933" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zlDyTrQuIJg4" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember" id="Fact000935" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Sociedade de Educa&#231;&#227;o, Cultura e Tecnologia da Amaz&#244;nia S.A. - (&#8220;FESAR&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zcHSROCuWJM7" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" id="Fact000937" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zkf4DTOFkzh" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" id="Fact000939" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Reden&#231;&#227;o - PA</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zMBjyVKo2kyl" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" id="Fact000941" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zOZfqEkf5plj" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" id="Fact000943" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zVx33b2Z4SE5" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" id="Fact000945" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Centro Superior de Ci&#234;ncias da Sa&#250;de Ltda. (&#8220;FCMPB&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zPJljvKsTKY3" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" id="Fact000947" name="afya:PrincipalActivities">Medicine undergraduate degree program</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_ztgmy5KQZoL4" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" id="Fact000949" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Jo&#227;o Pessoa - PB</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zixh7etHMAs6" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" id="Fact000951" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zhDdMICkhOpj" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" id="Fact000953" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zZUHbrDe94Qb" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" id="Fact000955" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">iClinic Desenvolvimento de Software Ltda. (&#8220;iClinic&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zKFuIzZDoVdb" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" id="Fact000957" name="afya:PrincipalActivities">Electronic Medical Record, Clinical Management System</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zYO3zEnLze0d" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" id="Fact000959" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Ribeir&#227;o Preto - SP</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zKMoyotrxxZc" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" id="Fact000961" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zq9uudZ4Wu6a" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" id="Fact000963" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Medicinae Solutions S.A. (&#8220;Medicinae&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z1SofMPFPlO2" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember" id="Fact000965" name="afya:PrincipalActivities">Healthcare payments and financial services</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zMOTdOw90wve" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember" id="Fact000967" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Rio de Janeiro - RJ</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z4wGxD0Is5yf" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember" id="Fact000969" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zaNYs0QSrnjl" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember" id="Fact000971" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Medical Harbour Aparelhos M&#233;dico Hospitalares e Servi&#231;os em Tecnologia Ltda. (&#8220;Medical Harbour&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90C_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zo5yxSCK4fcb" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" id="Fact000973" name="afya:PrincipalActivities">Educational health and medical imaging</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_z2EEbHDK43ib" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" id="Fact000975" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Florian&#243;polis - SC</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zXJnbFmJVJmf" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" id="Fact000977" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_ztoRoXecM1yk" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" id="Fact000979" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zUZr9aZ30Ma9" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" id="Fact000981" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Cliquefarma Drogarias Online Ltda. (&#8220;Cliquefarma&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90F_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_z2RckVYleRaf" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" id="Fact000983" name="afya:PrincipalActivities">Online platform</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zzCRFheNCFXj" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" id="Fact000985" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o Paulo - SP</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zf65vluVhRD7" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" id="Fact000987" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zYEwq8HrPsHl" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" id="Fact000989" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Shosp Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_907_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zh0RFfKTO0h" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember" id="Fact000991" name="afya:PrincipalActivities">Electronic Medical Record, Clinical Management System</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zZWb9ilnXxli" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember" id="Fact000993" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Rio de Janeiro - RJ</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zqPVdXTXS105" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember" id="Fact000995" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zT1Zp6mEFvBd" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember" id="Fact000997" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Sociedade Padr&#227;o de Educa&#231;&#227;o Superior Ltda. (&#8220;UnifipMoc&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_z6QpELqIicFk" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" id="Fact000999" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zKBF85Ceu6yg" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" id="Fact001001" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Montes Claros - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zsVdwsb7WRs7" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" id="Fact001003" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zDX65F3q2SW7" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" id="Fact001005" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zkeolXEixvxa" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" id="Fact001007" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Companhia Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura (&#8220;Unigranrio&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zJnkuIR4kAHf" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" id="Fact001009" name="afya:PrincipalActivities">Undergraduate and graduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zXNJn29mYOTi" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" id="Fact001011" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Duque de Caxias - RJ</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_905_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zSWG75kMUPD5" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" id="Fact001013" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zdOLXBhYnt9c" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" id="Fact001015" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_ztanF7UNSRe8" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" id="Fact001017" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">RX PRO Solu&#231;&#245;es de Tecnologia Ltda. (&#8220;RX PRO&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z6RLl3YkQS22" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember" id="Fact001019" name="afya:PrincipalActivities">Marketing for pharmaceutical industry</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zBQeFbmIbl35" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember" id="Fact001021" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o Paulo - SP</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90B_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zrtDD8tW8W01" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember" id="Fact001023" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z47hLNellYa9" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember" id="Fact001025" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Quasar Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#8220;Glic&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zPT1tFS9JPw2" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" id="Fact001027" name="afya:PrincipalActivities">Patient physician relationship</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zHZNuhCaxm9i" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" id="Fact001029" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Barueri - SP</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90F_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zcLRpP7Rhg04" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" id="Fact001031" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zTW4DPdvqT39" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" id="Fact001033" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#8220;DelRey&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zBVWD5GCo51f" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" id="Fact001035" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zQDYBK2PrV13" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" id="Fact001037" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Macei&#243; - AL</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zJ6HBLFonPJg" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" id="Fact001039" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zNsgE3mViXsd" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" id="Fact001041" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zhodVdvKA1zj" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" id="Fact001043" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Unidom Participa&#231;&#245;es S.A. (&#8220;Unidom&#8221;) (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_z2lVPdfMwtl3" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_UnidomParticipacoesS.A.UnidomMember" id="Fact001045" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_zpQPon9Ub1i3" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_UnidomParticipacoesS.A.UnidomMember" id="Fact001047" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Salvador - BA</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_za1ZaEX8hrqh" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_UnidomParticipacoesS.A.UnidomMember" id="Fact001049" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_zh9cTJCFCe95" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_UnidomParticipacoesS.A.UnidomMember" id="Fact001051" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Institui&#231;&#227;o Baiana de Ensino Superior Ltda. (&#8220;IBES&#8221;) (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_z1Saz06WwUnl" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" id="Fact001053" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zICkxiPWlCa1" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" id="Fact001055" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Salvador - BA</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zxUSj3cpH6pg" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" id="Fact001057" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zuMSslRL2ALl" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" id="Fact001059" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zH5T8zK1k4Cj" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" id="Fact001061" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">SESSA - Sociedade de Educa&#231;&#227;o Superior do Semi-&#193;rido Ltda. (&#8220;SESSA&#8221;) (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zv50ehHClrB7" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" id="Fact001063" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zpgyLpqvA3Jf" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" id="Fact001065" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Ribeira de Pombal - BA</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zHSATSvTBwKi" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" id="Fact001067" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zMQpJh7s9Wka" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" id="Fact001069" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zsoKyXtcwfZ2" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" id="Fact001071" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Faculdade Masterclass Ltda. (&#8220;FUNIC&#8221;) (iii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zJLSGdjCKky1" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaFUNICMember" id="Fact001073" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_ziHX1c9NEdm1" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaFUNICMember" id="Fact001075" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Contagem - MG</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zNS2Ibga4wN3" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaFUNICMember" id="Fact001077" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zWJegr0aqI2c" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaFUNICMember" id="Fact001079" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Uni&#227;o Educacional do Planalto Central S.A. (&#8220;UEPC&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zAfk9pP4wRYg" title="Principal activities"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" id="Fact001081" name="afya:PrincipalActivities">Undergraduate degree programs</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zVDZlkJfGQFf" title="Location"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" id="Fact001083" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Bras&#237;lia - DF</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zRtK0fl0ttEa" title="Investment type"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" id="Fact001085" name="afya:InvestmentType">Associate</ix:nonNumeric></span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_z9brl7z0M5E4" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" id="Fact001087" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zBQdakn8im8b" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-01-012024-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" id="Fact001089" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></span>%</span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0; color: #212121">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="background-color: white">(i)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="background-color: white">Unidom was merged with Afya Brazil on January 1, 2025.
As a result, from this date on, Afya Brazil directly controls the Unidom&#8217;s subsidiaries IBES and SESSA.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="background-color: white">(ii)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="background-color: white">Cliquefarma, RX PRO and Glic were merged with Afya Brazil
in August 2025; iClinic, Medicinae and Shosp were merged with Afya Brazil in October 2025.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="color: #212121; background-color: white">(iii)</span></td><td style="width: 5pt"/><td style="text-align: justify">See Note 1.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AE_zzPc0ZzQkUV2" style="font: 10.5pt Nunito Sans; margin: 0; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">The financial information of the
subsidiaries acquired is included in the Company&#8217;s consolidated financial statements beginning on the respective acquisition dates.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">The Company consolidates the financial
information for all entities it controls. Control is achieved when the Company is exposed to, or has rights, to variable returns from
its involvement with the investee and has the ability to affect those returns through its power over the investee.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0; color: #212121">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 183 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">Consolidation of a subsidiary begins
when the Company obtains control over the subsidiary and it ceases when the Company loses control of the subsidiary. Assets, liabilities,
income and expenses of a subsidiary acquired or disposed of during the year are included in the consolidated financial statements from
the date the Company gains control until the date the Company ceases to control the subsidiary.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">All intra-group assets and liabilities,
equity, income, expenses and cash flows relating to transactions are eliminated in full on consolidation.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">A change in the ownership interest
of a subsidiary, without a change of control, is accounted for as an equity transaction. If the Company loses control over a subsidiary,
it derecognizes the related assets (including goodwill), liabilities, non-controlling interest and other components of equity, while any
resulting gain or loss is recognized in the consolidated statement of income and other comprehensive income.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">Non-controlling interests in the
results and equity of subsidiaries are shown separately in the consolidated statement of financial position, consolidated statement of
income and other comprehensive income and consolidated statement of changes in equity.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>2.3 Summary of material accounting policies</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">This note provides a description of the material accounting policies adopted in
the preparation of these consolidated financial statements in addition to other policies that have been disclosed in other notes to these
consolidated financial statements. These policies have been consistently applied to all periods presented.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify">The accounting policies have been consistently applied to all consolidated
companies.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001091" name="afya:BusinessCombinationsAndGoodwillPolicyExplanatory"><p id="xdx_842_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zhSI7K0euRz1" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>a) <span id="xdx_866_zkCO45uQlw6f">Business combinations and goodwill</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Business combinations are accounted for using the acquisition method. The cost of an acquisition
is measured as the aggregate of the consideration transferred, which is measured at acquisition date fair value, and the amount of any
non-controlling interests in the acquiree. For each business combination, the Company elects whether to measure the non-controlling interests
in the acquiree at fair value or at the proportionate share of the acquiree&#8217;s identifiable net assets. Acquisition-related costs
are expensed as incurred and included in selling, general and administrative expenses.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company determines that it has acquired a business when the acquired set of activities
and assets include an input and a substantive process that together significantly contribute to the ability to create outputs. The acquired
process is considered substantive if it is critical to the ability to continue producing outputs, and the inputs acquired include an organized
workforce with the necessary skills, knowledge, or experience to perform that process or it significantly contributes to the ability to
continue producing outputs and is considered unique or scarce or cannot be replaced without significant cost, effort, or delay in the
ability to continue producing outputs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Any contingent consideration to be transferred by the acquirer will be recognized at fair
value at the acquisition date. Contingent consideration classified as equity is not remeasured and its subsequent settlement is accounted
for within equity. Contingent consideration classified as an asset or liability that is a financial instrument is measured at fair value
with the changes in fair value recognized in the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Goodwill is initially measured at cost (being the excess of the aggregate of the consideration
transferred and the amount recognized for non-controlling interests and any previous interest held over the net identifiable assets acquired
and liabilities assumed). If the fair value of the net assets acquired is in excess of the aggregate consideration transferred, the Company
re-assesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed and reviews the procedures
used to measure the amounts to be recognized at the acquisition date. If the reassessment still results in an excess of the fair value
of net assets acquired over the aggregate consideration transferred, then the gain is recognized in the consolidated statement of income
and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 184 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">After initial recognition, goodwill is measured at cost less any accumulated impairment
losses. For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated to
each of the Company&#8217;s cash-generating units that are expected to benefit from the combination.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Where goodwill has been allocated to a cash-generating unit (&#8220;CGU&#8221;) and part
of the operation within that unit is disposed of, the goodwill associated with the disposed operation is included in the carrying amount
of the operation when determining the gain or loss on disposal. Goodwill disposed in these circumstances is measured based on the relative
values of the disposed operation and the portion of the cash-generating unit retained.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>


<ix:exclude><!-- Field: Page; Sequence: 185 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001093" name="afya:CurrentVersusNoncurrentClassificationPoliciesExplanatory"><p id="xdx_845_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zarwdTpqf083" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>b) <span id="xdx_867_zq3H1xtNmHMb">Fair value measurement</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Fair value is the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption
that the transaction to sell the asset or transfer the liability takes place either: (i) in the principal market for the asset or liability;
or (ii) in the absence of a principal market, in the most advantageous market for the asset or liability.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The principal or the most advantageous market must be accessible by the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The fair value of an asset or a liability is measured using the assumptions that market
participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</p>

<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">A fair value measurement of a non-financial asset takes into account a market participant's
ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that
would use the asset in its highest and best use.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company uses valuation techniques that are appropriate in the circumstances and for
which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of
unobservable inputs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">All assets and liabilities for which fair value is measured or disclosed in these
consolidated financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input
that is significant to the fair value measurement as a whole:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10.5pt">Level 1 - Quoted (unadjusted) market prices in active markets
for identical assets or liabilities.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10.5pt">Level 2 - Valuation techniques for which the lowest level input
that is significant to the fair value measurement is directly or indirectly observable.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10.5pt">Level 3 - Valuation techniques for which the lowest level input
that is significant to the fair value measurement is unobservable.</span></td>
</tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The following table shows the evaluation techniques used in measuring fair values for financial
instruments classified at level 2 and 3, as well as the significant unobservable inputs used.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001095" name="afya:ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89C_ecustom--ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock_z9Lfc0gZO6z4" summary="xdx: Disclosure - Material accounting policies (Details 1)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B4_zeQBW9jYaF54" style="display: none">Schedule of fair values for financial
instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr>
    <td style="border: #D0CECE 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Type</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Valuation technique</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Significant unobservable inputs</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Inter-relationship between significant unobservable inputs and fair value measurement</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt">Level 2 - Stock options and Restricted stock units (Note 14)</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zbWrtvEd8R68" title="Valuation technique"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember" id="Fact001097" name="ifrs-full:DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets">Binomial model: The fair value is estimated by utilizing a simulation of possible future share prices, applying regression analysis, as well as comparing at each potential exercise date the discounted risk-neutral expectation of the option payoff if not exercised, and the relevant exercise price.</ix:nonNumeric></span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt"><span style="font-size: 7.5pt">&#8226; Expected volatility (December 31, 2025: <span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_ztMnLOO8bvX1" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember" id="Fact001099" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction></span>% to <span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0zfhCwyYU7e" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember" id="Fact001101" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">44</ix:nonFraction></span>%; December 31, 2024: <span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvl0bVSRFkng" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2024-01-012024-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember" id="Fact001103" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">32</ix:nonFraction></span>% to <span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEOHbmVlM4Rg" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2024-01-012024-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember" id="Fact001105" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45</ix:nonFraction></span>%).</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p id="xdx_982_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zrOsTuY8y0Lh" title="Inter-relationship between significant unobservable inputs and fair value measurement" style="font: 7.5pt Nunito Sans; margin: 0"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember" id="Fact001107" name="ifrs-full:DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets">The estimated fair value</ix:nonNumeric></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">would increase (decrease) if the expected volatility were higher (lower).</p></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt">Level 3 - Contingent consideration (Accounts payable to selling shareholders - Note 12.2.3)</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zxIHtVQ8f3Fl" title="Valuation technique"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember" id="Fact001109" name="ifrs-full:DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets">Probability-weighted cash flows: This valuation technique considers the probability-weighted expectation of future cash flow.</ix:nonNumeric></span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; Expected cash flows (December 31, 2025: R$<span id="xdx_907_ecustom--ExpectedCashFlows_pn3n3_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zwL4LiFAutuh" title="Expected cash flows"><ix:nonFraction name="afya:ExpectedCashFlows" contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember" id="Fact001111" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">325,150</ix:nonFraction></span>;
    December 31, 2024: R$<span id="xdx_908_ecustom--ExpectedCashFlows_pn3n3_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zLTVYXh0aIzi" title="Expected cash flows"><ix:nonFraction name="afya:ExpectedCashFlows" contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember" id="Fact001113" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">314,953</ix:nonFraction></span>).</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; Probability of disbursement (December 31, 2025 and
    2024: <span id="xdx_908_ecustom--ProbabilityOfDisbursement_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zJOYzkxwFFK5" title="Probability of disbursement"><span id="xdx_903_ecustom--ProbabilityOfDisbursement_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z0jpMqr4Ciue" title="Probability of disbursement"><ix:nonFraction name="afya:ProbabilityOfDisbursement" contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember" id="Fact001115" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="afya:ProbabilityOfDisbursement" contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember" id="Fact001117" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></ix:nonFraction></span></span>%).</p></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p id="xdx_985_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zPlc1vzSNOy9" title="Inter-relationship between significant unobservable inputs and fair value measurement" style="font: 7.5pt Nunito Sans; margin: 0"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember" id="Fact001119" name="ifrs-full:DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets">The estimated fair value would increase (decrease) if:</ix:nonNumeric></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; the expected cash flows were higher (lower); or</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; the probability rate were lower (higher).</p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A9_zplE3eA2TDq8" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The valuation model for other financial liabilities not measured at fair value considers
the present value of expected payments, discounted using a risk-adjusted discount rate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For assets and liabilities that are recognized in these  consolidated financial
statements at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy
by re-assessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end
of each reporting period.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">At each reporting date, the Company analyzes the movements in the values of assets and
liabilities which are required to be remeasured or reassessed as per the Company&#8217;s accounting policies. For this analysis, the
Company verifies the major inputs applied in the latest valuation by agreeing the information in the valuation computation to contracts
and other relevant documents.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>
<p style="font: 10.5pt Nunito Sans; margin: 0"></p>


<ix:exclude><!-- Field: Page; Sequence: 186 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zEb2MvBxM7Uc" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company also compares the change in the fair value of each asset and liability with
relevant external sources to determine whether the change is reasonable.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For the purpose of fair value disclosures, the Company has determined classes of assets
and liabilities on the basis of the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy,
as explained above.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001122" name="afya:FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory"><p id="xdx_843_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_zNMF30lxdisd" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>c) <span id="xdx_869_zpbtmZlgwRZe">Financial instruments - initial recognition and measurement</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><i>Recognition and initial measurement</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; text-align: left">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">Financial assets and financial liabilities are initially recognized when the
Company becomes a party to the contractual provisions of the instrument.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; text-align: left">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">A financial asset (unless it is a trade receivable without a significant financing
component) or financial liability is initially measured at fair value plus or minus, for an item not at fair value through profit or loss
(&#8220;FVTPL&#8221;), transaction costs that are directly attributable to its acquisition or issue. A trade receivable without a significant
financing component is initially measured at the transaction price. However, if the Company has an unconditional right to an amount that
differs from the transaction price (e.g. due to the Company's refund policy), the trade receivable will be initially measured at the amount
of that unconditional right.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 3%"/><td style="width: 14.2pt"><b>i)</b></td><td><b>Financial assets</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><i>Classification and subsequent measurement</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">On initial recognition, a financial asset is classified as subsequently measured
at: amortized cost; FVOCI - debt investment; FVOCI - equity investment; or FVTPL.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">Financial assets are not reclassified subsequent to their initial recognition
unless the Company changes its business model for managing financial assets, in which case all affected financial assets are reclassified
on the first day of the first reporting period following the change in the business model.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">A financial asset is measured at amortized cost if it meets both of the following
conditions and is not designated as at FVTPL:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10.5pt">it is held within a business model whose objective is to hold
assets to collect contractual cash flows; and</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10.5pt">its contractual terms give rise on specified dates to cash
flows that are solely payments of principal and interest (&#8220;SPPI&#8221;) on the principal amount outstanding.</span></td>
</tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">A debt investment is measured at FVOCI if it meets both of the following conditions
and is not designated as at FVTPL:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10.5pt">it is held within a business model whose objective is achieved
by both collecting contractual cash flows and selling financial assets; and</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10.5pt">its contractual terms give rise on specified dates to cash
flows that are SPPI on the principal amount outstanding.</span></td>
</tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">On initial recognition of certain equity investments that are not held for trading,
the Company has made an irrevocable election to present subsequent changes in the investment's fair value in OCI.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">This election is made on an investment-by-investment basis.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">All financial assets not measured at amortized cost or FVOCI as described above
(e.g. financial assets held for trading and those that are managed and whose performance is evaluated on a fair value basis) are measured
at FVTPL.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 187 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zc6szRJxAuCk" style="font: 8.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Business model assessment</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company makes an assessment of the objective of the business model in which
a financial asset is held at a portfolio level because this best reflects the way the business is managed and information is provided
to management.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Transfers of financial assets to third parties in transactions that do not qualify
for derecognition are not considered sales for this purpose, consistent with the Company's continuing recognition of the assets.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Assessment whether contractual cash flows are SPPI</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In assessing whether the contractual cash flows are SPPI, the Company considers
the contractual terms of the instrument. This includes assessing whether the financial asset contains a contractual term that could change
the timing or amount of contractual cash flows such that it would not meet this condition. In making this assessment, the Company considers:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;
</span><span style="font-size: 10.5pt">contingent events that would change the amount or timing of cash flows;</span></p>

<p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;
</span><span style="font-size: 10.5pt">terms that may adjust the contractual coupon rate, including variable-rate features;</span></p>

<p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;
</span><span style="font-size: 10.5pt">prepayment and extension features; and</span></p>

<p style="font: 8.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;
</span><span style="font-size: 10.5pt">terms that limit the Company&#8217;s claim to cash flows from specified assets (e.g. non-recourse
features).</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">A prepayment feature is consistent with the SPPI criterion if the prepayment
amount substantially represents unpaid amounts of principal and interest on the principal amount outstanding, which may include reasonable
compensation for early termination of the contract. Additionally, for a financial asset acquired at a discount or premium to its contractual
per amount, a feature that permits or requires prepayment at an amount that substantially represents the contractual par amount plus accrued
(but unpaid) contractual interest (which may also include reasonable compensation for early termination) is treated as consistent with
this criterion if the fair value of the prepayment feature is insignificant on initial recognition. The Company had no financial assets
held outside trading business models that failed the SPPI assessment.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Subsequent measurement and gains and losses</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001125" name="afya:ScheduleOfMeasurementAndGainsAndLossesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_895_ecustom--ScheduleOfMeasurementAndGainsAndLossesTableTextBlock_zis2ByfBzXce" summary="xdx: Disclosure - Material accounting policies (Details 2)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_zC3j1pqBL6wc" style="display: none">Schedule
    of measurement and gains and losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr>
    <td style="border: #AEAAAA 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Financial assets at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">FVTPL</p></td>
    <td style="border-top: #AEAAAA 1pt solid; border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; width: 78%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVTPLMember_zdt0sle527kc" title="Financial assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_FVTPLMember" id="Fact001127" name="ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss">These assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.</ix:nonNumeric></span></span></td></tr>
  <tr>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Financial assets at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">amortized cost</p></td>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FinancialAssetsAtAmortizedCostMember_z95KI8zi7w8d" title="Financial assets at amortized cost"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_FinancialAssetsAtAmortizedCostMember" id="Fact001129" name="ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss">These assets are subsequently measured at amortized cost under the effective interest method. The gross carrying amount is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.</ix:nonNumeric></span></span></td></tr>
  <tr>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Debt investments at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">FVOCI</p></td>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCIMember_zvzFySxDw8Gc" title="Debt investments"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_FVOCIMember" id="Fact001131" name="ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss">These assets are subsequently measured at fair value. Interest income calculated under the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.</ix:nonNumeric></span></span></td></tr>
  <tr>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Equity investments at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">FVOCI</p></td>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCI1Member_zqC4N7c5azq9" title="Equity investments"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_FVOCI1Member" id="Fact001133" name="ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss">These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never reclassified to profit or loss.</ix:nonNumeric></span></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AD_ztPiF7ltilEl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><i>Impairment of financial assets</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">Further disclosures relating to impairment of financial assets are also provided
in the following notes:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#8226; Significant accounting judgments, estimates and assumptions - Note 2.5</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#8226; Trade receivables - Note 6</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">The Company recognizes an allowance for expected credit losses (ECLs) for all
debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due
in accordance with the contract and the cash flows the Company expects to receive, discounted at an approximation of the original effective
interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements that are
integral to the contractual terms.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">For trade receivables, the Company applies a simplified approach in calculating
ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for credit losses based on both
quantitative and qualitative information and analysis on the Company&#8217;s historical experience and informed credit assessment, at
each reporting date.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#160;</p>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"></p>


<ix:exclude><!-- Field: Page; Sequence: 188 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_z2VI8CKIvytl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">The Company considers a financial asset to be in default when internal or external
information indicates that the Company is unlikely to receive the outstanding contractual amounts in full before considering any credit
enhancements held by the Company. Interest accrual is suspended once a financial asset meets the criteria for default. A financial asset
is written off when there is no reasonable expectation of recovering the contractual cash flows.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><b>ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial liabilities</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; color: #C00000">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><i>Classification, subsequent measurement and gain and losses</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">Financial liabilities are measured at amortized cost or FVTPL. A financial liability
is measured at FVTPL if it is classified as held-for-trading, it is a derivative or it is designated as such on initial recognition. Financial
liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognized in profit or
loss. Other financial liabilities are subsequently measured at amortized cost under the effective interest method. Interest expense and
foreign exchange gains and losses are recognized in profit or loss.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">The Company&#8217;s financial liabilities include trade payables, loans and
financing, lease liabilities, accounts payable to selling shareholders and dividends payable.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001136" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"><p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_z9Fj5sTtEi95" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>d) <span id="xdx_861_ztY0XKb4WM82">Cash and cash equivalents</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Cash and cash equivalents in the statement of financial position comprise cash at banks
and on hand, and short-term financial investments with an original maturity of three months or less from the date of purchase, held for
the purpose of meeting short-term cash commitments, readily convertible to a known amount of cash and subject to an insignificant risk
of changes in value.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For the purpose of the consolidated statement of cash flows, cash and cash equivalents
consist of cash and short-term financial investments, as they are considered an integral part of the Company&#8217;s cash management.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001138" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"><p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zUYOD2tsT21g" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>e) <span id="xdx_867_zUczxtH6FQ51">Property and equipment</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Property and equipment are stated at cost, net of accumulated depreciation and accumulated
impairment losses, if any.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Subsequent expenditures are capitalized only if it is probable that the future economic
benefits associated with the expenditure will flow to the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Depreciation is calculated on a straight-line basis over the estimated useful lives of
the assets, except for leasehold improvements, which are depreciated over the shorter of their estimated useful lives or the lease terms.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001140" name="afya:ScheduleOfEstimatedUsefulLivesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_pn3n3_zCa4de18nPW9" summary="xdx: Disclosure - Material accounting policies (Details 3)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B8_zyCXjuN9UFLf" style="display: none">Schedule of estimated useful lives of
the assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Building</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_ziGG6APQYSt2" title="Useful lives of assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_BuildingsMember" format="ixt-sec:duryear" id="Fact001142" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">25</ix:nonNumeric></span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Machinery and equipment</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zzWQqZWfoZmi" title="Useful lives of assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_MachineryAndEquipmentsMember" format="ixt-sec:duryear" id="Fact001144" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">10</ix:nonNumeric></span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Vehicles</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zCsQwDwpnOQ1" title="Useful lives of assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember" format="ixt-sec:duryear" id="Fact001146" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">5</ix:nonNumeric></span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Furniture and fixtures</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zc5myiWw2ged" title="Useful lives of assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_FixturesAndFittingsMember" format="ixt-sec:duryear" id="Fact001148" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">10</ix:nonNumeric></span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">IT equipment</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zRJs7ZnMWgl1" title="Useful lives of assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_ItEquipmentMember" format="ixt-sec:duryear" id="Fact001150" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">5</ix:nonNumeric></span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Library books</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zMkh1AmfUxWl" title="Useful lives of assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_LibraryBooksMember" format="ixt-sec:duryear" id="Fact001152" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">10</ix:nonNumeric></span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Leasehold improvements</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDRJaGRRs8Cb" title="Useful lives of assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact001154" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">1</ix:nonNumeric></span> - <span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ztPAUspLZAec" title="Useful lives of assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact001156" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">30</ix:nonNumeric></span> years</td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A1_z4OeLS3uKode" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">An item of property and equipment and any significant part initially recognized is derecognized
upon disposal or when no future economic benefit is expected from its use. Any gain or loss arising on the derecognition of the asset
(calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated
statement of income and other comprehensive income when the asset is derecognized.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The residual values, useful lives and methods of depreciation of property and equipment
are reviewed at each financial year end and adjusted prospectively, if appropriate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 189 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zDZBTjxXw7Jl" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001159" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory"><p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_ztFoOqn5blrl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>f) <span id="xdx_860_zRWo66GqKO3g">Leases</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company assesses at contract inception whether an arrangement is, or contains, a lease.
That is, if the arrangement conveys the right to control the use of an identified asset for a period of time in exchange for consideration.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Company as a lessee</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company applies a single recognition and measurement approach for all leases, except
for short-term leases and leases of low-value assets. The Company recognizes lease liabilities to make lease payments and right-of-use
assets representing the right to use the underlying assets.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Right-of-use assets</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company recognizes right-of-use assets at the commencement date of the lease (i.e.,
the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment
losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities
recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Right-of-use assets are depreciated on a straight-line basis over the shorter of its estimated
useful life and the lease term. The lease term of the contracts for properties range between five and 30 years. Right-of-use assets are
subject to impairment. Refer to the accounting policies in &#8216;Impairment of non-financial assets&#8217;.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Lease liabilities</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">At the commencement date of the lease, the Company recognizes lease liabilities measured
at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance
fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected
to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain
to be exercised by the Company and payments of penalties for terminating a lease, if the lease term reflects the Company exercising the
option to terminate. The variable lease payments that do not depend on an index or a rate are recognized as expense in the period on which
the event or condition that triggers the payment occurs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In calculating the present value of lease payments, the Company uses the incremental borrowing
rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After the commencement date,
the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition,
the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the in-substance
fixed lease payments or a change in the assessment to purchase the underlying asset.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>


<ix:exclude><!-- Field: Page; Sequence: 190 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Short-term leases and leases of low-value assets</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company applies the short-term lease recognition exemption to its short-term leases
of properties (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase
option). It also applies the lease of low-value assets recognition exemption to leases that are considered of low value. Lease payments
on short-term leases and leases of low-value assets are recognized as expense on a straight-line basis over the lease term.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001161" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory"><p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zC2NYRBNHPY8" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>g) <span id="xdx_869_zHbrvS2XFx63">Intangible assets</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Intangible assets acquired separately are measured on initial recognition at cost. The
cost of intangible assets acquired in a business combination or asset acquisition is their fair value at the date of acquisition. Following
initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally
generated intangibles, excluding capitalized development costs, are not capitalized and the related expenditure is reflected in the consolidated
statement of income and other comprehensive income in the period in which the expenditure is incurred.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The useful lives of intangible assets are assessed as finite or indefinite.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Intangible assets with finite lives are amortized on a straight-line over the estimated
useful lives and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The estimated useful
lives of intangible assets are as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001163" name="afya:ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_898_ecustom--ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zKBgfLCXIwy8" summary="xdx: Disclosure - Material accounting policies (Details 4)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BA_zJRQ405AQSG4" style="display: none">Schedule of estimated useful
lives of intangible assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="background-color: rgb(213,234,234)">
    <td style="width: 272px; padding-right: 5.4pt; padding-left: 5.4pt">Customer relationships - medicine</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z01NwOJL9RMi" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember" format="ixt-sec:duryear" id="Fact001165" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">6</ix:nonNumeric></span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Customer relationships - other courses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--CustomerRelationshipsOtherCoursesMember_zXjMKXoWxuC9" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CustomerRelationshipsOtherCoursesMember" format="ixt-sec:duryear" id="Fact001167" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">4.5</ix:nonNumeric></span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Software</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--ComputerSoftwareMember_zrOjKogqeteh" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember" format="ixt-sec:duryear" id="Fact001169" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">5</ix:nonNumeric></span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Trademarks</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zB1PLffvirPd" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_BrandNamesMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact001171" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">2</ix:nonNumeric></span> - <span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zWHwkdtG4848" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_BrandNamesMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact001173" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">30</ix:nonNumeric></span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Education content, Developed technology and Educational platform</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zQEMtlFWCwaj" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_EducationContentDevelopedTechnologyAndEducationalPlatformMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact001175" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">3</ix:nonNumeric></span> - <span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zy0K8Pm1co7e" title="Estimated useful lives of intangible assets"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_EducationContentDevelopedTechnologyAndEducationalPlatformMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact001177" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">5</ix:nonNumeric></span> years</td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zZnnyylInkJ6" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The amortization period and the amortization method for an intangible asset with a finite
useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected pattern of
consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate,
and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in the
consolidated statement of income and other comprehensive income in the expense category that is consistent with the function of the intangible
assets.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Intangible assets with indefinite useful lives are not amortized, but are tested for impairment
annually, either individually or at the cash-generating unit level. The assessment of indefinite life is reviewed annually to determine
whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective
basis.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">An intangible asset is derecognized upon disposal or when no future economic benefits are
expected from its use. Any gain or loss arising upon derecognition of the asset (calculated as the difference between the net disposal
proceeds and the carrying amount of the asset) is included in the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>


<ix:exclude><!-- Field: Page; Sequence: 191 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001179" name="afya:ImpairmentOfNonfinancialAssetsPolicyExplanatory"><p id="xdx_848_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_z6w2Tca5jcY2" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>h) <span id="xdx_861_z9SxAToULh87">Impairment of non-financial assets</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company assesses, at each reporting date, whether there is an indication that an asset
may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Company estimates the asset&#8217;s
recoverable amount. An asset&#8217;s recoverable amount is the higher of an asset&#8217;s or CGU&#8217;s fair value less costs of disposal
and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that
are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU exceeds its recoverable
amount, the asset is considered impaired and is written down to its recoverable amount.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In assessing value in use, the estimated future cash flows are discounted to their present
value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the
asset. In determining fair value less costs of disposal, recent market transactions are considered. If no such transactions can be identified,
an appropriate valuation model is used. These calculations are corroborated by valuation multiples, quoted share prices for publicly traded
companies or other available fair value indicators.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company bases its impairment calculation on detailed budgets and forecast calculations,
which are prepared separately for each of the Company&#8217;s CGUs to which the individual assets are allocated. These budgets and forecast
calculations cover a period of five years, considering the companies activities and maturation period of its graduate and undergraduate
courses. A long-term growth rate is calculated and applied to project future cash flows after the last projected year.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For impairment testing, goodwill and licenses with indefinite useful lives are allocated
to their respective CGUs. The Company defined each of its operating subsidiaries as a CGU, except for the following which combines subsidiaries:
(i) &#8220;Continuing education&#8221; and (ii) &#8220;Medical practice solutions&#8221;, where the subsidiaries were combined as one
CGU following the business strategy and interdependency of cash flow generation.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Whenever applicable, impairment losses of continuing operations are recognized in the consolidated
statement of income and other comprehensive income in expense categories consistent with the function of the impaired asset.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For assets excluding goodwill, an assessment is made at each reporting date to determine
whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such indication exists,
the Company estimates the asset&#8217;s or CGU&#8217;s recoverable amount. A previously recognized impairment loss is reversed only if
there has been a change in the assumptions used to determine the asset&#8217;s recoverable amount since the last impairment loss was recognized.
The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount
that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years. Such reversal
is recognized in the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Goodwill is tested for impairment annually as at December 31 and when circumstances indicate
that the carrying amounts may be impaired.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Impairment is determined for goodwill by assessing the recoverable amount of each CGU (or
group of CGUs) to which the goodwill relates. When the recoverable amount of the CGU is less than its carrying amount, an impairment loss
is recognized. Impairment losses relating to goodwill cannot be reversed in future periods.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Intangible assets with indefinite useful lives are tested for impairment annually as at
December 31 at the CGU level, as appropriate, and when circumstances indicate that the carrying amounts may be impaired.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001181" name="afya:DescriptionOfAccountingPolicyForInvestmentsExplanatory"><p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForInvestmentsExplanatory_zZfZwtNjoxp9" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>i) <span id="xdx_860_zjk6LVHMzzq3">Investments in associates</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Investments in associates are initially recognized at consideration transferred and adjusted
thereafter for the equity method, being increased or reduced from its interest in the investee's income after the acquisition date. An
associate is an entity over which the Company has significant influence. Significant influence is the power to participate in the financial
and operating policy decisions of the investee, but is not control or joint control over those policies.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The financial statements of the associate are prepared for the same reporting period as
the Company. The accounting policies of the associate are aligned with those of the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 192 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zrbNPTf24wLg" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001184" name="afya:AccountsPayableToSellingShareholdersPolicyExplanatory"><p id="xdx_84B_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_zb6FRoiaSayd" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>j) <span id="xdx_863_z9SEOZDjBA3h">Accounts payable to selling shareholders</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">These amounts represent liabilities related to the acquisitions made by the Company which
are not yet due. Accounts payable to selling shareholders are presented as current liabilities unless payment is not due within 12 months
after the reporting period. They are recognized initially at their fair value and subsequently measured at amortized cost using the effective
interest method, except for Unidom&#8217;s contingent consideration, which are measured at fair value through profit or loss.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001186" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory"><p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_zZIZ3k16lWq" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>k) <span id="xdx_863_z8hhHpR9iShj">Provisions</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Provisions are recognized when the Company has a present obligation (legal or constructive)
as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation,
and a reliable estimate can be made of the amount of the obligation. The expense relating to a provision is presented in the consolidated
statement of income and other comprehensive income, net of any reimbursement, when applicable.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001188" name="afya:DividendsPolicyExplanatory"><p id="xdx_846_ecustom--DividendsPolicyExplanatory_z4XB3eIoFmW9" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>l) <span id="xdx_868_ziIjYpKBuMu9">Dividends</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company recognizes a liability to pay a dividend when the distribution is authorized
and the distribution is no longer at the discretion of the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In respect to the consolidated statement of changes in equity, the amount corresponding
to the non-controlling interest over the dividends declared are recognized directly in equity.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001190" name="afya:LaborAndSocialObligationsPolicyExplanatory"><p id="xdx_84F_ecustom--LaborAndSocialObligationsPolicyExplanatory_zxb4E5jJMoLk" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>m) Labor and social obligations</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Labor and social obligations are expensed as the related service is provided. A liability
is recognized for the amount expected to be paid if the Company has a present legal or constructive obligation to pay this amount as a
result of past service provided by the employee and the obligation can be estimated reliably.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001192" name="afya:SharebasedPaymentsPolicyExplanatory"><p id="xdx_840_ecustom--SharebasedPaymentsPolicyExplanatory_z8dI0b79l0uc" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>n) <span id="xdx_864_zoOEZryg441a">Share-based payments</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Certain key executives of the Company receive compensation in the form of share-based payments,
which includes stock options and restricted stock units (&#8220;RSUs&#8221;), whereby the executives render services as consideration
for equity instruments (equity-settled transactions).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The expense of equity-settled transactions is determined by the fair value at the date
when the grant is made using an appropriate valuation model.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">That expense is recognized in selling, general and administrative expenses, together with
a corresponding increase in equity (Share-based compensation reserve), over the period in which the service (the vesting period) and,
where applicable, the performance conditions are fulfilled. The cumulative expense recognized for equity-settled transactions at each
reporting date until the vesting date reflects the extent to which the vesting period has expired and the Company&#8217;s best estimate
of the number of equity instruments that will ultimately vest. The expense or credit in the consolidated statement of income and other
comprehensive income for a period represents the movement in cumulative expense recognized as at the beginning and end of that period.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Service and non-market performance conditions are not considered when determining the grant
date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Company&#8217;s best estimate of
the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value.
No expense is recognized for awards that do not ultimately vest because non-market performance and/or service conditions have not been
met.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">When the terms of an equity-settled award are modified, the minimum expense recognized
is the grant date fair value of the unmodified award, provided the original vesting terms of the award are met. An additional expense,
measured as at the date of modification, is recognized for any modification that increases the total fair value of the share-based payment
transaction, or is otherwise beneficial to the employee. Where an award is cancelled by the entity or by the counterparty, any remaining
element of the fair value of the award is expensed immediately through the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"></p>


<ix:exclude><!-- Field: Page; Sequence: 193 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zZ3rC40gXBBg" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The dilutive effect of outstanding options is reflected as additional share dilution in
the computation of diluted earnings per share.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001195" name="ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory"><p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zaCk5ZZBZG3f" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>o) <span id="xdx_864_zZ8xOxplLlol">Earnings per share (&#8220;EPS&#8221;)</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">Basic EPS is calculated by dividing net income attributable to
the owners of the Company by the weighted average number of common shares outstanding during the year.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">Diluted EPS is calculated by dividing net income attributable
to the owners of the Company by the weighted average number of common shares outstanding during the year plus the weighted average number
of shares that would be issued on conversion of all potential shares with dilutive effects.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Diluted earnings per share are computed including stock options granted to key management
using the treasury shares method when the effect is dilutive. The Company has the stock options and RSUs plans in the category of potentially
dilutive shares.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001197" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue"><p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zsxlo93REFmb" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>p) <span id="xdx_862_znolsG70TOC">Revenue from contracts with customers</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company's revenue consists primarily of tuition fees charged for medical courses. The
Company also generates revenue from tuition fees for other undergraduate and graduate courses, administrative and application fees, education
content (e-books), subscription of medical practice solutions services (including medical content platforms, clinical decision-making
application, among other solutions), electronic medical records and marketing for pharmaceutical industry.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Revenue recognition transferred over time </i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Revenue from tuitions, subscription of medical practice solutions services and electronic
medical records are recognized over time when services are rendered to the customer and the Company satisfies its performance obligation
under the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services.
Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Revenues are recognized when services are rendered to the customer and the performance
obligation is satisfied.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Revenue recognition transferred at point in time</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Revenue from sale of education content, online platforms, administrative and application
fees and marketing for pharmaceutical industry are recognized at the point in time when control of the asset or services is transferred
to the customer. For education content this is generally on delivery of the goods and for e-books this is generally on the permission
to access the digital content is granted. The Company considers whether there are other promises in the contract that are separate performance
obligations to which a portion of the transaction price needs to be allocated.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company concluded that it is the principal in its revenue arrangements.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company assesses collectability on a portfolio basis prior to recording revenue. Generally,
in respect to undergraduate programs students cannot re-enroll for the next academic session without satisfactory resolution of any past-due
amounts. If a student withdraws from an institution, the Company's obligation to issue a refund depends on the refund policy at that institution
and the timing of the student's withdrawal. Generally, the refund obligations are reduced over the course of the academic term.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Trade receivables</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Trade receivables represent the Company&#8217;s right to an amount of consideration that
is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to the accounting policies
in &#8216;Financial instruments - initial recognition and measurement&#8217;.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>


<ix:exclude><!-- Field: Page; Sequence: 194 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Advances from customers</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Advances from customers (a contract liability) are the obligation to transfer services
to a customer for which the Company has received consideration (or an amount of consideration is due) from the customer, as a result of
pre-paid tuition, digital education content and mobile app subscription for digital medical content received from customers and is recognized
separately in current liabilities, when the payment is received. Advances from customers are recognized as revenue when the Company performs
all obligations related to the contract, over the contract term.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001199" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory"><p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zsryXjCHEuZ4" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>q) <span id="xdx_86B_zrrlk29DYpr">Taxes</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">The Company&#8217;s subsidiaries
in the undergraduate segment joined the PROUNI (<i>Programa Universidade para Todos</i> - University for All Program) program, which is
a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number of student
enrollment for low-income students, and benefits from the exemption of the following federal taxes:</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">&#8226; Income taxes and social contribution</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">&#8226; PIS and COFINS</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">The regulation of PROUNI defines
that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS. For income from other teaching
activities, PIS and COFINS are charged at rates of <span id="xdx_90F_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_ztNcdqw4ON9l" title="Tax rate"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2025-01-012025-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember" id="Fact001201" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.65</ix:nonFraction></span>% and <span id="xdx_907_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zC9xkyEeVZ9a" title="Tax rate"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2025-01-012025-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_TeachingActivitiesMember" id="Fact001203" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.00</ix:nonFraction></span>%, respectively, and for non-teaching activities, PIS is charged at a
rate of <span id="xdx_900_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zoCXn44uATTk" title="Tax rate"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2025-01-012025-12-31_custom_ProgramOfSocialIntegrationMember_custom_NonTeachingActivitiesMember" id="Fact001205" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.65</ix:nonFraction></span>% and to COFINS at <span id="xdx_90F_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zK1bbo498xRk" title="Tax rate"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2025-01-012025-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_NonTeachingActivitiesMember" id="Fact001207" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.6</ix:nonFraction></span>%.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Current income taxes</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">Current income taxes were calculated
based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service, specifically regarding the PROUNI
program, which allows exemption of these taxes from traditional and technological graduation activities.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Current income tax assets and liabilities are measured at the amount expected to be recovered
from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively
enacted at the reporting date.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Management periodically evaluates positions taken in the tax returns with respect to situations
in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Additional social contribution from Organization for Economic Co-operation
and Development (&#8220;OECD&#8221;) Pillar Two global minimum tax</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On December 27, 2024, Law 15,079/2024 was enacted, establishing the implementation of the
OECD&#8217;s Pillar Two global minimum tax in Brazil, effective as of January 1, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Law 15,079/2024 aligns the Brazilian tax legislation to the OECD&#8217;s Global Anti-Base
Erosion (GloBE) rules by introducing a minimum effective taxation of <span id="xdx_903_eifrs-full--AverageEffectiveTaxRate_pip0_dp_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zucbD4LVguS4" title="Effective tax"><ix:nonFraction name="ifrs-full:AverageEffectiveTaxRate" contextRef="From2024-12-262024-12-27_custom_OrganizationForEconomicCooperationAndDevelopmentMember" id="Fact001209" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>% through an additional Social Contribution on Net Profit (&#8220;CSLL&#8221;).
This regulation applies to multinational groups within the scope of the OECD&#8217;s GloBE rules, specifically those whose ultimate parent
entity reported annual consolidated revenues of at least &#8364;<span id="xdx_904_ecustom--ConsolidatedRevenues_pn6n6_uEUR_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zek9BvydSMM8" title="Consolidated revenues"><ix:nonFraction name="afya:ConsolidatedRevenues" contextRef="From2024-12-262024-12-27_custom_OrganizationForEconomicCooperationAndDevelopmentMember" id="Fact001211" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="EUR">750</ix:nonFraction></span> million in at least two of the four fiscal years immediately preceding
the year under review.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The rules are designed to ensure that the additional CSLL qualifies as a Qualified Domestic
Minimum Top-up Tax (QDMTT) under the OECD Inclusive Framework, subjecting Brazilian entities to a minimum tax rate of <span id="xdx_902_ecustom--MinimumTaxRate_pip0_dp_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zmTxN1IaWFhi" title="Minimum tax rate"><ix:nonFraction name="afya:MinimumTaxRate" contextRef="From2024-12-262024-12-27_custom_OrganizationForEconomicCooperationAndDevelopmentMember" id="Fact001213" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>%.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On March 28, 2025, the Company filed a writ of mandamus with the Brazilian Federal Court
challenging the enforceability of the newly enacted additional CSLL. The legal proceeding is grounded on constitutional and statutory
arguments, and is waiting for court decision to prevent the collection of the additional CSLL, which is scheduled to be disbursed in 2026
with respect to the 2025 fiscal year.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 195 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Considering that there is no court decision to date, the Company has recorded the amount
calculated in accordance with current legislation. The additional income tax expense as a result of Law 15,079/2024 for the year ended
December 31, 2025 was R$<span id="xdx_901_eifrs-full--CurrentTaxLiabilitiesCurrent_iI_pn3n3_c20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_z2JcxqbBhCvd" title="Income taxes payable"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="AsOf2025-12-31_custom_OrganizationForEconomicCooperationAndDevelopmentMember" id="Fact001215" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">109,458</ix:nonFraction></span>, accounted as income taxes payable in the current liabilities. The Company has applied the exception to
recognizing and disclosing information about deferred tax assets and liabilities related to Pillar Two income taxes.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Deferred tax</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Deferred tax is provided using the liability method on temporary differences between the
tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Deferred tax liabilities are recognized for all taxable temporary differences, except:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%">&#8226; When the deferred tax liability arises from the initial recognition of goodwill
or an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the
accounting profit nor taxable profit or loss and does not give rise to equal taxable and deductible temporary differences;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; In respect of taxable temporary differences associated with investments in subsidiaries,
associates and interests in joint arrangements, when the timing of the reversal of the temporary differences can be controlled and it
is probable that the temporary differences will not reverse in the foreseeable future.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Deferred tax assets are recognized to the extent that it is probable that taxable profit
will be available against which the deductible temporary differences, and the carry forward of unused tax credits and unused tax losses
can be utilized, except when the deferred tax asset relating to the deductible temporary difference arises from the initial recognition
of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the
accounting profit nor taxable profit or loss and does not give rise to equal taxable and deductible temporary differences.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The carrying amount of deferred tax assets is reviewed at each reporting date and reduced
to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax
asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it
has become probable that future taxable profits will allow the deferred tax asset to be recovered.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company offsets deferred tax assets and deferred tax liabilities if and only if it
has a legally enforceable right to set off current tax assets and current tax liabilities and the deferred tax assets and deferred tax
liabilities relate to income taxes levied by the same taxation authority by the same taxable entity.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Sales tax</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Expenses and assets are recognized net of the amount of sales tax, except:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%">&#8226; When the sales tax incurred on a purchase of assets or services is not recoverable
from the taxation authority, in which case, the sales tax is recognized as part of the cost of acquisition of the asset or as part of
the expense item, as applicable;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; When receivables and payables are stated with the amount of sales tax included.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001217" name="ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory"><p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForTreasurySharesExplanatory_zDR93UtWX9Xl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>r) <span id="xdx_86E_zynYSJo8MDId">Treasury shares</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Own equity instruments that are reacquired (treasury shares) are recognized at cost and
deducted from equity. No gain or loss is recognized in profit or loss on the purchase, sale, transfers under the share-based payments,
issue or cancellation of the Company&#8217;s own equity instruments. Any difference between the carrying amount and the consideration,
if reissued, is recognized in the share premium.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>2.4 Changes in accounting policies and disclosures</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>New and amended standards and interpretations</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The following standards and amendments, which are effective for annual periods beginning
on or after January 1, 2025, have been issued but are not applicable to the Company&#8217;s operations or consolidated financial statements.</p>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i></i></p>

<ix:exclude><p id="xdx_235_znIDyhGLLdO6" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 196 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zJCWWU42wxDi" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001221" name="afya:ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_895_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_z2lTvolZvvn6" summary="xdx: Disclosure - Material accounting policies (Details 5)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_8B6_zJFR57MUEwle" style="display: none">Schedule
    of changes in accounting policies and disclosures</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Amendment / standard</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS21Member_z8XUqBspnetd" title="Standard"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AmendmentsToIAS21Member" id="Fact001223" name="ifrs-full:TitleOfInitiallyAppliedIFRS">Lack of exchangeability &#8211; Amendments to IAS 21</ix:nonNumeric></span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90C_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--LackOfExchangeabilityAmendmentsToIAS21Member_gIFDONOCIAP-GOL_ztYW68Jhqa63" title="Description"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_LackOfExchangeabilityAmendmentsToIAS21Member" continuedAt="ConU001226-01" id="Fact001226" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">In August 2023, the IASB issued amendments to IAS 21 The Effects of Changes in Foreign Exchange
    Rates to specify how an entity should assess whether a currency is exchangeable and how it should determine a spot exchange rate when
    exchangeability is lacking. The amendments also require disclosure of information that enables users of its financial statements to understand
    how the currency not being exchangeable into the other currency affects, or is expected to affect, the entity&#8217;s financial performance,
    financial position and cash flows.</ix:nonNumeric></span></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C00_gIFDONOCIAP-GOL_ztsgVBnFLjv"><ix:continuation id="ConU001226-01"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments had no impact on the Company&#8217;s accounting policies, which remained
    unchanged in these  consolidated financial statements for the year ended December 31, 2025.</p></ix:continuation></div></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Standards issued but not yet effective</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 24%; text-indent: -21.3pt">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The new and amended standards and interpretations that are issued, but not yet effective,
up to the date of issuance of the Company&#8217;s  consolidated financial statements are presented below. The Company has not
early adopted any other standard, interpretation or amendment that has been issued but is not yet effective. The Company intends to adopt
these new and amended standards and interpretations, if applicable, when they become effective.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Amendment / standard</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_zLUko5jePu6c" title="Standard"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member" id="Fact001228" name="ifrs-full:TitleOfInitiallyAppliedIFRS">Classification and Measurement of Financial Instruments - Amendments to IFRS 9 and IFRS 7</ix:nonNumeric></span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-BAAR_zkjlISvlyJ43" title="Description"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member" continuedAt="ConU001236-01" id="Fact001236" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">In May 2024, the IASB issued Amendments to the Classification and Measurement of Financial
    Instruments (Amendments to IFRS 9 and IFRS 7), which:</ix:nonNumeric></span></p>
    <div id="xdx_C0A_gIFDONOCIAP-BAAR_zkExD70L8Wu5"><ix:continuation continuedAt="ConU001236-02" id="ConU001236-01"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Clarifies that a financial liability is derecognized on the &#8216;settlement date&#8217;,
    i.e., when the related obligation is discharged, cancelled, expires or the liability otherwise qualifies for derecognition. It also introduces
    an accounting policy option to derecognize financial liabilities that are settled through an electronic payment system before settlement
    date if certain conditions are met</p></ix:continuation></div>
    <div id="xdx_C05_gIFDONOCIAP-BAAR_zl5EKJmYu0D6"><ix:continuation continuedAt="ConU001236-03" id="ConU001236-02"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Clarified how to assess the contractual cash flow characteristics of financial assets
    that include environmental, social and governance (ESG)-linked features and other similar contingent features</p></ix:continuation></div>
    <div id="xdx_C0C_gIFDONOCIAP-BAAR_zXZjZnmDVoka"><ix:continuation continuedAt="ConU001236-04" id="ConU001236-03"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Clarifies the treatment of non-recourse assets and contractually linked instruments</p></ix:continuation></div>
    <div id="xdx_C08_gIFDONOCIAP-BAAR_zGNTWdsE70dd"><ix:continuation continuedAt="ConU001236-05" id="ConU001236-04"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Requires additional disclosures in IFRS 7 for financial assets and liabilities with
    contractual terms that reference a contingent event (including those that are ESG-linked), and equity instruments classified at fair value
    through other comprehensive income</p></ix:continuation></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0A_gIFDONOCIAP-BAAR_zITb02JpFPWc"><ix:continuation continuedAt="ConU001236-06" id="ConU001236-05"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Entities can early adopt the amendments that relate to the classification of financial assets plus the related disclosures and
    apply the other amendments later.</p></ix:continuation></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0F_gIFDONOCIAP-BAAR_z0cxvEBa6aYf"><ix:continuation id="ConU001236-06"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</p></ix:continuation></div></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_zZMM05VKXtCd" title="Standard"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AnnualImprovementsToIFRSAccountingStandardsVolume11Member" id="Fact001238" name="ifrs-full:TitleOfInitiallyAppliedIFRS">Annual Improvements to IFRS Accounting Standards - Volume 11</ix:nonNumeric></span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_gIFDONOCIAP-WCSGRG_zybD7ZfXRgpk" title="Description"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AnnualImprovementsToIFRSAccountingStandardsVolume11Member" continuedAt="ConU001248-01" id="Fact001248" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">In July 2024, the IASB issued Annual Improvements to IFRS Accounting Standards - Volume
    11. The following is a summary of the topics subject to amendments from the Annual Improvements to IFRS Accounting Standards - Volume
    11:</ix:nonNumeric></span></p>
    <div id="xdx_C0A_gIFDONOCIAP-WCSGRG_zxAD1eGVVtBh"><ix:continuation continuedAt="ConU001248-02" id="ConU001248-01"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 1 First-time Adoption of International Financial Reporting Standards</p></ix:continuation></div>
    <div id="xdx_C0D_gIFDONOCIAP-WCSGRG_znk2wakMtSe1"><ix:continuation continuedAt="ConU001248-03" id="ConU001248-02"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 7 Financial Instruments: Disclosures: Gain or Loss on Derecognition</p></ix:continuation></div>
    <div id="xdx_C0F_gIFDONOCIAP-WCSGRG_zliiiu9lVw48"><ix:continuation continuedAt="ConU001248-04" id="ConU001248-03"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Guidance on implementing IFRS 7 Financial Instruments: Disclosures</p></ix:continuation></div>
    <div id="xdx_C05_gIFDONOCIAP-WCSGRG_zGd4UI1Blmv8"><ix:continuation continuedAt="ConU001248-05" id="ConU001248-04"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 9 Financial Instruments</p></ix:continuation></div>
    <div id="xdx_C01_gIFDONOCIAP-WCSGRG_zx4B8x3qLari"><ix:continuation continuedAt="ConU001248-06" id="ConU001248-05"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 10 Consolidated Financial Statements</p></ix:continuation></div>
    <div id="xdx_C00_gIFDONOCIAP-WCSGRG_z9bOzr2sDbL1"><ix:continuation continuedAt="ConU001248-07" id="ConU001248-06"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IAS 7 Statement of Cash Flows</p></ix:continuation></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C05_gIFDONOCIAP-WCSGRG_zvrWub3MXcHg"><ix:continuation continuedAt="ConU001248-08" id="ConU001248-07"><p style="font: 7.5pt Nunito Sans; margin: 0">These amendments are effective for annual periods beginning on or after January 1, 2026.</p></ix:continuation></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C05_gIFDONOCIAP-WCSGRG_z4adLiUXIh56"><ix:continuation id="ConU001248-08"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</p></ix:continuation></div></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_z7y593ZhC2Fd" title="Standard"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member" id="Fact001250" name="ifrs-full:TitleOfInitiallyAppliedIFRS">Nature-dependent Electricity Contracts &#8211; Amendments to IFRS 9 and IFRS 7</ix:nonNumeric></span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90B_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-NDD_zo9W1bJrgfR1" title="Description"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member" continuedAt="ConU001254-01" id="Fact001254" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">In December 2024, the IASB issued Contracts Referencing Nature-dependent Electricity (Amendments
    to IFRS 9 and IFRS 7), clarifying the application of the &#8216;own-use&#8217; requirements; permitting hedge accounting if these contracts
    are used as hedging instruments; and adding new disclosure requirements to enable investors to understand the effect of these contracts
    on a company&#8217;s financial performance and cash flows.</ix:nonNumeric></span></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0B_gIFDONOCIAP-NDD_zJ4HQK4N9f39"><ix:continuation continuedAt="ConU001254-02" id="ConU001254-01"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Early adoption is permitted, but will need to be disclosed.</p></ix:continuation></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C00_gIFDONOCIAP-NDD_zUqyDVEPe8tk"><ix:continuation id="ConU001254-02"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</p></ix:continuation></div></td></tr>
  </table>

<ix:exclude><!-- Field: Page; Sequence: 197 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_zjKS3Rce4spl" title="Standard"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_IFRS18PresentationAndDisclosureInFinancialStatementsMember" id="Fact001256" name="ifrs-full:TitleOfInitiallyAppliedIFRS">IFRS 18 &#8211; Presentation and Disclosure in Financial Statements</ix:nonNumeric></span></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_908_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_gIFDONOCIAP-XTV_zJYW1fCYY9l7" title="Description"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_IFRS18PresentationAndDisclosureInFinancialStatementsMember" continuedAt="ConU001262-01" id="Fact001262" name="ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy">In April 2024, the IASB issued IFRS 18, which replaces IAS 1 Presentation of Financial Statements.
    IFRS 18 introduces new requirements for presentation within the statement of income, including specified totals and subtotals. Furthermore,
    entities are required to classify all income and expenses within the statement of income into one of five categories: operating, investing,
    financing, income taxes and discontinued operations, whereof the first three are new.</ix:nonNumeric></span></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0C_gIFDONOCIAP-XTV_z0z3tJ4qoMj5"><ix:continuation continuedAt="ConU001262-02" id="ConU001262-01"><p style="font: 7.5pt Nunito Sans; margin: 0">It also requires disclosure of management-defined performance measures, subtotals of income
    and expenses and includes new requirements for aggregation and disaggregation of financial information based on the identified &#8220;roles&#8221;
    of the primary financial statements (PFS) and the notes.</p></ix:continuation></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C07_gIFDONOCIAP-XTV_zDB2Ec8H07d5"><ix:continuation continuedAt="ConU001262-03" id="ConU001262-02"><p style="font: 7.5pt Nunito Sans; margin: 0">In addition, narrow-scope amendments have been made to IAS 7 Statement of Cash Flows, which
    include changing the starting point for determining cash flows from operations under the indirect method, from &#8216;profit or loss&#8217;
    to &#8216;operating profit or loss&#8217; and removing the optionality around classification of cash flows from dividends and interest.
    In addition, there are consequential amendments to several other standards.</p></ix:continuation></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0E_gIFDONOCIAP-XTV_z7Lw8rr9h7P2"><ix:continuation continuedAt="ConU001262-04" id="ConU001262-03"><p style="font: 7.5pt Nunito Sans; margin: 0">IFRS 18, and the amendments to the other standards, is effective for reporting periods beginning
    on or after January 1, 2027 and must be applied retrospectively. Early adoption is permitted and must be disclosed.</p></ix:continuation></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C04_gIFDONOCIAP-XTV_zwXw9WdU0HY3"><ix:continuation id="ConU001262-04"><p style="font: 7.5pt Nunito Sans; margin: 0">The Company is currently working to identify all IFRS 18 impacts on the consolidated financial
    statements.</p></ix:continuation></div></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A7_zQ4teMoATgy2" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>2.5 Significant accounting judgments, estimates and assumptions</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The preparation of the Company&#8217;s consolidated financial statements requires management
to make judgments, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the accompanying
disclosures. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment to the carrying
amount of assets or liabilities affected in future periods. Accounting estimates and judgments are continually evaluated and are based
on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revisions to estimates are recognized prospectively.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Other disclosures relating to the Company&#8217;s exposure to risks and uncertainties include:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; Financial instruments risk management objectives and policies - Note 12.4</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; Sensitivity analysis - Note 12.4.1</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b><i>Estimates and assumptions</i></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The key assumptions about the future and other key sources of estimated uncertainty as
of the reporting date that include a significant risk of a material adjustment to the carrying amounts of assets and liabilities within
the next financial year, are described below. The Company based its assumptions and estimates on parameters available when the consolidated
financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market
changes or circumstances that arise and that are beyond the Company&#8217;s control. Such changes are reflected in the assumptions when
they occur.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Identification and fair-value measurement of assets and liabilities
acquired in a business combination</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Business combinations are accounted for using the acquisition method. Such method requires
recognizing and measuring the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree.
The Company, as the acquirer, must classify or designate the identifiable assets and liabilities assumed on the basis of its own contractual
terms, economic conditions, operating and accounting policies and other relevant conditions as at the acquisition date. Moreover, the
acquisition method required the fair value measurement of contingent consideration liabilities, when applicable, such as the Unidom consideration
conditioned upon the maintenance of the authorization of the 175 operating medical school seats. Such assessments require judgments from
the Company on the methods used to determine the fair value of the consideration transferred, including contingent consideration, assets
acquired and liabilities assumed, including valuation techniques that may require prospective financial information inputs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Impairment of non-financial assets</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Impairment exists when the carrying amount of an asset or CGU or group of CGUs exceeds
its recoverable amount, defined as the higher of its fair value less costs of disposal and its value in use. The fair value less costs
of disposal calculation is based on data available from binding sales transactions, conducted at arm&#8217;s length, for similar assets
or observable market prices less incremental costs of disposing of the asset. The value in use calculation is based on a discounted cash
flow model (&#8220;DCF&#8221; model). The cash flows are derived from the budget for the next five years and do not include restructuring
activities to which the Company has not yet committed or significant future investments that will enhance the performance of the assets
of the CGU being tested. The recoverable amount is sensitive to the discount rate used for the DCF model as well as to expected future
cash-inflows and the growth rate used for extrapolation purposes.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">These estimates are most relevant to goodwill and indefinite lived intangible assets recognized
by the Company. The key assumptions used to determine the recoverable amount for each CGU, including a sensitivity analysis, are disclosed
and further explained in Note 11.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<ix:exclude><p id="xdx_231_z4ZrkFHN8b75" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 198 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Provision for legal proceedings</i></p>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Provisions for labor, tax, and civil risks are recorded for all legal proceedings that
represent probable losses. The assessment of the probability of loss includes the evaluation of available evidence, such as recent court
decisions and the opinion of the Company's internal and external legal counsel, the nature of the proceedings, and past experience.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Provisions are reviewed and adjusted to account for changes in circumstances, such as new
matters or court rulings.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Share-based compensation</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Estimating fair value for share-based payment transactions requires determination of the
most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of
the most appropriate inputs to the valuation model including the expected life of the share option, volatility and dividend yield and
making assumptions about them. For the measurement of the fair value of equity-settled transactions, the Company uses the Binomial model.
The assumptions and models used for estimating fair value for share-based payment transactions are disclosed in Note 14.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Leases - Estimating the incremental borrowing rate</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company cannot readily determine the interest rate implicit in the lease, therefore,
it uses its incremental borrowing rate (IBR) to measure lease liabilities. The IBR is the rate of interest that the Company would have
to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use
asset in a similar economic environment. The IBR therefore reflects what the Company &#8216;would have to pay&#8217;, which requires estimation
when no observable rates are available (such as for subsidiaries that do not enter into financing transactions) or when they need to be
adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary&#8217;s functional currency).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company estimates the IBR using observable inputs (such as market interest rates) when
available and is required to make certain entity-specific estimates.</p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001265" name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory"><p id="xdx_802_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_z3JxFLPwNRqc" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">3</td><td><span id="xdx_82D_zOWQU9rf8ml9">Segment information</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company has three reportable segments as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%">&#8226; Undergraduate, previously denominated Undergrad, which provides educational
services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%">&#8226; Continuing education, which provides medical education (including residency
preparation programs, specialization test preparation and other medical capabilities), specialization and graduate courses in medicine,
delivered through digital and in-person content; and</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; Medical practice solutions, which provides clinical decision, clinical management
and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Segment information is presented consistently with the internal reports provided to the
Company's Chief Executive Officer (CEO), which is the Chief Operating Decision Maker (CODM) and is responsible for allocating resources,
assessing the performance of the Company's operating segments, and making the Company's strategic decisions.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">No operating segments have been aggregated to form the reportable operating segments. There
is only one geographic region, and the results are monitored and evaluated based on the three reportable segments.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The tables below present assets and liabilities information for the Company&#8217;s operating
segments as of December 31, 2025 and 2024:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 199 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zC5da0wP922h" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001268" name="afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_892_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_pn3n3_zSfK3M8sPhth" summary="xdx: Disclosure - Segment information (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B1_zQbCp0YvgGU8" style="display: none">Schedule of present assets and liabilities information for the company operating
segments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Nunito Sans; margin: 0"><b>As of December 31, 2025</b></p>
    <p style="font: 8pt Nunito Sans; margin: 0"></p></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment balances)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Total assets</b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z0IDAw4jHPS7" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001270" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,959,964</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhKKNNM0mfFh" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001272" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">245,697</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zt62qO9dNl94" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001274" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">166,238</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zAkTkn5CCkM2" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001276" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,371,899</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zrcDiT5vxQq7" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="Fact001278" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,965</ix:nonFraction>)</b></span></td>
    <td id="xdx_98B_eifrs-full--Assets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpLEGHzzo0h" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001280" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,357,934</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Current assets</span></td>
    <td id="xdx_988_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5ruOyFRbYZ6" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001282" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,765,066</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsWktpCmqBEh" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001284" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">92,221</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zqTUsili2R3e" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001286" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">98,854</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrDCgQ9p7n3f" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001288" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,956,141</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zn1nKiEvc0fh" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="Fact001290" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,965</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3OlXnTazSAe" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001292" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,942,176</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Non-current assets</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zdSRyzV7O4ub" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001294" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,194,898</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zXvNrvVOw064" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001296" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,476</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zt0KShXm39Bk" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001298" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,384</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zQ0kgMRIFs0l" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001300" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,415,958</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zXmOyjW5O8ne" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1302">-</span></span></td>
    <td id="xdx_988_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXkvXRg3XHkg" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001304" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,415,758</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>

<tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Total liabilities and equity</b></span></td>
    <td id="xdx_987_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z8k4ovcS5Ze6" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001306" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,959,964</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zAZL4gjm31d1" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001308" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">245,697</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zp6bbVklz9M" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001310" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">166,238</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zmpCTizm3iA" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001312" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,371,899</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zi8vcYcx4Z7e" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="Fact001314" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,965</ix:nonFraction>)</b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFbMO9lRNXR8" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001316" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,357,934</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Current liabilities</span></td>
    <td id="xdx_982_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z85owyqqFng4" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001318" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">689,074</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWTM74SMwxQ" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001320" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">113,729</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zTbEXVx7qBYf" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001322" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">95,203</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zyrbRY78RQK2" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001324" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">898,006</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z207V2dhGwz3" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="Fact001326" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,965</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zT8CalH6QWTf" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001328" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">884,041</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Non-current liabilities</span></td>
    <td id="xdx_984_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjWmzGn2dUM3" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001330" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,474,357</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zoGfUrXntxud" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001332" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">84,581</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z1ePEVfZS3zj" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001334" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,770</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrGojnsC3PA9" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001336" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,582,708</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zdJ9PqmWvoGh" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1338">-</span></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zArxUHsHbOXj" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001340" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,582,708</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Equity</span></td>
    <td id="xdx_981_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_ziroTHJOayVh" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001342" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,796,533</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zGhPN4u1NvPc" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001344" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47,387</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zGFb5X6QadB6" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001346" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47,265</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zhfAzQa4E3Gd" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001348" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,891,185</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zDEckoRGCa6e" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1350">-</span></span></td>
    <td id="xdx_984_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ztwzYi3L8Vdf" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001352" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,891,185</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Other disclosures</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Investment in associate (i) </span></td>
    <td id="xdx_980_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5ZTAlPIIs53" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001354" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,518</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zehfvGCMRDdf" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1356">-</span></span></td>
    <td id="xdx_983_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zj4fDftvGKB" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrrJviKeuFf9" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001360" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,518</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zqxt4PrBlQSg" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1362">-</span></span></td>
    <td id="xdx_984_eifrs-full--InvestmentsInAssociates_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAyOm9Dm5eq1" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001364" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,518</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Capital expenditures (ii)</span></td>
    <td id="xdx_983_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zMFtw1eAT74g" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001366" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">281,313</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zt9of9eKhbxd" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001368" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">79,139</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLflSDjO8589" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001370" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,559</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvCDQ3yj7Vf6" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001372" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">404,011</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zBPhcNbewun6" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1374">-</span></span></td>
    <td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z259tjoX5We5" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001376" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">404,011</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Investment in UEPC is included in non-current assets in the statement of financial position.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">Capital expenditures consider the acquisitions of property and equipment and intangible assets.</td>
</tr></table>

<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>As of December 31, 2024</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment balances)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Total assets</b></span></td>
    <td id="xdx_986_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z2LF7qhSBzxj" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001378" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,393,185</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zKNwGOVhAeEi" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001380" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">274,318</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zj8H9cNmymC6" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001382" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">170,624</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZB2DUmNhWb8" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001384" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,838,127</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zT10ExxrPNTe" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="Fact001386" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,588</ix:nonFraction>)</b></span></td>
    <td id="xdx_989_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYGEHCRy542b" title="Total assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001388" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,829,539</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Current assets</span></td>
    <td id="xdx_98D_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zMlTmuiPL2rf" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,443,566</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWnchmTlTxYb" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001392" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,893</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z1WeQM32Mrn6" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001394" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82,913</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZUrdzsrET4i" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001396" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,598,372</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zRPrBX1zhByc" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="Fact001398" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,588</ix:nonFraction>)</span></td>
    <td id="xdx_988_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmSFAkViuqu7" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001400" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,589,784</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Non-current assets</span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zT3ESAIVxst8" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001402" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,949,619</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzQaPambi3k9" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001404" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">202,425</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zPRkQMeNyNYg" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001406" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,711</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zG9IfrjjMKdb" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001408" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,239,755</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zjPJR9QjWyyj" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1410">-</span></span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbQozNjcQtk5" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001412" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,239,755</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Total liabilities and equity</b></span></td>
    <td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zSINTn1sKckl" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001414" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,393,185</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_ze8A2jR6MO4l" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001416" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">274,318</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ze9u4pRFomQg" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001418" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">170,624</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zk6ElIR49Vxa" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001420" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,838,127</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z8GuJNtkzVN4" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="Fact001422" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,588</ix:nonFraction>)</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5HoUTMapXYi" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001424" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,829,539</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Current liabilities</span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_znjxdRN6a5U6" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001426" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">884,705</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFKaB9kwmC34" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001428" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">188,489</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_znc5WnXKg6u1" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001430" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,589</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziO6npa9sii7" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001432" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,148,783</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z0b1OG8aE1K" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember" id="Fact001434" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,588</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zix4bAYOMO9i" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001436" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,140,195</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Non-current liabilities</span></td>
    <td id="xdx_98C_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zUUPvH6fuvJ8" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001438" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,279,846</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhPCSJP4dF16" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001440" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,619</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zRPJ8U3p1EI8" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001442" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,296</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z61dd8Z1aZRk" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001444" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,378,761</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z2QqWhlxFCt5" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1446">-</span></span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zZVMZo4q2Qok" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001448" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,378,761</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Equity</span></td>
    <td id="xdx_982_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zYve7SyWjGOi" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001450" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,228,634</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z9YIrw4PmNbf" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001452" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,210</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zir62vAHUIWa" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001454" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,739</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zqmZX2clNO3e" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001456" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,310,583</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zYnOtQwrVGbd" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1458">-</span></span></td>
    <td id="xdx_98A_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8uEO0BCIWX2" title="Equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001460" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,310,583</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Other disclosures</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Investment in associate (i) </span></td>
    <td id="xdx_988_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zbZbsQxEf44d" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001462" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,442</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhCTgtN1C07" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1464">-</span></span></td>
    <td id="xdx_98B_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zFlZypv1ZCnj" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1466">-</span></span></td>
    <td id="xdx_98A_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zVo3r5KpYT1l" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001468" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,442</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_znpS8Xd6eDe7" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1470">-</span></span></td>
    <td id="xdx_98F_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUHE5RSocYvg" title="Investments in associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001472" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,442</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Capital expenditures (ii)</span></td>
    <td id="xdx_98A_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zYKkEYUkXOL5" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001474" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">301,368</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zkIyr5bk91Hi" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001476" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,162</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zFQPaakrKWm3" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001478" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,085</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zIqMjhB79Fpl" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001480" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">392,615</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zNPGZORnzzP5" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1482">-</span></span></td>
    <td id="xdx_985_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z7KWjBhTkMt" title="Capital expenditures" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">392,615</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Investment in UEPC is included in non-current assets in the statement of financial position.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">Capital expenditures consider the acquisitions of property and equipment and intangible assets.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A1_zKTvBrzlghw4" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 200 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zazMxSBvhhV4" style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zdHzCkw2fLId" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The tables below present the statements of income for the Company&#8217;s operating segments
for the years ended December 31, 2025, 2024 and 2023:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001488" name="ifrs-full:DisclosureOfOperatingSegmentsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_895_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_pn3n3_zlV9c1HZlyQb" summary="xdx: Disclosure - Segment information (Details 1)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B3_zxYSJIfbBJ1f" style="display: none">Schedule of statements of income for the company&#8217;s operating
segments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Nunito Sans; margin: 0"><b>December 31, 2025</b></p>
    <p style="font: 8pt Nunito Sans; margin: 0"></p></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">External customer</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zy1tUwUyUADa" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001490" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,255,426</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zQvcf43sFzzh" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001492" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">275,705</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zvIutQCpXlt4" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001494" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">166,124</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdjy8E85eiYh" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001496" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,697,255</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zaQhbCuBZEo5" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1498">-</span></span></td>
    <td id="xdx_98D_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2q8YukRrlTb" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001500" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,697,255</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zzGxg9eDhtj3" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1502">-</span></span></td>
    <td id="xdx_98C_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zr7PPPYIPRte" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001504" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,766</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zxmcM7nJqfX6" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001506" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,199</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zm5pDuZo4B5k" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001508" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,965</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3CfNyKrDkk4" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:InterSegment" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001510" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,965</ix:nonFraction>)</span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zkvmdqCvG7N2" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1512">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zgtJHgIdWoR7" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001514" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,255,426</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z4Vq3CArKr47" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001516" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">284,471</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zWttKLWZHCg7" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001518" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">171,323</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z2shCJp1fm26" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001520" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,711,220</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zUF2XQoQc3ui" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Revenue" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001522" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,965</ix:nonFraction>)</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zL1PzHZprqyf" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001524" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,697,255</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zttXNdJA7Ne5" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001526" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,176,785</ix:nonFraction>)</span></td>
    <td id="xdx_980_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zaaUNiUOwLdf" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001528" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">96,346</ix:nonFraction>)</span></td>
    <td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zaNhLMvx5trd" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001530" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">54,729</ix:nonFraction>)</span></td>
    <td id="xdx_989_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvQqLCRbz6l9" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001532" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,327,860</ix:nonFraction>)</span></td>
    <td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3tjdhLuAIqg" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:CostOfSale" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001534" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,965</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUX0Chni0r53" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001536" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,313,895</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zJa7u2x11Kab" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001538" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,078,641</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdWK02lcT0E8" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001540" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">188,125</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zakNsS8XEcP6" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001542" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">116,594</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zBmJbPpzL24k" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001544" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,383,360</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zgZaWjp2sqR7" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1546">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ze3cy6RpNyJc" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001548" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,383,360</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">SG&amp;A expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zsQ8RFW64ox4" title="Selling, general and administrative expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001550" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,113,065</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Allowance for expected credit losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98F_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zahZHIYhqjUi" title="Allowance for expected credit losses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001552" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">57,090</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--OtherIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWBfPaRz5ou6" title="Other income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherIncome" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001554" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,762</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--OtherGainsLosses_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfYI2NA4CPsb" title="Other expenses, net" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001556" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,857</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGTvmiEeHLW1" title="Operating income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001558" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,213,110</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--FinanceIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcipjbWqr7y1" title="Finance income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001560" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">194,943</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_986_ecustom--FinanceExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zjkmgaeSWpyi" title="Finance expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:FinanceExpense" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001562" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">561,024</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Share of profit of equity-accounted investee, net of tax</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2yROqgskKyh" title="Share of income of associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001564" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,916</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zhMcSR9VyNk7" title="Income before income taxes" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001566" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">860,945</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zV45npikcmc9" title="Income taxes expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001568" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">92,502</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98C_eifrs-full--ProfitLoss_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfm1WQsz8uXg" title="Net income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001570" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">768,443</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>December 31, 2024</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">External customer</span></td>
    <td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zBWIPxykQn17" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001572" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,895,692</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0v4MTsDbOn5" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001574" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">251,636</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ztCPWSJNQJYe" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001576" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">157,001</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z7d0c2hb9tag" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001578" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,304,329</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNqSPqzGiQQ1" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1580">-</span></span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zT183rga31pk" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001582" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,304,329</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_989_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zWR3FkKS8Kr1" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1584">-</span></span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znuytYBCVInh" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001586" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,802</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zgpyI2upzxo4" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001588" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,786</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zT4GubTFGLPh" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001590" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,588</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zJ7uZZ2lYezl" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:InterSegment" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001592" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,588</ix:nonFraction>)</span></td>
    <td id="xdx_98D_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zaNYPQ6oli6c" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1594">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5btkVQHaLZ7" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001596" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,895,692</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zPdikYW8WLI3" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001598" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">255,438</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zVyTc1f4ZgSj" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001600" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">161,787</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zU7yPuVCQYs7" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001602" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,312,917</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zGojnr9sWC7f" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Revenue" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001604" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,588</ix:nonFraction>)</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXQb1fTzg4t4" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001606" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,304,329</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_znE9qbRRraVa" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001608" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,086,081</ix:nonFraction>)</span></td>
    <td id="xdx_983_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsaiV1k55mOj" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001610" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">96,180</ix:nonFraction>)</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zc0n48tL8g51" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001612" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">41,930</ix:nonFraction>)</span></td>
    <td id="xdx_988_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zarm0F2DYLYk" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001614" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,224,191</ix:nonFraction>)</span></td>
    <td id="xdx_983_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zz1btLHuoW1h" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:CostOfSale" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001616" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,588</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxWaofoge8a4" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001618" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,215,603</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjocHooAiff1" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001620" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,809,611</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zDbRwSwPM77g" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001622" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">159,258</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z85fEFwzuQ1g" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001624" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">119,857</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zD1GCLbqr7Dc" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001626" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,088,726</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zbBcl2EFfeTl" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1628">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zP7vcl50NgJ4" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001630" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,088,726</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">SG&amp;A expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_988_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z86ld6yA3Jqi" title="Selling, general and administrative expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001632" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,008,427</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Allowance for expected credit losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98D_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zj7Hy5K1VuA8" title="Allowance for expected credit losses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001634" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">60,894</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98F_eifrs-full--OtherIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zd2jDp8LO9s1" title="Other income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherIncome" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001636" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,299</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_986_eifrs-full--OtherGainsLosses_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zkvma7C067ke" title="Other expenses, net" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001638" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,591</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zRmRQ6KIqTDb" title="Operating income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001640" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,012,113</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--FinanceIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3zT0jnjfS4l" title="Finance income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001642" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">111,283</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_ecustom--FinanceExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zo4LY5KrVD4k" title="Finance expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:FinanceExpense" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001644" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">458,742</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Share of profit of equity-accounted investee, net of tax</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCYR34rtwRUc" title="Share of income of associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001646" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,737</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--ProfitLossBeforeTax_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zHHNFga5ouQ5" title="Income before income taxes" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001648" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">676,391</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAgfxqJd7dc2" title="Income taxes expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001650" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">27,471</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--ProfitLoss_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMVIHIivPYfi" title="Net income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001652" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">648,920</ix:nonFraction></b></span></td></tr>
  </table>

<ix:exclude><!-- Field: Page; Sequence: 201 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zGbWzv6mOxM4" style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p></ix:exclude>

<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>December 31, 2023</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">External customer</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zPZsxW6js1ua" title="External customer" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001655" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,511,018</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRqBPrXPZg27" title="External customer" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001657" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">227,181</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zJpTQYr3a1S" title="External customer" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001659" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">137,714</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zKImPt23t0P8" title="External customer" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001661" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zn1QYQ4ucN76" title="External customer" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1663">-</span></span></td>
    <td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z56QTe3JQgWd" title="External customer" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001665" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zxlpN3cYRQlc" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1667">-</span></span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zchtRXv5rWx5" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001669" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,649</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLyHp2DSpUpj" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001671" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,568</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJWcVSALG3c" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001673" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,217</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z1uCXgRR1I9l" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:InterSegment" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001675" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</span></td>
    <td id="xdx_985_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z1TupQJ4Swcj" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1677">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zXim7TUBLj72" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001679" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,511,018</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z35nJmQgwIZa" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001681" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235,830</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zlLcmYX4vLqg" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001683" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">140,282</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zobFF2vSoOOf" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001685" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,887,130</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zoJd3B4Ud28g" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001687" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</b></span></td>
    <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zl9DyY9LCiNl" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001689" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Cost of services</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zf8SGki3wZw2" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001691" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">997,973</ix:nonFraction>)</span></td>
    <td id="xdx_981_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0gI8uZCvl57" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001693" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">91,915</ix:nonFraction>)</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zChfF1NJAS06" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001695" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,142</ix:nonFraction>)</span></td>
    <td id="xdx_986_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zE0lr67YA9H6" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001697" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,121,030</ix:nonFraction>)</span></td>
    <td id="xdx_98D_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zP80YVjk7mJd" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="afya:CostOfSale" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="Fact001699" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,217</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zDqY2iSHyKLh" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:CostOfSale" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001701" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,109,813</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_985_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zo7UraGR0W41" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember" id="Fact001703" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,513,045</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zMHxzgoP5ZG" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001705" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">143,915</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ziC6iTIJ76ba" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember" id="Fact001707" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">109,140</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zME1wBXQsR7e" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001709" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,766,100</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAIY8FIQDERd" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1711">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5ZvizdvLe0f" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001713" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,766,100</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">SG&amp;A expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_988_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zQHot6fEnyY5" title="Selling, general and administrative expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001715" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">940,132</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Allowance for expected credit losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98F_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYXewfwlwK7e" title="Allowance for expected credit losses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001717" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">74,552</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_982_eifrs-full--OtherIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIbmjr5sk3Ul" title="Other income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherIncome" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001719" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,206</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_981_eifrs-full--OtherGainsLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zY77776koTFh" title="Other expenses, net" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001721" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">37,561</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_983_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJzgZW3z9pDb" title="Operating income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001723" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">767,061</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_987_eifrs-full--FinanceIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zZjvOdgB9aJ2" title="Finance income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001725" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,642</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_ecustom--FinanceExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zm2Os64kyz8k" title="Finance expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="afya:FinanceExpense" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001727" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">457,616</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Share of profit of equity-accounted investee, net of tax</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98F_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zeFV66qrZtch" title="Share of income of associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001729" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,495</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlQ06Zi28mki" title="Income before income taxes" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001731" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">429,582</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98D_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdh1hrDVjKJb" title="Income taxes expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001733" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,166</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--ProfitLoss_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAFo3aRZMmLb" title="Net income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001735" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,416</ix:nonFraction></b></span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_z8cj1i9nMjc7" style="margin-top: 0; margin-bottom: 0">&#160;</p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001737" name="ifrs-full:DisclosureOfBusinessCombinationsExplanatory"><p id="xdx_800_eifrs-full--DisclosureOfBusinessCombinationsExplanatory_zbEEnN6TPBEf" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%"><b>4</b></td><td><b><span id="xdx_827_z1aF6XL5KXf4">Business combinations</span></b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>4.1 Acquisition in 2024 (Unidom)</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify">On July 1, 2024, Afya Brazil acquired 100% of the share capital of
Unidom, a post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate
programs in medicine and health, as well as other courses. The fair values of the identifiable assets acquired and liabilities assumed
as of acquisition date were:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001739" name="afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89E_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock_zDEMKjZWgrsa" summary="xdx: Disclosure - Business combinations (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B0_zkeUb1kFaXh5" style="display: none">Schedule of fair values of the identifiable assets acquired and liabilities</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 83%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Unidom</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Assets</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Cash and cash equivalents</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zK0MlxswDzBa" title="Cash and cash and equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001741" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,272</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Trade receivables</span></td>
    <td id="xdx_987_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zcU0pQXR2Obi" title="Trade receivables" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001743" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,368</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Advances</span></td>
    <td id="xdx_984_ecustom--AdvancesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zmZBJD7RLy0f" title="Advances" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:AdvancesRecognisedAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001745" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">94</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Recoverable taxes</span></td>
    <td id="xdx_983_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zhZSTIbMNsOh" title="Recoverable taxes" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001747" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Other assets</span></td>
    <td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z8qSPvR4Wdq8" title="Other assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001749" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">854</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Indemnification assets</span></td>
    <td id="xdx_983_ecustom--IndemnificationAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zTjUKZA5C853" title="Indemnification assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:IndemnificationAssetsAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001751" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,185</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Property and equipment</span></td>
    <td id="xdx_989_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z5BbVzqzsVzk" title="Property and equipment" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001753" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,709</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Rights-of-use assets</span></td>
    <td id="xdx_98B_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zHUXZuYZ6Xr7" title="Rights-of-use assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,989</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Intangible assets</span></td>
    <td id="xdx_98D_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z2nuzWvWX7ef" title="Intangible assets" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001757" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">462,042</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zpjqvbbbXa7e" title="Total" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001759" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">517,595</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Trade payables</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zzLSYEr6qeC8" title="Trade payables" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001761" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,732</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Loans and financing</span></td>
    <td id="xdx_98F_ecustom--LoansAndFinancingAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z9CCZXtMR5a3" title="Loans and financing" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:LoansAndFinancingAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001763" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,377</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Labor and social obligations</span></td>
    <td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zqcin45llBNc" title="Labor and social obligations" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001765" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,368</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Taxes payable</span></td>
    <td id="xdx_98D_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zZRhWNtwosSj" title="Taxes payable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001767" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,254</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Other taxes payable (i)</span></td>
    <td id="xdx_98A_ecustom--OtherTaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zrIb79ZxFjA7" title="Other taxes payable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:OtherTaxesPayableAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001769" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,274</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Advances from customers</span></td>
    <td id="xdx_983_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zy2y20LMSSRi" title="Advances from customers" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001771" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,234</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Lease liabilities</span></td>
    <td id="xdx_984_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zqb55dTwEBP4" title="Lease liabilities" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001773" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,989</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Provision for legal proceedings</span></td>
    <td id="xdx_984_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z7A2jQo3pOBa" title="Provision for legal proceedings" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001775" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,246</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Other liabilities</span></td>
    <td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zWpajxoyUOi2" title="Other liabilities" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001777" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,393</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98B_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zQqO6n8YhFic" title="Financial liabilities recognised as of acquisition date" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001779" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88,867</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Total identifiable net assets at fair value</b></span></td>
    <td id="xdx_98E_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zWeZWtY8QeG" title="Total identifiable net assets at fair value" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001781" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">428,728</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Goodwill arising on acquisition</span></td>
    <td id="xdx_987_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zaNykD1C1pt5" title="Goodwill arising on acquisition" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001783" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">192,034</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Purchase consideration transferred</b></span></td>
    <td id="xdx_980_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zy8juCLd7lji" title="Purchase consideration transferred" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001785" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">620,762</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Cash paid</span></td>
    <td id="xdx_989_eifrs-full--CashTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zyFGFziSFK81" title="Cash paid" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001787" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">340,773</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Consideration to be transferred</span></td>
    <td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zGbJrEKMUm2j" title="Consideration to be transferred" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001789" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">279,989</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b><i>Analysis of cash flows on acquisition</i></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transaction costs of the acquisition</span></td>
    <td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20240629__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zNbm8lyzhak8" title="Transaction costs of the acquisition (included in cash flows from operating activities)" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2024-06-292024-07-01_custom_UnidomMember" id="Fact001791" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,793</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Cash paid net of cash acquired with the subsidiary</span></td>
    <td id="xdx_981_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20240629__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zICBVH8O62T" title="Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2024-06-292024-07-01_custom_UnidomMember" id="Fact001793" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">337,501</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Net of cash flow on acquisition </b></span></td>
    <td id="xdx_98C_ecustom--NetOfCashFlowOnAcquisition_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zLCahM7UOSKh" title="Net of cash flow on acquisition" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact001795" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">339,294</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to deferred tax liabilities arising from transactions prior to Afya&#8217;s acquisition
of Unidom.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A6_zmytScREcl77" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify">The acquisition contributed with 300 operational medical school seats
to the Undergraduate segment. The authorization request for these 300 medical school seats was made to MEC before the Mais M&#233;dicos
Law was enacted and MEC concluded its analysis and issued Ordinance 630/2020 ("Ordinance") in 2020 to authorize the operation
considering 125 medical school seats. In 2021, as a result of a judicial order, MEC reviewed the Ordinance to authorize the 300 medical
school seats initially requested by Unidom. Such decision was confirmed by a federal judge in the State of Bahia in 2023. Currently,
Unidom has 300 medical school seats authorized, of which 125 are final and 175 are subject to a final conclusion of the aforementioned
court proceedings.</p>
<p style="font: 10.5pt Nunito Sans; margin: 0; text-align: justify"></p>


<ix:exclude><!-- Field: Page; Sequence: 202 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify"><span id="xdx_905_eifrs-full--DescriptionOfAcquiree_c20240629__20240701__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_z2Vs9R9UtlGa" title="Acquired purchase price"><ix:nonNumeric contextRef="From2024-06-292024-07-01_custom_AcquisitionOfUnidomMember" id="Fact001797" name="ifrs-full:DescriptionOfAcquiree">The total consideration of R$620,762, net of Net Debt, is comprised
of: (i) R$340,773 paid in cash on July 1, 2024; and (ii) R$279,989, considering purchase consideration adjustments, payable in up to ten
annual installments, adjusted by the CDI rate, and it is conditioned upon the maintenance of the authorization of the 175 medical school
seats in each of the prior year.</ix:nonNumeric></span> The remaining payment balance is accelerated if a final and non-appealable conclusion of the aforementioned
court proceedings, within the 10-year payment period, confirms the authorization for the 175 medical school seats. In turn, if, within
the same 10-year payment period, a final and non-appealable conclusion of the aforementioned court proceedings does not confirm the authorization
for such 175 medical school seats, the remaining payment balance will no longer be due.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">This acquisition was accounted for under IFRS 3 &#8211; Business Combinations.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Transaction costs to date amount to R$<span id="xdx_90D_ecustom--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zXK6gzWZ8fV6" title="Total transaction costs"><ix:nonFraction name="afya:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination" contextRef="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember" id="Fact001799" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,755</ix:nonFraction></span>, which R$<span id="xdx_90D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zl6VFzHp5Txa" title="Transaction costs"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember" id="Fact001801" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,793</ix:nonFraction></span> were expensed in the year ended
December 31, 2024 (R$<span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20240101__20241231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zFqb930kN4Hf" title="Transaction costs"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2024-01-012024-12-31_custom_AcquisitionOfUnidomMember" id="Fact001803" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">962</ix:nonFraction></span> in the year ended December 31, 2023) and are included in selling, general and administrative expenses in the
consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company measured the acquired lease liabilities using the present value of the remaining
lease payments at the date of acquisition. The right-of-use assets were measured at an amount equal to the lease liabilities.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">At the acquisition date, the fair value of the trade receivables acquired is substantially
the same as its carrying amount.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The goodwill recognized includes the value of expected synergies arising from the acquisition,
which is not separately recognized. Goodwill is allocated entirely to the Undergraduate segment. The goodwill recognized is not expected
to be deductible for income taxes purposes.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify">The Company did not recognize deferred taxes related to the business
combination because the tax basis and the accounting basis, including fair value adjustments, were the same at the date of the business
combination.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The fair value measurement of separately identified intangible assets acquired are based
on income approach, determined using discounted cash flows, which include significant estimates around revenue growth projections, operating
profit margins projections and discount rate. The Company engaged an independent valuation specialist to assist Management to assess the
fair value of the assets acquired and liabilities assumed at the date of acquisition. The valuation techniques used were as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001805" name="afya:ScheduleOfAcquisitionOfUnidomExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_89A_ecustom--ScheduleOfAcquisitionOfUnidomExplanatory_zj9bALLej2cg" summary="xdx: Disclosure - Business combinations (Details 1)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td><span id="xdx_8B4_z35CnO6fxUci" style="display: none">Schedule
    of intangible assets acquired unidom</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr>
    <td style="border: #D0CECE 1pt solid; width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 74%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Valuation technique</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><b>Licenses</b></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"><b>With-and-without method</b></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"><span id="xdx_90C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20240629__20240701__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesAndFranchisesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfUnidomMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--WithAndWithoutMethodMember_zbPtdWQqJRub" title="Valuation technique"><ix:nonNumeric contextRef="From2024-06-292024-07-01_ifrs-full_LicencesAndFranchisesMember_custom_AcquisitionOfUnidomMember_custom_WithAndWithoutMethodMember" id="Fact001807" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.</ix:nonNumeric></span></p></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><b>Customer relationships</b></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"><b>Multi-period excess earnings method</b></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"><span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20240629__20240701__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfUnidomMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zxtNXFabTRpd" title="Valuation technique"><ix:nonNumeric contextRef="From2024-06-292024-07-01_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfUnidomMember_ifrs-full_MultiperiodExcessEarningsMethodMember" id="Fact001809" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</ix:nonNumeric></span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A8_zy1meNcquKQd" style="font: 10.5pt Nunito Sans; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">From the date of acquisition, Unidom contributed R$<span id="xdx_90E_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zZtpGIyjNkF" title="Net revenue"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember" id="Fact001811" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,643</ix:nonFraction></span> of revenue and R$<span id="xdx_900_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zM1BMk0wtF2c" title="Income loss before income taxes"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember" id="Fact001813" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,013</ix:nonFraction></span> to income
before income taxes of the Company in the year ended December 31, 2024. If the acquisition had taken place at the beginning of the year,
revenue and income before income taxes for the year ended December 31, 2024 would have been R$<span id="xdx_902_ecustom--IncreaseInRevenue_pn3n3_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zCxumhd2URwc" title="Increase in revenue"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember" id="Fact001815" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,354,571</ix:nonFraction></span> and R$<span id="xdx_90D_ecustom--IncreaseInIncomeBeforeIncomeTaxes_pn3n3_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zr9vfmrFLfFj" title="Increase in income before income taxes"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember" id="Fact001817" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">697,449</ix:nonFraction></span>, respectively.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001819" name="afya:DisclosuresOfCashAndCashEquivalentsExplanatory"><p id="xdx_805_ecustom--DisclosuresOfCashAndCashEquivalentsExplanatory_z0lEYkx6rx52" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">5</td><td><span id="xdx_829_zvF0lnmuaA2">Cash and cash equivalents</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001821" name="afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_zJJ6dpRAmAo1" summary="xdx: Disclosure - Cash and cash equivalents (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BD_znVPwdwoRoS3" style="display: none">Schedule of cash and cash equivalents</span></td>
    <td id="xdx_49D_20251231_zBzTqHllkv1k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_498_20241231_zXEsK4Uqjfnh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"/>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--Cash_iI_pn3n3_zWH9qacnoI17" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Cash and bank deposits</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:Cash" contextRef="AsOf2025-12-31" id="Fact001823" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,470</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:Cash" contextRef="AsOf2024-12-31" id="Fact001824" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,078</ix:nonFraction> </td></tr>
  <tr id="xdx_403_eifrs-full--CashEquivalents_iI_pn3n3_zLYIVr4C2oR4" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Cash equivalents</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:CashEquivalents" contextRef="AsOf2025-12-31" id="Fact001826" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,109,911</ix:nonFraction> </td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:CashEquivalents" contextRef="AsOf2024-12-31" id="Fact001827" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">904,937</ix:nonFraction> </td></tr>
  <tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_zXIyr34M4Rzf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Cash and cash equivalents</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2025-12-31" id="Fact001829" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,125,381</ix:nonFraction> </b></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2024-12-31" id="Fact001830" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">911,015</ix:nonFraction> </b></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_z7OdyT4lDSjh" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 203 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Cash equivalents correspond to investment funds and Bank Certificates of Deposit (CDB)
with highly rated financial institutions, available for immediate use and have an insignificant risk of changes in value.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">As of December 31, 2025, the average interest on these investments is equivalent to <span id="xdx_906_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_z3PZYQQqTfs3" title="Percentage of average interest"><ix:nonFraction name="afya:PercenatgeOfAverageInterestOnFinancialInstrument" contextRef="AsOf2025-12-31_custom_BankCertificatesOfDepositMember" id="Fact001832" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">101.2</ix:nonFraction></span>%
of the CDI rate (December 31, 2024: <span id="xdx_90F_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_z8HNS0Zdenbl" title="Percentage of average interest"><ix:nonFraction name="afya:PercenatgeOfAverageInterestOnFinancialInstrument" contextRef="AsOf2024-12-31_custom_BankCertificatesOfDepositMember" id="Fact001834" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">99.1</ix:nonFraction></span>%). Cash equivalents denominated in U.S. dollars totaled R$<span id="xdx_905_eifrs-full--CashEquivalents_iI_pn3n3_uBRL_c20251231__ifrs-full--CurrencyInWhichInformationIsDisplayedAxis__custom--USDMember_zSeXnNoUw4zi" title="Cash equivalents"><ix:nonFraction name="ifrs-full:CashEquivalents" contextRef="AsOf2025-12-31_custom_USDMember" id="Fact001836" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,422</ix:nonFraction></span> as of December 31, 2025 (December
31, 2024: R$<span id="xdx_90D_eifrs-full--CashEquivalents_iI_pn3n3_uBRL_c20241231__ifrs-full--CurrencyInWhichInformationIsDisplayedAxis__custom--USDMember_z5bDxoiXBAA5" title="Cash equivalents"><ix:nonFraction name="ifrs-full:CashEquivalents" contextRef="AsOf2024-12-31_custom_USDMember" id="Fact001838" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,610</ix:nonFraction></span>).</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001840" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory"><p id="xdx_80A_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zxVshYmotQQf" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">6</td><td><span id="xdx_825_zbSURry6WVub">Trade receivables</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001842" name="afya:DisclosureOfTradeAndOtherReceivables1Explanatory"><table cellspacing="0" cellpadding="0" id="xdx_892_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_zByhnAZtBHNl" summary="xdx: Disclosure - Trade receivables (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BF_z3rvyRXRN7Y8" style="display: none">Schedule of trade accounts receivable</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Tuition fees</td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zPJqv2hIaCL7" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31_custom_TuitionFeesMember" id="Fact001844" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">596,568</ix:nonFraction> </td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zxU3kb6OcT1" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31_custom_TuitionFeesMember" id="Fact001846" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">488,962</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Educational content (i)</td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zKYDjV68pkHa" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31_custom_EducationalContentMember" id="Fact001848" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,679</ix:nonFraction> </td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zHaJpSKmVxA7" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31_custom_EducationalContentMember" id="Fact001850" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,194</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">FIES (ii)</td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_z8URSeeVnAqe" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31_custom_FIESMember" id="Fact001852" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">139,158</ix:nonFraction> </td>
    <td id="xdx_988_ecustom--ReceivablesGross_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zEJhmyCsjQ0h" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31_custom_FIESMember" id="Fact001854" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">79,712</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">Educational credits (iii)</td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_z5SF5AF187Kg" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31_custom_EducationalCreditsMember" id="Fact001856" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,399</ix:nonFraction> </td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zKUD0Fp9m9kc" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31_custom_EducationalCreditsMember" id="Fact001858" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,893</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">Mobile app subscription (iv)</td>
    <td id="xdx_989_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zrOUuPQ2sO7c" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31_custom_MobileAppSubscriptionMember" id="Fact001860" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,484</ix:nonFraction> </td>
    <td id="xdx_987_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zQxrS2cTqWvd" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31_custom_MobileAppSubscriptionMember" id="Fact001862" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,223</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">Other</td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zcTwoI5hXHMc" title="Trade receivables, gross" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31_custom_OthersMember" id="Fact001864" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,226</ix:nonFraction> </td>
    <td id="xdx_983_ecustom--ReceivablesGross_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zzL5IKSou6e1" title="Trade receivables, gross" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31_custom_OthersMember" id="Fact001866" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,339</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231_zn0Mji0qasyl" title="Trade receivables, gross" style="border-top: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31" id="Fact001868" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">852,514</ix:nonFraction> </b></td>
    <td id="xdx_985_ecustom--ReceivablesGross_pn3n3_c20241231_zRZEKIkbVCKe" title="Trade receivables, gross" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31" id="Fact001870" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">703,323</ix:nonFraction> </b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Allowance for expected credit losses</td>
    <td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20251231_zoWUWVhqZfbg" title="Trade receivables, gross" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:AllowanceForDoubtfulAccountsFoReceivable1" contextRef="AsOf2025-12-31" id="Fact001872" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">100,156</ix:nonFraction>)</td>
    <td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20241231_zprFL58UFyhc" title="(-) Allowance for doubtful accounts" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:AllowanceForDoubtfulAccountsFoReceivable1" contextRef="AsOf2024-12-31" id="Fact001874" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">71,477</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_989_eifrs-full--TradeReceivables_pn3n3_c20251231_zTk8m9Lgcuzc" title="Trade receivables, net" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2025-12-31" id="Fact001876" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">752,358</ix:nonFraction> </b></td>
    <td id="xdx_98D_eifrs-full--TradeReceivables_pn3n3_c20241231_z6vYQIjSpNE3" title="Trade receivables, net" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2024-12-31" id="Fact001878" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">631,846</ix:nonFraction> </b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_984_eifrs-full--CurrentTradeReceivables_pn3n3_c20251231_zVXqEOuatfN7" title="Current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="AsOf2025-12-31" id="Fact001880" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">717,373</ix:nonFraction> </td>
    <td id="xdx_988_eifrs-full--CurrentTradeReceivables_pn3n3_c20241231_z0oHGaUDoDC1" title="Current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="AsOf2024-12-31" id="Fact001882" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">595,898</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20251231_zMT2yhubKIva" title="Non-current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2025-12-31" id="Fact001884" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,985</ix:nonFraction> </td>
    <td id="xdx_984_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20241231_zCE1dpgvXXz2" title="Non-current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2024-12-31" id="Fact001886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,948</ix:nonFraction> </td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 7.5pt Nunito Sans; margin: 0">(i) Related to trade receivables from sales of e-books and medical courses through the Continuing
education&#8217;s platform.</p>

<p style="font: 7.5pt Nunito Sans; margin: 0">(ii) Related to trade receivables from the FIES program, created by the Brazilian federal
government to offer financing to low-income students enrolled in undergraduate programs in private higher education institutions.</p>

<p style="font: 7.5pt Nunito Sans; margin: 0">(iii) Related to the financing programs offered by the Company&#8217;s subsidiaries to its
students.</p>

<p style="font: 7.5pt Nunito Sans; margin: 0">(iv) Related to trade receivables from mobile applications subscriptions for Medical practice
solutions.</p>

</ix:nonNumeric><p id="xdx_8A6_zk47mO4K7qi8" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">As of December 31, 2025 and 2024, the aging of trade receivables was as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001888" name="afya:DisclosureOfTradeAccountsReceivableByAgingExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_897_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_pn3n3_zs5xJlZzct6g" summary="xdx: Disclosure - Trade receivables (Details 1)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BD_zWIkavE23pS7" style="display: none">Schedule of aging of trade accounts receivable</span></td>
    <td style="white-space: nowrap; padding-right: -3.35pt; padding-left: 3.5pt; text-align: right"/>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: -3.35pt; padding-left: 3.5pt; text-align: right"/>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Neither past due nor impaired</td>
    <td id="xdx_989_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z74pHOdCfMXb" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" id="Fact001890" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">383,887</ix:nonFraction> </td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z7uKZbZUst68" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" id="Fact001892" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">327,052</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Past due:</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt">1 to 30 days</td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--NotLaterThanOneMonthMember_zkfaV8fh8q4l" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneMonthMember" id="Fact001894" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,785</ix:nonFraction> </td>
    <td id="xdx_986_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--NotLaterThanOneMonthMember_zmviVnAWAKj9" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31_ifrs-full_NotLaterThanOneMonthMember" id="Fact001896" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">97,390</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt">31 to 90 days</td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zZ5lxnu3cKDk" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" id="Fact001898" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">165,512</ix:nonFraction> </td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zf25PPY6Oxoj" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" id="Fact001900" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">126,623</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt">91 to 180 days</td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_z36nIiQ1mIQa" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" id="Fact001902" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">102,369</ix:nonFraction> </td>
    <td id="xdx_985_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zJsqYDFE0QZk" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" id="Fact001904" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">91,411</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt">More than 180 days</td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanSixMonthsMember_zruq4TDEtiU2" title="Trade receivable" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31_ifrs-full_LaterThanSixMonthsMember" id="Fact001906" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,961</ix:nonFraction> </td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanSixMonthsMember_zTJHwVlTMB6i" title="Trade receivable" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31_ifrs-full_LaterThanSixMonthsMember" id="Fact001908" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,847</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_982_ecustom--ReceivablesGross_iI_pn3n3_c20251231_zpZVFvYk45D5" title="Trade receivable" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2025-12-31" id="Fact001910" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">852,514</ix:nonFraction> </b></td>
    <td id="xdx_988_ecustom--ReceivablesGross_iI_pn3n3_c20241231_z91Szi6EAZ1h" title="Trade receivable" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2024-12-31" id="Fact001912" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">703,323</ix:nonFraction></b></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A8_zYZZZyriGBZ9" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The changes in the allowance for expected credit losses for the years ended December 31,
2025, 2024 and 2023, were as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001914" name="afya:DisclosureOfAllowanceForDoubtfulAccountsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_899_ecustom--DisclosureOfAllowanceForDoubtfulAccountsExplanatory_pn3n3_zGQbIUaDMdl3" summary="xdx: Disclosure - Trade receivables (Details 2)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BB_zKnxa853uQm4" style="display: none">Schedule of allowance for doubtful accounts</span></td>
    <td id="xdx_492_20250101__20251231_zlxsu8oloE47" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"/>
    <td id="xdx_490_20240101__20241231_zz5EE2Z1VW42" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20230101__20231231_z7CsixPwnlOc" style="text-align: center">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AllowanceAccountForCreditLossesOfFinancialAsset_iNS_pn3n3_di_zY658UuznTM9" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><b>Opening balance</b></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(<ix:nonFraction name="afya:AllowanceAccountForCreditLossesOfFinancialAsset" contextRef="AsOf2024-12-31" id="Fact001916" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,477</ix:nonFraction>)</b></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(<ix:nonFraction name="afya:AllowanceAccountForCreditLossesOfFinancialAsset" contextRef="AsOf2023-12-31" id="Fact001917" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">61,398</ix:nonFraction>)</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><b>(<ix:nonFraction name="afya:AllowanceAccountForCreditLossesOfFinancialAsset" contextRef="AsOf2022-12-31" id="Fact001918" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,046</ix:nonFraction>)</b></td></tr>
  <tr id="xdx_400_ecustom--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_pn3n3_zhURD4FBtsDg" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Additions</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" contextRef="From2025-01-01to2025-12-31" id="Fact001920" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">57,090</ix:nonFraction>)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" contextRef="From2024-01-012024-12-31" id="Fact001921" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">60,894</ix:nonFraction>)</td>
    <td style="vertical-align: bottom; text-align: right">(<ix:nonFraction name="afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" contextRef="From2023-01-012023-12-31" id="Fact001922" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">74,552</ix:nonFraction>)</td></tr>
  <tr id="xdx_404_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_pn3n3_zliOtbLDa3V" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Write-offs</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" contextRef="From2025-01-01to2025-12-31" id="Fact001924" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,411</ix:nonFraction> </td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" contextRef="From2024-01-012024-12-31" id="Fact001925" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,815</ix:nonFraction> </td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><ix:nonFraction name="afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" contextRef="From2023-01-012023-12-31" id="Fact001926" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,200</ix:nonFraction></td></tr>
  <tr id="xdx_405_ecustom--AllowanceAccountForCreditLossesOfFinancialAsset_iNE_pn3n3_di_zVnJI3yuJtl1" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><b>Closing balance</b></td>
    <td style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(<ix:nonFraction name="afya:AllowanceAccountForCreditLossesOfFinancialAsset" contextRef="AsOf2025-12-31" id="Fact001928" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,156</ix:nonFraction>)</b></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(<ix:nonFraction name="afya:AllowanceAccountForCreditLossesOfFinancialAsset" contextRef="AsOf2024-12-31" id="Fact001929" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,477</ix:nonFraction>)</b></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: bottom; text-align: right"><b>(<ix:nonFraction name="afya:AllowanceAccountForCreditLossesOfFinancialAsset" contextRef="AsOf2023-12-31" id="Fact001930" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">61,398</ix:nonFraction>)</b></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A7_zyxyAgUcwWGj" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001932" name="ifrs-full:DisclosureOfRelatedPartyExplanatory"><p id="xdx_80A_eifrs-full--DisclosureOfRelatedPartyExplanatory_zGmCHPSyDao4" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">7</td><td><span id="xdx_820_zY30MF8yV4ci">Related parties</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The tables below summarize the balances and transactions with related parties:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact001934" name="afya:DisclosureOfRelatedPartiesExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_898_ecustom--DisclosureOfRelatedPartiesExplanatory_zSXDqJNfgQ96" summary="xdx: Disclosure - Related parties (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B1_zcSadTwFCeD9" style="display: none">Schedule of balances and transactions with related parties</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"/>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"/>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b>Assets</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Right-of-use assets</td>
    <td id="xdx_98E_ecustom--RightofuseAssetsRelatedPartyTransactions_iI_c20251231_zYLexd68nQL6" title="Right-of-use assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:RightofuseAssetsRelatedPartyTransactions" contextRef="AsOf2025-12-31" id="Fact001936" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">216,085</ix:nonFraction></td>
    <td id="xdx_981_ecustom--RightofuseAssetsRelatedPartyTransactions_iI_c20241231_zy0T8FcMcVla" title="Right-of-use assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:RightofuseAssetsRelatedPartyTransactions" contextRef="AsOf2024-12-31" id="Fact001938" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">205,911</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Trade receivables (i)</td>
    <td id="xdx_986_ecustom--TradeReceivablesRelatedPartyTransactions_iI_c20251231_zrUqgvVdSFse" title="Trade receivables" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:TradeReceivablesRelatedPartyTransactions" contextRef="AsOf2025-12-31" id="Fact001940" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">384</ix:nonFraction> </td>
    <td id="xdx_989_ecustom--TradeReceivablesRelatedPartyTransactions_iI_c20241231_zJY1U6AmhXF2" title="Trade receivables" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:TradeReceivablesRelatedPartyTransactions" contextRef="AsOf2024-12-31" id="Fact001942" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">507</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Other assets (ii)</td>
    <td id="xdx_983_ecustom--OtherAssetsRelatedPartyTransactions_iI_c20251231_zGeufvMf3VS5" title="Other assets" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1944">-</span></td>
    <td id="xdx_98F_ecustom--OtherAssetsRelatedPartyTransactions_iI_c20241231_z80kBkJ6eMs" title="Other assets" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:OtherAssetsRelatedPartyTransactions" contextRef="AsOf2024-12-31" id="Fact001946" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">597</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b></b></td>
    <td id="xdx_98B_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20251231_zg7xEEH9EsXe" title="Total assets" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:AmountsReceivableRelatedPartyTransactions" contextRef="AsOf2025-12-31" id="Fact001948" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">216,469</ix:nonFraction> </b></td>
    <td id="xdx_985_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20241231_zp1oV5skIiE4" title="Total assets" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:AmountsReceivableRelatedPartyTransactions" contextRef="AsOf2024-12-31" id="Fact001950" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">207,015</ix:nonFraction></b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td id="xdx_989_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_c20251231_zDX9XnJTd2hf" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1952">-</span></td>
    <td id="xdx_981_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_c20241231_zDmuIUpe32wa" title="Current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:TradeAndOtherCurrentPayablesToRelatedParties1" contextRef="AsOf2024-12-31" id="Fact001954" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,010</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td id="xdx_986_ecustom--NoncurrentAssetsOfRelatedParty1_iI_c20251231_zaOfHACm1eVj" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:NoncurrentAssetsOfRelatedParty1" contextRef="AsOf2025-12-31" id="Fact001956" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">216,469</ix:nonFraction> </td>
    <td id="xdx_98B_ecustom--NoncurrentAssetsOfRelatedParty1_iI_c20241231_zeVWYYse3vt6" title="Non-current assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:NoncurrentAssetsOfRelatedParty1" contextRef="AsOf2024-12-31" id="Fact001958" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">206,005</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b>Liabilities</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>

<tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Lease liabilities</td>
    <td id="xdx_984_ecustom--LeaseLiabilitiesRelatedPartyTransactions_iI_c20251231_zJkQvidvM5ek" title="Lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LeaseLiabilitiesRelatedPartyTransactions" contextRef="AsOf2025-12-31" id="Fact001960" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">260,790</ix:nonFraction> </td>
    <td id="xdx_981_ecustom--LeaseLiabilitiesRelatedPartyTransactions_iI_c20241231_zvIdrc1Y4JBd" title="Lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LeaseLiabilitiesRelatedPartyTransactions" contextRef="AsOf2024-12-31" id="Fact001962" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,703</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"/>
    <td id="xdx_989_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20251231_z0yllkSLA3X8" title="Total liabilities" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="AsOf2025-12-31" id="Fact001964" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">260,790</ix:nonFraction> </b></td>
    <td id="xdx_983_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20241231_z7cF2XbCkej4" title="Total liabilities" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="AsOf2024-12-31" id="Fact001966" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,703</ix:nonFraction></b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td id="xdx_98B_ecustom--TradeAndOtherCurrentPayableToRelatedParties_iI_c20251231_znJmzXxFyALj" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:TradeAndOtherCurrentPayableToRelatedParties" contextRef="AsOf2025-12-31" id="Fact001968" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,447</ix:nonFraction> </td>
    <td id="xdx_98D_ecustom--TradeAndOtherCurrentPayableToRelatedParties_iI_c20241231_zYhK5viCAll3" title="Current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:TradeAndOtherCurrentPayableToRelatedParties" contextRef="AsOf2024-12-31" id="Fact001970" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,610</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td id="xdx_989_ecustom--NoncurrenLliabilitiesOfRelatedParty1_iI_c20251231_z0zbCHbkPA66" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:NoncurrenLliabilitiesOfRelatedParty1" contextRef="AsOf2025-12-31" id="Fact001972" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">251,343</ix:nonFraction> </td>
    <td id="xdx_981_ecustom--NoncurrenLliabilitiesOfRelatedParty1_iI_c20241231_z11mbho9Cibh" title="Non-current liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:NoncurrenLliabilitiesOfRelatedParty1" contextRef="AsOf2024-12-31" id="Fact001974" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">236,093</ix:nonFraction></td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 204 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zTHcQZtS9VR3" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zgIy1XS3tTG8" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="vertical-align: bottom; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"/>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Income (expenses)</b></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">UEPC (i)</td>
    <td id="xdx_98C_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zL1iymVK0qcc" title="Other income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2025-01-012025-12-31_custom_UEPCMember" id="Fact001978" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">475</ix:nonFraction> </td>
    <td id="xdx_980_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zPhZU24bYjAj" title="Other income" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2024-01-012024-12-31_custom_UEPCMember" id="Fact001980" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">517</ix:nonFraction></td>
    <td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zUOjAfFZ9c1" title="Other income" style="vertical-align: top; text-align: right"><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2023-01-012023-12-31_custom_UEPCMember" id="Fact001982" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">465</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">EMIVE Patrulha 24 Horas Ltda. (iii)</td>
    <td id="xdx_98B_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zG7SxAT2mYNg" title="Other income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2025-01-012025-12-31_custom_EMIVEPatrulha24HorasLtdaMember" id="Fact001984" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7</ix:nonFraction>)</td>
    <td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_z9KswejRyaud" title="Other income" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2024-01-012024-12-31_custom_EMIVEPatrulha24HorasLtdaMember" id="Fact001986" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7</ix:nonFraction>)</td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zHNhvahmJvy9" title="Other income" style="vertical-align: bottom; text-align: right">(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2023-01-012023-12-31_custom_EMIVEPatrulha24HorasLtdaMember" id="Fact001988" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Depreciation - Right-of-use assets </td>
    <td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zn3VHH6Zpobe" title="Other income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2025-01-012025-12-31_custom_DepreciationRightofuseAssetsMember" id="Fact001990" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,637</ix:nonFraction>)</td>
    <td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zH9NFlsVwDi1" title="Other income" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2024-01-012024-12-31_custom_DepreciationRightofuseAssetsMember" id="Fact001992" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,639</ix:nonFraction>)</td>
    <td id="xdx_984_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zMRoYtgh8d3i" title="Other income" style="vertical-align: bottom; text-align: right">(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2023-01-012023-12-31_custom_DepreciationRightofuseAssetsMember" id="Fact001994" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,801</ix:nonFraction>)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Lease liabilities interest</td>
    <td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_zaScWXa69oOg" title="Other income" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2025-01-012025-12-31_custom_LeaseLiabilitiesInterestMember" id="Fact001996" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">30,841</ix:nonFraction>)</td>
    <td id="xdx_986_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_z3YsduwcK7r2" title="Other income" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2024-01-012024-12-31_custom_LeaseLiabilitiesInterestMember" id="Fact001998" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">28,343</ix:nonFraction>)</td>
    <td id="xdx_988_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_zqDxN6HCkJp2" title="Other income" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right">(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2023-01-012023-12-31_custom_LeaseLiabilitiesInterestMember" id="Fact002000" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">25,676</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231_zCHGo0wkLxwj" title="Other income" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2025-01-01to2025-12-31" id="Fact002002" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">48,010</ix:nonFraction>) </b></td>
    <td id="xdx_980_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231_zGoNzzgHoj33" title="Other income" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2024-01-012024-12-31" id="Fact002004" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">42,472</ix:nonFraction>)</b></td>
    <td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231_z8612BcjTEr6" title="Other income" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right"><b>(<ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2023-01-012023-12-31" id="Fact002006" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">39,018</ix:nonFraction>)</b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to sales of educational content to UEPC.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to expenses reimbursed by Bertelsmann.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to amounts of expenses related to security services provided by a company of which
one of Afya&#8217;s main shareholders has significant influence.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A4_z2gOQkmxC0ni" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Lease agreements with RVL Esteves Gest&#227;o Imobili&#225;ria S.A.</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company has entered into lease agreements with RVL Esteves Gest&#227;o Imobili&#225;ria
S.A. (&#8220;RVL&#8221;), an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato Tavares Esteves is
an executive officer. The main lease agreements with RVL are described below:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On June 21, 2016, RVL entered into lease agreements, as amended on April 26, 2018, with
ITPAC Aragua&#237;na and ITPAC Porto, pursuant to which RVL agreed to lease campuses to those entities in the cities of Aragua&#237;na
and Porto Nacional, both located in the State of Tocantins. The lease agreements are adjustable in accordance with the provisions of each
lease agreement. The lease agreements are for an initial term of 20 years and are renewable for an additional <span id="xdx_90D_ecustom--OperatingLeaseTermOfContract_dtY_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_z18aDpYk1vy2" title="Lease term"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_LeaseAgreements1Member" format="ixt-sec:duryear" id="Fact002008" name="afya:OperatingLeaseTermOfContract">20</ix:nonNumeric></span> years subject to the
provisions of each lease agreement. The balance of lease liabilities as of December 31, 2025 was R$<span id="xdx_90E_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zwqavTAsQSu7" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002010" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">83,992</ix:nonFraction></span> (December 31, 2024: R$<span id="xdx_902_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zTZCYsV8hUVi" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002012" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">84,102</ix:nonFraction></span>)
and the amount paid during the year ended December 31, 2025 was R$<span id="xdx_905_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zkAjvVUtKL8h" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002014" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">13,926</ix:nonFraction></span> (December 31, 2024 and 2023: R$<span id="xdx_90C_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zD0jZIaWDeK7" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002016" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">13,453</ix:nonFraction></span> and R$<span id="xdx_906_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zDopean6Gxu3" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002018" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">13,254</ix:nonFraction></span>, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On September 6, 2018, RVL entered into a lease agreement with ITPAC Aragua&#237;na, pursuant
to which RVL agreed to lease to ITPAC Aragua&#237;na the new campus by RVL in the city of Palmas, State of Tocantins. The lease agreement
is for an amount equal to <span id="xdx_901_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20180905__20180906__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zW1JOjc4Umf4" title="Percentage of revenue"><ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="From2018-09-052018-09-06_custom_LeaseAgreements1Member_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002020" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></span>% of the monthly revenue of ITPAC until July 2024. From August 2024, the monthly amount should be equal to
the amount paid in the first semester of 2024 and thereafter adjusted annually by the inflation rate (IGP-M). The lease agreement is for
an initial term of 20 years and is renewable for an additional <span id="xdx_90B_ecustom--OperatingLeaseTermOfContract_dtY_c20180905__20180906__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_z9u4OIpFi1ll" title="Lease term"><ix:nonNumeric contextRef="From2018-09-052018-09-06_custom_LeaseAgreements1Member" format="ixt-sec:duryear" id="Fact002022" name="afya:OperatingLeaseTermOfContract">20</ix:nonNumeric></span> years. The balance of lease liabilities as of December 31, 2025 was
R$<span id="xdx_904_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z2rSgWn6a8Cc" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002024" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">65,328</ix:nonFraction></span> (December 31, 2024: R$<span id="xdx_901_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zOx7QIww8Vid" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002026" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">63,989</ix:nonFraction></span>) and the amount paid during the year ended December 31, 2025 was R$<span id="xdx_90E_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zUvp0YhZAZPj" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002028" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">8,881</ix:nonFraction></span> (December 31, 2024 and
2023: R$<span id="xdx_90C_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z5XsQKltyZv7" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002030" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">8,568</ix:nonFraction></span> and R$<span id="xdx_908_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zc1QPh4rcrLj" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002032" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">7,615</ix:nonFraction></span>, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On October 30, 2019, RVL entered into a lease agreement with IPTAN, pursuant to which RVL
agreed to lease to IPTAN the medical campus in the city of Santa In&#234;s, State of Maranh&#227;o. The lease agreement, as amended
on February 27, 2025 is for a monthly amount adjusted in accordance with the provisions of the lease agreement of:  <span id="xdx_90E_ecustom--DescriptionOfLeaseTerm_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zKDZ1ZaBaX2" title="Description of lease term"><ix:nonNumeric contextRef="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002034" name="afya:DescriptionOfLeaseTerm">(i) R$<span id="xdx_90B_eifrs-full--CashOutflowForLeases_pn3n3_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z11GCfgnWhEd" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002036" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12</ix:nonFraction></span> until December
2020; (ii) from January 2021 to December 2025, 6.5% of the monthly revenue of IPTAN during the prior semester; (iii) from January 2026,
the monthly amount should be equal to the amount paid in the second semester of 2025; and (iv) from January 2027 thereon, the monthly
amount should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years and is renewable for an
additional 20 years.</ix:nonNumeric></span> The balance of lease liabilities as of December 31, 2025 was R$<span id="xdx_903_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z921QnCIOcze" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002038" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">15,962</ix:nonFraction></span> (December 31, 2024: R$<span id="xdx_90D_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zNDIDHfTQmU7" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002040" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">9,743</ix:nonFraction></span>) and the amount
paid during the year ended December 31, 2025 was R$<span id="xdx_90B_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zSps5Q93wVR5" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002042" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">2,136</ix:nonFraction></span> (December 31, 2024 and 2023: R$<span id="xdx_90F_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zrKY7JAfMEz7" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002044" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,338</ix:nonFraction></span> and R$<span id="xdx_907_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zQaHMebfeIHk" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002046" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,111</ix:nonFraction></span>, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On August 2, 2021, RVL entered into a lease agreement with ITPAC Aragua&#237;na, pursuant
to which RVL agreed to lease to ITPAC the new ITPAC Garanhuns medical campus, in the city of Garanhuns, State of Pernambuco. The lease
agreement is for a monthly amount equal to: <span id="xdx_902_ecustom--DescriptionOfLeaseTerm_c20210728__20210802__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z3vEc4kvXhce" title="Description of lease term"><ix:nonNumeric contextRef="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002048" name="afya:DescriptionOfLeaseTerm">(i) up to June 2022, R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20210728__20210802__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zeAZw73sx9e6" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002050" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40</ix:nonFraction></span>; (ii) from July 2022 until December 2028, 6.5% of the monthly revenue
of ITPAC Garanhuns during the prior semester, adjusted in accordance with the provisions of the lease agreement; and (iii) from January
2029 on, the monthly amount should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years.</ix:nonNumeric></span> The
balance of lease liabilities as of December 31, 2025 was R$<span id="xdx_907_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z2f0B16WFPX" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002052" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">26,326</ix:nonFraction></span> (December 31, 2024: R$<span id="xdx_902_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zY9gMZ7ExpQ3" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002054" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">17,556</ix:nonFraction></span>) and the amount paid during the year ended
December 31, 2025 was R$<span id="xdx_90C_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zGxeTGIg3zka" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002056" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">3,664</ix:nonFraction></span> (December 31, 2024 and 2023: R$<span id="xdx_905_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zLSRmu06o4Y3" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002058" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">2,199</ix:nonFraction></span> and R$<span id="xdx_906_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_ztLJKl7iMldf" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002060" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,159</ix:nonFraction></span>, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 205 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On May 2, 2024, RVL entered into a rent agreement with IPTAN, pursuant to which RVL agreed
to rent to IPTAN a property for the campus in the city of S&#227;o Jo&#227;o del Rei, State of Minas Gerais. <span id="xdx_900_ecustom--DescriptionOfLeaseTerm_c20240501__20240502__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_ztbWE3yytBu7" title="Description of lease term"><ix:nonNumeric contextRef="From2024-05-012024-05-02_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002062" name="afya:DescriptionOfLeaseTerm">The rent agreement is
for a monthly amount payable equal to R$4, adjusted annually by the inflation rate (IGP-M). The rent agreement is for a term of one year
and is renewable for an additional term of three years.</ix:nonNumeric></span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On June 14, 2024, RVL entered into a lease agreement with DelRey, pursuant to which RVL
agreed to lease to DelRey a property for the campus in the city of Jaboat&#227;o dos Guararapes, State of Pernambuco. <span id="xdx_90B_ecustom--DescriptionOfLeaseTerm_c20240713__20240714__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zmMGMHP3KyQg" title="Description of lease term"><ix:nonNumeric contextRef="From2024-07-132024-07-14_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002064" name="afya:DescriptionOfLeaseTerm">The lease agreement
is for a monthly amount payable equal to R$114.5, with a grace period of 12 months, extended by an additional six months. The monthly
amount payable should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years.</ix:nonNumeric></span> The balance of
lease liabilities as of December 31, 2025 was R$<span id="xdx_90C_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z8I0pNRZTFMe" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements5Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002066" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">10,905</ix:nonFraction></span> (December 31, 2024: R$<span id="xdx_909_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zzRUYKHAWI88" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements5Member_custom_RVLEstevesGestaoImobiliariaSAMember" id="Fact002068" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">9,383</ix:nonFraction></span>) and due to the grace period no payments were made
during the years ended December 31, 2025 and 2024.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Lease agreement with UNIVA&#199;O Patrimonial Ltda.</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On July 14, 2016, UNIVA&#199;O Patrimonial Ltda., an entity controlled by the shareholder
Nicolau Carvalho Esteves and of which Ms. Ros&#226;ngela de Oliveira Tavares Esteves is the chief executive officer, entered into a lease
agreement with UNIVA&#199;O, a subsidiary of Afya Brazil, pursuant to which UNIVA&#199;O Patrimonial Ltda. agreed to lease UNIVA&#199;O&#8217;s
campus to UNIVA&#199;O, located in the city of Ipatinga, State of Minas Gerais. The lease agreement is adjustable in accordance with
the provisions of the lease agreement. The lease agreement is for an initial term of <span id="xdx_90A_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zpr6HtkGPjNb" title="Renewal term"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" format="ixt-sec:duryear" id="Fact002070" name="afya:LesseeFinancesLeaseRenewalTerm">20</ix:nonNumeric></span> years and is renewable for an additional 20 years
subject to the provisions of the lease agreement. The balance of lease liabilities as of December 31, 2025 was R$<span id="xdx_908_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zWRAUk5rgnX4" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_custom_LeaseAgreements5Member_custom_UNIVACOPatrimonialLtdaMember" id="Fact002072" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">22,802</ix:nonFraction></span> (December 31,
2024: R$<span id="xdx_902_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zRMUkIQOpgv2" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_custom_LeaseAgreements5Member_custom_UNIVACOPatrimonialLtdaMember" id="Fact002074" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">22,818</ix:nonFraction></span>) and the amount paid during the year ended December 31, 2025 was R$<span id="xdx_905_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zFrsq2wNJqmk" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2025-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" id="Fact002076" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">3,752</ix:nonFraction></span> (December 31, 2024 and 2023: R$<span id="xdx_900_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zZ38bTqN4Rve" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2024-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" id="Fact002078" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">3,633</ix:nonFraction></span> and R$<span id="xdx_909_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_z1Gd1zg7RArl" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2023-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" id="Fact002080" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">3,582</ix:nonFraction></span>,
respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Lease agreement with IESVAP Patrimonial Ltda.</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On April 25, 2018, IESVAP Patrimonial Ltda., an entity controlled by the shareholder Nicolau
Carvalho Esteves and of which Mr. Renato Tavares Esteves is an executive officer, entered into a lease agreement with IESVAP, a subsidiary
of Afya Brazil, pursuant to which IESVAP Patrimonial Ltda. agreed to lease IESVAP&#8217;s campus to IESVAP located in the city of Parna&#237;ba,
State of Piau&#237;. <span id="xdx_908_ecustom--DescriptionOfLeaseTerms_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zS9BI4FxUHR" title="Description of lease term"><ix:nonNumeric contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" id="Fact002082" name="afya:DescriptionOfLeaseTerms">The lease agreement is for an amount equal to 7.5% of the monthly revenue of IESVAP until June 2021. From July
2021, the monthly amount should be equal to the amount paid in the first semester of 2021 and thereafter adjusted annually by the inflation
rate (IGP-M). The lease agreement is for an initial term of <span id="xdx_909_ecustom--OperatingLeaseTermOfContract_dtY_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zOGam0FTaaTb" title="Lease term"><ix:nonNumeric contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" format="ixt-sec:duryear" id="Fact002084" name="afya:OperatingLeaseTermOfContract">20</ix:nonNumeric></span> years and is renewable for an additional <span id="xdx_903_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zL6wyCyX8Q1j" title="Renewal term"><ix:nonNumeric contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" format="ixt-sec:duryear" id="Fact002086" name="afya:LesseeFinancesLeaseRenewalTerm">20</ix:nonNumeric></span> years subject to the provisions
of the lease agreement.</ix:nonNumeric></span> The balance of lease liabilities as of December 31, 2025 was R$<span id="xdx_902_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zPMqZvolffv6" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_custom_LeaseAgreements5Member_custom_IESVAPPatrimonialLtdaMember" id="Fact002088" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">35,475</ix:nonFraction></span> (December 31, 2024: R$<span id="xdx_908_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zwOGoS7KJE32" title="Lease liabilities"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_custom_LeaseAgreements5Member_custom_IESVAPPatrimonialLtdaMember" id="Fact002090" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">35,112</ix:nonFraction></span>) and the amount
paid during the year ended December 31, 2025 was R$<span id="xdx_900_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zFnxWL9REuR8" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2025-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" id="Fact002092" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">5,435</ix:nonFraction></span> (December 31, 2024 and 2023: R$<span id="xdx_90A_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zviisOkBSxN3" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2024-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" id="Fact002094" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">5,244</ix:nonFraction></span> and R$<span id="xdx_908_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_z9gNmPx9VKde" title="Related parties amount paid"><ix:nonFraction name="afya:RelatedPartiesAmountPaid" contextRef="AsOf2023-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" id="Fact002096" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">5,170</ix:nonFraction></span>, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Other related parties transactions</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The commercial notes issued by Afya Brazil on October 15, 2025 are guaranteed by the following
subsidiaries: Unigranrio, IESP and DelRey. See note 12.2.1.<br/>
</p>


<ix:exclude><!-- Field: Page; Sequence: 206 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Key management personnel compensation</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Key management personnel compensation included in the Company&#8217;s consolidated statement
of income and other comprehensive income comprised the following:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact002098" name="afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89E_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_pn3n3_zSdZMQ3s2431" summary="xdx: Disclosure - Related parties (Details 1)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BF_zVDQmnRApgib" style="display: none">Schedule of key management personnel compensation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Short-term employee benefits</td>
    <td id="xdx_98F_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20250101__20251231_zUGipzHxacB6" title="Short-term employee benefits" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="From2025-01-01to2025-12-31" id="Fact002100" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,160</ix:nonFraction> </td>
    <td id="xdx_983_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20240101__20241231_zwpKDE5fcGMe" title="Short-term employee benefits" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="From2024-01-012024-12-31" id="Fact002102" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,171</ix:nonFraction></td>
    <td id="xdx_98D_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20230101__20231231_zimm1I97VvVe" title="Short-term employee benefits" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="From2023-01-012023-12-31" id="Fact002104" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,979</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Share-based compensation plans</td>
    <td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20250101__20251231_z9zmnHRlOo35" title="Share-based compensation plans" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="From2025-01-01to2025-12-31" id="Fact002106" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,193</ix:nonFraction> </td>
    <td id="xdx_980_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20240101__20241231_zw835p9umPS5" title="Share-based compensation plans" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="From2024-01-012024-12-31" id="Fact002108" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,884</ix:nonFraction></td>
    <td id="xdx_98F_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20230101__20231231_zEedeEiPK7rd" title="Share-based compensation plans" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="From2023-01-012023-12-31" id="Fact002110" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,380</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_986_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20250101__20251231_zZHuN0dn7xn9" title="Total" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" contextRef="From2025-01-01to2025-12-31" id="Fact002112" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,353</ix:nonFraction> </b></td>
    <td id="xdx_98C_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20240101__20241231_zs5gTLuUXA73" title="Total" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" contextRef="From2024-01-012024-12-31" id="Fact002114" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,055</ix:nonFraction></b></td>
    <td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20230101__20231231_ztGiYD60Jr8f" title="Total" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" contextRef="From2023-01-012023-12-31" id="Fact002116" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,359</ix:nonFraction></b></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AB_zsXZ99BZooYl" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Compensation of the Company&#8217;s key management includes short-term employee benefits
comprised by salaries, labor and social obligations, and other ordinary short-term employee benefits. The amounts disclosed in the table
above are the amounts recognized as an expense in selling, general and administrative expenses during the reporting period related to
key management personnel. See Note 14 for additional information on the share-based compensation plans.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact002118" name="afya:DisclosureOfOtherAssetExplanatory"><p id="xdx_807_ecustom--DisclosureOfOtherAssetExplanatory_zyad0Pv4S4t3" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">8</td><td><span id="xdx_82E_z05LDXo3Qedi">Other assets</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact002120" name="afya:DisclosureOfOtherAssetsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_88F_ecustom--DisclosureOfOtherAssetsTableTextBlock_zs4DIcva5abd" summary="xdx: Disclosure - Other assets (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B9_z2OLv3BVLdci" style="display: none">Schedule of other assets</span></td>
    <td id="xdx_496_20251231_z5Phrdv9OPHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20241231_zOunPAkIrkA2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"/>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_maAzYGA_zJf8wnMyui84" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Indemnification assets - Note 21</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2025-12-31" id="Fact002122" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,379</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2024-12-31" id="Fact002123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">78,701</ix:nonFraction> </td></tr>
  <tr id="xdx_40D_ecustom--Advances1_iI_pn3n3_maAzYGA_z9LcLSTsnUC6" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Advances</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:Advances1" contextRef="AsOf2025-12-31" id="Fact002125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,205</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:Advances1" contextRef="AsOf2024-12-31" id="Fact002126" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,140</ix:nonFraction> </td></tr>
  <tr id="xdx_40D_ecustom--JudicialDeposits_iI_pn3n3_maAzYGA_z37fgIEFt25g" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Judicial deposits</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:JudicialDeposits" contextRef="AsOf2025-12-31" id="Fact002128" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,274</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:JudicialDeposits" contextRef="AsOf2024-12-31" id="Fact002129" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,938</ix:nonFraction> </td></tr>
  <tr id="xdx_403_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_maAzYGA_zuYRrDVzn6Rf" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Prepaid expenses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentPrepaidExpenses" contextRef="AsOf2025-12-31" id="Fact002131" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,070</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentPrepaidExpenses" contextRef="AsOf2024-12-31" id="Fact002132" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,761</ix:nonFraction> </td></tr>
  <tr id="xdx_40E_eifrs-full--OtherReceivables_iI_pn3n3_maAzYGA_zr0xWqywJhd" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Other FIES credits</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherReceivables" contextRef="AsOf2025-12-31" id="Fact002134" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,866</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherReceivables" contextRef="AsOf2024-12-31" id="Fact002135" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,982</ix:nonFraction> </td></tr>
  <tr id="xdx_404_ecustom--ConvertibleLoansFromVentureCapitalInvestments_iI_pn3n3_maAzYGA_zEs4LIJs7uS5" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Convertible loans from venture capital investments</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:ConvertibleLoansFromVentureCapitalInvestments" contextRef="AsOf2025-12-31" id="Fact002137" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,240</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:ConvertibleLoansFromVentureCapitalInvestments" contextRef="AsOf2024-12-31" id="Fact002138" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,724</ix:nonFraction></td></tr>
  <tr id="xdx_40F_ecustom--Dividend_iI_pn3n3_maAzYGA_zqF8wrlD3Mwe" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Dividends</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:Dividend" contextRef="AsOf2025-12-31" id="Fact002140" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,287</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:Dividend" contextRef="AsOf2024-12-31" id="Fact002141" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,628</ix:nonFraction></td></tr>
  <tr id="xdx_40E_ecustom--OtherAssets1_iI_pn3n3_maAzYGA_zGpqXbPOVXr9" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Other assets</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:OtherAssets1" contextRef="AsOf2025-12-31" id="Fact002143" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,106</ix:nonFraction> </td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:OtherAssets1" contextRef="AsOf2024-12-31" id="Fact002144" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,146</ix:nonFraction> </td></tr>
  <tr id="xdx_403_ecustom--Assets1_iTI_pn3n3_mtAzYGA_zfPANBEkonz1" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Total</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:Assets1" contextRef="AsOf2025-12-31" id="Fact002146" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">188,427</ix:nonFraction> </b></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:Assets1" contextRef="AsOf2024-12-31" id="Fact002147" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">173,020</ix:nonFraction> </b></td></tr>
  <tr id="xdx_40C_ecustom--CurrentAssets1_iI_pn3n3_zhfzmgJcCBW3" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:CurrentAssets1" contextRef="AsOf2025-12-31" id="Fact002149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,947</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:CurrentAssets1" contextRef="AsOf2024-12-31" id="Fact002150" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,145</ix:nonFraction> </td></tr>
  <tr id="xdx_409_ecustom--NoncurrentAssets1_iI_pn3n3_zRVQVZ1akpgl" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:NoncurrentAssets1" contextRef="AsOf2025-12-31" id="Fact002152" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">125,480</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:NoncurrentAssets1" contextRef="AsOf2024-12-31" id="Fact002153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">115,875</ix:nonFraction> </td></tr>
  </table></ix:nonNumeric>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact002155" name="ifrs-full:DisclosureOfJointVenturesExplanatory"><p id="xdx_80F_eifrs-full--DisclosureOfJointVenturesExplanatory_zOoU0SjIpNdg" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">9</td><td><span id="xdx_825_zPMTXbigJ7X4">Investment in associate</span></td></tr></table>

<p style="font: 10.5pt/107% Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company holds a 30% interest in UEPC, a medical school located in the Federal District
that offers higher education and post-graduate courses, both in person and long-distance learning. The Company&#8217;s interest in UEPC
is accounted for using the equity method. The tables below summarize the financial information of the Company&#8217;s investment in UEPC:</p>

<p style="font: 10.5pt/107% Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact002157" name="afya:DisclosureOfInvestmentsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_89D_ecustom--DisclosureOfInvestmentsExplanatory_z2kl9Rn7rje3" summary="xdx: Disclosure - Investment in associate (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span id="xdx_8B4_zu4Qt0g6a225" style="display: none">Schedule of investment</span></td>
    <td id="xdx_49D_20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zqnkoJsbamWi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_499_20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zoYlHItEqeUa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; width: 66%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"/>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentAssets_iI_pn3n3" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Current assets</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember" id="Fact002159" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,686</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember" id="Fact002160" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,122</ix:nonFraction> </td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentAssets_iI_pn3n3" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Non-current assets</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember" id="Fact002162" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">118,550</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember" id="Fact002163" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">116,846</ix:nonFraction> </td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentLiabilities_iNI_pn3n3_di_zeESBECtqTxg" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Current liabilities</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember" id="Fact002165" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,726</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember" id="Fact002166" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,049</ix:nonFraction>)</td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentLiabilities_iNI_pn3n3_di_z9Ws8PULOF6c" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Non-current liabilities</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember" id="Fact002168" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">90,394</ix:nonFraction>)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember" id="Fact002169" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,388</ix:nonFraction>)</td></tr>
  <tr id="xdx_409_ecustom--EquityInAssociate_iI_pn3n3_z8a91wCu2QX7" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Equity</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:EquityInAssociate" contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember" id="Fact002171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,116</ix:nonFraction> </b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:EquityInAssociate" contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember" id="Fact002172" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,531</ix:nonFraction> </b></td></tr>
  <tr id="xdx_40D_ecustom--CompanyShareInEquity1_iI_pn3n3_zn9naorrrbg3" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Company&#8217;s share in equity - 30%</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:CompanyShareInEquity1" contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember" id="Fact002174" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,335</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:CompanyShareInEquity1" contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember" id="Fact002175" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,259</ix:nonFraction> </td></tr>
  <tr id="xdx_40D_eifrs-full--Goodwill_iI_pn3n3" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Goodwill</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember" id="Fact002177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,183</ix:nonFraction> </td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember" id="Fact002178" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,183</ix:nonFraction> </td></tr>
  <tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_pn3n3_z8PBUEqnbSYf" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Carrying amount of the investment</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:InvestmentGrossAmount" contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember" id="Fact002180" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,518</ix:nonFraction> </b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:InvestmentGrossAmount" contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember" id="Fact002181" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,442</ix:nonFraction> </b></td></tr>
  </table>
<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td id="xdx_490_20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zI5Jr6SexoG3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_495_20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zYbtKW3cmkSh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_493_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zuoGhFuBU248" style="vertical-align: top; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"/>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--Revenue_pn3n3_z0y1XeNYNJvg" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Revenue</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">167,525</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002184" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">156,984</ix:nonFraction> </td>
    <td style="vertical-align: top; text-align: right"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002185" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">148,042</ix:nonFraction></td></tr>
  <tr id="xdx_40A_eifrs-full--CostOfSales_iN_pn3n3_di_zvnmvssAItbj" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Cost of services</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002187" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">79,116</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002188" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,898</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002189" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,282</ix:nonFraction>)</td></tr>
  <tr id="xdx_407_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_zNZSVOTFmAb2" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Selling, general and administrative expenses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002191" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,587</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002192" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,755</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002193" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,646</ix:nonFraction>)</td></tr>
  <tr id="xdx_403_ecustom--AllowanceForExpectedCreditLosses_pn3n3_zipcwdcIRnQl" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Allowance for expected credit losses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">445</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002196" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,587</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002197" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,029</ix:nonFraction>)</td></tr>
  <tr id="xdx_403_eifrs-full--OtherIncome_pn3n3_zfDVkaSx4Dc" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Other income</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherIncome" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002199" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">660</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherIncome" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002200" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">212</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right"><ix:nonFraction name="ifrs-full:OtherIncome" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002201" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">179</ix:nonFraction></td></tr>
  <tr id="xdx_401_ecustom--OtherExpense_pn3n3_zon92aCxS0xk" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Other expenses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:OtherExpense" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002203" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,111</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:OtherExpense" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002204" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,326</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right">(<ix:nonFraction name="afya:OtherExpense" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002205" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,709</ix:nonFraction>)</td></tr>
  <tr id="xdx_403_eifrs-full--FinanceIncome_iN_pn3n3_di_z4Jea73MIVnj" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Net finance result</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,298</ix:nonFraction>)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002208" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,946</ix:nonFraction>)</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">(<ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002209" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,123</ix:nonFraction>)</td></tr>
  <tr id="xdx_40F_eifrs-full--ProfitLossBeforeTax_pn3n3_zOwU9iG5Uyye" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Income before income taxes</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002211" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,518</ix:nonFraction> </b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002212" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,684</ix:nonFraction> </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002213" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,432</ix:nonFraction></b></td></tr>
  <tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_z2zaWivufW39" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Income taxes expenses</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002215" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,132</ix:nonFraction>)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002216" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,560</ix:nonFraction>)</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002217" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,782</ix:nonFraction>)</td></tr>
  <tr id="xdx_40A_eifrs-full--ProfitLoss_pn3n3_z4YLUkPW6hGg" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><b>Net income</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002219" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,386</ix:nonFraction> </b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002220" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,124</ix:nonFraction> </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002221" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,650</ix:nonFraction></b></td></tr>

<tr id="xdx_40C_ecustom--CompanyShareOfProfitss_pn3n3_zjD6sH1bfuUh" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><b>Company&#8217;s share of profit, net of tax</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:CompanyShareOfProfitss" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002223" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,916</ix:nonFraction> </b></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:CompanyShareOfProfitss" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002224" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,737</ix:nonFraction> </b></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; text-align: right"><b><ix:nonFraction name="afya:CompanyShareOfProfitss" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002225" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,495</ix:nonFraction></b></td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 207 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_z6MVU4DUWCNb" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zzAj6TRFnAHc" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The movements during the years ended December 31, 2025, 2024 and 2023 are shown below:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td id="xdx_49F_20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zAMonWbLKNGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49F_20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z0s46PoweWoi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49F_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zHosBaAYOWSg" style="vertical-align: top; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"/>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iS_pn3n3_zXpeuV7ysMNc" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Opening balance</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember" id="Fact002229" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,442</ix:nonFraction> </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember" id="Fact002230" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,834</ix:nonFraction></b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002231" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,907</ix:nonFraction></b></td></tr>
  <tr id="xdx_408_eifrs-full--ProfitLossOfAcquiree_pn3n3_zXx3YD2pFwbd" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Share of profit, net of tax</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:ProfitLossOfAcquiree" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002233" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,916</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:ProfitLossOfAcquiree" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002234" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,737</ix:nonFraction></td>
    <td style="vertical-align: top; text-align: right"><ix:nonFraction name="ifrs-full:ProfitLossOfAcquiree" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002235" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,495</ix:nonFraction></td></tr>
  <tr id="xdx_402_ecustom--DividendsReceived1_iS_pn3n3_zgcnlOOMLMXf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Dividends received</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DividendsReceived1" contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember" id="Fact002237" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">15,553</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DividendsReceived1" contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember" id="Fact002238" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,501</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right">(<ix:nonFraction name="afya:DividendsReceived1" contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember" id="Fact002239" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,900</ix:nonFraction>)</td></tr>
  <tr id="xdx_40C_eifrs-full--DividendsReceived_iN_pn3n3_di_zt8IrViKEAWl" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Dividends receivable - Other assets</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember" id="Fact002241" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,287</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember" id="Fact002242" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,628</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right">(<ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember" id="Fact002243" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,668</ix:nonFraction>)</td></tr>
  <tr id="xdx_40E_eifrs-full--InvestmentsInAssociates_iE_pn3n3_zLBYCfm882Xc" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Closing balance</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember" id="Fact002245" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,518</ix:nonFraction> </b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember" id="Fact002246" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,442</ix:nonFraction></b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; text-align: right"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember" id="Fact002247" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,834</ix:nonFraction></b></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A3_zylqmbP66dXl" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company tests the recoverability of the carrying amount of the Company&#8217;s investment
in UEPC at least annually. As of December 31, 2025 and 2024, no impairment had to be recognized.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact002249" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory"><p id="xdx_80A_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zBp0ooUlKdij" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">10</td><td><span id="xdx_822_zbl70p2U4iAl">Property and equipment</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company assesses at each reporting date, whether there is an indication that a property
and equipment asset may be impaired. If any indication exists, the Company estimates the asset&#8217;s recoverable amount. There were
no impairment indicatives of property and equipment as of and for the years ended December 31, 2025, 2024 and 2023. The following table
shows the balances and movements in property and equipment during the years ended December 31, 2025, 2024 and 2023.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 208 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zdincnrzs2Ce" style="font: 8.5pt/107% Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact002252" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_89D_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_z0iSFzr0zwc" summary="xdx: Disclosure - Property and equipment (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BB_zmsYtSvRd34d" style="display: none">Schedule of detailed information about property, plant and
    equipment</span></td>
    <td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_zwYUrrhnbzh4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zxETs61Yb0ja" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BD_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zGe1upplAu79" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BF_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_znnKO0XEL8Oe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zAGJbXCv7eR5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zMbMf1OcmPn" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_zrAwjHBjQ5D3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zlmbygeONabc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zTdynmPJzWn2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B1_zmji0Ti1d7fh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Building</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Machinery and equipment</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 4%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Lands</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Vehicles</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Furniture and fixtures</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>IT equipment</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Library books</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Leasehold improvements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Construction in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Cost</span></b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_ziP1XOH45Ed6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of January 1, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002254" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">91,857</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002255" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,390</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="Fact002256" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002257" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,053</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002258" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">90,712</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002259" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,593</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002260" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,362</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002261" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">145,846</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002262" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">86,688</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002263" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">641,353</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zc2ZFEQDlYq8" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002265" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">96</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002266" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,071</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2267">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002268" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">776</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002269" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,914</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002270" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,135</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002271" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">985</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002272" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,409</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002274" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">118,435</ix:nonFraction></span></td></tr>
  <tr id="xdx_433_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zxIHAyZ8oJUa" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Business combination</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2276">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002277" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,729</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2278">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2279">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002280" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,384</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002281" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">734</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002282" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,329</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002283" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,741</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002284" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,980</ix:nonFraction></span></td></tr>
  <tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zvhrdeWTQZTh" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2287">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002288" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,411</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2289">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002290" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">475</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002291" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,443</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002292" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,979</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002293" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,788</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002294" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">286</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2295">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002296" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">27,382</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zAZY9kK1NL9l" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002298" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,279</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002299" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,202</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2300">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2301">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002302" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">708</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002303" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">327</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2304">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002305" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,098</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002306" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">110,198</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2307">-</span></span></td></tr>
  <tr id="xdx_431_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zJGAS6c2Q7y3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002309" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">93,232</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002310" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">119,981</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="Fact002311" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002312" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,354</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002313" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,859</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002314" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82,810</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002315" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,888</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002316" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">264,448</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002317" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,962</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002318" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">757,386</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_434_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_z6Fv5AGZJoh7" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002320" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,003</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002321" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,195</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2322">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002323" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">130</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002324" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,582</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002325" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,945</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002326" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,293</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002327" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,001</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002328" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,775</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002329" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">136,924</ix:nonFraction> </span></td></tr>
  <tr id="xdx_43B_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zrX5LI0H0eJj" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Business combination</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002331" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002332" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,528</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2333">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2334">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002335" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">289</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002336" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">736</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002337" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">372</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002338" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,782</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2339">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002340" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,709</ix:nonFraction></span></td></tr>
  <tr id="xdx_43B_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zV63u24LOlQa" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2342">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002343" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,071</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2344">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002345" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">42</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002346" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,050</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002347" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,154</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2348">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2349">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2350">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002351" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,317</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_435_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zfLlynfE5ZH3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002353" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,129</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002354" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">226</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2355">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2356">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002357" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">862</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002358" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">480</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2359">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002360" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,182</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002361" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">45,703</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2362">-</span></span></td></tr>
  <tr id="xdx_436_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zsPoJeuzZSc1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002364" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,366</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002365" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">149,407</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="Fact002366" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002367" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,442</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002368" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">124,818</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002369" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,817</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002370" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,553</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002371" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">309,413</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002372" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,034</ix:nonFraction> </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002373" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">889,702</ix:nonFraction> </b></span></td></tr>
  <tr id="xdx_432_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zTCKgONU2NJh" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">121</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002376" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,301</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2377">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2378">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002379" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,575</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002380" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,204</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002381" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,178</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002382" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,812</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002383" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,823</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002384" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">166,014</ix:nonFraction></span></td></tr>
  <tr id="xdx_436_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zD29JwIf9CAg" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2386">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2387">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2388">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002389" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">435</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002390" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,220</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002391" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,536</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002392" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">80</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002393" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,781</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002394" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002395" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,059</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_438_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zeGk2KRZ6wv3" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002397" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,015</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002398" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">275</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2399">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2400">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002401" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,110</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002402" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">754</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2403">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002404" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,018</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002405" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">55,664</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2406">-</span></span></td></tr>
  <tr id="xdx_43B_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zDQ3xGNwvJra" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025
</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002408" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,502</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002409" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">177,983</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="Fact002410" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002411" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,007</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002412" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,283</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002413" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">129,731</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002414" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,651</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002415" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">351,462</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002416" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">69,186</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002417" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,044,657</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Depreciation</span></b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_43C_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zDMPSvGf2xIk" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of January 1, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002419" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,751</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002420" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,630</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2421">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002422" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">288</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002423" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,349</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002424" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">21,837</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002425" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">22,888</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002426" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,099</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2427">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002428" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">99,266</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zTvC1GdZ3F58" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Depreciation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002430" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,242</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002431" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,900</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2432">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002433" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">325</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002434" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,556</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002435" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,286</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002436" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,327</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002437" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,271</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2438">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002439" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,907</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zKXWCylEBpyf" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002441" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">118</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002442" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,684</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2443">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002444" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002445" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,528</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002446" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,254</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002447" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,563</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002448" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">90</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2449">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002450" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,472</ix:nonFraction></span></td></tr>
  <tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z8613PIdGmRl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">&#160;Transfer </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002452" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">196</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002453" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2454">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2455">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2456">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002457" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2458">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002459" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">196</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2460">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2461">-</span></span></td></tr>
  <tr id="xdx_43F_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zkIY1XQdd3S2" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002463" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,679</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002464" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">28,843</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2465">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002466" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">198</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002467" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,377</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002468" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">26,872</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002469" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,652</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002470" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">44,476</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2471">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002472" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">148,701</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_431_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zkUgUvQzxGz5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Depreciation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002474" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,188</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002475" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,684</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2476">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002477" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">377</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002478" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,778</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002479" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,608</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002480" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,058</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002481" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,604</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2482">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002483" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">90,297</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_439_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zk3FgCiDsY4l" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2485">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002486" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,491</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2487">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002489" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,593</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002490" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,150</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2491">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002492" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">502</ix:nonFraction> </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2493">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002494" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,778</ix:nonFraction> </span></td></tr>
  <tr id="xdx_43F_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zfDGhv0Tsvo5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002496" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">95</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002497" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">74</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2498">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2499">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002500" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">482</ix:nonFraction> </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002501" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">165</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2502">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002503" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">148</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2504">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2505">-</span></span></td></tr>
  <tr id="xdx_43C_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zLDi6SY0Wsf7" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002507" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,962</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002508" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">45,110</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002510" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">137</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002511" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">28,080</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002512" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">41,495</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002513" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">21,710</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002514" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">80,726</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2515">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002516" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">231,220</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_439_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zcgAwGVCOnzi" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Depreciation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002518" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,962</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002519" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,197</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2520">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002521" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">304</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002522" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,989</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002523" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,514</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002524" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,002</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002525" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,981</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2526">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002527" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">109,949</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_437_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zsgrJ6fvsOTb" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2529">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002530" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">881</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2531">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002532" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">301</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002533" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,055</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002534" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,545</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002535" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002536" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,135</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2537">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WritOffOfPropertyPlantAndEquipment" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002538" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,997</ix:nonFraction></span></td></tr>
  <tr id="xdx_43D_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zM31Zgorr3V2" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025 </b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="Fact002540" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,924</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact002541" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">62,426</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2542">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact002543" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">140</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact002544" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">43,014</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact002545" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">60,464</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact002546" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,632</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002547" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">123,572</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2548">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="afya:PropertyPlantAndEquipments" contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002549" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">333,172</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Net book value</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025 </b></span></td>
    <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zeG5wi5ayLQa" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2025-12-31_ifrs-full_BuildingsMember" id="Fact002551" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">89,578</ix:nonFraction></b></span></td>
    <td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zsOXyka6mW4a" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2025-12-31_custom_MachineryAndEquipmentsMember" id="Fact002553" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">115,557</ix:nonFraction></b></span></td>
    <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zY2FmOitXgQ2" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2025-12-31_ifrs-full_LandMember" id="Fact002555" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction></b></span></td>
    <td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zdoofmCptOc6" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2025-12-31_ifrs-full_VehiclesMember" id="Fact002557" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">867</ix:nonFraction></b></span></td>
    <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zQR10epQM8s7" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2025-12-31_ifrs-full_FixturesAndFittingsMember" id="Fact002559" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,269</ix:nonFraction></b></span></td>
    <td id="xdx_980_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_z9xZJ7QBwI2i" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2025-12-31_custom_ItEquipmentMember" id="Fact002561" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">69,267</ix:nonFraction></b></span></td>
    <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zhF2penUNz8k" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2025-12-31_custom_LibraryBooksMember" id="Fact002563" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,019</ix:nonFraction></b></span></td>
    <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zgkfNhEEcjFj" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember" id="Fact002565" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">227,890</ix:nonFraction></b></span></td>
    <td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zixBfGBtVMs" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2025-12-31_ifrs-full_ConstructionInProgressMember" id="Fact002567" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">69,186</ix:nonFraction></b></span></td>
    <td id="xdx_981_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231_zWe9Kl7kpYZa" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2025-12-31" id="Fact002569" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">711,485</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td id="xdx_985_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zxr6OuWoMEOa" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2024-12-31_ifrs-full_BuildingsMember" id="Fact002571" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85,404</ix:nonFraction> </b></span></td>
    <td id="xdx_985_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zmKYfUYtsZCg" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2024-12-31_custom_MachineryAndEquipmentsMember" id="Fact002573" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">104,297</ix:nonFraction> </b></span></td>
    <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zrHyaTej3sbl" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2024-12-31_ifrs-full_LandMember" id="Fact002575" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction> </b></span></td>
    <td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zrJC1T37K4q5" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2024-12-31_ifrs-full_VehiclesMember" id="Fact002577" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,305</ix:nonFraction> </b></span></td>
    <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zXnnYLSXLhij" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2024-12-31_ifrs-full_FixturesAndFittingsMember" id="Fact002579" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">96,738</ix:nonFraction> </b></span></td>
    <td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zR2NHAMaeSW8" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2024-12-31_custom_ItEquipmentMember" id="Fact002581" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,322</ix:nonFraction> </b></span></td>
    <td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_z0Hmdv469jE7" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2024-12-31_custom_LibraryBooksMember" id="Fact002583" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,843</ix:nonFraction> </b></span></td>
    <td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zY1gVN2Ldra5" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember" id="Fact002585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">228,687</ix:nonFraction> </b></span></td>
    <td id="xdx_980_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zzwE8fr90lea" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2024-12-31_ifrs-full_ConstructionInProgressMember" id="Fact002587" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,034</ix:nonFraction> </b></span></td>
    <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_iI_pn3n3_c20241231_zFBp3Y48MZE4" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:PropertyPlantAndEquipmentNetBookValue" contextRef="AsOf2024-12-31" id="Fact002589" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">658,482</ix:nonFraction> </b></span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to items written-off as result of lack of expectation of future use, in connection
with the Company&#8217;s physical inventory procedures.<br/></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A3_zOmb2pHatcOa" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 209 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact002591" name="afya:DisclosureOfIntangibleAssetExplanatory"><p id="xdx_807_ecustom--DisclosureOfIntangibleAssetExplanatory_zZCogGIzmr5b" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">11</td><td><span id="xdx_824_zvEhTKl4hQO4">Intangible assets</span></td></tr></table>

<p style="font: 2pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact002593" name="afya:SummaryOfIntangibleAssetsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_pn3n3_z5ARI5S96bml" summary="xdx: Disclosure - Intangible assets (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span id="xdx_8B8_zbQK7cpU4OWc" style="display: none">Schedule of intangible assets</span></td>
    <td title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 26%; padding-right: 1.45pt; padding-left: 1.45pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Goodwill </b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Licenses with indefinite useful life </b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Trademarks</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Customer relationships</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 4%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Software</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Education content</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Developed technology</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Educational platform</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Intangible in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 3%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Cost</span></b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of January 1, 2023</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXLPeIQtsM0j" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002595" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,257,045</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zFOX7zHbajF6" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002597" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,189,814</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXiG8vaOGrc2" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002599" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">182,060</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKtBCdSmaYpf" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002601" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">435,816</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zm0zVDYvxPfk" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002603" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,300</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zBOZOPk1hfs2" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002605" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">69,589</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z538J1iaB7O" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002607" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">90,749</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTpnT5DIci02" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002609" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,697</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRk43MPMsoTk" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002611" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,734</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWuhPKyt0i9j" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember" id="Fact002613" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,055</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEFwp1scJDS9" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002615" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,339,859</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLm6yaMH5Lvi" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2617">-</span></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1acKodXCkdd" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002619" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,314</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeZgI413YVDb" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002621" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,827</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4NNN5rP0Ba2" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002623" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,712</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuT2Gema61o1" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002625" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,164</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zi72d0PnOjVj" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002627" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,976</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc3RGBSiUd13" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002629" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,993</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Business combination</span></td>
    <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOwaP2JuCcbl" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002631" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,098</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoYyj8VkSOc1" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002633" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">586,263</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLXR21ueOcQ1" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002635" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">142,451</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwWf0AjbTBwi" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002637" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQcEnD4rS7hc" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002639" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">803,875</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoubWbHH41c5" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002641" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,235</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_za2kjFiaY8l" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002643" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">911</ix:nonFraction>)</span></td>
    <td id="xdx_987_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWvFdsOWtpD4" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002645" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">125</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJSyR6VaMbOe" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002647" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,271</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Remeasurement</span></td>
    <td id="xdx_98F_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsxrWEmRbbV1" title="Remesurement" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:Remesurement" contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002649" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,556</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98B_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z85DLoAnPyQ3" title="Remesurement" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:Remesurement" contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002651" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,556</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_985_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4NPqnUPWUH1" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002653" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,708</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVXxidglRRz4" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002655" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,785</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8qJyc1xtFwh" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002657" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOS0dqxmxRFc" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002659" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,058</ix:nonFraction>)</span></td>
    <td id="xdx_982_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7NTfIGPWNb8" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002661" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">30,451</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zaqo0QY2kps3" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002663" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,334,699</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfxJxqyGbhz3" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002665" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,776,077</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztBLF0yqKg0b" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002667" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">182,060</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z0udGq4J3JAa" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002669" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">578,267</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEQnogXAkGDe" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002671" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,150</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjOmK4lkxRjj" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002673" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">84,201</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmEAXoBdOzr8" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002675" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,477</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXahYkGKXbz7" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002677" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,892</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9c518H1B2Va" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002679" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,134</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc2lF7k3PuV5" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember" id="Fact002681" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,055</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMDVqDU2iGm1" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002683" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,243,012</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztjhdsWZ48q8" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002685" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">157,227</ix:nonFraction> </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQlDIfLJIM6a" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002687" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,511</ix:nonFraction> </span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqbZN68Fi4y8" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002689" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,701</ix:nonFraction> </span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcDS77okDfBl" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002691" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,092</ix:nonFraction> </span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJu9NUY2xEGd" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002693" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,255</ix:nonFraction> </span></td>
    <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzKOOsfStq5g" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002695" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,905</ix:nonFraction> </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZoF9KE45jqe" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002697" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">255,691</ix:nonFraction> </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Business combination</span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfQdl7Jwzgw3" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002699" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">192,034</ix:nonFraction> </span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHVDzhdq1pNe" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002701" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">427,482</ix:nonFraction> </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMlmrwAU16dc" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002703" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,560</ix:nonFraction> </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9EHfwC2LrTc" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002705" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">654,076</ix:nonFraction> </span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcPYGpUE1o0i" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002707" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">162</ix:nonFraction>)</span></td>
    <td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9PfFHXweTEk" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002709" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">117</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zl3j076XfJK4" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2024-01-012024-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002711" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8Mv2dpzntel" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002713" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">280</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_985_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlHOF6DpxLtb" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:Transfer" contextRef="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002715" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,292</ix:nonFraction> </span></td>
    <td id="xdx_983_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzJoVPwrmJrg" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:Transfer" contextRef="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002717" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,529</ix:nonFraction> </span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zh19xklC10Tb" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002719" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">39,929</ix:nonFraction>)</span></td>
    <td id="xdx_987_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1UFQS37Pcqf" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:Transfer" contextRef="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002721" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,673</ix:nonFraction> </span></td>
    <td id="xdx_986_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zATgoRNwq5sl" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2024-01-012024-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002723" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">19,565</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">- </span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zb3aHgCRNrye" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002725" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,526,733</ix:nonFraction> </b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z17ghQiVjPjg" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002727" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,360,786</ix:nonFraction> </b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zBKcZE2Rpj53" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002729" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">182,060</ix:nonFraction> </b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgmBoSuzYDFf" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002731" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">612,827</ix:nonFraction> </b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwJuzxYIXXv6" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002733" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">95,953</ix:nonFraction> </b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbf7wynp3fL1" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002735" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,269</ix:nonFraction> </b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoAJz80cGnW" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002737" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">102,523</ix:nonFraction> </b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zYBe5VnFW6af" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002739" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">134,820</ix:nonFraction> </b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zStSTVvDiuci" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002741" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,473</ix:nonFraction> </b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJzINBZ8US78" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember" id="Fact002743" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,055</ix:nonFraction> </b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrGHdmExU3s1" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002745" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,152,499</ix:nonFraction> </b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1gXhZJJwTQk" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002747" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,629</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zC2DQJ1hye48" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002749" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">276</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziCp74Ym0P1g" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002751" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,106</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyqSVlv6c4a4" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002753" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,552</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znsldTmHMJB3" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,250</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1zq7Da0DoP6" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002757" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,184</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvDiA7GhU28a" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002759" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">237,997</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_987_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRoBitc7xpof" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2025-01-012025-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002761" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2</ix:nonFraction>)</span></td>
    <td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zK6tQVTsOeCh" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2025-01-012025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002763" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQBVVyqpIE79" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2025-01-012025-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002765" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">272</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98B_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1125lsjVCZ" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002767" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">275</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_984_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwigvmbJNV71" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002769" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">691</ix:nonFraction>)</span></td>
    <td id="xdx_98E_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zDsgfLvEn9gj" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:Transfer" contextRef="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002771" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,531</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_982_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxIUOxYSq4Ac" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2025-01-012025-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002773" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">30,840</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025 </b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCSO2MwUKmGc" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact002775" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,526,733</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXBXukM7Si5a" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002777" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,460,415</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrlbuzIIxTva" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="Fact002779" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">182,060</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxP1Cv7ilbc4" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002781" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">612,136</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2KRCBoSwERc" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact002783" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">127,760</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqSzVMOrOKU9" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="Fact002785" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">133,373</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztzZ8bD8cXgi" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact002787" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">112,074</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zueKPfDvCyta" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact002789" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">166,070</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEeNDdP180Gd" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact002791" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,545</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQD6ZUai0DGk" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember" id="Fact002793" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,055</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zO6i4Tn13dpf" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002795" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,390,221</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Amortization</span></b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of January 1, 2023</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zYP5nIncY082" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2797">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zY06G9LJ8yAg" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2799">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBDoezezxq1l" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002801" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,955</ix:nonFraction>)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQkIjkse9ysl" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002803" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">212,363</ix:nonFraction>)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW7vj3B3THai" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002805" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,277</ix:nonFraction>)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1GCgzhcZ8Md" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002807" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">26,562</ix:nonFraction>)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOj3SX448FQi" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002809" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,093</ix:nonFraction>)</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8DIqTkiqDQ3" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002811" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,039</ix:nonFraction>)</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zy5s5ZYBxOE5" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2813">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTobSyUDpKQ5" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002815" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">79</ix:nonFraction>)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zw90gvVfX1El" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002817" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">298,368</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Amortization</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iP2custom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlO12eFJin97" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2819">-</span></span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zmkKKzT8I246" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2820">-</span></span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBBvb2yiVbC6" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002822" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,083</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zf9dNrm5aD6" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002824" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">89,584</ix:nonFraction>)</span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdP8l9MJmfK4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002825" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,764</ix:nonFraction>)</span></td>
    <td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8qsWZrGGNMf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002826" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">15,668</ix:nonFraction>)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBw7BNTnTQse" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002827" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">21,504</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTVeMXJciksa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002828" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,778</ix:nonFraction>)</span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkgdoP3P6UTi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2829">-</span></span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbM05cUjXAOe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002830" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">105</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqfk7c9cA9Z1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002831" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">151,486</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zXkVRlhPqD7g" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002833" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,947</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98C_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdZ1AGTjIqf8" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002835" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">911</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuTk98HSDYrl" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002837" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,858</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSJ9B8tOxBZg" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002839" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6</ix:nonFraction>)</span></td>
    <td id="xdx_98C_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIcnETa8xG4j" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:Transfer" contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002841" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zogL1bEPU7Q6" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2843">-</span></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z3TdCOnevdi5" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2845">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJQMe1Vmsuy6" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002847" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">26,038</ix:nonFraction>)</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z2KdKRDAToZk" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002849" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">301,947</ix:nonFraction>)</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zC0PdwKOvAl2" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002851" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,094</ix:nonFraction>)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8NhawO5DETf" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002853" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">42,230</ix:nonFraction>)</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxI6CYmNBBH6" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002855" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,603</ix:nonFraction>)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDYt8xaMzdQl" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002857" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,900</ix:nonFraction>)</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zB0QQiBTu0c8" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2859">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z2FlyJZKNgRa" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002861" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">184</ix:nonFraction>)</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZ9WemNDEDp5" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002863" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">446,996</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Amortization</span></td>
    <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxQADNzeSNJ7" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2865">-</span></span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zdFVlUz1RTp" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2866">-</span></span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z6vXTtiDjli9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002867" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,506</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmeELLcXy9h2" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002869" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">82,737</ix:nonFraction>)</span></td>
    <td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRYP7teYB8Fc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002870" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">16,457</ix:nonFraction>)</span></td>
    <td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzb3VRTgCDEb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002871" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,471</ix:nonFraction>)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDmE22bjtVG2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002872" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,086</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0T7T3xjMxN1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002873" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">22,387</ix:nonFraction>)</span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zF1TXpcV88Xb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2874">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZdHGZ5jS2n3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002875" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">106</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbRKG3XwKIng" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002876" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">172,750</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zrhhb7cXjGKi" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002878" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1</ix:nonFraction> </span></td>
    <td id="xdx_980_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z94orvM2exJh" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002880" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35</ix:nonFraction> </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_982_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBpUjhUAYwvg" title="Write-off" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:WriteoffOfIntangibleAssets" contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002882" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36</ix:nonFraction> </span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zfH9vKCVYgCe" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002884" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,207</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zoNAO8Ra76o9" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:Transfer" contextRef="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,019</ix:nonFraction> </span></td>
    <td id="xdx_986_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLcvketNOqg5" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002888" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,812</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNDvx4SnwcA7" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2890">-</span></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zITgQVqqBX42" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2892">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQr2cbGD6Mrc" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002894" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">38,544</ix:nonFraction>)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCfKYmgkjX47" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002896" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">384,684</ix:nonFraction>)</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0XFTXoZ3WL2" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002898" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">41,758</ix:nonFraction>)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwEyeVQyIQRk" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002900" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">60,700</ix:nonFraction>)</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1FXIpGLvVi1" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002902" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">42,635</ix:nonFraction>)</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zEOHxS5kJnY9" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002904" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">51,099</ix:nonFraction>)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z87OPQbuD2k4" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2906">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLkLtp0lw4kl" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002908" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">290</ix:nonFraction>)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1Gr7mO0CPx1" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002910" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">619,710</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Amortization</span></td>
    <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zg4bLcJItUN" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2912">-</span></span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zaNZbwG209ej" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2913">-</span></span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkJPcQA6T482" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002914" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,127</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8hkuzEL0kBg" title="Amortization" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002916" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">74,558</ix:nonFraction>)</span></td>
    <td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZqD47VyYlf8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002917" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,739</ix:nonFraction>)</span></td>
    <td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3jPyx8i7WJ9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002918" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,782</ix:nonFraction>)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zH0YCZrzDDD4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002919" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">16,741</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAuPBKI7GXFg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002920" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">40,478</ix:nonFraction>)</span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwJatCByCWX5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2921">-</span></span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQe25GoaXQrf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002922" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">106</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx6DIftNvWb4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002923" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">182,531</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98B_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHrFDpbQAPb9" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:Transfer" contextRef="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002925" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">380</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zORSQxglt5jj" title="Transfer" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="afya:Transfer" contextRef="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002927" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">380</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025 </b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztwyObFlgmp8" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2929">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zEPBONrHsckg" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2931">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zpq8KeBM5JZ3" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002933" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">43,671</ix:nonFraction>)</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0dkzd4sZruf" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002935" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">458,862</ix:nonFraction>)</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLzE3zymcaq7" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002937" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">66,877</ix:nonFraction>)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFag1O74Nzfg" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002939" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">81,482</ix:nonFraction>)</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDDyIAi72Fzg" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002941" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">59,376</ix:nonFraction>)</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVzMp4NQzLI8" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002943" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">91,577</ix:nonFraction>)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zWgPducxjut3" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2945">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1SDazwakQV3" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002947" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">396</ix:nonFraction>)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHiImOtkL3tl" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact002949" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">802,241</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Net book value</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31,
2025 </b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zqVRzYslf44a" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2025-12-31_ifrs-full_GoodwillMember" id="Fact002951" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,526,733</ix:nonFraction></b></span></td>
    <td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember_fKGkp_zFWPpvAORBf7" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2025-12-31_ifrs-full_LicencesMember" id="Fact002953" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,460,415</ix:nonFraction></b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zPn41sbedv6e" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2025-12-31_ifrs-full_BrandNamesMember" id="Fact002955" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">138,389</ix:nonFraction></b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z6uJXjSySJAh" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember" id="Fact002957" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,274</ix:nonFraction></b></span></td>
    <td id="xdx_98D_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zMnoFw5Kvy9a" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember" id="Fact002959" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,883</ix:nonFraction></b></span></td>
    <td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zwmWWCxsL8Id" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2025-12-31_custom_EducationContentMember" id="Fact002961" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,891</ix:nonFraction></b></span></td>
    <td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zDhtbgWZQ0e5" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember" id="Fact002963" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">52,698</ix:nonFraction></b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zOkhLYjsxBM7" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2025-12-31_custom_EducationalPlatformMember" id="Fact002965" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,493</ix:nonFraction></b></span></td>
    <td id="xdx_98E_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zcgAemG6Nj6c" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2025-12-31_custom_SoftwareInProgressMember" id="Fact002967" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,545</ix:nonFraction></b></span></td>
    <td id="xdx_981_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zds1pQlwXZzg" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2025-12-31_custom_OtherMember" id="Fact002969" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">659</ix:nonFraction></b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231_z8TSfdEq2Tag" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2025-12-31" id="Fact002971" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,587,980</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td id="xdx_980_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zdHu71cTahh9" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2024-12-31_ifrs-full_GoodwillMember" id="Fact002973" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,526,733</ix:nonFraction> </b></span></td>
    <td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember_fKGkp_z9zb49RZSku9" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2024-12-31_ifrs-full_LicencesMember" id="Fact002975" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,360,786</ix:nonFraction> </b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_za3bVZPwfUCg" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2024-12-31_ifrs-full_BrandNamesMember" id="Fact002977" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">143,516</ix:nonFraction> </b></span></td>
    <td id="xdx_987_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z48SyNzg0I62" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember" id="Fact002979" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">228,143</ix:nonFraction> </b></span></td>
    <td id="xdx_981_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z0VsiO7VsXoj" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember" id="Fact002981" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,195</ix:nonFraction> </b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zZ1ZOINCttHf" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2024-12-31_custom_EducationContentMember" id="Fact002983" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47,569</ix:nonFraction> </b></span></td>
    <td id="xdx_988_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zffl72aSoBm" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember" id="Fact002985" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59,888</ix:nonFraction> </b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zNiQH2slMBal" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2024-12-31_custom_EducationalPlatformMember" id="Fact002987" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">83,721</ix:nonFraction> </b></span></td>
    <td id="xdx_98A_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zlJfmIk1fM5j" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2024-12-31_custom_SoftwareInProgressMember" id="Fact002989" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,473</ix:nonFraction> </b></span></td>
    <td id="xdx_98B_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zjL7DAkd7Lpg" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2024-12-31_custom_OtherMember" id="Fact002991" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">765</ix:nonFraction> </b></span></td>
    <td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231_zgLP4RfwF6ai" title="Net book value" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IntangibleAssetsAndGoodwillNetBookValue" contextRef="AsOf2024-12-31" id="Fact002993" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,532,789</ix:nonFraction> </b></span></td></tr>
  </table>
<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to intangible assets written-off as result of lack of expectation of future use.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A5_zWlY92wPs63f" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 210 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Impairment testing of goodwill and intangible assets with indefinite
lives</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Licenses with indefinite useful life include intangible assets acquired through business
combinations and asset acquisitions. The licenses for medicine and other courses granted by MEC have no expiration date and the Company
has determined that these assets have indefinite useful lives.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For impairment testing goodwill and licenses with indefinite useful lives are allocated
to the respective CGUs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company performed its annual impairment test on December 31, 2025, 2024 and 2023. There
was no impairment for goodwill and licenses with indefinite useful lives for the years then ended.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company tests at least annually the recoverability of the carrying amount of goodwill
and licenses with indefinite useful lives for each CGU. The Company determines the recoverable amount of its CGUs based on the value-in-use.
Estimating these values involves the use of assumptions, judgments and estimates of future cash flows that represent the Company's best
estimate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The carrying amounts of goodwill and licenses with indefinite useful life by CGU and their
carrying amount as of December 31, 2025 and 2024 were as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact002995" name="afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_898_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_pn3n3_zXK7x6SVyuU1" summary="xdx: Disclosure - Intangible assets (Details 1)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B8_zZmfXMrPkdi7" style="display: none">Schedule of assumptions for impairment test</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center; text-indent: 0in"><span style="font-family: Nunito Sans; font-size: 8.5pt"><b>Carrying amount</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Goodwill</b></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Licenses with indefinite useful life</b></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>CGU</b></td></tr>
  <tr>
    <td style="width: 34%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">IPTAN</td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zLrB5OMD7sV5" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" id="Fact002997" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,446</ix:nonFraction></td>
    <td id="xdx_983_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zDt7RsN1BkE5" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" id="Fact002999" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,446</ix:nonFraction></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zLW5R67wAzVd" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" id="Fact003001" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,214</ix:nonFraction></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zwRHZalhKJc5" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" id="Fact003003" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,214</ix:nonFraction></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z3wtcvKnPsLl" title="Cash generating units" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" id="Fact003005" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">142,155</ix:nonFraction></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zVI5Ae6xqBP1" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" id="Fact003007" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">122,599</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">IESVAP</td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z0nWsHxsKkkb" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" id="Fact003009" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,956</ix:nonFraction></td>
    <td id="xdx_98D_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_ziFbQLWq6fYl" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" id="Fact003011" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,956</ix:nonFraction></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zPE0X0sip0Q" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" id="Fact003013" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">81,366</ix:nonFraction></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zxKEic920uO5" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" id="Fact003015" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">81,366</ix:nonFraction></td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zbtlPVaBo5Hk" title="Cash generating units" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" id="Fact003017" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,552</ix:nonFraction></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zI7CJOaMvxug" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" id="Fact003019" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">126,195</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">CCSI</td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_znwGVY9UohJd" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" id="Fact003021" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,664</ix:nonFraction></td>
    <td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_ziWE0EqlkPj2" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" id="Fact003023" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,664</ix:nonFraction></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zKcrnZMYM846" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" id="Fact003025" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,737</ix:nonFraction></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zs5UjofA1ZW6" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" id="Fact003027" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,737</ix:nonFraction></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zcuZhJuYx5Uj" title="Cash generating units" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" id="Fact003029" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,782</ix:nonFraction></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zz5aEanJbdYl" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" id="Fact003031" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,377</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">IESP</td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zM53NWWrSifl" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="Fact003033" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">73,838</ix:nonFraction></td>
    <td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zQlZAqgiYTQk" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="Fact003035" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">73,838</ix:nonFraction></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zRdC660jkWJ5" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="Fact003037" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">179,693</ix:nonFraction></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z4oRW5PRZTI5" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="Fact003039" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">179,693</ix:nonFraction></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zX70F1g1pw41" title="Cash generating units" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="Fact003041" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">336,287</ix:nonFraction></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z5W6LhpCPeXf" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="Fact003043" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">322,900</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FADEP</td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zmoktumZ9jfd" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" id="Fact003045" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,661</ix:nonFraction></td>
    <td id="xdx_986_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zaM5WgaZkZli" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" id="Fact003047" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,661</ix:nonFraction></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zs72RDpER8Zb" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" id="Fact003049" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,606</ix:nonFraction></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zxyaKSp796E7" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" id="Fact003051" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,606</ix:nonFraction></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zQ97tvgX0Hk7" title="Cash generating units" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" id="Fact003053" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">143,096</ix:nonFraction></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zBNRhjibBCBd" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" id="Fact003055" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">141,201</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FASA</td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zFJUUyTbKv1i" title="Goodwill" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" id="Fact003057" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,903</ix:nonFraction></td>
    <td id="xdx_987_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zd1IANS1lGTb" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" id="Fact003059" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,903</ix:nonFraction></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zp3SvRS1yZx5" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" id="Fact003061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">144,507</ix:nonFraction></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zW9S0YzGLd28" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" id="Fact003063" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">144,507</ix:nonFraction></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zRNQeMtV8sib" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" id="Fact003065" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">350,392</ix:nonFraction></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zJgccVUODXP" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" id="Fact003067" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">341,020</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">IPEC</td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zouKxAM3HrMa" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3069">-</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_znCr213aC6V7" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3071">-</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z5Iee4ZH4Q44" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="Fact003073" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zU3N9CC340pf" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="Fact003075" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z40nLOpJzQ65" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="Fact003077" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">168,247</ix:nonFraction></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zbL58Wfy4fI" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="Fact003079" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">168,174</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">UniRedentor</td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z0kCGEiwFh3d" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" id="Fact003081" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,662</ix:nonFraction></td>
    <td id="xdx_98A_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zPE0SBofqkV9" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" id="Fact003083" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,662</ix:nonFraction></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zphoVAGGq236" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" id="Fact003085" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">121,477</ix:nonFraction></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zZGtZYlHQfTk" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" id="Fact003087" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">121,477</ix:nonFraction></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z7RBBsg9pzqi" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" id="Fact003089" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">251,332</ix:nonFraction></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zoQWRg9EQal7" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" id="Fact003091" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">244,123</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">UniSL</td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zSl9fJeQEHSd" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniSLMember" id="Fact003093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,420</ix:nonFraction></td>
    <td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zUd40Bo4iKHi" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniSLMember" id="Fact003095" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,420</ix:nonFraction></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zz7Arkd5ami4" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniSLMember" id="Fact003097" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">273,795</ix:nonFraction></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zEvKK3bFJkLk" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniSLMember" id="Fact003099" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">273,795</ix:nonFraction></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z7EiUzT0zrDg" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniSLMember" id="Fact003101" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">401,911</ix:nonFraction></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z7eUkaeWXQv1" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniSLMember" id="Fact003103" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,889</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FESAR</td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zFwDxUkEufu8" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FESARMember" id="Fact003105" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,664</ix:nonFraction></td>
    <td id="xdx_981_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zno61gFLc00j" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FESARMember" id="Fact003107" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,664</ix:nonFraction></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zgL0K5E9Hfg9" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FESARMember" id="Fact003109" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">141,616</ix:nonFraction></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z3buY0VrOoOf" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FESARMember" id="Fact003111" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">141,616</ix:nonFraction></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_ziwVZLLUnFae" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FESARMember" id="Fact003113" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">248,037</ix:nonFraction></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zW4R3D4qPy7e" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FESARMember" id="Fact003115" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">246,385</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FCMPB</td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z2xfWn7gwwX1" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" id="Fact003117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,483</ix:nonFraction></td>
    <td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zQ6kQq6axnx6" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" id="Fact003119" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,483</ix:nonFraction></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_ziqF1qLPuDa3" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" id="Fact003121" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235,018</ix:nonFraction></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zXUXrAXTIpZa" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" id="Fact003123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235,018</ix:nonFraction></td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zAAPL9otdGac" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" id="Fact003125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">404,039</ix:nonFraction></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zU4uYngo4Ewd" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" id="Fact003127" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">392,862</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">ITPAC Garanhuns</td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z5VPFpHeGN4" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3129">-</span></td>
    <td id="xdx_98F_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zxRErLaJd2i" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3131">-</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zMKAf0CRw4ec" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember" id="Fact003133" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zmqdAjGn3z17" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember" id="Fact003135" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zmRhEVgb6oPl" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember" id="Fact003137" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">150,489</ix:nonFraction></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z4tm76TsTyrc" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember" id="Fact003139" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">129,458</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Continuing education (i)</td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z1FLiw9D5sql" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember" id="Fact003141" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">267,477</ix:nonFraction></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zdo8qakBz9l8" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember" id="Fact003143" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">267,477</ix:nonFraction></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zTHkeLlLA886" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3145">-</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z82UJjx0TCm7" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3147">-</span></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z9xhQ62Qsbba" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember" id="Fact003149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">574,048</ix:nonFraction></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zuk1ldNwFzZe" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember" id="Fact003151" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">542,354</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Medical practice solutions (i)</td>
    <td id="xdx_986_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zr0Zz8t2bYUc" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember" id="Fact003153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">238,477</ix:nonFraction></td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zaZy1j5XZoNa" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember" id="Fact003155" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">238,477</ix:nonFraction></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_z65NhKzCfiZ2" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3157">-</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zSGno3FZNjpg" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3159">-</span></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zHJyTIJnXBG5" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember" id="Fact003161" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">373,954</ix:nonFraction></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zGVRhnhKqW66" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember" id="Fact003163" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">411,873</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">UnifipMoc</td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zLah66A7F1wl" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember" id="Fact003165" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,777</ix:nonFraction></td>
    <td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zCUVQmvvjhb" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember" id="Fact003167" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,777</ix:nonFraction></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zKNSNd2Sx9Xf" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember" id="Fact003169" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">239,847</ix:nonFraction></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zPaFirPLHNs9" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember" id="Fact003171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">239,847</ix:nonFraction></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zBp26Rlvi7i2" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember" id="Fact003173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">427,474</ix:nonFraction></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z4gfTYv7k3og" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember" id="Fact003175" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">412,698</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Unigranrio</td>
    <td id="xdx_989_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zKSH3sgxth3l" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" id="Fact003177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">169,173</ix:nonFraction></td>
    <td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zjilK4LXDz73" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" id="Fact003179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">169,173</ix:nonFraction></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zngKiavC2xG1" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" id="Fact003181" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">421,538</ix:nonFraction></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zxAN2UNBpRd5" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" id="Fact003183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">421,538</ix:nonFraction></td>
    <td id="xdx_986_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zuiY9l1O2eyb" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" id="Fact003185" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">804,996</ix:nonFraction></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zVjHdFFP8rQg" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" id="Fact003187" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">819,682</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">DelRey</td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zXuauiuqwA4c" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_DelReyMember" id="Fact003189" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,098</ix:nonFraction></td>
    <td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIlKiCSMiiE4" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_DelReyMember" id="Fact003191" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,098</ix:nonFraction></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5ZEQAGON1K8" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_DelReyMember" id="Fact003193" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">693,890</ix:nonFraction></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zgqG4BFMsbgl" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_DelReyMember" id="Fact003195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">693,890</ix:nonFraction></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zwBmUYerww5f" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_DelReyMember" id="Fact003197" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">960,966</ix:nonFraction></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztkHC2LXdR05" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_DelReyMember" id="Fact003199" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">929,307</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Unidom</td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_ztfAQsJv2Kue" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnidomMember" id="Fact003201" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">192,034</ix:nonFraction></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z74iKouJt2x7" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnidomMember" id="Fact003203" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">192,034</ix:nonFraction></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zO8BJa8H3Ik2" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnidomMember" id="Fact003205" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">427,482</ix:nonFraction></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zZDyBdlmRcoj" title="Licenses with indefinite useful life" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnidomMember" id="Fact003207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">427,482</ix:nonFraction></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zI2WT6yJpi1l" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnidomMember" id="Fact003209" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">718,699</ix:nonFraction></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_znb3BnsJ31C5" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnidomMember" id="Fact003211" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">687,570</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FUNIC</td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zCPZhH25Ctvj" title="Goodwill" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3213">-</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z8A9V4L3huC7" title="Goodwill" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3215">-</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zMo1gKMd3Up" title="Licenses with indefinite useful life" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FUNICMember" id="Fact003217" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,629</ix:nonFraction></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z8kb4stCW9c6" title="Licenses with indefinite useful life" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3219">-</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zQ3gM7Z8eLs2" title="Cash generating units" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FUNICMember" id="Fact003221" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,943</ix:nonFraction></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zE0o8BSHujWb" title="Cash generating units" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3223">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98F_eifrs-full--Goodwill_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zwOuEWNuT7g3" title="Goodwill" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember" id="Fact003225" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,526,733</ix:nonFraction></b></td>
    <td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zvXOjOVsYcD5" title="Goodwill" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember" id="Fact003227" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,526,733</ix:nonFraction></b></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zsBHIabUbSO8" title="Licenses with indefinite useful life" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember" id="Fact003229" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,460,415</ix:nonFraction></b></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zk7GuD1HYmbj" title="Licenses with indefinite useful life" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember" id="Fact003231" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,360,786</ix:nonFraction></b></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_ztB1yVXhcBg8" title="Cash generating units" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2025-12-31_custom_CarryingAmountsMember" id="Fact003233" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,760,399</ix:nonFraction></b></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zcO4AqGiKNv9" title="Cash generating units" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2024-12-31_custom_CarryingAmountsMember" id="Fact003235" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,485,667</ix:nonFraction></b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">For the year ended December 31, 2025, the companies included in former Pillar 1 (Medcel,
Al&#233;m da Medicina, CardioPapers and Medical Harbour) where grouped together with IPEMED to constitute the Continuing education
CGU. The companies included in former Pillar 2 (PEBMED) and former Pilar 3 (iClinic, Medicinae, Shosp and RX Pro) where grouped together
with Glic and Cliquefarma to constitute the Medical practice solutions CGU. As a result, the prior period was revised for comparative
purposes. The grouping of these companies into a unified CGU reflects the economic reality of their business and is consistent with the
Company&#8217;s integrated operational model. This classification also represents how operations are internally monitored.<br/></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A6_zyGAanwnpwld" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 211 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The key assumptions used by the Company to determine the value in use of the CGUs were:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003237" name="afya:SchuduleOfAssumptionsUsedTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_898_ecustom--SchuduleOfAssumptionsUsedTableTextBlock_pn3n3_zs2q5xL5Xzcj" summary="xdx: Disclosure - Intangible assets (Details 2)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B9_zVtEPOJx43md" style="display: none">Schedule of assumptions</span></td>
    <td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr>
    <td style="border: #D0CECE 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Key assumption</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 51%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Description</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>2025</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>2024</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Discount rates</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><span id="xdx_901_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DiscountRatesMember_z4QcjuuHkqo5" title="Description"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_DiscountRatesMember" id="Fact003239" name="ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections">Represent the current market assessment of the specific risks associated to the CGUs, estimated based on information from both internal and external sources, including the Company&#8217;s and third parties historical weighted-average cost of capital (WACC).</ix:nonNumeric></span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Pre-tax discount rate applied to cash flow projections: between <span id="xdx_90A_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z6DR5vvKTDHg" title="Discount rate applied to cash flow projections"><ix:nonFraction name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" contextRef="AsOf2025-12-31_ifrs-full_BottomOfRangeMember" id="Fact003241" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.82</ix:nonFraction></span>% and <span id="xdx_905_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zkbt7PihCDw7" title="Discount rate applied to cash flow projections"><ix:nonFraction name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" contextRef="AsOf2025-12-31_ifrs-full_TopOfRangeMember" id="Fact003243" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.73</ix:nonFraction></span>%.</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Pre-tax discount rate applied to cash flow projections: between <span id="xdx_907_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20241231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zPif14jGTu9d" title="Discount rate applied to cash flow projections"><ix:nonFraction name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" contextRef="AsOf2024-12-31_ifrs-full_BottomOfRangeMember" id="Fact003245" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.66</ix:nonFraction></span>% and <span id="xdx_906_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z3nzF9GS73s5" title="Discount rate applied to cash flow projections"><ix:nonFraction name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" contextRef="AsOf2024-12-31_ifrs-full_TopOfRangeMember" id="Fact003247" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13.97</ix:nonFraction></span>%.</span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Perpetuity growth rate</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><span id="xdx_909_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PerpetuityGrowthRateMember_zgUfevbpw82a" title="Description"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_PerpetuityGrowthRateMember" id="Fact003249" name="ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections">Cash flow projections include specific estimates for a five-year period followed by a terminal growth rate, determined based on management's internal estimate of the long-term compound annual growth rate (CAGR), consistent with the assumptions that would be made by a market participant.</ix:nonNumeric></span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">From <span id="xdx_90E_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOPcJGfjIZIf" title="Growth rates"><ix:nonFraction name="afya:PerpetuityGrowthRate" contextRef="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember" id="Fact003251" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.5</ix:nonFraction></span>% to <span id="xdx_909_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_znr5YdVtYxFh" title="Growth rates"><ix:nonFraction name="afya:PerpetuityGrowthRate" contextRef="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember" id="Fact003253" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9.50</ix:nonFraction></span>%.</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">From <span id="xdx_90B_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zidxpqC2KL2c" title="Growth rates"><ix:nonFraction name="afya:PerpetuityGrowthRate" contextRef="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember" id="Fact003255" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.5</ix:nonFraction></span>% to <span id="xdx_901_ecustom--PerpetuityGrowthRate_pip0_dp_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zh43Ig1kwArd" title="Growth rates"><ix:nonFraction name="afya:PerpetuityGrowthRate" contextRef="From2024-01-012024-12-31_ifrs-full_TopOfRangeMember" id="Fact003257" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.53</ix:nonFraction></span>%.</span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">EBITDA<span style="font-family: Nunito Sans"><sup>[1]</sup></span> growth rate (annual average for the next five years)</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Nunito Sans; margin: 0"><span id="xdx_906_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EBITDAMember_gIFDOKAOWMHBC-WJE_zuncArDTfD7" title="Description"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_EBITDAMember" continuedAt="ConU003261-01" id="Fact003261" name="ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections">EBITDA growth rate was estimated using historical performance as a baseline, adjusted for:</ix:nonNumeric></span></p>
    <div id="xdx_C09_gIFDOKAOWMHBC-WJE_zqD6Jetl0JBi"><ix:continuation continuedAt="ConU003261-02" id="ConU003261-01"><p style="font: 9pt Nunito Sans; margin: 0">- Expected revenue growth, driven by increases in both sales volume and pricing.</p></ix:continuation></div>
    <div id="xdx_C07_gIFDOKAOWMHBC-WJE_zFxGavNFZ3Uf"><ix:continuation id="ConU003261-02"><p style="font: 9pt Nunito Sans; margin: 0">- Expected margin expansion, which reflects operational efficiencies and scale economies as
    volumes increase, partially offset by projected increases in costs.</p></ix:continuation></div></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_906_ecustom--EbitdaGrowthRates_pip0_dp_c20250101__20251231_zvtN9LF3duli" title="EBITDA growth rates"><ix:nonFraction name="afya:EbitdaGrowthRates" contextRef="From2025-01-01to2025-12-31" id="Fact003263" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.88</ix:nonFraction></span>%</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90A_ecustom--EbitdaGrowthRates_pip0_dp_c20240101__20241231_zbVabD28HFj9" title="EBITDA growth rates"><ix:nonFraction name="afya:EbitdaGrowthRates" contextRef="From2024-01-012024-12-31" id="Fact003265" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.69</ix:nonFraction></span>%</span></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><i>Sensitivity analysis: impacts of possible changes in key assumptions</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span id="xdx_902_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zBYiuCNYfPa2" title="Description of significant estimate"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_GoodwillMember" id="Fact003267" name="ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections">An increase of 25 basis points in management&#8217;s estimated discount rate applied to
the cash flow projections of each CGU for the year ended December 31, 2025, or a decrease of 25 basis points on perpetuity growth rate
or EBITDA growth rate would not have significant impacts on Company&#8217;s impairment testing.</ix:nonNumeric></span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Impairment testing of other intangible assets</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">There were <span id="xdx_90F_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_do_c20250101__20251231_zzOkniNzthrk" title="Impairment intangible assets"><ix:nonFraction name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" contextRef="From2025-01-01to2025-12-31" id="Fact003269" format="ixt-sec:numwordsen" decimals="0" unitRef="BRL">no</ix:nonFraction></span> impairment indicatives of intangible assets with finite useful lives as of
and for the year ended December 31, 2025.</p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003271" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory"><p id="xdx_802_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zgkxttcMo5vb" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">12</td><td><span id="xdx_825_zqd5gg680W7f">Financial assets and liabilities</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; color: #0D0E00">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%"><b>12.1</b></td><td><b>Financial assets</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003273" name="afya:ScheduleOfFinancialAssetsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_890_ecustom--ScheduleOfFinancialAssetsTableTextBlock_zfCKk7BKGG9e" summary="xdx: Disclosure - Financial assets and liabilities (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BD_zEgMmICCUAD4" style="display: none">Schedule of financial assets</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>At amortized cost</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cash and cash equivalents</td>
    <td id="xdx_98D_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zFSR0GqK3u9g" title="Cash and cash equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,125,381</ix:nonFraction> </td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zwNWrmprW5Kh" title="Cash and cash equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003277" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">911,015</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Trade receivables</td>
    <td id="xdx_98E_eifrs-full--TradeReceivables_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zyEySZtNuMuc" title="Trade receivables" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003279" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">752,358</ix:nonFraction> </td>
    <td id="xdx_983_eifrs-full--TradeReceivables_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_ziiNiLIaENTi" title="Trade receivables" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003281" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">631,846</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Other FIES credits - Other assets</td>
    <td id="xdx_980_eifrs-full--OtherAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zuf7UVBO9Rdl" title="Other FIES credits - Other assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherAssets" contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003283" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,866</ix:nonFraction> </td>
    <td id="xdx_982_eifrs-full--OtherAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zhBXyUUyRXNl" title="Other FIES credits - Other assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherAssets" contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,982</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Dividends receivable - Other assets</td>
    <td id="xdx_98B_ecustom--DividendReceivable_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zJPLRk7cOif4" title="Dividends receivable - Other assets" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:DividendReceivable" contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,287</ix:nonFraction> </td>
    <td id="xdx_981_ecustom--DividendReceivable_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zFPdpbw2cdj5" title="Dividends receivable" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:DividendReceivable" contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003289" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,628</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_984_eifrs-full--FinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zB3YEGMg3UCb" title="Total" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,890,892</ix:nonFraction> </b></td>
    <td id="xdx_986_eifrs-full--FinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRXN40G1V4e9" title="Total" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003293" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,553,471</ix:nonFraction> </b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_980_eifrs-full--CurrentFinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zkOY8WERLiRh" title="Current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentFinancialAssets" contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003295" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,849,041</ix:nonFraction> </td>
    <td id="xdx_98D_eifrs-full--CurrentFinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z06VAwl2Pyd" title="Current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentFinancialAssets" contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003297" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,508,541</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_988_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_znY5z8ZwboC5" title="Non-current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssets" contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003299" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,851</ix:nonFraction> </td>
    <td id="xdx_987_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zuMfYWo0Dwfh" title="Non-current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssets" contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="Fact003301" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,930</ix:nonFraction> </td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zvOvJxy8DbA8" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<hr style="height: 1px; width: 33%; margin-left: 3%"/>

<p style="font: 9pt Nunito Sans; margin: 0 0 0 3%"><span style="font-family: Nunito Sans"><sup>[1]</sup></span> EBITDA refers to Earnings Before
Interest, Taxes, Depreciation and Amortization. EBITDA is not a defined performance measure under IFRS Accounting Standards.</p>


<ix:exclude><!-- Field: Page; Sequence: 212 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zcwhynQwUox" style="font: 10pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p></ix:exclude>

<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%"><b>12.2</b></td><td><b>Financial liabilities</b></td></tr></table>

<p style="font: 7pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003304" name="afya:ScheduleOfFinancialLiabilitiesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_893_ecustom--ScheduleOfFinancialLiabilitiesTableTextBlock_zApM0bo416tj" summary="xdx: Disclosure - Financial assets and liabilities (Details 1)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B9_zwid6Khlho16" style="display: none">Schedule of financial liabilities</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>At amortized cost</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Trade payables</td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z967f8uR7pzf" title="Trade payables" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003306" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123,581</ix:nonFraction> </td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5iEBvLxnhBl" title="Trade payables" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003308" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,080</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Loans and financing</td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zlsu6fnkPwag" title="Loans and financing" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003310" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,054,267</ix:nonFraction> </td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFCAXvaqZ7Zd" title="Loans and financing" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003312" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,195,161</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Lease liabilities</td>
    <td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zWKhVwB4p6I5" title="Lease liabilities" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003314" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,065,746</ix:nonFraction> </td>
    <td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zPkwp9NZMQci" title="Lease liabilities" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003316" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">978,336</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders</td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zt0iPGHBgy48" title="Accounts payable to selling shareholders" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003318" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">115,447</ix:nonFraction> </td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z0ZirexSHOb6" title="Accounts payable to selling shareholders" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003320" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">215,819</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Dividends payable</td>
    <td id="xdx_988_eifrs-full--DividendsPayable_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFlWtsR8A402" title="Dividends payable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:DividendsPayable" contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003322" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">192</ix:nonFraction> </td>
    <td id="xdx_989_eifrs-full--DividendsPayable_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z80SeiiXaPI" title="Dividends payable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3324">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z2yumoKcDxu1" title="Total" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003326" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,359,233</ix:nonFraction> </b></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zzvYvHDyFZr7" title="Total" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003328" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,517,396</ix:nonFraction> </b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_980_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4xsAyUzUA2g" title="Current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilities" contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003330" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">326,432</ix:nonFraction> </td>
    <td id="xdx_988_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z1xpBTbijuV" title="Current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilities" contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003332" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">690,395</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_987_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zTpj8mv5vIpk" title="Non-current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilities" contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003334" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,032,801</ix:nonFraction> </td>
    <td id="xdx_986_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zYLJIetDc5I1" title="Non-current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilities" contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" id="Fact003336" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,827,001</ix:nonFraction></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_znvTOkGaQ9hc" style="font: 10pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003338" name="afya:ScheduleOfFairValuesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89F_ecustom--ScheduleOfFairValuesTableTextBlock_zmQJkcK0fO4j" summary="xdx: Disclosure - Financial assets and liabilities (Details 2)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B7_zZmKFkpt9Eh3" style="display: none">Schedule of fair value</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>At fair value</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders (earn-outs)</td>
    <td id="xdx_987_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersEarnOutsMember_zDvLTTDZJfg1" title="Financial liabilities, at fair value" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:FinancialLiabilitiesAtFairValues" contextRef="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersEarnOutsMember" id="Fact003340" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,337</ix:nonFraction> </td>
    <td id="xdx_98E_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersEarnOutsMember_z6W34HKHufi8" title="Financial liabilities, at fair value" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:FinancialLiabilitiesAtFairValues" contextRef="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersEarnOutsMember" id="Fact003342" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,067</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders (Unidom)</td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersUnidomMember_zdCzDsMpiktj" title="Financial liabilities, at fair value" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:FinancialLiabilitiesAtFairValues" contextRef="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersUnidomMember" id="Fact003344" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">321,813</ix:nonFraction> </td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersUnidomMember_zeSjmCcRFI0a" title="Financial liabilities, at fair value" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:FinancialLiabilitiesAtFairValues" contextRef="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersUnidomMember" id="Fact003346" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">294,886</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_985_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231_zcdPTjJeT4jh" title="Financial liabilities, at fair value" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="afya:FinancialLiabilitiesAtFairValues" contextRef="AsOf2025-12-31" id="Fact003348" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">325,150</ix:nonFraction> </b></td>
    <td id="xdx_981_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231_z1yq3E0XKkfb" title="Financial liabilities, at fair value" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="afya:FinancialLiabilitiesAtFairValues" contextRef="AsOf2024-12-31" id="Fact003350" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">314,953</ix:nonFraction> </b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_98E_eifrs-full--CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20251231_z5gzvupBWZx7" title="Current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="AsOf2025-12-31" id="Fact003352" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,421</ix:nonFraction> </td>
    <td id="xdx_984_eifrs-full--CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20241231_zeCC9zpsD9y7" title="Current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="AsOf2024-12-31" id="Fact003354" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,137</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_988_eifrs-full--NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20251231_z3QiGJ9fRsZ7" title="Non-current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="AsOf2025-12-31" id="Fact003356" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">300,729</ix:nonFraction> </td>
    <td id="xdx_98A_eifrs-full--NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20241231_zZsxNtpJh8he" title="Non-current" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" contextRef="AsOf2024-12-31" id="Fact003358" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">282,816</ix:nonFraction></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A1_zxjvVaOyTrv4" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%"><span style="color: #C00000"><b>12.2.1</b></span></td><td><span style="color: #C00000"><b>Loans and financing</b></span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003360" name="afya:ScheduleOfLoansAndFinancingTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89F_ecustom--ScheduleOfLoansAndFinancingTableTextBlock_zM8pNdh4cIHf" summary="xdx: Disclosure - Financial assets and liabilities (Details 3)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_z0Kd946A2336" style="display: none">Schedule of loans and financing</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="border-bottom: Black 1pt solid; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><b>Financial institution</b></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Currency</b></td>
    <td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Interest rate</b></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Maturity</b></td>
    <td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>&#160;2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"/>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_90E_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zsk6mgQ1aqZg" title="Financial institution"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_OctoberTwentyTwentyFiveMember" id="Fact003362" name="afya:FinancialInstitution">Banco Ita&#250; Unibanco S.A.</ix:nonNumeric></span> (a)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zghIEF7NWizh" title="Interest rate"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_OctoberTwentyTwentyFiveMember" id="Fact003364" name="ifrs-full:BorrowingsInterestRateBasis">CDI + 1.90% p.y.</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_902_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zfmdRINOXAp" title="Maturity"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_OctoberTwentyTwentyFiveMember" id="Fact003366" name="ifrs-full:BorrowingsMaturity">October 2025</ix:nonNumeric></span></td>
    <td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zIzv4cTdu8u1" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3368">-</span></td>
    <td id="xdx_981_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zZA230XVHKq" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_custom_OctoberTwentyTwentyFiveMember" id="Fact003370" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">309,496</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_90A_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zho5Ub0wj0d4" title="Financial institution"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_JulyTwentyTwentySevenMember" id="Fact003372" name="afya:FinancialInstitution">FINEP</ix:nonNumeric></span> (b)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zR4R7MHSOWSj" title="Interest rate"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_JulyTwentyTwentySevenMember" id="Fact003374" name="ifrs-full:BorrowingsInterestRateBasis">TJLP p.y.</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zQMduyFSaulk" title="Maturity"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_JulyTwentyTwentySevenMember" id="Fact003376" name="ifrs-full:BorrowingsMaturity">July 2027</ix:nonNumeric></span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zzMGfB6ps923" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_custom_JulyTwentyTwentySevenMember" id="Fact003378" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,262</ix:nonFraction></td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_z3PJqmXxSVUf" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_custom_JulyTwentyTwentySevenMember" id="Fact003380" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,209</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_900_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zOXOwdIGAdL6" title="Financial institution"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AprilTwentyTwentySixMember" id="Fact003382" name="afya:FinancialInstitution">Softbank</ix:nonNumeric></span> (c)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_908_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zmWpM8AvbL52" title="Interest rate"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AprilTwentyTwentySixMember" id="Fact003384" name="ifrs-full:BorrowingsInterestRateBasis">6.5% p.y.</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_z7BL1PKorwS" title="Maturity"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AprilTwentyTwentySixMember" id="Fact003386" name="ifrs-full:BorrowingsMaturity">April 2026</ix:nonNumeric></span></td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zt8EyJj7OKag" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3388">-</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zIk4zqzRAgAc" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_custom_AprilTwentyTwentySixMember" id="Fact003390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">845,492</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_900_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z9IeoQSgiGX5" title="Financial institution"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_JanuaryTwentyTwentyEightMember" id="Fact003392" name="afya:FinancialInstitution">Debentures</ix:nonNumeric></span> (d)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_zuZ0u6OuNYi4" title="Interest rate"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_JanuaryTwentyTwentyEightMember" id="Fact003394" name="ifrs-full:BorrowingsInterestRateBasis">CDI + 1.80% p.y.</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z896fjA34ps4" title="Maturity"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_JanuaryTwentyTwentyEightMember" id="Fact003396" name="ifrs-full:BorrowingsMaturity">January 2028</ix:nonNumeric></span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z1HLbfMnmsk3" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3398">-</span></td>
    <td id="xdx_981_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_zGBKe5Dsv8I4" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_custom_JanuaryTwentyTwentyEightMember" id="Fact003400" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">526,946</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_903_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zw9svEiE6aj4" title="Financial institution"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AprilTwentyThirtyMember" id="Fact003402" name="afya:FinancialInstitution">IFC</ix:nonNumeric></span> (e)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zaVgDULurkU7" title="Interest rate"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AprilTwentyThirtyMember" id="Fact003404" name="ifrs-full:BorrowingsInterestRateBasis">CDI + 1.05% p.y.</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_znlDd5q6YYb9" title="Maturity"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AprilTwentyThirtyMember" id="Fact003406" name="ifrs-full:BorrowingsMaturity">April 2030</ix:nonNumeric></span></td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zzCiOfkv4la6" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_custom_AprilTwentyThirtyMember" id="Fact003408" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">510,672</ix:nonFraction> </td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zaHAYXiw4Rp" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_custom_AprilTwentyThirtyMember" id="Fact003410" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">505,018</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_905_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zQCcBN51G4sl" title="Financial institution"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_OctoberTwentyTwentyEightMember" id="Fact003412" name="afya:FinancialInstitution">Commercial notes</ix:nonNumeric></span> (f)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_901_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zpGzhbR5Aszj" title="Interest rate"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_OctoberTwentyTwentyEightMember" id="Fact003414" name="ifrs-full:BorrowingsInterestRateBasis">CDI + 0.70% p.y.</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_z5CyciXkyRyb" title="Maturity"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_OctoberTwentyTwentyEightMember" id="Fact003416" name="ifrs-full:BorrowingsMaturity">October 2028</ix:nonNumeric></span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_ztPSc6KChh1l" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_custom_OctoberTwentyTwentyEightMember" id="Fact003418" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">512,678</ix:nonFraction> </td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zzxIKkmOKrk6" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3420">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_904_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zJbJTQxnQ0R7" title="Financial institution"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_OctoberTwentyThirtyMember" id="Fact003422" name="afya:FinancialInstitution">Commercial notes</ix:nonNumeric></span> (f)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_907_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zFXhJCDdwyha" title="Interest rate"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_OctoberTwentyThirtyMember" id="Fact003424" name="ifrs-full:BorrowingsInterestRateBasis">CDI + 0.85% p.y.</ix:nonNumeric></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90D_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zEBeVDWTnoL9" title="Maturity"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_OctoberTwentyThirtyMember" id="Fact003426" name="ifrs-full:BorrowingsMaturity">October 2030</ix:nonNumeric></span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zWski1IdqoVc" title="Loans and financing" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_custom_OctoberTwentyThirtyMember" id="Fact003428" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,025,655</ix:nonFraction> </td>
    <td id="xdx_988_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zqAzcJDkTw5k" title="Loans and financing" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3430">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20251231_zLHiAOy5g2N8" title="Loans and financing" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31" id="Fact003432" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,054,267</ix:nonFraction> </b></td>
    <td id="xdx_989_ecustom--LoansAndFinancing_pn3n3_c20241231_zX7ix0nhzp2" title="Loans and financing" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31" id="Fact003434" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,195,161</ix:nonFraction> </b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_982_ecustom--LoansAndFinancingCurrent_iI_pn3n3_c20251231_zbQpxAy2G1ug" title="Current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancingCurrent" contextRef="AsOf2025-12-31" id="Fact003436" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,668</ix:nonFraction> </td>
    <td id="xdx_98E_ecustom--LoansAndFinancingCurrent_iI_pn3n3_c20241231_zlokdgluSQRc" title="Current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancingCurrent" contextRef="AsOf2024-12-31" id="Fact003438" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">363,554</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98F_ecustom--LoansAndFinancingNonCurrent_iI_pn3n3_c20251231_zdtKQQANyR8" title="Non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancingNonCurrent" contextRef="AsOf2025-12-31" id="Fact003440" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,993,599</ix:nonFraction> </td>
    <td id="xdx_98A_ecustom--LoansAndFinancingNonCurrent_iI_pn3n3_c20241231_zc3HX6s9BtS8" title="Non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancingNonCurrent" contextRef="AsOf2024-12-31" id="Fact003442" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,831,607</ix:nonFraction> </td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A4_z2M9FEQY3ISi" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(a) On October 1, 2020, Afya Brazil entered into a loan with Banco Ita&#250; Unibanco
S.A. in the amount of R$500,000 adjusted by the CDI rate plus an interest rate of 1.62% per year and is repayable in three installments
in October 2022, April 2023 and October 2023. On September 28, 2022, Afya Brazil signed an amendment with Banco Ita&#250; Unibanco S.A
in order to extend its debt profile, postponing the original repayments dates from 2022 and 2023 to 2023, 2024 and 2025. Due to such extension,
the spread over the CDI rate increased from 1.62% p.y to 1.90% p.y. The aggregate outstanding amount was fully repaid on September 30,
2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(b) On July 23, 2019, Medcel entered into a loan of R$16,153 with <i>Financiadora de Estudos
e Projetos</i> (FINEP), a governmental agency focused on financing investments on R&amp;D, which has an interest rate based on TJLP (Long
term interest rate), and maturity in 2027. The first and second tranches of R$6,734 and R$4,130, respectively, were drawdown in October
2019 and December 2020, respectively, and additional tranches were drawdown in March and June 2023 totaling R$5,288 in order to develop
the Medical web series and other digital content. There is no financial covenant related to this agreement. The total balance is guaranteed
by a bank financial guarantee.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(c) On April 26, 2021, the Company issued and sold 150,000 shares of perpetual convertible
preferred shares designated as Series A perpetual convertible preferred shares, with a par value of US$0.00005 per share of Afya for US$150,000
thousands, equivalent to R$821,805 on the issuance date. The Series A perpetual convertible preferred shares is a class of equity security
that ranks senior to the common shares with respect to dividend rights or rights upon liquidation.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On November 3, 2025, the Company repurchased all 150,000 Series A perpetual convertible
preferred shares of a nominal or par value of US$0.00005 each in the capital of the Company for an aggregate purchase price of R$831,600,
following the Share Repurchase Agreement with SBLA Holdco LLC, an affiliate of Softbank. All repurchased Series A preferred shares were
cancelled by the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 213 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(d) On December 16, 2022, Afya Brazil issued 500,000 simple, non-convertible, unsecured
debentures in a single series, each with a par value of R$1, totaling an aggregate amount of R$500,000, in a public distribution with
restricted placement efforts in the Brazilian market, under the terms of the Brazilian Securities Commission (CVM) Rule No. 476. The debentures
were issued with a maturity date of January 15, 2028, with the principal to be amortized in two equal installments payable on January
15, 2027 and January 15, 2028, corresponding to the fourth and fifth years of the transaction, respectively. The debentures bear interest
at 100% of the CDI rate plus 1.80% per year, payable semi-annually on January 15 and July 15 of each year, until the maturity date. The
aggregate outstanding amount was fully repaid on October 22, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(e) On August 7, 2024, Afya Brazil entered into a loan agreement with International Finance
Corporation ("IFC") to support its expansion program, through acquisitions. The financing is IFC&#8217;s first sustainability-linked
loan based on social targets in the education sector. The pricing of IFC&#8217;s loan will be linked to Afya reaching performance target
levels in selected social key performance indicators encompassing free medical consultations for the community and quality of education
according to MEC criteria (&#8220;Sustainability KPIs&#8221; - unaudited).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The aggregate principal amount of the loan is R$<span id="xdx_902_ecustom--LoanAndFinancing_iI_pn3n3_c20240807__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InternationalFinanceCorporationMember_zWlbd2ITr9vg" title="Loans and financing"><ix:nonFraction name="afya:LoanAndFinancing" contextRef="AsOf2024-08-07_custom_InternationalFinanceCorporationMember" id="Fact003444" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">500,000</ix:nonFraction></span>, which shall be repaid in seven
equal semi-annual installments starting in April 2027. The interest rate of <span id="xdx_908_eifrs-full--BorrowingsInterestRateBasis_c20240801__20240807__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InternationalFinanceCorporationMember_zEgq9NrBv6Ah" title="Interest rate"><ix:nonNumeric contextRef="From2024-08-012024-08-07_custom_InternationalFinanceCorporationMember" id="Fact003446" name="ifrs-full:BorrowingsInterestRateBasis">CDI rate plus 1.20%</ix:nonNumeric></span> was reduced by 15 bps to 1.05% since the
Sustainability KPIs were achieved (unaudited).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Afya Brazil is subject to certain obligations including financial covenants, and the Company
shall maintain, as of the last day of each quarter of each financial year, Net Debt (Loans and financing plus Accounts payable to selling
shareholders less Cash and cash equivalents) to Adjusted EBITDA ratio below or equal to 3.0x, at the end of each fiscal year, until the
maturity date. Adjusted EBITDA for covenant purposes considers net income plus (i) income taxes expenses, (ii) net financial result (excluding
interest expenses on lease liabilities), (iii) depreciation and amortization expenses (excluding right-of-use assets depreciation expenses),
(iv) share-based compensation expenses, (v) share of income of associate, (vi) interest received and (vii) non-recurring expenses.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(f) On October 15, 2025, Afya Brazil issued commercial notes for private placement, sold
to Opea Securitizadora S.A. ("Opea&#8221;), a Brazilian securitization corporation pursuant to Section 45 of Brazilian Law No. 14,195/2021,
as amended. Opea issued a debenture backed by the commercial notes on the same terms and conditions.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The aggregate principal amount of the commercial notes is R$<span id="xdx_906_ecustom--LoanAndFinancing_iI_pn3n3_c20251015__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TwoSeriesMember_zU7IEEY5VW47" title="Loans and financing"><ix:nonFraction name="afya:LoanAndFinancing" contextRef="AsOf2025-10-15_custom_TwoSeriesMember" id="Fact003448" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,500,000</ix:nonFraction></span>, divided into two
series, the first in the aggregate amount of R$<span id="xdx_909_ecustom--LoanAndFinancing_iI_pn3n3_c20251015__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FirstSeriesMember_z4sgmX86Vd3b" title="Loans and financing"><ix:nonFraction name="afya:LoanAndFinancing" contextRef="AsOf2025-10-15_custom_FirstSeriesMember" id="Fact003450" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">500,000</ix:nonFraction></span> ("First Series&#8221;) and the second in the aggregate amount of R$<span id="xdx_90B_ecustom--LoanAndFinancing_iI_pn3n3_c20251015__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SecondSeriesMember_zDUAq51R50G8" title="Loans and financing"><ix:nonFraction name="afya:LoanAndFinancing" contextRef="AsOf2025-10-15_custom_SecondSeriesMember" id="Fact003452" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,000,000</ix:nonFraction></span>
("Second Series&#8221;). The First Series will mature on October 15, 2028 and the Second Series will mature on October 15, 2030.
The interest rate applicable to the First Series and Second Series will be equal to the <span id="xdx_903_eifrs-full--BorrowingsInterestRateBasis_c20251001__20251015__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InternationalFinanceCorporationMember_zxhpz9tfdiJc" title="Interest rate"><ix:nonNumeric contextRef="From2025-10-012025-10-15_custom_InternationalFinanceCorporationMember" id="Fact003454" name="ifrs-full:BorrowingsInterestRateBasis">CDI rate plus a spread of 0.70% and 0.85%</ix:nonNumeric></span> per
year, respectively, based on 252 business days.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Afya Brazil is subject to certain obligations including financial covenants, and the Company
shall maintain Net Debt (excluding lease liabilities) to adjusted EBITDA ratio below or equal to 3.0x, at the end of each fiscal year,
until maturity date, applicable from December 31, 2025 and thereafter. Adjusted EBITDA for covenant purposes considers net income plus
(i) income taxes expenses, (ii) net financial result (excluding interest expenses on lease liabilities), (iii) depreciation and amortization
expenses (excluding right-of-use assets depreciation expenses), (iv) share-based compensation expenses, (v) share of income of associate,
(vi) interest received and (vii) non-recurring expenses.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The transaction costs that are directly attributable to the issuance of the commercial
notes were measured at fair value together with the financial liability on initial measurement. The transaction costs totaled R$<span id="xdx_903_ecustom--TransactionCosts_iI_c20251231_zWKYLTepDQZh" title="Transaction costs"><ix:nonFraction name="afya:TransactionCosts" contextRef="AsOf2025-12-31" id="Fact003456" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">5,163</ix:nonFraction></span>,
including legal counsels and advisors.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">As disclosed in Note 7, the commercial notes are guaranteed by the following subsidiaries:
Unigranrio, IESP and DelRey.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%"><b>12.2.2</b></td><td><b>Leases</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company has property lease contracts with maturities between five <span id="xdx_906_ecustom--ContractualLeaseTerm_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCklIv3YYSAh" title="Contractual lease term" style="display: none"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact003458" name="afya:ContractualLeaseTerm">5</ix:nonNumeric></span> and <span id="xdx_902_ecustom--ContractualLeaseTerm_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zE9Egkr1BGn8" title="Contractual lease term"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact003460" name="afya:ContractualLeaseTerm">30</ix:nonNumeric></span>
years. There are no contract modification, sublease or variable payments in the period. The remeasurements are related to
index-based updates of the lease payments amounts.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 214 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The carrying amounts of right-of-use assets and lease liabilities as of December 31, 2025,
2024 and 2023 and the movements during years ended December 31, 2025, 2024 and 2023 are shown below:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003462" name="afya:ScheduleOfLeasesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89A_ecustom--ScheduleOfLeasesTableTextBlock_zD88JZhGdIE8" summary="xdx: Disclosure - Financial assets and liabilities  (Details 4)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BE_ziS5UYKrVDNc" style="display: none">Schedule of right-of-use assets and lease liabilities</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Right-of-use assets</b></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Lease liabilities</b></td></tr>
  <tr>
    <td style="width: 33%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td>
    <td style="vertical-align: top; width: 1%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Opening balance</b></td>
    <td id="xdx_984_eifrs-full--RightofuseAssets_iS_pn3n3_c20250101__20251231_zrmYjJND5XH8" title="Right-of-use assets, balance at beginning" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2024-12-31" id="Fact003464" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">842,219</ix:nonFraction> </b></td>
    <td id="xdx_987_eifrs-full--RightofuseAssets_iS_pn3n3_c20240101__20241231_zdSaOneFkP58" title="Right-of-use assets, balance at beginning" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2023-12-31" id="Fact003466" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">767,609</ix:nonFraction> </b></td>
    <td id="xdx_98A_eifrs-full--RightofuseAssets_iS_pn3n3_c20230101__20231231_zwtgdi1UNSs3" title="Right-of-use assets, balance at beginning" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2022-12-31" id="Fact003468" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">690,073</ix:nonFraction></b></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--LeaseLiabilities_iS_pn3n3_c20250101__20251231_z7hftFWQstSe" title="Lease liabilities, balance at beginning" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31" id="Fact003470" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">978,336</ix:nonFraction> </b></td>
    <td id="xdx_98F_eifrs-full--LeaseLiabilities_iS_pn3n3_c20240101__20241231_z56wJ6XHjch4" title="Lease liabilities, balance at beginning" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2023-12-31" id="Fact003472" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">874,569</ix:nonFraction> </b></td>
    <td id="xdx_989_eifrs-full--LeaseLiabilities_iS_pn3n3_c20230101__20231231_z16LqXKtL3Me" title="Lease liabilities, balance at beginning" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2022-12-31" id="Fact003474" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">769,525</ix:nonFraction></b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Additions</td>
    <td id="xdx_988_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231_zG5RCJMJlqpe" title="Right-of-use assets, additions" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionsToRightofuseAssets" contextRef="From2025-01-01to2025-12-31" id="Fact003476" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,727</ix:nonFraction> </td>
    <td id="xdx_986_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20240101__20241231_znlvQUfbfdu5" title="Right-of-use assets, additions" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionsToRightofuseAssets" contextRef="From2024-01-012024-12-31" id="Fact003478" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,671</ix:nonFraction> </td>
    <td id="xdx_98F_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20230101__20231231_zqK893yBmtB5" title="Right-of-use assets, additions" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionsToRightofuseAssets" contextRef="From2023-01-012023-12-31" id="Fact003480" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,328</ix:nonFraction></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_98A_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20250101__20251231_z9wOqaXwpX02" title="Lease liabilities, additions" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:AdditionsToLeaseLiabilities" contextRef="From2025-01-01to2025-12-31" id="Fact003482" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,727</ix:nonFraction> </td>
    <td id="xdx_98E_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20240101__20241231_zD25qWIes559" title="Lease liabilities, additions" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:AdditionsToLeaseLiabilities" contextRef="From2024-01-012024-12-31" id="Fact003484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,671</ix:nonFraction> </td>
    <td id="xdx_989_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20230101__20231231_zru1mqAVVLrd" title="Lease liabilities, additions" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:AdditionsToLeaseLiabilities" contextRef="From2023-01-012023-12-31" id="Fact003486" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,328</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Remeasurement</td>
    <td id="xdx_987_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20250101__20251231_zNyoJkpHTtI2" title="Right-of-use assets, remeasurement" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:RightofuseAssetsRemeasurement" contextRef="From2025-01-01to2025-12-31" id="Fact003488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">98,987</ix:nonFraction> </td>
    <td id="xdx_989_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20240101__20241231_z7etiMsyHe4h" title="Right-of-use assets, remeasurement" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:RightofuseAssetsRemeasurement" contextRef="From2024-01-012024-12-31" id="Fact003490" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,226</ix:nonFraction> </td>
    <td id="xdx_98C_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20230101__20231231_zUFlVmu95bDb" title="Right-of-use assets, remeasurement" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:RightofuseAssetsRemeasurement" contextRef="From2023-01-012023-12-31" id="Fact003492" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,387</ix:nonFraction></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_988_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20250101__20251231_zbSBWQuxdI15" title="Lease liabilities, remeasurement" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:LeaseLiabilitiesRemeasurement" contextRef="From2025-01-01to2025-12-31" id="Fact003494" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">98,987</ix:nonFraction> </td>
    <td id="xdx_987_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20240101__20241231_zljZVWVsx6Lb" title="Lease liabilities, remeasurement" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:LeaseLiabilitiesRemeasurement" contextRef="From2024-01-012024-12-31" id="Fact003496" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,226</ix:nonFraction> </td>
    <td id="xdx_989_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20230101__20231231_zdxRNFVcXfG9" title="Lease liabilities, remeasurement" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:LeaseLiabilitiesRemeasurement" contextRef="From2023-01-012023-12-31" id="Fact003498" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,387</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Business combinations</td>
    <td id="xdx_986_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20250101__20251231_z5EfWXvMwSHj" title="Right-of-use assets, business combinations" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3500">-</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20240101__20241231_zpMS5SSoieSi" title="Right-of-use assets, business combinations" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:RightofuseAssetsBusinessCombinations" contextRef="From2024-01-012024-12-31" id="Fact003502" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,989</ix:nonFraction> </td>
    <td id="xdx_98E_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20230101__20231231_zhg0bwUH5Rp9" title="Right-of-use assets, business combinations" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:RightofuseAssetsBusinessCombinations" contextRef="From2023-01-012023-12-31" id="Fact003504" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,408</ix:nonFraction></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_983_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20250101__20251231_zYuL6NwOy2I3" title="Lease liabilities, business combinations" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3506">-</span></td>
    <td id="xdx_987_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20240101__20241231_zzd6GS6LA7jj" title="Lease liabilities, business combinations" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:BusinessCombinationsLeaseLiabilities" contextRef="From2024-01-012024-12-31" id="Fact003508" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,989</ix:nonFraction> </td>
    <td id="xdx_981_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20230101__20231231_z1svd6hJRjnc" title="Lease liabilities, business combinations" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:BusinessCombinationsLeaseLiabilities" contextRef="From2023-01-012023-12-31" id="Fact003510" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,408</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Depreciation expense</td>
    <td id="xdx_986_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20250101__20251231_zaLcw6anITY" title="Right-of-use assets, depreciation expense" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationRightofuseAssets" contextRef="From2025-01-01to2025-12-31" id="Fact003512" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,864</ix:nonFraction>)</td>
    <td id="xdx_98B_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20240101__20241231_zCCby1j6NoAl" title="Right-of-use assets, depreciation expense" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationRightofuseAssets" contextRef="From2024-01-012024-12-31" id="Fact003514" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,294</ix:nonFraction>)</td>
    <td id="xdx_98B_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20230101__20231231_zPzojHIgCWnk" title="Right-of-use assets, depreciation expense" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationRightofuseAssets" contextRef="From2023-01-012023-12-31" id="Fact003516" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,118</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_98D_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20250101__20251231_zXNifSeHaype" title="Lease liabilities, depreciation expense" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3518">-</span></td>
    <td id="xdx_981_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20240101__20241231_z9P9X9mybrKk" title="Lease liabilities, depreciation expense" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3520">-</span></td>
    <td id="xdx_98D_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20230101__20231231_zik12oLFw6nk" title="Lease liabilities, depreciation expense" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3522">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Interest expense</td>
    <td id="xdx_980_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20250101__20251231_zcK8vh0zYxM5" title="Right-of-use assets, interest expense" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3524">-</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20240101__20241231_zRWQMeouzGka" title="Right-of-use assets, interest expense" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3526">-</span></td>
    <td id="xdx_988_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20230101__20231231_zRmqwqrHVgYj" title="Right-of-use assets, interest expense" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3528">-</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_98D_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20250101__20251231_z3WyXUMZlpye" title="Lease liabilities, interest expense" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2025-01-01to2025-12-31" id="Fact003530" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123,067</ix:nonFraction> </td>
    <td id="xdx_98A_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20240101__20241231_zRKcL939U0ya" title="Lease liabilities, interest expense" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2024-01-012024-12-31" id="Fact003532" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">111,966</ix:nonFraction> </td>
    <td id="xdx_980_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20230101__20231231_zpSz7Nt2nZM9" title="Lease liabilities, interest expense" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2023-01-012023-12-31" id="Fact003534" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,849</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Payments of principal</td>
    <td id="xdx_986_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20250101__20251231_zwD9zYJ3nvig" title="Right of use assets, payments of principal" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3536">-</span></td>
    <td id="xdx_980_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20240101__20241231_zvzRrODrMld1" title="Right of use assets, payments of principal" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3538">-</span></td>
    <td id="xdx_981_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20230101__20231231_zYluA0Wjjtz7" title="Right of use assets, payments of principal" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3540">-</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_982_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20250101__20251231_zRdowUBn6c43" title="Lease liabilities, payments of principal" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:LeaseLiabilitiesPaymentsOfPrincipal" contextRef="From2025-01-01to2025-12-31" id="Fact003542" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">49,411</ix:nonFraction>)</td>
    <td id="xdx_986_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20240101__20241231_zPepJ0SWODm9" title="Lease liabilities, payments of principal" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:LeaseLiabilitiesPaymentsOfPrincipal" contextRef="From2024-01-012024-12-31" id="Fact003544" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">41,221</ix:nonFraction>)</td>
    <td id="xdx_98B_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20230101__20231231_zNgzvuS7z2Dj" title="Lease liabilities, payments of principal" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:LeaseLiabilitiesPaymentsOfPrincipal" contextRef="From2023-01-012023-12-31" id="Fact003546" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,473</ix:nonFraction>)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Payments of interest</td>
    <td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20250101__20251231_ztdg2YuJlDn8" title="Right-of-use assets, payments of interest" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3548">-</span></td>
    <td id="xdx_98A_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20240101__20241231_zaDc92cMtB1h" title="Right-of-use assets, payments of interest" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3550">-</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20230101__20231231_zBYFRjGs86n1" title="Right-of-use assets, payments of interest" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3552">-</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20250101__20251231_z8n47pb78YV" title="Lease liabilities, payments of interest" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:PaymentsOfInterestLeaseLiabilities" contextRef="From2025-01-01to2025-12-31" id="Fact003554" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">121,475</ix:nonFraction>)</td>
    <td id="xdx_987_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20240101__20241231_ziYeoCmUxY8" title="Lease liabilities, payments of interest" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:PaymentsOfInterestLeaseLiabilities" contextRef="From2024-01-012024-12-31" id="Fact003556" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">111,605</ix:nonFraction>)</td>
    <td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20230101__20231231_zUykcHnsOZw2" title="Lease liabilities, payments of interest" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:PaymentsOfInterestLeaseLiabilities" contextRef="From2023-01-012023-12-31" id="Fact003558" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">103,911</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Write-off (i)</td>
    <td id="xdx_989_ecustom--RightofuseAssetsWriteoff_pn3n3_c20250101__20251231_zLYEa3sEOuJ3" title="Right-of-use assets, Write-off" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:RightofuseAssetsWriteoff" contextRef="From2025-01-01to2025-12-31" id="Fact003560" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,311</ix:nonFraction>)</td>
    <td id="xdx_98B_ecustom--RightofuseAssetsWriteoff_pn3n3_c20240101__20241231_zR6omVt1EKL9" title="Right-of-use assets, Write-off" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:RightofuseAssetsWriteoff" contextRef="From2024-01-012024-12-31" id="Fact003562" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,982</ix:nonFraction>)</td>
    <td id="xdx_985_ecustom--RightofuseAssetsWriteoff_pn3n3_c20230101__20231231_zP3Z43ppyj7h" title="Right-of-use assets, Write-off" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:RightofuseAssetsWriteoff" contextRef="From2023-01-012023-12-31" id="Fact003564" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,469</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_980_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20250101__20251231_zb8SmeLgEXli" title="Lease liabilities, Write-off" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:LeaseLiabilitiesWriteoff" contextRef="From2025-01-01to2025-12-31" id="Fact003566" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,485</ix:nonFraction>)</td>
    <td id="xdx_983_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20240101__20241231_zoINMVKtH2Oa" title="Lease liabilities, Write-off" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:LeaseLiabilitiesWriteoff" contextRef="From2024-01-012024-12-31" id="Fact003568" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,259</ix:nonFraction>)</td>
    <td id="xdx_98A_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20230101__20231231_zSQ18FdrODXf" title="Lease liabilities, Write-off" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:LeaseLiabilitiesWriteoff" contextRef="From2023-01-012023-12-31" id="Fact003570" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,544</ix:nonFraction>)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Closing balance</b></td>
    <td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20250101__20251231_z83FsUeGPdD1" title="Right-of-use assets, balance at ending" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2025-12-31" id="Fact003572" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">896,758</ix:nonFraction> </b></td>
    <td id="xdx_981_eifrs-full--RightofuseAssets_iE_pn3n3_c20240101__20241231_zIJlhrQ8DRN4" title="Right-of-use assets, balance at ending" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2024-12-31" id="Fact003574" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">842,219</ix:nonFraction> </b></td>
    <td id="xdx_980_eifrs-full--RightofuseAssets_iE_pn3n3_c20230101__20231231_zigy42ysc84h" title="Right-of-use assets, balance at ending" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2023-12-31" id="Fact003576" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">767,609</ix:nonFraction>&#160;</b></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--LeaseLiabilities_iE_pn3n3_c20250101__20251231_zj6U64o61w0f" title="Lease liabilities, balance at ending" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31" id="Fact003578" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,065,746</ix:nonFraction> </b></td>
    <td id="xdx_987_eifrs-full--LeaseLiabilities_iE_pn3n3_c20240101__20241231_zDOvzCg0E3rg" title="Lease liabilities, balance at ending" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31" id="Fact003580" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">978,336</ix:nonFraction> </b></td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iE_pn3n3_c20230101__20231231_z18Kd8AYjSZ9" title="Lease liabilities, balance at ending" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2023-12-31" id="Fact003582" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">874,569</ix:nonFraction></b></td></tr>
  </table>
<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="width: 33%; padding-right: 3.5pt; padding-left: 3.5pt"><b>Balances:</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td>
    <td style="width: 1%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_983_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20251231_zVQBU8Kzgxhj" title="Right-of-use assets, current" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3584">-</span></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20241231_zKmXCVBS5Yg1" title="Right-of-use assets, current" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3586">-</span></td>
    <td id="xdx_987_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20231231_zq92Mxs84Og5" title="Right-of-use assets, current" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3588">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20251231_zWRjzez5qT8j" title="Lease liabilities, current" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2025-12-31" id="Fact003590" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,772</ix:nonFraction> </td>
    <td id="xdx_982_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20241231_zF7bmEAkbuZ4" title="Lease liabilities, current" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2024-12-31" id="Fact003592" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,580</ix:nonFraction>&#160;</td>
    <td id="xdx_982_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20231231_zplwbGBHes59" title="Lease liabilities, current" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2023-12-31" id="Fact003594" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,898</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_985_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20251231_zjWfNlJTche9" title="Right-of-use assets, non-current" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:RightofuseAssetsNonCurrent" contextRef="AsOf2025-12-31" id="Fact003596" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">896,758</ix:nonFraction></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20241231_zzWw057iipp5" title="Right-of-use assets, non-current" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:RightofuseAssetsNonCurrent" contextRef="AsOf2024-12-31" id="Fact003598" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">842,219</ix:nonFraction> </td>
    <td id="xdx_98E_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20231231_zvT3AFPGNFm9" title="Right-of-use assets, non-current" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:RightofuseAssetsNonCurrent" contextRef="AsOf2023-12-31" id="Fact003600" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">767,609</ix:nonFraction></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_982_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20251231_zUBh0pMUPeM6" title="Lease liabilities, non-current" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2025-12-31" id="Fact003602" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,009,974</ix:nonFraction> </td>
    <td id="xdx_980_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20241231_zmuTAq8dkLw6" title="Lease liabilities, non-current" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2024-12-31" id="Fact003604" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">932,756</ix:nonFraction></td>
    <td id="xdx_983_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20231231_z5hwXbmG3bb9" title="Lease liabilities, non-current" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2023-12-31" id="Fact003606" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">837,671</ix:nonFraction></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Refers to early termination of lease contracts.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AD_zBUvT8I7dJ9b" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company recognized lease expense from short-term leases and low-value assets of R$<span id="xdx_90C_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20250101__20251231_z0UM1xVFfRF9" title="Lease expense from short-term leases and low-value assets"><ix:nonFraction name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" contextRef="From2025-01-01to2025-12-31" id="Fact003608" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,617</ix:nonFraction></span>
for the year ended December 31, 2025 (R$<span id="xdx_900_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20240101__20241231_zm5XXISCR7ql" title="Lease expense from short-term leases and low-value assets"><ix:nonFraction name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" contextRef="From2024-01-012024-12-31" id="Fact003610" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,207</ix:nonFraction></span> and R$<span id="xdx_90A_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20230101__20231231_zIjye3jokNci" title="Lease expense from short-term leases and low-value assets"><ix:nonFraction name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" contextRef="From2023-01-012023-12-31" id="Fact003612" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,871</ix:nonFraction></span> for the years ended December 31, 2024 and 2023, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%"><b>12.2.3</b></td><td><b>Accounts payable to selling shareholders</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003614" name="afya:ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89D_ecustom--ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock_zcVBNn7CbKga" summary="xdx: Disclosure - Financial assets and liabilities (Details 5)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span id="xdx_8B1_z8jHkXAu4UE4" style="display: none">Schedule of accounts payable to selling shareholders</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"/>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; text-align: center"><b>Interest rate</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"/>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Accounts payable at amortized cost (deferred consideration)</b></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Unigranrio (a)</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_908_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zJC5b0b1LD4g" title="Interest rate"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_UnigranrioMember" id="Fact003616" name="afya:AccountsPayableAamortizedCostInterestRateBasis">CDI</ix:nonNumeric></span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zHlARej95FEj" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3618">-</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zPDRzaJR4GJ2" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_custom_UnigranrioMember" id="Fact003620" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">90,543</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">DelRey (b)</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_907_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zlCk9dBjP4Fj" title="Interest rate"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_DelReyMember" id="Fact003622" name="afya:AccountsPayableAamortizedCostInterestRateBasis">Selic</ix:nonNumeric></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWPWg3dXB525" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_custom_DelReyMember" id="Fact003624" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,604</ix:nonFraction> </td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zDjUbjyGWY5i" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_custom_DelReyMember" id="Fact003626" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">125,276</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">FUNIC (c)</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_90A_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zFSiFuNVQ34d" title="Interest rate"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_FUNICMember" id="Fact003628" name="afya:AccountsPayableAamortizedCostInterestRateBasis">CDI</ix:nonNumeric></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zDKnG57YjhT4" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_custom_FUNICMember" id="Fact003630" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,843</ix:nonFraction> </td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zgXtCo5MQmFc" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3632">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><b>Accounts payable at fair value (contingent consideration)</b></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Shosp (d)</td>
    <td style="vertical-align: bottom; text-align: center">-</td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zJsnNpdxVcsi" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_custom_ShospMember" id="Fact003634" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">454</ix:nonFraction> </td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zBolMYi8Pky2" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_custom_ShospMember" id="Fact003636" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">454</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Al&#233;m da Medicina (e)</td>
    <td style="vertical-align: bottom; text-align: center">-</td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zpNHiASUYtR7" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3638">-</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zGRd88fogiBi" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_custom_AlemDaMedicinaMember" id="Fact003640" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,600</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">CardioPapers (f)</td>
    <td style="vertical-align: bottom; text-align: center">-</td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zoa3WyA6Hpvk" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_custom_CardiPapersMember" id="Fact003642" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,883</ix:nonFraction> </td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zYVvQmhCETv2" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_custom_CardiPapersMember" id="Fact003644" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,013</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Unidom (g)</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_90D_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zsGBJFbvzyud" title="Interest rate"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_UnidomMember" id="Fact003646" name="afya:AccountsPayableAamortizedCostInterestRateBasis">CDI</ix:nonNumeric></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_za0n4IlLlAD5" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_custom_UnidomMember" id="Fact003648" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">321,813</ix:nonFraction> </td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zIGd8gh76783" title="Opening balance" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_custom_UnidomMember" id="Fact003650" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">294,886</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231_ziCyVAdc5JXk" title="Opening balance" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31" id="Fact003652" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">440,597</ix:nonFraction> </b></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231_z5hhiKLHZf66" title="Accounts payable" style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31" id="Fact003654" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">530,772</ix:nonFraction> </b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td id="xdx_98A_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_pn3n3_c20251231_zoRMpepDJVVk" title="Current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersCurrent" contextRef="AsOf2025-12-31" id="Fact003656" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,640</ix:nonFraction> </td>
    <td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersCurrent_pn3n3_c20241231_z8RKSErz3t02" title="Current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersCurrent" contextRef="AsOf2024-12-31" id="Fact003658" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">185,318</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_pn3n3_c20251231_zwBpujq7o7lk" title="Non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersNonCurrent" contextRef="AsOf2025-12-31" id="Fact003660" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">329,957</ix:nonFraction> </td>
    <td id="xdx_986_ecustom--AccountsPayableToSellingShareholdersNonCurrent_pn3n3_c20241231_zSuXbKLI69R1" title="Non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersNonCurrent" contextRef="AsOf2024-12-31" id="Fact003662" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">345,454</ix:nonFraction> </td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AE_zXKjrUTQvmj5" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(a) On August 4, 2021, Afya Brazil acquired <span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20210803__20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zRjCy1E8z62h" title="Ownership interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-08-032021-08-04_custom_UnigranrioMember" id="Fact003664" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Unigranrio. The adjusted aggregate
purchase price was R$<span id="xdx_907_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_c20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_pn3n3" title="Non-current payables for purchase of energy"><ix:nonFraction name="ifrs-full:NoncurrentPayablesForPurchaseOfEnergy" contextRef="AsOf2021-08-04_custom_UnigranrioMember" id="Fact003666" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">618,956</ix:nonFraction></span> of which 60% was paid in cash on the transaction closing date, and 40% was payable in cash in four equal
installments through 2022 to 2025, adjusted by the CDI rate. The aggregate outstanding amount was fully paid on August 4, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(b) On January 2, 2023, Afya Brazil acquired <span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zSQ6vjtg7X2k" title="Ownership interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-12-292023-01-02_custom_DelReyMember" id="Fact003668" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of DelRey. The consideration of R$<span id="xdx_908_ecustom--ConsiderationToBeTransferred_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_pn3n3" title="Consideration to be transferred"><ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2023-01-02_custom_DelReyMember" id="Fact003670" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">234,000</ix:nonFraction></span>
is payable in cash in three annual installments of R$<span id="xdx_909_ecustom--FirstAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zaWX13vTpkAi" title="First annual installment"><ix:nonFraction name="afya:FirstAnnualInstallmentsPayable" contextRef="From2022-12-292023-01-02_custom_DelReyMember" id="Fact003672" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">134,000</ix:nonFraction></span> in January 2024, R$<span id="xdx_908_ecustom--SecondAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zpuBrLMrHzrd" title="Second annual installment"><ix:nonFraction name="afya:SecondAnnualInstallmentsPayable" contextRef="From2022-12-292023-01-02_custom_DelReyMember" id="Fact003674" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,000</ix:nonFraction></span> in January 2025 and R$<span id="xdx_904_ecustom--ThirdAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z32mIzvNyr8a" title="Third annual installment"><ix:nonFraction name="afya:ThirdAnnualInstallmentsPayable" contextRef="From2022-12-292023-01-02_custom_DelReyMember" id="Fact003676" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,000</ix:nonFraction></span> in January 2026, adjusted
by the SELIC rate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(c) On May 7, 2025, Afya Brazil acquired <span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250505__20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zYeIzDnYAjda" title="Ownership interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2025-05-052025-05-07_custom_FUNICMember" id="Fact003678" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of FUNIC. The aggregate purchase price was
R$<span id="xdx_902_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z50vhGtOzCef" title="Non-current payables for purchase of energy"><ix:nonFraction name="ifrs-full:NoncurrentPayablesForPurchaseOfEnergy" contextRef="AsOf2025-05-07_custom_FUNICMember" id="Fact003680" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,000</ix:nonFraction></span> of which 60% was paid in cash on the transaction closing date, and 40% is payable in cash in three annual installments adjusted
by the CDI rate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(d) On May 13, 2021, Afya Brazil acquired <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20210512__20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z2PyRfPNEcs2" title="Ownership interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-05-122021-05-13_custom_ShospMember" id="Fact003682" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Shosp which included an earn-out of R$<span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zdoIJjfX0f8b" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-05-13_custom_ShospMember" id="Fact003684" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">513</ix:nonFraction></span>
paid in August 2023 related to product development and R$<span id="xdx_90C_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_pn3n3" title="Transaction price allocated to remaining performance obligations"><ix:nonFraction name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" contextRef="AsOf2021-05-13_custom_ShospMember" id="Fact003686" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">454</ix:nonFraction></span> will be paid until 2026.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(e) On March 4, 2022, Afya Brazil acquired <span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zzs9IUjDXEf7" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember" id="Fact003688" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Al&#233;m da Medicina and an earn-out
of up to R$<span id="xdx_909_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_pn3n3" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember" id="Fact003690" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,200</ix:nonFraction></span> is payable in connection with revenue target achievements and product development goals for 2023 and 2024. The contingent
consideration of R$<span id="xdx_90D_eifrs-full--DefinedBenefitObligationAtPresentValue_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_pn3n3" title="Defined benefit obligation"><ix:nonFraction name="ifrs-full:DefinedBenefitObligationAtPresentValue" contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember" id="Fact003692" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,600</ix:nonFraction></span> was fully paid on May 23, 2025.</p>


<ix:exclude><!-- Field: Page; Sequence: 215 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(f) On April 5, 2022, Afya Brazil acquired <span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z4t8QuOCCkA8" title="Ownership interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2022-04-042022-04-05_custom_CardioPapersMember" id="Fact003694" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of CardioPapers and an earn-out of up to
R$<span id="xdx_901_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_pn3n3" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact003696" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,000</ix:nonFraction></span> is payable in connection with revenue target achievements and other goals regarding credentials in the market for 2023 and 2024.
The contingent consideration of R$<span id="xdx_904_eifrs-full--DefinedBenefitObligationAtPresentValue_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_pn3n3" title="Defined benefit obligation"><ix:nonFraction name="ifrs-full:DefinedBenefitObligationAtPresentValue" contextRef="AsOf2022-04-05_custom_CardioPapersMember" id="Fact003698" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,883</ix:nonFraction></span> is based on the estimated payment considering the facts and circumstances as of December 31, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(g) On July 1, 2024, Afya Brazil acquired <span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240630__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zQEycIt2JfZ1" title="Ownership interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2024-06-302024-07-01_custom_UnidomMember" id="Fact003700" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Unidom. The consideration of R$<span id="xdx_905_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zIyC6sBdROJf" title="Defined benefit obligation"><ix:nonFraction name="ifrs-full:DefinedBenefitObligationAtPresentValue" contextRef="AsOf2024-07-01_custom_UnidomMember" id="Fact003702" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">279,989</ix:nonFraction></span>
is payable in up to ten annual installments, adjusted by the CDI rate, and it is conditioned upon the maintenance of the authorization
of the 175 medical school seats in each of the prior year. The contingent consideration is based on the estimated payment considering
the facts and circumstances as of December 31, 2025. The accounts payable to the selling shareholders of Unidom is updated by the CDI
rate, as determined in the purchase agreement, and measured at fair value considering the maintenance of the authorization of the 175
operating medical school seats. See Note 4.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The movements during the years ended December 31, 2025, 2024 and 2023 are shown below:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003704" name="afya:AccountsPayableToSellingShareholders1Explanatory"><table cellspacing="0" cellpadding="0" id="xdx_89A_ecustom--AccountsPayableToSellingShareholders1Explanatory_ztrVH9uKlFoe" summary="xdx: Disclosure - Financial assets and liabilities (Details 6)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B5_zXqp6kpCmX4k" style="display: none">Schedule of
    accounts payable</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><b>Opening balance</b></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOtVHYMr1kHi" title="Opening balance" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003706" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">530,772</ix:nonFraction></b></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zaejO9yWZyWh" title="Opening balance" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003708" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">566,867</ix:nonFraction></b></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z462xqz8zDK1" title="Opening balance" style="border-bottom: Black 1pt solid; text-align: right"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003710" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">528,678</ix:nonFraction></b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Additions</td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zn8ME7H7tCCi" title="Additions consideration to be transferred on business combinations" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersBusinessCombinations" contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003712" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,000</ix:nonFraction> </td>
    <td id="xdx_98C_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zigz5mARamFd" title="Additions consideration to be transferred on business combinations" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersBusinessCombinations" contextRef="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003714" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">279,989</ix:nonFraction></td>
    <td id="xdx_985_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwCowbXQKk3l" title="Additions consideration to be transferred on business combinations" style="text-align: right"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersBusinessCombinations" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003716" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">234,000</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Payments of principal</td>
    <td id="xdx_986_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z4TQgHqWmWac" title="Payments of principal" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:PaymentsOfPrincipal" contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003718" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">144,076</ix:nonFraction>)</td>
    <td id="xdx_985_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFzyY9CIJ1e5" title="Payments of principal" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:PaymentsOfPrincipal" contextRef="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003720" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">290,067</ix:nonFraction>)</td>
    <td id="xdx_986_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z5bIiixptDSj" title="Payments of principal" style="text-align: right">(<ix:nonFraction name="afya:PaymentsOfPrincipal" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003722" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">225,460</ix:nonFraction>)</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Payments of interest</td>
    <td id="xdx_980_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zS2GT9Rsb8Vc" title="Payment of interest" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003724" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,608</ix:nonFraction>)</td>
    <td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zeYlP5wmZlH1" title="Payment of interest" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003726" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">78,931</ix:nonFraction>)</td>
    <td id="xdx_983_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoFgKldgXHAa" title="Payment of interest" style="text-align: right">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003728" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,989</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Interest</td>
    <td id="xdx_98B_eifrs-full--InterestExpense_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zdvB85FYxhK5" title="Interest" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:InterestExpense" contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003730" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,979</ix:nonFraction> </td>
    <td id="xdx_98E_eifrs-full--InterestExpense_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zrE7rcRWEn2h" title="Interest" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:InterestExpense" contextRef="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003732" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,276</ix:nonFraction></td>
    <td id="xdx_98F_eifrs-full--InterestExpense_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zk1A2shaDQo9" title="Interest" style="text-align: right"><ix:nonFraction name="ifrs-full:InterestExpense" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85,069</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Remeasurement of contingent consideration</td>
    <td id="xdx_988_ecustom--RemeasurementOfEarnouts_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zjz7TBASLwof" title="Remeasurement of contingent consideration" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:RemeasurementOfEarnouts" contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003736" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,530</ix:nonFraction> </td>
    <td id="xdx_987_ecustom--RemeasurementOfEarnouts_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwQGJEL7x3G4" title="Remeasurement of contingent consideration" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:RemeasurementOfEarnouts" contextRef="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003738" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,638</ix:nonFraction></td>
    <td id="xdx_981_ecustom--RemeasurementOfEarnouts_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoTZdqyxh2l2" title="Remeasurement of contingent consideration" style="text-align: right"><ix:nonFraction name="afya:RemeasurementOfEarnouts" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003740" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,556</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Other</td>
    <td id="xdx_981_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zdoHM8oQRhsl" title="Other" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3742">-</span> </td>
    <td id="xdx_982_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zR8s1QU08UAg" title="Other" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3744">-</span></td>
    <td id="xdx_98D_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zkOu8uRedqKd" title="Other" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003746" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,987</ix:nonFraction>)</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><b>Closing balance</b></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zTJGcfhg39xf" title="Closing balance" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003748" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">440,597</ix:nonFraction></b></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zEt4JXbwsDbc" title="Closing balance" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003750" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">530,772</ix:nonFraction></b></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ztC8TeVwHVP" title="Closing balance" style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right"><b><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember" id="Fact003752" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">566,867</ix:nonFraction></b></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AE_zrUt6Cu4o13" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%"><b>12.3</b></td><td><b>Fair values</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The table below compares the carrying amounts and fair values of the Company&#8217;s financial
instruments, other than those carrying amounts that are reasonable approximation of fair values:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003754" name="afya:ScheduleOfFairValuesFinancialInstrumentstTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_893_ecustom--ScheduleOfFairValuesFinancialInstrumentstTableTextBlock_zaWsNnNt4Wo8" summary="xdx: Disclosure - Financial assets and liabilities (Details 7)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B3_zvCQCh6mSFh8" style="display: none">Schedule of fair values of the company's financial instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>2025</b> </td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 36%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Carrying amount</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 15%; text-align: right"><b>Fair value</b></td>
    <td style="width: 1%; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; text-align: right"><b>Carrying amount</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Fair value</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b>Financial liabilities</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Loans and financing</td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z6mwy2GWAmLa" title="Financial liabilities, at carrying amount" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2025-12-31_custom_LoansAndFinancingMember" id="Fact003756" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,054,267</ix:nonFraction> </td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zkwwMXOc6eRl" title="Financial liabilities, at fair value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2025-12-31_custom_LoansAndFinancingMember" id="Fact003758" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,056,492</ix:nonFraction> </td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zZgXKeQVxdd2" title="Financial liabilities, at carrying amount" style="text-align: right"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2024-12-31_custom_LoansAndFinancingMember" id="Fact003760" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,195,161</ix:nonFraction> </td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zy6HppqWQO7c" title="Financial liabilities, at fair value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2024-12-31_custom_LoansAndFinancingMember" id="Fact003762" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,196,152</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_pn3n3_c20251231_zxgafQbwzMQ7" title="Financial liabilities, at carrying amount" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2025-12-31" id="Fact003764" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,054,267</ix:nonFraction> </b></td>
    <td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20251231_zTXrOYytLgt" title="Financial liabilities, at fair value" style="border-bottom: Black 1.5pt double; text-align: right"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2025-12-31" id="Fact003766" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,056,492</ix:nonFraction> </b></td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231_zsZax9Uj0Q5l" title="Financial liabilities, at carrying amount" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; text-align: right"><b><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2024-12-31" id="Fact003768" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,195,161</ix:nonFraction> </b></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20241231_z2K7rU9FZfN9" title="Financial liabilities, at fair value" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2024-12-31" id="Fact003770" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,196,152</ix:nonFraction></b></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AB_zAGAZA231skf" style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The Company assessed that the fair values of cash and cash equivalents,
trade receivables, other assets, trade payables and accounts payable to selling shareholders approximate their carrying amounts.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The financial instruments for which the fair value are disclosed
are based on Level 2 fair value measurement hierarchy. There has been no change in fair value hierarchy during the years ended December
31, 2025 and 2024.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%"><b>12.4</b></td><td><b>Financial instruments risk management objectives and policies</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The Company&#8217;s main financial liabilities comprise loans
and financing, lease liabilities, accounts payable to selling shareholders and trade payables. The main purpose of these financial liabilities
is to finance the Company&#8217;s operations and expansion. The Company&#8217;s main financial assets include cash and cash equivalents
and trade receivables.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company is exposed to market risk, credit risk and liquidity risk. The Company monitors
market, credit and liquidity risks in line with the objectives of capital management and counts on the support, monitoring and oversight
of the Board of Directors in decisions related to capital management and its alignment with the objectives and risks. The Company&#8217;s
policy is that no trading of derivatives for speculative purposes may be undertaken. The Board of Directors reviews and agrees with policies
for managing each of these risks, which are summarized below.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>


<ix:exclude><!-- Field: Page; Sequence: 216 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%"><b>12.4.1</b></td><td><b>Market risk</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">Market risk is the risk that the fair value or future cash flows
of a financial instrument will fluctuate because of changes in market prices. The Company&#8217;s exposure to market risk is related to
interest rate and foreign currency risk. The sensitivity analysis in the following sections relates to the position as of December 31,
2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>a) Interest rate risk</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">Interest rate risk is the risk that the fair value or future cash
flows of a financial instrument will fluctuate because of changes in market interest rates. The Company&#8217;s exposure to the risk of
changes in market interest rates relates primarily to the Company&#8217;s cash equivalents, loans and financing and accounts payable to
selling shareholders, with floating interest rates.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white; color: #C00000"><span style="text-decoration: underline">Sensitivity analysis</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The table below demonstrates the sensitivity to a reasonably possible
change in interest on cash equivalents, loans and financing and accounts payable to selling shareholders. With all variables held constant,
the Company&#8217;s income before income taxes is affected through the impact on floating interest rates, as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003772" name="afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_897_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_zf2q7oBUugg4" summary="xdx: Disclosure - Financial assets and liabilities (Details 8)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BE_zNPHtsgVSAVd" style="display: none">Schedule of income before income taxes</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Index</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>Base rate</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cash equivalents</td>
    <td id="xdx_98C_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zrA15uDD1pni" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2025-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003774" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,086,489</ix:nonFraction> </td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_900_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zbbsq91S658k" title="Index - % per year"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003776" name="afya:IndexRatePerYear">CDI</ix:nonNumeric></span></td>
    <td id="xdx_983_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zdQMczYG49Qg" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:BaseRate" contextRef="From2025-01-012025-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003778" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">163,781</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Loans and financing</td>
    <td id="xdx_986_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zmZVsDbj9s5e" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2025-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003780" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,049,005</ix:nonFraction>)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_904_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zVMagY5M7RPg" title="Index - % per year"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003782" name="afya:IndexRatePerYear">CDI</ix:nonNumeric></span></td>
    <td id="xdx_98E_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zzwxjja3r20l" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:BaseRate" contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003784" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">323,480</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Loans and financing</td>
    <td id="xdx_984_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zbv8b2feDyzk" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2025-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003786" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,262</ix:nonFraction>)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_909_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zQntQr53qNPi" title="Index - % per year"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003788" name="afya:IndexRatePerYear">TJLP</ix:nonNumeric></span></td>
    <td id="xdx_983_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zeCJDTfiKAWb" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:BaseRate" contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003790" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">477</ix:nonFraction>)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders</td>
    <td id="xdx_987_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z6speULioNpj" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003792" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">365,656</ix:nonFraction>)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_90F_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zkFk7JmS4N2j" title="Index - % per year"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003794" name="afya:IndexRatePerYear">CDI</ix:nonNumeric></span></td>
    <td id="xdx_987_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zjLQcDfzLzH3" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:BaseRate" contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003796" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">54,483</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders</td>
    <td id="xdx_981_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zDc056qLG1Y7" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003798" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">71,604</ix:nonFraction>)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_901_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zmeiYYfhn45j" title="Index - % per year"><ix:nonNumeric contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003800" name="afya:IndexRatePerYear">Selic</ix:nonNumeric></span></td>
    <td id="xdx_98A_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zTFiBj48wHSj" title="Base rate" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:BaseRate" contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003802" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,669</ix:nonFraction>)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Net exposure</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_985_ecustom--BaseRate_pn3n3_c20250101__20251231_zxkYdR3fXnsi" title="Base rate" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(<ix:nonFraction name="afya:BaseRate" contextRef="From2025-01-01to2025-12-31" id="Fact003804" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">225,328</ix:nonFraction>)</b></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Increase in basis points</b></td></tr>
  <tr>
    <td style="white-space: nowrap; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>+75</b></td>
    <td style="width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>+150</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Net effect on profit before tax</td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zU05K3J0Pjdj" title="Effect on profit before tax" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2025-01-012025-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003806" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,538</ix:nonFraction>)</td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z6mnSGiXUo5g" title="Effect on profit before tax" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2025-01-012025-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember" id="Fact003808" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">21,076</ix:nonFraction>)</td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A8_zFZPYIgmzoYk" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>b) Foreign currency risk</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Foreign currency risk is the risk that the fair value or future cash flows of exposure
will fluctuate because of changes in foreign exchange rates. The Company&#8217;s exposure to the risk of changes in foreign exchange rates
relates to cash and cash equivalents denominated in U.S. dollars in the amount of R$<span id="xdx_905_ecustom--CreditExposures_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zpKvhj6yKuUf" title="Exposure risk"><ix:nonFraction name="afya:CreditExposures" contextRef="AsOf2025-12-31_ifrs-full_CurrencyRiskMember" id="Fact003810" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,422</ix:nonFraction></span> as of December 31, 2025 (December 31, 2024:
R$<span id="xdx_90F_ecustom--CreditExposures_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zrJGDStDheMf" title="Exposure risk"><ix:nonFraction name="afya:CreditExposures" contextRef="AsOf2024-12-31_ifrs-full_CurrencyRiskMember" id="Fact003812" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,610</ix:nonFraction></span>).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><span style="text-decoration: underline">Sensitivity analysis</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The table below demonstrates the sensitivity in the Company&#8217;s income before income
taxes of a <span id="xdx_906_ecustom--SensitivityChangeInTheEuroExchangeRate_pip0_dp_c20250101__20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zaFmv1yYYctk" title="Percentage of sensitivity change in the Euro exchange rate"><ix:nonFraction name="afya:SensitivityChangeInTheEuroExchangeRate" contextRef="From2025-01-012025-12-31_ifrs-full_CurrencyRiskMember" id="Fact003814" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% change in the U.S. dollar exchange rate (R$<span id="xdx_903_eifrs-full--ClosingForeignExchangeRate_iI_uN_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zfah5scgOwti" title="Closing foreign exchange rate"><ix:nonFraction name="ifrs-full:ClosingForeignExchangeRate" contextRef="AsOf2025-12-31_ifrs-full_CurrencyRiskMember" id="Fact003816" format="ixt:numdotdecimal" decimals="INF" unitRef="N">5.5018</ix:nonFraction></span> to U.S. dollar <span id="xdx_900_eifrs-full--ClosingForeignExchangeRate_iI_uN_c20251231__ifrs-full--CurrencyInWhichInformationIsDisplayedAxis__currency--EUR__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zyKcCICooMng" title="Closing foreign exchange rate"><ix:nonFraction name="ifrs-full:ClosingForeignExchangeRate" contextRef="AsOf2025-12-31_currency_EUR_ifrs-full_CurrencyRiskMember" id="Fact003818" format="ixt:numdotdecimal" decimals="INF" unitRef="N">1.00</ix:nonFraction></span>) as of December 31, 2025, with all other variables
held constant.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003820" name="afya:SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89D_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_zb2oG5xFCrXf" summary="xdx: Disclosure - Financial assets and liabilities (Details 9)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BC_zcdunEBlLHa9" style="display: none">Schedule of sensitivity foreign currency</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>Exposure</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>+10%</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>-10%</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cash equivalents</td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zrjBauUu3ul3" title="Cash and cash equivalents" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2025-01-012025-12-31_custom_ForeignCurrencyExposuresMember_ifrs-full_CurrencyRiskMember" id="Fact003822" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,422</ix:nonFraction> </td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zAEuZErKtdkc" title="Cash and cash equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2025-01-012025-12-31_custom_IncreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember" id="Fact003824" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,342</ix:nonFraction> </td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_z3gubqkXuT0k" title="Cash and cash equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2025-01-012025-12-31_custom_DecreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember" id="Fact003826" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,342</ix:nonFraction>)</td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A7_z8TMNCSGIFPg" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><b>12.4.2</b></td><td><b>Credit risk</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white">Credit risk is the risk that a counterparty
will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Company is exposed to
credit risk from its operating activities (primarily trade receivables) and from its financing activities, including cash and cash equivalents.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white">Customer credit risk is managed by the Company
based on the established policy, procedures and control relating to customer credit risk management. Outstanding customer receivables
are regularly monitored. See Note 6 for additional information on the Company&#8217;s trade receivables.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 217 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white">Credit risk from balances with banks and
financial institutions is managed by the Company&#8217;s treasury department in accordance with the Company&#8217;s policy. Investments
of surplus funds are made only with approved counterparties and within limits assigned to each counterparty.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The carrying amounts of its financial assets are the Company&#8217;s
maximum exposure to credit risk for the components of the consolidated statements of financial position on December 31, 2025 and 2024.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><b>12.4.3</b></td><td><b>Liquidity risk</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company&#8217;s Management has responsibility for monitoring liquidity risk. In order
to achieve the Company&#8217;s objective, Management regularly reviews the risk and maintains appropriate reserves, including bank credit
facilities with first tier financial institutions. Management also continuously monitors projected and actual cash flows and the combination
of the maturity profiles of the financial assets and liabilities.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The main requirements for financial resources used by the Company arise from the need to
make payments for suppliers, operating expenses, labor and social obligations, loans and financing and accounts payable to selling shareholders.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The tables below summarize the maturity profile of the Company&#8217;s
financial liabilities based on contractual undiscounted amounts:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003828" name="afya:SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_898_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_zlPRrzpky833" summary="xdx: Disclosure - Financial assets and liabilities (Details 10)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BB_zvmS6iwPiNRl" style="display: none">Schedule of maturity profile of financial liabilities</span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"><b>As of December 31, 2025 </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Less than 1 year</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>1 to 3 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>3 to 5 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>More than 5 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Trade payables</td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFNRL9fH6a25" title="Trade payables" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact003830" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123,581</ix:nonFraction> </td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zqzNeDCGV9T" title="Trade payables" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3832">-</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z7WfLovmFZbe" title="Trade payables" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3834">-</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztQJUTZkLyFk" title="Trade payables" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3836">-</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zSLHywHPJ24l" title="Trade payables" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember" id="Fact003838" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123,581</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Loans and financing</td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z4d53RHtL1Wl" title="Loans and financing" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact003840" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">308,292</ix:nonFraction> </td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmk3Yp8XSZUl" title="Loans and financing" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003842" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,360,411</ix:nonFraction> </td>
    <td id="xdx_981_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcGC5AiqwmP9" title="Loans and financing" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003844" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,473,733</ix:nonFraction> </td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zb2ovbIa8IMh" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3846">-</span></td>
    <td id="xdx_981_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_za9LadJEq9db" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember" id="Fact003848" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,142,436</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Lease liabilities</td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z75BJ7Wxsg3g" title="Lease liabilities" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact003850" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">178,638</ix:nonFraction> </td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeWz7OcSCtTb" title="Lease liabilities" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003852" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">347,847</ix:nonFraction> </td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2ydSLgnAhRa" title="Lease liabilities" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003854" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">331,019</ix:nonFraction> </td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztypRWgxaSSg" title="Lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003856" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,342,713</ix:nonFraction> </td>
    <td id="xdx_98F_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zoNOa3bY0JQ6" title="Lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember" id="Fact003858" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,200,217</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Accounts payable to selling shareholders</td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2FpJZ9DRzZ7" title="Accounts payable to selling shareholders" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact003860" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">126,307</ix:nonFraction> </td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2Mq143BlYX3" title="Accounts payable to selling shareholders" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003862" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">131,446</ix:nonFraction> </td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGwmVXkw2aU3" title="Accounts payable to selling shareholders" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003864" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">185,821</ix:nonFraction> </td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2w3RgNl0xs5" title="Accounts payable to selling shareholders" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003866" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">502,355</ix:nonFraction> </td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zUSnIFNlp12h" title="Accounts payable to selling shareholders" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember" id="Fact003868" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">945,929</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvDmmPQnN9fb" title="Financial liabilities contractual undiscounted" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact003870" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">736,818</ix:nonFraction> </b></td>
    <td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zwyNtX3MoPBe" title="Financial liabilities contractual undiscounted" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003872" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,839,704</ix:nonFraction> </b></td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgXMgQ64ffSe" title="Financial liabilities contractual undiscounted" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003874" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,990,573</ix:nonFraction> </b></td>
    <td id="xdx_985_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z4Pv9XYrLA68" title="Financial liabilities contractual undiscounted" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003876" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,845,068</ix:nonFraction> </b></td>
    <td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znoWOLTGKGG7" title="Financial liabilities contractual undiscounted" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember" id="Fact003878" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,412,163</ix:nonFraction> </b></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="white-space: nowrap; width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"><b>As of December 31, 2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Less than 1 year</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>1 to 3 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>3 to 5 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>More than 5 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Trade payables</td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zK67vmK9kYWg" title="Trade payables" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact003880" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,080</ix:nonFraction> </td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z3GYF1pkIKs7" title="Trade payables" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3882">-</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zHxblqQ7dHB3" title="Trade payables" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3884">-</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgaXtjjdLgp5" title="Trade payables" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3886">-</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zHr12gbM9Ejf" title="Trade payables" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember" id="Fact003888" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,080</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Loans and financing</td>
    <td id="xdx_987_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zYPHdM6YwmQ8" title="Loans and financing" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact003890" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">526,659</ix:nonFraction> </td>
    <td id="xdx_984_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjaUH06nPRTl" title="Loans and financing" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003892" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,494,287</ix:nonFraction> </td>
    <td id="xdx_985_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z24hWxMtpVKh" title="Loans and financing" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003894" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">617,818</ix:nonFraction> </td>
    <td id="xdx_988_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z6MrqSHuPOPk" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003896" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,526</ix:nonFraction> </td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGHnFZjWePXh" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember" id="Fact003898" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,714,290</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Lease liabilities</td>
    <td id="xdx_985_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zSmfkiuF7NG5" title="Lease liabilities" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact003900" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">158,746</ix:nonFraction> </td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zpbidtQS0Fp5" title="Lease liabilities" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003902" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">303,211</ix:nonFraction> </td>
    <td id="xdx_988_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zCpTp9UABDul" title="Lease liabilities" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003904" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">293,178</ix:nonFraction> </td>
    <td id="xdx_988_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zA0ILEgs1OY9" title="Lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003906" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,360,107</ix:nonFraction> </td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zaFH7tK4Aav1" title="Lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember" id="Fact003908" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,115,242</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Accounts payable to selling shareholders</td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zAvtxN2ym6Uc" title="Accounts payable to selling shareholders" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact003910" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">205,322</ix:nonFraction> </td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zLsuZQxTUlvi" title="Accounts payable to selling shareholders" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003912" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">150,565</ix:nonFraction> </td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z26HD8qrCuul" title="Accounts payable to selling shareholders" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003914" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,100</ix:nonFraction> </td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zt61WVDLJHB8" title="Accounts payable to selling shareholders" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003916" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">373,498</ix:nonFraction> </td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVzHZ5fuAol5" title="Accounts payable to selling shareholders" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember" id="Fact003918" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">828,485</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z78KMxuHMQCb" title="Financial liabilities contractual undiscounted" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember" id="Fact003920" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,018,807</ix:nonFraction> </b></td>
    <td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmmRjyOUb2Kc" title="Financial liabilities contractual undiscounted" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003922" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,948,063</ix:nonFraction> </b></td>
    <td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zzG4uph8O9W5" title="Financial liabilities contractual undiscounted" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003924" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,010,096</ix:nonFraction> </b></td>
    <td id="xdx_98F_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zlTL7c9tc2w" title="Financial liabilities contractual undiscounted" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember" id="Fact003926" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,809,131</ix:nonFraction> </b></td>
    <td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zuVCIo9EUJnf" title="Financial liabilities contractual undiscounted" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember" id="Fact003928" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,786,097</ix:nonFraction> </b></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zYAT2NduYAmg" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 218 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_z4vEUIUOJE3j" style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_z5QBhxluZSnk" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%"><b>12.5</b></td><td><b>Changes in liabilities arising from financing activities</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact003932" name="afya:ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89B_ecustom--ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock_z8kQs7hpzSya" summary="xdx: Disclosure - Financial assets and liabilities (Details 11)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="vertical-align: bottom"><span id="xdx_8B7_zZMIgodaQ9w4" style="display: none">Schedule of changes in liabilities arising from financing activities</span></td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.55pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.85pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.85pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.55pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>January 1, 2025</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"><span style="font-size: 7.5pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Additions and remeasurements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2025</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-size: 7.5pt"> </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Loans and financing</span></td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zNA3f0cYJtea" title="Liabilities arising from financing activities, beginning" style="padding-right: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2024-12-31_custom_LoansAndFinancingMember197490421" id="Fact003934" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,195,161</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zBOHFfbu0WLk" title="Payments of principal" style="padding-right: 2.55pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember" id="Fact003936" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,624,911</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zoM0dpID9092" title="Payments of interest" style="padding-right: 2.85pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember" id="Fact003938" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">274,265</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zfy41l2ZmVW7" title="Addition" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember" id="Fact003940" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,494,881</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zL6iIrp0H5K" title="Interest" style="text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember" id="Fact003942" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">252,870</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zZv3GviSRJm7" title="Other" style="text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember" id="Fact003944" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,531</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbF8AF1o1TZg" title="Liabilities arising from financing activities, ending" style="padding-right: 5.55pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2025-12-31_custom_LoansAndFinancingMember197490453" id="Fact003946" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,054,267</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Lease liabilities</span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zu009vAZvI8k" title="Liabilities arising from financing activities, beginning" style="padding-right: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact003948" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">978,336</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zEWih0Bgtcic" title="Payments of principal" style="padding-right: 2.55pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact003950" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">49,411</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zymGryeACWE8" title="Payments of interest" style="padding-right: 2.85pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact003952" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">121,475</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z0GSRMmdqvKl" title="Addition" style="padding-right: 3.85pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact003954" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">136,714</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_ziiUPemjPDy7" title="Interest" style="text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact003956" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123,067</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zLUKEqMy2PCh" title="Other" style="text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact003958" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,485</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zs5KiVN6Aop" title="Liabilities arising from financing activities, ending" style="padding-right: 5.55pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2025-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact003960" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,065,746</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Dividends payable</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -0.1pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zkdrSnZEsdeg" title="Payments of principal" style="border-bottom: Black 1pt solid; padding-right: -2.45pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-012025-12-31_custom_DividendsPayableMember" id="Fact003962" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">146,813</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zIzXu7nINfsa" title="Payments of interest" style="border-bottom: Black 1pt solid; padding-right: 2.85pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl3964">-</span></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zSKFp8AK9nof" title="Addition" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-012025-12-31_custom_DividendsPayableMember" id="Fact003966" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">147,005</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -1.15pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zfGZctHTOnVk" title="Liabilities arising from financing activities, ending" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2025-12-31_custom_DividendsPayableMember" id="Fact003968" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">192</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_988_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231_z2WFPiVmqtNg" title="Liabilities arising from financing activities, beginning" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2024-12-31" id="Fact003970" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,173,497</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zW2OqeMp5wTj" title="Payments of principal" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact003972" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,821,135</ix:nonFraction>)</b></span></td>
    <td id="xdx_988_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231_zyK9JtYRGFM7" title="Payments of interest" style="border-bottom: Black 1.5pt double; padding-right: 2.85pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact003974" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">395,740</ix:nonFraction>)</b></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zLboev8UMJL5" title="Addition" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact003976" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,778,600</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zc6UOhD4NaZ8" title="Interest" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact003978" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">375,937</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zic6RnozFOs4" title="Other" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2025-01-01to2025-12-31" id="Fact003980" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,046</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231_zsWujkEPTGf7" title="Liabilities arising from financing activities, ending" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2025-12-31" id="Fact003982" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,120,205</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>January 1, 2024</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"><span style="font-size: 7.5pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Additions and remeasurements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"><span style="font-size: 7.5pt"><b>Business combination</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2024</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.65pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Loans and financing</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zKLN9ka4wkFa" title="Liabilities arising from financing activities, beginning" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2023-12-31_custom_LoansAndFinancingMember" id="Fact003984" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,800,775</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zpd5ABoY3Ux8" title="Payments of principal" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31_custom_LoansAndFinancingMember" id="Fact003986" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">128,696</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zWkWQ3p4CjV5" title="Payments of interest" style="text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2024-01-012024-12-31_custom_LoansAndFinancingMember" id="Fact003988" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">177,192</ix:nonFraction>)</span></td>
    <td id="xdx_981_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbKqCmIGWnCi" title="Addition" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31_custom_LoansAndFinancingMember" id="Fact003990" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">491,593</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIt7RnMFRZs2" title="Interest" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31_custom_LoansAndFinancingMember" id="Fact003992" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">201,472</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znWYrJAD8V98" title="Business combination" style="text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31_custom_LoansAndFinancingMember" id="Fact003994" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,377</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zgrkIU4AjEdc" title="Other" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31_custom_LoansAndFinancingMember" id="Fact003996" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,832</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIa2SyBR9xF1" title="Liabilities arising from financing activities, ending" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2024-12-31_custom_LoansAndFinancingMember197490421" id="Fact003998" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,195,161</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Lease liabilities</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zrJRlVf7rEZ2" title="Liabilities arising from financing activities, beginning" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004000" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">874,569</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJdqASoXhjH9" title="Payments of principal" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004002" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">41,221</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zWU57RmUQDsi" title="Payments of interest" style="text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004004" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">111,605</ix:nonFraction>)</span></td>
    <td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zWW85cX3A2Wd" title="Addition" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004006" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">117,897</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zAk44Z8kjpG8" title="Interest" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004008" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">111,966</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxVzCn18NZsi" title="Business combination" style="text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004010" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,989</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zwRNvkPWEvc2" title="Other" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004012" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,259</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zyna1kzChKhf" title="Liabilities arising from financing activities, ending" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004014" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">978,336</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Dividends payable</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zKUpL8DtHOc6" title="Payments of principal" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31_custom_DividendsPayableMember" id="Fact004016" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,289</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ztZphFGnuay5" title="Addition" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31_custom_DividendsPayableMember" id="Fact004018" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,289</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231_zTqseykaZ2Q" title="Liabilities arising from financing activities, beginning" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2023-12-31" id="Fact004020" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,675,344</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z0g21NsOOJQe" title="Payments of principal" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31" id="Fact004022" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">188,206</ix:nonFraction>)</b></span></td>
    <td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231_zWZQUxdK7b7d" title="Payments of interest" style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2024-01-012024-12-31" id="Fact004024" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">288,797</ix:nonFraction>)</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zRV633tmfSy4" title="Addition" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31" id="Fact004026" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">627,779</ix:nonFraction></b></span></td>
    <td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zFAZPF3WKB9e" title="Interest" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31" id="Fact004028" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">313,438</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z1u2drMUfPgb" title="Business combination" style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31" id="Fact004030" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,366</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z33QO5joSqkl" title="Other" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2024-01-012024-12-31" id="Fact004032" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">573</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231_zeXUegstGWO9" title="Liabilities arising from financing activities, ending" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2024-12-31" id="Fact004034" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,173,497</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>January 1, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"><span style="font-size: 7.5pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Additions and remeasurements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Business combination</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2023</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Loans and financing</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zAbvHkGuABqk" title="Liabilities arising from financing activities, beginning" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2022-12-31_custom_LoansAndFinancingMember" id="Fact004036" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,882,901</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zep7lXZTg8Lk" title="Payments of principal" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember" id="Fact004038" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">112,630</ix:nonFraction>)</span></td>
    <td id="xdx_98D_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzIM7vMREBXk" title="Payments of interest" style="text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember" id="Fact004040" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">175,889</ix:nonFraction>)</span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z6oaoM6rGxYg" title="Addition" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember" id="Fact004042" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,288</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z1Se6OcaDRl1" title="Interest" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember" id="Fact004044" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">197,678</ix:nonFraction></span></td>
    <td style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zEnAymCsmtjl" title="Other" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember" id="Fact004046" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,427</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_ztYE4ee2JSN1" title="Liabilities arising from financing activities, ending" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2023-12-31_custom_LoansAndFinancingMember" id="Fact004048" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,800,775</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Lease liabilities</span></td>
    <td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zfZOL2E5IoR" title="Liabilities arising from financing activities, beginning" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004050" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">769,525</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zCjCw1AzLStf" title="Payments of principal" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004052" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,473</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zhNowFen9q4i" title="Payments of interest" style="text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004054" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">103,911</ix:nonFraction>)</span></td>
    <td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_za0sgkcc3XC3" title="Addition" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004056" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,715</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zOIVXQn4FXFg" title="Interest" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004058" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,849</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zdefxndxLZu4" title="Business combination" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004060" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,408</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvUshu3gYp11" title="Other" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004062" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,544</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxmeQ7tHH9j1" title="Liabilities arising from financing activities, ending" style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember" id="Fact004064" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">874,569</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Dividends payable</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ztWQV1suQKy2" title="Payments of principal" style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_DividendsPayableMember" id="Fact004066" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,750</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zuw744fAB3b5" title="Addition" style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31_custom_DividendsPayableMember" id="Fact004068" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,750</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231_zGstjq78Ltrk" title="Liabilities arising from financing activities, beginning" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2022-12-31" id="Fact004070" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,652,426</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z3dzHL0Ons9f" title="Payments of principal" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact004072" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">162,853</ix:nonFraction>)</b></span></td>
    <td id="xdx_98A_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231_zwhQDlB760Mc" title="Payments of interest" style="border-bottom: Black 1.5pt double; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact004074" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">279,800</ix:nonFraction>)</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zggXI22NMHrb" title="Additions and remeasurements" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact004076" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">101,753</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zqJhwB3cVi18" title="Interest" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact004078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">298,527</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z33wsgDVjiD8" title="Business combination" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact004080" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,408</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zJYub1gEgp12" title="Other" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact004082" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">117</ix:nonFraction>)</b></span></td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231_z2j0PmtDGP03" title="Liabilities arising from financing activities, ending" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2023-12-31" id="Fact004084" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,675,344</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AB_zS9e2JhB8DGd" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The changes in equity arising from financing activities are disclosed in the consolidated
statement of changes in equity.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004086" name="afya:CapitalManagementExplanatory"><p id="xdx_803_ecustom--CapitalManagementExplanatory_zzLvrfn0psv7" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">13</td><td><span id="xdx_829_zeL97GfOrAR">Capital management</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">For the purposes of the Company&#8217;s capital management, capital
considers total equity. The primary objective of the Company&#8217;s capital management is to maximize shareholder value.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">In order to achieve its overall objective, the Company&#8217;s
capital management, among other things, aims to ensure that it meets financial and non-financial covenants under the debentures and other
loans and financing. Breaches in meeting the financial covenants would permit the bank to immediately call loans and financing. There
have been no breaches of the financial and non-financial covenants of any loans and financing in the current and previous years.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">No changes were made in the objectives, policies or processes
for managing capital during the year ended December 31, 2025.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004088" name="afya:LaborAndSocialObligationsExplanatory"><p id="xdx_806_ecustom--LaborAndSocialObligationsExplanatory_z9oHMjVdS73f" style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">14</td><td><span id="xdx_829_zb3Ygm8zrTj2">Labor and social obligations</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>a) Variable compensation (bonuses)</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">The bonuses related to variable compensation of employees
and management of R$<span id="xdx_907_ecustom--ShareBasedCompensationOfEmployees_pn3n3_c20250101__20251231_zdgwUTT1k7nd" title="Compensation of employees"><ix:nonFraction name="afya:ShareBasedCompensationOfEmployees" contextRef="From2025-01-01to2025-12-31" id="Fact004090" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,581</ix:nonFraction></span>, R$<span id="xdx_90E_ecustom--ShareBasedCompensationOfEmployees_c20240101__20241231_pn3n3" title="Compensation of employees"><ix:nonFraction name="afya:ShareBasedCompensationOfEmployees" contextRef="From2024-01-012024-12-31" id="Fact004092" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,857</ix:nonFraction></span> and R$<span id="xdx_90C_ecustom--ShareBasedCompensationOfEmployees_c20230101__20231231_pn3n3" title="Compensation of employees"><ix:nonFraction name="afya:ShareBasedCompensationOfEmployees" contextRef="From2023-01-012023-12-31" id="Fact004094" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,185</ix:nonFraction></span> are recognized in cost of services and selling, general and administrative expenses
in the consolidated statement of income and other comprehensive income for the years ended December 31, 2025, 2024 and 2023, respectively.<br/>
</span></p>


<ix:exclude><!-- Field: Page; Sequence: 219 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_z30VN8BFDlah" style="font: bold 14pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>b) Afya Limited share-based compensation plans</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>b.1) Stock options plan</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">The stock options plan was approved on August 30, 2019
and granted to senior executives and other employees of the Company from that date, with subsequent changes in the exercise price, as
approved, on July 29, 2020, July 8, 2022 and July 31, 2023. Such changes were assessed as modifications by the Company and were accounted
in accordance with IFRS 2.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">During the years ended December 31, 2025, 2024 and 2023 the Company had the following grants
of stock options to its executives:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004097" name="afya:ScheduleOfFairValueOfStockOptionsGrantsExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_893_ecustom--ScheduleOfFairValueOfStockOptionsGrantsExplanatory_zvhZDc74HnA6" summary="xdx: Disclosure - Labor and social obligations (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B3_zGgNPB2SqyUj" style="display: none">Schedule of grants
of stock options</span></td>
    <td id="xdx_495_20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z6T0fZrOvqI5" style="text-align: center">&#160;</td>
    <td id="xdx_493_20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zK235Tb9bNp2" style="text-align: center">&#160;</td>
    <td id="xdx_497_20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zNZa1lSl2609" style="text-align: center">&#160;</td>
    <td id="xdx_49B_20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zNvkL1rYPUsa" style="text-align: center">&#160;</td>
    <td id="xdx_498_20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zs3ztMRbK1Bc" style="text-align: center">&#160;</td>
    <td id="xdx_49B_20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHa3XnkjJA68" style="text-align: center">&#160;</td>
    <td id="xdx_49A_20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3OIbkyhLU5h" style="text-align: center">&#160;</td>
    <td id="xdx_492_20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zfs4Xs9Cb3H4" style="text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>November</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2025</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>April</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2025</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 8%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>October</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2024</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 8%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>December</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 7%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>October</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 7%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>August</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 7%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>April</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 7%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>February</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right"/>
    <td style="text-align: right"/>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr id="xdx_408_ecustom--NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement_pn3n3_zWqzUVBwknDh" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Amount</td>
    <td style="text-align: right"><ix:nonFraction name="afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember" id="Fact004099" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">692,000</ix:nonFraction></td>
    <td style="text-align: right">&#160;<ix:nonFraction name="afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember" id="Fact004100" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,000</ix:nonFraction> </td>
    <td style="text-align: right"><ix:nonFraction name="afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember" id="Fact004101" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">113,900</ix:nonFraction></td>
    <td style="text-align: right"><ix:nonFraction name="afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004102" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">232,000</ix:nonFraction></td>
    <td style="text-align: right"><ix:nonFraction name="afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember" id="Fact004103" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,000</ix:nonFraction></td>
    <td style="text-align: right"><ix:nonFraction name="afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember" id="Fact004104" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,000</ix:nonFraction></td>
    <td style="text-align: right"><ix:nonFraction name="afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember" id="Fact004105" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,000</ix:nonFraction></td>
    <td style="text-align: right"><ix:nonFraction name="afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember" id="Fact004106" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,000</ix:nonFraction></td></tr>
  <tr id="xdx_403_ecustom--SharePriceFairValueAtMeasurementDate_pip0_zt6sMhDJPCK6" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Exercise price at the measurement date</td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDate" contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember" id="Fact004108" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">62.57</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDate" contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember" id="Fact004109" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">79.91</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDate" contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember" id="Fact004110" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">73.75</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDate" contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004111" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">60</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDate" contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember" id="Fact004112" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">59</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDate" contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember" id="Fact004113" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">59</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDate" contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember" id="Fact004114" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">57</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDate" contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember" id="Fact004115" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">56</ix:nonFraction></td></tr>
  <tr id="xdx_404_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pip0_dp_zaQHGtSd4vK6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Dividend yield (%)</td>
    <td style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember" id="Fact004117" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction>%</td>
    <td style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember" id="Fact004118" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction>%</td>
    <td style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember" id="Fact004119" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction>%</td>
    <td style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004120" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction>%</td>
    <td style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember" id="Fact004121" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction>%</td>
    <td style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember" id="Fact004122" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction>%</td>
    <td style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember" id="Fact004123" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction>%</td>
    <td style="text-align: right"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember" id="Fact004124" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction>%</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Expected volatility (%)</td>
    <td style="text-align: right"><span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z3a2zokWHkni" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004126" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24</ix:nonFraction></span>-<span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zhYY03hXbIyk" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004128" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">41</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zmkAxaOJEPd2" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004130" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">35</ix:nonFraction></span>-<span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTPzINAqPsrj" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004132" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">44</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zRDwFMzwknRb" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004134" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">32</ix:nonFraction></span>-<span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTaePcHfivNe" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004136" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zsLUc0A16E82" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004138" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction></span>-<span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvQqfh9Pafxb" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004140" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">56</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zdJiyIN9wYk6" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004142" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">44</ix:nonFraction></span>-<span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zD39cWsDcLQ1" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004144" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">56</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOSZrXlcyZD3" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004146" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">47</ix:nonFraction></span>-<span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0TpV4isUZ76" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004148" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">56</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zzLnpWvuvqO2" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004150" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48</ix:nonFraction></span>-<span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zeEOMDZRaeG8" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004152" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">55</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDvwBftIf02h" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004154" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">46</ix:nonFraction></span>-<span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zbgyNuZPYWqg" title="Expected volatility"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004156" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">56</ix:nonFraction></span>%</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Risk-free interest rate (%)</td>
    <td style="text-align: right"><span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zXhzqbtNwI24" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004158" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>-<span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zK64lbUpWev2" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004160" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_908_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zL4FuMa3ygfe" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004162" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14</ix:nonFraction></span>-<span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zpQqpMVYktCe" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004164" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8UuU76vuby2" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004166" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span>-<span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZNJzCKOJZ7g" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004168" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zWqmaTXFX4I1" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004170" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>-<span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z3zFmkt2PGP4" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004172" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zSg6N5dHPT0l" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004174" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span>-<span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zmZaF4bP4NKg" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004176" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zUFWKlQGKDx3" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004178" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>-<span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z4JquBKNxWlc" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004180" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLYSuS7KNh63" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" id="Fact004182" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span>-<span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zI0vJM6gywRj" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" id="Fact004184" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>%</td>
    <td style="text-align: right"><span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zAJASHq0BBGh" title="Risk-free interest rate"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember" id="Fact004186" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>%</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Expected life of stock options (years)</td>
    <td style="text-align: right"><span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0jLLW2lU6J3" title="Expected life of stock options"><ix:nonNumeric contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact004188" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span>-<span id="xdx_90A_ecustom--ExpectedLifeOfStockOptions_dtY_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zcXSWBKRKiVi" title="Expected life of stock options"><ix:nonNumeric contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact004190" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zJ5SPoXZEyX6" title="Expected life of stock options"><ix:nonNumeric contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact004192" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span>-<span id="xdx_90C_ecustom--ExpectedLifeOfStockOptions_dtY_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z9CG5kRjj7C" title="Expected life of stock options"><ix:nonNumeric contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact004194" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_90F_ecustom--ExpectedLifeOfStockOptions_dtY_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo1yo9kxDfY5" title="Expected life of stock options"><ix:nonNumeric contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact004196" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span>-<span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zpwNuy5S3Tsf" title="Expected life of stock options"><ix:nonNumeric contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact004198" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_900_ecustom--ExpectedLifeOfStockOptions_dtY_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zUUeOhGyCg0i" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact004200" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span>-<span id="xdx_908_ecustom--ExpectedLifeOfStockOptions_dtY_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zKlUUVd2lpKh" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact004202" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_904_ecustom--ExpectedLifeOfStockOptions_dtY_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLCObi1GJ524" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact004204" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span>-<span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zp9XJ1CqRkm7" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact004206" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCcJKVef1vV9" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact004208" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span>-<span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_znWUS3p2NLj" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact004210" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zXgdDziYvER" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact004212" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span>-<span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zh9QH7khRfM8" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact004214" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0NENZi2yMJ4" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember" format="ixt-sec:duryear" id="Fact004216" name="afya:ExpectedLifeOfStockOptions">1</ix:nonNumeric></span>-<span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z7FWqTwEwbs" title="Expected life of stock options"><ix:nonNumeric contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember" format="ixt-sec:duryear" id="Fact004218" name="afya:ExpectedLifeOfStockOptions">5</ix:nonNumeric></span></td></tr>
  <tr id="xdx_409_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_pip0_zhSqRAp2Tre1" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Share price at the measurement date</td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember" id="Fact004220" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">79.36</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember" id="Fact004221" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">107.33</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember" id="Fact004222" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">92.78</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004223" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">100.97</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember" id="Fact004224" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">79.12</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember" id="Fact004225" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">76.45</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember" id="Fact004226" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">62.51</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember" id="Fact004227" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">70.69</ix:nonFraction></td></tr>
  <tr id="xdx_40D_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_i" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Valuation model</td>
    <td style="text-align: right"><ix:nonNumeric contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember" id="Fact004229" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></td>
    <td style="text-align: right"><ix:nonNumeric contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember" id="Fact004230" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></td>
    <td style="text-align: right"><ix:nonNumeric contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember" id="Fact004231" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></td>
    <td style="text-align: right"><ix:nonNumeric contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004232" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></td>
    <td style="text-align: right"><ix:nonNumeric contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember" id="Fact004233" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></td>
    <td style="text-align: right"><ix:nonNumeric contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember" id="Fact004234" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></td>
    <td style="text-align: right"><ix:nonNumeric contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember" id="Fact004235" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></td>
    <td style="text-align: right"><ix:nonNumeric contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember" id="Fact004236" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></td></tr>
  <tr id="xdx_406_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_pip0_z80Gu2ZEmFnh" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt">Weighted average fair value at the measurement date</td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember" id="Fact004238" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">33.27</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember" id="Fact004239" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">45.95</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember" id="Fact004240" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">39.71</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004241" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">54.25</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember" id="Fact004242" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">38.67</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember" id="Fact004243" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">37.04</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember" id="Fact004244" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">32.04</ix:nonFraction></td>
    <td style="text-align: right">R$<ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember" id="Fact004245" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">29.54</ix:nonFraction></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zOZCJZH2NT0c" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The table below presents the number and movements in stock options
for the years ended December 31, 2025, 2024 and 2023:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004247" name="afya:ScheduleOfSharebasedCompensationPlanExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_897_ecustom--ScheduleOfSharebasedCompensationPlanExplanatory_pn3n3_zFzoezmEhTV9" summary="xdx: Disclosure - Labor and social obligations (Details 1)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8B0_zLGkJU0tLkH5" style="display: none">Schedule of movements in stock options</span></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td rowspan="2" style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>Weighted average exercise price</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>(in Brazilian Reais)</b></p></td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1pt solid; font: 8.5pt Nunito Sans; margin: 0; text-align: center"><b>Number of stock options</b></p></td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b>2025</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b>2024</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b>2023</b></span></td></tr>
  <tr>
    <td style="width: 39%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="vertical-align: bottom; width: 28%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"/>
    <td style="white-space: nowrap; width: 11%; padding-left: 0.1in; font-size: 10pt; text-align: right">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at January 1</b></span></td>
    <td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zraIJSzFCkke" title="Weighted average exercise price, Outstanding at the beginning" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2024-12-31_ifrs-full_ShareOptionsMember" id="Fact004249" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">67.31</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zO4kayTsCld6" title="Number of stock options, Outstanding at the beginning" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2024-12-31_ifrs-full_ShareOptionsMember" id="Fact004251" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">1,610,679</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z5Q8ZFRA9Wtf" title="Number of stock options, Outstanding at the beginning" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember" id="Fact004253" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">1,696,064</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHZagAo9RIX5" title="Number of stock options, Outstanding at the beginning" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-12-31_ifrs-full_ShareOptionsMember" id="Fact004255" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">3,729,287</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Granted</span></td>
    <td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zD1ZddyRkMke" title="Weighted average exercise price, Granted" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember" id="Fact004257" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">63.95</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zarVmL6ef2xg" title="Number of stock options, Granted" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember" id="Fact004259" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">752,000</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z1kiz2uCbBz6" title="Number of stock options, Granted" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2024-01-012024-12-31_ifrs-full_ShareOptionsMember" id="Fact004261" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">113,900</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3IAUYRtt7q7" title="Number of stock options, Granted" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004263" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">467,000</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Exercised</span></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zpu4iEOMKoS1" title="Weighted average exercise price, Exercised" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember" id="Fact004265" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">63.62</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zxT2Mq5vrGY2" title="Number of stock options, Exercised" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember" id="Fact004267" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">404,478</ix:nonFraction>)</span></td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGKd39zZRU7l" title="Number of stock options, Exercised" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2024-01-012024-12-31_ifrs-full_ShareOptionsMember" id="Fact004269" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">147,955</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z9ZGh8Sebarh" title="Number of stock options, Exercised" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004271" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">164,214</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Stock options exchanged to RSUs</span></td>
    <td id="xdx_984_ecustom--WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_iI_pip0_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHdtqCer9AEf" title="Weighted average exercise price, Exercised" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><span style="-sec-ix-hidden: xdx2ixbrl4273">-</span></span></td>
    <td id="xdx_98E_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zhsjUI4JlqAh" title="Number of stock options, stock option exchanged" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><span style="-sec-ix-hidden: xdx2ixbrl4275">-</span></span></td>
    <td id="xdx_987_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmV62YvwqcVd" title="Number of stock options, stock option exchanged" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><span style="-sec-ix-hidden: xdx2ixbrl4277">-</span></span></td>
    <td id="xdx_98B_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGxPS01O5x75" title="Number of stock options, stock option exchanged" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004279" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">1,751,599</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Forfeited</span></td>
    <td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zaKvtHUKDlW8" title="Weighted average exercise price, Forfeited" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember" id="Fact004281" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">72.42</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_ze6ykiFid7Kg" title="Number of stock options, Forfeited" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember" id="Fact004283" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">57,152</ix:nonFraction>)</span></td>
    <td id="xdx_988_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zsidkfnTT7h4" title="Number of stock options, Forfeited" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2024-01-012024-12-31_ifrs-full_ShareOptionsMember" id="Fact004285" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">16,182</ix:nonFraction>)</span></td>
    <td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zMsaiNPv6mCi" title="Number of stock options, Forfeited" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004287" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">333,111</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Expired</span></td>
    <td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z8mHAL7v4bZe" title="Weighted average exercise price, Expired" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember" id="Fact004289" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">68.54</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zPcEiMVVab3c" title="Number of stock options, Expired" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember" id="Fact004291" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">57,680</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z91sTDJENHc4" title="Number of stock options, Expired" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="From2024-01-012024-12-31_ifrs-full_ShareOptionsMember" id="Fact004293" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">35,148</ix:nonFraction>)</span></td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zQJsLxD7amw3" title="Number of stock options, Expired" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember" id="Fact004295" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">251,299</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at December 31</b></span></td>
    <td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zATYUtVrdlh7" title="Weighted average exercise price, Outstanding at the ending" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2025-12-31_ifrs-full_ShareOptionsMember" id="Fact004297" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">65.91</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z2mW4KaitVZd" title="Number of stock options, Outstanding at the ending" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2025-12-31_ifrs-full_ShareOptionsMember" id="Fact004299" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">1,843,369</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGitrYnMUbB8" title="Number of stock options, Outstanding at the ending" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2024-12-31_ifrs-full_ShareOptionsMember" id="Fact004301" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">1,610,679</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zV27MvxAdFne" title="Number of stock options, Outstanding at the ending" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember" id="Fact004303" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">1,696,064</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Exercisable</b></span></td>
    <td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pip0_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmDdNrIKSON5" title="Weighted average exercise price, Exercisable" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="AsOf2025-12-31_ifrs-full_ShareOptionsMember" id="Fact004305" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">71.33</ix:nonFraction></b></span></td>
    <td id="xdx_98A_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zLVpGQ22dOC4" title="Number of stock options, Exercisable" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="afya:NumberOfStockOptionsExercisable" contextRef="AsOf2025-12-31_ifrs-full_ShareOptionsMember" id="Fact004307" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">340,219</ix:nonFraction></b></span></td>
    <td id="xdx_989_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zsJMf5UO94M6" title="Number of stock options, Exercisable" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="afya:NumberOfStockOptionsExercisable" contextRef="AsOf2024-12-31_ifrs-full_ShareOptionsMember" id="Fact004309" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">427,202</ix:nonFraction></b></span></td>
    <td id="xdx_981_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zK2nhsM4tARb" title="Number of stock options, Exercisable" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="afya:NumberOfStockOptionsExercisable" contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember" id="Fact004311" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">242,235</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zi6sz3L98kml" style="font: 10.5pt Nunito Sans; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The share-based compensation expense recognized in selling, general
and administrative expenses in the consolidated statement of income and other comprehensive income for the year ended December 31, 2025
was R$<span id="xdx_90B_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_z4t4P7XGUVG1" title="Share-based compensation expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2025-01-012025-12-31_custom_ShareBasedCompensationPlansMember" id="Fact004313" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,809</ix:nonFraction></span> (R$<span id="xdx_90A_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zhR2rKvMLxCl" title="Share-based compensation expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2024-01-012024-12-31_custom_ShareBasedCompensationPlansMember" id="Fact004315" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,394</ix:nonFraction></span> and R$<span id="xdx_909_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_z7LpqbyqduNc" title="Share-based compensation expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2023-01-012023-12-31_custom_ShareBasedCompensationPlansMember" id="Fact004317" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,850</ix:nonFraction></span> in 2024 and 2023, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white; color: #C00000"><b>b.2) Restricted Stock Units (RSU) Program</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">On July 8, 2022, the Company approved the Restricted Stock Units
program for its employees. The participant's right to effectively receive ownership of the restricted stock units will be conditioned
on the participant's continuance as an employee or director in the business group from the grant date until vesting. The executives will
be entitled to these shares in a proportion of <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pip0_dp_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z8GSA5kB6JC9" title="Proportion percentage"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember" id="Fact004319" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>%, <span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pip0_dp_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits1Member_zS5bG2c1d0lb" title="Proportion percentage"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnits1Member" id="Fact004321" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>%, <span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pip0_dp_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits2Member_z7jjDJ0jHrY" title="Proportion percentage"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnits2Member" id="Fact004323" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></span>%, <span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pip0_dp_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits3Member_ztL7nW4Klxq1" title="Proportion percentage"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnits3Member" id="Fact004325" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">40</ix:nonFraction></span>% each year.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company accounts for the RSU plan as an equity-settled plan, except for the portion
of labor and social securities obligations.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">During the years ended December 31, 2025, 2024 and 2023 the Company
had the following grants of RSUs to its executives:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004327" name="afya:ScheduleOfGrantsRestrictedStockUnitsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_896_ecustom--ScheduleOfGrantsRestrictedStockUnitsTableTextBlock_zV48BfBx6yL5" summary="xdx: Disclosure - Labor and social obligations (Details 2)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt"><span id="xdx_8BC_zuLxXAoP3M1" style="display: none">Schedule of grants
of RSUs</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>November</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2025</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>April</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2025</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>October</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2024</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>December</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>October</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>August</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>April</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>February</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; text-align: right"/>
    <td style="vertical-align: top; text-align: right"/>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Amount</td>
    <td id="xdx_989_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_zICCFZgsdfx2" title="Granted" style="text-align: right"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2025-01-012025-12-31_custom_November2025Member" id="Fact004329" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">346,000</ix:nonFraction></td>
    <td id="xdx_985_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_z6wKGwWz9FZk" title="Granted" style="text-align: right"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2025-01-012025-12-31_custom_April2025Member" id="Fact004331" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,000</ix:nonFraction></td>
    <td id="xdx_982_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zMXEDJuS1bJj" title="Granted" style="text-align: right"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2024-01-012024-12-31_custom_October2024Member" id="Fact004333" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,500</ix:nonFraction></td>
    <td id="xdx_986_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_ztVtzmnIuLG6" title="Granted" style="text-align: right"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_December2023Member" id="Fact004335" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,600</ix:nonFraction></td>
    <td id="xdx_982_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zpal9jAuBLck" title="Granted" style="text-align: right"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_October2023Member" id="Fact004337" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,000</ix:nonFraction></td>
    <td id="xdx_989_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zE0O4ptKVl31" title="Granted" style="text-align: right"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_August2023Member" id="Fact004339" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,490</ix:nonFraction></td>
    <td id="xdx_98B_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zhqa0iPvtezk" title="Granted" style="text-align: right"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_April2023Member" id="Fact004341" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,000</ix:nonFraction></td>
    <td id="xdx_98F_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_z9yQzaTS6Xni" title="Granted" style="text-align: right"><ix:nonFraction name="afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_February2023Member" id="Fact004343" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,000</ix:nonFraction></td></tr>

<tr style="background-color: White">
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt">Weighted average fair value at the measurement date</td>
    <td id="xdx_989_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_zWCPmhNdYxJ5" title="Fair values at grant date" style="width: 9%; text-align: right">R$<ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2025-01-012025-12-31_custom_November2025Member" id="Fact004345" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">79.36</ix:nonFraction></td>
    <td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_zYJr10Oa09M7" title="Fair values at grant date" style="width: 9%; text-align: right">R$<ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2025-01-012025-12-31_custom_April2025Member" id="Fact004347" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">107.33</ix:nonFraction></td>
    <td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zJGGHwdVffZ6" title="Fair values at grant date" style="width: 9%; text-align: right">R$<ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2024-01-012024-12-31_custom_October2024Member" id="Fact004349" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">92.78</ix:nonFraction></td>
    <td id="xdx_98B_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zNvnzT4Y0cn7" title="Fair values at grant date" style="width: 9%; text-align: right">R$<ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-01-012023-12-31_custom_December2023Member" id="Fact004351" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">100.97</ix:nonFraction></td>
    <td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zNMqQFYVlTlj" title="Fair values at grant date" style="width: 9%; text-align: right">R$<ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-01-012023-12-31_custom_October2023Member" id="Fact004353" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">79.12</ix:nonFraction></td>
    <td id="xdx_98A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zieMWlWClbXe" title="Fair values at grant date" style="width: 9%; text-align: right">R$<ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-01-012023-12-31_custom_August2023Member" id="Fact004355" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">76.45</ix:nonFraction></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zACW5bG8T6c5" title="Fair values at grant date" style="width: 9%; text-align: right">R$<ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-01-012023-12-31_custom_April2023Member" id="Fact004357" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">62.51</ix:nonFraction></td>
    <td id="xdx_987_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zHw7SUIVdxTg" title="Fair values at grant date" style="width: 9%; text-align: right">R$<ix:nonFraction name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="From2023-01-012023-12-31_custom_February2023Member" id="Fact004359" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">70.69</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Vesting period (years)</td>
    <td style="text-align: right"><span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_znAcmh3mMXpd" title="Vesting period"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember_custom_November2025Member" format="ixt-sec:duryear" id="Fact004361" name="afya:GrantedVestingPeriod">1</ix:nonNumeric></span>-<span id="xdx_90A_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_z8OXOynCf8J1" title="Vesting period"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember_custom_November2025Member" format="ixt-sec:duryear" id="Fact004363" name="afya:GrantedVestingPeriod">4</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_zPILF04KSlvk" title="Vesting period"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember_custom_April2025Member" format="ixt-sec:duryear" id="Fact004365" name="afya:GrantedVestingPeriod">1</ix:nonNumeric></span>-<span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_z3MS7RGKoXof" title="Vesting period"><ix:nonNumeric contextRef="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember_custom_April2025Member" format="ixt-sec:duryear" id="Fact004367" name="afya:GrantedVestingPeriod">4</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_90C_ecustom--GrantedVestingPeriod_dtY_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zphrbhAzCoq8" title="Vesting period"><ix:nonNumeric contextRef="From2024-01-012024-12-31_ifrs-full_BottomOfRangeMember_custom_October2024Member" format="ixt-sec:duryear" id="Fact004369" name="afya:GrantedVestingPeriod">1</ix:nonNumeric></span>-<span id="xdx_905_ecustom--GrantedVestingPeriod_dtY_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_z7dAnJ3MghPc" title="Vesting period"><ix:nonNumeric contextRef="From2024-01-012024-12-31_ifrs-full_TopOfRangeMember_custom_October2024Member" format="ixt-sec:duryear" id="Fact004371" name="afya:GrantedVestingPeriod">4</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_90D_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zaLtoQSJ7M5a" title="Vesting period"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_December2023Member" format="ixt-sec:duryear" id="Fact004373" name="afya:GrantedVestingPeriod">1</ix:nonNumeric></span>-<span id="xdx_904_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zVKrezoWsjae" title="Vesting period"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_December2023Member" format="ixt-sec:duryear" id="Fact004375" name="afya:GrantedVestingPeriod">4</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_908_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zYwjdE4YIn46" title="Vesting period"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_October2023Member" format="ixt-sec:duryear" id="Fact004377" name="afya:GrantedVestingPeriod">1</ix:nonNumeric></span>-<span id="xdx_905_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_z02xbUIzr3Gj" title="Vesting period"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_October2023Member" format="ixt-sec:duryear" id="Fact004379" name="afya:GrantedVestingPeriod">4</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zqm69NMWJsNb" title="Vesting period"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_August2023Member" format="ixt-sec:duryear" id="Fact004381" name="afya:GrantedVestingPeriod">1</ix:nonNumeric></span>-<span id="xdx_90A_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zqGjtgM78qVf" title="Vesting period"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_August2023Member" format="ixt-sec:duryear" id="Fact004383" name="afya:GrantedVestingPeriod">4</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zKkh2qfBvsD" title="Vesting period"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_April2023Member" format="ixt-sec:duryear" id="Fact004385" name="afya:GrantedVestingPeriod">1</ix:nonNumeric></span>-<span id="xdx_90E_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_znKKKNNMnb5l" title="Vesting period"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_April2023Member" format="ixt-sec:duryear" id="Fact004387" name="afya:GrantedVestingPeriod">4</ix:nonNumeric></span></td>
    <td style="text-align: right"><span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zBt1kX2xCEok" title="Vesting period"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_February2023Member" format="ixt-sec:duryear" id="Fact004389" name="afya:GrantedVestingPeriod">1</ix:nonNumeric></span>-<span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zjJb7xEFaRql" title="Vesting period"><ix:nonNumeric contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_February2023Member" format="ixt-sec:duryear" id="Fact004391" name="afya:GrantedVestingPeriod">4</ix:nonNumeric></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AB_zGQ4BkuzLlCb" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 220 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zA3HRX5Mejl" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zHu25ofEsA8j" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The table below presents the number and movements in RSUs for the years ended December
31, 2025, 2024 and 2023:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004395" name="afya:ScheduleOfStockOptionTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_890_ecustom--ScheduleOfStockOptionTableTextBlock_pn3n3_zcaFvNJVhna3" summary="xdx: Disclosure - Labor and social obligations (Details 3)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><span id="xdx_8B7_zcQK8v9WNAh7" style="display: none">Schedule of stock option</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 49%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; text-indent: -9.35pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"/>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Outstanding at January 1</b></td>
    <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zKQADaIQ2OK3" title="Number of stock options, Outstanding at the beginning" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2024-12-31_custom_RestrictedStockUnitsMember" id="Fact004397" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">656,634</ix:nonFraction></b></td>
    <td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zva28bMgxnV3" title="Number of stock options, Outstanding at the beginning" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-12-31_custom_RestrictedStockUnitsMember" id="Fact004399" format="ixt:numdotdecimal" decimals="INF" unitRef="N">854,431</ix:nonFraction></b></td>
    <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zCE4lHvJhfBj" title="Number of stock options, Outstanding at the beginning" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember" id="Fact004401" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">447,224</ix:nonFraction></b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Granted</td>
    <td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zXCsaRfq2Moj" title="Number of stock options, Granted" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember" id="Fact004403" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">381,000</ix:nonFraction></td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zIySk7IVqJo7" title="Number of stock options, Granted" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2024-01-012024-12-31_custom_RestrictedStockUnitsMember" id="Fact004405" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">44,500</ix:nonFraction></td>
    <td id="xdx_98A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zYh56vwbBwEi" title="Number of stock options, Granted" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember" id="Fact004407" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">317,090</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Stock options exchanged to RSUs</td>
    <td id="xdx_985_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zIXJzIvwsL02" title="Number of stock options, Stock options exchanged" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4409">-</span></td>
    <td id="xdx_98E_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z4ggG1ljDdj5" title="Number of stock options, Stock options exchanged" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4411">-</span></td>
    <td id="xdx_98B_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z46Le5Md8Qi1" title="Number of stock options, Stock options exchanged" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><ix:nonFraction name="afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember" id="Fact004413" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">215,797</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Exercised</td>
    <td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z64yoxIWwf72" title="Number of stock options, Exercised" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember" id="Fact004415" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">224,070</ix:nonFraction>)</td>
    <td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zP2UEEmgRBZg" title="Number of stock options, Exercised" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2024-01-012024-12-31_custom_RestrictedStockUnitsMember" id="Fact004417" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">222,910</ix:nonFraction>)</td>
    <td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z5CCL3T5mK66" title="Number of stock options, Exercised" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember" id="Fact004419" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">99,576</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Expired</td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zylOPFGb2J18" title="Number of stock options, Forfeited" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember" id="Fact004421" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">93,846</ix:nonFraction>)</td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zaMTLE4Mao49" title="Number of stock options, Forfeited" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2024-01-012024-12-31_custom_RestrictedStockUnitsMember" id="Fact004423" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">19,387</ix:nonFraction>)</td>
    <td id="xdx_986_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z0wLJ1wZxyMk" title="Number of stock options, Forfeited" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember" id="Fact004425" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">26,104</ix:nonFraction>)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Outstanding at December 31</b></td>
    <td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zb2Uk8Lq4n7k" title="Number of stock options, Outstanding at the ending" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2025-12-31_custom_RestrictedStockUnitsMember" id="Fact004427" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">719,718</ix:nonFraction></b></td>
    <td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zNE4wQnNJZ65" title="Number of stock options, Outstanding at the ending" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2024-12-31_custom_RestrictedStockUnitsMember" id="Fact004429" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">656,634</ix:nonFraction></b></td>
    <td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zXzCqgWBYC7" title="Number of stock options, Outstanding at the ending" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2023-12-31_custom_RestrictedStockUnitsMember" id="Fact004431" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="N">854,431</ix:nonFraction></b></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A4_zsNMEv2rjU5c" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Total RSU expenses recognized in selling, general and administrative expenses in the consolidated
statement of income and other comprehensive income for the year ended December 31, 2025 were R$<span id="xdx_903_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z7iqg38g1MBh" title="Share-based compensation expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember" id="Fact004433" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,509</ix:nonFraction></span> (R$<span id="xdx_90C_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z9hV6vWmtrv7" title="Share-based compensation expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2024-01-012024-12-31_custom_RestrictedStockUnitsMember" id="Fact004435" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,030</ix:nonFraction></span> and R$<span id="xdx_908_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zLUEh3KzsXV5" title="Share-based compensation expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember" id="Fact004437" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,685</ix:nonFraction></span> in 2024 and
2023, respectively). Labor and social obligations expenses were R$<span id="xdx_908_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20251231_zN29wCxaLLnh" title="Social obligations liabilities"><ix:nonFraction name="afya:SocialObligationsLiabilities" contextRef="AsOf2025-12-31" id="Fact004439" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,660</ix:nonFraction></span>, R$<span id="xdx_90C_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20241231_znQzFlSoSb19" title="Social obligations liabilities"><ix:nonFraction name="afya:SocialObligationsLiabilities" contextRef="AsOf2024-12-31" id="Fact004441" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,988</ix:nonFraction></span> and R$<span id="xdx_904_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20231231_zpMY7vO1TUbj" title="Social obligations liabilities"><ix:nonFraction name="afya:SocialObligationsLiabilities" contextRef="AsOf2023-12-31" id="Fact004443" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,177</ix:nonFraction></span> for the years ended December 31, 2025, 2024
and 2023, respectively.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004445" name="afya:DisclosureOfEquityExplanatory"><p id="xdx_80F_ecustom--DisclosureOfEquityExplanatory_z56SPHAr04A1" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">15</td><td><span id="xdx_824_zwT67diaK6p2">Equity</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><span style="text-decoration: underline">Share capital</span></p>

<p style="font: 7pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">As of December 31, 2025, the Company&#8217;s share capital was R$<span id="xdx_902_eifrs-full--IssuedCapital_iI_pn3n3_c20251231_zEir0WlgBYHl" title="Share capital"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2025-12-31" id="Fact004447" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></span> represented by <span id="xdx_90F_ecustom--NumberOfSharesIssued1_iI_pip0_c20251231_z1Nnei9eWG52" title="Total number of shares"><ix:nonFraction name="afya:NumberOfSharesIssued1" contextRef="AsOf2025-12-31" id="Fact004449" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">93,722,831</ix:nonFraction></span> shares comprised by
<span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pip0_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_z53a3OjaTXEf" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2025-12-31_custom_ClassAOrdinarySharesMember" id="Fact004451" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">55,148,697</ix:nonFraction></span> class A common shares and <span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_pip0_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zDJjXbp0Qr45" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2025-12-31_custom_ClassBOrdinarySharesMember" id="Fact004453" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">38,574,134</ix:nonFraction></span> class B common shares. As of December 31, 2024, the Company&#8217;s share capital was R$<span id="xdx_900_eifrs-full--IssuedCapital_iI_pn3n3_c20241231_z472mbs5CMyc" title="Share capital"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2024-12-31" id="Fact004455" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></span> represented
by <span id="xdx_90D_ecustom--NumberOfSharesIssued1_iI_pip0_c20241231_zCeLCeakWEGd" title="Total number of shares"><ix:nonFraction name="afya:NumberOfSharesIssued1" contextRef="AsOf2024-12-31" id="Fact004457" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">93,722,831</ix:nonFraction></span> shares comprised by <span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pip0_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zGveERBlzulh" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2024-12-31_custom_ClassAOrdinarySharesMember" id="Fact004459" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,920,068</ix:nonFraction></span> class A common shares and <span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pip0_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zv6uj5zbFZM6" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2024-12-31_custom_ClassBOrdinarySharesMember" id="Fact004461" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">43,802,763</ix:nonFraction></span> class B common shares. As of December 31, 2025 and 2024,
the Company&#8217;s authorized capital was US$<span id="xdx_900_ecustom--IssuedCapitals_c20251231_pn3n3" title="Authorized capital"><span id="xdx_907_ecustom--IssuedCapitals_iI_pn3n3_c20241231_zRwGtSAcHKRc" title="Authorized capital"><ix:nonFraction name="afya:IssuedCapitals" contextRef="AsOf2025-12-31" id="Fact004463" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL"><ix:nonFraction name="afya:IssuedCapitals" contextRef="AsOf2024-12-31" id="Fact004465" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50</ix:nonFraction></ix:nonFraction></span></span> thousand divided into <span id="xdx_90E_ecustom--CapitalUnitsAuthorizedShares_iI_pn3n3_c20251231_zFQu5rexiDNi" title="Authorized capital units"><ix:nonFraction name="afya:CapitalUnitsAuthorizedShares" contextRef="AsOf2025-12-31" id="Fact004467" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">1,000,000,000</ix:nonFraction></span> shares of a nominal value of US$<span id="xdx_90E_eifrs-full--ParValuePerShare_iI_c20251231_z12HwBjrisaa" title="Nominal value per share"><ix:nonFraction name="ifrs-full:ParValuePerShare" contextRef="AsOf2025-12-31" id="Fact004469" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">0.00005</ix:nonFraction></span> each.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white; color: #C00000"><span style="text-decoration: underline">Dividends</span></p>

<p style="font: 7pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In the year ended December 31, 2025, CCSI and IESVAP approved the payment of dividends
of R$<span id="xdx_900_ecustom--PaymentOfDividends_pn3n3_c20250101__20251231_zEb8bjx8NFg5" title="Payment of dividends"><ix:nonFraction name="afya:PaymentOfDividends" contextRef="From2025-01-01to2025-12-31" id="Fact004471" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,862</ix:nonFraction></span>, which R$<span id="xdx_909_ecustom--DividendDistributed_pn3n3_c20250101__20251231_zxEnf2ZO3Bmb" title="Dividend distributed"><ix:nonFraction name="afya:DividendDistributed" contextRef="From2025-01-01to2025-12-31" id="Fact004473" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59,641</ix:nonFraction></span> was distributed to the Company and R$<span id="xdx_900_eifrs-full--DividendsPaidToNoncontrollingInterests_c20250101__20251231_pn3n3" title="Dividends paid to non-controlling interests"><ix:nonFraction name="ifrs-full:DividendsPaidToNoncontrollingInterests" contextRef="From2025-01-01to2025-12-31" id="Fact004475" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,221</ix:nonFraction></span> to non-controlling shareholders (December 31 2024: R$<span id="xdx_90D_ecustom--PaymentOfDividends_c20240101__20241231_pn3n3" title="Payment of dividends"><ix:nonFraction name="afya:PaymentOfDividends" contextRef="From2024-01-012024-12-31" id="Fact004477" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">79,701</ix:nonFraction></span>, which
R$<span id="xdx_908_ecustom--DividendDistributed_c20240101__20241231_pn3n3" title="Dividend distributed"><ix:nonFraction name="afya:DividendDistributed" contextRef="From2024-01-012024-12-31" id="Fact004479" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">61,412</ix:nonFraction></span> was distributed to the Company and R$<span id="xdx_902_eifrs-full--DividendsPaidToNoncontrollingInterests_c20240101__20241231_pn3n3" title="Dividends paid to non-controlling interests"><ix:nonFraction name="ifrs-full:DividendsPaidToNoncontrollingInterests" contextRef="From2024-01-012024-12-31" id="Fact004481" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,289</ix:nonFraction></span> to non-controlling shareholders and December 31, 2023: R$<span id="xdx_90F_ecustom--PaymentOfDividends_c20230101__20231231_pn3n3" title="Payment of dividends"><ix:nonFraction name="afya:PaymentOfDividends" contextRef="From2023-01-012023-12-31" id="Fact004483" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,539</ix:nonFraction></span>, which R$<span id="xdx_90A_ecustom--DividendDistributed_c20230101__20231231_pn3n3" title="Dividend distributed"><ix:nonFraction name="afya:DividendDistributed" contextRef="From2023-01-012023-12-31" id="Fact004485" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,788</ix:nonFraction></span> was
distributed to the Company and R$<span id="xdx_90C_eifrs-full--DividendsPaidToNoncontrollingInterests_c20230101__20231231_pn3n3" title="Dividends paid to non-controlling interests"><ix:nonFraction name="ifrs-full:DividendsPaidToNoncontrollingInterests" contextRef="From2023-01-012023-12-31" id="Fact004487" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,750</ix:nonFraction></span> to non-controlling shareholders).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On March 12, 2025, the Company&#8217;s Board of Directors approved the first dividend distribution
in the amount of R$<span id="xdx_902_ecustom--FirstDividendDistributionInAmount_pn3n3_c20250311__20250312_zelXdXu8E3N5" title="First dividend distribution in amount"><ix:nonFraction name="afya:FirstDividendDistributionInAmount" contextRef="From2025-03-112025-03-12" id="Fact004489" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">129,784</ix:nonFraction></span>, representing <span id="xdx_90C_ecustom--PercentageOfDividendDistribution_pip0_dp_c20250311__20250312_zazk5TCNlOlf" title="Percentage of dividend distribution"><ix:nonFraction name="afya:PercentageOfDividendDistribution" contextRef="From2025-03-112025-03-12" id="Fact004491" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>% of the Company&#8217;s consolidated net income for the year ended December 31, 2024 and a
dividend per share of R$<span id="xdx_90B_eifrs-full--DividendsPaidOtherSharesPerShare_c20250403__20250404_zGDni4S6dZUg" title="Dividends per share"><ix:nonFraction name="ifrs-full:DividendsPaidOtherSharesPerShare" contextRef="From2025-04-032025-04-04" id="Fact004493" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">1.348923</ix:nonFraction></span>, to the shareholders on record as of the close of business on March 26, 2025, paid in U.S. dollars on
April 4, 2025, at the exchange rate (PTAX) published by the Brazilian Central Bank on March 13, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white; color: #C00000"><span style="text-decoration: underline">Treasury shares</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On August 13, 2025, the Company&#8217;s board of directors approved a new share repurchase
program. Under the share repurchase program, Afya may repurchase up to <span id="xdx_90B_ecustom--RepurchaseOfOrdinaryShares_iI_c20250813__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zzo6DK7blnfc" title="Repurchase of ordinary shares"><ix:nonFraction name="afya:RepurchaseOfOrdinaryShares" contextRef="AsOf2025-08-13_custom_ClassAOrdinarySharesMember" id="Fact004495" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000,000</ix:nonFraction></span> of its outstanding Class A common shares, in the open
market, based on prevailing market prices, or in privately negotiated transactions, beginning from August 15, 2025 until the earlier of
the completion of the repurchase or December 31, 2026, depending upon market conditions. During the year ended December 31, 2025, the
Company&#8217;s cash outflow was R$<span id="xdx_90A_ecustom--CashOutflow_pn3n3_c20250101__20251231_zuA1Vm3RslE9" title="Cash outflow"><ix:nonFraction name="afya:CashOutflow" contextRef="From2025-01-01to2025-12-31" id="Fact004497" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,002</ix:nonFraction></span>.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The table below illustrates the number and movements in treasury shares during the years
ended December 31, 2025, 2024 and 2023:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:exclude><p id="xdx_233_z5ptPKJzptr6" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 221 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zvmgeoS388B" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004501" name="afya:ScheduleOfTreasurySharesMovementExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_89D_ecustom--ScheduleOfTreasurySharesMovementExplanatory_pn3n3_zFqys31Z6pmf" summary="xdx: Disclosure - Equity (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8B7_z1lKQEh9mEhe" style="display: none">Schedule
    of number and movements in treasury shares</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 48%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b>Number of treasury shares</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 29%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"><span style="font-size: 8.5pt"><b>Average price (in Brazilian Reais)</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at January 1, 2023</b></span></td>
    <td id="xdx_98E_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20230101__20231231_zLIRN8DzrJs6" title="Number of shares, Outstanding, at beginning balance" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2022-12-31" id="Fact004503" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">3,786,285</ix:nonFraction></b></span></td>
    <td id="xdx_987_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20230101__20231231_zp4RN1pSehDc" title="Average price, at beginning balance" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2022-12-31" id="Fact004505" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">80.54</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Repurchased</span></td>
    <td id="xdx_986_ecustom--NumberOfSharesRepurchased_pip0_c20230101__20231231_zIFiSsp7ZrU6" title="Number of shares, Repurchased" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="afya:NumberOfSharesRepurchased" contextRef="From2023-01-012023-12-31" id="Fact004507" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">216,339</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--AveragePriceRepurchased_pip0_c20230101__20231231_zKgY03FRrdij" title="Average price repurchased" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="afya:AveragePriceRepurchased" contextRef="From2023-01-012023-12-31" id="Fact004509" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">57.17</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Delivered under the share-based compensation plans</span></td>
    <td id="xdx_982_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20230101__20231231_zBTy8AECDH69" title="Number of treasury shares, delivered under the share-based compensation plan" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="afya:NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" contextRef="From2023-01-012023-12-31" id="Fact004511" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="Shares">229,146</ix:nonFraction>)</span></td>
    <td id="xdx_989_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20230101__20231231_z3ymjGJWvvn4" title="Average price, delivered under the share-based compensation plan" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="afya:AveragePriceDeliveredUnderSharebasedCompensationPlan" contextRef="From2023-01-012023-12-31" id="Fact004513" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">79.28</ix:nonFraction></span></td></tr>

<tr style="background-color: White">
    <td style="width: 48%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at December 31, 2023</b></span></td>
    <td id="xdx_98A_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20240101__20241231_zQzjgrbWJZt" title="Number of shares, Outstanding, at beginning balance" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact004515" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">3,773,478</ix:nonFraction></b></span></td>
    <td id="xdx_98A_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20240101__20241231_zN8rACYg7P9c" title="Average price, at beginning balance" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 29%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2023-12-31" id="Fact004517" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">79.28</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Delivered under the share-based compensation plans</span></td>
    <td id="xdx_983_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20240101__20241231_zWarKk2kBdBc" title="Number of treasury shares, delivered under the share-based compensation plan" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="afya:NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" contextRef="From2024-01-012024-12-31" id="Fact004519" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="Shares">317,940</ix:nonFraction>)</span></td>
    <td id="xdx_98D_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20240101__20241231_ze05wOtMOcog" title="Average price, delivered under the share-based compensation plan" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="afya:AveragePriceDeliveredUnderSharebasedCompensationPlan" contextRef="From2024-01-012024-12-31" id="Fact004521" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">79.28</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at December 31, 2024</b></span></td>
    <td id="xdx_98C_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20250101__20251231_zjJrbHUyw2Da" title="Number of shares, Outstanding, at beginning balance" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2024-12-31" id="Fact004523" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">3,455,538</ix:nonFraction></b></span></td>
    <td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20250101__20251231_znhjjQqlaLG8" title="Average price, at beginning balance" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2024-12-31" id="Fact004525" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">79.28</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Repurchased</span></td>
    <td id="xdx_98D_ecustom--NumberOfSharesRepurchased_pip0_c20250101__20251231_zpFkaLnJResk" title="Number of shares, Repurchased" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="afya:NumberOfSharesRepurchased" contextRef="From2025-01-01to2025-12-31" id="Fact004527" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">966,541</ix:nonFraction> </span></td>
    <td id="xdx_989_ecustom--AveragePriceRepurchased_pip0_c20250101__20251231_zD2WH79RwTml" title="Average price repurchased" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="afya:AveragePriceRepurchased" contextRef="From2025-01-01to2025-12-31" id="Fact004529" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">80.24</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Delivered under the share-based compensation plans</span></td>
    <td id="xdx_984_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20250101__20251231_zdMXbpddoxZ9" title="Number of treasury shares, delivered under the share-based compensation plan" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt">(<ix:nonFraction name="afya:NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" contextRef="From2025-01-01to2025-12-31" id="Fact004531" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="Shares">566,929</ix:nonFraction>)</span></td>
    <td id="xdx_98C_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20250101__20251231_zFTLvkjxLdK2" title="Average price, delivered under the share-based compensation plan" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><ix:nonFraction name="afya:AveragePriceDeliveredUnderSharebasedCompensationPlan" contextRef="From2025-01-01to2025-12-31" id="Fact004533" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">79.28</ix:nonFraction> </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding
at December 31, 2025 </b></span></td>
    <td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iE_pip0_c20250101__20251231_znR8iogO0UV9" title="Number of shares, Outstanding, at ending balance" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="ifrs-full:NumberOfSharesOutstanding" contextRef="AsOf2025-12-31" id="Fact004535" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">3,855,150</ix:nonFraction> </b></span></td>
    <td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20250101__20251231_zF8D1o4cTSIj" title="Average price, at ending balance" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b><ix:nonFraction name="afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2025-12-31" id="Fact004537" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">79.52</ix:nonFraction> </b></span></td></tr>
  </table>
<p style="font: 8.5pt Nunito Sans; margin: 0"></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004539" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory"><p id="xdx_80D_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zH11XJlrXg58" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">16</td><td><span id="xdx_822_zH5jfAacIaUb">Earnings per share</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The table below presents the basic and diluted earnings per share
calculations:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004541" name="afya:ScheduleOfEarningsPerShareTableExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_881_ecustom--ScheduleOfEarningsPerShareTableExplanatory_pn3n3_zh6rgpEuBgn5" summary="xdx: Disclosure - Earnings per share (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt"><span id="xdx_8B9_zodizhWBFyXc" style="display: none">Schedule of earnings per share</span></td>
    <td id="xdx_496_20250101_20251231" style="padding-right: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_494_20240101_20241231" style="padding-right: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_492_20230101_20231231" style="padding-right: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 67%; padding-right: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><b>2023</b></td></tr>
  <tr id="xdx_400_ecustom--NumeratorAbstract_iB_z0RC0JVRVHcj">
    <td style="padding-right: 5.4pt"><b>Numerator</b></td>

    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_pn3n3_zNvLq2og6BKi" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt">Net income attributable to the owners of the Company</td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends" contextRef="From2025-01-01to2025-12-31" id="Fact004547" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">752,461</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends" contextRef="From2024-01-012024-12-31" id="Fact004548" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">631,510</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends" contextRef="From2023-01-012023-12-31" id="Fact004549" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">386,324</ix:nonFraction></td></tr>
  <tr id="xdx_40C_ecustom--DenominatorAbstract_iB_zPDlgkbW8LBa" style="background-color: White">
    <td style="padding-right: 5.4pt"><b>Denominator</b></td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--WeightedAverageShares_pip0_zkwRAE4k6qQ1" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt">Weighted average number of outstanding shares</td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="From2025-01-01to2025-12-31" id="Fact004555" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">90,475,878</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="From2024-01-012024-12-31" id="Fact004556" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">90,122,429</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="From2023-01-012023-12-31" id="Fact004557" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">89,830,351</ix:nonFraction></td></tr>
  <tr id="xdx_40B_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pip0_zd5BBGZokSp5" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt">Effects of dilution from stock options and restricted stock units</td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" contextRef="From2025-01-01to2025-12-31" id="Fact004559" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">791,733</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" contextRef="From2024-01-012024-12-31" id="Fact004560" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">1,032,207</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" contextRef="From2023-01-012023-12-31" id="Fact004561" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">706,492</ix:nonFraction></td></tr>
  <tr id="xdx_409_eifrs-full--AdjustedWeightedAverageShares_pip0_uShares_znBfrJta8Odd" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt">Weighted average number of outstanding shares adjusted for the effect of dilution</td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="From2025-01-01to2025-12-31" id="Fact004563" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">91,267,611</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="From2024-01-012024-12-31" id="Fact004564" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">91,154,636</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="From2023-01-012023-12-31" id="Fact004565" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">90,536,843</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--BasicEarningsLossPerShare_pip0_zvR340v2rBd4" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Basic earnings per share (R$)</td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2025-01-01to2025-12-31" id="Fact004567" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">8.32</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2024-01-012024-12-31" id="Fact004568" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">7.01</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2023-01-012023-12-31" id="Fact004569" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">4.30</ix:nonFraction></td></tr>
  <tr id="xdx_40E_eifrs-full--DilutedEarningsLossPerShare_pip0_z1dVhWo7H7Ze" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Diluted earnings per share (R$)</td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2025-01-01to2025-12-31" id="Fact004571" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">8.24</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2024-01-012024-12-31" id="Fact004572" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">6.93</ix:nonFraction></td>
    <td style="padding-right: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2023-01-012023-12-31" id="Fact004573" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="BRLPShares">4.27</ix:nonFraction></td></tr>
  </table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 222 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_z2apZLNQhP7l" style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004576" name="ifrs-full:DisclosureOfRevenueExplanatory"><p id="xdx_80C_eifrs-full--DisclosureOfRevenueExplanatory_zjXsL3NXZAja" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">17</td><td><span id="xdx_827_zJ2ZIj7ya1wl">Revenue</span></td></tr></table>

<p style="font: 10pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004578" name="afya:ScheduleOfNetSalesRevenueExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_895_ecustom--ScheduleOfNetSalesRevenueExplanatory_pn3n3_zCw9eshgzik3" summary="xdx: Disclosure - Revenue (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt"><span id="xdx_8BA_zPRZBJnC7Fod" style="display: none">Schedule of net sales revenue</span></td>
    <td id="xdx_49B_20250101__20251231_z0k2DkE3dr21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20240101__20241231_zTfpTc16bgq8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20230101__20231231_zHaKiN8J6dZ3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 67%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>

    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ProfessionalFeesExpenses_pn3n3_zyjYbgSzo7D4" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt">Tuition fees</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:ProfessionalFeesExpenses" contextRef="From2025-01-01to2025-12-31" id="Fact004580" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,684,322</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:ProfessionalFeesExpenses" contextRef="From2024-01-012024-12-31" id="Fact004581" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,052,379</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:ProfessionalFeesExpenses" contextRef="From2023-01-012023-12-31" id="Fact004582" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,505,250</ix:nonFraction></td></tr>
  <tr id="xdx_407_ecustom--OtherRevenue1_pn3n3_zK2rOdtULspa" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt">Other</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:OtherRevenue1" contextRef="From2025-01-01to2025-12-31" id="Fact004584" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">331,934</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:OtherRevenue1" contextRef="From2024-01-012024-12-31" id="Fact004585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">305,527</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:OtherRevenue1" contextRef="From2023-01-012023-12-31" id="Fact004586" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">263,937</ix:nonFraction></td></tr>
  <tr id="xdx_40C_ecustom--DeductionAbstract_iB_zmierXsa5567" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt"><b>Deductions</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DeductionOfGrantedDiscounts_pn3n3_zmSi6w4vfHif" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt">Discount and scholarships</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DeductionOfGrantedDiscounts" contextRef="From2025-01-01to2025-12-31" id="Fact004592" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">685,219</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DeductionOfGrantedDiscounts" contextRef="From2024-01-012024-12-31" id="Fact004593" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">515,311</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DeductionOfGrantedDiscounts" contextRef="From2023-01-012023-12-31" id="Fact004594" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">435,368</ix:nonFraction>)</td></tr>
  <tr id="xdx_40E_ecustom--DeductionOfReturnsOfNetRevenue_pn3n3_zyxMaG0JrtEd" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt">Returns</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DeductionOfReturnsOfNetRevenue" contextRef="From2025-01-01to2025-12-31" id="Fact004596" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,665</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DeductionOfReturnsOfNetRevenue" contextRef="From2024-01-012024-12-31" id="Fact004597" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">25,312</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DeductionOfReturnsOfNetRevenue" contextRef="From2023-01-012023-12-31" id="Fact004598" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">27,743</ix:nonFraction>)</td></tr>
  <tr id="xdx_405_ecustom--DeductionOfTaxes_pn3n3_ztUq5OcAl3ye" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt">Taxes</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DeductionOfTaxes" contextRef="From2025-01-01to2025-12-31" id="Fact004600" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">194,477</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DeductionOfTaxes" contextRef="From2024-01-012024-12-31" id="Fact004601" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">170,628</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DeductionOfTaxes" contextRef="From2023-01-012023-12-31" id="Fact004602" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">142,825</ix:nonFraction>)</td></tr>
  <tr id="xdx_405_ecustom--DeductionOfProuni_pn3n3_zMQegXTjKfub" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt">PROUNI</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DeductionOfProuni" contextRef="From2025-01-01to2025-12-31" id="Fact004604" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">407,640</ix:nonFraction>)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DeductionOfProuni" contextRef="From2024-01-012024-12-31" id="Fact004605" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">342,326</ix:nonFraction>)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:DeductionOfProuni" contextRef="From2023-01-012023-12-31" id="Fact004606" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">287,338</ix:nonFraction>)</td></tr>
  <tr id="xdx_40C_eifrs-full--RevenueFromContractsWithCustomers_pn3n3_zENpZA0g604i" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Revenue from contracts with customers</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="From2025-01-01to2025-12-31" id="Fact004608" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,697,255</ix:nonFraction> </b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="From2024-01-012024-12-31" id="Fact004609" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,304,329</ix:nonFraction> </b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="From2023-01-012023-12-31" id="Fact004610" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></b></td></tr>
  <tr id="xdx_401_ecustom--TimingOfRevenueRecognition_iB_zmLCzlqisHAi" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt"><b>Timing of revenue recognition</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_400_ecustom--TransferredOverTime_pn3n3_znL7OQZVEgVg" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt">Transferred over time</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:TransferredOverTime" contextRef="From2025-01-01to2025-12-31" id="Fact004616" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,618,234</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:TransferredOverTime" contextRef="From2024-01-012024-12-31" id="Fact004617" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,242,035</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:TransferredOverTime" contextRef="From2023-01-012023-12-31" id="Fact004618" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,821,251</ix:nonFraction></td></tr>
  <tr id="xdx_40E_ecustom--TransferredAtPointInTime_pn3n3_zJDK3Rvkhymh" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt">Transferred at a point in time</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:TransferredAtPointInTime" contextRef="From2025-01-01to2025-12-31" id="Fact004620" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">79,021</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:TransferredAtPointInTime" contextRef="From2024-01-012024-12-31" id="Fact004621" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,294</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:TransferredAtPointInTime" contextRef="From2023-01-012023-12-31" id="Fact004622" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,662</ix:nonFraction></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A9_zKRbFzCyyky" style="font: 10.5pt Nunito Sans; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">The Company&#8217;s revenue from contracts with customers
are all in Brazil. The Company is not subject to the payment of the contributions Social Integration Program (<i>Programa de Integra&#231;&#227;o
Social</i>, or PIS) and the Social Contribution on Revenue (<i>Contribui&#231;&#227;o para o Financiamento da Seguridade Social</i>,
or COFINS) on the revenue from under graduation degrees under the PROUNI program.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">The tables below present the revenue for the Company&#8217;s
operating segments for the years ended December 31, 2025, 2024 and 2023.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004624" name="afya:ScheduleOfRevenueBySegmentTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89E_ecustom--ScheduleOfRevenueBySegmentTableTextBlock_pn3n3_zkBZ5wNRCs13" summary="xdx: Disclosure - Revenue (Details 1)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="vertical-align: top; text-align: justify"><span id="xdx_8BA_zmVU54gwzEyj" style="display: none">Schedule of revenue by
    segment</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Undergraduate</b></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Continuing education</b></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Medical practice solutions</b></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Elimination (inter-segment transactions)</b></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><b>2025</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: -5.55pt; padding-left: 5.4pt; text-align: right"/></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><b>Types of services or goods</b></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zDQtF0xJChc1" title="Types of services or goods" style="text-align: right"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2025-01-012025-12-31_custom_UndergraduateMember" id="Fact004626" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,255,426</ix:nonFraction> </b></td>
    <td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z1ZBu6QWj095" title="Types of services or goods" style="text-align: right"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2025-01-012025-12-31_custom_ContinuingEducationMember" id="Fact004628" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">284,471</ix:nonFraction> </b></td>
    <td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zvdxvb73LEEh" title="Types of services or goods" style="text-align: right"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004630" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">171,323</ix:nonFraction> </b></td>
    <td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zd9whSpsZVi9" title="Types of services or goods" style="text-align: right"><b>(<ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact004632" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,965</ix:nonFraction>)</b></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231_zSOGH5Xnb3pe" title="Types of services or goods" style="text-align: right"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2025-01-01to2025-12-31" id="Fact004634" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,697,255</ix:nonFraction> </b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Tuition fees</td>
    <td id="xdx_984_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zxTj7MtzKt5d" title="Tuition fees" style="text-align: right"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2025-01-012025-12-31_custom_UndergraduateMember" id="Fact004636" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,239,729</ix:nonFraction> </td>
    <td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zew0tg46xSEe" title="Tuition fees" style="text-align: right"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2025-01-012025-12-31_custom_ContinuingEducationMember" id="Fact004638" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">187,707</ix:nonFraction> </td>
    <td id="xdx_986_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zqPYhTs7AE04" title="Tuition fees" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4640">-</span></td>
    <td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zSa4HZ6N1R8c" title="Tuition fees" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4642">-</span></td>
    <td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231_z2zUfl474Gf9" title="Tuition fees" style="text-align: right"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2025-01-01to2025-12-31" id="Fact004644" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,427,436</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Other</td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zr5a9NuReNjl" title="Other" style="text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2025-01-012025-12-31_custom_UndergraduateMember" id="Fact004646" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,697</ix:nonFraction> </td>
    <td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zMZj6PRwKhUl" title="Other" style="text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2025-01-012025-12-31_custom_ContinuingEducationMember" id="Fact004648" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">96,764</ix:nonFraction> </td>
    <td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z2y6DeN77sPj" title="Other" style="text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004650" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">171,323</ix:nonFraction> </td>
    <td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z9JjdkDCSW9l" title="Other" style="text-align: right">(<ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact004652" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,965</ix:nonFraction>)</td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231_zIR2Ku5Qv4pc" title="Other" style="text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2025-01-01to2025-12-31" id="Fact004654" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">269,819</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><b>Timing of revenue recognition</b></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z9z7x0eRjU47" title="Timing of revenue recognition" style="text-align: right"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2025-01-012025-12-31_custom_UndergraduateMember" id="Fact004656" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,255,426</ix:nonFraction> </b></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLNQK7yhLHA6" title="Timing of revenue recognition" style="text-align: right"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2025-01-012025-12-31_custom_ContinuingEducationMember" id="Fact004658" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">284,471</ix:nonFraction> </b></td>
    <td id="xdx_985_ecustom--TimingRevenueRecognition_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" title="Timing of revenue recognition" style="text-align: right"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004660" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">171,323</ix:nonFraction> </b></td>
    <td id="xdx_98E_ecustom--TimingRevenueRecognition_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" title="Timing of revenue recognition" style="text-align: right"><b>(<ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact004662" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,965</ix:nonFraction>)</b></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_c20250101__20251231_pn3n3" title="Timing of revenue recognition" style="text-align: right"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2025-01-01to2025-12-31" id="Fact004664" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,697,255</ix:nonFraction> </b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Transferred over time</td>
    <td id="xdx_98F_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjMafsieeqX9" title="Transferred over time" style="text-align: right"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2025-01-012025-12-31_custom_UndergraduateMember" id="Fact004666" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,239,729</ix:nonFraction> </td>
    <td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zKc0tSs6qB0a" title="Transferred over time" style="text-align: right"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2025-01-012025-12-31_custom_ContinuingEducationMember" id="Fact004668" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,774</ix:nonFraction> </td>
    <td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zlzJtCMPRm29" title="Transferred over time" style="text-align: right"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004670" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">168,696</ix:nonFraction> </td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z6s05TJfK2F4" title="Transferred over time" style="text-align: right">(<ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact004672" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,965</ix:nonFraction>)</td>
    <td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231_zRSIzEW3h2ii" title="Transferred over time" style="text-align: right"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2025-01-01to2025-12-31" id="Fact004674" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,618,234</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Transferred at a point in time</td>
    <td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zLuuUHMjM7jg" title="Transferred at a point in time" style="text-align: right"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2025-01-012025-12-31_custom_UndergraduateMember" id="Fact004676" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,697</ix:nonFraction> </td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" title="Transferred at a point in time" style="text-align: right"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2025-01-012025-12-31_custom_ContinuingEducationMember" id="Fact004678" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,697</ix:nonFraction> </td>
    <td id="xdx_98C_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" title="Transferred at a point in time" style="text-align: right"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004680" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,627</ix:nonFraction> </td>
    <td id="xdx_98F_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" title="Transferred at a point in time" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4682">-</span></td>
    <td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231_pn3n3" title="Transferred at a point in time" style="text-align: right"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2025-01-01to2025-12-31" id="Fact004684" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">79,021</ix:nonFraction> </td></tr>
  </table>
<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Undergraduate</b></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Continuing education</b></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Medical practice solutions</b></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Elimination (inter-segment transactions)</b></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><b>2024</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><b>Types of services or goods</b></td>
    <td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z61D4ieGN1Q5" title="Types of services or goods" style="text-align: right"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2024-01-012024-12-31_custom_UndergraduateMember" id="Fact004686" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,895,692</ix:nonFraction></b></td>
    <td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsearJYQim93" title="Types of services or goods" style="text-align: right"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2024-01-012024-12-31_custom_ContinuingEducationMember" id="Fact004688" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">255,438</ix:nonFraction></b></td>
    <td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zZQZ6vbN1941" title="Types of services or goods" style="text-align: right"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004690" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">161,787</ix:nonFraction></b></td>
    <td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zn8hHwScifS3" title="Types of services or goods" style="text-align: right"><b>(<ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact004692" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,588</ix:nonFraction>)</b></td>
    <td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231_znjkGmFJR3K6" title="Types of services or goods" style="text-align: right"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2024-01-012024-12-31" id="Fact004694" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,304,329</ix:nonFraction></b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Tuition fees</td>
    <td id="xdx_987_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zHCrZk6cnSFb" title="Tuition fees" style="text-align: right"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2024-01-012024-12-31_custom_UndergraduateMember" id="Fact004696" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,877,731</ix:nonFraction></td>
    <td id="xdx_988_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvaF2I7AKls" title="Tuition fees" style="text-align: right"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2024-01-012024-12-31_custom_ContinuingEducationMember" id="Fact004698" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">122,391</ix:nonFraction></td>
    <td id="xdx_98E_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zixdSE6vsQe4" title="Tuition fees" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4700">-</span></td>
    <td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zs3LypPBHb69" title="Tuition fees" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4702">-</span></td>
    <td id="xdx_98A_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231_znq0h0wEsSjk" title="Tuition fees" style="text-align: right"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2024-01-012024-12-31" id="Fact004704" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000,122</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Other</td>
    <td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zF42nkGGAJY7" title="Other" style="text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2024-01-012024-12-31_custom_UndergraduateMember" id="Fact004706" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,961</ix:nonFraction></td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSoGowoPnyC3" title="Other" style="text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2024-01-012024-12-31_custom_ContinuingEducationMember" id="Fact004708" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">133,047</ix:nonFraction></td>
    <td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zWrG05yAV7me" title="Other" style="text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004710" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">161,787</ix:nonFraction></td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zFovuHVYo7Ah" title="Other" style="text-align: right">(<ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact004712" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,588</ix:nonFraction>)</td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231_zM1MLMyzaWA1" title="Other" style="text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2024-01-012024-12-31" id="Fact004714" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">304,207</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><b>Timing of revenue recognition</b></td>
    <td id="xdx_983_ecustom--TimingRevenueRecognition_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zid68DJq1ZUh" title="Timing of revenue recognition" style="text-align: right"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2024-01-012024-12-31_custom_UndergraduateMember" id="Fact004716" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,895,692</ix:nonFraction></b></td>
    <td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zM1wOFLICcwg" title="Timing of revenue recognition" style="text-align: right"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2024-01-012024-12-31_custom_ContinuingEducationMember" id="Fact004718" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">255,438</ix:nonFraction></b></td>
    <td id="xdx_987_ecustom--TimingRevenueRecognition_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" title="Timing of revenue recognition" style="text-align: right"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004720" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">161,787</ix:nonFraction></b></td>
    <td id="xdx_98C_ecustom--TimingRevenueRecognition_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" title="Timing of revenue recognition" style="text-align: right"><b>(<ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact004722" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,588</ix:nonFraction>)</b></td>
    <td id="xdx_983_ecustom--TimingRevenueRecognition_c20240101__20241231_pn3n3" title="Timing of revenue recognition" style="text-align: right"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2024-01-012024-12-31" id="Fact004724" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,304,329</ix:nonFraction></b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Transferred over time</td>
    <td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zOD21ltPW7m6" title="Transferred over time" style="text-align: right"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2024-01-012024-12-31_custom_UndergraduateMember" id="Fact004726" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,877,731</ix:nonFraction></td>
    <td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdJcmR8TcIMe" title="Transferred over time" style="text-align: right"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2024-01-012024-12-31_custom_ContinuingEducationMember" id="Fact004728" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">218,573</ix:nonFraction></td>
    <td id="xdx_983_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z2oKNgmjiOn9" title="Transferred over time" style="text-align: right"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004730" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">154,319</ix:nonFraction></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zjnVkS5xFLbd" title="Transferred over time" style="text-align: right">(<ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact004732" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,588</ix:nonFraction>)</td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231_zUfbeLioV3A9" title="Transferred over time" style="text-align: right"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2024-01-012024-12-31" id="Fact004734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,242,035</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Transferred at a point in time</td>
    <td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z64dbGHZABl2" title="Transferred at a point in time" style="text-align: right"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2024-01-012024-12-31_custom_UndergraduateMember" id="Fact004736" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,961</ix:nonFraction></td>
    <td id="xdx_980_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" title="Transferred at a point in time" style="text-align: right"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2024-01-012024-12-31_custom_ContinuingEducationMember" id="Fact004738" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,865</ix:nonFraction></td>
    <td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zJORSYj10usj" title="Transferred at a point in time" style="text-align: right"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004740" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,468</ix:nonFraction></td>
    <td id="xdx_989_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" title="Transferred at a point in time" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4742">-</span></td>
    <td id="xdx_983_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231_pn3n3" title="Transferred at a point in time" style="text-align: right"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2024-01-012024-12-31" id="Fact004744" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,294</ix:nonFraction></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 223 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zAzuvTtQYHj9" style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_z2IKh0KovFrf" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p></ix:exclude>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Undergraduate</b></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Continuing education</b></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Medical practice solutions</b></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Elimination (inter-segment transactions)</b></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><b>2023</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><b>Types of services or goods</b></td>
    <td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zjhX9wnJre25" title="Types of services or goods" style="text-align: right"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2023-01-012023-12-31_custom_UndergradMember" id="Fact004748" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,511,018</ix:nonFraction></b></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRM8QS6uSIK9" title="Types of services or goods" style="text-align: right"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember" id="Fact004750" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235,830</ix:nonFraction></b></td>
    <td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z55qWKfUG7Ng" title="Types of services or goods" style="text-align: right"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004752" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">140,282</ix:nonFraction></b></td>
    <td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zm2MyO4OJAk" title="Types of services or goods" style="text-align: right"><b>(<ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact004754" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</b></td>
    <td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231_zld4rMWWtk1e" title="Types of services or goods" style="text-align: right"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2023-01-012023-12-31" id="Fact004756" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Tuition fees</td>
    <td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXnykqmuOb69" title="Tuition fees" style="text-align: right"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2023-01-012023-12-31_custom_UndergradMember" id="Fact004758" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,494,121</ix:nonFraction></td>
    <td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zw7rBSOvZ6T4" title="Tuition fees" style="text-align: right"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember" id="Fact004760" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">146,477</ix:nonFraction></td>
    <td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zmLHQC59KzQ8" title="Tuition fees" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4762">-</span></td>
    <td id="xdx_989_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_ztpdXN4ZDpNg" title="Tuition fees" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4764">-</span></td>
    <td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231_zT5GwOoPWnhb" title="Tuition fees" style="text-align: right"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2023-01-012023-12-31" id="Fact004766" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,640,598</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Other</td>
    <td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zSfGsU9WK1V3" title="Other" style="text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2023-01-012023-12-31_custom_UndergradMember" id="Fact004768" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,897</ix:nonFraction></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z8MJnsPKy61d" title="Other" style="text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember" id="Fact004770" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">89,353</ix:nonFraction></td>
    <td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLgl9PjD0rf1" title="Other" style="text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004772" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">140,282</ix:nonFraction></td>
    <td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zsfYdgiqpKu2" title="Other" style="text-align: right">(<ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact004774" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</td>
    <td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231_zx3Tmn32k685" title="Other" style="text-align: right"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2023-01-012023-12-31" id="Fact004776" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235,315</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><b>Timing of revenue recognition</b></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_pn3n3" title="Timing of revenue recognition" style="text-align: right"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2023-01-012023-12-31_custom_UndergradMember" id="Fact004778" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,511,018</ix:nonFraction></b></td>
    <td id="xdx_98F_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" title="Timing of revenue recognition" style="text-align: right"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember" id="Fact004780" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235,830</ix:nonFraction></b></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" title="Timing of revenue recognition" style="text-align: right"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004782" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">140,282</ix:nonFraction></b></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" title="Timing of revenue recognition" style="text-align: right"><b>(<ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact004784" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</b></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_c20230101__20231231_pn3n3" title="Timing of revenue recognition" style="text-align: right"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2023-01-012023-12-31" id="Fact004786" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,913</ix:nonFraction></b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Transferred over time</td>
    <td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zeYsuWApdDMd" title="Transferred over time" style="text-align: right"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2023-01-012023-12-31_custom_UndergradMember" id="Fact004788" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,494,121</ix:nonFraction></td>
    <td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zDYgQqqNhTW6" title="Transferred over time" style="text-align: right"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember" id="Fact004790" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">206,098</ix:nonFraction></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z7ou3VsSQmAj" title="Transferred over time" style="text-align: right"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004792" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">132,249</ix:nonFraction></td>
    <td id="xdx_988_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zkn5kwaV5YV9" title="Transferred over time" style="text-align: right">(<ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember" id="Fact004794" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,217</ix:nonFraction>)</td>
    <td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231_zyfOVLAEXie3" title="Transferred over time" style="text-align: right"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2023-01-012023-12-31" id="Fact004796" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,821,251</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Transferred at a point in time</td>
    <td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_pn3n3" title="Transferred at a point in time" style="text-align: right"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2023-01-012023-12-31_custom_UndergradMember" id="Fact004798" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,897</ix:nonFraction></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" title="Transferred at a point in time" style="text-align: right"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember" id="Fact004800" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,732</ix:nonFraction></td>
    <td id="xdx_981_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" title="Transferred at a point in time" style="text-align: right"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember" id="Fact004802" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,033</ix:nonFraction></td>
    <td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" title="Transferred at a point in time" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4804">-</span></td>
    <td id="xdx_981_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231_pn3n3" title="Transferred at a point in time" style="text-align: right"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2023-01-012023-12-31" id="Fact004806" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,662</ix:nonFraction></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_z1g7ib5Ccuuh" style="margin-top: 0; margin-bottom: 0">&#160;</p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004808" name="ifrs-full:DisclosureOfExpensesByNatureExplanatory"><p id="xdx_80F_eifrs-full--DisclosureOfExpensesByNatureExplanatory_znzh8xseTR83" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">18</td><td><span id="xdx_82A_zlCXbF7UWPbd">Costs and expenses by nature</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004810" name="afya:ScheduleOfExpensesByNatureTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_889_ecustom--ScheduleOfExpensesByNatureTableTextBlock_pn3n3_z8n8gPs6GOn7" summary="xdx: Disclosure - Costs and expenses by nature (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B7_zSWywQzRhBog" style="display: none">Schedule of expenses by nature</span></td>
    <td id="xdx_491_20250101__20251231_ztmpjTt7nWO4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_492_20240101__20241231_zIbN2xqQL1Ch" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_492_20230101__20231231_zPl01Wd7Pyw1" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 67%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_400_ecustom--Payroll_pn3n3_zhzXb4JCmU65" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Payroll (i)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:Payroll" contextRef="From2025-01-01to2025-12-31" id="Fact004812" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,370,361</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:Payroll" contextRef="From2024-01-012024-12-31" id="Fact004813" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,236,666</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:Payroll" contextRef="From2023-01-012023-12-31" id="Fact004814" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,149,225</ix:nonFraction>)</td></tr>
  <tr id="xdx_40C_ecustom--HospitalAndMedicalAgreements_pn3n3_zP5AfY4TrlNb" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Hospital and medical agreements</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:HospitalAndMedicalAgreements" contextRef="From2025-01-01to2025-12-31" id="Fact004816" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">80,449</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:HospitalAndMedicalAgreements" contextRef="From2024-01-012024-12-31" id="Fact004817" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">94,583</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:HospitalAndMedicalAgreements" contextRef="From2023-01-012023-12-31" id="Fact004818" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">86,151</ix:nonFraction>)</td></tr>
  <tr id="xdx_40C_eifrs-full--DepreciationExpense_iN_pn3n3_di_zp1OnaJxg55c" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Depreciation and amortization</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2025-01-01to2025-12-31" id="Fact004820" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">373,344</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2024-01-012024-12-31" id="Fact004821" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">333,341</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2023-01-012023-12-31" id="Fact004822" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">289,511</ix:nonFraction>)</td></tr>
  <tr id="xdx_401_ecustom--LeaseExpenses_pn3n3_zlDGpVvRi4M7" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Lease expenses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:LeaseExpenses" contextRef="From2025-01-01to2025-12-31" id="Fact004824" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,617</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:LeaseExpenses" contextRef="From2024-01-012024-12-31" id="Fact004825" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,207</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:LeaseExpenses" contextRef="From2023-01-012023-12-31" id="Fact004826" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,871</ix:nonFraction>)</td></tr>
  <tr id="xdx_408_eifrs-full--UtilitiesExpense_pn3n3_za8Rpqn1pGif" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Utilities</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:UtilitiesExpense" contextRef="From2025-01-01to2025-12-31" id="Fact004828" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,722</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:UtilitiesExpense" contextRef="From2024-01-012024-12-31" id="Fact004829" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">22,730</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:UtilitiesExpense" contextRef="From2023-01-012023-12-31" id="Fact004830" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,403</ix:nonFraction>)</td></tr>
  <tr id="xdx_402_eifrs-full--RepairsAndMaintenanceExpense_iN_pn3n3_di_zPtLi7zS7u5h" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Maintenance</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:RepairsAndMaintenanceExpense" contextRef="From2025-01-01to2025-12-31" id="Fact004832" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">134,156</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:RepairsAndMaintenanceExpense" contextRef="From2024-01-012024-12-31" id="Fact004833" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">127,777</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:RepairsAndMaintenanceExpense" contextRef="From2023-01-012023-12-31" id="Fact004834" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">105,919</ix:nonFraction>)</td></tr>
  <tr id="xdx_401_ecustom--SharesBasedCompensation_pn3n3_zqyPtLzbQrta" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Share-based compensation</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:SharesBasedCompensation" contextRef="From2025-01-01to2025-12-31" id="Fact004836" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">15,318</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:SharesBasedCompensation" contextRef="From2024-01-012024-12-31" id="Fact004837" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32,424</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:SharesBasedCompensation" contextRef="From2023-01-012023-12-31" id="Fact004838" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,535</ix:nonFraction>)</td></tr>
  <tr id="xdx_40B_ecustom--TaxExpenses_pn3n3_zRxtcxX9pDva" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Tax expenses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:TaxExpenses" contextRef="From2025-01-01to2025-12-31" id="Fact004840" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,091</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:TaxExpenses" contextRef="From2024-01-012024-12-31" id="Fact004841" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,105</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:TaxExpenses" contextRef="From2023-01-012023-12-31" id="Fact004842" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,447</ix:nonFraction>)</td></tr>
  <tr id="xdx_402_eifrs-full--SalesAndMarketingExpense_iN_pn3n3_di_zqVVQzAKi2Ai" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Sales and marketing</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:SalesAndMarketingExpense" contextRef="From2025-01-01to2025-12-31" id="Fact004844" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">114,803</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:SalesAndMarketingExpense" contextRef="From2024-01-012024-12-31" id="Fact004845" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85,469</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:SalesAndMarketingExpense" contextRef="From2023-01-012023-12-31" id="Fact004846" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,140</ix:nonFraction>)</td></tr>
  <tr id="xdx_40E_ecustom--AllowanceForExpectedCreditLosses_iN_pn3n3_di_zf0JeQaGosQ" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Allowance for expected credit losses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2025-01-01to2025-12-31" id="Fact004848" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,090</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2024-01-012024-12-31" id="Fact004849" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,894</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2023-01-012023-12-31" id="Fact004850" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,552</ix:nonFraction>)</td></tr>
  <tr id="xdx_404_eifrs-full--TravelExpense_iN_pn3n3_di_zSD3f0OT7H1a" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Travel expenses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:TravelExpense" contextRef="From2025-01-01to2025-12-31" id="Fact004852" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,144</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:TravelExpense" contextRef="From2024-01-012024-12-31" id="Fact004853" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,345</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="ifrs-full:TravelExpense" contextRef="From2023-01-012023-12-31" id="Fact004854" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,098</ix:nonFraction>)</td></tr>
  <tr id="xdx_408_ecustom--ConsultingFees_pn3n3_zgPQU4AwbE6f" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Consulting fees</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:ConsultingFees" contextRef="From2025-01-01to2025-12-31" id="Fact004856" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32,645</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:ConsultingFees" contextRef="From2024-01-012024-12-31" id="Fact004857" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">46,022</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:ConsultingFees" contextRef="From2023-01-012023-12-31" id="Fact004858" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">62,630</ix:nonFraction>)</td></tr>
  <tr id="xdx_40E_ecustom--CostExpensesOther_pn3n3_zHLtud2AJk6c" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Other</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:CostExpensesOther" contextRef="From2025-01-01to2025-12-31" id="Fact004860" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">230,310</ix:nonFraction>)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:CostExpensesOther" contextRef="From2024-01-012024-12-31" id="Fact004861" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">201,361</ix:nonFraction>)</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:CostExpensesOther" contextRef="From2023-01-012023-12-31" id="Fact004862" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">189,015</ix:nonFraction>)</td></tr>
  <tr id="xdx_404_eifrs-full--ExpenseByNature_pn3n3_zzBi1VnZmmo3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b style="display: none">Total</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(<ix:nonFraction name="ifrs-full:ExpenseByNature" contextRef="From2025-01-01to2025-12-31" id="Fact004864" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,484,050</ix:nonFraction>)</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(<ix:nonFraction name="ifrs-full:ExpenseByNature" contextRef="From2024-01-012024-12-31" id="Fact004865" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,284,924</ix:nonFraction>)</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(<ix:nonFraction name="ifrs-full:ExpenseByNature" contextRef="From2023-01-012023-12-31" id="Fact004866" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,124,497</ix:nonFraction>)</b></td></tr>
  <tr id="xdx_40A_ecustom--CostOfServices_iN_pn3n3_di_zBaib3z8pSK8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cost of services</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:CostOfServices" contextRef="From2025-01-01to2025-12-31" id="Fact004868" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,313,895</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:CostOfServices" contextRef="From2024-01-012024-12-31" id="Fact004869" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,215,603</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:CostOfServices" contextRef="From2023-01-012023-12-31" id="Fact004870" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,109,813</ix:nonFraction>)</td></tr>
  <tr id="xdx_401_ecustom--SellingGeneralAndAdministrativeExpenses_pn3n3_zEh8NUxuJNRa" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Selling, general and administrative expenses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:SellingGeneralAndAdministrativeExpenses" contextRef="From2025-01-01to2025-12-31" id="Fact004872" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,113,065</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:SellingGeneralAndAdministrativeExpenses" contextRef="From2024-01-012024-12-31" id="Fact004873" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,008,427</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:SellingGeneralAndAdministrativeExpenses" contextRef="From2023-01-012023-12-31" id="Fact004874" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">940,132</ix:nonFraction>)</td></tr>
  <tr id="xdx_40E_ecustom--AllowanceForExpectedCreditLosses_iN_pn3n3_di_zDLa9JtSQi3c" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Allowance for expected credit losses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2025-01-01to2025-12-31" id="Fact004876" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,090</ix:nonFraction>)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2024-01-012024-12-31" id="Fact004877" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,894</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:AllowanceForExpectedCreditLosses" contextRef="From2023-01-012023-12-31" id="Fact004878" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,552</ix:nonFraction>)</td></tr>
  </table></ix:nonNumeric>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Includes the costs of pedagogical services related to the practicing physician who provides
practical training and supervision to medical students (preceptors).</td>
</tr></table>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004880" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory"><p id="xdx_808_eifrs-full--DisclosureOfFinanceIncomeExpenseExplanatory_zfqcymkjYyh6" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">19</td><td><span id="xdx_826_zVneMG4DwHB">Finance result</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004882" name="afya:ScheduleOfFinanceResultTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_884_ecustom--ScheduleOfFinanceResultTableTextBlock_pn3n3_zmguLDbLBLwe" summary="xdx: Disclosure - Finance result (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BC_zQxOLJJVwUF6" style="display: none">Schedule of finance result</span></td>
    <td id="xdx_490_20250101__20251231_z5XTmwejGJF" style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: center">&#160;</td>
    <td id="xdx_496_20240101__20241231_z7TM4d819HD9" style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: center">&#160;</td>
    <td id="xdx_494_20230101__20231231_zboKnwVvvkTl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 67%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"/>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_407_ecustom--FinancialIncomeFromCashEquivalents_pn3n3_zp9TewKkqima" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Financial income from cash equivalents</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:FinancialIncomeFromCashEquivalents" contextRef="From2025-01-01to2025-12-31" id="Fact004884" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">138,456</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:FinancialIncomeFromCashEquivalents" contextRef="From2024-01-012024-12-31" id="Fact004885" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59,381</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="afya:FinancialIncomeFromCashEquivalents" contextRef="From2023-01-012023-12-31" id="Fact004886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">73,672</ix:nonFraction></td></tr>
  <tr id="xdx_40E_ecustom--InterestEarned_pn3n3_zdzzJBRVS35i" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Interest earned</td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><ix:nonFraction name="afya:InterestEarned" contextRef="From2025-01-01to2025-12-31" id="Fact004888" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,527</ix:nonFraction> </td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><ix:nonFraction name="afya:InterestEarned" contextRef="From2024-01-012024-12-31" id="Fact004889" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,417</ix:nonFraction> </td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><ix:nonFraction name="afya:InterestEarned" contextRef="From2023-01-012023-12-31" id="Fact004890" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,450</ix:nonFraction></td></tr>
  <tr id="xdx_400_eifrs-full--OtherFinanceIncome_pn3n3_zmOsmHpFjVXe" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Other</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherFinanceIncome" contextRef="From2025-01-01to2025-12-31" id="Fact004892" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,960</ix:nonFraction> </td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherFinanceIncome" contextRef="From2024-01-012024-12-31" id="Fact004893" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,485</ix:nonFraction> </td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherFinanceIncome" contextRef="From2023-01-012023-12-31" id="Fact004894" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,520</ix:nonFraction></td></tr>
  <tr id="xdx_40D_eifrs-full--FinanceIncome_pn3n3_zttyz74oPGP5" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Finance income</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2025-01-01to2025-12-31" id="Fact004896" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">194,943</ix:nonFraction> </b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2024-01-012024-12-31" id="Fact004897" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">111,283</ix:nonFraction> </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2023-01-012023-12-31" id="Fact004898" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,642</ix:nonFraction></b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_408_ecustom--InterestExpense1_pn3n3_zTiLXuBq4Qy8" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Interest expense</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:InterestExpense1" contextRef="From2025-01-01to2025-12-31" id="Fact004900" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">316,379</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:InterestExpense1" contextRef="From2024-01-012024-12-31" id="Fact004901" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">254,386</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:InterestExpense1" contextRef="From2023-01-012023-12-31" id="Fact004902" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">285,447</ix:nonFraction>)</td></tr>
  <tr id="xdx_404_ecustom--InterestExpenseOnLeaseLiabilities1_pn3n3_zQxZ5WvUitK5" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Interest expense on lease liabilities</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:InterestExpenseOnLeaseLiabilities1" contextRef="From2025-01-01to2025-12-31" id="Fact004904" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">123,067</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:InterestExpenseOnLeaseLiabilities1" contextRef="From2024-01-012024-12-31" id="Fact004905" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">111,966</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:InterestExpenseOnLeaseLiabilities1" contextRef="From2023-01-012023-12-31" id="Fact004906" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">100,849</ix:nonFraction>)</td></tr>
  <tr id="xdx_40C_ecustom--FinancialDiscountsGrantedExpenses_pn3n3_zyXc0MxQd62e" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Financial discounts</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:FinancialDiscountsGrantedExpenses" contextRef="From2025-01-01to2025-12-31" id="Fact004908" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">54,254</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:FinancialDiscountsGrantedExpenses" contextRef="From2024-01-012024-12-31" id="Fact004909" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">33,240</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:FinancialDiscountsGrantedExpenses" contextRef="From2023-01-012023-12-31" id="Fact004910" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">30,891</ix:nonFraction>)</td></tr>
  <tr id="xdx_40D_ecustom--CreditCardCharges_pn3n3_zZe32h7X88cf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Credit card charges</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:CreditCardCharges" contextRef="From2025-01-01to2025-12-31" id="Fact004912" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,901</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:CreditCardCharges" contextRef="From2024-01-012024-12-31" id="Fact004913" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,824</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:CreditCardCharges" contextRef="From2023-01-012023-12-31" id="Fact004914" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,096</ix:nonFraction>)</td></tr>
  <tr id="xdx_401_eifrs-full--BankAndSimilarCharges_iN_pn3n3_di_zGHj6RIWz7ce" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Bank fees</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:BankAndSimilarCharges" contextRef="From2025-01-01to2025-12-31" id="Fact004916" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,882</ix:nonFraction>)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:BankAndSimilarCharges" contextRef="From2024-01-012024-12-31" id="Fact004917" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,436</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:BankAndSimilarCharges" contextRef="From2023-01-012023-12-31" id="Fact004918" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,163</ix:nonFraction>)</td></tr>
  <tr id="xdx_40C_ecustom--ExchangeVariance_pn3n3_zT8vAy3GhiG" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Exchange variance</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:ExchangeVariance" contextRef="From2025-01-01to2025-12-31" id="Fact004920" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,095</ix:nonFraction>)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:ExchangeVariance" contextRef="From2024-01-012024-12-31" id="Fact004921" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,944</ix:nonFraction>) </td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="afya:ExchangeVariance" contextRef="From2023-01-012023-12-31" id="Fact004922" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">681</ix:nonFraction>)</td></tr>
  <tr id="xdx_40E_eifrs-full--OtherFinanceCost_iN_pn3n3_di_zwooNXSZn4A1" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Other</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:OtherFinanceCost" contextRef="From2025-01-01to2025-12-31" id="Fact004924" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,446</ix:nonFraction>)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:OtherFinanceCost" contextRef="From2024-01-012024-12-31" id="Fact004925" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,946</ix:nonFraction>)</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:OtherFinanceCost" contextRef="From2023-01-012023-12-31" id="Fact004926" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,489</ix:nonFraction>)</td></tr>
  <tr id="xdx_403_eifrs-full--FinanceCosts_iN_pn3n3_di_z37ZFntzkeef" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Finance expenses</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2025-01-01to2025-12-31" id="Fact004928" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">561,024</ix:nonFraction>)</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2024-01-012024-12-31" id="Fact004929" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">458,742</ix:nonFraction>)</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2023-01-012023-12-31" id="Fact004930" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">457,616</ix:nonFraction>)</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_402_ecustom--FinanceResult_pn3n3_zqXa2TCxRASg" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Net finance result</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(<ix:nonFraction name="afya:FinanceResult" contextRef="From2025-01-01to2025-12-31" id="Fact004932" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">366,081</ix:nonFraction>)</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(<ix:nonFraction name="afya:FinanceResult" contextRef="From2024-01-012024-12-31" id="Fact004933" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">347,459</ix:nonFraction>)</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(<ix:nonFraction name="afya:FinanceResult" contextRef="From2023-01-012023-12-31" id="Fact004934" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">346,974</ix:nonFraction>)</b></td></tr>
  </table></ix:nonNumeric>

<ix:exclude><!-- Field: Page; Sequence: 224 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004936" name="afya:DisclosureOfIncomeTaxesExplanatory"><p id="xdx_805_ecustom--DisclosureOfIncomeTaxesExplanatory_z0lvxiPEEwFd" style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">20</td><td><span id="xdx_826_zze3F8tGkhJi">Income taxes</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Income taxes are comprised of taxation over operations in Brazil, related to Corporate
Income Tax (IRPJ) and Social Contribution on Net Profit (CSLL). According to Brazilian tax legislation, income taxes and social contribution
are assessed and paid by legal entity and not on a consolidated basis, except by the requirements of the Pillar Two global minimum tax.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Income taxes expenses</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company calculates the income taxes expenses using the tax rate that would be applicable
to the expected total annual earnings, including the effects of the OECD&#8217;s Pillar Two global minimum tax, which is applicable for
the fiscal year ended December 31, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0in"><span style="font-weight: normal">The table below presents the reconciliation
of income tax expense for the years ended December 31, 2025, 2024 and 2023:</span></p>

<p style="font: bold 10.5pt Nunito Sans; margin: 0; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact004938" name="afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory"><table cellspacing="0" cellpadding="0" id="xdx_893_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_pn3n3_zOxwNd11tMSj" summary="xdx: Disclosure - Income taxes (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="white-space: nowrap"><span id="xdx_8BB_znVL8y7kXDX1" style="display: none">Schedule of reconciliation of income tax expense</span></td>
    <td id="xdx_495_20250101__20251231_znOokTZwOfY" style="text-align: center">&#160;</td>
    <td id="xdx_491_20240101__20241231_zxnR448aq4pd" style="text-align: center">&#160;</td>
    <td id="xdx_496_20230101__20231231_zXGdEcLS8i1h" style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 67%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right"/>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zdA3kZpuMZQ1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap">Income before income taxes</td>
    <td style="text-align: right"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2025-01-01to2025-12-31" id="Fact004940" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">860,945</ix:nonFraction> </td>
    <td style="text-align: right"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2024-01-012024-12-31" id="Fact004941" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">676,391</ix:nonFraction> </td>
    <td style="vertical-align: bottom; text-align: right"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2023-01-012023-12-31" id="Fact004942" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">429,582</ix:nonFraction></td></tr>
  <tr id="xdx_40D_eifrs-full--ApplicableTaxRate_pip0_dp_zaV7iIeDH041" style="background-color: White">
    <td style="white-space: nowrap">Statutory income taxes rate</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2025-01-01to2025-12-31" id="Fact004944" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction>%</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2024-01-012024-12-31" id="Fact004945" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction>%</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2023-01-012023-12-31" id="Fact004946" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction>%</td></tr>
  <tr id="xdx_40C_ecustom--TaxExpensesIncomeAtApplicableTaxRate_z5Pa0PaAdwo1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><b>Income taxes at statutory rate</b></td>
    <td style="text-align: right"><b>(<ix:nonFraction name="afya:TaxExpensesIncomeAtApplicableTaxRate" contextRef="From2025-01-01to2025-12-31" id="Fact004948" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">292,721</ix:nonFraction>)</b></td>
    <td style="text-align: right"><b>(<ix:nonFraction name="afya:TaxExpensesIncomeAtApplicableTaxRate" contextRef="From2024-01-012024-12-31" id="Fact004949" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">229,973</ix:nonFraction>)</b></td>
    <td style="vertical-align: bottom; text-align: right"><b>(<ix:nonFraction name="afya:TaxExpensesIncomeAtApplicableTaxRate" contextRef="From2023-01-012023-12-31" id="Fact004950" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">146,058</ix:nonFraction>)</b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-top: Black 1pt solid; text-align: right">&#160;</td>
    <td style="border-top: Black 1pt solid; text-align: right">&#160;</td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--ReconciliationAdjustmentsAbstract_iB_zDs3502i5SCl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><b>Reconciliation adjustments:</b></td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pn3n3_zjUOl0PuFLEc" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Tax effect on loss from entities not subject to taxation</td>
    <td style="text-align: right">(<ix:nonFraction name="afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" contextRef="From2025-01-01to2025-12-31" id="Fact004956" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,042</ix:nonFraction>)</td>
    <td style="text-align: right">(<ix:nonFraction name="afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" contextRef="From2024-01-012024-12-31" id="Fact004957" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">37,007</ix:nonFraction>)</td>
    <td style="vertical-align: bottom; text-align: right">(<ix:nonFraction name="afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" contextRef="From2023-01-012023-12-31" id="Fact004958" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32,274</ix:nonFraction>)</td></tr>
  <tr id="xdx_40B_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pn3n3_z3A1YRZV4sVk" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt">PROUNI - Fiscal incentive (i)</td>
    <td style="text-align: right"><ix:nonFraction name="afya:ProgramaUniversidadeParaTodosFiscalIncentive" contextRef="From2025-01-01to2025-12-31" id="Fact004960" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">454,380</ix:nonFraction> </td>
    <td style="text-align: right"><ix:nonFraction name="afya:ProgramaUniversidadeParaTodosFiscalIncentive" contextRef="From2024-01-012024-12-31" id="Fact004961" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">379,747</ix:nonFraction> </td>
    <td style="vertical-align: bottom; text-align: right"><ix:nonFraction name="afya:ProgramaUniversidadeParaTodosFiscalIncentive" contextRef="From2023-01-012023-12-31" id="Fact004962" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">309,952</ix:nonFraction></td></tr>
  <tr id="xdx_404_ecustom--UnrecognizedDeferredTaxesAssetsOnTaxLosses_pn3n3_zyyE9Npa9aek" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Unrecognized deferred taxes assets on tax losses</td>
    <td style="text-align: right">(<ix:nonFraction name="afya:UnrecognizedDeferredTaxesAssetsOnTaxLosses" contextRef="From2025-01-01to2025-12-31" id="Fact004964" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">161,215</ix:nonFraction>)</td>
    <td style="text-align: right">(<ix:nonFraction name="afya:UnrecognizedDeferredTaxesAssetsOnTaxLosses" contextRef="From2024-01-012024-12-31" id="Fact004965" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">130,074</ix:nonFraction>)</td>
    <td style="vertical-align: bottom; text-align: right">(<ix:nonFraction name="afya:UnrecognizedDeferredTaxesAssetsOnTaxLosses" contextRef="From2023-01-012023-12-31" id="Fact004966" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">154,062</ix:nonFraction>)</td></tr>
  <tr id="xdx_40A_ecustom--RecognisedDeferredTaxAssets_pn3n3_zyYpSoQ1tHI9" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt">Recognized deferred taxes</td>
    <td style="text-align: right"><ix:nonFraction name="afya:RecognisedDeferredTaxAssets" contextRef="From2025-01-01to2025-12-31" id="Fact004968" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,826</ix:nonFraction> </td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4969">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><ix:nonFraction name="afya:RecognisedDeferredTaxAssets" contextRef="From2023-01-012023-12-31" id="Fact004970" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,233</ix:nonFraction></td></tr>
  <tr id="xdx_40E_ecustom--TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_iN_pn3n3_di_zbIKRq0QB2n7" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Presumed profit income tax regime effect (ii)</td>
    <td style="text-align: right">(<ix:nonFraction name="afya:TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" contextRef="From2025-01-01to2025-12-31" id="Fact004972" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">372</ix:nonFraction>)</td>
    <td style="text-align: right"><ix:nonFraction name="afya:TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" contextRef="From2024-01-012024-12-31" id="Fact004973" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">338</ix:nonFraction> </td>
    <td style="vertical-align: bottom; text-align: right">(<ix:nonFraction name="afya:TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" contextRef="From2023-01-012023-12-31" id="Fact004974" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,787</ix:nonFraction>)</td></tr>
  <tr id="xdx_404_ecustom--PermanentAdjustmentsAbstract_iB_zb7VvPCHDIq4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt"><b>Permanent adjustments:</b></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--PermanentAdjustmentsManagementBonuses_pn3n3_zz0hgbw2jKu" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 14.2pt">Management bonuses</td>
    <td style="text-align: right">(<ix:nonFraction name="afya:PermanentAdjustmentsManagementBonuses" contextRef="From2025-01-01to2025-12-31" id="Fact004980" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,146</ix:nonFraction>)</td>
    <td style="text-align: right">(<ix:nonFraction name="afya:PermanentAdjustmentsManagementBonuses" contextRef="From2024-01-012024-12-31" id="Fact004981" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,533</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4982">-</span></td></tr>
  <tr id="xdx_408_ecustom--PermanentAdjustmentsGifts_pn3n3_zPofg9EGKgjl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 14.2pt">Gifts</td>
    <td style="text-align: right">(<ix:nonFraction name="afya:PermanentAdjustmentsGifts" contextRef="From2025-01-01to2025-12-31" id="Fact004984" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,742</ix:nonFraction>)</td>
    <td style="text-align: right">(<ix:nonFraction name="afya:PermanentAdjustmentsGifts" contextRef="From2024-01-012024-12-31" id="Fact004985" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,655</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right">(<ix:nonFraction name="afya:PermanentAdjustmentsGifts" contextRef="From2023-01-012023-12-31" id="Fact004986" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,552</ix:nonFraction>)</td></tr>
  <tr id="xdx_40C_ecustom--PermanentAdjustmentsSponsorship_pn3n3_zv71dBpa4083" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 14.2pt">Sponsorship</td>
    <td style="text-align: right">(<ix:nonFraction name="afya:PermanentAdjustmentsSponsorship" contextRef="From2025-01-01to2025-12-31" id="Fact004988" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">953</ix:nonFraction>)</td>
    <td style="text-align: right">(<ix:nonFraction name="afya:PermanentAdjustmentsSponsorship" contextRef="From2024-01-012024-12-31" id="Fact004989" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">521</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right">(<ix:nonFraction name="afya:PermanentAdjustmentsSponsorship" contextRef="From2023-01-012023-12-31" id="Fact004990" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">470</ix:nonFraction>)</td></tr>
  <tr id="xdx_400_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_iN_pn3n3_di_z4ogpR4zSypl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 14.2pt">Other</td>
    <td style="text-align: right">(<ix:nonFraction name="ifrs-full:TaxExpenseOtherThanIncomeTaxExpense" contextRef="From2025-01-01to2025-12-31" id="Fact004992" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,744</ix:nonFraction>)</td>
    <td style="text-align: right">(<ix:nonFraction name="ifrs-full:TaxExpenseOtherThanIncomeTaxExpense" contextRef="From2024-01-012024-12-31" id="Fact004993" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,744</ix:nonFraction>)</td>
    <td style="vertical-align: top; text-align: right">(<ix:nonFraction name="ifrs-full:TaxExpenseOtherThanIncomeTaxExpense" contextRef="From2023-01-012023-12-31" id="Fact004994" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,665</ix:nonFraction>)</td></tr>
  <tr id="xdx_40C_ecustom--PermanentAdjustmentsPillarTwo_pn3n3_zqxktTkAVWMc" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Pillar Two - See Note 2.3(q)</td>
    <td style="text-align: right">(<ix:nonFraction name="afya:PermanentAdjustmentsPillarTwo" contextRef="From2025-01-01to2025-12-31" id="Fact004996" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">109,458</ix:nonFraction>)</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4997">-</span></td>
    <td style="vertical-align: top; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4998">-</span></td></tr>
  <tr id="xdx_400_ecustom--OtherTaxExpenseBenefits_pn3n3_z9EZ70QrzWOj" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt">Other</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="afya:OtherTaxExpenseBenefits" contextRef="From2025-01-01to2025-12-31" id="Fact005000" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,685</ix:nonFraction> </td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="afya:OtherTaxExpenseBenefits" contextRef="From2024-01-012024-12-31" id="Fact005001" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,951</ix:nonFraction> </td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><ix:nonFraction name="afya:OtherTaxExpenseBenefits" contextRef="From2023-01-012023-12-31" id="Fact005002" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,517</ix:nonFraction></td></tr>
  <tr id="xdx_403_ecustom--IncomeTaxesExpense_pn3n3_zDJiK0RZG8Vj" style="background-color: White">
    <td style="white-space: nowrap"><b>Income taxes expense</b></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><b>(<ix:nonFraction name="afya:IncomeTaxesExpense" contextRef="From2025-01-01to2025-12-31" id="Fact005004" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">92,502</ix:nonFraction>)</b></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><b>(<ix:nonFraction name="afya:IncomeTaxesExpense" contextRef="From2024-01-012024-12-31" id="Fact005005" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">27,471</ix:nonFraction>)</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right"><b>(<ix:nonFraction name="afya:IncomeTaxesExpense" contextRef="From2023-01-012023-12-31" id="Fact005006" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,166</ix:nonFraction>)</b></td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentTaxExpenseIncome_pn3n3_zsYynNP0wjLc" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt">Current</td>
    <td style="text-align: right">(<ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="From2025-01-01to2025-12-31" id="Fact005008" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">133,328</ix:nonFraction>)</td>
    <td style="text-align: right">(<ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="From2024-01-012024-12-31" id="Fact005009" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,238</ix:nonFraction>)</td>
    <td style="vertical-align: bottom; text-align: right">(<ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="From2023-01-012023-12-31" id="Fact005010" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">27,399</ix:nonFraction>)</td></tr>
  <tr id="xdx_40F_eifrs-full--DeferredTaxExpenseIncome_pn3n3_z14lYFfKVhS4" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Deferred</td>
    <td style="text-align: right"><ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncome" contextRef="From2025-01-01to2025-12-31" id="Fact005012" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,826</ix:nonFraction> </td>
    <td style="text-align: right">(<ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncome" contextRef="From2024-01-012024-12-31" id="Fact005013" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,233</ix:nonFraction>)</td>
    <td style="vertical-align: bottom; text-align: right"><ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncome" contextRef="From2023-01-012023-12-31" id="Fact005014" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,233</ix:nonFraction></td></tr>
  <tr id="xdx_409_eifrs-full--TaxRateEffectFromChangeInTaxRate_pip0_dp_zhguVaETO6md" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><b>Effective rate</b></td>
    <td style="text-align: right"><b><ix:nonFraction name="ifrs-full:TaxRateEffectFromChangeInTaxRate" contextRef="From2025-01-01to2025-12-31" id="Fact005016" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.70</ix:nonFraction>%</b></td>
    <td style="text-align: right"><b><ix:nonFraction name="ifrs-full:TaxRateEffectFromChangeInTaxRate" contextRef="From2024-01-012024-12-31" id="Fact005017" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.10</ix:nonFraction>%</b></td>
    <td style="vertical-align: bottom; text-align: right"><b><ix:nonFraction name="ifrs-full:TaxRateEffectFromChangeInTaxRate" contextRef="From2023-01-012023-12-31" id="Fact005018" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.62</ix:nonFraction>%</b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">The Company adhered to PROUNI, established by Law 11,096/2005, which is a federal program
that exempts companies of paying income taxes and social contribution upon compliance with certain requirements required by this Law.</td>
</tr></table>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"/><td style="text-align: justify">Brazilian tax law establishes that companies that generate gross revenues of up to R$78,000
in the prior fiscal year may calculate income taxes as a percentage of gross revenue, using the presumed profit tax regime. The effect
of the presumed profit of certain subsidiaries represents the difference between the taxation based on this method and the amount that
would be due based on the statutory rate applied to the taxable profit of the subsidiaries.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A3_zT9hzx2NWvv5" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 225 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zFsVHBu6Tg6g" style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p></ix:exclude>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Deferred income taxes</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The table below shows the balances of deferred tax assets and liabilities as of December
31, 2025 and 2024:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact005021" name="afya:ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89D_ecustom--ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock_pn3n3_zfFtZthYcMk4" summary="xdx: Disclosure - Income taxes (Details 1)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B3_zj5ZHZtS9Kt7" style="display: none">Schedule of deferred tax assets and liabilities</span></td>
    <td id="xdx_495_20240101__20241231_zdlB1ItzZvsi" style="text-align: center">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td id="xdx_498_20250101__20251231_zmzgE2DdbQe1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 55%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; text-align: right"><b>Additions</b> (i)</td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"/></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsAbstract_iB_z2A1zPu07Ssl">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Deferred tax assets</b></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Tax losses carry forward</td>
    <td id="xdx_983_ecustom--DeferredTaxAssetsLossCarryforwards_pn3n3_c20240101__20241231_zQf72oyl0Bg9" title="Tax losses carry forward" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5026">-</span></td>
    <td id="xdx_986_ecustom--AdditionsTaxLossesCarryForward_pn3n3_c20250101__20251231_zNQ0PLM4Yza" title="Additions tax losses carry forward" style="text-align: right"><ix:nonFraction name="afya:AdditionsTaxLossesCarryForward" contextRef="From2025-01-01to2025-12-31" id="Fact005028" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,703</ix:nonFraction></td>
    <td id="xdx_981_ecustom--DeferredTaxAssetsLossCarryforwards_pn3n3_c20250101__20251231_zKy7a730nLul" title="Tax losses carry forward" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:DeferredTaxAssetsLossCarryforwards" contextRef="From2025-01-01to2025-12-31" id="Fact005030" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,703</ix:nonFraction></td></tr>
  <tr id="xdx_40D_eifrs-full--DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_iB_zivqGYh3Ocnh" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Temporary differences:</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Allowance for expected credit losses</td>
    <td id="xdx_987_ecustom--AllowanceForExpectedCreditLoss_pn3n3_c20240101__20241231_zufIhGscHNr6" title="Allowance for expected credit losses" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5035">-</span></td>
    <td id="xdx_98E_ecustom--AdditionsAllowanceForExpectedCreditLosses_pn3n3_c20250101__20251231_z2SzqGTOcXg4" title="Additions allowance for expected credit losses" style="text-align: right"><ix:nonFraction name="afya:AdditionsAllowanceForExpectedCreditLosses" contextRef="From2025-01-01to2025-12-31" id="Fact005037" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,196</ix:nonFraction></td>
    <td id="xdx_98E_ecustom--AllowanceForExpectedCreditLoss_pn3n3_c20250101__20251231_zRev5MrA0GJi" title="Allowance for expected credit losses" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:AllowanceForExpectedCreditLoss" contextRef="From2025-01-01to2025-12-31" id="Fact005039" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,196</ix:nonFraction></td></tr>
  <tr id="xdx_40E_eifrs-full--LeaseLiabilitiesAbstract_iB_zOJPMIyjjFU3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">IFRS 16 - Leases:</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 24.85pt">Right-of-use assets</td>
    <td id="xdx_989_ecustom--RightofuseAsset_iI_pn3n3_c20241231_zgEf2c29clF1" title="Allowance for expected credit losses" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5044">-</span></td>
    <td id="xdx_989_ecustom--AdditionsToRightofuseAsset_pn3n3_c20250101__20251231_zDm3UPMssZGg" title="Allowance for expected credit losses" style="text-align: right"><ix:nonFraction name="afya:AdditionsToRightofuseAsset" contextRef="From2025-01-01to2025-12-31" id="Fact005046" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,180</ix:nonFraction></td>
    <td id="xdx_98E_ecustom--RightofuseAsset_iI_pn3n3_c20251231_zN9ZySY92IMk" title="Allowance for expected credit losses" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:RightofuseAsset" contextRef="AsOf2025-12-31" id="Fact005048" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,180</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 24.85pt">Lease liabilities</td>
    <td id="xdx_98E_ecustom--LeaseLiability_iI_pn3n3_c20241231_zqmfSlIdAqSd" title="Lease liabilities" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5050">-</span></td>
    <td id="xdx_98D_ecustom--AdditionsLeaseLiability_iI_pn3n3_c20250101__20251231_ztDMXrnrPQO" title="Additions lease liabilities" style="text-align: right">(<ix:nonFraction name="afya:AdditionsLeaseLiability" contextRef="From2025-01-01to2025-12-31" id="Fact005052" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">47,232</ix:nonFraction>)</td>
    <td id="xdx_984_ecustom--LeaseLiability_iI_pn3n3_c20251231_z86EaaLu7bml" title="Lease liabilities" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:LeaseLiability" contextRef="AsOf2025-12-31" id="Fact005054" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">47,232</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Provision for profit sharing</td>
    <td id="xdx_985_ecustom--ProvisionForProfitSharing_pn3n3_c20240101__20241231_zue9J4DB7cEe" title="Provision for profit sharing" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5056">-</span></td>
    <td id="xdx_988_ecustom--AdditionsProvisionForProfitSharing_pn3n3_c20250101__20251231_zEXXPT4n0Ldk" title="Additions provision for profit sharing" style="text-align: right"><ix:nonFraction name="afya:AdditionsProvisionForProfitSharing" contextRef="From2025-01-01to2025-12-31" id="Fact005058" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,047</ix:nonFraction></td>
    <td id="xdx_982_ecustom--ProvisionForProfitSharing_pn3n3_c20250101__20251231_zHd2fuXaaHQj" title="Provision for profit sharing" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:ProvisionForProfitSharing" contextRef="From2025-01-01to2025-12-31" id="Fact005060" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,047</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Provision for legal proceedings and contingencies</td>
    <td id="xdx_983_eifrs-full--LegalProceedingsProvision_iI_pn3n3_c20241231_zu7zw2l8fDcb" title="Provision for legal proceedings and contingencies" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5062">-</span></td>
    <td id="xdx_980_ecustom--AdditionsProvisionForLegalProceedingsAndContingencies_pn3n3_c20250101__20251231_zo5tj6wuCZoc" title="Additions provision for legal proceedings and contingencies" style="text-align: right"><ix:nonFraction name="afya:AdditionsProvisionForLegalProceedingsAndContingencies" contextRef="From2025-01-01to2025-12-31" id="Fact005064" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,672</ix:nonFraction></td>
    <td id="xdx_984_eifrs-full--LegalProceedingsProvision_iI_pn3n3_c20251231_zPD1UwP8Ekke" title="Provision for legal proceedings and contingencies" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="ifrs-full:LegalProceedingsProvision" contextRef="AsOf2025-12-31" id="Fact005066" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,672</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Amortization of intangible assets</td>
    <td id="xdx_98E_ecustom--AmortizationOfIntangibleAsset_pn3n3_c20240101__20241231_zirgQCZHvRVc" title="Amortization of intangible assets" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5068">-</span></td>
    <td id="xdx_98B_ecustom--AdditionsAmortizationOfIntangibleAssets_pn3n3_c20250101__20251231_zKdHXBVf9hSf" title="Additions amortization of intangible assets" style="text-align: right"><ix:nonFraction name="afya:AdditionsAmortizationOfIntangibleAssets" contextRef="From2025-01-01to2025-12-31" id="Fact005070" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,486</ix:nonFraction></td>
    <td id="xdx_982_ecustom--AmortizationOfIntangibleAsset_pn3n3_c20250101__20251231_zej0kGux9YQ6" title="Amortization of intangible assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:AmortizationOfIntangibleAsset" contextRef="From2025-01-01to2025-12-31" id="Fact005072" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,486</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Other</td>
    <td id="xdx_98D_ecustom--Other_pn3n3_c20240101__20241231_z5dhx1ucZPI2" title="Other" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5074">-</span></td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231_zO01zfb4gnf" title="Additions other" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2025-01-01to2025-12-31" id="Fact005076" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67</ix:nonFraction></td>
    <td id="xdx_980_ecustom--Other_pn3n3_c20250101__20251231_zDVSNUxezidg" title="Other" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><ix:nonFraction name="afya:Other" contextRef="From2025-01-01to2025-12-31" id="Fact005078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_982_ecustom--DeferredTaxAsset_iI_pn3n3_c20241231_zVbOrBCNJBej" title="Total" style="border-bottom: Black 1pt solid; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl5080">-</span></b></td>
    <td id="xdx_982_ecustom--AdditionsDeferredTaxAssets_pn3n3_c20250101__20251231_zmYwrhLUYtS3" title="Additions deferred tax assets" style="border-bottom: Black 1pt solid; text-align: right"><b><ix:nonFraction name="afya:AdditionsDeferredTaxAssets" contextRef="From2025-01-01to2025-12-31" id="Fact005082" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">66,119</ix:nonFraction></b></td>
    <td id="xdx_981_ecustom--DeferredTaxAsset_iI_pn3n3_c20251231_zCqyen7f1v7j" title="Total" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="afya:DeferredTaxAsset" contextRef="AsOf2025-12-31" id="Fact005084" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">66,119</ix:nonFraction></b></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_zx3rdIzhLSX2" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Deferred tax liabilities</b></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="border-top: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Tax benefit from tax deductible goodwill</td>
    <td id="xdx_98B_ecustom--DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20240101__20241231_zKjOpLVQgxVb" title="Tax benefit from tax deductible goodwill" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5089">-</span></td>
    <td id="xdx_98D_ecustom--AdditionsTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20250101__20251231_z1WjRxB58sei" title="Additions tax benefit from tax deductible goodwill" style="text-align: right">(<ix:nonFraction name="afya:AdditionsTaxBenefitFromTaxDeductibleGoodwill" contextRef="From2025-01-01to2025-12-31" id="Fact005091" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">25,293</ix:nonFraction>)</td>
    <td id="xdx_985_ecustom--DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20250101__20251231_z57iuwhO0ehk" title="Total" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill" contextRef="From2025-01-01to2025-12-31" id="Fact005093" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">25,293</ix:nonFraction>)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Fair value remeasurements on business combinations</td>
    <td id="xdx_982_ecustom--FairValueRemeasurementsOnBusinessCombinations_pn3n3_c20240101__20241231_zYLa81w0NGKb" title="Fair value remeasurements on business combinations" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="afya:FairValueRemeasurementsOnBusinessCombinations" contextRef="From2024-01-012024-12-31" id="Fact005095" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">28,274</ix:nonFraction>)</td>
    <td id="xdx_98C_ecustom--AdditionsFairValueRemeasurementsOnBusinessCombinations_pn3n3_c20250101__20251231_zd1xNcN8ogDf" title="Additions fair value remeasurements on business combinations" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5097">-</span></td>
    <td id="xdx_989_ecustom--FairValueRemeasurementsOnBusinessCombinations_pn3n3_c20250101__20251231_zTpwaZ9tKL6i" title="Fair value remeasurements on business combinations" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(<ix:nonFraction name="afya:FairValueRemeasurementsOnBusinessCombinations" contextRef="From2025-01-01to2025-12-31" id="Fact005099" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">28,274</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_981_ecustom--DeferredsTaxLiabilities_iI_pn3n3_c20241231_zMdUQudxXY1h" title="Total" style="border-bottom: Black 1pt solid; text-align: right"><b>(<ix:nonFraction name="afya:DeferredsTaxLiabilities" contextRef="AsOf2024-12-31" id="Fact005101" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">28,274</ix:nonFraction>)</b></td>
    <td id="xdx_985_ecustom--AdditionsDeferredTaxLiabilities_pn3n3_c20250101__20251231_zC2ZsLiBNeJ5" title="Additions deferred tax liabilities" style="border-bottom: Black 1pt solid; text-align: right"><b>(<ix:nonFraction name="afya:AdditionsDeferredTaxLiabilities" contextRef="From2025-01-01to2025-12-31" id="Fact005103" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">25,293</ix:nonFraction>)</b></td>
    <td id="xdx_981_ecustom--DeferredsTaxLiabilities_iI_pn3n3_c20251231_zuudVW0DIoLk" title="Total" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(<ix:nonFraction name="afya:DeferredsTaxLiabilities" contextRef="AsOf2025-12-31" id="Fact005105" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">53,567</ix:nonFraction>)</b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Deferred tax assets (liabilities), net</b></td>
    <td id="xdx_986_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20241231_zlozLnAGLtRl" title="Deferred tax assets (liabilities), net" style="border-bottom: Black 1.5pt double; text-align: right"><b>(<ix:nonFraction name="ifrs-full:NetDeferredTaxLiabilities" contextRef="AsOf2024-12-31" id="Fact005107" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">28,274</ix:nonFraction>)</b></td>
    <td id="xdx_982_ecustom--AdditionsDeferredTaxAssetsLiabilitiesNet_pn3n3_c20250101__20251231_zRwXswmPwuF2" title="Additions deferred tax assets (liabilities), net" style="border-bottom: Black 1.5pt double; text-align: right"><b><ix:nonFraction name="afya:AdditionsDeferredTaxAssetsLiabilitiesNet" contextRef="From2025-01-01to2025-12-31" id="Fact005109" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,826</ix:nonFraction></b></td>
    <td id="xdx_98E_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20251231_zJdRABafBoXl" title="Deferred tax assets (liabilities), net" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b><ix:nonFraction name="ifrs-full:NetDeferredTaxLiabilities" contextRef="AsOf2025-12-31" id="Fact005111" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,552</ix:nonFraction></b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Recognized in the consolidated statement of income and other comprehensive income.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AF_zt7hVLjK22Ad" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The deferred tax assets were limited to the expected amount to be recovered, with the corresponding
impact recognized in the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">As of December 31, 2025, the Company had accumulated unrecognized deferred income tax assets
on temporary differences and tax losses in the amount of R$<span id="xdx_905_ecustom--DeferredTaxExpenseIncomes_pn3n3_c20250101__20251231_z8Sbr3bq2tFj" title="Unrecognized deferred income tax assets"><ix:nonFraction name="afya:DeferredTaxExpenseIncomes" contextRef="From2025-01-01to2025-12-31" id="Fact005113" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,603,167</ix:nonFraction></span> of tax-basis (December 31, 2024: R$<span id="xdx_909_ecustom--DeferredTaxExpenseIncomes_c20240101__20241231_pn3n3" title="Unrecognized deferred income tax assets"><ix:nonFraction name="afya:DeferredTaxExpenseIncomes" contextRef="From2024-01-012024-12-31" id="Fact005115" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,266,126</ix:nonFraction></span>) which does not have
expectations of future taxable income that could support the recognition as deferred tax assets, except for R$<span id="xdx_901_ecustom--RecognizedDeferredTaxAssets_pn3n3_c20250101__20251231_z3B1fcYc0Eo3" title="Recognized deferred tax assets"><ix:nonFraction name="afya:RecognizedDeferredTaxAssets" contextRef="From2025-01-01to2025-12-31" id="Fact005117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">392,391</ix:nonFraction></span> of tax basis from
temporary differences recognized as deferred tax assets as result of expected future taxable income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>


<ix:exclude><!-- Field: Page; Sequence: 226 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact005119" name="afya:DisclosureOfLegalProceedingsAndContingenciesExplanatory"><p id="xdx_80D_ecustom--DisclosureOfLegalProceedingsAndContingenciesExplanatory_zCkrE07RpKP4" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">21</td><td><span id="xdx_820_zMzaADaC9fhh">Legal proceedings and contingencies</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The provisions related to labor, civil and taxes proceedings whose likelihood of loss is
assessed as probable are as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact005121" name="afya:ScheduleOfLegalProceedingsAndContingenciesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_896_ecustom--ScheduleOfLegalProceedingsAndContingenciesTableTextBlock_pn3n3_zaYbuU3OiGJa" summary="xdx: Disclosure - Legal proceedings and contingencies (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="display: none"><span id="xdx_8B5_zDvFQ6ogRu47">Schedule of legal proceedings and contingencies</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Labor</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Civil</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Taxes</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Total</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Balances as of January 1, 2023</b></td>
    <td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zMPUP7yWvkUb" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,484</ix:nonFraction></b></td>
    <td id="xdx_987_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zEYXVMcMtOkk" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,664</ix:nonFraction></b></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zuu0D4NWBW0j" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005127" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">148,706</ix:nonFraction></b></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zXqE2w0Mescd" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005129" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">195,854</ix:nonFraction></b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Business combination</td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zOoi9r7FFo69" title="Business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005131" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64</ix:nonFraction></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zOLSjJ1M4Ad8" title="Business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005133" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88</ix:nonFraction></td>
    <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z3JldT5t38Fe" title="Business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5135">-</span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zMVgJlvFgrod" title="Business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005137" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">152</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Additions</td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgGziB3HeHK9" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005139" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,424</ix:nonFraction></td>
    <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zFMR9KOHFhEe" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005141" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,875</ix:nonFraction></td>
    <td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zhsTvUnQdBB4" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005143" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,037</ix:nonFraction></td>
    <td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zvLYMG4PIzPc" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005145" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,336</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Payments</td>
    <td id="xdx_98A_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zjxxbOccj9J9" title="Payments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005147" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">800</ix:nonFraction>)</td>
    <td id="xdx_98E_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zpuVDmtiHAsk" title="Payments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,051</ix:nonFraction>)</td>
    <td id="xdx_98C_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zRKwKO8cpVN2" title="Payments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005151" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,930</ix:nonFraction>)</td>
    <td id="xdx_98B_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zAC4DaVzVIvb" title="Payments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,781</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Reversals (i)</td>
    <td id="xdx_98F_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z6cVO1tkih71" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005155" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,451</ix:nonFraction>)</td>
    <td id="xdx_988_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuOr9hVKrDZa" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005157" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,276</ix:nonFraction>)</td>
    <td id="xdx_989_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zgiqgZBARFP1" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005159" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82,473</ix:nonFraction>)</td>
    <td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zcIC70dbufw7" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005161" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">93,200</ix:nonFraction>)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Balances as of December 31, 2023</b></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zYGZ7TphNIf7" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005163" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,721</ix:nonFraction></b></td>
    <td id="xdx_985_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zXX9pWkVPrIa" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005165" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,300</ix:nonFraction></b></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zsmhGeIdVD0d" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005167" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,340</ix:nonFraction></b></td>
    <td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z9TSm2VZtvDf" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005169" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">104,361</ix:nonFraction></b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Business combination</td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zlv1R9GFD8D3" title="Business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">721</ix:nonFraction></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zE2bkbXCJjki" title="Business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">481</ix:nonFraction></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zFk0iSvPaDC3" title="Business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005175" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,044</ix:nonFraction></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zUlatOTIfMPc" title="Business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,246</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Additions</td>
    <td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zMSz11wrKDag" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,744</ix:nonFraction></td>
    <td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zqEviugHnGVe" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005181" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,006</ix:nonFraction></td>
    <td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zLuLjOavQExb" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005183" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,119</ix:nonFraction></td>
    <td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z8jB2u7M0RCe" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005185" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,869</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Payments</td>
    <td id="xdx_98C_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zyWRp0WxL6If" title="Payments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005187" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,638</ix:nonFraction>)</td>
    <td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znDgL82bSSwa" title="Payments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005189" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,977</ix:nonFraction>)</td>
    <td id="xdx_985_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zZ01OUmmexFf" title="Payments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005191" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22</ix:nonFraction>)</td>
    <td id="xdx_980_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_ztl8tE8LPyk" title="Payments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005193" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,637</ix:nonFraction>)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Reversals (i)</td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zea77tSXO6Qd" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,093</ix:nonFraction>)</td>
    <td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z3dlA0d39UJ7" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005197" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,670</ix:nonFraction>)</td>
    <td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHyjD3uhGW8k" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005199" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,555</ix:nonFraction>)</td>
    <td id="xdx_98C_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zERfPJT1sXI6" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005201" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">52,318</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Balances as of December 31, 2024</b></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zxtLF9S2niG7" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005203" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,455</ix:nonFraction></b></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z1ybsx7j7OA5" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005205" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,140</ix:nonFraction></b></td>
    <td id="xdx_987_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zmrwueKMDQX4" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,926</ix:nonFraction></b></td>
    <td id="xdx_98A_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zFdAPi3qGX2i" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005209" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">113,521</ix:nonFraction></b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Additions</td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zGpxODUfcVke" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005211" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,014</ix:nonFraction> </td>
    <td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zrD9pb3ds7K5" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005213" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,568</ix:nonFraction> </td>
    <td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_znPPLGCPOtg6" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005215" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,799</ix:nonFraction> </td>
    <td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zyozkNUxBwT5" title="Additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005217" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,381</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Payments</td>
    <td id="xdx_98E_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ziYWFzlHD8Q7" title="Payments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005219" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,354</ix:nonFraction>)</td>
    <td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zaesi0QDNK5" title="Payments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005221" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,519</ix:nonFraction>)</td>
    <td id="xdx_981_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zkYXs0ORPb59" title="Payments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5223">-</span></td>
    <td id="xdx_982_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhgVR9gLLcdf" title="Payments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005225" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,873</ix:nonFraction>)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Reversals (i)</td>
    <td id="xdx_984_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zVqpOJ3uoaXe" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005227" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,386</ix:nonFraction>)</td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z6SZbaazXNqb" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005229" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,145</ix:nonFraction>)</td>
    <td id="xdx_98D_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_znoRZ1BA8sGe" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005231" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,278</ix:nonFraction>)</td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhxibWomxBd1" title="Reversals" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005233" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,809</ix:nonFraction>)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Balances as of December 31, 2025</b></td>
    <td id="xdx_983_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zinbUzDsoAv4" title="Balance as of ending of the year" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005235" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,729</ix:nonFraction> </b></td>
    <td id="xdx_985_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_ztO98Jsm2Gyg" title="Balance as of ending of the year" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" id="Fact005237" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,044</ix:nonFraction> </b></td>
    <td id="xdx_989_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zE2jpyEYuiZd" title="Balance as of ending of the year" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="Fact005239" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,447</ix:nonFraction> </b></td>
    <td id="xdx_985_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zquJoqn2NcEk" title="Balance as of ending of the year" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" id="Fact005241" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,220</ix:nonFraction> </b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"/><td style="text-align: justify">Includes the reversals of provision for legal proceedings with corresponding indemnification
asset.</td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A8_zu1fx0pPg5v3" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The major labor proceedings to which the Company is a party were filed by former employees
or outsourced service providers seeking enforcement of labor rights allegedly not provided by the Company. The judicial proceedings relate
to employment bonds (judicial proceedings filed by former service providers), overtime, premiums for hazardous workplace conditions, statutory
severance, fines for severance payment delays, and compensation for workplace-related accidents.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The civil claims to which the Company is a party generally relate to consumer claims, including
those related to student complaints.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The tax claims to which the Company is party are mostly tax foreclosures filed by the Brazilian
federal and municipal tax authorities.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">There are other civil, labor and taxes proceedings assessed by Management and its legal
counsels as possible risk of loss, for which no provisions are recognized, as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact005243" name="afya:ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89E_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock_pn3n3_z6TQ0Q7CUK2g" summary="xdx: Disclosure - Legal proceedings and contingencies (Details 1)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B5_zFCR4MkyXfv9" style="display: none">Schedule of social
    security proceedings assessed by management</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"/>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Labor</td>
    <td id="xdx_98D_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" title="Total" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember" id="Fact005245" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,818</ix:nonFraction> </td>
    <td id="xdx_98E_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" title="Total" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember" id="Fact005247" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,097</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Civil</td>
    <td id="xdx_983_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" title="Total" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember" id="Fact005249" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59,145</ix:nonFraction> </td>
    <td id="xdx_984_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" title="Total" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember" id="Fact005251" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,667</ix:nonFraction> </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Taxes</td>
    <td id="xdx_986_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" title="Total" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember" id="Fact005253" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,530</ix:nonFraction> </td>
    <td id="xdx_988_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" title="Total" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember" id="Fact005255" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,498</ix:nonFraction> </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--OtherProvisions_c20251231_pn3n3" title="Total" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2025-12-31" id="Fact005257" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">126,493</ix:nonFraction> </b></td>
    <td id="xdx_98B_eifrs-full--OtherProvisions_c20241231_pn3n3" title="Total" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2024-12-31" id="Fact005259" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">106,262</ix:nonFraction> </b></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A8_zp1xsNRWFYV2" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Under the terms of the Share Purchase and Sale Agreements ("Agreements") between
the Company and the selling shareholders of the subsidiaries acquired, the Company assesses that the selling shareholders are exclusively
responsible for any provisions (including labor, tax and civil), which are or will be the subject of a claim by any third party, arising
from the act or fact occurred, by action or omission, prior to or on the closing dates of the acquisitions.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Considering that the provisions for legal proceedings recorded by the Company that result
from causes arising from events occurring prior to the closing dates of the acquisitions, any liability for the amounts to be disbursed,
in case of their effective materialization in loss, belongs exclusively to the selling shareholders. In this context, the Agreements state
that the Company and its subsidiaries are indemnified and therefore exempt from any liability related to said contingent liabilities and,
therefore, the provision amounts related to such contingencies are presented in the non-current liabilities and the correspondent amount
of R$<span id="xdx_90C_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zcHoDUmliTwe" title="Contingencies correspondent amount"><ix:nonFraction name="afya:ContingenciesCorrespondentAmount" contextRef="AsOf2025-12-31_custom_OtherAssetsNonCurrentMember" id="Fact005261" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,379</ix:nonFraction></span> (December 31, 2024: R$<span id="xdx_905_ecustom--ContingenciesCorrespondentAmount_c20241231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_pn3n3" title="Contingencies correspondent amount"><ix:nonFraction name="afya:ContingenciesCorrespondentAmount" contextRef="AsOf2024-12-31_custom_OtherAssetsNonCurrentMember" id="Fact005263" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">78,701</ix:nonFraction></span>) is presented in non-current other assets.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 227 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td>&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: right">&#160;</td></tr><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="width: 3%">&#160;</td><td style="text-align: center; width: 97%"><p style="font: 12.5pt Nunito Sans; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 9.5pt Nunito Sans; margin: 0; text-align: left"><i>Expressed in thousands of Brazilian reais, unless otherwise stated</i></p><p style="font: 9.5pt Nunito Sans; margin: 0">&#160;</p></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact005265" name="afya:DisclosureNoncashTransactionsExplanatory"><p id="xdx_80E_ecustom--DisclosureNoncashTransactionsExplanatory_zfgnVQ6OBHo5" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%">22</td><td><span id="xdx_823_z9oJPQJUUDT6">Non-cash transactions</span></td></tr></table>
<p style="font: 8.5pt Nunito Sans; margin: 0"></p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">During the years ended December 31, 2025, 2024 and 2023, the Company carried out non-cash
transactions which are not reflected in the consolidated statement of cash flows. The main non-cash transactions are as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact005267" name="afya:ScheduleOfNonCashTransactionsTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89B_ecustom--ScheduleOfNonCashTransactionsTableTextBlock_pn3n3_zRQwgNhvuOoj" summary="xdx: Disclosure - Non-cash transactions (Details)" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt"><span id="xdx_8B2_zUoIiDVrKut8" style="display: none">Schedule
    of non-cash transactions</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 67%; padding-left: 8.7pt; text-align: right; text-indent: -8.7pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt">&#160;</td>
    <td style="text-align: right"/>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Remeasurement of earn-out of Al&#233;m da Medicina, CardioPapers and Glic</td>
    <td id="xdx_980_ecustom--RemeasurementOfEarnOut_pn3n3_c20250101__20251231_z4T31wLxjcN7" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5269">-</span></td>
    <td id="xdx_987_ecustom--RemeasurementOfEarnOut_pn3n3_c20240101__20241231_zcNmgAioEoOh" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl5271">-</span></td>
    <td id="xdx_98A_ecustom--RemeasurementOfEarnOut_pn3n3_c20230101__20231231_zliFR7QG0O0f" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic" style="text-align: right"><ix:nonFraction name="afya:RemeasurementOfEarnOut" contextRef="From2023-01-012023-12-31" id="Fact005273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,556</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Additions and remeasurements of right-of-use assets and lease liabilities</td>
    <td id="xdx_98E_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_c20250101__20251231_pn3n3" title="Additions and remeasurements of right-of-use assets and lease liabilities" style="text-align: right"><ix:nonFraction name="afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" contextRef="From2025-01-01to2025-12-31" id="Fact005275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">136,714</ix:nonFraction></td>
    <td id="xdx_98E_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20240101__20241231_zWdWTUeEC3P6" title="Additions and remeasurements of right-of-use assets and lease liabilities" style="text-align: right"><ix:nonFraction name="afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" contextRef="From2024-01-012024-12-31" id="Fact005277" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">117,897</ix:nonFraction></td>
    <td id="xdx_982_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_c20230101__20231231_pn3n3" title="Additions and remeasurements of right-of-use assets and lease liabilities" style="text-align: right"><ix:nonFraction name="afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" contextRef="From2023-01-012023-12-31" id="Fact005279" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,715</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net</td>
    <td id="xdx_98B_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_pn3n3_c20250101__20251231_zwMZpoTQkXf" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net" style="text-align: right"><ix:nonFraction name="afya:AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet" contextRef="From2025-01-01to2025-12-31" id="Fact005281" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,678</ix:nonFraction></td>
    <td id="xdx_98B_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_pn3n3_c20240101__20241231_zvLocT5FP47b" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net" style="text-align: right">(<ix:nonFraction name="afya:AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet" contextRef="From2024-01-012024-12-31" id="Fact005283" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,154</ix:nonFraction>)</td>
    <td id="xdx_98C_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_c20230101__20231231_pn3n3" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net" style="text-align: right"><ix:nonFraction name="afya:AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet" contextRef="From2023-01-012023-12-31" id="Fact005285" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,000</ix:nonFraction></td></tr>
  <tr style="background-color: White">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Additions to intangibles and goodwill through accounts payable to selling shareholders.</td>
    <td id="xdx_980_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_c20250101__20251231_pn3n3" title="Additions to intangibles and goodwill through accounts payable to selling shareholders" style="text-align: right"><ix:nonFraction name="afya:AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders" contextRef="From2025-01-01to2025-12-31" id="Fact005287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,000</ix:nonFraction></td>
    <td id="xdx_988_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_pn3n3_c20240101__20241231_zFZYBv0WO1Ma" title="Additions to intangibles and goodwill through accounts payable to selling shareholders" style="text-align: right"><ix:nonFraction name="afya:AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders" contextRef="From2024-01-012024-12-31" id="Fact005289" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">279,989</ix:nonFraction></td>
    <td id="xdx_983_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_c20230101__20231231_pn3n3" title="Additions to intangibles and goodwill through accounts payable to selling shareholders" style="text-align: right"><ix:nonFraction name="afya:AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders" contextRef="From2023-01-012023-12-31" id="Fact005291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">234,000</ix:nonFraction></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Dividends payable</td>
    <td id="xdx_986_ecustom--DividendsPayables_iI_pn3n3_c20250101__20251231_z5a5QsGtgHBd" title="Dividends payable" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt"><ix:nonFraction name="afya:DividendsPayables" contextRef="From2025-01-01to2025-12-31" id="Fact005293" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">192</ix:nonFraction></td>
    <td id="xdx_98A_ecustom--DividendsPayables_pn3n3_c20240101__20241231_zFRspycj9nD6" title="Dividends payable" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt"><span style="-sec-ix-hidden: xdx2ixbrl5295">-</span></td>
    <td id="xdx_98B_ecustom--DividendsPayables_pn3n3_c20230101__20231231_z85Q9IaTl1L1" title="Dividends payable" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt"><span style="-sec-ix-hidden: xdx2ixbrl5297">-</span></td></tr>
  </table>
</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-12-31" escape="true" id="Fact005299" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory"><p id="xdx_808_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zVblsUeamGP2" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 3%"><b>23</b></td><td><b><span id="xdx_828_zr0h6L49cs99">Subsequent events</span></b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Medical school seats increase in ITPAC Porto</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On February 6, 2026, MEC authorized the increase of 63 medical school seats of ITPAC Porto
located in the city of Abaetetuba, State of Par&#225;. With this authorization, Afya reached 113 medical school seats on this campus.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Dividend distribution</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On March 12, 2026, the Company&#8217;s Board of Directors approved a dividend distribution
in the amount of R$<span id="xdx_90E_ecustom--FirstDividendDistributionInAmount_pn5n6_c20260311__20260312__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z8hARqnokK42" title="First dividend distribution in amount"><ix:nonFraction name="afya:FirstDividendDistributionInAmount" contextRef="From2026-03-112026-03-12_custom_NonadjustingEventMember" id="Fact005301" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="BRL">307.4</ix:nonFraction></span> million, representing <span id="xdx_90B_ecustom--PercentageOfDividendDistribution_pip0_dp_c20260311__20260312__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zlcYv0mJTj69" title="Percentage of dividend distribution"><ix:nonFraction name="afya:PercentageOfDividendDistribution" contextRef="From2026-03-112026-03-12_custom_NonadjustingEventMember" id="Fact005303" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">40</ix:nonFraction></span>% of the Company&#8217;s consolidated net income for the year ended December 31, 2025
and a dividend per share of R$<span id="xdx_908_eifrs-full--DividendsPaidOtherSharesPerShare_c20260405__20260406__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zAqHnAsvO6n4" title="Dividends per share"><ix:nonFraction name="ifrs-full:DividendsPaidOtherSharesPerShare" contextRef="From2026-04-052026-04-06_custom_NonadjustingEventMember" id="Fact005305" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">3.446838</ix:nonFraction></span>, payable in U.S. dollars on April 6, 2026, to the shareholders on record as of the close of business
on March 25, 2026. The payment will be made at the exchange rate (PTAX) published by the Brazilian Central Bank on March 13, 2026.</p>

</ix:nonNumeric><p id="xdx_815_za7e2nbu6EF6" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: center">*****</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: center">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->&#160;</span></td></tr></table>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: center">&#160;</p>



<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ex02-1.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right">Exhibit 2.1</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION
12 OF THE EXCHANGE ACT</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a description of our outstanding securities
registered under Section 12 of the Exchange Act as required pursuant to the relevant Items under Form 20-F. As of December 31, 2025, Afya
Limited (&ldquo;we,&rdquo; &ldquo;us,&rdquo; and &ldquo;our&rdquo;) had the following series of securities registered pursuant to Section
12(b) of the Exchange Act:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 34%; padding-right: 2.9pt; padding-left: 2.9pt">
    <P STYLE="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Title of
    each class</P></TD>
    <TD STYLE="width: 33%; padding-right: 2.9pt; padding-left: 2.9pt">
    <P STYLE="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Trading Symbol(s)</P></TD>
    <TD STYLE="width: 33%; padding-right: 2.9pt; padding-left: 2.9pt">
    <P STYLE="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Name of each
    exchange on which registered</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Class A common shares, par value US$0.00005 per share</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">AFYA</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Nasdaq Global Select Market</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We were incorporated on March 22, 2019 as a Cayman
Islands exempted company with limited liability duly registered with the Cayman Islands Registrar of Companies. Our corporate purposes
are unrestricted and we have the authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies
Act (As Revised) of the Cayman Islands, or the Companies Act.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our affairs are governed principally by (i)&nbsp;our
Amended and Restated Memorandum and Articles of Association; (ii)&nbsp;the Companies Act; and (iii)&nbsp;the common law of the Cayman
Islands. As provided in our Amended and Restated Memorandum and Articles of Association, subject to Cayman Islands law, we have full capacity
to carry on or undertake any business or activity, do any act or enter into any transaction, and, for such purposes, full rights, powers
and privileges. Our registered office is c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman
Islands.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">CLASS A COMMON SHARES</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Item 9. General</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">9.A.3 Preemptive rights</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">See &ldquo;&mdash;Item 10.B Memorandum and articles
of association&mdash;Preemptive or Similar Rights&rdquo; below.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><A NAME="a_Hlk164693418"></A>9.A.5 Type and class of securities</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, the Company&rsquo;s share
capital was R$17,000 represented by 93,722,831 shares comprised by 55,148,697 Class A common shares and 38,574,134 class B common shares.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, our total authorized share
capital was US$50,000, divided into 1,000,000,000 shares par value US$0.00005 each, of which: (i) 500,000,000 shares are designated as
Class A common shares; (ii)&nbsp;250,000,000 shares are designated as Class B common shares; and (iii) 250,000,000 shares of such class
or classes (howsoever designated) and having the rights as the Board may determine.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Amended and Restated Memorandum and Articles of
Association currently authorize two classes of common shares: Class A common shares, which are entitled to one (1) vote per share, and
Class B common shares, which are entitled to ten (10) votes per share and to maintain a proportional ownership interest in the event that
additional Class A common shares, or any other class of share designated as a common share are issued. Any holder of Class B common shares
may convert his or her shares at any time into Class A common shares on a share-for-share basis. The rights of the two classes of common
shares are otherwise identical, except as described in our Amended and Restated Memorandum and Articles of Association. The implementation
of this dual class equity structure was required by the Esteves Family and Crescera, our principal shareholders in 2019, as a condition
of undertaking the initial public offering of our common shares. See &ldquo;&mdash;Anti-Takeover Provisions in Our Articles of Association&mdash;Two
Classes of Common Shares.&rdquo;</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Item 9.A.6. Limitations or qualifications</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Item 9.A.7. Other rights</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Item 10.B Memorandum and articles of association</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The following information describes our Class A common
shares and provisions set forth by our Amended and Restated Memorandum and Articles of Association, the Companies Act; and the common
law of the Cayman Islands. This description is only a summary. You should read and refer to our Amended and Restated Memorandum and Articles
of Association included as Exhibit&nbsp;1.4 to our annual report on Form 20-F for the fiscal year ended December 31, 2022.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Description of Our Amended and Restated Memorandum and Articles of
Association</P>

<P STYLE="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">History of Share Capital</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On July 19, 2019, our registration statement on Form
F-1 (File No 333-232309), as amended, was declared effective by the SEC for to our initial public offering of our Class A common shares,
pursuant to which we sold a total of 15,805,841 Class A common shares, par value $0.00005 per share, at a public offering price of US$19.00
per share.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On February 6, 2020, our registration statement on
Form F-1 (File No 333-236246), as amended, was declared effective by the SEC for a public offering of our Class A common shares, pursuant
to which we sold a total of 3,260,480 Class A common shares, par value $0.00005 per share, at a public offering price of US$27.50 per
share.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">On April 26, 2021, we issued R$822 million (equivalent
to US$150 million) of Series A perpetual convertible preferred shares to SBLA Holdco LLC, an affiliate of Softbank. On November 3, 2025,
we repurchased all outstanding Series A perpetual convertible preferred shares from SoftBank for an aggregate purchase price of R$831.6
million, and such shares were subsequently cancelled.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2025, Afya had 3,855,150 common
shares in treasury.</P>

<P STYLE="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">General</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our shareholders adopted our Amended and Restated Memorandum
and Articles of Association, effective as of May 4, 2022, included as Exhibit 1.4 to our annual report on Form 20-F for the fiscal year
ended December 31, 2022. The following summary is subject to and qualified in its entirety by Afya Limited&rsquo;s Amended and Restated
Memorandum and Articles of Association. This is not a summary of all the significant provisions of our Amended and Restated Memorandum
and Articles of Association, of the Companies Act or of the common law of the Cayman Islands and does not purport to be complete. Capitalized
terms used but not defined herein have the meanings given to them in our annual report on Form 20-F for the fiscal year ended December
31, 2022.</P>

<P STYLE="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Corporate Purposes</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our corporate purposes are unrestricted and we have
the authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies Act.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Issuance of Shares</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Except as expressly provided in our Articles of Association,
our board of directors has general and unconditional authority to allot, grant options over, offer or otherwise deal with or dispose of
any unissued shares in the company&rsquo;s capital without the approval of our shareholders (whether forming part of the original or any
increased share capital), either at a premium or at par, with or without preferred, deferred or other special rights or restrictions,
whether in regard to dividend, voting, return of capital or otherwise and to such persons, on such terms and conditions, and at such times
as the directors may decide, but so that no share shall be issued at a discount, except in accordance with the provisions of the Companies
Act. In accordance with its Articles of Association, Afya shall not issue bearer shares or warrants.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association provide that at any time
that there are Class A common shares in issue, additional Class B common shares may only be issued pursuant to (i)&nbsp;a share split,
subdivision of shares or similar transaction or where a dividend or other distribution is effected through the issue of shares, debentures,
or rights to acquire shares or through the capitalization of profits, ensuring proportional allocation and class consistency, (ii)&nbsp;a
merger, consolidation, or other business combination, or (iii)&nbsp;an issuance of shares including Class A common shares or any other
class of share designated as a common share pursuant to the Articles of Association, whereby each holder of the Class B common shares
is entitled to purchase a number of Class B common shares that would allow such holder to maintain its proportional ownership interests
in Afya.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under our Articles of Association, we may not issue
Common Shares and/or preferred shares to any person on any terms unless we first offer each holder of Class B common shares the opportunity
to subscribe for such number of Class B common shares, on the same economic terms and at the same price as would allow such holder to
maintain its proportional ownership interest in Afya. In light of: (a)&nbsp;the above provisions; (b)&nbsp;the fact that future transfers
of Class B common shares will generally result in their conversion into Class A common shares, subject to limited exceptions set forth
in our Articles of Association; and (c)&nbsp;the ten-to-one voting ratio between our Class B common shares and Class A common shares,
holders of our Class B common shares will in many circumstances continue to maintain control of all matters requiring shareholder approval.
This concentration of ownership and voting power will limit or preclude your ability to influence corporate matters for the foreseeable
future.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association also provide that the issuance
of non-voting common shares requires the affirmative vote of a majority of the then-outstanding Class A common shares, approval by ordinary
resolution of our shareholders, which requires the affirmative vote of a simple majority of the votes cast on the resolution by the shareholders
entitled to vote who are present, in person or by proxy, at the meeting and the prior written consent of a Bertelsmann Director and Esteves
Family Director as set out below in &ldquo;&mdash;Proceedings of the Board of Directors.&rdquo;</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Fiscal Year</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our fiscal year begins on January 1 of each year and
ends on December 31 of the same year.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Voting Rights</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The holders of the Class A common shares and Class
B common shares have identical rights, except that (i)&nbsp;the holder of Class B common shares is entitled to ten (10) votes per share,
whereas holders of Class A common shares are entitled to one (1) vote per share, (ii)&nbsp;Class B common shares have certain conversion
rights and (iii)&nbsp;the holders of Class B common shares are entitled to maintain their proportional ownership interest in the event
that common shares and/or preferred shares are proposed to be issued. For more information see below &ldquo;&mdash;Preemptive or Similar
Rights&rdquo; and &ldquo;&mdash;Conversion.&rdquo; The holders of Class A common shares and Class B common shares vote together as a single
class on all matters (including the election of directors) submitted to a vote of shareholders, except as provided below and as otherwise
required by law.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association provide as follows regarding
the respective rights of holders of Class A common shares and Class B common shares:</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><FONT STYLE="background-color: white">(i)</FONT> Class
consents from the holders of Class A common shares or Class B common shares, as applicable, shall be required for any variation to the
rights attached to their respective class of shares, however, the directors may treat any two or more classes of shares as forming one
class if they consider that all such classes would be affected in the same way by the proposal;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">(ii) The rights conferred on holders of Class A common
shares shall not be deemed to be varied by the creation or issue of further Class B common shares and vice versa; and</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">(iii) The rights attaching to the Class A common shares
and the Class B common shares shall not be deemed to be varied by the creation or issue of further shares ranking pari passu therewith,
the redemption or purchase of any shares of any class by the Company, the cancellation of authorized but unissued shares of that class
or the creation or issue of shares with preferred or other rights, including, without limitation, shares with enhanced or weighted voting
rights.</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As set forth in the Articles of Association, the holders
of Class A common shares and Class B common shares, respectively, do not have the right to vote separately if the number of authorized
shares of such class is increased or decreased. Rather, the number of authorized Class A common shares and Class B common shares may be
increased or decreased (but not below the number of shares of such class then outstanding) by the affirmative vote of the holders of a
majority of the voting power of the issued and outstanding Class A common shares and Class B common shares, voting together in a general
meeting.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Preemptive or Similar Rights</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares and Class B common shares
are not entitled to preemptive rights upon transfer and are not subject to conversion (except as described below under &ldquo;&mdash;Conversion&rdquo;),
redemption or sinking fund provisions.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Class B common shares are entitled to maintain
a proportional ownership interest in the event that additional common and/or preferred shares are issued. As such, if Afya issues common
and/or preferred shares, it must first make an offer to each holder of Class B common shares to issue to such holder on the same economic
terms such number of Class B common shares as would ensure such holder may maintain a proportional ownership interest in Afya. This right
to maintain a proportional ownership interest may be waived by all of the holders of Class B common shares, such waiver to remain effective
until the date specified therein or twelve (12) months from the date of the waiver. For more information see &ldquo;&mdash; Issuance of
Shares.&rdquo;</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Conversion</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The outstanding Class B common shares are convertible
into Class A Common Shares, on a share-to-share basis, at any time after issue and without payment of any additional sum, as follows:
(i)&nbsp;at the discretion of a holder of Class B common shares, a Class B common share may be converted into one Class A common share,
or (ii)&nbsp;upon the request of the holders of all the then issued and outstanding Class B common shares, all outstanding Class B common
shares may be converted into a like number of Class A common shares. In addition, each Class B common share will convert automatically
into one Class A common share upon any transfer, whether or not for value, except for certain transfers described in the Articles of Association,
including transfers to holders of Class B common shares, to affiliates, to and between the Esteves Family, Bertelsmann, their family members
and their respective children, heirs and successors, trusts solely for the benefit of the shareholder or their affiliates, and to partnerships,
corporations and other entities exclusively owned or controlled by the Class B shareholder or their affiliates and certain transfers to
organizations that are exempt from taxation under Section 501(c)(3) of the Internal Revenue Code of 1986, as amended. Furthermore, each
Class B common share will convert automatically into one Class A common share and no Class B common shares will be issued thereafter if,
at any time, the total number of the issued and outstanding Class B common shares is less than 10% of the total number of shares outstanding.
To the extent that Bertelsmann or the Esteves Family cease to be a Class B common shareholder, the rights nominally vested to each shall
vest in their permitted transferee within the meaning of our Articles of Association.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">No class of our common shares may be subdivided or
combined unless the other class of common shares is concurrently subdivided or combined in the same proportion and in the same manner.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Equal Status</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Except as expressly provided in our Articles of Association,
Class A common shares and Class B common shares have the same rights and privileges and rank equally, share ratably and are identical
in all respects as to all matters.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In the event of any merger, consolidation, scheme,
arrangement or other business combination requiring the approval of our shareholders entitled to vote thereon (whether or not Afya is
the surviving entity), the holders of Class A common shares shall have the right to receive, or the right to elect to receive, the same
form of consideration as the holders of Class B common shares, and the holders of Class A common shares shall have the right to receive,
or the right to elect to receive, at least the same amount of consideration on a per share basis as the holders of Class B common shares.
In the event of any (i)&nbsp;tender or exchange offer to acquire any Class A common shares or Class B common shares by any third-party
pursuant to an agreement to which Afya is a party, or (ii)&nbsp;any tender or exchange offer by Afya to acquire any Class A common shares
or Class B common shares, the holders of Class A common shares shall have the right to receive, or the right to elect
to receive, the same form of consideration as the holders of Class B common shares, and the holders of Class A common shares shall have
the right to receive, or the right to elect to receive, at least the same amount of consideration on a per share basis as the holders
of Class B common shares.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Record Dates</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For the purpose of determining shareholders entitled
to notice of, or to vote at any general meeting of shareholders or any adjournment thereof, or shareholders entitled to receive dividend
or other distribution payments, or in order to make a determination of shareholders for any other purpose, Our board of directors may
set a record date which shall not exceed 40 clear days prior to the date where the determination will be made.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">General Meetings of Shareholders</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a condition of admission to a shareholders&rsquo;
meeting, a shareholder must be duly registered as a shareholder of Afya at the applicable record date for that meeting and, in order to
vote, all calls or installments then payable by such shareholder to Afya in respect of the shares that such shareholder holds must have
been paid.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to any special rights or restrictions as to
voting then attached to any shares, at any general meeting every shareholder who is present in person or by proxy (or, in the case of
a shareholder being a corporation, by its duly authorized representative not being himself or herself a shareholder entitled to vote)
shall have one vote per Class A common share and 10 votes per Class B common share.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">As a Cayman Islands exempted company, Afya is not obliged
by the Companies Act to call annual general meetings; however, the Articles of Association provide that in each year the company will
hold an annual general meeting of shareholders, at a time determined by the board of directors. For the annual general meeting of shareholders
the agenda will include, among other things, the presentation of the annual accounts and the report of the directors (if any). In addition,
the agenda for an annual general meeting of shareholders will only include such items as have been included therein by the board of directors.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Also, Afya may, but is not required to (unless required
by the laws of the Cayman Islands), hold other extraordinary general meetings during the year. General meetings of shareholders are generally
expected to take place in Belo Horizonte, Brazil, but may be held elsewhere if the directors so decide.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act provides shareholders a limited right
to request a general meeting and does not provide shareholders with any right to put any proposal before a general meeting in default
of a company&rsquo;s Articles of Association. However, these rights may be provided in a company&rsquo;s Articles of Association. Our
Articles of Association provide that upon the requisition of one or more shareholders representing not less than one-third of the voting
rights entitled to vote at general meetings, the board will convene an extraordinary general meeting and put the resolutions so requisitioned
to a vote at such meeting. The Articles of Association provide no other right to put any proposals before annual general meetings or extraordinary
general meetings.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to regulatory requirements, the annual general
meeting and any extraordinary general meetings must be called with at least ten (10) clear calendar days&rsquo; notice prior to the relevant
shareholders meeting and convened by a notice discussed below. Alternatively, upon the prior consent of all holders entitled to receive
notice, with regards to the annual general meeting, and upon the prior consent of a majority in number of the members (which shall include
Bertelsmann and the Esteves Family) together holding at least 95% in par value of the shares entitled to attend and vote, with regards
to an extraordinary general meeting, that meeting may be convened by a shorter notice and in a manner deemed appropriate by those holders.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya will give notice of each general meeting of shareholders
by publication on its website and in any other manner that it may be required to follow in order to comply with Cayman Islands law, Nasdaq
and SEC requirements. The holders of registered shares may be given notice of a shareholders&rsquo; meeting by means of letters sent to
the addresses of those shareholders as registered in our shareholders&rsquo; register, or, subject to certain statutory requirements,
by electronic means.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><B>Holders whose shares are registered in the name
of DTC or its nominee, which we expect will be the case for all holders of Class A common shares, will not be a shareholder or member
of the company and must rely on the procedures of DTC regarding notice of shareholders&rsquo; meetings and the exercise of rights of a
holder of the Class A common shares.</B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A quorum for a general meeting consists of any one
or more persons holding or representing by proxy not less than one-third of the aggregate voting power of all shares in issue and entitled
to vote upon the business to be transacted.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A resolution put to a vote at a general meeting shall
be decided on a poll. An ordinary resolution to be passed by the shareholders at a general meeting requires the affirmative vote of a
simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote, present in person or by proxy and voting at
the meeting. A special resolution requires the affirmative vote on a poll of no less than two-thirds of the votes cast by the shareholders
entitled to vote who are present in person or by proxy at a general meeting. Both ordinary resolutions and special resolutions may also
be passed by a unanimous written resolution signed by all the shareholders of our Company, as permitted by the Companies Act and our Articles
of Association.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to our Articles of Association, general meetings
of shareholders are to be chaired by the co-chairman of our board of directors appointed by Bertelsmann or in his absence, the co-chairman
of the board of directors appointed by the Esteves Family. If both such co-chairmen are absent, the directors present at the meeting shall
appoint one of them to be chairman of the general meeting. If neither the chairmen nor another director is present at the general meeting
within 15 minutes after the time appointed for holding the meeting, the shareholders present in person or by proxy and entitled to vote
may elect any one of the shareholders to be chairman. The order of business at each meeting shall be determined by the chairman of the
meeting and he or she shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts and
things as are necessary or desirable for the proper conduct of the meeting, including, without limitation, the establishment of procedures
for the maintenance of order and safety, limitations on the time allotted to questions or comments on the affairs of the Company, restrictions
on entry to such meeting after the time prescribed for the commencement thereof, and the opening and closing of the polls. The chairman
shall not have the right to vote in his capacity as chairman and shall not have a casting vote.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Liquidation Rights</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If Afya is voluntarily wound up, the liquidator shall,
after taking into account and giving effect to:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>the rights of preferred and secured creditors and to</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>any agreement between Afya and any creditors that the claims of such creditors shall be subordinated or otherwise deferred to the
claims of any other creditors and to</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD>any contractual rights of set-off or netting of claims between Afya and any person or persons (including without limitation any bilateral
or any multi-lateral set-off or netting arrangements between the company and any person or persons) and subject to</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD>any agreement between Afya and any person or persons to waive or limit the same</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0in">apply our property in satisfaction of its liabilities
<I>pari passu. </I>Any remaining assets shall then be distributed among shareholders in accordance with their rights and interests in
Afya.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Special Matters</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya may not without the prior written consent of (i)&nbsp;Bertelsmann
for so long as it holds Class B common shares in excess of the Ownership Threshold and (ii)&nbsp;the Esteves Family for so long as it
holds Class B common shares in excess of the Ownership Threshold: change the number of directors; amend its Memorandum and Articles of
Association; vary the rights attaching to shares; approve the winding-up, liquidation or dissolution of Afya; or take certain actions
in respect of its share capital as set out in the Articles of Association; register as an exempted limited duration company; or approve the transfer by way of continuation
of Afya to a jurisdiction outside the Cayman Islands.</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Anti-Corruption and Anti-Money Laundering</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association contain stringent anti-corruption,
anti-money laundering and certain other related measures applicable to us, our officers and directors, and its service providers. The
Articles of Association provide that if one of our shareholders is found to have been involved in an act of corruption, money laundering
or other related irregular act, the directors shall convene a meeting to consider the circumstances of such incident, and establish a
course of action to be taken against such shareholder. The actions range from (i)&nbsp;suspending such shareholder from his/her duties
as a director, officer and/or employee (if applicable) of the Company; (ii)&nbsp;terminating such duties; (iii)&nbsp;directing such shareholder
to transfer the entirety of his/her shareholding in the Company to his/her children and/or heirs; or (iv)&nbsp;if such transfer is not
possible, resolve that the shares in the Company owned by such shareholder be mandatorily redeemed by us. Further, our Articles of Association
provide that we shall not engage the services of any provider that has been found to violate applicable anti-corruption laws, and further
provide that we and our shareholders shall not violate applicable anti-corruption laws or laws related to acts of improbity.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Changes to Capital</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the restrictions contained in the Articles
of Association and summarized above in &ldquo;&mdash;Special Matters,&rdquo; Afya may from time to time by ordinary resolution:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>increase its share capital by such sum, to be divided into shares of such amount, as the resolution shall prescribe;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>consolidate and divide all or any of its share capital into shares of a larger amount than its existing shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>convert all or any of its paid-up shares into stock and reconvert that stock into paid up shares of any denomination;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>subdivide its existing shares or any of them into shares of a smaller amount, provided that in the subdivision the proportion between
the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in the case of the share from which the
reduced share is derived; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and
diminish the amount of its share capital by the amount of the shares so canceled.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our shareholders may by special resolution, subject
to confirmation by the Grand Court of the Cayman Islands on an application by the Company for an order confirming such reduction, reduce
its share capital or any capital redemption reserve in any manner permitted by law.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, subject to the provisions of the Companies
Act and our Articles of Association, Afya may:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>issue shares on terms that they are to be redeemed or are liable to be redeemed;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>purchase its own shares (including any redeemable shares); and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>make a payment in respect of the redemption or purchase of its own shares in any manner authorized by the Companies Act, including
out of its own capital.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Transfer of Shares</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to any applicable restrictions set forth in
the Articles of Association, any shareholder of Afya may transfer all or any of his or her common shares by an instrument of transfer
in the usual or common form or in the form prescribed by the Nasdaq or any other form approved by the Company&rsquo;s board of directors.</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares are traded on the Nasdaq
in book-entry form and may be transferred in accordance with our Articles of Association and Nasdaq&rsquo;s rules and regulations.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">However, our board of directors may, in its absolute
discretion, decline to register any transfer of any common share which is either not fully paid up to a person of whom it does not approve
or is issued under any share incentive scheme for employees which contains a transfer restriction that is still applicable to such common
share. The board of directors may also decline to register any transfer of any common share unless:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the instrument of transfer is lodged with Afya, accompanied by the certificate (if any) for the common shares to which it relates
and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the instrument of transfer is in respect of only one class of shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the instrument of transfer is properly stamped, if required;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the common shares transferred are free of any lien in favor of Afya; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>in the case of a transfer to joint holders, the transfer is not to more than four joint holders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">If the directors refuse to register a transfer they
are required, within 15 business days after the date on which the instrument of transfer was lodged, to send to the transferee notice
of such refusal.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Share Repurchases</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act and the Articles of Association permit
Afya to purchase its own shares, subject to certain restrictions. The board of directors may only exercise this power on behalf of Afya,
and subject to the Companies Act, the Articles of Association and to any applicable requirements imposed from time to time by the SEC,
the Nasdaq, or by any recognized stock exchange on which our securities are listed. Set forth below is a description of our share repurchase
programs.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><B><I>1<SUP>st</SUP> Share Repurchase Program</I>.
</B>Our Board of Directors approved a share buyback program on December 23, 2020. Under the share buyback program, Afya may repurchase
up to 1,015,844 of its outstanding Class A common shares in the open market, based on prevailing market prices, or in privately negotiated
transactions, over a period beginning on December 24, 2020 continuing until the earlier of the completion of the repurchase or December
31, 2021, depending upon market conditions. We repurchased the shares to execute the stock option program for the executives of the Company
and utilized our existing funds to fund repurchases made under this program. Our Board of Directors also authorized management to appoint
BofA Securities, Inc. as our agent to purchase the shares on our behalf in the open market. It is our intention such purchases benefit
from the safe harbor provided by Rule 10b-18 (&ldquo;Rule 10b-18&rdquo;) promulgated by the SEC under the Exchange Act. Accordingly, we
shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rule 10b-18
for purchases of our common shares under the program. The share buyback program was completed on October 21, 2021, upon the completion
of the purchase of the full amount of Class A common shares permitted under the program.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><B><I>2<SUP>nd</SUP> Share Repurchase Program</I>.</B>
After the completion of our first share repurchase program on October 21, 2021 that resulted in the purchase of 1,015,844 Class A common
shares, our Board of Directors approved a new share repurchase program on October 27, 2021, or the second share repurchase program. Under
the second share repurchase program, Afya may repurchase up to 1,383,108 of its outstanding Class A common shares in the open market,
based on prevailing market prices, or in privately negotiated transactions, beginning on October 28, 2021 until the earlier of the completion
of the repurchase or December 31, 2022, depending upon market conditions. We repurchased the shares to execute the stock option program
for the executives of the Company and utilized our existing funds to fund repurchases made under this program. The Board of Directors
of Afya also authorized management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market.
It is Afya&rsquo;s intention that such purchases benefit from the safe harbor provided by Rule 10b-18 promulgated by the SEC under the
Exchange Act. Accordingly, Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize
the availability of Rule 10b-18 for purchases under the program. The second share repurchase program was completed on January 14, 2022, upon the purchase
of the full amount of Class A common shares permitted under the second share repurchase program.</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><B><I>3<SUP>rd</SUP> Share Repurchase Program</I>.</B>
After the completion of our second share repurchase program, which resulted in the purchase of 1,383,108 Class A common shares, our Board
of Directors approved a new share repurchase program on January 27, 2022, or the third share repurchase program. Under the third share
repurchase program, Afya may repurchase up to 1,874,457 of its outstanding Class A common shares which represents 4% of its free float,
in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on January 27, 2022, until the
earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions. We repurchased the shares for use
in our stock option program, as consideration in business combination transactions and for general corporate purposes and utilized our
existing funds and dividends received from Afya Brazil to fund repurchases made under this program. The Board of Directors of Afya also
authorized management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market. It is Afya&rsquo;s
intention that such purchases benefit from the safe harbor provided by Rule 10b-18 promulgated by the SEC under the Exchange Act. Accordingly,
Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rule
10b-18 for purchases under the program. The third share repurchase program was completed on May 4, 2022, upon the purchase of the full
amount of Class A common shares permitted under the third share repurchase program.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><B><I>4<SUP>th</SUP> Share Repurchase Program</I>.</B>
After the completion of our third share repurchase program, which resulted in the purchase of 1,874,457 Class A common shares, our board
of directors has approved a new share repurchase program on March 24, 2023, or the fourth share repurchase program. Under the fourth share
repurchase program, Afya may repurchase up to 2,000,000 of its outstanding Class A common shares, in the open market, based on prevailing
market prices, or in privately negotiated transactions, beginning on March 24, 2023 until the earlier of the completion of the repurchase
or December 31, 2024, depending upon market conditions.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><B><I>5th Share Repurchase Program</I>.</B> After the
completion of our fourth share repurchase program, which resulted in the purchase of 216,339 Class A common shares, our board of directors
approved a new share repurchase program on August 13, 2025, or the fifth share repurchase program. Under the fifth share repurchase program,
Afya may repurchase up to 4,000,000 of its outstanding Class A common shares, in the open market, based on prevailing market prices, or
in privately negotiated transactions, beginning on August 15, 2025 until the earlier of the completion of the repurchase or December 31,
2026, depending upon market conditions.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For the year ended December 31, 2024, there were no
Class A common shares repurchased by us. For the year ended December 31, 2025, we repurchased 966,541 Class A common shares.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The share repurchases may be made from time to time
through open market transactions and are subject to market and business conditions, levels of available liquidity, cash requirements for
other purposes, regulatory, and other relevant factors. Afya intends to repurchase the shares for use in its stock option and restricted
stock units programs, as consideration in future business combination transactions and for general corporate purposes. Afya expects to
utilize its existing funds and future dividends to be received from Afya Brazil and/or strike price funds to be received in connection
with any option exercises under its stock option program, to fund repurchases made under this program. Afya&rsquo;s Board of Directors
will review the share repurchase program periodically and may authorize adjustments to its terms and size or suspend or discontinue the
program.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Board of Directors of Afya also authorized management
to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market. It is Afya&rsquo;s intention that
such purchases benefit from the safe harbors provided by Rules 10b-18 and 10b5-1 promulgated by the SEC under the Exchange Act. Accordingly,
Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability of Rules
10b-18 or 10b5-1 for purchases under the program.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Dividends and Capitalization of Profits</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We have not adopted a dividend policy with
respect to payments of any future dividends by Afya. Subject to the Companies Act, our shareholders may, by resolution passed by a
simple majority of the voting rights entitled to vote at a general meeting, declare dividends (including interim dividends) to be
paid to shareholders but no dividend shall be declared in excess of the amount recommended by the board of directors. The board of
directors may also declare dividends. Dividends may be declared and paid out of funds lawfully available
to Afya. Except as otherwise provided by the rights attached to shares and the Articles of Association of Afya, all dividends shall be
paid in proportion to the number of Class A common shares or Class B common shares a shareholder holds at the date the dividend is declared
(or such other date as may be set as a record date); but, (i)&nbsp;if any share is issued on terms providing that it shall rank for dividend
as from a particular date, that share shall rank for dividend accordingly, and (ii)&nbsp;where we have shares in issue which are not fully
paid up (as to par value) we may pay dividends in proportion to the amounts paid up on each share.</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The holders of Class A common shares and Class B common
shares shall be entitled to share equally in any dividends that may be declared in respect of our common shares from time to time. In
the event that a dividend is paid in the form of Class A common shares or Class B common shares, or rights to acquire Class A common shares
or Class B common shares, (i)&nbsp;the holders of Class A common shares shall receive Class A common shares, or rights to acquire Class
A common shares, as the case may be; and (ii)&nbsp;the holders of Class B common shares shall receive Class B common shares, or rights
to acquire Class B common shares, as the case may be.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Appointment, Disqualification and Removal of Directors</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is managed by its board of directors. The Articles
of Association provide that, unless otherwise determined by a special resolution of shareholders, the board of directors will be composed
of four to 14 directors, with the number being determined by a majority of the directors then in office. There are no provisions relating
to retirement of directors upon reaching any age limit. The Articles of Association also provide that, while our shares are admitted to
trading on Nasdaq, the board of directors must always comply with the residency and citizenship requirements of the U.S. securities laws
applicable to foreign private issuers. Bertelsmann for so long as it holds Class B common shares in excess of the Ownership Threshold
may appoint up to seven directors at its discretion (and is entitled at any time to remove substitute or replace such directors) (&ldquo;Bertelsmann
Directors&rdquo;), and the Esteves Family for so long as it holds Class B common shares in excess of the Ownership Threshold may appoint
up to two directors at its discretion (and is entitled at any time to remove substitute or replace such directors) (&ldquo;Esteves Family
Directors&rdquo;). In addition for so long as both hold Class B common shares in excess of the Ownership Threshold, they may appoint a
further director (the &ldquo;Joint Director&rdquo;) and are entitled at any time to remove, substitute or replace the Joint Director (provided
that if only one of Bertelsmann and the Esteves Family holds Class B Common Shares in excess of the Ownership Threshold, then only Bertelsmann
or the Esteves Family, as applicable, shall have such right). The Board of Directors shall have one (1) co-chairman appointed by Bertelsmann,
for so long as it holds Class B Common Shares in excess of the Ownership Threshold and one (1) co-chairman appointed by the Esteves Family,
for so long as it holds Class B Common Shares in excess of the Ownership Threshold, thereafter, the chairman of the Board of Directors
shall be appointed by a majority of the Directors then in office.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing, the Articles of Association
provide that directors shall be elected by an ordinary resolution of our shareholders, which requires the affirmative vote of a simple
majority of the votes cast on the resolution by the shareholders entitled to vote who are present, in person or by proxy, at the meeting.
Each director shall be appointed and elected for a two-year term or until his or her death, resignation or removal, and is eligible for
re-election.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For the names of our directors, see &ldquo;Item 6.
Directors, Senior Management and Employees&mdash;A. Directors and Senior Management&mdash;Board of Directors.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Any vacancies on the board of directors that arise
other than in respect of the Bertelsmann and/or Esteves Family director appointments set out above or upon the removal of a director by
resolution passed at a general meeting can be filled by the remaining directors (notwithstanding that they may constitute less than a
quorum). Any such appointment shall be as an interim director to fill such vacancy until the next annual general meeting of shareholders.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing, additions to the existing
board (within the limits set pursuant to the Articles of Association) may be made by ordinary resolution of the shareholders.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors has an audit committee in place.
See &ldquo;Item 6. Directors, Senior Management and Employees&mdash;A. Directors and Senior Management&mdash;Audit Committee.&rdquo;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Grounds for Removing a Director</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">A director may be removed with or without cause by
ordinary resolution, save that each Bertelsmann Director may only be removed by Bertelsmann at its discretion and each Esteves Family
Director may only be removed by the Esteves Family at its discretion.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The notice of general meeting must contain a statement
of the intention to remove the director and must be served on the director not less than 10 calendar days before the meeting. The director
is entitled to attend the meeting and be heard on the motion for his removal.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The office of a director will be vacated automatically
if he or she (i)&nbsp;becomes prohibited by law from being a director, (ii)&nbsp;becomes bankrupt or makes an arrangement or composition
with his creditors, (iii)&nbsp;dies or is in the opinion of all his co-directors, incapable by reason of mental disorder of discharging
his duties as director, (iv)&nbsp;resigns his office by notice to us or (v)&nbsp;has for more than six months been absent without permission
of the directors from meetings of the board of directors held during that period, and the remaining directors resolve that his or her
office be vacated. Further, the Directors may remove a Director as set out above in &ldquo;&mdash;Anti-Corruption.&rdquo;</P>

<P STYLE="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Proceedings of the Board of Directors</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Articles of Association provide that our business
is to be managed and conducted by the board of directors, save that Afya may not without (i)&nbsp;the consent of a Bertelsmann Director
while there is a Bertelsmann Director and (ii)&nbsp;the consent of an Esteves Family Director while there is an Esteves Family Director:
create new classes of shares, issue new shares, options, warrants or convertible securities of similar nature conferring the right upon
the holders thereof to subscribe for purchase or receive any class of shares or securities in the capital of Afya; repurchase or redeem
any shares; execute and/or terminate any shareholders&rsquo; agreement, quotaholders&rsquo; agreement, or any other agreements related
to our interest in any subsidiary; approve our consolidated financial statements; effect any follow-on offerings of Afya; approve the
listing and/or the delisting of our securities with any designated stock exchange; conduct, negotiate, terminate and/or amend any business,
agreement, or transaction between Afya and any related party valued in excess of R$10.0 million, provided that, (A) if the Related Party
is the Esteves Family (or an Affiliate thereof), then the consent of the Esteves Family Director shall not be required and (B) if the
Related Party is Bertelsmann (or an Affiliate thereof), then the consent of the Bertelsmann Director shall not be required; approve any
sale or encumbrance, for the benefit of a person of shares issued by any subsidiary, or the admission of any new partner or shareholder
in such subsidiaries; carry out any investments outside the scope of the core business of Afya (as set out in the Articles of Association);
incorporate any entity; appoint or terminate the engagement of any auditor that is not an Authorized Auditor as set out in the Articles
of Association; provide any guarantee in respect of any person or related person of any of our shareholders, director and/or officers
inter alia; or take actions in connection with the Company&rsquo;s Anti-Corruption measures, provided that if the Anti-Corruption measures
relate to either Bertelsmann or the Esteves Family, then the consent of the Esteves Family Director or the Bertelsmann Director respectively
shall not be required.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The quorum necessary for the board meeting shall be
a simple majority of the directors then in office (subject to there being a minimum of two directors present), and business at any meeting
shall be decided by a majority of votes. None of the Bertelsmann Chairman, the Esteves Family Chairman and the chairman of the meeting
will have a second or casting vote; provided that if the votes are evenly split, a Bertelsmann Director (or Bertelsmann Chairman) shall
have a casting vote.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing and the provisions of the
Articles of Association, the board of directors may regulate its proceedings as they determine is appropriate. Board meetings shall be
held bi-monthly and shall take place either in Belo Horizonte, Brazil, or at such other place as the directors may determine.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the provisions of the Articles of Association,
to any directions given by ordinary resolution of the shareholders and the listing rules of the Nasdaq, the board of directors may from
time to time at its discretion exercise all powers of Afya, including, subject to the Companies Act, the power to issue debentures, bonds
and other securities of the company, whether outright or as collateral security for any debt, liability or obligation of our company or
of any third-party.</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Inspection of Books and Records</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Holders of Afya shares have no general right under
Cayman Islands law to inspect or obtain copies of the list of shareholders or corporate records of the Company. However, the board of
directors may determine from time to time whether and to what extent our accounting records and books shall be open to inspection by shareholders
who are not members of the board of directors. Notwithstanding the above, the Articles of Association provide shareholders with the right
to receive annual financial statements and upon request agreements executed by the Company and its Related Parties (as defined in the
Articles of Association), shareholder agreements to which the Company is a party and details of any incentive plan. Such right to receive
annual financial statements may be satisfied by publishing the same on the company&rsquo;s website or filing such annual reports as we
are required to file with the SEC.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Register of Shareholders</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares are held through DTC, and
DTC or Cede &amp; Co., as nominee for DTC, and recorded in the shareholders&rsquo; register as the holder of our Class A common shares.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, Afya must keep a register
of shareholders that includes:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the names and addresses of the shareholders, a statement of the shares held by each member and of the amount paid or agreed to be
considered as paid, on the shares of each member;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>whether voting rights attach to the shares in issue;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the date on which the name of any person was entered on the register as a member; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the date on which any person ceased to be a member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, the register of shareholders
of Afya is prima facie evidence of the matters set out therein (i.e., the register of shareholders will raise a presumption of fact on
the matters referred to above unless rebutted) and a shareholder registered in the register of shareholders is deemed as a matter of Cayman
Islands law to have <I>prima facie</I> legal title to the shares as set against his or her name in the register of shareholders.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">However, there are certain limited circumstances where
an application may be made to a Cayman Islands court for a determination on whether the register of members reflects the correct legal
position. Further, the Cayman Islands court has the power to order that the register of members maintained by a company should be rectified
where it considers that the register of members does not reflect the correct legal position. If an application for an order for rectification
of the register of members were made in respect of our ordinary shares, then the validity of such shares may be subject to re-examination
by a Cayman Islands court.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Exempted Company</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is an exempted company with limited liability
under the Companies Act. The Companies Act distinguishes between ordinary resident companies and exempted companies. Any company that
is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted
company. The requirements for an exempted company are essentially the same as for an ordinary company except for the exemptions and privileges
listed below:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>an exempted company does not have to file an annual return of its shareholders with the Registrar of Companies;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>an exempted company&rsquo;s register of shareholders is not open to inspection;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>an exempted company does not have to hold an annual general meeting;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>an exempted company may issue shares with no par value;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>an exempted company may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for
20 years in the first instance);</TD></TR></TABLE>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>an exempted company may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>an exempted company may register as a limited duration company; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>an exempted company may register as a segregated portfolio company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">&ldquo;Limited liability&rdquo; means that the liability
of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional circumstances,
such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which
a court may be prepared to pierce or lift the corporate veil).</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to reporting and other informational
requirements of the Exchange Act, as applicable to foreign private issuers. Except as otherwise disclosed in this annual report, we comply
with the Nasdaq rules in lieu of following home country practice.</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Anti-Takeover Provisions in Our Articles of Association</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Some provisions of the Articles of Association may
discourage, delay or prevent a change in control of Afya or management that shareholders may consider favorable. In particular, the capital
structure of Afya concentrates ownership of voting rights in the hands of the Esteves Family and Bertelsmann. These provisions, which
are summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed
to encourage persons seeking to acquire control of Afya to first negotiate with the board of directors. However, these provisions could
also have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations
in the market price of the Class A common shares that often result from actual or rumored hostile takeover attempts. These provisions
may also have the effect of preventing changes in the management of Afya. It is possible that these provisions could make it more difficult
to accomplish transactions that shareholders may otherwise deem to be in their best interests.</P>

<P STYLE="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Two Classes of Common Shares</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Class B common shares of Afya are entitled to 10
votes per share, while the Class A common shares are entitled to one vote per share. Since they own of all of the Class B common shares
of Afya, the Esteves Family and Bertelsmann currently have the ability to elect all directors and to determine the outcome of all matters
submitted for a vote of shareholders. This concentrated voting control could discourage others from initiating any potential merger, takeover,
or other change of control transaction that other shareholders may view as beneficial.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">So long as the Esteves Family and Bertelsmann have
the ability to determine the outcome of all matters submitted to a vote of shareholders, third parties may be deterred in their willingness
to make an unsolicited merger, takeover, or other change of control proposal, or to engage in a proxy contest for the election of directors.
As a result, the fact that Afya has two classes of common shares may have the effect of depriving you as a holder of Class A common shares
of an opportunity to sell your Class A common shares at a premium over prevailing market prices and make it more difficult to replace
the directors and management of Afya and for a proper corporate purpose.</P>

<P STYLE="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Preferred Shares</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors is given wide powers to issue
one or more classes or series of shares with preferred rights. Such preferences may include, for example, dividend rights, conversion
rights, redemption privileges, enhanced voting powers and liquidation preferences.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Despite the anti-takeover provisions described above,
under Cayman Islands law, our board of directors may only exercise the rights and powers granted to them under the Articles of Association,
for what they believe in good faith to be in the best interests of Afya.</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Protection of Non-Controlling Shareholders</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Grand Court of the Cayman Islands may, on the application
of shareholders holding not less than one fifth of the shares of Afya in issue, appoint an inspector to examine the Company&rsquo;s affairs
and report thereon in a manner as the Grand Court shall direct.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the provisions of the Companies Act, any
shareholder may petition the Grand Court of the Cayman Islands which may make a winding up order, if the court is of the opinion that
this winding up is just and equitable.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Notwithstanding the U.S. securities laws and regulations
that are applicable to Afya, general corporate claims against Afya by its shareholders must, as a general rule, be based on the general
laws of contract or tort applicable in the Cayman Islands or their individual rights as shareholders as established by our Articles of
Association.</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Cayman Islands courts ordinarily would be expected
to follow English case law precedents, which permit a minority shareholder to commence a representative action against Afya, or derivative
actions in our name, to challenge (i)&nbsp;an act which is ultra vires or illegal, (ii)&nbsp;an act which constitutes a fraud against
the minority and the wrongdoers themselves control Afya, and (iii)&nbsp;an irregularity in the passing of a resolution that requires a
qualified (or special) majority.</P>


<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>3
<FILENAME>ex04-3.htm
<DESCRIPTION>EX-4.3
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">THE SYMBOL &ldquo;[**]&rdquo; DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH
(I) NOT MATERIAL AND (II) OF THE TYPE THAT THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS AS PRIVATE OR CONFIDENTIAL.</P>


<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 0.75pt; border-top: Black 0.75pt solid; border-bottom: Black 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: right"><B>Execution Version<BR>
INVESTMENT NUMBER 47855</B></P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 24pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 24pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">Loan Agreement</P>

<P STYLE="font: bold 12pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">between</P>

<P STYLE="font: bold 12pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 14pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">AFYA PARTICIPA&Ccedil;&Otilde;ES S.A.</P>

<P STYLE="font: bold 12pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">and</P>

<P STYLE="font: bold 14pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">INTERNATIONAL FINANCE CORPORATION</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">Dated July 22, 2024</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 0.75pt; border-top: Black 0.75pt solid; border-bottom: Black 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">TABLE OF CONTENTS</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify">Article/<BR>
<U>Section</U>&#9;<U>Item</U>&#9;<U>Page No.</U></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="width: 90%; text-align: left; text-indent: -1.25in; padding-top: 11pt; padding-bottom: 0pt; padding-left: 1.25in">ARTICLE I&nbsp;&nbsp;&nbsp;Definitions and Interpretation</TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 11pt; padding-bottom: 0pt">1</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 1.01&nbsp;&nbsp;&nbsp;Definitions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">1</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 1.02&nbsp;&nbsp;&nbsp;Financial Calculations</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">15</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 1.03&nbsp;&nbsp;&nbsp;Interpretation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">16</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 1.04&nbsp;&nbsp;&nbsp;Business Day Adjustment</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">16</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 1.05&nbsp;&nbsp;&nbsp;Payments on Disbursements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">16</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1.25in; padding-top: 11pt; padding-bottom: 0pt; padding-left: 1.25in">ARTICLE II&nbsp;&nbsp;&nbsp;The Loan</TD>
    <TD STYLE="text-align: right; padding-top: 11pt; padding-bottom: 0pt">17</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.01&nbsp;&nbsp;&nbsp;The Loan</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">17</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.02&nbsp;&nbsp;&nbsp;Disbursement Procedure</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">17</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.03&nbsp;&nbsp;&nbsp;Interest</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">17</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.04&nbsp;&nbsp;&nbsp;Default Rate Interest and Other Costs</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">18</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.05&nbsp;&nbsp;&nbsp;Repayment</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.06&nbsp;&nbsp;&nbsp;Prepayment</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.07&nbsp;&nbsp;&nbsp;Fees</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">20</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.08&nbsp;&nbsp;&nbsp;Currency and Place of Payments</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">21</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.09&nbsp;&nbsp;&nbsp;Allocation of Partial Payments</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">21</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.10&nbsp;&nbsp;&nbsp;Unwinding Costs</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">21</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.11&nbsp;&nbsp;&nbsp;Suspension or Cancellation by IFC</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">22</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.12&nbsp;&nbsp;&nbsp;Cancellation by the Borrower</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">23</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.13&nbsp;&nbsp;&nbsp;Taxes</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">23</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.14&nbsp;&nbsp;&nbsp;Expenses</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">23</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.15&nbsp;&nbsp;&nbsp;Illegality of Participation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">24</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.16&nbsp;&nbsp;&nbsp;Promissory Notes</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">24</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 2.17&nbsp;&nbsp;&nbsp;Acceleration of Promissory Notes</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1.25in; padding-top: 11pt; padding-bottom: 0pt; padding-left: 1.25in">ARTICLE III&nbsp;&nbsp;&nbsp;Representations and Warranties</TD>
    <TD STYLE="text-align: right; padding-top: 11pt; padding-bottom: 0pt">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 3.01&nbsp;&nbsp;&nbsp;Representations and Warranties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 3.02&nbsp;&nbsp;&nbsp;IFC Reliance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">29</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1.25in; padding-top: 11pt; padding-bottom: 0pt; padding-left: 1.25in">ARTICLE IV&nbsp;&nbsp;&nbsp;Conditions of Disbursement</TD>
    <TD STYLE="text-align: right; padding-top: 11pt; padding-bottom: 0pt">29</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 4.01&nbsp;&nbsp;&nbsp;Conditions of First Disbursement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">29</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 4.02&nbsp;&nbsp;&nbsp;Conditions of All Disbursements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">30</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 4.03&nbsp;&nbsp;&nbsp;Borrower&rsquo;s Certification</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">31</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 4.04&nbsp;&nbsp;&nbsp;Conditions for IFC Benefit</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">32</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1.25in; padding-top: 11pt; padding-bottom: 0pt; padding-left: 1.25in">ARTICLE V&nbsp;&nbsp;&nbsp;Particular Covenants</TD>
    <TD STYLE="text-align: right; padding-top: 11pt; padding-bottom: 0pt">32</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 5.01&nbsp;&nbsp;&nbsp;Affirmative Covenants</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">32</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 5.02&nbsp;&nbsp;&nbsp;Negative Covenants</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 5.03&nbsp;&nbsp;&nbsp;Reporting Requirements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 5.04&nbsp;&nbsp;&nbsp;Insurance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">43</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 5.05&nbsp;&nbsp;&nbsp;Most Favored Nation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">43</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1.25in; padding-top: 11pt; padding-bottom: 0pt; padding-left: 1.25in">ARTICLE VI&nbsp;&nbsp;&nbsp;Events of Default</TD>
    <TD STYLE="text-align: right; padding-top: 11pt; padding-bottom: 0pt">44</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 6.01&nbsp;&nbsp;&nbsp;Acceleration after Default</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">44</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 6.02&nbsp;&nbsp;&nbsp;Events of Default</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">44</TD></TR>
</TABLE>
<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="width: 90%; text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 6.03&nbsp;&nbsp;&nbsp;Bankruptcy</TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt">47</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1.25in; padding-top: 11pt; padding-bottom: 0pt; padding-left: 1.25in">ARTICLE VII&nbsp;&nbsp;&nbsp;Miscellaneous</TD>
    <TD STYLE="text-align: right; padding-top: 11pt; padding-bottom: 0pt">47</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.01&nbsp;&nbsp;&nbsp;Saving of Rights</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">47</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.02&nbsp;&nbsp;&nbsp;Notices</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">47</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.03&nbsp;&nbsp;&nbsp;English Language</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">48</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.04&nbsp;&nbsp;&nbsp;Term of Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">48</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.05&nbsp;&nbsp;&nbsp;Applicable Law and Jurisdiction</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">48</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.06&nbsp;&nbsp;&nbsp;Disclosure of Information</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">50</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.07&nbsp;&nbsp;&nbsp;Indemnification; No Consequential Damage</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.08&nbsp;&nbsp;&nbsp;Successors and Assignees</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">52</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.09&nbsp;&nbsp;&nbsp;Amendments, Waivers and Consents</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">52</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.10&nbsp;&nbsp;&nbsp;Counterparts</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">52</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.11&nbsp;&nbsp;&nbsp;Third Party Rights</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">52</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.12&nbsp;&nbsp;&nbsp;Personal Data</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">52</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.13&nbsp;&nbsp;&nbsp;Independence of the Borrower</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.14&nbsp;&nbsp;&nbsp;Role of IFC</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.15&nbsp;&nbsp;&nbsp;Acknowledgment of CAO</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 11pt Times New Roman">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1.25in">Section 7.16&nbsp;&nbsp;&nbsp;Translation and Registration</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify"><U>EXHIBITS</U></P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex A &#9;Subsidiaries</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex B &#9;Borrower/Transaction Authorizations</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex C &#9;Investments</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex D &#9;Financial Debt</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex E &#9;Existing Liens</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex F &#9;Insurance Requirements</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex G &#9;[Reserved]</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex H &#9;Methodology for Financial Ratio Calculations</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex I &#9;Prohibited Activities</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex J &#9;Anti-Corruption Guidelines for IFC Transactions</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex K &#9;Methodology for Calculation of Loan Interest Payments
on an Interest Payment Date</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex L &#9;Methodology for Calculation of Payments upon Prepayment
or Acceleration</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex M &#9;Form of Principal Promissory and Interest Promissory
Note</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex N &#9;[Reserved]</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex O&#9;[Reserved]</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex P &#9;[Reserved]</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex Q &#9;Litigation; Disputed Taxes</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex R&#9;Leases</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Annex S&#9;Action Plan</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Schedule 1 &#9;Form of Certificate of Incumbency and Authority</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Schedule 2 &#9;Form of Request for Disbursement</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Schedule 2A &#9;Form of Confirmation</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Schedule 3 &#9;Form of Loan Disbursement Receipt</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Schedule 4 &#9;Matters to be Covered in Local Counsel&rsquo;s
Legal Opinion</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Schedule 5 &#9;Form of Solvency Certificate</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Schedule 6 &#9;Form of Service of Process Letter</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Schedule 7 &#9;Form of Letter to Borrower&rsquo;s Auditors</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Schedule 8 &#9;Annual Monitoring Report</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Schedule 9 &#9;Information to be Included in Quarterly and
Annual Review of Operations</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Schedule 10 &#9;Development Impact Indicators</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">Schedule 11&#9;Sustainability Performance Targets</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">LOAN AGREEMENT</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">LOAN AGREEMENT (the &ldquo;Agreement&rdquo;)
dated July 22, 2024, between AFYA PARTICIPA&Ccedil;&Otilde;ES S.A., a corporation organized and existing under the laws of Brazil (the
&ldquo;Borrower&rdquo;) and INTERNATIONAL FINANCE CORPORATION, an international organization established by Articles of Agreement among
its member countries including the Federative Republic of Brazil (&ldquo;IFC&rdquo;).</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">RECITAL</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Borrower has requested IFC
to provide the loans described in this Agreement to finance the Borrower&rsquo;s Expansion Program; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">IFC is willing to provide those
loans upon the terms and conditions set forth in this Agreement.</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">ARTICLE
I</FONT><BR>
Definitions and Interpretation</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 1.01<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Definitions</U></I>. Wherever used in this Agreement, the following terms have the following meanings:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Acceptable Auditors&rdquo;
</B> means, for any Obligor, any of Ernst &amp; Young Auditores Independentes S/S Ltda., Ernst &amp; Young Terco Auditores Independentes
S/S, PriceWaterhouseCoopers, KPMG Auditores Independentes, or Deloitte Touche Tohmatsu Auditores Independentes, or any of their respective
affiliates, or another firm of recognized independent public accountants acceptable to IFC;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Accounting Standards&rdquo;</B>
means (i) with respect to the Parent Company Guarantor, the International Financial Reporting Standards (IFRS) promulgated by the International
Accounting Standards Board (&ldquo;IASB&rdquo;) (which include standards and interpretations approved by the IASB and International Accounting
Standards issued under previous constitutions), together with its pronouncements thereon from time to time, and applied on a consistent
basis, and (ii) with respect to the Borrower and the Subsidiary Guarantors, the accounting principles prescribed by Brazilian Corporations
Law (Law No. 4,604 dated December 15, 1976, as amended), in both cases as such accounting rules have been adopted in the Country pursuant
to applicable rules and regulations issued periodically by the <I>Comiss&atilde;o de Valores Mobili&aacute;rios</I> &ndash; CVM and the
technical releases issued by the institute of independent auditors of the Country (Instituto dos Auditores Independentes do Brasil &ndash;
IBRACON) and by the Comit&ecirc; de Pronunciamentos Cont&aacute;beis &ndash; CPC;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Action Plan&rdquo;</B>
means the plan or plans set out in Annex S, developed by the Borrower setting out specific environmental and social measures to be undertaken
by the Borrower and its Subsidiaries, to enable their respective Operations to comply with the Performance Standards, as such may be amended
or supplemented from time to time in accordance with the terms hereof;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Adjusted Net Debt&rdquo;
</B>means, as of any date of calculation, (a)&nbsp;the aggregate amount of Financial Debt of the Parent Company Guarantor and its Consolidated
Subsidiaries (whether classified as current or not current liabilities), including accounts payable with respect to acquisitions in which
the seller finances a portion of the sale price owed by the Parent Company Guarantor or its Consolidated Subsidiaries, excluding, for
the avoidance of doubt, lease liabilities and without double counting, any Financial Debt with Affiliates, <I><U>minus</U></I> (b)&nbsp;cash
and cash equivalents (including earnings thereon) <FONT STYLE="background-color: white">and the aggregate outstanding balance of the SoftBank
Preferred Shares calculated on the basis of the most recently quarterly financial statements delivered to IFC pursuant to the terms and
conditions hereof</FONT>;</P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Adjusted Net Debt to
EBITDA Ratio&rdquo; </B>is the result obtained by dividing Adjusted Net Debt by EBITDA. For the purpose of this ratio, both Adjusted Net
Debt and EBITDA shall be calculated on a pre IFRS 16 basis.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Affiliate&rdquo;</B>
with respect to any Person, means any other Person directly or indirectly, through one or more Persons, controlling, controlled by or
under common control with, such Person (for purposes of this definition, &ldquo;control&rdquo; means possessing the power to direct or
cause the direction of the management and policies of a Person, directly or indirectly, whether through the ownership of voting securities,
by contract or otherwise, and &ldquo;controlling&rdquo; and &ldquo;controlled&rdquo; have corresponding meanings);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&ldquo;Aggregate EBITDA Amount&rdquo;
</B>means the sum of (i) the Borrower&rsquo;s unconsolidated EBITDA, for the relevant Calculation Period, <I>plus </I>(ii) the unconsolidated
EBITDA of each of the Guarantors, for the relevant Calculation Period, <I>plus</I> (iii) any cash received by the Borrower, during the
relevant Calculation Period, as cash dividend (or capital reduction), from any Person other than a Guarantor;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&ldquo;Aggregate Spread Rebate&rdquo;</B>
means as of any determination date, a percentage per annum equal to the sum of (i) the SPT1 Spread Rebate and (ii) the SPT2 Spread Rebate,
each as in effect in such date;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&ldquo;Agreement&rdquo; </B>has the
meaning assigned to it in the preamble;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;AIP&rdquo;</B> means
IFC Access to Information Policy dated January 1, 2012;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&ldquo;Annual Monitoring Report&rdquo;</B>
means the annual monitoring report substantially in the form attached as Schedule 8 (<I>Annual Monitoring Report</I>) hereto setting out
the specific environmental, social and corporate governance requirements of the Borrower in respect of its and its Subsidiaries&rsquo;
Operations, as such may be amended or supplemented from time to time in accordance with the terms hereof;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Applicable E&amp;S Law&rdquo;</B>
means all applicable statutes, laws, ordinances, rules and regulations of the Country, including but not limited to any license, permit
or other governmental Authorization, imposing liability or setting standards of conduct concerning any environmental, social, labor, health
and safety or security risks of the type contemplated by the Performance Standards;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Auditors&rdquo;</B> means,
for each Obligor the firm of Acceptable Auditors that such Obligor appoints from time to time as its auditors pursuant to Section 5.01(e)
(<I>Auditors</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Authority&rdquo;</B>
means any national, supranational, regional or local government or governmental, administrative, fiscal, judicial, or government-owned
body, department, commission, authority, tribunal, agency or entity, or central bank (or any Person, whether or not government owned and
howsoever constituted or called, that exercises the functions of a central bank);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Authorization&rdquo;</B>
means any consent, registration, filing, agreement, notarization, certificate, license, approval, permit, authority or exemption from,
by or with any Authority, whether given by express action or deemed given by failure to act within any specified time period and all corporate,
creditors&rsquo; and shareholders&rsquo; approvals or consents;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Authorized Representative&rdquo;</B>
means any natural person who is duly authorized by each Obligor to act on its behalf for the purposes specified in, and whose name and
a specimen of whose signature appear on, the Certificate of Incumbency and Authority most recently delivered by such Obligor to IFC;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Availability Period&rdquo;</B>
means the period commencing on the date hereof and ending on the date that is eighteen (18) months after the date of this Agreement;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;B3&rdquo; </B>means B3
S.A. &ndash; Brasil, Bolsa Balc&atilde;o - Segmento Cetip UTVM;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Banco Central do Brasil&rdquo;</B>
means the Banco Central do Brasil together with any Authority which may succeed to the exchange control duties or authority presently
vested in the Banco Central do Brasil;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Base Relevant Spread&rdquo;</B>
means 1.20% per annum;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;BCB Report&rdquo;</B>
means, in respect of each Disbursement, evidence of registration of the financial terms and conditions of such Disbursement with the Banco
Central do Brasil through the SCE-Cr&eacute;dito, which generates an identification code, authorizing the Borrower to: (a) enter into
the relevant foreign exchange transactions for the remittance of the funds disbursed in accordance with this Agreement to the Country;
and (b) after such Disbursement, register the relevant Schedule of Payments that allows the Borrower to make repayments or payments of
principal, interest, fees, commissions and expenses contemplated hereunder;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Borrower Permitted Merger&rdquo;
</B>has the meaning specified in Section 5.02(o);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Brazil and New York Business
Day&rdquo;</B> means a day that is both a Brazil Business Day and a New York Business Day;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Brazil and Washington
Business Day&rdquo;</B> means a day that is both a Brazil Business Day and a Washington Business Day;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Brazil Business Day&rdquo;</B>
means a day on which commercial banks and foreign exchange markets settle payments and are open for general business (including dealings
in foreign exchange and foreign currency deposits) in S&atilde;o Paulo, SP; Rio de Janeiro, RJ; or Bras&iacute;lia, DF, Brazil;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Brazil, New York and
Washington Business Day&rdquo; </B>means, a day that is (i) a Brazil Business Day; (ii) a New York Business Day; and (iii) a Washington
Business Day;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Brazil, SOFR, and New
York Business Day&rdquo;</B> means a day that is (a) a Brazil Business Day, (b) a SOFR Banking Day and (c) a New York Business Day;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Brazil, SOFR, New York
and Washington Business Day&rdquo;</B> means a day that is (a) a Brazil Business Day, (b) a SOFR Banking Day,(c) a New York Business Day,
and (d) a Washington Business Day;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Brazilian Bankruptcy
Law</B>&rdquo; means the Brazilian Law No. 11,101, of February 9, 2005, as amended from time to time, or any successor statute;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;BRL&rdquo;, &ldquo;Reais&rdquo;,
&ldquo;Real&rdquo;, &ldquo;R$&rdquo; </B>means the lawful currency of the Country; which, for the avoidance of doubt, shall include any
currency that from time to time may replace the Real as the lawful currency of the Country;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;BRL 09&rdquo; or &ldquo;BRL
PTAX&rdquo; </B>means the Real/Dollar offered rate for Dollars, expressed as the amount of Reais per one Dollar, for settlement in two
(2) Brazil Business Days, reported by Banco Central do Brasil on the website of Banco Central do Brasil, at approximately 1:00pm, S&atilde;o
Paulo time (or as such reporting is modified from time to time by Banco Central do Brasil), on the relevant BRL Valuation Date;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;BRL Benchmark Rate&rdquo;
or &ldquo;CDI&rdquo;</B> means in respect of a BRL Reset Date, the Brazil Interbank Deposit Rate Annualized, known as the average of the
DI-OVER-Extra Grupo as published by B3, on the</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify">first Brazil Business Day following such BRL Reset
Date (the &ldquo;<B>Overnight CDI Rate</B>&rdquo;). Any adjustments made to the Overnight CDI Rate, if made any time later than the end
of the business day on such BRL Reset Date, shall not be taken into account. If for any reason there is no Overnight CDI Rate published
by B3 with respect to a BRL Reset Date, then the BRL Benchmark Rate for such BRL Reset Date shall be determined by IFC according to the
then prevailing off-shore swap market convention, reasonably documented by IFC and shared with the Borrower;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;BRL Fixing Rate&rdquo;</B>
means BRL PTAX (BRL 09); being the Real/Dollar offered rate for Dollars, expressed as the amount of Reais per one Dollar, for settlement
in two Brazil Business Days, as reported by Banco Central do Brasil on the website of Banco Central do Brasil, at approximately 1:00pm,
S&atilde;o Paulo time (or as such reporting is modified from time to time by Banco Central do Brasil), on the relevant BRL Valuation Date;
provided, however, that if the BRL Fixing Rate is not published on or for the date the Dollar Equivalent amount is to be calculated, the
BRL Fixing Rate shall be determined by IFC in its sole discretion as such time and in such manner as it deems consistent with market conditions
and practices then in effect and based on other source or sources as IFC deems appropriate, including quotes obtained from dealers engaging
in foreign exchange or currency swap transactions in the Country;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;BRL Reset Date&rdquo;</B>
means, with respect to any Reference Period, each day that is a Brazil Business Day;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;BRL Valuation Date&rdquo;</B>
means a Scheduled BRL Valuation Date, except:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
such date is not a Brazil and New York Business Day (other than due to the occurrence of an Unscheduled Holiday), the BRL Valuation Date
shall be changed to the immediately preceding Brazil and New York Business Day; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
such date would be a BRL Valuation Date but for the occurrence of an Unscheduled Holiday or Price Source Disruption, the BRL Valuation
Date shall be such later date as shall be determined by IFC based on then prevailing conditions in the market for non-deliverable Reais/Dollar
swap transactions; <I>provided</I>, that if such BRL Valuation Date shall not have occurred on or before the 14th consecutive day following
the Scheduled BRL Valuation Date (any such period being a &ldquo;Deferral Period&rdquo;), then the first New York Business Day following
the Deferral Period shall be deemed to be the BRL Valuation Date (and if such day would be a Brazil Business Day but for the occurrence
of an Unscheduled Holiday, such date shall nevertheless be deemed the BRL Valuation Date);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Calculation Period&rdquo;</B>
means for any calculation, a period of four consecutive quarters most recently ended prior to the event requiring the calculation for
which financial statements should have been delivered to IFC pursuant to the terms and conditions hereof;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;CAO&rdquo;</B> means
Compliance Advisor Ombudsman, the independent accountability mechanism for IFC for environmental and social concerns, which is governed
by the CAO Policy;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;CAO Policy&rdquo;</B>
means the IFC/MIGA Independent Accountability Mechanism (CAO) Policy dated June 28, 2021 outlining CAO&rsquo;s purpose, mandate and functions,
core principles, governance, and operating procedures, as the same may be amended, updated or supplemented at any time and from time to
time;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Certificate of Incumbency
and Authority&rdquo;</B> means a certificate provided to IFC in the form of Schedule&nbsp;1 (<I>Form of Certificate of Incumbency and
Authority</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Change of Control&rdquo;</B>
means any of the following: (i) neither the Bertelsmann Group nor the Esteves Family beneficially owns at least a&nbsp;majority of the
total voting power in the Parent Company</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify">Guarantor&rsquo;s share capital (determined on a fully
diluted basis), (ii) the Parent Company Guarantor for any reason ceases to beneficially own at least a&nbsp;majority of both the economic
and voting interests in the Borrower&rsquo;s share capital (determined on a fully diluted basis), or (iii) a &ldquo;change of control&rdquo;
or similar event shall occur as provided in any other loan or preferred stock documentation relating to the Parent Company Guarantor or
the Borrower;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Charter&rdquo;</B> means
with respect to any Person that is not an individual, the memorandum and articles of association and/or such other constitutive document,
howsoever called, of such Person;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Coercive Practice&rdquo;</B>
has the meaning assigned to it in Annex J (<I>Anti-Corruption Guidelines for IFC Transactions</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Collusive Practice&rdquo;</B>
has the meaning assigned to it in Annex J (<I>Anti-Corruption Guidelines for IFC Transactions</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Condemnation Event&rdquo;</B>
means any of the events described in Section 6.02(e) (<I>Expropriation; Nationalization, Etc.</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Confirmation&rdquo;</B>
means with respect to any Disbursement, a notice from IFC to the Borrower, substantially in the form of Schedule 2A (<I>Form of Confirmation</I>),
specifying the amount, currency, date and initial Interest Rate of the Disbursement, and other relevant terms of such Disbursement;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Consolidated&rdquo; or
&ldquo;Consolidated Basis&rdquo;</B> means (with respect to any financial statements to be provided, or any financial calculation to be
made, under or for the purposes of this Agreement and any other IFC Financing Document) the method referred to in Section 1.02(c) (<I>Financial
Calculations</I>); and the entities whose accounts are to be consolidated with (i) the accounts of Parent Company Guarantor are the Borrower
and all the Subsidiaries of the Parent Company Guarantor and the Borrower; and (ii) the accounts of the Borrower are all the Subsidiaries
of the Borrower;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Consolidated Assets&rdquo;</B>
means, at any date of determination for any Person or specified group of Persons, the total amount of all assets of such Person or specified
group of Persons as reflected in the Consolidated balance sheet prepared as of the end of the most recently ended fiscal quarter of such
Person or specified group of Persons on a Consolidated Basis and in accordance with Accounting Standards;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Corrupt Practice&rdquo;</B>
has the meaning assigned to it in Annex J (<I>Anti-Corruption Guidelines for IFC Transactions</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Country&rdquo;</B> means
the Federative Republic of Brazil;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Credit Adjustment Spread&rdquo;</B>
means a per annum rate equal to 0.42826%;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Debtor Relief Laws&rdquo;</B>
means, with respect to any Person, any statute, law, code, or regulation relating to bankruptcy (<I>fal&ecirc;ncia</I>), insolvency, <I>recupera&ccedil;&atilde;o
judicial</I>, <I>recupera&ccedil;&atilde;o extrajudicial</I>, receivership, conservatorship, moratorium, suspension of payment, reorganization,
rearrangement, winding-up composition, liquidation, special liquidation, corporate restructuring, adjustment of debts, assignment for
the benefit of creditors, or other relief for debtors, including Title 11, U.S. Code, the Brazilian Bankruptcy Law, any applicable law
governing a proceeding of the type referred to in Section 6.02(g), and any similar debtor relief laws under foreign, federal, or state
laws of Brazil or other applicable jurisdictions from time to time in effect;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Derivative Transaction&rdquo;</B>
means any swap agreement, cap agreement, collar agreement, futures contract, forward contract or similar arrangement with respect to interest
rates, currencies or commodit<I>y</I> prices;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Disbursement&rdquo; </B>means
any disbursement made in accordance with Section 2.02 (<I>Disbursement Procedure</I>) and designated as such in the relevant request for
a BRL-linked Disbursement;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Dispute</B>&rdquo; has
the meaning assigned to it under&nbsp;Section 7.05 (<I>Applicable Law and Jurisdiction</I>).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Dollar Equivalent&rdquo;</B>
means (i) with respect to scheduled payments of principal and interest on any Disbursement, an amount in Dollars calculated with reference
to the BRL Fixing Rate on the relevant BRL Valuation Date; (ii) with respect to the acceleration of all or any Disbursement or the prepayment
of any Disbursement, an amount in Dollars calculated with reference to the Early Payment Fixing Rate; and (iii) with respect to any fee
amount denominated in Reais but payable in Dollars, an amount in Dollars calculated with reference to the BRL Fixing Rate;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Dollars&rdquo; and &ldquo;$&rdquo;</B>
means the lawful currency of the United States of America;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Early Payment Fixing
Rate&rdquo;</B> means, in connection with the acceleration of any Disbursement or the prepayment (whether mandatory or voluntary) of any
Disbursement, the exchange rate that will be used to convert the Reais amount due to be paid (or prepaid) into a Dollar Equivalent amount,
which rate shall be a rate determined by IFC in its sole discretion based on market conditions then in effect;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;E&amp;S Management System&rdquo;</B>
means the Borrower&rsquo;s environmental and social management system enabling it to identify, assess and manage Operations risks on an
ongoing basis;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;EBITDA&rdquo;</B> means
for the relevant Calculation Period for any Person or specified group of Persons, Net Income for such period, <I>plus</I> (without duplication)
(i) income tax expenses, (ii) net financial result (excluding interest expenses on lease liabilities), (iii) depreciation and amortization
expenses (excluding right-of-use depreciation expenses), (iv) share-based compensation expenses, (v) share of income of associates from
equity method investments, (vi) interest and fines received on past due student tuition fees paid to schools and educational systems and
(vii) non-recurring expenses, in each case, of such Person or specified group of Persons determined on a Consolidated Basis for such period
(unless the context specifies such calculation on a standalone basis for such Person). For the avoidance of doubt, EBITDA shall be calculated
on a Pre-IFRS 16 basis;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;EBITDA Threshold&rdquo;</B>
means sixty percent (60%) of the Parent Company Guarantor&rsquo;s Consolidated EBITDA;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Esteves Family&rdquo;</B>
means, individually or collectively, Nicolau Carvalho Esteves, Ros&acirc;ngela de Oliveira Tavares and any of their family members in
the third degree of consanguintiy (<I>parentes consanguineos at&eacute; o 3&deg; grau</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Event of Default&rdquo;</B>
means any one of the events specified in Section 6.02 (<I>Events of Default</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Expansion Program&rdquo;</B>
means the Borrower&rsquo;s medical school acquisition program consisting of the acquisition of universities, medical schools, and related
or complementary businesses performing activities substantially similar to the Operations of any of the Obligors and their respective
Subsidiaries;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Final Maturity Date&rdquo;</B>
means April 15, 2030;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Financial Debt&rdquo;</B>
means as to any Person:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
indebtedness of such Person for or in respect of borrowed money;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
outstanding principal amount of any bonds, debentures, notes, loan stock, commercial paper, acceptance credits, bills or promissory notes
drawn, accepted, endorsed or issued by such Person;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
indebtedness of such Person for or in respect of the deferred purchase price of assets or services (except trade accounts incurred and
payable in the ordinary course of business to trade creditors of such Person within 180 days of the date they are incurred and which are
not overdue);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;non-contingent
obligations of such Person to reimburse any other Person for amounts payable by that Person under a letter of credit or similar instrument
(excluding any letter of credit or similar instrument issued for the account of such Person with respect to trade accounts incurred and
payable in the ordinary course of business to trade creditors of such Person within 180 days of the date they are incurred and which are
not overdue);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amounts
raised by such Person under any other transaction having the financial effect of a borrowing and which would be classified as a borrowing
(and not as an off-balance sheet financing) under the Accounting Standards;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
amount of the obligations of such Person under Derivative Transactions entered into in connection with the protection against or benefit
from fluctuation in any rate or price (but only the net amount owing by such Person after marking the relevant derivative transactions
to market);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;without
double counting, all indebtedness of the types described in the foregoing items secured by a Lien on any property owned by such Person,
whether or not such indebtedness has been assumed by such Person;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
repurchase obligation or liability of such Person with respect to accounts or notes receivable sold by such Person, any liability of such
Person under any sale and leaseback transactions that do not create a liability on the balance sheet of such Person, any obligation under
a &ldquo;synthetic lease&rdquo; or any obligation arising with respect to any other transaction which is the functional equivalent of
or takes the place of borrowing but which does not constitute a liability on the balance sheet of such Person;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;without
double counting, the amount of any obligation in respect of any guarantee or indemnity given by such Person for any of the foregoing items
incurred by any other Person; <I>provided</I>, for the avoidance of doubt, that the amount of any such obligation shall be deemed to be
an amount equal to the stated or determinable amount of the primary obligation in respect of which such obligation is made or, if not
stated or determinable, the maximum reasonably anticipated liability in respect thereof (assuming such Person is required to perform thereunder)
as determined by such Person in good faith in accordance with the Accounting Standards; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
premium payable by such Person on a mandatory redemption or replacement of any of the foregoing items;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Financial Lease&rdquo;</B>
means any lease or hire purchase contract which would, under the Accounting Standards, be treated as a finance or capital lease;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Financial Year&rdquo;</B>
means with respect to each Obligor, the accounting year commencing each year on January 1<SUP>st</SUP> and ending on the following December
31<SUP>st</SUP>, or such other period as such Obligor, with IFC&rsquo;s consent, from time to time designates as its accounting year;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Fixing Rate&rdquo;</B>
means BRL PTAX (BRL 09); <I>provided</I>, however, that if the Fixing Rate is not published on or for the date the Dollar Equivalent amount
is to be calculated, the Fixing Rate shall be determined by IFC in its sole discretion as such time and in such manner as it deems consistent
with market conditions and practices then in effect and based on other source or sources as IFC deems appropriate, including quotes obtained
from dealers engaging in foreign exchange or currency swap transactions in BRL;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Fraudulent Practice&rdquo;</B>
has the meaning assigned to it in Annex J (<I>Anti-Corruption Guidelines for IFC Transactions</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Guarantee Agreement&rdquo;</B>
means the Parent Company Guarantee Agreement and each Subsidiary Guarantee Agreement, or some or all of such agreements as the context
requires;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Guarantors&rdquo;</B>
means the Parent Company Guarantor and each Subsidiary Guarantor;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;IFC Financing Documents&rdquo;</B>
means, collectively, this Agreement, each Guarantee Agreement and each Promissory Note;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Interest Payment Date&rdquo;</B>
means April 15 and October 15 in each year, subject to adjustment in accordance with Section 1.04 (<I>Business Day Adjustment</I>); <I>provided</I>
that if the final BRL Valuation Date in respect of a Reference Period is adjusted for any reason, then the corresponding Interest Payment
Date shall be two (2) Brazil and New York Business Days after the BRL Valuation Date;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Interest Period&rdquo;</B>
means each period of 6 months in each case beginning on an Interest Payment Date and ending on the day immediately before the next following
Interest Payment Date, except in the case of the first period applicable to each Disbursement when it means the period beginning on the
date on which that Disbursement is made and ending on the day immediately before the next following Interest Payment Date;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Interest Promissory Note&rdquo;</B>
has the meaning assigned to it in Section 2.16(a) (<I>Promissory Notes</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Interest Rate&rdquo;</B>
means, with respect to any Disbursement for any Interest Period, a rate per annum equal to the sum of (i) the BRL Benchmark Rate <U>plus</U>
(ii) the Relevant Spread;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Investment&rdquo;</B>
has the meaning specified in Section 5.02(j);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Lien&rdquo;</B> means
any mortgage, pledge, charge, assignment, hypothecation, fiduciary assignment (<I>aliena&ccedil;&atilde;o or cess&atilde;o fiduci&aacute;ria</I>)<I>,</I>
security interest, title retention, preferential right, trust arrangement, right of set-off, counterclaim or banker&rsquo;s lien, privilege
or priority of any kind having the effect of security, any designation of loss payees or beneficiaries or any similar arrangement under
or with respect to any insurance policy or any preference of one creditor over another arising by operation of law;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Loan&rdquo;</B> means
the loan specified in Section 2.01 (<I>The Loan</I>) or, as the context requires, its principal amount from time to time outstanding,
including, with respect to any Disbursement, the aggregate outstanding Notional Reais Principal Amount thereof;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Long-term Debt&rdquo;</B>
means Financial Debt whose final maturity falls due more than one year after the date it is incurred (including the current maturities
thereof);</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Loss&rdquo;</B> has the
meaning assigned to it under Section 7.07 (<I>Indemnification; No Consequential Damages)</I>.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Material Adverse Effect&rdquo;</B>
means a material adverse effect on:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Borrower, the Parent Company Guarantor and each of their respective Subsidiaries&rsquo; (taken as a whole) business, operations, property,
reputation, liabilities, condition (financial or otherwise), prospects or the carrying of their business or operations;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
implementation of the Expansion Program as a whole; or</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
ability of the Borrower and the Guarantors to comply with their respective obligations under this Agreement or under any other IFC Financing
Document to which any of them is a party;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Non-Material Liability&rdquo;
</B>means any liability (contingent or otherwise) of any Obligor, including unrealized or anticipated liabilities and losses arising from
commitments entered into by any such Obligor, which individually has an amount of less than sixteen million Reais (R$ 16,000,000) or its
equivalent in other currencies;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Maximum Reais Amount&rdquo;
</B>has the meaning given to this term in Section 2.01 (<I>the Loan</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;MEC&rdquo; </B>means
the Brazilian Ministry of Education;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Net Income&rdquo;</B>
means for any period, the excess (if any) of gross income over total expenses (provided that income taxes shall be treated as part of
total expenses) during such period for any Person or specified group of Persons;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;New York Business Day&rdquo;</B>
means a day on which commercial banks and foreign exchange markets settle payments and are open for general business in New York, New
York;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Notional Reais Principal
Amount&rdquo;</B> means, as the context requires and with respect to any Disbursement, the amount, expressed in Reais, specified in the
related Confirmation or such notional principal amount outstanding from time to time;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Obstructive Practice&rdquo;</B>
has the meaning assigned to it in Annex J (<I>Anti-Corruption Guidelines for IFC Transactions</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Obligors&rdquo; </B>means
the Borrower, the Parent Company Guarantor and each Subsidiary Guarantor;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Operations&rdquo;</B>
means the operations, activities and facilities of any Person (including the design, construction, operation, maintenance, management
and monitoring thereof, as applicable);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Parent Company Guarantee
Agreement&rdquo; </B>means the agreement entitled &ldquo;Parent Company Guarantee Agreement&rdquo; entered into on or about the same date
hereof between the Parent Company Guarantor and IFC pursuant to which the Parent Company Guarantor guarantees the obligations of the Borrower
under the IFC Financing Documents in accordance with the terms thereof;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Parent Company Guarantor&rdquo;</B>
means Afya Limited, an exempted company registered in the Cayman Islands, whose registered office is c/o Maples Corporate Services Limited,
P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Participant&rdquo;</B>
means any Person who acquires a Participation;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&ldquo;<B>Participation</B>&rdquo;
means the interest of any Participant in the Loan, or as the context requires, in any Disbursement;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Performance Standards&rdquo;</B>
means IFC&rsquo;s Performance Standards on Environmental &amp; Social Sustainability, dated January 1, 2012, a copy of which has been
delivered to and receipt of which has been acknowledged by the Borrower;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Permitted Acquisition&rdquo;</B>
means the acquisition by the Borrower, any Guarantor or any of their respective Subsidiaries of any Person or business (including by way
of merger of such Person or business with and into the Borrower, such Guarantor or such Subsidiary, as applicable (so long as the Borrower,
such Guarantor or such Subsidiary is the surviving Person)), <I>provided</I> that (in each case) (A) the consideration paid or to be paid
by the Borrower, such Guarantor or such Subsidiary consists solely of cash, common shares or equity instruments of the Borrower, such
Guarantor or such Subsidiary, the issuance or incurrence of Financial Debt otherwise permitted by the IFC Financing Documents and/or the
assumption/acquisition of any Financial Debt (calculated at face value) of such acquired Person or business which is permitted to remain
outstanding in accordance with the requirements of the IFC Financing Documents, (B) the acquired Person or business is in a business permitted
by the IFC Financing Documents and (C)&nbsp;all other requirements of the IFC Financing Documents applicable to Permitted Acquisitions
are satisfied;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Permitted Lien&rdquo;</B>
has the meaning specified in Section 5.02(f);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Permitted Refinancing
Debt&rdquo;</B> means any Financial Debt of the Borrower, the Guarantors or any of their respective Subsidiaries issued in exchange for,
or the net proceeds of which are used to renew, refund, refinance, replace, defease or discharge other Financial Debt of the Borrower,
the Guarantors or any of their Subsidiaries (other than intercompany Financial Debt); <I>provided</I> that:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
principal amount (or accreted value, if applicable) of such Permitted Refinancing Debt does not exceed the principal amount (or accreted
value, if applicable) of the Financial Debt renewed, refunded, refinanced, replaced, defeased or discharged (plus all accrued interest
on such Financial Debt and the amount of all fees and expenses, including premiums, incurred in connection therewith);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such
Permitted Refinancing Debt (a) has a final maturity date later than the final maturity date of, and has a weighted average life to maturity
that is equal to or greater than the weighted average life to maturity of, the Financial Debt being renewed, refunded, refinanced, replaced,
defeased or discharged or (b) has a final maturity date that falls more than 90 days after the Final Maturity Date of the Loan;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the Financial Debt being renewed, refunded, refinanced, replaced, defeased or discharged is subordinated in right of payment to the Loan,
such Permitted Refinancing Debt is subordinated in right of payment to the Loan on terms at least as favorable to the Loan as those contained
in the documentation governing the Financial Debt being renewed, refunded, refinanced, replaced, defeased or discharged;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such
Financial Debt is incurred either by the Borrower, any of the Guarantors or any of their respective Subsidiaries that was the obligor
on the Financial Debt being renewed, refunded, refinanced, replaced, defeased or discharged and is guaranteed only by Persons who were
obligors of the Financial Debt being renewed, refunded, refinanced, replaced, defeased or discharged; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(5)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
dividend restrictions in such Permitted Refinancing Debt, in the judgment of the Borrower or the Guarantor, as applicable, either (x)
do not materially impair the Borrower&rsquo;s or such Guarantor&rsquo;s, as applicable, ability to make payments under the Loan or (y)
are not more materially</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify">restrictive, taken as a whole, than those contained
in the Financial Debt being renewed, refunded, refinanced, replaced, defeased or discharged;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Person&rdquo;</B> means
any natural person, corporation, company, exempted company, partnership, exempted limited partnership, limited liability company, firm,
voluntary association, joint venture, trust, unincorporated organization, Authority or any other entity whether acting in an individual,
fiduciary or other capacity;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Policy on Disclosure
of Information&rdquo; </B>means IFC&rsquo;s Access to Information Policy, dated January 1, 2012, which is available at https://disclosures.ifc.org/#/accessInfoPolicy;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Potential Event of Default&rdquo;</B>
means any event or circumstance which would, with notice, lapse of time, the making of a determination or any combination thereof, become
an Event of Default;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Price Source Disruption&rdquo;</B>
means with respect to any BRL Valuation Date, the case when it is impossible to obtain the specified rate (BRL 09 or BRL PTAX) on that
BRL Valuation Date;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Principal Promissory
Note&rdquo;</B> has the meaning assigned to it in Section 2.16(a) (<I>Promissory Notes</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Principal Repayment Date&rdquo;
</B>means each of the dates set forth in Section 2.05 (<I>Repayment</I>), subject to adjustment in accordance with Section 1.04 (<I>Business
Day Adjustment</I>); provided, that if the final BRL Valuation Date in respect of a Reference Period is adjusted for any reason, then
the corresponding Principal Repayment Date for each Disbursement shall be two (2) Brazil and New York Business Days after the relevant
BRL Valuation Date;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Proceeding&rdquo;</B>
has the meaning assigned to it under Section 7.07 (<I>Indemnification; No Consequential Damages</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Process Agent&rdquo;</B>
has the meaning assigned thereto in Section 7.05(e) (<I>Applicable Law and Jurisdiction</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Pro Forma Basis&rdquo;</B>
means, in connection with any calculation of compliance with any financial covenant or financial term, the calculation thereof after giving
effect on a <U>pro forma</U> basis (in accordance with items (i), (ii) and (iii) below) to: (x) the incurrence of any Financial Debt,
(y)&nbsp;the permanent repayment of any Financial Debt after the first day of the relevant Calculation Period, and (z) any (1) Permitted
Acquisition, (2) Restricted Payment or (3) other transaction regarding which pro forma financial calculations are required hereunder on
a Pro Forma Basis that is consummated during the relevant Calculation Period:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Financial Debt (x) incurred or issued after the first day of the relevant Calculation Period shall be deemed to have been incurred or
issued (and the proceeds thereof applied) on the first day of such Calculation Period and remain outstanding through the date of determination
and (y) permanently retired or redeemed after the first day of the relevant Calculation Period shall be deemed to have been retired or
redeemed on the first day of such Calculation Period and remain retired through the date of determination;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Financial Debt assumed to be outstanding pursuant to preceding clause (i) shall be deemed to have borne interest at (x) in the case of
fixed rate Financial Debt, the rate applicable thereto, or (y) in the case of floating rate Financial Debt, the rates which would have
been applicable thereto during the respective period when the same was deemed outstanding; and</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in
making any determination of EBITDA on a Pro Forma Basis, <U>pro forma</U> effect shall be given to any Permitted Acquisition or permitted
Restricted Payments if effected during the respective Calculation Period as if the same had occurred on the first day of the respective
Calculation Period;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Prohibited Activities&rdquo;</B>
means the activities specified in Annex I (<I>Prohibited Activities</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Promissory Notes&rdquo;</B>
means a Principal Promissory Note, an Interest Promissory Note or both, as the context may require;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Reference Period&rdquo;</B>
means each period of six (6) months commencing on and including a Scheduled BRL Valuation Date (or, for the first Reference Period applicable
to a Disbursement, the relevant Disbursement date specified in the applicable Confirmation) and ending on but excluding the next succeeding
Scheduled BRL Valuation&nbsp;Date;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Related Parties&rdquo;
</B>means, with respect to any Person, such Person&rsquo;s Affiliates and the partners, directors, officers, employees, agents, brokers,
trustees, administrators, managers, advisors and representatives, including accountants, auditors and legal counsel of such Person and
of such Person&rsquo;s Affiliates;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Relevant Change&rdquo;
</B>has the meaning assigned to it in Section 2.15 (<I>Illegality of Participations</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Relevant Spread&rdquo;
</B>means, as of any determination date, a percentage per annum equal to (i) the Base Relevant Spread <U>minus</U> (ii) the Aggregate
Spread Rebate in effect on such date;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Restricted Payment&rdquo;</B>
means, with respect to any Person, the (i)&nbsp;declaration or payment of a dividend, distribution or return of any equity capital to
its stockholders, partners or members or authorization or making of any other distribution, payment or delivery of property (other than
common stock of such Person) or cash to its stockholders, partners or members in their capacity as such, or (ii) redemption, retirement,
purchase or other acquisition of, or permitting of any Subsidiary to redeem, retire, purchase or otherwise acquire, directly or indirectly,
any shares of any class of its capital stock outstanding on or after the date of this Agreement (or any options or warrants issued by
such Person with respect to its capital stock), or setting aside of any funds for any of the foregoing purposes, or (iii) making of any
payment of any kind on or in respect of Financial Debt held by any Affiliate of such Person. Without limiting the foregoing, &ldquo;Restricted
Payments&rdquo; with respect to any Person shall also include all payments made or required to be made by such Person with respect to
any stock appreciation rights, plans, equity incentive or achievement plans or any similar plans or setting aside of any funds for the
foregoing purposes;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Sanctionable Practice&rdquo;
</B>means any Corrupt Practice, Fraudulent Practice, Coercive Practice, Collusive Practice, or Obstructive Practice, as those terms are
defined herein and interpreted in accordance with the Anti-Corruption Guidelines attached to this Agreement as Annex J (<I>Anti-Corruption
Guidelines for IFC Transactions</I>).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SCE-Cr&eacute;dito&rdquo;
</B>means the reporting system of Banco Central do Brasil for foreign capital in the form of credit transactions (<I>Sistema de Presta&ccedil;&atilde;o
de Informa&ccedil;&otilde;es de Capital Estrangeiro &ndash; Cr&eacute;dito</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Schedule of Payments&rdquo;</B>
means the schedule of payments (<I>cronograma de pagamentos</I>) of Banco Central do Brasil that is registered with the SCE-Cr&eacute;dito
through a BCB Report subsequently to the receipt of the proceeds of a Disbursement in Brazil, indicating the dates of repayment of principal,
interest, charges, fees and any other amounts due and evidenced in the relevant BCB Report;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Scheduled BRL Valuation
Date&rdquo;</B> means in respect of any Interest Payment Date, the date that is two (2) Brazil and New York Business Days before such
Interest Payment Date, subject to adjustment in accordance with Section 1.04 (<I>Business Day Adjustment</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SOFR&rdquo;</B> means
the secured overnight financing rate administered by the Federal Reserve Bank of New York (or any other person which takes over the administration
of that rate) published by the Federal Reserve Bank of New York (or any other person which takes over the publication of that rate);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SOFR Banking Day&rdquo;</B>
means any day other than:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
Saturday or Sunday; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
day on which the Securities Industry and Financial Markets Association (or any successor organization) recommends that the fixed income
departments of its members be closed for the entire day for purposes of trading in US Government securities;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SoftBank Preferred Shares&rdquo;
</B>means the 150,000 outstanding Series A perpetual convertible preferred shares of the Parent Company Guarantor held by SoftBank Group
Corp., the aggregate outstanding balance of which shall be determined, as of any date of calculation, on the basis of the Parent Company
Guarantor&rsquo;s Financial Statements most recently delivered to IFC pursuant to Section 5.03(a) (<I>Quarterly Financial Statements and
Reports</I>) or Section 5.03(b) (<I>Annual Financial Statements and Reports</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPO Assessment&rdquo;
</B>means the report provided by an independent sustainability expert on the adequacy of the Sustainability Linked Loan Framework, the
selected Sustainability KPIs and the SPTs;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT&rdquo; </B>means
the sustainability performance targets specified in <U>Schedule&nbsp;11</U> (<I>Sustainability Performance Targets</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT Assessment&rdquo;</B>
means an annual assessment commissioned at the sole expense of the Borrower for the purpose of determining (based on a sample of data
collected as of the next preceding SPT Observation Date) whether each of the SPTs was achieved during the previous year, which assessment
shall be conducted by a third-party entity qualified and experienced in relevant assurance or attestation services, acceptable to IFC
(acting reasonably);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT Observation Date&rdquo;</B>
means December 31<SUP>st</SUP> of each year;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT1 Targets&rdquo; </B>means
SPT1A Targets and the SPT1B Targets, or each of them as the context requires;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT1A Targets&rdquo;</B>
means the annual sustainability performance targets specified in <U>Schedule&nbsp;11</U> (<I>Sustainability Performance Targets</I>) for
Sustainability KPI 1;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT1B Targets&rdquo;</B>
means the annual sustainability performance targets specified in <U>Schedule&nbsp;11</U> (<I>Sustainability Performance Targets</I>) for
Sustainability KPI 1B;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT2 Targets&rdquo;</B>
means the annual sustainability performance targets specified in <U>Schedule&nbsp;11</U> (<I>Sustainability Performance Targets</I>) for
Sustainability KPI 2;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT1 Spread Rebate&rdquo;</B>
means (a) on any determination date that falls on or after any SPT1 Spread Rebate Confirmation Notice (but before IFC has issued any SPT1
Spread Rebate Cancellation Notice), 0.075% per annum, and (b) on any other determination date, zero percent (0.0%) per annum;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT1 Spread Rebate Confirmation
Notice&rdquo; </B>has the meaning assigned to it in Section 2.03(e) (<I>Interest</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT1 Spread Rebate Cancellation
Notice&rdquo;</B> has the meaning assigned to it in Section 2.03(e) (<I>Interest</I>)</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT2 Spread Rebate&rdquo;</B>
means (a) on any determination date that falls on or after any SPT2 Spread Rebate Confirmation Notice (but before IFC has issued any SPT2
Spread Rebate Cancellation Notice), 0.075% per annum, and (b) on any other determination date, zero percent (0.0%) per annum;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT2 Spread Rebate Confirmation
Notice&rdquo; </B>has the meaning assigned to it in Section 2.03(f) (<I>Interest</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;SPT2 Spread Rebate Cancellation
Notice&rdquo;</B> has the meaning assigned to it in Section 2.03(f) (Interest);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Subsidiary&rdquo;</B>
means with respect to any Person, any Person over fifty percent (50%) of whose total voting share capital or other interest (including
partnership interest) entitled (without regard to any contingency) to vote in the election of directors, managers, general partners or
other Persons performing similar functions or trustees thereof, is, at any relevant time of determination, directly or indirectly, through
one or more intermediate entities by contract or otherwise, owned or controlled by (i) such Person; (ii) such Person and one or more Subsidiaries
of such Person; or (iii) one or more Subsidiaries of such Person;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Subsidiary Guarantee
Agreement&rdquo;</B> means the agreement entitled &ldquo;Subsidiary Guarantee Agreement&rdquo; entered into on or about the same date
hereof among the Subsidiary Guarantors and IFC pursuant to which the Subsidiary Guarantors guarantee the obligations of the Borrower under
the IFC Financing Documents in accordance with the terms thereof;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Subsidiary Guarantor&rdquo;</B>
means each of (i) Companhia Nilza Cordeiro Herdy De Educa&ccedil;&atilde;o e Cultura, a corporation (<I>sociedade an&ocirc;nima</I>) organized
and existing under the laws of the Country, (ii) Instituto de Ensino Superior do Piau&iacute; S.A., a corporation (<I>sociedade an&ocirc;nima</I>)
organized and existing under the laws of the Country, (iii) Sociedade Educacional e Cultural Sergipe del Rey LTDA., a limited liability
company (<I>sociedade limitada</I>) organized and existing under the laws of the Country, and (iv) any Subsidiary of the Borrower, whether
existing on the date hereof or established, created or acquired thereafter, that adheres as Guarantor to the Subsidiary Guarantee Agreement;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Subsidiary Guarantor
Adherence Instrument&rdquo; </B>means a document pursuant to which a new Subsidiary Guarantor adheres to the Subsidiary Guarantee Agreement
as Guarantor;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Sustainability KPIs&rdquo;</B>
means the two key performance indicators set forth in <U>Schedule&nbsp;11</U> (<I>Sustainability Performance Targets</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Sustainability KPI 1&rdquo;</B>
means the total number of free consultations offered by eligible students;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Sustainability KPI 1B&rdquo;
</B>means the total number of free consultations offered by eligible students in vulnerable and highly vulnerable areas;</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Sustainability KPI 2&rdquo;</B>
means, on any date of determination, the ratio for the five-year period ending on such date, resulting from dividing (i) the number of
medicine undergraduate courses with a <I>Conceito de Curso </I>(CC) grade 4 and 5 by (ii) the total number of medicine undergraduate courses
assessed by the MEC;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Sustainability Linked
Loan Framework&rdquo;</B> means the document issued by the Borrower and reviewed in the SPO Assessment defining the sustainability strategy,
Sustainability KPIs to be monitored and the SPTs;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Taxes&rdquo;</B> means
any present or future taxes, withholding obligations, duties and other charges of whatever nature levied by any Authority;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Term SOFR&rdquo;</B>
means for any day such rate may be required for purposes of this Agreement, the forward-looking term rate based on SOFR for the relevant
maturity as provided by the Term SOFR Administrator to, and published by, authorized distributors of Term SOFR at 6:00 a.m., New York
time (or any amended publication time for Term SOFR, as specified by the Term SOFR Administrator in the CME Term SOFR benchmark methodology
on the relevant rate setting day, provided, however, that if such rate is less than zero, Term SOFR shall be deemed to be zero and provided,
further, that if such rate is not published on such day, IFC shall substitute such rate with such other rate as IFC may determine to be
an appropriate successor or replacement for Term SOFR based on derivatives market practices then in effect;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Term SOFR Administrator&rdquo;</B>
means the CME Group Benchmark Administration Limited (CBA) (or a successor administrator);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Unscheduled Holiday&rdquo;</B>
means a BRL Valuation Date that is not a Brazil Business Day and the market was not aware of such fact (by means of a public announcement
or by reference to other publicly available information) until a time later than 9:00 a.m. local time in any of S&atilde;o Paulo, SP or
Rio de Janeiro, RJ or Bras&iacute;lia, DF, Brazil, two (2) Brazil Business Days prior to the BRL Valuation&nbsp;Date;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;Washington Business Day&rdquo;</B>
means a day when IFC&rsquo;s headquarters located in Washington D.C., United States of America, are open to conduct operations; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&ldquo;World Bank&rdquo; </B>means
the International Bank for Reconstruction and Development, an international organization established by Articles of Agreement among its
member countries.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 1.02<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Financial Calculations</U></I>. (a) All financial calculations to be made under, or for the purposes of, this Agreement and
any other IFC Financing Document shall be made in accordance with the Accounting Standards and, except as otherwise required in this Agreement
or to conform to any provision of this Agreement, shall be calculated from the then most recently issued quarterly financial statements
which the Borrower is obligated to furnish to IFC under Section 5.03(a)(<I>Reporting Requirements</I>).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Where quarterly financial statements from the last quarter of a Financial Year are used for the purpose of making certain financial
calculations then, at IFC&rsquo;s option, those calculations may instead be made from the audited financial statements for such Financial
Year.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If a financial calculation is to be made under or for the purposes of this Agreement or any other IFC Financing Document on a Consolidated
Basis, that calculation shall be made by reference to the sum of all amounts of similar nature reported in the relevant financial statements
of each of the entities whose accounts are to be consolidated with the accounts of the Parent Company Guarantor plus or minus the consolidation
adjustments customarily applied to avoid double counting of transactions among any of those entities, including the Parent Company Guarantor.</P>




<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 1.03<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Interpretation</U></I>. In this Agreement, unless the context otherwise requires:</P>


<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>headings are for convenience only and do not affect the interpretation of this Agreement;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>words importing the singular include the plural and vice versa;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a reference to an Annex, Article, party, Schedule or Section&nbsp;is a reference to that Article&nbsp;or Section&nbsp;of, or that
Annex, party or Schedule to, this Agreement;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a reference to a document includes an amendment or supplement to, or replacement or novation of, that document but disregarding
any amendment, supplement, replacement or novation made in breach of this Agreement; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a reference to a party to any document includes that party&rsquo;s successors and permitted assigns.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 1.04<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Business Day Adjustment</U>.</I> (a) When an Interest Payment Date is not a Brazil, SOFR, and New York Business Day, then
such Interest Payment Date shall be automatically changed to the next Brazil, SOFR, and New York Business Day in that calendar month (if
there is one) or the preceding Brazil, SOFR and New York Business Day (if there is not).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>When the day on or by which a payment (other than a payment of principal or interest) is due to be made is not a Brazil, SOFR,
and New York Business Day, that payment shall be made on or by the next Brazil, SOFR, and New York Business Day in that calendar month
(if there is one) or the preceding Brazil, SOFR, and New York Business Day (if there is not).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 1.05<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Payments on Disbursements</U></I>.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For the avoidance of doubt and for purposes of calculating the amount of any interest or principal payment due in relation to a
Disbursement, the outstanding principal amount from time to time of that Disbursement may be reduced from time to time upon becoming payable
in Dollar Equivalent amounts (whether as scheduled payments on any Principal Repayment Date or upon prepayment or acceleration), and in
the event any such Dollar Equivalent amount is not paid by the Borrower when due, such Dollar Equivalent amount shall accrue interest
in accordance with the provisions of Section 2.04 (<I>Default Interest and Other Costs</I>).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In respect of any Disbursement, when a disruption in the BRL/Dollar exchange markets results in IFC being unable to determine the
Dollar Equivalent of any amount in respect of principal or interest required to be paid under this Agreement, the due date for the relevant
payment of interest or principal in respect of such Disbursement shall be postponed, and upon IFC being able to determine the Dollar Equivalent
in accordance with prevailing market practice, IFC shall notify the Borrower of the Dollar Equivalent so determined by, or advised to,
IFC and the Borrower shall make the relevant payment of principal or interest two (2) New York Business Days after the date of such notice;
provided, however, that for purposes of determining amounts of interest to be paid on such date, there shall be no adjustment in the Interest
Period on which such payment is based.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Payment of the Dollar Equivalent of each Notional Reais Principal Amount (whether at scheduled maturity, upon prepayment or acceleration)
shall be deemed to be repayment in full of the principal amount disbursed in respect of the relevant Disbursement.</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0pt; text-align: center; text-indent: 0in">ARTICLE II</P>


<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">
The Loan</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.01<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>The Loan</U></I>. (a) Subject to the provisions of this Agreement, IFC agrees to lend, and the Borrower agrees to borrow,
the Loan consisting of up to five hundred million Reais (R$500,000,000) (the &ldquo;<B>Maximum Reais Amount</B>&rdquo;). The Loan shall
be disbursed in Reais in accordance with procedures described in Section 2.02 (<I>Disbursement Procedures</I>) and repaid in Dollars in
Dollar Equivalent amounts. The Borrower may request Disbursements, at the Borrower&rsquo;s discretion, in the form of one or more Disbursements.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>IFC shall be under no obligation to make any Disbursement if, after giving effect to such Disbursement, the aggregate of all amounts
disbursed to the Borrower would be in excess of the Maximum Reais Amount (as such amount may be reduced upon cancellation of the undisbursed
portion of the Loan by IFC pursuant to Section 2.10 (<I>Suspension or Cancellation by IFC</I>) or cancellation of the undisbursed portion
of the Loan by the Borrower pursuant to Section 2.11 (<I>Cancellation by the Borrower</I>)).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The proceeds of the Loan shall be used by the Borrower for the Expansion Program.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.02<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Disbursement Procedure</U></I>. (a) The Borrower may request a Disbursement at any time during the Availability Period by
delivering a Disbursement Request to IFC substantially in the form of Schedule 2 (<I>Form of Request for Disbursement</I>), at least fifteen
(15) Brazil and Washington Business Days prior to the proposed date of the Disbursement.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Disbursement shall be made in Reais to an account of the Borrower in the Country, all as specified by the Borrower in the
relevant Disbursement Request.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Disbursement (other than the last one) shall be made in an amount of not less than one hundred million Reais (R$100,000,000)
unless the amount available for Disbursement under the Loan is lower, in which case the Borrower may only request the amount available
to be disbursed.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In connection with each Disbursement, IFC shall provide to the Borrower a Confirmation substantially in the form of Schedule 2A
(<I>Form of Confirmation</I>) specifying the amount, currency, date and initial Interest Rate of the Disbursement, the amortization schedule
and any other relevant terms of such Disbursement. The Borrower shall promptly sign any such Confirmation and return the same to IFC (it
being understood and agreed, however, that such Confirmation is solely provided as a summary of the terms and conditions of the related
Disbursement, and that the terms set forth in this Agreement shall be effective and enforceable against the Borrower regardless of whether
or not the Borrower signs the related Confirmation).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower shall deliver to IFC a receipt, substantially in the form of Schedule 3 (<I>Form of Loan Disb</I>ursement Receipt),
within five (5) Brazil and Washington Business Days following each Disbursement.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 4.5pt; text-align: justify; text-indent: 0.5in">Section 2.03<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Interest</U>. </I>(a) Subject to the provisions of Section&nbsp;2.04 (<I>Default Rate Interest and Other Costs</I>) and consistent
with the provisions of Section 1.05 (<I>Payments on Disbursements</I>), the Borrower shall, on each Interest Payment Date, pay interest
on the principal amount of the Loan outstanding during the immediately preceding Interest Period by paying interest on each Disbursement
at the Interest Rate applicable to such Disbursement; provided that with respect to any Disbursement made less than fifteen (15) days
before an Interest Payment Date, interest shall be paid on the second Interest Payment Date following the date of that Disbursement.</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Interest on the Loan shall be calculated in Reais and converted into a Dollar amount, as set forth in Annex K (<I>Methodology
for Calculation of Loan Interest Payments on an Interest Payment Date</I>), and shall be payable in Dollars on each Interest Payment Date
as set forth in the Annex K at the bank account specified in Section 2.08(a) (<I>Currency and Place of Payments</I>).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In connection with and prior to each Interest Payment Date, IFC shall determine the interest amounts due under Section 2.03(b)
(<I>Interest</I>) and, as soon as practicable thereafter, notify the Borrower of the same.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Interest on the Loan shall be payable in arrears on the Interest Payment Date immediately following the end of that Interest Period.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If following an SPT Observation Date and in accordance with Section 5.03(b) (<I>Annual Financial Statements and Reports</I>), (i)
IFC receives an SPT Assessment confirming that as of such SPT Observation Date the Borrower has successfully achieved the SPT1 Targets,
(ii) IFC is satisfied that the Borrower has achieved the SPT1 Targets and (iii) no Event of Default or Potential Event of Default has
occurred and is continuing, IFC shall issue a notice (the &ldquo;<B><I>SPT1 Spread Rebate Confirmation Notice</I></B>&rdquo;). If any
SPT Assessment delivered after the issuance of an SPT1 Spread Rebate Confirmation Notice shows a deterioration of the Sustainability KPI
1A or the Sustainability KPI 1B as compared, respectively, to the then applicable SPT1A Targets and SPT1B Targets IFC may, at its discretion,
cancel any SPT1 Spread Rebate Confirmation Notice by giving written notice thereof to the Borrower (such notice, the &ldquo;<B>SPT1 Spread
Rebate Cancellation Notice</B>&rdquo;). The SPT1 Spread Rebate and any cancellation thereof, shall become effective ten (10) Brazil and
Washington Business Days after the date of, respectively, the SPT1 Spread Rebate Confirmation Notice or the SPT1 Spread Rebate Cancellation
Notice.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If following an SPT Observation Date and in accordance with Section 5.03(b) (<I>Annual Financial Statements and Reports</I>), (i)
IFC receives an SPT Assessment, confirming that as of such SPT Observation Date the Borrower has successfully achieved the SPT2 Targets,
(ii) IFC is satisfied that the Borrower has achieved the SPT2 Targets and (iii) no Event of Default or Potential Event of Default has
occurred and is continuing, IFC shall issue a notice (the &ldquo;<B><I>SPT2 Spread Rebate Confirmation Notice</I></B>&rdquo;). If any
SPT Assessment delivered after the issuance of an SPT2 Spread Rebate Confirmation Notice shows a deterioration of the Sustainability KPI
2 as compared to then applicable SPT2 Targets, IFC may, at its discretion, cancel any SPT2 Spread Rebate Confirmation Notice by giving
written notice thereof to the Borrower (such notice, the &ldquo;<B>SPT2 Spread Rebate Cancellation Notice</B>&rdquo;). The SPT2 Spread
Rebate and any cancellation thereof, shall become effective ten (10) Brazil and Washington Business Days after the date of, respectively,
the SPT2 Spread Rebate Confirmation Notice or the SPT2 Spread Rebate Cancellation Notice.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The determination by IFC, from time to time, of the applicable Interest Rate shall be final and conclusive and bind the Borrower
(unless the Borrower shows to IFC&rsquo;s satisfaction that the determination involves manifest error).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.04<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Default Rate Interest and Other Costs</U></I>. (a) Without limiting the remedies available to IFC under this Agreement
or otherwise (and to the maximum extent permitted by applicable law), if the Borrower fails to make any payment of principal or interest
(including interest payable pursuant to this Section) or any other payment provided for in Section 2.07 (<I>Fees</I>) when due as specified
in this Agreement (whether at stated maturity or upon acceleration), the Borrower shall pay in respect of the amount of such payment due
and unpaid as follows: if a payment default occurs with respect to amounts payable in Dollars (including, for the avoidance of doubt,
any payment in respect of a Disbursement to be made in Dollars), interest at a rate per annum equal to the sum of (i) the Relevant Spread;
(ii) two per cent (2.0%) per annum; (iii) the Credit Adjustment Spread; and (iv) Term SOFR for the date that is two (2) SOFR Banking Days</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify">prior to the commencement of the Interest Period in
which such default occurs and reset on the second SOFR Banking Day preceding each succeeding Interest Period during which any amount remains
unpaid; provided, however, that if a payment default occurs prior to the first Interest Payment Date under this Agreement (whether or
not a disbursement has occurred), the applicable Term SOFR rate used to calculate default interest during the period in which an amount
remains unpaid extending up to but excluding such first Interest Payment Date shall be Term SOFR for the date that is two (2) SOFR Banking
Days prior to the date of this Agreement;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Interest at the rate or rates referred to in Section 2.04(a) shall accrue from the date on which payment of the relevant overdue
amount became due until the date of actual payment of that amount (as well after as before judgment), and shall be payable on demand or,
if not demanded, on each Interest Payment Date falling after any such overdue amount became due.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.05<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Repayment</U></I>. (a) Subject to Section&nbsp;1.04 (<I>Business Day Adjustment</I>), the Borrower shall repay the Loan
on the following Interest Payment Dates by repaying each Disbursement in accordance with the following percentages:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 41%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">Interest Payment Date</TD>
    <TD STYLE="width: 59%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">Percentage of Notional Reais Principal Amount Due</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">April 15, 2027</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">14.3%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">October 15, 2027</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">14.3%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">April 15, 2028</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">14.3%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">October 15, 2028</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">14.3%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">April 15, 2029</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">14.3%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">October 15, 2029</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">14.3%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">April 15, 2030</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">14.2%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; font-weight: normal; text-align: justify; text-indent: 0in; font-family: Times New Roman,serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For the avoidance of doubt, with respect to any Disbursement, the principal amount to be repaid shall be the Dollar Equivalent
of the Notional Reais Principal Amount, as provided in Section 1.05 (<I>Payments on the Disbursements</I>).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any principal amount of the Loan repaid under this Agreement may not be re-borrowed.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.06<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Prepayment</U>. </I>(a) Subject to Section 2.10 (<I>Unwinding Costs</I>), on or after April 15, 2027, the Borrower may voluntarily
prepay all or any part of the Loan outstanding. In the case of any partial prepayment of any Disbursement, such partial prepayment shall
be applied pro rata to all remaining payments of principal in respect of such Disbursement, on not less than ten (10) Washington Business
Days&rsquo; prior notice to IFC, but only if:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the Borrower simultaneously pays the Dollar Equivalent of:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">the prepayment premium specified in Section 2.06(b), and</TD></TR></TABLE>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">all accrued interest on the amount of the Loan to be prepaid, and all other amounts then due and payable
under this Agreement, including the amount payable under Section 2.10 (<I>Unwinding Costs</I>);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">for a partial prepayment, that prepayment is an amount not less than the Dollar Equivalent of fifty million
(R$50,000,000) Reais; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">if requested by IFC, the Borrower delivers to IFC, prior to the date of prepayment, evidence satisfactory
to IFC that all necessary Authorizations with respect to the prepayment have been obtained.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>On the date of any prepayment of the Loan in accordance with Section&nbsp;2.06(a), the Borrower shall pay a prepayment premium
consisting of the Dollar Equivalent Amount corresponding to 0.3% of the Notional Reais Principal Amount to be prepaid. The determination
by IFC of the prepayment premium shall be final and conclusive and bind the Borrower (unless the Borrower shows to IFC&rsquo;s satisfaction
that the determination involves manifest error).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the case of any partial prepayment of the Loan, (i) such partial prepayment shall be applied pro rata to all Disbursements and
(ii) pro rata to the outstanding installments of principal in respect of each such Disbursement.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon delivery of a notice in accordance with Section 2.06, the Borrower shall make the prepayment in accordance with the terms
of that notice.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any principal amount prepaid under this Agreement, may not be reborrowed.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower shall comply with applicable laws of the Country in connection with any prepayment under this Section 2.06, including
the making of any filings and/or registrations with the Banco Central do Brasil or any Authority, as applicable, prior to the making of,
or in connection with, any such prepayment. If there are any Authorizations IFC deems necessary or appropriate in connection with any
swap termination related to such prepayment, there shall be no prepayment hereunder unless and until such Authorization has been obtained,
if applicable.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Without limiting the foregoing, in the event of any prepayment of the Loan prior to its scheduled maturity, the amount of principal
and accrued interest to be paid by the Borrower with respect to Loan on the relevant prepayment date (excluding, for the avoidance of
doubt, any default interest, prepayment premium, unwinding costs and any other costs and expenses relating thereto, all of which shall
be calculated in accordance with the specific provisions of this Agreement) shall be calculated as set forth in Annex L (<I>Methodology
for Calculation of Payments upon Prepayment or Acceleration</I>). Prior to the date of any such prepayment, IFC shall notify the Borrower
of the relevant principal and accrued interest amounts due.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.07<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Fees</U></I>. (a) The Borrower shall pay to IFC:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">a commitment fee equal to the Dollar Equivalent of a BRL amount calculated at the rate of [**]
([**]%) per annum on that part of the Loan that from time to time has not been disbursed or cancelled, beginning to accrue on the date of
this Agreement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify"><U>prorated</U> on the basis of a 360-day year for the actual number of days elapsed; and</TD></TR></TABLE>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">payable semi-annually, in arrears, on each Interest Payment Date, the first such payment to be due on
October 15, 2024.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower shall also pay to IFC:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">a front-end fee equal to the Dollar Equivalent of a BRL amount equal to [**] ([**]%) of the Maximum
Reais Amount, to be paid on the earlier of (x) the date which is thirty (30) days after the date of this Agreement and (y) the date immediately
preceding the date of the first Disbursement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">a portfolio supervision fee of $[**] per annum, payable upon receipt of a statement from IFC; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">if the Borrower and IFC agree to restructure all or part of the Loan, the Borrower and IFC shall negotiate
in good faith an appropriate amount to compensate IFC for the additional work of IFC staff required in connection with such restructuring.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.08<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Currency and Place of Payments</U></I>. (a) The Borrower shall make
all payments of principal, interest, fees, and any other amount due to IFC under this Agreement in same day funds, to the account of IFC
at Citibank, N.A., New York, New York, U.S.A., ABA#021000089, for credit to IFC&rsquo;s account number 36085579, with reference to Investment
No. 47855 or at such other bank or account in New York as IFC from time to time designates in writing to the Borrower. Payments must be
received in IFC&rsquo;s designated account no later than 1:00 p.m. New York time.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The payment obligations of the Borrower under this Agreement shall be discharged or satisfied only to the extent that (and as of
the date when) IFC actually receives funds in the currency or currencies specifically required under this Agreement and in the account
or accounts referred to in subsection (a) above, notwithstanding the tender or payment (including by way of recovery under a judgment)
of any amount in any other currency.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Accordingly, the Borrower shall, as a separate obligation, or by way of indemnity, as the case may be, pay such additional amount
as is necessary to enable IFC to receive, after conversion to Reais or Dollars, as the case may be, at a market rate and transfer to that
account, the full amount due to IFC under this Agreement in Reais or Dollars, as the case may be, and in the account specified in subsection
(a) above.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding the provisions of Section 2.08(a) and Section 2.08(b), IFC may require the Borrower to pay (or reimburse IFC) for
any Taxes, fees, costs, expenses and other amounts payable by the Borrower in accordance with Section 2.13(a) (<I>Taxes</I>) and Section
2.14 (<I>Expenses</I>) in the currency in which they are payable, if other than Reais or Dollars.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.09<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Allocation of Partial Payments</U></I>. Subject to Section 2.06 (<I>Prepayment</I>), if at any time IFC receives less than
the full amount then due and payable to it under this Agreement, IFC may allocate and apply the amount received as IFC in its sole discretion
determines, notwithstanding any instruction that the Borrower may give to the contrary.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.10<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Unwinding Costs</U></I>. (a) If IFC or any Participant incurs any cost, expense or loss as a result of the Borrower:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">failing to borrow in accordance with a request for Disbursement made pursuant to Section&nbsp;2.02 (<I>Disbursement
Procedure</I>);</TD></TR></TABLE>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">failing to prepay in accordance with a notice of prepayment in accordance with Section 2.06 (<I>Prepayment</I>);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">modifying the repayment schedule of the Loan or any Disbursement, whether at the request of the Borrower
or in connection with any rescheduling or restructuring of the Loan;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">after acceleration of the Loan, paying all or a portion of the Loan on a date other than an Interest Payment
Date;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify">then the Borrower shall pay to IFC the amount that
IFC from time to time notifies to the Borrower as being the amount of those documented costs, expenses and losses incurred, no later than
two (2) Brazilian and New York Business Day after the date of any such notification.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For the purposes of this Section, &ldquo;costs, expenses or losses&rdquo; include any documented premium, penalty or expense incurred
to liquidate or obtain third party deposits, borrowings, hedges or swaps in order to make, maintain, fund or hedge all or any part of
any Disbursement or in connection with the prepayment of all or part of any Disbursement or the modification of the repayment terms of
any Disbursement.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.11<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Suspension or Cancellation by IFC</U></I>. (a) IFC may, by notice to the Borrower, suspend the right of the Borrower to
Disbursements or cancel the undisbursed portion of the Loan in whole or in part:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">if the first Disbursement has not been made by the date that is six (6) months after the date of this
Agreement, or such other date as the parties agree;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">if any Event of Default has occurred and is continuing or if the Event of Default specified in Section
6.02(e) (<I>Expropriation, Nationalization, Etc.</I>) is, in the reasonable opinion of IFC, imminent;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">if any event or condition has occurred which (A) has a Material Adverse Effect , or (B) could reasonably
be expected to have a Material Adverse Effect, as reasonably determined by IFC; <I>provided</I> that with respect to item (B) hereof,
IFC has previously notified the Borrower of its concerns with respect to such event or condition; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">on or after the last day of the Availability Period.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the giving of any such notice, the right of the Borrower to any further Disbursement shall be suspended or cancelled, as the
case may be. The exercise by IFC of its right of suspension shall not preclude IFC from exercising its right of cancellation, either for
the same or any other reason specified in Section 2.11(a) and shall not limit any other provision of this Agreement. Upon any cancellation
the Borrower shall, subject to paragraph (c) of this Section 2.11, pay to IFC all fees and other amounts accrued (whether or not then
due and payable) under this Agreement up to the date of that cancellation. A suspension shall not limit any other provision of this Agreement.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the case of partial cancellation of the Loan pursuant to paragraph (a) of this Section 2.11, or Section 2.12(a) (<I>Cancellation
by the Borrower</I>), interest on the amount then outstanding of the Loan remains payable as provided in Section 2.03 (<I>Interest</I>).</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.12<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Cancellation by the Borrower</U></I>. (a) The Borrower may, by notice to IFC, irrevocably request IFC to cancel the undisbursed
portion of the Loan, in whole or in part, on the date specified in that notice (which shall be a date not earlier than 30 days after the
date of that notice).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>IFC shall, by notice to the Borrower, cancel the undisbursed portion of the Loan effective as of that specified date if, subject
to Section 2.12(c), IFC has received all fees and other amounts accrued (whether or not then due and payable) under this Agreement up
to such specified date.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any portion of the Loan that is cancelled under this Section 2.12 may not be reinstated.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.13<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Taxes</U></I>. (a) The Borrower shall pay or cause to be paid all Taxes (other than Taxes, if any, payable on the overall
income of IFC) on or in connection with the payment of all amounts due under this Agreement, and make all payments under this Agreement
without deducting any present or future taxes whatsoever by whomsoever levied or imposed in connection with the payment of any amount
under this Agreement; <I>provided</I> that, if the Borrower is prevented under applicable law from making payments without deduction,
the Borrower shall, in each case, pay to IFC an increased amount such that, after deduction, IFC receives the full amount it would have
received had that payment been made without deduction.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Section 2.13(a) does not apply to Taxes which directly result from a Participant having its principal office in the Country or
having or maintaining a permanent office or establishment in the Country, if and to the extent that such permanent office or establishment
acquires the relevant Participation.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.14<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Expenses</U></I>. (a) The Borrower shall pay or, as the case may be, reimburse IFC or its assignees any amount paid by them
on account of, all Taxes (including stamp taxes), duties, fees or other charges payable on or in connection with the execution, issue,
delivery, registration or notarization of the IFC Financing Documents and any other documents related to this Agreement or any other
IFC Financing Document.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower shall pay to IFC or as IFC may direct:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the reasonable and documented fees and expenses of IFC&rsquo;s counsel incurred in connection with:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">the preparation of the investment by IFC provided for under this Agreement and any other IFC Financing
Document;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">the preparation and/or review, execution and, where appropriate, translation and registration of the IFC
Financing Documents and any other documents related to them;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(C)</TD><TD STYLE="text-align: justify">the giving of any legal opinions required by IFC under this Agreement and any other IFC Financing Document;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(D)</TD><TD STYLE="text-align: justify">the administration by IFC of the investment provided for in this Agreement or otherwise in connection
with any amendment, supplement or modification to, or waiver under, any of the IFC Financing Documents;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(E)</TD><TD STYLE="text-align: justify">the registration (where appropriate) and the delivery of the evidence of indebtedness relating to the
Loan and its Disbursement; and</TD></TR></TABLE>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(F)</TD><TD STYLE="text-align: justify">the occurrence of any Event of Default or Potential Event of Default; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the documented costs and expenses incurred by IFC in relation to efforts to enforce or protect its rights
under any IFC Financing Document, or the exercise of its rights or powers consequent upon or arising out of the occurrence of any Event
of Default or Potential Event of Default, including legal and other professional consultants&rsquo; fees.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.15<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Illegality of Participation</U></I>. If IFC has sold a Participation in the Loan and after the date of this Agreement, any
change made in any applicable law or regulation or official directive (or its interpretation or application by any Authority charged with
its administration) (herein the &ldquo;<B>Relevant Change</B>&rdquo;) makes it unlawful for the Participant acquiring that Participation
to continue to maintain or to fund that Participation:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Borrower shall, upon request by IFC (but subject to any applicable Authorization having been obtained), on the earlier of (x)
the next Interest Payment Date and (y) the date that IFC advises the Borrower is the latest day permitted by the Relevant Change, prepay
in full that part of the Loan that IFC advises corresponds to that Participation;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>concurrently with the prepayment of the part of the Loan corresponding to the Participation affected by the Relevant Change, the
Borrower shall pay all accrued interest, Increased Costs (if any) on that part of the Loan (and, if that prepayment is not made on an
Interest Payment Date, any amount payable in respect of the prepayment under Section 2.10 (<I>Unwinding Costs</I>)); and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Borrower agrees to take all reasonable steps to obtain, as quickly as possible after receipt of IFC&rsquo;s request for prepayment,
the Authorization referred to in Section 2.15(a) if any such Authorization is then required.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.16<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Promissory Notes</U></I>.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To further evidence its obligation to repay the Loan, and to pay accrued interest, the Borrower shall issue and deliver to or at
the order of IFC, on each Disbursement date, two sets of promissory notes comprised of (i) seven (7) promissory notes, each for a portion
of the principal amount of such Disbursement equal to the percentage of each repayment instalment in accordance with the table in Section
2.05 (<I>Repayment</I>) (a &ldquo;<B>Principal Promissory Note</B>&rdquo;) and (ii) one (1) promissory note for interest payable on the
principal of the Principal Promissory Notes in accordance with the provisions of Section 2.03 (<I>Interest</I>) and Section 2.04 (<I>Default
Interest</I>) hereof, as reflected in such promissory note (an &ldquo;<B>Interest Promissory Note</B>&rdquo;), all of which shall bear
the guarantee (<I>aval</I>) of each of the Guarantors, on a joint and several basis and shall be substantially in the form of Annex&nbsp;M
(<I>Forms of Principal Promissory Note and Interest Promissory Note</I>). At IFC&rsquo;s reasonable request, the Borrower shall execute
and deliver one or more new Promissory Notes satisfactory to IFC to substitute for one or more Promissory Notes previously delivered hereunder,
provided that, concurrently with the delivery of the new Promissory Note(s), IFC shall return to the Borrower the respective Promissory
Notes previously delivered hereunder (or an affidavit of loss, theft or destruction in customary form, which shall indicate that such
previously delivered Promissory Note shall be of no further force and effect). The issuance, execution and delivery of any Promissory
Note pursuant to this Agreement shall not be construed as a novation hereunder or under any other agreement between IFC and the Borrower
and shall not affect the obligations of the Borrower hereunder, and the rights and claims of IFC under any Promissory Note shall not replace
or supersede its rights and claims hereunder.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding the above, within thirty (30) Brazil and Washington Business Days following the issuance by IFC of (i) an SPT1
Spread Rebate Confirmation Notice, (ii) an SPT2 Spread</P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify">Rebate Confirmation Notice, (iii) an SPT1 Spread Rebate
Cancellation Notice or (iv) an SPT2 Spread Rebate Cancellation Notice, as the case may be, the Borrower shall execute, notarize and deliver
to IFC and its assigns, if any, new Interest Promissory Notes to substitute for the Interest Promissory Note(s) then being held by IFC
and its assigns, if any, each such new Interest Promissory Note reflecting the applicable Relevant Spread after giving effect to any such
notice, <I>provided</I> that on the date the Borrower delivers the new Interest Promissory Notes reflecting the applicable Relevant Spread,
IFC shall return to the Borrower the respective Interest Promissory Notes previously delivered (or an affidavit of loss, theft or destruction
in customary form, which shall indicate that such previously delivered Promissory Note shall be of no further force and effect).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to the provisions of Section 2.17 (<I>Acceleration of Promissory Notes</I>), (i) within thirty (30) days from the repayment
by the Borrower of an installment of principal in accordance with Section 2.05 (<I>Repayment</I>), IFC shall deliver to the Borrower the
Principal Promissory Notes corresponding to such repayment, and (ii) within thirty (30) days following the date of repayment of the last
installment of principal in accordance with Section 2.05 (<I>Repayment</I>), and payment of interest thereon in accordance with Section
2.03 (<I>Interest</I>) and Section 2.04 (<I>Default Interest</I>), as applicable, IFC shall deliver to the Borrower, together with the
Principal Promissory Notes corresponding to such last instalment, all Interest Promissory Notes.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower hereby represents and warrants that each Promissory Note when issued, executed and delivered to IFC, will be a promissory
note duly issued, executed and delivered by or on behalf of the Borrower and each of the Guarantors (<I>por aval</I>) and will (i) constitute
an irrevocable acknowledgment of debt on its part to IFC, and a binding and enforceable obligation of the Obligors in accordance with
its terms, and (ii) entitle IFC to all rights attached to the enforcement of promissory notes by law in addition to any rights and remedies
of IFC under this Agreement. Notwithstanding the foregoing, payment of any amounts due under a Promissory Note shall <I>pro tanto</I>
discharge the obligation of the Borrower and the Guarantors to repay the corresponding portion of the Loan or the interest thereon, to
which such Promissory Note relates.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 2.17<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Acceleration of Promissory Notes</U></I>. To the extent permitted by law, in the event that repayment of the Loan shall have
for any reason been accelerated pursuant to the provisions of Section 6.01 (<I>Acceleration after Default</I>), all Promissory Notes may
be declared by IFC to be immediately due and payable notwithstanding any provision herein or therein to the contrary, and the same shall
thereupon become immediately due and payable without any further notice and without any presentment, demand or protest of any kind, all
of which are hereby expressly waived by the Borrower.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center; text-indent: 0in">ARTICLE III<BR>
Representations and Warranties</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 3.01<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Representations and Warranties</U></I>. The Borrower represents and warrants that:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Organization and Authority</U>. Each of the Obligors and each of their respective Subsidiaries has been duly incorporated, organized,
registered or formed and is validly existing under the laws of the jurisdiction of its organization, registration or formation and has
the corporate power &ndash; and has obtained all required Authorizations - to (i) own or lease its assets, conduct its business as presently
conducted and (ii) to enter into, and comply with its obligations under, the IFC Financing Documents to which it is a party or will, in
the case of any IFC Financing Document not executed as at the date of this Agreement, when that IFC Financing Document is executed, have
the corporate power to enter into, and comply with its obligations under, that IFC Financing Document;</P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <U>Validity</U>. Each IFC Financing Document to which each Obligor is a party has been, or will be, duly authorized and executed
by such Person and constitutes, or will, when executed, constitute, a valid and legally binding obligation of such Person, enforceable
in accordance with its terms (<FONT STYLE="background-color: white">except as the enforcement thereof may be limited by Debtor Relief
Laws and except as enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered in
a proceeding in equity or at law))</FONT> and none of the agreements listed in Section 4.01(a) (<I>Conditions of First Disbursement</I>)
has been, or will be, amended or modified except as permitted under this Agreement;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Conflict</U>. Neither the making of any IFC Financing Document to which any of the Obligors is a party nor (when all the
Authorizations referred to in Section 4.01(c) (<I>Conditions of First Disbursement)</I> have been obtained) the compliance with its terms
will conflict with or result in a breach of any of the terms, conditions or provisions of, or constitute a default or require any consent
under, any indenture, mortgage, agreement or other instrument or arrangement to which such Person is a party or by which it is bound,
or violate any of the terms or provisions of such Person&rsquo;s Charter or any Authorization, judgment, decree or order or any statute,
rule or regulation applicable to such Person;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Status of Authorizations</U>. To the best of the Borrower&rsquo;s knowledge after due inquiry, the Authorizations specified
in Annex B (<I>Borrower/Transaction Authorizations</I>) are all the Authorizations (other than Authorizations that are of a routine nature
and are obtained in the ordinary course of business) needed by each of the Obligors and each of their respective Subsidiaries to (i) conduct
its business and carry out the Expansion Program, except for any authorization (x) the absence of which is being contested in good faith
or (y) that is being renewed in the ordinary course in accordance with applicable law; and (ii) comply with its obligations under this
Agreement and each of the other IFC Financing Documents to which it is a party, and those Authorizations have all been obtained and are
in full force and effect;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>[Reserved]</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Immunity</U>. Neither the Obligors nor any of their respective Subsidiaries nor any of their respective property enjoys any
right of immunity from set&#45;off, suit or execution with respect to their respective assets or their respective obligations under any
IFC Financing Document;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Disclosure</U>. The information provided by the Obligors to IFC relating to the Obligors, their respective Subsidiaries and
the Expansion Program was and continues to be true and accurate in all material respects and does not contain any information which is
misleading in any material respect nor does it omit any information the omission of which makes the information contained in it misleading
in any material respect;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Financial Condition</U>. Since December 31, 2023, neither of the Obligors nor any of their respective Subsidiaries has suffered
any change that had a Material Adverse Effect;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Financial Statements</U>. The Consolidated and unconsolidated financial statements of the Obligors for the period ending on
December 31, 2023:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">have been prepared in accordance with the Accounting Standards, and give a true and fair view of the financial
condition of each of the Obligors and their respective Subsidiaries as of the date as of which they were prepared and the results of the
operations of each of the Obligors and their respective Subsidiaries during the period then ended; and</TD></TR></TABLE>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">disclose all liabilities (contingent or otherwise) of each Obligor and the reserves, if any, for such
liabilities (<I>provided</I> that Non-Material Liabilities are not required to be individually disclosed therein);</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Employee Benefit Plans</U>. Each of the Obligors is in compliance in all material respects with its respective obligations relating
to all employee benefit plans established, maintained or contributed to by it under and as required by applicable law, and does not have
outstanding any liabilities, in an amount equal to or exceeding in the aggregate, with respect to any such employee benefit plan, five
million Reais (R$5,000,000);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Title to Assets and Permitted Liens</U>. (i) Each of the Obligors has good and marketable title to all of the assets purported
to be owned by it and possesses a valid leasehold interest in all assets which it purports to lease, in all cases free and clear of all
Liens, other than Permitted Liens, and no contracts or arrangements, conditional or unconditional, exist for the creation by any of the
Obligors of any Lien, and (ii) all the Investments in an amount equal to or exceeding ten million Reais (R$10,000,000) of each of the
Obligors and their respective Subsidiaries are set forth in Annex C (<I>Investments</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Financial Debt</U>. Annex D (<I>Financial Debt</I>) (which may be updated in writing at least ten (10) Brazil and Washington
Business Days prior to each proposed date of Disbursement to include any Financial Debt incurred in accordance with this Agreement since
the most recently delivered Annex D) sets forth all Financial Debt of each of the Obligors and their respective Subsidiaries with an individual
amount equal to or exceeding forty million Reais (R$40,000,000), and there exists no outstanding default&nbsp;thereunder;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Taxes</U>. Except as disclosed in Annex Q (<I>Litigation; Disputed Taxes</I>), all tax returns and reports of the Obligors and
their respective Subsidiaries required by law to be filed have been duly filed (except where such non filing is inadvertent, has no material
consequences and will <FONT STYLE="background-color: white">be promptly remedied)</FONT> and all Taxes, obligations, fees and other governmental
charges upon each of the Obligors and their respective Subsidiaries, or their respective properties, income or assets, which are due and
payable or to be withheld, have been paid or withheld, other than payments or withholdings of immaterial amounts and those presently payable
without penalty or interest. All tax proceedings disclosed in Annex Q (<I>Litigation; Disputed Taxes</I>) are currently being contested
in good faith by appropriate proceedings and the Obligors have made or provide adequate reserves, guarantees or judicial deposits in connection
thereto, all in accordance with the Accounting Standards;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Litigation</U>. Except as disclosed in Annex Q (<I>Litigation; Disputed Taxes</I>), neither the Obligors nor any of their respective
Subsidiaries is engaged in nor, to its knowledge, threatened by, any litigation, arbitration or administrative proceedings, the outcome
of which, if adversely determined, could reasonably be expected to have a Material Adverse Effect. Any unfavorable final judgments on
the Declaratory Action of Constitutionality No. 81/2022 filed by the Brazilian National Association of Private Universities before the
Brazilian Supreme Court and the Direct Action to Render Unconstitutionality No. 7187/2022 filed by the Council of Brazilian University
Deans before the Brazilian Supreme Court could not reasonably be expected to have a Material Adverse Effect;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compliance with Law</U>.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">To the best of its knowledge and belief, after due inquiry, neither the Obligors nor any of their respective
Subsidiaries is in violation of any statute or regulation of any Authority in connection with the conduct of its respective business or
ownership of its respective property, except in such instances in which (a) such violation is being contested in good faith by appropriate
proceedings diligently</TD></TR></TABLE>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 1.5in; text-align: justify">conducted or is being remedied as per any decision
by or a compromise with a competent Authority or court, and in respect of which, where relevant, it has made adequate reserves or (b)
the failure to comply therewith, either individually or in the aggregate, could not reasonably be expected to have a Material Adverse
Effect;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">No judgment or order in an amount equal to or exceeding, individually, five million Reais (R$5,000,000)
or in the aggregate, fifty million Reais (R$50,000,000) has been issued which has or could reasonably be expected to have a Material Adverse
Effect.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(p)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Environmental Matters</U>.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">To the best of its knowledge and belief, after due inquiry, as of the date of this Agreement, there are
no material environmental or social risks or issues in respect of any of the Obligors&rsquo; Operations or any of their respective Subsidiaries&rsquo;
Operations other than those identified in the E&amp;SA;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">None of the Obligors nor any of their respective Subsidiaries has received nor is aware of (i) any existing
or threatened material complaint, order, directive, claim, citation or notice from any Authority or (ii) any material written communication
from any Person, in either case, concerning its Operations&rsquo; failure to comply with any matter covered by the Performance Standards
which has, or could reasonably be expected to have, a Material Adverse Effect or any material impact on the implementation or operation
of its Operations in accordance with the Performance Standards;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(q)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Labor Matters</U>. There are no ongoing or, to the best knowledge of each Obligor after due inquiry, threatened, material strikes,
slowdowns or work stoppages by employees of any of the Obligors or any of their respective Subsidiaries;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(r)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Use of Proceeds</U>. The proceeds of the Loan shall be utilized to finance the Expansion Program;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(s)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Subsidiaries</U>. The entities listed on Annex A (<I>Subsidiaries</I>) are the only Subsidiaries of the Obligors and Annex A
(<I>Subsidiaries</I>) correctly sets forth, as of the date hereof and the date of the first Disbursement, (i) the percentage ownership
(direct and indirect) of each of the Borrower and the Parent Company Guarantor in each class of capital stock of each of its respective
Subsidiaries, and the direct owner thereof and (ii) the percentage ownership (direct and indirect) of each holder in each class of capital
stock of the Obligors and the direct owner thereof;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(t)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law and Enforcement</U>. The choice of New York law as the governing law of the IFC Financing Documents which purport
to be governed thereby will be recognized and enforced in the Country. Any judgment obtained in New York in relation to an IFC Financing
Document will be recognized and enforced in the Country, <I>provided</I> that such judgment has been previously recognized by the Superior
Court of Justice of Brazil (<I>Superior Tribunal de Justi&ccedil;a</I>) in the form provided in its internal regulations;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(u)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Sanctionable Practices</U>. Neither of the Obligors nor any of their respective Subsidiaries, nor any of their respective Affiliates,
nor any Person acting on its or any of their behalf, has committed or engaged in, with respect to any of the Obligors&rsquo; Operations
or any transaction contemplated by this Agreement, any Sanctionable Practice;</P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <U>UN Security Council Resolutions</U>. Neither the Obligors nor any of their respective Subsidiaries has entered into any transaction
nor engaged in any activity prohibited by any resolution of the United Nations Security Council under Chapter VII of the United Nations
Charter; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(w)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Material Omissions</U>. None of the representations and warranties in this Section&nbsp;3.01 omits any matter the omission
of which makes any of such representations and warranties misleading.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 3.02<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>IFC Reliance</U></I>. The Borrower acknowledges that it makes the representations and warranties in Section 3.01 (<I>Representations
and Warranties</I>) with the intention of inducing IFC to enter into this Agreement and the other IFC Financing Documents (and the Participants
to enter into the Participation Agreement) and that IFC enters into this Agreement and the other IFC Financing Documents (and the Participants
will enter into the Participation Agreement) on the basis of, and in full reliance on, each of such representations and warranties.</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center; text-indent: 0in">ARTICLE IV<BR>
Conditions of Disbursement</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.01<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Conditions of First Disbursement</U>.</I> The obligation of IFC to make the first Disbursement is subject to the fulfillment
prior to or concurrently with the making of that first Disbursement of the following conditions:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>IFC Financing Documents</U>. Each IFC Financing Document, in form and substance satisfactory to IFC, have been entered into
by all parties to them and have become (or, as the case may be, remain) unconditional and fully effective in accordance with their respective
terms (except for this Agreement having become unconditional and fully effective, if that is a condition of any of those agreements),
and IFC has received a copy of each of those agreements to which it is not a party;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certificate of Incumbency and Authority</U>. IFC has received a Certificate of Incumbency and Authority from each of the Obligors,
in the form of Schedule 1 (<I>Form of Certificate of Incumbency and Authority</I>), dated the date of the first Disbursement, together
with copies of (as applicable) the Charter as in effect on the date thereof, certificate of registration of exempted company, by-laws,
statutory registers, certificate of good standing, resolutions and powers of attorney referred to in such Certificate of Incumbency and
Authority, including, without limitation, resolutions of the Borrower and of each of the Subsidiary Guarantors approving the execution
of the IFC Financing Documents, duly filed (<I>i.e.</I>, <I>protocolados</I>) with the appropriate Board of Trade (<I>Junta Comercial</I>)
in the Country, and all of the foregoing shall be in form and substance satisfactory to IFC;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Authorizations</U>. The Borrower has obtained or has caused the Obligors to obtain and has provided to IFC copies of, all Authorizations
listed in Annex B (<I>Borrower/Transaction Authorizations</I>), and such other Authorizations that may become necessary for:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the Loan;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the due execution, delivery, validity and enforceability of, and performance by each of the Obligors of
their respective obligations under this Agreement and the other IFC Financing Documents, and any other documents necessary or desirable
to the implementation of any of those agreements or documents; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">the remittance to IFC or its assigns in Dollars of all monies payable with respect to the IFC Financing
Documents;</TD></TR></TABLE>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">and all those Authorizations are
in full force and effect;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Legal Opinions</U>. IFC has received a legal opinion (i) from Mello Torres Advogados and concurred in by counsel for the Obligors
covering the topics listed in Schedule 4 (<I>Matters to be Covered in Local Counsel Legal Opinion</I>) and such other Brazilian law matters
relating to the transactions contemplated by this Agreement as IFC may reasonably request, and (ii) from Walkers (Cayman) LLP covering
such Cayman law matters relating to the transactions contemplated by this Agreement as IFC may reasonably request;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Insurance</U>. IFC has received copies of all insurance policies required to be obtained pursuant to Section 5.04 (<I>Insurance</I>)
and Annex F (<I>Insurance Requirements</I>).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fees</U>. IFC has received the fees which Section 2.07 (<I>Fees</I>) requires to be paid before the date of the first Disbursement
and all other amounts then due under this Agreement;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Legal Fees and Expenses</U>. IFC has received the reimbursement of all invoiced fees and expenses of IFC&rsquo;s counsel as
provided in Section 2.14(b)(i) (<I>Expenses</I>) or confirmation that those fees and expenses have been paid directly to that counsel;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Authorization of Auditors</U>. IFC has received a copy of the authorization to the Auditors referred to in Section 5.01(f) (<I>Affirmative
Covenants</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Solvency</U>. IFC has received a solvency certificate in the form of Schedule 5 (<I>Form of Solvency Certificate</I>) from the
chief financial officer of each of the Obligors;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Appointment of Process Agent</U>. The Borrower has delivered to IFC evidence, substantially in the form of Schedule 6 (<I>Form
of Service of Process Letter</I>), of appointment by each Obligor of the Process Agent pursuant to Section 7.05 (<I>Applicable Law and
Jurisdiction</I>), and Section 7.05 of the Parent Company Guarantee Agreement and Section 7.05 of the Subsidiary Guarantee Agreement;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Environmental Matters</U>. The Borrower has completed and delivered to IFC an Action Plan and is in compliance with such Action
Plan;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>BCB Report</U>. The Borrower has delivered to IFC evidence, in form and substance satisfactory to IFC, that the BCB Report has
been properly filed in a timely manner and remains in full force and effect; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>SPO Assessment</U>. The Borrower has delivered to IFC the SPO Assessment, in form and substance satisfactory to IFC.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.02<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Conditions of All Disbursements</U></I>. The obligation of IFC to make any Disbursement, including the first Disbursement,
is also subject to the conditions that:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Default</U>. No Event of Default and no Potential Event of Default has occurred and is continuing;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Use of Proceeds</U>. The proceeds of that Disbursement are, at the date of the relevant request, needed by the Borrower for
the purposes described in Section 3.01(r) (<I>Use of Proceeds</I>), or will be used solely for that purpose within three (3) months of
that date; and are not in reimbursement of, or to be used for, expenditures in the territories of any country that is not a member of
the World Bank or for goods produced in or services supplied from any such country;</P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <U>No Material Adverse Effect</U>. Since December 31<SUP>st</SUP>, 2023, nothing has occurred which has or could reasonably be
expected to have a Material Adverse Effect;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Material Loss or Liability</U>. Since December 31<SUP>st</SUP>, 2023, the Obligors and their respective Subsidiaries have
not incurred any material loss or liability (except such liabilities as may be incurred in accordance with Section 5.02 (<I>Negative Covenants</I>));</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Representations and Warranties</U>. The representations and warranties made in Article&nbsp;III are true and correct in all
material respects on and as of the date of that Disbursement with the same effect as if those representations and warranties had been
made on and as of the date of that Disbursement (but in the case of Section 3.01(c) (<I>Representations and Warranties</I>), without the
words in parentheses);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Legal Opinions</U>. IFC has received (if it so reasonably requires in connection with any Disbursement requested after the first
Disbursement) a legal opinion or opinions in form and substance satisfactory to IFC, of IFC&rsquo;s counsel in the Country, and, if requested
by IFC, concurred in by counsel for the Borrower, with respect to any matters relating to the fulfillment and/or satisfaction of the conditions
set forth herein for such Disbursement, changes in law, and compliance with regulatory, environmental, social, integrity or compliance
matters;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Violations</U>. After giving effect to that Disbursement, none of the Obligors would be in violation of:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">its Charter, other than non-material lapses or oversights in the implementation of the Charter;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">any provision contained in any material agreement to which it is a party (including this Agreement) or
by which it is bound; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">any law, rule, regulation, Authorization or agreement or other document binding on it directly or indirectly
limiting or otherwise restricting its borrowing or guarantee power or authority or its ability to borrow or guarantee;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Financial Ratios</U>. (Without limiting the generality of Section 4.02(g) (<I>Conditions of all Disbursements</I>)), after taking
into account the amount of that Disbursement and any other Long-term Debt incurred by the Borrower after the date of the latest financial
statements of the Borrower delivered to IFC pursuant to Section 5.03(a) (<I>Quarterly Financial Statements and Reports</I>), the Parent
Company Guarantor is in compliance with the financial covenant set forth in Section 5.01(m) (<I>Financial Ratios</I>) on a Pro Forma Basis;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Environmental Matters</U>. The Borrower has satisfied all conditions specified in the Action Plan as conditions for the applicable
Disbursement; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Promissory Notes</U>. IFC has received seven (7) Principal Promissory Notes and one (1) Interest Promissory Note with respect
to such Disbursement, in accordance with Section 2.16 (<I>Promissory Notes</I>) and in form and substance satisfactory to IFC.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.03<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Borrower&rsquo;s Certification</U></I>. The Borrower shall deliver to IFC with respect to each request for Disbursement:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>certifications, in the form included in Schedule 2 (<I>Form of Request for Disbursement</I>), relating to the conditions specified
in Section 4.02 (<I>Conditions of All Disbursements</I>) (other than the</P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify">condition in Section 4.02(g)) expressed to be effective
as of the date of that Disbursement, and in the case of Section 4.02(d), also certified by the Auditors if IFC so requires; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>such evidence as IFC may reasonably request of the proposed utilization of the proceeds of that Disbursement or the utilization
of the proceeds of any prior Disbursement.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 4.04<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Conditions for IFC Benefit</U></I>. The conditions in Section&nbsp;4.01 through Section&nbsp;4.04 are for the benefit of
IFC and may be waived only by IFC in its sole discretion.</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center; text-indent: 0in">ARTICLE V<BR>
Particular Covenants</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 5.01<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Affirmative Covenants</U></I>. Unless IFC otherwise agrees in writing, the Borrower shall (and shall cause each of its Subsidiaries
to):</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Corporate Existence; Conduct of Business</U>. (i) Maintain its and its Subsidiaries&rsquo; existence except (1) as permitted
under Section 5.02(p) (<I>Asset Sales</I>) or (2) if any Subsidiary is wound up, liquidated or dissolved pursuant to a Borrower Permitted
Merger; and (ii) keep in full force and effect its material rights, franchises, licenses, permits, copyrights, trademarks and patents,
and (iii) comply with its Charter, conduct its Operations with due diligence and efficiency and in accordance with sound industry, financial
and business practices;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Use of Proceeds; Compliance with Law</U>. Apply the proceeds of the Loan exclusively as set forth in Section 3.01(r) (<I>Use
of Proceeds</I>), comply in all material respects (or, in the case of Applicable E&amp;S Law, in all respects) with all applicable law,
statutes, regulations and orders of, and all applicable restrictions imposed by, all Authorities in respect of its Operations and the
ownership of its property (including applicable law, statutes, regulations, orders and restrictions relating to environmental standards
and controls), <FONT STYLE="background-color: white">except in such instances in which such non-compliance is being contested in good
faith by appropriate proceedings diligently conducted or is being remedied as per any </FONT>decision by or a compromise with <FONT STYLE="background-color: white">a
competent Authority or court, and in respect of which, where relevant, it has made adequate reserves</FONT>;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Accounting and Financial Management</U>. Maintain an accounting and control system, management information system and books
of account and other records, which together adequately reflect truly and fairly the financial condition of the Borrower and its Subsidiaries
and the results of their respective operations in conformity with the Accounting Standards;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Taxes</U>. Pay and discharge, all taxes, assessments and governmental charges or levies imposed upon it or upon its income or
profits or upon any properties belonging to it; <U>provided</U> that neither the Borrower nor any of its Subsidiaries shall be required
to pay any such tax, assessment, charge, levy or claim which is being contested in good faith and by proper proceedings if it has maintained
adequate reserves with respect thereto in accordance with the Accounting Standards;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Auditors</U>. Maintain at all times a firm of Acceptable Auditors as auditors of the Borrower and, if and when required under
the Accounting Standards for purposes of preparing Consolidated financial statements, the Subsidiaries;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Authorization to Auditors</U>. Irrevocably authorize, in the form of Schedule 7 (<I>Form of Letter to Borrower&rsquo;s Auditors</I>),
the Auditors (whose fees and expenses shall be for the account of the Borrower) to communicate directly with IFC (copying the Borrower
in any written communication) at any time regarding the Borrower&rsquo;s or any of its Subsidiary&rsquo;s accounts and operations, and
provide to IFC a copy of</P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify">that authorization, and, no later than 30 days after
any change in Auditors, issue a similar authorization to the new Auditors and provide a copy thereof to IFC;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>CAO Access</U>. Upon written request from IFC, permit representatives of IFC and the CAO, during normal business hours, to:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">visit any of the sites and premises where the business of the Borrower or any of its Subsidiaries is conducted;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">inspect any sites, facilities, plants and equipment of the Borrower and any of its Subsidiaries;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(C)</TD><TD STYLE="text-align: justify">have access to the books of account and all records and any of its Subsidiaries (including electronic
and hard copy files); and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(D)</TD><TD STYLE="text-align: justify">have access to those employees, agents, contractors and subcontractors of the Borrower and any of its
Subsidiaries who have or may have knowledge of matters with respect to which IFC or CAO seeks information;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 0.5in; text-align: justify">in each case, subject to any applicable laws
and regulations, so long as no Potential Event of Default or Event of Default has occurred and is continuing, upon five (5) Brazil Business
Days&rsquo; prior notice; <I>provided</I> that such access shall be for the purpose of carrying out the CAO&rsquo;s role under the CAO
Policy, and provided further that in carrying out its work, the CAO may disclose information gathered during its activities, subject to
the provisions and requirements of the AIP and of the CAO Policy;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Social &amp; Environmental Requirements</U>. Undertake its respective Operations in compliance with (i) all Applicable E&amp;S
Law, (ii) the Action Plan and (iii) the Performance Standards;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Annual Monitoring Report</U>. (i) Annually review the form of the Annual Monitoring Report and, following such review, (ii)
consult with IFC as to whether revision of the form is necessary or appropriate in light of changes to the Borrower&rsquo;s or its Subsidiaries&rsquo;
Operations, or in light of environmental or social risks identified by the Borrower&rsquo;s E&amp;S Management System; and (iii) revise
the form, if necessary or appropriate, as agreed with IFC;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>E&amp;S Management System</U>. Ensure the continuing operation of the E&amp;S Management System to assess and manage environmental
and social performance of the Borrower&rsquo;s and its Subsidiaries&rsquo; Operations in compliance with (i) all Applicable E&amp;S Law,
(ii) the Action Plan, and (iii) the Performance Standards in all material respects;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Authorizations</U>. (i) obtain and maintain in force (and where appropriate, renew in a timely manner) all Authorizations,
including without limitation the Authorizations specified in Annex B (<I>Borrower/Transaction Authorizations</I>), which are necessary
for the implementation of the Expansion Program, the carrying out of the business and Operations of the Borrower and its Subsidiaries
generally and the compliance by the Borrower and its Subsidiaries with all their respective obligations under the IFC Financing Documents,
except with respect to Authorizations that relate to the Borrower&rsquo;s and its Subsidiaries&rsquo; Operations which (A) are being contested
in good-faith pursuant administrative or judicial proceedings, or (B) are in the process of being timely renewed under the applicable
law, <I>provided</I> that (1) any Authorization that is required for the continuation of the Operations of the Borrower and any of its
Subsidiaries in the ordinary course of business shall be maintained in effect during any renewal process and</P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify">(2) no Material Adverse Effect could reasonably be
expected to occur during or as a result of, the pendency of such renewal of any such Authorization; and</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">comply in all material respects with all the conditions and restrictions contained in, or imposed on the
Borrower or any of its Subsidiaries by, those Authorizations;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Pension Plans</U>. Comply with all material requirements relating to any pension or employee benefit plans, pursuant to and
in accordance with applicable law;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Financial Ratios</U>. With respect to the Parent Company Guarantor, maintain as of the last day of each quarter of each Financial
Year an Adjusted Net Debt to EBITDA Ratio of not more than 3.0x, on a Consolidated Basis; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Aggregate EBITDA Amount; Additional Subsidiary Guarantor</U>. (i)&nbsp;Ensure that as of June 30th and December 31st of each
Financial Year, the Aggregate EBITDA Amount for the relevant Calculation Period is at least equal to the EBITDA Threshold; and</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">If on any relevant day of calculation, the Aggregate EBITDA Amount for the Calculation Period is less
than the EBITDA Threshold, then the Borrower shall cause one or more of its Subsidiaries to become Subsidiary Guarantors by signing a
Subsidiary Guarantor Adherence Instrument within thirty (30) days of the relevant day of calculation so as to ensure that the Aggregate
EBITDA Amount, calculated upon such Subsidiaries becoming Subsidiary Guarantors on a Pro Forma Basis, is at least equal to the EBITDA
Threshold for such relevant day of calculation.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 5.02<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Negative Covenants</U></I>. Unless IFC otherwise agrees in writing, the Borrower shall not, and shall cause each of its Subsidiaries
not to:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Restricted Payments</U>. Declare or pay any Restricted Payment, except that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">any Subsidiary of the Borrower may declare and pay Restricted Payments to the Borrower or to any wholly-owned
Subsidiary of the Borrower<B>;</B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">any partially-owned Subsidiary may declare and pay Restricted Payments to its stockholders, <U>provided</U>
that the Borrower and its Subsidiaries must receive at least their proportionate share of any Restricted Payments paid by such Subsidiary;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may declare and pay cash dividends or interest on own capital (<I>juros
sobre capital pr&oacute;prio</I>) expressly required to be paid under applicable law; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">the Borrower may declare and pay Restricted Payments if, at the time of and after giving effect to such
Restricted Payment (i) no Potential Event of Default or Event of Default shall have occurred and be continuing or would result therefrom,
(ii) the Parent Company Guarantor is in compliance with the financial covenant set forth in Section 5.01(m) (<I>Financial Ratios</I>)
and the corresponding section of the Parent Company Guarantee Agreement, on a Pro Forma Basis, and (iii) such Restricted Payment is made
out of retained earnings or such other reserve account(s) permitted or required under the Country&rsquo;s applicable laws or applicable
Accounting Standards;</TD></TR></TABLE>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <U>Permitted Financial Debt</U>. Incur, assume or permit to exist any Financial Debt except:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the Loan;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">Financial Debt in existence as of the date hereof, <I>provided</I> that the Parent Company Guarantor is
in compliance with the financial covenant set forth in Section 5.01(m) (<I>Financial Ratios</I>) and the corresponding section of the
Parent Company Guarantee Agreement, on a Pro Forma Basis;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">intercompany Financial Debt between or among the Obligors and any of their respective Subsidiaries;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">Permitted Refinancing Debt incurred by the Borrower or any of its Subsidiaries issued in exchange for,
or the net proceeds of which are used to renew, refund, refinance, replace, defease or discharge other Financial Debt (other than intercompany
Financial Debt) otherwise permitted by this Agreement; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">Financial Debt of the Borrower and its Subsidiaries if, after giving effect to the incurrence thereof
on a Pro Forma Basis, no Potential Event of Default or Event of Default then exists or would result therefrom;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Leases</U>. Enter into any agreement or arrangement to lease any property or equipment of any kind (other than Financial Leases)
if after giving effect to the incurrence thereof, a Potential Event of Default or Event of Default would exist, except (i) such existing
agreements or arrangements as disclosed in Annex R (<I>Leases</I>), or (ii) any renewal or amendment to any such existing agreements or
arrangements listed in Annex R (<I>Leases</I>);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Derivative Transactions</U>. Enter into any Derivative Transaction or assume the obligations of any party to any Derivative
Transaction, except for hedging purposes in the ordinary course of business;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Guarantees and Other Obligations</U>. Except as permitted pursuant to Section 5.02(b) (<I>Permitted Financial Debt</I>), enter
into any agreement or arrangement to guarantee or, in any way or under any condition, assume or become obligated for all or any part of
any financial or other obligation of another Person (other than (i) the Borrower and its Subsidiaries and (ii) members of the management
of the Borrower, so long as, for item (ii), the Parent Company Guarantor is in compliance with the financial covenant set forth in Section
5.01(m) (<I>Financial Ratios</I>) and the corresponding section of the Parent Company Guarantee Agreement, on a Pro Forma Basis and no
Event of Default or Potential Event of Default has occurred), except in an aggregate amount outstanding at any time equal to not more
than one million Reais (R$1,000,000);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Permitted Liens</U>. Create or permit to exist any Lien on any property, revenues or other assets, present or future, of the
Borrower or any of its Subsidiaries, except for the following (collectively, &ldquo;<B>Permitted Liens</B>&rdquo;):</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Liens in existence on the date hereof which are listed, and the property subject thereto described, in
Annex E (<I>Existing Liens</I>), without giving effect to any extensions or renewal thereof;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">Liens to secure Financial Debt provided by: (1) any multilateral development bank or foreign government-sponsored
agency; (2) any entity that sub-lends funds provided by such multilateral development bank or foreign government-sponsored</TD></TR></TABLE>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 1.5in; text-align: justify">agency; (3) Banco Nacional de Desenvolvimento
Econ&ocirc;mico e Social - BNDES (including loans from Financiadora de Estudos e Projetos - FINEP) or Caixa Econ&ocirc;mica Federal -
CEF; or (4) any other Brazilian governmental development bank or credit agency, or Brazilian federal or state governmental Authority that
provides financing for similar purposes; <I>provided</I> that any such Financial Debt is permitted pursuant to Section 5.02(b) (<I>Permitted
Financial Debt</I>);</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">Liens to secure Financial Debt incurred by the Borrower to acquire a portion or all of the share capital
of any entity that, by virtue of such share purchase transaction, becomes its Subsidiary, <I>provided</I> that any such Financial Debt
is permitted pursuant to Section 5.02(b) (<I>Permitted Financial Debt</I>);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">any Lien arising from any tax, assessment or other governmental charge or other Lien arising by operation
of law (including statutory lien obligations), in each case if the obligation underlying any such Lien is not yet due or, if due, is being
contested in good faith by appropriate proceedings so long as:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">those proceedings do not involve any substantial danger of the sale, forfeiture or loss of any material
asset(s), title thereto or any interest therein, nor interfere in any material respect with the use or disposition thereof or otherwise
materially interfere with the implementation of the Expansion Program or the carrying on of the business or Operations of the Borrower
and its Subsidiaries; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">the Borrower has set aside adequate reserves sufficient to promptly pay in full any amounts that the Borrower
may be ordered to pay on final determination of any such proceedings;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">Liens arising from judgments, decrees or attachments in circumstances not constituting an Event of Default
under Section 6.02(m) (<I>Judgments</I>) or Section 6.02(h) (<I>Attachment</I>); and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">easements, rights-of-way, restrictions, encroachments and other similar charges or encumbrances, and minor
title deficiencies, in each case not securing Financial Debt and not materially interfering with the conduct of the business and Operations
of the Borrower or any of its Subsidiaries;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">provided that the aggregate value
of the assets subject to Permitted Liens under subclauses (i), (ii), and (iii) of this Section 5.02(f) shall not, at any time, represent
more than fifteen percent (15%) of the Parent Company Guarantor&rsquo;s Consolidated Assets;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Arm&rsquo;s Length Transactions</U>. Enter into any transaction with Related Parties except on the basis of arm&rsquo;s length
arrangements (including, without limitation, transactions whereby the Borrower or a Subsidiary might pay more than the ordinary commercial
price for any purchase or might receive less than the full ex-works commercial price (subject to normal trade discounts) for its products);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Profit Sharing Arrangements</U>. Enter into any partnership, profit&#45;sharing or other similar arrangement whereby more than
ten percent (10%) of the Parent Company Guarantor&rsquo;s Consolidated income is shared with any other Person, other than a Parent Company
Guarantor&rsquo;s Subsidiary;</P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <U>Management Contracts</U>. Enter into any management contract or similar arrangement whereby, on any date of determination,
more than twenty percent (20%) of the Consolidated gross revenue of the Parent Company Guarantor, for the twelve-month period ended on
the date of the most recent financial statements delivered by the Borrower to IFC in accordance with Section 5.03 (<I>Reporting Requirements</I>),
are managed by any other Person, other than a Parent Company Guarantor&rsquo;s Subsidiary;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Permitted Investments</U>. Make or permit to exist loans or advances to, or deposits (except commercial bank deposits in the
ordinary course of business) with, other Persons or investments in any Person or enterprise (each of the foregoing an &ldquo;<U>Investment</U>&rdquo;
and, collectively, &ldquo;<U>Investments</U>&rdquo;) other than the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may acquire and hold accounts receivable owing to any of them, if created
or acquired in the ordinary course of business and payable or dischargeable in accordance with customary trade terms of the Borrower or
such Subsidiary;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may acquire and hold cash and cash equivalents;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may hold the Investments held by them on the date hereof and described
on Annex C (<I>Investments</I>), provided that any additional Investments made with respect thereto shall be permitted only if permitted
under the other provisions of this Section 5.02(j);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may acquire and own investments (including debt obligations) received
in connection with the bankruptcy or reorganization of suppliers and customers and in good faith settlement of delinquent obligations
of, and other disputes with, customers and suppliers arising in the ordinary course of business;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may make loans and advances to their officers and employees in the ordinary
course of business;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">the Borrower may enter into a Derivative Transaction or assume the obligations of any party to a Derivative
Transaction to the extent permitted by Section 5.02(d) (<I>Derivative Transactions</I>);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vii)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may make intercompany loans and advances to any Subsidiary to the extent
permitted by Section 5.02(b)(ii); <I>provided</I> that no Potential Event of Default or Event of Default has occurred and is continuing;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(viii)</TD><TD STYLE="text-align: justify">the Borrower and any Subsidiary may make capital contributions to, or acquire equity interests of, any
Subsidiary; <U>provided</U> that (A) no capital contribution, or equity interest acquisition may be made pursuant to this clause (viii)
at any time that an Event of Default or Potential Event of Default has occurred and its continuing, (B) after such capital contribution
or acquisition of equity interest the Aggregate EBITDA Amount is at least equal to the EBITDA Threshold or the Borrower takes such actions
as shall be necessary to comply with Section 5.01(n)(ii) (<I>Aggregate EBITDA Amount; Additional Subsidiary Guarantor</I>), and (C) any
Investment made in or to any Subsidiary pursuant to this clause (viii) shall cease to be permitted hereunder if such Subsidiary ceases
to constitute a Subsidiary of the Borrower or any of its Subsidiaries;</TD></TR></TABLE>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ix)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may create, form or establish Subsidiaries so long as at the time such
Subsidiaries are created the Aggregate EBITDA Amount is at least equal to the EBITDA Threshold or the Borrower takes such actions as shall
be necessary to comply with Section 5.01(n)(ii) (<I>Aggregate EBITDA Amount; Additional Subsidiary Guarantor</I>);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(x)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may make a Permitted Acquisition so long as:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">no Event of Default or Potential Event of Default shall have occurred at the time of, or after giving
effect to, such Permitted Acquisition;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">calculations made by the Borrower and the Parent Company Guarantor with respect to the financial covenant
set forth in Section 5.01(m) (<I>Financial Ratios</I>) and the corresponding section of the Parent Company Guarantee Agreement for the
respective Calculation Period on a Pro Forma Basis show that such financial covenant would have been complied with as if such Permitted
Acquisition had occurred on the first day of such Calculation Period; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(C)</TD><TD STYLE="text-align: justify">at the time of such Permitted Acquisition, the Aggregate EBITDA Amount for the most recent Calculation
Period (i) is at least equal to the EBITDA Threshold or (ii) will be at least equal to the EBITDA Threshold if the target company of such
Permitted Acquisition were a Subsidiary Guarantor, in which case the Borrower shall cause such target company to become a Subsidiary Guarantor
within thirty (30) days of such target company becoming a Subsidiary;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(xi)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may receive and hold promissory notes and other non-cash consideration
received in connection with any asset sale permitted by Section 5.02(p) (<I>Asset Sales</I>);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(xii)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may make advances in the form of a prepayment of expenses to vendors,
suppliers and trade creditors, so long as such expenses were incurred in the ordinary course of business of the Borrower or such Subsidiary;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(xiii)</TD><TD STYLE="text-align: justify">in addition to Investments permitted by clauses (i) through (xii) of this Section 5.02(j), the Borrower
and its Subsidiaries may make additional loans, advances and other Investments to or in a Person for all loans, advances and other Investments
made pursuant to this clause (xiii) (determined without regard to any write-downs or write-offs thereof), net of cash repayments of principal
in the case of loans, sale proceeds in the case of Investments in the form of debt instruments and cash equity returns (whether as a distribution,
dividend, redemption or sale) in the case of equity investments, not to exceed, as of any date of calculation and on an aggregate basis,
the equivalent of fifteen percent (15%) of the Parent Company Guarantor&rsquo;s Consolidated Assets;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fundamental Changes</U>. Change (i) its Charter in any manner which would be inconsistent with the provisions of any IFC Financing
Document; or (ii)&nbsp;change its Financial Year;</P>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <U>Amendments, Waivers, Etc. of Material Agreements</U>. Terminate, amend or assign or agree to any termination, amendment or
assignment of any IFC Financing Document without IFC&rsquo;s consent;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Prepayment of Financial Debt</U>. Make any voluntary, optional or mandatory prepayment of or repurchase or reacquire for value
any Financial Debt (other than the Loan) pursuant to any provision of any agreement or note with respect to that Financial Debt unless
(i) no Event of Default or Potential Event of Default has occurred and (ii) after giving effect to such prepayment, repurchase or reacquisition
the Parent Company Guarantor continues to be in compliance with the financial covenant set forth in Section 5.01(m) (<I>Financial Ratios</I>)
and the corresponding section of the Parent Company Guarantee Agreement, on a Pro Forma Basis;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Nature of Business</U>. (A) Engage directly or indirectly in any line of business other than (i) the businesses engaged in by
the Obligors and their respective Subsidiaries as of the date hereof and (ii) non-material changes to any such lines of business and (iii)
new line(s) of businesses reasonably related, ancillary, complementary or incidental thereto or representing a reasonable expansion thereof;
or (B) engage in any business or own any significant assets or have any material liabilities relating to any Prohibited Activity;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Winding Up, Liquidation, Merger or Consolidation</U>. Wind up, liquidate or dissolve its affairs or enter into any partnership,
joint venture or transaction of merger or consolidation, except that (i) any Subsidiary of the Borrower (other than a Subsidiary Guarantor)
may merge or consolidate with and into, or be dissolved or liquidated into, the Borrower or any wholly-owned Subsidiary of the Borrower,
so long as the Borrower or such wholly-owned Subsidiary of the Borrower is the surviving or continuing entity of any such merger, consolidation,
dissolution or liquidation (including, for the avoidance of doubt, as part of any internal corporate reorganization involving any Subsidiary
of the Borrower) and (ii) any Subsidiary of the Borrower (other than a Subsidiary Guarantor) that represents two percent (2%) or less
of the Parent Company Guarantor&rsquo;s Consolidated Assets may be wound up, liquidated or dissolved, (any such merger, consolidation,
dissolution, liquidation or winding up a &ldquo;<B>Borrower Permitted Merger</B>&rdquo;);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(p)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Asset Sales</U>. Sell, transfer, lease or otherwise dispose of all or any substantial part of its property or assets (other
than sales of inventory in the ordinary course of business), whether in a single transaction or in a series of transactions, related or
otherwise, except that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may liquidate or otherwise dispose of obsolete or worn-out property
in the ordinary course of business;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may sell assets (including the capital stock or other equity interests
of any Subsidiary), so long as (A) no Event of Default or Potential Event of Default then exists or would result therefrom, (B)&nbsp;after
giving effect to such sale, the Parent Company Guarantor is in compliance with the financial covenant set forth in Section 5.01(m) (<I>Financial
Ratios</I>) and the corresponding section of the Parent Company Guarantee Agreement, on a Pro Forma Basis, and (C) the aggregate book
value of assets disposed of by the Obligors during the term of the Loan does not exceed one hundred million Reais (R$100,000,000);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">each of the Borrower and its Subsidiaries may grant licenses, sublicenses, leases or subleases to other
Persons not materially interfering with the conduct of the business of the Borrower or any of its Subsidiaries;</TD></TR></TABLE>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">the Borrower or any Subsidiary may convey, sell or otherwise transfer all or any part of its business,
properties and assets to any of the Obligors or any of their respective Subsidiaries, provided that after giving effect to such disposition,
the Parent Company Guarantor is in compliance with the financial covenant set forth in Section 5.01(m) (<I>Financial Ratios</I>) on a
Pro Forma Basis and no Event of Default or Potential Event of Default then exist or would result therefrom; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">the Borrower and its Subsidiaries may liquidate or otherwise dispose of cash and cash equivalents in the
ordinary course of business, in each case for cash at fair market value.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(q)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Use of Proceeds</U>. Use the proceeds of any Disbursement in the territories (including overseas territories) of any country
that is not a member of the World Bank or for reimbursements of expenditures in those territories or for goods produced in or services
supplied from any such country;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(r)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendment of Action Plan</U>. Amend the Action Plan in any material respect;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(s)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Distributions from Subsidiaries</U>. Except as expressly required by applicable law, directly or indirectly, create or otherwise
cause or suffer to exist or become effective any encumbrance or restriction on the ability of any Subsidiary of the Borrower to (a) pay
dividends or make any other distributions on its capital stock or any other equity interest or participation in its profits owned by the
Borrower or any of its Subsidiaries (<I>provided</I>, for the avoidance of doubt, that no such encumbrance or restriction shall be considered
to exist if from time to time and in accordance with applicable law in effect as of such time, the amount of the minimum dividend payable
by any such Subsidiary is reduced), or to pay any Financial Debt owed to the Borrower or any of its Subsidiaries, (b) make loans or advances
to the Borrower or any of its Subsidiaries or (c) transfer any of its properties or assets to the Borrower or any of its Subsidiaries,
except for such encumbrances or restrictions existing under or by reason of (i) applicable law, (ii) the IFC Financing Documents, (iii)
customary provisions restricting subletting or assignment of any lease governing any leasehold interest of any of the Borrower&rsquo;s
Subsidiaries, (iv)&nbsp;customary provisions restricting assignment of any licensing agreement (in which any of the Borrower&rsquo;s Subsidiaries
is the licensee) or other contract entered into by any of the Borrower&rsquo;s Subsidiaries in the ordinary course of business, (v)&nbsp;restrictions
on the transfer of any asset pending the closing of the sale of such asset, and (vi)&nbsp;restrictions on the transfer of any asset subject
to a Permitted Lien;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(t)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>UN Security Council Resolutions</U>. Enter into any transaction or engage in any activity prohibited by any resolution of the
United Nations Security Council under Chapter VII of the United Nations Charter; or</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(u)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Sanctionable Practices</U>. Engage in (and neither the Borrower nor any Subsidiary shall authorize or permit any Affiliate or
any other Person acting on its behalf to engage in) with respect to its Operations or any transaction contemplated by this Agreement,
any Sanctionable Practices. The Borrower further covenants that should IFC notify the Borrower of its concerns that there has been a violation
of the provisions of this Section&nbsp;or of Section 3.01(u) (<I>Sanctionable Practices</I>) of this Agreement, it shall cooperate and
it shall cause each relevant Subsidiary to cooperate, in good faith with IFC and its representatives in determining whether such a violation
has occurred, and shall respond promptly and in reasonable detail to any notice from IFC, and shall furnish documentary support for such
response upon IFC&rsquo;s request.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 5.03<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Reporting Requirements</U></I>. Unless IFC otherwise agrees, the Borrower shall:</P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <U>Quarterly Financial Statements and Reports</U>. As soon as available but in any event within 60 days after the end of each
of the first three calendar quarters of each Financial Year, deliver to IFC:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">(1) copies of the Parent Company Guarantor&rsquo;s unaudited financial statements in a form substantially
similar to the extract of Hyperion statements for such quarter prepared, on a Consolidated Basis, on a basis consistent with the Parent
Company Guarantor&rsquo;s audited financial statements and (2) copies of the Borrower&rsquo;s unconsolidated unaudited financial statements
in a form substantially similar to the extract of Hyperion statements for such quarter on a basis consistent with the Borrower&rsquo;s
audited financial statements, in each case, in accordance with the Accounting Standards and certified, respectively, by the Parent Company
Guarantor&rsquo;s chief financial officer and the Borrower&rsquo;s chief financial officer, substantially in the form set forth in Schedule
9 (<I>Information to be Included in Quarterly and Annual Review of Operations</I>);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">a report by the Borrower on its operations during that quarter, in the form of, and addressing the topics
listed in, Schedule 9 (<I>Information to be Included in Quarterly and Annual Review of Operations</I>); and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">a report (in a form pre-agreed by IFC), signed by the Borrower&rsquo;s chief executive officer and chief
financial officer, concerning compliance with the covenants set forth in Section 5.01(m) (<I>Financial Ratios</I>) and Section 5.01(n)
(<I>Aggregate EBITDA Amount; Additional Subsidiary Guarantor</I>) of this Agreement (using the methodology of calculation in respect of
such covenants set forth in Annex H (<I>Methodology for Financial Ratio Calculations</I>));</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Annual Financial Statements and Reports</U>. As soon as available but in any event within 90 days after the end of each Financial
Year, deliver to IFC:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">copies of its complete and audited Consolidated financial statements for that Financial Year (which are
in agreement with its books of account and the consolidating financial statements of its Subsidiaries, in accordance with the Accounting
Standards, together with an unqualified audit report on them from the Auditors; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">a report by the Borrower&rsquo;s chief executive officer and chief financial officer certifying that,
on the basis of its financial statements, the Borrower and the Parent Company Guarantor are in compliance with the covenants set forth
in Section 5.01(m) (<I>Financial Ratios</I>) and Section 5.01(n) (<I>Aggregate EBITDA Amount; Additional Subsidiary Guarantor</I>) of
this Agreement (using the methodology of calculation in respect of such covenants set forth in Annex H (<I>Methodology for Financial Ratio
Calculations</I>)); and, where applicable, detailing any non-compliance;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">a report by the Borrower on its operations during that Financial Year, in the form of, and addressing
the topics listed in, Schedule 9 (<I>Information to be Included in Quarterly and Annual Review of Operations</I>);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">a certification by the Borrower&rsquo;s chief financial officer that all transactions between the Borrower
and/or its Subsidiaries and each of their respective</TD></TR></TABLE>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 1.5in; text-align: justify">Affiliates, if any, during that Financial Year
were on the basis of arm&rsquo;s-length arrangements; and</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">the SPT Assessment as of the most recent SPT Observation Date;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Management Letters</U>. Deliver to IFC, promptly following receipt, a copy of any management letter sent by the Auditors (or
any other accountants retained by the Borrower) to the Borrower or its management in relation to the Borrower&rsquo;s financial, accounting
and other systems, management or accounts, if not provided pursuant to Section&nbsp;5.03(b)(ii);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Annual Monitoring Report</U>. Within 120 days after the end of each Financial Year, deliver to IFC the Annual Monitoring Report
confirming compliance by the Borrower and its Subsidiaries with the Action Plan, the environmental and social covenants set forth in Section
5.01 (<I>Affirmative Covenants</I>) and Section 5.02 (<I>Negative Covenants</I>) and Applicable E&amp;S Law or, as the case may be, identifying
any non-compliance or failure, and the actions being taken to remedy any such deficiency and a summary of the key actions taken by the
Borrower in connection with environmental, social and corporate governance matters during the relevant Financial Year;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice of Accidents, Etc.</U> Within five (5) Brazil Business Days after its occurrence, notify IFC of any social, labor, health
and safety, security or environmental incident, accident or circumstance having, or which could reasonably be expected to have, a Material
Adverse Effect or material adverse impact on the implementation of the Expansion Program or on carrying on of Operations by the Obligors
and/or any of their respective Subsidiaries in accordance with the Performance Standards, specifying in each case the nature of the incident,
accident, or circumstance and any effect resulting or likely to result therefrom, and the measures the Borrower and/or the relevant Subsidiary
is taking or plans to take to address them and to prevent any future similar event; and keep IFC informed of the on-going implementation
of those measures and plans.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Changes to Business; Material Adverse Effect</U>. Promptly notify IFC of any proposed change in the business or operations of
the Obligors or any of their respective Subsidiaries and of any event or condition that has or could reasonably be expected to have a
Material Adverse Effect;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Litigation; Tax proceeding Etc</U>. Promptly and in any event within five (5) Brazil Business Days after becoming aware of any
litigation or administrative proceedings (including related to Taxes) before any Authority or arbitral body which has had or, if determined
adversely, could reasonably be expected to have, a Material Adverse Effect, notify IFC by electronic mail of that event specifying the
nature of that litigation or those proceedings and the steps the Borrower and/or the relevant Subsidiary is taking or proposes to take
with respect thereto;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Default</U>. Promptly upon the occurrence of an Event of Default or Potential Event of Default, notify IFC by electronic mail
specifying the nature of that Event of Default or Potential Event of Default and any steps the Borrower is taking to remedy it;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Development Impact Indicators</U>. Within one hundred and twenty (120) days after the end of each calendar year (January to
December), deliver to IFC certain information related to the Expansion Program and the Obligors&rsquo; Operations as reasonably required
to measure the ongoing development impact of the Expansion Program and the Obligors&rsquo; Operations against the development impact indicators
specified in Schedule 10 (<I>Development Impact Indicators</I>) hereto and which information IFC may hold and use in accordance with IFC&rsquo;s
Access to Information Policy (dated January 1, 2012). The data for development impact indicators, as described further in Schedule 10
(<I>Development Impact Indicators</I>) hereto, shall correspond to the previous calendar year (January to December); and</P>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <U>Other Information</U>. Promptly provide to IFC (i) such other information as IFC from time to time reasonably requests about
the Borrower, any of its Subsidiaries, their respective assets and Operations and the Expansion Program, <I>provided</I> that, unless
a Potential Event of Default or Event of Default has occurred and is continuing, the Borrower shall not be required to deliver any such
additional information unless it produces or compiles such information in the ordinary course of business or such information is otherwise
produced or compiled by similarly situated companies in the same industry in the ordinary course of business, <I>provided</I>, further,
that the Borrower shall not be required to provide commercially sensitive information the disclosure of which could cause competitive
harm, and (ii) such ordinary course &ldquo;know your customer&rdquo; (KYC) information that IFC requests on behalf of the Participants
for the Participants to satisfy requirements under applicable laws and regulations, including those concerning anti-money laundering and
combatting the financing of terrorism (AML/CFT).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 5.04<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Insurance</U></I>.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Insurance Requirements and Borrower&rsquo;s Undertakings</U>. Unless IFC otherwise agrees, the Borrower and its Subsidiaries
shall:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">insure and keep insured, with financially sound and reputable insurers, its assets and business in a manner
and with amounts and deductibles as set forth in Annex&nbsp;F (Insurance Requirements);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">promptly notify the relevant insurer of any claim by the Borrower and/or any of its Subsidiaries under
any policy written by that insurer and diligently pursue that claim;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">comply with all warranties and conditions under each insurance policy; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">not vary, rescind, terminate, cancel or cause a material change to any insurance policy required in Annex
F (<I>Insurance Requirements</I>) (to the extent such variation, termination, cancelation or change would result in a reduction in coverage).</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Reporting Requirements</U></I>. Unless IFC otherwise agrees, the Borrower and/or its Subsidiaries shall provide to IFC the
following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">as soon as possible after its occurrence, notice of any event which entitles the Borrower to claim for
an aggregate amount exceeding the equivalent of one million Dollars ($1,000,000) under any one or more insurance policies;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">notification of any material change in an identified risk exposure of the Borrower and/or its Subsidiaries;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">within 30 days of renewal of an insurance policy required in Annex F (<I>Insurance Requirements</I>) (other
than those in section&nbsp;3 of such Annex).</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 5.05<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Most Favored Nation</U></I>. If at any time after the date of this Agreement any Financial Debt (other than the Loan) incurred
by any of the Obligors, or with respect to which any of the Obligors is an obligor, (i) has the benefit of any financial covenant that
in the discretion of IFC is more favorable to the holders or lender of such Financial Debt than the terms of this Agreement and the other
IFC Financing Documents or (ii) has any Person(s) other than the Obligors as an obligor or guarantor thereto, then if IFC so requests,
the relevant IFC Financing Documents shall be amended or supplemented to incorporate such more favorable financial covenants or cause
such Person(s) to adhere to this Agreement as obligors.</P>


<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0pt; text-align: center; text-indent: 0in">ARTICLE VI</P>


<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center">Events of Default</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.01<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Acceleration after Default</U></I>. If any Event of Default occurs and is continuing (whether it is voluntary or involuntary,
or results from operation of law or otherwise), IFC may, by notice to the Borrower, require the Borrower to repay the Notional Reais Principal
Amount of the Loan or such part thereof as is specified in that notice. On receipt of any such notice, the Borrower shall immediately
repay the then Notional Reais Principal Amount of each Disbursement comprising the Loan (or such part thereof specified in that notice)
and pay all interest accrued in respect of each such Disbursement, the prepayment premium specified in Section 2.06 (<I>Prepayment</I>)
on the amount of the Loan whose payment is accelerated and any other amounts then payable under this Agreement and the other IFC Financing
Documents, by paying to IFC the Dollar Equivalent of all such amounts using the Early Payment Fixing Rate advised to the Borrower by IFC,
calculated as set forth in Annex L (<I>Methodology for Calculation of Payments upon a Prepayment or Acceleration</I>). The Borrower waives
any right it might have to further notice, presentment, demand or protest with respect to that demand for immediate payment.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.02<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Events of Default</U></I>. It shall be an Event of Default if:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Failure to Pay Principal or Interest</U>. (i) The Borrower fails to pay when due any part of the principal of, or interest on,
the Loan and such failure continues for a period of five days; or (ii) the Parent Company Guarantor or any Subsidiary Guarantor fails
to pay when due any amounts payable under its respective Guarantee Agreement and such failure continues for a period of five days;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Failure to Pay Other IFC Loans</U>. The Obligors or any of their respective Subsidiaries fails to pay when due any part of the
principal of, or interest on, any loan from IFC other than the Loan and any such failure continues for the relevant period of grace provided
for in the agreement providing for that loan;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Failure to Comply with Obligations</U>. Any of the Obligors fails to comply with any of its obligations under this Agreement
or any other IFC Financing Document to which it is a party or any other agreement between such Person and IFC (other than those referred
to in clauses (a) or (b) of this Section&nbsp;6.02), and any such failure continues for a period of 20 days after the date of that failure;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Misrepresentation</U>. Any representation or warranty made in (i) Article&nbsp;III or in connection with the execution of, or
any request (including a request for Disbursement) under, this Agreement, (ii) the SPO Assessment, (iii) any SPT Assessment, or (iv) other
IFC Financing Document is incorrect in any material respect;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Expropriation, Nationalization, Etc</U>. Any Authority condemns, nationalizes, seizes, or otherwise expropriates (<I>expropria&ccedil;&atilde;o</I>)
all or any substantial part of the property or other assets of any Obligor or any of their respective Subsidiaries or of any of their
respective share capital, or assumes custody or control of that property or other assets or of the business or operations of any Obligor
or any of its Subsidiaries or of any of their respective share capital, or takes any action for the dissolution or disestablishment of
any Obligors or any of its Subsidiaries or any action that would prevent any Obligor or any of its Subsidiaries or their respective officers
from carrying on all or a substantial part of their respective business or Operations and such condemnation, nationalization, seizure
or other action is not cured, suspended or reversed within twenty (20) days and is directed against assets that, in the aggregate, are
fifteen percent (15%) or more of the Consolidated Assets of the Parent Company Guarantor as per the most recent Consolidated Financial
Statements of the Parent Company Guarantor delivered to IFC pursuant to Section 5.03(a);</P>


<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <U>Involuntary Proceedings</U>. A decree or order by a court is entered against any of the Obligors or any of their respective
Subsidiaries:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">adjudging any Obligor or any of its Subsidiaries bankrupt (<I>fal&ecirc;ncia</I>) or insolvent;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">approving as properly filed a petition seeking a moratorium, reorganization, restructuring, arrangement,
adjustment or composition of, or with respect to, any Obligor or any of its Subsidiaries under any applicable law;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">appointing a receiver, liquidator, restructuring officer, assignee, trustee, <I>administrador judicial</I>,
sequestrator (or other similar official) of any Obligor or any of its Subsidiaries or of any substantial part of its property or other
assets; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">ordering the winding up or liquidation of its affairs;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 1in; text-align: justify">or any petition is filed seeking any of the above
and is not dismissed within 60 days; <I>provided, </I>that the foregoing shall not apply in the case of a Subsidiary whose assets are
equal to or less than two percent (2%) of the Parent Company Guarantor&rsquo;s Consolidated Assets, except where such event could reasonably
be expected to have a Material Adverse Effect;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Voluntary Proceedings</U>. Any of the Obligors or any of their respective Subsidiaries:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">requests a moratorium or suspension of payment of liabilities from any court;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">institutes proceedings or takes any form of corporate action to be liquidated, adjudicated bankrupt or
insolvent (including, without limitation<I>, recupera&ccedil;&atilde;o judicial</I> and <I>recupera&ccedil;&atilde;o extrajudicial</I>);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">consents to the institution of bankruptcy or insolvency proceedings (including, without limitation<I>,
recupera&ccedil;&atilde;o judicial</I> and <I>recupera&ccedil;&atilde;o extrajudicial</I>) against it;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">files a petition or answer or consent seeking restructuring, reorganization or relief (including, without
limitation<I>, recupera&ccedil;&atilde;o judicial</I> and <I>recupera&ccedil;&atilde;o extrajudicial</I>) under any applicable law, or
consents to the filing of any such petition or to the appointment of a receiver, liquidator, restructuring officer, assignee, trustee,
<I>administrador judicial</I>, sequestrator (or other similar official) of such Obligor or Subsidiary or of any substantial part of any
of their respective property;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">makes a general assignment for the benefit of creditors; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">admits in writing its inability to pay its liabilities generally as they become due or otherwise becomes
insolvent;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 1in; text-align: justify"><I>provided, </I>that the foregoing shall not apply
in the case of a Subsidiary whose assets are equal to or less than two percent (2%) of the Parent Company Guarantor&rsquo;s Consolidated
Assets, except where such event could reasonably be expected to have a Material Adverse Effect;</P>


<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <U>Attachment</U>. One or more attachments or analogous processes are levied or enforced upon or issued against any of the assets
of any Obligor or any of its Subsidiaries (i) for an amount, in the aggregate, in excess of the equivalent of one hundred million Reais
(R$100,000,000) or (ii) that could be reasonably expected to have a Material Adverse Effect, and any such attachment or analogous process
is not discharged within 60 days;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Analogous Events to Bankruptcy</U>. Any other event occurs which under any applicable law would have an effect analogous to
any of those events listed in Section 6.02(f) through Section 6.02(h);</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Cross-Default</U>. Any of the Obligors or any of their respective Subsidiaries fails to pay any of its Financial Debt (other
than the Loan or any other loan from IFC) or to perform any of its obligations under any agreement for any such Financial Debt and any
such failure continues for more than any applicable period of grace or any such Financial Debt becomes prematurely due and payable or
is placed on demand, in each case where amounts owed under or in connection with such Financial Debt exceed, in the aggregate, forty million
Reais (R$40,000,000) or its equivalent in other currencies;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Failure to Maintain Authorizations</U>. Any Authorization necessary for any of the Obligors or any of their respective Subsidiaries
to perform and observe its obligations under any IFC Financing Document, or to carry out the Expansion Program or its Operations, is not
obtained when required (except if such Authorization is in the process of being timely renewed under applicable law and no Material Adverse
Effect could reasonably be expected to occur during the pendency, or as a result of, such renewal), or is rescinded, terminated, lapses
or otherwise ceases to be in full force and effect, including with respect to the remittance to IFC or its assignees, in Dollars, of any
amounts payable in Dollars under any IFC Financing Document, and is not restored or reinstated within 60 days of notice by IFC to the
Borrower requiring that restoration or reinstatement;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Revocation Etc. of IFC Financing Documents</U>. Any IFC Financing Document or any of its provisions:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">is revoked, terminated or ceases to be in full force and effect without, in each case, the prior consent
of IFC, and that event, if capable of being remedied, is not remedied to the satisfaction of IFC within 30 days of IFC&rsquo;s notice
to the Borrower; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">becomes unlawful or is declared void by a competent Authority; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">is repudiated or the validity or enforceability of any of its provisions at any time is challenged by
any Person and such repudiation or challenge is not withdrawn within 30 days of IFC&rsquo;s notice to the Borrower requiring that withdrawal;
provided that no such notice shall be required or, as the case may be, the notice period shall terminate if and when such repudiation
or challenge becomes effective;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Judgments</U>. A final and non-appealable judgment, order or arbitral award for the payment of money in excess of the equivalent
of forty million Reais (R$40,000,000) (individually or in the aggregate) is rendered against any of the Obligors or any of their respective
Subsidiaries or any of their respective properties and that judgment, order or arbitral award continues to be unsatisfied for a period
of 60 consecutive days;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Change of Control</U>. A Change of Control shall have occurred; or</P>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <U>Criminal Judgments</U>. A judgment, arbitral award, or order issued against any of the Obligors, any of their respective Subsidiaries
or any of their board members or management acting in such capacity, with respect to any criminal conduct or any violation of any laws
related to money laundering or the financing of terrorism.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 6.03<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Bankruptcy</U></I>. If the Borrower is liquidated or declared bankrupt, the Loan, all interest accrued on it and any other
amounts payable under this Agreement will become immediately due and payable without any presentment, demand, protest or notice of any
kind, all of which the Borrower waives.</P>

<P STYLE="font: bold 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center; text-indent: 0in">ARTICLE VII<BR>
Miscellaneous</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.01<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Saving of Rights</U></I>. (a) The rights and remedies of IFC in relation to any misrepresentation or breach of warranty
on the part of the Borrower or any other Person shall not be prejudiced by any investigation by or on behalf of IFC or any of the Participants
into the affairs of the Borrower or any other Person, by the execution or the performance of this Agreement, any other IFC Financing Document
or the Participation Agreement or by any other act or thing which may be done by or on behalf of IFC in connection with this Agreement,
any other IFC Financing Document or the Participation Agreement and which might prejudice such rights or remedies.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No course of dealing or waiver by IFC in connection with any condition of Disbursement of the Loan under this Agreement or any
other IFC Financing Document shall impair any right, power or remedy of IFC with respect to any other condition of Disbursement, or be
construed to be a waiver thereof; nor shall the action of IFC with respect to any Disbursement affect or impair any right, power or remedy
of IFC with respect to any other Disbursement.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Unless otherwise notified to the Borrower by IFC and without prejudice to the generality of Section&nbsp;7.01(b), the right of
IFC to require compliance with any condition under this Agreement or any other IFC Financing Document that may be waived by IFC with respect
to any Disbursement is expressly preserved for the purposes of any subsequent Disbursement.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No course of dealing and no failure or delay by IFC in exercising, in whole or in part, any power, remedy, discretion, authority
or other right under this Agreement, any other IFC Financing Document or any other agreement shall waive or impair, or be construed to
be a waiver of, such or any other power, remedy, discretion, authority or right under this Agreement or any other IFC Financing Document,
or in any manner preclude its additional or future exercise; nor shall the action of IFC with respect to any default, or any acquiescence
by it therein, affect or impair any right, power or remedy of IFC with respect to any other default.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.02<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Notices</U></I>. (a) Any notice, request or other communication to be given or made under this Agreement shall be in writing.
Subject to Section 5.03(i) and Section 5.03(h) (<I>Reporting Requirements</I>), Section 7.02(b) (<I>Notices</I>) and Section 7.05 (<I>Applicable
Law and Jurisdiction</I>), any such communication may be delivered by hand, airmail, electronic mail, or established courier service to
the party&rsquo;s address specified below or at such other address as such party notifies to the other party from time to time, and will
be effective upon receipt.</P>


<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">For the Borrower:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 1in; text-align: left">Afya Participa&ccedil;&otilde;es S.A.<BR>
Alameda Oscar Niemeyer, n&ordm; 119, offices 402, 404, 502, 504, 1501 and 1503<BR>
Vila da Serra, CEP 34,006-056<BR>
<BR>
E-mails: [**]@afya.com.br / [**]@afya.com.br / [**]@afya.com.br / [**]@afya.com.br / [**]@afya.com.br<BR>
<BR>
Attention: Mr. Luis Blanco and Mr. Anibal Sousa</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">For IFC:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 1in; text-align: left">International Finance Corporation<BR>
2121 Pennsylvania Avenue, N.W.<BR>
Washington, D.C. 20433<BR>
United States of America<BR>
<BR>
E-mail: [**]@ifc.org<BR>
<BR>
Attention: Director, MAS Department<BR>
<BR>
With a copy (in the case of communications relating to payments) for the attention of the Director, Financial Operations.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>IFC has a secured document sharing website called &ldquo;AccessIFC&rdquo;, located at accessifc.ifc.org. Provided that the Borrower
has agreed to all the terms and conditions provided by IFC to access and use AccessIFC, IFC may, in its discretion, grant to the Borrower
access to AccessIFC. In the event the Borrower has been granted access to AccessIFC, the Borrower shall deliver via AccessIFC the reports
required in Sections 5.03 (a) (<I>Quarterly Financial Statements and Reports</I>), (b) (<I>Annual Financial Statements and Reports</I>),
(c) (<I>Management Letters</I>), and (d) (<I>Annual Monitoring Report</I>) and any other reporting requirements as may be mutually agreed
between the Borrower and IFC.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.03<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>English Language</U></I>. (a) All documents to be provided or communications to be given or made under this Agreement
or any other IFC Financing Document shall be in the English language.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the extent that the original version of any document to be provided, or communication to be given or made, to IFC under this
Agreement or any other IFC Financing Document is in a language other than English, that document or communication shall be accompanied
by an English translation certified by an Authorized Representative to be a true and correct translation of the original. IFC may, if
it so requires, obtain an English translation of any document or communication received in a language other than English at the cost and
expense of the Borrower. IFC may deem any such English translation to be the governing version between the Borrower and IFC.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.04<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Term of Agreement</U></I>. This Agreement shall continue in force until all monies payable under it have been fully paid
in accordance with its provisions.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.05<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Applicable Law and Jurisdiction</U></I>. (a)&nbsp;This Agreement shall be governed by and construed in accordance with
the laws of the State of New York, United States of America.</P>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> For the exclusive benefit of IFC, the Borrower irrevocably agrees to venue being laid in the courts of the United States of America
located in the Southern District of New York or in the courts of the State of New York located in the Borough of Manhattan, in any dispute,
claim, action, suit, litigation, proceeding or complaint arising out of, relating to or having any connection with this Agreement (including
any dispute regarding non-contractual obligations and any dispute regarding the existence, validity, interpretation, performance, breach
or termination of this Agreement or the consequences of its nullity) (a &ldquo;<B>Dispute</B>&rdquo;), and waives any objections to venue
based on grounds of <I>forum non conveniens</I> or inconvenient forum.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For the exclusive benefit of IFC, the Borrower irrevocably also submits to personal jurisdiction of any such court in any such
Dispute. Final judgment against the Borrower in any such Proceeding shall be conclusive and may be enforced in any other jurisdiction
in accordance with applicable laws, including the Country, by suit on the judgment, a certified or exemplified copy of which shall be
conclusive evidence of the judgment, or in any other manner provided by law.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The parties acknowledge and agree that no provision of this Agreement in any way constitutes or implies a waiver, renunciation,
termination or modification by IFC of any of its privileges, immunities or exemptions granted in the Articles of Agreement establishing
IFC, international conventions, or applicable law and the IFC expressly reserves all of its privileges, immunities and exemptions thereunder.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower hereby irrevocably designates, appoints and empowers Cogency Global Inc. (the &ldquo;<B>Process Agent</B>&rdquo;)
with an office on the date hereof located at 122 E. 42<SUP>nd</SUP> Street, 18<SUP>th</SUP> Floor, New York, NY 10168, United States,
as its authorized agent solely to receive for and on its behalf service of any summons, complaint or other legal process in any action,
suit or proceeding IFC may bring in the State of New York in respect of this Agreement.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As long as this Agreement remains in force, the Borrower shall maintain a duly appointed and authorized agent to receive for and
on its behalf service of any summons, complaint or other legal process in any Proceeding IFC may bring in New York, New York, United States
of America, with respect to this Agreement. The Borrower shall keep IFC advised of the identity and location of such agent.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower also irrevocably consents, if for any reason its authorized agent for service of process of summons, complaint and
other legal process in any Proceeding is not present in New York, New York, to the service of such papers being made out of the courts
of the United States of America located in the Southern District of New York and the courts of the State of New York located in the Borough
of Manhattan by mailing copies of the papers by registered United States air mail, postage prepaid, to the Borrower, at its address specified
pursuant to Section 7.02(<I>Notices</I>). In such a case, IFC shall also send by electronic mail or have sent by electronic mail a copy
of the papers to the Borrower. The Borrower agrees that failure by a process agent to notify it of any process will not invalidate the
relevant proceedings.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Service in the manner provided in Section 7.05(e), (f) and (g) in any Proceeding will be deemed personal service, will be accepted
by the Borrower as such and will be valid and binding upon the Borrower for all purposes of any such action, suit or proceeding.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower irrevocably waives to the fullest extent permitted by applicable law:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">its right of removal of any matter commenced by IFC in the courts of the State of New York to any court
of the United States of America; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">any and all rights to demand a trial by jury in any such action, suit or proceeding brought against it
by IFC.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> To the extent that the Borrower may be entitled in any jurisdiction to claim for itself or its assets immunity in respect of its
obligations under this Agreement or any other IFC Financing Document to which it is a party from any suit, execution, attachment (whether
provisional or final, in aid of execution, before judgment or otherwise) or other legal process or to the extent that in any jurisdiction
that immunity (whether or not claimed) may be attributed to it or its assets, the Borrower irrevocably agrees not to claim and irrevocably
waives such immunity to the fullest extent permitted now or in the future by the laws of such jurisdiction.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower hereby acknowledges that IFC shall be entitled under applicable law, including the provisions of the International
Organizations Immunities Act, to immunity from a trial by jury in any Proceeding arising out of or relating to this Agreement or the transactions
contemplated hereby brought against IFC in any court of the United States of America. The Borrower hereby waives any and all rights to
demand a trial by jury in any Proceeding arising out of or relating to this Agreement or the transactions contemplated by this Agreement,
brought against IFC in any forum in which IFC is not entitled to immunity from a trial by jury.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the extent that the Borrower may, in any Proceeding brought in any of the courts referred to in Section 7.05(b) or a court of
the Country or elsewhere arising out of or in connection with this Agreement or any other IFC Financing Document to which the Borrower
is a party, be entitled to the benefit of any provision of law requiring IFC in such Proceeding to post security for the costs of the
Borrower, or to post a bond or to take similar action, the Borrower hereby irrevocably waives such benefit, in each case to the fullest
extent now or in the future permitted under the laws of the Country or, as the case may be, the jurisdiction in which such court is located.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Nothing in this Agreement shall affect the right of IFC to commence legal proceedings or otherwise sue the Borrower in the Country
or any other appropriate jurisdiction, or concurrently in more than one jurisdiction, or to serve process, pleadings and other legal papers
upon the Borrower in any manner authorized by the laws of any such jurisdiction.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Enforcement</U>. At the option of IFC, this Agreement may be enforced against the Borrower in the courts of the Country or in
any other appropriate jurisdiction or concurrently in more than one jurisdiction, and service of process papers upon the Borrower may
be made in any manner authorized by the laws of any such jurisdiction.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.06<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Disclosure of Information</U></I>. (a) IFC may disclose any documents or records of, or information about, this Agreement
or any other IFC Financing Document, or the assets, business, Operations or affairs of the Borrower to:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">its outside counsel, auditors and rating agencies,</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">any Participant or any Person who intends to purchase a Participation in a portion of the Loan, or any
sub-participant, credit insurer, or any other party that is seeking to acquire or has acquired an economic interest in the Loan, whether
funded or unfunded, and, if a Participant or such a Person is an investment fund, any investors in such investment fund, and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">any other Person as IFC may deem appropriate in connection with the administration of the Loan, including
any proposed sale, transfer, assignment or other disposition of IFC&rsquo;s rights under this Agreement or any IFC Financing Document
or otherwise for the purpose of exercising any power, remedy, right,</TD></TR></TABLE>


<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 1.5in; text-align: justify">authority, or discretion relevant to this Agreement
or any other IFC Financing Document.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower acknowledges and agrees that, notwithstanding the terms of any other agreement between the Borrower and IFC, a disclosure
of information by IFC in the circumstances contemplated by Section&nbsp;7.06 (a) does not violate any duty owed to the Borrower under
this Agreement or under any such other agreement.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Borrower acknowledges that IFC in its absolute discretion may fund the Loan in whole or in part with proceeds from IFC thematic
bond programs, such as green bonds or social bonds. In such event the Borrower agrees that for the duration of the Loan: (i) IFC may disclose
non-confidential ex-ante estimates related to the Loan and its expected development impact in public reports to IFC&rsquo;s bond investors,
including the annual impact report for IFC&rsquo;s green bond program and other similar publications, and (ii) if requested by IFC, the
Borrower will confirm the details of any such estimates within 14 Business Days of receiving the request.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.07<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Indemnification; No Consequential Damage</U></I>. (a)&nbsp;The Borrower
shall, within ten (10) Business Days of demand, indemnify, defend and hold harmless IFC and each Participant and their respective officers,
directors, affiliates, employees, agents and representatives (each, an &ldquo;<B>Indemnitee</B>&rdquo;) against, and hold each Indemnitee
harmless from, any and all actual or contingent losses, damages, liabilities, obligations, commitments, deficiencies, awards, fines, penalties,
judgments, orders, decrees, claims, actions, suits, proceedings, investigations, demands, complaints, grievances, settlements, disputes,
litigation, documented costs and expenses (including attorney fees and expenses, consultant, engineer, and other professional costs and
expenses) (&ldquo;<B>Losses</B>&rdquo;) arising out of, in connection with, or related in any way to:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the execution, delivery or performance of any IFC Financing Document or any other agreement or instrument
contemplated hereby or thereby or the consummation of the Expansion Program or any other transactions contemplated hereby or thereby (including
any breach of, or failure to perform, any of the representations, warranties, covenants, or obligations in any IFC Financing Document
or other agreement or instrument contemplated thereby);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the Loan or the actual or proposed use of proceeds thereof;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">any actual or alleged non-compliance by the Obligors (or any Person acting on its or their behalf) with,
or any liability or obligation under, any law, any Applicable E&amp;S Law, and/or the Performance Standards, in each case in respect of
the Expansion Program; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">any actual or threatened (in writing) claim, action, suit, litigation, investigation, proceeding, inquiry,
request for information, demand, complaint, dispute or grievance (each, a &ldquo;<B>Proceeding</B>&rdquo;) relating to any of the foregoing,
whether based on contract, tort or any other theory and regardless of whether any Indemnitee is party thereto;</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>provided</I> that, in any case,
such indemnity will not be available to any Indemnitee to the extent that such Loss resulted directly from such Indemnitee&rsquo;s gross
negligence or willful misconduct (as determined by a final, non-appealable determination of a court or arbitral tribunal of competent
jurisdiction).</P>


<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> The Borrower&rsquo;s indemnity obligations in this Section are independent of and in addition to any rights of any Indemnitee
in connection with any Loss (provided, however, that no Indemnitee shall be entitled to recover an amount twice in respect of the same
Loss), and such obligations shall survive the execution, modification, and amendment of this Agreement and each other IFC Financing Document,
the expiration, cancellation, or termination of IFC&rsquo;s or any Participant&rsquo;s commitment, and the disbursement and repayment
of the Loan.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the maximum extent permitted by applicable law, the Borrower shall not assert, and hereby agrees to waive, any claim against
any Indemnitee, on any theory of liability, for special, indirect, consequential, contingent, or punitive damages arising out of, in connection
with, or relating to, this Agreement or any agreement or instrument contemplated hereby, the Loan or the use of the proceeds thereof.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In respect of any Proceeding in connection with a Loss, IFC and each Indemnitee shall have the right but not the obligation to
control its, his, or her defense; provided, however, that IFC and each Indemnitee shall, in respect of any decision to settle any such
Proceeding, consult in good faith with the&nbsp;Obligors.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.08<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Successors and Assignees</U></I>. This Agreement binds and benefits the respective successors and assignees of the parties.
However, the Borrower may not assign or delegate any of its rights or obligations under this Agreement without the prior written consent
of IFC.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.09<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Amendments, Waivers and Consents</U></I>. Any amendment or waiver of, or any consent given under, any provision of this Agreement
shall be in writing and, in the case of an amendment, signed by the parties.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.10<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Counterparts</U></I>. This Agreement may be executed in several counterparts, each of which is an original, but all of which
together constitute one and the same agreement.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.11<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Third Party Rights</U></I>. (a) Subject to paragraph (b), this Agreement is for the sole benefit of IFC and the Borrower
and is not intended to, nor shall it be interpreted, and does not, provide or create any third party beneficiary rights or any other rights
of any kind to any Person who, or entity that, is not a party to it. to enforce any of its terms.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This Section&nbsp;7.11 shall not apply to any Person who is defined as an Indemnitee in Section 7.07 (<I>Indemnification; No Consequential
Damages</I>), except and only to the extent that any such Indemnitee (while not a party to this Agreement) is entitled to enforce the
provisions of Section 7.07 (<I>Indemnification; No Consequential Damages</I>).</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.12<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Personal Data</U></I>. If the Borrower or anyone acting on its behalf discloses any information relating to individuals to
IFC in connection with the Expansion Program or any of the IFC Financing Documents, such Person shall ensure that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">unless IFC has requested or agreed to provision of the information in personally identifiable form, the
information is redacted or anonymized so that no individual is identifiable; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">if any individuals are identifiable from the information:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">the disclosure complies with any data protection or data privacy laws applicable to the Borrower (such
as any requirements to provide</TD></TR></TABLE>


<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 2in; text-align: justify">information to, or obtain consents from, those
individuals), taking full account of IFC&rsquo;s expected use of the information, including its inclusion in any IFC Financing Document,
its disclosure in accordance with Section 7.06 or as set forth in IFC&rsquo;s Products and Services Privacy Notice (ifc.org/privacy/productnotice);</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">reasonable steps are taken to ensure that the information is accurate, and proportionate to the purposes
of disclosure, and that the disclosure is fair to the individuals concerned; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman,serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(C)</TD><TD STYLE="text-align: justify">the information is protected by appropriate security measures in transmission.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.13<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Independence of the Borrower</U></I>. The Borrower confirms that:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>it has engaged legal, tax, regulatory and accounting advisors, and such other professional advisors as it deems appropriate, with
respect to all matters in connection with the Loan and the IFC Financing Documents; and</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>it has, upon its own due diligence as to all matters pertinent hereto with the assistance of its professional advisors, and notwithstanding
any involvement of or consultation with IFC or any member of the World Bank Group, independently evaluated, and fully understands, acknowledges,
and accepts, all risks arising or potentially arising under or in connection with the Loan and each IFC Financing Document.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.14<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Role of IFC</U>. </I>(a) Notwithstanding anything to the contrary provided under the IFC Financing Documents, it is specifically
understood and agreed that IFC is acting solely as lender and is not, and shall not be deemed or construed to act as, agent, advisor or
fiduciary for the Borrower, or any Obligor or for any other Person pursuant to the IFC Financing Documents.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as expressly assumed by IFC under the IFC Financing Documents, IFC shall have no liability or obligation whatsoever to any
Obligor or any other Person with respect to the transactions contemplated by IFC Financing Documents (including, without limitation, for
any oversight or monitoring, or any lack of oversight or monitoring, exercised by IFC in respect of, or the manner in which IFC may implement
(or refrain from implementing), comply with (or refrain from complying with), any IFC policy (including the Action Plan and Performance
Standards) or any Applicable E&amp;S Law) and the Borrower or any Obligor, as the case may be, assumes full responsibility in respect
of any action it takes (or fails to take) in connection with any recommendation, instruction or advice that IFC may or may not give from
time to time in connection with the Operations or any IFC Financing Document.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any reviews, approvals, or due diligence undertaken by IFC is for the sole benefit of IFC alone and not for the benefit of any
third party, foreseen or unforeseen, or the Borrower and shall create no fiduciary or other obligation in any respect to any third party,
foreseen or unforeseen, or the Borrower.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.15<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Acknowledgment of CAO</U></I>. The Borrower hereby acknowledges and agrees that the CAO is IFC&rsquo;s independent accountability
mechanism for environmental and social concerns; and it has reviewed additional information about the CAO, including the CAO Policy, which
is available at http://www.cao-ombudsman.org/.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Section 7.16<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I><U>Translation and Registration</U></I>. The Borrower shall obtain at its cost a sworn translation into Portuguese of each of
this Agreement and the Guarantee Agreement and the registration of each such IFC Financing Document and such sworn translations with the
appropriate registry of titles and</P>


<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --> -&nbsp;</TD></TR><TR><TD STYLE="text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify">deeds in the Country (<I>Cart&oacute;rio de Registro
de T&iacute;tulos e Documentos</I>), and shall provide IFC a signed copy of each IFC Financing Document and its sworn translation into
Portuguese duly registered within thirty (30) days from the date the Borrower receives from IFC the signed copies of such IFC Financing
Documents with duly notarized IFC signatures. In the event of any conflict between the Portuguese version and the English version of each
such IFC Financing Document, the English version shall prevail.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: center; text-indent: 0in">[<I>Signature Pages Follow</I>]</P>


<!-- Field: Page; Sequence: 58; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
have caused this Agreement to be signed in their respective names as of the date first above written.</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 0 3.25in; text-align: left"><B>AFYA PARTICIPA&Ccedil;&Otilde;ES S.A.</B></P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left"><BR></P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left">By <U>/s/ Luis Andr&eacute; Carpintero Blanco&#9;</U><BR>
Name: Luis Andr&eacute; Carpintero Blanco<BR>
Title: Chief Financial Officer</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left">By <U>/s/ Anibal Jos&eacute; Grifo de Sousa&#9;</U><BR>
Name: Anibal Jos&eacute; Grifo de Sousa<BR>
Title: Legal and Compliance Vice-President</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 0.5in; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 0.5in; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 0.5in; text-align: center"></P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">[<I>IFC &ndash; AFYA &ndash; AFYA Signature Page to Loan Agreement</I>]</P>


<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 0 3.25in; text-align: left"><B><U>Witnesses</U></B>:</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left; text-indent: 5.5in"><BR></P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left"><U>/s/ Virgilio Deloy Capobianco Gibbon&#9;</U><BR>
By: Virgilio Deloy Capobianco Gibbon<BR>
RG: [**]</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left"><U>/s/ Erico Coelho Ribeiro&#9;</U><BR>
By: Erico Coelho Ribeiro<BR>
RG: [**]</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">[<I>IFC &ndash; AFYA &ndash; Witnesses Signature Page to Loan
Agreement</I>]</P>


<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 0 3.25in; text-align: left"><B>INTERNATIONAL FINANCE CORPORATION</B></P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left"><BR></P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 12pt 3.25in; text-align: left">By <U>/s/ Luiz Daniel de Campos&#9;</U><BR>
Name: Luiz Daniel de Campos<BR>
Title: Authorized Signatory</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: center">[<I>IFC &ndash; AFYA &ndash; IFC Signature Page to Loan Agreement</I>]</P>

<P STYLE="font: 11pt Times New Roman,serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 61; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman,serif; margin: 0 0 24pt; text-align: right"></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>4
<FILENAME>ex04-4.htm
<DESCRIPTION>EX-4.4
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>THE SYMBOL &ldquo;[**]&rdquo;
DENOTES PLACES WHERE CERTAIN IDENTIFIE6D INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) OF
THE TYPE THAT THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS AS PRIVATE OR CONFIDENTIAL.</B></FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>TERMS OF THE FIRST
ISSUE OF REGISTERED COMMERCIAL NOTE, IN TWO SERIES, FOR PRIVATE PLACEMENT, BY AFYA PARTICIPA&Ccedil;&Otilde;ES S.A.</B></FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">By this private instrument, on the one hand, as issuer,</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><B>AFYA PARTICIPA&Ccedil;&Otilde;ES S.A.</B>, a corporation
not registered as a publicly traded company with the Brazilian Securities and Exchange Commission (&ldquo;<U>CVM</U>&rdquo;), with its
principal office located in the city of Belo Horizonte, state of Minas Gerais, at Rua Para&iacute;ba, No. 330, 17th floor, Funcion&aacute;rios,
ZIP Code 30.130-917, registered in the National Register of Legal Entities of the Ministry of Finance (&ldquo;<U>CNPJ/MF</U>&rdquo;) under
No. 23.399.329/0001-72, with its articles of incorporation duly filed with the Minas Gerais State Board of Trade (&ldquo;<U>JUCEMG</U>&rdquo;)
under NIRE No. 31.300.113.663 , hereby represented in accordance with its bylaws (&ldquo;<U>Issuer</U>&rdquo;);</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">and, on the other hand,</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/17pt Verdana,sans-serif; margin: 0; text-align: justify"><B>OPEA SECURITIZADORA S.A.</B> , a securitization company
duly registered with the CVM under No. 477, in category S1, with headquarters in the city of S&atilde;o Paulo, state of S&atilde;o Paulo,
at Rua Hungria, No. 1,240, Suite 12, Jardim Europa, ZIP Code 01455-000, registered with the CNPJ/MF under No. 02.773.542/0001-22 , hereby
represented in accordance with its articles of incorporation (<U>&ldquo;Holder of Book-Entry Commercial Note</U>s&rdquo; or &ldquo;<U>Securitization
Company</U>&rdquo;);</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">and, furthermore, acting as guarantors,</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>COMPANHIA
NILZA CORDEIRO HERDY DE EDUCA&Ccedil;&Atilde;O E CULTURA</B></FONT>, a joint-stock company not registered as publicly traded with the
CVM, headquartered in the city of Duque de Caxias, state of Rio de Janeiro, at Avenida Perimetral Professor Jos&eacute; de Souza Herdy,
No. 120, ZIP Code 25.075-142, Jardim Vinte e Cinco de Agosto, registered with the CNPJ/MF under No. 29.403.763/0001-65, with its articles
of incorporation filed with the Rio de Janeiro State Board of Trade (&ldquo;<U>JUCERJA</U>&rdquo;) under NIRE No. 33.300.322.370, herein
represented in accordance with its bylaws (&ldquo;<U>Unigranrio</U>&rdquo;);</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Instituto de
Ensino Superior do Piau&iacute; S.A.</B></FONT>, a corporation not registered as publicly traded with the CVM, headquartered in the city
of Teresina, state of Piau&iacute;, at Rua Vitorino Orthiges Fernandes, No. 6,123, Uruguai, CEP 64.073-505, registered with the CNPJ/MF
under No. 21.909.778/0001-98, with its articles of incorporation filed with the Piau&iacute; State Board of Trade (&ldquo;<U>JUCEPI</U>&rdquo;)
under NIRE No. 22.300.015.044, hereby represented in accordance with its articles of incorporation (&ldquo;<U>Uninovafapi</U>&rdquo;);
and</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Sociedade Educacional
e Cultural Sergipe Del Rey Ltda.</B></FONT>, a single-member limited liability company, headquartered in the city of Macei&oacute;, state
of Alagoas, at Avenida Comendador Gustavo Paiva, No. 5,017, Cruz das Almas, ZIP Code 57.038-</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/17pt Verdana,sans-serif; margin: 0; text-align: justify; text-indent: 0in">000, registered with the CNPJ/MF under No. 32.728.800/0001-10,
with its articles of incorporation filed with the Alagoas State Board of Trade (&ldquo;<U>JUCEAL</U>&rdquo;) under NIRE No. 27.201.363.855,
herein represented in accordance with its articles of incorporation (&ldquo;<U>UNIMA</U>&rdquo; and, when together with Unigranrio and
Uninovafapi, the &ldquo;<U>Guarantors</U>&rdquo;).</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">Considering the Issuer, the Securitization Entity, and the
Guarantors hereinafter collectively referred to as the &ldquo;<U>Parties</U>&rdquo; and, individually and without distinction, as a &ldquo;<U>Party</U>&rdquo;;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>WHEREAS: </B></FONT></P>

<P STYLE="font: 10pt/17pt Verdana,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 9pt/17pt Verdana,sans-serif; margin: 0; text-align: justify; text-indent: 0in"><B>(a)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">the Issuer intends to issue Book-Entry Commercial Notes (as defined below), pursuant to this
Issuance Agreement (as defined below), to be privately subscribed and paid in full by the Securitization Entity (&ldquo;<U>Issuance</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt/17pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/17pt Verdana,sans-serif; margin: 0; text-align: justify; text-indent: 0in"><B>(b)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The issuance (as defined below) of the Book-Entry Commercial Notes is part of a receivables securitization
transaction conducted in accordance with the provisions of Law No. 14,430, of August 3, 2022, as currently in force (<U>&ldquo;Law 14,</U>430&rdquo;),
and CVM Resolution No. 60, dated December 23, 2021, as in force (<U>&ldquo;CVM Resolution</U> 60&rdquo;), through the issuance of non-convertible
debentures, of the unsecured type, in two (2) series, for public distribution, under the automatic distribution registration procedure,
of the 26th (twenty-sixth) issuance of the Securitization Entity (&ldquo;<U>Debentures</U>&rdquo;), wherein the Book-Entry Commercial
Notes (as defined below) will be fully subscribed by the Securitization Entity with funds derived from the payment of the Debentures,
in a volume proportional to the number of Debentures actually paid, for which the Book-Entry Commercial Notes will serve as collateral,
in the manner to be provided for in <I>the &ldquo;Private Deed of the 26th (Twenty-Sixth) Issue of Non-Convertible Debentures, of the
Unsecured Type, in 2 (Two) Series, for Public Distribution under the Automatic Distribution Registration Procedure, of Opea Securitizadora
S.A., Backed by Book-Entry Commercial Notes Owed by Afya Participa&ccedil;&otilde;es S.A.</I>&rdquo; (&ldquo;<U>Debenture Issuance Deed</U>&rdquo;),
to be executed between the <U>Securitization Company</U> and <B>OLIVEIRA TRUST DISTRIBUIDORA DE T&Iacute;TULOS E VALORES MOBILI&Aacute;RIOS
S.A.</B>, a corporation with a branch located in the city of S&atilde;o Paulo, state of S&atilde;o Paulo, at Avenida das Na&ccedil;&otilde;es
Unidas, No. 12,901, 11th floor, suites 1,101 and 1,102, North Tower, Centro Empresarial Na&ccedil;&otilde;es Unidas (CENU), Brooklin,
ZIP Code 04.578-910, registered with the CNPJ/MF under No. 36.113.876/0004-34, acting as trustee (&ldquo;<U>Trustee</U>&rdquo;), such
that the Book-Entry Commercial Notes will be linked to the Debentures (&ldquo;<U>Securitization Transaction</U>&rdquo;);</FONT></P>

<P STYLE="font: 10pt/17pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/17pt Verdana,sans-serif; margin: 0; text-align: justify; text-indent: 0in"><B>(c)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">upon payment in full of the Book-Entry Commercial Notes, which is conditional upon the payment
in full of the Debentures, the Securitization Agent shall be the creditor</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/17pt Verdana,sans-serif; margin: 0; text-align: justify; text-indent: 0in">of all obligations, principal and ancillary, present and
future, owed by the Issuer under the Book-Entry Commercial Notes; and</P>

<P STYLE="font: 10pt/17pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/17pt Verdana,sans-serif; margin: 0; text-align: justify; text-indent: 0in"><B>(d)<FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">the Debentures will be distributed through a public offering, under the automatic distribution
registration procedure, pursuant to CVM Resolution No. 160, dated July 13, 2022, as in force (&ldquo;<U>Offering</U>&rdquo; and <U>&ldquo;CVM
Resolution 160</U>,&rdquo; respectively), and will be offered to professional investors, as defined in Articles 11 and 13 of CVM Resolution
No. 30, dated May 12, 2021, as in force (<U>&ldquo;Professional Investors</U>&rdquo; and, as they subscribe to and pay for the Debentures
under the Offering, the <U>&ldquo;Debenture Holders</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">THE <B>PARTIES </B>HEREBY <B>AGREE</B> to execute this <I>&ldquo;Terms
of the 1st (First) Issue of Book-Entry Commercial Notes, in 2 (Two) Series, for Private Placement, by Afya Participa&ccedil;&otilde;es
S.A.&rdquo;</I> (<U>&ldquo;Issuance Agreement</U>&rdquo;), pursuant to Article 45 et seq. of Law No. 14,195, of August 26, 2021, as in
force (<U>&ldquo;Law 14,195</U>&rdquo;), to be governed by the following clauses, terms, and conditions:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>AUTHORIZATIONS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>1.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Issuer&rsquo;s Authorization</U>: The issuance of Book-Entry Commercial
Notes by the Issuer, as well as the execution of this Issuance Agreement and the <I>&ldquo;Agreement for Coordination, Placement, and
Public Distribution via Automatic Registration, Under the Firm Placement Guarantee Regime, of Non-Convertible Debentures into Shares,
of the Unsecured Type, in 2 (Two) Series, for Public Distribution via Automatic Registration, of the 26th (Twenty-Sixth) Issuance by Opea
Securitizadora S.A., Backed by Book-Entry Commercial Notes Owed by Afya Participa&ccedil;&otilde;es S.A.&rdquo; </I>to be executed between
the Parties and the intermediary institutions of the Offering (&ldquo;<U>Distribution Agreement</U>&rdquo; and &ldquo;<U>Coordinators</U>,&rdquo;
respectively), will be carried out based on the resolutions of the Issuer&rsquo;s extraordinary general meeting, as held on October 8,
2025 (&ldquo;<U>Issuer&rsquo;s Corporate Approval</U>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>1.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The granting by Unigranrio of the Guarantee (as defined below), and the
assumption of the obligations set forth in this Issuance Agreement and any amendments thereto, were approved at Unigranrio&rsquo;s extraordinary
general meeting held on October 8, 2025 (&ldquo;<U>Unigranrio&rsquo;s Corporate Approval</U>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>1.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The granting by Uninovafapi of the Guarantee (as defined below) and the
assumption of the obligations set forth in this Issuance Agreement and any amendments thereto were approved at Uninovafapi&rsquo;s extraordinary
general meeting held on October 8, 2025 (<U>&ldquo;Corporate&rsquo;s Approval of </U>Uninovafapi&rdquo;)</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>1.4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The granting by UNIMA of the Guarantee (as defined below) and the assumption
of the obligations set forth in this Issuance Agreement and any amendments</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">thereto were approved in UNIMA&rsquo;s sole shareholder
resolution held on October 8, 2025 (&ldquo;<U>UNIMA Corporate Approval</U>&rdquo; and, together with the Issuer&rsquo;s Corporate Approval,
Unigranrio&rsquo;s Corporate Approval, and Uninovafapi&rsquo;s Corporate Approval, the &ldquo;<U>Corporate Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>REQUIREMENTS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: -42.55pt">The Offering will be
conducted in accordance with the following requirements:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>2.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The issuance of Book-Entry Commercial Notes, for private placement, pursuant
to Article 45 et seq. of Law 14,195, shall be conducted in compliance with the requirements below.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>2.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Exemption from Registration with the CVM and ANBIMA</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>2.2.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Offering will not be subject to registration with the CVM, since the Book-Entry Commercial
Notes will be offered through a private placement, without any sales or placement efforts directed at investors, or intermediation by
institutions within the distribution system, which is why the Issuer is exempt from the distribution registration requirement set forth
in Article 19 of Law No. 6,385, of December 7, 1976, as amended (&ldquo;<U>Securities Market Law</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>2.2.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Furthermore, the Offering will not be subject to registration with the Brazilian Association
of Financial and Capital Market Entities (&ldquo;<U>ANBIMA</U>&rdquo;), since the Book-Entry Commercial Notes will be offered through
a private placement, without any sales or placement efforts directed at investors, or intermediation by institutions within the distribution
system, which is why the Issuer is exempt from the distribution registration referred to in ANBIMA&rsquo;s <I>&ldquo;ANBIMA Self-Regulatory
Code for the Structuring, Coordination, and Distribution of Public Offerings of Securities and Public Tender Offers for </I>Securities&rdquo;
and the <I>&ldquo;Rules and Procedures for Public Offerings</I>,&rdquo; both in effect as of this date (&ldquo;<U>ANBIMA Code</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>2.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Filing of Corporate Approvals</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>2.3.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The minutes of the Issuer&rsquo;s Corporate Approval meeting that resolved on the Offering, as
well as any corporate acts related to the Offering that may be performed after the filing of this Offering , shall be filed with JUCEMG
and published in any widely circulated newspaper in the locality where the Issuer&rsquo;s headquarters is located (&ldquo;<U>Publication
Newspaper</U>&rdquo;), pursuant to Article 289 of the Brazilian Corporation Law, with simultaneous disclosure of the full text of the
Issuer&rsquo;s Corporate Approval on the Publication Newspaper&rsquo;s website, which must provide digital certification of the authenticity
of the documents</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in">maintained on its own pages issued by a certification
authority accredited within the Brazilian Public Key Infrastructure (ICP-Brasil), in accordance with applicable law<FONT STYLE="font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>2.3.1.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Issuer shall <B>(i) </B>file the Issuer&rsquo;s Corporate Approval with JUCEMG within five
(5) Business Days, counted from the respective date of signature; <B>(ii) </B>use its best efforts to obtain registration of the Issuer&rsquo;s
Corporate Approval and any subsequent corporate acts related to the Issuance and the Debentures with JUCEMG as quickly as possible, promptly
complying with any requirements made; and <B>(iii) </B>deliver to the Trustee one (1) electronic copy (PDF) of the Issuer&rsquo;s Corporate
Approval and any subsequent corporate acts related to the Offering and the Debentures registered with JUCEMG, as well as proof of publication
in the Official Gazette, within five (5) (five) Business Days from the date of the respective registration.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>2.3.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The minutes of Unigranrio&rsquo;s Corporate Approval meeting that resolved on the granting of
the Guarantee for this Issue, as well as any corporate acts related to the Issue that may be performed after the filing of this Issuance
Agreement, shall be filed with JUCERJA.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>2.3.3.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The minutes of Uninovafapi&rsquo;s Corporate Approval meeting that resolved on the granting of
a Guarantee for this Issue, as well as any corporate acts related to the Issue that may be performed after the filing of this Issuance
Agreement, shall be filed with JUCEPI.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>2.3.4.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The minutes of UNIMA&rsquo;s corporate resolution approving the provision of a guarantee for
this Offering, as well as any corporate acts related to the Offering and/or the Public Offering that may be carried out after the filing
of this Offering Memorandum, will be filed with JUCEAL.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>2.3.4.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Guarantors shall <B>(i) </B>file the respective Corporate Approval with the competent commercial
registry within five (5) Business Days from the respective date of signature; <B>(ii) </B>use their best efforts to obtain registration
of the respective Corporate Approval and any subsequent corporate acts related to the Issuance, the Guarantee, and the Book-Entry Commercial
Notes with the competent commercial registry as soon as possible, while timely comply with any requirements made; and <B>(iii) </B>deliver
to the Trustee one (1) electronic copy (PDF) of the respective Corporate Approval and any subsequent corporate acts related to the Issue
and the Book-Entry Commercial Notes registered with the competent commercial registry within five (5) Business Days, counted from the
date of the respective registration.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/16pt Segoe UI,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in"><FONT STYLE="font-family: Verdana,sans-serif; font-size: 10pt"><B>2.4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Verdana,sans-serif; font-size: 10pt"><U>Exemption from Registration for Distribution
and Trading</U>.</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/16pt Segoe UI,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Verdana,sans-serif; font-size: 10pt"><B>2.4.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-family: Verdana,sans-serif; font-size: 10pt">The Book-Entry Commercial Notes will not be registered for trading
on any regulated securities market. The Book-Entry Commercial Notes may not, under any circumstances, be assigned, sold, disposed of,
or transferred, except in the event of a liquidation of <U>the</U> separate estate of the Debentures (&ldquo;<U>Separate Estate</U>&rdquo;),
under the terms to be provided for in the Debenture Issuance Deed. Transfers of ownership of the Book-Entry Commercial Notes shall be
carried out in accordance with the procedures of the Book-Entry Commercial Notes Registrar (as defined below).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>THE ISSUER&rsquo;S CORPORATE PURPOSE AND THE CHARACTERISTICS OF THE ISSUE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>3.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Corporate Purpose of the Issuer</U>. The Issuer&rsquo;s corporate purpose
is: <B>(i) </B>to participate as a partner or shareholder in the capital of other companies or ventures; <B>(ii) </B>the development of
customizable, non-customizable, and custom software programs; <B>(iii) </B>information technology consulting; <B>(iv) </B>web design;
<B>(v) </B>reproduction of software on any medium; <B>(vi) </B>the provision of technical support, maintenance, and other information
technology services; <B>(vii) </B>data processing, application service providers, and internet hosting services; <B>(viii) </B>the provision
of content provider portal services and other internet information services; <B>(ix) </B>communication network access providers; <B>(x)
</B>other information service provision activities; <B>(xi) </B>direct marketing; <B>(xii) </B>advertising consulting; <B>(xiii) </B>brokerage
of advertising space, except in media outlets; <B>(xiv) </B>placement, on behalf of clients, of advertising material in newspapers, magazines,
radio, television, the internet, and other media outlets; <B>(xv) </B>other advertising activities not specified above; <B>(xvi) </B>film,
video, and television program production activities; <B>(xvii) </B>services for organizing trade fairs, conferences, exhibitions, and
events; <B>(xviii) </B>design and construction of booths for trade fairs and exhibitions; <B>(xix) </B>other service activities provided
primarily to businesses; <B>(xx) </B>intermediation and agency services for services and business, except real estate; <B>(xxi) </B>professional
and managerial development training, including related activities; <B>(xxii) </B>the management and of non-financial intangible assets,
including the licensing of the company&rsquo;s content and brands to third parties; <B>(xxiii) </B>higher education, including undergraduate,
graduate, and extension programs; <B>(xxiv) </B>technical-level vocational education; <B>(xxv) </B>preparatory courses for civil service
exams; <B>(xxvi) </B>educational support activities, except school supply stores; <B>(xxvii) </B>other teaching activities; <B>(xxviii)
</B>experimental research and development in social and human sciences; <B>(xxix) </B>experimental research and development in physical
and natural sciences; <B>(xxx) </B>collection and credit reporting activities; <B>(xxxi) </B>rental of scientific, medical, and hospital
equipment, without an operator; <B>(xxxii) </B>rental of owned real estate; <B>(xxxiii) </B>book publishing;</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify"><B>(xxxiv) </B>retail trade in books, newspapers,
and magazines; <B>(xxxv) </B>sales promotion; <B>(xxxvi) </B>design activities not previously specified; <B>(xxxvii) </B>outpatient medical
services with facilities for performing surgical procedures; <B>(xxxviii) </B>outpatient medical services limited to consultations; <B>(xxxix)
</B>human vaccination and immunization services; <B>(xl) </B>outpatient care services; <B>(xli) </B>other auxiliary financial services;
<B>(xlii) </B>aesthetic services and other beauty care services.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>3.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Securitization Transaction</U>. The issuance of the Book-Entry Commercial
Notes is part of the Securitization Transaction, such that all receivables arising from the Book-Entry Commercial Notes will be pledged
as collateral for the Debentures, as provided for in the Debenture Issuance Deed (&ldquo;<U>Pledged Receivables</U>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>3.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Issue Number</U>. This Issue constitutes the first (1st) issuance of
Book-Entry Commercial Notes by the Issuer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>3.4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Number of Series</U>. The Issue will be conducted in 2 (two) series,
each a &ldquo;<U>Series</U>,&rdquo; with the Book-Entry Commercial Notes to be subscribed to under the 1st (first) series hereinafter
referred to as &ldquo;<U>First Series Book-Entry Commercial Notes</U>,&rdquo; and the Book-Entry Commercial Notes to be subscribed to
under the 2nd (second) series hereinafter referred to as &ldquo;<U>Second Series Book-Entry Commercial Notes</U>,&rdquo; it being understood
that all references to Book-Entry Commercial Notes shall be understood as references to the First Series Book-Entry Commercial Notes and
Second Series Book-Entry Commercial Notes, collectively.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>3.5.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Total Issue Amount</U>. The total amount of the Issue shall be R$ 1,500,000,000.00
(one billion five hundred million reais) on the Issue Date (as defined below) (&ldquo;<U>Total Issue Amount</U>&rdquo;), consisting <B>of
(i) </B>R$ 500,000,000.00 (five hundred million reais) in First Series Book-Entry Commercial Note (as defined below); and <B>(ii) </B>R$
1,000,000,000.00 (one billion reais) in Second Series Book-Entry Commercial Note (as defined below).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><B>3.6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><U>Bookkeeper</U>.</FONT> <FONT STYLE="font-size: 10pt">The
Book-Entry Commercial Notes will be issued exclusively in book-entry form, pursuant to Article 45 of Law 14.195, with book-entry services
provided by <B>OLIVEIRA TRUST DISTRIBUIDORA DE T&Iacute;TULOS E VALORES MOBILI&Aacute;RIOS S.A.</B>, a corporation headquartered in the
city of Rio de Janeiro, state of Rio de Janeiro, at Avenida das Am&eacute;ricas, No. 3,434, Block 7, Room 201, Barra da Tijuca, CEP 22.640-102,
registered with the CNPJ/MF under No. 36.113.876/0001-91 (&ldquo;<U>Bookkeeper</U>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><B>3.6.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;
</FONT></B> <FONT STYLE="font-size: 10pt">Pursuant to Article 49 of Law 14,195, ownership of Book-Entry Commercial Notes shall be assigned
exclusively through a verification process conducted in the Bookkeeper&rsquo;s computerized systems.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0.55pt"><B>3.6.2.</B> For the purposes
of Article 51 of Law 14,195, the book-entry service for Book-Entry Commercial Notes must be performed on systems that meet the following
requirements:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 70.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(i)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">proof of compliance with appropriate technical standards, in accordance with the <I>Bank for
International Settlements </I>(BIS) Principles for Financial Market Infrastructures, including with respect to security, governance, and
business continuity;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 70.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(ii)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">guarantee of full access to information held by them or by third parties contracted by them to
perform activities related to bookkeeping;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 70.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(iii)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">guarantee of broad access to clear and objective information for market participants, subject
to legal restrictions on access to information; and</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 70.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(iv)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">compliance with requirements and the use of mechanisms that ensure interoperability with other
book-entry systems authorized by the CVM.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.8pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><B>3.6.3.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; letter-spacing: -0.1pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Book-Entry Commercial Note Registrar may not record securities in which it is a participant
as a creditor or issuer, either directly or indirectly.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 43.1pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>3.7.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Guarantee of Book-Entry Commercial Notes</U>. As security for the faithful,
timely, and full payment of all monetary and non-monetary obligations, principal and/or ancillary, present and/or future, assumed by the
Issuer in this Issuance Agreement with respect to the Book-Entry Commercial Notes and the s assumed by the Securitization Entity with
respect to the Debentures, including, but not limited to, <B>(a) </B>the obligations relating to the full and timely payment of the Unit
Par Value of the Book-Entry Commercial Notes and the Debentures or the balance of the Unit Par Value of the Book-Entry Commercial Notes
and the Debentures, the Remuneration (as defined below) of the Book-Entry Commercial Notes and the Debentures, Late Payment Charges, other
charges relating to the Book-Entry Commercial Notes and the Debentures subscribed, paid in full, and not redeemed, and other charges relating
to this Issuance Agreement and the other documents of the Offering, as applicable, when due, whether on the respective payment dates,
on the Maturity Date of the Book-Entry Commercial Notes and Debentures, or by virtue of the early maturity of the obligations arising
from the Book-Entry Commercial Notes and Debentures,</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">pursuant to this <FONT STYLE="font-size: 10pt">Issuance
Agreement and the other Issuance documents, as applicable; <B>(b) </B>the obligations relating to any other payment obligations assumed
by the Issuer in this Issuance Agreement and in the other offering documents, as well as by the Securitization Entity in the Debenture
Offering Deed and in the other offering documents, as applicable, including, but not limited to, obligations to pay the expenses arising
from the Offering, and any other expenses, costs, charges, taxes, reimbursements, indemnities, and other contractual and legal charges
provided for; <B>(c) </B>any expenses incurred by the Securitization Entity, in its capacity as holder of the Book-Entry Commercial Notes
and in the exercise of its rights related to the Offering; and <B>(d) </B>the obligations relating to the Book-Entry Agent, the Securitization
Entity, the Trustee, and the other service providers for the Offering, any and all costs or expenses demonstrably incurred by the Securitization
Entity as a result of proceedings, procedures, and/or other judicial or extrajudicial measures necessary to safeguard its rights and prerogatives
arising from the Book-Entry Commercial Notes, the Debentures, the Issuance Agreement, and the Debenture Issuance Deed; (&ldquo;Secured
Commercial Notes&rdquo;), as applicable, a surety bond shall be established in favor of the Securitization Entity, on an irrevocable and
irreversible basis, surety bond, provided in the form of a guarantee by the Guarantors, who hereby undertake, jointly and severally with
the Issuer, on an irrevocable and irreversible basis, before the Securitization Entity, as guarantors and primary payers, responsible
for the Secured Commercial Note, until full payment of the amount of the Secured Commercial Note, whether by the Issuer or by the Guarantors,
regardless of other contractual guarantees that may be established by the Issuer in connection with the Offering (<U>&ldquo;Guarantor(s)</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>3.8.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Guarantors shall not be released from the obligations assumed herein
by reason of any acts or omissions that may relieve them of their obligations or affect them, including, but not limited to, any: <B>(i)
</B>amendment to the terms and conditions of the Book-Entry Commercial Notes agreed upon between the Issuer and the Securitization Entity,
pursuant to this Issuance Agreement; <B>(ii) </B>novation or non-exercise of any right, action, privilege, and/or guarantee of the Securitization
Entity against the Issuer; or <B>(iii) </B>limitation or inability of the Issuer, including its filing for out-of-court reorganization,
filing for judicial reorganization, bankruptcy, or similar proceedings.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>3.8.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The amount of the Secured Commercial Note shall be paid within two (2) Business Days from receipt
of written notice sent by the Securitization Entity to the Issuer and the Guarantors informing of the Issuer&rsquo;s failure to pay, on
the respective payment date, of any amount owed by the Issuer under the terms of this Issuance Agreement, including, without limitation,
amounts owed to the Securitization Entity as principal, Remuneration on Book-Entry Commercial</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">Notes, <FONT STYLE="font-size: 10pt">or charges
of any nature. Payment of the amount of the Secured Commercial Note, in the exact amount of the defaulted amount, as stated in the aforementioned
written notice, shall be made by the Guarantors in accordance with the terms and procedures set forth in this Indenture.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>3.8.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The payment referred to in Clause 3.8.1 above shall be made outside the scope of B3 S.A. &ndash;
Brasil, Bolsa, Balc&atilde;o &ndash; Balc&atilde;o B3 (&ldquo;<U>B3</U>&rdquo;) through the actions of the Bookrunner, always in accordance
with the terms and procedures established in this Issuance Agreement.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>3.8.3.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Guarantors are authorized to make payment of the amount of the Guaranteed Commercial Note
obligations in default by the Issuer, regardless of whether they have received notification from the Securitization Entity, including
during any cure period established in the Issuance Agreement, in which case the Issuer&rsquo;s default shall be deemed cured by the Guarantors.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>3.8.4.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Any and all payments made by the Guarantors in connection with the Guarantees hereby provided
shall be made in such a manner that the Securitization Entity receives from the Guarantors the amounts that would have been paid had the
payment been made by the Issuer itself, that is, free and clear of any taxes, duties, fees, contributions of any nature, charges, or withholdings,
present or future, as well as any interest, fines, or other tax liabilities, and the Guarantors shall pay any additional amounts that
may be necessary.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>3.8.5.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">No objection or opposition by the Issuer may be accepted or invoked by the Guarantors for the
purpose of exempting themselves from fulfilling their obligations to the Securitization Entity.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>3.8.6.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Each Guarantor shall be subrogated to the Securitization Entity&rsquo;s and &rsquo;s credit rights
against the Issuer should it honor, in whole or in part, the Guarantees described in this Clause 3.8, provided that each Guarantor may
only demand and/or claim such amounts from the Issuer after the Securitization Entity has received all amounts due to it under the terms
of this Issuance Agreement. If any Guarantor receives any amount from the Issuer as a result of any amount it has honored under the terms
of this Issuance Agreement prior to the full settlement of all amounts due to the Securitization Company under the terms stipulated herein,
such Guarantor shall transfer such amount to the Securitization Company within two (2) Business Days from the date of receipt.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>3.8.7.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Each guarantee is provided by the Guarantors on an irrevocable and irreversible basis and shall
take effect on the Issue Date, remaining valid in all its terms and binding their respective successors until full payment of the</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">amount of the Secured Commercial Note, under
the terms set forth herein and in accordance with Article 897 et seq. of Law No. 10,406, of January 10, 2002, as amended (&ldquo;<U>Civil
Code</U>&rdquo;).</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>3.8.8.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Each guarantee may be enforced and claimed, judicially or extrajudicially, by the Securitization
Entity as many times as necessary until the full settlement of the amount of the Secured Commercial Note.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>3.8.9.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Each guarantee referred to in this section has been duly consented to in good faith by the Guarantors,
as legally sophisticated parties, in accordance with applicable legal provisions.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>3.8.10.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">It is hereby agreed and understood that the Securitization Entity&rsquo;s failure to comply with
the deadlines for enforcing the Guarantees shall under no circumstances result in the loss of any right or remedy provided for herein.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>3.8.11.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Based on the financial statements or balance sheets, as applicable, for the fiscal year ended
December 31, 2024, the shareholders&rsquo; equity: <B>(i) </B>of Unigranrio is R$ 79,419,000 (seventy-nine million, four hundred nineteen
thousand reais); <B>(ii) </B>of Uninovafapi is R$ 95,702,000 (ninety-five million, seven hundred and two thousand reais); and <B>(iii)
</B>of UNIMA is R$ 81,881,000 (eighty-one million, eight hundred and eighty-one thousand reais).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>GENERAL CHARACTERISTICS OF THE BOOK-ENTRY COMMERCIAL NOTES</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Issue Date</U>. For all legal purposes, the issue date of the Book-Entry
Commercial Notes shall be October 15, 2025 (&ldquo;<U>Issue Date</U>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Place of Issuance</U>. For all legal purposes, the place of issuance
of the Book-Entry Commercial Notes shall be the municipality of S&atilde;o Paulo, state of S&atilde;o Paulo.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Form, Type, and Proof of Ownership</U>. The Book-Entry Commercial Notes
will be issued exclusively in book-entry form, without the issuance of certificates or warrants, pursuant to Article 45 of Law 14,195;
for all legal purposes, ownership of the Book-Entry Commercial Notes will be evidenced by the deposit account statement issued by the
Book-Entry Agent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Place of Payment</U>. Payments relating to the Book-Entry Commercial
Notes and any other amounts that may be due by the Issuer and/or the Guarantors, pursuant to this Issuance Agreement, shall be made <B>(i)
</B>by the Issuer, with respect to payments relating to the Unit Par Value, the Remuneration, and the</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">Late Payment Charges (as defined below), through
the Bookkeeper and/or directly, by deposit into the Centralizing Account (as defined below); or <B>(ii) </B>by the Guarantors, through
the Bookkeeper and/or directly, by deposit into the Centralizing Account (as defined below).</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.5.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Use of Proceeds</U>. The proceeds obtained by the Issuer from the Book-Entry
Commercial Notes will be allocated to various corporate purposes, including, but not limited to, <B>(i) </B>the optional early redemption
in full of the Issuer&rsquo;s 1st (first) debenture issue (AFYA11) (&ldquo;<U>1st Debenture Issue</U>&rdquo;), <B>(ii) </B>the prepayment
of the total adjusted balance of the convertible loan provided for in the Share Purchase Agreement entered into between Afya Limited and
SBLA HOld CO on April 26, 2021 (&ldquo;<U>Softbank Prepayment</U>&rdquo; and, together with the 1st Debenture Issue, the &ldquo;<U>Existing
Debts</U>&rdquo;), and <B>(iii) </B>the management of the Issuer&rsquo;s liabilities and debt profile, within the scope of the ordinary
management of its business (&ldquo;<U>Allocation of Proceeds from Book-Entry Commercial Notes</U>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Issuer shall send to the Trustee, with a copy to the Securitization
Agent, from the First Payment Date until such time as the allocation of the proceeds from the Issue to items (i) and (ii) of Clause 4.5
above has been verified, a statement on letterhead signed by a legal representative, certifying the allocation of the proceeds from this
Issue , accompanied by the closing report of the 1st Debenture Issue and other supporting documents, and the Securitization Entity and
the Trustee may request from the Issuer any clarifications and additional documents that may be necessary at any time. The obligation
to prove the allocation of funds shall remain in effect until the Issuer proves the use of the proceeds from the Issue for items (i) and
(ii) of Clause 4.5 above, and proof of the allocation of the proceeds described in items (i) and (ii) of Clause 4.5 above must be provided
by the Maturity Date (as defined below).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.7.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Whenever requested in writing by authorities for the purpose of complying
with the rules and requirements of regulatory and supervisory bodies, within 10 (ten) Business Days from receipt of the request, or within
a shorter period if so requested by any authority or required by regulation, the Issuer undertakes to send to the Securitization Entity
the documents that, at the discretion of the respective authorities or regulatory bodies, prove the use of the proceeds from the Book-Entry
Commercial Notes in accordance with the allocations indicated above.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.8.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Convertibility</U>. The Book-Entry Commercial Notes are not convertible
into shares of the Issuer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.9.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Term and Maturity Date</U>. Subject to the provisions of this Issuance
Agreement, <B>(i) </B>the First Series Book-Entry Commercial Notes shall have a term of 1,097 (one thousand ninety-seven) calendar days
from the Issue Date, and shall therefore mature on October 16, 2028 (&ldquo;<U>Maturity Date of the First Series Book-Entry Commercial
Notes</U>&rdquo;); and <B>(ii) </B>the Second Series Book-Entry Commercial Notes shall have a term of 1,826 (one thousand eight hundred
twenty-six) calendar days from the Issue Date, maturing, therefore, on October 15, 2030 (&ldquo;<U>Maturity Date of the Second Series
Book-Entry Commercial Notes</U>&rdquo; and, together with the Maturity Date of the First Series Book-Entry Commercial Notes, the &ldquo;<U>Maturity
Dates</U>&rdquo;), subject to the events of early maturity of the obligations arising from the Book-Entry Commercial Notes, of total early
redemption arising from an Early Redemption Offer (as defined below) of all Book-Entry Commercial Notes, Optional Early Redemption, and
Optional Extraordinary Amortization (as defined below), pursuant to applicable laws and regulations and this Issuance Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.10.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Unit Par Value</U>. The Book-Entry Commercial Notes shall have a unit
par value of R$ 1,000.00 (one thousand reais) on the Issue Date (<U>&ldquo;Unit Par Value</U>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.11.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Number of Book-Entry Commercial Notes Issued</U>. A total of 1,500,000
(one million five hundred thousand) Book-Entry Commercial Notes will be issued in 2 (two) series, as follows: <B>(i)</B> 500,000 (five
hundred thousand) First Series Book-Entry Commercial Notes; and <B>(ii)</B> 1,000,000 (one million) Book-Entry Commercial Notes of the
Second Series (&ldquo;<U>Book-Entry Commercial Notes</U>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.12.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Collection of Investment Intentions</U>. The procedure for collecting
investment intentions organized by the Coordinators will be adopted, pursuant to the Distribution Agreement and CVM Resolution 160, to
verify the existence of demand for the placement of all Book-Entry Commercial Notes (and, consequently, the Debentures) with Professional
Investors (&ldquo;<U>Collection of Investment Intentions</U>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.13.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Subscription and Payment of Commercial Notes and Linkage to the Issuance
of Debentures</U>. The Book-Entry Commercial Notes will be subscribed to and paid for privately, exclusively by the Securitization Entity
and without joint liability, in cash and in local currency, after verification by the Securitization Entity of the effective subscription
and payment of the Debentures, on each payment date for the Debentures, subject to the terms and conditions of the Debenture Issuance
Deed, provided that <B>(i) </B>on the date of the first payment of Book-Entry Commercial Notes (&ldquo;<U>First Payment Date</U>&rdquo;),
the Book-Entry Commercial Notes shall be paid in full at the Unit Par Value, and, <B>(ii) </B>on the remaining payment dates (each, a
&ldquo;<U>Payment Date</U>&rdquo;), at the Unit Par Value plus the Remuneration for the respective Series, calculated <I>pro rata temporis
</I>from the First Payment</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">Date (inclusive) of the Book-Entry Commercial
Notes up to the date of their actual payment (exclusive) (&ldquo;<U>Payment Price</U>&rdquo;).</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0.55pt"><FONT STYLE="font-size: 10pt"><B>4.13.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Securitization Company, in its capacity as a securitization company, shall link all credits
arising from the Book-Entry Commercial Notes to the Debentures, in accordance with the Debenture Issuance Deed.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0.55pt"><FONT STYLE="font-size: 10pt"><B>4.13.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Due to the attachment of the Book-Entry Commercial Notes to the Debentures, the transfer of ownership
of the Book-Entry Commercial Notes to a third party other than the Securitization Company is prohibited, unless there is an express resolution
to that effect by the Debenture Holders, respecting the minimum quorum set forth in the Debenture Issuance Deed. Similarly, any modification
of the rights set forth in this Issuance Agreement shall be subject to the prior approval of the Debenture Holders, as well as the express
consent of the Issuer, which acknowledges and agrees that, due to the fiduciary regime to be established by the Securitization Company,
in its capacity as the securitization company and issuer of the Debentures, pursuant to Article 25 of Law 14,430, any and all funds due
to the Securitization Entity, arising from its ownership of the Book-Entry Commercial Notes, shall be expressly linked to the payments
to be made to the Debenture Holders and shall not be subject to any form of set-off, withholding, or discount. In this regard, the claims
arising from the Book-Entry Commercial Notes, as well as the other assets and rights subject to the fiduciary regime established within
the scope of the Securitization Transaction:</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(i)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">constitution of the Separate Estate, which is not to be confused with its common estate or with
other separate estates owned by the Securitization Entity arising from the establishment of a fiduciary regime within the scope of other
issuances of receivables certificates, debentures, or other securitization instruments; </FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 56.7pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(ii)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">shall be kept separate from the securitization company&rsquo;s general assets and other segregated
assets until the Secured Commercial Note Obligations have been fully discharged, including the full amortization of the issue to which
they are allocated, with payment in kind being permitted for this purpose upon approval by the General Meeting of Debenture Holders, or
until the conditions for partial release set forth in this Issuance Agreement are met; </FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 56.7pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(iii)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">shall be used exclusively for the settlement of the Debentures to which they are allocated and
for the payment of administrative costs and related tax obligations, in accordance with the procedures established in this Issuance Agreement;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 56.7pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(iv)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">shall not be liable to the Securitization Company&rsquo;s creditors for any obligation;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 56.7pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(v)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">shall not be subject to the creation of security interests by any of the Securitization Company&rsquo;s
creditors, however senior they may be; and</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 56.7pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(vi)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">are liable only for the obligations arising from the Debentures to which they are allocated.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0.55pt"><FONT STYLE="font-size: 10pt"><B>4.13.3.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The payment of the Debentures and, consequently, of the Book-Entry Commercial Notes is subject
to the fulfillment of the Conditions Precedent, as defined and listed in Clause 4.15 below, as well as the conditions precedent set forth
in the Distribution Agreement, provided that the amounts arising from the payment of the Book-Entry Commercial Notes, after withholding
the Initial Expense Fund Amount (as defined below) (&ldquo;<U>Redemption Proceeds</U>&rdquo;) must be deposited into checking account
no. 07952-2, held at branch no. 9699 of Banco Ita&uacute; (341), linked to the Separate Trust (&ldquo;<U>Centralizing Account</U>&rdquo;),
with formal notification provided via email.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.14.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Conditions precedent for the payment of Book-Entry Commercial Notes and
Debentures</U>. Without prejudice to the conditions precedent set forth in the Distribution Agreement, the payment of the Book-Entry Commercial
Notes by the Securitization Entity is subject to the cumulative satisfaction of the following conditions (&ldquo;<U>Conditions Preceden</U>t&rdquo;),
and the Securitization Entity is responsible, as defined in the Debenture Issuance Deed, for verifying:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(i)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">the proper execution of all Transaction Documents (as defined in the Debenture Indenture), which
includes the signature by the respective parties, as well as the verification of the powers of the representatives of those parties and
the obtaining of the necessary approvals for such, as well as the respective validation of digital signatures in accordance with ICP-Brasil
regulations in the ICP-Brasil Digital Signature Standard Compliance Checker provided by ITI &ndash; National Institute of Information
Technology, in the event that the documents are digitally signed;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(ii)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">subscription and payment of the Debentures;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(iii)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">issuance of a legal opinion by the legal advisors of the Issuer and the Coordinators, in terms
satisfactory to the Coordinators and without restrictions, and addressed to the Coordinators, pursuant to the Distribution Agreement;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(iv)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;
</FONT></B> <FONT STYLE="font-size: 10pt">receipt by the Securitization Entity of <I>the legal opinion </I>prepared by a specific legal
advisor to be engaged by the Securitization Entity, certifying, in terms satisfactory to the Securitization Entity, at its sole discretion
and without restrictions on use, the legality, validity, enforceability, and adequacy of the Transaction Documents in relation to applicable
regulations; confirmation of the powers of representation of the signatories to the Transaction Documents; and the obtaining of all necessary
corporate authorizations for their execution and the assumption of the obligations set forth therein; and the absence of any reservations
regarding the completion of the Transaction ; and</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(v)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">receipt by the Securitization Entity of the conclusion of the legal due diligence for the Transaction
performed by the legal advisors engaged in connection with the Transaction, in accordance with market standards, certifying, in terms
satisfactory to the Securitization Entity and at its sole discretion, the absence of contingencies of any nature that would prevent or
render inadvisable the execution of the Transaction, including the receipt of the final audit list prepared by the legal advisors engaged
in connection with the Transaction.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.14.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The release of the Funds from the Centralizing Account (as defined below) by the Securitization
Entity shall be made to a freely transferable account of the Issuer within one (1) Business Day after receipt in the Centralizing Account.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.15.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Monetary Restatement of Book-Entry Commercial Notes</U>. The unit face
value of the First Series Book-Entry Commercial Notes and the unit face value or the balance of the unit face value of the Second Series
Book-Entry Commercial Notes, as applicable, will not be subject to monetary restatement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.16.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Interest on Book-Entry Commercial Notes</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.16.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>Remuneration of Book-Entry Commercial Notes of the First Series</U>. Interest shall accrue
on the Unit Par Value of the First Series Book-Entry Commercial Notes at a rate corresponding to the cumulative variation of 100% (one
hundred percent) of the average daily rates of the DI &ndash; One-Day Interbank Deposit, <I>&ldquo;over </I>extra group,&rdquo; expressed
as an annual percentage rate, based on 252 (two hundred fifty-two) Business Days, calculated and disclosed daily by B3 in the daily bulletin
available on its website (www.b3.com.br) (<U>&ldquo;DI </U>Rate&rdquo;), plus an exponential spread of 0.70% (seventy hundredths of a
percent) per annum, based on 252 (two hundred fifty-two) Business Days (<U>&ldquo;Remuneration of the First Series Book-Entry Commercial
Notes</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.16.1.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B> <FONT STYLE="font-size: 10pt">The Remuneration on the First Series Book-Entry Commercial Notes shall be calculated on an exponential
and cumulative <I>pro rata temporis </I>basis for elapsed Business Days, applied to the Unit Par Value of the First Series Book-Entry
Commercial Notes, from the Interest Commencement Date or the immediately preceding (inclusive) Payment Date for the First Series Book-Entry
Commercial Notes (as defined below), as applicable, until the Payment Date for the First Series Book-Entry Commercial Notes in question,
the payment date resulting from early maturity due to a Default Event (as defined below) or the date of any Optional Early Total Redemption
(as defined below), redemption resulting from a Total Early Redemption Offer (as defined below), whichever occurs first. The Interest
on the First Series Book-Entry Commercial Notes will be calculated according to the following formula:</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: center"><B>J=Vne x (Interest Factor &ndash; 1)</B></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">where:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>J </B>= unit value of the Remuneration on
the First Series Book-Entry Commercial Note due at the end of the Capitalization Period (as defined below), calculated to 8 (eight) decimal
places, without rounding;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>Vne </B>= Unit Par Value of the First Series
Book-Entry Commercial Notes reported/calculated to 8 (eight) decimal places, without rounding; and</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>Interest Factor </B>= Interest Factor composed
of the fluctuation parameter plus the spread, calculated to 9 (nine) decimal places, rounded, determined as follows:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: center"><B>Interest Factor = (DI Factor x Spread Factor)</B></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">where:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>DI Factor </B>= Product of the DI Rates, from
the start date of the Capitalization Period, inclusive, through the calculation date, exclusive, calculated to 8 (eight) decimal places,
rounded, determined as follows:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/200% Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: center"><IMG SRC="image_014.jpg" ALT=""><FONT STYLE="font-family: Verdana,sans-serif; font-size: 9pt"></FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">where:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>n </B>= Total number of DI Rates considered
in the calculation of the asset, where &ldquo;n&rdquo; is an integer;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>k </B>= Sequence number of the DI Rates, ranging
from 1 (one) to &ldquo;n&rdquo;;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">Exclusively for the first Capitalization Period,
a remuneration premium equivalent to the product of 2 (two) Business Days preceding the Start Date of the Return on the funds <I>pro rata
temporis</I>, calculated as above, shall be capitalized to the DI Factor.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>TDIk </B>= DIk Rate, of order &ldquo;k&rdquo;,
expressed per day, calculated to 8 (eight) decimal places, rounded, determined as follows:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/200% Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: center"><IMG SRC="image_015.jpg" ALT=""><FONT STYLE="font-family: Verdana,sans-serif; font-size: 9pt"></FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">where:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>DIk </B>= DI Rate, published by B3, valid
for 1 (one) Business Day (overnight), used with 2 (two) decimal places, with a lag of 1 (one) Business Day; and</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>FactorSpread </B>= Fixed interest surcharge
calculated to 9 (nine) decimal places, rounded, determined according to the formula below:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/200% Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: center"><IMG SRC="image_016.jpg" ALT=""><FONT STYLE="font-family: Verdana,sans-serif; font-size: 9pt"></FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">where:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B><I>Spread </I></B><I>= 0.7000; </I>and</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>DP </B>= number of business days between the
First Settlement Date of the First Series Book-Entry Commercial Notes or the last Interest Payment Date of the First Series Book-Entry
Commercial Notes, as applicable, and the current date, where &ldquo;DP&rdquo; is an integer.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><U>Notes</U>:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(i)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The product of the daily factors (1 + TDI<SUB>k</SUB>) is calculated, and for each accumulated
daily factor, the result is truncated to 16 (sixteen) decimal places, applying the next daily factor, and so on until the last one considered.</FONT></P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(ii)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">If the daily factors are accumulated, the resulting factor &ldquo;DI Factor&rdquo; shall be considered
with 8 (eight) decimal places, rounded.</FONT></P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(iii)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The factor resulting from the expression (DI Factor &times; Spread Factor) is considered to have
9 (nine) decimal places, rounded. </FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(iv)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B> <FONT STYLE="font-size: 10pt">The DI Rate must be used with the same number of decimal places as disclosed by the agency responsible
for its calculation.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.16.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Interest <U>on Second Series Book-Entry Commercial Note</U>. Interest corresponding to the DI
Rate, plus <I>a </I>spread of 0.85% (eighty-five hundredths of a percent) per annum, compounded over 252 (two hundred fifty-two) Business
Days (<U>&ldquo;Remuneration of the Second Series Book-Entry Commercial </U>Notes&rdquo; and, together with the Remuneration of the First
Series Book-Entry Commercial Notes, the &ldquo;Remuneration&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.16.2.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Remuneration on the Second Series Book-Entry Commercial Notes shall be calculated on a compound
and cumulative <I>pro rata temporis </I>basis for elapsed Business Days, applied to the Unit Par Value or the balance of the Unit Par
Value of the Second Series Book-Entry Commercial Notes, as applicable, from the Interest Accrual Start Date or the immediately preceding
Payment Date for the Second Series Book-Entry Commercial Notes (inclusive), as applicable, until the Payment Date for the Second Series
Book-Entry Commercial Notes in question, the payment date resulting from early maturity due to a Default Event (as defined below) or the
date of any Optional Early Total Redemption (as defined below), redemption resulting from an Early Total Redemption Offer (as defined
below), whichever occurs first. The Remuneration shall be calculated according to the following formula:</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: center"><B>J = Vne &times; (Interest Factor &ndash; 1)</B></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">where:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>J </B>= Unit value of the Remuneration of
the Second Series Book-Entry Commercial Notes due at the end of each Capitalization Period, calculated to 8 (eight) decimal places, without
rounding;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>Vne </B>= Unit Par Value or balance of the
Unit Par Value of the Second Series Book-Entry Commercial Notes reported/calculated to 8 (eight) decimal places, without rounding;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>Interest Factor </B>= Interest factor composed
of the fluctuation parameter plus the <I>spread</I>, calculated to 9 (nine) decimal places, rounded, determined as follows:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: center"><B>Interest Factor = (DI Factor x Spread Factor)</B></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">where:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>DI Factor </B>= Product of the DI Rates from
the start date of the Capitalization Period, inclusive, through the calculation date, exclusive, calculated to 8 (eight) decimal places,
rounded, determined as follows:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/200% Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: center"><IMG SRC="image_017.jpg" ALT=""><FONT STYLE="font-family: Verdana,sans-serif; font-size: 9pt"></FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">where:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>n </B>= Total number of DI Rates considered
in the calculation of the asset, where &ldquo;n&rdquo; is an integer;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>k </B>= Sequence number of the DI Rates, ranging
from 1 (one) to &ldquo;n&rdquo;;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">Exclusively for the first Capitalization Period,
a remuneration premium equivalent to the product of the 2 (two) Business Days preceding the Start Date of the Return on the funds, calculated
<I>pro rata temporis </I>as described above, shall be capitalized at the DI Factor ( ).</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>TDIk </B>= DIk Rate, of order &ldquo;k&rdquo;,
expressed per day, calculated to 8 (eight) decimal places, rounded, determined as follows:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/200% Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: center"><IMG SRC="image_018.jpg" ALT=""><FONT STYLE="font-family: Verdana,sans-serif; font-size: 9pt"></FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">where:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>DIk </B>= DI Rate, published by B3, valid
for 1 (one) Business Day (overnight), used with 2 (two) decimal places; and</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>SpreadFactor </B>= Fixed interest surcharge
calculated to 9 (nine) decimal places, rounded, determined according to the formula below:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/200% Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: center"><IMG SRC="image_019.jpg" ALT=""><FONT STYLE="font-family: Verdana,sans-serif; font-size: 9pt"></FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">where:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>DP </B>= number
of business days between the First Settlement Date of the Second Series Book-Entry Commercial Notes or the last Payment Date of</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">the Second Series Book-Entry Commercial Notes,
as applicable, and the current date, where &ldquo;DP&rdquo; is an integer;
and</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B><I>Spread </I></B>= 0.8500.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><U>Notes</U>:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(i)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The daily factors are multiplied together (1 + TDI<SUB>k</SUB>), and for each accumulated daily
factor, the result is truncated to 16 (sixteen) decimal places, the next daily factor is applied, and so on until the last factor considered.</FONT></P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(ii)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">If the daily factors are accumulated, the resulting factor &ldquo;DI Factor&rdquo; is considered
with 8 (eight) decimal places, rounded.</FONT></P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(iii)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The factor resulting from the expression (DI Factor &times; Spread Factor) is considered to have
9 (nine) decimal places, rounded. </FONT></P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(iv)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The DI Rate shall be used with the same number of decimal places as disclosed by the body responsible
for its calculation.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.16.3.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Subject to the provisions of Clause 4.15.4 below, if, at any time during the term of the Book-Entry
Commercial Notes and, consequently, of the Debentures, the DI Rate is not disclosed by B3, the last available DI Rate up to that point
shall be applied to calculate the Remuneration, and no compensation shall be due between the Issuer, the Securitization Entity, and/or
the Debenture Holders upon subsequent disclosure of the DI Rate that would have been applicable (&ldquo;<U>Unavailability of the DI Rate</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.16.4.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">If the DI Rate ceases to be published for a period exceeding thirty (30) days, or if it is discontinued,
or if it becomes legally impossible to apply the DI Rate to calculate the interest on the Book-Entry Commercial Notes of the respective
Series and, consequently, on the Debentures (<U>&ldquo;Period of Absence of the DI </U>Rate&rdquo;), the Securitization Entity shall,
within a maximum of five (5) Business Days from the end of the aforementioned thirty (30)-day period or from the event of abolition or
inapplicability, as the case may be, convene a general meeting of Debenture Holders, in accordance with the provisions set forth in the
Debenture Issuance Deed (<U>&ldquo;General Meeting of Debenture </U>Holders&rdquo;), the purpose of which shall be for the Debenture Holders,
in agreement with the Issuer and in compliance with applicable regulations, to resolve upon the new Remuneration parameter for the Book-Entry
Commercial Notes and, consequently, for the Debentures, a parameter that shall preserve the real value and the same levels of Remuneration
of the Book-Entry Commercial Notes and, consequently, of the Debentures, provided that, as this is a structured transaction for the issuance
of the Debentures, the Securitization Entity&rsquo;s decision shall be made solely and exclusively as defined at the General</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">Meeting of Debenture Holders. Until the resolution
regarding this new Remuneration parameter for Book-Entry Commercial Notes, when calculating any monetary obligations related to the Book-Entry
Commercial Notes provided for in this <FONT STYLE="font-size: 10pt">Issuance Agreement, the most recently officially disclosed DI Rate
shall be used to determine the DI Rate, and no compensation shall be due between the Issuer, the Securitization Entity, and/or the Debenture
Holders upon the determination of the new Remuneration parameter for the Book-Entry Commercial Notes.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.16.5.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">If the DI Rate is published again prior to the convening of the General Meeting of Debenture
Holders, unless the application of the DI Rate is impossible due to a legal and/or judicial prohibition, said General Meeting of Debenture
Holders shall not be held, and the DI Rate, as of the date of its disclosure, shall once again be used to calculate any monetary obligations
relating to the Book-Entry Commercial Notes, as provided for in this Issuance Agreement.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.16.6.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">If: <B>(i) </B>there is no agreement on the new Remuneration parameter between the Securitization
Entity and the Debenture Holders representing at least two-thirds (2/3) of the Outstanding Debentures (as defined in the Debenture Issuance
Deed), on first call, or at least 50% (fifty percent) plus one of the Outstanding Debentures, on second call; <B>(ii) </B>there is no
quorum for deliberation on second call ; or <B>(iii) </B>there is no quorum for the meeting to convene on second call; the Securitization
Entity shall redeem all of the Debentures within a maximum period of 30 (thirty) calendar days from the closing date of the respective
General Meeting of Debenture Holders or within a longer period to be defined by mutual agreement at said meeting, or from the date on
which the General Meeting of Debenture Holders should have taken place upon second call, or on the Maturity Date, at their Unit Par Value
or the balance of the Unit Par Value of the Debentures, as the case may be, plus the Remuneration, calculated <I>pro rata temporis</I>,
from the Commencement Date of Remuneration or the immediately preceding Remuneration Payment Date due until the date of actual redemption.
Debentures redeemed under the terms of this Clause shall be canceled by the Securitization Entity. In this case, for the calculation of
the Remuneration of the Debentures to be redeemed, for each day of the period in which there are no rates, the last DI Rate officially
disclosed at shall be used.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.16.7.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Interest Accrual Period (&ldquo;Accrual Period&rdquo;) is, for the first Accrual Period,
the time interval beginning on the Interest Accrual Start Date, inclusive, and ending on the first Interest Payment Date, exclusive, and,
for the remaining Capitalization Periods, the time interval beginning on the immediately preceding Remuneration Payment Date, inclusive,
and ending on the subsequent</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">Remuneration Payment Date, exclusive. Each Capitalization
Period follows the previous one without interruption, until the Maturity Date.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.17.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Payment of Remuneration on Book-Entry Commercial Notes</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.17.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>Payment of Interest on the First Series Book-Entry Commercial Notes</U>. Without prejudice
to payments resulting from any Optional Full Early Redemption of the First Series Book-Entry Commercial Notes involving the cancellation
of all First Series Book-Entry Commercial Notes, total early redemption resulting from a Total Early Redemption Offer with the cancellation
of all First Series Book-Entry Commercial Notes or early maturity of the obligations arising from the First Series Book-Entry Commercial
Notes, pursuant to the terms set forth in this Issuance Agreement, the Interest on the First Series Book-Entry Commercial Notes will be
paid semiannually, with the first payment due on April 15, 2026, and the remaining payments due on the 15th (fifteenth) day of April and
Oct , each year, until the Maturity Date (each, a <U>&ldquo;Payment Date for the Remuneration of the First Series Book-Entry Commercial
</U>Notes&rdquo;), as shown in the table below:</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="width: 34%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt"><B>Installment Number</B></FONT></TD>
    <TD STYLE="width: 66%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt"><B>Payment Date for the First Series</B></FONT><B> Book-Entry <FONT STYLE="font-size: 10pt">Commercial Notes</FONT></B></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">1</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">April 15, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">2</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">October 15, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">April 15, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">4</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">October 15, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">5</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">April 17, 2028</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">6</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">Maturity Date</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.17.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>Payment of Interest on the Second Series Book-Entry Commercial Notes</U>. Without prejudice
to payments resulting from any Optional Full Early Redemption of the Second Series Book-Entry Commercial Notes involving the cancellation
of all Second Series Book-Entry Commercial Notes, full early redemption resulting from a Full Early Redemption Offer with the cancellation
of all Second Series Book-Entry Commercial Notes or early maturity of the obligations arising from the Second Series Book-Entry Commercial
Notes, pursuant to the terms set forth in this Issuance Agreement, the Interest on the Second Series Book-Entry Commercial Notes shall
be paid semiannually, with the first payment due on April 15, 2026, and all subsequent payments due on the 15th day of April and October
of each year, until the Maturity Date (each, a &ldquo;<U>Second Series Book-Entry Commercial Notes Interest Payment </U>Date&rdquo; and,
when taken together with the First Series Book-Entry Commercial Notes</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">Interest Payment Date, the <U>&ldquo;Interest
Payment Date(s)</U>&rdquo;), as shown in the table below <FONT STYLE="font-size: 10pt">:</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="width: 34%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt"><B>Installment Number</B></FONT></TD>
    <TD STYLE="width: 66%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt"><B>Payment Date for Interest on Second Series</B></FONT><B> Book-Entry <FONT STYLE="font-size: 10pt">Commercial Note</FONT></B></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">1</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">April 15, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">2</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">October 15, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">April 15, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">4</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">October 15, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">5</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">April 17, 2028</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">6</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">October 16, 2028</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">7</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">April 16, 2029</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">8</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">October 15, 2029</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">9</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">April 15, 2030</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">10</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">Maturity Date</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.18.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Amortization of the remaining Unit Par Value</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.18.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>Redemption of the First Series Book-Entry Commercial Notes</U>. Without prejudice to payments
resulting from any Optional Full Early Redemption of the First Series Book-Entry Commercial Notes involving the cancellation of all First
Series Book-Entry Commercial Notes, total early redemption resulting from a Total Early Redemption Offer with the cancellation of all
First Series Book-Entry Commercial Notes or early maturity of the obligations arising from the First Series Book-Entry Commercial Notes,
pursuant to the terms set forth in this Issuance Agreement, the Unit Par Value of the First Series Book-Entry Commercial Notes shall be
redeemed in a single installment on the Maturity Date of the First Series Book-Entry Commercial Notes, namely October 16, 2028 (<U>&ldquo;Redemption
Date of the First Series Book-Entry Commercial Notes</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.18.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>Redemption of the Second Series Book-Entry Commercial Notes</U>. Without prejudice to payments
resulting from any Optional Full Early Redemption of the Second Series Book-Entry Commercial Notes with the cancellation of all Second
Series Book-Entry Commercial Notes, total early redemption resulting from a Total Early Redemption Offer with the cancellation of all
Second Series Book-Entry Commercial Notes or early maturity of the obligations arising from the Second Series Book-Entry Commercial Notes,
pursuant to the terms set forth in this Issuance Agreement, the balance of the Unit Par Value of the Second Series Book-Entry Commercial
Notes shall be amortized in two (2) consecutive annual installments, with the first installment</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">due on October 15, 2029, and the other installment
due on the Maturity Date of the Second Series Book-Entry Commercial Notes, in accordance with the dates indicated in the second column
of the table below (each, a <U>&ldquo;Second Series Book-Entry Commercial Notes Redemption </U>Date&rdquo; and, when taken together with
the Redemption of the First Series Book-Entry Commercial Notes, the <U>&ldquo;Redemption Date of the Book-Entry Commercial Note</U>s&rdquo;)
and percentages set forth in the third column of the table below<FONT STYLE="font-size: 10pt">:</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="width: 24%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt"><B>Redemption Installment</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt"><B>Redemption Date</B></FONT></TD>
    <TD STYLE="width: 43%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt"><B>Percentage of the Nominal Value to be Amortized (%)</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">1</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">October 15, 2029</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">50.0000%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">2</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">Maturity Date</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; font-family: Verdana,sans-serif; line-height: 16pt"><FONT STYLE="font-size: 10pt">100.0000%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.19.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Payments relating to the Book-Entry Commercial Notes and any other amounts
that may be owed by the Issuer and/or the Guarantors, pursuant to this Issuance Agreement, shall be made <B>(i) </B>by the Issuer, with
respect to payments relating to the Unit Par Value, the Interest, and the Late Payment Charges (as defined below), through the Bookkeeper
and/or directly, by deposit into the Centralizing Account; or <B>(ii) </B>by the Guarantors, through the Bookkeeper and/or directly, by
deposit into the Centralizing Account.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.20.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Extension of Deadlines</U>. Deadlines for the payment of any obligation
shall be deemed extended until the 1st (first) subsequent Business Day, if the due date falls on a day when banks are not open for business
at the place of payment of the Book-Entry Commercial Notes, in which case an extension shall only apply when the payment date coincides
with a national holiday in the Federative Republic of Brazil, a Saturday, or a Sunday, without any increase in the amounts to be paid,
provided that an interval of at least 2 (two) Business Days between the Securitization Entity&rsquo;s receipt of funds from the Commercial
Note and the payment of its obligations relating to the Debentures, with no increase in the amounts received by the Securitization Entity
during the aforementioned extension.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.20.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Except as expressly provided otherwise in this Issuance Agreement, &ldquo;<U>Business Day(s)</U>&rdquo;
means: <B>(i) </B>with respect to any obligation settled through B3, including for calculation purposes, any day other than a Saturday,
Sunday, or national holiday in the Federative Republic of Brazil; and <B>(ii) </B>with respect to any obligation not executed through
B3, any day on which commercial banks are open for business in the city of S&atilde;o Paulo, State of S&atilde;o Paulo, and in the city
of Belo Horizonte, State of Minas Gerais.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.21.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">In the event of a delay in the payment of any monetary obligations related
to the Book-Entry Commercial Notes, overdue and unpaid amounts shall accrue default interest of 1% (one percent) per month, calculated
<I>pro rata temporis</I>, from the date of default until the date of actual payment, as well as a non-compensatory penalty of 2% (two
percent) on the amount due, regardless of any notice, notification, or judicial or extrajudicial demand (&ldquo;<U>Late Payment Charges</U>&rdquo;).
All amounts received by the Securitization Entity as a result of the payment of Late Payment Charges shall be used for the benefit of
the Noteholders and shall be passed on to them, and shall, for all purposes, be added to the amortization installment due to each Noteholder.
It is hereby established that the Securitization Entity shall not be held liable for delays, failures, and/or the fault of third parties
involved in the settlement and payment operations of the Book-Entry Commercial Notes.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.22.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Forfeiture of Rights to Accruals</U>. The Securitization Entity&rsquo;s
failure to appear to receive the amount corresponding to any monetary obligations on the dates set forth in this Issuance Term or in any
communication made pursuant to this Issuance Term shall not entitle it to any accruals for the period relating to the delay in receipt;
however, the rights accrued up to the respective maturity or payment date, in the event of late payment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.23.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Scheduled Refinancing</U>. The Book-Entry Commercial Notes shall not
be subject to scheduled refinancing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>4.24.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Publicity</U>. All relevant acts and decisions to be taken arising from
this Issuance that, in any way, involve the interests of the Securitization Entity must be communicated by the Issuer to the Securitization
Entity. The aforementioned disclosures shall be waived if the fact to be reported is communicated directly and individually by the Issuer
to the Securitization Entity, by physical or electronic means, in both cases with notice or proof of receipt.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/14pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in"><FONT STYLE="font-size: 10pt"><B>4.25.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Expense Fund</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.25.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Securitization Entity shall establish, in the Centralizing Account linked to the Separate
Trust, into which all payments due under the Book-Entry Commercial Notes will be made, in accordance with the Order of Allocation of Funds
(as defined in the Debenture Issuance Deed), a reserve for the payment of the Offering expenses described in the table contained in <B><U>Annex
I </U></B>of this Issuance Agreement (<U>&ldquo;Initial Expenses</U>,&rdquo; <U>&ldquo;Recurring Expenses</U>,&rdquo; and, collectively,
Initial Expenses and Recurring Expenses, &ldquo;Expenses&rdquo; and <U>&ldquo;Expense Fund</U>,&rdquo; respectively ), by withholding
funds related to the payment of the Book-Entry Commercial Notes on the First Payment Date, in an amount equivalent to R$ 210,660.00 (two
hundred and ten thousand, six hundred and sixty reais)</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">(<U>&ldquo;Initial Expense Fund </U>Amount&rdquo;)
to cover 12 (twelve) months of Expenses. Exclusively on the First Payment Date, of the Initial Expense Fund Amount will be withheld along
with the amount of the Initial Expenses.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.25.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">If, at any time, the funds in the Expense Fund total less than R$ 110,000.00 (one hundred and
ten thousand reais) (<U>&ldquo;Minimum Value of the Expense </U>Fund&rdquo;), the Securitization Entity must notify the Issuer and/or
the Guarantors, with a copy to the Trustee, within 2 (two) Business Days from the verification of the absence of funds, so that they may
transfer the amount necessary to replenish the Expense Fund to the Initial Value of the Expense Fund to the Centralizing Account, within
2 (two) Business Days from the date the notice is sent and, furthermore, forward, on the same date, proof of said replenishment to the
Securitization Entity.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.25.3.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">If the funds in the Expense Fund are insufficient and the Issuer does not make such payments
directly or does not replenish the Minimum Value of the Expense Fund to the Centralizing Account, as provided for in this instrument,
such expenses shall be borne by the Securitization Entity using the remaining funds in the Separate Equity. Expenses paid by the Securitization
Entity using the Separate Equity resources shall be reimbursed by the Issuer within five (5) Business Days from the date of such notification,
upon presentation by the Securitization Entity of a notice indicating the expenses incurred, accompanied by receipts/invoices.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.25.4.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">If the funds of the Separate Account are insufficient to cover the Expenses, the Securitization
Company may request that the Debenture Holders cover such payment by contributing funds to the Separate Account, provided that the Debenture
Holders shall decide on such payment(s) in accordance with a resolution adopted at the respective General Meeting to be convened for this
purpose.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.25.5.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">In the event described in Clause 4.25.4 above, the Debenture Holders, meeting at a General Meeting
convened for this purpose, pursuant to the Deed of Issue, shall resolve on the contribution of funds, in proportion to the number of Debentures
held by each Debenture Holder, provided that, if they agree to such contribution, they shall have a right of recourse against the Issuer
and a right of priority in the event of receipt of future proceeds by the Separate Estate of the Debentures, whether or not such proceeds
are the subject of litigation. Any Expenses that have not been paid in accordance with this Clause shall be added to the Issuer&rsquo;s
debt and must be paid in accordance with the order of allocation of funds provided for in the Debentures.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.25.6.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B> <FONT STYLE="font-size: 10pt">As provided in the Deed of Issuance, if any of the Debenture Holders fails to comply with any
obligation to contribute funds to the Separate Trust to cover any expenses necessary to safeguard their interests, the Securitization
Entity shall be authorized to offset any remuneration to which such defaulting Debenture Holder is entitled in its capacity as a Debenture
Holder of the Issue against the amounts spent by the Securitization Entity on such expenses.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.25.7.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Under no circumstances shall the Securitization Entity incur Expenses in advance and/or bear
Expenses with its own funds.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>4.25.8.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The amounts arising from the Expense Fund, while retained in the Centralizing Account, shall
be invested, at the sole discretion of the Securitization Entity, in accordance with the terms and conditions stipulated in this Issuance
Agreement and/or in the Debenture Issuance Deed, in <B>(i) </B>daily liquid bank certificates of deposit issued by financial institutions
that have a risk rating equivalent to AAA on a national scale, as assigned by Standard &amp; Poor&rsquo;s and/or Fitch Ratings and/or
Moody&rsquo;s Investors Service, or any of their representatives in the country; and/or <B>(ii) </B>repurchase agreements with daily liquidity,
entered into with any financial institutions that have a credit rating equivalent to AAA on a national scale, as assigned by Standard
&amp; Poor&rsquo;s and/or Fitch Ratings and/or Moody&rsquo;s Investors Service, or any of their representatives in Brazil (<U>&ldquo;Permitted
</U>Investments&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>5.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>Total Optional Early Redemption, EXTRAORDINARY
AMORTIZATION, early redemption offer, and optional acquisition.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>5.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Total Optional Early Redemption</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.1.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B> <FONT STYLE="font-size: 10pt">The Issuer may, at its sole discretion, effect the optional early redemption of the entire amount
(partial redemption being prohibited) of the First Series Book-Entry Commercial Notes that have been effectively subscribed and paid in
full (<U>&ldquo;Optional Early Redemption of the Entire First Series Book-Entry Commercial </U>Notes&rdquo;), starting on the 24th (twenty-fourth)
month from the Issue Date, that is, on or after October 15, 2027. Upon the Optional Full Early Redemption of the First Series Book-Entry
Commercial Notes, the amount due by the Issuer shall be equal to: <B>(i) </B>the Unit Par Value of the First Series Book-Entry Commercial
Notes, as applicable, plus <B>(ii) </B>the Interest on the First Series Book-Entry Commercial Notes, calculated <I>pro rata temporis </I>from
the Interest Commencement Date, or the Payment Date of the Remuneration for the immediately preceding First Series Book-Entry Commercial
Notes (inclusive), as applicable, until the date of the effective Optional Early Total Redemption of the First Series Book-Entry Commercial
Notes (exclusive); <B>(iii) </B>any Late</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">Payment Charges (if any); and <B>(iv)</B> <FONT STYLE="font-size: 10pt">of
the redemption premium for the First Series Book-Entry Commercial Notes equivalent to 0.30% (thirty hundredths of a percent) per annum
for the remaining term, calculated in accordance with Clause 5.1.3 below (&ldquo;<U>Optional Early Redemption Amount of the First Series
Commercial Notes</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.1.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>Optional Early Redemption of the Entire Second Series of Book-Entry Commercial Notes</U>.
The Issuer may, at its sole discretion, effect the optional early redemption of the entirety (partial redemption being prohibited) of
the Second Series Book-Entry Commercial Notes that have been effectively subscribed and paid in full (<U>&ldquo;Optional Early Redemption
of the Entire Second Series Book-Entry Commercial </U>Notes&rdquo; and, together with the Optional Early Redemption of the <U>Entire</U>
First Series Book-Entry Commercial Notes, the <U>&ldquo;Optional Early Redemption of the Book-Entry Commercial </U>Notes&rdquo;), starting
on the 36th (thirty-sixth) month from the Issue Date, that is, on or after October 15, 2028. Upon the Optional Early Redemption of the
Second Series Commercial Note, the amount due by the Issuer shall be equal to: <B>(i) </B>the Unit Par Value or the balance of the Unit
Par Value of the Second Series Commercial Note, as applicable, plus <B>(ii) </B>the Interest on the Second Series Commercial Note, calculated
<I>pro rata temporis </I>from the Interest Commencement Date, or the Payment Date of the immediately preceding Second Series Book-Entry
Commercial Notes Remuneration, as applicable (inclusive), through the date of the effective Optional Early Total Redemption of the Second
Series Book-Entry Commercial Notes (exclusive); <B>(iii) </B>any Late Payment Charges (if any); and <B>(iv) </B>the redemption premium
for the Second Series Book-Entry Commercial Notes, equivalent to 0.30% (thirty hundredths of a percent) per annum for the remaining term,
calculated in accordance with Clause 5.1.3 below (<U>&ldquo;Optional Early Redemption Amount of the Second Series Commercial Note</U>&rdquo;
and, together with the Optional Early Redemption Amount of the First Series Commercial Note, <U>&ldquo;Optional Early Redemption </U>Amount&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.1.3.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The redemption premium for the Book-Entry Commercial Notes will be 0.30% (thirty hundredths of
a percent) per annum, calculated <I>pro rata temporis</I>, based on 252 (two hundred fifty-two) Business Days, considering the number
of Business Days elapsing between the date of the Optional Early Redemption of the Book-Entry Commercial Notes of the respective Series
and the Maturity Date of the Book-Entry Commercial Notes of the respective Series, calculated according to the formula below:</FONT></P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="image_020.jpg" ALT=""></P>



<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">Where:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>P </B>= premium for the Optional Early Redemption
of the Book-Entry Commercial Notes, calculated to 8 (eight) decimal places, without rounding;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>PU </B>= Unit Par Value or balance of the
Unit Par Value of the Book-Entry Commercial Notes of the respective Series, plus the Remuneration of the Book-Entry Commercial Notes of
the respective Series to be redeemed on the date of the Optional Early Redemption of the Book-Entry Commercial Notes of the respective
Series;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>i </B>= 0.3000; and</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify"><B>DU </B>= number of Business Days to elapse
between the date of the Optional Early Redemption of the Book-Entry Commercial Notes of the respective Series (inclusive) and the Maturity
Date of the Book-Entry Commercial Notes of the respective Series (exclusive).</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 63.8pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.1.4.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Issuer, at least 5 (five) Business Days prior to the date of the Optional Early Redemption
of the Book-Entry Commercial Note, shall notify the Securitization Agent, with a copy to the Trustee, regarding the Optional Early Redemption
of the Book-Entry Commercial Note, by means of a written notice (<U>&ldquo;Notice of Early </U>Redemption&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.1.5.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Notice of Early Redemption of the Book-Entry Commercial Note shall describe the terms and
conditions of the Optional Early Redemption of the Book-Entry Commercial Note, including, at a minimum, <B>(i) </B>the preliminary estimate
of the Optional Early Redemption Amount; <B>(ii) </B>the effective date of the Optional Early Redemption of the Book-Entry Commercial
Note and of the payment of the Book-Entry Commercial Note subject to the Optional Early Redemption, which shall be a Business Day; <B>(iii)
</B>the place of payment for the Book-Entry Commercial Notes subject to the Optional Early Redemption; and <B>(iv) </B>other information
deemed relevant by the Issuer for the execution of the Optional Early Redemption.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.1.6.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Payment of the respective Early Redemption Amount shall be made in accordance with procedures
adopted by the Book-Entry Agent, provided that early redemption of the Debentures shall only be effected after the Securitization Entity
has received the funds.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.1.7.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">B3 must be notified at least 3 (three) Business Days prior to the date of such redemption event.</FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.1.8.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Book-Entry Commercial Notes redeemed by the Issuer, under the terms set forth herein, shall be
canceled by the Issuer.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>5.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Optional Extraordinary Redemption</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.2.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>Optional Extraordinary Redemption of the First Series Book-Entry Commercial Notes</U>. The
Issuer may, at its sole discretion, beginning on the 24th (twenty-fourth) month following the Issue Date, that is, as of October 15, 2027,
inclusive, carry out a partial optional extraordinary redemption of the First Series Book-Entry Commercial Notes limited to 98% (ninety-eight
percent) of the outstanding balance of the First Series Book-Entry Commercial Notes (<U>&ldquo;Extraordinary Redemption of the First Series
Book-Entry Commercial </U>Notes&rdquo;). Upon the Extraordinary Redemption of the First Series Book-Entry Commercial Notes, the amount
due by the Issuer shall be equal to <B>(i) </B>a portion of the Unit Par Value of the First Series Book-Entry Commercial Notes, plus <B>(ii)
</B>the Interest on the First Series Book-Entry Commercial Notes, calculated <I>pro rata temporis</I>, from the Interest Commencement
Date, or the Payment Date of the Remuneration on the First Series Book-Entry Commercial Notes immediately preceding it, as the case may
be, until the date of actual payment of the Extraordinary Redemption of the First Series Book-Entry Commercial Notes, <B>(iii) </B>any
Late Payment Charges (if any), and <B>(iv) </B>the Extraordinary Redemption Premium for the First Series Book-Entry Commercial Notes,
equivalent to 0.30% (thirty hundredths of a percent) per annum for the remaining term, calculated in accordance with Clause 5.2.3 below
(<U>&ldquo;Amount of the Extraordinary Redemption of the First Series Book-Entry Commercial </U>Notes&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.2.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>Extraordinary Redemption of the Second Series Book-Entry Commercial Notes</U><I>. </I>The
Issuer may, at its sole discretion, beginning on the 36th (thirty-sixth) month from the Issue Date, that is, as of October 15, 2028, inclusive,
carry out the optional partial extraordinary redemption of the Second Series Book-Entry Commercial Notes (<U>&ldquo;Extraordinary Redemption
of the Second Series Book-Entry Commercial </U>Notes&rdquo; and, together with the Extraordinary Redemption of the First Series Book-Entry
Commercial Notes, the <U>&ldquo;Extraordinary Redemption of Book-Entry Commercial </U>Notes&rdquo;). Upon the Extraordinary Redemption
of the Second Series Book-Entry Commercial Notes, the amount due by the Issuer shall be equal <B>t (i) </B>portion of the Unit Par Value
or the balance of the Unit Par Value of the Second Series Book-Entry Commercial Notes, as applicable, plus <B>(ii) </B>the Interest on
the Second Series Book-Entry Commercial Notes applicable to the portion of the Unit Par Value or the balance of the Unit Par Value of
the Second Series Book-Entry Commercial Notes to be redeemed, calculated <I>pro rata temporis</I>, from the Interest Commencement Date,
or the Payment Date of the Remuneration on the Second</FONT></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">Series Book-Entry Commercial Notes immediately
preceding it, as applicable, until the date of actual payment of the Extraordinary Redemption of the Second Series Book-Entry Commercial
Notes, <B>(iii) </B>any Late Payment Charges (if any), and <B>(iv) </B>the Extraordinary Redemption Premium for the Second Series Book-Entry
Commercial Notes, equivalent to 0.30% (thirty hundredths of a percent) per annum for the remaining term, calculated in accordance with
Clause 5.2.3 below <FONT STYLE="font-size: 10pt">(&ldquo;<U>Second Series Book-Entry Commercial Note Extraordinary Redemption </U>Amount&rdquo;
and, together with the First Series Book-Entry Commercial Note Extraordinary Redemption Amount, the <U>&ldquo;Book-Entry Commercial Note
Extraordinary Redemption </U>Amount&rdquo;).</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.2.3.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Extraordinary Redemption Premium for Book-Entry Commercial Notes shall be equal to 0.30%
(thirty hundredths of a percent) per annum, calculated <I>pro rata temporis</I>, based on 252 (two hundred fifty-two) Business Days, considering
the number of Business Days elapsing between the date of the Extraordinary Redemption of the Book-Entry Commercial Notes of the respective
Series and the Maturity Date of the Book-Entry Commercial Notes of the respective Series, calculated according to the formula below:</FONT></P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="image_021.jpg" ALT=""></P>

<P STYLE="font: 12pt Times New Roman,serif; text-align: justify; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify">Where:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify"><B>P </B>= premium for the Extraordinary Redemption
of Book-Entry Commercial Notes, calculated to eight (8) decimal places, without rounding;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify"><B>PU </B>= portion of the Unit Par Value or
the balance of the Unit Par Value of the Book-Entry Commercial Notes of the respective Series, as applicable, plus the Interest accrued
on the portion of the Unit Par Value or the balance of the Unit Par Value of the Book-Entry Commercial Notes of the respective Series
to be redeemed, calculated pro rata temporis, from the Interest Commencement Date, or the Interest Payment Date of the Book-Entry Commercial
Notes of the immediately preceding respective Series, as applicable, until the date of actual payment of the Extraordinary Redemption
of the Book- d Commercial Notes of the respective Series on the date of the Extraordinary Redemption of the Book- d Commercial Notes;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify"><B>i </B>= 0.3000; and</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify"><B>DU </B>= number of Business Days to elapse
between the date of the Extraordinary Redemption of the Book-Entry Commercial Notes of the respective Series (inclusive) and the Maturity
Date of the Book-Entry Commercial Notes of the respective Series (exclusive).</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0.55pt"><B>5.2.4.</B> The remaining
amount of the respective Book-Entry Commercial Note Interest will continue to accrue and shall be paid on the payment date of the immediately
subsequent Book-Entry Commercial Note Interest.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0.55pt"><B>5.2.5.</B> The Notice
of Extraordinary Redemption of Book-Entry Commercial Note shall describe the terms and conditions of the Extraordinary Redemption of Book-Entry
Commercial Note, including, at a minimum, <B>(i) </B>the preliminary estimate of the Redemption Amount of the Extraordinary Redemption
of Book-Entry Commercial Note; <B>(ii) </B>the effective date of the Extraordinary Redemption of the Book-Entry Commercial Notes and of
the payment of the Book-Entry Commercial Notes subject to the Extraordinary Redemption of the Book-Entry Commercial Notes, which must
be a Business Day; <B>(iii) </B>the place of payment of the Book-Entry Commercial Notes subject to the Extraordinary Redemption of Book-Entry
Commercial Notes; and <B>(iv) </B>other information deemed relevant by the Issuer for the execution of the Extraordinary Redemption of
Book-Entry Commercial Notes.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0.55pt"><B>5.2.6.</B> Payment of
the respective amount of the Extraordinary Redemption of the Book-Entry Commercial Notes shall be made in accordance with procedures adopted
by the Book-Entry Agent, provided that the extraordinary redemption of the Debentures shall only be effected after receipt of the funds
by the Securitization Entity.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0.55pt"><B>5.2.7.</B> B3 must be
notified at least 3 (three) Business Days prior to the date of said redemption event.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>5.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Early Redemption Offer</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.3.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Issuer may, at its sole discretion, at any time, make an offer for the early redemption of
all Book-Entry Commercial Notes and, consequently, of the Debentures (with optional partial redemption being prohibited in any case),
resulting in the cancellation of such Book-Entry Commercial Notes and Debentures that are actually redeemed. The Issuer shall send an
optional early redemption offer, and the Securitization Agent shall forward the proposal, in the form of an offer for the total early
redemption of the Debentures (with the optional offer for partial redemption of the Debentures being prohibited), to all Debenture Holders,
with a copy to the Trustee, 15 (fifteen) Business Days prior to the date on which the Full Early Redemption Offer is intended to be made,
as provided for in the Debenture Issuance Deed, who shall decide, without</FONT></P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">distinction and ensuring equal conditions for
all Debenture Holders, in accordance with the terms offered by the Issuer, regarding the early redemption of the Commercial Notes to which
the Debentures they hold are linked, in accordance with the terms and conditions set forth in the Debenture Indenture (<U>&ldquo;Total
Early Redemption </U>Offer&rdquo;).</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.3.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Total Early Redemption Offer proposed to the Securitization Entity shall describe the terms
and conditions of the Total Early Redemption Offer, including <B>(i) </B>that the Total Early Redemption Offer shall relate to all Book-Entry
Commercial Notes; <B>(ii) </B>the amount of the early redemption premium, if any, which may not be negative; <B>(iii) </B>the intended
date for the early redemption and payment of the Book-Entry Commercial Notes; and <B>(iv) </B>other information necessary for the Debenture
Holders to make a decision and for the execution of the early redemption of the Book-Entry Commercial Notes and, consequently, of the
Debentures through the Total Early Redemption Offer.</FONT></P>

<P STYLE="font: 10pt/14pt Verdana,sans-serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.3.3.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Securitization Entity shall, on the respective expiration date of the acceptance period for
the Total Early Redemption Offer of the Debentures, inform the Issuer of the number of Book-Entry Commercial Notes to be redeemed, which
shall correspond to the number of Debentures held by the Debenture Holders who choose to accept the Total Early Redemption Offer, pursuant
to the Debenture Issuance Deed, as well as the effective date for the redemption of such Book-Entry Commercial Notes.</FONT></P>

<P STYLE="font: 10pt/14pt Verdana,sans-serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.3.4.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Issuer shall proceed with the settlement of the Total Early Redemption Offer, which shall
occur on a single date for all Book-Entry Commercial Notes indicated pursuant to the above Clause (except in cases where, solely for operational
reasons, the settlement of the Book-Entry Commercial Notes subject to the Total Early Redemption Offer occurs on different dates).</FONT></P>

<P STYLE="font: 10pt/14pt Verdana,sans-serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.3.5.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The amount to be paid in respect of each of the Book-Entry Commercial Notes subject to redemption
shall be equal to the Unit Par Value or the balance of the Unit Par Value, as applicable, of the Book-Entry Commercial Notes subject to
redemption, plus <B>(i) </B>the respective Remuneration, calculated <I>pro rata temporis </I>from the First Payment Date or the date on
which the immediately preceding Remuneration payment occurred (inclusive), as applicable, up to the effective redemption date (exclusive);
<B>(ii) </B>any late payment charges due and unpaid as of the date of such redemption, if any; and <B>(iii) </B>if applicable, an early
redemption premium to be offered, at the Issuer&rsquo;s sole discretion, which may not be negative.</FONT></P>

<P STYLE="font: 10pt/14pt Verdana,sans-serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.3.6.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">An Optional Early Redemption Offer that is not extended to all Book-Entry Commercial Notes or
Book-Entry Commercial Notes of a particular series shall</FONT></P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">not be permitted, provided that the Optional
Early Redemption Offer is directed at only one series.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>5.4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Optional Purchase</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.4.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Issuer may, at any time, acquire Book-Entry Commercial Note on the secondary market, subject
to the Securitization Entity&rsquo;s acceptance, for an amount equal to or less than the balance of the Unit Par Value of the Book-Entry
Commercial Note in question. The Issuer shall record such acquisitions (<U>&ldquo;Optional </U>Acquisition&rdquo;) in the Issuer&rsquo;s
financial statements.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.4.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The Book-Entry Commercial Notes acquired by the Issuer may, at the Issuer&rsquo;s discretion,
<B>(i) </B>be canceled; <B>(ii) </B>remain in treasury; or <B>(iii) </B>be resold in the market.</FONT></P>

<P STYLE="font: 10pt/14pt Verdana,sans-serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>5.4.3.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Book-Entry Commercial Notes acquired by the Issuer to be held in treasury, if and when resold
in the market, shall be entitled to the same Remuneration applicable to the other Book-Entry Commercial Notes.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>EARLY <FONT STYLE="text-transform: uppercase">REDEMPTION</FONT></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt"><FONT STYLE="font-size: 10pt"><B>6.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Early Maturity</U>. Subject to the provisions of Clauses 6.1.1 through
6.1.2 below, the Securitization Entity shall deem the obligations arising from the Book-Entry Commercial Notes to be due and payable immediately,
and shall require the Issuer to immediately pay the Unit Par Value or the balance of the Unit Par Value of the Book-Entry Commercial Notes,
as the case may be, plus the Remuneration, calculated <I>pro rata temporis </I>from the Commencement Date of Remuneration or the immediately
preceding Remuneration Payment Date, as applicable, until the date of actual payment, without prejudice, where applicable, to Late Payment
Charges, upon the occurrence of any of the events set forth in Clauses 6.1.1 and 6.1.2 below (each event, an &ldquo;<U>Event of Default</U>&rdquo;):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>6.1.1.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>Automatic Early Maturity</U>. The occurrence of any of the events listed below shall result
in the automatic early maturity of the Book-Entry Commercial Notes, regardless of any prior judicial or extrajudicial notice or notification
to the Issuer, and the provisions of Clause 6.1.3 below shall apply:</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(i)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">failure by the Issuer and/or the Guarantors to comply with any monetary
obligation provided for in this Issuance Agreement, not remedied within two (2) Business Days from the date of such failure, without prejudice
to the payment of Late Payment Charges by the Issuer;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(ii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>(a) </B>filing of a petition, proposal, or initiation of judicial or
extrajudicial reorganization by the Issuer and/or the Guarantors and/or any of their Relevant Subsidiaries (as defined below), a petition
for voluntary bankruptcy, a declaration of bankruptcy, mediation, or conciliation, pursuant to Article 20-B or preliminary measures for
any such proceedings as provided for in paragraph 12 of Article 6 of Law No. 11,101, of February 9, 2005, or any preliminary or similar
proceeding, including in another jurisdiction, regardless of whether the reorganization proceedings are admitted or granted by the competent
judge, or, further, any similar or analogous proceeding in another jurisdiction to the proceedings described in this item; or <B>(b) </B>a
petition for bankruptcy filed by third parties, or analogous proceedings in foreign jurisdictions, unless the petition has been dismissed
within the statutory period;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(iii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">termination, liquidation, or dissolution of the Issuer and/or the Guarantors
and/or any subsidiary that individually or collectively represents at least R$25,000,000.00 (twenty-five million reais) of the Issuer&rsquo;s
consolidated EBITDA as measured most recently (<U>&ldquo;Relevant </U>Subsidiary&rdquo;), or any analogous proceeding that may be established
by law. If there is another issuance or another debt instrument, or if a new public offering is made by the Issuer or one of its Subsidiaries
of a debt security issued by it in the Brazilian capital markets, and such instrument provides for a lower threshold amount than that
set forth above, said lower threshold shall apply to this Issuance Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(iv)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a declaration of early maturity of any debts and/or financial obligations
in the local or international financial or capital markets of the Issuer and/or the Guarantors and/or their subsidiaries, where the remaining
individual or aggregate amount of the obligation, at the time of the declaration of early maturity, is equal to or greater than R$ 50,000,000.00
(fifty million reais), or its equivalent in other currencies. If there is another issuance or another debt instrument, or if a new public
offering is made by the Issuer or one of its Subsidiaries of a debt security issued by it in the Brazilian capital and/ y markets, and
such instrument provides for a lower threshold amount than that set forth above, said lower threshold shall apply to this Issuance Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(v)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">if this Issuance Agreement and/or the other Offering documents are the subject
of judicial, extrajudicial, administrative, and/or arbitral proceedings by the Issuer and/or the Guarantors and/or their parent companies
and/or their subsidiaries;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(vi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">invalidity, ineffectiveness, nullity, or unenforceability of this Issuance
Term, by means of a judicial and/or administrative decision, the effects of which have not been suspended or reversed by the Issuer and/or
the Guarantors within the statutory period, pursuant to the Code of Civil Procedure;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(vii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">assignment, promise of assignment, or any form of transfer or promise of
transfer to third parties, in whole or in part, by the Issuer and/or the Guarantors, of the obligations assumed in this Issuance Agreement,
except as provided in item (x) of Clause 6.1.2 below;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(viii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the payment of any dividends, interest on equity, or any form of participation
in the Issuer&rsquo;s earnings, if the Issuer is in default with the obligations covered by this Issuance Agreement, including non-compliance
with the Financial Ratio (as defined below), except <B>(a) </B>for the mandatory dividends provided for in Article 202 of the Brazilian
Corporation Law, pursuant to the Issuer&rsquo;s bylaws in effect on the Issue Date, and/or <B>(b) </B>interest on equity capital allocated
to mandatory dividends, pursuant to Article 9, Paragraph 7 of Law No. 9,249, of December 26, 1995;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(ix)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">if any of the representations or warranties made by the Issuer and/or the
Guarantors in this Issuance Agreement and/or in the other Offering documents, as applicable, prove to be false or misleading as of the
date they were made;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(x)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">if the use of the proceeds differs from that provided for in Clause 4.5;
and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a reduction in the Issuer&rsquo;s capital stock, unless such capital reduction
is carried out <B>(a) </B>for the purpose of absorbing accumulated losses; and <B>(b) </B>if previously authorized by the Debenture Holders
representing at least two-thirds (2/3) of the Outstanding Debentures (as defined in the Debenture Issuance Deed), in accordance with the
provisions of paragraph 3 of Article 174 of the Brazilian Corporations Act ( ).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>6.1.2.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>Non-Automatic Early Maturity</U>. The Securitization Entity shall, within five (5) Business
Days of the date on which it becomes aware of the occurrence of any of the events listed below, convene a General Meeting of Debenture
Holders to decide on the declaration of early maturity of the Book-Entry Commercial Notes and, consequently, of the Debentures, subject
to the provisions of Clause 9 below and the Debenture Issuance Deed, including the</FONT></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">provisions regarding the procedures for convening
and quorums of the General Meeting of Debenture Holders:</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(i)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">failure by the Issuer and/or the Guarantors to comply with any non-monetary
obligation provided for in this Indenture, provided that such failure is not remedied within 10 (ten) Business Days from the date of the
breach, except in cases where a specific cure period is provided for under the terms of this Indenture;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(ii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a legitimate protest of securities against the Issuer and/or the Guarantors,
even in their capacity as guarantors, with a value, individually or in aggregate, equal to or greater than R$ 50,000,000.00 (fifty million
reais) for the Issuer, or its equivalent in other currencies, unless the Issuer and/or the Guarantors validly prove to the Securitization
Entity, within 5 (five) Business Days from the date of notification of the protest, that: <B>(1) </B>the protest is withdrawn or canceled,
in any event; or <B>(2) </B>its effects have been judicially suspended. If there is another issuance or another debt instrument, or if
a new public offering is made by the Issuer or one of its Subsidiaries of a debt security issued by it in the Brazilian capital markets,
and such instrument provides for a lower threshold amount than that provided for above, said lower threshold shall apply to this Term
of Issuance;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(iii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">if this Issuance Agreement, the Debenture Issuance Deed, the declaration
of accuracy, the <I>bring-down</I> questionnaires, the debt summary, and/or the Corporate Approvals, prepared in connection with the Offering,
are the subject of judicial or extrajudicial challenges by third parties not belonging to the Issuer&rsquo;s economic group seeking the
annulment, nullity, or unenforceability of the Offering Memorandum, the Debenture Offering Deed, the declaration of truthfulness, the
<I>bring-down</I> questionnaires, the debt summary, and/or the Corporate Approvals prepared in connection with the Offering or any of
their provisions, without a stay of execution being obtained within 10 (ten) Business Days from the date of the request;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(iv)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any amendment or modification to the corporate purpose set forth in the
articles of incorporation and the articles of association, as applicable, of the Issuer and/or the Guarantors in effect as of the date
of this Issuance Agreement, in a manner that substantially alters the primary line of business currently operated by the Issuer, except
in the event of an amendment to the corporate purpose to include activities focused on technology companies, which are carried out by
subsidiaries of the Issuer and/or the Guarantors;</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(v)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; font-variant: small-caps; letter-spacing: -0.05pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">default or non-performance by the Issuer and/or the Guarantors of any payment obligation outside
the scope of the local or international financial or capital markets in an amount equal to or greater than, individually or in the aggregate,
R$ 50,000,000.00 (fifty million reais) for the Issuer, or its equivalent in other currencies, as provided for in any agreement or contract
to which the Issuer and/or the Guarantors are a party, unless the default is remedied by the Issuer and/or the Guarantors within the stipulated
contractual term. In the event of another issuance or another debt instrument, or in the event of a new public offering by the Issuer
or one of its Subsidiaries of debt securities issued by it in the Brazilian capital markets, where such instrument provides for a lower
threshold amount than that set forth above, said lower threshold shall apply to this Issuance Agreement;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(vi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">default or non-performance by the Issuer and/or the Guarantors of any debts
within the scope of the Issuer&rsquo;s and/or the Guarantors&rsquo; local or international financial or capital markets, whose individual
or aggregate value, at the time of the declaration of default, is equal to or greater than R$ 50,000,000.00 (fifty million reais), for
the Issuer, or its equivalent in other currencies, unless the default is remedied by the Issuer within the stipulated contractual term.
If there is another issuance or another debt instrument, or if a new public offering is made by the Issuer or one of its Subsidiaries
of a debt security issued by it in the Brazilian capital markets, and such instrument provides for a lower threshold amount than that
set forth above, the lower threshold shall apply to this Issuance Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(vii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">seizure, attachment, or garnishment of assets of the Issuer and/or the Guarantors
and/or their subsidiaries, the value of which, individually or in the aggregate, is equal to or greater than R$ 120,000,000.00 (one hundred
twenty million reais) for the Issuer, or that results in a Material Adverse Effect. For the purposes of this Issuance Agreement, <U>&ldquo;</U>Material
<U>Adverse </U>Effect&rdquo; means any material adverse change and/or alteration in the financial, economic, commercial, reputational,
operational, regulatory, corporate, or business conditions of the Issuer and/or the Guarantors or their subsidiaries, as the case may
be, or any events or situations that may adversely affect the Issuer&rsquo;s ability to fulfill its obligations. If there is another issuance
or another debt instrument, or if a new public offering is made by the Issuer or one of its Subsidiaries of a debt security issued by
it in the Brazilian capital markets, and such instrument provides for a lower threshold than that set forth above, said lower threshold
shall apply to this Issuance Agreement;</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(viii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">expropriation, confiscation, or any other measure by any governmental entity
in any jurisdiction that results in the loss, by the Issuer and/or the Guarantors, of direct or indirect ownership or possession of property
and/or the fixed assets of the Issuer and/or the Guarantors, as set forth in the most recent financial statements of the Issuer and/or
the Guarantors, resulting in a Material Adverse Effect and whose effects have not been suspended or reversed by the Issuer within ten
(10) Business Days from the date the Issuer is notified of such measure;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(ix)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any of the representations or warranties made by the Issuer and/or the Guarantors
in this Issuance Agreement and/or in the other Offering documents, as applicable, prove to be insufficient, inaccurate, or inconsistent
as of the date they were made;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(x)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; font-variant: small-caps; letter-spacing: -0.05pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">a spin-off, merger, or consolidation (including a stock consolidation) or any form of corporate
reorganization of the Issuer and/or the Guarantors and/or any of their subsidiaries, unless <B>(a) </B>previously approved by the Debenture
Holders, meeting at a General Meeting of Debenture Holders specially convened for this purpose; <B>(b) </B>if such corporate reorganization
is carried out between the Issuer, its subsidiaries, and/or any other company within the Issuer&rsquo;s economic group, provided that,
with respect to the subsidiaries and/or any other company within the Issuer&rsquo;s economic group, the surviving entity remains under
the direct or indirect control (as defined in the Brazilian Corporation Law) of the Issuer&rsquo;s ; or <B>(c) </B>for the Issuer to carry
out the merger or the merger of shares of Afya Limited, a company incorporated under the laws of the Cayman Islands, with its principal
office at Ugland House, P.O. Box 309, Maples Corporate Services KY1-1104, George Town, George Town, Cayman Islands, registered with the
CNPJ/MF under No. 33.858.154/0001-78 (<U>&ldquo;Afya </U>Limited&rdquo; and <U>&ldquo;Permitted Merger</U>,&rdquo; respectively), provided
that, should the Permitted Merger occur, the Financial Ratio (as defined below) must be observed by the Issuer);</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(xi)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; font-variant: small-caps; letter-spacing: -0.05pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">a change or transfer of direct shareholding control of the Issuer as defined in Article 116 of
the Brazilian Corporation Law, except if <B>(a) </B>indirect control of the Issuer remains held by Afya Limited; or <B>(b) </B>the Issuer
carries out a merger or stock swap involving Afya Limited, as authorized in item (x), subitem (c) of this Clause 6.1.2 above;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; font-variant: small-caps; letter-spacing: -0.05pt"><B>(xii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">change or transfer of direct shareholding control of the Guarantors, as
defined in Article 116 of the Brazilian Corporation Law, except if indirect control of the Guarantors continues to be held by the Issuer;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xiii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">failure to renew, failure to obtain, cancellation, revocation, termination,
or suspension of authorizations, concessions, permits, grants, or licenses, including environmental ones and/or those required by the
competent regulatory agencies for the regular conduct of the activities carried out by the Issuer and/or the Guarantors, except: <B>(a)
</B>they are being contested in good faith and provided that a stay of execution has been obtained within the legal timeframe, for as
long as such stay of execution remains in effect; <B>(b) </B>in cases where they cannot cause a Material Adverse Effect; or <B>(c) </B>if
such authorizations, concessions, permits, subsidies, or licenses, as applicable, are in the process of being obtained or renewed in a
timely manner under the laws and regulations applicable to the sector in which the Issuer and/or the Guarantors operate, provided that
authorization to continue operations is maintained; </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xiv)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">if the Issuer and/or the Guarantors and/or any of their subsidiaries sell,
assign, or otherwise dispose of all or part of their assets or rights, the value of which, individually or in the aggregate, is equal
to or greater than R$ 120,000,000.00 (one hundred twenty million reais). If there is another issuance or another debt instrument, or if
a new public offering is made by the Issuer or one of its Subsidiaries of debt securities issued by it in the Brazilian capital markets,
and such instrument provides for a threshold value lower than that set forth above, said lower threshold shall apply to this Issuance
Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xv)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">violation by the Issuer and/or the Guarantors, their subsidiaries, and,
when acting on behalf of and for the benefit of the Issuer and/or the Guarantors, their officers or employees, of laws and regulations
relating to <B>(a) </B>racial or gender discrimination, the promotion of prostitution, child labor, and/or forced labor, or <B>(b) </B>crimes
against the environment, as defined as the receipt of a complaint by a government authority resulting in a conviction for such violation
and, with respect to item (b), resulting in a Material Adverse Effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xvi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">violation by the Issuer and/or the Guarantors of the provisions of applicable
laws pertaining to the National Environmental Policy, the Resolutions of CONAMA &ndash; National Council for the Environment, and Socio-Environmental
Legislation (as defined below), except, exclusively in the case of Socio-Environmental Legislation that is not</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify">Reputational Socio-Environmental Legislation (as
defined below), provided that such violation does not result in a Material Adverse Effect, without prejudice to the provisions of subparagraph
(xv), item (b) above;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xvii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">failure to comply with an arbitral, administrative, or judicial award against
the Issuer and/or the Guarantors, imposing a payment obligation in an amount, individually or in aggregate, equal to or greater than R$
50,000,000.00 (fifty million reais) for the Issuer, or its equivalent in other currencies. If there is another issuance or another debt
instrument, or if a new public offering is made by the Issuer or one of its Subsidiaries of a debt security issued by it in the Brazilian
capital markets, and such instrument provides for a lower threshold amount than that set forth above, said lower threshold shall apply
to this Issuance Agreement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xviii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">if any direct or indirect Encumbrances (as defined below) are created or
established on the rights, property, and/or assets of the Issuer and/or the Guarantors, except for Encumbrances <B>(a) </B>existing as
of this date, <B>(b) </B>that are shared on a <I>pari passu </I>basis with the Book-Entry Commercial Notes and the Debentures, <B>(c)
</B>created as security for acquisitions in which a specific seller provides <I>seller financing </I>to the Issuer, with such seller being
the secured party; or <B>(d) </B>with an individual or aggregate value of less than R$50,000,000.00 (fifty million reais) and provided
that it does not cause a Material Adverse Effect. For the purposes of this Issuance Agreement, &ldquo; &rdquo; means any encumbrance,
lien, pledge, fiduciary sale/assignment, usufruct, trust, security right, <I>security interest</I>, lease, charge, option (except for
options to purchase shares issued by the Issuer and/or Guarantors under incentive plans established for the benefit of officers and employees),
preemptive rights, freezing, listing, and/or any other restriction or limitation on transfer, of whatever nature, agreed upon or imposed
by any means or form;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xix)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the provision, by the Issuer and/or the Guarantors, of sureties, bonds,
joint obligations, or guarantees of any nature in favor of third-party obligations, unless such guarantees are: <B>(a) </B>provided in
real estate lease transactions entered into by the Issuer and/or its subsidiaries to facilitate their activities, including, for clarity,
debt assumption agreements relating to real estate lease contracts; <B>(b) </B>provided in transactions involving the acquisition of equity
interests by the Issuer and/or its subsidiaries, provided that <B>(b.i) </B>the acquired company becomes a subsidiary of the Issuer as
a result of such acquisition and</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify"><B>(b.ii) </B>the guarantee is secured by the
acquired asset or by shares/quotas of the acquired company; <B>(c) </B>established in transactions in which the seller finances part of
the sale (<I>seller financing</I>), provided that the guarantee is linked to the acquired asset; <B>(d) </B>established on assets of the
Issuer and/or its subsidiaries in the context of leasing transactions; <B>(e) </B>granted in favor of the Issuer, the Guarantors, or any
of their subsidiaries; <B>(f) </B>granted in favor of Afya Limited, provided that the individual or aggregate amount is less than R$50,000,000.00
(fifty million reais) and provided that it does not cause a Material Adverse Effect; <B>(g) </B>in favor of officers of the Issuer and/or
its subsidiaries with an individual value of less than R$2,000,000.00 (two million reais); or <B>(h) </B>with an individual value of less
than R$2,000,000.00 (two million reais);</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xx)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">if, within <B>(i) </B>three (3) Business Days from the subscription and
payment of the Debentures, the Issuer fails to provide the Trustee with proof of full payment of the 1st Issue of Debentures; and <B>(ii)
</B>within 11 (eleven) Business Days from the subscription and payment of the Debentures, the Issuer fails to provide the Trustee with
proof of full settlement of the Softbank Prepayment; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xxi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Afya Limited&rsquo;s failure to meet the Adjusted Net Debt/Adjusted EBITDA
ratio, which must be equal to or less than 3.00x for fiscal years ending on or after 2025 (<U>&ldquo;Financial Ratio</U>&rdquo;), calculated
annually, based on information from Afya Limited&rsquo;s audited consolidated annual financial statements, reviewed by Afya Limited&rsquo;s
independent auditors on a consolidated basis and in accordance with applicable accounting principles, to be verified quarterly, with the
first calculation relating to the fiscal year ending December 31, 2025, subject to the Permitted Merger.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -0.05pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 85.05pt"></TD><TD STYLE="width: 0.05pt">Where:</TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -0.05pt"><U>&ldquo;Adjusted Net
Debt</U>&rdquo;: means the sum of the debts of Afya Limited and its consolidated subsidiaries owed to individuals and/or legal entities,
such as loans and financing from third parties, issuance of fixed-income securities, whether convertible into shares or not, in local
and/or international markets, including accounts payable for acquisitions in which the seller finances part of the sale (<I>seller financing</I>)
owed by Afya Limited or its consolidated subsidiaries, the margin payable on derivative transactions, as well as sureties, guarantees,
and other collateral provided for the benefit of companies not consolidated in Afya Limited&rsquo;s audited financial statements, classified
under Afya Limited&rsquo;s</P>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -0.05pt">current liabilities and non-current liabilities and
excluding lease liabilities (collectively, <U>&ldquo;Financial </U>Transactions&rdquo;); and any debts to related parties, without double
counting between debtor and guarantor; less cash on hand and cash equivalents (including income from such amounts).</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -0.05pt"><U>&ldquo;Adjusted EBITDA</U>&rdquo;:
&ldquo;Adjusted EBITDA&rdquo; is defined, based on the consolidated financial statements of Afya Limited for the 12 (twelve) months immediately
preceding the base date of December 31 of each year, net income plus income taxes, net financial income (excluding lease interest expenses),
and depreciation and amortization expenses (excluding depreciation expenses related to leasehold rights), expenses related to <I>share-based
compensation</I> plans, equity in earnings of affiliates, as well as interest and penalties received on overdue tuition payments to schools
and educational systems, and non-recurring expenses.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.1pt; text-align: justify; text-indent: -0.05pt"><U>&ldquo;Adjusted Net
Debt / Adjusted EBITDA</U>&rdquo;: the ratio of Adjusted Net Debt to Adjusted EBITDA.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>6.1.3.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Should any of the Events of Default set forth in Clause 6.1.1 above occur, it shall result in
the automatic early maturity of the Book-Entry Commercial Notes, and the Issuer and/or the Guarantors must, within a maximum of 3 (three)
Business Days from the date on which they ascertain such occurrence, notify the Securitization Entity and/or the Trustee so that appropriate
measures may be taken. Failure by the Issuer and/or the Guarantors to comply with this obligation shall not prevent the Securitization
Entity and the Trustee, in their sole discretion, from exercising the rights, powers, interests, authorities, actions, and prerogatives
provided for in this Issuance Agreement and in the Debenture Issuance Deed, including the right to declare the early maturity of the Debentures
and Book-Entry Commercial Notes, should they become aware of the occurrence of any of the aforementioned Events of Default.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>6.1.4.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">Subject to the provisions of clause 6.1.3 above, the Securitization Entity and/or the Trustee
shall convene a General Meeting of Debenture Holders within a maximum of <FONT STYLE="letter-spacing: -0.35pt">5</FONT> (five) Business
Days from the date on which they become aware of the occurrence of a Default Event, to be held within the minimum timeframe provided by
law. If, at said General Meeting of Debenture Holders, Debenture Holders representing at least 2/3 (two-thirds) of the Outstanding Debentures
(as defined in the Debenture Issuance Deed), at the first or second call, decide not to declare the early maturity of the obligations
arising from the Debentures and, consequently, of the Book-Entry Commercial</FONT></P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in">Notes, the Securitization Entity and/or the Trustee
shall not consider the early maturity of the obligations arising from the Debentures and, consequently, the Securitization Entity shall
not consider the early maturity of the Book-Entry Commercial Notes; otherwise, or in the event that the aforementioned General Meeting
of Debenture Holders is not convened upon second call, or in the event that a quorum for deliberation is not achieved upon second call,
the Trustee shall immediately deem the obligations arising from the Debentures and, consequently, the Book-Entry Commercial Notes to be
due and payable.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>6.1.5.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">In the event of early maturity of the obligations arising from the Debentures and, consequently,
from the Book-Entry Commercial Notes, the Issuer agrees to pay the full amount of the Book-Entry Commercial Notes and, consequently, of
the Debentures, by paying the respective Unit Par Value or the balance of the Unit Par Value of the Book-Entry Commercial Notes, as applicable,
plus the respective Remuneration of the Book-Entry Commercial Notes, <FONT STYLE="letter-spacing: -0.45pt">calculated </FONT><I>pro rata
temporis </I>from the Interest Commencement Date or the immediately preceding payment date of the Remuneration of the Book-Entry Commercial
Notes, as applicable, until the date of actual payment, without prejudice to the payment of Late Payment Charges, where applicable, and
any other amounts that may be owed by the Issuer under the terms of this Issuance Agreement, within five (5) Business Days from the date
of early maturity, failing which the Issuer shall also be obligated to pay Late Payment Charges outside the scope of B3. B3 must be notified,
via correspondence from the Issuer, in conjunction with the Trustee, on the date of the early maturity.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>6.1.6.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">If the payment of the total amount of the Book-Entry Commercial Notes and, consequently, of the
Debentures provided for in the above Clause is made through B3, the Issuer must notify B3, by correspondence jointly with the Trustee
and the Securitization Entity, of such payment, at least 3 (three) Business Days prior to the date set for such payment.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>6.1.7.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">The amounts established in Clauses 6.1.1 and 6.1.2 above shall be adjusted by the cumulative
positive variation of the Broad National Consumer Price Index, as published by the Brazilian Institute of Geography and Statistics, effective
as of the Issue Date, or, in the absence or impossibility of applying such index, by the official index that may replace it.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>7.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>ADDITIONAL </B></FONT><B><FONT STYLE="font-size: 10pt">OBLIGATIONS
<FONT STYLE="text-transform: uppercase">OF THE ISSUER AND THE GUARANTORS</FONT></FONT></B></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: -42.55pt"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>7.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Issuer and the Guarantors, as applicable, undertake, without prejudice
to the other obligations set forth in this Issuance Agreement and in the other Offering documents:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(i)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">To provide the Trustee and the Securitization Entity with:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(a)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">within a maximum of 90 (ninety) calendar days following the end of each fiscal year, or within
10 (ten) days following the date of their disclosure, whichever occurs first, a copy of its consolidated financial statements for the
fiscal year then ended, accompanied by the Independent Auditors&rsquo; report (as defined below), as well as a statement signed by the
Issuer&rsquo;s legal representative(s), in accordance with its Bylaws, certifying: <B>(1) </B>that the provisions contained in this Issuance
Agreement remain valid; <B>(2) </B>that no Event of Default has occurred and that there is no breach of the Issuer&rsquo;s obligations
to the Securitization Entity, under the terms established in this Issuance Agreement;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(b)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">with respect to Uninovafapi, within a maximum of 90 (ninety) calendar days following the end
of each fiscal year, with the first such provision to be made as of the fiscal year ending in 2026, or within 10 (ten) days following the
date of its disclosure, whichever occurs first, a copy of its consolidated financial statements for the then-ended fiscal year, accompanied
by an opinion from the Independent Auditors (as defined below);</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(c)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">within a maximum of 90 (ninety) calendar days after the end of each fiscal year, or within 10
(ten) days after the date of their disclosure, whichever occurs first, a copy of Afya Limited&rsquo;s consolidated financial statements
for the fiscal year then ended, accompanied by the Independent Auditors&rsquo; report and accompanied by the calculation memorandum, prepared
by the Issuer or by Afya Limited, containing all necessary items demonstrating compliance with the Financial Ratio, failing which the
Trustee will be unable to monitor said Financial Ratio, and the Trustee may request from the Issuer, Afya Limited, and/or the independent
auditors of Afya Limited any additional clarifications that may be necessary;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(d)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">within 5 (five) Business Days, provide any information that is reasonably and justifiably requested
by the Trustee and/or the Securitization Entity;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(e)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">when requested, within 5 (five) Business Days from the date of such request, confirm to the Trustee
and the Securitization Entity, by means of a statement signed by officers authorized to represent the Issuer and the Guarantors, that
it is in compliance with its obligations, under the terms established in this Issuance Agreement;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(f)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B> <FONT STYLE="font-size: 10pt">on the fifth Business Day following their publication or, if not published, from the date on
which notices are sent to the holders of the Book-Entry Commercial Notes, material facts and minutes of general meetings that in any way
involve the interests of the holders of the Book-Entry Commercial Notes; and</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 70.9pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>(g)</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt">an electronic copy (PDF), with an attendance list, containing the digital seal proving the filing
with JUCEMG of the acts and meetings of the Debenture Holders comprising the Issue.</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(ii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">notify the Trustee and the Securitization Entity, within three (3) Business
Days from the date on which the Issuer and/or the Guarantors become aware of the occurrence of any act or event that results in a Material
Adverse Effect on the Issuer and/or the Guarantors ;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(iii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">notify the Trustee and the Securitization Entity, within three (3) (three)
Business Days from the initiation of any administrative or judicial proceeding concerning <B>(a) </B>a violation of Reputational Social
and Environmental Legislation (as defined below) or <B>(b) </B>a violation of Social and Environmental Legislation (as defined below),
provided that such violation does not result in a Material Adverse Effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(iv)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">notify the Trustee and the Securitization Agent, within three (3) Business
Days from the respective receipt, of any assessments issued by competent government agencies, including those of a tax, environmental,
or regulatory nature, regarding the Issuer and/or its activities, imposing sanctions or penalties that may cause a Material Adverse Effect,
or, furthermore, assessments relating to competition law, regardless of any Material Adverse Effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(v)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If the Issuer and/or the Guarantors are named as defendants in a lawsuit
seeking a declaration of the total or partial invalidity or ineffectiveness of this Issuance Agreement, the Issuer and/or the Guarantors
undertake to take all necessary measures to contest such action within the legal timeframe, as well as to notify the Trustee and the Securitization
Entity of such action within three (3) Business Days from the date of their knowledge thereof;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(vi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">keep their relevant property and assets properly insured, in accordance
with current market practices, it being understood that the Trustee shall not perform any type of monitoring or control regarding such
insurance(s);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(vii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">not to engage in any act inconsistent with its Articles of Incorporation
and/or this Issuance Agreement, subject to the applicable cure periods, particularly those that may, directly or indirectly, compromise
the timely and full fulfillment of the obligations assumed before the Securitization Entity;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(viii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">comply with all laws, rules, regulations, including environmental ones,
applicable to the conduct of its activities, ensuring that its activities comply with the determinations of municipal, state, and federal
agencies and applicable orders in any jurisdiction in which it conducts business or holds assets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(ix)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">comply with all obligations assumed under the terms of this Underwriting
and Issuance Agreement, including with respect to the use of funds raised through the Issuance;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(x)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">with respect to the Issuer, bear all costs arising from <B>(a) </B>the Offering
and the Issuance, including all costs arising from the distribution of the Debentures, including all B3 costs and the CVM inspection fee,
<B>(b) </B>the registration and publication of the documents necessary for the Issuance, as applicable, such as this Issuance Agreement,
any amendments thereto, and the corporate acts of the Issuer and the Guarantors, and <B>(c) </B>expenses related to the engagement of,
but not limited to, legal advisors for the Offering, the Securitization Agent, the Credit Rating Agency (as defined in the Debenture Issuance
Deed), Trustee, Settlement Bank, and Bookrunner;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(xi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>(a) </B>update, at least once every calendar year, until the Maturity
Date of the Book-Entry Commercial Notes, the credit rating report prepared in connection with the Offering; <B>(b) </B>allow the Credit
Rating Agency to widely disclose to the market the reports containing the summaries of the credit ratings; and <B>(c) </B>deliver to the
Trustee and ANBIMA, as applicable, the credit rating reports prepared by the Credit Rating Agency within five (5) Business Days from the
date of their receipt by the Issuer;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(xii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">indemnify, regardless of fault, the Debenture Holders for any amount they
may be compelled to pay due to environmental damage resulting from their activities, as well as compensate the Debenture Holders for any
direct loss or damage they may demonstrably suffer as a result of such environmental damage;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(xiii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">keep in full force and effect at all times the licenses, permits, approvals,
permissions, and authorizations necessary for the regular conduct of the Issuer&rsquo;s and/or the Guarantors&rsquo; activities, except
for those that: <B>(a) </B>are being contested in good faith and provided that a stay of execution has been obtained; or <B>(b) </B>are
in the process of being obtained or renewed in a timely manner in accordance with the laws and regulations applicable to the Issuer&rsquo;s
and/or the Guarantors&rsquo; sector of operation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(xiv)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">within a maximum of 5 (five) Business Days from the effective call, forward
to the Trustee and the Securitization Entity a copy of the notice of call for any general meeting of shareholders and copies of the minutes
of the general meetings of shareholders exclusively relevant to the Issue and the Offering, as well as the date and agenda of the meeting
to be held;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(xv)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">comply with, and ensure that its subsidiaries, and&mdash;when acting on
behalf of and for the benefit of the Issuer and/or the Guarantors&mdash;its affiliates, officers, and employees comply with, during the
term of the Book-Entry Commercial Notes: <B>(a)</B> applicable laws regarding environmental crimes, labor analogous to slavery, child
labor, racial and gender discrimination, and the promotion of prostitution (&ldquo;<U>Socio-Environmental and Reputational Legislation</U>&rdquo;),
labor laws and regulations regarding occupational health and safety, provided that they do not promote prostitution, nor do they directly
or indirectly use or encourage child labor and/or labor in conditions analogous to slavery, or in any way infringe upon rights related
to race and gender, the rights of indigenous peoples, or the rights to areas of indigenous occupation, as declared by the competent authority;
and <B>(b) </B>all other applicable environmental and labor laws in force, as applicable, not mentioned in item (a), including, without
limitation, the provisions of the National Environmental Policy, the CONAMA Resolutions &mdash; National Environment Council&mdash;and
other supplementary environmental laws and regulations (together with Reputational Socio-Environmental Legislation, the &ldquo;Socio-<U>Environmental
</U>Legislation&rdquo;) , adopting preventive or remedial measures and actions aimed at avoiding and correcting any environmental damage,
as well as taking all steps required for the activity in question, preserving the environment and complying with the determinations of
municipal, state, and federal agencies that may subsidiarily legislate or regulate the environmental standards in force, except, with
respect exclusively to item (b), for (1) those challenged in good faith in the administrative and/or judicial spheres, whose enforceability
and/or applicability is suspended due to</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">the obtaining of suspensive effects within the
legal timeframe; or (2) whose non-compliance does not cause a Material Adverse Effect ;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(xvi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">observe, comply with, and/or enforce , by itself, its subsidiaries, and
when acting on behalf of and for the benefit of the Issuer and/or the Guarantors, its affiliates, its officers and employees, as well
as use its best efforts with respect to its potential subcontractors, as applicable, in accordance with the applicable regulations addressing
acts of corruption, crimes against the economic or tax order, &ldquo;money laundering&rdquo; or concealment of assets, rights, and values,
or against the national financial system, the capital markets, and acts harmful to public administration, whether national or foreign,
including, without limitation, unlawful acts that may give rise to administrative, civil, or criminal liability, pursuant to Laws No.
6,385, of December 7, 1976, No. 7,492, of June 16, 1986, No. 8,137, of December 27, 1990, No. 8,429, of June 2, 1992, No. 14,133, of April
1, 2021 (or other public administration bidding and contracting regulations), No. 9,613, of March 3, 1998, No. 12,529, of November 30,
2011, No. 12,846, of August 1, 2013, Decree No. 11.129, dated July 11, 2022, Decree-Law No. 2,848/40, Decree No. 5,687, dated January
31, 2006, which enacted the United Nations Convention against Corruption, adopted by the United Nations General Assembly on October 31,
2003, the <I>U.S. Foreign Corrupt Practices Act of 1977</I>, and the <I>UK Bribery Act </I>of 2010, as well as other domestic or foreign
regulations on such matters, if applicable (collectively, <U>&ldquo;Anti-Corruption </U>Legislation&rdquo;), and further undertakes that
<B>(a) </B>maintain internal policies and procedures aimed at compliance with such regulations, including with respect to its parent companies
and affiliates; <B>(b) </B>to make such regulations known to all its professionals who may be involved in the performance of this Agreement;
<B>(c) </B>to refrain from engaging in acts of corruption and from acting in a manner detrimental to public administration, whether domestic
or foreign, in the interest or for the benefit, whether exclusive or not, of the Issuer; <B>(d) </B>if it becomes aware of any act or
fact that violates the aforementioned standards and relates to the legal relationship established through this Agreement, immediately
notify the Trustee and the Securitization Entity, which may take all measures it deems necessary ;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(xvii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">pay any taxes or contributions that are or may become applicable to the
Issue and the Offering and that are the responsibility of the Issuer, as well as keep all tax (municipal, state, and federal), labor,
social security, environmental, and any other obligations imposed by law up to date;</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(xviii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">provide and submit the organizational chart, financial data, and corporate
acts necessary for the preparation of the annual report, as provided for in CVM Resolution No. 17, dated February 9, 2021 (&ldquo;<U>CVM
Resolution No.</U> 17&rdquo;), which may be requested by the Trustee, and which must be duly submitted by the Issuer no later than thirty
(30) calendar days prior to the deadline for making the report available on the Trustee&rsquo;s website. The aforementioned organizational
chart of the Issuer&rsquo;s corporate group must also include the controlling entities, the controlled entities, and members of the controlling
block at the end of each fiscal year;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(xix)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">ensure that the proceeds from the Offering are not used for <B>(a) </B>any
offer, promise, or payment of money or other improper benefit to a public official, employee, or agent, political parties, politicians,
or political candidates, whether at the national or international level, or to related third parties, <B>(b) </B>payments that may be
considered bribes, illicit rebates, illicit remuneration, bribery, influence peddling, or acts of corruption in general in relation to
domestic and foreign public authorities; and <B>(c) </B>any other act that may be considered detrimental to public administration under
the terms of Law No. 12,846;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(xx)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">in the case of the Issuer, to have its balance sheets and financial statements
audited by one of the following independent auditors: PriceWaterhouseCoopers, KPMG Auditores Independentes, Ernst &amp; Young Terco Auditores
Independentes S/A, or Deloitte Touche Tomatsu Auditores Independentes (&ldquo;<U>Independent Auditors</U>&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(xxi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">if the Issuer chooses to change the Credit Rating Agency , if the Credit
Rating Agency ceases its activities in Brazil or, for any reason , is prevented from issuing a credit rating for the Debentures or the
Company , as applicable: (a) engage another credit rating agency , without the need for approval by the Debenture Holders, provided that
the Trustee is notified within 5 (five) Business Days from the engagement of the new credit rating agency, provided that such credit rating
agency is , <I>Fitch Ratings </I>Brasil Ltda., or <I>Standard &amp; Poor&rsquo;s Ratings</I>, pursuant to the Debenture Issuance Deed;
or (b) notify the Trustee within 5 (five) Business Days and convene a General Meeting of Debenture Holders so that they may select a substitute
credit rating agency other than those indicated in item (a) of this Clause; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt"><B>(xxii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">provide proof to the Trustee, within <B>(i) </B>three (3) Business Days
from the subscription and payment of the Debentures, if the Issuer fails to</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">provide proof to the Trustee of full payment
of the 1st Debenture Issue; and <B>(ii) </B>eleven (eleven) Business Days from the subscription and payment of the Debentures, the Issuer
fails to prove to the Trustee the full settlement of the Softbank Prepayment.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>RESOLUTIONS OF THE SECURITIZATION ENTITY</B></FONT></TD></TR></TABLE>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>8.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">With respect to any matter under this Debenture Issuance Agreement, including
the prior, definitive, or temporary waiver of rights (<I>waiver</I>) relating to Early Maturity Events, except those already expressly
authorized, the Securitization Entity shall resolve in accordance with the guidance of the General Meeting of Debenture Holders, to be
convened and held within the timeframes and under the other conditions described in the Debenture Issuance Deed, subject to any circumstances
that may exempt the holding of a General Meeting of Debenture Holders for such purpose.</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>REPRESENTATIONS AND WARRANTIES OF THE ISSUER AND THE GUARANTORS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.3in"><FONT STYLE="font-size: 10pt"><B>9.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Issuer and the Guarantors, individually, hereby represent and warrant,
as of the date of execution of this Offering Memorandum, as applicable, that:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(i)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Issuer and the Guarantors are companies duly organized, incorporated,
and existing as a joint-stock company and a single-member limited liability company, as applicable, in accordance with Brazilian law and
applicable CVM regulations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(ii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">it is duly authorized and has obtained all necessary licenses and authorizations,
including corporate and regulatory ones, to enter into this Issuance Agreement and/or the other Offering documents to which the Issuer
and/or the Guarantors are parties, to issue the Book-Entry Commercial Notes or to grant the Guarantees, as applicable, and to fulfill
all obligations set forth herein, having satisfied all necessary legal, contractual, and statutory requirements therefor ;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(iii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the legal representatives of the Issuer and the Guarantors who sign this
Issuance Agreement and/or the other Offering documents to which the Issuer and/or the Guarantors are parties have statutory and/or delegated
powers to assume, on their behalf, the obligations hereby established and, as agents, have been lawfully granted such powers, with their
respective powers of attorney in full force and effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(iv)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the execution of this Offering Memorandum and/or the other offering documents
to which the Issuer and/or the Guarantors are parties, the performance of their obligations under this Offering Memorandum and/or the
other offering documents to which the Issuer and/or the</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">Guarantors are parties, and the issuance and
placement of the Book-Entry Commercial Notes do not violate or conflict with <B>(a) </B>any contract or document to which the Issuer and/or
the Guarantors (and/or their parent companies, direct or indirect subsidiaries) are parties or by which any of their assets and property
are bound, nor will it result in <B>(1) </B>the early maturity of any obligation established in any of these contracts or instruments;
<B>(2) </B>the creation of any encumbrance on any asset or property of the Issuer and/or the Guarantors; or <B>(3) </B>the termination
of any such contract or instrument; <B>(b) </B>any law, decree, or regulation to which the Issuer and/or the Guarantors (and/or their
parent companies, direct or indirect subsidiaries) or any of their assets and properties are subject; or <B>(c) </B>any administrative,
judicial, or arbitral order, decision, or judgment affecting the Issuer (and/or its parent companies, its direct or indirect subsidiaries)
or any of its assets and property<FONT STYLE="font-size: 10pt">;</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(v)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">has not omitted any material fact, of any nature, of which it is aware;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(vi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">no registration, consent, authorization, approval, license, order, or qualification
before any governmental authority or regulatory body is required for the Issuer and/or the Guarantors to fulfill their obligations under
this Offering Memorandum and/or the other Offering documents to which the Issuer and/or the Guarantors are parties, or for the completion
of the Offering;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(vii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Issuer and the Guarantors, as applicable, hold all necessary authorizations
and licenses required by federal, state, and municipal authorities to conduct their activities, all of which are valid as of this date,
except for those that: <B>(a) </B>are being challenged in good faith and provided that a stay of execution has been obtained; or <B>(b)
</B>are in the process of being obtained or renewed in a timely manner in accordance with the laws and regulations applicable to the Issuer&rsquo;s
and the Guarantors&rsquo; respective sectors of operation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(viii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the annual financial statements of the Issuer and the Guarantors for the
fiscal years ended December 31, 2022, 2023, and 2024 accurately represent the financial position of the Issuer and the Guarantors as of
that date and were properly prepared in accordance with applicable fundamental accounting principles and accurately reflect the assets,
liabilities, and contingencies of the Issuer and the Guarantors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(ix)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">is fully aware of and fully agrees with the method of disclosure and calculation
of the indices described in this Offering Memorandum,</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">including the DI Rate, and the method of calculating
the Remuneration, agreed upon of their own free will, in accordance with the principle of good faith;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(x)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">there is no connection between the Issuer and the Securitization Entity
that would prevent the Securitization Entity from fully exercising its functions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">To the best of the Issuer&rsquo;s and the Guarantors&rsquo; knowledge, they
are, as of this date, complying with the rules, laws, regulations, and administrative provisions&mdash;including legislation pertaining
to occupational health and safety, the environment, and orders issued by government agencies, local authorities, or courts&mdash;applicable
to the conduct of their business, except <B>(1) </B>for those that are being challenged in good-faith the administrative and/or judicial
spheres, the enforceability and/or applicability of which is suspended due to the obtaining of suspensive effects within the legal timeframe;
or <B>(2) </B>whose non-compliance does not cause a Material Adverse Effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">are complying with: <B>(a) </B>Reputational Socio-Environmental Legislation;
and <B>(b) </B>other Socio-Environmental Laws not covered by the concept set forth in item (a), adopting preventive or remedial measures
and actions designed to avoid and correct any environmental damage, as well as taking all steps required for the activity in question,
preserving the environment and complying with the determinations of municipal, state, and federal agencies that may subsequently legislate
or regulate the environmental standards in force, except, exclusively with respect to item (b), for <B>(1) </B>those challenged in good
faith in the administrative and/or judicial spheres, whose enforceability and/or applicability is suspended due to the obtaining of suspensive
effects within the legal timeframe; or <B>(2) </B>whose non-compliance does not cause a Material Adverse Effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xiii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">are current with the payment of all obligations of a tax nature (municipal,
state, and federal), labor, social security, environmental, and any other obligations imposed by law, except for those challenged in the
administrative and/or judicial spheres and whose enforceability and/or applicability is suspended or whose non-compliance is proven not
to cause a Material Adverse Effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xiv)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the economic, financial, and equity situation of the Issuer and the Guarantors,
as of the date this statement is made, has not undergone any significant change that could affect their solvency;</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xv)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the information and statements contained in this Offering Memorandum and/or
in the other Offering documents to which the Issuer and/or the Guarantors are parties, with respect to the Issuer and/or the Guarantors
and the Offering, as applicable, are true, consistent, correct, and sufficient;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xvi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the documents and information provided to the Securitization Entity are
true, consistent, accurate, current, and sufficient as of the date they were provided, enabling investors to make an informed decision
regarding the Debentures;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xvii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">this Issuance Agreement constitutes a legal, valid, effective, and binding
obligation of the Issuer, enforceable in accordance with its terms and conditions, with the force of an extrajudicial enforcement instrument
pursuant to item I and paragraph 4 of Article 784 of Law No. 13,105, of March 16, 2015, as amended (<U>&ldquo;Code of Civil </U>Procedure&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xviii)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">declare, on behalf of themselves and their subsidiaries, that their activities
are in compliance with: <B>(a) </B>Reputational Socio-Environmental Legislation; and <B>(b) </B>other Socio-Environmental Laws not included
in the concept set forth in item (a), except, exclusively with respect to item (b), for provisions <B>(1) </B>challenged in good faith
in administrative and/or judicial proceedings, the enforceability and/or applicability of which is suspended due to the obtaining of suspensive
effects within the legal timeframe or <B>(2) </B>whose non-compliance does not cause a Material Adverse Effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xix)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">comply with applicable regulations governing acts of corruption and acts
harmful to the public administration, in accordance with the Anti-Corruption Legislation, on its own behalf and on behalf of its subsidiaries
or, when acting on behalf of and for the benefit of the Issuer and/or the Guarantors, its affiliates, its officers, controlling shareholders,
or employees, and shall use its best efforts with respect to any subcontractors, <B>(a) </B>maintaining internal policies and procedures
aimed at compliance with such regulations; <B>(b) </B>making such regulations known to all its professionals who may be involved in the
performance of this contract; <B>(c) </B>refraining from engaging in acts of corruption and from acting in a manner harmful to public
administration, whether domestic or foreign;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xx)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">have not been duly notified, and there is no judicial action, administrative
or arbitration proceeding, or investigation in which they have been summoned or subpoenaed that could cause a Material Adverse Effect;
and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 85.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.55pt"></TD><TD STYLE="width: 42.5pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt"><B>(xxi)</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">they have not been convicted, in judicial or administrative proceedings,
for <B>(a)</B> labor issues involving work in conditions analogous to slavery and/or child labor and/or the promotion of prostitution,
<B>(b) </B>crimes against the environment; and/or <B>(c) </B>violations of Anti-Corruption Legislation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>10.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>GENERAL </B></FONT><B><FONT STYLE="font-size: 10pt">PROVISIONS</FONT></B></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Expenses</U>. The Issuer shall bear all costs incurred in connection
with the Issuance and the Offering and with the structuring, issuance, formalization, registration, and execution of the Book-Entry Commercial
Notes and Debentures, the Guarantees, and the Corporate Approvals with the respective commercial registries and/or notary offices, as
applicable, including publications, filings, registrations, and the engagement of the Bookrunner, the Securitization Agent, the Coordinators,
legal advisors, and other service providers, as well as any other costs related to the Book-Entry Commercial Notes, the Debentures, and
the Guarantees.</FONT></TD></TR></TABLE>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Communications</U>. All communications made pursuant to this Issuance
Agreement must always be made in writing, to the addresses below, and shall be deemed received upon delivery, by registered mail, or upon
issuance of a &ldquo;receipt of delivery&rdquo; by the Brazilian Post and Telegraph Company. Communications sent by email shall be deemed
received on the date of transmission, provided that receipt is confirmed by a receipt issued by the sender&rsquo;s email system. Any change
to the addresses listed below must be communicated to the other parties by the party whose address has changed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>I.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>To the Issuer</U>:</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left"><B>AFYA PARTICIPA&Ccedil;&Otilde;ES S.A. </B></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Rua Para&iacute;ba, No. 330, 17th Floor, Funcion&aacute;rios,
ZIP Code 30.130-917</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Belo Horizonte / MG</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Attn: Anibal Sousa / Luis Blanco</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Email: [**]@afya.com.br; [**]@afya.com.br;
[**]@afya.com.br; [**]@afya.com.br</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>II.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>For the Securitization Company</U>:</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left"><B>OPEA SECURITIZADORA S.A. </B></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">1240 Hungria Street, 1st floor, suite 12, Jardim
Europa, ZIP Code 01455-000</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">S&atilde;o Paulo / SP</P>


<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Attn: Fl&aacute;via Pal&aacute;cios</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Tel.: [**]</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Email:[**]@opea.com.br / [**]@opea.com.br
/ [**]@opea.com.br</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>III.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>To the Registrar</U>:</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; background-color: white"><B>OLIVEIRA TRUST SECURITIES
DISTRIBUTOR S.A.</B></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left; background-color: white">Avenida das Am&eacute;ricas,
No. 3,434, Block 7, Room 201, Barra da Tijuca, ZIP Code 22640-102</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left; background-color: white">Rio de Janeiro / RJ</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left; background-color: white">Attn: Raphael Morgado
and Jo&atilde;o Bezerra</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left; background-color: white">Tel.: [**]</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left; background-color: white">Email:[**]@oliveiratrust.com.br
;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">&nbsp;</P>

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>IV.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><FONT STYLE="font-size: 10pt"><U>To the Guarantors</U>:</FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left"><FONT STYLE="font-variant: small-caps"><B>NILZA
CORDEIRO HERDY EDUCATION AND CULTURE COMPANY</B></FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Avenida Perimetral Professor Jos&eacute; de Souza
Herdy, No. 120, Jardim Vinte e Cinco de Agosto, ZIP Code 25.071-202</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Duque de Caxias / RJ</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Attn: Anibal Sousa / Luis Blanco</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Email:[**]@afya.com.br ;[**]@afya.com.br
;[**]@afya.com.br ;[**]@afya.com.br ; [**]@afya.com.br</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left"><FONT STYLE="text-transform: uppercase"><B>INSTITUTO
DE ENSINO SUPERIOR DO PIAU&Iacute; S.A.</B></FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">6123 Vitorino Orthiges Fernandes Street, Uruguai,
ZIP Code 64.073-505</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Teresina / PI</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Attn: Anibal Sousa / Luis Blanco</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Email: [**]@afya.com.br; [**]@afya.com.br;
[**]@afya.com.br; [**]@afya.com.br; [**]@afya.com.br</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left"><FONT STYLE="text-transform: uppercase"><B>SOCIEDADE
EDUCACIONAL E CULTURAL SERGIPE DEL REY LTDA.</B></FONT></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Avenida Comendador Gustavo Paiva, No. 5017, Cruz
das Almas, ZIP Code 57.038-000</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Macei&oacute; / AL</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Attn: Anibal Sousa / Luis Blanco</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: left">Email: [**]@afya.com.br; [**]@afya.com.br;
[**]@afya.com.br; [**]@afya.com.br; [**]@afya.com.br</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">This Issuance Agreement is executed as irrevocable and irreversible, except
in the event of failure to meet the requirements listed in Clause 2 above, and is binding on the parties and their successors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">The Issuer authorizes the Securitization Entity,
during the term of the Offering, to consult the databases of BACEN, CERC, and B3, as applicable, to access CPF/CNPJ data for risk monitoring
purposes.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.5.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">The Securitization Entity may recognize, pursuant
to Article 22 of CVM Resolution 60, the financial results generated by the management of the funds.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">With the exception of obligations assumed with specific forms of performance,
compliance with the obligations agreed upon in this instrument and in the other Transaction Documents regarding the submission of documents
and periodic information to the Trustee shall be carried out via email to af.controles@oliveiratrust.com.br.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.7.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">The Issuer hereby guarantees to the Securitization
Entity that the obligations assumed by the Issuer under this Issuance Agreement will be assumed by the company that succeeds it in any
capacity</FONT><FONT STYLE="font-size: 10pt">.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.8.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">The Parties mutually and expressly declare that
this Issuance Agreement was entered into in accordance with the principles of integrity and good faith, through the free, conscious, and
firm expression of the Parties&rsquo; will and in a relationship of perfect equity</FONT><FONT STYLE="font-size: 10pt">.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.9.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">The time limits established in this Issuance Agreement
shall be calculated in accordance with the provisions of Article 132 of the Civil Code, excluding the starting date and including the
expiration date</FONT><FONT STYLE="font-size: 10pt">.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.10.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The obligations assumed in this Issuance Agreement are irrevocable and irreversible,
binding the Parties and their successors, in any capacity, to their full compliance.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.11.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The invalidity or nullity, in whole or in part, of any of the clauses of
this Issuance Agreement shall not affect the remaining clauses, which shall remain valid and effective until the Parties have fulfilled
all their obligations set forth herein. In the event of a declaration of invalidity or nullity of any clause of this Issuance Agreement,
the Parties undertake to negotiate, as soon as possible, to replace the clause declared invalid or null by including, in this Issuance
Agreement, of valid terms and conditions that reflect the terms and conditions of the invalidated or void clause, while observing the
intent and purpose of the Parties</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 9pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">at the time of negotiating the invalidated or
void clause and the context in which it is inserted.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.12.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If this Issuance Agreement is executed digitally, the Parties <B>(a) </B>acknowledge
that the Parties&rsquo; declarations of intent, made through digital signatures, are presumed to be true with respect to the signatories
when the certification process provided by the Brazilian Public Key and C s Infrastructure (ICP-Brasil) is used, constituting an enforceable
extrajudicial instrument for all legal purposes; and <B>(b) </B>waive the right to contest provided for in Article 225 of the Civil Code.
Subject to the provisions of this Clause, this Issuance Agreement may be digitally signed by electronic means.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.13.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">This Issuance Agreement shall be effective for all parties as of the date
indicated herein, even if one or more parties execute the electronic signature at a later date, with all parties being bound upon the
signature of all of them.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.14.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">This Issuance Agreement is governed by the laws of the Federative Republic
of Brazil.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.15.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Unless otherwise provided in this Issuance Agreement, the time periods established
herein shall be calculated in accordance with the rule prescribed in Article 132 of the Civil Code, excluding the starting date and including
the expiration date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 9pt/16pt Verdana,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 42.55pt"><FONT STYLE="font-size: 10pt"><B>10.16.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The jurisdiction of the District of the City of S&atilde;o Paulo, State
of S&atilde;o Paulo, is hereby elected, to the exclusion of any other, however privileged it may be, to settle any issues that may arise
from this Issuance Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: -42.55pt">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">And as the terms are hereby agreed upon and contracted,
the Issuer, the Securitization Entity, and the Guarantors execute this Issuance Agreement in a single copy signed electronically, waiving
the requirement for witness signatures, pursuant to Paragraph 4 of Article 784 of the Code of Civil Procedure.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: center">S&atilde;o Paulo, October 8, 2025.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: center">(<I>Signatures follow on the next page.</I>)</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: center"><I>(The remainder of this page has been intentionally left
blank.)</I></P>


<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Verdana,sans-serif; margin: 0 0 8pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><I>Signature page of the &ldquo;Terms of Issue for the 1st
(First) Issue of Book-Entry Commercial Notes, in 2 (Two) Series, for Private Placement, by Afya Participa&ccedil;&otilde;es S.A.&rdquo;</I></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center">AFYA PARTICIPA&Ccedil;&Otilde;ES S.A.</P>

<P STYLE="font: 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%; padding-right: 3.5pt; padding-left: 3.5pt">
    <P STYLE="font: 10pt Verdana,sans-serif; margin: 0; border-bottom: Black 0.5pt solid; text-align: left">s/ Anibal Jose Grifo de Sousa</P></TD>
    <TD STYLE="width: 53%; padding-right: 3.5pt; padding-left: 3.5pt">
    <P STYLE="font: 10pt Verdana,sans-serif; margin: 0; border-bottom: Black 0.5pt solid; text-align: left">s/ Luis Andre Carpintero Blanco</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Name: Anibal Jose Grifo de Sousa</FONT></TD>
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Name: Luis Andre Carpintero Blanco</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Position: </FONT></TD>
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Title: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center">OPEA SECURITIZADORA S.A.</P>

<P STYLE="font: 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%; padding-right: 3.5pt; padding-left: 3.5pt">
    <P STYLE="font: 10pt Verdana,sans-serif; margin: 0; border-bottom: Black 0.5pt solid; text-align: left">s/ Karine Simone Bincoletto</P></TD>
    <TD STYLE="width: 53%; padding-right: 3.5pt; padding-left: 3.5pt">
    <P STYLE="font: 10pt Verdana,sans-serif; margin: 0; border-bottom: Black 0.5pt solid; text-align: left">s/ Israel Ramos Santos</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Name: Karine Simone Bincoletto</FONT></TD>
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Name: Israel Ramos Santos</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Position: </FONT></TD>
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Title: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Verdana,sans-serif; margin: 0 0 8pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify"><I>Signature page for the &ldquo;Terms and Conditions for
the First Issue of Book-Entry Commercial Notes, in Two Series, for Private Placement, by Afya Participa&ccedil;&otilde;es S.A.&rdquo;</I></P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center">NILZA CORDEIRO HERDY COMPANY FOR EDUCATION AND CULTURE</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%; padding-right: 3.5pt; padding-left: 3.5pt">
    <P STYLE="font: 10pt Verdana,sans-serif; margin: 0; border-bottom: Black 0.5pt solid; text-align: left">s/ Anibal Jose Grifo de Sousa</P></TD>
    <TD STYLE="width: 53%; padding-right: 3.5pt; padding-left: 3.5pt">
    <P STYLE="font: 10pt Verdana,sans-serif; margin: 0; border-bottom: Black 0.5pt solid; text-align: left">s/ Luis Andre Carpintero Blanco</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Name: Anibal Jose Grifo de Sousa</FONT></TD>
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Name: Luis Andre Carpintero Blanco</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3.5pt; padding-bottom: 12pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 14pt"><FONT STYLE="font-size: 10pt">Position: </FONT></TD>
    <TD STYLE="padding-right: 3.5pt; padding-bottom: 12pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 14pt"><FONT STYLE="font-size: 10pt">Position: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center">PIAU&Iacute; INSTITUTE OF HIGHER EDUCATION, INC.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%; padding-right: 3.5pt; padding-left: 3.5pt">
    <P STYLE="font: 10pt Verdana,sans-serif; margin: 0; border-bottom: Black 0.5pt solid; text-align: left">s/ Anibal Jose Grifo de Sousa</P></TD>
    <TD STYLE="width: 53%; padding-right: 3.5pt; padding-left: 3.5pt">
    <P STYLE="font: 10pt Verdana,sans-serif; margin: 0; border-bottom: Black 0.5pt solid; text-align: left">s/ Luis Andre Carpintero Blanco</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Name: Anibal Jose Grifo de Sousa</FONT></TD>
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Name: Luis Andre Carpintero Blanco</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3.5pt; padding-bottom: 12pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 14pt"><FONT STYLE="font-size: 10pt">Position: </FONT></TD>
    <TD STYLE="padding-right: 3.5pt; padding-bottom: 12pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 14pt"><FONT STYLE="font-size: 10pt">Position: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center">SERGIPE DEL REY EDUCATIONAL AND CULTURAL SOCIETY, LTD.</P>

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt/15pt Verdana,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 9pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%; padding-right: 3.5pt; padding-bottom: 12pt; text-align: left; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">s/ Anibal Jose Grifo de Sousa </FONT></TD>
    <TD STYLE="width: 53%; padding-right: 3.5pt; padding-bottom: 12pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">s/ Luis Andre Carpintero Blanco</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Name: Anibal Jose Grifo de Sousa</FONT></TD>
    <TD STYLE="padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 15pt"><FONT STYLE="font-size: 10pt">Name: Luis Andre Carpintero Blanco</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3.5pt; padding-bottom: 12pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 14pt"><FONT STYLE="font-size: 10pt">Position: </FONT></TD>
    <TD STYLE="padding-right: 3.5pt; padding-bottom: 12pt; padding-left: 3.5pt; text-align: justify; font-family: Verdana,sans-serif; line-height: 14pt"><FONT STYLE="font-size: 10pt">Title: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 61; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/16pt Verdana,sans-serif; margin: 0; text-align: center">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.01
<SEQUENCE>5
<FILENAME>ex08-1.htm
<DESCRIPTION>EX-8.01
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right">Exhibit 8.01</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin-top: 10pt; margin-bottom: 10pt; text-align: center">LIST OF SUBSIDIARIES OF AFYA LIMITED</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 86%; padding-right: 2.9pt; padding-left: 2.9pt">
    <P STYLE="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Name of Subsidiary</P></TD>
    <TD STYLE="width: 14%; padding-right: 2.9pt; padding-left: 2.9pt">
    <P STYLE="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Jurisdiction
    of Incorporation or Organization</P></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Afya Participa&ccedil;&otilde;es S.A.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Instituto Tocantinense Presidente Ant&ocirc;nio Carlos Porto S.A.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Instituto Tocantinense Presidente Ant&ocirc;nio Carlos S.A.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Uni&atilde;o Educacional do Vale do A&ccedil;o S.A.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Instituto de Educa&ccedil;&atilde;o Superior do Vale do Parna&iacute;ba S.A.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Centro de Ci&ecirc;ncias em Sa&uacute;de de Itajub&aacute; S.A. &#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Instituto de Ensino Superior do Piau&iacute; S.A.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">FADEP &mdash; Faculdade Educacional de Pato Branco Ltda.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Instituto Educacional Santo Agostinho S.A.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Instituto Paraense de Educa&ccedil;&atilde;o e Cultura Ltda.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Sociedade Universit&aacute;ria Redentor S.A.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Centro Universit&aacute;rio S&atilde;o Lucas Ltda.&#9;</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Sociedade de Educa&ccedil;&atilde;o, Cultura e Tecnologia da Amaz&ocirc;nia S.A.&#9;</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Centro Superior de Ci&ecirc;ncias da Sa&uacute;de Ltda.&#9;</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Medical Harbour Aparelhos M&eacute;dico Hospitalares e Servi&ccedil;os em Tecnologia Ltda.&#9;</TD>
    <TD STYLE="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Sociedade Padr&atilde;o de Educa&ccedil;&atilde;o Superior Ltda.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Companhia Nilza Cordeiro Herdy de Educa&ccedil;&atilde;o e Cultura&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Sociedade Educacional e Cultural Sergipe DelRey Ltda.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Institui&ccedil;&atilde;o Baiana de Ensino Superior Ltda.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">SESSA &mdash; Sociedade de Educa&ccedil;&atilde;o Superior do Semi-&Aacute;rido Ltda.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 9.35pt; padding-left: 9.35pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Faculdade Masterclass Ltda.&#9;</TD>
    <TD STYLE="padding-right: 2.9pt; padding-left: 2.9pt; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11.1
<SEQUENCE>6
<FILENAME>ex11-1.htm
<DESCRIPTION>EX-11.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="border: black 1pt solid">
    <P STYLE="font: 4.5pt Times New Roman,serif; margin: 0.05pt 0">&nbsp;</P>
    <P STYLE="font: 11pt Calibri,sans-serif; margin: 0 0 0 15.2pt"><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt"><IMG SRC="image_013.jpg" ALT="" STYLE="height: 58px; width: 108px"></FONT></P></TD>
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt/13.5pt Calibri,sans-serif; padding-top: 6.05pt; padding-right: 135.95pt; padding-left: 137.5pt; text-align: center">Code of Ethics and <FONT STYLE="letter-spacing: -0.1pt">Conduct</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Calibri,sans-serif; padding-top: 3.8pt; padding-left: 22.9pt">VERSION: <FONT STYLE="letter-spacing: -0.25pt">03</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Calibri,sans-serif; padding-top: 3.8pt; padding-left: 38.55pt">DATE: <FONT STYLE="letter-spacing: -0.1pt">12/27/2023</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Calibri,sans-serif; padding-top: 3.8pt; padding-left: 30.15pt">PAGE: 1 of <FONT STYLE="letter-spacing: -0.25pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font: 11pt Calibri,sans-serif; padding-top: 3.55pt; padding-left: 57.8pt"><FONT STYLE="letter-spacing: -0.1pt">TITLE:</FONT></TD>
    <TD COLSPAN="3" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; font: 11pt Calibri,sans-serif; padding-top: 3.55pt; padding-left: 5.7pt">Code of Ethics and <FONT STYLE="letter-spacing: -0.1pt">Conduct</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 10.05pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0 0 0 7.05pt; color: #3F3F3F"><FONT STYLE="letter-spacing: -0.1pt">Summary</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0 0 0 7.05pt; color: #3F3F3F"><FONT STYLE="letter-spacing: -0.1pt"></FONT></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial MT; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left; width: 87%"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    INTRODUCTION</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right; width: 13%"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    MISSION, VISION AND VALUES</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    APPLICABILITY</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    WORKING ENVIRONMENT</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    SUPPLIERS</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    STUDENTS</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    GENERAL PUBLIC</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    SOCIETY</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    COMPETITION</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    GIFTS AND ENTERTAINMENT</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    INFORMATION CONFIDENTIALITY</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    COMPANY ASSETS AND SHAREHOLDERS</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    CONFLICT OF INTERESTS</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    ETHICS CHANNEL</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    INTERNAL ETHICS AND CONDUCT COMMISSION</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    DISCIPLINARY MEASURES</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    INTERACTIONS WITH PUBLIC AGENTS</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    ADDITIONAL GUIDELINES</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    ETHICS CHANNEL</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Arial MT">
    <TD STYLE="font: 10pt Arial MT; text-align: left"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    UPDATE</FONT></TD>
    <TD STYLE="font: 10pt Arial MT; text-align: right"><FONT STYLE="font-family: Arial MT,sans-serif; font-size: 10pt">21</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0 0 0 7.05pt; color: #3F3F3F"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 3.95pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">1</TD><TD><FONT STYLE="letter-spacing: -0.1pt">INTRODUCTION</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 5.75pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.35pt 0 7.05pt; text-align: justify; color: #3D3D3D">This Code of Ethics and
Conduct (the &#8220;<U>Code</U>&#8221;) was validated by the Audit, Risks and Ethics Committee and approved by our Chief Executive Officer
(the &#8220;CEO&#8221;) and the Board of Directors and summarizes the standards that are to guide our actions. Although it covers a wide
range of business practices and procedures, these standards are unable to cover, and therefore do not cover, all issues that may arise
or all situations in which ethical decisions must be made. However, they do establish the guiding principles that represent the policies
of Afya Educacional, its subsidiaries and/or investees (collectively, &quot;Afya&quot; or &quot;Company&quot;) and establish the conditions
for working at the Company.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 7.1pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.3pt 0 7.05pt; text-align: justify; color: #3D3D3D">In May 2020, Afya adhered
to the UN Global Compact, which provides guidelines for the promotion of sustainable development and citizenship, through committed and
innovative corporate leaderships. By adhering to the 10 principles of the Global Compact, related to human rights, protection of the environment,
working conditions and anti-corruption, Afya is committed to supporting it, making these principles an integral part of its strategy,
culture and daily <FONT STYLE="letter-spacing: -0.1pt">operations.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.85pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.3pt 0 7.05pt; text-align: justify; color: #3D3D3D">Afya guarantees the complete
fulfillment of this institutional commitment by carrying out initiatives related to environmental and social issues, with particular attention
to the following issues: a) environmental policies; b) social policies related to child labor, forced or compulsory labor, all forms of
exploitation of children and adolescents, health and safety at work, freedom of association and collective bargaining, non-discrimination,
disciplinary procedures, working hours, and compensation; c) relations with suppliers in the purchase process; d) customer relations.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.85pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.4pt 0 7.05pt; text-align: justify; color: #3D3D3D">We must strive to promote
a culture of honesty and responsibility. Our commitment to the highest level of ethical conduct must be reflected in all of the Company's
business activities, including, but not limited to, relationships with employees, customers, suppliers, competitors, government, the public
and our shareholders. All of our employees, officers and directors must behave in accordance with the content and spirit of this Code
and seek to avoid even an appearance of inappropriate behavior. Even well-intentioned actions that violate the law or this Code may result
in negative consequences for the Company and for the individuals involved.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 3.2pt 8.7pt 0 7.05pt; text-align: justify; color: #3D3D3D">One of our Company's
most valuable assets is our reputation of integrity, professionalism and fairness. We must all acknowledge that our actions are the basis
of our reputation and complying with this Code and the applicable legislation is imperative.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.8pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.45pt 0 7.05pt; text-align: justify; color: #3D3D3D">This Code also applies
to all third parties who have a business relationship with Afya, including suppliers, consultants and other service providers.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 2.15pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.2pt">2</TD><TD STYLE="text-align: justify">MISSION, VISION AND <FONT STYLE="letter-spacing: -0.1pt">VALUES</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 12.75pt 6.3pt 0 7.05pt; text-align: justify; text-indent: 21.7pt; color: #3F3F3F"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>i.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt">Our mission</FONT></B><FONT STYLE="font-size: 12pt">: Provide a hub
that integrates education and digital solutions for the medical journey, enhancing the training, updating, assertiveness and productivity
of healthcare <FONT STYLE="letter-spacing: -0.1pt">professionals.</FONT></FONT></P>

<P STYLE="font: 11pt/13.5pt Arial MT,sans-serif; margin: 0 0 0 42.35pt; text-align: justify; text-indent: -16.95pt; color: #3F3F3F"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>ii.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt">Our purpose</FONT></B><FONT STYLE="font-size: 12pt">: Transforming
health together with those whose vocation is <FONT STYLE="letter-spacing: -0.1pt">Medicine.</FONT></FONT></P>

<P STYLE="font: 11pt Arial MT,sans-serif; margin: 0.1in 0 0 42.55pt; text-align: justify; text-indent: -20.5pt; color: #3F3F3F"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>iii.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt">Our <FONT STYLE="letter-spacing: -0.1pt">values</FONT></FONT></B><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 6.8pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 26pt"></TD><TD STYLE="width: 7.5pt"><FONT STYLE="font-size: 12pt">&#8226;</FONT></TD><TD><FONT STYLE="font-size: 12pt">People are the best of <FONT STYLE="letter-spacing: -0.25pt">us;</FONT></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 6.85pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 26pt"></TD><TD STYLE="width: 7.5pt"><FONT STYLE="font-size: 12pt">&#8226;</FONT></TD><TD><FONT STYLE="font-size: 12pt">Trust connects <FONT STYLE="letter-spacing: -0.25pt">us;</FONT></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 7pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 26pt"></TD><TD STYLE="width: 7.5pt"><FONT STYLE="font-size: 12pt">&#8226;</FONT></TD><TD><FONT STYLE="font-size: 12pt">Diversity makes us <FONT STYLE="letter-spacing: -0.1pt">stronger;</FONT></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 6.8pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 26pt"></TD><TD STYLE="width: 7.5pt"><FONT STYLE="font-size: 12pt">&#8226;</FONT></TD><TD><FONT STYLE="font-size: 12pt">Restlessness moves <FONT STYLE="letter-spacing: -0.25pt">us;</FONT></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 7pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 26pt"></TD><TD STYLE="width: 7.5pt"><FONT STYLE="font-size: 12pt">&#8226;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">Excellence throughout the <FONT STYLE="letter-spacing: -0.1pt">journey;</FONT></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 6.8pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 26pt"></TD><TD STYLE="width: 7.5pt"><FONT STYLE="font-size: 12pt">&#8226;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt">Results build the <FONT STYLE="letter-spacing: -0.1pt">future.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 7pt 6.2pt 0 7.05pt; text-align: justify; color: #3F3F3F">Our Mission, Purpose and
Values are extremely important and any conduct or act that goes against it is subject to the application of one of the penalties provided
for in this Code of Ethics and Conduct.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 2.2pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">3</TD><TD><FONT STYLE="letter-spacing: -0.1pt">APPLICABILITY</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 12.6pt 8.5pt 0 7.05pt; text-align: justify; color: #3D3D3D">This Code is a duty
to be observed and fulfilled by the governing bodies, management, the employees (teaching staff and administrative personnel), the executives
of all companies pertaining to the Afya Group, as well as by the third parties, business partners and suppliers/service providers that
have commercial and business relations with companies from the Group (&#8220;Recipients&#8221;).</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 7.05pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.45pt 0 7.05pt; text-align: justify; color: #3D3D3D">Thus, Afya Group promotes
and disseminates the knowledge of this Code among the Recipients, making it available to everyone and providing to employees (teachers
and administrative personnel), management and executives, mandatory training for the correct understanding of <FONT STYLE="letter-spacing: -0.25pt">the</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 4.1pt 8.55pt 0 7.05pt; text-align: justify; color: #3D3D3D">principles and values.
Accordingly, it is the responsibility of all Recipients to be aware of and comply with all the principles, values and guidelines included
in this Code. The leadership of the Afya Group companies, in turn, shall support the dissemination of the terms of this Code and the completion
of the training program by their employees.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.85pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.55pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Recipients
must, whenever requested, adhere to it, confirming in writing or electronically that they comply and shall continue to fully comply with
the terms of this Code, as provided for in the internal activities of the companies of the Afya Group</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 2.2pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">4</TD><TD>WORKING <FONT STYLE="letter-spacing: -0.1pt">ENVIRONMENT</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 12.75pt 8.25pt 0 7.05pt; text-align: justify; color: #3D3D3D">We strive for a welcoming,
egalitarian and meritocratic environment. Our employees are our most important assets. Therefore, in order for them to perform at their
best, we are committed to providing them with a free, safe and inclusive working environment. Each of you is part of this team and everyone
is welcome. Afya does not tolerate any form of violation of human rights, such as child, forced and slave labor, disrespect, discrimination,
moral and sexual harassment, intimidation, aggression, exploitation or prejudice due to race, color, religion, political affiliation,
nationality, gender, sexual orientation, age or physical condition.</P>

<P STYLE="font: 12pt/13.75pt Arial MT,sans-serif; margin: 0 0 0 7.05pt; color: #3F3F3F"><FONT STYLE="letter-spacing: -0.5pt">.</FONT></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 6.95pt 6.3pt 0 7.05pt; text-align: justify; text-indent: 35.4pt"><FONT STYLE="font-family: Arial,sans-serif; color: #3D3D3D"><B>Diversity:</B></FONT>
<FONT STYLE="color: #3D3D3D">We want all our employees to feel welcomed by our organization. We believe in the diversity of stories, races,
beliefs, sexual orientations, ages, genders, regions and cultures. Each one brings in their experience some unique knowledge that can
be applied at work. It is the ability to interact with differences for the sake of productive results. Professionals from different backgrounds
have different opinions on each theme. This expands the Company's worldview, making it more competitive in the market. We promote an environment
that welcomes diversity and ensures that promotion and hiring decisions shall never be influenced by issues of gender, color, race, religion,
sexual orientation, sexual identity, political orientation, age, nationality or special needs. Diversity is the basis of our identity
and we truly believe that the best place to work is one where everyone has an active voice, with no distinctions, and we support issues
of gender, color, race, religion, sexual orientation, sexual identity, political guidelines, age, nationality or special needs. Afya does
not tolerate any practice that restricts, humiliates or otherwise violates the dignity or opinion or belief or color or gender or race
or sexual or political orientation or age or nationality or special needs of its employees or third parties or students or service providers</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 4.1pt 8.3pt 0 7.05pt; text-align: justify; text-indent: 28.3pt; color: #3D3D3D"><FONT STYLE="font-family: Arial,sans-serif"><B>Moral
and sexual harassment: </B></FONT>We encourage a work environment in which cordiality is the rule and everyone is treated with respect.
In no context is the use of rude or offensive words acceptable. Moral harassment occurs when an employee is subjected to constant humiliation,
even if veiled or perceived only by him/her, which diminishes his/her self-esteem. It is not allowed to display behaviors that in any
way harm an employee's dignity or reputation, to make unkind jokes about an employee, or criticize an employee's work without justification.
Sexual harassment occurs when a person in a higher position uses that position to obtain sexual favors. This can happen in an open or
secretive manner, through jokes and malicious comments. We remind you that sexual harassment is a crime, subject to penalties based on
applicable law. If you are experiencing any type of moral or sexual harassment, or suspect that one of your colleagues is involved in
this type of behavior, refer the incident to our Ethics Channel (the means of referral can be found in item 14 of this Code).</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.6pt 0 7.05pt; text-align: justify; text-indent: 28.3pt; color: #3D3D3D"><FONT STYLE="font-family: Arial,sans-serif"><B>Health
and safety: </B></FONT>Work safety is a legal obligation. However, both the health of our employees and the maintenance of a safe environment
depend on the cooperation of everyone. Internal health and safety rules and regulations must be followed. Safety equipment must always
be used with appropriate supervision. Therefore, always check that your colleagues, suppliers and any others are acting in accordance
with occupational health and safety regulations. This is a responsibility for all of us. Afya's policies are also aimed at ensuring the
safety and health of our employees, students and suppliers in our units, our offices and during business trips. Work in degrading manners
or outside health and safety standards is not allowed under any <FONT STYLE="letter-spacing: -0.1pt">circumstances.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 7.05pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.6pt 0 7.05pt; text-align: justify; text-indent: 27.35pt; color: #3D3D3D"><FONT STYLE="font-family: Arial,sans-serif"><B>Privacy:
</B></FONT>Afya respects the privacy of its employees and guarantees that their records and information shall be treated confidentially
and shall only be accessed by employees who really need to see them for specified purposes.</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.35pt 0 7.05pt; text-align: justify; color: #3D3D3D">The personal information
of our employees and students cannot be provided to third parties for any reason. If you receive a request for personal information in
the form of a court order or in accordance with an administrative proceeding, contact the Legal Department before sharing that <FONT STYLE="letter-spacing: -0.1pt">information.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0 0 0 7.05pt; text-align: justify; color: #3D3D3D">Please also note that all data generated
by our employees is the exclusive property of <FONT STYLE="letter-spacing: -0.1pt">Afya.</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 3.7pt 8.4pt 0 7.15pt; text-align: justify; text-indent: 30.35pt; color: #3D3D3D"><FONT STYLE="font-family: Arial,sans-serif"><B>Use
of alcohol, illegal substances or medication that affect the ability to work:</B></FONT> People are our greatest strength. Therefore,
we must always be in the best possible condition to provide quality services. Accordingly, the use of any substances that may impair your
ability to work is prohibited. Being under the influence of alcohol or drugs is strictly prohibited on our premises or anywhere else when
working as an Afya representative, in any position.</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 3.9pt 8.45pt 0 7.15pt; text-align: justify; color: #3D3D3D">We encourage employees
who are dependent on alcohol, illegal substances or medications to notify a representative of the People and Management department.</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 3.95pt 8.35pt 0 7.15pt; text-align: justify; color: #3D3D3D">If you use any medication
that may impair your ability to work, notify your manager or the Ethics Channel (see section 14), and they shall help you find the best
solution to your problem. Failure to notify our Ethics Channel (item 14) puts us all at risk Transparency is the best course of <FONT STYLE="letter-spacing: -0.1pt">action.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.35pt 0 7.05pt; text-align: justify; text-indent: 30.45pt; color: #3D3D3D"><FONT STYLE="font-family: Arial,sans-serif"><B>Possession
of weapons:</B></FONT> Afya seeks the safety and well-being of its employees and does not allow the possession of weapons on its premises.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.85pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.45pt 0 7.05pt; text-align: justify; color: #3D3D3D">If you suspect that one
of your colleagues has one, refer the incident to our Ethics Channel (item <FONT STYLE="letter-spacing: -0.2pt">14).</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0.05pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">5</TD><TD><FONT STYLE="letter-spacing: -0.1pt">SUPPLIERS</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 12.55pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 8.35pt 0 7.05pt; text-align: justify; color: #3D3D3D">All relationships
with suppliers and other Afya partners must be conducted with objective criteria and in accordance with our best commercial interests.
Employees may not seek in any way to obtain personal advantage for themselves or for others in negotiations with suppliers. You must immediately
report any potential conflict of interest (cases of conflict of interest outlined in the Related Party Relationship Policy) to your manager
or to our Ethics Channel (see item 14).</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.45pt 0 7.05pt; text-align: justify; color: #3D3D3D">Employees must base their
supplier decisions on a combination of quality, price, conditions offered, business needs and reputation, and must comply with existing
procedures applicable to those suppliers. It is strictly forbidden to accept benefits of any kind, except in the circumstances set forth
in section 10 of this Code.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0 0 0 7.05pt; text-align: justify; color: #3D3D3D">Afya employees must contract suppliers
who respect our principles and <FONT STYLE="letter-spacing: -0.1pt">values.</FONT></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 10.6pt 8.65pt 0 7.05pt; text-align: justify; color: #3D3D3D">If the employee is
aware that a supplier has worked for someone with whom you, your spouse or a relative has some type of family relationship or bond, you
must notify the Compliance Area immediately. The Compliance Area shall judge what needs to be done if it finds that there is <FONT STYLE="letter-spacing: -0.5pt">a</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 4.1pt 0 0 7.05pt; text-align: justify; color: #3D3D3D">real conflict of <FONT STYLE="letter-spacing: -0.1pt">interest.</FONT></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 6.95pt 9.2pt 0 7.05pt; text-align: justify; color: #3D3D3D">It is important to
emphasize that all the provisions of this Code are applicable to suppliers and that their contracts may be terminated if they are not
fulfilled.</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.9pt 0 7.05pt; text-align: justify; color: #3D3D3D">The Company periodically
monitors its relationships with suppliers and other partners, including any payments made to them. The Company also periodically reviews
the legal and regulatory status of these parties.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">6</TD><TD><FONT STYLE="letter-spacing: -0.1pt">STUDENTS</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 12.75pt 8.85pt 0 7.05pt; text-align: justify; color: #3D3D3D">Afya, together with
its employees and teachers, is at the service of all our students. Our primary purpose is to support them in their personal and professional
training, aiming at their future and preparing them for the marketplace.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.75pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 9.1pt 0 7.05pt; text-align: justify; color: #3D3D3D">In view of our purpose,
we undertake a responsibility to society to spare no effort to fulfill our role in the best way.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 8.5pt 0 7.05pt; text-align: justify; color: #3D3D3D">Our teaching staff
and employees directly involved in the education of our students have the following obligations:</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.8pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Arial MT,sans-serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 32.4pt"></TD><TD STYLE="width: 10.2pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 8.9pt"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Seek the continuous improvement and
deepening of their own knowledge and skills, for the benefit of the development of their students;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 32.4pt"></TD><TD STYLE="width: 10.15pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">-</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Seek quality in their teaching <FONT STYLE="letter-spacing: -0.1pt">activities;</FONT></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Arial MT,sans-serif; margin-top: 6.8pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 32.4pt"></TD><TD STYLE="width: 10.2pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 8.45pt"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Guide their conduct aiming at being
respectful, courteous, open to diversity, fair and focused on the development of students;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Arial MT,sans-serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 32.4pt"></TD><TD STYLE="width: 10.2pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 8.95pt"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Seek to encourage students, through
concrete projects, to work in the community around their unit;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Arial MT,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 32.4pt"></TD><TD STYLE="width: 10.2pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 9.1pt"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Behave in an exemplary manner, respecting
schedules, work plans, evaluation formats, in accordance with the pedagogical model adopted by Afya; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Arial MT,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 32.4pt"></TD><TD STYLE="width: 10.2pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">-</FONT></TD><TD STYLE="text-align: justify; padding-right: 8.95pt"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Observe the rules that govern the
performance of their profession, taking as a principle the Law of Guidelines and Bases of National Education (article 13) and the rules
of this Code of Conduct.</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 4.1pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">7</TD><TD>GENERAL <FONT STYLE="letter-spacing: -0.1pt">PUBLIC</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 12.6pt 6.45pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">All the
people we deal with, inside and outside Afya, shall be treated in a cordial, respectful and ethical manner. We believe that the way in
which we interact with the diverse people we deal with reinforces our values and reputation</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 2.2pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">8</TD><TD><FONT STYLE="letter-spacing: -0.1pt">SOCIETY</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 7.1pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 13.1pt 0 7.05pt; text-align: justify; color: #3D3D3D">We promote partnerships
with the communities in which we operate. We encourage respect for local customs and community development by hiring locally.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0.1pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 10.3pt 0 7.05pt; color: #3D3D3D">Through our business, we aim at developing the
communities in which we operate, offering services related to health and the environment.</P>

<P STYLE="font: 12pt/13.7pt Arial MT,sans-serif; margin: 0 0 0 7.05pt; color: #3F3F3F"><FONT STYLE="letter-spacing: -0.5pt">.</FONT></P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 7pt 8.25pt 0 7.15pt; text-indent: 21.7pt; color: #3D3D3D"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>i.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt">Child labor and slave-like labor:</FONT></B> <FONT STYLE="font-size: 12pt">We
are proud to have created a fair and dignified work environment. Thus, we reject the use of child labor or any form of labor analogous
to slavery.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.8pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 8.6pt 0 7.05pt; text-align: justify; color: #3D3D3D">This commitment must
also be observed by our suppliers, and we prefer to do business with those who participate in programs designed to eradicate these practices.
We shall not work with any Company that is, or has ever been, involved in child labor or any form of work analogous to <FONT STYLE="letter-spacing: -0.1pt">slavery.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.8pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 6.5pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">We comply
with the laws that established the Young Apprentice Program, which allows employing young people from 16 to 18 years of age, in order
to contribute to the training of workers of the <FONT STYLE="letter-spacing: -0.1pt">future</FONT></FONT><FONT STYLE="color: #3F3F3F; letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 7pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0 6.3pt 0 7.05pt; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>i.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Corruption and bribery:</FONT></B> <FONT STYLE="font-size: 12pt; color: #3D3D3D">We
shall not tolerate corruption involving national or international public entities, or involving suppliers, customers or other partners.
Corruption or bribery is defined as the acceptance, offer or promise of an advantage, of any nature, in exchange for an opportunity that
would not otherwise exist.</FONT></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.35pt 0 7.05pt; text-align: justify; color: #3D3D3D">Our employees must consider
the practice described above as a possible act of corruption when directed at public entities or suppliers, customers, shareholders, investors,
creditors, the community or other business partners. Public entities are understood to mean government controlled entities or bodies and/or
that have government participation.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 4pt 0 0 7.05pt; text-align: justify; color: #3D3D3D">Any employee involved in corruption
shall be subject to the sanctions described herein and <FONT STYLE="letter-spacing: -0.25pt">the</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 4.1pt 6.5pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">applicable
criminal and civil penalties. Any deviations must be reported to the Ethics Channel, using the means provided in chapter 14 of this Code</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.8pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 6.4pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Employees
cannot accept payment requests to speed up bureaucratic procedures. If there is such a request, you must refuse and report the issue using
our Ethics Channel, so that appropriate measures can be taken</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.8pt 0 7.05pt; text-align: justify; color: #3D3D3D">In addition to the provisions
of this Code, we comply with Law No. 12.846/13, known as the Brazilian Anticorruption Law, as well as the other international guidelines.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.5pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">You must follow
Afya's specific rules and guidelines related to negotiations with public officials, donations, gifts and sponsorships</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0.1pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0.05pt 6.3pt 0 7.05pt; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>ii.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Combating money laundering and terrorist financing:</FONT></B>
<FONT STYLE="font-size: 12pt; color: #3D3D3D">We are committed to maintaining our reputation in the financial community, assisting in
efforts to combat money laundering and terrorist financing. Money laundering is the practice of giving lawful appearance to funds that
were originated by criminal activities, using various transactions to &#8220;launder&quot; those funds.</FONT></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.35pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">We take measures
to avoid or mitigate the possibility of our facilities, products and services being used for a purpose characterized as an act of market
abuse or financial crime. Moreover, when necessary, we monitor customers, potential customers and suppliers to ensure that our products
and services cannot be used to facilitate money laundering and funding of terrorist activities. If you have any questions about our internal
processes and procedures to combat money laundering and terrorist financing, please refer to the Compliance Area</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0 6.4pt 0 7.05pt; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>iii.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Political contributions: </FONT></B><FONT STYLE="font-size: 12pt; color: #3D3D3D">Afya
does not make donations to political parties. However, we respect the political affiliations of our employees and their individual contributions
to political <FONT STYLE="letter-spacing: -0.1pt">parties</FONT></FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F; letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0 6.35pt 0 7.05pt; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>iv.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Donations: </FONT></B><FONT STYLE="font-size: 12pt; color: #3D3D3D">Donations
made by Afya must have a legitimate, objective and proven social benefit. The entity that receives a donation must submit documents that
prove its good standing, and these documents must be kept on file together with the evidence of the social action carried <FONT STYLE="letter-spacing: -0.2pt">out.</FONT></FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 4.1pt 9.25pt 0 7.05pt; text-align: justify; color: #3D3D3D">All donations from
Afya to charitable causes must be expressly authorized in advance by our <FONT STYLE="letter-spacing: -0.2pt">CEO.</FONT></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 3.95pt 6.5pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">No donation
or act of charity from a third party may be on behalf of or for the benefit of Afya. Donations made by Afya must be recorded correctly
and accurately in its administrative and accounting records</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 10.75pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0 6.4pt 0 7.05pt; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>v.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Political and community activities:</FONT></B> <FONT STYLE="font-size: 12pt; color: #3D3D3D">We
support the right of our employees to defend their own convictions and exercise their right to free association in groups that interest
them. However, Afya's resources, including any material or trademark of the Company, may not, under any circumstances, be used for these
activities</FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.85pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.4pt 0 7.05pt; text-align: justify; color: #3D3D3D">The Company does not allow
political demonstrations by its personnel on its premises. If you wish to apply for a political position of any kind, you must inform
the Compliance Area in advance, which shall assess the situation and monitor your progress in this matter.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.6pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">However, these
guidelines do not prevent the Company from organizing political debates and discussions for informational and academic purposes, including
for the purpose of training <FONT STYLE="letter-spacing: -0.1pt">students</FONT></FONT><FONT STYLE="color: #3F3F3F; letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0 6.3pt 0 7.05pt; text-align: justify; text-indent: 11.6pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>vi.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Mergers, acquisitions and corporate restructuring:</FONT></B>
<FONT STYLE="font-size: 12pt; color: #3D3D3D">Transactions in which the Company participates, including mergers, acquisitions or corporate
restructuring, shall be subject to prior due diligence to detect, among other incidents, if the parties have been involved in any irregularity
or criminal activity, in addition to knowing whether these Companies have some vulnerability or weakness that would make them susceptible
to irregularities or criminal activities. The procedures for assessing and analyzing transactions related to mergers, acquisitions and
corporate restructuring, must follow the general guidelines set out in the internal policy of the subject</FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 2.25pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">9</TD><TD><FONT STYLE="letter-spacing: -0.1pt">COMPETITION</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 12.7pt 6.45pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">We believe
that competition promotes the creation of an environment of constant improvement and generates more opportunities. Therefore, our competitors
must be treated in accordance with the same principles established herein</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0 0 0 7.05pt; text-align: justify; color: #3D3D3D">When assessing our competitors, we
must always ensure that information is obtained <FONT STYLE="letter-spacing: -0.1pt">legally,</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 4.1pt 0 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">respecting the practices
of antitrust laws and the highest ethical <FONT STYLE="letter-spacing: -0.1pt">standards</FONT></FONT><FONT STYLE="color: #3F3F3F; letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 9.1pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">10</TD><TD>GIFTS AND <FONT STYLE="letter-spacing: -0.1pt">ENTERTAINMENT</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.3pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Receiving and
offering gifts, entertainment or hospitality is a common market practice in certain circumstances, and the Company does not prohibit these
activities. However, certain conditions must be met to ensure transparency in such cases. They include</FONT><FONT STYLE="color: #3F3F3F">:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/13.75pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3D3D3D"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-size: 12pt">(a)</FONT></TD><TD><FONT STYLE="font-size: 12pt">the item must not have a value greater than five hundred reais (BRL <FONT STYLE="letter-spacing: -0.1pt">500);</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 7pt 8.65pt 0 7.05pt; text-indent: 0in"><FONT STYLE="font-size: 12pt; color: #3D3D3D">(b)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3D3D3D">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 12pt; color: #3D3D3D">the item must be given or received in the context of promoting/stimulating educational
activities of the Company</FONT><FONT STYLE="font-size: 12pt">;</FONT></P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 3.95pt 6.6pt 0 7.05pt; text-indent: 0in"><FONT STYLE="font-size: 12pt; color: #3D3D3D">(c)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3D3D3D">&nbsp;
</FONT><FONT STYLE="font-size: 12pt; color: #3D3D3D">the item must not be received more than once in the same year (January to December)
from the same supplier</FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F">;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 3.85pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 7.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-size: 12pt; color: #3D3D3D">(d)</FONT></TD><TD><FONT STYLE="font-size: 12pt; color: #3D3D3D">the item must not be given or received as a condition for conducting a particular <FONT STYLE="letter-spacing: -0.1pt">business</FONT></FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F; letter-spacing: -0.1pt">;</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0.15in 6.5pt 0 7.05pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt; color: #3D3D3D">(e)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3D3D3D">&nbsp;
</FONT><FONT STYLE="font-size: 12pt; color: #3D3D3D">the supplier who gives the item cannot be participating in the request for bid process
at the time of negotiation or before the contract is signed; and</FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F">; e</FONT></P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 3.95pt 6.4pt 0 7.05pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 12pt; color: #3D3D3D">(f)</FONT><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3D3D3D">&nbsp;
</FONT><FONT STYLE="font-size: 12pt; color: #3D3D3D">the item destined to students and/or teachers in raffles and/or academic prizes must
not have a value higher, individual or aggregated by raffle and/or prize, than five thousand reais (BRL <FONT STYLE="letter-spacing: -0.1pt">5,000.00)</FONT></FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F; letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0.9pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.3pt 0 7.05pt; text-align: justify; color: #3D3D3D">As a general rule, in any
situation, no gifts, entertainment or hospitality can be accepted or provided to influence any decisions, nor should the impression be
given that it is offered for that purpose. Gifts that do not meet the conditions described above must be sent to the Compliance Area for
evaluation. Offering and/or receiving gifts and presents involving the government is prohibited. Employees, management, officers and third
parties cannot receive money in any form, while acting as representatives of our Company in any capacity. If you have any questions or
would like to report an incident, please contact the Compliance Area or report any incident using the Ethics Channel.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 2.2pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">11</TD><TD>INFORMATION <FONT STYLE="letter-spacing: -0.1pt">CONFIDENTIALITY</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 13.65pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.4pt 0 7.05pt; text-align: justify; color: #3D3D3D">Afya complies with the provisions
of Law No. 13.709/2018 (General Data Protection Law) and confidential information means all information relating to the Company or its
respective shareholders that has been obtained and/or brought to the attention of the employee, arising <FONT STYLE="letter-spacing: -0.2pt">from</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 4.1pt 8.35pt 0 7.05pt; text-align: justify; color: #3D3D3D">the performance of
his/her functions, including, but not limited to: (a) any and all techniques used in conducting the Company's business; and (b) reports,
inventions, projects, new products and activities, methods and processes, technologies and market secrets, business and management practices,
corporate plans, our financial data, new business opportunities, accounting methods, management methods, structure of prices, salaries
and costs, advertising and marketing techniques and personal information or pertaining to our personnel not accessible to the public,
especially to the knowledge of the Company's competitors.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 10.75pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.5pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Confidential
information does not include information in the public domain or that has been obtained by employees of the Company in the performance
of their professional functions</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.35pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">The Company
handles the confidential information of our employees, students, suppliers, partners and shareholders with the greatest possible care</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.85pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.45pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">All information
we obtain is automatically treated as confidential. Confidential information may only be released after express and formal approval by
the Chief Legal Officer</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.4pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Considering
the risk inherent to the disclosure of information, information that has not yet been publicly disclosed, and to which the employee has
access due to the position held by him/her or under his/her responsibility, he/she cannot transmit to third parties and/or trade securities
of the Grupo Afya as long as the information remains as &#8220;confidential&#8221;, without disclosure to the market. See our Disclosure,
Use of Information and Securities Trading Policy for further details</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 13.75pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.25pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Employees
who, in the performance of their activities, have access to privileged information, which has not yet been publicly disclosed, about the
Afya Group, shall not be able to transact company securities or shares or transmit privileged information to third parties, by express
legal prohibition, and due to establishing a violation of internal policies</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 7pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.55pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Employees
cannot use the knowledge obtained through confidential information for personal purposes or contrary to the interests of the Company</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.8pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0.05pt 0 0 7.05pt; text-align: justify; color: #3D3D3D">The confidentiality obligation
remains in force and effect for an indefinite period of time, even <FONT STYLE="letter-spacing: -0.1pt">after</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 4.1pt 0 0 7.05pt"><FONT STYLE="color: #3D3D3D">the employee leaves the <FONT STYLE="letter-spacing: -0.1pt">Company</FONT></FONT><FONT STYLE="color: #3F3F3F; letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 9.1pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">12</TD><TD>COMPANY ASSETS AND <FONT STYLE="letter-spacing: -0.1pt">SHAREHOLDERS</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 12.6pt 10.3pt 0 7.05pt"><FONT STYLE="color: #3D3D3D">The Company trusts its employees
to make the best decisions aimed at the well-being of the Company and our students, adding value to our shareholders</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 10.3pt 0 7.05pt"><FONT STYLE="color: #3D3D3D">The good faith expected from
our employees also includes providing information about the Company's operations in a precise, ethical and transparent manner</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 10.75pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 6.45pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Considering
the importance of the need for good communication and the correct disclosure of information to the market, Afya observes specific internal
procedures for this purpose, safeguarding the confidentiality requirements required for conducting business and equal access to information</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0.15in 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.55pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Afya ensures
equal treatment for all categories of shareholders and aims at, within the principles and values contained in this Code, the profitability
of its activities and the creation of value for its shareholders without making any distinction between them</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.75pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0.05pt 10.25pt 0 7.05pt; text-indent: 21.7pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>i.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Proper use of assets and resources:</FONT></B> <FONT STYLE="font-size: 12pt; color: #3D3D3D">E-mail,
Internet and others: Company employees must use their resources properly and with maximum efficiency</FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 10.3pt 0 7.05pt; color: #3D3D3D">All resources provided are for professional
use only. During office hours, employees can use these resources for personal purposes, as long as they do not violate any internal rules
and their productivity is not adversely affected.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.65pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">It is strictly
forbidden to access sites that contain pornography or that promote gambling, pedophilia, racism, discrimination, political party propaganda
or terrorism and that publish defamatory or offensive material</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.35pt 0 7.05pt; text-align: justify; color: #3D3D3D">All information shared
on the work devices provided by the Company, whether cell phones, computers, tablets or e-mail, are subject to verification and control,
even when personal access passwords have been provided. The information exchanged using work devices may be verified at any time by the
Company and at its sole discretion, whenever it deems this <FONT STYLE="letter-spacing: -0.1pt">verification</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 4.1pt 6.5pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">necessary.
Therefore, you are hereby notified that you should have no expectation of privacy regarding information shared on your work devices</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.8pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 9.05pt 0 7.05pt; text-align: justify; color: #3D3D3D">This applies to personal
mobile devices containing applications, devices and tools pertaining exclusively to the Company (e-mail, servers, systems, Internet, etc.).</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0 6.4pt 0 7.05pt; text-align: justify; text-indent: 18.35pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>ii.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Passwords: </FONT></B><FONT STYLE="font-size: 12pt; color: #3D3D3D">Employees
shall receive passwords for access to various devices and work tools, including, among others, e-mail, Intranet, payment control systems,
information about employees and students, in each case according to the job description and responsibilities</FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.45pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">All passwords
are personal and non-transferable. Access passwords are granted confidentially and, under no circumstances may they be transferred or
assigned for use by other people, whether employees, suppliers or students</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.9pt 0 7.05pt; text-align: justify; color: #3D3D3D">The consequences of transferring
or assigning personal passwords to third parties are severe and subject to the penalties established in the Brazilian Penal Code and in
the Labor Laws.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 6.7pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">If any
employee has difficulty accessing any system or needs help in any emergency situation, he or she should contact the immediate supervisor</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 10.65pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0 6.4pt 0 7.05pt; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>iii.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Social media: </FONT></B><FONT STYLE="font-size: 12pt; color: #3D3D3D">The
Company uses social media tools to expand and improve the quality of its communications, generating greater transparency and speed of
response. However, it should be underlined that only duly authorized professionals can issue opinions or respond to comments published
on social media on behalf of the Company and any of its affiliates</FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 6.15pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Unless
they are authorized to do so, employees cannot speak on behalf of, or respond to comments addressed to, the Company or any of its affiliates
or professionals. The Company has its own channels to handle these situations. Furthermore, we discourage discussions about the Company
as part of your personal use of social media. Although business shall be conducted only through approved channels, we understand that
social media is used as a source of information and as a way of communicating with friends, family and contacts in the workplace</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.8pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0.05pt 0 0 7.05pt; text-align: justify; color: #3D3D3D">When using social media and
identifying yourself as an employee, executive or officer of <FONT STYLE="letter-spacing: -0.25pt">the</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 4.1pt 6.4pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Company,
or mentioning the Company, for example on a Facebook page or professional networking site, remember the following</FONT><FONT STYLE="color: #3F3F3F">:</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Arial MT,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.8pt"></TD><TD STYLE="width: 8.9pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">&#8226;</FONT></TD><TD STYLE="text-align: justify; padding-right: 8.6pt"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Never disclose confidential information
about the Company or its business, customers or suppliers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.8pt"></TD><TD STYLE="width: 8.8pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">&#8226;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Make it clear that any opinions expressed are your own and
not of the <FONT STYLE="letter-spacing: -0.1pt">Company;</FONT></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Arial MT,sans-serif; margin-top: 6.95pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.8pt"></TD><TD STYLE="width: 8.9pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">&#8226;</FONT></TD><TD STYLE="text-align: justify; padding-right: 8.75pt"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Remember that our Equal Opportunity,
Non-Discrimination and Fair Employment policy applies to social media sites;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Arial MT,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.8pt"></TD><TD STYLE="width: 8.9pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">&#8226;</FONT></TD><TD STYLE="text-align: justify; padding-right: 8.4pt"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Be respectful towards your colleagues
and all persons associated with the Company, including customers and suppliers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/148% Arial MT,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.8pt"></TD><TD STYLE="width: 8.9pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">&#8226;</FONT></TD><TD STYLE="text-align: justify; padding-right: 8.6pt"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Communicate any social media content
that discusses the Company in an inaccurate or inappropriate manner immediately to the Compliance Area;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Arial MT,sans-serif; margin-top: 0.2pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.8pt"></TD><TD STYLE="width: 8.9pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">&#8226;</FONT></TD><TD STYLE="text-align: justify; padding-right: 9.1pt"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Never respond to any information,
including information that may be inaccurate, about the Company; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/150% Arial MT,sans-serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54.8pt"></TD><TD STYLE="width: 8.9pt"><FONT STYLE="font-size: 12pt; color: #3F3F3F">&#8226;</FONT></TD><TD STYLE="text-align: justify; padding-right: 6.4pt"><FONT STYLE="font-size: 12pt; color: #3D3D3D">Never publish documents, parts of
documents, images or video or audio recordings made with Company&#8217;s properties or products, services or people of the Company or
in the functions or events of the Company</FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F">.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.75pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.55pt 0 7.15pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Moreover,
the language you use on social media is important. All employees, when representing the Company or making publications using any element
that may be linked to the name and/or image of the Company, must behave in a manner compatible with the representation of the Company
and comply with the rules of this Code</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.85pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.6pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Employees are
part of the teaching profession sector and therefore, they are expected to behave in an exemplary manner</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 10.95pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0 6.45pt 0 7.05pt; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>iv.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Professional Networking: </FONT></B><FONT STYLE="font-size: 12pt; color: #3D3D3D">Online
networking on professional or industry websites, such as LinkedIn, has become an important and effective way for colleagues to keep in
touch and exchange information. Employees, executives and officers must use common sense when publishing information about themselves
or about the Company in any of these services.</FONT></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.4pt 0 7.05pt; text-align: justify; color: #3D3D3D">What you publish about the
Company or yourself shall reflect on all of us. When using professional networking sites, you must abide by the same standards of professionalism
and <FONT STYLE="letter-spacing: -0.1pt">integrity</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 4.1pt 0 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">described in our
code and follow the social media guidelines described <FONT STYLE="letter-spacing: -0.1pt">above</FONT></FONT><FONT STYLE="color: #3F3F3F; letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 3.95pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0 6.45pt 0 7.05pt; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>v.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Accuracy of records: </FONT></B><FONT STYLE="font-size: 12pt; color: #3D3D3D">The
Company understands that most of the strategic decision- making process involves the monitoring and accuracy of its information. Therefore,
employees must undertake to keep all information, accounting, or other records, duly updated and available, if access to such records
is necessary.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.85pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.35pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">We maintain
the highest standards in all matters related to accounting, financial controls, internal reporting and taxation. All books, records and
financial accounts must accurately reflect transactions and events and be in accordance with the required accounting principles and internal
controls adopted by the Company. The records must not be distorted in any way to hide, disguise or change the true financial situation
of the Company. All employees have a duty to record only true information, respecting internal procedures and general rules of technical
behavior and good <FONT STYLE="letter-spacing: -0.1pt">faith</FONT></FONT><FONT STYLE="color: #3F3F3F; letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 10.85pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0 6.45pt 0 7.05pt; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>vi.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Intellectual property and confidential information:
</FONT></B><FONT STYLE="font-size: 12pt; color: #3D3D3D">We emphasize that all material, information, conclusions and ideas produced by
employees for the Company, or using material or information obtained in the performance of their duties, are the exclusive property of
the Company. Each individual is responsible for treating as confidential the information he/she has access to as a result of his/her work,
using it carefully. We do not allow the disclosure of this information without the express authorization of the Legal Officer of Afya.
Failure to comply with the guidelines set forth herein, are susceptible to the explicit sanctions in topic 16 below</FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 10.75pt 0 0">&nbsp;</P>

<P STYLE="font: 11pt/150% Arial MT,sans-serif; margin: 0.05pt 6.5pt 0 7.05pt; text-align: justify; text-indent: 11.6pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3F3F3F"><B>vii.</B></FONT><B><FONT STYLE="font-family: Times New Roman; font-size: 7pt; color: #3F3F3F">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt; color: #3D3D3D">Personal use of tools, software and internal communication
channels:</FONT></B> <FONT STYLE="font-size: 12pt; color: #3D3D3D">Afya prohibits the use of tools and software licensed and approved
by the Information Technology Department for professional purposes being used for personal purposes. Responsible users and managers of
access to the Company's communication channels or social media shall use the access only to carry out approved activities and on behalf
of Afya</FONT><FONT STYLE="font-size: 12pt; color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 2.2pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">13</TD><TD>CONFLICT OF <FONT STYLE="letter-spacing: -0.1pt">INTERESTS</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 12.6pt 6.35pt 0 7.05pt; text-align: justify; color: #3D3D3D">Our employees, executives
and officers have an obligation to behave honestly and ethically and to act in the best interest of the Company. All employees, executives
and officers must make efforts to avoid situations that pose a potential or real conflict between their interests and <FONT STYLE="letter-spacing: -0.25pt">the</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 4.1pt 6.5pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">interests
of the Company. See our Related Party Transaction and Conflict of Interest Policy for further details</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 8pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0.05pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">14</TD><TD>ETHICS <FONT STYLE="letter-spacing: -0.1pt">CHANNEL</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 12.45pt 6.4pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">The rules
and procedures established in this document do not cover all situations that may arise in the day-to-day activities of the Company and
our employees. Always use this Code and our principles as a general guide for making decisions</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 7.15pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.6pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Whenever you
have doubts or testify or become aware of anything that conflicts with this Code, it is your duty report to the Ethics Channel</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0.15in 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.55pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">You must report
to the Ethics Channel, whenever you become aware of or witness any action or omission that is in disagreement with this code, and in case
of failure to do so you may be considered an accomplice</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.55pt 0 7.05pt; text-align: justify; color: #3D3D3D">The e-mail address of the
Ethics Channel is etica@afya.com.br, and you can access it through the following portal: www.contatoseguro.com.br/afya and phone number:
0800 900 9050. The Ethics Channel may be monitored by a specialized third party, as determined by the Board of Directors, at its sole
discretion.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.8pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.35pt 0 7.05pt; text-align: justify; color: #3F3F3F">Upon receipt of the report,
the investigation procedure will begin and its conclusions will be evaluated by the Internal Ethics and Conduct Commission, which will
decide on the action to be adopted. Furthermore, the complaint, as appropriate, will be forwarded to the Audit, Risks and Ethics Committee
and the Board of Directors for information and any possible action. The Company may choose to include those involved in the complaint
on temporary leave during the <FONT STYLE="letter-spacing: -0.1pt">investigation.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 6.55pt 0 7.05pt; text-align: justify; color: #3F3F3F">Regardless of any
administrative actions taken by the Company, in the event of misconduct, the reported individual may also be held responsible according
to the penalties established by applicable legislation.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.4pt 0 7.05pt; text-align: justify; color: #3F3F3F">The Company will guarantee
the anonymity of whistleblowers, if they so wish. No form of retaliation will be tolerated against anyone who uses the Ethics Channel
in good faith.</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 12.05pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">15</TD><TD>INTERNAL ETHICS AND CONDUCT <FONT STYLE="letter-spacing: -0.1pt">COMMISSION</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 12.7pt 0 0 7.05pt"><FONT STYLE="color: #3D3D3D">Any reports and other communications
shall be analyzed in an impartial and confidential manner by the Company's Internal Ethics and Conduct Commission</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.85pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 0 0 7.05pt"><FONT STYLE="color: #3D3D3D">The composition and functioning of the
Internal Ethics and Conduct Commission are provided for in its internal regulations, which were approved by the Executive Management</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 10.3pt 0 7.05pt"><FONT STYLE="color: #3D3D3D">The Internal Ethics and Conduct
Commission and the Compliance Area are the Company's internal bodies responsible for complying with and implementing the provisions of
this Code</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0.6pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.3pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">The Compliance
Area shall be responsible for the preparation and periodic training of the Company's employees in the application of the provisions of
this Code. The Compliance Area has full independence and autonomy to report any incident directly to the Ethics Committee, Audit, Risks
and Ethics Committee and, depending on the seriousness of the situation or if any member of the referred to Committees is involved, to
the Board of Directors, including with regard to any incident allegedly involving the Chief Executive Officer (CEO), and may make recommendations
to the Audit, Risks and Ethics Committee and the Board of Directors on action to be taken in this <FONT STYLE="letter-spacing: -0.1pt">situation</FONT></FONT><FONT STYLE="color: #3F3F3F; letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 10.65pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0.05pt 6.45pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">The Internal
Ethics and Conduct Commission and the Compliance Area are also responsible for periodically analyzing risks in order to make any necessary
adjustments to the Code</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 8pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0.05pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">16</TD><TD>DISCIPLINARY <FONT STYLE="letter-spacing: -0.1pt">MEASURES</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 12.45pt 6.6pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Any employee
who violates any provision of this Code or fails to report a known violation or cooperate with the investigation of any report shall be
subject to the following disciplinary <FONT STYLE="letter-spacing: -0.1pt">sanctions</FONT></FONT><FONT STYLE="color: #3F3F3F; letter-spacing: -0.1pt">:</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 6.95pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.55pt"></TD><TD STYLE="width: 35.6pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>i.</B></FONT></TD><TD><FONT STYLE="font-size: 12pt">Verbal <FONT STYLE="letter-spacing: -0.1pt">admonition;</FONT></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 6.95pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.55pt"></TD><TD STYLE="width: 35.6pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>ii.</B></FONT></TD><TD><FONT STYLE="font-size: 12pt">Written <FONT STYLE="letter-spacing: -0.1pt">warning;</FONT></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 7pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 22.2pt"></TD><TD STYLE="width: 38.95pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>iii.</B></FONT></TD><TD><FONT STYLE="font-size: 12pt; letter-spacing: -0.1pt">Suspension;</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 4.1pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 22.2pt"></TD><TD STYLE="width: 38.95pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>iv.</B></FONT></TD><TD><FONT STYLE="font-size: 12pt">Dismissal without cause; <FONT STYLE="letter-spacing: -0.25pt">or</FONT></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 6.95pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.55pt"></TD><TD STYLE="width: 35.6pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>v.</B></FONT></TD><TD><FONT STYLE="font-size: 12pt">Dismissal for <FONT STYLE="letter-spacing: -0.1pt">cause.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0.1pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.45pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">The application
of any of the disciplinary measures listed above shall be decided by the Internal Ethics and Conduct Commission according to the seriousness
of each infraction based on this Code. The imposition of one penalty is independent of any other. In other words, a person may be dismissed
for cause without any previous penalty having been applied to him/her</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 13.7pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.5pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">The application
of any sanction shall be the responsibility of the Internal Ethics and Conduct Commission and shall follow the procedures provided for
in the Conduct Management <FONT STYLE="letter-spacing: -0.1pt">Procedure</FONT></FONT><FONT STYLE="color: #3F3F3F; letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.85pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Arial,sans-serif; margin: 0 0 0 7.05pt; text-align: justify; color: #3F3F3F"><B>Quality of public <FONT STYLE="letter-spacing: -0.1pt">disclosures</FONT></B></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 6.95pt 8.65pt 0 7.05pt; text-align: justify; color: #3D3D3D">The Company is responsible
for communicating effectively with shareholders, so that they receive complete and accurate information, in all relevant aspects, on the
financial situation and profit/loss of the Company's operations. Our reports and documents filed with or submitted to the Securities and
Exchange Commission (SEC) and our other public communications must include full, fair, accurate, timely and understandable disclosure.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.8pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt"><FONT STYLE="font-size: 12pt">17</FONT></TD><TD><FONT STYLE="font-size: 12pt">INTERACTIONS WITH GOVERNMENT <FONT STYLE="letter-spacing: -0.1pt">OFFICIALS</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.95pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.5pt 0 7.05pt; text-align: justify; text-indent: 3.35pt"><FONT STYLE="color: #3D3D3D">Afya's
relations with the public administration must be solely and exclusively institutional, performed in an ethical, transparent, integral
and official manner, in accordance with legislation. It is expressly forbidden to receive, offer, promise or authorize, directly or through
third parties, any undue advantage of any kind, whether in cash, goods or services of value, to government officials, political parties,
candidates for public office or any person with political exposure, in Brazil or abroad, in order to obtain personal benefit or for the
Company</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.85pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.4pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">The relationship
with the government, agencies or public authorities, as well as the relationship with suppliers, customers and partners must be conducted
in a transparent and honest manner, avoiding privileges of any kind</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.9pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0.05pt 0 0 7.05pt; text-align: justify; color: #3D3D3D">We are committed to strict compliance
with government procurement laws and regulations, <FONT STYLE="letter-spacing: -0.25pt">as</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 4.1pt 0 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">well as government
bidding rules and <FONT STYLE="letter-spacing: -0.1pt">contracts</FONT></FONT><FONT STYLE="color: #3F3F3F; letter-spacing: -0.1pt">.</FONT></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 6.85pt 6.5pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">For more
specific and targeted guidance on Afya procedures that involve interaction with public officials, we suggest referring to Anti-Fraud and
Anti-Corruption Policy</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.7pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.35pt"></TD><TD STYLE="width: 24.65pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>I.</B></FONT></TD><TD><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>Reporting violations to a government <FONT STYLE="letter-spacing: -0.1pt">agency</FONT></B></FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial,sans-serif; margin: 7.1pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.3pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">Based on applicable
law, you have the right to certain protections to cooperate with government agencies or entities and self-regulatory organizations or
to report legal violations to them. Accordingly, nothing in this Code is intended to prohibit you from reporting violations, or to cooperate
with a government agency or entity or self-regulatory organization, and you can do so without notifying the Company. The Company cannot
retaliate for any of these activities, and nothing in this Code or other document requires you to waive any monetary reward or other payment
that you may be entitled to receive from a government agency or entity or from a self- regulatory organization</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 3.7pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 15.1pt"></TD><TD STYLE="width: 27.9pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>II.</B></FONT></TD><TD><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>Record <FONT STYLE="letter-spacing: -0.1pt">Compliance</FONT></B></FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 7.1pt 6.55pt 0 7.05pt; text-align: justify; color: #3F3F3F">All of the Company's
business records and communications must be clear, reliable and accurate. The Company's employees, executives and officers must avoid
exaggeration,</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.85pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.35pt 0 7.05pt; text-align: justify; color: #3F3F3F">conjectures, legal conclusions
and derogatory comments or characterizations of people and Companies. This applies to communications of all types, including emails and
&quot;informal&quot; notes or memos. Records must always be handled in accordance with the Company's record compliance rules. If an employee,
executive or officer is unsure whether a document complies with these assumptions, they shall consult with the Legal Department before
proceeding.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 13.6pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 0.05pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 11.75pt"></TD><TD STYLE="width: 31.45pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>III.</B></FONT></TD><TD><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>Government <FONT STYLE="letter-spacing: -0.1pt">Investigations</FONT></B></FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 6.95pt 8.55pt 0 7.05pt; text-align: justify; color: #3D3D3D">The Company cooperates
with government agencies and authorities. Forward all requests for information to the Legal Department immediately to ensure that the
Company may respond <FONT STYLE="letter-spacing: -0.1pt">appropriately.</FONT></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.7pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">All information
provided must be true and accurate. Never try to deceive an investigator. Never alter or destroy documents or records that are subject
to an investigation</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial MT,sans-serif; margin-top: 4.1pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10.4pt"></TD><TD STYLE="width: 32.8pt"><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>IV.</B></FONT></TD><TD><FONT STYLE="font-family: Arial,sans-serif; font-size: 12pt"><B>Disclaimers and <FONT STYLE="letter-spacing: -0.1pt">amendments</FONT></B></FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 6.95pt 8.35pt 0 7.05pt; text-align: justify; color: #3D3D3D">Any waiver (including
any implied waiver) of the provisions of this Code for executives or officers shall be disclosed to the Company's shareholders in its
Annual Report on Form 20-F. Any waiver of this Code for other employees may only be granted by the Legal Department. Changes to this Code
shall also be disclosed in the Company's Annual Report on Form 20-F.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 9.1pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0.05pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">18</TD><TD>ADDITIONAL <FONT STYLE="letter-spacing: -0.1pt">GUIDELINES</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 6.95pt 9pt 0 7.05pt; text-align: justify; color: #3D3D3D">The guidelines of the
Afya Code of Ethics and Conduct allow us to evaluate most situations and minimize the subjectivity of interpretations about ethical and
conduct principles, but they do not necessarily detail all the situations that may arise in the Company's daily activities.</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 8.5pt 0 7.05pt; text-align: justify; color: #3D3D3D">Thus, in the event of any
doubts or evidence of non-compliance with the precepts of this Code, it is the responsibility of internal Recipients to seek guidance
and file the report through the Ethics Channel or directly to the Compliance Area before taking any decision that may compromise <FONT STYLE="letter-spacing: -0.1pt">compliance.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 0 0 0 7.05pt; text-align: justify; color: #3D3D3D">The Ethics Channel is also available
for suggestions for improving this <FONT STYLE="letter-spacing: -0.1pt">Code.</FONT></P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 10.6pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0.05pt; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">19</TD><TD>ETHICS <FONT STYLE="letter-spacing: -0.1pt">CHANNEL</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 6.95pt 8.25pt 0 7.05pt; text-align: justify; color: #3D3D3D">The e-mail address
of the Ethics Channel is etica@afya.com.br, and you may access it through the following portal: www.contatoseguro.com.br/afya and phone
number: 0800 900 9050.</P>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 2.15pt 0 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial MT,sans-serif; margin-top: 0; margin-bottom: 0; color: #3F3F3F"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25.05pt"></TD><TD STYLE="width: 35.25pt">20</TD><TD><FONT STYLE="letter-spacing: -0.1pt">UPDATE</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial MT,sans-serif; margin: 6.7pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.35pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3D3D3D">This Code
of Ethics and Conduct shall be annually reviewed by the Compliance Area and by the Internal Ethics Commission, and the result of this
review being forwarded to the Audit, Risks and Ethics Committee, even if there is no update to be made, for acknowledgement of the body
that approves this Code</FONT><FONT STYLE="color: #3F3F3F">.</FONT></P>

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.35pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3F3F3F"></FONT></P>

<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Gray 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR><TR><TD STYLE="text-align: right">&nbsp;<IMG SRC="image_013.jpg" ALT=""></TD></TR><TR><TD STYLE="font: 10pt Arial MT,sans-serif; text-align: right">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/150% Arial MT,sans-serif; margin: 0 6.35pt 0 7.05pt; text-align: justify"><FONT STYLE="color: #3F3F3F">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>7
<FILENAME>ex12-1.htm
<DESCRIPTION>EX-12.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right">Exhibit 12.1</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt"><FONT STYLE="background-color: white">I,</FONT> Virgilio Deloy Capobianco
Gibbon, certify that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>I have reviewed this annual report on Form 20-F for the year ended December 31, 2025 of Afya Limited (the &ldquo;Company&rdquo;);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>The Company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and have:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD><FONT STYLE="background-color: white">Designed such internal control over &#64257;nancial reporting, or caused such internal control
over &#64257;nancial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of &#64257;nancial
reporting and the preparation of &#64257;nancial statements for external purposes in accordance with generally accepted accounting principles</FONT>;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD>Evaluated the effectiveness of the Company&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD>Disclosed in this report any change in the Company&rsquo;s internal control over financial reporting that occurred during the period
covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal
control over financial reporting; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>The Company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the Company&rsquo;s auditors and the audit committee of the Company&rsquo;s board of directors (or persons performing the
equivalent functions):</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s
internal control over financial reporting.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%; padding-right: 5.75pt; padding-bottom: 24pt; font-family: Times New Roman,serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.75pt; font-family: Times New Roman,serif">/s/ Virgilio Deloy Capobianco Gibbon</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; font-family: Times New Roman,serif">Virgilio Deloy Capobianco Gibbon</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; font-family: Times New Roman,serif">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Date: March 31, 2026</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>8
<FILENAME>ex12-2.htm
<DESCRIPTION>EX-12.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right">Exhibit 12.2</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">CERTIFICATION BY THE PRINCIPAL FINANCIAL AND ACCOUNTING
OFFICER</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">I, Luis Andr&eacute; Carpintero Blanco, certify that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>I have reviewed this annual report on Form 20-F for the year ended December 31, 2025 of Afya Limited (the &ldquo;Company&rdquo;);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>The Company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and have:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD><FONT STYLE="background-color: white">Designed such internal control over &#64257;nancial reporting, or caused such internal control
over &#64257;nancial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of &#64257;nancial
reporting and the preparation of &#64257;nancial statements for external purposes in accordance with generally accepted accounting principles</FONT>;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD>Evaluated the effectiveness of the Company&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD>Disclosed in this report any change in the Company&rsquo;s internal control over financial reporting that occurred during the period
covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal
control over financial reporting; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>The Company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the Company&rsquo;s auditors and the audit committee of the Company&rsquo;s board of directors (or persons performing the
equivalent functions):</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s
internal control over financial reporting.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-bottom: 20pt; font-family: Times New Roman,serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-family: Times New Roman,serif">/s/ Luis Andr&eacute; Carpintero Blanco</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="width: 5%; font-family: Times New Roman,serif">Name:</TD>
    <TD STYLE="width: 32%; padding-right: 5.75pt; padding-left: 5.75pt; font-family: Times New Roman,serif">Luis Andr&eacute; Carpintero Blanco</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">Title:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-family: Times New Roman,serif">Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 12pt 0 0">Date: March 31, 2026</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>9
<FILENAME>ex13-1.htm
<DESCRIPTION>EX-13.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right"><B>Exhibit 13.1</B></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED<BR>
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)
and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Afya Limited (the &ldquo;Company&rdquo;),
does hereby certify, to such officer&rsquo;s knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">The Annual Report on Form 20-F for the year ended December 31, 2025 of the
Company (the &ldquo;Report&rdquo;), as filed with the U.S. Securities and Exchange Commission on the date hereof, fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-bottom: 20pt; font-family: Times New Roman,serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-family: Times New Roman,serif">/s/ Virgilio Deloy Capobianco Gibbon</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="width: 5%; font-family: Times New Roman,serif">Name:</TD>
    <TD STYLE="width: 32%; padding-right: 5.75pt; padding-left: 5.75pt; font-family: Times New Roman,serif">Virgilio Deloy Capobianco Gibbon</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">Title:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-family: Times New Roman,serif">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Date: March 31, 2026</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>10
<FILENAME>ex13-2.htm
<DESCRIPTION>EX-13.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right">Exhibit 13.2</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED<BR>
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)
and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Afya Limited (the &ldquo;Company&rdquo;),
does hereby certify, to such officer&rsquo;s knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">The Annual Report on Form 20-F for the year ended December 31, 2025 of the
Company (the &ldquo;Report&rdquo;), as filed with the U.S. Securities and Exchange Commission on the date hereof, fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-bottom: 20pt; font-family: Times New Roman,serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-family: Times New Roman,serif">/s/ Luis Andr&eacute; Carpintero Blanco</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="width: 5%; font-family: Times New Roman,serif">Name:</TD>
    <TD STYLE="width: 32%; padding-right: 5.75pt; padding-left: 5.75pt; font-family: Times New Roman,serif">Luis Andr&eacute; Carpintero Blanco</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif">Title:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-family: Times New Roman,serif">Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Date: March 31, 2026</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>11
<FILENAME>ex16-1.htm
<DESCRIPTION>EX-16.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">March 31, 2026</P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">Securities and Exchange Commission</P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">100 F Street, N.E.</P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">Washington, DC 20549</P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">Commissioners:</P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"><B>&nbsp;</B></P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">We have read Item 16F. &ldquo;Change in Registrant&rsquo;s
Certifying Accountant&rdquo; of the Annual Report on Form 20-F for the year ended December 31, 2025 of Afya Limited and are in agreement
with the statements contained therein in relation to Ernst &amp; Young Auditores Independentes S/S Ltda. We have no basis to agree or
disagree with other statements of the registrant contained therein.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">Very truly yours,</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">/s/ Ernst &amp; Young Auditores Independentes S/S Ltda.</P>

<P STYLE="font: 12pt/18pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>12
<FILENAME>ex23-1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"><B>&nbsp;</B></P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"><B>Consent of Independent Registered
Public Accounting Firm</B></P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">We consent to the incorporation by reference in the following
Registration Statements:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #333333"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">(1)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Registration Statement (Forms S-8
No. 333-291480) pertaining to the Amended and Restated Stock Option Plan of Afya Limited and the Restricted Stock Plan of Afya Limited;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #333333"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">(2)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Registration Statement (Forms S-8
No. 333-268886) pertaining to the Restricted Stock Plan of Afya Limited;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #333333"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">(3)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Registration Statement (Forms S-8
No. 333-268884) pertaining to the Amended and Restated Stock Option Plan of Afya Limited; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #333333"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">(4)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Registration Statement (Forms S-8
No. 333-251147) pertaining to the Long-term Incentive Plan of Afya Limited.</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; color: #333333">of our report dated March 13, 2025, with respect
to the consolidated financial statements of Afya Limited, included in this Annual Report (Form 20-F) for the year ended December 31, 2025.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">/s/ ERNST &amp; YOUNG</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">Auditores Independentes S/S Ltda.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">Belo Horizonte, Brazil</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">March 31, 2026</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>13
<FILENAME>ex23-2.htm
<DESCRIPTION>EX-23.2
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: center"><B>Consent of Independent Registered Public Accounting
Firm</B></P>

<P STYLE="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">We consent to the incorporation by reference in the registration
statements No. 333-291480, No. 333-268886, No. 333-268884, and Forms S-8 No. 333-251147 on Form S-8 of our report dated March 31, 2026,
with respect to the consolidated financial statements of Afya Limited and the effectiveness of internal control over financial reporting.</P>

<P STYLE="font: 10pt/12pt Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 11pt/12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">/s/ KPMG Auditores Independentes Ltda.</P>

<P STYLE="font: 11pt/12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt/12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">Belo Horizonte, Brazil</P>

<P STYLE="font: 11pt/12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">March 31, 2026</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 63pt 0 6pt">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $X!7$# 2(  A$! Q$!_\0
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ML!]?:D^8^PI>%'84F[/W1^-  %'4\GWI2P''?T%)M)^\?P%+PH["@!/F/L*
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M0I:3WI:1QB'I2T4G?% "TG0TM% !3XS@U&.E.3[U ,M+Z4ZFCH#3J1B!&12
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MAXWN;R/5('\/W2:II^WS+**59"V[IAAC/OQ^=%F#P-=7NMM]5Z=]M5KL=<%
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M()TD30]-1@059;2,%2.A!QQ5)V/0PF)A0C)2O=K2S5M5;5/=]/+U/*E_L/\
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M*"P%&">I_*@ "@!,L>@Q]:7;Z\TF[T&:,$]3CZ4 *2!29)Z#'UI0 *3=Z<T
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MH_&@!0H'N?>D+ <=3[4;2?O'\*7A1V% "?,?84!0/<^]&XG[H_$T;<_>.:
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M>?E]R_R,<:/J!Z^)-4 _ZYVW_P 9I1HMXO/_  DFJ?\ ?NU_^,UK98]!CW-
M3NQS1</;S\ON7^1D?V5?=O$FJG_MG:__ !F@:-J!^]XDU3\([;_XS6N65?\
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M\K%>W:GT7#V\_+[E_D8K:/?*0P\1ZI[_ +NV_P#C-/\ ['OO^ADU3_OW:_\
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MT&/K1M'?FEW#MS28)ZG'TH 4D"DR3T&/K2X I-WIS0 ;?7FE) I,$]3CZ4H
M% "9)Z#'UHVCOS1N].:,$]3CZ4 *6 I,L>@Q]:7 %)N]!F@ VC.3S2E@*3!/
M4_@*7 7VH 3YCTXHVC.3R:-V>@S1@GJ?P% "E@.*3YC[4N OM2;L_=&: #:,
MY/)I2P''>DP3U/X"EX4>E "?,?:@*,Y/)]Z-V?NC-&TGJ?P% "E@..I]J3YC
M[4O"CL*3=G[HS0 !0#GJ?>E+#IU/M2;2>I_*EX4=A0 GS'VH"@'/4^]&XG[H
MHVD]30 %AT')]J/F/M2\*.PI-Q/W1^)H 4*!SWI"XZ#D^U&W/WCGVI>%'84
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MR1Y  '/?-<IXHMTTK5%MK,:O;KY89X]1(60-DCC;P5P!R/>MUM4N;E=,CO\
MP9>74=C9+:K\\J-E2#O5E7Y3Q[_6J7BF[UGQ++9A= OK:WLXO*B1EDE?'<LY
M&3T%)7N3AW659.H[QUZQLM7;9Z].UCL;[X;V$$-SLN=<C6*V,PO))HGAR%SC
M: '/Y?C7++I6A:18Z8WB#5-6^U:C MRHLBNR&)ONEMW)[GCT/MG9E\67)U8Z
MQ#X&O4U40^4D[32LH&W;R@0 CVK*MM3N9;&P@UOP5<:G-8((K>8B2([!]U7
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MY)=6U[=V<TJ@2F H1)C@$AU89 XR #T]!22:&A>*:"]O+:YCB$)GC=6:1!R
M^]6#<DG.,C)QUH R)M1U>-9K'S)I6M;I$GN[:!6E\AHRP8)@@ONVJ< \<@=J
MV=&G2YLF9-1EO0KE6>6,1R*>/E90JX(SW /-,30XX+4Q07UY#.TOG272NIDE
M?&"6W*5(Q@8VX&!@# JQI]@M@DVV::>6>3S99IB-SMM"YX  X51@ =* +@4#
MM06 I,$]3^5+@"@!,D]!CZTNWUYHW>G-)@GJ<?2@!20*3)/08^M* !1N].:
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MFEFAD5D=\R%RP)=3D?.>V>G)H ([Z:W?2IQ>7<]G<RO!)]KMA#(&(^0E=B$
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MB-$V[6?YLGC!)YY]<]\U3CU/0XYXH8D4""0PQR1VC>5&Y."HD"[%.>#SUXH
MPSY?G7<$[>782Z[Y=Q@[5V?9UVJ2.BEP@]\X[U-K%I9Z7=M!I4,5N9K*X-W!
M  J; GRN5' .[ ![@GKCC5N=5T*W:[@E \LN?M3I:NT0; !\QPI0' &=QXXS
M4]G;:/;3S:=96UK"TD2RRQ0P!5=#E03@8/0B@#D1-/INF:#I5T[R0RW-G)93
M,<DC>I:)CZKU'JO^Z36HMK!INH?;KFRL+Y)M0VIJ"./M$;R2[50@CD*6"\-T
M'W>M;2WFDW!MK7,3XN&A@C,)PLL620,C *[3@^W%5;-_#][J@N+6RC:[<EEN
M_L#*']2)2@#?@>: *GB^ZMKA[31;A;MH+C,MU]EMY)F6-?NC$:DC+[>>F%85
MDR74_B&U\-E;B6VU&&YF1Y&C9&6:.)^60X.UL E3_"W:NC/B#181;WH$Y%]'
M%Y4\=C,WFJP+(-P0Y^\2!U&34RWFBB6XNF6&*6W5;F:2: QL@92H8E@"#M4C
MUP,4 <AJ-_\ VI_PD?GP"*XCL+&&Z@;D(XGGR/<$$$'N"#707MA8:5JVEG3(
M(;2[FN CQ6R!/-BVL6WJ.H'7)Z$ =^;D=YH>J7,ML]NIFN8P'2ZLVC,Z*3C_
M %BC>!D^N,^]1:?=>'+73+C5]-BLX;5=RS36\ 0_*<$$ 9X/;% &Z% [4%@*
MSI=:L8KM[5Y)FE1@K^5;2.J$C(#,JE5."#R1U'K6C@"@ R3T&/K1M]>:-WIS
M1@GJ<?2@ ) HR3T'YT  4;O3F@ V^IS02!28)ZG'TI0 * #)/08^M&WUYHW>
MG-)@GJ?RH 4D"DRQZ#'UI0 *-WH,T &WUYH+ 51U+5K+2(H9=0N/)2:98(R$
M9LNWW1P#^?2H+OQ)H^G75W;7-WY<UI;?:YU\MSMBSC=D#GGL.?:@#4RQZ#%+
MM'?FLH^)=)V::ZWBLNIMMM&56(E.,XX''XXJC<>.O#EM8QWL^I%;>2=[=&6W
ME.9%^\,!<\?E0!T98"D^8^U8=EXPT&^-F+:]9C>2O# &@D4NZ@,PY48P".3Q
M5:T^(7A:_O8[.WU0&>1_+0/#)&K-G& S*!G\: .EVCOS]:4L!QWJAI^L6&K-
M>)9W2RM9SM;W"@%3'(O4'('Y]#VJD/&'AX:,VK_VG$+!93#YQ5AN<=0HQEOP
M!S0!M_,?:EVCOR?>L?3/%6B:S:W%S8:A%)%;C,Q?,9C'7+!@"![D5!I7C/P_
MKE\+*PU-9K@@LJ>6Z;@.NTL &_"@#?+ <=Z3YC[4O"CTI-V>@S0 NT=3R?>@
ML!QU/M2;2?O'\J7A1V% "?,?:E"CJ>3[TF[/W11M)^\?RH "P!QU/M1\Q]J7
MA?04FXG[H_&@!0H'/4^]8GC!A_PB.J#J?L[5M;2?O'--FAAFA>&>..2)QAD=
M058>A!ZT <>7NM/\3Z[JT)D>WBFA2[MUYS'Y*'>H_O+R<#J"1R0*O^&H[.Z\
M$6QN&1K5T=G8OA2F]CDG/3'X8K5OK[3]'B>\N6BMDFE1'F*XW,<*NX@?09/0
M4R=-*BC729X8!#)!)*+7R<QF-"N_C&."Z\=\_6@"CX<MH4GO+ZSLQ96%R(UM
M[9(Q&"%W9E*C[I;<!CKA%SUP*UEI^EZE'J5SJT<$MU%=3+,\^-UNBN=@4G[@
MV!&!&,YSU-6=/U'P[:V[W=A9-:PM"9FFCTR6)6C W9SL&>.@[]JL7PT*;4+$
M7EM9RW=UD6KRP!V;:-W!(XP.: .8US58SK,U]!'?RMHY06WD6DTJ2D\S@NJE
M?N87D\$$FK4FH?8_%M_K4$CS6(M;43I&"P:-O,*R #J0<?@S>E=7:-:&2XMK
M<*#!)B5$3:JNP#GM@D[@Q_WN>M06D^D6^I2Z;:+;PW<4*,\446W$?(49 P0,
MGCMGMD4 <;J$5T=,UV6^B:2>XDLI9+;(.,RC$0R<<#"^A.3WJ?5=+D&E:M=6
MNB'2;8:=*DD!\K=,^5(;;$S+\JJPSG)W^U=%=:MHWGSQ2H)"'59Y/LKO&K*<
M@.X4J"IYY/'M4]UK6GVL\L$\LTCQ &40V\DHCR,C>44A>.><<<]* *FIS1S>
M(/#YA=9,/--\IS\GE,-WTRRC/N*QK2SBTB*UCGLK":6YADCAU2V8&2X(B9RT
MG&?F"DY!89].*Z*P&A6MVB:=!9Q37,'GJUM"%\R,$<[E&",L._>H(?\ A'[:
MYEDMK.SAF:X^QR.EJ%9I& .TD+SD$<]* ,GPKIABT*TN)M)TC3U_L]2E_;R[
MI@2@^8@Q+MX)).X_CUJQHD$.CW]G9RZ98K<S0,L=]:$$SA<%BX(!!/7.6'OS
M5FR3PU#?B*RTZ!)E=H1+!I[*@8<%?,";?48SZBDBU'PSI,:7EK:+ EQA1-:Z
M=)ARS[0I*)U+\8/<CU% &1XFU!KG5Y!#%>O+I*++;?9[.:97N3ABK,BD#Y %
MY[3&GF:6Z\33:[I!>8)I5G+]G!_U\3O<%EQ_?& 1[C'0FNEMM1L/,EC@ @;R
M_M4HDA:$A22-[;@,<J>O/%5=/U'0S=1QVJB&2X7;&QM'A68 LP"L5 ;[SL "
M>I/<T <W9-9:Q%I+&..ZM)_$%VX61 RL/*N2,@_AUK>L[:VL?%1M--5((&M&
MDNK>  1QON01G:.%9@9.@YV\]*F,OAN]TV\D:&RGM+&XF:X5K<,(YDW>82I'
MWN6YQSGOFA-1T;2!]FL[<0JRB9DM+)V"ANC,(U.W..^.E $VNV,=[I\D$=OI
M\U\48VJWRAE#?WL$$\9'0>E1>%GMQX>MX+2V,"6Y> IN##<C%6(8<,"P)S[]
MNE:%WIMEJ,:I?6D%T@.0L\0< _0BIHHX+6%(88TBB0;4CC4 */0 =* '89NI
MP/04H55Y_6DRS=!CW-+L!^\2: $WYX4$T89NIQ]*<65>]-W,?NC'N: %"JO:
M@R ' Y/M2;,_>)-.P%'84 -^=O04>6/XB32[U[<_2DRYZ #ZT .  Z"ER!6;
M%K&GW%G>W:7BO#9/+'<E0<QM'G>",9XQ^/;-%QJ^GVSQH[RR2/&)1'!!),^P
M]&*HI('N: *WBAE_LF#D?\A&Q_\ 2J*DUJ1?[6\.<_\ ,1?_ -);BK!N]&U>
M*&U?[/=Q72LZ1R1[D?RV&<@C&5)'!Y&.G!PV.'0=/DN!#:6=NUFHN)3';A?+
MRK@-D#KMWCCG!/8\@&%I]I9Z=/91WEAIUZ+QWBCU*,AI)MRL3Y@(Y!4$'#,/
M8"H6TK3;>Q\:RP6%K%)$TBQO'"JE%-E$2 0.!DG\S6]"?#MM:)KEO:VD:3@%
M;B*VQ(^_&!@+N)/ QC/M5JT_L_4(;DPV[!)7*W"S6S1&0[0/F5U!/RA1DCH!
M0!S?]G-;^$]3FET/2+$_V9($FLY-[MF,YS^Z3'YFK%WIVG:9I^F76GVT%IJ3
MRP)$;= C399=ZL!C<NTL3GH.>U:%M:^'X=4N-.MK&P6[6#,T<=LJGRVXP3C!
M![CW&>HJ)+KPQH]W*UO:6]O+#\DTUM8G;%WP[HN%ZY.2,4 2ZS'!=:WI=G?X
M:QE28^4_W)9ALV*PZ-\ID(4]<9[5SOB*TMK6+6-/TY5CLFM8VN8(3M2*0R@#
M 'W69=Q.,= ?>NREDT[496TZ98;G,2SM$Z;T9"2 >1@\@U5MY-"2W2QMX+9(
M)[I[98$M]J-,@9F&,8X\MCGIQUZ4 827=Q'XFT+2;]VDNK>:5HYV'_'Q%Y+@
M-_O#HWO@]&%3Z]:27?C"R2/2]/U BPE/EWTFQ5_>1\@^6_/X#ZUK0ZEIFI7L
M+P(\LJ;FAF:TD"=,$I(5VG(]#R*@O+KP[J-M87MW;P7@N8M]KNM#-(R$!B57
M:6Q@J3QQQF@#%M],%_X=O],2UTUM4MKB5(H9L/%;ABK$1,5)P%88.W[W! Q@
M=#X<FMGT&R%I 8+81^7'&3G;M.W&>XR.O?KWK.U#^P'T2);>RT['F&.V@GT]
MGV/_ ! 0A=^0,G  ]\=:MV.MVBZ"]S=/%#]D^2>*&*0>3S\J[&4/T*_PC/88
MH W:*S$UVR^SRRR?:84B +M-:2Q]3@ ;E&220,#)YJS9:A!?AS")U*$!A-;R
M1'GV=030!-]Q\=C4E-9=RXH1LK[CK0 ZHU^1RO8\BI*9(,C(ZB@!](1D$4*=
MR@TM #(SP5/44^HW^5PW;H:DH ;(,KD=1S2J=R@TM1K\KE>QY% $E1M\KANQ
MX-24C#<I% '#:] MU/KEN[.JRWVEH6C;:P!FC&0>Q]Z?)?WW_"16=C.H;5K.
MRN]K;<+< B/9(![D8([$$=,9ZX6EK*79[:%G9D9RR EF0@H3ZD$ @]L5%?W.
MGV,D-U=A!-DQ0L(B\A)Y*H "QSMR0/3VH R-%T_0S8V-]L@>X?8XO'.)7E.,
M@OU))X*_ACM7-Z5%$VGZ2D.AFSO);P!-580J#B0LPW*Q<EE4KA@ <XKK%;02
M+G6DM;>.6V+-//):&.5,#)+;E#=/SJ=[[1(=&M+ES;IITSQ>0?+^3<[ H<8X
M^8@Y.,'GB@#G]+TQKK5M3E;0](N8O[2DW74\G[Y<8Z+Y1SCM\P_"JFH:Y&-;
MEUKR[UO[.G%NACLYGB: 9$[>8%*=3GD_\L!TYKJ;VP\/6]U%/>6&GBXNIPB.
M]NI>24\CG&2>.OM42ZWHMOYELJNELDC02$6<@A5@<,"VW8!G(ZXH S;FVM[&
M]N=8N;.PU.V-TKBZW@SV_*J%&000#V# \XP2:KZ9IK7&L:E.VAZ3<PC4I-US
M/)^^4<=%\H@X[?,/PKH(;309)YKJ*PLO.LG\MY1; -&RJ" #C/ (Z53G?PLT
MD=T^G6\\US&MT'BTYII"K=';:A(SZG'3VH L:N<^(/#Q_P"GB;_T0]<4\T^D
M^ KA)G>33[^.7RV8Y^SS%S\I/]UNWHV1_$!7;OK.EB\6&2.::Y@595,=E+*8
MPX(!RJG:2,CUHN=0T6W@_L^6W+0F,.]O'8R2*BL<C>JJ0O.3AL=#0 [6TTU;
M82:G;"YA5P8X"F_S)#P $Z,QSQGIUXZU)X?L9=/TA()D$9+O((%.5@5F+",'
MT4$#CCCCC%6+_3K+4HD6\LX+E4.]%GB#A3C&0".#@T^SM;:SMQ%:6\-O%G.R
M) BY^@H G(R"*;&>"IZBGU&WRN&['@T 24R097(ZBGT4 (IW*#2U&GRL5/U%
M24 1M\D@;L>M<U>ZE<Z?XUGEDN"-+CLK59XV;Y8S)).!+Z#E5!/H<G[M=.Z[
ME(JLMC:R3SSO"KRSQ)!-NY#HI8J"#QU=OS^E ''WVHZA+I?B2],]Q&DEA%<6
MD:L4:%"90,<C#,%#'OSCM4]\9K;PUK,T=IK.G3);G8]U?^83GNNV5]I&.O!Y
MX[UU%WI5E?)=)<PEQ=0K!-AV7<@+$#@\?>;D<\U5FT"Q>VFAD^URPSH8Y$EO
M)G!4^FYC@^XP: *M[;?V-<65S:7=WF6YCMY()[F2995<X. Y."/O9&.%.:S=
M.EN=3ATVQGO+A8Y6O99'64J\GES[53>#D##YX(/RCMFNAMM%L;>Z2[59I9D!
M"/<7,DQ3/7;O8[2>F13)])TF.RAMID6*%9BT)\YD9978_=?(8,2QZ'OB@#,U
MJZM_#^AF(ZG);F]G6WCFN[K/D;OO,'<Y&%#,,D\X%4;77/MN@VB6VI"YDM=5
M@LY;B&;=YR^8N"6!YW(5S[DBMVRT[2;:[:YMRLDD)='E>X:5D8A=P8LQYPJ]
M>0.. :+^PT2ZMY-1NWC6&18I&N5N6B4A"6C;<K #!;@_3MB@#1NEE\ES P67
M:0K,,@''!-<K#))I]C-%>+JD&I-8RXDENVEBE95R63YB%/<<*<9XXK?T^'39
M[&46=R;RVFRK,UVUPI[$99FQ]!6?#:^'8;TV3W<;WA1H%@GOVD=58<JJLY*Y
M'IC@4 0^')-ME%>7=EJ]L$M1(]Q>W_FQO\H).T3/[GE169X;\0VVH:NUL^KQ
M7(U>!YT@BNPSVK G]V-IRA\LKTQ\R,>IKH5T/1AG33).X:'!M9+^9\Q=/N%S
M\O;I[5=N(;/4BN6CF>SG##8_,4@'?!X.&Z'LWH: .?M=/N7?Q*EC>78NX+CR
M;,SWLKI'FVA;HS$?>=CD@XS5[1C#%=O:/#J=M=-%O,5[=-.K@$ LC%V'4C/0
M\C(JQ.VAPVU[)=7%K%#=SXN6EG"AI0BKC)/#;47@8Z9INFIH<.;VSO8YRY%N
M+B2]:?G/"!F8XR<<#J: .?O+C49HKN&VU":"?^W4ABDW%@J^6A"D=TSU7ODT
MZZ\279NKB5-T%U::7<?:+9F+)#,KQ_,1W !W ]U/;-=%)8:7'>;75!*\WVTH
M93N+J N_&>@X'I44<_ARZO[G5(KO3Y;B*V,5Q,DZMMASN._!Q@8ZGWH EM]&
M2UDBN$OK^65/OF6Y9UER.ZD[1Z_*!^7%<EX>U 7%EX;%I/K#ZG-%$]R;MKCR
MI$V+YK9E^1NO!3/)&.,UT6FQ>&A<!]/OH)6MT+K&M^94A7&"50N508.,@#&:
METQ-#NK>UM-/GMKB+3MGD""XWF'"[5Y!)^[QSU'7- &3X9,UVR27%EK3G[3/
M_ICW^8#MD?'R>=G' 7&S].:J0^*K0^+EG&LV[037+:<+$7*EEQ]V79G.3(&7
M./NLI[5U$'A^PM6S ;R,;V?8M[,$RQ)/R[\=23C%32:18OHXTK[.!9K&(UB!
M(PHZ8.<@C YSF@#%19K+5#+JJZCF2\(ANH;IC;[7?$2-&&XX*J<J1GG/-5?#
M)FO"DEQ9:TY^TS_Z8]_F [9'Q\GG9QP%QL_3FMV/0M.:<7!CE+"7SO+-Q(8@
M^<[A'NV9SSTZ\TZVT"PLY ]O]KC D,@07LVS<26/R;]N"23C&* +\?!*'MTJ
M2HY!M(<=NM2 Y&: &R+N7W%"-N7-.J-?DD([&@"2HW^5@X_&I*1AN4B@ W#U
MHJOL;THH FD^[57O5J3[M5>]!I$****91S'[RW\07\CWFK01M<QNL-O9>9%*
M!%&"2WE,>2"IPPZ=CS2K/''9ZI8SZ=>7#S7$VV'[+)LD#'CYR-@!]2>*Z:B@
M1SEH\^BW3_;HKJX:2T@7S8('EWN@(8':#@YP><#GKUJ'28Y=$D@?4+:X8G3[
M>%'A@:;RBB_.A" D<D'.,'\!74TE 6.8OK*YUF8I!9""VMX,0>>3$4F;#!U
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MQM8/NQ@Y_P!D_I5&U\264PMP5E02K<,&<#"B%MKD\_E_2@#6@:5K>)IT"2E
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M\-L;>X21X+B$MN$<BG!&>X[_ (UM;2>I_"@ + >Y]J/F/M2\*.PI-Q/W1^-
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M/B"QLH8)+72]*GN4F=6/F3Q8R.",H"<'OD'F@#ORXS@<GVHPS=3CZ5YGH?Q
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MV<&H6Q<8;RRAW YQN7:1[CCG"UW,9RON*=4?W)?9J )*CD&"'';K4E(1D$4
M*#D9HID9QE3U%/H C'R28[&I*9(,KD=1S39'F^SLT"(\N/E5W**3[D X_(T
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MI\K%#^%24R08(8=J>#D9H :Z[E(H1MR^].J,?))[-0!)4;_*0X_&I*0C((H
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MGM]3FC(%>;?#V.+_ (2O6QI=C<Z5I4,4<;V%R_[Q9NN[86)4%?S_ )>D@ 4
M&2>@Q]:-OKS1N].:,$]3CZ4 &0*,D]!CZT  4;O3F@ V^O-!(%)@GJ<?2E
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M,$X@AC;Y#YN-V[.2>G'-<7X-U*P'P:^Q-?VPN_L=X/L_FKYGWI3]W.>G-8$
MU=-1\)W6B$->VOA]9_(/2X4.=T?X@\>X% 'H6B> 8-"-LEIKNM_9(&)6TDN4
M,+9))!4(."232#X;Z0L@1+S5$L%F$PTY;G%N&#;N%QD#/.,UY]IM\NIZ5:7\
M<;(MSX]294?JH900#[\UK:+;>&M4AOM1\77ZQ:['>NLIFNVAD@PV%5 ",+C'
M04 >M%@/_K4GS'VH&U5&,8]:-Q/W1F@!=H[\_6@L![_2DVD]3^ I>%'84 )\
MQ]J4*![_ %I-Q/W1^=&TG[QH "P'3GZ4?,?:EX4=A2;B?NC\30 H4#W^M(6
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M-:9J]C;6$D1CLX;A)S;P*JQRE>BN,<KZ@8Z5Q&@:CI[?!.6R^W6QN_[*N_\
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M2?.?04 /X%(74=Z38#U)-*%4= * &^8.P)HWM_<-/HH 9N?^Y^M&\CJAI]%
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MP"#A^!ST]LU5N?A]92SV-Q;ZMJ]E-9V$>GH]K.B%HD.1N^0Y)/7H.!Q76@Y
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M=3L;A;MXUM[6<)#;A6P%9"""2/[WK0!Z.1N!!IL9X*GJ*>.G7-1O\KANQZT
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M:($'@J!QP>XKR6ZU.TU#3M&O-6U*&PUG2TELIXK^R-Q SJ0I#8!PQ&#FO2?
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M]2U?2;\RG2;R#26M9[K]U-F0.< C)^\,-D#BNK\"Z3-HOA6VM+NTDM[P,[7
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M[JP#ZB0L96($(Q(&U^."-PSC/XUFZS\0?&6AZO<:;<WMF\UNP5FB@!4\ \9
M/?TJ<^-="UVUE6_ADTV:*_BOX7DF>X#N&&]1A1M&T<#I6-XV_P"$>U34;_6M
M/\0K/<3.K)9_8Y%/8'YV '09II=T5AL/#VBA7H):._NZ7NK:JZV;Z]#J+#Q%
MXWO=+M;^76]$L([O=]G2\*QO* <$@;3WHLM?\8W>CVFJ3>(O#]G!=[_)%X?+
M9MC%6XV8Z_S%9GA;Q#HUGHEK:ZMKD=Q9HK>;IEUIIE*DDG]W(.G;K^E6=/\
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MZ (U^5RO8\BI*9(.-PZBG*=P!H &&Y2*\YU'X2V.K:I=W\FJ7,;W$S2LBHI
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M9SW_  A7AD]-!L_QCH_X0?PV?^8'8C_MG714478?6J_\[^]_YG._\(-X;_Z
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M[$"6;8HV+Y>,J5SDXQW/2NVUK0%UOR6.I:C8R0[MKV-QY9(.,@\$'IZ51L/
MVDZ9=Z7=02W9FTZ2XE5I) QF>90KM(2.3@#&,4 <D?B!K#?V\\,<D;?;K:SL
M8;Z 1M;F0')< 9/3/)/:M>2]\2>&M>TRSO\ 4XM:BU,21H&MU@>*55W#&W@J
M>AST]:V9O!FD73ZR;A)IUU9TDG5V ",@PI0@ @]^IJ/3_ ]C9WPO;F_U/4;I
M(VBAEO;DN8%88.S &#[]: .8\.>)]7EOQ#K6N36^H-'*3I5QI@A&0IQY<G\6
M.#R>16=X?\9:Y+_PCD\OB6WU.?4KL07.F"WB$D"$D&3*8(P #SZUVMKX#L+:
M]ANKC4]6OC;JRVZ7EUYBP[EVDJ,#G'KFM#P_X:TSPWI\-I86X)B4K]HD1?-?
M)S\S #/6@#9"@>_UH+ <=?I2;2?O&EX4>E "?,?84H4#W^M)N)Z"C:3]XY]J
M %W#ZGVI/F/L*7A1V%)N)Z#\30 H4#_Z]!8=N3[4FW/WCFER%'I0 GS'KQ2A
M0/\ $TFXGH/Q-&W/WCF@ W#MR?:C#'KQ]*7(4>E)N)Z#\30 H4#_ !-(7';D
M^U&S/WCFE)5?04 )AFZG ]J JCG]31N)Z#\31LS]XYH "X[<FDPS=3CZ4XE5
M'I2;F/W1^)H  JC_ !H+CH.3[4;,_>.:7A1V% #?G;_9%*$'?D^]&_\ N@FD
MPY[X'M0 [@>U)O7MS]*-@[\_6G8 H 9N8]%_.C#GN!3Z* &;6_OFC8W]\T^B
M@!F''<&C>1]Y<>]/HH 0$'H:6F%.Z\&A7YPW!H ?3&7NO!I]% #5;</0^E.I
MCJ1\R]13E8,,B@!2,C!J-3M;:>G:I*:Z[A[CI0 ZBFHVY?>G4 1I\K%#T[5)
M3) 2,CJ*<K;E!H " 1@TV,]5/44^HW^5@X_&@"2FNNY?<=*=U%% #4;<H-.J
M,?))CL:DH C<;6#C\:DI",@BFQG@J>HH ?48^20CL:DID@RN1U% #Z1AN4BA
M3N4&EH 9&>,'J*?4;?)(&['K4E #)!P&'44X'(R*7K4:?*Q0_A0!)49^23/8
MU)377<I% #J",C%-1MR^XIU $<9P2A[=*DJ.08(<?C4@.1F@!L@RON*$;<H-
M.J,?)(1V/2@"2HW^5@WX&I*1AN4B@!:*9&>-IZBGT 1K\KE>QZ5)3)!QN'44
MY3N (H &7<I%-C.5P>HI]1GY) >QH DID@QAAU%/H/(H 0'(!I:CCX)0]NE2
M4 1_<D]FJ2FR+N7W%"-N4&@!Q&1BHXSC*GM4E1O\K!Q^- $E,D&5R.HI]% #
M4;<H-.J-?DD*]CTJ2@"-_E<-V/6I*1AN4BFQG*X/44 /J-/E<K^525'(. PZ
MB@"2FNNY2*4'(S2T ,C;*^XI]1GY)?8U)0!'(,8<=14@.1F@C(Q4<9QE3VH
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M8- "T4Q#C*GJ*?0!&?D?/8]:DI&7<I%-C.1@]10 ^HQ\CX['I4E-D&5R.HH
M=2$9&*%;<H-+0 R,XRIZBGU&_P K!_P-24 -D7<O'44JMN4&EJ-?DD*]CR*
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M!R?:CYCUX%+D*/2DW$]!^)J3S10H'_UZ3<.W/THVY^\<TN0H]* $PQZG ]J
MH'_UZ-Q/0?B:-F?O'-  7';GZ488]3@>U*2%%)N8]!^)H 4*!_C2%QVY/M1L
MS]XYI>%'84 -^=O]D4H0=^3[T;\_=!-)ASU./I0 [('M2;QVR?I0$4>_UIU
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M!&1BFHVY?>G4 1QG!*'M4E1R?*P<?C4@.1F@!LBY7W%"-N4&G5&OR2$=CTH
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MP!1GTYH ,>O-&0*,$]3^5& * #)/08^M&WUYHW<\<T8)ZG\J #('%&2>V*,
M4;O3F@ V]SS1D"C!/4_E1@"@ Y/M1MYR>:,^@S1@GJ?RH ,@4<GVHP!1G/09
MH YCQY9"^\,M;&^BL1)/$&N9GV+&-V2<_3\SQ7GWB+05U2WL=&T+5]'?3--@
MDE0?;0\KG&YW?:"!GL.G7IV]<U+2K/6;)K/481/;L03&20"1R.E9$/@+PS;>
M9Y.F"+S$,;[)I%W*>JG#<@^E4G8]G X^&'@DV[IMK1-:V5]6G>USR./5%M?
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M5(#D9H ;(NY:$;<HIU1CY)<=C0!)4;_*P?\ .I*1AN4B@!>HHJ.(\%3U%24
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M%%% !R>G%&/7FBB@ R!1R?:BB@ VCZT9 HHH .3[4;1WYHHH ,@4<GVHHH
MH^M!8"BB@!/F/M2A0***  L![FD^8^U%% "A0*-PZ=3[444 )\Q]J4*!110
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M,D&1D=1110 Y3N4&EHHH C/R2 ]C4E%%  >14<9VL4/X444 24V1=R^]%%
MC;E'K3J** (W^5@X_&I.M%% !4:_)(5['I110!)2,-RD444 -C.5P>HI]%%
M$<@X##J*>#D T44 +49^23/8T44 24$9&*** (XS@E#VJ2BB@!DBY7W%*C;E
M!HHH =4;_*X?\Z** )**** (T^1RO8]*DHHH 1EW*138VRN#U%%% #ZCE'1A
MVHHH >#D9I:** (_N2^QJ2BB@!",@BF1GJI[444 24R1<KD=1110 J-N4&G4
F44 1O\KANQZU)110 5&GRN5/X444 24UUW*1110!!EJ*** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *H [$# 2(  A$! Q$!_\0
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M1]D@_N?J:E+J/XA2>8G]X?G0!']C@_N?J:/LD']S]33S,@ZN!^- F0]'7\Z
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M:"",@@BG4P"BBB@ HHHH **** "BBB@ HI** #-+24M !1110 4444 %%%%
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M;9RRB1X%+#N15W%)CWH K_8K?<3Y0!/7WIB:9:1S^<L(W^OI5RDQ0 "EHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *0BEHH 8T:MC< <=,]J/*3).T9/4
MT_%&!0!$UO$X :-2!V(I1#&.B@=NE244 1>1'_<7G@\4""-3D(H.,<#M4M%
M$2P1KC:BC'3 J*>R@E0JT:@,>=HZU9J&ZD,-M)(O55R* %6-414"X51C%(L4
M<>,(%],"N9@UV_(MII?*,<K%< \BI9=<GC,F)(Y JDC [T =%Y$>[=Y:ANN<
M4BPQJ2RHH8]3BN7N;S5FL[.=Y8X_-<8Q4ESJ^I1S3+$8V6!06/K0!T@AB((\
MM=IZC'6D\B(((_*7R_3' KG)]?NWFV6Z9*H&(QUJQ'J>H7&JQVT:JB;0S;NM
M &YB*(9^1!Z]*188E.X1+GKG%8/B5YDFL@A^7=DCUJ./6KT+#.S1F&1BH0=1
MB@#I/+CVCY!@=!CI3"MNI+X16]2!FLO2+V]U">5Y-@@1L#'6LN_F,=Y?,<L
MR\$]* .I)BW*K;2PZ9IPCCS@(,CGITKCXYI8]9GN7PT<4(8+GI6KI6JWEW<H
M)$W0R#(?& /:@#<-O$Z@-&I [$4ODQ[=NQ=OICBGBEQ0!'Y,>20H!(QG%(;>
M(C!12/3%2XHH B^SP[=OEKM],54O=*@O556^0#^[Q6ABDQ0!6BL;>*%(EC4J
M@X!'2K(4*, <48I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"HYO]1)_NG^524R;_42?[I_E0!CT444 :EI_QZI^/\ZGJ"S_ ./5/Q_G4] !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+24 %
M%%% !1110 $@5BZYJRV<&Q&S(_  JUJFH)86S2$_-C@5@:382:I=F^NP?+!R
M@/>D!8T+27>3[?=C+'E5/:NF Q0J@ 8&!CI2TP"BBB@ HHHH **** "BBB@
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MEH **** "BBB@ HHHH **** "BBDH 6BDHS0 M%)FDS0 ZBFYHZT .HIM&:
M'44F:,T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 QAP1C.:Y76+!],O%OK4$1DY<"NMJ&:!)XVCD&5;BD,
MK:;?1WUNLBG+8Y%7A7&PO+X?U8Q/G[/(?E-=='()$5E.010!+124M,04444
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M***!!1110 4R;_42?[I_E3Z9-_J)/]T_RH QZ*** -2T_P"/5/Q_G4]06?\
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M:5QU8]ZN53LM0MM0026THD7/;M5R@PE>^H4444 %%%% !1110 4444 %%%%
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MJW]06YF\+A;* QR%0/+(QQWKI2GOBD*A<DX HL0ZK;N>66MCJ%E(!96LX@+
MS,1\P^E=;XAMIKW1X!!&S$LIP>N*Z55&-PP<^E.5<BBQ4Z[E*YYM<Z+J(NI;
M&.$_8@OF#ZXZ4R72+N*X5[B*X,#Q! $7.#7IFP4;!18KZS*UK'!/I36<FFR)
M;23Q*,'<.0?>H6T69K74939LTKR QDCM7H>REV 46#ZS(\YCLKFTEN!=Z?).
M9XP(V SS3(=-NM/DQ=6,EQ&\>% &[::])V"@K18%B7V/-(+&XM&G^TZ:\HF3
M]U@9V'^E"Z)J8C"&)@Y@."#^F:]*V"C8,&BP_K+['FD]NTEM#Y.GO;&",^;(
M1CMZU3TR**>6W_M ?ZS*1E!^6:]4DMXY8V1U!5A@@]ZS8/#NG6TWG1P ,O3/
M0?2BQ2Q*M9HY/P[9SW6M/'<',5@2J8Z&O0DQDX[56M+"WLMQA0 N<L?6K*_>
MSVQ3.6<^9CZ***" HHHH *9-_J)/]T_RI],F_P!1)_NG^5 &/1110!J6?_'J
MGX_SJ>H+3_CU3\?YU/0 4444 %%%% !1110 4444 %%%% !1110 4444 %!H
MHH ;4%VK-:2JHR2I 'KQ5@G%-8;O6@$['GN@11VDKQSP72S[FXYVD54;2M0'
MVQ3!(3+\T9_NCTKTO8-V<#\J-H]![4S?VSN>>W-HU[HIBL["2&5 /,8#&:@M
MM+D:QO'C\UY6C"[2F!7I.P \#ZT&,$8P/RI%*NT>8SZ3J$D,XC@=257/'84Y
M=)9K2XDA$[.5"E"N*],V8.3SQCI2;0.WZ4#>);.!U#1)TLK;[-;%0J*T@3OZ
MYIFHVSZA80-964EO'&_[P8Z_A7H>S@^]($ &  !Z 4$^V.6\(V*P2SS*TI+\
M$., 5UO:FA0,#&*=08R?,[A11102%%%% !1110 4444 %%%% !1110 444R1
MPB%FX I 0WMVEI;-*Y'%<@D=QXAU$@DBV!Z]JEU"YGUK4/LEO]P'#'TJ[?3Q
MZ'IZV-J!Y[C!/>@"'4K]8H_[+TX#.,,RUHZ+I"V,*R. 9#R2:@T+2/*43SKF
M5N<FNA7T'2F, /SI>E+2&@0 U!/<)",EA4-W>I;HW-<AJ>L&0D*:5P6IIZEK
MBJ&1&KEKF]:9RQ;CJ23P*HW^HQ65N]Q=2A$49Y/)^E>7:YXMO-5D:.%S#;@X
M 7JP]Z1O"G<[75_&-AIY9%<3S#^%>U<3J/BS4]1)Q)Y,9_A4U@@<D@=>I[U(
MHQTZTCKA2MN.):1MSL6/J33E4CI0HJ4#BAG5&"L"CVJ112!:E5:DZ(IK8%6I
M5% 7-/5:DWBF*%J55XH5:D44'3"( 8&*FB9E?*$J?44BK4RI4MG0J<7N:EEK
M=Y;\2,)$]^M=#9:O!=8VMMD]#7'!>E3("""I*D>E"9A6RV%5:'HUM?R0N"#Q
M]:ZS3M:20!6.<UY'8ZK+ P29LQ^M=/:W?W9(FROM6D6?-XO RH[H]3CE5QD&
MI,UQVF:V1A7/%=1:W*31@J<UI<\^Q9!XH- -'6F(3MBLO5]+CO;5CM&]>16K
MB@BD!RFB7PB9],O<G=]TMWJO>V\V@ZB)H03;2'MVK1U_2V<?:K8;94YXHTV[
MCUK3&M)\><HQSZT#-BRNTN[=9%YXJW7':1<RZ7J;6,Y(4GC-=@&# $=*$(6B
MBBF 4444 %%%% !1110 4F*6B@!*2EQ1B@+"8I<4N** &TM+10 AZ56OH&N+
M22-6*MC@BK)YHQ0!S7AZ^D,DMK.Y+H>,UT?/I7*:A;R66O)/$C&-SSM%=7&W
MF1JWJ* '4E.HH 3FC%+10 4F*6B@!,48HHQ0 E%.HQ0 W''2E%+10 4444 %
M%%% !3)O]1)_NG^5/IDW^HD_W3_*@#'HHHH U+3_ (]4_'^=3U!:?\>J?C_.
MIZ "BBB@ HHHH **** "BBB@ HHHH **** "D+ 4M% "9!HS2T4 -)YI:6B@
M!#2<8IU% #>,T9'2G4E "9&<4<>E+10 9I,BEHQ[4 )D<4N1110 F:,_6EHH
M ,T444 %%%% !1110 4444 %%%% "$\FN?\ $>H>5'Y$+?O&XP*V[N40V[N>
M,"N2TNW.KZR]S(3Y,)[]*0%_3;:/1-)>\F.97&3FJ6D6<FKWYO;G. ?ES1K%
MS)JFIQV$'^J0\XZ5U%G;+:VZQ* ,#K0,G V@ =!3A1BDS3$.JE=W:P Y85)<
MSB*)B3@BN,U?4S(Y4-^5)C2(]5U)II&4-QZYKD-;UZUT>U,L[ R'[D><EO\
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M_.(9I]+N#\C?=S3])1M,U^6U9OD?E<TT!U@Z4M(.E+3 **** "BBB@ HHHH
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M 4444 %%%% !0:*0T '6DR:.?2C\* 8H-%)@]J3G'0T .!I:0=>E+0 4444
M%%%% !1110 44F::TL:?><+GU- #Z2@$$9'2B@ HHHH **** "BBB@ HHHH
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MF,]K&Y[CFN>\2L)+NTM5/<$@5T=I'Y5M&GH*0%BBBBJ$%%%% !1110 4444
M-8<5E:K=&VGM5#, [8('>M5NE4+[3TOGA9F(\HY&* ,Y/$+.RE;1_+9]@;/>
MF6FN7(DO'N8<0PG (-7$T2)+9(=Y(27S!3?[!C,LY\YA'-]Y<4 1)XB1T?S(
MBN%W#FHO^$F.TXM2W("X/6EET2:'3YHXI!(6&U<CM4.FZ'.)56<;(DPR^I-
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MMU,<5CVNA+:3Y27]V&W!=O2ME: '4444 %%%% !4<W^HD_W3_*I*9-_J)/\
M=/\ *@#'HHHH U+3_CU3\?YU/4%I_P >J?C_ #J>@ HHHH **0TM !1110 4
M444 %%%% !1110 4444 %%%% !1110 GO7)Z_(TVI6]NA(RPS@UUE<E(/.\4
MQKUP:5P.KC79&J^@IU%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "HK@[87^E2U',-T##':@#D;&4"SU-CVS6AX3 ^Q$@<DU0LHOEU*W/4@F
MKGA-B;=U]#BD,Z6CO1]::YPN:!&#KL^R(BO,/%EXT&AW#*<,>,UW?B"<EV&:
M\J\?W?EZ?#;*>7.32-J:NSSE%/.XY).<U(H)YI%4@\]ZE Q2/3C'0 *D I *
MD5:5S>,045,HXI%2I47BD=$8@HJ4"D"U(%I-G1&(H%2JM-"U*HXJ3IC$55YJ
M95H1:E"U-SJA$514BK0JX%/' I'1%"XHHHH2'*048I!3JJQS2D+CBD%+3@*9
MR3D)WIPHQ3NE!R3D+B@4"E IG+.04Y<JRMZ4 4N,FF<=25U8ZS39]T<;5Z%H
M\X>V7->7:3)FW4>AKOO#\^Y0I-6CS9[G4CI0>E (P*#5F1F:KI4>HP[3]X=#
M7/V]S>Z#,8YPTL&<CBNRJ.6".88D0-]128'*6?FZMK8NS&5B'0,*Z]1@8J..
M"*+A$"_2I10 M%%%, HHHH **** "BBB@!,<48I:* $Q1BEHH ;M]NM&W(P:
M=10 F#THQ2TTF@!<48I-PI<T &,TFT4N:,T &T4;:,T T &*,<4M% #2 *7&
M>HI:* $Q1[4M% "8H P:6B@ HHHH **** "F3?ZB3_=/\J?3)O\ 42?[I_E0
M!CT444 :EI_QZI^/\ZGJ"S_X]4_'^=3T %%%% "'[P&*6D[TM !1110 4444
M %%%% !1110 4444 %%%% !1110 W/6N5TW]YXIN&/1:ZEN WTKF-#4MKMX_
MO4L#J1THI>U)5 %%%% !1110 4444 %%%!H **** "BBB@ HHHH **** "CM
M110!RNJPW=E?/);1[UF7:0!5WPY836ENS2C:6.<5N%0<9&<4N*0Q,<5%<MMB
M-3$U1U"3; U#$<1K,F^=@.>:\@\<W'G:TL8/"+C%>JW\FZX))Z'->->(I!/K
MUP^<X-2=F'5V986I%6@"I%%(].,156I%6D J112N=$8CE%/"T*M2JM)LZ(I
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MJ$%%%'>@!:2BB@ HHHH **** "BBCM0 4444 %%%% !11FHY)DC^\ZKGU.*
M)*6HA*"N0P(/<4XO0 ZBHVDQDY  [FCS?3!^E $AK-U4_N&QZ5?#9XJAJG^H
M;Z4F-'GU[_K9/H:\7U+YM5N#_MFO:+[_ %C_ $->,WPSJ5SG_GH:@]#"JY75
M:D5:%6I%6D>K&.@JK4H6D J0"D=$(@JU,HZ4BBI56I9T0CJ*%J14RP&<4*O%
M28X./2IN==G&+:-+1]!O=:+R0;(+>/[\\I^6M.3PM&$86NM6DLR#)C!ZU=N\
MP_#>!K;(5Y,2E:CT7P_H.K0O';WER+V.,N>< <=*VC'0\*6*GS7;.:WA6VO]
M[./E&:#*N!U+$XVJ,D5UL>H1Z%X7CGCLH9KEI"JLZYJ6:[30= M]1AM;=KR\
M;+N5^5:7(=/]J5$K(XTR(#\WRD?PXY/X4K2)MR3],#K7<+-:W^G6.MSVL$4R
M3!),+PV:T+'PY9Q>*KF]N$06)0,FX?+DTE3,Y9L^QYP9(U&[/'L*M26%Y%I\
M-[)#MM9FVJ<\UV,.BQZ+J&KZG-'&\$:Y@5E^6EUC6YKCP59RO;P(;A\$!?NC
MVJN0YJN83FO=.9UC2X]*>V597=IH]Y##.VLY6#C(!P:[O6-=;2X],ABLX),H
MH=I%R<&L3Q9:00ZM');QK"LL8<HO3-)QL31Q4F[,P@*4"BG"I-Y3ZB <TZE%
M+BF<TYB8IU %+BJ1QSD+24HH[U2.64M2:SXNE'K79Z3_ *]?K7&6G_'W'79Z
M1_Q\+2ZD-W/0+7_5+]*F'%5H'"0#-<VGB]I-;EM&A_T<9V2#^(CM5A&$I;'7
M9]J,YKCU\<Q_9996LY<H^S'8UHCQ5:&1(MDGF,F\J%Z4%.C/L;^:,BN?3Q;8
M-%*YWJT9PT9'S9J!O&,/VNW@2UF_>]V7&*!.E-'49I:C1]Z@^HS3Z#,6BBB@
M HHHH **** "BBB@ HHHS0 4444 %)BES10 F*3!SQ3J* &D<=:I3:59W$YE
MDA!<\GW^M7Z3% #40*H4  #C I=O'!IU% #0HIV***  4444 %%%% !1110
M4444 %%%% !4<W^HD_W3_*I*9-_J)/\ =/\ *@#'HHHH U+3_CV3\?YU/4%I
M_P >J?C_ #J>@ HHHH 3'S9ST[4M(>M+0 4444 %%%% !1110 4444 %%%%
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MG_'JGX_SJ>@ HHHH 3O2T8HQ0 44F.<T8H 6BDQ1CB@!:*3%&/6@!:*3%&*
M%HI,48H 6BDQ1B@!:*3% % #7'[MOI7.>'>+^]7ONKI2/E/TKE]$.W7KQ/4U
M+&CJ>U)2]J2J$+2444 %%%% !1110 4M)2T )1110 4444 %+244 &.:,444
M &*,444 &**** $VBHKE=T1%34UQE:3 \]UF(I.W'&:\T\96VV^CG'1ABO7?
M$$')8"O.O%=MYFG!\<J<YJ&=V#G::.% -2**11T]ZE"U!]/"(**E5:%6I56I
M;.F,152IE6D45*JXYJ3IA$4+BEIU&*#=VL)11BBJ,92%QQ0!2THH.6<@ I<4
MHI:HXYR "G "C%**#EE(6EQ0!2TTCDE(0"G 4 4HJ['+.04M%%,Y92%Q1110
M8A1128S3 U=(CP"QKN/#\&7#5R6EQX@''6N^\/P!8P>M3U$SHD'RBGTBC I:
MLD***3- "T4E% !2T44 )2T44 %%%% !1110 4444 (15*33K:2[^TR+N?&!
MFKIHP,YH RQHMHLA8 J-VX*/6JNJ:"ES!)Y( EE(W$^E;V*,4 9;Z/;R6]M$
MQ*M;@;2*4:-:@$?,27WDY[UIXHH S)-&MI&G8YS/C?[XJ(Z%;-*KAW5U&"!W
MK8Q1CF@#,M;"6.[DFDE9E8;0F>@J$>'[19Q*"V5)8#T)K7VCKCFEVB@#,.CV
MOV?R"&VB3S ,]ZB71P=?%^0 J+@#UK9QZ4F/>@#)?0[)YYIF4EIN&IZZ+:"&
M&-%(2$Y4>AK4VTFT#H* ,N?1+2;&=ZLIR&'6GKI,2M;L69FA^Z2:TL"DVC.<
M4 9LFC6[71N065B<E1T)K2 PHHVCM2XH 4=**** "BBB@ HHHH *9-_J)/\
M=/\ *GU'-_J)/]T_RH R**** -2T_P"/5/Q_G4]06G_'JGX_SJ>@ HHHH **
M** "BBB@ HHHH ***#0 E%%% !1110 4444 %+124 !Z5RFG'R_%=PAXSS75
MUR4Y\GQ7$YX#\5+ ZZBBBJ **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHI %%&:3-  :#0>M'>@#"URWWQ' KSO6;3S[*:#O@XKU>\A\V)A7
M!:M:M#,V1P:EHUHRY97/'?+\MF0]5)%2JM:VOV'V:_,B#Y6K-5>:R9]GAI*I
M330J+4JK0@J55J&=T(=Q56I.,4@&!2T&^P4444S.4@S2B@"EQ3.64P IP% %
M+31R3F %.Q0!2XIG).0 4H%**!UIHY92%I0*7%+5)')*0444M4<LY ****#
M****8!FE12\JJ.I-(3@9K0TNWW2>8WIQ0P-W3+?)1 *]"TJ 16Z\<URVA6ID
M=69>*[>)!&B@5*$R04M HJR0J-W\M"QZ 5)56_.+*4^@H YFZ\179N)/(3,<
M?WC6_I.HC4+59,8-<]H\0DL-0(4,3GDU8\),P22,] 32&=512"EIB"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ I":*#TH R]3U1[*>"-$#&4XYK37)0
M$]2*YK6'\[Q!:1=D&:Z4?= ]J '"BBBD 4444P"BBB@ HHHH **** "BBB@
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M_OY'2L[5=.@M8DO[!P$)R0#0!UXP1GK3ZH:7<?:;*-SW%7Z &MTZ5SNOV9>
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MBF(*SM9D\K3)6)[5HUS_ (IFV:=Y0^\[8%("IHH%OX?NIWZ.#BI/"B'R7?&
M34=^OV'PO'".&D K4T" 1:<G'4<T#-84M%%,04444 %%%% !1110 4444 %%
M%% !1110 4444 )0:6FNVQ&;T&: .5R;GQ41_<KJJY;0A]HU>ZN"/XCBNJI
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MD *>N:Z./P[90@+&A7Y-GX4R;PQIT\4:,&VH,*<T68<]*^QB_P#"4Z@+9O\
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M;HVT*X\4[4EG-JZVL1QYG]XU+HWBB+5KPVZQ&-\9!ZY%0GPBQ$T!O'%H_/E
M=#5K1?#ITJ4N9%?C (7!Q3,W[/ETW-T4M&**#G%I" >M+10 WRT_NBEV@=!B
MEHH 0KF@#%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **KW5U%:0F69@J],FJ\.JV<RLZ3J509(H T**SCJUG]G:
M<3KY:G!.:DMKZWO5)@D#$=0* +M%1;@& ) )Z#-+NZ=,&@"2BHBPSG(R.G-
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MJ)/]T_RI],F_U$G^Z?Y4 8]%%% &I:?\>J?C_.IJAM/^/5/Q_G4U !2TE+0
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M5OO+Q3Z3% &7>:'9W>=T84^PK(DT._L&,MA,WLA.:ZNCWH S='EO);7-XN)
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M@)2UF (6 <YH Z6BHXI/,B23LPSBI* "EI** "EI** %-)110 4444 %%%%
M!1110 4M)10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB2>IJS?Z=%>P1Q/D;#E2.M,CUBVFD>)-XD49VD<U7;6HKB$-;L599-A+#'-
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MBEQ10 E%+BC% "44N*,4 )12T8H 2BEHH 2BEHQ0 E%+10 E%+1B@!**6C%
M"44M% "44N** $HI<44 )2T8HH 2BEQ10 E%+10 E%+10 E%+1B@!**6B@!*
M*6C% "44M&* $IDW^ID_W3_*I*CF_P!1)_NG^5 &11110!?M[B*.!49L,,Y&
M#ZU+]L@_O_H:** #[7!_?_0T?;(/[_Z&BB@ ^V0?W_T-'VR#^_\ H:** #[9
M!_?_ $-'VR#^_P#H:** #[9!_?\ T-'VR#^_^AHHH /MD']_]#1]K@_O_H:*
M* #[7!_?_0T?:X/[_P"AHHH /M<']_\ 0T?:X/[_ .AHHH /M<']_P#0T?:X
M/[_Z&BB@ ^UP?W_T-'VR#^_^AHHH /M<'_/3]#1]L@_O_H:** #[9!_?_0T?
M;(/[_P"AHHH /MD']_\ 0T?;(/[_ .AHHH /MD']_P#0T?;(/[_Z&BB@ ^V0
M?W_T-'VR#^_^AHHH /MD']_]#1]L@_O_ *&BB@ ^V0?W_P!#1]L@_O\ Z&BB
M@ ^V0?W_ -#1]L@_O_H:** #[9!_?_0T?;(/[_Z&BB@ ^V0?W_T-'VR#^_\
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MR#^_^AHHH /MD']_]#1]L@_O_H:** #[9!_?_0T?;(/[_P"AHHH /MD']_\
M0T?;(/[_ .AHHH /MD']_P#0T?;(/[_Z&BB@ ^V0?W_T-'VR#^_^AHHH /MD
M']_]#1]L@_O_ *&BB@ ^V0?W_P!#1]L@_O\ Z&BB@ ^V0?W_ -#1]L@_O_H:
M** #[9!_?_0T?;(/[_Z&BB@ ^V0?W_T-'VR#^_\ H:** #[9!_?_ $-'VR#^
M_P#H:** #[9!_?\ T-'VR#^_^AHHH /MD']_]#1]L@_O_H:** #[9!_?_0T?
M;(/[_P"AHHH /MD']_\ 0T?;(/[_ .AHHH /MD']_P#0T?;(/[_Z&BB@ ^V0
M?W_T-'VR#^_^AHHH /MD']_]#1]L@_O_ *&BB@ ^V0?W_P!#1]L@_O\ Z&BB
M@ ^V0?W_ -#1]L@_O_H:** #[9!_?_0T?;(/[_Z&BB@ ^V0?W_T-'VR#^_\
MH:** #[9!_?_ $-'VR#^_P#H:** #[9!_?\ T-'VR#^_^AHHH /MD']_]#39
5;J%HG4/R5('!HHH S<'THHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &Y T<# 2(  A$! Q$!_\0
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M^^11]F@_YXQ_]\BI:* (OLT'_/&/_OD4?9H/^>,?_?(J6B@"+[-!_P \8_\
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M'_/&/_OD4?9H/^>,?_?(J6B@"+[-!_SQC_[Y%'V:#_GC'_WR*EHH B^S0?\
M/&/_ +Y%'V:#_GC'_P!\BH=4NI;+2KRZ@A\Z6&%Y$C_O$ D"N0EU6^MM(;51
MXSTZ=EB\T0>1&(Y#C.P8;?ST'.?:@#M?LT'_ #QC_P"^11]F@_YXQ_\ ?(I;
M>5I[:*5HS&SH&*-U4D9P:DH B^S0?\\8_P#OD4?9H/\ GC'_ -\BI:* *5]#
M%':.R1HK#'('O13]0_X\G_#^=% $MM_QZQ?[@_E4M16W_'K%_N#^52T %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)-P=-A:YN(KABH*31QF,.A'!*]CBKM0V< M;*WMPVX11J@;UP,9J:@ HHHH
MJZA_QY/^'\Z*-0_X\G_#^=% $MM_QZQ?[@_E4M16W_'K%_N#^52T %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO]P?RJ6HK;_CUB_W!_*I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%% !1110 5Y[\0-?U72-5M(K"\>"-X"S*JJ<G=C/(KT*O*_BE_R&['_KV/\
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MG_KZ;_T%:\GKUCX8?\BY<_\ 7TW_ *"M:TOB/%SS_<WZH[:BBBNL^%*NH?\
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M@ HHHH *1CM4L>@&:6FR_P"J?_=- T<5_P +0T?_ )]+[_OA?_BJ/^%H:/\
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M5\3_ /D6H/\ K[7_ -!:HJ?"ST,L_P!\I^O^9Y-1117$?H@5Z'\*O^/C5/\
M<B_FU>>5Z'\*O^/C5/\ <B_FU:4_B1Y>;_[E/Y?FCTNBBBNP_/PKROXI?\AN
MQ_Z]C_Z%7JE>5_%+_D-V/_7L?_0JRJ_">SDG^^+T?Y'"T445R'W85ZQ\,/\
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M^2"D/0TM(>AI&I]%P?\ 'O%_N#^525'!_P >\7^X/Y5)7H'Y9+=A39?]4_\
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M]:/"OAM-(N+^ZFTRRM+F6;$9MCD>7L0<$@$ LI./>@#IZ*** "BBB@ HHHH
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M33J;+_JG_P!TT MSYSHHHKSS]3"M#0?^1BTS_KZB_P#0A6?6AH/_ ",6F?\
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MO;YS<:=+ LSV\EK+'< [7C?T(Y4@CK@U%HVCZI%J-O>:F;",VMI]EBCLPWS
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M_P"@&N9KIO '_(YV7^[)_P"@&JA\2.3'?[M4_P +_(]HHHHKN/S8*XKXG_\
M(M0?]?:_^@M7:UQ7Q/\ ^1:@_P"OM?\ T%JBI\+/0RS_ 'RGZ_YGDU%%%<1^
MB!7H?PJ_X^-4_P!R+^;5YY7H?PJ_X^-4_P!R+^;5I3^)'EYO_N4_E^:/2Z**
M*[#\_"O*_BE_R&['_KV/_H5>J5Y7\4O^0W8_]>Q_]"K*K\)[.2?[XO1_D<+1
M117(?=A7K'PP_P"1<N?^OIO_ $%:\GKUCX8?\BY<_P#7TW_H*UK2^(\7//\
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M_P!?3?\ H*UK2^(\7//]S?JCMJ***ZSX4JZA_P >3_A_.BC4/^/)_P /YT4
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M:\'KFK;H^QX>_@S]?T"BBBL#Z,Z3P#_R.EC])/\ T U[57BO@'_D=+'Z2?\
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M7E?Q2_Y#=C_U['_T*LJOPGLY)_OB]'^1PM%%%<A]V%>L?##_ )%RY_Z^F_\
M05KR>O6/AA_R+ES_ -?3?^@K6M+XCQ<\_P!S?JCMJ***ZSX4JZA_QY/^'\Z*
M-0_X\G_#^=% $MM_QZQ?[@_E4M16W_'K%_N#^52T %8/BCQ,GAFWMYGM6N/.
M<IA7"XP,^E;U<!\5/^0;IW_7=O\ T&HFVHMH[LOHPK8F%.:NG_DR/_A:L/\
MT")?^_X_PH_X6K#_ - B7_O^/\*\THKF]K+N?8?V-@OY/Q9Z7_PM6'_H$2_]
M_P ?X5T?A?Q0GB:*YD2T:W\AE7#.&W9&?2O$:],^%7_'IJG_ %U3_P!!-73G
M)RLSSLRRW#4,-*I3C9JW5]ST*BBBND^2"O(OB7_R-*?]>J?^A-7KM>1?$O\
MY&E/^O5/_0FK*K\)[F1?[W\G^AQU%%%<A]P%>U^ _P#D3-/^C_\ H;5XI7M?
M@/\ Y$S3_H__ *&U;4?B/G\__P!VC_B_1G1T445U'Q85X;XR_P"1PU/_ *ZC
M_P!!%>Y5X;XR_P"1PU/_ *ZC_P!!%8UMCZ+A_P#CR]/U1AT445RGV0C?=/TK
MZ!T7_D!:?_U[1_\ H(KY^;[I^E?0.B_\@+3_ /KVC_\ 016]'=GS/$/\.GZO
M\B]11172?(C7_P!6WT-?.9ZGZU]&/_JV^AKYS/4_6N>MT/JN'?\ EY\OU"BB
MBN<^J);7_C]M_P#KJG_H0KZ)KYVM?^/VW_ZZI_Z$*^B:Z*/4^3XB^*G\_P!
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MN3_T(UF5I^(O^1FU3_K[D_\ 0C697 ]S]/H?PH^B_)!2'H:6D/0TC4^BX/\
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M5I3^)'EYO_N4_E^:/2Z***[#\_"O*_BE_P ANQ_Z]C_Z%7JE>5_%+_D-V/\
MU['_ -"K*K\)[.2?[XO1_D<+1117(?=A7K'PP_Y%RY_Z^F_]!6O)Z]8^&'_(
MN7/_ %]-_P"@K6M+XCQ<\_W-^J.VHHHKK/A2KJ'_ !Y/^'\Z*-0_X\G_  _G
M10!+;?\ 'K%_N#^52U%;?\>L7^X/Y5+0 5P'Q4_Y!NG?]=V_]!KOZX#XJ?\
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ME7XC[G(_]S7J_P! HHHK(]L[GX7?\AZ]_P"O7_V85ZK7E7PN_P"0]>_]>O\
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M#_CWB_W!_*I*] _+);L*;+_JG_W33J;+_JG_ -TT MSYSHHHKSS]3"M#0?\
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MUU3_ -!-:4OB/)SG_<I?+\ST*BBBNP^!"O(OB7_R-*?]>J?^A-7KM>1?$O\
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MBN<^J);7_C]M_P#KJG_H0KZ)KYVM?^/VW_ZZI_Z$*^B:Z*/4^3XB^*G\_P!
MHHHKH/ES)\4?\BKJO_7K)_(UX/7O'BC_ )%75?\ KUD_D:\'KFK;H^QX>_@S
M]?T"BBBL#Z,Z3P#_ ,CI8_23_P! ->U5XKX!_P"1TL?I)_Z :]JKJH_"?%9_
M_O,?\*_-A1116QX!Q?Q._P"18A_Z^T_]!:O):]:^)W_(L0_]?:?^@M7DM<E7
MXC[G(_\ <UZO] HHHK(]L[GX7?\ (>O?^O7_ -F%>JUY5\+O^0]>_P#7K_[,
M*]5KKI?"?"9W_OC]%^04445J>,>;?%7_ %FE?27_ -EKSJO1?BK_ *S2OI+_
M .RUYU7'4^)GZ!E'^Y0^?YL****S/4/5_A?_ ,B]=?\ 7TW_ *"M=O7$?"__
M )%ZZ_Z^F_\ 05KMZ[:?PH_.\S_WRIZ_Y!1115GGGD/Q*_Y&M?\ KV3^;5Q]
M=A\2O^1K7_KV3^;5Q]<4_B9^C9=_NE/T04445!W'MG@3_D2]._W7_P#0VKHJ
MYWP)_P B7IW^Z_\ Z&U=%7='X4?FN,_WFI_B?YA1115'*>">(O\ D9M4_P"O
MN3_T(UF5I^(O^1FU3_K[D_\ 0C697 ]S]/H?PH^B_)!2'H:6D/0TC4^BX/\
MCWB_W!_*I*C@_P"/>+_<'\JDKT#\LENPILO^J?\ W33J;+_JG_W30"W/G.BB
MBO//U,*T-!_Y&+3/^OJ+_P!"%9]:&@_\C%IG_7U%_P"A"FMS*M_"EZ/\F>_4
M445WGY@%<_XX_P"1,U+_ '%_]"%=!7/^./\ D3-2_P!Q?_0A4R^%G5@_]XI_
MXE^:/$:***X3]*"NF\ ?\CG9?[LG_H!KF:Z;P!_R.=E_NR?^@&JA\2.3'?[M
M4_PO\CVBBBBNX_-@KBOB?_R+4'_7VO\ Z"U=K7%?$_\ Y%J#_K[7_P!!:HJ?
M"ST,L_WRGZ_YGDU%%%<1^B!7H?PJ_P"/C5/]R+^;5YY7H?PJ_P"/C5/]R+^;
M5I3^)'EYO_N4_E^:/2Z***[#\_"O*_BE_P ANQ_Z]C_Z%7JE>5_%+_D-V/\
MU['_ -"K*K\)[.2?[XO1_D<+1117(?=A7K'PP_Y%RY_Z^F_]!6O)Z]8^&'_(
MN7/_ %]-_P"@K6M+XCQ<\_W-^J.VHHHKK/A2KJ'_ !Y/^'\Z*-0_X\G_  _G
M10!+;?\ 'K%_N#^52U%;?\>L7^X/Y5+0 5P'Q4_Y!NG?]=V_]!KOZX#XJ?\
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ME7XC[G(_]S7J_P! HHHK(]L[GX7?\AZ]_P"O7_V85ZK7E7PN_P"0]>_]>O\
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M#_CWB_W!_*I*] _+);L*;+_JG_W33J;+_JG_ -TT MSYSHHHKSS]3"M#0?\
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MUU3_ -!-:4OB/)SG_<I?+\ST*BBBNP^!"O(OB7_R-*?]>J?^A-7KM>1?$O\
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MBN<^J);7_C]M_P#KJG_H0KZ)KYVM?^/VW_ZZI_Z$*^B:Z*/4^3XB^*G\_P!
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MN3_T(UF5I^(O^1FU3_K[D_\ 0C697 ]S]/H?PH^B_)!2'H:6D/0TC4^BX/\
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M5I3^)'EYO_N4_E^:/2Z***[#\_"O*_BE_P ANQ_Z]C_Z%7JE>5_%+_D-V/\
MU['_ -"K*K\)[.2?[XO1_D<+1117(?=A7K'PP_Y%RY_Z^F_]!6O)Z]8^&'_(
MN7/_ %]-_P"@K6M+XCQ<\_W-^J.VHHHKK/A2KJ'_ !Y/^'\Z*-0_X\G_  _G
M10!+;?\ 'K%_N#^52U%;?\>L7^X/Y5+0 5P'Q4_Y!NG?]=V_]!KOZX#XJ?\
M(-T[_KNW_H-9U/A9Z>4_[Y3]?T9YA1117&?H(5Z9\*O^/35/^NJ?^@FO,Z],
M^%7_ !Z:I_UU3_T$UI2^(\G.?]RE\OS/0J***[#X$*\B^)?_ "-*?]>J?^A-
M7KM>1?$O_D:4_P"O5/\ T)JRJ_">YD7^]_)_H<=1117(?<!7M?@/_D3-/^C_
M /H;5XI7M?@/_D3-/^C_ /H;5M1^(^?S_P#W:/\ B_1G1T445U'Q85X;XR_Y
M'#4_^NH_]!%>Y5X;XR_Y'#4_^NH_]!%8UMCZ+A_^/+T_5&'1117*?9"-]T_2
MOH'1?^0%I_\ U[1_^@BOGYONGZ5] Z+_ ,@+3_\ KVC_ /016]'=GS/$/\.G
MZO\ (O4445TGR(U_]6WT-?.9ZGZU]&/_ *MOH:^<SU/UKGK=#ZKAW_EY\OU"
MBBBN<^J);7_C]M_^NJ?^A"OHFOG:U_X_;?\ ZZI_Z$*^B:Z*/4^3XB^*G\_T
M"BBBN@^7,GQ1_P BKJO_ %ZR?R->#U[QXH_Y%75?^O63^1KP>N:MNC['A[^#
M/U_0****P/HSI/ /_(Z6/TD_] ->U5XKX!_Y'2Q^DG_H!KVJNJC\)\5G_P#O
M,?\ "OS84445L> <7\3O^18A_P"OM/\ T%J\EKUKXG?\BQ#_ -?:?^@M7DM<
ME7XC[G(_]S7J_P! HHHK(]L[GX7?\AZ]_P"O7_V85ZK7E7PN_P"0]>_]>O\
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M#_CWB_W!_*I*] _+);L*;+_JG_W33J;+_JG_ -TT MSYSHHHKSS]3"M#0?\
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MUU3_ -!-:4OB/)SG_<I?+\ST*BBBNP^!"O(OB7_R-*?]>J?^A-7KM>1?$O\
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MBN<^J);7_C]M_P#KJG_H0KZ)KYVM?^/VW_ZZI_Z$*^B:Z*/4^3XB^*G\_P!
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MN3_T(UF5I^(O^1FU3_K[D_\ 0C697 ]S]/H?PH^B_)!2'H:6D/0TC4^BX/\
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M5I3^)'EYO_N4_E^:/2Z***[#\_"O*_BE_P ANQ_Z]C_Z%7JE>5_%+_D-V/\
MU['_ -"K*K\)[.2?[XO1_D<+1117(?=A7K'PP_Y%RY_Z^F_]!6O)Z]8^&'_(
MN7/_ %]-_P"@K6M+XCQ<\_W-^J.VHHHKK/A2KJ'_ !Y/^'\Z*-0_X\G_  _G
M10!+;?\ 'K%_N#^52U%;?\>L7^X/Y5+0 5P'Q4_Y!NG?]=V_]!KOZX#XJ?\
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ME7XC[G(_]S7J_P! HHHK(]L[GX7?\AZ]_P"O7_V85ZK7E7PN_P"0]>_]>O\
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M#_CWB_W!_*I*] _+);L*;+_JG_W33J;+_JG_ -TT MSYSHHHKSS]3"M#0?\
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MUU3_ -!-:4OB/)SG_<I?+\ST*BBBNP^!"O(OB7_R-*?]>J?^A-7KM>1?$O\
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MBN<^J);7_C]M_P#KJG_H0KZ)KYVM?^/VW_ZZI_Z$*^B:Z*/4^3XB^*G\_P!
MHHHKH/ES)\4?\BKJO_7K)_(UX/7O'BC_ )%75?\ KUD_D:\'KFK;H^QX>_@S
M]?T"BBBL#Z,Z3P#_ ,CI8_23_P! ->U5XKX!_P"1TL?I)_Z :]JKJH_"?%9_
M_O,?\*_-A1116QX!Q?Q._P"18A_Z^T_]!:O):]:^)W_(L0_]?:?^@M7DM<E7
MXC[G(_\ <UZO] HHHK(]L[GX7?\ (>O?^O7_ -F%>JUY5\+O^0]>_P#7K_[,
M*]5KKI?"?"9W_OC]%^04445J>,>;?%7_ %FE?27_ -EKSJO1?BK_ *S2OI+_
M .RUYU7'4^)GZ!E'^Y0^?YL****S/4/5_A?_ ,B]=?\ 7TW_ *"M=O7$?"__
M )%ZZ_Z^F_\ 05KMZ[:?PH_.\S_WRIZ_Y!1115GGGD/Q*_Y&M?\ KV3^;5Q]
M=A\2O^1K7_KV3^;5Q]<4_B9^C9=_NE/T04445!W'MG@3_D2]._W7_P#0VKHJ
MYWP)_P B7IW^Z_\ Z&U=%7='X4?FN,_WFI_B?YA1115'*>">(O\ D9M4_P"O
MN3_T(UF5I^(O^1FU3_K[D_\ 0C697 ]S]/H?PH^B_)!2'H:6D/0TC4^BX/\
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M5I3^)'EYO_N4_E^:/2Z***[#\_"O*_BE_P ANQ_Z]C_Z%7JE>5_%+_D-V/\
MU['_ -"K*K\)[.2?[XO1_D<+1117(?=A7K'PP_Y%RY_Z^F_]!6O)Z]8^&'_(
MN7/_ %]-_P"@K6M+XCQ<\_W-^J.VHHHKK/A2KJ'_ !Y/^'\Z*-0_X\G_  _G
M10!+;?\ 'K%_N#^52U%;?\>L7^X/Y5+0 5P'Q4_Y!NG?]=V_]!KOZX#XJ?\
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ME7XC[G(_]S7J_P! HHHK(]L[GX7?\AZ]_P"O7_V85ZK7E7PN_P"0]>_]>O\
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M#_CWB_W!_*I*] _+);L*;+_JG_W33J;+_JG_ -TT MSYSHHHKSS]3"M#0?\
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MMT__ #R3_OO_ .M4M%6E;0\V<Y3DYRW9%NG_ .>2?]]__6HW3_\ /)/^^_\
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M@8G&2<=ADX[XQ7'6_AC5Y?"[V8TZ*TU&"]AU%+BXO!,;RX5P[&0JHVYQC@8
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M#<71A  [#"MDGGK@<=:QHO&EQJL6DIH6EK<7>H6 U$QW4_DK#$< 98*V6).
M ,<$YI_C:SU[4XK;3].LTN-,E+?V@HN_(DE3M$&P<*W\1'..!C.:AFT[7+75
M['7M.TFS\[^SS83Z<UUL$0#[D*N%(('((P.HQTH E/BS4;SPO!KNE:3 \/DR
M2W"7EYY)B*$AD!"L"<JPR<#BHV\:7M\(_P"P]&%TZZ?%J-RES<>08UD!*1CY
M6S(0K=< 8'/-9\_A*\A\*6.BW&@Z9KI"RO*\UR81'-(S,Q4;2=N6X((/%.M/
M#_BG0&,MH;35KJ\TR"TNIKB<Q%9X@P$OW264A^1P?E]Z .RTC4X-:T>RU.VW
M""[A29 PP0&&<'WYJ[6;X?TD:%X=T[2A)YGV2W2$OC&XJ,$X]S6E0 4444 <
MSXC\1ZEX>87;Z5#-I*S1123"ZQ-^\94!6/;@X9AQN!-5-5\:W5C)JUS::2MU
MI>C.$OIS<;),[59_+3:0VQ6!.2,\@=*AURR\1WOBV&X?1X+[1[$I)9P_;A$&
MFQS+("IR5SA1T')ZXQ!JGAK7ROB+2;"&S?3M>F,K74LQ5K7>BI*"FWY^%)7!
M')YZ4 :^M^)=1T6XM[AM+@FTF:XAMQ,EU^_8R$*&6/;@@%NF[. 3BIO^$DN!
MXUAT%]*EBMY8)94O)) /,,93(5!DX^<<G'3IWK#\2>&-1U;484LM(L;:>W>+
M[-K8NCYT"(03A-N2<;EQG!SS5S4;;Q!+X^T[4H-'@>PLXI;<RF]"LZRF,E]N
MWC;L/&>: .QHHHH **** .9NO$>I:=XAT^RO]*A2QU&Y:UMYXKK?('"LP+)M
M "D*>C''&:IQ>-[B22UOCI2C0KJ^^P0W8N,RE]YC$ACVX"%QC[V>0<5%:V?B
M.7QL^J:IH\$T,<C06,BWPVVL!P&<)MR9&QR<], 8YS5M?"NN):6/AV6&S&D6
M6HB\6]$Q+R1+*94C\O'#9(!.<8!]: -R3Q%J5GXFL--O]*@CMM1EEBMY8;KS
M)%**6W.FT84@=03@D ]:2#Q'J47BBST?5=*AMQ?Q2R6LL%UYI'EXW"0;1CAA
M@@D=JRW\.:G=^,K/58](L=*DM[AI+G4(+HO)>1;2/**[1P3M)W=-O%/\.67B
M-?$T^J:[H\!N;@-$+F.^#K:P DK'&FT'DX+'.2>>@  !V]%%% !3)F=(9&BC
M\R0*2J;L;CV&>U/J&Z:=+.9[6));A8V,4;MM5FQP">P)[T <M_PFD^FWFJ6O
MB#3H[1['3_[2#VMQYZO%DKMY52'RO3H?6I;#Q/JCZE'IVIZ+':W5U9O=V:QW
M?F!]NW,;DJ-KC<O3(Y//%8EAX9UO4M&UVQUS3XH=0U>V9;C4Q=B7Y\81%0*-
ML:Y.!GUSDDFM*UTWQ'?:Q;ZKJ=C802Z=8RV\$*7)<7$K[=S%MOR)A, 8)Y/I
M0!;L/$FK3:GJ6D7.CVZZE:V\=S&L%YOBD5RP"LY0%&RIXP>.15GP]K]WJ>H:
MIINH6,5M>:<\8D-O.9HG#KN&&*J<C'((XX]:P-&\-:G8:AJE_;Z'I^G6UQ:"
M$Z2EV6CN9-W,CL$PIVY48!SGFK_@WP_>:/J&IW3V-MI5C=>7Y6F6TQE5'7.^
M4G  +?*, ?PC/- '7T444 %5[V2ZBLY'LK=+BX&-D;R>6I.>[8.!WZ&K%9NO
MOJZ:'='0H8)=3*X@6X?:@).,DX/09..^,4 <^OCF>WL]4COM+5=4L;R&R%M;
MW&^.>68*8PKE1@?.,Y'&#UJY9>(M5N9]3TR72;=-9LEBD$2W9,,L<F<.'* C
M&U@1MSQQG-8=OX8U:3PP;1=.CM-1MKZ'48Y[B\$QO)U?<YD95&W<!C@8&1@8
M&*O1Z1K-Q<:SK%_I-C)<7L$-JFFM=$KY*%BVZ3;@L2YXQC '- %S3_& ;3-9
MN=6M5M)=(G,$X@E\Y)&VJR^6V 6)W@8P#NXJWX2UZX\1Z(;VZL/L-PEQ+;R6
M_F^9L:-RIYP/2N9TSP'?M;S!KD:%;_;TO;33[,K/';LJ8.=ZX.6._ & 0#UK
M<\$:#J>@:=?0:G?&Z>:^GG3Y4&%>1F!^4#ELY(['@<4 =/1110 52U.;48;=
M3IEG!<SLV,3SF)%&.I(5C[8 [U=K \7KK\NCBW\/(AN)I DTAF$3QQ?Q&,D$
M;^P)'&<]J ,RV\<SWVF:?]ETL'5[V[GLUM7N,1*\)82,9 IR@VG!"Y.0,5;L
M?$6JZKIUQ]CTFW&IVEV]I=03W96*-E .X.$)92"I'R@\\XQ68N@ZI;V6@7>G
M:-:V=QHLDB)I[7FY9873:W[W;PV<-R#G!R>:5?#^I)H]^U]HFG:K/JE^UW<V
M3W.U(AM544,5(8@*,G Y)Q0 )X]NKO3]%DL].M([G47N(V6\O?+B0PG:VUPC
M;P2."!R*[.T:Y>TB:[CBCN"H,B1.70'V8@$C\!7$6/A[5=+\-VEA<:#IFLA9
MIG2VGN/DLHV;*1(SH=RJORYX/'I71^$M&GT#PQ9Z9<S+++"&R4)*)N8L$7/.
MU00HSV H VJ*** *NH?\>3_A_.BC4/\ CR?\/YT4 26Q'V6+G^ ?RJ;(]:YH
M]:* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<
MCUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUK
MFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<
MCUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUK
MFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<
MCUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUK
MFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<
MCUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUK
MFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<
MCUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUK
MFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<
BCUHR/6N:HH Z7(]:,CUKFJ* -O4"/L3_ (?SHK$HH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '* 9,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;FXMHY9(\?=8J"10!IT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHK$\6^(X_"?AF[UJ6V>Y2WV9B1@I;<P7J?K0!MT4B-O16Z9&:6@ HHHH
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M4 %<'>_\EQTO_L"S?^C!7>5P=[_R7'2_^P+-_P"C!0!WE%%% !1110 4444
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MU%0_:[;_ )^(O^^Q1]KMO^?B+_OL4!RR[$U%0_:[;_GXB_[[%'VNV_Y^(O\
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M#\1GQ)\9;&<VOD>5I$JXW;L_.*:G%NR,:^78FA#VE2-EZH];HHHJSSPHHHH
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M+:;<+.'+8&0''\)(H ]&K@_C-_R2G6OI%_Z-2N\K@_C-_P DIUKZ1?\ HU*
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M1V^M>L[5W;MHW>N.:  ,X &>M 'GWPZU[4]2NY;.9UGL(K*&4,MOY0MYCD-
M/7: *]"I%55SM4#)R<"EH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MN(USX?#6=9N-0_M%HO.(^01@XP .OX5V]%2XJ6YT8?$U</+FI.S/./\ A50_
MZ"[?]^1_C1_PJH?]!=O^_(_QKT>BI]G'L=O]L8W^?\%_D><?\*J'_07;_OR/
M\:/^%5#_ *"[?]^1_C7H]%'LX]@_MC&_S_@O\CSC_A50_P"@NW_?D?XT?\*J
M'_07;_OR/\:]'HH]G'L']L8W^?\ !?Y'G'_"JA_T%V_[\C_&C_A50_Z"[?\
M?D?XUZ/11[./8/[8QO\ /^"_R/./^%5#_H+M_P!^1_C6;HGAP>&_C-8P"Z-Q
MYND2MDKMQ\XKUFN#O?\ DN.E_P#8%F_]&"FH13NC&OF.)KP]G4E=>B.\HHHJ
MS@"BBB@ HHHH *X3XR#/PKUD>HB'_D5*[NN%^,?_ "2W5_K#_P"C4H P$^&&
MKM&A%[9_=']ZG?\ "K]7_P"?VS_\>KU2'_41_P"Z/Y4^LO91/:_MS&=U]R/*
M/^%7ZO\ \_MG_P"/4?\ "K]7_P"?VS_\>KU>BCV40_MS&=U]R/*/^%7ZO_S^
MV?\ X]1_PJ_5_P#G]L__ !ZO5Z*/91#^W,9W7W(\H_X5?J__ #^V?_CU'_"K
M]7_Y_;/_ ,>KU>BCV40_MS&=U]R/*/\ A5^K_P#/[9_^/4G_  J_5_\ G]L_
M_'J]8HH]E$/[<QG=?<C.T'3Y=*T*SL9F5I(8PK,O0GVK1HHK1*QY$YN<G)[O
M4****9 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7!WO\ R7'2_P#L"S?^C!7>5P=[_P EQTO_ + L
MW_HP4 =Y1110 4444 %%%% !7"_&/_DENK_6'_T:E=U7"_&/_DENK_6'_P!&
MI0!V\/\ J(_]T?RI],A_U$?^Z/Y4^@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBJ.M7$MKHE]<0MMEC@=D;&<$#BAE0BY245U+U%>)#QUXDQ_R$/_(2TO\
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MIMTW9>G^9V-%%%6>>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%4M5COY=-E33)X8+MAA)9D+*OJ<=^* +M%>;>!M;US5_AWJEU>:PG
MV^"ZGC%[/$-L:H?O%1Z#-4?AUXEU74O&^I:8OB,>(-'AMED^UO"L3)(3]U0.
MHZT >KT5QWCSQ#?6%O;:+H;J-=U(E8&."((U&7E.>P'3W-<9I_BGQ)=^ M!N
MY]1NL3R7"W=];PJT@90?*& , $C'2@#V2LSQ%_R+>I?]>S_R-<5H/BK5-?NM
M(M[B^BL$M47^T9&VJ;FXQ_J4![#JQ'?BNU\1?\BWJ7_7L_\ (TGL;4/XL?5?
MFCP,=!2T@Z"EK@/TX**** "M?X>?\E:M_P#L%2_^ABLBM?X>?\E:M_\ L%2_
M^ABM*7Q'CYU_N<O5?F>[T5'<3I:VTMQ*<1Q(78^@ R:\H\-?$V]\0ZU'.^LZ
M%:6#LY&F-N-TR+G!W?=W'&<5V'P9ZW17C]K\1O%?D:7XEN;73_\ A'-2OQ:1
MVRAO/C5F*JY;H>AXKU34OMDNG7$>ESV\=^4(A>8%D5NQ8#DB@"Y17D,GC3QG
MH/BVXT[5KG2=2MK#39=0O190,C1JJG:N6/4G'X59T+QWXG76/#IUU=+DT[Q$
MI-LMID/;-C< Q)^;C H ]5K@_C-_R2G6OI%_Z-2N\K@_C-_R2G6OI%_Z-2@#
MRQ?N+_NBEI%^XO\ NBEKSS]4"BBB@ HHHH **** "M7PQ_R-6E_]?"UE5J^&
M/^1JTO\ Z^%IK=&.(_@S]'^3/>:*BN97@M998X6F=$++&G5R!T'UK@]-\>ZV
MOC:T\.^(/#\>GM?0M-:O%<B4X&>''8\5WGYB>@T5YIX2^(7B'Q5J,?DZ1I,>
MGFX>)V_M >>JJ2"WEXSVKJO&OBA?"'AR35#:M<N)%BCC!V@LQP,GL/>@#H:*
M\PB^*&J6S:E9:MHEO#J-L8!']GN?-@;SF"KN<#C&<GVK5A\?W$^GB"+3XYM=
M>^DL8[6*0F-RA^:3=C(C YS^% '=44B;MB[\;L<XZ9I: "BBB@ HHHH ****
M "BBB@ HHHH **** "L_6AJITJ8:+]E^W\>7]JSY?7G..>E:%% 'F?@_PEXU
M\/:%J>F27NCH9W>X@EC1GQ*S L&!X*D9'XT:)X#\0Q^+)_$^IW.EVU\MFUM;
MP:=$5B+$'#/GKR:],HH X.3X=0^(;"SNO%K"[UV&W,+7-K*T2D9) P,>M5?#
M'@/5_"G@.31]-NX(M4NIOW]UO9EC0DY9 ?X@O3WYKT:B@#S+6?AA-),D&DM:
MK9/91VA:X),D#+)O,J<<NW<\5W&O)Y?A:_3).VU<9/?Y:U:S/$7_ "+>I?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7!WO_ "7'2_\ L"S?^C!7>5P=[_R7'2_^P+-_Z,% '>4444 %
M%%% !1110 5POQC_ .26ZO\ 6'_T:E=U7"_&/_DENK_6'_T:E ';P_ZB/_='
M\J?3(?\ 41_[H_E3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBCDCV%+,,5)-.H[,****LX0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MG9_#DLWC^T\2"X0106#VAAV\DLP;.?PKHJ* "BBB@ HHHH **** "N*^+5K<
M7OPTU6"U@EGF8Q;8XD+,<2H3@"NUHH 9$,0H#UVBGT44 %%%% !1110 4444
? %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &I YP# 2(  A$! Q$!_\0
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M^^11]F@_YXQ_]\BI:* (OLT'_/&/_OD4?9H/^>,?_?(J6B@"+[-!_P \8_\
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M'_/&/_OD4?9H/^>,?_?(J6B@"+[-!_SQC_[Y%'V:#_GC'_WR*EHH B^S0?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ]4_X^E_W!_,T :=M_QZQ?[@_E4M16W_ !ZQ?[@_E4M !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !5#5Q>?8UDL0SRQ2I(T:L%,B Y903QDBG:KJMKHM@U[>
M,RPJ0I*J6.2<#@5@?\+'\._\]KC_ +\-4N26[.FEA:]6/-3@VO)$6D_VK-K,
M,Y@U>)C/*UT;MP(/*^;8JID\_<Z#UR:[&N3_ .%C^'?^>UQ_WX:KND^,=(UJ
M_6RLY)FF*E@&B*C Z\T<\>Y4L#B81<I4VDO(WZ***HY HHHH **** "L?5/^
M/I?]P?S-;%8^J?\ 'TO^X/YF@#3MO^/6+_<'\JEJ*V_X]8O]P?RJ6@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4
M5S<PV=M)<7$@CAC4L[GH .]2U7O[*+4;">RG+"*=#&Q0X.#Z&@#*U+5[&&X3
M2H[C[/+OB!;[*9(DRPPC'&U2W09/<5NUCIX<MQ9W%O)=7<XN)DEE>9PS,4VX
M&<<#Y16Q0 4444 8WBUWC\)ZFZ.R,(&(93@C\:\2_M"^_P"?ZZ_[_-_C7M?C
M#_D4-4_Z]VKPRN:MN?8Y!%.A.ZZ_H6/[0OO^?ZZ_[_-_C72> [RZE\86:2W4
M\B%9,J\K$'Y#V)KDZZ;X?_\ (YV?^Y)_Z :S@_>1ZV-A'ZM4TZ/\CVBBBBNT
M_.#E?B)_R)]Q_P!=8_\ T(5XW7LGQ$_Y$^X_ZZQ_^A"O&ZY:WQ'V^0_[J_5_
MH%=7\.O^1PB_ZX2?TKE*ZOX=?\CA%_UPD_I6</B1Z&/_ -UJ>C/8Z***[C\X
M"BBB@ HHHH *Q]4_X^E_W!_,UL5CZI_Q]+_N#^9H T[;_CUB_P!P?RJ6HK;_
M (]8O]P?RJ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **@GO+6V0O/<11JI )=P,$G _6I@0P
M!4@@]"* %HHHH **** "FQR)+&LD;JZ,,JRG((^M<-+)X4M7N6O?$<TK/<L
M%U*8&/<V-N%?& 2>W ^E=9H=O%::%8V\$ZSPQP(J2KT< <'\: +]%%% !4<X
MD:WE$1Q(4(4^^.*DJ.>,RV\L:G:70J#Z9% ''R6>MWUF9+T7MI=VUDJVJQWB
MCSKD [F(4X8<+PW&">*[*/?Y2>9C?M&['3/>N+NO#L_]D7$^N'3V>TT]8+6<
M,Y$+*#F7)&5.=IR.?EKLX<^1'E]YVC+?WN.M #Z*** *&MW,MGH5_<P-MEBM
MW=&QG! )%>2?\)[XE_Z" _[\)_A7JWB3_D6-4_Z]9/\ T$UX+VKGJMIJQ]5D
M5"E5I3=2*>O5>1TG_">^)?\ H(#_ +\)_A6AH7C37[WQ!I]K<7P>&6=4=?)0
M9!]P*XNM;PO_ ,C5I7_7RE9*4K[GM5\'AU2DU36SZ+LSWBBBBNT_.S$\8?\
M(H:I_P!>[5X97N?C#_D4-4_Z]VKPRN6MNC[+A_\ @3]?T"NF^'__ ".=G_N2
M?^@&N9KIOA__ ,CG9_[DG_H!K.'Q(]?'?[M4_P +_(]HHHHKN/S8Y7XB?\B?
M<?\ 76/_ -"%>-U[)\1/^1/N/^NL?_H0KQNN6M\1]OD/^ZOU?Z!75_#K_D<(
MO^N$G]*Y2NK^'7_(X1?]<)/Z5G#XD>AC_P#=:GHSV.BBBNX_. HHHH ****
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M!Y;\D_A2YH]S7ZGB/^?;^YG044451RF7XD_Y%C5/^O63_P!!->"]J]Z\2?\
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M+C.!@$<8)KL;:W2TMHX(BY2,;5WN7./<G)/XUP?_  M2T_Z!5Q_W\6@_%6T
MS_95Q_W\6I]I'N=?]DXW_GW^7^9Z#14-G<"\L;>Z"E1-&L@4]1D9Q^M35H>:
MTT[,*X2Y^)UI;74T!TRX8Q2,A(=><'']*[NOGO4_^0O??]?,G_H1K*K)QM8]
MO)\'1Q,IJJKVMUL>B?\ "U+/_H%W/_?Q:4?%.S+ ?V7<\G'^L6O,*5/]8O\
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MBBB@ HHHH **;))'#&TDKJD:C+,QP /<U5L]6T[4'9+*_M;EE&66&57(_(T
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M@_E4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 45G:Y+=P:1-)9&03 J-T<?F.BEAN
M95_B(7) ]JYK3]4UF35[9+F:]W/,$C@>SV)+;8.97./E?/;([?+S0!VU%%%
M!1110!C>*(()M"E:XN;>WCA=)BUR,Q$JP(5QW4XQ618%]1OM+U"6318K=)2L
M,E@S2/*Y1ALW%1M&,DCG[HZ5TNH:?'J,,<<C%?+FCF4C!^9&##K]*S;W1;;^
MWK"_ABN4D,Q:40!?*<A& :0'N,D!ASS@\= #=HHHH **** ,O6M)&KBTBE;-
MK'-OGBWLGF+M('*\\$@XZ<5E:7H<&C:[:!;I#=203&=GD)EN1N7:2#UVCC/;
M\:U=:;4B+2#3I! 9IMLMP8?-\I=I/W<CJ0!D],UGZ3+KRZI;_P!IRB1;B*5I
M(5A"K;E6 7:W4[@<X)/Z4 =)1110 444A95ZD#ZF@#)U?6+C3[F"WM;#[7+)
M&\S S"/:B8SC(.6^88'ZBJ>A:B]_JLDUUIZ6UQ/:1S1.DQ?= 2=H88 5@>N,
M]>O%;Y\EG5VV%ESM)QD9ZXI L"RM*!&)& 4L,9('09_$_G0.S):*0,&Z$'Z&
MEH$%1R3QQ, YP2,]*DJA??ZY?]V@"Q]KA_O?H:/M</\ >_0UFT4 :\<BRKN0
MY&<4ZJUC_J#_ +U6: "L75/%>CZ->?9;ZY:.;8'VB-FX.>X'M6U7D/Q*_P"1
MK'_7LG\VJ*DG%71Z66X6&*K^SGM9O0[C_A8'AO\ Y_F_[\/_ (4?\+ \-_\
M/\W_ 'X?_"O%Z*P]M(^C_L##=W]Z_P CZ$T[4;;5;&.\LY#)!)G:Q4C.#@\'
MW%6JYKP#_P B98_]M/\ T-JZ6NF+NKGR.(IJG6E".R;05XEXX_Y'+4?]Y/\
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MX3W,B_WOY/\ 0X^BBBN0^X/:? /_ ")EC_VT_P#0VKI:YKP#_P B98_]M/\
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M\Q,3QA_R*&J?]>[5X97N?C#_ )%#5/\ KW:O#*Y:VZ/LN'_X$_7] KIOA_\
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M.'OXM3T7YF=2-]T_2EI&^Z?I7,?7GT#HO_(!T[_KUC_]!%7JHZ+_ ,@'3O\
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M *,6JJ_ _0\W _[U3_Q+\SYJHHHKPS]2.U^$_P#R4;3O]R;_ -%M7TA7S?\
M"?\ Y*-IW^Y-_P"BVKZ0KU,'_#^9\)Q%_O2_PK\V%<9\3?\ D5H_^OI/Y-79
MUQGQ-_Y%:/\ Z^D_DU=,_A9YF6_[W3]?\SR2BBBN(_13M?AA_P C)<?]>K?^
MA+7K->3?##_D9+C_ *]6_P#0EKUFNNE\)\+GG^^/T05PWQ1_Y -G_P!?0_\
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MN&^*/_(!L_\ KZ'_ *"U54^%G-E?^^4_7]&>54445Q'Z&>B?"K_7:K_NQ?\
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M +R?^@+6=;X3U<@_WB7I^J.>HHHKE/M#V_P3_P B;IG_ %S/_H1K?K \$_\
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M'3?^OJ+_ -"%>_UX!H7_ ",.F_\ 7U%_Z$*]_KIH[,^0XA_B4_1_F%9GB/\
MY%G5/^O63_T$UIUF>(_^19U3_KUD_P#036SV/ H?Q8>J_-'@G:BCM17 ?IQO
M^"?^1QTW_?;_ - :O;Z\0\$_\CCIO^^W_H#5[?751V/C.(/]XCZ?JPKC_BE_
MR3G5OI'_ .C%KL*X_P"*7_).=6^D?_HQ:JK\#]#R<#_O5/\ Q+\SYJHHHKPS
M]2.U^$__ "4;3O\ <F_]%M7TA7S?\)_^2C:=_N3?^BVKZ0KU,'_#^9\)Q%_O
M2_PK\V%<9\3?^16C_P"OI/Y-79UQGQ-_Y%:/_KZ3^35TS^%GF9;_ +W3]?\
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MH*^B[C_CVE_W#_*OG0=!7/6Z'U?#NU3Y?J+4UI_Q_6W_ %V3_P!"%0U-:?\
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M]CP*'\6'JOS1X)VHH[45P'Z<;_@G_D<=-_WV_P#0&KV^O$/!/_(XZ;_OM_Z
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M 5CZI_Q]+_N#^9K8K'U3_CZ7_<'\S0!IVW_'K%_N#^52U%;?\>L7^X/Y5+0
M4444 %%%% !1110 4444 >!^(?\ D9=4_P"ON3_T(UFUI>(?^1EU3_K[D_\
M0C6;7 ]S]/H_PH^B_)"'[I^E?0.B?\@'3O\ KUB_]!%?/Q^Z?I7T#HG_ " =
M._Z]8O\ T$5M1W9\_P 0_P .GZO\B]11172?('SG)_KI/]\_SIM.D_UTG^^?
MYTVO//U-;"K]]?J*^C%^Z/I7SFOWU^HKZ,7[H^E=%'J?+<1?\N_G^@M1S_\
M'O)_N'^525'/_P >\G^X?Y5T'RRW1\Z#H*6D'04M>>?J9?T+_D8=-_Z^HO\
MT(5[_7@&A?\ (PZ;_P!?47_H0KW^NFCLSY#B'^)3]'^85F>(_P#D6=4_Z]9/
M_036G69XC_Y%G5/^O63_ -!-;/8\"A_%AZK\T>"=J*.U%<!^G&_X)_Y''3?]
M]O\ T!J]OKQ#P3_R..F_[[?^@-7M]=5'8^,X@_WB/I^K"N/^*7_).=6^D?\
MZ,6NPKC_ (I?\DYU;Z1_^C%JJOP/T/)P/^]4_P#$OS/FJBBBO#/U([7X3_\
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M *&U=+7-> ?^1,L?^VG_ *&U=+7=#X4?FV-_WFI_B?YA7B7CC_D<M1_WD_\
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MQZQ?[@_E4M16W_'K%_N#^52T %%%% !1110 4444 %%%% '@?B'_ )&75/\
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MO$/!/_(XZ;_OM_Z U>WUU4=CXSB#_>(^GZL*X_XI?\DYU;Z1_P#HQ:["N/\
MBE_R3G5OI'_Z,6JJ_ _0\G _[U3_ ,2_,^:J***\,_4CM?A/_P E&T[_ ')O
M_1;5](5\W_"?_DHVG?[DW_HMJ^D*]3!_P_F?"<1?[TO\*_-A7&?$W_D5H_\
MKZ3^35V=<9\3?^16C_Z^D_DU=,_A9YF6_P"]T_7_ #/)****XC]%.U^&'_(R
M7'_7JW_H2UZS7DWPP_Y&2X_Z]6_]"6O6:ZZ7PGPN>?[X_1!7#?%'_D V?_7T
M/_06KN:X;XH_\@&S_P"OH?\ H+553X6<V5_[Y3]?T9Y51117$?H9Z)\*O]=J
MO^[%_P"S5Z57FOPJ_P!=JO\ NQ?^S5Z5792^$^!SG_?9_+\@KS?XJ_>TK_MK
M_P"RUZ17F_Q5^]I7_;7_ -EHJ_"Q9/\ [[#Y_DSSFBBBN,^_/2OA5_Q[ZK_O
MQ_R:O1*\[^%7_'OJO^_'_)J]$KLI_"C\_P W_P!]G\OR050OO]<O^[5^J%]_
MKE_W:T/+*M%%% &A8_Z@_P"]5FJUC_J#_O59H *\A^)7_(UC_KV3^;5Z]7D/
MQ*_Y&L?]>R?S:LJWPGN9%_O?R?Z''T445R'W![3X!_Y$RQ_[:?\ H;5TM<UX
M!_Y$RQ_[:?\ H;5TM=T/A1^;8W_>:G^)_F%>)>./^1RU'_>3_P! 6O;:\2\<
M?\CEJ/\ O)_Z M9UOA/5R#_>)>GZHYZBBBN4^T/;_!/_ ")NF?\ 7,_^A&M^
ML#P3_P B;IG_ %S/_H1K?KNC\*/S3%_[Q4]7^;"O O$'_(R:I_U]2?\ H1KW
MVO O$'_(R:I_U]2?^A&LJVR/<X>_BU/1?F9U(WW3]*6D;[I^E<Q]>?0.B_\
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M-95MD>YP]_%J>B_,SJ1ONGZ4M(WW3]*YCZ\^@=%_Y .G?]>L?_H(J]5'1?\
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MXP_Y%#5/^O=J\,KW/QA_R*&J?]>[5X97+6W1]EP__ GZ_H%=-\/_ /D<[/\
MW)/_ $ US-=-\/\ _D=+/_<D_P#0#6</B1Z^._W:I_A?Y'M%%%%=Q^;'*_$3
M_D3[C_KK'_Z$*\;KV3XB_P#(G7'_ %UC_P#0A7C=<M;XC[?(?]U?J_T"NK^'
M7_(X1?\ 7"3^E<I75_#K_D<(O^N$G]*SA\2/0Q_^ZU/1GL=%%%=Q^<!1110
M4444 %8^J?\ 'TO^X/YFMBL?5/\ CZ7_ '!_,T :=M_QZQ?[@_E4M16W_'K%
M_N#^52T %%%% !1110 4444 -= ZX)(^AQ3/LZ?WI/\ OX?\:EHH RI/#6BS
M2O++IMN\CDLS,F2Q/4DTW_A%M"_Z!5K_ -^Q6O5+3]4M]2:\6#>&M+AK:577
M!#@ _D0P(/H:5D:^VJ_S/[W_ )E7_A%M"_Z!5K_W[%:"6D44:QQ[T10%55<@
M #H!4]%%D3*I.7Q-OYLB^SI_>D_[^'_&C[.G]Z3_ +^'_&I:*9!D'PMH1.3I
M=KD_[ H_X1;0O^@5:_\ ?L5KU2TK5K+6K/[583>9&':-P5*LCJ<,K*>5(/8T
MK(U]O5_F?WO_ #*O_"+:%_T"K7_OV*TOLZ?WI/\ OX?\:EHHL3*<I?$V_F1?
M9T_O2?\ ?P_XTAMD((+2$'MO/^-344R#(_X1;0O^@5:_]^Q1_P (MH7_ $"K
M7_OV*T;J[MK&W:XN[B*W@7&Z25PBC)P,D\=:E5E=0RD,I&00<@BE9&OMZO\
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M(E*4G>3N1?9T_O2?]_#_ (U!=:597T:QW< N$4[@LI+ 'UYJY10)-IW1D?\
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MK_W[%'_"+:%_T"K7_OV*TK>Y@NX1-;3QS1$D!XW# XZ\BI:5D7[>K_,_O?\
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M;C+(\38*MP058$ CKW%>A:5I5IHUBMI:(0@)=W<[GE<\L[MU9B>2: +M%%%
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M]"U"ZU.ZO[MI['3)[HWBZ8WRR&8J%?S64D,F5W!0<'=D^E=F!@8'2@ HHHH
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MGDGWI] !1145S<Q6=K-=3OLAA1I)&QG"@9)_(4 +<3QVMM+<3-MBB0NY )P
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M%O-TF2RD=BD<B$/$=V?W1^4J,DC &< 5%X*\,0WL2Z_?S7+ZF9=HNH6,,=U
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M6TTTT%O%%+.P:5T0 R'&,L1U/UI+>RM;1I&MK:&%I2#(8XPI<@8&<=>.*GH
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M\S6Q6/JG_'TO^X/YF@#3MO\ CUB_W!_*I:BMO^/6+_<'\JEH **** "BBB@
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MX^E_W!_,T :5L1]EBY_@'\JFR/6N:/6B@#I<CUHR/6N:HH Z7(]:,CUKFJ*
M.ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR
M/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ*
M.ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR
M/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ*
M.ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR
M/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ*
M.ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR
M/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ*
M.ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR
M/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ*
M.ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR
M/6N:HH Z7(]:,CUKFJ* .ER/6C(]:YJB@#I<CUHR/6N:HH Z7(]:,CUKFJ*
3.ER/6L?5/^/I?]P?S-4J* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ([ T\# 2(  A$! Q$!_\0
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M_P"><7_?1_PHW77_ #SB_P"^C_A4]%%PL0;KK_GG%_WT?\*-UU_SSB_[Z/\
MA4]%%PL0;KK_ )YQ?]]'_"C==?\ /.+_ +Z/^%3T47"Q!NNO^><7_?1_PHW7
M7_/.+_OH_P"%3T47"Q!NNO\ GG%_WT?\*-UU_P \XO\ OH_X5/11<+$&ZZ_Y
MYQ?]]'_"C==?\\XO^^C_ (5/11<+$&ZZ_P"><7_?1_PHW77_ #SB_P"^C_A4
M]%%PL0;KK_GG%_WT?\*-UU_SSB_[Z/\ A4]%%PL0;KK_ )YQ?]]'_"C==?\
M/.+_ +Z/^%3T47"Q!NNO^><7_?1_PHW77_/.+_OH_P"%3T47"Q!NNO\ GG%_
MWT?\*-UU_P \XO\ OH_X5/11<+$&ZZ_YYQ?]]'_"C==?\\XO^^C_ (5/11<+
M$&ZZ_P"><7_?1_PHW77_ #SB_P"^C_A4]%%PL0;KK_GG%_WT?\*-UU_SSB_[
MZ/\ A4]%%PL0;KK_ )YQ?]]'_"C==?\ /.+_ +Z/^%3T47"Q!NNO^><7_?1_
MPHW77_/.+_OH_P"%3T47"Q!NNO\ GG%_WT?\*-UU_P \XO\ OH_X5/11<+$&
MZZ_YYQ?]]'_"C==?\\XO^^C_ (5/11<+$&ZZ_P"><7_?1_PHW77_ #SB_P"^
MC_A4]%%PL0;KK_GG%_WT?\*-UU_SSB_[Z/\ A4]%%PL0;KK_ )YQ?]]'_"C=
M=?\ /.+_ +Z/^%3T47"Q!NNO^><7_?1_PHW77_/.+_OH_P"%3T47"Q!NNO\
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M:*.9ARHI?9;[_H(_^05H^RWW_01_\@K5VBCF8<J*7V6^_P"@C_Y!6C[+??\
M01_\@K5VBCF8<J*7V6^_Z"/_ )!6C[+??]!'_P @K5VBCF8<J*7V6^_Z"/\
MY!6C[+??]!'_ ,@K5VBCF8<J*7V6^_Z"/_D%:/LM]_T$?_(*U=HHYF'*BE]E
MOO\ H(_^05H^RWW_ $$?_(*U=HHYF'*BE]EOO^@C_P"05H^RWW_01_\ (*U=
MHHYF'*BE]EOO^@C_ .05H^RWW_01_P#(*U=HHYF'*BE]EOO^@C_Y!6C[+??]
M!'_R"M7:*.9ARHKV\-Q&Q,UUYP(X'EA<?E5BBBI8TK!1110,**** "BBB@ H
MHHH **** "BBB@ JO:]9_P#KJ?Z58JO:]9_^NI_I5+9B>Z%3_C]E_P!Q?ZU/
M4"?\?LO^XO\ 6IZ3!!1112&%%%% %?4/^0;=?]<7_D:=9_\ 'C;_ /7-?Y4W
M4/\ D&W7_7%_Y&G6?_'C;_\ 7-?Y57V2?M$U%%%24!('4T5PFNZ59ZU\3;"S
MU"(S6XTN23R][*-PD SP1ZT^&T'A'QKIEA833?V7JL<P:UDD+B*2,!MR$G(!
M!P16O(K;ZVN9\[OMH=Q17$_\)=K,VE3^(;72[9]#A+G:TI%Q)&A(:0#&T="<
M'G J_>>([Z[U9-+\/V]M-/\ 94NY9KIV6-$;[HPHR2?TI>SD/G1T]%<#XEUO
MQ*?#UC<0VJ:;=#4$M[A)';YCO !0CK&W?VK7NM;UE+VST6UM;*36)+<W%P[.
MP@B0';QQN.3T%'LW8.='3T5QESXSN[30-8GFL(UU3298XYH Y,;[RNUE/!P0
M>_0TNI^*-9TI+&&\M-.M+F_F=8Y)YV\B! H(#MCESR.,"CV<@]I$[*BLK0=1
MO-1LG>^M%MYHY"FZ)]\4P'1T/=36-)XAUG4KO4QI&GVLMA82-;RM-,5DF<#+
M"/ P,9QSUI*#O8;DK7.MR..1ST]Z6O.?#MU&ND> DEMEFDF$NV61VW1$(QR,
M'!)Z<U>A\::G=W]S]EL;.2*VNC;O8F<B]*AMID"GC'?'IWJG2=]"5474[B@D
M 9)P!7%:?>^))/B+J=F\EFUA%%"QC+/\D9+X*CIO..>W JO'XDU36?"FL7]Y
MI5F--A@N4*F9MT[(2!P/NK@'/.<]*/9O\OQ#VB.]R#WHKSY[J^'BKP__ &5:
M1-)+HC;8Y)2(HAE#D]20.GK5Z3QC?VNBZZUW90)JND%!)&CDQ2!\%64]<$'I
M[4.F^@>T74[.BL36-:GT[5M$LXHHW74)GB=F)RF$+ C\17,Z'J'B&=/%/]JF
MRN+2VDG1HP[Y#",'8OHF/QY-)4VU<;FD['H(((R#D&BN+L_$-PFE>'M,T:PM
MQ?7MBLZQRR,(;>,*,DGECR0 .M.N_&-]I^B:\UW90)JVD1K(T:N6BE5N593P
M<'D8[$4>SD'M$=E17*0^(M9M]7TN+5=/M(+/4V,</E3%Y(GVE@'XP<@'ITJY
MXIUV[T./3?L5FEU+>7B6WEN^S[P/0]NE+D=TA\ZM<WZ*Y2\UKQ#;/;VK6NF6
M\_D^;/=7,S+;[B2!&AZLV!D^E8NJ^*-:U3PUI&HZ5]FMFDU!+>=3*Q!<2;<!
MAU0D'/?%4J;9+J)'HF1G&1GKBEKE/MI@\96BZC:VPNTTB2:6YB9\( XRJ@\;
M>^2,\54'B_6$TA/$<VF6RZ$^'VK*QN%B)P)",;>^=O7%+V;Z#YUU.VHK&\3Z
MS)HGA>]U:VC29X(PZ(Q.ULD#M]:S4\0ZU9ZAIO\ :VG6D5CJ,@AB:"8M)#(P
MRH?(P<XQQTI*#:N-R2=CJZ*X*^\?R+<7\EFVD_9;&5XFBNKK9/.4^]L'0=P,
M]<5>N_%6I3ZMIMCHEC;SB_T_[8DEQ(4$8R/O8ZC!Z#G-/V4B?:1.OHJI?P7=
MUISPVUW]CN7 'GK&'V>N >/7K7,^ ;=K-O$-JUQ/<>5JCKYL[[G;Y5Y)J5&\
M6RG+5([&BN7\<SSC3K#3X)GA_M*_BM))(VVL(SDM@]B0,?C6/*D/@OQ:MMI:
MNEE=Z;/.]LTC,HDB&0PR3@D<&JC"Z)<[,] HKRJ73_[+\"6/C&.>=M;W174]
MP9F/FAV&Z,C.-N&P!CC%;4>DVWB_Q/X@.J&9X;%TM;2-9601$H&9P 1\Q+=?
M:J=-+6^@E4;TL=W17-^ ]1N=2\(VLEW(99XGDMVD;J^QRH8^Y %=)64ERMHT
M3NKA1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %5[7K/_ -=3_2K%5[7K/_UU/]*I
M;,3W0J?\?LO^XO\ 6IZ@3_C]E_W%_K4])@@HHHI#"BBB@"OJ'_(-NO\ KB_\
MC3K/_CQM_P#KFO\ *FZA_P @VZ_ZXO\ R-.L_P#CQM_^N:_RJOLD_:)J***D
MHY36M)UO_A+[77-(CL91'9M;-'<R,G)8-D8!]*?IVA:I=:^FN:_-;&>")H;6
MUM=WEQ!OO,6;EF.,=JZ/[5;B[%KYT?V@IY@BW#=MSC..N,U+6G.[6(Y%>YPR
M>&?$-MH,_AFUN+$:7*7C2[;=YT<+DDKLQ@M@D YJ]/X?U'2]:35-!^RR;K-+
M.:WNF9053[C!@#R,D$8KIUGA>9X5E1I8P"Z!@67/3([9J2CVDA<B.3U'0-;U
M/PP+>ZOK>75%NTNT.TK$NUPPC'?;@8SUI]UI6M_VK9Z_:+9#41:FVNK621O+
M==VX%7 R"#ZCG-=.[I'&SR,%11EF8X 'J:(Y$FC62-U=&&593D$>H-'.Q\B.
M*N?"&I7>AZWY\]N=5U::*1PN1%&J,NU0>IP >>Y-;>O6.J7,EL]B;.XMT#+<
M6-XO[N8'H<X."#[8YK6CNK>:XE@CGC>:''F1JP+)GD9';-34.;OJ"@NASOA'
M0)]!M;U9O(C^TW)G2VMR3%;@@#:N?IGH.M4H]#U_2KS58=)DL&L=1G:X#W&[
M?;NPPV% PPR,CD5U]%+G=V^X<BLD<;IGA2_L[7PE%)+ S:1YGV@@GYMR%1MX
M]3575O">MZNC6EU_9DS"X$D.JLI6YA0-N   Z@<9SBN\HI^UE>XO9JUCG!I.
MIVGC.35;8VTMG=P10W D8K(FS=@K@8.=WM56Q\,7MMX#U'0WDA-U<BYV,"=H
M\QF*YX]ZZ>XNK>T5&N)XX@[B-"[ ;F/0#/>IJ7._Z\A\B_KS..FT#7+;5=(U
M#3I+)FLM-^R2Q3E@)#\O0@<?=SG]*8WA#4-0TGQ"=0NH(]2U@*/W()CA"#"+
MD\GIR?>NTHI^TD'LT<:='\2ZEK6B7VJ-IL4>G3,[1V[.Q?*%=V2/T_6IH-!U
M6UN_$,"&U>QU0R3)(682([(%VD8P1D=<UUE%'M&'(CC4\,:G81:!>V$EJVHZ
M;9?8YHI21',A SA@,@@C(XJ*]\):IJ6C^(9+N6U&JZM$D2+&6\J%$^ZN2,GJ
M23BNQ^U6_P!K^R>?']IV>9Y6X;MN<9QUQFIJ/:2W_KN+DB8&JZ+<WUYX?EB>
M,+I]SYLNXGD;"O'XFG^(M'N-6GT9X&C466H1W,F\GE5!R![\UN45/.]"N5'(
MZEX>U%_%<VK6\&G7L<UND*+?;O\ 1BI.2H ((.>>AXZU5B\'ZG!X0CTY+BU:
M^M]1-]&Q!6-\2EP"!]W(/;I7<457M)"]FCFSHEY?>(H-2OE@6-M+>SGBC<GY
MV8$X)'(P#S63_P (OX@D\/1^%I9['^REQ$UVI;SFA!R%V8P&P,9S7:W%S!9V
M[W%S,D,*#+22,%5?J34@(8 @@@\@BA5)(.1,Y?XA(L?P[U9%^55@ 'M\RU#'
MI&O:M=Z.=5>P2QT^1;D&W+%YW5<+D$84<Y/)KKF574JRAE/4$9%+0IV5@<+N
MYQ8\.:WI;:C;:0NF26UY.\\4UR#YELS\MP 0P!R1R*THM"NX_%6GZD]PLL5M
MIQM)&;AW<L#NP!CM7144G4;!005B:#I,^E76M33O&5O+YKF/83PI51S[\5JK
M=6[W4EJL\;7$:AGB##<H/0D=JFJ;M*Q5D]3BTLM7\6>%!)>/#;:C!?&XL9EC
M8(0C_(2IYP1D?0YJU9:#J6H:X^K>(!:*R6K6D%O:LS*%?[[%B!R>!CTKJ'D2
M*-I)'5$499F. !]:AM;ZSOT9[.Z@N%4X)AD#@'\*OG?0GD74XM/"6NRZ5:>&
M[NXLFT2VE0F=2WGRQ(VY8RN, \ $YZ"M&[T;7=/US4;_ $![%H]25#-'=%E\
MJ55VAUP#GC&1QTKHEU"R>\:S2\MVN5ZPB0%Q_P !SFBZU&QL61;N\M[=G^Z)
M950M],FGSR;V%R1*GAS14\/Z#:Z:LAE:($R2$8WNQ+,WXDFM2D!! (.0>A%,
MBN()S((9HY#&VQPC [6]#CH:S;;=V6DDK$E%4[K5]-L91%=ZA:V\A&0DLRH<
M>N":LPS17$2RPR))&PRKHP(/T(HLPNA]%%%(844R::.WA>::18XD4L[L<!0.
MI)IB7EM*T:QW$3-*GF1@."77^\/4<CF@":BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO:]9_P#KJ?Z5
M8JO:]9_^NI_I5+9B>Z%3_C]E_P!Q?ZU/4"?\?LO^XO\ 6IZ3!!1112&%%%%
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MF:C8WD<%Y8*Z+YT/F(RL #QD$'CJ#6<_@[439Z^JZZWVS5_*#7'D@&,*-K
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M5G./+(UIRYHA1114%A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *KVO6?_KJ?Z58JO:]9_\
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MK3KG5O"][8VBJUQ*JA S8'# ]?PJEXGCUZY-O9:=9^98.I-V\=R(I6_V%)'
M/<]<<"B*32!MJYJZ5J\6J:'!J@1HHY(RY5CDKC.?KT-9%EXMGE>QFO--^SV.
MH([VLHEW-A5+#>N.-R@D8)]*GBGNA_9^C_V0MK;SVTJS*DF[[,JC"C(&"#FL
M[3=%UHOHUE>P6\=KHX;;.LN[[20A1/EQ\HP<G--*.MQ-O2Q;L/%<\[:=/>V"
M6UCJ2DVLHGWL/E+@.,<94$\$^E2:/XCN]7FMY$TZ,65P"R,+E3+&G\+O'Q@-
M[$D9%8]GX2FGU.S,^D6VGP6C.[/#=-*)"5*@1J?N+\V3^%-T;PE>V-WI$/\
M9UE:_P!FR%I-1A?Y[I-I4*1C/.03DD<<534"4YG>TURRHQ5=S $A<XR?2G45
MSFYS6B:QK%[>ZY;WMI;)/9F/R((Y"1\R;@K/W.>X'%51K^KZ/J)AUEK.X4V$
MM[(MJA4V^S'RDDG<#D@'CD5JV^DW5GJ.MWT$\7FW_EF$.I(C94V_-ZC//%9V
ME^'-2B@N[?5'L;A;Z-DO+E-_G2D@@8SP ,\ <"MKQU,O>$\->(+S5;V,3:EI
M4ZS0^:UM &62'I@ DD.!G!/&#6MX@U>32['%I$)]0GRMM"3P2!DLWHJCDG_&
MLNS\/ZG;W&GSWEW;2II4$D=L(("'D)7:"^3CH.@ZFGKX=FU>QMK[5I9H-9-H
M89&M9FC49YQ@'UQGZ4/EYK] 7-:W4KQ:[J^IQZ+96+VL-[=Z>+ZXGEB+HHPH
MPJ@CJS>O %2VNJZYK>CVES9_8K!OWHO)9P9 CHVW"KD<$@G)/ IMMX5OM+M]
M)ETV^C-]96AM)&N@SI*AP?7(PPR!Z<5#-X3U./2;'2[:]MY;.,O)>).&4W4C
M,6.2IX3)/R]^]/W.G];_ / %[W4W?#>IS:SX?M+^XB6.653D)G:<$C<N><'&
M1[&M6JU@EREG&EV+=95&"+<$(!VQGVJS6+WT-5L%<YXCO=<L(KN^M9;"WL;.
M#S<W"L[3L,DKP1L'0 \DDUT=<UK.C:QJ&LQW"36,MA %:&UN X'F#^-L?>([
M \#KUJH6OJ*=[:&R+FZFT9;J"V'VMX!(D$C;1O*Y"D]N>*Q-/U/6H=>DTK4&
MM+R4V7VH&V0Q^4V[ 1LD\'L>.AXK2FBUQA*8;JR0M:[8U,3$+/GELYY7':J?
MAW2-4TEW%VUE+YOSSW"%S-,_J2>,>W0=J:M9DN]T.\.:IJ6H76K0ZG#;PRVM
MPL:QP$L%4HK8+'J>>N!6_69INEO8ZEJMTTJNM[.LJJ!RH$:K@_\ ?-:=3*U]
M"HWMJ%%%%24%%%% !5>UZS_]=3_2K%5[7K/_ -=3_2J6S$]T*G_'[+_N+_6I
MZ@3_ (_9?]Q?ZU/28(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ J.XC,MM)&.K*0*DJCJ>HC3HD;RR[.< 9Q3BFWH*325V<Y/HU
M[;0&5T4JO7:V2*H5M2>(GEMY8WMURX(!#<#ZUB]J[H.7VCSYJ/V0J6VG:UN8
MYU )0YP>]1459&QU^G:O%?N8]ACE SM/?Z5<GN8;5 \TBHI.!GO7"JS(P96*
ML.A!P:=)+)*09)&<CIN.<5SN@KZ;'2J[MKN=I=7T%I"9)'&2N57/+?2N;O-<
MNKKY8SY,>,$*>3^-4)IY9RIED9]HPN>PJ.KA24=R)UG+8* 2""#@CH:**U,2
MY=CSH8KQ2"7^67'9_7\15.K2\Z5*!_#,I/T(JK278J7<****9(59M+RYM'Q;
MR;2YQ@\@U%'!-,"8HG<#J57-3C3KL8.P(W8,X!_*I;6S*2>Z-74]:= ]K",2
M@ -*#T/?%84LLD[;I79V]6.:L:F,:E-TSD;L>N.:J4H126A4Y-O4****LS"B
MBB@ JW'?,V([L>?$2/ODY7W!JI12:3&FT374!M[AH^J]5/JO8U#5Q6>72)%8
MEA%(NW_9!S^E4Z$#0444Z.-Y9%CC7<[' %,0L44DT@CB1G<]E%=?I%K+::>D
M4V-^2<#MFETW3TL+<* #*1\[>IJ[7'4J<VB.VE2Y=7N%%%%8FX4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4UG1!EV51[G%.KD_%]N]WJ
M^A0I96UZQDF/D7+[4.(^I.#R/I515W83=E<ZL$, 000>A%+7'+;WNAI:V;7$
M5C#J%XQ8P'*6J^7D(A8=6*]<=2<"H$UB^N-1L+*353!;R2W<7VE0@,ZQ[-K
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M^D&&(^[&O]Q/0>_>@"+_ (2&Q_NW?_@))_\ $T?\)#8_W;O_ ,!)/_B:U:*
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M+4;.X4445!04444 %5[7K/\ ]=3_ $JQ5>UZS_\ 74_TJELQ/="I_P ?LO\
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MQ^R_[B_UJ>H$_P"/V7_<7^M3TF""BBBD,**** "BBB@ HHHH **** "BBB@
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M5TZ'J@/_ !Y.?H0?ZU8CB718));E89+YQB&!@'\KG[S=OPI+E6PWS/<QP"Q
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M%8WARV5&FU)P/W'R1#UD/?\  5HU%M3BKPC3?+$****9SA2@D$$'!!R#244
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M/^/V7_<7^M3U G_'[+_N+_6IZ3!!1112&%%%% !1110 4444 %%%% !1110
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MK+*JO>N/G?\ N^PK=HHKSI2<G=G=&*BK(****D84444 %%%% !1110 4444
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MRD(9OE/KQS5XC^&:4/C.LHHHKSCN"BBB@ HHHH **** "BBB@ HHHH ****
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MO)/^>8_QJ:*)(8A'&,*/\YIC'T444P"BBB@"2 PBXC-PK- &'F!3@E>]=;J
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M'?&GABS@NM1ELY%N&EB#M,\IQQD=3C]*L:7K=QJ'Q4NK97O(K-=+5Q;7"-&
M^_&[:?;O70W_ (>@U#Q%I>LO-(LVGB01HN-K;Q@YI4\/P)XLE\0B:3SY+06I
MCXVA0V[/KFL^>-O.Q?+*_P S7HHHK$U"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R_$,5Q)HTS6DC
M1SQ8E4COMYQ6I6?K=_\ V;H]S=  LB_*&&02>!51OS*PUN>;'68$=KFTT^*&
M[?DREBP0]RB]!6422Q8DEB<DGJ32LQ=V8XRQ).!@4E>JDD=-@QFK\6M:A#$L
M2SAE487S$#E1Z D50HH:3W T#KNJDY%]*OLN /R%3Z;,;E=1$]V@N)H/+1KB
M3 ;+ GD_2LBBDXJV@K&W]AFL-"OC<&)X)3&(6C<,K/GJ"/09KG)YWWBW@P9F
M&2>T8]3_ $%7+?5KC3IE@MG!\XC?&RATV]V93_DU=.AQGSY=*N8[Q23(Z#(E
M^I4]?PZ5%[.S$94,*01A$R>Y8]6/J?>I***U*"BK%E8W&H3^3;IN8#<Q)P%'
MJ3VK5C\/P*?])U.,>JP1EC^9P*RJ5J=/XW8B4XQ^)F%172+IFDP*$99KMNID
M+^6/H!4HATP# TJ$_P"](Q/\ZY99A03M<Q>)IKJ<N"P8>7NWY^7;US[5V&H;
MA-$'+&00QARWWL[><^]0P+8V,CSV4$D<[C +MN$7KM_Q-,)+,68DD\DGO7GX
MW%0JI1@<V(K1FDHB4445YAQA1110 4444 %%%% $]O9RW(9EPL:C+2/PH_&E
MU73(]2MQ)!-#+J* *-CG]ZH'H?XOYU/=%I=+M)1N5%)B*?PY'.?QJB"0002"
M.01VKII5G0DI1+T6@>%?#@U*9KJ\0_9HFV[",;V'8^PKT55"*%48 & *H:(\
MLNEQ23$%FR<XZC/?WK0KU)575]X[:<5&.@4445!H%%%% %>^FDMM/N9X45Y8
MXF=%=MH) ) )["N-T'Q3J%\TV+J&]/\ 9QN\/;FV\N3L@+'YE//S=L=>:[#4
MK&/4],NK"5F6.XB:)F7J 1C(K!/A2YOAMU;44F5+.2SB^SP>5A7 #,>3DX4<
M<"M8.-M3.2E?0J>$_$EYJVHQP2W<=U')9BX?_1C 87R!M7)^=>O(].O-6/$?
MB&6RUNWTN*^CL0UN;AYC;F=V&[:%5!^))]!4T&@ZC!/%>W5^EQ/8VLD%HL%N
M(^6 Y;+')^4<<"A-&UB3^S]3-]!#K*6GV>Z+0[XY 3NZ C!!]#5/EYKD^]:Q
M3US7M:M?!\.J:=+ITX\I9);M=Q0C<!\B>^>YXK7UUKVWM'U"/6%L;6"$O*#;
M+)G'.<DCZ8JO+X65_!K^'TNR"X^:=DZL7WD[1[YXJ_J^DG5HK6WDF"VL<ZRS
MQ[<^<%Y"^PW8)^E3>)5I#-&N+]/#4%WJ[*UWY)EEV)MQU(&/4# ^M<[H/BFZ
MU*6VN&U2TE-S$\HL$MV4C"Y"I)T=AQG\:Z6]CU";6+2*(K_9IBE%V&4?,2 %
M .<YZUE6?A6Z@?3H)]3$MCIK%K5%@"R9VE5W-G!V@]@,]Z:<;.XGS75C+T?Q
M?<S76D-<:G8W7]IDH]G"FU[5]I(!.2>"-IW 5>LM7U>+Q-::9>WME<7$ZN]S
M9P1X^R+C*L')RPZ#D=ZLV_AFY?4+>XU&_AN%MRSIY-L(GD<J5#R$'D@$XP!S
MS26WAF]%WIK7VJBZ@TUR\!\G;,YVE1O?)SP>P&>]-N DI'34445@;%'5K6XO
M++R+:]>S9G7=+& 7VYY"YZ$CC/:N8T5K_4[35;&+5;ZWCBND6-[I?]+2/:"P
MY'&3G:3DXKIM6TJ'5[18)9)8FCD66*6)L/&Z]&'^>]9O_"(VSV\XGOKR:\FE
MCF-Z742*Z?<VX 4 9/&.YK6+25F9R3;T,K2O$#:?::KYDUY<B*Y2&RM[WBY9
MV485LX."V2">P)[5H^#[B^E35HM0O?M<\-\R[A]U054[5'9020*M6WA>P19V
MO]VIS7#J\DMXJL3M!"@     GH.YJF_A".RL;Z'0Y?L$][=).\T>%,:@C*K@
M=, \?[1IMP=T)*2LQ-:DU2W\5Z&RZAML9[EHC:QIC=^[8Y9N_(X'%9NJW6I3
M+XAU:'4[BW.D2[+>W0@1,$17;>,?-NW$>W&*ZR^TN&_N["YD=P]E*98PO0DJ
M5Y_ UFZAX2M-0O;B8W=W#!=%&N[6)P(YRO3=QD<  X(R!1&4=+_UJ$HO6QA:
MI<:A'JM[J5U'K0TJ(1.KVERL<:1[ 6.S.7YSG'85W:.LD:NC!D8 J1W!K"O_
M  K#?W%R3J%]%:W9!N;2.0>7+@ =P2H( !VD9K>5510J@!0, #L*F;32L5%-
M-W%KF/&C20:8]U%=:O%)'$YC73UR-X&07X/'UXZUT]9>JZ1-J;#R]5O;)2A1
MTMRN'!_WE.#[BI@TG=CDKK0=8[]3\.VQFNLR3VR%Y[5\9)4992*Y_2+"6[UK
M6(8M8U1]/MU6U#/<EF,WWG*MCC:-J_G70V6CQ:<;=+2>>.UM[86\=MN!0 =&
M]=W;-+I>D0Z3I0L;:23'SLTK$%V=B26)]<FJYDKV%RMVN8OA:*9M8U::/4;V
MYT^%Q:PBYF\S=(O,C _4A?P-=55+2=,@T;2X+"VW&.%<;G.68DY+$^I))J[4
MR=V.*L@HHHJ2@HHHH *KVO6?_KJ?Z58JO:]9_P#KJ?Z52V8GNA4_X_9?]Q?Z
MU/4"?\?LO^XO]:GI,$%%%%(84444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRE9'1^'A(-(C\P<9)7/I6I2*H10J@  8 ':EKU(QY8I'H15E8****H84444
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MM0JO<ZA96;*MU=V\#,,@2R!21^)JQ7'ZY:W]QXOW6%OI\\B:;G;>QEE/[PX
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M(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS3QK9_9M?,P#;;A
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M7_PK5HH RCKUDPP8;LCWM7_PJM_:.F?VBU\8+TSM$L1S;/C:"2.,=<DUO44
M91UZS.,PW9Q_TZO_ (4G]NV7_/&[Z8_X]7Z?E6M10!E?V[98QY-WC&,?97_P
MH&O60Z0W8^EJ_P#A6K10!DC7;(  0W8 Z#[*_P#A2_V_9C_EE=_^ K_X5JT4
M 9?]OVG_ #RO/_ 5_P#"C^W[3_GE>?\ @*_^%:E% &2VNV3##0W1'O:O_A2_
MV]9XQY-WCT^RO_A6K10!E#7K(+M$-WCT^RO_ (4G]NV6 /(NL#H/LK\?I6M1
M0!E?V]99SY-WGU^RO_A2'7;$KM,%T5]#:O\ X5K44 97]OV?_/*[_P# 5_\
M"E_M^T_YY7G_ ("O_A6I10!E_P!OVG_/*\_\!7_PI/[?L\Y\J[S_ ->K_P"%
M:M% &3_;MEQ^YNN#G_CU?K^5']NV1QF&[XZ?Z*_'Z5K44 9)UVR(P8;LCT^R
MO_A5RSOXKY7,2RKL.#YD;)^61S5JB@ HHHH **** "J]KUG_ .NI_I5BJ]KU
MG_ZZG^E4MF)[H5/^/V7_ '%_K4]0)_Q^R_[B_P!:GI,$%%%%(84444 %%%%
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MRN& /J*$4JBJ3D@8SCK2UVTZ:@K(ZH0459#3&A96**2OW21TIU%%:%A1110
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M6/7W)-3UFQZ[82WBVRR/EI#$DAC81NXZJ&Q@G@_E6E4N_4:MT"BBBD,****
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M&N(3I]K<FYCPI\TG<6"DYQ@%NO?%=#6;]HUC_H'VO_@2?_B*/M&L?] ^U_\
M D__ !%2VWN-*QI45F_:-8_Z!]K_ .!)_P#B*/M&L?\ 0/M?_ D__$4AFE16
M;]HUC_H'VO\ X$G_ .(H^T:Q_P! ^U_\"3_\10!I45F_:-8_Z!]K_P"!)_\
MB*/M&L?] ^U_\"3_ /$4 :5%9OVC6/\ H'VO_@2?_B*/M&L?] ^U_P# D_\
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M>H$_X_9?]Q?ZU/28(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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D?\]!^1J:BC0-2'[7!_ST'Y&FVA#+*PZ&4D'UJQ11=6"S/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %V ^\# 2(  A$! Q$!_\0
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M>3-'<1A&#?0$\<'\JK^'?B+H/BCQ%J.AZ<TYN['=YAD0!'"MM)4Y.1G'8=:
M.LHKG;?QII=UXVN?"<*7+ZA;0^=*X0>4HP.-V<Y^8=JZ*@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** /%_CE/-;>(O!4]O;-=31WC-' IP
M9&#)A0>V>E<S\9/%'B#7/"=G;ZKX-N]%@2^5UN)KA9 S;'&W 4<X)/X5Z9\0
M_!VJ^)O$/A6]TX0&'3;OSKCS)-I"[E/ QST-+\7_  =JOC;PK:Z?I'D&XBO%
MG83/M&T(XZXZY84 9>O>(]5T_P"*/@?1[6Z"6%Y; SQ>4AWG!'WB,CH.A%<S
MK?C?Q1JFJ>*I(/%UEX<BT21HX+"6)#)<[<\Y;G)QV!Z]*[/7O!6KW_Q(\):[
M"(/L6E0;+DM)A@>>@QSUKRG2K:ZU?5?$VL6>D^']:M(M1DE^T:W(4FP.< !A
M\N,=>* -#QE=ZSJ7[/VFZGKFHR7US>Z@DR&2%8S&F' 7Y>HXSGWK>U+7_'O@
MG5O"]YJVLVE[8:K*D$NGPVX580=HPK=2<'KGJ.E2:B=3^,WP@MAI.GVUE=07
MX1H#)MB 12/D..GS#CZUTOQ#\$ZOXE3PJ-/\@G3+I);CS)-ORC;G''/0T >A
M77_'I-_US;^5?.WPIU_6-*\/WL-AX&FUV%KUV-RDJ(%.!\O*GZ_C7T7,AD@D
M0=64@9^E>+>#O#?Q1\#Z=<Z?ING:!/#-<-.6N)W+9.!V(XXH U?B3XI\2Z)X
MK\(Z=X?FBMVU'?&UO,@,9<[57=QG"[L\>E8AUOXD:7\1O^$*_P"$@LKZ>_@$
MT=Y-:A1;KR6*J.I 5@ <YXKI?$O@_P 2>(_$_@C69H[*.33&$FH*DIVJVY20
MF>2.#5N\\&ZK/\;+#Q8GD?V9#9&!R7^?=AQ]W'^T* ,CP+XH\2P^.?$7@WQ#
MJ*:E-I]O]HAO!$(R1\IP0..CKQVP:YSPMK?Q+\9^"[[4K/Q%;VG]FO)AC;JT
MMVX&[:>,* " ,#FNST_P9JUA\7/$GBJ80?V;>V/E0[9,ONVQCD8X^XWZ5YI\
M,['QW=^!M5@\+W&G&SO+F2"5+K*R0,5&70CCD''.<8H G\:>+;KQI\"=+U2^
M1%NTU58)B@PK,JM\P';((_&NU\2>*?$=]XSTKP-X9NX=.FDLEN+F^DB$A1=N
M<*#QT'XY[52UKX1ZE'\)M.\+:3-!<7L5Z+NXDD?8C$ALXXZ#('X5K>*? GB%
M/%VF>,/"MQ9_VI;6RVT]M=Y\N50,<$>Q([=!S0!G:5K_ (QTKQU=>!-;UB*^
MFO+%Y;#4D@6-XWVDJ2N,=0>#GH*I:)\4-4@^$WB*ZU:YW>(M)F:UWLB@EW.$
M.  .#N[?PUT7A;P1XAG\=R>-/%]Q9_;UA,%M:6>2D0Z9R?8GUZUYWXU\(B]^
M/,&B6D_^B:P\5Y>0(>%VY+;A]%8C_>H [6[OO%=MX"\/7.H^-[#0Y[B$RWEU
M=P*TKLQ#(J+@#A3@U6^&WCG5=3\7ZMX;O]=M]>M8K4SVVH10B,MTR, #^]^G
M6M3XC^ M8UWQ%HFNZ+#IMV=.0QFPU 'R7&<@XZ'Z>PJGX*^'WB31_B%>>(-5
MBTB&&ZL3'Y6G+Y:1N=ORA,=!CKWH X;X9V/C6\\):[)X;UNVTNVMKJ27!@$D
MEQ*%!*Y.0JX YQU-;.J?$_7M1^"$&OPS);:K'J*VD\BQ*ROA2<[6! R,?B#5
MG0/ 7Q*\)^'[^QTBYTAEU)Y/.AF8Y@)X$B,.I*]B.,"KFJ_"+4X?@_;>%=,F
M@N-1^VK=W#N^Q"V"#@X[#:/PH C\32--\=_ ,KG+O8AF/J2)*DL-:\1^(=?^
M(^B1ZP+5;3_CTE%NA,2ASN'0%LJ"O).,YK=U?P1K%[\3O">OPBW^PZ7:"&X)
MDPVX!^@QS]X4_P )^!]4TOQQXRU2_P#(%EK#$0;'W-@ENHQQP: .#^#>C^*+
MCP%J%[I/B-K:W_TB."Q%LAQ/M7:^\^^.,5I6_P 5=2'P0N]3FN3_ ,)%;W'V
M R%%W>83D-MQC.W/;J*Z#X8^$_&'@FXFT6[.F2^'_-DF6=&;SF8@  #H!P,Y
MKS^^\')=?M"MH5O,&TR2Z35+B!3\J$+N((Z9R2/HU 'O7A=-2C\+Z8-8G,^I
M&W5KB0J%)<C)X''&<?A6M110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% "/]QOI7SM\*]0\;6EIKB^&-%T^_MCJ+F5
M[JX\ME?'0#(XQ7T21D$>M<3\-O!%WX(L=4@N[N"Y:\O#<(800%!&,'/>@#S?
MX97&H_\ "9_$>YOHTM=2$4CRI"^1')N<D*?8]ZAL?&GB:U^ 0U6/5+J2\DU,
MV\M],YEDAB)Z@GGKQ^->@Z!\.KW2/$_C'5)+ZWDBUT2>2BJVZ/<6/S?3=VKS
MCQIX9F\!_"W0_#]Y>1R7DFL^?%<)D0)Q_P M 1R!UZ?RH ET W.I?%+2-+T3
MQ_KVM:9Y7VJ[E$[A8RN3M8'@J2%!'^U3O"^@:IXB^*'C^UL/$%UHT(O&,SV@
M'F2'S'V@-V Y)QUJUH?C#6/#OC31M(M]1\,:W;ZK,$G&C6ZHT8) W,4 '')Y
MST->@^#_  -=^&_&?BG6Y[N":+6)_-BCC!#1C<S8;/\ O=J //\ PW\2->T[
MX1>(KZ\N3>ZCI=W]DMKB;YB=V "WK@DGGVKFH/%'C"V@L-5TRY\;7NILR/<1
M7=GNLY5/)" $\=,<?E7IV@?"3[)X2\1Z!J]['-%JUT9XY+=2#%W4\]P0*;I?
M@GXC:=:6VDIXWM5TNWVHCK: S^6.BY(]..M &#XQOO%>J_&&T\.:)KD^E+J&
MEH7!9BL7WF9@O9\+C/!]Q7K?AO3;W2/#UEI^HZB^HW<";9+N3.Z4Y."<DGI@
M=>U<W<^!KN?XO67C(7D M;>S-N8"#O)*N,^F/F_2NYH \)TN_3P!\4_'ELY\
MNWGL'U*$=BP&\8_%F'X5S7@*RF\(>,?!.N3NVSQ%#,LY8\99B%_G&:](^*'P
MIO?'&M6>I:9J,%E*EN;:?S WSIG(Z?5NM7_'?PT?Q+X1T;2=+NXK.ZTET\B9
MP<!0NTCCD'A3^% '/?#)3JNH>/?&+W*VGVNXDM[>Z<#$*("=_/! ^3_OFN$\
M0^,ET:%;W0?B5K>K:M%*N^.6-A;2#O@'Y<=.*]JT'X?QZ9\,9/"%S<[GN(94
MN+B(=7<G+ 'TR/RKAKCX.>+[KPD/#4OBC3QIENP>WB2TVESNSF1@,]SZ\T /
M\=^*KZX\5>'],O\ Q%<>&]#O--%V]Y:Y5I)""=NX<@#C\ZH> =:U73M%\9>*
M9==U;6+'3%DAL/M<K&*?N'PQR",+T[,:H>+E,/Q7M=-AU33-/GLM&BMI[C64
M5[:3 !PBL",G(_(UT_@#7KSQE/XB\$ZO_9M[I<%L8UOM+C\N(AL#"XX[DC Z
MJ>M 'GT/BOQ?>Z2FLVNH>-)M:D;S$6*SSI[+NZ  \C'M79?$'Q)XC$_AF?4;
MG6-$\/W5BDM]/IL9$D<Y'*MW !V\>A/4UM:7\/\ X@>'[#^Q='\:VL>D(2(F
MEM TT:DYP,@_SKH/$?A[QM=30?V%XGM8H/LJP7$-[:B02,,YD'!Y/ITH T/A
M_-'/X3ADA\12:_"9'\N\E&'VYX1N^1[UU%<G\/?!,?@3PW_9BW1NII93//+M
MV@N0!A1V& *ZR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@!DLL<,3RRNL<: LSN<!0.I)[5SVF>/O"^L7=Y;V6LV
MLAM"JR.T@5"3G[I/WNG4<5T3HLB,CJ&5A@JPR"*P]-\%^'-(N[NYL-(M8&NR
MIE58QL)&<$*>%Z]L4 7AKVCGIJUB?^WA/\:/[=TC_H*V/_@0G^-2?V1IIZZ?
M:?\ ?E?\*3^R-,_Z!UI_WX7_  H 3^V])_Z"=E_X$)_C0-:TH]-3LS_VW7_&
ME_L?2_\ H&V?_?A?\*3^QM+/_,-L_P#OPO\ A0 O]LZ7_P!!*S_[_K_C2_VM
MIO\ T$+3_O\ +_C3?[%TK_H&6?\ WX7_  I/[$TG_H%V7_?A?\* 'C5=./34
M+4_]ME_QI?[4T_\ Y_[7_O\ +_C49T/23UTNR_[\+_A2?V%I'_0+LO\ OPO^
M% $W]I6!_P"7VV_[^K_C2C4;$]+RW_[^K_C5?^P-'_Z!5E_WX7_"@^']&/72
MK+_OPO\ A0!8_M"R_P"?NW_[^#_&N+U#X8_#O5-0:^N-+L_.=B[&.X:-6).2
M2JL!^E=7_P (]HO_ $";+_OPO^%)_P (YHG_ $";'_OPO^% #M-BTC2;&*QT
M[[);6L0PD43*%45;^UVW_/Q%_P!]BJ)\-Z(?^818_P#?A?\ "C_A&M#_ .@1
M8_\ ?A?\* +_ -JM_P#GO%_WV*!<0'I-&?\ @0K/_P"$8T(_\P>Q_P"_"_X4
MA\+Z"?\ F#V/_?A?\* -+SX?^>J?]]"E$L9Z2)_WT*S/^$6T#_H#6/\ WX7_
M  I#X5\/G_F#6/\ WX7_  H TV:*12A92&&",]JRO#OAK1O"E@]CHUL+:W>0
MRLOF,^6. 3EB3V%*?"GA\_\ ,%L?^_"_X4G_  B7A[_H"V'_ 'X7_"@#8!!Z
M&EK%/A'PZ?\ F"6'_?A?\*#X0\.'_F"6'_?A: -JL2#PEHMOXIG\2QV?_$WG
MC\M[AI&/RX P 3@< =!1_P (=X;_ .@'8?\ ?A:/^$/\.?\ 0%LOPA% &W16
M)_PA_AS_ * ME_WZ%'_"(>'?^@/:?]^Z -NBL3_A$/#W_0(MOP6C_A$/#_\
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MAAUG_OY%_P#&Z -RBL/_ (1Z?_H8=9_[^1?_ !NC_A'I_P#H8=9_[^1?_&Z
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M2&)VE<!-O/4@FO0: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR'MI["]N(!*(@T;0XVD(OS*.N0Y)^G- 'IU5-1U*TTFT:ZO9?*@4X+;"V/P
M)KB;GQ)K'A[2=(U?4;P7UK?VK"0"!4"7+('B5=O.TD,G.>2*Z*]TK5M5\*0:
M?-J26]])&@O)A#N#C'SH &7 /(R#G% &Y#-'<0QS0NLD4BAD=3D,#R"*?4%G
M!]ELH+?$8$4:H!$FQ!@8X&3@>V34] !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **"0!DG
M %9*>(M.N;JXM+.X2XN8$WLB'C&<'GOBE<N,)23<5>VYK5')<0P_ZR15^IKG
MI]2N9_X]B^B<54/)R>33(.B?5K1.CEO]U:2+5H)IDB5),L< D"N>JQ8?\?\
M!_OT#*DGQ*TB&XEADMKP-&[(2$4C(./6KEOX_P##MQ@&\:$_]-8R/UKR'4?^
M0I>?]?$G_H1JM7+[61]K_8>%E%-77S_X!]"VFHV5^@:TNX9AU_=N#5FOG.-W
MB</&[(XY#*<$5TVE>/M;TTJLLPO(1U2;[V/9NM6JRZGG5^'ZD5>C*_D]/^ >
MS45S>A>-=*ULK"'-M='_ )8S<9/L>AKI*V33V/GZM&I1ER5%9A1113,@HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1115GFA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!V'- 'H-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,(2>K)_"?Z?A76UW1=U<_.<10E0JRI3W04444S **** "BBB@ HHHH ****
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M\B?JG_7$_P Q6Y6'XR_Y$_5/^N)_F*F6S.C"_P >'JOS1X;1117"?I@4444
M3V/_ "$;7_KNG_H0KZ'KYXL?^0C:_P#7=/\ T(5]#UT4>I\GQ%\5/Y_H%%%%
M=!\N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@>E 6/4?-C_OK^=.KRU /,3C^(?SKU*F(**** "BBB@ HHHH **** "BBB@
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M4 ><T444B@HHHH <G^L3_>'\Z]1KRY/]8G^\/YUZC0)A1113$%%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2T444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!+&8>/Q5%]Z.5I0"S!5!+'@ <DUZ18_"U!AM0U%F]4@3 _,_X5U^E^&M(T<
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M*@#SFBBBD4%%%% #D_UB?[P_G7J->7)_K$_WA_.O4:!,****8@HHHH ****
M"JVH_P#(,N_^N+_R-6:K:C_R#+O_ *XO_(T >:CI10.E%(H**** "O44_P!6
MOT%>75ZBG^K7Z"@3'4444Q!1110 4444 %0W?_'E/_US;^535#=_\>4__7-O
MY4 >8K]T?2EI%^Z/I2TB@HHHH 1ONGZ5Z?;?\>L/^X/Y5Y@WW3]*]/MO^/6'
M_<'\J!,EHHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M *XO_(T >:CI10.E%(H**** "O44_P!6OT%>75ZBG^K7Z"@3'4444Q!1110
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M=0?8]-^RR7$D\LRG9L<IMVCYCG&<@8[=: .EHJM;ZA9W<'G6]U#+%MWETD!
M7U/MP?RJPK*ZAE(92,@@Y!% "T444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !5*YNKR*8K!I[3IC[XE5?T-7:* ,W[=J7_0'?
M_P "$H^W:E_T!W_\"$K2HIW%8S?MVI?] =__  (2L_75U75M#N["+2]CSQ[
MSW"8'UQ7144G9EPE*$E*.ZU/&_\ A7?B3_GWMO\ O^/\*/\ A7?B3_GWMO\
MO^/\*]DHK/V4.QZW]M8W^9?<CQO_ (5WXD_Y][;_ +_C_"C_ (5WXD_Y][;_
M +_C_"O9**/90[!_;6-_F7W(\?M_A_XCANH93;VY$<BN0+@<X(/I7IWV[4O^
M@.__ ($)6E15QBH[(XL5C*V*:=5WMY6,W[=J7_0'?_P(2C[=J7_0'?\ \"$K
M2HJKG'8S?MVI?] =_P#P(2C[=J7_ $!W_P# A*TJ*+A8S?MVI?\ 0'?_ ,"$
MH^W:E_T!W_\  A*TJ*+A8S?MVI?] =__  (2J]]-J=U8SVZZ2P,B%03<)@9K
M:HHN!Y[_ ,([K?\ SX1_^!"T?\([K?\ SX1_^!"UZ%10/4\]_P"$=UO_ )\(
M_P#P(6C_ (1W6_\ GPC_ / A:]"HH#4\^7P]K893]@CX(/\ Q\+77_;M2_Z
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MA'_X$+1_PCNM_P#/A'_X$+7H5% :GGI\.:V01]AC_P# A:ZV*[U*.%$.D/\
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MI?\ 0'?_ ,"$K2HHN*QF_;M2_P"@._\ X$)5FTGN9MWVBS-OCIF16S^56:*
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; HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ') C0# 2(  A$! Q$!_\0
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MKSZ, +A/); 9N%QZC/I6-\.?BS9^+].N!J0CM-0MHY)YU1&$21*0,[CWYZ4
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MY-%N(<:5 K)-.(7,HE'8#N,]\4 >M45A0>+M(N?%4GAN.60ZE' +AD,9"["
M1\W3/(XJO%X\T*:/6Y$FF(T4XO/W1^7Z>OX4 =+17%Z?\5/"FJ_:?L5Y+*+:
MT:\E(A;"Q@9/_ AZ54C^,_@B6YM(%U1LW07:WDMM0GLQ_A/M0!W]%<MXG^(7
MAOPB\$>JWI$LZ[TCA0R,5_O8';WK=TK5+/6M,@U&PF$MM.H=''&10!<HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBD+J&"E@&/0$\F@!:***
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ME\;:9X?T34$\0:(L3%99;0I+9 ]MQ'3^=7OA]JUGH/Q*\7Z9?+Y6HWE_(]G
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M:ZJB@#E<>/\ U\,_E/\ XT8\?^OAG\I_\:ZJB@#E<>/_ %\,_E/_ (T8\?\
MKX9_*?\ QKJJ* .5QX_]?#/Y3_XT8\?^OAG\I_\ &NJHH Y7'C_U\,_E/_C1
MCQ_Z^&?RG_QKJJ* .5QX_P#7PS^4_P#C1CQ_Z^&?RG_QKJJ* .5QX_\ 7PS^
M4_\ C1CQ_P"OAG\I_P#&NJHH Y7'C_U\,_E/_C1CQ_Z^&?RG_P :ZJB@#E<>
M/_7PS^4_^-&/'_KX9_*?_&NJHH Y7'C_ -?#/Y3_ .-&/'_KX9_*?_&NJHH
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M@W'!9CUV@<G% '2T5D+KUE96EE_;&IZ9!=7" J%N $D/^QNY(Y%6KW5]-TX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N0US6KJT^(G
MAS2XQ%]GNXIFD+("V5'&#VKKZY/Q6WB"#4["[T+0K'4FC5PSSR!'C)_ND^M
M'4RQ)-"\4@RCJ58>H/!KSZZ^'VIRV<6D)?:9-I,#C[.UU9E[F&/(.Q7S@8Z
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MKV_BK4/%OAYX+<6VEVQ$UX\=QC>Q'S(5[@'I0!VM%%% !1110 4444 %%%%
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MJ;3#6%M82R,Q\OR-HV&,=,=CWSFN[K+77+,ZC%9".Z\Z2#SU;[,^W;C."V,
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M"C^TK'_G\@_[^"@"U15;^T;'_G\@_P"_@I/[2L?^?N#_ +[% %JBJHU&R/\
MR]P?]]BE_M"R_P"?N#_OX* +-%5O[0LO^?N#_OX*/[0L_P#G[@_[^"@"S15;
M^T++_GZA_P"^Q1_:%G_S]0_]]B@"S15?[?9_\_4'_?P4?;[3_GZA_P"_@H L
M457^W6G_ #]0_P#?P4?;[3_GZA_[[% %BBJ_V^T_Y^H?^^Q2_;;3_GYA_P"^
MQ0!/14'VVU_Y^8?^^Q1]MM?^?F'_ +[% $]%0?;;7_GYA_[[%'VVU_Y^8O\
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MMP__ +Q+T_5&#1117*?9FAH/_(PZ=_U\I_.O4/&+Z<NL^%A>QSM*=2 MC$P
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MUYO7I'PJ^[J?U3^M:4OB1Y6<?[E/Y?F=_??\>%Q_US;^5?/'<_4_SKZ'OO\
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M>8^UL*?0=>:Z:.S/D.(?XE/T?YG._%/_ )"&G_\ 7-OYUP%=_P#%/_D(:?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?YUM1^(\#/\ _=EZ_HSI****ZCXH**** "BBB@ HHHH **** "BBB@ HHHH
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M0C'8PKX[$8B/)5E=!1115'$%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% $%]_QX7'_7-OY5\\=S]3_.OHB[1I+.9%&69" /?%
M>*?\(;XAR?\ B62=3W]ZYZR;M8^HR&K3IQJ<\DMMWZF%16[_ ,(;XA_Z!LGY
MT?\ "&^(?^@;)^=8\K['TGUJA_.OO1L?#'_D8KG_ *]C_P"A"O63T-><> -
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH JWUU)9P"2*TFN26
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^F6:6MJFR)<GKDDGJ2?6@"S1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+^/H+NX\/1I9WR6<
MHNX297DV J&&5S[UU%<WXWT>/6] 6TE6X91<Q28MX][?*P/3TH Z2BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ KGO'.?^$+U/:%+>6N W0G<,9]JZ&FO
M&DJ%)$5U/56&0: /+M5MM?T;2+K7Y38VEW=I;V6VTD98H8<DF5GQE6^8\XX
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M"'/N.]5_[&TW-J5LH4%HYD@5%VK&Q&"0!QW- %ZBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH R-8_P"$C\R/^Q/[*V8_>?;?,SGVVUF?\5_Z^&?_
M "/7544 <K_Q7_KX9_\ (]'_ !7_ *^&?_(]=510!RO_ !7_ *^&?_(]'_%?
M^OAG_P CUU5% '*_\5_Z^&?_ "/1_P 5_P"OAG_R/7544 <K_P 5_P"OAG_R
M/1_Q7_KX9_\ (]=510!RO_%?^OAG_P CT?\ %?\ KX9_\CUU5% '*_\ %?\
MKX9_\CT?\5_Z^&?_ "/7544 <K_Q7_KX9_\ (]'_ !7_ *^&?_(]=510!RO_
M !7_ *^&?_(]'_%?^OAG_P CUU5% '*_\5_Z^&?_ "/1_P 5_P"OAG_R/754
M4 <K_P 5_P"OAG_R/1_Q7_KX9_\ (]=510!RO_%?^OAG_P CT?\ %?\ KX9_
M\CUU5% '*_\ %?\ KX9_\CT?\5_Z^&?_ "/7544 <K_Q7_KX9_\ (]'_ !7_
M *^&?_(]=510!RO_ !7_ *^&?_(]'_%?^OAG_P CUU5% '*_\5_Z^&?_ "/1
M_P 5_P"OAG_R/7544 <K_P 5_P"OAG_R/1_Q7_KX9_\ (]=510!RO_%?^OAG
M_P CT?\ %?\ KX9_\CUU5% '*_\ %?\ KX9_\CT?\5_Z^&?_ "/7544 <K_Q
M7_KX9_\ (]'_ !7_ *^&?_(]=510!RO_ !7_ *^&?_(]'_%?^OAG_P CUU5%
M '*_\5_Z^&?_ "/1_P 5_P"OAG_R/7544 <K_P 5_P"OAG_R/1_Q7_KX9_\
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, "BBB@ HI#10!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '$ V\# 2(  A$! Q$!_\0
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M]GVO_/+_ ,>-']GVO_/+_P >-6J* *O]GVO_ #R_\>-']GVO_/+_ ,>-6J*
M*O\ 9]K_ ,\O_'C1_9]K_P \O_'C5JB@"K_9]K_SR_\ 'C1_9]K_ ,\O_'C5
MJB@"K_9]K_SR_P#'C1_9]K_SR_\ 'C5JB@"K_9]K_P \O_'C1_9]K_SR_P#'
MC5JB@"K_ &?:_P#/+_QXT?V?:_\ /+_QXU:HH J_V?:_\\O_ !XT?V?:_P#/
M+_QXU:HH J_V?:_\\O\ QXT?V?:_\\O_ !XU:HH J_V?:_\ /+_QXT?V?:_\
M\O\ QXU:HH J_P!GVO\ SR_\>-']GVO_ #R_\>-6J* *O]GVO_/+_P >-']G
MVO\ SR_\>-6J* *O]GVO_/+_ ,>-']GVO_/+_P >-6J* *O]GVO_ #R_\>-'
M]GVO_/+_ ,>-6J* *O\ 9]K_ ,\O_'C1_9]K_P \O_'C5JB@"K_9]K_SR_\
M'C1_9]K_ ,\O_'C5JB@"K_9]K_SR_P#'C1_9]K_SR_\ 'C5JB@"K_9]K_P \
MO_'C1_9]K_SR_P#'C5JB@"K_ &?:_P#/+_QXT?V?:_\ /+_QXU:HH J_V?:_
M\\O_ !XT?V?:_P#/+_QXU:HH J_V?:_\\O\ QXT?V?:_\\O_ !XU:HH J_V?
M:_\ /+_QXT?V?:_\\O\ QXU:HH J_P!GVO\ SR_\>-']GVO_ #R_\>-6J* *
MO]GVO_/+_P >-']GVO\ SR_\>-6J* *O]GVO_/+_ ,>-']GVO_/+_P >-6J*
M *O]GVO_ #R_\>-']GVO_/+_ ,>-6J* *O\ 9]K_ ,\O_'C1_9]K_P \O_'C
M5JB@"K_9]K_SR_\ 'C1_9]K_ ,\O_'C5JB@"K_9]K_SR_P#'C1_9]K_SR_\
M'C5JB@"K_9]K_P \O_'C1_9]K_SR_P#'C5JB@"K_ &?:_P#/+_QXT?V?:_\
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M/]\?UH ET_\ X\8OH?YU9JMI_P#QXQ?0_P ZLT %%%% !1110 4444 %%%%
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M*<70'!8 _6@!U%8?B&\U^V.G?V#86]X);E4NS-*$\N'NPY&3^?TK;R,XR,T
M+12!@W0@_2@LJ]6 ^IH 6BD#!NA!^E<WXS\7P^$=-@D6TDOM0O)A;V5G$<--
M(>V>P]30!TM%>?Q:O\2[!X[W5=#T>[L691);:=*_VF)21S\WRMCN!UKO]P"@
MDX!]: %HI"<H2#V[5POPFU"[U#P4UQ?WDUS-]NN$$D\A9L!^!D]A0!W=%%)N
M7.-PSZ9H 6BC(!Z]:R?$?B&S\,:!=ZS>+));VRAG6$ N<D#@$@=_6@#6HJ*V
MN([JVCGC/RR(' /4 C/-2T %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !5'5?^/0?[X_K5ZJ.J_\>@_WQ_6@
M"73_ /CQB^A_G5FJVG_\>,7T/\ZLT %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7G?Q% ;Q;X#4@$'5B"#W
M&PUZ)7*^*_#5YKFN^&+ZVD@2+2[[[3,)"067;C"X!Y^N* .3\*:O!X#E\8Z#
M?$K;:2SZE: D#= XSM'_  +C\:YR;2[BR\.^"=0O@?[1UCQ&FHW)(Y#2*Q5?
MP7''UKM/B#\-9/&/B'1]1@N4@CA/DZ@A8J9H-P;:,#GD=#Q^5;'C+PM=Z_+X
M=-B]O$FF:E'=2"0D915(PN >>?:@#(^(:^$I]4LX?$/]I:C<M$?L^CV32/OP
M<^9Y:8Y[9)QQ6-\*[R.W\;^(=%TVTU.PT=+>*X@L=15E>%CPVT,20IZ]:Z/Q
M%X5U]?&D7BKPQ<:=]L-I]DGM]15]C)G(967D'VI/"GA+Q#IOC;5/$6NZA9W;
MW]I'%BW5D$;*<[0#_"!T.<F@#C_AWX'T[Q,NJ:CK4MS=1VVK3BTMA,R) P?)
M<;2,L3Z]A5+7O$U[X=^(?BY+(&"74)+2U&HN,Q6>Y<;W[_3MFO3? 7AF]\+Z
M;J%M>R02/<ZA-=(822 KG(!R!S5.'P*;GQ-XLN=5%O/I>MQ11K$I)<;5P2<C
M .>1C- ')>-+6/P'X3T70=)FU!QK&H 7]W:_/=W QERI_O-P!CMQ65%':Z1K
MVC7?@GPGXJTZY^UI'>_:;67R9H&.&WEF/(SG-=;'\.]<N?"<>C:AK$1NM)O%
MN-%U% 6D15^Z)5. ?3@GMZ5LZ;!\19;V!=6O/#]O:1L#*UG%*\DH';#8"Y_&
M@#BIO 7AJ_\ CG>V%SIBR6LFD_;'C\UP#,9<%N#Z=NE>R00QVUO'!$NV.-0B
M+Z # %<-XE\*^)/^$V@\5>%KO35NC9_8KB#4 ^PINW!ALYSGM[5W, E%O&)R
MK3!1O*# +8YQ[9H \_\ $/@C7;3Q+<>*O!>IQ6NH7"K]LL;I<P76W@$D?=./
M_P!8YK&USQC)XK^$'BR.]L6L-5TY/L][;DY"ON'*GT-=)J-I\3(-2NO[(U'P
M_<V,LC-%]NAD22%2>%^3AL>IJB?AO>1?#_Q!I0U&.[UO6V,US=2@I&9"1Q@9
M(  H YG7_ -GIGPS_P"$J2_OY/$=G9QW2:@;A@PP =@7.T+@XQC\:ZGQ9=>'
M=0\-:#+XJN;U_M42LFG6;ONO)&0$@HG+8[<@#-;FO^'+S5/AO<>'8)(5NY+%
M;8.Y(3< !G.,XX]*Q];\$ZS(?#.JZ+=V2:SHD'D>7=JQ@E4H%;D<CO@XH Y3
MP/=6>F_%:+3-!TS6-(TJ\T]Y)K+48W0&13PZ!B3T.*ET?P=8^+_B)XT369KB
M;3K>^4BQ25HT>0H/G8J03@# %=)I7A+Q7)\0;'Q3K^H:=+Y5I);M;6BNJQ;L
M8"Y&6[DDD?2M?PQX9O-%\3>)]2N9(&AU6Z2:!8R2RJ%Q\V1U^F: //?%5_9W
M_P 0YO#NJZ=KFI:'I5E$([#3$>0.Y_CEVD$@#&.:U?ANUS9>,]1L-+T?7-/\
M,26HEBBU.%T$,X(!"%B>"#G&>U=#X@\)ZU'XJ'BCPK>6<.HR0"VNK:^1C#.@
M.025Y!%:_AV'Q9Y\T_B2ZTS:5VQ6VGQOM4Y^\7?DGMC% &CKO_(OZE_UZR_^
M@&O(? _PSTGQ'\--/O\ 5KJ]N+Q[=C:2"X9!9C)VB-0<=1DDYR:]CU*V>\TN
M[M8RH>:!XU+= 2I S^=>8:5X*^(OA[PS#H&DZ[I+6DD6V22Y1S):D_>$1 PP
MY)&X<4 8#ZAJE_\ "O0O%\TSSZGX;U!A++G)EA5]CY]>,5UOB:>+QAX^\*:)
M;/YME;I_;-T5/!0<1 ^H))KIM'\'Z?HG@3_A&6?S;7[.\<\K@#>6!W,?S)KB
M?@7HTL>D7^N74QN&FD%E:3-WMH?E7'H,Y_*@#U'4C*-*O##_ *T0/L_WMIQ7
M"_!!85^%NG&/'F-+,9O7?YAZ^^,5Z)7FJ^"O%7A/5+Z?P/J.FG3KZ4S2:?JB
MN4AD/5D9.>?2@#K_ !<^F1^%[UM8U&;3[#:/.N(9"C@9' (YYZ8')S7BFH3^
M']"U70M2\(:%X@TN9M1BC>[N(I5@N8G.""78YSG(XKT+5/ >O^)/"^HVNN^(
M(Y-2NGBE@6&'%M:M&<A54\L"<Y)YZ>E4=:\(^/\ Q3#IR:QJ&APQV-Y#<>19
MK)B;:P)+,PX(&< #'/6@"+QSHQ\0?%[P_I;WL]M;3:;-]H\AMK2QALE,]@<
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M-@'Y4#!+ENYXZ5TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 51U7_ (]!_OC^M7JHZK_QZ#_?']: )=/_
M ./&+Z'^=6:K:?\ \>,7T/\ .K- !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%U*[6[OM)L;FY7 66:W5V&.G)&:-0\.:)JTZS:CI%C=RHNQ7GMU=@OH"1TH
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M_P#'C%]#_.K-5M/_ ./&+Z'^=6: "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KEOB%_R)UU_OQ_^ABNIKEO
MB%_R)UU_OQ_^ABIG\+.S ?[U3]4>-4445PGZ0%%%% !1110![-\/O^1-M/\
M?D_]#-=17+_#[_D3;3_?D_\ 0S745W0^%'YOCO\ >JGJ_P PHHHJCC"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *HZ
MK_QZ#_?']:O51U7_ (]!_OC^M $NG_\ 'C%]#_.K-5M/_P"/&+Z'^=6: "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N6^(7_ ")UU_OQ_P#H8KJ:Y;XA?\B==?[\?_H8J9_"SLP'^]4_5'C5
M%%%<)^D!1110 4444 >S?#[_ )$VT_WY/_0S745R_P /O^1-M/\ ?D_]#-=1
M7=#X4?F^._WJIZO\PHHHJCC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *HZK_QZ#_?']:O51U7_CT'^^/ZT 2Z?_QX
MQ?0_SJS5;3_^/&+Z'^=6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "N6^(7_(G77^_'_P"ABNIKEOB%_P B
M==?[\?\ Z&*F?PL[,!_O5/U1XU1117"?I 4444 %%%% 'LWP^_Y$VT_WY/\
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MF^._WJIZO\PHHHJCC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNO\ ?C_]#%=37+?$+_D3KK_?C_\ 0Q4S^%G9@/\ >J?JCQJBBBN$_2 HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KEOB%_R)UU_OQ_\ H8KJ:Y;XA?\ (G77^_'_ .ABIG\+
M.S ?[U3]4>-4445PGZ0%%%% !1110![-\/O^1-M/]^3_ -#-=17+_#[_ )$V
MT_WY/_0S745W0^%'YOCO]ZJ>K_,****HXPHHHH **** "BBB@ HHHH ****
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M (\8OH?YU9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?\B==?[\?_H8KJ:Y;XA?\B==?[\?_H8J9_"SLP'^]4_5'C5%%%<)^D!1110
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M *&:ZBN7^'W_ ")MI_OR?^AFNHKNA\*/S?'?[U4]7^844451QA1110 4444
M%%%% !1110 4444 >??%7_CRTS_KJ_\ Z#7F5>F_%7_CRTS_ *ZO_P"@UYE7
M'5^(^]R;_<H_/\PHHHK,]<**** $;[I^E?0.B_\ ("T__KVC_P#017S\WW3]
M*^@=%_Y 6G_]>T?_ *"*WH[L^9XA_AT_5_D7J***Z3Y$**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J.J_\
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M/^NK_P#H->95QU?B/O<F_P!RC\_S"BBBLSUPHHHH 1ONGZ5] Z+_ ,@+3_\
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M[U'M8@\DQ:5[+[SU.BBBM3Q0HHHH **** "BBB@ JCJO_'H/]\?UJ]5'5?\
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M?G^84445F>N%%%% "-]T_2OH'1?^0%I__7M'_P"@BOGYONGZ5] Z+_R M/\
M^O:/_P!!%;T=V?,\0_PZ?J_R+U%%%=)\B%%%% !1110 4444 %%%% !1110
M5Y-\3_\ D9+;_KT7_P!":O6:\F^)_P#R,EM_UZ+_ .A-657X3VLC_P!\7HSB
MJ***Y#[H**** "K.G?\ (4L_^OB/_P!"%5JLZ=_R%+/_ *^(_P#T(4(F?POT
M?Y,^A:***] _+0HHHH **** "BBB@ JCJO\ QZ#_ 'Q_6KU4=5_X]!_OC^M
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M44 %%%% !1110 5RWQ"_Y$ZZ_P!^/_T,5U-<M\0_^1.NO]^/_P!#%3/X6=F
M_P!ZI^J/&J***X3]("BBB@ HHHH ]F^'W_(FVG^_)_Z&:ZBN7^'W_(FVG^_)
M_P"AFNHKNA\*/S?'?[U4]7^844451QA1110 4444 %%%% !1110 4444 >??
M%7_CRTS_ *ZO_P"@UYE7IOQ5_P"/+3/^NK_^@UYE7'5^(^]R;_<H_/\ ,***
M*S/7"BBB@!&^Z?I7T#HO_("T_P#Z]H__ $$5\_,?E/TKZ!T7_D!:=_U[1_\
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M 'W1]B_Z>;C_ +[JU10!5^Q?]/-Q_P!]T?8O^GFX_P"^ZM44 5?L7_3S<?\
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MU\W_ )F)_P (EHO_ #XP?]^E_P */^$2T7_GQ@_[]+_A6W119#]M5_F?WO\
MS,3_ (1+1?\ GQ@_[]+_ (4?\(EHO_/C!_WZ7_"MNBBR#VU7^9_>_P#,Q/\
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MKYJ'(W@HG';CUJ'6]+\3>(O#E]8W4&E6TKB/R4CN'D5F5PQ+,4&T8&,;3]:
M,[6-3O(?!]U<>'/%W]IWDES#!%<R>1(L3,X&/W: <Y[Y-3P>)+_6M0\/VT-R
M]D;V"ZCO$C52\4\8 .-P."K9]C6C?Z;KFMZ6+:[L].LGCNH)D\FZ:4,J.&;.
M8UP<#CK54>#;FW^)D7B*TGA737BD:>V).X3LH4NO&,$!<\]10 OAF+5Y]>U5
M+OQ'?W,&GW0B2%XH%612@/S%8P>I[$=*L:OJEW=>(IM'MM0&F6EG:"[O;T!2
MXW$A57>"H'RDDD'\.M:6BZ3/IVIZU<S/&R7UT)HPI.0 @7GCKD54U/1=1A\1
M#7M&-O)/);BVN;2Y=D290<JP<!MK+D_PG(/:@#F=2\0-;#1XH?'4<FGW-[)'
M-J2?9]R*(RP1FVE,Y_V1P:TK/Q'J*>!;N^FF,\_VAK:PNC&%-RI8+')MQCG.
M>!@XSC!I+/PCJ9UJTU6[%E&W]H2W<]O&[.JJT/E@*Q4;CW.0*A7P)>2R6VF7
M%P@T&UU&6\B2&>1)0I&40$8V[79CP>F* $G\0ZO!\-M5EDOA_;>F2M:37*QK
MRZN!O"XQRI!Z=ZOM=ZMX?UZTL+G5)=2M-2@E\F2XB19898UW=4505(]1D$=:
MH:CX!NH[?7[71YE^S:I!$V+RYDD87"-R2S;CM*@#\.E;-OH^K:GK<&I:XMI;
MQVD+QV]K:2M+EG&&=G95[<  >^: ,V[\0:I%\++364N<:A(D!:78O)9U!XQC
MH33_ !;XBU'3M9@^P3A+33DCN=138&\R-WV!<D?+CEN.PID?A?6Y-%MO#-VU
MDVD6\B9O$D;SI(T<,J^7MPI. "=Q]<5(W@"WU6ZURZUN:=Y=2E*A;:\EC00!
M0J*RJ0&(Y/(/6@"3Q6NJ0WVF36'B&^M8KZ]BMFACC@9%5@<E2T9.>.Y-9E_J
MDUIXQ?1=0\:3:=;PV,4D<C_9D>>1F8$DM'@G '  K93P]JLFA^'+6[GMWNM-
MN8I)W#'#J@(XXZD8ZTV]TG7+;QE<ZSIUIIUW#<6D<!2YN6B9"K$YXC;(YH J
MD:[JOB?7+*S\0W%HMA#;FW401,CLR$DOE,D$@="/:M_POK+Z_P"'+3498UCF
MD!65%Z!U8JV/;(.*Q7TOQ1:>(-6O].ATO&I10+OFN'S;LBD$[0GSCG(Y7..U
M=#H6DQZ%HEKIL<C2B!,&1A@NQ.6;\22: -&BBB@#D]6U6[N_$5QI%OJ(TNRL
M;5;J\O0$+C<3M5=X*@84DD@_A61J^O267ABWGL_&,5U;R:I#;OJ:" M%$Q^8
M,0-F1Z[1QBM[4M%U&W\1G7M&-M+--;BVNK2Z=D255)*L' ;:PR?X3D'M6/<>
M%-:ETV298]/%_)K$>I-;&9O* 3 V;]F22!UV]Z (=>U75K7P_ITGAGQ%_:UQ
M<:@$$\@A<2J%),644 9VXSC.3UJGXC\;WQMI+S2K_P"SVLFC)=H=BDQN9@C$
M[@>0,C!XKJ+C3-8U9M*EO+:QLWLK];ADAN&E#(%(X)1><GIC\:YC4_AMJ3:K
MKTNFW%H+&^MP+6WE9E\J4RK(XX4X4D$\=STH U;W5C9^!]<U/2O%;ZM+!"2D
MY,#B%A_N(!^>:?X4UN>ZUB>"/6SK6F)9K-)>,L?[B;/,>Z-0I^7G&,C\:NZG
MIVNZ]X7U73+JRTZRFN(?+A,-TTJDG^]F-<?AFJ6L>%-5>XO)='FM8#J&F"RN
MM[,N)%("R  ')VEQV[4 5-&\3ZK/-JK7=P#'=V4FH:8#&H\I%++MZ?-T5N<_
M>J[<Z[J4?PUTW5EN,7TT=LTDNQ>2[*&XQCG)JO??#N*U&GS:%-,MQ:JUN1>7
MDLB&!XRK* Q8+SM/ '2EC\/^([CPA;^'[NVTV$6T<"I/%=N^\QLI.5,8QD ]
MS0 MOK-]<>-[S3KW6VTR>*X LM/D@3RKN#'W@Q&YV/S?=8;<#@]WQ6NL_P#"
M;/I9\4ZFULEFMU@PV^2WF8VY\KIC\?>K/B#1-:\0RI83PZ8MC'=QW$=Z'8SQ
MA&# *A7 ;C;NW=">.U:9TR>'Q;/K1*M;?8!!L7)?<'+=,>E &7J>H:E<>)-1
M_LK=+_8^G.PMPY"S7,@RBL!UPJC_ +ZK"3Q#>2^#;C4+'Q5+=7),$<Z2V\23
M6<K2!7&W:-O\0PX/3.:Z7PQ9:A#X=NKQU6'5=1EDNV6=#A&8_(K#.<!0HK#U
M;P9JWB.[N;Z_M],M)I(([8P0R-*LRB57)D8HN< $ 8/4\T 5]:\0:QH=KXFL
MXM;:[^PVD%Q%>R1Q^9 SOM9&VJ$/ W#CH>]:$^O-8Z$TNC^)1KEU=W45E!+,
M87C@D<]3Y2KVR<'T%:NO^%89_!U_HNA6EE9-. 414\N,L&!YVCV]*BU#2-:U
M_27M[RVL--NK>:.YLY;>X:=?-0Y&X%$X[<>M $.MC6O#?AV]O%UZ>\?]T%-Q
M!$&1BX!QM4#!!Z$$^]1>+?$6HZ=K,'V&<)::<L=SJ*; WF1N^P+DCY<<MQV%
M6M3T[Q)X@T.[LKZ'3+1G$?EB&=Y0S!PS$L47 P.!@_6JS> +?5;G7+K6YKAY
M=2E*A;:\EC00!0J*RJ0&(Y/(/6@#4_M.Z/C^/35F!LFTLW&P*.7\P '/7H:Y
M[6O$FL6L.O-%/*MO::C##)-# )'M;8H"[JN#N(]P<9Z<58L]"\4:9?Z7?QQZ
M;>SV^E_8)A)=/%DAP0P(C;/ 'I6E;:7KNG3ZM>VJ6$D][<QS>1+*X7:(PK+O
M"\'(X.T\=N> #/U&2^?P5<:KIGB^>Y6WBEEAN;>.!A, . _R$$@@CY0ON,UT
M7AZWNXM*AEO-3N;^2=$DW3K&NS*C@;%7CZYK#M?"=ZGA[Q% _P!D@N]9DDE\
MB GR869 O7 ))QDG R3TKJK&!K;3[:W<@O%$J,1TR !0!8HHHH **** /-;O
M7-9M8-2UA=<<M;:Q]CBTZ2*,QRH65=@PN_=AB0=W;I6G:^-;.TU;Q+9ZQK=E
M;O:W6RTBGE2-@GE*> <$_,3S6EH7A*ST[4=0U*ZLK&2_GO9)XKE8P9%1@ !N
M(R#P:DTK0)[.\\0S3F!QJ-UYT..2J^6JX;(ZY4],T <;;>--;L=.B-W<?:Y]
M9L8WTEO+4?Z03M9.!@@9#\]@:U/[4U.+Q9_8VI^(GT^:.*#[%OMXQ%J)P/,)
M)'+;CC8I4@8/-:%KX4NX;'PK#(]NSZ1(7F.3S\C+\O'N.N*=XJT;6O$-M<Z1
MY&F'3KAE*W<CMYL !!)$>TAF!&0=R]1Z<@%"^\3:K!<:O:6\L;7#ZK!I]DTB
M K#O0,6(&-V &//?%6];_MKPWH4]RNNSWC-+ JM<01!D)D ;&U0,$'H1GWIM
MWX.O+@ZK-'=11W+W\-]8R'+!7C0*!(..#R#CUJ?4M-\1Z_I$UI?0Z;:'S(6C
M6&=Y<[7#,2Q1<<#@8/UH J^*/$6H:?X@@-G<!-/TX12ZDFP'S$E?8!DCC;]_
MCM47B;Q)JNB^-K Q3*=$CMA)?Q%!D*T@02 XS\I(SSC%2-\/;?5#KD^M37#7
M&IS/Q;WDJ1B(#;&K*" Q '<&K.G^%KR66 ZVUM<(=&_LZY5&)\QMPR>0."!^
M= %GP_J-]J=SXD@EN<_9KYH+9@J_NUV*1VYY.>:Y34?&FN6_@_0KFW96U$7#
M#4<QCF.!BLW&.,XSQCKQ71^ O#&H^%['4;?4;N.Z::[:2&5"23'M"KNR/O8%
M5;3P1<)XFUZYN9H6TJ^AD2VA4G?&TH'FD\8&2O&/4T ,\0>(M3BGUR73[H1V
MUA:VP3Y%.99'R3DC^X5X]Z?J-OK*^,[+3HO%&I16UY#-,RK%;G85(P%)B/'/
M?)]Z@T_P5JL/@*]TF\N;:35;N8.\JLWE[590@R1GA% Z=:Z6[TF>?Q;IVJJ\
M8@MK>:)U).XE]N,<>U &!9>-+2SU/Q'9:SKMG!):77EVJ7$B1ML\I#G'&?F)
MK?\ "=_/JGA33+ZZE$L\\ =W  W$]\#BJ^E:!/97GB&:<P.-1NO.AQR57RU7
M#9'7*GIFKGAO39M'\.6&G7#(TUO$$8QDE2?;- &K1110 4444 %4=5_X]!_O
MC^M7JHZK_P >@_WQ_6@"73_^/&+Z'^=6:K:?_P >,7T/\ZLT %%%% !1110
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M?_82NI_:<;O+_LRXSMSC=]SIGOTKHZYHG_BYJC_J#G_T<*Z6@ HHHH ****
M"BBB@ HHHH **** "BBB@#/U;6[#18XGO97#3/LBCBB:620XSA44%CQSP.*S
M;SQOH=C;0W,\EYY$JAEECL9G4$G;M)5#M;/&TX(/:CQ-I"ZG=:=-:ZJNG:Q9
MLTMI(P#A@0 ZLA(W*1@'!!'!S7.:CK5QKOPV2\NXHH[E;Z.&4P$F)V2<*60G
MG:2,B@#L;+Q!I]]/!!$TZ3SH\D<4]O)$Y5" QPZ@CDCKUJO?^+]%TZ::&XN9
M#-%.ENT<5O)(WF,NY5 523D<\52U.1+?XC:(\S!$ELKF)&;@,^4.W/K@$_A7
M)79#^-VN58&!_$=NBR \%EMR&&?8G% 'H-EXDTJ_T^ZOH+D^5:;OM"O&R20X
M&2&1@&!QSR*JVOC'1[NRGO4:\2UA@-PTTUC-&AC SD%D ;CL,USNI-%<Z_XO
MN+1PT$6BB"X9/NF<!S@G^\%(_,4V-=33X3W!OK^RN(3HR^2D%NT;(/+'WB7;
M=Q["@#K8_$ND2Z;I^H1WBO:Z@ZI:R*K'S&8$@8QD=#UJE#XXT:>_%BBZE]J^
M4F,Z9< J"< G*<#/<\5P5P#H.M^'-!\O98WNI6U_8$=%.W$L?MAB&'LWM7<6
MA_XN9J0_ZAL/_H;4 =11110 4444 %%%% !1110 4444 %%%% &%<^+M*LA?
MO</,D5E<);/(L3.&E8 A5"Y)/('3O1_PF&B#2;K4FN9$@M7$<ZO;R++&QQ@&
M,KOYR,<<UP=[Y[^"IVC=([M_$P):1-P5_/ !(!&>,=Q46MBY71O&"7\L9UH7
MEIYDJIMB:+<ODLJ9R!][())R#S0!Z%_PENDKI\M[*UW!#&ZQ_P"D64T3.S=%
M164,Y/HH-30>)-+N(;:59W47-Q]FC22%T?S<9VLI *G'/(';UK*U71[G5M(B
MM=5UVUAU%+E9K&[M(?*\N502OR.[;N^1GD5@G6+[4[K2[?4A;-=Z?X@%J\]J
M"(IL1E@P!S@X8 C)P1UH Z>+QQH$UV+<74J9G-L)I+:5(3*"1L\PJ$SD8Z\F
MIKGQ;I5MJLVFDWDMU"5$JV]E-*$W#(RRJ0,CWKB$FMA\*M?@E93+/>W<-O'U
M9YFE(0*/[V[&/I6GHD6KKXX\0+;ZA9Q(GV,7"SV[2/(?*YVL'7;WZ@T =;:^
M(=*O=6O]+M[M7O; *US#M(*!AD'D<_A4$GBO1H]*M=2^UEK>[.VW"1.TDQYX
M5 -Q/!Z#M7"WR/IFN>(/%%M$7DTZ_P!EVJ]7M6A3?]=IPX^A]:C\&311W?@R
MXN'46LNF7$=J[GY?.,F<#_:* _@#0!Z!8>)])U*\BL[>Y<7,L;R+#+"\;84@
M,"& P1D<'G!S26GBC3+Z_M[6V>23[09EBEV$(SQ'#J">I'Y'!YK!^(2B;P__
M &MI5Y%'J6F3@1S+AMF_$;J<>JM^8%&L:;;Z)_PA=C:%E^SZ@D*'NR^6^\GZ
M]30!V]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !69K'B#3]"-L+YY@]RY2&.&W>9G(&3A4!/2M.N+\:B[;Q'
MX4%C<06]P;J;;)/&9$'[HYRH9<_G0!OVGB/3;R[MK1))H[FYC>6&*>WDB9E4
MX;AU'3/3KCFJ%SX[T"UMC=//=/:AF0SPV4TD8*MM/S*A'48K!\?07]]I6E:=
M93QR^*&D:6UN+8>4$"J?,;!+84J=N"3R13M1N+"?X/*VFQ^5:K#$@B/6,K(H
M96]P0<T ;\OC71X!;B3^T%DN"_E0_P!G3^8VW&X[-F['(YQBK \4Z.-0T[3Y
M+EH;S44:2UAGA>-G"]>& P?8X-8'B=;YOB#X>&GW5M;3_9;KY[F$RKCY<C:&
M7G\:I^)](GUCQ-9PB6)M3@TE[BVG1=H6=)4*D#)P">.IX- '6W'B?1[6.^>:
M\"_895AG 1B1(P!55 &6)R,!<TMGXETJ^DMXH9Y!-<,ZI%)"\;@H,L&5@"IP
M0><9!XKSOP\;3QI;^()I+M]+NGU2%X'R-T%W'&!MPW#8(;CN*T=,U>_U'QSI
MEEJ?V:2[TZXNK=KFU!$<X\E6!P<[6 (!&3@T =O#KVF3Z')K,=T#I\:.[RE2
M-H0D-D$9XP>,51M?&FC7UW]FM#>S.)!&S1V$Y16(!P7V;1P1U/%<=>1M;ZS?
M>"1_J]4U*.\B4?\ /LWSS?AN3;_P.M;PBFI#6]?,%]91Z>NL2A[=[<F4_*G1
M]X [?PF@#J-8U_3]"%M]N>8-<N8X4A@>9G8#) 5 3TIMKXCTV[N[6U62:*XN
MHWDABN+>2)F5" W#J.F>GIS6!XW%TVO>%!97$%O<&\EV23QF1!^Z;JH9<_G5
M+Q[!?WNCZ5IMI/'+XH>5I+2XMAY2Q[5/F/@EL+M.W!)R2* .CE\9:)%:QW(N
M99HY;A[:/[/;22EY$SN"A5)(&#R..*C;QSH BMG2YGF:Y9UCB@M)9)-R??#(
MJEE([@@5RWVI'TSP._A^TA)29XUMKB4QA&$+AU9@K$$'/;DU7DT;5].\;Z3*
M+VP@U2_>\NI286EACRJ#8HW*3P!\Q(R>U '<WGBK2["VLIK@W:_;21!$+*9I
M6(&3^["[A@<\BI;?Q)I-U!930W89+V4PP_(P)D&<J1C*D8.0<5SGBE-2?7_"
M"6UY:)?^;<?OG@9HB?).?D#@\_[W'O6'HY4Q>'O,#+?_ -O7'V\,0?\ 2-K[
ML8Z*1@@>A% ';V'B[2=4N_L]F;R4[VC\T6,PBW*2"/,*[>"".M+;>+]"N]#N
M=9@OU>PM7:.:4(V493@@KC/7VKG?AXNI_P!D2.U]9'3_ +5=8MQ;D2@^:W\>
M_'7_ &:X;4 = \!&]1,:?K<#6]P5Z)<K*?+<_P"\,J3["@#V#4O$VE:5/'!<
M32O.\?FB&WMY)G"?WBJ D+[GBJ]QXST6"Y2W$MU<2O"LX6ULYI\(W0G8IQG!
MZUF^'98K;QGXCCNW1+F1+:6'><%H!$!D?[(?=GW/O5 />W7Q,OI='U&PAB;3
M;=F>:$S"1=[XVE77'UYH [Y'$D:NN0& (R"#^1Z4ZD'0<Y^E+0 51U7_ (]!
M_OC^M7JHZK_QZ#_?']: )=/_ ./&+Z'^=6:K:?\ \>,7T/\ .K- !1110 44
M44 %%%% !574-,L-6M_L^HV=O=PYW>7/&'7/K@U:HH JKIMBNGC3UL[<604*
M+<1CRP!VV]*=>V%GJ-JUK>VL-S;MC=%,@=3^!JQ10!FMX?T9]+73&TJR:P5M
MPMC OE@]<[<8S4]EI>GZ;9FTL;*WMK8Y)BAC"J<]>!Q5NB@#(M/"OA^PF:6T
MT33K>1E*,T5LBDJ>HX'0U<FTNPN(;>&:RMY(K9E:!'B!$17[I4=B.V*MT4 1
M?9H/M7VKR8_M&SR_-VC=MSG&>N,]JEHHH **** "BBB@ HHHH **** "BBB@
M HHHH IZCI.G:O"L.I6%M>1*VY4GB#@'U -/.GV;6:6;6D!MH]H2$QC8NWI@
M=!C%6:* *M_IUCJEL;;4+."Z@)!,<\8=<CH<&J\WA_1KC3HM.FTJRDLHCF.W
M>!3&A]0N,#K6E10!4MM,L+.P^P6UE;PV9!7R(XPJ8/4;1QS5.T\*^'['S?LF
MB:=!YJ&.3RK9%W*>JG Y'M6O10!6FTZRN&MFGM()&M6#P%XP3$P&,KZ'Z5(+
M:!;IKD0QB=U"-*%&XJ.@)ZXJ6B@ HHHH **** "BBB@ HHHH **** "BBB@#
M&L_#MM;7.HM+Y=Q;7=TMVL$D8(BEP,L,^I /M5RZT?3+XS&[T^UG,Z".7S8E
M;S%!R%;(Y /.*NT4 9$?A7P]#:36D>B:<EM,098EMD"N1T)&.<5;ATG3K:WM
M[>"PMHX;9M\,:1*%C;U48X/)Z>M7** ,R#PWH=KJ!U"WTBQBO22QN$MU#Y/4
M[@,Y--O/#&@ZC>&\O=&L+BY.,S2VZ,YQTY(S6K10! ME:H)PMM"!/_K@$'[S
MC'S>O''-5Y-#TJ72TTR33;1[!,!;9H5,:XZ87&!5^B@"G%I&FPZ<-/BL+9+(
M=+=8E$8YS]W&.O-07>D"\UW3]1DF^2R63RX=O5V &XGV&?SK3HH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "J6I:/IFL1I'J>GVMXB'<BW$2N%/J,CBKM% %"QT32M,96L=-M+9E0HIAA5
M"%)R0,#IGFI/[+L/L\UO]BM_(F<R2Q^4-KN3DL1W.><U;HH H:EH>DZSY?\
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M #T_\=%']HW7_/3_ ,=%%% !_:-U_P ]/_'11_:-U_ST_P#'1110 ?VC=?\
M/3_QT4?VC=?\]/\ QT444 ']HW7_ #T_\=%']HW7_/3_ ,=%%% !_:-U_P ]
M/_'11_:-U_ST_P#'1110 ?VC=?\ /3_QT4?VC=?\]/\ QT444 ']HW7_ #T_
M\=%']HW7_/3_ ,=%%% !_:-U_P ]/_'11_:-U_ST_P#'1110 ?VC=?\ /3_Q
MT4?VC=?\]/\ QT444 ']HW7_ #T_\=%']HW7_/3_ ,=%%% !_:-U_P ]/_'1
M1_:-U_ST_P#'1110 ?VC=?\ /3_QT4?VC=?\]/\ QT444 ']HW7_ #T_\=%'
M]HW7_/3_ ,=%%% !_:-U_P ]/_'11_:-U_ST_P#'1110 ?VC=?\ /3_QT4?V
MC=?\]/\ QT444 ']HW7_ #T_\=%']HW7_/3_ ,=%%% !_:-U_P ]/_'11_:-
MU_ST_P#'1110 ?VC=?\ /3_QT4?VC=?\]/\ QT444 ']HW7_ #T_\=%']HW7
M_/3_ ,=%%% !_:-U_P ]/_'11_:-U_ST_P#'1110 ?VC=?\ /3_QT4?VC=?\
M]/\ QT444 ']HW7_ #T_\=%']HW7_/3_ ,=%%% !_:-U_P ]/_'11_:-U_ST
M_P#'1110 ?VC=?\ /3_QT4?VC=?\]/\ QT444 ']HW7_ #T_\=%']HW7_/3_
M ,=%%% !_:-U_P ]/_'11_:-U_ST_P#'1110 ?VC=?\ /3_QT4?VC=?\]/\
MQT444 ']HW7_ #T_\=%']HW7_/3_ ,=%%% !_:-U_P ]/_'11_:-U_ST_P#'
M1110 ?VC=?\ /3_QT4?VC=?\]/\ QT444 ']HW7_ #T_\=%']HW7_/3_ ,=%
M%% !_:-U_P ]/_'11_:-U_ST_P#'1110 ?VC=?\ /3_QT4?VC=?\]/\ QT44
M4 ']HW7_ #T_\=%']HW7_/3_ ,=%%% !_:-U_P ]/_'11_:-U_ST_P#'1110
M ?VC=?\ /3_QT4?VC=?\]/\ QT444 ']HW7_ #T_\=%']HW7_/3_ ,=%%% !
M_:-U_P ]/_'11_:-U_ST_P#'1110 ?VC=?\ /3_QT4?VC=?\]/\ QT444 ']
MHW7_ #T_\=%']HW7_/3_ ,=%%% !_:-U_P ]/_'11_:-U_ST_P#'1110 ?VC
M=?\ /3_QT4?VC=?\]/\ QT444 ']HW7_ #T_\=%']HW7_/3_ ,=%%% !_:-U
L_P ]/_'11_:-U_ST_P#'1110 ?VC=?\ /3_QT4R2ZFN%"2/E<YZ"BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )B G4# 2(  A$! Q$!_\0
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M658[D(QZK+\IK>CGCE4/&P93W!H3,I4Y+=$QI13#STIRYZ&F2.HHHH ****
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M9_\ 'JGX_P ZGJ"S_P"/5/Q_G4] !1110 4444 %%%% !1110 4444 %%%%
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MKMPI:C!! Y_*I*#"UA:*** "BBB@ HHHH **** "BBB@ HHHH **** ,Z_\
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M7*7$2O&P96&58=Q4P8GK0<S30[FEI,TM !1110 4444 %%%% !1110 4444
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M#/)MR-@-;-PUG(GE3O$0W0$U%;Z18QD21Q GUZT 4[2U-OH<^_(\P%P#VKE
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MV+U%%)08BT444 %%%% !1110!G7_ /KU_P!W^IHHO_\ 7K_N_P!310!:L_\
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MY.ZU.YO(]DS C.< <53P/2BX'>_VC9_\_$>?]ZJUY>6\T(MTE1VE.W@Y(KC
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MP>X[4]CHFN>":W.S4TZF)U-/H.<**** "BBB@#.O_P#7K_N_U-%%_P#Z]?\
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MWKZ%;/KBZFSL6";-A'%:GEQ[0HC&!VQ18;KQZ'!%6M?&JR20D^9; 1MMRN[
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MS<SZ'8:-8BPTNW@48V(!BKYX%"C XH/ I&4GS.Y&QR:2@]:*!!1113$%%%%
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M** "BBBF(****!A1110(**** "BBB@ HHHH **** #C ^M47U6V2\^SEQO\
MK1JE\FGV4DYQD#C->33ZO.^JF[#'.[(%(+'LP(;H:6L30-5&HV:,2-V.:VZ
M"DQ[FEHIBL)CW-&/<TM% <HF/<T8]S2T4!RB8]S1CW-+10'*'YT444##FD+
M#DX/O2U@>)+E]L-E'(8Q,299!U5!UQ07%7);KQ/8V\P@CWW$G3;$N[!JQINM
M6VJ;TBW1S)@-&_#"LC3YKR"T#66CQM X&TE]K,/4\55U7SYYXS<VOV.[8'R9
MHGX)'9J#3DOH=D"6]11U]:I:3=->:9;S-]]DY/N*O=:#&4>5V$Q[FC'N:6B@
M3$Q[FC'N:6B@7*)CW-&/<TM% <HF/<T8]S2T4!RABCBB@<T#0R65((6D<@*H
MY-9^FZ]9ZH\B6\@+(<$9KF/B-XE&E:8;6)P)'7D#K7EOA'Q%-I6L([N=CO\
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M6D(3=&B)N9CCOZ47+EAI7L=R.N..>WM0<?0]!7GQ\5:B?":7JRJ;@2["V.&
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M-%%__KU_W?ZFB@"U9_\ 'JGX_P ZF;[IJ&S_ ./5/Q_G4QZ4 9'B&R%_H]U
M1G=&0![XK&\!7?G:"D#GYH&,9_ UUD@#(RD=17!>'2=*\7ZCIK'"2GS(A2ZG
M33]^#78[X<C-1N.:>#CCTIKCB@YD,HHHH&%%%%,04444 %%'O67KNHIIVG/(
M3AR.*!HY'QMK?F-]CA;@=<&N)%2W=P]U<22N<EC40Z5'4M!1113&3+:3-:/=
MC_5(VTGWJ#(Q6U9 -X7NEX(-T@PW?)K6(M9=:NM*^Q0I"L!8,!SN"YSF@DY#
MU]NM&:Z<2PZ?!I"+9P2M<'$K.N<C=CBB>*WTN+4+N&WCE=9Q'&'&5C4C/(H
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MZUZ."".*^9/#NK2:1JJ3(V$SR*^BM&U%-1L(ID<'([4B;&E11C HIDA1110
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M>[@1FG@8_)D@./E/J:CAT:^GMQ/'$"G.W<P!;'H.] #3J-R=,73]_P#HZMN
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MZ$+[4 >@:C/' =5O8XM+CAGB8I.DFYI<CC"YXKF-'UG3(=5L)&TN*V"./,N
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MY;_*0>K#M76YSCTIDSBXRL1D8Z"DJ4K49'-(@2BCO13 ****!!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4=L444!83 I:*/RH
M3 I<#TH[44 &!Z48'I110 8'I1@>E%% !@>E&!Z444 &!Z48'I110 8'I1@>
ME%% !@>E&!Z444 &!Z48'I110 8HHHH *,#THHH ,#THP/2BB@ P/2C ]***
M #\***!S2&**>.!0HXHSSB@ )QR<5P7B:]DUW5X_#]DQVA@9R.F/2MOQ5KRZ
M38$)\UQ+\D2=R:B\':"VGVQO+KYKVX^=RW49[4'1"/(N=F]IUE%86<5K$,+&
MH'%7<<4W9Z4\>E,YI.X"EHHH **** "BBB@#.O\ _7K_ +O]311?_P"O7_=_
MJ:* +5G_ ,>J?C_.IZ@L_P#CU3\?YU/0 4444 %%%% !4)Y#=*FIA YXH$<)
MXKTJ:PO8M>TY2)8S^^0?Q"NET35H=7L4N86R",,/0UHSQK-&R,H((Q@BO/;E
M)_!&NBXB#'2;ELR?[#4F=46IPL]ST:FE:@MKJ.Z@26-@R,,@YJ<4&#5MR,CF
MBGLO'%,Z4$A1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@+$-S<Q6D#32N%11SFJMOK6FW2*\=U#AAW<"JWB<9T*YXR-
MN?UKC_#XMK>SD%Y8/*&D)5D0'B@ZH4HNGS,]!AO;:X8K!/$^.H5LU8KDK QR
MZ_:/:6$L$:(X8E< Y]:ZW&.#2N8R204444S,**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ***!0 4]5R*0+^5+CC.:0]D. Q5/4+Z&PM)+
MF=@J("2:L2RB)2SG"@9+9Z5Y[>33^--=_L^ L-,MVS*X_B;TH-*4;N[V)M"L
MIO%&MOK5XG^BH<0(>GUKOU4!NM1V-K%9VJ00J%1!@ #%60*8JDN9VZ *6BB@
MRL%%%% PHHHH **** ,Z_P#]>O\ N_U-%%__ *]?]W^IHH M6?\ QZI^/\ZG
MJ"S_ ./5/Q_G4] !1110 4444 %)2T4 ,(R:HZEID&HV,EM.FY&!!!K0IK9V
MF@$^5W1YUI-[<^$]6.EZBQ:TE;]Q*>WM7H"2AT#*01V.>M9>N:';ZS8&"9.0
M,HW=6KF?#^M7.BWPT366(8']Q(W<5+['0U[2-^IWPZ5&RTJ.&&01SUIW&:=C
MG(J*<RTV@84444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !6=JFL0Z7&C2I([2-M54&<FM'(SP:Y_70#J.E\ ;IS@GUVF@TA%-V9D:K
MXIM=6L[BP@AF\YUVA2.],TOQ';:/;I87D$WGKU&,U0TITDU^*#R=ICN'8S$?
M?YZ4GB"58=;NHC"KO+Y>)?\ GG4:GH.,5'E.WTK6(-3\WRD=#$0&##%:> .!
MTKFO#@QJFI@<X9<UT@.3CO31YU96EH+12!AZTOI[U1%K!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%% YI##%/44@%2#% "=L4UF"CYNM*2!G
M.>E<=XG\0R&X&D:2?,OI."5_Y9COF@J$>9E7Q%K,^KW_ /8.E',C',\O91]:
MZG0]%@T>P2WA4 X^<XY8U1\,^'H]'M2SC?<R_--(W.3728XX]*9I4FDN5"*"
M.M.'6DYH&<T& ZBBB@ HHHH **** "BBB@#.O_\ 7K_N_P!311?_ .O7_=_J
M:* +5G_QZI^/\ZGJ"S_X]4_'^=3T %%%% !1110 4444 %(>E+2'I0 A (K
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M;?R<R2-V]A1X:\+QZ7F[N/WM]+S)(>>:Z95P #VH+G)15HC@,"GBFD<4X4S
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M.:!8979"&'1?45;7PK<M:I9M=VXBC)*L!R<UU#>%M(:3S/LH#=PC$ _E2?\
M"*:3_% WK_K#2L.6*N<Y;Z?/;>)=/FGFA9G)11&.P'>N\'0>]9=KX>TRTN5N
M(;<B1?NDL3BM0=!CKWIHY*L^86BBBF8A1110 4444 %%%% !1110 4444 %'
M>BG!:0( M. Q2@4G0XI[C%S4<LJQH2Q  ZDFJ]]J-OIT#37$JH@'4FN%GO\
M5O&5R;>P#0:7G#RD8+?2D:0IN2NRUK7B.[U6\.EZ$N]P=LLX^ZM;OAWPS;Z-
M%O/[RY;[\K=2:M:-H5EHELL5M& ?XG(Y8UKCK3L.51)<J *<8SBE"XI12TK&
M(F*6BBF 4444 %%%% !1110 4444 %%%% &=?_Z]?]W^IHHO_P#7K_N_U-%
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ML)QCI0!BG8HQ3,; *6CI104%%%% !1110 4444 %%%% !1110 4444 9U_\
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MQF[NSP G(6LZT\,ZIX@E^U:[<,L1.1;*<#\:Z;1_#>GZ1&/L]N _=R/F-;0
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M2*,32/#.G:.@$$ W'JYZFMI44#@8IV*".*$C"4I,4"EI!TI:8@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH SK_\ UZ_[O]311?\
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M6F1*HV1B/':E"$9I]%!F-P: #3J* $Q1BEHH !THHHH **** "BBB@ HHHH
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C1110 4444 %%%% !1110 4444 %%%% !1110 JT444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image_011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (D \\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-<[I/Q>\&:JJC^U19RMP8[M#&0?K]W]:[6">&Z@2>WECEA<962-@RL/4$=:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCK5YJRZA]MM@DDCJ1(TN06)'0+Q@#TQ7;W]G%J.G7-E-GRKB)HGQUPP(/\Z
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@N(EECW#!VD9&15F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH#)G>0I8J,[CT'<UT&H:'I6JR))J&G6MTZ#:K31!B!Z#-4_^$.\-?] +3_\
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M7^T#\^%V@-\_(V\8/&*U_P#A#O#7_0"T_P#\!U_PH_X0[PU_T M/_P# =?\
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M/!FID]!&/_0A6A_;VC_]!:P_\"4_QH T**S_ .WM'_Z"UC_X$I_C1_;VC_\
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M_OX* ,;PA_QX:A_V$[K_ -&&NAKF/"=W;1V-^'N(5)U*Y(RXY'F&M_[=9_\
M/W!_W\% %BBJ_P!NL_\ GZ@_[^"C[=:?\_4'_?P4 6**@^W6G_/U!_W\%'VZ
MT_Y^H?\ OX* )Z*@^VVG_/U#_P!_!1]MM/\ GZA_[^"@">BH/MMK_P _,/\
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M4?VB'_GM'_WT*//A_P">L?\ WT* )*Y_1_\ D;O$G^];?^BJW//A_P">L?\
MWT*PM%96\6>(RI!&ZVY!_P"F5 '0T444 %%%% !1110 4444 %%%% !1110
MR6*.>)HI8UDC889'&01[BJ7]A:/_ - JQ_\  =/\*T** ,_^PM'_ .@58_\
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MZ UA_P" Z_X5JT4 97_",:#_ - :P_\  =?\*3_A&-!_Z UA_P" Z_X5K44
M9/\ PC&@_P#0&L/_  '7_"C_ (1?0?\ H#6'_@.O^%:U% &3_P (OH/_ $!K
M#_P'7_"C_A%] _Z UA_X#K_A6M10!D_\(OH'_0&L/_ =?\*/^$6T#_H#6'_@
M.O\ A6M10!QOB3P]HUN='\G2K./S-3AC?;"HW*=V0>.E;?\ PBV@?] :P_\
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M"6/_ 'Y%;=% &)_PAWAO_H"6/_?D4G_"'>&_^@)8_P#?D5N44 8?_"'>&_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM$;F-<+Y.X =20JL2#CIC)ST%=A!*L]O%,@8+(@8!A@X(SS0'UJ/_/J/W/\
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M_1RUT- %<:?9"/RQ:6X3=NV^6,9]<8ZTD%A;6[2M'$-TLGFNS'<2V, \],
M =@*LT4 0M:6SIL:WB9< ;2@(X.1^M.6"%,;8D&#D84#!QC^7%244 0?8;3=
MN^RP;M_F9\L9W?WOK[T?8[7>'^S0[QG#>6,\\G^9_.IZ* (7M+:1=KV\3+QP
MR CCI^5+';012-)'#&CL &95 ) Z9-2T4 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!GZSI8U:SCMS,8MD\4VX+G.QPV/Q
MQBM"BB@ HHHH **JV>H6]_YGD&0^6=K;XF3G_@0&:M4#<7%V84444""BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)- '245S,/B"Z$ML]TUO'!<+&XV*S&/(Z'Z]O0<_7IJ "BBB@ HHHH ****
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M95@2X>V\N+R0Z#?()A&P;G>>.AP!Q\QI;GPK?S7%_*MS:,MRABV-%@;-X;G
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M3_\ @)-_\31_PFV@_P#/U/\ ^ DW_P 37044 <__ ,)MH/\ S]3_ /@)-_\
M$T?\)MH/_/U/_P" DW_Q-=!10!SK>-_#P(5KN0%NBFUERWX;>:7_ (330,8^
MTS8_Z\YO_B:76/\ D;/#?^_<?^BC704 <_\ \)MH/_/U/_X"3?\ Q-'_  FV
M@_\ /U/_ . DW_Q-=!10!S__  FV@_\ /U/_ . DW_Q-'_";:#_S]3_^ DW_
M ,37044 <_\ \)MH/_/U/_X"3?\ Q-1MXO\ #C2K*TLAD485S92Y ]CLKI**
M .9B\7^%Q'MAE.P9&$LI,#/4<)^=2)XS\/QH$2>5548"K9R@ ?\ ?%.\'G.E
M7?\ V$+K_P!&M704 <__ ,)MH/\ S]3_ /@)-_\ $T?\)MH/_/U/_P" DW_Q
M-=!10!S_ /PFV@_\_4__ ("3?_$T?\)MH/\ S]3_ /@)-_\ $UT%% '/_P#"
M;:#_ ,_4_P#X"3?_ !--/CCP^'"&\E#$9"_99<D?3;715S]]QXZT<^MI<C]8
MS0 ?\)MH/_/U/_X"3?\ Q-'_  FV@_\ /U/_ . DW_Q-=!10!S__  FV@_\
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M_B:Z"B@#G_\ A-M!_P"?J?\ \!)O_B:/^$VT'_GZG_\  2;_ .)KH** .?\
M^$VT'_GZG_\  2;_ .)H_P"$VT'_ )^I_P#P$F_^)KH** .%UKQ7H]QJVA2Q
M7$I2"[9Y";:08'E..A7GDCI6U_PFV@_\_4__ ("3?_$T>(3_ ,3OPW_U_/\
M^B9*Z"@#G_\ A-M!_P"?J?\ \!)O_B:/^$VT'_GZG_\  2;_ .)KH** .?\
M^$VT'_GZG_\  2;_ .)H_P"$VT'_ )^I_P#P$F_^)KH** .?_P"$VT'_ )^I
M_P#P$F_^)I#XWT!5+-=S #DDVDH _P#':Z&LWQ#_ ,BSJO\ UYS?^@&@"@/&
M^@, 1=S$'D$6DO/_ ([2_P#";:#_ ,_4_P#X"3?_ !-:6B_\@+3_ /KVC_\
M015Z@#G_ /A-M!_Y^I__  $F_P#B:/\ A-M!_P"?J?\ \!)O_B:Z"B@#G_\
MA-M!_P"?J?\ \!)O_B:/^$VT'_GZG_\  2;_ .)KH** .=7QQX?;.V\E;!P<
M6LIP?0_+3O\ A-M!_P"?J?\ \!)O_B:/#'_'QK__ &%)/_0$KH* .?\ ^$VT
M'_GZG_\  2;_ .)H_P"$VT'_ )^I_P#P$F_^)KH** .?_P"$VT'_ )^I_P#P
M$F_^)H_X3;0?^?J?_P !)O\ XFN@HH Y_P#X3;0?^?J?_P !)O\ XFC_ (3;
M0?\ GZG_ / 2;_XFN@HH YQ?'7A]W=1=390X/^BR_P#Q-/\ ^$VT'_GZG_\
M 2;_ .)HT3_D9_$G_7>#_P!$K704 <__ ,)MH/\ S]3_ /@)-_\ $T?\)MH/
M_/U/_P" DW_Q-=!10!S_ /PFV@_\_4__ ("3?_$T?\)MH/\ S]3_ /@)-_\
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MH2FI\MG;:_2Y]745\H_;KS_G[G_[^'_&C[=>?\_<_P#W\/\ C5<IZG^K$O\
MG[^'_!/H[6/^1L\-_P"_<?\ HHUT%?)YO+HL&-S,67H3(<BG?;KS_G[G_P"_
MA_QHY0_U8E_S]_#_ ()]745\H_;KS_G[G_[^'_&C[=>?\_<__?P_XT<H?ZL2
M_P"?OX?\$^KJ*\*^$]U<3>-0LL\KK]FD.&<D=J[/XPRR0^%+5HI'C;[:HRC$
M'[C^E3;6QY-;*G2QL<)S?%;6W>_3Y'H5%?*/VZ\_Y^Y_^_A_QH^W7G_/W/\
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M@'9?]^Z/^$'\+_\ 0#LO^_= K8?^:7W+_,W/M$/_ #VC_P"^A1]HA_Y[1_\
M?0K#_P"$'\+_ /0#LO\ OW6;?:#X3L=5L;!_#<#O=DA72$%4QZ^E!4*=";M%
MR^Y?YG7K+&YPDBL?0'-/KC;;1M-T;XAV2:;90VJR:=.7$2XW$/'C-=E095J<
M8-<KNFKZ_/\ R(;F[MK.,275Q% A. TKA03Z9-5?[>T?_H+6/_@0G^-8_C"W
MANKOP[!<0QS1/J:AHY%#*P\J3J#UK4_X1G0/^@'IO_@)'_A3-%3HQIQE-N[O
MM;H[=23^WM'_ .@M8_\ @0G^-']O:/\ ]!:Q_P# A/\ &H_^$9T#_H!Z;_X"
M1_X4?\(SH'_0#TW_ ,!(_P#"C07^S?WO_)23^WM'_P"@M8_^!"?XU@Z_K&EO
MJF@.FI6;".^)8B=3M!C<9/-;7_",Z!_T ]-_\!(_\*/^$:T'_H":;_X"1_X4
M:!_LW][_ ,E)/[>T?_H+6/\ X$)_C1_;VC_]!:Q_\"$_QJ/_ (1G0/\ H!Z;
M_P" D?\ A1_PC.@?] /3?_ 2/_"C0/\ 9O[W_DI)_;VC_P#06L?_  (3_&C^
MWM'_ .@M8_\ @0G^-1_\(SH'_0#TW_P$C_PH_P"$9T#_ * >F_\ @)'_ (4:
M!_LW][_R4L0ZOIMS*L4&HVDLC?=1)E8GZ &K32QH<.ZJ?<XKD=7TG3=/\2>&
M9++3[2V=KQPS0PJA(\E^"0*34])T_6/B-'!J-I%<Q)I)=4E7(#>=C/ZT&OU>
MD[23?+RM]+Z.WH=;]HA_Y[1_]]"C[1#_ ,]H_P#OH5A_\(/X7_Z =E_W[H_X
M0?PO_P! .R_[]TC*V&_FE]R_S-S[1#_SVC_[Z%'VB'_GM'_WT*P_^$'\+_\
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M?B*7489)GBO$1,3R(%7RD.,*P'4F@SHTHS4I3=DO*_6W='<45S7_  @/AO\
MY\)?_ N;_P"+H_X0'PW_ ,^$O_@7-_\ %T]"N3#_ ,[_ / 5_P#)$OB ?\3O
MPW_U_/\ ^B9*Z"N:/@#PR2"=/<D=,W4QQ_X]1_P@/AO_ )\)?_ N;_XN@7+A
M_P"=_P#@/_VQTM%<U_P@/AO_ )\)?_ N;_XNH+?P=X1NI)8[>#S7A;;(J7LQ
M*GT/ST%*GAVKJ4O_  '_ .V.LHKF_ 3,_@C3"S,QV-RQR?OM6:NA:?KOC?Q
M-2BDF$"VOE 3N@7<AS]UAZ"BP_JT54J0G+2%^GG;:Z.VK-\0_P#(LZK_ -><
MW_H!K,_X0'PW_P ^$O\ X%S?_%T'P!X:8$'3Y"#P0;J8@_\ C]&A/)A_YW_X
M"O\ Y(U]%_Y 6G_]>T?_ *"*O5S0\ >&@ !82 #H!=S?_%T?\(#X;_Y\)?\
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ME",%.$KIMK56VMYON%%<'X?\+Z1K4>IW>H6\LT_]I7*;OM,B\"0@# 8"M?\
MX0'PW_SX2_\ @7-_\70:5*-"G)PE-W7]WT_O>9TM%<U_P@/AO_GPE_\  N;_
M .+H_P"$!\-_\^$O_@7-_P#%T:$<F'_G?_@*_P#DB71ACQ3XD_ZZP'_R$*Z"
MN9'P_P##()(TYP3U(NILGZ_/2_\ " ^&_P#GPE_\"YO_ (NC0.3#_P [_P#
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M ]G0_P"?C_\  7_F=/17-_\ "%6'_00UG_P92_XT?\(58?\ 00UG_P &4O\
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MTEFD=2#(\AW EBQ88Q@[CG\!Z5<@T6SM[Q+N)66<-(S.#@OO.6#>HS@CTP*
M,S5/^1^\/?\ 7M=_RCI-8_Y'KPU_USO/_04I=4_Y'[P]_P!>UW_*.DUC_D>O
M#7_7.\_]!2F>I#>'^"7_ +<='(Q2)V R0":Y5/$ES_PC_P!L2ZM)KR;RTAC>
M%H8UD89P2S<C /(]*ZM@&4J1D$8(JLVFV;I;H]M&Z6PQ"K#(3C' /MQ2/+,B
M+7YI[VTFQY6F7,<;13"$R*Y<?=+@X0YP.1@^M3>']=.LM=AC#E&$D/E-G,+9
MV%N>&^5L_A5@^']+)'^B*%&<(&8*,Y/W<X[GMQ5FWTVRM9A+;VL43B/R@47'
MR^G'TH Q/'__ ")&I?2/_P!&+72US7C_ /Y$C4OI'_Z,6NEI]#JE_NT?\4OR
MB<WX+_Y!^I?]A6[_ /1AK=OKI;&PN;ME++!$TI4=2%!./TK"\%_\@_4O^PK=
M_P#HPUOW-O'=VLUM*"8YD:-P#C((P:08S^/+^NB,K4?$46G;B]M-(%CAD;R\
M$[9'*].^,$FG2:\#<Q16UJ;A9)C$KK( #^Y$H(]00<4L.@JKB2>\GN)08MKN
M%!"QL65> .Y.3UIEMX:M[*XBDMKB:...Z>Z$7RE0639M&1D*!G '3/I0<HK>
M([?[*UQ'#)(@LUNL#&<L<)'_ +Q((_"E77&N1;BQLGN)9(%G=2X01J20 2?X
ML@C'L:8/#%D(IHO-N/+ENA<L!)M(P<J@(P0H;D ?G48\-O9M&VEW\]LV\JY;
M$F8F8L5^8'D,6()Z;CUH GDUTH\DGV*0V44ODR7&\?*V=I^7J0"<$_6MBLAM
M!1F9#=W'V5Y!-);G;M=\@DYQD D9(!ZY]:UZ .:F_P"2E6G_ &"9?_1J4:Q_
MR//AG_<O/_0$HF_Y*5:?]@F7_P!&I1K'_(\^&?\ <O/_ $!*9ZD?CC_U[?Y2
M.EI#R" <'UI:0@$$'H:1Y9Q0UW4_LEKF])NFM7E2-+7=]HD$A 4@?=' ';KF
MK[ZI>:?<:S<7E[OM[*)'2$QJOS.,@%A[X%;]K86EBB):VT4*HNU0B@8&<X^F
M232M9VSNSO!&S,RLQ*C)*_=)^G:@#E[?Q+>M;Z?*'M[D1&9-1\E<[O+V@O'_
M -]!L=QGO6_HEZ^HZ/;W;NCF4%@R?=89."/PQ5H6MNLYG6&,3-R7"C)X Z_0
M ?@*=!;PVL"06\210H,*B* JCV H DKF[K_DHVF_]@V?_P!#CKI*YNZ_Y*-I
MO_8-G_\ 0XZ#JPV\O\,OR.DKFM'_ .1Z\2_]<[/_ -!>NEKFM'_Y'KQ+_P!<
M[/\ ]!>F%#X*G^'_ -NB=+45R&:UF"+N<HP5<XR<=*YS4KC4!XG@N(;6\:TL
MV2%RF/+82??)&<MM'ED$ XPWO65:KJEA#*T=E.D\]LZ1>6[N9I&EP&;=@(5'
M/N">>*1RF_8:=>1KH;2Q*AM+%X9EW@[6(C  QU^Z:H'P[J;:7;1R302W'D1V
MK(4VHD60S@X.7)VA>W4\5503K;06NI07@MK1)84\_>VYP5,32&,G=\AQG)&0
M>].6>]EM;FW>&ZANKPVK01JLA"J-@;YCT VDG.#Z]: +EA8ZKI+K/+:P77EP
MM; )*$V('+*1NZ#:P!YS\@ZUT\;%XD8A02H/RG(_ ]ZX2[EO9;37'N[.^%OJ
M-K,T8=20K)Q&%522NY<'D#D5;NX]0M[J[FMA<R6=Q<V\1C7=^Z 6+$BC^[]X
M,!]>QH [*N:D_P"2F0?]@>3_ -')3-$N+\Z]<37-K>);WX=T,N-B;#A  "2N
MY,$Y Y!I\G_)3(/^P/)_Z.2FCJPWV_\ #+] \7?\?'AS_L,1?^@25TM<UXN_
MX^/#G_88B_\ 0)*Z6@*O\&G_ -O?^E&=>7]S!J=M9001/Y\4KAWD*X*;>,!3
MP=W6LVW\0:A<6EG*+*T1[KS&4/=,%54ZY.SKGVK8EL(YM3MKYI)1);HZ*@(V
MD-C.1CV%5AX?T[R;2&2 31VN_P M9@''S=20>M(Y2K!XGAEGME:VD2":T%PT
MN<[&*EQ&1Z[58_A[U=L+Z[N;7[7/:1PP/%YL8$VY\$9 8;0 <>A-0R>&M,EO
M&NWA8W!F6;S-QR"   !TV[1C'H34]GI,=DI1+FZ>$)Y:12296-?0<9]N2: ,
MN'Q-<226]N]E";JZB26W6.<E<-D_.=HVX )Z'/:G7/B.>VD^SRV]K%<([+)Y
MUULCP$# JVWG(/<#&#5Y?#^G16$=I;PBW$95DDA 1PRC ;(')QGKZFFGP[I\
M@_TE'NF8N9&G.XR%E"G/'H !C&* *H\0W/GHSV<:6ALOMS.TI\Q4P,C;MQN_
M&KEKJ=TUY!;WMHD!N8VDB*2[^F,JW P<'MD=:E72+8,K2&28BV^RGS6W;T[Y
M]3[TEGI$-G.LQGN)WC0QQ>?)N\M3C(''L.3D\=: -"N:\(_\?'B/_L,2_P#H
M$==+7->$?^/CQ'_V&)?_ $".F=5+^#4_[=_]*.EKG]6_Y'#PY]+K_P! %=!7
M/ZM_R.'ASZ77_H I'*=!1110 4444 >.:G\(=8OM5O+M-0L52>=Y5#%\@,Q/
M/R^]5?\ A2^M_P#01T_\W_\ B:]MHI\S/<CGV-BDDUIY(\2_X4OK?_01T_\
M-_\ XFC_ (4OK?\ T$=/_-__ (FO;:*?,RO]8,=_,ON1XE_PI?6_^@CI_P";
M_P#Q-'_"E];_ .@CI_YO_P#$U[;11S,/]8,=_,ON1XE_PI?6_P#H(Z?^;_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KG]6_Y'#PY]+K_ - %=!7/ZM_R.'ASZ77_ * * .@HHHH
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MXN_Z".C_ /@))_\ %T =#17/?9_%W_01T?\ \!)/_BZ/L_B[_H(Z/_X"2?\
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M&BN>^S^+O^@CH_\ X"2?_%T?9_%W_01T?_P$D_\ BZ .AHKGOL_B[_H(Z/\
M^ DG_P 71]G\7?\ 01T?_P !)/\ XN@#H:*Y"YN_%=KJUAIYO-)9KP2%7%K)
MA=@!.1O[YJ]]G\7?]!'1_P#P$D_^+H Z&BN>^S^+O^@CH_\ X"2?_%T?9_%W
M_01T?_P$D_\ BZ .AHKGOL_B[_H(Z/\ ^ DG_P 71]G\7?\ 01T?_P !)/\
MXN@#H:*Y[[/XN_Z".C_^ DG_ ,71]G\7?]!'1_\ P$D_^+H Z&BN>^S^+O\
MH(Z/_P" DG_Q=48[OQ7)K=QI8O-)#PP).7^RR8(8L,8W_P"S^M '7T5SWV?Q
M=_T$='_\!)/_ (NC[/XN_P"@CH__ ("2?_%T =#17/?9_%W_ $$='_\  23_
M .+H^S^+O^@CH_\ X"2?_%T =#17/?9_%W_01T?_ ,!)/_BZ/L_B[_H(Z/\
M^ DG_P 70!T-%<]]G\7?]!'1_P#P$D_^+JC:W?BNZU6_L!>:2K68C+.;63#;
MP2,#?VQ0!U]%<]]G\7?]!'1__ 23_P"+H^S^+O\ H(Z/_P" DG_Q= '0T5SW
MV?Q=_P!!'1__  $D_P#BZ/L_B[_H(Z/_ . DG_Q= '0T5SWV?Q=_T$='_P#
M23_XNC[/XN_Z".C_ /@))_\ %T =#17/?9_%W_01T?\ \!)/_BZ/L_B[_H(Z
M/_X"2?\ Q= '0T5SWV?Q=_T$='_\!)/_ (NJ.D7?BO5[ 7<=YI,:F22/:UK(
M3\CE<_?[XS0!U]%<]]G\7?\ 01T?_P !)/\ XNC[/XN_Z".C_P#@))_\70!T
M-%<]]G\7?]!'1_\ P$D_^+H^S^+O^@CH_P#X"2?_ != '0T5SWV?Q=_T$='_
M / 23_XNC[/XN_Z".C_^ DG_ ,70!T-%<]]G\7?]!'1__ 23_P"+H^S^+O\
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M1]G\7?\ 01T?_P !)/\ XN@#H:*Y[[/XN_Z".C_^ DG_ ,71]G\7?]!'1_\
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MT>4+N&1DJ#4'_":Z=_SY:O\ ^"Z;_P")H-EA:[2:B]?Z[G245S?_  FNG?\
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M],_X373O^?+5_P#P73?_ !-9/AOQ+;:9I'V:YL=6$GGS28&GRGAI&8?P^A%
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M8K]Z:V3R[A!ZF/H__ <'VK>T[4K/5K&.\L9UF@?HR]CW!'8CT-6JY81)I/Q
MBCM!MAU6VDEN85^Z)(RN),=B0V#ZX%,M<M=/2TDF]-G;>ZZ/S7W$NG_\E UO
M_KSM?YR5OFY@"!S/&%.<,7&#C.?RP?RK T__ )*!K?\ UYVO\Y*JMI.H26L=
ME]C(%LUVXE+KLD\Q9 H49SGY^<@8P:1.)^*/^&/Y'3RWMK!'YDUS#&F VYY
M!@G .3VH-Y:K<_9VN81/C/E&0;L>N.M<?<>']2MH9[6&U^T6B6L4=LH==R_O
M%9HSN(X7!P?0@=JO26&I1S20P6A!DNI)9+@>65EC<DX)/S!@#M&/0<XH.4Z&
M&_L[B&2:&[@DBC&7=) 57OR0>*E\Z+?L\U-VW?C<,[?7Z>]<:- U<6S6DD5O
M.+B&WAD8XCC$29+QL 223TR,Y#=L&G#0]7\J.X,40U"SM#;PL)/DF 9OD)ZX
M9-O)Z$ ]J .K%_9M.(%NX#,1N$8D&[&,YQG.,<TTZG8"".<WUL(I"0DAE7:Q
M'H<\US=OH>HQ3VLLB(8(YX'>%57?\L"IN#YZ!ARN.0#@^JZ7I]W8P023Z.9\
MVQA\G=&3$?,=N<G&&##.#_#S0!9\:G_B2VO_ &$+7_T<M=)7'Z_:RV7@_2K6
M9@TL5W9HQ!R,B5>![5V%!U5/X$/67Z'->$?]=XB_[#$W_H"5TM<UX1_UWB+_
M +#$W_H"5TM-AB_XS^7Y1();ZTA=TENH(WC3>ZO( 57.,GT'O43:KIR0I,U_
M:K$Y(5S,H5B.N#GFL37-.O;K4+Y[>T=@]I"B2KL^9EF+$ ,>N#GGBJ*:7JD5
MX+D6]WL,LK$A+<RG<L8Y4G:!E#TYXYZTCE.O2\MI+@VZ7$+3 ;C&K@L!ZXZX
MJE#<:JVOSP2VL:Z:L8,4X;YF;N,9_P XJE96=W;Z\TEO#<16DK.\XG,;(21P
M4(RP)/4'CK[5T%!<9)7TO<YSQ'_R'O#'_7\__HEZZ.N<\1_\A[PQ_P!?S_\
MHEZZ.@WK?PJ?H_\ TIG->$?]?XC_ .PQ+_Z!'71R2)%&TDCJB*,LS'  ]S7.
M>$?^/CQ'_P!AB7_T".MC5[9;S2YH&BEE!VD+"P5\@@@@MQD$9Y]*;#%_QG\O
M_28CFU73D6-FO[55E&8R9E ?G''//-..H62F8&\MP8?]:#*O[O\ WN>/QKF8
M[+5TO[:YFBNF58W3*);E]OF J'!( .,\K_.EDTBY\V6)+6_%D',H3?#O63S
MRM$V>1]XD/ZBD<IU*7,$@B*3QL)?]65<'?WX]:HWYU<:I8BQ6 V6X_:BY^8#
MMMKGY--\03S6EV]O"\ECAH/,=4=LN2W"C:&,>%/09)[5V=!<)<KO:_J<YXD_
MY#OAC_K_ &_]$O71US?B3_D.^&/^O]__ $2]=)0;UOX5/T?_ *4PK*\3?\BI
MK'_7C/\ ^@&M6LKQ-_R*FL?]>,__ * :#.A_%AZK\T2Z#_R+VF?]>D7_ * *
M?%J^G37;6L=Y"TZEE,8;G(ZC\*9H/_(O:9_UZ1?^@"LM=/U&416DEK''##>O
M<_:#*#N!=F 4#D$[@#GMF@FK_$EZO\V:UMK&G7@S;WD4@W!05;J3G 'KG!I[
MZI81WPL7NXENCC$1;GGI^=<]:Z?K$&EVL36TLTMK+"X26Y0A@H((4@#'XU-+
MI.IW6H_;G(BB>>WEDL]ZD'8.3NQG(.#Z';CO09FO!K6FW+;8;V%SN"\-W)P!
M^)J#4_[1O!;G1KN!!'<;;G?SE1]Y1P>:S;#2;_\ L2YTZ[2<-Y.(G>=&57'*
ME, $8.#SGH*WM.M?L6G6]O\ Q(@WG.=S=6)/J3D_C07"7)+FM]YB:3_R/OB/
M_KA9_P I*Z6N:TG_ )'WQ'_UPL_Y25TM-F^*^-?X8_\ I*"N:\(??\0?]AB?
M^25TM<UX0^_XA_[#,_\ )* I?P:G_;OYLZ1G5%+.P51U). *:LL;KN1U9<9R
M#D5GZ]:RWFE^3#%'(YFA.V1=R8$BD[AW& :Q[^QN[;[5&EB)/M6G&U3['&%C
M63<_4$_*/G'/L:1RG5;E]1UQUIGGQ!-_FILSC=N&,UR1TG4;6]::"!GBN-0A
M^T1[N@0QXE7\%(([C![4RPL3;K!+=Z-+-:#[0JV_D*3&[3,V[9_M*1SVQVS0
M!U%SJEE:7MM9SSA+BY)$*$'Y\5C:Q_R//AG_ *YWG_H"5M_8[6X:VN);.,2Q
M &/>@+1<=!Z?A6)K'_(\^&?^N=Y_Z E-';AN7F]W?EE?[GL=+1112.(****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** .6GGAM_B6C32QQ*='(!=@H)\
MX>M;_P#:=A_S_6W_ ']7_&HK_0]*U259-0TZUNG0;5::)7('H,BJG_"(>&_^
M@#IO_@,G^%,[)3H34>:]TDM+=+]_4T/[3L/^?ZV_[^K_ (T?VG8?\_UM_P!_
M5_QK/_X1#PW_ - '3?\ P&3_  H_X1#PW_T =-_\!D_PI$VPW>7W1_S-#^T[
M#_G^MO\ OZO^-']IV'_/];?]_5_QK/\ ^$0\-_\ 0!TW_P !D_PH_P"$0\-_
M] '3?_ 9/\* MAN\ONC_ )FA_:=A_P _UM_W]7_&L#7KNVN->\,K#<12D7S$
MA'!(_<OZ5?\ ^$0\-_\ 0!TW_P !D_PJ:U\-:'97*7-KI%C!.ARDD<"JR_0@
M4%TYX>F^:/->S[=4UW\S4KDO U]:0^$K:.6Z@1Q-/E6D (_?/VKK:QG\)>'7
M=G?0].9F.23;)DG\J#.E4IJG*G4OJT]+=+]_4O\ ]IV'_/\ 6W_?U?\ &C^T
M[#_G^MO^_J_XUG_\(AX;_P"@#IO_ (#)_A1_PB'AO_H Z;_X#)_A0.V&[R^Z
M/^9H?VG8?\_UM_W]7_&C^T[#_G^MO^_J_P"-9_\ PB'AO_H Z;_X#)_A1_PB
M'AO_ * .F_\ @,G^% 6PW>7W1_S*6D313^/-=>&1)$^RVHW(P(_Y:>E=/5+3
M]'TS2C(=/L+:U,F-_D1!-V.F<?4U=H(KU(SG>.R26ODK'*Z9=6]OXY\2^?/%
M%N2TQO<+GY&]:Z#^T[#_ )_K;_OZO^-5[SP]HNHW)N+W2K*XG8 &26!68@=.
M2*K_ /"(>&_^@#IO_@,G^%,VG.A4LY<R=DNG16-#^T[#_G^MO^_J_P"-']IV
M'_/];?\ ?U?\:S_^$0\-_P#0!TW_ ,!D_P */^$0\-_] '3?_ 9/\*1%L-WE
M]T?\S0_M.P_Y_K;_ +^K_C1_:=A_S_6W_?U?\:S_ /A$/#?_ $ =-_\  9/\
M*/\ A$/#?_0!TW_P&3_"@+8;O+[H_P"9H?VG8?\ /];?]_5_QH_M.P_Y_K;_
M +^K_C6?_P (AX;_ .@#IO\ X#)_A1_PB'AO_H Z;_X#)_A0%L-WE]T?\S0_
MM.P_Y_K;_OZO^-8'VB&X^)-JT$T<H&DR@E&#8_>IZ5?_ .$0\-_] '3?_ 9/
M\*M6.@Z1I<QFL-,M+65EVEX850D>F0/84%QG0IJ7+S7::UMU-"L#6](O&OH=
M:T9T34H4\MXI#B.YBSG8Q['/(/8^U;]%!S4ZDJ<N9?\ #^1@Z=XLL+N<6=X'
MTW4>]I=_(Q/^R>CCW!K0UBP;4]*GLTD\MI0!O],$'^E27^F6.J6YM[^TAN8C
M_#*@;'T]*P_^$/%GSHVLZEIP[1"7SHA_P"3/Z&@WM0GJFXO[U]ZU^],?<>&)
M)S-%]N<6\LOFL9!YKDB,(!EN,#D_7%"^';QKM;F>^$C>9'(\6WY&98PA;IG=
MGD<X]J;]F\96W$>HZ1>KZW%L\3?^.L1^E'V[QA%P^B:;-[Q7S*/_ !Y*8OJU
M_AG%_.WYI$5CX:O[-K:4W$3R6T<:HLCM(KE0PZD9488X S@U;.C7R3O>1R6W
MVF7S1(A#!%#A!QCDD>6.O7)Z5#_:_BKI_P (M!GU_M)<?^@T?;O&$O":+ID/
MO+?,P_)4HL'U6764?_ D20>&Y8+V&;[87BBFC<0L,*=L0CW>N[C/7'MWKH:Y
MK[+XRN>)=3TFR7UM[9Y6_P#'V _2D_X0Y+SG6=7U+4AWB>7RHC_P!,?KF@/8
MTX_'47RN_P#)?B3ZAXML;>X-EIZOJFH]!:VGS;3_ +;?=0?4T[0](NH;N?5]
M7D275+E FV/[EO&#D1IZ\\D]S6I8Z=9:9;BWL;6&VB'\$2!1^E6:0I581BX4
ME:^[>[_1+R7S9RUK<P6_C_6C//'$#9VN-[A<\R>M;_\ :=A_S_6W_?U?\:@O
M?#^CZE<?:+[2[.YFP%\R:%6; [9(JM_PB'AO_H Z;_X#)_A0:3G0J6<N:Z27
M3HK&A_:=A_S_ %M_W]7_ !H_M.P_Y_K;_OZO^-9__"(>&_\ H Z;_P" R?X4
M?\(AX;_Z .F_^ R?X4$6PW>7W1_S-#^T[#_G^MO^_J_XT?VG8?\ /];?]_5_
MQK/_ .$0\-_] '3?_ 9/\*/^$0\-_P#0!TW_ ,!D_P * MAN\ONC_F:']IV'
M_/\ 6W_?U?\ &C^T[#_G^MO^_J_XUG_\(AX;_P"@#IO_ (#)_A1_PB'AO_H
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M_P S0_M.P_Y_K;_OZO\ C1_:=A_S_6W_ ']7_&L__A$/#?\ T =-_P# 9/\
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MO+[H_P"9H?VG8?\ /];?]_5_QH_M.P_Y_K;_ +^K_C6?_P (AX;_ .@#IO\
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M &MU:E !1110 4444 %%%% !1110 4444 %%9QURP'FA9)':.01%4B8EF()
M48YX!Z>AIG_"0::1N$SE-N[S!&VW.W=MSC[VWG'6@#4HJI9:C:Z@NZV<N-H8
MG:1C/8^_'2I!?6C!2+J AVV*1(.6]![^U $]%5)M4L+=&>6[A55=4;YQPS'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1114GSH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;:'.S/\ M$X)^@KT^**.")8HD6.-!A448 'H!3;70]_'X_"T^6&&7-RJRO\
M#'S2ZM]V<@GPR\/)8/%Y<[W;#/VUY6,H?LP.<=:\J\0:GJ>G>+K*;4D(U336
M1)9ATN%1LJ_XKQ7T/61J_A?1=>E274]/BN)$&U7)*L!Z9!'%"9RX'-G2J-XF
M\T[^JOIIY/JO1FG!,EQ;QSQG,<BAU/J",BI*AM+6&QM(;6W39#"@2-<DX4<
M9-35)X<K7=M@HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
>4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image_012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %^ Z\# 2(  A$! Q$!_\0
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M^Y^IH^QP?W/U-3T4 0?8X/[GZFC['!_<_4U/10!!]C@_N?J:/L<']S]34]%
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M#['!_<_4T?8X/[GZFIZ* (/L<']S]34%W!'#$&C7:=V,Y-7JJW_^H7_>_H:
M'V?_ !ZI^/\ .IZ@L_\ CU3\?YU/0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDA<0(K)Y<87J?:O(;VRL-8\*Z[?+;)%+IUQY<!08.S/0_G7:_LW?\?VL<?\
M+)/YT ?0:DD"G4U/NBG4 %%%% !56_\ ]0O^]_0U:JK?_P"H7_>_H: 'V?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !_:S_US3^=>"]Z]Z_9N_P"/[6?^N:?SH ^@T^Z*=34^Z*=0 4444 %5;_\
MU"_[W]#5JJM__J%_WOZ&@!]G_P >J?C_ #J>H+/_ (]4_'^=3T %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!;JL;-SMP.WXT^8Z/:M,ZF(?OHR ,%@:]7MO]1'_ +@KQK0Y99=+TZ24_.4
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3- "T4@.>U+0 444<T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 44F:,T +11FC- !11FDS0 M%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XWQ_XY3P+IUO
M>26WGK-)Y> 2,'&:\]'[15IWTP _5JM_M%8/A?3L]KK^AKQ+PK#X;:7&O"XF
M\UA&D<!P4S_$?7Z4 >Q?\-%VO_0+'YM1_P -%6G_ $#!^;5Y'<>%(HO'!TA9
M2;)95#39Z(?ZUKW7@O3K34M;N&=SIFFLJA=^'8G'^- 'HW_#1=IC_D&?JU>H
M>"_$R^+O#4.KI&(Q(S+M&>WUKY#\4:/%I%_$+61GM;B$31$GD ]C7TQ\#_\
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M0W??]?$G_H1H HT444 '>O>OV;O^/[6?^N:?SKP7O7O7[-W_ !_:S_US3^=
M'T&GW13J:GW13J "BBB@ JK?_P"H7_>_H:M55O\ _4+_ +W]#0 ^S_X]4_'^
M=3U!9_\ 'JGX_P ZGH **** "C-(<XX-<GXN^(&C>"I+=-6>8&?[NQ,B@#K<
MBC(]:\N_X7UX+[37/_?DT?\ "^_!G_/6Z_[\F@#U'(]:2O+_ /A??@S_ )ZW
M7_?DT?\ "^O!A_Y;7([_ .I- 'J(HK/T36+77=*AU&S+&"894L,&M"@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 0U\N?&77]7T_P"(MW!9ZC<P0B-"$CD(%?4?>ODOXX'_ (N9>_\ 7)*
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M0VPF$MPD3[C@J&..*W7MXXR648+>IKDOB#!/<^'[>.""6:07<;D1C.%##)H
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MO^/2+_<'\JM;'S.>;Q+ I:04M(^="@T4&@!*Y'XB_P#(K3?[PKKB:Y+XB_\
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MS0 _XF@MX:3_ *ZBO)BC,,%<CTQ7I>H?#B_U.W$%YXGNY$# XVUF?\*63/\
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M0_E7<_\ "F%)Y\0W9_"C_A2T?_0?NORI-'TZSBDNAPWEMZ'\J78<=_RKN/\
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M8*64$]!GDU)7E'C74YXM>BUNWN9?*TF94:%5)60'J30!ZMT[4 UQ>LZUJ/\
MPENA06,T)L;N-G8'JW3%:/BC7KO0/L,L%H)[>68).Q_Y9J?XJ .DHS7&77C7
MR7V1VX+32F.W;^\0.2:I?\)CKG]E23S:5';2Q!]_G'&_;Z"@#T"FL5498@ =
M2:X8>+]5OKS2K?3[&$F]MO/9I20%/<5M>)].U?5=$^SZ9-!#<MC=YH)7&.1Q
M0!MQ30SY,,L<@'=&S4H'^<UQOP_FMUL+FS6Q-G=VTICN(\Y4L/XE]C79CH*
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MM99DD-PSM%+&/+VD\X;W%=K+XNT6&[%L]V!+YPA*[3P_H?2GMXETE=1^QFX
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M]JJ#PUJ0TB^C%@PG?5Q<1XX.S)YS7K>!^/K1C/:@".W!\B/<"#M&0?6I:**
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MVGA72K.0O!;F-"V\QACLS["@#7@5$A1(Q\B@!?I4M(HP,"EH **** "BBB@
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M_P#ZA?\ >_H:M55O_P#4+_O?T- #[/\ X]4_'^=3U!9_\>J?C_.IZ "BBB@
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MAU1<<TO_  FUM<V<,UA"UQ,\)F,:]5 Z@^]4[+P?=:1+!<V=P'N/LWV:<,,
MCU%);^"I-&NK>[TRY_T@1-%*'3(8,22?KDT 9UWX@_MCQ#X;O=.NY5@EEVRP
MYP"><@_B*Z_7M;.BQ(4MGF9\XQP!CDY-8=KX#^Q7.F2V]W\MK.9Y R\LQSG^
M=:GB31+O6&M&M;Q8DB<M)$PR)01CF@#";QY=7.J>'8[.SW6NIEUE<@Y4KZ5W
MV>GO7#:=X)O+-=%W7Z&73+B23(3AE?M7= #'Z4 +1110 55O_P#4+_O?T-6J
MJW_^H7_>_H: 'V?_ !ZI^/\ .IZ@L_\ CU3\?YU/0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4C ,I! (/8TM% $:(D:A4557T48 I]+10 F!Z4M%%
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MC^T/^F7_ (]_]:@"[15+^T/^F7_CW_UJ/[0_Z9?^/?\ UJ +M%4O[0_Z9?\
MCW_UJ/[0_P"F7_CW_P!:@"[15+^T/^F7_CW_ -:C^T/^F7_CW_UJ +M%4O[0
M_P"F7_CW_P!:C^T/^F7_ (]_]:@"[15+^T/^F7_CW_UJ/[0_Z9?^/?\ UJ +
MM%4O[0_Z9?\ CW_UJ/[0_P"F7_CW_P!:@"[15+^T/^F7_CW_ -:C^T/^F7_C
MW_UJ +M%4O[0_P"F7_CW_P!:C^T/^F7_ (]_]:@"[15+^T/^F7_CW_UJ/[0_
MZ9?^/?\ UJ +M%4O[0_Z9?\ CW_UJ/[0_P"F7_CW_P!:@"[15+^T/^F7_CW_
M -:C^T/^F7_CW_UJ +M%4O[0_P"F7_CW_P!:C^T/^F7_ (]_]:@"[15+^T/^
MF7_CW_UJ/[0_Z9?^/?\ UJ +M%4O[0_Z9?\ CW_UJ/[0_P"F7_CW_P!:@"[1
M5+^T/^F7_CW_ -:C^T/^F7_CW_UJ +M%4O[0_P"F7_CW_P!:C^T/^F7_ (]_
M]:@"[15+^T/^F7_CW_UJ/[0_Z9?^/?\ UJ +M%4O[0_Z9?\ CW_UJ/[0_P"F
M7_CW_P!:@"[15+^T/^F7_CW_ -:C^T/^F7_CW_UJ +M%4O[0_P"F7_CW_P!:
MC^T/^F7_ (]_]:@"[15+^T/^F7_CW_UJ/[0_Z9?^/?\ UJ +M%4O[0_Z9?\
MCW_UJ/[0_P"F7_CW_P!:@"[15+^T/^F7_CW_ -:C^T/^F7_CW_UJ +M%4O[0
M_P"F7_CW_P!:C^T/^F7_ (]_]:@"[15+^T/^F7_CW_UJ/[0_Z9?^/?\ UJ +
MM%4O[0_Z9?\ CW_UJ/[0_P"F7_CW_P!:@"[15+^T/^F7_CW_ -:C^T/^F7_C
MW_UJ +M%4O[0_P"F7_CW_P!:C^T/^F7_ (]_]:@"[15+^T/^F7_CW_UJ/[0_
MZ9?^/?\ UJ +M%4O[0_Z9?\ CW_UJ/[0_P"F7_CW_P!:@"[15+^T/^F7_CW_
M -:C^T/^F7_CW_UJ +M%4O[0_P"F7_CW_P!:C^T/^F7_ (]_]:@"[15+^T/^
MF7_CW_UJ/[0_Z9?^/?\ UJ +M%4O[0_Z9?\ CW_UJ/[0_P"F7_CW_P!:@"[1
M5+^T/^F7_CW_ -:C^T/^F7_CW_UJ +M%4O[0_P"F7_CW_P!:C^T/^F7_ (]_
M]:@"[15+^T/^F7_CW_UJ/[0_Z9?^/?\ UJ +M%4O[0_Z9?\ CW_UJ/[0_P"F
M7_CW_P!:@"[15+^T/^F7_CW_ -:C^T/^F7_CW_UJ +M%4O[0_P"F7_CW_P!:
MC^T/^F7_ (]_]:@"[15+^T/^F7_CW_UJ/[0_Z9?^/?\ UJ +;*'!#=*C\A.H
M1<C@<=!4']H?],O_ ![_ .M1_:'_ $R_\>_^M0!.;>)@ 8T(!XRN:41*N H"
MXZ #I5?^T/\ IE_X]_\ 6H_M#_IE_P"/?_6H G6VA4DB) 3U.T9-*8(BFPQK
MMZD8XJO_ &A_TR_\>_\ K4?VA_TR_P#'O_K4 6!!&H(5$4'[P"]:#$A).Q02
M,'@<BJ_]H?\ 3+_Q[_ZU']H?],O_ ![_ .M0!.EM#&FQ(D5.NT*,4HA0-N"*
M&]0,57_M#_IE_P"/?_6H_M#_ *9?^/?_ %J +E+5+^T/^F7_ (]_]:C^T/\
LIE_X]_\ 6H NU5O_ /4+_O?T-,_M#_IE_P"/?_6J*>Z\] FS;SG.<T ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>image_013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_013.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !) (<# 2(  A$! Q$!_\0
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MV1\(N.,]W-=NM[H_@71H[>28;E'*CEG:O.=)UAM(MOL^D0^9J-S\LD^,E?\
M945UGA[P%)<2C4?$3M-<-R(6;./]X_TJCVL93A3@H3=H+9=6^Y+!XI\1Z^Y_
ML;3DAM^TLW^/_P!:G3ZS?2"?0?$D$44US$1#-&?D?_Z^:[>.)88UCC4*JC
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0 Z4444 %%%% !BBBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>image_014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !( ,T# 2(  A$! Q$!_\0
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M@#UP1FFR7<$5W!:N^)IPQC7!^8+C//3N* )J*IZKJ,>D:3=:C-%-*EO&9#'
MNZ1\?PJ.,L>@'J:Y^Q\=I>ZH;$^'M8MV2[6SEEE^SE(I602 ';,Q/RD'@'&<
M=: .LHKE+GQY:VEWJB3Z1JBV>ES"&\OPL30Q':K[L"0N5VLI)"G&><<UI:KX
MCATO4='L_L5W=-JLQAADM_+*H0NXEMS@XVAFR >%/? (!LT4R82F%Q Z)+CY
M&=2R@^X!&?S%4=&U0ZI:2M)#Y%S;S/;W$.X-L=3V/<$$,.^&&0#Q0!HT444
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M*YWP$)O^$:FOKN"Y@NKV\N;N:.XMWBD7=(VT%6 /"!!^'%=510!YA%)J&O\
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M2>]:- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>image_015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !8 .D# 2(  A$! Q$!_\0
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M_.>&>TEA.S=MW*74!ER" 02#B@#6HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
B**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>image_016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !3 14# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)Y8X. .>*LUYC'JEQXDG\-W-UJT9M-2N?M_]GE$6.&VBR\3$XWE]XBSEL<G
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M:OKF1'FU"Z$BE#G9$L:HB\C_ &2<=,L:K_;/&'_0"T/_ ,',W_R+1]L\8?\
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MD%,GT4\X[D+SQ@WJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
DB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>image_017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_017.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !. -P# 2(  A$! Q$!_\0
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M"Q4@GD#&:] HH X"[T'5]1@\0:G#IBV-S=:='ING6<C1,\(7S/WC%24!!E.
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8* "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>image_018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_018.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !, -\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH *XSXD?\@W0O^P_8?^CA79UQGQ(_Y!NA?]A^P_\ 1PH
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M4 0VMK;V-K':VEO%;V\2[8XHD"(@] !P!4U%% !1110 4444 %%%% !1110
M5GV6A:/IMY-=V&E6-K<SY\V:"W1'DR<G<P&3SSS6A10 4444 %%%% !1110!
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>image_019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_019.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  _ 04# 2(  A$! Q$!_\0
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M4EM7L[=0FHWXNI))QN\R4$.X56!3 #8X^ZO?LJ "BBB@ HHHH **0D*I9B
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MR)+]G$5Q'$61QC+2F3*,1@( ,?>QD]U%:V\$TTT4$4<L[!YG1 &D8 *"Q[G
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M8N9%V.(U5<!D!& .#^- '0?;/&'_ $ M#_\ !S-_\BT?;/&'_0"T/_P<S?\
MR+572KW4K#QB^@ZCJCZ@)]/%]$\D*(T;*X211L4#;\R$9RW7)-=50!12753I
M)D>RLUU+!_T=;MC#G/'[WRPW3!^YUXYZUS.D77B<^)-7WZ1I #30^<1JDAV#
MRU^[_H_S<<\[>>/>NTIB0Q1R22)&BO(078* 6P,#)[\4 4M;L[:^T>ZANXUE
M@\IBT;GY6^4\,.C#V/%97P[(/PX\-X.?^);!_P"@"MR_TZRU2T:TU"SM[NV8
M@M#<1+(A(.1E2".M0V.F:3H-G*FGV%GI]MDRR+;0K$N<<L0H S@=?:@#$\"J
MB6FN)&^Y%UR]QR#@F4DC\"3755S/@*VDA\*QW,RLDFH7$^H%64J5$TK2*"#W
M"L,UTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 51U/35U!('63R;FVE$T$P7)1L$'CN"I*D>A['!%ZB@ J"\2ZDM)%LIH8+DC
M]W)-$944^ZAE)_,5/10!Q]EX*N5\$2^&=2U:.Y08-O<V]H87B8/O5B"[AB'
M(Z=,5,?!@U"UUD:Y>K>76K6RVDTMO"8%2)0VT(I9\'+L223DGTXKJJ* ,#1M
M O+/59=4U74TO[PVZ6L316_DJD2DL>"S$LQ.2<@<# &*WZ** "BBB@ JEJNG
M_P!J6?V-Y2EO(P%PH7)EC[IGL#P"?3([Y%VB@!  H    X %+110 4444 %%
%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>image_020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_020.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !< 0X# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M &=IND1V%S=7CRM<7MWL\Z=U R%&%4 < #)/U)K1HHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
HB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>image_021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_021.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !D 1T# 2(  A$! Q$!_\0
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M?QI!J5R"NGZ4C+:QL""]PV0\F.X"G:/<L?0T =+1110 4444 %%%% !1110
M5S%OI/B&+Q9/J\M]IAM9H8[=H5MW#"-&=@0V_&[YSVQ73T4 <OX?U&SU/Q;K
MT]C=0W,(AM4+Q.& 8>;D9'<5LW6BZ;>W:W5S9Q2SJ,!V';&.?7VSTJ_C P**
M ,7Q7I-_KGAVYTS3[N&UDN $>26,N-F?F  (ZCC\36PH/E@/C.,';T_"G44
M<-IO@.^LM-BT*36%?0H;GSUC2#;-*N_?Y;OG&W=U( )'%=S110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
D !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>35
<FILENAME>afya-20251231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /6pZo7xRiXgen8uLbHIsOaGHeaP9xpV1WYlBtWl/Hakqvy8rZ1Vmnyd22JwGse0I -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:afya="http://afya.com.br/20251231" elementFormDefault="qualified" targetNamespace="http://afya.com.br/20251231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://afya.com.br/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/StatementOfFinancialPosition" id="StatementOfFinancialPosition">
          <link:definition>00000002 - Statement - Consolidated statement of financial position</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome" id="StatementOfIncomeAndOtherComprehensiveIncome">
          <link:definition>00000003 - Statement - Consolidated statement of income and other comprehensive income</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/StatementOfChangesInEquity" id="StatementOfChangesInEquity">
          <link:definition>00000004 - Statement - Consolidated statement of changes in equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/StatementOfCashFlows" id="StatementOfCashFlows">
          <link:definition>00000005 - Statement - Consolidated statement of cash flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CorporateInformation" id="CorporateInformation">
          <link:definition>999013 - Disclosure - Corporate information</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPolicies" id="MaterialAccountingPolicies">
          <link:definition>999014 - Disclosure - Material accounting policies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SegmentInformation" id="SegmentInformation">
          <link:definition>999015 - Disclosure - Segment information</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinations" id="BusinessCombinations">
          <link:definition>999016 - Disclosure - Business combinations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CashAndCashEquivalents" id="CashAndCashEquivalents">
          <link:definition>999017 - Disclosure - Cash and cash equivalents</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/TradeReceivables" id="TradeReceivables">
          <link:definition>999018 - Disclosure - Trade receivables</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RelatedParties" id="RelatedParties">
          <link:definition>999019 - Disclosure - Related parties</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/OtherAssets" id="OtherAssets">
          <link:definition>999020 - Disclosure - Other assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/InvestmentInAssociate" id="InvestmentInAssociate">
          <link:definition>999021 - Disclosure - Investment in associate</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>999022 - Disclosure - Property and equipment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IntangibleAssets" id="IntangibleAssets">
          <link:definition>999023 - Disclosure - Intangible assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilities" id="FinancialAssetsAndLiabilities">
          <link:definition>999024 - Disclosure - Financial assets and liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CapitalManagement" id="CapitalManagement">
          <link:definition>999025 - Disclosure - Capital management</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligations" id="LaborAndSocialObligations">
          <link:definition>999026 - Disclosure - Labor and social obligations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/Equity" id="Equity">
          <link:definition>999027 - Disclosure - Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/EarningsPerShare" id="EarningsPerShare">
          <link:definition>999028 - Disclosure - Earnings per share</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/Revenue" id="Revenue">
          <link:definition>999029 - Disclosure - Revenue</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CostsAndExpensesByNature" id="CostsAndExpensesByNature">
          <link:definition>999030 - Disclosure - Costs and expenses by nature</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinanceResult" id="FinanceResult">
          <link:definition>999031 - Disclosure - Finance result</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>999032 - Disclosure - Income taxes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LegalProceedingsAndContingencies" id="LegalProceedingsAndContingencies">
          <link:definition>999033 - Disclosure - Legal proceedings and contingencies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/Non-cashTransactions" id="Non-cashTransactions">
          <link:definition>999034 - Disclosure - Non-cash transactions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>999035 - Disclosure - Subsequent events</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" id="MaterialAccountingPoliciesPolicies">
          <link:definition>999036 - Disclosure - Material accounting policies (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CorporateInformationTables" id="CorporateInformationTables">
          <link:definition>999037 - Disclosure - Corporate information (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesTables" id="MaterialAccountingPoliciesTables">
          <link:definition>999038 - Disclosure - Material accounting policies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SegmentInformationTables" id="SegmentInformationTables">
          <link:definition>999039 - Disclosure - Segment information (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsTables" id="BusinessCombinationsTables">
          <link:definition>999040 - Disclosure - Business combinations (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CashAndCashEquivalentsTables" id="CashAndCashEquivalentsTables">
          <link:definition>999041 - Disclosure - Cash and cash equivalents (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/TradeReceivablesTables" id="TradeReceivablesTables">
          <link:definition>999042 - Disclosure - Trade receivables (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RelatedPartiesTables" id="RelatedPartiesTables">
          <link:definition>999043 - Disclosure - Related parties (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/OtherAssetsTables" id="OtherAssetsTables">
          <link:definition>999044 - Disclosure - Other assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/InvestmentInAssociateTables" id="InvestmentInAssociateTables">
          <link:definition>999045 - Disclosure - Investment in associate (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>999046 - Disclosure - Property and equipment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
          <link:definition>999047 - Disclosure - Intangible assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables" id="FinancialAssetsAndLiabilitiesTables">
          <link:definition>999048 - Disclosure - Financial assets and liabilities (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsTables" id="LaborAndSocialObligationsTables">
          <link:definition>999049 - Disclosure - Labor and social obligations (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/EquityTables" id="EquityTables">
          <link:definition>999050 - Disclosure - Equity (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/EarningsPerShareTables" id="EarningsPerShareTables">
          <link:definition>999051 - Disclosure - Earnings per share (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RevenueTables" id="RevenueTables">
          <link:definition>999052 - Disclosure - Revenue (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CostsAndExpensesByNatureTables" id="CostsAndExpensesByNatureTables">
          <link:definition>999053 - Disclosure - Costs and expenses by nature (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinanceResultTables" id="FinanceResultTables">
          <link:definition>999054 - Disclosure - Finance result (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>999055 - Disclosure - Income taxes (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesTables" id="LegalProceedingsAndContingenciesTables">
          <link:definition>999056 - Disclosure - Legal proceedings and contingencies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/Non-cashTransactionsTables" id="Non-cashTransactionsTables">
          <link:definition>999057 - Disclosure - Non-cash transactions (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CorporateInformationDetails" id="CorporateInformationDetails">
          <link:definition>999058 - Disclosure - Corporate information (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CorporateInformationDetailsNarrative" id="CorporateInformationDetailsNarrative">
          <link:definition>999059 - Disclosure - Corporate information (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails" id="MaterialAccountingPoliciesDetails">
          <link:definition>999060 - Disclosure - Material accounting policies (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" id="MaterialAccountingPoliciesDetails1">
          <link:definition>999061 - Disclosure - Material accounting policies (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" id="MaterialAccountingPoliciesDetails2">
          <link:definition>999062 - Disclosure - Material accounting policies (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails3" id="MaterialAccountingPoliciesDetails3">
          <link:definition>999063 - Disclosure - Material accounting policies (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails4" id="MaterialAccountingPoliciesDetails4">
          <link:definition>999064 - Disclosure - Material accounting policies (Details 4)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails5" id="MaterialAccountingPoliciesDetails5">
          <link:definition>999065 - Disclosure - Material accounting policies (Details 5)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" id="MaterialAccountingPoliciesDetailsNarrative">
          <link:definition>999066 - Disclosure - Material accounting policies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SegmentInformationDetails" id="SegmentInformationDetails">
          <link:definition>999067 - Disclosure - Segment information (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SegmentInformationDetails1" id="SegmentInformationDetails1">
          <link:definition>999068 - Disclosure - Segment information (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsDetails" id="BusinessCombinationsDetails">
          <link:definition>999069 - Disclosure - Business combinations (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsDetails1" id="BusinessCombinationsDetails1">
          <link:definition>999070 - Disclosure - Business combinations (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" id="BusinessCombinationsDetailsNarrative">
          <link:definition>999071 - Disclosure - Business combinations (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetails" id="CashAndCashEquivalentsDetails">
          <link:definition>999072 - Disclosure - Cash and cash equivalents (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" id="CashAndCashEquivalentsDetailsNarrative">
          <link:definition>999073 - Disclosure - Cash and cash equivalents (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/TradeReceivablesDetails" id="TradeReceivablesDetails">
          <link:definition>999074 - Disclosure - Trade receivables (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/TradeReceivablesDetails1" id="TradeReceivablesDetails1">
          <link:definition>999075 - Disclosure - Trade receivables (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/TradeReceivablesDetails2" id="TradeReceivablesDetails2">
          <link:definition>999076 - Disclosure - Trade receivables (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RelatedPartiesDetails" id="RelatedPartiesDetails">
          <link:definition>999077 - Disclosure - Related parties (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RelatedPartiesDetails1" id="RelatedPartiesDetails1">
          <link:definition>999078 - Disclosure - Related parties (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RelatedPartiesDetailsNarrative" id="RelatedPartiesDetailsNarrative">
          <link:definition>999079 - Disclosure - Related parties (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/OtherAssetsDetails" id="OtherAssetsDetails">
          <link:definition>999080 - Disclosure - Other assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/InvestmentInAssociateDetails" id="InvestmentInAssociateDetails">
          <link:definition>999081 - Disclosure - Investment in associate (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/PropertyAndEquipmentDetails" id="PropertyAndEquipmentDetails">
          <link:definition>999082 - Disclosure - Property and equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsDetails" id="IntangibleAssetsDetails">
          <link:definition>999083 - Disclosure - Intangible assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsDetails1" id="IntangibleAssetsDetails1">
          <link:definition>999084 - Disclosure - Intangible assets (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsDetails2" id="IntangibleAssetsDetails2">
          <link:definition>999085 - Disclosure - Intangible assets (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsDetailsNarrative" id="IntangibleAssetsDetailsNarrative">
          <link:definition>999086 - Disclosure - Intangible assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails" id="FinancialAssetsAndLiabilitiesDetails">
          <link:definition>999087 - Disclosure - Financial assets and liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1" id="FinancialAssetsAndLiabilitiesDetails1">
          <link:definition>999088 - Disclosure - Financial assets and liabilities (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2" id="FinancialAssetsAndLiabilitiesDetails2">
          <link:definition>999089 - Disclosure - Financial assets and liabilities (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3" id="FinancialAssetsAndLiabilitiesDetails3">
          <link:definition>999090 - Disclosure - Financial assets and liabilities (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4" id="FinancialAssetsAndLiabilitiesDetails4">
          <link:definition>999091 - Disclosure - Financial assets and liabilities  (Details 4)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5" id="FinancialAssetsAndLiabilitiesDetails5">
          <link:definition>999092 - Disclosure - Financial assets and liabilities (Details 5)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6" id="FinancialAssetsAndLiabilitiesDetails6">
          <link:definition>999093 - Disclosure - Financial assets and liabilities (Details 6)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7" id="FinancialAssetsAndLiabilitiesDetails7">
          <link:definition>999094 - Disclosure - Financial assets and liabilities (Details 7)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8" id="FinancialAssetsAndLiabilitiesDetails8">
          <link:definition>999095 - Disclosure - Financial assets and liabilities (Details 8)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9" id="FinancialAssetsAndLiabilitiesDetails9">
          <link:definition>999096 - Disclosure - Financial assets and liabilities (Details 9)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10" id="FinancialAssetsAndLiabilitiesDetails10">
          <link:definition>999097 - Disclosure - Financial assets and liabilities (Details 10)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11" id="FinancialAssetsAndLiabilitiesDetails11">
          <link:definition>999098 - Disclosure - Financial assets and liabilities (Details 11)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative" id="FinancialAssetsAndLiabilitiesDetailsNarrative">
          <link:definition>999099 - Disclosure - Financial assets and liabilities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails" id="LaborAndSocialObligationsDetails">
          <link:definition>999100 - Disclosure - Labor and social obligations (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails1" id="LaborAndSocialObligationsDetails1">
          <link:definition>999101 - Disclosure - Labor and social obligations (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails2" id="LaborAndSocialObligationsDetails2">
          <link:definition>999102 - Disclosure - Labor and social obligations (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails3" id="LaborAndSocialObligationsDetails3">
          <link:definition>999103 - Disclosure - Labor and social obligations (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" id="LaborAndSocialObligationsDetailsNarrative">
          <link:definition>999104 - Disclosure - Labor and social obligations (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/EquityDetails" id="EquityDetails">
          <link:definition>999105 - Disclosure - Equity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/EquityDetailsNarrative" id="EquityDetailsNarrative">
          <link:definition>999106 - Disclosure - Equity (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/EarningsPerShareDetails" id="EarningsPerShareDetails">
          <link:definition>999107 - Disclosure - Earnings per share (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RevenueDetails" id="RevenueDetails">
          <link:definition>999108 - Disclosure - Revenue (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/RevenueDetails1" id="RevenueDetails1">
          <link:definition>999109 - Disclosure - Revenue (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/CostsAndExpensesByNatureDetails" id="CostsAndExpensesByNatureDetails">
          <link:definition>999110 - Disclosure - Costs and expenses by nature (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/FinanceResultDetails" id="FinanceResultDetails">
          <link:definition>999111 - Disclosure - Finance result (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
          <link:definition>999112 - Disclosure - Income taxes (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IncomeTaxesDetails1" id="IncomeTaxesDetails1">
          <link:definition>999113 - Disclosure - Income taxes (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>999114 - Disclosure - Income taxes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails" id="LegalProceedingsAndContingenciesDetails">
          <link:definition>999115 - Disclosure - Legal proceedings and contingencies (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1" id="LegalProceedingsAndContingenciesDetails1">
          <link:definition>999116 - Disclosure - Legal proceedings and contingencies (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative" id="LegalProceedingsAndContingenciesDetailsNarrative">
          <link:definition>999117 - Disclosure - Legal proceedings and contingencies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/Non-cashTransactionsDetails" id="Non-cashTransactionsDetails">
          <link:definition>999118 - Disclosure - Non-cash transactions (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://afya.com.br/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>999119 - Disclosure - Subsequent events (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="afya-20251231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="afya-20251231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="afya-20251231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="afya-20251231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" schemaLocation="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <element id="afya_ClassAOrdinarySharesMember" name="ClassAOrdinarySharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ClassACommonSharesHeldInTreasuryMember" name="ClassACommonSharesHeldInTreasuryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ClassBOrdinarySharesMember" name="ClassBOrdinarySharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FaculdadeMasterclassLtdaMember" name="FaculdadeMasterclassLtdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AfyaParticipacoesS.A.Member" name="AfyaParticipacoesS.A.Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AfyaParticipacoesSAMember" name="AfyaParticipacoesSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" name="InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" name="InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" name="UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" name="IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" name="InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" name="CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" name="InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" name="FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" name="InstitutoEducacionalSantoAgostinhoS.A.FASAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" name="InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember" name="SociedadeUniversitariaRedentorS.A.UniRedentorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroDeEnsinoSaoLucasLtda.UniSLMember" name="CentroDeEnsinoSaoLucasLtda.UniSLMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" name="SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" name="CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" name="IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedicinaeSolutionsS.A.MedicinaeMember" name="MedicinaeSolutionsS.A.MedicinaeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" name="MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" name="CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShospTecnologiaDaInformacaoLtda.ShospMember" name="ShospTecnologiaDaInformacaoLtda.ShospMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" name="SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" name="CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember" name="RXPROSolucoesDeTecnologiaLtda.RXPROMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" name="QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" name="SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UnidomParticipacoesS.A.UnidomMember" name="UnidomParticipacoesS.A.UnidomMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" name="InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" name="SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FaculdadeMasterclassLtdaFUNICMember" name="FaculdadeMasterclassLtdaFUNICMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" name="UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FVTPLMember" name="FVTPLMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialAssetsAtAmortizedCostMember" name="FinancialAssetsAtAmortizedCostMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FVOCIMember" name="FVOCIMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FVOCI1Member" name="FVOCI1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MachineryAndEquipmentsMember" name="MachineryAndEquipmentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ItEquipmentMember" name="ItEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LibraryBooksMember" name="LibraryBooksMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CustomerRelationshipsOtherCoursesMember" name="CustomerRelationshipsOtherCoursesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember" name="EducationContentDevelopedTechnologyAndEducationalPlatformMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProgramOfSocialIntegrationMember" name="ProgramOfSocialIntegrationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TeachingActivitiesMember" name="TeachingActivitiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContributionForTheFinancingOfSocialSecurityMember" name="ContributionForTheFinancingOfSocialSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NonTeachingActivitiesMember" name="NonTeachingActivitiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OrganizationForEconomicCooperationAndDevelopmentMember" name="OrganizationForEconomicCooperationAndDevelopmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AmendmentsToIAS21Member" name="AmendmentsToIAS21Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LackOfExchangeabilityAmendmentsToIAS21Member" name="LackOfExchangeabilityAmendmentsToIAS21Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member" name="ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AnnualImprovementsToIFRSAccountingStandardsVolume11Member" name="AnnualImprovementsToIFRSAccountingStandardsVolume11Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member" name="PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IFRS18PresentationAndDisclosureInFinancialStatementsMember" name="IFRS18PresentationAndDisclosureInFinancialStatementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UndergraduateMember" name="UndergraduateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContinuingEducationMember" name="ContinuingEducationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedicalPracticeSolutionsMember" name="MedicalPracticeSolutionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TotalReportableSegmentsMember" name="TotalReportableSegmentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EliminationInterSegmentBalancesMember" name="EliminationInterSegmentBalancesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdjustmentsAndEliminationsMember" name="AdjustmentsAndEliminationsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UnidomMember" name="UnidomMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AcquisitionOfUnidomMember" name="AcquisitionOfUnidomMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WithAndWithoutMethodMember" name="WithAndWithoutMethodMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BankCertificatesOfDepositMember" name="BankCertificatesOfDepositMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_USDMember" name="USDMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TuitionFeesMember" name="TuitionFeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationalContentMember" name="EducationalContentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FIESMember" name="FIESMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationalCreditsMember" name="EducationalCreditsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MobileAppSubscriptionMember" name="MobileAppSubscriptionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OthersMember" name="OthersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" name="LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UEPCMember" name="UEPCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EMIVEPatrulha24HorasLtdaMember" name="EMIVEPatrulha24HorasLtdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DepreciationRightofuseAssetsMember" name="DepreciationRightofuseAssetsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesInterestMember" name="LeaseLiabilitiesInterestMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseAgreements1Member" name="LeaseAgreements1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" name="InstitutoTocantinensePresidenteAntonioCarlosSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RVLEstevesGestaoImobiliariaSAMember" name="RVLEstevesGestaoImobiliariaSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseAgreements2Member" name="LeaseAgreements2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" name="InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseAgreements3Member" name="LeaseAgreements3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseAgreements4Member" name="LeaseAgreements4Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseAgreements5Member" name="LeaseAgreements5Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UNIVACOPatrimonialLtdaMember" name="UNIVACOPatrimonialLtdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IESVAPPatrimonialLtdaMember" name="IESVAPPatrimonialLtdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationContentMember" name="EducationContentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationalPlatformMember" name="EducationalPlatformMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IntangibleInProgressMember" name="IntangibleInProgressMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherMember" name="OtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SoftwareInProgressMember" name="SoftwareInProgressMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CarryingAmountsMember" name="CarryingAmountsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" name="IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" name="InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroDeCienciasEmSaudeDeItajubaSAMember" name="CentroDeCienciasEmSaudeDeItajubaSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" name="InstitutoDeEnsinoSuperiorDoPiauiSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" name="FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoEducacionalSantoAgostinhoSAMember" name="InstitutoEducacionalSantoAgostinhoSAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" name="InstitutoParaensedeEducacaoeCulturaLtdaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniRedentorMember" name="UniRedentorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniSLMember" name="UniSLMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FESARMember" name="FESARMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FCMPBMember" name="FCMPBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ITPACGaranhunsMember" name="ITPACGaranhunsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UnifipMocMember" name="UnifipMocMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UnigranrioMember" name="UnigranrioMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DelReyMember" name="DelReyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FUNICMember" name="FUNICMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DiscountRatesMember" name="DiscountRatesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PerpetuityGrowthRateMember" name="PerpetuityGrowthRateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EBITDAMember" name="EBITDAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersEarnOutsMember" name="AccountsPayableToSellingShareholdersEarnOutsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersUnidomMember" name="AccountsPayableToSellingShareholdersUnidomMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OctoberTwentyTwentyFiveMember" name="OctoberTwentyTwentyFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_JulyTwentyTwentySevenMember" name="JulyTwentyTwentySevenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AprilTwentyTwentySixMember" name="AprilTwentyTwentySixMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_JanuaryTwentyTwentyEightMember" name="JanuaryTwentyTwentyEightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AprilTwentyThirtyMember" name="AprilTwentyThirtyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OctoberTwentyTwentyEightMember" name="OctoberTwentyTwentyEightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OctoberTwentyThirtyMember" name="OctoberTwentyThirtyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InternationalFinanceCorporationMember" name="InternationalFinanceCorporationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TwoSeriesMember" name="TwoSeriesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FirstSeriesMember" name="FirstSeriesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SecondSeriesMember" name="SecondSeriesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShospMember" name="ShospMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AlemDaMedicinaMember" name="AlemDaMedicinaMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CardioPapersMember" name="CardioPapersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CardiPapersMember" name="CardiPapersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersMember" name="AccountsPayableToSellingShareholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingMember" name="LoansAndFinancingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CashEquivalents1Member" name="CashEquivalents1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingOneMember" name="LoansAndFinancingOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersOneMember" name="AccountsPayableToSellingShareholdersOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersTwoMember" name="AccountsPayableToSellingShareholdersTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseBasisPointsMember" name="IncreaseBasisPointsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseBasisPointsOneMember" name="IncreaseBasisPointsOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ForeignCurrencyExposuresMember" name="ForeignCurrencyExposuresMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseForeignCurrencyMember" name="IncreaseForeignCurrencyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DecreaseForeignCurrencyMember" name="DecreaseForeignCurrencyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsPayableMember" name="DividendsPayableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShareBasedCompensationPlansMember" name="ShareBasedCompensationPlansMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedStockUnitsMember" name="RestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedStockUnits1Member" name="RestrictedStockUnits1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedStockUnits2Member" name="RestrictedStockUnits2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedStockUnits3Member" name="RestrictedStockUnits3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_November2025Member" name="November2025Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_April2025Member" name="April2025Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_October2024Member" name="October2024Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_December2023Member" name="December2023Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_October2023Member" name="October2023Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_August2023Member" name="August2023Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_April2023Member" name="April2023Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_February2023Member" name="February2023Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EliminationInterSegmentTransactionsMember" name="EliminationInterSegmentTransactionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UndergradMember" name="UndergradMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LabourMember" name="LabourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CivilMember" name="CivilMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxesMember" name="TaxesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TypesOfRiskMember" name="TypesOfRiskMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxesAndSocialSecurityMember" name="TaxesAndSocialSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherAssetsNonCurrentMember" name="OtherAssetsNonCurrentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NonadjustingEventMember" name="NonadjustingEventMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncomeTaxesRecoverable" name="IncomeTaxesRecoverable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentTradeReceivable" name="NoncurrentTradeReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CurrentTaxesPayable" name="CurrentTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentTaxesPayable" name="NoncurrentTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllowanceForExpectedCreditLosses" name="AllowanceForExpectedCreditLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncomeTaxesExpensesAbstract" name="IncomeTaxesExpensesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncomeTaxesExpensesCurrent" name="IncomeTaxesExpensesCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeferredTaxes" name="DeferredTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ComprehensiveIncomeLoss" name="ComprehensiveIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IfrsStatementLineItems" name="IfrsStatementLineItems" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TreasurySharesRepurchase" name="TreasurySharesRepurchase" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AcquisitionOfNoncontrollingInterests" name="AcquisitionOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedSharesTransferredToExecutives" name="RestrictedSharesTransferredToExecutives" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" name="TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncomeLossBeforeIncomeTaxes" name="IncomeLossBeforeIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WriteoffOfPropertyAndEquipment" name="WriteoffOfPropertyAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WriteoffOfIntangibleAssets" name="WriteoffOfIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" name="AllowanceForDoubtfulAccountsOfOpeartingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccruedInterestOfOpeartingActivities" name="AccruedInterestOfOpeartingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax" name="ShareOfProfitOfEquityaccountedInvesteeNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseDecreaseInOperatingLiabilities1Abstract" name="IncreaseDecreaseInOperatingLiabilities1Abstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseDecreaseInRecoverableTaxes" name="IncreaseDecreaseInRecoverableTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseDecreaseInPaymentsOfLegalProceedings" name="IncreaseDecreaseInPaymentsOfLegalProceedings" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" name="PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PurchaseOfAcquisitionOfNoncontrollingInterests" name="PurchaseOfAcquisitionOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentsOfInterest" name="PaymentsOfInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RepaymentsOfInterest" name="RepaymentsOfInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" name="PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureCorporateInformationAbstract" name="DisclosureCorporateInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfGeneralInformationAboutFinancialStatementExplanatory" name="DisclosureOfGeneralInformationAboutFinancialStatementExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureMaterialAccountingPoliciesAbstract" name="DisclosureMaterialAccountingPoliciesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfMaterialAccountingPoliciesExplanatory" name="DisclosureOfMaterialAccountingPoliciesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureCashAndCashEquivalentsAbstract" name="DisclosureCashAndCashEquivalentsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosuresOfCashAndCashEquivalentsExplanatory" name="DisclosuresOfCashAndCashEquivalentsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOtherAssetsAbstract" name="DisclosureOtherAssetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfOtherAssetExplanatory" name="DisclosureOfOtherAssetExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureIntangibleAssetsAbstract" name="DisclosureIntangibleAssetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfIntangibleAssetExplanatory" name="DisclosureOfIntangibleAssetExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureCapitalManagementAbstract" name="DisclosureCapitalManagementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CapitalManagementExplanatory" name="CapitalManagementExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureLaborAndSocialObligationsAbstract" name="DisclosureLaborAndSocialObligationsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaborAndSocialObligationsExplanatory" name="LaborAndSocialObligationsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureEquityAbstract" name="DisclosureEquityAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfEquityExplanatory" name="DisclosureOfEquityExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureIncomeTaxesAbstract" name="DisclosureIncomeTaxesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfIncomeTaxesExplanatory" name="DisclosureOfIncomeTaxesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureLegalProceedingsAndContingenciesAbstract" name="DisclosureLegalProceedingsAndContingenciesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfLegalProceedingsAndContingenciesExplanatory" name="DisclosureOfLegalProceedingsAndContingenciesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureNoncashTransactionsAbstract" name="DisclosureNoncashTransactionsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureNoncashTransactionsExplanatory" name="DisclosureNoncashTransactionsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BusinessCombinationsAndGoodwillPolicyExplanatory" name="BusinessCombinationsAndGoodwillPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" name="CurrentVersusNoncurrentClassificationPoliciesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" name="FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" name="ImpairmentOfNonfinancialAssetsPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory" name="DescriptionOfAccountingPolicyForInvestmentsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersPolicyExplanatory" name="AccountsPayableToSellingShareholdersPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsPolicyExplanatory" name="DividendsPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaborAndSocialObligationsPolicyExplanatory" name="LaborAndSocialObligationsPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SharebasedPaymentsPolicyExplanatory" name="SharebasedPaymentsPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" name="ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" name="SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock" name="ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfMeasurementAndGainsAndLossesTableTextBlock" name="ScheduleOfMeasurementAndGainsAndLossesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfEstimatedUsefulLivesTableTextBlock" name="ScheduleOfEstimatedUsefulLivesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock" name="ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" name="ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" name="ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock" name="ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfUnidomExplanatory" name="ScheduleOfAcquisitionOfUnidomExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" name="DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfTradeAndOtherReceivables1Explanatory" name="DisclosureOfTradeAndOtherReceivables1Explanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" name="DisclosureOfTradeAccountsReceivableByAgingExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory" name="DisclosureOfAllowanceForDoubtfulAccountsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfRelatedPartiesExplanatory" name="DisclosureOfRelatedPartiesExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" name="SummaryOfKeyManagementPersonnelCompensationTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfOtherAssetsTableTextBlock" name="DisclosureOfOtherAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfInvestmentsExplanatory" name="DisclosureOfInvestmentsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfIntangibleAssetsTableTextBlock" name="SummaryOfIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" name="SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SchuduleOfAssumptionsUsedTableTextBlock" name="SchuduleOfAssumptionsUsedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFinancialAssetsTableTextBlock" name="ScheduleOfFinancialAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFinancialLiabilitiesTableTextBlock" name="ScheduleOfFinancialLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFairValuesTableTextBlock" name="ScheduleOfFairValuesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfLoansAndFinancingTableTextBlock" name="ScheduleOfLoansAndFinancingTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfLeasesTableTextBlock" name="ScheduleOfLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock" name="ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholders1Explanatory" name="AccountsPayableToSellingShareholders1Explanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFairValuesFinancialInstrumentstTableTextBlock" name="ScheduleOfFairValuesFinancialInstrumentstTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" name="SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" name="SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" name="SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock" name="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFairValueOfStockOptionsGrantsExplanatory" name="ScheduleOfFairValueOfStockOptionsGrantsExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfSharebasedCompensationPlanExplanatory" name="ScheduleOfSharebasedCompensationPlanExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfGrantsRestrictedStockUnitsTableTextBlock" name="ScheduleOfGrantsRestrictedStockUnitsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfStockOptionTableTextBlock" name="ScheduleOfStockOptionTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfTreasurySharesMovementExplanatory" name="ScheduleOfTreasurySharesMovementExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfEarningsPerShareTableExplanatory" name="ScheduleOfEarningsPerShareTableExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfNetSalesRevenueExplanatory" name="ScheduleOfNetSalesRevenueExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfRevenueBySegmentTableTextBlock" name="ScheduleOfRevenueBySegmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfExpensesByNatureTableTextBlock" name="ScheduleOfExpensesByNatureTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFinanceResultTableTextBlock" name="ScheduleOfFinanceResultTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" name="ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock" name="ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfLegalProceedingsAndContingenciesTableTextBlock" name="ScheduleOfLegalProceedingsAndContingenciesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock" name="ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfNonCashTransactionsTableTextBlock" name="ScheduleOfNonCashTransactionsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingAsOfAcquisitionDate" name="LoansAndFinancingAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionalPaymentToShareholder" name="AdditionalPaymentToShareholder" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PrincipalActivities" name="PrincipalActivities" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InvestmentType" name="InvestmentType" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ExpectedCashFlows" name="ExpectedCashFlows" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProbabilityOfDisbursement" name="ProbabilityOfDisbursement" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ConsolidatedRevenues" name="ConsolidatedRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MinimumTaxRate" name="MinimumTaxRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CapitalExpenditures" name="CapitalExpenditures" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DepositsFromExternalCustomer" name="DepositsFromExternalCustomer" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InterSegment" name="InterSegment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CostOfSale" name="CostOfSale" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinanceExpense" name="FinanceExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeReceivablesAsOfAcquisitionDate" name="TradeReceivablesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdvancesRecognisedAsOfAcquisitionDate" name="AdvancesRecognisedAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RecoverableTaxesAsOfAcquisitionDate" name="RecoverableTaxesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherAssetsAsOfAcquisitionDate" name="OtherAssetsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IndemnificationAssetsAsOfAcquisitionDate" name="IndemnificationAssetsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightOfUseAssetsAsOfAcquisitionDate" name="RightOfUseAssetsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaborAndSocialObligationsAsOfAcquisitionDate" name="LaborAndSocialObligationsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxesPayableAsOfAcquisitionDate" name="TaxesPayableAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherTaxesPayableAsOfAcquisitionDate" name="OtherTaxesPayableAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdvancesFromCustomersAsOfAcquisitionDate" name="AdvancesFromCustomersAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesAsOfAcquisitionDate" name="LeaseLiabilitiesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" name="ProvisionForLegalProceedingsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherLiabilitiesAsOfAcquisitionDate" name="OtherLiabilitiesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ConsiderationToBeTransferred" name="ConsiderationToBeTransferred" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NetOfCashFlowOnAcquisition" name="NetOfCashFlowOnAcquisition" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination" name="AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseInRevenue" name="IncreaseInRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseInIncomeBeforeIncomeTaxes" name="IncreaseInIncomeBeforeIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PercenatgeOfAverageInterestOnFinancialInstrument" name="PercenatgeOfAverageInterestOnFinancialInstrument" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ReceivablesGross" name="ReceivablesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllowanceForDoubtfulAccountsFoReceivable1" name="AllowanceForDoubtfulAccountsFoReceivable1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllowanceAccountForCreditLossesOfFinancialAsset" name="AllowanceAccountForCreditLossesOfFinancialAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" name="AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" name="WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsRelatedPartyTransactions" name="RightofuseAssetsRelatedPartyTransactions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeReceivablesRelatedPartyTransactions" name="TradeReceivablesRelatedPartyTransactions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherAssetsRelatedPartyTransactions" name="OtherAssetsRelatedPartyTransactions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeAndOtherCurrentPayablesToRelatedParties1" name="TradeAndOtherCurrentPayablesToRelatedParties1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentAssetsOfRelatedParty1" name="NoncurrentAssetsOfRelatedParty1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesRelatedPartyTransactions" name="LeaseLiabilitiesRelatedPartyTransactions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeAndOtherCurrentPayableToRelatedParties" name="TradeAndOtherCurrentPayableToRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrenLliabilitiesOfRelatedParty1" name="NoncurrenLliabilitiesOfRelatedParty1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherIncomeRelatedPartyTransactions" name="OtherIncomeRelatedPartyTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OperatingLeaseTermOfContract" name="OperatingLeaseTermOfContract" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RelatedPartiesAmountPaid" name="RelatedPartiesAmountPaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DescriptionOfLeaseTerm" name="DescriptionOfLeaseTerm" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LesseeFinancesLeaseRenewalTerm" name="LesseeFinancesLeaseRenewalTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DescriptionOfLeaseTerms" name="DescriptionOfLeaseTerms" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Advances1" name="Advances1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_JudicialDeposits" name="JudicialDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ConvertibleLoansFromVentureCapitalInvestments" name="ConvertibleLoansFromVentureCapitalInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Dividend" name="Dividend" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherAssets1" name="OtherAssets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Assets1" name="Assets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CurrentAssets1" name="CurrentAssets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentAssets1" name="NoncurrentAssets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EquityInAssociate" name="EquityInAssociate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CompanyShareInEquity1" name="CompanyShareInEquity1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InvestmentGrossAmount" name="InvestmentGrossAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherExpense" name="OtherExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CompanyShareOfProfitss" name="CompanyShareOfProfitss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsReceived1" name="DividendsReceived1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PropertyPlantAndEquipments" name="PropertyPlantAndEquipments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WritOffOfPropertyPlantAndEquipment" name="WritOffOfPropertyPlantAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PropertyPlantAndEquipmentNetBookValue" name="PropertyPlantAndEquipmentNetBookValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Remesurement" name="Remesurement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Transfer" name="Transfer" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IntangibleAssetsAndGoodwillNetBookValue" name="IntangibleAssetsAndGoodwillNetBookValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CashGeneratingUnits" name="CashGeneratingUnits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PerpetuityGrowthRate" name="PerpetuityGrowthRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EbitdaGrowthRates" name="EbitdaGrowthRates" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendReceivable" name="DividendReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancing" name="LoansAndFinancing" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialLiabilitiesAtFairValues" name="FinancialLiabilitiesAtFairValues" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialInstitution" name="FinancialInstitution" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingCurrent" name="LoansAndFinancingCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingNonCurrent" name="LoansAndFinancingNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsToLeaseLiabilities" name="AdditionsToLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsRemeasurement" name="RightofuseAssetsRemeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesRemeasurement" name="LeaseLiabilitiesRemeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsBusinessCombinations" name="RightofuseAssetsBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BusinessCombinationsLeaseLiabilities" name="BusinessCombinationsLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DepreciationExpenseLeaseLiabilities" name="DepreciationExpenseLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsInterestExpense" name="RightofuseAssetsInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsPaymentsOfPrincipal" name="RightofuseAssetsPaymentsOfPrincipal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesPaymentsOfPrincipal" name="LeaseLiabilitiesPaymentsOfPrincipal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsPaymentsOfInterest" name="RightofuseAssetsPaymentsOfInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentsOfInterestLeaseLiabilities" name="PaymentsOfInterestLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsWriteoff" name="RightofuseAssetsWriteoff" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesWriteoff" name="LeaseLiabilitiesWriteoff" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsCurrent" name="RightofuseAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsNonCurrent" name="RightofuseAssetsNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableAamortizedCostInterestRateBasis" name="AccountsPayableAamortizedCostInterestRateBasis" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersCurrent" name="AccountsPayableToSellingShareholdersCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersNonCurrent" name="AccountsPayableToSellingShareholdersNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersBusinessCombinations" name="AccountsPayableToSellingShareholdersBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentsOfPrincipal" name="PaymentsOfPrincipal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RemeasurementOfEarnouts" name="RemeasurementOfEarnouts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IndexRatePerYear" name="IndexRatePerYear" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BaseRate" name="BaseRate" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialLiabilitiesContractualUndiscounted" name="FinancialLiabilitiesContractualUndiscounted" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" name="IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoanAndFinancing" name="LoanAndFinancing" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TransactionCosts" name="TransactionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContractualLeaseTerm" name="ContractualLeaseTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FirstAnnualInstallmentsPayable" name="FirstAnnualInstallmentsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SecondAnnualInstallmentsPayable" name="SecondAnnualInstallmentsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ThirdAnnualInstallmentsPayable" name="ThirdAnnualInstallmentsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RemainingTradeAndOtherPayablesToRelatedParties" name="RemainingTradeAndOtherPayablesToRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CreditExposures" name="CreditExposures" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SensitivityChangeInTheEuroExchangeRate" name="SensitivityChangeInTheEuroExchangeRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" name="NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SharePriceFairValueAtMeasurementDate" name="SharePriceFairValueAtMeasurementDate" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ExpectedLifeOfStockOptions" name="ExpectedLifeOfStockOptions" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" name="SharePriceFairValueAtMeasurementDateShareOptionsGranted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" name="WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" name="WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" name="NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" nillable="true" xbrli:periodType="duration" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfStockOptionsExercisable" name="NumberOfStockOptionsExercisable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" name="NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_GrantedVestingPeriod" name="GrantedVestingPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShareBasedCompensationOfEmployees" name="ShareBasedCompensationOfEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SocialObligationsLiabilities" name="SocialObligationsLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" name="WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfSharesRepurchased" name="NumberOfSharesRepurchased" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AveragePriceRepurchased" name="AveragePriceRepurchased" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" name="NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AveragePriceDeliveredUnderSharebasedCompensationPlan" name="AveragePriceDeliveredUnderSharebasedCompensationPlan" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfSharesIssued1" name="NumberOfSharesIssued1" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IssuedCapitals" name="IssuedCapitals" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CapitalUnitsAuthorizedShares" name="CapitalUnitsAuthorizedShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentOfDividends" name="PaymentOfDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendDistributed" name="DividendDistributed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FirstDividendDistributionInAmount" name="FirstDividendDistributionInAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PercentageOfDividendDistribution" name="PercentageOfDividendDistribution" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RepurchaseOfOrdinaryShares" name="RepurchaseOfOrdinaryShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CashOutflow" name="CashOutflow" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumeratorAbstract" name="NumeratorAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DenominatorAbstract" name="DenominatorAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProfessionalFeesExpenses" name="ProfessionalFeesExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherRevenue1" name="OtherRevenue1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionAbstract" name="DeductionAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfGrantedDiscounts" name="DeductionOfGrantedDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfReturnsOfNetRevenue" name="DeductionOfReturnsOfNetRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfTaxes" name="DeductionOfTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfProuni" name="DeductionOfProuni" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TimingOfRevenueRecognition" name="TimingOfRevenueRecognition" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TransferredOverTime" name="TransferredOverTime" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TransferredAtPointInTime" name="TransferredAtPointInTime" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TimingRevenueRecognition" name="TimingRevenueRecognition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NetRevenueOtherTransferredPoint" name="NetRevenueOtherTransferredPoint" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Payroll" name="Payroll" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_HospitalAndMedicalAgreements" name="HospitalAndMedicalAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseExpenses" name="LeaseExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SharesBasedCompensation" name="SharesBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxExpenses" name="TaxExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ConsultingFees" name="ConsultingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CostExpensesOther" name="CostExpensesOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CostOfServices" name="CostOfServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SellingGeneralAndAdministrativeExpenses" name="SellingGeneralAndAdministrativeExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialIncomeFromCashEquivalents" name="FinancialIncomeFromCashEquivalents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InterestEarned" name="InterestEarned" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InterestExpense1" name="InterestExpense1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InterestExpenseOnLeaseLiabilities1" name="InterestExpenseOnLeaseLiabilities1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialDiscountsGrantedExpenses" name="FinancialDiscountsGrantedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CreditCardCharges" name="CreditCardCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ExchangeVariance" name="ExchangeVariance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinanceResult" name="FinanceResult" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxExpensesIncomeAtApplicableTaxRate" name="TaxExpensesIncomeAtApplicableTaxRate" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ReconciliationAdjustmentsAbstract" name="ReconciliationAdjustmentsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" name="TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProgramaUniversidadeParaTodosFiscalIncentive" name="ProgramaUniversidadeParaTodosFiscalIncentive" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UnrecognizedDeferredTaxesAssetsOnTaxLosses" name="UnrecognizedDeferredTaxesAssetsOnTaxLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RecognisedDeferredTaxAssets" name="RecognisedDeferredTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" name="TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PermanentAdjustmentsAbstract" name="PermanentAdjustmentsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PermanentAdjustmentsManagementBonuses" name="PermanentAdjustmentsManagementBonuses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PermanentAdjustmentsGifts" name="PermanentAdjustmentsGifts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PermanentAdjustmentsSponsorship" name="PermanentAdjustmentsSponsorship" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PermanentAdjustmentsPillarTwo" name="PermanentAdjustmentsPillarTwo" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherTaxExpenseBenefits" name="OtherTaxExpenseBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncomeTaxesExpense" name="IncomeTaxesExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeferredTaxAssetsAbstract" name="DeferredTaxAssetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeferredTaxAssetsLossCarryforwards" name="DeferredTaxAssetsLossCarryforwards" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsTaxLossesCarryForward" name="AdditionsTaxLossesCarryForward" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllowanceForExpectedCreditLoss" name="AllowanceForExpectedCreditLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsAllowanceForExpectedCreditLosses" name="AdditionsAllowanceForExpectedCreditLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAsset" name="RightofuseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsToRightofuseAsset" name="AdditionsToRightofuseAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiability" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsLeaseLiability" name="AdditionsLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProvisionForProfitSharing" name="ProvisionForProfitSharing" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsProvisionForProfitSharing" name="AdditionsProvisionForProfitSharing" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsProvisionForLegalProceedingsAndContingencies" name="AdditionsProvisionForLegalProceedingsAndContingencies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AmortizationOfIntangibleAsset" name="AmortizationOfIntangibleAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsAmortizationOfIntangibleAssets" name="AdditionsAmortizationOfIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Other" name="Other" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeferredTaxAsset" name="DeferredTaxAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsDeferredTaxAssets" name="AdditionsDeferredTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill" name="DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsTaxBenefitFromTaxDeductibleGoodwill" name="AdditionsTaxBenefitFromTaxDeductibleGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FairValueRemeasurementsOnBusinessCombinations" name="FairValueRemeasurementsOnBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsFairValueRemeasurementsOnBusinessCombinations" name="AdditionsFairValueRemeasurementsOnBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeferredsTaxLiabilities" name="DeferredsTaxLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsDeferredTaxLiabilities" name="AdditionsDeferredTaxLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsDeferredTaxAssetsLiabilitiesNet" name="AdditionsDeferredTaxAssetsLiabilitiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeferredTaxExpenseIncomes" name="DeferredTaxExpenseIncomes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RecognizedDeferredTaxAssets" name="RecognizedDeferredTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContingenciesCorrespondentAmount" name="ContingenciesCorrespondentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RemeasurementOfEarnOut" name="RemeasurementOfEarnOut" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" name="AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet" name="AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders" name="AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsPayables" name="DividendsPayables" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>36
<FILENAME>afya-20251231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Cover" roleURI="http://afya.com.br/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#StatementOfFinancialPosition" roleURI="http://afya.com.br/role/StatementOfFinancialPosition" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#StatementOfIncomeAndOtherComprehensiveIncome" roleURI="http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#StatementOfChangesInEquity" roleURI="http://afya.com.br/role/StatementOfChangesInEquity" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#StatementOfCashFlows" roleURI="http://afya.com.br/role/StatementOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#MaterialCybersecurityIncidentDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CorporateInformation" roleURI="http://afya.com.br/role/CorporateInformation" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPolicies" roleURI="http://afya.com.br/role/MaterialAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SegmentInformation" roleURI="http://afya.com.br/role/SegmentInformation" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinations" roleURI="http://afya.com.br/role/BusinessCombinations" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CashAndCashEquivalents" roleURI="http://afya.com.br/role/CashAndCashEquivalents" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivables" roleURI="http://afya.com.br/role/TradeReceivables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedParties" roleURI="http://afya.com.br/role/RelatedParties" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#OtherAssets" roleURI="http://afya.com.br/role/OtherAssets" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#InvestmentInAssociate" roleURI="http://afya.com.br/role/InvestmentInAssociate" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#PropertyAndEquipment" roleURI="http://afya.com.br/role/PropertyAndEquipment" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssets" roleURI="http://afya.com.br/role/IntangibleAssets" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilities" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilities" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CapitalManagement" roleURI="http://afya.com.br/role/CapitalManagement" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligations" roleURI="http://afya.com.br/role/LaborAndSocialObligations" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Equity" roleURI="http://afya.com.br/role/Equity" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EarningsPerShare" roleURI="http://afya.com.br/role/EarningsPerShare" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Revenue" roleURI="http://afya.com.br/role/Revenue" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CostsAndExpensesByNature" roleURI="http://afya.com.br/role/CostsAndExpensesByNature" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinanceResult" roleURI="http://afya.com.br/role/FinanceResult" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxes" roleURI="http://afya.com.br/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingencies" roleURI="http://afya.com.br/role/LegalProceedingsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Non-cashTransactions" roleURI="http://afya.com.br/role/Non-cashTransactions" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SubsequentEvents" roleURI="http://afya.com.br/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesPolicies" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CorporateInformationTables" roleURI="http://afya.com.br/role/CorporateInformationTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesTables" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SegmentInformationTables" roleURI="http://afya.com.br/role/SegmentInformationTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinationsTables" roleURI="http://afya.com.br/role/BusinessCombinationsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CashAndCashEquivalentsTables" roleURI="http://afya.com.br/role/CashAndCashEquivalentsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivablesTables" roleURI="http://afya.com.br/role/TradeReceivablesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedPartiesTables" roleURI="http://afya.com.br/role/RelatedPartiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#OtherAssetsTables" roleURI="http://afya.com.br/role/OtherAssetsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#InvestmentInAssociateTables" roleURI="http://afya.com.br/role/InvestmentInAssociateTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#PropertyAndEquipmentTables" roleURI="http://afya.com.br/role/PropertyAndEquipmentTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsTables" roleURI="http://afya.com.br/role/IntangibleAssetsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesTables" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsTables" roleURI="http://afya.com.br/role/LaborAndSocialObligationsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EquityTables" roleURI="http://afya.com.br/role/EquityTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EarningsPerShareTables" roleURI="http://afya.com.br/role/EarningsPerShareTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RevenueTables" roleURI="http://afya.com.br/role/RevenueTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CostsAndExpensesByNatureTables" roleURI="http://afya.com.br/role/CostsAndExpensesByNatureTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinanceResultTables" roleURI="http://afya.com.br/role/FinanceResultTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxesTables" roleURI="http://afya.com.br/role/IncomeTaxesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingenciesTables" roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Non-cashTransactionsTables" roleURI="http://afya.com.br/role/Non-cashTransactionsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CorporateInformationDetails" roleURI="http://afya.com.br/role/CorporateInformationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CorporateInformationDetailsNarrative" roleURI="http://afya.com.br/role/CorporateInformationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails1" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails2" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails3" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails4" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails4" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails5" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails5" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetailsNarrative" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SegmentInformationDetails" roleURI="http://afya.com.br/role/SegmentInformationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SegmentInformationDetails1" roleURI="http://afya.com.br/role/SegmentInformationDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinationsDetails" roleURI="http://afya.com.br/role/BusinessCombinationsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinationsDetails1" roleURI="http://afya.com.br/role/BusinessCombinationsDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinationsDetailsNarrative" roleURI="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CashAndCashEquivalentsDetails" roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CashAndCashEquivalentsDetailsNarrative" roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivablesDetails" roleURI="http://afya.com.br/role/TradeReceivablesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivablesDetails1" roleURI="http://afya.com.br/role/TradeReceivablesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivablesDetails2" roleURI="http://afya.com.br/role/TradeReceivablesDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedPartiesDetails" roleURI="http://afya.com.br/role/RelatedPartiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedPartiesDetails1" roleURI="http://afya.com.br/role/RelatedPartiesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedPartiesDetailsNarrative" roleURI="http://afya.com.br/role/RelatedPartiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#OtherAssetsDetails" roleURI="http://afya.com.br/role/OtherAssetsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#InvestmentInAssociateDetails" roleURI="http://afya.com.br/role/InvestmentInAssociateDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#PropertyAndEquipmentDetails" roleURI="http://afya.com.br/role/PropertyAndEquipmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsDetails" roleURI="http://afya.com.br/role/IntangibleAssetsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsDetails1" roleURI="http://afya.com.br/role/IntangibleAssetsDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsDetails2" roleURI="http://afya.com.br/role/IntangibleAssetsDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsDetailsNarrative" roleURI="http://afya.com.br/role/IntangibleAssetsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails1" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails2" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails3" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails4" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails5" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails6" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails7" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails8" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails9" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails10" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails11" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetailsNarrative" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetails" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetails1" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetails2" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetails3" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetailsNarrative" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EquityDetails" roleURI="http://afya.com.br/role/EquityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EquityDetailsNarrative" roleURI="http://afya.com.br/role/EquityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EarningsPerShareDetails" roleURI="http://afya.com.br/role/EarningsPerShareDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RevenueDetails" roleURI="http://afya.com.br/role/RevenueDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RevenueDetails1" roleURI="http://afya.com.br/role/RevenueDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CostsAndExpensesByNatureDetails" roleURI="http://afya.com.br/role/CostsAndExpensesByNatureDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinanceResultDetails" roleURI="http://afya.com.br/role/FinanceResultDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxesDetails" roleURI="http://afya.com.br/role/IncomeTaxesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxesDetails1" roleURI="http://afya.com.br/role/IncomeTaxesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxesDetailsNarrative" roleURI="http://afya.com.br/role/IncomeTaxesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingenciesDetails" roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingenciesDetails1" roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingenciesDetailsNarrative" roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Non-cashTransactionsDetails" roleURI="http://afya.com.br/role/Non-cashTransactionsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SubsequentEventsDetailsNarrative" roleURI="http://afya.com.br/role/SubsequentEventsDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementOfFinancialPosition" xlink:title="00000002 - Statement - Consolidated statement of financial position">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCurrentTradeReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxAssets" xlink:label="loc_ifrs-fullCurrentTaxAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCurrentTaxAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeTaxesRecoverable" xlink:label="loc_afyaIncomeTaxesRecoverable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_afyaIncomeTaxesRecoverable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-fullOtherCurrentAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullOtherCurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrentTradeReceivable" xlink:label="loc_afyaNoncurrentTradeReceivable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_afyaNoncurrentTradeReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-fullDeferredTaxAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullDeferredTaxAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-fullOtherNoncurrentAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullOtherNoncurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-fullInvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullRightofuseAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayables" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermBorrowings" xlink:label="loc_ifrs-fullShorttermBorrowings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullShorttermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="loc_ifrs-fullCurrentDepositsFromCustomers" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentDepositsFromCustomers" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPayable" xlink:label="loc_ifrs-fullDividendsPayable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullDividendsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-fullCurrentRecognisedLiabilitiesDefinedBenefitPlan" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CurrentTaxesPayable" xlink:label="loc_afyaCurrentTaxesPayable" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_afyaCurrentTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="loc_ifrs-fullOtherCurrentLiabilities" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-fullLongtermBorrowings" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullLongtermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullNoncurrentPayablesToRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullNoncurrentPayablesToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrentTaxesPayable" xlink:label="loc_afyaNoncurrentTaxesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_afyaNoncurrentTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-fullDeferredTaxLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullDeferredTaxLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermLegalProceedingsProvision" xlink:label="loc_ifrs-fullLongtermLegalProceedingsProvision" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullLongtermLegalProceedingsProvision" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-fullOtherNoncurrentLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullOtherNoncurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-fullEquityAttributableToOwnersOfParent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalPaidinCapital" xlink:label="loc_ifrs-fullAdditionalPaidinCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullAdditionalPaidinCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-fullTreasuryShares" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullTreasuryShares" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-fullReserveOfSharebasedPayments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullReserveOfSharebasedPayments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-fullRetainedEarnings" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullRetainedEarnings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-fullNoncontrollingInterests" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullNoncontrollingInterests" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAndLiabilities" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAndLiabilities" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome" xlink:title="00000003 - Statement - Consolidated statement of income and other comprehensive income">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-fullGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullGrossProfit" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullGrossProfit" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForExpectedCreditLosses" xlink:label="loc_afyaAllowanceForExpectedCreditLosses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_afyaAllowanceForExpectedCreditLosses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-fullOtherOperatingIncomeExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullOtherOperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherExpenseByNature" xlink:label="loc_ifrs-fullOtherExpenseByNature" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullOtherExpenseByNature" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-fullFinanceIncomeCost" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceIncomeCost" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceIncomeCost" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullFinanceIncomeCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-fullShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeTaxesExpensesCurrent" xlink:label="loc_afyaIncomeTaxesExpensesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_afyaIncomeTaxesExpensesCurrent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxes" xlink:label="loc_afyaDeferredTaxes" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_afyaDeferredTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullComprehensiveIncome" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullComprehensiveIncome" xlink:to="loc_ifrs-fullOtherComprehensiveIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ComprehensiveIncomeLoss" xlink:label="loc_afyaComprehensiveIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-fullProfitLossAttributableToOwnersOfParent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaComprehensiveIncomeLoss" xlink:to="loc_ifrs-fullProfitLossAttributableToOwnersOfParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-fullProfitLossAttributableToNoncontrollingInterests" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaComprehensiveIncomeLoss" xlink:to="loc_ifrs-fullProfitLossAttributableToNoncontrollingInterests" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementOfChangesInEquity" xlink:title="00000004 - Statement - Consolidated statement of changes in equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementOfCashFlows" xlink:title="00000005 - Statement - Consolidated statement of cash flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeLossBeforeIncomeTaxes" xlink:label="loc_afyaIncomeLossBeforeIncomeTaxes" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaIncomeLossBeforeIncomeTaxes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-fullAdjustmentsForDepreciationAndAmortisationExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDepreciationAndAmortisationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WriteoffOfPropertyAndEquipment" xlink:label="loc_afyaWriteoffOfPropertyAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaWriteoffOfPropertyAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WriteoffOfIntangibleAssets" xlink:label="loc_afyaWriteoffOfIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaWriteoffOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:label="loc_afyaAllowanceForDoubtfulAccountsOfOpeartingActivities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaAllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-fullAdjustmentsForSharebasedPayments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForSharebasedPayments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccruedInterestOfOpeartingActivities" xlink:label="loc_afyaAccruedInterestOfOpeartingActivities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaAccruedInterestOfOpeartingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax" xlink:label="loc_afyaShareOfProfitOfEquityaccountedInvesteeNetOfTax" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaShareOfProfitOfEquityaccountedInvesteeNetOfTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="loc_ifrs-fullAdjustmentsForProvisions" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForProvisions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseDecreaseInRecoverableTaxes" xlink:label="loc_afyaIncreaseDecreaseInRecoverableTaxes" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaIncreaseDecreaseInRecoverableTaxes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="loc_ifrs-fullOtherAdjustmentsForNoncashItems" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullOtherAdjustmentsForNoncashItems" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseDecreaseInPaymentsOfLegalProceedings" xlink:label="loc_afyaIncreaseDecreaseInPaymentsOfLegalProceedings" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaIncreaseDecreaseInPaymentsOfLegalProceedings" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherLiabilities" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-fullIncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullIncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:label="loc_afyaPurchaseOfIntangibleAssetClassifiedAsInvestingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_afyaPurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsReceived" xlink:label="loc_ifrs-fullDividendsReceived" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullDividendsReceived" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PurchaseOfAcquisitionOfNoncontrollingInterests" xlink:label="loc_afyaPurchaseOfAcquisitionOfNoncontrollingInterests" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_afyaPurchaseOfAcquisitionOfNoncontrollingInterests" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentsOfInterest" xlink:label="loc_afyaPaymentsOfInterest" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_afyaPaymentsOfInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullRepaymentsOfBorrowingsClassifiedAsFinancingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullRepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RepaymentsOfInterest" xlink:label="loc_afyaRepaymentsOfInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_afyaRepaymentsOfInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullProceedsFromBorrowingsClassifiedAsFinancingActivities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_afyaPaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_afyaPaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TreasurySharesRepurchase" xlink:label="loc_afyaTreasurySharesRepurchase" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_afyaTreasurySharesRepurchase" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-fullProceedsFromExerciseOfOptions" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullProceedsFromExerciseOfOptions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullDividendsPaidClassifiedAsFinancingActivities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullDividendsPaidClassifiedAsFinancingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000011 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000012 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformation" xlink:title="999013 - Disclosure - Corporate information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPolicies" xlink:title="999014 - Disclosure - Material accounting policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformation" xlink:title="999015 - Disclosure - Segment information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinations" xlink:title="999016 - Disclosure - Business combinations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalents" xlink:title="999017 - Disclosure - Cash and cash equivalents" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivables" xlink:title="999018 - Disclosure - Trade receivables" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedParties" xlink:title="999019 - Disclosure - Related parties" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssets" xlink:title="999020 - Disclosure - Other assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociate" xlink:title="999021 - Disclosure - Investment in associate" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipment" xlink:title="999022 - Disclosure - Property and equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssets" xlink:title="999023 - Disclosure - Intangible assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilities" xlink:title="999024 - Disclosure - Financial assets and liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CapitalManagement" xlink:title="999025 - Disclosure - Capital management" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligations" xlink:title="999026 - Disclosure - Labor and social obligations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Equity" xlink:title="999027 - Disclosure - Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShare" xlink:title="999028 - Disclosure - Earnings per share" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Revenue" xlink:title="999029 - Disclosure - Revenue" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CostsAndExpensesByNature" xlink:title="999030 - Disclosure - Costs and expenses by nature" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResult" xlink:title="999031 - Disclosure - Finance result" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxes" xlink:title="999032 - Disclosure - Income taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingencies" xlink:title="999033 - Disclosure - Legal proceedings and contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactions" xlink:title="999034 - Disclosure - Non-cash transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEvents" xlink:title="999035 - Disclosure - Subsequent events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" xlink:title="999036 - Disclosure - Material accounting policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationTables" xlink:title="999037 - Disclosure - Corporate information (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesTables" xlink:title="999038 - Disclosure - Material accounting policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationTables" xlink:title="999039 - Disclosure - Segment information (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsTables" xlink:title="999040 - Disclosure - Business combinations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:title="999041 - Disclosure - Cash and cash equivalents (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesTables" xlink:title="999042 - Disclosure - Trade receivables (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesTables" xlink:title="999043 - Disclosure - Related parties (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsTables" xlink:title="999044 - Disclosure - Other assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateTables" xlink:title="999045 - Disclosure - Investment in associate (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:title="999046 - Disclosure - Property and equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsTables" xlink:title="999047 - Disclosure - Intangible assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables" xlink:title="999048 - Disclosure - Financial assets and liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:title="999049 - Disclosure - Labor and social obligations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityTables" xlink:title="999050 - Disclosure - Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareTables" xlink:title="999051 - Disclosure - Earnings per share (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueTables" xlink:title="999052 - Disclosure - Revenue (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CostsAndExpensesByNatureTables" xlink:title="999053 - Disclosure - Costs and expenses by nature (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultTables" xlink:title="999054 - Disclosure - Finance result (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesTables" xlink:title="999055 - Disclosure - Income taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingenciesTables" xlink:title="999056 - Disclosure - Legal proceedings and contingencies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactionsTables" xlink:title="999057 - Disclosure - Non-cash transactions (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationDetails" xlink:title="999058 - Disclosure - Corporate information (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:title="999059 - Disclosure - Corporate information (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails" xlink:title="999060 - Disclosure - Material accounting policies (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" xlink:title="999061 - Disclosure - Material accounting policies (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" xlink:title="999062 - Disclosure - Material accounting policies (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails3" xlink:title="999063 - Disclosure - Material accounting policies (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails4" xlink:title="999064 - Disclosure - Material accounting policies (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails5" xlink:title="999065 - Disclosure - Material accounting policies (Details 5)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" xlink:title="999066 - Disclosure - Material accounting policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationDetails" xlink:title="999067 - Disclosure - Segment information (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationDetails1" xlink:title="999068 - Disclosure - Segment information (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails" xlink:title="999069 - Disclosure - Business combinations (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails1" xlink:title="999070 - Disclosure - Business combinations (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:title="999071 - Disclosure - Business combinations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetails" xlink:title="999072 - Disclosure - Cash and cash equivalents (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:title="999073 - Disclosure - Cash and cash equivalents (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails" xlink:title="999074 - Disclosure - Trade receivables (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails1" xlink:title="999075 - Disclosure - Trade receivables (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails2" xlink:title="999076 - Disclosure - Trade receivables (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetails" xlink:title="999077 - Disclosure - Related parties (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetails1" xlink:title="999078 - Disclosure - Related parties (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:title="999079 - Disclosure - Related parties (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsDetails" xlink:title="999080 - Disclosure - Other assets (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Assets1" xlink:label="loc_afyaAssets1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Advances1" xlink:label="loc_afyaAdvances1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_afyaAdvances1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_JudicialDeposits" xlink:label="loc_afyaJudicialDeposits" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_afyaJudicialDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-fullCurrentPrepaidExpenses" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_ifrs-fullCurrentPrepaidExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-fullOtherReceivables" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_ifrs-fullOtherReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConvertibleLoansFromVentureCapitalInvestments" xlink:label="loc_afyaConvertibleLoansFromVentureCapitalInvestments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_afyaConvertibleLoansFromVentureCapitalInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Dividend" xlink:label="loc_afyaDividend" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_afyaDividend" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherAssets1" xlink:label="loc_afyaOtherAssets1" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_afyaOtherAssets1" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateDetails" xlink:title="999081 - Disclosure - Investment in associate (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentDetails" xlink:title="999082 - Disclosure - Property and equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsDetails" xlink:title="999083 - Disclosure - Intangible assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsDetails1" xlink:title="999084 - Disclosure - Intangible assets (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsDetails2" xlink:title="999085 - Disclosure - Intangible assets (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsDetailsNarrative" xlink:title="999086 - Disclosure - Intangible assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails" xlink:title="999087 - Disclosure - Financial assets and liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1" xlink:title="999088 - Disclosure - Financial assets and liabilities (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2" xlink:title="999089 - Disclosure - Financial assets and liabilities (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3" xlink:title="999090 - Disclosure - Financial assets and liabilities (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4" xlink:title="999091 - Disclosure - Financial assets and liabilities  (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5" xlink:title="999092 - Disclosure - Financial assets and liabilities (Details 5)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6" xlink:title="999093 - Disclosure - Financial assets and liabilities (Details 6)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7" xlink:title="999094 - Disclosure - Financial assets and liabilities (Details 7)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8" xlink:title="999095 - Disclosure - Financial assets and liabilities (Details 8)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9" xlink:title="999096 - Disclosure - Financial assets and liabilities (Details 9)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10" xlink:title="999097 - Disclosure - Financial assets and liabilities (Details 10)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11" xlink:title="999098 - Disclosure - Financial assets and liabilities (Details 11)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative" xlink:title="999099 - Disclosure - Financial assets and liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails" xlink:title="999100 - Disclosure - Labor and social obligations (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails1" xlink:title="999101 - Disclosure - Labor and social obligations (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails2" xlink:title="999102 - Disclosure - Labor and social obligations (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails3" xlink:title="999103 - Disclosure - Labor and social obligations (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:title="999104 - Disclosure - Labor and social obligations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetails" xlink:title="999105 - Disclosure - Equity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetailsNarrative" xlink:title="999106 - Disclosure - Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareDetails" xlink:title="999107 - Disclosure - Earnings per share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueDetails" xlink:title="999108 - Disclosure - Revenue (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueDetails1" xlink:title="999109 - Disclosure - Revenue (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CostsAndExpensesByNatureDetails" xlink:title="999110 - Disclosure - Costs and expenses by nature (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultDetails" xlink:title="999111 - Disclosure - Finance result (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetails" xlink:title="999112 - Disclosure - Income taxes (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetails1" xlink:title="999113 - Disclosure - Income taxes (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:title="999114 - Disclosure - Income taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails" xlink:title="999115 - Disclosure - Legal proceedings and contingencies (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1" xlink:title="999116 - Disclosure - Legal proceedings and contingencies (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative" xlink:title="999117 - Disclosure - Legal proceedings and contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactionsDetails" xlink:title="999118 - Disclosure - Non-cash transactions (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEventsDetailsNarrative" xlink:title="999119 - Disclosure - Subsequent events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>37
<FILENAME>afya-20251231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Cover" roleURI="http://afya.com.br/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#StatementOfFinancialPosition" roleURI="http://afya.com.br/role/StatementOfFinancialPosition" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#StatementOfIncomeAndOtherComprehensiveIncome" roleURI="http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#StatementOfChangesInEquity" roleURI="http://afya.com.br/role/StatementOfChangesInEquity" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#StatementOfCashFlows" roleURI="http://afya.com.br/role/StatementOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#MaterialCybersecurityIncidentDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CorporateInformation" roleURI="http://afya.com.br/role/CorporateInformation" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPolicies" roleURI="http://afya.com.br/role/MaterialAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SegmentInformation" roleURI="http://afya.com.br/role/SegmentInformation" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinations" roleURI="http://afya.com.br/role/BusinessCombinations" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CashAndCashEquivalents" roleURI="http://afya.com.br/role/CashAndCashEquivalents" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivables" roleURI="http://afya.com.br/role/TradeReceivables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedParties" roleURI="http://afya.com.br/role/RelatedParties" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#OtherAssets" roleURI="http://afya.com.br/role/OtherAssets" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#InvestmentInAssociate" roleURI="http://afya.com.br/role/InvestmentInAssociate" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#PropertyAndEquipment" roleURI="http://afya.com.br/role/PropertyAndEquipment" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssets" roleURI="http://afya.com.br/role/IntangibleAssets" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilities" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilities" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CapitalManagement" roleURI="http://afya.com.br/role/CapitalManagement" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligations" roleURI="http://afya.com.br/role/LaborAndSocialObligations" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Equity" roleURI="http://afya.com.br/role/Equity" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EarningsPerShare" roleURI="http://afya.com.br/role/EarningsPerShare" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Revenue" roleURI="http://afya.com.br/role/Revenue" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CostsAndExpensesByNature" roleURI="http://afya.com.br/role/CostsAndExpensesByNature" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinanceResult" roleURI="http://afya.com.br/role/FinanceResult" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxes" roleURI="http://afya.com.br/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingencies" roleURI="http://afya.com.br/role/LegalProceedingsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Non-cashTransactions" roleURI="http://afya.com.br/role/Non-cashTransactions" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SubsequentEvents" roleURI="http://afya.com.br/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesPolicies" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CorporateInformationTables" roleURI="http://afya.com.br/role/CorporateInformationTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesTables" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SegmentInformationTables" roleURI="http://afya.com.br/role/SegmentInformationTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinationsTables" roleURI="http://afya.com.br/role/BusinessCombinationsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CashAndCashEquivalentsTables" roleURI="http://afya.com.br/role/CashAndCashEquivalentsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivablesTables" roleURI="http://afya.com.br/role/TradeReceivablesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedPartiesTables" roleURI="http://afya.com.br/role/RelatedPartiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#OtherAssetsTables" roleURI="http://afya.com.br/role/OtherAssetsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#InvestmentInAssociateTables" roleURI="http://afya.com.br/role/InvestmentInAssociateTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#PropertyAndEquipmentTables" roleURI="http://afya.com.br/role/PropertyAndEquipmentTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsTables" roleURI="http://afya.com.br/role/IntangibleAssetsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesTables" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsTables" roleURI="http://afya.com.br/role/LaborAndSocialObligationsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EquityTables" roleURI="http://afya.com.br/role/EquityTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EarningsPerShareTables" roleURI="http://afya.com.br/role/EarningsPerShareTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RevenueTables" roleURI="http://afya.com.br/role/RevenueTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CostsAndExpensesByNatureTables" roleURI="http://afya.com.br/role/CostsAndExpensesByNatureTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinanceResultTables" roleURI="http://afya.com.br/role/FinanceResultTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxesTables" roleURI="http://afya.com.br/role/IncomeTaxesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingenciesTables" roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Non-cashTransactionsTables" roleURI="http://afya.com.br/role/Non-cashTransactionsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CorporateInformationDetails" roleURI="http://afya.com.br/role/CorporateInformationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CorporateInformationDetailsNarrative" roleURI="http://afya.com.br/role/CorporateInformationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails1" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails2" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails3" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails4" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails4" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails5" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails5" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetailsNarrative" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SegmentInformationDetails" roleURI="http://afya.com.br/role/SegmentInformationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SegmentInformationDetails1" roleURI="http://afya.com.br/role/SegmentInformationDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinationsDetails" roleURI="http://afya.com.br/role/BusinessCombinationsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinationsDetails1" roleURI="http://afya.com.br/role/BusinessCombinationsDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinationsDetailsNarrative" roleURI="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CashAndCashEquivalentsDetails" roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CashAndCashEquivalentsDetailsNarrative" roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivablesDetails" roleURI="http://afya.com.br/role/TradeReceivablesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivablesDetails1" roleURI="http://afya.com.br/role/TradeReceivablesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivablesDetails2" roleURI="http://afya.com.br/role/TradeReceivablesDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedPartiesDetails" roleURI="http://afya.com.br/role/RelatedPartiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedPartiesDetails1" roleURI="http://afya.com.br/role/RelatedPartiesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedPartiesDetailsNarrative" roleURI="http://afya.com.br/role/RelatedPartiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#OtherAssetsDetails" roleURI="http://afya.com.br/role/OtherAssetsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#InvestmentInAssociateDetails" roleURI="http://afya.com.br/role/InvestmentInAssociateDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#PropertyAndEquipmentDetails" roleURI="http://afya.com.br/role/PropertyAndEquipmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsDetails" roleURI="http://afya.com.br/role/IntangibleAssetsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsDetails1" roleURI="http://afya.com.br/role/IntangibleAssetsDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsDetails2" roleURI="http://afya.com.br/role/IntangibleAssetsDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsDetailsNarrative" roleURI="http://afya.com.br/role/IntangibleAssetsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails1" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails2" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails3" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails4" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails5" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails6" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails7" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails8" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails9" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails10" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails11" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetailsNarrative" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetails" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetails1" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetails2" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetails3" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetailsNarrative" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EquityDetails" roleURI="http://afya.com.br/role/EquityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EquityDetailsNarrative" roleURI="http://afya.com.br/role/EquityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EarningsPerShareDetails" roleURI="http://afya.com.br/role/EarningsPerShareDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RevenueDetails" roleURI="http://afya.com.br/role/RevenueDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RevenueDetails1" roleURI="http://afya.com.br/role/RevenueDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CostsAndExpensesByNatureDetails" roleURI="http://afya.com.br/role/CostsAndExpensesByNatureDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinanceResultDetails" roleURI="http://afya.com.br/role/FinanceResultDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxesDetails" roleURI="http://afya.com.br/role/IncomeTaxesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxesDetails1" roleURI="http://afya.com.br/role/IncomeTaxesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxesDetailsNarrative" roleURI="http://afya.com.br/role/IncomeTaxesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingenciesDetails" roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingenciesDetails1" roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingenciesDetailsNarrative" roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Non-cashTransactionsDetails" roleURI="http://afya.com.br/role/Non-cashTransactionsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SubsequentEventsDetailsNarrative" roleURI="http://afya.com.br/role/SubsequentEventsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-fullClassesOfShareCapitalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-fullClassesOfShareCapitalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalDomain" xlink:to="loc_afyaClassAOrdinarySharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassACommonSharesHeldInTreasuryMember" xlink:label="loc_afyaClassACommonSharesHeldInTreasuryMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalDomain" xlink:to="loc_afyaClassACommonSharesHeldInTreasuryMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalDomain" xlink:to="loc_afyaClassBOrdinarySharesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_60" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_60" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_60" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_60" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_60" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_60" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_60" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_60" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_60" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_60" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_60" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_60" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_60" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_60" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_60" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_60" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_60" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_60" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_60" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_60" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_deiContactPersonnelEmailAddress_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelEmailAddress_60" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag_60" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorFirmId_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorName_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorLocation_60" xlink:type="arc" order="64" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementOfFinancialPosition" xlink:title="00000002 - Statement - Consolidated statement of financial position" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome" xlink:title="00000003 - Statement - Consolidated statement of income and other comprehensive income" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementOfChangesInEquity" xlink:title="00000004 - Statement - Consolidated statement of changes in equity">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-fullComponentsOfEquityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullComponentsOfEquityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-fullComponentsOfEquityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullComponentsOfEquityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-fullComponentsOfEquityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullComponentsOfEquityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-fullIssuedCapitalMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_ifrs-fullIssuedCapitalMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalPaidinCapitalMember" xlink:label="loc_ifrs-fullAdditionalPaidinCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_ifrs-fullAdditionalPaidinCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-fullTreasurySharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_ifrs-fullTreasurySharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-fullReserveOfSharebasedPaymentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_ifrs-fullReserveOfSharebasedPaymentsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-fullRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_ifrs-fullRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-fullEquityAttributableToOwnersOfParentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_ifrs-fullEquityAttributableToOwnersOfParentMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-fullNoncontrollingInterestsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullComponentsOfEquityDomain" xlink:to="loc_ifrs-fullNoncontrollingInterestsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullComprehensiveIncome_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TreasurySharesRepurchase" xlink:label="loc_afyaTreasurySharesRepurchase_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesRepurchase_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AcquisitionOfNoncontrollingInterests" xlink:label="loc_afyaAcquisitionOfNoncontrollingInterests_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquisitionOfNoncontrollingInterests_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedSharesTransferredToExecutives" xlink:label="loc_afyaRestrictedSharesTransferredToExecutives_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRestrictedSharesTransferredToExecutives_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" xlink:label="loc_afyaTreasurySharesTransferredToExecutivesFromExerciseOfStockOptions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesTransferredToExecutivesFromExerciseOfStockOptions_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaid" xlink:label="loc_ifrs-fullDividendsPaid_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaid_90" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementOfCashFlows" xlink:title="00000005 - Statement - Consolidated statement of cash flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000011 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000012 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformation" xlink:title="999013 - Disclosure - Corporate information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPolicies" xlink:title="999014 - Disclosure - Material accounting policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformation" xlink:title="999015 - Disclosure - Segment information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinations" xlink:title="999016 - Disclosure - Business combinations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalents" xlink:title="999017 - Disclosure - Cash and cash equivalents" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivables" xlink:title="999018 - Disclosure - Trade receivables" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedParties" xlink:title="999019 - Disclosure - Related parties" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssets" xlink:title="999020 - Disclosure - Other assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociate" xlink:title="999021 - Disclosure - Investment in associate" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipment" xlink:title="999022 - Disclosure - Property and equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssets" xlink:title="999023 - Disclosure - Intangible assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilities" xlink:title="999024 - Disclosure - Financial assets and liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CapitalManagement" xlink:title="999025 - Disclosure - Capital management" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligations" xlink:title="999026 - Disclosure - Labor and social obligations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Equity" xlink:title="999027 - Disclosure - Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShare" xlink:title="999028 - Disclosure - Earnings per share" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Revenue" xlink:title="999029 - Disclosure - Revenue" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CostsAndExpensesByNature" xlink:title="999030 - Disclosure - Costs and expenses by nature" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResult" xlink:title="999031 - Disclosure - Finance result" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxes" xlink:title="999032 - Disclosure - Income taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingencies" xlink:title="999033 - Disclosure - Legal proceedings and contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactions" xlink:title="999034 - Disclosure - Non-cash transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEvents" xlink:title="999035 - Disclosure - Subsequent events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" xlink:title="999036 - Disclosure - Material accounting policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationTables" xlink:title="999037 - Disclosure - Corporate information (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesTables" xlink:title="999038 - Disclosure - Material accounting policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationTables" xlink:title="999039 - Disclosure - Segment information (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsTables" xlink:title="999040 - Disclosure - Business combinations (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:title="999041 - Disclosure - Cash and cash equivalents (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesTables" xlink:title="999042 - Disclosure - Trade receivables (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesTables" xlink:title="999043 - Disclosure - Related parties (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsTables" xlink:title="999044 - Disclosure - Other assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateTables" xlink:title="999045 - Disclosure - Investment in associate (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:title="999046 - Disclosure - Property and equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsTables" xlink:title="999047 - Disclosure - Intangible assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables" xlink:title="999048 - Disclosure - Financial assets and liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:title="999049 - Disclosure - Labor and social obligations (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityTables" xlink:title="999050 - Disclosure - Equity (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareTables" xlink:title="999051 - Disclosure - Earnings per share (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueTables" xlink:title="999052 - Disclosure - Revenue (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CostsAndExpensesByNatureTables" xlink:title="999053 - Disclosure - Costs and expenses by nature (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultTables" xlink:title="999054 - Disclosure - Finance result (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesTables" xlink:title="999055 - Disclosure - Income taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingenciesTables" xlink:title="999056 - Disclosure - Legal proceedings and contingencies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactionsTables" xlink:title="999057 - Disclosure - Non-cash transactions (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationDetails" xlink:title="999058 - Disclosure - Corporate information (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AfyaParticipacoesS.A.Member" xlink:label="loc_afyaAfyaParticipacoesS.A.Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaAfyaParticipacoesS.A.Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingAsOfAcquisitionDate" xlink:label="loc_afyaLoansAndFinancingAsOfAcquisitionDate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingAsOfAcquisitionDate_20" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate_20" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate_20" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:title="999059 - Disclosure - Corporate information (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-fullBusinessCombinationsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullBusinessCombinationsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-fullBusinessCombinationsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullBusinessCombinationsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FaculdadeMasterclassLtdaMember" xlink:label="loc_afyaFaculdadeMasterclassLtdaMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBusinessCombinationsDomain" xlink:to="loc_afyaFaculdadeMasterclassLtdaMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAcquiree" xlink:label="loc_ifrs-fullDescriptionOfAcquiree_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfAcquiree_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionalPaymentToShareholder" xlink:label="loc_afyaAdditionalPaymentToShareholder_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalPaymentToShareholder_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails" xlink:title="999060 - Disclosure - Material accounting policies (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AfyaParticipacoesSAMember" xlink:label="loc_afyaAfyaParticipacoesSAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaAfyaParticipacoesSAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" xlink:label="loc_afyaUniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" xlink:label="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" xlink:label="loc_afyaCentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" xlink:label="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoS.A.FASAMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoS.A.FASAMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" xlink:label="loc_afyaInstitutoParaenseDeEducacaoECulturaLtda.IPECMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoParaenseDeEducacaoECulturaLtda.IPECMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember" xlink:label="loc_afyaSociedadeUniversitariaRedentorS.A.UniRedentorMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaSociedadeUniversitariaRedentorS.A.UniRedentorMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CentroDeEnsinoSaoLucasLtda.UniSLMember" xlink:label="loc_afyaCentroDeEnsinoSaoLucasLtda.UniSLMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCentroDeEnsinoSaoLucasLtda.UniSLMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" xlink:label="loc_afyaSociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaSociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" xlink:label="loc_afyaCentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" xlink:label="loc_afyaIClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaIClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicinaeSolutionsS.A.MedicinaeMember" xlink:label="loc_afyaMedicinaeSolutionsS.A.MedicinaeMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaMedicinaeSolutionsS.A.MedicinaeMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaMedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" xlink:label="loc_afyaCliquefarmaDrogariasOnlineLtda.CliquefarmaMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCliquefarmaDrogariasOnlineLtda.CliquefarmaMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShospTecnologiaDaInformacaoLtda.ShospMember" xlink:label="loc_afyaShospTecnologiaDaInformacaoLtda.ShospMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaShospTecnologiaDaInformacaoLtda.ShospMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" xlink:label="loc_afyaSociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaSociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_400" xlink:type="arc" order="401" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" xlink:label="loc_afyaCompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember" xlink:label="loc_afyaRXPROSolucoesDeTecnologiaLtda.RXPROMember_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaRXPROSolucoesDeTecnologiaLtda.RXPROMember_440" xlink:type="arc" order="441" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" xlink:label="loc_afyaQuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaQuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_460" xlink:type="arc" order="461" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" xlink:label="loc_afyaSociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_480" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaSociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_480" xlink:type="arc" order="481" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnidomParticipacoesS.A.UnidomMember" xlink:label="loc_afyaUnidomParticipacoesS.A.UnidomMember_500" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnidomParticipacoesS.A.UnidomMember_500" xlink:type="arc" order="501" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" xlink:label="loc_afyaInstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_520" xlink:type="arc" order="521" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" xlink:label="loc_afyaSESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_540" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaSESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_540" xlink:type="arc" order="541" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FaculdadeMasterclassLtdaFUNICMember" xlink:label="loc_afyaFaculdadeMasterclassLtdaFUNICMember_560" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFaculdadeMasterclassLtdaFUNICMember_560" xlink:type="arc" order="561" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" xlink:label="loc_afyaUniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_570" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_570" xlink:type="arc" order="571" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PrincipalActivities" xlink:label="loc_afyaPrincipalActivities_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPrincipalActivities_600" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-fullPrincipalPlaceOfBusinessOfSubsidiary_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPrincipalPlaceOfBusinessOfSubsidiary_600" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InvestmentType" xlink:label="loc_afyaInvestmentType_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInvestmentType_600" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_600" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" xlink:title="999061 - Disclosure - Material accounting policies (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel2OfFairValueHierarchyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" xlink:to="loc_ifrs-fullLevel2OfFairValueHierarchyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel3OfFairValueHierarchyMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" xlink:to="loc_ifrs-fullLevel3OfFairValueHierarchyMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets" xlink:label="loc_ifrs-fullDescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets" xlink:label="loc_ifrs-fullDescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ExpectedCashFlows" xlink:label="loc_afyaExpectedCashFlows_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExpectedCashFlows_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProbabilityOfDisbursement" xlink:label="loc_afyaProbabilityOfDisbursement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProbabilityOfDisbursement_80" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" xlink:title="999062 - Disclosure - Material accounting policies (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis" xlink:label="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain" xlink:label="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementAxis" xlink:to="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain" xlink:label="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementAxis" xlink:to="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FVTPLMember" xlink:label="loc_afyaFVTPLMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain" xlink:to="loc_afyaFVTPLMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialAssetsAtAmortizedCostMember" xlink:label="loc_afyaFinancialAssetsAtAmortizedCostMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain" xlink:to="loc_afyaFinancialAssetsAtAmortizedCostMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FVOCIMember" xlink:label="loc_afyaFVOCIMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain" xlink:to="loc_afyaFVOCIMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FVOCI1Member" xlink:label="loc_afyaFVOCI1Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain" xlink:to="loc_afyaFVOCI1Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-fullExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails3" xlink:title="999063 - Disclosure - Material accounting policies (Details 3)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-fullBuildingsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullBuildingsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="loc_afyaMachineryAndEquipmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_afyaMachineryAndEquipmentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-fullVehiclesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullVehiclesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullFixturesAndFittingsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ItEquipmentMember" xlink:label="loc_afyaItEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_afyaItEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LibraryBooksMember" xlink:label="loc_afyaLibraryBooksMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_afyaLibraryBooksMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-fullLeaseholdImprovementsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullLeaseholdImprovementsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails4" xlink:title="999064 - Disclosure - Material accounting policies (Details 4)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:label="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:to="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:label="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:to="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:label="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:to="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CustomerRelationshipsOtherCoursesMember" xlink:label="loc_afyaCustomerRelationshipsOtherCoursesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:to="loc_afyaCustomerRelationshipsOtherCoursesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-fullComputerSoftwareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:to="loc_ifrs-fullComputerSoftwareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:to="loc_ifrs-fullBrandNamesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember" xlink:label="loc_afyaEducationContentDevelopedTechnologyAndEducationalPlatformMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:to="loc_afyaEducationContentDevelopedTechnologyAndEducationalPlatformMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_80" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails5" xlink:title="999065 - Disclosure - Material accounting policies (Details 5)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsAxis" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsDomain" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsAxis" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsDomain" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsAxis" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AmendmentsToIAS21Member" xlink:label="loc_afyaAmendmentsToIAS21Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaAmendmentsToIAS21Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LackOfExchangeabilityAmendmentsToIAS21Member" xlink:label="loc_afyaLackOfExchangeabilityAmendmentsToIAS21Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaLackOfExchangeabilityAmendmentsToIAS21Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member" xlink:label="loc_afyaClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AnnualImprovementsToIFRSAccountingStandardsVolume11Member" xlink:label="loc_afyaAnnualImprovementsToIFRSAccountingStandardsVolume11Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaAnnualImprovementsToIFRSAccountingStandardsVolume11Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member" xlink:label="loc_afyaPowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaPowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IFRS18PresentationAndDisclosureInFinancialStatementsMember" xlink:label="loc_afyaIFRS18PresentationAndDisclosureInFinancialStatementsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaIFRS18PresentationAndDisclosureInFinancialStatementsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:label="loc_ifrs-fullTitleOfInitiallyAppliedIFRS_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTitleOfInitiallyAppliedIFRS_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:label="loc_ifrs-fullDescriptionOfNatureOfChangeInAccountingPolicy_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfNatureOfChangeInAccountingPolicy_70" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" xlink:title="999066 - Disclosure - Material accounting policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProgramOfSocialIntegrationMember" xlink:label="loc_afyaProgramOfSocialIntegrationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="loc_afyaProgramOfSocialIntegrationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:label="loc_afyaContributionForTheFinancingOfSocialSecurityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="loc_afyaContributionForTheFinancingOfSocialSecurityMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-fullProductsAndServicesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="loc_ifrs-fullProductsAndServicesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-fullProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullProductsAndServicesAxis" xlink:to="loc_ifrs-fullProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-fullProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullProductsAndServicesAxis" xlink:to="loc_ifrs-fullProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TeachingActivitiesMember" xlink:label="loc_afyaTeachingActivitiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullProductsAndServicesDomain" xlink:to="loc_afyaTeachingActivitiesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NonTeachingActivitiesMember" xlink:label="loc_afyaNonTeachingActivitiesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullProductsAndServicesDomain" xlink:to="loc_afyaNonTeachingActivitiesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsAxis" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsDomain" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsAxis" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsDomain" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsAxis" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OrganizationForEconomicCooperationAndDevelopmentMember" xlink:label="loc_afyaOrganizationForEconomicCooperationAndDevelopmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaOrganizationForEconomicCooperationAndDevelopmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-fullApplicableTaxRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullApplicableTaxRate_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="loc_ifrs-fullAverageEffectiveTaxRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAverageEffectiveTaxRate_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConsolidatedRevenues" xlink:label="loc_afyaConsolidatedRevenues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsolidatedRevenues_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MinimumTaxRate" xlink:label="loc_afyaMinimumTaxRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaMinimumTaxRate_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-fullCurrentTaxLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentTaxLiabilitiesCurrent_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationDetails" xlink:title="999067 - Disclosure - Segment information (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-fullSegmentConsolidationItemsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain" xlink:label="loc_ifrs-fullSegmentConsolidationItemsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullSegmentConsolidationItemsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain" xlink:label="loc_ifrs-fullSegmentConsolidationItemsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullSegmentConsolidationItemsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-fullOperatingSegmentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentConsolidationItemsDomain" xlink:to="loc_ifrs-fullOperatingSegmentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-fullSegmentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-fullSegmentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UndergraduateMember" xlink:label="loc_afyaUndergraduateMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaUndergraduateMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaContinuingEducationMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicalPracticeSolutionsMember" xlink:label="loc_afyaMedicalPracticeSolutionsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaMedicalPracticeSolutionsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TotalReportableSegmentsMember" xlink:label="loc_afyaTotalReportableSegmentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaTotalReportableSegmentsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EliminationInterSegmentBalancesMember" xlink:label="loc_afyaEliminationInterSegmentBalancesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaEliminationInterSegmentBalancesMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAssets_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquityAndLiabilities_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CapitalExpenditures" xlink:label="loc_afyaCapitalExpenditures_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalExpenditures_130" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationDetails1" xlink:title="999068 - Disclosure - Segment information (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-fullSegmentConsolidationItemsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain" xlink:label="loc_ifrs-fullSegmentConsolidationItemsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullSegmentConsolidationItemsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain" xlink:label="loc_ifrs-fullSegmentConsolidationItemsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullSegmentConsolidationItemsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-fullOperatingSegmentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentConsolidationItemsDomain" xlink:to="loc_ifrs-fullOperatingSegmentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-fullSegmentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-fullSegmentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UndergraduateMember" xlink:label="loc_afyaUndergraduateMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaUndergraduateMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaContinuingEducationMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicalPracticeSolutionsMember" xlink:label="loc_afyaMedicalPracticeSolutionsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaMedicalPracticeSolutionsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TotalReportableSegmentsMember" xlink:label="loc_afyaTotalReportableSegmentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaTotalReportableSegmentsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="loc_afyaAdjustmentsAndEliminationsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaAdjustmentsAndEliminationsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DepositsFromExternalCustomer" xlink:label="loc_afyaDepositsFromExternalCustomer_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDepositsFromExternalCustomer_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InterSegment" xlink:label="loc_afyaInterSegment_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInterSegment_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CostOfSale" xlink:label="loc_afyaCostOfSale_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCostOfSale_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-fullGrossProfit_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGrossProfit_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullSellingGeneralAndAdministrativeExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullSellingGeneralAndAdministrativeExpense_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForExpectedCreditLosses" xlink:label="loc_afyaAllowanceForExpectedCreditLosses_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAllowanceForExpectedCreditLosses_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-fullOtherIncome_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherIncome_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherGainsLosses" xlink:label="loc_ifrs-fullOtherGainsLosses_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherGainsLosses_190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities_190" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinanceIncome_190" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinanceExpense" xlink:label="loc_afyaFinanceExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinanceExpense_190" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-fullAdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_190" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax_190" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations_190" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss_190" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails" xlink:title="999069 - Disclosure - Business combinations (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnidomMember" xlink:label="loc_afyaUnidomMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnidomMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="loc_afyaTradeReceivablesAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesAsOfAcquisitionDate_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdvancesRecognisedAsOfAcquisitionDate" xlink:label="loc_afyaAdvancesRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdvancesRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RecoverableTaxesAsOfAcquisitionDate" xlink:label="loc_afyaRecoverableTaxesAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRecoverableTaxesAsOfAcquisitionDate_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="loc_afyaOtherAssetsAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsAsOfAcquisitionDate_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IndemnificationAssetsAsOfAcquisitionDate" xlink:label="loc_afyaIndemnificationAssetsAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIndemnificationAssetsAsOfAcquisitionDate_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_afyaRightOfUseAssetsAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRightOfUseAssetsAsOfAcquisitionDate_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingAsOfAcquisitionDate" xlink:label="loc_afyaLoansAndFinancingAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingAsOfAcquisitionDate_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="loc_afyaTaxesPayableAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTaxesPayableAsOfAcquisitionDate_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherTaxesPayableAsOfAcquisitionDate" xlink:label="loc_afyaOtherTaxesPayableAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherTaxesPayableAsOfAcquisitionDate_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:label="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaOtherLiabilitiesAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherLiabilitiesAsOfAcquisitionDate_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred_30" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-fullCashTransferred_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashTransferred_30" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConsiderationToBeTransferred" xlink:label="loc_afyaConsiderationToBeTransferred_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsiderationToBeTransferred_30" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_30" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_30" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="loc_afyaNetOfCashFlowOnAcquisition_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetOfCashFlowOnAcquisition_30" xlink:type="arc" order="27" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails1" xlink:title="999070 - Disclosure - Business combinations (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="loc_ifrs-fullLicencesAndFranchisesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_ifrs-fullLicencesAndFranchisesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AcquisitionOfUnidomMember" xlink:label="loc_afyaAcquisitionOfUnidomMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaAcquisitionOfUnidomMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesDomain" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesDomain" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WithAndWithoutMethodMember" xlink:label="loc_afyaWithAndWithoutMethodMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesDomain" xlink:to="loc_afyaWithAndWithoutMethodMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:label="loc_ifrs-fullMultiperiodExcessEarningsMethodMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesDomain" xlink:to="loc_ifrs-fullMultiperiodExcessEarningsMethodMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:title="999071 - Disclosure - Business combinations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-fullBusinessCombinationsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullBusinessCombinationsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-fullBusinessCombinationsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullBusinessCombinationsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AcquisitionOfUnidomMember" xlink:label="loc_afyaAcquisitionOfUnidomMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBusinessCombinationsDomain" xlink:to="loc_afyaAcquisitionOfUnidomMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAcquiree" xlink:label="loc_ifrs-fullDescriptionOfAcquiree_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfAcquiree_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination" xlink:label="loc_afyaAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseInRevenue" xlink:label="loc_afyaIncreaseInRevenue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseInRevenue_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseInIncomeBeforeIncomeTaxes" xlink:label="loc_afyaIncreaseInIncomeBeforeIncomeTaxes_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseInIncomeBeforeIncomeTaxes_40" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetails" xlink:title="999072 - Disclosure - Cash and cash equivalents (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:title="999073 - Disclosure - Cash and cash equivalents (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_BankCertificatesOfDepositMember" xlink:label="loc_afyaBankCertificatesOfDepositMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaBankCertificatesOfDepositMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyInWhichInformationIsDisplayedAxis" xlink:label="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember" xlink:label="loc_ifrs-fullFunctionalOrPresentationCurrencyMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" xlink:to="loc_ifrs-fullFunctionalOrPresentationCurrencyMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember" xlink:label="loc_ifrs-fullFunctionalOrPresentationCurrencyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" xlink:to="loc_ifrs-fullFunctionalOrPresentationCurrencyMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_USDMember" xlink:label="loc_afyaUSDMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFunctionalOrPresentationCurrencyMember" xlink:to="loc_afyaUSDMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PercenatgeOfAverageInterestOnFinancialInstrument" xlink:label="loc_afyaPercenatgeOfAverageInterestOnFinancialInstrument_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPercenatgeOfAverageInterestOnFinancialInstrument_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashEquivalents" xlink:label="loc_ifrs-fullCashEquivalents_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashEquivalents_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails" xlink:title="999074 - Disclosure - Trade receivables (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TuitionFeesMember" xlink:label="loc_afyaTuitionFeesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaTuitionFeesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationalContentMember" xlink:label="loc_afyaEducationalContentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaEducationalContentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FIESMember" xlink:label="loc_afyaFIESMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaFIESMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationalCreditsMember" xlink:label="loc_afyaEducationalCreditsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaEducationalCreditsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MobileAppSubscriptionMember" xlink:label="loc_afyaMobileAppSubscriptionMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaMobileAppSubscriptionMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OthersMember" xlink:label="loc_afyaOthersMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaOthersMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ReceivablesGross" xlink:label="loc_afyaReceivablesGross_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReceivablesGross_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:label="loc_afyaAllowanceForDoubtfulAccountsFoReceivable1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAllowanceForDoubtfulAccountsFoReceivable1_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeReceivables_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentTradeReceivables_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="loc_ifrs-fullNoncurrentTradeReceivables_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentTradeReceivables_150" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails1" xlink:title="999075 - Disclosure - Trade receivables (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullImpairmentOfFinancialAssetsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullImpairmentOfFinancialAssetsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullImpairmentOfFinancialAssetsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullImpairmentOfFinancialAssetsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" xlink:label="loc_ifrs-fullFinancialAssetsNeitherPastDueNorImpairedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullImpairmentOfFinancialAssetsDomain" xlink:to="loc_ifrs-fullFinancialAssetsNeitherPastDueNorImpairedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusAxis" xlink:label="loc_ifrs-fullPastDueStatusAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_ifrs-fullPastDueStatusAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusDomain" xlink:label="loc_ifrs-fullPastDueStatusDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullPastDueStatusAxis" xlink:to="loc_ifrs-fullPastDueStatusDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusDomain" xlink:label="loc_ifrs-fullPastDueStatusDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullPastDueStatusAxis" xlink:to="loc_ifrs-fullPastDueStatusDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="loc_ifrs-fullNotLaterThanOneMonthMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPastDueStatusDomain" xlink:to="loc_ifrs-fullNotLaterThanOneMonthMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:label="loc_afyaLaterThanOneMonthsAndNotLaterThanThreeMonthsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPastDueStatusDomain" xlink:to="loc_afyaLaterThanOneMonthsAndNotLaterThanThreeMonthsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="loc_ifrs-fullLaterThanThreeMonthsAndNotLaterThanSixMonthsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPastDueStatusDomain" xlink:to="loc_ifrs-fullLaterThanThreeMonthsAndNotLaterThanSixMonthsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanSixMonthsMember" xlink:label="loc_ifrs-fullLaterThanSixMonthsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPastDueStatusDomain" xlink:to="loc_ifrs-fullLaterThanSixMonthsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ReceivablesGross" xlink:label="loc_afyaReceivablesGross_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReceivablesGross_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails2" xlink:title="999076 - Disclosure - Trade receivables (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetails" xlink:title="999077 - Disclosure - Related parties (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UEPCMember" xlink:label="loc_afyaUEPCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaUEPCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EMIVEPatrulha24HorasLtdaMember" xlink:label="loc_afyaEMIVEPatrulha24HorasLtdaMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaEMIVEPatrulha24HorasLtdaMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DepreciationRightofuseAssetsMember" xlink:label="loc_afyaDepreciationRightofuseAssetsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaDepreciationRightofuseAssetsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesInterestMember" xlink:label="loc_afyaLeaseLiabilitiesInterestMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaLeaseLiabilitiesInterestMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsRelatedPartyTransactions" xlink:label="loc_afyaRightofuseAssetsRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRightofuseAssetsRelatedPartyTransactions_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TradeReceivablesRelatedPartyTransactions" xlink:label="loc_afyaTradeReceivablesRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesRelatedPartyTransactions_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherAssetsRelatedPartyTransactions" xlink:label="loc_afyaOtherAssetsRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsRelatedPartyTransactions_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:label="loc_afyaTradeAndOtherCurrentPayablesToRelatedParties1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherCurrentPayablesToRelatedParties1_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrentAssetsOfRelatedParty1" xlink:label="loc_afyaNoncurrentAssetsOfRelatedParty1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNoncurrentAssetsOfRelatedParty1_180" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesRelatedPartyTransactions" xlink:label="loc_afyaLeaseLiabilitiesRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilitiesRelatedPartyTransactions_180" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsPayableRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmountsPayableRelatedPartyTransactions_180" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TradeAndOtherCurrentPayableToRelatedParties" xlink:label="loc_afyaTradeAndOtherCurrentPayableToRelatedParties_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherCurrentPayableToRelatedParties_180" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrenLliabilitiesOfRelatedParty1" xlink:label="loc_afyaNoncurrenLliabilitiesOfRelatedParty1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNoncurrenLliabilitiesOfRelatedParty1_180" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherIncomeRelatedPartyTransactions" xlink:label="loc_afyaOtherIncomeRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherIncomeRelatedPartyTransactions_180" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetails1" xlink:title="999078 - Disclosure - Related parties (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:title="999079 - Disclosure - Related parties (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements1Member" xlink:label="loc_afyaLeaseAgreements1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaLeaseAgreements1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements2Member" xlink:label="loc_afyaLeaseAgreements2Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaLeaseAgreements2Member_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements3Member" xlink:label="loc_afyaLeaseAgreements3Member_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaLeaseAgreements3Member_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements4Member" xlink:label="loc_afyaLeaseAgreements4Member_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaLeaseAgreements4Member_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements5Member" xlink:label="loc_afyaLeaseAgreements5Member_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaLeaseAgreements5Member_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:label="loc_afyaInstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="loc_afyaRVLEstevesGestaoImobiliariaSAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaRVLEstevesGestaoImobiliariaSAMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="loc_afyaUNIVACOPatrimonialLtdaMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaUNIVACOPatrimonialLtdaMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="loc_afyaIESVAPPatrimonialLtdaMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaIESVAPPatrimonialLtdaMember_290" xlink:type="arc" order="292" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OperatingLeaseTermOfContract" xlink:label="loc_afyaOperatingLeaseTermOfContract_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOperatingLeaseTermOfContract_360" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities_360" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RelatedPartiesAmountPaid" xlink:label="loc_afyaRelatedPartiesAmountPaid_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRelatedPartiesAmountPaid_360" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-fullPercentageOfEntitysRevenue_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfEntitysRevenue_360" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DescriptionOfLeaseTerm" xlink:label="loc_afyaDescriptionOfLeaseTerm_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDescriptionOfLeaseTerm_360" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-fullCashOutflowForLeases_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashOutflowForLeases_360" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LesseeFinancesLeaseRenewalTerm" xlink:label="loc_afyaLesseeFinancesLeaseRenewalTerm_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLesseeFinancesLeaseRenewalTerm_360" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DescriptionOfLeaseTerms" xlink:label="loc_afyaDescriptionOfLeaseTerms_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDescriptionOfLeaseTerms_360" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsDetails" xlink:title="999080 - Disclosure - Other assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateDetails" xlink:title="999081 - Disclosure - Investment in associate (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssociatesMember" xlink:label="loc_ifrs-fullAssociatesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_ifrs-fullAssociatesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EquityInAssociate" xlink:label="loc_afyaEquityInAssociate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEquityInAssociate_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CompanyShareInEquity1" xlink:label="loc_afyaCompanyShareInEquity1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompanyShareInEquity1_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-fullGoodwill_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwill_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InvestmentGrossAmount" xlink:label="loc_afyaInvestmentGrossAmount_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInvestmentGrossAmount_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCostOfSales_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullSellingGeneralAndAdministrativeExpense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullSellingGeneralAndAdministrativeExpense_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForExpectedCreditLosses" xlink:label="loc_afyaAllowanceForExpectedCreditLosses_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAllowanceForExpectedCreditLosses_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-fullOtherIncome_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherIncome_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherExpense" xlink:label="loc_afyaOtherExpense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherExpense_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinanceIncome_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss_80" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CompanyShareOfProfitss" xlink:label="loc_afyaCompanyShareOfProfitss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompanyShareOfProfitss_80" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates_80" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="loc_ifrs-fullProfitLossOfAcquiree_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossOfAcquiree_80" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendsReceived1" xlink:label="loc_afyaDividendsReceived1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendsReceived1_80" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsReceived" xlink:label="loc_ifrs-fullDividendsReceived_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsReceived_80" xlink:type="arc" order="22" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentDetails" xlink:title="999082 - Disclosure - Property and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_700" xlink:type="arc" order="701" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-fullBuildingsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullBuildingsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="loc_afyaMachineryAndEquipmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_afyaMachineryAndEquipmentsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-fullLandMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullLandMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-fullVehiclesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullVehiclesMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullFixturesAndFittingsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ItEquipmentMember" xlink:label="loc_afyaItEquipmentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_afyaItEquipmentMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LibraryBooksMember" xlink:label="loc_afyaLibraryBooksMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_afyaLibraryBooksMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-fullLeaseholdImprovementsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullLeaseholdImprovementsMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-fullConstructionInProgressMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullConstructionInProgressMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PropertyPlantAndEquipments" xlink:label="loc_afyaPropertyPlantAndEquipments_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPropertyPlantAndEquipments_1610" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1610" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_1610" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WritOffOfPropertyPlantAndEquipment" xlink:label="loc_afyaWritOffOfPropertyPlantAndEquipment_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWritOffOfPropertyPlantAndEquipment_1610" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_1610" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDepreciationPropertyPlantAndEquipment_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDepreciationPropertyPlantAndEquipment_1610" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PropertyPlantAndEquipmentNetBookValue" xlink:label="loc_afyaPropertyPlantAndEquipmentNetBookValue_1610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPropertyPlantAndEquipmentNetBookValue_1610" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsDetails" xlink:title="999083 - Disclosure - Intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-fullGoodwillMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullGoodwillMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-fullLicencesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullLicencesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullBrandNamesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-fullComputerSoftwareMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullComputerSoftwareMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationContentMember" xlink:label="loc_afyaEducationContentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaEducationContentMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationalPlatformMember" xlink:label="loc_afyaEducationalPlatformMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaEducationalPlatformMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IntangibleInProgressMember" xlink:label="loc_afyaIntangibleInProgressMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaIntangibleInProgressMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherMember" xlink:label="loc_afyaOtherMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaOtherMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SoftwareInProgressMember" xlink:label="loc_afyaSoftwareInProgressMember_1550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaSoftwareInProgressMember_1550" xlink:type="arc" order="1551" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_700" xlink:type="arc" order="702" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwill_1700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwill_1700" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1700" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_1700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_1700" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill_1700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill_1700" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WriteoffOfIntangibleAssets" xlink:label="loc_afyaWriteoffOfIntangibleAssets_1700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWriteoffOfIntangibleAssets_1700" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Remesurement" xlink:label="loc_afyaRemesurement_1700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemesurement_1700" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Transfer" xlink:label="loc_afyaTransfer_1700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTransfer_1700" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IntangibleAssetsAndGoodwillNetBookValue" xlink:label="loc_afyaIntangibleAssetsAndGoodwillNetBookValue_1700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIntangibleAssetsAndGoodwillNetBookValue_1700" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsDetails1" xlink:title="999084 - Disclosure - Intangible assets (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CarryingAmountsMember" xlink:label="loc_afyaCarryingAmountsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_afyaCarryingAmountsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:label="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:label="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:label="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUniRedentorMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUniSLMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FESARMember" xlink:label="loc_afyaFESARMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFESARMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFCMPBMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ITPACGaranhunsMember" xlink:label="loc_afyaITPACGaranhunsMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaITPACGaranhunsMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaContinuingEducationMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicalPracticeSolutionsMember" xlink:label="loc_afyaMedicalPracticeSolutionsMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaMedicalPracticeSolutionsMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnifipMocMember" xlink:label="loc_afyaUnifipMocMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnifipMocMember_280" xlink:type="arc" order="282" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnigranrioMember_300" xlink:type="arc" order="302" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaDelReyMember_320" xlink:type="arc" order="322" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnidomMember" xlink:label="loc_afyaUnidomMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnidomMember_340" xlink:type="arc" order="342" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FUNICMember" xlink:label="loc_afyaFUNICMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFUNICMember_360" xlink:type="arc" order="362" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-fullGoodwill_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwill_410" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLife_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLife_410" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CashGeneratingUnits" xlink:label="loc_afyaCashGeneratingUnits_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCashGeneratingUnits_410" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsDetails2" xlink:title="999085 - Disclosure - Intangible assets (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DiscountRatesMember" xlink:label="loc_afyaDiscountRatesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaDiscountRatesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PerpetuityGrowthRateMember" xlink:label="loc_afyaPerpetuityGrowthRateMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaPerpetuityGrowthRateMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EBITDAMember" xlink:label="loc_afyaEBITDAMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaEBITDAMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfDiscountRatesAppliedToCashFlowProjections_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfDiscountRatesAppliedToCashFlowProjections_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PerpetuityGrowthRate" xlink:label="loc_afyaPerpetuityGrowthRate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPerpetuityGrowthRate_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EbitdaGrowthRates" xlink:label="loc_afyaEbitdaGrowthRates_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEbitdaGrowthRates_130" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsDetailsNarrative" xlink:title="999086 - Disclosure - Intangible assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-fullGoodwillMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullGoodwillMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails" xlink:title="999087 - Disclosure - Financial assets and liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="loc_ifrs-fullFinancialAssetsAtAmortisedCostMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_ifrs-fullFinancialAssetsAtAmortisedCostMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalents_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeReceivables_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAssets" xlink:label="loc_ifrs-fullOtherAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherAssets_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendReceivable" xlink:label="loc_afyaDividendReceivable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendReceivable_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialAssets" xlink:label="loc_ifrs-fullCurrentFinancialAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialAssets_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="loc_ifrs-fullNoncurrentFinancialAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialAssets_30" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1" xlink:title="999088 - Disclosure - Financial assets and liabilities (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtAmortisedCostMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtAmortisedCostMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPayable" xlink:label="loc_ifrs-fullDividendsPayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPayable_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialLiabilities_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilities_30" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2" xlink:title="999089 - Disclosure - Financial assets and liabilities (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersEarnOutsMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersEarnOutsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaAccountsPayableToSellingShareholdersEarnOutsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersUnidomMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersUnidomMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaAccountsPayableToSellingShareholdersUnidomMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialLiabilitiesAtFairValues" xlink:label="loc_afyaFinancialLiabilitiesAtFairValues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialLiabilitiesAtFairValues_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-fullCurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3" xlink:title="999090 - Disclosure - Financial assets and liabilities (Details 3)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-fullMaturityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullMaturityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-fullMaturityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullMaturityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OctoberTwentyTwentyFiveMember" xlink:label="loc_afyaOctoberTwentyTwentyFiveMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaOctoberTwentyTwentyFiveMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_JulyTwentyTwentySevenMember" xlink:label="loc_afyaJulyTwentyTwentySevenMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaJulyTwentyTwentySevenMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AprilTwentyTwentySixMember" xlink:label="loc_afyaAprilTwentyTwentySixMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaAprilTwentyTwentySixMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_JanuaryTwentyTwentyEightMember" xlink:label="loc_afyaJanuaryTwentyTwentyEightMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaJanuaryTwentyTwentyEightMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AprilTwentyThirtyMember" xlink:label="loc_afyaAprilTwentyThirtyMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaAprilTwentyThirtyMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OctoberTwentyTwentyEightMember" xlink:label="loc_afyaOctoberTwentyTwentyEightMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaOctoberTwentyTwentyEightMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OctoberTwentyThirtyMember" xlink:label="loc_afyaOctoberTwentyThirtyMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaOctoberTwentyThirtyMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialInstitution" xlink:label="loc_afyaFinancialInstitution_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialInstitution_240" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-fullBorrowingsInterestRateBasis_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsInterestRateBasis_240" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-fullBorrowingsMaturity_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsMaturity_240" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing_240" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingCurrent" xlink:label="loc_afyaLoansAndFinancingCurrent_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingCurrent_240" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingNonCurrent" xlink:label="loc_afyaLoansAndFinancingNonCurrent_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingNonCurrent_240" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4" xlink:title="999091 - Disclosure - Financial assets and liabilities  (Details 4)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5" xlink:title="999092 - Disclosure - Financial assets and liabilities (Details 5)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnigranrioMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaDelReyMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FUNICMember" xlink:label="loc_afyaFUNICMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFUNICMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaShospMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaAlemDaMedicinaMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CardiPapersMember" xlink:label="loc_afyaCardiPapersMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCardiPapersMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnidomMember" xlink:label="loc_afyaUnidomMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnidomMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableAamortizedCostInterestRateBasis" xlink:label="loc_afyaAccountsPayableAamortizedCostInterestRateBasis_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableAamortizedCostInterestRateBasis_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersCurrent" xlink:label="loc_afyaAccountsPayableToSellingShareholdersCurrent_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersCurrent_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:label="loc_afyaAccountsPayableToSellingShareholdersNonCurrent_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersNonCurrent_210" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6" xlink:title="999093 - Disclosure - Financial assets and liabilities (Details 6)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaAccountsPayableToSellingShareholdersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:label="loc_afyaAccountsPayableToSellingShareholdersBusinessCombinations_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersBusinessCombinations_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentsOfPrincipal" xlink:label="loc_afyaPaymentsOfPrincipal_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPaymentsOfPrincipal_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpense" xlink:label="loc_ifrs-fullInterestExpense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestExpense_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RemeasurementOfEarnouts" xlink:label="loc_afyaRemeasurementOfEarnouts_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemeasurementOfEarnouts_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable_80" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7" xlink:title="999094 - Disclosure - Financial assets and liabilities (Details 7)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaLoansAndFinancingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtFairValue_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8" xlink:title="999095 - Disclosure - Financial assets and liabilities (Details 8)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CashEquivalents1Member" xlink:label="loc_afyaCashEquivalents1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaCashEquivalents1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="loc_ifrs-fullTypesOfInterestRatesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullTypesOfInterestRatesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain" xlink:label="loc_ifrs-fullTypesOfInterestRatesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfInterestRatesAxis" xlink:to="loc_ifrs-fullTypesOfInterestRatesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain" xlink:label="loc_ifrs-fullTypesOfInterestRatesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfInterestRatesAxis" xlink:to="loc_ifrs-fullTypesOfInterestRatesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FloatingInterestRateMember" xlink:label="loc_ifrs-fullFloatingInterestRateMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfInterestRatesDomain" xlink:to="loc_ifrs-fullFloatingInterestRateMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestRateRiskMember" xlink:label="loc_ifrs-fullInterestRateRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksDomain" xlink:to="loc_ifrs-fullInterestRateRiskMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaLoansAndFinancingMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingOneMember" xlink:label="loc_afyaLoansAndFinancingOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaLoansAndFinancingOneMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersOneMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersOneMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaAccountsPayableToSellingShareholdersOneMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersTwoMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersTwoMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaAccountsPayableToSellingShareholdersTwoMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CashEquivalents1Member" xlink:label="loc_afyaCashEquivalents1Member_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaCashEquivalents1Member_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProbabilityOfDefaultAxis" xlink:label="loc_ifrs-fullProbabilityOfDefaultAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullProbabilityOfDefaultAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProbabilityOfDefaultDomain" xlink:label="loc_ifrs-fullProbabilityOfDefaultDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullProbabilityOfDefaultAxis" xlink:to="loc_ifrs-fullProbabilityOfDefaultDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProbabilityOfDefaultDomain" xlink:label="loc_ifrs-fullProbabilityOfDefaultDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullProbabilityOfDefaultAxis" xlink:to="loc_ifrs-fullProbabilityOfDefaultDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseBasisPointsMember" xlink:label="loc_afyaIncreaseBasisPointsMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullProbabilityOfDefaultDomain" xlink:to="loc_afyaIncreaseBasisPointsMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseBasisPointsOneMember" xlink:label="loc_afyaIncreaseBasisPointsOneMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullProbabilityOfDefaultDomain" xlink:to="loc_afyaIncreaseBasisPointsOneMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IndexRatePerYear" xlink:label="loc_afyaIndexRatePerYear_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIndexRatePerYear_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_BaseRate" xlink:label="loc_afyaBaseRate_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaBaseRate_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_140" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9" xlink:title="999096 - Disclosure - Financial assets and liabilities (Details 9)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:label="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RiskExposuresAxis" xlink:label="loc_ifrs-fullRiskExposuresAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:to="loc_ifrs-fullRiskExposuresAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RiskExposuresDomain" xlink:label="loc_ifrs-fullRiskExposuresDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRiskExposuresAxis" xlink:to="loc_ifrs-fullRiskExposuresDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RiskExposuresDomain" xlink:label="loc_ifrs-fullRiskExposuresDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRiskExposuresAxis" xlink:to="loc_ifrs-fullRiskExposuresDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ForeignCurrencyExposuresMember" xlink:label="loc_afyaForeignCurrencyExposuresMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRiskExposuresDomain" xlink:to="loc_afyaForeignCurrencyExposuresMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseForeignCurrencyMember" xlink:label="loc_afyaIncreaseForeignCurrencyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRiskExposuresDomain" xlink:to="loc_afyaIncreaseForeignCurrencyMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DecreaseForeignCurrencyMember" xlink:label="loc_afyaDecreaseForeignCurrencyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRiskExposuresDomain" xlink:to="loc_afyaDecreaseForeignCurrencyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-fullCurrencyRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksDomain" xlink:to="loc_ifrs-fullCurrencyRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10" xlink:title="999097 - Disclosure - Financial assets and liabilities (Details 10)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-fullMaturityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullMaturityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-fullMaturityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullMaturityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-fullLaterThanOneYearMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanOneYearMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanThreeYearsAndNotLaterThanFiveYearsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanThreeYearsAndNotLaterThanFiveYearsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanFiveYearsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanFiveYearsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-fullLiquidityRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksDomain" xlink:to="loc_ifrs-fullLiquidityRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialLiabilitiesContractualUndiscounted" xlink:label="loc_afyaFinancialLiabilitiesContractualUndiscounted_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialLiabilitiesContractualUndiscounted_110" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11" xlink:title="999098 - Disclosure - Financial assets and liabilities (Details 11)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="loc_afyaLoansAndFinancingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-fullLeaseLiabilitiesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="loc_ifrs-fullLeaseLiabilitiesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendsPayableMember" xlink:label="loc_afyaDividendsPayableMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="loc_afyaDividendsPayableMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_260" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_260" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities_260" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_260" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:label="loc_afyaIncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_260" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_260" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_260" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative" xlink:title="999099 - Disclosure - Financial assets and liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InternationalFinanceCorporationMember" xlink:label="loc_afyaInternationalFinanceCorporationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaInternationalFinanceCorporationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TwoSeriesMember" xlink:label="loc_afyaTwoSeriesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaTwoSeriesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FirstSeriesMember" xlink:label="loc_afyaFirstSeriesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaFirstSeriesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SecondSeriesMember" xlink:label="loc_afyaSecondSeriesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaSecondSeriesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnigranrioMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaDelReyMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FUNICMember" xlink:label="loc_afyaFUNICMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFUNICMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaShospMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaAlemDaMedicinaMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CardioPapersMember" xlink:label="loc_afyaCardioPapersMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCardioPapersMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnidomMember" xlink:label="loc_afyaUnidomMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnidomMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-fullCurrencyRiskMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksDomain" xlink:to="loc_ifrs-fullCurrencyRiskMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyInWhichInformationIsDisplayedAxis" xlink:label="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember" xlink:label="loc_ifrs-fullFunctionalOrPresentationCurrencyMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" xlink:to="loc_ifrs-fullFunctionalOrPresentationCurrencyMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember" xlink:label="loc_ifrs-fullFunctionalOrPresentationCurrencyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" xlink:to="loc_ifrs-fullFunctionalOrPresentationCurrencyMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR" xlink:label="loc_currencyEUR_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFunctionalOrPresentationCurrencyMember" xlink:to="loc_currencyEUR_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoanAndFinancing" xlink:label="loc_afyaLoanAndFinancing_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoanAndFinancing_310" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-fullBorrowingsInterestRateBasis_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsInterestRateBasis_310" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TransactionCosts" xlink:label="loc_afyaTransactionCosts_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTransactionCosts_310" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContractualLeaseTerm" xlink:label="loc_afyaContractualLeaseTerm_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContractualLeaseTerm_310" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-fullExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_310" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_310" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" xlink:label="loc_ifrs-fullNoncurrentPayablesForPurchaseOfEnergy_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentPayablesForPurchaseOfEnergy_310" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConsiderationToBeTransferred" xlink:label="loc_afyaConsiderationToBeTransferred_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsiderationToBeTransferred_310" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FirstAnnualInstallmentsPayable" xlink:label="loc_afyaFirstAnnualInstallmentsPayable_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFirstAnnualInstallmentsPayable_310" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SecondAnnualInstallmentsPayable" xlink:label="loc_afyaSecondAnnualInstallmentsPayable_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSecondAnnualInstallmentsPayable_310" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ThirdAnnualInstallmentsPayable" xlink:label="loc_afyaThirdAnnualInstallmentsPayable_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaThirdAnnualInstallmentsPayable_310" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:label="loc_afyaRemainingTradeAndOtherPayablesToRelatedParties_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemainingTradeAndOtherPayablesToRelatedParties_310" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="loc_ifrs-fullTransactionPriceAllocatedToRemainingPerformanceObligations_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTransactionPriceAllocatedToRemainingPerformanceObligations_310" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="loc_ifrs-fullDefinedBenefitObligationAtPresentValue_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDefinedBenefitObligationAtPresentValue_310" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CreditExposures" xlink:label="loc_afyaCreditExposures_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCreditExposures_310" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SensitivityChangeInTheEuroExchangeRate" xlink:label="loc_afyaSensitivityChangeInTheEuroExchangeRate_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSensitivityChangeInTheEuroExchangeRate_310" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-fullClosingForeignExchangeRate_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullClosingForeignExchangeRate_310" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails" xlink:title="999100 - Disclosure - Labor and social obligations (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOptionsMember" xlink:label="loc_ifrs-fullShareOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_ifrs-fullShareOptionsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SharePriceFairValueAtMeasurementDate" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDate_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDate_250" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_250" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted_250" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_250" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ExpectedLifeOfStockOptions" xlink:label="loc_afyaExpectedLifeOfStockOptions_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExpectedLifeOfStockOptions_250" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted_250" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted_250" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_250" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails1" xlink:title="999101 - Disclosure - Labor and social obligations (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOptionsMember" xlink:label="loc_ifrs-fullShareOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_ifrs-fullShareOptionsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" xlink:label="loc_afyaWeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExpiredInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExpiredInSharebasedPaymentArrangement_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfStockOptionsExercisable" xlink:label="loc_afyaNumberOfStockOptionsExercisable_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfStockOptionsExercisable_80" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails2" xlink:title="999102 - Disclosure - Labor and social obligations (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-fullDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-fullDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-fullDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_November2025Member" xlink:label="loc_afyaNovember2025Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaNovember2025Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_April2025Member" xlink:label="loc_afyaApril2025Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaApril2025Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_October2024Member" xlink:label="loc_afyaOctober2024Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaOctober2024Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_December2023Member" xlink:label="loc_afyaDecember2023Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaDecember2023Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_October2023Member" xlink:label="loc_afyaOctober2023Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaOctober2023Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_August2023Member" xlink:label="loc_afyaAugust2023Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaAugust2023Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_April2023Member" xlink:label="loc_afyaApril2023Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaApril2023Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_February2023Member" xlink:label="loc_afyaFebruary2023Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaFebruary2023Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-fullWeightedAverageSharePriceShareOptionsGranted2019_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageSharePriceShareOptionsGranted2019_250" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_GrantedVestingPeriod" xlink:label="loc_afyaGrantedVestingPeriod_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaGrantedVestingPeriod_250" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails3" xlink:title="999103 - Disclosure - Labor and social obligations (Details 3)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-fullDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-fullDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-fullDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnitsMember" xlink:label="loc_afyaRestrictedStockUnitsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaRestrictedStockUnitsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_80" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:title="999104 - Disclosure - Labor and social obligations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-fullDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-fullDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-fullDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShareBasedCompensationPlansMember" xlink:label="loc_afyaShareBasedCompensationPlansMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaShareBasedCompensationPlansMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnitsMember" xlink:label="loc_afyaRestrictedStockUnitsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaRestrictedStockUnitsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnits1Member" xlink:label="loc_afyaRestrictedStockUnits1Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_afyaRestrictedStockUnits1Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnits2Member" xlink:label="loc_afyaRestrictedStockUnits2Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_afyaRestrictedStockUnits2Member_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnits3Member" xlink:label="loc_afyaRestrictedStockUnits3Member_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_afyaRestrictedStockUnits3Member_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShareBasedCompensationOfEmployees" xlink:label="loc_afyaShareBasedCompensationOfEmployees_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaShareBasedCompensationOfEmployees_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestInJointVenture_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestInJointVenture_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SocialObligationsLiabilities" xlink:label="loc_afyaSocialObligationsLiabilities_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSocialObligationsLiabilities_160" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetails" xlink:title="999105 - Disclosure - Equity (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetailsNarrative" xlink:title="999106 - Disclosure - Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-fullClassesOfShareCapitalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-fullClassesOfShareCapitalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalDomain" xlink:to="loc_afyaClassAOrdinarySharesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalDomain" xlink:to="loc_afyaClassBOrdinarySharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIssuedCapital_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfSharesIssued1" xlink:label="loc_afyaNumberOfSharesIssued1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfSharesIssued1_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-fullNumberOfSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesIssued_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IssuedCapitals" xlink:label="loc_afyaIssuedCapitals_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIssuedCapitals_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CapitalUnitsAuthorizedShares" xlink:label="loc_afyaCapitalUnitsAuthorizedShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalUnitsAuthorizedShares_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-fullParValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullParValuePerShare_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentOfDividends" xlink:label="loc_afyaPaymentOfDividends_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPaymentOfDividends_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendDistributed" xlink:label="loc_afyaDividendDistributed_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendDistributed_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:label="loc_ifrs-fullDividendsPaidToNoncontrollingInterests_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaidToNoncontrollingInterests_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FirstDividendDistributionInAmount" xlink:label="loc_afyaFirstDividendDistributionInAmount_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFirstDividendDistributionInAmount_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PercentageOfDividendDistribution" xlink:label="loc_afyaPercentageOfDividendDistribution_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPercentageOfDividendDistribution_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidOtherSharesPerShare" xlink:label="loc_ifrs-fullDividendsPaidOtherSharesPerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaidOtherSharesPerShare_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RepurchaseOfOrdinaryShares" xlink:label="loc_afyaRepurchaseOfOrdinaryShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRepurchaseOfOrdinaryShares_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CashOutflow" xlink:label="loc_afyaCashOutflow_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCashOutflow_130" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareDetails" xlink:title="999107 - Disclosure - Earnings per share (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueDetails" xlink:title="999108 - Disclosure - Revenue (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueDetails1" xlink:title="999109 - Disclosure - Revenue (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_ifrs-fullSegmentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-fullSegmentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-fullSegmentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UndergraduateMember" xlink:label="loc_afyaUndergraduateMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaUndergraduateMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaContinuingEducationMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicalPracticeSolutionsMember" xlink:label="loc_afyaMedicalPracticeSolutionsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaMedicalPracticeSolutionsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EliminationInterSegmentTransactionsMember" xlink:label="loc_afyaEliminationInterSegmentTransactionsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaEliminationInterSegmentTransactionsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaUndergradMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-fullProfessionalFeesExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfessionalFeesExpense_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-fullOtherRevenue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherRevenue_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TimingRevenueRecognition" xlink:label="loc_afyaTimingRevenueRecognition_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTimingRevenueRecognition_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FeeAndCommissionIncome" xlink:label="loc_ifrs-fullFeeAndCommissionIncome_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFeeAndCommissionIncome_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NetRevenueOtherTransferredPoint" xlink:label="loc_afyaNetRevenueOtherTransferredPoint_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetRevenueOtherTransferredPoint_160" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CostsAndExpensesByNatureDetails" xlink:title="999110 - Disclosure - Costs and expenses by nature (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultDetails" xlink:title="999111 - Disclosure - Finance result (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetails" xlink:title="999112 - Disclosure - Income taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetails1" xlink:title="999113 - Disclosure - Income taxes (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:title="999114 - Disclosure - Income taxes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails" xlink:title="999115 - Disclosure - Legal proceedings and contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-fullLegalProceedingsContingentLiabilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesDomain" xlink:to="loc_ifrs-fullLegalProceedingsContingentLiabilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-fullClassesOfProvisionsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfProvisionsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-fullClassesOfOtherProvisionsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-fullClassesOfOtherProvisionsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullClassesOfOtherProvisionsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LabourMember" xlink:label="loc_afyaLabourMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:to="loc_afyaLabourMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CivilMember" xlink:label="loc_afyaCivilMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:to="loc_afyaCivilMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxesMember" xlink:label="loc_afyaTaxesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:to="loc_afyaTaxesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-fullProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProvisions_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsOtherProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsOtherProvisions_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="loc_ifrs-fullAdditionalProvisionsOtherProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionalProvisionsOtherProvisions_290" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="loc_ifrs-fullProvisionUsedOtherProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProvisionUsedOtherProvisions_290" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="loc_ifrs-fullUnusedProvisionReversedOtherProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUnusedProvisionReversedOtherProvisions_290" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1" xlink:title="999116 - Disclosure - Legal proceedings and contingencies (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-fullLegalProceedingsContingentLiabilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesDomain" xlink:to="loc_ifrs-fullLegalProceedingsContingentLiabilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-fullClassesOfProvisionsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfProvisionsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-fullClassesOfOtherProvisionsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-fullClassesOfOtherProvisionsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullClassesOfOtherProvisionsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LabourMember" xlink:label="loc_afyaLabourMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:to="loc_afyaLabourMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CivilMember" xlink:label="loc_afyaCivilMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:to="loc_afyaCivilMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxesAndSocialSecurityMember" xlink:label="loc_afyaTaxesAndSocialSecurityMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:to="loc_afyaTaxesAndSocialSecurityMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TypesOfRiskMember" xlink:label="loc_afyaTypesOfRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksDomain" xlink:to="loc_afyaTypesOfRiskMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-fullOtherProvisions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherProvisions_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative" xlink:title="999117 - Disclosure - Legal proceedings and contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-fullClassesOfAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullClassesOfAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-fullClassesOfAssetsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfAssetsAxis" xlink:to="loc_ifrs-fullClassesOfAssetsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-fullClassesOfAssetsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfAssetsAxis" xlink:to="loc_ifrs-fullClassesOfAssetsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherAssetsNonCurrentMember" xlink:label="loc_afyaOtherAssetsNonCurrentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfAssetsDomain" xlink:to="loc_afyaOtherAssetsNonCurrentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContingenciesCorrespondentAmount" xlink:label="loc_afyaContingenciesCorrespondentAmount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContingenciesCorrespondentAmount_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactionsDetails" xlink:title="999118 - Disclosure - Non-cash transactions (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEventsDetailsNarrative" xlink:title="999119 - Disclosure - Subsequent events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" xlink:to="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" xlink:to="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NonadjustingEventMember" xlink:label="loc_afyaNonadjustingEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain" xlink:to="loc_afyaNonadjustingEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FirstDividendDistributionInAmount" xlink:label="loc_afyaFirstDividendDistributionInAmount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFirstDividendDistributionInAmount_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PercentageOfDividendDistribution" xlink:label="loc_afyaPercentageOfDividendDistribution_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPercentageOfDividendDistribution_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidOtherSharesPerShare" xlink:label="loc_ifrs-fullDividendsPaidOtherSharesPerShare_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaidOtherSharesPerShare_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>38
<FILENAME>afya-20251231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_lbl" xml:lang="en-US">Classes of share capital [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="afya_ClassAOrdinarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClassAOrdinarySharesMember" xlink:to="afya_ClassAOrdinarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClassAOrdinarySharesMember_lbl" xml:lang="en-US">Class A Ordinary Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassACommonSharesHeldInTreasuryMember" xlink:label="afya_ClassACommonSharesHeldInTreasuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClassACommonSharesHeldInTreasuryMember" xlink:to="afya_ClassACommonSharesHeldInTreasuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClassACommonSharesHeldInTreasuryMember_lbl" xml:lang="en-US">Class A Common Shares Held In Treasury [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="afya_ClassBOrdinarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClassBOrdinarySharesMember" xlink:to="afya_ClassBOrdinarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClassBOrdinarySharesMember_lbl" xml:lang="en-US">Class B Ordinary Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityAxis_lbl" xml:lang="en-US">Components of equity [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US">Issued capital [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalPaidinCapitalMember" xlink:label="ifrs-full_AdditionalPaidinCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalPaidinCapitalMember" xlink:to="ifrs-full_AdditionalPaidinCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalPaidinCapitalMember_lbl" xml:lang="en-US">Additional paid-in capital [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasurySharesMember" xlink:to="ifrs-full_TreasurySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TreasurySharesMember_lbl" xml:lang="en-US">Treasury shares [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:to="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl" xml:lang="en-US">Reserve of share-based payments [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="ifrs-full_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US">Retained earnings [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:to="ifrs-full_EquityAttributableToOwnersOfParentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember_lbl" xml:lang="en-US">Equity attributable to owners of parent [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="ifrs-full_NoncontrollingInterestsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterestsMember" xlink:to="ifrs-full_NoncontrollingInterestsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncontrollingInterestsMember_lbl" xml:lang="en-US">Non-controlling interests [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="ifrs-full_BusinessCombinationsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BusinessCombinationsAxis_lbl" xml:lang="en-US">Business combinations [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FaculdadeMasterclassLtdaMember" xlink:label="afya_FaculdadeMasterclassLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FaculdadeMasterclassLtdaMember" xlink:to="afya_FaculdadeMasterclassLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FaculdadeMasterclassLtdaMember_lbl" xml:lang="en-US">Faculdade Masterclass Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_lbl" xml:lang="en-US">Subsidiaries [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AfyaParticipacoesS.A.Member" xlink:label="afya_AfyaParticipacoesS.A.Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AfyaParticipacoesS.A.Member" xlink:to="afya_AfyaParticipacoesS.A.Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AfyaParticipacoesS.A.Member_lbl" xml:lang="en-US">Afya Participacoes S. A. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AfyaParticipacoesSAMember" xlink:label="afya_AfyaParticipacoesSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AfyaParticipacoesSAMember" xlink:to="afya_AfyaParticipacoesSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AfyaParticipacoesSAMember_lbl" xml:lang="en-US">Afya Participacoes S.A. (&#147;Afya Brazil&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" xlink:to="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_lbl" xml:lang="en-US">Instituto Tocantinense Presidente Antonio Carlos Porto S.A. - (&#147;ITPAC Porto&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" xlink:to="afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_lbl" xml:lang="en-US">Instituto Tocantinense Presidente Antonio Carlos S.A. - (&#147;ITPAC Araguaina&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" xlink:label="afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" xlink:to="afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_lbl" xml:lang="en-US">Uniao Educacional do Vale do Aco S.A. - (&#147;UNIVACO&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" xlink:label="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" xlink:to="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_lbl" xml:lang="en-US">IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#147;IPTAN&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" xlink:label="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" xlink:to="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_lbl" xml:lang="en-US">Instituto de Educacao Superior do Vale do Parnaiba S.A. (&#147;IESVAP&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" xlink:label="afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" xlink:to="afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_lbl" xml:lang="en-US">Centro de Ciencias em Saude de Itajuba S.A. (&#147;CCSI&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" xlink:label="afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" xlink:to="afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_lbl" xml:lang="en-US">Instituto de Ensino Superior do Piaui S.A. (&#147;IESP&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" xlink:label="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" xlink:to="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_lbl" xml:lang="en-US">FADEP - Faculdade Educacional de Pato Branco Ltda. (&#147;FADEP&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" xlink:label="afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" xlink:to="afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember_lbl" xml:lang="en-US">Instituto Educacional Santo Agostinho S.A. (&#147;FASA&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" xlink:label="afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" xlink:to="afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_lbl" xml:lang="en-US">Instituto Paraense de Educacao e Cultura Ltda. (&#147;IPEC&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember" xlink:label="afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember" xlink:to="afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember_lbl" xml:lang="en-US">Sociedade Universitaria Redentor S.A. (&#147;UniRedentor&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CentroDeEnsinoSaoLucasLtda.UniSLMember" xlink:label="afya_CentroDeEnsinoSaoLucasLtda.UniSLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroDeEnsinoSaoLucasLtda.UniSLMember" xlink:to="afya_CentroDeEnsinoSaoLucasLtda.UniSLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroDeEnsinoSaoLucasLtda.UniSLMember_lbl" xml:lang="en-US">Centro de Ensino Sao Lucas Ltda. (&#147;UniSL&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" xlink:label="afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" xlink:to="afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_lbl" xml:lang="en-US">Sociedade de Educacao, Cultura e Tecnologia da Amazonia S.A. - (&#147;FESAR&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" xlink:label="afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" xlink:to="afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_lbl" xml:lang="en-US">Centro Superior de Ciencias da Saude Ltda. (&#147;FCMPB&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" xlink:label="afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" xlink:to="afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_lbl" xml:lang="en-US">iClinic Desenvolvimento de Software Ltda. (&#147;iClinic&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicinaeSolutionsS.A.MedicinaeMember" xlink:label="afya_MedicinaeSolutionsS.A.MedicinaeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedicinaeSolutionsS.A.MedicinaeMember" xlink:to="afya_MedicinaeSolutionsS.A.MedicinaeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedicinaeSolutionsS.A.MedicinaeMember_lbl" xml:lang="en-US">Medicinae Solutions S.A. (&#147;Medicinae&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" xlink:label="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" xlink:to="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_lbl" xml:lang="en-US">Medical Harbour Aparelhos Medico Hospitalares e Servicos em Tecnologia Ltda. (&#147;Medical Harbour&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" xlink:label="afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" xlink:to="afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_lbl" xml:lang="en-US">Cliquefarma Drogarias Online Ltda. (&#147;Cliquefarma&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShospTecnologiaDaInformacaoLtda.ShospMember" xlink:label="afya_ShospTecnologiaDaInformacaoLtda.ShospMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShospTecnologiaDaInformacaoLtda.ShospMember" xlink:to="afya_ShospTecnologiaDaInformacaoLtda.ShospMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShospTecnologiaDaInformacaoLtda.ShospMember_lbl" xml:lang="en-US">Shosp Tecnologia da Informacao Ltda. (&#147;Shosp&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" xlink:label="afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" xlink:to="afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_lbl" xml:lang="en-US">Sociedade Padrao de Educacao Superior Ltda. (&#147;UnifipMoc&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" xlink:label="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" xlink:to="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_lbl" xml:lang="en-US">Companhia Nilza Cordeiro Herdy de Educacao e Cultura (&#147;Unigranrio&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember" xlink:label="afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember" xlink:to="afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember_lbl" xml:lang="en-US">RX PRO Solucoes de Tecnologia Ltda. (&#147;RX PRO&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" xlink:label="afya_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" xlink:to="afya_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_lbl" xml:lang="en-US">Quasar Telemedicina Desenvolvimentode Sistemas Computacionais Ltda Glic [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" xlink:label="afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" xlink:to="afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_lbl" xml:lang="en-US">Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#147;DelRey&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnidomParticipacoesS.A.UnidomMember" xlink:label="afya_UnidomParticipacoesS.A.UnidomMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UnidomParticipacoesS.A.UnidomMember" xlink:to="afya_UnidomParticipacoesS.A.UnidomMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UnidomParticipacoesS.A.UnidomMember_lbl" xml:lang="en-US">Unidom Participacoes S.A. (&#147;Unidom&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" xlink:label="afya_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" xlink:to="afya_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_lbl" xml:lang="en-US">Instituicao Baianade Ensino Superior Ltda I B E S [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" xlink:label="afya_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" xlink:to="afya_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_lbl" xml:lang="en-US">S E S S A Sociedadede Educacao Superiordo Semi Arido Ltda S E S S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FaculdadeMasterclassLtdaFUNICMember" xlink:label="afya_FaculdadeMasterclassLtdaFUNICMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FaculdadeMasterclassLtdaFUNICMember" xlink:to="afya_FaculdadeMasterclassLtdaFUNICMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FaculdadeMasterclassLtdaFUNICMember_lbl" xml:lang="en-US">Faculdade Masterclass Ltda F U N I C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" xlink:label="afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" xlink:to="afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_lbl" xml:lang="en-US">Uniao Educacional do Planalto Central S.A. (&#147;UEPC&#148;) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_LevelsOfFairValueHierarchyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis_lbl" xml:lang="en-US">Levels of fair value hierarchy [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level2OfFairValueHierarchyMember" xlink:to="ifrs-full_Level2OfFairValueHierarchyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 2 of fair value hierarchy [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeAxis_lbl" xml:lang="en-US">Range [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US">Bottom of range [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US">Top of range [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level3OfFairValueHierarchyMember" xlink:to="ifrs-full_Level3OfFairValueHierarchyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 3 of fair value hierarchy [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis" xlink:label="ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis" xlink:to="ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis_lbl" xml:lang="en-US">Valuation techniques used in fair value measurement [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FVTPLMember" xlink:label="afya_FVTPLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FVTPLMember" xlink:to="afya_FVTPLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FVTPLMember_lbl" xml:lang="en-US">F V T P L [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialAssetsAtAmortizedCostMember" xlink:label="afya_FinancialAssetsAtAmortizedCostMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialAssetsAtAmortizedCostMember" xlink:to="afya_FinancialAssetsAtAmortizedCostMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialAssetsAtAmortizedCostMember_lbl" xml:lang="en-US">Financial Assets At Amortized Cost [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FVOCIMember" xlink:label="afya_FVOCIMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FVOCIMember" xlink:to="afya_FVOCIMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FVOCIMember_lbl" xml:lang="en-US">F V O C I [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FVOCI1Member" xlink:label="afya_FVOCI1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FVOCI1Member" xlink:to="afya_FVOCI1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FVOCI1Member_lbl" xml:lang="en-US">F V O C I 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BuildingsMember" xlink:to="ifrs-full_BuildingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BuildingsMember_lbl" xml:lang="en-US">Buildings [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="afya_MachineryAndEquipmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MachineryAndEquipmentsMember" xlink:to="afya_MachineryAndEquipmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MachineryAndEquipmentsMember_lbl" xml:lang="en-US">Machinery And Equipments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="ifrs-full_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_VehiclesMember" xlink:to="ifrs-full_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_VehiclesMember_lbl" xml:lang="en-US">Vehicles [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="ifrs-full_FixturesAndFittingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FixturesAndFittingsMember" xlink:to="ifrs-full_FixturesAndFittingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FixturesAndFittingsMember_lbl" xml:lang="en-US">Fixtures and fittings [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ItEquipmentMember" xlink:label="afya_ItEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ItEquipmentMember" xlink:to="afya_ItEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ItEquipmentMember_lbl" xml:lang="en-US">It Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LibraryBooksMember" xlink:label="afya_LibraryBooksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LibraryBooksMember" xlink:to="afya_LibraryBooksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LibraryBooksMember_lbl" xml:lang="en-US">Library Books [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="ifrs-full_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseholdImprovementsMember" xlink:to="ifrs-full_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold improvements [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:to="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_lbl" xml:lang="en-US">Intangible assets with indefinite useful life [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="ifrs-full_CustomerrelatedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:to="ifrs-full_CustomerrelatedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CustomerrelatedIntangibleAssetsMember_lbl" xml:lang="en-US">Customer-related intangible assets [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CustomerRelationshipsOtherCoursesMember" xlink:label="afya_CustomerRelationshipsOtherCoursesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CustomerRelationshipsOtherCoursesMember" xlink:to="afya_CustomerRelationshipsOtherCoursesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CustomerRelationshipsOtherCoursesMember_lbl" xml:lang="en-US">Customer Relationships Other Courses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="ifrs-full_ComputerSoftwareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerSoftwareMember" xlink:to="ifrs-full_ComputerSoftwareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComputerSoftwareMember_lbl" xml:lang="en-US">Computer software [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="ifrs-full_BrandNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BrandNamesMember" xlink:to="ifrs-full_BrandNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BrandNamesMember_lbl" xml:lang="en-US">Brand names [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember" xlink:label="afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember" xlink:to="afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember_lbl" xml:lang="en-US">Education Content Developed Technology And Educational Platform [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProgramOfSocialIntegrationMember" xlink:label="afya_ProgramOfSocialIntegrationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProgramOfSocialIntegrationMember" xlink:to="afya_ProgramOfSocialIntegrationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProgramOfSocialIntegrationMember_lbl" xml:lang="en-US">Program Of Social Integration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesAxis_lbl" xml:lang="en-US">Products and services [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TeachingActivitiesMember" xlink:label="afya_TeachingActivitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TeachingActivitiesMember" xlink:to="afya_TeachingActivitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TeachingActivitiesMember_lbl" xml:lang="en-US">Teaching Activities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:label="afya_ContributionForTheFinancingOfSocialSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:to="afya_ContributionForTheFinancingOfSocialSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContributionForTheFinancingOfSocialSecurityMember_lbl" xml:lang="en-US">Contribution For The Financing Of Social Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NonTeachingActivitiesMember" xlink:label="afya_NonTeachingActivitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NonTeachingActivitiesMember" xlink:to="afya_NonTeachingActivitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NonTeachingActivitiesMember_lbl" xml:lang="en-US">Non Teaching Activities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsAxis" xlink:label="ifrs-full_InitiallyAppliedIFRSsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InitiallyAppliedIFRSsAxis" xlink:to="ifrs-full_InitiallyAppliedIFRSsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InitiallyAppliedIFRSsAxis_lbl" xml:lang="en-US">Initially applied IFRSs [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OrganizationForEconomicCooperationAndDevelopmentMember" xlink:label="afya_OrganizationForEconomicCooperationAndDevelopmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OrganizationForEconomicCooperationAndDevelopmentMember" xlink:to="afya_OrganizationForEconomicCooperationAndDevelopmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OrganizationForEconomicCooperationAndDevelopmentMember_lbl" xml:lang="en-US">Organization For Economic Cooperation And Development [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AmendmentsToIAS21Member" xlink:label="afya_AmendmentsToIAS21Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AmendmentsToIAS21Member" xlink:to="afya_AmendmentsToIAS21Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AmendmentsToIAS21Member_lbl" xml:lang="en-US">Amendments To I A S 21 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LackOfExchangeabilityAmendmentsToIAS21Member" xlink:label="afya_LackOfExchangeabilityAmendmentsToIAS21Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LackOfExchangeabilityAmendmentsToIAS21Member" xlink:to="afya_LackOfExchangeabilityAmendmentsToIAS21Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LackOfExchangeabilityAmendmentsToIAS21Member_lbl" xml:lang="en-US">Amendments To IAS 21 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member" xlink:label="afya_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member" xlink:to="afya_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_lbl" xml:lang="en-US">Financial Instruments Amendments To IFRS 9 And IFRS 7 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AnnualImprovementsToIFRSAccountingStandardsVolume11Member" xlink:label="afya_AnnualImprovementsToIFRSAccountingStandardsVolume11Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AnnualImprovementsToIFRSAccountingStandardsVolume11Member" xlink:to="afya_AnnualImprovementsToIFRSAccountingStandardsVolume11Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AnnualImprovementsToIFRSAccountingStandardsVolume11Member_lbl" xml:lang="en-US">Annual Improvements To IFRS Accounting Standards Volume 11 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member" xlink:label="afya_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member" xlink:to="afya_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_lbl" xml:lang="en-US">Power Purchase Agreements Amendments To IFRS 9 And IFRS 7 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IFRS18PresentationAndDisclosureInFinancialStatementsMember" xlink:label="afya_IFRS18PresentationAndDisclosureInFinancialStatementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IFRS18PresentationAndDisclosureInFinancialStatementsMember" xlink:to="afya_IFRS18PresentationAndDisclosureInFinancialStatementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IFRS18PresentationAndDisclosureInFinancialStatementsMember_lbl" xml:lang="en-US">IFRS 18 Presentation And Disclosure In Financial Statements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="ifrs-full_SegmentConsolidationItemsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SegmentConsolidationItemsAxis" xlink:to="ifrs-full_SegmentConsolidationItemsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SegmentConsolidationItemsAxis_lbl" xml:lang="en-US">Segment consolidation items [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="ifrs-full_OperatingSegmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OperatingSegmentsMember" xlink:to="ifrs-full_OperatingSegmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OperatingSegmentsMember_lbl" xml:lang="en-US">Operating segments [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SegmentsAxis_lbl" xml:lang="en-US">Segments [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UndergraduateMember" xlink:label="afya_UndergraduateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UndergraduateMember" xlink:to="afya_UndergraduateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UndergraduateMember_lbl" xml:lang="en-US">Undergraduate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContinuingEducationMember" xlink:label="afya_ContinuingEducationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContinuingEducationMember" xlink:to="afya_ContinuingEducationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContinuingEducationMember_lbl" xml:lang="en-US">Continuing Education [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicalPracticeSolutionsMember" xlink:label="afya_MedicalPracticeSolutionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedicalPracticeSolutionsMember" xlink:to="afya_MedicalPracticeSolutionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedicalPracticeSolutionsMember_lbl" xml:lang="en-US">Medical Practice Solutions [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TotalReportableSegmentsMember" xlink:label="afya_TotalReportableSegmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TotalReportableSegmentsMember" xlink:to="afya_TotalReportableSegmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TotalReportableSegmentsMember_lbl" xml:lang="en-US">Total Reportable Segments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EliminationInterSegmentBalancesMember" xlink:label="afya_EliminationInterSegmentBalancesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EliminationInterSegmentBalancesMember" xlink:to="afya_EliminationInterSegmentBalancesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EliminationInterSegmentBalancesMember_lbl" xml:lang="en-US">Elimination Inter Segment Balances [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="afya_AdjustmentsAndEliminationsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdjustmentsAndEliminationsMember" xlink:to="afya_AdjustmentsAndEliminationsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdjustmentsAndEliminationsMember_lbl" xml:lang="en-US">Adjustments And Eliminations [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnidomMember" xlink:label="afya_UnidomMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UnidomMember" xlink:to="afya_UnidomMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UnidomMember_lbl" xml:lang="en-US">Unidom [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AcquisitionOfUnidomMember" xlink:label="afya_AcquisitionOfUnidomMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AcquisitionOfUnidomMember" xlink:to="afya_AcquisitionOfUnidomMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AcquisitionOfUnidomMember_lbl" xml:lang="en-US">Acquisition Of Unidom [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="ifrs-full_LicencesAndFranchisesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicencesAndFranchisesMember" xlink:to="ifrs-full_LicencesAndFranchisesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LicencesAndFranchisesMember_lbl" xml:lang="en-US">Licences and franchises [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:label="ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis_lbl" xml:lang="en-US">Method of assessment of expected credit losses [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WithAndWithoutMethodMember" xlink:label="afya_WithAndWithoutMethodMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WithAndWithoutMethodMember" xlink:to="afya_WithAndWithoutMethodMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WithAndWithoutMethodMember_lbl" xml:lang="en-US">With And Without Method [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:label="ifrs-full_MultiperiodExcessEarningsMethodMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:to="ifrs-full_MultiperiodExcessEarningsMethodMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MultiperiodExcessEarningsMethodMember_lbl" xml:lang="en-US">Multi-period excess earnings method [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xml:lang="en-US">Classes of financial assets [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_BankCertificatesOfDepositMember" xlink:label="afya_BankCertificatesOfDepositMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BankCertificatesOfDepositMember" xlink:to="afya_BankCertificatesOfDepositMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BankCertificatesOfDepositMember_lbl" xml:lang="en-US">Bank Certificates Of Deposit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyInWhichInformationIsDisplayedAxis" xlink:label="ifrs-full_CurrencyInWhichInformationIsDisplayedAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrencyInWhichInformationIsDisplayedAxis" xlink:to="ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_lbl" xml:lang="en-US">Currency in which information is displayed [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_USDMember" xlink:label="afya_USDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_USDMember" xlink:to="afya_USDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_USDMember_lbl" xml:lang="en-US">U S D [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TuitionFeesMember" xlink:label="afya_TuitionFeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TuitionFeesMember" xlink:to="afya_TuitionFeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TuitionFeesMember_lbl" xml:lang="en-US">Tuition Fees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationalContentMember" xlink:label="afya_EducationalContentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationalContentMember" xlink:to="afya_EducationalContentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationalContentMember_lbl" xml:lang="en-US">Educational Content [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FIESMember" xlink:label="afya_FIESMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FIESMember" xlink:to="afya_FIESMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FIESMember_lbl" xml:lang="en-US">F I E S [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationalCreditsMember" xlink:label="afya_EducationalCreditsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationalCreditsMember" xlink:to="afya_EducationalCreditsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationalCreditsMember_lbl" xml:lang="en-US">Educational Credits [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MobileAppSubscriptionMember" xlink:label="afya_MobileAppSubscriptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MobileAppSubscriptionMember" xlink:to="afya_MobileAppSubscriptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MobileAppSubscriptionMember_lbl" xml:lang="en-US">Mobile App Subscription [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OthersMember" xlink:label="afya_OthersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OthersMember" xlink:to="afya_OthersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OthersMember_lbl" xml:lang="en-US">Others [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="ifrs-full_ImpairmentOfFinancialAssetsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:to="ifrs-full_ImpairmentOfFinancialAssetsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ImpairmentOfFinancialAssetsAxis_lbl" xml:lang="en-US">Impairment of financial assets [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" xlink:label="ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" xlink:to="ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember_lbl" xml:lang="en-US">Financial assets neither past due nor impaired [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusAxis" xlink:label="ifrs-full_PastDueStatusAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PastDueStatusAxis" xlink:to="ifrs-full_PastDueStatusAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PastDueStatusAxis_lbl" xml:lang="en-US">Past due status [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="ifrs-full_NotLaterThanOneMonthMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotLaterThanOneMonthMember" xlink:to="ifrs-full_NotLaterThanOneMonthMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotLaterThanOneMonthMember_lbl" xml:lang="en-US">Not later than one month [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:label="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:to="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_lbl" xml:lang="en-US">Later Than One Months And Not Later Than Three Months [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:to="ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_lbl" xml:lang="en-US">Later than three months and not later than six months [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanSixMonthsMember" xlink:label="ifrs-full_LaterThanSixMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanSixMonthsMember" xlink:to="ifrs-full_LaterThanSixMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanSixMonthsMember_lbl" xml:lang="en-US">Later than six months [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xml:lang="en-US">Categories of related parties [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UEPCMember" xlink:label="afya_UEPCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UEPCMember" xlink:to="afya_UEPCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UEPCMember_lbl" xml:lang="en-US">U E P C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EMIVEPatrulha24HorasLtdaMember" xlink:label="afya_EMIVEPatrulha24HorasLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EMIVEPatrulha24HorasLtdaMember" xlink:to="afya_EMIVEPatrulha24HorasLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EMIVEPatrulha24HorasLtdaMember_lbl" xml:lang="en-US">E M I V E Patrulha 24 Horas Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DepreciationRightofuseAssetsMember" xlink:label="afya_DepreciationRightofuseAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DepreciationRightofuseAssetsMember" xlink:to="afya_DepreciationRightofuseAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DepreciationRightofuseAssetsMember_lbl" xml:lang="en-US">Depreciation Rightofuse Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesInterestMember" xlink:label="afya_LeaseLiabilitiesInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesInterestMember" xlink:to="afya_LeaseLiabilitiesInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesInterestMember_lbl" xml:lang="en-US">Lease Liabilities Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements1Member" xlink:label="afya_LeaseAgreements1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseAgreements1Member" xlink:to="afya_LeaseAgreements1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseAgreements1Member_lbl" xml:lang="en-US">Lease Agreements 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:to="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember_lbl" xml:lang="en-US">Instituto Tocantinense Presidente Antonio Carlos S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="afya_RVLEstevesGestaoImobiliariaSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RVLEstevesGestaoImobiliariaSAMember" xlink:to="afya_RVLEstevesGestaoImobiliariaSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RVLEstevesGestaoImobiliariaSAMember_lbl" xml:lang="en-US">R V L Esteves Gestao Imobiliaria S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements2Member" xlink:label="afya_LeaseAgreements2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseAgreements2Member" xlink:to="afya_LeaseAgreements2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseAgreements2Member_lbl" xml:lang="en-US">Lease Agreements 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:label="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:to="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_lbl" xml:lang="en-US">Institutode Ensino Superior Presidente Trancredode Almeida Neves S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements3Member" xlink:label="afya_LeaseAgreements3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseAgreements3Member" xlink:to="afya_LeaseAgreements3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseAgreements3Member_lbl" xml:lang="en-US">Lease Agreements 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements4Member" xlink:label="afya_LeaseAgreements4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseAgreements4Member" xlink:to="afya_LeaseAgreements4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseAgreements4Member_lbl" xml:lang="en-US">Lease Agreements 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements5Member" xlink:label="afya_LeaseAgreements5Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseAgreements5Member" xlink:to="afya_LeaseAgreements5Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseAgreements5Member_lbl" xml:lang="en-US">Lease Agreements 5 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="afya_UNIVACOPatrimonialLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UNIVACOPatrimonialLtdaMember" xlink:to="afya_UNIVACOPatrimonialLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UNIVACOPatrimonialLtdaMember_lbl" xml:lang="en-US">U N I V A C O Patrimonial Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="afya_IESVAPPatrimonialLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IESVAPPatrimonialLtdaMember" xlink:to="afya_IESVAPPatrimonialLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IESVAPPatrimonialLtdaMember_lbl" xml:lang="en-US">I E S V A P Patrimonial Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssociatesMember" xlink:label="ifrs-full_AssociatesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssociatesMember" xlink:to="ifrs-full_AssociatesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssociatesMember_lbl" xml:lang="en-US">Total for all associates [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US">Gross carrying amount [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LandMember" xlink:label="ifrs-full_LandMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LandMember" xlink:to="ifrs-full_LandMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LandMember_lbl" xml:lang="en-US">Land [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="ifrs-full_ConstructionInProgressMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConstructionInProgressMember" xlink:to="ifrs-full_ConstructionInProgressMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConstructionInProgressMember_lbl" xml:lang="en-US">Construction in progress [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US">Accumulated depreciation and amortisation [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_lbl" xml:lang="en-US">Classes of intangible assets and goodwill [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="ifrs-full_GoodwillMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodwillMember" xlink:to="ifrs-full_GoodwillMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GoodwillMember_lbl" xml:lang="en-US">Goodwill [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LicencesMember" xlink:label="ifrs-full_LicencesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicencesMember" xlink:to="ifrs-full_LicencesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LicencesMember_lbl" xml:lang="en-US">Licences [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationContentMember" xlink:label="afya_EducationContentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationContentMember" xlink:to="afya_EducationContentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationContentMember_lbl" xml:lang="en-US">Education Content [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="ifrs-full_TechnologybasedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:to="ifrs-full_TechnologybasedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TechnologybasedIntangibleAssetsMember_lbl" xml:lang="en-US">Technology-based intangible assets [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationalPlatformMember" xlink:label="afya_EducationalPlatformMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationalPlatformMember" xlink:to="afya_EducationalPlatformMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationalPlatformMember_lbl" xml:lang="en-US">Educational Platform [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IntangibleInProgressMember" xlink:label="afya_IntangibleInProgressMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IntangibleInProgressMember" xlink:to="afya_IntangibleInProgressMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IntangibleInProgressMember_lbl" xml:lang="en-US">Intangible In Progress [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherMember" xlink:label="afya_OtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherMember" xlink:to="afya_OtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SoftwareInProgressMember" xlink:label="afya_SoftwareInProgressMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SoftwareInProgressMember" xlink:to="afya_SoftwareInProgressMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SoftwareInProgressMember_lbl" xml:lang="en-US">Software In Progress [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CarryingAmountsMember" xlink:label="afya_CarryingAmountsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CarryingAmountsMember" xlink:to="afya_CarryingAmountsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CarryingAmountsMember_lbl" xml:lang="en-US">Carrying Amounts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:label="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:to="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_lbl" xml:lang="en-US">IPTAN Instituto De Ensino Superior Presidente Trancredo DeAlmeida Neves SA [Membe]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:to="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_lbl" xml:lang="en-US">Instituto De Educacao Superior Do Vale Do Parnaiba SA [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:label="afya_CentroDeCienciasEmSaudeDeItajubaSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:to="afya_CentroDeCienciasEmSaudeDeItajubaSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroDeCienciasEmSaudeDeItajubaSAMember_lbl" xml:lang="en-US">Centro De Ciencias Em Saude De Itajuba SA [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:to="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember_lbl" xml:lang="en-US">Instituto De Ensino Superior Do Piaui SA [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:label="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:to="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_lbl" xml:lang="en-US">FADEP Faculdade Educaciona lDe Pato Branco Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="afya_InstitutoEducacionalSantoAgostinhoSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:to="afya_InstitutoEducacionalSantoAgostinhoSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoEducacionalSantoAgostinhoSAMember_lbl" xml:lang="en-US">Instituto Educacional Santo Agostinho SA [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:to="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember_lbl" xml:lang="en-US">Instituto Paraensede Educacaoe Cultura Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UniRedentorMember" xlink:label="afya_UniRedentorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniRedentorMember" xlink:to="afya_UniRedentorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniRedentorMember_lbl" xml:lang="en-US">Uni Redentor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UniSLMember" xlink:label="afya_UniSLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniSLMember" xlink:to="afya_UniSLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniSLMember_lbl" xml:lang="en-US">Uni SL [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FESARMember" xlink:label="afya_FESARMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FESARMember" xlink:to="afya_FESARMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FESARMember_lbl" xml:lang="en-US">FESAR [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FCMPBMember" xlink:label="afya_FCMPBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FCMPBMember" xlink:to="afya_FCMPBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FCMPBMember_lbl" xml:lang="en-US">FCMPB [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ITPACGaranhunsMember" xlink:label="afya_ITPACGaranhunsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ITPACGaranhunsMember" xlink:to="afya_ITPACGaranhunsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ITPACGaranhunsMember_lbl" xml:lang="en-US">ITPAC Garanhuns [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnifipMocMember" xlink:label="afya_UnifipMocMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UnifipMocMember" xlink:to="afya_UnifipMocMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UnifipMocMember_lbl" xml:lang="en-US">Unifip Moc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnigranrioMember" xlink:label="afya_UnigranrioMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UnigranrioMember" xlink:to="afya_UnigranrioMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UnigranrioMember_lbl" xml:lang="en-US">Unigranrio [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DelReyMember" xlink:label="afya_DelReyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DelReyMember" xlink:to="afya_DelReyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DelReyMember_lbl" xml:lang="en-US">Del Rey [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FUNICMember" xlink:label="afya_FUNICMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FUNICMember" xlink:to="afya_FUNICMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FUNICMember_lbl" xml:lang="en-US">F U N I C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DiscountRatesMember" xlink:label="afya_DiscountRatesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DiscountRatesMember" xlink:to="afya_DiscountRatesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DiscountRatesMember_lbl" xml:lang="en-US">Discount Rates [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PerpetuityGrowthRateMember" xlink:label="afya_PerpetuityGrowthRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PerpetuityGrowthRateMember" xlink:to="afya_PerpetuityGrowthRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PerpetuityGrowthRateMember_lbl" xml:lang="en-US">Perpetuity Growth Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EBITDAMember" xlink:label="afya_EBITDAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EBITDAMember" xlink:to="afya_EBITDAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EBITDAMember_lbl" xml:lang="en-US">E B I T D A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="ifrs-full_FinancialAssetsAtAmortisedCostMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:to="ifrs-full_FinancialAssetsAtAmortisedCostMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsAtAmortisedCostMember_lbl" xml:lang="en-US">Financial assets at amortised cost, class [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xml:lang="en-US">Classes of financial liabilities [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:to="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_lbl" xml:lang="en-US">Financial liabilities at amortised cost, class [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersEarnOutsMember" xlink:label="afya_AccountsPayableToSellingShareholdersEarnOutsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersEarnOutsMember" xlink:to="afya_AccountsPayableToSellingShareholdersEarnOutsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersEarnOutsMember_lbl" xml:lang="en-US">Accounts Payable To Selling Shareholders Earn Outs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersUnidomMember" xlink:label="afya_AccountsPayableToSellingShareholdersUnidomMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersUnidomMember" xlink:to="afya_AccountsPayableToSellingShareholdersUnidomMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersUnidomMember_lbl" xml:lang="en-US">Accounts Payable To Selling Shareholders Unidom [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAxis_lbl" xml:lang="en-US">Maturity [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OctoberTwentyTwentyFiveMember" xlink:label="afya_OctoberTwentyTwentyFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OctoberTwentyTwentyFiveMember" xlink:to="afya_OctoberTwentyTwentyFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OctoberTwentyTwentyFiveMember_lbl" xml:lang="en-US">October Twenty Twenty Five [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_JulyTwentyTwentySevenMember" xlink:label="afya_JulyTwentyTwentySevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_JulyTwentyTwentySevenMember" xlink:to="afya_JulyTwentyTwentySevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_JulyTwentyTwentySevenMember_lbl" xml:lang="en-US">July Twenty Twenty Seven [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AprilTwentyTwentySixMember" xlink:label="afya_AprilTwentyTwentySixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AprilTwentyTwentySixMember" xlink:to="afya_AprilTwentyTwentySixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AprilTwentyTwentySixMember_lbl" xml:lang="en-US">April Twenty Twenty Six [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_JanuaryTwentyTwentyEightMember" xlink:label="afya_JanuaryTwentyTwentyEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_JanuaryTwentyTwentyEightMember" xlink:to="afya_JanuaryTwentyTwentyEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_JanuaryTwentyTwentyEightMember_lbl" xml:lang="en-US">January Twenty Twenty Eight [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AprilTwentyThirtyMember" xlink:label="afya_AprilTwentyThirtyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AprilTwentyThirtyMember" xlink:to="afya_AprilTwentyThirtyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AprilTwentyThirtyMember_lbl" xml:lang="en-US">April Twenty Thirty [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OctoberTwentyTwentyEightMember" xlink:label="afya_OctoberTwentyTwentyEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OctoberTwentyTwentyEightMember" xlink:to="afya_OctoberTwentyTwentyEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OctoberTwentyTwentyEightMember_lbl" xml:lang="en-US">October Twenty Twenty Eight [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OctoberTwentyThirtyMember" xlink:label="afya_OctoberTwentyThirtyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OctoberTwentyThirtyMember" xlink:to="afya_OctoberTwentyThirtyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OctoberTwentyThirtyMember_lbl" xml:lang="en-US">October Twenty Thirty [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InternationalFinanceCorporationMember" xlink:label="afya_InternationalFinanceCorporationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InternationalFinanceCorporationMember" xlink:to="afya_InternationalFinanceCorporationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InternationalFinanceCorporationMember_lbl" xml:lang="en-US">International Finance Corporation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TwoSeriesMember" xlink:label="afya_TwoSeriesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwoSeriesMember" xlink:to="afya_TwoSeriesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TwoSeriesMember_lbl" xml:lang="en-US">Two Series [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FirstSeriesMember" xlink:label="afya_FirstSeriesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FirstSeriesMember" xlink:to="afya_FirstSeriesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FirstSeriesMember_lbl" xml:lang="en-US">First Series [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SecondSeriesMember" xlink:label="afya_SecondSeriesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SecondSeriesMember" xlink:to="afya_SecondSeriesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SecondSeriesMember_lbl" xml:lang="en-US">Second Series [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShospMember" xlink:label="afya_ShospMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShospMember" xlink:to="afya_ShospMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShospMember_lbl" xml:lang="en-US">Shosp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AlemDaMedicinaMember" xlink:label="afya_AlemDaMedicinaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AlemDaMedicinaMember" xlink:to="afya_AlemDaMedicinaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AlemDaMedicinaMember_lbl" xml:lang="en-US">Alem Da Medicina [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CardioPapersMember" xlink:label="afya_CardioPapersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CardioPapersMember" xlink:to="afya_CardioPapersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CardioPapersMember_lbl" xml:lang="en-US">Cardio Papers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksAxis_lbl" xml:lang="en-US">Types of risks [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyRiskMember" xlink:label="ifrs-full_CurrencyRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrencyRiskMember" xlink:to="ifrs-full_CurrencyRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrencyRiskMember_lbl" xml:lang="en-US">Currency risk [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR" xlink:label="currency_EUR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_EUR" xlink:to="currency_EUR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_EUR_lbl" xml:lang="en-US">Euro Member Countries, Euro</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CardiPapersMember" xlink:label="afya_CardiPapersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CardiPapersMember" xlink:to="afya_CardiPapersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CardiPapersMember_lbl" xml:lang="en-US">Cardi Papers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="afya_AccountsPayableToSellingShareholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersMember" xlink:to="afya_AccountsPayableToSellingShareholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersMember_lbl" xml:lang="en-US">Accounts Payable To Selling Shareholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingMember" xlink:label="afya_LoansAndFinancingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingMember" xlink:to="afya_LoansAndFinancingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingMember_lbl" xml:lang="en-US">Loans And Financing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CashEquivalents1Member" xlink:label="afya_CashEquivalents1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CashEquivalents1Member" xlink:to="afya_CashEquivalents1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CashEquivalents1Member_lbl" xml:lang="en-US">Cash Equivalents 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="ifrs-full_TypesOfInterestRatesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfInterestRatesAxis" xlink:to="ifrs-full_TypesOfInterestRatesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfInterestRatesAxis_lbl" xml:lang="en-US">Types of interest rates [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FloatingInterestRateMember" xlink:label="ifrs-full_FloatingInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FloatingInterestRateMember" xlink:to="ifrs-full_FloatingInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FloatingInterestRateMember_lbl" xml:lang="en-US">Floating interest rate [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestRateRiskMember" xlink:label="ifrs-full_InterestRateRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateRiskMember" xlink:to="ifrs-full_InterestRateRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestRateRiskMember_lbl" xml:lang="en-US">Interest rate risk [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingOneMember" xlink:label="afya_LoansAndFinancingOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingOneMember" xlink:to="afya_LoansAndFinancingOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingOneMember_lbl" xml:lang="en-US">Loans And Financing One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersOneMember" xlink:label="afya_AccountsPayableToSellingShareholdersOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersOneMember" xlink:to="afya_AccountsPayableToSellingShareholdersOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersOneMember_lbl" xml:lang="en-US">Accounts Payable To Selling Shareholders One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersTwoMember" xlink:label="afya_AccountsPayableToSellingShareholdersTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersTwoMember" xlink:to="afya_AccountsPayableToSellingShareholdersTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersTwoMember_lbl" xml:lang="en-US">Accounts Payable To Selling Shareholders Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProbabilityOfDefaultAxis" xlink:label="ifrs-full_ProbabilityOfDefaultAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProbabilityOfDefaultAxis" xlink:to="ifrs-full_ProbabilityOfDefaultAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProbabilityOfDefaultAxis_lbl" xml:lang="en-US">Probability of default [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseBasisPointsMember" xlink:label="afya_IncreaseBasisPointsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseBasisPointsMember" xlink:to="afya_IncreaseBasisPointsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseBasisPointsMember_lbl" xml:lang="en-US">Increase Basis Points [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseBasisPointsOneMember" xlink:label="afya_IncreaseBasisPointsOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseBasisPointsOneMember" xlink:to="afya_IncreaseBasisPointsOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseBasisPointsOneMember_lbl" xml:lang="en-US">Increase Basis Points One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RiskExposuresAxis" xlink:label="ifrs-full_RiskExposuresAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RiskExposuresAxis" xlink:to="ifrs-full_RiskExposuresAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RiskExposuresAxis_lbl" xml:lang="en-US">Risk variables [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ForeignCurrencyExposuresMember" xlink:label="afya_ForeignCurrencyExposuresMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ForeignCurrencyExposuresMember" xlink:to="afya_ForeignCurrencyExposuresMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ForeignCurrencyExposuresMember_lbl" xml:lang="en-US">Foreign Currency Exposures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseForeignCurrencyMember" xlink:label="afya_IncreaseForeignCurrencyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseForeignCurrencyMember" xlink:to="afya_IncreaseForeignCurrencyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseForeignCurrencyMember_lbl" xml:lang="en-US">Increase Foreign Currency [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DecreaseForeignCurrencyMember" xlink:label="afya_DecreaseForeignCurrencyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DecreaseForeignCurrencyMember" xlink:to="afya_DecreaseForeignCurrencyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DecreaseForeignCurrencyMember_lbl" xml:lang="en-US">Decrease Foreign Currency [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="ifrs-full_LaterThanOneYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearMember" xlink:to="ifrs-full_LaterThanOneYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearMember_lbl" xml:lang="en-US">Later than one year [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiquidityRiskMember" xlink:label="ifrs-full_LiquidityRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiquidityRiskMember" xlink:to="ifrs-full_LiquidityRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiquidityRiskMember_lbl" xml:lang="en-US">Liquidity risk [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xml:lang="en-US">Later than one year and not later than three years [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_lbl" xml:lang="en-US">Later than three years and not later than five years [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanFiveYearsMember_lbl" xml:lang="en-US">Later than five years [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl" xml:lang="en-US">Liabilities arising from financing activities [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesMember" xlink:to="ifrs-full_LeaseLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilitiesMember_lbl" xml:lang="en-US">Lease liabilities [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendsPayableMember" xlink:label="afya_DividendsPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsPayableMember" xlink:to="afya_DividendsPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsPayableMember_lbl" xml:lang="en-US">Dividends Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="ifrs-full_DefinedBenefitPlansAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DefinedBenefitPlansAxis" xlink:to="ifrs-full_DefinedBenefitPlansAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DefinedBenefitPlansAxis_lbl" xml:lang="en-US">Defined benefit plans [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShareBasedCompensationPlansMember" xlink:label="afya_ShareBasedCompensationPlansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareBasedCompensationPlansMember" xlink:to="afya_ShareBasedCompensationPlansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShareBasedCompensationPlansMember_lbl" xml:lang="en-US">Share Based Compensation Plans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnitsMember" xlink:label="afya_RestrictedStockUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedStockUnitsMember" xlink:to="afya_RestrictedStockUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedStockUnitsMember_lbl" xml:lang="en-US">Restricted Stock Units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnits1Member" xlink:label="afya_RestrictedStockUnits1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedStockUnits1Member" xlink:to="afya_RestrictedStockUnits1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedStockUnits1Member_lbl" xml:lang="en-US">Restricted Stock Units 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnits2Member" xlink:label="afya_RestrictedStockUnits2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedStockUnits2Member" xlink:to="afya_RestrictedStockUnits2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedStockUnits2Member_lbl" xml:lang="en-US">Restricted Stock Units 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnits3Member" xlink:label="afya_RestrictedStockUnits3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedStockUnits3Member" xlink:to="afya_RestrictedStockUnits3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedStockUnits3Member_lbl" xml:lang="en-US">Restricted Stock Units 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOptionsMember" xlink:label="ifrs-full_ShareOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOptionsMember" xlink:to="ifrs-full_ShareOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOptionsMember_lbl" xml:lang="en-US">Share options [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_November2025Member" xlink:label="afya_November2025Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_November2025Member" xlink:to="afya_November2025Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_November2025Member_lbl" xml:lang="en-US">November 2025 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_April2025Member" xlink:label="afya_April2025Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_April2025Member" xlink:to="afya_April2025Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_April2025Member_lbl" xml:lang="en-US">April 2025 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_October2024Member" xlink:label="afya_October2024Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_October2024Member" xlink:to="afya_October2024Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_October2024Member_lbl" xml:lang="en-US">October 2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_December2023Member" xlink:label="afya_December2023Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_December2023Member" xlink:to="afya_December2023Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_December2023Member_lbl" xml:lang="en-US">December 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_October2023Member" xlink:label="afya_October2023Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_October2023Member" xlink:to="afya_October2023Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_October2023Member_lbl" xml:lang="en-US">October 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_August2023Member" xlink:label="afya_August2023Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_August2023Member" xlink:to="afya_August2023Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_August2023Member_lbl" xml:lang="en-US">August 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_April2023Member" xlink:label="afya_April2023Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_April2023Member" xlink:to="afya_April2023Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_April2023Member_lbl" xml:lang="en-US">April 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_February2023Member" xlink:label="afya_February2023Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_February2023Member" xlink:to="afya_February2023Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_February2023Member_lbl" xml:lang="en-US">February 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EliminationInterSegmentTransactionsMember" xlink:label="afya_EliminationInterSegmentTransactionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EliminationInterSegmentTransactionsMember" xlink:to="afya_EliminationInterSegmentTransactionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EliminationInterSegmentTransactionsMember_lbl" xml:lang="en-US">Elimination Inter Segment Transactions [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UndergradMember" xlink:label="afya_UndergradMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UndergradMember" xlink:to="afya_UndergradMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UndergradMember_lbl" xml:lang="en-US">Undergrad [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfContingentLiabilitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis_lbl" xml:lang="en-US">Classes of contingent liabilities [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="ifrs-full_LegalProceedingsContingentLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:to="ifrs-full_LegalProceedingsContingentLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LegalProceedingsContingentLiabilityMember_lbl" xml:lang="en-US">Legal proceedings contingent liability [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="ifrs-full_ClassesOfProvisionsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ifrs-full_ClassesOfProvisionsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfProvisionsAxis_lbl" xml:lang="en-US">Classes of other provisions [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LabourMember" xlink:label="afya_LabourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LabourMember" xlink:to="afya_LabourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LabourMember_lbl" xml:lang="en-US">Labour [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CivilMember" xlink:label="afya_CivilMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CivilMember" xlink:to="afya_CivilMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CivilMember_lbl" xml:lang="en-US">Civil [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxesMember" xlink:label="afya_TaxesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesMember" xlink:to="afya_TaxesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxesMember_lbl" xml:lang="en-US">Taxes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TypesOfRiskMember" xlink:label="afya_TypesOfRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TypesOfRiskMember" xlink:to="afya_TypesOfRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TypesOfRiskMember_lbl" xml:lang="en-US">Types Of Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxesAndSocialSecurityMember" xlink:label="afya_TaxesAndSocialSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesAndSocialSecurityMember" xlink:to="afya_TaxesAndSocialSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxesAndSocialSecurityMember_lbl" xml:lang="en-US">Taxes And Social Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsAxis_lbl" xml:lang="en-US">Classes of assets [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherAssetsNonCurrentMember" xlink:label="afya_OtherAssetsNonCurrentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssetsNonCurrentMember" xlink:to="afya_OtherAssetsNonCurrentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherAssetsNonCurrentMember_lbl" xml:lang="en-US">Other Assets Non Current [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl" xml:lang="en-US">Non-adjusting events after reporting period [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NonadjustingEventMember" xlink:label="afya_NonadjustingEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NonadjustingEventMember" xlink:to="afya_NonadjustingEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NonadjustingEventMember_lbl" xml:lang="en-US">Nonadjusting Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelEmailAddress" xlink:label="dei_ContactPersonnelEmailAddress" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelEmailAddress" xlink:to="dei_ContactPersonnelEmailAddress_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelEmailAddress_lbl" xml:lang="en-US">Contact Personnel Email Address</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of financial position [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="ifrs-full_CurrentAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="ifrs-full_CurrentTradeReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTradeReceivables_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxAssets" xlink:label="ifrs-full_CurrentTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxAssets" xlink:to="ifrs-full_CurrentTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxAssets_lbl" xml:lang="en-US">Recoverable taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeTaxesRecoverable" xlink:label="afya_IncomeTaxesRecoverable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncomeTaxesRecoverable" xlink:to="afya_IncomeTaxesRecoverable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncomeTaxesRecoverable_lbl" xml:lang="en-US">Income taxes recoverable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentAssets" xlink:label="ifrs-full_OtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentAssets" xlink:to="ifrs-full_OtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="ifrs-full_NoncurrentAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrentTradeReceivable" xlink:label="afya_NoncurrentTradeReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentTradeReceivable" xlink:to="afya_NoncurrentTradeReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentTradeReceivable_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxAssets_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="ifrs-full_OtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xml:lang="en-US">Investment in associate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US">Right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US">Total non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="ifrs-full_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesAbstract" xlink:to="ifrs-full_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermBorrowings" xlink:label="ifrs-full_ShorttermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermBorrowings" xlink:to="ifrs-full_ShorttermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermBorrowings_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="ifrs-full_CurrentDepositsFromCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDepositsFromCustomers" xlink:to="ifrs-full_CurrentDepositsFromCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentDepositsFromCustomers_lbl" xml:lang="en-US">Advances from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPayable" xlink:label="ifrs-full_DividendsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPayable" xlink:to="ifrs-full_DividendsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPayable_lbl" xml:lang="en-US">Dividends payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:to="ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CurrentTaxesPayable" xlink:label="afya_CurrentTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentTaxesPayable" xlink:to="afya_CurrentTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CurrentTaxesPayable_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:to="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="ifrs-full_OtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentLiabilities" xlink:to="ifrs-full_OtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="ifrs-full_LongtermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_LongtermBorrowings_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPayablesToRelatedParties" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayablesToRelatedParties" xlink:to="ifrs-full_NoncurrentPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrentTaxesPayable" xlink:label="afya_NoncurrentTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentTaxesPayable" xlink:to="afya_NoncurrentTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentTaxesPayable_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="ifrs-full_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermLegalProceedingsProvision" xlink:label="ifrs-full_LongtermLegalProceedingsProvision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermLegalProceedingsProvision" xlink:to="ifrs-full_LongtermLegalProceedingsProvision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LongtermLegalProceedingsProvision_lbl" xml:lang="en-US">Provision for legal proceedings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="ifrs-full_OtherNoncurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherNoncurrentLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US">Total non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="ifrs-full_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAbstract_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US">Share capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalPaidinCapital" xlink:label="ifrs-full_AdditionalPaidinCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalPaidinCapital" xlink:to="ifrs-full_AdditionalPaidinCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalPaidinCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="ifrs-full_TreasuryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasuryShares" xlink:to="ifrs-full_TreasuryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TreasuryShares_lbl" xml:lang="en-US">Treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="ifrs-full_ReserveOfSharebasedPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPayments" xlink:to="ifrs-full_ReserveOfSharebasedPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfSharebasedPayments_lbl" xml:lang="en-US">Share-based compensation reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US">Retained earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent_lbl" xml:lang="en-US">Equity attributable to the owners of the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="ifrs-full_NoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterests" xlink:to="ifrs-full_NoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncontrollingInterests_lbl" xml:lang="en-US">Non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US">Total equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="ifrs-full_EquityAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US">Total liabilities and equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="ifrs-full_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeStatementAbstract_lbl" xml:lang="en-US">Profit or loss [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales" xlink:label="ifrs-full_CostOfSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CostOfSales_lbl" xml:lang="en-US">Cost of services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit" xlink:label="ifrs-full_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeneralAndAdministrativeExpense" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForExpectedCreditLosses" xlink:label="afya_AllowanceForExpectedCreditLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForExpectedCreditLosses" xlink:to="afya_AllowanceForExpectedCreditLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_AllowanceForExpectedCreditLosses_lbl" xml:lang="en-US">Allowance for expected credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="ifrs-full_OtherOperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherExpenseByNature" xlink:label="ifrs-full_OtherExpenseByNature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_OtherExpenseByNature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OtherExpenseByNature_lbl" xml:lang="en-US">Other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US">Operating income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncome" xlink:to="ifrs-full_FinanceIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncome_lbl" xml:lang="en-US">Finance income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinanceCosts_lbl" xml:lang="en-US">Finance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinanceIncomeCost_lbl" xml:lang="en-US">Net finance result</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl" xml:lang="en-US">Share of profit of equity-accounted investee, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US">Income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeTaxesExpensesAbstract" xlink:label="afya_IncomeTaxesExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncomeTaxesExpensesAbstract" xlink:to="afya_IncomeTaxesExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncomeTaxesExpensesAbstract_lbl" xml:lang="en-US">Income taxes expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeTaxesExpensesCurrent" xlink:label="afya_IncomeTaxesExpensesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncomeTaxesExpensesCurrent" xlink:to="afya_IncomeTaxesExpensesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_IncomeTaxesExpensesCurrent_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxes" xlink:label="afya_DeferredTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeferredTaxes" xlink:to="afya_DeferredTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeferredTaxes_lbl" xml:lang="en-US">Deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US">Other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US">Total comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="ifrs-full_ProfitLossAttributableToAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLossAttributableToAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToAbstract_lbl" xml:lang="en-US">Net income / total comprehensive income attributable to:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl" xml:lang="en-US">Owners of the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl" xml:lang="en-US">Non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ComprehensiveIncomeLoss" xlink:label="afya_ComprehensiveIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ComprehensiveIncomeLoss" xlink:to="afya_ComprehensiveIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="afya_ComprehensiveIncomeLoss_lbl" xml:lang="en-US">Total comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="ifrs-full_BasicEarningsLossPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US">Basic earnings per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US">Diluted earnings per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityTable_lbl" xml:lang="en-US">Statement of changes in equity [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="afya_IfrsStatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IfrsStatementLineItems" xlink:to="afya_IfrsStatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IfrsStatementLineItems_lbl" xml:lang="en-US">IfrsStatementLineItems [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Equity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncome_2_lbl" xml:lang="en-US">Total comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TreasurySharesRepurchase" xlink:label="afya_TreasurySharesRepurchase" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TreasurySharesRepurchase" xlink:to="afya_TreasurySharesRepurchase_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TreasurySharesRepurchase_lbl" xml:lang="en-US">Treasury shares repurchase</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AcquisitionOfNoncontrollingInterests" xlink:label="afya_AcquisitionOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AcquisitionOfNoncontrollingInterests" xlink:to="afya_AcquisitionOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AcquisitionOfNoncontrollingInterests_lbl" xml:lang="en-US">Acquisition of non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedSharesTransferredToExecutives" xlink:label="afya_RestrictedSharesTransferredToExecutives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedSharesTransferredToExecutives" xlink:to="afya_RestrictedSharesTransferredToExecutives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedSharesTransferredToExecutives_lbl" xml:lang="en-US">Restricted stock units transferred under the share-based compensation plan</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" xlink:label="afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" xlink:to="afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions_lbl" xml:lang="en-US">Treasury shares transferred to executives from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaid" xlink:label="ifrs-full_DividendsPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaid" xlink:to="ifrs-full_DividendsPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DividendsPaid_lbl" xml:lang="en-US">Dividends declared</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Equity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of cash flows [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeLossBeforeIncomeTaxes" xlink:label="afya_IncomeLossBeforeIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncomeLossBeforeIncomeTaxes" xlink:to="afya_IncomeLossBeforeIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_IncomeLossBeforeIncomeTaxes_lbl" xml:lang="en-US">Income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xml:lang="en-US">Adjustments to reconcile income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl" xml:lang="en-US">Depreciation and amortization expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WriteoffOfPropertyAndEquipment" xlink:label="afya_WriteoffOfPropertyAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WriteoffOfPropertyAndEquipment" xlink:to="afya_WriteoffOfPropertyAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WriteoffOfPropertyAndEquipment_lbl" xml:lang="en-US">Write-off of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WriteoffOfIntangibleAssets" xlink:label="afya_WriteoffOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WriteoffOfIntangibleAssets" xlink:to="afya_WriteoffOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WriteoffOfIntangibleAssets_lbl" xml:lang="en-US">Write-off of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:label="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:to="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities_lbl" xml:lang="en-US">Allowance for expected credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US">Share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl" xml:lang="en-US">Net foreign exchange differences</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccruedInterestOfOpeartingActivities" xlink:label="afya_AccruedInterestOfOpeartingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccruedInterestOfOpeartingActivities" xlink:to="afya_AccruedInterestOfOpeartingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccruedInterestOfOpeartingActivities_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xml:lang="en-US">Accrued interest on lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax" xlink:label="afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax" xlink:to="afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax_lbl" xml:lang="en-US">Share of profit of equity-accounted investee, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="ifrs-full_AdjustmentsForProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForProvisions" xlink:to="ifrs-full_AdjustmentsForProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForProvisions_lbl" xml:lang="en-US">Provision (reversal) for legal proceedings</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseDecreaseInOperatingLiabilities1Abstract" xlink:label="afya_IncreaseDecreaseInOperatingLiabilities1Abstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="afya_IncreaseDecreaseInOperatingLiabilities1Abstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseDecreaseInOperatingLiabilities1Abstract_lbl" xml:lang="en-US">Changes in assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseDecreaseInRecoverableTaxes" xlink:label="afya_IncreaseDecreaseInRecoverableTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseDecreaseInRecoverableTaxes" xlink:to="afya_IncreaseDecreaseInRecoverableTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_IncreaseDecreaseInRecoverableTaxes_lbl" xml:lang="en-US">Recoverable taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_lbl" xml:lang="en-US">Advances from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherAdjustmentsForNoncashItems" xlink:to="ifrs-full_OtherAdjustmentsForNoncashItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseDecreaseInPaymentsOfLegalProceedings" xlink:label="afya_IncreaseDecreaseInPaymentsOfLegalProceedings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseDecreaseInPaymentsOfLegalProceedings" xlink:to="afya_IncreaseDecreaseInPaymentsOfLegalProceedings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_IncreaseDecreaseInPaymentsOfLegalProceedings_lbl" xml:lang="en-US">Payments of legal proceedings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss_lbl" xml:lang="en-US">Net cash flows from operating activities before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash flows from operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Acquisition of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:label="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:to="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Acquisition of intangibles assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsReceived" xlink:label="ifrs-full_DividendsReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsReceived" xlink:to="ifrs-full_DividendsReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsReceived_lbl" xml:lang="en-US">Dividends received</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PurchaseOfAcquisitionOfNoncontrollingInterests" xlink:label="afya_PurchaseOfAcquisitionOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PurchaseOfAcquisitionOfNoncontrollingInterests" xlink:to="afya_PurchaseOfAcquisitionOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_PurchaseOfAcquisitionOfNoncontrollingInterests_lbl" xml:lang="en-US">Acquisition of non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Acquisition of assets and subsidiaries, net of cash acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentsOfInterest" xlink:label="afya_PaymentsOfInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfInterest" xlink:to="afya_PaymentsOfInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_PaymentsOfInterest_lbl" xml:lang="en-US">Payments of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash flows used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payments of principal of loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RepaymentsOfInterest" xlink:label="afya_RepaymentsOfInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RepaymentsOfInterest" xlink:to="afya_RepaymentsOfInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_RepaymentsOfInterest_lbl" xml:lang="en-US">Payments of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Proceeds from loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payments of principal of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payments of interest of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfOptions" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="ifrs-full_DividendsPaidClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_DividendsPaidClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DividendsPaidClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Dividends paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash flows from (used in) financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US">Net foreign exchange differences</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents at the beginning of the year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents at the end of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Role of Management [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentAbstract" xlink:label="cyd_MaterialCybersecurityIncidentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentAbstract" xlink:to="cyd_MaterialCybersecurityIncidentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentAbstract_lbl" xml:lang="en-US">Material Cybersecurity Incident [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentNatureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentNatureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentNatureTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Nature [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentScopeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentScopeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentScopeTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Scope [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentTimingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentTimingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentTimingTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Timing [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureCorporateInformationAbstract" xlink:label="afya_DisclosureCorporateInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureCorporateInformationAbstract" xlink:to="afya_DisclosureCorporateInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureCorporateInformationAbstract_lbl" xml:lang="en-US">Corporate Information</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfGeneralInformationAboutFinancialStatementExplanatory" xlink:label="afya_DisclosureOfGeneralInformationAboutFinancialStatementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfGeneralInformationAboutFinancialStatementExplanatory" xlink:to="afya_DisclosureOfGeneralInformationAboutFinancialStatementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfGeneralInformationAboutFinancialStatementExplanatory_lbl" xml:lang="en-US">Corporate information</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="afya_DisclosureMaterialAccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:to="afya_DisclosureMaterialAccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureMaterialAccountingPoliciesAbstract_lbl" xml:lang="en-US">Material Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfMaterialAccountingPoliciesExplanatory" xlink:label="afya_DisclosureOfMaterialAccountingPoliciesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfMaterialAccountingPoliciesExplanatory" xlink:to="afya_DisclosureOfMaterialAccountingPoliciesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfMaterialAccountingPoliciesExplanatory_lbl" xml:lang="en-US">Material accounting policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_NotesAndOtherExplanatoryInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract_lbl" xml:lang="en-US">Notes and other explanatory information [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl" xml:lang="en-US">Segment information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsExplanatory_lbl" xml:lang="en-US">Business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureCashAndCashEquivalentsAbstract" xlink:label="afya_DisclosureCashAndCashEquivalentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureCashAndCashEquivalentsAbstract" xlink:to="afya_DisclosureCashAndCashEquivalentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureCashAndCashEquivalentsAbstract_lbl" xml:lang="en-US">Cash And Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosuresOfCashAndCashEquivalentsExplanatory" xlink:label="afya_DisclosuresOfCashAndCashEquivalentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosuresOfCashAndCashEquivalentsExplanatory" xlink:to="afya_DisclosuresOfCashAndCashEquivalentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DisclosuresOfCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US">Related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOtherAssetsAbstract" xlink:label="afya_DisclosureOtherAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOtherAssetsAbstract" xlink:to="afya_DisclosureOtherAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOtherAssetsAbstract_lbl" xml:lang="en-US">Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfOtherAssetExplanatory" xlink:label="afya_DisclosureOfOtherAssetExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfOtherAssetExplanatory" xlink:to="afya_DisclosureOfOtherAssetExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DisclosureOfOtherAssetExplanatory_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl" xml:lang="en-US">Investment in associate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIntangibleAssetsAbstract" xlink:label="afya_DisclosureIntangibleAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureIntangibleAssetsAbstract" xlink:to="afya_DisclosureIntangibleAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureIntangibleAssetsAbstract_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfIntangibleAssetExplanatory" xlink:label="afya_DisclosureOfIntangibleAssetExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfIntangibleAssetExplanatory" xlink:to="afya_DisclosureOfIntangibleAssetExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DisclosureOfIntangibleAssetExplanatory_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Financial assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureCapitalManagementAbstract" xlink:label="afya_DisclosureCapitalManagementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureCapitalManagementAbstract" xlink:to="afya_DisclosureCapitalManagementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureCapitalManagementAbstract_lbl" xml:lang="en-US">Capital Management</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CapitalManagementExplanatory" xlink:label="afya_CapitalManagementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalManagementExplanatory" xlink:to="afya_CapitalManagementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CapitalManagementExplanatory_lbl" xml:lang="en-US">Capital management</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="afya_DisclosureLaborAndSocialObligationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureLaborAndSocialObligationsAbstract" xlink:to="afya_DisclosureLaborAndSocialObligationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureLaborAndSocialObligationsAbstract_lbl" xml:lang="en-US">Labor And Social Obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LaborAndSocialObligationsExplanatory" xlink:label="afya_LaborAndSocialObligationsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsExplanatory" xlink:to="afya_LaborAndSocialObligationsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LaborAndSocialObligationsExplanatory_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureEquityAbstract" xlink:label="afya_DisclosureEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureEquityAbstract" xlink:to="afya_DisclosureEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DisclosureEquityAbstract_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfEquityExplanatory" xlink:label="afya_DisclosureOfEquityExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfEquityExplanatory" xlink:to="afya_DisclosureOfEquityExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DisclosureOfEquityExplanatory_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US">Earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:label="ifrs-full_DisclosureOfExpensesByNatureExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:to="ifrs-full_DisclosureOfExpensesByNatureExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfExpensesByNatureExplanatory_lbl" xml:lang="en-US">Costs and expenses by nature</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xml:lang="en-US">Finance result</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIncomeTaxesAbstract" xlink:label="afya_DisclosureIncomeTaxesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureIncomeTaxesAbstract" xlink:to="afya_DisclosureIncomeTaxesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureIncomeTaxesAbstract_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfIncomeTaxesExplanatory" xlink:label="afya_DisclosureOfIncomeTaxesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfIncomeTaxesExplanatory" xlink:to="afya_DisclosureOfIncomeTaxesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfIncomeTaxesExplanatory_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLegalProceedingsAndContingenciesAbstract" xlink:label="afya_DisclosureLegalProceedingsAndContingenciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureLegalProceedingsAndContingenciesAbstract" xlink:to="afya_DisclosureLegalProceedingsAndContingenciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureLegalProceedingsAndContingenciesAbstract_lbl" xml:lang="en-US">Legal Proceedings And Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfLegalProceedingsAndContingenciesExplanatory" xlink:label="afya_DisclosureOfLegalProceedingsAndContingenciesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfLegalProceedingsAndContingenciesExplanatory" xlink:to="afya_DisclosureOfLegalProceedingsAndContingenciesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfLegalProceedingsAndContingenciesExplanatory_lbl" xml:lang="en-US">Legal proceedings and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureNoncashTransactionsAbstract" xlink:label="afya_DisclosureNoncashTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureNoncashTransactionsAbstract" xlink:to="afya_DisclosureNoncashTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureNoncashTransactionsAbstract_lbl" xml:lang="en-US">Non-cash Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureNoncashTransactionsExplanatory" xlink:label="afya_DisclosureNoncashTransactionsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureNoncashTransactionsExplanatory" xlink:to="afya_DisclosureNoncashTransactionsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureNoncashTransactionsExplanatory_lbl" xml:lang="en-US">Non-cash transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US">Subsequent events</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_BusinessCombinationsAndGoodwillPolicyExplanatory" xlink:label="afya_BusinessCombinationsAndGoodwillPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BusinessCombinationsAndGoodwillPolicyExplanatory" xlink:to="afya_BusinessCombinationsAndGoodwillPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BusinessCombinationsAndGoodwillPolicyExplanatory_lbl" xml:lang="en-US">Business combinations and goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" xlink:label="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" xlink:to="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory_lbl" xml:lang="en-US">Fair value measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" xlink:label="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" xlink:to="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_lbl" xml:lang="en-US">Financial instruments - initial recognition and measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" xlink:label="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" xlink:to="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory_lbl" xml:lang="en-US">Impairment of non-financial assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory" xlink:label="afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory" xlink:to="afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory_lbl" xml:lang="en-US">Investments in associates</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersPolicyExplanatory" xlink:label="afya_AccountsPayableToSellingShareholdersPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersPolicyExplanatory" xlink:to="afya_AccountsPayableToSellingShareholdersPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableToSellingShareholdersPolicyExplanatory_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xml:lang="en-US">Provisions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendsPolicyExplanatory" xlink:label="afya_DividendsPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsPolicyExplanatory" xlink:to="afya_DividendsPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsPolicyExplanatory_lbl" xml:lang="en-US">Dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LaborAndSocialObligationsPolicyExplanatory" xlink:label="afya_LaborAndSocialObligationsPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsPolicyExplanatory" xlink:to="afya_LaborAndSocialObligationsPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaborAndSocialObligationsPolicyExplanatory_lbl" xml:lang="en-US">m) Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SharebasedPaymentsPolicyExplanatory" xlink:label="afya_SharebasedPaymentsPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharebasedPaymentsPolicyExplanatory" xlink:to="afya_SharebasedPaymentsPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SharebasedPaymentsPolicyExplanatory_lbl" xml:lang="en-US">Share-based payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl" xml:lang="en-US">Earnings per share (&#8220;EPS&#8221;)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xml:lang="en-US">Revenue from contracts with customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xml:lang="en-US">Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_lbl" xml:lang="en-US">Treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">Schedule of identifiable assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" xlink:label="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" xlink:to="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_lbl" xml:lang="en-US">Schedule of company&#8217;s subsidiaries and associate</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock" xlink:label="afya_ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock" xlink:to="afya_ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock_lbl" xml:lang="en-US">Schedule of fair values for financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfMeasurementAndGainsAndLossesTableTextBlock" xlink:label="afya_ScheduleOfMeasurementAndGainsAndLossesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfMeasurementAndGainsAndLossesTableTextBlock" xlink:to="afya_ScheduleOfMeasurementAndGainsAndLossesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfMeasurementAndGainsAndLossesTableTextBlock_lbl" xml:lang="en-US">Schedule of measurement and gains and losses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:label="afya_ScheduleOfEstimatedUsefulLivesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:to="afya_ScheduleOfEstimatedUsefulLivesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfEstimatedUsefulLivesTableTextBlock_lbl" xml:lang="en-US">Schedule of estimated useful lives of the assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock" xlink:label="afya_ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock" xlink:to="afya_ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of estimated useful lives of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" xlink:label="afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" xlink:to="afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_lbl" xml:lang="en-US">Schedule of changes in accounting policies and disclosures</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" xlink:label="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" xlink:to="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_lbl" xml:lang="en-US">Schedule of present assets and liabilities information for the company operating segments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl" xml:lang="en-US">Schedule of statements of income for the company&#8217;s operating segments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock" xlink:label="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock" xlink:to="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock_lbl" xml:lang="en-US">Schedule of fair values of the identifiable assets acquired and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfAcquisitionOfUnidomExplanatory" xlink:label="afya_ScheduleOfAcquisitionOfUnidomExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfUnidomExplanatory" xlink:to="afya_ScheduleOfAcquisitionOfUnidomExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfUnidomExplanatory_lbl" xml:lang="en-US">Schedule of intangible assets acquired unidom</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:to="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US">Schedule of cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfTradeAndOtherReceivables1Explanatory" xlink:label="afya_DisclosureOfTradeAndOtherReceivables1Explanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfTradeAndOtherReceivables1Explanatory" xlink:to="afya_DisclosureOfTradeAndOtherReceivables1Explanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfTradeAndOtherReceivables1Explanatory_lbl" xml:lang="en-US">Schedule of trade accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" xlink:label="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" xlink:to="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory_lbl" xml:lang="en-US">Schedule of aging of trade accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory" xlink:label="afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory" xlink:to="afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory_lbl" xml:lang="en-US">Schedule of allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfRelatedPartiesExplanatory" xlink:label="afya_DisclosureOfRelatedPartiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfRelatedPartiesExplanatory" xlink:to="afya_DisclosureOfRelatedPartiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfRelatedPartiesExplanatory_lbl" xml:lang="en-US">Schedule of balances and transactions with related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" xlink:label="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" xlink:to="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock_lbl" xml:lang="en-US">Schedule of key management personnel compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfOtherAssetsTableTextBlock" xlink:label="afya_DisclosureOfOtherAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfOtherAssetsTableTextBlock" xlink:to="afya_DisclosureOfOtherAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfOtherAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfInvestmentsExplanatory" xlink:label="afya_DisclosureOfInvestmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfInvestmentsExplanatory" xlink:to="afya_DisclosureOfInvestmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfInvestmentsExplanatory_lbl" xml:lang="en-US">Schedule of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Schedule of detailed information about property, plant and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfIntangibleAssetsTableTextBlock" xlink:label="afya_SummaryOfIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfIntangibleAssetsTableTextBlock" xlink:to="afya_SummaryOfIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" xlink:label="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" xlink:to="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_lbl" xml:lang="en-US">Schedule of assumptions for impairment test</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SchuduleOfAssumptionsUsedTableTextBlock" xlink:label="afya_SchuduleOfAssumptionsUsedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SchuduleOfAssumptionsUsedTableTextBlock" xlink:to="afya_SchuduleOfAssumptionsUsedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SchuduleOfAssumptionsUsedTableTextBlock_lbl" xml:lang="en-US">Schedule of assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFinancialAssetsTableTextBlock" xlink:label="afya_ScheduleOfFinancialAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFinancialAssetsTableTextBlock" xlink:to="afya_ScheduleOfFinancialAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFinancialAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of financial assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFinancialLiabilitiesTableTextBlock" xlink:label="afya_ScheduleOfFinancialLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFinancialLiabilitiesTableTextBlock" xlink:to="afya_ScheduleOfFinancialLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFinancialLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of financial liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFairValuesTableTextBlock" xlink:label="afya_ScheduleOfFairValuesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFairValuesTableTextBlock" xlink:to="afya_ScheduleOfFairValuesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFairValuesTableTextBlock_lbl" xml:lang="en-US">Schedule of fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfLoansAndFinancingTableTextBlock" xlink:label="afya_ScheduleOfLoansAndFinancingTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfLoansAndFinancingTableTextBlock" xlink:to="afya_ScheduleOfLoansAndFinancingTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfLoansAndFinancingTableTextBlock_lbl" xml:lang="en-US">Schedule of loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfLeasesTableTextBlock" xlink:label="afya_ScheduleOfLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfLeasesTableTextBlock" xlink:to="afya_ScheduleOfLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of right-of-use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock" xlink:label="afya_ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock" xlink:to="afya_ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock_lbl" xml:lang="en-US">Schedule of accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholders1Explanatory" xlink:label="afya_AccountsPayableToSellingShareholders1Explanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholders1Explanatory" xlink:to="afya_AccountsPayableToSellingShareholders1Explanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholders1Explanatory_lbl" xml:lang="en-US">Schedule of accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFairValuesFinancialInstrumentstTableTextBlock" xlink:label="afya_ScheduleOfFairValuesFinancialInstrumentstTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFairValuesFinancialInstrumentstTableTextBlock" xlink:to="afya_ScheduleOfFairValuesFinancialInstrumentstTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFairValuesFinancialInstrumentstTableTextBlock_lbl" xml:lang="en-US">Schedule of fair values of the company's financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" xlink:label="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" xlink:to="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_lbl" xml:lang="en-US">Schedule of income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" xlink:label="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" xlink:to="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_lbl" xml:lang="en-US">Schedule of sensitivity foreign currency</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" xlink:label="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" xlink:to="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of maturity profile of financial liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock" xlink:label="afya_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock" xlink:to="afya_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of changes in liabilities arising from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFairValueOfStockOptionsGrantsExplanatory" xlink:label="afya_ScheduleOfFairValueOfStockOptionsGrantsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFairValueOfStockOptionsGrantsExplanatory" xlink:to="afya_ScheduleOfFairValueOfStockOptionsGrantsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFairValueOfStockOptionsGrantsExplanatory_lbl" xml:lang="en-US">Schedule of grants of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfSharebasedCompensationPlanExplanatory" xlink:label="afya_ScheduleOfSharebasedCompensationPlanExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfSharebasedCompensationPlanExplanatory" xlink:to="afya_ScheduleOfSharebasedCompensationPlanExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfSharebasedCompensationPlanExplanatory_lbl" xml:lang="en-US">Schedule of movements in stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfGrantsRestrictedStockUnitsTableTextBlock" xlink:label="afya_ScheduleOfGrantsRestrictedStockUnitsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfGrantsRestrictedStockUnitsTableTextBlock" xlink:to="afya_ScheduleOfGrantsRestrictedStockUnitsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfGrantsRestrictedStockUnitsTableTextBlock_lbl" xml:lang="en-US">Schedule of grants of RSUs</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfStockOptionTableTextBlock" xlink:label="afya_ScheduleOfStockOptionTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfStockOptionTableTextBlock" xlink:to="afya_ScheduleOfStockOptionTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfStockOptionTableTextBlock_lbl" xml:lang="en-US">Schedule of stock option</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfTreasurySharesMovementExplanatory" xlink:label="afya_ScheduleOfTreasurySharesMovementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfTreasurySharesMovementExplanatory" xlink:to="afya_ScheduleOfTreasurySharesMovementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfTreasurySharesMovementExplanatory_lbl" xml:lang="en-US">Schedule of number and movements in treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfEarningsPerShareTableExplanatory" xlink:label="afya_ScheduleOfEarningsPerShareTableExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfEarningsPerShareTableExplanatory" xlink:to="afya_ScheduleOfEarningsPerShareTableExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfEarningsPerShareTableExplanatory_lbl" xml:lang="en-US">Schedule of earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfNetSalesRevenueExplanatory" xlink:label="afya_ScheduleOfNetSalesRevenueExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfNetSalesRevenueExplanatory" xlink:to="afya_ScheduleOfNetSalesRevenueExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfNetSalesRevenueExplanatory_lbl" xml:lang="en-US">Schedule of net sales revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfRevenueBySegmentTableTextBlock" xlink:label="afya_ScheduleOfRevenueBySegmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfRevenueBySegmentTableTextBlock" xlink:to="afya_ScheduleOfRevenueBySegmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfRevenueBySegmentTableTextBlock_lbl" xml:lang="en-US">Schedule of revenue by segment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfExpensesByNatureTableTextBlock" xlink:label="afya_ScheduleOfExpensesByNatureTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfExpensesByNatureTableTextBlock" xlink:to="afya_ScheduleOfExpensesByNatureTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfExpensesByNatureTableTextBlock_lbl" xml:lang="en-US">Schedule of expenses by nature</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFinanceResultTableTextBlock" xlink:label="afya_ScheduleOfFinanceResultTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFinanceResultTableTextBlock" xlink:to="afya_ScheduleOfFinanceResultTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFinanceResultTableTextBlock_lbl" xml:lang="en-US">Schedule of finance result</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" xlink:label="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" xlink:to="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_lbl" xml:lang="en-US">Schedule of reconciliation of income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="afya_ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="afya_ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred tax assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfLegalProceedingsAndContingenciesTableTextBlock" xlink:label="afya_ScheduleOfLegalProceedingsAndContingenciesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfLegalProceedingsAndContingenciesTableTextBlock" xlink:to="afya_ScheduleOfLegalProceedingsAndContingenciesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfLegalProceedingsAndContingenciesTableTextBlock_lbl" xml:lang="en-US">Schedule of legal proceedings and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock" xlink:label="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock" xlink:to="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock_lbl" xml:lang="en-US">Schedule of social security proceedings assessed by management</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfNonCashTransactionsTableTextBlock" xlink:label="afya_ScheduleOfNonCashTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfNonCashTransactionsTableTextBlock" xlink:to="afya_ScheduleOfNonCashTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfNonCashTransactionsTableTextBlock_lbl" xml:lang="en-US">Schedule of non-cash transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_lbl" xml:lang="en-US">Disclosure of subsidiaries [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Cash and cash and equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingAsOfAcquisitionDate" xlink:label="afya_LoansAndFinancingAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingAsOfAcquisitionDate" xlink:to="afya_LoansAndFinancingAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancingAsOfAcquisitionDate_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Financial liabilities recognised as of acquisition date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Total net assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsTable_lbl" xml:lang="en-US">Disclosure of detailed information about business combination [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl" xml:lang="en-US">Acquired percenatge</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAcquiree" xlink:label="ifrs-full_DescriptionOfAcquiree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAcquiree" xlink:to="ifrs-full_DescriptionOfAcquiree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAcquiree_lbl" xml:lang="en-US">Acquired purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionalPaymentToShareholder" xlink:label="afya_AdditionalPaymentToShareholder" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionalPaymentToShareholder" xlink:to="afya_AdditionalPaymentToShareholder_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionalPaymentToShareholder_lbl" xml:lang="en-US">Additional payment to shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PrincipalActivities" xlink:label="afya_PrincipalActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PrincipalActivities" xlink:to="afya_PrincipalActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PrincipalActivities_lbl" xml:lang="en-US">Principal activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:to="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_lbl" xml:lang="en-US">Location</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InvestmentType" xlink:label="afya_InvestmentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InvestmentType" xlink:to="afya_InvestmentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InvestmentType_lbl" xml:lang="en-US">Investment type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:to="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_lbl" xml:lang="en-US">Direct and indirect interest of subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_lbl" xml:lang="en-US">Disclosure of fair value measurement of assets [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets" xlink:label="ifrs-full_DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets" xlink:to="ifrs-full_DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_lbl" xml:lang="en-US">Valuation technique</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets" xlink:label="ifrs-full_DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets" xlink:to="ifrs-full_DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_lbl" xml:lang="en-US">Inter-relationship between significant unobservable inputs and fair value measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ExpectedCashFlows" xlink:label="afya_ExpectedCashFlows" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ExpectedCashFlows" xlink:to="afya_ExpectedCashFlows_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ExpectedCashFlows_lbl" xml:lang="en-US">Expected cash flows</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProbabilityOfDisbursement" xlink:label="afya_ProbabilityOfDisbursement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProbabilityOfDisbursement" xlink:to="afya_ProbabilityOfDisbursement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProbabilityOfDisbursement_lbl" xml:lang="en-US">Probability of disbursement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:label="ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:to="ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_lbl" xml:lang="en-US">Disclosure of significant unobservable inputs used in fair value measurement of assets [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Equity investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xml:lang="en-US">Useful lives of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_lbl" xml:lang="en-US">Disclosure of intangible assets with indefinite useful life [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Estimated useful lives of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:label="ifrs-full_TitleOfInitiallyAppliedIFRS" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:to="ifrs-full_TitleOfInitiallyAppliedIFRS_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TitleOfInitiallyAppliedIFRS_lbl" xml:lang="en-US">Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:label="ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:to="ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy_lbl" xml:lang="en-US">Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_lbl" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ApplicableTaxRate_lbl" xml:lang="en-US">Tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="ifrs-full_AverageEffectiveTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AverageEffectiveTaxRate" xlink:to="ifrs-full_AverageEffectiveTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AverageEffectiveTaxRate_lbl" xml:lang="en-US">Effective tax</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConsolidatedRevenues" xlink:label="afya_ConsolidatedRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ConsolidatedRevenues" xlink:to="afya_ConsolidatedRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ConsolidatedRevenues_lbl" xml:lang="en-US">Consolidated revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MinimumTaxRate" xlink:label="afya_MinimumTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MinimumTaxRate" xlink:to="afya_MinimumTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MinimumTaxRate_lbl" xml:lang="en-US">Minimum tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable_lbl" xml:lang="en-US">Disclosure of operating segments [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Assets_2_lbl" xml:lang="en-US">Total assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentAssets_2_lbl" xml:lang="en-US">Current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentAssets_2_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilities_2_lbl" xml:lang="en-US">Total liabilities and equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentLiabilities_2_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLiabilities_2_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Equity_4_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="ifrs-full_InvestmentsInAssociates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInAssociates" xlink:to="ifrs-full_InvestmentsInAssociates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentsInAssociates_lbl" xml:lang="en-US">Investments in associate</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CapitalExpenditures" xlink:label="afya_CapitalExpenditures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalExpenditures" xlink:to="afya_CapitalExpenditures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CapitalExpenditures_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DepositsFromExternalCustomer" xlink:label="afya_DepositsFromExternalCustomer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DepositsFromExternalCustomer" xlink:to="afya_DepositsFromExternalCustomer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DepositsFromExternalCustomer_lbl" xml:lang="en-US">External customer</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InterSegment" xlink:label="afya_InterSegment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InterSegment" xlink:to="afya_InterSegment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InterSegment_lbl" xml:lang="en-US">Inter-segment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Revenue_2_lbl" xml:lang="en-US">Net revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CostOfSale" xlink:label="afya_CostOfSale" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CostOfSale" xlink:to="afya_CostOfSale_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CostOfSale_lbl" xml:lang="en-US">Cost of services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossProfit_2_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForExpectedCreditLosses" xlink:to="afya_AllowanceForExpectedCreditLosses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AllowanceForExpectedCreditLosses_2_lbl" xml:lang="en-US">Allowance for expected credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome" xlink:label="ifrs-full_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherIncome_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherGainsLosses" xlink:label="ifrs-full_OtherGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherGainsLosses" xlink:to="ifrs-full_OtherGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherGainsLosses_lbl" xml:lang="en-US">Other expenses, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_2_lbl" xml:lang="en-US">Operating income</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinanceExpense" xlink:label="afya_FinanceExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinanceExpense" xlink:to="afya_FinanceExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinanceExpense_lbl" xml:lang="en-US">Finance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xml:lang="en-US">Share of income of associate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossBeforeTax_2_lbl" xml:lang="en-US">Income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US">Income taxes expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="afya_TradeReceivablesAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeReceivablesAsOfAcquisitionDate" xlink:to="afya_TradeReceivablesAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TradeReceivablesAsOfAcquisitionDate_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdvancesRecognisedAsOfAcquisitionDate" xlink:label="afya_AdvancesRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdvancesRecognisedAsOfAcquisitionDate" xlink:to="afya_AdvancesRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdvancesRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Advances</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RecoverableTaxesAsOfAcquisitionDate" xlink:label="afya_RecoverableTaxesAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RecoverableTaxesAsOfAcquisitionDate" xlink:to="afya_RecoverableTaxesAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_RecoverableTaxesAsOfAcquisitionDate_lbl" xml:lang="en-US">Recoverable taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="afya_OtherAssetsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssetsAsOfAcquisitionDate" xlink:to="afya_OtherAssetsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherAssetsAsOfAcquisitionDate_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IndemnificationAssetsAsOfAcquisitionDate" xlink:label="afya_IndemnificationAssetsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IndemnificationAssetsAsOfAcquisitionDate" xlink:to="afya_IndemnificationAssetsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IndemnificationAssetsAsOfAcquisitionDate_lbl" xml:lang="en-US">Indemnification assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="afya_RightOfUseAssetsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:to="afya_RightOfUseAssetsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightOfUseAssetsAsOfAcquisitionDate_lbl" xml:lang="en-US">Rights-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="afya_LaborAndSocialObligationsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:to="afya_LaborAndSocialObligationsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LaborAndSocialObligationsAsOfAcquisitionDate_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="afya_TaxesPayableAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesPayableAsOfAcquisitionDate" xlink:to="afya_TaxesPayableAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TaxesPayableAsOfAcquisitionDate_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherTaxesPayableAsOfAcquisitionDate" xlink:label="afya_OtherTaxesPayableAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherTaxesPayableAsOfAcquisitionDate" xlink:to="afya_OtherTaxesPayableAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherTaxesPayableAsOfAcquisitionDate_lbl" xml:lang="en-US">Other taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="afya_AdvancesFromCustomersAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:to="afya_AdvancesFromCustomersAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AdvancesFromCustomersAsOfAcquisitionDate_lbl" xml:lang="en-US">Advances from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:label="afya_LeaseLiabilitiesAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:to="afya_LeaseLiabilitiesAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LeaseLiabilitiesAsOfAcquisitionDate_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:label="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:to="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate_lbl" xml:lang="en-US">Provision for legal proceedings</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="afya_OtherLiabilitiesAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:to="afya_OtherLiabilitiesAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherLiabilitiesAsOfAcquisitionDate_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Total identifiable net assets at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Goodwill arising on acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl" xml:lang="en-US">Purchase consideration transferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred" xlink:label="ifrs-full_CashTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashTransferred" xlink:to="ifrs-full_CashTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashTransferred_lbl" xml:lang="en-US">Cash paid</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConsiderationToBeTransferred" xlink:label="afya_ConsiderationToBeTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ConsiderationToBeTransferred" xlink:to="afya_ConsiderationToBeTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ConsiderationToBeTransferred_lbl" xml:lang="en-US">Consideration to be transferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:to="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl" xml:lang="en-US">Transaction costs of the acquisition (included in cash flows from operating activities)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:to="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_lbl" xml:lang="en-US">Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="afya_NetOfCashFlowOnAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetOfCashFlowOnAcquisition" xlink:to="afya_NetOfCashFlowOnAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NetOfCashFlowOnAcquisition_lbl" xml:lang="en-US">Net of cash flow on acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:to="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_lbl" xml:lang="en-US">Valuation technique</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination" xlink:label="afya_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination" xlink:to="afya_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination_lbl" xml:lang="en-US">Total transaction costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:to="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_2_lbl" xml:lang="en-US">Transaction costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_3_lbl" xml:lang="en-US">Income loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseInRevenue" xlink:label="afya_IncreaseInRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseInRevenue" xlink:to="afya_IncreaseInRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseInRevenue_lbl" xml:lang="en-US">Increase in revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseInIncomeBeforeIncomeTaxes" xlink:label="afya_IncreaseInIncomeBeforeIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseInIncomeBeforeIncomeTaxes" xlink:to="afya_IncreaseInIncomeBeforeIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseInIncomeBeforeIncomeTaxes_lbl" xml:lang="en-US">Increase in income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="ifrs-full_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Cash" xlink:to="ifrs-full_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Cash_lbl" xml:lang="en-US">Cash and bank deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashEquivalents" xlink:label="ifrs-full_CashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashEquivalents" xlink:to="ifrs-full_CashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashEquivalents_lbl" xml:lang="en-US">Cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="ifrs-full_DisclosureOfFinancialAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsTable" xlink:to="ifrs-full_DisclosureOfFinancialAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsTable_lbl" xml:lang="en-US">Disclosure of financial assets [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PercenatgeOfAverageInterestOnFinancialInstrument" xlink:label="afya_PercenatgeOfAverageInterestOnFinancialInstrument" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PercenatgeOfAverageInterestOnFinancialInstrument" xlink:to="afya_PercenatgeOfAverageInterestOnFinancialInstrument_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PercenatgeOfAverageInterestOnFinancialInstrument_lbl" xml:lang="en-US">Percentage of average interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ReceivablesGross" xlink:label="afya_ReceivablesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ReceivablesGross" xlink:to="afya_ReceivablesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ReceivablesGross_lbl" xml:lang="en-US">Trade receivables, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:label="afya_AllowanceForDoubtfulAccountsFoReceivable1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:to="afya_AllowanceForDoubtfulAccountsFoReceivable1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllowanceForDoubtfulAccountsFoReceivable1_lbl" xml:lang="en-US">(-) Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="ifrs-full_TradeReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeReceivables_lbl" xml:lang="en-US">Trade receivables, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentTradeReceivables_2_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="ifrs-full_NoncurrentTradeReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentTradeReceivables" xlink:to="ifrs-full_NoncurrentTradeReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentTradeReceivables_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:label="ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_lbl" xml:lang="en-US">Disclosure of financial assets that are either past due or impaired [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ReceivablesGross" xlink:to="afya_ReceivablesGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ReceivablesGross_2_lbl" xml:lang="en-US">Trade receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceAccountForCreditLossesOfFinancialAsset" xlink:label="afya_AllowanceAccountForCreditLossesOfFinancialAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceAccountForCreditLossesOfFinancialAsset" xlink:to="afya_AllowanceAccountForCreditLossesOfFinancialAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="afya_AllowanceAccountForCreditLossesOfFinancialAsset_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" xlink:label="afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" xlink:to="afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" xlink:label="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" xlink:to="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_lbl" xml:lang="en-US">Write-offs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceAccountForCreditLossesOfFinancialAsset" xlink:to="afya_AllowanceAccountForCreditLossesOfFinancialAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="afya_AllowanceAccountForCreditLossesOfFinancialAsset_2_lbl" xml:lang="en-US">Closing balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_lbl" xml:lang="en-US">Disclosure of transactions between related parties [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsRelatedPartyTransactions" xlink:label="afya_RightofuseAssetsRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsRelatedPartyTransactions" xlink:to="afya_RightofuseAssetsRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_RightofuseAssetsRelatedPartyTransactions_lbl" xml:lang="en-US">Right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TradeReceivablesRelatedPartyTransactions" xlink:label="afya_TradeReceivablesRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeReceivablesRelatedPartyTransactions" xlink:to="afya_TradeReceivablesRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TradeReceivablesRelatedPartyTransactions_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherAssetsRelatedPartyTransactions" xlink:label="afya_OtherAssetsRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssetsRelatedPartyTransactions" xlink:to="afya_OtherAssetsRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherAssetsRelatedPartyTransactions_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="ifrs-full_AmountsReceivableRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsReceivableRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AmountsReceivableRelatedPartyTransactions_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:label="afya_TradeAndOtherCurrentPayablesToRelatedParties1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:to="afya_TradeAndOtherCurrentPayablesToRelatedParties1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TradeAndOtherCurrentPayablesToRelatedParties1_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrentAssetsOfRelatedParty1" xlink:label="afya_NoncurrentAssetsOfRelatedParty1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentAssetsOfRelatedParty1" xlink:to="afya_NoncurrentAssetsOfRelatedParty1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentAssetsOfRelatedParty1_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesRelatedPartyTransactions" xlink:label="afya_LeaseLiabilitiesRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesRelatedPartyTransactions" xlink:to="afya_LeaseLiabilitiesRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LeaseLiabilitiesRelatedPartyTransactions_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TradeAndOtherCurrentPayableToRelatedParties" xlink:label="afya_TradeAndOtherCurrentPayableToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherCurrentPayableToRelatedParties" xlink:to="afya_TradeAndOtherCurrentPayableToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TradeAndOtherCurrentPayableToRelatedParties_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrenLliabilitiesOfRelatedParty1" xlink:label="afya_NoncurrenLliabilitiesOfRelatedParty1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrenLliabilitiesOfRelatedParty1" xlink:to="afya_NoncurrenLliabilitiesOfRelatedParty1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrenLliabilitiesOfRelatedParty1_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherIncomeRelatedPartyTransactions" xlink:label="afya_OtherIncomeRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherIncomeRelatedPartyTransactions" xlink:to="afya_OtherIncomeRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherIncomeRelatedPartyTransactions_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xml:lang="en-US">Short-term employee benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US">Share-based compensation plans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:label="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:to="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OperatingLeaseTermOfContract" xlink:label="afya_OperatingLeaseTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OperatingLeaseTermOfContract" xlink:to="afya_OperatingLeaseTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OperatingLeaseTermOfContract_lbl" xml:lang="en-US">Lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="ifrs-full_LeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_LeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RelatedPartiesAmountPaid" xlink:label="afya_RelatedPartiesAmountPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RelatedPartiesAmountPaid" xlink:to="afya_RelatedPartiesAmountPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RelatedPartiesAmountPaid_lbl" xml:lang="en-US">Related parties amount paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="ifrs-full_PercentageOfEntitysRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfEntitysRevenue" xlink:to="ifrs-full_PercentageOfEntitysRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfEntitysRevenue_lbl" xml:lang="en-US">Percentage of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DescriptionOfLeaseTerm" xlink:label="afya_DescriptionOfLeaseTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfLeaseTerm" xlink:to="afya_DescriptionOfLeaseTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DescriptionOfLeaseTerm_lbl" xml:lang="en-US">Description of lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="ifrs-full_CashOutflowForLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashOutflowForLeases" xlink:to="ifrs-full_CashOutflowForLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashOutflowForLeases_lbl" xml:lang="en-US">Lease expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LesseeFinancesLeaseRenewalTerm" xlink:label="afya_LesseeFinancesLeaseRenewalTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LesseeFinancesLeaseRenewalTerm" xlink:to="afya_LesseeFinancesLeaseRenewalTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LesseeFinancesLeaseRenewalTerm_lbl" xml:lang="en-US">Renewal term</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DescriptionOfLeaseTerms" xlink:label="afya_DescriptionOfLeaseTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfLeaseTerms" xlink:to="afya_DescriptionOfLeaseTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DescriptionOfLeaseTerms_lbl" xml:lang="en-US">Description of lease term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_3_lbl" xml:lang="en-US">Indemnification assets - Note 21</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Advances1" xlink:label="afya_Advances1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Advances1" xlink:to="afya_Advances1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_Advances1_lbl" xml:lang="en-US">Advances</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_JudicialDeposits" xlink:label="afya_JudicialDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_JudicialDeposits" xlink:to="afya_JudicialDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_JudicialDeposits_lbl" xml:lang="en-US">Judicial deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaidExpenses" xlink:to="ifrs-full_CurrentPrepaidExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaidExpenses_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="ifrs-full_OtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReceivables" xlink:to="ifrs-full_OtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherReceivables_lbl" xml:lang="en-US">Other FIES credits</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConvertibleLoansFromVentureCapitalInvestments" xlink:label="afya_ConvertibleLoansFromVentureCapitalInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ConvertibleLoansFromVentureCapitalInvestments" xlink:to="afya_ConvertibleLoansFromVentureCapitalInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ConvertibleLoansFromVentureCapitalInvestments_lbl" xml:lang="en-US">Convertible loans from venture capital investments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Dividend" xlink:label="afya_Dividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Dividend" xlink:to="afya_Dividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_Dividend_lbl" xml:lang="en-US">Dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherAssets1" xlink:label="afya_OtherAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssets1" xlink:to="afya_OtherAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherAssets1_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Assets1" xlink:label="afya_Assets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Assets1" xlink:to="afya_Assets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="afya_Assets1_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CurrentAssets1" xlink:label="afya_CurrentAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentAssets1" xlink:to="afya_CurrentAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CurrentAssets1_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrentAssets1" xlink:label="afya_NoncurrentAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentAssets1" xlink:to="afya_NoncurrentAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentAssets1_lbl" xml:lang="en-US">Non-current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CurrentLiabilities_3_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NoncurrentLiabilities_3_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EquityInAssociate" xlink:label="afya_EquityInAssociate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EquityInAssociate" xlink:to="afya_EquityInAssociate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_EquityInAssociate_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CompanyShareInEquity1" xlink:label="afya_CompanyShareInEquity1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CompanyShareInEquity1" xlink:to="afya_CompanyShareInEquity1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CompanyShareInEquity1_lbl" xml:lang="en-US">Company&#8217;s share in equity - 30%</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill" xlink:label="ifrs-full_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Goodwill" xlink:to="ifrs-full_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InvestmentGrossAmount" xlink:label="afya_InvestmentGrossAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InvestmentGrossAmount" xlink:to="afya_InvestmentGrossAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InvestmentGrossAmount_lbl" xml:lang="en-US">Carrying amount of the investment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherExpense" xlink:label="afya_OtherExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherExpense" xlink:to="afya_OtherExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherExpense_lbl" xml:lang="en-US">Other expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncome" xlink:to="ifrs-full_FinanceIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinanceIncome_2_lbl" xml:lang="en-US">Net finance result</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CompanyShareOfProfitss" xlink:label="afya_CompanyShareOfProfitss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CompanyShareOfProfitss" xlink:to="afya_CompanyShareOfProfitss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CompanyShareOfProfitss_lbl" xml:lang="en-US">Company&#8217;s share of profit, net of tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInAssociates" xlink:to="ifrs-full_InvestmentsInAssociates_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_InvestmentsInAssociates_2_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="ifrs-full_ProfitLossOfAcquiree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossOfAcquiree" xlink:to="ifrs-full_ProfitLossOfAcquiree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossOfAcquiree_lbl" xml:lang="en-US">Share of profit, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendsReceived1" xlink:label="afya_DividendsReceived1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsReceived1" xlink:to="afya_DividendsReceived1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="afya_DividendsReceived1_lbl" xml:lang="en-US">Dividends received</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsReceived" xlink:to="ifrs-full_DividendsReceived_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DividendsReceived_2_lbl" xml:lang="en-US">Dividends receivable - Other assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInAssociates" xlink:to="ifrs-full_InvestmentsInAssociates_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_InvestmentsInAssociates_3_lbl" xml:lang="en-US">Closing balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_lbl" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PropertyPlantAndEquipments" xlink:label="afya_PropertyPlantAndEquipments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PropertyPlantAndEquipments" xlink:to="afya_PropertyPlantAndEquipments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="afya_PropertyPlantAndEquipments_lbl" xml:lang="en-US">As of December 31, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WritOffOfPropertyPlantAndEquipment" xlink:label="afya_WritOffOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WritOffOfPropertyPlantAndEquipment" xlink:to="afya_WritOffOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WritOffOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Write-off (i)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Transfer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PropertyPlantAndEquipments" xlink:to="afya_PropertyPlantAndEquipments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="afya_PropertyPlantAndEquipments_2_lbl" xml:lang="en-US">As of December 31, 2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PropertyPlantAndEquipmentNetBookValue" xlink:label="afya_PropertyPlantAndEquipmentNetBookValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PropertyPlantAndEquipmentNetBookValue" xlink:to="afya_PropertyPlantAndEquipmentNetBookValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PropertyPlantAndEquipmentNetBookValue_lbl" xml:lang="en-US">Net book value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_lbl" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="ifrs-full_IntangibleAssetsAndGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill_lbl" xml:lang="en-US">Intangible assets and goodwill, balance at beginnning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl" xml:lang="en-US">Business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WriteoffOfIntangibleAssets" xlink:to="afya_WriteoffOfIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_WriteoffOfIntangibleAssets_2_lbl" xml:lang="en-US">Write-off</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Remesurement" xlink:label="afya_Remesurement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Remesurement" xlink:to="afya_Remesurement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Remesurement_lbl" xml:lang="en-US">Remesurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Transfer" xlink:label="afya_Transfer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Transfer" xlink:to="afya_Transfer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_Transfer_lbl" xml:lang="en-US">Transfer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="ifrs-full_IntangibleAssetsAndGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill_2_lbl" xml:lang="en-US">Intangible assets and goodwill, balance at end</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IntangibleAssetsAndGoodwillNetBookValue" xlink:label="afya_IntangibleAssetsAndGoodwillNetBookValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IntangibleAssetsAndGoodwillNetBookValue" xlink:to="afya_IntangibleAssetsAndGoodwillNetBookValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_IntangibleAssetsAndGoodwillNetBookValue_lbl" xml:lang="en-US">Net book value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:to="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_lbl" xml:lang="en-US">Licenses with indefinite useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CashGeneratingUnits" xlink:label="afya_CashGeneratingUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CashGeneratingUnits" xlink:to="afya_CashGeneratingUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CashGeneratingUnits_lbl" xml:lang="en-US">Cash generating units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:label="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:to="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_lbl" xml:lang="en-US">Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl" xml:lang="en-US">Discount rate applied to cash flow projections</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PerpetuityGrowthRate" xlink:label="afya_PerpetuityGrowthRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PerpetuityGrowthRate" xlink:to="afya_PerpetuityGrowthRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PerpetuityGrowthRate_lbl" xml:lang="en-US">Growth rates</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EbitdaGrowthRates" xlink:label="afya_EbitdaGrowthRates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EbitdaGrowthRates" xlink:to="afya_EbitdaGrowthRates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EbitdaGrowthRates_lbl" xml:lang="en-US">EBITDA growth rates</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:to="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_2_lbl" xml:lang="en-US">Description of significant estimate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_lbl" xml:lang="en-US">Impairment intangible assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeReceivables_2_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAssets" xlink:label="ifrs-full_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherAssets" xlink:to="ifrs-full_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherAssets_lbl" xml:lang="en-US">Other FIES credits - Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendReceivable" xlink:label="afya_DividendReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendReceivable" xlink:to="afya_DividendReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendReceivable_lbl" xml:lang="en-US">Dividends receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="ifrs-full_FinancialAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialAssets_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialAssets" xlink:label="ifrs-full_CurrentFinancialAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssets" xlink:to="ifrs-full_CurrentFinancialAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentFinancialAssets_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="ifrs-full_NoncurrentFinancialAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentFinancialAssets_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesTable_lbl" xml:lang="en-US">Disclosure of financial liabilities [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancing" xlink:label="afya_LoansAndFinancing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancing" xlink:to="afya_LoansAndFinancing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancing_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialLiabilities_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="ifrs-full_CurrentFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilities" xlink:to="ifrs-full_CurrentFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentFinancialLiabilities_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="ifrs-full_NoncurrentFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilities" xlink:to="ifrs-full_NoncurrentFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentFinancialLiabilities_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialLiabilitiesAtFairValues" xlink:label="afya_FinancialLiabilitiesAtFairValues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialLiabilitiesAtFairValues" xlink:to="afya_FinancialLiabilitiesAtFairValues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialLiabilitiesAtFairValues_lbl" xml:lang="en-US">Financial liabilities, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:label="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:label="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_lbl" xml:lang="en-US">Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialInstitution" xlink:label="afya_FinancialInstitution" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialInstitution" xlink:to="afya_FinancialInstitution_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialInstitution_lbl" xml:lang="en-US">Financial institution</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="ifrs-full_BorrowingsInterestRateBasis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRateBasis" xlink:to="ifrs-full_BorrowingsInterestRateBasis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsInterestRateBasis_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="ifrs-full_BorrowingsMaturity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsMaturity" xlink:to="ifrs-full_BorrowingsMaturity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsMaturity_lbl" xml:lang="en-US">Maturity</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingCurrent" xlink:label="afya_LoansAndFinancingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingCurrent" xlink:to="afya_LoansAndFinancingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancingCurrent_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingNonCurrent" xlink:label="afya_LoansAndFinancingNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingNonCurrent" xlink:to="afya_LoansAndFinancingNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancingNonCurrent_lbl" xml:lang="en-US">Non-current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_RightofuseAssets_2_lbl" xml:lang="en-US">Right-of-use assets, balance at beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LeaseLiabilities_2_lbl" xml:lang="en-US">Lease liabilities, balance at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="ifrs-full_AdditionsToRightofuseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl" xml:lang="en-US">Right-of-use assets, additions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsToLeaseLiabilities" xlink:label="afya_AdditionsToLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsToLeaseLiabilities" xlink:to="afya_AdditionsToLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsToLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities, additions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsRemeasurement" xlink:label="afya_RightofuseAssetsRemeasurement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsRemeasurement" xlink:to="afya_RightofuseAssetsRemeasurement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsRemeasurement_lbl" xml:lang="en-US">Right-of-use assets, remeasurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesRemeasurement" xlink:label="afya_LeaseLiabilitiesRemeasurement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesRemeasurement" xlink:to="afya_LeaseLiabilitiesRemeasurement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesRemeasurement_lbl" xml:lang="en-US">Lease liabilities, remeasurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsBusinessCombinations" xlink:label="afya_RightofuseAssetsBusinessCombinations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsBusinessCombinations" xlink:to="afya_RightofuseAssetsBusinessCombinations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsBusinessCombinations_lbl" xml:lang="en-US">Right-of-use assets, business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_BusinessCombinationsLeaseLiabilities" xlink:label="afya_BusinessCombinationsLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BusinessCombinationsLeaseLiabilities" xlink:to="afya_BusinessCombinationsLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BusinessCombinationsLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities, business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRightofuseAssets" xlink:to="ifrs-full_DepreciationRightofuseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US">Right-of-use assets, depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DepreciationExpenseLeaseLiabilities" xlink:label="afya_DepreciationExpenseLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DepreciationExpenseLeaseLiabilities" xlink:to="afya_DepreciationExpenseLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DepreciationExpenseLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities, depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsInterestExpense" xlink:label="afya_RightofuseAssetsInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsInterestExpense" xlink:to="afya_RightofuseAssetsInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsInterestExpense_lbl" xml:lang="en-US">Right-of-use assets, interest expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_2_lbl" xml:lang="en-US">Lease liabilities, interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsPaymentsOfPrincipal" xlink:label="afya_RightofuseAssetsPaymentsOfPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsPaymentsOfPrincipal" xlink:to="afya_RightofuseAssetsPaymentsOfPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsPaymentsOfPrincipal_lbl" xml:lang="en-US">Right of use assets, payments of principal</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesPaymentsOfPrincipal" xlink:label="afya_LeaseLiabilitiesPaymentsOfPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesPaymentsOfPrincipal" xlink:to="afya_LeaseLiabilitiesPaymentsOfPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesPaymentsOfPrincipal_lbl" xml:lang="en-US">Lease liabilities, payments of principal</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsPaymentsOfInterest" xlink:label="afya_RightofuseAssetsPaymentsOfInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsPaymentsOfInterest" xlink:to="afya_RightofuseAssetsPaymentsOfInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsPaymentsOfInterest_lbl" xml:lang="en-US">Right-of-use assets, payments of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentsOfInterestLeaseLiabilities" xlink:label="afya_PaymentsOfInterestLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfInterestLeaseLiabilities" xlink:to="afya_PaymentsOfInterestLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentsOfInterestLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities, payments of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsWriteoff" xlink:label="afya_RightofuseAssetsWriteoff" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsWriteoff" xlink:to="afya_RightofuseAssetsWriteoff_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsWriteoff_lbl" xml:lang="en-US">Right-of-use assets, Write-off</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesWriteoff" xlink:label="afya_LeaseLiabilitiesWriteoff" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesWriteoff" xlink:to="afya_LeaseLiabilitiesWriteoff_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesWriteoff_lbl" xml:lang="en-US">Lease liabilities, Write-off</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_RightofuseAssets_3_lbl" xml:lang="en-US">Right-of-use assets, balance at ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_LeaseLiabilities_3_lbl" xml:lang="en-US">Lease liabilities, balance at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsCurrent" xlink:label="afya_RightofuseAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsCurrent" xlink:to="afya_RightofuseAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsCurrent_lbl" xml:lang="en-US">Right-of-use assets, current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentLeaseLiabilities_2_lbl" xml:lang="en-US">Lease liabilities, current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsNonCurrent" xlink:label="afya_RightofuseAssetsNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsNonCurrent" xlink:to="afya_RightofuseAssetsNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsNonCurrent_lbl" xml:lang="en-US">Right-of-use assets, non-current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_2_lbl" xml:lang="en-US">Lease liabilities, non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableAamortizedCostInterestRateBasis" xlink:label="afya_AccountsPayableAamortizedCostInterestRateBasis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableAamortizedCostInterestRateBasis" xlink:to="afya_AccountsPayableAamortizedCostInterestRateBasis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableAamortizedCostInterestRateBasis_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties_2_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersCurrent" xlink:label="afya_AccountsPayableToSellingShareholdersCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableToSellingShareholdersCurrent_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:label="afya_AccountsPayableToSellingShareholdersNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableToSellingShareholdersNonCurrent_lbl" xml:lang="en-US">Non-current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties_3_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:label="afya_AccountsPayableToSellingShareholdersBusinessCombinations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:to="afya_AccountsPayableToSellingShareholdersBusinessCombinations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersBusinessCombinations_lbl" xml:lang="en-US">Additions consideration to be transferred on business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentsOfPrincipal" xlink:label="afya_PaymentsOfPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfPrincipal" xlink:to="afya_PaymentsOfPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_PaymentsOfPrincipal_lbl" xml:lang="en-US">Payments of principal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payment of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpense" xlink:label="ifrs-full_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpense" xlink:to="ifrs-full_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpense_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RemeasurementOfEarnouts" xlink:label="afya_RemeasurementOfEarnouts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RemeasurementOfEarnouts" xlink:to="afya_RemeasurementOfEarnouts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RemeasurementOfEarnouts_lbl" xml:lang="en-US">Remeasurement of contingent consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_2_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties_4_lbl" xml:lang="en-US">Closing balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilities_2_lbl" xml:lang="en-US">Financial liabilities, at carrying amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue_lbl" xml:lang="en-US">Financial liabilities, at fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssets_2_lbl" xml:lang="en-US">Balance as of ending</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IndexRatePerYear" xlink:label="afya_IndexRatePerYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IndexRatePerYear" xlink:to="afya_IndexRatePerYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IndexRatePerYear_lbl" xml:lang="en-US">Index - % per year</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_BaseRate" xlink:label="afya_BaseRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BaseRate" xlink:to="afya_BaseRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BaseRate_lbl" xml:lang="en-US">Base rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:to="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_lbl" xml:lang="en-US">Effect on profit before tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:to="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_lbl" xml:lang="en-US">Effect on profit before tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table_lbl" xml:lang="en-US">Disclosure of sensitivity analysis to changes in risk variables that arise from contracts within scope of IFRS 17 [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialLiabilitiesContractualUndiscounted" xlink:label="afya_FinancialLiabilitiesContractualUndiscounted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialLiabilitiesContractualUndiscounted" xlink:to="afya_FinancialLiabilitiesContractualUndiscounted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialLiabilitiesContractualUndiscounted_lbl" xml:lang="en-US">Financial liabilities contractual undiscounted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_lbl" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Liabilities arising from financing activities, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Payments of principal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">Payments of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Additions and remeasurements</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:label="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:to="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_2_lbl" xml:lang="en-US">Liabilities arising from financing activities, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoanAndFinancing" xlink:label="afya_LoanAndFinancing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoanAndFinancing" xlink:to="afya_LoanAndFinancing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoanAndFinancing_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TransactionCosts" xlink:label="afya_TransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TransactionCosts" xlink:to="afya_TransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TransactionCosts_lbl" xml:lang="en-US">Transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContractualLeaseTerm" xlink:label="afya_ContractualLeaseTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContractualLeaseTerm" xlink:to="afya_ContractualLeaseTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContractualLeaseTerm_lbl" xml:lang="en-US">Contractual lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:to="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl" xml:lang="en-US">Lease expense from short-term leases and low-value assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:to="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_2_lbl" xml:lang="en-US">Ownership interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" xlink:label="ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" xlink:to="ifrs-full_NoncurrentPayablesForPurchaseOfEnergy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentPayablesForPurchaseOfEnergy_lbl" xml:lang="en-US">Non-current payables for purchase of energy</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FirstAnnualInstallmentsPayable" xlink:label="afya_FirstAnnualInstallmentsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FirstAnnualInstallmentsPayable" xlink:to="afya_FirstAnnualInstallmentsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FirstAnnualInstallmentsPayable_lbl" xml:lang="en-US">First annual installment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SecondAnnualInstallmentsPayable" xlink:label="afya_SecondAnnualInstallmentsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SecondAnnualInstallmentsPayable" xlink:to="afya_SecondAnnualInstallmentsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SecondAnnualInstallmentsPayable_lbl" xml:lang="en-US">Second annual installment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ThirdAnnualInstallmentsPayable" xlink:label="afya_ThirdAnnualInstallmentsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ThirdAnnualInstallmentsPayable" xlink:to="afya_ThirdAnnualInstallmentsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ThirdAnnualInstallmentsPayable_lbl" xml:lang="en-US">Third annual installment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:label="afya_RemainingTradeAndOtherPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:to="afya_RemainingTradeAndOtherPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RemainingTradeAndOtherPayablesToRelatedParties_lbl" xml:lang="en-US">Remaining accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US">Transaction price allocated to remaining performance obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xml:lang="en-US">Defined benefit obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CreditExposures" xlink:label="afya_CreditExposures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CreditExposures" xlink:to="afya_CreditExposures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CreditExposures_lbl" xml:lang="en-US">Exposure risk</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SensitivityChangeInTheEuroExchangeRate" xlink:label="afya_SensitivityChangeInTheEuroExchangeRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SensitivityChangeInTheEuroExchangeRate" xlink:to="afya_SensitivityChangeInTheEuroExchangeRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SensitivityChangeInTheEuroExchangeRate_lbl" xml:lang="en-US">Percentage of sensitivity change in the Euro exchange rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClosingForeignExchangeRate" xlink:to="ifrs-full_ClosingForeignExchangeRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClosingForeignExchangeRate_lbl" xml:lang="en-US">Closing foreign exchange rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" xlink:label="afya_NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" xlink:to="afya_NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement_lbl" xml:lang="en-US">Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SharePriceFairValueAtMeasurementDate" xlink:label="afya_SharePriceFairValueAtMeasurementDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharePriceFairValueAtMeasurementDate" xlink:to="afya_SharePriceFairValueAtMeasurementDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SharePriceFairValueAtMeasurementDate_lbl" xml:lang="en-US">Exercise price at the measurement date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xml:lang="en-US">Dividend yield (%)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ExpectedLifeOfStockOptions" xlink:label="afya_ExpectedLifeOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ExpectedLifeOfStockOptions" xlink:to="afya_ExpectedLifeOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ExpectedLifeOfStockOptions_lbl" xml:lang="en-US">Expected life of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:to="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted_lbl" xml:lang="en-US">Share price at the measurement date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted_lbl" xml:lang="en-US">Valuation model</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:to="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_lbl" xml:lang="en-US">Weighted average fair value at the measurement date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price, Outstanding at the beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US">Number of stock options, Outstanding at the beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of stock options, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of stock options, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" xlink:label="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" xlink:to="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:label="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:to="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of stock options, stock option exchanged</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of stock options, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of stock options, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2_lbl" xml:lang="en-US">Weighted average exercise price, Outstanding at the ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_2_lbl" xml:lang="en-US">Number of stock options, Outstanding at the ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Weighted average exercise price, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfStockOptionsExercisable" xlink:label="afya_NumberOfStockOptionsExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfStockOptionsExercisable" xlink:to="afya_NumberOfStockOptionsExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="afya_NumberOfStockOptionsExercisable_lbl" xml:lang="en-US">Number of stock options, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:to="ifrs-full_DisclosureOfDefinedBenefitPlansTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansTable_lbl" xml:lang="en-US">Disclosure of defined benefit plans [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" xlink:label="afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" xlink:to="afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xml:lang="en-US">Fair values at grant date</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_GrantedVestingPeriod" xlink:label="afya_GrantedVestingPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_GrantedVestingPeriod" xlink:to="afya_GrantedVestingPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_GrantedVestingPeriod_lbl" xml:lang="en-US">Vesting period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:to="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of stock options, Stock options exchanged</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShareBasedCompensationOfEmployees" xlink:label="afya_ShareBasedCompensationOfEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareBasedCompensationOfEmployees" xlink:to="afya_ShareBasedCompensationOfEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShareBasedCompensationOfEmployees_lbl" xml:lang="en-US">Compensation of employees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xml:lang="en-US">Share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:label="ifrs-full_ProportionOfOwnershipInterestInJointVenture" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:to="ifrs-full_ProportionOfOwnershipInterestInJointVenture_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestInJointVenture_lbl" xml:lang="en-US">Proportion percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SocialObligationsLiabilities" xlink:label="afya_SocialObligationsLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SocialObligationsLiabilities" xlink:to="afya_SocialObligationsLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SocialObligationsLiabilities_lbl" xml:lang="en-US">Social obligations liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="ifrs-full_NumberOfSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl" xml:lang="en-US">Number of shares, Outstanding, at beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Average price, at beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfSharesRepurchased" xlink:label="afya_NumberOfSharesRepurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfSharesRepurchased" xlink:to="afya_NumberOfSharesRepurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfSharesRepurchased_lbl" xml:lang="en-US">Number of shares, Repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AveragePriceRepurchased" xlink:label="afya_AveragePriceRepurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AveragePriceRepurchased" xlink:to="afya_AveragePriceRepurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AveragePriceRepurchased_lbl" xml:lang="en-US">Average price repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" xlink:label="afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" xlink:to="afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_lbl" xml:lang="en-US">Number of treasury shares, delivered under the share-based compensation plan</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AveragePriceDeliveredUnderSharebasedCompensationPlan" xlink:label="afya_AveragePriceDeliveredUnderSharebasedCompensationPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AveragePriceDeliveredUnderSharebasedCompensationPlan" xlink:to="afya_AveragePriceDeliveredUnderSharebasedCompensationPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AveragePriceDeliveredUnderSharebasedCompensationPlan_lbl" xml:lang="en-US">Average price, delivered under the share-based compensation plan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_2_lbl" xml:lang="en-US">Number of shares, Outstanding, at ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_2_lbl" xml:lang="en-US">Average price, at ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfSharesIssued1" xlink:label="afya_NumberOfSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfSharesIssued1" xlink:to="afya_NumberOfSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfSharesIssued1_lbl" xml:lang="en-US">Total number of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US">Total number of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IssuedCapitals" xlink:label="afya_IssuedCapitals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IssuedCapitals" xlink:to="afya_IssuedCapitals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IssuedCapitals_lbl" xml:lang="en-US">Authorized capital</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CapitalUnitsAuthorizedShares" xlink:label="afya_CapitalUnitsAuthorizedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalUnitsAuthorizedShares" xlink:to="afya_CapitalUnitsAuthorizedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CapitalUnitsAuthorizedShares_lbl" xml:lang="en-US">Authorized capital units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US">Nominal value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentOfDividends" xlink:label="afya_PaymentOfDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentOfDividends" xlink:to="afya_PaymentOfDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentOfDividends_lbl" xml:lang="en-US">Payment of dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendDistributed" xlink:label="afya_DividendDistributed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendDistributed" xlink:to="afya_DividendDistributed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendDistributed_lbl" xml:lang="en-US">Dividend distributed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:label="ifrs-full_DividendsPaidToNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:to="ifrs-full_DividendsPaidToNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaidToNoncontrollingInterests_lbl" xml:lang="en-US">Dividends paid to non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FirstDividendDistributionInAmount" xlink:label="afya_FirstDividendDistributionInAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FirstDividendDistributionInAmount" xlink:to="afya_FirstDividendDistributionInAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FirstDividendDistributionInAmount_lbl" xml:lang="en-US">First dividend distribution in amount</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PercentageOfDividendDistribution" xlink:label="afya_PercentageOfDividendDistribution" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PercentageOfDividendDistribution" xlink:to="afya_PercentageOfDividendDistribution_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PercentageOfDividendDistribution_lbl" xml:lang="en-US">Percentage of dividend distribution</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidOtherSharesPerShare" xlink:label="ifrs-full_DividendsPaidOtherSharesPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidOtherSharesPerShare" xlink:to="ifrs-full_DividendsPaidOtherSharesPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaidOtherSharesPerShare_lbl" xml:lang="en-US">Dividends per share</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RepurchaseOfOrdinaryShares" xlink:label="afya_RepurchaseOfOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RepurchaseOfOrdinaryShares" xlink:to="afya_RepurchaseOfOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RepurchaseOfOrdinaryShares_lbl" xml:lang="en-US">Repurchase of ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CashOutflow" xlink:label="afya_CashOutflow" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CashOutflow" xlink:to="afya_CashOutflow_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CashOutflow_lbl" xml:lang="en-US">Cash outflow</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumeratorAbstract" xlink:label="afya_NumeratorAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumeratorAbstract" xlink:to="afya_NumeratorAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumeratorAbstract_lbl" xml:lang="en-US">Numerator</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:label="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:to="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends_lbl" xml:lang="en-US">Net income attributable to the owners of the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DenominatorAbstract" xlink:label="afya_DenominatorAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DenominatorAbstract" xlink:to="afya_DenominatorAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DenominatorAbstract_lbl" xml:lang="en-US">Denominator</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="ifrs-full_WeightedAverageShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageShares_lbl" xml:lang="en-US">Weighted average number of outstanding shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:to="ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_lbl" xml:lang="en-US">Effects of dilution from stock options and restricted stock units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="ifrs-full_AdjustedWeightedAverageShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl" xml:lang="en-US">Weighted average number of outstanding shares adjusted for the effect of dilution</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_2_lbl" xml:lang="en-US">Basic earnings per share (R$)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_2_lbl" xml:lang="en-US">Diluted earnings per share (R$)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProfessionalFeesExpenses" xlink:label="afya_ProfessionalFeesExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProfessionalFeesExpenses" xlink:to="afya_ProfessionalFeesExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProfessionalFeesExpenses_lbl" xml:lang="en-US">Tuition fees</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherRevenue1" xlink:label="afya_OtherRevenue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherRevenue1" xlink:to="afya_OtherRevenue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherRevenue1_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeductionAbstract" xlink:label="afya_DeductionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionAbstract" xlink:to="afya_DeductionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionAbstract_lbl" xml:lang="en-US">Deductions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeductionOfGrantedDiscounts" xlink:label="afya_DeductionOfGrantedDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfGrantedDiscounts" xlink:to="afya_DeductionOfGrantedDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfGrantedDiscounts_lbl" xml:lang="en-US">Discount and scholarships</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeductionOfReturnsOfNetRevenue" xlink:label="afya_DeductionOfReturnsOfNetRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfReturnsOfNetRevenue" xlink:to="afya_DeductionOfReturnsOfNetRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfReturnsOfNetRevenue_lbl" xml:lang="en-US">Returns</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeductionOfTaxes" xlink:label="afya_DeductionOfTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfTaxes" xlink:to="afya_DeductionOfTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DeductionOfTaxes_lbl" xml:lang="en-US">Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeductionOfProuni" xlink:label="afya_DeductionOfProuni" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfProuni" xlink:to="afya_DeductionOfProuni_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfProuni_lbl" xml:lang="en-US">PROUNI</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US">Revenue from contracts with customers</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TimingOfRevenueRecognition" xlink:label="afya_TimingOfRevenueRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TimingOfRevenueRecognition" xlink:to="afya_TimingOfRevenueRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TimingOfRevenueRecognition_lbl" xml:lang="en-US">Timing of revenue recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TransferredOverTime" xlink:label="afya_TransferredOverTime" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TransferredOverTime" xlink:to="afya_TransferredOverTime_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TransferredOverTime_lbl" xml:lang="en-US">Transferred over time</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TransferredAtPointInTime" xlink:label="afya_TransferredAtPointInTime" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TransferredAtPointInTime" xlink:to="afya_TransferredAtPointInTime_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TransferredAtPointInTime_lbl" xml:lang="en-US">Transferred at a point in time</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_lbl" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="ifrs-full_PaymentsToSuppliersForGoodsAndServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:to="ifrs-full_PaymentsToSuppliersForGoodsAndServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsToSuppliersForGoodsAndServices_lbl" xml:lang="en-US">Types of services or goods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="ifrs-full_ProfessionalFeesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfessionalFeesExpense" xlink:to="ifrs-full_ProfessionalFeesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfessionalFeesExpense_lbl" xml:lang="en-US">Tuition fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="ifrs-full_OtherRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherRevenue" xlink:to="ifrs-full_OtherRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherRevenue_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TimingRevenueRecognition" xlink:label="afya_TimingRevenueRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TimingRevenueRecognition" xlink:to="afya_TimingRevenueRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TimingRevenueRecognition_lbl" xml:lang="en-US">Timing of revenue recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FeeAndCommissionIncome" xlink:label="ifrs-full_FeeAndCommissionIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FeeAndCommissionIncome" xlink:to="ifrs-full_FeeAndCommissionIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FeeAndCommissionIncome_lbl" xml:lang="en-US">Transferred over time</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NetRevenueOtherTransferredPoint" xlink:label="afya_NetRevenueOtherTransferredPoint" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetRevenueOtherTransferredPoint" xlink:to="afya_NetRevenueOtherTransferredPoint_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NetRevenueOtherTransferredPoint_lbl" xml:lang="en-US">Transferred at a point in time</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Payroll" xlink:label="afya_Payroll" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Payroll" xlink:to="afya_Payroll_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Payroll_lbl" xml:lang="en-US">Payroll (i)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_HospitalAndMedicalAgreements" xlink:label="afya_HospitalAndMedicalAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_HospitalAndMedicalAgreements" xlink:to="afya_HospitalAndMedicalAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_HospitalAndMedicalAgreements_lbl" xml:lang="en-US">Hospital and medical agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="ifrs-full_DepreciationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationExpense_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseExpenses" xlink:label="afya_LeaseExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseExpenses" xlink:to="afya_LeaseExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LeaseExpenses_lbl" xml:lang="en-US">Lease expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UtilitiesExpense" xlink:label="ifrs-full_UtilitiesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UtilitiesExpense" xlink:to="ifrs-full_UtilitiesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UtilitiesExpense_lbl" xml:lang="en-US">Utilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepairsAndMaintenanceExpense" xlink:label="ifrs-full_RepairsAndMaintenanceExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepairsAndMaintenanceExpense" xlink:to="ifrs-full_RepairsAndMaintenanceExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RepairsAndMaintenanceExpense_lbl" xml:lang="en-US">Maintenance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SharesBasedCompensation" xlink:label="afya_SharesBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharesBasedCompensation" xlink:to="afya_SharesBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_SharesBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxExpenses" xlink:label="afya_TaxExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxExpenses" xlink:to="afya_TaxExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxExpenses_lbl" xml:lang="en-US">Tax expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="ifrs-full_SalesAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SalesAndMarketingExpense" xlink:to="ifrs-full_SalesAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_SalesAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TravelExpense" xlink:label="ifrs-full_TravelExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TravelExpense" xlink:to="ifrs-full_TravelExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TravelExpense_lbl" xml:lang="en-US">Travel expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConsultingFees" xlink:label="afya_ConsultingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ConsultingFees" xlink:to="afya_ConsultingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ConsultingFees_lbl" xml:lang="en-US">Consulting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CostExpensesOther" xlink:label="afya_CostExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CostExpensesOther" xlink:to="afya_CostExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_CostExpensesOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="ifrs-full_ExpenseByNature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseByNature" xlink:to="ifrs-full_ExpenseByNature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExpenseByNature_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CostOfServices" xlink:label="afya_CostOfServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CostOfServices" xlink:to="afya_CostOfServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_CostOfServices_lbl" xml:lang="en-US">Cost of services</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SellingGeneralAndAdministrativeExpenses" xlink:label="afya_SellingGeneralAndAdministrativeExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SellingGeneralAndAdministrativeExpenses" xlink:to="afya_SellingGeneralAndAdministrativeExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SellingGeneralAndAdministrativeExpenses_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialIncomeFromCashEquivalents" xlink:label="afya_FinancialIncomeFromCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialIncomeFromCashEquivalents" xlink:to="afya_FinancialIncomeFromCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialIncomeFromCashEquivalents_lbl" xml:lang="en-US">Financial income from cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InterestEarned" xlink:label="afya_InterestEarned" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InterestEarned" xlink:to="afya_InterestEarned_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InterestEarned_lbl" xml:lang="en-US">Interest earned</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceIncome" xlink:label="ifrs-full_OtherFinanceIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceIncome" xlink:to="ifrs-full_OtherFinanceIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherFinanceIncome_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InterestExpense1" xlink:label="afya_InterestExpense1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InterestExpense1" xlink:to="afya_InterestExpense1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InterestExpense1_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InterestExpenseOnLeaseLiabilities1" xlink:label="afya_InterestExpenseOnLeaseLiabilities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InterestExpenseOnLeaseLiabilities1" xlink:to="afya_InterestExpenseOnLeaseLiabilities1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InterestExpenseOnLeaseLiabilities1_lbl" xml:lang="en-US">Interest expense on lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialDiscountsGrantedExpenses" xlink:label="afya_FinancialDiscountsGrantedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialDiscountsGrantedExpenses" xlink:to="afya_FinancialDiscountsGrantedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialDiscountsGrantedExpenses_lbl" xml:lang="en-US">Financial discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CreditCardCharges" xlink:label="afya_CreditCardCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CreditCardCharges" xlink:to="afya_CreditCardCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CreditCardCharges_lbl" xml:lang="en-US">Credit card charges</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BankAndSimilarCharges" xlink:label="ifrs-full_BankAndSimilarCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BankAndSimilarCharges" xlink:to="ifrs-full_BankAndSimilarCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_BankAndSimilarCharges_lbl" xml:lang="en-US">Bank fees</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ExchangeVariance" xlink:label="afya_ExchangeVariance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ExchangeVariance" xlink:to="afya_ExchangeVariance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ExchangeVariance_lbl" xml:lang="en-US">Exchange variance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceCost" xlink:label="ifrs-full_OtherFinanceCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceCost" xlink:to="ifrs-full_OtherFinanceCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OtherFinanceCost_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinanceResult" xlink:label="afya_FinanceResult" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinanceResult" xlink:to="afya_FinanceResult_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinanceResult_lbl" xml:lang="en-US">Net finance result</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ApplicableTaxRate_2_lbl" xml:lang="en-US">Statutory income taxes rate</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxExpensesIncomeAtApplicableTaxRate" xlink:label="afya_TaxExpensesIncomeAtApplicableTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxExpensesIncomeAtApplicableTaxRate" xlink:to="afya_TaxExpensesIncomeAtApplicableTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxExpensesIncomeAtApplicableTaxRate_lbl" xml:lang="en-US">Income taxes at statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ReconciliationAdjustmentsAbstract" xlink:label="afya_ReconciliationAdjustmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ReconciliationAdjustmentsAbstract" xlink:to="afya_ReconciliationAdjustmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ReconciliationAdjustmentsAbstract_lbl" xml:lang="en-US">Reconciliation adjustments:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" xlink:label="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" xlink:to="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_lbl" xml:lang="en-US">Tax effect on loss from entities not subject to taxation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProgramaUniversidadeParaTodosFiscalIncentive" xlink:label="afya_ProgramaUniversidadeParaTodosFiscalIncentive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProgramaUniversidadeParaTodosFiscalIncentive" xlink:to="afya_ProgramaUniversidadeParaTodosFiscalIncentive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProgramaUniversidadeParaTodosFiscalIncentive_lbl" xml:lang="en-US">PROUNI - Fiscal incentive (i)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnrecognizedDeferredTaxesAssetsOnTaxLosses" xlink:label="afya_UnrecognizedDeferredTaxesAssetsOnTaxLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UnrecognizedDeferredTaxesAssetsOnTaxLosses" xlink:to="afya_UnrecognizedDeferredTaxesAssetsOnTaxLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UnrecognizedDeferredTaxesAssetsOnTaxLosses_lbl" xml:lang="en-US">Unrecognized deferred taxes assets on tax losses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RecognisedDeferredTaxAssets" xlink:label="afya_RecognisedDeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RecognisedDeferredTaxAssets" xlink:to="afya_RecognisedDeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RecognisedDeferredTaxAssets_lbl" xml:lang="en-US">Recognized deferred taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl" xml:lang="en-US">Presumed profit income tax regime effect (ii)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PermanentAdjustmentsAbstract" xlink:label="afya_PermanentAdjustmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PermanentAdjustmentsAbstract" xlink:to="afya_PermanentAdjustmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PermanentAdjustmentsAbstract_lbl" xml:lang="en-US">Permanent adjustments:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PermanentAdjustmentsManagementBonuses" xlink:label="afya_PermanentAdjustmentsManagementBonuses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PermanentAdjustmentsManagementBonuses" xlink:to="afya_PermanentAdjustmentsManagementBonuses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PermanentAdjustmentsManagementBonuses_lbl" xml:lang="en-US">Management bonuses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PermanentAdjustmentsGifts" xlink:label="afya_PermanentAdjustmentsGifts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PermanentAdjustmentsGifts" xlink:to="afya_PermanentAdjustmentsGifts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PermanentAdjustmentsGifts_lbl" xml:lang="en-US">Gifts</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PermanentAdjustmentsSponsorship" xlink:label="afya_PermanentAdjustmentsSponsorship" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PermanentAdjustmentsSponsorship" xlink:to="afya_PermanentAdjustmentsSponsorship_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PermanentAdjustmentsSponsorship_lbl" xml:lang="en-US">Sponsorship</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:label="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:to="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PermanentAdjustmentsPillarTwo" xlink:label="afya_PermanentAdjustmentsPillarTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PermanentAdjustmentsPillarTwo" xlink:to="afya_PermanentAdjustmentsPillarTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PermanentAdjustmentsPillarTwo_lbl" xml:lang="en-US">Pillar Two - See Note 2.3(q)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherTaxExpenseBenefits" xlink:label="afya_OtherTaxExpenseBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherTaxExpenseBenefits" xlink:to="afya_OtherTaxExpenseBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherTaxExpenseBenefits_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeTaxesExpense" xlink:label="afya_IncomeTaxesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncomeTaxesExpense" xlink:to="afya_IncomeTaxesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncomeTaxesExpense_lbl" xml:lang="en-US">Income taxes expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="ifrs-full_CurrentTaxExpenseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncome" xlink:to="ifrs-full_CurrentTaxExpenseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentTaxExpenseIncome_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="ifrs-full_DeferredTaxExpenseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncome" xlink:to="ifrs-full_DeferredTaxExpenseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DeferredTaxExpenseIncome_lbl" xml:lang="en-US">Deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:label="ifrs-full_TaxRateEffectFromChangeInTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:to="ifrs-full_TaxRateEffectFromChangeInTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxRateEffectFromChangeInTaxRate_lbl" xml:lang="en-US">Effective rate</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxAssetsAbstract" xlink:label="afya_DeferredTaxAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeferredTaxAssetsAbstract" xlink:to="afya_DeferredTaxAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxAssetsLossCarryforwards" xlink:label="afya_DeferredTaxAssetsLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeferredTaxAssetsLossCarryforwards" xlink:to="afya_DeferredTaxAssetsLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeferredTaxAssetsLossCarryforwards_lbl" xml:lang="en-US">Tax losses carry forward</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsTaxLossesCarryForward" xlink:label="afya_AdditionsTaxLossesCarryForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsTaxLossesCarryForward" xlink:to="afya_AdditionsTaxLossesCarryForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsTaxLossesCarryForward_lbl" xml:lang="en-US">Additions tax losses carry forward</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_lbl" xml:lang="en-US">Temporary differences:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForExpectedCreditLoss" xlink:label="afya_AllowanceForExpectedCreditLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForExpectedCreditLoss" xlink:to="afya_AllowanceForExpectedCreditLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AllowanceForExpectedCreditLoss_lbl" xml:lang="en-US">Allowance for expected credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsAllowanceForExpectedCreditLosses" xlink:label="afya_AdditionsAllowanceForExpectedCreditLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsAllowanceForExpectedCreditLosses" xlink:to="afya_AdditionsAllowanceForExpectedCreditLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsAllowanceForExpectedCreditLosses_lbl" xml:lang="en-US">Additions allowance for expected credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="ifrs-full_LeaseLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_LeaseLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilitiesAbstract_lbl" xml:lang="en-US">IFRS 16 - Leases:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAsset" xlink:label="afya_RightofuseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAsset" xlink:to="afya_RightofuseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_RightofuseAsset_lbl" xml:lang="en-US">Allowance for expected credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsToRightofuseAsset" xlink:label="afya_AdditionsToRightofuseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsToRightofuseAsset" xlink:to="afya_AdditionsToRightofuseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AdditionsToRightofuseAsset_lbl" xml:lang="en-US">Allowance for expected credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiability" xlink:label="afya_LeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiability" xlink:to="afya_LeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LeaseLiability_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsLeaseLiability" xlink:label="afya_AdditionsLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsLeaseLiability" xlink:to="afya_AdditionsLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsLeaseLiability_lbl" xml:lang="en-US">Additions lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProvisionForProfitSharing" xlink:label="afya_ProvisionForProfitSharing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProvisionForProfitSharing" xlink:to="afya_ProvisionForProfitSharing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProvisionForProfitSharing_lbl" xml:lang="en-US">Provision for profit sharing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsProvisionForProfitSharing" xlink:label="afya_AdditionsProvisionForProfitSharing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsProvisionForProfitSharing" xlink:to="afya_AdditionsProvisionForProfitSharing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsProvisionForProfitSharing_lbl" xml:lang="en-US">Additions provision for profit sharing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="ifrs-full_LegalProceedingsProvision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LegalProceedingsProvision" xlink:to="ifrs-full_LegalProceedingsProvision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LegalProceedingsProvision_lbl" xml:lang="en-US">Provision for legal proceedings and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsProvisionForLegalProceedingsAndContingencies" xlink:label="afya_AdditionsProvisionForLegalProceedingsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsProvisionForLegalProceedingsAndContingencies" xlink:to="afya_AdditionsProvisionForLegalProceedingsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsProvisionForLegalProceedingsAndContingencies_lbl" xml:lang="en-US">Additions provision for legal proceedings and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AmortizationOfIntangibleAsset" xlink:label="afya_AmortizationOfIntangibleAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AmortizationOfIntangibleAsset" xlink:to="afya_AmortizationOfIntangibleAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AmortizationOfIntangibleAsset_lbl" xml:lang="en-US">Amortization of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsAmortizationOfIntangibleAssets" xlink:label="afya_AdditionsAmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsAmortizationOfIntangibleAssets" xlink:to="afya_AdditionsAmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsAmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Additions amortization of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Other" xlink:label="afya_Other" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Other" xlink:to="afya_Other_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_Other_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions_lbl" xml:lang="en-US">Additions other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxAsset" xlink:label="afya_DeferredTaxAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeferredTaxAsset" xlink:to="afya_DeferredTaxAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DeferredTaxAsset_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsDeferredTaxAssets" xlink:label="afya_AdditionsDeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsDeferredTaxAssets" xlink:to="afya_AdditionsDeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsDeferredTaxAssets_lbl" xml:lang="en-US">Additions deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill" xlink:label="afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill" xlink:to="afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsTaxBenefitFromTaxDeductibleGoodwill" xlink:label="afya_AdditionsTaxBenefitFromTaxDeductibleGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsTaxBenefitFromTaxDeductibleGoodwill" xlink:to="afya_AdditionsTaxBenefitFromTaxDeductibleGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsTaxBenefitFromTaxDeductibleGoodwill_lbl" xml:lang="en-US">Additions tax benefit from tax deductible goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FairValueRemeasurementsOnBusinessCombinations" xlink:label="afya_FairValueRemeasurementsOnBusinessCombinations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FairValueRemeasurementsOnBusinessCombinations" xlink:to="afya_FairValueRemeasurementsOnBusinessCombinations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FairValueRemeasurementsOnBusinessCombinations_lbl" xml:lang="en-US">Fair value remeasurements on business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsFairValueRemeasurementsOnBusinessCombinations" xlink:label="afya_AdditionsFairValueRemeasurementsOnBusinessCombinations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsFairValueRemeasurementsOnBusinessCombinations" xlink:to="afya_AdditionsFairValueRemeasurementsOnBusinessCombinations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsFairValueRemeasurementsOnBusinessCombinations_lbl" xml:lang="en-US">Additions fair value remeasurements on business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredsTaxLiabilities" xlink:label="afya_DeferredsTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeferredsTaxLiabilities" xlink:to="afya_DeferredsTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DeferredsTaxLiabilities_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsDeferredTaxLiabilities" xlink:label="afya_AdditionsDeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsDeferredTaxLiabilities" xlink:to="afya_AdditionsDeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsDeferredTaxLiabilities_lbl" xml:lang="en-US">Additions deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities" xlink:label="ifrs-full_NetDeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxLiabilities" xlink:to="ifrs-full_NetDeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDeferredTaxLiabilities_lbl" xml:lang="en-US">Deferred tax assets (liabilities), net</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsDeferredTaxAssetsLiabilitiesNet" xlink:label="afya_AdditionsDeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsDeferredTaxAssetsLiabilitiesNet" xlink:to="afya_AdditionsDeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsDeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Additions deferred tax assets (liabilities), net</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxExpenseIncomes" xlink:label="afya_DeferredTaxExpenseIncomes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeferredTaxExpenseIncomes" xlink:to="afya_DeferredTaxExpenseIncomes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeferredTaxExpenseIncomes_lbl" xml:lang="en-US">Unrecognized deferred income tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RecognizedDeferredTaxAssets" xlink:label="afya_RecognizedDeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RecognizedDeferredTaxAssets" xlink:to="afya_RecognizedDeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RecognizedDeferredTaxAssets_lbl" xml:lang="en-US">Recognized deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_lbl" xml:lang="en-US">Disclosure of contingent liabilities in business combination [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Provisions" xlink:label="ifrs-full_Provisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Provisions" xlink:to="ifrs-full_Provisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Provisions_lbl" xml:lang="en-US">Balance as of beginning of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_lbl" xml:lang="en-US">Business combinations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions_2_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="ifrs-full_ProvisionUsedOtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProvisionUsedOtherProvisions" xlink:to="ifrs-full_ProvisionUsedOtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ProvisionUsedOtherProvisions_lbl" xml:lang="en-US">Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="ifrs-full_UnusedProvisionReversedOtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:to="ifrs-full_UnusedProvisionReversedOtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_UnusedProvisionReversedOtherProvisions_lbl" xml:lang="en-US">Reversals</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Provisions" xlink:to="ifrs-full_Provisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Provisions_2_lbl" xml:lang="en-US">Balance as of ending of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="ifrs-full_OtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherProvisions" xlink:to="ifrs-full_OtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherProvisions_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContingenciesCorrespondentAmount" xlink:label="afya_ContingenciesCorrespondentAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContingenciesCorrespondentAmount" xlink:to="afya_ContingenciesCorrespondentAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContingenciesCorrespondentAmount_lbl" xml:lang="en-US">Contingencies correspondent amount</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RemeasurementOfEarnOut" xlink:label="afya_RemeasurementOfEarnOut" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RemeasurementOfEarnOut" xlink:to="afya_RemeasurementOfEarnOut_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RemeasurementOfEarnOut_lbl" xml:lang="en-US">Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" xlink:label="afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" xlink:to="afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_lbl" xml:lang="en-US">Additions and remeasurements of right-of-use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet" xlink:label="afya_AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet" xlink:to="afya_AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_lbl" xml:lang="en-US">Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders" xlink:label="afya_AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders" xlink:to="afya_AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_lbl" xml:lang="en-US">Additions to intangibles and goodwill through accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendsPayables" xlink:label="afya_DividendsPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsPayables" xlink:to="afya_DividendsPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DividendsPayables_lbl" xml:lang="en-US">Dividends payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_lbl" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssets_3_lbl" xml:lang="en-US">Current assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentTradeReceivable" xlink:to="afya_NoncurrentTradeReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentTradeReceivable_2_lbl" xml:lang="en-US">NoncurrentTradeReceivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentAssets_2_lbl" xml:lang="en-US">Other non-current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssets_3_lbl" xml:lang="en-US">Non-current assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilities_4_lbl" xml:lang="en-US">Current liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LongtermBorrowings_2_lbl" xml:lang="en-US">Non-current portion of non-current borrowings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayablesToRelatedParties" xlink:to="ifrs-full_NoncurrentPayablesToRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties_2_lbl" xml:lang="en-US">Non-current payables to related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentTaxesPayable" xlink:to="afya_NoncurrentTaxesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentTaxesPayable_2_lbl" xml:lang="en-US">NoncurrentTaxesPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentLiabilities_2_lbl" xml:lang="en-US">Other non-current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilities_4_lbl" xml:lang="en-US">Non-current liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Liabilities_2_lbl" xml:lang="en-US">Liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasuryShares" xlink:to="ifrs-full_TreasuryShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TreasuryShares_2_lbl" xml:lang="en-US">Treasury shares [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent_2_lbl" xml:lang="en-US">Equity attributable to owners of parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Equity_5_lbl" xml:lang="en-US">Equity [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CostOfSales_2_lbl" xml:lang="en-US">Cost of sales</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeneralAndAdministrativeExpense" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">General and administrative expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForExpectedCreditLosses" xlink:to="afya_AllowanceForExpectedCreditLosses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllowanceForExpectedCreditLosses_3_lbl" xml:lang="en-US">AllowanceForExpectedCreditLosses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherExpenseByNature" xlink:to="ifrs-full_OtherExpenseByNature_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherExpenseByNature_2_lbl" xml:lang="en-US">Other expenses, by nature</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceCosts_2_lbl" xml:lang="en-US">Finance costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncomeCost_2_lbl" xml:lang="en-US">Finance income (cost)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncomeTaxesExpensesCurrent" xlink:to="afya_IncomeTaxesExpensesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncomeTaxesExpensesCurrent_2_lbl" xml:lang="en-US">IncomeTaxesExpensesCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_2_lbl" xml:lang="en-US">Profit (loss), attributable to non-controlling interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ComprehensiveIncomeLoss" xlink:to="afya_ComprehensiveIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ComprehensiveIncomeLoss_2_lbl" xml:lang="en-US">ComprehensiveIncomeLoss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaid" xlink:to="ifrs-full_DividendsPaid_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaid_2_lbl" xml:lang="en-US">Dividends recognised as distributions to owners</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncomeLossBeforeIncomeTaxes" xlink:to="afya_IncomeLossBeforeIncomeTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncomeLossBeforeIncomeTaxes_2_lbl" xml:lang="en-US">IncomeLossBeforeIncomeTaxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax" xlink:to="afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax_2_lbl" xml:lang="en-US">ShareOfProfitOfEquityaccountedInvesteeNetOfTax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_2_lbl" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseDecreaseInRecoverableTaxes" xlink:to="afya_IncreaseDecreaseInRecoverableTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseDecreaseInRecoverableTaxes_2_lbl" xml:lang="en-US">IncreaseDecreaseInRecoverableTaxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_2_lbl" xml:lang="en-US">Adjustments for decrease (increase) in other assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense_2_lbl" xml:lang="en-US">Adjustments for income tax expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_2_lbl" xml:lang="en-US">Adjustments for decrease (increase) in loans and advances to customers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherAdjustmentsForNoncashItems" xlink:to="ifrs-full_OtherAdjustmentsForNoncashItems_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems_2_lbl" xml:lang="en-US">Other adjustments for non-cash items</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseDecreaseInPaymentsOfLegalProceedings" xlink:to="afya_IncreaseDecreaseInPaymentsOfLegalProceedings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseDecreaseInPaymentsOfLegalProceedings_2_lbl" xml:lang="en-US">IncreaseDecreaseInPaymentsOfLegalProceedings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_2_lbl" xml:lang="en-US">Adjustments for increase (decrease) in other liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss_2_lbl" xml:lang="en-US">Adjustments to reconcile profit (loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_2_lbl" xml:lang="en-US">Income taxes paid (refund), classified as operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_2_lbl" xml:lang="en-US">Cash flows from (used in) operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2_lbl" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:to="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities_2_lbl" xml:lang="en-US">PurchaseOfIntangibleAssetClassifiedAsInvestingActivities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PurchaseOfAcquisitionOfNoncontrollingInterests" xlink:to="afya_PurchaseOfAcquisitionOfNoncontrollingInterests_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PurchaseOfAcquisitionOfNoncontrollingInterests_2_lbl" xml:lang="en-US">PurchaseOfAcquisitionOfNoncontrollingInterests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_2_lbl" xml:lang="en-US">Purchase of other long-term assets, classified as investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfInterest" xlink:to="afya_PaymentsOfInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentsOfInterest_2_lbl" xml:lang="en-US">PaymentsOfInterest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_2_lbl" xml:lang="en-US">Cash flows from (used in) investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">Repayments of borrowings, classified as financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RepaymentsOfInterest" xlink:to="afya_RepaymentsOfInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RepaymentsOfInterest_2_lbl" xml:lang="en-US">RepaymentsOfInterest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_DividendsPaidClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaidClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">Dividends paid, classified as financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_2_lbl" xml:lang="en-US">Cash flows from (used in) financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_2_lbl" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_3_lbl" xml:lang="en-US">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_3_lbl" xml:lang="en-US">Restricted cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosuresOfCashAndCashEquivalentsExplanatory" xlink:to="afya_DisclosuresOfCashAndCashEquivalentsExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosuresOfCashAndCashEquivalentsExplanatory_2_lbl" xml:lang="en-US">DisclosuresOfCashAndCashEquivalentsExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2_lbl" xml:lang="en-US">Disclosure of trade and other receivables [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfOtherAssetExplanatory" xlink:to="afya_DisclosureOfOtherAssetExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfOtherAssetExplanatory_2_lbl" xml:lang="en-US">DisclosureOfOtherAssetExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory_2_lbl" xml:lang="en-US">Disclosure of joint ventures [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_2_lbl" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfIntangibleAssetExplanatory" xlink:to="afya_DisclosureOfIntangibleAssetExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfIntangibleAssetExplanatory_2_lbl" xml:lang="en-US">DisclosureOfIntangibleAssetExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsExplanatory" xlink:to="afya_LaborAndSocialObligationsExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaborAndSocialObligationsExplanatory_2_lbl" xml:lang="en-US">LaborAndSocialObligationsExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfEquityExplanatory" xlink:to="afya_DisclosureOfEquityExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfEquityExplanatory_2_lbl" xml:lang="en-US">DisclosureOfEquityExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory_2_lbl" xml:lang="en-US">Disclosure of revenue [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_2_lbl" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_2_lbl" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_2_lbl" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersPolicyExplanatory" xlink:to="afya_AccountsPayableToSellingShareholdersPolicyExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersPolicyExplanatory_2_lbl" xml:lang="en-US">AccountsPayableToSellingShareholdersPolicyExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Property, plant and equipment recognised as of acquisition date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Identifiable intangible assets recognised as of acquisition date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Trade and other payables recognised as of acquisition date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingAsOfAcquisitionDate" xlink:to="afya_LoansAndFinancingAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingAsOfAcquisitionDate_2_lbl" xml:lang="en-US">LoansAndFinancingAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">Selling, general and administrative expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_OtherIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherIncome_2_lbl" xml:lang="en-US">Other income [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_2_lbl" xml:lang="en-US">Tax expense (income)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeReceivablesAsOfAcquisitionDate" xlink:to="afya_TradeReceivablesAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeReceivablesAsOfAcquisitionDate_2_lbl" xml:lang="en-US">TradeReceivablesAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RecoverableTaxesAsOfAcquisitionDate" xlink:to="afya_RecoverableTaxesAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RecoverableTaxesAsOfAcquisitionDate_2_lbl" xml:lang="en-US">RecoverableTaxesAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssetsAsOfAcquisitionDate" xlink:to="afya_OtherAssetsAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherAssetsAsOfAcquisitionDate_2_lbl" xml:lang="en-US">OtherAssetsAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:to="afya_LaborAndSocialObligationsAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaborAndSocialObligationsAsOfAcquisitionDate_2_lbl" xml:lang="en-US">LaborAndSocialObligationsAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesPayableAsOfAcquisitionDate" xlink:to="afya_TaxesPayableAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxesPayableAsOfAcquisitionDate_2_lbl" xml:lang="en-US">TaxesPayableAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:to="afya_AdvancesFromCustomersAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdvancesFromCustomersAsOfAcquisitionDate_2_lbl" xml:lang="en-US">AdvancesFromCustomersAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:to="afya_LeaseLiabilitiesAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesAsOfAcquisitionDate_2_lbl" xml:lang="en-US">LeaseLiabilitiesAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:to="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate_2_lbl" xml:lang="en-US">ProvisionForLegalProceedingsAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:to="afya_OtherLiabilitiesAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherLiabilitiesAsOfAcquisitionDate_2_lbl" xml:lang="en-US">OtherLiabilitiesAsOfAcquisitionDate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:to="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_2_lbl" xml:lang="en-US">Description of valuation techniques and significant inputs used to measure non-controlling interest in acquiree measured at fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceAccountForCreditLossesOfFinancialAsset" xlink:to="afya_AllowanceAccountForCreditLossesOfFinancialAsset_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllowanceAccountForCreditLossesOfFinancialAsset_3_lbl" xml:lang="en-US">AllowanceAccountForCreditLossesOfFinancialAsset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsRelatedPartyTransactions" xlink:to="afya_RightofuseAssetsRelatedPartyTransactions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsRelatedPartyTransactions_2_lbl" xml:lang="en-US">RightofuseAssetsRelatedPartyTransactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeReceivablesRelatedPartyTransactions" xlink:to="afya_TradeReceivablesRelatedPartyTransactions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeReceivablesRelatedPartyTransactions_2_lbl" xml:lang="en-US">TradeReceivablesRelatedPartyTransactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssetsRelatedPartyTransactions" xlink:to="afya_OtherAssetsRelatedPartyTransactions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherAssetsRelatedPartyTransactions_2_lbl" xml:lang="en-US">OtherAssetsRelatedPartyTransactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsReceivableRelatedPartyTransactions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountsReceivableRelatedPartyTransactions_2_lbl" xml:lang="en-US">Amounts receivable, related party transactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:to="afya_TradeAndOtherCurrentPayablesToRelatedParties1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeAndOtherCurrentPayablesToRelatedParties1_2_lbl" xml:lang="en-US">TradeAndOtherCurrentPayablesToRelatedParties1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentAssetsOfRelatedParty1" xlink:to="afya_NoncurrentAssetsOfRelatedParty1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentAssetsOfRelatedParty1_2_lbl" xml:lang="en-US">NoncurrentAssetsOfRelatedParty1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesRelatedPartyTransactions" xlink:to="afya_LeaseLiabilitiesRelatedPartyTransactions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesRelatedPartyTransactions_2_lbl" xml:lang="en-US">LeaseLiabilitiesRelatedPartyTransactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherCurrentPayableToRelatedParties" xlink:to="afya_TradeAndOtherCurrentPayableToRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeAndOtherCurrentPayableToRelatedParties_2_lbl" xml:lang="en-US">TradeAndOtherCurrentPayableToRelatedParties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrenLliabilitiesOfRelatedParty1" xlink:to="afya_NoncurrenLliabilitiesOfRelatedParty1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrenLliabilitiesOfRelatedParty1_2_lbl" xml:lang="en-US">NoncurrenLliabilitiesOfRelatedParty1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherIncomeRelatedPartyTransactions" xlink:to="afya_OtherIncomeRelatedPartyTransactions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherIncomeRelatedPartyTransactions_2_lbl" xml:lang="en-US">OtherIncomeRelatedPartyTransactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:to="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_2_lbl" xml:lang="en-US">Amount incurred by entity for provision of key management personnel services provided by separate management entity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilities_4_lbl" xml:lang="en-US">Lease liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfLeaseTerms" xlink:to="afya_DescriptionOfLeaseTerms_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DescriptionOfLeaseTerms_2_lbl" xml:lang="en-US">DescriptionOfLeaseTerms</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Advances1" xlink:to="afya_Advances1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Advances1_2_lbl" xml:lang="en-US">Advances1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Dividend" xlink:to="afya_Dividend_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Dividend_2_lbl" xml:lang="en-US">Dividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssets1" xlink:to="afya_OtherAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherAssets1_2_lbl" xml:lang="en-US">OtherAssets1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Assets1" xlink:to="afya_Assets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Assets1_2_lbl" xml:lang="en-US">Assets1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentAssets1" xlink:to="afya_NoncurrentAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentAssets1_2_lbl" xml:lang="en-US">NoncurrentAssets1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EquityInAssociate" xlink:to="afya_EquityInAssociate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EquityInAssociate_2_lbl" xml:lang="en-US">EquityInAssociate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsReceived1" xlink:to="afya_DividendsReceived1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsReceived1_2_lbl" xml:lang="en-US">DividendsReceived1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PropertyPlantAndEquipments" xlink:to="afya_PropertyPlantAndEquipments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PropertyPlantAndEquipments_3_lbl" xml:lang="en-US">PropertyPlantAndEquipments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Depreciation, property, plant and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="ifrs-full_IntangibleAssetsAndGoodwill_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill_3_lbl" xml:lang="en-US">Intangible assets and goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_2_lbl" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_2_lbl" xml:lang="en-US">Acquisitions through business combinations, intangible assets and goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Transfer" xlink:to="afya_Transfer_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Transfer_2_lbl" xml:lang="en-US">Transfer [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IntangibleAssetsAndGoodwillNetBookValue" xlink:to="afya_IntangibleAssetsAndGoodwillNetBookValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IntangibleAssetsAndGoodwillNetBookValue_2_lbl" xml:lang="en-US">IntangibleAssetsAndGoodwillNetBookValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssets" xlink:to="ifrs-full_CurrentFinancialAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialAssets_2_lbl" xml:lang="en-US">Current financial assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialAssets_2_lbl" xml:lang="en-US">Non-current financial assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_2_lbl" xml:lang="en-US">Trade payables [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancing" xlink:to="afya_LoansAndFinancing_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancing_2_lbl" xml:lang="en-US">LoansAndFinancing</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilities" xlink:to="ifrs-full_CurrentFinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialLiabilities_2_lbl" xml:lang="en-US">Current financial liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilities" xlink:to="ifrs-full_NoncurrentFinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialLiabilities_2_lbl" xml:lang="en-US">Non-current financial liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_2_lbl" xml:lang="en-US">Current financial liabilities at fair value through profit or loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_2_lbl" xml:lang="en-US">Non-current financial liabilities at fair value through profit or loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingCurrent" xlink:to="afya_LoansAndFinancingCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingCurrent_2_lbl" xml:lang="en-US">LoansAndFinancingCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingNonCurrent" xlink:to="afya_LoansAndFinancingNonCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingNonCurrent_2_lbl" xml:lang="en-US">LoansAndFinancingNonCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRightofuseAssets" xlink:to="ifrs-full_DepreciationRightofuseAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationRightofuseAssets_2_lbl" xml:lang="en-US">Depreciation, right-of-use assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableAamortizedCostInterestRateBasis" xlink:to="afya_AccountsPayableAamortizedCostInterestRateBasis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableAamortizedCostInterestRateBasis_2_lbl" xml:lang="en-US">AccountsPayableAamortizedCostInterestRateBasis</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersCurrent_2_lbl" xml:lang="en-US">AccountsPayableToSellingShareholdersCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersNonCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersNonCurrent_2_lbl" xml:lang="en-US">AccountsPayableToSellingShareholdersNonCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfPrincipal" xlink:to="afya_PaymentsOfPrincipal_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentsOfPrincipal_2_lbl" xml:lang="en-US">PaymentsOfPrincipal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_3_lbl" xml:lang="en-US">Interest paid, classified as financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue_2_lbl" xml:lang="en-US">Financial liabilities, at fair value [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:to="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_2_lbl" xml:lang="en-US">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_3_lbl" xml:lang="en-US">Liabilities arising from financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:to="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_2_lbl" xml:lang="en-US">IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_2_lbl" xml:lang="en-US">Increase (decrease) through other changes, liabilities arising from financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_2_lbl" xml:lang="en-US">Increase (decrease) through obtaining or losing control of subsidiaries or other businesses, liabilities arising from financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoanAndFinancing" xlink:to="afya_LoanAndFinancing_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoanAndFinancing_2_lbl" xml:lang="en-US">LoanAndFinancing</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_3_lbl" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_3_lbl" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" xlink:to="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_2_lbl" xml:lang="en-US">WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of share options expired in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfStockOptionsExercisable" xlink:to="afya_NumberOfStockOptionsExercisable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfStockOptionsExercisable_2_lbl" xml:lang="en-US">NumberOfStockOptionsExercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2_lbl" xml:lang="en-US">Expense from share-based payment transactions with employees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesOutstanding_3_lbl" xml:lang="en-US">Number of shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_3_lbl" xml:lang="en-US">WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssued_2_lbl" xml:lang="en-US">Number of shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherRevenue1" xlink:to="afya_OtherRevenue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherRevenue1_2_lbl" xml:lang="en-US">OtherRevenue1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfTaxes" xlink:to="afya_DeductionOfTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfTaxes_2_lbl" xml:lang="en-US">DeductionOfTaxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_2_lbl" xml:lang="en-US">Revenue from contracts with customers [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfessionalFeesExpense" xlink:to="ifrs-full_ProfessionalFeesExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfessionalFeesExpense_2_lbl" xml:lang="en-US">Professional fees expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherRevenue" xlink:to="ifrs-full_OtherRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherRevenue_2_lbl" xml:lang="en-US">Other revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TimingRevenueRecognition" xlink:to="afya_TimingRevenueRecognition_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TimingRevenueRecognition_2_lbl" xml:lang="en-US">TimingRevenueRecognition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FeeAndCommissionIncome" xlink:to="ifrs-full_FeeAndCommissionIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FeeAndCommissionIncome_2_lbl" xml:lang="en-US">Fee and commission income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetRevenueOtherTransferredPoint" xlink:to="afya_NetRevenueOtherTransferredPoint_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NetRevenueOtherTransferredPoint_2_lbl" xml:lang="en-US">NetRevenueOtherTransferredPoint</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationExpense_2_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseExpenses" xlink:to="afya_LeaseExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseExpenses_2_lbl" xml:lang="en-US">LeaseExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepairsAndMaintenanceExpense" xlink:to="ifrs-full_RepairsAndMaintenanceExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepairsAndMaintenanceExpense_2_lbl" xml:lang="en-US">Repairs and maintenance expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharesBasedCompensation" xlink:to="afya_SharesBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SharesBasedCompensation_2_lbl" xml:lang="en-US">SharesBasedCompensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SalesAndMarketingExpense" xlink:to="ifrs-full_SalesAndMarketingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SalesAndMarketingExpense_2_lbl" xml:lang="en-US">Sales and marketing expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TravelExpense" xlink:to="ifrs-full_TravelExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TravelExpense_2_lbl" xml:lang="en-US">Travel expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CostExpensesOther" xlink:to="afya_CostExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CostExpensesOther_2_lbl" xml:lang="en-US">CostExpensesOther</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseByNature" xlink:to="ifrs-full_ExpenseByNature_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseByNature_2_lbl" xml:lang="en-US">Expenses, by nature</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CostOfServices" xlink:to="afya_CostOfServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CostOfServices_2_lbl" xml:lang="en-US">CostOfServices</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceIncome" xlink:to="ifrs-full_OtherFinanceIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherFinanceIncome_2_lbl" xml:lang="en-US">Other finance income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BankAndSimilarCharges" xlink:to="ifrs-full_BankAndSimilarCharges_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BankAndSimilarCharges_2_lbl" xml:lang="en-US">Bank and similar charges</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceCost" xlink:to="ifrs-full_OtherFinanceCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherFinanceCost_2_lbl" xml:lang="en-US">Other finance cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_2_lbl" xml:lang="en-US">TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:to="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_2_lbl" xml:lang="en-US">Tax expense other than income tax expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherTaxExpenseBenefits" xlink:to="afya_OtherTaxExpenseBenefits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherTaxExpenseBenefits_2_lbl" xml:lang="en-US">OtherTaxExpenseBenefits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncome" xlink:to="ifrs-full_CurrentTaxExpenseIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxExpenseIncome_2_lbl" xml:lang="en-US">Current tax expense (income)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncome" xlink:to="ifrs-full_DeferredTaxExpenseIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncome_2_lbl" xml:lang="en-US">Deferred tax expense (income)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForExpectedCreditLoss" xlink:to="afya_AllowanceForExpectedCreditLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllowanceForExpectedCreditLoss_2_lbl" xml:lang="en-US">AllowanceForExpectedCreditLoss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAsset" xlink:to="afya_RightofuseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAsset_2_lbl" xml:lang="en-US">RightofuseAsset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsToRightofuseAsset" xlink:to="afya_AdditionsToRightofuseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsToRightofuseAsset_2_lbl" xml:lang="en-US">AdditionsToRightofuseAsset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiability" xlink:to="afya_LeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiability_2_lbl" xml:lang="en-US">LeaseLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Other" xlink:to="afya_Other_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Other_2_lbl" xml:lang="en-US">Other [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeferredTaxAsset" xlink:to="afya_DeferredTaxAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeferredTaxAsset_2_lbl" xml:lang="en-US">DeferredTaxAsset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill" xlink:to="afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_2_lbl" xml:lang="en-US">DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeferredsTaxLiabilities" xlink:to="afya_DeferredsTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeferredsTaxLiabilities_2_lbl" xml:lang="en-US">DeferredsTaxLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Provisions" xlink:to="ifrs-full_Provisions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Provisions_3_lbl" xml:lang="en-US">Provisions [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_2_lbl" xml:lang="en-US">Acquisitions through business combinations, other provisions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProvisionUsedOtherProvisions" xlink:to="ifrs-full_ProvisionUsedOtherProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProvisionUsedOtherProvisions_2_lbl" xml:lang="en-US">Provision used, other provisions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:to="ifrs-full_UnusedProvisionReversedOtherProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnusedProvisionReversedOtherProvisions_2_lbl" xml:lang="en-US">Unused provision reversed, other provisions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherProvisions" xlink:to="ifrs-full_OtherProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherProvisions_2_lbl" xml:lang="en-US">Other provisions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsPayables" xlink:to="afya_DividendsPayables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsPayables_2_lbl" xml:lang="en-US">DividendsPayables</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>39
<FILENAME>afya-20251231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Cover" roleURI="http://afya.com.br/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#StatementOfFinancialPosition" roleURI="http://afya.com.br/role/StatementOfFinancialPosition" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#StatementOfIncomeAndOtherComprehensiveIncome" roleURI="http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#StatementOfChangesInEquity" roleURI="http://afya.com.br/role/StatementOfChangesInEquity" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#StatementOfCashFlows" roleURI="http://afya.com.br/role/StatementOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#MaterialCybersecurityIncidentDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CorporateInformation" roleURI="http://afya.com.br/role/CorporateInformation" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPolicies" roleURI="http://afya.com.br/role/MaterialAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SegmentInformation" roleURI="http://afya.com.br/role/SegmentInformation" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinations" roleURI="http://afya.com.br/role/BusinessCombinations" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CashAndCashEquivalents" roleURI="http://afya.com.br/role/CashAndCashEquivalents" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivables" roleURI="http://afya.com.br/role/TradeReceivables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedParties" roleURI="http://afya.com.br/role/RelatedParties" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#OtherAssets" roleURI="http://afya.com.br/role/OtherAssets" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#InvestmentInAssociate" roleURI="http://afya.com.br/role/InvestmentInAssociate" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#PropertyAndEquipment" roleURI="http://afya.com.br/role/PropertyAndEquipment" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssets" roleURI="http://afya.com.br/role/IntangibleAssets" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilities" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilities" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CapitalManagement" roleURI="http://afya.com.br/role/CapitalManagement" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligations" roleURI="http://afya.com.br/role/LaborAndSocialObligations" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Equity" roleURI="http://afya.com.br/role/Equity" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EarningsPerShare" roleURI="http://afya.com.br/role/EarningsPerShare" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Revenue" roleURI="http://afya.com.br/role/Revenue" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CostsAndExpensesByNature" roleURI="http://afya.com.br/role/CostsAndExpensesByNature" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinanceResult" roleURI="http://afya.com.br/role/FinanceResult" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxes" roleURI="http://afya.com.br/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingencies" roleURI="http://afya.com.br/role/LegalProceedingsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Non-cashTransactions" roleURI="http://afya.com.br/role/Non-cashTransactions" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SubsequentEvents" roleURI="http://afya.com.br/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesPolicies" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CorporateInformationTables" roleURI="http://afya.com.br/role/CorporateInformationTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesTables" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SegmentInformationTables" roleURI="http://afya.com.br/role/SegmentInformationTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinationsTables" roleURI="http://afya.com.br/role/BusinessCombinationsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CashAndCashEquivalentsTables" roleURI="http://afya.com.br/role/CashAndCashEquivalentsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivablesTables" roleURI="http://afya.com.br/role/TradeReceivablesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedPartiesTables" roleURI="http://afya.com.br/role/RelatedPartiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#OtherAssetsTables" roleURI="http://afya.com.br/role/OtherAssetsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#InvestmentInAssociateTables" roleURI="http://afya.com.br/role/InvestmentInAssociateTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#PropertyAndEquipmentTables" roleURI="http://afya.com.br/role/PropertyAndEquipmentTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsTables" roleURI="http://afya.com.br/role/IntangibleAssetsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesTables" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsTables" roleURI="http://afya.com.br/role/LaborAndSocialObligationsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EquityTables" roleURI="http://afya.com.br/role/EquityTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EarningsPerShareTables" roleURI="http://afya.com.br/role/EarningsPerShareTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RevenueTables" roleURI="http://afya.com.br/role/RevenueTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CostsAndExpensesByNatureTables" roleURI="http://afya.com.br/role/CostsAndExpensesByNatureTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinanceResultTables" roleURI="http://afya.com.br/role/FinanceResultTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxesTables" roleURI="http://afya.com.br/role/IncomeTaxesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingenciesTables" roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Non-cashTransactionsTables" roleURI="http://afya.com.br/role/Non-cashTransactionsTables" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CorporateInformationDetails" roleURI="http://afya.com.br/role/CorporateInformationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CorporateInformationDetailsNarrative" roleURI="http://afya.com.br/role/CorporateInformationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails1" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails2" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails3" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails4" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails4" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetails5" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetails5" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#MaterialAccountingPoliciesDetailsNarrative" roleURI="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SegmentInformationDetails" roleURI="http://afya.com.br/role/SegmentInformationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SegmentInformationDetails1" roleURI="http://afya.com.br/role/SegmentInformationDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinationsDetails" roleURI="http://afya.com.br/role/BusinessCombinationsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinationsDetails1" roleURI="http://afya.com.br/role/BusinessCombinationsDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#BusinessCombinationsDetailsNarrative" roleURI="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CashAndCashEquivalentsDetails" roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CashAndCashEquivalentsDetailsNarrative" roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivablesDetails" roleURI="http://afya.com.br/role/TradeReceivablesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivablesDetails1" roleURI="http://afya.com.br/role/TradeReceivablesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#TradeReceivablesDetails2" roleURI="http://afya.com.br/role/TradeReceivablesDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedPartiesDetails" roleURI="http://afya.com.br/role/RelatedPartiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedPartiesDetails1" roleURI="http://afya.com.br/role/RelatedPartiesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RelatedPartiesDetailsNarrative" roleURI="http://afya.com.br/role/RelatedPartiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#OtherAssetsDetails" roleURI="http://afya.com.br/role/OtherAssetsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#InvestmentInAssociateDetails" roleURI="http://afya.com.br/role/InvestmentInAssociateDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#PropertyAndEquipmentDetails" roleURI="http://afya.com.br/role/PropertyAndEquipmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsDetails" roleURI="http://afya.com.br/role/IntangibleAssetsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsDetails1" roleURI="http://afya.com.br/role/IntangibleAssetsDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsDetails2" roleURI="http://afya.com.br/role/IntangibleAssetsDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IntangibleAssetsDetailsNarrative" roleURI="http://afya.com.br/role/IntangibleAssetsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails1" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails2" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails3" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails4" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails5" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails6" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails7" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails8" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails9" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails10" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetails11" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinancialAssetsAndLiabilitiesDetailsNarrative" roleURI="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetails" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetails1" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetails2" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetails3" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LaborAndSocialObligationsDetailsNarrative" roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EquityDetails" roleURI="http://afya.com.br/role/EquityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EquityDetailsNarrative" roleURI="http://afya.com.br/role/EquityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#EarningsPerShareDetails" roleURI="http://afya.com.br/role/EarningsPerShareDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RevenueDetails" roleURI="http://afya.com.br/role/RevenueDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#RevenueDetails1" roleURI="http://afya.com.br/role/RevenueDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#CostsAndExpensesByNatureDetails" roleURI="http://afya.com.br/role/CostsAndExpensesByNatureDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#FinanceResultDetails" roleURI="http://afya.com.br/role/FinanceResultDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxesDetails" roleURI="http://afya.com.br/role/IncomeTaxesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxesDetails1" roleURI="http://afya.com.br/role/IncomeTaxesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#IncomeTaxesDetailsNarrative" roleURI="http://afya.com.br/role/IncomeTaxesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingenciesDetails" roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingenciesDetails1" roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#LegalProceedingsAndContingenciesDetailsNarrative" roleURI="http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#Non-cashTransactionsDetails" roleURI="http://afya.com.br/role/Non-cashTransactionsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="afya-20251231.xsd#SubsequentEventsDetailsNarrative" roleURI="http://afya.com.br/role/SubsequentEventsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" roleURI="http://xbrl.sec.gov/ecd/role/Defaults" />
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-fullClassesOfShareCapitalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalDomain" xlink:to="loc_afyaClassAOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassACommonSharesHeldInTreasuryMember" xlink:label="loc_afyaClassACommonSharesHeldInTreasuryMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalDomain" xlink:to="loc_afyaClassACommonSharesHeldInTreasuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalDomain" xlink:to="loc_afyaClassBOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_deiContactPersonnelEmailAddress" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelEmailAddress" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="640" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementOfFinancialPosition" xlink:title="00000002 - Statement - Consolidated statement of financial position">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-fullStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-fullAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-fullCurrentAssetsAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullCurrentAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCurrentTradeReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxAssets" xlink:label="loc_ifrs-fullCurrentTaxAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCurrentTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeTaxesRecoverable" xlink:label="loc_afyaIncomeTaxesRecoverable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_afyaIncomeTaxesRecoverable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-fullOtherCurrentAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullOtherCurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-fullNoncurrentAssetsAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrentTradeReceivable" xlink:label="loc_afyaNoncurrentTradeReceivable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_afyaNoncurrentTradeReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-fullDeferredTaxAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullDeferredTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-fullOtherNoncurrentAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-fullInvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullRightofuseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-fullLiabilitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-fullCurrentLiabilitiesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayables" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermBorrowings" xlink:label="loc_ifrs-fullShorttermBorrowings" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullShorttermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="loc_ifrs-fullCurrentDepositsFromCustomers" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentDepositsFromCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPayable" xlink:label="loc_ifrs-fullDividendsPayable" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullDividendsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-fullCurrentRecognisedLiabilitiesDefinedBenefitPlan" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CurrentTaxesPayable" xlink:label="loc_afyaCurrentTaxesPayable" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_afyaCurrentTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="loc_ifrs-fullOtherCurrentLiabilities" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullOtherCurrentLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-fullNoncurrentLiabilitiesAbstract" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-fullLongtermBorrowings" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullLongtermBorrowings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullNoncurrentPayablesToRelatedParties" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrentTaxesPayable" xlink:label="loc_afyaNoncurrentTaxesPayable" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_afyaNoncurrentTaxesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-fullDeferredTaxLiabilities" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullDeferredTaxLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermLegalProceedingsProvision" xlink:label="loc_ifrs-fullLongtermLegalProceedingsProvision" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullLongtermLegalProceedingsProvision" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-fullOtherNoncurrentLiabilities" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullOtherNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-fullEquityAbstract" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalPaidinCapital" xlink:label="loc_ifrs-fullAdditionalPaidinCapital" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullAdditionalPaidinCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-fullTreasuryShares" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullTreasuryShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-fullReserveOfSharebasedPayments" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullReserveOfSharebasedPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-fullRetainedEarnings" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullRetainedEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-fullEquityAttributableToOwnersOfParent" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-fullNoncontrollingInterests" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullEquityAndLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome" xlink:title="00000003 - Statement - Consolidated statement of income and other comprehensive income">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-fullIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-fullGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForExpectedCreditLosses" xlink:label="loc_afyaAllowanceForExpectedCreditLosses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_afyaAllowanceForExpectedCreditLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-fullOtherOperatingIncomeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullOtherOperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherExpenseByNature" xlink:label="loc_ifrs-fullOtherExpenseByNature" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullOtherExpenseByNature" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-fullFinanceIncomeCost" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullFinanceIncomeCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-fullShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeTaxesExpensesAbstract" xlink:label="loc_afyaIncomeTaxesExpensesAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_afyaIncomeTaxesExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeTaxesExpensesCurrent" xlink:label="loc_afyaIncomeTaxesExpensesCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_afyaIncomeTaxesExpensesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxes" xlink:label="loc_afyaDeferredTaxes" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_afyaDeferredTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullOtherComprehensiveIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullComprehensiveIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="loc_ifrs-fullProfitLossAttributableToAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLossAttributableToAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-fullProfitLossAttributableToOwnersOfParent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProfitLossAttributableToAbstract" xlink:to="loc_ifrs-fullProfitLossAttributableToOwnersOfParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-fullProfitLossAttributableToNoncontrollingInterests" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProfitLossAttributableToAbstract" xlink:to="loc_ifrs-fullProfitLossAttributableToNoncontrollingInterests" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ComprehensiveIncomeLoss" xlink:label="loc_afyaComprehensiveIncomeLoss" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_afyaComprehensiveIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-fullBasicEarningsLossPerShare" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullBasicEarningsLossPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-fullDilutedEarningsLossPerShare" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullDilutedEarningsLossPerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementOfChangesInEquity" xlink:title="00000004 - Statement - Consolidated statement of changes in equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-fullStatementOfChangesInEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityAbstract" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-fullComponentsOfEquityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullComponentsOfEquityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-fullComponentsOfEquityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullComponentsOfEquityDomain" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-fullIssuedCapitalMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullIssuedCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalPaidinCapitalMember" xlink:label="loc_ifrs-fullAdditionalPaidinCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullAdditionalPaidinCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-fullTreasurySharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullTreasurySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-fullReserveOfSharebasedPaymentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullReserveOfSharebasedPaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-fullRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-fullEquityAttributableToOwnersOfParentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullEquityAttributableToOwnersOfParentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-fullNoncontrollingInterestsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullNoncontrollingInterestsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullComprehensiveIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TreasurySharesRepurchase" xlink:label="loc_afyaTreasurySharesRepurchase" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesRepurchase" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AcquisitionOfNoncontrollingInterests" xlink:label="loc_afyaAcquisitionOfNoncontrollingInterests" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquisitionOfNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedSharesTransferredToExecutives" xlink:label="loc_afyaRestrictedSharesTransferredToExecutives" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRestrictedSharesTransferredToExecutives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" xlink:label="loc_afyaTreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesTransferredToExecutivesFromExerciseOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaid" xlink:label="loc_ifrs-fullDividendsPaid" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaid" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementOfCashFlows" xlink:title="00000005 - Statement - Consolidated statement of cash flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-fullStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeLossBeforeIncomeTaxes" xlink:label="loc_afyaIncomeLossBeforeIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="loc_afyaIncomeLossBeforeIncomeTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-fullAdjustmentsForDepreciationAndAmortisationExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForDepreciationAndAmortisationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WriteoffOfPropertyAndEquipment" xlink:label="loc_afyaWriteoffOfPropertyAndEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaWriteoffOfPropertyAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WriteoffOfIntangibleAssets" xlink:label="loc_afyaWriteoffOfIntangibleAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaWriteoffOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:label="loc_afyaAllowanceForDoubtfulAccountsOfOpeartingActivities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaAllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-fullAdjustmentsForSharebasedPayments" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForSharebasedPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccruedInterestOfOpeartingActivities" xlink:label="loc_afyaAccruedInterestOfOpeartingActivities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaAccruedInterestOfOpeartingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax" xlink:label="loc_afyaShareOfProfitOfEquityaccountedInvesteeNetOfTax" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaShareOfProfitOfEquityaccountedInvesteeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="loc_ifrs-fullAdjustmentsForProvisions" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForProvisions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseDecreaseInOperatingLiabilities1Abstract" xlink:label="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseDecreaseInRecoverableTaxes" xlink:label="loc_afyaIncreaseDecreaseInRecoverableTaxes" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_afyaIncreaseDecreaseInRecoverableTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="loc_ifrs-fullOtherAdjustmentsForNoncashItems" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullOtherAdjustmentsForNoncashItems" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseDecreaseInPaymentsOfLegalProceedings" xlink:label="loc_afyaIncreaseDecreaseInPaymentsOfLegalProceedings" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_afyaIncreaseDecreaseInPaymentsOfLegalProceedings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-fullIncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullIncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:label="loc_afyaPurchaseOfIntangibleAssetClassifiedAsInvestingActivities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_afyaPurchaseOfIntangibleAssetClassifiedAsInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsReceived" xlink:label="loc_ifrs-fullDividendsReceived" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullDividendsReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PurchaseOfAcquisitionOfNoncontrollingInterests" xlink:label="loc_afyaPurchaseOfAcquisitionOfNoncontrollingInterests" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_afyaPurchaseOfAcquisitionOfNoncontrollingInterests" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullPurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentsOfInterest" xlink:label="loc_afyaPaymentsOfInterest" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_afyaPaymentsOfInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullRepaymentsOfBorrowingsClassifiedAsFinancingActivities" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullRepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RepaymentsOfInterest" xlink:label="loc_afyaRepaymentsOfInterest" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_afyaRepaymentsOfInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullProceedsFromBorrowingsClassifiedAsFinancingActivities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_afyaPaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_afyaPaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TreasurySharesRepurchase" xlink:label="loc_afyaTreasurySharesRepurchase" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_afyaTreasurySharesRepurchase" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-fullProceedsFromExerciseOfOptions" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullProceedsFromExerciseOfOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullDividendsPaidClassifiedAsFinancingActivities" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullDividendsPaidClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-fullRestrictedCashAndCashEquivalents" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullRestrictedCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-fullRestrictedCashAndCashEquivalents_2" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullRestrictedCashAndCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000011 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="loc_cydCybersecurityRiskManagementProcessesIntegratedFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementProcessesIntegratedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="loc_cydCybersecurityRiskManagementProcessesIntegratedTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="loc_cydCybersecurityRiskManagementThirdPartyEngagedFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementThirdPartyEngagedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="loc_cydCybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="loc_cydCybersecurityRiskBoardOfDirectorsOversightTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="loc_cydCybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="loc_cydCybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="loc_cydCybersecurityRiskRoleOfManagementTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskRoleOfManagementTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000012 - Disclosure - Material Cybersecurity Incident Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentAbstract" xlink:label="loc_cydMaterialCybersecurityIncidentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentNatureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentNatureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentScopeTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentScopeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentTimingTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentTimingTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformation" xlink:title="999013 - Disclosure - Corporate information">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureCorporateInformationAbstract" xlink:label="loc_afyaDisclosureCorporateInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfGeneralInformationAboutFinancialStatementExplanatory" xlink:label="loc_afyaDisclosureOfGeneralInformationAboutFinancialStatementExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCorporateInformationAbstract" xlink:to="loc_afyaDisclosureOfGeneralInformationAboutFinancialStatementExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPolicies" xlink:title="999014 - Disclosure - Material accounting policies">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfMaterialAccountingPoliciesExplanatory" xlink:label="loc_afyaDisclosureOfMaterialAccountingPoliciesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaDisclosureOfMaterialAccountingPoliciesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformation" xlink:title="999015 - Disclosure - Segment information">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfEntitysReportableSegmentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfEntitysReportableSegmentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinations" xlink:title="999016 - Disclosure - Business combinations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalents" xlink:title="999017 - Disclosure - Cash and cash equivalents">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureCashAndCashEquivalentsAbstract" xlink:label="loc_afyaDisclosureCashAndCashEquivalentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosuresOfCashAndCashEquivalentsExplanatory" xlink:label="loc_afyaDisclosuresOfCashAndCashEquivalentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCashAndCashEquivalentsAbstract" xlink:to="loc_afyaDisclosuresOfCashAndCashEquivalentsExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivables" xlink:title="999018 - Disclosure - Trade receivables">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfTradeAndOtherReceivablesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTradeAndOtherReceivablesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedParties" xlink:title="999019 - Disclosure - Related parties">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-fullDisclosureOfRelatedPartyExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfRelatedPartyExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssets" xlink:title="999020 - Disclosure - Other assets">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOtherAssetsAbstract" xlink:label="loc_afyaDisclosureOtherAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfOtherAssetExplanatory" xlink:label="loc_afyaDisclosureOfOtherAssetExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaDisclosureOfOtherAssetExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociate" xlink:title="999021 - Disclosure - Investment in associate">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfJointVenturesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfJointVenturesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipment" xlink:title="999022 - Disclosure - Property and equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssets" xlink:title="999023 - Disclosure - Intangible assets">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIntangibleAssetsAbstract" xlink:label="loc_afyaDisclosureIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfIntangibleAssetExplanatory" xlink:label="loc_afyaDisclosureOfIntangibleAssetExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAbstract" xlink:to="loc_afyaDisclosureOfIntangibleAssetExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilities" xlink:title="999024 - Disclosure - Financial assets and liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CapitalManagement" xlink:title="999025 - Disclosure - Capital management">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureCapitalManagementAbstract" xlink:label="loc_afyaDisclosureCapitalManagementAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CapitalManagementExplanatory" xlink:label="loc_afyaCapitalManagementExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_afyaCapitalManagementExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligations" xlink:title="999026 - Disclosure - Labor and social obligations">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LaborAndSocialObligationsExplanatory" xlink:label="loc_afyaLaborAndSocialObligationsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_afyaLaborAndSocialObligationsExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Equity" xlink:title="999027 - Disclosure - Equity">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureEquityAbstract" xlink:label="loc_afyaDisclosureEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfEquityExplanatory" xlink:label="loc_afyaDisclosureOfEquityExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaDisclosureOfEquityExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShare" xlink:title="999028 - Disclosure - Earnings per share">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-fullDisclosureOfEarningsPerShareExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfEarningsPerShareExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Revenue" xlink:title="999029 - Disclosure - Revenue">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="loc_ifrs-fullDisclosureOfRevenueExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfRevenueExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CostsAndExpensesByNature" xlink:title="999030 - Disclosure - Costs and expenses by nature">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:label="loc_ifrs-fullDisclosureOfExpensesByNatureExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfExpensesByNatureExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResult" xlink:title="999031 - Disclosure - Finance result">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinanceIncomeExpenseExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinanceIncomeExpenseExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxes" xlink:title="999032 - Disclosure - Income taxes">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIncomeTaxesAbstract" xlink:label="loc_afyaDisclosureIncomeTaxesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfIncomeTaxesExplanatory" xlink:label="loc_afyaDisclosureOfIncomeTaxesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaDisclosureOfIncomeTaxesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingencies" xlink:title="999033 - Disclosure - Legal proceedings and contingencies">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLegalProceedingsAndContingenciesAbstract" xlink:label="loc_afyaDisclosureLegalProceedingsAndContingenciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfLegalProceedingsAndContingenciesExplanatory" xlink:label="loc_afyaDisclosureOfLegalProceedingsAndContingenciesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLegalProceedingsAndContingenciesAbstract" xlink:to="loc_afyaDisclosureOfLegalProceedingsAndContingenciesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactions" xlink:title="999034 - Disclosure - Non-cash transactions">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureNoncashTransactionsAbstract" xlink:label="loc_afyaDisclosureNoncashTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureNoncashTransactionsExplanatory" xlink:label="loc_afyaDisclosureNoncashTransactionsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureNoncashTransactionsAbstract" xlink:to="loc_afyaDisclosureNoncashTransactionsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEvents" xlink:title="999035 - Disclosure - Subsequent events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-fullDisclosureOfEventsAfterReportingPeriodExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfEventsAfterReportingPeriodExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesPolicies" xlink:title="999036 - Disclosure - Material accounting policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_BusinessCombinationsAndGoodwillPolicyExplanatory" xlink:label="loc_afyaBusinessCombinationsAndGoodwillPolicyExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaBusinessCombinationsAndGoodwillPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" xlink:label="loc_afyaCurrentVersusNoncurrentClassificationPoliciesExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaCurrentVersusNoncurrentClassificationPoliciesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" xlink:label="loc_afyaFinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaFinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForLeasesExplanatory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForLeasesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" xlink:label="loc_afyaImpairmentOfNonfinancialAssetsPolicyExplanatory" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaImpairmentOfNonfinancialAssetsPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory" xlink:label="loc_afyaDescriptionOfAccountingPolicyForInvestmentsExplanatory" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaDescriptionOfAccountingPolicyForInvestmentsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersPolicyExplanatory" xlink:label="loc_afyaAccountsPayableToSellingShareholdersPolicyExplanatory" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaAccountsPayableToSellingShareholdersPolicyExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForProvisionsExplanatory" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendsPolicyExplanatory" xlink:label="loc_afyaDividendsPolicyExplanatory" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaDividendsPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LaborAndSocialObligationsPolicyExplanatory" xlink:label="loc_afyaLaborAndSocialObligationsPolicyExplanatory" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaLaborAndSocialObligationsPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SharebasedPaymentsPolicyExplanatory" xlink:label="loc_afyaSharebasedPaymentsPolicyExplanatory" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaSharebasedPaymentsPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForEarningsPerShareExplanatory" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForRecognitionOfRevenue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForIncomeTaxExplanatory" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForTreasurySharesExplanatory" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationTables" xlink:title="999037 - Disclosure - Corporate information (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureCorporateInformationAbstract" xlink:label="loc_afyaDisclosureCorporateInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_afyaScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCorporateInformationAbstract" xlink:to="loc_afyaScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesTables" xlink:title="999038 - Disclosure - Material accounting policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" xlink:label="loc_afyaSummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaSummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock" xlink:label="loc_afyaScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfMeasurementAndGainsAndLossesTableTextBlock" xlink:label="loc_afyaScheduleOfMeasurementAndGainsAndLossesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaScheduleOfMeasurementAndGainsAndLossesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:label="loc_afyaScheduleOfEstimatedUsefulLivesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock" xlink:label="loc_afyaScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" xlink:label="loc_afyaScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_afyaScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationTables" xlink:title="999039 - Disclosure - Segment information (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" xlink:label="loc_afyaScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsTables" xlink:title="999040 - Disclosure - Business combinations (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock" xlink:label="loc_afyaScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfAcquisitionOfUnidomExplanatory" xlink:label="loc_afyaScheduleOfAcquisitionOfUnidomExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfAcquisitionOfUnidomExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:title="999041 - Disclosure - Cash and cash equivalents (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureCashAndCashEquivalentsAbstract" xlink:label="loc_afyaDisclosureCashAndCashEquivalentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="loc_afyaDisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCashAndCashEquivalentsAbstract" xlink:to="loc_afyaDisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesTables" xlink:title="999042 - Disclosure - Trade receivables (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfTradeAndOtherReceivables1Explanatory" xlink:label="loc_afyaDisclosureOfTradeAndOtherReceivables1Explanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDisclosureOfTradeAndOtherReceivables1Explanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" xlink:label="loc_afyaDisclosureOfTradeAccountsReceivableByAgingExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDisclosureOfTradeAccountsReceivableByAgingExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory" xlink:label="loc_afyaDisclosureOfAllowanceForDoubtfulAccountsExplanatory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDisclosureOfAllowanceForDoubtfulAccountsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesTables" xlink:title="999043 - Disclosure - Related parties (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfRelatedPartiesExplanatory" xlink:label="loc_afyaDisclosureOfRelatedPartiesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDisclosureOfRelatedPartiesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" xlink:label="loc_afyaSummaryOfKeyManagementPersonnelCompensationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaSummaryOfKeyManagementPersonnelCompensationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsTables" xlink:title="999044 - Disclosure - Other assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOtherAssetsAbstract" xlink:label="loc_afyaDisclosureOtherAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfOtherAssetsTableTextBlock" xlink:label="loc_afyaDisclosureOfOtherAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaDisclosureOfOtherAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateTables" xlink:title="999045 - Disclosure - Investment in associate (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOfInvestmentsExplanatory" xlink:label="loc_afyaDisclosureOfInvestmentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDisclosureOfInvestmentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:title="999046 - Disclosure - Property and equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsTables" xlink:title="999047 - Disclosure - Intangible assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIntangibleAssetsAbstract" xlink:label="loc_afyaDisclosureIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfIntangibleAssetsTableTextBlock" xlink:label="loc_afyaSummaryOfIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAbstract" xlink:to="loc_afyaSummaryOfIntangibleAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" xlink:label="loc_afyaSummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAbstract" xlink:to="loc_afyaSummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SchuduleOfAssumptionsUsedTableTextBlock" xlink:label="loc_afyaSchuduleOfAssumptionsUsedTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAbstract" xlink:to="loc_afyaSchuduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables" xlink:title="999048 - Disclosure - Financial assets and liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFinancialAssetsTableTextBlock" xlink:label="loc_afyaScheduleOfFinancialAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfFinancialAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFinancialLiabilitiesTableTextBlock" xlink:label="loc_afyaScheduleOfFinancialLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfFinancialLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFairValuesTableTextBlock" xlink:label="loc_afyaScheduleOfFairValuesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfFairValuesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfLoansAndFinancingTableTextBlock" xlink:label="loc_afyaScheduleOfLoansAndFinancingTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfLoansAndFinancingTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfLeasesTableTextBlock" xlink:label="loc_afyaScheduleOfLeasesTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfLeasesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock" xlink:label="loc_afyaScheduleOfAccountsPayableToSellingShareholdersTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfAccountsPayableToSellingShareholdersTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholders1Explanatory" xlink:label="loc_afyaAccountsPayableToSellingShareholders1Explanatory" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaAccountsPayableToSellingShareholders1Explanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFairValuesFinancialInstrumentstTableTextBlock" xlink:label="loc_afyaScheduleOfFairValuesFinancialInstrumentstTableTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfFairValuesFinancialInstrumentstTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" xlink:label="loc_afyaSummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaSummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" xlink:label="loc_afyaSummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaSummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" xlink:label="loc_afyaSummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaSummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock" xlink:label="loc_afyaScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:title="999049 - Disclosure - Labor and social obligations (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFairValueOfStockOptionsGrantsExplanatory" xlink:label="loc_afyaScheduleOfFairValueOfStockOptionsGrantsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_afyaScheduleOfFairValueOfStockOptionsGrantsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfSharebasedCompensationPlanExplanatory" xlink:label="loc_afyaScheduleOfSharebasedCompensationPlanExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_afyaScheduleOfSharebasedCompensationPlanExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfGrantsRestrictedStockUnitsTableTextBlock" xlink:label="loc_afyaScheduleOfGrantsRestrictedStockUnitsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_afyaScheduleOfGrantsRestrictedStockUnitsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfStockOptionTableTextBlock" xlink:label="loc_afyaScheduleOfStockOptionTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_afyaScheduleOfStockOptionTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityTables" xlink:title="999050 - Disclosure - Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureEquityAbstract" xlink:label="loc_afyaDisclosureEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfTreasurySharesMovementExplanatory" xlink:label="loc_afyaScheduleOfTreasurySharesMovementExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaScheduleOfTreasurySharesMovementExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareTables" xlink:title="999051 - Disclosure - Earnings per share (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfEarningsPerShareTableExplanatory" xlink:label="loc_afyaScheduleOfEarningsPerShareTableExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfEarningsPerShareTableExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueTables" xlink:title="999052 - Disclosure - Revenue (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfNetSalesRevenueExplanatory" xlink:label="loc_afyaScheduleOfNetSalesRevenueExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfNetSalesRevenueExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfRevenueBySegmentTableTextBlock" xlink:label="loc_afyaScheduleOfRevenueBySegmentTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfRevenueBySegmentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CostsAndExpensesByNatureTables" xlink:title="999053 - Disclosure - Costs and expenses by nature (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfExpensesByNatureTableTextBlock" xlink:label="loc_afyaScheduleOfExpensesByNatureTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfExpensesByNatureTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultTables" xlink:title="999054 - Disclosure - Finance result (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfFinanceResultTableTextBlock" xlink:label="loc_afyaScheduleOfFinanceResultTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaScheduleOfFinanceResultTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesTables" xlink:title="999055 - Disclosure - Income taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIncomeTaxesAbstract" xlink:label="loc_afyaDisclosureIncomeTaxesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" xlink:label="loc_afyaScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_afyaScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingenciesTables" xlink:title="999056 - Disclosure - Legal proceedings and contingencies (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLegalProceedingsAndContingenciesAbstract" xlink:label="loc_afyaDisclosureLegalProceedingsAndContingenciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfLegalProceedingsAndContingenciesTableTextBlock" xlink:label="loc_afyaScheduleOfLegalProceedingsAndContingenciesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLegalProceedingsAndContingenciesAbstract" xlink:to="loc_afyaScheduleOfLegalProceedingsAndContingenciesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock" xlink:label="loc_afyaScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLegalProceedingsAndContingenciesAbstract" xlink:to="loc_afyaScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactionsTables" xlink:title="999057 - Disclosure - Non-cash transactions (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureNoncashTransactionsAbstract" xlink:label="loc_afyaDisclosureNoncashTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ScheduleOfNonCashTransactionsTableTextBlock" xlink:label="loc_afyaScheduleOfNonCashTransactionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureNoncashTransactionsAbstract" xlink:to="loc_afyaScheduleOfNonCashTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationDetails" xlink:title="999058 - Disclosure - Corporate information (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureCorporateInformationAbstract" xlink:label="loc_afyaDisclosureCorporateInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCorporateInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AfyaParticipacoesS.A.Member" xlink:label="loc_afyaAfyaParticipacoesS.A.Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaAfyaParticipacoesS.A.Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingAsOfAcquisitionDate" xlink:label="loc_afyaLoansAndFinancingAsOfAcquisitionDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:title="999059 - Disclosure - Corporate information (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureCorporateInformationAbstract" xlink:label="loc_afyaDisclosureCorporateInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCorporateInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-fullBusinessCombinationsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullBusinessCombinationsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FaculdadeMasterclassLtdaMember" xlink:label="loc_afyaFaculdadeMasterclassLtdaMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBusinessCombinationsDomain" xlink:to="loc_afyaFaculdadeMasterclassLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAcquiree" xlink:label="loc_ifrs-fullDescriptionOfAcquiree" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfAcquiree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionalPaymentToShareholder" xlink:label="loc_afyaAdditionalPaymentToShareholder" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalPaymentToShareholder" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails" xlink:title="999060 - Disclosure - Material accounting policies (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AfyaParticipacoesSAMember" xlink:label="loc_afyaAfyaParticipacoesSAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaAfyaParticipacoesSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" xlink:label="loc_afyaUniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUniaoEducacionalDoValeFoAcoS.A.UNIVACOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" xlink:label="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" xlink:label="loc_afyaCentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" xlink:label="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoS.A.FASAMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoS.A.FASAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember" xlink:label="loc_afyaInstitutoParaenseDeEducacaoECulturaLtda.IPECMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoParaenseDeEducacaoECulturaLtda.IPECMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember" xlink:label="loc_afyaSociedadeUniversitariaRedentorS.A.UniRedentorMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaSociedadeUniversitariaRedentorS.A.UniRedentorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CentroDeEnsinoSaoLucasLtda.UniSLMember" xlink:label="loc_afyaCentroDeEnsinoSaoLucasLtda.UniSLMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCentroDeEnsinoSaoLucasLtda.UniSLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" xlink:label="loc_afyaSociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaSociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" xlink:label="loc_afyaCentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" xlink:label="loc_afyaIClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaIClinicDesenvolvimentoDeSoftwareLtda.iClinicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicinaeSolutionsS.A.MedicinaeMember" xlink:label="loc_afyaMedicinaeSolutionsS.A.MedicinaeMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaMedicinaeSolutionsS.A.MedicinaeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaMedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember" xlink:label="loc_afyaCliquefarmaDrogariasOnlineLtda.CliquefarmaMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCliquefarmaDrogariasOnlineLtda.CliquefarmaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShospTecnologiaDaInformacaoLtda.ShospMember" xlink:label="loc_afyaShospTecnologiaDaInformacaoLtda.ShospMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaShospTecnologiaDaInformacaoLtda.ShospMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" xlink:label="loc_afyaSociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaSociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" xlink:label="loc_afyaCompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember" xlink:label="loc_afyaRXPROSolucoesDeTecnologiaLtda.RXPROMember" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaRXPROSolucoesDeTecnologiaLtda.RXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" xlink:label="loc_afyaQuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaQuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" xlink:label="loc_afyaSociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaSociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnidomParticipacoesS.A.UnidomMember" xlink:label="loc_afyaUnidomParticipacoesS.A.UnidomMember" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnidomParticipacoesS.A.UnidomMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" xlink:label="loc_afyaInstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstituicaoBaianadeEnsinoSuperiorLtdaIBESMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" xlink:label="loc_afyaSESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaSESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FaculdadeMasterclassLtdaFUNICMember" xlink:label="loc_afyaFaculdadeMasterclassLtdaFUNICMember" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFaculdadeMasterclassLtdaFUNICMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" xlink:label="loc_afyaUniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUniaoEducacionalDoPlanaltoCentralS.A.UEPCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PrincipalActivities" xlink:label="loc_afyaPrincipalActivities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPrincipalActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-fullPrincipalPlaceOfBusinessOfSubsidiary" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPrincipalPlaceOfBusinessOfSubsidiary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InvestmentType" xlink:label="loc_afyaInvestmentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInvestmentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails1" xlink:title="999061 - Disclosure - Material accounting policies (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel2OfFairValueHierarchyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" xlink:to="loc_ifrs-fullLevel2OfFairValueHierarchyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel3OfFairValueHierarchyMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyDomain" xlink:to="loc_ifrs-fullLevel3OfFairValueHierarchyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets" xlink:label="loc_ifrs-fullDescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets" xlink:label="loc_ifrs-fullDescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ExpectedCashFlows" xlink:label="loc_afyaExpectedCashFlows" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExpectedCashFlows" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProbabilityOfDisbursement" xlink:label="loc_afyaProbabilityOfDisbursement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProbabilityOfDisbursement" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails2" xlink:title="999062 - Disclosure - Material accounting policies (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis" xlink:label="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain" xlink:label="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementAxis" xlink:to="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FVTPLMember" xlink:label="loc_afyaFVTPLMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain" xlink:to="loc_afyaFVTPLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialAssetsAtAmortizedCostMember" xlink:label="loc_afyaFinancialAssetsAtAmortizedCostMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain" xlink:to="loc_afyaFinancialAssetsAtAmortizedCostMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FVOCIMember" xlink:label="loc_afyaFVOCIMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain" xlink:to="loc_afyaFVOCIMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FVOCI1Member" xlink:label="loc_afyaFVOCI1Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullValuationTechniquesUsedInFairValueMeasurementDomain" xlink:to="loc_afyaFVOCI1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-fullExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails3" xlink:title="999063 - Disclosure - Material accounting policies (Details 3)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-fullBuildingsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullBuildingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="loc_afyaMachineryAndEquipmentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_afyaMachineryAndEquipmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-fullVehiclesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullFixturesAndFittingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ItEquipmentMember" xlink:label="loc_afyaItEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_afyaItEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LibraryBooksMember" xlink:label="loc_afyaLibraryBooksMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_afyaLibraryBooksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-fullLeaseholdImprovementsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails4" xlink:title="999064 - Disclosure - Material accounting policies (Details 4)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:label="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:to="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:label="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:to="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CustomerRelationshipsOtherCoursesMember" xlink:label="loc_afyaCustomerRelationshipsOtherCoursesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:to="loc_afyaCustomerRelationshipsOtherCoursesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-fullComputerSoftwareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:to="loc_ifrs-fullComputerSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember" xlink:label="loc_afyaEducationContentDevelopedTechnologyAndEducationalPlatformMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:to="loc_afyaEducationContentDevelopedTechnologyAndEducationalPlatformMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetails5" xlink:title="999065 - Disclosure - Material accounting policies (Details 5)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsAxis" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsDomain" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsAxis" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AmendmentsToIAS21Member" xlink:label="loc_afyaAmendmentsToIAS21Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaAmendmentsToIAS21Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LackOfExchangeabilityAmendmentsToIAS21Member" xlink:label="loc_afyaLackOfExchangeabilityAmendmentsToIAS21Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaLackOfExchangeabilityAmendmentsToIAS21Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member" xlink:label="loc_afyaClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AnnualImprovementsToIFRSAccountingStandardsVolume11Member" xlink:label="loc_afyaAnnualImprovementsToIFRSAccountingStandardsVolume11Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaAnnualImprovementsToIFRSAccountingStandardsVolume11Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member" xlink:label="loc_afyaPowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaPowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IFRS18PresentationAndDisclosureInFinancialStatementsMember" xlink:label="loc_afyaIFRS18PresentationAndDisclosureInFinancialStatementsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaIFRS18PresentationAndDisclosureInFinancialStatementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:label="loc_ifrs-fullTitleOfInitiallyAppliedIFRS" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTitleOfInitiallyAppliedIFRS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:label="loc_ifrs-fullDescriptionOfNatureOfChangeInAccountingPolicy" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfNatureOfChangeInAccountingPolicy" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative" xlink:title="999066 - Disclosure - Material accounting policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureMaterialAccountingPoliciesAbstract" xlink:label="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureMaterialAccountingPoliciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProgramOfSocialIntegrationMember" xlink:label="loc_afyaProgramOfSocialIntegrationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="loc_afyaProgramOfSocialIntegrationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:label="loc_afyaContributionForTheFinancingOfSocialSecurityMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="loc_afyaContributionForTheFinancingOfSocialSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-fullProductsAndServicesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="loc_ifrs-fullProductsAndServicesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-fullProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProductsAndServicesAxis" xlink:to="loc_ifrs-fullProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TeachingActivitiesMember" xlink:label="loc_afyaTeachingActivitiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProductsAndServicesDomain" xlink:to="loc_afyaTeachingActivitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NonTeachingActivitiesMember" xlink:label="loc_afyaNonTeachingActivitiesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProductsAndServicesDomain" xlink:to="loc_afyaNonTeachingActivitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsAxis" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsDomain" xlink:label="loc_ifrs-fullInitiallyAppliedIFRSsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsAxis" xlink:to="loc_ifrs-fullInitiallyAppliedIFRSsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OrganizationForEconomicCooperationAndDevelopmentMember" xlink:label="loc_afyaOrganizationForEconomicCooperationAndDevelopmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInitiallyAppliedIFRSsDomain" xlink:to="loc_afyaOrganizationForEconomicCooperationAndDevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-fullApplicableTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullApplicableTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="loc_ifrs-fullAverageEffectiveTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAverageEffectiveTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConsolidatedRevenues" xlink:label="loc_afyaConsolidatedRevenues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsolidatedRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MinimumTaxRate" xlink:label="loc_afyaMinimumTaxRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaMinimumTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationDetails" xlink:title="999067 - Disclosure - Segment information (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-fullSegmentConsolidationItemsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentConsolidationItemsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain" xlink:label="loc_ifrs-fullSegmentConsolidationItemsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullSegmentConsolidationItemsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-fullOperatingSegmentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentConsolidationItemsDomain" xlink:to="loc_ifrs-fullOperatingSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-fullSegmentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UndergraduateMember" xlink:label="loc_afyaUndergraduateMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaUndergraduateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaContinuingEducationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicalPracticeSolutionsMember" xlink:label="loc_afyaMedicalPracticeSolutionsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaMedicalPracticeSolutionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TotalReportableSegmentsMember" xlink:label="loc_afyaTotalReportableSegmentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaTotalReportableSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EliminationInterSegmentBalancesMember" xlink:label="loc_afyaEliminationInterSegmentBalancesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaEliminationInterSegmentBalancesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquityAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CapitalExpenditures" xlink:label="loc_afyaCapitalExpenditures" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalExpenditures" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationDetails1" xlink:title="999068 - Disclosure - Segment information (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-fullSegmentConsolidationItemsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentConsolidationItemsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain" xlink:label="loc_ifrs-fullSegmentConsolidationItemsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullSegmentConsolidationItemsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-fullOperatingSegmentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentConsolidationItemsDomain" xlink:to="loc_ifrs-fullOperatingSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-fullSegmentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UndergraduateMember" xlink:label="loc_afyaUndergraduateMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaUndergraduateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaContinuingEducationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicalPracticeSolutionsMember" xlink:label="loc_afyaMedicalPracticeSolutionsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaMedicalPracticeSolutionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TotalReportableSegmentsMember" xlink:label="loc_afyaTotalReportableSegmentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaTotalReportableSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="loc_afyaAdjustmentsAndEliminationsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaAdjustmentsAndEliminationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DepositsFromExternalCustomer" xlink:label="loc_afyaDepositsFromExternalCustomer" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDepositsFromExternalCustomer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InterSegment" xlink:label="loc_afyaInterSegment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInterSegment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CostOfSale" xlink:label="loc_afyaCostOfSale" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCostOfSale" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-fullGrossProfit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullSellingGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForExpectedCreditLosses" xlink:label="loc_afyaAllowanceForExpectedCreditLosses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAllowanceForExpectedCreditLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-fullOtherIncome" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherGainsLosses" xlink:label="loc_ifrs-fullOtherGainsLosses" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherGainsLosses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinanceExpense" xlink:label="loc_afyaFinanceExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinanceExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-fullAdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails" xlink:title="999069 - Disclosure - Business combinations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnidomMember" xlink:label="loc_afyaUnidomMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnidomMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="loc_afyaTradeReceivablesAsOfAcquisitionDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdvancesRecognisedAsOfAcquisitionDate" xlink:label="loc_afyaAdvancesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdvancesRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RecoverableTaxesAsOfAcquisitionDate" xlink:label="loc_afyaRecoverableTaxesAsOfAcquisitionDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRecoverableTaxesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="loc_afyaOtherAssetsAsOfAcquisitionDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IndemnificationAssetsAsOfAcquisitionDate" xlink:label="loc_afyaIndemnificationAssetsAsOfAcquisitionDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIndemnificationAssetsAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_afyaRightOfUseAssetsAsOfAcquisitionDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRightOfUseAssetsAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingAsOfAcquisitionDate" xlink:label="loc_afyaLoansAndFinancingAsOfAcquisitionDate" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="loc_afyaTaxesPayableAsOfAcquisitionDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTaxesPayableAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherTaxesPayableAsOfAcquisitionDate" xlink:label="loc_afyaOtherTaxesPayableAsOfAcquisitionDate" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherTaxesPayableAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:label="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaOtherLiabilitiesAsOfAcquisitionDate" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherLiabilitiesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-fullCashTransferred" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConsiderationToBeTransferred" xlink:label="loc_afyaConsiderationToBeTransferred" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsiderationToBeTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="loc_afyaNetOfCashFlowOnAcquisition" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetOfCashFlowOnAcquisition" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetails1" xlink:title="999070 - Disclosure - Business combinations (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LicencesAndFranchisesMember" xlink:label="loc_ifrs-fullLicencesAndFranchisesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_ifrs-fullLicencesAndFranchisesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AcquisitionOfUnidomMember" xlink:label="loc_afyaAcquisitionOfUnidomMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaAcquisitionOfUnidomMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MethodOfAssessmentOfExpectedCreditLossesDomain" xlink:label="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesAxis" xlink:to="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WithAndWithoutMethodMember" xlink:label="loc_afyaWithAndWithoutMethodMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesDomain" xlink:to="loc_afyaWithAndWithoutMethodMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MultiperiodExcessEarningsMethodMember" xlink:label="loc_ifrs-fullMultiperiodExcessEarningsMethodMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMethodOfAssessmentOfExpectedCreditLossesDomain" xlink:to="loc_ifrs-fullMultiperiodExcessEarningsMethodMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:title="999071 - Disclosure - Business combinations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-fullBusinessCombinationsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullBusinessCombinationsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AcquisitionOfUnidomMember" xlink:label="loc_afyaAcquisitionOfUnidomMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBusinessCombinationsDomain" xlink:to="loc_afyaAcquisitionOfUnidomMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAcquiree" xlink:label="loc_ifrs-fullDescriptionOfAcquiree" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfAcquiree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination" xlink:label="loc_afyaAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseInRevenue" xlink:label="loc_afyaIncreaseInRevenue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseInRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseInIncomeBeforeIncomeTaxes" xlink:label="loc_afyaIncreaseInIncomeBeforeIncomeTaxes" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseInIncomeBeforeIncomeTaxes" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetails" xlink:title="999072 - Disclosure - Cash and cash equivalents (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureCashAndCashEquivalentsAbstract" xlink:label="loc_afyaDisclosureCashAndCashEquivalentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-fullCash" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCashAndCashEquivalentsAbstract" xlink:to="loc_ifrs-fullCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashEquivalents" xlink:label="loc_ifrs-fullCashEquivalents" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCashAndCashEquivalentsAbstract" xlink:to="loc_ifrs-fullCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCashAndCashEquivalentsAbstract" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:title="999073 - Disclosure - Cash and cash equivalents (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureCashAndCashEquivalentsAbstract" xlink:label="loc_afyaDisclosureCashAndCashEquivalentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCashAndCashEquivalentsAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_BankCertificatesOfDepositMember" xlink:label="loc_afyaBankCertificatesOfDepositMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaBankCertificatesOfDepositMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyInWhichInformationIsDisplayedAxis" xlink:label="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember" xlink:label="loc_ifrs-fullFunctionalOrPresentationCurrencyMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" xlink:to="loc_ifrs-fullFunctionalOrPresentationCurrencyMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_USDMember" xlink:label="loc_afyaUSDMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFunctionalOrPresentationCurrencyMember" xlink:to="loc_afyaUSDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PercenatgeOfAverageInterestOnFinancialInstrument" xlink:label="loc_afyaPercenatgeOfAverageInterestOnFinancialInstrument" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPercenatgeOfAverageInterestOnFinancialInstrument" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashEquivalents" xlink:label="loc_ifrs-fullCashEquivalents" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashEquivalents" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails" xlink:title="999074 - Disclosure - Trade receivables (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TuitionFeesMember" xlink:label="loc_afyaTuitionFeesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaTuitionFeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationalContentMember" xlink:label="loc_afyaEducationalContentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaEducationalContentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FIESMember" xlink:label="loc_afyaFIESMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaFIESMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationalCreditsMember" xlink:label="loc_afyaEducationalCreditsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaEducationalCreditsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MobileAppSubscriptionMember" xlink:label="loc_afyaMobileAppSubscriptionMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaMobileAppSubscriptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OthersMember" xlink:label="loc_afyaOthersMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaOthersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ReceivablesGross" xlink:label="loc_afyaReceivablesGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReceivablesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:label="loc_afyaAllowanceForDoubtfulAccountsFoReceivable1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAllowanceForDoubtfulAccountsFoReceivable1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentTradeReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="loc_ifrs-fullNoncurrentTradeReceivables" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentTradeReceivables" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails1" xlink:title="999075 - Disclosure - Trade receivables (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullImpairmentOfFinancialAssetsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullImpairmentOfFinancialAssetsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" xlink:label="loc_ifrs-fullFinancialAssetsNeitherPastDueNorImpairedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullImpairmentOfFinancialAssetsDomain" xlink:to="loc_ifrs-fullFinancialAssetsNeitherPastDueNorImpairedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusAxis" xlink:label="loc_ifrs-fullPastDueStatusAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_ifrs-fullPastDueStatusAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusDomain" xlink:label="loc_ifrs-fullPastDueStatusDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusAxis" xlink:to="loc_ifrs-fullPastDueStatusDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="loc_ifrs-fullNotLaterThanOneMonthMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusDomain" xlink:to="loc_ifrs-fullNotLaterThanOneMonthMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:label="loc_afyaLaterThanOneMonthsAndNotLaterThanThreeMonthsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusDomain" xlink:to="loc_afyaLaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="loc_ifrs-fullLaterThanThreeMonthsAndNotLaterThanSixMonthsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusDomain" xlink:to="loc_ifrs-fullLaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanSixMonthsMember" xlink:label="loc_ifrs-fullLaterThanSixMonthsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusDomain" xlink:to="loc_ifrs-fullLaterThanSixMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ReceivablesGross" xlink:label="loc_afyaReceivablesGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReceivablesGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesDetails2" xlink:title="999076 - Disclosure - Trade receivables (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceAccountForCreditLossesOfFinancialAsset" xlink:label="loc_afyaAllowanceAccountForCreditLossesOfFinancialAsset" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaAllowanceAccountForCreditLossesOfFinancialAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" xlink:label="loc_afyaAdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaAdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" xlink:label="loc_afyaWriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaWriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceAccountForCreditLossesOfFinancialAsset" xlink:label="loc_afyaAllowanceAccountForCreditLossesOfFinancialAsset_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaAllowanceAccountForCreditLossesOfFinancialAsset_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetails" xlink:title="999077 - Disclosure - Related parties (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UEPCMember" xlink:label="loc_afyaUEPCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaUEPCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EMIVEPatrulha24HorasLtdaMember" xlink:label="loc_afyaEMIVEPatrulha24HorasLtdaMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaEMIVEPatrulha24HorasLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DepreciationRightofuseAssetsMember" xlink:label="loc_afyaDepreciationRightofuseAssetsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaDepreciationRightofuseAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesInterestMember" xlink:label="loc_afyaLeaseLiabilitiesInterestMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaLeaseLiabilitiesInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsRelatedPartyTransactions" xlink:label="loc_afyaRightofuseAssetsRelatedPartyTransactions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRightofuseAssetsRelatedPartyTransactions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TradeReceivablesRelatedPartyTransactions" xlink:label="loc_afyaTradeReceivablesRelatedPartyTransactions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesRelatedPartyTransactions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherAssetsRelatedPartyTransactions" xlink:label="loc_afyaOtherAssetsRelatedPartyTransactions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsRelatedPartyTransactions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:label="loc_afyaTradeAndOtherCurrentPayablesToRelatedParties1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherCurrentPayablesToRelatedParties1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrentAssetsOfRelatedParty1" xlink:label="loc_afyaNoncurrentAssetsOfRelatedParty1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNoncurrentAssetsOfRelatedParty1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesRelatedPartyTransactions" xlink:label="loc_afyaLeaseLiabilitiesRelatedPartyTransactions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilitiesRelatedPartyTransactions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsPayableRelatedPartyTransactions" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmountsPayableRelatedPartyTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TradeAndOtherCurrentPayableToRelatedParties" xlink:label="loc_afyaTradeAndOtherCurrentPayableToRelatedParties" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherCurrentPayableToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrenLliabilitiesOfRelatedParty1" xlink:label="loc_afyaNoncurrenLliabilitiesOfRelatedParty1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNoncurrenLliabilitiesOfRelatedParty1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherIncomeRelatedPartyTransactions" xlink:label="loc_afyaOtherIncomeRelatedPartyTransactions" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherIncomeRelatedPartyTransactions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetails1" xlink:title="999078 - Disclosure - Related parties (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensationShorttermEmployeeBenefits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:label="loc_ifrs-fullAmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:title="999079 - Disclosure - Related parties (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements1Member" xlink:label="loc_afyaLeaseAgreements1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaLeaseAgreements1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements2Member" xlink:label="loc_afyaLeaseAgreements2Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaLeaseAgreements2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements3Member" xlink:label="loc_afyaLeaseAgreements3Member" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaLeaseAgreements3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements4Member" xlink:label="loc_afyaLeaseAgreements4Member" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaLeaseAgreements4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseAgreements5Member" xlink:label="loc_afyaLeaseAgreements5Member" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaLeaseAgreements5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:label="loc_afyaInstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="loc_afyaRVLEstevesGestaoImobiliariaSAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaRVLEstevesGestaoImobiliariaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="loc_afyaUNIVACOPatrimonialLtdaMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaUNIVACOPatrimonialLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="loc_afyaIESVAPPatrimonialLtdaMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaIESVAPPatrimonialLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OperatingLeaseTermOfContract" xlink:label="loc_afyaOperatingLeaseTermOfContract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOperatingLeaseTermOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RelatedPartiesAmountPaid" xlink:label="loc_afyaRelatedPartiesAmountPaid" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRelatedPartiesAmountPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-fullPercentageOfEntitysRevenue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfEntitysRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DescriptionOfLeaseTerm" xlink:label="loc_afyaDescriptionOfLeaseTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDescriptionOfLeaseTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-fullCashOutflowForLeases" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashOutflowForLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LesseeFinancesLeaseRenewalTerm" xlink:label="loc_afyaLesseeFinancesLeaseRenewalTerm" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLesseeFinancesLeaseRenewalTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DescriptionOfLeaseTerms" xlink:label="loc_afyaDescriptionOfLeaseTerms" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDescriptionOfLeaseTerms" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsDetails" xlink:title="999080 - Disclosure - Other assets (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureOtherAssetsAbstract" xlink:label="loc_afyaDisclosureOtherAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Advances1" xlink:label="loc_afyaAdvances1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaAdvances1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_JudicialDeposits" xlink:label="loc_afyaJudicialDeposits" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaJudicialDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-fullCurrentPrepaidExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_ifrs-fullCurrentPrepaidExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-fullOtherReceivables" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_ifrs-fullOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConvertibleLoansFromVentureCapitalInvestments" xlink:label="loc_afyaConvertibleLoansFromVentureCapitalInvestments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaConvertibleLoansFromVentureCapitalInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Dividend" xlink:label="loc_afyaDividend" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherAssets1" xlink:label="loc_afyaOtherAssets1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaOtherAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Assets1" xlink:label="loc_afyaAssets1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CurrentAssets1" xlink:label="loc_afyaCurrentAssets1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaCurrentAssets1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NoncurrentAssets1" xlink:label="loc_afyaNoncurrentAssets1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureOtherAssetsAbstract" xlink:to="loc_afyaNoncurrentAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateDetails" xlink:title="999081 - Disclosure - Investment in associate (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssociatesMember" xlink:label="loc_ifrs-fullAssociatesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_ifrs-fullAssociatesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EquityInAssociate" xlink:label="loc_afyaEquityInAssociate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEquityInAssociate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CompanyShareInEquity1" xlink:label="loc_afyaCompanyShareInEquity1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompanyShareInEquity1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-fullGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InvestmentGrossAmount" xlink:label="loc_afyaInvestmentGrossAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInvestmentGrossAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullSellingGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForExpectedCreditLosses" xlink:label="loc_afyaAllowanceForExpectedCreditLosses" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAllowanceForExpectedCreditLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-fullOtherIncome" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherExpense" xlink:label="loc_afyaOtherExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CompanyShareOfProfitss" xlink:label="loc_afyaCompanyShareOfProfitss" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompanyShareOfProfitss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="loc_ifrs-fullProfitLossOfAcquiree" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossOfAcquiree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendsReceived1" xlink:label="loc_afyaDividendsReceived1" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendsReceived1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsReceived" xlink:label="loc_ifrs-fullDividendsReceived" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsReceived" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates_2" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentDetails" xlink:title="999082 - Disclosure - Property and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" />
      <link:presentationArc order="710" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-fullBuildingsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullBuildingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="loc_afyaMachineryAndEquipmentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_afyaMachineryAndEquipmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-fullLandMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullLandMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-fullVehiclesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullFixturesAndFittingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ItEquipmentMember" xlink:label="loc_afyaItEquipmentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_afyaItEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LibraryBooksMember" xlink:label="loc_afyaLibraryBooksMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_afyaLibraryBooksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-fullLeaseholdImprovementsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-fullConstructionInProgressMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentDomain" xlink:to="loc_ifrs-fullConstructionInProgressMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PropertyPlantAndEquipments" xlink:label="loc_afyaPropertyPlantAndEquipments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPropertyPlantAndEquipments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WritOffOfPropertyPlantAndEquipment" xlink:label="loc_afyaWritOffOfPropertyPlantAndEquipment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWritOffOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PropertyPlantAndEquipments" xlink:label="loc_afyaPropertyPlantAndEquipments_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPropertyPlantAndEquipments_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDepreciationPropertyPlantAndEquipment" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDepreciationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PropertyPlantAndEquipmentNetBookValue" xlink:label="loc_afyaPropertyPlantAndEquipmentNetBookValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPropertyPlantAndEquipmentNetBookValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsDetails" xlink:title="999083 - Disclosure - Intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIntangibleAssetsAbstract" xlink:label="loc_afyaDisclosureIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAbstract" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-fullGoodwillMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullGoodwillMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-fullLicencesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullLicencesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-fullComputerSoftwareMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullComputerSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationContentMember" xlink:label="loc_afyaEducationContentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaEducationContentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EducationalPlatformMember" xlink:label="loc_afyaEducationalPlatformMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaEducationalPlatformMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IntangibleInProgressMember" xlink:label="loc_afyaIntangibleInProgressMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaIntangibleInProgressMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherMember" xlink:label="loc_afyaOtherMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SoftwareInProgressMember" xlink:label="loc_afyaSoftwareInProgressMember" />
      <link:presentationArc order="1560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaSoftwareInProgressMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" />
      <link:presentationArc order="710" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WriteoffOfIntangibleAssets" xlink:label="loc_afyaWriteoffOfIntangibleAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWriteoffOfIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Remesurement" xlink:label="loc_afyaRemesurement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemesurement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Transfer" xlink:label="loc_afyaTransfer" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTransfer" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwill_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwill_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IntangibleAssetsAndGoodwillNetBookValue" xlink:label="loc_afyaIntangibleAssetsAndGoodwillNetBookValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIntangibleAssetsAndGoodwillNetBookValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsDetails1" xlink:title="999084 - Disclosure - Intangible assets (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIntangibleAssetsAbstract" xlink:label="loc_afyaDisclosureIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAbstract" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CarryingAmountsMember" xlink:label="loc_afyaCarryingAmountsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_afyaCarryingAmountsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:label="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:label="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:label="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUniRedentorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUniSLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FESARMember" xlink:label="loc_afyaFESARMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFESARMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFCMPBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ITPACGaranhunsMember" xlink:label="loc_afyaITPACGaranhunsMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaITPACGaranhunsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaContinuingEducationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicalPracticeSolutionsMember" xlink:label="loc_afyaMedicalPracticeSolutionsMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaMedicalPracticeSolutionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnifipMocMember" xlink:label="loc_afyaUnifipMocMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnifipMocMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnigranrioMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaDelReyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnidomMember" xlink:label="loc_afyaUnidomMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnidomMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FUNICMember" xlink:label="loc_afyaFUNICMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFUNICMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-fullGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CashGeneratingUnits" xlink:label="loc_afyaCashGeneratingUnits" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCashGeneratingUnits" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsDetails2" xlink:title="999085 - Disclosure - Intangible assets (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIntangibleAssetsAbstract" xlink:label="loc_afyaDisclosureIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAbstract" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DiscountRatesMember" xlink:label="loc_afyaDiscountRatesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaDiscountRatesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PerpetuityGrowthRateMember" xlink:label="loc_afyaPerpetuityGrowthRateMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaPerpetuityGrowthRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EBITDAMember" xlink:label="loc_afyaEBITDAMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_afyaEBITDAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfDiscountRatesAppliedToCashFlowProjections" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PerpetuityGrowthRate" xlink:label="loc_afyaPerpetuityGrowthRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPerpetuityGrowthRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EbitdaGrowthRates" xlink:label="loc_afyaEbitdaGrowthRates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEbitdaGrowthRates" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsDetailsNarrative" xlink:title="999086 - Disclosure - Intangible assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIntangibleAssetsAbstract" xlink:label="loc_afyaDisclosureIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIntangibleAssetsAbstract" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-fullGoodwillMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="loc_ifrs-fullGoodwillMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails" xlink:title="999087 - Disclosure - Financial assets and liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="loc_ifrs-fullFinancialAssetsAtAmortisedCostMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_ifrs-fullFinancialAssetsAtAmortisedCostMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAssets" xlink:label="loc_ifrs-fullOtherAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendReceivable" xlink:label="loc_afyaDividendReceivable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialAssets" xlink:label="loc_ifrs-fullCurrentFinancialAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="loc_ifrs-fullNoncurrentFinancialAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1" xlink:title="999088 - Disclosure - Financial assets and liabilities (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtAmortisedCostMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtAmortisedCostMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPayable" xlink:label="loc_ifrs-fullDividendsPayable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentFinancialLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2" xlink:title="999089 - Disclosure - Financial assets and liabilities (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersEarnOutsMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersEarnOutsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaAccountsPayableToSellingShareholdersEarnOutsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersUnidomMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersUnidomMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaAccountsPayableToSellingShareholdersUnidomMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialLiabilitiesAtFairValues" xlink:label="loc_afyaFinancialLiabilitiesAtFairValues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialLiabilitiesAtFairValues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-fullCurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3" xlink:title="999090 - Disclosure - Financial assets and liabilities (Details 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-fullMaturityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullMaturityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OctoberTwentyTwentyFiveMember" xlink:label="loc_afyaOctoberTwentyTwentyFiveMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaOctoberTwentyTwentyFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_JulyTwentyTwentySevenMember" xlink:label="loc_afyaJulyTwentyTwentySevenMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaJulyTwentyTwentySevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AprilTwentyTwentySixMember" xlink:label="loc_afyaAprilTwentyTwentySixMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaAprilTwentyTwentySixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_JanuaryTwentyTwentyEightMember" xlink:label="loc_afyaJanuaryTwentyTwentyEightMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaJanuaryTwentyTwentyEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AprilTwentyThirtyMember" xlink:label="loc_afyaAprilTwentyThirtyMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaAprilTwentyThirtyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OctoberTwentyTwentyEightMember" xlink:label="loc_afyaOctoberTwentyTwentyEightMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaOctoberTwentyTwentyEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OctoberTwentyThirtyMember" xlink:label="loc_afyaOctoberTwentyThirtyMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_afyaOctoberTwentyThirtyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialInstitution" xlink:label="loc_afyaFinancialInstitution" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialInstitution" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-fullBorrowingsInterestRateBasis" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsInterestRateBasis" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-fullBorrowingsMaturity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsMaturity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingCurrent" xlink:label="loc_afyaLoansAndFinancingCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingNonCurrent" xlink:label="loc_afyaLoansAndFinancingNonCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingNonCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4" xlink:title="999091 - Disclosure - Financial assets and liabilities  (Details 4)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullRightofuseAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-fullAdditionsToRightofuseAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAdditionsToRightofuseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsToLeaseLiabilities" xlink:label="loc_afyaAdditionsToLeaseLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaAdditionsToLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsRemeasurement" xlink:label="loc_afyaRightofuseAssetsRemeasurement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsRemeasurement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesRemeasurement" xlink:label="loc_afyaLeaseLiabilitiesRemeasurement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaLeaseLiabilitiesRemeasurement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsBusinessCombinations" xlink:label="loc_afyaRightofuseAssetsBusinessCombinations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsBusinessCombinations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_BusinessCombinationsLeaseLiabilities" xlink:label="loc_afyaBusinessCombinationsLeaseLiabilities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaBusinessCombinationsLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-fullDepreciationRightofuseAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDepreciationRightofuseAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DepreciationExpenseLeaseLiabilities" xlink:label="loc_afyaDepreciationExpenseLeaseLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDepreciationExpenseLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsInterestExpense" xlink:label="loc_afyaRightofuseAssetsInterestExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsPaymentsOfPrincipal" xlink:label="loc_afyaRightofuseAssetsPaymentsOfPrincipal" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsPaymentsOfPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesPaymentsOfPrincipal" xlink:label="loc_afyaLeaseLiabilitiesPaymentsOfPrincipal" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaLeaseLiabilitiesPaymentsOfPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsPaymentsOfInterest" xlink:label="loc_afyaRightofuseAssetsPaymentsOfInterest" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsPaymentsOfInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentsOfInterestLeaseLiabilities" xlink:label="loc_afyaPaymentsOfInterestLeaseLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaPaymentsOfInterestLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsWriteoff" xlink:label="loc_afyaRightofuseAssetsWriteoff" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsWriteoff" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiabilitiesWriteoff" xlink:label="loc_afyaLeaseLiabilitiesWriteoff" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaLeaseLiabilitiesWriteoff" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullRightofuseAssets_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullLeaseLiabilities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsCurrent" xlink:label="loc_afyaRightofuseAssetsCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAssetsNonCurrent" xlink:label="loc_afyaRightofuseAssetsNonCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaRightofuseAssetsNonCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5" xlink:title="999092 - Disclosure - Financial assets and liabilities (Details 5)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnigranrioMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaDelReyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FUNICMember" xlink:label="loc_afyaFUNICMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFUNICMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaShospMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaAlemDaMedicinaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CardiPapersMember" xlink:label="loc_afyaCardiPapersMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCardiPapersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnidomMember" xlink:label="loc_afyaUnidomMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnidomMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableAamortizedCostInterestRateBasis" xlink:label="loc_afyaAccountsPayableAamortizedCostInterestRateBasis" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableAamortizedCostInterestRateBasis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersCurrent" xlink:label="loc_afyaAccountsPayableToSellingShareholdersCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:label="loc_afyaAccountsPayableToSellingShareholdersNonCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersNonCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6" xlink:title="999093 - Disclosure - Financial assets and liabilities (Details 6)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaAccountsPayableToSellingShareholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:label="loc_afyaAccountsPayableToSellingShareholdersBusinessCombinations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersBusinessCombinations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentsOfPrincipal" xlink:label="loc_afyaPaymentsOfPrincipal" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPaymentsOfPrincipal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpense" xlink:label="loc_ifrs-fullInterestExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RemeasurementOfEarnouts" xlink:label="loc_afyaRemeasurementOfEarnouts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemeasurementOfEarnouts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7" xlink:title="999094 - Disclosure - Financial assets and liabilities (Details 7)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaLoansAndFinancingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8" xlink:title="999095 - Disclosure - Financial assets and liabilities (Details 8)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CashEquivalents1Member" xlink:label="loc_afyaCashEquivalents1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsDomain" xlink:to="loc_afyaCashEquivalents1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="loc_ifrs-fullTypesOfInterestRatesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullTypesOfInterestRatesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain" xlink:label="loc_ifrs-fullTypesOfInterestRatesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfInterestRatesAxis" xlink:to="loc_ifrs-fullTypesOfInterestRatesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FloatingInterestRateMember" xlink:label="loc_ifrs-fullFloatingInterestRateMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfInterestRatesDomain" xlink:to="loc_ifrs-fullFloatingInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestRateRiskMember" xlink:label="loc_ifrs-fullInterestRateRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksDomain" xlink:to="loc_ifrs-fullInterestRateRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaLoansAndFinancingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingOneMember" xlink:label="loc_afyaLoansAndFinancingOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaLoansAndFinancingOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersOneMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersOneMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaAccountsPayableToSellingShareholdersOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AccountsPayableToSellingShareholdersTwoMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersTwoMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaAccountsPayableToSellingShareholdersTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CashEquivalents1Member" xlink:label="loc_afyaCashEquivalents1Member_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesDomain" xlink:to="loc_afyaCashEquivalents1Member_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProbabilityOfDefaultAxis" xlink:label="loc_ifrs-fullProbabilityOfDefaultAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullProbabilityOfDefaultAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProbabilityOfDefaultDomain" xlink:label="loc_ifrs-fullProbabilityOfDefaultDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProbabilityOfDefaultAxis" xlink:to="loc_ifrs-fullProbabilityOfDefaultDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseBasisPointsMember" xlink:label="loc_afyaIncreaseBasisPointsMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProbabilityOfDefaultDomain" xlink:to="loc_afyaIncreaseBasisPointsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseBasisPointsOneMember" xlink:label="loc_afyaIncreaseBasisPointsOneMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProbabilityOfDefaultDomain" xlink:to="loc_afyaIncreaseBasisPointsOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IndexRatePerYear" xlink:label="loc_afyaIndexRatePerYear" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIndexRatePerYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_BaseRate" xlink:label="loc_afyaBaseRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaBaseRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9" xlink:title="999096 - Disclosure - Financial assets and liabilities (Details 9)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:label="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RiskExposuresAxis" xlink:label="loc_ifrs-fullRiskExposuresAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:to="loc_ifrs-fullRiskExposuresAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RiskExposuresDomain" xlink:label="loc_ifrs-fullRiskExposuresDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRiskExposuresAxis" xlink:to="loc_ifrs-fullRiskExposuresDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ForeignCurrencyExposuresMember" xlink:label="loc_afyaForeignCurrencyExposuresMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRiskExposuresDomain" xlink:to="loc_afyaForeignCurrencyExposuresMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseForeignCurrencyMember" xlink:label="loc_afyaIncreaseForeignCurrencyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRiskExposuresDomain" xlink:to="loc_afyaIncreaseForeignCurrencyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DecreaseForeignCurrencyMember" xlink:label="loc_afyaDecreaseForeignCurrencyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRiskExposuresDomain" xlink:to="loc_afyaDecreaseForeignCurrencyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-fullCurrencyRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksDomain" xlink:to="loc_ifrs-fullCurrencyRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10" xlink:title="999097 - Disclosure - Financial assets and liabilities (Details 10)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-fullMaturityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullMaturityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-fullLaterThanOneYearMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanOneYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanThreeYearsAndNotLaterThanFiveYearsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanFiveYearsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityDomain" xlink:to="loc_ifrs-fullLaterThanFiveYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-fullLiquidityRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksDomain" xlink:to="loc_ifrs-fullLiquidityRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialLiabilitiesContractualUndiscounted" xlink:label="loc_afyaFinancialLiabilitiesContractualUndiscounted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialLiabilitiesContractualUndiscounted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11" xlink:title="999098 - Disclosure - Financial assets and liabilities (Details 11)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="loc_afyaLoansAndFinancingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-fullLeaseLiabilitiesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="loc_ifrs-fullLeaseLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendsPayableMember" xlink:label="loc_afyaDividendsPayableMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="loc_afyaDividendsPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestPaidClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:label="loc_afyaIncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative" xlink:title="999099 - Disclosure - Financial assets and liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InternationalFinanceCorporationMember" xlink:label="loc_afyaInternationalFinanceCorporationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaInternationalFinanceCorporationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TwoSeriesMember" xlink:label="loc_afyaTwoSeriesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaTwoSeriesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FirstSeriesMember" xlink:label="loc_afyaFirstSeriesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaFirstSeriesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SecondSeriesMember" xlink:label="loc_afyaSecondSeriesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesDomain" xlink:to="loc_afyaSecondSeriesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnigranrioMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DelReyMember" xlink:label="loc_afyaDelReyMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaDelReyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FUNICMember" xlink:label="loc_afyaFUNICMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaFUNICMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaShospMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AlemDaMedicinaMember" xlink:label="loc_afyaAlemDaMedicinaMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaAlemDaMedicinaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CardioPapersMember" xlink:label="loc_afyaCardioPapersMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaCardioPapersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnidomMember" xlink:label="loc_afyaUnidomMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesDomain" xlink:to="loc_afyaUnidomMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-fullCurrencyRiskMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksDomain" xlink:to="loc_ifrs-fullCurrencyRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrencyInWhichInformationIsDisplayedAxis" xlink:label="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember" xlink:label="loc_ifrs-fullFunctionalOrPresentationCurrencyMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrencyInWhichInformationIsDisplayedAxis" xlink:to="loc_ifrs-fullFunctionalOrPresentationCurrencyMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR" xlink:label="loc_currencyEUR" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFunctionalOrPresentationCurrencyMember" xlink:to="loc_currencyEUR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LoanAndFinancing" xlink:label="loc_afyaLoanAndFinancing" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoanAndFinancing" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-fullBorrowingsInterestRateBasis" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsInterestRateBasis" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TransactionCosts" xlink:label="loc_afyaTransactionCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContractualLeaseTerm" xlink:label="loc_afyaContractualLeaseTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContractualLeaseTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-fullExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" xlink:label="loc_ifrs-fullNoncurrentPayablesForPurchaseOfEnergy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentPayablesForPurchaseOfEnergy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConsiderationToBeTransferred" xlink:label="loc_afyaConsiderationToBeTransferred" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsiderationToBeTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FirstAnnualInstallmentsPayable" xlink:label="loc_afyaFirstAnnualInstallmentsPayable" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFirstAnnualInstallmentsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SecondAnnualInstallmentsPayable" xlink:label="loc_afyaSecondAnnualInstallmentsPayable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSecondAnnualInstallmentsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ThirdAnnualInstallmentsPayable" xlink:label="loc_afyaThirdAnnualInstallmentsPayable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaThirdAnnualInstallmentsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:label="loc_afyaRemainingTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemainingTradeAndOtherPayablesToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="loc_ifrs-fullTransactionPriceAllocatedToRemainingPerformanceObligations" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTransactionPriceAllocatedToRemainingPerformanceObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="loc_ifrs-fullDefinedBenefitObligationAtPresentValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDefinedBenefitObligationAtPresentValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CreditExposures" xlink:label="loc_afyaCreditExposures" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCreditExposures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SensitivityChangeInTheEuroExchangeRate" xlink:label="loc_afyaSensitivityChangeInTheEuroExchangeRate" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSensitivityChangeInTheEuroExchangeRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-fullClosingForeignExchangeRate" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullClosingForeignExchangeRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails" xlink:title="999100 - Disclosure - Labor and social obligations (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOptionsMember" xlink:label="loc_ifrs-fullShareOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_ifrs-fullShareOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SharePriceFairValueAtMeasurementDate" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ExpectedLifeOfStockOptions" xlink:label="loc_afyaExpectedLifeOfStockOptions" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaExpectedLifeOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails1" xlink:title="999101 - Disclosure - Labor and social obligations (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareOptionsMember" xlink:label="loc_ifrs-fullShareOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_ifrs-fullShareOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" xlink:label="loc_afyaWeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExpiredInSharebasedPaymentArrangement" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfStockOptionsExercisable" xlink:label="loc_afyaNumberOfStockOptionsExercisable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfStockOptionsExercisable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails2" xlink:title="999102 - Disclosure - Labor and social obligations (Details 2)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-fullDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-fullDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_November2025Member" xlink:label="loc_afyaNovember2025Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaNovember2025Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_April2025Member" xlink:label="loc_afyaApril2025Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaApril2025Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_October2024Member" xlink:label="loc_afyaOctober2024Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaOctober2024Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_December2023Member" xlink:label="loc_afyaDecember2023Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaDecember2023Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_October2023Member" xlink:label="loc_afyaOctober2023Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaOctober2023Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_August2023Member" xlink:label="loc_afyaAugust2023Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaAugust2023Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_April2023Member" xlink:label="loc_afyaApril2023Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaApril2023Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_February2023Member" xlink:label="loc_afyaFebruary2023Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaFebruary2023Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-fullRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeDomain" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-fullWeightedAverageSharePriceShareOptionsGranted2019" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullWeightedAverageSharePriceShareOptionsGranted2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_GrantedVestingPeriod" xlink:label="loc_afyaGrantedVestingPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaGrantedVestingPeriod" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetails3" xlink:title="999103 - Disclosure - Labor and social obligations (Details 3)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-fullDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-fullDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnitsMember" xlink:label="loc_afyaRestrictedStockUnitsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaRestrictedStockUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:label="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfShareOptionsExchangedInSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:title="999104 - Disclosure - Labor and social obligations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-fullDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-fullDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShareBasedCompensationPlansMember" xlink:label="loc_afyaShareBasedCompensationPlansMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaShareBasedCompensationPlansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnitsMember" xlink:label="loc_afyaRestrictedStockUnitsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansDomain" xlink:to="loc_afyaRestrictedStockUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnits1Member" xlink:label="loc_afyaRestrictedStockUnits1Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_afyaRestrictedStockUnits1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnits2Member" xlink:label="loc_afyaRestrictedStockUnits2Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_afyaRestrictedStockUnits2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RestrictedStockUnits3Member" xlink:label="loc_afyaRestrictedStockUnits3Member" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsDomain" xlink:to="loc_afyaRestrictedStockUnits3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ShareBasedCompensationOfEmployees" xlink:label="loc_afyaShareBasedCompensationOfEmployees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaShareBasedCompensationOfEmployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestInJointVenture" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestInJointVenture" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SocialObligationsLiabilities" xlink:label="loc_afyaSocialObligationsLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSocialObligationsLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetails" xlink:title="999105 - Disclosure - Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureEquityAbstract" xlink:label="loc_afyaDisclosureEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-fullNumberOfSharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_ifrs-fullNumberOfSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_afyaWeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaWeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfSharesRepurchased" xlink:label="loc_afyaNumberOfSharesRepurchased" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaNumberOfSharesRepurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AveragePriceRepurchased" xlink:label="loc_afyaAveragePriceRepurchased" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaAveragePriceRepurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" xlink:label="loc_afyaNumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaNumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AveragePriceDeliveredUnderSharebasedCompensationPlan" xlink:label="loc_afyaAveragePriceDeliveredUnderSharebasedCompensationPlan" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaAveragePriceDeliveredUnderSharebasedCompensationPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-fullNumberOfSharesOutstanding_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_ifrs-fullNumberOfSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_afyaWeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_afyaWeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetailsNarrative" xlink:title="999106 - Disclosure - Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureEquityAbstract" xlink:label="loc_afyaDisclosureEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureEquityAbstract" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-fullClassesOfShareCapitalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalDomain" xlink:to="loc_afyaClassAOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalDomain" xlink:to="loc_afyaClassBOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumberOfSharesIssued1" xlink:label="loc_afyaNumberOfSharesIssued1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-fullNumberOfSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IssuedCapitals" xlink:label="loc_afyaIssuedCapitals" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIssuedCapitals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CapitalUnitsAuthorizedShares" xlink:label="loc_afyaCapitalUnitsAuthorizedShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalUnitsAuthorizedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-fullParValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullParValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PaymentOfDividends" xlink:label="loc_afyaPaymentOfDividends" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPaymentOfDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendDistributed" xlink:label="loc_afyaDividendDistributed" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendDistributed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:label="loc_ifrs-fullDividendsPaidToNoncontrollingInterests" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaidToNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FirstDividendDistributionInAmount" xlink:label="loc_afyaFirstDividendDistributionInAmount" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFirstDividendDistributionInAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PercentageOfDividendDistribution" xlink:label="loc_afyaPercentageOfDividendDistribution" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPercentageOfDividendDistribution" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidOtherSharesPerShare" xlink:label="loc_ifrs-fullDividendsPaidOtherSharesPerShare" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaidOtherSharesPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RepurchaseOfOrdinaryShares" xlink:label="loc_afyaRepurchaseOfOrdinaryShares" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRepurchaseOfOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CashOutflow" xlink:label="loc_afyaCashOutflow" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCashOutflow" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareDetails" xlink:title="999107 - Disclosure - Earnings per share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NumeratorAbstract" xlink:label="loc_afyaNumeratorAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaNumeratorAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:label="loc_ifrs-fullAdjustmentToProfitLossForPreferenceShareDividends" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAdjustmentToProfitLossForPreferenceShareDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DenominatorAbstract" xlink:label="loc_afyaDenominatorAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDenominatorAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-fullWeightedAverageShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullWeightedAverageShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-fullDilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-fullAdjustedWeightedAverageShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullAdjustedWeightedAverageShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-fullBasicEarningsLossPerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullBasicEarningsLossPerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-fullDilutedEarningsLossPerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDilutedEarningsLossPerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueDetails" xlink:title="999108 - Disclosure - Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProfessionalFeesExpenses" xlink:label="loc_afyaProfessionalFeesExpenses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaProfessionalFeesExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherRevenue1" xlink:label="loc_afyaOtherRevenue1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaOtherRevenue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeductionAbstract" xlink:label="loc_afyaDeductionAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDeductionAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeductionOfGrantedDiscounts" xlink:label="loc_afyaDeductionOfGrantedDiscounts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDeductionOfGrantedDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeductionOfReturnsOfNetRevenue" xlink:label="loc_afyaDeductionOfReturnsOfNetRevenue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDeductionOfReturnsOfNetRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeductionOfTaxes" xlink:label="loc_afyaDeductionOfTaxes" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDeductionOfTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeductionOfProuni" xlink:label="loc_afyaDeductionOfProuni" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaDeductionOfProuni" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="loc_ifrs-fullRevenueFromContractsWithCustomers" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullRevenueFromContractsWithCustomers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TimingOfRevenueRecognition" xlink:label="loc_afyaTimingOfRevenueRecognition" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaTimingOfRevenueRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TransferredOverTime" xlink:label="loc_afyaTransferredOverTime" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaTransferredOverTime" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TransferredAtPointInTime" xlink:label="loc_afyaTransferredAtPointInTime" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaTransferredAtPointInTime" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueDetails1" xlink:title="999109 - Disclosure - Revenue (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_ifrs-fullSegmentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-fullSegmentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UndergraduateMember" xlink:label="loc_afyaUndergraduateMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaUndergraduateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaContinuingEducationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_MedicalPracticeSolutionsMember" xlink:label="loc_afyaMedicalPracticeSolutionsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaMedicalPracticeSolutionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_EliminationInterSegmentTransactionsMember" xlink:label="loc_afyaEliminationInterSegmentTransactionsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaEliminationInterSegmentTransactionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsDomain" xlink:to="loc_afyaUndergradMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-fullProfessionalFeesExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfessionalFeesExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-fullOtherRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TimingRevenueRecognition" xlink:label="loc_afyaTimingRevenueRecognition" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTimingRevenueRecognition" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FeeAndCommissionIncome" xlink:label="loc_ifrs-fullFeeAndCommissionIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFeeAndCommissionIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NetRevenueOtherTransferredPoint" xlink:label="loc_afyaNetRevenueOtherTransferredPoint" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetRevenueOtherTransferredPoint" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CostsAndExpensesByNatureDetails" xlink:title="999110 - Disclosure - Costs and expenses by nature (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Payroll" xlink:label="loc_afyaPayroll" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaPayroll" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_HospitalAndMedicalAgreements" xlink:label="loc_afyaHospitalAndMedicalAgreements" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaHospitalAndMedicalAgreements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-fullDepreciationExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDepreciationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseExpenses" xlink:label="loc_afyaLeaseExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaLeaseExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UtilitiesExpense" xlink:label="loc_ifrs-fullUtilitiesExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullUtilitiesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepairsAndMaintenanceExpense" xlink:label="loc_ifrs-fullRepairsAndMaintenanceExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullRepairsAndMaintenanceExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SharesBasedCompensation" xlink:label="loc_afyaSharesBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaSharesBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxExpenses" xlink:label="loc_afyaTaxExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaTaxExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-fullSalesAndMarketingExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullSalesAndMarketingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForExpectedCreditLosses" xlink:label="loc_afyaAllowanceForExpectedCreditLosses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaAllowanceForExpectedCreditLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TravelExpense" xlink:label="loc_ifrs-fullTravelExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullTravelExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ConsultingFees" xlink:label="loc_afyaConsultingFees" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaConsultingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CostExpensesOther" xlink:label="loc_afyaCostExpensesOther" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaCostExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-fullExpenseByNature" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullExpenseByNature" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CostOfServices" xlink:label="loc_afyaCostOfServices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaCostOfServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_SellingGeneralAndAdministrativeExpenses" xlink:label="loc_afyaSellingGeneralAndAdministrativeExpenses" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaSellingGeneralAndAdministrativeExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultDetails" xlink:title="999111 - Disclosure - Finance result (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialIncomeFromCashEquivalents" xlink:label="loc_afyaFinancialIncomeFromCashEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaFinancialIncomeFromCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InterestEarned" xlink:label="loc_afyaInterestEarned" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaInterestEarned" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceIncome" xlink:label="loc_ifrs-fullOtherFinanceIncome" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullOtherFinanceIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InterestExpense1" xlink:label="loc_afyaInterestExpense1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaInterestExpense1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_InterestExpenseOnLeaseLiabilities1" xlink:label="loc_afyaInterestExpenseOnLeaseLiabilities1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaInterestExpenseOnLeaseLiabilities1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinancialDiscountsGrantedExpenses" xlink:label="loc_afyaFinancialDiscountsGrantedExpenses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaFinancialDiscountsGrantedExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CreditCardCharges" xlink:label="loc_afyaCreditCardCharges" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaCreditCardCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BankAndSimilarCharges" xlink:label="loc_ifrs-fullBankAndSimilarCharges" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullBankAndSimilarCharges" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ExchangeVariance" xlink:label="loc_afyaExchangeVariance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaExchangeVariance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherFinanceCost" xlink:label="loc_ifrs-fullOtherFinanceCost" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullOtherFinanceCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FinanceResult" xlink:label="loc_afyaFinanceResult" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_afyaFinanceResult" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetails" xlink:title="999112 - Disclosure - Income taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIncomeTaxesAbstract" xlink:label="loc_afyaDisclosureIncomeTaxesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-fullApplicableTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullApplicableTaxRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxExpensesIncomeAtApplicableTaxRate" xlink:label="loc_afyaTaxExpensesIncomeAtApplicableTaxRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaTaxExpensesIncomeAtApplicableTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ReconciliationAdjustmentsAbstract" xlink:label="loc_afyaReconciliationAdjustmentsAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaReconciliationAdjustmentsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" xlink:label="loc_afyaTaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaTaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProgramaUniversidadeParaTodosFiscalIncentive" xlink:label="loc_afyaProgramaUniversidadeParaTodosFiscalIncentive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaProgramaUniversidadeParaTodosFiscalIncentive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_UnrecognizedDeferredTaxesAssetsOnTaxLosses" xlink:label="loc_afyaUnrecognizedDeferredTaxesAssetsOnTaxLosses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaUnrecognizedDeferredTaxesAssetsOnTaxLosses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RecognisedDeferredTaxAssets" xlink:label="loc_afyaRecognisedDeferredTaxAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaRecognisedDeferredTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_afyaTaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaTaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PermanentAdjustmentsAbstract" xlink:label="loc_afyaPermanentAdjustmentsAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaPermanentAdjustmentsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PermanentAdjustmentsManagementBonuses" xlink:label="loc_afyaPermanentAdjustmentsManagementBonuses" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaPermanentAdjustmentsManagementBonuses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PermanentAdjustmentsGifts" xlink:label="loc_afyaPermanentAdjustmentsGifts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaPermanentAdjustmentsGifts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PermanentAdjustmentsSponsorship" xlink:label="loc_afyaPermanentAdjustmentsSponsorship" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaPermanentAdjustmentsSponsorship" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:label="loc_ifrs-fullTaxExpenseOtherThanIncomeTaxExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullTaxExpenseOtherThanIncomeTaxExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PermanentAdjustmentsPillarTwo" xlink:label="loc_afyaPermanentAdjustmentsPillarTwo" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaPermanentAdjustmentsPillarTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherTaxExpenseBenefits" xlink:label="loc_afyaOtherTaxExpenseBenefits" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaOtherTaxExpenseBenefits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IncomeTaxesExpense" xlink:label="loc_afyaIncomeTaxesExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaIncomeTaxesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-fullCurrentTaxExpenseIncome" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullCurrentTaxExpenseIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-fullDeferredTaxExpenseIncome" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullDeferredTaxExpenseIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:label="loc_ifrs-fullTaxRateEffectFromChangeInTaxRate" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullTaxRateEffectFromChangeInTaxRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetails1" xlink:title="999113 - Disclosure - Income taxes (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIncomeTaxesAbstract" xlink:label="loc_afyaDisclosureIncomeTaxesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxAssetsAbstract" xlink:label="loc_afyaDeferredTaxAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaDeferredTaxAssetsAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxAssetsLossCarryforwards" xlink:label="loc_afyaDeferredTaxAssetsLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaDeferredTaxAssetsLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsTaxLossesCarryForward" xlink:label="loc_afyaAdditionsTaxLossesCarryForward" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAdditionsTaxLossesCarryForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:label="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullDisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AllowanceForExpectedCreditLoss" xlink:label="loc_afyaAllowanceForExpectedCreditLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAllowanceForExpectedCreditLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsAllowanceForExpectedCreditLosses" xlink:label="loc_afyaAdditionsAllowanceForExpectedCreditLosses" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAdditionsAllowanceForExpectedCreditLosses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract" xlink:label="loc_ifrs-fullLeaseLiabilitiesAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullLeaseLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RightofuseAsset" xlink:label="loc_afyaRightofuseAsset" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaRightofuseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsToRightofuseAsset" xlink:label="loc_afyaAdditionsToRightofuseAsset" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAdditionsToRightofuseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LeaseLiability" xlink:label="loc_afyaLeaseLiability" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsLeaseLiability" xlink:label="loc_afyaAdditionsLeaseLiability" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAdditionsLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ProvisionForProfitSharing" xlink:label="loc_afyaProvisionForProfitSharing" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaProvisionForProfitSharing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsProvisionForProfitSharing" xlink:label="loc_afyaAdditionsProvisionForProfitSharing" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAdditionsProvisionForProfitSharing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="loc_ifrs-fullLegalProceedingsProvision" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullLegalProceedingsProvision" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsProvisionForLegalProceedingsAndContingencies" xlink:label="loc_afyaAdditionsProvisionForLegalProceedingsAndContingencies" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAdditionsProvisionForLegalProceedingsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AmortizationOfIntangibleAsset" xlink:label="loc_afyaAmortizationOfIntangibleAsset" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAmortizationOfIntangibleAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsAmortizationOfIntangibleAssets" xlink:label="loc_afyaAdditionsAmortizationOfIntangibleAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAdditionsAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_Other" xlink:label="loc_afyaOther" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="loc_ifrs-fullAdditionalProvisionsOtherProvisions" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullAdditionalProvisionsOtherProvisions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxAsset" xlink:label="loc_afyaDeferredTaxAsset" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaDeferredTaxAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsDeferredTaxAssets" xlink:label="loc_afyaAdditionsDeferredTaxAssets" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAdditionsDeferredTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaapDeferredTaxLiabilitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill" xlink:label="loc_afyaDeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaDeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsTaxBenefitFromTaxDeductibleGoodwill" xlink:label="loc_afyaAdditionsTaxBenefitFromTaxDeductibleGoodwill" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAdditionsTaxBenefitFromTaxDeductibleGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FairValueRemeasurementsOnBusinessCombinations" xlink:label="loc_afyaFairValueRemeasurementsOnBusinessCombinations" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaFairValueRemeasurementsOnBusinessCombinations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsFairValueRemeasurementsOnBusinessCombinations" xlink:label="loc_afyaAdditionsFairValueRemeasurementsOnBusinessCombinations" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAdditionsFairValueRemeasurementsOnBusinessCombinations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredsTaxLiabilities" xlink:label="loc_afyaDeferredsTaxLiabilities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaDeferredsTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsDeferredTaxLiabilities" xlink:label="loc_afyaAdditionsDeferredTaxLiabilities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAdditionsDeferredTaxLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities" xlink:label="loc_ifrs-fullNetDeferredTaxLiabilities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_ifrs-fullNetDeferredTaxLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsDeferredTaxAssetsLiabilitiesNet" xlink:label="loc_afyaAdditionsDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaAdditionsDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:title="999114 - Disclosure - Income taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureIncomeTaxesAbstract" xlink:label="loc_afyaDisclosureIncomeTaxesAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DeferredTaxExpenseIncomes" xlink:label="loc_afyaDeferredTaxExpenseIncomes" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaDeferredTaxExpenseIncomes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RecognizedDeferredTaxAssets" xlink:label="loc_afyaRecognizedDeferredTaxAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureIncomeTaxesAbstract" xlink:to="loc_afyaRecognizedDeferredTaxAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails" xlink:title="999115 - Disclosure - Legal proceedings and contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLegalProceedingsAndContingenciesAbstract" xlink:label="loc_afyaDisclosureLegalProceedingsAndContingenciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLegalProceedingsAndContingenciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-fullLegalProceedingsContingentLiabilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesDomain" xlink:to="loc_ifrs-fullLegalProceedingsContingentLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-fullClassesOfProvisionsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfProvisionsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-fullClassesOfOtherProvisionsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullClassesOfOtherProvisionsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LabourMember" xlink:label="loc_afyaLabourMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:to="loc_afyaLabourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CivilMember" xlink:label="loc_afyaCivilMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:to="loc_afyaCivilMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxesMember" xlink:label="loc_afyaTaxesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:to="loc_afyaTaxesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-fullProvisions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsOtherProvisions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="loc_ifrs-fullAdditionalProvisionsOtherProvisions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionalProvisionsOtherProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="loc_ifrs-fullProvisionUsedOtherProvisions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProvisionUsedOtherProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="loc_ifrs-fullUnusedProvisionReversedOtherProvisions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUnusedProvisionReversedOtherProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-fullProvisions_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProvisions_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1" xlink:title="999116 - Disclosure - Legal proceedings and contingencies (Details 1)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLegalProceedingsAndContingenciesAbstract" xlink:label="loc_afyaDisclosureLegalProceedingsAndContingenciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLegalProceedingsAndContingenciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-fullLegalProceedingsContingentLiabilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesDomain" xlink:to="loc_ifrs-fullLegalProceedingsContingentLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-fullClassesOfProvisionsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfProvisionsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-fullClassesOfOtherProvisionsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullClassesOfOtherProvisionsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_LabourMember" xlink:label="loc_afyaLabourMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:to="loc_afyaLabourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_CivilMember" xlink:label="loc_afyaCivilMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:to="loc_afyaCivilMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TaxesAndSocialSecurityMember" xlink:label="loc_afyaTaxesAndSocialSecurityMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfOtherProvisionsDomain" xlink:to="loc_afyaTaxesAndSocialSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-fullTypesOfRisksDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_TypesOfRiskMember" xlink:label="loc_afyaTypesOfRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksDomain" xlink:to="loc_afyaTypesOfRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-fullOtherProvisions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative" xlink:title="999117 - Disclosure - Legal proceedings and contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureLegalProceedingsAndContingenciesAbstract" xlink:label="loc_afyaDisclosureLegalProceedingsAndContingenciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLegalProceedingsAndContingenciesAbstract" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-fullClassesOfAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullClassesOfAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-fullClassesOfAssetsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfAssetsAxis" xlink:to="loc_ifrs-fullClassesOfAssetsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_OtherAssetsNonCurrentMember" xlink:label="loc_afyaOtherAssetsNonCurrentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfAssetsDomain" xlink:to="loc_afyaOtherAssetsNonCurrentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_ContingenciesCorrespondentAmount" xlink:label="loc_afyaContingenciesCorrespondentAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContingenciesCorrespondentAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactionsDetails" xlink:title="999118 - Disclosure - Non-cash transactions (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DisclosureNoncashTransactionsAbstract" xlink:label="loc_afyaDisclosureNoncashTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_RemeasurementOfEarnOut" xlink:label="loc_afyaRemeasurementOfEarnOut" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureNoncashTransactionsAbstract" xlink:to="loc_afyaRemeasurementOfEarnOut" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" xlink:label="loc_afyaAdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureNoncashTransactionsAbstract" xlink:to="loc_afyaAdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet" xlink:label="loc_afyaAdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureNoncashTransactionsAbstract" xlink:to="loc_afyaAdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders" xlink:label="loc_afyaAdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureNoncashTransactionsAbstract" xlink:to="loc_afyaAdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_DividendsPayables" xlink:label="loc_afyaDividendsPayables" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureNoncashTransactionsAbstract" xlink:to="loc_afyaDividendsPayables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEventsDetailsNarrative" xlink:title="999119 - Disclosure - Subsequent events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:label="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNotesAndOtherExplanatoryInformationAbstract" xlink:to="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodAxis" xlink:to="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_NonadjustingEventMember" xlink:label="loc_afyaNonadjustingEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNonadjustingEventsAfterReportingPeriodDomain" xlink:to="loc_afyaNonadjustingEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_FirstDividendDistributionInAmount" xlink:label="loc_afyaFirstDividendDistributionInAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFirstDividendDistributionInAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20251231.xsd#afya_PercentageOfDividendDistribution" xlink:label="loc_afyaPercentageOfDividendDistribution" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPercentageOfDividendDistribution" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidOtherSharesPerShare" xlink:label="loc_ifrs-fullDividendsPaidOtherSharesPerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaidOtherSharesPerShare" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AFYA LIMITED<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001771007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Rua
Paraiba<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">No.
330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">17th
floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minas Gerais<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">BR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common shares, par value US$0.00005 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AFYA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KPMG Auditores Independentes Ltda.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Belo
Horizonte<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">55,148,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesHeldInTreasuryMember', window );">Class A Common Shares Held In Treasury [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">3,855,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember', window );">Class B Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">38,574,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Rua Paraiba<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">No. 330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">17th floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minas Gerais<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">BR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">3515-7550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Virgilio Deloy Capobianco Gibbon<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">ir@afya.com.br<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesHeldInTreasuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesHeldInTreasuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated statement of financial position - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">R$ 1,125,381<span></span>
</td>
<td class="nump">R$ 911,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables</a></td>
<td class="nump">717,373<span></span>
</td>
<td class="nump">595,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxAssets', window );">Recoverable taxes</a></td>
<td class="nump">13,429<span></span>
</td>
<td class="nump">7,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncomeTaxesRecoverable', window );">Income taxes recoverable</a></td>
<td class="nump">23,046<span></span>
</td>
<td class="nump">18,587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentAssets', window );">Other assets</a></td>
<td class="nump">62,947<span></span>
</td>
<td class="nump">57,145<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">1,942,176<span></span>
</td>
<td class="nump">1,589,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NoncurrentTradeReceivable', window );">Trade receivables</a></td>
<td class="nump">34,985<span></span>
</td>
<td class="nump">35,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">12,552<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">125,480<span></span>
</td>
<td class="nump">115,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Investment in associate</a></td>
<td class="nump">46,518<span></span>
</td>
<td class="nump">54,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">711,485<span></span>
</td>
<td class="nump">658,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">896,758<span></span>
</td>
<td class="nump">842,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">5,587,980<span></span>
</td>
<td class="nump">5,532,789<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">7,415,758<span></span>
</td>
<td class="nump">7,239,755<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">9,357,934<span></span>
</td>
<td class="nump">8,829,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade payables</a></td>
<td class="nump">123,581<span></span>
</td>
<td class="nump">128,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Loans and financing</a></td>
<td class="nump">60,668<span></span>
</td>
<td class="nump">363,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">55,772<span></span>
</td>
<td class="nump">45,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">110,640<span></span>
</td>
<td class="nump">185,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDepositsFromCustomers', window );">Advances from customers</a></td>
<td class="nump">158,035<span></span>
</td>
<td class="nump">161,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPayable', window );">Dividends payable</a></td>
<td class="nump">192<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan', window );">Labor and social obligations</a></td>
<td class="nump">217,526<span></span>
</td>
<td class="nump">208,076<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CurrentTaxesPayable', window );">Taxes payable</a></td>
<td class="nump">36,043<span></span>
</td>
<td class="nump">33,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Income taxes payable</a></td>
<td class="nump">112,638<span></span>
</td>
<td class="nump">4,247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">8,946<span></span>
</td>
<td class="nump">10,836<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">884,041<span></span>
</td>
<td class="nump">1,140,195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Loans and financing</a></td>
<td class="nump">1,993,599<span></span>
</td>
<td class="nump">1,831,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,009,974<span></span>
</td>
<td class="nump">932,756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">329,957<span></span>
</td>
<td class="nump">345,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NoncurrentTaxesPayable', window );">Taxes payable</a></td>
<td class="nump">77,487<span></span>
</td>
<td class="nump">84,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermLegalProceedingsProvision', window );">Provision for legal proceedings</a></td>
<td class="nump">128,220<span></span>
</td>
<td class="nump">113,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">43,471<span></span>
</td>
<td class="nump">42,742<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">3,582,708<span></span>
</td>
<td class="nump">3,378,761<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">4,466,749<span></span>
</td>
<td class="nump">4,518,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalPaidinCapital', window );">Additional paid-in capital</a></td>
<td class="nump">2,320,422<span></span>
</td>
<td class="nump">2,344,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury shares</a></td>
<td class="num">(306,010)<span></span>
</td>
<td class="num">(273,955)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfSharebasedPayments', window );">Share-based compensation reserve</a></td>
<td class="nump">202,815<span></span>
</td>
<td class="nump">187,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Retained earnings</a></td>
<td class="nump">2,634,552<span></span>
</td>
<td class="nump">2,011,875<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Equity attributable to the owners of the Company</a></td>
<td class="nump">4,851,796<span></span>
</td>
<td class="nump">4,269,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="nump">39,389<span></span>
</td>
<td class="nump">40,628<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">4,891,185<span></span>
</td>
<td class="nump">4,310,583<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">R$ 9,357,934<span></span>
</td>
<td class="nump">R$ 8,829,539<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CurrentTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CurrentTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncomeTaxesRecoverable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncomeTaxesRecoverable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentTradeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentTradeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalPaidinCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalPaidinCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDepositsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deposits from customers. [Refer: Deposits from customers]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDepositsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current net defined benefit liability. [Refer: Net defined benefit liability]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The excess of amount paid for current tax in respect of current and prior periods over the amount due for those periods. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends payable by means of the distribution of non-cash assets to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRIC<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRIC&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph r<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_r&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermLegalProceedingsProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provision for legal proceedings. [Refer: Legal proceedings provision]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Section Example 10 A court case<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS37_IE_C_ex10_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 87<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_87&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermLegalProceedingsProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2024-01-01<br> -Paragraph 22<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current payables due to related parties. [Refer: Total for all related parties [member]; Payables to related parties]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity resulting from share-based payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables due to related parties. [Refer: Total for all related parties [member]; Payables to related parties]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated statement of income and other comprehensive income - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">R$ 3,697,255<span></span>
</td>
<td class="nump">R$ 3,304,329<span></span>
</td>
<td class="nump">R$ 2,875,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="num">(1,313,895)<span></span>
</td>
<td class="num">(1,215,603)<span></span>
</td>
<td class="num">(1,109,813)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,383,360<span></span>
</td>
<td class="nump">2,088,726<span></span>
</td>
<td class="nump">1,766,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="num">(1,113,065)<span></span>
</td>
<td class="num">(1,008,427)<span></span>
</td>
<td class="num">(940,132)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceForExpectedCreditLosses', window );">Allowance for expected credit losses</a></td>
<td class="num">(57,090)<span></span>
</td>
<td class="num">(60,894)<span></span>
</td>
<td class="num">(74,552)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">18,762<span></span>
</td>
<td class="nump">13,299<span></span>
</td>
<td class="nump">53,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByNature', window );">Other expenses</a></td>
<td class="num">(18,857)<span></span>
</td>
<td class="num">(20,591)<span></span>
</td>
<td class="num">(37,561)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="nump">1,213,110<span></span>
</td>
<td class="nump">1,012,113<span></span>
</td>
<td class="nump">767,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="nump">194,943<span></span>
</td>
<td class="nump">111,283<span></span>
</td>
<td class="nump">110,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance expenses</a></td>
<td class="num">(561,024)<span></span>
</td>
<td class="num">(458,742)<span></span>
</td>
<td class="num">(457,616)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Net finance result</a></td>
<td class="num">(366,081)<span></span>
</td>
<td class="num">(347,459)<span></span>
</td>
<td class="num">(346,974)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit of equity-accounted investee, net of tax</a></td>
<td class="nump">13,916<span></span>
</td>
<td class="nump">11,737<span></span>
</td>
<td class="nump">9,495<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">860,945<span></span>
</td>
<td class="nump">676,391<span></span>
</td>
<td class="nump">429,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncomeTaxesExpensesAbstract', window );"><strong>Income taxes expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncomeTaxesExpensesCurrent', window );">Current</a></td>
<td class="num">(133,328)<span></span>
</td>
<td class="num">(24,238)<span></span>
</td>
<td class="num">(27,399)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeferredTaxes', window );">Deferred</a></td>
<td class="nump">40,826<span></span>
</td>
<td class="num">(3,233)<span></span>
</td>
<td class="nump">3,233<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">768,443<span></span>
</td>
<td class="nump">648,920<span></span>
</td>
<td class="nump">405,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="nump">768,443<span></span>
</td>
<td class="nump">648,920<span></span>
</td>
<td class="nump">405,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToAbstract', window );"><strong>Net income / total comprehensive income attributable to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Owners of the Company</a></td>
<td class="nump">752,461<span></span>
</td>
<td class="nump">631,510<span></span>
</td>
<td class="nump">386,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="nump">15,982<span></span>
</td>
<td class="nump">17,410<span></span>
</td>
<td class="nump">19,092<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ComprehensiveIncomeLoss', window );">Total comprehensive income</a></td>
<td class="nump">R$ 768,443<span></span>
</td>
<td class="nump">R$ 648,920<span></span>
</td>
<td class="nump">R$ 405,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic earnings per common share</a></td>
<td class="nump">R$ 8.32<span></span>
</td>
<td class="nump">R$ 7.01<span></span>
</td>
<td class="nump">R$ 4.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted earnings per common share</a></td>
<td class="nump">R$ 8.24<span></span>
</td>
<td class="nump">R$ 6.93<span></span>
</td>
<td class="nump">R$ 4.27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForExpectedCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForExpectedCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeferredTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeferredTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncomeTaxesExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncomeTaxesExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncomeTaxesExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncomeTaxesExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2024-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Total for all associates [member]; Investments accounted for using equity method; Total for all joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated statement of changes in equity - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Issued capital [member]</div></th>
<th class="th"><div>Additional paid-in capital [member]</div></th>
<th class="th"><div>Treasury shares [member]</div></th>
<th class="th"><div>Reserve of share-based payments [member]</div></th>
<th class="th"><div>Retained earnings [member]</div></th>
<th class="th"><div>Equity attributable to owners of parent [member]</div></th>
<th class="th"><div>Non-controlling interests [member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance, value at Dec. 31, 2022</a></td>
<td class="nump">R$ 17<span></span>
</td>
<td class="nump">R$ 2,375,344<span></span>
</td>
<td class="num">R$ (304,947)<span></span>
</td>
<td class="nump">R$ 123,538<span></span>
</td>
<td class="nump">R$ 1,004,886<span></span>
</td>
<td class="nump">R$ 3,198,838<span></span>
</td>
<td class="nump">R$ 51,320<span></span>
</td>
<td class="nump">R$ 3,250,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">386,324<span></span>
</td>
<td class="nump">386,324<span></span>
</td>
<td class="nump">19,092<span></span>
</td>
<td class="nump">405,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">386,324<span></span>
</td>
<td class="nump">386,324<span></span>
</td>
<td class="nump">19,092<span></span>
</td>
<td class="nump">405,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">31,535<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">31,535<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">31,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasurySharesRepurchase', window );">Treasury shares repurchase</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,369)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,369)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,369)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AcquisitionOfNoncontrollingInterests', window );">Acquisition of non-controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(10,845)<span></span>
</td>
<td class="num">(10,845)<span></span>
</td>
<td class="num">(10,155)<span></span>
</td>
<td class="num">(21,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RestrictedSharesTransferredToExecutives', window );">Restricted stock units transferred under the share-based compensation plan</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(7,491)<span></span>
</td>
<td class="nump">5,722<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,769)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,769)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions', window );">Treasury shares transferred to executives from exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,653)<span></span>
</td>
<td class="nump">12,444<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,791<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Dividends declared</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(18,750)<span></span>
</td>
<td class="num">(18,750)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance, value at Dec. 31, 2023</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">2,365,200<span></span>
</td>
<td class="num">(299,150)<span></span>
</td>
<td class="nump">155,073<span></span>
</td>
<td class="nump">1,380,365<span></span>
</td>
<td class="nump">3,601,505<span></span>
</td>
<td class="nump">41,507<span></span>
</td>
<td class="nump">3,643,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">631,510<span></span>
</td>
<td class="nump">631,510<span></span>
</td>
<td class="nump">17,410<span></span>
</td>
<td class="nump">648,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">631,510<span></span>
</td>
<td class="nump">631,510<span></span>
</td>
<td class="nump">17,410<span></span>
</td>
<td class="nump">648,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">32,424<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">32,424<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">32,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasurySharesRepurchase', window );">Treasury shares repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RestrictedSharesTransferredToExecutives', window );">Restricted stock units transferred under the share-based compensation plan</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(17,672)<span></span>
</td>
<td class="nump">12,812<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,860)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,860)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions', window );">Treasury shares transferred to executives from exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(3,007)<span></span>
</td>
<td class="nump">12,383<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,376<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Dividends declared</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(18,289)<span></span>
</td>
<td class="num">(18,289)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance, value at Dec. 31, 2024</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">2,344,521<span></span>
</td>
<td class="num">(273,955)<span></span>
</td>
<td class="nump">187,497<span></span>
</td>
<td class="nump">2,011,875<span></span>
</td>
<td class="nump">4,269,955<span></span>
</td>
<td class="nump">40,628<span></span>
</td>
<td class="nump">4,310,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">752,461<span></span>
</td>
<td class="nump">752,461<span></span>
</td>
<td class="nump">15,982<span></span>
</td>
<td class="nump">768,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">752,461<span></span>
</td>
<td class="nump">752,461<span></span>
</td>
<td class="nump">15,982<span></span>
</td>
<td class="nump">768,443<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,318<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,318<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasurySharesRepurchase', window );">Treasury shares repurchase</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(77,002)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(77,002)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(77,002)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RestrictedSharesTransferredToExecutives', window );">Restricted stock units transferred under the share-based compensation plan</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(17,764)<span></span>
</td>
<td class="nump">12,879<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,885)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,885)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions', window );">Treasury shares transferred to executives from exercise of stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(6,335)<span></span>
</td>
<td class="nump">32,068<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,733<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Dividends declared</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(129,784)<span></span>
</td>
<td class="num">(129,784)<span></span>
</td>
<td class="num">(17,221)<span></span>
</td>
<td class="num">(147,005)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance, value at Dec. 31, 2025</a></td>
<td class="nump">R$ 17<span></span>
</td>
<td class="nump">R$ 2,320,422<span></span>
</td>
<td class="num">R$ (306,010)<span></span>
</td>
<td class="nump">R$ 202,815<span></span>
</td>
<td class="nump">R$ 2,634,552<span></span>
</td>
<td class="nump">R$ 4,851,796<span></span>
</td>
<td class="nump">R$ 39,389<span></span>
</td>
<td class="nump">R$ 4,891,185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AcquisitionOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AcquisitionOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RestrictedSharesTransferredToExecutives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RestrictedSharesTransferredToExecutives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TreasurySharesRepurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TreasurySharesRepurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends recognised as distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 107<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_107&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated statement of cash flows - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncomeLossBeforeIncomeTaxes', window );">Income before income taxes</a></td>
<td class="nump">R$ 860,945<span></span>
</td>
<td class="nump">R$ 676,391<span></span>
</td>
<td class="nump">R$ 429,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments to reconcile income before income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Depreciation and amortization expenses</a></td>
<td class="nump">373,344<span></span>
</td>
<td class="nump">333,341<span></span>
</td>
<td class="nump">289,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfPropertyAndEquipment', window );">Write-off of property and equipment</a></td>
<td class="nump">3,062<span></span>
</td>
<td class="nump">2,539<span></span>
</td>
<td class="nump">1,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off of intangible assets</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceForDoubtfulAccountsOfOpeartingActivities', window );">Allowance for expected credit losses</a></td>
<td class="nump">57,090<span></span>
</td>
<td class="nump">60,894<span></span>
</td>
<td class="nump">74,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation expense</a></td>
<td class="nump">15,318<span></span>
</td>
<td class="nump">32,424<span></span>
</td>
<td class="nump">31,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains', window );">Net foreign exchange differences</a></td>
<td class="nump">1,816<span></span>
</td>
<td class="nump">7,027<span></span>
</td>
<td class="nump">681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccruedInterestOfOpeartingActivities', window );">Accrued interest</a></td>
<td class="nump">316,379<span></span>
</td>
<td class="nump">254,386<span></span>
</td>
<td class="nump">285,447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Accrued interest on lease liabilities</a></td>
<td class="nump">123,067<span></span>
</td>
<td class="nump">111,966<span></span>
</td>
<td class="nump">100,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax', window );">Share of profit of equity-accounted investee, net of tax</a></td>
<td class="num">(13,916)<span></span>
</td>
<td class="num">(11,737)<span></span>
</td>
<td class="num">(9,495)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForProvisions', window );">Provision (reversal) for legal proceedings</a></td>
<td class="nump">23,250<span></span>
</td>
<td class="nump">9,705<span></span>
</td>
<td class="num">(40,044)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseDecreaseInOperatingLiabilities1Abstract', window );"><strong>Changes in assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">Trade receivables</a></td>
<td class="num">(177,602)<span></span>
</td>
<td class="num">(97,449)<span></span>
</td>
<td class="num">(131,336)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseDecreaseInRecoverableTaxes', window );">Recoverable taxes</a></td>
<td class="num">(10,749)<span></span>
</td>
<td class="nump">18,107<span></span>
</td>
<td class="num">(15,353)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets', window );">Other assets</a></td>
<td class="num">(10,798)<span></span>
</td>
<td class="nump">11,220<span></span>
</td>
<td class="nump">88,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Trade payables</a></td>
<td class="num">(4,499)<span></span>
</td>
<td class="nump">18,126<span></span>
</td>
<td class="nump">24,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncomeTaxExpense', window );">Taxes payable</a></td>
<td class="num">(18,109)<span></span>
</td>
<td class="num">(14,798)<span></span>
</td>
<td class="nump">3,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers', window );">Advances from customers</a></td>
<td class="num">(3,013)<span></span>
</td>
<td class="nump">6,329<span></span>
</td>
<td class="num">(17,892)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsForNoncashItems', window );">Labor and social obligations</a></td>
<td class="nump">9,450<span></span>
</td>
<td class="nump">8,414<span></span>
</td>
<td class="nump">31,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseDecreaseInPaymentsOfLegalProceedings', window );">Payments of legal proceedings</a></td>
<td class="num">(6,873)<span></span>
</td>
<td class="num">(4,637)<span></span>
</td>
<td class="num">(16,781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">9,196<span></span>
</td>
<td class="nump">30,687<span></span>
</td>
<td class="num">(42,542)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLoss', window );">Net cash flows from operating activities before income taxes</a></td>
<td class="nump">1,547,633<span></span>
</td>
<td class="nump">1,453,179<span></span>
</td>
<td class="nump">1,088,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Income taxes paid</a></td>
<td class="num">(16,046)<span></span>
</td>
<td class="num">(20,520)<span></span>
</td>
<td class="num">(45,144)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash flows from operating activities</a></td>
<td class="nump">1,531,587<span></span>
</td>
<td class="nump">1,432,659<span></span>
</td>
<td class="nump">1,043,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Acquisition of property and equipment</a></td>
<td class="num">(166,014)<span></span>
</td>
<td class="num">(136,924)<span></span>
</td>
<td class="num">(118,435)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities', window );">Acquisition of intangibles assets</a></td>
<td class="num">(197,997)<span></span>
</td>
<td class="num">(255,691)<span></span>
</td>
<td class="num">(126,993)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Dividends received</a></td>
<td class="nump">15,553<span></span>
</td>
<td class="nump">7,501<span></span>
</td>
<td class="nump">9,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PurchaseOfAcquisitionOfNoncontrollingInterests', window );">Acquisition of non-controlling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(21,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities', window );">Acquisition of assets and subsidiaries, net of cash acquired</a></td>
<td class="num">(144,076)<span></span>
</td>
<td class="num">(627,568)<span></span>
</td>
<td class="num">(815,005)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PaymentsOfInterest', window );">Payments of interest</a></td>
<td class="num">(14,536)<span></span>
</td>
<td class="num">(78,931)<span></span>
</td>
<td class="num">(71,518)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash flows used in investing activities</a></td>
<td class="num">(507,070)<span></span>
</td>
<td class="num">(1,091,613)<span></span>
</td>
<td class="num">(1,143,051)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Payments of principal of loans and financing</a></td>
<td class="num">(1,624,911)<span></span>
</td>
<td class="num">(128,696)<span></span>
</td>
<td class="num">(112,630)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RepaymentsOfInterest', window );">Payments of interest</a></td>
<td class="num">(309,337)<span></span>
</td>
<td class="num">(177,192)<span></span>
</td>
<td class="num">(175,889)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from loans and financing</a></td>
<td class="nump">1,494,881<span></span>
</td>
<td class="nump">491,593<span></span>
</td>
<td class="nump">5,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments of principal of lease liabilities</a></td>
<td class="num">(49,411)<span></span>
</td>
<td class="num">(41,221)<span></span>
</td>
<td class="num">(31,473)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments of interest of lease liabilities</a></td>
<td class="num">(121,475)<span></span>
</td>
<td class="num">(111,605)<span></span>
</td>
<td class="num">(103,911)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TreasurySharesRepurchase', window );">Treasury shares repurchase</a></td>
<td class="num">(77,002)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,369)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">25,733<span></span>
</td>
<td class="nump">9,376<span></span>
</td>
<td class="nump">9,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidClassifiedAsFinancingActivities', window );">Dividends paid</a></td>
<td class="num">(146,813)<span></span>
</td>
<td class="num">(18,289)<span></span>
</td>
<td class="num">(18,750)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash flows from (used in) financing activities</a></td>
<td class="num">(808,335)<span></span>
</td>
<td class="nump">23,966<span></span>
</td>
<td class="num">(439,943)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Net foreign exchange differences</a></td>
<td class="num">(1,816)<span></span>
</td>
<td class="num">(7,027)<span></span>
</td>
<td class="num">(681)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">214,366<span></span>
</td>
<td class="nump">357,985<span></span>
</td>
<td class="num">(540,052)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Cash and cash equivalents at the beginning of the year</a></td>
<td class="nump">911,015<span></span>
</td>
<td class="nump">553,030<span></span>
</td>
<td class="nump">1,093,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Cash and cash equivalents at the end of the year</a></td>
<td class="nump">R$ 1,125,381<span></span>
</td>
<td class="nump">R$ 911,015<span></span>
</td>
<td class="nump">R$ 553,030<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccruedInterestOfOpeartingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccruedInterestOfOpeartingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForDoubtfulAccountsOfOpeartingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForDoubtfulAccountsOfOpeartingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncomeLossBeforeIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncomeLossBeforeIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseDecreaseInOperatingLiabilities1Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseDecreaseInOperatingLiabilities1Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseDecreaseInPaymentsOfLegalProceedings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseDecreaseInPaymentsOfLegalProceedings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseDecreaseInRecoverableTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseDecreaseInRecoverableTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentsOfInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentsOfInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PurchaseOfAcquisitionOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PurchaseOfAcquisitionOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RepaymentsOfInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RepaymentsOfInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TreasurySharesRepurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TreasurySharesRepurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WriteoffOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WriteoffOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WriteoffOfPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WriteoffOfPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in loans and advances to customers to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Loans and advances to customers; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for dividends paid by the entity, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAdjustmentsForNoncashItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAdjustmentsForNoncashItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of long-term assets that the entity does not separately disclose in the same statement or note, classified as investing activities. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><b style="display: none">Risk Management and Strategy</b><p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Overview</p><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Company has policies and procedures in place to
address information technology and cybersecurity risks as part of its corporate risk management process. These processes are integrated
into Afya&#8217;s enterprise risk management (ERM) framework to ensure alignment with our overall approach to corporate risk. This includes
activities such as risk identification, classification, and mitigation, as well as the development of action plans aligned with industry
best practices.</p><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Cybersecurity initiatives at Afya are overseen by our
Chief Information Security Office, or CISO. The CISO&#8217;s responsibilities include defining and aligning action plans with Afya&#8217;s
corporate risk management team. Additionally, the CISO serves as the Data Protection Officer, handling privacy and data protection matters
and defining cybersecurity strategies for the entire company. This includes ensuring effective monitoring, threat detection, response
to events and incidents, and overall cybersecurity management. Cybersecurity monitoring with respect to our newly acquired companies is
managed from the outset by our IT technical team. Exposure to risk during this period is naturally greater as such acquired company is
not always mature in terms of cybersecurity risk management, but we seek to mitigate these risks by making adjustments to their practices
and applying our policies.</p><p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Risk Management and Strategy</p><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya has comprehensive policies, procedures, and a
dedicated risk management team responsible for addressing corporate risks across various themes, including strategic, operational, financial,
and compliance areas. Within each theme, Afya identifies and manages risks related to quality, procurement, cybersecurity, privacy and
data protection, financial reporting, legal compliance, regulatory matters, as well as risks related to ESG.</p><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">The Company follows a structured approach, including
a risk matrix with defined risk levels and criticality, which guides the need for risk treatment and the development of action plans.
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90E_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20250101__20251231_zJIUVjcAO06h">These plans are monitored by the responsible parties for each theme under the oversight of the risk and controls department.</span> <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20250101__20251231_zjqhMoD1cRii">Furthermore,
Afya has an assessment process that evaluates cybersecurity, privacy, and data protection policies of critical suppliers before onboarding.
This process aligns with frameworks such as COSO-ERM and COSO Internal Control - <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20250101__20251231_zMaUWL0wXdM5">Integrated</span> Framework.</span> To ensure compliance with industry
standards and enhance cybersecurity maturity levels, Afya engages specialized companies to review its plans and procedures, aiming to
adopt market best practices.</p><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Within the further detailed governance scheme, the
Company has established the audit, risk, and ethics committee to oversee risk management guidelines through a structured approach known
as the three lines of defense:</p><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For the monitoring and response to cyber incidents,
Afya has teams responsible for detecting and monitoring the Company&#8217;s environment, performing threat intelligence analysis, conducting
intrusion testing, and verifying the coverage and effectiveness of its detection and monitoring tools.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">Furthermore,
Afya has an assessment process that evaluates cybersecurity, privacy, and data protection policies of critical suppliers before onboarding.
This process aligns with frameworks such as COSO-ERM and COSO Internal Control - <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20250101__20251231_zMaUWL0wXdM5">Integrated</span> Framework.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text">no events were identified that could indicate the materialization of risks or the identification of material
incidents under the cybersecurity aspect that <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbT_c20250101__20251231_zAEWZ3w1Nql8">affected or could affect</span> the business strategy, results of operations, or financial condition
of the company.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text">Governance<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya places significant emphasis on cybersecurity within
its information technology area, covering areas such as incident management, information technology governance, privacy and data protection,
cybersecurity, infrastructure, and systems management. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_909_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_c20250101__20251231_zVkFW06F3D2l">These efforts are led by <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20250101__20251231_zUjZtfj6cte4">our chief information officer, or CIO</span>, and our CISO. The
CISO, drawing from extensive experience in leading technology and information security departments in large companies, is responsible
for developing a proactive security strategy capable of continuous threat exposure management, in balance with the organization&#8217;s
business goals.</span> This includes ensuring compliance with relevant information security and data privacy regulations, conducting training
for the security team and promoting user awareness to keep stakeholders informed about emerging technologies and threats.</p><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_900_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250101__20251231_zwvX3hCilYj2">Afya&#8217;s governance structure includes the audit,
risk, and ethics committee, which oversees risks identified by the risk and controls department, including cyber risks.</span> <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_c20250101__20251231_zpKhXmXTeEjk">The audit, risk,
and ethics committee reports to our <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_dbT_c20250101__20251231_zuUcoGh3ttP">board of directors</span> on a quarterly basis and, where applicable, review of specific incident responses.</span>
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250101__20251231_zY3dFlRPx7Bf">Our board of directors then sets strategic objectives and monitors the company&#8217;s risk landscape and corresponding action plans.</span></p><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_c20250101__20251231_zrREuBV8rDAb">Afya&#8217;s cybersecurity team holds regular meetings
to ensure continuous alignment and enhancement of the infrastructure and technology supporting the organization&#8217;s cybersecurity
strategy.</span> Potential improvements are identified and evaluated for feasibility and implementation in accordance with internal governance
processes. Afya continuously adopts and invests in technological solutions to strengthen its cybersecurity posture, enhancing monitoring,
threat detection, incident response, recovery, and protection capabilities across the organization.</p><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90C_ecyd--CybersecurityRiskRoleOfManagementTextBlock_c20250101__20251231_zvCDNHKXqHJ">In terms of disaster preparedness, Afya has a comprehensive
disaster recovery plan that includes a dedicated committee, trigger mechanisms, and defined recovery points focused on the Company&#8217;s
infrastructure. Additionally, Afya maintains a robust business continuity plan involving key teams and critical service mapping, with
criteria for defining criticality, financial impact, and brand reputation.</span></p><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">Afya&#8217;s privacy team is responsible for addressing
risks and controls related to personal data. They adhere to industry best practices such as ISO27000, LGPD, GDPR, and the NIST Cybersecurity
Framework, leveraging governance, risk management and compliance solutions to support their risk management processes.</p><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">According to processes and controls established by
Afya, as of December 31, 2025, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20250101__20251231_zNemqp6VQP6a">no events were identified that could indicate the materialization of risks or the identification of material
incidents under the cybersecurity aspect that <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbT_c20250101__20251231_zAEWZ3w1Nql8">affected or could affect</span> the business strategy, results of operations, or financial condition
of the company.</span> Minor incidents that occurred during the period were identified, treated, and communicated in accordance with the protocols,
policies, and procedures established for response. However, despite our efforts, we cannot eliminate all risks from cybersecurity threats,
or provide assurances that we have not experienced an undetected cybersecurity incident.</p><p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in">For more information about these risks, please see
&#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks Relating to Our Business and Industry&#8212; Failure to prevent or detect
a malicious cyber-attack on our systems and databases could result in a misappropriation of confidential information or access to highly
sensitive information&#8221; and &#8220;&#8212;Our success depends on our ability to monitor and adapt to technological changes and maintain
a technological infrastructure that works adequately and without interruption&#8221; in this annual report.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Afya&#8217;s governance structure includes the audit,
risk, and ethics committee, which oversees risks identified by the risk and controls department, including cyber risks.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Our board of directors then sets strategic objectives and monitors the company&#8217;s risk landscape and corresponding action plans.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text">In terms of disaster preparedness, Afya has a comprehensive
disaster recovery plan that includes a dedicated committee, trigger mechanisms, and defined recovery points focused on the Company&#8217;s
infrastructure. Additionally, Afya maintains a robust business continuity plan involving key teams and critical service mapping, with
criteria for defining criticality, financial impact, and brand reputation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">These efforts are led by <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20250101__20251231_zUjZtfj6cte4">our chief information officer, or CIO</span>, and our CISO. The
CISO, drawing from extensive experience in leading technology and information security departments in large companies, is responsible
for developing a proactive security strategy capable of continuous threat exposure management, in balance with the organization&#8217;s
business goals.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">The audit, risk,
and ethics committee reports to our <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_dbT_c20250101__20251231_zuUcoGh3ttP">board of directors</span> on a quarterly basis and, where applicable, review of specific incident responses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">Afya&#8217;s cybersecurity team holds regular meetings
to ensure continuous alignment and enhancement of the infrastructure and technology supporting the organization&#8217;s cybersecurity
strategy.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Corporate information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureCorporateInformationAbstract', window );"><strong>Corporate Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfGeneralInformationAboutFinancialStatementExplanatory', window );">Corporate information</a></td>
<td class="text"><p id="xdx_808_ecustom--DisclosureOfGeneralInformationAboutFinancialStatementExplanatory_znzvRxEeyWbg" style="margin-top: 0; margin-bottom: 0"><span id="a_0005"></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">1</td><td><span id="xdx_82E_zLcNmNOSZjee">Corporate information</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0pt 0pt 0pt 3%">Afya Limited (&#8220;Afya&#8221;), collectively with its subsidiaries referred to as the
&#8220;Company&#8221;, is a holding company incorporated under the laws of the Cayman Islands on March 22, 2019. Afya completed its initial
public offering (IPO) on July 19, 2019, and its shares are listed on the Nasdaq under the symbol &#8220;AFYA&#8221;. The Company&#8217;s
ultimate parent company is Bertelsmann SE&amp; Co. KGaA (&#8220;Bertelsmann&#8221;).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0pt 0pt 0pt 3%">The Company is formed by a network of higher education and post-graduate institutions,
focused on medical schools, under the regulations of the Ministry of Education (&#8220;MEC&#8221;). The Company also provides other educational
services that comprise the development and sale of electronically distributed educational courses on medicine science and soft skills
educational content. The Company also offers solutions to empower the physicians in their daily routine including supporting clinic decisions
through mobile app subscription, delivering practice management tools through a SaaS (Software as a Service) model and supporting the
patient-physician relationship.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0pt 0pt 0pt 3%; color: #C00000"><span style="text-decoration: underline">Acquisition in 2025</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On May 7, 2025, Afya Participa&#231;&#245;es S.A. (&#8220;Afya Brazil&#8221;) acquired
<span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_c20250507__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeMasterclassLtdaMember_z0zy4jJ7h9R4" title="Acquired percenatge">100</span>% of the total share capital of Faculdade Masterclass Ltda. (&#8220;FUNIC&#8221;), located in the city of Contagem, a city in the metropolitan
area of Belo Horizonte, the capital of the State of Minas Gerais. The acquisition contributed 60 medical school seats to Afya. FUNIC started
its operations in the second semester of 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span id="xdx_90A_eifrs-full--DescriptionOfAcquiree_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeMasterclassLtdaMember_zieAbuTcqVgj" title="Acquired purchase price">The aggregate purchase price is R$100,000. The price and payment conditions are: (i) R$60,000,
net of the estimated Net Debt, paid in cash on May 7, 2025 and presented in &#8220;Acquisition of assets and subsidiaries, net of cash
acquired&#8221; in the consolidated statement of cash flows; and (ii) R$40,000 payable in three equal annual installments adjusted by
100% of the Brazilian interbank interest rate (&#8220;CDI&#8221;) - see Note 22. FUNIC&#8217;s installments are not contingent consideration
and therefore are not included in the fair value disclosure in Note 2.3(b). The time value on the deferred installments is recognized
as finance expense using the effective interest rate method.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The acquisition includes a potential additional payment for up to 60 medical school seats,
contingent upon regulatory approval. If approved by MEC within 36 months from the closing date, an additional payment of R$<span id="xdx_90E_ecustom--AdditionalPaymentToShareholder_pn3n3_c20250506__20250507_zSlxzI1UiYei" title="Additional payment to shareholders">1,000</span> per approved
seat will become payable. Afya Brazil does not have a legal or constructive obligation at the acquisition date or at any reporting date.
Upon approval, the additional seats will give rise to additional licenses, which will be recognized and measured at that time, together
with the recognition of the related liability.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Management assessed the aspects of such transaction in accordance with IFRS 3 - Business
Combinations and applied the optional &#8216;concentration test&#8217;, designed to simplify the evaluation of whether an acquired set
of activities and assets is not a business. Since substantially all of the fair value of the gross assets acquired is concentrated in
a single identifiable asset, Management concluded that the transaction does not fall under the definition of a business, but an acquisition
of assets, which were measured on initial recognition at cost allocated to identifiable assets and liabilities on a relative fair value
basis.</p>








<table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_pn3n3_zcYr6u6Ajd7e" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Corporate information (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BE_zb9ZC67chhye" style="display: none">Schedule of identifiable assets and liabilities</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 83%; padding-right: 3.5pt; padding-left: 3.5pt"><b>Assets</b></td>
    <td style="white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cash and cash equivalents</td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zMBwY30cG01d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash and equivalents">3</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Property and equipment</td>
    <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zKzqNGtR8Svb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Property and equipment">2,683</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Intangible assets - Licenses with indefinite useful life</td>
    <td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zFDVFctUyYC" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Intangible assets">99,628</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zTRAGlXx52D" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>102,314</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Liabilities</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Trade payables</td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zghtsN3MIQGj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables">71</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Loans and financing</td>
    <td id="xdx_98A_ecustom--LoansAndFinancingAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zUSmDaDYT1n" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing">2,243</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_981_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zTD15KcIWIZj" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities recognised as of acquisition date"><b>2,314</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Total net assets</b></td>
    <td id="xdx_981_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zb7lxY6QyGvh" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total net assets"><b>100,000</b></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The valuation techniques used to licenses with indefinite useful life, which is the most
representative asset acquired, were the With-and-without method, which consists of estimating the fair value of an asset by the difference
between the value of this asset in two scenarios: a scenario considering the existence of the asset in question and another considering
its non-existence.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><span style="text-decoration: underline">Acquisition in 2024</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On July 1, 2024, Afya Brazil acquired Unidom Participa&#231;&#245;es S.A. (&#8220;Unidom&#8221;).
Unidom is a post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate
programs in medicine and health, as well as other courses. It encompasses &#8220;Unidompedro&#8221; and &#8220;Faculdade Dom Luiz&#8221;,
both located in the State of Bahia with operations in the cities of Salvador, Luis Eduardo Magalh&#227;es, Barreiras and Ribeira do
Pombal. See Note 4.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCorporateInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCorporateInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfGeneralInformationAboutFinancialStatementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfGeneralInformationAboutFinancialStatementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureMaterialAccountingPoliciesAbstract', window );"><strong>Material Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfMaterialAccountingPoliciesExplanatory', window );">Material accounting policies</a></td>
<td class="text"><p id="xdx_803_ecustom--DisclosureOfMaterialAccountingPoliciesExplanatory_zGjNOx92TI29" style="font: 10.5pt Nunito Sans; margin: 0; color: #C00000">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">2</td><td><span id="xdx_822_zfp2L1I6Lw4j">Material accounting policies</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: bold 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">2.1 Basis of preparation</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">These consolidated financial statements have been prepared in accordance with IFRS Accounting
Standards as issued by the International Accounting Standards Board (IFRS Accounting Standards).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In preparing these consolidated financial statements, Management has assessed the Company&#8217;s
ability to continue as a going concern and concluded that the going concern basis of accounting is appropriate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">These consolidated financial statements have been prepared on a historical cost
basis, except for the following items measured at fair value: (i) certain financial instruments - including the contingent consideration
payable to selling shareholders - measured at fair value through profit or loss (Notes 2.3(b) and 12.2.3); (ii) the initial recognition
of identifiable assets and liabilities acquired in business combinations, which are measured at fair value at the acquisition date (Note
4); and (iii) equity-settled share-based payment awards, which are measured at grant-date fair value (Note 14). Disclosures about fair
value hierarchy and valuation techniques for recurring measurements are provided in Note 2.3(b).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Substantially all operations are conducted in Brazil. Accordingly, Management determined
the functional currency of the Company to be the Brazilian real (&#8220;R$&#8221;). These   consolidated financial statements
are presented in R$, and amounts are rounded to the nearest thousand, unless otherwise stated.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company improved the presentation of some items in the consolidated statement of income
and other comprehensive income for the current year, by segregating the &#8216;Allowance for expected credit losses&#8217; expenses from
the &#8216;Selling, general and administrative expenses&#8217; and the &#8216;Other income&#8217; and &#8216;Other expenses&#8217; from
the &#8216;Other income (expenses), net&#8217;. To ensure comparability, the Company reflected these changes in the previous years.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">These  consolidated financial statements were authorized for issue by the Board
of Directors on March 12, 2026.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>2.2 Basis of consolidation</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The table below presents a list of the Company&#8217;s subsidiaries and associate:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>






<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zcj6lFUACLga" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B5_zynWLHfQVvif" style="display: none">Schedule of company&#8217;s subsidiaries and associate</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Direct and indirect interest</b></span></td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; width: 260px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Name</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 165px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Main activities</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 106px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Location</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Investment type</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 94px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2025</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 95px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2024</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Afya Participa&#231;&#245;es S.A. (&#8220;Afya Brazil&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90F_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zv5MTqPDekz" title="Principal activities">Holding</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zPQvVIsNbXAl" title="Location">Nova Lima - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zPhxWSLNNFYb" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z3dUyGsNEGAj" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zykxwE9jljwb" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto Tocantinense Presidente Ant&#244;nio Carlos Porto S.A. - (&#8220;ITPAC Porto&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zN6FDhFYiu8g" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_z6JBWPXjcXY9" title="Location">Porto Nacional - TO</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zHBIi1cxo8R2" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zIegwX923u7h" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_z9fDNnTtrmke" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto Tocantinense Presidente Ant&#244;nio Carlos S.A. - (&#8220;ITPAC Aragua&#237;na&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zeVY7TuruoTj" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zmJbPAAr1cw2" title="Location">Aragua&#237;na - TO</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zDNrwBhUTADl" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zBxnAE9RObwa" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_z7lLtAtqjHJ5" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Uni&#227;o Educacional do Vale do A&#231;o S.A. - (&#8220;UNIVA&#199;O&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zb1MPrkWtBj7" title="Principal activities">Medicine undergraduate degree program</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zkBKk14iQtJ3" title="Location">Ipatinga - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_ztAaXWaBOmXk" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zq7PR9YcZf4l" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z3hzjt4buVzc" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#8220;IPTAN&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zKEFurG6PIJk" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_z34RwQCvWmkg" title="Location">S&#227;o Jo&#227;o Del Rei - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zC6MdwGisMA3" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zYYLghJr7UPh" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_z3Vs4M6uzCu8" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A. (&#8220;IESVAP&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zxk0We0LsPTa" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zIGxc588gUV3" title="Location">Parna&#237;ba - PI</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_909_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zP79vi4r5u25" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zLKyjBMsY4q" title="Direct and indirect interest of subsidiary">80</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zqRuGSlSR3c5" title="Direct and indirect interest of subsidiary">80</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Centro de Ci&#234;ncias em Sa&#250;de de Itajub&#225; S.A. (&#8220;CCSI&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90C_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_znpmsbq0xH48" title="Principal activities">Medicine undergraduate degree program</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zRwHby9YAzig" title="Location">Itajub&#225; - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z4hzcx6IE5V5" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zQRvYSVGO8l1" title="Direct and indirect interest of subsidiary">75</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zqvLSDfXd139" title="Direct and indirect interest of subsidiary">75</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto de Ensino Superior do Piau&#237; S.A. (&#8220;IESP&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zj3jTfZwlLji" title="Principal activities">Undergraduate and graduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_ztDnmW1MZkv1" title="Location">Teresina - PI</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zdGWxYEdRXe1" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_znSqGAUxHmSh" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zSkFjQ6kWxcj" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">FADEP - Faculdade Educacional de Pato Branco Ltda. (&#8220;FADEP&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zHlgWNtXlL1i" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_z56ixa0OF8z1" title="Location">Pato Branco - PR</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zngY2U4fEaAc" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zSdYtCrll9g3" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zmiMsMyM8Z15" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto Educacional Santo Agostinho S.A. (&#8220;FASA&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zEGxfStAXTxh" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zj2TQxkuupd1" title="Location">Montes Claros - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zItnb4CAdbX7" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zyjNud4yCVT9" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zjp7cIlEofq4" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto Paraense de Educa&#231;&#227;o e Cultura Ltda. (&#8220;IPEC&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zdUIpIjzmRrf" title="Principal activities">Medicine undergraduate degree program</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_900_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_z6DdHhd4Xmza" title="Location">Marab&#225; - PA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zr87jn2JTCXc" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zcjdzX044wOl" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zqUtS4RqBPee" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Sociedade Universit&#225;ria Redentor S.A. (&#8220;UniRedentor&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_909_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_za0Q6jdh9pak" title="Principal activities">Undergraduate and graduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z6VCJPMUsi1f" title="Location">Itaperuna - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zD4jfTDq71j6" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zIVijpv6VO43" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z07aHHXjuuVe" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Centro de Ensino S&#227;o Lucas Ltda. (&#8220;UniSL&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zIhMyuuAKua2" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zhZhAnIDU9E1" title="Location">Porto Velho - RO</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zQRwvub5eTIa" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zgs2o9pY6Cmh" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zlDyTrQuIJg4" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Sociedade de Educa&#231;&#227;o, Cultura e Tecnologia da Amaz&#244;nia S.A. - (&#8220;FESAR&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zcHSROCuWJM7" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zkf4DTOFkzh" title="Location">Reden&#231;&#227;o - PA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zMBjyVKo2kyl" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zOZfqEkf5plj" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zVx33b2Z4SE5" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Centro Superior de Ci&#234;ncias da Sa&#250;de Ltda. (&#8220;FCMPB&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zPJljvKsTKY3" title="Principal activities">Medicine undergraduate degree program</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_ztgmy5KQZoL4" title="Location">Jo&#227;o Pessoa - PB</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zixh7etHMAs6" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zhDdMICkhOpj" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zZUHbrDe94Qb" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">iClinic Desenvolvimento de Software Ltda. (&#8220;iClinic&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zKFuIzZDoVdb" title="Principal activities">Electronic Medical Record, Clinical Management System</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zYO3zEnLze0d" title="Location">Ribeir&#227;o Preto - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zKMoyotrxxZc" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zq9uudZ4Wu6a" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Medicinae Solutions S.A. (&#8220;Medicinae&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z1SofMPFPlO2" title="Principal activities">Healthcare payments and financial services</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zMOTdOw90wve" title="Location">Rio de Janeiro - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z4wGxD0Is5yf" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zaNYs0QSrnjl" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Medical Harbour Aparelhos M&#233;dico Hospitalares e Servi&#231;os em Tecnologia Ltda. (&#8220;Medical Harbour&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90C_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zo5yxSCK4fcb" title="Principal activities">Educational health and medical imaging</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_z2EEbHDK43ib" title="Location">Florian&#243;polis - SC</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zXJnbFmJVJmf" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_ztoRoXecM1yk" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zUZr9aZ30Ma9" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Cliquefarma Drogarias Online Ltda. (&#8220;Cliquefarma&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90F_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_z2RckVYleRaf" title="Principal activities">Online platform</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zzCRFheNCFXj" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zf65vluVhRD7" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zYEwq8HrPsHl" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Shosp Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_907_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zh0RFfKTO0h" title="Principal activities">Electronic Medical Record, Clinical Management System</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zZWb9ilnXxli" title="Location">Rio de Janeiro - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zqPVdXTXS105" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zT1Zp6mEFvBd" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Sociedade Padr&#227;o de Educa&#231;&#227;o Superior Ltda. (&#8220;UnifipMoc&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_z6QpELqIicFk" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zKBF85Ceu6yg" title="Location">Montes Claros - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zsVdwsb7WRs7" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zDX65F3q2SW7" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zkeolXEixvxa" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Companhia Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura (&#8220;Unigranrio&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zJnkuIR4kAHf" title="Principal activities">Undergraduate and graduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zXNJn29mYOTi" title="Location">Duque de Caxias - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_905_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zSWG75kMUPD5" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zdOLXBhYnt9c" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_ztanF7UNSRe8" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">RX PRO Solu&#231;&#245;es de Tecnologia Ltda. (&#8220;RX PRO&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z6RLl3YkQS22" title="Principal activities">Marketing for pharmaceutical industry</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zBQeFbmIbl35" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90B_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zrtDD8tW8W01" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z47hLNellYa9" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Quasar Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#8220;Glic&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zPT1tFS9JPw2" title="Principal activities">Patient physician relationship</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zHZNuhCaxm9i" title="Location">Barueri - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90F_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zcLRpP7Rhg04" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zTW4DPdvqT39" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#8220;DelRey&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zBVWD5GCo51f" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zQDYBK2PrV13" title="Location">Macei&#243; - AL</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zJ6HBLFonPJg" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zNsgE3mViXsd" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zhodVdvKA1zj" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Unidom Participa&#231;&#245;es S.A. (&#8220;Unidom&#8221;) (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_z2lVPdfMwtl3" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_zpQPon9Ub1i3" title="Location">Salvador - BA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_za1ZaEX8hrqh" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_zh9cTJCFCe95" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Institui&#231;&#227;o Baiana de Ensino Superior Ltda. (&#8220;IBES&#8221;) (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_z1Saz06WwUnl" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zICkxiPWlCa1" title="Location">Salvador - BA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zxUSj3cpH6pg" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zuMSslRL2ALl" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zH5T8zK1k4Cj" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">SESSA - Sociedade de Educa&#231;&#227;o Superior do Semi-&#193;rido Ltda. (&#8220;SESSA&#8221;) (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zv50ehHClrB7" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zpgyLpqvA3Jf" title="Location">Ribeira de Pombal - BA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zHSATSvTBwKi" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zMQpJh7s9Wka" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zsoKyXtcwfZ2" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Faculdade Masterclass Ltda. (&#8220;FUNIC&#8221;) (iii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zJLSGdjCKky1" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_ziHX1c9NEdm1" title="Location">Contagem - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zNS2Ibga4wN3" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zWJegr0aqI2c" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Uni&#227;o Educacional do Planalto Central S.A. (&#8220;UEPC&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zAfk9pP4wRYg" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zVDZlkJfGQFf" title="Location">Bras&#237;lia - DF</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zRtK0fl0ttEa" title="Investment type">Associate</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_z9brl7z0M5E4" title="Direct and indirect interest of subsidiary">30</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zBQdakn8im8b" title="Direct and indirect interest of subsidiary">30</span>%</span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0; color: #212121">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="background-color: white">(i)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="background-color: white">Unidom was merged with Afya Brazil on January 1, 2025.
As a result, from this date on, Afya Brazil directly controls the Unidom&#8217;s subsidiaries IBES and SESSA.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="background-color: white">(ii)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="background-color: white">Cliquefarma, RX PRO and Glic were merged with Afya Brazil
in August 2025; iClinic, Medicinae and Shosp were merged with Afya Brazil in October 2025.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="color: #212121; background-color: white">(iii)</span></td><td style="width: 5pt"></td><td style="text-align: justify">See Note 1.</td>
</tr></table>

<p id="xdx_8AE_zzPc0ZzQkUV2" style="font: 10.5pt Nunito Sans; margin: 0; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">The financial information of the
subsidiaries acquired is included in the Company&#8217;s consolidated financial statements beginning on the respective acquisition dates.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">The Company consolidates the financial
information for all entities it controls. Control is achieved when the Company is exposed to, or has rights, to variable returns from
its involvement with the investee and has the ability to affect those returns through its power over the investee.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0; color: #212121">&#160;</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">Consolidation of a subsidiary begins
when the Company obtains control over the subsidiary and it ceases when the Company loses control of the subsidiary. Assets, liabilities,
income and expenses of a subsidiary acquired or disposed of during the year are included in the consolidated financial statements from
the date the Company gains control until the date the Company ceases to control the subsidiary.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">All intra-group assets and liabilities,
equity, income, expenses and cash flows relating to transactions are eliminated in full on consolidation.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">A change in the ownership interest
of a subsidiary, without a change of control, is accounted for as an equity transaction. If the Company loses control over a subsidiary,
it derecognizes the related assets (including goodwill), liabilities, non-controlling interest and other components of equity, while any
resulting gain or loss is recognized in the consolidated statement of income and other comprehensive income.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">Non-controlling interests in the
results and equity of subsidiaries are shown separately in the consolidated statement of financial position, consolidated statement of
income and other comprehensive income and consolidated statement of changes in equity.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>2.3 Summary of material accounting policies</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">This note provides a description of the material accounting policies adopted in
the preparation of these consolidated financial statements in addition to other policies that have been disclosed in other notes to these
consolidated financial statements. These policies have been consistently applied to all periods presented.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify">The accounting policies have been consistently applied to all consolidated
companies.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_842_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zhSI7K0euRz1" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>a) <span id="xdx_866_zkCO45uQlw6f">Business combinations and goodwill</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Business combinations are accounted for using the acquisition method. The cost of an acquisition
is measured as the aggregate of the consideration transferred, which is measured at acquisition date fair value, and the amount of any
non-controlling interests in the acquiree. For each business combination, the Company elects whether to measure the non-controlling interests
in the acquiree at fair value or at the proportionate share of the acquiree&#8217;s identifiable net assets. Acquisition-related costs
are expensed as incurred and included in selling, general and administrative expenses.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company determines that it has acquired a business when the acquired set of activities
and assets include an input and a substantive process that together significantly contribute to the ability to create outputs. The acquired
process is considered substantive if it is critical to the ability to continue producing outputs, and the inputs acquired include an organized
workforce with the necessary skills, knowledge, or experience to perform that process or it significantly contributes to the ability to
continue producing outputs and is considered unique or scarce or cannot be replaced without significant cost, effort, or delay in the
ability to continue producing outputs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Any contingent consideration to be transferred by the acquirer will be recognized at fair
value at the acquisition date. Contingent consideration classified as equity is not remeasured and its subsequent settlement is accounted
for within equity. Contingent consideration classified as an asset or liability that is a financial instrument is measured at fair value
with the changes in fair value recognized in the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Goodwill is initially measured at cost (being the excess of the aggregate of the consideration
transferred and the amount recognized for non-controlling interests and any previous interest held over the net identifiable assets acquired
and liabilities assumed). If the fair value of the net assets acquired is in excess of the aggregate consideration transferred, the Company
re-assesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed and reviews the procedures
used to measure the amounts to be recognized at the acquisition date. If the reassessment still results in an excess of the fair value
of net assets acquired over the aggregate consideration transferred, then the gain is recognized in the consolidated statement of income
and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">After initial recognition, goodwill is measured at cost less any accumulated impairment
losses. For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated to
each of the Company&#8217;s cash-generating units that are expected to benefit from the combination.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Where goodwill has been allocated to a cash-generating unit (&#8220;CGU&#8221;) and part
of the operation within that unit is disposed of, the goodwill associated with the disposed operation is included in the carrying amount
of the operation when determining the gain or loss on disposal. Goodwill disposed in these circumstances is measured based on the relative
values of the disposed operation and the portion of the cash-generating unit retained.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>




<p id="xdx_845_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zarwdTpqf083" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>b) <span id="xdx_867_zq3H1xtNmHMb">Fair value measurement</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Fair value is the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption
that the transaction to sell the asset or transfer the liability takes place either: (i) in the principal market for the asset or liability;
or (ii) in the absence of a principal market, in the most advantageous market for the asset or liability.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The principal or the most advantageous market must be accessible by the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The fair value of an asset or a liability is measured using the assumptions that market
participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</p>

<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">A fair value measurement of a non-financial asset takes into account a market participant's
ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that
would use the asset in its highest and best use.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company uses valuation techniques that are appropriate in the circumstances and for
which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of
unobservable inputs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">All assets and liabilities for which fair value is measured or disclosed in these
consolidated financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input
that is significant to the fair value measurement as a whole:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">Level 1 - Quoted (unadjusted) market prices in active markets
for identical assets or liabilities.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">Level 2 - Valuation techniques for which the lowest level input
that is significant to the fair value measurement is directly or indirectly observable.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">Level 3 - Valuation techniques for which the lowest level input
that is significant to the fair value measurement is unobservable.</span></td>
</tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The following table shows the evaluation techniques used in measuring fair values for financial
instruments classified at level 2 and 3, as well as the significant unobservable inputs used.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock_z9Lfc0gZO6z4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 1)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B4_zeQBW9jYaF54" style="display: none">Schedule of fair values for financial
instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr>
    <td style="border: #D0CECE 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Type</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Valuation technique</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Significant unobservable inputs</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Inter-relationship between significant unobservable inputs and fair value measurement</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt">Level 2 - Stock options and Restricted stock units (Note 14)</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zbWrtvEd8R68" title="Valuation technique">Binomial model: The fair value is estimated by utilizing a simulation of possible future share prices, applying regression analysis, as well as comparing at each potential exercise date the discounted risk-neutral expectation of the option payoff if not exercised, and the relevant exercise price.</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt"><span style="font-size: 7.5pt">&#8226; Expected volatility (December 31, 2025: <span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_ztMnLOO8bvX1" title="Expected volatility">24</span>% to <span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0zfhCwyYU7e" title="Expected volatility">44</span>%; December 31, 2024: <span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvl0bVSRFkng" title="Expected volatility">32</span>% to <span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEOHbmVlM4Rg" title="Expected volatility">45</span>%).</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p id="xdx_982_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zrOsTuY8y0Lh" style="font: 7.5pt Nunito Sans; margin: 0" title="Inter-relationship between significant unobservable inputs and fair value measurement">The estimated fair value</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">would increase (decrease) if the expected volatility were higher (lower).</p></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt">Level 3 - Contingent consideration (Accounts payable to selling shareholders - Note 12.2.3)</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zxIHtVQ8f3Fl" title="Valuation technique">Probability-weighted cash flows: This valuation technique considers the probability-weighted expectation of future cash flow.</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; Expected cash flows (December 31, 2025: R$<span id="xdx_907_ecustom--ExpectedCashFlows_pn3n3_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zwL4LiFAutuh" title="Expected cash flows">325,150</span>;
    December 31, 2024: R$<span id="xdx_908_ecustom--ExpectedCashFlows_pn3n3_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zLTVYXh0aIzi" title="Expected cash flows">314,953</span>).</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; Probability of disbursement (December 31, 2025 and
    2024: <span id="xdx_908_ecustom--ProbabilityOfDisbursement_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zJOYzkxwFFK5" title="Probability of disbursement"><span id="xdx_903_ecustom--ProbabilityOfDisbursement_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z0jpMqr4Ciue" title="Probability of disbursement">100</span></span>%).</p></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p id="xdx_985_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zPlc1vzSNOy9" style="font: 7.5pt Nunito Sans; margin: 0" title="Inter-relationship between significant unobservable inputs and fair value measurement">The estimated fair value would increase (decrease) if:</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; the expected cash flows were higher (lower); or</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; the probability rate were lower (higher).</p></td></tr>
  </table>
<p id="xdx_8A9_zplE3eA2TDq8" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The valuation model for other financial liabilities not measured at fair value considers
the present value of expected payments, discounted using a risk-adjusted discount rate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For assets and liabilities that are recognized in these  consolidated financial
statements at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy
by re-assessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end
of each reporting period.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">At each reporting date, the Company analyzes the movements in the values of assets and
liabilities which are required to be remeasured or reassessed as per the Company&#8217;s accounting policies. For this analysis, the
Company verifies the major inputs applied in the latest valuation by agreeing the information in the valuation computation to contracts
and other relevant documents.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>
<p style="font: 10.5pt Nunito Sans; margin: 0"></p>






<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company also compares the change in the fair value of each asset and liability with
relevant external sources to determine whether the change is reasonable.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For the purpose of fair value disclosures, the Company has determined classes of assets
and liabilities on the basis of the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy,
as explained above.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_843_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_zNMF30lxdisd" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>c) <span id="xdx_869_zpbtmZlgwRZe">Financial instruments - initial recognition and measurement</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><i>Recognition and initial measurement</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; text-align: left">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">Financial assets and financial liabilities are initially recognized when the
Company becomes a party to the contractual provisions of the instrument.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; text-align: left">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">A financial asset (unless it is a trade receivable without a significant financing
component) or financial liability is initially measured at fair value plus or minus, for an item not at fair value through profit or loss
(&#8220;FVTPL&#8221;), transaction costs that are directly attributable to its acquisition or issue. A trade receivable without a significant
financing component is initially measured at the transaction price. However, if the Company has an unconditional right to an amount that
differs from the transaction price (e.g. due to the Company's refund policy), the trade receivable will be initially measured at the amount
of that unconditional right.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 3%"></td><td style="width: 14.2pt"><b>i)</b></td><td><b>Financial assets</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><i>Classification and subsequent measurement</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">On initial recognition, a financial asset is classified as subsequently measured
at: amortized cost; FVOCI - debt investment; FVOCI - equity investment; or FVTPL.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">Financial assets are not reclassified subsequent to their initial recognition
unless the Company changes its business model for managing financial assets, in which case all affected financial assets are reclassified
on the first day of the first reporting period following the change in the business model.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">A financial asset is measured at amortized cost if it meets both of the following
conditions and is not designated as at FVTPL:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">it is held within a business model whose objective is to hold
assets to collect contractual cash flows; and</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">its contractual terms give rise on specified dates to cash
flows that are solely payments of principal and interest (&#8220;SPPI&#8221;) on the principal amount outstanding.</span></td>
</tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">A debt investment is measured at FVOCI if it meets both of the following conditions
and is not designated as at FVTPL:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">it is held within a business model whose objective is achieved
by both collecting contractual cash flows and selling financial assets; and</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">its contractual terms give rise on specified dates to cash
flows that are SPPI on the principal amount outstanding.</span></td>
</tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">On initial recognition of certain equity investments that are not held for trading,
the Company has made an irrevocable election to present subsequent changes in the investment's fair value in OCI.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">This election is made on an investment-by-investment basis.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">All financial assets not measured at amortized cost or FVOCI as described above
(e.g. financial assets held for trading and those that are managed and whose performance is evaluated on a fair value basis) are measured
at FVTPL.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#160;</p>






<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Business model assessment</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company makes an assessment of the objective of the business model in which
a financial asset is held at a portfolio level because this best reflects the way the business is managed and information is provided
to management.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Transfers of financial assets to third parties in transactions that do not qualify
for derecognition are not considered sales for this purpose, consistent with the Company's continuing recognition of the assets.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Assessment whether contractual cash flows are SPPI</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In assessing whether the contractual cash flows are SPPI, the Company considers
the contractual terms of the instrument. This includes assessing whether the financial asset contains a contractual term that could change
the timing or amount of contractual cash flows such that it would not meet this condition. In making this assessment, the Company considers:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;
</span><span style="font-size: 10.5pt">contingent events that would change the amount or timing of cash flows;</span></p>

<p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;
</span><span style="font-size: 10.5pt">terms that may adjust the contractual coupon rate, including variable-rate features;</span></p>

<p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;
</span><span style="font-size: 10.5pt">prepayment and extension features; and</span></p>

<p style="font: 8.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;
</span><span style="font-size: 10.5pt">terms that limit the Company&#8217;s claim to cash flows from specified assets (e.g. non-recourse
features).</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">A prepayment feature is consistent with the SPPI criterion if the prepayment
amount substantially represents unpaid amounts of principal and interest on the principal amount outstanding, which may include reasonable
compensation for early termination of the contract. Additionally, for a financial asset acquired at a discount or premium to its contractual
per amount, a feature that permits or requires prepayment at an amount that substantially represents the contractual par amount plus accrued
(but unpaid) contractual interest (which may also include reasonable compensation for early termination) is treated as consistent with
this criterion if the fair value of the prepayment feature is insignificant on initial recognition. The Company had no financial assets
held outside trading business models that failed the SPPI assessment.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Subsequent measurement and gains and losses</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfMeasurementAndGainsAndLossesTableTextBlock_zis2ByfBzXce" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 2)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_zC3j1pqBL6wc" style="display: none">Schedule
    of measurement and gains and losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr>
    <td style="border: #AEAAAA 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Financial assets at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">FVTPL</p></td>
    <td style="border-top: #AEAAAA 1pt solid; border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; width: 78%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVTPLMember_zdt0sle527kc" title="Financial assets">These assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.</span></span></td></tr>
  <tr>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Financial assets at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">amortized cost</p></td>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FinancialAssetsAtAmortizedCostMember_z95KI8zi7w8d" title="Financial assets at amortized cost">These assets are subsequently measured at amortized cost under the effective interest method. The gross carrying amount is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.</span></span></td></tr>
  <tr>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Debt investments at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">FVOCI</p></td>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCIMember_zvzFySxDw8Gc" title="Debt investments">These assets are subsequently measured at fair value. Interest income calculated under the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.</span></span></td></tr>
  <tr>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Equity investments at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">FVOCI</p></td>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCI1Member_zqC4N7c5azq9" title="Equity investments">These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never reclassified to profit or loss.</span></span></td></tr>
  </table>
<p id="xdx_8AD_ztPiF7ltilEl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><i>Impairment of financial assets</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">Further disclosures relating to impairment of financial assets are also provided
in the following notes:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#8226; Significant accounting judgments, estimates and assumptions - Note 2.5</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#8226; Trade receivables - Note 6</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">The Company recognizes an allowance for expected credit losses (ECLs) for all
debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due
in accordance with the contract and the cash flows the Company expects to receive, discounted at an approximation of the original effective
interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements that are
integral to the contractual terms.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">For trade receivables, the Company applies a simplified approach in calculating
ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for credit losses based on both
quantitative and qualitative information and analysis on the Company&#8217;s historical experience and informed credit assessment, at
each reporting date.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#160;</p>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"></p>






<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">The Company considers a financial asset to be in default when internal or external
information indicates that the Company is unlikely to receive the outstanding contractual amounts in full before considering any credit
enhancements held by the Company. Interest accrual is suspended once a financial asset meets the criteria for default. A financial asset
is written off when there is no reasonable expectation of recovering the contractual cash flows.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><b>ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial liabilities</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; color: #C00000">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><i>Classification, subsequent measurement and gain and losses</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">Financial liabilities are measured at amortized cost or FVTPL. A financial liability
is measured at FVTPL if it is classified as held-for-trading, it is a derivative or it is designated as such on initial recognition. Financial
liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognized in profit or
loss. Other financial liabilities are subsequently measured at amortized cost under the effective interest method. Interest expense and
foreign exchange gains and losses are recognized in profit or loss.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">The Company&#8217;s financial liabilities include trade payables, loans and
financing, lease liabilities, accounts payable to selling shareholders and dividends payable.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_z9Fj5sTtEi95" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>d) <span id="xdx_861_ztY0XKb4WM82">Cash and cash equivalents</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Cash and cash equivalents in the statement of financial position comprise cash at banks
and on hand, and short-term financial investments with an original maturity of three months or less from the date of purchase, held for
the purpose of meeting short-term cash commitments, readily convertible to a known amount of cash and subject to an insignificant risk
of changes in value.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For the purpose of the consolidated statement of cash flows, cash and cash equivalents
consist of cash and short-term financial investments, as they are considered an integral part of the Company&#8217;s cash management.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zUYOD2tsT21g" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>e) <span id="xdx_867_zUczxtH6FQ51">Property and equipment</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Property and equipment are stated at cost, net of accumulated depreciation and accumulated
impairment losses, if any.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Subsequent expenditures are capitalized only if it is probable that the future economic
benefits associated with the expenditure will flow to the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Depreciation is calculated on a straight-line basis over the estimated useful lives of
the assets, except for leasehold improvements, which are depreciated over the shorter of their estimated useful lives or the lease terms.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_pn3n3_zCa4de18nPW9" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 3)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B8_zyCXjuN9UFLf" style="display: none">Schedule of estimated useful lives of
the assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Building</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_ziGG6APQYSt2" title="Useful lives of assets">25</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Machinery and equipment</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zzWQqZWfoZmi" title="Useful lives of assets">10</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Vehicles</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zCsQwDwpnOQ1" title="Useful lives of assets">5</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Furniture and fixtures</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zc5myiWw2ged" title="Useful lives of assets">10</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">IT equipment</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zRJs7ZnMWgl1" title="Useful lives of assets">5</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Library books</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zMkh1AmfUxWl" title="Useful lives of assets">10</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Leasehold improvements</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDRJaGRRs8Cb" title="Useful lives of assets">1</span> - <span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ztPAUspLZAec" title="Useful lives of assets">30</span> years</td></tr>
  </table>
<p id="xdx_8A1_z4OeLS3uKode" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">An item of property and equipment and any significant part initially recognized is derecognized
upon disposal or when no future economic benefit is expected from its use. Any gain or loss arising on the derecognition of the asset
(calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated
statement of income and other comprehensive income when the asset is derecognized.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The residual values, useful lives and methods of depreciation of property and equipment
are reviewed at each financial year end and adjusted prospectively, if appropriate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>






<p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_ztFoOqn5blrl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>f) <span id="xdx_860_zRWo66GqKO3g">Leases</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company assesses at contract inception whether an arrangement is, or contains, a lease.
That is, if the arrangement conveys the right to control the use of an identified asset for a period of time in exchange for consideration.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Company as a lessee</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company applies a single recognition and measurement approach for all leases, except
for short-term leases and leases of low-value assets. The Company recognizes lease liabilities to make lease payments and right-of-use
assets representing the right to use the underlying assets.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Right-of-use assets</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company recognizes right-of-use assets at the commencement date of the lease (i.e.,
the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment
losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities
recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Right-of-use assets are depreciated on a straight-line basis over the shorter of its estimated
useful life and the lease term. The lease term of the contracts for properties range between five and 30 years. Right-of-use assets are
subject to impairment. Refer to the accounting policies in &#8216;Impairment of non-financial assets&#8217;.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Lease liabilities</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">At the commencement date of the lease, the Company recognizes lease liabilities measured
at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance
fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected
to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain
to be exercised by the Company and payments of penalties for terminating a lease, if the lease term reflects the Company exercising the
option to terminate. The variable lease payments that do not depend on an index or a rate are recognized as expense in the period on which
the event or condition that triggers the payment occurs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In calculating the present value of lease payments, the Company uses the incremental borrowing
rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After the commencement date,
the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition,
the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the in-substance
fixed lease payments or a change in the assessment to purchase the underlying asset.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Short-term leases and leases of low-value assets</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company applies the short-term lease recognition exemption to its short-term leases
of properties (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase
option). It also applies the lease of low-value assets recognition exemption to leases that are considered of low value. Lease payments
on short-term leases and leases of low-value assets are recognized as expense on a straight-line basis over the lease term.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zC2NYRBNHPY8" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>g) <span id="xdx_869_zHbrvS2XFx63">Intangible assets</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Intangible assets acquired separately are measured on initial recognition at cost. The
cost of intangible assets acquired in a business combination or asset acquisition is their fair value at the date of acquisition. Following
initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally
generated intangibles, excluding capitalized development costs, are not capitalized and the related expenditure is reflected in the consolidated
statement of income and other comprehensive income in the period in which the expenditure is incurred.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The useful lives of intangible assets are assessed as finite or indefinite.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Intangible assets with finite lives are amortized on a straight-line over the estimated
useful lives and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The estimated useful
lives of intangible assets are as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zKBgfLCXIwy8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 4)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BA_zJRQ405AQSG4" style="display: none">Schedule of estimated useful
lives of intangible assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="background-color: rgb(213,234,234)">
    <td style="width: 272px; padding-right: 5.4pt; padding-left: 5.4pt">Customer relationships - medicine</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z01NwOJL9RMi" title="Estimated useful lives of intangible assets">6</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Customer relationships - other courses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--CustomerRelationshipsOtherCoursesMember_zXjMKXoWxuC9" title="Estimated useful lives of intangible assets">4.5</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Software</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--ComputerSoftwareMember_zrOjKogqeteh" title="Estimated useful lives of intangible assets">5</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Trademarks</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zB1PLffvirPd" title="Estimated useful lives of intangible assets">2</span> - <span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zWHwkdtG4848" title="Estimated useful lives of intangible assets">30</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Education content, Developed technology and Educational platform</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zQEMtlFWCwaj" title="Estimated useful lives of intangible assets">3</span> - <span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zy0K8Pm1co7e" title="Estimated useful lives of intangible assets">5</span> years</td></tr>
  </table>
<p id="xdx_8A5_zZnnyylInkJ6" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The amortization period and the amortization method for an intangible asset with a finite
useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected pattern of
consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate,
and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in the
consolidated statement of income and other comprehensive income in the expense category that is consistent with the function of the intangible
assets.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Intangible assets with indefinite useful lives are not amortized, but are tested for impairment
annually, either individually or at the cash-generating unit level. The assessment of indefinite life is reviewed annually to determine
whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective
basis.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">An intangible asset is derecognized upon disposal or when no future economic benefits are
expected from its use. Any gain or loss arising upon derecognition of the asset (calculated as the difference between the net disposal
proceeds and the carrying amount of the asset) is included in the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>




<p id="xdx_848_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_z6w2Tca5jcY2" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>h) <span id="xdx_861_z9SxAToULh87">Impairment of non-financial assets</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company assesses, at each reporting date, whether there is an indication that an asset
may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Company estimates the asset&#8217;s
recoverable amount. An asset&#8217;s recoverable amount is the higher of an asset&#8217;s or CGU&#8217;s fair value less costs of disposal
and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that
are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU exceeds its recoverable
amount, the asset is considered impaired and is written down to its recoverable amount.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In assessing value in use, the estimated future cash flows are discounted to their present
value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the
asset. In determining fair value less costs of disposal, recent market transactions are considered. If no such transactions can be identified,
an appropriate valuation model is used. These calculations are corroborated by valuation multiples, quoted share prices for publicly traded
companies or other available fair value indicators.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company bases its impairment calculation on detailed budgets and forecast calculations,
which are prepared separately for each of the Company&#8217;s CGUs to which the individual assets are allocated. These budgets and forecast
calculations cover a period of five years, considering the companies activities and maturation period of its graduate and undergraduate
courses. A long-term growth rate is calculated and applied to project future cash flows after the last projected year.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For impairment testing, goodwill and licenses with indefinite useful lives are allocated
to their respective CGUs. The Company defined each of its operating subsidiaries as a CGU, except for the following which combines subsidiaries:
(i) &#8220;Continuing education&#8221; and (ii) &#8220;Medical practice solutions&#8221;, where the subsidiaries were combined as one
CGU following the business strategy and interdependency of cash flow generation.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Whenever applicable, impairment losses of continuing operations are recognized in the consolidated
statement of income and other comprehensive income in expense categories consistent with the function of the impaired asset.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For assets excluding goodwill, an assessment is made at each reporting date to determine
whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such indication exists,
the Company estimates the asset&#8217;s or CGU&#8217;s recoverable amount. A previously recognized impairment loss is reversed only if
there has been a change in the assumptions used to determine the asset&#8217;s recoverable amount since the last impairment loss was recognized.
The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount
that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years. Such reversal
is recognized in the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Goodwill is tested for impairment annually as at December 31 and when circumstances indicate
that the carrying amounts may be impaired.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Impairment is determined for goodwill by assessing the recoverable amount of each CGU (or
group of CGUs) to which the goodwill relates. When the recoverable amount of the CGU is less than its carrying amount, an impairment loss
is recognized. Impairment losses relating to goodwill cannot be reversed in future periods.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Intangible assets with indefinite useful lives are tested for impairment annually as at
December 31 at the CGU level, as appropriate, and when circumstances indicate that the carrying amounts may be impaired.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForInvestmentsExplanatory_zZfZwtNjoxp9" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>i) <span id="xdx_860_zjk6LVHMzzq3">Investments in associates</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Investments in associates are initially recognized at consideration transferred and adjusted
thereafter for the equity method, being increased or reduced from its interest in the investee's income after the acquisition date. An
associate is an entity over which the Company has significant influence. Significant influence is the power to participate in the financial
and operating policy decisions of the investee, but is not control or joint control over those policies.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The financial statements of the associate are prepared for the same reporting period as
the Company. The accounting policies of the associate are aligned with those of the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>






<p id="xdx_84B_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_zb6FRoiaSayd" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>j) <span id="xdx_863_z9SEOZDjBA3h">Accounts payable to selling shareholders</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">These amounts represent liabilities related to the acquisitions made by the Company which
are not yet due. Accounts payable to selling shareholders are presented as current liabilities unless payment is not due within 12 months
after the reporting period. They are recognized initially at their fair value and subsequently measured at amortized cost using the effective
interest method, except for Unidom&#8217;s contingent consideration, which are measured at fair value through profit or loss.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_zZIZ3k16lWq" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>k) <span id="xdx_863_z8hhHpR9iShj">Provisions</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Provisions are recognized when the Company has a present obligation (legal or constructive)
as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation,
and a reliable estimate can be made of the amount of the obligation. The expense relating to a provision is presented in the consolidated
statement of income and other comprehensive income, net of any reimbursement, when applicable.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_846_ecustom--DividendsPolicyExplanatory_z4XB3eIoFmW9" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>l) <span id="xdx_868_ziIjYpKBuMu9">Dividends</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company recognizes a liability to pay a dividend when the distribution is authorized
and the distribution is no longer at the discretion of the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In respect to the consolidated statement of changes in equity, the amount corresponding
to the non-controlling interest over the dividends declared are recognized directly in equity.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_84F_ecustom--LaborAndSocialObligationsPolicyExplanatory_zxb4E5jJMoLk" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>m) Labor and social obligations</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Labor and social obligations are expensed as the related service is provided. A liability
is recognized for the amount expected to be paid if the Company has a present legal or constructive obligation to pay this amount as a
result of past service provided by the employee and the obligation can be estimated reliably.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_840_ecustom--SharebasedPaymentsPolicyExplanatory_z8dI0b79l0uc" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>n) <span id="xdx_864_zoOEZryg441a">Share-based payments</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Certain key executives of the Company receive compensation in the form of share-based payments,
which includes stock options and restricted stock units (&#8220;RSUs&#8221;), whereby the executives render services as consideration
for equity instruments (equity-settled transactions).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The expense of equity-settled transactions is determined by the fair value at the date
when the grant is made using an appropriate valuation model.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">That expense is recognized in selling, general and administrative expenses, together with
a corresponding increase in equity (Share-based compensation reserve), over the period in which the service (the vesting period) and,
where applicable, the performance conditions are fulfilled. The cumulative expense recognized for equity-settled transactions at each
reporting date until the vesting date reflects the extent to which the vesting period has expired and the Company&#8217;s best estimate
of the number of equity instruments that will ultimately vest. The expense or credit in the consolidated statement of income and other
comprehensive income for a period represents the movement in cumulative expense recognized as at the beginning and end of that period.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Service and non-market performance conditions are not considered when determining the grant
date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Company&#8217;s best estimate of
the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value.
No expense is recognized for awards that do not ultimately vest because non-market performance and/or service conditions have not been
met.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">When the terms of an equity-settled award are modified, the minimum expense recognized
is the grant date fair value of the unmodified award, provided the original vesting terms of the award are met. An additional expense,
measured as at the date of modification, is recognized for any modification that increases the total fair value of the share-based payment
transaction, or is otherwise beneficial to the employee. Where an award is cancelled by the entity or by the counterparty, any remaining
element of the fair value of the award is expensed immediately through the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"></p>






<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The dilutive effect of outstanding options is reflected as additional share dilution in
the computation of diluted earnings per share.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zaCk5ZZBZG3f" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>o) <span id="xdx_864_zZ8xOxplLlol">Earnings per share (&#8220;EPS&#8221;)</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">Basic EPS is calculated by dividing net income attributable to
the owners of the Company by the weighted average number of common shares outstanding during the year.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">Diluted EPS is calculated by dividing net income attributable
to the owners of the Company by the weighted average number of common shares outstanding during the year plus the weighted average number
of shares that would be issued on conversion of all potential shares with dilutive effects.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Diluted earnings per share are computed including stock options granted to key management
using the treasury shares method when the effect is dilutive. The Company has the stock options and RSUs plans in the category of potentially
dilutive shares.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zsxlo93REFmb" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>p) <span id="xdx_862_znolsG70TOC">Revenue from contracts with customers</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company's revenue consists primarily of tuition fees charged for medical courses. The
Company also generates revenue from tuition fees for other undergraduate and graduate courses, administrative and application fees, education
content (e-books), subscription of medical practice solutions services (including medical content platforms, clinical decision-making
application, among other solutions), electronic medical records and marketing for pharmaceutical industry.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Revenue recognition transferred over time </i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Revenue from tuitions, subscription of medical practice solutions services and electronic
medical records are recognized over time when services are rendered to the customer and the Company satisfies its performance obligation
under the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services.
Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Revenues are recognized when services are rendered to the customer and the performance
obligation is satisfied.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Revenue recognition transferred at point in time</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Revenue from sale of education content, online platforms, administrative and application
fees and marketing for pharmaceutical industry are recognized at the point in time when control of the asset or services is transferred
to the customer. For education content this is generally on delivery of the goods and for e-books this is generally on the permission
to access the digital content is granted. The Company considers whether there are other promises in the contract that are separate performance
obligations to which a portion of the transaction price needs to be allocated.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company concluded that it is the principal in its revenue arrangements.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company assesses collectability on a portfolio basis prior to recording revenue. Generally,
in respect to undergraduate programs students cannot re-enroll for the next academic session without satisfactory resolution of any past-due
amounts. If a student withdraws from an institution, the Company's obligation to issue a refund depends on the refund policy at that institution
and the timing of the student's withdrawal. Generally, the refund obligations are reduced over the course of the academic term.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Trade receivables</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Trade receivables represent the Company&#8217;s right to an amount of consideration that
is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to the accounting policies
in &#8216;Financial instruments - initial recognition and measurement&#8217;.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Advances from customers</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Advances from customers (a contract liability) are the obligation to transfer services
to a customer for which the Company has received consideration (or an amount of consideration is due) from the customer, as a result of
pre-paid tuition, digital education content and mobile app subscription for digital medical content received from customers and is recognized
separately in current liabilities, when the payment is received. Advances from customers are recognized as revenue when the Company performs
all obligations related to the contract, over the contract term.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zsryXjCHEuZ4" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>q) <span id="xdx_86B_zrrlk29DYpr">Taxes</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">The Company&#8217;s subsidiaries
in the undergraduate segment joined the PROUNI (<i>Programa Universidade para Todos</i> - University for All Program) program, which is
a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number of student
enrollment for low-income students, and benefits from the exemption of the following federal taxes:</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">&#8226; Income taxes and social contribution</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">&#8226; PIS and COFINS</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">The regulation of PROUNI defines
that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS. For income from other teaching
activities, PIS and COFINS are charged at rates of <span id="xdx_90F_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_ztNcdqw4ON9l" title="Tax rate">0.65</span>% and <span id="xdx_907_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zC9xkyEeVZ9a" title="Tax rate">3.00</span>%, respectively, and for non-teaching activities, PIS is charged at a
rate of <span id="xdx_900_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zoCXn44uATTk" title="Tax rate">1.65</span>% and to COFINS at <span id="xdx_90F_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zK1bbo498xRk" title="Tax rate">7.6</span>%.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Current income taxes</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">Current income taxes were calculated
based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service, specifically regarding the PROUNI
program, which allows exemption of these taxes from traditional and technological graduation activities.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Current income tax assets and liabilities are measured at the amount expected to be recovered
from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively
enacted at the reporting date.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Management periodically evaluates positions taken in the tax returns with respect to situations
in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Additional social contribution from Organization for Economic Co-operation
and Development (&#8220;OECD&#8221;) Pillar Two global minimum tax</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On December 27, 2024, Law 15,079/2024 was enacted, establishing the implementation of the
OECD&#8217;s Pillar Two global minimum tax in Brazil, effective as of January 1, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Law 15,079/2024 aligns the Brazilian tax legislation to the OECD&#8217;s Global Anti-Base
Erosion (GloBE) rules by introducing a minimum effective taxation of <span id="xdx_903_eifrs-full--AverageEffectiveTaxRate_pip0_dp_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zucbD4LVguS4" title="Effective tax">15</span>% through an additional Social Contribution on Net Profit (&#8220;CSLL&#8221;).
This regulation applies to multinational groups within the scope of the OECD&#8217;s GloBE rules, specifically those whose ultimate parent
entity reported annual consolidated revenues of at least &#8364;<span id="xdx_904_ecustom--ConsolidatedRevenues_pn6n6_uEUR_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zek9BvydSMM8" title="Consolidated revenues">750</span> million in at least two of the four fiscal years immediately preceding
the year under review.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The rules are designed to ensure that the additional CSLL qualifies as a Qualified Domestic
Minimum Top-up Tax (QDMTT) under the OECD Inclusive Framework, subjecting Brazilian entities to a minimum tax rate of <span id="xdx_902_ecustom--MinimumTaxRate_pip0_dp_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zmTxN1IaWFhi" title="Minimum tax rate">15</span>%.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On March 28, 2025, the Company filed a writ of mandamus with the Brazilian Federal Court
challenging the enforceability of the newly enacted additional CSLL. The legal proceeding is grounded on constitutional and statutory
arguments, and is waiting for court decision to prevent the collection of the additional CSLL, which is scheduled to be disbursed in 2026
with respect to the 2025 fiscal year.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Considering that there is no court decision to date, the Company has recorded the amount
calculated in accordance with current legislation. The additional income tax expense as a result of Law 15,079/2024 for the year ended
December 31, 2025 was R$<span id="xdx_901_eifrs-full--CurrentTaxLiabilitiesCurrent_iI_pn3n3_c20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_z2JcxqbBhCvd" title="Income taxes payable">109,458</span>, accounted as income taxes payable in the current liabilities. The Company has applied the exception to
recognizing and disclosing information about deferred tax assets and liabilities related to Pillar Two income taxes.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Deferred tax</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Deferred tax is provided using the liability method on temporary differences between the
tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Deferred tax liabilities are recognized for all taxable temporary differences, except:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%">&#8226; When the deferred tax liability arises from the initial recognition of goodwill
or an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the
accounting profit nor taxable profit or loss and does not give rise to equal taxable and deductible temporary differences;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; In respect of taxable temporary differences associated with investments in subsidiaries,
associates and interests in joint arrangements, when the timing of the reversal of the temporary differences can be controlled and it
is probable that the temporary differences will not reverse in the foreseeable future.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Deferred tax assets are recognized to the extent that it is probable that taxable profit
will be available against which the deductible temporary differences, and the carry forward of unused tax credits and unused tax losses
can be utilized, except when the deferred tax asset relating to the deductible temporary difference arises from the initial recognition
of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the
accounting profit nor taxable profit or loss and does not give rise to equal taxable and deductible temporary differences.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The carrying amount of deferred tax assets is reviewed at each reporting date and reduced
to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax
asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it
has become probable that future taxable profits will allow the deferred tax asset to be recovered.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company offsets deferred tax assets and deferred tax liabilities if and only if it
has a legally enforceable right to set off current tax assets and current tax liabilities and the deferred tax assets and deferred tax
liabilities relate to income taxes levied by the same taxation authority by the same taxable entity.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Sales tax</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Expenses and assets are recognized net of the amount of sales tax, except:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%">&#8226; When the sales tax incurred on a purchase of assets or services is not recoverable
from the taxation authority, in which case, the sales tax is recognized as part of the cost of acquisition of the asset or as part of
the expense item, as applicable;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; When receivables and payables are stated with the amount of sales tax included.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForTreasurySharesExplanatory_zDR93UtWX9Xl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>r) <span id="xdx_86E_zynYSJo8MDId">Treasury shares</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Own equity instruments that are reacquired (treasury shares) are recognized at cost and
deducted from equity. No gain or loss is recognized in profit or loss on the purchase, sale, transfers under the share-based payments,
issue or cancellation of the Company&#8217;s own equity instruments. Any difference between the carrying amount and the consideration,
if reissued, is recognized in the share premium.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>2.4 Changes in accounting policies and disclosures</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>New and amended standards and interpretations</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The following standards and amendments, which are effective for annual periods beginning
on or after January 1, 2025, have been issued but are not applicable to the Company&#8217;s operations or consolidated financial statements.</p>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i></i></p>








<table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_z2lTvolZvvn6" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 5)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_8B6_zJFR57MUEwle" style="display: none">Schedule
    of changes in accounting policies and disclosures</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Amendment / standard</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS21Member_z8XUqBspnetd" title="Standard">Lack of exchangeability &#8211; Amendments to IAS 21</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90C_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--LackOfExchangeabilityAmendmentsToIAS21Member_gIFDONOCIAP-GOL_ztYW68Jhqa63" title="Description">In August 2023, the IASB issued amendments to IAS 21 The Effects of Changes in Foreign Exchange
    Rates to specify how an entity should assess whether a currency is exchangeable and how it should determine a spot exchange rate when
    exchangeability is lacking. The amendments also require disclosure of information that enables users of its financial statements to understand
    how the currency not being exchangeable into the other currency affects, or is expected to affect, the entity&#8217;s financial performance,
    financial position and cash flows.</span></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C00_gIFDONOCIAP-GOL_ztsgVBnFLjv"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments had no impact on the Company&#8217;s accounting policies, which remained
    unchanged in these  consolidated financial statements for the year ended December 31, 2025.</p></div></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Standards issued but not yet effective</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 24%; text-indent: -21.3pt">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The new and amended standards and interpretations that are issued, but not yet effective,
up to the date of issuance of the Company&#8217;s  consolidated financial statements are presented below. The Company has not
early adopted any other standard, interpretation or amendment that has been issued but is not yet effective. The Company intends to adopt
these new and amended standards and interpretations, if applicable, when they become effective.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Amendment / standard</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_zLUko5jePu6c" title="Standard">Classification and Measurement of Financial Instruments - Amendments to IFRS 9 and IFRS 7</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-BAAR_zkjlISvlyJ43" title="Description">In May 2024, the IASB issued Amendments to the Classification and Measurement of Financial
    Instruments (Amendments to IFRS 9 and IFRS 7), which:</span></p>
    <div id="xdx_C0A_gIFDONOCIAP-BAAR_zkExD70L8Wu5"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Clarifies that a financial liability is derecognized on the &#8216;settlement date&#8217;,
    i.e., when the related obligation is discharged, cancelled, expires or the liability otherwise qualifies for derecognition. It also introduces
    an accounting policy option to derecognize financial liabilities that are settled through an electronic payment system before settlement
    date if certain conditions are met</p></div>
    <div id="xdx_C05_gIFDONOCIAP-BAAR_zl5EKJmYu0D6"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Clarified how to assess the contractual cash flow characteristics of financial assets
    that include environmental, social and governance (ESG)-linked features and other similar contingent features</p></div>
    <div id="xdx_C0C_gIFDONOCIAP-BAAR_zXZjZnmDVoka"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Clarifies the treatment of non-recourse assets and contractually linked instruments</p></div>
    <div id="xdx_C08_gIFDONOCIAP-BAAR_zGNTWdsE70dd"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Requires additional disclosures in IFRS 7 for financial assets and liabilities with
    contractual terms that reference a contingent event (including those that are ESG-linked), and equity instruments classified at fair value
    through other comprehensive income</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0A_gIFDONOCIAP-BAAR_zITb02JpFPWc"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Entities can early adopt the amendments that relate to the classification of financial assets plus the related disclosures and
    apply the other amendments later.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0F_gIFDONOCIAP-BAAR_z0cxvEBa6aYf"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</p></div></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_zZMM05VKXtCd" title="Standard">Annual Improvements to IFRS Accounting Standards - Volume 11</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_gIFDONOCIAP-WCSGRG_zybD7ZfXRgpk" title="Description">In July 2024, the IASB issued Annual Improvements to IFRS Accounting Standards - Volume
    11. The following is a summary of the topics subject to amendments from the Annual Improvements to IFRS Accounting Standards - Volume
    11:</span></p>
    <div id="xdx_C0A_gIFDONOCIAP-WCSGRG_zxAD1eGVVtBh"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 1 First-time Adoption of International Financial Reporting Standards</p></div>
    <div id="xdx_C0D_gIFDONOCIAP-WCSGRG_znk2wakMtSe1"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 7 Financial Instruments: Disclosures: Gain or Loss on Derecognition</p></div>
    <div id="xdx_C0F_gIFDONOCIAP-WCSGRG_zliiiu9lVw48"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Guidance on implementing IFRS 7 Financial Instruments: Disclosures</p></div>
    <div id="xdx_C05_gIFDONOCIAP-WCSGRG_zGd4UI1Blmv8"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 9 Financial Instruments</p></div>
    <div id="xdx_C01_gIFDONOCIAP-WCSGRG_zx4B8x3qLari"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 10 Consolidated Financial Statements</p></div>
    <div id="xdx_C00_gIFDONOCIAP-WCSGRG_z9bOzr2sDbL1"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IAS 7 Statement of Cash Flows</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C05_gIFDONOCIAP-WCSGRG_zvrWub3MXcHg"><p style="font: 7.5pt Nunito Sans; margin: 0">These amendments are effective for annual periods beginning on or after January 1, 2026.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C05_gIFDONOCIAP-WCSGRG_z4adLiUXIh56"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</p></div></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_z7y593ZhC2Fd" title="Standard">Nature-dependent Electricity Contracts &#8211; Amendments to IFRS 9 and IFRS 7</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90B_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-NDD_zo9W1bJrgfR1" title="Description">In December 2024, the IASB issued Contracts Referencing Nature-dependent Electricity (Amendments
    to IFRS 9 and IFRS 7), clarifying the application of the &#8216;own-use&#8217; requirements; permitting hedge accounting if these contracts
    are used as hedging instruments; and adding new disclosure requirements to enable investors to understand the effect of these contracts
    on a company&#8217;s financial performance and cash flows.</span></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0B_gIFDONOCIAP-NDD_zJ4HQK4N9f39"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Early adoption is permitted, but will need to be disclosed.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C00_gIFDONOCIAP-NDD_zUqyDVEPe8tk"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</p></div></td></tr>
  </table>



<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_zjKS3Rce4spl" title="Standard">IFRS 18 &#8211; Presentation and Disclosure in Financial Statements</span></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_908_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_gIFDONOCIAP-XTV_zJYW1fCYY9l7" title="Description">In April 2024, the IASB issued IFRS 18, which replaces IAS 1 Presentation of Financial Statements.
    IFRS 18 introduces new requirements for presentation within the statement of income, including specified totals and subtotals. Furthermore,
    entities are required to classify all income and expenses within the statement of income into one of five categories: operating, investing,
    financing, income taxes and discontinued operations, whereof the first three are new.</span></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0C_gIFDONOCIAP-XTV_z0z3tJ4qoMj5"><p style="font: 7.5pt Nunito Sans; margin: 0">It also requires disclosure of management-defined performance measures, subtotals of income
    and expenses and includes new requirements for aggregation and disaggregation of financial information based on the identified &#8220;roles&#8221;
    of the primary financial statements (PFS) and the notes.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C07_gIFDONOCIAP-XTV_zDB2Ec8H07d5"><p style="font: 7.5pt Nunito Sans; margin: 0">In addition, narrow-scope amendments have been made to IAS 7 Statement of Cash Flows, which
    include changing the starting point for determining cash flows from operations under the indirect method, from &#8216;profit or loss&#8217;
    to &#8216;operating profit or loss&#8217; and removing the optionality around classification of cash flows from dividends and interest.
    In addition, there are consequential amendments to several other standards.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0E_gIFDONOCIAP-XTV_z7Lw8rr9h7P2"><p style="font: 7.5pt Nunito Sans; margin: 0">IFRS 18, and the amendments to the other standards, is effective for reporting periods beginning
    on or after January 1, 2027 and must be applied retrospectively. Early adoption is permitted and must be disclosed.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C04_gIFDONOCIAP-XTV_zwXw9WdU0HY3"><p style="font: 7.5pt Nunito Sans; margin: 0">The Company is currently working to identify all IFRS 18 impacts on the consolidated financial
    statements.</p></div></td></tr>
  </table>
<p id="xdx_8A7_zQ4teMoATgy2" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>2.5 Significant accounting judgments, estimates and assumptions</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The preparation of the Company&#8217;s consolidated financial statements requires management
to make judgments, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the accompanying
disclosures. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment to the carrying
amount of assets or liabilities affected in future periods. Accounting estimates and judgments are continually evaluated and are based
on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revisions to estimates are recognized prospectively.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Other disclosures relating to the Company&#8217;s exposure to risks and uncertainties include:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; Financial instruments risk management objectives and policies - Note 12.4</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; Sensitivity analysis - Note 12.4.1</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b><i>Estimates and assumptions</i></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The key assumptions about the future and other key sources of estimated uncertainty as
of the reporting date that include a significant risk of a material adjustment to the carrying amounts of assets and liabilities within
the next financial year, are described below. The Company based its assumptions and estimates on parameters available when the consolidated
financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market
changes or circumstances that arise and that are beyond the Company&#8217;s control. Such changes are reflected in the assumptions when
they occur.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Identification and fair-value measurement of assets and liabilities
acquired in a business combination</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Business combinations are accounted for using the acquisition method. Such method requires
recognizing and measuring the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree.
The Company, as the acquirer, must classify or designate the identifiable assets and liabilities assumed on the basis of its own contractual
terms, economic conditions, operating and accounting policies and other relevant conditions as at the acquisition date. Moreover, the
acquisition method required the fair value measurement of contingent consideration liabilities, when applicable, such as the Unidom consideration
conditioned upon the maintenance of the authorization of the 175 operating medical school seats. Such assessments require judgments from
the Company on the methods used to determine the fair value of the consideration transferred, including contingent consideration, assets
acquired and liabilities assumed, including valuation techniques that may require prospective financial information inputs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Impairment of non-financial assets</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Impairment exists when the carrying amount of an asset or CGU or group of CGUs exceeds
its recoverable amount, defined as the higher of its fair value less costs of disposal and its value in use. The fair value less costs
of disposal calculation is based on data available from binding sales transactions, conducted at arm&#8217;s length, for similar assets
or observable market prices less incremental costs of disposing of the asset. The value in use calculation is based on a discounted cash
flow model (&#8220;DCF&#8221; model). The cash flows are derived from the budget for the next five years and do not include restructuring
activities to which the Company has not yet committed or significant future investments that will enhance the performance of the assets
of the CGU being tested. The recoverable amount is sensitive to the discount rate used for the DCF model as well as to expected future
cash-inflows and the growth rate used for extrapolation purposes.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">These estimates are most relevant to goodwill and indefinite lived intangible assets recognized
by the Company. The key assumptions used to determine the recoverable amount for each CGU, including a sensitivity analysis, are disclosed
and further explained in Note 11.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>






<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Provision for legal proceedings</i></p>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Provisions for labor, tax, and civil risks are recorded for all legal proceedings that
represent probable losses. The assessment of the probability of loss includes the evaluation of available evidence, such as recent court
decisions and the opinion of the Company's internal and external legal counsel, the nature of the proceedings, and past experience.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Provisions are reviewed and adjusted to account for changes in circumstances, such as new
matters or court rulings.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Share-based compensation</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Estimating fair value for share-based payment transactions requires determination of the
most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of
the most appropriate inputs to the valuation model including the expected life of the share option, volatility and dividend yield and
making assumptions about them. For the measurement of the fair value of equity-settled transactions, the Company uses the Binomial model.
The assumptions and models used for estimating fair value for share-based payment transactions are disclosed in Note 14.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Leases - Estimating the incremental borrowing rate</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company cannot readily determine the interest rate implicit in the lease, therefore,
it uses its incremental borrowing rate (IBR) to measure lease liabilities. The IBR is the rate of interest that the Company would have
to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use
asset in a similar economic environment. The IBR therefore reflects what the Company &#8216;would have to pay&#8217;, which requires estimation
when no observable rates are available (such as for subsidiaries that do not enter into financing transactions) or when they need to be
adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary&#8217;s functional currency).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company estimates the IBR using observable inputs (such as market interest rates) when
available and is required to make certain entity-specific estimates.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureMaterialAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureMaterialAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfMaterialAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfMaterialAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">Segment information</a></td>
<td class="text"><p id="xdx_802_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_z3JxFLPwNRqc" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">3</td><td><span id="xdx_82D_zOWQU9rf8ml9">Segment information</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company has three reportable segments as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%">&#8226; Undergraduate, previously denominated Undergrad, which provides educational
services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%">&#8226; Continuing education, which provides medical education (including residency
preparation programs, specialization test preparation and other medical capabilities), specialization and graduate courses in medicine,
delivered through digital and in-person content; and</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; Medical practice solutions, which provides clinical decision, clinical management
and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Segment information is presented consistently with the internal reports provided to the
Company's Chief Executive Officer (CEO), which is the Chief Operating Decision Maker (CODM) and is responsible for allocating resources,
assessing the performance of the Company's operating segments, and making the Company's strategic decisions.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">No operating segments have been aggregated to form the reportable operating segments. There
is only one geographic region, and the results are monitored and evaluated based on the three reportable segments.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The tables below present assets and liabilities information for the Company&#8217;s operating
segments as of December 31, 2025 and 2024:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>





<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_pn3n3_zSfK3M8sPhth" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Segment information (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B1_zQbCp0YvgGU8" style="display: none">Schedule of present assets and liabilities information for the company operating
segments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Nunito Sans; margin: 0"><b>As of December 31, 2025</b></p>
    <p style="font: 8pt Nunito Sans; margin: 0"></p></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment balances)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Total assets</b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z0IDAw4jHPS7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>8,959,964</b></span></td>
    <td id="xdx_984_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhKKNNM0mfFh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>245,697</b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zt62qO9dNl94" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>166,238</b></span></td>
    <td id="xdx_987_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zAkTkn5CCkM2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>9,371,899</b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zrcDiT5vxQq7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>(13,965)</b></span></td>
    <td id="xdx_98B_eifrs-full--Assets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpLEGHzzo0h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>9,357,934</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Current assets</span></td>
    <td id="xdx_988_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5ruOyFRbYZ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">1,765,066</span></td>
    <td id="xdx_987_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsWktpCmqBEh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">92,221</span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zqTUsili2R3e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">98,854</span></td>
    <td id="xdx_980_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrDCgQ9p7n3f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">1,956,141</span></td>
    <td id="xdx_98A_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zn1nKiEvc0fh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">(13,965)</span></td>
    <td id="xdx_985_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3OlXnTazSAe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt"><b>1,942,176</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Non-current assets</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zdSRyzV7O4ub" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">7,194,898</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zXvNrvVOw064" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">153,476</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zt0KShXm39Bk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">67,384</span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zQ0kgMRIFs0l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">7,415,958</span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zXmOyjW5O8ne" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1302">-</span></span></td>
    <td id="xdx_988_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXkvXRg3XHkg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt"><b>7,415,758</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>

<tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Total liabilities and equity</b></span></td>
    <td id="xdx_987_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z8k4ovcS5Ze6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>8,959,964</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zAZL4gjm31d1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>245,697</b></span></td>
    <td id="xdx_981_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zp6bbVklz9M" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>166,238</b></span></td>
    <td id="xdx_98E_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zmpCTizm3iA" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>9,371,899</b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zi8vcYcx4Z7e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>(13,965)</b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFbMO9lRNXR8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>9,357,934</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Current liabilities</span></td>
    <td id="xdx_982_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z85owyqqFng4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">689,074</span></td>
    <td id="xdx_98A_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWTM74SMwxQ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">113,729</span></td>
    <td id="xdx_98F_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zTbEXVx7qBYf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">95,203</span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zyrbRY78RQK2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">898,006</span></td>
    <td id="xdx_981_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z207V2dhGwz3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">(13,965)</span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zT8CalH6QWTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt"><b>884,041</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Non-current liabilities</span></td>
    <td id="xdx_984_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjWmzGn2dUM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">3,474,357</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zoGfUrXntxud" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">84,581</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z1ePEVfZS3zj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">23,770</span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrGojnsC3PA9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">3,582,708</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zdJ9PqmWvoGh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1338">-</span></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zArxUHsHbOXj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt"><b>3,582,708</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Equity</span></td>
    <td id="xdx_981_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_ziroTHJOayVh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">4,796,533</span></td>
    <td id="xdx_981_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zGhPN4u1NvPc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">47,387</span></td>
    <td id="xdx_988_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zGFb5X6QadB6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">47,265</span></td>
    <td id="xdx_984_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zhfAzQa4E3Gd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">4,891,185</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zDEckoRGCa6e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1350">-</span></span></td>
    <td id="xdx_984_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ztwzYi3L8Vdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt"><b>4,891,185</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Other disclosures</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Investment in associate (i) </span></td>
    <td id="xdx_980_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5ZTAlPIIs53" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt">46,518</span></td>
    <td id="xdx_989_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zehfvGCMRDdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1356">-</span></span></td>
    <td id="xdx_983_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zj4fDftvGKB" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrrJviKeuFf9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt">46,518</span></td>
    <td id="xdx_98D_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zqxt4PrBlQSg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1362">-</span></span></td>
    <td id="xdx_984_eifrs-full--InvestmentsInAssociates_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAyOm9Dm5eq1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><b>46,518</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Capital expenditures (ii)</span></td>
    <td id="xdx_983_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zMFtw1eAT74g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">281,313</span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zt9of9eKhbxd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">79,139</span></td>
    <td id="xdx_986_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLflSDjO8589" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">43,559</span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvCDQ3yj7Vf6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">404,011</span></td>
    <td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zBPhcNbewun6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1374">-</span></span></td>
    <td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z259tjoX5We5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt"><b>404,011</b></span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Investment in UEPC is included in non-current assets in the statement of financial position.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Capital expenditures consider the acquisitions of property and equipment and intangible assets.</td>
</tr></table>

<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>As of December 31, 2024</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment balances)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Total assets</b></span></td>
    <td id="xdx_986_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z2LF7qhSBzxj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>8,393,185</b></span></td>
    <td id="xdx_984_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zKNwGOVhAeEi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>274,318</b></span></td>
    <td id="xdx_986_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zj8H9cNmymC6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>170,624</b></span></td>
    <td id="xdx_98A_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZB2DUmNhWb8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>8,838,127</b></span></td>
    <td id="xdx_985_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zT10ExxrPNTe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>(8,588)</b></span></td>
    <td id="xdx_989_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYGEHCRy542b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>8,829,539</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Current assets</span></td>
    <td id="xdx_98D_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zMlTmuiPL2rf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">1,443,566</span></td>
    <td id="xdx_985_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWnchmTlTxYb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">71,893</span></td>
    <td id="xdx_981_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z1WeQM32Mrn6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">82,913</span></td>
    <td id="xdx_983_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZUrdzsrET4i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">1,598,372</span></td>
    <td id="xdx_98B_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zRPrBX1zhByc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">(8,588)</span></td>
    <td id="xdx_988_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmSFAkViuqu7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt"><b>1,589,784</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Non-current assets</span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zT3ESAIVxst8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">6,949,619</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzQaPambi3k9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">202,425</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zPRkQMeNyNYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">87,711</span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zG9IfrjjMKdb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">7,239,755</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zjPJR9QjWyyj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1410">-</span></span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbQozNjcQtk5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt"><b>7,239,755</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Total liabilities and equity</b></span></td>
    <td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zSINTn1sKckl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>8,393,185</b></span></td>
    <td id="xdx_98A_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_ze8A2jR6MO4l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>274,318</b></span></td>
    <td id="xdx_980_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ze9u4pRFomQg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>170,624</b></span></td>
    <td id="xdx_987_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zk6ElIR49Vxa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>8,838,127</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z8GuJNtkzVN4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>(8,588)</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5HoUTMapXYi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>8,829,539</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Current liabilities</span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_znjxdRN6a5U6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">884,705</span></td>
    <td id="xdx_989_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFKaB9kwmC34" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">188,489</span></td>
    <td id="xdx_98F_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_znc5WnXKg6u1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">75,589</span></td>
    <td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziO6npa9sii7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">1,148,783</span></td>
    <td id="xdx_982_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z0b1OG8aE1K" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">(8,588)</span></td>
    <td id="xdx_983_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zix4bAYOMO9i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt"><b>1,140,195</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Non-current liabilities</span></td>
    <td id="xdx_98C_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zUUPvH6fuvJ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">3,279,846</span></td>
    <td id="xdx_98F_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhPCSJP4dF16" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">75,619</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zRPJ8U3p1EI8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">23,296</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z61dd8Z1aZRk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">3,378,761</span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z2QqWhlxFCt5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1446">-</span></span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zZVMZo4q2Qok" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt"><b>3,378,761</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Equity</span></td>
    <td id="xdx_982_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zYve7SyWjGOi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">4,228,634</span></td>
    <td id="xdx_98B_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z9YIrw4PmNbf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">10,210</span></td>
    <td id="xdx_98A_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zir62vAHUIWa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">71,739</span></td>
    <td id="xdx_98A_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zqmZX2clNO3e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">4,310,583</span></td>
    <td id="xdx_980_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zYnOtQwrVGbd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1458">-</span></span></td>
    <td id="xdx_98A_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8uEO0BCIWX2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt"><b>4,310,583</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Other disclosures</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Investment in associate (i) </span></td>
    <td id="xdx_988_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zbZbsQxEf44d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt">54,442</span></td>
    <td id="xdx_98F_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhCTgtN1C07" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1464">-</span></span></td>
    <td id="xdx_98B_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zFlZypv1ZCnj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1466">-</span></span></td>
    <td id="xdx_98A_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zVo3r5KpYT1l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt">54,442</span></td>
    <td id="xdx_980_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_znpS8Xd6eDe7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1470">-</span></span></td>
    <td id="xdx_98F_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUHE5RSocYvg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><b>54,442</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Capital expenditures (ii)</span></td>
    <td id="xdx_98A_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zYKkEYUkXOL5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">301,368</span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zkIyr5bk91Hi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">53,162</span></td>
    <td id="xdx_981_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zFQPaakrKWm3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">38,085</span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zIqMjhB79Fpl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">392,615</span></td>
    <td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zNPGZORnzzP5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1482">-</span></span></td>
    <td id="xdx_985_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z7KWjBhTkMt" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt"><b>392,615</b></span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Investment in UEPC is included in non-current assets in the statement of financial position.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Capital expenditures consider the acquisitions of property and equipment and intangible assets.</td>
</tr></table>

<p id="xdx_8A1_zKTvBrzlghw4" style="margin-top: 0; margin-bottom: 0">&#160;</p>








<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The tables below present the statements of income for the Company&#8217;s operating segments
for the years ended December 31, 2025, 2024 and 2023:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_pn3n3_zlV9c1HZlyQb" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Segment information (Details 1)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B3_zxYSJIfbBJ1f" style="display: none">Schedule of statements of income for the company&#8217;s operating
segments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Nunito Sans; margin: 0"><b>December 31, 2025</b></p>
    <p style="font: 8pt Nunito Sans; margin: 0"></p></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">External customer</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zy1tUwUyUADa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">3,255,426</span></td>
    <td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zQvcf43sFzzh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">275,705</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zvIutQCpXlt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">166,124</span></td>
    <td id="xdx_98B_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdjy8E85eiYh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">3,697,255</span></td>
    <td id="xdx_98A_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zaQhbCuBZEo5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1498">-</span></span></td>
    <td id="xdx_98D_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2q8YukRrlTb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">3,697,255</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zzGxg9eDhtj3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1502">-</span></span></td>
    <td id="xdx_98C_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zr7PPPYIPRte" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">8,766</span></td>
    <td id="xdx_98E_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zxmcM7nJqfX6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">5,199</span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zm5pDuZo4B5k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">13,965</span></td>
    <td id="xdx_982_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3CfNyKrDkk4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">(13,965)</span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zkvmdqCvG7N2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1512">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zgtJHgIdWoR7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>3,255,426</b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z4Vq3CArKr47" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>284,471</b></span></td>
    <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zWttKLWZHCg7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>171,323</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z2shCJp1fm26" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>3,711,220</b></span></td>
    <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zUF2XQoQc3ui" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>(13,965)</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zL1PzHZprqyf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>3,697,255</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zttXNdJA7Ne5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,176,785)</span></td>
    <td id="xdx_980_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zaaUNiUOwLdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(96,346)</span></td>
    <td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zaNhLMvx5trd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(54,729)</span></td>
    <td id="xdx_989_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvQqLCRbz6l9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,327,860)</span></td>
    <td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3tjdhLuAIqg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">13,965</span></td>
    <td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUX0Chni0r53" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,313,895)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zJa7u2x11Kab" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>2,078,641</b></span></td>
    <td id="xdx_98D_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdWK02lcT0E8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>188,125</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zakNsS8XEcP6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>116,594</b></span></td>
    <td id="xdx_984_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zBmJbPpzL24k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>2,383,360</b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zgZaWjp2sqR7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1546">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ze3cy6RpNyJc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>2,383,360</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">SG&amp;A expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zsQ8RFW64ox4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"><span style="font-size: 8pt">(1,113,065)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Allowance for expected credit losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98F_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zahZHIYhqjUi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Allowance for expected credit losses"><span style="font-size: 8pt">(57,090)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--OtherIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWBfPaRz5ou6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-size: 8pt">18,762</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--OtherGainsLosses_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfYI2NA4CPsb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-size: 8pt">(18,857)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGTvmiEeHLW1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-size: 8pt"><b>1,213,110</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--FinanceIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcipjbWqr7y1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-size: 8pt">194,943</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_986_ecustom--FinanceExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zjkmgaeSWpyi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-size: 8pt">(561,024)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Share of profit of equity-accounted investee, net of tax</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2yROqgskKyh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-size: 8pt">13,916</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zhMcSR9VyNk7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-size: 8pt"><b>860,945</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zV45npikcmc9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-size: 8pt">(92,502)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98C_eifrs-full--ProfitLoss_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfm1WQsz8uXg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-size: 8pt"><b>768,443</b></span></td></tr>
  </table>
<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>December 31, 2024</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">External customer</span></td>
    <td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zBWIPxykQn17" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">2,895,692</span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0v4MTsDbOn5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">251,636</span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ztCPWSJNQJYe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">157,001</span></td>
    <td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z7d0c2hb9tag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">3,304,329</span></td>
    <td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNqSPqzGiQQ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1580">-</span></span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zT183rga31pk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">3,304,329</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_989_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zWR3FkKS8Kr1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1584">-</span></span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znuytYBCVInh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">3,802</span></td>
    <td id="xdx_98D_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zgpyI2upzxo4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">4,786</span></td>
    <td id="xdx_986_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zT4GubTFGLPh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">8,588</span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zJ7uZZ2lYezl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">(8,588)</span></td>
    <td id="xdx_98D_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zaNYPQ6oli6c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1594">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5btkVQHaLZ7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>2,895,692</b></span></td>
    <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zPdikYW8WLI3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>255,438</b></span></td>
    <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zVyTc1f4ZgSj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>161,787</b></span></td>
    <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zU7yPuVCQYs7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>3,312,917</b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zGojnr9sWC7f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>(8,588)</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXQb1fTzg4t4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>3,304,329</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_znE9qbRRraVa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,086,081)</span></td>
    <td id="xdx_983_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsaiV1k55mOj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(96,180)</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zc0n48tL8g51" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(41,930)</span></td>
    <td id="xdx_988_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zarm0F2DYLYk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,224,191)</span></td>
    <td id="xdx_983_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zz1btLHuoW1h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">8,588</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxWaofoge8a4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,215,603)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjocHooAiff1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>1,809,611</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zDbRwSwPM77g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>159,258</b></span></td>
    <td id="xdx_984_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z85fEFwzuQ1g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>119,857</b></span></td>
    <td id="xdx_98C_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zD1GCLbqr7Dc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>2,088,726</b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zbBcl2EFfeTl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1628">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zP7vcl50NgJ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt"><b>2,088,726</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">SG&amp;A expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_988_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z86ld6yA3Jqi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"><span style="font-size: 8pt">(1,008,427)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Allowance for expected credit losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98D_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zj7Hy5K1VuA8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Allowance for expected credit losses"><span style="font-size: 8pt">(60,894)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98F_eifrs-full--OtherIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zd2jDp8LO9s1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-size: 8pt">13,299</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_986_eifrs-full--OtherGainsLosses_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zkvma7C067ke" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-size: 8pt">(20,591)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zRmRQ6KIqTDb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-size: 8pt"><b>1,012,113</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--FinanceIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3zT0jnjfS4l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-size: 8pt">111,283</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_ecustom--FinanceExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zo4LY5KrVD4k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-size: 8pt">(458,742)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Share of profit of equity-accounted investee, net of tax</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCYR34rtwRUc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-size: 8pt">11,737</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--ProfitLossBeforeTax_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zHHNFga5ouQ5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-size: 8pt"><b>676,391</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAgfxqJd7dc2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-size: 8pt">(27,471)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--ProfitLoss_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMVIHIivPYfi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-size: 8pt"><b>648,920</b></span></td></tr>
  </table>





<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>December 31, 2023</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">External customer</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zPZsxW6js1ua" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">2,511,018</span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRqBPrXPZg27" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">227,181</span></td>
    <td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zJpTQYr3a1S" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">137,714</span></td>
    <td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zKImPt23t0P8" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">2,875,913</span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zn1QYQ4ucN76" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1663">-</span></span></td>
    <td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z56QTe3JQgWd" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">2,875,913</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zxlpN3cYRQlc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1667">-</span></span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zchtRXv5rWx5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">8,649</span></td>
    <td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLyHp2DSpUpj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">2,568</span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJWcVSALG3c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">11,217</span></td>
    <td id="xdx_985_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z1uCXgRR1I9l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">(11,217)</span></td>
    <td id="xdx_985_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z1TupQJ4Swcj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1677">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zXim7TUBLj72" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>2,511,018</b></span></td>
    <td id="xdx_98B_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z35nJmQgwIZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>235,830</b></span></td>
    <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zlLcmYX4vLqg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>140,282</b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zobFF2vSoOOf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>2,887,130</b></span></td>
    <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zoJd3B4Ud28g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>(11,217)</b></span></td>
    <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zl9DyY9LCiNl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>2,875,913</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Cost of services</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zf8SGki3wZw2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(997,973)</span></td>
    <td id="xdx_981_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0gI8uZCvl57" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(91,915)</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zChfF1NJAS06" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(31,142)</span></td>
    <td id="xdx_986_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zE0lr67YA9H6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,121,030)</span></td>
    <td id="xdx_98D_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zP80YVjk7mJd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">11,217</span></td>
    <td id="xdx_986_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zDqY2iSHyKLh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,109,813)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_985_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zo7UraGR0W41" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>1,513,045</b></span></td>
    <td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zMHxzgoP5ZG" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>143,915</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ziC6iTIJ76ba" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>109,140</b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zME1wBXQsR7e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>1,766,100</b></span></td>
    <td id="xdx_985_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAIY8FIQDERd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1711">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5ZvizdvLe0f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>1,766,100</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">SG&amp;A expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_988_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zQHot6fEnyY5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"><span style="font-size: 8pt">(940,132)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Allowance for expected credit losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98F_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYXewfwlwK7e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Allowance for expected credit losses"><span style="font-size: 8pt">(74,552)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_982_eifrs-full--OtherIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIbmjr5sk3Ul" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-size: 8pt">53,206</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_981_eifrs-full--OtherGainsLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zY77776koTFh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-size: 8pt">(37,561)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_983_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJzgZW3z9pDb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-size: 8pt"><b>767,061</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_987_eifrs-full--FinanceIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zZjvOdgB9aJ2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-size: 8pt">110,642</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_ecustom--FinanceExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zm2Os64kyz8k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-size: 8pt">(457,616)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Share of profit of equity-accounted investee, net of tax</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98F_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zeFV66qrZtch" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-size: 8pt">9,495</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlQ06Zi28mki" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-size: 8pt"><b>429,582</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98D_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdh1hrDVjKJb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-size: 8pt">(24,166)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--ProfitLoss_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAFo3aRZMmLb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-size: 8pt"><b>405,416</b></span></td></tr>
  </table>

<p id="xdx_8AC_z8cj1i9nMjc7" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory', window );">Business combinations</a></td>
<td class="text"><p id="xdx_800_eifrs-full--DisclosureOfBusinessCombinationsExplanatory_zbEEnN6TPBEf" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%"><b>4</b></td><td><b><span id="xdx_827_z1aF6XL5KXf4">Business combinations</span></b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>4.1 Acquisition in 2024 (Unidom)</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify">On July 1, 2024, Afya Brazil acquired 100% of the share capital of
Unidom, a post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate
programs in medicine and health, as well as other courses. The fair values of the identifiable assets acquired and liabilities assumed
as of acquisition date were:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock_zDEMKjZWgrsa" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Business combinations (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B0_zkeUb1kFaXh5" style="display: none">Schedule of fair values of the identifiable assets acquired and liabilities</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 83%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Unidom</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Assets</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Cash and cash equivalents</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zK0MlxswDzBa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash and equivalents"><span style="font-size: 7.5pt">3,272</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Trade receivables</span></td>
    <td id="xdx_987_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zcU0pQXR2Obi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables"><span style="font-size: 7.5pt">9,368</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Advances</span></td>
    <td id="xdx_984_ecustom--AdvancesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zmZBJD7RLy0f" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Advances"><span style="font-size: 7.5pt">94</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Recoverable taxes</span></td>
    <td id="xdx_983_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zhZSTIbMNsOh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Recoverable taxes"><span style="font-size: 7.5pt">82</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Other assets</span></td>
    <td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z8qSPvR4Wdq8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other assets"><span style="font-size: 7.5pt">854</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Indemnification assets</span></td>
    <td id="xdx_983_ecustom--IndemnificationAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zTjUKZA5C853" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Indemnification assets"><span style="font-size: 7.5pt">7,185</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Property and equipment</span></td>
    <td id="xdx_989_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z5BbVzqzsVzk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Property and equipment"><span style="font-size: 7.5pt">5,709</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Rights-of-use assets</span></td>
    <td id="xdx_98B_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zHUXZuYZ6Xr7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Rights-of-use assets"><span style="font-size: 7.5pt">28,989</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Intangible assets</span></td>
    <td id="xdx_98D_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z2nuzWvWX7ef" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Intangible assets"><span style="font-size: 7.5pt">462,042</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zpjqvbbbXa7e" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><span style="font-size: 7.5pt"><b>517,595</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Trade payables</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zzLSYEr6qeC8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables"><span style="font-size: 7.5pt">1,732</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Loans and financing</span></td>
    <td id="xdx_98F_ecustom--LoansAndFinancingAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z9CCZXtMR5a3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing"><span style="font-size: 7.5pt">4,377</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Labor and social obligations</span></td>
    <td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zqcin45llBNc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Labor and social obligations"><span style="font-size: 7.5pt">7,368</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Taxes payable</span></td>
    <td id="xdx_98D_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zZRhWNtwosSj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Taxes payable"><span style="font-size: 7.5pt">5,254</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Other taxes payable (i)</span></td>
    <td id="xdx_98A_ecustom--OtherTaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zrIb79ZxFjA7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other taxes payable"><span style="font-size: 7.5pt">28,274</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Advances from customers</span></td>
    <td id="xdx_983_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zy2y20LMSSRi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Advances from customers"><span style="font-size: 7.5pt">1,234</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Lease liabilities</span></td>
    <td id="xdx_984_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zqb55dTwEBP4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities"><span style="font-size: 7.5pt">28,989</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Provision for legal proceedings</span></td>
    <td id="xdx_984_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z7A2jQo3pOBa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Provision for legal proceedings"><span style="font-size: 7.5pt">7,246</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Other liabilities</span></td>
    <td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zWpajxoyUOi2" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other liabilities"><span style="font-size: 7.5pt">4,393</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98B_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zQqO6n8YhFic" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities recognised as of acquisition date"><span style="font-size: 7.5pt"><b>88,867</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Total identifiable net assets at fair value</b></span></td>
    <td id="xdx_98E_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zWeZWtY8QeG" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-size: 7.5pt"><b>428,728</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Goodwill arising on acquisition</span></td>
    <td id="xdx_987_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zaNykD1C1pt5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill arising on acquisition"><span style="font-size: 7.5pt">192,034</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Purchase consideration transferred</b></span></td>
    <td id="xdx_980_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zy8juCLd7lji" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Purchase consideration transferred"><span style="font-size: 7.5pt"><b>620,762</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Cash paid</span></td>
    <td id="xdx_989_eifrs-full--CashTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zyFGFziSFK81" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash paid"><span style="font-size: 7.5pt">340,773</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Consideration to be transferred</span></td>
    <td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zGbJrEKMUm2j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Consideration to be transferred"><span style="font-size: 7.5pt">279,989</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b><i>Analysis of cash flows on acquisition</i></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transaction costs of the acquisition</span></td>
    <td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20240629__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zNbm8lyzhak8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Transaction costs of the acquisition (included in cash flows from operating activities)"><span style="font-size: 7.5pt">1,793</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Cash paid net of cash acquired with the subsidiary</span></td>
    <td id="xdx_981_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20240629__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zICBVH8O62T" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-size: 7.5pt">337,501</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Net of cash flow on acquisition </b></span></td>
    <td id="xdx_98C_ecustom--NetOfCashFlowOnAcquisition_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zLCahM7UOSKh" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-size: 7.5pt"><b>339,294</b></span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to deferred tax liabilities arising from transactions prior to Afya&#8217;s acquisition
of Unidom.</td>
</tr></table>

<p id="xdx_8A6_zmytScREcl77" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify">The acquisition contributed with 300 operational medical school seats
to the Undergraduate segment. The authorization request for these 300 medical school seats was made to MEC before the Mais M&#233;dicos
Law was enacted and MEC concluded its analysis and issued Ordinance 630/2020 ("Ordinance") in 2020 to authorize the operation
considering 125 medical school seats. In 2021, as a result of a judicial order, MEC reviewed the Ordinance to authorize the 300 medical
school seats initially requested by Unidom. Such decision was confirmed by a federal judge in the State of Bahia in 2023. Currently,
Unidom has 300 medical school seats authorized, of which 125 are final and 175 are subject to a final conclusion of the aforementioned
court proceedings.</p>
<p style="font: 10.5pt Nunito Sans; margin: 0; text-align: justify"></p>




<p style="font: 10.5pt Nunito Sans; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify"><span id="xdx_905_eifrs-full--DescriptionOfAcquiree_c20240629__20240701__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_z2Vs9R9UtlGa" title="Acquired purchase price">The total consideration of R$620,762, net of Net Debt, is comprised
of: (i) R$340,773 paid in cash on July 1, 2024; and (ii) R$279,989, considering purchase consideration adjustments, payable in up to ten
annual installments, adjusted by the CDI rate, and it is conditioned upon the maintenance of the authorization of the 175 medical school
seats in each of the prior year.</span> The remaining payment balance is accelerated if a final and non-appealable conclusion of the aforementioned
court proceedings, within the 10-year payment period, confirms the authorization for the 175 medical school seats. In turn, if, within
the same 10-year payment period, a final and non-appealable conclusion of the aforementioned court proceedings does not confirm the authorization
for such 175 medical school seats, the remaining payment balance will no longer be due.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">This acquisition was accounted for under IFRS 3 &#8211; Business Combinations.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Transaction costs to date amount to R$<span id="xdx_90D_ecustom--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zXK6gzWZ8fV6" title="Total transaction costs">2,755</span>, which R$<span id="xdx_90D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zl6VFzHp5Txa" title="Transaction costs">1,793</span> were expensed in the year ended
December 31, 2024 (R$<span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20240101__20241231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zFqb930kN4Hf" title="Transaction costs">962</span> in the year ended December 31, 2023) and are included in selling, general and administrative expenses in the
consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company measured the acquired lease liabilities using the present value of the remaining
lease payments at the date of acquisition. The right-of-use assets were measured at an amount equal to the lease liabilities.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">At the acquisition date, the fair value of the trade receivables acquired is substantially
the same as its carrying amount.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The goodwill recognized includes the value of expected synergies arising from the acquisition,
which is not separately recognized. Goodwill is allocated entirely to the Undergraduate segment. The goodwill recognized is not expected
to be deductible for income taxes purposes.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify">The Company did not recognize deferred taxes related to the business
combination because the tax basis and the accounting basis, including fair value adjustments, were the same at the date of the business
combination.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The fair value measurement of separately identified intangible assets acquired are based
on income approach, determined using discounted cash flows, which include significant estimates around revenue growth projections, operating
profit margins projections and discount rate. The Company engaged an independent valuation specialist to assist Management to assess the
fair value of the assets acquired and liabilities assumed at the date of acquisition. The valuation techniques used were as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAcquisitionOfUnidomExplanatory_zj9bALLej2cg" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Business combinations (Details 1)">
  <tr>
    <td><span id="xdx_8B4_z35CnO6fxUci" style="display: none">Schedule
    of intangible assets acquired unidom</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr>
    <td style="border: #D0CECE 1pt solid; width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 74%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Valuation technique</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><b>Licenses</b></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"><b>With-and-without method</b></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"><span id="xdx_90C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20240629__20240701__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesAndFranchisesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfUnidomMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--WithAndWithoutMethodMember_zbPtdWQqJRub" title="Valuation technique">The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.</span></p></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><b>Customer relationships</b></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"><b>Multi-period excess earnings method</b></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"><span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20240629__20240701__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfUnidomMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zxtNXFabTRpd" title="Valuation technique">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</span></p></td></tr>
  </table>
<p id="xdx_8A8_zy1meNcquKQd" style="font: 10.5pt Nunito Sans; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">From the date of acquisition, Unidom contributed R$<span id="xdx_90E_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zZtpGIyjNkF" title="Net revenue">63,643</span> of revenue and R$<span id="xdx_900_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zM1BMk0wtF2c" title="Income loss before income taxes">30,013</span> to income
before income taxes of the Company in the year ended December 31, 2024. If the acquisition had taken place at the beginning of the year,
revenue and income before income taxes for the year ended December 31, 2024 would have been R$<span id="xdx_902_ecustom--IncreaseInRevenue_pn3n3_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zCxumhd2URwc" title="Increase in revenue">3,354,571</span> and R$<span id="xdx_90D_ecustom--IncreaseInIncomeBeforeIncomeTaxes_pn3n3_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zr9vfmrFLfFj" title="Increase in income before income taxes">697,449</span>, respectively.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS03_g59-63_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureCashAndCashEquivalentsAbstract', window );"><strong>Cash And Cash Equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosuresOfCashAndCashEquivalentsExplanatory', window );">Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_805_ecustom--DisclosuresOfCashAndCashEquivalentsExplanatory_z0lEYkx6rx52" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">5</td><td><span id="xdx_829_zvF0lnmuaA2">Cash and cash equivalents</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_zJJ6dpRAmAo1" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Cash and cash equivalents (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BD_znVPwdwoRoS3" style="display: none">Schedule of cash and cash equivalents</span></td>
    <td id="xdx_49D_20251231_zBzTqHllkv1k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_498_20241231_zXEsK4Uqjfnh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--Cash_iI_pn3n3_zWH9qacnoI17" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Cash and bank deposits</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">15,470 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">6,078 </td></tr>
  <tr id="xdx_403_eifrs-full--CashEquivalents_iI_pn3n3_zLYIVr4C2oR4" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Cash equivalents</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1,109,911 </td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">904,937 </td></tr>
  <tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_zXIyr34M4Rzf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Cash and cash equivalents</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>1,125,381 </b></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>911,015 </b></td></tr>
  </table>
<p id="xdx_8A0_z7OdyT4lDSjh" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Cash equivalents correspond to investment funds and Bank Certificates of Deposit (CDB)
with highly rated financial institutions, available for immediate use and have an insignificant risk of changes in value.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">As of December 31, 2025, the average interest on these investments is equivalent to <span id="xdx_906_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_z3PZYQQqTfs3" title="Percentage of average interest">101.2</span>%
of the CDI rate (December 31, 2024: <span id="xdx_90F_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_z8HNS0Zdenbl" title="Percentage of average interest">99.1</span>%). Cash equivalents denominated in U.S. dollars totaled R$<span id="xdx_905_eifrs-full--CashEquivalents_iI_pn3n3_uBRL_c20251231__ifrs-full--CurrencyInWhichInformationIsDisplayedAxis__custom--USDMember_zSeXnNoUw4zi" title="Cash equivalents">23,422</span> as of December 31, 2025 (December
31, 2024: R$<span id="xdx_90D_eifrs-full--CashEquivalents_iI_pn3n3_uBRL_c20241231__ifrs-full--CurrencyInWhichInformationIsDisplayedAxis__custom--USDMember_z5bDxoiXBAA5" title="Cash equivalents">21,610</span>).</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosuresOfCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosuresOfCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">Trade receivables</a></td>
<td class="text"><p id="xdx_80A_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zxVshYmotQQf" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">6</td><td><span id="xdx_825_zbSURry6WVub">Trade receivables</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_zByhnAZtBHNl" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Trade receivables (Details)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BF_z3rvyRXRN7Y8" style="display: none">Schedule of trade accounts receivable</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Tuition fees</td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zPJqv2hIaCL7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">596,568 </td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zxU3kb6OcT1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">488,962 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Educational content (i)</td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zKYDjV68pkHa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">44,679 </td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zHaJpSKmVxA7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">62,194 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">FIES (ii)</td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_z8URSeeVnAqe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">139,158 </td>
    <td id="xdx_988_ecustom--ReceivablesGross_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zEJhmyCsjQ0h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">79,712 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">Educational credits (iii)</td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_z5SF5AF187Kg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">33,399 </td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zKUD0Fp9m9kc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">26,893 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">Mobile app subscription (iv)</td>
    <td id="xdx_989_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zrOUuPQ2sO7c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">21,484 </td>
    <td id="xdx_987_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zQxrS2cTqWvd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">24,223 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">Other</td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zcTwoI5hXHMc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">17,226 </td>
    <td id="xdx_983_ecustom--ReceivablesGross_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zzL5IKSou6e1" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">21,339</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231_zn0Mji0qasyl" style="border-top: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"><b>852,514 </b></td>
    <td id="xdx_985_ecustom--ReceivablesGross_pn3n3_c20241231_zRZEKIkbVCKe" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"><b>703,323 </b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Allowance for expected credit losses</td>
    <td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20251231_zoWUWVhqZfbg" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">(100,156)</td>
    <td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20241231_zprFL58UFyhc" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="(-) Allowance for doubtful accounts">(71,477)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_989_eifrs-full--TradeReceivables_pn3n3_c20251231_zTk8m9Lgcuzc" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, net"><b>752,358 </b></td>
    <td id="xdx_98D_eifrs-full--TradeReceivables_pn3n3_c20241231_z6vYQIjSpNE3" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, net"><b>631,846 </b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_984_eifrs-full--CurrentTradeReceivables_pn3n3_c20251231_zVXqEOuatfN7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">717,373 </td>
    <td id="xdx_988_eifrs-full--CurrentTradeReceivables_pn3n3_c20241231_z0oHGaUDoDC1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">595,898 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20251231_zMT2yhubKIva" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">34,985 </td>
    <td id="xdx_984_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20241231_zCE1dpgvXXz2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">35,948 </td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 7.5pt Nunito Sans; margin: 0">(i) Related to trade receivables from sales of e-books and medical courses through the Continuing
education&#8217;s platform.</p>

<p style="font: 7.5pt Nunito Sans; margin: 0">(ii) Related to trade receivables from the FIES program, created by the Brazilian federal
government to offer financing to low-income students enrolled in undergraduate programs in private higher education institutions.</p>

<p style="font: 7.5pt Nunito Sans; margin: 0">(iii) Related to the financing programs offered by the Company&#8217;s subsidiaries to its
students.</p>

<p style="font: 7.5pt Nunito Sans; margin: 0">(iv) Related to trade receivables from mobile applications subscriptions for Medical practice
solutions.</p>

<p id="xdx_8A6_zk47mO4K7qi8" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">As of December 31, 2025 and 2024, the aging of trade receivables was as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_pn3n3_zs5xJlZzct6g" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Trade receivables (Details 1)">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BD_zWIkavE23pS7" style="display: none">Schedule of aging of trade accounts receivable</span></td>
    <td style="white-space: nowrap; padding-right: -3.35pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: -3.35pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Neither past due nor impaired</td>
    <td id="xdx_989_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z74pHOdCfMXb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">383,887 </td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z7uKZbZUst68" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">327,052</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Past due:</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt">1 to 30 days</td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--NotLaterThanOneMonthMember_zkfaV8fh8q4l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">128,785 </td>
    <td id="xdx_986_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--NotLaterThanOneMonthMember_zmviVnAWAKj9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">97,390</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt">31 to 90 days</td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zZ5lxnu3cKDk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">165,512 </td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zf25PPY6Oxoj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">126,623</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt">91 to 180 days</td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_z36nIiQ1mIQa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">102,369 </td>
    <td id="xdx_985_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zJsqYDFE0QZk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">91,411</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt">More than 180 days</td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanSixMonthsMember_zruq4TDEtiU2" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">71,961 </td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanSixMonthsMember_zTJHwVlTMB6i" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">60,847</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_982_ecustom--ReceivablesGross_iI_pn3n3_c20251231_zpZVFvYk45D5" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"><b>852,514 </b></td>
    <td id="xdx_988_ecustom--ReceivablesGross_iI_pn3n3_c20241231_z91Szi6EAZ1h" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"><b>703,323</b></td></tr>
  </table>
<p id="xdx_8A8_zYZZZyriGBZ9" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The changes in the allowance for expected credit losses for the years ended December 31,
2025, 2024 and 2023, were as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfAllowanceForDoubtfulAccountsExplanatory_pn3n3_zGQbIUaDMdl3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Trade receivables (Details 2)">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BB_zKnxa853uQm4" style="display: none">Schedule of allowance for doubtful accounts</span></td>
    <td id="xdx_492_20250101__20251231_zlxsu8oloE47" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"></td>
    <td id="xdx_490_20240101__20241231_zz5EE2Z1VW42" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20230101__20231231_z7CsixPwnlOc" style="text-align: center">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AllowanceAccountForCreditLossesOfFinancialAsset_iNS_pn3n3_di_zY658UuznTM9" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><b>Opening balance</b></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(71,477)</b></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(61,398)</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><b>(44,046)</b></td></tr>
  <tr id="xdx_400_ecustom--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_pn3n3_zhURD4FBtsDg" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Additions</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(57,090)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(60,894)</td>
    <td style="vertical-align: bottom; text-align: right">(74,552)</td></tr>
  <tr id="xdx_404_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_pn3n3_zliOtbLDa3V" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Write-offs</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">28,411 </td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">50,815 </td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right">57,200</td></tr>
  <tr id="xdx_405_ecustom--AllowanceAccountForCreditLossesOfFinancialAsset_iNE_pn3n3_di_zVnJI3yuJtl1" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><b>Closing balance</b></td>
    <td style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(100,156)</b></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(71,477)</b></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: bottom; text-align: right"><b>(61,398)</b></td></tr>
  </table>
<p id="xdx_8A7_zyxyAgUcwWGj" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related parties</a></td>
<td class="text"><p id="xdx_80A_eifrs-full--DisclosureOfRelatedPartyExplanatory_zGmCHPSyDao4" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">7</td><td><span id="xdx_820_zY30MF8yV4ci">Related parties</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The tables below summarize the balances and transactions with related parties:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfRelatedPartiesExplanatory_zSXDqJNfgQ96" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Related parties (Details)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B1_zcSadTwFCeD9" style="display: none">Schedule of balances and transactions with related parties</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b>Assets</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Right-of-use assets</td>
    <td id="xdx_98E_ecustom--RightofuseAssetsRelatedPartyTransactions_iI_c20251231_zYLexd68nQL6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets">216,085</td>
    <td id="xdx_981_ecustom--RightofuseAssetsRelatedPartyTransactions_iI_c20241231_zy0T8FcMcVla" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets">205,911</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Trade receivables (i)</td>
    <td id="xdx_986_ecustom--TradeReceivablesRelatedPartyTransactions_iI_c20251231_zrUqgvVdSFse" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables">384 </td>
    <td id="xdx_989_ecustom--TradeReceivablesRelatedPartyTransactions_iI_c20241231_zJY1U6AmhXF2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables">507</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Other assets (ii)</td>
    <td id="xdx_983_ecustom--OtherAssetsRelatedPartyTransactions_iI_c20251231_zGeufvMf3VS5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="-sec-ix-hidden: xdx2ixbrl1944">-</span></td>
    <td id="xdx_98F_ecustom--OtherAssetsRelatedPartyTransactions_iI_c20241231_z80kBkJ6eMs" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets">597</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b></b></td>
    <td id="xdx_98B_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20251231_zg7xEEH9EsXe" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><b>216,469 </b></td>
    <td id="xdx_985_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20241231_zp1oV5skIiE4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><b>207,015</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td id="xdx_989_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_c20251231_zDX9XnJTd2hf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="-sec-ix-hidden: xdx2ixbrl1952">-</span></td>
    <td id="xdx_981_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_c20241231_zDmuIUpe32wa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets">1,010</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td id="xdx_986_ecustom--NoncurrentAssetsOfRelatedParty1_iI_c20251231_zaOfHACm1eVj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets">216,469 </td>
    <td id="xdx_98B_ecustom--NoncurrentAssetsOfRelatedParty1_iI_c20241231_zeVWYYse3vt6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets">206,005</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b>Liabilities</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>

<tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Lease liabilities</td>
    <td id="xdx_984_ecustom--LeaseLiabilitiesRelatedPartyTransactions_iI_c20251231_zJkQvidvM5ek" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">260,790 </td>
    <td id="xdx_981_ecustom--LeaseLiabilitiesRelatedPartyTransactions_iI_c20241231_zvIdrc1Y4JBd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">242,703</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"></td>
    <td id="xdx_989_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20251231_z0yllkSLA3X8" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities"><b>260,790 </b></td>
    <td id="xdx_983_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20241231_z7cF2XbCkej4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities"><b>242,703</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td id="xdx_98B_ecustom--TradeAndOtherCurrentPayableToRelatedParties_iI_c20251231_znJmzXxFyALj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities">9,447 </td>
    <td id="xdx_98D_ecustom--TradeAndOtherCurrentPayableToRelatedParties_iI_c20241231_zYhK5viCAll3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities">6,610</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td id="xdx_989_ecustom--NoncurrenLliabilitiesOfRelatedParty1_iI_c20251231_z0zbCHbkPA66" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities">251,343 </td>
    <td id="xdx_981_ecustom--NoncurrenLliabilitiesOfRelatedParty1_iI_c20241231_z11mbho9Cibh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities">236,093</td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="vertical-align: bottom; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Income (expenses)</b></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">UEPC (i)</td>
    <td id="xdx_98C_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zL1iymVK0qcc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">475 </td>
    <td id="xdx_980_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zPhZU24bYjAj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">517</td>
    <td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zUOjAfFZ9c1" style="vertical-align: top; text-align: right" title="Other income">465</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">EMIVE Patrulha 24 Horas Ltda. (iii)</td>
    <td id="xdx_98B_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zG7SxAT2mYNg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">(7)</td>
    <td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_z9KswejRyaud" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">(7)</td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zHNhvahmJvy9" style="vertical-align: bottom; text-align: right" title="Other income">(6)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Depreciation - Right-of-use assets </td>
    <td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zn3VHH6Zpobe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">(17,637)</td>
    <td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zH9NFlsVwDi1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">(14,639)</td>
    <td id="xdx_984_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zMRoYtgh8d3i" style="vertical-align: bottom; text-align: right" title="Other income">(13,801)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Lease liabilities interest</td>
    <td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_zaScWXa69oOg" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">(30,841)</td>
    <td id="xdx_986_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_z3YsduwcK7r2" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">(28,343)</td>
    <td id="xdx_988_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_zqDxN6HCkJp2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right" title="Other income">(25,676)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231_zCHGo0wkLxwj" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><b>(48,010) </b></td>
    <td id="xdx_980_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231_zGoNzzgHoj33" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><b>(42,472)</b></td>
    <td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231_z8612BcjTEr6" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right" title="Other income"><b>(39,018)</b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to sales of educational content to UEPC.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to expenses reimbursed by Bertelsmann.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to amounts of expenses related to security services provided by a company of which
one of Afya&#8217;s main shareholders has significant influence.</td>
</tr></table>

<p id="xdx_8A4_z2gOQkmxC0ni" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Lease agreements with RVL Esteves Gest&#227;o Imobili&#225;ria S.A.</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company has entered into lease agreements with RVL Esteves Gest&#227;o Imobili&#225;ria
S.A. (&#8220;RVL&#8221;), an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato Tavares Esteves is
an executive officer. The main lease agreements with RVL are described below:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On June 21, 2016, RVL entered into lease agreements, as amended on April 26, 2018, with
ITPAC Aragua&#237;na and ITPAC Porto, pursuant to which RVL agreed to lease campuses to those entities in the cities of Aragua&#237;na
and Porto Nacional, both located in the State of Tocantins. The lease agreements are adjustable in accordance with the provisions of each
lease agreement. The lease agreements are for an initial term of 20 years and are renewable for an additional <span id="xdx_90D_ecustom--OperatingLeaseTermOfContract_dtY_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_z18aDpYk1vy2" title="Lease term">20</span> years subject to the
provisions of each lease agreement. The balance of lease liabilities as of December 31, 2025 was R$<span id="xdx_90E_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zwqavTAsQSu7" title="Lease liabilities">83,992</span> (December 31, 2024: R$<span id="xdx_902_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zTZCYsV8hUVi" title="Lease liabilities">84,102</span>)
and the amount paid during the year ended December 31, 2025 was R$<span id="xdx_905_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zkAjvVUtKL8h" title="Related parties amount paid">13,926</span> (December 31, 2024 and 2023: R$<span id="xdx_90C_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zD0jZIaWDeK7" title="Related parties amount paid">13,453</span> and R$<span id="xdx_906_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zDopean6Gxu3" title="Related parties amount paid">13,254</span>, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On September 6, 2018, RVL entered into a lease agreement with ITPAC Aragua&#237;na, pursuant
to which RVL agreed to lease to ITPAC Aragua&#237;na the new campus by RVL in the city of Palmas, State of Tocantins. The lease agreement
is for an amount equal to <span id="xdx_901_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20180905__20180906__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zW1JOjc4Umf4" title="Percentage of revenue">7.5</span>% of the monthly revenue of ITPAC until July 2024. From August 2024, the monthly amount should be equal to
the amount paid in the first semester of 2024 and thereafter adjusted annually by the inflation rate (IGP-M). The lease agreement is for
an initial term of 20 years and is renewable for an additional <span id="xdx_90B_ecustom--OperatingLeaseTermOfContract_dtY_c20180905__20180906__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_z9u4OIpFi1ll" title="Lease term">20</span> years. The balance of lease liabilities as of December 31, 2025 was
R$<span id="xdx_904_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z2rSgWn6a8Cc" title="Lease liabilities">65,328</span> (December 31, 2024: R$<span id="xdx_901_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zOx7QIww8Vid" title="Lease liabilities">63,989</span>) and the amount paid during the year ended December 31, 2025 was R$<span id="xdx_90E_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zUvp0YhZAZPj" title="Related parties amount paid">8,881</span> (December 31, 2024 and
2023: R$<span id="xdx_90C_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z5XsQKltyZv7" title="Related parties amount paid">8,568</span> and R$<span id="xdx_908_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zc1QPh4rcrLj" title="Related parties amount paid">7,615</span>, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On October 30, 2019, RVL entered into a lease agreement with IPTAN, pursuant to which RVL
agreed to lease to IPTAN the medical campus in the city of Santa In&#234;s, State of Maranh&#227;o. The lease agreement, as amended
on February 27, 2025 is for a monthly amount adjusted in accordance with the provisions of the lease agreement of:  <span id="xdx_90E_ecustom--DescriptionOfLeaseTerm_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zKDZ1ZaBaX2" title="Description of lease term">(i) R$<span id="xdx_90B_eifrs-full--CashOutflowForLeases_pn3n3_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z11GCfgnWhEd" title="Lease expenses">12</span> until December
2020; (ii) from January 2021 to December 2025, 6.5% of the monthly revenue of IPTAN during the prior semester; (iii) from January 2026,
the monthly amount should be equal to the amount paid in the second semester of 2025; and (iv) from January 2027 thereon, the monthly
amount should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years and is renewable for an
additional 20 years.</span> The balance of lease liabilities as of December 31, 2025 was R$<span id="xdx_903_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z921QnCIOcze" title="Lease liabilities">15,962</span> (December 31, 2024: R$<span id="xdx_90D_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zNDIDHfTQmU7" title="Lease liabilities">9,743</span>) and the amount
paid during the year ended December 31, 2025 was R$<span id="xdx_90B_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zSps5Q93wVR5" title="Related parties amount paid">2,136</span> (December 31, 2024 and 2023: R$<span id="xdx_90F_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zrKY7JAfMEz7" title="Related parties amount paid">1,338</span> and R$<span id="xdx_907_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zQaHMebfeIHk" title="Related parties amount paid">1,111</span>, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On August 2, 2021, RVL entered into a lease agreement with ITPAC Aragua&#237;na, pursuant
to which RVL agreed to lease to ITPAC the new ITPAC Garanhuns medical campus, in the city of Garanhuns, State of Pernambuco. The lease
agreement is for a monthly amount equal to: <span id="xdx_902_ecustom--DescriptionOfLeaseTerm_c20210728__20210802__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z3vEc4kvXhce" title="Description of lease term">(i) up to June 2022, R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20210728__20210802__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zeAZw73sx9e6" title="Lease expenses">40</span>; (ii) from July 2022 until December 2028, 6.5% of the monthly revenue
of ITPAC Garanhuns during the prior semester, adjusted in accordance with the provisions of the lease agreement; and (iii) from January
2029 on, the monthly amount should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years.</span> The
balance of lease liabilities as of December 31, 2025 was R$<span id="xdx_907_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z2f0B16WFPX" title="Lease liabilities">26,326</span> (December 31, 2024: R$<span id="xdx_902_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zY9gMZ7ExpQ3" title="Lease liabilities">17,556</span>) and the amount paid during the year ended
December 31, 2025 was R$<span id="xdx_90C_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zGxeTGIg3zka" title="Related parties amount paid">3,664</span> (December 31, 2024 and 2023: R$<span id="xdx_905_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zLSRmu06o4Y3" title="Related parties amount paid">2,199</span> and R$<span id="xdx_906_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_ztLJKl7iMldf" title="Related parties amount paid">1,159</span>, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On May 2, 2024, RVL entered into a rent agreement with IPTAN, pursuant to which RVL agreed
to rent to IPTAN a property for the campus in the city of S&#227;o Jo&#227;o del Rei, State of Minas Gerais. <span id="xdx_900_ecustom--DescriptionOfLeaseTerm_c20240501__20240502__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_ztbWE3yytBu7" title="Description of lease term">The rent agreement is
for a monthly amount payable equal to R$4, adjusted annually by the inflation rate (IGP-M). The rent agreement is for a term of one year
and is renewable for an additional term of three years.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On June 14, 2024, RVL entered into a lease agreement with DelRey, pursuant to which RVL
agreed to lease to DelRey a property for the campus in the city of Jaboat&#227;o dos Guararapes, State of Pernambuco. <span id="xdx_90B_ecustom--DescriptionOfLeaseTerm_c20240713__20240714__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zmMGMHP3KyQg" title="Description of lease term">The lease agreement
is for a monthly amount payable equal to R$114.5, with a grace period of 12 months, extended by an additional six months. The monthly
amount payable should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years.</span> The balance of
lease liabilities as of December 31, 2025 was R$<span id="xdx_90C_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z8I0pNRZTFMe" title="Lease liabilities">10,905</span> (December 31, 2024: R$<span id="xdx_909_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zzRUYKHAWI88" title="Lease liabilities">9,383</span>) and due to the grace period no payments were made
during the years ended December 31, 2025 and 2024.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Lease agreement with UNIVA&#199;O Patrimonial Ltda.</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On July 14, 2016, UNIVA&#199;O Patrimonial Ltda., an entity controlled by the shareholder
Nicolau Carvalho Esteves and of which Ms. Ros&#226;ngela de Oliveira Tavares Esteves is the chief executive officer, entered into a lease
agreement with UNIVA&#199;O, a subsidiary of Afya Brazil, pursuant to which UNIVA&#199;O Patrimonial Ltda. agreed to lease UNIVA&#199;O&#8217;s
campus to UNIVA&#199;O, located in the city of Ipatinga, State of Minas Gerais. The lease agreement is adjustable in accordance with
the provisions of the lease agreement. The lease agreement is for an initial term of <span id="xdx_90A_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zpr6HtkGPjNb" title="Renewal term">20</span> years and is renewable for an additional 20 years
subject to the provisions of the lease agreement. The balance of lease liabilities as of December 31, 2025 was R$<span id="xdx_908_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zWRAUk5rgnX4" title="Lease liabilities">22,802</span> (December 31,
2024: R$<span id="xdx_902_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zRMUkIQOpgv2" title="Lease liabilities">22,818</span>) and the amount paid during the year ended December 31, 2025 was R$<span id="xdx_905_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zFrsq2wNJqmk" title="Related parties amount paid">3,752</span> (December 31, 2024 and 2023: R$<span id="xdx_900_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zZ38bTqN4Rve" title="Related parties amount paid">3,633</span> and R$<span id="xdx_909_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_z1Gd1zg7RArl" title="Related parties amount paid">3,582</span>,
respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Lease agreement with IESVAP Patrimonial Ltda.</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On April 25, 2018, IESVAP Patrimonial Ltda., an entity controlled by the shareholder Nicolau
Carvalho Esteves and of which Mr. Renato Tavares Esteves is an executive officer, entered into a lease agreement with IESVAP, a subsidiary
of Afya Brazil, pursuant to which IESVAP Patrimonial Ltda. agreed to lease IESVAP&#8217;s campus to IESVAP located in the city of Parna&#237;ba,
State of Piau&#237;. <span id="xdx_908_ecustom--DescriptionOfLeaseTerms_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zS9BI4FxUHR" title="Description of lease term">The lease agreement is for an amount equal to 7.5% of the monthly revenue of IESVAP until June 2021. From July
2021, the monthly amount should be equal to the amount paid in the first semester of 2021 and thereafter adjusted annually by the inflation
rate (IGP-M). The lease agreement is for an initial term of <span id="xdx_909_ecustom--OperatingLeaseTermOfContract_dtY_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zOGam0FTaaTb" title="Lease term">20</span> years and is renewable for an additional <span id="xdx_903_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zL6wyCyX8Q1j" title="Renewal term">20</span> years subject to the provisions
of the lease agreement.</span> The balance of lease liabilities as of December 31, 2025 was R$<span id="xdx_902_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zPMqZvolffv6" title="Lease liabilities">35,475</span> (December 31, 2024: R$<span id="xdx_908_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zwOGoS7KJE32" title="Lease liabilities">35,112</span>) and the amount
paid during the year ended December 31, 2025 was R$<span id="xdx_900_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zFnxWL9REuR8" title="Related parties amount paid">5,435</span> (December 31, 2024 and 2023: R$<span id="xdx_90A_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zviisOkBSxN3" title="Related parties amount paid">5,244</span> and R$<span id="xdx_908_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_z9gNmPx9VKde" title="Related parties amount paid">5,170</span>, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Other related parties transactions</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The commercial notes issued by Afya Brazil on October 15, 2025 are guaranteed by the following
subsidiaries: Unigranrio, IESP and DelRey. See note 12.2.1.<br/>
</p>




<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Key management personnel compensation</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Key management personnel compensation included in the Company&#8217;s consolidated statement
of income and other comprehensive income comprised the following:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_pn3n3_zSdZMQ3s2431" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Related parties (Details 1)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BF_zVDQmnRApgib" style="display: none">Schedule of key management personnel compensation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Short-term employee benefits</td>
    <td id="xdx_98F_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20250101__20251231_zUGipzHxacB6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits">27,160 </td>
    <td id="xdx_983_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20240101__20241231_zwpKDE5fcGMe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits">21,171</td>
    <td id="xdx_98D_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20230101__20231231_zimm1I97VvVe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits">16,979</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Share-based compensation plans</td>
    <td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20250101__20251231_z9zmnHRlOo35" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans">16,193 </td>
    <td id="xdx_980_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20240101__20241231_zw835p9umPS5" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans">19,884</td>
    <td id="xdx_98F_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20230101__20231231_zEedeEiPK7rd" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans">21,380</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_986_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20250101__20251231_zZHuN0dn7xn9" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>43,353 </b></td>
    <td id="xdx_98C_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20240101__20241231_zs5gTLuUXA73" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>41,055</b></td>
    <td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20230101__20231231_ztGiYD60Jr8f" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>38,359</b></td></tr>
  </table>
<p id="xdx_8AB_zsXZ99BZooYl" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Compensation of the Company&#8217;s key management includes short-term employee benefits
comprised by salaries, labor and social obligations, and other ordinary short-term employee benefits. The amounts disclosed in the table
above are the amounts recognized as an expense in selling, general and administrative expenses during the reporting period related to
key management personnel. See Note 14 for additional information on the share-based compensation plans.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOtherAssetsAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfOtherAssetExplanatory', window );">Other assets</a></td>
<td class="text"><p id="xdx_807_ecustom--DisclosureOfOtherAssetExplanatory_zyad0Pv4S4t3" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">8</td><td><span id="xdx_82E_z05LDXo3Qedi">Other assets</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--DisclosureOfOtherAssetsTableTextBlock_zs4DIcva5abd" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Other assets (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B9_z2OLv3BVLdci" style="display: none">Schedule of other assets</span></td>
    <td id="xdx_496_20251231_z5Phrdv9OPHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20241231_zOunPAkIrkA2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_maAzYGA_zJf8wnMyui84" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Indemnification assets - Note 21</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">80,379 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">78,701 </td></tr>
  <tr id="xdx_40D_ecustom--Advances1_iI_pn3n3_maAzYGA_z9LcLSTsnUC6" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Advances</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">40,205 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">35,140 </td></tr>
  <tr id="xdx_40D_ecustom--JudicialDeposits_iI_pn3n3_maAzYGA_z37fgIEFt25g" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Judicial deposits</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">19,274 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">16,938 </td></tr>
  <tr id="xdx_403_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_maAzYGA_zuYRrDVzn6Rf" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Prepaid expenses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">18,070 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">19,761 </td></tr>
  <tr id="xdx_40E_eifrs-full--OtherReceivables_iI_pn3n3_maAzYGA_zr0xWqywJhd" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Other FIES credits</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">6,866 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8,982 </td></tr>
  <tr id="xdx_404_ecustom--ConvertibleLoansFromVentureCapitalInvestments_iI_pn3n3_maAzYGA_zEs4LIJs7uS5" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Convertible loans from venture capital investments</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">13,240 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8,724</td></tr>
  <tr id="xdx_40F_ecustom--Dividend_iI_pn3n3_maAzYGA_zqF8wrlD3Mwe" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Dividends</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">6,287 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1,628</td></tr>
  <tr id="xdx_40E_ecustom--OtherAssets1_iI_pn3n3_maAzYGA_zGpqXbPOVXr9" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Other assets</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">4,106 </td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3,146 </td></tr>
  <tr id="xdx_403_ecustom--Assets1_iTI_pn3n3_mtAzYGA_zfPANBEkonz1" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Total</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>188,427 </b></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>173,020 </b></td></tr>
  <tr id="xdx_40C_ecustom--CurrentAssets1_iI_pn3n3_zhfzmgJcCBW3" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">62,947 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">57,145 </td></tr>
  <tr id="xdx_409_ecustom--NoncurrentAssets1_iI_pn3n3_zRVQVZ1akpgl" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">125,480 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">115,875 </td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfOtherAssetExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfOtherAssetExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in associate<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesExplanatory', window );">Investment in associate</a></td>
<td class="text"><p id="xdx_80F_eifrs-full--DisclosureOfJointVenturesExplanatory_zOoU0SjIpNdg" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">9</td><td><span id="xdx_825_zPMTXbigJ7X4">Investment in associate</span></td></tr></table>

<p style="font: 10.5pt/107% Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company holds a 30% interest in UEPC, a medical school located in the Federal District
that offers higher education and post-graduate courses, both in person and long-distance learning. The Company&#8217;s interest in UEPC
is accounted for using the equity method. The tables below summarize the financial information of the Company&#8217;s investment in UEPC:</p>

<p style="font: 10.5pt/107% Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfInvestmentsExplanatory_z2kl9Rn7rje3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Investment in associate (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span id="xdx_8B4_zu4Qt0g6a225" style="display: none">Schedule of investment</span></td>
    <td id="xdx_49D_20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zqnkoJsbamWi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_499_20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zoYlHItEqeUa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; width: 66%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentAssets_iI_pn3n3" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Current assets</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">27,686 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">38,122 </td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentAssets_iI_pn3n3" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Non-current assets</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">118,550 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">116,846 </td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentLiabilities_iNI_pn3n3_di_zeESBECtqTxg" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Current liabilities</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(44,726)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(30,049)</td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentLiabilities_iNI_pn3n3_di_z9Ws8PULOF6c" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Non-current liabilities</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(90,394)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(87,388)</td></tr>
  <tr id="xdx_409_ecustom--EquityInAssociate_iI_pn3n3_z8a91wCu2QX7" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Equity</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>11,116 </b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>37,531 </b></td></tr>
  <tr id="xdx_40D_ecustom--CompanyShareInEquity1_iI_pn3n3_zn9naorrrbg3" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Company&#8217;s share in equity - 30%</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3,335 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">11,259 </td></tr>
  <tr id="xdx_40D_eifrs-full--Goodwill_iI_pn3n3" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Goodwill</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">43,183 </td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">43,183 </td></tr>
  <tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_pn3n3_z8PBUEqnbSYf" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Carrying amount of the investment</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>46,518 </b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>54,442 </b></td></tr>
  </table>
<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td id="xdx_490_20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zI5Jr6SexoG3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_495_20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zYbtKW3cmkSh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_493_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zuoGhFuBU248" style="vertical-align: top; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--Revenue_pn3n3_z0y1XeNYNJvg" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Revenue</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">167,525 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">156,984 </td>
    <td style="vertical-align: top; text-align: right">148,042</td></tr>
  <tr id="xdx_40A_eifrs-full--CostOfSales_iN_pn3n3_di_zvnmvssAItbj" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Cost of services</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(79,116)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(72,898)</td>
    <td style="vertical-align: top; text-align: right">(71,282)</td></tr>
  <tr id="xdx_407_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_zNZSVOTFmAb2" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Selling, general and administrative expenses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(32,587)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(30,755)</td>
    <td style="vertical-align: top; text-align: right">(27,646)</td></tr>
  <tr id="xdx_403_ecustom--AllowanceForExpectedCreditLosses_pn3n3_zipcwdcIRnQl" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Allowance for expected credit losses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">445</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(1,587)</td>
    <td style="vertical-align: top; text-align: right">(1,029)</td></tr>
  <tr id="xdx_403_eifrs-full--OtherIncome_pn3n3_zfDVkaSx4Dc" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Other income</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">660 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">212</td>
    <td style="vertical-align: top; text-align: right">179</td></tr>
  <tr id="xdx_401_ecustom--OtherExpense_pn3n3_zon92aCxS0xk" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Other expenses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(5,111)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(5,326)</td>
    <td style="vertical-align: top; text-align: right">(8,709)</td></tr>
  <tr id="xdx_403_eifrs-full--FinanceIncome_iN_pn3n3_di_z4Jea73MIVnj" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Net finance result</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(3,298)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(4,946)</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">(6,123)</td></tr>
  <tr id="xdx_40F_eifrs-full--ProfitLossBeforeTax_pn3n3_zOwU9iG5Uyye" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Income before income taxes</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>48,518 </b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>41,684 </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"><b>33,432</b></td></tr>
  <tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_z2zaWivufW39" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Income taxes expenses</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(2,132)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(2,560)</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">(1,782)</td></tr>
  <tr id="xdx_40A_eifrs-full--ProfitLoss_pn3n3_z4YLUkPW6hGg" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><b>Net income</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>46,386 </b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>39,124 </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"><b>31,650</b></td></tr>

<tr id="xdx_40C_ecustom--CompanyShareOfProfitss_pn3n3_zjD6sH1bfuUh" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><b>Company&#8217;s share of profit, net of tax</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>13,916 </b></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>11,737 </b></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; text-align: right"><b>9,495</b></td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The movements during the years ended December 31, 2025, 2024 and 2023 are shown below:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td id="xdx_49F_20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zAMonWbLKNGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49F_20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z0s46PoweWoi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49F_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zHosBaAYOWSg" style="vertical-align: top; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iS_pn3n3_zXpeuV7ysMNc" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Opening balance</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>54,442 </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>51,834</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><b>53,907</b></td></tr>
  <tr id="xdx_408_eifrs-full--ProfitLossOfAcquiree_pn3n3_zXx3YD2pFwbd" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Share of profit, net of tax</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">13,916 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">11,737</td>
    <td style="vertical-align: top; text-align: right">9,495</td></tr>
  <tr id="xdx_402_ecustom--DividendsReceived1_iS_pn3n3_zgcnlOOMLMXf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Dividends received</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(15,553)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(7,501)</td>
    <td style="vertical-align: top; text-align: right">(9,900)</td></tr>
  <tr id="xdx_40C_eifrs-full--DividendsReceived_iN_pn3n3_di_zt8IrViKEAWl" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Dividends receivable - Other assets</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(6,287)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(1,628)</td>
    <td style="vertical-align: top; text-align: right">(1,668)</td></tr>
  <tr id="xdx_40E_eifrs-full--InvestmentsInAssociates_iE_pn3n3_zLBYCfm882Xc" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Closing balance</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>46,518 </b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>54,442</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; text-align: right"><b>51,834</b></td></tr>
  </table>
<p id="xdx_8A3_zylqmbP66dXl" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company tests the recoverability of the carrying amount of the Company&#8217;s investment
in UEPC at least annually. As of December 31, 2025 and 2024, no impairment had to be recognized.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfJointVenturesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of joint ventures. [Refer: Total for all joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B4<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B4_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfJointVenturesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property and equipment</a></td>
<td class="text"><p id="xdx_80A_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zBp0ooUlKdij" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">10</td><td><span id="xdx_822_zbl70p2U4iAl">Property and equipment</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company assesses at each reporting date, whether there is an indication that a property
and equipment asset may be impaired. If any indication exists, the Company estimates the asset&#8217;s recoverable amount. There were
no impairment indicatives of property and equipment as of and for the years ended December 31, 2025, 2024 and 2023. The following table
shows the balances and movements in property and equipment during the years ended December 31, 2025, 2024 and 2023.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>






<table cellpadding="0" cellspacing="0" id="xdx_89D_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_z0iSFzr0zwc" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Property and equipment (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BB_zmsYtSvRd34d" style="display: none">Schedule of detailed information about property, plant and
    equipment</span></td>
    <td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_zwYUrrhnbzh4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zxETs61Yb0ja" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BD_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zGe1upplAu79" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BF_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_znnKO0XEL8Oe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zAGJbXCv7eR5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zMbMf1OcmPn" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_zrAwjHBjQ5D3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zlmbygeONabc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zTdynmPJzWn2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B1_zmji0Ti1d7fh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Building</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Machinery and equipment</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 4%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Lands</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Vehicles</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Furniture and fixtures</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>IT equipment</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Library books</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Leasehold improvements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Construction in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Cost</span></b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_ziP1XOH45Ed6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of January 1, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>91,857</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>100,390</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>18,852</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>1,053</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>90,712</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>68,593</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>37,362</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>145,846</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>86,688</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>641,353</b></span></td></tr>
  <tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zc2ZFEQDlYq8" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">96</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">20,071</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2267">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">776</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">17,914</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">21,135</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">985</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">49</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">57,409</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">118,435</span></td></tr>
  <tr id="xdx_433_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zxIHAyZ8oJUa" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Business combination</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2276">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">7,729</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2278">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2279">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">4,384</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">734</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,329</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">10,741</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">63</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">24,980</span></td></tr>
  <tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zvhrdeWTQZTh" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2287">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(9,411)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2289">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(475)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(1,443)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(7,979)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(7,788)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(286)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2295">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(27,382)</span></td></tr>
  <tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zAZY9kK1NL9l" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,279</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,202</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2300">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2301">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(708)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">327</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2304">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">108,098</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(110,198)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2307">-</span></span></td></tr>
  <tr id="xdx_431_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zJGAS6c2Q7y3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>93,232</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>119,981</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>18,852</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>1,354</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>110,859</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>82,810</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>31,888</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>264,448</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>33,962</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>757,386</b></span></td></tr>
  <tr id="xdx_434_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_z6Fv5AGZJoh7" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,003 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">29,195 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2322">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">130 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">21,582 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">25,945 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,293 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">2,001 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">55,775 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">136,924 </span></td></tr>
  <tr id="xdx_43B_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zrX5LI0H0eJj" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Business combination</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">2 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">2,528 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2333">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2334">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">289 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">736 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">372 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,782 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2339">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">5,709</span></td></tr>
  <tr id="xdx_43B_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zV63u24LOlQa" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2342">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(2,071)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2344">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(42)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(7,050)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(1,154)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2348">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2349">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2350">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(10,317)</span></td></tr>
  <tr id="xdx_435_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zfLlynfE5ZH3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">5,129 </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(226)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2355">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2356">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(862)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">480 </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2359">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">41,182 </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(45,703)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2362">-</span></span></td></tr>
  <tr id="xdx_436_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zsPoJeuzZSc1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>99,366 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>149,407 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>18,852 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>1,442 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>124,818 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>108,817 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>33,553 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>309,413 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>44,034 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>889,702 </b></span></td></tr>
  <tr id="xdx_432_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zTCKgONU2NJh" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">121</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">28,301</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2377">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2378">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">28,575</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">24,204</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,178</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">2,812</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">80,823</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">166,014</span></td></tr>
  <tr id="xdx_436_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zD29JwIf9CAg" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2386">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2387">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2388">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(435)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(1,220)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(2,536)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(80)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(6,781)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(7)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(11,059)</span></td></tr>
  <tr id="xdx_438_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zeGk2KRZ6wv3" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">9,015</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">275</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2399">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2400">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,110</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(754)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2403">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">46,018</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(55,664)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2406">-</span></span></td></tr>
  <tr id="xdx_43B_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zDQ3xGNwvJra" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025
</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>108,502</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>177,983</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>18,852</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>1,007</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>153,283</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>129,731</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>34,651</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>351,462</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>69,186</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>1,044,657</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Depreciation</span></b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_43C_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zDMPSvGf2xIk" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of January 1, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(5,751)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(20,630)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2421">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>288</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(10,349)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(21,837)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(22,888)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(18,099)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2427">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(99,266)</b></span></td></tr>
  <tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zTvC1GdZ3F58" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Depreciation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(4,242)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(14,900)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2432">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(325)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(12,556)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(13,286)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(3,327)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(26,271)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2438">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(74,907)</span></td></tr>
  <tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zKXWCylEBpyf" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">118</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">6,684</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2443">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">235</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">2,528</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">8,254</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">7,563</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">90</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2449">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">25,472</span></td></tr>
  <tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z8613PIdGmRl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">&#160;Transfer </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">196</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">3</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2454">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2455">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2456">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(3)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2458">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(196)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2460">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2461">-</span></span></td></tr>
  <tr id="xdx_43F_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zkIY1XQdd3S2" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(9,679)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(28,843)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2465">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>198</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(20,377)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(26,872)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(18,652)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(44,476)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2471">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(148,701)</b></span></td></tr>
  <tr id="xdx_431_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zkUgUvQzxGz5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Depreciation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(4,188)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(17,684)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2476">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(377)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(12,778)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(15,608)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(3,058)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(36,604)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2482">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(90,297)</span></td></tr>
  <tr id="xdx_439_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zk3FgCiDsY4l" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2485">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,491 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2487">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">42 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">4,593 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,150 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2491">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">502 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2493">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">7,778 </span></td></tr>
  <tr id="xdx_43F_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zfDGhv0Tsvo5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(95)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(74)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2498">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2499">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">482 </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(165)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2502">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(148)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2504">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2505">-</span></span></td></tr>
  <tr id="xdx_43C_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zLDi6SY0Wsf7" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(13,962)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(45,110)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(137)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(28,080)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(41,495)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(21,710)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(80,726)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2515">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(231,220)</b></span></td></tr>
  <tr id="xdx_439_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zcgAwGVCOnzi" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Depreciation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(4,962)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(18,197)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2520">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(304)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(15,989)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(20,514)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(3,002)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(46,981)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2526">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(109,949)</span></td></tr>
  <tr id="xdx_437_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zsgrJ6fvsOTb" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2529">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">881</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2531">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">301</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,055</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,545</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">80</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">4,135</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2537">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">7,997</span></td></tr>
  <tr id="xdx_43D_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zM31Zgorr3V2" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025 </b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(18,924)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(62,426)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2542">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(140)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(43,014)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(60,464)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(24,632)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(123,572)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2548">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(333,172)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Net book value</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025 </b></span></td>
    <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zeG5wi5ayLQa" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>89,578</b></span></td>
    <td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zsOXyka6mW4a" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>115,557</b></span></td>
    <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zY2FmOitXgQ2" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>18,852</b></span></td>
    <td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zdoofmCptOc6" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>867</b></span></td>
    <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zQR10epQM8s7" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>110,269</b></span></td>
    <td id="xdx_980_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_z9xZJ7QBwI2i" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>69,267</b></span></td>
    <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zhF2penUNz8k" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>10,019</b></span></td>
    <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zgkfNhEEcjFj" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>227,890</b></span></td>
    <td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zixBfGBtVMs" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>69,186</b></span></td>
    <td id="xdx_981_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231_zWe9Kl7kpYZa" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>711,485</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td id="xdx_985_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zxr6OuWoMEOa" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>85,404 </b></span></td>
    <td id="xdx_985_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zmKYfUYtsZCg" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>104,297 </b></span></td>
    <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zrHyaTej3sbl" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>18,852 </b></span></td>
    <td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zrJC1T37K4q5" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>1,305 </b></span></td>
    <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zXnnYLSXLhij" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>96,738 </b></span></td>
    <td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zR2NHAMaeSW8" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>67,322 </b></span></td>
    <td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_z0Hmdv469jE7" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>11,843 </b></span></td>
    <td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zY1gVN2Ldra5" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>228,687 </b></span></td>
    <td id="xdx_980_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zzwE8fr90lea" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>44,034 </b></span></td>
    <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_iI_pn3n3_c20241231_zFBp3Y48MZE4" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>658,482 </b></span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to items written-off as result of lack of expectation of future use, in connection
with the Company&#8217;s physical inventory procedures.<br/></td>
</tr></table>

<p id="xdx_8A3_zOmb2pHatcOa" style="margin-top: 0; margin-bottom: 0">&#160;</p>




<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureIntangibleAssetsAbstract', window );"><strong>Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfIntangibleAssetExplanatory', window );">Intangible assets</a></td>
<td class="text"><p id="xdx_807_ecustom--DisclosureOfIntangibleAssetExplanatory_zZCogGIzmr5b" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">11</td><td><span id="xdx_824_zvEhTKl4hQO4">Intangible assets</span></td></tr></table>

<p style="font: 2pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_pn3n3_z5ARI5S96bml" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Intangible assets (Details)">
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span id="xdx_8B8_zbQK7cpU4OWc" style="display: none">Schedule of intangible assets</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td></tr>
<tr>
    <td style="width: 26%; padding-right: 1.45pt; padding-left: 1.45pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Goodwill </b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Licenses with indefinite useful life </b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Trademarks</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Customer relationships</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 4%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Software</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Education content</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Developed technology</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Educational platform</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Intangible in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 3%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Cost</span></b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of January 1, 2023</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXLPeIQtsM0j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>1,257,045</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zFOX7zHbajF6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>2,189,814</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXiG8vaOGrc2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>182,060</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKtBCdSmaYpf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>435,816</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zm0zVDYvxPfk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>43,300</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zBOZOPk1hfs2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>69,589</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z538J1iaB7O" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>90,749</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTpnT5DIci02" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>55,697</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRk43MPMsoTk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>14,734</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWuhPKyt0i9j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>1,055</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEFwp1scJDS9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>4,339,859</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLm6yaMH5Lvi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2617">-</span></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1acKodXCkdd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">1,314</span></td>
    <td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeZgI413YVDb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">9,827</span></td>
    <td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4NNN5rP0Ba2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">37,712</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuT2Gema61o1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">23,164</span></td>
    <td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zi72d0PnOjVj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">27,976</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc3RGBSiUd13" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">99,993</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Business combination</span></td>
    <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOwaP2JuCcbl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">75,098</span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoYyj8VkSOc1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">586,263</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLXR21ueOcQ1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">142,451</span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwWf0AjbTBwi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">63</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQcEnD4rS7hc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">803,875</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoubWbHH41c5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(2,235)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_za2kjFiaY8l" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(911)</span></td>
    <td id="xdx_987_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWvFdsOWtpD4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(125)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJSyR6VaMbOe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(3,271)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Remeasurement</span></td>
    <td id="xdx_98F_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsxrWEmRbbV1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Remesurement"><span style="font-size: 7.5pt">2,556</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98B_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z85DLoAnPyQ3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Remesurement"><span style="font-size: 7.5pt">2,556</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_985_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4NPqnUPWUH1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">28,708</span></td>
    <td id="xdx_980_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVXxidglRRz4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">4,785</span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8qJyc1xtFwh" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">16</span></td>
    <td id="xdx_987_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOS0dqxmxRFc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(3,058)</span></td>
    <td id="xdx_982_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7NTfIGPWNb8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(30,451)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zaqo0QY2kps3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>1,334,699</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfxJxqyGbhz3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>2,776,077</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztBLF0yqKg0b" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>182,060</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z0udGq4J3JAa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>578,267</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEQnogXAkGDe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>71,150</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjOmK4lkxRjj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>84,201</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmEAXoBdOzr8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>128,477</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXahYkGKXbz7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>74,892</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9c518H1B2Va" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>12,134</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc2lF7k3PuV5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>1,055</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMDVqDU2iGm1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>5,243,012</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztjhdsWZ48q8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">157,227 </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQlDIfLJIM6a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">1,511 </span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqbZN68Fi4y8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">17,701 </span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcDS77okDfBl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">14,092 </span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJu9NUY2xEGd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">30,255 </span></td>
    <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzKOOsfStq5g" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">34,905 </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZoF9KE45jqe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">255,691 </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Business combination</span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfQdl7Jwzgw3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">192,034 </span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHVDzhdq1pNe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">427,482 </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMlmrwAU16dc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">34,560 </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9EHfwC2LrTc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">654,076 </span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcPYGpUE1o0i" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(162)</span></td>
    <td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9PfFHXweTEk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(117)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zl3j076XfJK4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(1)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8Mv2dpzntel" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(280)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_985_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlHOF6DpxLtb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">23,292 </span></td>
    <td id="xdx_983_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzJoVPwrmJrg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">6,529 </span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zh19xklC10Tb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(39,929)</span></td>
    <td id="xdx_987_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1UFQS37Pcqf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">29,673 </span></td>
    <td id="xdx_986_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zATgoRNwq5sl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(19,565)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">- </span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zb3aHgCRNrye" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>1,526,733 </b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z17ghQiVjPjg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>3,360,786 </b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zBKcZE2Rpj53" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>182,060 </b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgmBoSuzYDFf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>612,827 </b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwJuzxYIXXv6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>95,953 </b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbf7wynp3fL1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>108,269 </b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoAJz80cGnW" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>102,523 </b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zYBe5VnFW6af" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>134,820 </b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zStSTVvDiuci" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>27,473 </b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJzINBZ8US78" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>1,055 </b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrGHdmExU3s1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>6,152,499 </b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1gXhZJJwTQk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">99,629</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zC2DQJ1hye48" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">276</span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziCp74Ym0P1g" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">25,106</span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyqSVlv6c4a4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">9,552</span></td>
    <td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znsldTmHMJB3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">31,250</span></td>
    <td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1zq7Da0DoP6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">72,184</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvDiA7GhU28a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">237,997</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_987_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRoBitc7xpof" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(2)</span></td>
    <td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zK6tQVTsOeCh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(1)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQBVVyqpIE79" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(272)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98B_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1125lsjVCZ" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(275)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_984_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwigvmbJNV71" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(691)</span></td>
    <td id="xdx_98E_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zDsgfLvEn9gj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">31,531</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_982_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxIUOxYSq4Ac" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(30,840)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025 </b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCSO2MwUKmGc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>1,526,733</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXBXukM7Si5a" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>3,460,415</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrlbuzIIxTva" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>182,060</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxP1Cv7ilbc4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>612,136</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2KRCBoSwERc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>127,760</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqSzVMOrOKU9" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>133,373</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztzZ8bD8cXgi" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>112,074</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zueKPfDvCyta" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>166,070</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEeNDdP180Gd" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>68,545</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQD6ZUai0DGk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>1,055</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zO6i4Tn13dpf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>6,390,221</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Amortization</span></b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of January 1, 2023</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zYP5nIncY082" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2797">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zY06G9LJ8yAg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2799">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBDoezezxq1l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(14,955)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQkIjkse9ysl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(212,363)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW7vj3B3THai" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(17,277)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1GCgzhcZ8Md" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(26,562)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOj3SX448FQi" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(10,093)</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8DIqTkiqDQ3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(17,039)</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zy5s5ZYBxOE5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2813">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTobSyUDpKQ5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(79)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zw90gvVfX1El" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(298,368)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Amortization</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iP2custom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlO12eFJin97" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2819">-</span></span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zmkKKzT8I246" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2820">-</span></span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBBvb2yiVbC6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt">(11,083)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zf9dNrm5aD6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt">(89,584)</span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdP8l9MJmfK4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(8,764)</span></td>
    <td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8qsWZrGGNMf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(15,668)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBw7BNTnTQse" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(21,504)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTVeMXJciksa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(4,778)</span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkgdoP3P6UTi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2829">-</span></span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbM05cUjXAOe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(105)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqfk7c9cA9Z1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(151,486)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zXkVRlhPqD7g" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">1,947</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98C_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdZ1AGTjIqf8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">911</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuTk98HSDYrl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">2,858</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSJ9B8tOxBZg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(6)</span></td>
    <td id="xdx_98C_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIcnETa8xG4j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">6</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zogL1bEPU7Q6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2843">-</span></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z3TdCOnevdi5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2845">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJQMe1Vmsuy6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(26,038)</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z2KdKRDAToZk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(301,947)</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zC0PdwKOvAl2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(24,094)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8NhawO5DETf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(42,230)</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxI6CYmNBBH6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(31,603)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDYt8xaMzdQl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(20,900)</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zB0QQiBTu0c8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2859">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z2FlyJZKNgRa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(184)</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZ9WemNDEDp5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(446,996)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Amortization</span></td>
    <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxQADNzeSNJ7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2865">-</span></span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zdFVlUz1RTp" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2866">-</span></span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z6vXTtiDjli9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(12,506)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmeELLcXy9h2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt">(82,737)</span></td>
    <td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRYP7teYB8Fc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(16,457)</span></td>
    <td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzb3VRTgCDEb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(18,471)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDmE22bjtVG2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(20,086)</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0T7T3xjMxN1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(22,387)</span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zF1TXpcV88Xb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2874">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZdHGZ5jS2n3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(106)</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbRKG3XwKIng" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(172,750)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zrhhb7cXjGKi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">1 </span></td>
    <td id="xdx_980_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z94orvM2exJh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">35 </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_982_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBpUjhUAYwvg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">36 </span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zfH9vKCVYgCe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(1,207)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zoNAO8Ra76o9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">9,019 </span></td>
    <td id="xdx_986_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLcvketNOqg5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(7,812)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNDvx4SnwcA7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2890">-</span></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zITgQVqqBX42" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2892">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQr2cbGD6Mrc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(38,544)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCfKYmgkjX47" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(384,684)</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0XFTXoZ3WL2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(41,758)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwEyeVQyIQRk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(60,700)</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1FXIpGLvVi1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(42,635)</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zEOHxS5kJnY9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(51,099)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z87OPQbuD2k4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2906">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLkLtp0lw4kl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(290)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1Gr7mO0CPx1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(619,710)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Amortization</span></td>
    <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zg4bLcJItUN" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2912">-</span></span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zaNZbwG209ej" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2913">-</span></span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkJPcQA6T482" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(5,127)</span></td>
    <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8hkuzEL0kBg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt">(74,558)</span></td>
    <td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZqD47VyYlf8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(24,739)</span></td>
    <td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3jPyx8i7WJ9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(20,782)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zH0YCZrzDDD4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(16,741)</span></td>
    <td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAuPBKI7GXFg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(40,478)</span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwJatCByCWX5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2921">-</span></span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQe25GoaXQrf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(106)</span></td>
    <td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx6DIftNvWb4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(182,531)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98B_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHrFDpbQAPb9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">380</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zORSQxglt5jj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(380)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025 </b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztwyObFlgmp8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2929">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zEPBONrHsckg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2931">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zpq8KeBM5JZ3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(43,671)</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0dkzd4sZruf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(458,862)</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLzE3zymcaq7" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(66,877)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFag1O74Nzfg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(81,482)</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDDyIAi72Fzg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(59,376)</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVzMp4NQzLI8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(91,577)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zWgPducxjut3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2945">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1SDazwakQV3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(396)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHiImOtkL3tl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(802,241)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Net book value</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31,
2025 </b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zqVRzYslf44a" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>1,526,733</b></span></td>
    <td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember_fKGkp_zFWPpvAORBf7" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>3,460,415</b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zPn41sbedv6e" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>138,389</b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z6uJXjSySJAh" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>153,274</b></span></td>
    <td id="xdx_98D_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zMnoFw5Kvy9a" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>60,883</b></span></td>
    <td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zwmWWCxsL8Id" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>51,891</b></span></td>
    <td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zDhtbgWZQ0e5" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>52,698</b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zOkhLYjsxBM7" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>74,493</b></span></td>
    <td id="xdx_98E_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zcgAemG6Nj6c" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>68,545</b></span></td>
    <td id="xdx_981_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zds1pQlwXZzg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>659</b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231_z8TSfdEq2Tag" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>5,587,980</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td id="xdx_980_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zdHu71cTahh9" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>1,526,733 </b></span></td>
    <td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember_fKGkp_z9zb49RZSku9" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>3,360,786 </b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_za3bVZPwfUCg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>143,516 </b></span></td>
    <td id="xdx_987_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z48SyNzg0I62" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>228,143 </b></span></td>
    <td id="xdx_981_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z0VsiO7VsXoj" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>54,195 </b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zZ1ZOINCttHf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>47,569 </b></span></td>
    <td id="xdx_988_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zffl72aSoBm" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>59,888 </b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zNiQH2slMBal" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>83,721 </b></span></td>
    <td id="xdx_98A_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zlJfmIk1fM5j" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>27,473 </b></span></td>
    <td id="xdx_98B_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zjL7DAkd7Lpg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>765 </b></span></td>
    <td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231_zgLP4RfwF6ai" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>5,532,789 </b></span></td></tr>
  </table>
<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to intangible assets written-off as result of lack of expectation of future use.</td>
</tr></table>

<p id="xdx_8A5_zWlY92wPs63f" style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Impairment testing of goodwill and intangible assets with indefinite
lives</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Licenses with indefinite useful life include intangible assets acquired through business
combinations and asset acquisitions. The licenses for medicine and other courses granted by MEC have no expiration date and the Company
has determined that these assets have indefinite useful lives.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For impairment testing goodwill and licenses with indefinite useful lives are allocated
to the respective CGUs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company performed its annual impairment test on December 31, 2025, 2024 and 2023. There
was no impairment for goodwill and licenses with indefinite useful lives for the years then ended.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company tests at least annually the recoverability of the carrying amount of goodwill
and licenses with indefinite useful lives for each CGU. The Company determines the recoverable amount of its CGUs based on the value-in-use.
Estimating these values involves the use of assumptions, judgments and estimates of future cash flows that represent the Company's best
estimate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The carrying amounts of goodwill and licenses with indefinite useful life by CGU and their
carrying amount as of December 31, 2025 and 2024 were as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_pn3n3_zXK7x6SVyuU1" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Intangible assets (Details 1)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B8_zZmfXMrPkdi7" style="display: none">Schedule of assumptions for impairment test</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center; text-indent: 0in"><span style="font-family: Nunito Sans; font-size: 8.5pt"><b>Carrying amount</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Goodwill</b></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Licenses with indefinite useful life</b></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>CGU</b></td></tr>
  <tr>
    <td style="width: 34%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">IPTAN</td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zLrB5OMD7sV5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">17,446</td>
    <td id="xdx_983_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zDt7RsN1BkE5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">17,446</td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zLW5R67wAzVd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">57,214</td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zwRHZalhKJc5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">57,214</td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z3wtcvKnPsLl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">142,155</td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zVI5Ae6xqBP1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">122,599</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">IESVAP</td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z0nWsHxsKkkb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">27,956</td>
    <td id="xdx_98D_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_ziFbQLWq6fYl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">27,956</td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zPE0X0sip0Q" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">81,366</td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zxKEic920uO5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">81,366</td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zbtlPVaBo5Hk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">128,552</td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zI7CJOaMvxug" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">126,195</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">CCSI</td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_znwGVY9UohJd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">4,664</td>
    <td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_ziWE0EqlkPj2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">4,664</td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zKcrnZMYM846" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">56,737</td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zs5UjofA1ZW6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">56,737</td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zcuZhJuYx5Uj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">64,782</td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zz5aEanJbdYl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">60,377</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">IESP</td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zM53NWWrSifl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">73,838</td>
    <td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zQlZAqgiYTQk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">73,838</td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zRdC660jkWJ5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">179,693</td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z4oRW5PRZTI5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">179,693</td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zX70F1g1pw41" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">336,287</td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z5W6LhpCPeXf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">322,900</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FADEP</td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zmoktumZ9jfd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">49,661</td>
    <td id="xdx_986_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zaM5WgaZkZli" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">49,661</td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zs72RDpER8Zb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">70,606</td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zxyaKSp796E7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">70,606</td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zQ97tvgX0Hk7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">143,096</td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zBNRhjibBCBd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">141,201</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FASA</td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zFJUUyTbKv1i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">58,903</td>
    <td id="xdx_987_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zd1IANS1lGTb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">58,903</td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zp3SvRS1yZx5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">144,507</td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zW9S0YzGLd28" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">144,507</td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zRNQeMtV8sib" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">350,392</td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zJgccVUODXP" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">341,020</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">IPEC</td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zouKxAM3HrMa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl3069">-</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_znCr213aC6V7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl3071">-</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z5Iee4ZH4Q44" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">108,000</td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zU3N9CC340pf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">108,000</td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z40nLOpJzQ65" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">168,247</td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zbL58Wfy4fI" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">168,174</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">UniRedentor</td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z0kCGEiwFh3d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">77,662</td>
    <td id="xdx_98A_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zPE0SBofqkV9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">77,662</td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zphoVAGGq236" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">121,477</td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zZGtZYlHQfTk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">121,477</td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z7RBBsg9pzqi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">251,332</td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zoQWRg9EQal7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">244,123</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">UniSL</td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zSl9fJeQEHSd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">4,420</td>
    <td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zUd40Bo4iKHi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">4,420</td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zz7Arkd5ami4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">273,795</td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zEvKK3bFJkLk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">273,795</td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z7EiUzT0zrDg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">401,911</td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z7eUkaeWXQv1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">386,889</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FESAR</td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zFwDxUkEufu8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">71,664</td>
    <td id="xdx_981_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zno61gFLc00j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">71,664</td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zgL0K5E9Hfg9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">141,616</td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z3buY0VrOoOf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">141,616</td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_ziwVZLLUnFae" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">248,037</td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zW4R3D4qPy7e" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">246,385</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FCMPB</td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z2xfWn7gwwX1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">110,483</td>
    <td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zQ6kQq6axnx6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">110,483</td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_ziqF1qLPuDa3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">235,018</td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zXUXrAXTIpZa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">235,018</td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zAAPL9otdGac" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">404,039</td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zU4uYngo4Ewd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">392,862</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">ITPAC Garanhuns</td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z5VPFpHeGN4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl3129">-</span></td>
    <td id="xdx_98F_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zxRErLaJd2i" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl3131">-</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zMKAf0CRw4ec" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">108,000</td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zmqdAjGn3z17" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">108,000</td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zmRhEVgb6oPl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">150,489</td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z4tm76TsTyrc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">129,458</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Continuing education (i)</td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z1FLiw9D5sql" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">267,477</td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zdo8qakBz9l8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">267,477</td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zTHkeLlLA886" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="-sec-ix-hidden: xdx2ixbrl3145">-</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z82UJjx0TCm7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="-sec-ix-hidden: xdx2ixbrl3147">-</span></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z9xhQ62Qsbba" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">574,048</td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zuk1ldNwFzZe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">542,354</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Medical practice solutions (i)</td>
    <td id="xdx_986_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zr0Zz8t2bYUc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">238,477</td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zaZy1j5XZoNa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">238,477</td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_z65NhKzCfiZ2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="-sec-ix-hidden: xdx2ixbrl3157">-</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zSGno3FZNjpg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="-sec-ix-hidden: xdx2ixbrl3159">-</span></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zHJyTIJnXBG5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">373,954</td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zGVRhnhKqW66" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">411,873</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">UnifipMoc</td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zLah66A7F1wl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">87,777</td>
    <td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zCUVQmvvjhb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">87,777</td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zKNSNd2Sx9Xf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">239,847</td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zPaFirPLHNs9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">239,847</td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zBp26Rlvi7i2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">427,474</td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z4gfTYv7k3og" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">412,698</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Unigranrio</td>
    <td id="xdx_989_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zKSH3sgxth3l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">169,173</td>
    <td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zjilK4LXDz73" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">169,173</td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zngKiavC2xG1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">421,538</td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zxAN2UNBpRd5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">421,538</td>
    <td id="xdx_986_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zuiY9l1O2eyb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">804,996</td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zVjHdFFP8rQg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">819,682</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">DelRey</td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zXuauiuqwA4c" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">75,098</td>
    <td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIlKiCSMiiE4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">75,098</td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5ZEQAGON1K8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">693,890</td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zgqG4BFMsbgl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">693,890</td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zwBmUYerww5f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">960,966</td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztkHC2LXdR05" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">929,307</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Unidom</td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_ztfAQsJv2Kue" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">192,034</td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z74iKouJt2x7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">192,034</td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zO8BJa8H3Ik2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">427,482</td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zZDyBdlmRcoj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">427,482</td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zI2WT6yJpi1l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">718,699</td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_znb3BnsJ31C5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">687,570</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FUNIC</td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zCPZhH25Ctvj" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl3213">-</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z8A9V4L3huC7" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl3215">-</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zMo1gKMd3Up" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">99,629</td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z8kb4stCW9c6" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="-sec-ix-hidden: xdx2ixbrl3219">-</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zQ3gM7Z8eLs2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">110,943</td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zE0o8BSHujWb" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="-sec-ix-hidden: xdx2ixbrl3223">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98F_eifrs-full--Goodwill_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zwOuEWNuT7g3" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><b>1,526,733</b></td>
    <td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zvXOjOVsYcD5" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><b>1,526,733</b></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zsBHIabUbSO8" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><b>3,460,415</b></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zk7GuD1HYmbj" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><b>3,360,786</b></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_ztB1yVXhcBg8" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><b>6,760,399</b></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zcO4AqGiKNv9" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><b>6,485,667</b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">For the year ended December 31, 2025, the companies included in former Pillar 1 (Medcel,
Al&#233;m da Medicina, CardioPapers and Medical Harbour) where grouped together with IPEMED to constitute the Continuing education
CGU. The companies included in former Pillar 2 (PEBMED) and former Pilar 3 (iClinic, Medicinae, Shosp and RX Pro) where grouped together
with Glic and Cliquefarma to constitute the Medical practice solutions CGU. As a result, the prior period was revised for comparative
purposes. The grouping of these companies into a unified CGU reflects the economic reality of their business and is consistent with the
Company&#8217;s integrated operational model. This classification also represents how operations are internally monitored.<br/></td>
</tr></table>

<p id="xdx_8A6_zyGAanwnpwld" style="margin-top: 0; margin-bottom: 0">&#160;</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The key assumptions used by the Company to determine the value in use of the CGUs were:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SchuduleOfAssumptionsUsedTableTextBlock_pn3n3_zs2q5xL5Xzcj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Intangible assets (Details 2)">
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B9_zVtEPOJx43md" style="display: none">Schedule of assumptions</span></td>
    <td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr>
    <td style="border: #D0CECE 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Key assumption</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 51%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Description</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>2025</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>2024</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Discount rates</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><span id="xdx_901_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DiscountRatesMember_z4QcjuuHkqo5" title="Description">Represent the current market assessment of the specific risks associated to the CGUs, estimated based on information from both internal and external sources, including the Company&#8217;s and third parties historical weighted-average cost of capital (WACC).</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Pre-tax discount rate applied to cash flow projections: between <span id="xdx_90A_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z6DR5vvKTDHg" title="Discount rate applied to cash flow projections">10.82</span>% and <span id="xdx_905_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zkbt7PihCDw7" title="Discount rate applied to cash flow projections">11.73</span>%.</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Pre-tax discount rate applied to cash flow projections: between <span id="xdx_907_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20241231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zPif14jGTu9d" title="Discount rate applied to cash flow projections">11.66</span>% and <span id="xdx_906_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z3nzF9GS73s5" title="Discount rate applied to cash flow projections">13.97</span>%.</span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Perpetuity growth rate</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><span id="xdx_909_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PerpetuityGrowthRateMember_zgUfevbpw82a" title="Description">Cash flow projections include specific estimates for a five-year period followed by a terminal growth rate, determined based on management's internal estimate of the long-term compound annual growth rate (CAGR), consistent with the assumptions that would be made by a market participant.</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">From <span id="xdx_90E_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOPcJGfjIZIf" title="Growth rates">3.5</span>% to <span id="xdx_909_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_znr5YdVtYxFh" title="Growth rates">9.50</span>%.</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">From <span id="xdx_90B_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zidxpqC2KL2c" title="Growth rates">3.5</span>% to <span id="xdx_901_ecustom--PerpetuityGrowthRate_pip0_dp_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zh43Ig1kwArd" title="Growth rates">7.53</span>%.</span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">EBITDA<span style="font-family: Nunito Sans"><sup>[1]</sup></span> growth rate (annual average for the next five years)</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Nunito Sans; margin: 0"><span id="xdx_906_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EBITDAMember_gIFDOKAOWMHBC-WJE_zuncArDTfD7" title="Description">EBITDA growth rate was estimated using historical performance as a baseline, adjusted for:</span></p>
    <div id="xdx_C09_gIFDOKAOWMHBC-WJE_zqD6Jetl0JBi"><p style="font: 9pt Nunito Sans; margin: 0">- Expected revenue growth, driven by increases in both sales volume and pricing.</p></div>
    <div id="xdx_C07_gIFDOKAOWMHBC-WJE_zFxGavNFZ3Uf"><p style="font: 9pt Nunito Sans; margin: 0">- Expected margin expansion, which reflects operational efficiencies and scale economies as
    volumes increase, partially offset by projected increases in costs.</p></div></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_906_ecustom--EbitdaGrowthRates_pip0_dp_c20250101__20251231_zvtN9LF3duli" title="EBITDA growth rates">6.88</span>%</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90A_ecustom--EbitdaGrowthRates_pip0_dp_c20240101__20241231_zbVabD28HFj9" title="EBITDA growth rates">5.69</span>%</span></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><i>Sensitivity analysis: impacts of possible changes in key assumptions</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span id="xdx_902_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zBYiuCNYfPa2" title="Description of significant estimate">An increase of 25 basis points in management&#8217;s estimated discount rate applied to
the cash flow projections of each CGU for the year ended December 31, 2025, or a decrease of 25 basis points on perpetuity growth rate
or EBITDA growth rate would not have significant impacts on Company&#8217;s impairment testing.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Impairment testing of other intangible assets</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">There were <span id="xdx_90F_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_do_c20250101__20251231_zzOkniNzthrk" title="Impairment intangible assets">no</span> impairment indicatives of intangible assets with finite useful lives as of
and for the year ended December 31, 2025.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfIntangibleAssetExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfIntangibleAssetExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">Financial assets and liabilities</a></td>
<td class="text"><p id="xdx_802_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zgkxttcMo5vb" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">12</td><td><span id="xdx_825_zqd5gg680W7f">Financial assets and liabilities</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; color: #0D0E00">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%"><b>12.1</b></td><td><b>Financial assets</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfFinancialAssetsTableTextBlock_zfCKk7BKGG9e" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BD_zEgMmICCUAD4" style="display: none">Schedule of financial assets</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>At amortized cost</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cash and cash equivalents</td>
    <td id="xdx_98D_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zFSR0GqK3u9g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents">1,125,381 </td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zwNWrmprW5Kh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents">911,015</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Trade receivables</td>
    <td id="xdx_98E_eifrs-full--TradeReceivables_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zyEySZtNuMuc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables">752,358 </td>
    <td id="xdx_983_eifrs-full--TradeReceivables_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_ziiNiLIaENTi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables">631,846 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Other FIES credits - Other assets</td>
    <td id="xdx_980_eifrs-full--OtherAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zuf7UVBO9Rdl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other FIES credits - Other assets">6,866 </td>
    <td id="xdx_982_eifrs-full--OtherAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zhBXyUUyRXNl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other FIES credits - Other assets">8,982</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Dividends receivable - Other assets</td>
    <td id="xdx_98B_ecustom--DividendReceivable_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zJPLRk7cOif4" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends receivable - Other assets">6,287 </td>
    <td id="xdx_981_ecustom--DividendReceivable_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zFPdpbw2cdj5" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends receivable">1,628</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_984_eifrs-full--FinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zB3YEGMg3UCb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>1,890,892 </b></td>
    <td id="xdx_986_eifrs-full--FinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRXN40G1V4e9" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>1,553,471 </b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_980_eifrs-full--CurrentFinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zkOY8WERLiRh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">1,849,041 </td>
    <td id="xdx_98D_eifrs-full--CurrentFinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z06VAwl2Pyd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">1,508,541 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_988_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_znY5z8ZwboC5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">41,851 </td>
    <td id="xdx_987_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zuMfYWo0Dwfh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">44,930 </td></tr>
  </table>

<p id="xdx_8A2_zvOvJxy8DbA8" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<hr style="height: 1px; width: 33%; margin-left: 3%"/>

<p style="font: 9pt Nunito Sans; margin: 0 0 0 3%"><span style="font-family: Nunito Sans"><sup>[1]</sup></span> EBITDA refers to Earnings Before
Interest, Taxes, Depreciation and Amortization. EBITDA is not a defined performance measure under IFRS Accounting Standards.</p>






<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%"><b>12.2</b></td><td><b>Financial liabilities</b></td></tr></table>

<p style="font: 7pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfFinancialLiabilitiesTableTextBlock_zApM0bo416tj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 1)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B9_zwid6Khlho16" style="display: none">Schedule of financial liabilities</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>At amortized cost</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Trade payables</td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z967f8uR7pzf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables">123,581 </td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5iEBvLxnhBl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables">128,080 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Loans and financing</td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zlsu6fnkPwag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing">2,054,267 </td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFCAXvaqZ7Zd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing">2,195,161 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Lease liabilities</td>
    <td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zWKhVwB4p6I5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities">1,065,746 </td>
    <td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zPkwp9NZMQci" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities">978,336 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders</td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zt0iPGHBgy48" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Accounts payable to selling shareholders">115,447 </td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z0ZirexSHOb6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Accounts payable to selling shareholders">215,819 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Dividends payable</td>
    <td id="xdx_988_eifrs-full--DividendsPayable_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFlWtsR8A402" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends payable">192 </td>
    <td id="xdx_989_eifrs-full--DividendsPayable_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z80SeiiXaPI" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends payable"><span style="-sec-ix-hidden: xdx2ixbrl3324">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z2yumoKcDxu1" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>3,359,233 </b></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zzvYvHDyFZr7" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>3,517,396 </b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_980_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4xsAyUzUA2g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">326,432 </td>
    <td id="xdx_988_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z1xpBTbijuV" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">690,395</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_987_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zTpj8mv5vIpk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">3,032,801 </td>
    <td id="xdx_986_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zYLJIetDc5I1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">2,827,001</td></tr>
  </table>
<p id="xdx_8A2_znvTOkGaQ9hc" style="font: 10pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfFairValuesTableTextBlock_zmQJkcK0fO4j" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 2)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B7_zZmKFkpt9Eh3" style="display: none">Schedule of fair value</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>At fair value</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders (earn-outs)</td>
    <td id="xdx_987_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersEarnOutsMember_zDvLTTDZJfg1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value">3,337 </td>
    <td id="xdx_98E_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersEarnOutsMember_z6W34HKHufi8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value">20,067 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders (Unidom)</td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersUnidomMember_zdCzDsMpiktj" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value">321,813 </td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersUnidomMember_zeSjmCcRFI0a" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value">294,886 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_985_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231_zcdPTjJeT4jh" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"><b>325,150 </b></td>
    <td id="xdx_981_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231_z1yq3E0XKkfb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"><b>314,953 </b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_98E_eifrs-full--CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20251231_z5gzvupBWZx7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">24,421 </td>
    <td id="xdx_984_eifrs-full--CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20241231_zeCC9zpsD9y7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">32,137</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_988_eifrs-full--NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20251231_z3QiGJ9fRsZ7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">300,729 </td>
    <td id="xdx_98A_eifrs-full--NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20241231_zZsxNtpJh8he" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">282,816</td></tr>
  </table>
<p id="xdx_8A1_zxjvVaOyTrv4" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%"><span style="color: #C00000"><b>12.2.1</b></span></td><td><span style="color: #C00000"><b>Loans and financing</b></span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfLoansAndFinancingTableTextBlock_zM8pNdh4cIHf" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 3)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_z0Kd946A2336" style="display: none">Schedule of loans and financing</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="border-bottom: Black 1pt solid; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><b>Financial institution</b></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Currency</b></td>
    <td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Interest rate</b></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Maturity</b></td>
    <td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>&#160;2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_90E_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zsk6mgQ1aqZg" title="Financial institution">Banco Ita&#250; Unibanco S.A.</span> (a)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zghIEF7NWizh" title="Interest rate">CDI + 1.90% p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_902_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zfmdRINOXAp" title="Maturity">October 2025</span></td>
    <td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zIzv4cTdu8u1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="-sec-ix-hidden: xdx2ixbrl3368">-</span></td>
    <td id="xdx_981_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zZA230XVHKq" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">309,496 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_90A_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zho5Ub0wj0d4" title="Financial institution">FINEP</span> (b)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zR4R7MHSOWSj" title="Interest rate">TJLP p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zQMduyFSaulk" title="Maturity">July 2027</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zzMGfB6ps923" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">5,262</td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_z3PJqmXxSVUf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">8,209 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_900_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zOXOwdIGAdL6" title="Financial institution">Softbank</span> (c)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_908_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zmWpM8AvbL52" title="Interest rate">6.5% p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_z7BL1PKorwS" title="Maturity">April 2026</span></td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zt8EyJj7OKag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="-sec-ix-hidden: xdx2ixbrl3388">-</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zIk4zqzRAgAc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">845,492 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_900_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z9IeoQSgiGX5" title="Financial institution">Debentures</span> (d)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_zuZ0u6OuNYi4" title="Interest rate">CDI + 1.80% p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z896fjA34ps4" title="Maturity">January 2028</span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z1HLbfMnmsk3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="-sec-ix-hidden: xdx2ixbrl3398">-</span></td>
    <td id="xdx_981_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_zGBKe5Dsv8I4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">526,946 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_903_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zw9svEiE6aj4" title="Financial institution">IFC</span> (e)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zaVgDULurkU7" title="Interest rate">CDI + 1.05% p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_znlDd5q6YYb9" title="Maturity">April 2030</span></td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zzCiOfkv4la6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">510,672 </td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zaHAYXiw4Rp" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">505,018 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_905_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zQCcBN51G4sl" title="Financial institution">Commercial notes</span> (f)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_901_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zpGzhbR5Aszj" title="Interest rate">CDI + 0.70% p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_z5CyciXkyRyb" title="Maturity">October 2028</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_ztPSc6KChh1l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">512,678 </td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zzxIKkmOKrk6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="-sec-ix-hidden: xdx2ixbrl3420">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_904_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zJbJTQxnQ0R7" title="Financial institution">Commercial notes</span> (f)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_907_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zFXhJCDdwyha" title="Interest rate">CDI + 0.85% p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90D_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zEBeVDWTnoL9" title="Maturity">October 2030</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zWski1IdqoVc" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">1,025,655 </td>
    <td id="xdx_988_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zqAzcJDkTw5k" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="-sec-ix-hidden: xdx2ixbrl3430">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20251231_zLHiAOy5g2N8" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><b>2,054,267 </b></td>
    <td id="xdx_989_ecustom--LoansAndFinancing_pn3n3_c20241231_zX7ix0nhzp2" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><b>2,195,161 </b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_982_ecustom--LoansAndFinancingCurrent_iI_pn3n3_c20251231_zbQpxAy2G1ug" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current">60,668 </td>
    <td id="xdx_98E_ecustom--LoansAndFinancingCurrent_iI_pn3n3_c20241231_zlokdgluSQRc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current">363,554 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98F_ecustom--LoansAndFinancingNonCurrent_iI_pn3n3_c20251231_zdtKQQANyR8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current">1,993,599 </td>
    <td id="xdx_98A_ecustom--LoansAndFinancingNonCurrent_iI_pn3n3_c20241231_zc3HX6s9BtS8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current">1,831,607 </td></tr>
  </table>
<p id="xdx_8A4_z2M9FEQY3ISi" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(a) On October 1, 2020, Afya Brazil entered into a loan with Banco Ita&#250; Unibanco
S.A. in the amount of R$500,000 adjusted by the CDI rate plus an interest rate of 1.62% per year and is repayable in three installments
in October 2022, April 2023 and October 2023. On September 28, 2022, Afya Brazil signed an amendment with Banco Ita&#250; Unibanco S.A
in order to extend its debt profile, postponing the original repayments dates from 2022 and 2023 to 2023, 2024 and 2025. Due to such extension,
the spread over the CDI rate increased from 1.62% p.y to 1.90% p.y. The aggregate outstanding amount was fully repaid on September 30,
2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(b) On July 23, 2019, Medcel entered into a loan of R$16,153 with <i>Financiadora de Estudos
e Projetos</i> (FINEP), a governmental agency focused on financing investments on R&amp;D, which has an interest rate based on TJLP (Long
term interest rate), and maturity in 2027. The first and second tranches of R$6,734 and R$4,130, respectively, were drawdown in October
2019 and December 2020, respectively, and additional tranches were drawdown in March and June 2023 totaling R$5,288 in order to develop
the Medical web series and other digital content. There is no financial covenant related to this agreement. The total balance is guaranteed
by a bank financial guarantee.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(c) On April 26, 2021, the Company issued and sold 150,000 shares of perpetual convertible
preferred shares designated as Series A perpetual convertible preferred shares, with a par value of US$0.00005 per share of Afya for US$150,000
thousands, equivalent to R$821,805 on the issuance date. The Series A perpetual convertible preferred shares is a class of equity security
that ranks senior to the common shares with respect to dividend rights or rights upon liquidation.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On November 3, 2025, the Company repurchased all 150,000 Series A perpetual convertible
preferred shares of a nominal or par value of US$0.00005 each in the capital of the Company for an aggregate purchase price of R$831,600,
following the Share Repurchase Agreement with SBLA Holdco LLC, an affiliate of Softbank. All repurchased Series A preferred shares were
cancelled by the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(d) On December 16, 2022, Afya Brazil issued 500,000 simple, non-convertible, unsecured
debentures in a single series, each with a par value of R$1, totaling an aggregate amount of R$500,000, in a public distribution with
restricted placement efforts in the Brazilian market, under the terms of the Brazilian Securities Commission (CVM) Rule No. 476. The debentures
were issued with a maturity date of January 15, 2028, with the principal to be amortized in two equal installments payable on January
15, 2027 and January 15, 2028, corresponding to the fourth and fifth years of the transaction, respectively. The debentures bear interest
at 100% of the CDI rate plus 1.80% per year, payable semi-annually on January 15 and July 15 of each year, until the maturity date. The
aggregate outstanding amount was fully repaid on October 22, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(e) On August 7, 2024, Afya Brazil entered into a loan agreement with International Finance
Corporation ("IFC") to support its expansion program, through acquisitions. The financing is IFC&#8217;s first sustainability-linked
loan based on social targets in the education sector. The pricing of IFC&#8217;s loan will be linked to Afya reaching performance target
levels in selected social key performance indicators encompassing free medical consultations for the community and quality of education
according to MEC criteria (&#8220;Sustainability KPIs&#8221; - unaudited).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The aggregate principal amount of the loan is R$<span id="xdx_902_ecustom--LoanAndFinancing_iI_pn3n3_c20240807__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InternationalFinanceCorporationMember_zWlbd2ITr9vg" title="Loans and financing">500,000</span>, which shall be repaid in seven
equal semi-annual installments starting in April 2027. The interest rate of <span id="xdx_908_eifrs-full--BorrowingsInterestRateBasis_c20240801__20240807__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InternationalFinanceCorporationMember_zEgq9NrBv6Ah" title="Interest rate">CDI rate plus 1.20%</span> was reduced by 15 bps to 1.05% since the
Sustainability KPIs were achieved (unaudited).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Afya Brazil is subject to certain obligations including financial covenants, and the Company
shall maintain, as of the last day of each quarter of each financial year, Net Debt (Loans and financing plus Accounts payable to selling
shareholders less Cash and cash equivalents) to Adjusted EBITDA ratio below or equal to 3.0x, at the end of each fiscal year, until the
maturity date. Adjusted EBITDA for covenant purposes considers net income plus (i) income taxes expenses, (ii) net financial result (excluding
interest expenses on lease liabilities), (iii) depreciation and amortization expenses (excluding right-of-use assets depreciation expenses),
(iv) share-based compensation expenses, (v) share of income of associate, (vi) interest received and (vii) non-recurring expenses.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(f) On October 15, 2025, Afya Brazil issued commercial notes for private placement, sold
to Opea Securitizadora S.A. ("Opea&#8221;), a Brazilian securitization corporation pursuant to Section 45 of Brazilian Law No. 14,195/2021,
as amended. Opea issued a debenture backed by the commercial notes on the same terms and conditions.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The aggregate principal amount of the commercial notes is R$<span id="xdx_906_ecustom--LoanAndFinancing_iI_pn3n3_c20251015__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TwoSeriesMember_zU7IEEY5VW47" title="Loans and financing">1,500,000</span>, divided into two
series, the first in the aggregate amount of R$<span id="xdx_909_ecustom--LoanAndFinancing_iI_pn3n3_c20251015__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FirstSeriesMember_z4sgmX86Vd3b" title="Loans and financing">500,000</span> ("First Series&#8221;) and the second in the aggregate amount of R$<span id="xdx_90B_ecustom--LoanAndFinancing_iI_pn3n3_c20251015__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SecondSeriesMember_zDUAq51R50G8" title="Loans and financing">1,000,000</span>
("Second Series&#8221;). The First Series will mature on October 15, 2028 and the Second Series will mature on October 15, 2030.
The interest rate applicable to the First Series and Second Series will be equal to the <span id="xdx_903_eifrs-full--BorrowingsInterestRateBasis_c20251001__20251015__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InternationalFinanceCorporationMember_zxhpz9tfdiJc" title="Interest rate">CDI rate plus a spread of 0.70% and 0.85%</span> per
year, respectively, based on 252 business days.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Afya Brazil is subject to certain obligations including financial covenants, and the Company
shall maintain Net Debt (excluding lease liabilities) to adjusted EBITDA ratio below or equal to 3.0x, at the end of each fiscal year,
until maturity date, applicable from December 31, 2025 and thereafter. Adjusted EBITDA for covenant purposes considers net income plus
(i) income taxes expenses, (ii) net financial result (excluding interest expenses on lease liabilities), (iii) depreciation and amortization
expenses (excluding right-of-use assets depreciation expenses), (iv) share-based compensation expenses, (v) share of income of associate,
(vi) interest received and (vii) non-recurring expenses.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The transaction costs that are directly attributable to the issuance of the commercial
notes were measured at fair value together with the financial liability on initial measurement. The transaction costs totaled R$<span id="xdx_903_ecustom--TransactionCosts_iI_c20251231_zWKYLTepDQZh" title="Transaction costs">5,163</span>,
including legal counsels and advisors.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">As disclosed in Note 7, the commercial notes are guaranteed by the following subsidiaries:
Unigranrio, IESP and DelRey.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%"><b>12.2.2</b></td><td><b>Leases</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company has property lease contracts with maturities between five <span id="xdx_906_ecustom--ContractualLeaseTerm_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCklIv3YYSAh" style="display: none" title="Contractual lease term">5</span> and <span id="xdx_902_ecustom--ContractualLeaseTerm_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zE9Egkr1BGn8" title="Contractual lease term">30</span>
years. There are no contract modification, sublease or variable payments in the period. The remeasurements are related to
index-based updates of the lease payments amounts.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The carrying amounts of right-of-use assets and lease liabilities as of December 31, 2025,
2024 and 2023 and the movements during years ended December 31, 2025, 2024 and 2023 are shown below:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfLeasesTableTextBlock_zD88JZhGdIE8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities  (Details 4)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BE_ziS5UYKrVDNc" style="display: none">Schedule of right-of-use assets and lease liabilities</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Right-of-use assets</b></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Lease liabilities</b></td></tr>
  <tr>
    <td style="width: 33%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td>
    <td style="vertical-align: top; width: 1%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Opening balance</b></td>
    <td id="xdx_984_eifrs-full--RightofuseAssets_iS_pn3n3_c20250101__20251231_zrmYjJND5XH8" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at beginning"><b>842,219 </b></td>
    <td id="xdx_987_eifrs-full--RightofuseAssets_iS_pn3n3_c20240101__20241231_zdSaOneFkP58" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at beginning"><b>767,609 </b></td>
    <td id="xdx_98A_eifrs-full--RightofuseAssets_iS_pn3n3_c20230101__20231231_zwtgdi1UNSs3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at beginning"><b>690,073</b></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--LeaseLiabilities_iS_pn3n3_c20250101__20251231_z7hftFWQstSe" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at beginning"><b>978,336 </b></td>
    <td id="xdx_98F_eifrs-full--LeaseLiabilities_iS_pn3n3_c20240101__20241231_z56wJ6XHjch4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at beginning"><b>874,569 </b></td>
    <td id="xdx_989_eifrs-full--LeaseLiabilities_iS_pn3n3_c20230101__20231231_z16LqXKtL3Me" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at beginning"><b>769,525</b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Additions</td>
    <td id="xdx_988_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231_zG5RCJMJlqpe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, additions">37,727 </td>
    <td id="xdx_986_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20240101__20241231_znlvQUfbfdu5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, additions">37,671 </td>
    <td id="xdx_98F_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20230101__20231231_zqK893yBmtB5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, additions">7,328</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_98A_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20250101__20251231_z9wOqaXwpX02" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, additions">37,727 </td>
    <td id="xdx_98E_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20240101__20241231_zD25qWIes559" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, additions">37,671 </td>
    <td id="xdx_989_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20230101__20231231_zru1mqAVVLrd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, additions">7,328</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Remeasurement</td>
    <td id="xdx_987_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20250101__20251231_zNyoJkpHTtI2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, remeasurement">98,987 </td>
    <td id="xdx_989_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20240101__20241231_z7etiMsyHe4h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, remeasurement">80,226 </td>
    <td id="xdx_98C_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20230101__20231231_zUFlVmu95bDb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, remeasurement">70,387</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_988_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20250101__20251231_zbSBWQuxdI15" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, remeasurement">98,987 </td>
    <td id="xdx_987_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20240101__20241231_zljZVWVsx6Lb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, remeasurement">80,226 </td>
    <td id="xdx_989_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20230101__20231231_zdxRNFVcXfG9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, remeasurement">70,387</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Business combinations</td>
    <td id="xdx_986_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20250101__20251231_z5EfWXvMwSHj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, business combinations"><span style="-sec-ix-hidden: xdx2ixbrl3500">-</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20240101__20241231_zpMS5SSoieSi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, business combinations">28,989 </td>
    <td id="xdx_98E_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20230101__20231231_zhg0bwUH5Rp9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, business combinations">65,408</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_983_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20250101__20251231_zYuL6NwOy2I3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, business combinations"><span style="-sec-ix-hidden: xdx2ixbrl3506">-</span></td>
    <td id="xdx_987_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20240101__20241231_zzd6GS6LA7jj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, business combinations">28,989 </td>
    <td id="xdx_981_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20230101__20231231_z1svd6hJRjnc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, business combinations">65,408</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Depreciation expense</td>
    <td id="xdx_986_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20250101__20251231_zaLcw6anITY" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, depreciation expense">(80,864)</td>
    <td id="xdx_98B_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20240101__20241231_zCCby1j6NoAl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, depreciation expense">(70,294)</td>
    <td id="xdx_98B_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20230101__20231231_zPzojHIgCWnk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, depreciation expense">(63,118)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_98D_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20250101__20251231_zXNifSeHaype" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="-sec-ix-hidden: xdx2ixbrl3518">-</span></td>
    <td id="xdx_981_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20240101__20241231_z9P9X9mybrKk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="-sec-ix-hidden: xdx2ixbrl3520">-</span></td>
    <td id="xdx_98D_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20230101__20231231_zik12oLFw6nk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="-sec-ix-hidden: xdx2ixbrl3522">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Interest expense</td>
    <td id="xdx_980_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20250101__20251231_zcK8vh0zYxM5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, interest expense"><span style="-sec-ix-hidden: xdx2ixbrl3524">-</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20240101__20241231_zRWQMeouzGka" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, interest expense"><span style="-sec-ix-hidden: xdx2ixbrl3526">-</span></td>
    <td id="xdx_988_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20230101__20231231_zRmqwqrHVgYj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, interest expense"><span style="-sec-ix-hidden: xdx2ixbrl3528">-</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_98D_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20250101__20251231_z3WyXUMZlpye" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, interest expense">123,067 </td>
    <td id="xdx_98A_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20240101__20241231_zRKcL939U0ya" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, interest expense">111,966 </td>
    <td id="xdx_980_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20230101__20231231_zpSz7Nt2nZM9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, interest expense">100,849</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Payments of principal</td>
    <td id="xdx_986_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20250101__20251231_zwD9zYJ3nvig" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right of use assets, payments of principal"><span style="-sec-ix-hidden: xdx2ixbrl3536">-</span></td>
    <td id="xdx_980_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20240101__20241231_zvzRrODrMld1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right of use assets, payments of principal"><span style="-sec-ix-hidden: xdx2ixbrl3538">-</span></td>
    <td id="xdx_981_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20230101__20231231_zYluA0Wjjtz7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right of use assets, payments of principal"><span style="-sec-ix-hidden: xdx2ixbrl3540">-</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_982_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20250101__20251231_zRdowUBn6c43" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of principal">(49,411)</td>
    <td id="xdx_986_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20240101__20241231_zPepJ0SWODm9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of principal">(41,221)</td>
    <td id="xdx_98B_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20230101__20231231_zNgzvuS7z2Dj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of principal">(31,473)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Payments of interest</td>
    <td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20250101__20251231_ztdg2YuJlDn8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, payments of interest"><span style="-sec-ix-hidden: xdx2ixbrl3548">-</span></td>
    <td id="xdx_98A_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20240101__20241231_zaDc92cMtB1h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, payments of interest"><span style="-sec-ix-hidden: xdx2ixbrl3550">-</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20230101__20231231_zBYFRjGs86n1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, payments of interest"><span style="-sec-ix-hidden: xdx2ixbrl3552">-</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20250101__20251231_z8n47pb78YV" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of interest">(121,475)</td>
    <td id="xdx_987_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20240101__20241231_ziYeoCmUxY8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of interest">(111,605)</td>
    <td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20230101__20231231_zUykcHnsOZw2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of interest">(103,911)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Write-off (i)</td>
    <td id="xdx_989_ecustom--RightofuseAssetsWriteoff_pn3n3_c20250101__20251231_zLYEa3sEOuJ3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, Write-off">(1,311)</td>
    <td id="xdx_98B_ecustom--RightofuseAssetsWriteoff_pn3n3_c20240101__20241231_zR6omVt1EKL9" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, Write-off">(1,982)</td>
    <td id="xdx_985_ecustom--RightofuseAssetsWriteoff_pn3n3_c20230101__20231231_zP3Z43ppyj7h" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, Write-off">(2,469)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_980_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20250101__20251231_zb8SmeLgEXli" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, Write-off">(1,485)</td>
    <td id="xdx_983_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20240101__20241231_zoINMVKtH2Oa" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, Write-off">(2,259)</td>
    <td id="xdx_98A_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20230101__20231231_zSQ18FdrODXf" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, Write-off">(3,544)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Closing balance</b></td>
    <td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20250101__20251231_z83FsUeGPdD1" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at ending"><b>896,758 </b></td>
    <td id="xdx_981_eifrs-full--RightofuseAssets_iE_pn3n3_c20240101__20241231_zIJlhrQ8DRN4" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at ending"><b>842,219 </b></td>
    <td id="xdx_980_eifrs-full--RightofuseAssets_iE_pn3n3_c20230101__20231231_zigy42ysc84h" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at ending"><b>767,609&#160;</b></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--LeaseLiabilities_iE_pn3n3_c20250101__20251231_zj6U64o61w0f" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at ending"><b>1,065,746 </b></td>
    <td id="xdx_987_eifrs-full--LeaseLiabilities_iE_pn3n3_c20240101__20241231_zDOvzCg0E3rg" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at ending"><b>978,336 </b></td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iE_pn3n3_c20230101__20231231_z18Kd8AYjSZ9" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at ending"><b>874,569</b></td></tr>
  </table>
<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="width: 33%; padding-right: 3.5pt; padding-left: 3.5pt"><b>Balances:</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td>
    <td style="width: 1%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_983_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20251231_zVQBU8Kzgxhj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, current"><span style="-sec-ix-hidden: xdx2ixbrl3584">-</span></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20241231_zKmXCVBS5Yg1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, current"><span style="-sec-ix-hidden: xdx2ixbrl3586">-</span></td>
    <td id="xdx_987_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20231231_zq92Mxs84Og5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, current"><span style="-sec-ix-hidden: xdx2ixbrl3588">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20251231_zWRjzez5qT8j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, current">55,772 </td>
    <td id="xdx_982_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20241231_zF7bmEAkbuZ4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, current">45,580&#160;</td>
    <td id="xdx_982_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20231231_zplwbGBHes59" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, current">36,898</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_985_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20251231_zjWfNlJTche9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, non-current">896,758</td>
    <td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20241231_zzWw057iipp5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, non-current">842,219 </td>
    <td id="xdx_98E_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20231231_zvT3AFPGNFm9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, non-current">767,609</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_982_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20251231_zUBh0pMUPeM6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, non-current">1,009,974 </td>
    <td id="xdx_980_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20241231_zmuTAq8dkLw6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, non-current">932,756</td>
    <td id="xdx_983_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20231231_z5hwXbmG3bb9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, non-current">837,671</td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to early termination of lease contracts.</td>
</tr></table>

<p id="xdx_8AD_zBUvT8I7dJ9b" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company recognized lease expense from short-term leases and low-value assets of R$<span id="xdx_90C_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20250101__20251231_z0UM1xVFfRF9" title="Lease expense from short-term leases and low-value assets">12,617</span>
for the year ended December 31, 2025 (R$<span id="xdx_900_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20240101__20241231_zm5XXISCR7ql" title="Lease expense from short-term leases and low-value assets">11,207</span> and R$<span id="xdx_90A_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20230101__20231231_zIjye3jokNci" title="Lease expense from short-term leases and low-value assets">10,871</span> for the years ended December 31, 2024 and 2023, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%"><b>12.2.3</b></td><td><b>Accounts payable to selling shareholders</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock_zcVBNn7CbKga" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 5)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span id="xdx_8B1_z8jHkXAu4UE4" style="display: none">Schedule of accounts payable to selling shareholders</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; text-align: center"><b>Interest rate</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Accounts payable at amortized cost (deferred consideration)</b></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Unigranrio (a)</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_908_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zJC5b0b1LD4g" title="Interest rate">CDI</span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zHlARej95FEj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="-sec-ix-hidden: xdx2ixbrl3618">-</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zPDRzaJR4GJ2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">90,543 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">DelRey (b)</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_907_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zlCk9dBjP4Fj" title="Interest rate">Selic</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWPWg3dXB525" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">71,604 </td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zDjUbjyGWY5i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">125,276 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">FUNIC (c)</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_90A_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zFSiFuNVQ34d" title="Interest rate">CDI</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zDKnG57YjhT4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">43,843 </td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zgXtCo5MQmFc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="-sec-ix-hidden: xdx2ixbrl3632">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><b>Accounts payable at fair value (contingent consideration)</b></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Shosp (d)</td>
    <td style="vertical-align: bottom; text-align: center">-</td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zJsnNpdxVcsi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">454 </td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zBolMYi8Pky2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">454 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Al&#233;m da Medicina (e)</td>
    <td style="vertical-align: bottom; text-align: center">-</td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zpNHiASUYtR7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="-sec-ix-hidden: xdx2ixbrl3638">-</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zGRd88fogiBi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">9,600 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">CardioPapers (f)</td>
    <td style="vertical-align: bottom; text-align: center">-</td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zoa3WyA6Hpvk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">2,883 </td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zYVvQmhCETv2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">10,013 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Unidom (g)</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_90D_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zsGBJFbvzyud" title="Interest rate">CDI</span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_za0n4IlLlAD5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">321,813 </td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zIGd8gh76783" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">294,886 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231_ziCyVAdc5JXk" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><b>440,597 </b></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231_z5hhiKLHZf66" style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable"><b>530,772 </b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td id="xdx_98A_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_pn3n3_c20251231_zoRMpepDJVVk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current">110,640 </td>
    <td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersCurrent_pn3n3_c20241231_z8RKSErz3t02" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current">185,318 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_pn3n3_c20251231_zwBpujq7o7lk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current">329,957 </td>
    <td id="xdx_986_ecustom--AccountsPayableToSellingShareholdersNonCurrent_pn3n3_c20241231_zSuXbKLI69R1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current">345,454 </td></tr>
  </table>
<p id="xdx_8AE_zXKjrUTQvmj5" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(a) On August 4, 2021, Afya Brazil acquired <span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20210803__20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zRjCy1E8z62h" title="Ownership interest">100</span>% of Unigranrio. The adjusted aggregate
purchase price was R$<span id="xdx_907_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_c20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_pn3n3" title="Non-current payables for purchase of energy">618,956</span> of which 60% was paid in cash on the transaction closing date, and 40% was payable in cash in four equal
installments through 2022 to 2025, adjusted by the CDI rate. The aggregate outstanding amount was fully paid on August 4, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(b) On January 2, 2023, Afya Brazil acquired <span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zSQ6vjtg7X2k" title="Ownership interest">100</span>% of DelRey. The consideration of R$<span id="xdx_908_ecustom--ConsiderationToBeTransferred_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_pn3n3" title="Consideration to be transferred">234,000</span>
is payable in cash in three annual installments of R$<span id="xdx_909_ecustom--FirstAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zaWX13vTpkAi" title="First annual installment">134,000</span> in January 2024, R$<span id="xdx_908_ecustom--SecondAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zpuBrLMrHzrd" title="Second annual installment">50,000</span> in January 2025 and R$<span id="xdx_904_ecustom--ThirdAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z32mIzvNyr8a" title="Third annual installment">50,000</span> in January 2026, adjusted
by the SELIC rate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(c) On May 7, 2025, Afya Brazil acquired <span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250505__20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zYeIzDnYAjda" title="Ownership interest">100</span>% of FUNIC. The aggregate purchase price was
R$<span id="xdx_902_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z50vhGtOzCef" title="Non-current payables for purchase of energy">100,000</span> of which 60% was paid in cash on the transaction closing date, and 40% is payable in cash in three annual installments adjusted
by the CDI rate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(d) On May 13, 2021, Afya Brazil acquired <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20210512__20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z2PyRfPNEcs2" title="Ownership interest">100</span>% of Shosp which included an earn-out of R$<span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zdoIJjfX0f8b" title="Remaining accounts payable">513</span>
paid in August 2023 related to product development and R$<span id="xdx_90C_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_pn3n3" title="Transaction price allocated to remaining performance obligations">454</span> will be paid until 2026.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(e) On March 4, 2022, Afya Brazil acquired <span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zzs9IUjDXEf7" title="Ownership Interest">100</span>% of Al&#233;m da Medicina and an earn-out
of up to R$<span id="xdx_909_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_pn3n3" title="Remaining accounts payable">19,200</span> is payable in connection with revenue target achievements and product development goals for 2023 and 2024. The contingent
consideration of R$<span id="xdx_90D_eifrs-full--DefinedBenefitObligationAtPresentValue_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_pn3n3" title="Defined benefit obligation">9,600</span> was fully paid on May 23, 2025.</p>




<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(f) On April 5, 2022, Afya Brazil acquired <span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z4t8QuOCCkA8" title="Ownership interest">100</span>% of CardioPapers and an earn-out of up to
R$<span id="xdx_901_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_pn3n3" title="Remaining accounts payable">15,000</span> is payable in connection with revenue target achievements and other goals regarding credentials in the market for 2023 and 2024.
The contingent consideration of R$<span id="xdx_904_eifrs-full--DefinedBenefitObligationAtPresentValue_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_pn3n3" title="Defined benefit obligation">2,883</span> is based on the estimated payment considering the facts and circumstances as of December 31, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">(g) On July 1, 2024, Afya Brazil acquired <span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240630__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zQEycIt2JfZ1" title="Ownership interest">100</span>% of Unidom. The consideration of R$<span id="xdx_905_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zIyC6sBdROJf" title="Defined benefit obligation">279,989</span>
is payable in up to ten annual installments, adjusted by the CDI rate, and it is conditioned upon the maintenance of the authorization
of the 175 medical school seats in each of the prior year. The contingent consideration is based on the estimated payment considering
the facts and circumstances as of December 31, 2025. The accounts payable to the selling shareholders of Unidom is updated by the CDI
rate, as determined in the purchase agreement, and measured at fair value considering the maintenance of the authorization of the 175
operating medical school seats. See Note 4.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The movements during the years ended December 31, 2025, 2024 and 2023 are shown below:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--AccountsPayableToSellingShareholders1Explanatory_ztrVH9uKlFoe" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 6)">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B5_zXqp6kpCmX4k" style="display: none">Schedule of
    accounts payable</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><b>Opening balance</b></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOtVHYMr1kHi" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Opening balance"><b>530,772</b></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zaejO9yWZyWh" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Opening balance"><b>566,867</b></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z462xqz8zDK1" style="border-bottom: Black 1pt solid; text-align: right" title="Opening balance"><b>528,678</b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Additions</td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zn8ME7H7tCCi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Additions consideration to be transferred on business combinations">40,000 </td>
    <td id="xdx_98C_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zigz5mARamFd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Additions consideration to be transferred on business combinations">279,989</td>
    <td id="xdx_985_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwCowbXQKk3l" style="text-align: right" title="Additions consideration to be transferred on business combinations">234,000</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Payments of principal</td>
    <td id="xdx_986_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z4TQgHqWmWac" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payments of principal">(144,076)</td>
    <td id="xdx_985_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFzyY9CIJ1e5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payments of principal">(290,067)</td>
    <td id="xdx_986_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z5bIiixptDSj" style="text-align: right" title="Payments of principal">(225,460)</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Payments of interest</td>
    <td id="xdx_980_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zS2GT9Rsb8Vc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payment of interest">(49,608)</td>
    <td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zeYlP5wmZlH1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payment of interest">(78,931)</td>
    <td id="xdx_983_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoFgKldgXHAa" style="text-align: right" title="Payment of interest">(55,989)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Interest</td>
    <td id="xdx_98B_eifrs-full--InterestExpense_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zdvB85FYxhK5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Interest">19,979 </td>
    <td id="xdx_98E_eifrs-full--InterestExpense_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zrE7rcRWEn2h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Interest">37,276</td>
    <td id="xdx_98F_eifrs-full--InterestExpense_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zk1A2shaDQo9" style="text-align: right" title="Interest">85,069</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Remeasurement of contingent consideration</td>
    <td id="xdx_988_ecustom--RemeasurementOfEarnouts_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zjz7TBASLwof" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Remeasurement of contingent consideration">43,530 </td>
    <td id="xdx_987_ecustom--RemeasurementOfEarnouts_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwQGJEL7x3G4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Remeasurement of contingent consideration">15,638</td>
    <td id="xdx_981_ecustom--RemeasurementOfEarnouts_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoTZdqyxh2l2" style="text-align: right" title="Remeasurement of contingent consideration">2,556</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Other</td>
    <td id="xdx_981_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zdoHM8oQRhsl" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other"><span style="-sec-ix-hidden: xdx2ixbrl3742">-</span> </td>
    <td id="xdx_982_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zR8s1QU08UAg" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other"><span style="-sec-ix-hidden: xdx2ixbrl3744">-</span></td>
    <td id="xdx_98D_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zkOu8uRedqKd" style="border-bottom: Black 1pt solid; text-align: right" title="Other">(1,987)</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><b>Closing balance</b></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zTJGcfhg39xf" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Closing balance"><b>440,597</b></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zEt4JXbwsDbc" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Closing balance"><b>530,772</b></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ztC8TeVwHVP" style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right" title="Closing balance"><b>566,867</b></td></tr>
  </table>
<p id="xdx_8AE_zrUt6Cu4o13" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%"><b>12.3</b></td><td><b>Fair values</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The table below compares the carrying amounts and fair values of the Company&#8217;s financial
instruments, other than those carrying amounts that are reasonable approximation of fair values:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfFairValuesFinancialInstrumentstTableTextBlock_zaWsNnNt4Wo8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 7)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B3_zvCQCh6mSFh8" style="display: none">Schedule of fair values of the company's financial instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>2025</b> </td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 36%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Carrying amount</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 15%; text-align: right"><b>Fair value</b></td>
    <td style="width: 1%; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; text-align: right"><b>Carrying amount</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Fair value</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b>Financial liabilities</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Loans and financing</td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z6mwy2GWAmLa" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at carrying amount">2,054,267 </td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zkwwMXOc6eRl" style="border-bottom: Black 1pt solid; text-align: right" title="Financial liabilities, at fair value">2,056,492 </td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zZgXKeQVxdd2" style="text-align: right" title="Financial liabilities, at carrying amount">2,195,161 </td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zy6HppqWQO7c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at fair value">2,196,152</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_pn3n3_c20251231_zxgafQbwzMQ7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at carrying amount"><b>2,054,267 </b></td>
    <td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20251231_zTXrOYytLgt" style="border-bottom: Black 1.5pt double; text-align: right" title="Financial liabilities, at fair value"><b>2,056,492 </b></td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231_zsZax9Uj0Q5l" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; text-align: right" title="Financial liabilities, at carrying amount"><b>2,195,161 </b></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20241231_z2K7rU9FZfN9" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at fair value"><b>2,196,152</b></td></tr>
  </table>
<p id="xdx_8AB_zAGAZA231skf" style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The Company assessed that the fair values of cash and cash equivalents,
trade receivables, other assets, trade payables and accounts payable to selling shareholders approximate their carrying amounts.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The financial instruments for which the fair value are disclosed
are based on Level 2 fair value measurement hierarchy. There has been no change in fair value hierarchy during the years ended December
31, 2025 and 2024.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%"><b>12.4</b></td><td><b>Financial instruments risk management objectives and policies</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The Company&#8217;s main financial liabilities comprise loans
and financing, lease liabilities, accounts payable to selling shareholders and trade payables. The main purpose of these financial liabilities
is to finance the Company&#8217;s operations and expansion. The Company&#8217;s main financial assets include cash and cash equivalents
and trade receivables.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company is exposed to market risk, credit risk and liquidity risk. The Company monitors
market, credit and liquidity risks in line with the objectives of capital management and counts on the support, monitoring and oversight
of the Board of Directors in decisions related to capital management and its alignment with the objectives and risks. The Company&#8217;s
policy is that no trading of derivatives for speculative purposes may be undertaken. The Board of Directors reviews and agrees with policies
for managing each of these risks, which are summarized below.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>




<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%"><b>12.4.1</b></td><td><b>Market risk</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">Market risk is the risk that the fair value or future cash flows
of a financial instrument will fluctuate because of changes in market prices. The Company&#8217;s exposure to market risk is related to
interest rate and foreign currency risk. The sensitivity analysis in the following sections relates to the position as of December 31,
2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>a) Interest rate risk</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">Interest rate risk is the risk that the fair value or future cash
flows of a financial instrument will fluctuate because of changes in market interest rates. The Company&#8217;s exposure to the risk of
changes in market interest rates relates primarily to the Company&#8217;s cash equivalents, loans and financing and accounts payable to
selling shareholders, with floating interest rates.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white; color: #C00000"><span style="text-decoration: underline">Sensitivity analysis</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The table below demonstrates the sensitivity to a reasonably possible
change in interest on cash equivalents, loans and financing and accounts payable to selling shareholders. With all variables held constant,
the Company&#8217;s income before income taxes is affected through the impact on floating interest rates, as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_zf2q7oBUugg4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 8)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BE_zNPHtsgVSAVd" style="display: none">Schedule of income before income taxes</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Index</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>Base rate</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cash equivalents</td>
    <td id="xdx_98C_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zrA15uDD1pni" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending">1,086,489 </td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_900_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zbbsq91S658k" title="Index - % per year">CDI</span></td>
    <td id="xdx_983_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zdQMczYG49Qg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate">163,781 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Loans and financing</td>
    <td id="xdx_986_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zmZVsDbj9s5e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending">(2,049,005)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_904_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zVMagY5M7RPg" title="Index - % per year">CDI</span></td>
    <td id="xdx_98E_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zzwxjja3r20l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate">(323,480)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Loans and financing</td>
    <td id="xdx_984_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zbv8b2feDyzk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending">(5,262)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_909_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zQntQr53qNPi" title="Index - % per year">TJLP</span></td>
    <td id="xdx_983_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zeCJDTfiKAWb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate">(477)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders</td>
    <td id="xdx_987_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z6speULioNpj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending">(365,656)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_90F_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zkFk7JmS4N2j" title="Index - % per year">CDI</span></td>
    <td id="xdx_987_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zjLQcDfzLzH3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate">(54,483)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders</td>
    <td id="xdx_981_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zDc056qLG1Y7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending">(71,604)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_901_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zmeiYYfhn45j" title="Index - % per year">Selic</span></td>
    <td id="xdx_98A_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zTFiBj48wHSj" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate">(10,669)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Net exposure</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_985_ecustom--BaseRate_pn3n3_c20250101__20251231_zxkYdR3fXnsi" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><b>(225,328)</b></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Increase in basis points</b></td></tr>
  <tr>
    <td style="white-space: nowrap; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>+75</b></td>
    <td style="width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>+150</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Net effect on profit before tax</td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zU05K3J0Pjdj" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax">(10,538)</td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z6mnSGiXUo5g" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax">(21,076)</td></tr>
  </table>
<p id="xdx_8A8_zFZPYIgmzoYk" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>b) Foreign currency risk</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Foreign currency risk is the risk that the fair value or future cash flows of exposure
will fluctuate because of changes in foreign exchange rates. The Company&#8217;s exposure to the risk of changes in foreign exchange rates
relates to cash and cash equivalents denominated in U.S. dollars in the amount of R$<span id="xdx_905_ecustom--CreditExposures_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zpKvhj6yKuUf" title="Exposure risk">23,422</span> as of December 31, 2025 (December 31, 2024:
R$<span id="xdx_90F_ecustom--CreditExposures_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zrJGDStDheMf" title="Exposure risk">21,610</span>).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><span style="text-decoration: underline">Sensitivity analysis</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The table below demonstrates the sensitivity in the Company&#8217;s income before income
taxes of a <span id="xdx_906_ecustom--SensitivityChangeInTheEuroExchangeRate_pip0_dp_c20250101__20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zaFmv1yYYctk" title="Percentage of sensitivity change in the Euro exchange rate">10</span>% change in the U.S. dollar exchange rate (R$<span id="xdx_903_eifrs-full--ClosingForeignExchangeRate_iI_uN_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zfah5scgOwti" title="Closing foreign exchange rate">5.5018</span> to U.S. dollar <span id="xdx_900_eifrs-full--ClosingForeignExchangeRate_iI_uN_c20251231__ifrs-full--CurrencyInWhichInformationIsDisplayedAxis__currency--EUR__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zyKcCICooMng" title="Closing foreign exchange rate">1.00</span>) as of December 31, 2025, with all other variables
held constant.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_zb2oG5xFCrXf" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 9)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BC_zcdunEBlLHa9" style="display: none">Schedule of sensitivity foreign currency</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>Exposure</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>+10%</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>-10%</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cash equivalents</td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zrjBauUu3ul3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents">23,422 </td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zAEuZErKtdkc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents">2,342 </td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_z3gubqkXuT0k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents">(2,342)</td></tr>
  </table>
<p id="xdx_8A7_z8TMNCSGIFPg" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><b>12.4.2</b></td><td><b>Credit risk</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white">Credit risk is the risk that a counterparty
will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Company is exposed to
credit risk from its operating activities (primarily trade receivables) and from its financing activities, including cash and cash equivalents.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white">Customer credit risk is managed by the Company
based on the established policy, procedures and control relating to customer credit risk management. Outstanding customer receivables
are regularly monitored. See Note 6 for additional information on the Company&#8217;s trade receivables.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white">Credit risk from balances with banks and
financial institutions is managed by the Company&#8217;s treasury department in accordance with the Company&#8217;s policy. Investments
of surplus funds are made only with approved counterparties and within limits assigned to each counterparty.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The carrying amounts of its financial assets are the Company&#8217;s
maximum exposure to credit risk for the components of the consolidated statements of financial position on December 31, 2025 and 2024.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><b>12.4.3</b></td><td><b>Liquidity risk</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company&#8217;s Management has responsibility for monitoring liquidity risk. In order
to achieve the Company&#8217;s objective, Management regularly reviews the risk and maintains appropriate reserves, including bank credit
facilities with first tier financial institutions. Management also continuously monitors projected and actual cash flows and the combination
of the maturity profiles of the financial assets and liabilities.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The main requirements for financial resources used by the Company arise from the need to
make payments for suppliers, operating expenses, labor and social obligations, loans and financing and accounts payable to selling shareholders.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The tables below summarize the maturity profile of the Company&#8217;s
financial liabilities based on contractual undiscounted amounts:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_zlPRrzpky833" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 10)">
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BB_zvmS6iwPiNRl" style="display: none">Schedule of maturity profile of financial liabilities</span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"><b>As of December 31, 2025 </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Less than 1 year</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>1 to 3 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>3 to 5 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>More than 5 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Trade payables</td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFNRL9fH6a25" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables">123,581 </td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zqzNeDCGV9T" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="-sec-ix-hidden: xdx2ixbrl3832">-</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z7WfLovmFZbe" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="-sec-ix-hidden: xdx2ixbrl3834">-</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztQJUTZkLyFk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="-sec-ix-hidden: xdx2ixbrl3836">-</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zSLHywHPJ24l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables">123,581 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Loans and financing</td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z4d53RHtL1Wl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">308,292 </td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmk3Yp8XSZUl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">1,360,411 </td>
    <td id="xdx_981_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcGC5AiqwmP9" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">1,473,733 </td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zb2ovbIa8IMh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="-sec-ix-hidden: xdx2ixbrl3846">-</span></td>
    <td id="xdx_981_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_za9LadJEq9db" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">3,142,436 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Lease liabilities</td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z75BJ7Wxsg3g" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">178,638 </td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeWz7OcSCtTb" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">347,847 </td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2ydSLgnAhRa" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">331,019 </td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztypRWgxaSSg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">1,342,713 </td>
    <td id="xdx_98F_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zoNOa3bY0JQ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">2,200,217 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Accounts payable to selling shareholders</td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2FpJZ9DRzZ7" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">126,307 </td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2Mq143BlYX3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">131,446 </td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGwmVXkw2aU3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">185,821 </td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2w3RgNl0xs5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">502,355 </td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zUSnIFNlp12h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">945,929 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvDmmPQnN9fb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>736,818 </b></td>
    <td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zwyNtX3MoPBe" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,839,704 </b></td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgXMgQ64ffSe" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,990,573 </b></td>
    <td id="xdx_985_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z4Pv9XYrLA68" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,845,068 </b></td>
    <td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znoWOLTGKGG7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>6,412,163 </b></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="white-space: nowrap; width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"><b>As of December 31, 2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Less than 1 year</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>1 to 3 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>3 to 5 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>More than 5 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Trade payables</td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zK67vmK9kYWg" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables">128,080 </td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z3GYF1pkIKs7" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="-sec-ix-hidden: xdx2ixbrl3882">-</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zHxblqQ7dHB3" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="-sec-ix-hidden: xdx2ixbrl3884">-</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgaXtjjdLgp5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="-sec-ix-hidden: xdx2ixbrl3886">-</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zHr12gbM9Ejf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables">128,080 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Loans and financing</td>
    <td id="xdx_987_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zYPHdM6YwmQ8" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">526,659 </td>
    <td id="xdx_984_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjaUH06nPRTl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">1,494,287 </td>
    <td id="xdx_985_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z24hWxMtpVKh" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">617,818 </td>
    <td id="xdx_988_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z6MrqSHuPOPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">75,526 </td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGHnFZjWePXh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">2,714,290 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Lease liabilities</td>
    <td id="xdx_985_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zSmfkiuF7NG5" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">158,746 </td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zpbidtQS0Fp5" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">303,211 </td>
    <td id="xdx_988_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zCpTp9UABDul" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">293,178 </td>
    <td id="xdx_988_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zA0ILEgs1OY9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">1,360,107 </td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zaFH7tK4Aav1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">2,115,242 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Accounts payable to selling shareholders</td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zAvtxN2ym6Uc" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">205,322 </td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zLsuZQxTUlvi" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">150,565 </td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z26HD8qrCuul" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">99,100 </td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zt61WVDLJHB8" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">373,498 </td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVzHZ5fuAol5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">828,485 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z78KMxuHMQCb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,018,807 </b></td>
    <td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmmRjyOUb2Kc" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,948,063 </b></td>
    <td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zzG4uph8O9W5" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,010,096 </b></td>
    <td id="xdx_98F_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zlTL7c9tc2w" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,809,131 </b></td>
    <td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zuVCIo9EUJnf" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>5,786,097 </b></td></tr>
  </table>

<p id="xdx_8AC_zYAT2NduYAmg" style="margin-top: 0; margin-bottom: 0">&#160;</p>







<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%"><b>12.5</b></td><td><b>Changes in liabilities arising from financing activities</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock_z8kQs7hpzSya" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 11)">
  <tr>
    <td style="vertical-align: bottom"><span id="xdx_8B7_zZMIgodaQ9w4" style="display: none">Schedule of changes in liabilities arising from financing activities</span></td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.55pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.85pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.85pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.55pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>January 1, 2025</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"><span style="font-size: 7.5pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Additions and remeasurements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2025</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-size: 7.5pt"> </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Loans and financing</span></td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zNA3f0cYJtea" style="padding-right: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt">2,195,161</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zBOHFfbu0WLk" style="padding-right: 2.55pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(1,624,911)</span></td>
    <td id="xdx_98B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zoM0dpID9092" style="padding-right: 2.85pt; text-align: right" title="Payments of interest"><span style="font-size: 7.5pt">(274,265)</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zfy41l2ZmVW7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">1,494,881</span></td>
    <td id="xdx_989_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zL6iIrp0H5K" style="text-align: right" title="Interest"><span style="font-size: 7.5pt">252,870</span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zZv3GviSRJm7" style="text-align: right" title="Other"><span style="font-size: 7.5pt">10,531</span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbF8AF1o1TZg" style="padding-right: 5.55pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">2,054,267</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Lease liabilities</span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zu009vAZvI8k" style="padding-right: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt">978,336</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zEWih0Bgtcic" style="padding-right: 2.55pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(49,411)</span></td>
    <td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zymGryeACWE8" style="padding-right: 2.85pt; text-align: right" title="Payments of interest"><span style="font-size: 7.5pt">(121,475)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z0GSRMmdqvKl" style="padding-right: 3.85pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">136,714</span></td>
    <td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_ziiUPemjPDy7" style="text-align: right" title="Interest"><span style="font-size: 7.5pt">123,067</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zLUKEqMy2PCh" style="text-align: right" title="Other"><span style="font-size: 7.5pt">(1,485)</span></td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zs5KiVN6Aop" style="padding-right: 5.55pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">1,065,746</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Dividends payable</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -0.1pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zkdrSnZEsdeg" style="border-bottom: Black 1pt solid; padding-right: -2.45pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(146,813)</span></td>
    <td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zIzXu7nINfsa" style="border-bottom: Black 1pt solid; padding-right: 2.85pt; text-align: right" title="Payments of interest"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl3964">-</span></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zSKFp8AK9nof" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">147,005</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -1.15pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zfGZctHTOnVk" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">192</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_988_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231_z2WFPiVmqtNg" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt"><b>3,173,497</b></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zW2OqeMp5wTj" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt"><b>(1,821,135)</b></span></td>
    <td id="xdx_988_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231_zyK9JtYRGFM7" style="border-bottom: Black 1.5pt double; padding-right: 2.85pt; text-align: right" title="Payments of interest"><span style="font-size: 7.5pt"><b>(395,740)</b></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zLboev8UMJL5" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt"><b>1,778,600</b></span></td>
    <td id="xdx_984_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zc6UOhD4NaZ8" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-size: 7.5pt"><b>375,937</b></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zic6RnozFOs4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-size: 7.5pt"><b>9,046</b></span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231_zsWujkEPTGf7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt"><b>3,120,205</b></span></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>January 1, 2024</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"><span style="font-size: 7.5pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Additions and remeasurements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"><span style="font-size: 7.5pt"><b>Business combination</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2024</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.65pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Loans and financing</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zKLN9ka4wkFa" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt">1,800,775</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zpd5ABoY3Ux8" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(128,696)</span></td>
    <td id="xdx_985_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zWkWQ3p4CjV5" style="text-align: right" title="Payments of interest"><span style="font-size: 7.5pt">(177,192)</span></td>
    <td id="xdx_981_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbKqCmIGWnCi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">491,593</span></td>
    <td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIt7RnMFRZs2" style="padding-right: 5.65pt; text-align: right" title="Interest"><span style="font-size: 7.5pt">201,472</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znWYrJAD8V98" style="text-align: right" title="Business combination"><span style="font-size: 7.5pt">4,377</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zgrkIU4AjEdc" style="padding-right: 5.65pt; text-align: right" title="Other"><span style="font-size: 7.5pt">2,832</span></td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIa2SyBR9xF1" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">2,195,161</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Lease liabilities</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zrJRlVf7rEZ2" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt">874,569</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJdqASoXhjH9" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(41,221)</span></td>
    <td id="xdx_983_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zWU57RmUQDsi" style="text-align: right" title="Payments of interest"><span style="font-size: 7.5pt">(111,605)</span></td>
    <td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zWW85cX3A2Wd" style="padding-right: 5.65pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">117,897</span></td>
    <td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zAk44Z8kjpG8" style="padding-right: 5.65pt; text-align: right" title="Interest"><span style="font-size: 7.5pt">111,966</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxVzCn18NZsi" style="text-align: right" title="Business combination"><span style="font-size: 7.5pt">28,989</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zwRNvkPWEvc2" style="padding-right: 5.65pt; text-align: right" title="Other"><span style="font-size: 7.5pt">(2,259)</span></td>
    <td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zyna1kzChKhf" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">978,336</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Dividends payable</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zKUpL8DtHOc6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(18,289)</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ztZphFGnuay5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">18,289</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231_zTqseykaZ2Q" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt"><b>2,675,344</b></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z0g21NsOOJQe" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt"><b>(188,206)</b></span></td>
    <td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231_zWZQUxdK7b7d" style="border-bottom: Black 1.5pt double; text-align: right" title="Payments of interest"><span style="font-size: 7.5pt"><b>(288,797)</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zRV633tmfSy4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt"><b>627,779</b></span></td>
    <td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zFAZPF3WKB9e" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-size: 7.5pt"><b>313,438</b></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z1u2drMUfPgb" style="border-bottom: Black 1.5pt double; text-align: right" title="Business combination"><span style="font-size: 7.5pt"><b>33,366</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z33QO5joSqkl" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-size: 7.5pt"><b>573</b></span></td>
    <td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231_zeXUegstGWO9" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt"><b>3,173,497</b></span></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>January 1, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"><span style="font-size: 7.5pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Additions and remeasurements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Business combination</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2023</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Loans and financing</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zAbvHkGuABqk" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt">1,882,901</span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zep7lXZTg8Lk" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(112,630)</span></td>
    <td id="xdx_98D_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzIM7vMREBXk" style="text-align: right" title="Payments of interest"><span style="font-size: 7.5pt">(175,889)</span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z6oaoM6rGxYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">5,288</span></td>
    <td id="xdx_983_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z1Se6OcaDRl1" style="padding-right: 5.65pt; text-align: right" title="Interest"><span style="font-size: 7.5pt">197,678</span></td>
    <td style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zEnAymCsmtjl" style="padding-right: 5.65pt; text-align: right" title="Other"><span style="font-size: 7.5pt">3,427</span></td>
    <td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_ztYE4ee2JSN1" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">1,800,775</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Lease liabilities</span></td>
    <td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zfZOL2E5IoR" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt">769,525</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zCjCw1AzLStf" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(31,473)</span></td>
    <td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zhNowFen9q4i" style="text-align: right" title="Payments of interest"><span style="font-size: 7.5pt">(103,911)</span></td>
    <td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_za0sgkcc3XC3" style="padding-right: 5.65pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">77,715</span></td>
    <td id="xdx_98D_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zOIVXQn4FXFg" style="padding-right: 5.65pt; text-align: right" title="Interest"><span style="font-size: 7.5pt">100,849</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zdefxndxLZu4" style="padding-right: 5.65pt; text-align: right" title="Business combination"><span style="font-size: 7.5pt">65,408</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvUshu3gYp11" style="padding-right: 5.65pt; text-align: right" title="Other"><span style="font-size: 7.5pt">(3,544)</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxmeQ7tHH9j1" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">874,569</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Dividends payable</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ztWQV1suQKy2" style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(18,750)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zuw744fAB3b5" style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">18,750</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231_zGstjq78Ltrk" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt"><b>2,652,426</b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z3dzHL0Ons9f" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt"><b>(162,853)</b></span></td>
    <td id="xdx_98A_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231_zwhQDlB760Mc" style="border-bottom: Black 1.5pt double; text-align: right" title="Payments of interest"><span style="font-size: 7.5pt"><b>(279,800)</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zggXI22NMHrb" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions and remeasurements"><span style="font-size: 7.5pt"><b>101,753</b></span></td>
    <td id="xdx_984_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zqJhwB3cVi18" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-size: 7.5pt"><b>298,527</b></span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z33wsgDVjiD8" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-size: 7.5pt"><b>65,408</b></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zJYub1gEgp12" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-size: 7.5pt"><b>(117)</b></span></td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231_z2j0PmtDGP03" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt"><b>2,675,344</b></span></td></tr>
  </table>
<p id="xdx_8AB_zS9e2JhB8DGd" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The changes in equity arising from financing activities are disclosed in the consolidated
statement of changes in equity.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section Scope<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureCapitalManagementAbstract', window );"><strong>Capital Management</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalManagementExplanatory', window );">Capital management</a></td>
<td class="text"><p id="xdx_803_ecustom--CapitalManagementExplanatory_zzLvrfn0psv7" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">13</td><td><span id="xdx_829_zeL97GfOrAR">Capital management</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">For the purposes of the Company&#8217;s capital management, capital
considers total equity. The primary objective of the Company&#8217;s capital management is to maximize shareholder value.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">In order to achieve its overall objective, the Company&#8217;s
capital management, among other things, aims to ensure that it meets financial and non-financial covenants under the debentures and other
loans and financing. Breaches in meeting the financial covenants would permit the bank to immediately call loans and financing. There
have been no breaches of the financial and non-financial covenants of any loans and financing in the current and previous years.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">No changes were made in the objectives, policies or processes
for managing capital during the year ended December 31, 2025.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CapitalManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CapitalManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCapitalManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCapitalManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureLaborAndSocialObligationsAbstract', window );"><strong>Labor And Social Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LaborAndSocialObligationsExplanatory', window );">Labor and social obligations</a></td>
<td class="text"><p id="xdx_806_ecustom--LaborAndSocialObligationsExplanatory_z9oHMjVdS73f" style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">14</td><td><span id="xdx_829_zb3Ygm8zrTj2">Labor and social obligations</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>a) Variable compensation (bonuses)</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">The bonuses related to variable compensation of employees
and management of R$<span id="xdx_907_ecustom--ShareBasedCompensationOfEmployees_pn3n3_c20250101__20251231_zdgwUTT1k7nd" title="Compensation of employees">56,581</span>, R$<span id="xdx_90E_ecustom--ShareBasedCompensationOfEmployees_c20240101__20241231_pn3n3" title="Compensation of employees">35,857</span> and R$<span id="xdx_90C_ecustom--ShareBasedCompensationOfEmployees_c20230101__20231231_pn3n3" title="Compensation of employees">22,185</span> are recognized in cost of services and selling, general and administrative expenses
in the consolidated statement of income and other comprehensive income for the years ended December 31, 2025, 2024 and 2023, respectively.<br/>
</span></p>






<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>b) Afya Limited share-based compensation plans</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>b.1) Stock options plan</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">The stock options plan was approved on August 30, 2019
and granted to senior executives and other employees of the Company from that date, with subsequent changes in the exercise price, as
approved, on July 29, 2020, July 8, 2022 and July 31, 2023. Such changes were assessed as modifications by the Company and were accounted
in accordance with IFRS 2.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">During the years ended December 31, 2025, 2024 and 2023 the Company had the following grants
of stock options to its executives:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfFairValueOfStockOptionsGrantsExplanatory_zvhZDc74HnA6" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B3_zGgNPB2SqyUj" style="display: none">Schedule of grants
of stock options</span></td>
    <td id="xdx_495_20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z6T0fZrOvqI5" style="text-align: center">&#160;</td>
    <td id="xdx_493_20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zK235Tb9bNp2" style="text-align: center">&#160;</td>
    <td id="xdx_497_20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zNZa1lSl2609" style="text-align: center">&#160;</td>
    <td id="xdx_49B_20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zNvkL1rYPUsa" style="text-align: center">&#160;</td>
    <td id="xdx_498_20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zs3ztMRbK1Bc" style="text-align: center">&#160;</td>
    <td id="xdx_49B_20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHa3XnkjJA68" style="text-align: center">&#160;</td>
    <td id="xdx_49A_20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3OIbkyhLU5h" style="text-align: center">&#160;</td>
    <td id="xdx_492_20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zfs4Xs9Cb3H4" style="text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>November</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2025</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>April</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2025</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 8%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>October</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2024</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 8%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>December</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 7%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>October</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 7%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>August</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 7%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>April</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 7%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>February</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right"></td>
    <td style="text-align: right"></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr id="xdx_408_ecustom--NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement_pn3n3_zWqzUVBwknDh" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Amount</td>
    <td style="text-align: right">692,000</td>
    <td style="text-align: right">&#160;60,000 </td>
    <td style="text-align: right">113,900</td>
    <td style="text-align: right">232,000</td>
    <td style="text-align: right">37,000</td>
    <td style="text-align: right">153,000</td>
    <td style="text-align: right">30,000</td>
    <td style="text-align: right">15,000</td></tr>
  <tr id="xdx_403_ecustom--SharePriceFairValueAtMeasurementDate_pip0_zt6sMhDJPCK6" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Exercise price at the measurement date</td>
    <td style="text-align: right">R$62.57</td>
    <td style="text-align: right">R$79.91</td>
    <td style="text-align: right">R$73.75</td>
    <td style="text-align: right">R$60</td>
    <td style="text-align: right">R$59</td>
    <td style="text-align: right">R$59</td>
    <td style="text-align: right">R$57</td>
    <td style="text-align: right">R$56</td></tr>
  <tr id="xdx_404_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pip0_dp_zaQHGtSd4vK6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Dividend yield (%)</td>
    <td style="text-align: right">0%</td>
    <td style="text-align: right">0%</td>
    <td style="text-align: right">0%</td>
    <td style="text-align: right">0.0%</td>
    <td style="text-align: right">0.0%</td>
    <td style="text-align: right">0.0%</td>
    <td style="text-align: right">0.0%</td>
    <td style="text-align: right">0.0%</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Expected volatility (%)</td>
    <td style="text-align: right"><span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z3a2zokWHkni" title="Expected volatility">24</span>-<span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zhYY03hXbIyk" title="Expected volatility">41</span>%</td>
    <td style="text-align: right"><span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zmkAxaOJEPd2" title="Expected volatility">35</span>-<span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTPzINAqPsrj" title="Expected volatility">44</span>%</td>
    <td style="text-align: right"><span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zRDwFMzwknRb" title="Expected volatility">32</span>-<span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTaePcHfivNe" title="Expected volatility">45</span>%</td>
    <td style="text-align: right"><span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zsLUc0A16E82" title="Expected volatility">34</span>-<span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvQqfh9Pafxb" title="Expected volatility">56</span>%</td>
    <td style="text-align: right"><span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zdJiyIN9wYk6" title="Expected volatility">44</span>-<span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zD39cWsDcLQ1" title="Expected volatility">56</span>%</td>
    <td style="text-align: right"><span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOSZrXlcyZD3" title="Expected volatility">47</span>-<span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0TpV4isUZ76" title="Expected volatility">56</span>%</td>
    <td style="text-align: right"><span id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zzLnpWvuvqO2" title="Expected volatility">48</span>-<span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zeEOMDZRaeG8" title="Expected volatility">55</span>%</td>
    <td style="text-align: right"><span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDvwBftIf02h" title="Expected volatility">46</span>-<span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zbgyNuZPYWqg" title="Expected volatility">56</span>%</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Risk-free interest rate (%)</td>
    <td style="text-align: right"><span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zXhzqbtNwI24" title="Risk-free interest rate">13</span>-<span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zK64lbUpWev2" title="Risk-free interest rate">15</span>%</td>
    <td style="text-align: right"><span id="xdx_908_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zL4FuMa3ygfe" title="Risk-free interest rate">14</span>-<span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zpQqpMVYktCe" title="Risk-free interest rate">15</span>%</td>
    <td style="text-align: right"><span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8UuU76vuby2" title="Risk-free interest rate">11</span>-<span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZNJzCKOJZ7g" title="Risk-free interest rate">13</span>%</td>
    <td style="text-align: right"><span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zWqmaTXFX4I1" title="Risk-free interest rate">10</span>-<span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z3zFmkt2PGP4" title="Risk-free interest rate">11</span>%</td>
    <td style="text-align: right"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zSg6N5dHPT0l" title="Risk-free interest rate">11</span>-<span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zmZaF4bP4NKg" title="Risk-free interest rate">12</span>%</td>
    <td style="text-align: right"><span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zUFWKlQGKDx3" title="Risk-free interest rate">10</span>-<span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z4JquBKNxWlc" title="Risk-free interest rate">12</span>%</td>
    <td style="text-align: right"><span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLYSuS7KNh63" title="Risk-free interest rate">11</span>-<span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zI0vJM6gywRj" title="Risk-free interest rate">13</span>%</td>
    <td style="text-align: right"><span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zAJASHq0BBGh" title="Risk-free interest rate">13</span>%</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Expected life of stock options (years)</td>
    <td style="text-align: right"><span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0jLLW2lU6J3" title="Expected life of stock options">1</span>-<span id="xdx_90A_ecustom--ExpectedLifeOfStockOptions_dtY_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zcXSWBKRKiVi" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zJ5SPoXZEyX6" title="Expected life of stock options">1</span>-<span id="xdx_90C_ecustom--ExpectedLifeOfStockOptions_dtY_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z9CG5kRjj7C" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_90F_ecustom--ExpectedLifeOfStockOptions_dtY_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo1yo9kxDfY5" title="Expected life of stock options">1</span>-<span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zpwNuy5S3Tsf" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_900_ecustom--ExpectedLifeOfStockOptions_dtY_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zUUeOhGyCg0i" title="Expected life of stock options">1</span>-<span id="xdx_908_ecustom--ExpectedLifeOfStockOptions_dtY_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zKlUUVd2lpKh" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_904_ecustom--ExpectedLifeOfStockOptions_dtY_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLCObi1GJ524" title="Expected life of stock options">1</span>-<span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zp9XJ1CqRkm7" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCcJKVef1vV9" title="Expected life of stock options">1</span>-<span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_znWUS3p2NLj" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zXgdDziYvER" title="Expected life of stock options">1</span>-<span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zh9QH7khRfM8" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0NENZi2yMJ4" title="Expected life of stock options">1</span>-<span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z7FWqTwEwbs" title="Expected life of stock options">5</span></td></tr>
  <tr id="xdx_409_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_pip0_zhSqRAp2Tre1" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Share price at the measurement date</td>
    <td style="text-align: right">R$79.36</td>
    <td style="text-align: right">R$107.33</td>
    <td style="text-align: right">R$92.78</td>
    <td style="text-align: right">R$100.97</td>
    <td style="text-align: right">R$79.12</td>
    <td style="text-align: right">R$76.45</td>
    <td style="text-align: right">R$62.51</td>
    <td style="text-align: right">R$70.69</td></tr>
  <tr id="xdx_40D_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_i" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Valuation model</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td></tr>
  <tr id="xdx_406_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_pip0_z80Gu2ZEmFnh" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt">Weighted average fair value at the measurement date</td>
    <td style="text-align: right">R$33.27</td>
    <td style="text-align: right">R$45.95</td>
    <td style="text-align: right">R$39.71</td>
    <td style="text-align: right">R$54.25</td>
    <td style="text-align: right">R$38.67</td>
    <td style="text-align: right">R$37.04</td>
    <td style="text-align: right">R$32.04</td>
    <td style="text-align: right">R$29.54</td></tr>
  </table>

<p id="xdx_8A8_zOZCJZH2NT0c" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The table below presents the number and movements in stock options
for the years ended December 31, 2025, 2024 and 2023:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfSharebasedCompensationPlanExplanatory_pn3n3_zFzoezmEhTV9" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details 1)">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8B0_zLGkJU0tLkH5" style="display: none">Schedule of movements in stock options</span></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td rowspan="2" style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>Weighted average exercise price</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>(in Brazilian Reais)</b></p></td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1pt solid; font: 8.5pt Nunito Sans; margin: 0; text-align: center"><b>Number of stock options</b></p></td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b>2025</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b>2024</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b>2023</b></span></td></tr>
  <tr>
    <td style="width: 39%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="vertical-align: bottom; width: 28%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"></td>
    <td style="white-space: nowrap; width: 11%; padding-left: 0.1in; font-size: 10pt; text-align: right">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at January 1</b></span></td>
    <td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zraIJSzFCkke" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Outstanding at the beginning"><span style="font-size: 8.5pt"><b>67.31</b></span></td>
    <td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zO4kayTsCld6" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-size: 8.5pt"><b>1,610,679</b></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z5Q8ZFRA9Wtf" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-size: 8.5pt"><b>1,696,064</b></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHZagAo9RIX5" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-size: 8.5pt"><b>3,729,287</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Granted</span></td>
    <td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zD1ZddyRkMke" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Granted"><span style="font-size: 8.5pt">63.95</span></td>
    <td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zarVmL6ef2xg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-size: 8.5pt">752,000</span></td>
    <td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z1kiz2uCbBz6" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-size: 8.5pt">113,900</span></td>
    <td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3IAUYRtt7q7" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-size: 8.5pt">467,000</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Exercised</span></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zpu4iEOMKoS1" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercised"><span style="font-size: 8.5pt">63.62</span></td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zxT2Mq5vrGY2" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-size: 8.5pt">(404,478)</span></td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGKd39zZRU7l" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-size: 8.5pt">(147,955)</span></td>
    <td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z9ZGh8Sebarh" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-size: 8.5pt">(164,214)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Stock options exchanged to RSUs</span></td>
    <td id="xdx_984_ecustom--WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_iI_pip0_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHdtqCer9AEf" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercised"><span style="font-size: 8.5pt"><span style="-sec-ix-hidden: xdx2ixbrl4273">-</span></span></td>
    <td id="xdx_98E_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zhsjUI4JlqAh" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, stock option exchanged"><span style="font-size: 8.5pt"><span style="-sec-ix-hidden: xdx2ixbrl4275">-</span></span></td>
    <td id="xdx_987_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmV62YvwqcVd" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, stock option exchanged"><span style="font-size: 8.5pt"><span style="-sec-ix-hidden: xdx2ixbrl4277">-</span></span></td>
    <td id="xdx_98B_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGxPS01O5x75" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, stock option exchanged"><span style="font-size: 8.5pt">(1,751,599)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Forfeited</span></td>
    <td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zaKvtHUKDlW8" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Forfeited"><span style="font-size: 8.5pt">72.42</span></td>
    <td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_ze6ykiFid7Kg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-size: 8.5pt">(57,152)</span></td>
    <td id="xdx_988_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zsidkfnTT7h4" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-size: 8.5pt">(16,182)</span></td>
    <td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zMsaiNPv6mCi" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-size: 8.5pt">(333,111)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Expired</span></td>
    <td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z8mHAL7v4bZe" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Expired"><span style="font-size: 8.5pt">68.54</span></td>
    <td id="xdx_987_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zPcEiMVVab3c" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"><span style="font-size: 8.5pt">(57,680)</span></td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z91sTDJENHc4" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Expired"><span style="font-size: 8.5pt">(35,148)</span></td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zQJsLxD7amw3" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"><span style="font-size: 8.5pt">(251,299)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at December 31</b></span></td>
    <td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zATYUtVrdlh7" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Outstanding at the ending"><span style="font-size: 8.5pt"><b>65.91</b></span></td>
    <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z2mW4KaitVZd" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-size: 8.5pt"><b>1,843,369</b></span></td>
    <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGitrYnMUbB8" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-size: 8.5pt"><b>1,610,679</b></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zV27MvxAdFne" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-size: 8.5pt"><b>1,696,064</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Exercisable</b></span></td>
    <td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pip0_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmDdNrIKSON5" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-size: 8.5pt"><b>71.33</b></span></td>
    <td id="xdx_98A_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zLVpGQ22dOC4" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"><span style="font-size: 8.5pt"><b>340,219</b></span></td>
    <td id="xdx_989_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zsJMf5UO94M6" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"><span style="font-size: 8.5pt"><b>427,202</b></span></td>
    <td id="xdx_981_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zK2nhsM4tARb" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"><span style="font-size: 8.5pt"><b>242,235</b></span></td></tr>
  </table>
<p id="xdx_8A0_zi6sz3L98kml" style="font: 10.5pt Nunito Sans; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The share-based compensation expense recognized in selling, general
and administrative expenses in the consolidated statement of income and other comprehensive income for the year ended December 31, 2025
was R$<span id="xdx_90B_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_z4t4P7XGUVG1" title="Share-based compensation expense">4,809</span> (R$<span id="xdx_90A_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zhR2rKvMLxCl" title="Share-based compensation expense">17,394</span> and R$<span id="xdx_909_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_z7LpqbyqduNc" title="Share-based compensation expense">20,850</span> in 2024 and 2023, respectively).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white; color: #C00000"><b>b.2) Restricted Stock Units (RSU) Program</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">On July 8, 2022, the Company approved the Restricted Stock Units
program for its employees. The participant's right to effectively receive ownership of the restricted stock units will be conditioned
on the participant's continuance as an employee or director in the business group from the grant date until vesting. The executives will
be entitled to these shares in a proportion of <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pip0_dp_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z8GSA5kB6JC9" title="Proportion percentage">10</span>%, <span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pip0_dp_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits1Member_zS5bG2c1d0lb" title="Proportion percentage">20</span>%, <span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pip0_dp_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits2Member_z7jjDJ0jHrY" title="Proportion percentage">30</span>%, <span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pip0_dp_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits3Member_ztL7nW4Klxq1" title="Proportion percentage">40</span>% each year.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company accounts for the RSU plan as an equity-settled plan, except for the portion
of labor and social securities obligations.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">During the years ended December 31, 2025, 2024 and 2023 the Company
had the following grants of RSUs to its executives:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfGrantsRestrictedStockUnitsTableTextBlock_zV48BfBx6yL5" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details 2)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt"><span id="xdx_8BC_zuLxXAoP3M1" style="display: none">Schedule of grants
of RSUs</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>November</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2025</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>April</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2025</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>October</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2024</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>December</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>October</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>August</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>April</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>February</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; text-align: right"></td>
    <td style="vertical-align: top; text-align: right"></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Amount</td>
    <td id="xdx_989_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_zICCFZgsdfx2" style="text-align: right" title="Granted">346,000</td>
    <td id="xdx_985_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_z6wKGwWz9FZk" style="text-align: right" title="Granted">35,000</td>
    <td id="xdx_982_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zMXEDJuS1bJj" style="text-align: right" title="Granted">44,500</td>
    <td id="xdx_986_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_ztVtzmnIuLG6" style="text-align: right" title="Granted">76,600</td>
    <td id="xdx_982_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zpal9jAuBLck" style="text-align: right" title="Granted">63,000</td>
    <td id="xdx_989_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zE0O4ptKVl31" style="text-align: right" title="Granted">153,490</td>
    <td id="xdx_98B_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zhqa0iPvtezk" style="text-align: right" title="Granted">16,000</td>
    <td id="xdx_98F_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_z9yQzaTS6Xni" style="text-align: right" title="Granted">8,000</td></tr>

<tr style="background-color: White">
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt">Weighted average fair value at the measurement date</td>
    <td id="xdx_989_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_zWCPmhNdYxJ5" style="width: 9%; text-align: right" title="Fair values at grant date">R$79.36</td>
    <td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_zYJr10Oa09M7" style="width: 9%; text-align: right" title="Fair values at grant date">R$107.33</td>
    <td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zJGGHwdVffZ6" style="width: 9%; text-align: right" title="Fair values at grant date">R$92.78</td>
    <td id="xdx_98B_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zNvnzT4Y0cn7" style="width: 9%; text-align: right" title="Fair values at grant date">R$100.97</td>
    <td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zNMqQFYVlTlj" style="width: 9%; text-align: right" title="Fair values at grant date">R$79.12</td>
    <td id="xdx_98A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zieMWlWClbXe" style="width: 9%; text-align: right" title="Fair values at grant date">R$76.45</td>
    <td id="xdx_98D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zACW5bG8T6c5" style="width: 9%; text-align: right" title="Fair values at grant date">R$62.51</td>
    <td id="xdx_987_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zHw7SUIVdxTg" style="width: 9%; text-align: right" title="Fair values at grant date">R$70.69</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Vesting period (years)</td>
    <td style="text-align: right"><span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_znAcmh3mMXpd" title="Vesting period">1</span>-<span id="xdx_90A_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_z8OXOynCf8J1" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_zPILF04KSlvk" title="Vesting period">1</span>-<span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_z3MS7RGKoXof" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_90C_ecustom--GrantedVestingPeriod_dtY_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zphrbhAzCoq8" title="Vesting period">1</span>-<span id="xdx_905_ecustom--GrantedVestingPeriod_dtY_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_z7dAnJ3MghPc" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_90D_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zaLtoQSJ7M5a" title="Vesting period">1</span>-<span id="xdx_904_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zVKrezoWsjae" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_908_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zYwjdE4YIn46" title="Vesting period">1</span>-<span id="xdx_905_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_z02xbUIzr3Gj" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zqm69NMWJsNb" title="Vesting period">1</span>-<span id="xdx_90A_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zqGjtgM78qVf" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zKkh2qfBvsD" title="Vesting period">1</span>-<span id="xdx_90E_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_znKKKNNMnb5l" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zBt1kX2xCEok" title="Vesting period">1</span>-<span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zjJb7xEFaRql" title="Vesting period">4</span></td></tr>
  </table>
<p id="xdx_8AB_zGQ4BkuzLlCb" style="margin-top: 0; margin-bottom: 0">&#160;</p>







<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The table below presents the number and movements in RSUs for the years ended December
31, 2025, 2024 and 2023:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfStockOptionTableTextBlock_pn3n3_zcaFvNJVhna3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details 3)">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><span id="xdx_8B7_zcQK8v9WNAh7" style="display: none">Schedule of stock option</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 49%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; text-indent: -9.35pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Outstanding at January 1</b></td>
    <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zKQADaIQ2OK3" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><b>656,634</b></td>
    <td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zva28bMgxnV3" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><b>854,431</b></td>
    <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zCE4lHvJhfBj" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><b>447,224</b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Granted</td>
    <td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zXCsaRfq2Moj" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Granted">381,000</td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zIySk7IVqJo7" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Granted">44,500</td>
    <td id="xdx_98A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zYh56vwbBwEi" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Granted">317,090</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Stock options exchanged to RSUs</td>
    <td id="xdx_985_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zIXJzIvwsL02" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="-sec-ix-hidden: xdx2ixbrl4409">-</span></td>
    <td id="xdx_98E_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z4ggG1ljDdj5" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="-sec-ix-hidden: xdx2ixbrl4411">-</span></td>
    <td id="xdx_98B_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z46Le5Md8Qi1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Stock options exchanged">215,797</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Exercised</td>
    <td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z64yoxIWwf72" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Exercised">(224,070)</td>
    <td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zP2UEEmgRBZg" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Exercised">(222,910)</td>
    <td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z5CCL3T5mK66" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Exercised">(99,576)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Expired</td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zylOPFGb2J18" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Forfeited">(93,846)</td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zaMTLE4Mao49" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Forfeited">(19,387)</td>
    <td id="xdx_986_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z0wLJ1wZxyMk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Forfeited">(26,104)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Outstanding at December 31</b></td>
    <td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zb2Uk8Lq4n7k" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the ending"><b>719,718</b></td>
    <td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zNE4wQnNJZ65" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the ending"><b>656,634</b></td>
    <td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zXzCqgWBYC7" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the ending"><b>854,431</b></td></tr>
  </table>
<p id="xdx_8A4_zsNMEv2rjU5c" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Total RSU expenses recognized in selling, general and administrative expenses in the consolidated
statement of income and other comprehensive income for the year ended December 31, 2025 were R$<span id="xdx_903_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z7iqg38g1MBh" title="Share-based compensation expense">10,509</span> (R$<span id="xdx_90C_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z9hV6vWmtrv7" title="Share-based compensation expense">15,030</span> and R$<span id="xdx_908_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zLUEh3KzsXV5" title="Share-based compensation expense">10,685</span> in 2024 and
2023, respectively). Labor and social obligations expenses were R$<span id="xdx_908_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20251231_zN29wCxaLLnh" title="Social obligations liabilities">2,660</span>, R$<span id="xdx_90C_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20241231_znQzFlSoSb19" title="Social obligations liabilities">8,988</span> and R$<span id="xdx_904_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20231231_zpMY7vO1TUbj" title="Social obligations liabilities">7,177</span> for the years ended December 31, 2025, 2024
and 2023, respectively.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureLaborAndSocialObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureLaborAndSocialObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LaborAndSocialObligationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LaborAndSocialObligationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureEquityAbstract', window );"><strong>Disclosure Equity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfEquityExplanatory', window );">Equity</a></td>
<td class="text"><p id="xdx_80F_ecustom--DisclosureOfEquityExplanatory_z56SPHAr04A1" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">15</td><td><span id="xdx_824_zwT67diaK6p2">Equity</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><span style="text-decoration: underline">Share capital</span></p>

<p style="font: 7pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">As of December 31, 2025, the Company&#8217;s share capital was R$<span id="xdx_902_eifrs-full--IssuedCapital_iI_pn3n3_c20251231_zEir0WlgBYHl" title="Share capital">17</span> represented by <span id="xdx_90F_ecustom--NumberOfSharesIssued1_iI_pip0_c20251231_z1Nnei9eWG52" title="Total number of shares">93,722,831</span> shares comprised by
<span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pip0_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_z53a3OjaTXEf" title="Total number of shares">55,148,697</span> class A common shares and <span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_pip0_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zDJjXbp0Qr45" title="Total number of shares">38,574,134</span> class B common shares. As of December 31, 2024, the Company&#8217;s share capital was R$<span id="xdx_900_eifrs-full--IssuedCapital_iI_pn3n3_c20241231_z472mbs5CMyc" title="Share capital">17</span> represented
by <span id="xdx_90D_ecustom--NumberOfSharesIssued1_iI_pip0_c20241231_zCeLCeakWEGd" title="Total number of shares">93,722,831</span> shares comprised by <span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pip0_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zGveERBlzulh" title="Total number of shares">49,920,068</span> class A common shares and <span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pip0_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zv6uj5zbFZM6" title="Total number of shares">43,802,763</span> class B common shares. As of December 31, 2025 and 2024,
the Company&#8217;s authorized capital was US$<span id="xdx_900_ecustom--IssuedCapitals_c20251231_pn3n3" title="Authorized capital"><span id="xdx_907_ecustom--IssuedCapitals_iI_pn3n3_c20241231_zRwGtSAcHKRc" title="Authorized capital">50</span></span> thousand divided into <span id="xdx_90E_ecustom--CapitalUnitsAuthorizedShares_iI_pn3n3_c20251231_zFQu5rexiDNi" title="Authorized capital units">1,000,000,000</span> shares of a nominal value of US$<span id="xdx_90E_eifrs-full--ParValuePerShare_iI_c20251231_z12HwBjrisaa" title="Nominal value per share">0.00005</span> each.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white; color: #C00000"><span style="text-decoration: underline">Dividends</span></p>

<p style="font: 7pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In the year ended December 31, 2025, CCSI and IESVAP approved the payment of dividends
of R$<span id="xdx_900_ecustom--PaymentOfDividends_pn3n3_c20250101__20251231_zEb8bjx8NFg5" title="Payment of dividends">76,862</span>, which R$<span id="xdx_909_ecustom--DividendDistributed_pn3n3_c20250101__20251231_zxEnf2ZO3Bmb" title="Dividend distributed">59,641</span> was distributed to the Company and R$<span id="xdx_900_eifrs-full--DividendsPaidToNoncontrollingInterests_c20250101__20251231_pn3n3" title="Dividends paid to non-controlling interests">17,221</span> to non-controlling shareholders (December 31 2024: R$<span id="xdx_90D_ecustom--PaymentOfDividends_c20240101__20241231_pn3n3" title="Payment of dividends">79,701</span>, which
R$<span id="xdx_908_ecustom--DividendDistributed_c20240101__20241231_pn3n3" title="Dividend distributed">61,412</span> was distributed to the Company and R$<span id="xdx_902_eifrs-full--DividendsPaidToNoncontrollingInterests_c20240101__20241231_pn3n3" title="Dividends paid to non-controlling interests">18,289</span> to non-controlling shareholders and December 31, 2023: R$<span id="xdx_90F_ecustom--PaymentOfDividends_c20230101__20231231_pn3n3" title="Payment of dividends">65,539</span>, which R$<span id="xdx_90A_ecustom--DividendDistributed_c20230101__20231231_pn3n3" title="Dividend distributed">46,788</span> was
distributed to the Company and R$<span id="xdx_90C_eifrs-full--DividendsPaidToNoncontrollingInterests_c20230101__20231231_pn3n3" title="Dividends paid to non-controlling interests">18,750</span> to non-controlling shareholders).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On March 12, 2025, the Company&#8217;s Board of Directors approved the first dividend distribution
in the amount of R$<span id="xdx_902_ecustom--FirstDividendDistributionInAmount_pn3n3_c20250311__20250312_zelXdXu8E3N5" title="First dividend distribution in amount">129,784</span>, representing <span id="xdx_90C_ecustom--PercentageOfDividendDistribution_pip0_dp_c20250311__20250312_zazk5TCNlOlf" title="Percentage of dividend distribution">20</span>% of the Company&#8217;s consolidated net income for the year ended December 31, 2024 and a
dividend per share of R$<span id="xdx_90B_eifrs-full--DividendsPaidOtherSharesPerShare_c20250403__20250404_zGDni4S6dZUg" title="Dividends per share">1.348923</span>, to the shareholders on record as of the close of business on March 26, 2025, paid in U.S. dollars on
April 4, 2025, at the exchange rate (PTAX) published by the Brazilian Central Bank on March 13, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white; color: #C00000"><span style="text-decoration: underline">Treasury shares</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On August 13, 2025, the Company&#8217;s board of directors approved a new share repurchase
program. Under the share repurchase program, Afya may repurchase up to <span id="xdx_90B_ecustom--RepurchaseOfOrdinaryShares_iI_c20250813__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zzo6DK7blnfc" title="Repurchase of ordinary shares">4,000,000</span> of its outstanding Class A common shares, in the open
market, based on prevailing market prices, or in privately negotiated transactions, beginning from August 15, 2025 until the earlier of
the completion of the repurchase or December 31, 2026, depending upon market conditions. During the year ended December 31, 2025, the
Company&#8217;s cash outflow was R$<span id="xdx_90A_ecustom--CashOutflow_pn3n3_c20250101__20251231_zuA1Vm3RslE9" title="Cash outflow">77,002</span>.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The table below illustrates the number and movements in treasury shares during the years
ended December 31, 2025, 2024 and 2023:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>







<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfTreasurySharesMovementExplanatory_pn3n3_zFqys31Z6pmf" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Equity (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8B7_z1lKQEh9mEhe" style="display: none">Schedule
    of number and movements in treasury shares</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 48%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b>Number of treasury shares</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 29%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"><span style="font-size: 8.5pt"><b>Average price (in Brazilian Reais)</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at January 1, 2023</b></span></td>
    <td id="xdx_98E_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20230101__20231231_zLIRN8DzrJs6" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"><span style="font-size: 8.5pt"><b>3,786,285</b></span></td>
    <td id="xdx_987_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20230101__20231231_zp4RN1pSehDc" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"><span style="font-size: 8.5pt"><b>80.54</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Repurchased</span></td>
    <td id="xdx_986_ecustom--NumberOfSharesRepurchased_pip0_c20230101__20231231_zIFiSsp7ZrU6" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"><span style="font-size: 8.5pt">216,339</span></td>
    <td id="xdx_98A_ecustom--AveragePriceRepurchased_pip0_c20230101__20231231_zKgY03FRrdij" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"><span style="font-size: 8.5pt">57.17</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Delivered under the share-based compensation plans</span></td>
    <td id="xdx_982_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20230101__20231231_zBTy8AECDH69" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"><span style="font-size: 8.5pt">(229,146)</span></td>
    <td id="xdx_989_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20230101__20231231_z3ymjGJWvvn4" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"><span style="font-size: 8.5pt">79.28</span></td></tr>

<tr style="background-color: White">
    <td style="width: 48%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at December 31, 2023</b></span></td>
    <td id="xdx_98A_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20240101__20241231_zQzjgrbWJZt" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"><span style="font-size: 8.5pt"><b>3,773,478</b></span></td>
    <td id="xdx_98A_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20240101__20241231_zN8rACYg7P9c" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 29%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"><span style="font-size: 8.5pt"><b>79.28</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Delivered under the share-based compensation plans</span></td>
    <td id="xdx_983_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20240101__20241231_zWarKk2kBdBc" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"><span style="font-size: 8.5pt">(317,940)</span></td>
    <td id="xdx_98D_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20240101__20241231_ze05wOtMOcog" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"><span style="font-size: 8.5pt">79.28</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at December 31, 2024</b></span></td>
    <td id="xdx_98C_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20250101__20251231_zjJrbHUyw2Da" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"><span style="font-size: 8.5pt"><b>3,455,538</b></span></td>
    <td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20250101__20251231_znhjjQqlaLG8" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"><span style="font-size: 8.5pt"><b>79.28</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Repurchased</span></td>
    <td id="xdx_98D_ecustom--NumberOfSharesRepurchased_pip0_c20250101__20251231_zpFkaLnJResk" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"><span style="font-size: 8.5pt">966,541 </span></td>
    <td id="xdx_989_ecustom--AveragePriceRepurchased_pip0_c20250101__20251231_zD2WH79RwTml" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"><span style="font-size: 8.5pt">80.24</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Delivered under the share-based compensation plans</span></td>
    <td id="xdx_984_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20250101__20251231_zdMXbpddoxZ9" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"><span style="font-size: 8.5pt">(566,929)</span></td>
    <td id="xdx_98C_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20250101__20251231_zFTLvkjxLdK2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"><span style="font-size: 8.5pt">79.28 </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding
at December 31, 2025 </b></span></td>
    <td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iE_pip0_c20250101__20251231_znR8iogO0UV9" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at ending balance"><span style="font-size: 8.5pt"><b>3,855,150 </b></span></td>
    <td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20250101__20251231_zF8D1o4cTSIj" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at ending balance"><span style="font-size: 8.5pt"><b>79.52 </b></span></td></tr>
  </table>
<p style="font: 8.5pt Nunito Sans; margin: 0"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfEquityExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfEquityExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Earnings per share</a></td>
<td class="text"><p id="xdx_80D_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zH11XJlrXg58" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">16</td><td><span id="xdx_822_zH5jfAacIaUb">Earnings per share</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">The table below presents the basic and diluted earnings per share
calculations:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--ScheduleOfEarningsPerShareTableExplanatory_pn3n3_zh6rgpEuBgn5" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Earnings per share (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt"><span id="xdx_8B9_zodizhWBFyXc" style="display: none">Schedule of earnings per share</span></td>
    <td id="xdx_496_20250101_20251231" style="padding-right: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_494_20240101_20241231" style="padding-right: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_492_20230101_20231231" style="padding-right: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 67%; padding-right: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><b>2023</b></td></tr>
  <tr id="xdx_400_ecustom--NumeratorAbstract_iB_z0RC0JVRVHcj">
    <td style="padding-right: 5.4pt"><b>Numerator</b></td>

    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_pn3n3_zNvLq2og6BKi" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt">Net income attributable to the owners of the Company</td>
    <td style="padding-right: 5.4pt; text-align: right">752,461</td>
    <td style="padding-right: 5.4pt; text-align: right">631,510</td>
    <td style="padding-right: 5.4pt; text-align: right">386,324</td></tr>
  <tr id="xdx_40C_ecustom--DenominatorAbstract_iB_zPDlgkbW8LBa" style="background-color: White">
    <td style="padding-right: 5.4pt"><b>Denominator</b></td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--WeightedAverageShares_pip0_zkwRAE4k6qQ1" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt">Weighted average number of outstanding shares</td>
    <td style="padding-right: 5.4pt; text-align: right">90,475,878</td>
    <td style="padding-right: 5.4pt; text-align: right">90,122,429</td>
    <td style="padding-right: 5.4pt; text-align: right">89,830,351</td></tr>
  <tr id="xdx_40B_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pip0_zd5BBGZokSp5" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt">Effects of dilution from stock options and restricted stock units</td>
    <td style="padding-right: 5.4pt; text-align: right">791,733</td>
    <td style="padding-right: 5.4pt; text-align: right">1,032,207</td>
    <td style="padding-right: 5.4pt; text-align: right">706,492</td></tr>
  <tr id="xdx_409_eifrs-full--AdjustedWeightedAverageShares_pip0_uShares_znBfrJta8Odd" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt">Weighted average number of outstanding shares adjusted for the effect of dilution</td>
    <td style="padding-right: 5.4pt; text-align: right">91,267,611</td>
    <td style="padding-right: 5.4pt; text-align: right">91,154,636</td>
    <td style="padding-right: 5.4pt; text-align: right">90,536,843</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--BasicEarningsLossPerShare_pip0_zvR340v2rBd4" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Basic earnings per share (R$)</td>
    <td style="padding-right: 5.4pt; text-align: right">8.32</td>
    <td style="padding-right: 5.4pt; text-align: right">7.01</td>
    <td style="padding-right: 5.4pt; text-align: right">4.30</td></tr>
  <tr id="xdx_40E_eifrs-full--DilutedEarningsLossPerShare_pip0_z1dVhWo7H7Ze" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Diluted earnings per share (R$)</td>
    <td style="padding-right: 5.4pt; text-align: right">8.24</td>
    <td style="padding-right: 5.4pt; text-align: right">6.93</td>
    <td style="padding-right: 5.4pt; text-align: right">4.27</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>





<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueExplanatory', window );">Revenue</a></td>
<td class="text"><p id="xdx_80C_eifrs-full--DisclosureOfRevenueExplanatory_zjXsL3NXZAja" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">17</td><td><span id="xdx_827_zJ2ZIj7ya1wl">Revenue</span></td></tr></table>

<p style="font: 10pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfNetSalesRevenueExplanatory_pn3n3_zCw9eshgzik3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Revenue (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt"><span id="xdx_8BA_zPRZBJnC7Fod" style="display: none">Schedule of net sales revenue</span></td>
    <td id="xdx_49B_20250101__20251231_z0k2DkE3dr21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20240101__20241231_zTfpTc16bgq8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20230101__20231231_zHaKiN8J6dZ3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 67%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>

    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ProfessionalFeesExpenses_pn3n3_zyjYbgSzo7D4" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt">Tuition fees</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">4,684,322 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">4,052,379 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3,505,250</td></tr>
  <tr id="xdx_407_ecustom--OtherRevenue1_pn3n3_zK2rOdtULspa" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt">Other</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">331,934 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">305,527 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">263,937</td></tr>
  <tr id="xdx_40C_ecustom--DeductionAbstract_iB_zmierXsa5567" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt"><b>Deductions</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DeductionOfGrantedDiscounts_pn3n3_zmSi6w4vfHif" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt">Discount and scholarships</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(685,219)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(515,311)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(435,368)</td></tr>
  <tr id="xdx_40E_ecustom--DeductionOfReturnsOfNetRevenue_pn3n3_zyxMaG0JrtEd" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt">Returns</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(31,665)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(25,312)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(27,743)</td></tr>
  <tr id="xdx_405_ecustom--DeductionOfTaxes_pn3n3_ztUq5OcAl3ye" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt">Taxes</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(194,477)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(170,628)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(142,825)</td></tr>
  <tr id="xdx_405_ecustom--DeductionOfProuni_pn3n3_zMQegXTjKfub" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt">PROUNI</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(407,640)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(342,326)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(287,338)</td></tr>
  <tr id="xdx_40C_eifrs-full--RevenueFromContractsWithCustomers_pn3n3_zENpZA0g604i" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Revenue from contracts with customers</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>3,697,255 </b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>3,304,329 </b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2,875,913</b></td></tr>
  <tr id="xdx_401_ecustom--TimingOfRevenueRecognition_iB_zmLCzlqisHAi" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt"><b>Timing of revenue recognition</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_400_ecustom--TransferredOverTime_pn3n3_znL7OQZVEgVg" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt">Transferred over time</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3,618,234 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3,242,035 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">2,821,251</td></tr>
  <tr id="xdx_40E_ecustom--TransferredAtPointInTime_pn3n3_zJDK3Rvkhymh" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt">Transferred at a point in time</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">79,021 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">62,294 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">54,662</td></tr>
  </table>
<p id="xdx_8A9_zKRbFzCyyky" style="font: 10.5pt Nunito Sans; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">The Company&#8217;s revenue from contracts with customers
are all in Brazil. The Company is not subject to the payment of the contributions Social Integration Program (<i>Programa de Integra&#231;&#227;o
Social</i>, or PIS) and the Social Contribution on Revenue (<i>Contribui&#231;&#227;o para o Financiamento da Seguridade Social</i>,
or COFINS) on the revenue from under graduation degrees under the PROUNI program.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span style="font-weight: normal">The tables below present the revenue for the Company&#8217;s
operating segments for the years ended December 31, 2025, 2024 and 2023.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfRevenueBySegmentTableTextBlock_pn3n3_zkBZ5wNRCs13" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Revenue (Details 1)">
  <tr>
    <td style="vertical-align: top; text-align: justify"><span id="xdx_8BA_zmVU54gwzEyj" style="display: none">Schedule of revenue by
    segment</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Undergraduate</b></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Continuing education</b></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Medical practice solutions</b></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Elimination (inter-segment transactions)</b></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><b>2025</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: -5.55pt; padding-left: 5.4pt; text-align: right"></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><b>Types of services or goods</b></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zDQtF0xJChc1" style="text-align: right" title="Types of services or goods"><b>3,255,426 </b></td>
    <td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z1ZBu6QWj095" style="text-align: right" title="Types of services or goods"><b>284,471 </b></td>
    <td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zvdxvb73LEEh" style="text-align: right" title="Types of services or goods"><b>171,323 </b></td>
    <td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zd9whSpsZVi9" style="text-align: right" title="Types of services or goods"><b>(13,965)</b></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231_zSOGH5Xnb3pe" style="text-align: right" title="Types of services or goods"><b>3,697,255 </b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Tuition fees</td>
    <td id="xdx_984_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zxTj7MtzKt5d" style="text-align: right" title="Tuition fees">3,239,729 </td>
    <td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zew0tg46xSEe" style="text-align: right" title="Tuition fees">187,707 </td>
    <td id="xdx_986_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zqPYhTs7AE04" style="text-align: right" title="Tuition fees"><span style="-sec-ix-hidden: xdx2ixbrl4640">-</span></td>
    <td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zSa4HZ6N1R8c" style="text-align: right" title="Tuition fees"><span style="-sec-ix-hidden: xdx2ixbrl4642">-</span></td>
    <td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231_z2zUfl474Gf9" style="text-align: right" title="Tuition fees">3,427,436 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Other</td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zr5a9NuReNjl" style="text-align: right" title="Other">15,697 </td>
    <td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zMZj6PRwKhUl" style="text-align: right" title="Other">96,764 </td>
    <td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z2y6DeN77sPj" style="text-align: right" title="Other">171,323 </td>
    <td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z9JjdkDCSW9l" style="text-align: right" title="Other">(13,965)</td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231_zIR2Ku5Qv4pc" style="text-align: right" title="Other">269,819 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><b>Timing of revenue recognition</b></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z9z7x0eRjU47" style="text-align: right" title="Timing of revenue recognition"><b>3,255,426 </b></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLNQK7yhLHA6" style="text-align: right" title="Timing of revenue recognition"><b>284,471 </b></td>
    <td id="xdx_985_ecustom--TimingRevenueRecognition_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>171,323 </b></td>
    <td id="xdx_98E_ecustom--TimingRevenueRecognition_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>(13,965)</b></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_c20250101__20251231_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>3,697,255 </b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Transferred over time</td>
    <td id="xdx_98F_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjMafsieeqX9" style="text-align: right" title="Transferred over time">3,239,729 </td>
    <td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zKc0tSs6qB0a" style="text-align: right" title="Transferred over time">223,774 </td>
    <td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zlzJtCMPRm29" style="text-align: right" title="Transferred over time">168,696 </td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z6s05TJfK2F4" style="text-align: right" title="Transferred over time">(13,965)</td>
    <td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231_zRSIzEW3h2ii" style="text-align: right" title="Transferred over time">3,618,234 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Transferred at a point in time</td>
    <td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zLuuUHMjM7jg" style="text-align: right" title="Transferred at a point in time">15,697 </td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Transferred at a point in time">60,697 </td>
    <td id="xdx_98C_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time">2,627 </td>
    <td id="xdx_98F_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"><span style="-sec-ix-hidden: xdx2ixbrl4682">-</span></td>
    <td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231_pn3n3" style="text-align: right" title="Transferred at a point in time">79,021 </td></tr>
  </table>
<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Undergraduate</b></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Continuing education</b></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Medical practice solutions</b></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Elimination (inter-segment transactions)</b></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><b>2024</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><b>Types of services or goods</b></td>
    <td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z61D4ieGN1Q5" style="text-align: right" title="Types of services or goods"><b>2,895,692</b></td>
    <td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsearJYQim93" style="text-align: right" title="Types of services or goods"><b>255,438</b></td>
    <td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zZQZ6vbN1941" style="text-align: right" title="Types of services or goods"><b>161,787</b></td>
    <td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zn8hHwScifS3" style="text-align: right" title="Types of services or goods"><b>(8,588)</b></td>
    <td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231_znjkGmFJR3K6" style="text-align: right" title="Types of services or goods"><b>3,304,329</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Tuition fees</td>
    <td id="xdx_987_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zHCrZk6cnSFb" style="text-align: right" title="Tuition fees">2,877,731</td>
    <td id="xdx_988_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvaF2I7AKls" style="text-align: right" title="Tuition fees">122,391</td>
    <td id="xdx_98E_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zixdSE6vsQe4" style="text-align: right" title="Tuition fees"><span style="-sec-ix-hidden: xdx2ixbrl4700">-</span></td>
    <td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zs3LypPBHb69" style="text-align: right" title="Tuition fees"><span style="-sec-ix-hidden: xdx2ixbrl4702">-</span></td>
    <td id="xdx_98A_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231_znq0h0wEsSjk" style="text-align: right" title="Tuition fees">3,000,122</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Other</td>
    <td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zF42nkGGAJY7" style="text-align: right" title="Other">17,961</td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSoGowoPnyC3" style="text-align: right" title="Other">133,047</td>
    <td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zWrG05yAV7me" style="text-align: right" title="Other">161,787</td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zFovuHVYo7Ah" style="text-align: right" title="Other">(8,588)</td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231_zM1MLMyzaWA1" style="text-align: right" title="Other">304,207</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><b>Timing of revenue recognition</b></td>
    <td id="xdx_983_ecustom--TimingRevenueRecognition_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zid68DJq1ZUh" style="text-align: right" title="Timing of revenue recognition"><b>2,895,692</b></td>
    <td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zM1wOFLICcwg" style="text-align: right" title="Timing of revenue recognition"><b>255,438</b></td>
    <td id="xdx_987_ecustom--TimingRevenueRecognition_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>161,787</b></td>
    <td id="xdx_98C_ecustom--TimingRevenueRecognition_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>(8,588)</b></td>
    <td id="xdx_983_ecustom--TimingRevenueRecognition_c20240101__20241231_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>3,304,329</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Transferred over time</td>
    <td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zOD21ltPW7m6" style="text-align: right" title="Transferred over time">2,877,731</td>
    <td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdJcmR8TcIMe" style="text-align: right" title="Transferred over time">218,573</td>
    <td id="xdx_983_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z2oKNgmjiOn9" style="text-align: right" title="Transferred over time">154,319</td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zjnVkS5xFLbd" style="text-align: right" title="Transferred over time">(8,588)</td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231_zUfbeLioV3A9" style="text-align: right" title="Transferred over time">3,242,035</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Transferred at a point in time</td>
    <td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z64dbGHZABl2" style="text-align: right" title="Transferred at a point in time">17,961</td>
    <td id="xdx_980_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Transferred at a point in time">36,865</td>
    <td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zJORSYj10usj" style="text-align: right" title="Transferred at a point in time">7,468</td>
    <td id="xdx_989_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"><span style="-sec-ix-hidden: xdx2ixbrl4742">-</span></td>
    <td id="xdx_983_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231_pn3n3" style="text-align: right" title="Transferred at a point in time">62,294</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Undergraduate</b></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Continuing education</b></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Medical practice solutions</b></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Elimination (inter-segment transactions)</b></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><b>2023</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><b>Types of services or goods</b></td>
    <td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zjhX9wnJre25" style="text-align: right" title="Types of services or goods"><b>2,511,018</b></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRM8QS6uSIK9" style="text-align: right" title="Types of services or goods"><b>235,830</b></td>
    <td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z55qWKfUG7Ng" style="text-align: right" title="Types of services or goods"><b>140,282</b></td>
    <td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zm2MyO4OJAk" style="text-align: right" title="Types of services or goods"><b>(11,217)</b></td>
    <td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231_zld4rMWWtk1e" style="text-align: right" title="Types of services or goods"><b>2,875,913</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Tuition fees</td>
    <td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXnykqmuOb69" style="text-align: right" title="Tuition fees">2,494,121</td>
    <td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zw7rBSOvZ6T4" style="text-align: right" title="Tuition fees">146,477</td>
    <td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zmLHQC59KzQ8" style="text-align: right" title="Tuition fees"><span style="-sec-ix-hidden: xdx2ixbrl4762">-</span></td>
    <td id="xdx_989_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_ztpdXN4ZDpNg" style="text-align: right" title="Tuition fees"><span style="-sec-ix-hidden: xdx2ixbrl4764">-</span></td>
    <td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231_zT5GwOoPWnhb" style="text-align: right" title="Tuition fees">2,640,598</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Other</td>
    <td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zSfGsU9WK1V3" style="text-align: right" title="Other">16,897</td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z8MJnsPKy61d" style="text-align: right" title="Other">89,353</td>
    <td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLgl9PjD0rf1" style="text-align: right" title="Other">140,282</td>
    <td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zsfYdgiqpKu2" style="text-align: right" title="Other">(11,217)</td>
    <td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231_zx3Tmn32k685" style="text-align: right" title="Other">235,315</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><b>Timing of revenue recognition</b></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>2,511,018</b></td>
    <td id="xdx_98F_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>235,830</b></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>140,282</b></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>(11,217)</b></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_c20230101__20231231_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>2,875,913</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Transferred over time</td>
    <td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zeYsuWApdDMd" style="text-align: right" title="Transferred over time">2,494,121</td>
    <td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zDYgQqqNhTW6" style="text-align: right" title="Transferred over time">206,098</td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z7ou3VsSQmAj" style="text-align: right" title="Transferred over time">132,249</td>
    <td id="xdx_988_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zkn5kwaV5YV9" style="text-align: right" title="Transferred over time">(11,217)</td>
    <td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231_zyfOVLAEXie3" style="text-align: right" title="Transferred over time">2,821,251</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Transferred at a point in time</td>
    <td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_pn3n3" style="text-align: right" title="Transferred at a point in time">16,897</td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Transferred at a point in time">29,732</td>
    <td id="xdx_981_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time">8,033</td>
    <td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"><span style="-sec-ix-hidden: xdx2ixbrl4804">-</span></td>
    <td id="xdx_981_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231_pn3n3" style="text-align: right" title="Transferred at a point in time">54,662</td></tr>
  </table>

<p id="xdx_8A9_z1g7ib5Ccuuh" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Costs and expenses by nature<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfExpensesByNatureExplanatory', window );">Costs and expenses by nature</a></td>
<td class="text"><p id="xdx_80F_eifrs-full--DisclosureOfExpensesByNatureExplanatory_znzh8xseTR83" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">18</td><td><span id="xdx_82A_zlCXbF7UWPbd">Costs and expenses by nature</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--ScheduleOfExpensesByNatureTableTextBlock_pn3n3_z8n8gPs6GOn7" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Costs and expenses by nature (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B7_zSWywQzRhBog" style="display: none">Schedule of expenses by nature</span></td>
    <td id="xdx_491_20250101__20251231_ztmpjTt7nWO4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_492_20240101__20241231_zIbN2xqQL1Ch" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_492_20230101__20231231_zPl01Wd7Pyw1" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 67%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_400_ecustom--Payroll_pn3n3_zhzXb4JCmU65" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Payroll (i)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,370,361)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,236,666)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,149,225)</td></tr>
  <tr id="xdx_40C_ecustom--HospitalAndMedicalAgreements_pn3n3_zP5AfY4TrlNb" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Hospital and medical agreements</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(80,449)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(94,583)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(86,151)</td></tr>
  <tr id="xdx_40C_eifrs-full--DepreciationExpense_iN_pn3n3_di_zp1OnaJxg55c" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Depreciation and amortization</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(373,344)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(333,341)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(289,511)</td></tr>
  <tr id="xdx_401_ecustom--LeaseExpenses_pn3n3_zlDGpVvRi4M7" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Lease expenses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(12,617)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(11,207)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(10,871)</td></tr>
  <tr id="xdx_408_eifrs-full--UtilitiesExpense_pn3n3_za8Rpqn1pGif" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Utilities</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(24,722)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(22,730)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(20,403)</td></tr>
  <tr id="xdx_402_eifrs-full--RepairsAndMaintenanceExpense_iN_pn3n3_di_zPtLi7zS7u5h" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Maintenance</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(134,156)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(127,777)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(105,919)</td></tr>
  <tr id="xdx_401_ecustom--SharesBasedCompensation_pn3n3_zqyPtLzbQrta" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Share-based compensation</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(15,318)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(32,424)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(31,535)</td></tr>
  <tr id="xdx_40B_ecustom--TaxExpenses_pn3n3_zRxtcxX9pDva" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Tax expenses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(12,091)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(12,105)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(14,447)</td></tr>
  <tr id="xdx_402_eifrs-full--SalesAndMarketingExpense_iN_pn3n3_di_zqVVQzAKi2Ai" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Sales and marketing</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(114,803)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(85,469)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(74,140)</td></tr>
  <tr id="xdx_40E_ecustom--AllowanceForExpectedCreditLosses_iN_pn3n3_di_zf0JeQaGosQ" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Allowance for expected credit losses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(57,090)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(60,894)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(74,552)</td></tr>
  <tr id="xdx_404_eifrs-full--TravelExpense_iN_pn3n3_di_zSD3f0OT7H1a" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Travel expenses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(26,144)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(20,345)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(16,098)</td></tr>
  <tr id="xdx_408_ecustom--ConsultingFees_pn3n3_zgPQU4AwbE6f" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Consulting fees</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(32,645)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(46,022)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(62,630)</td></tr>
  <tr id="xdx_40E_ecustom--CostExpensesOther_pn3n3_zHLtud2AJk6c" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Other</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(230,310)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(201,361)</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(189,015)</td></tr>
  <tr id="xdx_404_eifrs-full--ExpenseByNature_pn3n3_zzBi1VnZmmo3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b style="display: none">Total</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(2,484,050)</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(2,284,924)</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(2,124,497)</b></td></tr>
  <tr id="xdx_40A_ecustom--CostOfServices_iN_pn3n3_di_zBaib3z8pSK8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cost of services</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,313,895)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,215,603)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,109,813)</td></tr>
  <tr id="xdx_401_ecustom--SellingGeneralAndAdministrativeExpenses_pn3n3_zEh8NUxuJNRa" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Selling, general and administrative expenses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,113,065)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,008,427)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(940,132)</td></tr>
  <tr id="xdx_40E_ecustom--AllowanceForExpectedCreditLosses_iN_pn3n3_di_zDLa9JtSQi3c" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Allowance for expected credit losses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(57,090)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(60,894)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(74,552)</td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Includes the costs of pedagogical services related to the practicing physician who provides
practical training and supervision to medical students (preceptors).</td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfExpensesByNatureExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of expenses by nature. [Refer: Expenses, by nature]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfExpensesByNatureExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance result<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Finance result</a></td>
<td class="text"><p id="xdx_808_eifrs-full--DisclosureOfFinanceIncomeExpenseExplanatory_zfqcymkjYyh6" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">19</td><td><span id="xdx_826_zVneMG4DwHB">Finance result</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfFinanceResultTableTextBlock_pn3n3_zmguLDbLBLwe" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Finance result (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BC_zQxOLJJVwUF6" style="display: none">Schedule of finance result</span></td>
    <td id="xdx_490_20250101__20251231_z5XTmwejGJF" style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: center">&#160;</td>
    <td id="xdx_496_20240101__20241231_z7TM4d819HD9" style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: center">&#160;</td>
    <td id="xdx_494_20230101__20231231_zboKnwVvvkTl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 67%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_407_ecustom--FinancialIncomeFromCashEquivalents_pn3n3_zp9TewKkqima" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Financial income from cash equivalents</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">138,456 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">59,381 </td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">73,672</td></tr>
  <tr id="xdx_40E_ecustom--InterestEarned_pn3n3_zdzzJBRVS35i" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Interest earned</td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt">49,527 </td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt">43,417 </td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt">33,450</td></tr>
  <tr id="xdx_400_eifrs-full--OtherFinanceIncome_pn3n3_zmOsmHpFjVXe" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Other</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">6,960 </td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8,485 </td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3,520</td></tr>
  <tr id="xdx_40D_eifrs-full--FinanceIncome_pn3n3_zttyz74oPGP5" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Finance income</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>194,943 </b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>111,283 </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>110,642</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_408_ecustom--InterestExpense1_pn3n3_zTiLXuBq4Qy8" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Interest expense</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(316,379)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(254,386)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(285,447)</td></tr>
  <tr id="xdx_404_ecustom--InterestExpenseOnLeaseLiabilities1_pn3n3_zQxZ5WvUitK5" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Interest expense on lease liabilities</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(123,067)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(111,966)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(100,849)</td></tr>
  <tr id="xdx_40C_ecustom--FinancialDiscountsGrantedExpenses_pn3n3_zyXc0MxQd62e" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Financial discounts</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(54,254)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(33,240)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(30,891)</td></tr>
  <tr id="xdx_40D_ecustom--CreditCardCharges_pn3n3_zZe32h7X88cf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Credit card charges</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(6,901)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(5,824)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(4,096)</td></tr>
  <tr id="xdx_401_eifrs-full--BankAndSimilarCharges_iN_pn3n3_di_zGHj6RIWz7ce" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Bank fees</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(3,882)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(4,436)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(7,163)</td></tr>
  <tr id="xdx_40C_ecustom--ExchangeVariance_pn3n3_zT8vAy3GhiG" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Exchange variance</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(3,095)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(8,944) </td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(681)</td></tr>
  <tr id="xdx_40E_eifrs-full--OtherFinanceCost_iN_pn3n3_di_zwooNXSZn4A1" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Other</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(53,446)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(39,946)</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(28,489)</td></tr>
  <tr id="xdx_403_eifrs-full--FinanceCosts_iN_pn3n3_di_z37ZFntzkeef" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Finance expenses</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(561,024)</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(458,742)</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(457,616)</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_402_ecustom--FinanceResult_pn3n3_zqXa2TCxRASg" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Net finance result</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(366,081)</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(347,459)</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(346,974)</b></td></tr>
  </table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income (cost). [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureIncomeTaxesAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfIncomeTaxesExplanatory', window );">Income taxes</a></td>
<td class="text"><p id="xdx_805_ecustom--DisclosureOfIncomeTaxesExplanatory_z0lvxiPEEwFd" style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">20</td><td><span id="xdx_826_zze3F8tGkhJi">Income taxes</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Income taxes are comprised of taxation over operations in Brazil, related to Corporate
Income Tax (IRPJ) and Social Contribution on Net Profit (CSLL). According to Brazilian tax legislation, income taxes and social contribution
are assessed and paid by legal entity and not on a consolidated basis, except by the requirements of the Pillar Two global minimum tax.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Income taxes expenses</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company calculates the income taxes expenses using the tax rate that would be applicable
to the expected total annual earnings, including the effects of the OECD&#8217;s Pillar Two global minimum tax, which is applicable for
the fiscal year ended December 31, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0in"><span style="font-weight: normal">The table below presents the reconciliation
of income tax expense for the years ended December 31, 2025, 2024 and 2023:</span></p>

<p style="font: bold 10.5pt Nunito Sans; margin: 0; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_pn3n3_zOxwNd11tMSj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Income taxes (Details)">
  <tr style="background-color: White">
    <td style="white-space: nowrap"><span id="xdx_8BB_znVL8y7kXDX1" style="display: none">Schedule of reconciliation of income tax expense</span></td>
    <td id="xdx_495_20250101__20251231_znOokTZwOfY" style="text-align: center">&#160;</td>
    <td id="xdx_491_20240101__20241231_zxnR448aq4pd" style="text-align: center">&#160;</td>
    <td id="xdx_496_20230101__20231231_zXGdEcLS8i1h" style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 67%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right"></td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zdA3kZpuMZQ1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap">Income before income taxes</td>
    <td style="text-align: right">860,945 </td>
    <td style="text-align: right">676,391 </td>
    <td style="vertical-align: bottom; text-align: right">429,582</td></tr>
  <tr id="xdx_40D_eifrs-full--ApplicableTaxRate_pip0_dp_zaV7iIeDH041" style="background-color: White">
    <td style="white-space: nowrap">Statutory income taxes rate</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">34%</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">34%</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right">34%</td></tr>
  <tr id="xdx_40C_ecustom--TaxExpensesIncomeAtApplicableTaxRate_z5Pa0PaAdwo1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><b>Income taxes at statutory rate</b></td>
    <td style="text-align: right"><b>(292,721)</b></td>
    <td style="text-align: right"><b>(229,973)</b></td>
    <td style="vertical-align: bottom; text-align: right"><b>(146,058)</b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-top: Black 1pt solid; text-align: right">&#160;</td>
    <td style="border-top: Black 1pt solid; text-align: right">&#160;</td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--ReconciliationAdjustmentsAbstract_iB_zDs3502i5SCl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><b>Reconciliation adjustments:</b></td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pn3n3_zjUOl0PuFLEc" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Tax effect on loss from entities not subject to taxation</td>
    <td style="text-align: right">(20,042)</td>
    <td style="text-align: right">(37,007)</td>
    <td style="vertical-align: bottom; text-align: right">(32,274)</td></tr>
  <tr id="xdx_40B_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pn3n3_z3A1YRZV4sVk" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt">PROUNI - Fiscal incentive (i)</td>
    <td style="text-align: right">454,380 </td>
    <td style="text-align: right">379,747 </td>
    <td style="vertical-align: bottom; text-align: right">309,952</td></tr>
  <tr id="xdx_404_ecustom--UnrecognizedDeferredTaxesAssetsOnTaxLosses_pn3n3_zyyE9Npa9aek" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Unrecognized deferred taxes assets on tax losses</td>
    <td style="text-align: right">(161,215)</td>
    <td style="text-align: right">(130,074)</td>
    <td style="vertical-align: bottom; text-align: right">(154,062)</td></tr>
  <tr id="xdx_40A_ecustom--RecognisedDeferredTaxAssets_pn3n3_zyYpSoQ1tHI9" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt">Recognized deferred taxes</td>
    <td style="text-align: right">40,826 </td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4969">-</span></td>
    <td style="vertical-align: bottom; text-align: right">3,233</td></tr>
  <tr id="xdx_40E_ecustom--TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_iN_pn3n3_di_zbIKRq0QB2n7" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Presumed profit income tax regime effect (ii)</td>
    <td style="text-align: right">(372)</td>
    <td style="text-align: right">338 </td>
    <td style="vertical-align: bottom; text-align: right">(8,787)</td></tr>
  <tr id="xdx_404_ecustom--PermanentAdjustmentsAbstract_iB_zb7VvPCHDIq4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt"><b>Permanent adjustments:</b></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--PermanentAdjustmentsManagementBonuses_pn3n3_zz0hgbw2jKu" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 14.2pt">Management bonuses</td>
    <td style="text-align: right">(9,146)</td>
    <td style="text-align: right">(6,533)</td>
    <td style="vertical-align: top; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4982">-</span></td></tr>
  <tr id="xdx_408_ecustom--PermanentAdjustmentsGifts_pn3n3_zPofg9EGKgjl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 14.2pt">Gifts</td>
    <td style="text-align: right">(1,742)</td>
    <td style="text-align: right">(1,655)</td>
    <td style="vertical-align: top; text-align: right">(1,552)</td></tr>
  <tr id="xdx_40C_ecustom--PermanentAdjustmentsSponsorship_pn3n3_zv71dBpa4083" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 14.2pt">Sponsorship</td>
    <td style="text-align: right">(953)</td>
    <td style="text-align: right">(521)</td>
    <td style="vertical-align: top; text-align: right">(470)</td></tr>
  <tr id="xdx_400_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_iN_pn3n3_di_z4ogpR4zSypl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 14.2pt">Other</td>
    <td style="text-align: right">(1,744)</td>
    <td style="text-align: right">(4,744)</td>
    <td style="vertical-align: top; text-align: right">(2,665)</td></tr>
  <tr id="xdx_40C_ecustom--PermanentAdjustmentsPillarTwo_pn3n3_zqxktTkAVWMc" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Pillar Two - See Note 2.3(q)</td>
    <td style="text-align: right">(109,458)</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4997">-</span></td>
    <td style="vertical-align: top; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4998">-</span></td></tr>
  <tr id="xdx_400_ecustom--OtherTaxExpenseBenefits_pn3n3_z9EZ70QrzWOj" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt">Other</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">9,685 </td>
    <td style="border-bottom: Black 1pt solid; text-align: right">2,951 </td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right">8,517</td></tr>
  <tr id="xdx_403_ecustom--IncomeTaxesExpense_pn3n3_zDJiK0RZG8Vj" style="background-color: White">
    <td style="white-space: nowrap"><b>Income taxes expense</b></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><b>(92,502)</b></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><b>(27,471)</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right"><b>(24,166)</b></td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentTaxExpenseIncome_pn3n3_zsYynNP0wjLc" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt">Current</td>
    <td style="text-align: right">(133,328)</td>
    <td style="text-align: right">(24,238)</td>
    <td style="vertical-align: bottom; text-align: right">(27,399)</td></tr>
  <tr id="xdx_40F_eifrs-full--DeferredTaxExpenseIncome_pn3n3_z14lYFfKVhS4" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Deferred</td>
    <td style="text-align: right">40,826 </td>
    <td style="text-align: right">(3,233)</td>
    <td style="vertical-align: bottom; text-align: right">3,233</td></tr>
  <tr id="xdx_409_eifrs-full--TaxRateEffectFromChangeInTaxRate_pip0_dp_zhguVaETO6md" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><b>Effective rate</b></td>
    <td style="text-align: right"><b>10.70%</b></td>
    <td style="text-align: right"><b>4.10%</b></td>
    <td style="vertical-align: bottom; text-align: right"><b>5.62%</b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The Company adhered to PROUNI, established by Law 11,096/2005, which is a federal program
that exempts companies of paying income taxes and social contribution upon compliance with certain requirements required by this Law.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Brazilian tax law establishes that companies that generate gross revenues of up to R$78,000
in the prior fiscal year may calculate income taxes as a percentage of gross revenue, using the presumed profit tax regime. The effect
of the presumed profit of certain subsidiaries represents the difference between the taxation based on this method and the amount that
would be due based on the statutory rate applied to the taxable profit of the subsidiaries.</td>
</tr></table>

<p id="xdx_8A3_zT9hzx2NWvv5" style="margin-top: 0; margin-bottom: 0">&#160;</p>






<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Deferred income taxes</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The table below shows the balances of deferred tax assets and liabilities as of December
31, 2025 and 2024:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock_pn3n3_zfFtZthYcMk4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Income taxes (Details 1)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B3_zj5ZHZtS9Kt7" style="display: none">Schedule of deferred tax assets and liabilities</span></td>
    <td id="xdx_495_20240101__20241231_zdlB1ItzZvsi" style="text-align: center">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td id="xdx_498_20250101__20251231_zmzgE2DdbQe1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 55%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; text-align: right"><b>Additions</b> (i)</td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsAbstract_iB_z2A1zPu07Ssl">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Deferred tax assets</b></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Tax losses carry forward</td>
    <td id="xdx_983_ecustom--DeferredTaxAssetsLossCarryforwards_pn3n3_c20240101__20241231_zQf72oyl0Bg9" style="text-align: right" title="Tax losses carry forward"><span style="-sec-ix-hidden: xdx2ixbrl5026">-</span></td>
    <td id="xdx_986_ecustom--AdditionsTaxLossesCarryForward_pn3n3_c20250101__20251231_zNQ0PLM4Yza" style="text-align: right" title="Additions tax losses carry forward">1,703</td>
    <td id="xdx_981_ecustom--DeferredTaxAssetsLossCarryforwards_pn3n3_c20250101__20251231_zKy7a730nLul" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Tax losses carry forward">1,703</td></tr>
  <tr id="xdx_40D_eifrs-full--DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_iB_zivqGYh3Ocnh" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Temporary differences:</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Allowance for expected credit losses</td>
    <td id="xdx_987_ecustom--AllowanceForExpectedCreditLoss_pn3n3_c20240101__20241231_zufIhGscHNr6" style="text-align: right" title="Allowance for expected credit losses"><span style="-sec-ix-hidden: xdx2ixbrl5035">-</span></td>
    <td id="xdx_98E_ecustom--AdditionsAllowanceForExpectedCreditLosses_pn3n3_c20250101__20251231_z2SzqGTOcXg4" style="text-align: right" title="Additions allowance for expected credit losses">1,196</td>
    <td id="xdx_98E_ecustom--AllowanceForExpectedCreditLoss_pn3n3_c20250101__20251231_zRev5MrA0GJi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Allowance for expected credit losses">1,196</td></tr>
  <tr id="xdx_40E_eifrs-full--LeaseLiabilitiesAbstract_iB_zOJPMIyjjFU3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">IFRS 16 - Leases:</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 24.85pt">Right-of-use assets</td>
    <td id="xdx_989_ecustom--RightofuseAsset_iI_pn3n3_c20241231_zgEf2c29clF1" style="text-align: right" title="Allowance for expected credit losses"><span style="-sec-ix-hidden: xdx2ixbrl5044">-</span></td>
    <td id="xdx_989_ecustom--AdditionsToRightofuseAsset_pn3n3_c20250101__20251231_zDm3UPMssZGg" style="text-align: right" title="Allowance for expected credit losses">56,180</td>
    <td id="xdx_98E_ecustom--RightofuseAsset_iI_pn3n3_c20251231_zN9ZySY92IMk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Allowance for expected credit losses">56,180</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 24.85pt">Lease liabilities</td>
    <td id="xdx_98E_ecustom--LeaseLiability_iI_pn3n3_c20241231_zqmfSlIdAqSd" style="text-align: right" title="Lease liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5050">-</span></td>
    <td id="xdx_98D_ecustom--AdditionsLeaseLiability_iI_pn3n3_c20250101__20251231_ztDMXrnrPQO" style="text-align: right" title="Additions lease liabilities">(47,232)</td>
    <td id="xdx_984_ecustom--LeaseLiability_iI_pn3n3_c20251231_z86EaaLu7bml" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities">(47,232)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Provision for profit sharing</td>
    <td id="xdx_985_ecustom--ProvisionForProfitSharing_pn3n3_c20240101__20241231_zue9J4DB7cEe" style="text-align: right" title="Provision for profit sharing"><span style="-sec-ix-hidden: xdx2ixbrl5056">-</span></td>
    <td id="xdx_988_ecustom--AdditionsProvisionForProfitSharing_pn3n3_c20250101__20251231_zEXXPT4n0Ldk" style="text-align: right" title="Additions provision for profit sharing">2,047</td>
    <td id="xdx_982_ecustom--ProvisionForProfitSharing_pn3n3_c20250101__20251231_zHd2fuXaaHQj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Provision for profit sharing">2,047</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Provision for legal proceedings and contingencies</td>
    <td id="xdx_983_eifrs-full--LegalProceedingsProvision_iI_pn3n3_c20241231_zu7zw2l8fDcb" style="text-align: right" title="Provision for legal proceedings and contingencies"><span style="-sec-ix-hidden: xdx2ixbrl5062">-</span></td>
    <td id="xdx_980_ecustom--AdditionsProvisionForLegalProceedingsAndContingencies_pn3n3_c20250101__20251231_zo5tj6wuCZoc" style="text-align: right" title="Additions provision for legal proceedings and contingencies">7,672</td>
    <td id="xdx_984_eifrs-full--LegalProceedingsProvision_iI_pn3n3_c20251231_zPD1UwP8Ekke" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Provision for legal proceedings and contingencies">7,672</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Amortization of intangible assets</td>
    <td id="xdx_98E_ecustom--AmortizationOfIntangibleAsset_pn3n3_c20240101__20241231_zirgQCZHvRVc" style="text-align: right" title="Amortization of intangible assets"><span style="-sec-ix-hidden: xdx2ixbrl5068">-</span></td>
    <td id="xdx_98B_ecustom--AdditionsAmortizationOfIntangibleAssets_pn3n3_c20250101__20251231_zKdHXBVf9hSf" style="text-align: right" title="Additions amortization of intangible assets">44,486</td>
    <td id="xdx_982_ecustom--AmortizationOfIntangibleAsset_pn3n3_c20250101__20251231_zej0kGux9YQ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Amortization of intangible assets">44,486</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Other</td>
    <td id="xdx_98D_ecustom--Other_pn3n3_c20240101__20241231_z5dhx1ucZPI2" style="border-bottom: Black 1pt solid; text-align: right" title="Other"><span style="-sec-ix-hidden: xdx2ixbrl5074">-</span></td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231_zO01zfb4gnf" style="border-bottom: Black 1pt solid; text-align: right" title="Additions other">67</td>
    <td id="xdx_980_ecustom--Other_pn3n3_c20250101__20251231_zDVSNUxezidg" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other">67</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_982_ecustom--DeferredTaxAsset_iI_pn3n3_c20241231_zVbOrBCNJBej" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><b><span style="-sec-ix-hidden: xdx2ixbrl5080">-</span></b></td>
    <td id="xdx_982_ecustom--AdditionsDeferredTaxAssets_pn3n3_c20250101__20251231_zmYwrhLUYtS3" style="border-bottom: Black 1pt solid; text-align: right" title="Additions deferred tax assets"><b>66,119</b></td>
    <td id="xdx_981_ecustom--DeferredTaxAsset_iI_pn3n3_c20251231_zCqyen7f1v7j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>66,119</b></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_zx3rdIzhLSX2" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Deferred tax liabilities</b></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="border-top: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Tax benefit from tax deductible goodwill</td>
    <td id="xdx_98B_ecustom--DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20240101__20241231_zKjOpLVQgxVb" style="text-align: right" title="Tax benefit from tax deductible goodwill"><span style="-sec-ix-hidden: xdx2ixbrl5089">-</span></td>
    <td id="xdx_98D_ecustom--AdditionsTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20250101__20251231_z1WjRxB58sei" style="text-align: right" title="Additions tax benefit from tax deductible goodwill">(25,293)</td>
    <td id="xdx_985_ecustom--DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20250101__20251231_z57iuwhO0ehk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total">(25,293)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Fair value remeasurements on business combinations</td>
    <td id="xdx_982_ecustom--FairValueRemeasurementsOnBusinessCombinations_pn3n3_c20240101__20241231_zYLa81w0NGKb" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value remeasurements on business combinations">(28,274)</td>
    <td id="xdx_98C_ecustom--AdditionsFairValueRemeasurementsOnBusinessCombinations_pn3n3_c20250101__20251231_zd1xNcN8ogDf" style="border-bottom: Black 1pt solid; text-align: right" title="Additions fair value remeasurements on business combinations"><span style="-sec-ix-hidden: xdx2ixbrl5097">-</span></td>
    <td id="xdx_989_ecustom--FairValueRemeasurementsOnBusinessCombinations_pn3n3_c20250101__20251231_zTpwaZ9tKL6i" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Fair value remeasurements on business combinations">(28,274)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_981_ecustom--DeferredsTaxLiabilities_iI_pn3n3_c20241231_zMdUQudxXY1h" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><b>(28,274)</b></td>
    <td id="xdx_985_ecustom--AdditionsDeferredTaxLiabilities_pn3n3_c20250101__20251231_zC2ZsLiBNeJ5" style="border-bottom: Black 1pt solid; text-align: right" title="Additions deferred tax liabilities"><b>(25,293)</b></td>
    <td id="xdx_981_ecustom--DeferredsTaxLiabilities_iI_pn3n3_c20251231_zuudVW0DIoLk" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>(53,567)</b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Deferred tax assets (liabilities), net</b></td>
    <td id="xdx_986_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20241231_zlozLnAGLtRl" style="border-bottom: Black 1.5pt double; text-align: right" title="Deferred tax assets (liabilities), net"><b>(28,274)</b></td>
    <td id="xdx_982_ecustom--AdditionsDeferredTaxAssetsLiabilitiesNet_pn3n3_c20250101__20251231_zRwXswmPwuF2" style="border-bottom: Black 1.5pt double; text-align: right" title="Additions deferred tax assets (liabilities), net"><b>40,826</b></td>
    <td id="xdx_98E_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20251231_zJdRABafBoXl" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Deferred tax assets (liabilities), net"><b>12,552</b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Recognized in the consolidated statement of income and other comprehensive income.</td>
</tr></table>

<p id="xdx_8AF_zt7hVLjK22Ad" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The deferred tax assets were limited to the expected amount to be recovered, with the corresponding
impact recognized in the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">As of December 31, 2025, the Company had accumulated unrecognized deferred income tax assets
on temporary differences and tax losses in the amount of R$<span id="xdx_905_ecustom--DeferredTaxExpenseIncomes_pn3n3_c20250101__20251231_z8Sbr3bq2tFj" title="Unrecognized deferred income tax assets">1,603,167</span> of tax-basis (December 31, 2024: R$<span id="xdx_909_ecustom--DeferredTaxExpenseIncomes_c20240101__20241231_pn3n3" title="Unrecognized deferred income tax assets">1,266,126</span>) which does not have
expectations of future taxable income that could support the recognition as deferred tax assets, except for R$<span id="xdx_901_ecustom--RecognizedDeferredTaxAssets_pn3n3_c20250101__20251231_z3B1fcYc0Eo3" title="Recognized deferred tax assets">392,391</span> of tax basis from
temporary differences recognized as deferred tax assets as result of expected future taxable income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>




<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfIncomeTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfIncomeTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal proceedings and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureLegalProceedingsAndContingenciesAbstract', window );"><strong>Legal Proceedings And Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfLegalProceedingsAndContingenciesExplanatory', window );">Legal proceedings and contingencies</a></td>
<td class="text"><p id="xdx_80D_ecustom--DisclosureOfLegalProceedingsAndContingenciesExplanatory_zCkrE07RpKP4" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">21</td><td><span id="xdx_820_zMzaADaC9fhh">Legal proceedings and contingencies</span></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The provisions related to labor, civil and taxes proceedings whose likelihood of loss is
assessed as probable are as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfLegalProceedingsAndContingenciesTableTextBlock_pn3n3_zaYbuU3OiGJa" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Legal proceedings and contingencies (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="display: none"><span id="xdx_8B5_zDvFQ6ogRu47">Schedule of legal proceedings and contingencies</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Labor</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Civil</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Taxes</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Total</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Balances as of January 1, 2023</b></td>
    <td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zMPUP7yWvkUb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>22,484</b></td>
    <td id="xdx_987_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zEYXVMcMtOkk" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>24,664</b></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zuu0D4NWBW0j" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>148,706</b></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zXqE2w0Mescd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>195,854</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Business combination</td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zOoi9r7FFo69" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">64</td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zOLSjJ1M4Ad8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">88</td>
    <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z3JldT5t38Fe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="-sec-ix-hidden: xdx2ixbrl5135">-</span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zMVgJlvFgrod" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">152</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Additions</td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgGziB3HeHK9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">3,424</td>
    <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zFMR9KOHFhEe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">5,875</td>
    <td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zhsTvUnQdBB4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">9,037</td>
    <td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zvLYMG4PIzPc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">18,336</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Payments</td>
    <td id="xdx_98A_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zjxxbOccj9J9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(800)</td>
    <td id="xdx_98E_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zpuVDmtiHAsk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(1,051)</td>
    <td id="xdx_98C_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zRKwKO8cpVN2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(14,930)</td>
    <td id="xdx_98B_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zAC4DaVzVIvb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(16,781)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Reversals (i)</td>
    <td id="xdx_98F_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z6cVO1tkih71" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(2,451)</td>
    <td id="xdx_988_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuOr9hVKrDZa" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(8,276)</td>
    <td id="xdx_989_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zgiqgZBARFP1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(82,473)</td>
    <td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zcIC70dbufw7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(93,200)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Balances as of December 31, 2023</b></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zYGZ7TphNIf7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>22,721</b></td>
    <td id="xdx_985_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zXX9pWkVPrIa" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>21,300</b></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zsmhGeIdVD0d" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>60,340</b></td>
    <td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z9TSm2VZtvDf" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>104,361</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Business combination</td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zlv1R9GFD8D3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">721</td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zE2bkbXCJjki" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">481</td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zFk0iSvPaDC3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">6,044</td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zUlatOTIfMPc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">7,246</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Additions</td>
    <td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zMSz11wrKDag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">22,744</td>
    <td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zqEviugHnGVe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">10,006</td>
    <td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zLuLjOavQExb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">26,119</td>
    <td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z8jB2u7M0RCe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">58,869</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Payments</td>
    <td id="xdx_98C_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zyWRp0WxL6If" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(1,638)</td>
    <td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znDgL82bSSwa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(2,977)</td>
    <td id="xdx_985_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zZ01OUmmexFf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(22)</td>
    <td id="xdx_980_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_ztl8tE8LPyk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(4,637)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Reversals (i)</td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zea77tSXO6Qd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(13,093)</td>
    <td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z3dlA0d39UJ7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(3,670)</td>
    <td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHyjD3uhGW8k" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(35,555)</td>
    <td id="xdx_98C_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zERfPJT1sXI6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(52,318)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Balances as of December 31, 2024</b></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zxtLF9S2niG7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>31,455</b></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z1ybsx7j7OA5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>25,140</b></td>
    <td id="xdx_987_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zmrwueKMDQX4" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>56,926</b></td>
    <td id="xdx_98A_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zFdAPi3qGX2i" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>113,521</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Additions</td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zGpxODUfcVke" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">20,014 </td>
    <td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zrD9pb3ds7K5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">9,568 </td>
    <td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_znPPLGCPOtg6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">6,799 </td>
    <td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zyozkNUxBwT5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">36,381 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Payments</td>
    <td id="xdx_98E_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ziYWFzlHD8Q7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(3,354)</td>
    <td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zaesi0QDNK5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(3,519)</td>
    <td id="xdx_981_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zkYXs0ORPb59" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"><span style="-sec-ix-hidden: xdx2ixbrl5223">-</span></td>
    <td id="xdx_982_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhgVR9gLLcdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(6,873)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Reversals (i)</td>
    <td id="xdx_984_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zVqpOJ3uoaXe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(4,386)</td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z6SZbaazXNqb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(3,145)</td>
    <td id="xdx_98D_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_znoRZ1BA8sGe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(7,278)</td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhxibWomxBd1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(14,809)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Balances as of December 31, 2025</b></td>
    <td id="xdx_983_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zinbUzDsoAv4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><b>43,729 </b></td>
    <td id="xdx_985_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_ztO98Jsm2Gyg" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><b>28,044 </b></td>
    <td id="xdx_989_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zE2jpyEYuiZd" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><b>56,447 </b></td>
    <td id="xdx_985_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zquJoqn2NcEk" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><b>128,220 </b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Includes the reversals of provision for legal proceedings with corresponding indemnification
asset.</td>
</tr></table>

<p id="xdx_8A8_zu1fx0pPg5v3" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The major labor proceedings to which the Company is a party were filed by former employees
or outsourced service providers seeking enforcement of labor rights allegedly not provided by the Company. The judicial proceedings relate
to employment bonds (judicial proceedings filed by former service providers), overtime, premiums for hazardous workplace conditions, statutory
severance, fines for severance payment delays, and compensation for workplace-related accidents.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The civil claims to which the Company is a party generally relate to consumer claims, including
those related to student complaints.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The tax claims to which the Company is party are mostly tax foreclosures filed by the Brazilian
federal and municipal tax authorities.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">There are other civil, labor and taxes proceedings assessed by Management and its legal
counsels as possible risk of loss, for which no provisions are recognized, as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock_pn3n3_z6TQ0Q7CUK2g" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Legal proceedings and contingencies (Details 1)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B5_zFCR4MkyXfv9" style="display: none">Schedule of social
    security proceedings assessed by management</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Labor</td>
    <td id="xdx_98D_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total">36,818 </td>
    <td id="xdx_98E_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total">38,097 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Civil</td>
    <td id="xdx_983_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total">59,145 </td>
    <td id="xdx_984_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total">50,667 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Taxes</td>
    <td id="xdx_986_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total">30,530 </td>
    <td id="xdx_988_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total">17,498 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--OtherProvisions_c20251231_pn3n3" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><b>126,493 </b></td>
    <td id="xdx_98B_eifrs-full--OtherProvisions_c20241231_pn3n3" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><b>106,262 </b></td></tr>
  </table>
<p id="xdx_8A8_zp1xsNRWFYV2" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Under the terms of the Share Purchase and Sale Agreements ("Agreements") between
the Company and the selling shareholders of the subsidiaries acquired, the Company assesses that the selling shareholders are exclusively
responsible for any provisions (including labor, tax and civil), which are or will be the subject of a claim by any third party, arising
from the act or fact occurred, by action or omission, prior to or on the closing dates of the acquisitions.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Considering that the provisions for legal proceedings recorded by the Company that result
from causes arising from events occurring prior to the closing dates of the acquisitions, any liability for the amounts to be disbursed,
in case of their effective materialization in loss, belongs exclusively to the selling shareholders. In this context, the Agreements state
that the Company and its subsidiaries are indemnified and therefore exempt from any liability related to said contingent liabilities and,
therefore, the provision amounts related to such contingencies are presented in the non-current liabilities and the correspondent amount
of R$<span id="xdx_90C_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zcHoDUmliTwe" title="Contingencies correspondent amount">80,379</span> (December 31, 2024: R$<span id="xdx_905_ecustom--ContingenciesCorrespondentAmount_c20241231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_pn3n3" title="Contingencies correspondent amount">78,701</span>) is presented in non-current other assets.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureLegalProceedingsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureLegalProceedingsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfLegalProceedingsAndContingenciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfLegalProceedingsAndContingenciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-cash transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureNoncashTransactionsAbstract', window );"><strong>Non-cash Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureNoncashTransactionsExplanatory', window );">Non-cash transactions</a></td>
<td class="text"><p id="xdx_80E_ecustom--DisclosureNoncashTransactionsExplanatory_zfgnVQ6OBHo5" style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%">22</td><td><span id="xdx_823_z9oJPQJUUDT6">Non-cash transactions</span></td></tr></table>
<p style="font: 8.5pt Nunito Sans; margin: 0"></p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">During the years ended December 31, 2025, 2024 and 2023, the Company carried out non-cash
transactions which are not reflected in the consolidated statement of cash flows. The main non-cash transactions are as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfNonCashTransactionsTableTextBlock_pn3n3_zRQwgNhvuOoj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Non-cash transactions (Details)">
  <tr style="background-color: White">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt"><span id="xdx_8B2_zUoIiDVrKut8" style="display: none">Schedule
    of non-cash transactions</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 67%; padding-left: 8.7pt; text-align: right; text-indent: -8.7pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt">&#160;</td>
    <td style="text-align: right"></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Remeasurement of earn-out of Al&#233;m da Medicina, CardioPapers and Glic</td>
    <td id="xdx_980_ecustom--RemeasurementOfEarnOut_pn3n3_c20250101__20251231_z4T31wLxjcN7" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic"><span style="-sec-ix-hidden: xdx2ixbrl5269">-</span></td>
    <td id="xdx_987_ecustom--RemeasurementOfEarnOut_pn3n3_c20240101__20241231_zcNmgAioEoOh" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic"><span style="-sec-ix-hidden: xdx2ixbrl5271">-</span></td>
    <td id="xdx_98A_ecustom--RemeasurementOfEarnOut_pn3n3_c20230101__20231231_zliFR7QG0O0f" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic">2,556</td></tr>
  <tr style="background-color: White">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Additions and remeasurements of right-of-use assets and lease liabilities</td>
    <td id="xdx_98E_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_c20250101__20251231_pn3n3" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities">136,714</td>
    <td id="xdx_98E_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20240101__20241231_zWdWTUeEC3P6" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities">117,897</td>
    <td id="xdx_982_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_c20230101__20231231_pn3n3" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities">77,715</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net</td>
    <td id="xdx_98B_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_pn3n3_c20250101__20251231_zwMZpoTQkXf" style="text-align: right" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net">1,678</td>
    <td id="xdx_98B_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_pn3n3_c20240101__20241231_zvLocT5FP47b" style="text-align: right" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net">(3,154)</td>
    <td id="xdx_98C_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_c20230101__20231231_pn3n3" style="text-align: right" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net">20,000</td></tr>
  <tr style="background-color: White">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Additions to intangibles and goodwill through accounts payable to selling shareholders.</td>
    <td id="xdx_980_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_c20250101__20251231_pn3n3" style="text-align: right" title="Additions to intangibles and goodwill through accounts payable to selling shareholders">40,000</td>
    <td id="xdx_988_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_pn3n3_c20240101__20241231_zFZYBv0WO1Ma" style="text-align: right" title="Additions to intangibles and goodwill through accounts payable to selling shareholders">279,989</td>
    <td id="xdx_983_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_c20230101__20231231_pn3n3" style="text-align: right" title="Additions to intangibles and goodwill through accounts payable to selling shareholders">234,000</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Dividends payable</td>
    <td id="xdx_986_ecustom--DividendsPayables_iI_pn3n3_c20250101__20251231_z5a5QsGtgHBd" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt" title="Dividends payable">192</td>
    <td id="xdx_98A_ecustom--DividendsPayables_pn3n3_c20240101__20241231_zFRspycj9nD6" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt" title="Dividends payable"><span style="-sec-ix-hidden: xdx2ixbrl5295">-</span></td>
    <td id="xdx_98B_ecustom--DividendsPayables_pn3n3_c20230101__20231231_z85Q9IaTl1L1" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt" title="Dividends payable"><span style="-sec-ix-hidden: xdx2ixbrl5297">-</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureNoncashTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureNoncashTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureNoncashTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureNoncashTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Subsequent events</a></td>
<td class="text"><p id="xdx_808_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zVblsUeamGP2" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 3%"><b>23</b></td><td><b><span id="xdx_828_zr0h6L49cs99">Subsequent events</span></b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Medical school seats increase in ITPAC Porto</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On February 6, 2026, MEC authorized the increase of 63 medical school seats of ITPAC Porto
located in the city of Abaetetuba, State of Par&#225;. With this authorization, Afya reached 113 medical school seats on this campus.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Dividend distribution</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On March 12, 2026, the Company&#8217;s Board of Directors approved a dividend distribution
in the amount of R$<span id="xdx_90E_ecustom--FirstDividendDistributionInAmount_pn5n6_c20260311__20260312__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z8hARqnokK42" title="First dividend distribution in amount">307.4</span> million, representing <span id="xdx_90B_ecustom--PercentageOfDividendDistribution_pip0_dp_c20260311__20260312__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zlcYv0mJTj69" title="Percentage of dividend distribution">40</span>% of the Company&#8217;s consolidated net income for the year ended December 31, 2025
and a dividend per share of R$<span id="xdx_908_eifrs-full--DividendsPaidOtherSharesPerShare_c20260405__20260406__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zAqHnAsvO6n4" title="Dividends per share">3.446838</span>, payable in U.S. dollars on April 6, 2026, to the shareholders on record as of the close of business
on March 25, 2026. The payment will be made at the exchange rate (PTAX) published by the Brazilian Central Bank on March 13, 2026.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureMaterialAccountingPoliciesAbstract', window );"><strong>Material Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BusinessCombinationsAndGoodwillPolicyExplanatory', window );">Business combinations and goodwill</a></td>
<td class="text"><p id="xdx_842_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zhSI7K0euRz1" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>a) <span id="xdx_866_zkCO45uQlw6f">Business combinations and goodwill</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Business combinations are accounted for using the acquisition method. The cost of an acquisition
is measured as the aggregate of the consideration transferred, which is measured at acquisition date fair value, and the amount of any
non-controlling interests in the acquiree. For each business combination, the Company elects whether to measure the non-controlling interests
in the acquiree at fair value or at the proportionate share of the acquiree&#8217;s identifiable net assets. Acquisition-related costs
are expensed as incurred and included in selling, general and administrative expenses.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company determines that it has acquired a business when the acquired set of activities
and assets include an input and a substantive process that together significantly contribute to the ability to create outputs. The acquired
process is considered substantive if it is critical to the ability to continue producing outputs, and the inputs acquired include an organized
workforce with the necessary skills, knowledge, or experience to perform that process or it significantly contributes to the ability to
continue producing outputs and is considered unique or scarce or cannot be replaced without significant cost, effort, or delay in the
ability to continue producing outputs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Any contingent consideration to be transferred by the acquirer will be recognized at fair
value at the acquisition date. Contingent consideration classified as equity is not remeasured and its subsequent settlement is accounted
for within equity. Contingent consideration classified as an asset or liability that is a financial instrument is measured at fair value
with the changes in fair value recognized in the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Goodwill is initially measured at cost (being the excess of the aggregate of the consideration
transferred and the amount recognized for non-controlling interests and any previous interest held over the net identifiable assets acquired
and liabilities assumed). If the fair value of the net assets acquired is in excess of the aggregate consideration transferred, the Company
re-assesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed and reviews the procedures
used to measure the amounts to be recognized at the acquisition date. If the reassessment still results in an excess of the fair value
of net assets acquired over the aggregate consideration transferred, then the gain is recognized in the consolidated statement of income
and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">After initial recognition, goodwill is measured at cost less any accumulated impairment
losses. For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated to
each of the Company&#8217;s cash-generating units that are expected to benefit from the combination.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Where goodwill has been allocated to a cash-generating unit (&#8220;CGU&#8221;) and part
of the operation within that unit is disposed of, the goodwill associated with the disposed operation is included in the carrying amount
of the operation when determining the gain or loss on disposal. Goodwill disposed in these circumstances is measured based on the relative
values of the disposed operation and the portion of the cash-generating unit retained.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>




<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory', window );">Fair value measurement</a></td>
<td class="text"><p id="xdx_845_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zarwdTpqf083" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>b) <span id="xdx_867_zq3H1xtNmHMb">Fair value measurement</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Fair value is the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption
that the transaction to sell the asset or transfer the liability takes place either: (i) in the principal market for the asset or liability;
or (ii) in the absence of a principal market, in the most advantageous market for the asset or liability.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The principal or the most advantageous market must be accessible by the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The fair value of an asset or a liability is measured using the assumptions that market
participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</p>

<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">A fair value measurement of a non-financial asset takes into account a market participant's
ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that
would use the asset in its highest and best use.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company uses valuation techniques that are appropriate in the circumstances and for
which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of
unobservable inputs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">All assets and liabilities for which fair value is measured or disclosed in these
consolidated financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input
that is significant to the fair value measurement as a whole:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">Level 1 - Quoted (unadjusted) market prices in active markets
for identical assets or liabilities.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">Level 2 - Valuation techniques for which the lowest level input
that is significant to the fair value measurement is directly or indirectly observable.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">Level 3 - Valuation techniques for which the lowest level input
that is significant to the fair value measurement is unobservable.</span></td>
</tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The following table shows the evaluation techniques used in measuring fair values for financial
instruments classified at level 2 and 3, as well as the significant unobservable inputs used.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock_z9Lfc0gZO6z4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 1)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B4_zeQBW9jYaF54" style="display: none">Schedule of fair values for financial
instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr>
    <td style="border: #D0CECE 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Type</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Valuation technique</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Significant unobservable inputs</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Inter-relationship between significant unobservable inputs and fair value measurement</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt">Level 2 - Stock options and Restricted stock units (Note 14)</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zbWrtvEd8R68" title="Valuation technique">Binomial model: The fair value is estimated by utilizing a simulation of possible future share prices, applying regression analysis, as well as comparing at each potential exercise date the discounted risk-neutral expectation of the option payoff if not exercised, and the relevant exercise price.</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt"><span style="font-size: 7.5pt">&#8226; Expected volatility (December 31, 2025: <span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_ztMnLOO8bvX1" title="Expected volatility">24</span>% to <span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0zfhCwyYU7e" title="Expected volatility">44</span>%; December 31, 2024: <span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvl0bVSRFkng" title="Expected volatility">32</span>% to <span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEOHbmVlM4Rg" title="Expected volatility">45</span>%).</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p id="xdx_982_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zrOsTuY8y0Lh" style="font: 7.5pt Nunito Sans; margin: 0" title="Inter-relationship between significant unobservable inputs and fair value measurement">The estimated fair value</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">would increase (decrease) if the expected volatility were higher (lower).</p></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt">Level 3 - Contingent consideration (Accounts payable to selling shareholders - Note 12.2.3)</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zxIHtVQ8f3Fl" title="Valuation technique">Probability-weighted cash flows: This valuation technique considers the probability-weighted expectation of future cash flow.</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; Expected cash flows (December 31, 2025: R$<span id="xdx_907_ecustom--ExpectedCashFlows_pn3n3_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zwL4LiFAutuh" title="Expected cash flows">325,150</span>;
    December 31, 2024: R$<span id="xdx_908_ecustom--ExpectedCashFlows_pn3n3_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zLTVYXh0aIzi" title="Expected cash flows">314,953</span>).</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; Probability of disbursement (December 31, 2025 and
    2024: <span id="xdx_908_ecustom--ProbabilityOfDisbursement_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zJOYzkxwFFK5" title="Probability of disbursement"><span id="xdx_903_ecustom--ProbabilityOfDisbursement_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z0jpMqr4Ciue" title="Probability of disbursement">100</span></span>%).</p></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p id="xdx_985_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zPlc1vzSNOy9" style="font: 7.5pt Nunito Sans; margin: 0" title="Inter-relationship between significant unobservable inputs and fair value measurement">The estimated fair value would increase (decrease) if:</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; the expected cash flows were higher (lower); or</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; the probability rate were lower (higher).</p></td></tr>
  </table>
<p id="xdx_8A9_zplE3eA2TDq8" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The valuation model for other financial liabilities not measured at fair value considers
the present value of expected payments, discounted using a risk-adjusted discount rate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For assets and liabilities that are recognized in these  consolidated financial
statements at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy
by re-assessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end
of each reporting period.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">At each reporting date, the Company analyzes the movements in the values of assets and
liabilities which are required to be remeasured or reassessed as per the Company&#8217;s accounting policies. For this analysis, the
Company verifies the major inputs applied in the latest valuation by agreeing the information in the valuation computation to contracts
and other relevant documents.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>
<p style="font: 10.5pt Nunito Sans; margin: 0"></p>






<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company also compares the change in the fair value of each asset and liability with
relevant external sources to determine whether the change is reasonable.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For the purpose of fair value disclosures, the Company has determined classes of assets
and liabilities on the basis of the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy,
as explained above.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory', window );">Financial instruments - initial recognition and measurement</a></td>
<td class="text"><p id="xdx_843_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_zNMF30lxdisd" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>c) <span id="xdx_869_zpbtmZlgwRZe">Financial instruments - initial recognition and measurement</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><i>Recognition and initial measurement</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; text-align: left">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">Financial assets and financial liabilities are initially recognized when the
Company becomes a party to the contractual provisions of the instrument.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; text-align: left">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">A financial asset (unless it is a trade receivable without a significant financing
component) or financial liability is initially measured at fair value plus or minus, for an item not at fair value through profit or loss
(&#8220;FVTPL&#8221;), transaction costs that are directly attributable to its acquisition or issue. A trade receivable without a significant
financing component is initially measured at the transaction price. However, if the Company has an unconditional right to an amount that
differs from the transaction price (e.g. due to the Company's refund policy), the trade receivable will be initially measured at the amount
of that unconditional right.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 3%"></td><td style="width: 14.2pt"><b>i)</b></td><td><b>Financial assets</b></td></tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><i>Classification and subsequent measurement</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">On initial recognition, a financial asset is classified as subsequently measured
at: amortized cost; FVOCI - debt investment; FVOCI - equity investment; or FVTPL.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">Financial assets are not reclassified subsequent to their initial recognition
unless the Company changes its business model for managing financial assets, in which case all affected financial assets are reclassified
on the first day of the first reporting period following the change in the business model.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">A financial asset is measured at amortized cost if it meets both of the following
conditions and is not designated as at FVTPL:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">it is held within a business model whose objective is to hold
assets to collect contractual cash flows; and</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">its contractual terms give rise on specified dates to cash
flows that are solely payments of principal and interest (&#8220;SPPI&#8221;) on the principal amount outstanding.</span></td>
</tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">A debt investment is measured at FVOCI if it meets both of the following conditions
and is not designated as at FVTPL:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">it is held within a business model whose objective is achieved
by both collecting contractual cash flows and selling financial assets; and</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-size: 10.5pt">its contractual terms give rise on specified dates to cash
flows that are SPPI on the principal amount outstanding.</span></td>
</tr></table>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">On initial recognition of certain equity investments that are not held for trading,
the Company has made an irrevocable election to present subsequent changes in the investment's fair value in OCI.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">This election is made on an investment-by-investment basis.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">All financial assets not measured at amortized cost or FVOCI as described above
(e.g. financial assets held for trading and those that are managed and whose performance is evaluated on a fair value basis) are measured
at FVTPL.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#160;</p>






<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Business model assessment</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company makes an assessment of the objective of the business model in which
a financial asset is held at a portfolio level because this best reflects the way the business is managed and information is provided
to management.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Transfers of financial assets to third parties in transactions that do not qualify
for derecognition are not considered sales for this purpose, consistent with the Company's continuing recognition of the assets.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Assessment whether contractual cash flows are SPPI</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In assessing whether the contractual cash flows are SPPI, the Company considers
the contractual terms of the instrument. This includes assessing whether the financial asset contains a contractual term that could change
the timing or amount of contractual cash flows such that it would not meet this condition. In making this assessment, the Company considers:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;
</span><span style="font-size: 10.5pt">contingent events that would change the amount or timing of cash flows;</span></p>

<p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;
</span><span style="font-size: 10.5pt">terms that may adjust the contractual coupon rate, including variable-rate features;</span></p>

<p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;
</span><span style="font-size: 10.5pt">prepayment and extension features; and</span></p>

<p style="font: 8.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"><span style="font-family: Symbol; font-size: 10.5pt">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;
</span><span style="font-size: 10.5pt">terms that limit the Company&#8217;s claim to cash flows from specified assets (e.g. non-recourse
features).</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">A prepayment feature is consistent with the SPPI criterion if the prepayment
amount substantially represents unpaid amounts of principal and interest on the principal amount outstanding, which may include reasonable
compensation for early termination of the contract. Additionally, for a financial asset acquired at a discount or premium to its contractual
per amount, a feature that permits or requires prepayment at an amount that substantially represents the contractual par amount plus accrued
(but unpaid) contractual interest (which may also include reasonable compensation for early termination) is treated as consistent with
this criterion if the fair value of the prepayment feature is insignificant on initial recognition. The Company had no financial assets
held outside trading business models that failed the SPPI assessment.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Subsequent measurement and gains and losses</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfMeasurementAndGainsAndLossesTableTextBlock_zis2ByfBzXce" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 2)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_zC3j1pqBL6wc" style="display: none">Schedule
    of measurement and gains and losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr>
    <td style="border: #AEAAAA 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Financial assets at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">FVTPL</p></td>
    <td style="border-top: #AEAAAA 1pt solid; border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; width: 78%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVTPLMember_zdt0sle527kc" title="Financial assets">These assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.</span></span></td></tr>
  <tr>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Financial assets at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">amortized cost</p></td>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FinancialAssetsAtAmortizedCostMember_z95KI8zi7w8d" title="Financial assets at amortized cost">These assets are subsequently measured at amortized cost under the effective interest method. The gross carrying amount is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.</span></span></td></tr>
  <tr>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Debt investments at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">FVOCI</p></td>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCIMember_zvzFySxDw8Gc" title="Debt investments">These assets are subsequently measured at fair value. Interest income calculated under the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.</span></span></td></tr>
  <tr>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Equity investments at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">FVOCI</p></td>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCI1Member_zqC4N7c5azq9" title="Equity investments">These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never reclassified to profit or loss.</span></span></td></tr>
  </table>
<p id="xdx_8AD_ztPiF7ltilEl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><i>Impairment of financial assets</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">Further disclosures relating to impairment of financial assets are also provided
in the following notes:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#8226; Significant accounting judgments, estimates and assumptions - Note 2.5</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#8226; Trade receivables - Note 6</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">The Company recognizes an allowance for expected credit losses (ECLs) for all
debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due
in accordance with the contract and the cash flows the Company expects to receive, discounted at an approximation of the original effective
interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements that are
integral to the contractual terms.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">For trade receivables, the Company applies a simplified approach in calculating
ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for credit losses based on both
quantitative and qualitative information and analysis on the Company&#8217;s historical experience and informed credit assessment, at
each reporting date.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">&#160;</p>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"></p>






<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">The Company considers a financial asset to be in default when internal or external
information indicates that the Company is unlikely to receive the outstanding contractual amounts in full before considering any credit
enhancements held by the Company. Interest accrual is suspended once a financial asset meets the criteria for default. A financial asset
is written off when there is no reasonable expectation of recovering the contractual cash flows.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><b>ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial liabilities</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; color: #C00000">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"><i>Classification, subsequent measurement and gain and losses</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">Financial liabilities are measured at amortized cost or FVTPL. A financial liability
is measured at FVTPL if it is classified as held-for-trading, it is a derivative or it is designated as such on initial recognition. Financial
liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognized in profit or
loss. Other financial liabilities are subsequently measured at amortized cost under the effective interest method. Interest expense and
foreign exchange gains and losses are recognized in profit or loss.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left">The Company&#8217;s financial liabilities include trade payables, loans and
financing, lease liabilities, accounts payable to selling shareholders and dividends payable.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_z9Fj5sTtEi95" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>d) <span id="xdx_861_ztY0XKb4WM82">Cash and cash equivalents</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Cash and cash equivalents in the statement of financial position comprise cash at banks
and on hand, and short-term financial investments with an original maturity of three months or less from the date of purchase, held for
the purpose of meeting short-term cash commitments, readily convertible to a known amount of cash and subject to an insignificant risk
of changes in value.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For the purpose of the consolidated statement of cash flows, cash and cash equivalents
consist of cash and short-term financial investments, as they are considered an integral part of the Company&#8217;s cash management.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property and equipment</a></td>
<td class="text"><p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zUYOD2tsT21g" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>e) <span id="xdx_867_zUczxtH6FQ51">Property and equipment</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Property and equipment are stated at cost, net of accumulated depreciation and accumulated
impairment losses, if any.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Subsequent expenditures are capitalized only if it is probable that the future economic
benefits associated with the expenditure will flow to the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Depreciation is calculated on a straight-line basis over the estimated useful lives of
the assets, except for leasehold improvements, which are depreciated over the shorter of their estimated useful lives or the lease terms.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_pn3n3_zCa4de18nPW9" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 3)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B8_zyCXjuN9UFLf" style="display: none">Schedule of estimated useful lives of
the assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Building</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_ziGG6APQYSt2" title="Useful lives of assets">25</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Machinery and equipment</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zzWQqZWfoZmi" title="Useful lives of assets">10</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Vehicles</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zCsQwDwpnOQ1" title="Useful lives of assets">5</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Furniture and fixtures</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zc5myiWw2ged" title="Useful lives of assets">10</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">IT equipment</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zRJs7ZnMWgl1" title="Useful lives of assets">5</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Library books</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zMkh1AmfUxWl" title="Useful lives of assets">10</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Leasehold improvements</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDRJaGRRs8Cb" title="Useful lives of assets">1</span> - <span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ztPAUspLZAec" title="Useful lives of assets">30</span> years</td></tr>
  </table>
<p id="xdx_8A1_z4OeLS3uKode" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">An item of property and equipment and any significant part initially recognized is derecognized
upon disposal or when no future economic benefit is expected from its use. Any gain or loss arising on the derecognition of the asset
(calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated
statement of income and other comprehensive income when the asset is derecognized.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The residual values, useful lives and methods of depreciation of property and equipment
are reviewed at each financial year end and adjusted prospectively, if appropriate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>






<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases</a></td>
<td class="text"><p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_ztFoOqn5blrl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>f) <span id="xdx_860_zRWo66GqKO3g">Leases</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company assesses at contract inception whether an arrangement is, or contains, a lease.
That is, if the arrangement conveys the right to control the use of an identified asset for a period of time in exchange for consideration.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Company as a lessee</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company applies a single recognition and measurement approach for all leases, except
for short-term leases and leases of low-value assets. The Company recognizes lease liabilities to make lease payments and right-of-use
assets representing the right to use the underlying assets.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Right-of-use assets</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company recognizes right-of-use assets at the commencement date of the lease (i.e.,
the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment
losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities
recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Right-of-use assets are depreciated on a straight-line basis over the shorter of its estimated
useful life and the lease term. The lease term of the contracts for properties range between five and 30 years. Right-of-use assets are
subject to impairment. Refer to the accounting policies in &#8216;Impairment of non-financial assets&#8217;.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Lease liabilities</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">At the commencement date of the lease, the Company recognizes lease liabilities measured
at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance
fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected
to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain
to be exercised by the Company and payments of penalties for terminating a lease, if the lease term reflects the Company exercising the
option to terminate. The variable lease payments that do not depend on an index or a rate are recognized as expense in the period on which
the event or condition that triggers the payment occurs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In calculating the present value of lease payments, the Company uses the incremental borrowing
rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After the commencement date,
the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition,
the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the in-substance
fixed lease payments or a change in the assessment to purchase the underlying asset.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Short-term leases and leases of low-value assets</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company applies the short-term lease recognition exemption to its short-term leases
of properties (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase
option). It also applies the lease of low-value assets recognition exemption to leases that are considered of low value. Lease payments
on short-term leases and leases of low-value assets are recognized as expense on a straight-line basis over the lease term.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Intangible assets</a></td>
<td class="text"><p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zC2NYRBNHPY8" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>g) <span id="xdx_869_zHbrvS2XFx63">Intangible assets</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Intangible assets acquired separately are measured on initial recognition at cost. The
cost of intangible assets acquired in a business combination or asset acquisition is their fair value at the date of acquisition. Following
initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally
generated intangibles, excluding capitalized development costs, are not capitalized and the related expenditure is reflected in the consolidated
statement of income and other comprehensive income in the period in which the expenditure is incurred.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The useful lives of intangible assets are assessed as finite or indefinite.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Intangible assets with finite lives are amortized on a straight-line over the estimated
useful lives and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The estimated useful
lives of intangible assets are as follows:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zKBgfLCXIwy8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 4)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BA_zJRQ405AQSG4" style="display: none">Schedule of estimated useful
lives of intangible assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="background-color: rgb(213,234,234)">
    <td style="width: 272px; padding-right: 5.4pt; padding-left: 5.4pt">Customer relationships - medicine</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z01NwOJL9RMi" title="Estimated useful lives of intangible assets">6</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Customer relationships - other courses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--CustomerRelationshipsOtherCoursesMember_zXjMKXoWxuC9" title="Estimated useful lives of intangible assets">4.5</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Software</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--ComputerSoftwareMember_zrOjKogqeteh" title="Estimated useful lives of intangible assets">5</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Trademarks</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zB1PLffvirPd" title="Estimated useful lives of intangible assets">2</span> - <span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zWHwkdtG4848" title="Estimated useful lives of intangible assets">30</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Education content, Developed technology and Educational platform</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zQEMtlFWCwaj" title="Estimated useful lives of intangible assets">3</span> - <span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zy0K8Pm1co7e" title="Estimated useful lives of intangible assets">5</span> years</td></tr>
  </table>
<p id="xdx_8A5_zZnnyylInkJ6" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The amortization period and the amortization method for an intangible asset with a finite
useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected pattern of
consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate,
and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in the
consolidated statement of income and other comprehensive income in the expense category that is consistent with the function of the intangible
assets.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Intangible assets with indefinite useful lives are not amortized, but are tested for impairment
annually, either individually or at the cash-generating unit level. The assessment of indefinite life is reviewed annually to determine
whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective
basis.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">An intangible asset is derecognized upon disposal or when no future economic benefits are
expected from its use. Any gain or loss arising upon derecognition of the asset (calculated as the difference between the net disposal
proceeds and the carrying amount of the asset) is included in the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>




<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory', window );">Impairment of non-financial assets</a></td>
<td class="text"><p id="xdx_848_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_z6w2Tca5jcY2" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>h) <span id="xdx_861_z9SxAToULh87">Impairment of non-financial assets</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company assesses, at each reporting date, whether there is an indication that an asset
may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Company estimates the asset&#8217;s
recoverable amount. An asset&#8217;s recoverable amount is the higher of an asset&#8217;s or CGU&#8217;s fair value less costs of disposal
and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that
are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU exceeds its recoverable
amount, the asset is considered impaired and is written down to its recoverable amount.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In assessing value in use, the estimated future cash flows are discounted to their present
value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the
asset. In determining fair value less costs of disposal, recent market transactions are considered. If no such transactions can be identified,
an appropriate valuation model is used. These calculations are corroborated by valuation multiples, quoted share prices for publicly traded
companies or other available fair value indicators.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company bases its impairment calculation on detailed budgets and forecast calculations,
which are prepared separately for each of the Company&#8217;s CGUs to which the individual assets are allocated. These budgets and forecast
calculations cover a period of five years, considering the companies activities and maturation period of its graduate and undergraduate
courses. A long-term growth rate is calculated and applied to project future cash flows after the last projected year.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For impairment testing, goodwill and licenses with indefinite useful lives are allocated
to their respective CGUs. The Company defined each of its operating subsidiaries as a CGU, except for the following which combines subsidiaries:
(i) &#8220;Continuing education&#8221; and (ii) &#8220;Medical practice solutions&#8221;, where the subsidiaries were combined as one
CGU following the business strategy and interdependency of cash flow generation.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Whenever applicable, impairment losses of continuing operations are recognized in the consolidated
statement of income and other comprehensive income in expense categories consistent with the function of the impaired asset.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">For assets excluding goodwill, an assessment is made at each reporting date to determine
whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such indication exists,
the Company estimates the asset&#8217;s or CGU&#8217;s recoverable amount. A previously recognized impairment loss is reversed only if
there has been a change in the assumptions used to determine the asset&#8217;s recoverable amount since the last impairment loss was recognized.
The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount
that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years. Such reversal
is recognized in the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Goodwill is tested for impairment annually as at December 31 and when circumstances indicate
that the carrying amounts may be impaired.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Impairment is determined for goodwill by assessing the recoverable amount of each CGU (or
group of CGUs) to which the goodwill relates. When the recoverable amount of the CGU is less than its carrying amount, an impairment loss
is recognized. Impairment losses relating to goodwill cannot be reversed in future periods.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Intangible assets with indefinite useful lives are tested for impairment annually as at
December 31 at the CGU level, as appropriate, and when circumstances indicate that the carrying amounts may be impaired.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory', window );">Investments in associates</a></td>
<td class="text"><p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForInvestmentsExplanatory_zZfZwtNjoxp9" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>i) <span id="xdx_860_zjk6LVHMzzq3">Investments in associates</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Investments in associates are initially recognized at consideration transferred and adjusted
thereafter for the equity method, being increased or reduced from its interest in the investee's income after the acquisition date. An
associate is an entity over which the Company has significant influence. Significant influence is the power to participate in the financial
and operating policy decisions of the investee, but is not control or joint control over those policies.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The financial statements of the associate are prepared for the same reporting period as
the Company. The accounting policies of the associate are aligned with those of the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>






<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersPolicyExplanatory', window );">Accounts payable to selling shareholders</a></td>
<td class="text"><p id="xdx_84B_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_zb6FRoiaSayd" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>j) <span id="xdx_863_z9SEOZDjBA3h">Accounts payable to selling shareholders</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">These amounts represent liabilities related to the acquisitions made by the Company which
are not yet due. Accounts payable to selling shareholders are presented as current liabilities unless payment is not due within 12 months
after the reporting period. They are recognized initially at their fair value and subsequently measured at amortized cost using the effective
interest method, except for Unidom&#8217;s contingent consideration, which are measured at fair value through profit or loss.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions</a></td>
<td class="text"><p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_zZIZ3k16lWq" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>k) <span id="xdx_863_z8hhHpR9iShj">Provisions</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Provisions are recognized when the Company has a present obligation (legal or constructive)
as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation,
and a reliable estimate can be made of the amount of the obligation. The expense relating to a provision is presented in the consolidated
statement of income and other comprehensive income, net of any reimbursement, when applicable.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DividendsPolicyExplanatory', window );">Dividends</a></td>
<td class="text"><p id="xdx_846_ecustom--DividendsPolicyExplanatory_z4XB3eIoFmW9" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>l) <span id="xdx_868_ziIjYpKBuMu9">Dividends</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company recognizes a liability to pay a dividend when the distribution is authorized
and the distribution is no longer at the discretion of the Company.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">In respect to the consolidated statement of changes in equity, the amount corresponding
to the non-controlling interest over the dividends declared are recognized directly in equity.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LaborAndSocialObligationsPolicyExplanatory', window );">m) Labor and social obligations</a></td>
<td class="text"><p id="xdx_84F_ecustom--LaborAndSocialObligationsPolicyExplanatory_zxb4E5jJMoLk" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>m) Labor and social obligations</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Labor and social obligations are expensed as the related service is provided. A liability
is recognized for the amount expected to be paid if the Company has a present legal or constructive obligation to pay this amount as a
result of past service provided by the employee and the obligation can be estimated reliably.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SharebasedPaymentsPolicyExplanatory', window );">Share-based payments</a></td>
<td class="text"><p id="xdx_840_ecustom--SharebasedPaymentsPolicyExplanatory_z8dI0b79l0uc" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>n) <span id="xdx_864_zoOEZryg441a">Share-based payments</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Certain key executives of the Company receive compensation in the form of share-based payments,
which includes stock options and restricted stock units (&#8220;RSUs&#8221;), whereby the executives render services as consideration
for equity instruments (equity-settled transactions).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The expense of equity-settled transactions is determined by the fair value at the date
when the grant is made using an appropriate valuation model.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">That expense is recognized in selling, general and administrative expenses, together with
a corresponding increase in equity (Share-based compensation reserve), over the period in which the service (the vesting period) and,
where applicable, the performance conditions are fulfilled. The cumulative expense recognized for equity-settled transactions at each
reporting date until the vesting date reflects the extent to which the vesting period has expired and the Company&#8217;s best estimate
of the number of equity instruments that will ultimately vest. The expense or credit in the consolidated statement of income and other
comprehensive income for a period represents the movement in cumulative expense recognized as at the beginning and end of that period.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Service and non-market performance conditions are not considered when determining the grant
date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Company&#8217;s best estimate of
the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value.
No expense is recognized for awards that do not ultimately vest because non-market performance and/or service conditions have not been
met.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">When the terms of an equity-settled award are modified, the minimum expense recognized
is the grant date fair value of the unmodified award, provided the original vesting terms of the award are met. An additional expense,
measured as at the date of modification, is recognized for any modification that increases the total fair value of the share-based payment
transaction, or is otherwise beneficial to the employee. Where an award is cancelled by the entity or by the counterparty, any remaining
element of the fair value of the award is expensed immediately through the consolidated statement of income and other comprehensive income.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"></p>






<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The dilutive effect of outstanding options is reflected as additional share dilution in
the computation of diluted earnings per share.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory', window );">Earnings per share (&#8220;EPS&#8221;)</a></td>
<td class="text"><p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zaCk5ZZBZG3f" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>o) <span id="xdx_864_zZ8xOxplLlol">Earnings per share (&#8220;EPS&#8221;)</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">Basic EPS is calculated by dividing net income attributable to
the owners of the Company by the weighted average number of common shares outstanding during the year.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">Diluted EPS is calculated by dividing net income attributable
to the owners of the Company by the weighted average number of common shares outstanding during the year plus the weighted average number
of shares that would be issued on conversion of all potential shares with dilutive effects.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Diluted earnings per share are computed including stock options granted to key management
using the treasury shares method when the effect is dilutive. The Company has the stock options and RSUs plans in the category of potentially
dilutive shares.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue from contracts with customers</a></td>
<td class="text"><p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zsxlo93REFmb" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>p) <span id="xdx_862_znolsG70TOC">Revenue from contracts with customers</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company's revenue consists primarily of tuition fees charged for medical courses. The
Company also generates revenue from tuition fees for other undergraduate and graduate courses, administrative and application fees, education
content (e-books), subscription of medical practice solutions services (including medical content platforms, clinical decision-making
application, among other solutions), electronic medical records and marketing for pharmaceutical industry.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Revenue recognition transferred over time </i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Revenue from tuitions, subscription of medical practice solutions services and electronic
medical records are recognized over time when services are rendered to the customer and the Company satisfies its performance obligation
under the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services.
Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Revenues are recognized when services are rendered to the customer and the performance
obligation is satisfied.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Revenue recognition transferred at point in time</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Revenue from sale of education content, online platforms, administrative and application
fees and marketing for pharmaceutical industry are recognized at the point in time when control of the asset or services is transferred
to the customer. For education content this is generally on delivery of the goods and for e-books this is generally on the permission
to access the digital content is granted. The Company considers whether there are other promises in the contract that are separate performance
obligations to which a portion of the transaction price needs to be allocated.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company concluded that it is the principal in its revenue arrangements.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company assesses collectability on a portfolio basis prior to recording revenue. Generally,
in respect to undergraduate programs students cannot re-enroll for the next academic session without satisfactory resolution of any past-due
amounts. If a student withdraws from an institution, the Company's obligation to issue a refund depends on the refund policy at that institution
and the timing of the student's withdrawal. Generally, the refund obligations are reduced over the course of the academic term.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Trade receivables</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Trade receivables represent the Company&#8217;s right to an amount of consideration that
is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to the accounting policies
in &#8216;Financial instruments - initial recognition and measurement&#8217;.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><br/>
</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Advances from customers</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Advances from customers (a contract liability) are the obligation to transfer services
to a customer for which the Company has received consideration (or an amount of consideration is due) from the customer, as a result of
pre-paid tuition, digital education content and mobile app subscription for digital medical content received from customers and is recognized
separately in current liabilities, when the payment is received. Advances from customers are recognized as revenue when the Company performs
all obligations related to the contract, over the contract term.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Taxes</a></td>
<td class="text"><p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zsryXjCHEuZ4" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>q) <span id="xdx_86B_zrrlk29DYpr">Taxes</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">The Company&#8217;s subsidiaries
in the undergraduate segment joined the PROUNI (<i>Programa Universidade para Todos</i> - University for All Program) program, which is
a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number of student
enrollment for low-income students, and benefits from the exemption of the following federal taxes:</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">&#8226; Income taxes and social contribution</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">&#8226; PIS and COFINS</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">The regulation of PROUNI defines
that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS. For income from other teaching
activities, PIS and COFINS are charged at rates of <span id="xdx_90F_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_ztNcdqw4ON9l" title="Tax rate">0.65</span>% and <span id="xdx_907_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zC9xkyEeVZ9a" title="Tax rate">3.00</span>%, respectively, and for non-teaching activities, PIS is charged at a
rate of <span id="xdx_900_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zoCXn44uATTk" title="Tax rate">1.65</span>% and to COFINS at <span id="xdx_90F_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zK1bbo498xRk" title="Tax rate">7.6</span>%.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Current income taxes</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"><span style="background-color: white">Current income taxes were calculated
based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service, specifically regarding the PROUNI
program, which allows exemption of these taxes from traditional and technological graduation activities.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Current income tax assets and liabilities are measured at the amount expected to be recovered
from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively
enacted at the reporting date.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Management periodically evaluates positions taken in the tax returns with respect to situations
in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000">Additional social contribution from Organization for Economic Co-operation
and Development (&#8220;OECD&#8221;) Pillar Two global minimum tax</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On December 27, 2024, Law 15,079/2024 was enacted, establishing the implementation of the
OECD&#8217;s Pillar Two global minimum tax in Brazil, effective as of January 1, 2025.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Law 15,079/2024 aligns the Brazilian tax legislation to the OECD&#8217;s Global Anti-Base
Erosion (GloBE) rules by introducing a minimum effective taxation of <span id="xdx_903_eifrs-full--AverageEffectiveTaxRate_pip0_dp_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zucbD4LVguS4" title="Effective tax">15</span>% through an additional Social Contribution on Net Profit (&#8220;CSLL&#8221;).
This regulation applies to multinational groups within the scope of the OECD&#8217;s GloBE rules, specifically those whose ultimate parent
entity reported annual consolidated revenues of at least &#8364;<span id="xdx_904_ecustom--ConsolidatedRevenues_pn6n6_uEUR_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zek9BvydSMM8" title="Consolidated revenues">750</span> million in at least two of the four fiscal years immediately preceding
the year under review.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The rules are designed to ensure that the additional CSLL qualifies as a Qualified Domestic
Minimum Top-up Tax (QDMTT) under the OECD Inclusive Framework, subjecting Brazilian entities to a minimum tax rate of <span id="xdx_902_ecustom--MinimumTaxRate_pip0_dp_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zmTxN1IaWFhi" title="Minimum tax rate">15</span>%.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">On March 28, 2025, the Company filed a writ of mandamus with the Brazilian Federal Court
challenging the enforceability of the newly enacted additional CSLL. The legal proceeding is grounded on constitutional and statutory
arguments, and is waiting for court decision to prevent the collection of the additional CSLL, which is scheduled to be disbursed in 2026
with respect to the 2025 fiscal year.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>




<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Considering that there is no court decision to date, the Company has recorded the amount
calculated in accordance with current legislation. The additional income tax expense as a result of Law 15,079/2024 for the year ended
December 31, 2025 was R$<span id="xdx_901_eifrs-full--CurrentTaxLiabilitiesCurrent_iI_pn3n3_c20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_z2JcxqbBhCvd" title="Income taxes payable">109,458</span>, accounted as income taxes payable in the current liabilities. The Company has applied the exception to
recognizing and disclosing information about deferred tax assets and liabilities related to Pillar Two income taxes.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Deferred tax</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Deferred tax is provided using the liability method on temporary differences between the
tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Deferred tax liabilities are recognized for all taxable temporary differences, except:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%">&#8226; When the deferred tax liability arises from the initial recognition of goodwill
or an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the
accounting profit nor taxable profit or loss and does not give rise to equal taxable and deductible temporary differences;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; In respect of taxable temporary differences associated with investments in subsidiaries,
associates and interests in joint arrangements, when the timing of the reversal of the temporary differences can be controlled and it
is probable that the temporary differences will not reverse in the foreseeable future.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Deferred tax assets are recognized to the extent that it is probable that taxable profit
will be available against which the deductible temporary differences, and the carry forward of unused tax credits and unused tax losses
can be utilized, except when the deferred tax asset relating to the deductible temporary difference arises from the initial recognition
of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the
accounting profit nor taxable profit or loss and does not give rise to equal taxable and deductible temporary differences.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The carrying amount of deferred tax assets is reviewed at each reporting date and reduced
to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax
asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it
has become probable that future taxable profits will allow the deferred tax asset to be recovered.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company offsets deferred tax assets and deferred tax liabilities if and only if it
has a legally enforceable right to set off current tax assets and current tax liabilities and the deferred tax assets and deferred tax
liabilities relate to income taxes levied by the same taxation authority by the same taxable entity.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Sales tax</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Expenses and assets are recognized net of the amount of sales tax, except:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%">&#8226; When the sales tax incurred on a purchase of assets or services is not recoverable
from the taxation authority, in which case, the sales tax is recognized as part of the cost of acquisition of the asset or as part of
the expense item, as applicable;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; When receivables and payables are stated with the amount of sales tax included.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory', window );">Treasury shares</a></td>
<td class="text"><p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForTreasurySharesExplanatory_zDR93UtWX9Xl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>r) <span id="xdx_86E_zynYSJo8MDId">Treasury shares</span></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Own equity instruments that are reacquired (treasury shares) are recognized at cost and
deducted from equity. No gain or loss is recognized in profit or loss on the purchase, sale, transfers under the share-based payments,
issue or cancellation of the Company&#8217;s own equity instruments. Any difference between the carrying amount and the consideration,
if reissued, is recognized in the share premium.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>2.4 Changes in accounting policies and disclosures</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>New and amended standards and interpretations</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The following standards and amendments, which are effective for annual periods beginning
on or after January 1, 2025, have been issued but are not applicable to the Company&#8217;s operations or consolidated financial statements.</p>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i></i></p>








<table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_z2lTvolZvvn6" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 5)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_8B6_zJFR57MUEwle" style="display: none">Schedule
    of changes in accounting policies and disclosures</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Amendment / standard</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS21Member_z8XUqBspnetd" title="Standard">Lack of exchangeability &#8211; Amendments to IAS 21</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90C_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--LackOfExchangeabilityAmendmentsToIAS21Member_gIFDONOCIAP-GOL_ztYW68Jhqa63" title="Description">In August 2023, the IASB issued amendments to IAS 21 The Effects of Changes in Foreign Exchange
    Rates to specify how an entity should assess whether a currency is exchangeable and how it should determine a spot exchange rate when
    exchangeability is lacking. The amendments also require disclosure of information that enables users of its financial statements to understand
    how the currency not being exchangeable into the other currency affects, or is expected to affect, the entity&#8217;s financial performance,
    financial position and cash flows.</span></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C00_gIFDONOCIAP-GOL_ztsgVBnFLjv"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments had no impact on the Company&#8217;s accounting policies, which remained
    unchanged in these  consolidated financial statements for the year ended December 31, 2025.</p></div></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Standards issued but not yet effective</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 24%; text-indent: -21.3pt">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The new and amended standards and interpretations that are issued, but not yet effective,
up to the date of issuance of the Company&#8217;s  consolidated financial statements are presented below. The Company has not
early adopted any other standard, interpretation or amendment that has been issued but is not yet effective. The Company intends to adopt
these new and amended standards and interpretations, if applicable, when they become effective.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Amendment / standard</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_zLUko5jePu6c" title="Standard">Classification and Measurement of Financial Instruments - Amendments to IFRS 9 and IFRS 7</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-BAAR_zkjlISvlyJ43" title="Description">In May 2024, the IASB issued Amendments to the Classification and Measurement of Financial
    Instruments (Amendments to IFRS 9 and IFRS 7), which:</span></p>
    <div id="xdx_C0A_gIFDONOCIAP-BAAR_zkExD70L8Wu5"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Clarifies that a financial liability is derecognized on the &#8216;settlement date&#8217;,
    i.e., when the related obligation is discharged, cancelled, expires or the liability otherwise qualifies for derecognition. It also introduces
    an accounting policy option to derecognize financial liabilities that are settled through an electronic payment system before settlement
    date if certain conditions are met</p></div>
    <div id="xdx_C05_gIFDONOCIAP-BAAR_zl5EKJmYu0D6"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Clarified how to assess the contractual cash flow characteristics of financial assets
    that include environmental, social and governance (ESG)-linked features and other similar contingent features</p></div>
    <div id="xdx_C0C_gIFDONOCIAP-BAAR_zXZjZnmDVoka"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Clarifies the treatment of non-recourse assets and contractually linked instruments</p></div>
    <div id="xdx_C08_gIFDONOCIAP-BAAR_zGNTWdsE70dd"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Requires additional disclosures in IFRS 7 for financial assets and liabilities with
    contractual terms that reference a contingent event (including those that are ESG-linked), and equity instruments classified at fair value
    through other comprehensive income</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0A_gIFDONOCIAP-BAAR_zITb02JpFPWc"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Entities can early adopt the amendments that relate to the classification of financial assets plus the related disclosures and
    apply the other amendments later.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0F_gIFDONOCIAP-BAAR_z0cxvEBa6aYf"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</p></div></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_zZMM05VKXtCd" title="Standard">Annual Improvements to IFRS Accounting Standards - Volume 11</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_gIFDONOCIAP-WCSGRG_zybD7ZfXRgpk" title="Description">In July 2024, the IASB issued Annual Improvements to IFRS Accounting Standards - Volume
    11. The following is a summary of the topics subject to amendments from the Annual Improvements to IFRS Accounting Standards - Volume
    11:</span></p>
    <div id="xdx_C0A_gIFDONOCIAP-WCSGRG_zxAD1eGVVtBh"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 1 First-time Adoption of International Financial Reporting Standards</p></div>
    <div id="xdx_C0D_gIFDONOCIAP-WCSGRG_znk2wakMtSe1"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 7 Financial Instruments: Disclosures: Gain or Loss on Derecognition</p></div>
    <div id="xdx_C0F_gIFDONOCIAP-WCSGRG_zliiiu9lVw48"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Guidance on implementing IFRS 7 Financial Instruments: Disclosures</p></div>
    <div id="xdx_C05_gIFDONOCIAP-WCSGRG_zGd4UI1Blmv8"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 9 Financial Instruments</p></div>
    <div id="xdx_C01_gIFDONOCIAP-WCSGRG_zx4B8x3qLari"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 10 Consolidated Financial Statements</p></div>
    <div id="xdx_C00_gIFDONOCIAP-WCSGRG_z9bOzr2sDbL1"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IAS 7 Statement of Cash Flows</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C05_gIFDONOCIAP-WCSGRG_zvrWub3MXcHg"><p style="font: 7.5pt Nunito Sans; margin: 0">These amendments are effective for annual periods beginning on or after January 1, 2026.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C05_gIFDONOCIAP-WCSGRG_z4adLiUXIh56"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</p></div></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_z7y593ZhC2Fd" title="Standard">Nature-dependent Electricity Contracts &#8211; Amendments to IFRS 9 and IFRS 7</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90B_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-NDD_zo9W1bJrgfR1" title="Description">In December 2024, the IASB issued Contracts Referencing Nature-dependent Electricity (Amendments
    to IFRS 9 and IFRS 7), clarifying the application of the &#8216;own-use&#8217; requirements; permitting hedge accounting if these contracts
    are used as hedging instruments; and adding new disclosure requirements to enable investors to understand the effect of these contracts
    on a company&#8217;s financial performance and cash flows.</span></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0B_gIFDONOCIAP-NDD_zJ4HQK4N9f39"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Early adoption is permitted, but will need to be disclosed.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C00_gIFDONOCIAP-NDD_zUqyDVEPe8tk"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</p></div></td></tr>
  </table>



<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_zjKS3Rce4spl" title="Standard">IFRS 18 &#8211; Presentation and Disclosure in Financial Statements</span></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_908_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_gIFDONOCIAP-XTV_zJYW1fCYY9l7" title="Description">In April 2024, the IASB issued IFRS 18, which replaces IAS 1 Presentation of Financial Statements.
    IFRS 18 introduces new requirements for presentation within the statement of income, including specified totals and subtotals. Furthermore,
    entities are required to classify all income and expenses within the statement of income into one of five categories: operating, investing,
    financing, income taxes and discontinued operations, whereof the first three are new.</span></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0C_gIFDONOCIAP-XTV_z0z3tJ4qoMj5"><p style="font: 7.5pt Nunito Sans; margin: 0">It also requires disclosure of management-defined performance measures, subtotals of income
    and expenses and includes new requirements for aggregation and disaggregation of financial information based on the identified &#8220;roles&#8221;
    of the primary financial statements (PFS) and the notes.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C07_gIFDONOCIAP-XTV_zDB2Ec8H07d5"><p style="font: 7.5pt Nunito Sans; margin: 0">In addition, narrow-scope amendments have been made to IAS 7 Statement of Cash Flows, which
    include changing the starting point for determining cash flows from operations under the indirect method, from &#8216;profit or loss&#8217;
    to &#8216;operating profit or loss&#8217; and removing the optionality around classification of cash flows from dividends and interest.
    In addition, there are consequential amendments to several other standards.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0E_gIFDONOCIAP-XTV_z7Lw8rr9h7P2"><p style="font: 7.5pt Nunito Sans; margin: 0">IFRS 18, and the amendments to the other standards, is effective for reporting periods beginning
    on or after January 1, 2027 and must be applied retrospectively. Early adoption is permitted and must be disclosed.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C04_gIFDONOCIAP-XTV_zwXw9WdU0HY3"><p style="font: 7.5pt Nunito Sans; margin: 0">The Company is currently working to identify all IFRS 18 impacts on the consolidated financial
    statements.</p></div></td></tr>
  </table>
<p id="xdx_8A7_zQ4teMoATgy2" style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b>2.5 Significant accounting judgments, estimates and assumptions</b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The preparation of the Company&#8217;s consolidated financial statements requires management
to make judgments, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the accompanying
disclosures. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment to the carrying
amount of assets or liabilities affected in future periods. Accounting estimates and judgments are continually evaluated and are based
on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revisions to estimates are recognized prospectively.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Other disclosures relating to the Company&#8217;s exposure to risks and uncertainties include:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; Financial instruments risk management objectives and policies - Note 12.4</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#8226; Sensitivity analysis - Note 12.4.1</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><b><i>Estimates and assumptions</i></b></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The key assumptions about the future and other key sources of estimated uncertainty as
of the reporting date that include a significant risk of a material adjustment to the carrying amounts of assets and liabilities within
the next financial year, are described below. The Company based its assumptions and estimates on parameters available when the consolidated
financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market
changes or circumstances that arise and that are beyond the Company&#8217;s control. Such changes are reflected in the assumptions when
they occur.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Identification and fair-value measurement of assets and liabilities
acquired in a business combination</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Business combinations are accounted for using the acquisition method. Such method requires
recognizing and measuring the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree.
The Company, as the acquirer, must classify or designate the identifiable assets and liabilities assumed on the basis of its own contractual
terms, economic conditions, operating and accounting policies and other relevant conditions as at the acquisition date. Moreover, the
acquisition method required the fair value measurement of contingent consideration liabilities, when applicable, such as the Unidom consideration
conditioned upon the maintenance of the authorization of the 175 operating medical school seats. Such assessments require judgments from
the Company on the methods used to determine the fair value of the consideration transferred, including contingent consideration, assets
acquired and liabilities assumed, including valuation techniques that may require prospective financial information inputs.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Impairment of non-financial assets</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Impairment exists when the carrying amount of an asset or CGU or group of CGUs exceeds
its recoverable amount, defined as the higher of its fair value less costs of disposal and its value in use. The fair value less costs
of disposal calculation is based on data available from binding sales transactions, conducted at arm&#8217;s length, for similar assets
or observable market prices less incremental costs of disposing of the asset. The value in use calculation is based on a discounted cash
flow model (&#8220;DCF&#8221; model). The cash flows are derived from the budget for the next five years and do not include restructuring
activities to which the Company has not yet committed or significant future investments that will enhance the performance of the assets
of the CGU being tested. The recoverable amount is sensitive to the discount rate used for the DCF model as well as to expected future
cash-inflows and the growth rate used for extrapolation purposes.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">These estimates are most relevant to goodwill and indefinite lived intangible assets recognized
by the Company. The key assumptions used to determine the recoverable amount for each CGU, including a sensitivity analysis, are disclosed
and further explained in Note 11.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>






<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Provision for legal proceedings</i></p>
<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Provisions for labor, tax, and civil risks are recorded for all legal proceedings that
represent probable losses. The assessment of the probability of loss includes the evaluation of available evidence, such as recent court
decisions and the opinion of the Company's internal and external legal counsel, the nature of the proceedings, and past experience.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Provisions are reviewed and adjusted to account for changes in circumstances, such as new
matters or court rulings.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Share-based compensation</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">Estimating fair value for share-based payment transactions requires determination of the
most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of
the most appropriate inputs to the valuation model including the expected life of the share option, volatility and dividend yield and
making assumptions about them. For the measurement of the fair value of equity-settled transactions, the Company uses the Binomial model.
The assumptions and models used for estimating fair value for share-based payment transactions are disclosed in Note 14.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Leases - Estimating the incremental borrowing rate</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company cannot readily determine the interest rate implicit in the lease, therefore,
it uses its incremental borrowing rate (IBR) to measure lease liabilities. The IBR is the rate of interest that the Company would have
to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use
asset in a similar economic environment. The IBR therefore reflects what the Company &#8216;would have to pay&#8217;, which requires estimation
when no observable rates are available (such as for subsidiaries that do not enter into financing transactions) or when they need to be
adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary&#8217;s functional currency).</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The Company estimates the IBR using observable inputs (such as market interest rates) when
available and is required to make certain entity-specific estimates.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_BusinessCombinationsAndGoodwillPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_BusinessCombinationsAndGoodwillPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureMaterialAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureMaterialAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendsPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendsPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LaborAndSocialObligationsPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LaborAndSocialObligationsPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharebasedPaymentsPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharebasedPaymentsPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 46<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Corporate information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureCorporateInformationAbstract', window );"><strong>Corporate Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of identifiable assets and liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_pn3n3_zcYr6u6Ajd7e" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Corporate information (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BE_zb9ZC67chhye" style="display: none">Schedule of identifiable assets and liabilities</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 83%; padding-right: 3.5pt; padding-left: 3.5pt"><b>Assets</b></td>
    <td style="white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cash and cash equivalents</td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zMBwY30cG01d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash and equivalents">3</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Property and equipment</td>
    <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zKzqNGtR8Svb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Property and equipment">2,683</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Intangible assets - Licenses with indefinite useful life</td>
    <td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zFDVFctUyYC" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Intangible assets">99,628</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zTRAGlXx52D" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>102,314</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Liabilities</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Trade payables</td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zghtsN3MIQGj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables">71</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Loans and financing</td>
    <td id="xdx_98A_ecustom--LoansAndFinancingAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zUSmDaDYT1n" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing">2,243</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_981_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zTD15KcIWIZj" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities recognised as of acquisition date"><b>2,314</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Total net assets</b></td>
    <td id="xdx_981_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zb7lxY6QyGvh" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total net assets"><b>100,000</b></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCorporateInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCorporateInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureMaterialAccountingPoliciesAbstract', window );"><strong>Material Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock', window );">Schedule of company&#8217;s subsidiaries and associate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zcj6lFUACLga" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B5_zynWLHfQVvif" style="display: none">Schedule of company&#8217;s subsidiaries and associate</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Direct and indirect interest</b></span></td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; width: 260px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Name</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 165px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Main activities</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 106px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Location</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Investment type</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 94px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2025</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 95px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2024</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Afya Participa&#231;&#245;es S.A. (&#8220;Afya Brazil&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90F_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zv5MTqPDekz" title="Principal activities">Holding</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zPQvVIsNbXAl" title="Location">Nova Lima - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zPhxWSLNNFYb" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z3dUyGsNEGAj" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zykxwE9jljwb" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto Tocantinense Presidente Ant&#244;nio Carlos Porto S.A. - (&#8220;ITPAC Porto&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zN6FDhFYiu8g" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_z6JBWPXjcXY9" title="Location">Porto Nacional - TO</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zHBIi1cxo8R2" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zIegwX923u7h" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_z9fDNnTtrmke" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto Tocantinense Presidente Ant&#244;nio Carlos S.A. - (&#8220;ITPAC Aragua&#237;na&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zeVY7TuruoTj" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zmJbPAAr1cw2" title="Location">Aragua&#237;na - TO</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zDNrwBhUTADl" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zBxnAE9RObwa" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_z7lLtAtqjHJ5" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Uni&#227;o Educacional do Vale do A&#231;o S.A. - (&#8220;UNIVA&#199;O&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zb1MPrkWtBj7" title="Principal activities">Medicine undergraduate degree program</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zkBKk14iQtJ3" title="Location">Ipatinga - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_ztAaXWaBOmXk" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zq7PR9YcZf4l" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z3hzjt4buVzc" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#8220;IPTAN&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zKEFurG6PIJk" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_z34RwQCvWmkg" title="Location">S&#227;o Jo&#227;o Del Rei - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zC6MdwGisMA3" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zYYLghJr7UPh" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_z3Vs4M6uzCu8" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A. (&#8220;IESVAP&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zxk0We0LsPTa" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zIGxc588gUV3" title="Location">Parna&#237;ba - PI</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_909_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zP79vi4r5u25" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zLKyjBMsY4q" title="Direct and indirect interest of subsidiary">80</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zqRuGSlSR3c5" title="Direct and indirect interest of subsidiary">80</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Centro de Ci&#234;ncias em Sa&#250;de de Itajub&#225; S.A. (&#8220;CCSI&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90C_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_znpmsbq0xH48" title="Principal activities">Medicine undergraduate degree program</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zRwHby9YAzig" title="Location">Itajub&#225; - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z4hzcx6IE5V5" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zQRvYSVGO8l1" title="Direct and indirect interest of subsidiary">75</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zqvLSDfXd139" title="Direct and indirect interest of subsidiary">75</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto de Ensino Superior do Piau&#237; S.A. (&#8220;IESP&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zj3jTfZwlLji" title="Principal activities">Undergraduate and graduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_ztDnmW1MZkv1" title="Location">Teresina - PI</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zdGWxYEdRXe1" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_znSqGAUxHmSh" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zSkFjQ6kWxcj" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">FADEP - Faculdade Educacional de Pato Branco Ltda. (&#8220;FADEP&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zHlgWNtXlL1i" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_z56ixa0OF8z1" title="Location">Pato Branco - PR</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zngY2U4fEaAc" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zSdYtCrll9g3" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zmiMsMyM8Z15" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto Educacional Santo Agostinho S.A. (&#8220;FASA&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zEGxfStAXTxh" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zj2TQxkuupd1" title="Location">Montes Claros - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zItnb4CAdbX7" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zyjNud4yCVT9" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zjp7cIlEofq4" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Instituto Paraense de Educa&#231;&#227;o e Cultura Ltda. (&#8220;IPEC&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zdUIpIjzmRrf" title="Principal activities">Medicine undergraduate degree program</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_900_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_z6DdHhd4Xmza" title="Location">Marab&#225; - PA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zr87jn2JTCXc" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zcjdzX044wOl" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zqUtS4RqBPee" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Sociedade Universit&#225;ria Redentor S.A. (&#8220;UniRedentor&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_909_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_za0Q6jdh9pak" title="Principal activities">Undergraduate and graduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z6VCJPMUsi1f" title="Location">Itaperuna - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zD4jfTDq71j6" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zIVijpv6VO43" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z07aHHXjuuVe" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Centro de Ensino S&#227;o Lucas Ltda. (&#8220;UniSL&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zIhMyuuAKua2" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zhZhAnIDU9E1" title="Location">Porto Velho - RO</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zQRwvub5eTIa" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zgs2o9pY6Cmh" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zlDyTrQuIJg4" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Sociedade de Educa&#231;&#227;o, Cultura e Tecnologia da Amaz&#244;nia S.A. - (&#8220;FESAR&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zcHSROCuWJM7" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zkf4DTOFkzh" title="Location">Reden&#231;&#227;o - PA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zMBjyVKo2kyl" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zOZfqEkf5plj" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zVx33b2Z4SE5" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Centro Superior de Ci&#234;ncias da Sa&#250;de Ltda. (&#8220;FCMPB&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zPJljvKsTKY3" title="Principal activities">Medicine undergraduate degree program</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_ztgmy5KQZoL4" title="Location">Jo&#227;o Pessoa - PB</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zixh7etHMAs6" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zhDdMICkhOpj" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zZUHbrDe94Qb" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">iClinic Desenvolvimento de Software Ltda. (&#8220;iClinic&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zKFuIzZDoVdb" title="Principal activities">Electronic Medical Record, Clinical Management System</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zYO3zEnLze0d" title="Location">Ribeir&#227;o Preto - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zKMoyotrxxZc" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zq9uudZ4Wu6a" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Medicinae Solutions S.A. (&#8220;Medicinae&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z1SofMPFPlO2" title="Principal activities">Healthcare payments and financial services</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zMOTdOw90wve" title="Location">Rio de Janeiro - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z4wGxD0Is5yf" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zaNYs0QSrnjl" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Medical Harbour Aparelhos M&#233;dico Hospitalares e Servi&#231;os em Tecnologia Ltda. (&#8220;Medical Harbour&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90C_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zo5yxSCK4fcb" title="Principal activities">Educational health and medical imaging</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_z2EEbHDK43ib" title="Location">Florian&#243;polis - SC</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zXJnbFmJVJmf" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_ztoRoXecM1yk" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zUZr9aZ30Ma9" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Cliquefarma Drogarias Online Ltda. (&#8220;Cliquefarma&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90F_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_z2RckVYleRaf" title="Principal activities">Online platform</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zzCRFheNCFXj" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zf65vluVhRD7" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zYEwq8HrPsHl" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Shosp Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_907_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zh0RFfKTO0h" title="Principal activities">Electronic Medical Record, Clinical Management System</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zZWb9ilnXxli" title="Location">Rio de Janeiro - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zqPVdXTXS105" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zT1Zp6mEFvBd" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Sociedade Padr&#227;o de Educa&#231;&#227;o Superior Ltda. (&#8220;UnifipMoc&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_z6QpELqIicFk" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zKBF85Ceu6yg" title="Location">Montes Claros - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zsVdwsb7WRs7" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zDX65F3q2SW7" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zkeolXEixvxa" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Companhia Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura (&#8220;Unigranrio&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zJnkuIR4kAHf" title="Principal activities">Undergraduate and graduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zXNJn29mYOTi" title="Location">Duque de Caxias - RJ</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_905_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zSWG75kMUPD5" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zdOLXBhYnt9c" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_ztanF7UNSRe8" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">RX PRO Solu&#231;&#245;es de Tecnologia Ltda. (&#8220;RX PRO&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z6RLl3YkQS22" title="Principal activities">Marketing for pharmaceutical industry</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zBQeFbmIbl35" title="Location">S&#227;o Paulo - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90B_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zrtDD8tW8W01" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z47hLNellYa9" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Quasar Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#8220;Glic&#8221;) (ii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_904_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zPT1tFS9JPw2" title="Principal activities">Patient physician relationship</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zHZNuhCaxm9i" title="Location">Barueri - SP</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90F_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zcLRpP7Rhg04" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zTW4DPdvqT39" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#8220;DelRey&#8221;)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zBVWD5GCo51f" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zQDYBK2PrV13" title="Location">Macei&#243; - AL</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zJ6HBLFonPJg" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zNsgE3mViXsd" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zhodVdvKA1zj" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Unidom Participa&#231;&#245;es S.A. (&#8220;Unidom&#8221;) (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_90B_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_z2lVPdfMwtl3" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_zpQPon9Ub1i3" title="Location">Salvador - BA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_za1ZaEX8hrqh" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_zh9cTJCFCe95" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Institui&#231;&#227;o Baiana de Ensino Superior Ltda. (&#8220;IBES&#8221;) (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_z1Saz06WwUnl" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zICkxiPWlCa1" title="Location">Salvador - BA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zxUSj3cpH6pg" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zuMSslRL2ALl" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zH5T8zK1k4Cj" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">SESSA - Sociedade de Educa&#231;&#227;o Superior do Semi-&#193;rido Ltda. (&#8220;SESSA&#8221;) (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zv50ehHClrB7" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zpgyLpqvA3Jf" title="Location">Ribeira de Pombal - BA</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zHSATSvTBwKi" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zMQpJh7s9Wka" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zsoKyXtcwfZ2" title="Direct and indirect interest of subsidiary">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Faculdade Masterclass Ltda. (&#8220;FUNIC&#8221;) (iii)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zJLSGdjCKky1" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_ziHX1c9NEdm1" title="Location">Contagem - MG</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zNS2Ibga4wN3" title="Investment type">Subsidiary</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zWJegr0aqI2c" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Uni&#227;o Educacional do Planalto Central S.A. (&#8220;UEPC&#8221;) </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_905_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zAfk9pP4wRYg" title="Principal activities">Undergraduate degree programs</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zVDZlkJfGQFf" title="Location">Bras&#237;lia - DF</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zRtK0fl0ttEa" title="Investment type">Associate</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_z9brl7z0M5E4" title="Direct and indirect interest of subsidiary">30</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zBQdakn8im8b" title="Direct and indirect interest of subsidiary">30</span>%</span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0; color: #212121">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="background-color: white">(i)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="background-color: white">Unidom was merged with Afya Brazil on January 1, 2025.
As a result, from this date on, Afya Brazil directly controls the Unidom&#8217;s subsidiaries IBES and SESSA.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="background-color: white">(ii)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="background-color: white">Cliquefarma, RX PRO and Glic were merged with Afya Brazil
in August 2025; iClinic, Medicinae and Shosp were merged with Afya Brazil in October 2025.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1%; text-align: right"><span style="color: #212121; background-color: white">(iii)</span></td><td style="width: 5pt"></td><td style="text-align: justify">See Note 1.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock', window );">Schedule of fair values for financial instruments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock_z9Lfc0gZO6z4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 1)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B4_zeQBW9jYaF54" style="display: none">Schedule of fair values for financial
instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr>
    <td style="border: #D0CECE 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Type</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Valuation technique</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Significant unobservable inputs</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Inter-relationship between significant unobservable inputs and fair value measurement</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt">Level 2 - Stock options and Restricted stock units (Note 14)</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zbWrtvEd8R68" title="Valuation technique">Binomial model: The fair value is estimated by utilizing a simulation of possible future share prices, applying regression analysis, as well as comparing at each potential exercise date the discounted risk-neutral expectation of the option payoff if not exercised, and the relevant exercise price.</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt"><span style="font-size: 7.5pt">&#8226; Expected volatility (December 31, 2025: <span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_ztMnLOO8bvX1" title="Expected volatility">24</span>% to <span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0zfhCwyYU7e" title="Expected volatility">44</span>%; December 31, 2024: <span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvl0bVSRFkng" title="Expected volatility">32</span>% to <span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEOHbmVlM4Rg" title="Expected volatility">45</span>%).</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p id="xdx_982_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zrOsTuY8y0Lh" style="font: 7.5pt Nunito Sans; margin: 0" title="Inter-relationship between significant unobservable inputs and fair value measurement">The estimated fair value</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">would increase (decrease) if the expected volatility were higher (lower).</p></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt">Level 3 - Contingent consideration (Accounts payable to selling shareholders - Note 12.2.3)</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90E_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zxIHtVQ8f3Fl" title="Valuation technique">Probability-weighted cash flows: This valuation technique considers the probability-weighted expectation of future cash flow.</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; Expected cash flows (December 31, 2025: R$<span id="xdx_907_ecustom--ExpectedCashFlows_pn3n3_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zwL4LiFAutuh" title="Expected cash flows">325,150</span>;
    December 31, 2024: R$<span id="xdx_908_ecustom--ExpectedCashFlows_pn3n3_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zLTVYXh0aIzi" title="Expected cash flows">314,953</span>).</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; Probability of disbursement (December 31, 2025 and
    2024: <span id="xdx_908_ecustom--ProbabilityOfDisbursement_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zJOYzkxwFFK5" title="Probability of disbursement"><span id="xdx_903_ecustom--ProbabilityOfDisbursement_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z0jpMqr4Ciue" title="Probability of disbursement">100</span></span>%).</p></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p id="xdx_985_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zPlc1vzSNOy9" style="font: 7.5pt Nunito Sans; margin: 0" title="Inter-relationship between significant unobservable inputs and fair value measurement">The estimated fair value would increase (decrease) if:</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; the expected cash flows were higher (lower); or</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt">&#8226; the probability rate were lower (higher).</p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfMeasurementAndGainsAndLossesTableTextBlock', window );">Schedule of measurement and gains and losses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfMeasurementAndGainsAndLossesTableTextBlock_zis2ByfBzXce" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 2)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_zC3j1pqBL6wc" style="display: none">Schedule
    of measurement and gains and losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr>
    <td style="border: #AEAAAA 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Financial assets at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">FVTPL</p></td>
    <td style="border-top: #AEAAAA 1pt solid; border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; width: 78%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_908_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVTPLMember_zdt0sle527kc" title="Financial assets">These assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.</span></span></td></tr>
  <tr>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Financial assets at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">amortized cost</p></td>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_909_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FinancialAssetsAtAmortizedCostMember_z95KI8zi7w8d" title="Financial assets at amortized cost">These assets are subsequently measured at amortized cost under the effective interest method. The gross carrying amount is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.</span></span></td></tr>
  <tr>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Debt investments at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">FVOCI</p></td>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_904_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCIMember_zvzFySxDw8Gc" title="Debt investments">These assets are subsequently measured at fair value. Interest income calculated under the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.</span></span></td></tr>
  <tr>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0">Equity investments at</p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">FVOCI</p></td>
    <td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90B_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCI1Member_zqC4N7c5azq9" title="Equity investments">These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never reclassified to profit or loss.</span></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfEstimatedUsefulLivesTableTextBlock', window );">Schedule of estimated useful lives of the assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_pn3n3_zCa4de18nPW9" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 3)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B8_zyCXjuN9UFLf" style="display: none">Schedule of estimated useful lives of
the assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Building</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_ziGG6APQYSt2" title="Useful lives of assets">25</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Machinery and equipment</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zzWQqZWfoZmi" title="Useful lives of assets">10</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Vehicles</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zCsQwDwpnOQ1" title="Useful lives of assets">5</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Furniture and fixtures</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zc5myiWw2ged" title="Useful lives of assets">10</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">IT equipment</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zRJs7ZnMWgl1" title="Useful lives of assets">5</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Library books</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zMkh1AmfUxWl" title="Useful lives of assets">10</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Leasehold improvements</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDRJaGRRs8Cb" title="Useful lives of assets">1</span> - <span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ztPAUspLZAec" title="Useful lives of assets">30</span> years</td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock', window );">Schedule of estimated useful lives of intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zKBgfLCXIwy8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 4)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BA_zJRQ405AQSG4" style="display: none">Schedule of estimated useful
lives of intangible assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="background-color: rgb(213,234,234)">
    <td style="width: 272px; padding-right: 5.4pt; padding-left: 5.4pt">Customer relationships - medicine</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z01NwOJL9RMi" title="Estimated useful lives of intangible assets">6</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Customer relationships - other courses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--CustomerRelationshipsOtherCoursesMember_zXjMKXoWxuC9" title="Estimated useful lives of intangible assets">4.5</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Software</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--ComputerSoftwareMember_zrOjKogqeteh" title="Estimated useful lives of intangible assets">5</span> years</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Trademarks</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zB1PLffvirPd" title="Estimated useful lives of intangible assets">2</span> - <span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zWHwkdtG4848" title="Estimated useful lives of intangible assets">30</span> years</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Education content, Developed technology and Educational platform</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zQEMtlFWCwaj" title="Estimated useful lives of intangible assets">3</span> - <span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zy0K8Pm1co7e" title="Estimated useful lives of intangible assets">5</span> years</td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory', window );">Schedule of changes in accounting policies and disclosures</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_z2lTvolZvvn6" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 5)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_8B6_zJFR57MUEwle" style="display: none">Schedule
    of changes in accounting policies and disclosures</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr>
    <td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Amendment / standard</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS21Member_z8XUqBspnetd" title="Standard">Lack of exchangeability &#8211; Amendments to IAS 21</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90C_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--LackOfExchangeabilityAmendmentsToIAS21Member_gIFDONOCIAP-GOL_ztYW68Jhqa63" title="Description">In August 2023, the IASB issued amendments to IAS 21 The Effects of Changes in Foreign Exchange
    Rates to specify how an entity should assess whether a currency is exchangeable and how it should determine a spot exchange rate when
    exchangeability is lacking. The amendments also require disclosure of information that enables users of its financial statements to understand
    how the currency not being exchangeable into the other currency affects, or is expected to affect, the entity&#8217;s financial performance,
    financial position and cash flows.</span></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C00_gIFDONOCIAP-GOL_ztsgVBnFLjv"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments had no impact on the Company&#8217;s accounting policies, which remained
    unchanged in these  consolidated financial statements for the year ended December 31, 2025.</p></div></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Standards issued but not yet effective</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 24%; text-indent: -21.3pt">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The new and amended standards and interpretations that are issued, but not yet effective,
up to the date of issuance of the Company&#8217;s  consolidated financial statements are presented below. The Company has not
early adopted any other standard, interpretation or amendment that has been issued but is not yet effective. The Company intends to adopt
these new and amended standards and interpretations, if applicable, when they become effective.</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Amendment / standard</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_90F_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_zLUko5jePu6c" title="Standard">Classification and Measurement of Financial Instruments - Amendments to IFRS 9 and IFRS 7</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-BAAR_zkjlISvlyJ43" title="Description">In May 2024, the IASB issued Amendments to the Classification and Measurement of Financial
    Instruments (Amendments to IFRS 9 and IFRS 7), which:</span></p>
    <div id="xdx_C0A_gIFDONOCIAP-BAAR_zkExD70L8Wu5"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Clarifies that a financial liability is derecognized on the &#8216;settlement date&#8217;,
    i.e., when the related obligation is discharged, cancelled, expires or the liability otherwise qualifies for derecognition. It also introduces
    an accounting policy option to derecognize financial liabilities that are settled through an electronic payment system before settlement
    date if certain conditions are met</p></div>
    <div id="xdx_C05_gIFDONOCIAP-BAAR_zl5EKJmYu0D6"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Clarified how to assess the contractual cash flow characteristics of financial assets
    that include environmental, social and governance (ESG)-linked features and other similar contingent features</p></div>
    <div id="xdx_C0C_gIFDONOCIAP-BAAR_zXZjZnmDVoka"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Clarifies the treatment of non-recourse assets and contractually linked instruments</p></div>
    <div id="xdx_C08_gIFDONOCIAP-BAAR_zGNTWdsE70dd"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Requires additional disclosures in IFRS 7 for financial assets and liabilities with
    contractual terms that reference a contingent event (including those that are ESG-linked), and equity instruments classified at fair value
    through other comprehensive income</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0A_gIFDONOCIAP-BAAR_zITb02JpFPWc"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Entities can early adopt the amendments that relate to the classification of financial assets plus the related disclosures and
    apply the other amendments later.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0F_gIFDONOCIAP-BAAR_z0cxvEBa6aYf"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</p></div></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_901_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_zZMM05VKXtCd" title="Standard">Annual Improvements to IFRS Accounting Standards - Volume 11</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_gIFDONOCIAP-WCSGRG_zybD7ZfXRgpk" title="Description">In July 2024, the IASB issued Annual Improvements to IFRS Accounting Standards - Volume
    11. The following is a summary of the topics subject to amendments from the Annual Improvements to IFRS Accounting Standards - Volume
    11:</span></p>
    <div id="xdx_C0A_gIFDONOCIAP-WCSGRG_zxAD1eGVVtBh"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 1 First-time Adoption of International Financial Reporting Standards</p></div>
    <div id="xdx_C0D_gIFDONOCIAP-WCSGRG_znk2wakMtSe1"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 7 Financial Instruments: Disclosures: Gain or Loss on Derecognition</p></div>
    <div id="xdx_C0F_gIFDONOCIAP-WCSGRG_zliiiu9lVw48"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; Guidance on implementing IFRS 7 Financial Instruments: Disclosures</p></div>
    <div id="xdx_C05_gIFDONOCIAP-WCSGRG_zGd4UI1Blmv8"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 9 Financial Instruments</p></div>
    <div id="xdx_C01_gIFDONOCIAP-WCSGRG_zx4B8x3qLari"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IFRS 10 Consolidated Financial Statements</p></div>
    <div id="xdx_C00_gIFDONOCIAP-WCSGRG_z9bOzr2sDbL1"><p style="font: 7.5pt Nunito Sans; margin: 0">&#8226; IAS 7 Statement of Cash Flows</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C05_gIFDONOCIAP-WCSGRG_zvrWub3MXcHg"><p style="font: 7.5pt Nunito Sans; margin: 0">These amendments are effective for annual periods beginning on or after January 1, 2026.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C05_gIFDONOCIAP-WCSGRG_z4adLiUXIh56"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</p></div></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_z7y593ZhC2Fd" title="Standard">Nature-dependent Electricity Contracts &#8211; Amendments to IFRS 9 and IFRS 7</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_90B_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-NDD_zo9W1bJrgfR1" title="Description">In December 2024, the IASB issued Contracts Referencing Nature-dependent Electricity (Amendments
    to IFRS 9 and IFRS 7), clarifying the application of the &#8216;own-use&#8217; requirements; permitting hedge accounting if these contracts
    are used as hedging instruments; and adding new disclosure requirements to enable investors to understand the effect of these contracts
    on a company&#8217;s financial performance and cash flows.</span></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0B_gIFDONOCIAP-NDD_zJ4HQK4N9f39"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Early adoption is permitted, but will need to be disclosed.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C00_gIFDONOCIAP-NDD_zUqyDVEPe8tk"><p style="font: 7.5pt Nunito Sans; margin: 0">The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.</p></div></td></tr>
  </table>



<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_zjKS3Rce4spl" title="Standard">IFRS 18 &#8211; Presentation and Disclosure in Financial Statements</span></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0"><span id="xdx_908_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_gIFDONOCIAP-XTV_zJYW1fCYY9l7" title="Description">In April 2024, the IASB issued IFRS 18, which replaces IAS 1 Presentation of Financial Statements.
    IFRS 18 introduces new requirements for presentation within the statement of income, including specified totals and subtotals. Furthermore,
    entities are required to classify all income and expenses within the statement of income into one of five categories: operating, investing,
    financing, income taxes and discontinued operations, whereof the first three are new.</span></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0C_gIFDONOCIAP-XTV_z0z3tJ4qoMj5"><p style="font: 7.5pt Nunito Sans; margin: 0">It also requires disclosure of management-defined performance measures, subtotals of income
    and expenses and includes new requirements for aggregation and disaggregation of financial information based on the identified &#8220;roles&#8221;
    of the primary financial statements (PFS) and the notes.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C07_gIFDONOCIAP-XTV_zDB2Ec8H07d5"><p style="font: 7.5pt Nunito Sans; margin: 0">In addition, narrow-scope amendments have been made to IAS 7 Statement of Cash Flows, which
    include changing the starting point for determining cash flows from operations under the indirect method, from &#8216;profit or loss&#8217;
    to &#8216;operating profit or loss&#8217; and removing the optionality around classification of cash flows from dividends and interest.
    In addition, there are consequential amendments to several other standards.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C0E_gIFDONOCIAP-XTV_z7Lw8rr9h7P2"><p style="font: 7.5pt Nunito Sans; margin: 0">IFRS 18, and the amendments to the other standards, is effective for reporting periods beginning
    on or after January 1, 2027 and must be applied retrospectively. Early adoption is permitted and must be disclosed.</p></div>
    <p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>
    <div id="xdx_C04_gIFDONOCIAP-XTV_zwXw9WdU0HY3"><p style="font: 7.5pt Nunito Sans; margin: 0">The Company is currently working to identify all IFRS 18 impacts on the consolidated financial
    statements.</p></div></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureMaterialAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureMaterialAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfEstimatedUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfEstimatedUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfMeasurementAndGainsAndLossesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfMeasurementAndGainsAndLossesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory', window );">Schedule of present assets and liabilities information for the company operating segments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_pn3n3_zSfK3M8sPhth" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Segment information (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B1_zQbCp0YvgGU8" style="display: none">Schedule of present assets and liabilities information for the company operating
segments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Nunito Sans; margin: 0"><b>As of December 31, 2025</b></p>
    <p style="font: 8pt Nunito Sans; margin: 0"></p></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment balances)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Total assets</b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z0IDAw4jHPS7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>8,959,964</b></span></td>
    <td id="xdx_984_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhKKNNM0mfFh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>245,697</b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zt62qO9dNl94" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>166,238</b></span></td>
    <td id="xdx_987_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zAkTkn5CCkM2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>9,371,899</b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zrcDiT5vxQq7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>(13,965)</b></span></td>
    <td id="xdx_98B_eifrs-full--Assets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpLEGHzzo0h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>9,357,934</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Current assets</span></td>
    <td id="xdx_988_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5ruOyFRbYZ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">1,765,066</span></td>
    <td id="xdx_987_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsWktpCmqBEh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">92,221</span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zqTUsili2R3e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">98,854</span></td>
    <td id="xdx_980_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrDCgQ9p7n3f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">1,956,141</span></td>
    <td id="xdx_98A_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zn1nKiEvc0fh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">(13,965)</span></td>
    <td id="xdx_985_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3OlXnTazSAe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt"><b>1,942,176</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Non-current assets</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zdSRyzV7O4ub" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">7,194,898</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zXvNrvVOw064" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">153,476</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zt0KShXm39Bk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">67,384</span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zQ0kgMRIFs0l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">7,415,958</span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zXmOyjW5O8ne" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1302">-</span></span></td>
    <td id="xdx_988_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXkvXRg3XHkg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt"><b>7,415,758</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>

<tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Total liabilities and equity</b></span></td>
    <td id="xdx_987_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z8k4ovcS5Ze6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>8,959,964</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zAZL4gjm31d1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>245,697</b></span></td>
    <td id="xdx_981_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zp6bbVklz9M" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>166,238</b></span></td>
    <td id="xdx_98E_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zmpCTizm3iA" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>9,371,899</b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zi8vcYcx4Z7e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>(13,965)</b></span></td>
    <td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFbMO9lRNXR8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>9,357,934</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Current liabilities</span></td>
    <td id="xdx_982_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z85owyqqFng4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">689,074</span></td>
    <td id="xdx_98A_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWTM74SMwxQ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">113,729</span></td>
    <td id="xdx_98F_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zTbEXVx7qBYf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">95,203</span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zyrbRY78RQK2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">898,006</span></td>
    <td id="xdx_981_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z207V2dhGwz3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">(13,965)</span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zT8CalH6QWTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt"><b>884,041</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Non-current liabilities</span></td>
    <td id="xdx_984_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjWmzGn2dUM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">3,474,357</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zoGfUrXntxud" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">84,581</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z1ePEVfZS3zj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">23,770</span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrGojnsC3PA9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">3,582,708</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zdJ9PqmWvoGh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1338">-</span></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zArxUHsHbOXj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt"><b>3,582,708</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Equity</span></td>
    <td id="xdx_981_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_ziroTHJOayVh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">4,796,533</span></td>
    <td id="xdx_981_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zGhPN4u1NvPc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">47,387</span></td>
    <td id="xdx_988_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zGFb5X6QadB6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">47,265</span></td>
    <td id="xdx_984_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zhfAzQa4E3Gd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">4,891,185</span></td>
    <td id="xdx_982_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zDEckoRGCa6e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1350">-</span></span></td>
    <td id="xdx_984_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ztwzYi3L8Vdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt"><b>4,891,185</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Other disclosures</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Investment in associate (i) </span></td>
    <td id="xdx_980_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5ZTAlPIIs53" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt">46,518</span></td>
    <td id="xdx_989_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zehfvGCMRDdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1356">-</span></span></td>
    <td id="xdx_983_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zj4fDftvGKB" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrrJviKeuFf9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt">46,518</span></td>
    <td id="xdx_98D_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zqxt4PrBlQSg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1362">-</span></span></td>
    <td id="xdx_984_eifrs-full--InvestmentsInAssociates_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAyOm9Dm5eq1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><b>46,518</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Capital expenditures (ii)</span></td>
    <td id="xdx_983_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zMFtw1eAT74g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">281,313</span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zt9of9eKhbxd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">79,139</span></td>
    <td id="xdx_986_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLflSDjO8589" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">43,559</span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvCDQ3yj7Vf6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">404,011</span></td>
    <td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zBPhcNbewun6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1374">-</span></span></td>
    <td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z259tjoX5We5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt"><b>404,011</b></span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Investment in UEPC is included in non-current assets in the statement of financial position.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Capital expenditures consider the acquisitions of property and equipment and intangible assets.</td>
</tr></table>

<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>As of December 31, 2024</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment balances)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Total assets</b></span></td>
    <td id="xdx_986_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z2LF7qhSBzxj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>8,393,185</b></span></td>
    <td id="xdx_984_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zKNwGOVhAeEi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>274,318</b></span></td>
    <td id="xdx_986_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zj8H9cNmymC6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>170,624</b></span></td>
    <td id="xdx_98A_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZB2DUmNhWb8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>8,838,127</b></span></td>
    <td id="xdx_985_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zT10ExxrPNTe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>(8,588)</b></span></td>
    <td id="xdx_989_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYGEHCRy542b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-size: 8pt"><b>8,829,539</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Current assets</span></td>
    <td id="xdx_98D_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zMlTmuiPL2rf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">1,443,566</span></td>
    <td id="xdx_985_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWnchmTlTxYb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">71,893</span></td>
    <td id="xdx_981_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z1WeQM32Mrn6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">82,913</span></td>
    <td id="xdx_983_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZUrdzsrET4i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">1,598,372</span></td>
    <td id="xdx_98B_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zRPrBX1zhByc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt">(8,588)</span></td>
    <td id="xdx_988_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmSFAkViuqu7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-size: 8pt"><b>1,589,784</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Non-current assets</span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zT3ESAIVxst8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">6,949,619</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzQaPambi3k9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">202,425</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zPRkQMeNyNYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">87,711</span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zG9IfrjjMKdb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt">7,239,755</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zjPJR9QjWyyj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1410">-</span></span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbQozNjcQtk5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-size: 8pt"><b>7,239,755</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Total liabilities and equity</b></span></td>
    <td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zSINTn1sKckl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>8,393,185</b></span></td>
    <td id="xdx_98A_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_ze8A2jR6MO4l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>274,318</b></span></td>
    <td id="xdx_980_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ze9u4pRFomQg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>170,624</b></span></td>
    <td id="xdx_987_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zk6ElIR49Vxa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>8,838,127</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z8GuJNtkzVN4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>(8,588)</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5HoUTMapXYi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-size: 8pt"><b>8,829,539</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Current liabilities</span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_znjxdRN6a5U6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">884,705</span></td>
    <td id="xdx_989_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFKaB9kwmC34" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">188,489</span></td>
    <td id="xdx_98F_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_znc5WnXKg6u1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">75,589</span></td>
    <td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziO6npa9sii7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">1,148,783</span></td>
    <td id="xdx_982_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z0b1OG8aE1K" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt">(8,588)</span></td>
    <td id="xdx_983_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zix4bAYOMO9i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-size: 8pt"><b>1,140,195</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Non-current liabilities</span></td>
    <td id="xdx_98C_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zUUPvH6fuvJ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">3,279,846</span></td>
    <td id="xdx_98F_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhPCSJP4dF16" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">75,619</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zRPJ8U3p1EI8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">23,296</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z61dd8Z1aZRk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt">3,378,761</span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z2QqWhlxFCt5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1446">-</span></span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zZVMZo4q2Qok" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-size: 8pt"><b>3,378,761</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Equity</span></td>
    <td id="xdx_982_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zYve7SyWjGOi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">4,228,634</span></td>
    <td id="xdx_98B_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z9YIrw4PmNbf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">10,210</span></td>
    <td id="xdx_98A_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zir62vAHUIWa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">71,739</span></td>
    <td id="xdx_98A_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zqmZX2clNO3e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt">4,310,583</span></td>
    <td id="xdx_980_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zYnOtQwrVGbd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1458">-</span></span></td>
    <td id="xdx_98A_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8uEO0BCIWX2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-size: 8pt"><b>4,310,583</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Other disclosures</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Investment in associate (i) </span></td>
    <td id="xdx_988_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zbZbsQxEf44d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt">54,442</span></td>
    <td id="xdx_98F_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhCTgtN1C07" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1464">-</span></span></td>
    <td id="xdx_98B_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zFlZypv1ZCnj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1466">-</span></span></td>
    <td id="xdx_98A_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zVo3r5KpYT1l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt">54,442</span></td>
    <td id="xdx_980_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_znpS8Xd6eDe7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1470">-</span></span></td>
    <td id="xdx_98F_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUHE5RSocYvg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-size: 8pt"><b>54,442</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Capital expenditures (ii)</span></td>
    <td id="xdx_98A_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zYKkEYUkXOL5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">301,368</span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zkIyr5bk91Hi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">53,162</span></td>
    <td id="xdx_981_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zFQPaakrKWm3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">38,085</span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zIqMjhB79Fpl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt">392,615</span></td>
    <td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zNPGZORnzzP5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1482">-</span></span></td>
    <td id="xdx_985_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z7KWjBhTkMt" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-size: 8pt"><b>392,615</b></span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Investment in UEPC is included in non-current assets in the statement of financial position.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Capital expenditures consider the acquisitions of property and equipment and intangible assets.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">Schedule of statements of income for the company&#8217;s operating segments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_pn3n3_zlV9c1HZlyQb" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Segment information (Details 1)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B3_zxYSJIfbBJ1f" style="display: none">Schedule of statements of income for the company&#8217;s operating
segments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 8pt Nunito Sans; margin: 0"><b>December 31, 2025</b></p>
    <p style="font: 8pt Nunito Sans; margin: 0"></p></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">External customer</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zy1tUwUyUADa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">3,255,426</span></td>
    <td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zQvcf43sFzzh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">275,705</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zvIutQCpXlt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">166,124</span></td>
    <td id="xdx_98B_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdjy8E85eiYh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">3,697,255</span></td>
    <td id="xdx_98A_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zaQhbCuBZEo5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1498">-</span></span></td>
    <td id="xdx_98D_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2q8YukRrlTb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">3,697,255</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zzGxg9eDhtj3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1502">-</span></span></td>
    <td id="xdx_98C_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zr7PPPYIPRte" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">8,766</span></td>
    <td id="xdx_98E_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zxmcM7nJqfX6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">5,199</span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zm5pDuZo4B5k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">13,965</span></td>
    <td id="xdx_982_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3CfNyKrDkk4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">(13,965)</span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zkvmdqCvG7N2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1512">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zgtJHgIdWoR7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>3,255,426</b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z4Vq3CArKr47" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>284,471</b></span></td>
    <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zWttKLWZHCg7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>171,323</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z2shCJp1fm26" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>3,711,220</b></span></td>
    <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zUF2XQoQc3ui" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>(13,965)</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zL1PzHZprqyf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>3,697,255</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zttXNdJA7Ne5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,176,785)</span></td>
    <td id="xdx_980_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zaaUNiUOwLdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(96,346)</span></td>
    <td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zaNhLMvx5trd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(54,729)</span></td>
    <td id="xdx_989_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvQqLCRbz6l9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,327,860)</span></td>
    <td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3tjdhLuAIqg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">13,965</span></td>
    <td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUX0Chni0r53" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,313,895)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zJa7u2x11Kab" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>2,078,641</b></span></td>
    <td id="xdx_98D_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdWK02lcT0E8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>188,125</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zakNsS8XEcP6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>116,594</b></span></td>
    <td id="xdx_984_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zBmJbPpzL24k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>2,383,360</b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zgZaWjp2sqR7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1546">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ze3cy6RpNyJc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>2,383,360</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">SG&amp;A expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zsQ8RFW64ox4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"><span style="font-size: 8pt">(1,113,065)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Allowance for expected credit losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98F_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zahZHIYhqjUi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Allowance for expected credit losses"><span style="font-size: 8pt">(57,090)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--OtherIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWBfPaRz5ou6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-size: 8pt">18,762</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--OtherGainsLosses_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfYI2NA4CPsb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-size: 8pt">(18,857)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGTvmiEeHLW1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-size: 8pt"><b>1,213,110</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--FinanceIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcipjbWqr7y1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-size: 8pt">194,943</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_986_ecustom--FinanceExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zjkmgaeSWpyi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-size: 8pt">(561,024)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Share of profit of equity-accounted investee, net of tax</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2yROqgskKyh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-size: 8pt">13,916</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zhMcSR9VyNk7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-size: 8pt"><b>860,945</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zV45npikcmc9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-size: 8pt">(92,502)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98C_eifrs-full--ProfitLoss_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfm1WQsz8uXg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-size: 8pt"><b>768,443</b></span></td></tr>
  </table>
<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>December 31, 2024</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">External customer</span></td>
    <td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zBWIPxykQn17" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">2,895,692</span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0v4MTsDbOn5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">251,636</span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ztCPWSJNQJYe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">157,001</span></td>
    <td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z7d0c2hb9tag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">3,304,329</span></td>
    <td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNqSPqzGiQQ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1580">-</span></span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zT183rga31pk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">3,304,329</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_989_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zWR3FkKS8Kr1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1584">-</span></span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znuytYBCVInh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">3,802</span></td>
    <td id="xdx_98D_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zgpyI2upzxo4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">4,786</span></td>
    <td id="xdx_986_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zT4GubTFGLPh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">8,588</span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zJ7uZZ2lYezl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">(8,588)</span></td>
    <td id="xdx_98D_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zaNYPQ6oli6c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1594">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_985_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5btkVQHaLZ7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>2,895,692</b></span></td>
    <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zPdikYW8WLI3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>255,438</b></span></td>
    <td id="xdx_989_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zVyTc1f4ZgSj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>161,787</b></span></td>
    <td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zU7yPuVCQYs7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>3,312,917</b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zGojnr9sWC7f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>(8,588)</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXQb1fTzg4t4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>3,304,329</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Cost of services</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_znE9qbRRraVa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,086,081)</span></td>
    <td id="xdx_983_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsaiV1k55mOj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(96,180)</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zc0n48tL8g51" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(41,930)</span></td>
    <td id="xdx_988_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zarm0F2DYLYk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,224,191)</span></td>
    <td id="xdx_983_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zz1btLHuoW1h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">8,588</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxWaofoge8a4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,215,603)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjocHooAiff1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>1,809,611</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zDbRwSwPM77g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>159,258</b></span></td>
    <td id="xdx_984_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z85fEFwzuQ1g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>119,857</b></span></td>
    <td id="xdx_98C_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zD1GCLbqr7Dc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>2,088,726</b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zbBcl2EFfeTl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1628">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zP7vcl50NgJ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt"><b>2,088,726</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">SG&amp;A expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_988_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z86ld6yA3Jqi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"><span style="font-size: 8pt">(1,008,427)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Allowance for expected credit losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98D_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zj7Hy5K1VuA8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Allowance for expected credit losses"><span style="font-size: 8pt">(60,894)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98F_eifrs-full--OtherIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zd2jDp8LO9s1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-size: 8pt">13,299</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_986_eifrs-full--OtherGainsLosses_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zkvma7C067ke" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-size: 8pt">(20,591)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zRmRQ6KIqTDb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-size: 8pt"><b>1,012,113</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--FinanceIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3zT0jnjfS4l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-size: 8pt">111,283</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_ecustom--FinanceExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zo4LY5KrVD4k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-size: 8pt">(458,742)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Share of profit of equity-accounted investee, net of tax</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCYR34rtwRUc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-size: 8pt">11,737</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--ProfitLossBeforeTax_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zHHNFga5ouQ5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-size: 8pt"><b>676,391</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAgfxqJd7dc2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-size: 8pt">(27,471)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--ProfitLoss_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMVIHIivPYfi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-size: 8pt"><b>648,920</b></span></td></tr>
  </table>





<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>December 31, 2023</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Undergraduate</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Continuing education</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Medical practice solutions</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total reportable segments</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Elimination (inter-segment transactions)</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">External customer</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zPZsxW6js1ua" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">2,511,018</span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRqBPrXPZg27" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">227,181</span></td>
    <td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zJpTQYr3a1S" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">137,714</span></td>
    <td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zKImPt23t0P8" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">2,875,913</span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zn1QYQ4ucN76" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1663">-</span></span></td>
    <td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z56QTe3JQgWd" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-size: 8pt">2,875,913</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zxlpN3cYRQlc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1667">-</span></span></td>
    <td id="xdx_98F_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zchtRXv5rWx5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">8,649</span></td>
    <td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLyHp2DSpUpj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">2,568</span></td>
    <td id="xdx_98B_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJWcVSALG3c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">11,217</span></td>
    <td id="xdx_985_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z1uCXgRR1I9l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt">(11,217)</span></td>
    <td id="xdx_985_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z1TupQJ4Swcj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1677">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Revenue</b></span></td>
    <td id="xdx_983_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zXim7TUBLj72" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>2,511,018</b></span></td>
    <td id="xdx_98B_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z35nJmQgwIZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>235,830</b></span></td>
    <td id="xdx_984_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zlLcmYX4vLqg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>140,282</b></span></td>
    <td id="xdx_987_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zobFF2vSoOOf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>2,887,130</b></span></td>
    <td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zoJd3B4Ud28g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>(11,217)</b></span></td>
    <td id="xdx_981_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zl9DyY9LCiNl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-size: 8pt"><b>2,875,913</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Cost of services</span></td>
    <td id="xdx_982_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zf8SGki3wZw2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(997,973)</span></td>
    <td id="xdx_981_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0gI8uZCvl57" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(91,915)</span></td>
    <td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zChfF1NJAS06" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(31,142)</span></td>
    <td id="xdx_986_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zE0lr67YA9H6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,121,030)</span></td>
    <td id="xdx_98D_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zP80YVjk7mJd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">11,217</span></td>
    <td id="xdx_986_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zDqY2iSHyKLh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-size: 8pt">(1,109,813)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Gross profit</b></span></td>
    <td id="xdx_985_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zo7UraGR0W41" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>1,513,045</b></span></td>
    <td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zMHxzgoP5ZG" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>143,915</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ziC6iTIJ76ba" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>109,140</b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zME1wBXQsR7e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>1,766,100</b></span></td>
    <td id="xdx_985_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAIY8FIQDERd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1711">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5ZvizdvLe0f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-size: 8pt"><b>1,766,100</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">SG&amp;A expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_988_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zQHot6fEnyY5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"><span style="font-size: 8pt">(940,132)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Allowance for expected credit losses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98F_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYXewfwlwK7e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Allowance for expected credit losses"><span style="font-size: 8pt">(74,552)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_982_eifrs-full--OtherIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIbmjr5sk3Ul" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-size: 8pt">53,206</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Other expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_981_eifrs-full--OtherGainsLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zY77776koTFh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-size: 8pt">(37,561)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Operating income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_983_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJzgZW3z9pDb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-size: 8pt"><b>767,061</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_987_eifrs-full--FinanceIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zZjvOdgB9aJ2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-size: 8pt">110,642</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Finance expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_ecustom--FinanceExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zm2Os64kyz8k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-size: 8pt">(457,616)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Share of profit of equity-accounted investee, net of tax</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98F_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zeFV66qrZtch" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-size: 8pt">9,495</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Income before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlQ06Zi28mki" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-size: 8pt"><b>429,582</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt">Income taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_98D_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdh1hrDVjKJb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-size: 8pt">(24,166)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 8pt"><b>Net income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td id="xdx_980_eifrs-full--ProfitLoss_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAFo3aRZMmLb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-size: 8pt"><b>405,416</b></span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock', window );">Schedule of fair values of the identifiable assets acquired and liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock_zDEMKjZWgrsa" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Business combinations (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B0_zkeUb1kFaXh5" style="display: none">Schedule of fair values of the identifiable assets acquired and liabilities</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 83%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Unidom</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Assets</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Cash and cash equivalents</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zK0MlxswDzBa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash and equivalents"><span style="font-size: 7.5pt">3,272</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Trade receivables</span></td>
    <td id="xdx_987_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zcU0pQXR2Obi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables"><span style="font-size: 7.5pt">9,368</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Advances</span></td>
    <td id="xdx_984_ecustom--AdvancesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zmZBJD7RLy0f" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Advances"><span style="font-size: 7.5pt">94</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Recoverable taxes</span></td>
    <td id="xdx_983_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zhZSTIbMNsOh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Recoverable taxes"><span style="font-size: 7.5pt">82</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Other assets</span></td>
    <td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z8qSPvR4Wdq8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other assets"><span style="font-size: 7.5pt">854</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Indemnification assets</span></td>
    <td id="xdx_983_ecustom--IndemnificationAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zTjUKZA5C853" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Indemnification assets"><span style="font-size: 7.5pt">7,185</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Property and equipment</span></td>
    <td id="xdx_989_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z5BbVzqzsVzk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Property and equipment"><span style="font-size: 7.5pt">5,709</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Rights-of-use assets</span></td>
    <td id="xdx_98B_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zHUXZuYZ6Xr7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Rights-of-use assets"><span style="font-size: 7.5pt">28,989</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Intangible assets</span></td>
    <td id="xdx_98D_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z2nuzWvWX7ef" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Intangible assets"><span style="font-size: 7.5pt">462,042</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zpjqvbbbXa7e" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><span style="font-size: 7.5pt"><b>517,595</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Trade payables</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zzLSYEr6qeC8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables"><span style="font-size: 7.5pt">1,732</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Loans and financing</span></td>
    <td id="xdx_98F_ecustom--LoansAndFinancingAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z9CCZXtMR5a3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing"><span style="font-size: 7.5pt">4,377</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Labor and social obligations</span></td>
    <td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zqcin45llBNc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Labor and social obligations"><span style="font-size: 7.5pt">7,368</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Taxes payable</span></td>
    <td id="xdx_98D_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zZRhWNtwosSj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Taxes payable"><span style="font-size: 7.5pt">5,254</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Other taxes payable (i)</span></td>
    <td id="xdx_98A_ecustom--OtherTaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zrIb79ZxFjA7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other taxes payable"><span style="font-size: 7.5pt">28,274</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Advances from customers</span></td>
    <td id="xdx_983_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zy2y20LMSSRi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Advances from customers"><span style="font-size: 7.5pt">1,234</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Lease liabilities</span></td>
    <td id="xdx_984_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zqb55dTwEBP4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities"><span style="font-size: 7.5pt">28,989</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Provision for legal proceedings</span></td>
    <td id="xdx_984_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z7A2jQo3pOBa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Provision for legal proceedings"><span style="font-size: 7.5pt">7,246</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Other liabilities</span></td>
    <td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zWpajxoyUOi2" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other liabilities"><span style="font-size: 7.5pt">4,393</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98B_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zQqO6n8YhFic" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities recognised as of acquisition date"><span style="font-size: 7.5pt"><b>88,867</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Total identifiable net assets at fair value</b></span></td>
    <td id="xdx_98E_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zWeZWtY8QeG" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-size: 7.5pt"><b>428,728</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Goodwill arising on acquisition</span></td>
    <td id="xdx_987_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zaNykD1C1pt5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill arising on acquisition"><span style="font-size: 7.5pt">192,034</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Purchase consideration transferred</b></span></td>
    <td id="xdx_980_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zy8juCLd7lji" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Purchase consideration transferred"><span style="font-size: 7.5pt"><b>620,762</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Cash paid</span></td>
    <td id="xdx_989_eifrs-full--CashTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zyFGFziSFK81" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash paid"><span style="font-size: 7.5pt">340,773</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Consideration to be transferred</span></td>
    <td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zGbJrEKMUm2j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Consideration to be transferred"><span style="font-size: 7.5pt">279,989</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b><i>Analysis of cash flows on acquisition</i></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transaction costs of the acquisition</span></td>
    <td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20240629__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zNbm8lyzhak8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Transaction costs of the acquisition (included in cash flows from operating activities)"><span style="font-size: 7.5pt">1,793</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Cash paid net of cash acquired with the subsidiary</span></td>
    <td id="xdx_981_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20240629__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zICBVH8O62T" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-size: 7.5pt">337,501</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>Net of cash flow on acquisition </b></span></td>
    <td id="xdx_98C_ecustom--NetOfCashFlowOnAcquisition_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zLCahM7UOSKh" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-size: 7.5pt"><b>339,294</b></span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to deferred tax liabilities arising from transactions prior to Afya&#8217;s acquisition
of Unidom.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfUnidomExplanatory', window );">Schedule of intangible assets acquired unidom</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAcquisitionOfUnidomExplanatory_zj9bALLej2cg" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Business combinations (Details 1)">
  <tr>
    <td><span id="xdx_8B4_z35CnO6fxUci" style="display: none">Schedule
    of intangible assets acquired unidom</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr>
    <td style="border: #D0CECE 1pt solid; width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Intangible assets acquired</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 74%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Valuation technique</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><b>Licenses</b></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"><b>With-and-without method</b></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"><span id="xdx_90C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20240629__20240701__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesAndFranchisesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfUnidomMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--WithAndWithoutMethodMember_zbPtdWQqJRub" title="Valuation technique">The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.</span></p></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 7.5pt"><b>Customer relationships</b></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"><b>Multi-period excess earnings method</b></p>
    <p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"><span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20240629__20240701__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfUnidomMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zxtNXFabTRpd" title="Valuation technique">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfUnidomExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfUnidomExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureCashAndCashEquivalentsAbstract', window );"><strong>Cash And Cash Equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory', window );">Schedule of cash and cash equivalents</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_zJJ6dpRAmAo1" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Cash and cash equivalents (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BD_znVPwdwoRoS3" style="display: none">Schedule of cash and cash equivalents</span></td>
    <td id="xdx_49D_20251231_zBzTqHllkv1k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_498_20241231_zXEsK4Uqjfnh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--Cash_iI_pn3n3_zWH9qacnoI17" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Cash and bank deposits</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">15,470 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">6,078 </td></tr>
  <tr id="xdx_403_eifrs-full--CashEquivalents_iI_pn3n3_zLYIVr4C2oR4" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Cash equivalents</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1,109,911 </td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">904,937 </td></tr>
  <tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_zXIyr34M4Rzf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Cash and cash equivalents</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>1,125,381 </b></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>911,015 </b></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfTradeAndOtherReceivables1Explanatory', window );">Schedule of trade accounts receivable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_zByhnAZtBHNl" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Trade receivables (Details)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BF_z3rvyRXRN7Y8" style="display: none">Schedule of trade accounts receivable</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Tuition fees</td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zPJqv2hIaCL7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">596,568 </td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zxU3kb6OcT1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">488,962 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Educational content (i)</td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zKYDjV68pkHa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">44,679 </td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zHaJpSKmVxA7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">62,194 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">FIES (ii)</td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_z8URSeeVnAqe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">139,158 </td>
    <td id="xdx_988_ecustom--ReceivablesGross_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zEJhmyCsjQ0h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">79,712 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">Educational credits (iii)</td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_z5SF5AF187Kg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">33,399 </td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zKUD0Fp9m9kc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">26,893 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">Mobile app subscription (iv)</td>
    <td id="xdx_989_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zrOUuPQ2sO7c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">21,484 </td>
    <td id="xdx_987_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zQxrS2cTqWvd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">24,223 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">Other</td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zcTwoI5hXHMc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">17,226 </td>
    <td id="xdx_983_ecustom--ReceivablesGross_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zzL5IKSou6e1" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">21,339</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231_zn0Mji0qasyl" style="border-top: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"><b>852,514 </b></td>
    <td id="xdx_985_ecustom--ReceivablesGross_pn3n3_c20241231_zRZEKIkbVCKe" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"><b>703,323 </b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Allowance for expected credit losses</td>
    <td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20251231_zoWUWVhqZfbg" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross">(100,156)</td>
    <td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20241231_zprFL58UFyhc" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="(-) Allowance for doubtful accounts">(71,477)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_989_eifrs-full--TradeReceivables_pn3n3_c20251231_zTk8m9Lgcuzc" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, net"><b>752,358 </b></td>
    <td id="xdx_98D_eifrs-full--TradeReceivables_pn3n3_c20241231_z6vYQIjSpNE3" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, net"><b>631,846 </b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_984_eifrs-full--CurrentTradeReceivables_pn3n3_c20251231_zVXqEOuatfN7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">717,373 </td>
    <td id="xdx_988_eifrs-full--CurrentTradeReceivables_pn3n3_c20241231_z0oHGaUDoDC1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">595,898 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20251231_zMT2yhubKIva" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">34,985 </td>
    <td id="xdx_984_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20241231_zCE1dpgvXXz2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">35,948 </td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 7.5pt Nunito Sans; margin: 0">(i) Related to trade receivables from sales of e-books and medical courses through the Continuing
education&#8217;s platform.</p>

<p style="font: 7.5pt Nunito Sans; margin: 0">(ii) Related to trade receivables from the FIES program, created by the Brazilian federal
government to offer financing to low-income students enrolled in undergraduate programs in private higher education institutions.</p>

<p style="font: 7.5pt Nunito Sans; margin: 0">(iii) Related to the financing programs offered by the Company&#8217;s subsidiaries to its
students.</p>

<p style="font: 7.5pt Nunito Sans; margin: 0">(iv) Related to trade receivables from mobile applications subscriptions for Medical practice
solutions.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory', window );">Schedule of aging of trade accounts receivable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_pn3n3_zs5xJlZzct6g" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Trade receivables (Details 1)">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BD_zWIkavE23pS7" style="display: none">Schedule of aging of trade accounts receivable</span></td>
    <td style="white-space: nowrap; padding-right: -3.35pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: -3.35pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Neither past due nor impaired</td>
    <td id="xdx_989_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z74pHOdCfMXb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">383,887 </td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z7uKZbZUst68" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">327,052</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Past due:</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt">1 to 30 days</td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--NotLaterThanOneMonthMember_zkfaV8fh8q4l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">128,785 </td>
    <td id="xdx_986_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--NotLaterThanOneMonthMember_zmviVnAWAKj9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">97,390</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt">31 to 90 days</td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zZ5lxnu3cKDk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">165,512 </td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zf25PPY6Oxoj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">126,623</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt">91 to 180 days</td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_z36nIiQ1mIQa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">102,369 </td>
    <td id="xdx_985_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zJsqYDFE0QZk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">91,411</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt">More than 180 days</td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanSixMonthsMember_zruq4TDEtiU2" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">71,961 </td>
    <td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanSixMonthsMember_zTJHwVlTMB6i" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable">60,847</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_982_ecustom--ReceivablesGross_iI_pn3n3_c20251231_zpZVFvYk45D5" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"><b>852,514 </b></td>
    <td id="xdx_988_ecustom--ReceivablesGross_iI_pn3n3_c20241231_z91Szi6EAZ1h" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"><b>703,323</b></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory', window );">Schedule of allowance for doubtful accounts</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfAllowanceForDoubtfulAccountsExplanatory_pn3n3_zGQbIUaDMdl3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Trade receivables (Details 2)">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BB_zKnxa853uQm4" style="display: none">Schedule of allowance for doubtful accounts</span></td>
    <td id="xdx_492_20250101__20251231_zlxsu8oloE47" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"></td>
    <td id="xdx_490_20240101__20241231_zz5EE2Z1VW42" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20230101__20231231_z7CsixPwnlOc" style="text-align: center">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AllowanceAccountForCreditLossesOfFinancialAsset_iNS_pn3n3_di_zY658UuznTM9" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><b>Opening balance</b></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(71,477)</b></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(61,398)</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><b>(44,046)</b></td></tr>
  <tr id="xdx_400_ecustom--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_pn3n3_zhURD4FBtsDg" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Additions</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(57,090)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(60,894)</td>
    <td style="vertical-align: bottom; text-align: right">(74,552)</td></tr>
  <tr id="xdx_404_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_pn3n3_zliOtbLDa3V" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Write-offs</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">28,411 </td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">50,815 </td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right">57,200</td></tr>
  <tr id="xdx_405_ecustom--AllowanceAccountForCreditLossesOfFinancialAsset_iNE_pn3n3_di_zVnJI3yuJtl1" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><b>Closing balance</b></td>
    <td style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(100,156)</b></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(71,477)</b></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: bottom; text-align: right"><b>(61,398)</b></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfTradeAndOtherReceivables1Explanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfTradeAndOtherReceivables1Explanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfRelatedPartiesExplanatory', window );">Schedule of balances and transactions with related parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfRelatedPartiesExplanatory_zSXDqJNfgQ96" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Related parties (Details)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B1_zcSadTwFCeD9" style="display: none">Schedule of balances and transactions with related parties</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b>Assets</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Right-of-use assets</td>
    <td id="xdx_98E_ecustom--RightofuseAssetsRelatedPartyTransactions_iI_c20251231_zYLexd68nQL6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets">216,085</td>
    <td id="xdx_981_ecustom--RightofuseAssetsRelatedPartyTransactions_iI_c20241231_zy0T8FcMcVla" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets">205,911</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Trade receivables (i)</td>
    <td id="xdx_986_ecustom--TradeReceivablesRelatedPartyTransactions_iI_c20251231_zrUqgvVdSFse" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables">384 </td>
    <td id="xdx_989_ecustom--TradeReceivablesRelatedPartyTransactions_iI_c20241231_zJY1U6AmhXF2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables">507</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Other assets (ii)</td>
    <td id="xdx_983_ecustom--OtherAssetsRelatedPartyTransactions_iI_c20251231_zGeufvMf3VS5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="-sec-ix-hidden: xdx2ixbrl1944">-</span></td>
    <td id="xdx_98F_ecustom--OtherAssetsRelatedPartyTransactions_iI_c20241231_z80kBkJ6eMs" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets">597</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b></b></td>
    <td id="xdx_98B_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20251231_zg7xEEH9EsXe" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><b>216,469 </b></td>
    <td id="xdx_985_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20241231_zp1oV5skIiE4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><b>207,015</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td id="xdx_989_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_c20251231_zDX9XnJTd2hf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="-sec-ix-hidden: xdx2ixbrl1952">-</span></td>
    <td id="xdx_981_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_c20241231_zDmuIUpe32wa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets">1,010</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td id="xdx_986_ecustom--NoncurrentAssetsOfRelatedParty1_iI_c20251231_zaOfHACm1eVj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets">216,469 </td>
    <td id="xdx_98B_ecustom--NoncurrentAssetsOfRelatedParty1_iI_c20241231_zeVWYYse3vt6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets">206,005</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b>Liabilities</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>

<tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Lease liabilities</td>
    <td id="xdx_984_ecustom--LeaseLiabilitiesRelatedPartyTransactions_iI_c20251231_zJkQvidvM5ek" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">260,790 </td>
    <td id="xdx_981_ecustom--LeaseLiabilitiesRelatedPartyTransactions_iI_c20241231_zvIdrc1Y4JBd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">242,703</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"></td>
    <td id="xdx_989_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20251231_z0yllkSLA3X8" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities"><b>260,790 </b></td>
    <td id="xdx_983_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20241231_z7cF2XbCkej4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities"><b>242,703</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td id="xdx_98B_ecustom--TradeAndOtherCurrentPayableToRelatedParties_iI_c20251231_znJmzXxFyALj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities">9,447 </td>
    <td id="xdx_98D_ecustom--TradeAndOtherCurrentPayableToRelatedParties_iI_c20241231_zYhK5viCAll3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities">6,610</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td id="xdx_989_ecustom--NoncurrenLliabilitiesOfRelatedParty1_iI_c20251231_z0zbCHbkPA66" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities">251,343 </td>
    <td id="xdx_981_ecustom--NoncurrenLliabilitiesOfRelatedParty1_iI_c20241231_z11mbho9Cibh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities">236,093</td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="vertical-align: bottom; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Income (expenses)</b></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">UEPC (i)</td>
    <td id="xdx_98C_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zL1iymVK0qcc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">475 </td>
    <td id="xdx_980_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zPhZU24bYjAj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">517</td>
    <td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zUOjAfFZ9c1" style="vertical-align: top; text-align: right" title="Other income">465</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">EMIVE Patrulha 24 Horas Ltda. (iii)</td>
    <td id="xdx_98B_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zG7SxAT2mYNg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">(7)</td>
    <td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_z9KswejRyaud" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">(7)</td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zHNhvahmJvy9" style="vertical-align: bottom; text-align: right" title="Other income">(6)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Depreciation - Right-of-use assets </td>
    <td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zn3VHH6Zpobe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">(17,637)</td>
    <td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zH9NFlsVwDi1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">(14,639)</td>
    <td id="xdx_984_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zMRoYtgh8d3i" style="vertical-align: bottom; text-align: right" title="Other income">(13,801)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Lease liabilities interest</td>
    <td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_zaScWXa69oOg" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">(30,841)</td>
    <td id="xdx_986_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_z3YsduwcK7r2" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income">(28,343)</td>
    <td id="xdx_988_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_zqDxN6HCkJp2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right" title="Other income">(25,676)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231_zCHGo0wkLxwj" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><b>(48,010) </b></td>
    <td id="xdx_980_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231_zGoNzzgHoj33" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><b>(42,472)</b></td>
    <td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231_z8612BcjTEr6" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right" title="Other income"><b>(39,018)</b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to sales of educational content to UEPC.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to expenses reimbursed by Bertelsmann.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to amounts of expenses related to security services provided by a company of which
one of Afya&#8217;s main shareholders has significant influence.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock', window );">Schedule of key management personnel compensation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_pn3n3_zSdZMQ3s2431" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Related parties (Details 1)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BF_zVDQmnRApgib" style="display: none">Schedule of key management personnel compensation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Short-term employee benefits</td>
    <td id="xdx_98F_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20250101__20251231_zUGipzHxacB6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits">27,160 </td>
    <td id="xdx_983_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20240101__20241231_zwpKDE5fcGMe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits">21,171</td>
    <td id="xdx_98D_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20230101__20231231_zimm1I97VvVe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits">16,979</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Share-based compensation plans</td>
    <td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20250101__20251231_z9zmnHRlOo35" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans">16,193 </td>
    <td id="xdx_980_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20240101__20241231_zw835p9umPS5" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans">19,884</td>
    <td id="xdx_98F_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20230101__20231231_zEedeEiPK7rd" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans">21,380</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_986_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20250101__20251231_zZHuN0dn7xn9" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>43,353 </b></td>
    <td id="xdx_98C_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20240101__20241231_zs5gTLuUXA73" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>41,055</b></td>
    <td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20230101__20231231_ztGiYD60Jr8f" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>38,359</b></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOtherAssetsAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfOtherAssetsTableTextBlock', window );">Schedule of other assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--DisclosureOfOtherAssetsTableTextBlock_zs4DIcva5abd" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Other assets (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B9_z2OLv3BVLdci" style="display: none">Schedule of other assets</span></td>
    <td id="xdx_496_20251231_z5Phrdv9OPHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20241231_zOunPAkIrkA2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_maAzYGA_zJf8wnMyui84" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Indemnification assets - Note 21</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">80,379 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">78,701 </td></tr>
  <tr id="xdx_40D_ecustom--Advances1_iI_pn3n3_maAzYGA_z9LcLSTsnUC6" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Advances</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">40,205 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">35,140 </td></tr>
  <tr id="xdx_40D_ecustom--JudicialDeposits_iI_pn3n3_maAzYGA_z37fgIEFt25g" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Judicial deposits</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">19,274 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">16,938 </td></tr>
  <tr id="xdx_403_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_maAzYGA_zuYRrDVzn6Rf" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Prepaid expenses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">18,070 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">19,761 </td></tr>
  <tr id="xdx_40E_eifrs-full--OtherReceivables_iI_pn3n3_maAzYGA_zr0xWqywJhd" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Other FIES credits</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">6,866 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8,982 </td></tr>
  <tr id="xdx_404_ecustom--ConvertibleLoansFromVentureCapitalInvestments_iI_pn3n3_maAzYGA_zEs4LIJs7uS5" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Convertible loans from venture capital investments</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">13,240 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8,724</td></tr>
  <tr id="xdx_40F_ecustom--Dividend_iI_pn3n3_maAzYGA_zqF8wrlD3Mwe" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Dividends</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">6,287 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1,628</td></tr>
  <tr id="xdx_40E_ecustom--OtherAssets1_iI_pn3n3_maAzYGA_zGpqXbPOVXr9" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Other assets</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">4,106 </td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3,146 </td></tr>
  <tr id="xdx_403_ecustom--Assets1_iTI_pn3n3_mtAzYGA_zfPANBEkonz1" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Total</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>188,427 </b></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>173,020 </b></td></tr>
  <tr id="xdx_40C_ecustom--CurrentAssets1_iI_pn3n3_zhfzmgJcCBW3" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">62,947 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">57,145 </td></tr>
  <tr id="xdx_409_ecustom--NoncurrentAssets1_iI_pn3n3_zRVQVZ1akpgl" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">125,480 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">115,875 </td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in associate (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOfInvestmentsExplanatory', window );">Schedule of investment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfInvestmentsExplanatory_z2kl9Rn7rje3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Investment in associate (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span id="xdx_8B4_zu4Qt0g6a225" style="display: none">Schedule of investment</span></td>
    <td id="xdx_49D_20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zqnkoJsbamWi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_499_20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zoYlHItEqeUa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; width: 66%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentAssets_iI_pn3n3" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Current assets</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">27,686 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">38,122 </td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentAssets_iI_pn3n3" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Non-current assets</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">118,550 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">116,846 </td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentLiabilities_iNI_pn3n3_di_zeESBECtqTxg" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Current liabilities</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(44,726)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(30,049)</td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentLiabilities_iNI_pn3n3_di_z9Ws8PULOF6c" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Non-current liabilities</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(90,394)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(87,388)</td></tr>
  <tr id="xdx_409_ecustom--EquityInAssociate_iI_pn3n3_z8a91wCu2QX7" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Equity</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>11,116 </b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>37,531 </b></td></tr>
  <tr id="xdx_40D_ecustom--CompanyShareInEquity1_iI_pn3n3_zn9naorrrbg3" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Company&#8217;s share in equity - 30%</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3,335 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">11,259 </td></tr>
  <tr id="xdx_40D_eifrs-full--Goodwill_iI_pn3n3" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Goodwill</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">43,183 </td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">43,183 </td></tr>
  <tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_pn3n3_z8PBUEqnbSYf" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Carrying amount of the investment</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>46,518 </b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>54,442 </b></td></tr>
  </table>
<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td id="xdx_490_20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zI5Jr6SexoG3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_495_20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zYbtKW3cmkSh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_493_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zuoGhFuBU248" style="vertical-align: top; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--Revenue_pn3n3_z0y1XeNYNJvg" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Revenue</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">167,525 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">156,984 </td>
    <td style="vertical-align: top; text-align: right">148,042</td></tr>
  <tr id="xdx_40A_eifrs-full--CostOfSales_iN_pn3n3_di_zvnmvssAItbj" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Cost of services</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(79,116)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(72,898)</td>
    <td style="vertical-align: top; text-align: right">(71,282)</td></tr>
  <tr id="xdx_407_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_zNZSVOTFmAb2" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Selling, general and administrative expenses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(32,587)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(30,755)</td>
    <td style="vertical-align: top; text-align: right">(27,646)</td></tr>
  <tr id="xdx_403_ecustom--AllowanceForExpectedCreditLosses_pn3n3_zipcwdcIRnQl" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Allowance for expected credit losses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">445</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(1,587)</td>
    <td style="vertical-align: top; text-align: right">(1,029)</td></tr>
  <tr id="xdx_403_eifrs-full--OtherIncome_pn3n3_zfDVkaSx4Dc" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Other income</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">660 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">212</td>
    <td style="vertical-align: top; text-align: right">179</td></tr>
  <tr id="xdx_401_ecustom--OtherExpense_pn3n3_zon92aCxS0xk" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Other expenses</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(5,111)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(5,326)</td>
    <td style="vertical-align: top; text-align: right">(8,709)</td></tr>
  <tr id="xdx_403_eifrs-full--FinanceIncome_iN_pn3n3_di_z4Jea73MIVnj" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Net finance result</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(3,298)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(4,946)</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">(6,123)</td></tr>
  <tr id="xdx_40F_eifrs-full--ProfitLossBeforeTax_pn3n3_zOwU9iG5Uyye" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Income before income taxes</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>48,518 </b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>41,684 </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"><b>33,432</b></td></tr>
  <tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_z2zaWivufW39" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Income taxes expenses</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(2,132)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(2,560)</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right">(1,782)</td></tr>
  <tr id="xdx_40A_eifrs-full--ProfitLoss_pn3n3_z4YLUkPW6hGg" style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><b>Net income</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>46,386 </b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>39,124 </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"><b>31,650</b></td></tr>

<tr id="xdx_40C_ecustom--CompanyShareOfProfitss_pn3n3_zjD6sH1bfuUh" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><b>Company&#8217;s share of profit, net of tax</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>13,916 </b></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>11,737 </b></td>
    <td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; text-align: right"><b>9,495</b></td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">The movements during the years ended December 31, 2025, 2024 and 2023 are shown below:</p>

<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td id="xdx_49F_20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zAMonWbLKNGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49F_20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z0s46PoweWoi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49F_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zHosBaAYOWSg" style="vertical-align: top; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iS_pn3n3_zXpeuV7ysMNc" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Opening balance</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>54,442 </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>51,834</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><b>53,907</b></td></tr>
  <tr id="xdx_408_eifrs-full--ProfitLossOfAcquiree_pn3n3_zXx3YD2pFwbd" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Share of profit, net of tax</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">13,916 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">11,737</td>
    <td style="vertical-align: top; text-align: right">9,495</td></tr>
  <tr id="xdx_402_ecustom--DividendsReceived1_iS_pn3n3_zgcnlOOMLMXf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Dividends received</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(15,553)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(7,501)</td>
    <td style="vertical-align: top; text-align: right">(9,900)</td></tr>
  <tr id="xdx_40C_eifrs-full--DividendsReceived_iN_pn3n3_di_zt8IrViKEAWl" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Dividends receivable - Other assets</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(6,287)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(1,628)</td>
    <td style="vertical-align: top; text-align: right">(1,668)</td></tr>
  <tr id="xdx_40E_eifrs-full--InvestmentsInAssociates_iE_pn3n3_zLBYCfm882Xc" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><b>Closing balance</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>46,518 </b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>54,442</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; text-align: right"><b>51,834</b></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfInvestmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfInvestmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of detailed information about property, plant and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_z0iSFzr0zwc" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Property and equipment (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BB_zmsYtSvRd34d" style="display: none">Schedule of detailed information about property, plant and
    equipment</span></td>
    <td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_zwYUrrhnbzh4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zxETs61Yb0ja" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BD_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zGe1upplAu79" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BF_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_znnKO0XEL8Oe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zAGJbXCv7eR5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zMbMf1OcmPn" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_zrAwjHBjQ5D3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zlmbygeONabc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zTdynmPJzWn2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_4B1_zmji0Ti1d7fh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Building</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Machinery and equipment</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 4%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Lands</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Vehicles</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Furniture and fixtures</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>IT equipment</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Library books</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Leasehold improvements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Construction in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-size: 7.5pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Cost</span></b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_ziP1XOH45Ed6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of January 1, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>91,857</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>100,390</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>18,852</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>1,053</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>90,712</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>68,593</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>37,362</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>145,846</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>86,688</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>641,353</b></span></td></tr>
  <tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zc2ZFEQDlYq8" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">96</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">20,071</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2267">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">776</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">17,914</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">21,135</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">985</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">49</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">57,409</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">118,435</span></td></tr>
  <tr id="xdx_433_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zxIHAyZ8oJUa" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Business combination</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2276">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">7,729</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2278">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2279">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">4,384</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">734</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,329</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">10,741</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">63</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">24,980</span></td></tr>
  <tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zvhrdeWTQZTh" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2287">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(9,411)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2289">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(475)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(1,443)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(7,979)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(7,788)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(286)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2295">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(27,382)</span></td></tr>
  <tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zAZY9kK1NL9l" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,279</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,202</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2300">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2301">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(708)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">327</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2304">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">108,098</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(110,198)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2307">-</span></span></td></tr>
  <tr id="xdx_431_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zJGAS6c2Q7y3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>93,232</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>119,981</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>18,852</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>1,354</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>110,859</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>82,810</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>31,888</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>264,448</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>33,962</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>757,386</b></span></td></tr>
  <tr id="xdx_434_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_z6Fv5AGZJoh7" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,003 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">29,195 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2322">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">130 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">21,582 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">25,945 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,293 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">2,001 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">55,775 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">136,924 </span></td></tr>
  <tr id="xdx_43B_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zrX5LI0H0eJj" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Business combination</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">2 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">2,528 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2333">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2334">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">289 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">736 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">372 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,782 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2339">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">5,709</span></td></tr>
  <tr id="xdx_43B_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zV63u24LOlQa" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2342">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(2,071)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2344">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(42)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(7,050)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(1,154)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2348">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2349">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2350">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(10,317)</span></td></tr>
  <tr id="xdx_435_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zfLlynfE5ZH3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">5,129 </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(226)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2355">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2356">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(862)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">480 </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2359">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">41,182 </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(45,703)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2362">-</span></span></td></tr>
  <tr id="xdx_436_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zsPoJeuzZSc1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>99,366 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>149,407 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>18,852 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>1,442 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>124,818 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>108,817 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>33,553 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>309,413 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>44,034 </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>889,702 </b></span></td></tr>
  <tr id="xdx_432_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zTCKgONU2NJh" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">121</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">28,301</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2377">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2378">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">28,575</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">24,204</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,178</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">2,812</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">80,823</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">166,014</span></td></tr>
  <tr id="xdx_436_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zD29JwIf9CAg" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2386">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2387">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2388">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(435)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(1,220)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(2,536)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(80)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(6,781)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(7)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(11,059)</span></td></tr>
  <tr id="xdx_438_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zeGk2KRZ6wv3" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">9,015</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">275</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2399">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2400">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,110</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(754)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2403">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">46,018</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(55,664)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2406">-</span></span></td></tr>
  <tr id="xdx_43B_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zDQ3xGNwvJra" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025
</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>108,502</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>177,983</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>18,852</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>1,007</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>153,283</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>129,731</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>34,651</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>351,462</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>69,186</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>1,044,657</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Depreciation</span></b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr id="xdx_43C_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zDMPSvGf2xIk" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of January 1, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(5,751)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(20,630)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2421">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>288</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(10,349)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(21,837)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(22,888)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(18,099)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2427">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(99,266)</b></span></td></tr>
  <tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zTvC1GdZ3F58" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Depreciation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(4,242)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(14,900)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2432">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(325)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(12,556)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(13,286)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(3,327)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(26,271)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2438">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(74,907)</span></td></tr>
  <tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zKXWCylEBpyf" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">118</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">6,684</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2443">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">235</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">2,528</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">8,254</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">7,563</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">90</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2449">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">25,472</span></td></tr>
  <tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z8613PIdGmRl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">&#160;Transfer </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">196</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">3</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2454">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2455">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2456">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(3)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2458">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(196)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2460">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2461">-</span></span></td></tr>
  <tr id="xdx_43F_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zkIY1XQdd3S2" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(9,679)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(28,843)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2465">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>198</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(20,377)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(26,872)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(18,652)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(44,476)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2471">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(148,701)</b></span></td></tr>
  <tr id="xdx_431_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zkUgUvQzxGz5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Depreciation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(4,188)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(17,684)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2476">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(377)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(12,778)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(15,608)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(3,058)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(36,604)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2482">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(90,297)</span></td></tr>
  <tr id="xdx_439_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zk3FgCiDsY4l" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2485">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,491 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2487">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">42 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">4,593 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,150 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2491">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">502 </span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2493">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">7,778 </span></td></tr>
  <tr id="xdx_43F_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zfDGhv0Tsvo5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(95)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(74)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2498">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2499">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">482 </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(165)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2502">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(148)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2504">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2505">-</span></span></td></tr>
  <tr id="xdx_43C_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zLDi6SY0Wsf7" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(13,962)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(45,110)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(137)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(28,080)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(41,495)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(21,710)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(80,726)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2515">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(231,220)</b></span></td></tr>
  <tr id="xdx_439_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zcgAwGVCOnzi" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Depreciation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(4,962)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(18,197)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2520">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(304)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(15,989)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(20,514)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(3,002)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(46,981)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2526">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">(109,949)</span></td></tr>
  <tr id="xdx_437_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zsgrJ6fvsOTb" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2529">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">881</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2531">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">301</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,055</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">1,545</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">80</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">4,135</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2537">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt">7,997</span></td></tr>
  <tr id="xdx_43D_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zM31Zgorr3V2" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025 </b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(18,924)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(62,426)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2542">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(140)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(43,014)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(60,464)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(24,632)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(123,572)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2548">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-size: 7.5pt"><b>(333,172)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Net book value</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025 </b></span></td>
    <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zeG5wi5ayLQa" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>89,578</b></span></td>
    <td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zsOXyka6mW4a" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>115,557</b></span></td>
    <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zY2FmOitXgQ2" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>18,852</b></span></td>
    <td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zdoofmCptOc6" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>867</b></span></td>
    <td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zQR10epQM8s7" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>110,269</b></span></td>
    <td id="xdx_980_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_z9xZJ7QBwI2i" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>69,267</b></span></td>
    <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zhF2penUNz8k" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>10,019</b></span></td>
    <td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zgkfNhEEcjFj" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>227,890</b></span></td>
    <td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zixBfGBtVMs" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>69,186</b></span></td>
    <td id="xdx_981_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231_zWe9Kl7kpYZa" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>711,485</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td id="xdx_985_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zxr6OuWoMEOa" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>85,404 </b></span></td>
    <td id="xdx_985_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zmKYfUYtsZCg" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>104,297 </b></span></td>
    <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zrHyaTej3sbl" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>18,852 </b></span></td>
    <td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zrJC1T37K4q5" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>1,305 </b></span></td>
    <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zXnnYLSXLhij" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>96,738 </b></span></td>
    <td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zR2NHAMaeSW8" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>67,322 </b></span></td>
    <td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_z0Hmdv469jE7" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>11,843 </b></span></td>
    <td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zY1gVN2Ldra5" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>228,687 </b></span></td>
    <td id="xdx_980_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zzwE8fr90lea" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>44,034 </b></span></td>
    <td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_iI_pn3n3_c20241231_zFBp3Y48MZE4" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>658,482 </b></span></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to items written-off as result of lack of expectation of future use, in connection
with the Company&#8217;s physical inventory procedures.<br/></td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureIntangibleAssetsAbstract', window );"><strong>Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_pn3n3_z5ARI5S96bml" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Intangible assets (Details)">
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span id="xdx_8B8_zbQK7cpU4OWc" style="display: none">Schedule of intangible assets</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions">&#160;</td></tr>
<tr>
    <td style="width: 26%; padding-right: 1.45pt; padding-left: 1.45pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Goodwill </b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Licenses with indefinite useful life </b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Trademarks</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Customer relationships</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 4%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Software</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Education content</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Developed technology</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Educational platform</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Intangible in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 3%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"><span style="font-size: 7.5pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Cost</span></b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of January 1, 2023</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXLPeIQtsM0j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>1,257,045</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zFOX7zHbajF6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>2,189,814</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXiG8vaOGrc2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>182,060</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKtBCdSmaYpf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>435,816</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zm0zVDYvxPfk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>43,300</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zBOZOPk1hfs2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>69,589</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z538J1iaB7O" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>90,749</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTpnT5DIci02" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>55,697</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRk43MPMsoTk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>14,734</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWuhPKyt0i9j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>1,055</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEFwp1scJDS9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>4,339,859</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLm6yaMH5Lvi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2617">-</span></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1acKodXCkdd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">1,314</span></td>
    <td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeZgI413YVDb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">9,827</span></td>
    <td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4NNN5rP0Ba2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">37,712</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuT2Gema61o1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">23,164</span></td>
    <td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zi72d0PnOjVj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">27,976</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc3RGBSiUd13" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">99,993</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Business combination</span></td>
    <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOwaP2JuCcbl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">75,098</span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoYyj8VkSOc1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">586,263</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLXR21ueOcQ1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">142,451</span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwWf0AjbTBwi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">63</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQcEnD4rS7hc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">803,875</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoubWbHH41c5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(2,235)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_za2kjFiaY8l" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(911)</span></td>
    <td id="xdx_987_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWvFdsOWtpD4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(125)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJSyR6VaMbOe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(3,271)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Remeasurement</span></td>
    <td id="xdx_98F_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsxrWEmRbbV1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Remesurement"><span style="font-size: 7.5pt">2,556</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98B_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z85DLoAnPyQ3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Remesurement"><span style="font-size: 7.5pt">2,556</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_985_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4NPqnUPWUH1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">28,708</span></td>
    <td id="xdx_980_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVXxidglRRz4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">4,785</span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8qJyc1xtFwh" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">16</span></td>
    <td id="xdx_987_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOS0dqxmxRFc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(3,058)</span></td>
    <td id="xdx_982_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7NTfIGPWNb8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(30,451)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zaqo0QY2kps3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>1,334,699</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfxJxqyGbhz3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>2,776,077</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztBLF0yqKg0b" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>182,060</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z0udGq4J3JAa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>578,267</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEQnogXAkGDe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>71,150</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjOmK4lkxRjj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>84,201</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmEAXoBdOzr8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>128,477</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXahYkGKXbz7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>74,892</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9c518H1B2Va" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>12,134</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc2lF7k3PuV5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>1,055</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMDVqDU2iGm1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>5,243,012</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztjhdsWZ48q8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">157,227 </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQlDIfLJIM6a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">1,511 </span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqbZN68Fi4y8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">17,701 </span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcDS77okDfBl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">14,092 </span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJu9NUY2xEGd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">30,255 </span></td>
    <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzKOOsfStq5g" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">34,905 </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZoF9KE45jqe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">255,691 </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Business combination</span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfQdl7Jwzgw3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">192,034 </span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHVDzhdq1pNe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">427,482 </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMlmrwAU16dc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">34,560 </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9EHfwC2LrTc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"><span style="font-size: 7.5pt">654,076 </span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcPYGpUE1o0i" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(162)</span></td>
    <td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9PfFHXweTEk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(117)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zl3j076XfJK4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(1)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8Mv2dpzntel" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(280)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_985_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlHOF6DpxLtb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">23,292 </span></td>
    <td id="xdx_983_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzJoVPwrmJrg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">6,529 </span></td>
    <td id="xdx_98A_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zh19xklC10Tb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(39,929)</span></td>
    <td id="xdx_987_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1UFQS37Pcqf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">29,673 </span></td>
    <td id="xdx_986_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zATgoRNwq5sl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(19,565)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">- </span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zb3aHgCRNrye" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>1,526,733 </b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z17ghQiVjPjg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>3,360,786 </b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zBKcZE2Rpj53" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>182,060 </b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgmBoSuzYDFf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>612,827 </b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwJuzxYIXXv6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>95,953 </b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbf7wynp3fL1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>108,269 </b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoAJz80cGnW" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>102,523 </b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zYBe5VnFW6af" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>134,820 </b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zStSTVvDiuci" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>27,473 </b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJzINBZ8US78" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>1,055 </b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrGHdmExU3s1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>6,152,499 </b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Additions</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1gXhZJJwTQk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">99,629</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zC2DQJ1hye48" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">276</span></td>
    <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziCp74Ym0P1g" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">25,106</span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyqSVlv6c4a4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">9,552</span></td>
    <td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znsldTmHMJB3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">31,250</span></td>
    <td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1zq7Da0DoP6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">72,184</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvDiA7GhU28a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"><span style="font-size: 7.5pt">237,997</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_987_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRoBitc7xpof" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(2)</span></td>
    <td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zK6tQVTsOeCh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(1)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQBVVyqpIE79" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(272)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98B_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1125lsjVCZ" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">(275)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_984_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwigvmbJNV71" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(691)</span></td>
    <td id="xdx_98E_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zDsgfLvEn9gj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">31,531</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_982_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxIUOxYSq4Ac" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(30,840)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025 </b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCSO2MwUKmGc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>1,526,733</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXBXukM7Si5a" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>3,460,415</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrlbuzIIxTva" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>182,060</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxP1Cv7ilbc4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>612,136</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2KRCBoSwERc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>127,760</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqSzVMOrOKU9" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>133,373</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztzZ8bD8cXgi" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>112,074</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zueKPfDvCyta" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>166,070</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEeNDdP180Gd" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>68,545</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQD6ZUai0DGk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>1,055</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zO6i4Tn13dpf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>6,390,221</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Amortization</span></b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of January 1, 2023</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zYP5nIncY082" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2797">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zY06G9LJ8yAg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2799">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBDoezezxq1l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(14,955)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQkIjkse9ysl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(212,363)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW7vj3B3THai" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(17,277)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1GCgzhcZ8Md" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(26,562)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOj3SX448FQi" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(10,093)</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8DIqTkiqDQ3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(17,039)</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zy5s5ZYBxOE5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2813">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTobSyUDpKQ5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(79)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zw90gvVfX1El" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(298,368)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Amortization</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iP2custom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlO12eFJin97" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2819">-</span></span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zmkKKzT8I246" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2820">-</span></span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBBvb2yiVbC6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt">(11,083)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zf9dNrm5aD6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt">(89,584)</span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdP8l9MJmfK4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(8,764)</span></td>
    <td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8qsWZrGGNMf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(15,668)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBw7BNTnTQse" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(21,504)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTVeMXJciksa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(4,778)</span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkgdoP3P6UTi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2829">-</span></span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbM05cUjXAOe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(105)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqfk7c9cA9Z1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(151,486)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zXkVRlhPqD7g" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">1,947</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98C_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdZ1AGTjIqf8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">911</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuTk98HSDYrl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">2,858</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSJ9B8tOxBZg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(6)</span></td>
    <td id="xdx_98C_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIcnETa8xG4j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">6</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2023</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zogL1bEPU7Q6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2843">-</span></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z3TdCOnevdi5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2845">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJQMe1Vmsuy6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(26,038)</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z2KdKRDAToZk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(301,947)</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zC0PdwKOvAl2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(24,094)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8NhawO5DETf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(42,230)</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxI6CYmNBBH6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(31,603)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDYt8xaMzdQl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(20,900)</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zB0QQiBTu0c8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2859">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z2FlyJZKNgRa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(184)</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZ9WemNDEDp5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(446,996)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Amortization</span></td>
    <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxQADNzeSNJ7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2865">-</span></span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zdFVlUz1RTp" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2866">-</span></span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z6vXTtiDjli9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(12,506)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmeELLcXy9h2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt">(82,737)</span></td>
    <td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRYP7teYB8Fc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(16,457)</span></td>
    <td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzb3VRTgCDEb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(18,471)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDmE22bjtVG2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(20,086)</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0T7T3xjMxN1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(22,387)</span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zF1TXpcV88Xb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2874">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZdHGZ5jS2n3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(106)</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbRKG3XwKIng" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(172,750)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Write-off (i)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zrhhb7cXjGKi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">1 </span></td>
    <td id="xdx_980_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z94orvM2exJh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">35 </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_982_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBpUjhUAYwvg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"><span style="font-size: 7.5pt">36 </span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zfH9vKCVYgCe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(1,207)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zoNAO8Ra76o9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">9,019 </span></td>
    <td id="xdx_986_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLcvketNOqg5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(7,812)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNDvx4SnwcA7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2890">-</span></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zITgQVqqBX42" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2892">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQr2cbGD6Mrc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(38,544)</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCfKYmgkjX47" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(384,684)</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0XFTXoZ3WL2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(41,758)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwEyeVQyIQRk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(60,700)</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1FXIpGLvVi1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(42,635)</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zEOHxS5kJnY9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(51,099)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z87OPQbuD2k4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2906">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLkLtp0lw4kl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(290)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1Gr7mO0CPx1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"><span style="font-size: 7.5pt"><b>(619,710)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Amortization</span></td>
    <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zg4bLcJItUN" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2912">-</span></span></td>
    <td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zaNZbwG209ej" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2913">-</span></span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkJPcQA6T482" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(5,127)</span></td>
    <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8hkuzEL0kBg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"><span style="font-size: 7.5pt">(74,558)</span></td>
    <td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZqD47VyYlf8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(24,739)</span></td>
    <td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3jPyx8i7WJ9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(20,782)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zH0YCZrzDDD4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(16,741)</span></td>
    <td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAuPBKI7GXFg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(40,478)</span></td>
    <td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwJatCByCWX5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl2921">-</span></span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQe25GoaXQrf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(106)</span></td>
    <td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx6DIftNvWb4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">(182,531)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt">Transfer</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98B_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHrFDpbQAPb9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">380</span></td>
    <td id="xdx_98D_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zORSQxglt5jj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"><span style="font-size: 7.5pt">(380)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2025 </b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztwyObFlgmp8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2929">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zEPBONrHsckg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2931">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zpq8KeBM5JZ3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(43,671)</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0dkzd4sZruf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(458,862)</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLzE3zymcaq7" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(66,877)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFag1O74Nzfg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(81,482)</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDDyIAi72Fzg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(59,376)</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVzMp4NQzLI8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(91,577)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zWgPducxjut3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2945">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1SDazwakQV3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(396)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHiImOtkL3tl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"><span style="font-size: 7.5pt"><b>(802,241)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b><span style="text-decoration: underline">Net book value</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31,
2025 </b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zqVRzYslf44a" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>1,526,733</b></span></td>
    <td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember_fKGkp_zFWPpvAORBf7" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>3,460,415</b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zPn41sbedv6e" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>138,389</b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z6uJXjSySJAh" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>153,274</b></span></td>
    <td id="xdx_98D_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zMnoFw5Kvy9a" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>60,883</b></span></td>
    <td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zwmWWCxsL8Id" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>51,891</b></span></td>
    <td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zDhtbgWZQ0e5" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>52,698</b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zOkhLYjsxBM7" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>74,493</b></span></td>
    <td id="xdx_98E_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zcgAemG6Nj6c" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>68,545</b></span></td>
    <td id="xdx_981_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zds1pQlwXZzg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>659</b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231_z8TSfdEq2Tag" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>5,587,980</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-size: 7.5pt"><b>As of December 31, 2024</b></span></td>
    <td id="xdx_980_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zdHu71cTahh9" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>1,526,733 </b></span></td>
    <td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember_fKGkp_z9zb49RZSku9" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>3,360,786 </b></span></td>
    <td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_za3bVZPwfUCg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>143,516 </b></span></td>
    <td id="xdx_987_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z48SyNzg0I62" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>228,143 </b></span></td>
    <td id="xdx_981_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z0VsiO7VsXoj" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>54,195 </b></span></td>
    <td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zZ1ZOINCttHf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>47,569 </b></span></td>
    <td id="xdx_988_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zffl72aSoBm" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>59,888 </b></span></td>
    <td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zNiQH2slMBal" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>83,721 </b></span></td>
    <td id="xdx_98A_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zlJfmIk1fM5j" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>27,473 </b></span></td>
    <td id="xdx_98B_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zjL7DAkd7Lpg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>765 </b></span></td>
    <td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231_zgLP4RfwF6ai" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"><span style="font-size: 7.5pt"><b>5,532,789 </b></span></td></tr>
  </table>
<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to intangible assets written-off as result of lack of expectation of future use.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock', window );">Schedule of assumptions for impairment test</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_pn3n3_zXK7x6SVyuU1" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Intangible assets (Details 1)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B8_zZmfXMrPkdi7" style="display: none">Schedule of assumptions for impairment test</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center; text-indent: 0in"><span style="font-family: Nunito Sans; font-size: 8.5pt"><b>Carrying amount</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Goodwill</b></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Licenses with indefinite useful life</b></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>CGU</b></td></tr>
  <tr>
    <td style="width: 34%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">IPTAN</td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zLrB5OMD7sV5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">17,446</td>
    <td id="xdx_983_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zDt7RsN1BkE5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">17,446</td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zLW5R67wAzVd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">57,214</td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zwRHZalhKJc5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">57,214</td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z3wtcvKnPsLl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">142,155</td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zVI5Ae6xqBP1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">122,599</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">IESVAP</td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z0nWsHxsKkkb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">27,956</td>
    <td id="xdx_98D_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_ziFbQLWq6fYl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">27,956</td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zPE0X0sip0Q" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">81,366</td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zxKEic920uO5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">81,366</td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zbtlPVaBo5Hk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">128,552</td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zI7CJOaMvxug" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">126,195</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">CCSI</td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_znwGVY9UohJd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">4,664</td>
    <td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_ziWE0EqlkPj2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">4,664</td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zKcrnZMYM846" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">56,737</td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zs5UjofA1ZW6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">56,737</td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zcuZhJuYx5Uj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">64,782</td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zz5aEanJbdYl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">60,377</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">IESP</td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zM53NWWrSifl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">73,838</td>
    <td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zQlZAqgiYTQk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">73,838</td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zRdC660jkWJ5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">179,693</td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z4oRW5PRZTI5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">179,693</td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zX70F1g1pw41" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">336,287</td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z5W6LhpCPeXf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">322,900</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FADEP</td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zmoktumZ9jfd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">49,661</td>
    <td id="xdx_986_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zaM5WgaZkZli" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">49,661</td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zs72RDpER8Zb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">70,606</td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zxyaKSp796E7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">70,606</td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zQ97tvgX0Hk7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">143,096</td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zBNRhjibBCBd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">141,201</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FASA</td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zFJUUyTbKv1i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">58,903</td>
    <td id="xdx_987_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zd1IANS1lGTb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">58,903</td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zp3SvRS1yZx5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">144,507</td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zW9S0YzGLd28" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">144,507</td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zRNQeMtV8sib" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">350,392</td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zJgccVUODXP" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">341,020</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">IPEC</td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zouKxAM3HrMa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl3069">-</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_znCr213aC6V7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl3071">-</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z5Iee4ZH4Q44" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">108,000</td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zU3N9CC340pf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">108,000</td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z40nLOpJzQ65" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">168,247</td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zbL58Wfy4fI" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">168,174</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">UniRedentor</td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z0kCGEiwFh3d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">77,662</td>
    <td id="xdx_98A_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zPE0SBofqkV9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">77,662</td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zphoVAGGq236" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">121,477</td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zZGtZYlHQfTk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">121,477</td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z7RBBsg9pzqi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">251,332</td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zoQWRg9EQal7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">244,123</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">UniSL</td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zSl9fJeQEHSd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">4,420</td>
    <td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zUd40Bo4iKHi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">4,420</td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zz7Arkd5ami4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">273,795</td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zEvKK3bFJkLk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">273,795</td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z7EiUzT0zrDg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">401,911</td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z7eUkaeWXQv1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">386,889</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FESAR</td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zFwDxUkEufu8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">71,664</td>
    <td id="xdx_981_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zno61gFLc00j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">71,664</td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zgL0K5E9Hfg9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">141,616</td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z3buY0VrOoOf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">141,616</td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_ziwVZLLUnFae" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">248,037</td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zW4R3D4qPy7e" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">246,385</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FCMPB</td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z2xfWn7gwwX1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">110,483</td>
    <td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zQ6kQq6axnx6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">110,483</td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_ziqF1qLPuDa3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">235,018</td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zXUXrAXTIpZa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">235,018</td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zAAPL9otdGac" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">404,039</td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zU4uYngo4Ewd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">392,862</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">ITPAC Garanhuns</td>
    <td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z5VPFpHeGN4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl3129">-</span></td>
    <td id="xdx_98F_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zxRErLaJd2i" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl3131">-</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zMKAf0CRw4ec" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">108,000</td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zmqdAjGn3z17" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">108,000</td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zmRhEVgb6oPl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">150,489</td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z4tm76TsTyrc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">129,458</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Continuing education (i)</td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z1FLiw9D5sql" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">267,477</td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zdo8qakBz9l8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">267,477</td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zTHkeLlLA886" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="-sec-ix-hidden: xdx2ixbrl3145">-</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z82UJjx0TCm7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="-sec-ix-hidden: xdx2ixbrl3147">-</span></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z9xhQ62Qsbba" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">574,048</td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zuk1ldNwFzZe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">542,354</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Medical practice solutions (i)</td>
    <td id="xdx_986_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zr0Zz8t2bYUc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">238,477</td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zaZy1j5XZoNa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">238,477</td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_z65NhKzCfiZ2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="-sec-ix-hidden: xdx2ixbrl3157">-</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zSGno3FZNjpg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="-sec-ix-hidden: xdx2ixbrl3159">-</span></td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zHJyTIJnXBG5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">373,954</td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zGVRhnhKqW66" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">411,873</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">UnifipMoc</td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zLah66A7F1wl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">87,777</td>
    <td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zCUVQmvvjhb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">87,777</td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zKNSNd2Sx9Xf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">239,847</td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zPaFirPLHNs9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">239,847</td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zBp26Rlvi7i2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">427,474</td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z4gfTYv7k3og" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">412,698</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Unigranrio</td>
    <td id="xdx_989_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zKSH3sgxth3l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">169,173</td>
    <td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zjilK4LXDz73" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">169,173</td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zngKiavC2xG1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">421,538</td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zxAN2UNBpRd5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">421,538</td>
    <td id="xdx_986_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zuiY9l1O2eyb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">804,996</td>
    <td id="xdx_98E_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zVjHdFFP8rQg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">819,682</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">DelRey</td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zXuauiuqwA4c" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">75,098</td>
    <td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIlKiCSMiiE4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">75,098</td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5ZEQAGON1K8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">693,890</td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zgqG4BFMsbgl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">693,890</td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zwBmUYerww5f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">960,966</td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztkHC2LXdR05" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">929,307</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Unidom</td>
    <td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_ztfAQsJv2Kue" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">192,034</td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z74iKouJt2x7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill">192,034</td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zO8BJa8H3Ik2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">427,482</td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zZDyBdlmRcoj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">427,482</td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zI2WT6yJpi1l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">718,699</td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_znb3BnsJ31C5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">687,570</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">FUNIC</td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zCPZhH25Ctvj" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl3213">-</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z8A9V4L3huC7" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl3215">-</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zMo1gKMd3Up" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life">99,629</td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z8kb4stCW9c6" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="-sec-ix-hidden: xdx2ixbrl3219">-</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zQ3gM7Z8eLs2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units">110,943</td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zE0o8BSHujWb" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="-sec-ix-hidden: xdx2ixbrl3223">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_98F_eifrs-full--Goodwill_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zwOuEWNuT7g3" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><b>1,526,733</b></td>
    <td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zvXOjOVsYcD5" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><b>1,526,733</b></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zsBHIabUbSO8" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><b>3,460,415</b></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zk7GuD1HYmbj" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><b>3,360,786</b></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_ztB1yVXhcBg8" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><b>6,760,399</b></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zcO4AqGiKNv9" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><b>6,485,667</b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">For the year ended December 31, 2025, the companies included in former Pillar 1 (Medcel,
Al&#233;m da Medicina, CardioPapers and Medical Harbour) where grouped together with IPEMED to constitute the Continuing education
CGU. The companies included in former Pillar 2 (PEBMED) and former Pilar 3 (iClinic, Medicinae, Shosp and RX Pro) where grouped together
with Glic and Cliquefarma to constitute the Medical practice solutions CGU. As a result, the prior period was revised for comparative
purposes. The grouping of these companies into a unified CGU reflects the economic reality of their business and is consistent with the
Company&#8217;s integrated operational model. This classification also represents how operations are internally monitored.<br/></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SchuduleOfAssumptionsUsedTableTextBlock', window );">Schedule of assumptions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SchuduleOfAssumptionsUsedTableTextBlock_pn3n3_zs2q5xL5Xzcj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Intangible assets (Details 2)">
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B9_zVtEPOJx43md" style="display: none">Schedule of assumptions</span></td>
    <td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr>
    <td style="border: #D0CECE 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Key assumption</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 51%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Description</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>2025</b></span></td>
    <td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>2024</b></span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Discount rates</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><span id="xdx_901_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DiscountRatesMember_z4QcjuuHkqo5" title="Description">Represent the current market assessment of the specific risks associated to the CGUs, estimated based on information from both internal and external sources, including the Company&#8217;s and third parties historical weighted-average cost of capital (WACC).</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Pre-tax discount rate applied to cash flow projections: between <span id="xdx_90A_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z6DR5vvKTDHg" title="Discount rate applied to cash flow projections">10.82</span>% and <span id="xdx_905_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zkbt7PihCDw7" title="Discount rate applied to cash flow projections">11.73</span>%.</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Pre-tax discount rate applied to cash flow projections: between <span id="xdx_907_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20241231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zPif14jGTu9d" title="Discount rate applied to cash flow projections">11.66</span>% and <span id="xdx_906_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z3nzF9GS73s5" title="Discount rate applied to cash flow projections">13.97</span>%.</span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Perpetuity growth rate</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><span id="xdx_909_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PerpetuityGrowthRateMember_zgUfevbpw82a" title="Description">Cash flow projections include specific estimates for a five-year period followed by a terminal growth rate, determined based on management's internal estimate of the long-term compound annual growth rate (CAGR), consistent with the assumptions that would be made by a market participant.</span></span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">From <span id="xdx_90E_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOPcJGfjIZIf" title="Growth rates">3.5</span>% to <span id="xdx_909_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_znr5YdVtYxFh" title="Growth rates">9.50</span>%.</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">From <span id="xdx_90B_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zidxpqC2KL2c" title="Growth rates">3.5</span>% to <span id="xdx_901_ecustom--PerpetuityGrowthRate_pip0_dp_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zh43Ig1kwArd" title="Growth rates">7.53</span>%.</span></td></tr>
  <tr>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">EBITDA<span style="font-family: Nunito Sans"><sup>[1]</sup></span> growth rate (annual average for the next five years)</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Nunito Sans; margin: 0"><span id="xdx_906_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EBITDAMember_gIFDOKAOWMHBC-WJE_zuncArDTfD7" title="Description">EBITDA growth rate was estimated using historical performance as a baseline, adjusted for:</span></p>
    <div id="xdx_C09_gIFDOKAOWMHBC-WJE_zqD6Jetl0JBi"><p style="font: 9pt Nunito Sans; margin: 0">- Expected revenue growth, driven by increases in both sales volume and pricing.</p></div>
    <div id="xdx_C07_gIFDOKAOWMHBC-WJE_zFxGavNFZ3Uf"><p style="font: 9pt Nunito Sans; margin: 0">- Expected margin expansion, which reflects operational efficiencies and scale economies as
    volumes increase, partially offset by projected increases in costs.</p></div></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_906_ecustom--EbitdaGrowthRates_pip0_dp_c20250101__20251231_zvtN9LF3duli" title="EBITDA growth rates">6.88</span>%</span></td>
    <td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90A_ecustom--EbitdaGrowthRates_pip0_dp_c20240101__20241231_zbVabD28HFj9" title="EBITDA growth rates">5.69</span>%</span></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><i>Sensitivity analysis: impacts of possible changes in key assumptions</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"><span id="xdx_902_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zBYiuCNYfPa2" title="Description of significant estimate">An increase of 25 basis points in management&#8217;s estimated discount rate applied to
the cash flow projections of each CGU for the year ended December 31, 2025, or a decrease of 25 basis points on perpetuity growth rate
or EBITDA growth rate would not have significant impacts on Company&#8217;s impairment testing.</span></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"><i>Impairment testing of other intangible assets</i></p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">&#160;</p>

<p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%">There were <span id="xdx_90F_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_do_c20250101__20251231_zzOkniNzthrk" title="Impairment intangible assets">no</span> impairment indicatives of intangible assets with finite useful lives as of
and for the year ended December 31, 2025.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SchuduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SchuduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFinancialAssetsTableTextBlock', window );">Schedule of financial assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfFinancialAssetsTableTextBlock_zfCKk7BKGG9e" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BD_zEgMmICCUAD4" style="display: none">Schedule of financial assets</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>At amortized cost</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cash and cash equivalents</td>
    <td id="xdx_98D_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zFSR0GqK3u9g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents">1,125,381 </td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zwNWrmprW5Kh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents">911,015</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Trade receivables</td>
    <td id="xdx_98E_eifrs-full--TradeReceivables_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zyEySZtNuMuc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables">752,358 </td>
    <td id="xdx_983_eifrs-full--TradeReceivables_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_ziiNiLIaENTi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables">631,846 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Other FIES credits - Other assets</td>
    <td id="xdx_980_eifrs-full--OtherAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zuf7UVBO9Rdl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other FIES credits - Other assets">6,866 </td>
    <td id="xdx_982_eifrs-full--OtherAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zhBXyUUyRXNl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other FIES credits - Other assets">8,982</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Dividends receivable - Other assets</td>
    <td id="xdx_98B_ecustom--DividendReceivable_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zJPLRk7cOif4" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends receivable - Other assets">6,287 </td>
    <td id="xdx_981_ecustom--DividendReceivable_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zFPdpbw2cdj5" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends receivable">1,628</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_984_eifrs-full--FinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zB3YEGMg3UCb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>1,890,892 </b></td>
    <td id="xdx_986_eifrs-full--FinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRXN40G1V4e9" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>1,553,471 </b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_980_eifrs-full--CurrentFinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zkOY8WERLiRh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">1,849,041 </td>
    <td id="xdx_98D_eifrs-full--CurrentFinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z06VAwl2Pyd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">1,508,541 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_988_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_znY5z8ZwboC5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">41,851 </td>
    <td id="xdx_987_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zuMfYWo0Dwfh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">44,930 </td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFinancialLiabilitiesTableTextBlock', window );">Schedule of financial liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfFinancialLiabilitiesTableTextBlock_zApM0bo416tj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 1)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B9_zwid6Khlho16" style="display: none">Schedule of financial liabilities</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>At amortized cost</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Trade payables</td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z967f8uR7pzf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables">123,581 </td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5iEBvLxnhBl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables">128,080 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Loans and financing</td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zlsu6fnkPwag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing">2,054,267 </td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFCAXvaqZ7Zd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing">2,195,161 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Lease liabilities</td>
    <td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zWKhVwB4p6I5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities">1,065,746 </td>
    <td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zPkwp9NZMQci" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities">978,336 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders</td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zt0iPGHBgy48" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Accounts payable to selling shareholders">115,447 </td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z0ZirexSHOb6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Accounts payable to selling shareholders">215,819 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Dividends payable</td>
    <td id="xdx_988_eifrs-full--DividendsPayable_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFlWtsR8A402" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends payable">192 </td>
    <td id="xdx_989_eifrs-full--DividendsPayable_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z80SeiiXaPI" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends payable"><span style="-sec-ix-hidden: xdx2ixbrl3324">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z2yumoKcDxu1" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>3,359,233 </b></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zzvYvHDyFZr7" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>3,517,396 </b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_980_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4xsAyUzUA2g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">326,432 </td>
    <td id="xdx_988_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z1xpBTbijuV" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">690,395</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_987_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zTpj8mv5vIpk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">3,032,801 </td>
    <td id="xdx_986_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zYLJIetDc5I1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">2,827,001</td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFairValuesTableTextBlock', window );">Schedule of fair value</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfFairValuesTableTextBlock_zmQJkcK0fO4j" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 2)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B7_zZmKFkpt9Eh3" style="display: none">Schedule of fair value</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>At fair value</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders (earn-outs)</td>
    <td id="xdx_987_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersEarnOutsMember_zDvLTTDZJfg1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value">3,337 </td>
    <td id="xdx_98E_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersEarnOutsMember_z6W34HKHufi8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value">20,067 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders (Unidom)</td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersUnidomMember_zdCzDsMpiktj" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value">321,813 </td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersUnidomMember_zeSjmCcRFI0a" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value">294,886 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_985_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231_zcdPTjJeT4jh" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"><b>325,150 </b></td>
    <td id="xdx_981_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231_z1yq3E0XKkfb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"><b>314,953 </b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_98E_eifrs-full--CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20251231_z5gzvupBWZx7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">24,421 </td>
    <td id="xdx_984_eifrs-full--CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20241231_zeCC9zpsD9y7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current">32,137</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_988_eifrs-full--NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20251231_z3QiGJ9fRsZ7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">300,729 </td>
    <td id="xdx_98A_eifrs-full--NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20241231_zZsxNtpJh8he" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current">282,816</td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfLoansAndFinancingTableTextBlock', window );">Schedule of loans and financing</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfLoansAndFinancingTableTextBlock_zM8pNdh4cIHf" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 3)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_z0Kd946A2336" style="display: none">Schedule of loans and financing</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="border-bottom: Black 1pt solid; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"><b>Financial institution</b></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Currency</b></td>
    <td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Interest rate</b></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Maturity</b></td>
    <td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>&#160;2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_90E_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zsk6mgQ1aqZg" title="Financial institution">Banco Ita&#250; Unibanco S.A.</span> (a)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zghIEF7NWizh" title="Interest rate">CDI + 1.90% p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_902_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zfmdRINOXAp" title="Maturity">October 2025</span></td>
    <td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zIzv4cTdu8u1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="-sec-ix-hidden: xdx2ixbrl3368">-</span></td>
    <td id="xdx_981_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zZA230XVHKq" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">309,496 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_90A_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zho5Ub0wj0d4" title="Financial institution">FINEP</span> (b)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zR4R7MHSOWSj" title="Interest rate">TJLP p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90A_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zQMduyFSaulk" title="Maturity">July 2027</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zzMGfB6ps923" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">5,262</td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_z3PJqmXxSVUf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">8,209 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_900_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zOXOwdIGAdL6" title="Financial institution">Softbank</span> (c)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_908_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zmWpM8AvbL52" title="Interest rate">6.5% p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_z7BL1PKorwS" title="Maturity">April 2026</span></td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zt8EyJj7OKag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="-sec-ix-hidden: xdx2ixbrl3388">-</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zIk4zqzRAgAc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">845,492 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_900_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z9IeoQSgiGX5" title="Financial institution">Debentures</span> (d)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_zuZ0u6OuNYi4" title="Interest rate">CDI + 1.80% p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z896fjA34ps4" title="Maturity">January 2028</span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z1HLbfMnmsk3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="-sec-ix-hidden: xdx2ixbrl3398">-</span></td>
    <td id="xdx_981_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_zGBKe5Dsv8I4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">526,946 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_903_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zw9svEiE6aj4" title="Financial institution">IFC</span> (e)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zaVgDULurkU7" title="Interest rate">CDI + 1.05% p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_znlDd5q6YYb9" title="Maturity">April 2030</span></td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zzCiOfkv4la6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">510,672 </td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zaHAYXiw4Rp" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">505,018 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_905_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zQCcBN51G4sl" title="Financial institution">Commercial notes</span> (f)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_901_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zpGzhbR5Aszj" title="Interest rate">CDI + 0.70% p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_z5CyciXkyRyb" title="Maturity">October 2028</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_ztPSc6KChh1l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">512,678 </td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zzxIKkmOKrk6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="-sec-ix-hidden: xdx2ixbrl3420">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_904_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zJbJTQxnQ0R7" title="Financial institution">Commercial notes</span> (f)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Brazilian real</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_907_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zFXhJCDdwyha" title="Interest rate">CDI + 0.85% p.y.</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90D_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zEBeVDWTnoL9" title="Maturity">October 2030</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zWski1IdqoVc" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">1,025,655 </td>
    <td id="xdx_988_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zqAzcJDkTw5k" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="-sec-ix-hidden: xdx2ixbrl3430">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20251231_zLHiAOy5g2N8" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><b>2,054,267 </b></td>
    <td id="xdx_989_ecustom--LoansAndFinancing_pn3n3_c20241231_zX7ix0nhzp2" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><b>2,195,161 </b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_982_ecustom--LoansAndFinancingCurrent_iI_pn3n3_c20251231_zbQpxAy2G1ug" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current">60,668 </td>
    <td id="xdx_98E_ecustom--LoansAndFinancingCurrent_iI_pn3n3_c20241231_zlokdgluSQRc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current">363,554 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98F_ecustom--LoansAndFinancingNonCurrent_iI_pn3n3_c20251231_zdtKQQANyR8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current">1,993,599 </td>
    <td id="xdx_98A_ecustom--LoansAndFinancingNonCurrent_iI_pn3n3_c20241231_zc3HX6s9BtS8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current">1,831,607 </td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfLeasesTableTextBlock', window );">Schedule of right-of-use assets and lease liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfLeasesTableTextBlock_zD88JZhGdIE8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities  (Details 4)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BE_ziS5UYKrVDNc" style="display: none">Schedule of right-of-use assets and lease liabilities</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Right-of-use assets</b></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Lease liabilities</b></td></tr>
  <tr>
    <td style="width: 33%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td>
    <td style="vertical-align: top; width: 1%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Opening balance</b></td>
    <td id="xdx_984_eifrs-full--RightofuseAssets_iS_pn3n3_c20250101__20251231_zrmYjJND5XH8" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at beginning"><b>842,219 </b></td>
    <td id="xdx_987_eifrs-full--RightofuseAssets_iS_pn3n3_c20240101__20241231_zdSaOneFkP58" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at beginning"><b>767,609 </b></td>
    <td id="xdx_98A_eifrs-full--RightofuseAssets_iS_pn3n3_c20230101__20231231_zwtgdi1UNSs3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at beginning"><b>690,073</b></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--LeaseLiabilities_iS_pn3n3_c20250101__20251231_z7hftFWQstSe" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at beginning"><b>978,336 </b></td>
    <td id="xdx_98F_eifrs-full--LeaseLiabilities_iS_pn3n3_c20240101__20241231_z56wJ6XHjch4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at beginning"><b>874,569 </b></td>
    <td id="xdx_989_eifrs-full--LeaseLiabilities_iS_pn3n3_c20230101__20231231_z16LqXKtL3Me" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at beginning"><b>769,525</b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Additions</td>
    <td id="xdx_988_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231_zG5RCJMJlqpe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, additions">37,727 </td>
    <td id="xdx_986_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20240101__20241231_znlvQUfbfdu5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, additions">37,671 </td>
    <td id="xdx_98F_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20230101__20231231_zqK893yBmtB5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, additions">7,328</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_98A_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20250101__20251231_z9wOqaXwpX02" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, additions">37,727 </td>
    <td id="xdx_98E_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20240101__20241231_zD25qWIes559" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, additions">37,671 </td>
    <td id="xdx_989_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20230101__20231231_zru1mqAVVLrd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, additions">7,328</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Remeasurement</td>
    <td id="xdx_987_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20250101__20251231_zNyoJkpHTtI2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, remeasurement">98,987 </td>
    <td id="xdx_989_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20240101__20241231_z7etiMsyHe4h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, remeasurement">80,226 </td>
    <td id="xdx_98C_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20230101__20231231_zUFlVmu95bDb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, remeasurement">70,387</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_988_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20250101__20251231_zbSBWQuxdI15" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, remeasurement">98,987 </td>
    <td id="xdx_987_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20240101__20241231_zljZVWVsx6Lb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, remeasurement">80,226 </td>
    <td id="xdx_989_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20230101__20231231_zdxRNFVcXfG9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, remeasurement">70,387</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Business combinations</td>
    <td id="xdx_986_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20250101__20251231_z5EfWXvMwSHj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, business combinations"><span style="-sec-ix-hidden: xdx2ixbrl3500">-</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20240101__20241231_zpMS5SSoieSi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, business combinations">28,989 </td>
    <td id="xdx_98E_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20230101__20231231_zhg0bwUH5Rp9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, business combinations">65,408</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_983_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20250101__20251231_zYuL6NwOy2I3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, business combinations"><span style="-sec-ix-hidden: xdx2ixbrl3506">-</span></td>
    <td id="xdx_987_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20240101__20241231_zzd6GS6LA7jj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, business combinations">28,989 </td>
    <td id="xdx_981_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20230101__20231231_z1svd6hJRjnc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, business combinations">65,408</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Depreciation expense</td>
    <td id="xdx_986_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20250101__20251231_zaLcw6anITY" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, depreciation expense">(80,864)</td>
    <td id="xdx_98B_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20240101__20241231_zCCby1j6NoAl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, depreciation expense">(70,294)</td>
    <td id="xdx_98B_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20230101__20231231_zPzojHIgCWnk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, depreciation expense">(63,118)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_98D_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20250101__20251231_zXNifSeHaype" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="-sec-ix-hidden: xdx2ixbrl3518">-</span></td>
    <td id="xdx_981_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20240101__20241231_z9P9X9mybrKk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="-sec-ix-hidden: xdx2ixbrl3520">-</span></td>
    <td id="xdx_98D_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20230101__20231231_zik12oLFw6nk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="-sec-ix-hidden: xdx2ixbrl3522">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Interest expense</td>
    <td id="xdx_980_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20250101__20251231_zcK8vh0zYxM5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, interest expense"><span style="-sec-ix-hidden: xdx2ixbrl3524">-</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20240101__20241231_zRWQMeouzGka" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, interest expense"><span style="-sec-ix-hidden: xdx2ixbrl3526">-</span></td>
    <td id="xdx_988_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20230101__20231231_zRmqwqrHVgYj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, interest expense"><span style="-sec-ix-hidden: xdx2ixbrl3528">-</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_98D_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20250101__20251231_z3WyXUMZlpye" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, interest expense">123,067 </td>
    <td id="xdx_98A_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20240101__20241231_zRKcL939U0ya" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, interest expense">111,966 </td>
    <td id="xdx_980_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20230101__20231231_zpSz7Nt2nZM9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, interest expense">100,849</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Payments of principal</td>
    <td id="xdx_986_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20250101__20251231_zwD9zYJ3nvig" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right of use assets, payments of principal"><span style="-sec-ix-hidden: xdx2ixbrl3536">-</span></td>
    <td id="xdx_980_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20240101__20241231_zvzRrODrMld1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right of use assets, payments of principal"><span style="-sec-ix-hidden: xdx2ixbrl3538">-</span></td>
    <td id="xdx_981_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20230101__20231231_zYluA0Wjjtz7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right of use assets, payments of principal"><span style="-sec-ix-hidden: xdx2ixbrl3540">-</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_982_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20250101__20251231_zRdowUBn6c43" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of principal">(49,411)</td>
    <td id="xdx_986_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20240101__20241231_zPepJ0SWODm9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of principal">(41,221)</td>
    <td id="xdx_98B_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20230101__20231231_zNgzvuS7z2Dj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of principal">(31,473)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Payments of interest</td>
    <td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20250101__20251231_ztdg2YuJlDn8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, payments of interest"><span style="-sec-ix-hidden: xdx2ixbrl3548">-</span></td>
    <td id="xdx_98A_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20240101__20241231_zaDc92cMtB1h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, payments of interest"><span style="-sec-ix-hidden: xdx2ixbrl3550">-</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20230101__20231231_zBYFRjGs86n1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, payments of interest"><span style="-sec-ix-hidden: xdx2ixbrl3552">-</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20250101__20251231_z8n47pb78YV" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of interest">(121,475)</td>
    <td id="xdx_987_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20240101__20241231_ziYeoCmUxY8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of interest">(111,605)</td>
    <td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20230101__20231231_zUykcHnsOZw2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of interest">(103,911)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Write-off (i)</td>
    <td id="xdx_989_ecustom--RightofuseAssetsWriteoff_pn3n3_c20250101__20251231_zLYEa3sEOuJ3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, Write-off">(1,311)</td>
    <td id="xdx_98B_ecustom--RightofuseAssetsWriteoff_pn3n3_c20240101__20241231_zR6omVt1EKL9" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, Write-off">(1,982)</td>
    <td id="xdx_985_ecustom--RightofuseAssetsWriteoff_pn3n3_c20230101__20231231_zP3Z43ppyj7h" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, Write-off">(2,469)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_980_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20250101__20251231_zb8SmeLgEXli" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, Write-off">(1,485)</td>
    <td id="xdx_983_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20240101__20241231_zoINMVKtH2Oa" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, Write-off">(2,259)</td>
    <td id="xdx_98A_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20230101__20231231_zSQ18FdrODXf" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, Write-off">(3,544)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Closing balance</b></td>
    <td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20250101__20251231_z83FsUeGPdD1" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at ending"><b>896,758 </b></td>
    <td id="xdx_981_eifrs-full--RightofuseAssets_iE_pn3n3_c20240101__20241231_zIJlhrQ8DRN4" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at ending"><b>842,219 </b></td>
    <td id="xdx_980_eifrs-full--RightofuseAssets_iE_pn3n3_c20230101__20231231_zigy42ysc84h" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at ending"><b>767,609&#160;</b></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_989_eifrs-full--LeaseLiabilities_iE_pn3n3_c20250101__20251231_zj6U64o61w0f" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at ending"><b>1,065,746 </b></td>
    <td id="xdx_987_eifrs-full--LeaseLiabilities_iE_pn3n3_c20240101__20241231_zDOvzCg0E3rg" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at ending"><b>978,336 </b></td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iE_pn3n3_c20230101__20231231_z18Kd8AYjSZ9" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at ending"><b>874,569</b></td></tr>
  </table>
<p style="font: 8.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="width: 33%; padding-right: 3.5pt; padding-left: 3.5pt"><b>Balances:</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td>
    <td style="width: 1%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Current</td>
    <td id="xdx_983_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20251231_zVQBU8Kzgxhj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, current"><span style="-sec-ix-hidden: xdx2ixbrl3584">-</span></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20241231_zKmXCVBS5Yg1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, current"><span style="-sec-ix-hidden: xdx2ixbrl3586">-</span></td>
    <td id="xdx_987_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20231231_zq92Mxs84Og5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, current"><span style="-sec-ix-hidden: xdx2ixbrl3588">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_984_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20251231_zWRjzez5qT8j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, current">55,772 </td>
    <td id="xdx_982_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20241231_zF7bmEAkbuZ4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, current">45,580&#160;</td>
    <td id="xdx_982_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20231231_zplwbGBHes59" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, current">36,898</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Non-current</td>
    <td id="xdx_985_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20251231_zjWfNlJTche9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, non-current">896,758</td>
    <td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20241231_zzWw057iipp5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, non-current">842,219 </td>
    <td id="xdx_98E_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20231231_zvT3AFPGNFm9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, non-current">767,609</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td id="xdx_982_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20251231_zUBh0pMUPeM6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, non-current">1,009,974 </td>
    <td id="xdx_980_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20241231_zmuTAq8dkLw6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, non-current">932,756</td>
    <td id="xdx_983_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20231231_z5hwXbmG3bb9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, non-current">837,671</td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to early termination of lease contracts.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock', window );">Schedule of accounts payable to selling shareholders</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock_zcVBNn7CbKga" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 5)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span id="xdx_8B1_z8jHkXAu4UE4" style="display: none">Schedule of accounts payable to selling shareholders</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; text-align: center"><b>Interest rate</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Accounts payable at amortized cost (deferred consideration)</b></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Unigranrio (a)</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_908_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zJC5b0b1LD4g" title="Interest rate">CDI</span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zHlARej95FEj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="-sec-ix-hidden: xdx2ixbrl3618">-</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zPDRzaJR4GJ2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">90,543 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">DelRey (b)</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_907_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zlCk9dBjP4Fj" title="Interest rate">Selic</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWPWg3dXB525" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">71,604 </td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zDjUbjyGWY5i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">125,276 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">FUNIC (c)</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_90A_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zFSiFuNVQ34d" title="Interest rate">CDI</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zDKnG57YjhT4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">43,843 </td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zgXtCo5MQmFc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="-sec-ix-hidden: xdx2ixbrl3632">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><b>Accounts payable at fair value (contingent consideration)</b></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Shosp (d)</td>
    <td style="vertical-align: bottom; text-align: center">-</td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zJsnNpdxVcsi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">454 </td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zBolMYi8Pky2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">454 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Al&#233;m da Medicina (e)</td>
    <td style="vertical-align: bottom; text-align: center">-</td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zpNHiASUYtR7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><span style="-sec-ix-hidden: xdx2ixbrl3638">-</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zGRd88fogiBi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">9,600 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">CardioPapers (f)</td>
    <td style="vertical-align: bottom; text-align: center">-</td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zoa3WyA6Hpvk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">2,883 </td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zYVvQmhCETv2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">10,013 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Unidom (g)</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_90D_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zsGBJFbvzyud" title="Interest rate">CDI</span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_za0n4IlLlAD5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">321,813 </td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zIGd8gh76783" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance">294,886 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231_ziCyVAdc5JXk" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"><b>440,597 </b></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231_z5hhiKLHZf66" style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable"><b>530,772 </b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Current</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td id="xdx_98A_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_pn3n3_c20251231_zoRMpepDJVVk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current">110,640 </td>
    <td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersCurrent_pn3n3_c20241231_z8RKSErz3t02" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current">185,318 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Non-current</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_pn3n3_c20251231_zwBpujq7o7lk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current">329,957 </td>
    <td id="xdx_986_ecustom--AccountsPayableToSellingShareholdersNonCurrent_pn3n3_c20241231_zSuXbKLI69R1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current">345,454 </td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholders1Explanatory', window );">Schedule of accounts payable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--AccountsPayableToSellingShareholders1Explanatory_ztrVH9uKlFoe" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 6)">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B5_zXqp6kpCmX4k" style="display: none">Schedule of
    accounts payable</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><b>Opening balance</b></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOtVHYMr1kHi" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Opening balance"><b>530,772</b></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zaejO9yWZyWh" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Opening balance"><b>566,867</b></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z462xqz8zDK1" style="border-bottom: Black 1pt solid; text-align: right" title="Opening balance"><b>528,678</b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Additions</td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zn8ME7H7tCCi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Additions consideration to be transferred on business combinations">40,000 </td>
    <td id="xdx_98C_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zigz5mARamFd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Additions consideration to be transferred on business combinations">279,989</td>
    <td id="xdx_985_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwCowbXQKk3l" style="text-align: right" title="Additions consideration to be transferred on business combinations">234,000</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Payments of principal</td>
    <td id="xdx_986_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z4TQgHqWmWac" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payments of principal">(144,076)</td>
    <td id="xdx_985_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFzyY9CIJ1e5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payments of principal">(290,067)</td>
    <td id="xdx_986_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z5bIiixptDSj" style="text-align: right" title="Payments of principal">(225,460)</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Payments of interest</td>
    <td id="xdx_980_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zS2GT9Rsb8Vc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payment of interest">(49,608)</td>
    <td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zeYlP5wmZlH1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payment of interest">(78,931)</td>
    <td id="xdx_983_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoFgKldgXHAa" style="text-align: right" title="Payment of interest">(55,989)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Interest</td>
    <td id="xdx_98B_eifrs-full--InterestExpense_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zdvB85FYxhK5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Interest">19,979 </td>
    <td id="xdx_98E_eifrs-full--InterestExpense_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zrE7rcRWEn2h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Interest">37,276</td>
    <td id="xdx_98F_eifrs-full--InterestExpense_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zk1A2shaDQo9" style="text-align: right" title="Interest">85,069</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Remeasurement of contingent consideration</td>
    <td id="xdx_988_ecustom--RemeasurementOfEarnouts_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zjz7TBASLwof" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Remeasurement of contingent consideration">43,530 </td>
    <td id="xdx_987_ecustom--RemeasurementOfEarnouts_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwQGJEL7x3G4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Remeasurement of contingent consideration">15,638</td>
    <td id="xdx_981_ecustom--RemeasurementOfEarnouts_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoTZdqyxh2l2" style="text-align: right" title="Remeasurement of contingent consideration">2,556</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">Other</td>
    <td id="xdx_981_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zdoHM8oQRhsl" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other"><span style="-sec-ix-hidden: xdx2ixbrl3742">-</span> </td>
    <td id="xdx_982_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zR8s1QU08UAg" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other"><span style="-sec-ix-hidden: xdx2ixbrl3744">-</span></td>
    <td id="xdx_98D_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zkOu8uRedqKd" style="border-bottom: Black 1pt solid; text-align: right" title="Other">(1,987)</td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><b>Closing balance</b></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zTJGcfhg39xf" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Closing balance"><b>440,597</b></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zEt4JXbwsDbc" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Closing balance"><b>530,772</b></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ztC8TeVwHVP" style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right" title="Closing balance"><b>566,867</b></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFairValuesFinancialInstrumentstTableTextBlock', window );">Schedule of fair values of the company's financial instruments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfFairValuesFinancialInstrumentstTableTextBlock_zaWsNnNt4Wo8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 7)">
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B3_zvCQCh6mSFh8" style="display: none">Schedule of fair values of the company's financial instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>2025</b> </td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 36%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Carrying amount</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 15%; text-align: right"><b>Fair value</b></td>
    <td style="width: 1%; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; text-align: right"><b>Carrying amount</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Fair value</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b>Financial liabilities</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Loans and financing</td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z6mwy2GWAmLa" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at carrying amount">2,054,267 </td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zkwwMXOc6eRl" style="border-bottom: Black 1pt solid; text-align: right" title="Financial liabilities, at fair value">2,056,492 </td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zZgXKeQVxdd2" style="text-align: right" title="Financial liabilities, at carrying amount">2,195,161 </td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zy6HppqWQO7c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at fair value">2,196,152</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_pn3n3_c20251231_zxgafQbwzMQ7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at carrying amount"><b>2,054,267 </b></td>
    <td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20251231_zTXrOYytLgt" style="border-bottom: Black 1.5pt double; text-align: right" title="Financial liabilities, at fair value"><b>2,056,492 </b></td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231_zsZax9Uj0Q5l" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; text-align: right" title="Financial liabilities, at carrying amount"><b>2,195,161 </b></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20241231_z2K7rU9FZfN9" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at fair value"><b>2,196,152</b></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock', window );">Schedule of income before income taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_zf2q7oBUugg4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 8)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BE_zNPHtsgVSAVd" style="display: none">Schedule of income before income taxes</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Index</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>Base rate</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cash equivalents</td>
    <td id="xdx_98C_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zrA15uDD1pni" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending">1,086,489 </td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_900_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zbbsq91S658k" title="Index - % per year">CDI</span></td>
    <td id="xdx_983_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zdQMczYG49Qg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate">163,781 </td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Loans and financing</td>
    <td id="xdx_986_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zmZVsDbj9s5e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending">(2,049,005)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_904_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zVMagY5M7RPg" title="Index - % per year">CDI</span></td>
    <td id="xdx_98E_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zzwxjja3r20l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate">(323,480)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Loans and financing</td>
    <td id="xdx_984_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zbv8b2feDyzk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending">(5,262)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_909_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zQntQr53qNPi" title="Index - % per year">TJLP</span></td>
    <td id="xdx_983_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zeCJDTfiKAWb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate">(477)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders</td>
    <td id="xdx_987_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z6speULioNpj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending">(365,656)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_90F_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zkFk7JmS4N2j" title="Index - % per year">CDI</span></td>
    <td id="xdx_987_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zjLQcDfzLzH3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate">(54,483)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Accounts payable to selling shareholders</td>
    <td id="xdx_981_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zDc056qLG1Y7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending">(71,604)</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span id="xdx_901_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zmeiYYfhn45j" title="Index - % per year">Selic</span></td>
    <td id="xdx_98A_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zTFiBj48wHSj" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate">(10,669)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Net exposure</b></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_985_ecustom--BaseRate_pn3n3_c20250101__20251231_zxkYdR3fXnsi" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><b>(225,328)</b></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><b>Increase in basis points</b></td></tr>
  <tr>
    <td style="white-space: nowrap; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>+75</b></td>
    <td style="width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>+150</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Net effect on profit before tax</td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zU05K3J0Pjdj" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax">(10,538)</td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z6mnSGiXUo5g" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax">(21,076)</td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock', window );">Schedule of sensitivity foreign currency</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_zb2oG5xFCrXf" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 9)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8BC_zcdunEBlLHa9" style="display: none">Schedule of sensitivity foreign currency</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>Exposure</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>+10%</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>-10%</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cash equivalents</td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zrjBauUu3ul3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents">23,422 </td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zAEuZErKtdkc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents">2,342 </td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_z3gubqkXuT0k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents">(2,342)</td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock', window );">Schedule of maturity profile of financial liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_zlPRrzpky833" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 10)">
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BB_zvmS6iwPiNRl" style="display: none">Schedule of maturity profile of financial liabilities</span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"><b>As of December 31, 2025 </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Less than 1 year</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>1 to 3 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>3 to 5 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>More than 5 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Trade payables</td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFNRL9fH6a25" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables">123,581 </td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zqzNeDCGV9T" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="-sec-ix-hidden: xdx2ixbrl3832">-</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z7WfLovmFZbe" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="-sec-ix-hidden: xdx2ixbrl3834">-</span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztQJUTZkLyFk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="-sec-ix-hidden: xdx2ixbrl3836">-</span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zSLHywHPJ24l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables">123,581 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Loans and financing</td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z4d53RHtL1Wl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">308,292 </td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmk3Yp8XSZUl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">1,360,411 </td>
    <td id="xdx_981_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcGC5AiqwmP9" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">1,473,733 </td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zb2ovbIa8IMh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="-sec-ix-hidden: xdx2ixbrl3846">-</span></td>
    <td id="xdx_981_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_za9LadJEq9db" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">3,142,436 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Lease liabilities</td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z75BJ7Wxsg3g" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">178,638 </td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeWz7OcSCtTb" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">347,847 </td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2ydSLgnAhRa" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">331,019 </td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztypRWgxaSSg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">1,342,713 </td>
    <td id="xdx_98F_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zoNOa3bY0JQ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">2,200,217 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Accounts payable to selling shareholders</td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2FpJZ9DRzZ7" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">126,307 </td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2Mq143BlYX3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">131,446 </td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGwmVXkw2aU3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">185,821 </td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2w3RgNl0xs5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">502,355 </td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zUSnIFNlp12h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">945,929 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvDmmPQnN9fb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>736,818 </b></td>
    <td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zwyNtX3MoPBe" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,839,704 </b></td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgXMgQ64ffSe" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,990,573 </b></td>
    <td id="xdx_985_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z4Pv9XYrLA68" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,845,068 </b></td>
    <td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znoWOLTGKGG7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>6,412,163 </b></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr>
    <td style="white-space: nowrap; width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"><b>As of December 31, 2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Less than 1 year</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>1 to 3 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>3 to 5 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>More than 5 years</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Trade payables</td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zK67vmK9kYWg" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables">128,080 </td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z3GYF1pkIKs7" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="-sec-ix-hidden: xdx2ixbrl3882">-</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zHxblqQ7dHB3" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="-sec-ix-hidden: xdx2ixbrl3884">-</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgaXtjjdLgp5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="-sec-ix-hidden: xdx2ixbrl3886">-</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zHr12gbM9Ejf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables">128,080 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Loans and financing</td>
    <td id="xdx_987_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zYPHdM6YwmQ8" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">526,659 </td>
    <td id="xdx_984_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjaUH06nPRTl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">1,494,287 </td>
    <td id="xdx_985_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z24hWxMtpVKh" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">617,818 </td>
    <td id="xdx_988_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z6MrqSHuPOPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">75,526 </td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGHnFZjWePXh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing">2,714,290 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Lease liabilities</td>
    <td id="xdx_985_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zSmfkiuF7NG5" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">158,746 </td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zpbidtQS0Fp5" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">303,211 </td>
    <td id="xdx_988_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zCpTp9UABDul" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">293,178 </td>
    <td id="xdx_988_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zA0ILEgs1OY9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">1,360,107 </td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zaFH7tK4Aav1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities">2,115,242 </td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Accounts payable to selling shareholders</td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zAvtxN2ym6Uc" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">205,322 </td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zLsuZQxTUlvi" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">150,565 </td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z26HD8qrCuul" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">99,100 </td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zt61WVDLJHB8" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">373,498 </td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVzHZ5fuAol5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders">828,485 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z78KMxuHMQCb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,018,807 </b></td>
    <td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmmRjyOUb2Kc" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,948,063 </b></td>
    <td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zzG4uph8O9W5" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,010,096 </b></td>
    <td id="xdx_98F_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zlTL7c9tc2w" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>1,809,131 </b></td>
    <td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zuVCIo9EUJnf" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><b>5,786,097 </b></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock', window );">Schedule of changes in liabilities arising from financing activities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock_z8kQs7hpzSya" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 11)">
  <tr>
    <td style="vertical-align: bottom"><span id="xdx_8B7_zZMIgodaQ9w4" style="display: none">Schedule of changes in liabilities arising from financing activities</span></td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.55pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.85pt; text-align: right">&#160;</td>
    <td style="padding-right: 3.85pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.55pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>January 1, 2025</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"><span style="font-size: 7.5pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Additions and remeasurements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 12%; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2025</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right"><span style="font-size: 7.5pt"> </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Loans and financing</span></td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zNA3f0cYJtea" style="padding-right: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt">2,195,161</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zBOHFfbu0WLk" style="padding-right: 2.55pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(1,624,911)</span></td>
    <td id="xdx_98B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zoM0dpID9092" style="padding-right: 2.85pt; text-align: right" title="Payments of interest"><span style="font-size: 7.5pt">(274,265)</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zfy41l2ZmVW7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">1,494,881</span></td>
    <td id="xdx_989_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zL6iIrp0H5K" style="text-align: right" title="Interest"><span style="font-size: 7.5pt">252,870</span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zZv3GviSRJm7" style="text-align: right" title="Other"><span style="font-size: 7.5pt">10,531</span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbF8AF1o1TZg" style="padding-right: 5.55pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">2,054,267</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Lease liabilities</span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zu009vAZvI8k" style="padding-right: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt">978,336</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zEWih0Bgtcic" style="padding-right: 2.55pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(49,411)</span></td>
    <td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zymGryeACWE8" style="padding-right: 2.85pt; text-align: right" title="Payments of interest"><span style="font-size: 7.5pt">(121,475)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z0GSRMmdqvKl" style="padding-right: 3.85pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">136,714</span></td>
    <td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_ziiUPemjPDy7" style="text-align: right" title="Interest"><span style="font-size: 7.5pt">123,067</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zLUKEqMy2PCh" style="text-align: right" title="Other"><span style="font-size: 7.5pt">(1,485)</span></td>
    <td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zs5KiVN6Aop" style="padding-right: 5.55pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">1,065,746</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Dividends payable</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -0.1pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zkdrSnZEsdeg" style="border-bottom: Black 1pt solid; padding-right: -2.45pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(146,813)</span></td>
    <td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zIzXu7nINfsa" style="border-bottom: Black 1pt solid; padding-right: 2.85pt; text-align: right" title="Payments of interest"><span style="font-size: 7.5pt"><span style="-sec-ix-hidden: xdx2ixbrl3964">-</span></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zSKFp8AK9nof" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">147,005</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -1.15pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zfGZctHTOnVk" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">192</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_988_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231_z2WFPiVmqtNg" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt"><b>3,173,497</b></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zW2OqeMp5wTj" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt"><b>(1,821,135)</b></span></td>
    <td id="xdx_988_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231_zyK9JtYRGFM7" style="border-bottom: Black 1.5pt double; padding-right: 2.85pt; text-align: right" title="Payments of interest"><span style="font-size: 7.5pt"><b>(395,740)</b></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zLboev8UMJL5" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt"><b>1,778,600</b></span></td>
    <td id="xdx_984_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zc6UOhD4NaZ8" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-size: 7.5pt"><b>375,937</b></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zic6RnozFOs4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-size: 7.5pt"><b>9,046</b></span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231_zsWujkEPTGf7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt"><b>3,120,205</b></span></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>January 1, 2024</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"><span style="font-size: 7.5pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Additions and remeasurements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"><span style="font-size: 7.5pt"><b>Business combination</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2024</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.65pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Loans and financing</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zKLN9ka4wkFa" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt">1,800,775</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zpd5ABoY3Ux8" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(128,696)</span></td>
    <td id="xdx_985_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zWkWQ3p4CjV5" style="text-align: right" title="Payments of interest"><span style="font-size: 7.5pt">(177,192)</span></td>
    <td id="xdx_981_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbKqCmIGWnCi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">491,593</span></td>
    <td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIt7RnMFRZs2" style="padding-right: 5.65pt; text-align: right" title="Interest"><span style="font-size: 7.5pt">201,472</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znWYrJAD8V98" style="text-align: right" title="Business combination"><span style="font-size: 7.5pt">4,377</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zgrkIU4AjEdc" style="padding-right: 5.65pt; text-align: right" title="Other"><span style="font-size: 7.5pt">2,832</span></td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIa2SyBR9xF1" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">2,195,161</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Lease liabilities</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zrJRlVf7rEZ2" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt">874,569</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJdqASoXhjH9" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(41,221)</span></td>
    <td id="xdx_983_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zWU57RmUQDsi" style="text-align: right" title="Payments of interest"><span style="font-size: 7.5pt">(111,605)</span></td>
    <td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zWW85cX3A2Wd" style="padding-right: 5.65pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">117,897</span></td>
    <td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zAk44Z8kjpG8" style="padding-right: 5.65pt; text-align: right" title="Interest"><span style="font-size: 7.5pt">111,966</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxVzCn18NZsi" style="text-align: right" title="Business combination"><span style="font-size: 7.5pt">28,989</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zwRNvkPWEvc2" style="padding-right: 5.65pt; text-align: right" title="Other"><span style="font-size: 7.5pt">(2,259)</span></td>
    <td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zyna1kzChKhf" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">978,336</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Dividends payable</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zKUpL8DtHOc6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(18,289)</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ztZphFGnuay5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">18,289</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231_zTqseykaZ2Q" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt"><b>2,675,344</b></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z0g21NsOOJQe" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt"><b>(188,206)</b></span></td>
    <td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231_zWZQUxdK7b7d" style="border-bottom: Black 1.5pt double; text-align: right" title="Payments of interest"><span style="font-size: 7.5pt"><b>(288,797)</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zRV633tmfSy4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt"><b>627,779</b></span></td>
    <td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zFAZPF3WKB9e" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-size: 7.5pt"><b>313,438</b></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z1u2drMUfPgb" style="border-bottom: Black 1.5pt double; text-align: right" title="Business combination"><span style="font-size: 7.5pt"><b>33,366</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z33QO5joSqkl" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-size: 7.5pt"><b>573</b></span></td>
    <td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231_zeXUegstGWO9" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt"><b>3,173,497</b></span></td></tr>
  </table>
<p style="font: 10.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>January 1, 2023</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Payments of principal</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"><span style="font-size: 7.5pt"><b>Payments of interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Additions and remeasurements</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Interest</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Business combination</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 7.5pt"><b>Other</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"><span style="font-size: 7.5pt"><b>December 31, 2023</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Loans and financing</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zAbvHkGuABqk" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt">1,882,901</span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zep7lXZTg8Lk" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(112,630)</span></td>
    <td id="xdx_98D_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzIM7vMREBXk" style="text-align: right" title="Payments of interest"><span style="font-size: 7.5pt">(175,889)</span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z6oaoM6rGxYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">5,288</span></td>
    <td id="xdx_983_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z1Se6OcaDRl1" style="padding-right: 5.65pt; text-align: right" title="Interest"><span style="font-size: 7.5pt">197,678</span></td>
    <td style="padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zEnAymCsmtjl" style="padding-right: 5.65pt; text-align: right" title="Other"><span style="font-size: 7.5pt">3,427</span></td>
    <td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_ztYE4ee2JSN1" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">1,800,775</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Lease liabilities</span></td>
    <td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zfZOL2E5IoR" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt">769,525</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zCjCw1AzLStf" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(31,473)</span></td>
    <td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zhNowFen9q4i" style="text-align: right" title="Payments of interest"><span style="font-size: 7.5pt">(103,911)</span></td>
    <td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_za0sgkcc3XC3" style="padding-right: 5.65pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">77,715</span></td>
    <td id="xdx_98D_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zOIVXQn4FXFg" style="padding-right: 5.65pt; text-align: right" title="Interest"><span style="font-size: 7.5pt">100,849</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zdefxndxLZu4" style="padding-right: 5.65pt; text-align: right" title="Business combination"><span style="font-size: 7.5pt">65,408</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvUshu3gYp11" style="padding-right: 5.65pt; text-align: right" title="Other"><span style="font-size: 7.5pt">(3,544)</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxmeQ7tHH9j1" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt">874,569</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-size: 7.5pt">Dividends payable</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ztWQV1suQKy2" style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt">(18,750)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zuw744fAB3b5" style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right" title="Addition"><span style="font-size: 7.5pt">18,750</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"><span style="font-size: 7.5pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231_zGstjq78Ltrk" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-size: 7.5pt"><b>2,652,426</b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z3dzHL0Ons9f" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"><span style="font-size: 7.5pt"><b>(162,853)</b></span></td>
    <td id="xdx_98A_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231_zwhQDlB760Mc" style="border-bottom: Black 1.5pt double; text-align: right" title="Payments of interest"><span style="font-size: 7.5pt"><b>(279,800)</b></span></td>
    <td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zggXI22NMHrb" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions and remeasurements"><span style="font-size: 7.5pt"><b>101,753</b></span></td>
    <td id="xdx_984_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zqJhwB3cVi18" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-size: 7.5pt"><b>298,527</b></span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z33wsgDVjiD8" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-size: 7.5pt"><b>65,408</b></span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zJYub1gEgp12" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-size: 7.5pt"><b>(117)</b></span></td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231_z2j0PmtDGP03" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-size: 7.5pt"><b>2,675,344</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholders1Explanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholders1Explanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFairValuesFinancialInstrumentstTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFairValuesFinancialInstrumentstTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFairValuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFairValuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFinancialAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFinancialAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFinancialLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFinancialLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfLoansAndFinancingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfLoansAndFinancingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureLaborAndSocialObligationsAbstract', window );"><strong>Labor And Social Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFairValueOfStockOptionsGrantsExplanatory', window );">Schedule of grants of stock options</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfFairValueOfStockOptionsGrantsExplanatory_zvhZDc74HnA6" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B3_zGgNPB2SqyUj" style="display: none">Schedule of grants
of stock options</span></td>
    <td id="xdx_495_20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z6T0fZrOvqI5" style="text-align: center">&#160;</td>
    <td id="xdx_493_20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zK235Tb9bNp2" style="text-align: center">&#160;</td>
    <td id="xdx_497_20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zNZa1lSl2609" style="text-align: center">&#160;</td>
    <td id="xdx_49B_20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zNvkL1rYPUsa" style="text-align: center">&#160;</td>
    <td id="xdx_498_20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zs3ztMRbK1Bc" style="text-align: center">&#160;</td>
    <td id="xdx_49B_20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHa3XnkjJA68" style="text-align: center">&#160;</td>
    <td id="xdx_49A_20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3OIbkyhLU5h" style="text-align: center">&#160;</td>
    <td id="xdx_492_20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zfs4Xs9Cb3H4" style="text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>November</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2025</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>April</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2025</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 8%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>October</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2024</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 8%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>December</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 7%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>October</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 7%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>August</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 7%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>April</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 7%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>February</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="text-align: right"></td>
    <td style="text-align: right"></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr id="xdx_408_ecustom--NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement_pn3n3_zWqzUVBwknDh" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Amount</td>
    <td style="text-align: right">692,000</td>
    <td style="text-align: right">&#160;60,000 </td>
    <td style="text-align: right">113,900</td>
    <td style="text-align: right">232,000</td>
    <td style="text-align: right">37,000</td>
    <td style="text-align: right">153,000</td>
    <td style="text-align: right">30,000</td>
    <td style="text-align: right">15,000</td></tr>
  <tr id="xdx_403_ecustom--SharePriceFairValueAtMeasurementDate_pip0_zt6sMhDJPCK6" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Exercise price at the measurement date</td>
    <td style="text-align: right">R$62.57</td>
    <td style="text-align: right">R$79.91</td>
    <td style="text-align: right">R$73.75</td>
    <td style="text-align: right">R$60</td>
    <td style="text-align: right">R$59</td>
    <td style="text-align: right">R$59</td>
    <td style="text-align: right">R$57</td>
    <td style="text-align: right">R$56</td></tr>
  <tr id="xdx_404_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pip0_dp_zaQHGtSd4vK6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Dividend yield (%)</td>
    <td style="text-align: right">0%</td>
    <td style="text-align: right">0%</td>
    <td style="text-align: right">0%</td>
    <td style="text-align: right">0.0%</td>
    <td style="text-align: right">0.0%</td>
    <td style="text-align: right">0.0%</td>
    <td style="text-align: right">0.0%</td>
    <td style="text-align: right">0.0%</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Expected volatility (%)</td>
    <td style="text-align: right"><span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z3a2zokWHkni" title="Expected volatility">24</span>-<span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zhYY03hXbIyk" title="Expected volatility">41</span>%</td>
    <td style="text-align: right"><span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zmkAxaOJEPd2" title="Expected volatility">35</span>-<span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTPzINAqPsrj" title="Expected volatility">44</span>%</td>
    <td style="text-align: right"><span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zRDwFMzwknRb" title="Expected volatility">32</span>-<span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTaePcHfivNe" title="Expected volatility">45</span>%</td>
    <td style="text-align: right"><span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zsLUc0A16E82" title="Expected volatility">34</span>-<span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvQqfh9Pafxb" title="Expected volatility">56</span>%</td>
    <td style="text-align: right"><span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zdJiyIN9wYk6" title="Expected volatility">44</span>-<span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zD39cWsDcLQ1" title="Expected volatility">56</span>%</td>
    <td style="text-align: right"><span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOSZrXlcyZD3" title="Expected volatility">47</span>-<span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0TpV4isUZ76" title="Expected volatility">56</span>%</td>
    <td style="text-align: right"><span id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zzLnpWvuvqO2" title="Expected volatility">48</span>-<span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zeEOMDZRaeG8" title="Expected volatility">55</span>%</td>
    <td style="text-align: right"><span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDvwBftIf02h" title="Expected volatility">46</span>-<span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zbgyNuZPYWqg" title="Expected volatility">56</span>%</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Risk-free interest rate (%)</td>
    <td style="text-align: right"><span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zXhzqbtNwI24" title="Risk-free interest rate">13</span>-<span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zK64lbUpWev2" title="Risk-free interest rate">15</span>%</td>
    <td style="text-align: right"><span id="xdx_908_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zL4FuMa3ygfe" title="Risk-free interest rate">14</span>-<span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zpQqpMVYktCe" title="Risk-free interest rate">15</span>%</td>
    <td style="text-align: right"><span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8UuU76vuby2" title="Risk-free interest rate">11</span>-<span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZNJzCKOJZ7g" title="Risk-free interest rate">13</span>%</td>
    <td style="text-align: right"><span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zWqmaTXFX4I1" title="Risk-free interest rate">10</span>-<span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z3zFmkt2PGP4" title="Risk-free interest rate">11</span>%</td>
    <td style="text-align: right"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zSg6N5dHPT0l" title="Risk-free interest rate">11</span>-<span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zmZaF4bP4NKg" title="Risk-free interest rate">12</span>%</td>
    <td style="text-align: right"><span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zUFWKlQGKDx3" title="Risk-free interest rate">10</span>-<span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z4JquBKNxWlc" title="Risk-free interest rate">12</span>%</td>
    <td style="text-align: right"><span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLYSuS7KNh63" title="Risk-free interest rate">11</span>-<span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zI0vJM6gywRj" title="Risk-free interest rate">13</span>%</td>
    <td style="text-align: right"><span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zAJASHq0BBGh" title="Risk-free interest rate">13</span>%</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Expected life of stock options (years)</td>
    <td style="text-align: right"><span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0jLLW2lU6J3" title="Expected life of stock options">1</span>-<span id="xdx_90A_ecustom--ExpectedLifeOfStockOptions_dtY_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zcXSWBKRKiVi" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zJ5SPoXZEyX6" title="Expected life of stock options">1</span>-<span id="xdx_90C_ecustom--ExpectedLifeOfStockOptions_dtY_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z9CG5kRjj7C" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_90F_ecustom--ExpectedLifeOfStockOptions_dtY_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo1yo9kxDfY5" title="Expected life of stock options">1</span>-<span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zpwNuy5S3Tsf" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_900_ecustom--ExpectedLifeOfStockOptions_dtY_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zUUeOhGyCg0i" title="Expected life of stock options">1</span>-<span id="xdx_908_ecustom--ExpectedLifeOfStockOptions_dtY_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zKlUUVd2lpKh" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_904_ecustom--ExpectedLifeOfStockOptions_dtY_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLCObi1GJ524" title="Expected life of stock options">1</span>-<span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zp9XJ1CqRkm7" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCcJKVef1vV9" title="Expected life of stock options">1</span>-<span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_znWUS3p2NLj" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zXgdDziYvER" title="Expected life of stock options">1</span>-<span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zh9QH7khRfM8" title="Expected life of stock options">5</span></td>
    <td style="text-align: right"><span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0NENZi2yMJ4" title="Expected life of stock options">1</span>-<span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z7FWqTwEwbs" title="Expected life of stock options">5</span></td></tr>
  <tr id="xdx_409_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_pip0_zhSqRAp2Tre1" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Share price at the measurement date</td>
    <td style="text-align: right">R$79.36</td>
    <td style="text-align: right">R$107.33</td>
    <td style="text-align: right">R$92.78</td>
    <td style="text-align: right">R$100.97</td>
    <td style="text-align: right">R$79.12</td>
    <td style="text-align: right">R$76.45</td>
    <td style="text-align: right">R$62.51</td>
    <td style="text-align: right">R$70.69</td></tr>
  <tr id="xdx_40D_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_i" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Valuation model</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td>
    <td style="text-align: right">Binomial</td></tr>
  <tr id="xdx_406_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_pip0_z80Gu2ZEmFnh" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt">Weighted average fair value at the measurement date</td>
    <td style="text-align: right">R$33.27</td>
    <td style="text-align: right">R$45.95</td>
    <td style="text-align: right">R$39.71</td>
    <td style="text-align: right">R$54.25</td>
    <td style="text-align: right">R$38.67</td>
    <td style="text-align: right">R$37.04</td>
    <td style="text-align: right">R$32.04</td>
    <td style="text-align: right">R$29.54</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfSharebasedCompensationPlanExplanatory', window );">Schedule of movements in stock options</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfSharebasedCompensationPlanExplanatory_pn3n3_zFzoezmEhTV9" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details 1)">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8B0_zLGkJU0tLkH5" style="display: none">Schedule of movements in stock options</span></td>
    <td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td rowspan="2" style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>Weighted average exercise price</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>(in Brazilian Reais)</b></p></td>
    <td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 1pt solid; font: 8.5pt Nunito Sans; margin: 0; text-align: center"><b>Number of stock options</b></p></td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b>2025</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b>2024</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b>2023</b></span></td></tr>
  <tr>
    <td style="width: 39%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="vertical-align: bottom; width: 28%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"></td>
    <td style="white-space: nowrap; width: 11%; padding-left: 0.1in; font-size: 10pt; text-align: right">&#160;</td>
    <td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at January 1</b></span></td>
    <td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zraIJSzFCkke" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Outstanding at the beginning"><span style="font-size: 8.5pt"><b>67.31</b></span></td>
    <td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zO4kayTsCld6" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-size: 8.5pt"><b>1,610,679</b></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z5Q8ZFRA9Wtf" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-size: 8.5pt"><b>1,696,064</b></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHZagAo9RIX5" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><span style="font-size: 8.5pt"><b>3,729,287</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Granted</span></td>
    <td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zD1ZddyRkMke" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Granted"><span style="font-size: 8.5pt">63.95</span></td>
    <td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zarVmL6ef2xg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-size: 8.5pt">752,000</span></td>
    <td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z1kiz2uCbBz6" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-size: 8.5pt">113,900</span></td>
    <td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3IAUYRtt7q7" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"><span style="font-size: 8.5pt">467,000</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Exercised</span></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zpu4iEOMKoS1" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercised"><span style="font-size: 8.5pt">63.62</span></td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zxT2Mq5vrGY2" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-size: 8.5pt">(404,478)</span></td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGKd39zZRU7l" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-size: 8.5pt">(147,955)</span></td>
    <td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z9ZGh8Sebarh" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"><span style="font-size: 8.5pt">(164,214)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Stock options exchanged to RSUs</span></td>
    <td id="xdx_984_ecustom--WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_iI_pip0_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHdtqCer9AEf" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercised"><span style="font-size: 8.5pt"><span style="-sec-ix-hidden: xdx2ixbrl4273">-</span></span></td>
    <td id="xdx_98E_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zhsjUI4JlqAh" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, stock option exchanged"><span style="font-size: 8.5pt"><span style="-sec-ix-hidden: xdx2ixbrl4275">-</span></span></td>
    <td id="xdx_987_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmV62YvwqcVd" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, stock option exchanged"><span style="font-size: 8.5pt"><span style="-sec-ix-hidden: xdx2ixbrl4277">-</span></span></td>
    <td id="xdx_98B_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGxPS01O5x75" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, stock option exchanged"><span style="font-size: 8.5pt">(1,751,599)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Forfeited</span></td>
    <td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zaKvtHUKDlW8" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Forfeited"><span style="font-size: 8.5pt">72.42</span></td>
    <td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_ze6ykiFid7Kg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-size: 8.5pt">(57,152)</span></td>
    <td id="xdx_988_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zsidkfnTT7h4" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-size: 8.5pt">(16,182)</span></td>
    <td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zMsaiNPv6mCi" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"><span style="font-size: 8.5pt">(333,111)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Expired</span></td>
    <td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z8mHAL7v4bZe" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Expired"><span style="font-size: 8.5pt">68.54</span></td>
    <td id="xdx_987_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zPcEiMVVab3c" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"><span style="font-size: 8.5pt">(57,680)</span></td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z91sTDJENHc4" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Expired"><span style="font-size: 8.5pt">(35,148)</span></td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zQJsLxD7amw3" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"><span style="font-size: 8.5pt">(251,299)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at December 31</b></span></td>
    <td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zATYUtVrdlh7" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Outstanding at the ending"><span style="font-size: 8.5pt"><b>65.91</b></span></td>
    <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z2mW4KaitVZd" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-size: 8.5pt"><b>1,843,369</b></span></td>
    <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGitrYnMUbB8" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-size: 8.5pt"><b>1,610,679</b></span></td>
    <td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zV27MvxAdFne" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"><span style="font-size: 8.5pt"><b>1,696,064</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Exercisable</b></span></td>
    <td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pip0_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmDdNrIKSON5" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-size: 8.5pt"><b>71.33</b></span></td>
    <td id="xdx_98A_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zLVpGQ22dOC4" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"><span style="font-size: 8.5pt"><b>340,219</b></span></td>
    <td id="xdx_989_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zsJMf5UO94M6" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"><span style="font-size: 8.5pt"><b>427,202</b></span></td>
    <td id="xdx_981_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zK2nhsM4tARb" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"><span style="font-size: 8.5pt"><b>242,235</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfGrantsRestrictedStockUnitsTableTextBlock', window );">Schedule of grants of RSUs</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfGrantsRestrictedStockUnitsTableTextBlock_zV48BfBx6yL5" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details 2)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt"><span id="xdx_8BC_zuLxXAoP3M1" style="display: none">Schedule of grants
of RSUs</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>November</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2025</b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>April</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2025</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>October</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2024</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>December</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>October</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>August</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>April</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td>
    <td style="border-bottom: Black 1pt solid; width: 9%">
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>February</b></p>
    <p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"><b>2023</b></p></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: top; text-align: right"></td>
    <td style="vertical-align: top; text-align: right"></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Amount</td>
    <td id="xdx_989_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_zICCFZgsdfx2" style="text-align: right" title="Granted">346,000</td>
    <td id="xdx_985_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_z6wKGwWz9FZk" style="text-align: right" title="Granted">35,000</td>
    <td id="xdx_982_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zMXEDJuS1bJj" style="text-align: right" title="Granted">44,500</td>
    <td id="xdx_986_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_ztVtzmnIuLG6" style="text-align: right" title="Granted">76,600</td>
    <td id="xdx_982_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zpal9jAuBLck" style="text-align: right" title="Granted">63,000</td>
    <td id="xdx_989_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zE0O4ptKVl31" style="text-align: right" title="Granted">153,490</td>
    <td id="xdx_98B_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zhqa0iPvtezk" style="text-align: right" title="Granted">16,000</td>
    <td id="xdx_98F_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_z9yQzaTS6Xni" style="text-align: right" title="Granted">8,000</td></tr>

<tr style="background-color: White">
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt">Weighted average fair value at the measurement date</td>
    <td id="xdx_989_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_zWCPmhNdYxJ5" style="width: 9%; text-align: right" title="Fair values at grant date">R$79.36</td>
    <td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_zYJr10Oa09M7" style="width: 9%; text-align: right" title="Fair values at grant date">R$107.33</td>
    <td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zJGGHwdVffZ6" style="width: 9%; text-align: right" title="Fair values at grant date">R$92.78</td>
    <td id="xdx_98B_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zNvnzT4Y0cn7" style="width: 9%; text-align: right" title="Fair values at grant date">R$100.97</td>
    <td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zNMqQFYVlTlj" style="width: 9%; text-align: right" title="Fair values at grant date">R$79.12</td>
    <td id="xdx_98A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zieMWlWClbXe" style="width: 9%; text-align: right" title="Fair values at grant date">R$76.45</td>
    <td id="xdx_98D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zACW5bG8T6c5" style="width: 9%; text-align: right" title="Fair values at grant date">R$62.51</td>
    <td id="xdx_987_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zHw7SUIVdxTg" style="width: 9%; text-align: right" title="Fair values at grant date">R$70.69</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Vesting period (years)</td>
    <td style="text-align: right"><span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_znAcmh3mMXpd" title="Vesting period">1</span>-<span id="xdx_90A_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_z8OXOynCf8J1" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_zPILF04KSlvk" title="Vesting period">1</span>-<span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_z3MS7RGKoXof" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_90C_ecustom--GrantedVestingPeriod_dtY_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zphrbhAzCoq8" title="Vesting period">1</span>-<span id="xdx_905_ecustom--GrantedVestingPeriod_dtY_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_z7dAnJ3MghPc" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_90D_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zaLtoQSJ7M5a" title="Vesting period">1</span>-<span id="xdx_904_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zVKrezoWsjae" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_908_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zYwjdE4YIn46" title="Vesting period">1</span>-<span id="xdx_905_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_z02xbUIzr3Gj" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zqm69NMWJsNb" title="Vesting period">1</span>-<span id="xdx_90A_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zqGjtgM78qVf" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zKkh2qfBvsD" title="Vesting period">1</span>-<span id="xdx_90E_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_znKKKNNMnb5l" title="Vesting period">4</span></td>
    <td style="text-align: right"><span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zBt1kX2xCEok" title="Vesting period">1</span>-<span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zjJb7xEFaRql" title="Vesting period">4</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfStockOptionTableTextBlock', window );">Schedule of stock option</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfStockOptionTableTextBlock_pn3n3_zcaFvNJVhna3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details 3)">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><span id="xdx_8B7_zcQK8v9WNAh7" style="display: none">Schedule of stock option</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 49%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; text-indent: -9.35pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Outstanding at January 1</b></td>
    <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zKQADaIQ2OK3" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><b>656,634</b></td>
    <td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zva28bMgxnV3" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><b>854,431</b></td>
    <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zCE4lHvJhfBj" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the beginning"><b>447,224</b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Granted</td>
    <td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zXCsaRfq2Moj" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Granted">381,000</td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zIySk7IVqJo7" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Granted">44,500</td>
    <td id="xdx_98A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zYh56vwbBwEi" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Granted">317,090</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Stock options exchanged to RSUs</td>
    <td id="xdx_985_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zIXJzIvwsL02" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="-sec-ix-hidden: xdx2ixbrl4409">-</span></td>
    <td id="xdx_98E_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z4ggG1ljDdj5" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Stock options exchanged"><span style="-sec-ix-hidden: xdx2ixbrl4411">-</span></td>
    <td id="xdx_98B_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z46Le5Md8Qi1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Stock options exchanged">215,797</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Exercised</td>
    <td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z64yoxIWwf72" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Exercised">(224,070)</td>
    <td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zP2UEEmgRBZg" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Exercised">(222,910)</td>
    <td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z5CCL3T5mK66" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Exercised">(99,576)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt">Expired</td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zylOPFGb2J18" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Forfeited">(93,846)</td>
    <td id="xdx_989_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zaMTLE4Mao49" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Forfeited">(19,387)</td>
    <td id="xdx_986_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z0wLJ1wZxyMk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Forfeited">(26,104)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"><b>Outstanding at December 31</b></td>
    <td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zb2Uk8Lq4n7k" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the ending"><b>719,718</b></td>
    <td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zNE4wQnNJZ65" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the ending"><b>656,634</b></td>
    <td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zXzCqgWBYC7" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the ending"><b>854,431</b></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureLaborAndSocialObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureLaborAndSocialObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFairValueOfStockOptionsGrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFairValueOfStockOptionsGrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfGrantsRestrictedStockUnitsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfGrantsRestrictedStockUnitsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfSharebasedCompensationPlanExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfSharebasedCompensationPlanExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfStockOptionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfStockOptionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureEquityAbstract', window );"><strong>Disclosure Equity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfTreasurySharesMovementExplanatory', window );">Schedule of number and movements in treasury shares</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfTreasurySharesMovementExplanatory_pn3n3_zFqys31Z6pmf" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Equity (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span id="xdx_8B7_z1lKQEh9mEhe" style="display: none">Schedule
    of number and movements in treasury shares</span></td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 48%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-size: 8.5pt"><b>Number of treasury shares</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 29%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"><span style="font-size: 8.5pt"><b>Average price (in Brazilian Reais)</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td>
    <td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at January 1, 2023</b></span></td>
    <td id="xdx_98E_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20230101__20231231_zLIRN8DzrJs6" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"><span style="font-size: 8.5pt"><b>3,786,285</b></span></td>
    <td id="xdx_987_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20230101__20231231_zp4RN1pSehDc" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"><span style="font-size: 8.5pt"><b>80.54</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Repurchased</span></td>
    <td id="xdx_986_ecustom--NumberOfSharesRepurchased_pip0_c20230101__20231231_zIFiSsp7ZrU6" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"><span style="font-size: 8.5pt">216,339</span></td>
    <td id="xdx_98A_ecustom--AveragePriceRepurchased_pip0_c20230101__20231231_zKgY03FRrdij" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"><span style="font-size: 8.5pt">57.17</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Delivered under the share-based compensation plans</span></td>
    <td id="xdx_982_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20230101__20231231_zBTy8AECDH69" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"><span style="font-size: 8.5pt">(229,146)</span></td>
    <td id="xdx_989_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20230101__20231231_z3ymjGJWvvn4" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"><span style="font-size: 8.5pt">79.28</span></td></tr>

<tr style="background-color: White">
    <td style="width: 48%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at December 31, 2023</b></span></td>
    <td id="xdx_98A_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20240101__20241231_zQzjgrbWJZt" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"><span style="font-size: 8.5pt"><b>3,773,478</b></span></td>
    <td id="xdx_98A_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20240101__20241231_zN8rACYg7P9c" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 29%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"><span style="font-size: 8.5pt"><b>79.28</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Delivered under the share-based compensation plans</span></td>
    <td id="xdx_983_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20240101__20241231_zWarKk2kBdBc" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"><span style="font-size: 8.5pt">(317,940)</span></td>
    <td id="xdx_98D_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20240101__20241231_ze05wOtMOcog" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"><span style="font-size: 8.5pt">79.28</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding at December 31, 2024</b></span></td>
    <td id="xdx_98C_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20250101__20251231_zjJrbHUyw2Da" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"><span style="font-size: 8.5pt"><b>3,455,538</b></span></td>
    <td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20250101__20251231_znhjjQqlaLG8" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"><span style="font-size: 8.5pt"><b>79.28</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Repurchased</span></td>
    <td id="xdx_98D_ecustom--NumberOfSharesRepurchased_pip0_c20250101__20251231_zpFkaLnJResk" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"><span style="font-size: 8.5pt">966,541 </span></td>
    <td id="xdx_989_ecustom--AveragePriceRepurchased_pip0_c20250101__20251231_zD2WH79RwTml" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"><span style="font-size: 8.5pt">80.24</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt">Delivered under the share-based compensation plans</span></td>
    <td id="xdx_984_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20250101__20251231_zdMXbpddoxZ9" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"><span style="font-size: 8.5pt">(566,929)</span></td>
    <td id="xdx_98C_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20250101__20251231_zFTLvkjxLdK2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"><span style="font-size: 8.5pt">79.28 </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-size: 8.5pt"><b>Outstanding
at December 31, 2025 </b></span></td>
    <td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iE_pip0_c20250101__20251231_znR8iogO0UV9" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at ending balance"><span style="font-size: 8.5pt"><b>3,855,150 </b></span></td>
    <td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20250101__20251231_zF8D1o4cTSIj" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at ending balance"><span style="font-size: 8.5pt"><b>79.52 </b></span></td></tr>
  </table>
<p style="font: 8.5pt Nunito Sans; margin: 0"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfTreasurySharesMovementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfTreasurySharesMovementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfEarningsPerShareTableExplanatory', window );">Schedule of earnings per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--ScheduleOfEarningsPerShareTableExplanatory_pn3n3_zh6rgpEuBgn5" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Earnings per share (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt"><span id="xdx_8B9_zodizhWBFyXc" style="display: none">Schedule of earnings per share</span></td>
    <td id="xdx_496_20250101_20251231" style="padding-right: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_494_20240101_20241231" style="padding-right: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_492_20230101_20231231" style="padding-right: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 67%; padding-right: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><b>2023</b></td></tr>
  <tr id="xdx_400_ecustom--NumeratorAbstract_iB_z0RC0JVRVHcj">
    <td style="padding-right: 5.4pt"><b>Numerator</b></td>

    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_40C_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_pn3n3_zNvLq2og6BKi" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt">Net income attributable to the owners of the Company</td>
    <td style="padding-right: 5.4pt; text-align: right">752,461</td>
    <td style="padding-right: 5.4pt; text-align: right">631,510</td>
    <td style="padding-right: 5.4pt; text-align: right">386,324</td></tr>
  <tr id="xdx_40C_ecustom--DenominatorAbstract_iB_zPDlgkbW8LBa" style="background-color: White">
    <td style="padding-right: 5.4pt"><b>Denominator</b></td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_404_eifrs-full--WeightedAverageShares_pip0_zkwRAE4k6qQ1" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt">Weighted average number of outstanding shares</td>
    <td style="padding-right: 5.4pt; text-align: right">90,475,878</td>
    <td style="padding-right: 5.4pt; text-align: right">90,122,429</td>
    <td style="padding-right: 5.4pt; text-align: right">89,830,351</td></tr>
  <tr id="xdx_40B_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pip0_zd5BBGZokSp5" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt">Effects of dilution from stock options and restricted stock units</td>
    <td style="padding-right: 5.4pt; text-align: right">791,733</td>
    <td style="padding-right: 5.4pt; text-align: right">1,032,207</td>
    <td style="padding-right: 5.4pt; text-align: right">706,492</td></tr>
  <tr id="xdx_409_eifrs-full--AdjustedWeightedAverageShares_pip0_uShares_znBfrJta8Odd" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt">Weighted average number of outstanding shares adjusted for the effect of dilution</td>
    <td style="padding-right: 5.4pt; text-align: right">91,267,611</td>
    <td style="padding-right: 5.4pt; text-align: right">91,154,636</td>
    <td style="padding-right: 5.4pt; text-align: right">90,536,843</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_408_eifrs-full--BasicEarningsLossPerShare_pip0_zvR340v2rBd4" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Basic earnings per share (R$)</td>
    <td style="padding-right: 5.4pt; text-align: right">8.32</td>
    <td style="padding-right: 5.4pt; text-align: right">7.01</td>
    <td style="padding-right: 5.4pt; text-align: right">4.30</td></tr>
  <tr id="xdx_40E_eifrs-full--DilutedEarningsLossPerShare_pip0_z1dVhWo7H7Ze" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">Diluted earnings per share (R$)</td>
    <td style="padding-right: 5.4pt; text-align: right">8.24</td>
    <td style="padding-right: 5.4pt; text-align: right">6.93</td>
    <td style="padding-right: 5.4pt; text-align: right">4.27</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfEarningsPerShareTableExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfEarningsPerShareTableExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfNetSalesRevenueExplanatory', window );">Schedule of net sales revenue</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfNetSalesRevenueExplanatory_pn3n3_zCw9eshgzik3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Revenue (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt"><span id="xdx_8BA_zPRZBJnC7Fod" style="display: none">Schedule of net sales revenue</span></td>
    <td id="xdx_49B_20250101__20251231_z0k2DkE3dr21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20240101__20241231_zTfpTc16bgq8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td id="xdx_49A_20230101__20231231_zHaKiN8J6dZ3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 67%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>

    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ProfessionalFeesExpenses_pn3n3_zyjYbgSzo7D4" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt">Tuition fees</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">4,684,322 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">4,052,379 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3,505,250</td></tr>
  <tr id="xdx_407_ecustom--OtherRevenue1_pn3n3_zK2rOdtULspa" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt">Other</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">331,934 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">305,527 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">263,937</td></tr>
  <tr id="xdx_40C_ecustom--DeductionAbstract_iB_zmierXsa5567" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt"><b>Deductions</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DeductionOfGrantedDiscounts_pn3n3_zmSi6w4vfHif" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt">Discount and scholarships</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(685,219)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(515,311)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(435,368)</td></tr>
  <tr id="xdx_40E_ecustom--DeductionOfReturnsOfNetRevenue_pn3n3_zyxMaG0JrtEd" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt">Returns</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(31,665)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(25,312)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(27,743)</td></tr>
  <tr id="xdx_405_ecustom--DeductionOfTaxes_pn3n3_ztUq5OcAl3ye" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt">Taxes</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(194,477)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(170,628)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(142,825)</td></tr>
  <tr id="xdx_405_ecustom--DeductionOfProuni_pn3n3_zMQegXTjKfub" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt">PROUNI</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(407,640)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(342,326)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(287,338)</td></tr>
  <tr id="xdx_40C_eifrs-full--RevenueFromContractsWithCustomers_pn3n3_zENpZA0g604i" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><b style="display: none">Revenue from contracts with customers</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>3,697,255 </b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>3,304,329 </b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2,875,913</b></td></tr>
  <tr id="xdx_401_ecustom--TimingOfRevenueRecognition_iB_zmLCzlqisHAi" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt"><b>Timing of revenue recognition</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_400_ecustom--TransferredOverTime_pn3n3_znL7OQZVEgVg" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt">Transferred over time</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3,618,234 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3,242,035 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">2,821,251</td></tr>
  <tr id="xdx_40E_ecustom--TransferredAtPointInTime_pn3n3_zJDK3Rvkhymh" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 1.7pt">Transferred at a point in time</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">79,021 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">62,294 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">54,662</td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfRevenueBySegmentTableTextBlock', window );">Schedule of revenue by segment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfRevenueBySegmentTableTextBlock_pn3n3_zkBZ5wNRCs13" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Revenue (Details 1)">
  <tr>
    <td style="vertical-align: top; text-align: justify"><span id="xdx_8BA_zmVU54gwzEyj" style="display: none">Schedule of revenue by
    segment</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Undergraduate</b></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Continuing education</b></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Medical practice solutions</b></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Elimination (inter-segment transactions)</b></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><b>2025</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: -5.55pt; padding-left: 5.4pt; text-align: right"></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><b>Types of services or goods</b></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zDQtF0xJChc1" style="text-align: right" title="Types of services or goods"><b>3,255,426 </b></td>
    <td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z1ZBu6QWj095" style="text-align: right" title="Types of services or goods"><b>284,471 </b></td>
    <td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zvdxvb73LEEh" style="text-align: right" title="Types of services or goods"><b>171,323 </b></td>
    <td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zd9whSpsZVi9" style="text-align: right" title="Types of services or goods"><b>(13,965)</b></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231_zSOGH5Xnb3pe" style="text-align: right" title="Types of services or goods"><b>3,697,255 </b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Tuition fees</td>
    <td id="xdx_984_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zxTj7MtzKt5d" style="text-align: right" title="Tuition fees">3,239,729 </td>
    <td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zew0tg46xSEe" style="text-align: right" title="Tuition fees">187,707 </td>
    <td id="xdx_986_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zqPYhTs7AE04" style="text-align: right" title="Tuition fees"><span style="-sec-ix-hidden: xdx2ixbrl4640">-</span></td>
    <td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zSa4HZ6N1R8c" style="text-align: right" title="Tuition fees"><span style="-sec-ix-hidden: xdx2ixbrl4642">-</span></td>
    <td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231_z2zUfl474Gf9" style="text-align: right" title="Tuition fees">3,427,436 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Other</td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zr5a9NuReNjl" style="text-align: right" title="Other">15,697 </td>
    <td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zMZj6PRwKhUl" style="text-align: right" title="Other">96,764 </td>
    <td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z2y6DeN77sPj" style="text-align: right" title="Other">171,323 </td>
    <td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z9JjdkDCSW9l" style="text-align: right" title="Other">(13,965)</td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231_zIR2Ku5Qv4pc" style="text-align: right" title="Other">269,819 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><b>Timing of revenue recognition</b></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z9z7x0eRjU47" style="text-align: right" title="Timing of revenue recognition"><b>3,255,426 </b></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLNQK7yhLHA6" style="text-align: right" title="Timing of revenue recognition"><b>284,471 </b></td>
    <td id="xdx_985_ecustom--TimingRevenueRecognition_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>171,323 </b></td>
    <td id="xdx_98E_ecustom--TimingRevenueRecognition_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>(13,965)</b></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_c20250101__20251231_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>3,697,255 </b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Transferred over time</td>
    <td id="xdx_98F_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjMafsieeqX9" style="text-align: right" title="Transferred over time">3,239,729 </td>
    <td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zKc0tSs6qB0a" style="text-align: right" title="Transferred over time">223,774 </td>
    <td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zlzJtCMPRm29" style="text-align: right" title="Transferred over time">168,696 </td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z6s05TJfK2F4" style="text-align: right" title="Transferred over time">(13,965)</td>
    <td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231_zRSIzEW3h2ii" style="text-align: right" title="Transferred over time">3,618,234 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Transferred at a point in time</td>
    <td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zLuuUHMjM7jg" style="text-align: right" title="Transferred at a point in time">15,697 </td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Transferred at a point in time">60,697 </td>
    <td id="xdx_98C_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time">2,627 </td>
    <td id="xdx_98F_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"><span style="-sec-ix-hidden: xdx2ixbrl4682">-</span></td>
    <td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231_pn3n3" style="text-align: right" title="Transferred at a point in time">79,021 </td></tr>
  </table>
<p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Undergraduate</b></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Continuing education</b></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Medical practice solutions</b></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Elimination (inter-segment transactions)</b></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><b>2024</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><b>Types of services or goods</b></td>
    <td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z61D4ieGN1Q5" style="text-align: right" title="Types of services or goods"><b>2,895,692</b></td>
    <td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsearJYQim93" style="text-align: right" title="Types of services or goods"><b>255,438</b></td>
    <td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zZQZ6vbN1941" style="text-align: right" title="Types of services or goods"><b>161,787</b></td>
    <td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zn8hHwScifS3" style="text-align: right" title="Types of services or goods"><b>(8,588)</b></td>
    <td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231_znjkGmFJR3K6" style="text-align: right" title="Types of services or goods"><b>3,304,329</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Tuition fees</td>
    <td id="xdx_987_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zHCrZk6cnSFb" style="text-align: right" title="Tuition fees">2,877,731</td>
    <td id="xdx_988_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvaF2I7AKls" style="text-align: right" title="Tuition fees">122,391</td>
    <td id="xdx_98E_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zixdSE6vsQe4" style="text-align: right" title="Tuition fees"><span style="-sec-ix-hidden: xdx2ixbrl4700">-</span></td>
    <td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zs3LypPBHb69" style="text-align: right" title="Tuition fees"><span style="-sec-ix-hidden: xdx2ixbrl4702">-</span></td>
    <td id="xdx_98A_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231_znq0h0wEsSjk" style="text-align: right" title="Tuition fees">3,000,122</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Other</td>
    <td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zF42nkGGAJY7" style="text-align: right" title="Other">17,961</td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSoGowoPnyC3" style="text-align: right" title="Other">133,047</td>
    <td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zWrG05yAV7me" style="text-align: right" title="Other">161,787</td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zFovuHVYo7Ah" style="text-align: right" title="Other">(8,588)</td>
    <td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231_zM1MLMyzaWA1" style="text-align: right" title="Other">304,207</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><b>Timing of revenue recognition</b></td>
    <td id="xdx_983_ecustom--TimingRevenueRecognition_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zid68DJq1ZUh" style="text-align: right" title="Timing of revenue recognition"><b>2,895,692</b></td>
    <td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zM1wOFLICcwg" style="text-align: right" title="Timing of revenue recognition"><b>255,438</b></td>
    <td id="xdx_987_ecustom--TimingRevenueRecognition_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>161,787</b></td>
    <td id="xdx_98C_ecustom--TimingRevenueRecognition_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>(8,588)</b></td>
    <td id="xdx_983_ecustom--TimingRevenueRecognition_c20240101__20241231_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>3,304,329</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Transferred over time</td>
    <td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zOD21ltPW7m6" style="text-align: right" title="Transferred over time">2,877,731</td>
    <td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdJcmR8TcIMe" style="text-align: right" title="Transferred over time">218,573</td>
    <td id="xdx_983_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z2oKNgmjiOn9" style="text-align: right" title="Transferred over time">154,319</td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zjnVkS5xFLbd" style="text-align: right" title="Transferred over time">(8,588)</td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231_zUfbeLioV3A9" style="text-align: right" title="Transferred over time">3,242,035</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Transferred at a point in time</td>
    <td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z64dbGHZABl2" style="text-align: right" title="Transferred at a point in time">17,961</td>
    <td id="xdx_980_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Transferred at a point in time">36,865</td>
    <td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zJORSYj10usj" style="text-align: right" title="Transferred at a point in time">7,468</td>
    <td id="xdx_989_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"><span style="-sec-ix-hidden: xdx2ixbrl4742">-</span></td>
    <td id="xdx_983_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231_pn3n3" style="text-align: right" title="Transferred at a point in time">62,294</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>







<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%">
  <tr style="vertical-align: bottom">
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Undergraduate</b></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Continuing education</b></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Medical practice solutions</b></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b>Elimination (inter-segment transactions)</b></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"><b>2023</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><b>Types of services or goods</b></td>
    <td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zjhX9wnJre25" style="text-align: right" title="Types of services or goods"><b>2,511,018</b></td>
    <td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRM8QS6uSIK9" style="text-align: right" title="Types of services or goods"><b>235,830</b></td>
    <td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z55qWKfUG7Ng" style="text-align: right" title="Types of services or goods"><b>140,282</b></td>
    <td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zm2MyO4OJAk" style="text-align: right" title="Types of services or goods"><b>(11,217)</b></td>
    <td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231_zld4rMWWtk1e" style="text-align: right" title="Types of services or goods"><b>2,875,913</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Tuition fees</td>
    <td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXnykqmuOb69" style="text-align: right" title="Tuition fees">2,494,121</td>
    <td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zw7rBSOvZ6T4" style="text-align: right" title="Tuition fees">146,477</td>
    <td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zmLHQC59KzQ8" style="text-align: right" title="Tuition fees"><span style="-sec-ix-hidden: xdx2ixbrl4762">-</span></td>
    <td id="xdx_989_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_ztpdXN4ZDpNg" style="text-align: right" title="Tuition fees"><span style="-sec-ix-hidden: xdx2ixbrl4764">-</span></td>
    <td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231_zT5GwOoPWnhb" style="text-align: right" title="Tuition fees">2,640,598</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Other</td>
    <td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zSfGsU9WK1V3" style="text-align: right" title="Other">16,897</td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z8MJnsPKy61d" style="text-align: right" title="Other">89,353</td>
    <td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLgl9PjD0rf1" style="text-align: right" title="Other">140,282</td>
    <td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zsfYdgiqpKu2" style="text-align: right" title="Other">(11,217)</td>
    <td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231_zx3Tmn32k685" style="text-align: right" title="Other">235,315</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><b>Timing of revenue recognition</b></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>2,511,018</b></td>
    <td id="xdx_98F_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>235,830</b></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>140,282</b></td>
    <td id="xdx_981_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>(11,217)</b></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_c20230101__20231231_pn3n3" style="text-align: right" title="Timing of revenue recognition"><b>2,875,913</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify">Transferred over time</td>
    <td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zeYsuWApdDMd" style="text-align: right" title="Transferred over time">2,494,121</td>
    <td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zDYgQqqNhTW6" style="text-align: right" title="Transferred over time">206,098</td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z7ou3VsSQmAj" style="text-align: right" title="Transferred over time">132,249</td>
    <td id="xdx_988_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zkn5kwaV5YV9" style="text-align: right" title="Transferred over time">(11,217)</td>
    <td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231_zyfOVLAEXie3" style="text-align: right" title="Transferred over time">2,821,251</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify">Transferred at a point in time</td>
    <td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_pn3n3" style="text-align: right" title="Transferred at a point in time">16,897</td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Transferred at a point in time">29,732</td>
    <td id="xdx_981_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time">8,033</td>
    <td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"><span style="-sec-ix-hidden: xdx2ixbrl4804">-</span></td>
    <td id="xdx_981_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231_pn3n3" style="text-align: right" title="Transferred at a point in time">54,662</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfNetSalesRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfNetSalesRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfRevenueBySegmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfRevenueBySegmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Costs and expenses by nature (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfExpensesByNatureTableTextBlock', window );">Schedule of expenses by nature</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--ScheduleOfExpensesByNatureTableTextBlock_pn3n3_z8n8gPs6GOn7" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Costs and expenses by nature (Details)">
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B7_zSWywQzRhBog" style="display: none">Schedule of expenses by nature</span></td>
    <td id="xdx_491_20250101__20251231_ztmpjTt7nWO4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_492_20240101__20241231_zIbN2xqQL1Ch" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td>
    <td id="xdx_492_20230101__20231231_zPl01Wd7Pyw1" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 67%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_400_ecustom--Payroll_pn3n3_zhzXb4JCmU65" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Payroll (i)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,370,361)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,236,666)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,149,225)</td></tr>
  <tr id="xdx_40C_ecustom--HospitalAndMedicalAgreements_pn3n3_zP5AfY4TrlNb" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Hospital and medical agreements</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(80,449)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(94,583)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(86,151)</td></tr>
  <tr id="xdx_40C_eifrs-full--DepreciationExpense_iN_pn3n3_di_zp1OnaJxg55c" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Depreciation and amortization</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(373,344)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(333,341)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(289,511)</td></tr>
  <tr id="xdx_401_ecustom--LeaseExpenses_pn3n3_zlDGpVvRi4M7" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Lease expenses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(12,617)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(11,207)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(10,871)</td></tr>
  <tr id="xdx_408_eifrs-full--UtilitiesExpense_pn3n3_za8Rpqn1pGif" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Utilities</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(24,722)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(22,730)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(20,403)</td></tr>
  <tr id="xdx_402_eifrs-full--RepairsAndMaintenanceExpense_iN_pn3n3_di_zPtLi7zS7u5h" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Maintenance</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(134,156)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(127,777)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(105,919)</td></tr>
  <tr id="xdx_401_ecustom--SharesBasedCompensation_pn3n3_zqyPtLzbQrta" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Share-based compensation</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(15,318)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(32,424)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(31,535)</td></tr>
  <tr id="xdx_40B_ecustom--TaxExpenses_pn3n3_zRxtcxX9pDva" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Tax expenses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(12,091)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(12,105)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(14,447)</td></tr>
  <tr id="xdx_402_eifrs-full--SalesAndMarketingExpense_iN_pn3n3_di_zqVVQzAKi2Ai" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Sales and marketing</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(114,803)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(85,469)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(74,140)</td></tr>
  <tr id="xdx_40E_ecustom--AllowanceForExpectedCreditLosses_iN_pn3n3_di_zf0JeQaGosQ" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Allowance for expected credit losses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(57,090)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(60,894)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(74,552)</td></tr>
  <tr id="xdx_404_eifrs-full--TravelExpense_iN_pn3n3_di_zSD3f0OT7H1a" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Travel expenses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(26,144)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(20,345)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(16,098)</td></tr>
  <tr id="xdx_408_ecustom--ConsultingFees_pn3n3_zgPQU4AwbE6f" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Consulting fees</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(32,645)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(46,022)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(62,630)</td></tr>
  <tr id="xdx_40E_ecustom--CostExpensesOther_pn3n3_zHLtud2AJk6c" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Other</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(230,310)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(201,361)</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(189,015)</td></tr>
  <tr id="xdx_404_eifrs-full--ExpenseByNature_pn3n3_zzBi1VnZmmo3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b style="display: none">Total</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(2,484,050)</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(2,284,924)</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>(2,124,497)</b></td></tr>
  <tr id="xdx_40A_ecustom--CostOfServices_iN_pn3n3_di_zBaib3z8pSK8" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Cost of services</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,313,895)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,215,603)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,109,813)</td></tr>
  <tr id="xdx_401_ecustom--SellingGeneralAndAdministrativeExpenses_pn3n3_zEh8NUxuJNRa" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Selling, general and administrative expenses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,113,065)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(1,008,427)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(940,132)</td></tr>
  <tr id="xdx_40E_ecustom--AllowanceForExpectedCreditLosses_iN_pn3n3_di_zDLa9JtSQi3c" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Allowance for expected credit losses</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(57,090)</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(60,894)</td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">(74,552)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfExpensesByNatureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfExpensesByNatureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance result (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfFinanceResultTableTextBlock', window );">Schedule of finance result</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfFinanceResultTableTextBlock_pn3n3_zmguLDbLBLwe" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Finance result (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BC_zQxOLJJVwUF6" style="display: none">Schedule of finance result</span></td>
    <td id="xdx_490_20250101__20251231_z5XTmwejGJF" style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: center">&#160;</td>
    <td id="xdx_496_20240101__20241231_z7TM4d819HD9" style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: center">&#160;</td>
    <td id="xdx_494_20230101__20231231_zboKnwVvvkTl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 67%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_407_ecustom--FinancialIncomeFromCashEquivalents_pn3n3_zp9TewKkqima" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Financial income from cash equivalents</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">138,456 </td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">59,381 </td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">73,672</td></tr>
  <tr id="xdx_40E_ecustom--InterestEarned_pn3n3_zdzzJBRVS35i" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Interest earned</td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt">49,527 </td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt">43,417 </td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt">33,450</td></tr>
  <tr id="xdx_400_eifrs-full--OtherFinanceIncome_pn3n3_zmOsmHpFjVXe" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Other</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">6,960 </td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8,485 </td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3,520</td></tr>
  <tr id="xdx_40D_eifrs-full--FinanceIncome_pn3n3_zttyz74oPGP5" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Finance income</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>194,943 </b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>111,283 </b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>110,642</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_408_ecustom--InterestExpense1_pn3n3_zTiLXuBq4Qy8" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Interest expense</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(316,379)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(254,386)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(285,447)</td></tr>
  <tr id="xdx_404_ecustom--InterestExpenseOnLeaseLiabilities1_pn3n3_zQxZ5WvUitK5" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Interest expense on lease liabilities</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(123,067)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(111,966)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(100,849)</td></tr>
  <tr id="xdx_40C_ecustom--FinancialDiscountsGrantedExpenses_pn3n3_zyXc0MxQd62e" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Financial discounts</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(54,254)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(33,240)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(30,891)</td></tr>
  <tr id="xdx_40D_ecustom--CreditCardCharges_pn3n3_zZe32h7X88cf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Credit card charges</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(6,901)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(5,824)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(4,096)</td></tr>
  <tr id="xdx_401_eifrs-full--BankAndSimilarCharges_iN_pn3n3_di_zGHj6RIWz7ce" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Bank fees</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(3,882)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(4,436)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(7,163)</td></tr>
  <tr id="xdx_40C_ecustom--ExchangeVariance_pn3n3_zT8vAy3GhiG" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Exchange variance</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(3,095)</td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(8,944) </td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(681)</td></tr>
  <tr id="xdx_40E_eifrs-full--OtherFinanceCost_iN_pn3n3_di_zwooNXSZn4A1" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Other</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(53,446)</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(39,946)</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(28,489)</td></tr>
  <tr id="xdx_403_eifrs-full--FinanceCosts_iN_pn3n3_di_z37ZFntzkeef" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Finance expenses</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(561,024)</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(458,742)</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(457,616)</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr id="xdx_402_ecustom--FinanceResult_pn3n3_zqXa2TCxRASg" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Net finance result</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(366,081)</b></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(347,459)</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>(346,974)</b></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFinanceResultTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFinanceResultTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureIncomeTaxesAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory', window );">Schedule of reconciliation of income tax expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_pn3n3_zOxwNd11tMSj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Income taxes (Details)">
  <tr style="background-color: White">
    <td style="white-space: nowrap"><span id="xdx_8BB_znVL8y7kXDX1" style="display: none">Schedule of reconciliation of income tax expense</span></td>
    <td id="xdx_495_20250101__20251231_znOokTZwOfY" style="text-align: center">&#160;</td>
    <td id="xdx_491_20240101__20241231_zxnR448aq4pd" style="text-align: center">&#160;</td>
    <td id="xdx_496_20230101__20231231_zXGdEcLS8i1h" style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; width: 67%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: right"></td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zdA3kZpuMZQ1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap">Income before income taxes</td>
    <td style="text-align: right">860,945 </td>
    <td style="text-align: right">676,391 </td>
    <td style="vertical-align: bottom; text-align: right">429,582</td></tr>
  <tr id="xdx_40D_eifrs-full--ApplicableTaxRate_pip0_dp_zaV7iIeDH041" style="background-color: White">
    <td style="white-space: nowrap">Statutory income taxes rate</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">34%</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">34%</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right">34%</td></tr>
  <tr id="xdx_40C_ecustom--TaxExpensesIncomeAtApplicableTaxRate_z5Pa0PaAdwo1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><b>Income taxes at statutory rate</b></td>
    <td style="text-align: right"><b>(292,721)</b></td>
    <td style="text-align: right"><b>(229,973)</b></td>
    <td style="vertical-align: bottom; text-align: right"><b>(146,058)</b></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap">&#160;</td>
    <td style="border-top: Black 1pt solid; text-align: right">&#160;</td>
    <td style="border-top: Black 1pt solid; text-align: right">&#160;</td>
    <td style="border-top: Black 1pt solid; vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--ReconciliationAdjustmentsAbstract_iB_zDs3502i5SCl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><b>Reconciliation adjustments:</b></td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pn3n3_zjUOl0PuFLEc" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Tax effect on loss from entities not subject to taxation</td>
    <td style="text-align: right">(20,042)</td>
    <td style="text-align: right">(37,007)</td>
    <td style="vertical-align: bottom; text-align: right">(32,274)</td></tr>
  <tr id="xdx_40B_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pn3n3_z3A1YRZV4sVk" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt">PROUNI - Fiscal incentive (i)</td>
    <td style="text-align: right">454,380 </td>
    <td style="text-align: right">379,747 </td>
    <td style="vertical-align: bottom; text-align: right">309,952</td></tr>
  <tr id="xdx_404_ecustom--UnrecognizedDeferredTaxesAssetsOnTaxLosses_pn3n3_zyyE9Npa9aek" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Unrecognized deferred taxes assets on tax losses</td>
    <td style="text-align: right">(161,215)</td>
    <td style="text-align: right">(130,074)</td>
    <td style="vertical-align: bottom; text-align: right">(154,062)</td></tr>
  <tr id="xdx_40A_ecustom--RecognisedDeferredTaxAssets_pn3n3_zyYpSoQ1tHI9" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt">Recognized deferred taxes</td>
    <td style="text-align: right">40,826 </td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4969">-</span></td>
    <td style="vertical-align: bottom; text-align: right">3,233</td></tr>
  <tr id="xdx_40E_ecustom--TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_iN_pn3n3_di_zbIKRq0QB2n7" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Presumed profit income tax regime effect (ii)</td>
    <td style="text-align: right">(372)</td>
    <td style="text-align: right">338 </td>
    <td style="vertical-align: bottom; text-align: right">(8,787)</td></tr>
  <tr id="xdx_404_ecustom--PermanentAdjustmentsAbstract_iB_zb7VvPCHDIq4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt"><b>Permanent adjustments:</b></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--PermanentAdjustmentsManagementBonuses_pn3n3_zz0hgbw2jKu" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 14.2pt">Management bonuses</td>
    <td style="text-align: right">(9,146)</td>
    <td style="text-align: right">(6,533)</td>
    <td style="vertical-align: top; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4982">-</span></td></tr>
  <tr id="xdx_408_ecustom--PermanentAdjustmentsGifts_pn3n3_zPofg9EGKgjl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 14.2pt">Gifts</td>
    <td style="text-align: right">(1,742)</td>
    <td style="text-align: right">(1,655)</td>
    <td style="vertical-align: top; text-align: right">(1,552)</td></tr>
  <tr id="xdx_40C_ecustom--PermanentAdjustmentsSponsorship_pn3n3_zv71dBpa4083" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 14.2pt">Sponsorship</td>
    <td style="text-align: right">(953)</td>
    <td style="text-align: right">(521)</td>
    <td style="vertical-align: top; text-align: right">(470)</td></tr>
  <tr id="xdx_400_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_iN_pn3n3_di_z4ogpR4zSypl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 14.2pt">Other</td>
    <td style="text-align: right">(1,744)</td>
    <td style="text-align: right">(4,744)</td>
    <td style="vertical-align: top; text-align: right">(2,665)</td></tr>
  <tr id="xdx_40C_ecustom--PermanentAdjustmentsPillarTwo_pn3n3_zqxktTkAVWMc" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Pillar Two - See Note 2.3(q)</td>
    <td style="text-align: right">(109,458)</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4997">-</span></td>
    <td style="vertical-align: top; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4998">-</span></td></tr>
  <tr id="xdx_400_ecustom--OtherTaxExpenseBenefits_pn3n3_z9EZ70QrzWOj" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt">Other</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">9,685 </td>
    <td style="border-bottom: Black 1pt solid; text-align: right">2,951 </td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right">8,517</td></tr>
  <tr id="xdx_403_ecustom--IncomeTaxesExpense_pn3n3_zDJiK0RZG8Vj" style="background-color: White">
    <td style="white-space: nowrap"><b>Income taxes expense</b></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><b>(92,502)</b></td>
    <td style="border-bottom: Black 1.5pt double; text-align: right"><b>(27,471)</b></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right"><b>(24,166)</b></td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentTaxExpenseIncome_pn3n3_zsYynNP0wjLc" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; text-indent: 7.1pt">Current</td>
    <td style="text-align: right">(133,328)</td>
    <td style="text-align: right">(24,238)</td>
    <td style="vertical-align: bottom; text-align: right">(27,399)</td></tr>
  <tr id="xdx_40F_eifrs-full--DeferredTaxExpenseIncome_pn3n3_z14lYFfKVhS4" style="background-color: White">
    <td style="white-space: nowrap; text-indent: 7.1pt">Deferred</td>
    <td style="text-align: right">40,826 </td>
    <td style="text-align: right">(3,233)</td>
    <td style="vertical-align: bottom; text-align: right">3,233</td></tr>
  <tr id="xdx_409_eifrs-full--TaxRateEffectFromChangeInTaxRate_pip0_dp_zhguVaETO6md" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><b>Effective rate</b></td>
    <td style="text-align: right"><b>10.70%</b></td>
    <td style="text-align: right"><b>4.10%</b></td>
    <td style="vertical-align: bottom; text-align: right"><b>5.62%</b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The Company adhered to PROUNI, established by Law 11,096/2005, which is a federal program
that exempts companies of paying income taxes and social contribution upon compliance with certain requirements required by this Law.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Brazilian tax law establishes that companies that generate gross revenues of up to R$78,000
in the prior fiscal year may calculate income taxes as a percentage of gross revenue, using the presumed profit tax regime. The effect
of the presumed profit of certain subsidiaries represents the difference between the taxation based on this method and the amount that
would be due based on the statutory rate applied to the taxable profit of the subsidiaries.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax assets and liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock_pn3n3_zfFtZthYcMk4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Income taxes (Details 1)">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span id="xdx_8B3_zj5ZHZtS9Kt7" style="display: none">Schedule of deferred tax assets and liabilities</span></td>
    <td id="xdx_495_20240101__20241231_zdlB1ItzZvsi" style="text-align: center">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td id="xdx_498_20250101__20251231_zmzgE2DdbQe1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="width: 55%; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 17%; text-align: right"><b>Additions</b> (i)</td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><b>2025</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"></td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsAbstract_iB_z2A1zPu07Ssl">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Deferred tax assets</b></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Tax losses carry forward</td>
    <td id="xdx_983_ecustom--DeferredTaxAssetsLossCarryforwards_pn3n3_c20240101__20241231_zQf72oyl0Bg9" style="text-align: right" title="Tax losses carry forward"><span style="-sec-ix-hidden: xdx2ixbrl5026">-</span></td>
    <td id="xdx_986_ecustom--AdditionsTaxLossesCarryForward_pn3n3_c20250101__20251231_zNQ0PLM4Yza" style="text-align: right" title="Additions tax losses carry forward">1,703</td>
    <td id="xdx_981_ecustom--DeferredTaxAssetsLossCarryforwards_pn3n3_c20250101__20251231_zKy7a730nLul" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Tax losses carry forward">1,703</td></tr>
  <tr id="xdx_40D_eifrs-full--DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_iB_zivqGYh3Ocnh" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Temporary differences:</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Allowance for expected credit losses</td>
    <td id="xdx_987_ecustom--AllowanceForExpectedCreditLoss_pn3n3_c20240101__20241231_zufIhGscHNr6" style="text-align: right" title="Allowance for expected credit losses"><span style="-sec-ix-hidden: xdx2ixbrl5035">-</span></td>
    <td id="xdx_98E_ecustom--AdditionsAllowanceForExpectedCreditLosses_pn3n3_c20250101__20251231_z2SzqGTOcXg4" style="text-align: right" title="Additions allowance for expected credit losses">1,196</td>
    <td id="xdx_98E_ecustom--AllowanceForExpectedCreditLoss_pn3n3_c20250101__20251231_zRev5MrA0GJi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Allowance for expected credit losses">1,196</td></tr>
  <tr id="xdx_40E_eifrs-full--LeaseLiabilitiesAbstract_iB_zOJPMIyjjFU3" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">IFRS 16 - Leases:</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 24.85pt">Right-of-use assets</td>
    <td id="xdx_989_ecustom--RightofuseAsset_iI_pn3n3_c20241231_zgEf2c29clF1" style="text-align: right" title="Allowance for expected credit losses"><span style="-sec-ix-hidden: xdx2ixbrl5044">-</span></td>
    <td id="xdx_989_ecustom--AdditionsToRightofuseAsset_pn3n3_c20250101__20251231_zDm3UPMssZGg" style="text-align: right" title="Allowance for expected credit losses">56,180</td>
    <td id="xdx_98E_ecustom--RightofuseAsset_iI_pn3n3_c20251231_zN9ZySY92IMk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Allowance for expected credit losses">56,180</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 24.85pt">Lease liabilities</td>
    <td id="xdx_98E_ecustom--LeaseLiability_iI_pn3n3_c20241231_zqmfSlIdAqSd" style="text-align: right" title="Lease liabilities"><span style="-sec-ix-hidden: xdx2ixbrl5050">-</span></td>
    <td id="xdx_98D_ecustom--AdditionsLeaseLiability_iI_pn3n3_c20250101__20251231_ztDMXrnrPQO" style="text-align: right" title="Additions lease liabilities">(47,232)</td>
    <td id="xdx_984_ecustom--LeaseLiability_iI_pn3n3_c20251231_z86EaaLu7bml" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities">(47,232)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Provision for profit sharing</td>
    <td id="xdx_985_ecustom--ProvisionForProfitSharing_pn3n3_c20240101__20241231_zue9J4DB7cEe" style="text-align: right" title="Provision for profit sharing"><span style="-sec-ix-hidden: xdx2ixbrl5056">-</span></td>
    <td id="xdx_988_ecustom--AdditionsProvisionForProfitSharing_pn3n3_c20250101__20251231_zEXXPT4n0Ldk" style="text-align: right" title="Additions provision for profit sharing">2,047</td>
    <td id="xdx_982_ecustom--ProvisionForProfitSharing_pn3n3_c20250101__20251231_zHd2fuXaaHQj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Provision for profit sharing">2,047</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Provision for legal proceedings and contingencies</td>
    <td id="xdx_983_eifrs-full--LegalProceedingsProvision_iI_pn3n3_c20241231_zu7zw2l8fDcb" style="text-align: right" title="Provision for legal proceedings and contingencies"><span style="-sec-ix-hidden: xdx2ixbrl5062">-</span></td>
    <td id="xdx_980_ecustom--AdditionsProvisionForLegalProceedingsAndContingencies_pn3n3_c20250101__20251231_zo5tj6wuCZoc" style="text-align: right" title="Additions provision for legal proceedings and contingencies">7,672</td>
    <td id="xdx_984_eifrs-full--LegalProceedingsProvision_iI_pn3n3_c20251231_zPD1UwP8Ekke" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Provision for legal proceedings and contingencies">7,672</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Amortization of intangible assets</td>
    <td id="xdx_98E_ecustom--AmortizationOfIntangibleAsset_pn3n3_c20240101__20241231_zirgQCZHvRVc" style="text-align: right" title="Amortization of intangible assets"><span style="-sec-ix-hidden: xdx2ixbrl5068">-</span></td>
    <td id="xdx_98B_ecustom--AdditionsAmortizationOfIntangibleAssets_pn3n3_c20250101__20251231_zKdHXBVf9hSf" style="text-align: right" title="Additions amortization of intangible assets">44,486</td>
    <td id="xdx_982_ecustom--AmortizationOfIntangibleAsset_pn3n3_c20250101__20251231_zej0kGux9YQ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Amortization of intangible assets">44,486</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt">Other</td>
    <td id="xdx_98D_ecustom--Other_pn3n3_c20240101__20241231_z5dhx1ucZPI2" style="border-bottom: Black 1pt solid; text-align: right" title="Other"><span style="-sec-ix-hidden: xdx2ixbrl5074">-</span></td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231_zO01zfb4gnf" style="border-bottom: Black 1pt solid; text-align: right" title="Additions other">67</td>
    <td id="xdx_980_ecustom--Other_pn3n3_c20250101__20251231_zDVSNUxezidg" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other">67</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_982_ecustom--DeferredTaxAsset_iI_pn3n3_c20241231_zVbOrBCNJBej" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><b><span style="-sec-ix-hidden: xdx2ixbrl5080">-</span></b></td>
    <td id="xdx_982_ecustom--AdditionsDeferredTaxAssets_pn3n3_c20250101__20251231_zmYwrhLUYtS3" style="border-bottom: Black 1pt solid; text-align: right" title="Additions deferred tax assets"><b>66,119</b></td>
    <td id="xdx_981_ecustom--DeferredTaxAsset_iI_pn3n3_c20251231_zCqyen7f1v7j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>66,119</b></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_zx3rdIzhLSX2" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Deferred tax liabilities</b></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="border-top: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Tax benefit from tax deductible goodwill</td>
    <td id="xdx_98B_ecustom--DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20240101__20241231_zKjOpLVQgxVb" style="text-align: right" title="Tax benefit from tax deductible goodwill"><span style="-sec-ix-hidden: xdx2ixbrl5089">-</span></td>
    <td id="xdx_98D_ecustom--AdditionsTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20250101__20251231_z1WjRxB58sei" style="text-align: right" title="Additions tax benefit from tax deductible goodwill">(25,293)</td>
    <td id="xdx_985_ecustom--DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20250101__20251231_z57iuwhO0ehk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total">(25,293)</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">Fair value remeasurements on business combinations</td>
    <td id="xdx_982_ecustom--FairValueRemeasurementsOnBusinessCombinations_pn3n3_c20240101__20241231_zYLa81w0NGKb" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value remeasurements on business combinations">(28,274)</td>
    <td id="xdx_98C_ecustom--AdditionsFairValueRemeasurementsOnBusinessCombinations_pn3n3_c20250101__20251231_zd1xNcN8ogDf" style="border-bottom: Black 1pt solid; text-align: right" title="Additions fair value remeasurements on business combinations"><span style="-sec-ix-hidden: xdx2ixbrl5097">-</span></td>
    <td id="xdx_989_ecustom--FairValueRemeasurementsOnBusinessCombinations_pn3n3_c20250101__20251231_zTpwaZ9tKL6i" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Fair value remeasurements on business combinations">(28,274)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt">&#160;</td>
    <td id="xdx_981_ecustom--DeferredsTaxLiabilities_iI_pn3n3_c20241231_zMdUQudxXY1h" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><b>(28,274)</b></td>
    <td id="xdx_985_ecustom--AdditionsDeferredTaxLiabilities_pn3n3_c20250101__20251231_zC2ZsLiBNeJ5" style="border-bottom: Black 1pt solid; text-align: right" title="Additions deferred tax liabilities"><b>(25,293)</b></td>
    <td id="xdx_981_ecustom--DeferredsTaxLiabilities_iI_pn3n3_c20251231_zuudVW0DIoLk" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"><b>(53,567)</b></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><b>Deferred tax assets (liabilities), net</b></td>
    <td id="xdx_986_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20241231_zlozLnAGLtRl" style="border-bottom: Black 1.5pt double; text-align: right" title="Deferred tax assets (liabilities), net"><b>(28,274)</b></td>
    <td id="xdx_982_ecustom--AdditionsDeferredTaxAssetsLiabilitiesNet_pn3n3_c20250101__20251231_zRwXswmPwuF2" style="border-bottom: Black 1.5pt double; text-align: right" title="Additions deferred tax assets (liabilities), net"><b>40,826</b></td>
    <td id="xdx_98E_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20251231_zJdRABafBoXl" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Deferred tax assets (liabilities), net"><b>12,552</b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Recognized in the consolidated statement of income and other comprehensive income.</td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal proceedings and contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureLegalProceedingsAndContingenciesAbstract', window );"><strong>Legal Proceedings And Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfLegalProceedingsAndContingenciesTableTextBlock', window );">Schedule of legal proceedings and contingencies</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfLegalProceedingsAndContingenciesTableTextBlock_pn3n3_zaYbuU3OiGJa" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Legal proceedings and contingencies (Details)">
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="display: none"><span id="xdx_8B5_zDvFQ6ogRu47">Schedule of legal proceedings and contingencies</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Labor</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Civil</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Taxes</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>Total</b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Balances as of January 1, 2023</b></td>
    <td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zMPUP7yWvkUb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>22,484</b></td>
    <td id="xdx_987_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zEYXVMcMtOkk" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>24,664</b></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zuu0D4NWBW0j" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>148,706</b></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zXqE2w0Mescd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>195,854</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Business combination</td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zOoi9r7FFo69" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">64</td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zOLSjJ1M4Ad8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">88</td>
    <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z3JldT5t38Fe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="-sec-ix-hidden: xdx2ixbrl5135">-</span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zMVgJlvFgrod" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">152</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Additions</td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgGziB3HeHK9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">3,424</td>
    <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zFMR9KOHFhEe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">5,875</td>
    <td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zhsTvUnQdBB4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">9,037</td>
    <td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zvLYMG4PIzPc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">18,336</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Payments</td>
    <td id="xdx_98A_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zjxxbOccj9J9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(800)</td>
    <td id="xdx_98E_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zpuVDmtiHAsk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(1,051)</td>
    <td id="xdx_98C_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zRKwKO8cpVN2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(14,930)</td>
    <td id="xdx_98B_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zAC4DaVzVIvb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(16,781)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Reversals (i)</td>
    <td id="xdx_98F_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z6cVO1tkih71" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(2,451)</td>
    <td id="xdx_988_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuOr9hVKrDZa" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(8,276)</td>
    <td id="xdx_989_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zgiqgZBARFP1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(82,473)</td>
    <td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zcIC70dbufw7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(93,200)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Balances as of December 31, 2023</b></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zYGZ7TphNIf7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>22,721</b></td>
    <td id="xdx_985_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zXX9pWkVPrIa" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>21,300</b></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zsmhGeIdVD0d" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>60,340</b></td>
    <td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z9TSm2VZtvDf" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>104,361</b></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Business combination</td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zlv1R9GFD8D3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">721</td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zE2bkbXCJjki" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">481</td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zFk0iSvPaDC3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">6,044</td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zUlatOTIfMPc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations">7,246</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Additions</td>
    <td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zMSz11wrKDag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">22,744</td>
    <td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zqEviugHnGVe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">10,006</td>
    <td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zLuLjOavQExb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">26,119</td>
    <td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z8jB2u7M0RCe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">58,869</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Payments</td>
    <td id="xdx_98C_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zyWRp0WxL6If" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(1,638)</td>
    <td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znDgL82bSSwa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(2,977)</td>
    <td id="xdx_985_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zZ01OUmmexFf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(22)</td>
    <td id="xdx_980_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_ztl8tE8LPyk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(4,637)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Reversals (i)</td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zea77tSXO6Qd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(13,093)</td>
    <td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z3dlA0d39UJ7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(3,670)</td>
    <td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHyjD3uhGW8k" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(35,555)</td>
    <td id="xdx_98C_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zERfPJT1sXI6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(52,318)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Balances as of December 31, 2024</b></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zxtLF9S2niG7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>31,455</b></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z1ybsx7j7OA5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>25,140</b></td>
    <td id="xdx_987_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zmrwueKMDQX4" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>56,926</b></td>
    <td id="xdx_98A_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zFdAPi3qGX2i" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><b>113,521</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Additions</td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zGpxODUfcVke" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">20,014 </td>
    <td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zrD9pb3ds7K5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">9,568 </td>
    <td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_znPPLGCPOtg6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">6,799 </td>
    <td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zyozkNUxBwT5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions">36,381 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Payments</td>
    <td id="xdx_98E_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ziYWFzlHD8Q7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(3,354)</td>
    <td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zaesi0QDNK5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(3,519)</td>
    <td id="xdx_981_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zkYXs0ORPb59" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"><span style="-sec-ix-hidden: xdx2ixbrl5223">-</span></td>
    <td id="xdx_982_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhgVR9gLLcdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments">(6,873)</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Reversals (i)</td>
    <td id="xdx_984_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zVqpOJ3uoaXe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(4,386)</td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z6SZbaazXNqb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(3,145)</td>
    <td id="xdx_98D_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_znoRZ1BA8sGe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(7,278)</td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhxibWomxBd1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals">(14,809)</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><b>Balances as of December 31, 2025</b></td>
    <td id="xdx_983_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zinbUzDsoAv4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><b>43,729 </b></td>
    <td id="xdx_985_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_ztO98Jsm2Gyg" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><b>28,044 </b></td>
    <td id="xdx_989_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zE2jpyEYuiZd" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><b>56,447 </b></td>
    <td id="xdx_985_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zquJoqn2NcEk" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><b>128,220 </b></td></tr>
  </table>
<p style="font: 7.5pt Nunito Sans; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Includes the reversals of provision for legal proceedings with corresponding indemnification
asset.</td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock', window );">Schedule of social security proceedings assessed by management</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock_pn3n3_z6TQ0Q7CUK2g" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Legal proceedings and contingencies (Details 1)">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B5_zFCR4MkyXfv9" style="display: none">Schedule of social
    security proceedings assessed by management</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 66%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><b>2024</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Labor</td>
    <td id="xdx_98D_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total">36,818 </td>
    <td id="xdx_98E_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total">38,097 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Civil</td>
    <td id="xdx_983_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total">59,145 </td>
    <td id="xdx_984_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total">50,667 </td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Taxes</td>
    <td id="xdx_986_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total">30,530 </td>
    <td id="xdx_988_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total">17,498 </td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_98A_eifrs-full--OtherProvisions_c20251231_pn3n3" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><b>126,493 </b></td>
    <td id="xdx_98B_eifrs-full--OtherProvisions_c20241231_pn3n3" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><b>106,262 </b></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureLegalProceedingsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureLegalProceedingsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfLegalProceedingsAndContingenciesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfLegalProceedingsAndContingenciesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-cash transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureNoncashTransactionsAbstract', window );"><strong>Non-cash Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ScheduleOfNonCashTransactionsTableTextBlock', window );">Schedule of non-cash transactions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfNonCashTransactionsTableTextBlock_pn3n3_zRQwgNhvuOoj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Non-cash transactions (Details)">
  <tr style="background-color: White">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt"><span id="xdx_8B2_zUoIiDVrKut8" style="display: none">Schedule
    of non-cash transactions</span></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr>
    <td style="width: 67%; padding-left: 8.7pt; text-align: right; text-indent: -8.7pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2025</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2024</b></td>
    <td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><b>2023</b></td></tr>
  <tr>
    <td style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt">&#160;</td>
    <td style="text-align: right"></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Remeasurement of earn-out of Al&#233;m da Medicina, CardioPapers and Glic</td>
    <td id="xdx_980_ecustom--RemeasurementOfEarnOut_pn3n3_c20250101__20251231_z4T31wLxjcN7" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic"><span style="-sec-ix-hidden: xdx2ixbrl5269">-</span></td>
    <td id="xdx_987_ecustom--RemeasurementOfEarnOut_pn3n3_c20240101__20241231_zcNmgAioEoOh" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic"><span style="-sec-ix-hidden: xdx2ixbrl5271">-</span></td>
    <td id="xdx_98A_ecustom--RemeasurementOfEarnOut_pn3n3_c20230101__20231231_zliFR7QG0O0f" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic">2,556</td></tr>
  <tr style="background-color: White">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Additions and remeasurements of right-of-use assets and lease liabilities</td>
    <td id="xdx_98E_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_c20250101__20251231_pn3n3" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities">136,714</td>
    <td id="xdx_98E_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20240101__20241231_zWdWTUeEC3P6" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities">117,897</td>
    <td id="xdx_982_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_c20230101__20231231_pn3n3" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities">77,715</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net</td>
    <td id="xdx_98B_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_pn3n3_c20250101__20251231_zwMZpoTQkXf" style="text-align: right" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net">1,678</td>
    <td id="xdx_98B_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_pn3n3_c20240101__20241231_zvLocT5FP47b" style="text-align: right" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net">(3,154)</td>
    <td id="xdx_98C_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_c20230101__20231231_pn3n3" style="text-align: right" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net">20,000</td></tr>
  <tr style="background-color: White">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Additions to intangibles and goodwill through accounts payable to selling shareholders.</td>
    <td id="xdx_980_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_c20250101__20251231_pn3n3" style="text-align: right" title="Additions to intangibles and goodwill through accounts payable to selling shareholders">40,000</td>
    <td id="xdx_988_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_pn3n3_c20240101__20241231_zFZYBv0WO1Ma" style="text-align: right" title="Additions to intangibles and goodwill through accounts payable to selling shareholders">279,989</td>
    <td id="xdx_983_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_c20230101__20231231_pn3n3" style="text-align: right" title="Additions to intangibles and goodwill through accounts payable to selling shareholders">234,000</td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-left: 8.7pt; text-indent: -8.7pt">Dividends payable</td>
    <td id="xdx_986_ecustom--DividendsPayables_iI_pn3n3_c20250101__20251231_z5a5QsGtgHBd" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt" title="Dividends payable">192</td>
    <td id="xdx_98A_ecustom--DividendsPayables_pn3n3_c20240101__20241231_zFRspycj9nD6" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt" title="Dividends payable"><span style="-sec-ix-hidden: xdx2ixbrl5295">-</span></td>
    <td id="xdx_98B_ecustom--DividendsPayables_pn3n3_c20230101__20231231_z85Q9IaTl1L1" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt" title="Dividends payable"><span style="-sec-ix-hidden: xdx2ixbrl5297">-</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureNoncashTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureNoncashTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfNonCashTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfNonCashTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Corporate information (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>May 07, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total net assets</a></td>
<td class="nump">R$ 80,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 78,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AfyaParticipacoesS.A.Member', window );">Afya Participacoes S. A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancingAsOfAcquisitionDate', window );">Loans and financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Financial liabilities recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancingAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancingAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial assets acquired in a business combination. [Refer: Financial assets; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial liabilities assumed in a business combination. [Refer: Financial liabilities; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AfyaParticipacoesS.A.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AfyaParticipacoesS.A.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Corporate information (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 07, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionalPaymentToShareholder', window );">Additional payment to shareholders</a></td>
<td class="nump">R$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_FaculdadeMasterclassLtdaMember', window );">Faculdade Masterclass Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Acquired percenatge</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Acquired purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The aggregate purchase price is R$100,000. The price and payment conditions are: (i) R$60,000,
net of the estimated Net Debt, paid in cash on May 7, 2025 and presented in &#8220;Acquisition of assets and subsidiaries, net of cash
acquired&#8221; in the consolidated statement of cash flows; and (ii) R$40,000 payable in three equal annual installments adjusted by
100% of the Brazilian interbank interest rate (&#8220;CDI&#8221;) - see Note 22. FUNIC&#8217;s installments are not contingent consideration
and therefore are not included in the fair value disclosure in Note 2.3(b). The time value on the deferred installments is recognized
as finance expense using the effective interest rate method.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionalPaymentToShareholder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionalPaymentToShareholder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the business or businesses that the acquirer obtains control of in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_FaculdadeMasterclassLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_FaculdadeMasterclassLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AfyaParticipacoesSAMember', window );">Afya Participacoes S.A. (&#147;Afya Brazil&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Holding<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Nova Lima - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember', window );">Instituto Tocantinense Presidente Antonio Carlos Porto S.A. - (&#147;ITPAC Porto&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Porto Nacional - TO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember', window );">Instituto Tocantinense Presidente Antonio Carlos S.A. - (&#147;ITPAC Araguaina&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Aragua&#237;na - TO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember', window );">Uniao Educacional do Vale do Aco S.A. - (&#147;UNIVACO&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medicine undergraduate degree program<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Ipatinga - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember', window );">IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#147;IPTAN&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o Jo&#227;o Del Rei - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember', window );">Instituto de Educacao Superior do Vale do Parnaiba S.A. (&#147;IESVAP&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Parna&#237;ba - PI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember', window );">Centro de Ciencias em Saude de Itajuba S.A. (&#147;CCSI&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medicine undergraduate degree program<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Itajub&#225; - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember', window );">Instituto de Ensino Superior do Piaui S.A. (&#147;IESP&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate and graduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Teresina - PI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember', window );">FADEP - Faculdade Educacional de Pato Branco Ltda. (&#147;FADEP&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Pato Branco - PR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember', window );">Instituto Educacional Santo Agostinho S.A. (&#147;FASA&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Montes Claros - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember', window );">Instituto Paraense de Educacao e Cultura Ltda. (&#147;IPEC&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medicine undergraduate degree program<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Marab&#225; - PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember', window );">Sociedade Universitaria Redentor S.A. (&#147;UniRedentor&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate and graduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Itaperuna - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeEnsinoSaoLucasLtda.UniSLMember', window );">Centro de Ensino Sao Lucas Ltda. (&#147;UniSL&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Porto Velho - RO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember', window );">Sociedade de Educacao, Cultura e Tecnologia da Amazonia S.A. - (&#147;FESAR&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Reden&#231;&#227;o - PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember', window );">Centro Superior de Ciencias da Saude Ltda. (&#147;FCMPB&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medicine undergraduate degree program<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Jo&#227;o Pessoa - PB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember', window );">iClinic Desenvolvimento de Software Ltda. (&#147;iClinic&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Electronic Medical Record, Clinical Management System<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Ribeir&#227;o Preto - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeSolutionsS.A.MedicinaeMember', window );">Medicinae Solutions S.A. (&#147;Medicinae&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Healthcare payments and financial services<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Rio de Janeiro - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember', window );">Medical Harbour Aparelhos Medico Hospitalares e Servicos em Tecnologia Ltda. (&#147;Medical Harbour&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Educational health and medical imaging<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Florian&#243;polis - SC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember', window );">Cliquefarma Drogarias Online Ltda. (&#147;Cliquefarma&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Online platform<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o Paulo - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospTecnologiaDaInformacaoLtda.ShospMember', window );">Shosp Tecnologia da Informacao Ltda. (&#147;Shosp&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Electronic Medical Record, Clinical Management System<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Rio de Janeiro - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember', window );">Sociedade Padrao de Educacao Superior Ltda. (&#147;UnifipMoc&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Montes Claros - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember', window );">Companhia Nilza Cordeiro Herdy de Educacao e Cultura (&#147;Unigranrio&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate and graduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Duque de Caxias - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember', window );">RX PRO Solucoes de Tecnologia Ltda. (&#147;RX PRO&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Marketing for pharmaceutical industry<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o Paulo - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember', window );">Quasar Telemedicina Desenvolvimentode Sistemas Computacionais Ltda Glic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Patient physician relationship<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Barueri - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember', window );">Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#147;DelRey&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Macei&#243; - AL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomParticipacoesS.A.UnidomMember', window );">Unidom Participacoes S.A. (&#147;Unidom&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Salvador - BA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember', window );">Instituicao Baianade Ensino Superior Ltda I B E S [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Salvador - BA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember', window );">S E S S A Sociedadede Educacao Superiordo Semi Arido Ltda S E S S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Ribeira de Pombal - BA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeMasterclassLtdaFUNICMember', window );">Faculdade Masterclass Ltda F U N I C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Contagem - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember', window );">Uniao Educacional do Planalto Central S.A. (&#147;UEPC&#148;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Bras&#237;lia - DF<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Associate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InvestmentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InvestmentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PrincipalActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PrincipalActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The principal place of business of a subsidiary. [Refer: Principal place of business; Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_b_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_b_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 12<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_12_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 19B<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_19B_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Total for all subsidiaries [member]; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 12<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_12_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AfyaParticipacoesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AfyaParticipacoesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeEnsinoSaoLucasLtda.UniSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeEnsinoSaoLucasLtda.UniSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeSolutionsS.A.MedicinaeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeSolutionsS.A.MedicinaeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospTecnologiaDaInformacaoLtda.ShospMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospTecnologiaDaInformacaoLtda.ShospMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomParticipacoesS.A.UnidomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomParticipacoesS.A.UnidomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeMasterclassLtdaFUNICMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeMasterclassLtdaFUNICMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level 2 of fair value hierarchy [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets', window );">Valuation technique</a></td>
<td class="text">Binomial model: The fair value is estimated by utilizing a simulation of possible future share prices, applying regression analysis, as well as comparing at each potential exercise date the discounted risk-neutral expectation of the option payoff if not exercised, and the relevant exercise price.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets', window );">Inter-relationship between significant unobservable inputs and fair value measurement</a></td>
<td class="text">The estimated fair value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level 2 of fair value hierarchy [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level 2 of fair value hierarchy [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level 3 of fair value hierarchy [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets', window );">Valuation technique</a></td>
<td class="text">Probability-weighted cash flows: This valuation technique considers the probability-weighted expectation of future cash flow.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets', window );">Inter-relationship between significant unobservable inputs and fair value measurement</a></td>
<td class="text">The estimated fair value would increase (decrease) if:<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedCashFlows', window );">Expected cash flows</a></td>
<td class="nump">R$ 325,150<span></span>
</td>
<td class="nump">R$ 314,953<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ProbabilityOfDisbursement', window );">Probability of disbursement</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ExpectedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ExpectedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProbabilityOfDisbursement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProbabilityOfDisbursement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of a change in valuation technique (for example, changing from a market approach to an income approach or the use of an additional valuation technique) for the fair value measurement of assets. [Refer: Income approach [member]; Market approach [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the interrelationships between unobservable inputs and of how they might magnify or mitigate the effect of changes in the unobservable inputs on the fair value measurement of assets. [Refer: Disclosure of significant unobservable inputs used in fair value measurement of assets [text block]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Details 2)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=afya_FVTPLMember', window );">F V T P L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Equity investments</a></td>
<td class="text">These assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=afya_FinancialAssetsAtAmortizedCostMember', window );">Financial Assets At Amortized Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Equity investments</a></td>
<td class="text">These assets are subsequently measured at amortized cost under the effective interest method. The gross carrying amount is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=afya_FVOCIMember', window );">F V O C I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Equity investments</a></td>
<td class="text">These assets are subsequently measured at fair value. Interest income calculated under the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=afya_FVOCI1Member', window );">F V O C I 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Equity investments</a></td>
<td class="text">These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never reclassified to profit or loss.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The explanation of facts and circumstances indicating a rare situation for the reclassification of financial assets that are no longer held for the purpose of selling or repurchasing in the near term out of the fair value through profit or loss category. [Refer: Financial assets at fair value through profit or loss; Reclassification out of financial assets at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 12A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_12A_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=afya_FVTPLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=afya_FVTPLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=afya_FinancialAssetsAtAmortizedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=afya_FinancialAssetsAtAmortizedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=afya_FVOCIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=afya_FVOCIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=afya_FVOCI1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis=afya_FVOCI1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Details 3)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">25 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember', window );">Machinery And Equipments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixtures and fittings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember', window );">It Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember', window );">Library Books [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Details 4)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=afya_CustomerRelationshipsOtherCoursesMember', window );">Customer Relationships Other Courses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember', window );">Education Content Developed Technology And Educational Platform [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember', window );">Education Content Developed Technology And Educational Platform [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=afya_CustomerRelationshipsOtherCoursesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=afya_CustomerRelationshipsOtherCoursesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Details 5)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS21Member', window );">Amendments To I A S 21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">Lack of exchangeability &#8211; Amendments to IAS 21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_LackOfExchangeabilityAmendmentsToIAS21Member', window );">Amendments To IAS 21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">In August 2023, the IASB issued amendments to IAS 21 The Effects of Changes in Foreign Exchange
    Rates to specify how an entity should assess whether a currency is exchangeable and how it should determine a spot exchange rate when
    exchangeability is lacking. The amendments also require disclosure of information that enables users of its financial statements to understand
    how the currency not being exchangeable into the other currency affects, or is expected to affect, the entity&#8217;s financial performance,
    financial position and cash flows.The amendments had no impact on the Company&#8217;s accounting policies, which remained
    unchanged in these  consolidated financial statements for the year ended December 31, 2025.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member', window );">Financial Instruments Amendments To IFRS 9 And IFRS 7 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">Classification and Measurement of Financial Instruments - Amendments to IFRS 9 and IFRS 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">In May 2024, the IASB issued Amendments to the Classification and Measurement of Financial
    Instruments (Amendments to IFRS 9 and IFRS 7), which:&#8226; Clarifies that a financial liability is derecognized on the &#8216;settlement date&#8217;,
    i.e., when the related obligation is discharged, cancelled, expires or the liability otherwise qualifies for derecognition. It also introduces
    an accounting policy option to derecognize financial liabilities that are settled through an electronic payment system before settlement
    date if certain conditions are met&#8226; Clarified how to assess the contractual cash flow characteristics of financial assets
    that include environmental, social and governance (ESG)-linked features and other similar contingent features&#8226; Clarifies the treatment of non-recourse assets and contractually linked instruments&#8226; Requires additional disclosures in IFRS 7 for financial assets and liabilities with
    contractual terms that reference a contingent event (including those that are ESG-linked), and equity instruments classified at fair value
    through other comprehensive incomeThe amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Entities can early adopt the amendments that relate to the classification of financial assets plus the related disclosures and
    apply the other amendments later.The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AnnualImprovementsToIFRSAccountingStandardsVolume11Member', window );">Annual Improvements To IFRS Accounting Standards Volume 11 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">Annual Improvements to IFRS Accounting Standards - Volume 11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">In July 2024, the IASB issued Annual Improvements to IFRS Accounting Standards - Volume
    11. The following is a summary of the topics subject to amendments from the Annual Improvements to IFRS Accounting Standards - Volume
    11:&#8226; IFRS 1 First-time Adoption of International Financial Reporting Standards&#8226; IFRS 7 Financial Instruments: Disclosures: Gain or Loss on Derecognition&#8226; Guidance on implementing IFRS 7 Financial Instruments: Disclosures&#8226; IFRS 9 Financial Instruments&#8226; IFRS 10 Consolidated Financial Statements&#8226; IAS 7 Statement of Cash FlowsThese amendments are effective for annual periods beginning on or after January 1, 2026.The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member', window );">Power Purchase Agreements Amendments To IFRS 9 And IFRS 7 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">Nature-dependent Electricity Contracts &#8211; Amendments to IFRS 9 and IFRS 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">In December 2024, the IASB issued Contracts Referencing Nature-dependent Electricity (Amendments
    to IFRS 9 and IFRS 7), clarifying the application of the &#8216;own-use&#8217; requirements; permitting hedge accounting if these contracts
    are used as hedging instruments; and adding new disclosure requirements to enable investors to understand the effect of these contracts
    on a company&#8217;s financial performance and cash flows.The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Early adoption is permitted, but will need to be disclosed.The amendments are not expected to have a material impact on the Company&#8217;s consolidated
    financial statements.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_IFRS18PresentationAndDisclosureInFinancialStatementsMember', window );">IFRS 18 Presentation And Disclosure In Financial Statements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Standard</a></td>
<td class="text">IFRS 18 &#8211; Presentation and Disclosure in Financial Statements<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy', window );">Description</a></td>
<td class="text">In April 2024, the IASB issued IFRS 18, which replaces IAS 1 Presentation of Financial Statements.
    IFRS 18 introduces new requirements for presentation within the statement of income, including specified totals and subtotals. Furthermore,
    entities are required to classify all income and expenses within the statement of income into one of five categories: operating, investing,
    financing, income taxes and discontinued operations, whereof the first three are new.It also requires disclosure of management-defined performance measures, subtotals of income
    and expenses and includes new requirements for aggregation and disaggregation of financial information based on the identified &#8220;roles&#8221;
    of the primary financial statements (PFS) and the notes.In addition, narrow-scope amendments have been made to IAS 7 Statement of Cash Flows, which
    include changing the starting point for determining cash flows from operations under the indirect method, from &#8216;profit or loss&#8217;
    to &#8216;operating profit or loss&#8217; and removing the optionality around classification of cash flows from dividends and interest.
    In addition, there are consequential amendments to several other standards.IFRS 18, and the amendments to the other standards, is effective for reporting periods beginning
    on or after January 1, 2027 and must be applied retrospectively. Early adoption is permitted and must be disclosed.The Company is currently working to identify all IFRS 18 impacts on the consolidated financial
    statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the nature of a change in accounting policy related to an initial application of an IFRS. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TitleOfInitiallyAppliedIFRS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of an initially applied IFRS. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TitleOfInitiallyAppliedIFRS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS21Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_AmendmentsToIAS21Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_LackOfExchangeabilityAmendmentsToIAS21Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_LackOfExchangeabilityAmendmentsToIAS21Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_AnnualImprovementsToIFRSAccountingStandardsVolume11Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_AnnualImprovementsToIFRSAccountingStandardsVolume11Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_IFRS18PresentationAndDisclosureInFinancialStatementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_IFRS18PresentationAndDisclosureInFinancialStatementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Details Narrative)<br> R$ in Thousands, &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 27, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>BRL (R$)</div>
</th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Income taxes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 112,638<span></span>
</td>
<td class="nump">R$ 4,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_OrganizationForEconomicCooperationAndDevelopmentMember', window );">Organization For Economic Cooperation And Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageEffectiveTaxRate', window );">Effective tax</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsolidatedRevenues', window );">Consolidated revenues | &#8364;</a></td>
<td class="nump">&#8364; 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_MinimumTaxRate', window );">Minimum tax rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Income taxes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 109,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ProgramOfSocialIntegrationMember', window );">Program Of Social Integration [Member] | Teaching Activities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ProgramOfSocialIntegrationMember', window );">Program Of Social Integration [Member] | Non Teaching Activities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ContributionForTheFinancingOfSocialSecurityMember', window );">Contribution For The Financing Of Social Security [Member] | Teaching Activities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ContributionForTheFinancingOfSocialSecurityMember', window );">Contribution For The Financing Of Social Security [Member] | Non Teaching Activities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ConsolidatedRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ConsolidatedRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_MinimumTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_MinimumTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=afya_OrganizationForEconomicCooperationAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=afya_OrganizationForEconomicCooperationAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ProgramOfSocialIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ProgramOfSocialIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=afya_TeachingActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=afya_TeachingActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=afya_NonTeachingActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=afya_NonTeachingActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ContributionForTheFinancingOfSocialSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=afya_ContributionForTheFinancingOfSocialSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment information (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">R$ 9,357,934<span></span>
</td>
<td class="nump">R$ 8,829,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">1,942,176<span></span>
</td>
<td class="nump">1,589,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">7,415,758<span></span>
</td>
<td class="nump">7,239,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">9,357,934<span></span>
</td>
<td class="nump">8,829,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">884,041<span></span>
</td>
<td class="nump">1,140,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">3,582,708<span></span>
</td>
<td class="nump">3,378,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">4,891,185<span></span>
</td>
<td class="nump">4,310,583<span></span>
</td>
<td class="nump">R$ 3,643,012<span></span>
</td>
<td class="nump">R$ 3,250,158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">9,357,934<span></span>
</td>
<td class="nump">8,829,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">1,942,176<span></span>
</td>
<td class="nump">1,589,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">7,415,758<span></span>
</td>
<td class="nump">7,239,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">9,357,934<span></span>
</td>
<td class="nump">8,829,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">884,041<span></span>
</td>
<td class="nump">1,140,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">3,582,708<span></span>
</td>
<td class="nump">3,378,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">4,891,185<span></span>
</td>
<td class="nump">4,310,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="nump">46,518<span></span>
</td>
<td class="nump">54,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">404,011<span></span>
</td>
<td class="nump">392,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Undergraduate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">8,959,964<span></span>
</td>
<td class="nump">8,393,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">1,765,066<span></span>
</td>
<td class="nump">1,443,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">7,194,898<span></span>
</td>
<td class="nump">6,949,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">8,959,964<span></span>
</td>
<td class="nump">8,393,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">689,074<span></span>
</td>
<td class="nump">884,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">3,474,357<span></span>
</td>
<td class="nump">3,279,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">4,796,533<span></span>
</td>
<td class="nump">4,228,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="nump">46,518<span></span>
</td>
<td class="nump">54,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">281,313<span></span>
</td>
<td class="nump">301,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Continuing Education [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">245,697<span></span>
</td>
<td class="nump">274,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">92,221<span></span>
</td>
<td class="nump">71,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">153,476<span></span>
</td>
<td class="nump">202,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">245,697<span></span>
</td>
<td class="nump">274,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">113,729<span></span>
</td>
<td class="nump">188,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">84,581<span></span>
</td>
<td class="nump">75,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">47,387<span></span>
</td>
<td class="nump">10,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">79,139<span></span>
</td>
<td class="nump">53,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Medical Practice Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">166,238<span></span>
</td>
<td class="nump">170,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">98,854<span></span>
</td>
<td class="nump">82,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">67,384<span></span>
</td>
<td class="nump">87,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">166,238<span></span>
</td>
<td class="nump">170,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">95,203<span></span>
</td>
<td class="nump">75,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">23,770<span></span>
</td>
<td class="nump">23,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">47,265<span></span>
</td>
<td class="nump">71,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">43,559<span></span>
</td>
<td class="nump">38,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Total Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">9,371,899<span></span>
</td>
<td class="nump">8,838,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">1,956,141<span></span>
</td>
<td class="nump">1,598,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">7,415,958<span></span>
</td>
<td class="nump">7,239,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">9,371,899<span></span>
</td>
<td class="nump">8,838,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">898,006<span></span>
</td>
<td class="nump">1,148,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">3,582,708<span></span>
</td>
<td class="nump">3,378,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">4,891,185<span></span>
</td>
<td class="nump">4,310,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="nump">46,518<span></span>
</td>
<td class="nump">54,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">404,011<span></span>
</td>
<td class="nump">392,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Elimination Inter Segment Balances [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="num">(13,965)<span></span>
</td>
<td class="num">(8,588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="num">(13,965)<span></span>
</td>
<td class="num">(8,588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="num">(13,965)<span></span>
</td>
<td class="num">(8,588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(13,965)<span></span>
</td>
<td class="num">(8,588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CapitalExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CapitalExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in associates in an entity's separate financial statements. [Refer: Total for all associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_UndergraduateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_UndergraduateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_ContinuingEducationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_ContinuingEducationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_MedicalPracticeSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_MedicalPracticeSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_TotalReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_TotalReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_EliminationInterSegmentBalancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_EliminationInterSegmentBalancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">R$ 3,697,255<span></span>
</td>
<td class="nump">R$ 3,304,329<span></span>
</td>
<td class="nump">R$ 2,875,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,383,360<span></span>
</td>
<td class="nump">2,088,726<span></span>
</td>
<td class="nump">1,766,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceForExpectedCreditLosses', window );">Allowance for expected credit losses</a></td>
<td class="nump">57,090<span></span>
</td>
<td class="nump">60,894<span></span>
</td>
<td class="nump">74,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="nump">1,213,110<span></span>
</td>
<td class="nump">1,012,113<span></span>
</td>
<td class="nump">767,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="nump">194,943<span></span>
</td>
<td class="nump">111,283<span></span>
</td>
<td class="nump">110,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">860,945<span></span>
</td>
<td class="nump">676,391<span></span>
</td>
<td class="nump">429,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">768,443<span></span>
</td>
<td class="nump">648,920<span></span>
</td>
<td class="nump">405,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="nump">3,697,255<span></span>
</td>
<td class="nump">3,304,329<span></span>
</td>
<td class="nump">2,875,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">3,697,255<span></span>
</td>
<td class="nump">3,304,329<span></span>
</td>
<td class="nump">2,875,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfSale', window );">Cost of services</a></td>
<td class="num">(1,313,895)<span></span>
</td>
<td class="num">(1,215,603)<span></span>
</td>
<td class="num">(1,109,813)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,383,360<span></span>
</td>
<td class="nump">2,088,726<span></span>
</td>
<td class="nump">1,766,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="num">(1,113,065)<span></span>
</td>
<td class="num">(1,008,427)<span></span>
</td>
<td class="num">(940,132)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceForExpectedCreditLosses', window );">Allowance for expected credit losses</a></td>
<td class="num">(57,090)<span></span>
</td>
<td class="num">(60,894)<span></span>
</td>
<td class="num">(74,552)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="nump">18,762<span></span>
</td>
<td class="nump">13,299<span></span>
</td>
<td class="nump">53,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherGainsLosses', window );">Other expenses, net</a></td>
<td class="num">(18,857)<span></span>
</td>
<td class="num">(20,591)<span></span>
</td>
<td class="num">(37,561)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="nump">1,213,110<span></span>
</td>
<td class="nump">1,012,113<span></span>
</td>
<td class="nump">767,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="nump">194,943<span></span>
</td>
<td class="nump">111,283<span></span>
</td>
<td class="nump">110,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinanceExpense', window );">Finance expenses</a></td>
<td class="num">(561,024)<span></span>
</td>
<td class="num">(458,742)<span></span>
</td>
<td class="num">(457,616)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Share of income of associate</a></td>
<td class="nump">13,916<span></span>
</td>
<td class="nump">11,737<span></span>
</td>
<td class="nump">9,495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">860,945<span></span>
</td>
<td class="nump">676,391<span></span>
</td>
<td class="nump">429,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="num">(92,502)<span></span>
</td>
<td class="num">(27,471)<span></span>
</td>
<td class="num">(24,166)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">768,443<span></span>
</td>
<td class="nump">648,920<span></span>
</td>
<td class="nump">405,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Undergraduate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="nump">3,255,426<span></span>
</td>
<td class="nump">2,895,692<span></span>
</td>
<td class="nump">2,511,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">3,255,426<span></span>
</td>
<td class="nump">2,895,692<span></span>
</td>
<td class="nump">2,511,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfSale', window );">Cost of services</a></td>
<td class="num">(1,176,785)<span></span>
</td>
<td class="num">(1,086,081)<span></span>
</td>
<td class="num">(997,973)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,078,641<span></span>
</td>
<td class="nump">1,809,611<span></span>
</td>
<td class="nump">1,513,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Continuing Education [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="nump">275,705<span></span>
</td>
<td class="nump">251,636<span></span>
</td>
<td class="nump">227,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="nump">8,766<span></span>
</td>
<td class="nump">3,802<span></span>
</td>
<td class="nump">8,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">284,471<span></span>
</td>
<td class="nump">255,438<span></span>
</td>
<td class="nump">235,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfSale', window );">Cost of services</a></td>
<td class="num">(96,346)<span></span>
</td>
<td class="num">(96,180)<span></span>
</td>
<td class="num">(91,915)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">188,125<span></span>
</td>
<td class="nump">159,258<span></span>
</td>
<td class="nump">143,915<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Medical Practice Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="nump">166,124<span></span>
</td>
<td class="nump">157,001<span></span>
</td>
<td class="nump">137,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="nump">5,199<span></span>
</td>
<td class="nump">4,786<span></span>
</td>
<td class="nump">2,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">171,323<span></span>
</td>
<td class="nump">161,787<span></span>
</td>
<td class="nump">140,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfSale', window );">Cost of services</a></td>
<td class="num">(54,729)<span></span>
</td>
<td class="num">(41,930)<span></span>
</td>
<td class="num">(31,142)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">116,594<span></span>
</td>
<td class="nump">119,857<span></span>
</td>
<td class="nump">109,140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Total Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="nump">3,697,255<span></span>
</td>
<td class="nump">3,304,329<span></span>
</td>
<td class="nump">2,875,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="nump">13,965<span></span>
</td>
<td class="nump">8,588<span></span>
</td>
<td class="nump">11,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">3,711,220<span></span>
</td>
<td class="nump">3,312,917<span></span>
</td>
<td class="nump">2,887,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfSale', window );">Cost of services</a></td>
<td class="num">(1,327,860)<span></span>
</td>
<td class="num">(1,224,191)<span></span>
</td>
<td class="num">(1,121,030)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,383,360<span></span>
</td>
<td class="nump">2,088,726<span></span>
</td>
<td class="nump">1,766,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Adjustments And Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="num">(13,965)<span></span>
</td>
<td class="num">(8,588)<span></span>
</td>
<td class="num">(11,217)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="num">(13,965)<span></span>
</td>
<td class="num">(8,588)<span></span>
</td>
<td class="num">(11,217)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfSale', window );">Cost of services</a></td>
<td class="nump">13,965<span></span>
</td>
<td class="nump">8,588<span></span>
</td>
<td class="nump">11,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForExpectedCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForExpectedCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CostOfSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CostOfSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DepositsFromExternalCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DepositsFromExternalCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InterSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InterSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2024-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_UndergraduateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_UndergraduateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_ContinuingEducationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_ContinuingEducationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_MedicalPracticeSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_MedicalPracticeSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_TotalReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_TotalReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_AdjustmentsAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_AdjustmentsAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business combinations (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Jul. 01, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable net assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 80,379<span></span>
</td>
<td class="nump">R$ 78,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomMember', window );">Unidom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="nump">R$ 3,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade receivables</a></td>
<td class="nump">9,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdvancesRecognisedAsOfAcquisitionDate', window );">Advances</a></td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">Recoverable taxes</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">Other assets</a></td>
<td class="nump">854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndemnificationAssetsAsOfAcquisitionDate', window );">Indemnification assets</a></td>
<td class="nump">7,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property and equipment</a></td>
<td class="nump">5,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">Rights-of-use assets</a></td>
<td class="nump">28,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">462,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="nump">517,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade payables</a></td>
<td class="nump">1,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancingAsOfAcquisitionDate', window );">Loans and financing</a></td>
<td class="nump">4,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">Labor and social obligations</a></td>
<td class="nump">7,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">Taxes payable</a></td>
<td class="nump">5,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherTaxesPayableAsOfAcquisitionDate', window );">Other taxes payable</a></td>
<td class="nump">28,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">Advances from customers</a></td>
<td class="nump">1,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">Lease liabilities</a></td>
<td class="nump">28,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">Provision for legal proceedings</a></td>
<td class="nump">7,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">Other liabilities</a></td>
<td class="nump">4,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Financial liabilities recognised as of acquisition date</a></td>
<td class="nump">88,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable net assets at fair value</a></td>
<td class="nump">428,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill arising on acquisition</a></td>
<td class="nump">192,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Purchase consideration transferred</a></td>
<td class="nump">620,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="nump">340,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">Consideration to be transferred</a></td>
<td class="nump">279,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs of the acquisition (included in cash flows from operating activities)</a></td>
<td class="nump">1,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</a></td>
<td class="nump">337,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">Net of cash flow on acquisition</a></td>
<td class="nump">R$ 339,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdvancesFromCustomersAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdvancesFromCustomersAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdvancesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdvancesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ConsiderationToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ConsiderationToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IndemnificationAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IndemnificationAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LaborAndSocialObligationsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancingAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancingAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NetOfCashFlowOnAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NetOfCashFlowOnAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherLiabilitiesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherLiabilitiesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherTaxesPayableAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherTaxesPayableAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProvisionForLegalProceedingsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RecoverableTaxesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RecoverableTaxesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightOfUseAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightOfUseAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxesPayableAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxesPayableAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeReceivablesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeReceivablesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents in subsidiaries or other businesses over which control is obtained or lost. [Refer: Total for all subsidiaries [member]; Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 40<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_40_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial assets acquired in a business combination. [Refer: Financial assets; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial liabilities assumed in a business combination. [Refer: Financial liabilities; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business combinations (Details 1) - Acquisition Of Unidom [Member]<br></strong></div></th>
<th class="th"><div>Jul. 01, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember', window );">Licences and franchises [member] | With And Without Method [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Multi-period excess earnings method [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Total for all business combinations [member]; Valuation techniques used in fair value measurement [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_o_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesAndFranchisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AcquisitionOfUnidomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AcquisitionOfUnidomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_WithAndWithoutMethodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=afya_WithAndWithoutMethodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=ifrs-full_MultiperiodExcessEarningsMethodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis=ifrs-full_MultiperiodExcessEarningsMethodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 3,697,255<span></span>
</td>
<td class="nump">R$ 3,304,329<span></span>
</td>
<td class="nump">R$ 2,875,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">860,945<span></span>
</td>
<td class="nump">676,391<span></span>
</td>
<td class="nump">R$ 429,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_AcquisitionOfUnidomMember', window );">Acquisition Of Unidom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Acquired purchase price</a></td>
<td class="text">The total consideration of R$620,762, net of Net Debt, is comprised
of: (i) R$340,773 paid in cash on July 1, 2024; and (ii) R$279,989, considering purchase consideration adjustments, payable in up to ten
annual installments, adjusted by the CDI rate, and it is conditioned upon the maintenance of the authorization of the 175 medical school
seats in each of the prior year.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination', window );">Total transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,793<span></span>
</td>
<td class="nump">R$ 962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,354,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 697,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseInIncomeBeforeIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseInIncomeBeforeIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseInRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseInRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the business or businesses that the acquirer obtains control of in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_AcquisitionOfUnidomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_AcquisitionOfUnidomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and cash equivalents (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureCashAndCashEquivalentsAbstract', window );"><strong>Cash And Cash Equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash and bank deposits</a></td>
<td class="nump">R$ 15,470<span></span>
</td>
<td class="nump">R$ 6,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Cash equivalents</a></td>
<td class="nump">1,109,911<span></span>
</td>
<td class="nump">904,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">R$ 1,125,381<span></span>
</td>
<td class="nump">R$ 911,015<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and cash equivalents (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Cash equivalents</a></td>
<td class="nump">R$ 1,109,911<span></span>
</td>
<td class="nump">R$ 904,937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=afya_USDMember', window );">U S D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Cash equivalents</a></td>
<td class="nump">R$ 23,422<span></span>
</td>
<td class="nump">R$ 21,610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_BankCertificatesOfDepositMember', window );">Bank Certificates Of Deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PercenatgeOfAverageInterestOnFinancialInstrument', window );">Percentage of average interest</a></td>
<td class="nump">101.20%<span></span>
</td>
<td class="nump">99.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PercenatgeOfAverageInterestOnFinancialInstrument">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PercenatgeOfAverageInterestOnFinancialInstrument</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=afya_USDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=afya_USDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_BankCertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_BankCertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade receivables (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">R$ 852,514<span></span>
</td>
<td class="nump">R$ 703,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceForDoubtfulAccountsFoReceivable1', window );">(-) Allowance for doubtful accounts</a></td>
<td class="num">(100,156)<span></span>
</td>
<td class="num">(71,477)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables, net</a></td>
<td class="nump">752,358<span></span>
</td>
<td class="nump">631,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Current</a></td>
<td class="nump">717,373<span></span>
</td>
<td class="nump">595,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentTradeReceivables', window );">Non-current</a></td>
<td class="nump">34,985<span></span>
</td>
<td class="nump">35,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_TuitionFeesMember', window );">Tuition Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">596,568<span></span>
</td>
<td class="nump">488,962<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalContentMember', window );">Educational Content [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">44,679<span></span>
</td>
<td class="nump">62,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_FIESMember', window );">F I E S [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">139,158<span></span>
</td>
<td class="nump">79,712<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalCreditsMember', window );">Educational Credits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">33,399<span></span>
</td>
<td class="nump">26,893<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_MobileAppSubscriptionMember', window );">Mobile App Subscription [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">21,484<span></span>
</td>
<td class="nump">24,223<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_OthersMember', window );">Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="nump">R$ 17,226<span></span>
</td>
<td class="nump">R$ 21,339<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForDoubtfulAccountsFoReceivable1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForDoubtfulAccountsFoReceivable1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ReceivablesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ReceivablesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_TuitionFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_TuitionFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_FIESMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_FIESMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalCreditsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalCreditsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_MobileAppSubscriptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_MobileAppSubscriptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_OthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_OthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade receivables (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">R$ 852,514<span></span>
</td>
<td class="nump">R$ 703,323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=ifrs-full_NotLaterThanOneMonthMember', window );">Not later than one month [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">128,785<span></span>
</td>
<td class="nump">97,390<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember', window );">Later Than One Months And Not Later Than Three Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">165,512<span></span>
</td>
<td class="nump">126,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember', window );">Later than three months and not later than six months [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">102,369<span></span>
</td>
<td class="nump">91,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanSixMonthsMember', window );">Later than six months [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">71,961<span></span>
</td>
<td class="nump">60,847<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentOfFinancialAssetsAxis=ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember', window );">Financial assets neither past due nor impaired [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">R$ 383,887<span></span>
</td>
<td class="nump">R$ 327,052<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ReceivablesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ReceivablesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_NotLaterThanOneMonthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_NotLaterThanOneMonthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentOfFinancialAssetsAxis=ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentOfFinancialAssetsAxis=ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade receivables (Details 2) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceAccountForCreditLossesOfFinancialAsset', window );">Opening balance</a></td>
<td class="num">R$ (71,477)<span></span>
</td>
<td class="num">R$ (61,398)<span></span>
</td>
<td class="num">R$ (44,046)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset', window );">Additions</a></td>
<td class="num">(57,090)<span></span>
</td>
<td class="num">(60,894)<span></span>
</td>
<td class="num">(74,552)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable', window );">Write-offs</a></td>
<td class="nump">28,411<span></span>
</td>
<td class="nump">50,815<span></span>
</td>
<td class="nump">57,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceAccountForCreditLossesOfFinancialAsset', window );">Closing balance</a></td>
<td class="num">R$ (100,156)<span></span>
</td>
<td class="num">R$ (71,477)<span></span>
</td>
<td class="num">R$ (61,398)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceAccountForCreditLossesOfFinancialAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceAccountForCreditLossesOfFinancialAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsRelatedPartyTransactions', window );">Right-of-use assets</a></td>
<td class="nump">R$ 216,085<span></span>
</td>
<td class="nump">R$ 205,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TradeReceivablesRelatedPartyTransactions', window );">Trade receivables</a></td>
<td class="nump">384<span></span>
</td>
<td class="nump">507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherAssetsRelatedPartyTransactions', window );">Other assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsReceivableRelatedPartyTransactions', window );">Total assets</a></td>
<td class="nump">216,469<span></span>
</td>
<td class="nump">207,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TradeAndOtherCurrentPayablesToRelatedParties1', window );">Current assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NoncurrentAssetsOfRelatedParty1', window );">Non-current assets</a></td>
<td class="nump">216,469<span></span>
</td>
<td class="nump">206,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseLiabilitiesRelatedPartyTransactions', window );">Lease liabilities</a></td>
<td class="nump">260,790<span></span>
</td>
<td class="nump">242,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Total liabilities</a></td>
<td class="nump">260,790<span></span>
</td>
<td class="nump">242,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TradeAndOtherCurrentPayableToRelatedParties', window );">Current liabilities</a></td>
<td class="nump">9,447<span></span>
</td>
<td class="nump">6,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NoncurrenLliabilitiesOfRelatedParty1', window );">Non-current liabilities</a></td>
<td class="nump">251,343<span></span>
</td>
<td class="nump">236,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherIncomeRelatedPartyTransactions', window );">Other income</a></td>
<td class="num">(48,010)<span></span>
</td>
<td class="num">(42,472)<span></span>
</td>
<td class="num">R$ (39,018)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UEPCMember', window );">U E P C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherIncomeRelatedPartyTransactions', window );">Other income</a></td>
<td class="nump">475<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_EMIVEPatrulha24HorasLtdaMember', window );">E M I V E Patrulha 24 Horas Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherIncomeRelatedPartyTransactions', window );">Other income</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_DepreciationRightofuseAssetsMember', window );">Depreciation Rightofuse Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherIncomeRelatedPartyTransactions', window );">Other income</a></td>
<td class="num">(17,637)<span></span>
</td>
<td class="num">(14,639)<span></span>
</td>
<td class="num">(13,801)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseLiabilitiesInterestMember', window );">Lease Liabilities Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherIncomeRelatedPartyTransactions', window );">Other income</a></td>
<td class="num">R$ (30,841)<span></span>
</td>
<td class="num">R$ (28,343)<span></span>
</td>
<td class="num">R$ (25,676)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrenLliabilitiesOfRelatedParty1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrenLliabilitiesOfRelatedParty1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentAssetsOfRelatedParty1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentAssetsOfRelatedParty1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherAssetsRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherAssetsRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherIncomeRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherIncomeRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeAndOtherCurrentPayableToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeAndOtherCurrentPayableToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeAndOtherCurrentPayablesToRelatedParties1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeAndOtherCurrentPayablesToRelatedParties1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeReceivablesRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeReceivablesRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsPayableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts payable resulting from related party transactions. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsPayableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsReceivableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts receivable resulting from related party transactions. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsReceivableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UEPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UEPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_EMIVEPatrulha24HorasLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_EMIVEPatrulha24HorasLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_DepreciationRightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_DepreciationRightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseLiabilitiesInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseLiabilitiesInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Short-term employee benefits</a></td>
<td class="nump">R$ 27,160<span></span>
</td>
<td class="nump">R$ 21,171<span></span>
</td>
<td class="nump">R$ 16,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Share-based compensation plans</a></td>
<td class="nump">16,193<span></span>
</td>
<td class="nump">19,884<span></span>
</td>
<td class="nump">21,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity', window );">Total</a></td>
<td class="nump">R$ 43,353<span></span>
</td>
<td class="nump">R$ 41,055<span></span>
</td>
<td class="nump">R$ 38,359<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount incurred by the entity for provision of key management personnel services that are provided by a separate management entity. [Refer: Key management personnel of entity or parent [member]; Separate management entities [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 18A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18A&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Details Narrative) - BRL (R$)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 14, 2024</div></th>
<th class="th"><div>May 02, 2024</div></th>
<th class="th"><div>Aug. 02, 2021</div></th>
<th class="th"><div>Oct. 30, 2019</div></th>
<th class="th"><div>Sep. 06, 2018</div></th>
<th class="th"><div>Apr. 25, 2018</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,065,746,000<span></span>
</td>
<td class="nump">R$ 978,336,000<span></span>
</td>
<td class="nump">R$ 874,569,000<span></span>
</td>
<td class="nump">R$ 769,525,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member', window );">Lease Agreements 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member', window );">Lease Agreements 1 [Member] | R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 40,000<span></span>
</td>
<td class="nump">R$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member', window );">Lease Agreements 1 [Member] | U N I V A C O Patrimonial Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RelatedPartiesAmountPaid', window );">Related parties amount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 3,752<span></span>
</td>
<td class="nump">3,633<span></span>
</td>
<td class="nump">3,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LesseeFinancesLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member', window );">Lease Agreements 1 [Member] | I E S V A P Patrimonial Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RelatedPartiesAmountPaid', window );">Related parties amount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 5,435<span></span>
</td>
<td class="nump">5,244<span></span>
</td>
<td class="nump">5,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LesseeFinancesLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DescriptionOfLeaseTerms', window );">Description of lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The lease agreement is for an amount equal to 7.5% of the monthly revenue of IESVAP until June 2021. From July
2021, the monthly amount should be equal to the amount paid in the first semester of 2021 and thereafter adjusted annually by the inflation
rate (IGP-M). The lease agreement is for an initial term of 20 years and is renewable for an additional 20 years subject to the provisions
of the lease agreement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member', window );">Lease Agreements 1 [Member] | Instituto Tocantinense Presidente Antonio Carlos S A [Member] | R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,992<span></span>
</td>
<td class="nump">84,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RelatedPartiesAmountPaid', window );">Related parties amount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,926<span></span>
</td>
<td class="nump">13,453<span></span>
</td>
<td class="nump">13,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member', window );">Lease Agreements 1 [Member] | Institutode Ensino Superior Presidente Trancredode Almeida Neves S A [Member] | R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DescriptionOfLeaseTerm', window );">Description of lease term</a></td>
<td class="text">The lease agreement
is for a monthly amount payable equal to R$114.5, with a grace period of 12 months, extended by an additional six months. The monthly
amount payable should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years.<span></span>
</td>
<td class="text">The rent agreement is
for a monthly amount payable equal to R$4, adjusted annually by the inflation rate (IGP-M). The rent agreement is for a term of one year
and is renewable for an additional term of three years.<span></span>
</td>
<td class="text">(i) up to June 2022, R$40; (ii) from July 2022 until December 2028, 6.5% of the monthly revenue
of ITPAC Garanhuns during the prior semester, adjusted in accordance with the provisions of the lease agreement; and (iii) from January
2029 on, the monthly amount should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years.<span></span>
</td>
<td class="text">(i) R$12 until December
2020; (ii) from January 2021 to December 2025, 6.5% of the monthly revenue of IPTAN during the prior semester; (iii) from January 2026,
the monthly amount should be equal to the amount paid in the second semester of 2025; and (iv) from January 2027 thereon, the monthly
amount should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years and is renewable for an
additional 20 years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements2Member', window );">Lease Agreements 2 [Member] | Instituto Tocantinense Presidente Antonio Carlos S A [Member] | R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,328<span></span>
</td>
<td class="nump">63,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RelatedPartiesAmountPaid', window );">Related parties amount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,881<span></span>
</td>
<td class="nump">8,568<span></span>
</td>
<td class="nump">7,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements3Member', window );">Lease Agreements 3 [Member] | Instituto Tocantinense Presidente Antonio Carlos S A [Member] | R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,962<span></span>
</td>
<td class="nump">9,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RelatedPartiesAmountPaid', window );">Related parties amount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,136<span></span>
</td>
<td class="nump">1,338<span></span>
</td>
<td class="nump">1,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements4Member', window );">Lease Agreements 4 [Member] | Instituto Tocantinense Presidente Antonio Carlos S A [Member] | R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,326<span></span>
</td>
<td class="nump">17,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RelatedPartiesAmountPaid', window );">Related parties amount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,664<span></span>
</td>
<td class="nump">2,199<span></span>
</td>
<td class="nump">R$ 1,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements5Member', window );">Lease Agreements 5 [Member] | U N I V A C O Patrimonial Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,802<span></span>
</td>
<td class="nump">22,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements5Member', window );">Lease Agreements 5 [Member] | I E S V A P Patrimonial Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,475<span></span>
</td>
<td class="nump">35,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements5Member', window );">Lease Agreements 5 [Member] | Instituto Tocantinense Presidente Antonio Carlos S A [Member] | R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 10,905<span></span>
</td>
<td class="nump">R$ 9,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DescriptionOfLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DescriptionOfLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DescriptionOfLeaseTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DescriptionOfLeaseTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LesseeFinancesLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LesseeFinancesLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RelatedPartiesAmountPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RelatedPartiesAmountPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfEntitysRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of the entity's revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfEntitysRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=afya_RVLEstevesGestaoImobiliariaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=afya_RVLEstevesGestaoImobiliariaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=afya_UNIVACOPatrimonialLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=afya_UNIVACOPatrimonialLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=afya_IESVAPPatrimonialLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=afya_IESVAPPatrimonialLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_LeaseAgreements5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other assets (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureOtherAssetsAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets - Note 21</a></td>
<td class="nump">R$ 80,379<span></span>
</td>
<td class="nump">R$ 78,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Advances1', window );">Advances</a></td>
<td class="nump">40,205<span></span>
</td>
<td class="nump">35,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_JudicialDeposits', window );">Judicial deposits</a></td>
<td class="nump">19,274<span></span>
</td>
<td class="nump">16,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">18,070<span></span>
</td>
<td class="nump">19,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReceivables', window );">Other FIES credits</a></td>
<td class="nump">6,866<span></span>
</td>
<td class="nump">8,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConvertibleLoansFromVentureCapitalInvestments', window );">Convertible loans from venture capital investments</a></td>
<td class="nump">13,240<span></span>
</td>
<td class="nump">8,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Dividend', window );">Dividends</a></td>
<td class="nump">6,287<span></span>
</td>
<td class="nump">1,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherAssets1', window );">Other assets</a></td>
<td class="nump">4,106<span></span>
</td>
<td class="nump">3,146<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Assets1', window );">Total</a></td>
<td class="nump">188,427<span></span>
</td>
<td class="nump">173,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CurrentAssets1', window );">Current</a></td>
<td class="nump">62,947<span></span>
</td>
<td class="nump">57,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NoncurrentAssets1', window );">Non-current</a></td>
<td class="nump">R$ 125,480<span></span>
</td>
<td class="nump">R$ 115,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Advances1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Advances1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Assets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Assets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ConvertibleLoansFromVentureCapitalInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ConvertibleLoansFromVentureCapitalInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CurrentAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CurrentAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Dividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Dividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_JudicialDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_JudicialDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount receivable by the entity that it does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in associate (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">R$ 1,942,176<span></span>
</td>
<td class="nump">R$ 1,589,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">7,415,758<span></span>
</td>
<td class="nump">7,239,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(884,041)<span></span>
</td>
<td class="num">(1,140,195)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="num">(3,582,708)<span></span>
</td>
<td class="num">(3,378,761)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">3,697,255<span></span>
</td>
<td class="nump">3,304,329<span></span>
</td>
<td class="nump">R$ 2,875,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="num">(1,313,895)<span></span>
</td>
<td class="num">(1,215,603)<span></span>
</td>
<td class="num">(1,109,813)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceForExpectedCreditLosses', window );">Allowance for expected credit losses</a></td>
<td class="nump">57,090<span></span>
</td>
<td class="nump">60,894<span></span>
</td>
<td class="nump">74,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Net finance result</a></td>
<td class="num">(194,943)<span></span>
</td>
<td class="num">(111,283)<span></span>
</td>
<td class="num">(110,642)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">860,945<span></span>
</td>
<td class="nump">676,391<span></span>
</td>
<td class="nump">429,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">768,443<span></span>
</td>
<td class="nump">648,920<span></span>
</td>
<td class="nump">405,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Dividends receivable - Other assets</a></td>
<td class="num">(15,553)<span></span>
</td>
<td class="num">(7,501)<span></span>
</td>
<td class="num">(9,900)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_AssociatesMember', window );">Total for all associates [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">27,686<span></span>
</td>
<td class="nump">38,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">118,550<span></span>
</td>
<td class="nump">116,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(44,726)<span></span>
</td>
<td class="num">(30,049)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="num">(90,394)<span></span>
</td>
<td class="num">(87,388)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_EquityInAssociate', window );">Equity</a></td>
<td class="nump">11,116<span></span>
</td>
<td class="nump">37,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CompanyShareInEquity1', window );">Company&#8217;s share in equity - 30%</a></td>
<td class="nump">3,335<span></span>
</td>
<td class="nump">11,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">43,183<span></span>
</td>
<td class="nump">43,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InvestmentGrossAmount', window );">Carrying amount of the investment</a></td>
<td class="nump">46,518<span></span>
</td>
<td class="nump">54,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">167,525<span></span>
</td>
<td class="nump">156,984<span></span>
</td>
<td class="nump">148,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="num">(79,116)<span></span>
</td>
<td class="num">(72,898)<span></span>
</td>
<td class="num">(71,282)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="num">(32,587)<span></span>
</td>
<td class="num">(30,755)<span></span>
</td>
<td class="num">(27,646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceForExpectedCreditLosses', window );">Allowance for expected credit losses</a></td>
<td class="nump">445<span></span>
</td>
<td class="num">(1,587)<span></span>
</td>
<td class="num">(1,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">212<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherExpense', window );">Other expenses</a></td>
<td class="num">(5,111)<span></span>
</td>
<td class="num">(5,326)<span></span>
</td>
<td class="num">(8,709)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Net finance result</a></td>
<td class="num">(3,298)<span></span>
</td>
<td class="num">(4,946)<span></span>
</td>
<td class="num">(6,123)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">48,518<span></span>
</td>
<td class="nump">41,684<span></span>
</td>
<td class="nump">33,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="num">(2,132)<span></span>
</td>
<td class="num">(2,560)<span></span>
</td>
<td class="num">(1,782)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">46,386<span></span>
</td>
<td class="nump">39,124<span></span>
</td>
<td class="nump">31,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CompanyShareOfProfitss', window );">Company&#8217;s share of profit, net of tax</a></td>
<td class="nump">13,916<span></span>
</td>
<td class="nump">11,737<span></span>
</td>
<td class="nump">9,495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Opening balance</a></td>
<td class="nump">54,442<span></span>
</td>
<td class="nump">51,834<span></span>
</td>
<td class="nump">53,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossOfAcquiree', window );">Share of profit, net of tax</a></td>
<td class="nump">13,916<span></span>
</td>
<td class="nump">11,737<span></span>
</td>
<td class="nump">9,495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DividendsReceived1', window );">Dividends received</a></td>
<td class="num">(15,553)<span></span>
</td>
<td class="num">(7,501)<span></span>
</td>
<td class="num">(9,900)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Dividends receivable - Other assets</a></td>
<td class="num">(6,287)<span></span>
</td>
<td class="num">(1,628)<span></span>
</td>
<td class="num">(1,668)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Closing balance</a></td>
<td class="nump">R$ 46,518<span></span>
</td>
<td class="nump">R$ 54,442<span></span>
</td>
<td class="nump">R$ 51,834<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForExpectedCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForExpectedCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CompanyShareInEquity1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CompanyShareInEquity1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CompanyShareOfProfitss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CompanyShareOfProfitss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendsReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendsReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_EquityInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_EquityInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InvestmentGrossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InvestmentGrossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in associates in an entity's separate financial statements. [Refer: Total for all associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph q<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_q_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_AssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_AssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">R$ 711,485<span></span>
</td>
<td class="nump">R$ 658,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">89,578<span></span>
</td>
<td class="nump">85,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember', window );">Machinery And Equipments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">115,557<span></span>
</td>
<td class="nump">104,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">18,852<span></span>
</td>
<td class="nump">18,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">867<span></span>
</td>
<td class="nump">1,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixtures and fittings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">110,269<span></span>
</td>
<td class="nump">96,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember', window );">It Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">69,267<span></span>
</td>
<td class="nump">67,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember', window );">Library Books [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">10,019<span></span>
</td>
<td class="nump">11,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">227,890<span></span>
</td>
<td class="nump">228,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Construction in progress [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipmentNetBookValue', window );">Net book value</a></td>
<td class="nump">69,186<span></span>
</td>
<td class="nump">44,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="nump">889,702<span></span>
</td>
<td class="nump">757,386<span></span>
</td>
<td class="nump">R$ 641,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">166,014<span></span>
</td>
<td class="nump">136,924<span></span>
</td>
<td class="nump">118,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,709<span></span>
</td>
<td class="nump">24,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(11,059)<span></span>
</td>
<td class="num">(10,317)<span></span>
</td>
<td class="num">(27,382)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="nump">1,044,657<span></span>
</td>
<td class="nump">889,702<span></span>
</td>
<td class="nump">757,386<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="nump">99,366<span></span>
</td>
<td class="nump">93,232<span></span>
</td>
<td class="nump">91,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="nump">9,015<span></span>
</td>
<td class="nump">5,129<span></span>
</td>
<td class="nump">1,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="nump">108,502<span></span>
</td>
<td class="nump">99,366<span></span>
</td>
<td class="nump">93,232<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Machinery And Equipments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="nump">149,407<span></span>
</td>
<td class="nump">119,981<span></span>
</td>
<td class="nump">100,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">28,301<span></span>
</td>
<td class="nump">29,195<span></span>
</td>
<td class="nump">20,071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,528<span></span>
</td>
<td class="nump">7,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,071)<span></span>
</td>
<td class="num">(9,411)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="nump">275<span></span>
</td>
<td class="num">(226)<span></span>
</td>
<td class="nump">1,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="nump">177,983<span></span>
</td>
<td class="nump">149,407<span></span>
</td>
<td class="nump">119,981<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Land [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="nump">18,852<span></span>
</td>
<td class="nump">18,852<span></span>
</td>
<td class="nump">18,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="nump">18,852<span></span>
</td>
<td class="nump">18,852<span></span>
</td>
<td class="nump">18,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="nump">1,442<span></span>
</td>
<td class="nump">1,354<span></span>
</td>
<td class="nump">1,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(435)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(475)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="nump">1,007<span></span>
</td>
<td class="nump">1,442<span></span>
</td>
<td class="nump">1,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Fixtures and fittings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="nump">124,818<span></span>
</td>
<td class="nump">110,859<span></span>
</td>
<td class="nump">90,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">28,575<span></span>
</td>
<td class="nump">21,582<span></span>
</td>
<td class="nump">17,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289<span></span>
</td>
<td class="nump">4,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(1,220)<span></span>
</td>
<td class="num">(7,050)<span></span>
</td>
<td class="num">(1,443)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="nump">1,110<span></span>
</td>
<td class="num">(862)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="nump">153,283<span></span>
</td>
<td class="nump">124,818<span></span>
</td>
<td class="nump">110,859<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | It Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="nump">108,817<span></span>
</td>
<td class="nump">82,810<span></span>
</td>
<td class="nump">68,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">24,204<span></span>
</td>
<td class="nump">25,945<span></span>
</td>
<td class="nump">21,135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">736<span></span>
</td>
<td class="nump">734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(2,536)<span></span>
</td>
<td class="num">(1,154)<span></span>
</td>
<td class="num">(7,979)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="num">(754)<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="nump">327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="nump">129,731<span></span>
</td>
<td class="nump">108,817<span></span>
</td>
<td class="nump">82,810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Library Books [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="nump">33,553<span></span>
</td>
<td class="nump">31,888<span></span>
</td>
<td class="nump">37,362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">1,178<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="nump">1,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(80)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,788)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="nump">34,651<span></span>
</td>
<td class="nump">33,553<span></span>
</td>
<td class="nump">31,888<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Leasehold improvements [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="nump">309,413<span></span>
</td>
<td class="nump">264,448<span></span>
</td>
<td class="nump">145,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">2,812<span></span>
</td>
<td class="nump">2,001<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,782<span></span>
</td>
<td class="nump">10,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(6,781)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(286)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="nump">46,018<span></span>
</td>
<td class="nump">41,182<span></span>
</td>
<td class="nump">108,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="nump">351,462<span></span>
</td>
<td class="nump">309,413<span></span>
</td>
<td class="nump">264,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Construction in progress [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="nump">44,034<span></span>
</td>
<td class="nump">33,962<span></span>
</td>
<td class="nump">86,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">80,823<span></span>
</td>
<td class="nump">55,775<span></span>
</td>
<td class="nump">57,409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="num">(55,664)<span></span>
</td>
<td class="num">(45,703)<span></span>
</td>
<td class="num">(110,198)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="nump">69,186<span></span>
</td>
<td class="nump">44,034<span></span>
</td>
<td class="nump">33,962<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="num">(231,220)<span></span>
</td>
<td class="num">(148,701)<span></span>
</td>
<td class="num">(99,266)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">7,997<span></span>
</td>
<td class="nump">7,778<span></span>
</td>
<td class="nump">25,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="num">(333,172)<span></span>
</td>
<td class="num">(231,220)<span></span>
</td>
<td class="num">(148,701)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(109,949)<span></span>
</td>
<td class="num">(90,297)<span></span>
</td>
<td class="num">(74,907)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="num">(13,962)<span></span>
</td>
<td class="num">(9,679)<span></span>
</td>
<td class="num">(5,751)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="num">(18,924)<span></span>
</td>
<td class="num">(13,962)<span></span>
</td>
<td class="num">(9,679)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(4,962)<span></span>
</td>
<td class="num">(4,188)<span></span>
</td>
<td class="num">(4,242)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Machinery And Equipments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="num">(45,110)<span></span>
</td>
<td class="num">(28,843)<span></span>
</td>
<td class="num">(20,630)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">881<span></span>
</td>
<td class="nump">1,491<span></span>
</td>
<td class="nump">6,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="num">(62,426)<span></span>
</td>
<td class="num">(45,110)<span></span>
</td>
<td class="num">(28,843)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(18,197)<span></span>
</td>
<td class="num">(17,684)<span></span>
</td>
<td class="num">(14,900)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Land [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="num">(137)<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">301<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="num">(140)<span></span>
</td>
<td class="num">(137)<span></span>
</td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(304)<span></span>
</td>
<td class="num">(377)<span></span>
</td>
<td class="num">(325)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Fixtures and fittings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="num">(28,080)<span></span>
</td>
<td class="num">(20,377)<span></span>
</td>
<td class="num">(10,349)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">1,055<span></span>
</td>
<td class="nump">4,593<span></span>
</td>
<td class="nump">2,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="num">(43,014)<span></span>
</td>
<td class="num">(28,080)<span></span>
</td>
<td class="num">(20,377)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(15,989)<span></span>
</td>
<td class="num">(12,778)<span></span>
</td>
<td class="num">(12,556)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | It Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="num">(41,495)<span></span>
</td>
<td class="num">(26,872)<span></span>
</td>
<td class="num">(21,837)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">1,545<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="nump">8,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(165)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="num">(60,464)<span></span>
</td>
<td class="num">(41,495)<span></span>
</td>
<td class="num">(26,872)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(20,514)<span></span>
</td>
<td class="num">(15,608)<span></span>
</td>
<td class="num">(13,286)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Library Books [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="num">(21,710)<span></span>
</td>
<td class="num">(18,652)<span></span>
</td>
<td class="num">(22,888)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">80<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="num">(24,632)<span></span>
</td>
<td class="num">(21,710)<span></span>
</td>
<td class="num">(18,652)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(3,002)<span></span>
</td>
<td class="num">(3,058)<span></span>
</td>
<td class="num">(3,327)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Leasehold improvements [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="num">(80,726)<span></span>
</td>
<td class="num">(44,476)<span></span>
</td>
<td class="num">(18,099)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="nump">4,135<span></span>
</td>
<td class="nump">502<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(148)<span></span>
</td>
<td class="num">(196)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="num">(123,572)<span></span>
</td>
<td class="num">(80,726)<span></span>
</td>
<td class="num">(44,476)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(46,981)<span></span>
</td>
<td class="num">(36,604)<span></span>
</td>
<td class="num">(26,271)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Construction in progress [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WritOffOfPropertyPlantAndEquipment', window );">Write-off (i)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PropertyPlantAndEquipments', window );">As of December 31, 2025</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PropertyPlantAndEquipmentNetBookValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PropertyPlantAndEquipmentNetBookValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PropertyPlantAndEquipments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PropertyPlantAndEquipments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WritOffOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WritOffOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="nump">R$ 275<span></span>
</td>
<td class="nump">R$ 244<span></span>
</td>
<td class="nump">R$ 413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">5,587,980<span></span>
</td>
<td class="nump">5,532,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">6,152,499<span></span>
</td>
<td class="nump">5,243,012<span></span>
</td>
<td class="nump">4,339,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">237,997<span></span>
</td>
<td class="nump">255,691<span></span>
</td>
<td class="nump">99,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">654,076<span></span>
</td>
<td class="nump">803,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="num">(275)<span></span>
</td>
<td class="num">(280)<span></span>
</td>
<td class="num">(3,271)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Remesurement', window );">Remesurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">6,390,221<span></span>
</td>
<td class="nump">6,152,499<span></span>
</td>
<td class="nump">5,243,012<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(619,710)<span></span>
</td>
<td class="num">(446,996)<span></span>
</td>
<td class="num">(298,368)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(182,531)<span></span>
</td>
<td class="num">(172,750)<span></span>
</td>
<td class="num">(151,486)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">2,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(802,241)<span></span>
</td>
<td class="num">(619,710)<span></span>
</td>
<td class="num">(446,996)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">1,526,733<span></span>
</td>
<td class="nump">1,526,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">1,526,733<span></span>
</td>
<td class="nump">1,334,699<span></span>
</td>
<td class="nump">1,257,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,034<span></span>
</td>
<td class="nump">75,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Remesurement', window );">Remesurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">1,526,733<span></span>
</td>
<td class="nump">1,526,733<span></span>
</td>
<td class="nump">1,334,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">3,460,415<span></span>
</td>
<td class="nump">3,360,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">3,360,786<span></span>
</td>
<td class="nump">2,776,077<span></span>
</td>
<td class="nump">2,189,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">99,629<span></span>
</td>
<td class="nump">157,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,482<span></span>
</td>
<td class="nump">586,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">3,460,415<span></span>
</td>
<td class="nump">3,360,786<span></span>
</td>
<td class="nump">2,776,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">138,389<span></span>
</td>
<td class="nump">143,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">182,060<span></span>
</td>
<td class="nump">182,060<span></span>
</td>
<td class="nump">182,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">182,060<span></span>
</td>
<td class="nump">182,060<span></span>
</td>
<td class="nump">182,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(38,544)<span></span>
</td>
<td class="num">(26,038)<span></span>
</td>
<td class="num">(14,955)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(5,127)<span></span>
</td>
<td class="num">(12,506)<span></span>
</td>
<td class="num">(11,083)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(43,671)<span></span>
</td>
<td class="num">(38,544)<span></span>
</td>
<td class="num">(26,038)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">153,274<span></span>
</td>
<td class="nump">228,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">612,827<span></span>
</td>
<td class="nump">578,267<span></span>
</td>
<td class="nump">435,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,560<span></span>
</td>
<td class="nump">142,451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer</a></td>
<td class="num">(691)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">612,136<span></span>
</td>
<td class="nump">612,827<span></span>
</td>
<td class="nump">578,267<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(384,684)<span></span>
</td>
<td class="num">(301,947)<span></span>
</td>
<td class="num">(212,363)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(74,558)<span></span>
</td>
<td class="num">(82,737)<span></span>
</td>
<td class="num">(89,584)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer</a></td>
<td class="nump">380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(458,862)<span></span>
</td>
<td class="num">(384,684)<span></span>
</td>
<td class="num">(301,947)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">60,883<span></span>
</td>
<td class="nump">54,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">95,953<span></span>
</td>
<td class="nump">71,150<span></span>
</td>
<td class="nump">43,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">1,511<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,235)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer</a></td>
<td class="nump">31,531<span></span>
</td>
<td class="nump">23,292<span></span>
</td>
<td class="nump">28,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">127,760<span></span>
</td>
<td class="nump">95,953<span></span>
</td>
<td class="nump">71,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(41,758)<span></span>
</td>
<td class="num">(24,094)<span></span>
</td>
<td class="num">(17,277)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(24,739)<span></span>
</td>
<td class="num">(16,457)<span></span>
</td>
<td class="num">(8,764)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer</a></td>
<td class="num">(380)<span></span>
</td>
<td class="num">(1,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(66,877)<span></span>
</td>
<td class="num">(41,758)<span></span>
</td>
<td class="num">(24,094)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember', window );">Education Content [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">51,891<span></span>
</td>
<td class="nump">47,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember', window );">Education Content [Member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">108,269<span></span>
</td>
<td class="nump">84,201<span></span>
</td>
<td class="nump">69,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">25,106<span></span>
</td>
<td class="nump">17,701<span></span>
</td>
<td class="nump">9,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,529<span></span>
</td>
<td class="nump">4,785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">133,373<span></span>
</td>
<td class="nump">108,269<span></span>
</td>
<td class="nump">84,201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember', window );">Education Content [Member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(60,700)<span></span>
</td>
<td class="num">(42,230)<span></span>
</td>
<td class="num">(26,562)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(20,782)<span></span>
</td>
<td class="num">(18,471)<span></span>
</td>
<td class="num">(15,668)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(81,482)<span></span>
</td>
<td class="num">(60,700)<span></span>
</td>
<td class="num">(42,230)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">52,698<span></span>
</td>
<td class="nump">59,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">102,523<span></span>
</td>
<td class="nump">128,477<span></span>
</td>
<td class="nump">90,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">9,552<span></span>
</td>
<td class="nump">14,092<span></span>
</td>
<td class="nump">37,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,929)<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">112,074<span></span>
</td>
<td class="nump">102,523<span></span>
</td>
<td class="nump">128,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(42,635)<span></span>
</td>
<td class="num">(31,603)<span></span>
</td>
<td class="num">(10,093)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(16,741)<span></span>
</td>
<td class="num">(20,086)<span></span>
</td>
<td class="num">(21,504)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,019<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(59,376)<span></span>
</td>
<td class="num">(42,635)<span></span>
</td>
<td class="num">(31,603)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember', window );">Educational Platform [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">74,493<span></span>
</td>
<td class="nump">83,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember', window );">Educational Platform [Member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">134,820<span></span>
</td>
<td class="nump">74,892<span></span>
</td>
<td class="nump">55,697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">31,250<span></span>
</td>
<td class="nump">30,255<span></span>
</td>
<td class="nump">23,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(911)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,673<span></span>
</td>
<td class="num">(3,058)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">166,070<span></span>
</td>
<td class="nump">134,820<span></span>
</td>
<td class="nump">74,892<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember', window );">Educational Platform [Member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(51,099)<span></span>
</td>
<td class="num">(20,900)<span></span>
</td>
<td class="num">(17,039)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(40,478)<span></span>
</td>
<td class="num">(22,387)<span></span>
</td>
<td class="num">(4,778)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,812)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(91,577)<span></span>
</td>
<td class="num">(51,099)<span></span>
</td>
<td class="num">(20,900)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_IntangibleInProgressMember', window );">Intangible In Progress [Member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">27,473<span></span>
</td>
<td class="nump">12,134<span></span>
</td>
<td class="nump">14,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">72,184<span></span>
</td>
<td class="nump">34,905<span></span>
</td>
<td class="nump">27,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WriteoffOfIntangibleAssets', window );">Write-off</a></td>
<td class="num">(272)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Transfer', window );">Transfer</a></td>
<td class="num">(30,840)<span></span>
</td>
<td class="num">(19,565)<span></span>
</td>
<td class="num">(30,451)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">68,545<span></span>
</td>
<td class="nump">27,473<span></span>
</td>
<td class="nump">12,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_IntangibleInProgressMember', window );">Intangible In Progress [Member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_OtherMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">659<span></span>
</td>
<td class="nump">765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_OtherMember', window );">Other [Member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="nump">1,055<span></span>
</td>
<td class="nump">1,055<span></span>
</td>
<td class="nump">1,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="nump">1,055<span></span>
</td>
<td class="nump">1,055<span></span>
</td>
<td class="nump">1,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_OtherMember', window );">Other [Member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="num">(290)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="num">(396)<span></span>
</td>
<td class="num">(290)<span></span>
</td>
<td class="num">R$ (184)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember', window );">Software In Progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IntangibleAssetsAndGoodwillNetBookValue', window );">Net book value</a></td>
<td class="nump">R$ 68,545<span></span>
</td>
<td class="nump">R$ 27,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IntangibleAssetsAndGoodwillNetBookValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IntangibleAssetsAndGoodwillNetBookValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Remesurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Remesurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Transfer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Transfer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WriteoffOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WriteoffOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_IntangibleInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_IntangibleInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible assets (Details 1) - Carrying Amounts [Member] - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">R$ 1,526,733<span></span>
</td>
<td class="nump">R$ 1,526,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">3,460,415<span></span>
</td>
<td class="nump">3,360,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">6,760,399<span></span>
</td>
<td class="nump">6,485,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">IPTAN Instituto De Ensino Superior Presidente Trancredo DeAlmeida Neves SA [Membe]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">17,446<span></span>
</td>
<td class="nump">17,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">57,214<span></span>
</td>
<td class="nump">57,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">142,155<span></span>
</td>
<td class="nump">122,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Instituto De Educacao Superior Do Vale Do Parnaiba SA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">27,956<span></span>
</td>
<td class="nump">27,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">81,366<span></span>
</td>
<td class="nump">81,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">128,552<span></span>
</td>
<td class="nump">126,195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Centro De Ciencias Em Saude De Itajuba SA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,664<span></span>
</td>
<td class="nump">4,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">56,737<span></span>
</td>
<td class="nump">56,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">64,782<span></span>
</td>
<td class="nump">60,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Instituto De Ensino Superior Do Piaui SA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">73,838<span></span>
</td>
<td class="nump">73,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">179,693<span></span>
</td>
<td class="nump">179,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">336,287<span></span>
</td>
<td class="nump">322,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">FADEP Faculdade Educaciona lDe Pato Branco Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">49,661<span></span>
</td>
<td class="nump">49,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">70,606<span></span>
</td>
<td class="nump">70,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">143,096<span></span>
</td>
<td class="nump">141,201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Instituto Educacional Santo Agostinho SA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">58,903<span></span>
</td>
<td class="nump">58,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">144,507<span></span>
</td>
<td class="nump">144,507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">350,392<span></span>
</td>
<td class="nump">341,020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Instituto Paraensede Educacaoe Cultura Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">108,000<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">168,247<span></span>
</td>
<td class="nump">168,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Uni Redentor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">77,662<span></span>
</td>
<td class="nump">77,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">121,477<span></span>
</td>
<td class="nump">121,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">251,332<span></span>
</td>
<td class="nump">244,123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Uni SL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,420<span></span>
</td>
<td class="nump">4,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">273,795<span></span>
</td>
<td class="nump">273,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">401,911<span></span>
</td>
<td class="nump">386,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">FESAR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">71,664<span></span>
</td>
<td class="nump">71,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">141,616<span></span>
</td>
<td class="nump">141,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">248,037<span></span>
</td>
<td class="nump">246,385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">FCMPB [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">110,483<span></span>
</td>
<td class="nump">110,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">235,018<span></span>
</td>
<td class="nump">235,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">404,039<span></span>
</td>
<td class="nump">392,862<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">ITPAC Garanhuns [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">108,000<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">150,489<span></span>
</td>
<td class="nump">129,458<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Continuing Education [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">267,477<span></span>
</td>
<td class="nump">267,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">574,048<span></span>
</td>
<td class="nump">542,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Medical Practice Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">238,477<span></span>
</td>
<td class="nump">238,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">373,954<span></span>
</td>
<td class="nump">411,873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Unifip Moc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">87,777<span></span>
</td>
<td class="nump">87,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">239,847<span></span>
</td>
<td class="nump">239,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">427,474<span></span>
</td>
<td class="nump">412,698<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Unigranrio [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">169,173<span></span>
</td>
<td class="nump">169,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">421,538<span></span>
</td>
<td class="nump">421,538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">804,996<span></span>
</td>
<td class="nump">819,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Del Rey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">75,098<span></span>
</td>
<td class="nump">75,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">693,890<span></span>
</td>
<td class="nump">693,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">960,966<span></span>
</td>
<td class="nump">929,307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Unidom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">192,034<span></span>
</td>
<td class="nump">192,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">427,482<span></span>
</td>
<td class="nump">427,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">718,699<span></span>
</td>
<td class="nump">687,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">F U N I C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">99,629<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">R$ 110,943<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CashGeneratingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CashGeneratingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 122<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_122_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaensedeEducacaoeCulturaLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaensedeEducacaoeCulturaLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FESARMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FESARMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ITPACGaranhunsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ITPACGaranhunsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ContinuingEducationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ContinuingEducationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalPracticeSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalPracticeSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnifipMocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnifipMocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FUNICMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FUNICMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Details 2)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_EbitdaGrowthRates', window );">EBITDA growth rates</a></td>
<td class="nump">6.88%<span></span>
</td>
<td class="nump">5.69%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Discount rate applied to cash flow projections</a></td>
<td class="nump">10.82%<span></span>
</td>
<td class="nump">11.66%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PerpetuityGrowthRate', window );">Growth rates</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Discount rate applied to cash flow projections</a></td>
<td class="nump">11.73%<span></span>
</td>
<td class="nump">13.97%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PerpetuityGrowthRate', window );">Growth rates</a></td>
<td class="nump">9.50%<span></span>
</td>
<td class="nump">7.53%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_DiscountRatesMember', window );">Discount Rates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections', window );">Description</a></td>
<td class="text">Represent the current market assessment of the specific risks associated to the CGUs, estimated based on information from both internal and external sources, including the Company&#8217;s and third parties historical weighted-average cost of capital (WACC).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_PerpetuityGrowthRateMember', window );">Perpetuity Growth Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections', window );">Description</a></td>
<td class="text">Cash flow projections include specific estimates for a five-year period followed by a terminal growth rate, determined based on management's internal estimate of the long-term compound annual growth rate (CAGR), consistent with the assumptions that would be made by a market participant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EBITDAMember', window );">E B I T D A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections', window );">Description</a></td>
<td class="text">EBITDA growth rate was estimated using historical performance as a baseline, adjusted for:- Expected revenue growth, driven by increases in both sales volume and pricing.- Expected margin expansion, which reflects operational efficiencies and scale economies as
    volumes increase, partially offset by projected increases in costs.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_EbitdaGrowthRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_EbitdaGrowthRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PerpetuityGrowthRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PerpetuityGrowthRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_d_v&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph e<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_e_v&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of key assumptions on which management has based its cash flow projections for the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). Key assumptions are those to which the unit's (group of units') recoverable amount is most sensitive. [Refer: Total for all cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 135<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_135_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_DiscountRatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_DiscountRatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_PerpetuityGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_PerpetuityGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EBITDAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EBITDAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>BRL (R$)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment intangible assets</a></td>
<td class="nump">R$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections', window );">Description of significant estimate</a></td>
<td class="text">An increase of 25 basis points in management&#8217;s estimated discount rate applied to
the cash flow projections of each CGU for the year ended December 31, 2025, or a decrease of 25 basis points on perpetuity growth rate
or EBITDA growth rate would not have significant impacts on Company&#8217;s impairment testing.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of key assumptions on which management has based its cash flow projections for the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). Key assumptions are those to which the unit's (group of units') recoverable amount is most sensitive. [Refer: Total for all cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 135<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_135_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets and goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial assets and liabilities (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">R$ 1,125,381<span></span>
</td>
<td class="nump">R$ 911,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">752,358<span></span>
</td>
<td class="nump">631,846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">1,125,381<span></span>
</td>
<td class="nump">911,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">752,358<span></span>
</td>
<td class="nump">631,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAssets', window );">Other FIES credits - Other assets</a></td>
<td class="nump">6,866<span></span>
</td>
<td class="nump">8,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DividendReceivable', window );">Dividends receivable</a></td>
<td class="nump">6,287<span></span>
</td>
<td class="nump">1,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="nump">1,890,892<span></span>
</td>
<td class="nump">1,553,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssets', window );">Current</a></td>
<td class="nump">1,849,041<span></span>
</td>
<td class="nump">1,508,541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Non-current</a></td>
<td class="nump">R$ 41,851<span></span>
</td>
<td class="nump">R$ 44,930<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial assets and liabilities (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 2,054,267<span></span>
</td>
<td class="nump">R$ 2,195,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,065,746<span></span>
</td>
<td class="nump">978,336<span></span>
</td>
<td class="nump">R$ 874,569<span></span>
</td>
<td class="nump">R$ 769,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">440,597<span></span>
</td>
<td class="nump">530,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPayable', window );">Dividends payable</a></td>
<td class="nump">192<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="nump">2,054,267<span></span>
</td>
<td class="nump">2,195,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">123,581<span></span>
</td>
<td class="nump">128,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">2,054,267<span></span>
</td>
<td class="nump">2,195,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,065,746<span></span>
</td>
<td class="nump">978,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">115,447<span></span>
</td>
<td class="nump">215,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPayable', window );">Dividends payable</a></td>
<td class="nump">192<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="nump">3,359,233<span></span>
</td>
<td class="nump">3,517,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current</a></td>
<td class="nump">326,432<span></span>
</td>
<td class="nump">690,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current</a></td>
<td class="nump">R$ 3,032,801<span></span>
</td>
<td class="nump">R$ 2,827,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends payable by means of the distribution of non-cash assets to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRIC<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRIC&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial assets and liabilities (Details 2) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesAtFairValues', window );">Financial liabilities, at fair value</a></td>
<td class="nump">R$ 325,150<span></span>
</td>
<td class="nump">R$ 314,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Current</a></td>
<td class="nump">24,421<span></span>
</td>
<td class="nump">32,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss', window );">Non-current</a></td>
<td class="nump">300,729<span></span>
</td>
<td class="nump">282,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersEarnOutsMember', window );">Accounts Payable To Selling Shareholders Earn Outs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesAtFairValues', window );">Financial liabilities, at fair value</a></td>
<td class="nump">3,337<span></span>
</td>
<td class="nump">20,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersUnidomMember', window );">Accounts Payable To Selling Shareholders Unidom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesAtFairValues', window );">Financial liabilities, at fair value</a></td>
<td class="nump">R$ 321,813<span></span>
</td>
<td class="nump">R$ 294,886<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialLiabilitiesAtFairValues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialLiabilitiesAtFairValues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities measured at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 8<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_8_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities measured at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 8<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_8_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersEarnOutsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersEarnOutsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersUnidomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersUnidomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities (Details 3) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 2,054,267<span></span>
</td>
<td class="nump">R$ 2,195,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancingCurrent', window );">Current</a></td>
<td class="nump">60,668<span></span>
</td>
<td class="nump">363,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancingNonCurrent', window );">Non-current</a></td>
<td class="nump">R$ 1,993,599<span></span>
</td>
<td class="nump">1,831,607<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_OctoberTwentyTwentyFiveMember', window );">October Twenty Twenty Five [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="text">Banco Ita&#250; Unibanco S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">CDI + 1.90% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="text">October 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">309,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_JulyTwentyTwentySevenMember', window );">July Twenty Twenty Seven [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="text">FINEP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">TJLP p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="text">July 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 5,262<span></span>
</td>
<td class="nump">8,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_AprilTwentyTwentySixMember', window );">April Twenty Twenty Six [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="text">Softbank<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">6.5% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="text">April 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">845,492<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_JanuaryTwentyTwentyEightMember', window );">January Twenty Twenty Eight [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="text">Debentures<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">CDI + 1.80% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="text">January 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">526,946<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_AprilTwentyThirtyMember', window );">April Twenty Thirty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="text">IFC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">CDI + 1.05% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="text">April 2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 510,672<span></span>
</td>
<td class="nump">505,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_OctoberTwentyTwentyEightMember', window );">October Twenty Twenty Eight [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="text">Commercial notes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">CDI + 0.70% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="text">October 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 512,678<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_OctoberTwentyThirtyMember', window );">October Twenty Thirty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="text">Commercial notes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">CDI + 0.85% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="text">October 2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 1,025,655<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialInstitution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialInstitution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancingCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancingCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancingNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancingNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maturity of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_OctoberTwentyTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_OctoberTwentyTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_JulyTwentyTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_JulyTwentyTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_AprilTwentyTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_AprilTwentyTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_JanuaryTwentyTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_JanuaryTwentyTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_AprilTwentyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_AprilTwentyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_OctoberTwentyTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_OctoberTwentyTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_OctoberTwentyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_OctoberTwentyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities  (Details 4) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets, balance at beginning</a></td>
<td class="nump">R$ 842,219<span></span>
</td>
<td class="nump">R$ 767,609<span></span>
</td>
<td class="nump">R$ 690,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities, balance at beginning</a></td>
<td class="nump">978,336<span></span>
</td>
<td class="nump">874,569<span></span>
</td>
<td class="nump">769,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Right-of-use assets, additions</a></td>
<td class="nump">37,727<span></span>
</td>
<td class="nump">37,671<span></span>
</td>
<td class="nump">7,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsToLeaseLiabilities', window );">Lease liabilities, additions</a></td>
<td class="nump">37,727<span></span>
</td>
<td class="nump">37,671<span></span>
</td>
<td class="nump">7,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsRemeasurement', window );">Right-of-use assets, remeasurement</a></td>
<td class="nump">98,987<span></span>
</td>
<td class="nump">80,226<span></span>
</td>
<td class="nump">70,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseLiabilitiesRemeasurement', window );">Lease liabilities, remeasurement</a></td>
<td class="nump">98,987<span></span>
</td>
<td class="nump">80,226<span></span>
</td>
<td class="nump">70,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsBusinessCombinations', window );">Right-of-use assets, business combinations</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28,989<span></span>
</td>
<td class="nump">65,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BusinessCombinationsLeaseLiabilities', window );">Lease liabilities, business combinations</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28,989<span></span>
</td>
<td class="nump">65,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Right-of-use assets, depreciation expense</a></td>
<td class="num">(80,864)<span></span>
</td>
<td class="num">(70,294)<span></span>
</td>
<td class="num">(63,118)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DepreciationExpenseLeaseLiabilities', window );">Lease liabilities, depreciation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsInterestExpense', window );">Right-of-use assets, interest expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Lease liabilities, interest expense</a></td>
<td class="nump">123,067<span></span>
</td>
<td class="nump">111,966<span></span>
</td>
<td class="nump">100,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsPaymentsOfPrincipal', window );">Right of use assets, payments of principal</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseLiabilitiesPaymentsOfPrincipal', window );">Lease liabilities, payments of principal</a></td>
<td class="num">(49,411)<span></span>
</td>
<td class="num">(41,221)<span></span>
</td>
<td class="num">(31,473)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsPaymentsOfInterest', window );">Right-of-use assets, payments of interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PaymentsOfInterestLeaseLiabilities', window );">Lease liabilities, payments of interest</a></td>
<td class="num">(121,475)<span></span>
</td>
<td class="num">(111,605)<span></span>
</td>
<td class="num">(103,911)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsWriteoff', window );">Right-of-use assets, Write-off</a></td>
<td class="num">(1,311)<span></span>
</td>
<td class="num">(1,982)<span></span>
</td>
<td class="num">(2,469)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseLiabilitiesWriteoff', window );">Lease liabilities, Write-off</a></td>
<td class="num">(1,485)<span></span>
</td>
<td class="num">(2,259)<span></span>
</td>
<td class="num">(3,544)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets, balance at ending</a></td>
<td class="nump">896,758<span></span>
</td>
<td class="nump">842,219<span></span>
</td>
<td class="nump">767,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities, balance at ending</a></td>
<td class="nump">1,065,746<span></span>
</td>
<td class="nump">978,336<span></span>
</td>
<td class="nump">874,569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsCurrent', window );">Right-of-use assets, current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liabilities, current</a></td>
<td class="nump">55,772<span></span>
</td>
<td class="nump">45,580<span></span>
</td>
<td class="nump">36,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAssetsNonCurrent', window );">Right-of-use assets, non-current</a></td>
<td class="nump">896,758<span></span>
</td>
<td class="nump">842,219<span></span>
</td>
<td class="nump">767,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities, non-current</a></td>
<td class="nump">R$ 1,009,974<span></span>
</td>
<td class="nump">R$ 932,756<span></span>
</td>
<td class="nump">R$ 837,671<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsToLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsToLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_BusinessCombinationsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_BusinessCombinationsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DepreciationExpenseLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DepreciationExpenseLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesPaymentsOfPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesPaymentsOfPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentsOfInterestLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentsOfInterestLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsPaymentsOfInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsPaymentsOfInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsPaymentsOfPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsPaymentsOfPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities (Details 5) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable</a></td>
<td class="nump">R$ 440,597<span></span>
</td>
<td class="nump">R$ 530,772<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersCurrent', window );">Current</a></td>
<td class="nump">110,640<span></span>
</td>
<td class="nump">185,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersNonCurrent', window );">Non-current</a></td>
<td class="nump">R$ 329,957<span></span>
</td>
<td class="nump">345,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember', window );">Unigranrio [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableAamortizedCostInterestRateBasis', window );">Interest rate</a></td>
<td class="text">CDI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">90,543<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember', window );">Del Rey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableAamortizedCostInterestRateBasis', window );">Interest rate</a></td>
<td class="text">Selic<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable</a></td>
<td class="nump">R$ 71,604<span></span>
</td>
<td class="nump">125,276<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FUNICMember', window );">F U N I C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableAamortizedCostInterestRateBasis', window );">Interest rate</a></td>
<td class="text">CDI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable</a></td>
<td class="nump">R$ 43,843<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember', window );">Shosp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable</a></td>
<td class="nump">454<span></span>
</td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember', window );">Alem Da Medicina [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardiPapersMember', window );">Cardi Papers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable</a></td>
<td class="nump">R$ 2,883<span></span>
</td>
<td class="nump">10,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomMember', window );">Unidom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableAamortizedCostInterestRateBasis', window );">Interest rate</a></td>
<td class="text">CDI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable</a></td>
<td class="nump">R$ 321,813<span></span>
</td>
<td class="nump">R$ 294,886<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableAamortizedCostInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableAamortizedCostInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FUNICMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FUNICMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardiPapersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardiPapersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities (Details 6) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">R$ 530,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payment of interest</a></td>
<td class="num">(395,740)<span></span>
</td>
<td class="num">R$ (288,797)<span></span>
</td>
<td class="num">R$ (279,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Other</a></td>
<td class="num">(4,499)<span></span>
</td>
<td class="nump">18,126<span></span>
</td>
<td class="nump">24,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Closing balance</a></td>
<td class="nump">440,597<span></span>
</td>
<td class="nump">530,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember', window );">Accounts Payable To Selling Shareholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="nump">530,772<span></span>
</td>
<td class="nump">566,867<span></span>
</td>
<td class="nump">528,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersBusinessCombinations', window );">Additions consideration to be transferred on business combinations</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">279,989<span></span>
</td>
<td class="nump">234,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PaymentsOfPrincipal', window );">Payments of principal</a></td>
<td class="num">(144,076)<span></span>
</td>
<td class="num">(290,067)<span></span>
</td>
<td class="num">(225,460)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payment of interest</a></td>
<td class="num">(49,608)<span></span>
</td>
<td class="num">(78,931)<span></span>
</td>
<td class="num">(55,989)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest</a></td>
<td class="nump">19,979<span></span>
</td>
<td class="nump">37,276<span></span>
</td>
<td class="nump">85,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemeasurementOfEarnouts', window );">Remeasurement of contingent consideration</a></td>
<td class="nump">43,530<span></span>
</td>
<td class="nump">15,638<span></span>
</td>
<td class="nump">2,556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Other</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,987)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Closing balance</a></td>
<td class="nump">R$ 440,597<span></span>
</td>
<td class="nump">R$ 530,772<span></span>
</td>
<td class="nump">R$ 566,867<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentsOfPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentsOfPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RemeasurementOfEarnouts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RemeasurementOfEarnouts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial assets and liabilities (Details 7) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, at carrying amount</a></td>
<td class="nump">R$ 2,054,267<span></span>
</td>
<td class="nump">R$ 2,195,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">2,056,492<span></span>
</td>
<td class="nump">2,196,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember', window );">Loans And Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, at carrying amount</a></td>
<td class="nump">2,054,267<span></span>
</td>
<td class="nump">2,195,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">R$ 2,056,492<span></span>
</td>
<td class="nump">R$ 2,196,152<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities (Details 8)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>BRL (R$)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (225,328)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Loans And Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (2,049,005)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">CDI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (323,480)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Loans And Financing One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (5,262)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">TJLP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (477)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Accounts Payable To Selling Shareholders One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (365,656)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">CDI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (54,483)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Accounts Payable To Selling Shareholders Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (71,604)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">Selic<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (10,669)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Cash Equivalents 1 [Member] | Increase Basis Points [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Effect on profit before tax</a></td>
<td class="num">(10,538)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember', window );">Floating interest rate [member] | Interest rate risk [member] | Cash Equivalents 1 [Member] | Increase Basis Points One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Effect on profit before tax</a></td>
<td class="num">(21,076)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_CashEquivalents1Member', window );">Cash Equivalents 1 [Member] | Floating interest rate [member] | Interest rate risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="nump">R$ 1,086,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">CDI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="nump">R$ 163,781<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_BaseRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_BaseRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IndexRatePerYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IndexRatePerYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of assets, recognised in profit or loss before tax, due to a reasonably possible decrease in an unobservable input. [Refer: Tax income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of assets, recognised in profit or loss before tax, due to a reasonably possible increase in an unobservable input. [Refer: Tax income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_CashEquivalents1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_CashEquivalents1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProbabilityOfDefaultAxis=afya_IncreaseBasisPointsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProbabilityOfDefaultAxis=afya_IncreaseBasisPointsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProbabilityOfDefaultAxis=afya_IncreaseBasisPointsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProbabilityOfDefaultAxis=afya_IncreaseBasisPointsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_CashEquivalents1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_CashEquivalents1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities (Details 9) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">R$ 214,366<span></span>
</td>
<td class="nump">R$ 357,985<span></span>
</td>
<td class="num">R$ (540,052)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RiskExposuresAxis=afya_ForeignCurrencyExposuresMember', window );">Foreign Currency Exposures [Member] | Currency risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">23,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RiskExposuresAxis=afya_IncreaseForeignCurrencyMember', window );">Increase Foreign Currency [Member] | Currency risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">2,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RiskExposuresAxis=afya_DecreaseForeignCurrencyMember', window );">Decrease Foreign Currency [Member] | Currency risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">R$ (2,342)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposuresAxis=afya_ForeignCurrencyExposuresMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposuresAxis=afya_ForeignCurrencyExposuresMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposuresAxis=afya_IncreaseForeignCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposuresAxis=afya_IncreaseForeignCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposuresAxis=afya_DecreaseForeignCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposuresAxis=afya_DecreaseForeignCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial assets and liabilities (Details 10) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 2,054,267<span></span>
</td>
<td class="nump">R$ 2,195,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,065,746<span></span>
</td>
<td class="nump">978,336<span></span>
</td>
<td class="nump">R$ 874,569<span></span>
</td>
<td class="nump">R$ 769,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">440,597<span></span>
</td>
<td class="nump">530,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">123,581<span></span>
</td>
<td class="nump">128,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">3,142,436<span></span>
</td>
<td class="nump">2,714,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">2,200,217<span></span>
</td>
<td class="nump">2,115,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">945,929<span></span>
</td>
<td class="nump">828,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">6,412,163<span></span>
</td>
<td class="nump">5,786,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember', window );">Later than one year [member] | Liquidity risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">123,581<span></span>
</td>
<td class="nump">128,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">308,292<span></span>
</td>
<td class="nump">526,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">178,638<span></span>
</td>
<td class="nump">158,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">126,307<span></span>
</td>
<td class="nump">205,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">736,818<span></span>
</td>
<td class="nump">1,018,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">Later than one year and not later than three years [member] | Liquidity risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">1,360,411<span></span>
</td>
<td class="nump">1,494,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">347,847<span></span>
</td>
<td class="nump">303,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">131,446<span></span>
</td>
<td class="nump">150,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">1,839,704<span></span>
</td>
<td class="nump">1,948,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">Later than three years and not later than five years [member] | Liquidity risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">1,473,733<span></span>
</td>
<td class="nump">617,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">331,019<span></span>
</td>
<td class="nump">293,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">185,821<span></span>
</td>
<td class="nump">99,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">1,990,573<span></span>
</td>
<td class="nump">1,010,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years [member] | Liquidity risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">75,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,342,713<span></span>
</td>
<td class="nump">1,360,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">502,355<span></span>
</td>
<td class="nump">373,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">R$ 1,845,068<span></span>
</td>
<td class="nump">R$ 1,809,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialLiabilitiesContractualUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialLiabilitiesContractualUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities (Details 11) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning</a></td>
<td class="nump">R$ 3,173,497<span></span>
</td>
<td class="nump">R$ 2,675,344<span></span>
</td>
<td class="nump">R$ 2,652,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Payments of principal</a></td>
<td class="num">(1,821,135)<span></span>
</td>
<td class="num">(188,206)<span></span>
</td>
<td class="num">(162,853)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payments of interest</a></td>
<td class="num">(395,740)<span></span>
</td>
<td class="num">(288,797)<span></span>
</td>
<td class="num">(279,800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Additions and remeasurements</a></td>
<td class="nump">1,778,600<span></span>
</td>
<td class="nump">627,779<span></span>
</td>
<td class="nump">101,753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities', window );">Interest</a></td>
<td class="nump">375,937<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
<td class="nump">298,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other</a></td>
<td class="nump">9,046<span></span>
</td>
<td class="nump">573<span></span>
</td>
<td class="num">(117)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">3,120,205<span></span>
</td>
<td class="nump">3,173,497<span></span>
</td>
<td class="nump">2,675,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,366<span></span>
</td>
<td class="nump">65,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_LoansAndFinancingMember', window );">Loans And Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning</a></td>
<td class="nump">2,195,161<span></span>
</td>
<td class="nump">1,800,775<span></span>
</td>
<td class="nump">1,882,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Payments of principal</a></td>
<td class="num">(1,624,911)<span></span>
</td>
<td class="num">(128,696)<span></span>
</td>
<td class="num">(112,630)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payments of interest</a></td>
<td class="num">(274,265)<span></span>
</td>
<td class="num">(177,192)<span></span>
</td>
<td class="num">(175,889)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Additions and remeasurements</a></td>
<td class="nump">1,494,881<span></span>
</td>
<td class="nump">491,593<span></span>
</td>
<td class="nump">5,288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities', window );">Interest</a></td>
<td class="nump">252,870<span></span>
</td>
<td class="nump">201,472<span></span>
</td>
<td class="nump">197,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other</a></td>
<td class="nump">10,531<span></span>
</td>
<td class="nump">2,832<span></span>
</td>
<td class="nump">3,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">2,054,267<span></span>
</td>
<td class="nump">2,195,161<span></span>
</td>
<td class="nump">1,800,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning</a></td>
<td class="nump">978,336<span></span>
</td>
<td class="nump">874,569<span></span>
</td>
<td class="nump">769,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Payments of principal</a></td>
<td class="num">(49,411)<span></span>
</td>
<td class="num">(41,221)<span></span>
</td>
<td class="num">(31,473)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payments of interest</a></td>
<td class="num">(121,475)<span></span>
</td>
<td class="num">(111,605)<span></span>
</td>
<td class="num">(103,911)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Additions and remeasurements</a></td>
<td class="nump">136,714<span></span>
</td>
<td class="nump">117,897<span></span>
</td>
<td class="nump">77,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities', window );">Interest</a></td>
<td class="nump">123,067<span></span>
</td>
<td class="nump">111,966<span></span>
</td>
<td class="nump">100,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other</a></td>
<td class="num">(1,485)<span></span>
</td>
<td class="num">(2,259)<span></span>
</td>
<td class="num">(3,544)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">1,065,746<span></span>
</td>
<td class="nump">978,336<span></span>
</td>
<td class="nump">874,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,989<span></span>
</td>
<td class="nump">65,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_DividendsPayableMember', window );">Dividends Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Payments of principal</a></td>
<td class="num">(146,813)<span></span>
</td>
<td class="num">(18,289)<span></span>
</td>
<td class="num">(18,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payments of interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Additions and remeasurements</a></td>
<td class="nump">147,005<span></span>
</td>
<td class="nump">R$ 18,289<span></span>
</td>
<td class="nump">R$ 18,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">R$ 192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44B<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44B_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from obtaining or losing control of subsidiaries or other businesses. [Refer: Liabilities arising from financing activities; Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44B<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44B_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44B<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44B_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44B<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44B&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_LoansAndFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_LoansAndFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_DividendsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_DividendsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and liabilities (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 15, 2025 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>May 07, 2025 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Aug. 07, 2024 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Jul. 01, 2024 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Jan. 02, 2023 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Apr. 05, 2022 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Mar. 04, 2022 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Aug. 04, 2021 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>May 13, 2021 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>BRL (R$) </div>
<div>Number</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>BRL (R$)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 5,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed', window );">Lease expense from short-term leases and low-value assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,617,000<span></span>
</td>
<td class="nump">R$ 11,207,000<span></span>
</td>
<td class="nump">R$ 10,871,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CreditExposures', window );">Exposure risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 23,422,000<span></span>
</td>
<td class="nump">R$ 21,610,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SensitivityChangeInTheEuroExchangeRate', window );">Percentage of sensitivity change in the Euro exchange rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Closing foreign exchange rate | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.5018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member] | Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Closing foreign exchange rate | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember', window );">Unigranrio [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPayablesForPurchaseOfEnergy', window );">Non-current payables for purchase of energy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 618,956,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember', window );">Del Rey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">Consideration to be transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 234,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FirstAnnualInstallmentsPayable', window );">First annual installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SecondAnnualInstallmentsPayable', window );">Second annual installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ThirdAnnualInstallmentsPayable', window );">Third annual installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FUNICMember', window );">F U N I C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPayablesForPurchaseOfEnergy', window );">Non-current payables for purchase of energy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember', window );">Shosp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 513,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Transaction price allocated to remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 454,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember', window );">Alem Da Medicina [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 19,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 9,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardioPapersMember', window );">Cardio Papers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 2,883,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomMember', window );">Unidom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">Consideration to be transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 279,989,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 279,989,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ContractualLeaseTerm', window );">Contractual lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ContractualLeaseTerm', window );">Contractual lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_InternationalFinanceCorporationMember', window );">International Finance Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoanAndFinancing', window );">Loans and financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="text">CDI rate plus a spread of 0.70% and 0.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">CDI rate plus 1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_TwoSeriesMember', window );">Two Series [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoanAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_FirstSeriesMember', window );">First Series [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoanAndFinancing', window );">Loans and financing</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_SecondSeriesMember', window );">Second Series [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LoanAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ConsiderationToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ConsiderationToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ContractualLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ContractualLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CreditExposures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CreditExposures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FirstAnnualInstallmentsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FirstAnnualInstallmentsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoanAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoanAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RemainingTradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RemainingTradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SecondAnnualInstallmentsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SecondAnnualInstallmentsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SensitivityChangeInTheEuroExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SensitivityChangeInTheEuroExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ThirdAnnualInstallmentsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ThirdAnnualInstallmentsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClosingForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClosingForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to leases of low-value assets accounted for applying paragraph 6 of IFRS 16. This expense shall not include the expense relating to short-term leases of low-value assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPayablesForPurchaseOfEnergy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current payables for the purchase of energy. [Refer: Payables for purchase of energy]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPayablesForPurchaseOfEnergy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Total for all subsidiaries [member]; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 12<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_12_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_DelReyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FUNICMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FUNICMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AlemDaMedicinaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardioPapersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CardioPapersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnidomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_InternationalFinanceCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_InternationalFinanceCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_TwoSeriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_TwoSeriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_FirstSeriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_FirstSeriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_SecondSeriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_SecondSeriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Details) - Share options [member] - BRL (R$)<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th" colspan="8">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2025</div></th>
<th class="th"><div>Apr. 30, 2025</div></th>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement', window );">Amount</a></td>
<td class="nump">R$ 692,000<span></span>
</td>
<td class="nump">R$ 60,000<span></span>
</td>
<td class="nump">R$ 113,900<span></span>
</td>
<td class="nump">R$ 232,000<span></span>
</td>
<td class="nump">R$ 37,000<span></span>
</td>
<td class="nump">R$ 153,000<span></span>
</td>
<td class="nump">R$ 30,000<span></span>
</td>
<td class="nump">R$ 15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SharePriceFairValueAtMeasurementDate', window );">Exercise price at the measurement date</a></td>
<td class="nump">R$ 62.57<span></span>
</td>
<td class="nump">R$ 79.91<span></span>
</td>
<td class="nump">R$ 73.75<span></span>
</td>
<td class="nump">R$ 60<span></span>
</td>
<td class="nump">R$ 59<span></span>
</td>
<td class="nump">R$ 59<span></span>
</td>
<td class="nump">R$ 57<span></span>
</td>
<td class="nump">R$ 56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield (%)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted', window );">Share price at the measurement date</a></td>
<td class="nump">R$ 79.36<span></span>
</td>
<td class="nump">R$ 107.33<span></span>
</td>
<td class="nump">R$ 92.78<span></span>
</td>
<td class="nump">R$ 100.97<span></span>
</td>
<td class="nump">R$ 79.12<span></span>
</td>
<td class="nump">R$ 76.45<span></span>
</td>
<td class="nump">R$ 62.51<span></span>
</td>
<td class="nump">R$ 70.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted', window );">Valuation model</a></td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne', window );">Weighted average fair value at the measurement date</a></td>
<td class="nump">R$ 33.27<span></span>
</td>
<td class="nump">R$ 45.95<span></span>
</td>
<td class="nump">R$ 39.71<span></span>
</td>
<td class="nump">R$ 54.25<span></span>
</td>
<td class="nump">R$ 38.67<span></span>
</td>
<td class="nump">R$ 37.04<span></span>
</td>
<td class="nump">R$ 32.04<span></span>
</td>
<td class="nump">R$ 29.54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedLifeOfStockOptions', window );">Expected life of stock options</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExpectedLifeOfStockOptions', window );">Expected life of stock options</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ExpectedLifeOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ExpectedLifeOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharePriceFairValueAtMeasurementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharePriceFairValueAtMeasurementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the option pricing model used for share options granted. [Refer: Option pricing model [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Details 1) - Share options [member]<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>Number </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>Number </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Number </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Outstanding at the beginning</a></td>
<td class="nump">R$ 67.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of stock options, Outstanding at the beginning | Number</a></td>
<td class="nump">1,610,679<span></span>
</td>
<td class="nump">1,696,064<span></span>
</td>
<td class="nump">3,729,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Granted</a></td>
<td class="nump">R$ 63.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of stock options, Granted | Number</a></td>
<td class="nump">752,000<span></span>
</td>
<td class="nump">113,900<span></span>
</td>
<td class="nump">467,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Exercised</a></td>
<td class="nump">R$ 63.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of stock options, Exercised | Number</a></td>
<td class="num">(404,478)<span></span>
</td>
<td class="num">(147,955)<span></span>
</td>
<td class="num">(164,214)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement', window );">Number of stock options, stock option exchanged | Number</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,751,599)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Forfeited</a></td>
<td class="nump">R$ 72.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Number of stock options, Forfeited | Number</a></td>
<td class="num">(57,152)<span></span>
</td>
<td class="num">(16,182)<span></span>
</td>
<td class="num">(333,111)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Expired</a></td>
<td class="nump">R$ 68.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement', window );">Number of stock options, Expired | Number</a></td>
<td class="num">(57,680)<span></span>
</td>
<td class="num">(35,148)<span></span>
</td>
<td class="num">(251,299)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Outstanding at the ending</a></td>
<td class="nump">R$ 65.91<span></span>
</td>
<td class="nump">R$ 67.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of stock options, Outstanding at the ending | Number</a></td>
<td class="nump">1,843,369<span></span>
</td>
<td class="nump">1,610,679<span></span>
</td>
<td class="nump">1,696,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise price, Exercisable</a></td>
<td class="nump">R$ 71.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfStockOptionsExercisable', window );">Number of stock options, Exercisable | shares</a></td>
<td class="nump">340,219<span></span>
</td>
<td class="nump">427,202<span></span>
</td>
<td class="nump">242,235<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfStockOptionsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfStockOptionsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Details 2) - BRL (R$)<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_November2025Member', window );">November 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement', window );">Granted</a></td>
<td class="nump">R$ 346,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Fair values at grant date</a></td>
<td class="nump">R$ 79.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_November2025Member', window );">November 2025 [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_November2025Member', window );">November 2025 [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_April2025Member', window );">April 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement', window );">Granted</a></td>
<td class="nump">R$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Fair values at grant date</a></td>
<td class="nump">R$ 107.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_April2025Member', window );">April 2025 [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_April2025Member', window );">April 2025 [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_October2024Member', window );">October 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 44,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Fair values at grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 92.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_October2024Member', window );">October 2024 [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_October2024Member', window );">October 2024 [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_December2023Member', window );">December 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 76,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Fair values at grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 100.97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_December2023Member', window );">December 2023 [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_December2023Member', window );">December 2023 [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_October2023Member', window );">October 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 63,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Fair values at grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 79.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_October2023Member', window );">October 2023 [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_October2023Member', window );">October 2023 [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_August2023Member', window );">August 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 153,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Fair values at grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 76.45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_August2023Member', window );">August 2023 [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_August2023Member', window );">August 2023 [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_April2023Member', window );">April 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 16,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Fair values at grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 62.51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_April2023Member', window );">April 2023 [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_April2023Member', window );">April 2023 [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_February2023Member', window );">February 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 8,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Fair values at grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 70.69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_February2023Member', window );">February 2023 [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_February2023Member', window );">February 2023 [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_GrantedVestingPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_GrantedVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_GrantedVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_November2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_November2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_April2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_April2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_October2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_October2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_December2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_December2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_October2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_October2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_August2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_August2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_April2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_April2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_February2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_February2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Details 3) - Restricted Stock Units [Member] - Number<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of stock options, Outstanding at the beginning</a></td>
<td class="nump">656,634<span></span>
</td>
<td class="nump">854,431<span></span>
</td>
<td class="nump">447,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of stock options, Granted</a></td>
<td class="nump">381,000<span></span>
</td>
<td class="nump">44,500<span></span>
</td>
<td class="nump">317,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement', window );">Number of stock options, Stock options exchanged</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">215,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of stock options, Exercised</a></td>
<td class="num">(224,070)<span></span>
</td>
<td class="num">(222,910)<span></span>
</td>
<td class="num">(99,576)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Number of stock options, Forfeited</a></td>
<td class="num">(93,846)<span></span>
</td>
<td class="num">(19,387)<span></span>
</td>
<td class="num">(26,104)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of stock options, Outstanding at the ending</a></td>
<td class="nump">719,718<span></span>
</td>
<td class="nump">656,634<span></span>
</td>
<td class="nump">854,431<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ShareBasedCompensationOfEmployees', window );">Compensation of employees</a></td>
<td class="nump">R$ 56,581<span></span>
</td>
<td class="nump">R$ 35,857<span></span>
</td>
<td class="nump">R$ 22,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SocialObligationsLiabilities', window );">Social obligations liabilities</a></td>
<td class="nump">R$ 2,660<span></span>
</td>
<td class="nump">8,988<span></span>
</td>
<td class="nump">7,177<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits1Member', window );">Restricted Stock Units 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits2Member', window );">Restricted Stock Units 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion percentage</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits3Member', window );">Restricted Stock Units 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion percentage</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_ShareBasedCompensationPlansMember', window );">Share Based Compensation Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expense</a></td>
<td class="nump">R$ 4,809<span></span>
</td>
<td class="nump">17,394<span></span>
</td>
<td class="nump">20,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_RestrictedStockUnitsMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expense</a></td>
<td class="nump">R$ 10,509<span></span>
</td>
<td class="nump">R$ 15,030<span></span>
</td>
<td class="nump">R$ 10,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ShareBasedCompensationOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ShareBasedCompensationOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SocialObligationsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SocialObligationsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Total for all joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_RestrictedStockUnits3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_ShareBasedCompensationPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_ShareBasedCompensationPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details) - R$ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureEquityAbstract', window );"><strong>Disclosure Equity Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares, Outstanding, at beginning balance</a></td>
<td class="nump">3,455,538<span></span>
</td>
<td class="nump">3,773,478<span></span>
</td>
<td class="nump">3,786,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Average price, at beginning balance</a></td>
<td class="nump">R$ 79.28<span></span>
</td>
<td class="nump">R$ 79.28<span></span>
</td>
<td class="nump">R$ 80.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfSharesRepurchased', window );">Number of shares, Repurchased</a></td>
<td class="nump">966,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AveragePriceRepurchased', window );">Average price repurchased</a></td>
<td class="nump">R$ 80.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 57.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan', window );">Number of treasury shares, delivered under the share-based compensation plan</a></td>
<td class="num">(566,929)<span></span>
</td>
<td class="num">(317,940)<span></span>
</td>
<td class="num">(229,146)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AveragePriceDeliveredUnderSharebasedCompensationPlan', window );">Average price, delivered under the share-based compensation plan</a></td>
<td class="nump">R$ 79.28<span></span>
</td>
<td class="nump">R$ 79.28<span></span>
</td>
<td class="nump">R$ 79.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares, Outstanding, at ending balance</a></td>
<td class="nump">3,855,150<span></span>
</td>
<td class="nump">3,455,538<span></span>
</td>
<td class="nump">3,773,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Average price, at ending balance</a></td>
<td class="nump">R$ 79.52<span></span>
</td>
<td class="nump">R$ 79.28<span></span>
</td>
<td class="nump">R$ 79.28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AveragePriceDeliveredUnderSharebasedCompensationPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AveragePriceDeliveredUnderSharebasedCompensationPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AveragePriceRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AveragePriceRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details Narrative) - BRL (R$)<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 04, 2025</div></th>
<th class="th"><div>Mar. 12, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Aug. 13, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 17<span></span>
</td>
<td class="nump">R$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumberOfSharesIssued1', window );">Total number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,722,831<span></span>
</td>
<td class="nump">93,722,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IssuedCapitals', window );">Authorized capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 50<span></span>
</td>
<td class="nump">R$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CapitalUnitsAuthorizedShares', window );">Authorized capital units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 0.00005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PaymentOfDividends', window );">Payment of dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 76,862<span></span>
</td>
<td class="nump">79,701<span></span>
</td>
<td class="nump">R$ 65,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DividendDistributed', window );">Dividend distributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,641<span></span>
</td>
<td class="nump">61,412<span></span>
</td>
<td class="nump">46,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidToNoncontrollingInterests', window );">Dividends paid to non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,221<span></span>
</td>
<td class="nump">R$ 18,289<span></span>
</td>
<td class="nump">R$ 18,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FirstDividendDistributionInAmount', window );">First dividend distribution in amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 129,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PercentageOfDividendDistribution', window );">Percentage of dividend distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidOtherSharesPerShare', window );">Dividends per share</a></td>
<td class="nump">R$ 1.348923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CashOutflow', window );">Cash outflow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 77,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Total number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,148,697<span></span>
</td>
<td class="nump">49,920,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RepurchaseOfOrdinaryShares', window );">Repurchase of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember', window );">Class B Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Total number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,574,134<span></span>
</td>
<td class="nump">43,802,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CapitalUnitsAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CapitalUnitsAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CashOutflow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CashOutflow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FirstDividendDistributionInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FirstDividendDistributionInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IssuedCapitals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IssuedCapitals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PercentageOfDividendDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PercentageOfDividendDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RepurchaseOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RepurchaseOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidOtherSharesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends paid per other share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 34<br> -IssueDate 2024-01-01<br> -Paragraph 16A<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=34&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16A_f&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidOtherSharesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends paid to non-controlling interests. [Refer: Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Details) - BRL (R$)<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NumeratorAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends', window );">Net income attributable to the owners of the Company</a></td>
<td class="nump">R$ 752,461<span></span>
</td>
<td class="nump">R$ 631,510<span></span>
</td>
<td class="nump">R$ 386,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DenominatorAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of outstanding shares</a></td>
<td class="nump">90,475,878<span></span>
</td>
<td class="nump">90,122,429<span></span>
</td>
<td class="nump">89,830,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares', window );">Effects of dilution from stock options and restricted stock units</a></td>
<td class="nump">791,733<span></span>
</td>
<td class="nump">1,032,207<span></span>
</td>
<td class="nump">706,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of outstanding shares adjusted for the effect of dilution</a></td>
<td class="nump">91,267,611<span></span>
</td>
<td class="nump">91,154,636<span></span>
</td>
<td class="nump">90,536,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic earnings per share (R$)</a></td>
<td class="nump">R$ 8.32<span></span>
</td>
<td class="nump">R$ 7.01<span></span>
</td>
<td class="nump">R$ 4.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted earnings per share (R$)</a></td>
<td class="nump">R$ 8.24<span></span>
</td>
<td class="nump">R$ 6.93<span></span>
</td>
<td class="nump">R$ 4.27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to profit (loss) for non-participating preference share dividends to calculate profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Preference shares [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Section Example 12 Calculation and presentation of basic and diluted earnings per share (comprehensive example)<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS33_ex12_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The potential dilutive effect on the weighted average number of ordinary shares that relate to the assumed exercise of the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ProfessionalFeesExpenses', window );">Tuition fees</a></td>
<td class="nump">R$ 4,684,322<span></span>
</td>
<td class="nump">R$ 4,052,379<span></span>
</td>
<td class="nump">R$ 3,505,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherRevenue1', window );">Other</a></td>
<td class="nump">331,934<span></span>
</td>
<td class="nump">305,527<span></span>
</td>
<td class="nump">263,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeductionAbstract', window );"><strong>Deductions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeductionOfGrantedDiscounts', window );">Discount and scholarships</a></td>
<td class="num">(685,219)<span></span>
</td>
<td class="num">(515,311)<span></span>
</td>
<td class="num">(435,368)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeductionOfReturnsOfNetRevenue', window );">Returns</a></td>
<td class="num">(31,665)<span></span>
</td>
<td class="num">(25,312)<span></span>
</td>
<td class="num">(27,743)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeductionOfTaxes', window );">Taxes</a></td>
<td class="num">(194,477)<span></span>
</td>
<td class="num">(170,628)<span></span>
</td>
<td class="num">(142,825)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeductionOfProuni', window );">PROUNI</a></td>
<td class="num">(407,640)<span></span>
</td>
<td class="num">(342,326)<span></span>
</td>
<td class="num">(287,338)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">3,697,255<span></span>
</td>
<td class="nump">3,304,329<span></span>
</td>
<td class="nump">2,875,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TimingOfRevenueRecognition', window );"><strong>Timing of revenue recognition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TransferredOverTime', window );">Transferred over time</a></td>
<td class="nump">3,618,234<span></span>
</td>
<td class="nump">3,242,035<span></span>
</td>
<td class="nump">2,821,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TransferredAtPointInTime', window );">Transferred at a point in time</a></td>
<td class="nump">R$ 79,021<span></span>
</td>
<td class="nump">R$ 62,294<span></span>
</td>
<td class="nump">R$ 54,662<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfGrantedDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfGrantedDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfProuni">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfProuni</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfReturnsOfNetRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfReturnsOfNetRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherRevenue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherRevenue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProfessionalFeesExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProfessionalFeesExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TimingOfRevenueRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TimingOfRevenueRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TransferredAtPointInTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TransferredAtPointInTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TransferredOverTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TransferredOverTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="nump">R$ 3,697,255<span></span>
</td>
<td class="nump">R$ 3,304,329<span></span>
</td>
<td class="nump">R$ 2,875,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="nump">3,427,436<span></span>
</td>
<td class="nump">3,000,122<span></span>
</td>
<td class="nump">2,640,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="nump">269,819<span></span>
</td>
<td class="nump">304,207<span></span>
</td>
<td class="nump">235,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="nump">3,697,255<span></span>
</td>
<td class="nump">3,304,329<span></span>
</td>
<td class="nump">2,875,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="nump">3,618,234<span></span>
</td>
<td class="nump">3,242,035<span></span>
</td>
<td class="nump">2,821,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="nump">79,021<span></span>
</td>
<td class="nump">62,294<span></span>
</td>
<td class="nump">54,662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_UndergraduateMember', window );">Undergraduate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="nump">3,255,426<span></span>
</td>
<td class="nump">2,895,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="nump">3,239,729<span></span>
</td>
<td class="nump">2,877,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="nump">15,697<span></span>
</td>
<td class="nump">17,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="nump">3,255,426<span></span>
</td>
<td class="nump">2,895,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="nump">3,239,729<span></span>
</td>
<td class="nump">2,877,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="nump">15,697<span></span>
</td>
<td class="nump">17,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_ContinuingEducationMember', window );">Continuing Education [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="nump">284,471<span></span>
</td>
<td class="nump">255,438<span></span>
</td>
<td class="nump">235,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="nump">187,707<span></span>
</td>
<td class="nump">122,391<span></span>
</td>
<td class="nump">146,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="nump">96,764<span></span>
</td>
<td class="nump">133,047<span></span>
</td>
<td class="nump">89,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="nump">284,471<span></span>
</td>
<td class="nump">255,438<span></span>
</td>
<td class="nump">235,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="nump">223,774<span></span>
</td>
<td class="nump">218,573<span></span>
</td>
<td class="nump">206,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="nump">60,697<span></span>
</td>
<td class="nump">36,865<span></span>
</td>
<td class="nump">29,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_MedicalPracticeSolutionsMember', window );">Medical Practice Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="nump">171,323<span></span>
</td>
<td class="nump">161,787<span></span>
</td>
<td class="nump">140,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="nump">171,323<span></span>
</td>
<td class="nump">161,787<span></span>
</td>
<td class="nump">140,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="nump">171,323<span></span>
</td>
<td class="nump">161,787<span></span>
</td>
<td class="nump">140,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="nump">168,696<span></span>
</td>
<td class="nump">154,319<span></span>
</td>
<td class="nump">132,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="nump">2,627<span></span>
</td>
<td class="nump">7,468<span></span>
</td>
<td class="nump">8,033<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_EliminationInterSegmentTransactionsMember', window );">Elimination Inter Segment Transactions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="num">(13,965)<span></span>
</td>
<td class="num">(8,588)<span></span>
</td>
<td class="num">(11,217)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="num">(13,965)<span></span>
</td>
<td class="num">(8,588)<span></span>
</td>
<td class="num">(11,217)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="num">(13,965)<span></span>
</td>
<td class="num">(8,588)<span></span>
</td>
<td class="num">(11,217)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="num">(13,965)<span></span>
</td>
<td class="num">(8,588)<span></span>
</td>
<td class="num">(11,217)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_UndergradMember', window );">Undergrad [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,511,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,494,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,511,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,494,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 16,897<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NetRevenueOtherTransferredPoint">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NetRevenueOtherTransferredPoint</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TimingRevenueRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TimingRevenueRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FeeAndCommissionIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income relating to fees and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FeeAndCommissionIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to suppliers for goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 14<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_14_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsToSuppliersForGoodsAndServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_UndergraduateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_UndergraduateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_ContinuingEducationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_ContinuingEducationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_MedicalPracticeSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_MedicalPracticeSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_EliminationInterSegmentTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_EliminationInterSegmentTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_UndergradMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_UndergradMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Costs and expenses by nature (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Payroll', window );">Payroll (i)</a></td>
<td class="num">R$ (1,370,361)<span></span>
</td>
<td class="num">R$ (1,236,666)<span></span>
</td>
<td class="num">R$ (1,149,225)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_HospitalAndMedicalAgreements', window );">Hospital and medical agreements</a></td>
<td class="num">(80,449)<span></span>
</td>
<td class="num">(94,583)<span></span>
</td>
<td class="num">(86,151)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation and amortization</a></td>
<td class="num">(373,344)<span></span>
</td>
<td class="num">(333,341)<span></span>
</td>
<td class="num">(289,511)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseExpenses', window );">Lease expenses</a></td>
<td class="num">(12,617)<span></span>
</td>
<td class="num">(11,207)<span></span>
</td>
<td class="num">(10,871)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UtilitiesExpense', window );">Utilities</a></td>
<td class="num">(24,722)<span></span>
</td>
<td class="num">(22,730)<span></span>
</td>
<td class="num">(20,403)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepairsAndMaintenanceExpense', window );">Maintenance</a></td>
<td class="num">(134,156)<span></span>
</td>
<td class="num">(127,777)<span></span>
</td>
<td class="num">(105,919)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SharesBasedCompensation', window );">Share-based compensation</a></td>
<td class="num">(15,318)<span></span>
</td>
<td class="num">(32,424)<span></span>
</td>
<td class="num">(31,535)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxExpenses', window );">Tax expenses</a></td>
<td class="num">(12,091)<span></span>
</td>
<td class="num">(12,105)<span></span>
</td>
<td class="num">(14,447)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="num">(114,803)<span></span>
</td>
<td class="num">(85,469)<span></span>
</td>
<td class="num">(74,140)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceForExpectedCreditLosses', window );">Allowance for expected credit losses</a></td>
<td class="num">(57,090)<span></span>
</td>
<td class="num">(60,894)<span></span>
</td>
<td class="num">(74,552)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TravelExpense', window );">Travel expenses</a></td>
<td class="num">(26,144)<span></span>
</td>
<td class="num">(20,345)<span></span>
</td>
<td class="num">(16,098)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ConsultingFees', window );">Consulting fees</a></td>
<td class="num">(32,645)<span></span>
</td>
<td class="num">(46,022)<span></span>
</td>
<td class="num">(62,630)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostExpensesOther', window );">Other</a></td>
<td class="num">(230,310)<span></span>
</td>
<td class="num">(201,361)<span></span>
</td>
<td class="num">(189,015)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total</a></td>
<td class="num">(2,484,050)<span></span>
</td>
<td class="num">(2,284,924)<span></span>
</td>
<td class="num">(2,124,497)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CostOfServices', window );">Cost of services</a></td>
<td class="num">(1,313,895)<span></span>
</td>
<td class="num">(1,215,603)<span></span>
</td>
<td class="num">(1,109,813)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_SellingGeneralAndAdministrativeExpenses', window );">Selling, general and administrative expenses</a></td>
<td class="num">R$ (1,113,065)<span></span>
</td>
<td class="num">R$ (1,008,427)<span></span>
</td>
<td class="num">R$ (940,132)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForExpectedCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForExpectedCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ConsultingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ConsultingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CostExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CostExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CostOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CostOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_HospitalAndMedicalAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_HospitalAndMedicalAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Payroll">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Payroll</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SellingGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SellingGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharesBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharesBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepairsAndMaintenanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepairsAndMaintenanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TravelExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from travel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TravelExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UtilitiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from purchased utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UtilitiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance result (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>Notes and other explanatory information [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialIncomeFromCashEquivalents', window );">Financial income from cash equivalents</a></td>
<td class="nump">R$ 138,456<span></span>
</td>
<td class="nump">R$ 59,381<span></span>
</td>
<td class="nump">R$ 73,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterestEarned', window );">Interest earned</a></td>
<td class="nump">49,527<span></span>
</td>
<td class="nump">43,417<span></span>
</td>
<td class="nump">33,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncome', window );">Other</a></td>
<td class="nump">6,960<span></span>
</td>
<td class="nump">8,485<span></span>
</td>
<td class="nump">3,520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="nump">194,943<span></span>
</td>
<td class="nump">111,283<span></span>
</td>
<td class="nump">110,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterestExpense1', window );">Interest expense</a></td>
<td class="num">(316,379)<span></span>
</td>
<td class="num">(254,386)<span></span>
</td>
<td class="num">(285,447)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_InterestExpenseOnLeaseLiabilities1', window );">Interest expense on lease liabilities</a></td>
<td class="num">(123,067)<span></span>
</td>
<td class="num">(111,966)<span></span>
</td>
<td class="num">(100,849)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinancialDiscountsGrantedExpenses', window );">Financial discounts</a></td>
<td class="num">(54,254)<span></span>
</td>
<td class="num">(33,240)<span></span>
</td>
<td class="num">(30,891)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_CreditCardCharges', window );">Credit card charges</a></td>
<td class="num">(6,901)<span></span>
</td>
<td class="num">(5,824)<span></span>
</td>
<td class="num">(4,096)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankAndSimilarCharges', window );">Bank fees</a></td>
<td class="num">(3,882)<span></span>
</td>
<td class="num">(4,436)<span></span>
</td>
<td class="num">(7,163)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ExchangeVariance', window );">Exchange variance</a></td>
<td class="num">(3,095)<span></span>
</td>
<td class="num">(8,944)<span></span>
</td>
<td class="num">(681)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinanceCost', window );">Other</a></td>
<td class="num">(53,446)<span></span>
</td>
<td class="num">(39,946)<span></span>
</td>
<td class="num">(28,489)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance expenses</a></td>
<td class="num">(561,024)<span></span>
</td>
<td class="num">(458,742)<span></span>
</td>
<td class="num">(457,616)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FinanceResult', window );">Net finance result</a></td>
<td class="num">R$ (366,081)<span></span>
</td>
<td class="num">R$ (347,459)<span></span>
</td>
<td class="num">R$ (346,974)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CreditCardCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CreditCardCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ExchangeVariance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ExchangeVariance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinanceResult">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinanceResult</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialDiscountsGrantedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialDiscountsGrantedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialIncomeFromCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialIncomeFromCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InterestEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InterestEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InterestExpense1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InterestExpense1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InterestExpenseOnLeaseLiabilities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InterestExpenseOnLeaseLiabilities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BankAndSimilarCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of bank and similar charges recognised by the entity as an expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BankAndSimilarCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of finance income that the entity does not separately disclose in the same statement or note. [Refer: Finance income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureIncomeTaxesAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">R$ 860,945<span></span>
</td>
<td class="nump">R$ 676,391<span></span>
</td>
<td class="nump">R$ 429,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Statutory income taxes rate</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxExpensesIncomeAtApplicableTaxRate', window );">Income taxes at statutory rate</a></td>
<td class="num">R$ (292,721)<span></span>
</td>
<td class="num">R$ (229,973)<span></span>
</td>
<td class="num">R$ (146,058)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ReconciliationAdjustmentsAbstract', window );"><strong>Reconciliation adjustments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation', window );">Tax effect on loss from entities not subject to taxation</a></td>
<td class="num">(20,042)<span></span>
</td>
<td class="num">(37,007)<span></span>
</td>
<td class="num">(32,274)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ProgramaUniversidadeParaTodosFiscalIncentive', window );">PROUNI - Fiscal incentive (i)</a></td>
<td class="nump">454,380<span></span>
</td>
<td class="nump">379,747<span></span>
</td>
<td class="nump">309,952<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_UnrecognizedDeferredTaxesAssetsOnTaxLosses', window );">Unrecognized deferred taxes assets on tax losses</a></td>
<td class="num">(161,215)<span></span>
</td>
<td class="num">(130,074)<span></span>
</td>
<td class="num">(154,062)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RecognisedDeferredTaxAssets', window );">Recognized deferred taxes</a></td>
<td class="nump">40,826<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Presumed profit income tax regime effect (ii)</a></td>
<td class="num">(372)<span></span>
</td>
<td class="nump">338<span></span>
</td>
<td class="num">(8,787)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PermanentAdjustmentsAbstract', window );"><strong>Permanent adjustments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PermanentAdjustmentsManagementBonuses', window );">Management bonuses</a></td>
<td class="num">(9,146)<span></span>
</td>
<td class="num">(6,533)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PermanentAdjustmentsGifts', window );">Gifts</a></td>
<td class="num">(1,742)<span></span>
</td>
<td class="num">(1,655)<span></span>
</td>
<td class="num">(1,552)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PermanentAdjustmentsSponsorship', window );">Sponsorship</a></td>
<td class="num">(953)<span></span>
</td>
<td class="num">(521)<span></span>
</td>
<td class="num">(470)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense', window );">Other</a></td>
<td class="num">(1,744)<span></span>
</td>
<td class="num">(4,744)<span></span>
</td>
<td class="num">(2,665)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PermanentAdjustmentsPillarTwo', window );">Pillar Two - See Note 2.3(q)</a></td>
<td class="num">(109,458)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_OtherTaxExpenseBenefits', window );">Other</a></td>
<td class="nump">9,685<span></span>
</td>
<td class="nump">2,951<span></span>
</td>
<td class="nump">8,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IncomeTaxesExpense', window );">Income taxes expense</a></td>
<td class="num">(92,502)<span></span>
</td>
<td class="num">(27,471)<span></span>
</td>
<td class="num">(24,166)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Current</a></td>
<td class="num">(133,328)<span></span>
</td>
<td class="num">(24,238)<span></span>
</td>
<td class="num">(27,399)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred</a></td>
<td class="nump">R$ 40,826<span></span>
</td>
<td class="num">R$ (3,233)<span></span>
</td>
<td class="nump">R$ 3,233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxRateEffectFromChangeInTaxRate', window );">Effective rate</a></td>
<td class="nump">10.70%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">5.62%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncomeTaxesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncomeTaxesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherTaxExpenseBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherTaxExpenseBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PermanentAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PermanentAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PermanentAdjustmentsGifts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PermanentAdjustmentsGifts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PermanentAdjustmentsManagementBonuses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PermanentAdjustmentsManagementBonuses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PermanentAdjustmentsPillarTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PermanentAdjustmentsPillarTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PermanentAdjustmentsSponsorship">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PermanentAdjustmentsSponsorship</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProgramaUniversidadeParaTodosFiscalIncentive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProgramaUniversidadeParaTodosFiscalIncentive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RecognisedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RecognisedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ReconciliationAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ReconciliationAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxExpensesIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxExpensesIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_UnrecognizedDeferredTaxesAssetsOnTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_UnrecognizedDeferredTaxesAssetsOnTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense exclusive of income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseOtherThanIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectFromChangeInTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectFromChangeInTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeferredTaxAssetsLossCarryforwards', window );">Tax losses carry forward</a></td>
<td class="nump">R$ 1,703<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsTaxLossesCarryForward', window );">Additions tax losses carry forward</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract', window );"><strong>Temporary differences:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AllowanceForExpectedCreditLoss', window );">Allowance for expected credit losses</a></td>
<td class="nump">1,196<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsAllowanceForExpectedCreditLosses', window );">Additions allowance for expected credit losses</a></td>
<td class="nump">1,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>IFRS 16 - Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RightofuseAsset', window );">Allowance for expected credit losses</a></td>
<td class="nump">56,180<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsToRightofuseAsset', window );">Allowance for expected credit losses</a></td>
<td class="nump">56,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_LeaseLiability', window );">Lease liabilities</a></td>
<td class="num">(47,232)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsLeaseLiability', window );">Additions lease liabilities</a></td>
<td class="num">(47,232)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ProvisionForProfitSharing', window );">Provision for profit sharing</a></td>
<td class="nump">2,047<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsProvisionForProfitSharing', window );">Additions provision for profit sharing</a></td>
<td class="nump">2,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LegalProceedingsProvision', window );">Provision for legal proceedings and contingencies</a></td>
<td class="nump">7,672<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsProvisionForLegalProceedingsAndContingencies', window );">Additions provision for legal proceedings and contingencies</a></td>
<td class="nump">7,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AmortizationOfIntangibleAsset', window );">Amortization of intangible assets</a></td>
<td class="nump">44,486<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsAmortizationOfIntangibleAssets', window );">Additions amortization of intangible assets</a></td>
<td class="nump">44,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_Other', window );">Other</a></td>
<td class="nump">67<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions other</a></td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeferredTaxAsset', window );">Total</a></td>
<td class="nump">66,119<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsDeferredTaxAssets', window );">Additions deferred tax assets</a></td>
<td class="nump">66,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill', window );">Total</a></td>
<td class="num">(25,293)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsTaxBenefitFromTaxDeductibleGoodwill', window );">Additions tax benefit from tax deductible goodwill</a></td>
<td class="num">(25,293)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FairValueRemeasurementsOnBusinessCombinations', window );">Fair value remeasurements on business combinations</a></td>
<td class="num">(28,274)<span></span>
</td>
<td class="num">(28,274)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsFairValueRemeasurementsOnBusinessCombinations', window );">Additions fair value remeasurements on business combinations</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeferredsTaxLiabilities', window );">Total</a></td>
<td class="num">(53,567)<span></span>
</td>
<td class="num">(28,274)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsDeferredTaxLiabilities', window );">Additions deferred tax liabilities</a></td>
<td class="num">(25,293)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Deferred tax assets (liabilities), net</a></td>
<td class="nump">12,552<span></span>
</td>
<td class="num">R$ (28,274)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsDeferredTaxAssetsLiabilitiesNet', window );">Additions deferred tax assets (liabilities), net</a></td>
<td class="nump">R$ 40,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsAllowanceForExpectedCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsAllowanceForExpectedCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsAmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsAmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsDeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsDeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsFairValueRemeasurementsOnBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsFairValueRemeasurementsOnBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsProvisionForLegalProceedingsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsProvisionForLegalProceedingsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsProvisionForProfitSharing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsProvisionForProfitSharing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsTaxBenefitFromTaxDeductibleGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsTaxBenefitFromTaxDeductibleGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsTaxLossesCarryForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsTaxLossesCarryForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsToRightofuseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsToRightofuseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForExpectedCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForExpectedCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AmortizationOfIntangibleAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AmortizationOfIntangibleAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeferredTaxAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeferredTaxAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeferredTaxAssetsLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeferredTaxAssetsLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeferredsTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeferredsTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FairValueRemeasurementsOnBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FairValueRemeasurementsOnBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Other">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Other</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProvisionForProfitSharing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProvisionForProfitSharing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalProvisionsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additional other provisions made. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalProvisionsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LegalProceedingsProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provision for legal proceedings. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Section Example 10 A court case<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS37_IE_C_ex10_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 87<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_87&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LegalProceedingsProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureIncomeTaxesAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DeferredTaxExpenseIncomes', window );">Unrecognized deferred income tax assets</a></td>
<td class="nump">R$ 1,603,167<span></span>
</td>
<td class="nump">R$ 1,266,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RecognizedDeferredTaxAssets', window );">Recognized deferred tax assets</a></td>
<td class="nump">R$ 392,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeferredTaxExpenseIncomes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeferredTaxExpenseIncomes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RecognizedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RecognizedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal proceedings and contingencies (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">R$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of beginning of the year</a></td>
<td class="nump">113,521<span></span>
</td>
<td class="nump">R$ 104,361<span></span>
</td>
<td class="nump">R$ 195,854<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,246<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">36,381<span></span>
</td>
<td class="nump">58,869<span></span>
</td>
<td class="nump">18,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Payments</a></td>
<td class="num">(6,873)<span></span>
</td>
<td class="num">(4,637)<span></span>
</td>
<td class="num">(16,781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversals</a></td>
<td class="num">(14,809)<span></span>
</td>
<td class="num">(52,318)<span></span>
</td>
<td class="num">(93,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of ending of the year</a></td>
<td class="nump">128,220<span></span>
</td>
<td class="nump">113,521<span></span>
</td>
<td class="nump">104,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member] | Labour [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of beginning of the year</a></td>
<td class="nump">31,455<span></span>
</td>
<td class="nump">22,721<span></span>
</td>
<td class="nump">22,484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">721<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">20,014<span></span>
</td>
<td class="nump">22,744<span></span>
</td>
<td class="nump">3,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Payments</a></td>
<td class="num">(3,354)<span></span>
</td>
<td class="num">(1,638)<span></span>
</td>
<td class="num">(800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversals</a></td>
<td class="num">(4,386)<span></span>
</td>
<td class="num">(13,093)<span></span>
</td>
<td class="num">(2,451)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of ending of the year</a></td>
<td class="nump">43,729<span></span>
</td>
<td class="nump">31,455<span></span>
</td>
<td class="nump">22,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member] | Civil [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of beginning of the year</a></td>
<td class="nump">25,140<span></span>
</td>
<td class="nump">21,300<span></span>
</td>
<td class="nump">24,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">481<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">9,568<span></span>
</td>
<td class="nump">10,006<span></span>
</td>
<td class="nump">5,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Payments</a></td>
<td class="num">(3,519)<span></span>
</td>
<td class="num">(2,977)<span></span>
</td>
<td class="num">(1,051)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversals</a></td>
<td class="num">(3,145)<span></span>
</td>
<td class="num">(3,670)<span></span>
</td>
<td class="num">(8,276)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of ending of the year</a></td>
<td class="nump">28,044<span></span>
</td>
<td class="nump">25,140<span></span>
</td>
<td class="nump">21,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member] | Taxes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of beginning of the year</a></td>
<td class="nump">56,926<span></span>
</td>
<td class="nump">60,340<span></span>
</td>
<td class="nump">148,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,044<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">6,799<span></span>
</td>
<td class="nump">26,119<span></span>
</td>
<td class="nump">9,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Payments</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(14,930)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversals</a></td>
<td class="num">(7,278)<span></span>
</td>
<td class="num">(35,555)<span></span>
</td>
<td class="num">(82,473)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of ending of the year</a></td>
<td class="nump">R$ 56,447<span></span>
</td>
<td class="nump">R$ 56,926<span></span>
</td>
<td class="nump">R$ 60,340<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in other provisions resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalProvisionsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additional other provisions made. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalProvisionsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProvisionUsedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProvisionUsedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Provisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities of uncertain timing or amount, including provisions for employee benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Provisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnusedProvisionReversedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount reversed for unused other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnusedProvisionReversedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_LabourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_LabourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_CivilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_CivilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_TaxesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_TaxesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Legal proceedings and contingencies (Details 1) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Total</a></td>
<td class="nump">R$ 126,493<span></span>
</td>
<td class="nump">R$ 106,262<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member] | Labour [Member] | Types Of Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Total</a></td>
<td class="nump">36,818<span></span>
</td>
<td class="nump">38,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member] | Civil [Member] | Types Of Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Total</a></td>
<td class="nump">59,145<span></span>
</td>
<td class="nump">50,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member] | Taxes And Social Security [Member] | Types Of Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Total</a></td>
<td class="nump">R$ 30,530<span></span>
</td>
<td class="nump">R$ 17,498<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provisions other than provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_LabourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_LabourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=afya_TypesOfRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=afya_TypesOfRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_CivilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_CivilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_TaxesAndSocialSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_TaxesAndSocialSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Legal proceedings and contingencies (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=afya_OtherAssetsNonCurrentMember', window );">Other Assets Non Current [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_ContingenciesCorrespondentAmount', window );">Contingencies correspondent amount</a></td>
<td class="nump">R$ 80,379<span></span>
</td>
<td class="nump">R$ 78,701<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ContingenciesCorrespondentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ContingenciesCorrespondentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=afya_OtherAssetsNonCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=afya_OtherAssetsNonCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-cash transactions (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DisclosureNoncashTransactionsAbstract', window );"><strong>Non-cash Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_RemeasurementOfEarnOut', window );">Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">R$ 2,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities', window );">Additions and remeasurements of right-of-use assets and lease liabilities</a></td>
<td class="nump">136,714<span></span>
</td>
<td class="nump">117,897<span></span>
</td>
<td class="nump">77,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet', window );">Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net</a></td>
<td class="nump">1,678<span></span>
</td>
<td class="num">(3,154)<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders', window );">Additions to intangibles and goodwill through accounts payable to selling shareholders</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">279,989<span></span>
</td>
<td class="nump">234,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_DividendsPayables', window );">Dividends payable</a></td>
<td class="nump">R$ 192<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureNoncashTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureNoncashTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendsPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendsPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RemeasurementOfEarnOut">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RemeasurementOfEarnOut</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent events (Details Narrative) - BRL (R$)<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th"><div>Apr. 06, 2026</div></th>
<th class="th"><div>Mar. 12, 2026</div></th>
<th class="th"><div>Apr. 04, 2025</div></th>
<th class="th"><div>Mar. 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FirstDividendDistributionInAmount', window );">First dividend distribution in amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 129,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PercentageOfDividendDistribution', window );">Percentage of dividend distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidOtherSharesPerShare', window );">Dividends per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1.348923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=afya_NonadjustingEventMember', window );">Nonadjusting Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_FirstDividendDistributionInAmount', window );">First dividend distribution in amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 307,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_afya_PercentageOfDividendDistribution', window );">Percentage of dividend distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidOtherSharesPerShare', window );">Dividends per share</a></td>
<td class="nump">R$ 3.446838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FirstDividendDistributionInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FirstDividendDistributionInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PercentageOfDividendDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PercentageOfDividendDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidOtherSharesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends paid per other share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 34<br> -IssueDate 2024-01-01<br> -Paragraph 16A<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=34&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16A_f&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidOtherSharesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=afya_NonadjustingEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=afya_NonadjustingEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>885</ContextCount>
  <ElementCount>614</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>220</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated statement of financial position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/StatementOfFinancialPosition</Role>
      <ShortName>Consolidated statement of financial position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated statement of income and other comprehensive income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome</Role>
      <ShortName>Consolidated statement of income and other comprehensive income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated statement of changes in equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/StatementOfChangesInEquity</Role>
      <ShortName>Consolidated statement of changes in equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated statement of cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/StatementOfCashFlows</Role>
      <ShortName>Consolidated statement of cash flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>999013 - Disclosure - Corporate information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CorporateInformation</Role>
      <ShortName>Corporate information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>999014 - Disclosure - Material accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPolicies</Role>
      <ShortName>Material accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>999015 - Disclosure - Segment information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SegmentInformation</Role>
      <ShortName>Segment information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>999016 - Disclosure - Business combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinations</Role>
      <ShortName>Business combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>999017 - Disclosure - Cash and cash equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CashAndCashEquivalents</Role>
      <ShortName>Cash and cash equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>999018 - Disclosure - Trade receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TradeReceivables</Role>
      <ShortName>Trade receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>999019 - Disclosure - Related parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedParties</Role>
      <ShortName>Related parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>999020 - Disclosure - Other assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/OtherAssets</Role>
      <ShortName>Other assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>999021 - Disclosure - Investment in associate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InvestmentInAssociate</Role>
      <ShortName>Investment in associate</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>999022 - Disclosure - Property and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/PropertyAndEquipment</Role>
      <ShortName>Property and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>999023 - Disclosure - Intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssets</Role>
      <ShortName>Intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>999024 - Disclosure - Financial assets and liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilities</Role>
      <ShortName>Financial assets and liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>999025 - Disclosure - Capital management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CapitalManagement</Role>
      <ShortName>Capital management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>999026 - Disclosure - Labor and social obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligations</Role>
      <ShortName>Labor and social obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>999027 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>999028 - Disclosure - Earnings per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EarningsPerShare</Role>
      <ShortName>Earnings per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>999029 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>999030 - Disclosure - Costs and expenses by nature</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CostsAndExpensesByNature</Role>
      <ShortName>Costs and expenses by nature</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>999031 - Disclosure - Finance result</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinanceResult</Role>
      <ShortName>Finance result</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>999032 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IncomeTaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>999033 - Disclosure - Legal proceedings and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LegalProceedingsAndContingencies</Role>
      <ShortName>Legal proceedings and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>999034 - Disclosure - Non-cash transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Non-cashTransactions</Role>
      <ShortName>Non-cash transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>999035 - Disclosure - Subsequent events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SubsequentEvents</Role>
      <ShortName>Subsequent events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>999036 - Disclosure - Material accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesPolicies</Role>
      <ShortName>Material accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>999037 - Disclosure - Corporate information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CorporateInformationTables</Role>
      <ShortName>Corporate information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/CorporateInformation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>999038 - Disclosure - Material accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesTables</Role>
      <ShortName>Material accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>999039 - Disclosure - Segment information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SegmentInformationTables</Role>
      <ShortName>Segment information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/SegmentInformation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>999040 - Disclosure - Business combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsTables</Role>
      <ShortName>Business combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinations</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>999041 - Disclosure - Cash and cash equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CashAndCashEquivalentsTables</Role>
      <ShortName>Cash and cash equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/CashAndCashEquivalents</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>999042 - Disclosure - Trade receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TradeReceivablesTables</Role>
      <ShortName>Trade receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/TradeReceivables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>999043 - Disclosure - Related parties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedPartiesTables</Role>
      <ShortName>Related parties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/RelatedParties</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>999044 - Disclosure - Other assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/OtherAssetsTables</Role>
      <ShortName>Other assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/OtherAssets</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>999045 - Disclosure - Investment in associate (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InvestmentInAssociateTables</Role>
      <ShortName>Investment in associate (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/InvestmentInAssociate</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>999046 - Disclosure - Property and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/PropertyAndEquipment</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>999047 - Disclosure - Intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/IntangibleAssets</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>999048 - Disclosure - Financial assets and liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</Role>
      <ShortName>Financial assets and liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilities</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>999049 - Disclosure - Labor and social obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsTables</Role>
      <ShortName>Labor and social obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligations</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>999050 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/Equity</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>999051 - Disclosure - Earnings per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EarningsPerShareTables</Role>
      <ShortName>Earnings per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/EarningsPerShare</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>999052 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/Revenue</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>999053 - Disclosure - Costs and expenses by nature (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CostsAndExpensesByNatureTables</Role>
      <ShortName>Costs and expenses by nature (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/CostsAndExpensesByNature</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>999054 - Disclosure - Finance result (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinanceResultTables</Role>
      <ShortName>Finance result (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinanceResult</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>999055 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IncomeTaxesTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/IncomeTaxes</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>999056 - Disclosure - Legal proceedings and contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LegalProceedingsAndContingenciesTables</Role>
      <ShortName>Legal proceedings and contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/LegalProceedingsAndContingencies</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>999057 - Disclosure - Non-cash transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Non-cashTransactionsTables</Role>
      <ShortName>Non-cash transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/Non-cashTransactions</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>999058 - Disclosure - Corporate information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CorporateInformationDetails</Role>
      <ShortName>Corporate information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/CorporateInformationTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>999059 - Disclosure - Corporate information (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CorporateInformationDetailsNarrative</Role>
      <ShortName>Corporate information (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/CorporateInformationTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>999060 - Disclosure - Material accounting policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesDetails</Role>
      <ShortName>Material accounting policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPoliciesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>999061 - Disclosure - Material accounting policies (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesDetails1</Role>
      <ShortName>Material accounting policies (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPoliciesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>999062 - Disclosure - Material accounting policies (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesDetails2</Role>
      <ShortName>Material accounting policies (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPoliciesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>999063 - Disclosure - Material accounting policies (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesDetails3</Role>
      <ShortName>Material accounting policies (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPoliciesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>999064 - Disclosure - Material accounting policies (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesDetails4</Role>
      <ShortName>Material accounting policies (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPoliciesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>999065 - Disclosure - Material accounting policies (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesDetails5</Role>
      <ShortName>Material accounting policies (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPoliciesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>999066 - Disclosure - Material accounting policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Material accounting policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/MaterialAccountingPoliciesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>999067 - Disclosure - Segment information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SegmentInformationDetails</Role>
      <ShortName>Segment information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/SegmentInformationTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>999068 - Disclosure - Segment information (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SegmentInformationDetails1</Role>
      <ShortName>Segment information (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/SegmentInformationTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>999069 - Disclosure - Business combinations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsDetails</Role>
      <ShortName>Business combinations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinationsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>999070 - Disclosure - Business combinations (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsDetails1</Role>
      <ShortName>Business combinations (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinationsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>999071 - Disclosure - Business combinations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsDetailsNarrative</Role>
      <ShortName>Business combinations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinationsTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>999072 - Disclosure - Cash and cash equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CashAndCashEquivalentsDetails</Role>
      <ShortName>Cash and cash equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/CashAndCashEquivalentsTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>999073 - Disclosure - Cash and cash equivalents (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative</Role>
      <ShortName>Cash and cash equivalents (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/CashAndCashEquivalentsTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>999074 - Disclosure - Trade receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TradeReceivablesDetails</Role>
      <ShortName>Trade receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/TradeReceivablesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>999075 - Disclosure - Trade receivables (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TradeReceivablesDetails1</Role>
      <ShortName>Trade receivables (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/TradeReceivablesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>999076 - Disclosure - Trade receivables (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TradeReceivablesDetails2</Role>
      <ShortName>Trade receivables (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/TradeReceivablesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>999077 - Disclosure - Related parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedPartiesDetails</Role>
      <ShortName>Related parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/RelatedPartiesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>999078 - Disclosure - Related parties (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedPartiesDetails1</Role>
      <ShortName>Related parties (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/RelatedPartiesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>999079 - Disclosure - Related parties (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedPartiesDetailsNarrative</Role>
      <ShortName>Related parties (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/RelatedPartiesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>999080 - Disclosure - Other assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/OtherAssetsDetails</Role>
      <ShortName>Other assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/OtherAssetsTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>999081 - Disclosure - Investment in associate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InvestmentInAssociateDetails</Role>
      <ShortName>Investment in associate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/InvestmentInAssociateTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>999082 - Disclosure - Property and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/PropertyAndEquipmentDetails</Role>
      <ShortName>Property and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/PropertyAndEquipmentTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>999083 - Disclosure - Intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsDetails</Role>
      <ShortName>Intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IntangibleAssetsTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>999084 - Disclosure - Intangible assets (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsDetails1</Role>
      <ShortName>Intangible assets (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IntangibleAssetsTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>999085 - Disclosure - Intangible assets (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsDetails2</Role>
      <ShortName>Intangible assets (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IntangibleAssetsTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>999086 - Disclosure - Intangible assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsDetailsNarrative</Role>
      <ShortName>Intangible assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IntangibleAssetsTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>999087 - Disclosure - Financial assets and liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails</Role>
      <ShortName>Financial assets and liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>999088 - Disclosure - Financial assets and liabilities (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1</Role>
      <ShortName>Financial assets and liabilities (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>999089 - Disclosure - Financial assets and liabilities (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2</Role>
      <ShortName>Financial assets and liabilities (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>999090 - Disclosure - Financial assets and liabilities (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3</Role>
      <ShortName>Financial assets and liabilities (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>999091 - Disclosure - Financial assets and liabilities  (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4</Role>
      <ShortName>Financial assets and liabilities  (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>999092 - Disclosure - Financial assets and liabilities (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5</Role>
      <ShortName>Financial assets and liabilities (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>999093 - Disclosure - Financial assets and liabilities (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6</Role>
      <ShortName>Financial assets and liabilities (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>999094 - Disclosure - Financial assets and liabilities (Details 7)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7</Role>
      <ShortName>Financial assets and liabilities (Details 7)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>999095 - Disclosure - Financial assets and liabilities (Details 8)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8</Role>
      <ShortName>Financial assets and liabilities (Details 8)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>999096 - Disclosure - Financial assets and liabilities (Details 9)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9</Role>
      <ShortName>Financial assets and liabilities (Details 9)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>999097 - Disclosure - Financial assets and liabilities (Details 10)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10</Role>
      <ShortName>Financial assets and liabilities (Details 10)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>999098 - Disclosure - Financial assets and liabilities (Details 11)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11</Role>
      <ShortName>Financial assets and liabilities (Details 11)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>999099 - Disclosure - Financial assets and liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative</Role>
      <ShortName>Financial assets and liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>999100 - Disclosure - Labor and social obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetails</Role>
      <ShortName>Labor and social obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>999101 - Disclosure - Labor and social obligations (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetails1</Role>
      <ShortName>Labor and social obligations (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>999102 - Disclosure - Labor and social obligations (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetails2</Role>
      <ShortName>Labor and social obligations (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>999103 - Disclosure - Labor and social obligations (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetails3</Role>
      <ShortName>Labor and social obligations (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>999104 - Disclosure - Labor and social obligations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative</Role>
      <ShortName>Labor and social obligations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>999105 - Disclosure - Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EquityDetails</Role>
      <ShortName>Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/EquityTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>999106 - Disclosure - Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EquityDetailsNarrative</Role>
      <ShortName>Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/EquityTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>999107 - Disclosure - Earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/EarningsPerShareTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>999108 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/RevenueTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>999109 - Disclosure - Revenue (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RevenueDetails1</Role>
      <ShortName>Revenue (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/RevenueTables</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>999110 - Disclosure - Costs and expenses by nature (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CostsAndExpensesByNatureDetails</Role>
      <ShortName>Costs and expenses by nature (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/CostsAndExpensesByNatureTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>999111 - Disclosure - Finance result (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinanceResultDetails</Role>
      <ShortName>Finance result (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinanceResultTables</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>999112 - Disclosure - Income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IncomeTaxesDetails</Role>
      <ShortName>Income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IncomeTaxesTables</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>999113 - Disclosure - Income taxes (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IncomeTaxesDetails1</Role>
      <ShortName>Income taxes (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IncomeTaxesTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>999114 - Disclosure - Income taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IncomeTaxesTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>999115 - Disclosure - Legal proceedings and contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LegalProceedingsAndContingenciesDetails</Role>
      <ShortName>Legal proceedings and contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LegalProceedingsAndContingenciesTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>999116 - Disclosure - Legal proceedings and contingencies (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1</Role>
      <ShortName>Legal proceedings and contingencies (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LegalProceedingsAndContingenciesTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>999117 - Disclosure - Legal proceedings and contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative</Role>
      <ShortName>Legal proceedings and contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LegalProceedingsAndContingenciesTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>999118 - Disclosure - Non-cash transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Non-cashTransactionsDetails</Role>
      <ShortName>Non-cash transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/Non-cashTransactionsTables</ParentRole>
      <Position>113</Position>
    </Report>
    <Report instance="afyaform20f_2025.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>999119 - Disclosure - Subsequent events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/SubsequentEvents</ParentRole>
      <Position>114</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>afya-20251231.xsd</File>
    <File>afya-20251231_cal.xml</File>
    <File>afya-20251231_def.xml</File>
    <File>afya-20251231_lab.xml</File>
    <File>afya-20251231_pre.xml</File>
    <File doctype="20-F" isDefinitelyFs="true" isIfrs="true" isUsgaap="true" original="afyaform20f_2025.htm">afyaform20f_2025.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
    <File>image_006.jpg</File>
    <File>image_007.jpg</File>
    <File>image_008.jpg</File>
    <File>image_009.jpg</File>
    <File>image_010.jpg</File>
    <File>image_011.jpg</File>
    <File>image_012.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="47">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="1">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
    <BaseTaxonomy items="1716">https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>161
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "afyaform20f_2025.htm": {
   "nsprefix": "afya",
   "nsuri": "http://afya.com.br/20251231",
   "dts": {
    "schema": {
     "local": [
      "afya-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2024-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd",
      "https://xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "afya-20251231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "afya-20251231_def.xml"
     ],
     "remote": [
      "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/dimensions/dim_full_ifrs_2024-03-27_role-995000.xml"
     ]
    },
    "labelLink": {
     "local": [
      "afya-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "afya-20251231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "afyaform20f_2025.htm"
     ]
    }
   },
   "keyStandard": 311,
   "keyCustom": 303,
   "axisStandard": 38,
   "axisCustom": 0,
   "memberStandard": 48,
   "memberCustom": 163,
   "hidden": {
    "total": 306,
    "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full": 170,
    "http://afya.com.br/20251231": 132,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "contextCount": 885,
   "entityCount": 1,
   "segmentCount": 220,
   "elementCount": 1090,
   "unitCount": 6,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full": 1716,
    "http://xbrl.sec.gov/dei/2024": 47,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://xbrl.sec.gov/ecd/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://afya.com.br/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://afya.com.br/role/StatementOfFinancialPosition",
     "longName": "00000002 - Statement - Consolidated statement of financial position",
     "shortName": "Consolidated statement of financial position",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:CurrentTaxAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome",
     "longName": "00000003 - Statement - Consolidated statement of income and other comprehensive income",
     "shortName": "Consolidated statement of income and other comprehensive income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:Revenue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:GeneralAndAdministrativeExpense",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://afya.com.br/role/StatementOfChangesInEquity",
     "longName": "00000004 - Statement - Consolidated statement of changes in equity",
     "shortName": "Consolidated statement of changes in equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_ifrs-full_IssuedCapitalMember",
      "name": "ifrs-full:Equity",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_ifrs-full_IssuedCapitalMember",
      "name": "ifrs-full:Equity",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://afya.com.br/role/StatementOfCashFlows",
     "longName": "00000005 - Statement - Consolidated statement of cash flows",
     "shortName": "Consolidated statement of cash flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:IncomeLossBeforeIncomeTaxes",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:IncomeLossBeforeIncomeTaxes",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://afya.com.br/role/CorporateInformation",
     "longName": "999013 - Disclosure - Corporate information",
     "shortName": "Corporate information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfGeneralInformationAboutFinancialStatementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfGeneralInformationAboutFinancialStatementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://afya.com.br/role/MaterialAccountingPolicies",
     "longName": "999014 - Disclosure - Material accounting policies",
     "shortName": "Material accounting policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://afya.com.br/role/SegmentInformation",
     "longName": "999015 - Disclosure - Segment information",
     "shortName": "Segment information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://afya.com.br/role/BusinessCombinations",
     "longName": "999016 - Disclosure - Business combinations",
     "shortName": "Business combinations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://afya.com.br/role/CashAndCashEquivalents",
     "longName": "999017 - Disclosure - Cash and cash equivalents",
     "shortName": "Cash and cash equivalents",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://afya.com.br/role/TradeReceivables",
     "longName": "999018 - Disclosure - Trade receivables",
     "shortName": "Trade receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://afya.com.br/role/RelatedParties",
     "longName": "999019 - Disclosure - Related parties",
     "shortName": "Related parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://afya.com.br/role/OtherAssets",
     "longName": "999020 - Disclosure - Other assets",
     "shortName": "Other assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfOtherAssetExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfOtherAssetExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://afya.com.br/role/InvestmentInAssociate",
     "longName": "999021 - Disclosure - Investment in associate",
     "shortName": "Investment in associate",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfJointVenturesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfJointVenturesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://afya.com.br/role/PropertyAndEquipment",
     "longName": "999022 - Disclosure - Property and equipment",
     "shortName": "Property and equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://afya.com.br/role/IntangibleAssets",
     "longName": "999023 - Disclosure - Intangible assets",
     "shortName": "Intangible assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfIntangibleAssetExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfIntangibleAssetExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilities",
     "longName": "999024 - Disclosure - Financial assets and liabilities",
     "shortName": "Financial assets and liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://afya.com.br/role/CapitalManagement",
     "longName": "999025 - Disclosure - Capital management",
     "shortName": "Capital management",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:CapitalManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:CapitalManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://afya.com.br/role/LaborAndSocialObligations",
     "longName": "999026 - Disclosure - Labor and social obligations",
     "shortName": "Labor and social obligations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:LaborAndSocialObligationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:LaborAndSocialObligationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://afya.com.br/role/Equity",
     "longName": "999027 - Disclosure - Equity",
     "shortName": "Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfEquityExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfEquityExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://afya.com.br/role/EarningsPerShare",
     "longName": "999028 - Disclosure - Earnings per share",
     "shortName": "Earnings per share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://afya.com.br/role/Revenue",
     "longName": "999029 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://afya.com.br/role/CostsAndExpensesByNature",
     "longName": "999030 - Disclosure - Costs and expenses by nature",
     "shortName": "Costs and expenses by nature",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://afya.com.br/role/FinanceResult",
     "longName": "999031 - Disclosure - Finance result",
     "shortName": "Finance result",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://afya.com.br/role/IncomeTaxes",
     "longName": "999032 - Disclosure - Income taxes",
     "shortName": "Income taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfIncomeTaxesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfIncomeTaxesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://afya.com.br/role/LegalProceedingsAndContingencies",
     "longName": "999033 - Disclosure - Legal proceedings and contingencies",
     "shortName": "Legal proceedings and contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfLegalProceedingsAndContingenciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfLegalProceedingsAndContingenciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://afya.com.br/role/Non-cashTransactions",
     "longName": "999034 - Disclosure - Non-cash transactions",
     "shortName": "Non-cash transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureNoncashTransactionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureNoncashTransactionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://afya.com.br/role/SubsequentEvents",
     "longName": "999035 - Disclosure - Subsequent events",
     "shortName": "Subsequent events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesPolicies",
     "longName": "999036 - Disclosure - Material accounting policies (Policies)",
     "shortName": "Material accounting policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:BusinessCombinationsAndGoodwillPolicyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:BusinessCombinationsAndGoodwillPolicyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://afya.com.br/role/CorporateInformationTables",
     "longName": "999037 - Disclosure - Corporate information (Tables)",
     "shortName": "Corporate information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfGeneralInformationAboutFinancialStatementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfGeneralInformationAboutFinancialStatementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesTables",
     "longName": "999038 - Disclosure - Material accounting policies (Tables)",
     "shortName": "Material accounting policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://afya.com.br/role/SegmentInformationTables",
     "longName": "999039 - Disclosure - Segment information (Tables)",
     "shortName": "Segment information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://afya.com.br/role/BusinessCombinationsTables",
     "longName": "999040 - Disclosure - Business combinations (Tables)",
     "shortName": "Business combinations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://afya.com.br/role/CashAndCashEquivalentsTables",
     "longName": "999041 - Disclosure - Cash and cash equivalents (Tables)",
     "shortName": "Cash and cash equivalents (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://afya.com.br/role/TradeReceivablesTables",
     "longName": "999042 - Disclosure - Trade receivables (Tables)",
     "shortName": "Trade receivables (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://afya.com.br/role/RelatedPartiesTables",
     "longName": "999043 - Disclosure - Related parties (Tables)",
     "shortName": "Related parties (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfRelatedPartiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfRelatedPartiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://afya.com.br/role/OtherAssetsTables",
     "longName": "999044 - Disclosure - Other assets (Tables)",
     "shortName": "Other assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://afya.com.br/role/InvestmentInAssociateTables",
     "longName": "999045 - Disclosure - Investment in associate (Tables)",
     "shortName": "Investment in associate (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfInvestmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DisclosureOfInvestmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://afya.com.br/role/PropertyAndEquipmentTables",
     "longName": "999046 - Disclosure - Property and equipment (Tables)",
     "shortName": "Property and equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://afya.com.br/role/IntangibleAssetsTables",
     "longName": "999047 - Disclosure - Intangible assets (Tables)",
     "shortName": "Intangible assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:SummaryOfIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:SummaryOfIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables",
     "longName": "999048 - Disclosure - Financial assets and liabilities (Tables)",
     "shortName": "Financial assets and liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfFinancialAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfFinancialAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsTables",
     "longName": "999049 - Disclosure - Labor and social obligations (Tables)",
     "shortName": "Labor and social obligations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfFairValueOfStockOptionsGrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfFairValueOfStockOptionsGrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://afya.com.br/role/EquityTables",
     "longName": "999050 - Disclosure - Equity (Tables)",
     "shortName": "Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfTreasurySharesMovementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfEquityExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfTreasurySharesMovementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfEquityExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://afya.com.br/role/EarningsPerShareTables",
     "longName": "999051 - Disclosure - Earnings per share (Tables)",
     "shortName": "Earnings per share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfEarningsPerShareTableExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfEarningsPerShareTableExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://afya.com.br/role/RevenueTables",
     "longName": "999052 - Disclosure - Revenue (Tables)",
     "shortName": "Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfNetSalesRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfNetSalesRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://afya.com.br/role/CostsAndExpensesByNatureTables",
     "longName": "999053 - Disclosure - Costs and expenses by nature (Tables)",
     "shortName": "Costs and expenses by nature (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfExpensesByNatureTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfExpensesByNatureTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://afya.com.br/role/FinanceResultTables",
     "longName": "999054 - Disclosure - Finance result (Tables)",
     "shortName": "Finance result (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfFinanceResultTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfFinanceResultTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://afya.com.br/role/IncomeTaxesTables",
     "longName": "999055 - Disclosure - Income taxes (Tables)",
     "shortName": "Income taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://afya.com.br/role/LegalProceedingsAndContingenciesTables",
     "longName": "999056 - Disclosure - Legal proceedings and contingencies (Tables)",
     "shortName": "Legal proceedings and contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfLegalProceedingsAndContingenciesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfLegalProceedingsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfLegalProceedingsAndContingenciesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureOfLegalProceedingsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://afya.com.br/role/Non-cashTransactionsTables",
     "longName": "999057 - Disclosure - Non-cash transactions (Tables)",
     "shortName": "Non-cash transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfNonCashTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureNoncashTransactionsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ScheduleOfNonCashTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "afya:DisclosureNoncashTransactionsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://afya.com.br/role/CorporateInformationDetails",
     "longName": "999058 - Disclosure - Corporate information (Details)",
     "shortName": "Corporate information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member",
      "name": "ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "afya:DisclosureOfGeneralInformationAboutFinancialStatementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://afya.com.br/role/CorporateInformationDetailsNarrative",
     "longName": "999059 - Disclosure - Corporate information (Details Narrative)",
     "shortName": "Corporate information (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2025-05-062025-05-07",
      "name": "afya:AdditionalPaymentToShareholder",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfGeneralInformationAboutFinancialStatementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-05-062025-05-07",
      "name": "afya:AdditionalPaymentToShareholder",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfGeneralInformationAboutFinancialStatementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesDetails",
     "longName": "999060 - Disclosure - Material accounting policies (Details)",
     "shortName": "Material accounting policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "From2025-01-012025-12-31_custom_AfyaParticipacoesSAMember",
      "name": "afya:PrincipalActivities",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-012025-12-31_custom_AfyaParticipacoesSAMember",
      "name": "afya:PrincipalActivities",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
     "longName": "999061 - Disclosure - Material accounting policies (Details 1)",
     "shortName": "Material accounting policies (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember",
      "name": "ifrs-full:DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock",
       "afya:CurrentVersusNoncurrentClassificationPoliciesExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember",
      "name": "ifrs-full:DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock",
       "afya:CurrentVersusNoncurrentClassificationPoliciesExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesDetails2",
     "longName": "999062 - Disclosure - Material accounting policies (Details 2)",
     "shortName": "Material accounting policies (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "From2025-01-012025-12-31_custom_FVTPLMember",
      "name": "ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfMeasurementAndGainsAndLossesTableTextBlock",
       "afya:FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-012025-12-31_custom_FVTPLMember",
      "name": "ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfMeasurementAndGainsAndLossesTableTextBlock",
       "afya:FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
     "longName": "999063 - Disclosure - Material accounting policies (Details 3)",
     "shortName": "Material accounting policies (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "From2025-01-012025-12-31_ifrs-full_BuildingsMember",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfEstimatedUsefulLivesTableTextBlock",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-012025-12-31_ifrs-full_BuildingsMember",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfEstimatedUsefulLivesTableTextBlock",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesDetails4",
     "longName": "999064 - Disclosure - Material accounting policies (Details 4)",
     "shortName": "Material accounting policies (Details 4)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock",
       "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock",
       "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesDetails5",
     "longName": "999065 - Disclosure - Material accounting policies (Details 5)",
     "shortName": "Material accounting policies (Details 5)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "From2025-01-012025-12-31_custom_AmendmentsToIAS21Member",
      "name": "ifrs-full:TitleOfInitiallyAppliedIFRS",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-012025-12-31_custom_AmendmentsToIAS21Member",
      "name": "ifrs-full:TitleOfInitiallyAppliedIFRS",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative",
     "longName": "999066 - Disclosure - Material accounting policies (Details Narrative)",
     "shortName": "Material accounting policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-12-262024-12-27_custom_OrganizationForEconomicCooperationAndDevelopmentMember",
      "name": "ifrs-full:AverageEffectiveTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
       "afya:DisclosureOfMaterialAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://afya.com.br/role/SegmentInformationDetails",
     "longName": "999067 - Disclosure - Segment information (Details)",
     "shortName": "Segment information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:Assets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31_ifrs-full_OperatingSegmentsMember",
      "name": "ifrs-full:Assets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://afya.com.br/role/SegmentInformationDetails1",
     "longName": "999068 - Disclosure - Segment information (Details 1)",
     "shortName": "Segment information (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:Revenue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember",
      "name": "afya:DepositsFromExternalCustomer",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://afya.com.br/role/BusinessCombinationsDetails",
     "longName": "999069 - Disclosure - Business combinations (Details)",
     "shortName": "Business combinations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-01_custom_UnidomMember",
      "name": "ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://afya.com.br/role/BusinessCombinationsDetails1",
     "longName": "999070 - Disclosure - Business combinations (Details 1)",
     "shortName": "Business combinations (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "From2024-06-292024-07-01_ifrs-full_LicencesAndFranchisesMember_custom_AcquisitionOfUnidomMember_custom_WithAndWithoutMethodMember",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfUnidomExplanatory",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-292024-07-01_ifrs-full_LicencesAndFranchisesMember_custom_AcquisitionOfUnidomMember_custom_WithAndWithoutMethodMember",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfUnidomExplanatory",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
     "longName": "999071 - Disclosure - Business combinations (Details Narrative)",
     "shortName": "Business combinations (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:Revenue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-292024-07-01_custom_AcquisitionOfUnidomMember",
      "name": "ifrs-full:DescriptionOfAcquiree",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://afya.com.br/role/CashAndCashEquivalentsDetails",
     "longName": "999072 - Disclosure - Cash and cash equivalents (Details)",
     "shortName": "Cash and cash equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:Cash",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:Cash",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
     "longName": "999073 - Disclosure - Cash and cash equivalents (Details Narrative)",
     "shortName": "Cash and cash equivalents (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:CashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31_custom_USDMember",
      "name": "ifrs-full:CashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosuresOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://afya.com.br/role/TradeReceivablesDetails",
     "longName": "999074 - Disclosure - Trade receivables (Details)",
     "shortName": "Trade receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:ReceivablesGross",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:AllowanceForDoubtfulAccountsFoReceivable1",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://afya.com.br/role/TradeReceivablesDetails1",
     "longName": "999075 - Disclosure - Trade receivables (Details 1)",
     "shortName": "Trade receivables (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:ReceivablesGross",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31_ifrs-full_NotLaterThanOneMonthMember",
      "name": "afya:ReceivablesGross",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAccountsReceivableByAgingExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://afya.com.br/role/TradeReceivablesDetails2",
     "longName": "999076 - Disclosure - Trade receivables (Details 2)",
     "shortName": "Trade receivables (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "afya:AllowanceAccountForCreditLossesOfFinancialAsset",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfAllowanceForDoubtfulAccountsExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "afya:AllowanceAccountForCreditLossesOfFinancialAsset",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfAllowanceForDoubtfulAccountsExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://afya.com.br/role/RelatedPartiesDetails",
     "longName": "999077 - Disclosure - Related parties (Details)",
     "shortName": "Related parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:RightofuseAssetsRelatedPartyTransactions",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:DisclosureOfRelatedPartiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:RightofuseAssetsRelatedPartyTransactions",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:DisclosureOfRelatedPartiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://afya.com.br/role/RelatedPartiesDetails1",
     "longName": "999078 - Disclosure - Related parties (Details 1)",
     "shortName": "Related parties (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://afya.com.br/role/RelatedPartiesDetailsNarrative",
     "longName": "999079 - Disclosure - Related parties (Details Narrative)",
     "shortName": "Related parties (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:LeaseLiabilities",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfLeasesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2018-09-052018-09-06_custom_LeaseAgreements1Member",
      "name": "afya:OperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://afya.com.br/role/OtherAssetsDetails",
     "longName": "999080 - Disclosure - Other assets (Details)",
     "shortName": "Other assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:Advances1",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "afya:DisclosureOfOtherAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://afya.com.br/role/InvestmentInAssociateDetails",
     "longName": "999081 - Disclosure - Investment in associate (Details)",
     "shortName": "Investment in associate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:CurrentAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31_ifrs-full_AssociatesMember",
      "name": "ifrs-full:CurrentAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:DisclosureOfInvestmentsExplanatory",
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://afya.com.br/role/PropertyAndEquipmentDetails",
     "longName": "999082 - Disclosure - Property and equipment (Details)",
     "shortName": "Property and equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:PropertyPlantAndEquipmentNetBookValue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:PropertyPlantAndEquipmentNetBookValue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://afya.com.br/role/IntangibleAssetsDetails",
     "longName": "999083 - Disclosure - Intangible assets (Details)",
     "shortName": "Intangible assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:WriteoffOfIntangibleAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:IntangibleAssetsAndGoodwillNetBookValue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfIntangibleAssetsTableTextBlock",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://afya.com.br/role/IntangibleAssetsDetails1",
     "longName": "999084 - Disclosure - Intangible assets (Details 1)",
     "shortName": "Intangible assets (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31_custom_CarryingAmountsMember",
      "name": "ifrs-full:Goodwill",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31_custom_CarryingAmountsMember",
      "name": "ifrs-full:Goodwill",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://afya.com.br/role/IntangibleAssetsDetails2",
     "longName": "999085 - Disclosure - Intangible assets (Details 2)",
     "shortName": "Intangible assets (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:EbitdaGrowthRates",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:SchuduleOfAssumptionsUsedTableTextBlock",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:EbitdaGrowthRates",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:SchuduleOfAssumptionsUsedTableTextBlock",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://afya.com.br/role/IntangibleAssetsDetailsNarrative",
     "longName": "999086 - Disclosure - Intangible assets (Details Narrative)",
     "shortName": "Intangible assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "afya:SchuduleOfAssumptionsUsedTableTextBlock",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "afya:SchuduleOfAssumptionsUsedTableTextBlock",
       "afya:DisclosureOfIntangibleAssetExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails",
     "longName": "999087 - Disclosure - Financial assets and liabilities (Details)",
     "shortName": "Financial assets and liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFinancialAssetsTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1",
     "longName": "999088 - Disclosure - Financial assets and liabilities (Details 1)",
     "shortName": "Financial assets and liabilities (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:LoansAndFinancing",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfLoansAndFinancingTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember",
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFinancialLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2",
     "longName": "999089 - Disclosure - Financial assets and liabilities (Details 2)",
     "shortName": "Financial assets and liabilities (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:FinancialLiabilitiesAtFairValues",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValuesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:FinancialLiabilitiesAtFairValues",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValuesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3",
     "longName": "999090 - Disclosure - Financial assets and liabilities (Details 3)",
     "shortName": "Financial assets and liabilities (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:LoansAndFinancing",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfLoansAndFinancingTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:LoansAndFinancingCurrent",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfLoansAndFinancingTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4",
     "longName": "999091 - Disclosure - Financial assets and liabilities  (Details 4)",
     "shortName": "Financial assets and liabilities  (Details 4)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "ifrs-full:RightofuseAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "ifrs-full:RightofuseAssets",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfLeasesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R87": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5",
     "longName": "999092 - Disclosure - Financial assets and liabilities (Details 5)",
     "shortName": "Financial assets and liabilities (Details 5)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:TradeAndOtherPayablesToRelatedParties",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:AccountsPayableToSellingShareholdersCurrent",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6",
     "longName": "999093 - Disclosure - Financial assets and liabilities (Details 6)",
     "shortName": "Financial assets and liabilities (Details 6)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "ifrs-full:TradeAndOtherPayablesToRelatedParties",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember",
      "name": "ifrs-full:TradeAndOtherPayablesToRelatedParties",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:AccountsPayableToSellingShareholders1Explanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7",
     "longName": "999094 - Disclosure - Financial assets and liabilities (Details 7)",
     "shortName": "Financial assets and liabilities (Details 7)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:FinancialLiabilities",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValuesFinancialInstrumentstTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:FinancialLiabilitiesAtFairValue",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValuesFinancialInstrumentstTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R90": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8",
     "longName": "999095 - Disclosure - Financial assets and liabilities (Details 8)",
     "shortName": "Financial assets and liabilities (Details 8)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:BaseRate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:BaseRate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9",
     "longName": "999096 - Disclosure - Financial assets and liabilities (Details 9)",
     "shortName": "Financial assets and liabilities (Details 9)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-012025-12-31_custom_ForeignCurrencyExposuresMember_ifrs-full_CurrencyRiskMember",
      "name": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R92": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10",
     "longName": "999097 - Disclosure - Financial assets and liabilities (Details 10)",
     "shortName": "Financial assets and liabilities (Details 10)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:LoansAndFinancing",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfLoansAndFinancingTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31_ifrs-full_LiquidityRiskMember",
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R93": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11",
     "longName": "999098 - Disclosure - Financial assets and liabilities (Details 11)",
     "shortName": "Financial assets and liabilities (Details 11)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R94": {
     "role": "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
     "longName": "999099 - Disclosure - Financial assets and liabilities (Details Narrative)",
     "shortName": "Financial assets and liabilities (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:TransactionCosts",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:TransactionCosts",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R95": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetails",
     "longName": "999100 - Disclosure - Labor and social obligations (Details)",
     "shortName": "Labor and social obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "From2025-11-012025-11-30_ifrs-full_ShareOptionsMember",
      "name": "afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValueOfStockOptionsGrantsExplanatory",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-11-012025-11-30_ifrs-full_ShareOptionsMember",
      "name": "afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValueOfStockOptionsGrantsExplanatory",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
     "longName": "999101 - Disclosure - Labor and social obligations (Details 1)",
     "shortName": "Labor and social obligations (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31_ifrs-full_ShareOptionsMember",
      "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
      "unitRef": "BRLPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfSharebasedCompensationPlanExplanatory",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_ifrs-full_ShareOptionsMember",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "N",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfSharebasedCompensationPlanExplanatory",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R97": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
     "longName": "999102 - Disclosure - Labor and social obligations (Details 2)",
     "shortName": "Labor and social obligations (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "From2025-01-012025-12-31_custom_November2025Member",
      "name": "afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfGrantsRestrictedStockUnitsTableTextBlock",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-012025-12-31_custom_November2025Member",
      "name": "afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfGrantsRestrictedStockUnitsTableTextBlock",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
     "longName": "999103 - Disclosure - Labor and social obligations (Details 3)",
     "shortName": "Labor and social obligations (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31_custom_RestrictedStockUnitsMember",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "N",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfStockOptionTableTextBlock",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_custom_RestrictedStockUnitsMember",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "N",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfStockOptionTableTextBlock",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R99": {
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative",
     "longName": "999104 - Disclosure - Labor and social obligations (Details Narrative)",
     "shortName": "Labor and social obligations (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ShareBasedCompensationOfEmployees",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ShareBasedCompensationOfEmployees",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R100": {
     "role": "http://afya.com.br/role/EquityDetails",
     "longName": "999105 - Disclosure - Equity (Details)",
     "shortName": "Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "ifrs-full:NumberOfSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfTreasurySharesMovementExplanatory",
       "afya:DisclosureOfEquityExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "ifrs-full:NumberOfSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfTreasurySharesMovementExplanatory",
       "afya:DisclosureOfEquityExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R101": {
     "role": "http://afya.com.br/role/EquityDetailsNarrative",
     "longName": "999106 - Disclosure - Equity (Details Narrative)",
     "shortName": "Equity (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:IssuedCapital",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "afya:NumberOfSharesIssued1",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfEquityExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R102": {
     "role": "http://afya.com.br/role/EarningsPerShareDetails",
     "longName": "999107 - Disclosure - Earnings per share (Details)",
     "shortName": "Earnings per share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfEarningsPerShareTableExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfEarningsPerShareTableExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R103": {
     "role": "http://afya.com.br/role/RevenueDetails",
     "longName": "999108 - Disclosure - Revenue (Details)",
     "shortName": "Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ProfessionalFeesExpenses",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfNetSalesRevenueExplanatory",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:ProfessionalFeesExpenses",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfNetSalesRevenueExplanatory",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://afya.com.br/role/RevenueDetails1",
     "longName": "999109 - Disclosure - Revenue (Details 1)",
     "shortName": "Revenue (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:PaymentsToSuppliersForGoodsAndServices",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfRevenueBySegmentTableTextBlock",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:PaymentsToSuppliersForGoodsAndServices",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfRevenueBySegmentTableTextBlock",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R105": {
     "role": "http://afya.com.br/role/CostsAndExpensesByNatureDetails",
     "longName": "999110 - Disclosure - Costs and expenses by nature (Details)",
     "shortName": "Costs and expenses by nature (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:Payroll",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfExpensesByNatureTableTextBlock",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:Payroll",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfExpensesByNatureTableTextBlock",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R106": {
     "role": "http://afya.com.br/role/FinanceResultDetails",
     "longName": "999111 - Disclosure - Finance result (Details)",
     "shortName": "Finance result (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:FinancialIncomeFromCashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFinanceResultTableTextBlock",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:FinancialIncomeFromCashEquivalents",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFinanceResultTableTextBlock",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R107": {
     "role": "http://afya.com.br/role/IncomeTaxesDetails",
     "longName": "999112 - Disclosure - Income taxes (Details)",
     "shortName": "Income taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:ProfitLossBeforeTax",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:TaxExpensesIncomeAtApplicableTaxRate",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R108": {
     "role": "http://afya.com.br/role/IncomeTaxesDetails1",
     "longName": "999113 - Disclosure - Income taxes (Details 1)",
     "shortName": "Income taxes (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DeferredTaxAssetsLossCarryforwards",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DeferredTaxAssetsLossCarryforwards",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R109": {
     "role": "http://afya.com.br/role/IncomeTaxesDetailsNarrative",
     "longName": "999114 - Disclosure - Income taxes (Details Narrative)",
     "shortName": "Income taxes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DeferredTaxExpenseIncomes",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "afya:DeferredTaxExpenseIncomes",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R110": {
     "role": "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails",
     "longName": "999115 - Disclosure - Legal proceedings and contingencies (Details)",
     "shortName": "Legal proceedings and contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-12-31",
      "name": "ifrs-full:AdditionalProvisionsOtherProvisions",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "afya:DisclosureOfIncomeTaxesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember",
      "name": "ifrs-full:Provisions",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfLegalProceedingsAndContingenciesTableTextBlock",
       "afya:DisclosureOfLegalProceedingsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    },
    "R111": {
     "role": "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1",
     "longName": "999116 - Disclosure - Legal proceedings and contingencies (Details 1)",
     "shortName": "Legal proceedings and contingencies (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:OtherProvisions",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock",
       "afya:DisclosureOfLegalProceedingsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31",
      "name": "ifrs-full:OtherProvisions",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock",
       "afya:DisclosureOfLegalProceedingsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R112": {
     "role": "http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative",
     "longName": "999117 - Disclosure - Legal proceedings and contingencies (Details Narrative)",
     "shortName": "Legal proceedings and contingencies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-31_custom_OtherAssetsNonCurrentMember",
      "name": "afya:ContingenciesCorrespondentAmount",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfLegalProceedingsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-31_custom_OtherAssetsNonCurrentMember",
      "name": "afya:ContingenciesCorrespondentAmount",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfLegalProceedingsAndContingenciesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R113": {
     "role": "http://afya.com.br/role/Non-cashTransactionsDetails",
     "longName": "999118 - Disclosure - Non-cash transactions (Details)",
     "shortName": "Non-cash transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "afya:RemeasurementOfEarnOut",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfNonCashTransactionsTableTextBlock",
       "afya:DisclosureNoncashTransactionsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "afya:RemeasurementOfEarnOut",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfNonCashTransactionsTableTextBlock",
       "afya:DisclosureNoncashTransactionsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true,
      "unique": true
     }
    },
    "R114": {
     "role": "http://afya.com.br/role/SubsequentEventsDetailsNarrative",
     "longName": "999119 - Disclosure - Subsequent events (Details Narrative)",
     "shortName": "Subsequent events (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "From2025-03-112025-03-12",
      "name": "afya:FirstDividendDistributionInAmount",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "afya:DisclosureOfEquityExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2026-03-112026-03-12_custom_NonadjustingEventMember",
      "name": "afya:FirstDividendDistributionInAmount",
      "unitRef": "BRL",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "afyaform20f_2025.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "afya_AccountsPayableAamortizedCostInterestRateBasis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AccountsPayableAamortizedCostInterestRateBasis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest rate",
        "label": "AccountsPayableAamortizedCostInterestRateBasis"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholders1Explanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AccountsPayableToSellingShareholders1Explanatory",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of accounts payable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersBusinessCombinations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AccountsPayableToSellingShareholdersBusinessCombinations",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions consideration to be transferred on business combinations"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AccountsPayableToSellingShareholdersCurrent",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "AccountsPayableToSellingShareholdersCurrent"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersEarnOutsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AccountsPayableToSellingShareholdersEarnOutsMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable To Selling Shareholders Earn Outs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AccountsPayableToSellingShareholdersMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable To Selling Shareholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AccountsPayableToSellingShareholdersNonCurrent",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "label": "AccountsPayableToSellingShareholdersNonCurrent"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AccountsPayableToSellingShareholdersOneMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable To Selling Shareholders One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AccountsPayableToSellingShareholdersPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable to selling shareholders",
        "label": "AccountsPayableToSellingShareholdersPolicyExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AccountsPayableToSellingShareholdersTwoMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable To Selling Shareholders Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccountsPayableToSellingShareholdersUnidomMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AccountsPayableToSellingShareholdersUnidomMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable To Selling Shareholders Unidom [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AccruedInterestOfOpeartingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AccruedInterestOfOpeartingActivities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated depreciation and amortisation [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]"
       }
      }
     },
     "auth_ref": [
      "r54",
      "r441",
      "r447",
      "r452",
      "r453"
     ]
    },
    "afya_AcquisitionOfNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AcquisitionOfNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition of non-controlling interests"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AcquisitionOfUnidomMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AcquisitionOfUnidomMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition Of Unidom [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase consideration transferred"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction costs of the acquisition (included in cash flows from operating activities)",
        "verboseLabel": "Transaction costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "afya_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total transaction costs"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Business combinations",
        "label": "Acquisitions through business combinations, intangible assets and goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Business combinations",
        "label": "Acquisitions through business combinations, other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in other provisions resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combination"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "afya_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionalPaidinCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionalPaidinCapital",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "ifrs-full_AdditionalPaidinCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionalPaidinCapitalMember",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for amounts received from issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "afya_AdditionalPaymentToShareholder": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionalPaymentToShareholder",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional payment to shareholders"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionalProvisionsOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionalProvisionsOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions other",
        "verboseLabel": "Additions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additional other provisions made. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "afya_AdditionsAllowanceForExpectedCreditLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsAllowanceForExpectedCreditLosses",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions allowance for expected credit losses"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsAmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsAmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions amortization of intangible assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions and remeasurements of right-of-use assets and lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsDeferredTaxAssets",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions deferred tax assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsDeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsDeferredTaxAssetsLiabilitiesNet",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions deferred tax assets (liabilities), net"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsDeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions deferred tax liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsFairValueRemeasurementsOnBusinessCombinations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsFairValueRemeasurementsOnBusinessCombinations",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions fair value remeasurements on business combinations"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additions",
        "label": "Additions other than through business combinations, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additions",
        "label": "Additions other than through business combinations, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "afya_AdditionsProvisionForLegalProceedingsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsProvisionForLegalProceedingsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions provision for legal proceedings and contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsProvisionForProfitSharing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsProvisionForProfitSharing",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions provision for profit sharing"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsTaxBenefitFromTaxDeductibleGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsTaxBenefitFromTaxDeductibleGoodwill",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions tax benefit from tax deductible goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsTaxLossesCarryForward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsTaxLossesCarryForward",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions tax losses carry forward"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions to intangibles and goodwill through accounts payable to selling shareholders"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsToLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsToLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, additions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdditionsToRightofuseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdditionsToRightofuseAsset",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Allowance for expected credit losses",
        "label": "AdditionsToRightofuseAsset"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionsToRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, additions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustedWeightedAverageShares",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of outstanding shares adjusted for the effect of dilution"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentToProfitLossForPreferenceShareDividends",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income attributable to the owners of the Company"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustment to profit (loss) for non-participating preference share dividends to calculate profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Preference shares [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r265",
      "r266"
     ]
    },
    "afya_AdjustmentsAndEliminationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdjustmentsAndEliminationsMember",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments And Eliminations [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Advances from customers",
        "label": "Adjustments for decrease (increase) in loans and advances to customers"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in loans and advances to customers to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Loans and advances to customers; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "Adjustments for decrease (increase) in other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade receivables",
        "label": "Adjustments for decrease (increase) in trade accounts receivable"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForDepreciationAndAmortisationExpense",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share of income of associate"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "ifrs-full_AdjustmentsForIncomeTaxExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForIncomeTaxExpense",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Taxes payable",
        "label": "Adjustments for income tax expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInOtherLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Adjustments for increase (decrease) in other liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6",
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade payables",
        "label": "Other"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "ifrs-full_AdjustmentsForProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForProvisions",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision (reversal) for legal proceedings"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLoss",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows from operating activities before income taxes",
        "label": "Adjustments to reconcile profit (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile income before income taxes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net foreign exchange differences"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r283",
      "r456"
     ]
    },
    "afya_Advances1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "Advances1",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Advances",
        "label": "Advances1"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdvancesFromCustomersAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdvancesFromCustomersAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Advances from customers",
        "label": "AdvancesFromCustomersAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AdvancesRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AdvancesRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advances"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AfyaParticipacoesS.A.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AfyaParticipacoesS.A.Member",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Afya Participacoes S. A. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AfyaParticipacoesSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AfyaParticipacoesSAMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Afya Participacoes S.A. (\u0093Afya Brazil\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r342",
      "r353",
      "r367",
      "r393"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r345",
      "r356",
      "r370",
      "r396"
     ]
    },
    "afya_AlemDaMedicinaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AlemDaMedicinaMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Alem Da Medicina [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r381"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r388"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r346",
      "r357",
      "r371",
      "r388",
      "r397",
      "r401",
      "r409"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r407"
     ]
    },
    "afya_AllowanceAccountForCreditLossesOfFinancialAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AllowanceAccountForCreditLossesOfFinancialAsset",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodStartLabel": "Opening balance",
        "negatedPeriodEndLabel": "Closing balance",
        "label": "AllowanceAccountForCreditLossesOfFinancialAsset"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AllowanceForDoubtfulAccountsFoReceivable1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AllowanceForDoubtfulAccountsFoReceivable1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(-) Allowance for doubtful accounts"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AllowanceForDoubtfulAccountsOfOpeartingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AllowanceForDoubtfulAccountsOfOpeartingActivities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for expected credit losses"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AllowanceForExpectedCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AllowanceForExpectedCreditLoss",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Allowance for expected credit losses",
        "label": "AllowanceForExpectedCreditLoss"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AllowanceForExpectedCreditLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AllowanceForExpectedCreditLosses",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Allowance for expected credit losses",
        "verboseLabel": "Allowance for expected credit losses",
        "label": "AllowanceForExpectedCreditLosses"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "afya_AmendmentsToIAS21Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AmendmentsToIAS21Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendments To I A S 21 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "afya_AmortizationOfIntangibleAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AmortizationOfIntangibleAsset",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of intangible assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Amount incurred by entity for provision of key management personnel services provided by separate management entity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount incurred by the entity for provision of key management personnel services that are provided by a separate management entity. [Refer: Key management personnel of entity or parent [member]; Separate management entities [domain]]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "ifrs-full_AmountsPayableRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AmountsPayableRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts payable resulting from related party transactions. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r61",
      "r65"
     ]
    },
    "ifrs-full_AmountsReceivableRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AmountsReceivableRelatedPartyTransactions",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total assets",
        "label": "Amounts receivable, related party transactions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts receivable resulting from related party transactions. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r61",
      "r65"
     ]
    },
    "afya_AnnualImprovementsToIFRSAccountingStandardsVolume11Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AnnualImprovementsToIFRSAccountingStandardsVolume11Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Improvements To IFRS Accounting Standards Volume 11 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_ApplicableTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ApplicableTaxRate",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax rate",
        "verboseLabel": "Statutory income taxes rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "afya_April2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "April2023Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_April2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "April2025Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AprilTwentyThirtyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AprilTwentyThirtyMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April Twenty Thirty [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AprilTwentyTwentySixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AprilTwentyTwentySixMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April Twenty Twenty Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Total assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r158",
      "r159",
      "r161",
      "r236",
      "r239"
     ]
    },
    "afya_Assets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "Assets1",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Assets1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AssociatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AssociatesMember",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total for all associates [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entities over which the investor has significant influence."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r72",
      "r75",
      "r157"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r324",
      "r326",
      "r349"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r324",
      "r326",
      "r349"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r324",
      "r326",
      "r349"
     ]
    },
    "afya_August2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "August2023Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "August 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AverageEffectiveTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AverageEffectiveTaxRate",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "afya_AveragePriceDeliveredUnderSharebasedCompensationPlan": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AveragePriceDeliveredUnderSharebasedCompensationPlan",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average price, delivered under the share-based compensation plan"
       }
      }
     },
     "auth_ref": []
    },
    "afya_AveragePriceRepurchased": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "AveragePriceRepurchased",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average price repurchased"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r400"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "ifrs-full_BankAndSimilarCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BankAndSimilarCharges",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Bank fees",
        "label": "Bank and similar charges"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of bank and similar charges recognised by the entity as an expense."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "afya_BankCertificatesOfDepositMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "BankCertificatesOfDepositMember",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bank Certificates Of Deposit [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_BaseRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "BaseRate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Base rate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareDetails",
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings per common share",
        "verboseLabel": "Basic earnings per share (R$)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78"
     ]
    },
    "ifrs-full_BorrowingsInterestRateBasis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsInterestRateBasis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "ifrs-full_BorrowingsMaturity": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsMaturity",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity"
       }
      },
      "en": {
       "role": {
        "documentation": "The maturity of borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bottom of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r164",
      "r183",
      "r198",
      "r287",
      "r288",
      "r462"
     ]
    },
    "ifrs-full_BrandNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BrandNamesMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brand names [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing rights to a group of complementary assets such as a trademark (or service mark) and its related trade name, formulas, recipes and technological expertise. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "ifrs-full_BuildingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BuildingsMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Buildings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "afya_BusinessCombinationsAndGoodwillPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "BusinessCombinationsAndGoodwillPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combinations and goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BusinessCombinationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BusinessCombinationsAxis",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combinations [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r210"
     ]
    },
    "ifrs-full_BusinessCombinationsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BusinessCombinationsDomain",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r213"
     ]
    },
    "afya_BusinessCombinationsLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "BusinessCombinationsLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, business combinations"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r326",
      "r349"
     ]
    },
    "afya_CapitalExpenditures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CapitalExpenditures",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital expenditures"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CapitalManagementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CapitalManagementExplanatory",
     "presentation": [
      "http://afya.com.br/role/CapitalManagement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital management"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CapitalUnitsAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CapitalUnitsAuthorizedShares",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Authorized capital units"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CardiPapersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CardiPapersMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cardi Papers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CardioPapersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CardioPapersMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cardio Papers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/IntangibleAssetsDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r51",
      "r102",
      "r105",
      "r108",
      "r109",
      "r110",
      "r111",
      "r112",
      "r212",
      "r221",
      "r222"
     ]
    },
    "ifrs-full_CarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CarryingAmountMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/IntangibleAssetsDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r105",
      "r108",
      "r110",
      "r111",
      "r212",
      "r221",
      "r222"
     ]
    },
    "afya_CarryingAmountsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CarryingAmountsMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying Amounts [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and bank deposits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetails",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r125",
      "r152"
     ]
    },
    "ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents in subsidiaries or other businesses over which control is obtained or lost. [Refer: Total for all subsidiaries [member]; Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/CorporateInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash and equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "ifrs-full_CashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetails",
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "afya_CashEquivalents1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CashEquivalents1Member",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Equivalents 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows from (used in) financing activities",
        "label": "Cash flows from (used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r127"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows used in investing activities",
        "label": "Cash flows from (used in) investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r127"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows from operating activities",
        "label": "Cash flows from (used in) operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r113",
      "r127"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CashGeneratingUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CashGeneratingUnits",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash generating units"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CashOutflow": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CashOutflow",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash outflow"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashOutflowForLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashOutflowForLeases",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for leases."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ifrs-full_CashTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashTransferred",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/RelatedPartiesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesDomain",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/RelatedPartiesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "afya_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro de Ciencias em Saude de Itajuba S.A. (\u0093CCSI\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CentroDeCienciasEmSaudeDeItajubaSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CentroDeCienciasEmSaudeDeItajubaSAMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro De Ciencias Em Saude De Itajuba SA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CentroDeEnsinoSaoLucasLtda.UniSLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CentroDeEnsinoSaoLucasLtda.UniSLMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro de Ensino Sao Lucas Ltda. (\u0093UniSL\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro Superior de Ciencias da Saude Ltda. (\u0093FCMPB\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CivilMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CivilMember",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Civil [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ClassACommonSharesHeldInTreasuryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ClassACommonSharesHeldInTreasuryMember",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Common Shares Held In Treasury [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ClassAOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ClassAOrdinarySharesMember",
     "presentation": [
      "http://afya.com.br/role/Cover",
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Ordinary Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ClassBOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ClassBOrdinarySharesMember",
     "presentation": [
      "http://afya.com.br/role/Cover",
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Ordinary Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfAssetsAxis",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r83",
      "r163",
      "r178"
     ]
    },
    "ifrs-full_ClassesOfAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfAssetsDomain",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r163",
      "r178"
     ]
    },
    "ifrs-full_ClassesOfContingentLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfContingentLiabilitiesAxis",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of contingent liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r211"
     ]
    },
    "ifrs-full_ClassesOfContingentLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfContingentLiabilitiesDomain",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the entity; or, present obligations that arise from past events but are not recognised because (a) it is probable that an outflow of resources embodying economic benefits will be required to settle the obligations; or (b) the amount of the obligations cannot be measured with sufficient reliability. It also represents the standard value for the 'Classes of contingent liabilities' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r211"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsAxis",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8",
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r225",
      "r226",
      "r247",
      "r248"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsDomain",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8",
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r190",
      "r225",
      "r226",
      "r247",
      "r248"
     ]
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfFinancialLiabilitiesAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r247",
      "r248"
     ]
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfFinancialLiabilitiesDomain",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r247",
      "r248"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/IntangibleAssetsDetails2",
      "http://afya.com.br/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets and goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsAndGoodwillDomain",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/IntangibleAssetsDetails2",
      "http://afya.com.br/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillDomain",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ifrs-full_ClassesOfOtherProvisionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfOtherProvisionsDomain",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentDomain",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of property, plant and equipment' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ifrs-full_ClassesOfProvisionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfProvisionsAxis",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of other provisions [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalAxis",
     "presentation": [
      "http://afya.com.br/role/Cover",
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalDomain",
     "presentation": [
      "http://afya.com.br/role/Cover",
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "afya_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments Amendments To IFRS 9 And IFRS 7 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CliquefarmaDrogariasOnlineLtda.CliquefarmaMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cliquefarma Drogarias Online Ltda. (\u0093Cliquefarma\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClosingForeignExchangeRate": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClosingForeignExchangeRate",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing foreign exchange rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "afya_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Companhia Nilza Cordeiro Herdy de Educacao e Cultura (\u0093Unigranrio\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CompanyShareInEquity1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CompanyShareInEquity1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company\u2019s share in equity - 30%"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CompanyShareOfProfitss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CompanyShareOfProfitss",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company\u2019s share of profit, net of tax"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_ComponentsOfEquityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComponentsOfEquityDomain",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity",
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive income",
        "label": "Total comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r29",
      "r133",
      "r135",
      "r149",
      "r285"
     ]
    },
    "afya_ComprehensiveIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ComprehensiveIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive income",
        "label": "ComprehensiveIncomeLoss"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComputerSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComputerSoftwareMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer software [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "afya_ConsiderationToBeTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ConsiderationToBeTransferred",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration to be transferred"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ConsolidatedRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ConsolidatedRevenues",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated revenues"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Construction in progress [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "afya_ConsultingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ConsultingFees",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consulting fees"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ContingenciesCorrespondentAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ContingenciesCorrespondentAmount",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingencies correspondent amount"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ContinuingEducationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ContinuingEducationMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1",
      "http://afya.com.br/role/RevenueDetails1",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Continuing Education [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ContractualLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ContractualLeaseTerm",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual lease term"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ContributionForTheFinancingOfSocialSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ContributionForTheFinancingOfSocialSecurityMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contribution For The Financing Of Social Security [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ConvertibleLoansFromVentureCapitalInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ConvertibleLoansFromVentureCapitalInvestments",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible loans from venture capital investments"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CostExpensesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CostExpensesOther",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "CostExpensesOther"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CostOfSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CostOfSale",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of services"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of services",
        "label": "Cost of sales"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r37"
     ]
    },
    "afya_CostOfServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CostOfServices",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of services",
        "label": "CostOfServices"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "afya_CreditCardCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CreditCardCharges",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit card charges"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CreditExposures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CreditExposures",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exposure risk"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrencyInWhichInformationIsDisplayedAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrencyInWhichInformationIsDisplayedAxis",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency in which information is displayed [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ifrs-full_CurrencyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrencyRiskMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r187",
      "r230"
     ]
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "verboseLabel": "Current assets",
        "label": "Current assets [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r20",
      "r145",
      "r285"
     ]
    },
    "afya_CurrentAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CurrentAssets1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentDepositsFromCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentDepositsFromCustomers",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advances from customers"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current deposits from customers. [Refer: Deposits from customers]"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "ifrs-full_CurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentFinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "Current financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "ifrs-full_CurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "Current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "Current financial liabilities at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities measured at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "verboseLabel": "Lease liabilities, current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "verboseLabel": "Current liabilities",
        "negatedLabel": "Current liabilities",
        "label": "Current liabilities [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r147",
      "r285"
     ]
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentRecognisedLiabilitiesDefinedBenefitPlan",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Labor and social obligations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current net defined benefit liability. [Refer: Net defined benefit liability]"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "ifrs-full_CurrentTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recoverable taxes"
       }
      },
      "en": {
       "role": {
        "documentation": "The excess of amount paid for current tax in respect of current and prior periods over the amount due for those periods. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncome",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "Current tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "ifrs-full_CurrentTaxLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentTaxLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes payable"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of current tax liabilities. [Refer: Current tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "afya_CurrentTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CurrentTaxesPayable",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes payable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentTradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition",
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables",
        "verboseLabel": "Current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256"
     ]
    },
    "afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CurrentVersusNoncurrentClassificationPoliciesExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value measurement"
       }
      }
     },
     "auth_ref": []
    },
    "afya_CustomerRelationshipsOtherCoursesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "CustomerRelationshipsOtherCoursesMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships Other Courses [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CustomerrelatedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CustomerrelatedIntangibleAssetsMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer-related intangible assets [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r334",
      "r419"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r334",
      "r419"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r336",
      "r421"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r336",
      "r421"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r338",
      "r423"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r336",
      "r421"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r329",
      "r414"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r330",
      "r415"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r330",
      "r415"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r328",
      "r413"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r331",
      "r416"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r333",
      "r418"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r333",
      "r418"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r334",
      "r419"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r337",
      "r422"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r335",
      "r420"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r332",
      "r417"
     ]
    },
    "afya_December2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "December2023Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "December 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DecreaseForeignCurrencyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DecreaseForeignCurrencyMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease Foreign Currency [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeductionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DeductionAbstract",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deductions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeductionOfGrantedDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DeductionOfGrantedDiscounts",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount and scholarships"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeductionOfProuni": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DeductionOfProuni",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROUNI"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeductionOfReturnsOfNetRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DeductionOfReturnsOfNetRevenue",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Returns"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeductionOfTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DeductionOfTaxes",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Taxes",
        "label": "DeductionOfTaxes"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeferredTaxAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DeferredTaxAsset",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "DeferredTaxAsset"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r17",
      "r43"
     ]
    },
    "afya_DeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DeferredTaxAssetsAbstract",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred tax assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeferredTaxAssetsLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DeferredTaxAssetsLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax losses carry forward"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncome",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred",
        "label": "Deferred tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "afya_DeferredTaxExpenseIncomes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DeferredTaxExpenseIncomes",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized deferred income tax assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r17",
      "r43"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred tax liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeferredTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DeferredTaxes",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DeferredsTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DeferredsTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "DeferredsTaxLiabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DefinedBenefitObligationAtPresentValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DefinedBenefitObligationAtPresentValue",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined benefit obligation"
       }
      },
      "en": {
       "role": {
        "documentation": "The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DefinedBenefitPlansAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DefinedBenefitPlansAxis",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined benefit plans [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "ifrs-full_DefinedBenefitPlansDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DefinedBenefitPlansDomain",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "afya_DelReyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DelReyMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Del Rey [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DenominatorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DenominatorAbstract",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Denominator"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DepositsFromExternalCustomer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DepositsFromExternalCustomer",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "External customer"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DepreciationExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation and amortization",
        "label": "Depreciation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "afya_DepreciationExpenseLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DepreciationExpenseLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, depreciation expense"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DepreciationPropertyPlantAndEquipment",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation",
        "label": "Depreciation, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r53"
     ]
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DepreciationRightofuseAssets",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Right-of-use assets, depreciation expense",
        "label": "Depreciation, right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "afya_DepreciationRightofuseAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DepreciationRightofuseAssetsMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation Rightofuse Assets [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share (\u201cEPS\u201d)"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for income tax."
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets",
        "label": "Description of accounting policy for intangible assets other than goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "afya_DescriptionOfAccountingPolicyForInvestmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DescriptionOfAccountingPolicyForInvestmentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in associates"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment",
        "label": "Description of accounting policy for property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for provisions. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from contracts with customers"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTreasurySharesExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for treasury shares. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ifrs-full_DescriptionOfAcquiree": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAcquiree",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired purchase price"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the business or businesses that the acquirer obtains control of in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "ifrs-full_DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation technique"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of a change in valuation technique (for example, changing from a market approach to an income approach or the use of an additional valuation technique) for the fair value measurement of assets. [Refer: Income approach [member]; Market approach [member]]"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfDiscountRatesAppliedToCashFlowProjections",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount rate applied to cash flow projections"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r90"
     ]
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "ifrs-full_DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inter-relationship between significant unobservable inputs and fair value measurement"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the interrelationships between unobservable inputs and of how they might magnify or mitigate the effect of changes in the unobservable inputs on the fair value measurement of assets. [Refer: Disclosure of significant unobservable inputs used in fair value measurement of assets [text block]]"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails2",
      "http://afya.com.br/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Description",
        "label": "Description of significant estimate"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of key assumptions on which management has based its cash flow projections for the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). Key assumptions are those to which the unit's (group of units') recoverable amount is most sensitive. [Refer: Total for all cash-generating units [member]]"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r93"
     ]
    },
    "afya_DescriptionOfLeaseTerm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DescriptionOfLeaseTerm",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of lease term"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DescriptionOfLeaseTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DescriptionOfLeaseTerms",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Description of lease term",
        "label": "DescriptionOfLeaseTerms"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfNatureOfChangeInAccountingPolicy",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the nature of a change in accounting policy related to an initial application of an IFRS. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfOptionPricingModelShareOptionsGranted",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation model"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the option pricing model used for share options granted. [Refer: Option pricing model [member]]"
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Valuation technique",
        "label": "Description of valuation techniques and significant inputs used to measure non-controlling interest in acquiree measured at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Total for all business combinations [member]; Valuation techniques used in fair value measurement [domain]]"
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareDetails",
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted earnings per common share",
        "verboseLabel": "Diluted earnings per share (R$)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78"
     ]
    },
    "ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of dilution from stock options and restricted stock units"
       }
      },
      "en": {
       "role": {
        "documentation": "The potential dilutive effect on the weighted average number of ordinary shares that relate to the assumed exercise of the entity's share options."
       }
      }
     },
     "auth_ref": [
      "r444"
     ]
    },
    "afya_DisclosureCapitalManagementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureCapitalManagementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Management"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureCashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureCashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash And Cash Equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureCorporateInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureCorporateInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate Information"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureIncomeTaxesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureIncomeTaxesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureIntangibleAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureIntangibleAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureLaborAndSocialObligationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureLaborAndSocialObligationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Labor And Social Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureLegalProceedingsAndContingenciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureLegalProceedingsAndContingenciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Proceedings And Contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureMaterialAccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureMaterialAccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Accounting Policies"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureNoncashTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureNoncashTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureNoncashTransactionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureNoncashTransactionsExplanatory",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash transactions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureOfAllowanceForDoubtfulAccountsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfAllowanceForDoubtfulAccountsExplanatory",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of allowance for doubtful accounts"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more, and more than, twelve months after reporting date."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsExplanatory",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combinations"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for business combinations."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "ifrs-full_DisclosureOfBusinessCombinationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsTable",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of business combinations."
       }
      }
     },
     "auth_ref": [
      "r210"
     ]
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesInBusinessCombinationTable",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities in business combination [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to contingent liabilities in business combinations."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r211"
     ]
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansTable",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to defined benefit plans."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of cash and cash equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of detailed information about property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment information"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      }
     },
     "auth_ref": [
      "r246"
     ]
    },
    "afya_DisclosureOfEquityExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfEquityExplanatory",
     "presentation": [
      "http://afya.com.br/role/Equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity",
        "label": "DisclosureOfEquityExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "presentation": [
      "http://afya.com.br/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent events"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ifrs-full_DisclosureOfExpensesByNatureExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfExpensesByNatureExplanatory",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNature"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and expenses by nature"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of expenses by nature. [Refer: Expenses, by nature]"
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsTable",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "presentation": [
      "http://afya.com.br/role/FinanceResult"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance result"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]"
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsTable",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8",
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets that are either past due or impaired [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets that are either past due or impaired."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets and liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesTable",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial liabilities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial liabilities."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "afya_DisclosureOfGeneralInformationAboutFinancialStatementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementExplanatory",
     "presentation": [
      "http://afya.com.br/role/CorporateInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate information"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureOfIncomeTaxesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfIncomeTaxesExplanatory",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureOfIntangibleAssetExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfIntangibleAssetExplanatory",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets",
        "label": "DisclosureOfIntangibleAssetExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsTable",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets with indefinite useful life [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to intangible assets with an indefinite useful life."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "afya_DisclosureOfInvestmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfInvestmentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of investment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfJointVenturesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfJointVenturesExplanatory",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociate"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investment in associate",
        "label": "Disclosure of joint ventures [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of joint ventures. [Refer: Total for all joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r75",
      "r156"
     ]
    },
    "afya_DisclosureOfLegalProceedingsAndContingenciesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfLegalProceedingsAndContingenciesExplanatory",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal proceedings and contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureOfMaterialAccountingPoliciesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfMaterialAccountingPoliciesExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material accounting policies"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "presentation": [
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of statements of income for the company\u2019s operating segments"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "ifrs-full_DisclosureOfOperatingSegmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsTable",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to operating segments."
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "afya_DisclosureOfOtherAssetExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfOtherAssetExplanatory",
     "presentation": [
      "http://afya.com.br/role/OtherAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "DisclosureOfOtherAssetExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureOfOtherAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfOtherAssetsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/OtherAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment",
        "label": "Disclosure of property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in goodwill [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill."
       }
      }
     },
     "auth_ref": [
      "r212"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/IntangibleAssetsDetails2",
      "http://afya.com.br/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of liabilities arising from financing activities."
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "afya_DisclosureOfRelatedPartiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfRelatedPartiesExplanatory",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of balances and transactions with related parties"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "presentation": [
      "http://afya.com.br/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related parties"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ifrs-full_DisclosureOfRevenueExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfRevenueExplanatory",
     "presentation": [
      "http://afya.com.br/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "label": "Disclosure of revenue [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis to changes in risk variables that arise from contracts within scope of IFRS 17 [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the sensitivity analysis to changes in risk variables that arise from contracts within the scope of IFRS 17."
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/CorporateInformationDetails",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to subsidiaries."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r75",
      "r155"
     ]
    },
    "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of significant unobservable inputs used in fair value measurement of assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to significant unobservable inputs used in the fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary differences:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfTradeAccountsReceivableByAgingExplanatory",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of aging of trade accounts receivable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosureOfTradeAndOtherReceivables1Explanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOfTradeAndOtherReceivables1Explanatory",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of trade accounts receivable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://afya.com.br/role/TradeReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade receivables",
        "label": "Disclosure of trade and other receivables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/RelatedPartiesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions between related parties."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "afya_DisclosureOtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosureOtherAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DisclosuresOfCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DisclosuresOfCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "DisclosuresOfCashAndCashEquivalentsExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DiscountRatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DiscountRatesMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount Rates [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_Dividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "Dividend",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Dividends",
        "label": "Dividend"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DividendDistributed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DividendDistributed",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend distributed"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DividendReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DividendReceivable",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends receivable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DividendsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DividendsPaid",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dividends declared",
        "label": "Dividends recognised as distributions to owners"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends recognised as distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ifrs-full_DividendsPaidClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DividendsPaidClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dividends paid",
        "label": "Dividends paid, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid by the entity, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "ifrs-full_DividendsPaidOtherSharesPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DividendsPaidOtherSharesPerShare",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends paid per other share."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ifrs-full_DividendsPaidToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DividendsPaidToNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends paid to non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends paid to non-controlling interests. [Refer: Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ifrs-full_DividendsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DividendsPayable",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends payable"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends payable by means of the distribution of non-cash assets to owners."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "afya_DividendsPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DividendsPayableMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends Payable [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DividendsPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DividendsPayables",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Dividends payable",
        "label": "DividendsPayables"
       }
      }
     },
     "auth_ref": []
    },
    "afya_DividendsPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DividendsPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DividendsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DividendsReceived",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends received",
        "negatedLabel": "Dividends receivable - Other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends received."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "afya_DividendsReceived1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "DividendsReceived1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Dividends received",
        "label": "DividendsReceived1"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r326",
      "r349"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r326",
      "r349",
      "r389"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r313"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r316"
     ]
    },
    "afya_EBITDAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "EBITDAMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "E B I T D A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EMIVEPatrulha24HorasLtdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "EMIVEPatrulha24HorasLtdaMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "E M I V E Patrulha 24 Horas Ltda [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "currency_EUR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "EUR",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EbitdaGrowthRates": {
     "xbrltype": "percentItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "EbitdaGrowthRates",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EBITDA growth rates"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EducationContentDevelopedTechnologyAndEducationalPlatformMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "EducationContentDevelopedTechnologyAndEducationalPlatformMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Education Content Developed Technology And Educational Platform [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EducationContentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "EducationContentMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Education Content [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EducationalContentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "EducationalContentMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Educational Content [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EducationalCreditsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "EducationalCreditsMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Educational Credits [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EducationalPlatformMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "EducationalPlatformMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Educational Platform [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net foreign exchange differences",
        "label": "Effect of exchange rate changes on cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r116",
      "r117"
     ]
    },
    "afya_EliminationInterSegmentBalancesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "EliminationInterSegmentBalancesMember",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elimination Inter Segment Balances [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_EliminationInterSegmentTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "EliminationInterSegmentTransactionsMember",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elimination Inter Segment Transactions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementOfChangesInEquity",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Beginning balance, value",
        "periodEndLabel": "Ending balance, value",
        "verboseLabel": "Equity",
        "label": "Equity [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r23",
      "r132",
      "r134",
      "r158",
      "r159",
      "r161"
     ]
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EquityAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and equity",
        "label": "Total liabilities and equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "ifrs-full_EquityAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EquityAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Equity attributable to the owners of the Company",
        "label": "Equity attributable to owners of parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "ifrs-full_EquityAttributableToOwnersOfParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EquityAttributableToOwnersOfParentMember",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity attributable to the owners of the parent."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "afya_EquityInAssociate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "EquityInAssociate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity",
        "label": "EquityInAssociate"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r342",
      "r353",
      "r367",
      "r393"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r339",
      "r350",
      "r364",
      "r390"
     ]
    },
    "afya_ExchangeVariance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ExchangeVariance",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange variance"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "afya_ExpectedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ExpectedCashFlows",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected cash flows"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield (%)"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "afya_ExpectedLifeOfStockOptions": {
     "xbrltype": "durationItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ExpectedLifeOfStockOptions",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life of stock options"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseByNature": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpenseByNature",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Expenses, by nature"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation expense",
        "label": "Expense from share-based payment transactions with employees"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]"
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease expense from short-term leases and low-value assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the expense relating to leases of low-value assets accounted for applying paragraph 6 of IFRS 16. This expense shall not include the expense relating to short-term leases of low-value assets."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ifrs-full_ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity investments"
       }
      },
      "en": {
       "role": {
        "documentation": "The explanation of facts and circumstances indicating a rare situation for the reclassification of financial assets that are no longer held for the purpose of selling or repurchasing in the near term out of the fair value through profit or loss category. [Refer: Financial assets at fair value through profit or loss; Reclassification out of financial assets at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r250"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FADEP - Faculdade Educacional de Pato Branco Ltda. (\u0093FADEP\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FADEPFaculdadeEducacionalDePatoBrancoLtdaMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FADEP Faculdade Educaciona lDe Pato Branco Ltda [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FCMPBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FCMPBMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FCMPB [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FESARMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FESARMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FESAR [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FIESMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FIESMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "F I E S [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FUNICMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FUNICMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "F U N I C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FVOCI1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FVOCI1Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "F V O C I 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FVOCIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FVOCIMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "F V O C I [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FVTPLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FVTPLMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "F V T P L [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FaculdadeMasterclassLtdaFUNICMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FaculdadeMasterclassLtdaFUNICMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Faculdade Masterclass Ltda F U N I C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FaculdadeMasterclassLtdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FaculdadeMasterclassLtdaMember",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Faculdade Masterclass Ltda [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FairValueRemeasurementsOnBusinessCombinations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FairValueRemeasurementsOnBusinessCombinations",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value remeasurements on business combinations"
       }
      }
     },
     "auth_ref": []
    },
    "afya_February2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "February2023Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "February 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FeeAndCommissionIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FeeAndCommissionIncome",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Transferred over time",
        "label": "Fee and commission income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income relating to fees and commissions."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails",
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Finance expenses",
        "label": "Finance costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "afya_FinanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FinanceExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinanceIncome",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance income",
        "negatedLabel": "Net finance result"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ifrs-full_FinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net finance result",
        "label": "Finance income (cost)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "afya_FinanceResult": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FinanceResult",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net finance result"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Balance as of ending"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r218",
      "r221",
      "r222",
      "r223",
      "r299"
     ]
    },
    "ifrs-full_FinancialAssetsAtAmortisedCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialAssetsAtAmortisedCostMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets at amortised cost, class [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial assets measured at amortised cost class. [Refer: Financial assets at amortised cost]"
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "afya_FinancialAssetsAtAmortizedCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FinancialAssetsAtAmortizedCostMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Assets At Amortized Cost [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialAssetsNeitherPastDueNorImpairedMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets neither past due nor impaired [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for financial assets that are neither past due nor impaired. A financial asset is past due when a counterparty has failed to make a payment when contractually due. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialAssetsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/CorporateInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for financial assets acquired in a business combination. [Refer: Financial assets; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r292",
      "r294"
     ]
    },
    "afya_FinancialDiscountsGrantedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FinancialDiscountsGrantedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial discounts"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FinancialIncomeFromCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FinancialIncomeFromCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial income from cash equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FinancialInstitution": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FinancialInstitution",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial institution"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial instruments - initial recognition and measurement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Financial liabilities, at carrying amount"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtAmortisedCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtAmortisedCostMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities at amortised cost, class [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial liabilities measured at amortised cost class. [Refer: Financial liabilities at amortised cost]"
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Financial liabilities, at fair value",
        "label": "Financial liabilities, at fair value [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "afya_FinancialLiabilitiesAtFairValues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FinancialLiabilitiesAtFairValues",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities, at fair value"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FinancialLiabilitiesContractualUndiscounted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FinancialLiabilitiesContractualUndiscounted",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities contractual undiscounted"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/CorporateInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for financial liabilities assumed in a business combination. [Refer: Financial liabilities; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r292",
      "r294"
     ]
    },
    "afya_FirstAnnualInstallmentsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FirstAnnualInstallmentsPayable",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First annual installment"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FirstDividendDistributionInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FirstDividendDistributionInAmount",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First dividend distribution in amount"
       }
      }
     },
     "auth_ref": []
    },
    "afya_FirstSeriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "FirstSeriesMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Series [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FixturesAndFittingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FixturesAndFittingsMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixtures and fittings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "ifrs-full_FloatingInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FloatingInterestRateMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Floating interest rate [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a non-fixed interest rate. [Refer: Interest rate risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "afya_ForeignCurrencyExposuresMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ForeignCurrencyExposuresMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Exposures [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r371",
      "r397"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r371",
      "r397"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r371",
      "r397"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r371",
      "r397"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r371",
      "r397"
     ]
    },
    "ifrs-full_FunctionalOrPresentationCurrencyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FunctionalOrPresentationCurrencyMember",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member indicates information displayed in the functional or presentation currency. It also represents the standard value for the \u2018Currency in which information is displayed\u2019 axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Selling, general and administrative expenses",
        "label": "General and administrative expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to general and administrative activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "ifrs-full_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Goodwill",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1",
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r85",
      "r91",
      "r212"
     ]
    },
    "ifrs-full_GoodwillMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GoodwillMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "ifrs-full_GoodwillRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GoodwillRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill arising on acquisition"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r293",
      "r294"
     ]
    },
    "afya_GrantedVestingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "GrantedVestingPeriod",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GrossCarryingAmountMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross carrying amount [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r102",
      "r109",
      "r112",
      "r212",
      "r222",
      "r223",
      "r299"
     ]
    },
    "ifrs-full_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross profit"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "afya_HospitalAndMedicalAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "HospitalAndMedicalAgreements",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hospital and medical agreements"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "iClinic Desenvolvimento de Software Ltda. (\u0093iClinic\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IESVAPPatrimonialLtdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IESVAPPatrimonialLtdaMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "I E S V A P Patrimonial Ltda [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IFRS18PresentationAndDisclosureInFinancialStatementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IFRS18PresentationAndDisclosureInFinancialStatementsMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IFRS 18 Presentation And Disclosure In Financial Statements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (\u0093IPTAN\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPTAN Instituto De Ensino Superior Presidente Trancredo DeAlmeida Neves SA [Membe]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ITPACGaranhunsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ITPACGaranhunsMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ITPAC Garanhuns [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r324",
      "r326",
      "r349"
     ]
    },
    "ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/CorporateInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets",
        "label": "Identifiable intangible assets recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r292",
      "r294"
     ]
    },
    "afya_IfrsStatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IfrsStatementLineItems",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetails",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/IntangibleAssetsDetails1",
      "http://afya.com.br/role/IntangibleAssetsDetails2",
      "http://afya.com.br/role/IntangibleAssetsDetailsNarrative",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails5",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative",
      "http://afya.com.br/role/PropertyAndEquipmentDetails",
      "http://afya.com.br/role/RelatedPartiesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative",
      "http://afya.com.br/role/RevenueDetails1",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementOfChangesInEquity",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative",
      "http://afya.com.br/role/TradeReceivablesDetails",
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IfrsStatementLineItems [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets and goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "ifrs-full_ImpairmentOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentOfFinancialAssetsAxis",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "ifrs-full_ImpairmentOfFinancialAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentOfFinancialAssetsDomain",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Impairment of financial assets' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ImpairmentOfNonfinancialAssetsPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of non-financial assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncomeLossBeforeIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncomeLossBeforeIncomeTaxes",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income before income taxes",
        "label": "IncomeLossBeforeIncomeTaxes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income taxes expenses",
        "label": "Tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r35",
      "r40",
      "r41",
      "r42",
      "r68",
      "r154",
      "r235"
     ]
    },
    "afya_IncomeTaxesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncomeTaxesExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes expense"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncomeTaxesExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncomeTaxesExpensesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes expenses"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncomeTaxesExpensesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncomeTaxesExpensesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Current",
        "label": "IncomeTaxesExpensesCurrent"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income taxes paid",
        "label": "Income taxes paid (refund), classified as operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]"
       }
      }
     },
     "auth_ref": [
      "r119",
      "r275"
     ]
    },
    "afya_IncomeTaxesRecoverable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncomeTaxesRecoverable",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes recoverable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncreaseBasisPointsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncreaseBasisPointsMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Basis Points [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncreaseBasisPointsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncreaseBasisPointsOneMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Basis Points One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9",
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect on profit before tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of increase (decrease) in the fair value measurement of assets, recognised in profit or loss before tax, due to a reasonably possible decrease in an unobservable input. [Refer: Tax income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Effect on profit before tax",
        "label": "Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of increase (decrease) in the fair value measurement of assets, recognised in profit or loss before tax, due to a reasonably possible increase in an unobservable input. [Refer: Tax income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "afya_IncreaseDecreaseInOperatingLiabilities1Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncreaseDecreaseInOperatingLiabilities1Abstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncreaseDecreaseInPaymentsOfLegalProceedings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncreaseDecreaseInPaymentsOfLegalProceedings",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of legal proceedings",
        "label": "IncreaseDecreaseInPaymentsOfLegalProceedings"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncreaseDecreaseInRecoverableTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncreaseDecreaseInRecoverableTaxes",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Recoverable taxes",
        "label": "IncreaseDecreaseInRecoverableTaxes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of principal"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Business combination",
        "label": "Increase (decrease) through obtaining or losing control of subsidiaries or other businesses, liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from obtaining or losing control of subsidiaries or other businesses. [Refer: Liabilities arising from financing activities; Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Increase (decrease) through other changes, liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transfer"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r442"
     ]
    },
    "afya_IncreaseForeignCurrencyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncreaseForeignCurrencyMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Foreign Currency [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncreaseInIncomeBeforeIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncreaseInIncomeBeforeIncomeTaxes",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in income before income taxes"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncreaseInRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncreaseInRevenue",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in revenue"
       }
      }
     },
     "auth_ref": []
    },
    "afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest",
        "label": "IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions and remeasurements"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r280",
      "r283"
     ]
    },
    "afya_IndemnificationAssetsAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IndemnificationAssetsAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indemnification assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IndemnificationAssetsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/CorporateInformationDetails",
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total net assets",
        "verboseLabel": "Total identifiable net assets at fair value",
        "terseLabel": "Indemnification assets - Note 21"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "afya_IndexRatePerYear": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IndexRatePerYear",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Index - % per year"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r371",
      "r388",
      "r397",
      "r401",
      "r409"
     ]
    },
    "ifrs-full_InitiallyAppliedIFRSsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InitiallyAppliedIFRSsAxis",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails5",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initially applied IFRSs [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ifrs-full_InitiallyAppliedIFRSsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InitiallyAppliedIFRSsDomain",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails5",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for IFRSs that have been initially applied by the entity. It also represents the standard value for the 'Initially applied IFRSs' axis if no other member is used. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r407"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r327",
      "r412"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r327",
      "r412"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r327",
      "r412"
     ]
    },
    "afya_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituicao Baianade Ensino Superior Ltda I B E S [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto de Educacao Superior do Vale do Parnaiba S.A. (\u0093IESVAP\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto De Educacao Superior Do Vale Do Parnaiba SA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto de Ensino Superior do Piaui S.A. (\u0093IESP\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstitutoDeEnsinoSuperiorDoPiauiSAMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto De Ensino Superior Do Piaui SA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoEducacionalSantoAgostinhoS.A.FASAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstitutoEducacionalSantoAgostinhoS.A.FASAMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Educacional Santo Agostinho S.A. (\u0093FASA\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoEducacionalSantoAgostinhoSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstitutoEducacionalSantoAgostinhoSAMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Educacional Santo Agostinho SA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstitutoParaenseDeEducacaoECulturaLtda.IPECMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Paraense de Educacao e Cultura Ltda. (\u0093IPEC\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoParaensedeEducacaoeCulturaLtdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstitutoParaensedeEducacaoeCulturaLtdaMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Paraensede Educacaoe Cultura Ltda [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Tocantinense Presidente Antonio Carlos Porto S.A. - (\u0093ITPAC Porto\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Tocantinense Presidente Antonio Carlos S.A. - (\u0093ITPAC Araguaina\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstitutoTocantinensePresidenteAntonioCarlosSAMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Tocantinense Presidente Antonio Carlos S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Institutode Ensino Superior Presidente Trancredode Almeida Neves S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsAndGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Intangible assets and goodwill, balance at beginnning",
        "periodEndLabel": "Intangible assets and goodwill, balance at end",
        "label": "Intangible assets and goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "afya_IntangibleAssetsAndGoodwillNetBookValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IntangibleAssetsAndGoodwillNetBookValue",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net book value",
        "label": "IntangibleAssetsAndGoodwillNetBookValue"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r105"
     ]
    },
    "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsWithIndefiniteUsefulLife",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licenses with indefinite useful life"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r92",
      "r107"
     ]
    },
    "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsWithIndefiniteUsefulLifeAxis",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets with indefinite useful life [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsWithIndefiniteUsefulLifeDomain",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets with an indefinite useful life. It also represents the standard value for the 'Intangible assets with indefinite useful life' axis if no other member is used. [Refer: Intangible assets with indefinite useful life]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "afya_IntangibleInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IntangibleInProgressMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible In Progress [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InterSegment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InterSegment",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inter-segment"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InterestEarned": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InterestEarned",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest earned"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from interest."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r233",
      "r241"
     ]
    },
    "afya_InterestExpense1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InterestExpense1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestExpenseOnLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4",
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest on lease liabilities",
        "verboseLabel": "Lease liabilities, interest expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "afya_InterestExpenseOnLeaseLiabilities1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InterestExpenseOnLeaseLiabilities1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense on lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestPaidClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestPaidClassifiedAsFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of interest",
        "negatedTerseLabel": "Payments of interest",
        "label": "Interest paid, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "ifrs-full_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r187",
      "r230"
     ]
    },
    "afya_InternationalFinanceCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InternationalFinanceCorporationMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "International Finance Corporation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InvestmentGrossAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InvestmentGrossAmount",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount of the investment"
       }
      }
     },
     "auth_ref": []
    },
    "afya_InvestmentType": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "InvestmentType",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment type"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InvestmentsInAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InvestmentsInAssociates",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in associate",
        "periodStartLabel": "Opening balance",
        "periodEndLabel": "Closing balance"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investments in associates in an entity's separate financial statements. [Refer: Total for all associates [member]]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in associate"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r257"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "afya_IssuedCapitals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "IssuedCapitals",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Authorized capital"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ItEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ItEquipmentMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "It Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_JanuaryTwentyTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "JanuaryTwentyTwentyEightMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "January Twenty Twenty Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_JudicialDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "JudicialDeposits",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Judicial deposits"
       }
      }
     },
     "auth_ref": []
    },
    "afya_JulyTwentyTwentySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "JulyTwentyTwentySevenMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July Twenty Twenty Seven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensation",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation plans"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "afya_LaborAndSocialObligationsAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LaborAndSocialObligationsAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Labor and social obligations",
        "label": "LaborAndSocialObligationsAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LaborAndSocialObligationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LaborAndSocialObligationsExplanatory",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Labor and social obligations",
        "label": "LaborAndSocialObligationsExplanatory"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LaborAndSocialObligationsPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LaborAndSocialObligationsPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "m) Labor and social obligations"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LabourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LabourMember",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Labour [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LackOfExchangeabilityAmendmentsToIAS21Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LackOfExchangeabilityAmendmentsToIAS21Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendments To IAS 21 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LandMember",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing land held by the entity for use in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanFiveYearsMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r180",
      "r189",
      "r301",
      "r306",
      "r310"
     ]
    },
    "afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LaterThanOneMonthsAndNotLaterThanThreeMonthsMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later Than One Months And Not Later Than Three Months [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than one year and not later than three years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than three years."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r304",
      "r310"
     ]
    },
    "ifrs-full_LaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanOneYearMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than one year [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "ifrs-full_LaterThanSixMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanSixMonthsMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than six months [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than six months."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanThreeMonthsAndNotLaterThanSixMonthsMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than three months and not later than six months [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three months and not later than six months."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r303",
      "r310"
     ]
    },
    "ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanThreeYearsAndNotLaterThanFiveYearsMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than three years and not later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three years and not later than five years."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r305",
      "r310"
     ]
    },
    "afya_LeaseAgreements1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseAgreements1Member",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Agreements 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseAgreements2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseAgreements2Member",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Agreements 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseAgreements3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseAgreements3Member",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Agreements 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseAgreements4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseAgreements4Member",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Agreements 4 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseAgreements5Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseAgreements5Member",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Agreements 5 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseExpenses",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease expenses",
        "label": "LeaseExpenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liabilities",
        "periodStartLabel": "Lease liabilities, balance at beginning",
        "periodEndLabel": "Lease liabilities, balance at ending",
        "label": "Lease liabilities [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ifrs-full_LeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LeaseLiabilitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IFRS 16 - Leases:"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseLiabilitiesAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseLiabilitiesAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liabilities",
        "label": "LeaseLiabilitiesAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseLiabilitiesInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseLiabilitiesInterestMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Liabilities Interest [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LeaseLiabilitiesMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r281",
      "r284"
     ]
    },
    "afya_LeaseLiabilitiesPaymentsOfPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseLiabilitiesPaymentsOfPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, payments of principal"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseLiabilitiesRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseLiabilitiesRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liabilities",
        "label": "LeaseLiabilitiesRelatedPartyTransactions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseLiabilitiesRemeasurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseLiabilitiesRemeasurement",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, remeasurement"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseLiabilitiesWriteoff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseLiabilitiesWriteoff",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, Write-off"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liabilities",
        "label": "LeaseLiability"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold improvements [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LegalProceedingsContingentLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LegalProceedingsContingentLiabilityMember",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal proceedings contingent liability [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a contingent liability for legal proceedings. [Refer: Classes of contingent liabilities [domain]]"
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "ifrs-full_LegalProceedingsProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LegalProceedingsProvision",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for legal proceedings and contingencies"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of provision for legal proceedings. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r268",
      "r270"
     ]
    },
    "afya_LesseeFinancesLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LesseeFinancesLeaseRenewalTerm",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Renewal term"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Level2OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Level2OfFairValueHierarchyMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 2 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r89",
      "r159"
     ]
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Level3OfFairValueHierarchyMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 3 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r89",
      "r159"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyAxis",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r159"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyDomain",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r159"
     ]
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r158",
      "r159",
      "r161",
      "r236",
      "r240"
     ]
    },
    "ifrs-full_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Liabilities arising from financing activities, beginning",
        "periodEndLabel": "Liabilities arising from financing activities, ending",
        "label": "Liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesDomain",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "afya_LibraryBooksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LibraryBooksMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Library Books [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LicencesAndFranchisesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LicencesAndFranchisesMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licences and franchises [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity and the right to operate a business using the name, merchandise, services, methodologies, promotional support, marketing and supplies granted by another entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "ifrs-full_LicencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LicencesMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licences [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "ifrs-full_LiquidityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiquidityRiskMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r295"
     ]
    },
    "afya_LoanAndFinancing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LoanAndFinancing",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loans and financing",
        "label": "LoanAndFinancing"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LoansAndFinancing",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loans and financing",
        "label": "LoansAndFinancing"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LoansAndFinancingAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/CorporateInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loans and financing",
        "label": "LoansAndFinancingAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LoansAndFinancingCurrent",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "LoansAndFinancingCurrent"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LoansAndFinancingMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails11",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails7",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans And Financing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LoansAndFinancingNonCurrent",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "label": "LoansAndFinancingNonCurrent"
       }
      }
     },
     "auth_ref": []
    },
    "afya_LoansAndFinancingOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "LoansAndFinancingOneMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans And Financing One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LongtermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LongtermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loans and financing",
        "label": "Non-current portion of non-current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "ifrs-full_LongtermLegalProceedingsProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LongtermLegalProceedingsProvision",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for legal proceedings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current provision for legal proceedings. [Refer: Legal proceedings provision]"
       }
      }
     },
     "auth_ref": [
      "r268",
      "r270"
     ]
    },
    "afya_MachineryAndEquipmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "MachineryAndEquipmentsMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery And Equipments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cyd_MaterialCybersecurityIncidentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r360",
      "r361"
     ]
    },
    "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r360",
      "r362"
     ]
    },
    "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r360",
      "r363"
     ]
    },
    "cyd_MaterialCybersecurityIncidentNatureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentNatureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Nature [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r360",
      "r363"
     ]
    },
    "cyd_MaterialCybersecurityIncidentScopeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentScopeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Scope [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r360",
      "r363"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTimingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTimingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Timing [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r360",
      "r363"
     ]
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r169",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r189",
      "r217",
      "r224",
      "r263",
      "r301"
     ]
    },
    "ifrs-full_MaturityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaturityDomain",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r169",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r189",
      "r217",
      "r263",
      "r301",
      "r307"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical Harbour Aparelhos Medico Hospitalares e Servicos em Tecnologia Ltda. (\u0093Medical Harbour\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_MedicalPracticeSolutionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "MedicalPracticeSolutionsMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1",
      "http://afya.com.br/role/RevenueDetails1",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical Practice Solutions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_MedicinaeSolutionsS.A.MedicinaeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "MedicinaeSolutionsS.A.MedicinaeMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicinae Solutions S.A. (\u0093Medicinae\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MethodOfAssessmentOfExpectedCreditLossesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MethodOfAssessmentOfExpectedCreditLossesAxis",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Method of assessment of expected credit losses [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r297",
      "r308"
     ]
    },
    "ifrs-full_MethodOfAssessmentOfExpectedCreditLossesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MethodOfAssessmentOfExpectedCreditLossesDomain",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all methods of assessment of expected credit losses. Expected credit losses are the weighted average of credit losses with the respective risks of a default occurring as the weights. This member also represents the standard value for the 'Method of assessment of expected credit losses' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r297",
      "r308"
     ]
    },
    "afya_MinimumTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "MinimumTaxRate",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum tax rate"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "afya_MobileAppSubscriptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "MobileAppSubscriptionMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mobile App Subscription [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "ifrs-full_MultiperiodExcessEarningsMethodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MultiperiodExcessEarningsMethodMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Multi-period excess earnings method [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a specific valuation technique consistent with the income approach that involves analysing the excess earnings over periods of time, and is used to measure the fair value of some intangible assets. [Refer: Income approach [member]]"
       }
      }
     },
     "auth_ref": [
      "r286"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "ifrs-full_NetDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NetDeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets (liabilities), net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NetOfCashFlowOnAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NetOfCashFlowOnAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net of cash flow on acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NetRevenueOtherTransferredPoint": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NetRevenueOtherTransferredPoint",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Transferred at a point in time",
        "label": "NetRevenueOtherTransferredPoint"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "afya_NonTeachingActivitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NonTeachingActivitiesMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Teaching Activities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NonadjustingEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NonadjustingEventMember",
     "presentation": [
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonadjusting Event [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "presentation": [
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodDomain",
     "presentation": [
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_NoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r136",
      "r140"
     ]
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncontrollingInterestsMember",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-controlling interests [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "afya_NoncurrenLliabilitiesOfRelatedParty1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NoncurrenLliabilitiesOfRelatedParty1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current liabilities",
        "label": "NoncurrenLliabilitiesOfRelatedParty1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "verboseLabel": "Non-current assets",
        "label": "Non-current assets [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r20",
      "r146",
      "r285"
     ]
    },
    "afya_NoncurrentAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NoncurrentAssets1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "label": "NoncurrentAssets1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NoncurrentAssetsOfRelatedParty1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NoncurrentAssetsOfRelatedParty1",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current assets",
        "label": "NoncurrentAssetsOfRelatedParty1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentFinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "label": "Non-current financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "ifrs-full_NoncurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "label": "Non-current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "ifrs-full_NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current",
        "label": "Non-current financial liabilities at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities measured at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liabilities",
        "label": "Lease liabilities, non-current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current liabilities",
        "verboseLabel": "Non-current liabilities",
        "negatedLabel": "Non-current liabilities",
        "label": "Non-current liabilities [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r21",
      "r148",
      "r285"
     ]
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentLiabilitiesAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentPayablesForPurchaseOfEnergy": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentPayablesForPurchaseOfEnergy",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current payables for purchase of energy"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current payables for the purchase of energy. [Refer: Payables for purchase of energy]"
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "ifrs-full_NoncurrentPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentPayablesToRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable to selling shareholders",
        "label": "Non-current payables to related parties"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current payables due to related parties. [Refer: Total for all related parties [member]; Payables to related parties]"
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "afya_NoncurrentTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NoncurrentTaxesPayable",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Taxes payable",
        "label": "NoncurrentTaxesPayable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NoncurrentTradeReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NoncurrentTradeReceivable",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade receivables",
        "label": "NoncurrentTradeReceivable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentTradeReceivables",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r256"
     ]
    },
    "ifrs-full_NotLaterThanOneMonthMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NotLaterThanOneMonthMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Not later than one month [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one month."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r302",
      "r310"
     ]
    },
    "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NotesAndOtherExplanatoryInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes and other explanatory information [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_November2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "November2025Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "November 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfOutstandingShareOptions",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of stock options, Outstanding at the beginning",
        "periodEndLabel": "Number of stock options, Outstanding at the ending",
        "label": "Number of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r196",
      "r198"
     ]
    },
    "afya_NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NumberOfShareOptionsExchangedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NumberOfShareOptionsExchangedInSharebasedPaymentArrangement",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of stock options, stock option exchanged",
        "label": "Number of stock options, Stock options exchanged"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of stock options, Exercised",
        "label": "Number of share options exercised in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of stock options, Expired",
        "label": "Number of share options expired in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options expired in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of stock options, Forfeited",
        "label": "Number of share options forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of stock options, Granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "afya_NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total number of shares",
        "label": "Number of shares issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "afya_NumberOfSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NumberOfSharesIssued1",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total number of shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfSharesOutstanding",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of shares, Outstanding, at beginning balance",
        "periodEndLabel": "Number of shares, Outstanding, at ending balance",
        "label": "Number of shares outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "afya_NumberOfSharesRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NumberOfSharesRepurchased",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares, Repurchased"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NumberOfStockOptionsExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NumberOfStockOptionsExercisable",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of stock options, Exercisable",
        "label": "NumberOfStockOptionsExercisable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of treasury shares, delivered under the share-based compensation plan"
       }
      }
     },
     "auth_ref": []
    },
    "afya_NumeratorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "NumeratorAbstract",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Numerator"
       }
      }
     },
     "auth_ref": []
    },
    "afya_October2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "October2023Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "October 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_October2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "October2024Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "October 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OctoberTwentyThirtyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OctoberTwentyThirtyMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "October Twenty Thirty [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OctoberTwentyTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OctoberTwentyTwentyEightMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "October Twenty Twenty Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OctoberTwentyTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OctoberTwentyTwentyFiveMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "October Twenty Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OperatingLeaseTermOfContract",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease term"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating segments [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for operating segments. An operating segment is a component of an entity: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same entity); (b) whose operating results are regularly reviewed by the entity\u2019s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance; and (c) for which discrete financial information is available. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r242"
     ]
    },
    "afya_OrganizationForEconomicCooperationAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OrganizationForEconomicCooperationAndDevelopmentMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization For Economic Cooperation And Development [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_Other": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "Other",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Other [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherAdjustmentsForNoncashItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherAdjustmentsForNoncashItems",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Labor and social obligations",
        "label": "Other adjustments for non-cash items"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "ifrs-full_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other FIES credits - Other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "afya_OtherAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OtherAssets1",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "OtherAssets1"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherAssetsAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OtherAssetsAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "OtherAssetsAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherAssetsNonCurrentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OtherAssetsNonCurrentMember",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets Non Current [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherAssetsRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OtherAssetsRelatedPartyTransactions",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "OtherAssetsRelatedPartyTransactions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r28",
      "r36",
      "r151"
     ]
    },
    "ifrs-full_OtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherCurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "ifrs-full_OtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "afya_OtherExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OtherExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherExpenseByNature": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherExpenseByNature",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other expenses",
        "label": "Other expenses, by nature"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]"
       }
      }
     },
     "auth_ref": [
      "r37",
      "r252"
     ]
    },
    "ifrs-full_OtherFinanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherFinanceCost",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Other finance cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]"
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "ifrs-full_OtherFinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherFinanceIncome",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinanceResultDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Other finance income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of finance income that the entity does not separately disclose in the same statement or note. [Refer: Finance income]"
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "ifrs-full_OtherGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherGainsLosses",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expenses, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r430"
     ]
    },
    "ifrs-full_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherIncome",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other income",
        "label": "Other income [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of operating income that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r252",
      "r253"
     ]
    },
    "afya_OtherIncomeRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OtherIncomeRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other income",
        "label": "OtherIncomeRelatedPartyTransactions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherLiabilitiesAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OtherLiabilitiesAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "OtherLiabilitiesAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OtherMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "label": "Other non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "ifrs-full_OtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherNoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Other non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherOperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "ifrs-full_OtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of provisions other than provisions for employee benefits. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r22",
      "r94"
     ]
    },
    "ifrs-full_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/OtherAssetsDetails": {
       "parentTag": "afya_Assets1",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other FIES credits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r256"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "ifrs-full_OtherRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherRevenue",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Other revenue"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "afya_OtherRevenue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OtherRevenue1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "OtherRevenue1"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherTaxExpenseBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OtherTaxExpenseBenefits",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "OtherTaxExpenseBenefits"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OtherTaxesPayableAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OtherTaxesPayableAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other taxes payable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_OthersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "OthersMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Others [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r344",
      "r355",
      "r369",
      "r395"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r347",
      "r358",
      "r372",
      "r398"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r347",
      "r358",
      "r372",
      "r398"
     ]
    },
    "ifrs-full_ParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ParValuePerShare",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nominal value per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "ifrs-full_PastDueStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PastDueStatusAxis",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Past due status [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "ifrs-full_PastDueStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PastDueStatusDomain",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all past-due statuses. It also represents the standard value for the 'Past due status' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r376"
     ]
    },
    "afya_PaymentOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PaymentOfDividends",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment of dividends"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PaymentsOfInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PaymentsOfInterest",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of interest",
        "label": "PaymentsOfInterest"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PaymentsOfInterestLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PaymentsOfInterestLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, payments of interest"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of interest of lease liabilities",
        "label": "PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of principal of lease liabilities",
        "label": "Payments of lease liabilities, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "afya_PaymentsOfPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PaymentsOfPrincipal",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of principal",
        "label": "PaymentsOfPrincipal"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsToSuppliersForGoodsAndServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PaymentsToSuppliersForGoodsAndServices",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of services or goods"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow to suppliers for goods and services."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "afya_Payroll": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "Payroll",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payroll (i)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "afya_PercenatgeOfAverageInterestOnFinancialInstrument": {
     "xbrltype": "percentItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PercenatgeOfAverageInterestOnFinancialInstrument",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of average interest"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PercentageOfDividendDistribution": {
     "xbrltype": "percentItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PercentageOfDividendDistribution",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of dividend distribution"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PercentageOfEntitysRevenue": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PercentageOfEntitysRevenue",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of revenue"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of the entity's revenue. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "ifrs-full_PercentageOfVotingEquityInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PercentageOfVotingEquityInterestsAcquired",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired percenatge"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "afya_PermanentAdjustmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PermanentAdjustmentsAbstract",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Permanent adjustments:"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PermanentAdjustmentsGifts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PermanentAdjustmentsGifts",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gifts"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PermanentAdjustmentsManagementBonuses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PermanentAdjustmentsManagementBonuses",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management bonuses"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PermanentAdjustmentsPillarTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PermanentAdjustmentsPillarTwo",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pillar Two - See Note 2.3(q)"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PermanentAdjustmentsSponsorship": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PermanentAdjustmentsSponsorship",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sponsorship"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PerpetuityGrowthRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PerpetuityGrowthRate",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Growth rates"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PerpetuityGrowthRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PerpetuityGrowthRateMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Perpetuity Growth Rate [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "afya_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Power Purchase Agreements Amendments To IFRS 9 And IFRS 7 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "afya_PrincipalActivities": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PrincipalActivities",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PrincipalPlaceOfBusinessOfSubsidiary",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Location"
       }
      },
      "en": {
       "role": {
        "documentation": "The principal place of business of a subsidiary. [Refer: Principal place of business; Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r73",
      "r137",
      "r141"
     ]
    },
    "ifrs-full_ProbabilityOfDefaultAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProbabilityOfDefaultAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Probability of default [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r309"
     ]
    },
    "ifrs-full_ProbabilityOfDefaultDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProbabilityOfDefaultDomain",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Probability of default' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r309"
     ]
    },
    "afya_ProbabilityOfDisbursement": {
     "xbrltype": "percentItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ProbabilityOfDisbursement",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Probability of disbursement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from loans and financing"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromExerciseOfOptions",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of stock options"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r454"
     ]
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProductsAndServicesAxis",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r289"
     ]
    },
    "ifrs-full_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r289"
     ]
    },
    "ifrs-full_ProfessionalFeesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfessionalFeesExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Tuition fees",
        "label": "Professional fees expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable for professional services."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "afya_ProfessionalFeesExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ProfessionalFeesExpenses",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tuition fees"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementOfChangesInEquity",
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "label": "Net income"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r27",
      "r114",
      "r133",
      "r135",
      "r236",
      "r238",
      "r285",
      "r290"
     ]
    },
    "ifrs-full_ProfitLossAttributableToAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToAbstract",
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income / total comprehensive income attributable to:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "afya_ComprehensiveIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-controlling interests",
        "label": "Profit (loss), attributable to non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r30",
      "r139"
     ]
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "afya_ComprehensiveIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Owners of the Company"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/IncomeTaxesDetails",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income taxes",
        "label": "Income before income taxes",
        "verboseLabel": "Income loss before income taxes"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r215",
      "r252",
      "r253",
      "r311",
      "r312"
     ]
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossFromOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income",
        "label": "Operating income"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r264",
      "r438"
     ]
    },
    "ifrs-full_ProfitLossOfAcquiree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossOfAcquiree",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share of profit, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r209"
     ]
    },
    "afya_ProgramOfSocialIntegrationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ProgramOfSocialIntegrationMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Program Of Social Integration [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ProgramaUniversidadeParaTodosFiscalIncentive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ProgramaUniversidadeParaTodosFiscalIncentive",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROUNI - Fiscal incentive (i)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r51"
     ]
    },
    "afya_PropertyPlantAndEquipmentNetBookValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PropertyPlantAndEquipmentNetBookValue",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net book value"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/CorporateInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment",
        "label": "Property, plant and equipment recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r292",
      "r294"
     ]
    },
    "afya_PropertyPlantAndEquipments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PropertyPlantAndEquipments",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "As of December 31, 2024",
        "periodEndLabel": "As of December 31, 2025",
        "label": "PropertyPlantAndEquipments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProportionOfOwnershipInterestInJointVenture": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInJointVenture",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proportion percentage"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Total for all joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r74",
      "r142"
     ]
    },
    "ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestsHeldByNoncontrollingInterests",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Direct and indirect interest of subsidiary",
        "verboseLabel": "Ownership interest"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Total for all subsidiaries [member]; Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "afya_ProvisionForLegalProceedingsAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ProvisionForLegalProceedingsAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Provision for legal proceedings",
        "label": "ProvisionForLegalProceedingsAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ProvisionForProfitSharing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ProvisionForProfitSharing",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for profit sharing"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProvisionUsedOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProvisionUsedOtherProvisions",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments",
        "label": "Provision used, other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ifrs-full_Provisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Provisions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance as of beginning of the year",
        "periodEndLabel": "Balance as of ending of the year",
        "label": "Provisions [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities of uncertain timing or amount, including provisions for employee benefits."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "afya_PurchaseOfAcquisitionOfNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PurchaseOfAcquisitionOfNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of non-controlling interest",
        "label": "PurchaseOfAcquisitionOfNoncontrollingInterests"
       }
      }
     },
     "auth_ref": []
    },
    "afya_PurchaseOfIntangibleAssetClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "PurchaseOfIntangibleAssetClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of intangibles assets",
        "label": "PurchaseOfIntangibleAssetClassifiedAsInvestingActivities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of assets and subsidiaries, net of cash acquired",
        "label": "Purchase of other long-term assets, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of long-term assets that the entity does not separately disclose in the same statement or note, classified as investing activities. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of property and equipment",
        "label": "Purchase of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "afya_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quasar Telemedicina Desenvolvimentode Sistemas Computacionais Ltda Glic [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RVLEstevesGestaoImobiliariaSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RVLEstevesGestaoImobiliariaSAMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "R V L Esteves Gestao Imobiliaria S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RXPROSolucoesDeTecnologiaLtda.RXPROMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RXPROSolucoesDeTecnologiaLtda.RXPROMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RX PRO Solucoes de Tecnologia Ltda. (\u0093RX PRO\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r164",
      "r183",
      "r198",
      "r287",
      "r288",
      "r462"
     ]
    },
    "ifrs-full_RangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RangeDomain",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r164",
      "r183",
      "r198",
      "r287",
      "r288",
      "r462"
     ]
    },
    "afya_ReceivablesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ReceivablesGross",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails",
      "http://afya.com.br/role/TradeReceivablesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables, gross",
        "verboseLabel": "Trade receivable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RecognisedDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RecognisedDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognized deferred taxes"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RecognizedDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RecognizedDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognized deferred tax assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ReconciliationAdjustmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ReconciliationAdjustmentsAbstract",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation adjustments:"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RecoverableTaxesAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RecoverableTaxesAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Recoverable taxes",
        "label": "RecoverableTaxesAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r339",
      "r350",
      "r364",
      "r390"
     ]
    },
    "afya_RelatedPartiesAmountPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RelatedPartiesAmountPaid",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related parties amount paid"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RemainingTradeAndOtherPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RemainingTradeAndOtherPayablesToRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining accounts payable"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RemeasurementOfEarnOut": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RemeasurementOfEarnOut",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RemeasurementOfEarnouts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RemeasurementOfEarnouts",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remeasurement of contingent consideration"
       }
      }
     },
     "auth_ref": []
    },
    "afya_Remesurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "Remesurement",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remesurement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RepairsAndMaintenanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RepairsAndMaintenanceExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Maintenance",
        "label": "Repairs and maintenance expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of principal of loans and financing",
        "label": "Repayments of borrowings, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r278"
     ]
    },
    "afya_RepaymentsOfInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RepaymentsOfInterest",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments of interest",
        "label": "RepaymentsOfInterest"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RepurchaseOfOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RepurchaseOfOrdinaryShares",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repurchase of ordinary shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfSharebasedPayments",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation reserve"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity resulting from share-based payments."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "ifrs-full_ReserveOfSharebasedPaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfSharebasedPaymentsMember",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve of share-based payments [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from share-based payments."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r340",
      "r351",
      "r365",
      "r391"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r341",
      "r352",
      "r366",
      "r392"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r348",
      "r359",
      "r373",
      "r399"
     ]
    },
    "ifrs-full_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at the beginning of the year",
        "periodEndLabel": "Cash and cash equivalents at the end of the year",
        "label": "Restricted cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "afya_RestrictedSharesTransferredToExecutives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RestrictedSharesTransferredToExecutives",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock units transferred under the share-based compensation plan"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RestrictedStockUnits1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RestrictedStockUnits1Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RestrictedStockUnits2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RestrictedStockUnits2Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RestrictedStockUnits3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RestrictedStockUnits3Member",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RestrictedStockUnitsMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails3",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RetainedEarnings",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained earnings"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r258"
     ]
    },
    "ifrs-full_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained earnings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r254"
     ]
    },
    "ifrs-full_Revenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Revenue",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1",
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "verboseLabel": "Net revenue"
       }
      },
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r150",
      "r215",
      "r232",
      "r237",
      "r243",
      "r244",
      "r245",
      "r252",
      "r253",
      "r285"
     ]
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RevenueFromContractsWithCustomers",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue from contracts with customers",
        "label": "Revenue from contracts with customers [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166"
     ]
    },
    "afya_RightOfUseAssetsAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RightOfUseAssetsAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights-of-use assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RightofuseAsset",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Allowance for expected credit losses",
        "label": "RightofuseAsset"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4",
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "periodStartLabel": "Right-of-use assets, balance at beginning",
        "periodEndLabel": "Right-of-use assets, balance at ending"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r177"
     ]
    },
    "afya_RightofuseAssetsBusinessCombinations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RightofuseAssetsBusinessCombinations",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, business combinations"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RightofuseAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, current"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RightofuseAssetsInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, interest expense"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RightofuseAssetsNonCurrent",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, non-current"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsPaymentsOfInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RightofuseAssetsPaymentsOfInterest",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, payments of interest"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsPaymentsOfPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RightofuseAssetsPaymentsOfPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of use assets, payments of principal"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RightofuseAssetsRelatedPartyTransactions",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Right-of-use assets",
        "label": "RightofuseAssetsRelatedPartyTransactions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsRemeasurement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RightofuseAssetsRemeasurement",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, remeasurement"
       }
      }
     },
     "auth_ref": []
    },
    "afya_RightofuseAssetsWriteoff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "RightofuseAssetsWriteoff",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, Write-off"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RiskExposuresAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RiskExposuresAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk variables [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "ifrs-full_RiskExposuresDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RiskExposuresDomain",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the risk variables. It also represents the standard value for the 'Risk variables' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "afya_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "S E S S A Sociedadede Educacao Superiordo Semi Arido Ltda S E S S A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SalesAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SalesAndMarketingExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sales and marketing",
        "label": "Sales and marketing expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to the marketing and selling of goods or services."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "afya_ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of accounts payable to selling shareholders"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfAcquisitionOfUnidomExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfAcquisitionOfUnidomExplanatory",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of intangible assets acquired unidom"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of present assets and liabilities information for the company operating segments"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of deferred tax assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of changes in accounting policies and disclosures"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of changes in liabilities arising from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfEarningsPerShareTableExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfEarningsPerShareTableExplanatory",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of earnings per share"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfEstimatedUsefulLivesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfEstimatedUsefulLivesTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of estimated useful lives of the assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of estimated useful lives of intangible assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfExpensesByNatureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfExpensesByNatureTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of expenses by nature"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFairValueOfStockOptionsGrantsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfFairValueOfStockOptionsGrantsExplanatory",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of grants of stock options"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFairValuesFinancialInstrumentstTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfFairValuesFinancialInstrumentstTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair values of the company's financial instruments"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair values of the identifiable assets acquired and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of identifiable assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFairValuesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfFairValuesTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair value"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFinanceResultTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfFinanceResultTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinanceResultTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of finance result"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFinancialAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfFinancialAssetsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of financial assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfFinancialLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfFinancialLiabilitiesTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of financial liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfGrantsRestrictedStockUnitsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfGrantsRestrictedStockUnitsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of grants of RSUs"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfLeasesTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of right-of-use assets and lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfLegalProceedingsAndContingenciesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfLegalProceedingsAndContingenciesTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of legal proceedings and contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfLoansAndFinancingTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfLoansAndFinancingTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of loans and financing"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfMeasurementAndGainsAndLossesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfMeasurementAndGainsAndLossesTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of measurement and gains and losses"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair values for financial instruments"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfNetSalesRevenueExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfNetSalesRevenueExplanatory",
     "presentation": [
      "http://afya.com.br/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of net sales revenue"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfNonCashTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfNonCashTransactionsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of non-cash transactions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of reconciliation of income tax expense"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfRevenueBySegmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfRevenueBySegmentTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of revenue by segment"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfSharebasedCompensationPlanExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfSharebasedCompensationPlanExplanatory",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of movements in stock options"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of social security proceedings assessed by management"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfStockOptionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfStockOptionTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock option"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ScheduleOfTreasurySharesMovementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ScheduleOfTreasurySharesMovementExplanatory",
     "presentation": [
      "http://afya.com.br/role/EquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of number and movements in treasury shares"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SchuduleOfAssumptionsUsedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SchuduleOfAssumptionsUsedTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of assumptions"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SecondAnnualInstallmentsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SecondAnnualInstallmentsPayable",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second annual installment"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SecondSeriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SecondSeriesMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second Series [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r318"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "ifrs-full_SegmentConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SegmentConsolidationItemsAxis",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment consolidation items [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "ifrs-full_SegmentConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SegmentConsolidationItemsDomain",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r242"
     ]
    },
    "ifrs-full_SegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SegmentsAxis",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r167",
      "r236",
      "r262",
      "r291"
     ]
    },
    "ifrs-full_SegmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SegmentsDomain",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r167",
      "r242",
      "r262",
      "r291"
     ]
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Selling, general and administrative expenses",
        "label": "Selling, general and administrative expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling, general and administrative activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "afya_SellingGeneralAndAdministrativeExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SellingGeneralAndAdministrativeExpenses",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expenses"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SensitivityChangeInTheEuroExchangeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SensitivityChangeInTheEuroExchangeRate",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of sensitivity change in the Euro exchange rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "auth_ref": []
    },
    "afya_ShareBasedCompensationOfEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ShareBasedCompensationOfEmployees",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation of employees"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ShareBasedCompensationPlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ShareBasedCompensationPlansMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Plans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfIncomeAndOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share of profit of equity-accounted investee, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Total for all associates [member]; Investments accounted for using equity method; Total for all joint ventures [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r34",
      "r234",
      "r241"
     ]
    },
    "afya_ShareOfProfitOfEquityaccountedInvesteeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ShareOfProfitOfEquityaccountedInvesteeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share of profit of equity-accounted investee, net of tax",
        "label": "ShareOfProfitOfEquityaccountedInvesteeNetOfTax"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ShareOptionsMember",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share options [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share options."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "afya_SharePriceFairValueAtMeasurementDate": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SharePriceFairValueAtMeasurementDate",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price at the measurement date"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SharePriceFairValueAtMeasurementDateShareOptionsGranted",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price at the measurement date"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SharebasedPaymentsPolicyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SharebasedPaymentsPolicyExplanatory",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payments"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SharesBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SharesBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation",
        "label": "SharesBasedCompensation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShorttermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ShorttermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans and financing"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "afya_ShospMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ShospMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shosp [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_ShospTecnologiaDaInformacaoLtda.ShospMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ShospTecnologiaDaInformacaoLtda.ShospMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shosp Tecnologia da Informacao Ltda. (\u0093Shosp\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/CorporateInformationDetails",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsDetails1",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r75",
      "r155"
     ]
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesDomain",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/BusinessCombinationsDetails1",
      "http://afya.com.br/role/CorporateInformationDetails",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsDetails1",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r75",
      "r155"
     ]
    },
    "afya_SocialObligationsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SocialObligationsLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Social obligations liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade de Educacao, Cultura e Tecnologia da Amazonia S.A. - (\u0093FESAR\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Educacional e Cultural Sergipe DelRey Ltda. (\u0093DelRey\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Padrao de Educacao Superior Ltda. (\u0093UnifipMoc\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SociedadeUniversitariaRedentorS.A.UniRedentorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SociedadeUniversitariaRedentorS.A.UniRedentorMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Universitaria Redentor S.A. (\u0093UniRedentor\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SoftwareInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SoftwareInProgressMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software In Progress [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityAbstract",
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails5",
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r343",
      "r354",
      "r368",
      "r394"
     ]
    },
    "afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of assumptions for impairment test"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of maturity profile of financial liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of sensitivity foreign currency"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SummaryOfIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of intangible assets"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SummaryOfKeyManagementPersonnelCompensationTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of key management personnel compensation"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of income before income taxes"
       }
      }
     },
     "auth_ref": []
    },
    "afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of company\u2019s subsidiaries and associate"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "afya_TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Presumed profit income tax regime effect (ii)",
        "label": "TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax effect on loss from entities not subject to taxation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxExpenseOtherThanIncomeTaxExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TaxExpenseOtherThanIncomeTaxExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Tax expense other than income tax expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tax expense exclusive of income tax expense."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "afya_TaxExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TaxExpenses",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax expenses"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TaxExpensesIncomeAtApplicableTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TaxExpensesIncomeAtApplicableTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes at statutory rate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxRateEffectFromChangeInTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TaxRateEffectFromChangeInTaxRate",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "afya_TaxesAndSocialSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TaxesAndSocialSecurityMember",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes And Social Security [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TaxesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TaxesMember",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TaxesPayableAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TaxesPayableAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Taxes payable",
        "label": "TaxesPayableAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TeachingActivitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TeachingActivitiesMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Teaching Activities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TechnologybasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TechnologybasedIntangibleAssetsMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Technology-based intangible assets [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing assets based on technology. Such assets may include patented and unpatented technology, databases as well as trade secrets. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "afya_ThirdAnnualInstallmentsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "ThirdAnnualInstallmentsPayable",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third annual installment"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TimingOfRevenueRecognition": {
     "xbrltype": "stringItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TimingOfRevenueRecognition",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of revenue recognition"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TimingRevenueRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TimingRevenueRecognition",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Timing of revenue recognition",
        "label": "TimingRevenueRecognition"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TitleOfInitiallyAppliedIFRS": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TitleOfInitiallyAppliedIFRS",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Standard"
       }
      },
      "en": {
       "role": {
        "documentation": "The title of an initially applied IFRS. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsDetails2",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails1",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Top of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r164",
      "r183",
      "r198",
      "r287",
      "r288",
      "r462"
     ]
    },
    "afya_TotalReportableSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TotalReportableSegmentsMember",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Reportable Segments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "afya_TradeAndOtherCurrentPayableToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TradeAndOtherCurrentPayableToRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current liabilities",
        "label": "TradeAndOtherCurrentPayableToRelatedParties"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesToRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable to selling shareholders"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current payables due to related parties. [Refer: Total for all related parties [member]; Payables to related parties]"
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "afya_TradeAndOtherCurrentPayablesToRelatedParties1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TradeAndOtherCurrentPayablesToRelatedParties1",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current assets",
        "label": "TradeAndOtherCurrentPayablesToRelatedParties1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherPayablesRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/CorporateInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade payables",
        "label": "Trade and other payables recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "ifrs-full_TradeAndOtherPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherPayablesToRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable to selling shareholders",
        "label": "Accounts payable",
        "periodStartLabel": "Opening balance",
        "periodEndLabel": "Closing balance"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of payables due to related parties. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherPayablesToTradeSuppliers",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails1",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade payables",
        "label": "Trade payables [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "ifrs-full_TradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeReceivables",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails",
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables, net",
        "verboseLabel": "Trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount due from customers for goods and services sold."
       }
      }
     },
     "auth_ref": [
      "r256"
     ]
    },
    "afya_TradeReceivablesAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TradeReceivablesAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade receivables",
        "label": "TradeReceivablesAsOfAcquisitionDate"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TradeReceivablesRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TradeReceivablesRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade receivables",
        "label": "TradeReceivablesRelatedPartyTransactions"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "afya_TransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction costs"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TransactionPriceAllocatedToRemainingPerformanceObligations",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction price allocated to remaining performance obligations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [domain]]"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "afya_Transfer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "Transfer",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Transfer",
        "label": "Transfer [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TransferredAtPointInTime": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TransferredAtPointInTime",
     "crdr": "credit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transferred at a point in time"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TransferredOverTime": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TransferredOverTime",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transferred over time"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TravelExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TravelExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Travel expenses",
        "label": "Travel expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from travel."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "ifrs-full_TreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TreasuryShares",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury shares",
        "label": "Treasury shares [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r257"
     ]
    },
    "ifrs-full_TreasurySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TreasurySharesMember",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "afya_TreasurySharesRepurchase": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TreasurySharesRepurchase",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows",
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares repurchase"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/StatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares transferred to executives from exercise of stock options"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TuitionFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TuitionFeesMember",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tuition Fees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_TwoSeriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TwoSeriesMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Series [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfInterestRatesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfInterestRatesAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of interest rates [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "ifrs-full_TypesOfInterestRatesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfInterestRatesDomain",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "afya_TypesOfRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "TypesOfRiskMember",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types Of Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfRisksAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfRisksAxis",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r188",
      "r216",
      "r219",
      "r220",
      "r249"
     ]
    },
    "ifrs-full_TypesOfRisksDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfRisksDomain",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails10",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails8",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails9",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails1"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r188",
      "r216",
      "r219",
      "r220",
      "r249"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsDomain",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails",
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "afya_UEPCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UEPCMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "U E P C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UNIVACOPatrimonialLtdaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UNIVACOPatrimonialLtdaMember",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "U N I V A C O Patrimonial Ltda [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_USDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "USDMember",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "U S D [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UndergradMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UndergradMember",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Undergrad [member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UndergraduateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UndergraduateMember",
     "presentation": [
      "http://afya.com.br/role/RevenueDetails1",
      "http://afya.com.br/role/SegmentInformationDetails",
      "http://afya.com.br/role/SegmentInformationDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Undergraduate [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "afya_UniRedentorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UniRedentorMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uni Redentor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UniSLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UniSLMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uni SL [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uniao Educacional do Planalto Central S.A. (\u0093UEPC\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uniao Educacional do Vale do Aco S.A. - (\u0093UNIVACO\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UnidomMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UnidomMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unidom [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UnidomParticipacoesS.A.UnidomMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UnidomParticipacoesS.A.UnidomMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unidom Participacoes S.A. (\u0093Unidom\u0094) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UnifipMocMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UnifipMocMember",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unifip Moc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UnigranrioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UnigranrioMember",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetails5",
      "http://afya.com.br/role/FinancialAssetsAndLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unigranrio [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_UnrecognizedDeferredTaxesAssetsOnTaxLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "UnrecognizedDeferredTaxesAssetsOnTaxLosses",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized deferred taxes assets on tax losses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UnusedProvisionReversedOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UnusedProvisionReversedOtherProvisions",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/LegalProceedingsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Reversals",
        "label": "Unused provision reversed, other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount reversed for unused other provisions. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated useful lives of intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Useful lives of assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "ifrs-full_UtilitiesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UtilitiesExpense",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/CostsAndExpensesByNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Utilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from purchased utilities."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "ifrs-full_ValuationTechniquesUsedInFairValueMeasurementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ValuationTechniquesUsedInFairValueMeasurementAxis",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation techniques used in fair value measurement [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ifrs-full_ValuationTechniquesUsedInFairValueMeasurementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ValuationTechniquesUsedInFairValueMeasurementDomain",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails2"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for valuation techniques used by the entity to measure fair value. It also represents the standard value for the 'Valuation techniques used in fair value measurement' axis if no other member is used. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ifrs-full_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "VehiclesMember",
     "presentation": [
      "http://afya.com.br/role/MaterialAccountingPoliciesDetails3",
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vehicles [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "afya_WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average exercise price, Exercised",
        "label": "WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, Exercisable"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, Exercised"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, Expired"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, Forfeited"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, Granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price, Outstanding at the beginning",
        "periodEndLabel": "Weighted average exercise price, Outstanding at the ending",
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r191",
      "r196"
     ]
    },
    "afya_WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://afya.com.br/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Average price, at beginning balance",
        "periodEndLabel": "Average price, at ending balance",
        "label": "WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019"
       }
      }
     },
     "auth_ref": []
    },
    "afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average fair value at the measurement date"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair values at grant date"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageShares",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of outstanding shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "afya_WithAndWithoutMethodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "WithAndWithoutMethodMember",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "With And Without Method [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "afya_WritOffOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "WritOffOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Write-off (i)"
       }
      }
     },
     "auth_ref": []
    },
    "afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable",
     "crdr": "debit",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Write-offs"
       }
      }
     },
     "auth_ref": []
    },
    "afya_WriteoffOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "WriteoffOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsDetails",
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Write-off of intangible assets",
        "verboseLabel": "Write-off"
       }
      }
     },
     "auth_ref": []
    },
    "afya_WriteoffOfPropertyAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://afya.com.br/20251231",
     "localname": "WriteoffOfPropertyAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://afya.com.br/role/StatementOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://afya.com.br/role/StatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Write-off of property and equipment"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "107",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_107&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "l",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_l&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "n",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_n&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_q&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "r",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_r&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "61",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_61_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81B_a_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2024-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2024-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2024-03-27"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2024-03-27"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "138",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "142",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2024-01-01",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "18A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_18A&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "19",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_19_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2024-03-27"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2024-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2024-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2024-03-27"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "34",
   "IssueDate": "2024-01-01",
   "Paragraph": "16A",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=34&code=ifrs-tx-2024-en-r&anchor=para_16A_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "130",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "130",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_130_f_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_d_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "d",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_d_v&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "iiA",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_e_iiA&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_e_v&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "135",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_135_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "135",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_135_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "84",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_84_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "84",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_84_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "84",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_84_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "84",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_84_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "84",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "86",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_86&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "88",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_88&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_122_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2024-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "40",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_40_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44B_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44B_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44B",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44B_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44H_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRIC",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRIC&num=17&code=ifrs-tx-2024-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "10",
   "IssueDate": "2024-01-01",
   "Paragraph": "22",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2024-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_12_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "12",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_12_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "12",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_12_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "19B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_19B_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "21",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_21_a_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B4",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B4",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "h",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_h_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2024-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "114",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "120",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_120_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "C32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2024-03-27"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_v&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_j&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "m",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "o",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_o_ii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "q",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_q_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B67&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS03_g59-63_TI",
   "URIDate": "2024-03-27"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "21C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "8",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B2",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B2_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "Defined terms",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI",
   "URIDate": "2024-03-27"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI",
   "URIDate": "2024-03-27"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI",
   "URIDate": "2024-03-27"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2024-01-01",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2024-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2024-01-01",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2024-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2025-01-01",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2024-01-01",
   "Paragraph": "A19",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_A19_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "12A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_12A_c&doctype=Standard&book=b",
   "URIDate": "2024-03-27"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b",
   "URIDate": "2024-03-27"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2024-01-01",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2024-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2024-03-27"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Section": "Example 12 Calculation and presentation of basic and diluted earnings per share (comprehensive example)",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS33_ex12_TI",
   "URIDate": "2024-03-27"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "87",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_87&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "88",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_88&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Section": "Example 10 A court case",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex10_TI",
   "URIDate": "2024-03-27"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "14",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_14_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "14",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_14_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44B&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI",
   "URIDate": "2024-03-27"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI",
   "URIDate": "2024-03-27"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_B11_c&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2024-03-27"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "IE72",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_IE72&doctype=Illustrative%20Examples",
   "URIDate": "2024-03-27"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B35",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B35",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35_c&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B35",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B35",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35_f&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG20B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG20B&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG20C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG20C&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 6-K",
   "Section": "General Instruction",
   "Subsection": "B"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "Instruction",
   "Paragraph": "2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "a"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r429": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r430": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r431": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r432": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r433": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r434": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r435": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r436": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r437": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r438": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r439": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r440": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r441": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r442": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r443": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r444": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r445": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r446": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "84",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r447": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r448": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r449": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r450": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r451": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r452": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r453": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r454": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r455": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r456": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r457": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r458": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r459": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "h",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_h_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r460": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r461": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "39",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r462": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r463": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2024-03-27"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>162
<FILENAME>0001292814-26-002013-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001292814-26-002013-xbrl.zip
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M 4=)$*O+U?R3 P_&ICHK8<1D$4/-U^S=A(/&"KW@8MM6?G"H=6/GG.8?Q:*
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MW]\L>?PP\-B?QX_N/'YTX=$PUKCS^''@L3^/G]QY_.3"HV'%<>?QT\#C$8:
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M/B:,_H:9?S 7F1S"AN\GN():RSZR$ @5\?#WQ<-<#-W"='J%M>%(IE9!=\D
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M6)GMJA-@G0A8ZG_G>UM,U^OY>L'$2RIQY4FS'%RK%%3B2L7+L"OIIMB$9I&
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M4"M ]DTWIMU$H0(5)A/B9Q$S5O02*P_@J6:5!AFHT.034;E5;AXJG.3 &B6
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M3XLPU,4)$R^=W.-8>R>D5>I'P%=Y(\3R_4? P(>M)"06$$4"6!0KPF>-C6A
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MQ"YF04L"@#G]E]/(V^(=XO_\_U!+ P04    " #<BW]<+99U>@09  !-9 $
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M=/%4,06Y355R\]3"I95&PRJ(.?BN/LT&5G+E%P]QV?]F/D'T+_\'4$L#!!0
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M87J^#0WX0@F6VM@?]<;@!$!LKD-Z24FR764T48OL8T+XB@_!YO$3?N>19U'
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M+1W,DSGZ_7[T8S <2_'6&:*[9[1.PU6;1PB_VD]L0>MX\CBXW\^Z:WS#]9"
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M"/YF2O$T/0,NRA@"_3_'PI#T[:S"C_(B+86W@B/7=N[+$\"5])U]=!/=*I9
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MHNMK(P8DGN4!],O5C2:IR?Q21^:7[F8D $R $_V\6;%_T!'[AQW%+L_U(R9
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MEW;B;$44Z=K,-FR]T&(=ET&!8(>" ?E:-3)D\FU= *>49O>6C6*XIMC:!8P
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M9*^= "W,$NAC-OSN]XT7SQ-S3Y1#J\I@*V]L01J;-@05W$#2_VCA2GK$\U5
M?;K</*&PSA:J-( %R7/UUYDZAZ#?OZEEA_P)W]87E#VKK;Q\>PLRX4Y;?*4,
M@9Y^PS <2%=(7TL?*H Z6)"W5@N("HX@)+X81B*)OTI%GVDQ^^JFK/,L0,+]
M:EBX._U"<9)#S6?G'QT]ZBLX FW=CS8>^'T])#=B'ZV72+(Q0[POD=272-(%
MW/)HAPV3PKTX2%\B2:U$DH6;>%\BJ9T2219"+]%^Y.G%8+?9>>O(ULH8KF(
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M/Y2%>L^U0[V'6.^'?\OPVCX_'\OXN:@?NO[8AZYU0M=3L@S(@LQ1$(V"%ZX
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M"U1:+9\'HIK +<,X>UOKE)F@.)Y[<T&+,6@V&,YIV,W/.[+ 7*N(Z/S/+37
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MP1+GY+B=1^+_GE"(^6_^?U!+ P04    " #<BW]<64'_^9O+  "'P0L %0
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MKEQ:K-?DD+&S+,L29@G,D^(+22GFM[I<8+HQ?]G"L0YW^<142W'0_ECX0J?
M[8&^P9;1G4W0&@655?!V]J[C@7Q%^0-]<<^P0(MMCM#4_F&J)7]K?4>YVJT
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M:IYWOU@Y,=KRHM6)B(E60(7-+:T2FY=J+K[?5WHS[V>Y?KC4;&CI_>IO1XL
MJ=O2TOX4_)/+\8B;6J[! [B<?2GTX^V7ZP=8YH?T&;[[\2\DA\5=F4#-@JA!
MP]^RJ!7T;G%4*QX'*ZPP"@NEX".X!5\87VI-\.Y'P'4!4YZ;0E=HGZ,UYFNU
MCWC[7)+-H:A/:ZII9*/EC4KV+K1T,JO$02EKG&-:]15!IPD6]9+'O*2Z0[!
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M36IWH([^Y:><%,7(BGY7VEP/]+V?;=X7-]X)-\_3(FIL,[LH[KZK! 'DDF\
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MJG>-F%TI";5FH!H2)E<4Q2-4:A&QUA:KIES$IF5OVKLO+OHJ$5*'IX5;LX5
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M*KF@KV_^3(J]YF/W?_;WE450W>?M?HODNPJ A _*)&:?8TC1[@I^1 E>TTQ
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MSP@0KL_N9V1_NZ1!$&8QCR+9U!O)2OK*Z/.VMUF)Z,LVE!*3RON? =7 %N=
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MAEDO6.(7=/V-S::J^QJCGF<NV;DQXI=>*;[H9 =8F"6O3B>\ =M*G2?5<&
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MW2E6I9:YZM^K?YBY.L)_Y+A$9+/AI6AHPL$O7F$CO_U.42'!I.&M_[>#WJ8
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MKS$J'G*ROL,9NBW13K;28:7EBQL.+C2$L5")@D7V.,?4JC7;^>]&%\ L <P
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M_(UI:;)74E_NJVT*/^70I6:9O960(UE+%W6#6(.)V)CMB%O'X"W7J0HI44N
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M].2TIY@O(1/2GK3>Q$W>=>(VK^KRI"H1Y=Z&O^=@,[O7OP=S;""X.)Z#6@@
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M[P"618=E&N*R2.-8MONU.J8I /1>%A3<)D,NGWMX>'EY/&8I21Z+V>O'H;F
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M%6'($AUK\W'K&?PEZ+8!WF?LUE'C$!<;B%::I1PRKG56F BT46P,#/[."S;
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MO)G4*GB=+3TE"#[;.E3BX8F211?1/T74!HC>*.%:V5>HA0=P9%C[W_QE49G
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M*GZ(!A]I5_=[2 ?;^NL'\(=#IQQ](Y_G!UAVW9@\O=(SX11[.]#"RRO&)1R
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MO_ ME,)@"_J< "[T9=N<[R A?X7/.W#;[^$UBF<,VYGWX'8?>Z?&L7L/Y]Y
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MK=8^6ZK@X:J9"-@;Z.JQ>#@=CUE*4=\4Y<]%D527>?) RI=TJXD5L&7WG;7
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M4 $=ZXLI5?"MR AM*CD=&6*AN2?'."W!^?PEAMR$.11\, F0GLEW=)*Y ]/
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M@LF_C6KJ@&BBJCAPB),M3+6!FK2,:WE-2I*D]75<)M?/<;E7.$Y$(G^^$Q7
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MV@X:6EM1GBV?<UORKSS/D]AYS> 0W;.PJU7K#HLTMR9*-;91=-:,0.K=OE2
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MM.W:9&D:VU:CN&LV7#P8-1%NLN*U@I*RD(.6:BY; ;#C137ECI"%FQDPJ';
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M>,Q24BKFR8H5U9RY(9:G$^R2""+8KH2D>,+&)% @F \#,&/F/S3;BC$"1,.
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MV#-4A C&W Z?D)Q&P1 NOI] IIWKXG!(V1KDY:GD4B^G13 7UA"%('Y"6(K
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M)(;>E +!6!N "<;=E%(RTL-_^DS_1/^Y_2?Z'WAZ3O_E_P-02P,$%     @
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M^W>*7X((52<,'CB54("K!UD#4(U!"3$EYSY#EK,I+A2(]]81'_ISA-28R4C
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M\(Z+7\]F-"5<6_G!X7/,MYS<(_X))4M:];+MP>W>XE<\J$-OJE+M"]GC7>#
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M6SR"VPEBF>-1-:D51![4BC?=G[4B\'BEOL%1FARN84$!5))Y4!/>%$* &"I
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M4K=;5Z:S"1#'LZT=OGV98[N%8S";B2=^"Q>LJF;:.^GI-=C37ZUW'5C17_F
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MQ-OIB'/(=_S*^?;;Z7S+B*Y8@<JSG>.R>Q[OGAE@.T8*:-?804%=G=TN:B#
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MCQ9!E%7L1>)-9#'!AS0KBX"(I';'VU*:2=8)M[7WO>1W&8_ZL1-9T(P>'F
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M@%]?6B[7"\GAHE0B#@:VH(61.JOP!4<6SHQ[&+M8]@L)#\W7?GAGSLJ&-=D
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M_J7>9:H:NK\8UD34<M8]7J/N41"C)8W"T6K-Z M2FP=[.B49$$:+1<X:KU,
ML7@,ZCE<\:MY,+[<[[O<[_/O?I_%I>YROZ_1_3Z+]1K/]'[?YQCQ?^_Q?!>3
M#@?Q1%1M#<?S*5XAZ<*MPJ]!ISV*E38670_"G.^JPISOZH4YWUW"G+;"G".N
M#F2!N2F5A]G_P,ERQ-5@C@E.T$%1C:*>AIV>8Q#44 27F*CAL:"6WO8]1 IE
M6G?D,^OG[."O*0>/8ZA01O1'3=.>?%&..E.CMC[X?Z8=IC$_Z6VO3(L$TF/&
M] <I8 ?NX[#U5+\<4#<1F*WW];9C>"S><Q\G2\2&5%S@53O2P=3N([?-,#-B
MUOMC=/XZ&&*[9[$!4U-"X3ZTV]9<5(K$8RRO64#"AV %"<R7V[H/Z[:$GTP,
MM@IFB,=,A)"&E"0BI"-J,](U"K-+%.(5QBS+8]<J>[XA$4_C*I?3QKVZ#V(V
M7V9;$JW'4_8<0F3M'(8N$;-+Q,R_B)G%W>X2,6L4,;.8Z/2=1LQ.U_'L/#-=
M!N0CI>%7'$5-(F> SL\H@@8690\B:>^K(FGOZT72WE\B:6W.Z+W&%HH)BF!M
MLM'&R[2DYQ(5TS)ZB7U!'OV$:5K_(UPXX6H6;0;K=811.+I[?(KUX2PI44_A
M@[#F=3BJ8M20V)."S!<DM1H*P]!NK:4!5[4PRU6>TM'@Z8VZ"HJTM0_1':TF
M%9<\#=^V[CH$L[]$S>U9-K.W=5?-(##KPH<(CA$N=21D*\AV5&ED0,*CNGO[
MHB,CPLV:-!O=T3@YGQ\XD?CW5W4XKOWO^!#@,8+=FJPMZ<: D)0/IW#5(Q_%
MP>KE^S@) Q;&7VC$1_Q:L[#6[\^]>\QTZ6TJ.UO%O^E7Q"8IXTM/C 8+AE"#
M25VW,_<N-4,TFTG-UN5-_J77OTV*LB/AX8PZ(OL596]NJU,FFG3H0WC/"-+F
MTO/8M3H5KC$1"2N+1.G\5I'UR!T*8-]C\(Y>^G@(DBRHN7O:Z,3CM%'!:=A1
M;Y_W@<JH!\[MAX Q_J&7@PNDX.3^I9Z3>]_GQ=EMZ]K(%*W65-QRO\'S.>*Z
M/D.?21JC<!I\$_48L\H.^]\,&0JQX5L/3;YP+J[SMN1Q\; ;9M0T5^^^.^)K
M24#GJ&_0Z7EK21L2\C@>4(LK?;R@4;>^*%3CB=:.#MF-1TP87;!@-9X_T=SA
MEZ %RT2M=K=HR=Q'*%K0[9.7VT"2LN4=IR1A^#G=%N:>+M'6*T 6NR$]H5G*
M<+)1>[_-^W$?U&@9RMJR]/BHSM4S3//:[D^(O> 9TF[Z4A)?5F#+6[J4?X^S
MK"O&K-^.%42^0*U17PAV=C?**<H*DRX&LP2_X 1K[OS)F[O?&+4Z5%PK=7Q;
MVNX>Q$LK1A)74K@/T!H)'<"]QUO1N::*6=Z.]!EE;SW<D"X998XSRL9L$1#\
M7[L7>VYG E,\&U)1J6H?3<RO!VJKZ];MK'=A]&92\WCQS=B?B86&KSN/0:)T
MZU<T[E%L5<JJS_"\</5:H%N^:8B-'022C*1/45(-W_:<)C&-<"@*ASSRR4Q2
M) N"5#=UYOJ BU@^>*NB_80)7J4KN?YFCSF<-')FAIN)LYHWCU>58<H$]\+V
MQ'D.+S\O;'^I6EK4=,XR'6NL+Q )N$^Z>$(+P<Z(B$H,68?;S(BJ'(M?3W,L
MMM17^$"^3ZVHEU!A424?:)*=@;+[G;LG*"G;%'A7Y&3L^S'JQK=I63PPCG.[
MDBRV*)KE7,BH?3DIU4!;F5,AX_>2+V'HIU"K7=]S(;9,'<P?+NELV#IODX:P
MOTA".?0X)T$Z<KU724OJ"[ @Q85CZG]AFI+VZNN?2$G<1U" *EH"4",%CT\8
MNP$#%]:S6T?]CPSO!@I>)7U=%$%KH&6G^F=^IF,+%H0I-XB4'O/*EMZL4 H/
MN()%BRE,F*1\ZNWK$FI3E23MW:<DZ06L9=>69PZ%>!9$$W'8PC/T1*,LT4GS
MI*R&R'T 72]P&..6I#ZE21 ]HC5EB=A/M&9.EENAIG%_TU@O<Q#;MLK+1GB%
M26Y\$5&5./_X=1 %9*;)%@'2NH]KZB$P$H/')F9>#TX9"=NVZ%.,\H@ICZ6_
M]97K03AIV*<@9"6/!4SXV.?BH8'P/N=;.L)L>"^(/=,896W]P_.!DAD4TG+;
M'L0]%:,_:V#SXF0#$A8"72IPJ]OW(!*KX: O*RH0IJK6/0S JB$ZIWEX6':
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MBW< C83B\>)0&''(1WP78/8EB%(TGF<U$T7M:!QN;Z5-64#B7*U5<-?N$JH
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M)6L^( _<]]1Y9-+6X'BSE^ I6?-^R=V.U&3^24F@.'KN#]&(I =>$&U*IXH
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MVW.IM=)\II[_M[QZA1BP*(_;NH\6#[$B93SPV)P^H4V$*2?\:\1\7T0B,D<
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M [:\#T,*U,8+L8X_L6NV=MAMU,;S?2U[O[5IDB$E8,TL2S0WNB8=(Y'YZN9
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ML.H+_BV5O#?-E*6TLT/GUQ2WVFMC1B_&:N>Z/_"CZC"99 8X3[>1 .>A( '
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M0'9?8AX(L9X]/UR ['PQ:"%$=CY'#('LNL2TR#Z[GC\F0'9<7BH(LYY=="Y
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MQ(!*#+$YY*M0JB9=H0>5%%!) 6P(9@-40D E!# "*AF@D@&X$P-WH!(!*A&
M'2OL@$H"J"0 5@2/&5 ) )4 P)VWC"B0R8=,/G #,O&0B0=VA&('9-(ADUX,
M_'LU);5%34D-LN.0'1>:%RL5)K4#*DQJ25=H[6(39-<ANPYLBHM-D)V'[#PP
M*DY&078?LOO O8RX!]4!4!T [(J575!= -4%P*KDQBRH3H#J!.!>EB,:5#=
M=0-P*U9N074$5$< NY)B%U170'4%\&=O31)48D EAM@<\E4HU9*NT(-*"JBD
M #8$LP$J(: 2 A@!E0Q0R0#<B8$[4(D E0C CA5V0"4!5!( *X+'#*@$@$H
MX,Y;1A3(Y$,F'[@!F7C(Q ,[0K$#,NF022\&_KV:DOJBIJ0.V7'(C@O-BY4*
MD_H!%2;UI"NT=K$)LNN070<VQ<4FR,Y#=AX8%2>C(+L/V7W@7D;<@^H J X
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MP\Q/MBR>WH6(&0IPAF/Q-"](S%#4TPJ+!PB18X;"G,M70%B(%#,4XP2ZHH!
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MXT^ #R&.W5O3=/PVH<Q>4*XL/E47\8F)8<T*J'-?O[.<23"E1)U),/4E.I,
M?&2&C]7Y@U_32<P?2E4WSN!^6LP>&QJ>MM M5FEG=51 Y6\30(;S":ZF2%;"
M4VAR5@(0(Q9B?'9C3?>)V(T:_6?Q:1'S;B)3)48/T6=+D>N(B('-[F=I,VH^
M#(2U&37?#"41FP%H$00MJ_;"K_=$*F?.3JHE]]/Y2:GLBU)+LEEC] AU)OLQ
MKE?$,+5$K8@Y]^7+TCC_HNF8)M9'KWUB?9<!*L/7&4^8TNYL;$"^V=?L\N9I
M;T@/>I:JDC;$.4B@<5A%L;F*PI73M_9]7V*HS/O3T?^8D-&DHX\-<\H+8CI6
MBU@S#;UBU<707"(?J$3V8D86P*8R%.U;Z@5%%"*4VPANK@ I@I3;I+W\"W2>
MO<ZS6P8,!30P)NP>$P AQ1D+0-=%' .@7 I&@%TC ."C*/8?-"V?]=_.:2B'
M*PJG0=-%X304KXE3O);ZUJZ@>V%TGS;O>056L>O/!"@_2YOQH'41M)Y=U :*
M#B%NLS>;"P@IR&@ NI9Q# CP]4<CPZ$RZ:%7]*#AH3' FD;TQ\$$F7AB:*HD
M+D%30Y;%"KO<[98(TFX(>B :6=N:*;P\9 5(%0"2:X!4DP9(!0"2:X!4LCLU
M#*"2 Z@(/#=9+IXKS[>=!H#E&V"U P!62QI@U07 P!O*.\"J!P"LFG)T!6"5
M!UBE&9)9 \B-@72KH:N>W/3'(J$AH/.RJKX&JA=4]>DG8ZU)^Q^'/"&-Q2W+
M;B]]2T"O-0/95"I\0W%LV7TZ2FU<Y/]1FK6B&_AIT+_MU:S>-N'M14ZT=GBK
M1?TBWE@U&JRD9!JS=>GJ=A!(9T+W12" 4< H:1@E<* FDA<+]$O>(0(2RCRL
M ;& 6+(1*_^C6U??I!CP,"H/%U($*L(8!_0">DE'K]R-=&'2,\#.A/)>0-C,
M"2O$> @D!!(6F812CIK#9P,(FP1A%X(%PL*H"20$$A:4A */F@?F[KU?._K(
MQ,C"5\@B5L\@] H@<502IY+A[YG&@_ORU^ZXA<?(T6Q?&P(5"48#C$;R1@.F
MS/+8#9BE@^EXPU:VAHG)HSX_]*/],C,LATIS@_FR'<3"^K'HK7]GRYT"21'6
M<'#0@9">V\@U3186T3OE 8 6'] M#(!>W7L> "TTH ./]+RA+S"'$Z13I_4O
MC,P-"-\0ZF"K5 :R8/@6V8Y)V[N.G>V22!&\6R0M79P\- X;NGIGV(MOAQ,3
M\^\WW>#" G2/B "Y*2-WJ8 US5R3)\!N1"$!>E-&+X#T V Q8RS*!C30=, !
M\S#K@%G'!@Y3VX,69ATPZY &N3#K@%E'?M$+((591]98E UHH.D(^]F5+\]K
MEZ5:I9QOG?OKHTQBT>ZQ%.:BKXV139Z*NLG=@;N8 " R $1^4JBAS$J]"B@J
MR+:I/H>"54+X)%= <^*[<:LPBC/& "P$A45^1AJ D* 0$F)E:8N*ARI'G:^
M+" FW!+$K7( B[+#=P7HB *=-!W6*LQ^<S!O2>XXO7V'60$@Q &$P$=6K5D3
M<%+%=U(SL"D "T%A(;!EV3= @=LJBMLJ,(BV'QH,OHTXODV:1P,''JP)@! '
M$.(?GUD!KT9LKR9;FP*P$!06 EN6?0,4.+M".KM"@B@P1\0WP[RB+%2;QG1&
M%8)LJI*>1H=\&?#4PF.B8_4*Z_2#S;OE0\[>SD..*-2T&T D)(C$FG;O&\X
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MJ=UV^'[IZ-?X]H_^98W$"5_;=-;1>[D-O?X&>J ]"P/:QMW=?>-&Z;=[W7X
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M>M/Y9AV?3K[JIBTGHC(A<?-J32/I.)+)PII<9!V"C/G%!KB%=55-Z=Z[)''
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M(#W,86;\@X.I!AR5BI2RD?@ZXFQ<JIHB_1%*?<AC?'=Z<E:XVR]6<TI&'S#
M3S)(?I_^N\SL>PS,7Y6 LS?3IHM/_O3YX\\?3F\GP/F( #OS0(Z)1: Q4!%I
M$C0) AO*7&+ ZTTMN15MKB40!#X #;*3-/Z*S-&OO;-8N5Q&O0PMT[K[T_%-
M>E"".0-CS%RF3F2Y([O!T/_T(UQ ?LU9H4I,6T.\&N-;K"KZ$HE>/DBT9V-9
MC%\K?0 ZW&I._9'?2\LWVR'EM%RQZ;RN)I=2- GOM[?^_GC"]FQ:KWKI2V+^
M(<_1C&RM:=K[_;EY?SBU(\@'V222<W?_E1MR"]KZGRY%SU0FD@0*IY+!_1)P
M$31ZAWQ1M5J;PMW<;\8M-F,:,0 2P(*ON%)G4[U'9%DL8I!7*_+7Z**$FTY[
MH/\DIYS#LOV$SR2_K,HY/75";I8'R/+^7<R;<WB@]QOUS5H-@:\:2.5R31?/
MQ&7HX<#BOY:T '8=WB_P-R_P G& TNK7)B5+>OY?=!Y49>'[]VK_-P@PC*TJ
MJ/7-I!<H,,.(0WWW"WR[>Y4<O8D")#0DR=8+W9E<;IKXD^64!]V9ZB!A7C0&
MV9G- CP2BH0^PPX59!NU5XA<ZK9QBMW=(9GDY?&I!C;9HF[:^R/R;7X. Z\6
M%0AR%ESC*#L4JQ.X2#BQ:&D_.7=3A.7WT;CELF&T%]JGTPW?+!ENP8$!?>W]
M#OTZVY7O! Y?@S&D62ZK>2CA=CL@-[.L>/CB_9K?[N*8"&^!>@4:]B2M@_5'
MGO=\74UQ:]ROY^UDV,K9NIB"&N5+N%_/F]<3M!L3IK%2DV6YX;(:@!33<)3D
MTKSA: %$*8_QX<5K6F :#NGF]F+<_-D+67IY#UGZ[9"EI_>0I3\,9.E>9^VP
M-,F40; 3,<VV/M^$^U6B.-&+F#3=?2#AUO8*T.IU*+,6D]P6'= '%_"<E]<,
MF$ZSNDA"*<Q)DE4*GD&-V6HUW]Z'.&^=6]5,CZ7X')JGR%=T\_$ "WA:4J,%
M"/'2@=+27)"ESCTJOP+:H11H'F>2%.B4U,%D(<=8+:_JMM%PMWH*BW+2-J-5
ME_&5PQ?%$IJ5D=!QD'9N\"DIL+@D=8@'?9RL&S)-LL/'AR^2VD;&M/.!YVI]
M)A^XKA@O!(^_2J,Q-NBZ#<-9)L&;>[&\G1E><0*ZL]ULEA>-J-KE;%Y/A+'A
M9-.2$@YR\KZ>3FD53\INK0%?J1(F_=UN5DE98U_P=TEUYD3LKU#V5N=T'Z3_
MQCV=S3=(F82#:VX6M,5L'GW7'KE FA7YMK-XORVWN)%Y-0W(Q[=IA(,*K>$8
MOA.,Q?44X1NM?1RB/>]7_UL477T5RO>X5 M039HG&>E\%>(NGEB1''G(DVJZ
M:=.8M> AM%)<8Q8Y3"FW@X&0A''-]QMTJPU*CTBL,!PB<HV!\;8XVZ3(XF!T
M.[Y_K<>GMN$L=LWJ\JKJ>%K 4D]*=G&X^DMI1#@DVT,W>Y(:*X\(I:6^/,+5
M*"B6:&\!J+%[XM6[L-EYQ&9G#IM](PQ;"#_ \,2$5WVVB9O8/_P^^3,'!Z;9
MK#-&;H=:W^317;7&N-:73EXNJY)_[H';SP_RC\&AQ$)$0LK/U55=,5(^M\V+
M<F4(\0[V)KV'=B%+U+G0QM#>=EI_*2O)J9*#_)2\W)JK.I4Q"'M3C%7F=MUF
MH494J:7?QCNY>]V+;-ML<BG58$%9S4N2!EJ*C=8V,UO1DH5MW_8=30."3,3'
MV%(@&]'_FU:TE/7"I$1BB.4Z,SG5&F7ZIE0(L*>H2U3.NT;7:4R8M**B5V&\
MOVX*KZ17-*C6OF-&K]T5""0P)7B8YEMEN@1D#\13\N\;A)W!1 QEQ618AM?E
MUTI,L7.2G0#]VJRF4@&/+7!BA21I0NK9FH+P"!LPV'(J:%Z!V3>RQBS!<WI5
M=^:S:7%Q0MW&L5OY^0S^70[#O[4M Z2P;B>;A4#3)+(<O\LZ?J(,7<RNL%G&
MTJ:I/N5NJ,I<A[7#FSJL[>F/)AW6GM_486WW%[3#VN[V9]IA[>7.+VB'M=U?
MT YK.Z=I'=8B91N:J&9/2$>]/?GPY?3+_\X_OLO?GGX^.?[R\?-9D9^=?#C]
M^#E_?_3AZ$=N:YL??7B;'[W]V^G9R>>S.SMM'U -&/#+=RX6._OJF5CLV501
MBQ<WB<7N+ZA8[-XS%8M7-XG%[B^H6.QN'RAB\>)Q*A:'=%V^>W?RF9L:GYY]
M.3T^X^T_^5^?2#Y.WN9?3M^??#EZ\]>3/XH@[#S^)@A[ME$$84_W0Q&$W5]0
M0=C3Y)$%X=GN%HTB"'N^H(*P6\NI(#Q)!0$%;R?_.S_]\.[CY_='W[7_XHZ-
MV'G@;"/V+*-LQ!XE*1NQ^PNZ$7ON MF(W9I<USG.XNA <D>W^;\@=&JOJNE=
MK_%.6;8UWK-"LL9[-(ZL\>XOZ!KO4:RRQGNN,A'VW5_03=A]9%78QP_<9/5_
M)$CV?WZ(Z_#F&[;Q.,&,,./9J8.*_%%4YLZ#:%*T1P98BG[8HZY8BO9\0:5H
MCU86*=IS\XD4[?Z"2M&>MK<B15%;''_360?S9)<9O^Q'=L A*S]W[#M\0ARJ
MFO[.XK(7V_'J'MOQV[$=S^ZQ'7\8;,>=Z=:=%[#JUJ=[-*/HUCTFBNC6/=ZH
MZ-8]AI;HUCW&I.C6/4W)1;?N<7A%MT8K(7O[+<K5Q8COZAJT(>ZQ,L@$>?'*
M;=799@':?W"#W3S"[]&28*DQ:*WOYBS&,?J,Y4<I]P=(#)7L ]W0NNJ*$[@:
MKXPA68D.>F[>I'3"TQ86(U]VR<;Q)Z6#RV1P$EZ>-?-Y<XWOSNN.;A=>R_J?
MH&MK%E7D^2CG\R+2Y/%K#O)/$O<"8_L($?%>X@_L5-;+-^#2+O-% S+^RT9X
MA*=5-VGKE2L*[BJ'9Y*!C&\U6XN3;Y?)_-7!T^>^E_UG7M3/;E$1O7SCM\<(
M/.^91$824O]1@W-PAB!Z1V.H9^!<7<?Z["@MS/7?N6+IM(Z7:U60 )@EY2C*
M>PW6<0F4UC.$?V<E'8I8FI15S #-D?3"HO#@D>SQ!%FU!8UE1B*DB']\&<R$
M*++IT,% LLWP*K5WAU5 <7;!J'.T:E(RH,S/FZV:;OVH XAC"JWEZ]!C8;C7
M#L/RY*3X79+9BX9>/6\"1_C>)9IN*N@CCG;C$$6Z Z9&:Y%#B:6?Z'A0[%S6
MF NVGGV1BFDTQY[R.T4*_- KP.7+PBJ/)QKOCUGOF!T'2*(DQC9S6&G_V$QK
M;5-&"[M"Y8H*63E=""$XEY,!^*XY"V[E/2^W_*]NTZVJI1U+0[2ORJWD,K1A
M!.OK#!0A@L;HG1011Z/0BC5E)BW<:_#_N5V.S5]>/'W^^/&K5WWC[E>)P2D?
M5-9M$(/S:EG-:CF'UDP2>%3IV\?['9JLQ(2O4+)8:4/_:(\17#A8398>>=6>
M_F /%.E!#@GX>V5?)K472[%"0X5T5%(YA'EB=+TYU;,L)@$9P:N=":T%!;B%
MZU:SM?_/B=ZODJRC>(W@SE8=H8Q TVI6LKZWVUPTQ!C+#EV*W&L9[;&"?3=3
M*,9"V=A77 D/JZ&9RV67[=0L: JYT#K6H&3^W]0IO]9 P]JRD3:YI"-:64&!
MHC6VAO$H)S@U1DE@>W4I-%2[K!DA/]0.037K&.R:,4%.LI3T\:(IYPF  K8%
M,"!H#Z1T?M[PX)OMP@%1&(8F_V$"RR,.I5P\BZZ.ZBE(5>:D*HPO;]B+0\VU
M-,6E]2KK!3-!_;*RN\QI//0X"0MUJT7B<2N]!BJ!L]"4P1N#@;D#[/W.F/:\
MFA/^%*B$*_[(3?4@_ZFYAAM::$5: H02)T[1.3)$0!S< X2JOY;C8]/:,1^<
MZ/*J:87!A4E?\##V)?M[F^P?KUMH)UL+-WBF,!@GG;%W2]SN?(X"NQ9-#@S]
MSZM!MPFJ=('^:=JOY&F"@S9P&N*G&UK+AIO/, Q1>$L#9I$M> 4T%IEXY(!?
MX)?85DQMLPP,N&$^;-=V]_?+MZDAO9E!06L(JMF&:6 =58I2#I=BF1H1);L^
MVB-BLS3V("'_I^?1@P'XF05R/"^EF4BI.C=SX;/8.K8<?Q)8!A)2S#@8Y<#%
M'R_:YII.M UOS!2"4AV:0U S&<TECIE70.<56DTU;>1[CG]<)NQ)F%5P><_]
MNN"9Z=B+6)RMSPE3SIH5P%:;92W01X5"80C5\E)0<>(X,_T'JR3EE\#O9G1\
M&G8D'6.!)VECKEHY;LE] <;B,JQ8IFNE^K]?JW(KKS,:K??G\E;G\B.WXN!F
MJBR"'+^_[?\'_3C?"K_(<BU]NXUES]N%UY761X>.DW;#D"#0CL,B6(:;.A:
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MT7*VE;NE+3$;L-830Q1#T.J4 5DV19D$;- IN(Z+[+LJLD"WD9@N.]\FI*8
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M-G$A..$T %->A=9*TVI6<BJC)<-XJ0_8N<#NS-PMM"B**3,'1$=K1 ,PVU\
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MF"DI_RARQ/94=LDD FG/D3CZ!8!TOL)?USS0QYUOUAY'!;]+"E4%1U7W*,B
MF&(SSJB#Y^46!>WR'AFU.@P(<%C5L")EZTK:5RNNVY)\PF@&JSDQ]2V*+B],
M(%3J4H8H$-MX;.U!@X53[)ZFA.+"%E%I]PTEP3NO"B#UEFN>KSMEG2:_98R6
M6RFP?VI5%KU>-@EO/B<?!D)<W*+SB_UJM-[D]PASJ0\*#>0A75CKCR?';_-/
MI&_*-O]RW607\^8<93;*Z"E+?L$=,UQN+.P0UM.,[R?/B\<_O&+[V5;%:% #
MR0VMHW0Z9?M:GQQ,[,Z0?YFO=XJ:FQ,?$K*+C[3C(58M>LJ67%&QYM30@*5>
M<A?&R$G#ESOKD=Y-N;^;I .36QX-#?89U (V+'\K91#B;UR#)+?M-O34$-4+
M*3V!EZ)R@-U4#_H+0(&8!+!0NSEV=C_!9O^,&.PZAN.GC"?O:O;<'H+7#*YM
MI_;212N Z%@HS%F9N;B <(;.FVDM,01+C =,Y!4B;#6(UY@)T0$@A8I\SUIJ
M&XFU]1SH!$[+.HD.-:VTU#!@ YD=5Y(E;NUI+=D71[Y52:?$N>RT""*67 ?:
MR"$GJ@"H@T[9X7]](&UX*C  <XUNXWLU^5\W$S*?_HKO_/ :$?GH0AV?_?6O
M#V])F.*8'R-ARHX\ -<\_I[AK80=RIH(L_GG#HH<;2$8Z[)F*7PT"YJ XF%0
M.2=Y$.2,P.^_4HGBU)EA_HWXDM1/U8&PP)-OC*5?7$\I5FZ1ICZKP?!$$V?P
M+],QD^T$12R#@X[>3^N<M$R0T]D#=-BPTU2Z[[*4*5TS$X\J$MG)YT#9*).0
M7,-=_4^4H%VCBNBRQM9: ZE&@GILF@ -S4WODQ8N? [UEBU_ 9T= K17:8Q7
M!A<.<*-'N@AUL^=5K^L#YSR@Y?V=P<V)6NAOU'BX(+\6;24<P]P)4B!;HOND
MGBM5\7+=:O4%\@Z>SE*9QV@H"]U([LQ(4@5MTSJ@O9!A]\R80@T@% XX_5;T
M:O\\5-[RAQ'&W,5+S5)Y9;==+*IUN]T7LQZK^RLR->E$+40:$GD=)W,8G7"'
M-O1:;_JIM2</=D2(O;J<"FY+U]?=H^C% )4;GO<7IU@1*_;]!C<@X#WP>"+E
M!(-]?$L0X]_C9_(O-EQ(30=)R4R$204*"#+&5GY(+?B7T,T@-4Z(E3?+1UJG
MRTR ROK-KC-CO1B6@;XN3BBEW"!$&3G(^(*T 2WJG_PTV=ME&F91.;#^$:1]
M)$&Q."3S4><*4.>;BCN]2XI'=WC2S)OVW_-_>7R$__<__G)@B%?7)ZONDH7&
M<0^*+\(DPWCBJJS*>AH)SL-2!&U76/[:E9#,PN_C4I-3#=>?D[W]G$\6"MZ"
M<[@"_),%P35/TGHL5TRQK. LT%%<6N;9.L"*6L-QBM*"*'T]K9E9;YAL/-^R
MR^=%I^?/+F=S";L936H5)5,J?Z1*VK*1TCP@=I-Q" J;"V-_*HQ7:'W4"LF\
M@HM0#;4".J,B',/\= +LL8J97B;;;XQ=R>>5N3MW2Z0V;]0J"!:@*\3">&*B
M*V#[LGAW]T-).[CC;@-_NATBXO<%7?> 4)CQS\N:6_^LMTQA<30'FZ\T927S
M\T%('-GW.$?#:9POS;3I"FYC!Y,Y6;F'N):BY]9?UIL GMF%=(XN?37=9JXL
M2)B$MI(CHP462==#%*?@X3#] 7AX=P%;M*Z,-2Q!:>T*/5Y7J<ECAMD."?1P
MBF3,04?Q36R@7/MKUNO2$&O2?66CWG*>#^S3Z5E"NR6A6VLC>O60O86BY_L&
M^ //:$AE%X87NT;<F53'HFM2BM&5"T&<=#_820D<_KVUKQU+I_: $SLP^@ >
M$F4K'$N@U\U: #.C IG"NK.(9M'F+"%DFR"DZ?: @: B@18T'5D,CP)H'=7;
MK&?*-<!X)1.L:\_K "&=(A"V62<@&KFX8!CX428D= !LW@DF9<"RGSM=/;(S
M ]9*MSL9#[60^NCQ3B.&5Q#*T)A(36H)?YMJ#[6*MU'N^U.7+^Y3E]\A=?GD
M/G7Y1TE=WE'NLJV$J0)U+AH&B?$X#PN#'UE>2WR =/-E?5XS-0_Z8FY67*VB
M1,X,11/D<:"?3%598>Q7-[3*$;[&P%#%=PV>A/M+//Y@S@Z") $(?<4P^LLJ
M3$$H1[5N26WU@_S=H+5MGV7:+8R/P=HBB:/"Z4*??DO"KI': ):-[[B>WM!:
MTAWJ&XND55,H4 !%E0+S6W+X76A"P+(CETB@\2B7P;.I-/ZQW W;NVLVLAUW
M7J&]:O6#&"7+QFK\IX4U)AB](V/WX@33S63>3M*!,Y)2E![KK&=*ZWAC,]O8
M[^(1I5,:X^R^.R\1XJ:5"-R?C5M::]B#<78^2</K$FE6,[78YDP"W?:R\E[\
MU5#J2M&ZYTWS%;;Y@!9+B; >#G([.QD [@C8,:0"\F@YCD8=P?V9HVWBX\+\
M,Y95ZU H309MM;RB4C-75ZO@=;%D4+)&G#?C0%('/II"2S;EH5M+8(9FX-E-
MG'10^9P<+W^)I9OFB_WMZ$O^0,. 2NM11U[=+9\8,X8_G<8VD;RS'..S)Z#]
ME,RC=3.RO'[RH./W9_:D (B+($8_I(@$<#\_"[\FS3G*Y10J=^:6('U<O'P!
M#.OC9X4WWR59KR)K/I0 <1Z%[&83!6(D9T5C2T% H8=F2]=%.4?N82V$+!>,
M$%57\FYEV2-]P1"G*<%$3O6X5RX(A#^G8FYZ8?Q(<!R3J;!^H6/=A>8'"O1Q
M$(!EKWN4TD9KVA662=7!.JJ[2QI'"ADZQI-24B1.#SR:I&A6%_I.$S\W8%8M
M"Z.)><"R]&RY>DI9AK" "B7">;K]:G5R9M@-@XJT7[ZZTQMW%Z+7$E?:%%/X
M30'%\H%<X0>PEN"(JT[EJNW?'\/+PSGWCO0(FJ';>R'(!S#[JD=H1T*WP,-@
M1*9.,2-]<(X92Q2+/:WM462[]<;.;PA*W@5]QN,GKWYX'&I&8G2'9!W%9:4&
M2C+:WK845@/03EVE?CY8V=M^?9?/U.TW!.N%=H$HDF#]GC*XWR/ U5L"2<Q,
M0H2D,;HYCD^BUIMS"=(7E+NW*%NF=IW2U/4"7:&8>*Z_6J[B9CZOK/@5O7.:
MY2.V+FLF[& +$Y$IGVV#Q"8,>W0YU2I^]?(?F[;V#6:F)58<WI'DM1R!JQ]V
MT1]T(:>T;C4(/)R&1F8,@C:9E_5")E%=A(:$CF:5#[FHXDCDE <"4=@C.GCQ
M>LXKJ1>3WD"(4P%&$,*/;G_B"[->%+[P$[*",-TE#$7^;7S6%>USNCW6Y$?H
M8#NK4E->/:4343"A%FQ8OP>^XI+D,@G11L MK$O8\Q1/D@^5:@_MKUN'KF@I
M6>%FV96S*JV^FE9PF!-N7EXFJ>9#(!++QU%,"S0+M5:75HER9US=1Q;, !7]
M%4*/IL.2?UTT+0=OLZ[Z!:'5RY)6I;.K07ZW69(-1:YY7@9RT4AD[; (DK9T
M=;\0#L/TTJ_^C%)SV*W)^;.Y(.(TN:SX'"?$E>>(()< DYV@52$Y;RG82+PS
M71H&7C DQM" 6J/N>&9]#;CD51P->* 0!\>R\C8 _@F:W36JRWVS6I3N+CMK
MUXC$D,8 &'T#AVYMC I&\LS])80G>L_E$W,.K'6S_^:2N@AFI(TWL(B0]?+)
M6",;Q/=]."!2D<R[A^@*CLPU1Y]Z!+TQ)R=.C:LI!U1^J'*UOSG_EDX;3G6D
MK_:U?,)+@1 6>=B^]!WFS*:+=]RDIU?(>+GD?(8UMV'-S49M''SA5;7,WF.C
MA.%YH+]NVR]ZS7"H-6_:6&0#G[*.<A/&D",)AOC=O#XX4/-Y;TC9F$JUB?Q>
M90$])7P%0O16[AR^:\B-LRLLF"QB\_ J^(K97K;>T3FK+\*T#>N KM]Z2$#<
M2I*EV4P.F#*?KYNL)PC?P*ED9Z74=I8QC1MN:GV7S5F)N1FJAUX'RER4.<@;
MG+N@#6+SAFII;6?*_*)"6'%UB5'C$JH[[#YX<*LUXSM"<P<:KWN[XD8"(:4C
M>\BLXA4',Z!=C$(IGEHE@I>(!\I!&\7Z Y?.:/<P5C!Q+^'?QYE$D4WOVQA!
M)FU'XI*S4S(5OM>55K4/UL+W!MH=?:9I96X-!"WD3^!Y[/^CY?<K5'+X8!\;
M9&AP)../Z!1YVOP:E #GE4:XFW-F$YH>Y._89&*$=\/_2VMBN?(X)&MX2K(.
M[Z?L<M>,($B2X'4XULF1XEK:H<;EIB.Y )8&D+BYT."$2Q[QT:G%?2!PKO55
MLDOLOV&2 6B\P"UG_042=O[8\M%W%TDGEJBU>._+.[*@V]7PC&K<\Y"0?",G
MH6K?Y3/()8RW F+\W:0E3WS)MH!I"#%[%JSR RE7M'UOD[W\X3Y[^1VREX?W
MV<O[[.5NV^%D+/@1'"33;;7<=YRC1"0KWI36 =CTI;&FB<N:4*RUEM DMZ+K
MVJ8!N"@Q9H/BE,?E_::'9\&#E/;,&EY,&AD5 4'.MH5&"GHN@+\#9S773*T8
MH4UFMT0/9O.F$><QXJ(3N\I<Y(-LX-YJX!6Q,OBYA?/L]"J1S(5;W GG[N+"
ML!*713C?U'-E?'*D<8[?74T.LLAQPC2Y$%C9O2'&SU?S*#2J\?=Y$MPUX#Q&
MK 4"VF,%>+960X^A8XEMY#;C%E-\5P.5UDH;'6M9F7!HN2I"ZQ\3A"ST?G$$
M*L+3.9;5VQU/RW9Y=HQ(8C'7#(B"BSX)_YKZ1"01K/G@K*YJ7C)IHD6/E?]0
MCL]!GPZ#R%K-0A8M[O$&POMI=;[#83_NM>T.AU8M:L8P-MR42&NA,NZL"42Q
M,FQR"O\?Y83-_B8Q.QQ%+5Z,6E]Q#EQ,S3M&")B 7PT^O^4H',B*W\I?:I:9
M&&C#$).,R<V%LWQ<%PEP>V>1#![$(PS"<>FZP7-PHUR(#CIOM8E"J&B)U*59
M>.-.4&<1U0Y##E0#!472\[I81]@!X]/DM5.EX1G8V&'@39LY9E^&BQ?*>Q63
M.6DD[7P['B,,9EQLV*'\@US<K1V0EB+1C+=(,.69B[>$MC^\?IJ"-7M0R%.F
MUA2;27XJ[ON3LT[J%@HEC*!5)XJT,LKV.R:V.( 9KS(C-EG_,>VH!^7E^H5M
M<D$H,VT,%8NHFQ\_E+C430L(3XV+DM,#-]6BV[R;<1I"X^G>;G=(82Y.O*^D
MU9,9X"P:,C1_ )T ]RSYA%$PX(MJ:Q+2<!VV59MT,0H3 S-[E&S8T[O,KMUP
MI?;B$:.@R5'P1[\D(D?QA>AP'_I(LSG=7EQ/&CO,?H?8X4?1/R1$4LVA9 :L
M E@>T3\H%N[11243DPMQW!Q9E=M"4*V1WE="9%<"KX(:)5^C4Q.N7G3AI U?
M*G&C5G<O#;M+37MF,;@(L[*X=IQ::- 205Y<F<=]F]0@C"W97+QZ5&"E>YFI
MJ;ACNJO?%Z-\:I.X8[:\&/ST@4K-7:'>>5ZC5IIC)OB6E&@C]E4O-'P4(BLI
M^S)7Q:U:AM]+RB!\\0Y1%HYH-O3_3@I-I/$7B'JU&)).W((IN?")M32"#")*
MQ(:#E!*LC-.AA[UB3<[VBL/&&'@C=&BUA82O$>C[S/J=S*L25FZ1T:9?5:AX
MU>#0O J5F$G>3.%($5MI.S9XO6Q8L ["KIG9Z+=/3E&W;L#$H24=TN]SY=VU
M\-.=7>9\AGNOT;JCB#NT@'#71?;.NVG[^K9JC[N>X7;3SNAM;.(#CH\!U7+$
M,L4D6.2/9]H2]QLFS=[4\$1HKAY*8YG1XV;*/NT)#70B/SC6:"H+'?2=?C7V
M*0PDJ8P_V#$=?Q9Y<+3.*\T*\I<8(.3/*/UKK:6<T.NK $91%XP97$.2,!BW
M$EL6&J,FETAV+\.R P\6$XE^.Q578"F"\,) 5'+#/C):2I[L]^*V/^_E)OC,
MW'BFE>+:KDHQ/;(X=F:]*.U"!.\RAR'3S*V"WG"Q1$1@H*0P.)"2S*"N&G#Q
MNDN][O!].P)9'"9VJ^8^&2*  #)*F;4LER3<8SW15=W,X^I=;A;(V8$)A_/:
MZ#C-M.A<V,UIZ,EE/=<$HZ9?6S[O+5N+^'>F,1S:(]2]Z#8Q;+TB.ZJ;E^RR
ME]H&1)3(]2CP!-U$2 7/-0A4Y#J>N5IN"5-PPGP=#@:+BB(^U.'@B+O:A-UZ
MI#L%1L*)?^#FL.SF833GUO&W:4-PW25LZ%]T4W-NVJ#E;'VL542SA#5J3!/G
MNS5QX<U55V<K 83%JIIKC2WM&Q-QQQIDJ:CF*:BKAL$PQ1/TQEUH\MN$[U_>
MA^^_0_C^Z7WX_H\2OK\+RY_#<Q$M! C-([JIU=DOY _G;7UN2IG_L&B6U98,
M(#:)6*^-=;*]2QRBBS@" ]=-:\TV2W]5CJAR';5<DC..>-FT/&;53?ZJ% S*
MMRQ"?L,BI$0R8_Q5@2OLL'CY[,6?#Q\_>5J()?!U"8HYY=0_AH,0X/%'-&+F
M''X+5KQ*'O"D>'+(9&.'1B+'PZAV/.!AL6<TKXH73YZBR?)+AD>[!E.[&S/3
M#%Z\?(H9',IMM/NK+XMG-%1Z_*%_?+;_\<^*PZ>/>7Y<\V'!0+/7?EYRJ8#R
M0)*K4-&YHPE+9=RGD/S'VM&!?_+JAQ_\RPMK1?'N^-/10?:F47-^N/ 6Y\07
M<5LC&.;:NE^ -73MF5FP&=$),T&B,7C,-X=,I'5\+4!4MI?F6ZGL$;X"CL2Q
MA8)\UUW2129'(%;LA3X=$ :0P6B<S(H1LTV\[]':P)(Z"K!4&_:?TB!)&[=+
M@P:=K;<5A;I<*]ICL,$:-32N\I##0)-Z52N70N8"T1QW$&8%(1Y-8[!D(C;+
M"VXOS=:[XF)$7#A6E2H.V[_SK2)IV(W*80AJ1^HJ^'*9;9P$_,%MKNWGA0+
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M?W*CQ#!74!VH9PYRE"WY(]%6_D)BM=LQ>OW&T=-7%(%,6B")@B;8!9_$X!Z
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MR,_+3KH;P:7>*>]A#N*:&/E-9&_/)*;-Z]5)Z(2<*5 9Q3JM5I:-7%O@M5;
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M-T:,29=NP(/P9>HR]B@XY*M/6!7+S@]7371?$)NFA:I?E*92!A\6+1NLD9*
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MG?PN6]]G6@85NM;MD[4O^91KA$K6&_G8D]L[]=)E36!GGM% K [SED.I ZQ
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M$E4_W3-+!W9P SB0NX@D=>BOC).XX8B+'0(M699<KX[>^2.IG9J+I92'=C>
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MJ 3H]2&'0&BH/92H!OYY)&*_G_3>I(^<CS%*8"<CVL,,]'K41(>9G/$WBA\
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MM+]3WNXZ23=\$5XOC#Q=P3\SD/?/)IZ[AM)-U@=Q9M6;@8)&[=.AY*Q0%I^
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M-B:_SK#$2B= '@75_*=]"';8.^.'IR;_>?^PQ$5B7R"^KL@FR82&;-ZTY*D
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M)%[4T;D\',]0-'<4QQ?W:-S&"ZH3<7TJ^Y@O<*CSI_#JJ[JK4GI8V\/2(J-
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M(OP99M8&M!<\OZHPQIB$CG"5/C%GZ\9Y5Q/50SPZZQ-F."+I5BYC+\QM ES
M)W3E@H%_.8=PZV<C@\DJC*3;;TIZ4-@Q88';U)B?W->8[Z#&_/5]C?F^QGQ-
MRT[_?JT!HX=KZF*,I#ZK58-PQ7QZ1Y.?.5K"1SM8K?@W"Q(G=K%2AM^WMI"/
M%5_F\M,DSUHKK40:0C+!F557@+!O IBJ'RK*G^P#=]+A#HCCH[/=(X(Z)I)P
M@H51J(<+BZJCZ..REIWLV>)S*=EQO0EU&GYT,TG$1NLUT0<%3%R>25J!EC/$
MW_/%TQ*?'XV@9@UVX'Q'PDXB1YPG'LK.J:0$278E#Y%XK[@A499PW+5)SF:U
M85'6:D<^)Y=FV^';L8<!VIEZQ0XGU?[!"65-5-R!P5YK6LI"1'0D-J#[GMK\
M4GLE7;%&>5+DW'G*>J><,5?5&1A)F/; TQ52;!!\T(+PJ@)+2;R&Y"FJWIFU
MO1 J3)=I('"M7 'PT<3!I#4SQ\7[==;OQSEC[L>\9*(R*G F_] T.]AEW;-4
MZG:2-6$F(=X*]$3+-$=O:/;;MN.0-[VTT*\X$1R'_A_IX?+;ELZ!T(=QGU.I
M@J7Q0"@_1Z$Q5G0H+LMZH7R&S%"$YLXUV;M@K&'R][)16,Y /SFN <3<%AY)
MG\+_/:NSSZ4/*0B(1ZWJQ0^N<3/7$BE&^3+R-J"F506W0?SKZTBD&B02\]IH
M9;TP+E#-VF9<^$AMEK]M5U/[4N.CL 8,.AM3 >ZK3\E$9\:!.Z_LOX,9GL,%
M>Q\0SVM?C_:H,1$\U2IQDS +HH5<P339=0[M!W5'C<\DZD+KGZHO"50"Q(A(
MMAO@%.%>RD"SF@-!Q^7)%(00BI8AWP@:"*/J %6+\BJUK:E?+U_; D@:SS];
M#P)3D"X*?Y-\JU/$3:^4O0@/U+^*R#^$?#, @K-%IT+\#+JG*O<A/KP4[5U!
MMN"B7G/#4+PET^MFW7]IP_D=)<=/;R T"60/*20RX9:SKO>"A@..WYTN."5B
M3GO2?7FZUZ8L(GY1\370'_THTQC^L@=4]G%\VE2]"R#5+>#RGC<2)YO!*!1=
M/:+#=J,&V[\)3*RO[D>S&J//"8>;[H"A-R7>Q@("@ELPG%/6P78)O@YR/];1
MPM=;PO'O^2)VN6KW1$QN(6T=/CU$;<DSN92L0*.$9-DN'_TNV72NFYG]'?>W
M6D>@ZVMX.L;.H!U =:O'S]V5Y*Q,,X/0\*/C!/D0RQO>,$X*ZGFD;%_'GF;G
M-B4=",%PD8$TFW;_9B@]8P56RGY#O CP:*+#HQ)C\/(I>98^HD^<-JX)N;\L
M'"&8#T&=:'%S7W+K/[#NUGSC1TG/C*=IFTB!@] C$N/"JB&CQ(D41]PD(%4>
M\M!(N&>WW(0GIFI.][SJO%+K'^6<_V5FX0_GK/5JEFJ'LLI9DG4ZW:XY/& <
MW9EO-76]C[B 5^F2=VG(O%^16BWG"@;#<QUA E+^\77XW16B7,2GJ>9MCZU/
M[H3@!DZP0GE, IM:6V(A38EVFXP/5&"H32(29D<Y>Y>#NTN]-;'ER&(.^WU@
M"$/G?*U$T0E3T$RYU#V^F),_MIC2I,:S'*[_I ;VXZN9//8;UO)6BQ1^H%BL
ME5J9J0NRM)W7JWN.E/UO\:\_]/LOWTO6^AWQ6?\2_?Q.HB$1LKO^#RA)#]$
MZ-D^U]PW0,^-P \F8[)^7T@#%"K83TZ>/'UB\I3_4+6QT>)9J$?<KG7).1?M
M0K V=G8)%9BNG/2>(%$%M9B91VMWD%JEF%9I-Y;QY2]0$6/1B: 2'4JZ7+,*
M\G[GY* L)$S":E<'62\J8M8L^-T?O9?,$.F+WK2(ZG-*MU CV'E;SJB6+,V5
MJ'#47K;;: ,S;+YI&-&=BOTF7;.A-W6S^IQ:Q4:G<+(5IL/UQ:X#"^;*0YF9
MH&DJ4=T<"KRH(8@B0GQAO,[8?A!-A*"]<4L<0A'MX'1<)]K+%CFN3+"\$)J4
MQ1BA?";S^_09Z4P\?0I]"?QQ_,'Q5V9T;&!)/.$S1"A8N6)$A.)G2I09#>U@
MA!:O8=ZLA3>>LCC-3.*^73G6H<E%#"(KKS(G<M;T;*H;Q_.JEIUR(/B:L[C#
M5)0\X1,;&.AE#0J LFU+ 91WENICBE@OXP4_# ^Y0*X19=95O=PN.;L131[;
MU<M2<[]4$*($5S0EJVI.1+UE/ OGLF?$?94$4QH9WB3+>D 1-$!Q3&B('4D[
M_'&@&&8DN2A4&=2^ RJ@O:PCC@\4I-EPROF)PJ@V;<3WZO>;!+N(9)LWJ6MJ
M0#B?%EC_1):S:3EC"A?\8T42 DJW8^E?7O_HIK;;=<:QDKX8^3V7*&A4"'O<
M.O?[Q&3/.RD%(3CU\TQ^[@T[R8B$R62SL*<DTWN6CS-/U/-^MDO&[C,,^6?1
M%(:L4'V;0N33^T+D'R]$GCZ^+T3^60J1!\]$D7=7$A2;TAW),4"%<2, BG0M
M/\!U ^V0F::!<3/!!!1<5(,1D>MV$W^POD LHQ]_F&[9"7L$SU1YZMG1R5>)
MU><ZIR/<PNFX$_?AG4D!#!VG(C#S/J$#DP()_I#HSOQ4(-%"MKE2RD&P#W#2
MG2@U->2/>Y8JHXYH :P<?!6P/*@OT\20)N@MLT'8,Z?8>7?;0* ?!&2JNF?V
M&,WR,>]*EW)1?S0J*$1%JP38IY\4CGX*Y8'7#;:@5BU->8X(>1+3@C1GQL>=
M+YHS5 &+X&CS$J;NR^,27R]J7)%*!C,%]Q#SU=*:B68O&&X+\>WA;1'C;?+O
MA0'W&H&K0W81ZBL0CP=X/WGH& $04T:RB7?#W +'$..@2\8^15<+3K*>R$V\
MO'@307U+L$[N_:@80=2_RB,X%)<:T= KK'*>%. +8Q_IPJR"[N&9(EIK P"^
MQ_!_H#$:ZJ_C[/O1Y#LBX51*,VAAL-0 .80:D>%WOY3=1T&$KR8R7X\T,_&#
M->I_SVE/ -HDJ[T"551K=&<M'^W-5=,+:YDL,]M+CQ30YT31\:[?V#[2)G+9
M9H?;(>_T"WDA^;"97SL='H&S*A 8^]&L)=[9!S%,VU0/2=(D'OU'"$XFT>6?
M;W#G1 ]W54\?DMLLSUH#[M&NNOOFU;$FD%>8S;0->%64(#6QRW9H8)=H/RXK
MTO/HMB*3H[IKRA8]HRAC4TPN4'",:R@QSWS1-+/[YKI;+,IKWL;[EL7=^M%'
MFM9KU?;0K2X7."\38,SN M15T[\M)A)8+BN0-,4P%1<AV9T@QPE)HVANRTN^
MM>7ONZH45V-\20_%%8^WSN?%KA1I*=ER:H(,1=CWMQ*P)XU XCFH@5GF>W+
M3.M3]07,RXJ8B0T&9FI"18YDQZCJEG(T4CHS)'"TRPD8+ Z0CK=)>;Y<^>2
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M+=T0(O;++T2 '.;"RO1L\,M'9R4S,V#9J:EE41X2NOZSJ:<T A4C(5YBD'>
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MC2R24$\9'X%J;(.$MV0.RB)(/I9=AO'M)<!#=C)2?)PU1U8J?#\B[4".MY?
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M3OL_'JV%MN'W%\(']J,722IUA%N4.OKJJ&/%5&/\[]T=<%*UE)]7./OUC<#
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M9><8+;['BE.WO=*D9<_K9\*CDU=N.)L^9I*X[4G/%0,KR^X"M-%7+/.9-4[
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M^>)7X&8Z4W(5I'#1&J==)<MV6NDH]K7<G9I/4R )B8A)@ T0DIE??\_Z+B!
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M4^LL^-6>: ?&PHM.!39.0A +@Y1"F)W$^O?O%$VA(YID&=VT'F)+^86F6T6
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M%UD5+M7,G,\HC*CY#<*Y78:P3A^M[\5A?=,YV':FG!#ERV;[GZX[=K\''4U
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M^?,"+)8J)6RFBU0KIFX//\I997?M]!&R'AN[*2\]&(OT1G="!;+PA*J5A(=
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MIX@LI4[5VC!1&8'3/]$,&<:C!,&8=!]F$B] J&8^2B84?C-4F/%P;(+'UMC
M@-1T,"$+IYRG\XI+&.1B3H2Y7N-%E,G$(&XUN<*?T22:PEV#[QA^L8'#$N*L
M"$?.B,*LQ!Z?]?EBK<S, DF)\ -;L>Z6"0QE$)=I&0EIH90-7+P^8T%PD8Q
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MA,5FLD[#4>4>83);!V+NLM!SSW 7>X#AB(=!:\ GW<K2U>"-O:#.'8N,H0Z
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M5;2S*!2GA0H^7%!PMD3Q8I,=]\YMV0^NHK].I=/PRV5:#;0H. KQ:5@,LXC
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M]=Q^(#V#^X><.S4FF3_M6RM8I+<DLX9ASX)55HB5XDDM$AUIQ@<>\BF=5M.
MTS/- _\]076$@H*B"G$X@<V>X%G%8"C!TC%NG@\FZ;7XV?.EA1QI\KL95G!
M>?J@N4%)AF4376+$PNAE!?--1AXT'A[.^RS[-0J329G<CA-Z7#.]Z(9:@O7[
MO8->WVD)QF1#$N&_P:[319)=PVYO2!:>V;I4(9K*,$]75#.VZ%?1;6[9L1MH
M5C7:3BB W5$R4\8]H_,<$%"-<9[,! ;[4YM![,\U9 %@$(\.R.ZT;(+F!;4\
MEL/%C>_!^[U+N;=!7*8E\[8)TV-NF-F)&%]2!::,"(_BB*-L\2B>"8&EZ8IE
M4QH-<<[M.6DY)Y;? Q-08$Z-B&8 3P=)830P81,<^M28XCO:Z8A;8-VDH\KC
M_')1S,C:E\]]6B]E)@Q8>FYW;*T=&U8%W %L-L:E-XF)&O.VE#:NG(PBI^@?
MOL$EI%SJ;;&JJ%>I,:<'<I#2:;GSC9NS,HL&VGF;1?OK6;2#;1;MF\FB;659
M398-DDD*NJ<1Y;\F@;G22'J6C#$W(L9TK>R>4(^D*GZ;W3>?LK[>5M6,8ZN\
M/FO#K>5A<S>INFB>Q7^;#-#.PX@[)4/A*]?4UQV=8*:3,(!S:9H^O\5,;5R"
M+MMNSWVW1RF >4_:[7FGI.VJ0G"H:^&!,X<<6'\FAH.EA;43F:Q<CK3M?OVU
M_6*F'KLYB)*>)$SOV2 OC06)F9^T&.UR#V3/&K1,%HIX0/&L_PX(KT61].W6
MK;-UX(H77&PCM-:Z!W1OE >$6;7PSK1Q,KA 3Y]<!WVWLKDKS4-'</Z17H]W
M!8,74I A+D:;0T[^?_*FE/G1BPPC&Y*,1B^&08 SC!IS,&\O>.NA#-/LJH@-
M/X7 !;/\AO&T;2XPQU2&8[QR(Z[JP:*="<4'2_AN>24@"*>\MH:Q199!V\5@
MB:R! A]"2B!4[^Q_*7&P\<&)+H@;+%0EUT QQ?ZP2(FWDV:%I)M$M,'ED+^]
MN\0Z.2Q+G"P"9'3#WH'%3;)P)KU@1W(*FI/(.ZA3>$I5Q(1SPM0/R77A$T3N
M&ZSQ&M%F4)="8Q\UTG!%83G.;Y.1D-MSS4:03BG>RXPUO'[HE0H.VJU:<\)0
M!&5P:\FX=?0I<7R:#YJ>-=V?0!"^*.=P'^%_-=&]3[^=C_FW00ECP#P'Q]9A
MR9#721CYZ4E@#4I=+3YAOZ\#T<JMO$PT=W'@/5I?V.WXO[9O3.>6_C^@E_5.
MJ$0.'YY*R#_V9R>OFL"!%I.'GV:"\Z;.@K(BU*W@%E<9]#B]HM^E5QQC;@2N
M%-O%2*YH-B202#8N!C\ =["4[@>F-@S/03H79G&Z($8H+$<9?:2SZ2Y@Z<3]
M/(<)[06RB!BC+.>"<*#N)+Q%DH*U!;S76/23:<MU1FA16%ZJP'ZF^K<)>) (
M.@S/0=A\,CTX2KT''#319O>C0%M(DNPH;8M!A:<[NI,O>&986CV>[WB($">!
M,#JD37J-(THU]?8..QPZ+:E^'@N\88V#@X@;'66)Z1WMS%QG2$5FA[T]<&O]
MYNG[F&ZU+"^2PSIS+G%ON1FJ_/X]MT[)BT70^A<LB6+$(X[A75[.=\L$$^&(
M,;*5A.>.G2'/.!W"+1BE<Y,%7^O+5-E\ZB6<*04'7[O.3)=VWFAM!D_:52O
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M'9O,Q@#F[CCG-" W\$TM^#MQ6F7@S>:H(1[O@DQNMV) 4/@(;ZV&0MB&>=Q
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M^67RT>)ZL-/K[$>]_G'4.SAXMJ;$KRT.^^3UU='?>L;IKO[6RZHVSOZ[%^_
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MO=WM5ZT_\9W:+.(@XV)HSO9(_31UF80)"EJ.P,OFFV8_?>^!!:<!\ZQ^VGM
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M)V%4'TSGENT:H /9%M /4W/]P?VP_9MMKB;LV$:!#!K<?;JD247H,\!(B-N
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MQQ*<25194UAT0V ,@P7>RFF2(E3OB9+WC0</SHC$D7#W40F@20(#T!Z-7&B
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M*>$=Y,',6#B#[OZ)"E[0#[9TO+-90<H67-X+WBX&QEXF<*31B\8#EA:2]D(
M1LDMY629']I4*0.Q=?V=&G0:$7=]R@I.CN.N1ITN:-0%)\BC6WRF]D>6$<U0
MEIO[,D92P7IKW'_VE9)GW<LD7VG K7N-K##M$J4%#=O.</$,U\+;HIO=^-?\
M S6+[%Q^B<-&!$8/7@]&\_:X(#2.KV02:L(9IA%4[]Q$5+V;L$PN1\[MB@N
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MH,:J(5N%3"["PN+:Z?CPHDO"FG7+_.F((74=^X7,&S6@AK>BKU=E[R)J?JQ
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M$^P)B0?>$]<8@J]J]0C-%]Q[,0DVBV\RE!OBK<<+[785AMW%=PJ&IJB<Y+V
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M77<+K[F(R/?L=002;%"YI25.>2:*)[/ 1:O#:!>FB;"-F:/$"I+5<MX\P?8
M#'H,M_?,]BBUT2>X04OJ>A50ULOA=ZW9WJ<?%^G2G(AW_&U484E\\>;JG\\B
M$[D*'$.\P-./?'1*@B^!<+9TM_L080?IPD,J[]7T0<$&W=0PE;BXX"8%$V1[
MHC#0IH\58C%NNB!<XMVN@5@\2Y U-!@X7^_SA;T2>^^GB-*SE!Q)=%>V;+*H
M58,U86,MS>^;."91%Z(1R<!RHZ<5"- )O8'1M+;E?VMQ>ZQQWW=.M)-/.!*:
MX AJ0GVP?4I-]0+V_(%BI$@2M?VZ47].KUY<!L%AJ7K@"(@\T=CS03AX(C4=
M7J)ZUP930U!I+M>$L5&\Z&3PM0B0P7"!!T<-XW*.,9K0\CC+%XWH%Y5W^C7'
MF0,Y=C:^]R9 K00M/244C[EQ^2WHA98891.TVP/H:J?[(*=^--?IX7+<4XT_
M];JW4[D6"5@357(OC-WILL$E6'U#J",)=3K-_.1';3[# QFPW*=W[/* >P;'
M'F94@D)"M#-Q5*+!DR,,2:AWF0]$S1.9EN]Q$MXM9CY?JS[LLI"&%5+@U[./
MM:29[!C,(:RR94)&3O8)N3^TIB"M)P&7+;IHON<$[KXF'GK1*Z)5!V%&DY[/
MM:*#O(3AB7W.H'\,KL!X@XC P>&Q1 1""/X@L)YRRN0LD,4O,"&.I*P8I>3J
M!$ =M0L!%/=)8,#::+DOQFQ)UC#)$].!FUQHP/:PM?0&K@I<,T0][)@U7H\X
MR7-D^W1<F&+5A"BW_:22S402Z'+\4S0=;K(HA 5>CS%N@EVDB<,@!Z&4+W +
MD:=T;[F26+!"@G)9:1UR)%U#!BEH'DZYG6U3;H^0<CO<IMR^E93;5FD&2K.0
MQM&=X%7=(3$;OKKPNO:ZTV8/5O06$<B(U:S-?1F1/D4=.];\0M?LH"Y<=;/U
MFM;;58_TJB7LK9D-V<N^Y69WWR)49_D\%XL8V3\^4IR.S-H[ T_28)5O0,&H
M4$G+SD#M399V$)P "20N"'0YS%Q/ZEQ8ID/;L/*ZCN2Z%K?I2I@U!JYF[ T/
M(R[7O)5WY5K^2K;Y*V<+\F&EZ/90^'J=\&+B"1 GV2(KF":FDZDSGHDD4(1M
M<"7!O:(6?W=[8=D?HG5()*04P(PJ&)(?B[ -4/%'^D>I<9I/#8YB<DH&Z)B<
M4=0X\%-3",^"E1.L,42Z&>K<**TL00Q1'C'"!DY'O1S?4I%)$A?X%D$^S-)[
M?T;X3"FL&DYQY/&B#FYG\K8\4X[K%WIBT*NLDSZDPH*5!PL<7$Z[P>Y>RICB
M,FF$)_<(WEZ%@O8>L94*F^REU"\XHL&&>]M!=B@D7AO>^:WG1N1)&-V!K9^5
MXS*DG"'$]7V:W[FTCH4ZNR;J>;=NTKIG$6[(/&L,4M&'"?Z*?["20D<TT:'Z
M!Y:+SY=.I$,\-+W"V&[ZBD2D5K&3LV./"W(@A11(0C2D',J:U3%A-)?5V9SP
MO&-3@9:[)T"I1A]ZV17A;3);:A(!Q%K3YZSYO#!C0#)S2UCE!/$UL]PU76;>
ME<@@NK$S(.7\DH%XGV.)\A0H/@^N@<",42%:N!EDTH/.C)U*.6(1BS0POK*P
MB.L)$CP1'K<0Q$%G>=T,D+@FKG^SC\CYT6,V3_J_%)1\P>J;TG]SQ:76>R05
M(;K<)4'.4!67U0>*WJ$P, TO8G$X/Z@GHY?LL '1:'5 =).EL)^^/JFE);:+
MH[Z6;O_2;LH_%4)<NFP-O\$:MZ'+@C#=.6'1AIY 21QN_^,OW'[!A'0EDJN<
M?YF1Q 3FPE F7O:.<MN8D,^*/\JEVAMH_P6EB#F50%09!^?Z\6!Z=5"E%,2&
M!8#%?:AW-%WO^E3']6UY3YEW00:YF-"0SH_6U?D#ZMX9GAB2K"B6D!"0Q0.Q
M./3\Z?5+'J0\IC92K@S,FUQHCCBX7.&8E3\I2OB!'X/+S=DEW]SA>4OYV($;
M@2%JJDH1M4'N+-N^:W*OVY3 "BFUFY&8?N13)!A)U<,U^"H+JXD";<\8%HDN
MNU\X]"UA<P,4GE&! JCE<+9%;>B-B..15#=9D [;,L\G]^D2UB/W-QW\;1Z4
MB.A@I$6A&0-(/4/*)KEO1RG)4SA!.^[0A3^5*'LUY_M+- ;1&$:?>U_3C6N:
M.=X.,)UAH<D89H(,9.9>7:!37V3V8C4YX"1Z\NGK#O_@#X;;K<KEZ:<D4EAF
M2;2-'?ML\!KJYN6BKW$-]3%@PT0 ED$@ZEU ZX7F+?>H"T6@T!$14L8, ]G$
M(701[V5DPB 5K1DJ-G!"W'X9=7>W0MR#/UD783F>>0BE8*\VI[3:![SMGA/H
M<Q>1N,F>BL'VWZ, BO<TP5W/6!?-TP\X671?L^D4K;NPN3'EI5; 4YO2Q0QC
M9O;L0 =U!'KU-E[)A-TX-H-YG#@VHY_;G+$WL(;/7>53_-KW7J"K:?]9Y'MG
ML\&R28_W>7O3$G7ZP3$[JGP!4P#FO<N$OT%(/[&#4:4KWM]HC''Q&AP,,'@8
MW$+DDSI+A>().):TB)^X:3J1=YN":G]O-=DV[/1SVA3_GJR>-+I$\&30<5P\
MX<O@X&,J-R<#1JDKTZ:I6#5-VDJ5@KJ!8"TSL:NG3:HI.CK-*SAV&#KT2P5V
M:=JP6I.A(F*20?"4\B_A1!'^RR/E$:R8P_Q),5E4?E&T!A:&)Y7J=6M*+C4(
MD0972^*N_5LJ,G/QO 3QXA9-/\:'TR!J,0CE+>HW,K+ ='2WG>Y=?2&R1/7[
MVX-QCM[U>@R;Y]O\XR/D'X^V^<=O)?_X5=K0AJI3D-I*4D*5.R-D(\CFW&VA
MDZX+2L7I.EC=.>N1JB0XT95/_OY=^G]_F7W8/SG<.SP[.SF'OW!JZS48=Q8-
M9S"]+RDM]/6+BA1"1$96P.81'1RN!R[B.QP3:YWII0/9UG(\QFB58R9SL8Q4
MV9;S+L8HDI\R'8@P[!&UB/0')GU^"Q< %B!B[YDPML.D1OSP%.['<5.OK 14
M.I(=,")-X<]N[/)6Y*]E!4BA!DM7+0BYFYTE&4Y!4Z/K 4H7;G:/N, I9U%^
M*>]QU>C9*U%J>1TD4L R0/XQDUP4(BCOTQ9U.Y]W?&V)85)I41(D62@HLT#?
MG)'BT1"D.]NA 5/7;!S!V$>KT3'!DK%<H(144JDA4XSN=@#KC'!T&0QZB\&J
MTQ1H=[$3F"-[2]G#$D++G'>K"[4> E33_(@+EY[,OA4-C-@&^DV:-UN),?12
MJNA9(?V<CQON0N[#8 ]$5-?QU&R9'6TI%?3X)*NT)!(K> ":84I^5U)'[,;>
MW=%B.Z3])R<OY/Y?U4(]&BC,H[B?536.V]TUF1!![19-! 43&]]X8J*=LL'L
M6P-X'UC+-(E8+:\C[N,[H^XOM_DH]QUZEUZGT"[<E;,[T^F<ZJP=N*5/4+*:
M<D-VT?L6STP(*?P9^1"&GBYTT B<(/_]M_P?6&I(#8E;Z7*HA"#Y T\?D*[(
ML?DU91A/2S0*/( AL77XOEQ5?"W7AF @672W:FP1L7K65+(9]O/3C-2.+36E
MK3;H=N20JJBM&V;0BYN2<[6N)%.BKK5$/46W=8'+*A8<<,QGLA'X3!S)P/,L
M TM_O1?$1IXO K7_ZO+E==#?Y!._0X?SZMW;W]Y<]AN6V)]2 HP$7$#=_BET
MC#F^V<N9?]KG?R0S[_SH[-"9>8-VX/G>\0-?.#H_.SH[<U]XQ54X8&T\GU&B
MGR\FU-K7<O9^C"\+HHI%PJA-1W;T!;$/U(CW/6T+1RZL1#Q9@?<2-S323E:8
M;H(=^B1V.648C#Y^ ;[T>"E0>>XM2\A]E(#5]Y3PYR=Q)KR_)H<(5MP.ULI1
M@N[&)KP7Y4)\ LXK4$EVCLCX)N5"#>$NKK(PR;ZI:)]IQ(6C?SYS,3SF6:5S
ML]$[:*T1L/7>I!]AOU4B-3.BM'^6;.T*94@*7EYG:8W,5V@\'^P?)N0598N&
MT@TP.J3]W3M"1LJ& !P%XA(I_P 2\&MZ+[2#R=[Y"?WVGVG1(EP,'P6_)"L<
MZWB5$E3 ,]G<(1 TJJBZ ^:!6=8YFKJ3 3D+Y)8>3N44F&\IP=ND6G_\F9>S
MJ'<P^A'*@/O%0QBZ?]^-?UKZ\@TL=W1+3B\%[9OHKF .<#%+E^P=.SF.8 BD
M,N&7></TV>4]1L7ICN#3"C8"J%L-IO+A6'':X#.X-#9(AR%#>F@;""XP(4\2
M%H'GKU 8QX8L'JFCIU%PA@O@)\('A)*^O\?U$9(80KX4#!LXUE!,"'.V1GP<
M_SB'(F67.>),1 W_1%M2,A"^RIV)ADS^<2"IUQ&MD.,#DV:.LQ=Q+,R9A( ;
M3K_=@Y!&8?UZ\$37LTZ9  A]-\EOL@+1!Z1UIU6YPTHU3Y%8Y]+0A':N8E[^
MA*K)ALURLLJWY3]#F&?8A79!;2VH=2^UU<9P!9ST$J3C1JLNMPCR=5;3)OT>
M*$2+G^RKI4V(4MM\V/2<-(>&#!(ZU_M[NZ>&/G^1+LD?UP2'T_C2\(#0P&H'
MUWQKE#/2-0DW 7$9E\$7U_Z0RHTJVKZL!NQ^[,X:/SFPDXO6F-/!P>H9!7>8
M[:[2;_9@>#!<+ETC<Y&BKLB9%Y1F,,\GQ[[79M/26YXJ^AT3V9E'%)WM'G_O
M5S48KO-0.5%583BK178B30]%0X;K7YF;:X+A=W2PWO7!3-/YWC;3] B9IN-M
MINE;R31MR+&A8+4+H3U@;@GV)/)_7JT:/6L98D,T:LBJ9X8$:4(7SR%<QWG7
MO:5X;)(:3ZU"B4;9.&U=3U+ZR:1*[SE#X+%?W? /X_0F?^#_/#!78G<&#4VQ
M9E!\B)Q(FT9J+#AU,9+4?A3JN:^0MGK#.#5P+M^U%+SB-G2'YT>AUQCM'U"S
M&/  0TX"9[_&K\37>\?70?QV.J6^!^L%O]GK0_>*?0Y'M.#=8?8P$[A<&H),
M8$ #K&2,8CMF1(/O(I?3@=3;L$<(OP3U%SL<6\-YR-2[Y)#.>S"4GPC"^/+=
MU3\%8_R4SO$UTP*AUJORD3B%!2Q%$\O/]:<7U[_^JC^5FCM!G^I>%QDA./%'
MP8F)'"<(BQ8(&I7AN&T/.T&]8.#UE6V<^]+UZW:![ZVYOXX,!!M+L5+>\&OE
M@7)A5;_1Y11.=B EP5-D-^5!EP+RQ[_\_^R]6W/;2)8N^GSP*Q UY0DI F(1
M *]EMR-D67:KIGS9ECUUSM,$1((2NDB #9"2-0_[MY]UR4PD0( B)4(@*>Z(
MW>,2 >1MY<J5Z_)]Q(\D/_/UXE*)BU$D+J7BL*Z9^8P8*I2 OZ)*%/>IQ&#D
M,$FFH(8IG0+R,JNYK5+<5G3W#_7)D11%=/2@)UA5B,J""9'VIF5V"#5*20,*
M]%:!WWA8]X9>/V\\D,[>2CVH6D-I(CA,P)4?^J. R"[P&)#X@S(&D^)'ZRF]
M#QYDEU@@!R?%T9O@[3?$1)IYZIEAA"\FP1AC:L?Y%/*O2HEA-\\I30++CK\,
M!O-IYCRZU$P&]@)_.7]G*5Y4)#C")$$MT<*;(+^-NLS!Z)4'MBK7N8B2:#M>
M]UMCE*K252]MGE;FPSP<4IVV^!F3:V:1X47F.=IP>+_'U3J'0R",,$D(93C&
M95.]/[9T1AWE"&]:3J?)CG!,HF!+J&E;[*+' +ATS,\B ?664B#!$D98/ I[
M"@Q-CZT1LF $$:K"YU(ZH$&=2<M-9J5A$V7>4!Q'44RH:$Y!?$C(N9XD.D:?
MR=#'X@6!)4UU6VD"O([WRX4Q"9Q&E(*#?='80H5&5EDPF>KKDJ!5%EV\,@FB
M.<6LG$#,N@RR2=^/T ,*-A$%B@)<YYK#52/S8['Y_/X\$Z9++S*ZWP.+<S,5
MR859(7*&$)U52Y,0>1\T &4EDV1([%=LC>L0M.+P4RK/T9SSB3_669?0DYW>
MLACEFKS.TK@&R:62B;E(4C.H!Y2-' A[G5&I:1+DB9,7%LY#29.K]5(?H<.&
MH&0EL(/8X^*$7T5F*KPH<>TN!R<GL#W8:+W&U %F1[J"@= 63ZBOR(!K2 #J
M()$E$F!X4@TCZ.BA?S73@-Q7">127&# R=N2NBZ,Q)<X<)$V,ERXIQI8N8Z9
M6 (WC+LLYE<?"M8C>6&2B^CDL=U3K2"2#B,*+R- /3(7H"G @=Y1S!XBF5F>
M^(:6AE0**2PCX"EB9H253U@^DA(4#H,$Q$J>GRA^U0E!45I!VVEWTK2"C++&
MRSRJ:(Z/P[S?>%/]/#'A"MUVX3@9TF9]#_8$N0T4%RO%F=0DS[3BOH ]&]@2
MDF$+)N6YB*A>Z:Q^(L]1F&]&AOM;)Z-C'94]K#38'E(8W/L/% 5=+?$@CSHQ
MD,:_NLBA3H&94 [F!Q5!)N\F83T^E"25ZA34%'7"1ALJ9+P;:F#W6+U!P"_2
MO1,PF1J>YMR-+!=Z-H,V=3"DH4Q-EJ7SRVZ^HI^<U(F>[3,,%<'KT3BGG*$P
MW7*#(![,)YS"5.&!6"C8'3M-J/D2FI^\&.Q/&V73:1$0HR'</SF.P@ZR*. C
M"Q%7<<NC72(D6<RVE&NF6F=G/X>(1)2"WDE+>&185IUCLEB/!""580YG3 D2
M98K&.E]TI6>!$FW).O+&J.HD%L6==PUG6>;<I0&<P5?Y.I!68XI!20^#+/F7
MMX*/J5H].O.&__D?CMU['0:#Z)AT(ZAR'^[S=$2J;K.:AML%[#[T%4@5*"&(
MYX%$BZ")RM8,"W&5VZNH#I0F\VH^O/9GE65M.8[;[/7ZKJUD2%E3_V2-D?('
MG*>%DY>$P5+IW6&-?J!=9W#U)LA$4G(EZ'5LG-E3T(ACTV[)E)J4M5)8 ?",
M+!%=%732RJ:Q&'H:RX12>S0'>5ITK!$_BE0KJK<DP2#^R!&7IFD5JPQ^(RP5
M07N!G9<(!MAYS>22Y7$A(QNIK#6L)P2!#H6_58 P8=;_$"/OV>%1P#!+8&/H
M1<)I;LB8 P-%]</Y+&:Q7$&R8'["G0G[*921-K"RI3#4'4F4_Y/9@V,:D*BC
M"V1T3T23 T1,EH ;:0IJJLA34D3J2B;)*4*B57]X+VY_I%9E9DPRGU )>Z"Q
M6Z]45->W#Z'.#80Z.X=0Y[Z$.BMS1BF-(Z#11&' ("(+W-,\"F=?\%$J=$=@
M> YR,>%KZM&1"828-:81(U%8E:J(4V+L#!WLBA  LMC?R"3<BLL6*QU1KN,S
MLA[A(YZ,T=UA)@./2WZ%6_40+"L*E/Q)<]6F+#\FS\ ZZS$B7FHG03$DY&$F
M%V>RI<TD$?X2QEV&&.DPK>M/JZM-:]ED'D*CJT]H8MI\TU?S"N9[R<0^5YQ1
MS_ HKL_.H'BJ\\80_G'AG8Y]Q-4)R4>GR,7(:X(IC>R;DP8N<T.D=>;Y0BDN
M+18)BY(>+ A'L<>X1G-$*F,0/J,((HE0^"3\4@&(D@ FY#M1YBIT3B<M.7SH
M^$UC?W@,3_S9333D-$WVH)M,$RO!$0UF'R$/TX2]6=*%G4'@4.ZE6ZR 5<=F
MM8'0DB7BRF\"R_JI>#FNO,0?&K <\A(DY#7"R=O$V2[BBSNPX8^\8[6)E6=
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M4!HKS=5GHCGHQ@D]@1F,)Q0$4+$P)(X07T?94#B%AAQ22K\KX!Q"9MK[-Q8
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MW#4/3N+%88&(NA)8(LD>ZX@\*NZ0^,LV=:U=W:;)#YFT<?ZVB9T=^]=!PGI
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MI%5>L2MF MM/F!P-<Z%Y=O5S:VZ[T7YEF6ZGT7M%[[J]1N>5U(M": SA+N/
M9)EKW^3X-GR#&0E$G(8<,56MX25G8UCF1U$;@,V?9K TS7,YR?C;%Q1T0_ZI
MTJU<0#:PN/!D))!%%_JPYM?:,+*0H%;>]A!G)V,.AXDP?KDV0KJ[(@%,3C$%
M/6>JNJ/K38"ESSR>!F5TJ_],1RVT&XH9X1%:1D0VXH12?X2S^VB">$>WT7R
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MVVS5U[QM[P'N?3Y*5BQ*"Z-_;18DMSR'BEW)X"Y!U;=<VVWTCU<Z0,0HMWQ
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MS87SNIF[22-*U)KG]=IAX85^M?2K$%ASDFU*S<*"\6?DC3_V5C[F(FUQ$+;
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M<N>'*=.8 ZQ9/IXW5ZO1&RY'+-GL\N@TAAM>JIP0/@^[W^:6BJG\EM0#[_#
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ME=C$7F$4'47[6.CI)>.I*!V]\\-XSCW?Q<VSS9OG,3F-//%9)#)*_SAX'X.
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MNH4/D-:V!"; S<Y(WY-_)Y6O# _!K-XX5)X%DT4)4H*40)RV3/-PN2?-D:$
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M5G*<98829QIPCYVE<ZEE,9(4_$YC%2&+)"L"$8X0\0K>S2,!<'FM74; 5H5
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M$'H)[!IL@\<\P)O<(0P=FL/H31 U90D.FC-H#-:O.MSM(Q.@?XX=!F#83PA
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MRZ.QA/2/E-"V3X=@0/^X+LQA: +I IZ9I?SV[U% UXELVK?^A.3XVS"?"1_
MP>]OWQY*F_8B3K/;Q)L@8ICU)IB'($HYAC*;YQBN_>!GZ&>N^K;2)7[-)U[*
MIT)<&/80H=UYJJ0P&$ABF\S1HCDR$H18&BPV7*1!*K6>Z].3'U]?;54_6)N^
MQ]I"^3&K_-BSF06L)[/;F+S_UNG5.\W$'1$,UA=_O>V@HNJ2-<F$R2)[.GD5
M8D#&^#2='<M,2XJ9R5V0XL6DQ0L@*/YGV0T$BM>M;X:RBPQ=<-A/<89X05D
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MBDCY9*G[] J_T1!C;W";SGW<=J*(TXTO5D&_Q_S-\W<,,;)TM5*5=%EUN:;
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M T.$>PVSHBZ.#KZ/]O/<'^=1@-=9D18"/?A!]+V<<JMXRDMEPP\Z[)-IX-^
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M0<V&C3A!8/-=*S:2K>B@N*5C^1BAX>+;[(MUR5<'*XTPTQLVB[)/<;G>^']
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M06VH<;K-^;]LYI K?V4UDU@U4(:1+AQ]T^ZLG@]!""E\[_ V](Z1N<LQ MN
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M!N/1\<!@?( 3%L=+[QT,MT?-; J%ATNU(13^]%FO#O!.H?#XG+=F.A">?,%
MN!'$>T#T/S6C'?6,&(0-CEZ^/'EVZHL#WV=V.]XS"^6BF-=M\B6(D@+T$Z\
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M(XR:9)26YEKQ)I_=AI-']&FYS.?>4 U6VCUM"G8XNKHF6@.GKV'ZE_6\<]!
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MKT+O-/X$'4LC@K8?9:2VK$Q6T0I<OY+B1OHO4W=IO(X)+5HAN!"_G2(E()7
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MCCTM\X6AY_AV=.$,M4T;6YPMVZ*\XK-;/>-H2XBV;OIQDN5T"CPW5EO\1HT
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MY_E=9ZB%]6@J\B>I\[I:"#29Y9*@5]P&HRSKFR>0\$M(BM:O2MBMN)3J35T
MDJZY_M)7/>M".SCI0L(, ^:U5T;N6NIK/M)H8?$B;L2,UO)R<=,D7KP @3O>
M_5P7DG MMXPD(2"#\6'LCW\Z/'B:V.-9H@VRSAO+G)4Y(P;GW6K6$%UWZLB
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MZ&Z&MH@"M>?XN[RLD[^354)B(I4Z*[;;UR%^F[\H,,QX(FZ<7VQ+AHW>IC;
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M]\ Z=E<,MS?A$JB!+SV?ILFD!IUI&-RK5E;<HS</.F$B5&1?WUL,ZYI[H8\
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MD'7!:(EA($,Z55YXXGQ["&,#[;=6<_>GFL!:<]<KM9WMC=4I[=6,H,II&ZB
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MDI&UN'WF$!7O [C-8D_]-8TGWL6L6%0@T!/^1Q#:Z(%2]03<QD&R]MNI-8X
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MI%:-^#)A8< -U3.O&[7-(PXIYRSVBKZ,25GZ/BG2GWM?;.2!^(+Y1W:>\,'
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M"3 @UCTHJAC_8314<Z'O_:]PFCNU5M, G&._!D7W<1AL\K^.W!560)_<-EZ
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M!I;%$-1IA!7+N)Q3QQNB&\+[M\F-7K#K[:>VZV7(C6;[J</=[MS>#O90.PC
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MHN?@JX ,UX@UI?<F1GD%#3&?!)<-AU]ZSG;^.5=7R W"ABKX&"NHPH74M.Y
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MXV<3C#E?SAB3*6L)$=.AM%9L=U K8(%?SS[ZX"M]_SIN\:'*":EH=<%Q-?B
MTB?X]M[K.TZNL3O'O6'4J<SJE(S,[K2=O].;W8.SHUKO_=E>_S8[;<[OM#&_
MTWOP+<X-B_ * 1#$SLT:M.!94+ 5+"M+BNOA=VQ[4\K '5P%H1]><F7HP.16
M.P)6HH**L8R>Q<+1)/6/?\;@EN*T,?.S C$:*_8FTQ0#=)?XM:%%_>-8KZ+M
M9%)OG+W-/O1EI_=QP[Z(X$+=A-%7RG$$7 >)NI$^0\8LVIMHO6/9",6(':SK
M##/KQ<51]2"5:\<65CI<<SR8ZZUC7H''UU#JW2LL[XQ_XV&-X'N7ZM]I8WT(
M%KD?CE5OF10VCFG +*W;'2H3?#B-)]',ZF-AJ&ZJJ=Z*A[?R>7BT_7W8&?['
M\S_MW8:'M^9YN+D2'DZ)1C@).$X' [8Q5E!2/1,R3DB=8VZ ;A/Z!@=7GGMA
M=PT>/E./."%7BGH)#KIG)UP8BC\9_6_@M(%3TO=\)KHP J>7554648C^8=*-
MZ&6RK55\%2:N,\K6-4]D,5QG'"M6.70F#DX<GDC>AS<15>!:!T-?VBNNG0%?
MT"%^>IQ\FIN88JK9U7M(W^*8A;]G="TB;T>J"GJ6N1-\O_ Y[L4%A]!M\%X]
M<%>ENA=UD8VY5.GLD%-U$0>",U42DQ_0-1)G4EW.].J20P-C*/T7_<ZYVAZ\
MZX%[@W@O XG/ZXINQ$KBAZKB+ZP;GH+7/!$6LKOG+/<PG2*DZGP;<W4UUATA
M,74##IR,],C 3U3;C>2T+_$07*H:DT:-U$)FN Q,(#C^#0(PC+@H'#,"B"A!
MZ;$Y66L<1H5@36XP8>62T!-A0R7F(B8IDC!ROA*G#O\".<)M?ISU\HP>/6(/
M#"+.J'T$CD#IB]L)FNU\0?/7X=_'WR^W?M\=WDK0M.8%S=8*S()R@^C'Q>S7
MP7^:WLY5ZRBNWV;WV_.[;ZU$S)(D11N!JF_<*[C>>*45!U12O9C$*-;0':*F
M0XS!',&62%&?L0_%L"#1DQ*)( <&40@FQ[4#-VA* H]\7)W'UM)I4$%4(ZY[
M<'RCJ93[$8S0E8-1KJK]&\@$S(P[W+XQ KE/.U6:6VPA7GLLRXE<WY'*1^IK
MP*YAW/XTDEN7NI054_1:&=%;R>O!JMB^>PF_2)9;44&T,%)]M>E8VMS".F?O
M;G<K#_/YLO;7?EP_FGPXV[Z5";LSSY?;*S=AN5 3BU>!'Z8#E)5#;<49[&(Y
MBB,GD?>-]8*J#*,_^&AX,>4'F.<?")$Y(TTP/:QV ]=EA +ZV@2EN98."RRX
MJI4-UG>*O/1SS'&?8HH;G9,8^Q;!J^NFC,O$#2R-YO_2_?3YKT'[I+9]]9/=
M[Y5&^'?V2KWE6Q\@\57L*EL[TK9+DOHWQ1=Z-LHR2D2) ;<4JM?J=B?D%Q9)
M5-Z"I8GX%$$SRD\S9!GF-F&=KO:<DKA-+H?\]??5Q_"P/NAYWA/AD.(@RF[M
MMD&4G&-Z\=;L\K6T(D1 "HJWF&XK)U3<:\<'"0D<D:\)*KE6N/:^T:P3L0-F
M(69ML4!1$.G"@ J1L2?,(HM;O9G\#7$PM*>;.*0')V<GF^ &TZOQ'S;N-4*H
MO0/F07OSGCBL7 1]=#[]]J%V\_OP8^N),-A2(FBW?G=>8Y&3_+M( !PILA:*
MB',=V)A/TTF,0.?9.%487''Y:,:?FO /K G%*&*HFYAKD(#=OJ<\)NJUP,@9
M!7A$<J;B2,#VWHC\(0PCA>.)0I_\D;#%7K[=<G@]:=SL]<^OAQ>WL5MVY^V6
MG978+6)X4G\)BQ?TA1W*9QI5O?& C5+$OC,C=4:C$]=O8E=_A=2*I(#A\0.S
M)!T=7@Z"S)GC!NZ@0G#(-:'LKT%X$U@2<D /'GN  Y988$ !Y[FO%Q!O70N9
MPOCVWAYY$3#_!SA&1GNG4T1 ^M<<4%'=#A)2! *@,KBY"B57GW:BI+"=XCTB
M9BK*F2&WG1P%0:)$" UD #*)3=/4_@UD##EB6*GHSQ)LE#*[I<(-\,0K7#*I
MWPRZC<K+T<LA3^5&L[\7)2Y;7+$2GR[QW=(^W7R$V:&03IR-0 &#^[/O*@(G
M\5DN2)!RA"MO+ HS4;-LNH.]:(E5MZ[I78J/SUQ$ BYB9#?ES&;\^TI2?!N0
MVRNLA3XZCF/PG3Y]6FAEW@.,:;%E;DFH $,/*5X^7\"V\+L0[2EZ 3#O):4W
MLL^A' A\ ]\*;*-TJBR9X64PK,%1,B[N(:4Y#5 =*BN,$6AUM@2_H9 .DE"T
M9FS^LW(F51B!8XWG>->DMH6O$5P89$05NK,6ZH0U9R_%V>0]YC-V3PW/2/S"
M')ZH"&H4/@$OR71 9=U)IY#X"U0$=D$0%TDX&^EL@?Q#]B#H)>R4P- ;L"MW
M9<Q?'"PSI\"Z*3D%RD1%FX8$JT*OA"U,?880Q%#W!5@A7%X?H2,Q13QHC&EH
M(9K/-VFS;"??+/OMFS?9^_R]_WN08Y5E+:_=E5A>1Y*^,#(#K!0X_4#9/E0O
M1N8A<?KHBL]I7<EBR).,!^?!^+G!M1>% 6M,(2Q_EC(B2$T?V)V*I$B%Q5Y<
M47R#JMI#[R/FO&LLH$[PVFL\A9EZZX 2)9>"(*-2, &*-DG!ZM3+W*+!Q5ED
MA"\HG=M9E\[=1^E<8UTZ]XQ*YY)ZK+VBL,H^AG9.+@Y58:\.5Y8'[4C4[I\<
MGISO;_[^QY_?/WOUJ^'^T7C<'#YHD=4/9]WNL^1J=V]!R=5N>1!Y,6U>O'VG
M/?>E"J2VYRAWLS?=CZ(;]ZOW==FP!>XK4QO%6UU9&I!J@<"FQ?H&#)^C!3,:
MXQ # E=+.V?LZ5G>I+AD"(13A146J5#,S&F#62GA5%:[X$%)W*125NY0L3)1
M67A<Y.AX!VO3>!9/W%&<,L6RT='":VP$^U1Q_TFD@5OB7F(^+ C&?_YZ]%MM
M^ZAYV/"?2*RT^'KM+1V,7_;,5)8&S!OJE,2 B$PLR9)J]\=)51[5_O37'Y.+
MO[8'$W?KB5!JJ:CVWM)1[25.[\5;@E6ETBOS"H>J6(E*KDX*8ML5C76ER[(L
M_*EB#R/G1GLOU*9-M0GN-RRY(8L),8A<[A[)U"KF^MU)<(#\?A]DHX'V6&%H
M*+TUBUT RO0R#JL.@=G9^JF9#==#F2TBSKFD@8Q_5Q40I:6=W7?\)))/"<7H
M$M;RG=:M*\GZ.(T2+?S+T"$+OB!'D%^GE4T8:$3&W",RY"H+VE273^*M8-<.
MU9-I$/A4=$-E"$8A?7@:8S'4#5QDV@>X8E]=%[68\U4Z]Y46P;!T/YRBYG%1
M<QF$56$^/M.[I1-,E3RI]SZ_\P;UNG<;E=R<5\FK*>+-BKI:J7&I+^=)=#;M
MZU"0>5/#:$FS\_O-]>_-JP//__)7XXD(O1+UU%AL_=WQ\-ALT@$ ,[VCC([D
M/B;9'*LX<J=*422CH^I_=-524J50&J]/@NT<\:"G_'CY@60XX2RXP!9>D"B*
MNQE"XU^O?A_]?NYV_OKZ]#FM6<II/W1Z7!!E1GZMW&R@ I>0,M@L:8]^W%SJ
MT1O.0[HXY;;3]-,@?'?5G$Q.GPAMES.=MN[)=)H[R1=OY['HBBXMAO>P2C&:
MN)$_ T,"G31@"1K?$;D&*$!%I>\1_49A[VOW2X5'"\7#7#G;_BW$P_VKIB]-
M.*K>Z;>=_8LGPE0E J-U6X'Q8]KJ)!?M$/4)&H"8S5+EMG9(*)W<;I%$D6,#
M'CT)?'-I)8+CX$85DADSUC#;*%'$9K<RYEISQMST^KOS_<MUXV-]Z2)SM-RV
MYHVYU72S9"]1:[$@[J";,_%B]^0B^>7RFC7J=:;[GW>CPW;_Z5^4[25%[M)G
MEC'=TJ$M<F#0+8G%^XD47'ML38Q"+.WE)<UF1NF5*@Z6++ 1B6(O)O%7L4B!
M*\0+?<#T"BWE=1;:=*>Z+L,;T5 S&;^&%FEB3-)JI::1ZYTO7$?ZGV;I6A+)
MY.7,0559RL3\M72-2I5SY<E185,.5HBI'J!K2G9Z1KB/JR,%8I\,&=BL&UR2
ME*(6PQ2MP*_FX!Z?.IZAT8YDS;<CS6F^"HV'@[5+^:91N4D^O6H&DV:%+(5N
MYX8>S$FN#UL?0O?CD?>NN74;R=6:EUPY[3$KD%P'19*K%_JI:[= /ET?'!Z_
M__7WO]__\O3%TTZI>"H\&"P-33J^<,88S@#$21'@RKE##)5(A2;5):=;="S]
M><6^I& 5&+.JE;*3;AW#RYQ$WN6E&R4C6:161W=+Z$?BB$@L7AC0[#2!V\X.
MG4J+MVQK(^U 01GADJ*PCW-1=%A+F)RN,VX!Q$+H7^-5_NK.)#5O]FRH08OP
MT/&8\N0HB2S\,U#4D=2]:G<T&SV2,@D0;$ ]WG4_XD*!\72BKO2/VRBUN9M^
M[8?7_>E)([K^ZS8W?7O^IJ^N%4SK&[,H*1,7S71U&05:.AAA-"R!0HZI3 6C
MBE+>Y S)1YF$NGHY4RJLTT3=LY/&#NRZ8G]X=WI8L=\=GO:2RJGC[MEYNB_4
MTJ74%:IQC@@@(95!RE;)9AK(TJJ'-;,48A6TM-^VLGEG/A3YM]N]Z;6<46?I
M)D%D@YUYSEA-,U:;=#[7D)B=^R;)S<KE_HPJ:RHR[E6/DI?9<ZW*7&"B46P/
MTYT&0=*F8A=W>!+U-)#5!^^KZ\_.P^RG>C1/%:[U(BUT[([^'F]__L_IMO/T
MU= B:)%[.LD7;P/=R4W#+ V+4J"Y<?PE5BT.I"<9&P_HL6(T(5>PV)#D01I1
M ?^LOF'I<BVC[RJO3IC?G8.4MQK&*@]]M3N__=&\J1__[>\^$;Y:+O957DIQ
M'V?ZXJTCWV40:60E_DV1KX,,H6T)Y1E5I/J1T?>20O3T>$3,9WD*,-B(;13Z
M51\]Q%I/6))X+AP0VOK0G,LIJ "9^U'A7E(U$!8MLFD@YEF.;\75P>$D'("$
MK5A)4W8&Q\64O=2U*JY-U7X?WJ 6K"#BWQC,(T;)Y[PZ01D/G "!"%S?(RAZ
M'A[$5Y/2KAG/F%-O%8NG<_)@OQC<80(IUZB#,OEF8J1JT=FD"SQAVJ:?JP[T
M1YVI/VY^OV@?77^=M/,@B++*<C4=0$<TASI*EWYS3M- 9ZB J0LW@R <+)ER
M06-]FU7[5S"1# @3LLD:;PZK-H$5'#G)A,/&FQZ1JD>=#ZR?,<JWKZX#,DI7
M;"SY!CR ZH!9E_/L)5WK:J&ECER&80VBT:8SF3@(&,_#4U7]C,H3(SI\+->4
M;QPQLCT"[P3;B\".U"(=!SSR74 #W"P4H''<DAF^\BZO_)D5HYM#N78O?10T
M&QG>+H<FN\)=@]%(#^$";#W'W)%X1M)3P%T 0V?,LX!2H0=&J%?P .RTP*FD
M/Y2)YS#?4UNF,W3_QG"*/Y.Q19,KI#Q%2:+IV-P$]<E0U-[ L_RQ^MS==7WN
M?=3G-M?UN<^E/O?NV)8-_$Q*TM,84I1%KVWP"]UH +(O?[T%4)6%,)$*JK($
MB9*A*DNP[1D_NF0$,F-9E@"Y,Q)E"48ZH:R7P+ +&F8QX*:@K!M@EZ?MWKG=
M[797C5Q>N"9U]"4(G7ST)>#R=/3%$[#5T9> H_/1%]-&CGXAM'DQ \G1)]1E
M[/.=JGW4Q8'4W?8'^^R\#;_L')^O#O;\-[$.)3W(,2(R?.J[YDA!THQ@L(Y6
MCFE?>&2*,TJN%'%&">&%,THF&S!GE$#4,F<4LXYP1C$JOG!&R>ASYHPL*O[N
M3^:,,Y>]$YP;A(8)YZ2TJP8NSD2R6'UP& .J/<2L,HKZH\WZROFD\ "%3^HE
M]Y_YI.3V,I^4C#9@/BG1#\PG)>,5F T634\I$__,)ZT,G^Q5[<[O[[O[7<T;
MB3UCVB]9^V;>GGECBZ5*O<'C&$PF]=,;FWH[8^^[J_I)0>N7M)2R-?M";(.Y
M]M$ZODU6LQEAG00H_.H>,J?Z+9I%\DOUF'&!1;WOHX=4J[82H]K@OMWQY-7>
M8@:LD[G1T/<C8U(($OZ_^]$K7LUQ*+X"&$4%N]Q[<KL\=.-!Y)&;I#='%A]3
M>VZC2V].&$@U!^>NTK![KR:3<?SZU:N;FYMJ[ ZJE^'UJW8TN,**F%?N\-*)
M7J'W^ZJ^LP.<N_.J!H9Q8Z^Q6]]J-.''O>;N*_=;K;ZY5;V:C/*ZE$U.KE?K
M.L/DY!,TLT_NH\H*4B]XS+MLCUS2]S00S"5Q/K0_NJ,0LV]3KA@O&ANM1E@[
M/,T#/?OV./)\N[%'&85&Q8 CY:3#1W!RM_B/.%9/0Q-0"2WLWHW(IT-(/35C
MHKJEZC62D*1.B+792^_-3YV0:14Z8G?6.3 6N$MK:&Y4LR1^"+8&:C5 52Y!
MK4:U_O\>ABF772-H"Y!'EU$X#8:H,<+H-59/3]R4%$&*GB5C_2(BK(O!6LXF
MG$FI1[VA:-_Y)D,*VX/)HR#:76YI;6MG:WL/K(+:%OSXRFDTFO"O^G?WVV:]
M]F=S&0[8JM8YQK;UYNE(IWO8=R>XI!&IY.W[6OZ<RK@?NWT9N9S_91.5Q<TQ
MUEAACK.Q@Q>^#M?>&87!I7W<Z]@(4>@-O+'SO__=:-;?P']NM=[ WL^J[6K%
M_N7 _N6D>WQN'P%+(L*#W:6Z* ]?$MK@&A5]_R/".[B4\L"_--]<>D[%W@?)
M%MH?/92KCGT>.?VI']JG7H!)[- ^P-I,SV&\N(B&]#@@+;%P0GT'EG 63F,G
M(S@Q:>\%Q?*S5FVJH9I*@#($MS+=M=@$>[U :OXR]6<V"?4Z_.<1? 8-';O9
M;&XVP$"M[3T.07K_O+F4#MVJ-I[;G5QJWW>[D[KNH'7K*QG"+QH[;^"V.)$?
MQG;/Z]/E.76'41B'%?N#&P8>7AO8,OBJ]C[X'V 3!_C=F"^C^NXO3C#%Q[7>
M1!Y\LP=N2C0T'G7H>$[@JG_#MP(:6PM6TJ'='HZ\@&Z27B<MR\W9 /WAPV3H
M5&]];[?^*?<6C(NMS2757_/_/>A5,Y>*;_P0PFH31N^[DQL<?$!V<0$W6\C-
MD@.D*EU!##KRN$WM0'@$B6U>'"(F&M5@N6Y5'YY@2\K&K4= L!\19WB=&#:P
MBP/%\5>]Q%[%M@\WHEC8<3AAG'3[_":DO G^$S/_IS)#^U3-T*[P<'+R>LI8
MA01?B@E.!I,0A2<[,*W'<GUWE_-?=A_2?UERC1^ M.2?3/NQ-_2<B#&X'L,Q
MU^O+;:%>?\!S7G:1!^&0+E.'NR7)\.5&]L=PV#\0A&G!CSOP*SJ*QI+T:CP=
MR_'.VY19L.C\4-DJ382=<19YR6 0#AQ=532HM5&U'P/KP8$N&0ZJ/V0\:-E%
M'F .P*PAI5X%@B7I,'[NM:LF*.'XWGB*,!B34 >!FC5-\S,GZH-5'F^>?//=
MV:.)!=%A+'?3&]7&0U)LJ4664.Q(9_Z>/,6:2]ZQYD/>L247>><[5M^U/U7/
MJ@?5).3:;-6H14!%]?,(O%?;?@H$7NY*-A_R2BZYR#M?R>=,X.TE;_#V0][@
M)1?YP9UPU^ ECQN1BE?T)@=$^QGW[ _":8"8Q(^$!HTE!53C(:7HLHL\P.I\
M;@_O1 %X@?_KC,9O["]PY)=V&U%>0JSK[R98TN2AGU4YOO=H*+*41&D\I-A;
M=I$&162IOYY^?%=("R'#TW0;M^#';?*G]G:6X]>]G2=8HG#[;6)?LQO$K/JP
M!WK*(]ZH\696D?"83O4U:YS;OUVX'<]2A=M3I?\9-U(ZXV:N$]E<.9'MHVQ6
MRIW-;0[@/FSDO5QAUNK5[O%9(AU6SE<+P@:$Y?_[?N\#W'=$Y ?2'8:#*7)!
M:H+ 8SK LX/WC_$ SYUO81".9L#XA-R)"26<>N0\_A,]:']X(B=ZX/@#@>?$
M219?L1WK\9_O8>?HB9SO(<%(/+'C_=#>?R+'^\'IN_X3.MG37N>)G.PISZ]Y
M6I)AZ[$<[@'BA5!+(&?.!?7Y$(&1J;;AI9[%P@T(1(:)<\D06VBE#8=BF,DT
M0,^@UU#(8%AF)B&2V3M&3UMOZKN;JJ_-[#$T^PF;>""9?D[ZG12$-ZBY;[XU
ME+Z<[0LU3P4/137A8<N=_*?9<Y=:X(/.F]JJMNXX<*H!Q_/_](RH(S*NT9Q'
M.O[(5"T^YOO:< Z19<O6PCWGM0G@KG7E!%^\G%Z"W7]Q<-#!B6G8^Q\SH(++
M?@WG57&N)<Z5BKG+JX\5*B&A3J6C?]3QM5VKO^QOO&QL2*6#,F3.-G\U#MM*
M3GM1^_/>NOWY/MJ?M];MS\^E_?G.[7#TF5K^<LZZ[X[;YY]ZG=4U ])P1YUV
M)QG<GTE\VE-((]Z$<#ECPBP)+RP>W_[WU(ND49 0+3T?X]FIV KCA_$3$%IO
MB/5N X<@[@@:8CJY"B.:@XS/I$X!G(K#W:KX4PYR@WJ%1:\(&:RR[UXY_D7U
M$37&*35 ,M[D+&UN(=@,&"7_]Z+QHL#T:E5W6J8AJ&1G8VMI2[#_MGWTI6U_
MZ'[LGG<.__VJ/V>,+K6!S&%MU_[U(G=/Z8\UY]OBU):66?S^['7NTW/[Y0Q-
MH]Z^\V.O?Q6_LC][<(U\+P0'U0]G]H$S#ON(7Q?:[[Q^'YOG[G"892?W ^M=
MS5-);?W7^AS.O8D/!U&0@L]W+'Y$8"?[6(NT(O*NI=AR4NS#U,-2NF&4-$R,
M"2DIQ-?"+7[^UY?%V/H@TG)LKM)D%7+LT)F @/GH1(,KNUG'5-GV#]BS9-.H
MHT%K9OQV@;NZ4UN[J_?AKK;6[NH_WEU= 5A7(5**PGLI0?5AO)<23![&>RG&
M6A&\EQ)0*L9[*<%[8CB78D@I!H0I0?,2O)<$4L;"&IAOZ (G\EGW",;WAK]#
M-3?4\&0  27O$<!':F;ZX(WPH_?TZC1[D [+) KH[T-W($USKSDT@(']%V^1
MBPV@^$=B&R_ P<E#B*E5ZYA%26=Y5+9EL2K/1'0V]<QG+:6</VN(=*>:)R[,
MVBJSX^UTVL<QTVTN1<0HSI$7C>R7IP?MDWV[>_@Z#T9\Z'J;FU*VA1_O#@L&
M27W>'1T%O_[QH2OC'^^ F6Q (P/=%#0RK.!U:@'8=M/8*H 4WOBOPHJJ$JRB
M5G5K/A,GOUR:1!E&S]+G:+.>5S%T6TY[".[:OA?NJF]M[9:0YV>39!M)LK54
M$5>.6_ PUQP-D (YCJ1)](@:EE<T,H#BLEC-5DR/?(;\^5<']WRTV7IBA&J4
M$JH+/NB(!U>=3*Z +@?F+!KU9[-F,2XH6FQQ4:*B9_,)T+.!]-Q^8O1LEM+S
M0%"NO<#N_$V3=YXI[9I(NYTG1KNM<MHY\95]Y(<W\7,EVA82;?>)$:WUXBWA
M,JC:[A0%\QRFYTJ]%E)O;YYZ*\@^/,(G+8CYU=<QO_N(^6VO8W[/)>:WTFN\
M1VBUQU,<^V&?.4%L/.&-+:B1_WV $V$X@F_$[G_X6;RR=*#JOI\^EW&XI^>6
M/''KMD\\6(3H?9\O6^0_X@_W^;Z[*/'[?/_]DVO9]%7CC7U"&*OQ:[RGJJ%[
M"?TVEU/.4W!FN?%#B^T%POC^$AX_3/_"(/BK>@,>W,;!:Q7[O>M?NV@M5N@=
MFV?SPK4Q%Q#/RY?4C)$E2T;<K$S$K=@ N^V261^<L_E]-@D'7W&(MQMQ:?)^
MZ/#D^T,O<FF$%F.I+TXD>!,<B76G)9&C<#+V @)3X$Z G-8#_/FU'>"8*S_M
M^UERN,MG7'9+."BO[T'9^^6;FDL[J$$>#F=KJ/@200-H?A[!"IA2/TZ@)"\,
M%3!643\%\"UT(-!"YNS8 $?CM@N9/KR1"17RQT'B6BQQN1K4E]''>6NAKWM)
M9"NDR%9JRK+\N:+'@GF![5+ 1";XH2]^,>>+LQZPYI8FRD#-KU7+"\AO?(E)
M'L8PQ[')W&&R0'-N5.&RT=B,D)EL_GM6[@R-,?<'V1>.%^';<&B;[^NIFS2?
M!=82\_/R*680HX@6R8:E.E?/9,3JV&0N(X^#Q^GN90=:^'R/IN1BMA=#6=0.
MW3WJG9G!?;@VP1 D0&S!4A-,1'Q!&APS[SLL/(!$:E)?T<-EMIMN[+'_Z[[%
MVV\XHC$.4Y>O4C0\,M8;8')9DO105#.V<')--<Y7$Q&4+S\%GHX]Q1N2%]FH
MY T Y_%V 0_4Q'' -G5&)5S#%=*$*X)+*;P8V*1&Z/YZEK<YVA(VV54O.I 7
MT1+J;^@/E]Q_KT= VR\;M7IS(T/M S4&'6=^GN&<S)"F=IY$ETX@\VG5>=GG
M8&<,;\ ;IV_%,=TPDA732-5]\^VD.J+4?K9Q_"4.R5;#+_^>@AZA,;EA2B-8
M>G8!S6Q,WZP[G''!*)P?56/[3NSQK12%=N^:F\9C+I[_XT2NB$^924[S':V"
M<TL&=E=I-F;Z6SC;'$'6F5)(IS1MEEJ09EO@"HON9%RU\:+"0AU[S'?.2>[:
M!28:C5$$^KYR[I%:$"+=RT!-!WU418E51=\0&9T$'/E2IV2!I9^-X$SVA0OV
M$"X^&8G@.S>QUDC.> QK);,YHC8N_$.D6[,T<QHC%? 3>F9"<DWT(VE/!2SY
M0V)PP!B>+E]&/O9E!*&5K,H^OPIC\Z]RY'J2[=AW>">@J5"]\"'AJ_#4PSYU
MPT5JQ+$Q#%<FOMY<N614%"MS*\/8%Y'KFO.O<9*J_DA%/W X)5 1-XK@/F*;
M2P2K8@;7)S'PIZ@T9>G(>,;,8,08QRGN,4D@&<9=\%I%]84W8<'Z*N919M<#
M)V[)5#CFZ%#-RJW:9]/!E?EAO3?WFX, Z<%E!:\?CFF-)W@=/6Q,Q/'$2(H$
MZHJH-\)K*!-LO7C@A[$\<SG3*77(I(J3U5P[/@YL56]*;OPXPA''8[Q1NLL(
M^X@(:0T.F,8]H*(% @Q=5%6)V*J@Q7(#3BLJS\PK4 >@W38VV[V7I1;)J+[K
M>^ZU<+QQD?1X9X.]K;Y6 8;)65TF6-#,#1:\L3_#=O #]Q8VN)W37U)HE2K(
MFG-_RFNPY\.W+]YF"K)O$8#/_Z0D7W*BNK=?6+:SH/FOHA6H3VS]*S\X<+1Y
MIX!^83B_Z/W-?^6FHAYW]/^GA9%^U-1;C0%Y@!8#CL^FZCBPF!&(L""*\<,[
M6!1DP0[3@5H0:_01+\@"CW\T#1 "$[T&%YQ1TLSR9_C9B\F*BT*V!\ 4B@@F
M#-82#N5ARPIA96I$^%GCO6%D9>R_U)\5@!B]:Z!<&MW9^MI^6=^0^ *I>E9%
M,4UZ-Y0>O5PVQWI?'KPX@H"OPMY]+[@.@29LA9%%"A_$?MHK^"\WN"3E'$_[
M?[&+4\$E8(S%=[_9?TV'EZ**B!YZAVIB?(I EJ+ ,(2E!R&LW$<H2[3YP.Y%
M-\U02RK<MH31,G&^NE1YYH#]$OHNVRDW;,##>RJHD(W%!9=D0^:S#W-,110H
M,DKLCAUT3=7*8KVT_ >@>@U,"V*>;"&..AM<X3)F0N;J_\_>EW8GBJT+?_=7
M<.N>OF_W6B3-/'3UJ;7,6*G*5!DK]24+!2.)@@681'_]NP= 5)#!C8+Q#-T9
M#.S]S/,S77R\:G[*7"=]Z%LP&,-/MJV_F;U> T(<G-"P@$V*[7;H[Z#I2P:T
MF3K#'OC]JX'-#Q.X.L")BHZR6>?EFRY"SQ#Y^H <42%(@]O%:2>6C>.J)%J,
M<6$#(%'9@30=CVM,0BQ(TES]AZ5%3J)EGH>&]M!%+B=<.?0?GA8DAA98,?P%
M'3B:*#"Y2QU'3V/"&;%/IN_[P&;\1<=J(-<=&+OP^E-H]'OI@=Q K-<%_-@V
MG?:PCZ?P0?-<1Z(/BRP$3,UQ\*Q:9-$#M(V0FXR>"6/()Y.G ZM5-P!S 6<!
MRC/PZJ?BMX#2 /M.@1D.9T5"2QP] )\&0-_0@->R?WP;LBOZ[!3%YWRQS^G4
M3?P[X;W"EYK(LZ.ZP# ",C((CAS?AE0%0[\49$:CT8-^8-MV<6@6D/+ =K5>
M&)1%'X)T#0Y#_7EW<HO#SA,8@!]AR@W\&(#>H3>$.FT2SX6XAUP"CQIJ,'"$
M(!2-CS)$#]3@3W<\[3W\"\I!-[^'E!&'?7!N#=W;>&\;ANZB@\_#B [  .$#
MV1'NB8!,ZU--$+9H+$,?\*9O#M3(%M!5;];DKO,'<G>QV0=1"L (M!@,@N.I
M?H!4AR&-14 7 I7JV[K1F\+[+K471*-P^ ICR9<NEAWE.:!.7/1">"S@C([G
M5Z<%@F/-V@4XJM"9]W#X%%%:J$8:$3622T+B_;)!_*WMSS8",)S5,=@TB-76
MN["4-K!S<.P/_&E@U_C G9AQ_JD-ZL5 ,F38QTXQC@IX]D1*H4M"@H!F4.1H
MN]3WF3\-PP\H4P,\&4 >D'0<X-9;@&^?'/L-1@LUM#1J^D/4X=[)S4$SYC,]
MVWK:@6>9^5T0UIOB2W"J,]."AMTD38:I#]RS$3TL^)N>CI,770U0VW04!,7!
M ^,G]O)0[  ?S M371@9X"]A*'X6I\%C K&$)/\4HD/D^(8KX@'W!9 2MG!?
M+/NM9^A/ZS:O;A#:>H#GD<SS(^ #!US+&?E B 3(8.@2A]DP60&8P?AV XVM
M22#D^Y"I?%K2#33J!F$<ZVP4<L)).W"*N;1% -G95(4;9CJQ(&S,Y38FK&;$
MFH?9^1HJ1S/"% E'F+6Q&CK@EIX]B(8[8WD4)H Q-06"&1+8+%W%0'/VSA$F
MG.;4!N(H=./%C#KW5M]- =Z&?[8^O"T !Y!)".%Q(@&]*/*9J1?Y9_%I"06V
M@[3LQ"CT;WPT<QIH:_K'20!!S,E0-F'^J@WDPWIXVA+.(4\%L.<>K?GI'>S[
M#N%#>J,0GC-RY,V8>+$3\@/LU#%0+D/K89IKI D)&/]&QS(1S@"+)W6$9IZ)
MF%.RY!B36'1((HQ__AT3DV.%72Y>E@4E)M>C?LON!='4:0$'K""%_SPU#Q/^
M/TTNSL3#)['J:"IU6E>ELPU W&#H889O3-+&*+N&=#02%7&/!K_%Z3[HR+QJ
M9@\A' #^Q4")8@V_'+T,_0K:-#"-]GEN$FCN(9-;LBE,-HFRF"HLBQNQLCCQ
MZ1C(E#WT8+V1.TLFN*YJ:C]D#)VL/.:S%6ZKI-)8DSRC$0 </,ON UC[?VJ\
M0^6-D_J^D[E8<.4A/%3 GY'8,O3A9'X2G"DU.Q) GAX) #-/\0,!+O8'>YQV
M;@]DE<Q  #9F( !\_:=,JV5BAP60KJ)( WWAV@SDX+F&\XHC"K$6FN\K ]H#
M5J4?8UB>!F;QKT[C_]3&V85X&AATGE\/1M+=WBLA&N!B:" XPJ<O>\",:'R%
MDT;ALQ-P3E-[CC8V>[A:.1A714?F5971]+$PF2\L3N9SVV3^1T[F<]MD/MF>
MD.)-;$2;@<KO+*EI!PD<9AQI7J"28;:T1=Z*-I/,%4/#&NY(J_E54!'<6- >
MMK26]VO0I_HW<'U;8N=&(V>]>&+=?VJ]^+_FEPPEXXW9DG&@BK\DE8U3Q<K&
MXQLU@JA"7X,I)IB<I!O)K1AAP#5OP7TQ #8R W"NYKX, &YD)\6"SJ0L33>-
M!;A->3S)QJ=&ICX=DGU/\5T8,^9QQ@8,.TN1?TE-%4"BS_55+% @2S57+&B-
M@-GPL#&BAX,*@4R""J20Y+'\(@_/C22A QJ>2QYE?C"4D'YRQYR4285]AV?A
MI<)[-O&>AJMP3T-FS9G>,M*8:QE9HG,GVDB"15*>/I)&B7TD5.8^DL8&])%D
MUP*K;2-)9L-&(DW!$H2)>9'8Z!EI:\C%C9-,*[X&*H.P_)TI$"#P,[G8>[:V
MRG1?_#K5R:G?@*N'!(?Q#H@_*$N B5E?\$Q"IXV95/:"_/7<&5N14AK_6#!%
M $X4!==T$TBDO<6%;2M8N4YR\[B;(UI[9 %MZ;HPCQ_TH$0KWQ9T:01-&NY4
MEP:UL$N#O/Z*[,B$\$4NP(3+8T5M(T;4EJ+UFG[FI( P;L %/QAOKNL3$):A
M06M,+,-.-QL!2\<,4M%3)MVTFL2U'+A,V+?S8AO$4*'7NW^!P= !AJ$1V_/V
M!&C:P>64[;8Q0"Y97#?2+I410HT%K._Z-A1:DQV(\IG6+EB/CJW!@9^K\+4-
M$DV&A8X.K@TKT: $A7^#C/$(D'4#_&&/;D02^LC&0"WL<-EV#VDQ\% T_%MK
M3UK+<4FC.:5[_$J^L% ?0>$SK&GW#[H(S:A=;?HUCN&?'L>\)UP-2086=7F)
M.(Z:YGFQV9A@,ZC. N &)S',@5^F#Y,]0!!["!O3]T7';AD0FZCSS+9ZL9H_
M6(DU8>R(\0BUOA[$1.8 BAH%^"Q G?#. "5*,9P<RC/[$-FP-JX=P&YH1;9T
M:6V@;S%ZZ<;0Q4T&$9S/G&F2@\ D@" 6J4R+*)KIDK0<CD%QF;5GH%5DP9 $
MTX+;SV"UYD2PTFEBK#%A4E@6#7LE?) BR"! 3K5X0DD U!AJ6W@VVB&6(8E,
MEV1-:TU VWZE+^Y^P7S@MWLT?!Z?J/"P&@L7:R,/%)Q9!_82S&6V)E>/^)W0
M0#/]>Z/B([\ 7#>>_&99U$]B3MMJH30"[FE$&,$7HR)+TW9PU\1J4VI9'Q@7
MW(?YS2RYPS+>7>:]8!Z,"O-@.["6% C08R#S8!^OG_XBD!N<29[YP5OTS[*C
MY74:["4N3N_QV_3>1T[O\=OTWII'OBUVE(H)XF V:_ Z'OTGFR JXZ730^8F
M.VC24H2-^+4.9$Y/LE8I2#)V@;T433+"'\XG&L$W1(ICIC.5I' ZBS]RMD(,
M9<Q,TXL?C%>W>\TF4^>BVO&)G$:F:7H+Q^8%YI! :&)>(S%Q%#<P#W6M^<Z9
M]V;[4U3],)C?3Q\_4U7(-$8/^$$=P_%CWWXAFC_#+37C$\YR2QVQ%^_(SXS8
M6Y#7G78M$[-]WF(@9!^MUU@:]'D&[E&+!^XUD@?N47^>-*_W_DKR:-AJ\G)<
M2J]^$ND&M>_EF+\6I$1\<OU_RTY>FV^82AN]1DU&KS7RCUY;-I\?EVYKE)]N
MH[*DVX+9> 33;56DV:)#X0+PK&$H7!Q1-]8V!XZ:FP/7B)L#5\+H-RKCZ+=&
MB:/?\DU[:Y0T[8W*-^VML0 GN0>\Y4H=5E4*5/_)57S2_&UAM/GPZOSZAOH_
MK3_X3#U<W)X?E_&BI&CV]=_7Y"+:J]1"^-G0H?-GF*-&&/RUYN)_ Y[%7X3V
MDO][# S\#1PQAK_B&%:"Z11"?3*KA,=T=)]</'_^33B^S_*XW# F=)42^)86
M![Z%;>"[8H'ON$Y-PN%NX>.%NV/W=!$,>',9 ]XB(QSDB%DN:I.9W5K"3):W
M[\=&NN(+L(N\N)FRD&CVF;'RA$&O\"5*INN:7_X\0<7-:(8;.@,6O*:&G!/3
M147Z\3?B%CQY2E%D6W$>=&/R#/?(LNSCP.(M_G'<^7W#W[P_?W7W54"CPSX<
M98,^^,\DEDOM4'D0---?'K,+)=N>]4])^R;?NH (=^!E49_VFZ/-[YOD=\7Y
M%8O^#Z=72:(?3O$6V??%/SI AZ#N17I?>8?E;HX.O.NKUJ<\;Q=A8_RBVR8K
MC92-VL7O)<!["?A>W=;K#_WGZ??1UY=/"Z4=.4CCE9>9R<<G25&>W_.>%P09
M7J/D>4O"!J@67G6*97'.][.YKAF_<+3U!1EXB:_WW[02>!*[CQ#>)[+P=D+4
MS.&C878<=Z<S[/5V=IJH=*W9<CU':WN/YM[C^+=QYK[*T@^IR7U:C>""NAF=
M(Q\E+$E^"Q#E"W1D(<U9XB3/@C'W=W$1EF8CKOEF\^)LEASWILAQ'\_ CJ'*
MX<WK1:?W]?+DV5@=5?K'\0L\2Z+.I15W5M693AVK.W,N%3A+,^(TS6ANMVGI
M\%]P"?VKUH-!RT>384]\$[&O[3?'YIGW./XV?GAOCBZ>3X?RQ"\&7/#DV$-+
MW_&=!N>I]2<'_'^.%^#__\I)</@R\BZ+IM7#=&F8LC8F!\P.NCCA)>:'/#X6
MGD 4KS_PX) C!]>B^R-'0DC_$P_H3U,C39KN12=IC D+;'@T_\\#3WWW_K&&
M?=WV=*-MPC%%E/^%^]]/.SQ #G#FP=O!5]#L1L_>NSK]](6E64ZD>84-YIP$
MQ_U"+23IU-L7)>A5@E6(!2M+ *PJR](,*R8 -9X-]^-$]XVCZ<85;!MXA4Y=
M A_VKGM[^P=2[T?W>0$?WD.X+\-\Z#"XB0&?9CFFD]9!'?%@S<%U/ 'RD%F9
MYF5^<W@N!U3CF4X@ %51%6E%50@PG?:.3:9X;AN.'^SCSOW!X'=W15KO*C*@
MW-/>LS->!6@B@&4.%I-(*#:>%CAUXSAL(33C64LF(;!HED\"9CQC,8]&>^AZ
M=G]GYP35'MY NHT0<CQOW>W]O.UU]+>G\TZ9F@P?"?-2=/S_<@IMQ=2A=4;:
M/_' S<%L*@'RX'B:$:2:,UM><,9R&T?$*%=H49'GP+F8VR)J[ )6_$SY_O',
M9AZ]LT+[]R_GI;4B189.%OK_R_":L@8A/ _7['S&<00(0^)H59@GC/+X+"V-
M7@EXQS,B"3M=!'I/R.?%-9,#<) );T(N]'PN[&O-\=[)T^/XAW?^6QN.SX^D
M1=R87?6AD-N-[<%VY"4";R1CO87(*3XTG]%@RLVF(I&@BBIP-"O':L0$V*^
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M\;EJT+TR!<?L&IXG4I*2-6%1_4Z5=##&:G@BZW83P9@E4-P$ (!_HO4N-1/
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MH+>@(V9&.;3F0A*^=.+GSY>3'L!1(*LFGB26!(/7S[]=VE67),;E(9#O#!@
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MON=(HG%HE3 9/B$2@HX'9S""\U6CVFOIX$X:944P4E ZDZA4X&A> 6:4%#O
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M2<=/FE F,MA>E&F)G<^O+2I,$)--5GB9:,@LD,O1@-D3VW5'KO-^>[ZH8)=
MP.S<\/R9DP9<-33LD>OV6=KSSDH=$[ 6%++%G&T77 '\;"Z#($DTH\2F$"H1
M,*D*6M(D:[$BA22D"#(MB//E"ENDY!.GQ7R\1*1(M"K'VB7; -6F178VY!I9
M E1H2]M%9Q(8ON@T7==NFYIGN$U+_V:;EG<'7C $&K?9;@-B]@S]R'9N77!&
M/"W[S/"ZMCYE$[@'W>O[P[,7YZ%;HDV 5U?;';_W%WZ%I\3O:,%)*=-Z-5S/
M,&C*,O D:^V=O$^WCC@8.=05,D5XAD@0@:?5&'-U\V,X)6-OL<7",T1F/["T
MS&?=B+[%76;<+39L>(9$G$6EA9BA*EM#IA(6P+9R:!650T)"Y= >6@!PH[U/
MUPKYI@VT<L9[@[/'L370=4^_Z?T2%XTZ(1#WP'X0A1<3!-/2@1FS8!KQII8,
MA;@I:+(0V<\B,;0JY%ENM4EL11!=:38*B:(@299H/J96>8NLG,A*,TI(% $)
M<.^1$I=1W,98*J*SM]?(8EJ(DS9[K+QOH+;V^P;<9@N.$&A[C^;>X]A^.U/'
M>^?&Q5G)Y<8G$;LADMW.;D!DCX:@Z?2)C]Z2T$9>([$\?P$G[ \=O,+]/.C<
MPZ;UP[&BV'W;$P^4U51]^ >I?^L>ZII/AG0QLYDE,HB2YVD^9J%P%2H'*H.*
M%).8)5'"P4%NV>)A(1Y2K%V6R/1,&7@FL6G>1&G:G$C3 Z-C@//KZ$J1J,3>
M^.5M_--U1OQ3B?9$\/8:"<P%Q#$%RX(BDHC_P]!*_)3.#>;,=."G"46RU1=
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MH&K4K%$%."![^'D1D(M9SCR1X9<B1PLQPR_K7_A1(FK23&02BT,DGJ7%^&G
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M]'?P5_ W2>_G_X@10#'0\-GLW[\!6<40&'"?7W9:!LPA_0,H'U*M3U2H6*
M147(!E%)W.$3H1MGA/A_I,KP>;,<SRW@^'E<?Z9\*^Q_]QF1$0Y0M*'9&6G4
MJ=D'2E+'7OE@[CUJKM=\^G*.) OX++3#4B4(B3?^:WXY?!\XANO/*_>Z]M#5
M8/4A$&5[CC8V>R:0<@#?IDL#@=T#GZ1LN)[C#=:(H\. ZYNYKQ\5R8OI+DKB
MD/21R&OXRNU\V#> #LL<'S6 ]AE BG&&QHP.$SY%6Q .3+?=L]VA8UQTC@W+
M "+^Q,(Z#@C@9LL>>D<!3JX#E !0]C1+\VQGA(@N< P41IET-"W[9. RC%^O
MW@^-T7UK$K*)LA\S)^*9H&T$GDA[!/<5P4]P;\B4:LS%LQC++;NGQ^K0*4V0
M<KXHB\'_I&D*X K-"P@@.OY.D!ML(#(B<$"8X8 +=MH^[Y]?7/]Z-H"+M6\[
M ]L!8 ?L$&(EVD8S1:BYK8G"A@CX1?!_>*&H^*'^_+__53B.^0Q_B+YD/_]%
M(YT,[857HS<"R/"ZE D<ONAB+L#7'<-QP!/ ^S07BIV&_ZA];._X3Z,I$U@\
M5!>@&EI OC$$DT$!M'0@'(!)@"173WMS V]R7QOU ;Q/W!Z6*A9UICGM+L5Q
M-,4QK+I+H9O )_8,^!AX1A,  %!_8S!L]0!SV[ P ;[WSY/+B[_@,[X-P958
M%3^"1IXMNAONQ(.F6<]TX=-L"YWB7'-U[7?DB.ZH#^B6"N!V]-#T;[I+07LO
M<GM6_NPVACT/6+" )H"5![AQ @"7V@/$:?1<<$F+NC[\/ZT/C(5]>Y?Z?JPU
M0\1$/A3@9[>0,4J*?"*7A)> A Z@U1H!)%N&]V8[+Q"!76 = ( 9^K"-V  !
M>F"[W@XP>?4A9A+7,[TA,E'I1L=NHPI&\%'P/,BSP-SOVG8/*8\ ^([Q-.RA
M!X9D<@90#KR1$?S^,'Q= +ZSP_T0;%'\4,"IL*F!8\-"5E\O34X+",@UG%>S
M#75J5\-8<Z#:@F_4#< 7]@ *5[RP#G@E\.T&Y!G'MN#A 9'I\%AF:PB)*?)D
M\*RAXQIN>%/@?X&KFLC^0H^S.\#>?C&!X&Q,_QU05)87<PU$Y2ZTT3$T(4\:
M_8']YD-MT!VYX#UP[!A2U(;I4+IF@C,Z0&7 ]P-V[ T1@[K# 6!+M'>D#5Q#
MP$/0!W/A8QM>%WS^J4OU[98)KJP-!D@FM!T3.1HT^&@/R S$< /DA($K <H%
MJA<!RX/HI(*G:(#0M&OJSVMPWS?D$T%!<8WA_A=X"7B:OQ P/!(4,P, $/"T
MG?!6@"I\FNB:@W4R1XPJBG9<(AL*0!-*/7#:?S!=0_][>ATBP!$T/$+-L<K[
MH/]"-K^ XG9$R30Z"XUE[:4&U:DY *J"X]G/X)^"^!F0\O5N<W=*E?@&8,!Z
MX>;&QK0.56=Z;BX-!QKA@%XN.G<VQ#@,*GBC<&]GTW_.HWGR.# 'S*,^>&S#
M P+K6GY\C#QJ;^@"P+HN8)06L(D0>33?3??Q,;"F@/DV[.F:;IQI0. [;5C&
M?NKIVIG1;QG.XY@9CX3G;W)7O0+V'9!4$(+!^ZD!.JGF/1D9VJ.RWBHA6,B
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MS*$#4L#WD%G(H('97UIUSS<+.AL8/C@U7*-ID1)UU0M":[FLFG1?N\7@!$S
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M*2V9??C*VHA*DBD4$UY]AY.+$8:(Q?Z4KK6?-P>;GZO>9G&.:2M3S#!U/$9
M25^=Q/TT\-1B$_<GX9[O![_VOY4N_)_%\IS2]Z?FF(E!U$_A.YLA1X+6NW>R
M=!K,(MOP3,4U7[>^[)\<>>[%U^9\$_FG9IZ515M?Q:ZC4_'46= \++=_VK?!
M:M1[SI]Y*R^,5?=F0\V5P5N>^=-\_+97?%Z-!KO#$_RG9O!EM)7F'E7XX=JF
MU]8O#-@K5&)2V2B)AE#L625LL""3:/^E32*V<$DCC%8A8=C'$F_1^7EA-DZ[
MH5.>G^DSPDQ27/U7F3A+D6DR$C=TOE]X[NZ/6M&>L2DS/@=,;+)<&<ZC87H^
MV"O[>ZN@D[Z8O3(2"QC%W\;A[4[+_].:BUTR/B>LK/VQ1-[U^:3ESU8S'(D]
M6[OUZZ_5HZJUN[G:&N#8YV#SM<-N'[L!;'AD)XLW]PW;< VJ['3A.NB+8G.\
M?WBU>"6P].*MZ3G1ZH;'* 4F!]%)K21&VL2]08WGC:V;[@_7F9]"..:L4@=A
M!/SM-^5POEQR7'UXLB]NG*I1G*VB.!UG3([%O5)*8_$E>\V/RQI//Z[NR_7.
MEZW.?!S;TW'(RF)PKR(VS=B\$YU>!<[E26GO9#5PL.?$I*^J\]!\HC*S-4W&
M9N0OF]<[S]^*#Y7JBCNJIV+DK64T6>:/YWYX=;6'.:(RBV<(W*8)?UMM>^W_
M_D]QM_S1!P,P#?6.(R[>>-E\\:0>7+<DHYE!03(]I-L>4@P)1H^+$_BXN6&U
MOE0=?W][CCD]$T\P=5#^*I,FW:-C,2D]4_!.I]D[Z?QYW"M_;<PXHV=6_#*Q
MH7-IURS;)W_)A=>NP5%8"8OG\"73>J;@G"]7>]=7C]?[W6_V?+)Z9L5 ?XT=
M=+0"=M T''7ZO?.UM1WLWCRL!J;A_%GW55E'\VE8/..4GBG8._"^]6[#>K?Q
MN[02[-T_HV=&[+V]C#;32X9Y@!"10V;3J1' 5M0=(T@7 A_].#NNJI7 BS*)
MRB]M$DGJ*,1!VA!%9&[QR=5G\[[Z[:%7G)_M,\),4IS]5QDYZ5S+A1@Y(W&#
M_>6V6-\].S3;,X[5C,\!$YLM59@6MCA[ZR,P$0N<796.:TVCTCTKS\4L&9\3
M_AK[8Q7B,"/QR,U7D+8;QI_CTHK#6H[/C'^U1;&V?![R'ZXMG.!J@:OIZ7 )
MP%^AIU=A<53IFDCE/KR(M;Y7X@,'6AF>0J4#3]"(DXBRQH PXASO-1YV.Q>5
M[N6OYEPSNL>95?*\[8S0]G1U%,&E %H?FTM^'OQV'KXV/G\_FK&+>SK.F+C-
MZ;YO!!A>V_[HV 9HB0='2Z\YO*26.#9_7(;?-AK.1A@>&O-* Y^"309W.]T+
M J]N@]Q8>A;87P'E<6S6V:WYSO;SQNGF866U%<GI>'1&8-'E9=0I5[%S[MA\
MO/_=-![<';N]4UL)/AY4:C %'\_(.!J1CZ6!\D]HU!SKD_;?CLJ&G /U,QS=
MTZ\,-_BHMPV_:0/S;GS4N07S/Z4B_N?=I__[/\6MC8___:?S2=/^2R,"BSL.
M/P?_[]W&._HWO+\N_CWL;<E7B+>OA5X'9H#GB7]0\T(@_K_Z%G[6M<VP]:^^
MN_T?^3T_@_\!1HF-L4?+)\AL<1YAU.0!O8<MM1O 79IRV/GHQ?\DGZ6SGSK+
M66NORZR]5%91=G0\^/^HG^=.:[27\?K=KA'H<#,W+1,(%+;T/;C-==#DGFU'
MAP/SU7 C.$EZL:"C<%[7]@+=T.$ 1$Y8T!O ]7K8L@/=1!/!<PN)W[/#Z?1T
M?GX">-;2XV+@XO;'(#ZN("UTS&*CDTVQF?6$="6VE#SYQDI#6.DE>:GJV'\B
MJX& \P6==RC 741T,;T+\K(?BVFVJ^]%37@;L=='W8:A7+M>T$\YEAEK]T7-
MQ0>.!%> ?EX//1">C%/?>&<([Z1G/XB79L-,5Y:EGWD@*(KK^=N2MA4Z4K_9
MV3N\>WZ^J&_\?O[^\.-G*;4YQ8W)KZ3.&$/1?\K_R8XXVCFY!O'7 *8&8YI:
M,K!+'143T%M -FH)86C4_T0@04'-">#9NA.9^+=+0I2U5.E)*0H2-O <&\6P
MJ;PB".$#4LOTF@5+<+$[A,>& "'>L=#=8[$W!3;-!(<(XM,S.Q(MDNB<7"J9
MV&4D2:6INX'],PS'T8%PY O3[5#>8>MZE?V%VV+46[;UB.*H924V!K^TGCI>
M -^%7D&' 5MPT](Y# KPD?X(FTQ2R+?"R'<#NDPU.\2]1NQ&VC8FYG!<FS1L
MBXE#' H_-&JV8X<]',YH-% 1#D%0QD.&+2!(LZ7CJ!T/Q*?N@5A)C#?%3@_>
M8@UU;^N)V/;3?_^_M37]R 9]^E_]PFA:'_4K"VX,MP[V3'&GK*^M<>O)M!_E
MAF*?(%\*SWT'-E@OPFQH!_.$*\K/<00[?P.LPC$Z 4Q%_"6E='%C _A.,;Z*
M&^PUHXMI%.[X"U-2)RE!\TR_X4]R@:X^2+)TDHFE9'D9+Z+\&8@G*O_)-UF/
MUM2-%EO\44>?T+_ZG@_\6O^HGX$1QMC@S,.=+Q;57_TC?H9?]9M .?]^RY"#
M7RW__0?X*H?#?,MX6*M9<-QA0AWB2_4.GX"E%+XA-LF;?%_R9DFJJ@OO/F5.
M9VG@Z4QO=GQ>JQN;&Y4#&+#VB52H$[L-HM+\[S\UD@/I]^R.]9IWG_".#U H
MH: 9>C/-XHW_M3\=/G7@1@O$%>E% 4C* "]6IB R+'K#!ND;N0X\J7LP/;]K
M@[RDR<#R[;&7K\J\P7RGLCCR/F-O14:^[*U8E=O"U0]#<9PP92'0,K>:5PL-
M^$)<AO%UHOR6'#-P7UI& %R0&<+Q\&,Y0"/U\W5]#S81[TC8,;K>X/XMP.U<
M]]KL\H-KU7)QC/2DI;Z$]3QVP"Y?>,B,?%1[\#T]RX";W;<R^M1P_8FN9WR4
M3%UU1<T$22+0&1P]]T%.$MA+\7!J[7^1UK7GH((;^L8:?MW1#=I5VL#$QH*P
M!PVFH+,-+L2[BT_6C:"E-QRO&_ V$KB-(%9\F"IS8 6TFY8# LREO8/]1,\>
M*KEUE<7_*MKJ]9;A-BW!O)[P7$H_J)8Z&P52)+THA$_Y;^$)SH4%ILG6X4W$
M_:C\(OUUMC<JN=?UX\:@TXSB(/%>4&AUT+&LNM=T08$*N.7AT%YQGGC/#B-N
M;M/SS*[M.!^2QU\'HW!-<<+&_E[D$I+C,(=VQW/IJ,+2!%L!Q1P4&SV-^:SH
M)7!>44; W -<NIQ=OC20,@#'5>10_%K? B$7H"'%OOZ;>.VL#^4#3BM.5W9>
M.<.H3G@R9.&(!BW@4CVP.H8/Y'1ZPTD=2V&0Y&2;%OH_K8VT,4RH]'TC.QFT
M,K:2Y=[(Z@;^#VEQI?6R?A6UVW@-PD+ C+5\FU)-Z%3CQG5@S778#:'D3?;V
MZ>>/!CD<.A?]0!W?>[1-Y! 0$D'=MSN*,V3@*G3#]#I,WM.E#%M-G!7_/!CE
M4H>=1IV>?@8S9IPCWQ&VC!!L;6"?F@5:#.@4=<?C&B9[U%4TW<#2AKYP7;^F
MF<E7Q*/C;[%-@XL.<Z/3<6QR'9 ?@LH70)E%#1?M G-]D3O8QPV)?I:\G1IM
MB2KIM#K=+C;YH6:TSE'3)$(O#D*_TX$IC0Y:9GYD)6-RN\D$*I$1 _=B#341
M5$WV7/,SO\\ND!@],%$PZ!=Z%)I4G)L5!9-JW)'NGEM7Q]O?-JSH\KDXCEMT
MD#PQ/NC)^/+.UM;=\T/UO+(9?7>Z6XUWG\0\4=#*B9* %9>X%)Z+%CA]INI;
M*:T''V-V@NH0;5N@.9ET<F$ %F,&RBB/:#;&T(P@\DFI82,TF[[5I*A80UYT
M(.NXC"*=JF'Y\ M24NHM/3%(F/')Z@W#]O5'PXE 2T8RTUO:.'TVHY[63TL2
M=[6PD*QU_0B6:QGPUEH.;0H)%<]RK'I(AAR)/* SGR8]U?>=6NJ=N*9X":A_
M&:'.1+>(P>,J@Q;N"Z>9^*UT<P,!0;HTF./4M4*N0H+1&%-K3:B7N%F!1O8!
M,RIH<T 3B'RB,240Q&9@8-$*"GK3 G4:KQUXP##!L "9A=OV* >:H5R:\ :-
MM\>T@.!MW$-V7]DAN8>E,6S$6RQM<?DE$(^81V9]:K1HII=SXB"SVVXG8LHV
MT^Y#PR5ZP-[5<61Z<^@U&8L$<6*("/[:M0B-82_MMJ[[%IV1*(07L.M1SDX3
MH]N!/#TX9^7]=@/7B]_[-NMSG?,*#R^DB"9K1G6*@+#7Q>>(UJ=&7.*E>W[3
M(.- ZWK^ XB)NA5[Y5T+)XA:5_  $@]&?'"]KF.938M\_L@OH *C-Q-F G]C
MC(%12RP.GH(E]"-9D%V0UG]!C*<3U )&^L..&UQE.'?X"]X"B@O<R6#Z=#"C
MTY3FH3(/.C]@D#=@SB&MQH2#)11W;20*+_B<[+&0#^HC%BTH(8(]I( BB/5:
M3ST=OHZ7&*.2-!"Y$-.8$.,2+"VJ68@H]Z54"0$$9K*(VTM,'8;7Q/*??&@L
M.8+<X2$>U=!AIHIJKFMX<>'NQ4;+J&_'2RP@">!+:[O'A0BJY&JD$B1@)-ZM
MWE*Q1-?DH5#,*$7@S\/*7B1O"86,16=A\T&+[25H0\K"^YHEE KKB1WXQ@@*
M@J;R9>JV5RB)F]__UB=Y#4< 2/=H>U$0NTU:EF/&SEN\2!,WJW#6"4&<\MKA
M]\ -Y@?I#E(O]H8<,S4,HU1?,@Q0D!1U1/.M-1PWX,YE8@]^Y]4]GR<<B=4@
M\1SI94[/A^@3?YVS0GH$J6=U Z&L@+B$'0ZTB,5V$]H0VZ& RY:DW,B7%)R
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M]&>JCWI:@%6R JP\2RX;!/>^! +LT=FH_;RZ/'IPFTO!:%FX][D(L.)&>48
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MAZP2_LCS+V56*<N)/H]"&$-L!\-LV0LEGLLU*XRXH+J(<Q]%PE"XGRSF93
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M_1A[H+. LL#HYCMCN2U<=;**C&;1Q-_DX%U1)LKRU4 =\;JDQ$E*@2T3)''
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MEM2G_$10(A"I??;GSUM[%]]_784EF=KW(\D=4]7<Q=WN4Z]^IS-'.2AU0-3
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MO1]!Y^3WGE5?"I9)SW!4?IFMZ50>1Y*.5"A9O'NNG%LG5^7HFV=:XT0=9X+
MRINM$QIJ?IB/2DYZB2[P%+:.FWZKZ51!7- /_]8(0!E]W%[ ,F\IH12A,).1
M,9U'QJA[D*B%HE0(C)9%@94#N&+X-D&HBYJP!/B*BIVOO5?B5(8HSLVM(,,
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MH.&JJ5+2)" ".' %VWJ9CT;=OY247_8MJRMA?\+V.5YWC1?9L)9=B1X "CA
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M<H"+A]TKES%HY'GC$A.+8-3D154=ZZ+*&_#N.7ARO-WRY>%1NS:K&ZJ3O:%
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MMWLT-@!&JM!)&^ P;/X8PGZ-WHT/'N[K>M?N[8Q<'(@7*!84F%Z0L&E!UT]
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MWKCKQGD=4Z")HZ..NW(7_DV;*=4/_VH-9# NT(G0HWH/ZP&VI744<$)&NJG
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M0$'[#80:?2A#>19]6->'0/2<_/<_ D7RO\$W7($8,QV)>,O]ZD26#!,#=S!
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MP 6QB#Y=)4EM=NOMST:E[W/@4&VC("N!NS[3IG3%;*I+/>Z.A.,ST0QT4P[
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MTZU>QAY-V8<79=I].9:)W@<[U>$#2Q8C^V8]L%5V=+;V_BL-1[]KG]76W^W
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MG6K1,F@07ZY&>$2<J&_FZ^YTQZ\7%%XL_"&PX"\KY EIZ$Q1'!<@;UC#A%^
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MG7/&%ZNC*ZHFEC-0;TD8%Z$Q;J(/[-S07P 5 ;EA]R15[@/5:F3H'5F&0^4
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M7;#07"U( !B'$J'%_'[6.9<Y3P!U'7<I:XB(6E1&4>O@M.G)6MM40-@Z'QM
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MX' B)DDZ:4?(Q7?$"9.:$%="LW/2N5&E#=Z16/67+J3E','BXBJR;'(<T9@
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M3%"8_F0)II]_]B\O,!ESCBUS\"@R@U$#231UIQ7*E>9423&*S&RKLJ+G#G!
MXK?-L2T>/(J,DV5OB^7B1;M^UW^(/RT\/AAB6Y9E(\,0$A!<FIAX@,@G&$#D
M_'& R#AYO#8PN3N)^7R\YPX%1-Z:X2-C&#2@&&P9MF?' 2+C9&;CZD6XS+5O
M2M.# 9&W9N;H^>* 8<*"R,)Q@,@X>?9.OKA1&FVE?/%^*"#RUCP;/2L<4)1G
M%"]Q(/(\I<ZZ#*@=)]?.LVGM?YU;&/%(,]=09K .,R\^N 0P5Q4#,F%CU%Q&
MET]<O/HUU&*.5?QTX+]T$/R7IDC!QMS@3R+\3H;_KJH69EQJLN_CYVY3P0(
MT]0I*5C 'OI)/(5'GG0 F!4# \"C 1(.NQ\"24.A=%YO9 A$.%;NQ, <2N[U
M4V#,+TGA8T>$HS).:')S. 80L6X3QZT;9 7]G>5'TVLP,?J=Z(O^GBPRK;^U
MKB<.#+8/L<VQW74X&0':$K&&ZSH1Y5AQ73^L]@0C5BL</%;+XLSX;9-YBG\Z
MJSZG&*IEM]4ET6$ 'C"A*FV/LQT"3HY]D3HWKT+I:W#'I!BJW9IEHSO[ N X
M3Y8-D?![$E0CA\B1S-2RS>3G7TK]O-QAIN_RH6"U6W-\9*B  3SO68H;%JL-
MT=LCT]@V,U_7[OLCDM?9EQT7EB=8?4<.#M. DCS+-8Z[&0).GAU>7U[U!/6F
MUVH?"E:[+<_RD:/#%* X3Y[%@-6N@K0GB!3*5[,W:BG__O-_IZ?$F:KT6C^)
MJMQ1?A$UY</J(_L3JGB..#V=-3UOJ>.@PRF<[7Y11]\PK85G;VCJO9X\,.%2
MYC\M^@93)/G'+P+M_=14IPKZA?V:X(V#4;MA](W6RD!W][:_30N,_A'@DQXS
MXB,M;*TQ,;,,M[NV+F;8/U8?-5_WV>DRH><D_D74)P-X=CD#FOG-7\0ME$F;
M#6YU1'F&6?[6W_.OH3]Y+8#YP[7?LN,X9HV)__D;\I4+AQF*_'[:4* XP04-
M++Y<[BH=@:66^,9B$[?%>QZO\TB7&UC_^-<AC;2/-#J)O=P#F2/9HM64'_5_
M)J[5O@I5H]W'?N!XCQ3J-3_^O=6'\_:Q"E*NEL!:.KNM:K+61&T!3!3+L!0B
MCC?^H_X+75&HP<QYDUE]9,);V(*L\H8\12I5@RI.5DT U6(/?I+049KEIPI=
M5FLQK7DOYS"+6=9Y_GRWS.*(]VWV7M*16\2U;N3)+*C%N@:U# 0)ABB+F 6Q
M4&#+^NJB*D)&X.< :I:)!2]:]'4OCICWE+[4YS^UE!YQKZC+=1*0&U ':@-2
MY2]'2(H,%))B(2O/9IC G[*0E,.":CR5F,EDF%_JM+I52(H]);GYJ!3T4_)#
M4CP=*"2%8/0U05'-$]<XZD">6)?"(O?[_O^Q(%H#%<<;UW![U*8?@3TG =JF
MS+\S[,+'^</]>P_%6V$_BO516JZ1^*+2NU<F(:JY["\$5UR7<D.7%QWQ6SK4
M3R/9@/\9*%X1>)^D2%_%)5#,3'$)%)LIKC7%U;\YO[FH,E>3NPXVQ26<4LSB
M)S;YBBM8,95?E[4 FHNBV+\X>XX _'P'^H4*8>W0&M! T?8C(//#\[2S@]%
MD17%8ZI?LT_-YC*LEJS,7YJ $.=2.<K)MB'.PL&'.#F,\BR6R<'M_6O][";-
MY2C<MB(=/=..!!+I6:\=,,8I'7R,$R?+3N\?7JXN<D]E44QQC'-KEHT,DDN
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M%U%3%.OUJ*2._HOZZY^&\?>_)Z$+6?FLD/6H"UG9K) U*V3-"ED=UX$8N&L
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M+O&EIP1$T2UFB,>4\U/X):6EE-3JE6"TCH*<&S0_A<5PHP CND4#]^(LN+E
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MR&42+3OH]!UAM$[_!+YPK%AY-L.E#QM*4^]HZA15],P*ZJSY=>B[IM+K03D
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MM*Y0_8'M+O7EW/3E//=[>MD6/[6;R4A%-;Q;@%D8M.+:?N8WP:EM\=%4D R
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M^6&&H<4%2Z6!* *6=KT<@AU3(T''Y"XU6&Q&@0$D[6HT.F.:2[)36'(Y;+S
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M'$<\:(TN6 ;LB("3,M$)11=GH&N5,#R65MP"8/A,8$)?_]X!O#4B89G6R7)
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MXZ[14I[J=Z_U[CX3%=""E5.]W2;^I_Z9>/] 3$(PU6].Q&;Z[],/%K'.X)
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MAL338$D$I.16%9Y0VJ;[4@D<)V=(K$XS19& <B%S@N^6H K)(W[H%W9F%Q
MFS@((%2WP\OS7(UOTG?"A-EGQ'G1XG!];-T1-3G$[Z4S) YO3D)@SC%WT(G3
MX68H',FW%"4!271+0<MH%*')(4-A:6IT[$T.L6<<,!2F!%O.:X9V1I8MP0P*
M2T(MM#5%S@T9SF@4%9"@<&3-BC00J6/NI8L_*8&A<#CAT%H6C[HS6\Q("86E
M6Q'/ I;-J!0?Y$'AJ.ED&" ==<?0J&D:#(6E]1*'TC,V]P)UAV?8Q,,SL74Y
MY,_&7.[\]5+O"@G)SSCJAH?L NAE\0,[-!;4 )"D,[>7R(@5&]A#X\ 5: E0
MDC-7?H]T"PBTTW0"$AQ3QV3!D!$:B]_-.'V[3!W$!Y;0.'QRF@*<2S9K1C?,
M  J-I=J5 Q*;*-V=4F)M0E5H+&.* .TRTR,C5IQ("XW#A:>A9>N,AF6$BQ5\
MH7%X_QP'!)="T(QTT1 9&DLZ-\,#B7:&S(C-<$P^57 ,I@Z(QC-W728O2.7R
M;9\Y-<EJ>[B/'B>Q0C ,%E\^39HN.20*#;PP.!(':,#1SNA-\G$7ADD"[A)T
ML0'3PS-1B @Z,%C\6-&9G9%I+FQ8 X/#>Q489Q MHQ$^B('!$FP6,A-@5] "
M@Z=F64@6VAKT7DU"@ZOT\-<JY[ XPJT<$#9,=DBK#QV^T>$CSXQH]KK2NTO*
MD(!4]3QDV"2$4F/H%;,C=Y#%V@B*=AU"F (F2H*KE1@F"A9G9Z-Y3UX]#S=T
M(3IV2@1T:5FLE:X"(#EG'D1&EX"^*QO-+?+L/TFY%.ND0+>F:,(*PR;"-PBX
M6"Y@%YZCD,E5T>/PMGXE 4,Y&Y $:)/')=YCB;%-7ONZ-]':)>[U8J\5]5EO
MO+U%!CDL@R !Y3(&QA=G.N*N*COR&SF\;6KID&UJ4]%.A0O8QC8=FPDXA3$3
MO;A]/ ZK6R&Z%/@E6/321]]@OB*'(R+#NHP/2NX]&5CS!/3),L:,/6[(8YF/
M20$J;. PNU5VD+;,8W6:613E"SDP)17ZB/>(.+DC +R% ' +!(!+' (0JDN>
M6=4OE='TM=:DM@I7?B*O_Q0>7A,20-,_#7D0@KS1N^BQQ].\( 9_GL=1IB=)
M@.%=$[(RRF#PS'DLK6Q9";"D$_+,B!2QCQZ/I0K/O8]>1I0MPM@\CMQ%-!LN
MHTM<@ >/)5N19H%(N18M9$2*BEKP6(KJ2*C67,)K&66VR<D6<+CJ# ,XSK7N
M.Z,,%D!%P%$ZQY!HUG!&IABA$0%'U1S+ I)Q+1[.R+0AGT/ $4@610D(+N.X
M' 1P1W+HQ",YL374JQ>N.I7;!_KVLAL^DR-FJ.>H6^MQ"W"8PX_V"%B0!-JM
M&7]&J9C0'P%+>UX1,"Y=8Q*?$"EXS*])YF(3D1>;-H$(#1X(.%Q4*!"<2R^>
MC&QXX001A\]*LX FW:9:9+3""C"(6";# $H(-S OH]66D(.(IP&,2(6;:YS1
M;5L,0L3B Y- I)U044:Y2+"$B",>3O$\("G_&ROMN27!Z^&+M'3Y66Y+A5PG
MR0DFZ2J2%P,F;R=CL6GRXL0D>'$QU.!M>ZWYA=S%:"Z95YXAXW3,#JI$>4>.
MLA3-^?*L5J;I R\=C],3EK"FXM* <^F EA$CJ*LK17.9O"IN,KG X\E*6'O7
M\$!PF1N<42:2KRIA+0_=4'I_E&19.V^LS7@H"I N0V<#]#L0$^^1QMCO0#E_
MIZ_N7_G/<81^!S'[JUD3A+V%T24<&<82(*EP :B,FC&'VB4<:<ETR+!B*BKD
MI%14[ ;;#$L&[+*4R5N\  5+8@HXNHYM3RA=]UMZ'"/"P9)8?6HA;&N\=*B>
M@.,J,M43-]; DC@B?2P*](5+=\BT3_QH!4MB]9XY#O#\0:HCCRBB7[/V)$,!
M01H?E!9QZ3OFZ_SV<WQI;->G?5^-#[B3XRDSP>_$LR26&E12!)Q+ 4I&&1P.
M.4MBJ485!"");AE2&8TB-#Y@*1PYO1Z-#S*:1$["8"D\WC3ITB0D(PL6O(/"
MD:A+<= 8R=095NB"PI&(2]$2$!BW(JN,,%$3-5@*AY<.37>>RP@3&Y1"X2@K
M93@*L"ZM:S,JX0)%*!R5I+P$*-&9>I91:5-&!TOAZ4M%LDB;;;;1EC&<7:<N
M_/<_%$_^<F6$,3QJ%6YN3L&A'N;1KM3W>1N>-1_*\@[O*6DZ\$ "F02X<>43
MUOE"W:0;%F#[$^HCJ,A[J@;5QC*JNU ]_O= )OX)X<:#>$J:#MP]IE*P8BK,
M(J;"[">FXO58K;7\Y$C]I8LWU=KXO$U_E=\3ET.YB*U<RMH(NJ&$'5EADF[-
M^J4LAS1G:8<Y&XH7 @9;**P%8AP07-SY/S.J!:5:Z$ ,C;64C"8!S[C6S"2;
M@$'#ZC2U'%9/^)Z2PI/!@APTEEX7HEO*3K+IE!SE$3KL06.MZD*C.UG74I:,
M@*&T_X:8"(UW'B %1,:UZBNC6BBJ;0J8T%@SWV@:B"[*,B-;!&T9.)Q"8QWY
M3HF E%*H+P,;6T)ZC*W$L.4:PT5+A?-@.$D"M,LT( ?#^269I@P06?KB\J>]
MZTO5VQD\TE)_3^OC G7>>F7.T,C(Y"+#KFAO0HJUOQ/8 YV_:W8ZL\A.9W:"
MB3!81B\"VF5.3>**Z1-%G]#H!X,ELXX%$IFD1B%!+UC&8SIBQE>1$ P&1ZX9
M0Z>@159"B1,0M6"P=(*D <>EH%%3HD@5#)]@L,PR0+FT&7UB02(8'.EF#&#H
M%#0+2A1](D .#([<-)H'M)"DAEN!+9P$M_Q,$F>M\0R.XBP!6<4;!/R @(+P
MW9.OGI\*DUXI/YBT$Y<^D9"6R=C;M^T:"6"Q^)<A^Q <*TU">_\LCI S#W@Q
M22-, MZ,;,!^)<?*3,%<?A:'*TF[=,7.2(+!T6=Q.)+0SZ<S_8O/NV=Q.(\B
MH%VZ2&5$B>S2LSC<1 %P?.+GU22"*A$<>19'5Q,I7#^]9%@J 3M4'BDOK7()
MAV4L'P=8P7]DF+OG7DJCYQYCEVF1IYAJN77>O^\E.?YOU[+,=TDD-\]FGRWN
M=@T=<%A:BDAN!=T9>9.$0G!8PL8I(G/ >Y]CT]!1->AFN$/:3, 1=4?<$'7'
M3C47S7WSR/-T*I/T-T3E D8",Y[=BW?+82TC=3-[TL_"?"JF&P3=#!6F0?&9
MY5BR"\>238-C&:J8_KW\0CW?M5I,C4Y<--BS4?$QE=/OQNOCL5942H 74E@@
ME!RJA7;F>+RUE2(065=K+-D$#'P)<.FI\$H,3P:+3/,XPFR4=-3E]+N.5_-8
MO3B:!(QPW(79._&]>:PUEC0/1)?82T8UW!%O'J_'*0+>I>M]1K8X00,!:^\B
ME@6L$*"Z.6DD#&IL"2GJ7908MEQC.*R#\"A6! (9H-V9.R9"I1$3V:Z>_OVA
M\S"^FWZ=3[DDQ],/O9Z>70#%[$Y $0'+0#] N?>[R>B##_X0L)1N"JXI]<FO
M-A,"QD6/GJ^"01@"CIQ4#Q<X(PX^V$+ ,F^/!H*0Z><X  H!RZP]#O!D1I]8
MH @11](N T@NHT_LF(.(HZ*3X:$PI='"$0^\8Q NSEKC&1P9GA():"E2/;V4
M1J @?#W].W/6*:A%\X7U2[8_ZGKZH%(>,%DU914W^W.+12S!6,!*3K#0MUHC
M&=PD9-RTO3,LXG"R7!I*[I%_TD"2@"ZPB,/%8@$G.9-],@)%=GPE+//, <4Y
MJV:3KW8ECP3;C(4B^WX2CI(\CDR4$@[*38?9+B8>?T_"$:\27/%08K.[E\I<
M^1B+L-O%\^Z8K)MC/=%!X_G^$IN6L=_BI%W'G"6LHSJDD$V=,T+OP4N7L*;?
M"B'QW514;4EIJ*(,O)F C66.MRG"WAQJCL0R0D,,:6IG:G='KCE'1@NC>652
M\FFZ7P/J)^@HID _'0C7AD<#.!+O\$LV9/ ^'2Q\0#U<.-(C+.8W_YU;N.%<
M&MSP4"7KUT65K[V03V9;2%S U;-DG3VBTH>=>,H<B=5MHA@@\<==2+5COY<C
ML18PLAR@J,,= <^1TE&64>TBR,U16 OZJ",?2[UKGYW"ZM/1(B#%%.J1Y! P
MF"=.8:UI9%&6DJLSGE$-9\XX1V'U/FD*"&F\M)-#M@@  H6U5Y!( H$^W/)U
MCDI1KZ#$L.4:PV&-:=+0HZ;I $K#+RL]9?C(=N7KS4[N\_RQ4-&F:I(S$0Z]
M?)U;@,;<3@ 2"DOJKA<LDM$''Q)"8:F4% &UJ5 GB3E^'!VPO^S1\U4P,(/&
M4BF8J#+!=!$G(&Q!8QFTP0%)=&VUFI%J2X""QE$]29, ^EL9?>* (F@<Z<X,
M(%T2XS/Z8,8<:!P->E@>*KL4CH/GZ -OT(.+L]9X!D<?'HJ4@,1NN"'=D0(A
MC4A!^/IULV-<\NVQ6:DW$I=.D:KZ=8X^S(F1^_.+&1S9N*++E9%X5F(.LXIR
MQZXP@\/%8EQ:I68DP>  ,S@<+ J0W$&/L=^QU\O@<*HHP+$943"ZN@P.]\DE
MJR4C"1;OEL'19X<%%),DH0EJJ1QFFYUX7%H&1TA. ))+G&>S/UM,LS_K5QE0
MFKNR-PSUVM$-@WGT&V:W]T"W9Y$ 1P3,,!GJ Y?T$O?T$_1.HJ6/&CTE51DH
MNPF2LWA3?T4@T:YP?T96/&0-C2&P6+.#>1JP6V2[)9; 06][E@Z=#9?8/2>'
MJ8.A&2SFPL_H>;<92?&C(2S6K%R6 :1[W#DC,-:+: .<PD9SW+UN'Q*P?$;5
M^*FZ"8]A\68TLX!GHM>>9F2- ]-A\987TPS@MIBOF5@:!S8<Q<QPQ,[7:QR+
M=;(HPS" "L*QRV#3KM,'_OL?BB=_Q8 W9@_.'IP].-B# RF )("N*Y^P]@1U
MHFY8"O4G5'_P7NFI&E13M\H0WC/Z.S&6>R,E$<5_/H3$]N+=O.7 MY>])6,(
M[[?LTUB*(2HU#RY*HA@@5 ?5*O*H'Y%2G87LFNYQR)YLFHKI$[-U1!77@CR_
MI\HY]ZER\N3Z3OY!#-4AVO2J7O_A3^K=NE$1/(KEXPSH7/B&PC@<A6.B!/U<
M9TO! !PD[8.#YF_TBR?]GIJ5Y\F[S/>?V*/GI=#Q-PY+EA_% 8YS2WK8R%;Y
M/2NF:UEKS?GHA3[K5]3A<^>./G8^6D+D%@>TQCA89GJ+0.2<($92U='25U8C
M@;^G+5UO]PN#8:7)9[P3)%S*X2@?$OE(2B>W9^;QC#G^GM[=4Z0RN+L132'C
MHY Q6@Y+GP:*!#3OK$@+P%;D/DTD1Z3S]U3Z>KT4[O*?95H]=EX*%@[F<9C8
MO 3Y)Y):VHN3-G^C,Z;Z>]H]HP>*]G [%=\S!@H4>>:QF-,D(*E(&FC?;KY/
M^/;WM//>ONV62LVWL[=CYZ8( 6\>A[U-TP(0);="DXVL5=@S:Q5TS1P:(VN]
M950 WX$&P8*WU*]\^SP_?+PQ,]::LY;?B:WQ%@Y;'-Y[E.C,O0W 6M2VK#5]
M4J2KGO ^>'D]=@1HC; X+&*!H@ KNM4^1<@T2$*@,>P(B&].Y:)SJLN\30PP
M^I?!5T9/^DVI<K2,[VR%Z@NC"UA@= ZP+BW8@D1B]L)"P7#T_M5+^^%E:+X6
M.L?.3*%Q= &/X0^5HDOQ8!"^*NY9-2T#Z<;%1*XK;XS9Z!T[(VT&TH48@?0@
MC$/OF7'6D73CLD#5&>&*_> RY@F"I M8&G$!AG2:>$'X9XL('A;^\0'3GS7M
MY;KV?-U5CQ9Q<+)20#!=P.$Z2#P0&-=Q]7'B#=O;22Y@^CU]>Y&[D97:DWCL
MO!0,3!>Q@.D"8.@4W6M^:#IYT6^-65YZ*QUM:(\-AZ:+>))3@,@RZ6&AH'#Z
M"]5YO*6O6X:<V4GAX701#YPN EZ,YJ]M$2S&PEO^>/KTLR2V#8GL*1FN% %0
M%W&8Y"P+2"8:R!0:#%#+#OZ:GN4'S LKWKR6V"/G@37BXK",>4X$K!C LEF@
MZG\/97B0_Y[\,U@^A]D1$+?H\3I1DS7S%]&7C8X*#X_\3FX?_'MR\H_U!**I
M]'JS<___?I _K'\CN'W^[V!/M^L_242OV2_FU.?1[S[5UK#[DY"$/Q9_G]'X
M#TBN[PC!&!)&A6<TIS=\ZBH#O$$^5MN3'W#C2S$"^^F4%[M8[8C1X3F^@MCE
M[^7?N[X+TDDQ3+@80ATJ?9/X-*"GI&A6JV/9)*#8CWI#%$2P&!W^?^5KH#2'
M5JD2^F=[A%PL8F0J@% UQ%F:8M'WY%,==HEA5R$*>A_2>/+?_X@T)?PRB4%W
M8J*#@)\?0];4C0D!;["FTD*^VE__-(R_9])N,<2"&T[F''0[ZBN&VOP7LL=<
M#X@YYO>TTF_0@PMYV$01@MF>5RCHH-\:UYP@R5*^FKU12_GWG_\[/27.5*77
M^DE4Y0Z4ZYKR,5(T%*NA28DX/9VIHY8Z#EJJX60?Q"%A6'7VAJ;>Z\D#$RYE
M_M."#RF2A(RXI#@HTGY-<$9$[(N^T5HI&'%GI":D(+P3 GS2HUXOTL+66)U!
MHN:^@ODGV#]6'S5?]]GI,J'G)/Y%U"<#>'8Y0VZHS5_$+52Q-AO<ZHCRC+#\
MK;_G7T-_\EH \T>@\L4YN__S-^0K%PXS%/G]M*% K0P7-+#X<IG'([#4$M]8
M;.*V>,_C=1[ILD+\\>^Z"J=H'QWN)/8O8A9,_4^!Y$BV: <UX4U'7*M]J+!:
M]ATR<+Q'"O6:'__>ZD/%TH)(84$E9@DL*GTGVJHF:TT5JBL3:CW;S,;QQG_4
M?TM? V16P9= S3GLZB-3UEI6Q#9OR%.UIT)# -);-0&\4GOPDX0.EV=\JJ9B
M+P9N7PV]_66=Y\]WRRR.>-]F[R4=Z:*35_[IT\]RJ"]'\A5H/ P0.QG(/%DV
M023XUR4#IZB:S9YNPINBTBYK0UGKJ'#5.7B(0WB:T.J1T7WR8^5N((5O&S'8
M]W]/7PMZY[P\[1M<(]I=$L4":4!O#LJADW8KJGW#,I9%!OW/)M7O:FY 5?"W
MAQZ@J+D.F)FJBW.FV=_3<:E;O^JQW;L*^^/?[P,FD-.&Y&;-VENZW-<XF YJ
MZ6%G.&:%X6JC/GSSQ,$M9ATMO [?E>_IS?<5I;M,X'4&6)R6=/;-E0%?,N\N
MRN7NRUQ-XAM]:(2;]G>MI_XDOOF;."4<YT_\KZ@,9;5G_KG&>:(GSUEFK8_5
MX;!X8ZPII?YB75PI^[<_UKDQ+_Z>-NZNA.;@@:T\-1<;;JDFE/,)>@FJL*\U
MN]#PA"<$M:[JQZ^+!<_\PQQ< [)SS<630ZQVRQ8)1_SHG9Y^]K+TO2SE^[!!
MD']L)&150]H*F>;_"*D8M^@ML&XOV!]<7 YBN*6X>V"; :]S76]]JKU>T*;4
M4;=#D;O9S[4*/VM"?\."2%2MI4 G UY_"$5ICWI$3VTK<>\U)!=%W6K=D%L*
MM!'>S9CWLR-6+%@6FV) OZQG86!F5QW$O3=V-WNKZ>WAIVPH,>^&V\UN2JU1
MTT8I+9] &\:\+6$WVRHJ8Z6G#Q1X&RG-K@9MZLXDYIU).R:8W".@A3Y$@8?#
MV-F2'Z9J".NVHFDQ[XW9S=XJ")$Z#(U1UX=RSZ?4(S:?%4NKN()N#@,VB/,Z
M[FW-V V[F=NAV<*RA64+V[@P*_H5HX>\[_=E![_O@]AA&>.VUZ!=R'@I:R/9
MF!!V&2,3K$W 4B;8.KR.!H7-L(7?:FTI+XA9S"9CO#/0?)[FR$&;_V&6=;;S
M66<NGUF4#EQ7E?+=T+PAOTL'G)$#66L1G=DF -&0>S**=\M#HJ%T5$W3X&,W
MY$AY=JS$S>B>*5+?$^9]2.>:'44[,N36"+KT!Z^37@LS8:F% C0G -)UQ&F0
ME-]$B(:%AC4755%)$HVSRK,PO6C(;V=\)AJ!16.-H.%% T=**0TH40*BR^BA
M *+!)T0T\@;D+91[E$3A>%;/Q;%<.3>:="8<@87#0=+PXH&E]YM( Y*/U!Z'
M2HAPS*%X"XE76NM?3:#$7 WSA5:M+[\,VIG$!):88'0.*T8\B:-HCV4X>,=$
M:@4D)46,]/Y@-%2,>?0G@7+3)Z>/Q9?Q5[7]GLE-<+EQ)VQX0<%1FL@R@"'3
M=]W,$_06L:F"'4M,H)#D*Z^5ZCO5;9N9.;9)2&9%N1Y4#2\A.'QY7@*<&*D5
M9B$A-TE]$9!NR&8J##*.$2\I5<X+E4QD M\KP<@<7HAP>/T2"00VDA!QB;IF
MY%YUE@&10*FI#[0Z5RPW53*[:<+>- ["AI<3'.X_QP'>I?M:L&+^_<O)]P<=
M]?Q)$I3[=Y:YJ=Z8>CWS6P(*B@]E0TL*A</#IU@@N+0F2,N-8J5G)5 TGD;=
MZM5D2*I2%G0,*!K+I PO"UCZ"P&2BQ1JC$,4]LS I;// 64V+XLU*6/@X%'S
M@-R*PZ%F <-(0.0VNP-QS\+<*OEE46T4"D]>?,O2&O6NK-6[<#N=;GYDJAJ\
M5 MZOZ%J=@G#.ET7WUF(Y7%FQESW^8E\<\%=C[^G"N$O_MHDE\M_/C65YJGZ
M==I56RT%/@*2GE:_&D8/RHSPX]_3!8]X9[O%O-S3[-T!4@K2(YXI" ]1<O-*
M;ST7WENM/8KIAKL3+\5_N#4Z8.Q&!]9/<06#*"S)!X!QS<L)@7(G7(!2%#=2
M7CMEEF)>'HN-3'I6I =SE(C& 4= @Y9VP^U")$$G7'12'5!B;V]O.:-*YF4Z
M$R:/JRBF^!&- ^%@!"!0;E.:?>7K+$WRE:Y8TZA.GRM]F:=T*A,HW]MI^\@2
MC:51- ,H/K1Q5TJC!*4D"J4*=(NL:I6WQ[=,A-Q$"&?,B<92NR  27!+*DTL
MNI&$&W#/8M9D[L_S-?6AA4(MF9BYFGY!A0C+0!X)2))S&$8:ZU_GQ(''O:!.
M.+2D^3%239OR(0B^')@[S@A Y5.NTI>C0G-IO)\;-9(CX%M3.KQ0;U<)RS,X
M<!&! Z3D'+^U04IR*9*2!)?)ZB^3-_'QO59I4IF4>$C)ED6Q/(,#WN!$'L!'
MI<FRS*=(1--7D7C]?$]3(Z72O,LDUS-T%D_](8.E 01+ Y:CPMY[7)J$*OD!
MZ,^G-IE[:]3SGVHF13$'H!D< $L:KL#LW<?U[OU[)7O6HG?-DE9DC9K0;69:
M=#L C<$!H(DD T3!+=\[)9FS3P9Z 1ID9PW)2YB\9^_>LXZ=A_$L-H%<XC1+
MC]RLU4>-I\;%!4LUO\<N+V1J5TKX?S[33KTIMS?SE(T&9IKP1.#OG$W,:,:I
M@#-=YMDI9 \RG:Y\&IE^?SM3Y1>Q=Z BC3\MAHV&O'J(M$0YT1IW@?YF;&&O
MC)V2-)>G\5G+K#P-!T7VL%D;9[H*&PV$].!MBD[#9;52,H=/KO;,_I>UR3W_
M*-\T*LJ!LG]XYHX&%7HP-P-H88/J3DL^R;W25V0T([1OC47:E-DUEQ'TM?FW
MCC0?Q/PRGDK]^T;C\3M>MGPL^X6F+#E;7<Z.<SE8', 3#3@N!=F/V;NS=V?O
M/MQWK^2@;','[OG.$KGBM9[3JI,[YC#OK&!7$X<CS7#SU93HB$C=D#6SC>;U
M><O:GMO0^.J!;&T'M+:5=*2Y?IUSZ)&'7MC;ZH?V4'UZN/CV,^9'DYB&4=[Z
M_'NI>PK#<#BR96D1"&3HG')R!\R<HO82C\]?:JO3N[^?LD? R9A;1G!X^J )
MHG\6AW]\?!<J.7V='L2/RTF3^AJ>?7:/@*]C[][ X4CK=!W$$C2RMCMEG>@
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M)ZRM0/6K&]9]^A.J7'AM]50-+LZ^:*?6'Q;:U<,L2!6%LD=GC\X>C5^I):#
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MLL#K4F+E- XQW5VZAA@-U5X;- 1(2@J-5_ [$(C4HQ/7S?&[,KRM?'2XQ$H
MQIMJ-U@%UL'E A I^@!NJFQMQ]64G0U0YTY'JW/G%KJ;.\82VMOB^(NM:9_-
MG' P=?-!,XXD,E0+$BDA#);&&MQRO7/W^/&1?V8/I\UH8#:C0[%94O18VDI[
M[PRZV3@O\C=&\V!8#'L'D!W5!TM8\15&!!P;K?E-4H3I((J""^VKEW[G_>V9
M/1Q;80<2MKLB8@EKVA\CLH"/V'2JE!2Y2R7D3SZ?U9_U5^;I^G"LI5T(6GP!
M PDK#,-20'"9O!QC*UL\@I7N;,'/TD1YO)N4[^ZSF2(;I2KVS$.)Q%K2SY-
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MD4V/)=\0S3;65+6AZ8@( _9<,VVLS5;R?\#LP,-G[@OV@.L+O#-]FF@Y\X"
M!S(5T-Z5G8IQM@@),>2:O<E&8["A#"4,1($*B?AKA74MD&3.@8JX*+6O>>M!
M9>"=Z]#8,Z#_/^?CL]^\,82JU04CC^Z;Z1E0@+Q=""W,5'T-,+T&,5L#T\@
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M1:H994,&ST'=7C/$7L.0)?"3M-J5%4DLR6" :GIZ0::18>_O<KSY-&L4,FO
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M__Y'H$C^MSV:W#*@4,<TW99?6@\0H*M)L@KG"E^CBJ9IA]1LL0>DC0;&!AK
MA)$UK*T-9X^"L0$/X$L-\!IU!%X$M[0A2Q?_UHU_)EK*%C9327/F2J62!;BN
M-/X T>/J+R'-_1V/+M-B;]C3AZHT%1MSTL$G&Q8DTAD4W?*GC;X___[/^3E6
M4&15^H65Q1;0#%490*('G2:*)+'S\XD:E91!W!B?7S1!Z9-$#$Y&:&A@/^@F
MF(K[IZF,(PD""#DH+L]-92S##YQAX@LY*!KA$Y(W;!<BI( K )CX+<8O)\+0
M^T.;OZM,;$&,TE",!\_ _07S??Y5[KP+YUY&NRS^C=5&.J!=VA#K2N,W5@(Z
MW(%!28.<IU/>I_YQ'X-?A4V _AZH&WSDF,#]WW\ K@(0!G9SY[PN [D!)J3;
MN/1B? 5(>7!CPR1H\J'D]9/4JVR__5DT#T@JPC[P,_LW-HE _R=+L 23LPVL
M-#"EL%NE"WPWR3%,=-\XJ43#?/M3TOI IH+?.EJT9V]86]P!)U'L 2-6!0.
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M)OR!!H/I=M!J:OGBP/KL*UW[XSH<&=, $GI.+!C&89J ) "*=J;.";?8<1]
M,><OIF89#1F\QPF[P6B3QP2?!H#@,_VV8D@ GL!+!\Y26P$D->PXV%"& ):E
M<Q&X\-!1:&BFO0Q@%RM]\(,?S^EL]N>%+X+C;J^#V&5E0S[OBY^8Y!41F*CK
MJN+PI %S#TW =4R?L?T75I?[0UGN88N[-!V^2^=PFG9&J&E!FQ*6VBDZ\5?2
M0_)Z%; 596?;>3[-V.2Z;]K?NCN/RU78P>"FEKN:]>G,)5KL\@KNU989F5^;
MOOQOP*KFMS<3-S5;+!6F>9)SRI,H*0-OZ-L?X%,&GL:T<?S=WBR+W&9WR.V:
MIB^PNE/O\V6EG<T-^<-D]>*2%O@<-Y&ZC,_D16"#?X?/%U]4</$;@+(_K9Q
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M64((%OJVO(D:X''8$@;6*HJP2!DZ$RIP*W!,E&"]N5.2_"O4=M<])8DN?++
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M0W^NG/H[)FZD%,.E*;OF8WFN7 T"9'C2//;<@MM^1B2/O]";EU<+('MQ>%E
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MVF"& )@]"8X230K87 I.PS;,X?U) *4RG'S?!&BK]S$=]B!691S3-;.O:ST
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M:D@EL5='4\3WL')SJ#@-*+*<  %0R77==.+\\ 0YD(90K@+U&R"JG&@LE,,
M+!+V8V\$UKQ9#-15_7T2(&L ,UB$X6!@C+8F$ATL$9CGMMCW175-)Q3MB9N<
M.9NE"]X"WX3#2*4K 44 $$D<3:T:L'L,P)SIWV?O=^R=DMP'5GV]#T/T/B'D
M,"\-=(CEM1&A6@>>*?C!F1WF:6LJL(2!LH0.3U8T'?NO ?\P"V*:MCF0=E-N
M^4RQEDMC-N+ ME>U(0R-.9L=_(Z^(#[M&\%MC0T#XM/Y0T&S:*R=+1AKB\-
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M/1M$^*\@(CDZU+P_F\D[%9A]4-;!%*]J3HHH!XJI&;M&8MJ$F=^&JDW2]["
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M@GB0,OUY3?-I\0CI?,E6LM=WU^J'+D>K<+=WHAG6E#<I$):@(&(]WV)GT.;
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M+7%Z:"3=^DD23W$)<I'$RCSSB3N].N9+?:KW=A>9DCPHGBUQ>6@4CBI)$+C
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M!#8:G8AY/B&M%4MW3S?]*^H^,FU\L,Q;)J*1&FD43K%+=WE@V"4&ZWPBNOI
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M]"2U"G$I$;-6(=GK_-4#$15S+.<OQ%E]N'5+A%SJ3Z7J]V!. )DV;9UMB/V
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M]"!D2BH-2U\GEN39$/>88A@4[4&O36]/+TI7XB=[RL5 428 @U_W88F<\Z3
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MEL(K!GB[8O@@RS:>,AED"8 OZK1V=]UO?DPN>X'#+#Z9,0<24@D)-"S."BO
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ML:'E9AG'O6JJ*EAA:K/\G?Q9II,JDLQF\"16[V,92SO00+V/#Z 7%9>QH&&
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M+63A[5@E >5((:LA=B)LVVS#=Z\Y?WJ]??AL7HIUL8FM7U4V&U/MXC:6.>J
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MD5-3']=[:F9\@FRUIXA@66$MJN-/Y$CM*="Y;9YUV*7T*^B8_A-WJ6BCQ]<
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M?N\BN (K VXBIK<#-U@$IRE8>AMJ%^^/[J3$W0I+%K)FU#&X9N:*,DV*+ I
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MZ:%Q).V Z:$E>([>.X>9E"PQUB/QB-=HHC# +:98I#T^1*+$&0 <3@J\:=/
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ML-ME\W5\>OM@BKG>/GN),0<"1'H_@0",7)Q=TI>5R^E,N<O1[WE6UNB(Q:T
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MD8/?4 -)0G0V<=%[&?_)D+QCIH6MM4NSL.$:O8+%)V![,VK=Y6,_HQ<L_H>
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M3-Z/5U /4PX8S&'$?C.>>RSC;2A28I+.R$)MV%]^<VQK[6/][;BGJX"L/PG
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MFOO.0+JO7@\VZ;X?AWI.M-%L*EC"FA2223HQVLK>:!"C<B6LF%8"R2-\E10
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M7_#; W<V'&"$TP/<LQQ%-X+XH?,?5 ]<%"P)+/:[=\[6D6,_O4QL*11K8+&
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MP-0=)#(HE*=(\.]/(8H!M_;^7A[=]6]KUIGR)8DIG5D!R]6+)EF$[OX==&+
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MDN/W,0D8Y!@+LK5(<G+8!?*='7=4C"H,4"O<,J07M?V68Z10G&O\QS(UAQ&
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MXX'CD;"MC*$4S,E*N+_37EUA]*@)?[LD6R*"D2[7!@MC[Z[0_<P0V$K'K6$
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MS][;L%.D%9 YAQGD%@@_7X)YX54$9EA\F?TE0(+#.XN1^YMO;:0;BY(]128
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MZVS7VPOV.)!2*5?T(J-PF0E$O<X4+BV<>P,VZ[7(F< 7Z ^H8\R-$C"T#'Q
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M#>R:BZ\[">%TYR(I'Y!'LF8-B/+>=;ZQ[J]BV0"33O-K:SD]U%%$JV,4,.M
MT&HQ@@Z!OW028M+R]_H&25$KQ^K)":;=W."3.GCW@*3>!4,A I';%-) 9T/
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M->/1&F%#2_4=I8TDW0V+FZ@I;88$RWHVT!4Q?S=9C>GGAP_U/'B$5*>S?JM
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M^6E]@;#>AQQ#>.3)/)G?E,K7WJERH)?('VZ/R+N*&:DPMR5R79Y'O#S?'EE
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MQ<0=<->0HR19@IQ,\5=7><6!&%!0BPOB77)<8P(W%#V-A9@8G]3$(J@R98[
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M#H_OGK_K1F^WP.7&-N\B3S F>Z:*Y(M%PB77VAV<UQO;LT^#U]IH.LVJ&0B
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M>-6AF<QIHK)YTWT6A-NGHCPGD$ :20'DU9?<.4!$=D/U=BQQ58\JZ5);M0;
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M<BB6+%JBS@01C+5?P!YG*G2/28P\L CEFE!Q[KGDAL,H-!O>)\'8)Y8K3^/
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MGZ.U9^N:"M0AAR?ZS]2!2R71T>14(;MT&O+0K&%$5O.1\W'H.&GLQ4R5M))
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MR42ME SG?2DALVF<_;1JBM1,51J'CS,JIU \H8, =$7UX8UCQM]J7EY\YKS
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M]TXN<I5W .=WZQ6;#7S26S-Y*PK*9>[,;-8J]BGN3^(IW#BQ.7/%J2<S$!#
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M[%6IF@T"DM5L?.<8(XI7Q;]"[2YE1!(*6!P&T1IK#8%]=[A>=>^P<?I9UO$
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M1E7-)G:AKF: ^XQ>@@"LG;=0>Q7:2Z:4MY"D'I'CSWN5JUZ/.Y9_[ZS$M_8
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M[!M]Q5>.@C>F'=/B/=GP^EQ%I\9Q6$/ZA+>W72@7S>*5[\'=I=W>XG",>U:
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MS<A+7T?OR)J%T'Y/#M3,A1FR9'D:B39T2%I:6TP'N!1;A+YVY#U!)P1IM5!
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M##Z^.SG[T+\8G'P4O_?/Q=OCXX_B^+\.WW\Z.CX2[\Y./@A\U/%__3YX.[B
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M+KJ?;&KT.]_SB%HME/N9ND,#*Q=KJY!1)_N<SH#]0N6KDUFPSOPJN3IHWL)
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M[9:&SA"DQ \SN&J=//[M4.VCD.T*!&OKEX%HJ7680A%2TTN+%:0!$AR!GR)
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M:H"R>#@Z_]0T%2Z.RN9!&J8'*W9GD:$89_PW^JT=9ZW[B6AZP78C-,.<K_B
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M@AU#;C'<2S9/NW4$NHV:X^[VT"3:V>/8A3-L+%'$*K#,.KW-C2P#6OH4^I=
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M5N(\FJ18'PN4H5_$>6&\&PB7Z)*!]P;A7+%-K)3MC8^_\* ?#!D/TR2_BVX
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M$(ZV218BH>L9.4TJP*8"'GLZY5S0@ZC +]4(ZOLFK&?BJ&K@E_N80^M)G6*
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MHXSN4.J6T;C8>XP!Q?Y(Y0U4)R[$IE@#/_^<>B4WCT5L2Q(4^TV"XOM)4#R
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MZCZQ@==@BM5!"52UH9O;<W+)V11[6G+_._#Q;T(=5$HIV:P+TQ['O[(:V=7
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MH/F,W2I/+ZJ?CUD%5[#;X H:7 %KVSGP&J0]F^30%^5'^VPDFVYY[\)<Q9*
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MT!0++^0W<08(1B&.":39I1QQ<C:&ECR*_'#DCV6B!L9[@@>"P3.N4(/#:ZA
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MT?\:J"3N&=$C/F'4OXS55=T)V<TW[BZ])2?! F=3XW6\DT7-'[1CM%N80A!
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MD>DIFN?,HMGT!Z>!!B(S7?\*^##I)L,^<)P=BD4L6+9,YV3)O.61N(K\AC@
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M](S\I(N%IXY^WDW!1PO*"0F6PZ463_S%.8V#W2:GT>0T&D-68\C6;LD,9>X
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M^H^"Q_E0H[PGH[M@!*XUQM10G$=3U.\V-G@M?%9/T^3^:_,QP@_978NBN\^
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MSO@.88"IE'F$5A"PD O;4H:+D-GT'J_FU*R?3NW5'&_,ZPO&N$3&F<9[+EX
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MWV5X'9RMCQ,>-JZ0#+NSZ6XV& 5^6'^13,4D8.":83GR$S8GX)3!^ L5Z!?
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M"AL134QXFZ'R08/Q>_I]54Q0%N(Y@,=E2H7I"*_W<QHCW8[.MQ'(7@\6&,0
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M6CNX%,*]-\OW4I<0E+7+M[Y&ZV?$W11BB98!\076)^-&UE& V-#(.;K.ZEN
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M^A3/6[5X7N>N\;PE=V]:RM[4:U4/,K_\>'+P!XK\EU\NOA[!'_X_4$L#!!0
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M9YE.6M5&Q[?5A#-2,.!QY0&,(P1UQH-*8B[#;(JY#HY/I6H03@?=Y[N;!Y5
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MK51YI.L[1,3)"A'CE?5VC"4NM:7#RW1&8::C2.+1V77$N!$NYN .Z<?"<;D
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M)6D+K3,CJIJ6M'7ZU?*XM(;\(HUF'B>XNQ<83C2Y.UJ1.#RS>J+!&/4E8*^
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M.X>WGO-=.;DRU8:.QH:_')O_R_04?2B.BOQF&(9P_NR8[K\F+;PBT 7_@Z+
ML0K_18M5<<>"%XTT]"_]Y9'>1907U\744W!VD88J\>^]/_RK@[A23/K/]MWK
M::[A2+I+,?$FZ761=]N<2Z)Q6H);0)\DM1052G\5Q<F#EA3\\AW74.O^Y[?>
MFC9QDZ^=<6Z<-7![PXR"?>^$_VRY\]0%B\9Z@GFZ" =KO]"$R63S4]<(D:BH
MB9H\+^QS?:ICV R>SI:H46:3+4,K?97,-(T '19C:* @D")%NL]A.?)-^4PC
M,0T9?D!I?Q3%^DE6>Z?0RY5]PIHWNU_#.Y)PQBO*Q^_D>&.5B:..*.4[']DL
M1[')=I;-#YO##')(TJ+1,3G_(_#T>F4]T_]VG*E75:2D%(%?MO/-A^;887H[
M<C7A-PY(@;R9Y?M7V"9^*\W+%YJW^C?0]_S+_JUY,O_;0LI7HKBTQ+[]$>E_
MNW+Z?_@69*#/FX#W_X&E9"4KMT;905>.*K%R!2-R_NO@;+];:==:^!\%MV<8
MF4B ]+_XPV]GYC1OT#\9>*9AM2ND?O07)Z?^2R"#MAG3#,CQ-'E!TYU7UEFA
MZ#J1^7>XT=7PU=_#^[0^#?[YZL;?5J:ZE1O7TF%L,20JEG!4&)M(+VJOY=\N
M($]= A) C4A>]\&:))Y4.@Q@S=Q2D,3V7'S?X!GUZ@(!Z!O&N @BTCQ59*09
MB"WAR PF5DX6)SUB/PL.A,(DO6C2XY E&("3!"U2&H X./CANJ*;1PO^O' !
M2E^8Q\& 1Y$C>UGH-#%JME<];:ZQ:*VWJVE"<^@N(%M)8_XW8<I)@ZI!X/IR
MVH3[MC2+5Q64=K&K<DD>LH#B*(9IB7(_8"SPBQKR:DO6%Q+D[163-9F^Z42#
MI@K(.Y:\UGY_DK=LO,K(6S#_1PE%'@ GL" ;&3,:(';[BZ'(AY*XVG\NR) @
M.V^0W;K=;,9LW,KJ1[CZ& =P].,()59DJV[&G_,5LLD7IOSN5.WGW3+F]?.^
M1.!>Z/RNE0)*JR>X#K+!ER8&V:$+9_W5&WR: ;FJ<_SSBDOXUV@WW^5N $52
M:-5G18$P6;F,N1_9<_VG.1@7I4=]2P8\=F18B2D"&"^EKOIR!_]3S0 ET>-Y
M?PX^?ZKZ]\"!G!F,(KETW/?K?LO$5<'@U_V6XJO&XU^=*."R2PB(/366A/Q5
M5^V"AMO5[9B?*B1W(5=]QWV?)3P6_0GF*B3DN5OSONR3("_0)+T[[VO-@P/L
MQ1*%E*U/D.T=U__>C4'K52%]C+P]@RPU_&V8_57HR(JUJC)!UA&N;L<@[ZX8
MKS8GXK'WHMJ"BWHBK\<DF/^J44Q$2V*>G?<J,@_;(:_5?"ID7I1P,9GH10U&
MMK82@JPH)IPV)SH 7BIH3DMPU(@[M+70+*Z,>M^8I/?[1M_]J0!J#$X^&YK"
MB"P:[4WHF27*#YI2.YKTZ$XC>=&R?3B6ZJ/=D7)I,M=E9P0<JT^14)B&0-B?
MHHTRY>7P6Q[UD#,"\;?^39B@/3Z-RK'QQ4R5Q'?MZ1*&.97/).J&AH55NHA9
M(EM-9S:%U7/AF!EV1K[[JZ%G$34ER+Y41G)R:EG(@BWRCHFX[/CH/AR'+?S>
M1\>C@17LMD8X1GH"^6I.;DXONLE\-'5B9G;U@L>JL%J!G0KR_AAF$C)CSX:@
M/$/6W7M1]?6DW/$>..,[/YQ4D\;/V>97FY89@.R:E@P4<AK52*&F2;PMQ&5E
M4X(ZY<!_5>Z]B[0J5-54H)3>GS#7/?B9&+@6;D=2.IW" %>95 Z2,V3AGNS)
MH K:2E%-_-1[0AG+*PY^7VN)\F?PQ?93*F.B)T=7-T$VG0+B&;2,+]S$V,%Y
M')'(><CR,_+6BB1^Z,[?RL%P)AQ33G "%-+5Y9I4#M*S7%3YT+,HBQ)DJ3N>
M!%@5ACVS13:_HE!9H*=MJ&DX$2#K%IE8#!#@QRVGT]ZP*JD<#:10P@ H,O*"
M<"PJ,F3A-J@'4XNP*Y'9[,IIE:RHJ3-2V2'KZI(0@'LB4]WD61&1JG)N3SN=
M&')J&T\(M314BIP,COXGMR]6K1$#O"-1ZY/$C]X<,D28*]=HUO1:77E#TD5?
MAKZT85$_MY.P]8-$S>08)WV%&\&-C,'D0F@LXR7%CXJ%=EIJ"E>J7PPGTB0(
M)+"%Z]C?1.%VQ96,L+HO*+K$KSJQO]MCM9&8DV%5,,EA6]2PK>0,W0YLGZ7V
M4QS,&6*D,#67ZV]O36#]K@4$16F$BZT4S(Q3RR\>*@TT5*PCM#<>'I2?)+&3
MM[$X;0!N+80^/NP#1\4&D1;)M0*Y7!F..3XPO<I#^CO"<B0LZ*;;1#F/'F-&
M2+QRV;H^9J/E:9[GQUDE*O_)[DD@3V50>)EGJC+IJWC( F.B?,?:X_A)\Q$]
M,47Z&2^W';.B%]6@+Q)K2"[0QY$9?670=2,<^&FZ%+VAG<(QD'I_.*RN<'U/
M1_&ZOFY'OVGM,UXB*M>V,P[=IL<C+MG#=G=*\481!/(&7Q?2[LYGGW]S^W3M
MQW<<\0D-8<1!W:P8^U>\<\*=XD+RUK%AU+2^JC%5%91PH4N POKP7A9[7^$M
M(19*G37J#:_Q$<6#E<&Q@3-2*W>N^!J50:(QE]0*4>*N>M/BUG8:2<!YFK_#
M(WT24JAJ^Z&EV*Y>VR)"E=Z4($IPO%$?I>VP<'B(RT[K4?@ET!@?KSKZ@S/_
M;#?#3$YD*-97O;5A.,\C>TMGYT[Y$Q>\-1LOP=K<R#BH$76G$+D8!I-7]$O7
M6--5D5;#DD]#XQ;%2L,BE%LA!]<>.']:T@][6LZ'U\[\>J9-?\X2I6?A:.1.
M]>/@3.V5L%D"]<>GCS-0)W(_<7PB2]J,FVS?]-@7__$C_EL\RV/A9G',.D6-
M!PN,&Y /<-OQ#G0@PKJC?'#3K.1CD-ZV9DL.?R!VX>)MN?#&0\TO:F1$?JM.
ML=_E)715S]>+:K/PU@^&5KR,=J<.C1H/*#C#BYV+C*P'.,,ZI,D_N1KQ4&L4
M/ FX.!0]X+<F>NF@;WT2!EL=R2VP(.W.D)N13Q  /N$[=QRTZN80A7KKH5-$
MMV889)TC.GH.7@24PU4*/C]1CPQ&$^J6=9XET/5*=IL1Y<MC6!WNQ#-+KLT&
MPCIW7>:]Z^HL!SG#AO>T$&'U/4JI-B.:9FF&<XT4[_KV2U!J+D:K$CT6*^(<
M<M-Y/2VH0SS?'Q1;?&1<&<[<]8ZYN%\;LM>L6U1BEC6^EG*CIN'TYB7 $Y%
MFR*_@3[CP1 TN#16Y_F%=* P)A#[M116!6I,\>#N9ZO'#H$%-E-Z.A?*-K:N
MA]$I,:5J+H*YHL26AE04;%IQ<#R;_KC$5'>:F%69V\B&X[>A,)0V.#ZUO,*:
MF,Q QQ!CE%=2C$8),7,3X<PB;4W#PJ/D\9+W^,ZPB&:*E*P<&XJGHSG):(R[
M$WK!&%G2/PZ5#T-F);="W=NJ(;S5M6-1UNX%=\8?<(W*OZ"^=H.<WO.]11Y+
MH5ZJ,LQ'9O@XH;F\_38=NBW]P9*HWR=6M'>#WM(.P[K=0[%KE!YA"1519$%O
MHT@G-&Q%7J-O2YUHYO'CS/1SN5+:/M!(L#5@3+#_X!W:3$9^+^CZC5V[>8NW
M['W;V:D+JZI?]\;?'&<D2E'B,V1@8J"@XW]LIPJ-UN6VVHSLIAY"?%MW*OH:
M_<$8\#QO-JS?1PEW;8?O4#?UL!>%D_XTBO$K"D,/_;'/KF]RD4"KJ[>VH33^
MA6\5T_ZNZBG;.QYI<3T!>L=0ZBJT:5(1#V4E/R*I])H)_EKEABXNT5;&J/%P
MH0GR@+FW+:6N'-AEG/=F6\Q=0UQ8OV'CH^Q_MT1+'3R#ND$>WDR[/>3T=8:G
M4FHA<I'&,R@6;ZU.47N$_TV-@:QK043)2MOG58Y2ZK8ELA[;?)H'$=+K-FI+
MTB75IR9D@0H>L&@%6OQ&3TT=49:T"65'1Z]LW6E]97KWQ%7TR..?K(RFK  @
MEHM:GN:75Y16H+>RU,T].M:-BZ$F]9R9L$E,:9 ,?8[.,[$BW:!59$*&7Z0F
M[X:593&=MND;H8MKKQP<!\-;,>.FFWIU6SI)%V9K=!NMF?8P$=H)/P@=VX_;
MA+Y+DE,[B\7%E,>K32JX.[L[WKYC#CW 9V7T1V4/:&?)]J.7)$NT?VT6C# ;
MHG1J<A31_92+*=>OF**-5H!6L5;GLQHS5I_NTLWD2IDPZY4T7LGU+3;W_88Z
M*_8MDRC,7KYPR?8M T9=C!=>[C+F;&Z'K\P:?S!<A](^VCG2</;P%<(H@1VL
M3BEXO2YBB!)[L?FVQ-B=C>SXN^ ^'/>ZHO"XY>,#W;!]58.I4D[&\CR2=/Y
M<[R2=!29Y9$CYP@3U36!DY279ODR=\=F&CYMVG-:1$&N/]S!:*.7?$SNRK"P
M[OP>-E39QU@=/M ]9/_HH +3(P?OFH,\KW%8DEQ3Q;/30:<C.[PDO:.B+:Y-
ML[H*&QV6MW#7L  ,%0S<.N>!Z- E$/G6#_&+',T.,GZJ^!QIK(IN:3#14J3S
MI@#_R1< I??]+EL2 J\;NK^3QU\])D6>:'E;<4]NO!H3GU322 FZ$6X[85G
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MF>TR(7#IWG?R@+(INSO+JLKH!$/]98.\A)O%$0SFO>Q2-/^SXP ;$)KT##1
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MAQ CO\ QZ;R(QK/K2"]N[*\M4X53)+FASQ:NNOUY,XT!V?/POV_6B@[A)6:
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MCF=Q&V3%>7S<?9E]V*0+EQ,^]=GZYO'*5SOEW(ANE*YOE@5YT=-H$/.%H&C
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MX/K@_A_'9HF0?5]E*8UD_VI:D?IV3_+GU N%.-<2M7$('HYDMH?U^(<VV,G
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MILPM<D90V (O1+<_37^MP+38R#9AI)BNT-XSF,FQ4$]')N6(L\TU0%YPL'I
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M+$H"V';WWIZL=MAIC;0U$_9=YM%_/1.>11X[2L5 R0_L%S=>T6IJTGT#YT5
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MX.PPZ/0<*X>YHD?4=C"_ +\3*__H-+,\_N?Z5&9,,J&)87$MBI3YO^(_9R'
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M7ED^;V23D6F8QD[A*[]U =^\',+5UEYNLY$S>[<1U D2FB"J?HI8: 7I<.P
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M(=^U1<W4M^H2:9T8=:A5]*E&@(%,Z1@H_#50A#ZJ W1H;QEUH',&2Q.>I)U
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MF,8Y-5&QZ"3Q>#$@%0"CM.S+"4'>)"-M1A6SF)"_N"E2MW:Q.#]6D&47*!C
MIF?A9BA1XQY/;3*#/]5,.4W5!+.7%"?0?>X 4N6+;:>7R.9YB(P[5N34Q,R(
M":> OQS$XKTO22G.LR;R(B9:F%*7*\O(O9\;*6!!!O9G%J3I-S^MG(3SBF9[
MK7CK V%KVQXJ?>P22)"#-';+?.;_!C$]!,EA72#&).G$[A&HU,'T"]FC=#%1
MG 550I6Y& ,A6<Z?'QV1?4@?H"E/W1F6<"C 9/UV?5OJD/_G/?[$PLYK%:[>
M$L\XP9_-\5J\Q@((AUK4"U+@Y/#[$ WZ-[B(#%=R#2&S/._&Z\^WX)9B'5"(
MO=5RLG[RR>_)\GAM07@V^2#,AZ_/ RU#VLF&L=9OB\%2LMH/OJFNF:7L4(\L
M?""D:)'3^\N36C.)P;U%?."5^^E&-.R=&&JRW:%'D-GIZ5(3VCW>C??A$[!!
M,L?MSI?P?+V6?;91P'E691-C<3/Z!(5(\&!3L6:?/*!E!&X"K0$/!B^YE.0T
M-1QAY7_R,UP&+#>,R&V1.^-X06FLR4[(S5#B;((H2&^[@Q1#^PVBR0-8,L,(
M5M@C)6P0_;SK$(?Q&O2 +VETMS-'IE=:E5?/B763>?:&V<ZJ]B(LIG,;=RF6
M<P#V68N]@?>+A=<3.55:V0FN[A>X6&,FH-TC[A/4@V[AH_9X'@U*B^^JDU]*
MTT"A2^[R4:0Z 43HBJQ*]<B-CH]K3HYC*_H1B8G,B2^O<,&=PFK#LB.@F)D8
M;?Q^)*)/T ^^?>@^Z(^KMP;7K;>3Q ^+\(RG;Z.Q(?RAGN1F2$A]Z/%9BD\E
M$#FRHKCIT4HF#[@C]O*A&3(#>+_6?L@XAJ<_=$/V+HOB?3#2*:O/4Q'%DIK)
MF"CDN@ Q3!\^B$AN-3#YG1_M'V\K4DIQ5$2)2<X"OUR+GE;)"\WF3!88HDVF
MM.J$U'_RX16DS#$M\W7,F7@UX8%HJ9@KN7IOA,4X@;W;Y9!VCI+C]/$Q!EJ4
M[*37]_A[F/Y'Z-1PH*=B]]_2=^^1XSR,VZD6S\F.3X?4&LX]C1E/>0@N:\N,
MN5*_N;D)%6\$9$I$-:WP@4XV>,DTM+%%.:N1?M/Z'DN->E="/EB]N,G;H3 _
MNMZ[V&PKW7.3]T8VKY#VLF;APM@N0FA4NS<U=$5GOW]"'T1$[C#>*/$/!L:V
MWN[0YJQ5[5YI'&0*W3S4*<+A[$('?C'U'1; D9NK\66R>E4'B8Z2RL]IC$3G
M*PCNZY8F[J!S5T:-HYR)F8;&_B%DZ%41Q7Y OO^ !.)_!U27VPP_8.R'-\M\
M8'M_>96'9??]$OZUU..+?*Q_H^Q$TGM4_IB37?SA\'Y5_A]=Q,.J'/<_X=30
MAY3L#FP!IP*&_A/P]^2VX+1754DV!/(V2#7/>S.'Q24:J< N,X#^%<.;0L")
MCSV'I&M-;98[=NH!%J5R Y-1)8:):[*C?@,OW.'P:(1\FUH)]]S_/>P8HQ[4
MT%P;]$O]+"F@2$:S+Z>V^8>0CA'9R<*:CY#MHZB"H==QR.OV<D2Z(>)#<[1
M!+[@)\C(D;CH*VREV3N :8Z5B]O<67>M!O_J>HB3 &E DPML#F8;B0CX@F9$
MY2=S>W:/E?E(??]5Q;J<IP/]I\WY(9_'+@KZ82,#]4.#6$[^Q.KG]+C_Q//(
M/M0QJTHA$F:44?H>SCO\@87X:(_Y?+GF(9#?F:4^#R4JB>XAP9NB^H&*6+X'
MH/=PA XIVA->-%?</U[DG#$.(K2Q(T/;R0J4)G\W_F.*?%B\[K 0SOV3NR#O
M>T-)-)JSL'J_?)#86 =]'C!_.5?(POVDP?)S;07X=]?B<OWGPBVQOCX@952A
M-G;BFT2L@69;T>BA-6G++UW=R#LH&)'\D;+M*+1Y]@-T<)=&AA'LH4*F(M#H
MSA&3[@52,%S",%*LC_>$7*SH>\$6#TG 34M.6%&O.7^GGF6M>%=/M"DR=_O-
M KF[ND+OMU*C_9VP:AY<R7QP5WG?Q1L^PYFG'WK<C<AL/4,*5O:/O*TM2/PW
M&H6.1FQC)(0&ES0[NTD,;SX88GZ#4!QC?!#WM.VP*:BH81)*^8YO&[3V>=&C
MF<RNOESOG H:?]DYR_WC59 SXJ?Y,!@=](PCC4\@48/,2?A'/HNCN;6'A+E7
M="8"(#Q!O+5#L4P@'#"=GI$E,Y8[<<)P%6(4MO@585&4TDML$N5[-K-B]T?=
M!P3CZAH'U4I]&USCWI3YXLJ&C"+C*<K8[)XN%[^GDFK3'196.*-(@]=GE# H
M XTF!#&019?X /=3EJKV!/GL\K<(SWA(<KJ;G7&_&X?.?C;XU/NJN0\1_?M/
M[Q<WU3^;C:WI*XK18%T=#*?:5..H2)G\H=76A3RL0(% ;-GM7BH"_8\M\UB9
MYEM.0'7GD%(V,C-L'L)GBCB?ZFA3?/V5!Y>>,EGM2DY&AN_^6<3!&VS0,K(-
MW9HFIG3/!])[59]53ZHOD4NB)>NYFKPM&:SLZ6]B".H0""J=(4M#,_YEZ51:
MFGD6*6ONR6A'3=,YIT,!)I2<$SUB[XK6@!@HHY^<%IPR;+O;T'JG8H[OSD)<
M/[GT".S>T$/X;X:VP=+&QBA*3+$:D)B9'^T:P\B18?5A>8*8=MM*_%X_/=WJ
M-/HM,22L&-E [-6^20H-G^5* 7  D9""AB?)WA5S9X^"B'PKV%US>580$D86
M6O]:1MQN@M+Q#B"*L:[:Y"GN3NK.JVUFM9#:C/#[?M43B1L9E)=POE[+EV>\
M1%IP/"M\ZO[DL_QF5CA7^$H#4E6TO7\ND/P(7FRNK384<*1@9UNUU@F;[H]I
MF.-X:\)W<@1TF#\H0P]R(@C*TN*,O*CED 1]>^%'R-=+<0M%$CFMN6E/LA)Y
M+__=+#528.:OJUP*=S=<C!@5LW*=(@4JT:V>IUI>=Y@"GFM_+>_?+D7[#"*
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MX$8+N'?SOH:B0'Q[I-WF]^D[>$(\Q/+-8#OHOG:KKI1-;\DJ?9P;W_8 %X<
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M?#/NR_'<>2O Q.+-Y:U T15SK1<*IS.NWS^Y5AENRG1]HD)UHBI-LRF9UQT
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MR$;>A9V-U=!+7?YFP$-J]"3US0E" 3:K_0&%'13]1LU73[A>J#__6$%"J^F
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MY\.:>'O8$',M<F\I9%3@-*25?GU=Y'D3-/[GRJB^HF?"QP$^F__P.6L/VA?
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MM':S+.\ X!/=,)$YMU!ANPWSXX\4@*&__#^OWW;$'G-6C_N<9@!5W@_2ZFG
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ME)3 ]K?*0(-[?Q<\5Z+^N"Q^0[KS?"X6P V>B%7D=10X5?\(@MZXS^=]Q[$
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M'N8T]KWTG8JG_'%F]L8NFZB_'Q;PF7_O+.L!MGD-DG)7Q.Z7#7.\Z'/,IK;
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M&8[>-;I(JQY)$&8%(Q+<<%$@A']70'5%@DYP-LB,O<IH-G-+Y%&.MH(E;?F
MY?IB1(?9=890#=1$LO$1RK9L3Y;A@TL _^ER;%:-X^#6:\4'T<1D+Z2Q(P0D
M0]-@>@1K!G[B[_D^?;DO$]UD8OE$E=-9^+F*K_E.0@Q:Q=Q(#A,=13]#Y8.'
M(V^:1W6LHK4BCAB/Q9Z['!QL25 >!< -&Q2F"LVUR-6:TCIN&11U]@N[OO#U
M[Y81"7:9(ZT_MM"HCMV2MF1\.GR PAY1DLM))>-/MEO 7^CC6ROP2S1[8&,?
MCV= TH.8S:["OG&'0D?+.JP :T)98OYHKEB[M*"T>"!Y8&-VW(+D%KI2XPP
MQX")LJ U5S'G3,#$_:7\JW],K9&3"PQ:6IF$RY)-,;N_::!$HV"(G2CR>&0(
M/E5G+4)NF).11_?#%G1_<<FR(ZHVM!3?C+4('N3.TF.;YDNF-]#&-PY05*>/
MZ?$]7A+GMY/L80C'D_28MKZ^2O7)<'*%J[HA_Y7PER<]V2S"NCL8WAPN%JKE
M0PC>]%5R6<;XV4DF&PQ!QLQ#42^J(:CD/K;L"385D/@,X +2X#!U"9RG3DLK
M8%QE#H'BN(]G*3M0/O8E8!!A \'@*]+ZRM6 ]:'/Q9T(6U',/[7Y&#/C"6D4
MQB,!>DBA0S<"B.U&0RC=M 6/4_^C.JC(#0E2L!CN\%D9]_ZO/+_\5!4$\/3R
M:D]DC)0F6JZX<MR+.V_G2L7E^5]MT4": "!,_WJ&H^+M.'_65RON<$/N/5+W
M8MUG0Z[*J>U4=2$/7(^;D4!7MQN'6)%1CR;:"@3.P9_3F[Z%2Z!H$$+M3QV\
MN@,K#BA/U9<3,=[C'>QGJ&NC.:ZMR5)D-=B)FJ+L!R;Y0Z*U3<_QA]=&3P=6
M?E2^KS4G*OP% NDARA-J\7JWP<AW)L]Z4?L4'P5F0:)=E"?THB$ZX6$Q?T2J
M28#3P#<AP2#(58*8UZN2I21(_@O$B'-W_U"SF @\.0F\,&=.6JF[2$]F9)K9
M+6^FS*D%F\F*?^'F*XS(=Z*79S4$ MRZ_TB^08*]&J\@IWL Q++<_K3?Y;%:
MFP 0L:;]$92&W*'=[T-)$35SL1H@0@=8*='5&44U#DB1N8/O$<NH\B:^;/_1
MX+*KKM2(1*&^JE.+#*S\XQP(!A/(R(#T-@B,*1Q)D"K58?*0#!LP.FYW%N H
M<W2%FYG1!3:&4Y'UNT1*@0?JD%#U583R/Z,MC0#2TBN&F!K)$,_;3(+SZ$W)
M,&>SRMKNS,('AB&YZKN)V'=Y=V4)C(>A,$E/!2T3(IW'[?:ND+/:U6A^X0MK
M>,^_]*:^M6GH1E3*DJ&!S 4!)Z5M-]_V&/K.B"1P!U45KU Z\#<T,/D$!0Q0
M9\ 5#QY(EYR@>B4^!ORQ1SP%OT,).Y2TS-Z-Y^^WLUA0>7<5XINAT4!=<58#
M LC@@/A]\9_>>M$CV\C!*&)Z_F4 D+=XG_1!=$VD"JK<D7F.CFW8$QB&KZP?
MJ=_L\NM-/O'"*=%^W2X15;+B9[FX F@1S3S2'MGMF.^?6W^LW0YBW]@:16S$
M(?H6C5]NEK6L:$;U:&'Z^-\BCLSH,/D]TF<]LBW:'[ 3I/ZXET]?O6W(L#&:
M?^I55&_[3B'L5H&?QMU4!_:O<\>N)!8ZXOY\"N,LN=9O'E*YJPJ6: :E7?N
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MP&:D_NQ;@*\8.F!?!)=C_P=02P,$%     @ W(M_7#'TS[8+<0  \(T   T
M  !I;6%G95\P,#(N:G!GM+P%7%3;]@ \0W?(T"DYI+0T@TC7,/0 2J> =(D"
M"N+0#4/'T$-W*"*-=(<H+2 HK0+ZX8UW[WWWWO?N_WW?=_@M?LPYL]?>:Z]>
M>QV^SWU_!R!35U93!@"!0(#%U0_@^R) $8"'@X.+@XV'BXN+CX]'0 0B)B(D
M)**]1D$*8J1C9F*D8V!@81?@8F'E8V-@ -_DYA,4$A459>:2E)40EA$0$17^
M@02(AX]/1$A$0TQ,(WR=X;KP__GZW@D@Q\,HP:S!!+(",,B!F.3 []T 9@
MB W\Z0+\<@$Q,+&P<7#Q\ D(K[[00 ;  &)B8F!A8F-C85T]#;IZ#L BQ[YV
M74@!AT+7$I?5'20<$I^'QW:KYB4E;/P3NXB51R@^ 14U#2T=!R<7F)M'5$S\
MIH2DE.)M)645535U/7T#0R-C$[BUC:V=O8.CDZ>7MX^OGW_ XR=AX4\CGB$2
M$I.24U+3TI'Y!86HHN*2TK+:NOJ&QJ;FEM:N5]T]O7W] X,3DU/3,[-S\PLK
MJVOK&YM;[[=W#@Z/CD].SSY_^?J#+B  $_CK]9=TD5_1A8&%A8F%^X,N((;O
MCR^08V%?%\*YIJ"+:^E.P2H<@@>Z%9]7\Q*?303VB=+*8YR BEUTA>/@!VD_
M4?;/" O]GRC[%V&_T;4 (,($7C$/DQP@#SB3#O0K##&?Y?-,3-R%7<:0[C\L
MBI3_?*+3]V7J&(@[]^[;UH[#.0/STJ66CA) X51"ON4K4JX/]TQ>3V\<0A;T
MTX#8FI>7HU-3QU L9NO'YSFE!1_N/_(\$9,%_0L!^_];!'^_@H2?$-0J_(0@
M"4@ZS_+;C%I* ,53U9\&#/PT0!="=OG[ 5-0+'F;GV>,^S&C&.@?(_AYR?\(
M@<2_(8CY_9)_HSGN;S?M]RN8L N^_O,CYI\F+JU3UG$"//UIM.C/NU$TRC".
M_.,MU!(V_=.27+SG/R%1^6F)3K =^0B8_[/+E2]C6(]^MPC1(V&22MPU2#JI
MRMV18-K?3P_S+Y./@++K+3WT C+_GE"-MFWEC]H.&#=^(FO\YS$9,A[@7+R'
MOY_SP9_7K_$O,?C3EOPW,1CX6SFR^3<$OZR5X=_V]&_DZ"]6\'MB_\,*_IZK
M?T*@^E](^*][\-<D_&D/_BA7CK4+73726.O<;(F&CHF/2A(O)R]*,-D\'_E]
M\X+I0NA2<@YV<F*/2G<(?S4# %TET+\!XWM /@+\)RA$%>9B(.#J &Z'JS]2
M$A  <#X" .<&7]W](V 7_G@ S@\F !?5]'$&,RH9($\)W=,Y,&HKVW4<26[9
MCMZ#XIPZ5@Q*55?JGKQ1/L)W=K@XELCSVO,XNKSW7%7N.-PKX:[I;9)M?>NI
MF0?/V6IBY>5T&G1U"/8M7 6R+OW1-#+RQ:]BE_;96G)%P6JKA3)*A#=7H,QD
M3A0,B@Y;GRICI*4=OJV3QW85X97)&6"^YPX9O"R^D[/?:;2K<7J73&.ZZZ'8
M])$Z&#-92J!^B]\/=TV;CJ1\^6LK H[E@5YYH_;MY$O>@YLEUP??TNV4%$IG
MUCE(E6X_TJ(3J'VZT8[36J>&L/1,$K_#\C0>_*@W8\OYT^%8RE<C4U7/CVHA
M@]\!KDYQ1_P%WPQ8_8J9=_.\OR*V58DDF=.*9.N%B614WQH4XMR6XZSSP&1L
M.4'3--";A!O:7NS0'LO*W5<T+3EC,+R731$I&;JI.HH28B1H;>+IG*PS*W!8
MZ*@27/J2&X",<FIMB'1I:;)CZ@J6NAA';KE<Z+GVW1N$GL_4TR57K'&S; 8+
M;"(<6*)"\8KU_LS.*^:):*AI0+!!NO\;"+N=7'O4^BA9KB#C\G;.?LX&A!:D
MJP1P@C_J*WLH/U)<PB^_-BW/O*4W!E0"0?\1J&FH_8P;YU\KE;YZPG8-V*,@
M]MIP^[FC <5T#!B[U H1RCWA30I"[ 26#LM[0DEOJ?.T+15:/A@P(&3 Z*,M
MEAFBH[8#@FQJ<F]//44;Q1S2LAS-& @QKXZJ^P7MT BR'+.LT^%HQ ;P"/=-
MQG_1?=&H'+0-9"E NNI\GG!ER_P4H(>AH.(4?=>]4_*D%$Q.5 1]T08U79H1
M^T WW<\3S6 ]-_,-W,E80COT:L713OIC959LKEBY<][V:7O%]8C]BYELV9*^
M!H 8.=32 '(*NM!58B$ YZ?]H Y?XS=="[Y2((L?VT9;B/JA+/EQP&U-"U(H
MWEGQ.,("VCQ1X1IRY#*6N$0PF-,USOW&^?Y!SBV_REC,B3@$8,N%KZ%<>7&3
M_=F^L].;2O=G<0\I+8Y+E@V>$4IC0R6M'# @CIX&W\:R59,&0TBO/ULM5"$-
MOT6K<XL4!.3@,(SYBK_NMYIL$K?2*?-8SU6"EFUQ.9@]/W]I?@O@(UGR\(W;
MIO\CA\C7N-B^(1#>VFGN;=V/''XL8S1G$E\1@"#F:!$?;9%A6MF ( ?@*B)Z
M'9_6 Z([A8R13DI69$?L^&,Q@;$]ABGAO,V;,*MX9EPBT!8.:LE_G0"0*)HT
MYL$]A><-"DT)"?N?A"[]YM=G\F_D!X.%WE]9FJFZ[X!8_8M'63I0D^^ G^7O
M3S;I;R$A)>''UE]!@>B_C&"4A$2E:8^4V=D 89=U7+>'R[H$J;D:@Z%/0<'"
M3J#F3G?5+1H$P9.*$2EB*R6-0$9QCIH4E>YT!N[34L[9$VE[Y/"62I(JI3T;
MS=?96P]N%-$KN)P^8)$DPG^3@Y:5$2E6<3CM(NJ]:-16DX>3I!KF6!-" X?\
M7!8.5^FKEFVD6>B="I'#ZTW7%CM>:;BQWX[NQ^$MCGP%?Z"+U]YHBRLO0H&\
M=X=JDC4+9:R]2G#8QS"!;<@8]6"M<RN!V@T:M%-V=V<YP,1DF5VPQY4Y"2N;
MM_K;8,,Y[MR#%TMK-"6)2K5J4:%\TIQ=024<^F$G*EQ4#6A3=.89M5!_G=!=
M/BX&Z,),W:F_F]P;VFB.!<L%"<JI@=RY=MWBQ&_E''(-R;8KA-[V@:BEGC,+
MBL<*NJ4Z9<(ZB,I9J!YC[^<YQH&FX(<-4G><OJ:DRKZ;@DFDFY)C;\<&+-\E
MV([T/<V[]]R^R*]89<5%G#8JDGQ+7F M)N  LF&8<]O@DU_+MP'#YC;G4&T%
MV?*B/9,%NUAGU%.J08AG)L5$O6-F7:I(<SY"W>Q(X;H2IQ(M"% /LX']0PO#
MJ40?[@XA5'5T) 90JG^;,I\;=GT4K7KAM"?Z]0 R6;,YOCS,40\'/;U6V/SH
M3,FD==;51: @9N+,2[>?+#?*@A3M'9DW5UDRNXI]KDB:?NE4YZ>G'I@H^63_
M37NEWS ;RB"L046$JD L^7)J+%F/?8>4V8\N1^^ XT*J/F7LM;B%9Q.[7:OC
M ]GBP81RTP,N+MP.?1T\1U7Z,_8Z;ZL^4>H]Q^=/I'#R2LWI(SX:9%$GQ2=A
MJ*R8E4QN3-T0@"WT/>AZ<%D@[V77@:DSD3>9;Q/1@CM=!X-OS\QH[A$%:CZ]
ML>^X-"*6GU$K*>VB8D2=BA"(4[!I[ZN3;CXIU++6-^:O6F]70?CV)=;?EVN8
M[D&9*O+MQU],/JH899D&7_ 6O?3@4O48],A-#)-7!QI<284D9U.%O]%-JT,Q
M!!?/=; D,]QAMN'1A_?>BGY%-X.*WEI\\ZZQ?7=NF^)8]32=;= 8H(WWU:#[
M4THJ8U]F-9,_GG$R[K;J"V>=FE&!IA*QUS5O1S=28=9/776?SI2:#OF[/[*P
M:CDD3ZZCBTU%?, -.YYN%A&]MQ[E8M</JOWLIIU\70$?@RV9Y[X2YNG43/_Z
MGICSU*/:11FHENB&9H@\/"4HT*B1FBI\1QQYDX!S?E9L4FTEB#]/,$V;T+5?
MYO$)*O85G9/I%PT@C[$0GX<'=\+.RV/63WLG&[,YQ.OE;-TJKW%$S $,!AK.
M>/?6XU<@=#KM3EM.)(ZBRZ$(;F%<N(@"Z[@:4@1"^$_]E^8OGE"G2.M;OLZ9
MSF$N4<"571'C^P[XV15.43WZ.?KZZ_CJ[V(NS 85]O%7T8<\6T7:(C"FY,%=
M!_X38,!((J>@I77_&0@XA8.;E]<ZRS.;^$JL^^"U3]HK5J8N5)#KHYMGKNR+
M.)>YOKDDD2/1=L;I?6D!1%,-/0K>TCOWE]3D,[^IW2_XK(,RKI]NX/95-S?&
MEKR[/X9K$H_$Q!Q#K.=/-?#/5+&OK#83">*RYM>TM39.5-H$HN=27RQC!$O+
M?2Y@K:V\8>)ULS7LFT4Z3$4LC*KA067,+"%+ FLW^/SI<K T6X]HYMGV3(O^
ME!C>\1QGRKIK<R)V31<I7*_TSJTZES3-. E.B-RGCQ!&WB$Z:T\ J>:$Z/AU
M SM@1K&L,S)#/WM3OCZ,R2C]T-U@LSGKA%<EX9W&P'50T +@P^<2NVQ>;QQ#
M OS.84\?>':!IU\%K0\U2W%N:;L&J';(JFR=3?4FE"WO%J,B=[\L]\7L#>+3
M7*:3]L[QQ?LEN'#;;'1)DG/XY8>')M(J4 ?:&>N9&%Y<Q8[6=KXC.?VHD*5
M?7*GFT;43>Q+>$^P5D6FWV.B&'21ZWG35:2)]V=YEFTR-"$>V&(-+BJ>KSF!
M6.<8:PT [R]%JCL(DPP"*>1F;[DGXT6Y:$$RI]@=IZS>&ID%JUY;HOWBUY@E
MN20M'&H \$K(>\<O)Y4"TULQIZ^H.:X+V;L8T_7TG2)40!NK<7'SC&#,,D=K
M@R%!PDG)4E!H;DQR]RO^A9?28C,G)@<;U7N&E6(:U9.4+<9/ "ZQS ^#I5Y/
MS();4PI\I9\D*9>$]+,=%YLXI6J5%OIZ/$"?88SAZB&YRZ<F2_Y6W(J:9/1*
M2>\& /+D2NU=E\WJGL@=?[Z!WN<X+ CJHZVH(C,M6)IG!E-L/ECR+C-*T?[:
M,1ZRS!)OJSZ&"R=105'V+9F]&7097W=8.WQ^T#^D'].4,,R@Y<Y:UF7JX2L*
MG+%"]AAH" %(-IMW>3.:.=/M$NRCE')ZD1S9QOOY>EQ)X_NT(PZ8Y<[-R?&^
M-B\P&:;#CKGBS<Q;ZX7F!MSX8@\;WZDHPNED!RWW75UMCU*EQXY[ %XQ76)+
M?9@S\>;&&'@LQV)99<FM8YL.0Q9%1HS.3 /L?FBV</];$0/WOEY)MNIKC(1N
M"^]*)3%\)'V@C[_,=X!$^$F/O-<+A]:F!*-$L$_R* @XV<>JWA8?PI2/ZKLW
M2^YZJ%#8%=<>3"OOI^V1C]80F_*)#V_QO#?Q'5!QISF7)(6WV97#;[RV_[Y3
MYS&7V-!G/W^=$N%4KP$>8P^G0NI)8O6;844$YX_+O4# ^7B#?8'\AL7-3%<)
MRB'EV7AZYQ"9RF$VC.(BGHSV)B.R]@GU2?2HT%HP&+,^>Y_^+I^J^R8#]TGI
M;/:2D?RJY<U4!ZM;$SC]/;J.KG:-=5%:PO4)S()7-F#."K'.@7RG0=E^-,3
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MSLT+MD_E;HA;L0EJO9Z&U!JQ(VH:"8,94CYH.C FS7LRO'PE7ST**IBLXW?
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MD"E1M8G!Q0\S/;?RZT.DOVZFERS*Y5EBFIBHN3&XG;^,>1$6P#1"VL$"P0$
M H *<G,;[6Q6U1HR@Q,)%V1K "/3!22(B,@J2R$J1Z3YBNYK?YW0:L9W7;=[
M1P!1#/1)21GFC>_QP&?LB_"^AL\ZQ]119GYK,\@9>L[Q8@F7*(AG[_C@?4#
MW$+(5O-+V?<8C.J75K'G-[0Q)5X)S\1$%O)'\;(%V\@D.!$3JAXFZ4AM&FYQ
MME(>,W)' 2ZV V 3=%B *8HE=C:.,$7?@)3W2[/72W=Q;MU"&F&7%I<Z(_+B
MZ5J<,V;2AZC62MD_\41_*Z!,;ELR5R<'V2<.?#5*=<[F;Y^V<5CQ)&Z6  94
MGQ6Z$?A*F]_M%:?SMS&B>"T?%FA$4?*Y3F]*K3M;T_ZS_@P>0P+NG>(.U0)&
MJ0FI%?7%&(Y"EY&>V%+1#9@4-!^%B:"=IN'%B'6*5V*!)QL6OD<X6QB4ZD.I
M14_@B7Y%8'BR$8+220G$*!@!#$$@.6T?Y/$$*;&B-4MA\V.E/?M.)LZ^*1>J
M7;?/=LV)4ZJP9\0;YV6)W5\&Z/?CL93RJ*#PTPR'+ T< L0:+N*:60Y.*NNT
M9Q(@E#&>=U2LRX8PL=+KF-%>ITV/?%0S>/?@2CDW(SL'8]Z?2&P8T>(4#KLO
MV#4J4XY23L&7"L=#B\50HW(]<7ZY8\2,CA':<Q4==S5B3J=CQCO\*<L1>(6X
MW/EW\=*/AY:RWGHU!50%NHD_+GF6A[6H&NB#9GRD8<_LU$AOJ^U7H-46"Y^D
MFWC@/R@TBL84YZN<V']C<\>OW+O/D5IX.R##>$05YC?L WP,4%$G"_N1OOQ>
M=6!6*0B NKJ9+@*CRRH5U'RE2!H:2H#KVP95N<Z1:FR&/'/O$+7^!2#@L%_
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MYJR6 9J%ZG2(+B;9+NUQAU _('$A"SDZ+= >:23YL@=@Y8R, 4*7IU_M?*V
M>T>^&>GDN1P+2(0;S=[QBAJYC\N?/;WV37 VPWA*J]WF$BD2(T6G_"GL==9=
M@QSC*:9-*U6NC3N=!K>AW'G:N*[3PC%@:4MZ@OQ"7=5\E&X/FRTCA%^&'PSZ
M5%_IU<M:-I7G2.D."U'?'(_@F0IQT(5AE]KKLTHJJ>+@JE^YC)]$GV74*?W*
M@025Z<,?YPM1&J)ZN4%665-C(\GY%**Z"/@U5MBU+%7N+J3DEC2^845E]@1D
M\.$M?S@: 95<0QN,RK7K3Z<OFI@+3,?35XDMOF]%#) 9NCH/'$>.<EP4GQ<7
M.5=-NB[@@RAF&B+E[I(K=:D48N"]FRQ#/>ER]G9S:D#6)7'C]??P7]^&Q$AW
M4^U9EO0%TDC@9AIT**P]JG%RC,K$A$N=-.=H6T?%FZW;O C7D73(*4:IJ;A@
M?@PSG=)/SB@TXYLA7PE9K5<H(ZO_0]"@D(NWOH+/".FO--5H:GR!]/]8.-RE
M>I^VO[,2W4R9_54I*?'+)O:12"8"T*ME=6I:RT(;S3[?Q%A:ZRP5E^!(I=K>
MC,*S)ASA=:_/D)?1M 1>EFYI-<P=I(7/2D?TZ4%HJ&93!TKO]L]R-Y )1K]
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M[WX*&HI6__I1)^QBA5:MJX:!XJ0R\9RI\S8KF4"7A\1';2FEN"9!/*,A+HY
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M]:W[QZPUD&1G?ID],WOOV<^S!=1*%$A2#;(SAR*]])TU!54(\ 4(SK!K1'T
M1H:! U"=PFFZ@',M%!#QUK3$E\(J+=R!:PEP'GMD<<I-@]&ED)C!QKB\U;"6
M>ZTR_]+Y3W!^[V;)@()<NU*XH<$NSE!&?O7]G2R;0"]%H+]Z?>\MW%92M5"(
M>XN/65V$LZVOO05??12>(U(O6T@>*I=3FE X^Z6&/Q 'IF]Z& W6PFX_]IL=
MAO8+6NS"S"%WQ[\E%\8JC-EVD?M,22M R>4BR#0#1&U>J;=SQ1SA81C&=%3
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M>A4"GSQTQ,^85VFN,4]HF3VJ=71#<XX)2,0<O$.'J[^$;NI[3KKJRMT&U9"
M0Q_E)@ER6([6I.#T;GR6L'?0,4/-/IF"W>HIU[V;!F%_Y$()&TZ3,S;(SIF'
M:;\[$%!4<Z1\0B05-.[9&<BR\FQOATSH10;:>5?9D%M%UF#GBHE,BYB5G5.&
M)6PA#\%@'5S."@ZE?)6W?=PRE0VY"@84D#A(KXB32.I,I9!0J+[5!COF%#%7
M9V!W ITWRYXY<#7KAAH=&,2#J__A[:Y03L#1CHO2H-;EATGW<0MJ1^BD10I\
M/AO*.^6K2I4SPQK@:>/E["0E8>9^R7E;^@[T)8SN"14?FI;&IW)R/I#!2!\H
M%>;B9F%7@H&*SCEDKF363*!%@),*4'0YU2HV\S$@<(*IT**_S.)KTGM/A?OV
M+%C+HS*]@[%0G[!'\3!0_ZL5QB%2M;X;SUW'@"=M^O5GRUC X3M+FQ+&LOE-
M!J[,<K2WK?N3/)TAHZDR5%4'DHRD>AV!+Z##_@] KD#B;[YO-L@\6E29.5/B
M:4=FU"I,>SE9<9/-)B)S;UP\G*WHL6DOLE'68=R6RT468%W![/\6L=P_:R?"
M?MI\L0X)=GPBB7)6<A0Y"/I$3.S[]#* O#_NC*GD#2^SW4AN%Y?-:(D;^(3+
MX@M-P9,[DL=(".MV.^@&FI<\DNR#;I$@5.X!7%A% T@'UY@%.P)R$$;AW;*C
MV6&[<I$ZJ@@3 A#,Y_?Q'J* GM)6%RWH)DSP,*S3&4,%QNE9JP\]16CL]:PU
M%IIIS/??(DMV[F8;>T^U'E=VW&=5._$,GO1J@Y+*:=M%\OXI 66A;,TC=U,S
MU"@?!_,#X4Y-"F7:+E.SF4_W3[9."._<VINM-/=M[?"G)GR\1(W TX!P.SF'
M@F-P-L!'#[4)?%<RF3>4YE304.WAO*@H;17T&2U>!7_H(UP4LC6>OZ':X$T?
MJS*FRGXX-<YMFK7? N6?G=>"QK>:O1N<&$?@9+16\-B)U5<@98B&42BX4PZ'
MQ5NV=@::W\_ :=6IDZX9^W)<\3.L+O\[P*BQCT+FZ_I"71Z&W>:@4BUT;?MY
MFLZG$6[]"\)@%\4SCMNG:R]3@2KIWP*ORJ:\-4,[,!)RUQ(D:!F'7,F2X;@L
M [T4>-7!Y@+A)Z5=E!'\34!E!.?,A")%5O0K!>&C,B*1DLBVZ4Z<RD%Y5 Z5
MG50\LLS4A>.=T4+;1S1\Y'7'P:MZ 9&[V9>NXV$JS%9KMJF7/,WOHHNG7O'*
M?; ORU,+=:/OO,E0S"8G]@%K79O]@ %FS\?14>7HB'@76K*IZN7#4F.W;(DT
MO.Q?:.[B?]NN6HDTR[0"A!;\G)8K5N;-OQ7&*6[/@N\$82F(Y"=.3,WGE%T:
M#2K](NIXD7W'S%LJ64_ ]>K'DFQ__U? 5WZ@4"@I--;];#M=\43B#7QS,=9:
MKA@ Q#PEHVX+L]'.9<'7@#OB_<%>N2_R>_M5>1&KN3,8C"T)H&-?8"*QX%1Q
MMZ_K2E>$R[&YI"AGDK">Q]%TWU=S+E[IB/5DT[5L*K8M*1C.44W*R]B_ODG]
M^\#J7^*8B.Q?CHH?/?O?&3.,/SA@4#GB\Y&K!.H64:H!%C\.7C!?1WRAZZ5I
MS;[4XKY0$-Z1\;+9>!)2HT;RW,3W6[C 3C/7#DZM8YW-"Q>":P0;Q+1'Y+R^
M/AGU_B"6"KUGOF)+^ZE%=:F+C^2%R!Y:Q<2;U,K6L^]-;^A *H_=B<8B;.9+
MD$F$U49+!\>1#ORJWP$DT^E:S0U[(\9-O W@>B *[\UU4P8Z"Y[61PNT+8[N
M'&DR6]8;STW&PKOH:-H.Z5?T-0F6S[JG<FOWWOHAI" @ZNB">/SBUHE(]^=*
MU8]D<H+\*.N1SCC%KJV78D1.'JDRV,5TC[%X.N,L9HK'63>0QQ1O+4?6V@W.
M?S6$!>R@.>(8X'AZBNV=%M%RC1I*Q'O-L/<VP<&%%&IVIRW&-K0UN@]3Q[7F
M]9?OUVJ&,-YJBJBA.^X7\:%LD2S3TV#2JXZ\#F$NG4\-/^Y7>,$XZHH8<%10
MV2!*U=I;Q3Q( 3-=6R27X:$.XV1W>R0GJ^^AEG8-9#Q8Q$2?F[K,8G0-M['A
MGD  ^>9.K7%NDL;IG.=-DC41#<8@ING&_%O3[&]L"G-A/"0NUN@BM$5W&1.1
M/7Q,[$$YV]DJIH;RL>6##2:)L*3ET-EELL+2KR%:H[O1TZC4EDIF4.*+@TMF
M8RX:E'HCZ/:8;L^D0F.6!KO/VKROR,:2.X^I9P(LS$J;ZQ@4OB _VS^[9VQY
M+19IS A9?LR,8Q3RSJ3*M+> WTNT-+ZYGV>ETZ)B;VGO:R47IVU4I2GS$,U#
MFJO3G^I>!0V[WT!KTKZ[5W94-A;\7LODPU$YJ;F)>4?R9$FI1B(X :N9.XOT
MK 7CX9+%)#-Y3U#Y(X5"OZBO(A0"4.:ROL4[4X16UL/8CZ CMA.OV*P"/[VH
MG61-94[D+ZIM9#E4(6-R>:I%;93AH)U,0;2+R+7Q\<K>N&3;.+MTX:!.O&##
M!*_N\&DSW977STB"6X],6BY9C5[$FO"ONN& =>LGW'(][=7K,/=NDT75T7LW
MQ3",IN[(.$\^'ZT)-X\$JS8/13G&MI4T1"F]+94\JB<?%T.E<7[/73,>95I(
MD)<3"NZS CWIH54SIP$+=[IB+M3 *LQ6+N]M."Q_TS=N$?=I_\J'GLE;Y)1-
MF2D2\8X84/Y&_7HCY IE)&7YNGE(G])%4*.R3[(6A<_@08GG)^_KWB&I=Q1Q
M'[Q^AI!06+$UD2;^ A0-Y#-*_H2OD1A7DULFA=_QCE >BK6IJ#)RQ5'YS?@P
M+7DYTBQ>@D:7[P"J&9GV^LJ8:F <OH)OL+)Z)MT)WDUQED(@>K;+.76GR,V.
MP8F91@IH=C2U?9S_3>.AJ_ 7HSQ)2&V%\<?H'(SO.W+V&"KS3W%+/6^'C>-6
M8\9*8M5&(/5GW%G9J](.:&?B\JL? 0)W>MZ*Y<:^ZW)1ANX=&3R$7C^\+-,/
MT!X142UWA\SN\W<G4#IO+,;::!=>Q[\2F@OP6M<";;$+0G_CV2AH.3L@LNO2
M<%J%-:4-:4LM^IP6TA/I$Q(<K*0OR'O%"U=.>>11)L<8TCHLR.CVUP3E1;]I
M)#/T<-73^?34X'IP4=*EJH YXVXS[=L5J0-KO7$YZ2&:DA,T<YQC/'$+![/6
M=!5B)/6ZM^Y?R[1\WG^+LOUA2)"(.>7&H=1MX9@/&)&-4#IV>?%>-/VG7!W3
M#)L0<)I9S/9-\.<Q(U^F8\Q5NQ9?!+L8H3@GPI!O U-7D/-$<#K>Y,8$E;1B
M82\(,UG*Y^:<ZWE?%?4=\#!9KSF93J?C<65 S&W$5>6*Q*G3)PR=2O4Z$E-5
M[!YR :4JHO&UG^RAZ^][+Q/9L\1ZRS*TGHF5T*=) *NI'B9!P^>B'SHV<@>:
M:C[&L2>14>T417.2-C1M;_FTHV]W)>&XN+74IV$ ;S)52HE>C#AYB#P 1R0F
MWG(2]M%<\\I92BM $1 FB&\BM&<F:'R_:NHW)/5;T1VW$5".CFA%U4*++FU!
MB?2CW[I]^:;GR/K*4"J,6RDDDT#=#TT70C]G/<L>H1[S]/DRSP&J<=_M*)FH
M#$G=5.A@ .M &"I^KAE8?=LE1/0M)4I2UB]!;H?<JV^!W.#@0"KHKDT,_8D:
M,_-X\(O& .=[3\5S#QV>9?.K,N0L' MM!7+OJ[XL)X3/W^[T/S[&* MU7(7=
MYF\\RZF])U'BS!@]X-ZAQ.7*A]Q4YU'P,G30)&?(+U#S#R3#_Y>#0\5,OV*A
M_LBG38!UN7A_($WG_9$XW2DG,]Z9%^=E!&A+1XZ\DUFWL UI0-\IQ_6,)([O
ML0.7\I5*"Z1>7-APRA%'(^#2K8DJU0.4]$IT1-SK/6304"F#(C AT#H3TL6M
MY+@)A0O*D:^DXV9"<%7<98H$M7)!.*SDXKJ%G3A66*_@C\S**@2)69.?Q\5*
M<E!#0NT'ZA+X+NY)H1)\P18;K[\RP:+?1N<O"'=*NK%VZUQR''''<P^8HN#+
M::QZL$[21\\U3M[]:"GLRR8Q0NRHGXS$>M48H\D=FQ<5!!^NV8?4A!*_4-S5
MEYTM-;J73DV\N)N(B'-II3AY&FT/U_P$"EVW&A/@[NJ5'Y0W)"#J63?CKVO2
M5DK#?!R;R$DVOQKNQ74,?,N5^'X\@W$41F)B"1I'<6?,#!%>K>L/\O7Q/DE2
M&I8@*7ZWKDU)J\G_,$M[[O)!1=#9>.DWUKJT+<U!WMY>?5>@?OQ#D9.G_6]#
M'PT,S>@4#5]4=;>'+L@H&;DKN,+US-LU5!#'Q38/0"K]KY57!&4$34KFH_'3
MC+4RMJ]L<V6E3$KS.>[?>F'[L$MLAWP [.RT#68@7V@^3864DC9JUSP\"]33
M6OBJ((Y1+5O43\#-:D3'W:285,#MBKBO\3Q"R(/,::23\;I;X?4"$>-(&;XM
M:^P6KUM(:O\=H*0KME>L!5AIZI<TC7)+W$DU,&".6..3D)9PYGPWL%OSH%&T
MFC&BC070*:-^18UR_C)6[X0NB*:C9Y]JR,SX<M(6*M,^+36J_?@D]OZ)LYS=
M7?NW[4Z7%]'KEYZQUHA%BV4'3J2_%XIO2#68VS6NBM[J!5BV$A?=GU@@_C15
M= 3*("X:+%RO=*NM5;%:;U4606C"??'/]&?*V&7S4VNV[;?]S+0.+O3?2:,K
M<7"N! \0B@#6!*SJY1*5 +0R K1R?XPOB7QL7S<ZF<*OW=Z<:;3<>GJWK)B7
MT<W5\A*%"?T']9<[PO7[>5KD4V5/:O&VWJ_X;)I^ ED&:AO69)Y(.$FSN]H%
M)[]-5/'>S_XP>F)!7]'47(>XQ8ZDUY8TA(2M*Q&B\(.,3R22YZ5L J^25;GI
M-AI* ]6D+[M*CQW:3G)Z\&7AH--91RUU;%FG@@>L0XA->X6E?529W0D^M<\7
MS\BRUH;-YI(!E9<794I\@)B8(!W;:RZ<C#(D8R+Y(SW<=(3BHNF7PC\88V[7
MFM'%?(D<,C3%?BOO$*TJUW!Z$$KQ?@5_Q[>E!WG^J)>8^5%V%=N9;"/J>.>1
MMJ-<(":6&.8\+A'UY;(;_TZO2&7)AZHB['=:,-<^,&8@!:PO?_"C;?SU&>KV
M,E]P.**2)#C77A>!-N/)VOE7[JXF@54 55D:=XQ ECJ6Q]7!ZD'!=$3N$5VK
M#GPUR:-C>GME.>I5C]SZP D.XTW\)-=E>"_6I/L\GKAWC?\IJEKA[/V]QUHF
MC?/1I)L&"3- 9N4=B+F%3.&4#*_(W:@WTJ40U"X4SOMGN_Q?LL6U?L=1_VN8
MNR9%&T?MAT -J"8%4)/BOD0BO"V'#\Z;Q3J^()A]*"X?I_E(Y_*3*[*^:RZW
M94<QR"+"9Q@@Y6O_E2##NH1OQYSAS]5F=9\A"CSR3:?-I/=Q63Z/#0DB "9@
M\(T@79Q1'17-\YO!07'47](*X+7EM@I<!H@F7MKEO6F"NIIHQT<SA';^2H^R
M%-**+"7=.6C[;) BMM].%2<80<LML^X(R%_)5(5;7K;^A/CLPL+HE.T6U[IO
M>K?TZVVH.:Q]V_C8_=LU-9+8\J*!J;OQ9S<T'IF.)]FE?SI>),24#BYD4Y.R
MI*#]"'FFDK1(9#J;Y'W];.-N-B#U)>X)!G'GZ;L_L::.F(TC.D+Y^9I$^]L>
MWAV?)0OB<'CSB"U0%RVMNQ(0Y>8&9K58\?HB4OZAIZ.RUX-7 4G0,P"QN$UQ
M)3H&&B[DVL/"VTP<Q/I(>_^A027DPD[JJR_]ZP:Y^[:PF5*H^XKTO<%WNK9[
MUH]BLY_Q\;ZF,UM!*\_GP<Y0/=9"N O1%>ZQ-7SQH&U5!S%T725SP/,YT:NQ
M"X]K75Z[5]*_9R!$0Q3N<71HX+1X.7XYE;LCZ@+96\>@KMH:+@(BVCN%;VR=
MWIF9!=58PRF\G(@(R[ 6YGN!FTU@O["A<R"B0B.2[+<(P?]D^Z=CB 5(/%3>
M'_0B 8/Y?3:EX#D?%O"'2,QYJ84P)7R!'Y77.MGQZ+S$@B "^SK]/XN[^@5_
M)5*30J1.XB[Y0+P -L3X6/PCZLNZ(]):IU_@?%W\LX\+8TT!T. SA8K&+JC:
M1FNPZL7%#! LBY=B1M8G*DVCBR['.4*O^^UN.0)+9F2<;E":+*<;I8T38;CZ
M$K1V-7V.1$ZON9._ABYO-1S<L.&YE JX<Q99QN;+ Y@0$7W:'(070$;./?N6
MN+=3\LWVKNC:,O^;,@H_]T41'(P[:XVM ==46<\X*X97NYO&W4_&2U_@XV9)
ME'YN[?L+-$*-@R <3+K.Z'"KU[,80Z&ICG2_BTIW5-Z$]#'/%V<5% V,)TZ;
M9A/A)IU]LY)CR9I/'E3#(6A,G4"3GOH-$=-PT!Y0:/!/?5UHF=/(<0UG.F%F
MUB:$-@2>Z31X[1I1N5PT3+?0R!.<-_39E1Y1>GD#X=:2=Y'5?O;%7 W.4!)A
MH,;F,P?$FS%?XII/BX*WXKF>6<4S%!.7S\Q<KI)W8T@S>&V[]U(-L.Y/:2+$
MAY#\.)R)8=+>B*_\)/$%7+4YX3Q2X]>[W*:TW7^H3:B5"-7?SC^#-&G$-H\R
MZRVBL*KPVZ2&?YG:J5D;YT^54@C@Y+]F(?RFD4)P_S,,>(+_+-O?;YL&=R8$
M !OEMQX50,Q93Q,/OG$N0T<XN#6$'@B#S7>\Y<K<<C&QN2B SXTFO#*AIY9B
M5ZB0=23/389J,*$0ER)&XV-7?BWY=9-FPN\ BW3'(R29X=YL]%6AQ=@6QDJW
MO&GC@>HNXD1=Z^1U$RFYE2+S]YT.(CJ]"5QK<RF EY9A'A:;[K9V4Z\KBRL=
M_8X/+\)5]1RD@)[":HCMI_E[W;M;P'&$Z+1!RBW:N)7IYKE0'*0)7>K[MWX)
MEI72\2BN;ZR5#8+I%(S2EH^ZO#;UMK[(&:A&8)IYT_L,@6$FZ8C,VCS3>F*&
M!I+\4/9@FID!^]CEV 'AFD7QHDLJM1[2"=/YP* +R3HSF]>G7<EB;KLOY%;D
MU[UT3I*G*6E))BO4&=F4HW"CZ%^%^QY2#^$<, ,_%DZH<MZ^\1UPM:V!?E.C
M?GR,,W4UH3=RJJ2MB.*E,SL-[;VT*9!O/^"FT0A%7D+^?8B$NZ>SRIUH%3+^
MQ\IIUUM.2A+Z5G(:E124 :/-\B"<M"F!YEG1-RV5U<P52FW].K<IN"8.M3QW
M*WNN%,XP!TY :EA;AFL"M0G,N](SEN@.1#S82">0M-FX =H<MIFY>(AT1Q;>
MMGX $"7P-Z;W'VFLGMA/&EL(^--.^;^\X4F/^Y7GQZJ][;AD$Y[JH8;)Z[J?
M@C,H/Y]-NP1[4DT3ISOZ>00YQ#JU5E7C1NWVSFK )81UU#I4HGI^.I>39RIR
M<O*DRAH]YYC8AP/UU;??Z$[BNPW"OMY[[P:[H[F]0>)%ISDA<K-(%<?=[ 9^
M)(?;E=QPDZ^\2 H_+0IA);6WI*<17<K *50PG7VEHP_=L00_7;UC=RU ;V2K
M/Q.A,& 6ES<V,/ILY1\PD/[;,<^_T=CSEI[9GT/G95,NQ)=)P@$/NY\(KZ@>
MS7:J#C)_.T\];5F=BN\8*402?+..67) ^(( <X%+F/#>E33$JU 6!-_S\5(/
M^M/QY!ZB58:%=*7Q\:5@Q%I*HX6LN[ <TY&NCQKX3RB,_[%VI75LU"#AB;UE
MR0AWR>OBR;>EZY*I\DF\0 7X@&3M\\DI+\E39T]-9ZC+9M 8-S&0>I0$T R!
M-!  $HC7A*'-!>J,@"3XXXH!;R%)'SE.F8#=?@ 4HE?7 E\WSKY7+&@P:*/K
MN^H_M!)Z.2=G4$991@)%/H#Q^C2$EZ)G&]9^TPQA/<C\](%D)6$"I1H@"UXB
M,^JW)[+SGB.K"P67O\(/]RX5XL4U^7\YP7]WX@$QU$:2X_"K+S&6IPZ:#[U,
MEVQAU@G,7>GH%ABIC+R?BCA9T(1:*25G@I(WWS7]8:N7,0E(%4GJ\4K7CWS]
M-%K5<P1!GIZ7&I 4+31.8Q:DC]$VQM:6^Q4]ELYN,_89%#EA_P0D\]]IY_S5
MP L='^H2Y BENN41G2/<IM GRW;&"<K/'K9]-K1]O7^<OZWSO#E\&H33-4.$
M&IYRK&Y=(=/CF;VD]A*9QIC:ID^CI'T#04 0+&C.V@F8UW,H!T7:.A)?"3]
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MF8H'>F'MV _UMQ]A3V'@]\G_ E!+ P04    " #<BW]<9V/P%KY&  !HC
M#0   &EM86=E7S P,RYJ<&?LO0=4%%NW[UL(2A0D20Z2I04$03(-*EE 0')2
M$0DM.8/0B&(@9Y0H I)!<LX9)"?).>><.MQR[\^]=9_[C7ON"_>=,Q[-J#%Z
M=76MFFNM.?_SMU95%^COZ&G@BH*,O R @8$!/ +_ /08<!? N70)^])%'&QL
M;%Q<'#P"LLL$^/@$5"2D1&1TU ST=-2TM(PLW.R,3#>8:6DY!*_?N,G+S\_/
MP"XL+L0GQGV+G^]')1@XN+@$^ 24ER]3\EVCO<;WO_U"UP+$.!AEF+*8&$S
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MEEFE5#*,VF2EWU&;\BX^A4NM_966R5%9YNVZS/)OFGO+4;T&[=>*7>A,@M'
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M7QJ'<'][&=?AO^2_6!' N:F(9.K:-:M,9_=A 1FN7 XK$!9;4+Y#_B;&.M-
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MZ=*< TBI(Q4=S*NT7P WA[%DH/(6_1>NY]4=%*<//0VGX4- (]^\,3L5Y9S
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MJK]K29/10;16GQ$RLG*UBF(V][03LL*#ZC!TU'>48/-\&0XON[MT\A6L_-:
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M92>^KLOXNJC!*J8_RL@V>]8H:R2RS+XRV1T!3Y]MU%C __\F %!+ P04
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MM77_\MK*.3C_T3*G10OC0?2Y %6>O(8RK$T(3V84X\[+8T-!QX=/=DWR97,
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M>B8G[I/Y-6=1.]?A]8!>"[_$JR3_3 8\M"WK2"VM('GCUAI]9M:4./P]3N%
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M" Z=B)<OC?2V63%*;19GV_!/81O,X# :/3"P?6KX]+G\@#)MOP/R$_BO6!+
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M@G?I9T:-">K/ES+S*:82UWV-WJ$/AV>]$A$#@7.V_$07?-<&0C!3\3 HLOG
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M,0\^^NPO6[W/N;4\:EU7/=9H2OPP[_VC@!K9[?XBL2T(5]T?K6(L;%$YIMR
MK.7!$.2%#(4F1V\P (M'&^I%& :0IIY[T:4W*SEU!0.\\"S<(UQ%,\':9RZB
M;*,0T&L&1LV%QXPL&*#@ NQ^#_,%"6+82;Z*K!L3E:I!VQ*6#-7#/S9M1!;2
MX^:)SW'\MW^<'; 8@[7E&6V0+:A]U9K:7KL('M<H/376_^,V#:CPK>]C"G9V
MET-IOY94+0.;:D-N)YQE# 0_LJZS)!$_>S@]C: '.K^6N=':4-X/G?NQLQE
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M&[3NWS<G%O.K)9O]&WPAFL?GK%R,T++YW.AZM8]6>F#JM"-H8;2_$QTX<>F
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M+LV=1.RWUI=D3'PI&K/4<KC_O4E.M(31#0=JM;CY>AK6U#;8, XR4Z;,@]7
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M8<2R80,$6PDT QJ/Y *]/0<$]T5TMV&TP=MZRFD'^"G1+Q<*'^4>EA:>6&&
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M,$![R<_)6OFB7[:9D4&B?YG/]Q\N5) @,LWCM$8Q5871F$JRP9 _UYG.96*
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MO%HTN>S)&;=9WW4C.E^?S=X2RGOL-RGI/12[\=JXJ>)!<8\R ="]?3Z7[(U
M0FQR[_W8%GJ2EE=[<[<J%0/*P_C-/ST1"G>A(Z&E'C:_1!&D7%%VHISAD".'
MK_-(KY7X<BS>4G!$G2PI=J0ME\'%Q@-=::*GH9.+/<//A95T'IU7%-_1@*AA
M<>!]P,.-7UX&_GZKP%_/##2BM+HK.ZA ,M]E2T][P^1!,W&K2HPII"FCB'^0
MO3R'.\'\)D]&>=4;=F_-:VSV-S3?;MW!^Y!"QC?$8[//Q*HX('XGU6 L;P1[
MDDG6[6BI.G2F\=B[X*ZL_!4_J3&DR,JHN21]R2"N\\>547?Z7%F:647.SGM?
M1,9S^RZ(S8G/L2>E'1EV*;@DQ14LE),P)8XP"\1LP8^?,F3C1$3UW"(0R>_\
M$T+1VW*!<P,V//E7JBLJR&R+)R:[OSA9RL[4FOG9-2WA2*A(V5C67_FH^-U1
M4>G)YQ%]WMQFIKZKRBJ,)C8]9,!2G?VAM0='8-[<<*TP^X0L?Y;1,=%!D&+
ME@ZS$Y9:?N7C3S,]!*V %HQLO#XU4^FQ9#:-[PN'J^-$Q)850M +)B]#:B_T
M)74WTAG,B=N*U5V4$U5381MAMJBK>G3(_WJG)>]\WQA64U+JG39]30^B9II1
MJL@'-PHV;0B/%23&$R9%[G2V9)VDC62+1UK9_TG'I;)-*O:@'%UMI8PI QEG
MXE#3,JD3[&F*4J8OMM^/[XBLZU1C@  CK?BUYGCB'?:4_OJQXIV6'M\'X=>3
M[B7H;0).2U^?%)G6^+>,XM+?HR"!:'IOFOK!&1K@EL7!(DG^7'D9;XOF+MP@
MHI2B_+YZ025=?WE4-XQJV;F_E";J^K&5=?-YAAC(K8=\=R-J<' IO=WJ*%6L
M.:2+!I,UH_,?R3\(?(5C#9CA9"B897RSF"]+"JFKX;O^[$GP-:Y:3C92J76M
M/VVI@$%KN#>PL+"6-V,"%?2BAJHVG"\HCOJ325#F'BW7/+GLAEA\U6S-<6$2
M4N*1(8_,:X<\-?E'>LLXG@<B"W17BAO;6"7]!1/[)]9&O5T<=(I+/D:*P<IU
M5#(GXMB+'*]H%'/=:G/&2WO\JKT;>+*L*XA"BFX$7W?,Y7:+NZ<;&J Y^*-3
M@S/F(IT6\4678ZG_U-Z91[.!;W$\1FN-ZF)4"4U):8,.J=:2:"TE-6D:J@N)
MF"II$$'$%D8MP1B)+8K7-)3:8RE56\H4C;U4:]_5,F.-K=*.UIO7.68Z?[QY
MY\T?[[R_YH][SOWW=\X]=_G=[[D?#6:$3% *1VR@8V(\!Z9GPST,/4P1/=(P
M1>RYTJC4"B1I97ATA#OBLU!)DZ+YA@;O"EUWB8PC<9&*>>G&<6VAZKXG/H"R
M <'1(+H VB4GTJS.*'"'S/.&:TCW@0YN[(\ S:W6KJ&+1CHM@Z"9 N6[%$AP
M+#>:FG8S4]Y 5&,R'/-;^=O<(3J^_M;6BPP\O#XV?P,6PEK)ZD 3*74T&&@C
M.VCE.=#ED0W;LW)&XJA-GS9Q,,V<U122"+7L11^33J6I-KZ J.C&WQN#VY2O
MT=_3K?O  T]JKK1L'*"*%>8YK%P1W*$<^=#HX"2L,H''7[8 N-F[L<='\:Y&
M6PG""(S^/5IA]_MH.^3VL^-R=!!=-#PN1[Z]K;3W<N^*;Y%$<7'6 1Q?ARMY
M;I9%@W!8& BG/Z8'J9BI918&:X7LH'\]\)ES6PK&%UE$ \QI-'+^""J AO#&
M\?41K+/]-@+2=WW?$KC(8EP[02RMX#W5VE29TZEKKE47'=/FP^7O]-\4:8')
M?@D:"5M/YU?)>GOXP7'30OE.29JV"F@:%_[NZW.6XI=@4ZFS\.=W%'^H>\RC
M7\\(A=+F_MG?6UJ2M"* >/VC731,JA"RWX?"!.ET 6S7JJ/./]$6'"2%F%^*
MT*3O$0X>6-8_$:EWL%!<6O7;HGJKL4.<]01T7@M#CJ0(A(9E:R"D_#[-7=?\
M9+[NM*H@U9L)E' $L%Z%P;4]')'D3P]3S^7:NPK) :'>B282^"Z6%0( F$V>
M-WRDNZY>22U8E"Y8X"5W$K763?/'+7P'UH:Z%;Q0.4N;;Y7N;DF'<]+1SGC>
MIT+_,[BZFI?:/2?0VXKV?N6N<Q>ZF/"*:#(\$A3_W9ZDW#Q[F6 ^+[KP%,,X
MXY[?+>U3-Y]%:CI>5#K&/A=XK6-V:WS^A @;$_FFIC^S/Z?WE*_24WAJXN@(
M7G/40?Z*-$ <0'\I==FPR[\OEAMSP$0J^U/?O]ME*;QNB8_IYJXFQEZ6=DY.
MP$X12.-$O@]&V.:+)J&K W^*^'',X5$B3G5:-&6)>8@^;VG2[5]=.OZ-P]@"
M6WB?APHQ976$'&,X8LOPZQUJB+(A4ZU:A3&I0636D/M(558>*:BDBUD^W BN
M8@V<5 M.T %@+;RE@"(;U)>&4U( A#Y1O=I+++<HK;:F_&GR![BUKA+M=F08
MK$-W@V7GK'"32\&'[,K']BKM.':BV0/2]V(R%H2F!]7@M0(3Z\MB-&/QH$WX
M]V<Z'QQ Y[JG!F!3^$DO!D>"QQYBQT9=:&@/I:,PCLNL#GAV0\8O0[7J6?DZ
M8$![Q5.PHE%V]C1#^YEKU<\,237Q5:(!F+I1V-AL\>;\OKL',<%$A+_W.&T;
M7;^<06@NO;$/-9M4P_)G429[ .>;%.5SG??F/PCQ9A.XL&'[.K.399.;ZQ'F
MO+=[O.^LMR/\_XP1^QD21+I5OH5YO_W-._%-/9'\/U8$-KC?M7 ]GU5S?\7L
M@O+I;XUOOY]P'$Y-3T1J(C5;?P+//]X+-A!Z#,S) ?HNQ)^Y8%V0N??:KR-?
M^I] -6SQ\A;0Q2,8:TL+H_]"[1:U7;_S( ^/$D\*"1R8T=<F>/1JURQM)O7,
M<( <:BR]^1SX@PKGU9#C<[FF#6G4_0R0O:3$ST,JIR-T,\[=Q'QIMMVQVK1=
MIV]T:*=J^N,AOSPTM,7KR%51H[-?%(>1QQN Q@V9$@C[[-9IF]Q%K!OJJ8S)
M\=PE"\5.WG#W7 JUP<4SKM^\? 7O&)>-F_<GNY'.]"5ZCC$H<-0<4Z02Y;(R
MDZ6>M=:=K/Y]IBE!TY( W&A35; @^LQ=#?65!P=+#>XBE&K'B<TZ=HT4;6;5
MX'>7TT.?3"%?E)G=V8P"S9G*O+26#:+;KRL8I0B2R$'L8"RN>/#&QLI.(S6F
M24UVPA-,'_+MQH":!^BAE!D4L?\)\N#$L6CRC:\]H(\+3YZZ\Y9XQ-)RK%AJ
M@Q(+6*RSR!]_8F29]68)3A-X".J&9B;4+.,M"-0'&(YNJX9*95'.0AQA/UMP
ML=3/4$Z:41EEDS.;6$=]XA(F::#<I1Z>\PO R?5ZD!V/O4!.[K3/:YD^W3 E
MTM"@TG ]9?>/O2,PC9\X['[0M9KMGS.0/*SW,MC%YU7I2K&)[;.Y-DB!P9A!
M:6GMJGR@1V#T1*>3S9F2CO;H6T5:%\*U+B'A]M16,Y,N@ ^*4O ^VXR!KMZ_
M]!6H;3LTAIS/U,)=5+42"X!P85+AT<(]X0O[AT=Q:+T>7+-<19D;?K_HL188
MW^\\%A6LB;-,*BG)BLH%MSDS3_J(B5$&XZ%!?QI#6=PA="@!(C\81]#*5'-
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MCG;DM6V5NFX]##-R2,#"C$GLO[V_O;_J?8ZG?N@)T5^&_P502P,$%     @
MW(M_7&UJ]KE/EP  Q+D   T   !I;6%G95\P,#8N:G!G[+MU5-S/LB\Z. $"
M(;B3X.YNP2VX:P1W'9Q@ 9+!(9#@[C.X.P1W'6 &">YNP2^__>YO[WW.V6?=
M?=^ZY[R[UML]J_[JJ>ZNZNI/577U]W'N\1?@A9*<HAP  0$!\/[I!WB$ Z0!
MZ*BH:*@HZ&AH:,^>H6-@X3_'PL3$(GF)AX-/04I%24%*3DY-R\Y _9J5AIR<
M48")E9.+EY>7BD%(3)!;E)V'E_N/01#0GSW#PL0B?OZ<F/L5^2ON_^WVV '
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M2=M,$-&7%C6T4-XQ/!.3>;&6L%=\.9+!N_M$'G?'"UN CTWP*.2Q5;V9AW&
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M"<I3)S0J\J93+5KYAK9ZNM_Y83F#R,Y=ZO J]D,R"<Z#$3,[<8X9]Y.BI4>
M[<XVU#4VQ=S%&[Z&1B4*^J1+D^9Q9!+Z\,4)V$JF@?>9U.7;-W@FCX_#'IQ@
M3.67B60-RP$&A</K*4=2>74V^=3O#G.68S0,93S1%QK.$^U[FN:%X[7LM>N_
MNPPHB3^-47YQPO0V&UDYB[IWB5[DT:8R.:&+"3^XT_)TL:+[UF8<O[.#C>4B
M!"!($&)%0%XW@QA45]\Z11].=_+,&^V\[K(QI9?UY!@LEO"-7@.Y_N:^4<;T
M)STRY+%..LS_< I(G%#5(3GK)Z9 566\TBE?ISR;2Q&3-ID6M2G:@7[7K=BY
ME(+I<F#O$ O2%FV1KQ7O:'F5:\_8<[@KFS =0)7WDD*'=PW>S*EZ;45:+=78
MNYM9K5+H:9^%8*X'R?BZ5 ]A"5^-[CI"<M+5M";9NU>Y"A=X>SRV/JF7B35-
MFXH.U=\A[N^/FJF?T!>B5L!>S1 N&;%X+:V>\&ZFC="8_WJ]_GKM9#-?G&7&
M<H(W?H<B=.9BS5#9DY>5)I)]7U"W\[J"$P=B_^[WIW.[>#M2\:RD[SS=%0NT
MX]=Q_40B1B3(G ,$H[]3I1OJIVKL6$J;]WZ@#">8OOOB=PJ6I.%Z'Y67AHV]
M@#$I&MT?/ERFTSS#AWX>0S3F$D!9 *74YN*1*9@/@BF<WC@BGPT\A1.]N:6[
MGZB_RTTZ9E4JBUAO9GB&#[..I9>4Q@*ZXE4^VMRH'%;FVRY1A6U*YPX@>A.Y
MSF&Z5AT.,:H3.7>0_W*URVL[OMB>>034ND?)LK%GH-2G6X0/1^L8)PKV4T=F
MCGX5+'3:R\K)O_<;%BDGLL-<N1:MK5,QG-55$38+V5!,HN(\1$#V9Y$;TX2>
M/P(("V**%^#+=#.Y"UT3TAO$\^@HPFDA&84I6K^R>+T.Q!?&7&$@6R(!]K0A
M:OL,-,D.I,F:<EX\SU5?$^,%?'T'NCJNHO4CZG7*N1[E;_RF%G1L]]CO9$Y4
M*SV+8?+  .MZUV'-+84,).18=K6_@ ;:4BM&(\YO&3[,A$*C7</^YNJI0T*O
M'YU?%XH'_\ %) :"XNPRR'T^>"" I3;5>'6 ]DV^.A9E>O5X)H3IM%5]9;C&
MDN^PW,UNE8K F\DQRBJ_3U037>X4;GPW,A-.\5PWPNB$+KT^_,+HMEG( <CT
M(=A(_Q=UX8_&)Y^1=D'<XV#RVZ2LELWUZ."#7+%Y79!'0&G'A^9R"=]\MN4P
MPSW9"=XGU:((FT-/O\]G\@P1]_+TVIQ)J^T57D<DO9LMSH9LU\'N0?.FO)E6
M9YKR,H(O481@2R6^H'6VT!*O5+V9%C$'?$)"8?M8%5I&0J9#A 4 4A@,]=E5
M#Y"2?K+\ D(!MN>CJN"-1(Y'7C 0*5K'S=30.3<ATYV*9Q&):!4[[U_CBK#S
MY:$B7DOO>P24*[%/+*\+L0R9@9JFV'B/0GT\FIWPS72^=/I>=K2W>)/T[M=K
M8J]RF:BV%GCYJCZ,SP)_H*S76\?1:F7%;A'KKQI;T3[4(HNC-NFSN1=?A/"'
MV'$FL4@#L*72A\C$O=7]JSN*@3B8>WJF# Z68H;37WKA"HYLRA$NT4IW/S?%
M6WUU&NFOCAX!6%(1RDY[C;J3:YKCHGBYVUDAY2;R&U+1\Z?RM-6^<GG^"HB9
MQY>#%-SO< VD]O<(\^2N[*O30<I4KHI\%4\Y]<R'H#MIE()LWQ<6>*RR $VW
M0.Z =-F5,;0Y+T_U:<>#2;%9S:08V[@-^:!3X%9<9F_^*#L;,&!3,V+S[>:%
MI\(#HPG1>*;^:"+Q:1QNW:?CL[-8L9*VQ&+E;"^!'@%^A3J!<>/:KITJACOO
M,!B!RWA(L-=:!DO!=(M0J02(%GH.T5V:6:\ULE*$M$P$]E1?A4/T I!5W/+M
M%'U+R**4=;45'?VRBD#M0!V$;:$CW4(RVKNO&XEP4S,@A?*[*58VE<WB J/6
M]?76SI@(<QBZC)0;#=[R<CY'>"U$S3C<<"I!\_/"O$($=E8=7!K59)XK8=I5
MC$59__BBY^ AN6AN21YE([B)(QWG1R08(&K^PFOWN95$2"V>57G)'N1RY-W@
M<Y?U0#,,_@H Y6=G,6:\$-. XX#^@KSD5(M2NWIA@:].91R0H_,A.V^:VK@#
M IE3YO21R%@M4=\S7?>=MP^<Q]/#1> ;LDKT;&WS7F? MEBIW/+/E(KQ0W>[
M**FA?35+Z'A^:W;,$.U[JA:W/MM$/RY1HAN*@]K?BKQ[3E5*$,(5W@!VE['!
M3Z8M4Z[1[;.2C$-J>\63&K($HXY_5 K_*XG =!;\%!9//P*4*G4.?,8> 29J
MYR5&7&+CQ8\ JJI'0$,[M+ ([Z^!MF(P!F-.;!>(,0OC)OPNQ+%]+^(10*-:
M_0B((0NXV6P?3"T*Z.??>VAH/^7=D_A]4O\4Z=C=E;0-2%BG@!B+&1F+-'<9
MFI-FC+B[2X:YQOE=[J(L.U<=^%>ZPI(%Y$[E)J4&JYC]5_.B751'0-MS.57[
MP%NRZY9O/+*OPL=T,NACW .62':%J-();^X3-W^DA&9EK**YA@R&)@>AH=$4
M[:@EAG/S,8*M137R%PS]\^E<B+Y-6>12[^O.J8K75@F1Y$T9!=OLX^N:-]U_
M%HZ9,UD_0P+;K](SEBT#E<T &8)71=^[;[2\M\8L]#7REB8J]'1$]+/[1D+Z
M\*_?O=^4ZR%(=RK37S R437WTIU-AGH-.Q#WNDINQ8T85+:&:%0&G\Y'2'*C
MR5%'ANS;\(Z;</?\)9O"5T?XOYW^NOFE?V<2^=5XBQC_J(I-G0-B^DNI*?B"
M9)\=%X%U@A/@*5AH6*RLH!-&+)<5 @<E@3PGN^KJ_S"7X5(=FF[8U\[.8')R
MWU8W77'BZ5=>4O.RCB<_15W'+N,?O)R=LUU"29C=#DQF"&P=[*6#K? 80H$L
M^DDBSX;(4@EJ,I2_1D:AL33TJGK!FZ.3,=4:QR_@C&7[^[1&I<IU47FN>UA?
M +#=!F(2C);;E/WMP@/BUA0ALA$RC;;Z;WUFSPOOE%.@(BZ<[[$OF+G1WF+,
M!3\"=&P.S#(57X#CN?N'G*F&U!N?=U"HHDJ00G,2$J^8Y/I$?!U*3.U.2,!Q
MYT/>!*O/!#6/[J^(MYPL+D?4:R: J:_LZF PN<F#3= LSWMCGKC@!;\LA#%3
MN\J<:,^*1MP!^+9PXDRC73%*[9 J.SO)Y7 ]*RK^"ZY:[34D6)V?F 6PT)H_
MZ7M9C,O+#X-86-!T?*$Z,!]^[9/"LK)R0(R ?TOF\7T8AW$S:&\K>P#B(%D@
M$"N21$T*V\;ZJ4_N/<C@"P:JHE@1@FUT8?%S85Z'H/EH_L/.FQFR<MP^\GSJ
MB!&DWU?OJ?+?+QH/>#M/*7TR&_= FJP/I5]<=YL&Q]=X"M_SG[^#/:L[L(_]
M.3[3M'7N8!#@9GZ"LH;QZT+\8ES7+88URF8HY94LOC;A?S4F_=?@%>+_+B6S
M<HV1*&J8J%F2%$Z\(6\=F8'&^!R_Z9!,W_YL_GXF(N E82*AEX[Z\7!AX8J!
M3ZX2+.W!SM'"'LO'HP0(RR9A4T73U'#LO:PM*04K6KG.#["KKU;"#C=B<XV5
MM"]08OB>$V@$@RJY4Q,:GJ#>G-">S;RE62'7(<^OI[T)S>?@VXLLO'@TK:6*
M%C[2:YZAF!\5QK>Z%R[0Q W'/@=BF,#ADSX^_CL'H0/$[*FJ]HY9VLZ=GE(Z
M[%>9-_D&7)2!_[ST2KVJPOD1LX+?A#+?4,.E2+]#(TBR5U_KAGU$4]U,Z"%$
M"YT-2R>TF:[ [G"@S&FR4)%+C];7=BUVR\L!L7S;^Z-L\%].?SZ>T2^Y;+5Z
M\AR%-SIL/S*VM9^\RWS PKL]K>EG?]OEO$Z4?QY<(SNUJ\D!W(I9*#G54T93
MBS^\5UP6@P#W3 %U-7=K!YC7I&6*'@P98D/GNMH9U%51/Y@\.WX5_9H1>0Y<
M;S5OH&I.K/CQ@&.;KZK;^A5HYFN\;9T#&A[_ P%[VL=59GZ.D=\:C#'_!/5.
MUZP5*I(F(QV1C'*-V-F1UD!G7Y/9X)%]<N26!#?[-CKF$\YR>W^E9F[N]:@W
MRX0 ?V;,^I(#A3@L&J5 FOGZI5B<@C1+\?5"?]CL\^7G"Z'Q1A^%G-+5SLJB
M&^Q8<JT\R7]9V:S[@ [>IXA\T=6?XZ[HYQLPY/<4L58ZJ:3#UW95PZ=]1BO#
M4+ 6"45=_Z;+U_<E"V09+9BBHQ75<?SI6^>JM=M(2Z#/NF[&J'_D/5@D)>$=
M##ZT,<1-L^;Q[,"@ZG?\//F7U?@W$A'Y%G9$Q^^&R+HB,8(Q.7OM!,\AV;*&
M^UW ] .\EF#WAE ZU>CLR@6MR"]@@F1IRL",VD&TLQ2BFA9<U=?:IZ-ZM!YC
M2KG.CECSC=S>(;?7(TJYGHVJK4E]GFGG95JF+3Q+UQ@!GD2%;DM%D(W!G^O@
M4_1'0--S24.I[RS-/,5&R08H:E:N]H=K:>P'A7&[S!@LEN79((_IHYGZUW5<
M<2F&6^X0>WF2L)-C?+]H^6V[3R1F&71)]%B1W.AESR1[=GU>I,2/^^-KJ.O_
M$Y4T!-.;=0.;*P$+3_37-NBC/#5X]RQD<K-.0"]S=Q.V-"D*L^#S_L%N<Y:[
M=H[9E/GV,*,H\55B&7H#&@L-X4,IA8=7"SZS8@4V/I]3+O+O>Y-M"N2M[(_M
MZV,%THR<R!%"R5P1ME(F^:L;7[;.1.CZ]!8]O%)A/NR=<$/(4*1NL#KM=6Y$
MD=?*[)]J45ME$A4S9XA0R3C+MM0D%)REMOAQ[P4@GW(O%4D7AVO/.)FI'9 5
MVI@@F3,SON;MWP<<+*1$Z(1HG! %D4I48?K>%FE$8M_1.")'/N ?4%K,Z?F5
M-PI\O9-G" >+3U"FBFU)]:#KKQD')9E-E0.04JJ+;4G3!+B,=F#O&]E(XC:3
MWK'S]G(V=M+%3-7*KT*$MW2/6P^B<DJ-E4I>\+QW[KBX8_[^=6VV3*4U*=UJ
M4U\XP>-DX4N^TR5^7(?8F+$S(TB%VJ$TI4FWG+ XN[,$V3HWGGM#?[V,)[-<
MVH#0E"U#KS+E3.56+#HK^K+JJR<_@?+SO6@!1MKWF4H93(?AEY]B[F/KZL[@
M2M7,BLW[@[D8W*CH0N # 5EHQ#94K\*HSRXW#"X\U'Q ^TKFVN4TDCQM2DEX
M0:65U:CBQ/BL+EWLX"GGW%52 >?X[XMK_A+L(U%70[[13I'X<GCA#5E7$>:R
M<,:DP4SD[LWL.J(B?KZO2$(08[7"5#B]/WPC6Y>)DBM2_=-]\NLSS2RYPD..
MD83?6NY.STSG%G=>/ *L# P? 9;]ABIR1->'"3;J>6:BZWCQ\N0Z?(A:R4M3
MQE6Y!";#"*_<(C.5@$_1NYLA?278=&DOZ:HN:4 L.:8_6.@9%;<CQMC"5@.Y
MCD;Y[HUXS@>HX>B*RN?Z*K82 OY;KM-XQ05L!;1H65OXCH"N3W2]/_*)=_V#
MP6?A>!H+E7:!HC%178_O*R-*C.P'%_*5#4;;\QSL6@'I3-1!D<> ,8 SBUV?
M%H>7VG.OX#.=UDB58ALM\/@UQ %@$4_Y Q O'92&U_O<SBM$+T&YLB=/RE_*
M#U)#>ZQ PKH$RHT/Z*W:OY,HAB_8G"V9P)52M%_*VU,'AL<FPC#7U[*VA5-\
M?GLXF/;";G63K/D2K#_$02RMIZW2WE,96^U(;VRVOS&&UFNV&!Z6%_?ES.NW
M@@7J?;S:&C+T(W(B&;N*:$H%R@':=4UEC9#MR^_\ 1\KG)8B!JQ0WT1'U6,T
MDK]\-B"*X5 ?ZE33[$]OPG_#XV]A[4!KES4:G]UYT?\3*VBG1UK@\X7@>2H%
M.^QRR4AP:, K(4P+2,-E%E_X>4""X]/Y_6@F]!%PC'($%/ 3*!X!__XT^;!*
M%VV@O4[OD?92@-V[LU>^$F((>?^=R8K4) *8*(=>CTQ-49EI6ZW?>LYGA.*6
M0=,ZR_JZN:TVJ6NI=Q1'0 !C=*IB@*63#.T-#FV""86;X6@4V)9TV/,97V3=
M"Q1K!T>DH$V<-7O_51&DCCUH"6%;3OI!=A6[8\%$TB[FA\OZ0(58!;C<:2.&
MFJ,76$5""YH]FS=9BUK3\FW>OXC,G.M:I1F!C/;8EU*8DD7)NK;WY0]'<&QM
MV=QT=S?K]49UAAY%26:X>Y26HB>1@P5'ZMF8<^CPE$0Q0Z2O.T5QJ4'\D;O(
MSY2"_"(3V_%=9_A/-DA7;V6',HHF:([5)\/GE^Z]I4V3T=RN(61*J:R^&ER2
MY9HE5QKR"/"#IK^%^&-$'10]!1]T3Y[T#<J?#PC ?WM4D#2LYLX<T+???LAQ
M4;R+_%<_//D^&,28Q_D?P]3_2$6'--QP1>+=P3?%S-&%15'"M$ZLS4(=)#V"
M!4O!"8HF:>LW? <UJ'JRS*T>=0HE!+4,7S*,O,U\@4/!",\[;J <MH<AWV&B
MUT7WL<4.A79&/[;4GTFG45X0$)C; V\\R@EN?UP2;R")J 7D&V=LDFGC\()
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M_\EBE7%]=ZC5;T\(,PL/L2 &M]HP2W$N1-LDY:/M;E^85X)2Z_%#9OZ\ 7R
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M-2E_EOA:LN8^MYQ$(^M+,6S0SXH3RT1OQ)8$2$LZEFL:[N^9SK(=^8)LIT=
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M?TXR61TAID]1)TN0,1"IRTL*>'_C4SC^T2"5CC\Q<I59'W'XIN@+51*I-R(
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MENQ=J/,T[NWWF!X+7!>]D2$R%T)Q@V/UJ>103>O.OMRRV6+HNOX\H>NO'NC
M&2&EW7YZ#<YA6?QMZK7<UA(OIXI#+3,ONI)\O1)Y+/P'@VI2*:NODW8J!A[\
M(\23,6/1(W:4'2\W=%'H:-H++UYF9P=O6T&=3>K9N5QP#PCPTR36RTGC,+1D
MX$-W[EN6X0VY)I79Y7.G%1:_UQ)\/AK6J_=)B2:S52;5-?=?^K&I*>E@X0AE
MZ1DH:R_+F2;>>Y"V8H'6J;/$[0P\;/*+NHSW3(6 AW=<Y!SBLAOT]'(^XW]-
M.N)BX1TXH.$%O%+)$)*,RY!)[>W(J!KH>$3(4:U ,<(?B&/>/-";SG;%"!K=
M4'153X$[P=DV?"OQWO?C^ZMRH1/,7O:2Z'YA_%]*^ST<KA&KR?(WPY5_7,_1
M_WCI L,==]2R$"-L:6Q46Q\HF/Z3>J7DQN6QAGU)$V-%WV8]GFJW<P88Y#+C
MI'.+XK51_ 0(>^?\4RWK7<"F#\-AV'BS?^ZA';RV-JG+H'#\R/OGN'ZMY,9!
MI(5 .^@AAT:E(L+^TZ:5[:;4?0^_'XEOK4#',X51@R< I>J]Z1U:R1/@4\1]
MG,YI\;;S.SI6*SYJ!X29S 0%\:I*27T?7-3RFLGRP5EN<@'?$BU7NJUC:6E\
M#FQ#S0_&R)]G9#*]]^!>1",..XQ#'_\)V9PY"7!@GN /2@='L@91Z<87)LRF
M9V)3NI"F)T!-;P'QZSW44@,/(D6.; VI<9&6#Y\ZT,30J</C; YXRA]>"YZI
M>'5'_-QKN<![ O2I/ $(P =?"X=MWA1.<$CCE4GUN)D15V+6LWP7KA>H&1-+
M!TLD#8^^MN#])YUE98[8HV<FLJO^F1!RV01D$)3/+VE6)DO7*EOB<NVN[,?+
M-I&$K&8.=Y?BO5 :0NHLK6'(FC.*;\;6%H149N.X\2AMN4>^3#T!_GZDOQ_
M_/<L7Z'OLECCQ"4^Q<_&(/IM)[?,>,Q!1/D6X$N6R)Q"#J0;9Z.JZ"GK43JM
MA[*I^Z98S\V3A?L.BO %E>5_1M7,@7E3E/WDH-R3^*%KKGEZ#K8F$W6HB,LI
M*L3V"'.0RQ".M[('7L8C"DL05;/@Q N]YF0S@?^&8_)/9,.=:)\C&SSX]Z_N
MWY_,S9&M;^9J5S #S9G5NBJ>C87?^7^'8V7AC6L\[^$/+"7]I[,LXOB9_*4/
M>A);80%2/5NFSX>Y42[T?HD. .'I:Q)9'R!(I2]W. BSWR0?$A BU]:%8*PF
MJ0GV+UP.7%X]ST1ORFN'Y0D07?+([OGCF7AFSZ-4^<V40R^XL #]1WY8:>G<
M(5J&E;VU?J#HC\7H-FF33.H)CA;UC/^\XV3MTKI4=YK1SO:AHM8>A1U?"OGS
M"C4[BQ@\$@RC2/Y61&'Y0_T]\_LHR\P(6#5#IK2F:>DZ*84YSC??R#[3_Q#9
MY[GE[-Y^+V%8S+5O"'VM-TQ+*C:AS<0 8>AW=],O5Y!+NB:>]2DR2V:,RUO0
MXDQ +F:B*^D[U-9UH_#QEI.3NI*1ZC7G<>K*X1RCPUD,C]M,:,#-,7"@8+(
M!IY][116^5'JK+<!.;KD\&,KS)/7\BVD'[0%[,F8/0'TJV5"!O9Y]05NV5/2
M/ .)]XNJH>SU":+F7L:SBX9FM\%-WBNB]K_4;;)VU:_?2INQB=@1BI-=@O#8
M::G>D6>GDCMK#1#&[4;F!M?.B=X[,[E1-HIC>LL^XOEU"^U'N!-*($5UGTM5
M? X]XVXO#HVVD+H2G2B538&CC?/FLB\:7G]H]438,V._MK!BDV\,/4RT]"=M
M"!B6N&[M,E9<O$6DPSO2CU]3P[)SK:@[7$^?/3*+D3J3LBH=)B5MBGETBS@M
MR@[Z$"B.UQYQGFQ *HJM!/@++H1"ML9F"QE]3:*KY*O:[-3@W;4JCRU6G,W0
MS&FP^0","L!G- E'3/CZIRJUDA:XT IR"-F(E.8#E/0BP(V)E_%;] ]&;VBD
MNE;7@W*Q%41=Q9/_88]3?Z;'.O]VQ0<>@=_-^2!GJ21< D>ZTP4S34J:_K 6
M:BF.AP<77C!Y-VV-CGY84-:;MS!8GU9FG5]G"R>UV4M<:3'YE>U=S.H Y7QU
M[(+XY%93T;NO@=]7V%YD=#=G4V"T!_+0>0/G.QLIPD[V03UCHCCM3O^E0]'_
M^W B338=)/0P^M7):5!3O";PNB&X?T^<HHW/[3?;/'G4$7 6&$V*?E%[DK?]
M8RO>S.K(FF1]T-(F;&8;V&,.2\V.422SBS'+B1^_3-,!59S(!CWD.;R89#"L
M:VH$/1P$)_T6(?E^S5%GU'2RW4G,)!4AW] P42/MYH#:F6X@O,-6Q[*-4,"1
M]01 I,IX",E5RQN:5-H5/-UU(WP5A_[UU!?=+KA&;U6M]+(*LK0,WB,(#.P@
MBK%"QB3)4A&"XQ]22B4^W)(*;2$?O#AT(FT] R]8)/=.;\2K'<+;2WR.MOZ
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M2<O=6&NPTI3ZH5JM1AFMELR-JY87]/.TX4+OT0-F<T_&.6+S,?WVS*(O+]S
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MTT?$1W9&X\V('?$46NJFHV]JJ# ^B)6._N>ED2!N&Y[F+M50_5J6-"@6[1-
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M_U161&#L M%'&:B02EGT?6T^*)U^^1M02P,$%     @ W(M_7/.+%!C\00
MW5L   T   !I;6%G95\P,#<N:G!G[;P%7%7?MB^^" DID49*0A $E%)R$](B
M)5TJTB4@'9M&NB0$82.-E$AWMW1W=VXZ-GN_C:?\O7O?_;]S_N>\>]__?S>?
M 7.N.==<<XSQ'37W^H"80"P =^2D9*4 %!04X#7R!T!, Q( %@8&)L8M+$Q,
M3&QLK-NXQ'BX.#BX%'>)"(BI*6EIJ"FIJ.@8.9CIZ!\Q4%&Q/'WXZ/$3'AX>
M6F9^X6=<0AS</%PWBZ!@86/CXN"2X^&1<]VGNL_U=W\0C0 A%HHCVCX:"CV
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M1;L).O\&6B0:%-1^?*G(C$R+1.^]4N>$T;MRPBX;X.A( ;;=<)T2A@!$AA#
MPHL&F!I@I:S9<!!L>EVP1BN?*PWO1>X[$02#0A  ZAK2,^6@F0<C"T\_51D$
MD*(!.K_W% &0(>=4RVQ2#USJ]X%.78&ALOK2>@T+^81LPJHP6 5>62 ZU0>1
MT;>5_;=AO$-"#_/GML:&YQ1<G!BJN%Y,OWK2-UMU45\0HY<,$/\Z;_DS>7LS
MHF)32[FJ64GUEN$)N#VO3AG,%$]S<\2A=\NE.](U\:NGGCNWGKK$KE7.[5^?
MY=FFYPJ@\Q+QZ)ZT%O#M3TW%/PUN06[5%7Q)[@"YNB!# />0"D*B8^/-&'A_
MQ0!F[?64)1]T+IV- +X&(FV](0H,K08MTD#@ =0F<#C2.MHWT.S^-8MD(ON>
M-_V(/_5OX$($)[SXM3!HO[+A?);V( )I9Q+X2!OS:/NUC'5PZ]]NV^.$/Y6&
M,2 M8J E'SQOBWSLG]!(>_-H0_@5TB.$#2(5#$, QX^W:<]F;C;+MY&O>"Z]
M?K-9I/G5+R& Y0_@9A#H&E>@X_KL?[$3SM-;_<@)%=<GR F$OV#TARO2_PGC
M>/TV=[8:0I#R;56^]G6X$53N!5),K4H8HVHC/-/4ZH,%#C@R' 73^?92U& &
MI&HFGAH</]Z"?#& 2=+^U@8$90^R X\I$JW8I'Z4Q ;@M-S.,]P>*V<CN\+8
M1HI2]0@IR8_IOW=2\;[]OQR]O5_QT0'4T8VT*19X<^V-/E1@:3>]&PO[XY4_
M]E 5#%HH2>L[I\JC3%P['Q<(W?](J]JK-<P3)BA91EIM%%;WA=J]D@&+^UR-
M<X>M'XD5SFY..'W$;VTOOIQ\@W]P3'%'<&_N_@AX/Z'A/-A@1W ?.4A[M?;7
M.W^[$/%_;A09H27@ 6P(X&J)$_X@XJ^]&T03_7+@IP^^(C%"@@"N;PPC*/V*
M2 DIU& $ +^^0<T QBQ)T'50#GB@#8P, $B[6#*%MXZ -MXV(&T::5P\*!62
M;\%OS6F/GQ@@G2O2+!)!Q;P$E^1%R'P":5H*@-6@)F0B,? :%QF/S_9^;4/O
MWVZ#(_-F&_O7EW_:!9G*S2[.X->2?][$^G@*.I2D/]SJ),?=P,G&C*2Z@YZ5
MXT+FK6-LHT+M"5WB,>4__9SRO^F?3Z91.%;X-77<O0*URTV#S7&)_EV4O/D^
M2^<%<+7"='J-56]]+Y/S:A2UU]#Z,MNO72ZV+E9OWE<X.O9211Y$=4I9X[]W
MK.17GL!UZ 5<PTC6R?39QMA_5KN3!3FGOR(-R8U@!7UJ9F*+%JJ;KG^Q?-"K
M%:@WEAG_<GC_1$>!/R-XR;A.@LK'@+WYVSN8]W>GQS1?WGH);K'U6CLD*TK5
M0_UAVNESPC]T:DG#R7I:TF +#K>Y%'5M^PL4$  V?H/-NQY;-\MB13<K&^K%
M: K]6S&"D\V EWOJ0X8\^R]*F*G20BJE(50YN_>LWN=CJX8N7%(17@RWL-U%
M0Y76I8EM=Z87'7;.3+GF*-]ZSCMT2V\BX$E,.)?@<KC [>9A!W)W6KR3KZ0:
MG-3>E1'JWU'FC(Y0(X1EVP]U[[1]!#U9QO 2YM-:"C1)8I6N\WEPBF9/X^4*
M,8^N+;5PJLYL*\N$Y;%-G </\<2X6[;R&'U_X:PBQIR:RP#M2V?:V<7K=#/;
MX;2FN_O15VI@V0RK@2N\"E_VTEZ4)EF-EUIN6+;4(F_2/8=XH;QY @8\J$R"
MW+6@H1GZ$&:@7$LV5G&:SXAZ2S3^D?>2VG3?D 0S_TKP1M&' AVU@PQ*]ZEH
MG7E92IPN/T'?4/<-P*A1*-3WBQ+&"K>T+:Z]^#:C"LL[!WY< KI@#S$3S$G+
MU(K6UY*4J80/6LG)%]XMN+T;.0:4)8G_OTPH,J:7FI_7**T@B1?X</$]RY.N
M#OZ<,H7;'>KAC)41-+K%\I\ TL-IN]SEV'[SH30O-K")9@AG,8X@^ >XG^"A
MHT/_;+O D>R#)$/>4L>A21TAPM<=1,\S5:D?/_%6_U:8376X^31JZHNN$'XQ
MU?(:J^WE /J;XUR;=LK>?7V.QZ\Z#>%N8+F  5,NLT,)8YZU'RXO7D:A/RE-
MOAWYC'TXO*Q[VMGQ5$\.[Z6@YE1O]!WV3L+Z6U4O]J]:T)=MEF7Q8_/P,*:(
MTF0Y)T]P7*P,/R]H?0WF$V^;N).1G(]"%2EEBO8C6(^KOR^ @IWND)BG,S1O
M-?2])KXOX+"KW)SXB/6^MR4#V3=->G1:4_*5!8]%W_VQ*IPBO*UH_5[6S>)G
M 6MFDZ&Y\"\17#+%D#,U1]C,^R=M(N,MU7Y/HX02W[%&=U'UT$4I3L0:NU ^
M%OB2AW((C79#$:7^0LI'^-QG;FR2H?/#X;(2EP!AQ+I<M56P+&.(D771 Z?O
M06*_!/U-A#Q8TUW0-$9JL.*G^%,UE=:<TPN9 E>@?Z340D&=[5DA&I:5-4.E
MS#"*5DPLNF'JLV?+D6SBP2Q VG_3OX9\1"F8 74YYY"75=65I265\B$)1&[T
M-$^^T+@MQ?:$,C'.J.U6%2AWV>*"MAG5+A/7LT<*3>#"(1M?U"2ZNE:&Z38@
MZJ4OPW6N1S-"U'W,HIEDN3J 2+:4/%):* + O#K&S65N+:"_%_0F>NJ Q[I3
M1I*!;GFL4.<< ;14D&- OX*.Q[A VH?4TG#Q>,@)E!GN9UYF=Z5%:W$=Z/])
M5<, =(XY4)X8%GN)45H3\&;\S!I/J^C+LE-02_M..#]N-KJ&0J;SE<ZP7'X)
M3J?TJZ1]P\GJT6\]N>L:BY=1&NEL%\*@!9I>27M7LK /!9;Y]WO+D"5''+=M
MS(XKY2;;N^&)B\M2<^5X)DEC9%''3?>?KH]_(7VK#D@WRYRLFUWI(7XXD@)O
M=.*9554M&WK$6%L3\TX&1"KL=<*[Y$D'O37_T0&C\DMLD'/P'6<QN,C)E_5N
MURI'/2'=PN/@67C(Y< P]&E8D4.%,_OGW7P!=$P\.@1@B@#DV@8=^'FL].<N
M1=RS+L:ONIT9#K\1:[#%6*]/#S</9<M/2HEL[MCGN\5IDO/<S8E^0#URR,K:
M<J">>7I-J<<E]?,47!LH_,(D!T9P5-"]$UH5V]]OZ^P46,"JF+TZP-H6" ,W
MP:\U_@*M$^DG*]H1,'].T/:2XC76J'E)#@+H5#F"US,B:\XP]2)A2([$HG[(
MH9@DL9*FAL4BA';6++^\.EVX-UN,62,")KVMJT8\\D5OL/]CBTJK1'1:-;Q<
MY&-9M<_I) =[IM:;2".]EV(DO,X1_C!5^\7I[]AFEN] =8'#UYG'H+ZZM*$]
MG&V9PH*,NQ+T>^K4;8[BYC+GNBV<*7<]ED[!ZVL*DL1J*:;_2)SZ4&@H!M79
M3KD_\DAE0-H$79Z]KAWV^5,)QXZA]Z=G)R392VSR5]>WUX9?Q+$4&NMYK[P%
M5#RM11FIWFDP&+U98A%2S9&T,3$TEXH@OB-3=#^([S/?Z]@5'Q?J !8TZ^FV
M,*=EJ<$WI:JFQ0V7RN Z>D,[[W#?9WVN:TE//YZ$@=2*(U2'Z +:+]=W!H6<
M!%>D^*>T;$.I')E)@K(W7><^+_5B8/PHO:,SV1WV2$6F6XRNY FKB)U+AWNB
M1WD51LE2SCZOH)XXN173D\W3]G9=4M##S]/6*#N8;Y!Y(M[-ZRW_%8E/]BYY
MBA8Y*]VCGZZ X'">UWE,$3E[C%2%NU"+^XKCRQ8H/)8KGK5JU*]%GDA+)<*@
M)[?CO*0UVCE0]5%F7!^].E8_W,^C][6RI"W?= U(,E..^'5NDQ;2GSRDC"^U
M>JE JU%1'P%Y6&\$/TS!@N6-FA#&:;VV&GB1)I/@I-KKO.I*YE/&6;%QN&G'
M9U+R,W(]-_2$UAON4$>A-7$Q<X;=KZ 1#IT?AJ/!>KN+WR  V@-P@]K6GRWB
M X3*A30= =R7[[\\CT$ XKS:^5N@0V)D55X4!#IF4,OK-]FZ<ZZ1!HM$PHOT
MYO2*9/R<K U3JI[TZ4O/EO<3Z,=!_>"O^[K^Q,-FL^1O6<3KGKYTX][88HL^
MP*]WL*+=*:FW+GCLEY(/:09G+^I9.4G.ZL+6"<5?L79_.D.:E^KC?_,^UG]$
MXDUBCT31<GG* I<Y+XA.%"^7P D9L[&]#R6F7H4*EM8?&>[>00#]2)>R_U5Z
MZCX"2$$Z[7GQ^@^-Q\2O76^W3+O0*L(+BRXNSL%-(B%7ST%'4Z"K#>73C^#U
M4O#90%'R8^%;Y#0^$58KM%M;"  ""801;32(W 6/=2  C]O1]<[%:%=2X][P
M.M#Q?0.)L4C(DY4U?M>FRDRVN>M'2/F8NHC]"[\G_4<([<%G]H5HLWN6MKG&
M(EZXB0?4.LHQZJ.%-IG,W/QT-#T3GII%FN>^.?=H<10HOPCW8$D/'(+%]'EU
M1U/*11KH6J:^Y G/A0R"FY *^"[RZ:8"9#V-R.U*WQH[&[1[:_,97)OM V)-
MUVOP@V$^R(F:WW)+*Q7*D B(=(6(J1%/#ZRVC:5+Q3BD1"@:,!1$\\8.R2N]
M"S"Z^_R5":OY;*S_T*PDPW,UM1]V%L9#0SCW-'<+T@E;R*<^"J"H:MA>U!8X
M]10O4V;["HG&QW.'"6>$K3K1Z 0\>R2SS-O7;R.<'R#X\9U_QT%GIN*VP?-1
MG6N^'E6O%C<KJDZWQRL>!.9-@WH4QQ^X+]J[\XGTI?L_:)@L]:/VI.?-FZUF
M_:#Z0:-]_UK2-K9O:6FG/Z=EZ>'2_7Z%6:1=R\S<\#E]D)+_P890YZ7.G<ZY
M5W-)BN#&A?&J\3[>O3G2$?SLQ;Q[<995H6R0TWA?6%Y:R(9[T9TWXS5ZKJ#A
M$S[D_1LBK_Z>NIJ-H-W@D'D+<M** )[HQ/Z&\-RXGQO-"("&)N](.F!0DJ39
M,^'&%!4-D99[S^!R#W)YI^CK]GH([076% (8_X ,8OX>!'K$KA#F5@,2$&0#
M.?L#+<<?#J'_"Y!+=IM@FLEP?M,"FYSTN#<LS&75$70W@W/)3V*0?82@-4;7
MP?:5YQ%(HGNQRS>KMNCL1BF^@S>.0" "S=G=PK4C2<"ZI*REDT#*NN?:8E+T
M-@  SP"-AP=[75;N;%03%WMZ&8:[7PA6]8P<5</2W/&M@AR*N?08TJ[!=]**
M3VSN;E[R-E9\T94'?1HN51\HS8_"Q_F.YIWRL&+NX7"^Y=LZ' <'"T9:L[M3
M.J7?Z-N=[F*^\.3]NI+T2OT1G'7H=>(0MV!GA2Q5T"/EN# 5B3**A/=?@QI[
M#<I'=FTXK7?99U/DI=0^^R1_:S6QWO/S#@V?)$8QB]63^WY+I@GS*\G2',\
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MC.=J% CSW6W8CD9& 7UC5\KC'H(+S&GP.!-<W)NKC5CYQ7_:MZ;_OTSMK1'
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MW5I&9\]U),P'M+S(IH*\4^C8V4D'#2[T#VDDNZ5ZDA;Z)XTXG@E\X1M\_B&
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MIDF\/D'E:S<--4R_U_(Y>WN<A=8<;8?S0ODD3M6M;]&0Y;_J=)WZB!!*YI8
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MCU>H3UE8E_I80>Y/*5F_KTFZW6KG696*'_XO_[^U_W<0 6+R?P!02P,$%
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M[P6C/]A0]8UYIFI"73UO5&DQ\H29P3QOX#I"1M_>'+=?T@B.DA,*%_<*5;W
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MIOC:CF.^OSV>JGJN^;A7=XUC<+- @]I#PDV#X)JDK"_\3>B=YIQ4/XTK*2^
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MK)-WG91Y1(U)M@#E!8#>[Y,_KEL3:8H]'+O.OKZADS5Z?]%WHORR%?#;U+\
M4$L#!!0    ( -R+?USR:AYH/DT  -9S   -    :6UA9V5?,# Y+FIP9^R\
M!51<6[8NO'$([NX0"!K<+00+ 4((K@D$#>Z60H(&)Y"$X.X$*1R*!+<0G*#!
M+4BAA57]E;[WG-NG[^GW=_?K?J_?N&?76&/ WG.M6FNN.;_YS;GW+L0,XCM
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MF-(J*)'IW/V7*O/?#.&1&VE^Q&'ZIXWD+JDT7J&\CIHV/^A% #G1[Z]Y?G2
MVG1.56*UE<@_OTSXA3_XBW4>7) ZRBTE(P!%D0E]_L,K^/TYK?,U!/!UV)-\
M@3",\<,J9+'4#S*$M.:\F/\YKK+>S@SJR_"$7X,NJ2H+_URY7#:'M;4H\%.M
M2081)3)]G$MY;24R -E0?BP10M8TD)O^4NL&;UK;!/);Y7K(DKUTCD, ?B4[
M".!N;C17W-U_90SYM6A=-ODK2ZQ#X<M"*ED@D/"X3,18"WF6JCWB8C+M7XZ#
MW*DPI%^S>$Y?01' UK/FM#_7;TG6YR]#6%>3<D]\)LFT33BV?ZF18]4&R"*
M1-'QFPNY$R%3)3<$\!L-FWZ%:5^T2]WL%)5=?X[F+!7__#^#'OS6NW<<?JO<
M0A"NU%W&@R<WVJM/M)5<LO)_H=4,P[]U[\'KWVC76W%990-V<%Z:676,]('B
MU3_@\P_X_ ,^_Z?#9R.$QJ?]2K&Y'CQFT9"FY+-X6HA>KBWUZM%=E:&N=/\[
ME6.MO=UF%% Z&J<"D8J;BN7VB:<9"7;[XP"]5^7R;=%LALSV.I0IG]1=TYJ&
MIM:/K6..CA45LUHG?0M#,2CB;(*OZ"SEQ(S&OH*I10(Q.[53OU7D-P6SVQJ7
MD@A%;P8H7PI7G)D3V5)*QDX\(N1;P1=9)U!=4QYL['&32HPC\)_,PC?92=.+
MR+9KG@3O]>2XQ-0,Y0T1K;+Y5F4V=HQ(" -S^#8&4/S3B6:3,XHT1_"@\9U,
MBC3UD B"3H(<93<LL_=GI54KNZ=0UJZ7?<TO_.+/W+L& KX'9&^8SGVDS/S@
M1P#NTUA> X^"-:@]<-]"!=H3RT70P<_NCCFK8?3<#4+KXY$DCG.HG1+F! >^
M7/QJ!\VC4K273 AU&*3Z?J_&4DZ [OLAQ B8.827N5=TRF8_4SVY8*0PH3]2
M%C^FE7EWA"EI.57O,')-D9;K\""YLO"#8SY-B"F.=*+8^RL(A_=@;$O[)E6W
M'\8_5"'Z]ZL28;@M$4'6-)N15BAW@Z>O8]+0Q7]!6@E9BD?Z.;D0S/!;$-+)
MBW;B:7*CN5_=,/WB V?.$4M'MV=!$ YXN$-QI?GR^754?=9!/Q*ATW:XFQEO
MR8GU@MJ>G(+>(4%:A>H_4>6WS6"1"<J>%<$2HMZWX2I$;GY'X1.:]%IT)P((
MR\I% "/@\YLK<SA7P1=NY2\#!G0:!L?CH0Z7QU)&W-%_(1(/,[SDO[XR!RV!
M$<!*B;_JN3!\J <TTG 3\&4J>@6R;+,%.=X+1"YR&@%$Y\$I7KY& ++32^=[
M(%BI3+Y_Q)FU$#P0LKOA5:=/\I)C*]OFQW]>_.'H1+(_1OON$XZP TOX;HC0
ML C;V=V*L H%#CU>DU2DGTJ$_$%?_D'Z(GVU4G7M:Y=U.HD 3FB.N4Z6HB'0
M]4+0M#YR3(>ALKBJKL!]#?@Z8]8&TG.L_9:1,(HJMB#WX!)+"0$D4"#AWVP4
M.4N6]I?.S2]33@B0N\K$*P=ORT/V5W)6\0H8(4( !%EEUZ\GM)4\LEC^\-=_
MW%]1-I?(0:N##Q% 914"R)Y^KU]X_5,SO$+P9@@\U.RYB>=+U@,WYW/.ZS\Q
M FZAZ9][3-R^?:G_59+_.@@9Z2[/D--4(#\^#AP_J<KV,+] 0>KN=(\1'L+M
M)U6[X1,!\[@Q7S-#=LZ_(/HWY@DU(B!2.S^Z$*EOMQ<M!5-"%M6BF7:&JS5'
M]VW1S**_-$Z??# EO+(/O(<^_O"9MIOY.I>?Y;1LAGV@F#9X\F0N\%Z/N>C4
M,GJB[)C8G2T7WVS<)WI\>2L5_.H3D-HB,3?3R%<]W X2-ERO$G!FBNA"U8M]
MBM3&DKY5<:3*U7&\*SOSQ>5R/1;'?8/&ROX1 W@QJDNK4VMZ#Y=0FO;]JF O
M38A;*+5E7&AB_Z[>UA]^_^_M]Q:P,F-3QH='RQ%[DBD;%C5@^N<)2%[](R[_
MC+S-(*WJU4F&C4[$XQ;U'%\\:\[UD'V#!R42K&M/IX*X#'R<\+D[ZIMU)UQ-
M96*KN?:#PA+N#/+YN6G*E,C2IP=(?L411Z*")N3!Z(?.>J%M[D(U7FB#3OI-
M\U/FW4^!<Y&;.>*E'WVX%1N^YH_JX8:/Y\]=1?&MN^1HRC\V2*&FQ^1$K2_+
MM8?"0G;-1T]I.0O\V8.S6^KMR'[P=.SKF]AX2=)LGE)HD?B8+75O[%[)2E5(
M5#A5#,FZJ\8@ #>AQ B>NX2LB=V>LV^1B]!;WVQ23QACBM,-WS=(U:4#=LK1
M7'M9"TS?*H]O&),Y/">>:?3WF4BYSV01D!<:/"[#B1;^%:S>QFKP_L!CW3MM
M979L'R3'_\)4)87D]J*V(I^FRM"0JUF\H9"/PX/&J63]I(78V90742:L@B'D
MT39V%H3H,7$RW$;_AED1VD@[%S(13'V/ $S-D7A8)5BE ?N9+QK9W'B";C!;
M!QIWKE46UY;VM2_@3Y7(]&PJ?QHDZW\'S<V-JZ)M<_DMR!$JTBYW9^5NT/5.
MO&V&H(2'VY>0OC;DY-6.F/^1YR%_+0+HE_Z:RMJBFOY"2^SK?X54X?].[/[6
M9F FD.E@CF-/:CP ?5#<8DJ+'M"90[[&>)BP:WY"V8X ('MPD?0=SA:&=BSN
M3+X/Z58I&<V9%TH^C-=LDM,W& >0@RM0[&_%&;YY24$F=R#'T,"A\P'N#@2P
MS#P%V>)'DC_0W+4M G@5880,7VWG-PC &9HWQ_<)7H5T]*S7^S;MVF98" "'
M ,DA%?P/KN!+JV8%AY?[&^>=#(Z37;7]FXU+W*GBJS%IQ1./O<2A30\/W[3E
MYV?6[W@B(=+>Y]/OZ?&W\7EBFA>*"[^_6W6^BD2J[H=P"B\+N<62R[R>XMSH
M93G57VQ3YL-OX_-;6."?U];W(S['#T.7#G1ES'\"I';/[^&7[WFW.>QH7&X7
MN7U;(ANZVY"_"-_TYI%7\Q]N!N3D?M9#ADY_YIOHOX.G ==+'C?<6_24<'DC
MT(V_"K)W]&+<CXM,9CB]G/X%)7+JV[+W_VVK)!((@ [4][X$U BY)*HBKG*"
M]EY'I;V]0JXQYQ:49KT"RFB7 &H9O#;/18I7RP;]*<6?;J=! 'W(F3B3@!X<
MT9P>A$..[B" N:ZL,7 >E('!'[Y];%XR@R1+4P'BOV?<^K_9:4^1P8![R#@I
MN7L#0\8\ 1VYL(QWA.>E+XNAI9RYC5ICOR0&A-:_W>IU.".H[X,=_#KKDKHR
MMR7G,.\XP/MJ4DO_(HQ,^XEKV.^$%(9 J#Y<NF[D$HE!E_B^*7[.OS6$7OT5
MV?/;2(2.'_D9HFME7)"8A$*[GU40B(;,J?IPD12I"NDH)\3F<K\7=!OR6F1M
M(D$16I-PI1W.W&:MQ+^F>G%37D]CK>BW>M.S7>>)PX6^NP2BBI0'JBB/_#TY
MV$97,"8=7S+[.+F7:YUQE[UG-J8*[_L<&<5^U=1WT'%RH%/X?L5R=;2R+2Z5
M5Z-J9N#U-!_IT *$04\H?GED51-Z^^V*AF*7G\9>;.:[J5FK/4'?Z;AXOJV!
M[\'4N#&7F6]0)A<.KLC@9@="@XXM?IMTSQH94>?M1GL+.@,]*U16<'C;?<!W
MG%*L7&0#RYAGNFRD;>@=JN7F'$%\LAVIUA.^OHMCO+T!)QB2?C1=@8QFTR(9
M++M&K[5J0Q^^F2^NRRBP*YA]@E?#-[F6[J:%&B01*V8X>>(0ZNZ6]N;M6">;
M/L5YS"[96VO%]<B&@)Q[^VQ%*,H:WB\ITA8="80(JAG*K^*S/.D^*]D1\F 2
M -3?O:A*:8K"G<#]GK[.-K$,QG:\PH>O:CIB($*)P<<"/:Y? 2$=F*4*Y&/C
M!+\GU1YSYL& .<OH8$^NR%QZBIFFEE-G!>#QY)_,8?3<'68E[4,?.CX>=N[O
MJ!>J>J<I%-LT\@ 8S<W+]*G(3O)=4\V-59=J^EQ,KR83]GS6IZJSX5Q[]MMN
MLV=W5P0.F3[GT)(\@0;P0OO)GHBC)'QC9?8+?';%W[+>=B7%,$_ZL(-!DJ$]
M19KRKBFSOV]>"AH93PP5)A:ZZ_PC]+K_!3ESAR.93:+08P3@"CIA-F,U6UB-
MOR 5X3^G1 #WR%=$!HU79,>9$(#W6QCD/K+#L\#_<,JJ !%D/RWX(AL\94UD
M=PD?M*:# !JBY H<5%:DI<]OQC<@.A^1^4<YS.4/TOQ[NC>1BPFP+/;QUX\>
M&Z.UB?U.0LI5+=%/'WE2\N:-[K?1\,XG71-G'N=2T=S]D&6;7?/C74L$$""&
M0-KB-<^- SSP!>@@' &LE,J4:ZE?$5)_"]PL'S730 "X<LBXG&7,>+4,@97*
M_457<"3HZ:H4?^MIVG\;5L?H^L$41VM#6$5Y2#]7#C.M.!OA@?;>,T*V[@)_
M9 ])SERP]*-_6I+('0;M!A<<S+1*%,UVWQ0%^M)_L_V*AIH7[CL3EW%7*LG5
M=-*M['M]A#%DTC% L=1XWES<SJN< * G5E=6U=Y. W8BT2V.N*.CA:?A[!HL
MQ5>W@['>Y..AN7/VR^D^)'2<'%<JI +[BJ %>JU_-WCY9>SEED5R*Y^X9::&
M4LZ6WBP^N$OT@"?6U95]:&Q P<9;0J*#H</_%G#L_UI&_?,*MR$?;VX:OJ0!
M1G<)WZXSQ'U>,N'N KFRIF&\-,U!P)W Y[<S9QT+PGHR9WU4%\?6^$XQW,H?
M)!'L:[JG;XH(9U)79X@\;[*SD<R^(R6%5VJ)0HD61K<ZGSRLEFNKO?5Y>7@=
M^>F\D[JR5GEVZV[>.@!@@0'[T;_.\E!&8*OP^\/J-]U(,POSB?7WCI-;>S@!
MF3>_P=:/G.9UCKQZ&'JS:+YR0X0,IE$G__$V3MOA-%Q)[LHG^5(_8?K/G;:"
M,?+P>.E<*^U&$\E7*FN7?[=*_G_M_M'QP6^=<OSE7S#]2DD(\7F3V-6;EW^J
MM+S?_1G!L?\[P;JX^)VZ21O]MV-IQ6O)EU5'_,C.8P&1O\L\D@.0]IN8- =O
M^XF&]J=I1\Y1".!(T!@TC8SO6QJ&NC M!U:D^YC%K"#)VYKLUI_(V)<,!,"L
M+G<)B_^)H4;EVTM'9+5(*A")Q!OF>[=!N">@9-DP)#9^E>/]I]T\Y,+MX;9T
M&5!]2DNDXL1)H^_%D=N*$:!8\8(1*M:.'$$.'RX,^97@=R"1@Z9SCJ]W#%0V
M"<I ,OQ9[@[(KP0_&"D,^JQ8 ?IJ=H4 4&FO;<\&/_XCDL$PNV*S)01@=U.Y
M[Q^;:;8D>F_.O45\V'NR_/E0I8]/N52GGL>'MI"_5OXE /4R'MVV-]_GA[_B
M[G*8"W!%1@GK O@*4OWW6A\T.02HS+H@@*M62/<E$U*CI%M_ZMGFOUQU'0TZ
M@W*<5#%7F<$<D+VR;EK5;KB-Y(B7-R'[62*7&4B#,;7I_#WB]SNU0;G_!VN#
MC&]^<0;OORO;X.YOYT#2UWY'9*#[2>Y%_(9]Q;H0P 4U+V1W%'1RN[STF@.<
MB #:^95=D?'9C='C3QS)1A,9'@NR;@)4?F8$%7K"!Q>W#!' =!?HDBB'5"[L
M4JX_2Q&Y\BW&U-]H_6]_(Q'-5"S'=*AIOPA=%U0-&A_NO3G_T\O(SQ! T8?X
MJ_WXO_ED8KGB';W&]!(JI@:C!B7@&>@S^\_;(#&,Y]N@S_&P^W7F%]!0^ T_
M3&^!K#PV$&R^ ?)' $*D<&)>2GB !3)%5H>3_:93_59NG\S?*R<Z?:_FX]*9
M\)7LM=-1D.G,=OJMZC/^2]]&I')W)LF&YM,SYIKT?YB?'",-/W#TSRYAE_WR
MS]85Y8WT/&C)\^=KW/^"DWFR;_$G>/&[DM1)7?K6R.6TGT"6249!FSV$5R>0
M96./QS5\(ASDMO7MSM=#6G^F.6T$@)WZ\_;07=!2 0*X-9?[FJ7M?TN1Y$YS
MJ@TUKP? _.B^7_H^YLDVHM9QYO:]?Y*>4G ;[GP]\#M[7JCPN^I#^9>?G="G
M>4CI\L[)2"U7G)V-.?@:N^SDD?"LMS+'-8L1_S7L$Q)=WEYS(H!7ZDA:F44E
M=S"& ,(<1Q_TC<_IPFW.(<<"<G^F9Y4_[\7M%,T3^G=)<1IO/S*ZQUQOQQSE
M_BHF#.T0M>"_MMC:L7[_]W27K63^GW^KS$"V-U;A5V5/'F'\D\]A.DY%V024
M-D0[H=(5O\'\=-97NG0890LY7L6ZN30_K&B^8TBC7+Y2GC\]C #>1_V%4<G]
MQA2UK>0<]2^R%A' 4-=?*);Q-V-RUA#^-4';VYG5/=6]P@/1@*Y>!^!%CM1B
M5(K:X(KC];??W?(^KIO7\$PGN8-F620UTQ)C/%_X^<L)_\J3)9[+>[)G"NSS
M++[ +(TNGOQ)/WF9$H:R)A_4ZW]I#WI*5_:0(?@YW/K_QPJ5$OQ_3_"._N<T
M2<&:;_?*BY@BIYG@NF E"H4])&T1NEJZ2'GYRUP9?[&E"NV'??\ _.Q\YNO"
M;:S'TI.XG?$/)=_NDJ=[)W#6<6%:VJGJJ_N"\R.N--RJQ*)!98WDU+S]3(?<
MA97^)F-@RJF3/0<UBC%3(Q4>?HS.=U,&2U@'8<^PN0@5,VU1VDDG^?97)EYX
MTK[*W-5L\S>70GE8"G!UJP#+3;UT>G)1TBJE15%U<XY<GM&?\947IR[.,(\S
M%>'EI..X_:Q9[_3B(KX/2GF_?3S%\\/I],/KU&;?Z^Q%';JGVI%?D'R> :QN
M O-\[B]27D]B*K\T:^?OAG^];. TO_Y$%(VARW*'$Q4!1(/+LO 7[6;K&E \
MY(?Q+U,86^9EU81B#COM]HYO;3@%*)3V+#(Z&G?QYBF4@H<[FPR>=#.@1$LW
M)Z9;RAQI>+5SC+%-M?+[%\A;'G/$L+R/XOZ$E=R_]T1DCU'W@]&HIXP@+G>H
M15)^POS0*.9B-BJV\G;\ Z"J<LD>9_E&LO?>%,VJ]@151=L5F].#TK?\03FJ
MW_FU5DII-J/7WW;*TDP\G035Y$PX6:J7!;'>S'!YXS5RW>VDE]*]:.7UKG(X
MM/?;X,VKKQ-0P @[*=53?M'B_.A5"&J,KI0YFIG!3=P8CH6D9VKMV1:%&OW\
MO2?[CU4E'-?C.7)VY<F>0V5K*<.*6HR_%8RO3'3)S1$;E_6]@*:^XS2M"#W:
MQXUQC_Y1]W[0)["2=8I4-]ZA3BR:=-/L&_=1$H&R/..#H>I1<!NPX[JM]E0D
M?SI\97'1EUZT+#[#C6SOXH*.@4"\Y%IL^2J66W,2'0'8Q 4J;ZBGABS)/F$/
MHGWRW:90K:.?(QKH.M1Z[<S8.3VR0ILC,IS/<OYEAC2  /=.QVH(M7O<Y*MV
MKNFI1?+)TZ4?HZ*5+*E/Z=3/?(P8!71X\ET3!'TK2MH9S48<EQMCYP5>JZ;.
MZ>AR4-[%)"!RO5D_^!9K,-%ZIYS>$$S+;"G$5\JO1[UNA9>I]3;DGBB![Y8M
MRF7;S80D172S>=3M9LK9-X_HE>[S]8BR$35J9#2OE.XT+S8LKTW5-7F2>@OK
MH5X.0%<4F$ROJ$T L@0_(BQ,L&>%D-GD29NH4MUX#J1F@K7Y2'9BX_:3$=KK
MUA#WF]FRP&5'2T/P%-_!6MUK[3:PL;H/BY=M=HSHODDQC]JFE+(X&8KDO'T[
MRS285LI4SU1T7,,@SZ8A6C3)+@,MR;L,R";_#JAQI$5TS]:#"^<,9^VF[9V_
M!Q]49CQE;(OF<3*AVUM*DB/@6MV67$RN,+.GX?$2$UC*MU[!+4GC3<H-(R@O
M_88ACV[A\<6^\=!X)VWOK*1J7JKU8Z_SK9D%#8 X^"T>>;A;UZ%:-JZ^Y/R1
M3U;GHUE-V<YB!>G*'(5%5$R=S+PJ^^W=D;V .U5;"&#F=O\+OO"$:0'E9)-6
M_YR7K!?U8D.4 '2NPELOUNVL&CROW>VB?QY%%C:I54LD='$+2/LEP6#LNBS8
MRXIZ8&*?5O\AG_==\DA--2G'^\9-?ZHL6]P1\<IFJ4;,] 8<%SY6HHL0>05!
M/!MIUQ&PM8/#RITT!T?1)8VD*9]ZW[>DDM+WUTCK[A!(?!%L3V&(_SY,J_*Q
M(5J*VZLE;L88?)"4JT_KE61<)8P2O PB*P3[6WK[5BXJL4.M&ZJO&-^^Z*1C
M&1A=GR'09$S.%"^3O0U%INIAIV7!0N_W^/>\MJM?45-:K [VT>VCB\DM""^(
M?4X;<MU*>WX\$RNFU'B<D\EAR7.EB/WI,? 0<RT$:9N0JJVCG?%MDOO/4 <N
M^,R'X#LAXJO(;^]3*S.;@[VSG9V.F=.P]8 QNKWV.-YX]JEO,>*K"[=Z#\U9
M4<'"W.T/[E=MLL2!+V]Q4^?,DSIKO4FOM;+<GRP;YC8!0V,7:XL,MZ==3&:[
M,0<_I$8EY%AFLKXX+<8*MIP$XYLATX8D<]'K<G7RC!_%KU&S48SM'LVG2L>=
MH)AW^UV H;(9MO#;\)[QHH^IJU^T*0_H!/<VE&2BOGN6ZLNR3V%F+/>+O-[V
MD%+OR]K3AW;DD81&=CKC58<SBK%649,7Y<-DX=RQG#LU1O.*=H4:10,H;'WE
MG<[:-Y]"#W1FMC/9QP*D' O8:/3RZ%0/R9LSI@76+JPR8K.2@4HISVS<EVSM
MD/%6-%]OQY>Q@?0?!19ZJ68-5@G(UKQ'"FR,?0I/ PC9:@7;F_"6O@V)!C=O
M>DTZMG^/Z"TP0(;(!QN$X4N',9WNM//8TM6LJ,4$/[X3J*)E%S:$;CHS5C:<
MY=-8CTK-NJ<VXWY4VXXM.D8-DG!@)+4G&<PSVGW))_FLWU(X:3XL1$[RR0>+
MJRWY5>E;VYYJX#NMZME;9WZG$Q3G%&Z#[%UW<*6[O?8DK+B_^*,\*9?FK=IJ
M.*-,_6CW-IS6L&(MSN%MS/.-16P6T1$ZKPH-G8?3Z]-U@4Y?IK5\*QP+HOU]
MG3+(*.?.393=,*6"Y:E'?5[KA]MZM'S(]Q_4L.>^LVD01$G4[(P>-Z1 W>O:
M;3RZ,=6JF;P#=1 T,,8MBIN:$F>ULAVM3[[]W2"5Z6:LD:H@_K-?L+'#A]<?
M?/G7)I.U6[FPY<F]7FENW@+Z>WREGZ1Y):_@HVQ^'*?4S'J8NEP8;1QE:M5
M,/?>"X/Y4(UUPZP.Q=@$2I%CL]*'1\G5K!&3H%"L\I%H3X)9<S_/9L!'KMNH
MWB]CK5UVXJ3WK:C+-T4>USTZ(2%4]^F/Y6(P5XJ\0OM-W<;W8%YE.VM+C+5!
M;(F;J4=$1;:X$UYE%+-:T<)[WE>/I0(%C]1.8+Q%)*:M!HE"3>&L+T*S[($]
MVWSJ64% !OH?OY5#UQL/-LY@_+SG[>!_QG%U7P#<0W9A^P6-\1WQU\S<I@\0
MTATO.#64MSNUWMF19TC.:G) V<T@F&6-4WEN!XOZT[9I_&MAAUAO974IFR@3
MDTX!P23,"9?>;.GO>A0-W_?NK4NK8*9-E3F6E@NQN4EQJK]ZVIJ.%C10UK<O
M^0A5JQ*<&K%A"V>G69]<G]=[I'$G; S+?>+B05-'_Z>S(MA[<!6>C[IVNSFQ
MEA1&_(MIHOLT)":8K/9A/83W"*<J[6DTP55V&O@+X/ /WH["WJ)N"B[C56D1
MK#Z<Z5ZK4SE3)Q!2G]>=;Z?$'MGIC37&]ZON,RA9Z^.I"RC465C2:DT%"8%C
M-8\8L19,?-R[EV:]DTPZT?4%?4EX'G[!E/,*<L^\$)%F8(-,@0D)YQ3=SI3/
M<(L/2$0>0[6H@%47<:YO9R)YH,+=M,54WLH?)[L<<3LXR?W-=HI<XM9?+$WH
M""0GM;_/?0!%)?I$C_GH:_CDV^U%2;WZD:->1?4)Q7U$6QYW^1W8]W1/E^]:
M!>2.F>7!HFK&26[U..BZVQ*KY(?*@^JRG;?>9BP?5.HG,-_;V=CR'3C+/UYU
M9=;U#LD.R$]2N):<2GV=/U)D[S<Y-$++?OHU[6[^&A#LNUJI]&3BQ%29D1C?
M7UGT2(N]L;ZIKLGK_GN%@8\NM Y\6H?IH;-!$AGJ7?@OA'URH!-N=N=B-2JB
M^5DV\]&L/,0?[!YNWB1^JN"6(]ZY\]VX9;M0:.0LO/YCLT"8&)<!CYMCC\07
M'RKQ+W?M>*Y92S+LQW5;*+0;SEXUN,_U_-@I_7IAP4U.&^^>P$5^R+Y68VSW
MEA);F-94V;@OB7I-[5[B&WEET3TORT_;T8#:M6+9I\,YW53UY9N&P@=3R2;E
M#H-EP:U\ @,)?MYE>]YE/B"SNH]-D^P3%2*<[$=6C5$4!L]CO3V5'CV)UTY0
M,<HIAF'N2 6^G%9Y_W*X5('TV=&&&I4)JYNZZ&I=,=KAMK'HI6Q%R:Z+O='*
MK'&O'6ZOLX,=MWJJ:[B7E^Y>!^"_$23D=*U0JG18,VZHGFY/PH91,-.:ZHD5
M8YDCC  H8*^UQ\'O9#^)JVM(L#9-Z%@X"XH%!KNI#,89QWU^SQAVVB1L[(RW
M $ZVHSBZ[4RB?)P?2R=8];;AEB; X7K:K;H(-$PZ@0<KG.P631\\SG&L8H]%
M1[F76U."$KEV1&@$)'<[E"H&%FH\7:'=-:BJ>E9O:QF'J:2'Q:ZNK.FSKV%M
MOI-LY--]8JK8DVPW=3C3S>8F]RUQ,_%],%N=#P?@ E2\.3PKNQVQ/&C<M+>X
MJ]$4K38OT%F**KY:0K6KT3;F.>A,;;(KZ5F8X8W?G>]"UM1D^_Y6M<2*:-]&
M$%=BY4X[QS1/^;6BJVT]T=P'3Z+[?3_ZU/C?]*,'?XVW7SILK[E$ !&\(M26
M!AL)Y"F4V9[/*N)?A$9W!_)W4V0R35:=;'FTVFO+MVPT!LS5W$'?PSF.<Y,P
M605[2%(D,X3E&FU7]XU%DF(J4_%UK7^ LJ4!HS^?4$F>!!NW0(A-["@N(\=^
ME#OJ[1R=H/.)D8+U?;@PR9)4Y<*L["]/4LVH&C)'>@1,C?M+%9TNT[!QE4@9
MWPF@6:M4CO9P^S\>]:0%$6<@S7ML6*2QOKFNV>M^RI.D<CK,V4X.F*;"GL$Y
M ]E4P;C5>\OQ[NNT+K]D8^H/ RAW19V_):G2>YUG8WONZ>N!#^$9'.$!2C<5
MKJ[%Z*1]S*Y<86S=;QYA>JV*?]$R*EJ1HUVBM>,7+D, M;/]>>RS]-$/G:RQ
MN_:Q$@3O^E3FKCZ<$K$>*VBMKZ[UYSYMM I?+L +5OW^QLS-SQ):::D#<RP1
M+:M2+YPWPJ7==>%U7+<VY]+AZEL-$W^L(.TMPXFF=ZXG^A)K6D2&N]NY3!V=
M+7^M8X6"<9^),=,.3C:UV3S%$2+S8M?HF6'YF)E@[U54[9!_WJ.B]4VJOFO[
M_:(BA^;SL%-3P9U!S9JT%48^4OSQ!_E9!]8BO<MI!>4^.KK^K_L]?"LL),/?
M\50VU/*Q/4;M [ X[%SGP,"3T5:MTA'1TFEOH-?[^>V<0C2:^#MD-7O;QQYZ
MFW)^E?.[S6] ^!X+ADX"@<)>PVPME$D_<AI[)/I+SY<(5L T ;-DX[S=I> F
MRK=)?>%8,66<> ;\4EJ 1T%\)YRU\3 ,$K&_5S>C5.?"I44^UWY,>T="AZI'
M7F88X&VO#71=]1^6/#=V%/2I!&K&UX*ERQH%SD.)FV:NESS#YPD(O;L=RA'
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MEOC1.YI/=CZ &,FY$NR._ U02P,$%     @ W(M_7#'O^! ;@@  P(\   T
M  !I;6%G95\P,3 N:G!GO'L%4)S-LO;B! ($LK@$=PCNGN#N#L'=W8(% AN<
M0&"1H(LN!'=W@GMP=_>@/_GL?.?><[WJ?ZFNVMV9Z7=ZIJ?[Z9[F<>9Q&?!"
M1D): @ # P-X]_0'>)P#O $@(R(B(2(@(R$A/7N&C/(<B/8<%?4Y/M9+#" Q
MP2L28@(B(E)*9AI2<D8*(B):;CI&%E8.#HY7-+R"/&P"S.P<;+^8P" _>_8<
M]3D>&AH>&QD1&=O_^'EL!6 BPQK#NL'!D -@,6'@,&$>.P&O   8!)C?'L ?
M#PPL'#P"(A+R,Q34IPY5+P"P,'!PL/!P" CP\$^M?D_M 'A,!"PR5E'$E\I&
M2.1.0+; V$QD"K&R-FR5T6-*=F/GH&<H.+AX^ 14U#2T=/0<G%S</+Q\;]Z*
M2TA*2<NHJJEK:&IIZYB8FIE;6%I9N[BZN7MX>GD'?P@)_1@6#HJ+_YR0^"4I
M&9R5G9,+R<LO*"ROJ*RJKJFMJV_OZ.SJ[NGMZQ\;GYB<FI[Y,;NRNK:^L;FU
MO;-[<GIV?G%Y=?WSYI=<,  XF#^??RD7YI-<L/#P</!(O^2"@?7XU0$3'H&,
M%1%+5!G)R.DE.5L@,E L-K.L[1D%N\HQMK'S* H.)<<*U<DOT7Z3[+\G6-#_
M2K*_!/N'7+. YW P3YL'APD0!ESQ^WCF!.I/,[K$Q^^IW$=A'+Z'?!*^OE#L
M^3EQ#H,TL_RPM6MY2_1J_EY>41P@>LDC7'<#%NI!NA)651T5>>'WVX#HLK;[
MX8F)<R7X5R;!MU\+LO<=_5TN. 6!__\8E(O^R<#T;PRX+ <!;_YIA'E$Q$4&
M\OO?ODC^QMO:%J0' @3_-H#C=VYYO3F]Q-NP+ZU^Z_6#]%<ONXX)50(U@V($
M&&/A<M%'@, C0%7V4NH7:YM%W6ZV,]K">,^/TL'W9N<V%\/72IJ4Z;T-O[<+
M]2'=G=W+F]1$W/%!0R<SD$X> 2B*U_*^O(\ 44MAZJ=OFN(^]%_[']8L]F-^
MFT;<KVF4M:QP'B_=(V3<I=S1/@(^S'7XG^,$GSH<9VT+)BAN^#N5/?'?^OJT
M.I2_5L?T=<0=3T^D!MPU][5Z4J-T]G T@U)X<_(3>P_1?4B]<&W+'TO1]TLN
MN6BEJB_W>KM+,DDRD:.!&1]Q:M[\WO(D\2,@W;^@X W<8N3W/9'TE-A_VJ:Y
M$/P,;K+?M^3W_2JHP5"6$']::JE_\%<U508C.+_Z;<CH[R].X8 #PZX+__,6
M/__GI<\*(/TGSML9R$)_WRUO6EB,O_-,_[=[]_^! 1S; 0Z^6$\"@LL4R.T1
M<'/Q"/"X =/"3GZ]\\Y;N]OU#AI^$%0]>7 3! "5Q?][%)H(7ERP!.2N)J=W
MGLE;J0,K6 !N@S V<6,D:39P*B?V"9#@+?V2E;MG?<7/?*T*#%GE&:03VF[+
MI5C0$$'Q%NY#(%Z*$TZ%+<VR*I5QO<X&[XT0IVRI$X42;D-KV%$,J56BR2+#
MCY>T#V8;G5=L) TSRR-6^ZLU9D6E)#LO6*5RO%+=Q8=L>.]<\A?NJ@DX.UX=
ML;26I(]WW-AE=&K$TMPA45=B+?(\[ 8(AL ,RKO6=?A5=$]WL(HBU HO"=)U
M="PR-!B>1UJ^Q5 7+]FSC@I*#+@<WL\.)4%(UR.$ZNS,-:/3[1V?]J;V.;D^
M HXXW1>LK+1AN]2VG9\=/P(DE,_>U-Z4%7QI!9.^.MEER.=PIM/&OBA<&G!Y
M=1QL^?5L4UA'\5J40_41P%RD+V'9Q4#F9UTJ3121#AA-]<^GV+:&.][M>-"6
M=<*[M#ZP;.T24BY6M]]ZO@C#ZM]37>3\<:$@N^,]=>7FM#YC<T350OIGU3*A
M10>7H)?7LSWN&S5UHO-N#ZZ?UI@,)AX!G1WB*7 %3V=\JN0*5=[3)/Z(/O9(
M\=WE-W^@@LKX*N+G?2P32BP/;6"@[F7]U%?OC XW0KB'2:JI\#S]Z,79MS_V
M3J<%/8ZOY),_Z396#WC=SQ' W-)Y$0?5?^LEO4?C>7=5 KCVZ/26.1J_8.?#
M6(X?2\/]5-7$<C#)\9&>KP^7 ECRVN2N9,L7D+NLR9WG.2PUH:W!'Q/A7=Q"
M!]W>BE+'($14G2=XR9; RS3*F@OL&)9QWLJ$2.W29@6@_ ^(O?01,%UZVS(Q
M*OY_5.+/*N8!./&..90FX(%)SN],]%A7[/3>S%YW^43&&UD<=VUJ1U6RLLAR
M7UYFP>QV""<XN7CF:4U3<MT0QV*F"XW3;M/[",-YG3+>=*U_47%CB*\DD-C]
M\KJ[L_YD3J__W6AQ;GU\AC&RS@=+ XKI)*%<OTM+Q;NR3\'Z"25I-A;(4J1O
MX0*K1(IDN"Z!:).@,535U'%?[%PMHUE,CI:E+_'Z\!HG[9G*0)@1VH+ 0<(R
MT?@4G\A9001FP9W<'6ZE-[4G/1"Z9U<04[!<Z@@NY3Q=;@@7R)B((')BEDX+
M8=X*-8;O1-)Z>/(U0E4=_OH(V]N);*L(OQYBZ^UX\EKQY"E#;D%Y-SZSF=HP
M[Q'$Q%W]B<5*U1<'$_:049&/FU_(D\$*EO3KR>>Y;4().%)YB*L!)(ATT2A2
MN=K.&"8*&+)@#0+WF=:)1K*<7=**.?J^'^/!6DPK=@X20O:Q^>P9.\"/G$NJ
MR#3Y=Y$,!!+%B1$K&2==BVDLP7KCZQ]KD@JE2BH4IO;=\(+G]"B"QS<W(;7E
M03M<@UA\Z2R[:,ZS7P+M&L>=((I4J4T2[>Y;.W*ESOJ<_"++8X?86[%[Z:3'
M.YC6[I#->:>MC+XN-S[%<(Y[ Y9W:;)KGP4PY8;4<JHD%BT'.?$P>V38!REH
M(&M=P/GQ@@C:+!#@OZ*AED> 0<OADY\4QWT$[$W?+^U:9J!J^)_L?HT^*]A%
M_1-E )3%@?\!D0UY9B!P?)XR%J2#4D_V42S-!A#'"+<7&%IKS/I*Z";'41&=
M>D_S0CW'&*PBTY-"3\^/"YM@"G$,7C9-6>@.OU 8G!=!!]R,<84(OB:S]]7.
MMU'EA 3;MBDBKHH&""4()2Q_8$=M,O=HJJ7A<3F%NKE7XUPZ9;W!RD)G0="F
M9X_OJ<*AFY"5LGR#4,RUC0-44QY!^5*0YR0ESXY$,\$.$OL!2<S)D)67M%\#
MCKF( T/_.!"L"$!ED2>:#7AC&FNB82[($#/)/#@X"I<!3;._ZO_4;X"J(>#M
MA7D/V55V0&?3;A@SDV 6Q^SQ;H(L_'P9H @_KF9YUMS+J360GEY%W)53_8$]
M\-O]-#&:C)FSM+U[+(\K@@_(S63[JMG4F$L --,K2#_0#J+-@/V#C"2<Q($?
M:(WI5G8%1N4\J) XB-1\PG9D\$9P"1F?T;]H?2')6Z*I>2Q>-?#5\IN+A3,O
M&OY*<]7TEJ EP(+C4Z3TV[-KS@.;#H5O-DJ< \0X*TBBNS:EXVXI@AJ83,7?
MR6-G)@L.*&K%RDE=!; %0&M5KQ$%H7U-(Q8V7E^^,@@SO <2W,8ON=0!L.AE
M5CB&"01P87OTPF;G7\.$_=1=;)#*T\[6C S4P(=WA9C0\L2/RJ,=R8*1<?XF
MP;^BYWN/@(N]AZ,+#F7_AR;_A0<("%!E\0@@*;A^!/"E9U0\ J+5[OS3%$7^
M6/Y_3RPU0I5Y --ISE5%[-GMF1!_/]<[2MF^X28$"69=@OITJ!5$MW*:[8,2
M_X50>VWXZZIH?,6-'Q\KQMLVW[0YJ>PL$DQPSL7FVQS*6+BZ+Q\+5<V_L2/.
MD262*@QX1TM,RWU%5\K.+GZ\$!6+%9:-1G,B,U_&^4T4*>KSX<2'$9=^E?C:
MS":KG#'S&/ ;6'D:#F6Y6#K+?V&;05X?6-GC>[%?FV@1;%SZNWX\S9D9HV\5
M/SBOZ/\!PFQ K-575*T[86ZL/N).L,7+-ZP'8,_N%&WJ&(JU^*V2$IPAV]&D
M7^MTHDKI099\IYQM+TYW'>,^Y];S85Q+GN^%T>BB]J%U??L>O[2C8X Z17*1
M(M'L1&I&32Y)@:VS.^2 OA-I8V''4:,:O30<4<C,AS)T+-X8[YF^$%.&":O=
M),Z@G<:,F?9,1M+$CJZ\V6P8IDS?K_$[Q[M2)SV[.3@_=M<.\-3H:Q:!&D$>
M*.;9 3&NM8PX+WYNX8M_=\+!M!D(@[36=L!0V=K8'F"(--&9'/QXL!*B>U&6
MMO6(EX=2T4E;-\HTP>B>$.J7 0F?!8YTI5,E'\VL-5"4EHH:_3);;&2.6\84
M)U/VS/"HVZV@.4+<HHCN=<S%JQ#K@I]-1:%3 E1,T.'+J \'#LXM[!)">Y,+
M<%T[?G3E+8H5!J4(N@$3/?16>W E\W36+*)P7_MS,MJG_C-5_%^J(2*(%H8W
M.Q?X(76$#/\;7;$CFR) 16J/(-$8 ,=;\E+K!'NSQMO5#R-/VAY)_,Z2(X2;
M29;@$0#*M8G>;R+RRSH90HUZZR;\\8ZZ^O5EPQ8W;NEW_C-02X:G_?3;FI\2
MMZ&;TAB44]MW 3EV].%6+]21$84951X!]*@84-84#J*KA@DG:R..U%$Y47&@
M$LR_I@\!.6  U,N9*<.<)E7S%4<D1V[XEH!&8I7'EI3)F];B].#%W,_AT#P;
MJRGQ@ZNF733)CF@OC_NBS(%8O;5-,=9A;T,9=??(&C(SFI$QSCP-M4OV:9F3
MR(E0?/,Y0D?ML%9L*&1G:A&_S#+;+?%0]*/3;&A3G>4EQZ'F.">&H)/<F%9X
MG[8MV98+B58J. Y?#NLCD8ORZ#0(W:6BK%9[!8G3H<EY5G KX75B3[ ^WS=Z
M#&O+1#X0+80T"T0+^!<$TV^UO)F%!-8#(PIVB[LLDAX/-I>^2JH-VGF_7S2A
M*8;NR6$WK"/>K3&SPN&/N;!]Q9"SUUID8:N)E(WA?6@2:RJBWJ;G*+JG73_U
MT:9X%L]"[A'@UE!0(M&CVG(<>:IE/6#ZS24L[^%H*KD(!*X7Q#-/+)K3R^V4
M.?EF9I1@-*_6%KXG.C#^IBXW9Y#I7R(G"\-'0*GAE7]!UJ<_M4H)H>@/SWB!
M\"<4^YM?C0O B0.)>6; D6>!Q:.XS'G@XN1YD^@/>0#/XWPT84KVN(5()_S+
M7$.-7O"D.\WMB.;2NO _*]J]>D_59,<@0?DV[Z4"'X;UKJL\RI)XN9:1@7_D
ML ;'/89XU6BQ!J%GJZWOD"2CG[PU3%3C5A/Y%K]/V?-W[V! <K=*/8C90]*0
M=SQ57" Z]!51GJR88S06F745_3FQ6\IT#@>Q&8B_Y8^M5]:?'FZQVVS&.MV^
MQSO12EU%?R6*_I)KAA63>28DUHFGE'^_+#BHR)7GR^+;?Y!>'E5.O?[N>T00
MAHX3'N?'%?TM"9$?I/PPZ1V<->DM.MF@'"_]D*>])/T[M$!0FF3N:FIXMQS;
MI>^.6;+6Y:P#'=?32X-^)E*QM0)*SW>%[PU22Q](XM].-$B3OG#V5DLPHN^J
M2NCZ<3]@*^$$;K+*T)>EYQ@-Q-4+'G2+%4O<+B ( /3(N&,/D6\IQHU99L6)
MUCT"9#Q^+)._A0^/L<"N6&6@,2+NE-$J6$=?O/C$<<)A2OXM^=J>3_E=G0*H
MBNNK (ZL&WT,T7*TJ+JBSAML:8GG3:*#;O7Z(^D+SLXVL44W^C]JOL(O$U@%
M2QJ*LW%C2>"1T%V\_2<;07PBPH&#MS=L(K+?F@IW,!7#(HCF3$([>8%WP<_$
M+A=KDKB\7G>@Y&_NV4)D'?->G7MB0;E^XB 0?FP+O'+NIZI=?L(R=L$[9D3I
M$TR[HU]>>RC*,9JZP].$Y)$[2"V*#U2E*K(D&N]0I06&ZV)=[:FY"3(OJ57X
M^"0%=]^+/B0XR?.?9.37X+H,0>U+&_'SH=#S2.9DAO>';X:_'.C?0SL]6!A'
M>5R-8EHO"F_2DQT*= 1PD8GQ3.;]&,++&NJ/S:&7#&-C5LY?YWD?X(Y$&RJG
M4M*CQ[YP&CP;\_P0UI80*EK0!G'AM.LQ!\G0PEC^7_&BBLJXK(F $IG4:M*2
MQU2H+[JX<S/C":'5"5-DWJ"?<'\8AMQ51JUXWTSFJI_[ZNFY)5AT@?^$O_2M
MSN+Q0Z!#EC:C94.NT5FO=[R:+]W*2NZ<U_C=5?S=:8-;279D;<9L#A0;+XQG
MV16(DU&-2,_F(M6^$O?[I(,<GT$8](KR%_U"NVTB&RZ9G?0^78_M?'UF\^+B
MYXV3;+%G(6H^3<7I*Z-^^V'_7!<;0L%ZUO:SU.XZICG$BI1]'SPY<L?&[R\7
M[DLV90N6H\2.!KQXNEG5L9.*BO(=.Y%_#/EF;M-ARW();%'<?UYWT=%)C'.]
MSF3R'-YB/CE]AP$53][)E6!3-DOC[ZSALRO2[;&/(S5NK<!<K#E7?"E;8(!,
M D39=50.;\-N[VF:]@??O4#7;#(LGY!(+N 8R@R*3GB9)U1EK3^D<\W#4P/T
M_K@G;KH-'K,^Z:OFDH@(:#V'6H]=">#W)&H\X9&@WSQ?5,"H\C!M*-;Z&@@P
M,%7ZEM56]8Q@$]447.;#KS>/0Q,QZ7MR46!&H3 T:EIY!E!IO2H(HBS&,ND5
MH,6[M[9D.F)RW?!<0=?=I!C+C"PYI 9HQ\# CWWCLMV^0A/,#N*)K [>TS&!
MH%G@'=KI<39*C9)H\V%JSQ[,ATY1AS7*Z<*[%E(NU!DSS6<\GW-$M$;5I54!
MFH<(='S'XI]FA_1Y"=[YZ"=K'IWIA^V=7MR,L/%F@#9Q0.+])GC%_"WHG<K@
M,3F6!RP7^2G.9^9-.(FG^^JWZ^H^VU3CY$&>]OK)T7*;"0%]8-P@5:*B4&R\
MY<V:UQ/6.BI+M(BFJW+H51]C]V0+)!6S%\.-,.,';:9?&O'6U*JFPNF'-+9K
M!<.!K>+Z\K- F7^<9#D4G=P?9>,ES("-%[$7)=1]=^K%/S[5EI))?>4QE-GS
ME8W>1VU19'P***.O(=!C1"E.085>(:TSK0UX@@@2IC%<M31*WYA<SU)I6XF0
ME S\'3T+4*9GU2UAEVNX,7R!_8<;=<(EW-T7?>N'-0DR6-IL_BBZ]G:T]=4;
M;!<+#OYABP]=R7*R%5YR@3J72M<5*I6@328QXBANN$J4_C'SD$;.@HH#+'[>
M-NR%:U&1X\'8H?>*>V)UU62W/%0F7S^J3U=&VH]-JR;R9M7:HF7G>J2%.)'0
MKW7>L.(-)T]H.@H=L(.JZE2?-".YNP1X;/4Y8PS_-5[QH*%TS>3^>G5M!+;1
M=*U0509TF&-_1,VL?UAHM(JA!<VZ9:8^Y54%ZR- (J%)\%FI2)1XK%JT0M6G
M56)$8N>V3$>!SDVN0XRI,E^&$D6T<4OO6/)=+-]JX<ZL8"MQ>7WB^C,%"(4]
M/C'=:O)03.7_T8^RR\WS G>A;@+NQ]*,$; 9?1E6AF_X._GF^9A3K[ P6[)H
M=W7JCIYM5^CK2Y=8@W0V39(2'@&!/NH,:E^ZWY-R.P???[%>:E =G9MJ@J7M
MM"S,@!F+YZ.R=JI1WFWPZJ+;$>6!L&9T^$G$@VFSDI*>K!4R'9Z9U$5NAA+/
MH5?"0?(G-?#$3PF1]7#=;T)5!H3N:1$LG24[$SU#)^E9E6X9A)TNH>$;>J\6
M2N%/5#W5MI1$4VDC5MDG^8YM^$G6K7G&ZEDAVFU:U"(ITK.L576"TM#H%[)H
M QI":H4K%,CNZ1]<U!PH@NR<-ZCC;7W"*5/?8^M)VK')R=(+O/.R1F=7+8#6
MY>*CV!WF1<GF!0!YC%N-I(A4D$<GU]7#0E:6'\@%BWP4\(_MID6<%8GKBJE@
MFL>ZV0:_&=M_/U#HB-1D-G5[P*Q\,2O- F \J'MYF[U8K]-]W KW)GCC1F/0
MLEJ ?GC)2!RHROI;--,Z_5KJOA\\W5BKZXD?OD6D22@ =:)S%]QAH2 ""%KK
MFJ&Y8*5'K&8!KPF_)[\JK[8">C^WA@7PH[# M )>*NL.58@2A3D7\PHE) L5
MN+'7SXCAT;69R"7:O><,7I5:E#+2&DU"[&O-=).]??L(D \4JT$6/=))[*/Y
M_'RP+B756PF)QH)H9$X_KA1SKDU O0EF*U$Z("$<!3!OD]50*9O_G,W":@]4
M8&-DE2N<5#P3'V6)_]'/?HHO.6ZE3QMI$0Y4Y^;_SA?R_-2N=P;-=IXS-7Q#
MX>3% @PG=G.L"3Z6Y N::2A M;**ZX;H]E2@50]NMDX$D7U/WR.,>6JQI\^P
MB0;OO$2V3F_,!)87::RF4G<_FJY! TW6@37(S-&S0#?L$(F'HTJCWRT=@;>O
M2-TJ0%G2FR[LEY;VG;R^"V#NN6?G*7R/NM;AWIH^/WF$&3E+//((,,'^E&W%
MUU62_%QC-J3VD_W&@&FZ/X&D&N.*24'<+&_V''DV[3:>>5%UBOGW0 ?D8<//
M*$.ZAB^"HP\8;/VG*1XX$XIV^19C"3B^?.MK*NL4%-9AK@=AQK_?8Y)>_O0,
M'_2=OH@H 0FT]*T<U#[%;UE1AHAH@X-\L1>&I3;!U&H4\YSFSEJQ_#H@"#'7
M7O@@_!% ("M62"<K,>"/\]PS18+BP5O3G@]EQ<T'=6/B_'O17M(& PN,B=RK
M+?V191AYE)KVA*XL$%UJ_B\Y^2= "X5\2DXB&*0W%MA]US4=!WXH2S]>,=^\
MK-/V_D9<!%6-E7M77'LAH,+QX:>9"U([^&:/2[B)GSG[I^F;:8HFUT\&7J4_
MY%<&K3@; &_9B"NZ6X8:_-B5/BE71FUBH? ,LA6V/]S,-(D#/^-]^EO,@_BW
M[/T_T = YZ\83DG[$=!3^%YX*.^WV ^>.LA)TMMHD(S;2-:WJNVZ0>6KRD36
M\7TXU<:FN>$*R<7H]2=M^5>R<2M11&CYS=#9,@'<'+ZW-VG+U+L;G^P%100+
MTCC6+,_8,T?/>UV+D*$92MB(SX@'+8]Y,UPA99NQP;[#RGAG\ED@X[^2 ?SF
M4>=NO7>6\,/\$PM4TUN)O)<2 ZI#Q,#5^#>UH/9[ B^)KOZ?K8Y;4_7)OG20
M/LH(S&\'M26'[,J/@':*/&Q 47G4I_0$'$%. Z'AA%2["8V:V<I2'F$+#TJ6
MBRZ11/>Z1.E@I&=A@4>#'DCM.EZ$"O=-H5:*'RK/^K"(''EW9+H_X0*_Q [K
M&'1AA%I4Q((&.N]"O 2F;"V_$QUMEN/C6M8H3]Q,F_M2Y<4YFU*FUVVF/ *0
M$S[QN% &M@V);J:%19'3']71A)AJC)E$\"5&))@1BUY!=[,A.UPW>O;5*Q44
M]N[V.9.[.5Z35(/\(4_N,R"[C'=968V3O\S!5L%1*J<[PL_^:N"S1,ZRAC@#
MKP>C@LL@-6^.>E#$*H@63JQ'(W$(-R30\H<4R:3+T])SY-V2(@Q\W.3\N'.@
M<>!&^(E'AT=JMH>' WFD";SI1^F7"V]?'F7CO/@P:I>UX(1OERW,[;U^6,6?
MTGLIUQJQ!7!2.Q:DK24^NHS\>G<G^?6JL&ICHW'DDVL"<2Z_)R]Y;2NBM]I4
M/%73O O;.EU?%RXJ+EIN0\T LP+/O#><CH'C*'16*L]KFM^];$>-X!0)SFTN
M!(FG9T<BS]_&R6%C+NB978_@3J#8ZJ9NW<!I:MDV^UAF%W%?%S" %BY8'/!N
MA%U7HNETZ;O#5'T(:8"DDQX!;V0'W,BT+D3_V0K1*0)\^2/ F[8+6^R7>N S
MT@DH C_5$=E1S);UA!I'AY7:9T>7,S@R.)0B<;Q#;T61RF7 L^@HA!&>U0Q^
M@&=(FG:=MK*#'ES@Z\6,L1JCPT[["XCY>(3WP72C,R1&MTZYGU:6Z0\5NYS9
M#R-!J:- V.1I,P?L<E&[4]0$N=V7!LIZ&&.E3ZK% [.FW+@U&2*:ZRDS+M^H
MFY-N;C3"NEK/S![DJ"A&%Z\A<Y",\_"J)FB#F2K=YF/TH5=D6E79-!B)^)LE
MQ'C#\2FFH_S3'2M-+,,@49 G*ZC.!BZ)H>[QE#*9AIHA$+NG3F-FZ@VN^/F=
M\\=_DB9T:XCO$2P:T5MV9&, G[A_O"_(Q2=;/82IIR9VIF.W5AE/2*.O7D46
MK%#XKLF]@N9PJRNKEH+J\NP'^15>2<3+*$L)=KV2 <]!)M+<OY(&<'R/@'OO
M1T##O3SP+Q01P/37P<]G? 2L30J_VE(=^64RX*0WP?N%=31XN;;Q72X&;%/"
MY>?F6N'<[ ^'9$M"E=C(9U);1_AWVJL;U6]2"*F_W[!K^C\WYIF@77X.H_<(
M"#YWR;4\20ZUIR+<<'#1)]U1B;266=Q]X2IP)B=H-> %,6EB?YH57<"?08Y'
M\=-QPK("N_75U-;2O5;A6I\J&!(L&KHP<19PX_[!.+;[!OFGWKTE=S8"T]":
MXJ3MA51$M4MQ(5_@A/JBS]5E"?I0^Y'(6!63Q*Y:N==/6,Y>Q8ZI(BN^JCOO
M?8U'@&6=I5E("CO,&9$;25!LWN3/M+6R;47ZMQ&';<#G<?)<^&MI.%));#5B
MO-A;CCWYN^G$+4VU$T3T^$!2_.>($K2@U2N%X^:$2]DZ.(5=]&4A]?,,P:"R
M'4&D*ORCN:E:V@N&^]<&#54VD#2A(3.EM6S_$*5ODQ<?$X?N*9-GO0"QAB3:
MA@[>\-_&JC]"W@,U\;.D\ZW?DS9:.9CJ^D@W:XGL[<N[NP[0H$N: U%H@2\X
MYRR9TAGB)NT'N]J4/*%0XV/=MHW,]6EFY_<F*C^DD1&?M GQ"1"2_F$^ Q&(
M^93%X6"^=G^.C\J*^\NL!G[4:<E=P&/FBF\K!,)5'A);ON2OG?,V_ZK-)WB4
MAJPIS'*@LU  8?@%YN4&6DX04R *Y(UU6DD1@8NYY5.,I6/23"4FL2_,P@0"
MSTL4U:-XF\EU<O+C7L>\U]"+JD+-TKJ>'.NDEYC:6!??2?4 1K48%T>MCEVB
MSH!UK>"ZT=DD91*EL8 6--:T\X,&;G;%2\UI-E;/"^!K-.5"Q0V &A^X;R*;
M*UQ,.)?2B-PWOM#S"IWK&6IZ\/5>\/,N1VU8&#*_"6'JEM?5Z,5?QTR-FMS@
M=M9;V*E_#EF6,- #? I,O8"FN:C5A5J T&1,*&G9B92#STP*SH$EJAV7_-IN
MJ#8^87:Y7[ &KQ"T2P6J&[XJM1P?=+6AL3O,+]9B;YM .0:L53=&GE;3_)?2
ML_PZ*[E(8!E:?'HP'B*\4[ <6J B$DAL3G78C6>I?9$^6ND#IH6[>W]S:!,L
M/HZEREO;HN?!>]H&I&.:ZN-4U0XM-<Y?WV@M(DVFR_)R-$"Z%K*QVP[Y56>V
MP5M!-BX5J@H0&E7%C*W_^=6DBGG$"!PEF:BQ(Z!4$/]$.+)F.45>.-K<>D=
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M55YEHF2LO]TG= <+AP.-H0(T35SU%&O-[M@,-I4>F5UQ+G8WF*".N,+-UK;
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MW4BVRD;U)]N.XCK3W464,?&;NC"$=OV'K8^ "PWB\R_<C@AQB""M0VX.UJZ
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M_L:(*1UO_Q24>'Y5[&E/'?A);(/;#0XL3>6UOKBO=3N"&+FQ;",1?2!DPOJ
MW0JW6 $ O',EILV*^>5JVW.KDS-2A6U7L[("B7.A[<.(R]Z@U</S/K=7A'K=
M7U[J!B+_7.49M-F>;M"3Z,$O^4S^LA&F]JJ+PTHA.[2'L-CRQ8X05I.4;Q]E
MS$=WDT03<']S@^=F1<BJ%*LE<MJXD[W0-O8.@GJ@!LS'3 AGHV)0[T=B-CY5
MCE *0\_3_&6D]L13Z9>LH.-#>.>B\W-HF8W#ZT],8.0 B<KY7$G\'NP%+U:8
M&N/ER[DNVG"8_JRH#MA8Q1?1;&%S<U8$(0G[6%PYIZPHFHDTF4ACT-F=(^[P
M\][2; M+*.^PW'2FE_+AO(G*8JZ$U1RN^T%1K2M/KK%?N<"];=:73H);:0 _
M&?\S(G1^#8^91&)4\61R<E67,R$A6]/S4J73<<I]?*/@5DA8]BQB5^LEY./!
M9$@T/Z(?__AV5OY&?,-O*/<?MTA3 92J76A];1"Z+BG> YGEA6BA6C9/GQZG
MWFR[)\O1[S?HC4)TII<757GFEM5X@K&D^W"" >&;*@V]@"FP3*PA72\W:JXD
MQA;<A@RF3V3GDNXI0%R>@G(1_.D_+V6R_F'$8*S'?T=BK#S8:'^@,_,=$30*
M@6G\M;V?..V"7!2WWVN>]>2ZFWU[)E@T7-(V]4#6&6!.2-5W,S*X334X<$,<
M&FG,R-'@"30QA@$U>P)I6U>#6W/,: 8.)7JHXX*G0/!_*ZGY!Q%Y_S)E7].8
M@ B_P;0":TVQQ9FS,Y($NZ@)1F^4#4Z;"L$VN;NLP*Q/=;'?N:F3Q;$1_AJ-
M/P@,A@(LM0O[('I(GSL;VA:BO<'X9!&BMG&5N9M(3D0HP[H?=2T^PMG$@DT5
M-^3B:.$S>P=A.<G#\?-B6C\DRWSYO/PJ5TLKLZJN03R,A26TRX(Y:X7EA#*C
MS)'P6I["6B5Y5@4D2]T1*(<:N:$WJR5F#*,?Y9[NCQ( K6J?;Z_>(Q1[)D&L
M@.'O73P=AXD^B6)$F4E<<&K-)OV2-/Q%RY*M\P2,9YO=Y7<;9=B8?E16@<U,
M88M;QG%"M867!X;^4(U;E_LR9EA:6JY 9?R9-DHJB6F[[@"JEBB..#H*^693
MHS"DS,(JQBLT1Z7R->,#;.Q?(5%@R!_RHT<.V.-[=KG5VXW4!GJM:Y+I$,C_
M"'7,N<L9%YO9RX<4(2EU-/'E?\G_JU+CS]*BIVC@GZ[;"Y1.E%5CQO"^?W>K
MK?%,-=-Z%VV])O#2<8HO/3-;^A' .%_Y[E+G4,M4$Z:XYSYZ+05-U+ELX?U!
MWP[8_+PJ(FM89'C 25$U5D[B><:M:H\,NI/E?WD7J+=BS?!';G^ C18V=WW/
MP8JQV+$P-WJ9(?J8DGI3]UY#0<<K3.\&3F>1JY[K/4&=F3 [6H"?9]ZUQ/=]
M/H0<K0Z[>7\"19<LH0.<VY3[2-9!6A[$I$ZE=U1_W.#\AU42HDBY0 LP(+.P
M=\=:G;UW"[M'IHOHRY!-8R(9>8P-LSX.G2XERAM)NBTHB??MM.I]"."!P'"?
M5KA.U6A^P_?B*GO8T'NWY5O&P\:K&25_YX"Z_I][1Y+IS1>3_D:B]_W"OUI@
M7!+.IA>C!?WV"A_:@V\__]8"N\6P5=KT!U.D*]I?+97%#*DUZ<WG7GM'^IJ7
MP%?SV;<H&(?*[_YB.O$(>-=V/VNXCR?<(![JW.Q]._K$Q,WPZ=7N\;_ZCG\K
M<5[\^Z_1O^8JHO<OIAKX/YQ_:D5DOV800QX?\-5"KCXZYHQY_K/*E&!* +?.
M^)&ZW0'.$HR31OZO'-"[_[2X-!M*!80A$]"D6MM3%'Y[*^-;/EL;JSM#L(?$
M4\C753-;6;!"BK4M@3$6+*-2]98ZT+/FAK.J5]@/\7TM5'U'3[.C8&8[;E9J
M2; QUVF;73_K/(.^)]'6#:@LFISV9P7/ZS_#31&<XC_3/:RM^;9_?%:1OI('
M."[R?SG@YK-/%=XH7JX9P=1/J!0C-(V^+41PPNTTN).N#@G5P+MZS[E0NK"9
M5S"NNQ!A#&]DS3Z58](EX3W.^T>!WF]Y)[Q?%T+_MEZ2I_5F$G?2+NYL?Z/[
M$0 ER#VUNE11<(KA&?3BN&D\*DSYUL-?CD!:MM\:NFUE\U)D4B+;/$)J(<K&
M/@!%S@>L0P=J-YD?C7:1%8?IIQ8<Q+OBJ%0BROKKIU=I3ZK= 19K15? :&)Z
MYQFW<=EA1A3*RDJMC:0N.@W$Q7;6+7TY,S= &NW7F<;5V?#-NCL%JFN=,L8T
M.I"$1GC<7L[QLY2T$LTLNWN$AU#:K[ACXD3=S5#(:XV;J\6DX9UO<M;[9\3@
M8 79;7>1Q N@VT6ACORX@57B&?>2Z?HMJ&DJ&%\R8>9IJJR'5I89<G]^T,OZ
M]]/.!/%D!0["O:%*( W)<8;-7Y]ZGU*JO1M-KMN+2M:&7V*RRATND0 AU$I]
M1NP%!_5R^. KSI503-&0%O4(X)(GJ]@>^I%5:'5EY64;3P%;S!X[5F*<S(WU
MAP'[QX$F#C_/II@*J/@KVXX&) !XIY]+-6135*.1GW<)IZJ0S*;2?&3-\YQ3
M*QONO78KN2.:3M_UJKB.-&+!TS:9W9J8SLB<KX-$[NV9\SV]8.L_R%UD/@+$
M?UFL.,?0[,H_[A=PY:L7AJO(NO13F</0EJ+==(/8R&'4IKU&-#&6.=GUK#7M
M[EP2AL<:G*THO)<(]$._0<:JJ)2'';- 2%  T"G=AD)I"CR[M^]>#77BP;=]
M 7LO;Z1G?>4<$[\K_<Q8,MZ:NV63CJ [8?1'A.GQLTO>+MJ=J5J8S=FRU+X"
MW:VOG*'+[[.KK&=M=,)6N:I;%!YT#XRN"9A5<X8*0;D0:TQK]R#/8-J^Y] )
M@@:Y]JGYOVLKGY(4BK0 ^CE*SPEB(=@]A6(=29B6I#*)Z&,D9[S (\ LI%EY
MJG;^)*KYHLDJ8U=GG'-Q]#G3UT79UB**MO'>3+NC@]P8?X!]%3<7R+TI[(ZI
MB#-RMW.?B^""EDK;^'D>*>A$MX&_B7F[RPE5DI0LF"2T";?=N[:A2FNAV0QX
M:,'@R@>FA<>4H __Y_+)[*@[)6KLWNMBX 2Y^4_57EOA9DGLJ3B8MM7RJEOX
MB?.Z=[:(/;V+H;%-A 5:=7GE@A'\K#7ONAD(NZC><A4. 7^N(8U].Q<&1A+,
M[X"[M\V#/QBSX:DY+]9$N/7"RVC*A92/6=BO*6S)0-;XFZ(J.HQ:RI58>@;<
M[QGT7/,SP\E"-#C;Z4, WFIY=ZM?W\0Y+/X":+'I*W]7._4JPMY]QMS:V* 0
M?&SSQM)5C_ /+&E"BW(61U]W1$:W%NFGEG2F*#^7L0:)@=KABQ"'\$AX2HHD
MKOU+]EA0XPET=+G)MG;]6J'/WN-:,Q%R0C*M'%O]NNRM] DH#WR(#3L<L B+
MC$P$@KU=2^6'1$BW0#\+6Y<\50TC[3,]]17)&J9'"- AX,0TX*YH[^:G6$KK
M44D=NKB_+"X! [OZA%GYJ5%U]&!=6AG!K0=U8*Z[Y@GQP60Q5YF.%'G<ZKN0
MWB$$(WE_2A4!%<]8]5$0R]QBI(-:+89]S3%R3I#ZYP->!+\BMA7_*DXKQ+1<
M,8E15J]N5(LFY1\*<;MV/ZQQP]W,Z'>+O.P<-_ 0=KK<L5OG=NK7V77VRZNB
M\(AJW_I:@*;C.VL<YU-X;5N;WCV7@G:,F;O1[66.CVI5$T!7FF])<F&[&$JV
M?Z"+7D)+O-UZO"70F9X\MRAYJ<Z7W+=\XT,*=(A;&&N> ]SUZMN4MJET0I/S
MNK4^KD;SFA0GZ.2+)%:2=^4Q+"6?1+\,CS*9TE#%J/+10#DI9/Z3,YSW.\)%
M,U!DD$M[!-3G3%Q^_0V2%!^]E"(?84YZZ@A,[QJ?LFR]=F7/P!7N8>!TUQIT
M_HJQ=GKWVMZ_4;JD/&ZF?HF0W+[R,[0OIY!%IDUT'6Y'_%6'R- ;M365*2T3
MZA^\2(B)#"E^?,A,MON^WPLHEF)8))OE"2!H#Y7(:_M]789\@E4/R7!]"<DF
M[;W%HD0J?.-7RBG/=:(^D];'4M9)2G#3ZI'XJ/3;;C:.'AV\_"ZM7Q$8<;*8
MXI!GN#1HY^!/%"MJF\/^#/D,PSXANVAGZEA+Q"1)QR_I,"+5.'!)11C-<$X2
M;<!YF$ X?49EAF?059K#GBT"S[_<18_D)W/.7"37ILG]?!$G1=A*9>(JGFEE
M8W4R=FM, B\'N9ELP390%;/F[<<Z?(X;"XZ$I-\]7?!8/$PY5Z?Y$ "_!,?K
M2R<)F6O,YM"H;_<-:.;$_%LBESP!+Q9+E_-[///$#BT4Q?23EU)3**=2O=-W
M;]P*EO"83#T/E/:ELH^.Y!I''2HC^=#$M!>I8UM1<H+8M;F^L,TH;G8CI;R2
MGYS8TXQ;N&;KUU[RC:1EM*'MW_FJL)RQALQ$L@$E>00\8/FQZ7/=8GA@;>(K
MJFI[,YV#S7.KHB;10B'7.'08(+*>MQ*OSPO!*476TW)?7?NEBL+73 HDL,&2
MY=IZT*Y&9P:X6'#-;*T#XAZ)Z?LWU5++FH[(%*"B=)>G4YX?\R<HSC[-RDX7
MQ6Z,(_(ME(?33<;EV_,KD=5%]:A+\W2Y8] [J#"T$:*H&Z_"O\QA/?R!"T<#
ML<D^GI?&B;+'\SWC;V"] 6^=SWTFX:YM>M=GPQ>V^CD*OXFV;!PQS@QUL'O;
MBML';B[HP:24RD?9R@7[(*FVOA/'/4S4]:='B_7>A3]Z1Z'!&Y<K?+5L'ZAS
M.ME8]K>:<0Y9IX3T=[I+0*V]$#-:VICM=,8)\=$:,ZR>U,X2E@'!2 \^<RA.
ME@&GAO1:3S*AF\Y&HU%>ETV>ML';%*JJ6/?/Q V;52OM>]7<&0BZ23)E.W%(
M3Q ].5(=IR0J/FI"Y;6(/Y^.)-P_#'&.,6!]-4#"O*6P)V>'78\?X)Y6M?:
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M(^+%^%  >6,R$BD6A@["QZN"'^#ZA(W+LH(?MN/F0<A:#0)IM9SCGJ;1^R&
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MJO:R^BU0KG&5=/ J)?C-(,19+U#(F8[T2/+M%;LYSQ/NXPM.4VL<P1'4TI^
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M $8(,XX)CB1US/->;@FF*?7Q-P@T6( ]&13#7\H%.D2)X0^O+7PE*#XS6H/
M8K*93+(]@OCL68/M]<S\3X"A$(P--DE[[OZ=[FD_V, 84N6S,4S;)\+F\\Z?
MK?6=&9?DN(8<K0)S_L>1?Z5?3'5OY/W]WJ'"_&(/P%F, ;FK5\CPE$+N;7[
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M6,9<8HL/8<]?'74&)QFAGV%W.Y7O0QWP W9X8NOVJ'%:7S=KQY_*TEP4DI
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M4VZRQJA71&J-<4!TH'C_?+NC3[Q(PH.<7%^FH0JB;ADO$D?S'>X[$L!@ZO+
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MM2(JR6/^4>MG%%5LWP.&9/.HK$@X&65PR/ATJ]3&8HQ\,%@..Y7(W]_6@[^
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MEA]JI08_3N>73.+HG[1*',H/9K3/%O67WL3+WFADHMU@W[Z&!NY" C0#.QG
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ME$]Q"SBOOD3[![7G"]&IK2;KJ3E69WM;;.0X^'GYX6L,GD)YTPJGE+@B0_#
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M[I>V3CF>%>*?</+\6B:<[9B,77O@(Y=_2R"G,3%7>.H4C^Z]HQJC%3P;D+,
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M>TY*WURRK#(;*9.R$KIR&:&Q>0<%='XS2MGS\YA592KLQ/6#VY^G +/B90O
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M!TP.P5;0+<;?P;?@OT!A6XRO?T#+M])^@]HN_ ,H'C@$'_D%7+)//@2"0>4
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MH'VX><G^8/]P<THP!@\8P,?[#[DN4[F!ZWWUCZ ]A]"1[]"X8 QNY%=@Z:_
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M:,"S22D)BB'11A51"!/"#D@/SR:M8!RA$%H'^_"0N& #2#SV._%WW<CY(W=
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MFPDJ;!ZV1?(W#EC!DHSZ.P.%( /P^E.'!2S[7PR(_+Z@2 4 C?';BD,63<"
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M2<'_V&)$_"\B6O(8;W@7:%,%L0NUO=?JQ^&9@P<>]2HU*O:>ABUUV.,$$_1
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M%+BN3+ZBSSY N/&?UKZ&)AI?*_ Y;L+XH>&RXPC4WE;P;V2H7%2')4-B0E#
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M'M:CDA)#+<">C"S0L,JO8+>0+')ZV7@E=&OOO3:UG!J[!1X>,KPUPILK.=O
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MS=7,T'R.F3L :I/@H=.-N[,=I.TQ:!-314IC(JAI9:4M^0SW?OTTLA;XH.@
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M!;)$=(DRZLEF194BQ07%4--@2A%>X.ULFV2UU;K[WE(2;WVNB<CB"?[PB7J
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M^!X5\21<2]X.R@P\ K=0OS)>D8@"9PVFGFL[HYW5!ON*OHLHR.O&^RUT9W>
M(4:AJ0_1ZVD6GYI.8NRC^YP1(,([VE<[-E#?GE0+7*^'A0+8H>C6L?I^$Y;L
MUY=W *?D?-#9BK/6-$&:*<-7#EB(FHLOZ,W)SG"DU(ZXKEI&K3>9?CF/^(.H
MK>3F<:Z2,?H9I:3)CD8UHH(5*F8)$9B@#2_$?J;IG"D3IROMJ64/OG>55=7,
MHC%'\*WE!AP+73Q'H,6WH8II4?(E_J(&#55"I-\-,^3K74-=\L$R;KUU><:L
M'J)]E('F<Z+]>('H:82+XP;<%K<5)TX/AHV704S!<HC).B8<#WG"".V.SI^7
MT]D'13>I!_E](/=;=]$3EDVLBNE<'WC#;HV0E?&P52-RO6I>*/-7IPN:R,B"
MC!9&UC1P0,1NW2 -] )G&?:?")8;J>X ?@(1?<8+1[P7R;>]LK<P>6E.JIV:
M/L'>D38]BRI<::#NXV70.;W "7R!YKMYLT0><Z1U\<@.JC?>=?IYCY!6.+$F
M]1K9(%"Y;U'5;'2L(]Z,SLO,U?G9!:^0R)B$>!CG*Q6FH#[J%@HWH.*D/T%H
ML"LSGG#]<#[]G=YT?6WOV3M#>A3$"*QP='3)A. D=)KB80<)"T<IO9+^LR>=
M'9IJ3\4^O=2J(2<<YI+YRD:+).F_;Y'LZ B.EK'IZ>*K&_G:5%8M-ZC90D5?
MC!7.KH[7172H&N\7YT%QUKM6T*+*H)0IK#HFE8+\4L:E2UYI[6!LKE5=@J6U
M"B9U'6ZR^//0617%'L]GHYE P)9A7>4'S8SJ0"9BV!AK]HU,#^I2;: (LC3E
M*-*3VRX3@/(5\>GWF<W8<6#:PH E(XIXZ??''_<IF,!T7\,.#@!\N6::_-O]
ME_L&([P7F9APE:*O+(ZF]@0O:Q.(,0H ICM,IF73[:QN_KJQ?0I@JF[J672T
M=[W)%VK*4&>2(MQTQ4:;%O:<@NX+.KP*UPQ88W7A2 $LL/N$$1(B:61)K*(0
M4AG<]#HC-SXIRRA=M6'MI)5*)3A)ZLD@S&C4)LV<[:%P;5%8$=KD;/P;)H^8
MYYO$@E(285H/?&?B15E-.BUJS*,73K<A@F477[0("B)8>9Y>E\KX2,42U_%O
M>W*Q[E^\*O=!O<J/=4T/Y,!I3$P4&X+'\E0:>8OC)U#RG3):3U0A8W(1]?#6
MF'XYLSQKKX@><GL'P#)4EUVJ0U$WL5#N1+0D,]%]V0Y_HC0KWKS+E5>0KR8:
MP<*:MQY)K@CWY0OL"UA+F]#3 $:_\DGZL]L&/>.TESQ<!'+U;B_A/35BYD)7
M1R.FQ,R<3*R>9AG'.N:W"W_K2^P)?<UOYYW4P"-G]TU&YLB)[0Y0>;*,=*T
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MCHSZ4W"QL(%FL\U8@RO^S' 1_AU .G"I&7T*[4-S-X5-STIH35ZYG/@?E,^
MZ;W(I68X!6%,HN35.5M:4JI)E_<]>?F8!5VL&CMV.0PC!*>MBOM#9E&!RT&Y
MF],V)O,QF6]$DO/SV@)MH9'3#F^KM(AZ/T8",5K1MQ&^W\)=E=6=482LX2*T
MQ&L0S.:_-R^N&CS-=*UV5^(4Q8E2GE/CV?&X9>4VI4J-6,-]:%Y!<&E8-EJI
MB8!)/16.#"^Z$]*V3KIX8"/L2H</[-R0H[:,1'+L3HL+W)U+?IVP,GY?-[AQ
M!B' <BZ+894UCBIWV,H0)8FE>:""S%D)/NF@AXY%1M>'+4;52;^W2T[VE0A
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M*U%4)#-*9LB9(8=AYC5^\^[^WGF[[_W/V3UO!^J<ZNFJKJZZ]W[NY]XJP/W
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M=AI4LTVSFC0'KYC"/-7' <A!^+6]3_+G?YLERTL\%1,<\%QV\=3#==Z:8I4
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MRB.<R,H&Y^<<,\I1;8'%RL*I\[ 9T\,&;$B-]<%\2VO\H5$P__I;D*Q/)>,
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M6JZI6._W\'?1N<3O%P2#K,ZDJ6EU2>,//_@-\NF)$5GSE0:RW(M*SF6A54\
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M>45E(O9.XNUHSR5-P'E@SIAM5H!&Z>WR=[Y2:LL("_X;@II>(Q]>EUQ-J/_
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M_COK;XB_(?Z&^!OB_QF$1WX7PVC!%EN)UL""#]948$9@9^C'.#X#UHQ.\L\
M_7>;&Z<-P%W/17N*.!IJ5)6KIEX3+>52'E4A[ ^0 AJC(8*@<[M*V@:BD8)9
M].YO2[D6R\\ E[ QR>^(,Z!29^_9B<P9T/_N"$]AK\X=R<&B?MPI":?7A2BQ
MLTH%\<96_QOY/^HQ/$?RI'>M%=2ZVZJ!,GYN*+\0RX.G-PO[@PX9C_]1[\9_
MSH*1GQEEHE_;=B[6>]\:]E,3.)O^'U!+ 0(4 Q0    ( -R+?UQ$L:/&:RT
M 'YI @ 1              "  0    !A9GEA+3(P,C4Q,C,Q+GAS9%!+ 0(4
M Q0    ( -R+?UPMEG5Z!!D  $UD 0 5              "  9HM  !A9GEA
M+3(P,C4Q,C,Q7V-A;"YX;6Q02P$"% ,4    " #<BW]<\%3(+6QG  #'30<
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M<FTR,&9?,C R-2YH=&U02P$"% ,4    " #<BW]<=I-.5@%'  #<3P$ "@
M            @ &<$@D 97@P,BTQ+FAT;5!+ 0(4 Q0    ( -R+?UPF^=(Y
MA.T  */8!0 *              "  <59"0!E># T+3,N:'1M4$L! A0#%
M  @ W(M_7$AY&B%)N@  H48%  H              ( !<4<* &5X,#0M-"YH
M=&U02P$"% ,4    " #<BW]<^ZCA')T$   =)0  "@              @ 'B
M 0L 97@P."TQ+FAT;5!+ 0(4 Q0    ( -R+?UPC4?"KC%   /SD 0 *
M          "  :<&"P!E>#$Q+3$N:'1M4$L! A0#%     @ W(M_7#ZW#,<3
M!P  HAP   H              ( !6U<+ &5X,3(M,2YH=&U02P$"% ,4
M" #<BW]<6TESR5H'  #X'0  "@              @ &67@L 97@Q,BTR+FAT
M;5!+ 0(4 Q0    ( -R+?USW$""UYP,  (T*   *              "  1AF
M"P!E>#$S+3$N:'1M4$L! A0#%     @ W(M_7,F2(?K? P  VPH   H
M         ( !)VH+ &5X,3,M,BYH=&U02P$"% ,4    " #<BW]<Z033L"P"
M  !3"0  "@              @ $N;@L 97@Q-BTQ+FAT;5!+ 0(4 Q0    (
M -R+?UQ^UD^"(0,   02   *              "  8)P"P!E>#(S+3$N:'1M
M4$L! A0#%     @ W(M_7*.5U>'M 0    4   H              ( !RW,+
M &5X,C,M,BYH=&U02P$"% ,4    " #<BW]<DU(0<[T" 0!L$P$ #0
M        @ '@=0L :6UA9V5?,# Q+FIP9U!+ 0(4 Q0    ( -R+?UPQ],^V
M"W$  /"-   -              "  <AX# !I;6%G95\P,#(N:G!G4$L! A0#
M%     @ W(M_7&=C\!:^1@  :(P   T              ( !_ND, &EM86=E
M7S P,RYJ<&=02P$"% ,4    " #<BW]<]_LYLP@S  !G/P  #0
M    @ 'G, T :6UA9V5?,# T+FIP9U!+ 0(4 Q0    ( -R+?UPUB&KA $X
M (:,   -              "  1ID#0!I;6%G95\P,#4N:G!G4$L! A0#%
M  @ W(M_7&UJ]KE/EP  Q+D   T              ( !1;(- &EM86=E7S P
M-BYJ<&=02P$"% ,4    " #<BW]<\XL4&/Q!  #=6P  #0
M@ &_20X :6UA9V5?,# W+FIP9U!+ 0(4 Q0    ( -R+?USJP*<JVDP  $%A
M   -              "  >:+#@!I;6%G95\P,#@N:G!G4$L! A0#%     @
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52P4&     !X '@#Q!@  FWD0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>afyaform20f_2025_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:afya="http://afya.com.br/20251231"
  xmlns:currency="http://xbrl.sec.gov/currency/2024"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="afya-20251231.xsd" xlink:type="simple"/>
    <context id="From2025-01-01to2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ClassACommonSharesHeldInTreasuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesHeldInTreasuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-05-07_custom_FaculdadeMasterclassLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeMasterclassLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-07</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeMasterclassLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-05-062025-05-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2025-05-06</startDate>
            <endDate>2025-05-07</endDate>
        </period>
    </context>
    <context id="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesS.A.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-07</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AfyaParticipacoesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AfyaParticipacoesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoS.A.FASAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoS.A.FASAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaenseDeEducacaoECulturaLtda.IPECMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaenseDeEducacaoECulturaLtda.IPECMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorS.A.UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorS.A.UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeEnsinoSaoLucasLtda.UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeEnsinoSaoLucasLtda.UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeSolutionsS.A.MedicinaeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeSolutionsS.A.MedicinaeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtda.CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtda.CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiaDaInformacaoLtda.ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiaDaInformacaoLtda.ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesDeTecnologiaLtda.RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesDeTecnologiaLtda.RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_UnidomParticipacoesS.A.UnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomParticipacoesS.A.UnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_UnidomParticipacoesS.A.UnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomParticipacoesS.A.UnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaFUNICMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeMasterclassLtdaFUNICMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FVTPLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">afya:FVTPLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FinancialAssetsAtAmortizedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">afya:FinancialAssetsAtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FVOCIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">afya:FVOCIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FVOCI1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis">afya:FVOCI1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CustomerRelationshipsOtherCoursesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">afya:CustomerRelationshipsOtherCoursesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_BrandNamesMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_BrandNamesMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EducationContentDevelopedTechnologyAndEducationalPlatformMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">afya:EducationContentDevelopedTechnologyAndEducationalPlatformMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EducationContentDevelopedTechnologyAndEducationalPlatformMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">afya:EducationContentDevelopedTechnologyAndEducationalPlatformMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:TeachingActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ProgramOfSocialIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_TeachingActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:TeachingActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ContributionForTheFinancingOfSocialSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ProgramOfSocialIntegrationMember_custom_NonTeachingActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:NonTeachingActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ProgramOfSocialIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_NonTeachingActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:NonTeachingActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">afya:ContributionForTheFinancingOfSocialSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-12-262024-12-27_custom_OrganizationForEconomicCooperationAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:OrganizationForEconomicCooperationAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-26</startDate>
            <endDate>2024-12-27</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OrganizationForEconomicCooperationAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:OrganizationForEconomicCooperationAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AmendmentsToIAS21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AmendmentsToIAS21Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LackOfExchangeabilityAmendmentsToIAS21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:LackOfExchangeabilityAmendmentsToIAS21Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AnnualImprovementsToIFRSAccountingStandardsVolume11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:AnnualImprovementsToIFRSAccountingStandardsVolume11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_IFRS18PresentationAndDisclosureInFinancialStatementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">afya:IFRS18PresentationAndDisclosureInFinancialStatementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentBalancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentBalancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-01_custom_UnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-01</instant>
        </period>
    </context>
    <context id="From2024-06-292024-07-01_custom_UnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-29</startDate>
            <endDate>2024-07-01</endDate>
        </period>
    </context>
    <context id="From2024-06-292024-07-01_custom_AcquisitionOfUnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfUnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-29</startDate>
            <endDate>2024-07-01</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfUnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AcquisitionOfUnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:AcquisitionOfUnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-06-292024-07-01_ifrs-full_LicencesAndFranchisesMember_custom_AcquisitionOfUnidomMember_custom_WithAndWithoutMethodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesAndFranchisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">afya:WithAndWithoutMethodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfUnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-29</startDate>
            <endDate>2024-07-01</endDate>
        </period>
    </context>
    <context id="From2024-06-292024-07-01_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfUnidomMember_ifrs-full_MultiperiodExcessEarningsMethodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MethodOfAssessmentOfExpectedCreditLossesAxis">ifrs-full:MultiperiodExcessEarningsMethodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AcquisitionOfUnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-29</startDate>
            <endDate>2024-07-01</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_BankCertificatesOfDepositMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:BankCertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_BankCertificatesOfDepositMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:BankCertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_USDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">afya:USDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_USDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">afya:USDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TuitionFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:TuitionFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_TuitionFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:TuitionFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_EducationalContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_EducationalContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FIESMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:FIESMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FIESMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:FIESMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_EducationalCreditsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_EducationalCreditsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_MobileAppSubscriptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:MobileAppSubscriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_MobileAppSubscriptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:MobileAppSubscriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OthersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OthersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsNeitherPastDueNorImpairedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsNeitherPastDueNorImpairedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_NotLaterThanOneMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_NotLaterThanOneMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanSixMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanSixMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EMIVEPatrulha24HorasLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:EMIVEPatrulha24HorasLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EMIVEPatrulha24HorasLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:EMIVEPatrulha24HorasLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EMIVEPatrulha24HorasLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:EMIVEPatrulha24HorasLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DepreciationRightofuseAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:DepreciationRightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_DepreciationRightofuseAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:DepreciationRightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DepreciationRightofuseAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:DepreciationRightofuseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LeaseLiabilitiesInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseLiabilitiesInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_LeaseLiabilitiesInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseLiabilitiesInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LeaseLiabilitiesInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseLiabilitiesInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LeaseAgreements1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2018-09-052018-09-06_custom_LeaseAgreements1Member_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-05</startDate>
            <endDate>2018-09-06</endDate>
        </period>
    </context>
    <context id="From2018-09-052018-09-06_custom_LeaseAgreements1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-05</startDate>
            <endDate>2018-09-06</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-28</startDate>
            <endDate>2019-10-30</endDate>
        </period>
    </context>
    <context id="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-28</startDate>
            <endDate>2019-10-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-08-02</endDate>
        </period>
    </context>
    <context id="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-08-02</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-05-012024-05-02_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-02</endDate>
        </period>
    </context>
    <context id="From2024-07-132024-07-14_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-13</startDate>
            <endDate>2024-07-14</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements5Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements5Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LeaseAgreements5Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LeaseAgreements5Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-23</startDate>
            <endDate>2018-04-25</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LeaseAgreements5Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LeaseAgreements5Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:IntangibleInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_EducationContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_EducationalPlatformMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SoftwareInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_EducationContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_EducationalPlatformMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SoftwareInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ITPACGaranhunsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ITPACGaranhunsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnifipMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnifipMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FUNICMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FUNICMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CarryingAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CarryingAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DiscountRatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:DiscountRatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_PerpetuityGrowthRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:PerpetuityGrowthRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EBITDAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EBITDAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersEarnOutsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersEarnOutsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersEarnOutsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersEarnOutsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersUnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersUnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersUnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersUnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_OctoberTwentyTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OctoberTwentyTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OctoberTwentyTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_JulyTwentyTwentySevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:JulyTwentyTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_JulyTwentyTwentySevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:JulyTwentyTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_JulyTwentyTwentySevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:JulyTwentyTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AprilTwentyTwentySixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:AprilTwentyTwentySixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AprilTwentyTwentySixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:AprilTwentyTwentySixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AprilTwentyTwentySixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:AprilTwentyTwentySixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_JanuaryTwentyTwentyEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:JanuaryTwentyTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_JanuaryTwentyTwentyEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:JanuaryTwentyTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_JanuaryTwentyTwentyEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:JanuaryTwentyTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AprilTwentyThirtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:AprilTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AprilTwentyThirtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:AprilTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AprilTwentyThirtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:AprilTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_OctoberTwentyTwentyEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OctoberTwentyTwentyEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OctoberTwentyTwentyEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyTwentyEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_OctoberTwentyThirtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OctoberTwentyThirtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OctoberTwentyThirtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:OctoberTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-07_custom_InternationalFinanceCorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:InternationalFinanceCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-07</instant>
        </period>
    </context>
    <context id="From2024-08-012024-08-07_custom_InternationalFinanceCorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:InternationalFinanceCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-07</endDate>
        </period>
    </context>
    <context id="AsOf2025-10-15_custom_TwoSeriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:TwoSeriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-15</instant>
        </period>
    </context>
    <context id="AsOf2025-10-15_custom_FirstSeriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:FirstSeriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-15</instant>
        </period>
    </context>
    <context id="AsOf2025-10-15_custom_SecondSeriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:SecondSeriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-15</instant>
        </period>
    </context>
    <context id="From2025-10-012025-10-15_custom_InternationalFinanceCorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:InternationalFinanceCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-10-15</endDate>
        </period>
    </context>
    <context id="From2021-08-032021-08-04_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-03</startDate>
            <endDate>2021-08-04</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-04_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-04</instant>
        </period>
    </context>
    <context id="From2022-12-292023-01-02_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-29</startDate>
            <endDate>2023-01-02</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-02_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-02</instant>
        </period>
    </context>
    <context id="From2025-05-052025-05-07_custom_FUNICMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-05</startDate>
            <endDate>2025-05-07</endDate>
        </period>
    </context>
    <context id="AsOf2025-05-07_custom_FUNICMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-07</instant>
        </period>
    </context>
    <context id="From2021-05-122021-05-13_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-12</startDate>
            <endDate>2021-05-13</endDate>
        </period>
    </context>
    <context id="AsOf2021-05-13_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-13</instant>
        </period>
    </context>
    <context id="From2022-03-032022-03-04_custom_AlemDaMedicinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-03</startDate>
            <endDate>2022-03-04</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-04_custom_AlemDaMedicinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-04</instant>
        </period>
    </context>
    <context id="From2022-04-042022-04-05_custom_CardioPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-05_custom_CardioPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardioPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-05</instant>
        </period>
    </context>
    <context id="From2024-06-302024-07-01_custom_UnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-30</startDate>
            <endDate>2024-07-01</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_currency_EUR_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_DelReyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:DelReyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_FUNICMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_FUNICMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FUNICMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FUNICMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AlemDaMedicinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AlemDaMedicinaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AlemDaMedicinaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CardiPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardiPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_CardiPapersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CardiPapersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_UnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_UnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_UnidomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnidomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ForeignCurrencyExposuresMember_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:ForeignCurrencyExposuresMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_IncreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:IncreaseForeignCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DecreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:DecreaseForeignCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_LoansAndFinancingMember197490421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_LoansAndFinancingMember197490453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ShareBasedCompensationPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ShareBasedCompensationPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ShareBasedCompensationPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_RestrictedStockUnits1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnits1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_RestrictedStockUnits2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnits2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_RestrictedStockUnits3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:RestrictedStockUnits3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_November2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:November2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_April2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:April2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_October2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:October2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_December2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:December2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_October2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:October2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_August2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:August2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_April2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:April2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_February2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:February2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember_custom_November2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:November2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember_custom_November2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:November2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember_custom_April2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:April2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember_custom_April2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:April2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_BottomOfRangeMember_custom_October2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:October2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_TopOfRangeMember_custom_October2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:October2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_December2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:December2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_December2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:December2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_October2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:October2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_October2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:October2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_August2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:August2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_August2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:August2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_April2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:April2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_April2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:April2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_February2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:February2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_February2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:February2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-03-112025-03-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2025-03-11</startDate>
            <endDate>2025-03-12</endDate>
        </period>
    </context>
    <context id="From2025-04-032025-04-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2025-04-03</startDate>
            <endDate>2025-04-04</endDate>
        </period>
    </context>
    <context id="AsOf2025-08-13_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-13</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_UndergraduateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_UndergraduateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergraduateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:MedicalPracticeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:EliminationInterSegmentTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_OtherAssetsNonCurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">afya:OtherAssetsNonCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OtherAssetsNonCurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">afya:OtherAssetsNonCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2026-03-112026-03-12_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">afya:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-11</startDate>
            <endDate>2026-03-12</endDate>
        </period>
    </context>
    <context id="From2026-04-052026-04-06_custom_NonadjustingEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">afya:NonadjustingEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-05</startDate>
            <endDate>2026-04-06</endDate>
        </period>
    </context>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="BRL">
        <measure>iso4217:BRL</measure>
    </unit>
    <unit id="BRLPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:BRL</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="N">
        <measure>afya:Number</measure>
    </unit>
    <unit id="EUR">
        <measure>iso4217:EUR</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2025-01-01to2025-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2025-01-01to2025-12-31" id="Fact000004">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-01-01to2025-12-31" id="Fact000005">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2025-01-01to2025-12-31" id="Fact000006">0001771007</dei:EntityCentralIndexKey>
    <ifrs-full:DeferredTaxAssets
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0135"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPayable
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0180"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0212"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0325"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0326"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0327"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0366"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0367"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0368"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0369"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0375"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0376"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0377"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0378"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0384"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0385"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0386"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0388"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0390"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesRepurchase
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0393"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesRepurchase
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0394"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesRepurchase
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0396"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesRepurchase
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0397"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesRepurchase
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0399"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0402"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0403"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0404"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0405"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0411"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0414"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0415"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0417"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0420"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0423"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0424"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0426"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0429"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0430"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0431"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0432"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0433"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      id="xdx2ixbrl0434"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0447"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0448"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0449"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0450"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0456"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0457"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0458"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0459"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0465"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0466"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0467"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0469"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0471"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0474"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0477"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0478"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0480"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0483"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0486"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0487"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0489"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0492"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0493"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0494"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0495"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0496"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      id="xdx2ixbrl0497"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0510"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0511"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0512"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0513"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0519"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0520"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0521"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0522"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0528"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0529"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0530"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0532"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0534"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesRepurchase
      contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0537"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesRepurchase
      contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0538"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesRepurchase
      contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0540"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesRepurchase
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0541"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesRepurchase
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0543"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0546"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0549"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0550"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0552"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0555"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0558"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0559"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0561"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2025-01-012025-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0564"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0565"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0566"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0567"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PurchaseOfAcquisitionOfNoncontrollingInterests
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0702"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PurchaseOfAcquisitionOfNoncontrollingInterests
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0703"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesRepurchase
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0743"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      id="xdx2ixbrl1302"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      id="xdx2ixbrl1338"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      id="xdx2ixbrl1350"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1356"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      id="xdx2ixbrl1358"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      id="xdx2ixbrl1362"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalExpenditures
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      id="xdx2ixbrl1374"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      id="xdx2ixbrl1410"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      id="xdx2ixbrl1446"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      id="xdx2ixbrl1458"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1464"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      id="xdx2ixbrl1466"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      id="xdx2ixbrl1470"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalExpenditures
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      id="xdx2ixbrl1482"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepositsFromExternalCustomer
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1498"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      id="xdx2ixbrl1502"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      id="xdx2ixbrl1512"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1546"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepositsFromExternalCustomer
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1580"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      id="xdx2ixbrl1584"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      id="xdx2ixbrl1594"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1628"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepositsFromExternalCustomer
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1663"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      id="xdx2ixbrl1667"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      id="xdx2ixbrl1677"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1711"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherAssetsRelatedPartyTransactions
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl1944"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TradeAndOtherCurrentPayablesToRelatedParties1
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl1952"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2267"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2276"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2278"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2279"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2287"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2289"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2295"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2300"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2301"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2304"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl2307"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2322"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2333"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2334"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2339"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2342"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2344"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2348"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      id="xdx2ixbrl2349"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2350"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2355"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2356"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2359"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl2362"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2377"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2378"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2386"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      id="xdx2ixbrl2387"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2388"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2399"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2400"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2403"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl2406"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2421"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2427"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2432"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2438"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2443"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2449"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2454"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2455"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      id="xdx2ixbrl2456"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2458"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2460"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2461"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2465"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2471"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2476"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2482"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2485"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2487"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2491"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2493"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2498"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2499"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2502"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2504"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2505"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2509"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2515"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2520"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2526"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2529"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2531"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2537"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2542"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2548"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl2617"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2797"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2799"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2813"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2819"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2820"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2829"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2843"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2845"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2859"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2865"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2866"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2874"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2890"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2892"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2906"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2912"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2913"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2921"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2929"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2931"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_IntangibleInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2945"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      id="xdx2ixbrl3069"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      id="xdx2ixbrl3071"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember"
      id="xdx2ixbrl3129"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember"
      id="xdx2ixbrl3131"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl3145"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl3147"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember"
      id="xdx2ixbrl3157"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember"
      id="xdx2ixbrl3159"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FUNICMember"
      id="xdx2ixbrl3213"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FUNICMember"
      id="xdx2ixbrl3215"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FUNICMember"
      id="xdx2ixbrl3219"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FUNICMember"
      id="xdx2ixbrl3223"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPayable
      contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      id="xdx2ixbrl3324"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_custom_OctoberTwentyTwentyFiveMember"
      id="xdx2ixbrl3368"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_custom_AprilTwentyTwentySixMember"
      id="xdx2ixbrl3388"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_custom_JanuaryTwentyTwentyEightMember"
      id="xdx2ixbrl3398"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_custom_OctoberTwentyTwentyEightMember"
      id="xdx2ixbrl3420"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_custom_OctoberTwentyThirtyMember"
      id="xdx2ixbrl3430"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsBusinessCombinations
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3500"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:BusinessCombinationsLeaseLiabilities
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3506"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepreciationExpenseLeaseLiabilities
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3518"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepreciationExpenseLeaseLiabilities
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl3520"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepreciationExpenseLeaseLiabilities
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3522"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsInterestExpense
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3524"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsInterestExpense
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl3526"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsInterestExpense
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3528"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfPrincipal
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3536"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfPrincipal
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl3538"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfPrincipal
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3540"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfInterest
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl3548"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfInterest
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl3550"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfInterest
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3552"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsCurrent
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl3584"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsCurrent
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl3586"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl3588"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_custom_UnigranrioMember"
      id="xdx2ixbrl3618"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_custom_FUNICMember"
      id="xdx2ixbrl3632"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_custom_AlemDaMedicinaMember"
      id="xdx2ixbrl3638"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember"
      id="xdx2ixbrl3742"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember"
      id="xdx2ixbrl3744"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl3832"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl3834"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl3836"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl3846"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl3882"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl3884"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      id="xdx2ixbrl3886"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_DividendsPayableMember"
      id="xdx2ixbrl3964"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019
      contextRef="AsOf2025-12-31_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl4273"
      unitRef="BRLPShares"
      xsi:nil="true"/>
    <afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl4275"
      unitRef="N"
      xsi:nil="true"/>
    <afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_ifrs-full_ShareOptionsMember"
      id="xdx2ixbrl4277"
      unitRef="N"
      xsi:nil="true"/>
    <afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember"
      id="xdx2ixbrl4409"
      unitRef="N"
      xsi:nil="true"/>
    <afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_RestrictedStockUnitsMember"
      id="xdx2ixbrl4411"
      unitRef="N"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember"
      id="xdx2ixbrl4640"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember"
      id="xdx2ixbrl4642"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember"
      id="xdx2ixbrl4682"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember"
      id="xdx2ixbrl4700"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember"
      id="xdx2ixbrl4702"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember"
      id="xdx2ixbrl4742"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember"
      id="xdx2ixbrl4762"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember"
      id="xdx2ixbrl4764"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember"
      id="xdx2ixbrl4804"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RecognisedDeferredTaxAssets
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl4969"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PermanentAdjustmentsManagementBonuses
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4982"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PermanentAdjustmentsPillarTwo
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl4997"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PermanentAdjustmentsPillarTwo
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4998"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DeferredTaxAssetsLossCarryforwards
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl5026"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AllowanceForExpectedCreditLoss
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl5035"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAsset
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl5044"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LeaseLiability
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl5050"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ProvisionForProfitSharing
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl5056"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:LegalProceedingsProvision
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl5062"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AmortizationOfIntangibleAsset
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl5068"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Other
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl5074"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DeferredTaxAsset
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl5080"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl5089"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AdditionsFairValueRemeasurementsOnBusinessCombinations
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl5097"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      id="xdx2ixbrl5135"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      id="xdx2ixbrl5223"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RemeasurementOfEarnOut
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl5269"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RemeasurementOfEarnOut
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl5271"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsPayables
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl5295"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsPayables
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl5297"
      unitRef="BRL"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2025-01-01to2025-12-31" id="Fact000017">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="From2025-01-01to2025-12-31" id="Fact000018">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="From2025-01-01to2025-12-31" id="Fact000019">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2025-01-01to2025-12-31" id="Fact000020">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-01-01to2025-12-31" id="Fact000021">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="From2025-01-01to2025-12-31" id="Fact000022">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="From2025-01-01to2025-12-31" id="Fact000023">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="From2025-01-01to2025-12-31" id="Fact000024">001-38992</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2025-01-01to2025-12-31" id="Fact000025">AFYA LIMITED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-01-01to2025-12-31" id="Fact000026">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="From2025-01-01to2025-12-31" id="Fact000027">Rua Paraiba</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-01-01to2025-12-31" id="Fact000028">No. 330</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2025-01-01to2025-12-31" id="Fact000029">17th floor</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="From2025-01-01to2025-12-31" id="Fact000030">Minas Gerais</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2025-01-01to2025-12-31" id="Fact000031">BR</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000033">Virgilio Deloy Capobianco Gibbon</dei:ContactPersonnelName>
    <dei:CityAreaCode
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000035">55</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000037">3515-7550</dei:LocalPhoneNumber>
    <dei:ContactPersonnelEmailAddress
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000039">ir@afya.com.br</dei:ContactPersonnelEmailAddress>
    <dei:EntityAddressAddressLine1
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000041">Rua Paraiba</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000043">No. 330</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000044">17th floor</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000046">Minas Gerais</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="From2025-01-012025-12-31_dei_BusinessContactMember"
      id="Fact000048">BR</dei:EntityAddressCountry>
    <dei:Security12bTitle contextRef="From2025-01-01to2025-12-31" id="Fact000049">Class A common shares, par value US$0.00005 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2025-01-01to2025-12-31" id="Fact000050">AFYA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2025-01-01to2025-12-31" id="Fact000051">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact000052"
      unitRef="Shares">55148697</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_ClassACommonSharesHeldInTreasuryMember"
      decimals="INF"
      id="Fact000053"
      unitRef="Shares">3855150</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact000054"
      unitRef="Shares">38574134</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2025-01-01to2025-12-31" id="Fact000055">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2025-01-01to2025-12-31" id="Fact000056">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2025-01-01to2025-12-31" id="Fact000057">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2025-01-01to2025-12-31" id="Fact000058">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2025-01-01to2025-12-31" id="Fact000059">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-01-01to2025-12-31" id="Fact000061">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2025-01-01to2025-12-31" id="Fact000063">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:IcfrAuditorAttestationFlag contextRef="From2025-01-01to2025-12-31" id="Fact000064">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentAccountingStandard contextRef="From2025-01-01to2025-12-31" id="Fact000066">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="From2025-01-01to2025-12-31" id="Fact000068">false</dei:EntityShellCompany>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2025-01-01to2025-12-31" id="Fact000069">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000078">&lt;b style="display: none"&gt;Risk Management and Strategy&lt;/b&gt;&lt;p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"&gt;Overview&lt;/p&gt;&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Company has policies and procedures in place to
address information technology and cybersecurity risks as part of its corporate risk management process. These processes are integrated
into Afya&#x2019;s enterprise risk management (ERM) framework to ensure alignment with our overall approach to corporate risk. This includes
activities such as risk identification, classification, and mitigation, as well as the development of action plans aligned with industry
best practices.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Cybersecurity initiatives at Afya are overseen by our
Chief Information Security Office, or CISO. The CISO&#x2019;s responsibilities include defining and aligning action plans with Afya&#x2019;s
corporate risk management team. Additionally, the CISO serves as the Data Protection Officer, handling privacy and data protection matters
and defining cybersecurity strategies for the entire company. This includes ensuring effective monitoring, threat detection, response
to events and incidents, and overall cybersecurity management. Cybersecurity monitoring with respect to our newly acquired companies is
managed from the outset by our IT technical team. Exposure to risk during this period is naturally greater as such acquired company is
not always mature in terms of cybersecurity risk management, but we seek to mitigate these risks by making adjustments to their practices
and applying our policies.&lt;/p&gt;&lt;p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"&gt;Risk Management and Strategy&lt;/p&gt;&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Afya has comprehensive policies, procedures, and a
dedicated risk management team responsible for addressing corporate risks across various themes, including strategic, operational, financial,
and compliance areas. Within each theme, Afya identifies and manages risks related to quality, procurement, cybersecurity, privacy and
data protection, financial reporting, legal compliance, regulatory matters, as well as risks related to ESG.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;The Company follows a structured approach, including
a risk matrix with defined risk levels and criticality, which guides the need for risk treatment and the development of action plans.
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90E_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20250101__20251231_zJIUVjcAO06h"&gt;These plans are monitored by the responsible parties for each theme under the oversight of the risk and controls department.&lt;/span&gt; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20250101__20251231_zjqhMoD1cRii"&gt;Furthermore,
Afya has an assessment process that evaluates cybersecurity, privacy, and data protection policies of critical suppliers before onboarding.
This process aligns with frameworks such as COSO-ERM and COSO Internal Control - &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20250101__20251231_zMaUWL0wXdM5"&gt;Integrated&lt;/span&gt; Framework.&lt;/span&gt; To ensure compliance with industry
standards and enhance cybersecurity maturity levels, Afya engages specialized companies to review its plans and procedures, aiming to
adopt market best practices.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Within the further detailed governance scheme, the
Company has established the audit, risk, and ethics committee to oversee risk management guidelines through a structured approach known
as the three lines of defense:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;For the monitoring and response to cyber incidents,
Afya has teams responsible for detecting and monitoring the Company&#x2019;s environment, performing threat intelligence analysis, conducting
intrusion testing, and verifying the coverage and effectiveness of its detection and monitoring tools.&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="From2025-01-01to2025-12-31" id="Fact000079">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000080">Furthermore,
Afya has an assessment process that evaluates cybersecurity, privacy, and data protection policies of critical suppliers before onboarding.
This process aligns with frameworks such as COSO-ERM and COSO Internal Control - &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20250101__20251231_zMaUWL0wXdM5"&gt;Integrated&lt;/span&gt; Framework.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="From2025-01-01to2025-12-31" id="Fact000081">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000089">Governance&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Afya places significant emphasis on cybersecurity within
its information technology area, covering areas such as incident management, information technology governance, privacy and data protection,
cybersecurity, infrastructure, and systems management. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_909_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_c20250101__20251231_zVkFW06F3D2l"&gt;These efforts are led by &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20250101__20251231_zUjZtfj6cte4"&gt;our chief information officer, or CIO&lt;/span&gt;, and our CISO. The
CISO, drawing from extensive experience in leading technology and information security departments in large companies, is responsible
for developing a proactive security strategy capable of continuous threat exposure management, in balance with the organization&#x2019;s
business goals.&lt;/span&gt; This includes ensuring compliance with relevant information security and data privacy regulations, conducting training
for the security team and promoting user awareness to keep stakeholders informed about emerging technologies and threats.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_900_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250101__20251231_zwvX3hCilYj2"&gt;Afya&#x2019;s governance structure includes the audit,
risk, and ethics committee, which oversees risks identified by the risk and controls department, including cyber risks.&lt;/span&gt; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_c20250101__20251231_zpKhXmXTeEjk"&gt;The audit, risk,
and ethics committee reports to our &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_dbT_c20250101__20251231_zuUcoGh3ttP"&gt;board of directors&lt;/span&gt; on a quarterly basis and, where applicable, review of specific incident responses.&lt;/span&gt;
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250101__20251231_zY3dFlRPx7Bf"&gt;Our board of directors then sets strategic objectives and monitors the company&#x2019;s risk landscape and corresponding action plans.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_c20250101__20251231_zrREuBV8rDAb"&gt;Afya&#x2019;s cybersecurity team holds regular meetings
to ensure continuous alignment and enhancement of the infrastructure and technology supporting the organization&#x2019;s cybersecurity
strategy.&lt;/span&gt; Potential improvements are identified and evaluated for feasibility and implementation in accordance with internal governance
processes. Afya continuously adopts and invests in technological solutions to strengthen its cybersecurity posture, enhancing monitoring,
threat detection, incident response, recovery, and protection capabilities across the organization.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90C_ecyd--CybersecurityRiskRoleOfManagementTextBlock_c20250101__20251231_zvCDNHKXqHJ"&gt;In terms of disaster preparedness, Afya has a comprehensive
disaster recovery plan that includes a dedicated committee, trigger mechanisms, and defined recovery points focused on the Company&#x2019;s
infrastructure. Additionally, Afya maintains a robust business continuity plan involving key teams and critical service mapping, with
criteria for defining criticality, financial impact, and brand reputation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;Afya&#x2019;s privacy team is responsible for addressing
risks and controls related to personal data. They adhere to industry best practices such as ISO27000, LGPD, GDPR, and the NIST Cybersecurity
Framework, leveraging governance, risk management and compliance solutions to support their risk management processes.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;According to processes and controls established by
Afya, as of December 31, 2025, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20250101__20251231_zNemqp6VQP6a"&gt;no events were identified that could indicate the materialization of risks or the identification of material
incidents under the cybersecurity aspect that &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbT_c20250101__20251231_zAEWZ3w1Nql8"&gt;affected or could affect&lt;/span&gt; the business strategy, results of operations, or financial condition
of the company.&lt;/span&gt; Minor incidents that occurred during the period were identified, treated, and communicated in accordance with the protocols,
policies, and procedures established for response. However, despite our efforts, we cannot eliminate all risks from cybersecurity threats,
or provide assurances that we have not experienced an undetected cybersecurity incident.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0.25in"&gt;For more information about these risks, please see
&#x201c;Item 3. Key Information&#x2014;D. Risk Factors&#x2014;Risks Relating to Our Business and Industry&#x2014; Failure to prevent or detect
a malicious cyber-attack on our systems and databases could result in a misappropriation of confidential information or access to highly
sensitive information&#x201d; and &#x201c;&#x2014;Our success depends on our ability to monitor and adapt to technological changes and maintain
a technological infrastructure that works adequately and without interruption&#x201d; in this annual report.&lt;/p&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000090">These efforts are led by &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20250101__20251231_zUjZtfj6cte4"&gt;our chief information officer, or CIO&lt;/span&gt;, and our CISO. The
CISO, drawing from extensive experience in leading technology and information security departments in large companies, is responsible
for developing a proactive security strategy capable of continuous threat exposure management, in balance with the organization&#x2019;s
business goals.</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="From2025-01-01to2025-12-31" id="Fact000091">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000092">Afya&#x2019;s governance structure includes the audit,
risk, and ethics committee, which oversees risks identified by the risk and controls department, including cyber risks.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000093">The audit, risk,
and ethics committee reports to our &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_dbT_c20250101__20251231_zuUcoGh3ttP"&gt;board of directors&lt;/span&gt; on a quarterly basis and, where applicable, review of specific incident responses.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="From2025-01-01to2025-12-31" id="Fact000094">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000095">Our board of directors then sets strategic objectives and monitors the company&#x2019;s risk landscape and corresponding action plans.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000096">Afya&#x2019;s cybersecurity team holds regular meetings
to ensure continuous alignment and enhancement of the infrastructure and technology supporting the organization&#x2019;s cybersecurity
strategy.</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000097">In terms of disaster preparedness, Afya has a comprehensive
disaster recovery plan that includes a dedicated committee, trigger mechanisms, and defined recovery points focused on the Company&#x2019;s
infrastructure. Additionally, Afya maintains a robust business continuity plan involving key teams and critical service mapping, with
criteria for defining criticality, financial impact, and brand reputation.</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000098">no events were identified that could indicate the materialization of risks or the identification of material
incidents under the cybersecurity aspect that &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbT_c20250101__20251231_zAEWZ3w1Nql8"&gt;affected or could affect&lt;/span&gt; the business strategy, results of operations, or financial condition
of the company.</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="From2025-01-01to2025-12-31" id="Fact000099">true</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <dei:AuditorFirmId contextRef="From2025-01-01to2025-12-31" id="Fact000100">1124</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2025-01-01to2025-12-31" id="Fact000101">KPMG Auditores Independentes Ltda.</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2025-01-01to2025-12-31" id="Fact000102">Belo Horizonte</dei:AuditorLocation>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000110"
      unitRef="BRL">1125381000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000111"
      unitRef="BRL">911015000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000113"
      unitRef="BRL">717373000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000114"
      unitRef="BRL">595898000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTaxAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000116"
      unitRef="BRL">13429000</ifrs-full:CurrentTaxAssets>
    <ifrs-full:CurrentTaxAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000117"
      unitRef="BRL">7139000</ifrs-full:CurrentTaxAssets>
    <afya:IncomeTaxesRecoverable
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000119"
      unitRef="BRL">23046000</afya:IncomeTaxesRecoverable>
    <afya:IncomeTaxesRecoverable
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000120"
      unitRef="BRL">18587000</afya:IncomeTaxesRecoverable>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000122"
      unitRef="BRL">62947000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000123"
      unitRef="BRL">57145000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000125"
      unitRef="BRL">1942176000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000126"
      unitRef="BRL">1589784000</ifrs-full:CurrentAssets>
    <afya:NoncurrentTradeReceivable
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000131"
      unitRef="BRL">34985000</afya:NoncurrentTradeReceivable>
    <afya:NoncurrentTradeReceivable
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000132"
      unitRef="BRL">35948000</afya:NoncurrentTradeReceivable>
    <ifrs-full:DeferredTaxAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000134"
      unitRef="BRL">12552000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000137"
      unitRef="BRL">125480000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000138"
      unitRef="BRL">115875000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000140"
      unitRef="BRL">46518000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000141"
      unitRef="BRL">54442000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000143"
      unitRef="BRL">711485000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000144"
      unitRef="BRL">658482000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000146"
      unitRef="BRL">896758000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000147"
      unitRef="BRL">842219000</ifrs-full:RightofuseAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000149"
      unitRef="BRL">5587980000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000150"
      unitRef="BRL">5532789000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000152"
      unitRef="BRL">7415758000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000153"
      unitRef="BRL">7239755000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000155"
      unitRef="BRL">9357934000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000156"
      unitRef="BRL">8829539000</ifrs-full:Assets>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000164"
      unitRef="BRL">123581000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000165"
      unitRef="BRL">128080000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:ShorttermBorrowings
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000167"
      unitRef="BRL">60668000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000168"
      unitRef="BRL">363554000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000170"
      unitRef="BRL">55772000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000171"
      unitRef="BRL">45580000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000173"
      unitRef="BRL">110640000</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000174"
      unitRef="BRL">185318000</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:CurrentDepositsFromCustomers
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000176"
      unitRef="BRL">158035000</ifrs-full:CurrentDepositsFromCustomers>
    <ifrs-full:CurrentDepositsFromCustomers
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000177"
      unitRef="BRL">161048000</ifrs-full:CurrentDepositsFromCustomers>
    <ifrs-full:DividendsPayable
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000179"
      unitRef="BRL">192000</ifrs-full:DividendsPayable>
    <ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000182"
      unitRef="BRL">217526000</ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000183"
      unitRef="BRL">208076000</ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <afya:CurrentTaxesPayable
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000185"
      unitRef="BRL">36043000</afya:CurrentTaxesPayable>
    <afya:CurrentTaxesPayable
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000186"
      unitRef="BRL">33456000</afya:CurrentTaxesPayable>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000188"
      unitRef="BRL">112638000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000189"
      unitRef="BRL">4247000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:OtherCurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000191"
      unitRef="BRL">8946000</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:OtherCurrentLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000192"
      unitRef="BRL">10836000</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000194"
      unitRef="BRL">884041000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000195"
      unitRef="BRL">1140195000</ifrs-full:CurrentLiabilities>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000200"
      unitRef="BRL">1993599000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000201"
      unitRef="BRL">1831607000</ifrs-full:LongtermBorrowings>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000203"
      unitRef="BRL">1009974000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000204"
      unitRef="BRL">932756000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentPayablesToRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000206"
      unitRef="BRL">329957000</ifrs-full:NoncurrentPayablesToRelatedParties>
    <ifrs-full:NoncurrentPayablesToRelatedParties
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000207"
      unitRef="BRL">345454000</ifrs-full:NoncurrentPayablesToRelatedParties>
    <afya:NoncurrentTaxesPayable
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000209"
      unitRef="BRL">77487000</afya:NoncurrentTaxesPayable>
    <afya:NoncurrentTaxesPayable
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000210"
      unitRef="BRL">84407000</afya:NoncurrentTaxesPayable>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000213"
      unitRef="BRL">28274000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:LongtermLegalProceedingsProvision
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000215"
      unitRef="BRL">128220000</ifrs-full:LongtermLegalProceedingsProvision>
    <ifrs-full:LongtermLegalProceedingsProvision
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000216"
      unitRef="BRL">113521000</ifrs-full:LongtermLegalProceedingsProvision>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000218"
      unitRef="BRL">43471000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000219"
      unitRef="BRL">42742000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000221"
      unitRef="BRL">3582708000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000222"
      unitRef="BRL">3378761000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000224"
      unitRef="BRL">4466749000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000225"
      unitRef="BRL">4518956000</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000230"
      unitRef="BRL">17000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000231"
      unitRef="BRL">17000</ifrs-full:IssuedCapital>
    <ifrs-full:AdditionalPaidinCapital
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000233"
      unitRef="BRL">2320422000</ifrs-full:AdditionalPaidinCapital>
    <ifrs-full:AdditionalPaidinCapital
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000234"
      unitRef="BRL">2344521000</ifrs-full:AdditionalPaidinCapital>
    <ifrs-full:TreasuryShares
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000236"
      unitRef="BRL">306010000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000237"
      unitRef="BRL">273955000</ifrs-full:TreasuryShares>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000239"
      unitRef="BRL">202815000</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000240"
      unitRef="BRL">187497000</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000242"
      unitRef="BRL">2634552000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000243"
      unitRef="BRL">2011875000</ifrs-full:RetainedEarnings>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000245"
      unitRef="BRL">4851796000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000246"
      unitRef="BRL">4269955000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:NoncontrollingInterests
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000248"
      unitRef="BRL">39389000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000249"
      unitRef="BRL">40628000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000251"
      unitRef="BRL">4891185000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000252"
      unitRef="BRL">4310583000</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000254"
      unitRef="BRL">9357934000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000255"
      unitRef="BRL">8829539000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:Revenue
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000257"
      unitRef="BRL">3697255000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000258"
      unitRef="BRL">3304329000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000259"
      unitRef="BRL">2875913000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000261"
      unitRef="BRL">1313895000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000262"
      unitRef="BRL">1215603000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000263"
      unitRef="BRL">1109813000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000265"
      unitRef="BRL">2383360000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000266"
      unitRef="BRL">2088726000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000267"
      unitRef="BRL">1766100000</ifrs-full:GrossProfit>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000269"
      unitRef="BRL">1113065000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000270"
      unitRef="BRL">1008427000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000271"
      unitRef="BRL">940132000</ifrs-full:GeneralAndAdministrativeExpense>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000273"
      unitRef="BRL">57090000</afya:AllowanceForExpectedCreditLosses>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000274"
      unitRef="BRL">60894000</afya:AllowanceForExpectedCreditLosses>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000275"
      unitRef="BRL">74552000</afya:AllowanceForExpectedCreditLosses>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000277"
      unitRef="BRL">18762000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000278"
      unitRef="BRL">13299000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000279"
      unitRef="BRL">53206000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000281"
      unitRef="BRL">18857000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000282"
      unitRef="BRL">20591000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:OtherExpenseByNature
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000283"
      unitRef="BRL">37561000</ifrs-full:OtherExpenseByNature>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000285"
      unitRef="BRL">1213110000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000286"
      unitRef="BRL">1012113000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000287"
      unitRef="BRL">767061000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000289"
      unitRef="BRL">194943000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000290"
      unitRef="BRL">111283000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000291"
      unitRef="BRL">110642000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000293"
      unitRef="BRL">561024000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000294"
      unitRef="BRL">458742000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000295"
      unitRef="BRL">457616000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceIncomeCost
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000297"
      unitRef="BRL">-366081000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000298"
      unitRef="BRL">-347459000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000299"
      unitRef="BRL">-346974000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000301"
      unitRef="BRL">13916000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000302"
      unitRef="BRL">11737000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000303"
      unitRef="BRL">9495000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000305"
      unitRef="BRL">860945000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000306"
      unitRef="BRL">676391000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000307"
      unitRef="BRL">429582000</ifrs-full:ProfitLossBeforeTax>
    <afya:IncomeTaxesExpensesCurrent
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000313"
      unitRef="BRL">133328000</afya:IncomeTaxesExpensesCurrent>
    <afya:IncomeTaxesExpensesCurrent
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000314"
      unitRef="BRL">24238000</afya:IncomeTaxesExpensesCurrent>
    <afya:IncomeTaxesExpensesCurrent
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000315"
      unitRef="BRL">27399000</afya:IncomeTaxesExpensesCurrent>
    <afya:DeferredTaxes
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000317"
      unitRef="BRL">40826000</afya:DeferredTaxes>
    <afya:DeferredTaxes
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000318"
      unitRef="BRL">-3233000</afya:DeferredTaxes>
    <afya:DeferredTaxes
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000319"
      unitRef="BRL">3233000</afya:DeferredTaxes>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000321"
      unitRef="BRL">768443000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000322"
      unitRef="BRL">648920000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000323"
      unitRef="BRL">405416000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000329"
      unitRef="BRL">768443000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000330"
      unitRef="BRL">648920000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000331"
      unitRef="BRL">405416000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000337"
      unitRef="BRL">752461000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000338"
      unitRef="BRL">631510000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000339"
      unitRef="BRL">386324000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000341"
      unitRef="BRL">15982000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000342"
      unitRef="BRL">17410000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000343"
      unitRef="BRL">19092000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <afya:ComprehensiveIncomeLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000345"
      unitRef="BRL">768443000</afya:ComprehensiveIncomeLoss>
    <afya:ComprehensiveIncomeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000346"
      unitRef="BRL">648920000</afya:ComprehensiveIncomeLoss>
    <afya:ComprehensiveIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000347"
      unitRef="BRL">405416000</afya:ComprehensiveIncomeLoss>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact000349"
      unitRef="BRLPShares">8.32</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000350"
      unitRef="BRLPShares">7.01</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000351"
      unitRef="BRLPShares">4.30</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact000353"
      unitRef="BRLPShares">8.24</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000354"
      unitRef="BRLPShares">6.93</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000355"
      unitRef="BRLPShares">4.27</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      id="Fact000357"
      unitRef="BRL">17000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000358"
      unitRef="BRL">2375344000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000359"
      unitRef="BRL">-304947000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000360"
      unitRef="BRL">123538000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000361"
      unitRef="BRL">1004886000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000362"
      unitRef="BRL">3198838000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000363"
      unitRef="BRL">51320000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000364"
      unitRef="BRL">3250158000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000370"
      unitRef="BRL">386324000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000371"
      unitRef="BRL">386324000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000372"
      unitRef="BRL">19092000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000373"
      unitRef="BRL">405416000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000379"
      unitRef="BRL">386324000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000380"
      unitRef="BRL">386324000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000381"
      unitRef="BRL">19092000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000382"
      unitRef="BRL">405416000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000387"
      unitRef="BRL">31535000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000389"
      unitRef="BRL">31535000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000391"
      unitRef="BRL">31535000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <afya:TreasurySharesRepurchase
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000395"
      unitRef="BRL">-12369000</afya:TreasurySharesRepurchase>
    <afya:TreasurySharesRepurchase
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000398"
      unitRef="BRL">-12369000</afya:TreasurySharesRepurchase>
    <afya:TreasurySharesRepurchase
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000400"
      unitRef="BRL">-12369000</afya:TreasurySharesRepurchase>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000406"
      unitRef="BRL">-10845000</afya:AcquisitionOfNoncontrollingInterests>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000407"
      unitRef="BRL">-10845000</afya:AcquisitionOfNoncontrollingInterests>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000408"
      unitRef="BRL">-10155000</afya:AcquisitionOfNoncontrollingInterests>
    <afya:AcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000409"
      unitRef="BRL">-21000000</afya:AcquisitionOfNoncontrollingInterests>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000412"
      unitRef="BRL">-7491000</afya:RestrictedSharesTransferredToExecutives>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000413"
      unitRef="BRL">5722000</afya:RestrictedSharesTransferredToExecutives>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000416"
      unitRef="BRL">-1769000</afya:RestrictedSharesTransferredToExecutives>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000418"
      unitRef="BRL">-1769000</afya:RestrictedSharesTransferredToExecutives>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000421"
      unitRef="BRL">-2653000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000422"
      unitRef="BRL">12444000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000425"
      unitRef="BRL">9791000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000427"
      unitRef="BRL">9791000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000435"
      unitRef="BRL">18750000</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000436"
      unitRef="BRL">18750000</ifrs-full:DividendsPaid>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      id="Fact000438"
      unitRef="BRL">17000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000439"
      unitRef="BRL">2365200000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000440"
      unitRef="BRL">-299150000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000441"
      unitRef="BRL">155073000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000442"
      unitRef="BRL">1380365000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000443"
      unitRef="BRL">3601505000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000444"
      unitRef="BRL">41507000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000445"
      unitRef="BRL">3643012000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000451"
      unitRef="BRL">631510000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000452"
      unitRef="BRL">631510000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000453"
      unitRef="BRL">17410000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000454"
      unitRef="BRL">648920000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000460"
      unitRef="BRL">631510000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000461"
      unitRef="BRL">631510000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000462"
      unitRef="BRL">17410000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000463"
      unitRef="BRL">648920000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000468"
      unitRef="BRL">32424000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000470"
      unitRef="BRL">32424000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000472"
      unitRef="BRL">32424000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000475"
      unitRef="BRL">-17672000</afya:RestrictedSharesTransferredToExecutives>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000476"
      unitRef="BRL">12812000</afya:RestrictedSharesTransferredToExecutives>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000479"
      unitRef="BRL">-4860000</afya:RestrictedSharesTransferredToExecutives>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000481"
      unitRef="BRL">-4860000</afya:RestrictedSharesTransferredToExecutives>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2024-01-012024-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000484"
      unitRef="BRL">-3007000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2024-01-012024-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000485"
      unitRef="BRL">12383000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2024-01-012024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000488"
      unitRef="BRL">9376000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000490"
      unitRef="BRL">9376000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <ifrs-full:DividendsPaid
      contextRef="From2024-01-012024-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000498"
      unitRef="BRL">18289000</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000499"
      unitRef="BRL">18289000</ifrs-full:DividendsPaid>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      id="Fact000501"
      unitRef="BRL">17000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000502"
      unitRef="BRL">2344521000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000503"
      unitRef="BRL">-273955000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000504"
      unitRef="BRL">187497000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000505"
      unitRef="BRL">2011875000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000506"
      unitRef="BRL">4269955000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000507"
      unitRef="BRL">40628000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000508"
      unitRef="BRL">4310583000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000514"
      unitRef="BRL">752461000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000515"
      unitRef="BRL">752461000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000516"
      unitRef="BRL">15982000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000517"
      unitRef="BRL">768443000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000523"
      unitRef="BRL">752461000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000524"
      unitRef="BRL">752461000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000525"
      unitRef="BRL">15982000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000526"
      unitRef="BRL">768443000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000531"
      unitRef="BRL">15318000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000533"
      unitRef="BRL">15318000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000535"
      unitRef="BRL">15318000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <afya:TreasurySharesRepurchase
      contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000539"
      unitRef="BRL">-77002000</afya:TreasurySharesRepurchase>
    <afya:TreasurySharesRepurchase
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000542"
      unitRef="BRL">-77002000</afya:TreasurySharesRepurchase>
    <afya:TreasurySharesRepurchase
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000544"
      unitRef="BRL">-77002000</afya:TreasurySharesRepurchase>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000547"
      unitRef="BRL">-17764000</afya:RestrictedSharesTransferredToExecutives>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000548"
      unitRef="BRL">12879000</afya:RestrictedSharesTransferredToExecutives>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000551"
      unitRef="BRL">-4885000</afya:RestrictedSharesTransferredToExecutives>
    <afya:RestrictedSharesTransferredToExecutives
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000553"
      unitRef="BRL">-4885000</afya:RestrictedSharesTransferredToExecutives>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2025-01-012025-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000556"
      unitRef="BRL">-6335000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2025-01-012025-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000557"
      unitRef="BRL">32068000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000560"
      unitRef="BRL">25733000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000562"
      unitRef="BRL">25733000</afya:TreasurySharesTransferredToExecutivesFromExerciseOfStockOptions>
    <ifrs-full:DividendsPaid
      contextRef="From2025-01-012025-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000568"
      unitRef="BRL">129784000</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid
      contextRef="From2025-01-012025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000569"
      unitRef="BRL">129784000</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid
      contextRef="From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000570"
      unitRef="BRL">17221000</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000571"
      unitRef="BRL">147005000</ifrs-full:DividendsPaid>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      id="Fact000573"
      unitRef="BRL">17000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      id="Fact000574"
      unitRef="BRL">2320422000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      id="Fact000575"
      unitRef="BRL">-306010000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      id="Fact000576"
      unitRef="BRL">202815000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      id="Fact000577"
      unitRef="BRL">2634552000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      id="Fact000578"
      unitRef="BRL">4851796000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      id="Fact000579"
      unitRef="BRL">39389000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000580"
      unitRef="BRL">4891185000</ifrs-full:Equity>
    <afya:IncomeLossBeforeIncomeTaxes
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000586"
      unitRef="BRL">-860945000</afya:IncomeLossBeforeIncomeTaxes>
    <afya:IncomeLossBeforeIncomeTaxes
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000587"
      unitRef="BRL">-676391000</afya:IncomeLossBeforeIncomeTaxes>
    <afya:IncomeLossBeforeIncomeTaxes
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000588"
      unitRef="BRL">-429582000</afya:IncomeLossBeforeIncomeTaxes>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000594"
      unitRef="BRL">373344000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000595"
      unitRef="BRL">333341000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000596"
      unitRef="BRL">289511000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <afya:WriteoffOfPropertyAndEquipment
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000598"
      unitRef="BRL">3062000</afya:WriteoffOfPropertyAndEquipment>
    <afya:WriteoffOfPropertyAndEquipment
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000599"
      unitRef="BRL">2539000</afya:WriteoffOfPropertyAndEquipment>
    <afya:WriteoffOfPropertyAndEquipment
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000600"
      unitRef="BRL">1910000</afya:WriteoffOfPropertyAndEquipment>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000602"
      unitRef="BRL">275000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000603"
      unitRef="BRL">244000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000604"
      unitRef="BRL">413000</afya:WriteoffOfIntangibleAssets>
    <afya:AllowanceForDoubtfulAccountsOfOpeartingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000606"
      unitRef="BRL">57090000</afya:AllowanceForDoubtfulAccountsOfOpeartingActivities>
    <afya:AllowanceForDoubtfulAccountsOfOpeartingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000607"
      unitRef="BRL">60894000</afya:AllowanceForDoubtfulAccountsOfOpeartingActivities>
    <afya:AllowanceForDoubtfulAccountsOfOpeartingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000608"
      unitRef="BRL">74552000</afya:AllowanceForDoubtfulAccountsOfOpeartingActivities>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000610"
      unitRef="BRL">15318000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000611"
      unitRef="BRL">32424000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000612"
      unitRef="BRL">31535000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000614"
      unitRef="BRL">1816000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000615"
      unitRef="BRL">7027000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000616"
      unitRef="BRL">681000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <afya:AccruedInterestOfOpeartingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000618"
      unitRef="BRL">316379000</afya:AccruedInterestOfOpeartingActivities>
    <afya:AccruedInterestOfOpeartingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000619"
      unitRef="BRL">254386000</afya:AccruedInterestOfOpeartingActivities>
    <afya:AccruedInterestOfOpeartingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000620"
      unitRef="BRL">285447000</afya:AccruedInterestOfOpeartingActivities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000622"
      unitRef="BRL">123067000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000623"
      unitRef="BRL">111966000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000624"
      unitRef="BRL">100849000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <afya:ShareOfProfitOfEquityaccountedInvesteeNetOfTax
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000626"
      unitRef="BRL">13916000</afya:ShareOfProfitOfEquityaccountedInvesteeNetOfTax>
    <afya:ShareOfProfitOfEquityaccountedInvesteeNetOfTax
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000627"
      unitRef="BRL">11737000</afya:ShareOfProfitOfEquityaccountedInvesteeNetOfTax>
    <afya:ShareOfProfitOfEquityaccountedInvesteeNetOfTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000628"
      unitRef="BRL">9495000</afya:ShareOfProfitOfEquityaccountedInvesteeNetOfTax>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000630"
      unitRef="BRL">23250000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000631"
      unitRef="BRL">9705000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000632"
      unitRef="BRL">-40044000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000638"
      unitRef="BRL">-177602000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000639"
      unitRef="BRL">-97449000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000640"
      unitRef="BRL">-131336000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <afya:IncreaseDecreaseInRecoverableTaxes
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000642"
      unitRef="BRL">10749000</afya:IncreaseDecreaseInRecoverableTaxes>
    <afya:IncreaseDecreaseInRecoverableTaxes
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000643"
      unitRef="BRL">-18107000</afya:IncreaseDecreaseInRecoverableTaxes>
    <afya:IncreaseDecreaseInRecoverableTaxes
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000644"
      unitRef="BRL">15353000</afya:IncreaseDecreaseInRecoverableTaxes>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000646"
      unitRef="BRL">-10798000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000647"
      unitRef="BRL">11220000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000648"
      unitRef="BRL">88427000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000650"
      unitRef="BRL">-4499000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000651"
      unitRef="BRL">18126000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000652"
      unitRef="BRL">24500000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000654"
      unitRef="BRL">-18109000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000655"
      unitRef="BRL">-14798000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000656"
      unitRef="BRL">3278000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000658"
      unitRef="BRL">-3013000</ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000659"
      unitRef="BRL">6329000</ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000660"
      unitRef="BRL">-17892000</ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000662"
      unitRef="BRL">9450000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000663"
      unitRef="BRL">8414000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000664"
      unitRef="BRL">31525000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <afya:IncreaseDecreaseInPaymentsOfLegalProceedings
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000666"
      unitRef="BRL">6873000</afya:IncreaseDecreaseInPaymentsOfLegalProceedings>
    <afya:IncreaseDecreaseInPaymentsOfLegalProceedings
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000667"
      unitRef="BRL">4637000</afya:IncreaseDecreaseInPaymentsOfLegalProceedings>
    <afya:IncreaseDecreaseInPaymentsOfLegalProceedings
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000668"
      unitRef="BRL">16781000</afya:IncreaseDecreaseInPaymentsOfLegalProceedings>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000670"
      unitRef="BRL">9196000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000671"
      unitRef="BRL">30687000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000672"
      unitRef="BRL">-42542000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000674"
      unitRef="BRL">1547633000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000675"
      unitRef="BRL">1453179000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000676"
      unitRef="BRL">1088767000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000678"
      unitRef="BRL">16046000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000679"
      unitRef="BRL">20520000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000680"
      unitRef="BRL">45144000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000682"
      unitRef="BRL">1531587000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000683"
      unitRef="BRL">1432659000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000684"
      unitRef="BRL">1043623000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000690"
      unitRef="BRL">166014000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000691"
      unitRef="BRL">136924000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000692"
      unitRef="BRL">118435000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000694"
      unitRef="BRL">197997000</afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities>
    <afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000695"
      unitRef="BRL">255691000</afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities>
    <afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000696"
      unitRef="BRL">126993000</afya:PurchaseOfIntangibleAssetClassifiedAsInvestingActivities>
    <ifrs-full:DividendsReceived
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000698"
      unitRef="BRL">15553000</ifrs-full:DividendsReceived>
    <ifrs-full:DividendsReceived
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000699"
      unitRef="BRL">7501000</ifrs-full:DividendsReceived>
    <ifrs-full:DividendsReceived
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000700"
      unitRef="BRL">9900000</ifrs-full:DividendsReceived>
    <afya:PurchaseOfAcquisitionOfNoncontrollingInterests
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000704"
      unitRef="BRL">21000000</afya:PurchaseOfAcquisitionOfNoncontrollingInterests>
    <ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000706"
      unitRef="BRL">144076000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000707"
      unitRef="BRL">627568000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000708"
      unitRef="BRL">815005000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
    <afya:PaymentsOfInterest
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000710"
      unitRef="BRL">14536000</afya:PaymentsOfInterest>
    <afya:PaymentsOfInterest
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000711"
      unitRef="BRL">78931000</afya:PaymentsOfInterest>
    <afya:PaymentsOfInterest
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000712"
      unitRef="BRL">71518000</afya:PaymentsOfInterest>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000714"
      unitRef="BRL">-507070000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000715"
      unitRef="BRL">-1091613000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000716"
      unitRef="BRL">-1143051000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000722"
      unitRef="BRL">1624911000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000723"
      unitRef="BRL">128696000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000724"
      unitRef="BRL">112630000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <afya:RepaymentsOfInterest
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000726"
      unitRef="BRL">309337000</afya:RepaymentsOfInterest>
    <afya:RepaymentsOfInterest
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000727"
      unitRef="BRL">177192000</afya:RepaymentsOfInterest>
    <afya:RepaymentsOfInterest
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000728"
      unitRef="BRL">175889000</afya:RepaymentsOfInterest>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000730"
      unitRef="BRL">1494881000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000731"
      unitRef="BRL">491593000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000732"
      unitRef="BRL">5288000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000734"
      unitRef="BRL">49411000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000735"
      unitRef="BRL">41221000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000736"
      unitRef="BRL">31473000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000738"
      unitRef="BRL">121475000</afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities>
    <afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000739"
      unitRef="BRL">111605000</afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities>
    <afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000740"
      unitRef="BRL">103911000</afya:PaymentsOfInterestOnLeaseLiabilitiesClassifiedAsFinancingActivities>
    <afya:TreasurySharesRepurchase
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000742"
      unitRef="BRL">-77002000</afya:TreasurySharesRepurchase>
    <afya:TreasurySharesRepurchase
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000744"
      unitRef="BRL">-12369000</afya:TreasurySharesRepurchase>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000746"
      unitRef="BRL">25733000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000747"
      unitRef="BRL">9376000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000748"
      unitRef="BRL">9791000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:DividendsPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000750"
      unitRef="BRL">146813000</ifrs-full:DividendsPaidClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000751"
      unitRef="BRL">18289000</ifrs-full:DividendsPaidClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000752"
      unitRef="BRL">18750000</ifrs-full:DividendsPaidClassifiedAsFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000754"
      unitRef="BRL">-808335000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000755"
      unitRef="BRL">23966000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000756"
      unitRef="BRL">-439943000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000758"
      unitRef="BRL">-1816000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000759"
      unitRef="BRL">-7027000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000760"
      unitRef="BRL">-681000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact000762"
      unitRef="BRL">214366000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact000763"
      unitRef="BRL">357985000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact000764"
      unitRef="BRL">-540052000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000766"
      unitRef="BRL">911015000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000767"
      unitRef="BRL">553030000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000768"
      unitRef="BRL">1093082000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact000770"
      unitRef="BRL">1125381000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact000771"
      unitRef="BRL">911015000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000772"
      unitRef="BRL">553030000</ifrs-full:RestrictedCashAndCashEquivalents>
    <afya:DisclosureOfGeneralInformationAboutFinancialStatementExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000774">&lt;p id="xdx_808_ecustom--DisclosureOfGeneralInformationAboutFinancialStatementExplanatory_znzvRxEeyWbg" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="a_0005"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;1&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82E_zLcNmNOSZjee"&gt;Corporate information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0pt 0pt 0pt 3%"&gt;Afya Limited (&#x201c;Afya&#x201d;), collectively with its subsidiaries referred to as the
&#x201c;Company&#x201d;, is a holding company incorporated under the laws of the Cayman Islands on March 22, 2019. Afya completed its initial
public offering (IPO) on July 19, 2019, and its shares are listed on the Nasdaq under the symbol &#x201c;AFYA&#x201d;. The Company&#x2019;s
ultimate parent company is Bertelsmann SE&amp;amp; Co. KGaA (&#x201c;Bertelsmann&#x201d;).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0pt 0pt 0pt 3%"&gt;The Company is formed by a network of higher education and post-graduate institutions,
focused on medical schools, under the regulations of the Ministry of Education (&#x201c;MEC&#x201d;). The Company also provides other educational
services that comprise the development and sale of electronically distributed educational courses on medicine science and soft skills
educational content. The Company also offers solutions to empower the physicians in their daily routine including supporting clinic decisions
through mobile app subscription, delivering practice management tools through a SaaS (Software as a Service) model and supporting the
patient-physician relationship.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0pt 0pt 0pt 3%; color: #C00000"&gt;&lt;span style="text-decoration: underline"&gt;Acquisition in 2025&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On May 7, 2025, Afya Participa&#xe7;&#xf5;es S.A. (&#x201c;Afya Brazil&#x201d;) acquired
&lt;span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pip0_dp_c20250507__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeMasterclassLtdaMember_z0zy4jJ7h9R4" title="Acquired percenatge"&gt;100&lt;/span&gt;% of the total share capital of Faculdade Masterclass Ltda. (&#x201c;FUNIC&#x201d;), located in the city of Contagem, a city in the metropolitan
area of Belo Horizonte, the capital of the State of Minas Gerais. The acquisition contributed 60 medical school seats to Afya. FUNIC started
its operations in the second semester of 2025.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfAcquiree_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeMasterclassLtdaMember_zieAbuTcqVgj" title="Acquired purchase price"&gt;The aggregate purchase price is R$100,000. The price and payment conditions are: (i) R$60,000,
net of the estimated Net Debt, paid in cash on May 7, 2025 and presented in &#x201c;Acquisition of assets and subsidiaries, net of cash
acquired&#x201d; in the consolidated statement of cash flows; and (ii) R$40,000 payable in three equal annual installments adjusted by
100% of the Brazilian interbank interest rate (&#x201c;CDI&#x201d;) - see Note 22. FUNIC&#x2019;s installments are not contingent consideration
and therefore are not included in the fair value disclosure in Note 2.3(b). The time value on the deferred installments is recognized
as finance expense using the effective interest rate method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The acquisition includes a potential additional payment for up to 60 medical school seats,
contingent upon regulatory approval. If approved by MEC within 36 months from the closing date, an additional payment of R$&lt;span id="xdx_90E_ecustom--AdditionalPaymentToShareholder_pn3n3_c20250506__20250507_zSlxzI1UiYei" title="Additional payment to shareholders"&gt;1,000&lt;/span&gt; per approved
seat will become payable. Afya Brazil does not have a legal or constructive obligation at the acquisition date or at any reporting date.
Upon approval, the additional seats will give rise to additional licenses, which will be recognized and measured at that time, together
with the recognition of the related liability.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Management assessed the aspects of such transaction in accordance with IFRS 3 - Business
Combinations and applied the optional &#x2018;concentration test&#x2019;, designed to simplify the evaluation of whether an acquired set
of activities and assets is not a business. Since substantially all of the fair value of the gross assets acquired is concentrated in
a single identifiable asset, Management concluded that the transaction does not fall under the definition of a business, but an acquisition
of assets, which were measured on initial recognition at cost allocated to identifiable assets and liabilities on a relative fair value
basis.&lt;/p&gt;








&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_pn3n3_zcYr6u6Ajd7e" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Corporate information (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BE_zb9ZC67chhye" style="display: none"&gt;Schedule of identifiable assets and liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 83%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Cash and cash equivalents&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zMBwY30cG01d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash and equivalents"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Property and equipment&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zKzqNGtR8Svb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Property and equipment"&gt;2,683&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Intangible assets - Licenses with indefinite useful life&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zFDVFctUyYC" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Intangible assets"&gt;99,628&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zTRAGlXx52D" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;102,314&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Trade payables&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zghtsN3MIQGj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables"&gt;71&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LoansAndFinancingAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zUSmDaDYT1n" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing"&gt;2,243&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zTD15KcIWIZj" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities recognised as of acquisition date"&gt;&lt;b&gt;2,314&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Total net assets&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zb7lxY6QyGvh" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total net assets"&gt;&lt;b&gt;100,000&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The valuation techniques used to licenses with indefinite useful life, which is the most
representative asset acquired, were the With-and-without method, which consists of estimating the fair value of an asset by the difference
between the value of this asset in two scenarios: a scenario considering the existence of the asset in question and another considering
its non-existence.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;span style="text-decoration: underline"&gt;Acquisition in 2024&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On July 1, 2024, Afya Brazil acquired Unidom Participa&#xe7;&#xf5;es S.A. (&#x201c;Unidom&#x201d;).
Unidom is a post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate
programs in medicine and health, as well as other courses. It encompasses &#x201c;Unidompedro&#x201d; and &#x201c;Faculdade Dom Luiz&#x201d;,
both located in the State of Bahia with operations in the cities of Salvador, Luis Eduardo Magalh&#xe3;es, Barreiras and Ribeira do
Pombal. See Note 4.&lt;/p&gt;

</afya:DisclosureOfGeneralInformationAboutFinancialStatementExplanatory>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2025-05-07_custom_FaculdadeMasterclassLtdaMember"
      decimals="INF"
      id="Fact000776"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree
      contextRef="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaMember"
      id="Fact000778">The aggregate purchase price is R$100,000. The price and payment conditions are: (i) R$60,000,
net of the estimated Net Debt, paid in cash on May 7, 2025 and presented in &#x201c;Acquisition of assets and subsidiaries, net of cash
acquired&#x201d; in the consolidated statement of cash flows; and (ii) R$40,000 payable in three equal annual installments adjusted by
100% of the Brazilian interbank interest rate (&#x201c;CDI&#x201d;) - see Note 22. FUNIC&#x2019;s installments are not contingent consideration
and therefore are not included in the fair value disclosure in Note 2.3(b). The time value on the deferred installments is recognized
as finance expense using the effective interest rate method.</ifrs-full:DescriptionOfAcquiree>
    <afya:AdditionalPaymentToShareholder
      contextRef="From2025-05-062025-05-07"
      decimals="-3"
      id="Fact000780"
      unitRef="BRL">1000000</afya:AdditionalPaymentToShareholder>
    <afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000784">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_pn3n3_zcYr6u6Ajd7e" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Corporate information (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BE_zb9ZC67chhye" style="display: none"&gt;Schedule of identifiable assets and liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 83%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Cash and cash equivalents&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zMBwY30cG01d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash and equivalents"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Property and equipment&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zKzqNGtR8Svb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Property and equipment"&gt;2,683&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Intangible assets - Licenses with indefinite useful life&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zFDVFctUyYC" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Intangible assets"&gt;99,628&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zTRAGlXx52D" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;102,314&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Trade payables&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zghtsN3MIQGj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables"&gt;71&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LoansAndFinancingAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zUSmDaDYT1n" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing"&gt;2,243&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zTD15KcIWIZj" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities recognised as of acquisition date"&gt;&lt;b&gt;2,314&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Total net assets&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesS.A.Member_zb7lxY6QyGvh" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total net assets"&gt;&lt;b&gt;100,000&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member"
      decimals="-3"
      id="Fact000786"
      unitRef="BRL">3000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member"
      decimals="-3"
      id="Fact000788"
      unitRef="BRL">2683000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member"
      decimals="-3"
      id="Fact000790"
      unitRef="BRL">99628000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member"
      decimals="-3"
      id="Fact000792"
      unitRef="BRL">102314000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member"
      decimals="-3"
      id="Fact000794"
      unitRef="BRL">71000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <afya:LoansAndFinancingAsOfAcquisitionDate
      contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member"
      decimals="-3"
      id="Fact000796"
      unitRef="BRL">2243000</afya:LoansAndFinancingAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member"
      decimals="-3"
      id="Fact000798"
      unitRef="BRL">2314000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2025-05-07_custom_AfyaParticipacoesS.A.Member"
      decimals="-3"
      id="Fact000800"
      unitRef="BRL">100000000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <afya:DisclosureOfMaterialAccountingPoliciesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact000802">&lt;p id="xdx_803_ecustom--DisclosureOfMaterialAccountingPoliciesExplanatory_zGjNOx92TI29" style="font: 10.5pt Nunito Sans; margin: 0; color: #C00000"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;2&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_822_zfp2L1I6Lw4j"&gt;Material accounting policies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;2.1 Basis of preparation&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;These consolidated financial statements have been prepared in accordance with IFRS Accounting
Standards as issued by the International Accounting Standards Board (IFRS Accounting Standards).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;In preparing these consolidated financial statements, Management has assessed the Company&#x2019;s
ability to continue as a going concern and concluded that the going concern basis of accounting is appropriate.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;These consolidated financial statements have been prepared on a historical cost
basis, except for the following items measured at fair value: (i) certain financial instruments - including the contingent consideration
payable to selling shareholders - measured at fair value through profit or loss (Notes 2.3(b) and 12.2.3); (ii) the initial recognition
of identifiable assets and liabilities acquired in business combinations, which are measured at fair value at the acquisition date (Note
4); and (iii) equity-settled share-based payment awards, which are measured at grant-date fair value (Note 14). Disclosures about fair
value hierarchy and valuation techniques for recurring measurements are provided in Note 2.3(b).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Substantially all operations are conducted in Brazil. Accordingly, Management determined
the functional currency of the Company to be the Brazilian real (&#x201c;R$&#x201d;). These   consolidated financial statements
are presented in R$, and amounts are rounded to the nearest thousand, unless otherwise stated.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company improved the presentation of some items in the consolidated statement of income
and other comprehensive income for the current year, by segregating the &#x2018;Allowance for expected credit losses&#x2019; expenses from
the &#x2018;Selling, general and administrative expenses&#x2019; and the &#x2018;Other income&#x2019; and &#x2018;Other expenses&#x2019; from
the &#x2018;Other income (expenses), net&#x2019;. To ensure comparability, the Company reflected these changes in the previous years.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;These  consolidated financial statements were authorized for issue by the Board
of Directors on March 12, 2026.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;2.2 Basis of consolidation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The table below presents a list of the Company&#x2019;s subsidiaries and associate:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;






&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zcj6lFUACLga" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B5_zynWLHfQVvif" style="display: none"&gt;Schedule of company&#x2019;s subsidiaries and associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Direct and indirect interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 260px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 165px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Main activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 106px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Investment type&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 94px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 95px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Afya Participa&#xe7;&#xf5;es S.A. (&#x201c;Afya Brazil&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zv5MTqPDekz" title="Principal activities"&gt;Holding&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zPQvVIsNbXAl" title="Location"&gt;Nova Lima - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zPhxWSLNNFYb" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z3dUyGsNEGAj" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zykxwE9jljwb" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Instituto Tocantinense Presidente Ant&#xf4;nio Carlos Porto S.A. - (&#x201c;ITPAC Porto&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zN6FDhFYiu8g" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_z6JBWPXjcXY9" title="Location"&gt;Porto Nacional - TO&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zHBIi1cxo8R2" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zIegwX923u7h" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_z9fDNnTtrmke" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Instituto Tocantinense Presidente Ant&#xf4;nio Carlos S.A. - (&#x201c;ITPAC Aragua&#xed;na&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zeVY7TuruoTj" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zmJbPAAr1cw2" title="Location"&gt;Aragua&#xed;na - TO&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zDNrwBhUTADl" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zBxnAE9RObwa" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_z7lLtAtqjHJ5" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Uni&#xe3;o Educacional do Vale do A&#xe7;o S.A. - (&#x201c;UNIVA&#xc7;O&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zb1MPrkWtBj7" title="Principal activities"&gt;Medicine undergraduate degree program&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zkBKk14iQtJ3" title="Location"&gt;Ipatinga - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_ztAaXWaBOmXk" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zq7PR9YcZf4l" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z3hzjt4buVzc" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#x201c;IPTAN&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zKEFurG6PIJk" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_z34RwQCvWmkg" title="Location"&gt;S&#xe3;o Jo&#xe3;o Del Rei - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zC6MdwGisMA3" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zYYLghJr7UPh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_z3Vs4M6uzCu8" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Instituto de Educa&#xe7;&#xe3;o Superior do Vale do Parna&#xed;ba S.A. (&#x201c;IESVAP&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zxk0We0LsPTa" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zIGxc588gUV3" title="Location"&gt;Parna&#xed;ba - PI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zP79vi4r5u25" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zLKyjBMsY4q" title="Direct and indirect interest of subsidiary"&gt;80&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zqRuGSlSR3c5" title="Direct and indirect interest of subsidiary"&gt;80&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Centro de Ci&#xea;ncias em Sa&#xfa;de de Itajub&#xe1; S.A. (&#x201c;CCSI&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_znpmsbq0xH48" title="Principal activities"&gt;Medicine undergraduate degree program&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zRwHby9YAzig" title="Location"&gt;Itajub&#xe1; - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z4hzcx6IE5V5" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zQRvYSVGO8l1" title="Direct and indirect interest of subsidiary"&gt;75&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zqvLSDfXd139" title="Direct and indirect interest of subsidiary"&gt;75&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Instituto de Ensino Superior do Piau&#xed; S.A. (&#x201c;IESP&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zj3jTfZwlLji" title="Principal activities"&gt;Undergraduate and graduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_ztDnmW1MZkv1" title="Location"&gt;Teresina - PI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zdGWxYEdRXe1" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_znSqGAUxHmSh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zSkFjQ6kWxcj" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;FADEP - Faculdade Educacional de Pato Branco Ltda. (&#x201c;FADEP&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zHlgWNtXlL1i" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_z56ixa0OF8z1" title="Location"&gt;Pato Branco - PR&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zngY2U4fEaAc" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zSdYtCrll9g3" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zmiMsMyM8Z15" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Instituto Educacional Santo Agostinho S.A. (&#x201c;FASA&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zEGxfStAXTxh" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zj2TQxkuupd1" title="Location"&gt;Montes Claros - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zItnb4CAdbX7" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zyjNud4yCVT9" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zjp7cIlEofq4" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Instituto Paraense de Educa&#xe7;&#xe3;o e Cultura Ltda. (&#x201c;IPEC&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zdUIpIjzmRrf" title="Principal activities"&gt;Medicine undergraduate degree program&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_900_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_z6DdHhd4Xmza" title="Location"&gt;Marab&#xe1; - PA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zr87jn2JTCXc" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zcjdzX044wOl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zqUtS4RqBPee" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Sociedade Universit&#xe1;ria Redentor S.A. (&#x201c;UniRedentor&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_za0Q6jdh9pak" title="Principal activities"&gt;Undergraduate and graduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z6VCJPMUsi1f" title="Location"&gt;Itaperuna - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zD4jfTDq71j6" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zIVijpv6VO43" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z07aHHXjuuVe" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Centro de Ensino S&#xe3;o Lucas Ltda. (&#x201c;UniSL&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zIhMyuuAKua2" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zhZhAnIDU9E1" title="Location"&gt;Porto Velho - RO&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zQRwvub5eTIa" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zgs2o9pY6Cmh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zlDyTrQuIJg4" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Sociedade de Educa&#xe7;&#xe3;o, Cultura e Tecnologia da Amaz&#xf4;nia S.A. - (&#x201c;FESAR&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zcHSROCuWJM7" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zkf4DTOFkzh" title="Location"&gt;Reden&#xe7;&#xe3;o - PA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zMBjyVKo2kyl" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zOZfqEkf5plj" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zVx33b2Z4SE5" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Centro Superior de Ci&#xea;ncias da Sa&#xfa;de Ltda. (&#x201c;FCMPB&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zPJljvKsTKY3" title="Principal activities"&gt;Medicine undergraduate degree program&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_ztgmy5KQZoL4" title="Location"&gt;Jo&#xe3;o Pessoa - PB&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zixh7etHMAs6" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zhDdMICkhOpj" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zZUHbrDe94Qb" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;iClinic Desenvolvimento de Software Ltda. (&#x201c;iClinic&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zKFuIzZDoVdb" title="Principal activities"&gt;Electronic Medical Record, Clinical Management System&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zYO3zEnLze0d" title="Location"&gt;Ribeir&#xe3;o Preto - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zKMoyotrxxZc" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zq9uudZ4Wu6a" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Medicinae Solutions S.A. (&#x201c;Medicinae&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z1SofMPFPlO2" title="Principal activities"&gt;Healthcare payments and financial services&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zMOTdOw90wve" title="Location"&gt;Rio de Janeiro - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z4wGxD0Is5yf" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zaNYs0QSrnjl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Medical Harbour Aparelhos M&#xe9;dico Hospitalares e Servi&#xe7;os em Tecnologia Ltda. (&#x201c;Medical Harbour&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zo5yxSCK4fcb" title="Principal activities"&gt;Educational health and medical imaging&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_z2EEbHDK43ib" title="Location"&gt;Florian&#xf3;polis - SC&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zXJnbFmJVJmf" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_ztoRoXecM1yk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zUZr9aZ30Ma9" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Cliquefarma Drogarias Online Ltda. (&#x201c;Cliquefarma&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_z2RckVYleRaf" title="Principal activities"&gt;Online platform&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zzCRFheNCFXj" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zf65vluVhRD7" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zYEwq8HrPsHl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Shosp Tecnologia da Informa&#xe7;&#xe3;o Ltda. (&#x201c;Shosp&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zh0RFfKTO0h" title="Principal activities"&gt;Electronic Medical Record, Clinical Management System&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zZWb9ilnXxli" title="Location"&gt;Rio de Janeiro - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zqPVdXTXS105" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zT1Zp6mEFvBd" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Sociedade Padr&#xe3;o de Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;UnifipMoc&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_z6QpELqIicFk" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zKBF85Ceu6yg" title="Location"&gt;Montes Claros - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zsVdwsb7WRs7" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zDX65F3q2SW7" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zkeolXEixvxa" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Companhia Nilza Cordeiro Herdy de Educa&#xe7;&#xe3;o e Cultura (&#x201c;Unigranrio&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zJnkuIR4kAHf" title="Principal activities"&gt;Undergraduate and graduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zXNJn29mYOTi" title="Location"&gt;Duque de Caxias - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zSWG75kMUPD5" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zdOLXBhYnt9c" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_ztanF7UNSRe8" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;RX PRO Solu&#xe7;&#xf5;es de Tecnologia Ltda. (&#x201c;RX PRO&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z6RLl3YkQS22" title="Principal activities"&gt;Marketing for pharmaceutical industry&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zBQeFbmIbl35" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zrtDD8tW8W01" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z47hLNellYa9" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Quasar Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#x201c;Glic&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zPT1tFS9JPw2" title="Principal activities"&gt;Patient physician relationship&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zHZNuhCaxm9i" title="Location"&gt;Barueri - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zcLRpP7Rhg04" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zTW4DPdvqT39" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#x201c;DelRey&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zBVWD5GCo51f" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zQDYBK2PrV13" title="Location"&gt;Macei&#xf3; - AL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zJ6HBLFonPJg" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zNsgE3mViXsd" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zhodVdvKA1zj" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Unidom Participa&#xe7;&#xf5;es S.A. (&#x201c;Unidom&#x201d;) (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_z2lVPdfMwtl3" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_zpQPon9Ub1i3" title="Location"&gt;Salvador - BA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_za1ZaEX8hrqh" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_zh9cTJCFCe95" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Institui&#xe7;&#xe3;o Baiana de Ensino Superior Ltda. (&#x201c;IBES&#x201d;) (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_z1Saz06WwUnl" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zICkxiPWlCa1" title="Location"&gt;Salvador - BA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zxUSj3cpH6pg" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zuMSslRL2ALl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zH5T8zK1k4Cj" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;SESSA - Sociedade de Educa&#xe7;&#xe3;o Superior do Semi-&#xc1;rido Ltda. (&#x201c;SESSA&#x201d;) (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zv50ehHClrB7" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zpgyLpqvA3Jf" title="Location"&gt;Ribeira de Pombal - BA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zHSATSvTBwKi" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zMQpJh7s9Wka" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zsoKyXtcwfZ2" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Faculdade Masterclass Ltda. (&#x201c;FUNIC&#x201d;) (iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zJLSGdjCKky1" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_ziHX1c9NEdm1" title="Location"&gt;Contagem - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zNS2Ibga4wN3" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zWJegr0aqI2c" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Uni&#xe3;o Educacional do Planalto Central S.A. (&#x201c;UEPC&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zAfk9pP4wRYg" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zVDZlkJfGQFf" title="Location"&gt;Bras&#xed;lia - DF&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zRtK0fl0ttEa" title="Investment type"&gt;Associate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_z9brl7z0M5E4" title="Direct and indirect interest of subsidiary"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zBQdakn8im8b" title="Direct and indirect interest of subsidiary"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="background-color: white"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="background-color: white"&gt;Unidom was merged with Afya Brazil on January 1, 2025.
As a result, from this date on, Afya Brazil directly controls the Unidom&#x2019;s subsidiaries IBES and SESSA.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="background-color: white"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="background-color: white"&gt;Cliquefarma, RX PRO and Glic were merged with Afya Brazil
in August 2025; iClinic, Medicinae and Shosp were merged with Afya Brazil in October 2025.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="color: #212121; background-color: white"&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;See Note 1.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AE_zzPc0ZzQkUV2" style="font: 10.5pt Nunito Sans; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;The financial information of the
subsidiaries acquired is included in the Company&#x2019;s consolidated financial statements beginning on the respective acquisition dates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;The Company consolidates the financial
information for all entities it controls. Control is achieved when the Company is exposed to, or has rights, to variable returns from
its involvement with the investee and has the ability to affect those returns through its power over the investee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;Consolidation of a subsidiary begins
when the Company obtains control over the subsidiary and it ceases when the Company loses control of the subsidiary. Assets, liabilities,
income and expenses of a subsidiary acquired or disposed of during the year are included in the consolidated financial statements from
the date the Company gains control until the date the Company ceases to control the subsidiary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;All intra-group assets and liabilities,
equity, income, expenses and cash flows relating to transactions are eliminated in full on consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;A change in the ownership interest
of a subsidiary, without a change of control, is accounted for as an equity transaction. If the Company loses control over a subsidiary,
it derecognizes the related assets (including goodwill), liabilities, non-controlling interest and other components of equity, while any
resulting gain or loss is recognized in the consolidated statement of income and other comprehensive income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;Non-controlling interests in the
results and equity of subsidiaries are shown separately in the consolidated statement of financial position, consolidated statement of
income and other comprehensive income and consolidated statement of changes in equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;2.3 Summary of material accounting policies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;This note provides a description of the material accounting policies adopted in
the preparation of these consolidated financial statements in addition to other policies that have been disclosed in other notes to these
consolidated financial statements. These policies have been consistently applied to all periods presented.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify"&gt;The accounting policies have been consistently applied to all consolidated
companies.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zhSI7K0euRz1" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;a) &lt;span id="xdx_866_zkCO45uQlw6f"&gt;Business combinations and goodwill&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Business combinations are accounted for using the acquisition method. The cost of an acquisition
is measured as the aggregate of the consideration transferred, which is measured at acquisition date fair value, and the amount of any
non-controlling interests in the acquiree. For each business combination, the Company elects whether to measure the non-controlling interests
in the acquiree at fair value or at the proportionate share of the acquiree&#x2019;s identifiable net assets. Acquisition-related costs
are expensed as incurred and included in selling, general and administrative expenses.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company determines that it has acquired a business when the acquired set of activities
and assets include an input and a substantive process that together significantly contribute to the ability to create outputs. The acquired
process is considered substantive if it is critical to the ability to continue producing outputs, and the inputs acquired include an organized
workforce with the necessary skills, knowledge, or experience to perform that process or it significantly contributes to the ability to
continue producing outputs and is considered unique or scarce or cannot be replaced without significant cost, effort, or delay in the
ability to continue producing outputs.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Any contingent consideration to be transferred by the acquirer will be recognized at fair
value at the acquisition date. Contingent consideration classified as equity is not remeasured and its subsequent settlement is accounted
for within equity. Contingent consideration classified as an asset or liability that is a financial instrument is measured at fair value
with the changes in fair value recognized in the consolidated statement of income and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Goodwill is initially measured at cost (being the excess of the aggregate of the consideration
transferred and the amount recognized for non-controlling interests and any previous interest held over the net identifiable assets acquired
and liabilities assumed). If the fair value of the net assets acquired is in excess of the aggregate consideration transferred, the Company
re-assesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed and reviews the procedures
used to measure the amounts to be recognized at the acquisition date. If the reassessment still results in an excess of the fair value
of net assets acquired over the aggregate consideration transferred, then the gain is recognized in the consolidated statement of income
and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;After initial recognition, goodwill is measured at cost less any accumulated impairment
losses. For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated to
each of the Company&#x2019;s cash-generating units that are expected to benefit from the combination.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Where goodwill has been allocated to a cash-generating unit (&#x201c;CGU&#x201d;) and part
of the operation within that unit is disposed of, the goodwill associated with the disposed operation is included in the carrying amount
of the operation when determining the gain or loss on disposal. Goodwill disposed in these circumstances is measured based on the relative
values of the disposed operation and the portion of the cash-generating unit retained.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;p id="xdx_845_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zarwdTpqf083" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;b) &lt;span id="xdx_867_zq3H1xtNmHMb"&gt;Fair value measurement&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Fair value is the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption
that the transaction to sell the asset or transfer the liability takes place either: (i) in the principal market for the asset or liability;
or (ii) in the absence of a principal market, in the most advantageous market for the asset or liability.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The principal or the most advantageous market must be accessible by the Company.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The fair value of an asset or a liability is measured using the assumptions that market
participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.&lt;/p&gt;

&lt;p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;A fair value measurement of a non-financial asset takes into account a market participant's
ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that
would use the asset in its highest and best use.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company uses valuation techniques that are appropriate in the circumstances and for
which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of
unobservable inputs.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;All assets and liabilities for which fair value is measured or disclosed in these
consolidated financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input
that is significant to the fair value measurement as a whole:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;Level 1 - Quoted (unadjusted) market prices in active markets
for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;Level 2 - Valuation techniques for which the lowest level input
that is significant to the fair value measurement is directly or indirectly observable.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;Level 3 - Valuation techniques for which the lowest level input
that is significant to the fair value measurement is unobservable.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The following table shows the evaluation techniques used in measuring fair values for financial
instruments classified at level 2 and 3, as well as the significant unobservable inputs used.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock_z9Lfc0gZO6z4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B4_zeQBW9jYaF54" style="display: none"&gt;Schedule of fair values for financial
instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Type&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Significant unobservable inputs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Inter-relationship between significant unobservable inputs and fair value measurement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Level 2 - Stock options and Restricted stock units (Note 14)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zbWrtvEd8R68" title="Valuation technique"&gt;Binomial model: The fair value is estimated by utilizing a simulation of possible future share prices, applying regression analysis, as well as comparing at each potential exercise date the discounted risk-neutral expectation of the option payoff if not exercised, and the relevant exercise price.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&#x2022; Expected volatility (December 31, 2025: &lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_ztMnLOO8bvX1" title="Expected volatility"&gt;24&lt;/span&gt;% to &lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0zfhCwyYU7e" title="Expected volatility"&gt;44&lt;/span&gt;%; December 31, 2024: &lt;span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvl0bVSRFkng" title="Expected volatility"&gt;32&lt;/span&gt;% to &lt;span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEOHbmVlM4Rg" title="Expected volatility"&gt;45&lt;/span&gt;%).&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p id="xdx_982_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zrOsTuY8y0Lh" style="font: 7.5pt Nunito Sans; margin: 0" title="Inter-relationship between significant unobservable inputs and fair value measurement"&gt;The estimated fair value&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;would increase (decrease) if the expected volatility were higher (lower).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Level 3 - Contingent consideration (Accounts payable to selling shareholders - Note 12.2.3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zxIHtVQ8f3Fl" title="Valuation technique"&gt;Probability-weighted cash flows: This valuation technique considers the probability-weighted expectation of future cash flow.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt"&gt;&#x2022; Expected cash flows (December 31, 2025: R$&lt;span id="xdx_907_ecustom--ExpectedCashFlows_pn3n3_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zwL4LiFAutuh" title="Expected cash flows"&gt;325,150&lt;/span&gt;;
    December 31, 2024: R$&lt;span id="xdx_908_ecustom--ExpectedCashFlows_pn3n3_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zLTVYXh0aIzi" title="Expected cash flows"&gt;314,953&lt;/span&gt;).&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt"&gt;&#x2022; Probability of disbursement (December 31, 2025 and
    2024: &lt;span id="xdx_908_ecustom--ProbabilityOfDisbursement_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zJOYzkxwFFK5" title="Probability of disbursement"&gt;&lt;span id="xdx_903_ecustom--ProbabilityOfDisbursement_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z0jpMqr4Ciue" title="Probability of disbursement"&gt;100&lt;/span&gt;&lt;/span&gt;%).&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p id="xdx_985_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zPlc1vzSNOy9" style="font: 7.5pt Nunito Sans; margin: 0" title="Inter-relationship between significant unobservable inputs and fair value measurement"&gt;The estimated fair value would increase (decrease) if:&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt"&gt;&#x2022; the expected cash flows were higher (lower); or&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt"&gt;&#x2022; the probability rate were lower (higher).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A9_zplE3eA2TDq8" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The valuation model for other financial liabilities not measured at fair value considers
the present value of expected payments, discounted using a risk-adjusted discount rate.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;For assets and liabilities that are recognized in these  consolidated financial
statements at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy
by re-assessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end
of each reporting period.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;At each reporting date, the Company analyzes the movements in the values of assets and
liabilities which are required to be remeasured or reassessed as per the Company&#x2019;s accounting policies. For this analysis, the
Company verifies the major inputs applied in the latest valuation by agreeing the information in the valuation computation to contracts
and other relevant documents.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company also compares the change in the fair value of each asset and liability with
relevant external sources to determine whether the change is reasonable.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;For the purpose of fair value disclosures, the Company has determined classes of assets
and liabilities on the basis of the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy,
as explained above.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_zNMF30lxdisd" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;c) &lt;span id="xdx_869_zpbtmZlgwRZe"&gt;Financial instruments - initial recognition and measurement&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"&gt;&lt;i&gt;Recognition and initial measurement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;Financial assets and financial liabilities are initially recognized when the
Company becomes a party to the contractual provisions of the instrument.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;A financial asset (unless it is a trade receivable without a significant financing
component) or financial liability is initially measured at fair value plus or minus, for an item not at fair value through profit or loss
(&#x201c;FVTPL&#x201d;), transaction costs that are directly attributable to its acquisition or issue. A trade receivable without a significant
financing component is initially measured at the transaction price. However, if the Company has an unconditional right to an amount that
differs from the transaction price (e.g. due to the Company's refund policy), the trade receivable will be initially measured at the amount
of that unconditional right.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 3%"&gt;&lt;/td&gt;&lt;td style="width: 14.2pt"&gt;&lt;b&gt;i)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Financial assets&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"&gt;&lt;i&gt;Classification and subsequent measurement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;On initial recognition, a financial asset is classified as subsequently measured
at: amortized cost; FVOCI - debt investment; FVOCI - equity investment; or FVTPL.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;Financial assets are not reclassified subsequent to their initial recognition
unless the Company changes its business model for managing financial assets, in which case all affected financial assets are reclassified
on the first day of the first reporting period following the change in the business model.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;A financial asset is measured at amortized cost if it meets both of the following
conditions and is not designated as at FVTPL:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;it is held within a business model whose objective is to hold
assets to collect contractual cash flows; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;its contractual terms give rise on specified dates to cash
flows that are solely payments of principal and interest (&#x201c;SPPI&#x201d;) on the principal amount outstanding.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;A debt investment is measured at FVOCI if it meets both of the following conditions
and is not designated as at FVTPL:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;it is held within a business model whose objective is achieved
by both collecting contractual cash flows and selling financial assets; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;its contractual terms give rise on specified dates to cash
flows that are SPPI on the principal amount outstanding.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;On initial recognition of certain equity investments that are not held for trading,
the Company has made an irrevocable election to present subsequent changes in the investment's fair value in OCI.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;This election is made on an investment-by-investment basis.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;All financial assets not measured at amortized cost or FVOCI as described above
(e.g. financial assets held for trading and those that are managed and whose performance is evaluated on a fair value basis) are measured
at FVTPL.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&#160;&lt;/p&gt;






&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Business model assessment&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company makes an assessment of the objective of the business model in which
a financial asset is held at a portfolio level because this best reflects the way the business is managed and information is provided
to management.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Transfers of financial assets to third parties in transactions that do not qualify
for derecognition are not considered sales for this purpose, consistent with the Company's continuing recognition of the assets.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Assessment whether contractual cash flows are SPPI&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;In assessing whether the contractual cash flows are SPPI, the Company considers
the contractual terms of the instrument. This includes assessing whether the financial asset contains a contractual term that could change
the timing or amount of contractual cash flows such that it would not meet this condition. In making this assessment, the Company considers:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;
&lt;/span&gt;&lt;span style="font-size: 10.5pt"&gt;contingent events that would change the amount or timing of cash flows;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;
&lt;/span&gt;&lt;span style="font-size: 10.5pt"&gt;terms that may adjust the contractual coupon rate, including variable-rate features;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;
&lt;/span&gt;&lt;span style="font-size: 10.5pt"&gt;prepayment and extension features; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;
&lt;/span&gt;&lt;span style="font-size: 10.5pt"&gt;terms that limit the Company&#x2019;s claim to cash flows from specified assets (e.g. non-recourse
features).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;A prepayment feature is consistent with the SPPI criterion if the prepayment
amount substantially represents unpaid amounts of principal and interest on the principal amount outstanding, which may include reasonable
compensation for early termination of the contract. Additionally, for a financial asset acquired at a discount or premium to its contractual
per amount, a feature that permits or requires prepayment at an amount that substantially represents the contractual par amount plus accrued
(but unpaid) contractual interest (which may also include reasonable compensation for early termination) is treated as consistent with
this criterion if the fair value of the prepayment feature is insignificant on initial recognition. The Company had no financial assets
held outside trading business models that failed the SPPI assessment.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Subsequent measurement and gains and losses&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfMeasurementAndGainsAndLossesTableTextBlock_zis2ByfBzXce" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B2_zC3j1pqBL6wc" style="display: none"&gt;Schedule
    of measurement and gains and losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border: #AEAAAA 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;Financial assets at&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;FVTPL&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-top: #AEAAAA 1pt solid; border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; width: 78%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVTPLMember_zdt0sle527kc" title="Financial assets"&gt;These assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;Financial assets at&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;amortized cost&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FinancialAssetsAtAmortizedCostMember_z95KI8zi7w8d" title="Financial assets at amortized cost"&gt;These assets are subsequently measured at amortized cost under the effective interest method. The gross carrying amount is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;Debt investments at&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;FVOCI&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCIMember_zvzFySxDw8Gc" title="Debt investments"&gt;These assets are subsequently measured at fair value. Interest income calculated under the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;Equity investments at&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;FVOCI&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCI1Member_zqC4N7c5azq9" title="Equity investments"&gt;These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never reclassified to profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AD_ztPiF7ltilEl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"&gt;&lt;i&gt;Impairment of financial assets&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;Further disclosures relating to impairment of financial assets are also provided
in the following notes:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&#x2022; Significant accounting judgments, estimates and assumptions - Note 2.5&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&#x2022; Trade receivables - Note 6&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;The Company recognizes an allowance for expected credit losses (ECLs) for all
debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due
in accordance with the contract and the cash flows the Company expects to receive, discounted at an approximation of the original effective
interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements that are
integral to the contractual terms.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;For trade receivables, the Company applies a simplified approach in calculating
ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for credit losses based on both
quantitative and qualitative information and analysis on the Company&#x2019;s historical experience and informed credit assessment, at
each reporting date.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"&gt;&lt;/p&gt;






&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;The Company considers a financial asset to be in default when internal or external
information indicates that the Company is unlikely to receive the outstanding contractual amounts in full before considering any credit
enhancements held by the Company. Interest accrual is suspended once a financial asset meets the criteria for default. A financial asset
is written off when there is no reasonable expectation of recovering the contractual cash flows.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"&gt;&lt;b&gt;ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial liabilities&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; color: #C00000"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"&gt;&lt;i&gt;Classification, subsequent measurement and gain and losses&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;Financial liabilities are measured at amortized cost or FVTPL. A financial liability
is measured at FVTPL if it is classified as held-for-trading, it is a derivative or it is designated as such on initial recognition. Financial
liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognized in profit or
loss. Other financial liabilities are subsequently measured at amortized cost under the effective interest method. Interest expense and
foreign exchange gains and losses are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;The Company&#x2019;s financial liabilities include trade payables, loans and
financing, lease liabilities, accounts payable to selling shareholders and dividends payable.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_z9Fj5sTtEi95" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;d) &lt;span id="xdx_861_ztY0XKb4WM82"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Cash and cash equivalents in the statement of financial position comprise cash at banks
and on hand, and short-term financial investments with an original maturity of three months or less from the date of purchase, held for
the purpose of meeting short-term cash commitments, readily convertible to a known amount of cash and subject to an insignificant risk
of changes in value.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;For the purpose of the consolidated statement of cash flows, cash and cash equivalents
consist of cash and short-term financial investments, as they are considered an integral part of the Company&#x2019;s cash management.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zUYOD2tsT21g" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;e) &lt;span id="xdx_867_zUczxtH6FQ51"&gt;Property and equipment&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Property and equipment are stated at cost, net of accumulated depreciation and accumulated
impairment losses, if any.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Subsequent expenditures are capitalized only if it is probable that the future economic
benefits associated with the expenditure will flow to the Company.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Depreciation is calculated on a straight-line basis over the estimated useful lives of
the assets, except for leasehold improvements, which are depreciated over the shorter of their estimated useful lives or the lease terms.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_pn3n3_zCa4de18nPW9" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 3)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B8_zyCXjuN9UFLf" style="display: none"&gt;Schedule of estimated useful lives of
the assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Building&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_ziGG6APQYSt2" title="Useful lives of assets"&gt;25&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Machinery and equipment&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zzWQqZWfoZmi" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zCsQwDwpnOQ1" title="Useful lives of assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zc5myiWw2ged" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;IT equipment&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zRJs7ZnMWgl1" title="Useful lives of assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Library books&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zMkh1AmfUxWl" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Leasehold improvements&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDRJaGRRs8Cb" title="Useful lives of assets"&gt;1&lt;/span&gt; - &lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ztPAUspLZAec" title="Useful lives of assets"&gt;30&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_z4OeLS3uKode" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;An item of property and equipment and any significant part initially recognized is derecognized
upon disposal or when no future economic benefit is expected from its use. Any gain or loss arising on the derecognition of the asset
(calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated
statement of income and other comprehensive income when the asset is derecognized.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The residual values, useful lives and methods of depreciation of property and equipment
are reviewed at each financial year end and adjusted prospectively, if appropriate.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;






&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_ztFoOqn5blrl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;f) &lt;span id="xdx_860_zRWo66GqKO3g"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company assesses at contract inception whether an arrangement is, or contains, a lease.
That is, if the arrangement conveys the right to control the use of an identified asset for a period of time in exchange for consideration.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;Company as a lessee&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company applies a single recognition and measurement approach for all leases, except
for short-term leases and leases of low-value assets. The Company recognizes lease liabilities to make lease payments and right-of-use
assets representing the right to use the underlying assets.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;Right-of-use assets&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company recognizes right-of-use assets at the commencement date of the lease (i.e.,
the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment
losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities
recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Right-of-use assets are depreciated on a straight-line basis over the shorter of its estimated
useful life and the lease term. The lease term of the contracts for properties range between five and 30 years. Right-of-use assets are
subject to impairment. Refer to the accounting policies in &#x2018;Impairment of non-financial assets&#x2019;.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;Lease liabilities&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;At the commencement date of the lease, the Company recognizes lease liabilities measured
at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance
fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected
to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain
to be exercised by the Company and payments of penalties for terminating a lease, if the lease term reflects the Company exercising the
option to terminate. The variable lease payments that do not depend on an index or a rate are recognized as expense in the period on which
the event or condition that triggers the payment occurs.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;In calculating the present value of lease payments, the Company uses the incremental borrowing
rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After the commencement date,
the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition,
the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the in-substance
fixed lease payments or a change in the assessment to purchase the underlying asset.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;Short-term leases and leases of low-value assets&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company applies the short-term lease recognition exemption to its short-term leases
of properties (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase
option). It also applies the lease of low-value assets recognition exemption to leases that are considered of low value. Lease payments
on short-term leases and leases of low-value assets are recognized as expense on a straight-line basis over the lease term.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zC2NYRBNHPY8" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;g) &lt;span id="xdx_869_zHbrvS2XFx63"&gt;Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Intangible assets acquired separately are measured on initial recognition at cost. The
cost of intangible assets acquired in a business combination or asset acquisition is their fair value at the date of acquisition. Following
initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally
generated intangibles, excluding capitalized development costs, are not capitalized and the related expenditure is reflected in the consolidated
statement of income and other comprehensive income in the period in which the expenditure is incurred.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The useful lives of intangible assets are assessed as finite or indefinite.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Intangible assets with finite lives are amortized on a straight-line over the estimated
useful lives and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The estimated useful
lives of intangible assets are as follows:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zKBgfLCXIwy8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 4)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BA_zJRQ405AQSG4" style="display: none"&gt;Schedule of estimated useful
lives of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="width: 272px; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Customer relationships - medicine&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z01NwOJL9RMi" title="Estimated useful lives of intangible assets"&gt;6&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Customer relationships - other courses&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--CustomerRelationshipsOtherCoursesMember_zXjMKXoWxuC9" title="Estimated useful lives of intangible assets"&gt;4.5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Software&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--ComputerSoftwareMember_zrOjKogqeteh" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Trademarks&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zB1PLffvirPd" title="Estimated useful lives of intangible assets"&gt;2&lt;/span&gt; - &lt;span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zWHwkdtG4848" title="Estimated useful lives of intangible assets"&gt;30&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Education content, Developed technology and Educational platform&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zQEMtlFWCwaj" title="Estimated useful lives of intangible assets"&gt;3&lt;/span&gt; - &lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zy0K8Pm1co7e" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zZnnyylInkJ6" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The amortization period and the amortization method for an intangible asset with a finite
useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected pattern of
consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate,
and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in the
consolidated statement of income and other comprehensive income in the expense category that is consistent with the function of the intangible
assets.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Intangible assets with indefinite useful lives are not amortized, but are tested for impairment
annually, either individually or at the cash-generating unit level. The assessment of indefinite life is reviewed annually to determine
whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective
basis.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;An intangible asset is derecognized upon disposal or when no future economic benefits are
expected from its use. Any gain or loss arising upon derecognition of the asset (calculated as the difference between the net disposal
proceeds and the carrying amount of the asset) is included in the consolidated statement of income and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;p id="xdx_848_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_z6w2Tca5jcY2" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;h) &lt;span id="xdx_861_z9SxAToULh87"&gt;Impairment of non-financial assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company assesses, at each reporting date, whether there is an indication that an asset
may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Company estimates the asset&#x2019;s
recoverable amount. An asset&#x2019;s recoverable amount is the higher of an asset&#x2019;s or CGU&#x2019;s fair value less costs of disposal
and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that
are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU exceeds its recoverable
amount, the asset is considered impaired and is written down to its recoverable amount.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;In assessing value in use, the estimated future cash flows are discounted to their present
value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the
asset. In determining fair value less costs of disposal, recent market transactions are considered. If no such transactions can be identified,
an appropriate valuation model is used. These calculations are corroborated by valuation multiples, quoted share prices for publicly traded
companies or other available fair value indicators.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company bases its impairment calculation on detailed budgets and forecast calculations,
which are prepared separately for each of the Company&#x2019;s CGUs to which the individual assets are allocated. These budgets and forecast
calculations cover a period of five years, considering the companies activities and maturation period of its graduate and undergraduate
courses. A long-term growth rate is calculated and applied to project future cash flows after the last projected year.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;For impairment testing, goodwill and licenses with indefinite useful lives are allocated
to their respective CGUs. The Company defined each of its operating subsidiaries as a CGU, except for the following which combines subsidiaries:
(i) &#x201c;Continuing education&#x201d; and (ii) &#x201c;Medical practice solutions&#x201d;, where the subsidiaries were combined as one
CGU following the business strategy and interdependency of cash flow generation.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Whenever applicable, impairment losses of continuing operations are recognized in the consolidated
statement of income and other comprehensive income in expense categories consistent with the function of the impaired asset.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;For assets excluding goodwill, an assessment is made at each reporting date to determine
whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such indication exists,
the Company estimates the asset&#x2019;s or CGU&#x2019;s recoverable amount. A previously recognized impairment loss is reversed only if
there has been a change in the assumptions used to determine the asset&#x2019;s recoverable amount since the last impairment loss was recognized.
The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount
that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years. Such reversal
is recognized in the consolidated statement of income and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Goodwill is tested for impairment annually as at December 31 and when circumstances indicate
that the carrying amounts may be impaired.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Impairment is determined for goodwill by assessing the recoverable amount of each CGU (or
group of CGUs) to which the goodwill relates. When the recoverable amount of the CGU is less than its carrying amount, an impairment loss
is recognized. Impairment losses relating to goodwill cannot be reversed in future periods.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Intangible assets with indefinite useful lives are tested for impairment annually as at
December 31 at the CGU level, as appropriate, and when circumstances indicate that the carrying amounts may be impaired.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForInvestmentsExplanatory_zZfZwtNjoxp9" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;i) &lt;span id="xdx_860_zjk6LVHMzzq3"&gt;Investments in associates&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Investments in associates are initially recognized at consideration transferred and adjusted
thereafter for the equity method, being increased or reduced from its interest in the investee's income after the acquisition date. An
associate is an entity over which the Company has significant influence. Significant influence is the power to participate in the financial
and operating policy decisions of the investee, but is not control or joint control over those policies.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The financial statements of the associate are prepared for the same reporting period as
the Company. The accounting policies of the associate are aligned with those of the Company.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;






&lt;p id="xdx_84B_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_zb6FRoiaSayd" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;j) &lt;span id="xdx_863_z9SEOZDjBA3h"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;These amounts represent liabilities related to the acquisitions made by the Company which
are not yet due. Accounts payable to selling shareholders are presented as current liabilities unless payment is not due within 12 months
after the reporting period. They are recognized initially at their fair value and subsequently measured at amortized cost using the effective
interest method, except for Unidom&#x2019;s contingent consideration, which are measured at fair value through profit or loss.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_zZIZ3k16lWq" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;k) &lt;span id="xdx_863_z8hhHpR9iShj"&gt;Provisions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Provisions are recognized when the Company has a present obligation (legal or constructive)
as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation,
and a reliable estimate can be made of the amount of the obligation. The expense relating to a provision is presented in the consolidated
statement of income and other comprehensive income, net of any reimbursement, when applicable.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--DividendsPolicyExplanatory_z4XB3eIoFmW9" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;l) &lt;span id="xdx_868_ziIjYpKBuMu9"&gt;Dividends&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company recognizes a liability to pay a dividend when the distribution is authorized
and the distribution is no longer at the discretion of the Company.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;In respect to the consolidated statement of changes in equity, the amount corresponding
to the non-controlling interest over the dividends declared are recognized directly in equity.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_ecustom--LaborAndSocialObligationsPolicyExplanatory_zxb4E5jJMoLk" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;m) Labor and social obligations&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Labor and social obligations are expensed as the related service is provided. A liability
is recognized for the amount expected to be paid if the Company has a present legal or constructive obligation to pay this amount as a
result of past service provided by the employee and the obligation can be estimated reliably.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--SharebasedPaymentsPolicyExplanatory_z8dI0b79l0uc" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;n) &lt;span id="xdx_864_zoOEZryg441a"&gt;Share-based payments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Certain key executives of the Company receive compensation in the form of share-based payments,
which includes stock options and restricted stock units (&#x201c;RSUs&#x201d;), whereby the executives render services as consideration
for equity instruments (equity-settled transactions).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The expense of equity-settled transactions is determined by the fair value at the date
when the grant is made using an appropriate valuation model.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;That expense is recognized in selling, general and administrative expenses, together with
a corresponding increase in equity (Share-based compensation reserve), over the period in which the service (the vesting period) and,
where applicable, the performance conditions are fulfilled. The cumulative expense recognized for equity-settled transactions at each
reporting date until the vesting date reflects the extent to which the vesting period has expired and the Company&#x2019;s best estimate
of the number of equity instruments that will ultimately vest. The expense or credit in the consolidated statement of income and other
comprehensive income for a period represents the movement in cumulative expense recognized as at the beginning and end of that period.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Service and non-market performance conditions are not considered when determining the grant
date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Company&#x2019;s best estimate of
the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value.
No expense is recognized for awards that do not ultimately vest because non-market performance and/or service conditions have not been
met.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;When the terms of an equity-settled award are modified, the minimum expense recognized
is the grant date fair value of the unmodified award, provided the original vesting terms of the award are met. An additional expense,
measured as at the date of modification, is recognized for any modification that increases the total fair value of the share-based payment
transaction, or is otherwise beneficial to the employee. Where an award is cancelled by the entity or by the counterparty, any remaining
element of the fair value of the award is expensed immediately through the consolidated statement of income and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;/p&gt;






&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The dilutive effect of outstanding options is reflected as additional share dilution in
the computation of diluted earnings per share.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zaCk5ZZBZG3f" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;o) &lt;span id="xdx_864_zZ8xOxplLlol"&gt;Earnings per share (&#x201c;EPS&#x201d;)&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;Basic EPS is calculated by dividing net income attributable to
the owners of the Company by the weighted average number of common shares outstanding during the year.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;Diluted EPS is calculated by dividing net income attributable
to the owners of the Company by the weighted average number of common shares outstanding during the year plus the weighted average number
of shares that would be issued on conversion of all potential shares with dilutive effects.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Diluted earnings per share are computed including stock options granted to key management
using the treasury shares method when the effect is dilutive. The Company has the stock options and RSUs plans in the category of potentially
dilutive shares.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zsxlo93REFmb" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;p) &lt;span id="xdx_862_znolsG70TOC"&gt;Revenue from contracts with customers&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company's revenue consists primarily of tuition fees charged for medical courses. The
Company also generates revenue from tuition fees for other undergraduate and graduate courses, administrative and application fees, education
content (e-books), subscription of medical practice solutions services (including medical content platforms, clinical decision-making
application, among other solutions), electronic medical records and marketing for pharmaceutical industry.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Revenue recognition transferred over time &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Revenue from tuitions, subscription of medical practice solutions services and electronic
medical records are recognized over time when services are rendered to the customer and the Company satisfies its performance obligation
under the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services.
Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Revenues are recognized when services are rendered to the customer and the performance
obligation is satisfied.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Revenue recognition transferred at point in time&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Revenue from sale of education content, online platforms, administrative and application
fees and marketing for pharmaceutical industry are recognized at the point in time when control of the asset or services is transferred
to the customer. For education content this is generally on delivery of the goods and for e-books this is generally on the permission
to access the digital content is granted. The Company considers whether there are other promises in the contract that are separate performance
obligations to which a portion of the transaction price needs to be allocated.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company concluded that it is the principal in its revenue arrangements.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company assesses collectability on a portfolio basis prior to recording revenue. Generally,
in respect to undergraduate programs students cannot re-enroll for the next academic session without satisfactory resolution of any past-due
amounts. If a student withdraws from an institution, the Company's obligation to issue a refund depends on the refund policy at that institution
and the timing of the student's withdrawal. Generally, the refund obligations are reduced over the course of the academic term.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Trade receivables&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Trade receivables represent the Company&#x2019;s right to an amount of consideration that
is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to the accounting policies
in &#x2018;Financial instruments - initial recognition and measurement&#x2019;.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Advances from customers&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Advances from customers (a contract liability) are the obligation to transfer services
to a customer for which the Company has received consideration (or an amount of consideration is due) from the customer, as a result of
pre-paid tuition, digital education content and mobile app subscription for digital medical content received from customers and is recognized
separately in current liabilities, when the payment is received. Advances from customers are recognized as revenue when the Company performs
all obligations related to the contract, over the contract term.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zsryXjCHEuZ4" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;q) &lt;span id="xdx_86B_zrrlk29DYpr"&gt;Taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;The Company&#x2019;s subsidiaries
in the undergraduate segment joined the PROUNI (&lt;i&gt;Programa Universidade para Todos&lt;/i&gt; - University for All Program) program, which is
a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number of student
enrollment for low-income students, and benefits from the exemption of the following federal taxes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;&#x2022; Income taxes and social contribution&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;&#x2022; PIS and COFINS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;The regulation of PROUNI defines
that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS. For income from other teaching
activities, PIS and COFINS are charged at rates of &lt;span id="xdx_90F_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_ztNcdqw4ON9l" title="Tax rate"&gt;0.65&lt;/span&gt;% and &lt;span id="xdx_907_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zC9xkyEeVZ9a" title="Tax rate"&gt;3.00&lt;/span&gt;%, respectively, and for non-teaching activities, PIS is charged at a
rate of &lt;span id="xdx_900_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zoCXn44uATTk" title="Tax rate"&gt;1.65&lt;/span&gt;% and to COFINS at &lt;span id="xdx_90F_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zK1bbo498xRk" title="Tax rate"&gt;7.6&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Current income taxes&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;Current income taxes were calculated
based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service, specifically regarding the PROUNI
program, which allows exemption of these taxes from traditional and technological graduation activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Current income tax assets and liabilities are measured at the amount expected to be recovered
from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively
enacted at the reporting date.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Management periodically evaluates positions taken in the tax returns with respect to situations
in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;Additional social contribution from Organization for Economic Co-operation
and Development (&#x201c;OECD&#x201d;) Pillar Two global minimum tax&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On December 27, 2024, Law 15,079/2024 was enacted, establishing the implementation of the
OECD&#x2019;s Pillar Two global minimum tax in Brazil, effective as of January 1, 2025.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Law 15,079/2024 aligns the Brazilian tax legislation to the OECD&#x2019;s Global Anti-Base
Erosion (GloBE) rules by introducing a minimum effective taxation of &lt;span id="xdx_903_eifrs-full--AverageEffectiveTaxRate_pip0_dp_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zucbD4LVguS4" title="Effective tax"&gt;15&lt;/span&gt;% through an additional Social Contribution on Net Profit (&#x201c;CSLL&#x201d;).
This regulation applies to multinational groups within the scope of the OECD&#x2019;s GloBE rules, specifically those whose ultimate parent
entity reported annual consolidated revenues of at least &#x20ac;&lt;span id="xdx_904_ecustom--ConsolidatedRevenues_pn6n6_uEUR_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zek9BvydSMM8" title="Consolidated revenues"&gt;750&lt;/span&gt; million in at least two of the four fiscal years immediately preceding
the year under review.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The rules are designed to ensure that the additional CSLL qualifies as a Qualified Domestic
Minimum Top-up Tax (QDMTT) under the OECD Inclusive Framework, subjecting Brazilian entities to a minimum tax rate of &lt;span id="xdx_902_ecustom--MinimumTaxRate_pip0_dp_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zmTxN1IaWFhi" title="Minimum tax rate"&gt;15&lt;/span&gt;%.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On March 28, 2025, the Company filed a writ of mandamus with the Brazilian Federal Court
challenging the enforceability of the newly enacted additional CSLL. The legal proceeding is grounded on constitutional and statutory
arguments, and is waiting for court decision to prevent the collection of the additional CSLL, which is scheduled to be disbursed in 2026
with respect to the 2025 fiscal year.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Considering that there is no court decision to date, the Company has recorded the amount
calculated in accordance with current legislation. The additional income tax expense as a result of Law 15,079/2024 for the year ended
December 31, 2025 was R$&lt;span id="xdx_901_eifrs-full--CurrentTaxLiabilitiesCurrent_iI_pn3n3_c20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_z2JcxqbBhCvd" title="Income taxes payable"&gt;109,458&lt;/span&gt;, accounted as income taxes payable in the current liabilities. The Company has applied the exception to
recognizing and disclosing information about deferred tax assets and liabilities related to Pillar Two income taxes.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Deferred tax&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Deferred tax is provided using the liability method on temporary differences between the
tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Deferred tax liabilities are recognized for all taxable temporary differences, except:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%"&gt;&#x2022; When the deferred tax liability arises from the initial recognition of goodwill
or an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the
accounting profit nor taxable profit or loss and does not give rise to equal taxable and deductible temporary differences;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#x2022; In respect of taxable temporary differences associated with investments in subsidiaries,
associates and interests in joint arrangements, when the timing of the reversal of the temporary differences can be controlled and it
is probable that the temporary differences will not reverse in the foreseeable future.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Deferred tax assets are recognized to the extent that it is probable that taxable profit
will be available against which the deductible temporary differences, and the carry forward of unused tax credits and unused tax losses
can be utilized, except when the deferred tax asset relating to the deductible temporary difference arises from the initial recognition
of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the
accounting profit nor taxable profit or loss and does not give rise to equal taxable and deductible temporary differences.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The carrying amount of deferred tax assets is reviewed at each reporting date and reduced
to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax
asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it
has become probable that future taxable profits will allow the deferred tax asset to be recovered.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company offsets deferred tax assets and deferred tax liabilities if and only if it
has a legally enforceable right to set off current tax assets and current tax liabilities and the deferred tax assets and deferred tax
liabilities relate to income taxes levied by the same taxation authority by the same taxable entity.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Sales tax&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Expenses and assets are recognized net of the amount of sales tax, except:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%"&gt;&#x2022; When the sales tax incurred on a purchase of assets or services is not recoverable
from the taxation authority, in which case, the sales tax is recognized as part of the cost of acquisition of the asset or as part of
the expense item, as applicable;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#x2022; When receivables and payables are stated with the amount of sales tax included.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForTreasurySharesExplanatory_zDR93UtWX9Xl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;r) &lt;span id="xdx_86E_zynYSJo8MDId"&gt;Treasury shares&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Own equity instruments that are reacquired (treasury shares) are recognized at cost and
deducted from equity. No gain or loss is recognized in profit or loss on the purchase, sale, transfers under the share-based payments,
issue or cancellation of the Company&#x2019;s own equity instruments. Any difference between the carrying amount and the consideration,
if reissued, is recognized in the share premium.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;2.4 Changes in accounting policies and disclosures&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;New and amended standards and interpretations&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The following standards and amendments, which are effective for annual periods beginning
on or after January 1, 2025, have been issued but are not applicable to the Company&#x2019;s operations or consolidated financial statements.&lt;/p&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;&lt;/i&gt;&lt;/p&gt;








&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_z2lTvolZvvn6" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 5)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_8B6_zJFR57MUEwle" style="display: none"&gt;Schedule
    of changes in accounting policies and disclosures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Amendment / standard&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS21Member_z8XUqBspnetd" title="Standard"&gt;Lack of exchangeability &#x2013; Amendments to IAS 21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--LackOfExchangeabilityAmendmentsToIAS21Member_gIFDONOCIAP-GOL_ztYW68Jhqa63" title="Description"&gt;In August 2023, the IASB issued amendments to IAS 21 The Effects of Changes in Foreign Exchange
    Rates to specify how an entity should assess whether a currency is exchangeable and how it should determine a spot exchange rate when
    exchangeability is lacking. The amendments also require disclosure of information that enables users of its financial statements to understand
    how the currency not being exchangeable into the other currency affects, or is expected to affect, the entity&#x2019;s financial performance,
    financial position and cash flows.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C00_gIFDONOCIAP-GOL_ztsgVBnFLjv"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments had no impact on the Company&#x2019;s accounting policies, which remained
    unchanged in these  consolidated financial statements for the year ended December 31, 2025.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Standards issued but not yet effective&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 24%; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The new and amended standards and interpretations that are issued, but not yet effective,
up to the date of issuance of the Company&#x2019;s  consolidated financial statements are presented below. The Company has not
early adopted any other standard, interpretation or amendment that has been issued but is not yet effective. The Company intends to adopt
these new and amended standards and interpretations, if applicable, when they become effective.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Amendment / standard&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_zLUko5jePu6c" title="Standard"&gt;Classification and Measurement of Financial Instruments - Amendments to IFRS 9 and IFRS 7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-BAAR_zkjlISvlyJ43" title="Description"&gt;In May 2024, the IASB issued Amendments to the Classification and Measurement of Financial
    Instruments (Amendments to IFRS 9 and IFRS 7), which:&lt;/span&gt;&lt;/p&gt;
    &lt;div id="xdx_C0A_gIFDONOCIAP-BAAR_zkExD70L8Wu5"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Clarifies that a financial liability is derecognized on the &#x2018;settlement date&#x2019;,
    i.e., when the related obligation is discharged, cancelled, expires or the liability otherwise qualifies for derecognition. It also introduces
    an accounting policy option to derecognize financial liabilities that are settled through an electronic payment system before settlement
    date if certain conditions are met&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C05_gIFDONOCIAP-BAAR_zl5EKJmYu0D6"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Clarified how to assess the contractual cash flow characteristics of financial assets
    that include environmental, social and governance (ESG)-linked features and other similar contingent features&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C0C_gIFDONOCIAP-BAAR_zXZjZnmDVoka"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Clarifies the treatment of non-recourse assets and contractually linked instruments&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C08_gIFDONOCIAP-BAAR_zGNTWdsE70dd"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Requires additional disclosures in IFRS 7 for financial assets and liabilities with
    contractual terms that reference a contingent event (including those that are ESG-linked), and equity instruments classified at fair value
    through other comprehensive income&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0A_gIFDONOCIAP-BAAR_zITb02JpFPWc"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Entities can early adopt the amendments that relate to the classification of financial assets plus the related disclosures and
    apply the other amendments later.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0F_gIFDONOCIAP-BAAR_z0cxvEBa6aYf"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments are not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_zZMM05VKXtCd" title="Standard"&gt;Annual Improvements to IFRS Accounting Standards - Volume 11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_gIFDONOCIAP-WCSGRG_zybD7ZfXRgpk" title="Description"&gt;In July 2024, the IASB issued Annual Improvements to IFRS Accounting Standards - Volume
    11. The following is a summary of the topics subject to amendments from the Annual Improvements to IFRS Accounting Standards - Volume
    11:&lt;/span&gt;&lt;/p&gt;
    &lt;div id="xdx_C0A_gIFDONOCIAP-WCSGRG_zxAD1eGVVtBh"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IFRS 1 First-time Adoption of International Financial Reporting Standards&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C0D_gIFDONOCIAP-WCSGRG_znk2wakMtSe1"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IFRS 7 Financial Instruments: Disclosures: Gain or Loss on Derecognition&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C0F_gIFDONOCIAP-WCSGRG_zliiiu9lVw48"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Guidance on implementing IFRS 7 Financial Instruments: Disclosures&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C05_gIFDONOCIAP-WCSGRG_zGd4UI1Blmv8"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IFRS 9 Financial Instruments&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C01_gIFDONOCIAP-WCSGRG_zx4B8x3qLari"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IFRS 10 Consolidated Financial Statements&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C00_gIFDONOCIAP-WCSGRG_z9bOzr2sDbL1"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IAS 7 Statement of Cash Flows&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C05_gIFDONOCIAP-WCSGRG_zvrWub3MXcHg"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;These amendments are effective for annual periods beginning on or after January 1, 2026.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C05_gIFDONOCIAP-WCSGRG_z4adLiUXIh56"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments are not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_z7y593ZhC2Fd" title="Standard"&gt;Nature-dependent Electricity Contracts &#x2013; Amendments to IFRS 9 and IFRS 7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-NDD_zo9W1bJrgfR1" title="Description"&gt;In December 2024, the IASB issued Contracts Referencing Nature-dependent Electricity (Amendments
    to IFRS 9 and IFRS 7), clarifying the application of the &#x2018;own-use&#x2019; requirements; permitting hedge accounting if these contracts
    are used as hedging instruments; and adding new disclosure requirements to enable investors to understand the effect of these contracts
    on a company&#x2019;s financial performance and cash flows.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0B_gIFDONOCIAP-NDD_zJ4HQK4N9f39"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Early adoption is permitted, but will need to be disclosed.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C00_gIFDONOCIAP-NDD_zUqyDVEPe8tk"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments are not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_zjKS3Rce4spl" title="Standard"&gt;IFRS 18 &#x2013; Presentation and Disclosure in Financial Statements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_gIFDONOCIAP-XTV_zJYW1fCYY9l7" title="Description"&gt;In April 2024, the IASB issued IFRS 18, which replaces IAS 1 Presentation of Financial Statements.
    IFRS 18 introduces new requirements for presentation within the statement of income, including specified totals and subtotals. Furthermore,
    entities are required to classify all income and expenses within the statement of income into one of five categories: operating, investing,
    financing, income taxes and discontinued operations, whereof the first three are new.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0C_gIFDONOCIAP-XTV_z0z3tJ4qoMj5"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;It also requires disclosure of management-defined performance measures, subtotals of income
    and expenses and includes new requirements for aggregation and disaggregation of financial information based on the identified &#x201c;roles&#x201d;
    of the primary financial statements (PFS) and the notes.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C07_gIFDONOCIAP-XTV_zDB2Ec8H07d5"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;In addition, narrow-scope amendments have been made to IAS 7 Statement of Cash Flows, which
    include changing the starting point for determining cash flows from operations under the indirect method, from &#x2018;profit or loss&#x2019;
    to &#x2018;operating profit or loss&#x2019; and removing the optionality around classification of cash flows from dividends and interest.
    In addition, there are consequential amendments to several other standards.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0E_gIFDONOCIAP-XTV_z7Lw8rr9h7P2"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;IFRS 18, and the amendments to the other standards, is effective for reporting periods beginning
    on or after January 1, 2027 and must be applied retrospectively. Early adoption is permitted and must be disclosed.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C04_gIFDONOCIAP-XTV_zwXw9WdU0HY3"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The Company is currently working to identify all IFRS 18 impacts on the consolidated financial
    statements.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A7_zQ4teMoATgy2" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;2.5 Significant accounting judgments, estimates and assumptions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The preparation of the Company&#x2019;s consolidated financial statements requires management
to make judgments, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the accompanying
disclosures. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment to the carrying
amount of assets or liabilities affected in future periods. Accounting estimates and judgments are continually evaluated and are based
on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revisions to estimates are recognized prospectively.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Other disclosures relating to the Company&#x2019;s exposure to risks and uncertainties include:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#x2022; Financial instruments risk management objectives and policies - Note 12.4&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#x2022; Sensitivity analysis - Note 12.4.1&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;&lt;i&gt;Estimates and assumptions&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The key assumptions about the future and other key sources of estimated uncertainty as
of the reporting date that include a significant risk of a material adjustment to the carrying amounts of assets and liabilities within
the next financial year, are described below. The Company based its assumptions and estimates on parameters available when the consolidated
financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market
changes or circumstances that arise and that are beyond the Company&#x2019;s control. Such changes are reflected in the assumptions when
they occur.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Identification and fair-value measurement of assets and liabilities
acquired in a business combination&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Business combinations are accounted for using the acquisition method. Such method requires
recognizing and measuring the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree.
The Company, as the acquirer, must classify or designate the identifiable assets and liabilities assumed on the basis of its own contractual
terms, economic conditions, operating and accounting policies and other relevant conditions as at the acquisition date. Moreover, the
acquisition method required the fair value measurement of contingent consideration liabilities, when applicable, such as the Unidom consideration
conditioned upon the maintenance of the authorization of the 175 operating medical school seats. Such assessments require judgments from
the Company on the methods used to determine the fair value of the consideration transferred, including contingent consideration, assets
acquired and liabilities assumed, including valuation techniques that may require prospective financial information inputs.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Impairment of non-financial assets&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Impairment exists when the carrying amount of an asset or CGU or group of CGUs exceeds
its recoverable amount, defined as the higher of its fair value less costs of disposal and its value in use. The fair value less costs
of disposal calculation is based on data available from binding sales transactions, conducted at arm&#x2019;s length, for similar assets
or observable market prices less incremental costs of disposing of the asset. The value in use calculation is based on a discounted cash
flow model (&#x201c;DCF&#x201d; model). The cash flows are derived from the budget for the next five years and do not include restructuring
activities to which the Company has not yet committed or significant future investments that will enhance the performance of the assets
of the CGU being tested. The recoverable amount is sensitive to the discount rate used for the DCF model as well as to expected future
cash-inflows and the growth rate used for extrapolation purposes.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;These estimates are most relevant to goodwill and indefinite lived intangible assets recognized
by the Company. The key assumptions used to determine the recoverable amount for each CGU, including a sensitivity analysis, are disclosed
and further explained in Note 11.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;






&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Provision for legal proceedings&lt;/i&gt;&lt;/p&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Provisions for labor, tax, and civil risks are recorded for all legal proceedings that
represent probable losses. The assessment of the probability of loss includes the evaluation of available evidence, such as recent court
decisions and the opinion of the Company's internal and external legal counsel, the nature of the proceedings, and past experience.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Provisions are reviewed and adjusted to account for changes in circumstances, such as new
matters or court rulings.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Share-based compensation&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Estimating fair value for share-based payment transactions requires determination of the
most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of
the most appropriate inputs to the valuation model including the expected life of the share option, volatility and dividend yield and
making assumptions about them. For the measurement of the fair value of equity-settled transactions, the Company uses the Binomial model.
The assumptions and models used for estimating fair value for share-based payment transactions are disclosed in Note 14.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Leases - Estimating the incremental borrowing rate&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company cannot readily determine the interest rate implicit in the lease, therefore,
it uses its incremental borrowing rate (IBR) to measure lease liabilities. The IBR is the rate of interest that the Company would have
to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use
asset in a similar economic environment. The IBR therefore reflects what the Company &#x2018;would have to pay&#x2019;, which requires estimation
when no observable rates are available (such as for subsidiaries that do not enter into financing transactions) or when they need to be
adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary&#x2019;s functional currency).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company estimates the IBR using observable inputs (such as market interest rates) when
available and is required to make certain entity-specific estimates.&lt;/p&gt;

</afya:DisclosureOfMaterialAccountingPoliciesExplanatory>
    <afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000805">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zcj6lFUACLga" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B5_zynWLHfQVvif" style="display: none"&gt;Schedule of company&#x2019;s subsidiaries and associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Direct and indirect interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 260px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 165px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Main activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 106px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Investment type&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 94px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 95px; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Afya Participa&#xe7;&#xf5;es S.A. (&#x201c;Afya Brazil&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zv5MTqPDekz" title="Principal activities"&gt;Holding&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zPQvVIsNbXAl" title="Location"&gt;Nova Lima - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zPhxWSLNNFYb" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z3dUyGsNEGAj" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zykxwE9jljwb" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Instituto Tocantinense Presidente Ant&#xf4;nio Carlos Porto S.A. - (&#x201c;ITPAC Porto&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zN6FDhFYiu8g" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_z6JBWPXjcXY9" title="Location"&gt;Porto Nacional - TO&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zHBIi1cxo8R2" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_zIegwX923u7h" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember_z9fDNnTtrmke" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Instituto Tocantinense Presidente Ant&#xf4;nio Carlos S.A. - (&#x201c;ITPAC Aragua&#xed;na&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zeVY7TuruoTj" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zmJbPAAr1cw2" title="Location"&gt;Aragua&#xed;na - TO&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zDNrwBhUTADl" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_zBxnAE9RObwa" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember_z7lLtAtqjHJ5" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Uni&#xe3;o Educacional do Vale do A&#xe7;o S.A. - (&#x201c;UNIVA&#xc7;O&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zb1MPrkWtBj7" title="Principal activities"&gt;Medicine undergraduate degree program&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zkBKk14iQtJ3" title="Location"&gt;Ipatinga - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_ztAaXWaBOmXk" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_zq7PR9YcZf4l" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember_z3hzjt4buVzc" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#x201c;IPTAN&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zKEFurG6PIJk" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_z34RwQCvWmkg" title="Location"&gt;S&#xe3;o Jo&#xe3;o Del Rei - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zC6MdwGisMA3" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_zYYLghJr7UPh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember_z3Vs4M6uzCu8" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Instituto de Educa&#xe7;&#xe3;o Superior do Vale do Parna&#xed;ba S.A. (&#x201c;IESVAP&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zxk0We0LsPTa" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zIGxc588gUV3" title="Location"&gt;Parna&#xed;ba - PI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zP79vi4r5u25" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zLKyjBMsY4q" title="Direct and indirect interest of subsidiary"&gt;80&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember_zqRuGSlSR3c5" title="Direct and indirect interest of subsidiary"&gt;80&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Centro de Ci&#xea;ncias em Sa&#xfa;de de Itajub&#xe1; S.A. (&#x201c;CCSI&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_znpmsbq0xH48" title="Principal activities"&gt;Medicine undergraduate degree program&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zRwHby9YAzig" title="Location"&gt;Itajub&#xe1; - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_z4hzcx6IE5V5" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zQRvYSVGO8l1" title="Direct and indirect interest of subsidiary"&gt;75&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember_zqvLSDfXd139" title="Direct and indirect interest of subsidiary"&gt;75&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Instituto de Ensino Superior do Piau&#xed; S.A. (&#x201c;IESP&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zj3jTfZwlLji" title="Principal activities"&gt;Undergraduate and graduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_ztDnmW1MZkv1" title="Location"&gt;Teresina - PI&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zdGWxYEdRXe1" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_znSqGAUxHmSh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember_zSkFjQ6kWxcj" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;FADEP - Faculdade Educacional de Pato Branco Ltda. (&#x201c;FADEP&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zHlgWNtXlL1i" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_z56ixa0OF8z1" title="Location"&gt;Pato Branco - PR&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zngY2U4fEaAc" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zSdYtCrll9g3" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember_zmiMsMyM8Z15" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Instituto Educacional Santo Agostinho S.A. (&#x201c;FASA&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zEGxfStAXTxh" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zj2TQxkuupd1" title="Location"&gt;Montes Claros - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zItnb4CAdbX7" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zyjNud4yCVT9" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoS.A.FASAMember_zjp7cIlEofq4" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Instituto Paraense de Educa&#xe7;&#xe3;o e Cultura Ltda. (&#x201c;IPEC&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zdUIpIjzmRrf" title="Principal activities"&gt;Medicine undergraduate degree program&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_900_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_z6DdHhd4Xmza" title="Location"&gt;Marab&#xe1; - PA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zr87jn2JTCXc" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zcjdzX044wOl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaenseDeEducacaoECulturaLtda.IPECMember_zqUtS4RqBPee" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Sociedade Universit&#xe1;ria Redentor S.A. (&#x201c;UniRedentor&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_za0Q6jdh9pak" title="Principal activities"&gt;Undergraduate and graduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z6VCJPMUsi1f" title="Location"&gt;Itaperuna - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zD4jfTDq71j6" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_zIVijpv6VO43" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorS.A.UniRedentorMember_z07aHHXjuuVe" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Centro de Ensino S&#xe3;o Lucas Ltda. (&#x201c;UniSL&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zIhMyuuAKua2" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zhZhAnIDU9E1" title="Location"&gt;Porto Velho - RO&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zQRwvub5eTIa" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zgs2o9pY6Cmh" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeEnsinoSaoLucasLtda.UniSLMember_zlDyTrQuIJg4" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Sociedade de Educa&#xe7;&#xe3;o, Cultura e Tecnologia da Amaz&#xf4;nia S.A. - (&#x201c;FESAR&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zcHSROCuWJM7" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zkf4DTOFkzh" title="Location"&gt;Reden&#xe7;&#xe3;o - PA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zMBjyVKo2kyl" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zOZfqEkf5plj" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember_zVx33b2Z4SE5" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Centro Superior de Ci&#xea;ncias da Sa&#xfa;de Ltda. (&#x201c;FCMPB&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zPJljvKsTKY3" title="Principal activities"&gt;Medicine undergraduate degree program&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_ztgmy5KQZoL4" title="Location"&gt;Jo&#xe3;o Pessoa - PB&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zixh7etHMAs6" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zhDdMICkhOpj" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember_zZUHbrDe94Qb" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;iClinic Desenvolvimento de Software Ltda. (&#x201c;iClinic&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zKFuIzZDoVdb" title="Principal activities"&gt;Electronic Medical Record, Clinical Management System&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zYO3zEnLze0d" title="Location"&gt;Ribeir&#xe3;o Preto - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zKMoyotrxxZc" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember_zq9uudZ4Wu6a" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Medicinae Solutions S.A. (&#x201c;Medicinae&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z1SofMPFPlO2" title="Principal activities"&gt;Healthcare payments and financial services&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zMOTdOw90wve" title="Location"&gt;Rio de Janeiro - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_z4wGxD0Is5yf" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsS.A.MedicinaeMember_zaNYs0QSrnjl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Medical Harbour Aparelhos M&#xe9;dico Hospitalares e Servi&#xe7;os em Tecnologia Ltda. (&#x201c;Medical Harbour&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zo5yxSCK4fcb" title="Principal activities"&gt;Educational health and medical imaging&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_z2EEbHDK43ib" title="Location"&gt;Florian&#xf3;polis - SC&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zXJnbFmJVJmf" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_ztoRoXecM1yk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember_zUZr9aZ30Ma9" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Cliquefarma Drogarias Online Ltda. (&#x201c;Cliquefarma&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_z2RckVYleRaf" title="Principal activities"&gt;Online platform&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zzCRFheNCFXj" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zf65vluVhRD7" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtda.CliquefarmaMember_zYEwq8HrPsHl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Shosp Tecnologia da Informa&#xe7;&#xe3;o Ltda. (&#x201c;Shosp&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zh0RFfKTO0h" title="Principal activities"&gt;Electronic Medical Record, Clinical Management System&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zZWb9ilnXxli" title="Location"&gt;Rio de Janeiro - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zqPVdXTXS105" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtda.ShospMember_zT1Zp6mEFvBd" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Sociedade Padr&#xe3;o de Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;UnifipMoc&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_z6QpELqIicFk" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zKBF85Ceu6yg" title="Location"&gt;Montes Claros - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zsVdwsb7WRs7" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zDX65F3q2SW7" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember_zkeolXEixvxa" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Companhia Nilza Cordeiro Herdy de Educa&#xe7;&#xe3;o e Cultura (&#x201c;Unigranrio&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zJnkuIR4kAHf" title="Principal activities"&gt;Undergraduate and graduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zXNJn29mYOTi" title="Location"&gt;Duque de Caxias - RJ&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zSWG75kMUPD5" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_zdOLXBhYnt9c" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember_ztanF7UNSRe8" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;RX PRO Solu&#xe7;&#xf5;es de Tecnologia Ltda. (&#x201c;RX PRO&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z6RLl3YkQS22" title="Principal activities"&gt;Marketing for pharmaceutical industry&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zBQeFbmIbl35" title="Location"&gt;S&#xe3;o Paulo - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_zrtDD8tW8W01" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtda.RXPROMember_z47hLNellYa9" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Quasar Telemedicina Desenvolvimento de Sistemas Computacionais Ltda. (&#x201c;Glic&#x201d;) (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zPT1tFS9JPw2" title="Principal activities"&gt;Patient physician relationship&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zHZNuhCaxm9i" title="Location"&gt;Barueri - SP&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zcLRpP7Rhg04" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember_zTW4DPdvqT39" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Sociedade Educacional e Cultural Sergipe DelRey Ltda. (&#x201c;DelRey&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90A_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zBVWD5GCo51f" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_906_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zQDYBK2PrV13" title="Location"&gt;Macei&#xf3; - AL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zJ6HBLFonPJg" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zNsgE3mViXsd" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember_zhodVdvKA1zj" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Unidom Participa&#xe7;&#xf5;es S.A. (&#x201c;Unidom&#x201d;) (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_z2lVPdfMwtl3" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_zpQPon9Ub1i3" title="Location"&gt;Salvador - BA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_za1ZaEX8hrqh" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomParticipacoesS.A.UnidomMember_zh9cTJCFCe95" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Institui&#xe7;&#xe3;o Baiana de Ensino Superior Ltda. (&#x201c;IBES&#x201d;) (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_z1Saz06WwUnl" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zICkxiPWlCa1" title="Location"&gt;Salvador - BA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zxUSj3cpH6pg" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zuMSslRL2ALl" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember_zH5T8zK1k4Cj" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;SESSA - Sociedade de Educa&#xe7;&#xe3;o Superior do Semi-&#xc1;rido Ltda. (&#x201c;SESSA&#x201d;) (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zv50ehHClrB7" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zpgyLpqvA3Jf" title="Location"&gt;Ribeira de Pombal - BA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zHSATSvTBwKi" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zMQpJh7s9Wka" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember_zsoKyXtcwfZ2" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Faculdade Masterclass Ltda. (&#x201c;FUNIC&#x201d;) (iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zJLSGdjCKky1" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_ziHX1c9NEdm1" title="Location"&gt;Contagem - MG&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zNS2Ibga4wN3" title="Investment type"&gt;Subsidiary&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeMasterclassLtdaFUNICMember_zWJegr0aqI2c" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Uni&#xe3;o Educacional do Planalto Central S.A. (&#x201c;UEPC&#x201d;) &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_905_ecustom--PrincipalActivities_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zAfk9pP4wRYg" title="Principal activities"&gt;Undergraduate degree programs&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_907_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zVDZlkJfGQFf" title="Location"&gt;Bras&#xed;lia - DF&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_900_ecustom--InvestmentType_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zRtK0fl0ttEa" title="Investment type"&gt;Associate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_z9brl7z0M5E4" title="Direct and indirect interest of subsidiary"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240101__20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember_zBQdakn8im8b" title="Direct and indirect interest of subsidiary"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="background-color: white"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="background-color: white"&gt;Unidom was merged with Afya Brazil on January 1, 2025.
As a result, from this date on, Afya Brazil directly controls the Unidom&#x2019;s subsidiaries IBES and SESSA.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="background-color: white"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="background-color: white"&gt;Cliquefarma, RX PRO and Glic were merged with Afya Brazil
in August 2025; iClinic, Medicinae and Shosp were merged with Afya Brazil in October 2025.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; color: #212121; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="color: #212121; background-color: white"&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;See Note 1.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_AfyaParticipacoesSAMember"
      id="Fact000807">Holding</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_AfyaParticipacoesSAMember"
      id="Fact000809">Nova Lima - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_AfyaParticipacoesSAMember"
      id="Fact000811">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_AfyaParticipacoesSAMember"
      decimals="INF"
      id="Fact000813"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_AfyaParticipacoesSAMember"
      decimals="INF"
      id="Fact000815"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember"
      id="Fact000817">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember"
      id="Fact000819">Porto Nacional - TO</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember"
      id="Fact000821">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember"
      decimals="INF"
      id="Fact000823"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoS.A.ITPACPortoMember"
      decimals="INF"
      id="Fact000825"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember"
      id="Fact000827">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember"
      id="Fact000829">Aragua&#xed;na - TO</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember"
      id="Fact000831">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember"
      decimals="INF"
      id="Fact000833"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosS.A.ITPACAraguainaMember"
      decimals="INF"
      id="Fact000835"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember"
      id="Fact000837">Medicine undergraduate degree program</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember"
      id="Fact000839">Ipatinga - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember"
      id="Fact000841">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember"
      decimals="INF"
      id="Fact000843"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_UniaoEducacionalDoValeFoAcoS.A.UNIVACOMember"
      decimals="INF"
      id="Fact000845"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember"
      id="Fact000847">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember"
      id="Fact000849">S&#xe3;o Jo&#xe3;o Del Rei - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember"
      id="Fact000851">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember"
      decimals="INF"
      id="Fact000853"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTancredoDeAlmeidaNevesS.A.IPTANMember"
      decimals="INF"
      id="Fact000855"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember"
      id="Fact000857">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember"
      id="Fact000859">Parna&#xed;ba - PI</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember"
      id="Fact000861">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember"
      decimals="INF"
      id="Fact000863"
      unitRef="Pure">0.80</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaS.A.IESVAPMember"
      decimals="INF"
      id="Fact000865"
      unitRef="Pure">0.80</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember"
      id="Fact000867">Medicine undergraduate degree program</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember"
      id="Fact000869">Itajub&#xe1; - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember"
      id="Fact000871">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember"
      decimals="INF"
      id="Fact000873"
      unitRef="Pure">0.75</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_CentroDeCienciasEmSaudeDeItajubaS.A.CCSIMember"
      decimals="INF"
      id="Fact000875"
      unitRef="Pure">0.75</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember"
      id="Fact000877">Undergraduate and graduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember"
      id="Fact000879">Teresina - PI</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember"
      id="Fact000881">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember"
      decimals="INF"
      id="Fact000883"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiS.A.IESPMember"
      decimals="INF"
      id="Fact000885"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember"
      id="Fact000887">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember"
      id="Fact000889">Pato Branco - PR</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember"
      id="Fact000891">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember"
      decimals="INF"
      id="Fact000893"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaFADEPMember"
      decimals="INF"
      id="Fact000895"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember"
      id="Fact000897">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember"
      id="Fact000899">Montes Claros - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember"
      id="Fact000901">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember"
      decimals="INF"
      id="Fact000903"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_InstitutoEducacionalSantoAgostinhoS.A.FASAMember"
      decimals="INF"
      id="Fact000905"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember"
      id="Fact000907">Medicine undergraduate degree program</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember"
      id="Fact000909">Marab&#xe1; - PA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember"
      id="Fact000911">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember"
      decimals="INF"
      id="Fact000913"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_InstitutoParaenseDeEducacaoECulturaLtda.IPECMember"
      decimals="INF"
      id="Fact000915"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember"
      id="Fact000917">Undergraduate and graduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember"
      id="Fact000919">Itaperuna - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember"
      id="Fact000921">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember"
      decimals="INF"
      id="Fact000923"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_SociedadeUniversitariaRedentorS.A.UniRedentorMember"
      decimals="INF"
      id="Fact000925"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember"
      id="Fact000927">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember"
      id="Fact000929">Porto Velho - RO</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember"
      id="Fact000931">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember"
      decimals="INF"
      id="Fact000933"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_CentroDeEnsinoSaoLucasLtda.UniSLMember"
      decimals="INF"
      id="Fact000935"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember"
      id="Fact000937">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember"
      id="Fact000939">Reden&#xe7;&#xe3;o - PA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember"
      id="Fact000941">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember"
      decimals="INF"
      id="Fact000943"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_SociedadeDeEducacaoCulturaETecnologiaDaAmazoniaS.A.FESARMember"
      decimals="INF"
      id="Fact000945"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember"
      id="Fact000947">Medicine undergraduate degree program</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember"
      id="Fact000949">Jo&#xe3;o Pessoa - PB</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember"
      id="Fact000951">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember"
      decimals="INF"
      id="Fact000953"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtda.FCMPBMember"
      decimals="INF"
      id="Fact000955"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember"
      id="Fact000957">Electronic Medical Record, Clinical Management System</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember"
      id="Fact000959">Ribeir&#xe3;o Preto - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember"
      id="Fact000961">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtda.iClinicMember"
      decimals="INF"
      id="Fact000963"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember"
      id="Fact000965">Healthcare payments and financial services</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember"
      id="Fact000967">Rio de Janeiro - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember"
      id="Fact000969">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_MedicinaeSolutionsS.A.MedicinaeMember"
      decimals="INF"
      id="Fact000971"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember"
      id="Fact000973">Educational health and medical imaging</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember"
      id="Fact000975">Florian&#xf3;polis - SC</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember"
      id="Fact000977">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember"
      decimals="INF"
      id="Fact000979"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtda.MedicalHarbourMember"
      decimals="INF"
      id="Fact000981"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember"
      id="Fact000983">Online platform</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember"
      id="Fact000985">S&#xe3;o Paulo - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember"
      id="Fact000987">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_CliquefarmaDrogariasOnlineLtda.CliquefarmaMember"
      decimals="INF"
      id="Fact000989"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember"
      id="Fact000991">Electronic Medical Record, Clinical Management System</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember"
      id="Fact000993">Rio de Janeiro - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember"
      id="Fact000995">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_ShospTecnologiaDaInformacaoLtda.ShospMember"
      decimals="INF"
      id="Fact000997"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember"
      id="Fact000999">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember"
      id="Fact001001">Montes Claros - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember"
      id="Fact001003">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember"
      decimals="INF"
      id="Fact001005"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtda.UnifipMocMember"
      decimals="INF"
      id="Fact001007"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember"
      id="Fact001009">Undergraduate and graduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember"
      id="Fact001011">Duque de Caxias - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember"
      id="Fact001013">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember"
      decimals="INF"
      id="Fact001015"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoECulturaUnigranrioMember"
      decimals="INF"
      id="Fact001017"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember"
      id="Fact001019">Marketing for pharmaceutical industry</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember"
      id="Fact001021">S&#xe3;o Paulo - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember"
      id="Fact001023">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_RXPROSolucoesDeTecnologiaLtda.RXPROMember"
      decimals="INF"
      id="Fact001025"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember"
      id="Fact001027">Patient physician relationship</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember"
      id="Fact001029">Barueri - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember"
      id="Fact001031">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_QuasarTelemedicinaDesenvolvimentodeSistemasComputacionaisLtdaGlicMember"
      decimals="INF"
      id="Fact001033"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember"
      id="Fact001035">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember"
      id="Fact001037">Macei&#xf3; - AL</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember"
      id="Fact001039">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember"
      decimals="INF"
      id="Fact001041"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_SociedadeEducacionalECulturalSergipeDelReyLtda.DelReyMember"
      decimals="INF"
      id="Fact001043"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_UnidomParticipacoesS.A.UnidomMember"
      id="Fact001045">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_UnidomParticipacoesS.A.UnidomMember"
      id="Fact001047">Salvador - BA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_UnidomParticipacoesS.A.UnidomMember"
      id="Fact001049">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_UnidomParticipacoesS.A.UnidomMember"
      decimals="INF"
      id="Fact001051"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember"
      id="Fact001053">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember"
      id="Fact001055">Salvador - BA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember"
      id="Fact001057">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember"
      decimals="INF"
      id="Fact001059"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_InstituicaoBaianadeEnsinoSuperiorLtdaIBESMember"
      decimals="INF"
      id="Fact001061"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember"
      id="Fact001063">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember"
      id="Fact001065">Ribeira de Pombal - BA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember"
      id="Fact001067">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember"
      decimals="INF"
      id="Fact001069"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_SESSASociedadedeEducacaoSuperiordoSemiAridoLtdaSESSAMember"
      decimals="INF"
      id="Fact001071"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaFUNICMember"
      id="Fact001073">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaFUNICMember"
      id="Fact001075">Contagem - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaFUNICMember"
      id="Fact001077">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_FaculdadeMasterclassLtdaFUNICMember"
      decimals="INF"
      id="Fact001079"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:PrincipalActivities
      contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember"
      id="Fact001081">Undergraduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary
      contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember"
      id="Fact001083">Bras&#xed;lia - DF</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType
      contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember"
      id="Fact001085">Associate</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-01-012025-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember"
      decimals="INF"
      id="Fact001087"
      unitRef="Pure">0.30</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-01-012024-12-31_custom_UniaoEducacionalDoPlanaltoCentralS.A.UEPCMember"
      decimals="INF"
      id="Fact001089"
      unitRef="Pure">0.30</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:BusinessCombinationsAndGoodwillPolicyExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001091">&lt;p id="xdx_842_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zhSI7K0euRz1" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;a) &lt;span id="xdx_866_zkCO45uQlw6f"&gt;Business combinations and goodwill&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Business combinations are accounted for using the acquisition method. The cost of an acquisition
is measured as the aggregate of the consideration transferred, which is measured at acquisition date fair value, and the amount of any
non-controlling interests in the acquiree. For each business combination, the Company elects whether to measure the non-controlling interests
in the acquiree at fair value or at the proportionate share of the acquiree&#x2019;s identifiable net assets. Acquisition-related costs
are expensed as incurred and included in selling, general and administrative expenses.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company determines that it has acquired a business when the acquired set of activities
and assets include an input and a substantive process that together significantly contribute to the ability to create outputs. The acquired
process is considered substantive if it is critical to the ability to continue producing outputs, and the inputs acquired include an organized
workforce with the necessary skills, knowledge, or experience to perform that process or it significantly contributes to the ability to
continue producing outputs and is considered unique or scarce or cannot be replaced without significant cost, effort, or delay in the
ability to continue producing outputs.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Any contingent consideration to be transferred by the acquirer will be recognized at fair
value at the acquisition date. Contingent consideration classified as equity is not remeasured and its subsequent settlement is accounted
for within equity. Contingent consideration classified as an asset or liability that is a financial instrument is measured at fair value
with the changes in fair value recognized in the consolidated statement of income and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Goodwill is initially measured at cost (being the excess of the aggregate of the consideration
transferred and the amount recognized for non-controlling interests and any previous interest held over the net identifiable assets acquired
and liabilities assumed). If the fair value of the net assets acquired is in excess of the aggregate consideration transferred, the Company
re-assesses whether it has correctly identified all of the assets acquired and all of the liabilities assumed and reviews the procedures
used to measure the amounts to be recognized at the acquisition date. If the reassessment still results in an excess of the fair value
of net assets acquired over the aggregate consideration transferred, then the gain is recognized in the consolidated statement of income
and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;After initial recognition, goodwill is measured at cost less any accumulated impairment
losses. For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated to
each of the Company&#x2019;s cash-generating units that are expected to benefit from the combination.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Where goodwill has been allocated to a cash-generating unit (&#x201c;CGU&#x201d;) and part
of the operation within that unit is disposed of, the goodwill associated with the disposed operation is included in the carrying amount
of the operation when determining the gain or loss on disposal. Goodwill disposed in these circumstances is measured based on the relative
values of the disposed operation and the portion of the cash-generating unit retained.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;br/&gt;
&lt;/p&gt;




</afya:BusinessCombinationsAndGoodwillPolicyExplanatory>
    <afya:CurrentVersusNoncurrentClassificationPoliciesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001093">&lt;p id="xdx_845_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zarwdTpqf083" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;b) &lt;span id="xdx_867_zq3H1xtNmHMb"&gt;Fair value measurement&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Fair value is the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption
that the transaction to sell the asset or transfer the liability takes place either: (i) in the principal market for the asset or liability;
or (ii) in the absence of a principal market, in the most advantageous market for the asset or liability.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The principal or the most advantageous market must be accessible by the Company.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The fair value of an asset or a liability is measured using the assumptions that market
participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.&lt;/p&gt;

&lt;p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;A fair value measurement of a non-financial asset takes into account a market participant's
ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that
would use the asset in its highest and best use.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company uses valuation techniques that are appropriate in the circumstances and for
which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of
unobservable inputs.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;All assets and liabilities for which fair value is measured or disclosed in these
consolidated financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input
that is significant to the fair value measurement as a whole:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;Level 1 - Quoted (unadjusted) market prices in active markets
for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;Level 2 - Valuation techniques for which the lowest level input
that is significant to the fair value measurement is directly or indirectly observable.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;Level 3 - Valuation techniques for which the lowest level input
that is significant to the fair value measurement is unobservable.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The following table shows the evaluation techniques used in measuring fair values for financial
instruments classified at level 2 and 3, as well as the significant unobservable inputs used.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock_z9Lfc0gZO6z4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B4_zeQBW9jYaF54" style="display: none"&gt;Schedule of fair values for financial
instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Type&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Significant unobservable inputs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Inter-relationship between significant unobservable inputs and fair value measurement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Level 2 - Stock options and Restricted stock units (Note 14)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zbWrtvEd8R68" title="Valuation technique"&gt;Binomial model: The fair value is estimated by utilizing a simulation of possible future share prices, applying regression analysis, as well as comparing at each potential exercise date the discounted risk-neutral expectation of the option payoff if not exercised, and the relevant exercise price.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&#x2022; Expected volatility (December 31, 2025: &lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_ztMnLOO8bvX1" title="Expected volatility"&gt;24&lt;/span&gt;% to &lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0zfhCwyYU7e" title="Expected volatility"&gt;44&lt;/span&gt;%; December 31, 2024: &lt;span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvl0bVSRFkng" title="Expected volatility"&gt;32&lt;/span&gt;% to &lt;span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEOHbmVlM4Rg" title="Expected volatility"&gt;45&lt;/span&gt;%).&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p id="xdx_982_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zrOsTuY8y0Lh" style="font: 7.5pt Nunito Sans; margin: 0" title="Inter-relationship between significant unobservable inputs and fair value measurement"&gt;The estimated fair value&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;would increase (decrease) if the expected volatility were higher (lower).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Level 3 - Contingent consideration (Accounts payable to selling shareholders - Note 12.2.3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zxIHtVQ8f3Fl" title="Valuation technique"&gt;Probability-weighted cash flows: This valuation technique considers the probability-weighted expectation of future cash flow.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt"&gt;&#x2022; Expected cash flows (December 31, 2025: R$&lt;span id="xdx_907_ecustom--ExpectedCashFlows_pn3n3_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zwL4LiFAutuh" title="Expected cash flows"&gt;325,150&lt;/span&gt;;
    December 31, 2024: R$&lt;span id="xdx_908_ecustom--ExpectedCashFlows_pn3n3_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zLTVYXh0aIzi" title="Expected cash flows"&gt;314,953&lt;/span&gt;).&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt"&gt;&#x2022; Probability of disbursement (December 31, 2025 and
    2024: &lt;span id="xdx_908_ecustom--ProbabilityOfDisbursement_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zJOYzkxwFFK5" title="Probability of disbursement"&gt;&lt;span id="xdx_903_ecustom--ProbabilityOfDisbursement_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z0jpMqr4Ciue" title="Probability of disbursement"&gt;100&lt;/span&gt;&lt;/span&gt;%).&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p id="xdx_985_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zPlc1vzSNOy9" style="font: 7.5pt Nunito Sans; margin: 0" title="Inter-relationship between significant unobservable inputs and fair value measurement"&gt;The estimated fair value would increase (decrease) if:&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt"&gt;&#x2022; the expected cash flows were higher (lower); or&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt"&gt;&#x2022; the probability rate were lower (higher).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A9_zplE3eA2TDq8" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The valuation model for other financial liabilities not measured at fair value considers
the present value of expected payments, discounted using a risk-adjusted discount rate.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;For assets and liabilities that are recognized in these  consolidated financial
statements at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy
by re-assessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end
of each reporting period.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;At each reporting date, the Company analyzes the movements in the values of assets and
liabilities which are required to be remeasured or reassessed as per the Company&#x2019;s accounting policies. For this analysis, the
Company verifies the major inputs applied in the latest valuation by agreeing the information in the valuation computation to contracts
and other relevant documents.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&lt;/p&gt;






&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company also compares the change in the fair value of each asset and liability with
relevant external sources to determine whether the change is reasonable.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;For the purpose of fair value disclosures, the Company has determined classes of assets
and liabilities on the basis of the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy,
as explained above.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

</afya:CurrentVersusNoncurrentClassificationPoliciesExplanatory>
    <afya:ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001095">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock_z9Lfc0gZO6z4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B4_zeQBW9jYaF54" style="display: none"&gt;Schedule of fair values for financial
instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Type&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Significant unobservable inputs&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Inter-relationship between significant unobservable inputs and fair value measurement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Level 2 - Stock options and Restricted stock units (Note 14)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zbWrtvEd8R68" title="Valuation technique"&gt;Binomial model: The fair value is estimated by utilizing a simulation of possible future share prices, applying regression analysis, as well as comparing at each potential exercise date the discounted risk-neutral expectation of the option payoff if not exercised, and the relevant exercise price.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.65pt; text-indent: -5.65pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&#x2022; Expected volatility (December 31, 2025: &lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_ztMnLOO8bvX1" title="Expected volatility"&gt;24&lt;/span&gt;% to &lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0zfhCwyYU7e" title="Expected volatility"&gt;44&lt;/span&gt;%; December 31, 2024: &lt;span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvl0bVSRFkng" title="Expected volatility"&gt;32&lt;/span&gt;% to &lt;span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEOHbmVlM4Rg" title="Expected volatility"&gt;45&lt;/span&gt;%).&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p id="xdx_982_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zrOsTuY8y0Lh" style="font: 7.5pt Nunito Sans; margin: 0" title="Inter-relationship between significant unobservable inputs and fair value measurement"&gt;The estimated fair value&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;would increase (decrease) if the expected volatility were higher (lower).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Level 3 - Contingent consideration (Accounts payable to selling shareholders - Note 12.2.3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zxIHtVQ8f3Fl" title="Valuation technique"&gt;Probability-weighted cash flows: This valuation technique considers the probability-weighted expectation of future cash flow.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt"&gt;&#x2022; Expected cash flows (December 31, 2025: R$&lt;span id="xdx_907_ecustom--ExpectedCashFlows_pn3n3_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zwL4LiFAutuh" title="Expected cash flows"&gt;325,150&lt;/span&gt;;
    December 31, 2024: R$&lt;span id="xdx_908_ecustom--ExpectedCashFlows_pn3n3_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zLTVYXh0aIzi" title="Expected cash flows"&gt;314,953&lt;/span&gt;).&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt"&gt;&#x2022; Probability of disbursement (December 31, 2025 and
    2024: &lt;span id="xdx_908_ecustom--ProbabilityOfDisbursement_pip0_dp_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zJOYzkxwFFK5" title="Probability of disbursement"&gt;&lt;span id="xdx_903_ecustom--ProbabilityOfDisbursement_pip0_dp_c20240101__20241231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_z0jpMqr4Ciue" title="Probability of disbursement"&gt;100&lt;/span&gt;&lt;/span&gt;%).&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p id="xdx_985_eifrs-full--DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets_c20250101__20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zPlc1vzSNOy9" style="font: 7.5pt Nunito Sans; margin: 0" title="Inter-relationship between significant unobservable inputs and fair value measurement"&gt;The estimated fair value would increase (decrease) if:&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt"&gt;&#x2022; the expected cash flows were higher (lower); or&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0 0 0 5.65pt; text-indent: -5.65pt"&gt;&#x2022; the probability rate were lower (higher).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfMeasuringFairValuesForFinancialInstrumentsTableTextBlock>
    <ifrs-full:DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      id="Fact001097">Binomial model: The fair value is estimated by utilizing a simulation of possible future share prices, applying regression analysis, as well as comparing at each potential exercise date the discounted risk-neutral expectation of the option payoff if not exercised, and the relevant exercise price.</ifrs-full:DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact001099"
      unitRef="Pure">0.24</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact001101"
      unitRef="Pure">0.44</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-01-012024-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact001103"
      unitRef="Pure">0.32</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-01-012024-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact001105"
      unitRef="Pure">0.45</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      id="Fact001107">The estimated fair value</ifrs-full:DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets>
    <ifrs-full:DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      id="Fact001109">Probability-weighted cash flows: This valuation technique considers the probability-weighted expectation of future cash flow.</ifrs-full:DescriptionOfChangeInValuationTechniqueUsedInFairValueMeasurementAssets>
    <afya:ExpectedCashFlows
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact001111"
      unitRef="BRL">325150000</afya:ExpectedCashFlows>
    <afya:ExpectedCashFlows
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fact001113"
      unitRef="BRL">314953000</afya:ExpectedCashFlows>
    <afya:ProbabilityOfDisbursement
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="INF"
      id="Fact001115"
      unitRef="Pure">1</afya:ProbabilityOfDisbursement>
    <afya:ProbabilityOfDisbursement
      contextRef="From2024-01-012024-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="INF"
      id="Fact001117"
      unitRef="Pure">1</afya:ProbabilityOfDisbursement>
    <ifrs-full:DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      id="Fact001119">The estimated fair value would increase (decrease) if:</ifrs-full:DescriptionOfInterrelationshipsBetweenUnobservableInputsAndOfHowTheyMightMagnifyOrMitigateEffectOfChangesInUnobservableInputsOnFairValueMeasurementAssets>
    <afya:FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001122">&lt;p id="xdx_843_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_zNMF30lxdisd" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;c) &lt;span id="xdx_869_zpbtmZlgwRZe"&gt;Financial instruments - initial recognition and measurement&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"&gt;&lt;i&gt;Recognition and initial measurement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;Financial assets and financial liabilities are initially recognized when the
Company becomes a party to the contractual provisions of the instrument.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;A financial asset (unless it is a trade receivable without a significant financing
component) or financial liability is initially measured at fair value plus or minus, for an item not at fair value through profit or loss
(&#x201c;FVTPL&#x201d;), transaction costs that are directly attributable to its acquisition or issue. A trade receivable without a significant
financing component is initially measured at the transaction price. However, if the Company has an unconditional right to an amount that
differs from the transaction price (e.g. due to the Company's refund policy), the trade receivable will be initially measured at the amount
of that unconditional right.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 3%"&gt;&lt;/td&gt;&lt;td style="width: 14.2pt"&gt;&lt;b&gt;i)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Financial assets&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"&gt;&lt;i&gt;Classification and subsequent measurement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;On initial recognition, a financial asset is classified as subsequently measured
at: amortized cost; FVOCI - debt investment; FVOCI - equity investment; or FVTPL.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;Financial assets are not reclassified subsequent to their initial recognition
unless the Company changes its business model for managing financial assets, in which case all affected financial assets are reclassified
on the first day of the first reporting period following the change in the business model.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;A financial asset is measured at amortized cost if it meets both of the following
conditions and is not designated as at FVTPL:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;it is held within a business model whose objective is to hold
assets to collect contractual cash flows; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;its contractual terms give rise on specified dates to cash
flows that are solely payments of principal and interest (&#x201c;SPPI&#x201d;) on the principal amount outstanding.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;A debt investment is measured at FVOCI if it meets both of the following conditions
and is not designated as at FVTPL:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;it is held within a business model whose objective is achieved
by both collecting contractual cash flows and selling financial assets; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1%; text-align: right"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10.5pt"&gt;its contractual terms give rise on specified dates to cash
flows that are SPPI on the principal amount outstanding.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;On initial recognition of certain equity investments that are not held for trading,
the Company has made an irrevocable election to present subsequent changes in the investment's fair value in OCI.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;This election is made on an investment-by-investment basis.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;All financial assets not measured at amortized cost or FVOCI as described above
(e.g. financial assets held for trading and those that are managed and whose performance is evaluated on a fair value basis) are measured
at FVTPL.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&#160;&lt;/p&gt;






&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Business model assessment&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company makes an assessment of the objective of the business model in which
a financial asset is held at a portfolio level because this best reflects the way the business is managed and information is provided
to management.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Transfers of financial assets to third parties in transactions that do not qualify
for derecognition are not considered sales for this purpose, consistent with the Company's continuing recognition of the assets.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Assessment whether contractual cash flows are SPPI&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;In assessing whether the contractual cash flows are SPPI, the Company considers
the contractual terms of the instrument. This includes assessing whether the financial asset contains a contractual term that could change
the timing or amount of contractual cash flows such that it would not meet this condition. In making this assessment, the Company considers:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;
&lt;/span&gt;&lt;span style="font-size: 10.5pt"&gt;contingent events that would change the amount or timing of cash flows;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;
&lt;/span&gt;&lt;span style="font-size: 10.5pt"&gt;terms that may adjust the contractual coupon rate, including variable-rate features;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8.5pt Nunito Sans; margin: 0 0 3pt 3%; text-align: left"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;
&lt;/span&gt;&lt;span style="font-size: 10.5pt"&gt;prepayment and extension features; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&lt;span style="font-family: Symbol; font-size: 10.5pt"&gt;&#xb7;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"&gt;&#160;
&lt;/span&gt;&lt;span style="font-size: 10.5pt"&gt;terms that limit the Company&#x2019;s claim to cash flows from specified assets (e.g. non-recourse
features).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;A prepayment feature is consistent with the SPPI criterion if the prepayment
amount substantially represents unpaid amounts of principal and interest on the principal amount outstanding, which may include reasonable
compensation for early termination of the contract. Additionally, for a financial asset acquired at a discount or premium to its contractual
per amount, a feature that permits or requires prepayment at an amount that substantially represents the contractual par amount plus accrued
(but unpaid) contractual interest (which may also include reasonable compensation for early termination) is treated as consistent with
this criterion if the fair value of the prepayment feature is insignificant on initial recognition. The Company had no financial assets
held outside trading business models that failed the SPPI assessment.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Subsequent measurement and gains and losses&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfMeasurementAndGainsAndLossesTableTextBlock_zis2ByfBzXce" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B2_zC3j1pqBL6wc" style="display: none"&gt;Schedule
    of measurement and gains and losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border: #AEAAAA 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;Financial assets at&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;FVTPL&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-top: #AEAAAA 1pt solid; border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; width: 78%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVTPLMember_zdt0sle527kc" title="Financial assets"&gt;These assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;Financial assets at&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;amortized cost&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FinancialAssetsAtAmortizedCostMember_z95KI8zi7w8d" title="Financial assets at amortized cost"&gt;These assets are subsequently measured at amortized cost under the effective interest method. The gross carrying amount is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;Debt investments at&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;FVOCI&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCIMember_zvzFySxDw8Gc" title="Debt investments"&gt;These assets are subsequently measured at fair value. Interest income calculated under the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;Equity investments at&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;FVOCI&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCI1Member_zqC4N7c5azq9" title="Equity investments"&gt;These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never reclassified to profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AD_ztPiF7ltilEl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"&gt;&lt;i&gt;Impairment of financial assets&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;Further disclosures relating to impairment of financial assets are also provided
in the following notes:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&#x2022; Significant accounting judgments, estimates and assumptions - Note 2.5&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&#x2022; Trade receivables - Note 6&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;The Company recognizes an allowance for expected credit losses (ECLs) for all
debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due
in accordance with the contract and the cash flows the Company expects to receive, discounted at an approximation of the original effective
interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements that are
integral to the contractual terms.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;For trade receivables, the Company applies a simplified approach in calculating
ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for credit losses based on both
quantitative and qualitative information and analysis on the Company&#x2019;s historical experience and informed credit assessment, at
each reporting date.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 14.2pt"&gt;&lt;/p&gt;






&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;The Company considers a financial asset to be in default when internal or external
information indicates that the Company is unlikely to receive the outstanding contractual amounts in full before considering any credit
enhancements held by the Company. Interest accrual is suspended once a financial asset meets the criteria for default. A financial asset
is written off when there is no reasonable expectation of recovering the contractual cash flows.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"&gt;&lt;b&gt;ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial liabilities&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%; color: #C00000"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left; color: #C00000"&gt;&lt;i&gt;Classification, subsequent measurement and gain and losses&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;Financial liabilities are measured at amortized cost or FVTPL. A financial liability
is measured at FVTPL if it is classified as held-for-trading, it is a derivative or it is designated as such on initial recognition. Financial
liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognized in profit or
loss. Other financial liabilities are subsequently measured at amortized cost under the effective interest method. Interest expense and
foreign exchange gains and losses are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: left"&gt;The Company&#x2019;s financial liabilities include trade payables, loans and
financing, lease liabilities, accounts payable to selling shareholders and dividends payable.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 15%"&gt;&#160;&lt;/p&gt;

</afya:FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory>
    <afya:ScheduleOfMeasurementAndGainsAndLossesTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001125">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfMeasurementAndGainsAndLossesTableTextBlock_zis2ByfBzXce" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B2_zC3j1pqBL6wc" style="display: none"&gt;Schedule
    of measurement and gains and losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border: #AEAAAA 1pt solid; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;Financial assets at&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;FVTPL&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-top: #AEAAAA 1pt solid; border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; width: 78%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_908_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVTPLMember_zdt0sle527kc" title="Financial assets"&gt;These assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;Financial assets at&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;amortized cost&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_909_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FinancialAssetsAtAmortizedCostMember_z95KI8zi7w8d" title="Financial assets at amortized cost"&gt;These assets are subsequently measured at amortized cost under the effective interest method. The gross carrying amount is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;Debt investments at&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;FVOCI&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_904_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCIMember_zvzFySxDw8Gc" title="Debt investments"&gt;These assets are subsequently measured at fair value. Interest income calculated under the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; border-left: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;Equity investments at&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;FVOCI&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-right: #AEAAAA 1pt solid; border-bottom: #AEAAAA 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90B_eifrs-full--ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss_c20250101__20251231__ifrs-full--ValuationTechniquesUsedInFairValueMeasurementAxis__custom--FVOCI1Member_zqC4N7c5azq9" title="Equity investments"&gt;These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never reclassified to profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfMeasurementAndGainsAndLossesTableTextBlock>
    <ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="From2025-01-012025-12-31_custom_FVTPLMember"
      id="Fact001127">These assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss.</ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="From2025-01-012025-12-31_custom_FinancialAssetsAtAmortizedCostMember"
      id="Fact001129">These assets are subsequently measured at amortized cost under the effective interest method. The gross carrying amount is reduced by impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss. Any gain or loss on derecognition is recognized in profit or loss.</ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="From2025-01-012025-12-31_custom_FVOCIMember"
      id="Fact001131">These assets are subsequently measured at fair value. Interest income calculated under the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.</ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="From2025-01-012025-12-31_custom_FVOCI1Member"
      id="Fact001133">These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never reclassified to profit or loss.</ifrs-full:ExplanationOfFactsAndCircumstancesIndicatingRareSituationForReclassificationOutOfFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="From2025-01-01to2025-12-31" id="Fact001136">&lt;p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_z9Fj5sTtEi95" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;d) &lt;span id="xdx_861_ztY0XKb4WM82"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Cash and cash equivalents in the statement of financial position comprise cash at banks
and on hand, and short-term financial investments with an original maturity of three months or less from the date of purchase, held for
the purpose of meeting short-term cash commitments, readily convertible to a known amount of cash and subject to an insignificant risk
of changes in value.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;For the purpose of the consolidated statement of cash flows, cash and cash equivalents
consist of cash and short-term financial investments, as they are considered an integral part of the Company&#x2019;s cash management.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001138">&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zUYOD2tsT21g" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;e) &lt;span id="xdx_867_zUczxtH6FQ51"&gt;Property and equipment&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Property and equipment are stated at cost, net of accumulated depreciation and accumulated
impairment losses, if any.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Subsequent expenditures are capitalized only if it is probable that the future economic
benefits associated with the expenditure will flow to the Company.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Depreciation is calculated on a straight-line basis over the estimated useful lives of
the assets, except for leasehold improvements, which are depreciated over the shorter of their estimated useful lives or the lease terms.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_pn3n3_zCa4de18nPW9" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 3)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B8_zyCXjuN9UFLf" style="display: none"&gt;Schedule of estimated useful lives of
the assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Building&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_ziGG6APQYSt2" title="Useful lives of assets"&gt;25&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Machinery and equipment&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zzWQqZWfoZmi" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zCsQwDwpnOQ1" title="Useful lives of assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zc5myiWw2ged" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;IT equipment&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zRJs7ZnMWgl1" title="Useful lives of assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Library books&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zMkh1AmfUxWl" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Leasehold improvements&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDRJaGRRs8Cb" title="Useful lives of assets"&gt;1&lt;/span&gt; - &lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ztPAUspLZAec" title="Useful lives of assets"&gt;30&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_z4OeLS3uKode" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;An item of property and equipment and any significant part initially recognized is derecognized
upon disposal or when no future economic benefit is expected from its use. Any gain or loss arising on the derecognition of the asset
(calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the consolidated
statement of income and other comprehensive income when the asset is derecognized.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The residual values, useful lives and methods of depreciation of property and equipment
are reviewed at each financial year end and adjusted prospectively, if appropriate.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;






</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <afya:ScheduleOfEstimatedUsefulLivesTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001140">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_pn3n3_zCa4de18nPW9" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 3)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B8_zyCXjuN9UFLf" style="display: none"&gt;Schedule of estimated useful lives of
the assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Building&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_ziGG6APQYSt2" title="Useful lives of assets"&gt;25&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Machinery and equipment&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zzWQqZWfoZmi" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Vehicles&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zCsQwDwpnOQ1" title="Useful lives of assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Furniture and fixtures&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zc5myiWw2ged" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;IT equipment&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zRJs7ZnMWgl1" title="Useful lives of assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Library books&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zMkh1AmfUxWl" title="Useful lives of assets"&gt;10&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Leasehold improvements&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDRJaGRRs8Cb" title="Useful lives of assets"&gt;1&lt;/span&gt; - &lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dtY_c20250101__20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ztPAUspLZAec" title="Useful lives of assets"&gt;30&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfEstimatedUsefulLivesTableTextBlock>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_BuildingsMember"
      id="Fact001142">P25Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_MachineryAndEquipmentsMember"
      id="Fact001144">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_VehiclesMember"
      id="Fact001146">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_FixturesAndFittingsMember"
      id="Fact001148">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_ItEquipmentMember"
      id="Fact001150">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_custom_LibraryBooksMember"
      id="Fact001152">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_BottomOfRangeMember"
      id="Fact001154">P1Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseholdImprovementsMember_ifrs-full_TopOfRangeMember"
      id="Fact001156">P30Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001159">&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_ztFoOqn5blrl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;f) &lt;span id="xdx_860_zRWo66GqKO3g"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company assesses at contract inception whether an arrangement is, or contains, a lease.
That is, if the arrangement conveys the right to control the use of an identified asset for a period of time in exchange for consideration.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;Company as a lessee&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company applies a single recognition and measurement approach for all leases, except
for short-term leases and leases of low-value assets. The Company recognizes lease liabilities to make lease payments and right-of-use
assets representing the right to use the underlying assets.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;Right-of-use assets&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company recognizes right-of-use assets at the commencement date of the lease (i.e.,
the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment
losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities
recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Right-of-use assets are depreciated on a straight-line basis over the shorter of its estimated
useful life and the lease term. The lease term of the contracts for properties range between five and 30 years. Right-of-use assets are
subject to impairment. Refer to the accounting policies in &#x2018;Impairment of non-financial assets&#x2019;.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;Lease liabilities&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;At the commencement date of the lease, the Company recognizes lease liabilities measured
at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance
fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected
to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain
to be exercised by the Company and payments of penalties for terminating a lease, if the lease term reflects the Company exercising the
option to terminate. The variable lease payments that do not depend on an index or a rate are recognized as expense in the period on which
the event or condition that triggers the payment occurs.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;In calculating the present value of lease payments, the Company uses the incremental borrowing
rate at the lease commencement date if the interest rate implicit in the lease is not readily determinable. After the commencement date,
the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition,
the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the in-substance
fixed lease payments or a change in the assessment to purchase the underlying asset.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;Short-term leases and leases of low-value assets&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company applies the short-term lease recognition exemption to its short-term leases
of properties (i.e., those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase
option). It also applies the lease of low-value assets recognition exemption to leases that are considered of low value. Lease payments
on short-term leases and leases of low-value assets are recognized as expense on a straight-line basis over the lease term.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001161">&lt;p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zC2NYRBNHPY8" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;g) &lt;span id="xdx_869_zHbrvS2XFx63"&gt;Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Intangible assets acquired separately are measured on initial recognition at cost. The
cost of intangible assets acquired in a business combination or asset acquisition is their fair value at the date of acquisition. Following
initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally
generated intangibles, excluding capitalized development costs, are not capitalized and the related expenditure is reflected in the consolidated
statement of income and other comprehensive income in the period in which the expenditure is incurred.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The useful lives of intangible assets are assessed as finite or indefinite.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Intangible assets with finite lives are amortized on a straight-line over the estimated
useful lives and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The estimated useful
lives of intangible assets are as follows:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zKBgfLCXIwy8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 4)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BA_zJRQ405AQSG4" style="display: none"&gt;Schedule of estimated useful
lives of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="width: 272px; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Customer relationships - medicine&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z01NwOJL9RMi" title="Estimated useful lives of intangible assets"&gt;6&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Customer relationships - other courses&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--CustomerRelationshipsOtherCoursesMember_zXjMKXoWxuC9" title="Estimated useful lives of intangible assets"&gt;4.5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Software&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--ComputerSoftwareMember_zrOjKogqeteh" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Trademarks&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zB1PLffvirPd" title="Estimated useful lives of intangible assets"&gt;2&lt;/span&gt; - &lt;span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zWHwkdtG4848" title="Estimated useful lives of intangible assets"&gt;30&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Education content, Developed technology and Educational platform&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zQEMtlFWCwaj" title="Estimated useful lives of intangible assets"&gt;3&lt;/span&gt; - &lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zy0K8Pm1co7e" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zZnnyylInkJ6" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The amortization period and the amortization method for an intangible asset with a finite
useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected pattern of
consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate,
and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in the
consolidated statement of income and other comprehensive income in the expense category that is consistent with the function of the intangible
assets.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Intangible assets with indefinite useful lives are not amortized, but are tested for impairment
annually, either individually or at the cash-generating unit level. The assessment of indefinite life is reviewed annually to determine
whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective
basis.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;An intangible asset is derecognized upon disposal or when no future economic benefits are
expected from its use. Any gain or loss arising upon derecognition of the asset (calculated as the difference between the net disposal
proceeds and the carrying amount of the asset) is included in the consolidated statement of income and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;br/&gt;
&lt;/p&gt;




</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <afya:ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001163">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zKBgfLCXIwy8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 4)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BA_zJRQ405AQSG4" style="display: none"&gt;Schedule of estimated useful
lives of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="width: 272px; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Customer relationships - medicine&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z01NwOJL9RMi" title="Estimated useful lives of intangible assets"&gt;6&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Customer relationships - other courses&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--CustomerRelationshipsOtherCoursesMember_zXjMKXoWxuC9" title="Estimated useful lives of intangible assets"&gt;4.5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Software&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--ComputerSoftwareMember_zrOjKogqeteh" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Trademarks&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zB1PLffvirPd" title="Estimated useful lives of intangible assets"&gt;2&lt;/span&gt; - &lt;span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zWHwkdtG4848" title="Estimated useful lives of intangible assets"&gt;30&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Education content, Developed technology and Educational platform&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zQEMtlFWCwaj" title="Estimated useful lives of intangible assets"&gt;3&lt;/span&gt; - &lt;span id="xdx_902_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20250101__20251231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--EducationContentDevelopedTechnologyAndEducationalPlatformMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zy0K8Pm1co7e" title="Estimated useful lives of intangible assets"&gt;5&lt;/span&gt; years&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfEtimatedUsefulLivesOfIntangibleAssetsTableTextBlock>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember"
      id="Fact001165">P6Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_CustomerRelationshipsOtherCoursesMember"
      id="Fact001167">P4Y6M</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember"
      id="Fact001169">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_BrandNamesMember_ifrs-full_BottomOfRangeMember"
      id="Fact001171">P2Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_BrandNamesMember_ifrs-full_TopOfRangeMember"
      id="Fact001173">P30Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_EducationContentDevelopedTechnologyAndEducationalPlatformMember_ifrs-full_BottomOfRangeMember"
      id="Fact001175">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_EducationContentDevelopedTechnologyAndEducationalPlatformMember_ifrs-full_TopOfRangeMember"
      id="Fact001177">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <afya:ImpairmentOfNonfinancialAssetsPolicyExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001179">&lt;p id="xdx_848_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_z6w2Tca5jcY2" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;h) &lt;span id="xdx_861_z9SxAToULh87"&gt;Impairment of non-financial assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company assesses, at each reporting date, whether there is an indication that an asset
may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Company estimates the asset&#x2019;s
recoverable amount. An asset&#x2019;s recoverable amount is the higher of an asset&#x2019;s or CGU&#x2019;s fair value less costs of disposal
and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that
are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU exceeds its recoverable
amount, the asset is considered impaired and is written down to its recoverable amount.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;In assessing value in use, the estimated future cash flows are discounted to their present
value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the
asset. In determining fair value less costs of disposal, recent market transactions are considered. If no such transactions can be identified,
an appropriate valuation model is used. These calculations are corroborated by valuation multiples, quoted share prices for publicly traded
companies or other available fair value indicators.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company bases its impairment calculation on detailed budgets and forecast calculations,
which are prepared separately for each of the Company&#x2019;s CGUs to which the individual assets are allocated. These budgets and forecast
calculations cover a period of five years, considering the companies activities and maturation period of its graduate and undergraduate
courses. A long-term growth rate is calculated and applied to project future cash flows after the last projected year.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;For impairment testing, goodwill and licenses with indefinite useful lives are allocated
to their respective CGUs. The Company defined each of its operating subsidiaries as a CGU, except for the following which combines subsidiaries:
(i) &#x201c;Continuing education&#x201d; and (ii) &#x201c;Medical practice solutions&#x201d;, where the subsidiaries were combined as one
CGU following the business strategy and interdependency of cash flow generation.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Whenever applicable, impairment losses of continuing operations are recognized in the consolidated
statement of income and other comprehensive income in expense categories consistent with the function of the impaired asset.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;For assets excluding goodwill, an assessment is made at each reporting date to determine
whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such indication exists,
the Company estimates the asset&#x2019;s or CGU&#x2019;s recoverable amount. A previously recognized impairment loss is reversed only if
there has been a change in the assumptions used to determine the asset&#x2019;s recoverable amount since the last impairment loss was recognized.
The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount
that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years. Such reversal
is recognized in the consolidated statement of income and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Goodwill is tested for impairment annually as at December 31 and when circumstances indicate
that the carrying amounts may be impaired.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Impairment is determined for goodwill by assessing the recoverable amount of each CGU (or
group of CGUs) to which the goodwill relates. When the recoverable amount of the CGU is less than its carrying amount, an impairment loss
is recognized. Impairment losses relating to goodwill cannot be reversed in future periods.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Intangible assets with indefinite useful lives are tested for impairment annually as at
December 31 at the CGU level, as appropriate, and when circumstances indicate that the carrying amounts may be impaired.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

</afya:ImpairmentOfNonfinancialAssetsPolicyExplanatory>
    <afya:DescriptionOfAccountingPolicyForInvestmentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001181">&lt;p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForInvestmentsExplanatory_zZfZwtNjoxp9" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;i) &lt;span id="xdx_860_zjk6LVHMzzq3"&gt;Investments in associates&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Investments in associates are initially recognized at consideration transferred and adjusted
thereafter for the equity method, being increased or reduced from its interest in the investee's income after the acquisition date. An
associate is an entity over which the Company has significant influence. Significant influence is the power to participate in the financial
and operating policy decisions of the investee, but is not control or joint control over those policies.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The financial statements of the associate are prepared for the same reporting period as
the Company. The accounting policies of the associate are aligned with those of the Company.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;






</afya:DescriptionOfAccountingPolicyForInvestmentsExplanatory>
    <afya:AccountsPayableToSellingShareholdersPolicyExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001184">&lt;p id="xdx_84B_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_zb6FRoiaSayd" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;j) &lt;span id="xdx_863_z9SEOZDjBA3h"&gt;Accounts payable to selling shareholders&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;These amounts represent liabilities related to the acquisitions made by the Company which
are not yet due. Accounts payable to selling shareholders are presented as current liabilities unless payment is not due within 12 months
after the reporting period. They are recognized initially at their fair value and subsequently measured at amortized cost using the effective
interest method, except for Unidom&#x2019;s contingent consideration, which are measured at fair value through profit or loss.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

</afya:AccountsPayableToSellingShareholdersPolicyExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001186">&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_zZIZ3k16lWq" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;k) &lt;span id="xdx_863_z8hhHpR9iShj"&gt;Provisions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Provisions are recognized when the Company has a present obligation (legal or constructive)
as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation,
and a reliable estimate can be made of the amount of the obligation. The expense relating to a provision is presented in the consolidated
statement of income and other comprehensive income, net of any reimbursement, when applicable.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <afya:DividendsPolicyExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001188">&lt;p id="xdx_846_ecustom--DividendsPolicyExplanatory_z4XB3eIoFmW9" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;l) &lt;span id="xdx_868_ziIjYpKBuMu9"&gt;Dividends&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company recognizes a liability to pay a dividend when the distribution is authorized
and the distribution is no longer at the discretion of the Company.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;In respect to the consolidated statement of changes in equity, the amount corresponding
to the non-controlling interest over the dividends declared are recognized directly in equity.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

</afya:DividendsPolicyExplanatory>
    <afya:LaborAndSocialObligationsPolicyExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001190">&lt;p id="xdx_84F_ecustom--LaborAndSocialObligationsPolicyExplanatory_zxb4E5jJMoLk" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;m) Labor and social obligations&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Labor and social obligations are expensed as the related service is provided. A liability
is recognized for the amount expected to be paid if the Company has a present legal or constructive obligation to pay this amount as a
result of past service provided by the employee and the obligation can be estimated reliably.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

</afya:LaborAndSocialObligationsPolicyExplanatory>
    <afya:SharebasedPaymentsPolicyExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001192">&lt;p id="xdx_840_ecustom--SharebasedPaymentsPolicyExplanatory_z8dI0b79l0uc" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;n) &lt;span id="xdx_864_zoOEZryg441a"&gt;Share-based payments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Certain key executives of the Company receive compensation in the form of share-based payments,
which includes stock options and restricted stock units (&#x201c;RSUs&#x201d;), whereby the executives render services as consideration
for equity instruments (equity-settled transactions).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The expense of equity-settled transactions is determined by the fair value at the date
when the grant is made using an appropriate valuation model.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;That expense is recognized in selling, general and administrative expenses, together with
a corresponding increase in equity (Share-based compensation reserve), over the period in which the service (the vesting period) and,
where applicable, the performance conditions are fulfilled. The cumulative expense recognized for equity-settled transactions at each
reporting date until the vesting date reflects the extent to which the vesting period has expired and the Company&#x2019;s best estimate
of the number of equity instruments that will ultimately vest. The expense or credit in the consolidated statement of income and other
comprehensive income for a period represents the movement in cumulative expense recognized as at the beginning and end of that period.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Service and non-market performance conditions are not considered when determining the grant
date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Company&#x2019;s best estimate of
the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value.
No expense is recognized for awards that do not ultimately vest because non-market performance and/or service conditions have not been
met.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;When the terms of an equity-settled award are modified, the minimum expense recognized
is the grant date fair value of the unmodified award, provided the original vesting terms of the award are met. An additional expense,
measured as at the date of modification, is recognized for any modification that increases the total fair value of the share-based payment
transaction, or is otherwise beneficial to the employee. Where an award is cancelled by the entity or by the counterparty, any remaining
element of the fair value of the award is expensed immediately through the consolidated statement of income and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;/p&gt;






&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The dilutive effect of outstanding options is reflected as additional share dilution in
the computation of diluted earnings per share.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

</afya:SharebasedPaymentsPolicyExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001195">&lt;p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zaCk5ZZBZG3f" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;o) &lt;span id="xdx_864_zZ8xOxplLlol"&gt;Earnings per share (&#x201c;EPS&#x201d;)&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;Basic EPS is calculated by dividing net income attributable to
the owners of the Company by the weighted average number of common shares outstanding during the year.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;Diluted EPS is calculated by dividing net income attributable
to the owners of the Company by the weighted average number of common shares outstanding during the year plus the weighted average number
of shares that would be issued on conversion of all potential shares with dilutive effects.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Diluted earnings per share are computed including stock options granted to key management
using the treasury shares method when the effect is dilutive. The Company has the stock options and RSUs plans in the category of potentially
dilutive shares.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue contextRef="From2025-01-01to2025-12-31" id="Fact001197">&lt;p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_zsxlo93REFmb" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;p) &lt;span id="xdx_862_znolsG70TOC"&gt;Revenue from contracts with customers&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company's revenue consists primarily of tuition fees charged for medical courses. The
Company also generates revenue from tuition fees for other undergraduate and graduate courses, administrative and application fees, education
content (e-books), subscription of medical practice solutions services (including medical content platforms, clinical decision-making
application, among other solutions), electronic medical records and marketing for pharmaceutical industry.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Revenue recognition transferred over time &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Revenue from tuitions, subscription of medical practice solutions services and electronic
medical records are recognized over time when services are rendered to the customer and the Company satisfies its performance obligation
under the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services.
Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Revenues are recognized when services are rendered to the customer and the performance
obligation is satisfied.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Revenue recognition transferred at point in time&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Revenue from sale of education content, online platforms, administrative and application
fees and marketing for pharmaceutical industry are recognized at the point in time when control of the asset or services is transferred
to the customer. For education content this is generally on delivery of the goods and for e-books this is generally on the permission
to access the digital content is granted. The Company considers whether there are other promises in the contract that are separate performance
obligations to which a portion of the transaction price needs to be allocated.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company concluded that it is the principal in its revenue arrangements.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company assesses collectability on a portfolio basis prior to recording revenue. Generally,
in respect to undergraduate programs students cannot re-enroll for the next academic session without satisfactory resolution of any past-due
amounts. If a student withdraws from an institution, the Company's obligation to issue a refund depends on the refund policy at that institution
and the timing of the student's withdrawal. Generally, the refund obligations are reduced over the course of the academic term.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Trade receivables&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Trade receivables represent the Company&#x2019;s right to an amount of consideration that
is unconditional (i.e., only the passage of time is required before payment of the consideration is due). Refer to the accounting policies
in &#x2018;Financial instruments - initial recognition and measurement&#x2019;.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Advances from customers&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Advances from customers (a contract liability) are the obligation to transfer services
to a customer for which the Company has received consideration (or an amount of consideration is due) from the customer, as a result of
pre-paid tuition, digital education content and mobile app subscription for digital medical content received from customers and is recognized
separately in current liabilities, when the payment is received. Advances from customers are recognized as revenue when the Company performs
all obligations related to the contract, over the contract term.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001199">&lt;p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zsryXjCHEuZ4" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;q) &lt;span id="xdx_86B_zrrlk29DYpr"&gt;Taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;The Company&#x2019;s subsidiaries
in the undergraduate segment joined the PROUNI (&lt;i&gt;Programa Universidade para Todos&lt;/i&gt; - University for All Program) program, which is
a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number of student
enrollment for low-income students, and benefits from the exemption of the following federal taxes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;&#x2022; Income taxes and social contribution&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;&#x2022; PIS and COFINS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;The regulation of PROUNI defines
that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS. For income from other teaching
activities, PIS and COFINS are charged at rates of &lt;span id="xdx_90F_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_ztNcdqw4ON9l" title="Tax rate"&gt;0.65&lt;/span&gt;% and &lt;span id="xdx_907_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zC9xkyEeVZ9a" title="Tax rate"&gt;3.00&lt;/span&gt;%, respectively, and for non-teaching activities, PIS is charged at a
rate of &lt;span id="xdx_900_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zoCXn44uATTk" title="Tax rate"&gt;1.65&lt;/span&gt;% and to COFINS at &lt;span id="xdx_90F_eifrs-full--ApplicableTaxRate_pip0_dp_c20250101__20251231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zK1bbo498xRk" title="Tax rate"&gt;7.6&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Current income taxes&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #212121"&gt;&lt;span style="background-color: white"&gt;Current income taxes were calculated
based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service, specifically regarding the PROUNI
program, which allows exemption of these taxes from traditional and technological graduation activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Current income tax assets and liabilities are measured at the amount expected to be recovered
from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively
enacted at the reporting date.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Management periodically evaluates positions taken in the tax returns with respect to situations
in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;Additional social contribution from Organization for Economic Co-operation
and Development (&#x201c;OECD&#x201d;) Pillar Two global minimum tax&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On December 27, 2024, Law 15,079/2024 was enacted, establishing the implementation of the
OECD&#x2019;s Pillar Two global minimum tax in Brazil, effective as of January 1, 2025.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Law 15,079/2024 aligns the Brazilian tax legislation to the OECD&#x2019;s Global Anti-Base
Erosion (GloBE) rules by introducing a minimum effective taxation of &lt;span id="xdx_903_eifrs-full--AverageEffectiveTaxRate_pip0_dp_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zucbD4LVguS4" title="Effective tax"&gt;15&lt;/span&gt;% through an additional Social Contribution on Net Profit (&#x201c;CSLL&#x201d;).
This regulation applies to multinational groups within the scope of the OECD&#x2019;s GloBE rules, specifically those whose ultimate parent
entity reported annual consolidated revenues of at least &#x20ac;&lt;span id="xdx_904_ecustom--ConsolidatedRevenues_pn6n6_uEUR_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zek9BvydSMM8" title="Consolidated revenues"&gt;750&lt;/span&gt; million in at least two of the four fiscal years immediately preceding
the year under review.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The rules are designed to ensure that the additional CSLL qualifies as a Qualified Domestic
Minimum Top-up Tax (QDMTT) under the OECD Inclusive Framework, subjecting Brazilian entities to a minimum tax rate of &lt;span id="xdx_902_ecustom--MinimumTaxRate_pip0_dp_c20241226__20241227__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_zmTxN1IaWFhi" title="Minimum tax rate"&gt;15&lt;/span&gt;%.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On March 28, 2025, the Company filed a writ of mandamus with the Brazilian Federal Court
challenging the enforceability of the newly enacted additional CSLL. The legal proceeding is grounded on constitutional and statutory
arguments, and is waiting for court decision to prevent the collection of the additional CSLL, which is scheduled to be disbursed in 2026
with respect to the 2025 fiscal year.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Considering that there is no court decision to date, the Company has recorded the amount
calculated in accordance with current legislation. The additional income tax expense as a result of Law 15,079/2024 for the year ended
December 31, 2025 was R$&lt;span id="xdx_901_eifrs-full--CurrentTaxLiabilitiesCurrent_iI_pn3n3_c20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--OrganizationForEconomicCooperationAndDevelopmentMember_z2JcxqbBhCvd" title="Income taxes payable"&gt;109,458&lt;/span&gt;, accounted as income taxes payable in the current liabilities. The Company has applied the exception to
recognizing and disclosing information about deferred tax assets and liabilities related to Pillar Two income taxes.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Deferred tax&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Deferred tax is provided using the liability method on temporary differences between the
tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Deferred tax liabilities are recognized for all taxable temporary differences, except:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%"&gt;&#x2022; When the deferred tax liability arises from the initial recognition of goodwill
or an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the
accounting profit nor taxable profit or loss and does not give rise to equal taxable and deductible temporary differences;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#x2022; In respect of taxable temporary differences associated with investments in subsidiaries,
associates and interests in joint arrangements, when the timing of the reversal of the temporary differences can be controlled and it
is probable that the temporary differences will not reverse in the foreseeable future.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Deferred tax assets are recognized to the extent that it is probable that taxable profit
will be available against which the deductible temporary differences, and the carry forward of unused tax credits and unused tax losses
can be utilized, except when the deferred tax asset relating to the deductible temporary difference arises from the initial recognition
of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the
accounting profit nor taxable profit or loss and does not give rise to equal taxable and deductible temporary differences.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The carrying amount of deferred tax assets is reviewed at each reporting date and reduced
to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax
asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it
has become probable that future taxable profits will allow the deferred tax asset to be recovered.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company offsets deferred tax assets and deferred tax liabilities if and only if it
has a legally enforceable right to set off current tax assets and current tax liabilities and the deferred tax assets and deferred tax
liabilities relate to income taxes levied by the same taxation authority by the same taxable entity.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Sales tax&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Expenses and assets are recognized net of the amount of sales tax, except:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%"&gt;&#x2022; When the sales tax incurred on a purchase of assets or services is not recoverable
from the taxation authority, in which case, the sales tax is recognized as part of the cost of acquisition of the asset or as part of
the expense item, as applicable;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#x2022; When receivables and payables are stated with the amount of sales tax included.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2025-01-012025-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember"
      decimals="INF"
      id="Fact001201"
      unitRef="Pure">0.0065</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2025-01-012025-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_TeachingActivitiesMember"
      decimals="INF"
      id="Fact001203"
      unitRef="Pure">0.0300</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2025-01-012025-12-31_custom_ProgramOfSocialIntegrationMember_custom_NonTeachingActivitiesMember"
      decimals="INF"
      id="Fact001205"
      unitRef="Pure">0.0165</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2025-01-012025-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_NonTeachingActivitiesMember"
      decimals="INF"
      id="Fact001207"
      unitRef="Pure">0.076</ifrs-full:ApplicableTaxRate>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="From2024-12-262024-12-27_custom_OrganizationForEconomicCooperationAndDevelopmentMember"
      decimals="INF"
      id="Fact001209"
      unitRef="Pure">0.15</ifrs-full:AverageEffectiveTaxRate>
    <afya:ConsolidatedRevenues
      contextRef="From2024-12-262024-12-27_custom_OrganizationForEconomicCooperationAndDevelopmentMember"
      decimals="-6"
      id="Fact001211"
      unitRef="EUR">750000000</afya:ConsolidatedRevenues>
    <afya:MinimumTaxRate
      contextRef="From2024-12-262024-12-27_custom_OrganizationForEconomicCooperationAndDevelopmentMember"
      decimals="INF"
      id="Fact001213"
      unitRef="Pure">0.15</afya:MinimumTaxRate>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="AsOf2025-12-31_custom_OrganizationForEconomicCooperationAndDevelopmentMember"
      decimals="-3"
      id="Fact001215"
      unitRef="BRL">109458000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001217">&lt;p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForTreasurySharesExplanatory_zDR93UtWX9Xl" style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;r) &lt;span id="xdx_86E_zynYSJo8MDId"&gt;Treasury shares&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Own equity instruments that are reacquired (treasury shares) are recognized at cost and
deducted from equity. No gain or loss is recognized in profit or loss on the purchase, sale, transfers under the share-based payments,
issue or cancellation of the Company&#x2019;s own equity instruments. Any difference between the carrying amount and the consideration,
if reissued, is recognized in the share premium.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;2.4 Changes in accounting policies and disclosures&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;New and amended standards and interpretations&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The following standards and amendments, which are effective for annual periods beginning
on or after January 1, 2025, have been issued but are not applicable to the Company&#x2019;s operations or consolidated financial statements.&lt;/p&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;&lt;/i&gt;&lt;/p&gt;








&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_z2lTvolZvvn6" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 5)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_8B6_zJFR57MUEwle" style="display: none"&gt;Schedule
    of changes in accounting policies and disclosures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Amendment / standard&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS21Member_z8XUqBspnetd" title="Standard"&gt;Lack of exchangeability &#x2013; Amendments to IAS 21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--LackOfExchangeabilityAmendmentsToIAS21Member_gIFDONOCIAP-GOL_ztYW68Jhqa63" title="Description"&gt;In August 2023, the IASB issued amendments to IAS 21 The Effects of Changes in Foreign Exchange
    Rates to specify how an entity should assess whether a currency is exchangeable and how it should determine a spot exchange rate when
    exchangeability is lacking. The amendments also require disclosure of information that enables users of its financial statements to understand
    how the currency not being exchangeable into the other currency affects, or is expected to affect, the entity&#x2019;s financial performance,
    financial position and cash flows.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C00_gIFDONOCIAP-GOL_ztsgVBnFLjv"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments had no impact on the Company&#x2019;s accounting policies, which remained
    unchanged in these  consolidated financial statements for the year ended December 31, 2025.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Standards issued but not yet effective&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 24%; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The new and amended standards and interpretations that are issued, but not yet effective,
up to the date of issuance of the Company&#x2019;s  consolidated financial statements are presented below. The Company has not
early adopted any other standard, interpretation or amendment that has been issued but is not yet effective. The Company intends to adopt
these new and amended standards and interpretations, if applicable, when they become effective.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Amendment / standard&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_zLUko5jePu6c" title="Standard"&gt;Classification and Measurement of Financial Instruments - Amendments to IFRS 9 and IFRS 7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-BAAR_zkjlISvlyJ43" title="Description"&gt;In May 2024, the IASB issued Amendments to the Classification and Measurement of Financial
    Instruments (Amendments to IFRS 9 and IFRS 7), which:&lt;/span&gt;&lt;/p&gt;
    &lt;div id="xdx_C0A_gIFDONOCIAP-BAAR_zkExD70L8Wu5"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Clarifies that a financial liability is derecognized on the &#x2018;settlement date&#x2019;,
    i.e., when the related obligation is discharged, cancelled, expires or the liability otherwise qualifies for derecognition. It also introduces
    an accounting policy option to derecognize financial liabilities that are settled through an electronic payment system before settlement
    date if certain conditions are met&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C05_gIFDONOCIAP-BAAR_zl5EKJmYu0D6"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Clarified how to assess the contractual cash flow characteristics of financial assets
    that include environmental, social and governance (ESG)-linked features and other similar contingent features&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C0C_gIFDONOCIAP-BAAR_zXZjZnmDVoka"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Clarifies the treatment of non-recourse assets and contractually linked instruments&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C08_gIFDONOCIAP-BAAR_zGNTWdsE70dd"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Requires additional disclosures in IFRS 7 for financial assets and liabilities with
    contractual terms that reference a contingent event (including those that are ESG-linked), and equity instruments classified at fair value
    through other comprehensive income&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0A_gIFDONOCIAP-BAAR_zITb02JpFPWc"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Entities can early adopt the amendments that relate to the classification of financial assets plus the related disclosures and
    apply the other amendments later.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0F_gIFDONOCIAP-BAAR_z0cxvEBa6aYf"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments are not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_zZMM05VKXtCd" title="Standard"&gt;Annual Improvements to IFRS Accounting Standards - Volume 11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_gIFDONOCIAP-WCSGRG_zybD7ZfXRgpk" title="Description"&gt;In July 2024, the IASB issued Annual Improvements to IFRS Accounting Standards - Volume
    11. The following is a summary of the topics subject to amendments from the Annual Improvements to IFRS Accounting Standards - Volume
    11:&lt;/span&gt;&lt;/p&gt;
    &lt;div id="xdx_C0A_gIFDONOCIAP-WCSGRG_zxAD1eGVVtBh"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IFRS 1 First-time Adoption of International Financial Reporting Standards&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C0D_gIFDONOCIAP-WCSGRG_znk2wakMtSe1"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IFRS 7 Financial Instruments: Disclosures: Gain or Loss on Derecognition&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C0F_gIFDONOCIAP-WCSGRG_zliiiu9lVw48"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Guidance on implementing IFRS 7 Financial Instruments: Disclosures&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C05_gIFDONOCIAP-WCSGRG_zGd4UI1Blmv8"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IFRS 9 Financial Instruments&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C01_gIFDONOCIAP-WCSGRG_zx4B8x3qLari"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IFRS 10 Consolidated Financial Statements&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C00_gIFDONOCIAP-WCSGRG_z9bOzr2sDbL1"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IAS 7 Statement of Cash Flows&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C05_gIFDONOCIAP-WCSGRG_zvrWub3MXcHg"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;These amendments are effective for annual periods beginning on or after January 1, 2026.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C05_gIFDONOCIAP-WCSGRG_z4adLiUXIh56"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments are not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_z7y593ZhC2Fd" title="Standard"&gt;Nature-dependent Electricity Contracts &#x2013; Amendments to IFRS 9 and IFRS 7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-NDD_zo9W1bJrgfR1" title="Description"&gt;In December 2024, the IASB issued Contracts Referencing Nature-dependent Electricity (Amendments
    to IFRS 9 and IFRS 7), clarifying the application of the &#x2018;own-use&#x2019; requirements; permitting hedge accounting if these contracts
    are used as hedging instruments; and adding new disclosure requirements to enable investors to understand the effect of these contracts
    on a company&#x2019;s financial performance and cash flows.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0B_gIFDONOCIAP-NDD_zJ4HQK4N9f39"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Early adoption is permitted, but will need to be disclosed.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C00_gIFDONOCIAP-NDD_zUqyDVEPe8tk"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments are not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_zjKS3Rce4spl" title="Standard"&gt;IFRS 18 &#x2013; Presentation and Disclosure in Financial Statements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_gIFDONOCIAP-XTV_zJYW1fCYY9l7" title="Description"&gt;In April 2024, the IASB issued IFRS 18, which replaces IAS 1 Presentation of Financial Statements.
    IFRS 18 introduces new requirements for presentation within the statement of income, including specified totals and subtotals. Furthermore,
    entities are required to classify all income and expenses within the statement of income into one of five categories: operating, investing,
    financing, income taxes and discontinued operations, whereof the first three are new.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0C_gIFDONOCIAP-XTV_z0z3tJ4qoMj5"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;It also requires disclosure of management-defined performance measures, subtotals of income
    and expenses and includes new requirements for aggregation and disaggregation of financial information based on the identified &#x201c;roles&#x201d;
    of the primary financial statements (PFS) and the notes.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C07_gIFDONOCIAP-XTV_zDB2Ec8H07d5"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;In addition, narrow-scope amendments have been made to IAS 7 Statement of Cash Flows, which
    include changing the starting point for determining cash flows from operations under the indirect method, from &#x2018;profit or loss&#x2019;
    to &#x2018;operating profit or loss&#x2019; and removing the optionality around classification of cash flows from dividends and interest.
    In addition, there are consequential amendments to several other standards.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0E_gIFDONOCIAP-XTV_z7Lw8rr9h7P2"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;IFRS 18, and the amendments to the other standards, is effective for reporting periods beginning
    on or after January 1, 2027 and must be applied retrospectively. Early adoption is permitted and must be disclosed.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C04_gIFDONOCIAP-XTV_zwXw9WdU0HY3"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The Company is currently working to identify all IFRS 18 impacts on the consolidated financial
    statements.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A7_zQ4teMoATgy2" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;2.5 Significant accounting judgments, estimates and assumptions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The preparation of the Company&#x2019;s consolidated financial statements requires management
to make judgments, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the accompanying
disclosures. Uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment to the carrying
amount of assets or liabilities affected in future periods. Accounting estimates and judgments are continually evaluated and are based
on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revisions to estimates are recognized prospectively.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Other disclosures relating to the Company&#x2019;s exposure to risks and uncertainties include:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#x2022; Financial instruments risk management objectives and policies - Note 12.4&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#x2022; Sensitivity analysis - Note 12.4.1&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;&lt;i&gt;Estimates and assumptions&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The key assumptions about the future and other key sources of estimated uncertainty as
of the reporting date that include a significant risk of a material adjustment to the carrying amounts of assets and liabilities within
the next financial year, are described below. The Company based its assumptions and estimates on parameters available when the consolidated
financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market
changes or circumstances that arise and that are beyond the Company&#x2019;s control. Such changes are reflected in the assumptions when
they occur.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Identification and fair-value measurement of assets and liabilities
acquired in a business combination&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Business combinations are accounted for using the acquisition method. Such method requires
recognizing and measuring the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree.
The Company, as the acquirer, must classify or designate the identifiable assets and liabilities assumed on the basis of its own contractual
terms, economic conditions, operating and accounting policies and other relevant conditions as at the acquisition date. Moreover, the
acquisition method required the fair value measurement of contingent consideration liabilities, when applicable, such as the Unidom consideration
conditioned upon the maintenance of the authorization of the 175 operating medical school seats. Such assessments require judgments from
the Company on the methods used to determine the fair value of the consideration transferred, including contingent consideration, assets
acquired and liabilities assumed, including valuation techniques that may require prospective financial information inputs.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Impairment of non-financial assets&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Impairment exists when the carrying amount of an asset or CGU or group of CGUs exceeds
its recoverable amount, defined as the higher of its fair value less costs of disposal and its value in use. The fair value less costs
of disposal calculation is based on data available from binding sales transactions, conducted at arm&#x2019;s length, for similar assets
or observable market prices less incremental costs of disposing of the asset. The value in use calculation is based on a discounted cash
flow model (&#x201c;DCF&#x201d; model). The cash flows are derived from the budget for the next five years and do not include restructuring
activities to which the Company has not yet committed or significant future investments that will enhance the performance of the assets
of the CGU being tested. The recoverable amount is sensitive to the discount rate used for the DCF model as well as to expected future
cash-inflows and the growth rate used for extrapolation purposes.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;These estimates are most relevant to goodwill and indefinite lived intangible assets recognized
by the Company. The key assumptions used to determine the recoverable amount for each CGU, including a sensitivity analysis, are disclosed
and further explained in Note 11.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;






&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Provision for legal proceedings&lt;/i&gt;&lt;/p&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Provisions for labor, tax, and civil risks are recorded for all legal proceedings that
represent probable losses. The assessment of the probability of loss includes the evaluation of available evidence, such as recent court
decisions and the opinion of the Company's internal and external legal counsel, the nature of the proceedings, and past experience.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Provisions are reviewed and adjusted to account for changes in circumstances, such as new
matters or court rulings.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Share-based compensation&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Estimating fair value for share-based payment transactions requires determination of the
most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of
the most appropriate inputs to the valuation model including the expected life of the share option, volatility and dividend yield and
making assumptions about them. For the measurement of the fair value of equity-settled transactions, the Company uses the Binomial model.
The assumptions and models used for estimating fair value for share-based payment transactions are disclosed in Note 14.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Leases - Estimating the incremental borrowing rate&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company cannot readily determine the interest rate implicit in the lease, therefore,
it uses its incremental borrowing rate (IBR) to measure lease liabilities. The IBR is the rate of interest that the Company would have
to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use
asset in a similar economic environment. The IBR therefore reflects what the Company &#x2018;would have to pay&#x2019;, which requires estimation
when no observable rates are available (such as for subsidiaries that do not enter into financing transactions) or when they need to be
adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary&#x2019;s functional currency).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company estimates the IBR using observable inputs (such as market interest rates) when
available and is required to make certain entity-specific estimates.&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory>
    <afya:ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001221">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory_z2lTvolZvvn6" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Material accounting policies (Details 5)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_8B6_zJFR57MUEwle" style="display: none"&gt;Schedule
    of changes in accounting policies and disclosures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Amendment / standard&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_903_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AmendmentsToIAS21Member_z8XUqBspnetd" title="Standard"&gt;Lack of exchangeability &#x2013; Amendments to IAS 21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--LackOfExchangeabilityAmendmentsToIAS21Member_gIFDONOCIAP-GOL_ztYW68Jhqa63" title="Description"&gt;In August 2023, the IASB issued amendments to IAS 21 The Effects of Changes in Foreign Exchange
    Rates to specify how an entity should assess whether a currency is exchangeable and how it should determine a spot exchange rate when
    exchangeability is lacking. The amendments also require disclosure of information that enables users of its financial statements to understand
    how the currency not being exchangeable into the other currency affects, or is expected to affect, the entity&#x2019;s financial performance,
    financial position and cash flows.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C00_gIFDONOCIAP-GOL_ztsgVBnFLjv"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments had no impact on the Company&#x2019;s accounting policies, which remained
    unchanged in these  consolidated financial statements for the year ended December 31, 2025.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Standards issued but not yet effective&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 24%; text-indent: -21.3pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The new and amended standards and interpretations that are issued, but not yet effective,
up to the date of issuance of the Company&#x2019;s  consolidated financial statements are presented below. The Company has not
early adopted any other standard, interpretation or amendment that has been issued but is not yet effective. The Company intends to adopt
these new and amended standards and interpretations, if applicable, when they become effective.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Amendment / standard&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_90F_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_zLUko5jePu6c" title="Standard"&gt;Classification and Measurement of Financial Instruments - Amendments to IFRS 9 and IFRS 7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-BAAR_zkjlISvlyJ43" title="Description"&gt;In May 2024, the IASB issued Amendments to the Classification and Measurement of Financial
    Instruments (Amendments to IFRS 9 and IFRS 7), which:&lt;/span&gt;&lt;/p&gt;
    &lt;div id="xdx_C0A_gIFDONOCIAP-BAAR_zkExD70L8Wu5"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Clarifies that a financial liability is derecognized on the &#x2018;settlement date&#x2019;,
    i.e., when the related obligation is discharged, cancelled, expires or the liability otherwise qualifies for derecognition. It also introduces
    an accounting policy option to derecognize financial liabilities that are settled through an electronic payment system before settlement
    date if certain conditions are met&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C05_gIFDONOCIAP-BAAR_zl5EKJmYu0D6"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Clarified how to assess the contractual cash flow characteristics of financial assets
    that include environmental, social and governance (ESG)-linked features and other similar contingent features&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C0C_gIFDONOCIAP-BAAR_zXZjZnmDVoka"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Clarifies the treatment of non-recourse assets and contractually linked instruments&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C08_gIFDONOCIAP-BAAR_zGNTWdsE70dd"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Requires additional disclosures in IFRS 7 for financial assets and liabilities with
    contractual terms that reference a contingent event (including those that are ESG-linked), and equity instruments classified at fair value
    through other comprehensive income&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0A_gIFDONOCIAP-BAAR_zITb02JpFPWc"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Entities can early adopt the amendments that relate to the classification of financial assets plus the related disclosures and
    apply the other amendments later.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0F_gIFDONOCIAP-BAAR_z0cxvEBa6aYf"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments are not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_901_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_zZMM05VKXtCd" title="Standard"&gt;Annual Improvements to IFRS Accounting Standards - Volume 11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--AnnualImprovementsToIFRSAccountingStandardsVolume11Member_gIFDONOCIAP-WCSGRG_zybD7ZfXRgpk" title="Description"&gt;In July 2024, the IASB issued Annual Improvements to IFRS Accounting Standards - Volume
    11. The following is a summary of the topics subject to amendments from the Annual Improvements to IFRS Accounting Standards - Volume
    11:&lt;/span&gt;&lt;/p&gt;
    &lt;div id="xdx_C0A_gIFDONOCIAP-WCSGRG_zxAD1eGVVtBh"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IFRS 1 First-time Adoption of International Financial Reporting Standards&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C0D_gIFDONOCIAP-WCSGRG_znk2wakMtSe1"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IFRS 7 Financial Instruments: Disclosures: Gain or Loss on Derecognition&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C0F_gIFDONOCIAP-WCSGRG_zliiiu9lVw48"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; Guidance on implementing IFRS 7 Financial Instruments: Disclosures&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C05_gIFDONOCIAP-WCSGRG_zGd4UI1Blmv8"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IFRS 9 Financial Instruments&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C01_gIFDONOCIAP-WCSGRG_zx4B8x3qLari"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IFRS 10 Consolidated Financial Statements&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C00_gIFDONOCIAP-WCSGRG_z9bOzr2sDbL1"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#x2022; IAS 7 Statement of Cash Flows&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C05_gIFDONOCIAP-WCSGRG_zvrWub3MXcHg"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;These amendments are effective for annual periods beginning on or after January 1, 2026.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C05_gIFDONOCIAP-WCSGRG_z4adLiUXIh56"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments are not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_z7y593ZhC2Fd" title="Standard"&gt;Nature-dependent Electricity Contracts &#x2013; Amendments to IFRS 9 and IFRS 7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member_gIFDONOCIAP-NDD_zo9W1bJrgfR1" title="Description"&gt;In December 2024, the IASB issued Contracts Referencing Nature-dependent Electricity (Amendments
    to IFRS 9 and IFRS 7), clarifying the application of the &#x2018;own-use&#x2019; requirements; permitting hedge accounting if these contracts
    are used as hedging instruments; and adding new disclosure requirements to enable investors to understand the effect of these contracts
    on a company&#x2019;s financial performance and cash flows.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0B_gIFDONOCIAP-NDD_zJ4HQK4N9f39"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Early adoption is permitted, but will need to be disclosed.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C00_gIFDONOCIAP-NDD_zUqyDVEPe8tk"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The amendments are not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span id="xdx_902_eifrs-full--TitleOfInitiallyAppliedIFRS_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_zjKS3Rce4spl" title="Standard"&gt;IFRS 18 &#x2013; Presentation and Disclosure in Financial Statements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 81%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfNatureOfChangeInAccountingPolicy_c20250101__20251231__ifrs-full--InitiallyAppliedIFRSsAxis__custom--IFRS18PresentationAndDisclosureInFinancialStatementsMember_gIFDONOCIAP-XTV_zJYW1fCYY9l7" title="Description"&gt;In April 2024, the IASB issued IFRS 18, which replaces IAS 1 Presentation of Financial Statements.
    IFRS 18 introduces new requirements for presentation within the statement of income, including specified totals and subtotals. Furthermore,
    entities are required to classify all income and expenses within the statement of income into one of five categories: operating, investing,
    financing, income taxes and discontinued operations, whereof the first three are new.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0C_gIFDONOCIAP-XTV_z0z3tJ4qoMj5"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;It also requires disclosure of management-defined performance measures, subtotals of income
    and expenses and includes new requirements for aggregation and disaggregation of financial information based on the identified &#x201c;roles&#x201d;
    of the primary financial statements (PFS) and the notes.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C07_gIFDONOCIAP-XTV_zDB2Ec8H07d5"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;In addition, narrow-scope amendments have been made to IAS 7 Statement of Cash Flows, which
    include changing the starting point for determining cash flows from operations under the indirect method, from &#x2018;profit or loss&#x2019;
    to &#x2018;operating profit or loss&#x2019; and removing the optionality around classification of cash flows from dividends and interest.
    In addition, there are consequential amendments to several other standards.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C0E_gIFDONOCIAP-XTV_z7Lw8rr9h7P2"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;IFRS 18, and the amendments to the other standards, is effective for reporting periods beginning
    on or after January 1, 2027 and must be applied retrospectively. Early adoption is permitted and must be disclosed.&lt;/p&gt;&lt;/div&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;
    &lt;div id="xdx_C04_gIFDONOCIAP-XTV_zwXw9WdU0HY3"&gt;&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;The Company is currently working to identify all IFRS 18 impacts on the consolidated financial
    statements.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfChangesInAccountingPoliciesAndDisclosuresExplanatory>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2025-01-012025-12-31_custom_AmendmentsToIAS21Member"
      id="Fact001223">Lack of exchangeability &#x2013; Amendments to IAS 21</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2025-01-012025-12-31_custom_LackOfExchangeabilityAmendmentsToIAS21Member"
      id="Fact001226">In August 2023, the IASB issued amendments to IAS 21 The Effects of Changes in Foreign Exchange
    Rates to specify how an entity should assess whether a currency is exchangeable and how it should determine a spot exchange rate when
    exchangeability is lacking. The amendments also require disclosure of information that enables users of its financial statements to understand
    how the currency not being exchangeable into the other currency affects, or is expected to affect, the entity&#x2019;s financial performance,
    financial position and cash flows.The amendments had no impact on the Company&#x2019;s accounting policies, which remained
    unchanged in these  consolidated financial statements for the year ended December 31, 2025.</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2025-01-012025-12-31_custom_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member"
      id="Fact001228">Classification and Measurement of Financial Instruments - Amendments to IFRS 9 and IFRS 7</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2025-01-012025-12-31_custom_ClassificationAndMeasurementOfFinancialInstrumentsAmendmentsToIFRS9AndIFRS7Member"
      id="Fact001236">In May 2024, the IASB issued Amendments to the Classification and Measurement of Financial
    Instruments (Amendments to IFRS 9 and IFRS 7), which:&#x2022; Clarifies that a financial liability is derecognized on the &#x2018;settlement date&#x2019;,
    i.e., when the related obligation is discharged, cancelled, expires or the liability otherwise qualifies for derecognition. It also introduces
    an accounting policy option to derecognize financial liabilities that are settled through an electronic payment system before settlement
    date if certain conditions are met&#x2022; Clarified how to assess the contractual cash flow characteristics of financial assets
    that include environmental, social and governance (ESG)-linked features and other similar contingent features&#x2022; Clarifies the treatment of non-recourse assets and contractually linked instruments&#x2022; Requires additional disclosures in IFRS 7 for financial assets and liabilities with
    contractual terms that reference a contingent event (including those that are ESG-linked), and equity instruments classified at fair value
    through other comprehensive incomeThe amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Entities can early adopt the amendments that relate to the classification of financial assets plus the related disclosures and
    apply the other amendments later.The amendments are not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2025-01-012025-12-31_custom_AnnualImprovementsToIFRSAccountingStandardsVolume11Member"
      id="Fact001238">Annual Improvements to IFRS Accounting Standards - Volume 11</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2025-01-012025-12-31_custom_AnnualImprovementsToIFRSAccountingStandardsVolume11Member"
      id="Fact001248">In July 2024, the IASB issued Annual Improvements to IFRS Accounting Standards - Volume
    11. The following is a summary of the topics subject to amendments from the Annual Improvements to IFRS Accounting Standards - Volume
    11:&#x2022; IFRS 1 First-time Adoption of International Financial Reporting Standards&#x2022; IFRS 7 Financial Instruments: Disclosures: Gain or Loss on Derecognition&#x2022; Guidance on implementing IFRS 7 Financial Instruments: Disclosures&#x2022; IFRS 9 Financial Instruments&#x2022; IFRS 10 Consolidated Financial Statements&#x2022; IAS 7 Statement of Cash FlowsThese amendments are effective for annual periods beginning on or after January 1, 2026.The amendments are not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2025-01-012025-12-31_custom_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member"
      id="Fact001250">Nature-dependent Electricity Contracts &#x2013; Amendments to IFRS 9 and IFRS 7</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2025-01-012025-12-31_custom_PowerPurchaseAgreementsAmendmentsToIFRS9AndIFRS7Member"
      id="Fact001254">In December 2024, the IASB issued Contracts Referencing Nature-dependent Electricity (Amendments
    to IFRS 9 and IFRS 7), clarifying the application of the &#x2018;own-use&#x2019; requirements; permitting hedge accounting if these contracts
    are used as hedging instruments; and adding new disclosure requirements to enable investors to understand the effect of these contracts
    on a company&#x2019;s financial performance and cash flows.The amendments will be effective for annual reporting periods beginning on or after January
    1, 2026. Early adoption is permitted, but will need to be disclosed.The amendments are not expected to have a material impact on the Company&#x2019;s consolidated
    financial statements.</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <ifrs-full:TitleOfInitiallyAppliedIFRS
      contextRef="From2025-01-012025-12-31_custom_IFRS18PresentationAndDisclosureInFinancialStatementsMember"
      id="Fact001256">IFRS 18 &#x2013; Presentation and Disclosure in Financial Statements</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy
      contextRef="From2025-01-012025-12-31_custom_IFRS18PresentationAndDisclosureInFinancialStatementsMember"
      id="Fact001262">In April 2024, the IASB issued IFRS 18, which replaces IAS 1 Presentation of Financial Statements.
    IFRS 18 introduces new requirements for presentation within the statement of income, including specified totals and subtotals. Furthermore,
    entities are required to classify all income and expenses within the statement of income into one of five categories: operating, investing,
    financing, income taxes and discontinued operations, whereof the first three are new.It also requires disclosure of management-defined performance measures, subtotals of income
    and expenses and includes new requirements for aggregation and disaggregation of financial information based on the identified &#x201c;roles&#x201d;
    of the primary financial statements (PFS) and the notes.In addition, narrow-scope amendments have been made to IAS 7 Statement of Cash Flows, which
    include changing the starting point for determining cash flows from operations under the indirect method, from &#x2018;profit or loss&#x2019;
    to &#x2018;operating profit or loss&#x2019; and removing the optionality around classification of cash flows from dividends and interest.
    In addition, there are consequential amendments to several other standards.IFRS 18, and the amendments to the other standards, is effective for reporting periods beginning
    on or after January 1, 2027 and must be applied retrospectively. Early adoption is permitted and must be disclosed.The Company is currently working to identify all IFRS 18 impacts on the consolidated financial
    statements.</ifrs-full:DescriptionOfNatureOfChangeInAccountingPolicy>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001265">&lt;p id="xdx_802_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_z3JxFLPwNRqc" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;3&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82D_zOWQU9rf8ml9"&gt;Segment information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company has three reportable segments as follows:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%"&gt;&#x2022; Undergraduate, previously denominated Undergrad, which provides educational
services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 3pt 3%"&gt;&#x2022; Continuing education, which provides medical education (including residency
preparation programs, specialization test preparation and other medical capabilities), specialization and graduate courses in medicine,
delivered through digital and in-person content; and&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#x2022; Medical practice solutions, which provides clinical decision, clinical management
and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Segment information is presented consistently with the internal reports provided to the
Company's Chief Executive Officer (CEO), which is the Chief Operating Decision Maker (CODM) and is responsible for allocating resources,
assessing the performance of the Company's operating segments, and making the Company's strategic decisions.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;No operating segments have been aggregated to form the reportable operating segments. There
is only one geographic region, and the results are monitored and evaluated based on the three reportable segments.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The tables below present assets and liabilities information for the Company&#x2019;s operating
segments as of December 31, 2025 and 2024:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_pn3n3_zSfK3M8sPhth" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Segment information (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zQbCp0YvgGU8" style="display: none"&gt;Schedule of present assets and liabilities information for the company operating
segments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Nunito Sans; margin: 0"&gt;&lt;b&gt;As of December 31, 2025&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Nunito Sans; margin: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment balances)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z0IDAw4jHPS7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,959,964&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhKKNNM0mfFh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;245,697&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zt62qO9dNl94" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;166,238&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zAkTkn5CCkM2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;9,371,899&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zrcDiT5vxQq7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(13,965)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Assets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpLEGHzzo0h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;9,357,934&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5ruOyFRbYZ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;1,765,066&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsWktpCmqBEh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;92,221&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zqTUsili2R3e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;98,854&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrDCgQ9p7n3f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;1,956,141&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zn1nKiEvc0fh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;(13,965)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3OlXnTazSAe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,942,176&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zdSRyzV7O4ub" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;7,194,898&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zXvNrvVOw064" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;153,476&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zt0KShXm39Bk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;67,384&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zQ0kgMRIFs0l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;7,415,958&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zXmOyjW5O8ne" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1302"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXkvXRg3XHkg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;7,415,758&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total liabilities and equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z8k4ovcS5Ze6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,959,964&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zAZL4gjm31d1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;245,697&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zp6bbVklz9M" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;166,238&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zmpCTizm3iA" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;9,371,899&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zi8vcYcx4Z7e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(13,965)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFbMO9lRNXR8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;9,357,934&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z85owyqqFng4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;689,074&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWTM74SMwxQ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;113,729&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zTbEXVx7qBYf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;95,203&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zyrbRY78RQK2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;898,006&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z207V2dhGwz3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;(13,965)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zT8CalH6QWTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;884,041&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjWmzGn2dUM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;3,474,357&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zoGfUrXntxud" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;84,581&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z1ePEVfZS3zj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;23,770&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrGojnsC3PA9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;3,582,708&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zdJ9PqmWvoGh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1338"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zArxUHsHbOXj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,582,708&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Equity&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_ziroTHJOayVh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;4,796,533&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zGhPN4u1NvPc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;47,387&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zGFb5X6QadB6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;47,265&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zhfAzQa4E3Gd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;4,891,185&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zDEckoRGCa6e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1350"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ztwzYi3L8Vdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;4,891,185&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Other disclosures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Investment in associate (i) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5ZTAlPIIs53" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;46,518&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zehfvGCMRDdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1356"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zj4fDftvGKB" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrrJviKeuFf9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;46,518&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zqxt4PrBlQSg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1362"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--InvestmentsInAssociates_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAyOm9Dm5eq1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;46,518&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Capital expenditures (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zMFtw1eAT74g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;281,313&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zt9of9eKhbxd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;79,139&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLflSDjO8589" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;43,559&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvCDQ3yj7Vf6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;404,011&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zBPhcNbewun6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1374"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z259tjoX5We5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;404,011&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Investment in UEPC is included in non-current assets in the statement of financial position.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Capital expenditures consider the acquisitions of property and equipment and intangible assets.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment balances)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z2LF7qhSBzxj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,393,185&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zKNwGOVhAeEi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;274,318&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zj8H9cNmymC6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;170,624&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZB2DUmNhWb8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,838,127&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zT10ExxrPNTe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(8,588)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYGEHCRy542b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,829,539&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zMlTmuiPL2rf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;1,443,566&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWnchmTlTxYb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;71,893&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z1WeQM32Mrn6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;82,913&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZUrdzsrET4i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;1,598,372&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zRPrBX1zhByc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;(8,588)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmSFAkViuqu7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,589,784&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zT3ESAIVxst8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;6,949,619&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzQaPambi3k9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;202,425&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zPRkQMeNyNYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;87,711&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zG9IfrjjMKdb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;7,239,755&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zjPJR9QjWyyj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1410"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbQozNjcQtk5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;7,239,755&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total liabilities and equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zSINTn1sKckl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,393,185&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_ze8A2jR6MO4l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;274,318&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ze9u4pRFomQg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;170,624&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zk6ElIR49Vxa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,838,127&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z8GuJNtkzVN4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(8,588)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5HoUTMapXYi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,829,539&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_znjxdRN6a5U6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;884,705&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFKaB9kwmC34" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;188,489&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_znc5WnXKg6u1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;75,589&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziO6npa9sii7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;1,148,783&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z0b1OG8aE1K" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;(8,588)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zix4bAYOMO9i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,140,195&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zUUPvH6fuvJ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;3,279,846&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhPCSJP4dF16" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;75,619&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zRPJ8U3p1EI8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;23,296&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z61dd8Z1aZRk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;3,378,761&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z2QqWhlxFCt5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1446"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zZVMZo4q2Qok" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,378,761&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Equity&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zYve7SyWjGOi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;4,228,634&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z9YIrw4PmNbf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;10,210&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zir62vAHUIWa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;71,739&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zqmZX2clNO3e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;4,310,583&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zYnOtQwrVGbd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1458"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8uEO0BCIWX2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;4,310,583&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Other disclosures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Investment in associate (i) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zbZbsQxEf44d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;54,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhCTgtN1C07" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1464"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zFlZypv1ZCnj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1466"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zVo3r5KpYT1l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;54,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_znpS8Xd6eDe7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1470"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUHE5RSocYvg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;54,442&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Capital expenditures (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zYKkEYUkXOL5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;301,368&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zkIyr5bk91Hi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;53,162&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zFQPaakrKWm3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;38,085&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zIqMjhB79Fpl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;392,615&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zNPGZORnzzP5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z7KWjBhTkMt" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;392,615&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Investment in UEPC is included in non-current assets in the statement of financial position.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Capital expenditures consider the acquisitions of property and equipment and intangible assets.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A1_zKTvBrzlghw4" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;








&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The tables below present the statements of income for the Company&#x2019;s operating segments
for the years ended December 31, 2025, 2024 and 2023:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_pn3n3_zlV9c1HZlyQb" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Segment information (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B3_zxYSJIfbBJ1f" style="display: none"&gt;Schedule of statements of income for the company&#x2019;s operating
segments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Nunito Sans; margin: 0"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Nunito Sans; margin: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;External customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zy1tUwUyUADa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;3,255,426&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zQvcf43sFzzh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;275,705&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zvIutQCpXlt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;166,124&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdjy8E85eiYh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;3,697,255&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zaQhbCuBZEo5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1498"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2q8YukRrlTb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;3,697,255&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zzGxg9eDhtj3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1502"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zr7PPPYIPRte" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;8,766&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zxmcM7nJqfX6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;5,199&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zm5pDuZo4B5k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;13,965&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3CfNyKrDkk4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;(13,965)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zkvmdqCvG7N2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1512"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zgtJHgIdWoR7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,255,426&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z4Vq3CArKr47" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;284,471&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zWttKLWZHCg7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;171,323&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z2shCJp1fm26" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,711,220&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zUF2XQoQc3ui" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(13,965)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zL1PzHZprqyf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,697,255&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zttXNdJA7Ne5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,176,785)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zaaUNiUOwLdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(96,346)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zaNhLMvx5trd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(54,729)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvQqLCRbz6l9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,327,860)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3tjdhLuAIqg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;13,965&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUX0Chni0r53" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,313,895)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zJa7u2x11Kab" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,078,641&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdWK02lcT0E8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;188,125&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zakNsS8XEcP6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;116,594&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zBmJbPpzL24k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,383,360&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zgZaWjp2sqR7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1546"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ze3cy6RpNyJc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,383,360&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;SG&amp;amp;A expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zsQ8RFW64ox4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"&gt;&lt;span style="font-size: 8pt"&gt;(1,113,065)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zahZHIYhqjUi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Allowance for expected credit losses"&gt;&lt;span style="font-size: 8pt"&gt;(57,090)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Other income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--OtherIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWBfPaRz5ou6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-size: 8pt"&gt;18,762&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Other expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--OtherGainsLosses_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfYI2NA4CPsb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-size: 8pt"&gt;(18,857)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Operating income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGTvmiEeHLW1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,213,110&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Finance income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinanceIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcipjbWqr7y1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-size: 8pt"&gt;194,943&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Finance expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinanceExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zjkmgaeSWpyi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-size: 8pt"&gt;(561,024)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Share of profit of equity-accounted investee, net of tax&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2yROqgskKyh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-size: 8pt"&gt;13,916&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zhMcSR9VyNk7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;860,945&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zV45npikcmc9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-size: 8pt"&gt;(92,502)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfitLoss_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfm1WQsz8uXg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;768,443&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;External customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zBWIPxykQn17" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;2,895,692&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0v4MTsDbOn5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;251,636&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ztCPWSJNQJYe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;157,001&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z7d0c2hb9tag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;3,304,329&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNqSPqzGiQQ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1580"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zT183rga31pk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;3,304,329&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zWR3FkKS8Kr1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1584"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znuytYBCVInh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;3,802&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zgpyI2upzxo4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;4,786&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zT4GubTFGLPh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;8,588&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zJ7uZZ2lYezl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;(8,588)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zaNYPQ6oli6c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1594"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5btkVQHaLZ7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,895,692&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zPdikYW8WLI3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;255,438&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zVyTc1f4ZgSj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;161,787&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zU7yPuVCQYs7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,312,917&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zGojnr9sWC7f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(8,588)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXQb1fTzg4t4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,304,329&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_znE9qbRRraVa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,086,081)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsaiV1k55mOj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(96,180)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zc0n48tL8g51" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(41,930)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zarm0F2DYLYk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,224,191)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zz1btLHuoW1h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;8,588&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxWaofoge8a4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,215,603)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjocHooAiff1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,809,611&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zDbRwSwPM77g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;159,258&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z85fEFwzuQ1g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;119,857&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zD1GCLbqr7Dc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,088,726&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zbBcl2EFfeTl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1628"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zP7vcl50NgJ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,088,726&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;SG&amp;amp;A expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z86ld6yA3Jqi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"&gt;&lt;span style="font-size: 8pt"&gt;(1,008,427)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zj7Hy5K1VuA8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Allowance for expected credit losses"&gt;&lt;span style="font-size: 8pt"&gt;(60,894)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Other income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--OtherIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zd2jDp8LO9s1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-size: 8pt"&gt;13,299&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Other expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--OtherGainsLosses_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zkvma7C067ke" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-size: 8pt"&gt;(20,591)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Operating income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zRmRQ6KIqTDb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,012,113&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Finance income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinanceIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3zT0jnjfS4l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-size: 8pt"&gt;111,283&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Finance expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinanceExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zo4LY5KrVD4k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-size: 8pt"&gt;(458,742)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Share of profit of equity-accounted investee, net of tax&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCYR34rtwRUc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-size: 8pt"&gt;11,737&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ProfitLossBeforeTax_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zHHNFga5ouQ5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;676,391&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAgfxqJd7dc2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-size: 8pt"&gt;(27,471)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ProfitLoss_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMVIHIivPYfi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;648,920&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;





&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;External customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zPZsxW6js1ua" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;2,511,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRqBPrXPZg27" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;227,181&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zJpTQYr3a1S" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;137,714&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zKImPt23t0P8" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;2,875,913&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zn1QYQ4ucN76" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1663"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z56QTe3JQgWd" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;2,875,913&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zxlpN3cYRQlc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1667"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zchtRXv5rWx5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;8,649&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLyHp2DSpUpj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;2,568&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJWcVSALG3c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;11,217&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z1uCXgRR1I9l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;(11,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z1TupQJ4Swcj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1677"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zXim7TUBLj72" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,511,018&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z35nJmQgwIZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;235,830&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zlLcmYX4vLqg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;140,282&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zobFF2vSoOOf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,887,130&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zoJd3B4Ud28g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zl9DyY9LCiNl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zf8SGki3wZw2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(997,973)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0gI8uZCvl57" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(91,915)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zChfF1NJAS06" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(31,142)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zE0lr67YA9H6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,121,030)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zP80YVjk7mJd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;11,217&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zDqY2iSHyKLh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,109,813)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zo7UraGR0W41" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,513,045&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zMHxzgoP5ZG" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;143,915&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ziC6iTIJ76ba" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;109,140&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zME1wBXQsR7e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,766,100&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAIY8FIQDERd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1711"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5ZvizdvLe0f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,766,100&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;SG&amp;amp;A expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zQHot6fEnyY5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"&gt;&lt;span style="font-size: 8pt"&gt;(940,132)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYXewfwlwK7e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Allowance for expected credit losses"&gt;&lt;span style="font-size: 8pt"&gt;(74,552)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Other income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--OtherIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIbmjr5sk3Ul" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-size: 8pt"&gt;53,206&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Other expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherGainsLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zY77776koTFh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-size: 8pt"&gt;(37,561)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Operating income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJzgZW3z9pDb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;767,061&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Finance income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinanceIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zZjvOdgB9aJ2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-size: 8pt"&gt;110,642&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Finance expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinanceExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zm2Os64kyz8k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-size: 8pt"&gt;(457,616)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Share of profit of equity-accounted investee, net of tax&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zeFV66qrZtch" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-size: 8pt"&gt;9,495&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlQ06Zi28mki" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;429,582&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdh1hrDVjKJb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-size: 8pt"&gt;(24,166)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ProfitLoss_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAFo3aRZMmLb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;405,416&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_z8cj1i9nMjc7" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
</ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001268">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_pn3n3_zSfK3M8sPhth" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Segment information (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zQbCp0YvgGU8" style="display: none"&gt;Schedule of present assets and liabilities information for the company operating
segments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Nunito Sans; margin: 0"&gt;&lt;b&gt;As of December 31, 2025&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Nunito Sans; margin: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment balances)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z0IDAw4jHPS7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,959,964&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhKKNNM0mfFh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;245,697&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zt62qO9dNl94" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;166,238&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zAkTkn5CCkM2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;9,371,899&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Assets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zrcDiT5vxQq7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(13,965)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Assets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zpLEGHzzo0h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;9,357,934&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5ruOyFRbYZ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;1,765,066&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsWktpCmqBEh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;92,221&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zqTUsili2R3e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;98,854&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrDCgQ9p7n3f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;1,956,141&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zn1nKiEvc0fh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;(13,965)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3OlXnTazSAe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,942,176&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zdSRyzV7O4ub" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;7,194,898&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zXvNrvVOw064" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;153,476&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zt0KShXm39Bk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;67,384&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zQ0kgMRIFs0l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;7,415,958&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentAssets_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zXmOyjW5O8ne" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1302"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentAssets_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXkvXRg3XHkg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;7,415,758&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total liabilities and equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z8k4ovcS5Ze6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,959,964&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zAZL4gjm31d1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;245,697&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zp6bbVklz9M" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;166,238&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zmpCTizm3iA" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;9,371,899&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zi8vcYcx4Z7e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(13,965)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--EquityAndLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFbMO9lRNXR8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;9,357,934&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z85owyqqFng4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;689,074&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWTM74SMwxQ" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;113,729&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zTbEXVx7qBYf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;95,203&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zyrbRY78RQK2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;898,006&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z207V2dhGwz3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;(13,965)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zT8CalH6QWTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;884,041&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjWmzGn2dUM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;3,474,357&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zoGfUrXntxud" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;84,581&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z1ePEVfZS3zj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;23,770&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrGojnsC3PA9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;3,582,708&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zdJ9PqmWvoGh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1338"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentLiabilities_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zArxUHsHbOXj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,582,708&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Equity&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_ziroTHJOayVh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;4,796,533&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zGhPN4u1NvPc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;47,387&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zGFb5X6QadB6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;47,265&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zhfAzQa4E3Gd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;4,891,185&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zDEckoRGCa6e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1350"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Equity_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ztwzYi3L8Vdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;4,891,185&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Other disclosures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Investment in associate (i) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5ZTAlPIIs53" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;46,518&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zehfvGCMRDdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1356"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zj4fDftvGKB" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InvestmentsInAssociates_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zrrJviKeuFf9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;46,518&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zqxt4PrBlQSg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1362"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--InvestmentsInAssociates_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAyOm9Dm5eq1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;46,518&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Capital expenditures (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zMFtw1eAT74g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;281,313&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zt9of9eKhbxd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;79,139&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLflSDjO8589" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;43,559&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvCDQ3yj7Vf6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;404,011&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zBPhcNbewun6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1374"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z259tjoX5We5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;404,011&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Investment in UEPC is included in non-current assets in the statement of financial position.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Capital expenditures consider the acquisitions of property and equipment and intangible assets.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment balances)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z2LF7qhSBzxj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,393,185&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zKNwGOVhAeEi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;274,318&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zj8H9cNmymC6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;170,624&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZB2DUmNhWb8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,838,127&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Assets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zT10ExxrPNTe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(8,588)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Assets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYGEHCRy542b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,829,539&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zMlTmuiPL2rf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;1,443,566&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWnchmTlTxYb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;71,893&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z1WeQM32Mrn6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;82,913&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZUrdzsrET4i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;1,598,372&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zRPrBX1zhByc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;(8,588)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmSFAkViuqu7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,589,784&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zT3ESAIVxst8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;6,949,619&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzQaPambi3k9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;202,425&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zPRkQMeNyNYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;87,711&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zG9IfrjjMKdb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;7,239,755&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentAssets_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zjPJR9QjWyyj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1410"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentAssets_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbQozNjcQtk5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;7,239,755&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total liabilities and equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zSINTn1sKckl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,393,185&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_ze8A2jR6MO4l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;274,318&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ze9u4pRFomQg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;170,624&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zk6ElIR49Vxa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,838,127&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z8GuJNtkzVN4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(8,588)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--EquityAndLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5HoUTMapXYi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;8,829,539&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_znjxdRN6a5U6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;884,705&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zFKaB9kwmC34" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;188,489&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_znc5WnXKg6u1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;75,589&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziO6npa9sii7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;1,148,783&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z0b1OG8aE1K" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;(8,588)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zix4bAYOMO9i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,140,195&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zUUPvH6fuvJ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;3,279,846&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhPCSJP4dF16" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;75,619&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zRPJ8U3p1EI8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;23,296&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z61dd8Z1aZRk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;3,378,761&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_z2QqWhlxFCt5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1446"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentLiabilities_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zZVMZo4q2Qok" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,378,761&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Equity&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zYve7SyWjGOi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;4,228,634&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z9YIrw4PmNbf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;10,210&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zir62vAHUIWa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;71,739&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zqmZX2clNO3e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;4,310,583&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Equity_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zYnOtQwrVGbd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1458"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Equity_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8uEO0BCIWX2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;4,310,583&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Other disclosures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Investment in associate (i) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zbZbsQxEf44d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;54,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhCTgtN1C07" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1464"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zFlZypv1ZCnj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1466"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zVo3r5KpYT1l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;54,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InvestmentsInAssociates_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_znpS8Xd6eDe7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1470"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--InvestmentsInAssociates_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUHE5RSocYvg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;54,442&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Capital expenditures (ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zYKkEYUkXOL5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;301,368&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zkIyr5bk91Hi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;53,162&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zFQPaakrKWm3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;38,085&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zIqMjhB79Fpl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;392,615&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentBalancesMember_zNPGZORnzzP5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CapitalExpenditures_iI_pn3n3_c20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z7KWjBhTkMt" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;392,615&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Investment in UEPC is included in non-current assets in the statement of financial position.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Capital expenditures consider the acquisitions of property and equipment and intangible assets.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001270"
      unitRef="BRL">8959964000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001272"
      unitRef="BRL">245697000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001274"
      unitRef="BRL">166238000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001276"
      unitRef="BRL">9371899000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      decimals="-3"
      id="Fact001278"
      unitRef="BRL">-13965000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001280"
      unitRef="BRL">9357934000</ifrs-full:Assets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001282"
      unitRef="BRL">1765066000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001284"
      unitRef="BRL">92221000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001286"
      unitRef="BRL">98854000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001288"
      unitRef="BRL">1956141000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      decimals="-3"
      id="Fact001290"
      unitRef="BRL">-13965000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001292"
      unitRef="BRL">1942176000</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001294"
      unitRef="BRL">7194898000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001296"
      unitRef="BRL">153476000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001298"
      unitRef="BRL">67384000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001300"
      unitRef="BRL">7415958000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001304"
      unitRef="BRL">7415758000</ifrs-full:NoncurrentAssets>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001306"
      unitRef="BRL">8959964000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001308"
      unitRef="BRL">245697000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001310"
      unitRef="BRL">166238000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001312"
      unitRef="BRL">9371899000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      decimals="-3"
      id="Fact001314"
      unitRef="BRL">-13965000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001316"
      unitRef="BRL">9357934000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001318"
      unitRef="BRL">689074000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001320"
      unitRef="BRL">113729000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001322"
      unitRef="BRL">95203000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001324"
      unitRef="BRL">898006000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      decimals="-3"
      id="Fact001326"
      unitRef="BRL">-13965000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001328"
      unitRef="BRL">884041000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001330"
      unitRef="BRL">3474357000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001332"
      unitRef="BRL">84581000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001334"
      unitRef="BRL">23770000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001336"
      unitRef="BRL">3582708000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001340"
      unitRef="BRL">3582708000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001342"
      unitRef="BRL">4796533000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001344"
      unitRef="BRL">47387000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001346"
      unitRef="BRL">47265000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001348"
      unitRef="BRL">4891185000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001352"
      unitRef="BRL">4891185000</ifrs-full:Equity>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001354"
      unitRef="BRL">46518000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001360"
      unitRef="BRL">46518000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001364"
      unitRef="BRL">46518000</ifrs-full:InvestmentsInAssociates>
    <afya:CapitalExpenditures
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001366"
      unitRef="BRL">281313000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001368"
      unitRef="BRL">79139000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001370"
      unitRef="BRL">43559000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001372"
      unitRef="BRL">404011000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001376"
      unitRef="BRL">404011000</afya:CapitalExpenditures>
    <ifrs-full:Assets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001378"
      unitRef="BRL">8393185000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001380"
      unitRef="BRL">274318000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001382"
      unitRef="BRL">170624000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001384"
      unitRef="BRL">8838127000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      decimals="-3"
      id="Fact001386"
      unitRef="BRL">-8588000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001388"
      unitRef="BRL">8829539000</ifrs-full:Assets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001390"
      unitRef="BRL">1443566000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001392"
      unitRef="BRL">71893000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001394"
      unitRef="BRL">82913000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001396"
      unitRef="BRL">1598372000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      decimals="-3"
      id="Fact001398"
      unitRef="BRL">-8588000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001400"
      unitRef="BRL">1589784000</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001402"
      unitRef="BRL">6949619000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001404"
      unitRef="BRL">202425000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001406"
      unitRef="BRL">87711000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001408"
      unitRef="BRL">7239755000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001412"
      unitRef="BRL">7239755000</ifrs-full:NoncurrentAssets>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001414"
      unitRef="BRL">8393185000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001416"
      unitRef="BRL">274318000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001418"
      unitRef="BRL">170624000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001420"
      unitRef="BRL">8838127000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      decimals="-3"
      id="Fact001422"
      unitRef="BRL">-8588000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001424"
      unitRef="BRL">8829539000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001426"
      unitRef="BRL">884705000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001428"
      unitRef="BRL">188489000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001430"
      unitRef="BRL">75589000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001432"
      unitRef="BRL">1148783000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_EliminationInterSegmentBalancesMember"
      decimals="-3"
      id="Fact001434"
      unitRef="BRL">-8588000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001436"
      unitRef="BRL">1140195000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001438"
      unitRef="BRL">3279846000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001440"
      unitRef="BRL">75619000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001442"
      unitRef="BRL">23296000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001444"
      unitRef="BRL">3378761000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001448"
      unitRef="BRL">3378761000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001450"
      unitRef="BRL">4228634000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001452"
      unitRef="BRL">10210000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001454"
      unitRef="BRL">71739000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001456"
      unitRef="BRL">4310583000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001460"
      unitRef="BRL">4310583000</ifrs-full:Equity>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001462"
      unitRef="BRL">54442000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001468"
      unitRef="BRL">54442000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001472"
      unitRef="BRL">54442000</ifrs-full:InvestmentsInAssociates>
    <afya:CapitalExpenditures
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001474"
      unitRef="BRL">301368000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001476"
      unitRef="BRL">53162000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001478"
      unitRef="BRL">38085000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001480"
      unitRef="BRL">392615000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001484"
      unitRef="BRL">392615000</afya:CapitalExpenditures>
    <ifrs-full:DisclosureOfOperatingSegmentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001488">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_pn3n3_zlV9c1HZlyQb" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Segment information (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B3_zxYSJIfbBJ1f" style="display: none"&gt;Schedule of statements of income for the company&#x2019;s operating
segments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 8pt Nunito Sans; margin: 0"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8pt Nunito Sans; margin: 0"&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;External customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zy1tUwUyUADa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;3,255,426&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zQvcf43sFzzh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;275,705&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zvIutQCpXlt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;166,124&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdjy8E85eiYh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;3,697,255&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zaQhbCuBZEo5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1498"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DepositsFromExternalCustomer_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2q8YukRrlTb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;3,697,255&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zzGxg9eDhtj3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1502"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zr7PPPYIPRte" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;8,766&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zxmcM7nJqfX6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;5,199&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zm5pDuZo4B5k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;13,965&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3CfNyKrDkk4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;(13,965)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zkvmdqCvG7N2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1512"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zgtJHgIdWoR7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,255,426&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z4Vq3CArKr47" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;284,471&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zWttKLWZHCg7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;171,323&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z2shCJp1fm26" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,711,220&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zUF2XQoQc3ui" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(13,965)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zL1PzHZprqyf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,697,255&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zttXNdJA7Ne5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,176,785)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zaaUNiUOwLdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(96,346)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zaNhLMvx5trd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(54,729)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zvQqLCRbz6l9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,327,860)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z3tjdhLuAIqg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;13,965&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CostOfSale_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUX0Chni0r53" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,313,895)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zJa7u2x11Kab" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,078,641&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdWK02lcT0E8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;188,125&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zakNsS8XEcP6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;116,594&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zBmJbPpzL24k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,383,360&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zgZaWjp2sqR7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1546"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--GrossProfit_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_ze3cy6RpNyJc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,383,360&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;SG&amp;amp;A expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zsQ8RFW64ox4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"&gt;&lt;span style="font-size: 8pt"&gt;(1,113,065)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zahZHIYhqjUi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Allowance for expected credit losses"&gt;&lt;span style="font-size: 8pt"&gt;(57,090)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Other income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--OtherIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWBfPaRz5ou6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-size: 8pt"&gt;18,762&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Other expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--OtherGainsLosses_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfYI2NA4CPsb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-size: 8pt"&gt;(18,857)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Operating income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGTvmiEeHLW1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,213,110&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Finance income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinanceIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcipjbWqr7y1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-size: 8pt"&gt;194,943&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Finance expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinanceExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zjkmgaeSWpyi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-size: 8pt"&gt;(561,024)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Share of profit of equity-accounted investee, net of tax&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z2yROqgskKyh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-size: 8pt"&gt;13,916&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zhMcSR9VyNk7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;860,945&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zV45npikcmc9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-size: 8pt"&gt;(92,502)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfitLoss_pn3n3_c20250101__20251231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfm1WQsz8uXg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;768,443&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;External customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zBWIPxykQn17" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;2,895,692&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0v4MTsDbOn5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;251,636&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ztCPWSJNQJYe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;157,001&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z7d0c2hb9tag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;3,304,329&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zNqSPqzGiQQ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1580"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zT183rga31pk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;3,304,329&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zWR3FkKS8Kr1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1584"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_znuytYBCVInh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;3,802&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zgpyI2upzxo4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;4,786&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zT4GubTFGLPh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;8,588&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zJ7uZZ2lYezl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;(8,588)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--InterSegment_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zaNYPQ6oli6c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1594"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z5btkVQHaLZ7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,895,692&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zPdikYW8WLI3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;255,438&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zVyTc1f4ZgSj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;161,787&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zU7yPuVCQYs7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,312,917&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zGojnr9sWC7f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(8,588)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Revenue_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXQb1fTzg4t4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;3,304,329&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_znE9qbRRraVa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,086,081)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsaiV1k55mOj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(96,180)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zc0n48tL8g51" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(41,930)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zarm0F2DYLYk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,224,191)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zz1btLHuoW1h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;8,588&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CostOfSale_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxWaofoge8a4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,215,603)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjocHooAiff1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,809,611&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zDbRwSwPM77g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;159,258&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z85fEFwzuQ1g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;119,857&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zD1GCLbqr7Dc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,088,726&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zbBcl2EFfeTl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1628"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--GrossProfit_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zP7vcl50NgJ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,088,726&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;SG&amp;amp;A expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z86ld6yA3Jqi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"&gt;&lt;span style="font-size: 8pt"&gt;(1,008,427)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zj7Hy5K1VuA8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Allowance for expected credit losses"&gt;&lt;span style="font-size: 8pt"&gt;(60,894)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Other income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--OtherIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zd2jDp8LO9s1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-size: 8pt"&gt;13,299&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Other expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--OtherGainsLosses_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zkvma7C067ke" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-size: 8pt"&gt;(20,591)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Operating income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zRmRQ6KIqTDb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,012,113&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Finance income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinanceIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3zT0jnjfS4l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-size: 8pt"&gt;111,283&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Finance expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinanceExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zo4LY5KrVD4k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-size: 8pt"&gt;(458,742)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Share of profit of equity-accounted investee, net of tax&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCYR34rtwRUc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-size: 8pt"&gt;11,737&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ProfitLossBeforeTax_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zHHNFga5ouQ5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;676,391&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAgfxqJd7dc2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-size: 8pt"&gt;(27,471)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ProfitLoss_pn3n3_c20240101__20241231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zMVIHIivPYfi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;648,920&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;





&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;External customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zPZsxW6js1ua" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;2,511,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRqBPrXPZg27" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;227,181&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zJpTQYr3a1S" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;137,714&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zKImPt23t0P8" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;2,875,913&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zn1QYQ4ucN76" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1663"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DepositsFromExternalCustomer_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z56QTe3JQgWd" style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-size: 8pt"&gt;2,875,913&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zxlpN3cYRQlc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1667"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zchtRXv5rWx5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;8,649&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLyHp2DSpUpj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;2,568&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJWcVSALG3c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;11,217&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z1uCXgRR1I9l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;(11,217)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InterSegment_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z1TupQJ4Swcj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1677"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zXim7TUBLj72" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,511,018&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z35nJmQgwIZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;235,830&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zlLcmYX4vLqg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;140,282&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zobFF2vSoOOf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,887,130&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zoJd3B4Ud28g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Revenue_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zl9DyY9LCiNl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zf8SGki3wZw2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(997,973)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0gI8uZCvl57" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(91,915)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zChfF1NJAS06" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(31,142)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zE0lr67YA9H6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,121,030)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zP80YVjk7mJd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;11,217&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CostOfSale_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zDqY2iSHyKLh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-size: 8pt"&gt;(1,109,813)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Gross profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zo7UraGR0W41" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,513,045&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zMHxzgoP5ZG" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;143,915&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_ziC6iTIJ76ba" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;109,140&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zME1wBXQsR7e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,766,100&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zAIY8FIQDERd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1711"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--GrossProfit_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5ZvizdvLe0f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;1,766,100&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;SG&amp;amp;A expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zQHot6fEnyY5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Selling, general and administrative expenses"&gt;&lt;span style="font-size: 8pt"&gt;(940,132)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--AllowanceForExpectedCreditLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYXewfwlwK7e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Allowance for expected credit losses"&gt;&lt;span style="font-size: 8pt"&gt;(74,552)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Other income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--OtherIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIbmjr5sk3Ul" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-size: 8pt"&gt;53,206&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Other expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherGainsLosses_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zY77776koTFh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-size: 8pt"&gt;(37,561)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Operating income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfitLossFromOperatingActivities_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJzgZW3z9pDb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;767,061&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Finance income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinanceIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zZjvOdgB9aJ2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-size: 8pt"&gt;110,642&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Finance expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinanceExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zm2Os64kyz8k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-size: 8pt"&gt;(457,616)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Share of profit of equity-accounted investee, net of tax&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zeFV66qrZtch" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-size: 8pt"&gt;9,495&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--ProfitLossBeforeTax_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlQ06Zi28mki" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;429,582&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;Income taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdh1hrDVjKJb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-size: 8pt"&gt;(24,166)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ProfitLoss_pn3n3_c20230101__20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zAFo3aRZMmLb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;405,416&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
    <afya:DepositsFromExternalCustomer
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001490"
      unitRef="BRL">3255426000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001492"
      unitRef="BRL">275705000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001494"
      unitRef="BRL">166124000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001496"
      unitRef="BRL">3697255000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001500"
      unitRef="BRL">3697255000</afya:DepositsFromExternalCustomer>
    <afya:InterSegment
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001504"
      unitRef="BRL">8766000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001506"
      unitRef="BRL">5199000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001508"
      unitRef="BRL">13965000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001510"
      unitRef="BRL">-13965000</afya:InterSegment>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001514"
      unitRef="BRL">3255426000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001516"
      unitRef="BRL">284471000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001518"
      unitRef="BRL">171323000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001520"
      unitRef="BRL">3711220000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001522"
      unitRef="BRL">-13965000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001524"
      unitRef="BRL">3697255000</ifrs-full:Revenue>
    <afya:CostOfSale
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001526"
      unitRef="BRL">-1176785000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001528"
      unitRef="BRL">-96346000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001530"
      unitRef="BRL">-54729000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001532"
      unitRef="BRL">-1327860000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001534"
      unitRef="BRL">13965000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001536"
      unitRef="BRL">-1313895000</afya:CostOfSale>
    <ifrs-full:GrossProfit
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001538"
      unitRef="BRL">2078641000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001540"
      unitRef="BRL">188125000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001542"
      unitRef="BRL">116594000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001544"
      unitRef="BRL">2383360000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001548"
      unitRef="BRL">2383360000</ifrs-full:GrossProfit>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001550"
      unitRef="BRL">1113065000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001552"
      unitRef="BRL">-57090000</afya:AllowanceForExpectedCreditLosses>
    <ifrs-full:OtherIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001554"
      unitRef="BRL">18762000</ifrs-full:OtherIncome>
    <ifrs-full:OtherGainsLosses
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001556"
      unitRef="BRL">-18857000</ifrs-full:OtherGainsLosses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001558"
      unitRef="BRL">1213110000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001560"
      unitRef="BRL">194943000</ifrs-full:FinanceIncome>
    <afya:FinanceExpense
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001562"
      unitRef="BRL">-561024000</afya:FinanceExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001564"
      unitRef="BRL">13916000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001566"
      unitRef="BRL">860945000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001568"
      unitRef="BRL">-92502000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001570"
      unitRef="BRL">768443000</ifrs-full:ProfitLoss>
    <afya:DepositsFromExternalCustomer
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001572"
      unitRef="BRL">2895692000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001574"
      unitRef="BRL">251636000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001576"
      unitRef="BRL">157001000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001578"
      unitRef="BRL">3304329000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001582"
      unitRef="BRL">3304329000</afya:DepositsFromExternalCustomer>
    <afya:InterSegment
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001586"
      unitRef="BRL">3802000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001588"
      unitRef="BRL">4786000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001590"
      unitRef="BRL">8588000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001592"
      unitRef="BRL">-8588000</afya:InterSegment>
    <ifrs-full:Revenue
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001596"
      unitRef="BRL">2895692000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001598"
      unitRef="BRL">255438000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001600"
      unitRef="BRL">161787000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001602"
      unitRef="BRL">3312917000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001604"
      unitRef="BRL">-8588000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001606"
      unitRef="BRL">3304329000</ifrs-full:Revenue>
    <afya:CostOfSale
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001608"
      unitRef="BRL">-1086081000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001610"
      unitRef="BRL">-96180000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001612"
      unitRef="BRL">-41930000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001614"
      unitRef="BRL">-1224191000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001616"
      unitRef="BRL">8588000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001618"
      unitRef="BRL">-1215603000</afya:CostOfSale>
    <ifrs-full:GrossProfit
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001620"
      unitRef="BRL">1809611000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001622"
      unitRef="BRL">159258000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001624"
      unitRef="BRL">119857000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001626"
      unitRef="BRL">2088726000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001630"
      unitRef="BRL">2088726000</ifrs-full:GrossProfit>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001632"
      unitRef="BRL">1008427000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001634"
      unitRef="BRL">-60894000</afya:AllowanceForExpectedCreditLosses>
    <ifrs-full:OtherIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001636"
      unitRef="BRL">13299000</ifrs-full:OtherIncome>
    <ifrs-full:OtherGainsLosses
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001638"
      unitRef="BRL">-20591000</ifrs-full:OtherGainsLosses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001640"
      unitRef="BRL">1012113000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001642"
      unitRef="BRL">111283000</ifrs-full:FinanceIncome>
    <afya:FinanceExpense
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001644"
      unitRef="BRL">-458742000</afya:FinanceExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001646"
      unitRef="BRL">11737000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001648"
      unitRef="BRL">676391000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001650"
      unitRef="BRL">-27471000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001652"
      unitRef="BRL">648920000</ifrs-full:ProfitLoss>
    <afya:DepositsFromExternalCustomer
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001655"
      unitRef="BRL">2511018000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001657"
      unitRef="BRL">227181000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001659"
      unitRef="BRL">137714000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001661"
      unitRef="BRL">2875913000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001665"
      unitRef="BRL">2875913000</afya:DepositsFromExternalCustomer>
    <afya:InterSegment
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001669"
      unitRef="BRL">8649000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001671"
      unitRef="BRL">2568000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001673"
      unitRef="BRL">11217000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001675"
      unitRef="BRL">-11217000</afya:InterSegment>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001679"
      unitRef="BRL">2511018000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001681"
      unitRef="BRL">235830000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001683"
      unitRef="BRL">140282000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001685"
      unitRef="BRL">2887130000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001687"
      unitRef="BRL">-11217000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001689"
      unitRef="BRL">2875913000</ifrs-full:Revenue>
    <afya:CostOfSale
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001691"
      unitRef="BRL">-997973000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001693"
      unitRef="BRL">-91915000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001695"
      unitRef="BRL">-31142000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001697"
      unitRef="BRL">-1121030000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      id="Fact001699"
      unitRef="BRL">11217000</afya:CostOfSale>
    <afya:CostOfSale
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001701"
      unitRef="BRL">-1109813000</afya:CostOfSale>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergraduateMember"
      decimals="-3"
      id="Fact001703"
      unitRef="BRL">1513045000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001705"
      unitRef="BRL">143915000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact001707"
      unitRef="BRL">109140000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001709"
      unitRef="BRL">1766100000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001713"
      unitRef="BRL">1766100000</ifrs-full:GrossProfit>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001715"
      unitRef="BRL">940132000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001717"
      unitRef="BRL">-74552000</afya:AllowanceForExpectedCreditLosses>
    <ifrs-full:OtherIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001719"
      unitRef="BRL">53206000</ifrs-full:OtherIncome>
    <ifrs-full:OtherGainsLosses
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001721"
      unitRef="BRL">-37561000</ifrs-full:OtherGainsLosses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001723"
      unitRef="BRL">767061000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001725"
      unitRef="BRL">110642000</ifrs-full:FinanceIncome>
    <afya:FinanceExpense
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001727"
      unitRef="BRL">-457616000</afya:FinanceExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001729"
      unitRef="BRL">9495000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001731"
      unitRef="BRL">429582000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001733"
      unitRef="BRL">-24166000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001735"
      unitRef="BRL">405416000</ifrs-full:ProfitLoss>
    <ifrs-full:DisclosureOfBusinessCombinationsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001737">&lt;p id="xdx_800_eifrs-full--DisclosureOfBusinessCombinationsExplanatory_zbEEnN6TPBEf" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;b&gt;4&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_827_z1aF6XL5KXf4"&gt;Business combinations&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;4.1 Acquisition in 2024 (Unidom)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify"&gt;On July 1, 2024, Afya Brazil acquired 100% of the share capital of
Unidom, a post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate
programs in medicine and health, as well as other courses. The fair values of the identifiable assets acquired and liabilities assumed
as of acquisition date were:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock_zDEMKjZWgrsa" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Business combinations (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B0_zkeUb1kFaXh5" style="display: none"&gt;Schedule of fair values of the identifiable assets acquired and liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 83%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Unidom&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zK0MlxswDzBa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-size: 7.5pt"&gt;3,272&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zcU0pQXR2Obi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-size: 7.5pt"&gt;9,368&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Advances&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--AdvancesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zmZBJD7RLy0f" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Advances"&gt;&lt;span style="font-size: 7.5pt"&gt;94&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Recoverable taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zhZSTIbMNsOh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-size: 7.5pt"&gt;82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z8qSPvR4Wdq8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other assets"&gt;&lt;span style="font-size: 7.5pt"&gt;854&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Indemnification assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IndemnificationAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zTjUKZA5C853" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-size: 7.5pt"&gt;7,185&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z5BbVzqzsVzk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-size: 7.5pt"&gt;5,709&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Rights-of-use assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zHUXZuYZ6Xr7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Rights-of-use assets"&gt;&lt;span style="font-size: 7.5pt"&gt;28,989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z2nuzWvWX7ef" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-size: 7.5pt"&gt;462,042&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zpjqvbbbXa7e" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;517,595&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zzLSYEr6qeC8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-size: 7.5pt"&gt;1,732&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LoansAndFinancingAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z9CCZXtMR5a3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-size: 7.5pt"&gt;4,377&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Labor and social obligations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zqcin45llBNc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-size: 7.5pt"&gt;7,368&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zZRhWNtwosSj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-size: 7.5pt"&gt;5,254&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Other taxes payable (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OtherTaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zrIb79ZxFjA7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other taxes payable"&gt;&lt;span style="font-size: 7.5pt"&gt;28,274&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Advances from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zy2y20LMSSRi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-size: 7.5pt"&gt;1,234&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zqb55dTwEBP4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-size: 7.5pt"&gt;28,989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Provision for legal proceedings&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z7A2jQo3pOBa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-size: 7.5pt"&gt;7,246&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zWpajxoyUOi2" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-size: 7.5pt"&gt;4,393&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zQqO6n8YhFic" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities recognised as of acquisition date"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;88,867&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Total identifiable net assets at fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zWeZWtY8QeG" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;428,728&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Goodwill arising on acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zaNykD1C1pt5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill arising on acquisition"&gt;&lt;span style="font-size: 7.5pt"&gt;192,034&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Purchase consideration transferred&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zy8juCLd7lji" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;620,762&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Cash paid&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CashTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zyFGFziSFK81" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-size: 7.5pt"&gt;340,773&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Consideration to be transferred&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zGbJrEKMUm2j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Consideration to be transferred"&gt;&lt;span style="font-size: 7.5pt"&gt;279,989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;i&gt;Analysis of cash flows on acquisition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transaction costs of the acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20240629__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zNbm8lyzhak8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Transaction costs of the acquisition (included in cash flows from operating activities)"&gt;&lt;span style="font-size: 7.5pt"&gt;1,793&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Cash paid net of cash acquired with the subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20240629__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zICBVH8O62T" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-size: 7.5pt"&gt;337,501&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Net of cash flow on acquisition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NetOfCashFlowOnAcquisition_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zLCahM7UOSKh" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;339,294&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to deferred tax liabilities arising from transactions prior to Afya&#x2019;s acquisition
of Unidom.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A6_zmytScREcl77" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify"&gt;The acquisition contributed with 300 operational medical school seats
to the Undergraduate segment. The authorization request for these 300 medical school seats was made to MEC before the Mais M&#xe9;dicos
Law was enacted and MEC concluded its analysis and issued Ordinance 630/2020 ("Ordinance") in 2020 to authorize the operation
considering 125 medical school seats. In 2021, as a result of a judicial order, MEC reviewed the Ordinance to authorize the 300 medical
school seats initially requested by Unidom. Such decision was confirmed by a federal judge in the State of Bahia in 2023. Currently,
Unidom has 300 medical school seats authorized, of which 125 are final and 175 are subject to a final conclusion of the aforementioned
court proceedings.&lt;/p&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0; text-align: justify"&gt;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfAcquiree_c20240629__20240701__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_z2Vs9R9UtlGa" title="Acquired purchase price"&gt;The total consideration of R$620,762, net of Net Debt, is comprised
of: (i) R$340,773 paid in cash on July 1, 2024; and (ii) R$279,989, considering purchase consideration adjustments, payable in up to ten
annual installments, adjusted by the CDI rate, and it is conditioned upon the maintenance of the authorization of the 175 medical school
seats in each of the prior year.&lt;/span&gt; The remaining payment balance is accelerated if a final and non-appealable conclusion of the aforementioned
court proceedings, within the 10-year payment period, confirms the authorization for the 175 medical school seats. In turn, if, within
the same 10-year payment period, a final and non-appealable conclusion of the aforementioned court proceedings does not confirm the authorization
for such 175 medical school seats, the remaining payment balance will no longer be due.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;This acquisition was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Transaction costs to date amount to R$&lt;span id="xdx_90D_ecustom--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zXK6gzWZ8fV6" title="Total transaction costs"&gt;2,755&lt;/span&gt;, which R$&lt;span id="xdx_90D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zl6VFzHp5Txa" title="Transaction costs"&gt;1,793&lt;/span&gt; were expensed in the year ended
December 31, 2024 (R$&lt;span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_uBRL_c20240101__20241231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zFqb930kN4Hf" title="Transaction costs"&gt;962&lt;/span&gt; in the year ended December 31, 2023) and are included in selling, general and administrative expenses in the
consolidated statement of income and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company measured the acquired lease liabilities using the present value of the remaining
lease payments at the date of acquisition. The right-of-use assets were measured at an amount equal to the lease liabilities.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;At the acquisition date, the fair value of the trade receivables acquired is substantially
the same as its carrying amount.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The goodwill recognized includes the value of expected synergies arising from the acquisition,
which is not separately recognized. Goodwill is allocated entirely to the Undergraduate segment. The goodwill recognized is not expected
to be deductible for income taxes purposes.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-align: justify"&gt;The Company did not recognize deferred taxes related to the business
combination because the tax basis and the accounting basis, including fair value adjustments, were the same at the date of the business
combination.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The fair value measurement of separately identified intangible assets acquired are based
on income approach, determined using discounted cash flows, which include significant estimates around revenue growth projections, operating
profit margins projections and discount rate. The Company engaged an independent valuation specialist to assist Management to assess the
fair value of the assets acquired and liabilities assumed at the date of acquisition. The valuation techniques used were as follows:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAcquisitionOfUnidomExplanatory_zj9bALLej2cg" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Business combinations (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td&gt;&lt;span id="xdx_8B4_z35CnO6fxUci" style="display: none"&gt;Schedule
    of intangible assets acquired unidom&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Intangible assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 74%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"&gt;&lt;b&gt;With-and-without method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20240629__20240701__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesAndFranchisesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfUnidomMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--WithAndWithoutMethodMember_zbPtdWQqJRub" title="Valuation technique"&gt;The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"&gt;&lt;b&gt;Multi-period excess earnings method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20240629__20240701__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfUnidomMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zxtNXFabTRpd" title="Valuation technique"&gt;The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A8_zy1meNcquKQd" style="font: 10.5pt Nunito Sans; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;From the date of acquisition, Unidom contributed R$&lt;span id="xdx_90E_eifrs-full--Revenue_pn3n3_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zZtpGIyjNkF" title="Net revenue"&gt;63,643&lt;/span&gt; of revenue and R$&lt;span id="xdx_900_eifrs-full--ProfitLossBeforeTax_pn3n3_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zM1BMk0wtF2c" title="Income loss before income taxes"&gt;30,013&lt;/span&gt; to income
before income taxes of the Company in the year ended December 31, 2024. If the acquisition had taken place at the beginning of the year,
revenue and income before income taxes for the year ended December 31, 2024 would have been R$&lt;span id="xdx_902_ecustom--IncreaseInRevenue_pn3n3_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zCxumhd2URwc" title="Increase in revenue"&gt;3,354,571&lt;/span&gt; and R$&lt;span id="xdx_90D_ecustom--IncreaseInIncomeBeforeIncomeTaxes_pn3n3_c20250101__20251231__ifrs-full--BusinessCombinationsAxis__custom--AcquisitionOfUnidomMember_zr9vfmrFLfFj" title="Increase in income before income taxes"&gt;697,449&lt;/span&gt;, respectively.&lt;/p&gt;

</ifrs-full:DisclosureOfBusinessCombinationsExplanatory>
    <afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001739">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock_zDEMKjZWgrsa" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Business combinations (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B0_zkeUb1kFaXh5" style="display: none"&gt;Schedule of fair values of the identifiable assets acquired and liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 83%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Unidom&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zK0MlxswDzBa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-size: 7.5pt"&gt;3,272&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zcU0pQXR2Obi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-size: 7.5pt"&gt;9,368&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Advances&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--AdvancesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zmZBJD7RLy0f" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Advances"&gt;&lt;span style="font-size: 7.5pt"&gt;94&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Recoverable taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zhZSTIbMNsOh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-size: 7.5pt"&gt;82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z8qSPvR4Wdq8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other assets"&gt;&lt;span style="font-size: 7.5pt"&gt;854&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Indemnification assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IndemnificationAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zTjUKZA5C853" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-size: 7.5pt"&gt;7,185&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z5BbVzqzsVzk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-size: 7.5pt"&gt;5,709&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Rights-of-use assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zHUXZuYZ6Xr7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Rights-of-use assets"&gt;&lt;span style="font-size: 7.5pt"&gt;28,989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z2nuzWvWX7ef" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-size: 7.5pt"&gt;462,042&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zpjqvbbbXa7e" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;517,595&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zzLSYEr6qeC8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-size: 7.5pt"&gt;1,732&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LoansAndFinancingAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z9CCZXtMR5a3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-size: 7.5pt"&gt;4,377&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Labor and social obligations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zqcin45llBNc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-size: 7.5pt"&gt;7,368&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zZRhWNtwosSj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-size: 7.5pt"&gt;5,254&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Other taxes payable (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OtherTaxesPayableAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zrIb79ZxFjA7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other taxes payable"&gt;&lt;span style="font-size: 7.5pt"&gt;28,274&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Advances from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zy2y20LMSSRi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-size: 7.5pt"&gt;1,234&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zqb55dTwEBP4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-size: 7.5pt"&gt;28,989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Provision for legal proceedings&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z7A2jQo3pOBa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-size: 7.5pt"&gt;7,246&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zWpajxoyUOi2" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-size: 7.5pt"&gt;4,393&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zQqO6n8YhFic" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities recognised as of acquisition date"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;88,867&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Total identifiable net assets at fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zWeZWtY8QeG" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;428,728&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Goodwill arising on acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zaNykD1C1pt5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill arising on acquisition"&gt;&lt;span style="font-size: 7.5pt"&gt;192,034&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Purchase consideration transferred&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zy8juCLd7lji" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;620,762&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Cash paid&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CashTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zyFGFziSFK81" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-size: 7.5pt"&gt;340,773&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Consideration to be transferred&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zGbJrEKMUm2j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Consideration to be transferred"&gt;&lt;span style="font-size: 7.5pt"&gt;279,989&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;i&gt;Analysis of cash flows on acquisition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transaction costs of the acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20240629__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zNbm8lyzhak8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Transaction costs of the acquisition (included in cash flows from operating activities)"&gt;&lt;span style="font-size: 7.5pt"&gt;1,793&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Cash paid net of cash acquired with the subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_pn3n3_c20240629__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zICBVH8O62T" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash paid net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-size: 7.5pt"&gt;337,501&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Net of cash flow on acquisition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NetOfCashFlowOnAcquisition_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zLCahM7UOSKh" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;339,294&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to deferred tax liabilities arising from transactions prior to Afya&#x2019;s acquisition
of Unidom.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAcquisitionTableTextBlock>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001741"
      unitRef="BRL">3272000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001743"
      unitRef="BRL">9368000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:AdvancesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001745"
      unitRef="BRL">94000</afya:AdvancesRecognisedAsOfAcquisitionDate>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001747"
      unitRef="BRL">82000</afya:RecoverableTaxesAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001749"
      unitRef="BRL">854000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:IndemnificationAssetsAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001751"
      unitRef="BRL">7185000</afya:IndemnificationAssetsAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001753"
      unitRef="BRL">5709000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001755"
      unitRef="BRL">28989000</afya:RightOfUseAssetsAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001757"
      unitRef="BRL">462042000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001759"
      unitRef="BRL">517595000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001761"
      unitRef="BRL">1732000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <afya:LoansAndFinancingAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001763"
      unitRef="BRL">4377000</afya:LoansAndFinancingAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001765"
      unitRef="BRL">7368000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001767"
      unitRef="BRL">5254000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:OtherTaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001769"
      unitRef="BRL">28274000</afya:OtherTaxesPayableAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001771"
      unitRef="BRL">1234000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001773"
      unitRef="BRL">28989000</afya:LeaseLiabilitiesAsOfAcquisitionDate>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001775"
      unitRef="BRL">7246000</afya:ProvisionForLegalProceedingsAsOfAcquisitionDate>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001777"
      unitRef="BRL">4393000</afya:OtherLiabilitiesAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001779"
      unitRef="BRL">88867000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001781"
      unitRef="BRL">428728000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001783"
      unitRef="BRL">192034000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001785"
      unitRef="BRL">620762000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001787"
      unitRef="BRL">340773000</ifrs-full:CashTransferred>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001789"
      unitRef="BRL">279989000</afya:ConsiderationToBeTransferred>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2024-06-292024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001791"
      unitRef="BRL">1793000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2024-06-292024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001793"
      unitRef="BRL">337501000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact001795"
      unitRef="BRL">339294000</afya:NetOfCashFlowOnAcquisition>
    <ifrs-full:DescriptionOfAcquiree
      contextRef="From2024-06-292024-07-01_custom_AcquisitionOfUnidomMember"
      id="Fact001797">The total consideration of R$620,762, net of Net Debt, is comprised
of: (i) R$340,773 paid in cash on July 1, 2024; and (ii) R$279,989, considering purchase consideration adjustments, payable in up to ten
annual installments, adjusted by the CDI rate, and it is conditioned upon the maintenance of the authorization of the 175 medical school
seats in each of the prior year.</ifrs-full:DescriptionOfAcquiree>
    <afya:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination
      contextRef="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember"
      decimals="-3"
      id="Fact001799"
      unitRef="BRL">2755000</afya:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionsOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember"
      decimals="-3"
      id="Fact001801"
      unitRef="BRL">1793000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2024-01-012024-12-31_custom_AcquisitionOfUnidomMember"
      decimals="-3"
      id="Fact001803"
      unitRef="BRL">962000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfUnidomExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001805">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAcquisitionOfUnidomExplanatory_zj9bALLej2cg" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Business combinations (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td&gt;&lt;span id="xdx_8B4_z35CnO6fxUci" style="display: none"&gt;Schedule
    of intangible assets acquired unidom&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Intangible assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 74%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Valuation technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"&gt;&lt;b&gt;With-and-without method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20240629__20240701__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesAndFranchisesMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfUnidomMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__custom--WithAndWithoutMethodMember_zbPtdWQqJRub" title="Valuation technique"&gt;The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"&gt;&lt;b&gt;Multi-period excess earnings method&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 7.5pt Nunito Sans; margin: 0; text-align: justify"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20240629__20240701__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AcquisitionOfUnidomMember__ifrs-full--MethodOfAssessmentOfExpectedCreditLossesAxis__ifrs-full--MultiperiodExcessEarningsMethodMember_zxtNXFabTRpd" title="Valuation technique"&gt;The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfUnidomExplanatory>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2024-06-292024-07-01_ifrs-full_LicencesAndFranchisesMember_custom_AcquisitionOfUnidomMember_custom_WithAndWithoutMethodMember"
      id="Fact001807">The with-and-without method consists of estimating the fair value of
    an asset by the difference between the value of this asset in two scenarios: a scenario considering the existence of the asset in question
    and another considering its non-existence.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue
      contextRef="From2024-06-292024-07-01_ifrs-full_CustomerrelatedIntangibleAssetsMember_custom_AcquisitionOfUnidomMember_ifrs-full_MultiperiodExcessEarningsMethodMember"
      id="Fact001809">The method considers the present value of net cash flows expected to
    be generated by customer relationships, by excluding any cash flows related to contributory assets.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember"
      decimals="-3"
      id="Fact001811"
      unitRef="BRL">63643000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember"
      decimals="-3"
      id="Fact001813"
      unitRef="BRL">30013000</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember"
      decimals="-3"
      id="Fact001815"
      unitRef="BRL">3354571000</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2025-01-012025-12-31_custom_AcquisitionOfUnidomMember"
      decimals="-3"
      id="Fact001817"
      unitRef="BRL">697449000</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <afya:DisclosuresOfCashAndCashEquivalentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001819">&lt;p id="xdx_805_ecustom--DisclosuresOfCashAndCashEquivalentsExplanatory_z0lEYkx6rx52" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;5&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_829_zvF0lnmuaA2"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_zJJ6dpRAmAo1" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Cash and cash equivalents (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BD_znVPwdwoRoS3" style="display: none"&gt;Schedule of cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49D_20251231_zBzTqHllkv1k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20241231_zXEsK4Uqjfnh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--Cash_iI_pn3n3_zWH9qacnoI17" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Cash and bank deposits&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;15,470 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;6,078 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CashEquivalents_iI_pn3n3_zLYIVr4C2oR4" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Cash equivalents&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;1,109,911 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;904,937 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_zXIyr34M4Rzf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b style="display: none"&gt;Cash and cash equivalents&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;1,125,381 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;911,015 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_z7OdyT4lDSjh" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Cash equivalents correspond to investment funds and Bank Certificates of Deposit (CDB)
with highly rated financial institutions, available for immediate use and have an insignificant risk of changes in value.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;As of December 31, 2025, the average interest on these investments is equivalent to &lt;span id="xdx_906_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_z3PZYQQqTfs3" title="Percentage of average interest"&gt;101.2&lt;/span&gt;%
of the CDI rate (December 31, 2024: &lt;span id="xdx_90F_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_z8HNS0Zdenbl" title="Percentage of average interest"&gt;99.1&lt;/span&gt;%). Cash equivalents denominated in U.S. dollars totaled R$&lt;span id="xdx_905_eifrs-full--CashEquivalents_iI_pn3n3_uBRL_c20251231__ifrs-full--CurrencyInWhichInformationIsDisplayedAxis__custom--USDMember_zSeXnNoUw4zi" title="Cash equivalents"&gt;23,422&lt;/span&gt; as of December 31, 2025 (December
31, 2024: R$&lt;span id="xdx_90D_eifrs-full--CashEquivalents_iI_pn3n3_uBRL_c20241231__ifrs-full--CurrencyInWhichInformationIsDisplayedAxis__custom--USDMember_z5bDxoiXBAA5" title="Cash equivalents"&gt;21,610&lt;/span&gt;).&lt;/p&gt;

</afya:DisclosuresOfCashAndCashEquivalentsExplanatory>
    <afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001821">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_pn3n3_zJJ6dpRAmAo1" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Cash and cash equivalents (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BD_znVPwdwoRoS3" style="display: none"&gt;Schedule of cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49D_20251231_zBzTqHllkv1k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20241231_zXEsK4Uqjfnh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--Cash_iI_pn3n3_zWH9qacnoI17" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Cash and bank deposits&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;15,470 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;6,078 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CashEquivalents_iI_pn3n3_zLYIVr4C2oR4" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Cash equivalents&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;1,109,911 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;904,937 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_zXIyr34M4Rzf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b style="display: none"&gt;Cash and cash equivalents&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;1,125,381 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;911,015 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory>
    <ifrs-full:Cash
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001823"
      unitRef="BRL">15470000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001824"
      unitRef="BRL">6078000</ifrs-full:Cash>
    <ifrs-full:CashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001826"
      unitRef="BRL">1109911000</ifrs-full:CashEquivalents>
    <ifrs-full:CashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001827"
      unitRef="BRL">904937000</ifrs-full:CashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001829"
      unitRef="BRL">1125381000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001830"
      unitRef="BRL">911015000</ifrs-full:CashAndCashEquivalents>
    <afya:PercenatgeOfAverageInterestOnFinancialInstrument
      contextRef="AsOf2025-12-31_custom_BankCertificatesOfDepositMember"
      decimals="INF"
      id="Fact001832"
      unitRef="Pure">1.012</afya:PercenatgeOfAverageInterestOnFinancialInstrument>
    <afya:PercenatgeOfAverageInterestOnFinancialInstrument
      contextRef="AsOf2024-12-31_custom_BankCertificatesOfDepositMember"
      decimals="INF"
      id="Fact001834"
      unitRef="Pure">0.991</afya:PercenatgeOfAverageInterestOnFinancialInstrument>
    <ifrs-full:CashEquivalents
      contextRef="AsOf2025-12-31_custom_USDMember"
      decimals="-3"
      id="Fact001836"
      unitRef="BRL">23422000</ifrs-full:CashEquivalents>
    <ifrs-full:CashEquivalents
      contextRef="AsOf2024-12-31_custom_USDMember"
      decimals="-3"
      id="Fact001838"
      unitRef="BRL">21610000</ifrs-full:CashEquivalents>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001840">&lt;p id="xdx_80A_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zxVshYmotQQf" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;6&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_825_zbSURry6WVub"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_zByhnAZtBHNl" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Trade receivables (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BF_z3rvyRXRN7Y8" style="display: none"&gt;Schedule of trade accounts receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Tuition fees&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zPJqv2hIaCL7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;596,568 &lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zxU3kb6OcT1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;488,962 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Educational content (i)&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zKYDjV68pkHa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;44,679 &lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zHaJpSKmVxA7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;62,194 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;FIES (ii)&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_z8URSeeVnAqe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;139,158 &lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ReceivablesGross_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zEJhmyCsjQ0h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;79,712 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Educational credits (iii)&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_z5SF5AF187Kg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;33,399 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zKUD0Fp9m9kc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;26,893 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Mobile app subscription (iv)&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zrOUuPQ2sO7c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;21,484 &lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zQxrS2cTqWvd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;24,223 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Other&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zcTwoI5hXHMc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;17,226 &lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ReceivablesGross_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zzL5IKSou6e1" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;21,339&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231_zn0Mji0qasyl" style="border-top: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;&lt;b&gt;852,514 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ReceivablesGross_pn3n3_c20241231_zRZEKIkbVCKe" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;&lt;b&gt;703,323 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Allowance for expected credit losses&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20251231_zoWUWVhqZfbg" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;(100,156)&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20241231_zprFL58UFyhc" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="(-) Allowance for doubtful accounts"&gt;(71,477)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeReceivables_pn3n3_c20251231_zTk8m9Lgcuzc" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, net"&gt;&lt;b&gt;752,358 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeReceivables_pn3n3_c20241231_z6vYQIjSpNE3" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, net"&gt;&lt;b&gt;631,846 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentTradeReceivables_pn3n3_c20251231_zVXqEOuatfN7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;717,373 &lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentTradeReceivables_pn3n3_c20241231_z0oHGaUDoDC1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;595,898 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20251231_zMT2yhubKIva" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;34,985 &lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20241231_zCE1dpgvXXz2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;35,948 &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;(i) Related to trade receivables from sales of e-books and medical courses through the Continuing
education&#x2019;s platform.&lt;/p&gt;

&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;(ii) Related to trade receivables from the FIES program, created by the Brazilian federal
government to offer financing to low-income students enrolled in undergraduate programs in private higher education institutions.&lt;/p&gt;

&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;(iii) Related to the financing programs offered by the Company&#x2019;s subsidiaries to its
students.&lt;/p&gt;

&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;(iv) Related to trade receivables from mobile applications subscriptions for Medical practice
solutions.&lt;/p&gt;

&lt;p id="xdx_8A6_zk47mO4K7qi8" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;As of December 31, 2025 and 2024, the aging of trade receivables was as follows:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_pn3n3_zs5xJlZzct6g" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Trade receivables (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BD_zWIkavE23pS7" style="display: none"&gt;Schedule of aging of trade accounts receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: -3.35pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: -3.35pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Neither past due nor impaired&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z74pHOdCfMXb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;383,887 &lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z7uKZbZUst68" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;327,052&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Past due:&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt"&gt;1 to 30 days&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--NotLaterThanOneMonthMember_zkfaV8fh8q4l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;128,785 &lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--NotLaterThanOneMonthMember_zmviVnAWAKj9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;97,390&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt"&gt;31 to 90 days&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zZ5lxnu3cKDk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;165,512 &lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zf25PPY6Oxoj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;126,623&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt"&gt;91 to 180 days&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_z36nIiQ1mIQa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;102,369 &lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zJsqYDFE0QZk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;91,411&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt"&gt;More than 180 days&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanSixMonthsMember_zruq4TDEtiU2" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;71,961 &lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanSixMonthsMember_zTJHwVlTMB6i" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;60,847&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ReceivablesGross_iI_pn3n3_c20251231_zpZVFvYk45D5" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;&lt;b&gt;852,514 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ReceivablesGross_iI_pn3n3_c20241231_z91Szi6EAZ1h" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;&lt;b&gt;703,323&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A8_zYZZZyriGBZ9" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The changes in the allowance for expected credit losses for the years ended December 31,
2025, 2024 and 2023, were as follows:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfAllowanceForDoubtfulAccountsExplanatory_pn3n3_zGQbIUaDMdl3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Trade receivables (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BB_zKnxa853uQm4" style="display: none"&gt;Schedule of allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_492_20250101__20251231_zlxsu8oloE47" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;/td&gt;
    &lt;td id="xdx_490_20240101__20241231_zz5EE2Z1VW42" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20230101__20231231_z7CsixPwnlOc" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 49%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AllowanceAccountForCreditLossesOfFinancialAsset_iNS_pn3n3_di_zY658UuznTM9" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Opening balance&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(71,477)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(61,398)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;&lt;b&gt;(44,046)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_pn3n3_zhURD4FBtsDg" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Additions&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(57,090)&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(60,894)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;(74,552)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_pn3n3_zliOtbLDa3V" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Write-offs&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;28,411 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;50,815 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;57,200&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AllowanceAccountForCreditLossesOfFinancialAsset_iNE_pn3n3_di_zVnJI3yuJtl1" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Closing balance&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(100,156)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(71,477)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: bottom; text-align: right"&gt;&lt;b&gt;(61,398)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A7_zyxyAgUcwWGj" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <afya:DisclosureOfTradeAndOtherReceivables1Explanatory contextRef="From2025-01-01to2025-12-31" id="Fact001842">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_zByhnAZtBHNl" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Trade receivables (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BF_z3rvyRXRN7Y8" style="display: none"&gt;Schedule of trade accounts receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Tuition fees&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zPJqv2hIaCL7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;596,568 &lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zxU3kb6OcT1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;488,962 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Educational content (i)&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zKYDjV68pkHa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;44,679 &lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_zHaJpSKmVxA7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;62,194 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;FIES (ii)&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_z8URSeeVnAqe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;139,158 &lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ReceivablesGross_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zEJhmyCsjQ0h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;79,712 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Educational credits (iii)&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_z5SF5AF187Kg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;33,399 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zKUD0Fp9m9kc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;26,893 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Mobile app subscription (iv)&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zrOUuPQ2sO7c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;21,484 &lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_zQxrS2cTqWvd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;24,223 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Other&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zcTwoI5hXHMc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;17,226 &lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ReceivablesGross_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zzL5IKSou6e1" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;21,339&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231_zn0Mji0qasyl" style="border-top: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;&lt;b&gt;852,514 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ReceivablesGross_pn3n3_c20241231_zRZEKIkbVCKe" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;&lt;b&gt;703,323 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Allowance for expected credit losses&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20251231_zoWUWVhqZfbg" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, gross"&gt;(100,156)&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iI_pn3n3_c20241231_zprFL58UFyhc" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="(-) Allowance for doubtful accounts"&gt;(71,477)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeReceivables_pn3n3_c20251231_zTk8m9Lgcuzc" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, net"&gt;&lt;b&gt;752,358 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeReceivables_pn3n3_c20241231_z6vYQIjSpNE3" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables, net"&gt;&lt;b&gt;631,846 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentTradeReceivables_pn3n3_c20251231_zVXqEOuatfN7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;717,373 &lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentTradeReceivables_pn3n3_c20241231_z0oHGaUDoDC1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;595,898 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20251231_zMT2yhubKIva" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;34,985 &lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NoncurrentTradeReceivables_pn3n3_c20241231_zCE1dpgvXXz2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;35,948 &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;(i) Related to trade receivables from sales of e-books and medical courses through the Continuing
education&#x2019;s platform.&lt;/p&gt;

&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;(ii) Related to trade receivables from the FIES program, created by the Brazilian federal
government to offer financing to low-income students enrolled in undergraduate programs in private higher education institutions.&lt;/p&gt;

&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;(iii) Related to the financing programs offered by the Company&#x2019;s subsidiaries to its
students.&lt;/p&gt;

&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;(iv) Related to trade receivables from mobile applications subscriptions for Medical practice
solutions.&lt;/p&gt;

</afya:DisclosureOfTradeAndOtherReceivables1Explanatory>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31_custom_TuitionFeesMember"
      decimals="-3"
      id="Fact001844"
      unitRef="BRL">596568000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31_custom_TuitionFeesMember"
      decimals="-3"
      id="Fact001846"
      unitRef="BRL">488962000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31_custom_EducationalContentMember"
      decimals="-3"
      id="Fact001848"
      unitRef="BRL">44679000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31_custom_EducationalContentMember"
      decimals="-3"
      id="Fact001850"
      unitRef="BRL">62194000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31_custom_FIESMember"
      decimals="-3"
      id="Fact001852"
      unitRef="BRL">139158000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31_custom_FIESMember"
      decimals="-3"
      id="Fact001854"
      unitRef="BRL">79712000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31_custom_EducationalCreditsMember"
      decimals="-3"
      id="Fact001856"
      unitRef="BRL">33399000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31_custom_EducationalCreditsMember"
      decimals="-3"
      id="Fact001858"
      unitRef="BRL">26893000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31_custom_MobileAppSubscriptionMember"
      decimals="-3"
      id="Fact001860"
      unitRef="BRL">21484000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31_custom_MobileAppSubscriptionMember"
      decimals="-3"
      id="Fact001862"
      unitRef="BRL">24223000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31_custom_OthersMember"
      decimals="-3"
      id="Fact001864"
      unitRef="BRL">17226000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31_custom_OthersMember"
      decimals="-3"
      id="Fact001866"
      unitRef="BRL">21339000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001868"
      unitRef="BRL">852514000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001870"
      unitRef="BRL">703323000</afya:ReceivablesGross>
    <afya:AllowanceForDoubtfulAccountsFoReceivable1
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001872"
      unitRef="BRL">-100156000</afya:AllowanceForDoubtfulAccountsFoReceivable1>
    <afya:AllowanceForDoubtfulAccountsFoReceivable1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001874"
      unitRef="BRL">-71477000</afya:AllowanceForDoubtfulAccountsFoReceivable1>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001876"
      unitRef="BRL">752358000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001878"
      unitRef="BRL">631846000</ifrs-full:TradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001880"
      unitRef="BRL">717373000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001882"
      unitRef="BRL">595898000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001884"
      unitRef="BRL">34985000</ifrs-full:NoncurrentTradeReceivables>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001886"
      unitRef="BRL">35948000</ifrs-full:NoncurrentTradeReceivables>
    <afya:DisclosureOfTradeAccountsReceivableByAgingExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001888">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_pn3n3_zs5xJlZzct6g" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Trade receivables (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BD_zWIkavE23pS7" style="display: none"&gt;Schedule of aging of trade accounts receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: -3.35pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: -3.35pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Neither past due nor impaired&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z74pHOdCfMXb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;383,887 &lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_z7uKZbZUst68" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;327,052&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Past due:&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt"&gt;1 to 30 days&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--NotLaterThanOneMonthMember_zkfaV8fh8q4l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;128,785 &lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--NotLaterThanOneMonthMember_zmviVnAWAKj9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;97,390&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt"&gt;31 to 90 days&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zZ5lxnu3cKDk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;165,512 &lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zf25PPY6Oxoj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;126,623&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt"&gt;91 to 180 days&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_z36nIiQ1mIQa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;102,369 &lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zJsqYDFE0QZk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;91,411&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt"&gt;More than 180 days&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_pn3n3_c20251231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanSixMonthsMember_zruq4TDEtiU2" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;71,961 &lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ReceivablesGross_iI_pn3n3_c20241231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanSixMonthsMember_zTJHwVlTMB6i" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;60,847&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ReceivablesGross_iI_pn3n3_c20251231_zpZVFvYk45D5" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;&lt;b&gt;852,514 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ReceivablesGross_iI_pn3n3_c20241231_z91Szi6EAZ1h" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivable"&gt;&lt;b&gt;703,323&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:DisclosureOfTradeAccountsReceivableByAgingExplanatory>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember"
      decimals="-3"
      id="Fact001890"
      unitRef="BRL">383887000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember"
      decimals="-3"
      id="Fact001892"
      unitRef="BRL">327052000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneMonthMember"
      decimals="-3"
      id="Fact001894"
      unitRef="BRL">128785000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31_ifrs-full_NotLaterThanOneMonthMember"
      decimals="-3"
      id="Fact001896"
      unitRef="BRL">97390000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember"
      decimals="-3"
      id="Fact001898"
      unitRef="BRL">165512000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember"
      decimals="-3"
      id="Fact001900"
      unitRef="BRL">126623000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember"
      decimals="-3"
      id="Fact001902"
      unitRef="BRL">102369000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember"
      decimals="-3"
      id="Fact001904"
      unitRef="BRL">91411000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanSixMonthsMember"
      decimals="-3"
      id="Fact001906"
      unitRef="BRL">71961000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanSixMonthsMember"
      decimals="-3"
      id="Fact001908"
      unitRef="BRL">60847000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001910"
      unitRef="BRL">852514000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001912"
      unitRef="BRL">703323000</afya:ReceivablesGross>
    <afya:DisclosureOfAllowanceForDoubtfulAccountsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001914">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--DisclosureOfAllowanceForDoubtfulAccountsExplanatory_pn3n3_zGQbIUaDMdl3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Trade receivables (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BB_zKnxa853uQm4" style="display: none"&gt;Schedule of allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_492_20250101__20251231_zlxsu8oloE47" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;/td&gt;
    &lt;td id="xdx_490_20240101__20241231_zz5EE2Z1VW42" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20230101__20231231_z7CsixPwnlOc" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 49%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AllowanceAccountForCreditLossesOfFinancialAsset_iNS_pn3n3_di_zY658UuznTM9" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Opening balance&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(71,477)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(61,398)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;&lt;b&gt;(44,046)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset_pn3n3_zhURD4FBtsDg" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Additions&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(57,090)&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(60,894)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;(74,552)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_pn3n3_zliOtbLDa3V" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Write-offs&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;28,411 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;50,815 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;57,200&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AllowanceAccountForCreditLossesOfFinancialAsset_iNE_pn3n3_di_zVnJI3yuJtl1" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Closing balance&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(100,156)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(71,477)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: bottom; text-align: right"&gt;&lt;b&gt;(61,398)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:DisclosureOfAllowanceForDoubtfulAccountsExplanatory>
    <afya:AllowanceAccountForCreditLossesOfFinancialAsset
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001916"
      unitRef="BRL">71477000</afya:AllowanceAccountForCreditLossesOfFinancialAsset>
    <afya:AllowanceAccountForCreditLossesOfFinancialAsset
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001917"
      unitRef="BRL">61398000</afya:AllowanceAccountForCreditLossesOfFinancialAsset>
    <afya:AllowanceAccountForCreditLossesOfFinancialAsset
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001918"
      unitRef="BRL">44046000</afya:AllowanceAccountForCreditLossesOfFinancialAsset>
    <afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001920"
      unitRef="BRL">-57090000</afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset>
    <afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001921"
      unitRef="BRL">-60894000</afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset>
    <afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001922"
      unitRef="BRL">-74552000</afya:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAsset>
    <afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact001924"
      unitRef="BRL">28411000</afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable>
    <afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact001925"
      unitRef="BRL">50815000</afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable>
    <afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001926"
      unitRef="BRL">57200000</afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable>
    <afya:AllowanceAccountForCreditLossesOfFinancialAsset
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001928"
      unitRef="BRL">100156000</afya:AllowanceAccountForCreditLossesOfFinancialAsset>
    <afya:AllowanceAccountForCreditLossesOfFinancialAsset
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001929"
      unitRef="BRL">71477000</afya:AllowanceAccountForCreditLossesOfFinancialAsset>
    <afya:AllowanceAccountForCreditLossesOfFinancialAsset
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001930"
      unitRef="BRL">61398000</afya:AllowanceAccountForCreditLossesOfFinancialAsset>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001932">&lt;p id="xdx_80A_eifrs-full--DisclosureOfRelatedPartyExplanatory_zGmCHPSyDao4" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;7&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_820_zY30MF8yV4ci"&gt;Related parties&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The tables below summarize the balances and transactions with related parties:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfRelatedPartiesExplanatory_zSXDqJNfgQ96" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Related parties (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zcSadTwFCeD9" style="display: none"&gt;Schedule of balances and transactions with related parties&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Right-of-use assets&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RightofuseAssetsRelatedPartyTransactions_iI_c20251231_zYLexd68nQL6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;216,085&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RightofuseAssetsRelatedPartyTransactions_iI_c20241231_zy0T8FcMcVla" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;205,911&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Trade receivables (i)&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--TradeReceivablesRelatedPartyTransactions_iI_c20251231_zrUqgvVdSFse" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;384 &lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TradeReceivablesRelatedPartyTransactions_iI_c20241231_zJY1U6AmhXF2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;507&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Other assets (ii)&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OtherAssetsRelatedPartyTransactions_iI_c20251231_zGeufvMf3VS5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1944"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OtherAssetsRelatedPartyTransactions_iI_c20241231_z80kBkJ6eMs" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;597&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20251231_zg7xEEH9EsXe" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;b&gt;216,469 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20241231_zp1oV5skIiE4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;b&gt;207,015&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_c20251231_zDX9XnJTd2hf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1952"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_c20241231_zDmuIUpe32wa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;1,010&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NoncurrentAssetsOfRelatedParty1_iI_c20251231_zaOfHACm1eVj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;216,469 &lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NoncurrentAssetsOfRelatedParty1_iI_c20241231_zeVWYYse3vt6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;206,005&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LeaseLiabilitiesRelatedPartyTransactions_iI_c20251231_zJkQvidvM5ek" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;260,790 &lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LeaseLiabilitiesRelatedPartyTransactions_iI_c20241231_zvIdrc1Y4JBd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;242,703&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20251231_z0yllkSLA3X8" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities"&gt;&lt;b&gt;260,790 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20241231_z7cF2XbCkej4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities"&gt;&lt;b&gt;242,703&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TradeAndOtherCurrentPayableToRelatedParties_iI_c20251231_znJmzXxFyALj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;9,447 &lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TradeAndOtherCurrentPayableToRelatedParties_iI_c20241231_zYhK5viCAll3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;6,610&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NoncurrenLliabilitiesOfRelatedParty1_iI_c20251231_z0zbCHbkPA66" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;251,343 &lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NoncurrenLliabilitiesOfRelatedParty1_iI_c20241231_z11mbho9Cibh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;236,093&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Income (expenses)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;UEPC (i)&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zL1iymVK0qcc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;475 &lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zPhZU24bYjAj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;517&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zUOjAfFZ9c1" style="vertical-align: top; text-align: right" title="Other income"&gt;465&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;EMIVE Patrulha 24 Horas Ltda. (iii)&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zG7SxAT2mYNg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;(7)&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_z9KswejRyaud" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;(7)&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zHNhvahmJvy9" style="vertical-align: bottom; text-align: right" title="Other income"&gt;(6)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Depreciation - Right-of-use assets &lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zn3VHH6Zpobe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;(17,637)&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zH9NFlsVwDi1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;(14,639)&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zMRoYtgh8d3i" style="vertical-align: bottom; text-align: right" title="Other income"&gt;(13,801)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Lease liabilities interest&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_zaScWXa69oOg" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;(30,841)&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_z3YsduwcK7r2" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;(28,343)&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_zqDxN6HCkJp2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right" title="Other income"&gt;(25,676)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231_zCHGo0wkLxwj" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;b&gt;(48,010) &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231_zGoNzzgHoj33" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;b&gt;(42,472)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231_z8612BcjTEr6" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right" title="Other income"&gt;&lt;b&gt;(39,018)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to sales of educational content to UEPC.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to expenses reimbursed by Bertelsmann.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to amounts of expenses related to security services provided by a company of which
one of Afya&#x2019;s main shareholders has significant influence.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A4_z2gOQkmxC0ni" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Lease agreements with RVL Esteves Gest&#xe3;o Imobili&#xe1;ria S.A.&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company has entered into lease agreements with RVL Esteves Gest&#xe3;o Imobili&#xe1;ria
S.A. (&#x201c;RVL&#x201d;), an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato Tavares Esteves is
an executive officer. The main lease agreements with RVL are described below:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On June 21, 2016, RVL entered into lease agreements, as amended on April 26, 2018, with
ITPAC Aragua&#xed;na and ITPAC Porto, pursuant to which RVL agreed to lease campuses to those entities in the cities of Aragua&#xed;na
and Porto Nacional, both located in the State of Tocantins. The lease agreements are adjustable in accordance with the provisions of each
lease agreement. The lease agreements are for an initial term of 20 years and are renewable for an additional &lt;span id="xdx_90D_ecustom--OperatingLeaseTermOfContract_dtY_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_z18aDpYk1vy2" title="Lease term"&gt;20&lt;/span&gt; years subject to the
provisions of each lease agreement. The balance of lease liabilities as of December 31, 2025 was R$&lt;span id="xdx_90E_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zwqavTAsQSu7" title="Lease liabilities"&gt;83,992&lt;/span&gt; (December 31, 2024: R$&lt;span id="xdx_902_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zTZCYsV8hUVi" title="Lease liabilities"&gt;84,102&lt;/span&gt;)
and the amount paid during the year ended December 31, 2025 was R$&lt;span id="xdx_905_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zkAjvVUtKL8h" title="Related parties amount paid"&gt;13,926&lt;/span&gt; (December 31, 2024 and 2023: R$&lt;span id="xdx_90C_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zD0jZIaWDeK7" title="Related parties amount paid"&gt;13,453&lt;/span&gt; and R$&lt;span id="xdx_906_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zDopean6Gxu3" title="Related parties amount paid"&gt;13,254&lt;/span&gt;, respectively).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On September 6, 2018, RVL entered into a lease agreement with ITPAC Aragua&#xed;na, pursuant
to which RVL agreed to lease to ITPAC Aragua&#xed;na the new campus by RVL in the city of Palmas, State of Tocantins. The lease agreement
is for an amount equal to &lt;span id="xdx_901_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20180905__20180906__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zW1JOjc4Umf4" title="Percentage of revenue"&gt;7.5&lt;/span&gt;% of the monthly revenue of ITPAC until July 2024. From August 2024, the monthly amount should be equal to
the amount paid in the first semester of 2024 and thereafter adjusted annually by the inflation rate (IGP-M). The lease agreement is for
an initial term of 20 years and is renewable for an additional &lt;span id="xdx_90B_ecustom--OperatingLeaseTermOfContract_dtY_c20180905__20180906__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member_z9u4OIpFi1ll" title="Lease term"&gt;20&lt;/span&gt; years. The balance of lease liabilities as of December 31, 2025 was
R$&lt;span id="xdx_904_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z2rSgWn6a8Cc" title="Lease liabilities"&gt;65,328&lt;/span&gt; (December 31, 2024: R$&lt;span id="xdx_901_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zOx7QIww8Vid" title="Lease liabilities"&gt;63,989&lt;/span&gt;) and the amount paid during the year ended December 31, 2025 was R$&lt;span id="xdx_90E_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zUvp0YhZAZPj" title="Related parties amount paid"&gt;8,881&lt;/span&gt; (December 31, 2024 and
2023: R$&lt;span id="xdx_90C_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z5XsQKltyZv7" title="Related parties amount paid"&gt;8,568&lt;/span&gt; and R$&lt;span id="xdx_908_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements2Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zc1QPh4rcrLj" title="Related parties amount paid"&gt;7,615&lt;/span&gt;, respectively).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On October 30, 2019, RVL entered into a lease agreement with IPTAN, pursuant to which RVL
agreed to lease to IPTAN the medical campus in the city of Santa In&#xea;s, State of Maranh&#xe3;o. The lease agreement, as amended
on February 27, 2025 is for a monthly amount adjusted in accordance with the provisions of the lease agreement of:  &lt;span id="xdx_90E_ecustom--DescriptionOfLeaseTerm_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zKDZ1ZaBaX2" title="Description of lease term"&gt;(i) R$&lt;span id="xdx_90B_eifrs-full--CashOutflowForLeases_pn3n3_c20191028__20191030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z11GCfgnWhEd" title="Lease expenses"&gt;12&lt;/span&gt; until December
2020; (ii) from January 2021 to December 2025, 6.5% of the monthly revenue of IPTAN during the prior semester; (iii) from January 2026,
the monthly amount should be equal to the amount paid in the second semester of 2025; and (iv) from January 2027 thereon, the monthly
amount should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years and is renewable for an
additional 20 years.&lt;/span&gt; The balance of lease liabilities as of December 31, 2025 was R$&lt;span id="xdx_903_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z921QnCIOcze" title="Lease liabilities"&gt;15,962&lt;/span&gt; (December 31, 2024: R$&lt;span id="xdx_90D_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zNDIDHfTQmU7" title="Lease liabilities"&gt;9,743&lt;/span&gt;) and the amount
paid during the year ended December 31, 2025 was R$&lt;span id="xdx_90B_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zSps5Q93wVR5" title="Related parties amount paid"&gt;2,136&lt;/span&gt; (December 31, 2024 and 2023: R$&lt;span id="xdx_90F_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zrKY7JAfMEz7" title="Related parties amount paid"&gt;1,338&lt;/span&gt; and R$&lt;span id="xdx_907_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements3Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zQaHMebfeIHk" title="Related parties amount paid"&gt;1,111&lt;/span&gt;, respectively).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On August 2, 2021, RVL entered into a lease agreement with ITPAC Aragua&#xed;na, pursuant
to which RVL agreed to lease to ITPAC the new ITPAC Garanhuns medical campus, in the city of Garanhuns, State of Pernambuco. The lease
agreement is for a monthly amount equal to: &lt;span id="xdx_902_ecustom--DescriptionOfLeaseTerm_c20210728__20210802__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z3vEc4kvXhce" title="Description of lease term"&gt;(i) up to June 2022, R$&lt;span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20210728__20210802__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zeAZw73sx9e6" title="Lease expenses"&gt;40&lt;/span&gt;; (ii) from July 2022 until December 2028, 6.5% of the monthly revenue
of ITPAC Garanhuns during the prior semester, adjusted in accordance with the provisions of the lease agreement; and (iii) from January
2029 on, the monthly amount should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years.&lt;/span&gt; The
balance of lease liabilities as of December 31, 2025 was R$&lt;span id="xdx_907_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z2f0B16WFPX" title="Lease liabilities"&gt;26,326&lt;/span&gt; (December 31, 2024: R$&lt;span id="xdx_902_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zY9gMZ7ExpQ3" title="Lease liabilities"&gt;17,556&lt;/span&gt;) and the amount paid during the year ended
December 31, 2025 was R$&lt;span id="xdx_90C_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zGxeTGIg3zka" title="Related parties amount paid"&gt;3,664&lt;/span&gt; (December 31, 2024 and 2023: R$&lt;span id="xdx_905_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zLSRmu06o4Y3" title="Related parties amount paid"&gt;2,199&lt;/span&gt; and R$&lt;span id="xdx_906_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements4Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_ztLJKl7iMldf" title="Related parties amount paid"&gt;1,159&lt;/span&gt;, respectively).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On May 2, 2024, RVL entered into a rent agreement with IPTAN, pursuant to which RVL agreed
to rent to IPTAN a property for the campus in the city of S&#xe3;o Jo&#xe3;o del Rei, State of Minas Gerais. &lt;span id="xdx_900_ecustom--DescriptionOfLeaseTerm_c20240501__20240502__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_ztbWE3yytBu7" title="Description of lease term"&gt;The rent agreement is
for a monthly amount payable equal to R$4, adjusted annually by the inflation rate (IGP-M). The rent agreement is for a term of one year
and is renewable for an additional term of three years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On June 14, 2024, RVL entered into a lease agreement with DelRey, pursuant to which RVL
agreed to lease to DelRey a property for the campus in the city of Jaboat&#xe3;o dos Guararapes, State of Pernambuco. &lt;span id="xdx_90B_ecustom--DescriptionOfLeaseTerm_c20240713__20240714__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zmMGMHP3KyQg" title="Description of lease term"&gt;The lease agreement
is for a monthly amount payable equal to R$114.5, with a grace period of 12 months, extended by an additional six months. The monthly
amount payable should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years.&lt;/span&gt; The balance of
lease liabilities as of December 31, 2025 was R$&lt;span id="xdx_90C_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z8I0pNRZTFMe" title="Lease liabilities"&gt;10,905&lt;/span&gt; (December 31, 2024: R$&lt;span id="xdx_909_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zzRUYKHAWI88" title="Lease liabilities"&gt;9,383&lt;/span&gt;) and due to the grace period no payments were made
during the years ended December 31, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Lease agreement with UNIVA&#xc7;O Patrimonial Ltda.&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On July 14, 2016, UNIVA&#xc7;O Patrimonial Ltda., an entity controlled by the shareholder
Nicolau Carvalho Esteves and of which Ms. Ros&#xe2;ngela de Oliveira Tavares Esteves is the chief executive officer, entered into a lease
agreement with UNIVA&#xc7;O, a subsidiary of Afya Brazil, pursuant to which UNIVA&#xc7;O Patrimonial Ltda. agreed to lease UNIVA&#xc7;O&#x2019;s
campus to UNIVA&#xc7;O, located in the city of Ipatinga, State of Minas Gerais. The lease agreement is adjustable in accordance with
the provisions of the lease agreement. The lease agreement is for an initial term of &lt;span id="xdx_90A_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zpr6HtkGPjNb" title="Renewal term"&gt;20&lt;/span&gt; years and is renewable for an additional 20 years
subject to the provisions of the lease agreement. The balance of lease liabilities as of December 31, 2025 was R$&lt;span id="xdx_908_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zWRAUk5rgnX4" title="Lease liabilities"&gt;22,802&lt;/span&gt; (December 31,
2024: R$&lt;span id="xdx_902_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zRMUkIQOpgv2" title="Lease liabilities"&gt;22,818&lt;/span&gt;) and the amount paid during the year ended December 31, 2025 was R$&lt;span id="xdx_905_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zFrsq2wNJqmk" title="Related parties amount paid"&gt;3,752&lt;/span&gt; (December 31, 2024 and 2023: R$&lt;span id="xdx_900_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zZ38bTqN4Rve" title="Related parties amount paid"&gt;3,633&lt;/span&gt; and R$&lt;span id="xdx_909_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_z1Gd1zg7RArl" title="Related parties amount paid"&gt;3,582&lt;/span&gt;,
respectively).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Lease agreement with IESVAP Patrimonial Ltda.&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On April 25, 2018, IESVAP Patrimonial Ltda., an entity controlled by the shareholder Nicolau
Carvalho Esteves and of which Mr. Renato Tavares Esteves is an executive officer, entered into a lease agreement with IESVAP, a subsidiary
of Afya Brazil, pursuant to which IESVAP Patrimonial Ltda. agreed to lease IESVAP&#x2019;s campus to IESVAP located in the city of Parna&#xed;ba,
State of Piau&#xed;. &lt;span id="xdx_908_ecustom--DescriptionOfLeaseTerms_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zS9BI4FxUHR" title="Description of lease term"&gt;The lease agreement is for an amount equal to 7.5% of the monthly revenue of IESVAP until June 2021. From July
2021, the monthly amount should be equal to the amount paid in the first semester of 2021 and thereafter adjusted annually by the inflation
rate (IGP-M). The lease agreement is for an initial term of &lt;span id="xdx_909_ecustom--OperatingLeaseTermOfContract_dtY_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zOGam0FTaaTb" title="Lease term"&gt;20&lt;/span&gt; years and is renewable for an additional &lt;span id="xdx_903_ecustom--LesseeFinancesLeaseRenewalTerm_dtY_c20180423__20180425__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zL6wyCyX8Q1j" title="Renewal term"&gt;20&lt;/span&gt; years subject to the provisions
of the lease agreement.&lt;/span&gt; The balance of lease liabilities as of December 31, 2025 was R$&lt;span id="xdx_902_eifrs-full--LeaseLiabilities_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zPMqZvolffv6" title="Lease liabilities"&gt;35,475&lt;/span&gt; (December 31, 2024: R$&lt;span id="xdx_908_eifrs-full--LeaseLiabilities_iI_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements5Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zwOGoS7KJE32" title="Lease liabilities"&gt;35,112&lt;/span&gt;) and the amount
paid during the year ended December 31, 2025 was R$&lt;span id="xdx_900_ecustom--RelatedPartiesAmountPaid_iI_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zFnxWL9REuR8" title="Related parties amount paid"&gt;5,435&lt;/span&gt; (December 31, 2024 and 2023: R$&lt;span id="xdx_90A_ecustom--RelatedPartiesAmountPaid_iI_c20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zviisOkBSxN3" title="Related parties amount paid"&gt;5,244&lt;/span&gt; and R$&lt;span id="xdx_908_ecustom--RelatedPartiesAmountPaid_iI_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_z9gNmPx9VKde" title="Related parties amount paid"&gt;5,170&lt;/span&gt;, respectively).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Other related parties transactions&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The commercial notes issued by Afya Brazil on October 15, 2025 are guaranteed by the following
subsidiaries: Unigranrio, IESP and DelRey. See note 12.2.1.&lt;br/&gt;
&lt;/p&gt;




&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Key management personnel compensation&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Key management personnel compensation included in the Company&#x2019;s consolidated statement
of income and other comprehensive income comprised the following:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_pn3n3_zSdZMQ3s2431" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Related parties (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BF_zVDQmnRApgib" style="display: none"&gt;Schedule of key management personnel compensation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Short-term employee benefits&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20250101__20251231_zUGipzHxacB6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"&gt;27,160 &lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20240101__20241231_zwpKDE5fcGMe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"&gt;21,171&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20230101__20231231_zimm1I97VvVe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"&gt;16,979&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Share-based compensation plans&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20250101__20251231_z9zmnHRlOo35" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"&gt;16,193 &lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20240101__20241231_zw835p9umPS5" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"&gt;19,884&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20230101__20231231_zEedeEiPK7rd" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"&gt;21,380&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20250101__20251231_zZHuN0dn7xn9" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;43,353 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20240101__20241231_zs5gTLuUXA73" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;41,055&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20230101__20231231_ztGiYD60Jr8f" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;38,359&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AB_zsXZ99BZooYl" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Compensation of the Company&#x2019;s key management includes short-term employee benefits
comprised by salaries, labor and social obligations, and other ordinary short-term employee benefits. The amounts disclosed in the table
above are the amounts recognized as an expense in selling, general and administrative expenses during the reporting period related to
key management personnel. See Note 14 for additional information on the share-based compensation plans.&lt;/p&gt;

</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <afya:DisclosureOfRelatedPartiesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact001934">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfRelatedPartiesExplanatory_zSXDqJNfgQ96" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Related parties (Details)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zcSadTwFCeD9" style="display: none"&gt;Schedule of balances and transactions with related parties&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Right-of-use assets&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RightofuseAssetsRelatedPartyTransactions_iI_c20251231_zYLexd68nQL6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;216,085&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RightofuseAssetsRelatedPartyTransactions_iI_c20241231_zy0T8FcMcVla" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;205,911&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Trade receivables (i)&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--TradeReceivablesRelatedPartyTransactions_iI_c20251231_zrUqgvVdSFse" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;384 &lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TradeReceivablesRelatedPartyTransactions_iI_c20241231_zJY1U6AmhXF2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;507&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Other assets (ii)&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OtherAssetsRelatedPartyTransactions_iI_c20251231_zGeufvMf3VS5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1944"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OtherAssetsRelatedPartyTransactions_iI_c20241231_z80kBkJ6eMs" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;597&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20251231_zg7xEEH9EsXe" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;b&gt;216,469 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20241231_zp1oV5skIiE4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;b&gt;207,015&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_c20251231_zDX9XnJTd2hf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1952"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_c20241231_zDmuIUpe32wa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;1,010&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NoncurrentAssetsOfRelatedParty1_iI_c20251231_zaOfHACm1eVj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;216,469 &lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NoncurrentAssetsOfRelatedParty1_iI_c20241231_zeVWYYse3vt6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;206,005&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LeaseLiabilitiesRelatedPartyTransactions_iI_c20251231_zJkQvidvM5ek" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;260,790 &lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LeaseLiabilitiesRelatedPartyTransactions_iI_c20241231_zvIdrc1Y4JBd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;242,703&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20251231_z0yllkSLA3X8" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities"&gt;&lt;b&gt;260,790 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20241231_z7cF2XbCkej4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities"&gt;&lt;b&gt;242,703&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TradeAndOtherCurrentPayableToRelatedParties_iI_c20251231_znJmzXxFyALj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;9,447 &lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TradeAndOtherCurrentPayableToRelatedParties_iI_c20241231_zYhK5viCAll3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;6,610&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NoncurrenLliabilitiesOfRelatedParty1_iI_c20251231_z0zbCHbkPA66" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;251,343 &lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NoncurrenLliabilitiesOfRelatedParty1_iI_c20241231_z11mbho9Cibh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;236,093&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Income (expenses)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;UEPC (i)&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zL1iymVK0qcc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;475 &lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zPhZU24bYjAj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;517&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zUOjAfFZ9c1" style="vertical-align: top; text-align: right" title="Other income"&gt;465&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;EMIVE Patrulha 24 Horas Ltda. (iii)&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zG7SxAT2mYNg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;(7)&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_z9KswejRyaud" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;(7)&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EMIVEPatrulha24HorasLtdaMember_zHNhvahmJvy9" style="vertical-align: bottom; text-align: right" title="Other income"&gt;(6)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Depreciation - Right-of-use assets &lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zn3VHH6Zpobe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;(17,637)&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zH9NFlsVwDi1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;(14,639)&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DepreciationRightofuseAssetsMember_zMRoYtgh8d3i" style="vertical-align: bottom; text-align: right" title="Other income"&gt;(13,801)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Lease liabilities interest&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_zaScWXa69oOg" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;(30,841)&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_z3YsduwcK7r2" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;(28,343)&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LeaseLiabilitiesInterestMember_zqDxN6HCkJp2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right" title="Other income"&gt;(25,676)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20250101__20251231_zCHGo0wkLxwj" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;b&gt;(48,010) &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20240101__20241231_zGoNzzgHoj33" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;b&gt;(42,472)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20230101__20231231_z8612BcjTEr6" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right" title="Other income"&gt;&lt;b&gt;(39,018)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to sales of educational content to UEPC.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to expenses reimbursed by Bertelsmann.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(iii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to amounts of expenses related to security services provided by a company of which
one of Afya&#x2019;s main shareholders has significant influence.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:DisclosureOfRelatedPartiesExplanatory>
    <afya:RightofuseAssetsRelatedPartyTransactions
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001936"
      unitRef="BRL">216085000</afya:RightofuseAssetsRelatedPartyTransactions>
    <afya:RightofuseAssetsRelatedPartyTransactions
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001938"
      unitRef="BRL">205911000</afya:RightofuseAssetsRelatedPartyTransactions>
    <afya:TradeReceivablesRelatedPartyTransactions
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001940"
      unitRef="BRL">384000</afya:TradeReceivablesRelatedPartyTransactions>
    <afya:TradeReceivablesRelatedPartyTransactions
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001942"
      unitRef="BRL">507000</afya:TradeReceivablesRelatedPartyTransactions>
    <afya:OtherAssetsRelatedPartyTransactions
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001946"
      unitRef="BRL">597000</afya:OtherAssetsRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001948"
      unitRef="BRL">216469000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001950"
      unitRef="BRL">207015000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <afya:TradeAndOtherCurrentPayablesToRelatedParties1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001954"
      unitRef="BRL">1010000</afya:TradeAndOtherCurrentPayablesToRelatedParties1>
    <afya:NoncurrentAssetsOfRelatedParty1
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001956"
      unitRef="BRL">216469000</afya:NoncurrentAssetsOfRelatedParty1>
    <afya:NoncurrentAssetsOfRelatedParty1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001958"
      unitRef="BRL">206005000</afya:NoncurrentAssetsOfRelatedParty1>
    <afya:LeaseLiabilitiesRelatedPartyTransactions
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001960"
      unitRef="BRL">260790000</afya:LeaseLiabilitiesRelatedPartyTransactions>
    <afya:LeaseLiabilitiesRelatedPartyTransactions
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001962"
      unitRef="BRL">242703000</afya:LeaseLiabilitiesRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001964"
      unitRef="BRL">260790000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001966"
      unitRef="BRL">242703000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <afya:TradeAndOtherCurrentPayableToRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001968"
      unitRef="BRL">9447000</afya:TradeAndOtherCurrentPayableToRelatedParties>
    <afya:TradeAndOtherCurrentPayableToRelatedParties
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001970"
      unitRef="BRL">6610000</afya:TradeAndOtherCurrentPayableToRelatedParties>
    <afya:NoncurrenLliabilitiesOfRelatedParty1
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact001972"
      unitRef="BRL">251343000</afya:NoncurrenLliabilitiesOfRelatedParty1>
    <afya:NoncurrenLliabilitiesOfRelatedParty1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact001974"
      unitRef="BRL">236093000</afya:NoncurrenLliabilitiesOfRelatedParty1>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2025-01-012025-12-31_custom_UEPCMember"
      decimals="-3"
      id="Fact001978"
      unitRef="BRL">475000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2024-01-012024-12-31_custom_UEPCMember"
      decimals="-3"
      id="Fact001980"
      unitRef="BRL">517000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2023-01-012023-12-31_custom_UEPCMember"
      decimals="-3"
      id="Fact001982"
      unitRef="BRL">465000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2025-01-012025-12-31_custom_EMIVEPatrulha24HorasLtdaMember"
      decimals="-3"
      id="Fact001984"
      unitRef="BRL">-7000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2024-01-012024-12-31_custom_EMIVEPatrulha24HorasLtdaMember"
      decimals="-3"
      id="Fact001986"
      unitRef="BRL">-7000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2023-01-012023-12-31_custom_EMIVEPatrulha24HorasLtdaMember"
      decimals="-3"
      id="Fact001988"
      unitRef="BRL">-6000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2025-01-012025-12-31_custom_DepreciationRightofuseAssetsMember"
      decimals="-3"
      id="Fact001990"
      unitRef="BRL">-17637000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2024-01-012024-12-31_custom_DepreciationRightofuseAssetsMember"
      decimals="-3"
      id="Fact001992"
      unitRef="BRL">-14639000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2023-01-012023-12-31_custom_DepreciationRightofuseAssetsMember"
      decimals="-3"
      id="Fact001994"
      unitRef="BRL">-13801000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2025-01-012025-12-31_custom_LeaseLiabilitiesInterestMember"
      decimals="-3"
      id="Fact001996"
      unitRef="BRL">-30841000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2024-01-012024-12-31_custom_LeaseLiabilitiesInterestMember"
      decimals="-3"
      id="Fact001998"
      unitRef="BRL">-28343000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2023-01-012023-12-31_custom_LeaseLiabilitiesInterestMember"
      decimals="-3"
      id="Fact002000"
      unitRef="BRL">-25676000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002002"
      unitRef="BRL">-48010000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002004"
      unitRef="BRL">-42472000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002006"
      unitRef="BRL">-39018000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OperatingLeaseTermOfContract
      contextRef="From2025-01-012025-12-31_custom_LeaseAgreements1Member"
      id="Fact002008">P20Y</afya:OperatingLeaseTermOfContract>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002010"
      unitRef="BRL">83992</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002012"
      unitRef="BRL">84102</ifrs-full:LeaseLiabilities>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002014"
      unitRef="BRL">13926</afya:RelatedPartiesAmountPaid>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002016"
      unitRef="BRL">13453</afya:RelatedPartiesAmountPaid>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002018"
      unitRef="BRL">13254</afya:RelatedPartiesAmountPaid>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="From2018-09-052018-09-06_custom_LeaseAgreements1Member_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="INF"
      id="Fact002020"
      unitRef="Pure">0.075</ifrs-full:PercentageOfEntitysRevenue>
    <afya:OperatingLeaseTermOfContract
      contextRef="From2018-09-052018-09-06_custom_LeaseAgreements1Member"
      id="Fact002022">P20Y</afya:OperatingLeaseTermOfContract>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002024"
      unitRef="BRL">65328</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002026"
      unitRef="BRL">63989</ifrs-full:LeaseLiabilities>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002028"
      unitRef="BRL">8881</afya:RelatedPartiesAmountPaid>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002030"
      unitRef="BRL">8568</afya:RelatedPartiesAmountPaid>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements2Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002032"
      unitRef="BRL">7615</afya:RelatedPartiesAmountPaid>
    <afya:DescriptionOfLeaseTerm
      contextRef="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember"
      id="Fact002034">(i) R$12 until December
2020; (ii) from January 2021 to December 2025, 6.5% of the monthly revenue of IPTAN during the prior semester; (iii) from January 2026,
the monthly amount should be equal to the amount paid in the second semester of 2025; and (iv) from January 2027 thereon, the monthly
amount should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years and is renewable for an
additional 20 years.</afya:DescriptionOfLeaseTerm>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2019-10-282019-10-30_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      id="Fact002036"
      unitRef="BRL">12000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002038"
      unitRef="BRL">15962</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002040"
      unitRef="BRL">9743</ifrs-full:LeaseLiabilities>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002042"
      unitRef="BRL">2136</afya:RelatedPartiesAmountPaid>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002044"
      unitRef="BRL">1338</afya:RelatedPartiesAmountPaid>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements3Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002046"
      unitRef="BRL">1111</afya:RelatedPartiesAmountPaid>
    <afya:DescriptionOfLeaseTerm
      contextRef="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember"
      id="Fact002048">(i) up to June 2022, R$40; (ii) from July 2022 until December 2028, 6.5% of the monthly revenue
of ITPAC Garanhuns during the prior semester, adjusted in accordance with the provisions of the lease agreement; and (iii) from January
2029 on, the monthly amount should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years.</afya:DescriptionOfLeaseTerm>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2021-07-282021-08-02_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      id="Fact002050"
      unitRef="BRL">40000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002052"
      unitRef="BRL">26326</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002054"
      unitRef="BRL">17556</ifrs-full:LeaseLiabilities>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002056"
      unitRef="BRL">3664</afya:RelatedPartiesAmountPaid>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002058"
      unitRef="BRL">2199</afya:RelatedPartiesAmountPaid>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2023-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements4Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002060"
      unitRef="BRL">1159</afya:RelatedPartiesAmountPaid>
    <afya:DescriptionOfLeaseTerm
      contextRef="From2024-05-012024-05-02_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember"
      id="Fact002062">The rent agreement is
for a monthly amount payable equal to R$4, adjusted annually by the inflation rate (IGP-M). The rent agreement is for a term of one year
and is renewable for an additional term of three years.</afya:DescriptionOfLeaseTerm>
    <afya:DescriptionOfLeaseTerm
      contextRef="From2024-07-132024-07-14_custom_LeaseAgreements1Member_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_custom_RVLEstevesGestaoImobiliariaSAMember"
      id="Fact002064">The lease agreement
is for a monthly amount payable equal to R$114.5, with a grace period of 12 months, extended by an additional six months. The monthly
amount payable should be adjusted annually by the inflation rate (IPCA). The lease agreement is for a term of 20 years.</afya:DescriptionOfLeaseTerm>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements5Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002066"
      unitRef="BRL">10905</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember_custom_LeaseAgreements5Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="0"
      id="Fact002068"
      unitRef="BRL">9383</ifrs-full:LeaseLiabilities>
    <afya:LesseeFinancesLeaseRenewalTerm
      contextRef="From2025-01-012025-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      id="Fact002070">P20Y</afya:LesseeFinancesLeaseRenewalTerm>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_LeaseAgreements5Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="0"
      id="Fact002072"
      unitRef="BRL">22802</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_LeaseAgreements5Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="0"
      id="Fact002074"
      unitRef="BRL">22818</ifrs-full:LeaseLiabilities>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2025-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="0"
      id="Fact002076"
      unitRef="BRL">3752</afya:RelatedPartiesAmountPaid>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2024-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="0"
      id="Fact002078"
      unitRef="BRL">3633</afya:RelatedPartiesAmountPaid>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2023-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="0"
      id="Fact002080"
      unitRef="BRL">3582</afya:RelatedPartiesAmountPaid>
    <afya:DescriptionOfLeaseTerms
      contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      id="Fact002082">The lease agreement is for an amount equal to 7.5% of the monthly revenue of IESVAP until June 2021. From July
2021, the monthly amount should be equal to the amount paid in the first semester of 2021 and thereafter adjusted annually by the inflation
rate (IGP-M). The lease agreement is for an initial term of 20 years and is renewable for an additional 20 years subject to the provisions
of the lease agreement.</afya:DescriptionOfLeaseTerms>
    <afya:OperatingLeaseTermOfContract
      contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      id="Fact002084">P20Y</afya:OperatingLeaseTermOfContract>
    <afya:LesseeFinancesLeaseRenewalTerm
      contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      id="Fact002086">P20Y</afya:LesseeFinancesLeaseRenewalTerm>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_custom_LeaseAgreements5Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="0"
      id="Fact002088"
      unitRef="BRL">35475</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_custom_LeaseAgreements5Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="0"
      id="Fact002090"
      unitRef="BRL">35112</ifrs-full:LeaseLiabilities>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2025-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="0"
      id="Fact002092"
      unitRef="BRL">5435</afya:RelatedPartiesAmountPaid>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2024-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="0"
      id="Fact002094"
      unitRef="BRL">5244</afya:RelatedPartiesAmountPaid>
    <afya:RelatedPartiesAmountPaid
      contextRef="AsOf2023-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="0"
      id="Fact002096"
      unitRef="BRL">5170</afya:RelatedPartiesAmountPaid>
    <afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact002098">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_pn3n3_zSdZMQ3s2431" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Related parties (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BF_zVDQmnRApgib" style="display: none"&gt;Schedule of key management personnel compensation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Short-term employee benefits&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20250101__20251231_zUGipzHxacB6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"&gt;27,160 &lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20240101__20241231_zwpKDE5fcGMe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"&gt;21,171&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20230101__20231231_zimm1I97VvVe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Short-term employee benefits"&gt;16,979&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Share-based compensation plans&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20250101__20251231_z9zmnHRlOo35" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"&gt;16,193 &lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20240101__20241231_zw835p9umPS5" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"&gt;19,884&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20230101__20231231_zEedeEiPK7rd" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Share-based compensation plans"&gt;21,380&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20250101__20251231_zZHuN0dn7xn9" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;43,353 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20240101__20241231_zs5gTLuUXA73" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;41,055&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20230101__20231231_ztGiYD60Jr8f" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;38,359&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002100"
      unitRef="BRL">27160000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002102"
      unitRef="BRL">21171000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002104"
      unitRef="BRL">16979000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002106"
      unitRef="BRL">16193000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002108"
      unitRef="BRL">19884000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002110"
      unitRef="BRL">21380000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact002112"
      unitRef="BRL">43353000</ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity>
    <ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact002114"
      unitRef="BRL">41055000</ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity>
    <ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002116"
      unitRef="BRL">38359000</ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity>
    <afya:DisclosureOfOtherAssetExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002118">&lt;p id="xdx_807_ecustom--DisclosureOfOtherAssetExplanatory_zyad0Pv4S4t3" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;8&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82E_z05LDXo3Qedi"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--DisclosureOfOtherAssetsTableTextBlock_zs4DIcva5abd" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Other assets (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B9_z2OLv3BVLdci" style="display: none"&gt;Schedule of other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20251231_z5Phrdv9OPHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20241231_zOunPAkIrkA2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_maAzYGA_zJf8wnMyui84" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Indemnification assets - Note 21&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;80,379 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;78,701 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--Advances1_iI_pn3n3_maAzYGA_z9LcLSTsnUC6" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Advances&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;40,205 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;35,140 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--JudicialDeposits_iI_pn3n3_maAzYGA_z37fgIEFt25g" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Judicial deposits&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;19,274 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;16,938 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_maAzYGA_zuYRrDVzn6Rf" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Prepaid expenses&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;18,070 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;19,761 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--OtherReceivables_iI_pn3n3_maAzYGA_zr0xWqywJhd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Other FIES credits&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;6,866 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;8,982 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ConvertibleLoansFromVentureCapitalInvestments_iI_pn3n3_maAzYGA_zEs4LIJs7uS5" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Convertible loans from venture capital investments&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;13,240 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;8,724&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--Dividend_iI_pn3n3_maAzYGA_zqF8wrlD3Mwe" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Dividends&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;6,287 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;1,628&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--OtherAssets1_iI_pn3n3_maAzYGA_zGpqXbPOVXr9" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Other assets&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;4,106 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,146 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--Assets1_iTI_pn3n3_mtAzYGA_zfPANBEkonz1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;188,427 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;173,020 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--CurrentAssets1_iI_pn3n3_zhfzmgJcCBW3" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Current&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;62,947 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;57,145 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NoncurrentAssets1_iI_pn3n3_zRVQVZ1akpgl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Non-current&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;125,480 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;115,875 &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:DisclosureOfOtherAssetExplanatory>
    <afya:DisclosureOfOtherAssetsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact002120">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--DisclosureOfOtherAssetsTableTextBlock_zs4DIcva5abd" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Other assets (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B9_z2OLv3BVLdci" style="display: none"&gt;Schedule of other assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20251231_z5Phrdv9OPHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20241231_zOunPAkIrkA2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_pn3n3_maAzYGA_zJf8wnMyui84" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Indemnification assets - Note 21&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;80,379 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;78,701 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--Advances1_iI_pn3n3_maAzYGA_z9LcLSTsnUC6" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Advances&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;40,205 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;35,140 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--JudicialDeposits_iI_pn3n3_maAzYGA_z37fgIEFt25g" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Judicial deposits&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;19,274 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;16,938 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_maAzYGA_zuYRrDVzn6Rf" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Prepaid expenses&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;18,070 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;19,761 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--OtherReceivables_iI_pn3n3_maAzYGA_zr0xWqywJhd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Other FIES credits&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;6,866 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;8,982 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ConvertibleLoansFromVentureCapitalInvestments_iI_pn3n3_maAzYGA_zEs4LIJs7uS5" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Convertible loans from venture capital investments&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;13,240 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;8,724&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--Dividend_iI_pn3n3_maAzYGA_zqF8wrlD3Mwe" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Dividends&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;6,287 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;1,628&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--OtherAssets1_iI_pn3n3_maAzYGA_zGpqXbPOVXr9" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Other assets&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;4,106 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,146 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--Assets1_iTI_pn3n3_mtAzYGA_zfPANBEkonz1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;188,427 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;173,020 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--CurrentAssets1_iI_pn3n3_zhfzmgJcCBW3" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Current&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;62,947 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;57,145 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NoncurrentAssets1_iI_pn3n3_zRVQVZ1akpgl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Non-current&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;125,480 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;115,875 &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:DisclosureOfOtherAssetsTableTextBlock>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002122"
      unitRef="BRL">80379000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002123"
      unitRef="BRL">78701000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <afya:Advances1
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002125"
      unitRef="BRL">40205000</afya:Advances1>
    <afya:Advances1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002126"
      unitRef="BRL">35140000</afya:Advances1>
    <afya:JudicialDeposits
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002128"
      unitRef="BRL">19274000</afya:JudicialDeposits>
    <afya:JudicialDeposits
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002129"
      unitRef="BRL">16938000</afya:JudicialDeposits>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002131"
      unitRef="BRL">18070000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002132"
      unitRef="BRL">19761000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002134"
      unitRef="BRL">6866000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002135"
      unitRef="BRL">8982000</ifrs-full:OtherReceivables>
    <afya:ConvertibleLoansFromVentureCapitalInvestments
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002137"
      unitRef="BRL">13240000</afya:ConvertibleLoansFromVentureCapitalInvestments>
    <afya:ConvertibleLoansFromVentureCapitalInvestments
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002138"
      unitRef="BRL">8724000</afya:ConvertibleLoansFromVentureCapitalInvestments>
    <afya:Dividend
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002140"
      unitRef="BRL">6287000</afya:Dividend>
    <afya:Dividend
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002141"
      unitRef="BRL">1628000</afya:Dividend>
    <afya:OtherAssets1
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002143"
      unitRef="BRL">4106000</afya:OtherAssets1>
    <afya:OtherAssets1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002144"
      unitRef="BRL">3146000</afya:OtherAssets1>
    <afya:Assets1
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002146"
      unitRef="BRL">188427000</afya:Assets1>
    <afya:Assets1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002147"
      unitRef="BRL">173020000</afya:Assets1>
    <afya:CurrentAssets1
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002149"
      unitRef="BRL">62947000</afya:CurrentAssets1>
    <afya:CurrentAssets1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002150"
      unitRef="BRL">57145000</afya:CurrentAssets1>
    <afya:NoncurrentAssets1
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002152"
      unitRef="BRL">125480000</afya:NoncurrentAssets1>
    <afya:NoncurrentAssets1
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002153"
      unitRef="BRL">115875000</afya:NoncurrentAssets1>
    <ifrs-full:DisclosureOfJointVenturesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002155">&lt;p id="xdx_80F_eifrs-full--DisclosureOfJointVenturesExplanatory_zOoU0SjIpNdg" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;9&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_825_zPMTXbigJ7X4"&gt;Investment in associate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt/107% Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company holds a 30% interest in UEPC, a medical school located in the Federal District
that offers higher education and post-graduate courses, both in person and long-distance learning. The Company&#x2019;s interest in UEPC
is accounted for using the equity method. The tables below summarize the financial information of the Company&#x2019;s investment in UEPC:&lt;/p&gt;

&lt;p style="font: 10.5pt/107% Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfInvestmentsExplanatory_z2kl9Rn7rje3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Investment in associate (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span id="xdx_8B4_zu4Qt0g6a225" style="display: none"&gt;Schedule of investment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49D_20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zqnkoJsbamWi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zoYlHItEqeUa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: top; width: 66%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CurrentAssets_iI_pn3n3" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Current assets&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;27,686 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;38,122 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--NoncurrentAssets_iI_pn3n3" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Non-current assets&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;118,550 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;116,846 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CurrentLiabilities_iNI_pn3n3_di_zeESBECtqTxg" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Current liabilities&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(44,726)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(30,049)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--NoncurrentLiabilities_iNI_pn3n3_di_z9Ws8PULOF6c" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Non-current liabilities&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(90,394)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(87,388)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--EquityInAssociate_iI_pn3n3_z8a91wCu2QX7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;11,116 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;37,531 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CompanyShareInEquity1_iI_pn3n3_zn9naorrrbg3" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Company&#x2019;s share in equity - 30%&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,335 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;11,259 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--Goodwill_iI_pn3n3" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Goodwill&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;43,183 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;43,183 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_pn3n3_z8PBUEqnbSYf" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;b&gt;Carrying amount of the investment&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;46,518 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;54,442 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zI5Jr6SexoG3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zYbtKW3cmkSh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zuoGhFuBU248" style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--Revenue_pn3n3_z0y1XeNYNJvg" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Revenue&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;167,525 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;156,984 &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;148,042&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--CostOfSales_iN_pn3n3_di_zvnmvssAItbj" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Cost of services&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(79,116)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(72,898)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(71,282)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_zNZSVOTFmAb2" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Selling, general and administrative expenses&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(32,587)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(30,755)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(27,646)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AllowanceForExpectedCreditLosses_pn3n3_zipcwdcIRnQl" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Allowance for expected credit losses&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;445&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(1,587)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(1,029)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--OtherIncome_pn3n3_zfDVkaSx4Dc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Other income&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;660 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;212&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;179&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--OtherExpense_pn3n3_zon92aCxS0xk" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Other expenses&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(5,111)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(5,326)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(8,709)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--FinanceIncome_iN_pn3n3_di_z4Jea73MIVnj" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Net finance result&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(3,298)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(4,946)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"&gt;(6,123)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ProfitLossBeforeTax_pn3n3_zOwU9iG5Uyye" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;48,518 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;41,684 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;b&gt;33,432&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_z2zaWivufW39" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Income taxes expenses&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(2,132)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(2,560)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"&gt;(1,782)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ProfitLoss_pn3n3_z4YLUkPW6hGg" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;46,386 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;39,124 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;b&gt;31,650&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr id="xdx_40C_ecustom--CompanyShareOfProfitss_pn3n3_zjD6sH1bfuUh" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Company&#x2019;s share of profit, net of tax&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;13,916 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;11,737 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; text-align: right"&gt;&lt;b&gt;9,495&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The movements during the years ended December 31, 2025, 2024 and 2023 are shown below:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zAMonWbLKNGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z0s46PoweWoi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zHosBaAYOWSg" style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iS_pn3n3_zXpeuV7ysMNc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;b&gt;Opening balance&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;54,442 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;51,834&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;&lt;b&gt;53,907&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--ProfitLossOfAcquiree_pn3n3_zXx3YD2pFwbd" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Share of profit, net of tax&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;13,916 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;11,737&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;9,495&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DividendsReceived1_iS_pn3n3_zgcnlOOMLMXf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Dividends received&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(15,553)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(7,501)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(9,900)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--DividendsReceived_iN_pn3n3_di_zt8IrViKEAWl" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Dividends receivable - Other assets&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(6,287)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(1,628)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(1,668)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--InvestmentsInAssociates_iE_pn3n3_zLBYCfm882Xc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;b&gt;Closing balance&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;46,518 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;54,442&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; text-align: right"&gt;&lt;b&gt;51,834&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A3_zylqmbP66dXl" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company tests the recoverability of the carrying amount of the Company&#x2019;s investment
in UEPC at least annually. As of December 31, 2025 and 2024, no impairment had to be recognized.&lt;/p&gt;

</ifrs-full:DisclosureOfJointVenturesExplanatory>
    <afya:DisclosureOfInvestmentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002157">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfInvestmentsExplanatory_z2kl9Rn7rje3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Investment in associate (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span id="xdx_8B4_zu4Qt0g6a225" style="display: none"&gt;Schedule of investment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49D_20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zqnkoJsbamWi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_499_20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zoYlHItEqeUa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: top; width: 66%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CurrentAssets_iI_pn3n3" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Current assets&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;27,686 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;38,122 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--NoncurrentAssets_iI_pn3n3" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Non-current assets&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;118,550 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;116,846 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CurrentLiabilities_iNI_pn3n3_di_zeESBECtqTxg" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Current liabilities&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(44,726)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(30,049)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--NoncurrentLiabilities_iNI_pn3n3_di_z9Ws8PULOF6c" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Non-current liabilities&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(90,394)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(87,388)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--EquityInAssociate_iI_pn3n3_z8a91wCu2QX7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;11,116 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;37,531 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CompanyShareInEquity1_iI_pn3n3_zn9naorrrbg3" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Company&#x2019;s share in equity - 30%&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,335 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;11,259 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--Goodwill_iI_pn3n3" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Goodwill&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;43,183 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;43,183 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_pn3n3_z8PBUEqnbSYf" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;b&gt;Carrying amount of the investment&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;46,518 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;54,442 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zI5Jr6SexoG3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_495_20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zYbtKW3cmkSh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zuoGhFuBU248" style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--Revenue_pn3n3_z0y1XeNYNJvg" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Revenue&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;167,525 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;156,984 &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;148,042&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--CostOfSales_iN_pn3n3_di_zvnmvssAItbj" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Cost of services&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(79,116)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(72,898)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(71,282)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--SellingGeneralAndAdministrativeExpense_iN_pn3n3_di_zNZSVOTFmAb2" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Selling, general and administrative expenses&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(32,587)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(30,755)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(27,646)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AllowanceForExpectedCreditLosses_pn3n3_zipcwdcIRnQl" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Allowance for expected credit losses&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;445&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(1,587)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(1,029)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--OtherIncome_pn3n3_zfDVkaSx4Dc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Other income&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;660 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;212&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;179&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--OtherExpense_pn3n3_zon92aCxS0xk" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Other expenses&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(5,111)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(5,326)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(8,709)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--FinanceIncome_iN_pn3n3_di_z4Jea73MIVnj" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Net finance result&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(3,298)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(4,946)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"&gt;(6,123)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ProfitLossBeforeTax_pn3n3_zOwU9iG5Uyye" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;b&gt;Income before income taxes&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;48,518 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;41,684 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;b&gt;33,432&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_z2zaWivufW39" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Income taxes expenses&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(2,132)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(2,560)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"&gt;(1,782)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ProfitLoss_pn3n3_z4YLUkPW6hGg" style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Net income&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;46,386 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;39,124 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;b&gt;31,650&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr id="xdx_40C_ecustom--CompanyShareOfProfitss_pn3n3_zjD6sH1bfuUh" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Company&#x2019;s share of profit, net of tax&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;13,916 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;11,737 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; text-align: right"&gt;&lt;b&gt;9,495&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The movements during the years ended December 31, 2025, 2024 and 2023 are shown below:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20250101__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zAMonWbLKNGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z0s46PoweWoi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zHosBaAYOWSg" style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: top; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iS_pn3n3_zXpeuV7ysMNc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;b&gt;Opening balance&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;54,442 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;51,834&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;&lt;b&gt;53,907&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--ProfitLossOfAcquiree_pn3n3_zXx3YD2pFwbd" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Share of profit, net of tax&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;13,916 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;11,737&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;9,495&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DividendsReceived1_iS_pn3n3_zgcnlOOMLMXf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Dividends received&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(15,553)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(7,501)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(9,900)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--DividendsReceived_iN_pn3n3_di_zt8IrViKEAWl" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;Dividends receivable - Other assets&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(6,287)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(1,628)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(1,668)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--InvestmentsInAssociates_iE_pn3n3_zLBYCfm882Xc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;b&gt;Closing balance&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;46,518 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;54,442&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; text-align: right"&gt;&lt;b&gt;51,834&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:DisclosureOfInvestmentsExplanatory>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002159"
      unitRef="BRL">27686000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002160"
      unitRef="BRL">38122000</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002162"
      unitRef="BRL">118550000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002163"
      unitRef="BRL">116846000</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002165"
      unitRef="BRL">44726000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002166"
      unitRef="BRL">30049000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002168"
      unitRef="BRL">90394000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002169"
      unitRef="BRL">87388000</ifrs-full:NoncurrentLiabilities>
    <afya:EquityInAssociate
      contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002171"
      unitRef="BRL">11116000</afya:EquityInAssociate>
    <afya:EquityInAssociate
      contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002172"
      unitRef="BRL">37531000</afya:EquityInAssociate>
    <afya:CompanyShareInEquity1
      contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002174"
      unitRef="BRL">3335000</afya:CompanyShareInEquity1>
    <afya:CompanyShareInEquity1
      contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002175"
      unitRef="BRL">11259000</afya:CompanyShareInEquity1>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002177"
      unitRef="BRL">43183000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002178"
      unitRef="BRL">43183000</ifrs-full:Goodwill>
    <afya:InvestmentGrossAmount
      contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002180"
      unitRef="BRL">46518000</afya:InvestmentGrossAmount>
    <afya:InvestmentGrossAmount
      contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002181"
      unitRef="BRL">54442000</afya:InvestmentGrossAmount>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002183"
      unitRef="BRL">167525000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002184"
      unitRef="BRL">156984000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002185"
      unitRef="BRL">148042000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002187"
      unitRef="BRL">79116000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002188"
      unitRef="BRL">72898000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002189"
      unitRef="BRL">71282000</ifrs-full:CostOfSales>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002191"
      unitRef="BRL">32587000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002192"
      unitRef="BRL">30755000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002193"
      unitRef="BRL">27646000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002195"
      unitRef="BRL">445000</afya:AllowanceForExpectedCreditLosses>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002196"
      unitRef="BRL">-1587000</afya:AllowanceForExpectedCreditLosses>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002197"
      unitRef="BRL">-1029000</afya:AllowanceForExpectedCreditLosses>
    <ifrs-full:OtherIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002199"
      unitRef="BRL">660000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002200"
      unitRef="BRL">212000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002201"
      unitRef="BRL">179000</ifrs-full:OtherIncome>
    <afya:OtherExpense
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002203"
      unitRef="BRL">-5111000</afya:OtherExpense>
    <afya:OtherExpense
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002204"
      unitRef="BRL">-5326000</afya:OtherExpense>
    <afya:OtherExpense
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002205"
      unitRef="BRL">-8709000</afya:OtherExpense>
    <ifrs-full:FinanceIncome
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002207"
      unitRef="BRL">3298000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002208"
      unitRef="BRL">4946000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002209"
      unitRef="BRL">6123000</ifrs-full:FinanceIncome>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002211"
      unitRef="BRL">48518000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002212"
      unitRef="BRL">41684000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002213"
      unitRef="BRL">33432000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002215"
      unitRef="BRL">-2132000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002216"
      unitRef="BRL">-2560000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002217"
      unitRef="BRL">-1782000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002219"
      unitRef="BRL">46386000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002220"
      unitRef="BRL">39124000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002221"
      unitRef="BRL">31650000</ifrs-full:ProfitLoss>
    <afya:CompanyShareOfProfitss
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002223"
      unitRef="BRL">13916000</afya:CompanyShareOfProfitss>
    <afya:CompanyShareOfProfitss
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002224"
      unitRef="BRL">11737000</afya:CompanyShareOfProfitss>
    <afya:CompanyShareOfProfitss
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002225"
      unitRef="BRL">9495000</afya:CompanyShareOfProfitss>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002229"
      unitRef="BRL">54442000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002230"
      unitRef="BRL">51834000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002231"
      unitRef="BRL">53907000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002233"
      unitRef="BRL">13916000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002234"
      unitRef="BRL">11737000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002235"
      unitRef="BRL">9495000</ifrs-full:ProfitLossOfAcquiree>
    <afya:DividendsReceived1
      contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002237"
      unitRef="BRL">-15553000</afya:DividendsReceived1>
    <afya:DividendsReceived1
      contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002238"
      unitRef="BRL">-7501000</afya:DividendsReceived1>
    <afya:DividendsReceived1
      contextRef="AsOf2022-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002239"
      unitRef="BRL">-9900000</afya:DividendsReceived1>
    <ifrs-full:DividendsReceived
      contextRef="From2025-01-012025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002241"
      unitRef="BRL">6287000</ifrs-full:DividendsReceived>
    <ifrs-full:DividendsReceived
      contextRef="From2024-01-012024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002242"
      unitRef="BRL">1628000</ifrs-full:DividendsReceived>
    <ifrs-full:DividendsReceived
      contextRef="From2023-01-012023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002243"
      unitRef="BRL">1668000</ifrs-full:DividendsReceived>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2025-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002245"
      unitRef="BRL">46518000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2024-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002246"
      unitRef="BRL">54442000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2023-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      id="Fact002247"
      unitRef="BRL">51834000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002249">&lt;p id="xdx_80A_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zBp0ooUlKdij" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;10&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_822_zbl70p2U4iAl"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company assesses at each reporting date, whether there is an indication that a property
and equipment asset may be impaired. If any indication exists, the Company estimates the asset&#x2019;s recoverable amount. There were
no impairment indicatives of property and equipment as of and for the years ended December 31, 2025, 2024 and 2023. The following table
shows the balances and movements in property and equipment during the years ended December 31, 2025, 2024 and 2023.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;






&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_z0iSFzr0zwc" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Property and equipment (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BB_zmsYtSvRd34d" style="display: none"&gt;Schedule of detailed information about property, plant and
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_zwYUrrhnbzh4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zxETs61Yb0ja" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BD_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zGe1upplAu79" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BF_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_znnKO0XEL8Oe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zAGJbXCv7eR5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zMbMf1OcmPn" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_zrAwjHBjQ5D3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zlmbygeONabc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zTdynmPJzWn2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B1_zmji0Ti1d7fh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 20%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Machinery and equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 4%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Lands&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Furniture and fixtures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;IT equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Library books&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Leasehold improvements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Construction in progress&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Cost&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_ziP1XOH45Ed6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;91,857&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;100,390&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,053&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;90,712&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;68,593&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;37,362&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;145,846&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;86,688&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;641,353&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zc2ZFEQDlYq8" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;96&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;20,071&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2267"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;776&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;17,914&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;21,135&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;985&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;49&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;57,409&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;118,435&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zxIHAyZ8oJUa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2276"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;7,729&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2278"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2279"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;4,384&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;734&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,329&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;10,741&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;63&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;24,980&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zvhrdeWTQZTh" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2287"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(9,411)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2289"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(475)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(1,443)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(7,979)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(7,788)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(286)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2295"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(27,382)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zAZY9kK1NL9l" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,279&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,202&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2300"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2301"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(708)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;327&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2304"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;108,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(110,198)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2307"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zJGAS6c2Q7y3" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;93,232&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;119,981&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,354&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;110,859&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;82,810&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;31,888&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;264,448&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;33,962&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;757,386&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_z6Fv5AGZJoh7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,003 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;29,195 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2322"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;130 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;21,582 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;25,945 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,293 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;2,001 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;55,775 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;136,924 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zrX5LI0H0eJj" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;2 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;2,528 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2333"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2334"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;289 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;736 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;372 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,782 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2339"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;5,709&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zV63u24LOlQa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2342"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(2,071)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2344"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(42)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(7,050)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(1,154)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2348"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2349"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2350"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(10,317)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zfLlynfE5ZH3" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;5,129 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(226)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2355"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2356"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(862)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;480 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2359"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;41,182 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(45,703)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2362"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zsPoJeuzZSc1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;99,366 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;149,407 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;18,852 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,442 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;124,818 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;108,817 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;33,553 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;309,413 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;44,034 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;889,702 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zTCKgONU2NJh" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;121&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;28,301&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2377"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2378"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;28,575&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;24,204&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,178&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;2,812&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;80,823&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;166,014&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zD29JwIf9CAg" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2386"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2387"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2388"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(435)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(2,536)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(80)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(6,781)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(7)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(11,059)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zeGk2KRZ6wv3" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;9,015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;275&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2399"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2400"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,110&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(754)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2403"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;46,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(55,664)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2406"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zDQ3xGNwvJra" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2025
&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;108,502&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;177,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,007&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;153,283&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;129,731&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;34,651&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;351,462&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;69,186&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,044,657&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Depreciation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zDMPSvGf2xIk" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(5,751)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(20,630)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2421"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;288&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(10,349)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(21,837)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(22,888)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(18,099)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2427"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(99,266)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zTvC1GdZ3F58" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(4,242)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(14,900)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2432"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(325)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(12,556)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(13,286)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(3,327)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(26,271)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2438"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(74,907)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zKXWCylEBpyf" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;118&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;6,684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2443"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;235&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;2,528&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;8,254&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;7,563&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2449"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;25,472&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z8613PIdGmRl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;Transfer &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;196&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2454"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2455"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2456"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2458"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(196)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2460"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2461"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zkIY1XQdd3S2" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(9,679)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(28,843)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2465"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;198&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(20,377)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(26,872)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(18,652)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(44,476)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2471"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(148,701)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zkUgUvQzxGz5" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(4,188)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(17,684)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2476"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(377)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(12,778)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(15,608)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(3,058)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(36,604)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(90,297)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zk3FgCiDsY4l" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2485"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,491 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2487"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;42 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;4,593 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,150 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2491"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;502 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2493"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;7,778 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zfDGhv0Tsvo5" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(95)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(74)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2498"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2499"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;482 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(165)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2502"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(148)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2504"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2505"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zLDi6SY0Wsf7" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(13,962)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(45,110)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2509"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(137)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(28,080)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(41,495)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(21,710)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(80,726)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2515"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(231,220)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zcgAwGVCOnzi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(4,962)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(18,197)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2520"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(304)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(15,989)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(20,514)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(3,002)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(46,981)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2526"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(109,949)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zsgrJ6fvsOTb" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2529"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;881&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2531"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;301&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,055&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,545&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;80&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;4,135&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2537"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;7,997&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zM31Zgorr3V2" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2025 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(18,924)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(62,426)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2542"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(140)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(43,014)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(60,464)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(24,632)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(123,572)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2548"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(333,172)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Net book value&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2025 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zeG5wi5ayLQa" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;89,578&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zsOXyka6mW4a" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;115,557&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zY2FmOitXgQ2" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zdoofmCptOc6" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;867&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zQR10epQM8s7" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;110,269&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_z9xZJ7QBwI2i" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;69,267&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zhF2penUNz8k" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;10,019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zgkfNhEEcjFj" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;227,890&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zixBfGBtVMs" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;69,186&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231_zWe9Kl7kpYZa" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;711,485&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zxr6OuWoMEOa" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;85,404 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zmKYfUYtsZCg" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;104,297 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zrHyaTej3sbl" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;18,852 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zrJC1T37K4q5" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,305 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zXnnYLSXLhij" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;96,738 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zR2NHAMaeSW8" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;67,322 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_z0Hmdv469jE7" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;11,843 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zY1gVN2Ldra5" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;228,687 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zzwE8fr90lea" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;44,034 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_iI_pn3n3_c20241231_zFBp3Y48MZE4" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;658,482 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to items written-off as result of lack of expectation of future use, in connection
with the Company&#x2019;s physical inventory procedures.&lt;br/&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A3_zOmb2pHatcOa" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002252">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn3n3_z0iSFzr0zwc" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Property and equipment (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BB_zmsYtSvRd34d" style="display: none"&gt;Schedule of detailed information about property, plant and
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_zwYUrrhnbzh4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zxETs61Yb0ja" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BD_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zGe1upplAu79" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BF_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_znnKO0XEL8Oe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B7_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zAGJbXCv7eR5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zMbMf1OcmPn" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_zrAwjHBjQ5D3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zlmbygeONabc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zTdynmPJzWn2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B1_zmji0Ti1d7fh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 20%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Machinery and equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 4%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Lands&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Furniture and fixtures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;IT equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Library books&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Leasehold improvements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Construction in progress&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Cost&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_ziP1XOH45Ed6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;91,857&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;100,390&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,053&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;90,712&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;68,593&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;37,362&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;145,846&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;86,688&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;641,353&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zc2ZFEQDlYq8" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;96&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;20,071&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2267"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;776&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;17,914&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;21,135&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;985&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;49&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;57,409&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;118,435&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zxIHAyZ8oJUa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2276"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;7,729&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2278"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2279"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;4,384&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;734&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,329&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;10,741&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;63&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;24,980&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zvhrdeWTQZTh" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2287"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(9,411)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2289"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(475)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(1,443)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(7,979)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(7,788)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(286)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2295"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(27,382)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zAZY9kK1NL9l" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,279&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,202&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2300"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2301"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(708)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;327&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2304"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;108,098&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(110,198)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2307"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zJGAS6c2Q7y3" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;93,232&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;119,981&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,354&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;110,859&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;82,810&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;31,888&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;264,448&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;33,962&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;757,386&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_z6Fv5AGZJoh7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,003 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;29,195 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2322"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;130 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;21,582 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;25,945 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,293 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;2,001 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;55,775 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;136,924 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zrX5LI0H0eJj" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;2 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;2,528 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2333"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2334"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;289 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;736 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;372 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,782 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2339"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;5,709&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zV63u24LOlQa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2342"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(2,071)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2344"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(42)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(7,050)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(1,154)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2348"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2349"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2350"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(10,317)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zfLlynfE5ZH3" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;5,129 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(226)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2355"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2356"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(862)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;480 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2359"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;41,182 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(45,703)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2362"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zsPoJeuzZSc1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;99,366 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;149,407 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;18,852 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,442 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;124,818 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;108,817 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;33,553 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;309,413 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;44,034 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;889,702 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_zTCKgONU2NJh" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;121&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;28,301&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2377"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2378"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;28,575&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;24,204&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,178&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;2,812&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;80,823&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;166,014&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zD29JwIf9CAg" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2386"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2387"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2388"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(435)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(2,536)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(80)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(6,781)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(7)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(11,059)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zeGk2KRZ6wv3" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;9,015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;275&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2399"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2400"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,110&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(754)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2403"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;46,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(55,664)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2406"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zDQ3xGNwvJra" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2025
&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;108,502&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;177,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,007&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;153,283&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;129,731&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;34,651&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;351,462&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;69,186&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,044,657&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Depreciation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zDMPSvGf2xIk" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(5,751)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(20,630)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2421"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;288&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(10,349)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(21,837)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(22,888)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(18,099)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2427"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(99,266)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zTvC1GdZ3F58" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(4,242)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(14,900)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2432"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(325)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(12,556)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(13,286)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(3,327)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(26,271)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2438"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(74,907)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zKXWCylEBpyf" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;118&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;6,684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2443"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;235&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;2,528&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;8,254&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;7,563&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2449"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;25,472&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_z8613PIdGmRl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;Transfer &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;196&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2454"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2455"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2456"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2458"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(196)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2460"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2461"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zkIY1XQdd3S2" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(9,679)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(28,843)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2465"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;198&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(20,377)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(26,872)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(18,652)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(44,476)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2471"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(148,701)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zkUgUvQzxGz5" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(4,188)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(17,684)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2476"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(377)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(12,778)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(15,608)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(3,058)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(36,604)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(90,297)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zk3FgCiDsY4l" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2485"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,491 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2487"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;42 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;4,593 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,150 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2491"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;502 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2493"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;7,778 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_pn3n3_zfDGhv0Tsvo5" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(95)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(74)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2498"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2499"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;482 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(165)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2502"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(148)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2504"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2505"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iS_pn3n3_zLDi6SY0Wsf7" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(13,962)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(45,110)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2509"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(137)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(28,080)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(41,495)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(21,710)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(80,726)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2515"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(231,220)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn3n3_di_zcgAwGVCOnzi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(4,962)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(18,197)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2520"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(304)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(15,989)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(20,514)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(3,002)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(46,981)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2526"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(109,949)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--WritOffOfPropertyPlantAndEquipment_pn3n3_zsgrJ6fvsOTb" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2529"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;881&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2531"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;301&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,055&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;1,545&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;80&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;4,135&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2537"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;7,997&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ecustom--PropertyPlantAndEquipments_iE_pn3n3_zM31Zgorr3V2" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2025 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(18,924)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(62,426)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2542"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(140)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(43,014)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(60,464)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(24,632)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(123,572)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2548"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(333,172)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Net book value&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2025 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zeG5wi5ayLQa" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;89,578&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zsOXyka6mW4a" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;115,557&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zY2FmOitXgQ2" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zdoofmCptOc6" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;867&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zQR10epQM8s7" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;110,269&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_z9xZJ7QBwI2i" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;69,267&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zhF2penUNz8k" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;10,019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zgkfNhEEcjFj" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;227,890&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zixBfGBtVMs" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;69,186&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20251231_zWe9Kl7kpYZa" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;711,485&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zxr6OuWoMEOa" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;85,404 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_zmKYfUYtsZCg" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;104,297 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandMember_zrHyaTej3sbl" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;18,852 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zrJC1T37K4q5" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,305 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zXnnYLSXLhij" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;96,738 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_zR2NHAMaeSW8" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;67,322 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_z0Hmdv469jE7" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;11,843 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zY1gVN2Ldra5" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;228,687 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PropertyPlantAndEquipmentNetBookValue_pn3n3_c20241231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zzwE8fr90lea" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;44,034 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentNetBookValue_iI_pn3n3_c20241231_zFBp3Y48MZE4" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;658,482 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to items written-off as result of lack of expectation of future use, in connection
with the Company&#x2019;s physical inventory procedures.&lt;br/&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002254"
      unitRef="BRL">91857000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002255"
      unitRef="BRL">100390000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002256"
      unitRef="BRL">18852000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002257"
      unitRef="BRL">1053000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002258"
      unitRef="BRL">90712000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002259"
      unitRef="BRL">68593000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002260"
      unitRef="BRL">37362000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002261"
      unitRef="BRL">145846000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002262"
      unitRef="BRL">86688000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002263"
      unitRef="BRL">641353000</afya:PropertyPlantAndEquipments>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002265"
      unitRef="BRL">96000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002266"
      unitRef="BRL">20071000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002268"
      unitRef="BRL">776000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002269"
      unitRef="BRL">17914000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002270"
      unitRef="BRL">21135000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002271"
      unitRef="BRL">985000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002272"
      unitRef="BRL">49000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002273"
      unitRef="BRL">57409000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002274"
      unitRef="BRL">118435000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002277"
      unitRef="BRL">7729000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002280"
      unitRef="BRL">4384000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002281"
      unitRef="BRL">734000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002282"
      unitRef="BRL">1329000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002283"
      unitRef="BRL">10741000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002284"
      unitRef="BRL">63000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002285"
      unitRef="BRL">24980000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002288"
      unitRef="BRL">-9411000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002290"
      unitRef="BRL">-475000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002291"
      unitRef="BRL">-1443000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002292"
      unitRef="BRL">-7979000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002293"
      unitRef="BRL">-7788000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002294"
      unitRef="BRL">-286000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002296"
      unitRef="BRL">-27382000</afya:WritOffOfPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002298"
      unitRef="BRL">1279000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002299"
      unitRef="BRL">1202000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002302"
      unitRef="BRL">-708000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002303"
      unitRef="BRL">327000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002305"
      unitRef="BRL">108098000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002306"
      unitRef="BRL">-110198000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002309"
      unitRef="BRL">93232000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002310"
      unitRef="BRL">119981000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002311"
      unitRef="BRL">18852000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002312"
      unitRef="BRL">1354000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002313"
      unitRef="BRL">110859000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002314"
      unitRef="BRL">82810000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002315"
      unitRef="BRL">31888000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002316"
      unitRef="BRL">264448000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002317"
      unitRef="BRL">33962000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002318"
      unitRef="BRL">757386000</afya:PropertyPlantAndEquipments>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002320"
      unitRef="BRL">1003000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002321"
      unitRef="BRL">29195000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002323"
      unitRef="BRL">130000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002324"
      unitRef="BRL">21582000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002325"
      unitRef="BRL">25945000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002326"
      unitRef="BRL">1293000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002327"
      unitRef="BRL">2001000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002328"
      unitRef="BRL">55775000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002329"
      unitRef="BRL">136924000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002331"
      unitRef="BRL">2000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002332"
      unitRef="BRL">2528000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002335"
      unitRef="BRL">289000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002336"
      unitRef="BRL">736000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002337"
      unitRef="BRL">372000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002338"
      unitRef="BRL">1782000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002340"
      unitRef="BRL">5709000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002343"
      unitRef="BRL">-2071000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002345"
      unitRef="BRL">-42000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002346"
      unitRef="BRL">-7050000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002347"
      unitRef="BRL">-1154000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002351"
      unitRef="BRL">-10317000</afya:WritOffOfPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002353"
      unitRef="BRL">5129000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002354"
      unitRef="BRL">-226000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002357"
      unitRef="BRL">-862000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002358"
      unitRef="BRL">480000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002360"
      unitRef="BRL">41182000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002361"
      unitRef="BRL">-45703000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002364"
      unitRef="BRL">99366000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002365"
      unitRef="BRL">149407000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002366"
      unitRef="BRL">18852000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002367"
      unitRef="BRL">1442000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002368"
      unitRef="BRL">124818000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002369"
      unitRef="BRL">108817000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002370"
      unitRef="BRL">33553000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002371"
      unitRef="BRL">309413000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002372"
      unitRef="BRL">44034000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002373"
      unitRef="BRL">889702000</afya:PropertyPlantAndEquipments>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002375"
      unitRef="BRL">121000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002376"
      unitRef="BRL">28301000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002379"
      unitRef="BRL">28575000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002380"
      unitRef="BRL">24204000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002381"
      unitRef="BRL">1178000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002382"
      unitRef="BRL">2812000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002383"
      unitRef="BRL">80823000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002384"
      unitRef="BRL">166014000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002389"
      unitRef="BRL">-435000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002390"
      unitRef="BRL">-1220000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002391"
      unitRef="BRL">-2536000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002392"
      unitRef="BRL">-80000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002393"
      unitRef="BRL">-6781000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002394"
      unitRef="BRL">-7000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002395"
      unitRef="BRL">-11059000</afya:WritOffOfPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002397"
      unitRef="BRL">9015000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002398"
      unitRef="BRL">275000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002401"
      unitRef="BRL">1110000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002402"
      unitRef="BRL">-754000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002404"
      unitRef="BRL">46018000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002405"
      unitRef="BRL">-55664000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002408"
      unitRef="BRL">108502000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002409"
      unitRef="BRL">177983000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002410"
      unitRef="BRL">18852000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002411"
      unitRef="BRL">1007000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002412"
      unitRef="BRL">153283000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002413"
      unitRef="BRL">129731000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002414"
      unitRef="BRL">34651000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002415"
      unitRef="BRL">351462000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002416"
      unitRef="BRL">69186000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002417"
      unitRef="BRL">1044657000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002419"
      unitRef="BRL">-5751000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002420"
      unitRef="BRL">-20630000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002422"
      unitRef="BRL">288000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002423"
      unitRef="BRL">-10349000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002424"
      unitRef="BRL">-21837000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002425"
      unitRef="BRL">-22888000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002426"
      unitRef="BRL">-18099000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002428"
      unitRef="BRL">-99266000</afya:PropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002430"
      unitRef="BRL">4242000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002431"
      unitRef="BRL">14900000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002433"
      unitRef="BRL">325000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002434"
      unitRef="BRL">12556000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002435"
      unitRef="BRL">13286000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002436"
      unitRef="BRL">3327000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002437"
      unitRef="BRL">26271000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002439"
      unitRef="BRL">74907000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002441"
      unitRef="BRL">118000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002442"
      unitRef="BRL">6684000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002444"
      unitRef="BRL">235000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002445"
      unitRef="BRL">2528000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002446"
      unitRef="BRL">8254000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002447"
      unitRef="BRL">7563000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002448"
      unitRef="BRL">90000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002450"
      unitRef="BRL">25472000</afya:WritOffOfPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002452"
      unitRef="BRL">196000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002453"
      unitRef="BRL">3000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002457"
      unitRef="BRL">-3000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002459"
      unitRef="BRL">-196000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002463"
      unitRef="BRL">-9679000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002464"
      unitRef="BRL">-28843000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002466"
      unitRef="BRL">198000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002467"
      unitRef="BRL">-20377000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002468"
      unitRef="BRL">-26872000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002469"
      unitRef="BRL">-18652000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002470"
      unitRef="BRL">-44476000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002472"
      unitRef="BRL">-148701000</afya:PropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002474"
      unitRef="BRL">4188000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002475"
      unitRef="BRL">17684000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002477"
      unitRef="BRL">377000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002478"
      unitRef="BRL">12778000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002479"
      unitRef="BRL">15608000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002480"
      unitRef="BRL">3058000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002481"
      unitRef="BRL">36604000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002483"
      unitRef="BRL">90297000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002486"
      unitRef="BRL">1491000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002488"
      unitRef="BRL">42000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002489"
      unitRef="BRL">4593000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002490"
      unitRef="BRL">1150000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002492"
      unitRef="BRL">502000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002494"
      unitRef="BRL">7778000</afya:WritOffOfPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002496"
      unitRef="BRL">-95000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002497"
      unitRef="BRL">-74000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002500"
      unitRef="BRL">482000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002501"
      unitRef="BRL">-165000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002503"
      unitRef="BRL">-148000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002507"
      unitRef="BRL">-13962000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002508"
      unitRef="BRL">-45110000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002510"
      unitRef="BRL">-137000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002511"
      unitRef="BRL">-28080000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002512"
      unitRef="BRL">-41495000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002513"
      unitRef="BRL">-21710000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002514"
      unitRef="BRL">-80726000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002516"
      unitRef="BRL">-231220000</afya:PropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002518"
      unitRef="BRL">4962000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002519"
      unitRef="BRL">18197000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002521"
      unitRef="BRL">304000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002522"
      unitRef="BRL">15989000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002523"
      unitRef="BRL">20514000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002524"
      unitRef="BRL">3002000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002525"
      unitRef="BRL">46981000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002527"
      unitRef="BRL">109949000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002530"
      unitRef="BRL">881000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002532"
      unitRef="BRL">301000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002533"
      unitRef="BRL">1055000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002534"
      unitRef="BRL">1545000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002535"
      unitRef="BRL">80000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002536"
      unitRef="BRL">4135000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:WritOffOfPropertyPlantAndEquipment
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002538"
      unitRef="BRL">7997000</afya:WritOffOfPropertyPlantAndEquipment>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002540"
      unitRef="BRL">-18924000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002541"
      unitRef="BRL">-62426000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002543"
      unitRef="BRL">-140000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002544"
      unitRef="BRL">-43014000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002545"
      unitRef="BRL">-60464000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002546"
      unitRef="BRL">-24632000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002547"
      unitRef="BRL">-123572000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipments
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002549"
      unitRef="BRL">-333172000</afya:PropertyPlantAndEquipments>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2025-12-31_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002551"
      unitRef="BRL">89578000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2025-12-31_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002553"
      unitRef="BRL">115557000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2025-12-31_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002555"
      unitRef="BRL">18852000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2025-12-31_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002557"
      unitRef="BRL">867000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2025-12-31_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002559"
      unitRef="BRL">110269000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2025-12-31_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002561"
      unitRef="BRL">69267000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2025-12-31_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002563"
      unitRef="BRL">10019000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2025-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002565"
      unitRef="BRL">227890000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2025-12-31_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002567"
      unitRef="BRL">69186000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002569"
      unitRef="BRL">711485000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2024-12-31_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002571"
      unitRef="BRL">85404000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2024-12-31_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002573"
      unitRef="BRL">104297000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2024-12-31_ifrs-full_LandMember"
      decimals="-3"
      id="Fact002575"
      unitRef="BRL">18852000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2024-12-31_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002577"
      unitRef="BRL">1305000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2024-12-31_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002579"
      unitRef="BRL">96738000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2024-12-31_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002581"
      unitRef="BRL">67322000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2024-12-31_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002583"
      unitRef="BRL">11843000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2024-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002585"
      unitRef="BRL">228687000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2024-12-31_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002587"
      unitRef="BRL">44034000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:PropertyPlantAndEquipmentNetBookValue
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002589"
      unitRef="BRL">658482000</afya:PropertyPlantAndEquipmentNetBookValue>
    <afya:DisclosureOfIntangibleAssetExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact002591">&lt;p id="xdx_807_ecustom--DisclosureOfIntangibleAssetExplanatory_zZCogGIzmr5b" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;11&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_824_zvEhTKl4hQO4"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 2pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_pn3n3_z5ARI5S96bml" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Intangible assets (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span id="xdx_8B8_zbQK7cpU4OWc" style="display: none"&gt;Schedule of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 26%; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Goodwill &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Licenses with indefinite useful life &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Trademarks&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 4%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Education content&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Developed technology&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Educational platform&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Intangible in progress&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 3%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Cost&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXLPeIQtsM0j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,257,045&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zFOX7zHbajF6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;2,189,814&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXiG8vaOGrc2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;182,060&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKtBCdSmaYpf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;435,816&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zm0zVDYvxPfk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;43,300&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zBOZOPk1hfs2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;69,589&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z538J1iaB7O" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;90,749&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTpnT5DIci02" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;55,697&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRk43MPMsoTk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;14,734&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWuhPKyt0i9j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,055&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEFwp1scJDS9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;4,339,859&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLm6yaMH5Lvi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2617"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1acKodXCkdd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;1,314&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeZgI413YVDb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;9,827&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4NNN5rP0Ba2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;37,712&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuT2Gema61o1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;23,164&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zi72d0PnOjVj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;27,976&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc3RGBSiUd13" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;99,993&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOwaP2JuCcbl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;75,098&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoYyj8VkSOc1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;586,263&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLXR21ueOcQ1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;142,451&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwWf0AjbTBwi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;63&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQcEnD4rS7hc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;803,875&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoubWbHH41c5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(2,235)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_za2kjFiaY8l" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(911)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWvFdsOWtpD4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(125)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJSyR6VaMbOe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(3,271)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Remeasurement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsxrWEmRbbV1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Remesurement"&gt;&lt;span style="font-size: 7.5pt"&gt;2,556&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z85DLoAnPyQ3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Remesurement"&gt;&lt;span style="font-size: 7.5pt"&gt;2,556&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4NPqnUPWUH1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;28,708&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVXxidglRRz4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;4,785&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8qJyc1xtFwh" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;16&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOS0dqxmxRFc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(3,058)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7NTfIGPWNb8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(30,451)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zaqo0QY2kps3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,334,699&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfxJxqyGbhz3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;2,776,077&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztBLF0yqKg0b" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;182,060&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z0udGq4J3JAa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;578,267&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEQnogXAkGDe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;71,150&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjOmK4lkxRjj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;84,201&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmEAXoBdOzr8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;128,477&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXahYkGKXbz7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;74,892&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9c518H1B2Va" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;12,134&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc2lF7k3PuV5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,055&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMDVqDU2iGm1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;5,243,012&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztjhdsWZ48q8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;157,227 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQlDIfLJIM6a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;1,511 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqbZN68Fi4y8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;17,701 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcDS77okDfBl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;14,092 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJu9NUY2xEGd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;30,255 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzKOOsfStq5g" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;34,905 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZoF9KE45jqe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;255,691 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfQdl7Jwzgw3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;192,034 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHVDzhdq1pNe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;427,482 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMlmrwAU16dc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;34,560 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9EHfwC2LrTc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;654,076 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcPYGpUE1o0i" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(162)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9PfFHXweTEk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(117)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zl3j076XfJK4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8Mv2dpzntel" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlHOF6DpxLtb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;23,292 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzJoVPwrmJrg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;6,529 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zh19xklC10Tb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(39,929)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1UFQS37Pcqf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;29,673 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zATgoRNwq5sl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(19,565)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;- &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zb3aHgCRNrye" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,526,733 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z17ghQiVjPjg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,360,786 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zBKcZE2Rpj53" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;182,060 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgmBoSuzYDFf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;612,827 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwJuzxYIXXv6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;95,953 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbf7wynp3fL1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;108,269 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoAJz80cGnW" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;102,523 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zYBe5VnFW6af" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;134,820 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zStSTVvDiuci" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;27,473 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJzINBZ8US78" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,055 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrGHdmExU3s1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;6,152,499 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1gXhZJJwTQk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;99,629&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zC2DQJ1hye48" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;276&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziCp74Ym0P1g" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;25,106&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyqSVlv6c4a4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;9,552&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znsldTmHMJB3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;31,250&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1zq7Da0DoP6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;72,184&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvDiA7GhU28a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;237,997&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRoBitc7xpof" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zK6tQVTsOeCh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQBVVyqpIE79" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(272)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1125lsjVCZ" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwigvmbJNV71" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(691)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zDsgfLvEn9gj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;31,531&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxIUOxYSq4Ac" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(30,840)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2025 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCSO2MwUKmGc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,526,733&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXBXukM7Si5a" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,460,415&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrlbuzIIxTva" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;182,060&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxP1Cv7ilbc4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;612,136&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2KRCBoSwERc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;127,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqSzVMOrOKU9" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;133,373&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztzZ8bD8cXgi" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;112,074&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zueKPfDvCyta" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;166,070&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEeNDdP180Gd" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;68,545&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQD6ZUai0DGk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,055&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zO6i4Tn13dpf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;6,390,221&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Amortization&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zYP5nIncY082" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2797"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zY06G9LJ8yAg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2799"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBDoezezxq1l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(14,955)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQkIjkse9ysl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(212,363)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW7vj3B3THai" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(17,277)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1GCgzhcZ8Md" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(26,562)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOj3SX448FQi" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(10,093)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8DIqTkiqDQ3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(17,039)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zy5s5ZYBxOE5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2813"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTobSyUDpKQ5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(79)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zw90gvVfX1El" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(298,368)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iP2custom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlO12eFJin97" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2819"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zmkKKzT8I246" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2820"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBBvb2yiVbC6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;(11,083)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zf9dNrm5aD6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;(89,584)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdP8l9MJmfK4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(8,764)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8qsWZrGGNMf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(15,668)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBw7BNTnTQse" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(21,504)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTVeMXJciksa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(4,778)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkgdoP3P6UTi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2829"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbM05cUjXAOe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(105)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqfk7c9cA9Z1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(151,486)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zXkVRlhPqD7g" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;1,947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdZ1AGTjIqf8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;911&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuTk98HSDYrl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;2,858&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSJ9B8tOxBZg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(6)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIcnETa8xG4j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zogL1bEPU7Q6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2843"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z3TdCOnevdi5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2845"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJQMe1Vmsuy6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(26,038)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z2KdKRDAToZk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(301,947)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zC0PdwKOvAl2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(24,094)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8NhawO5DETf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(42,230)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxI6CYmNBBH6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(31,603)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDYt8xaMzdQl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(20,900)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zB0QQiBTu0c8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2859"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z2FlyJZKNgRa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(184)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZ9WemNDEDp5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(446,996)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxQADNzeSNJ7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2865"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zdFVlUz1RTp" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2866"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z6vXTtiDjli9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(12,506)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmeELLcXy9h2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;(82,737)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRYP7teYB8Fc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(16,457)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzb3VRTgCDEb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(18,471)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDmE22bjtVG2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(20,086)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0T7T3xjMxN1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(22,387)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zF1TXpcV88Xb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2874"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZdHGZ5jS2n3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(106)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbRKG3XwKIng" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(172,750)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zrhhb7cXjGKi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;1 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z94orvM2exJh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;35 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBpUjhUAYwvg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;36 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zfH9vKCVYgCe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(1,207)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zoNAO8Ra76o9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;9,019 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLcvketNOqg5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(7,812)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNDvx4SnwcA7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2890"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zITgQVqqBX42" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2892"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQr2cbGD6Mrc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(38,544)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCfKYmgkjX47" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(384,684)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0XFTXoZ3WL2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(41,758)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwEyeVQyIQRk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(60,700)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1FXIpGLvVi1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(42,635)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zEOHxS5kJnY9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(51,099)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z87OPQbuD2k4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2906"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLkLtp0lw4kl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(290)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1Gr7mO0CPx1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(619,710)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zg4bLcJItUN" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2912"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zaNZbwG209ej" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2913"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkJPcQA6T482" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(5,127)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8hkuzEL0kBg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;(74,558)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZqD47VyYlf8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(24,739)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3jPyx8i7WJ9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(20,782)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zH0YCZrzDDD4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(16,741)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAuPBKI7GXFg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(40,478)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwJatCByCWX5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2921"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQe25GoaXQrf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(106)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx6DIftNvWb4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(182,531)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHrFDpbQAPb9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;380&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zORSQxglt5jj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(380)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2025 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztwyObFlgmp8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2929"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zEPBONrHsckg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2931"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zpq8KeBM5JZ3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(43,671)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0dkzd4sZruf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(458,862)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLzE3zymcaq7" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(66,877)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFag1O74Nzfg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(81,482)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDDyIAi72Fzg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(59,376)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVzMp4NQzLI8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(91,577)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zWgPducxjut3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2945"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1SDazwakQV3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(396)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHiImOtkL3tl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(802,241)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Net book value&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31,
2025 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zqVRzYslf44a" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,526,733&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember_fKGkp_zFWPpvAORBf7" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,460,415&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zPn41sbedv6e" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;138,389&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z6uJXjSySJAh" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;153,274&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zMnoFw5Kvy9a" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;60,883&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zwmWWCxsL8Id" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;51,891&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zDhtbgWZQ0e5" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;52,698&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zOkhLYjsxBM7" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;74,493&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zcgAemG6Nj6c" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;68,545&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zds1pQlwXZzg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;659&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231_z8TSfdEq2Tag" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;5,587,980&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zdHu71cTahh9" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,526,733 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember_fKGkp_z9zb49RZSku9" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,360,786 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_za3bVZPwfUCg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;143,516 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z48SyNzg0I62" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;228,143 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z0VsiO7VsXoj" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;54,195 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zZ1ZOINCttHf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;47,569 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zffl72aSoBm" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;59,888 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zNiQH2slMBal" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;83,721 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zlJfmIk1fM5j" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;27,473 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zjL7DAkd7Lpg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;765 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231_zgLP4RfwF6ai" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;5,532,789 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to intangible assets written-off as result of lack of expectation of future use.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A5_zWlY92wPs63f" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Impairment testing of goodwill and intangible assets with indefinite
lives&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Licenses with indefinite useful life include intangible assets acquired through business
combinations and asset acquisitions. The licenses for medicine and other courses granted by MEC have no expiration date and the Company
has determined that these assets have indefinite useful lives.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;For impairment testing goodwill and licenses with indefinite useful lives are allocated
to the respective CGUs.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company performed its annual impairment test on December 31, 2025, 2024 and 2023. There
was no impairment for goodwill and licenses with indefinite useful lives for the years then ended.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company tests at least annually the recoverability of the carrying amount of goodwill
and licenses with indefinite useful lives for each CGU. The Company determines the recoverable amount of its CGUs based on the value-in-use.
Estimating these values involves the use of assumptions, judgments and estimates of future cash flows that represent the Company's best
estimate.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The carrying amounts of goodwill and licenses with indefinite useful life by CGU and their
carrying amount as of December 31, 2025 and 2024 were as follows:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_pn3n3_zXK7x6SVyuU1" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Intangible assets (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B8_zZmfXMrPkdi7" style="display: none"&gt;Schedule of assumptions for impairment test&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Nunito Sans; font-size: 8.5pt"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;Goodwill&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;Licenses with indefinite useful life&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;CGU&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;IPTAN&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zLrB5OMD7sV5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;17,446&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zDt7RsN1BkE5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;17,446&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zLW5R67wAzVd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;57,214&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zwRHZalhKJc5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;57,214&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z3wtcvKnPsLl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;142,155&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zVI5Ae6xqBP1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;122,599&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;IESVAP&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z0nWsHxsKkkb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;27,956&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_ziFbQLWq6fYl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;27,956&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zPE0X0sip0Q" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;81,366&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zxKEic920uO5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;81,366&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zbtlPVaBo5Hk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;128,552&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zI7CJOaMvxug" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;126,195&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;CCSI&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_znwGVY9UohJd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;4,664&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_ziWE0EqlkPj2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;4,664&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zKcrnZMYM846" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;56,737&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zs5UjofA1ZW6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;56,737&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zcuZhJuYx5Uj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;64,782&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zz5aEanJbdYl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;60,377&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;IESP&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zM53NWWrSifl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;73,838&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zQlZAqgiYTQk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;73,838&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zRdC660jkWJ5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;179,693&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z4oRW5PRZTI5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;179,693&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zX70F1g1pw41" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;336,287&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z5W6LhpCPeXf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;322,900&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;FADEP&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zmoktumZ9jfd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;49,661&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zaM5WgaZkZli" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;49,661&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zs72RDpER8Zb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;70,606&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zxyaKSp796E7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;70,606&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zQ97tvgX0Hk7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;143,096&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zBNRhjibBCBd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;141,201&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;FASA&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zFJUUyTbKv1i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;58,903&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zd1IANS1lGTb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;58,903&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zp3SvRS1yZx5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;144,507&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zW9S0YzGLd28" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;144,507&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zRNQeMtV8sib" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;350,392&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zJgccVUODXP" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;341,020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;IPEC&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zouKxAM3HrMa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3069"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_znCr213aC6V7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3071"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z5Iee4ZH4Q44" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;108,000&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zU3N9CC340pf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;108,000&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z40nLOpJzQ65" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;168,247&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zbL58Wfy4fI" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;168,174&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;UniRedentor&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z0kCGEiwFh3d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;77,662&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zPE0SBofqkV9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;77,662&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zphoVAGGq236" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;121,477&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zZGtZYlHQfTk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;121,477&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z7RBBsg9pzqi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;251,332&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zoQWRg9EQal7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;244,123&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;UniSL&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zSl9fJeQEHSd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;4,420&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zUd40Bo4iKHi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;4,420&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zz7Arkd5ami4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;273,795&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zEvKK3bFJkLk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;273,795&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z7EiUzT0zrDg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;401,911&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z7eUkaeWXQv1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;386,889&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;FESAR&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zFwDxUkEufu8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;71,664&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zno61gFLc00j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;71,664&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zgL0K5E9Hfg9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;141,616&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z3buY0VrOoOf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;141,616&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_ziwVZLLUnFae" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;248,037&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zW4R3D4qPy7e" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;246,385&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;FCMPB&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z2xfWn7gwwX1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;110,483&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zQ6kQq6axnx6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;110,483&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_ziqF1qLPuDa3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;235,018&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zXUXrAXTIpZa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;235,018&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zAAPL9otdGac" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;404,039&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zU4uYngo4Ewd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;392,862&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;ITPAC Garanhuns&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z5VPFpHeGN4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3129"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zxRErLaJd2i" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3131"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zMKAf0CRw4ec" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;108,000&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zmqdAjGn3z17" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;108,000&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zmRhEVgb6oPl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;150,489&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z4tm76TsTyrc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;129,458&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Continuing education (i)&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z1FLiw9D5sql" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;267,477&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zdo8qakBz9l8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;267,477&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zTHkeLlLA886" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3145"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z82UJjx0TCm7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3147"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z9xhQ62Qsbba" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;574,048&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zuk1ldNwFzZe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;542,354&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Medical practice solutions (i)&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zr0Zz8t2bYUc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;238,477&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zaZy1j5XZoNa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;238,477&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_z65NhKzCfiZ2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3157"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zSGno3FZNjpg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3159"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zHJyTIJnXBG5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;373,954&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zGVRhnhKqW66" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;411,873&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;UnifipMoc&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zLah66A7F1wl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;87,777&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zCUVQmvvjhb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;87,777&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zKNSNd2Sx9Xf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;239,847&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zPaFirPLHNs9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;239,847&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zBp26Rlvi7i2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;427,474&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z4gfTYv7k3og" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;412,698&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Unigranrio&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zKSH3sgxth3l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;169,173&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zjilK4LXDz73" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;169,173&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zngKiavC2xG1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;421,538&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zxAN2UNBpRd5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;421,538&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zuiY9l1O2eyb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;804,996&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zVjHdFFP8rQg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;819,682&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;DelRey&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zXuauiuqwA4c" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;75,098&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIlKiCSMiiE4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;75,098&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5ZEQAGON1K8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;693,890&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zgqG4BFMsbgl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;693,890&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zwBmUYerww5f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;960,966&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztkHC2LXdR05" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;929,307&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Unidom&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_ztfAQsJv2Kue" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;192,034&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z74iKouJt2x7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;192,034&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zO8BJa8H3Ik2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;427,482&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zZDyBdlmRcoj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;427,482&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zI2WT6yJpi1l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;718,699&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_znb3BnsJ31C5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;687,570&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;FUNIC&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zCPZhH25Ctvj" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3213"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z8A9V4L3huC7" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3215"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zMo1gKMd3Up" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;99,629&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z8kb4stCW9c6" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3219"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zQ3gM7Z8eLs2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;110,943&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zE0o8BSHujWb" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3223"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zwOuEWNuT7g3" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;b&gt;1,526,733&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zvXOjOVsYcD5" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;b&gt;1,526,733&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zsBHIabUbSO8" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;b&gt;3,460,415&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zk7GuD1HYmbj" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;b&gt;3,360,786&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_ztB1yVXhcBg8" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;b&gt;6,760,399&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zcO4AqGiKNv9" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;b&gt;6,485,667&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;For the year ended December 31, 2025, the companies included in former Pillar 1 (Medcel,
Al&#xe9;m da Medicina, CardioPapers and Medical Harbour) where grouped together with IPEMED to constitute the Continuing education
CGU. The companies included in former Pillar 2 (PEBMED) and former Pilar 3 (iClinic, Medicinae, Shosp and RX Pro) where grouped together
with Glic and Cliquefarma to constitute the Medical practice solutions CGU. As a result, the prior period was revised for comparative
purposes. The grouping of these companies into a unified CGU reflects the economic reality of their business and is consistent with the
Company&#x2019;s integrated operational model. This classification also represents how operations are internally monitored.&lt;br/&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A6_zyGAanwnpwld" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The key assumptions used by the Company to determine the value in use of the CGUs were:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SchuduleOfAssumptionsUsedTableTextBlock_pn3n3_zs2q5xL5Xzcj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Intangible assets (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B9_zVtEPOJx43md" style="display: none"&gt;Schedule of assumptions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Key assumption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 51%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DiscountRatesMember_z4QcjuuHkqo5" title="Description"&gt;Represent the current market assessment of the specific risks associated to the CGUs, estimated based on information from both internal and external sources, including the Company&#x2019;s and third parties historical weighted-average cost of capital (WACC).&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;Pre-tax discount rate applied to cash flow projections: between &lt;span id="xdx_90A_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z6DR5vvKTDHg" title="Discount rate applied to cash flow projections"&gt;10.82&lt;/span&gt;% and &lt;span id="xdx_905_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zkbt7PihCDw7" title="Discount rate applied to cash flow projections"&gt;11.73&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;Pre-tax discount rate applied to cash flow projections: between &lt;span id="xdx_907_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20241231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zPif14jGTu9d" title="Discount rate applied to cash flow projections"&gt;11.66&lt;/span&gt;% and &lt;span id="xdx_906_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z3nzF9GS73s5" title="Discount rate applied to cash flow projections"&gt;13.97&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;Perpetuity growth rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PerpetuityGrowthRateMember_zgUfevbpw82a" title="Description"&gt;Cash flow projections include specific estimates for a five-year period followed by a terminal growth rate, determined based on management's internal estimate of the long-term compound annual growth rate (CAGR), consistent with the assumptions that would be made by a market participant.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;From &lt;span id="xdx_90E_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOPcJGfjIZIf" title="Growth rates"&gt;3.5&lt;/span&gt;% to &lt;span id="xdx_909_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_znr5YdVtYxFh" title="Growth rates"&gt;9.50&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;From &lt;span id="xdx_90B_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zidxpqC2KL2c" title="Growth rates"&gt;3.5&lt;/span&gt;% to &lt;span id="xdx_901_ecustom--PerpetuityGrowthRate_pip0_dp_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zh43Ig1kwArd" title="Growth rates"&gt;7.53&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;EBITDA&lt;span style="font-family: Nunito Sans"&gt;&lt;sup&gt;[1]&lt;/sup&gt;&lt;/span&gt; growth rate (annual average for the next five years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EBITDAMember_gIFDOKAOWMHBC-WJE_zuncArDTfD7" title="Description"&gt;EBITDA growth rate was estimated using historical performance as a baseline, adjusted for:&lt;/span&gt;&lt;/p&gt;
    &lt;div id="xdx_C09_gIFDOKAOWMHBC-WJE_zqD6Jetl0JBi"&gt;&lt;p style="font: 9pt Nunito Sans; margin: 0"&gt;- Expected revenue growth, driven by increases in both sales volume and pricing.&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C07_gIFDOKAOWMHBC-WJE_zFxGavNFZ3Uf"&gt;&lt;p style="font: 9pt Nunito Sans; margin: 0"&gt;- Expected margin expansion, which reflects operational efficiencies and scale economies as
    volumes increase, partially offset by projected increases in costs.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_906_ecustom--EbitdaGrowthRates_pip0_dp_c20250101__20251231_zvtN9LF3duli" title="EBITDA growth rates"&gt;6.88&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_90A_ecustom--EbitdaGrowthRates_pip0_dp_c20240101__20241231_zbVabD28HFj9" title="EBITDA growth rates"&gt;5.69&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;i&gt;Sensitivity analysis: impacts of possible changes in key assumptions&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zBYiuCNYfPa2" title="Description of significant estimate"&gt;An increase of 25 basis points in management&#x2019;s estimated discount rate applied to
the cash flow projections of each CGU for the year ended December 31, 2025, or a decrease of 25 basis points on perpetuity growth rate
or EBITDA growth rate would not have significant impacts on Company&#x2019;s impairment testing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Impairment testing of other intangible assets&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;There were &lt;span id="xdx_90F_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_do_c20250101__20251231_zzOkniNzthrk" title="Impairment intangible assets"&gt;no&lt;/span&gt; impairment indicatives of intangible assets with finite useful lives as of
and for the year ended December 31, 2025.&lt;/p&gt;

</afya:DisclosureOfIntangibleAssetExplanatory>
    <afya:SummaryOfIntangibleAssetsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact002593">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_pn3n3_z5ARI5S96bml" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Intangible assets (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span id="xdx_8B8_zbQK7cpU4OWc" style="display: none"&gt;Schedule of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 26%; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Goodwill &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Licenses with indefinite useful life &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Trademarks&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Customer relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 4%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Education content&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Developed technology&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Educational platform&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Intangible in progress&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 3%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Cost&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXLPeIQtsM0j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,257,045&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zFOX7zHbajF6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;2,189,814&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXiG8vaOGrc2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;182,060&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKtBCdSmaYpf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;435,816&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zm0zVDYvxPfk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;43,300&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zBOZOPk1hfs2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;69,589&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z538J1iaB7O" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;90,749&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTpnT5DIci02" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;55,697&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRk43MPMsoTk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;14,734&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWuhPKyt0i9j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,055&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEFwp1scJDS9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;4,339,859&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLm6yaMH5Lvi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2617"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1acKodXCkdd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;1,314&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeZgI413YVDb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;9,827&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4NNN5rP0Ba2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;37,712&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuT2Gema61o1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;23,164&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zi72d0PnOjVj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;27,976&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc3RGBSiUd13" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;99,993&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOwaP2JuCcbl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;75,098&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoYyj8VkSOc1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;586,263&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLXR21ueOcQ1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;142,451&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwWf0AjbTBwi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;63&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQcEnD4rS7hc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;803,875&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoubWbHH41c5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(2,235)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_za2kjFiaY8l" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(911)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWvFdsOWtpD4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(125)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJSyR6VaMbOe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(3,271)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Remeasurement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsxrWEmRbbV1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Remesurement"&gt;&lt;span style="font-size: 7.5pt"&gt;2,556&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--Remesurement_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z85DLoAnPyQ3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Remesurement"&gt;&lt;span style="font-size: 7.5pt"&gt;2,556&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4NPqnUPWUH1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;28,708&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVXxidglRRz4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;4,785&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8qJyc1xtFwh" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;16&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOS0dqxmxRFc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(3,058)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7NTfIGPWNb8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(30,451)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zaqo0QY2kps3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,334,699&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfxJxqyGbhz3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;2,776,077&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztBLF0yqKg0b" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;182,060&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z0udGq4J3JAa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;578,267&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEQnogXAkGDe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;71,150&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjOmK4lkxRjj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;84,201&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zmEAXoBdOzr8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;128,477&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXahYkGKXbz7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;74,892&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9c518H1B2Va" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;12,134&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc2lF7k3PuV5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,055&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMDVqDU2iGm1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;5,243,012&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztjhdsWZ48q8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;157,227 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQlDIfLJIM6a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;1,511 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqbZN68Fi4y8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;17,701 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcDS77okDfBl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;14,092 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJu9NUY2xEGd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;30,255 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzKOOsfStq5g" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;34,905 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZoF9KE45jqe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;255,691 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Business combination&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfQdl7Jwzgw3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;192,034 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHVDzhdq1pNe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;427,482 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMlmrwAU16dc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;34,560 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9EHfwC2LrTc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-size: 7.5pt"&gt;654,076 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcPYGpUE1o0i" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(162)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9PfFHXweTEk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(117)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zl3j076XfJK4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8Mv2dpzntel" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlHOF6DpxLtb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;23,292 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzJoVPwrmJrg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;6,529 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zh19xklC10Tb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(39,929)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1UFQS37Pcqf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;29,673 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zATgoRNwq5sl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(19,565)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;- &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zb3aHgCRNrye" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,526,733 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z17ghQiVjPjg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,360,786 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zBKcZE2Rpj53" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;182,060 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgmBoSuzYDFf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;612,827 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwJuzxYIXXv6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;95,953 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbf7wynp3fL1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;108,269 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoAJz80cGnW" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;102,523 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zYBe5VnFW6af" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;134,820 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zStSTVvDiuci" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;27,473 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJzINBZ8US78" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,055 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrGHdmExU3s1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;6,152,499 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1gXhZJJwTQk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;99,629&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zC2DQJ1hye48" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;276&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziCp74Ym0P1g" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;25,106&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyqSVlv6c4a4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;9,552&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znsldTmHMJB3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;31,250&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1zq7Da0DoP6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;72,184&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvDiA7GhU28a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Additions"&gt;&lt;span style="font-size: 7.5pt"&gt;237,997&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRoBitc7xpof" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zK6tQVTsOeCh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQBVVyqpIE79" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(272)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1125lsjVCZ" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwigvmbJNV71" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(691)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zDsgfLvEn9gj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;31,531&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxIUOxYSq4Ac" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(30,840)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2025 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCSO2MwUKmGc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,526,733&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXBXukM7Si5a" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,460,415&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrlbuzIIxTva" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;182,060&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxP1Cv7ilbc4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;612,136&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2KRCBoSwERc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;127,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqSzVMOrOKU9" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;133,373&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztzZ8bD8cXgi" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;112,074&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zueKPfDvCyta" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;166,070&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEeNDdP180Gd" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;68,545&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQD6ZUai0DGk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,055&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zO6i4Tn13dpf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;6,390,221&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Amortization&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zYP5nIncY082" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2797"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zY06G9LJ8yAg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2799"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBDoezezxq1l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(14,955)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQkIjkse9ysl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(212,363)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW7vj3B3THai" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(17,277)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1GCgzhcZ8Md" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(26,562)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOj3SX448FQi" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(10,093)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8DIqTkiqDQ3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(17,039)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zy5s5ZYBxOE5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2813"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTobSyUDpKQ5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(79)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zw90gvVfX1El" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(298,368)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iP2custom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zlO12eFJin97" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2819"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zmkKKzT8I246" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2820"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBBvb2yiVbC6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;(11,083)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zf9dNrm5aD6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;(89,584)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdP8l9MJmfK4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(8,764)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8qsWZrGGNMf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(15,668)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBw7BNTnTQse" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(21,504)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zTVeMXJciksa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(4,778)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkgdoP3P6UTi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2829"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbM05cUjXAOe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(105)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqfk7c9cA9Z1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(151,486)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zXkVRlhPqD7g" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;1,947&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zdZ1AGTjIqf8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;911&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuTk98HSDYrl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;2,858&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSJ9B8tOxBZg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(6)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--Transfer_pn3n3_c20230101__20231231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIcnETa8xG4j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zogL1bEPU7Q6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2843"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_z3TdCOnevdi5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2845"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJQMe1Vmsuy6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(26,038)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z2KdKRDAToZk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(301,947)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zC0PdwKOvAl2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(24,094)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8NhawO5DETf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(42,230)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxI6CYmNBBH6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(31,603)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDYt8xaMzdQl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(20,900)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zB0QQiBTu0c8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2859"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z2FlyJZKNgRa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(184)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZ9WemNDEDp5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(446,996)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxQADNzeSNJ7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2865"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zdFVlUz1RTp" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2866"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z6vXTtiDjli9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(12,506)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zmeELLcXy9h2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;(82,737)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRYP7teYB8Fc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(16,457)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzb3VRTgCDEb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(18,471)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDmE22bjtVG2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(20,086)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0T7T3xjMxN1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(22,387)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zF1TXpcV88Xb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2874"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZdHGZ5jS2n3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(106)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbRKG3XwKIng" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(172,750)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Write-off (i)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zrhhb7cXjGKi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;1 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z94orvM2exJh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;35 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--WriteoffOfIntangibleAssets_pn3n3_c20240101__20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zBpUjhUAYwvg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Write-off"&gt;&lt;span style="font-size: 7.5pt"&gt;36 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zfH9vKCVYgCe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(1,207)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zoNAO8Ra76o9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;9,019 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--Transfer_pn3n3_c20240101__20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLcvketNOqg5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(7,812)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNDvx4SnwcA7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2890"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zITgQVqqBX42" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2892"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQr2cbGD6Mrc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(38,544)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCfKYmgkjX47" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(384,684)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0XFTXoZ3WL2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(41,758)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwEyeVQyIQRk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(60,700)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1FXIpGLvVi1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(42,635)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zEOHxS5kJnY9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(51,099)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z87OPQbuD2k4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2906"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLkLtp0lw4kl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(290)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1Gr7mO0CPx1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(619,710)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zg4bLcJItUN" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2912"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zaNZbwG209ej" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2913"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkJPcQA6T482" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(5,127)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z8hkuzEL0kBg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Amortization"&gt;&lt;span style="font-size: 7.5pt"&gt;(74,558)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZqD47VyYlf8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(24,739)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z3jPyx8i7WJ9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(20,782)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zH0YCZrzDDD4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(16,741)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAuPBKI7GXFg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(40,478)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zwJatCByCWX5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2921"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQe25GoaXQrf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(106)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx6DIftNvWb4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;(182,531)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHrFDpbQAPb9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;380&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Transfer_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zORSQxglt5jj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Transfer"&gt;&lt;span style="font-size: 7.5pt"&gt;(380)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2025 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztwyObFlgmp8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2929"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_fKGkp_zEPBONrHsckg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2931"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zpq8KeBM5JZ3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(43,671)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0dkzd4sZruf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(458,862)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zLzE3zymcaq7" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(66,877)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zFag1O74Nzfg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(81,482)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDDyIAi72Fzg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(59,376)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVzMp4NQzLI8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(91,577)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangibleInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zWgPducxjut3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2945"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1SDazwakQV3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(396)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_pn3n3_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zHiImOtkL3tl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(802,241)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Net book value&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31,
2025 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zqVRzYslf44a" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,526,733&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember_fKGkp_zFWPpvAORBf7" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,460,415&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zPn41sbedv6e" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;138,389&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z6uJXjSySJAh" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;153,274&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zMnoFw5Kvy9a" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;60,883&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zwmWWCxsL8Id" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;51,891&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zDhtbgWZQ0e5" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;52,698&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zOkhLYjsxBM7" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;74,493&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zcgAemG6Nj6c" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;68,545&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zds1pQlwXZzg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;659&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20251231_z8TSfdEq2Tag" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;5,587,980&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zdHu71cTahh9" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,526,733 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember_fKGkp_z9zb49RZSku9" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,360,786 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_za3bVZPwfUCg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;143,516 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z48SyNzg0I62" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;228,143 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z0VsiO7VsXoj" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;54,195 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zZ1ZOINCttHf" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;47,569 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zffl72aSoBm" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;59,888 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zNiQH2slMBal" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;83,721 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zlJfmIk1fM5j" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;27,473 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OtherMember_zjL7DAkd7Lpg" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;765 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntangibleAssetsAndGoodwillNetBookValue_iI_pn3n3_c20241231_zgLP4RfwF6ai" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Net book value"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;5,532,789 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to intangible assets written-off as result of lack of expectation of future use.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:SummaryOfIntangibleAssetsTableTextBlock>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002595"
      unitRef="BRL">1257045000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002597"
      unitRef="BRL">2189814000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002599"
      unitRef="BRL">182060000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002601"
      unitRef="BRL">435816000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002603"
      unitRef="BRL">43300000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002605"
      unitRef="BRL">69589000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002607"
      unitRef="BRL">90749000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002609"
      unitRef="BRL">55697000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002611"
      unitRef="BRL">14734000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002613"
      unitRef="BRL">1055000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002615"
      unitRef="BRL">4339859000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002619"
      unitRef="BRL">1314000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002621"
      unitRef="BRL">9827000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002623"
      unitRef="BRL">37712000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002625"
      unitRef="BRL">23164000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002627"
      unitRef="BRL">27976000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002629"
      unitRef="BRL">99993000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002631"
      unitRef="BRL">75098000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002633"
      unitRef="BRL">586263000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002635"
      unitRef="BRL">142451000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002637"
      unitRef="BRL">63000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002639"
      unitRef="BRL">803875000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002641"
      unitRef="BRL">-2235000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002643"
      unitRef="BRL">-911000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002645"
      unitRef="BRL">-125000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002647"
      unitRef="BRL">-3271000</afya:WriteoffOfIntangibleAssets>
    <afya:Remesurement
      contextRef="From2023-01-012023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002649"
      unitRef="BRL">2556000</afya:Remesurement>
    <afya:Remesurement
      contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002651"
      unitRef="BRL">2556000</afya:Remesurement>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002653"
      unitRef="BRL">28708000</afya:Transfer>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002655"
      unitRef="BRL">4785000</afya:Transfer>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002657"
      unitRef="BRL">16000</afya:Transfer>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002659"
      unitRef="BRL">-3058000</afya:Transfer>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002661"
      unitRef="BRL">-30451000</afya:Transfer>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002663"
      unitRef="BRL">1334699000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002665"
      unitRef="BRL">2776077000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002667"
      unitRef="BRL">182060000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002669"
      unitRef="BRL">578267000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002671"
      unitRef="BRL">71150000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002673"
      unitRef="BRL">84201000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002675"
      unitRef="BRL">128477000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002677"
      unitRef="BRL">74892000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002679"
      unitRef="BRL">12134000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002681"
      unitRef="BRL">1055000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002683"
      unitRef="BRL">5243012000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002685"
      unitRef="BRL">157227000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002687"
      unitRef="BRL">1511000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002689"
      unitRef="BRL">17701000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002691"
      unitRef="BRL">14092000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002693"
      unitRef="BRL">30255000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002695"
      unitRef="BRL">34905000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002697"
      unitRef="BRL">255691000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002699"
      unitRef="BRL">192034000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002701"
      unitRef="BRL">427482000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002703"
      unitRef="BRL">34560000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002705"
      unitRef="BRL">654076000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002707"
      unitRef="BRL">-162000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002709"
      unitRef="BRL">-117000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2024-01-012024-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002711"
      unitRef="BRL">-1000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002713"
      unitRef="BRL">-280000</afya:WriteoffOfIntangibleAssets>
    <afya:Transfer
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002715"
      unitRef="BRL">23292000</afya:Transfer>
    <afya:Transfer
      contextRef="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002717"
      unitRef="BRL">6529000</afya:Transfer>
    <afya:Transfer
      contextRef="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002719"
      unitRef="BRL">-39929000</afya:Transfer>
    <afya:Transfer
      contextRef="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002721"
      unitRef="BRL">29673000</afya:Transfer>
    <afya:Transfer
      contextRef="From2024-01-012024-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002723"
      unitRef="BRL">-19565000</afya:Transfer>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002725"
      unitRef="BRL">1526733000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002727"
      unitRef="BRL">3360786000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002729"
      unitRef="BRL">182060000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002731"
      unitRef="BRL">612827000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002733"
      unitRef="BRL">95953000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002735"
      unitRef="BRL">108269000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002737"
      unitRef="BRL">102523000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002739"
      unitRef="BRL">134820000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002741"
      unitRef="BRL">27473000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002743"
      unitRef="BRL">1055000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002745"
      unitRef="BRL">6152499000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002747"
      unitRef="BRL">99629000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002749"
      unitRef="BRL">276000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002751"
      unitRef="BRL">25106000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002753"
      unitRef="BRL">9552000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002755"
      unitRef="BRL">31250000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002757"
      unitRef="BRL">72184000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002759"
      unitRef="BRL">237997000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2025-01-012025-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002761"
      unitRef="BRL">-2000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002763"
      unitRef="BRL">-1000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2025-01-012025-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002765"
      unitRef="BRL">-272000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002767"
      unitRef="BRL">-275000</afya:WriteoffOfIntangibleAssets>
    <afya:Transfer
      contextRef="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002769"
      unitRef="BRL">-691000</afya:Transfer>
    <afya:Transfer
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002771"
      unitRef="BRL">31531000</afya:Transfer>
    <afya:Transfer
      contextRef="From2025-01-012025-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002773"
      unitRef="BRL">-30840000</afya:Transfer>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002775"
      unitRef="BRL">1526733000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002777"
      unitRef="BRL">3460415000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002779"
      unitRef="BRL">182060000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002781"
      unitRef="BRL">612136000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002783"
      unitRef="BRL">127760000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002785"
      unitRef="BRL">133373000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002787"
      unitRef="BRL">112074000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002789"
      unitRef="BRL">166070000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_IntangibleInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002791"
      unitRef="BRL">68545000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_OtherMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002793"
      unitRef="BRL">1055000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002795"
      unitRef="BRL">6390221000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002801"
      unitRef="BRL">-14955000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002803"
      unitRef="BRL">-212363000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002805"
      unitRef="BRL">-17277000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002807"
      unitRef="BRL">-26562000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002809"
      unitRef="BRL">-10093000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002811"
      unitRef="BRL">-17039000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002815"
      unitRef="BRL">-79000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002817"
      unitRef="BRL">-298368000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002822"
      unitRef="BRL">-11083000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002824"
      unitRef="BRL">-89584000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002825"
      unitRef="BRL">-8764000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002826"
      unitRef="BRL">-15668000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002827"
      unitRef="BRL">-21504000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002828"
      unitRef="BRL">-4778000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002830"
      unitRef="BRL">-105000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002831"
      unitRef="BRL">-151486000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002833"
      unitRef="BRL">1947000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002835"
      unitRef="BRL">911000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002837"
      unitRef="BRL">2858000</afya:WriteoffOfIntangibleAssets>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002839"
      unitRef="BRL">-6000</afya:Transfer>
    <afya:Transfer
      contextRef="From2023-01-012023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002841"
      unitRef="BRL">6000</afya:Transfer>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002847"
      unitRef="BRL">-26038000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002849"
      unitRef="BRL">-301947000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002851"
      unitRef="BRL">-24094000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002853"
      unitRef="BRL">-42230000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002855"
      unitRef="BRL">-31603000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002857"
      unitRef="BRL">-20900000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002861"
      unitRef="BRL">-184000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002863"
      unitRef="BRL">-446996000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002867"
      unitRef="BRL">-12506000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002869"
      unitRef="BRL">-82737000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002870"
      unitRef="BRL">-16457000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002871"
      unitRef="BRL">-18471000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002872"
      unitRef="BRL">-20086000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002873"
      unitRef="BRL">-22387000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002875"
      unitRef="BRL">-106000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002876"
      unitRef="BRL">-172750000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2024-01-012024-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002878"
      unitRef="BRL">1000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002880"
      unitRef="BRL">35000</afya:WriteoffOfIntangibleAssets>
    <afya:WriteoffOfIntangibleAssets
      contextRef="From2024-01-012024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002882"
      unitRef="BRL">36000</afya:WriteoffOfIntangibleAssets>
    <afya:Transfer
      contextRef="From2024-01-012024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002884"
      unitRef="BRL">-1207000</afya:Transfer>
    <afya:Transfer
      contextRef="From2024-01-012024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002886"
      unitRef="BRL">9019000</afya:Transfer>
    <afya:Transfer
      contextRef="From2024-01-012024-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002888"
      unitRef="BRL">-7812000</afya:Transfer>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002894"
      unitRef="BRL">-38544000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002896"
      unitRef="BRL">-384684000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002898"
      unitRef="BRL">-41758000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002900"
      unitRef="BRL">-60700000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002902"
      unitRef="BRL">-42635000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002904"
      unitRef="BRL">-51099000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002908"
      unitRef="BRL">-290000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2024-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002910"
      unitRef="BRL">-619710000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002914"
      unitRef="BRL">-5127000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002916"
      unitRef="BRL">-74558000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002917"
      unitRef="BRL">-24739000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002918"
      unitRef="BRL">-20782000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002919"
      unitRef="BRL">-16741000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002920"
      unitRef="BRL">-40478000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002922"
      unitRef="BRL">-106000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2025-01-012025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002923"
      unitRef="BRL">-182531000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <afya:Transfer
      contextRef="From2025-01-012025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002925"
      unitRef="BRL">380000</afya:Transfer>
    <afya:Transfer
      contextRef="From2025-01-012025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002927"
      unitRef="BRL">-380000</afya:Transfer>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002933"
      unitRef="BRL">-43671000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002935"
      unitRef="BRL">-458862000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002937"
      unitRef="BRL">-66877000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002939"
      unitRef="BRL">-81482000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002941"
      unitRef="BRL">-59376000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002943"
      unitRef="BRL">-91577000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_custom_OtherMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002947"
      unitRef="BRL">-396000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact002949"
      unitRef="BRL">-802241000</ifrs-full:IntangibleAssetsAndGoodwill>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2025-12-31_ifrs-full_GoodwillMember"
      decimals="-3"
      id="Fact002951"
      unitRef="BRL">1526733000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2025-12-31_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact002953"
      unitRef="BRL">3460415000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2025-12-31_ifrs-full_BrandNamesMember"
      decimals="-3"
      id="Fact002955"
      unitRef="BRL">138389000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2025-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember"
      decimals="-3"
      id="Fact002957"
      unitRef="BRL">153274000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2025-12-31_ifrs-full_ComputerSoftwareMember"
      decimals="-3"
      id="Fact002959"
      unitRef="BRL">60883000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2025-12-31_custom_EducationContentMember"
      decimals="-3"
      id="Fact002961"
      unitRef="BRL">51891000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2025-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fact002963"
      unitRef="BRL">52698000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2025-12-31_custom_EducationalPlatformMember"
      decimals="-3"
      id="Fact002965"
      unitRef="BRL">74493000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2025-12-31_custom_SoftwareInProgressMember"
      decimals="-3"
      id="Fact002967"
      unitRef="BRL">68545000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2025-12-31_custom_OtherMember"
      decimals="-3"
      id="Fact002969"
      unitRef="BRL">659000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact002971"
      unitRef="BRL">5587980000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2024-12-31_ifrs-full_GoodwillMember"
      decimals="-3"
      id="Fact002973"
      unitRef="BRL">1526733000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2024-12-31_ifrs-full_LicencesMember"
      decimals="-3"
      id="Fact002975"
      unitRef="BRL">3360786000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2024-12-31_ifrs-full_BrandNamesMember"
      decimals="-3"
      id="Fact002977"
      unitRef="BRL">143516000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2024-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember"
      decimals="-3"
      id="Fact002979"
      unitRef="BRL">228143000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2024-12-31_ifrs-full_ComputerSoftwareMember"
      decimals="-3"
      id="Fact002981"
      unitRef="BRL">54195000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2024-12-31_custom_EducationContentMember"
      decimals="-3"
      id="Fact002983"
      unitRef="BRL">47569000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2024-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fact002985"
      unitRef="BRL">59888000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2024-12-31_custom_EducationalPlatformMember"
      decimals="-3"
      id="Fact002987"
      unitRef="BRL">83721000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2024-12-31_custom_SoftwareInProgressMember"
      decimals="-3"
      id="Fact002989"
      unitRef="BRL">27473000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2024-12-31_custom_OtherMember"
      decimals="-3"
      id="Fact002991"
      unitRef="BRL">765000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:IntangibleAssetsAndGoodwillNetBookValue
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact002993"
      unitRef="BRL">5532789000</afya:IntangibleAssetsAndGoodwillNetBookValue>
    <afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact002995">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_pn3n3_zXK7x6SVyuU1" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Intangible assets (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B8_zZmfXMrPkdi7" style="display: none"&gt;Schedule of assumptions for impairment test&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; text-align: center; text-indent: 0in"&gt;&lt;span style="font-family: Nunito Sans; font-size: 8.5pt"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;Goodwill&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;Licenses with indefinite useful life&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;CGU&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;IPTAN&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zLrB5OMD7sV5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;17,446&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zDt7RsN1BkE5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;17,446&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zLW5R67wAzVd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;57,214&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zwRHZalhKJc5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;57,214&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z3wtcvKnPsLl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;142,155&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zVI5Ae6xqBP1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;122,599&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;IESVAP&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z0nWsHxsKkkb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;27,956&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_ziFbQLWq6fYl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;27,956&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zPE0X0sip0Q" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;81,366&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zxKEic920uO5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;81,366&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zbtlPVaBo5Hk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;128,552&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zI7CJOaMvxug" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;126,195&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;CCSI&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_znwGVY9UohJd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;4,664&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_ziWE0EqlkPj2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;4,664&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zKcrnZMYM846" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;56,737&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zs5UjofA1ZW6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;56,737&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zcuZhJuYx5Uj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;64,782&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zz5aEanJbdYl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;60,377&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;IESP&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zM53NWWrSifl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;73,838&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zQlZAqgiYTQk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;73,838&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zRdC660jkWJ5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;179,693&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z4oRW5PRZTI5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;179,693&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zX70F1g1pw41" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;336,287&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z5W6LhpCPeXf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;322,900&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;FADEP&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zmoktumZ9jfd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;49,661&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zaM5WgaZkZli" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;49,661&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zs72RDpER8Zb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;70,606&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zxyaKSp796E7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;70,606&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zQ97tvgX0Hk7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;143,096&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zBNRhjibBCBd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;141,201&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;FASA&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zFJUUyTbKv1i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;58,903&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zd1IANS1lGTb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;58,903&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zp3SvRS1yZx5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;144,507&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zW9S0YzGLd28" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;144,507&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zRNQeMtV8sib" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;350,392&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zJgccVUODXP" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;341,020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;IPEC&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zouKxAM3HrMa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3069"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_znCr213aC6V7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3071"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z5Iee4ZH4Q44" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;108,000&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zU3N9CC340pf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;108,000&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z40nLOpJzQ65" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;168,247&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zbL58Wfy4fI" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;168,174&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;UniRedentor&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z0kCGEiwFh3d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;77,662&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zPE0SBofqkV9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;77,662&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zphoVAGGq236" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;121,477&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zZGtZYlHQfTk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;121,477&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z7RBBsg9pzqi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;251,332&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zoQWRg9EQal7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;244,123&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;UniSL&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zSl9fJeQEHSd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;4,420&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zUd40Bo4iKHi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;4,420&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zz7Arkd5ami4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;273,795&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zEvKK3bFJkLk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;273,795&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z7EiUzT0zrDg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;401,911&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z7eUkaeWXQv1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;386,889&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;FESAR&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zFwDxUkEufu8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;71,664&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zno61gFLc00j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;71,664&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zgL0K5E9Hfg9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;141,616&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z3buY0VrOoOf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;141,616&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_ziwVZLLUnFae" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;248,037&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zW4R3D4qPy7e" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;246,385&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;FCMPB&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z2xfWn7gwwX1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;110,483&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zQ6kQq6axnx6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;110,483&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_ziqF1qLPuDa3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;235,018&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zXUXrAXTIpZa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;235,018&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zAAPL9otdGac" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;404,039&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zU4uYngo4Ewd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;392,862&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;ITPAC Garanhuns&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z5VPFpHeGN4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3129"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zxRErLaJd2i" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3131"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zMKAf0CRw4ec" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;108,000&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zmqdAjGn3z17" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;108,000&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_zmRhEVgb6oPl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;150,489&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ITPACGaranhunsMember_z4tm76TsTyrc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;129,458&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Continuing education (i)&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z1FLiw9D5sql" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;267,477&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zdo8qakBz9l8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;267,477&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zTHkeLlLA886" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3145"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z82UJjx0TCm7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3147"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_z9xhQ62Qsbba" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;574,048&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ContinuingEducationMember_zuk1ldNwFzZe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;542,354&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Medical practice solutions (i)&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zr0Zz8t2bYUc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;238,477&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zaZy1j5XZoNa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;238,477&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_z65NhKzCfiZ2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3157"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zSGno3FZNjpg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3159"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zHJyTIJnXBG5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;373,954&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalPracticeSolutionsMember_zGVRhnhKqW66" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;411,873&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;UnifipMoc&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zLah66A7F1wl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;87,777&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zCUVQmvvjhb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;87,777&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zKNSNd2Sx9Xf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;239,847&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zPaFirPLHNs9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;239,847&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_zBp26Rlvi7i2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;427,474&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnifipMocMember_z4gfTYv7k3og" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;412,698&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Unigranrio&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zKSH3sgxth3l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;169,173&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zjilK4LXDz73" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;169,173&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zngKiavC2xG1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;421,538&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zxAN2UNBpRd5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;421,538&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zuiY9l1O2eyb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;804,996&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zVjHdFFP8rQg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;819,682&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;DelRey&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zXuauiuqwA4c" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;75,098&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zIlKiCSMiiE4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;75,098&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z5ZEQAGON1K8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;693,890&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zgqG4BFMsbgl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;693,890&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zwBmUYerww5f" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;960,966&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_ztkHC2LXdR05" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;929,307&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Unidom&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_ztfAQsJv2Kue" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;192,034&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_z74iKouJt2x7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;192,034&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zO8BJa8H3Ik2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;427,482&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zZDyBdlmRcoj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;427,482&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zI2WT6yJpi1l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;718,699&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_znb3BnsJ31C5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;687,570&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;FUNIC&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zCPZhH25Ctvj" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3213"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z8A9V4L3huC7" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3215"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zMo1gKMd3Up" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;99,629&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z8kb4stCW9c6" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3219"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zQ3gM7Z8eLs2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;110,943&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_iI_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zE0o8BSHujWb" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3223"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Goodwill_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zwOuEWNuT7g3" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;b&gt;1,526,733&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zvXOjOVsYcD5" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;b&gt;1,526,733&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zsBHIabUbSO8" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;b&gt;3,460,415&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zk7GuD1HYmbj" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;b&gt;3,360,786&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CashGeneratingUnits_pn3n3_c20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_ztB1yVXhcBg8" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;b&gt;6,760,399&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_pn3n3_c20241231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember_zcO4AqGiKNv9" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;b&gt;6,485,667&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 7.5pt Nunito Sans; margin-top: 0pt; margin-bottom: 6pt; width: 97%; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;For the year ended December 31, 2025, the companies included in former Pillar 1 (Medcel,
Al&#xe9;m da Medicina, CardioPapers and Medical Harbour) where grouped together with IPEMED to constitute the Continuing education
CGU. The companies included in former Pillar 2 (PEBMED) and former Pilar 3 (iClinic, Medicinae, Shosp and RX Pro) where grouped together
with Glic and Cliquefarma to constitute the Medical practice solutions CGU. As a result, the prior period was revised for comparative
purposes. The grouping of these companies into a unified CGU reflects the economic reality of their business and is consistent with the
Company&#x2019;s integrated operational model. This classification also represents how operations are internally monitored.&lt;br/&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      id="Fact002997"
      unitRef="BRL">17446000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      id="Fact002999"
      unitRef="BRL">17446000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      id="Fact003001"
      unitRef="BRL">57214000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      id="Fact003003"
      unitRef="BRL">57214000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      id="Fact003005"
      unitRef="BRL">142155000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      id="Fact003007"
      unitRef="BRL">122599000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      id="Fact003009"
      unitRef="BRL">27956000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      id="Fact003011"
      unitRef="BRL">27956000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      id="Fact003013"
      unitRef="BRL">81366000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      id="Fact003015"
      unitRef="BRL">81366000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      id="Fact003017"
      unitRef="BRL">128552000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      id="Fact003019"
      unitRef="BRL">126195000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      id="Fact003021"
      unitRef="BRL">4664000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      id="Fact003023"
      unitRef="BRL">4664000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      id="Fact003025"
      unitRef="BRL">56737000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      id="Fact003027"
      unitRef="BRL">56737000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      id="Fact003029"
      unitRef="BRL">64782000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      id="Fact003031"
      unitRef="BRL">60377000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      id="Fact003033"
      unitRef="BRL">73838000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      id="Fact003035"
      unitRef="BRL">73838000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      id="Fact003037"
      unitRef="BRL">179693000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      id="Fact003039"
      unitRef="BRL">179693000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      id="Fact003041"
      unitRef="BRL">336287000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      id="Fact003043"
      unitRef="BRL">322900000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      id="Fact003045"
      unitRef="BRL">49661000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      id="Fact003047"
      unitRef="BRL">49661000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      id="Fact003049"
      unitRef="BRL">70606000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      id="Fact003051"
      unitRef="BRL">70606000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      id="Fact003053"
      unitRef="BRL">143096000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      id="Fact003055"
      unitRef="BRL">141201000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      id="Fact003057"
      unitRef="BRL">58903000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      id="Fact003059"
      unitRef="BRL">58903000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      id="Fact003061"
      unitRef="BRL">144507000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      id="Fact003063"
      unitRef="BRL">144507000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      id="Fact003065"
      unitRef="BRL">350392000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      id="Fact003067"
      unitRef="BRL">341020000</afya:CashGeneratingUnits>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      id="Fact003073"
      unitRef="BRL">108000000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      id="Fact003075"
      unitRef="BRL">108000000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      id="Fact003077"
      unitRef="BRL">168247000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      id="Fact003079"
      unitRef="BRL">168174000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003081"
      unitRef="BRL">77662000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003083"
      unitRef="BRL">77662000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003085"
      unitRef="BRL">121477000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003087"
      unitRef="BRL">121477000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003089"
      unitRef="BRL">251332000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      id="Fact003091"
      unitRef="BRL">244123000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      id="Fact003093"
      unitRef="BRL">4420000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      id="Fact003095"
      unitRef="BRL">4420000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      id="Fact003097"
      unitRef="BRL">273795000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      id="Fact003099"
      unitRef="BRL">273795000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      id="Fact003101"
      unitRef="BRL">401911000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      id="Fact003103"
      unitRef="BRL">386889000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      id="Fact003105"
      unitRef="BRL">71664000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      id="Fact003107"
      unitRef="BRL">71664000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      id="Fact003109"
      unitRef="BRL">141616000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      id="Fact003111"
      unitRef="BRL">141616000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      id="Fact003113"
      unitRef="BRL">248037000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      id="Fact003115"
      unitRef="BRL">246385000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      id="Fact003117"
      unitRef="BRL">110483000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      id="Fact003119"
      unitRef="BRL">110483000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      id="Fact003121"
      unitRef="BRL">235018000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      id="Fact003123"
      unitRef="BRL">235018000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      id="Fact003125"
      unitRef="BRL">404039000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      id="Fact003127"
      unitRef="BRL">392862000</afya:CashGeneratingUnits>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember"
      decimals="-3"
      id="Fact003133"
      unitRef="BRL">108000000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember"
      decimals="-3"
      id="Fact003135"
      unitRef="BRL">108000000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember"
      decimals="-3"
      id="Fact003137"
      unitRef="BRL">150489000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ITPACGaranhunsMember"
      decimals="-3"
      id="Fact003139"
      unitRef="BRL">129458000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact003141"
      unitRef="BRL">267477000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact003143"
      unitRef="BRL">267477000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact003149"
      unitRef="BRL">574048000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact003151"
      unitRef="BRL">542354000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact003153"
      unitRef="BRL">238477000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact003155"
      unitRef="BRL">238477000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact003161"
      unitRef="BRL">373954000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact003163"
      unitRef="BRL">411873000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember"
      decimals="-3"
      id="Fact003165"
      unitRef="BRL">87777000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember"
      decimals="-3"
      id="Fact003167"
      unitRef="BRL">87777000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember"
      decimals="-3"
      id="Fact003169"
      unitRef="BRL">239847000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember"
      decimals="-3"
      id="Fact003171"
      unitRef="BRL">239847000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember"
      decimals="-3"
      id="Fact003173"
      unitRef="BRL">427474000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnifipMocMember"
      decimals="-3"
      id="Fact003175"
      unitRef="BRL">412698000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003177"
      unitRef="BRL">169173000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003179"
      unitRef="BRL">169173000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003181"
      unitRef="BRL">421538000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003183"
      unitRef="BRL">421538000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003185"
      unitRef="BRL">804996000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003187"
      unitRef="BRL">819682000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_DelReyMember"
      decimals="-3"
      id="Fact003189"
      unitRef="BRL">75098000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_DelReyMember"
      decimals="-3"
      id="Fact003191"
      unitRef="BRL">75098000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_DelReyMember"
      decimals="-3"
      id="Fact003193"
      unitRef="BRL">693890000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_DelReyMember"
      decimals="-3"
      id="Fact003195"
      unitRef="BRL">693890000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_DelReyMember"
      decimals="-3"
      id="Fact003197"
      unitRef="BRL">960966000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_DelReyMember"
      decimals="-3"
      id="Fact003199"
      unitRef="BRL">929307000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnidomMember"
      decimals="-3"
      id="Fact003201"
      unitRef="BRL">192034000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnidomMember"
      decimals="-3"
      id="Fact003203"
      unitRef="BRL">192034000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnidomMember"
      decimals="-3"
      id="Fact003205"
      unitRef="BRL">427482000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnidomMember"
      decimals="-3"
      id="Fact003207"
      unitRef="BRL">427482000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_UnidomMember"
      decimals="-3"
      id="Fact003209"
      unitRef="BRL">718699000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember_custom_UnidomMember"
      decimals="-3"
      id="Fact003211"
      unitRef="BRL">687570000</afya:CashGeneratingUnits>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FUNICMember"
      decimals="-3"
      id="Fact003217"
      unitRef="BRL">99629000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember_custom_FUNICMember"
      decimals="-3"
      id="Fact003221"
      unitRef="BRL">110943000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember"
      decimals="-3"
      id="Fact003225"
      unitRef="BRL">1526733000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember"
      decimals="-3"
      id="Fact003227"
      unitRef="BRL">1526733000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember"
      decimals="-3"
      id="Fact003229"
      unitRef="BRL">3460415000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember"
      decimals="-3"
      id="Fact003231"
      unitRef="BRL">3360786000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2025-12-31_custom_CarryingAmountsMember"
      decimals="-3"
      id="Fact003233"
      unitRef="BRL">6760399000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2024-12-31_custom_CarryingAmountsMember"
      decimals="-3"
      id="Fact003235"
      unitRef="BRL">6485667000</afya:CashGeneratingUnits>
    <afya:SchuduleOfAssumptionsUsedTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003237">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SchuduleOfAssumptionsUsedTableTextBlock_pn3n3_zs2q5xL5Xzcj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Intangible assets (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B9_zVtEPOJx43md" style="display: none"&gt;Schedule of assumptions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border: #D0CECE 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Key assumption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 51%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;Description&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: #D0CECE 1pt solid; border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DiscountRatesMember_z4QcjuuHkqo5" title="Description"&gt;Represent the current market assessment of the specific risks associated to the CGUs, estimated based on information from both internal and external sources, including the Company&#x2019;s and third parties historical weighted-average cost of capital (WACC).&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;Pre-tax discount rate applied to cash flow projections: between &lt;span id="xdx_90A_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z6DR5vvKTDHg" title="Discount rate applied to cash flow projections"&gt;10.82&lt;/span&gt;% and &lt;span id="xdx_905_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zkbt7PihCDw7" title="Discount rate applied to cash flow projections"&gt;11.73&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;Pre-tax discount rate applied to cash flow projections: between &lt;span id="xdx_907_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20241231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zPif14jGTu9d" title="Discount rate applied to cash flow projections"&gt;11.66&lt;/span&gt;% and &lt;span id="xdx_906_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pip0_dp_c20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z3nzF9GS73s5" title="Discount rate applied to cash flow projections"&gt;13.97&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;Perpetuity growth rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--PerpetuityGrowthRateMember_zgUfevbpw82a" title="Description"&gt;Cash flow projections include specific estimates for a five-year period followed by a terminal growth rate, determined based on management's internal estimate of the long-term compound annual growth rate (CAGR), consistent with the assumptions that would be made by a market participant.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;From &lt;span id="xdx_90E_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOPcJGfjIZIf" title="Growth rates"&gt;3.5&lt;/span&gt;% to &lt;span id="xdx_909_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_znr5YdVtYxFh" title="Growth rates"&gt;9.50&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;From &lt;span id="xdx_90B_ecustom--PerpetuityGrowthRate_pip0_dp_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zidxpqC2KL2c" title="Growth rates"&gt;3.5&lt;/span&gt;% to &lt;span id="xdx_901_ecustom--PerpetuityGrowthRate_pip0_dp_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zh43Ig1kwArd" title="Growth rates"&gt;7.53&lt;/span&gt;%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; border-left: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;EBITDA&lt;span style="font-family: Nunito Sans"&gt;&lt;sup&gt;[1]&lt;/sup&gt;&lt;/span&gt; growth rate (annual average for the next five years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;
    &lt;p style="font: 9pt Nunito Sans; margin: 0"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EBITDAMember_gIFDOKAOWMHBC-WJE_zuncArDTfD7" title="Description"&gt;EBITDA growth rate was estimated using historical performance as a baseline, adjusted for:&lt;/span&gt;&lt;/p&gt;
    &lt;div id="xdx_C09_gIFDOKAOWMHBC-WJE_zqD6Jetl0JBi"&gt;&lt;p style="font: 9pt Nunito Sans; margin: 0"&gt;- Expected revenue growth, driven by increases in both sales volume and pricing.&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_C07_gIFDOKAOWMHBC-WJE_zFxGavNFZ3Uf"&gt;&lt;p style="font: 9pt Nunito Sans; margin: 0"&gt;- Expected margin expansion, which reflects operational efficiencies and scale economies as
    volumes increase, partially offset by projected increases in costs.&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_906_ecustom--EbitdaGrowthRates_pip0_dp_c20250101__20251231_zvtN9LF3duli" title="EBITDA growth rates"&gt;6.88&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: #D0CECE 1pt solid; border-bottom: #D0CECE 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_90A_ecustom--EbitdaGrowthRates_pip0_dp_c20240101__20241231_zbVabD28HFj9" title="EBITDA growth rates"&gt;5.69&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;i&gt;Sensitivity analysis: impacts of possible changes in key assumptions&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20250101__20251231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zBYiuCNYfPa2" title="Description of significant estimate"&gt;An increase of 25 basis points in management&#x2019;s estimated discount rate applied to
the cash flow projections of each CGU for the year ended December 31, 2025, or a decrease of 25 basis points on perpetuity growth rate
or EBITDA growth rate would not have significant impacts on Company&#x2019;s impairment testing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Impairment testing of other intangible assets&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;There were &lt;span id="xdx_90F_eifrs-full--ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_do_c20250101__20251231_zzOkniNzthrk" title="Impairment intangible assets"&gt;no&lt;/span&gt; impairment indicatives of intangible assets with finite useful lives as of
and for the year ended December 31, 2025.&lt;/p&gt;

</afya:SchuduleOfAssumptionsUsedTableTextBlock>
    <ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections
      contextRef="From2025-01-012025-12-31_custom_DiscountRatesMember"
      id="Fact003239">Represent the current market assessment of the specific risks associated to the CGUs, estimated based on information from both internal and external sources, including the Company&#x2019;s and third parties historical weighted-average cost of capital (WACC).</ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections
      contextRef="AsOf2025-12-31_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact003241"
      unitRef="Pure">0.1082</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections
      contextRef="AsOf2025-12-31_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact003243"
      unitRef="Pure">0.1173</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections
      contextRef="AsOf2024-12-31_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact003245"
      unitRef="Pure">0.1166</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections
      contextRef="AsOf2024-12-31_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact003247"
      unitRef="Pure">0.1397</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections
      contextRef="From2025-01-012025-12-31_custom_PerpetuityGrowthRateMember"
      id="Fact003249">Cash flow projections include specific estimates for a five-year period followed by a terminal growth rate, determined based on management's internal estimate of the long-term compound annual growth rate (CAGR), consistent with the assumptions that would be made by a market participant.</ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections>
    <afya:PerpetuityGrowthRate
      contextRef="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact003251"
      unitRef="Pure">0.035</afya:PerpetuityGrowthRate>
    <afya:PerpetuityGrowthRate
      contextRef="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact003253"
      unitRef="Pure">0.0950</afya:PerpetuityGrowthRate>
    <afya:PerpetuityGrowthRate
      contextRef="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact003255"
      unitRef="Pure">0.035</afya:PerpetuityGrowthRate>
    <afya:PerpetuityGrowthRate
      contextRef="From2024-01-012024-12-31_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact003257"
      unitRef="Pure">0.0753</afya:PerpetuityGrowthRate>
    <ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections
      contextRef="From2025-01-012025-12-31_custom_EBITDAMember"
      id="Fact003261">EBITDA growth rate was estimated using historical performance as a baseline, adjusted for:- Expected revenue growth, driven by increases in both sales volume and pricing.- Expected margin expansion, which reflects operational efficiencies and scale economies as
    volumes increase, partially offset by projected increases in costs.</ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections>
    <afya:EbitdaGrowthRates
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact003263"
      unitRef="Pure">0.0688</afya:EbitdaGrowthRates>
    <afya:EbitdaGrowthRates
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact003265"
      unitRef="Pure">0.0569</afya:EbitdaGrowthRates>
    <ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections
      contextRef="From2025-01-012025-12-31_ifrs-full_GoodwillMember"
      id="Fact003267">An increase of 25 basis points in management&#x2019;s estimated discount rate applied to
the cash flow projections of each CGU for the year ended December 31, 2025, or a decrease of 25 basis points on perpetuity growth rate
or EBITDA growth rate would not have significant impacts on Company&#x2019;s impairment testing.</ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact003269"
      unitRef="BRL">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact003271">&lt;p id="xdx_802_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zgkxttcMo5vb" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;12&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_825_zqd5gg680W7f"&gt;Financial assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; color: #0D0E00"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;b&gt;12.1&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Financial assets&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfFinancialAssetsTableTextBlock_zfCKk7BKGG9e" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BD_zEgMmICCUAD4" style="display: none"&gt;Schedule of financial assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;At amortized cost&lt;/b&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Cash and cash equivalents&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zFSR0GqK3u9g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;1,125,381 &lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zwNWrmprW5Kh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;911,015&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Trade receivables&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeReceivables_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zyEySZtNuMuc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables"&gt;752,358 &lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeReceivables_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_ziiNiLIaENTi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables"&gt;631,846 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Other FIES credits - Other assets&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--OtherAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zuf7UVBO9Rdl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other FIES credits - Other assets"&gt;6,866 &lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--OtherAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zhBXyUUyRXNl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other FIES credits - Other assets"&gt;8,982&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Dividends receivable - Other assets&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DividendReceivable_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zJPLRk7cOif4" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends receivable - Other assets"&gt;6,287 &lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DividendReceivable_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zFPdpbw2cdj5" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends receivable"&gt;1,628&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zB3YEGMg3UCb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;1,890,892 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRXN40G1V4e9" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;1,553,471 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentFinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zkOY8WERLiRh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;1,849,041 &lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CurrentFinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z06VAwl2Pyd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;1,508,541 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_znY5z8ZwboC5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;41,851 &lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zuMfYWo0Dwfh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;44,930 &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zvOvJxy8DbA8" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;hr style="height: 1px; width: 33%; margin-left: 3%"/&gt;

&lt;p style="font: 9pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;span style="font-family: Nunito Sans"&gt;&lt;sup&gt;[1]&lt;/sup&gt;&lt;/span&gt; EBITDA refers to Earnings Before
Interest, Taxes, Depreciation and Amortization. EBITDA is not a defined performance measure under IFRS Accounting Standards.&lt;/p&gt;






&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;b&gt;12.2&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Financial liabilities&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 7pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfFinancialLiabilitiesTableTextBlock_zApM0bo416tj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B9_zwid6Khlho16" style="display: none"&gt;Schedule of financial liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;At amortized cost&lt;/b&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Trade payables&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z967f8uR7pzf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables"&gt;123,581 &lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5iEBvLxnhBl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables"&gt;128,080 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zlsu6fnkPwag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing"&gt;2,054,267 &lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFCAXvaqZ7Zd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing"&gt;2,195,161 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zWKhVwB4p6I5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities"&gt;1,065,746 &lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zPkwp9NZMQci" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities"&gt;978,336 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Accounts payable to selling shareholders&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zt0iPGHBgy48" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Accounts payable to selling shareholders"&gt;115,447 &lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z0ZirexSHOb6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Accounts payable to selling shareholders"&gt;215,819 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Dividends payable&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--DividendsPayable_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFlWtsR8A402" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends payable"&gt;192 &lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--DividendsPayable_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z80SeiiXaPI" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends payable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3324"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z2yumoKcDxu1" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;3,359,233 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zzvYvHDyFZr7" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;3,517,396 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4xsAyUzUA2g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;326,432 &lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z1xpBTbijuV" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;690,395&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zTpj8mv5vIpk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;3,032,801 &lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zYLJIetDc5I1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;2,827,001&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_znvTOkGaQ9hc" style="font: 10pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfFairValuesTableTextBlock_zmQJkcK0fO4j" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B7_zZmKFkpt9Eh3" style="display: none"&gt;Schedule of fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;At fair value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Accounts payable to selling shareholders (earn-outs)&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersEarnOutsMember_zDvLTTDZJfg1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"&gt;3,337 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersEarnOutsMember_z6W34HKHufi8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"&gt;20,067 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Accounts payable to selling shareholders (Unidom)&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersUnidomMember_zdCzDsMpiktj" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"&gt;321,813 &lt;/td&gt;
    &lt;td id="xdx_988_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersUnidomMember_zeSjmCcRFI0a" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"&gt;294,886 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231_zcdPTjJeT4jh" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"&gt;&lt;b&gt;325,150 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231_z1yq3E0XKkfb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"&gt;&lt;b&gt;314,953 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20251231_z5gzvupBWZx7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;24,421 &lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20241231_zeCC9zpsD9y7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;32,137&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20251231_z3QiGJ9fRsZ7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;300,729 &lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20241231_zZsxNtpJh8he" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;282,816&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_zxjvVaOyTrv4" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;span style="color: #C00000"&gt;&lt;b&gt;12.2.1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="color: #C00000"&gt;&lt;b&gt;Loans and financing&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfLoansAndFinancingTableTextBlock_zM8pNdh4cIHf" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 3)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B2_z0Kd946A2336" style="display: none"&gt;Schedule of loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Financial institution&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Interest rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;&#160;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_90E_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zsk6mgQ1aqZg" title="Financial institution"&gt;Banco Ita&#xfa; Unibanco S.A.&lt;/span&gt; (a)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_905_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zghIEF7NWizh" title="Interest rate"&gt;CDI + 1.90% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_902_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zfmdRINOXAp" title="Maturity"&gt;October 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zIzv4cTdu8u1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3368"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zZA230XVHKq" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;309,496 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_90A_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zho5Ub0wj0d4" title="Financial institution"&gt;FINEP&lt;/span&gt; (b)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90F_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zR4R7MHSOWSj" title="Interest rate"&gt;TJLP p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90A_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zQMduyFSaulk" title="Maturity"&gt;July 2027&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zzMGfB6ps923" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;5,262&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_z3PJqmXxSVUf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;8,209 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_900_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zOXOwdIGAdL6" title="Financial institution"&gt;Softbank&lt;/span&gt; (c)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_908_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zmWpM8AvbL52" title="Interest rate"&gt;6.5% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_z7BL1PKorwS" title="Maturity"&gt;April 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zt8EyJj7OKag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3388"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zIk4zqzRAgAc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;845,492 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_900_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z9IeoQSgiGX5" title="Financial institution"&gt;Debentures&lt;/span&gt; (d)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_zuZ0u6OuNYi4" title="Interest rate"&gt;CDI + 1.80% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90F_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z896fjA34ps4" title="Maturity"&gt;January 2028&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z1HLbfMnmsk3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3398"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_zGBKe5Dsv8I4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;526,946 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_903_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zw9svEiE6aj4" title="Financial institution"&gt;IFC&lt;/span&gt; (e)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zaVgDULurkU7" title="Interest rate"&gt;CDI + 1.05% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_znlDd5q6YYb9" title="Maturity"&gt;April 2030&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zzCiOfkv4la6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;510,672 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zaHAYXiw4Rp" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;505,018 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_905_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zQCcBN51G4sl" title="Financial institution"&gt;Commercial notes&lt;/span&gt; (f)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_901_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zpGzhbR5Aszj" title="Interest rate"&gt;CDI + 0.70% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90C_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_z5CyciXkyRyb" title="Maturity"&gt;October 2028&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_ztPSc6KChh1l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;512,678 &lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zzxIKkmOKrk6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3420"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_904_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zJbJTQxnQ0R7" title="Financial institution"&gt;Commercial notes&lt;/span&gt; (f)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_907_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zFXhJCDdwyha" title="Interest rate"&gt;CDI + 0.85% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90D_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zEBeVDWTnoL9" title="Maturity"&gt;October 2030&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zWski1IdqoVc" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;1,025,655 &lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zqAzcJDkTw5k" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3430"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20251231_zLHiAOy5g2N8" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;b&gt;2,054,267 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LoansAndFinancing_pn3n3_c20241231_zX7ix0nhzp2" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;b&gt;2,195,161 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Current&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LoansAndFinancingCurrent_iI_pn3n3_c20251231_zbQpxAy2G1ug" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;60,668 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LoansAndFinancingCurrent_iI_pn3n3_c20241231_zlokdgluSQRc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;363,554 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Non-current&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LoansAndFinancingNonCurrent_iI_pn3n3_c20251231_zdtKQQANyR8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;1,993,599 &lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LoansAndFinancingNonCurrent_iI_pn3n3_c20241231_zc3HX6s9BtS8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;1,831,607 &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A4_z2M9FEQY3ISi" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(a) On October 1, 2020, Afya Brazil entered into a loan with Banco Ita&#xfa; Unibanco
S.A. in the amount of R$500,000 adjusted by the CDI rate plus an interest rate of 1.62% per year and is repayable in three installments
in October 2022, April 2023 and October 2023. On September 28, 2022, Afya Brazil signed an amendment with Banco Ita&#xfa; Unibanco S.A
in order to extend its debt profile, postponing the original repayments dates from 2022 and 2023 to 2023, 2024 and 2025. Due to such extension,
the spread over the CDI rate increased from 1.62% p.y to 1.90% p.y. The aggregate outstanding amount was fully repaid on September 30,
2025.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(b) On July 23, 2019, Medcel entered into a loan of R$16,153 with &lt;i&gt;Financiadora de Estudos
e Projetos&lt;/i&gt; (FINEP), a governmental agency focused on financing investments on R&amp;amp;D, which has an interest rate based on TJLP (Long
term interest rate), and maturity in 2027. The first and second tranches of R$6,734 and R$4,130, respectively, were drawdown in October
2019 and December 2020, respectively, and additional tranches were drawdown in March and June 2023 totaling R$5,288 in order to develop
the Medical web series and other digital content. There is no financial covenant related to this agreement. The total balance is guaranteed
by a bank financial guarantee.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(c) On April 26, 2021, the Company issued and sold 150,000 shares of perpetual convertible
preferred shares designated as Series A perpetual convertible preferred shares, with a par value of US$0.00005 per share of Afya for US$150,000
thousands, equivalent to R$821,805 on the issuance date. The Series A perpetual convertible preferred shares is a class of equity security
that ranks senior to the common shares with respect to dividend rights or rights upon liquidation.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On November 3, 2025, the Company repurchased all 150,000 Series A perpetual convertible
preferred shares of a nominal or par value of US$0.00005 each in the capital of the Company for an aggregate purchase price of R$831,600,
following the Share Repurchase Agreement with SBLA Holdco LLC, an affiliate of Softbank. All repurchased Series A preferred shares were
cancelled by the Company.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(d) On December 16, 2022, Afya Brazil issued 500,000 simple, non-convertible, unsecured
debentures in a single series, each with a par value of R$1, totaling an aggregate amount of R$500,000, in a public distribution with
restricted placement efforts in the Brazilian market, under the terms of the Brazilian Securities Commission (CVM) Rule No. 476. The debentures
were issued with a maturity date of January 15, 2028, with the principal to be amortized in two equal installments payable on January
15, 2027 and January 15, 2028, corresponding to the fourth and fifth years of the transaction, respectively. The debentures bear interest
at 100% of the CDI rate plus 1.80% per year, payable semi-annually on January 15 and July 15 of each year, until the maturity date. The
aggregate outstanding amount was fully repaid on October 22, 2025.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(e) On August 7, 2024, Afya Brazil entered into a loan agreement with International Finance
Corporation ("IFC") to support its expansion program, through acquisitions. The financing is IFC&#x2019;s first sustainability-linked
loan based on social targets in the education sector. The pricing of IFC&#x2019;s loan will be linked to Afya reaching performance target
levels in selected social key performance indicators encompassing free medical consultations for the community and quality of education
according to MEC criteria (&#x201c;Sustainability KPIs&#x201d; - unaudited).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The aggregate principal amount of the loan is R$&lt;span id="xdx_902_ecustom--LoanAndFinancing_iI_pn3n3_c20240807__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InternationalFinanceCorporationMember_zWlbd2ITr9vg" title="Loans and financing"&gt;500,000&lt;/span&gt;, which shall be repaid in seven
equal semi-annual installments starting in April 2027. The interest rate of &lt;span id="xdx_908_eifrs-full--BorrowingsInterestRateBasis_c20240801__20240807__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InternationalFinanceCorporationMember_zEgq9NrBv6Ah" title="Interest rate"&gt;CDI rate plus 1.20%&lt;/span&gt; was reduced by 15 bps to 1.05% since the
Sustainability KPIs were achieved (unaudited).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Afya Brazil is subject to certain obligations including financial covenants, and the Company
shall maintain, as of the last day of each quarter of each financial year, Net Debt (Loans and financing plus Accounts payable to selling
shareholders less Cash and cash equivalents) to Adjusted EBITDA ratio below or equal to 3.0x, at the end of each fiscal year, until the
maturity date. Adjusted EBITDA for covenant purposes considers net income plus (i) income taxes expenses, (ii) net financial result (excluding
interest expenses on lease liabilities), (iii) depreciation and amortization expenses (excluding right-of-use assets depreciation expenses),
(iv) share-based compensation expenses, (v) share of income of associate, (vi) interest received and (vii) non-recurring expenses.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(f) On October 15, 2025, Afya Brazil issued commercial notes for private placement, sold
to Opea Securitizadora S.A. ("Opea&#x201d;), a Brazilian securitization corporation pursuant to Section 45 of Brazilian Law No. 14,195/2021,
as amended. Opea issued a debenture backed by the commercial notes on the same terms and conditions.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The aggregate principal amount of the commercial notes is R$&lt;span id="xdx_906_ecustom--LoanAndFinancing_iI_pn3n3_c20251015__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TwoSeriesMember_zU7IEEY5VW47" title="Loans and financing"&gt;1,500,000&lt;/span&gt;, divided into two
series, the first in the aggregate amount of R$&lt;span id="xdx_909_ecustom--LoanAndFinancing_iI_pn3n3_c20251015__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FirstSeriesMember_z4sgmX86Vd3b" title="Loans and financing"&gt;500,000&lt;/span&gt; ("First Series&#x201d;) and the second in the aggregate amount of R$&lt;span id="xdx_90B_ecustom--LoanAndFinancing_iI_pn3n3_c20251015__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SecondSeriesMember_zDUAq51R50G8" title="Loans and financing"&gt;1,000,000&lt;/span&gt;
("Second Series&#x201d;). The First Series will mature on October 15, 2028 and the Second Series will mature on October 15, 2030.
The interest rate applicable to the First Series and Second Series will be equal to the &lt;span id="xdx_903_eifrs-full--BorrowingsInterestRateBasis_c20251001__20251015__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InternationalFinanceCorporationMember_zxhpz9tfdiJc" title="Interest rate"&gt;CDI rate plus a spread of 0.70% and 0.85%&lt;/span&gt; per
year, respectively, based on 252 business days.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Afya Brazil is subject to certain obligations including financial covenants, and the Company
shall maintain Net Debt (excluding lease liabilities) to adjusted EBITDA ratio below or equal to 3.0x, at the end of each fiscal year,
until maturity date, applicable from December 31, 2025 and thereafter. Adjusted EBITDA for covenant purposes considers net income plus
(i) income taxes expenses, (ii) net financial result (excluding interest expenses on lease liabilities), (iii) depreciation and amortization
expenses (excluding right-of-use assets depreciation expenses), (iv) share-based compensation expenses, (v) share of income of associate,
(vi) interest received and (vii) non-recurring expenses.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The transaction costs that are directly attributable to the issuance of the commercial
notes were measured at fair value together with the financial liability on initial measurement. The transaction costs totaled R$&lt;span id="xdx_903_ecustom--TransactionCosts_iI_c20251231_zWKYLTepDQZh" title="Transaction costs"&gt;5,163&lt;/span&gt;,
including legal counsels and advisors.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;As disclosed in Note 7, the commercial notes are guaranteed by the following subsidiaries:
Unigranrio, IESP and DelRey.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;b&gt;12.2.2&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Leases&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company has property lease contracts with maturities between five &lt;span id="xdx_906_ecustom--ContractualLeaseTerm_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCklIv3YYSAh" style="display: none" title="Contractual lease term"&gt;5&lt;/span&gt; and &lt;span id="xdx_902_ecustom--ContractualLeaseTerm_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zE9Egkr1BGn8" title="Contractual lease term"&gt;30&lt;/span&gt;
years. There are no contract modification, sublease or variable payments in the period. The remeasurements are related to
index-based updates of the lease payments amounts.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The carrying amounts of right-of-use assets and lease liabilities as of December 31, 2025,
2024 and 2023 and the movements during years ended December 31, 2025, 2024 and 2023 are shown below:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfLeasesTableTextBlock_zD88JZhGdIE8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities  (Details 4)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BE_ziS5UYKrVDNc" style="display: none"&gt;Schedule of right-of-use assets and lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;Right-of-use assets&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;Lease liabilities&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Opening balance&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--RightofuseAssets_iS_pn3n3_c20250101__20251231_zrmYjJND5XH8" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;b&gt;842,219 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--RightofuseAssets_iS_pn3n3_c20240101__20241231_zdSaOneFkP58" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;b&gt;767,609 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--RightofuseAssets_iS_pn3n3_c20230101__20231231_zwtgdi1UNSs3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;b&gt;690,073&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LeaseLiabilities_iS_pn3n3_c20250101__20251231_z7hftFWQstSe" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;b&gt;978,336 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LeaseLiabilities_iS_pn3n3_c20240101__20241231_z56wJ6XHjch4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;b&gt;874,569 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LeaseLiabilities_iS_pn3n3_c20230101__20231231_z16LqXKtL3Me" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;b&gt;769,525&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Additions&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231_zG5RCJMJlqpe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, additions"&gt;37,727 &lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20240101__20241231_znlvQUfbfdu5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, additions"&gt;37,671 &lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20230101__20231231_zqK893yBmtB5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, additions"&gt;7,328&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20250101__20251231_z9wOqaXwpX02" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, additions"&gt;37,727 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20240101__20241231_zD25qWIes559" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, additions"&gt;37,671 &lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20230101__20231231_zru1mqAVVLrd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, additions"&gt;7,328&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Remeasurement&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20250101__20251231_zNyoJkpHTtI2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;98,987 &lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20240101__20241231_z7etiMsyHe4h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;80,226 &lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20230101__20231231_zUFlVmu95bDb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;70,387&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20250101__20251231_zbSBWQuxdI15" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, remeasurement"&gt;98,987 &lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20240101__20241231_zljZVWVsx6Lb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, remeasurement"&gt;80,226 &lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20230101__20231231_zdxRNFVcXfG9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, remeasurement"&gt;70,387&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Business combinations&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20250101__20251231_z5EfWXvMwSHj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, business combinations"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3500"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20240101__20241231_zpMS5SSoieSi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, business combinations"&gt;28,989 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20230101__20231231_zhg0bwUH5Rp9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, business combinations"&gt;65,408&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20250101__20251231_zYuL6NwOy2I3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, business combinations"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3506"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20240101__20241231_zzd6GS6LA7jj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, business combinations"&gt;28,989 &lt;/td&gt;
    &lt;td id="xdx_981_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20230101__20231231_z1svd6hJRjnc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, business combinations"&gt;65,408&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Depreciation expense&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20250101__20251231_zaLcw6anITY" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;(80,864)&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20240101__20241231_zCCby1j6NoAl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;(70,294)&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20230101__20231231_zPzojHIgCWnk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;(63,118)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20250101__20251231_zXNifSeHaype" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3518"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20240101__20241231_z9P9X9mybrKk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3520"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20230101__20231231_zik12oLFw6nk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3522"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Interest expense&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20250101__20251231_zcK8vh0zYxM5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3524"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20240101__20241231_zRWQMeouzGka" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3526"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20230101__20231231_zRmqwqrHVgYj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3528"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20250101__20251231_z3WyXUMZlpye" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, interest expense"&gt;123,067 &lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20240101__20241231_zRKcL939U0ya" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, interest expense"&gt;111,966 &lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20230101__20231231_zpSz7Nt2nZM9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, interest expense"&gt;100,849&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Payments of principal&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20250101__20251231_zwD9zYJ3nvig" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right of use assets, payments of principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3536"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20240101__20241231_zvzRrODrMld1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right of use assets, payments of principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3538"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20230101__20231231_zYluA0Wjjtz7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right of use assets, payments of principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3540"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20250101__20251231_zRdowUBn6c43" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of principal"&gt;(49,411)&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20240101__20241231_zPepJ0SWODm9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of principal"&gt;(41,221)&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20230101__20231231_zNgzvuS7z2Dj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of principal"&gt;(31,473)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Payments of interest&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20250101__20251231_ztdg2YuJlDn8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, payments of interest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3548"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20240101__20241231_zaDc92cMtB1h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, payments of interest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3550"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20230101__20231231_zBYFRjGs86n1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, payments of interest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3552"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20250101__20251231_z8n47pb78YV" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of interest"&gt;(121,475)&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20240101__20241231_ziYeoCmUxY8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of interest"&gt;(111,605)&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20230101__20231231_zUykcHnsOZw2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of interest"&gt;(103,911)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Write-off (i)&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightofuseAssetsWriteoff_pn3n3_c20250101__20251231_zLYEa3sEOuJ3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, Write-off"&gt;(1,311)&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsWriteoff_pn3n3_c20240101__20241231_zR6omVt1EKL9" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, Write-off"&gt;(1,982)&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RightofuseAssetsWriteoff_pn3n3_c20230101__20231231_zP3Z43ppyj7h" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, Write-off"&gt;(2,469)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20250101__20251231_zb8SmeLgEXli" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, Write-off"&gt;(1,485)&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20240101__20241231_zoINMVKtH2Oa" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, Write-off"&gt;(2,259)&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20230101__20231231_zSQ18FdrODXf" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, Write-off"&gt;(3,544)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Closing balance&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20250101__20251231_z83FsUeGPdD1" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;b&gt;896,758 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--RightofuseAssets_iE_pn3n3_c20240101__20241231_zIJlhrQ8DRN4" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;b&gt;842,219 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--RightofuseAssets_iE_pn3n3_c20230101__20231231_zigy42ysc84h" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;b&gt;767,609&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LeaseLiabilities_iE_pn3n3_c20250101__20251231_zj6U64o61w0f" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;b&gt;1,065,746 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LeaseLiabilities_iE_pn3n3_c20240101__20241231_zDOvzCg0E3rg" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;b&gt;978,336 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iE_pn3n3_c20230101__20231231_z18Kd8AYjSZ9" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;b&gt;874,569&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="width: 33%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Balances:&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20251231_zVQBU8Kzgxhj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3584"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20241231_zKmXCVBS5Yg1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3586"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20231231_zq92Mxs84Og5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3588"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20251231_zWRjzez5qT8j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, current"&gt;55,772 &lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20241231_zF7bmEAkbuZ4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, current"&gt;45,580&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20231231_zplwbGBHes59" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, current"&gt;36,898&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20251231_zjWfNlJTche9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, non-current"&gt;896,758&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20241231_zzWw057iipp5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, non-current"&gt;842,219 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20231231_zvT3AFPGNFm9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, non-current"&gt;767,609&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20251231_zUBh0pMUPeM6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, non-current"&gt;1,009,974 &lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20241231_zmuTAq8dkLw6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, non-current"&gt;932,756&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20231231_z5hwXbmG3bb9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, non-current"&gt;837,671&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to early termination of lease contracts.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AD_zBUvT8I7dJ9b" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company recognized lease expense from short-term leases and low-value assets of R$&lt;span id="xdx_90C_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20250101__20251231_z0UM1xVFfRF9" title="Lease expense from short-term leases and low-value assets"&gt;12,617&lt;/span&gt;
for the year ended December 31, 2025 (R$&lt;span id="xdx_900_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20240101__20241231_zm5XXISCR7ql" title="Lease expense from short-term leases and low-value assets"&gt;11,207&lt;/span&gt; and R$&lt;span id="xdx_90A_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_pn3n3_c20230101__20231231_zIjye3jokNci" title="Lease expense from short-term leases and low-value assets"&gt;10,871&lt;/span&gt; for the years ended December 31, 2024 and 2023, respectively).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;b&gt;12.2.3&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Accounts payable to selling shareholders&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock_zcVBNn7CbKga" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 5)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"&gt;&lt;span id="xdx_8B1_z8jHkXAu4UE4" style="display: none"&gt;Schedule of accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; text-align: center"&gt;&lt;b&gt;Interest rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Accounts payable at amortized cost (deferred consideration)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Unigranrio (a)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_908_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zJC5b0b1LD4g" title="Interest rate"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zHlARej95FEj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3618"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zPDRzaJR4GJ2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;90,543 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;DelRey (b)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_907_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zlCk9dBjP4Fj" title="Interest rate"&gt;Selic&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWPWg3dXB525" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;71,604 &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zDjUbjyGWY5i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;125,276 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;FUNIC (c)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_90A_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zFSiFuNVQ34d" title="Interest rate"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zDKnG57YjhT4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;43,843 &lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zgXtCo5MQmFc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3632"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Accounts payable at fair value (contingent consideration)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Shosp (d)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;-&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zJsnNpdxVcsi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;454 &lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zBolMYi8Pky2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;454 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Al&#xe9;m da Medicina (e)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;-&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zpNHiASUYtR7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3638"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zGRd88fogiBi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;9,600 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;CardioPapers (f)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;-&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zoa3WyA6Hpvk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;2,883 &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zYVvQmhCETv2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;10,013 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Unidom (g)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zsGBJFbvzyud" title="Interest rate"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_za0n4IlLlAD5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;321,813 &lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zIGd8gh76783" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;294,886 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231_ziCyVAdc5JXk" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;b&gt;440,597 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231_z5hhiKLHZf66" style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable"&gt;&lt;b&gt;530,772 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Current&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_pn3n3_c20251231_zoRMpepDJVVk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;110,640 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersCurrent_pn3n3_c20241231_z8RKSErz3t02" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;185,318 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Non-current&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_pn3n3_c20251231_zwBpujq7o7lk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;329,957 &lt;/td&gt;
    &lt;td id="xdx_986_ecustom--AccountsPayableToSellingShareholdersNonCurrent_pn3n3_c20241231_zSuXbKLI69R1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;345,454 &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AE_zXKjrUTQvmj5" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(a) On August 4, 2021, Afya Brazil acquired &lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20210803__20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zRjCy1E8z62h" title="Ownership interest"&gt;100&lt;/span&gt;% of Unigranrio. The adjusted aggregate
purchase price was R$&lt;span id="xdx_907_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_c20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_pn3n3" title="Non-current payables for purchase of energy"&gt;618,956&lt;/span&gt; of which 60% was paid in cash on the transaction closing date, and 40% was payable in cash in four equal
installments through 2022 to 2025, adjusted by the CDI rate. The aggregate outstanding amount was fully paid on August 4, 2025.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(b) On January 2, 2023, Afya Brazil acquired &lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zSQ6vjtg7X2k" title="Ownership interest"&gt;100&lt;/span&gt;% of DelRey. The consideration of R$&lt;span id="xdx_908_ecustom--ConsiderationToBeTransferred_c20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_pn3n3" title="Consideration to be transferred"&gt;234,000&lt;/span&gt;
is payable in cash in three annual installments of R$&lt;span id="xdx_909_ecustom--FirstAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zaWX13vTpkAi" title="First annual installment"&gt;134,000&lt;/span&gt; in January 2024, R$&lt;span id="xdx_908_ecustom--SecondAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zpuBrLMrHzrd" title="Second annual installment"&gt;50,000&lt;/span&gt; in January 2025 and R$&lt;span id="xdx_904_ecustom--ThirdAnnualInstallmentsPayable_pn3n3_c20221229__20230102__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_z32mIzvNyr8a" title="Third annual installment"&gt;50,000&lt;/span&gt; in January 2026, adjusted
by the SELIC rate.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(c) On May 7, 2025, Afya Brazil acquired &lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20250505__20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zYeIzDnYAjda" title="Ownership interest"&gt;100&lt;/span&gt;% of FUNIC. The aggregate purchase price was
R$&lt;span id="xdx_902_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_pn3n3_c20250507__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_z50vhGtOzCef" title="Non-current payables for purchase of energy"&gt;100,000&lt;/span&gt; of which 60% was paid in cash on the transaction closing date, and 40% is payable in cash in three annual installments adjusted
by the CDI rate.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(d) On May 13, 2021, Afya Brazil acquired &lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20210512__20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z2PyRfPNEcs2" title="Ownership interest"&gt;100&lt;/span&gt;% of Shosp which included an earn-out of R$&lt;span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zdoIJjfX0f8b" title="Remaining accounts payable"&gt;513&lt;/span&gt;
paid in August 2023 related to product development and R$&lt;span id="xdx_90C_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_pn3n3" title="Transaction price allocated to remaining performance obligations"&gt;454&lt;/span&gt; will be paid until 2026.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(e) On March 4, 2022, Afya Brazil acquired &lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220303__20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zzs9IUjDXEf7" title="Ownership Interest"&gt;100&lt;/span&gt;% of Al&#xe9;m da Medicina and an earn-out
of up to R$&lt;span id="xdx_909_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_pn3n3" title="Remaining accounts payable"&gt;19,200&lt;/span&gt; is payable in connection with revenue target achievements and product development goals for 2023 and 2024. The contingent
consideration of R$&lt;span id="xdx_90D_eifrs-full--DefinedBenefitObligationAtPresentValue_c20220304__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_pn3n3" title="Defined benefit obligation"&gt;9,600&lt;/span&gt; was fully paid on May 23, 2025.&lt;/p&gt;




&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(f) On April 5, 2022, Afya Brazil acquired &lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20220404__20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_z4t8QuOCCkA8" title="Ownership interest"&gt;100&lt;/span&gt;% of CardioPapers and an earn-out of up to
R$&lt;span id="xdx_901_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_pn3n3" title="Remaining accounts payable"&gt;15,000&lt;/span&gt; is payable in connection with revenue target achievements and other goals regarding credentials in the market for 2023 and 2024.
The contingent consideration of R$&lt;span id="xdx_904_eifrs-full--DefinedBenefitObligationAtPresentValue_c20220405__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardioPapersMember_pn3n3" title="Defined benefit obligation"&gt;2,883&lt;/span&gt; is based on the estimated payment considering the facts and circumstances as of December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;(g) On July 1, 2024, Afya Brazil acquired &lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pip0_dp_c20240630__20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zQEycIt2JfZ1" title="Ownership interest"&gt;100&lt;/span&gt;% of Unidom. The consideration of R$&lt;span id="xdx_905_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_pn3n3_c20240701__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zIyC6sBdROJf" title="Defined benefit obligation"&gt;279,989&lt;/span&gt;
is payable in up to ten annual installments, adjusted by the CDI rate, and it is conditioned upon the maintenance of the authorization
of the 175 medical school seats in each of the prior year. The contingent consideration is based on the estimated payment considering
the facts and circumstances as of December 31, 2025. The accounts payable to the selling shareholders of Unidom is updated by the CDI
rate, as determined in the purchase agreement, and measured at fair value considering the maintenance of the authorization of the 175
operating medical school seats. See Note 4.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The movements during the years ended December 31, 2025, 2024 and 2023 are shown below:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--AccountsPayableToSellingShareholders1Explanatory_ztrVH9uKlFoe" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 6)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B5_zXqp6kpCmX4k" style="display: none"&gt;Schedule of
    accounts payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 49%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Opening balance&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOtVHYMr1kHi" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Opening balance"&gt;&lt;b&gt;530,772&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zaejO9yWZyWh" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Opening balance"&gt;&lt;b&gt;566,867&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z462xqz8zDK1" style="border-bottom: Black 1pt solid; text-align: right" title="Opening balance"&gt;&lt;b&gt;528,678&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Additions&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zn8ME7H7tCCi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Additions consideration to be transferred on business combinations"&gt;40,000 &lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zigz5mARamFd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Additions consideration to be transferred on business combinations"&gt;279,989&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwCowbXQKk3l" style="text-align: right" title="Additions consideration to be transferred on business combinations"&gt;234,000&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Payments of principal&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z4TQgHqWmWac" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payments of principal"&gt;(144,076)&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFzyY9CIJ1e5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payments of principal"&gt;(290,067)&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z5bIiixptDSj" style="text-align: right" title="Payments of principal"&gt;(225,460)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Payments of interest&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zS2GT9Rsb8Vc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payment of interest"&gt;(49,608)&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zeYlP5wmZlH1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payment of interest"&gt;(78,931)&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoFgKldgXHAa" style="text-align: right" title="Payment of interest"&gt;(55,989)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Interest&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--InterestExpense_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zdvB85FYxhK5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Interest"&gt;19,979 &lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--InterestExpense_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zrE7rcRWEn2h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Interest"&gt;37,276&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--InterestExpense_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zk1A2shaDQo9" style="text-align: right" title="Interest"&gt;85,069&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Remeasurement of contingent consideration&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RemeasurementOfEarnouts_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zjz7TBASLwof" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Remeasurement of contingent consideration"&gt;43,530 &lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RemeasurementOfEarnouts_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwQGJEL7x3G4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Remeasurement of contingent consideration"&gt;15,638&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RemeasurementOfEarnouts_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoTZdqyxh2l2" style="text-align: right" title="Remeasurement of contingent consideration"&gt;2,556&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Other&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zdoHM8oQRhsl" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3742"&gt;-&lt;/span&gt; &lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zR8s1QU08UAg" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3744"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zkOu8uRedqKd" style="border-bottom: Black 1pt solid; text-align: right" title="Other"&gt;(1,987)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Closing balance&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zTJGcfhg39xf" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Closing balance"&gt;&lt;b&gt;440,597&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zEt4JXbwsDbc" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Closing balance"&gt;&lt;b&gt;530,772&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ztC8TeVwHVP" style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right" title="Closing balance"&gt;&lt;b&gt;566,867&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AE_zrUt6Cu4o13" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;b&gt;12.3&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Fair values&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The table below compares the carrying amounts and fair values of the Company&#x2019;s financial
instruments, other than those carrying amounts that are reasonable approximation of fair values:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfFairValuesFinancialInstrumentstTableTextBlock_zaWsNnNt4Wo8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 7)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B3_zvCQCh6mSFh8" style="display: none"&gt;Schedule of fair values of the company's financial instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 36%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 15%; text-align: right"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; text-align: right"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Financial liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z6mwy2GWAmLa" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at carrying amount"&gt;2,054,267 &lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zkwwMXOc6eRl" style="border-bottom: Black 1pt solid; text-align: right" title="Financial liabilities, at fair value"&gt;2,056,492 &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zZgXKeQVxdd2" style="text-align: right" title="Financial liabilities, at carrying amount"&gt;2,195,161 &lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zy6HppqWQO7c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at fair value"&gt;2,196,152&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialLiabilities_pn3n3_c20251231_zxgafQbwzMQ7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at carrying amount"&gt;&lt;b&gt;2,054,267 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20251231_zTXrOYytLgt" style="border-bottom: Black 1.5pt double; text-align: right" title="Financial liabilities, at fair value"&gt;&lt;b&gt;2,056,492 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231_zsZax9Uj0Q5l" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; text-align: right" title="Financial liabilities, at carrying amount"&gt;&lt;b&gt;2,195,161 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20241231_z2K7rU9FZfN9" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at fair value"&gt;&lt;b&gt;2,196,152&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AB_zAGAZA231skf" style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;The Company assessed that the fair values of cash and cash equivalents,
trade receivables, other assets, trade payables and accounts payable to selling shareholders approximate their carrying amounts.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;The financial instruments for which the fair value are disclosed
are based on Level 2 fair value measurement hierarchy. There has been no change in fair value hierarchy during the years ended December
31, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;b&gt;12.4&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Financial instruments risk management objectives and policies&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;The Company&#x2019;s main financial liabilities comprise loans
and financing, lease liabilities, accounts payable to selling shareholders and trade payables. The main purpose of these financial liabilities
is to finance the Company&#x2019;s operations and expansion. The Company&#x2019;s main financial assets include cash and cash equivalents
and trade receivables.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company is exposed to market risk, credit risk and liquidity risk. The Company monitors
market, credit and liquidity risks in line with the objectives of capital management and counts on the support, monitoring and oversight
of the Board of Directors in decisions related to capital management and its alignment with the objectives and risks. The Company&#x2019;s
policy is that no trading of derivatives for speculative purposes may be undertaken. The Board of Directors reviews and agrees with policies
for managing each of these risks, which are summarized below.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;br/&gt;
&lt;/p&gt;




&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;b&gt;12.4.1&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Market risk&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;Market risk is the risk that the fair value or future cash flows
of a financial instrument will fluctuate because of changes in market prices. The Company&#x2019;s exposure to market risk is related to
interest rate and foreign currency risk. The sensitivity analysis in the following sections relates to the position as of December 31,
2025.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;a) Interest rate risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;Interest rate risk is the risk that the fair value or future cash
flows of a financial instrument will fluctuate because of changes in market interest rates. The Company&#x2019;s exposure to the risk of
changes in market interest rates relates primarily to the Company&#x2019;s cash equivalents, loans and financing and accounts payable to
selling shareholders, with floating interest rates.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white; color: #C00000"&gt;&lt;span style="text-decoration: underline"&gt;Sensitivity analysis&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;The table below demonstrates the sensitivity to a reasonably possible
change in interest on cash equivalents, loans and financing and accounts payable to selling shareholders. With all variables held constant,
the Company&#x2019;s income before income taxes is affected through the impact on floating interest rates, as follows:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_zf2q7oBUugg4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 8)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BE_zNPHtsgVSAVd" style="display: none"&gt;Schedule of income before income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;Index&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;Base rate&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Cash equivalents&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zrA15uDD1pni" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;1,086,489 &lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span id="xdx_900_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zbbsq91S658k" title="Index - % per year"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zdQMczYG49Qg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;163,781 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zmZVsDbj9s5e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;(2,049,005)&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span id="xdx_904_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zVMagY5M7RPg" title="Index - % per year"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zzwxjja3r20l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;(323,480)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zbv8b2feDyzk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;(5,262)&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span id="xdx_909_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zQntQr53qNPi" title="Index - % per year"&gt;TJLP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zeCJDTfiKAWb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;(477)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Accounts payable to selling shareholders&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z6speULioNpj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;(365,656)&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span id="xdx_90F_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zkFk7JmS4N2j" title="Index - % per year"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zjLQcDfzLzH3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;(54,483)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Accounts payable to selling shareholders&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zDc056qLG1Y7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;(71,604)&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span id="xdx_901_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zmeiYYfhn45j" title="Index - % per year"&gt;Selic&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zTFiBj48wHSj" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;(10,669)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Net exposure&lt;/b&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--BaseRate_pn3n3_c20250101__20251231_zxkYdR3fXnsi" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;b&gt;(225,328)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;Increase in basis points&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;+75&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;+150&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Net effect on profit before tax&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zU05K3J0Pjdj" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax"&gt;(10,538)&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z6mnSGiXUo5g" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax"&gt;(21,076)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A8_zFZPYIgmzoYk" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;b) Foreign currency risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Foreign currency risk is the risk that the fair value or future cash flows of exposure
will fluctuate because of changes in foreign exchange rates. The Company&#x2019;s exposure to the risk of changes in foreign exchange rates
relates to cash and cash equivalents denominated in U.S. dollars in the amount of R$&lt;span id="xdx_905_ecustom--CreditExposures_iI_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zpKvhj6yKuUf" title="Exposure risk"&gt;23,422&lt;/span&gt; as of December 31, 2025 (December 31, 2024:
R$&lt;span id="xdx_90F_ecustom--CreditExposures_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zrJGDStDheMf" title="Exposure risk"&gt;21,610&lt;/span&gt;).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;span style="text-decoration: underline"&gt;Sensitivity analysis&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The table below demonstrates the sensitivity in the Company&#x2019;s income before income
taxes of a &lt;span id="xdx_906_ecustom--SensitivityChangeInTheEuroExchangeRate_pip0_dp_c20250101__20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zaFmv1yYYctk" title="Percentage of sensitivity change in the Euro exchange rate"&gt;10&lt;/span&gt;% change in the U.S. dollar exchange rate (R$&lt;span id="xdx_903_eifrs-full--ClosingForeignExchangeRate_iI_uN_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zfah5scgOwti" title="Closing foreign exchange rate"&gt;5.5018&lt;/span&gt; to U.S. dollar &lt;span id="xdx_900_eifrs-full--ClosingForeignExchangeRate_iI_uN_c20251231__ifrs-full--CurrencyInWhichInformationIsDisplayedAxis__currency--EUR__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zyKcCICooMng" title="Closing foreign exchange rate"&gt;1.00&lt;/span&gt;) as of December 31, 2025, with all other variables
held constant.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_zb2oG5xFCrXf" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 9)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BC_zcdunEBlLHa9" style="display: none"&gt;Schedule of sensitivity foreign currency&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;Exposure&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;+10%&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;-10%&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Cash equivalents&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zrjBauUu3ul3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;23,422 &lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zAEuZErKtdkc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;2,342 &lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_z3gubqkXuT0k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;(2,342)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A7_z8TMNCSGIFPg" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 14.2pt"&gt;&lt;b&gt;12.4.2&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Credit risk&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white"&gt;Credit risk is the risk that a counterparty
will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Company is exposed to
credit risk from its operating activities (primarily trade receivables) and from its financing activities, including cash and cash equivalents.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white"&gt;Customer credit risk is managed by the Company
based on the established policy, procedures and control relating to customer credit risk management. Outstanding customer receivables
are regularly monitored. See Note 6 for additional information on the Company&#x2019;s trade receivables.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white"&gt;Credit risk from balances with banks and
financial institutions is managed by the Company&#x2019;s treasury department in accordance with the Company&#x2019;s policy. Investments
of surplus funds are made only with approved counterparties and within limits assigned to each counterparty.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;The carrying amounts of its financial assets are the Company&#x2019;s
maximum exposure to credit risk for the components of the consolidated statements of financial position on December 31, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 14.2pt"&gt;&lt;b&gt;12.4.3&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Liquidity risk&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company&#x2019;s Management has responsibility for monitoring liquidity risk. In order
to achieve the Company&#x2019;s objective, Management regularly reviews the risk and maintains appropriate reserves, including bank credit
facilities with first tier financial institutions. Management also continuously monitors projected and actual cash flows and the combination
of the maturity profiles of the financial assets and liabilities.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0.55pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The main requirements for financial resources used by the Company arise from the need to
make payments for suppliers, operating expenses, labor and social obligations, loans and financing and accounts payable to selling shareholders.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;The tables below summarize the maturity profile of the Company&#x2019;s
financial liabilities based on contractual undiscounted amounts:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_zlPRrzpky833" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 10)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BB_zvmS6iwPiNRl" style="display: none"&gt;Schedule of maturity profile of financial liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;As of December 31, 2025 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Less than 1 year&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;1 to 3 years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;3 to 5 years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;More than 5 years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="color: #222222"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Trade payables&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFNRL9fH6a25" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;123,581 &lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zqzNeDCGV9T" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3832"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z7WfLovmFZbe" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3834"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztQJUTZkLyFk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3836"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zSLHywHPJ24l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;123,581 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z4d53RHtL1Wl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;308,292 &lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmk3Yp8XSZUl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;1,360,411 &lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcGC5AiqwmP9" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;1,473,733 &lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zb2ovbIa8IMh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3846"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_za9LadJEq9db" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;3,142,436 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z75BJ7Wxsg3g" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;178,638 &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeWz7OcSCtTb" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;347,847 &lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2ydSLgnAhRa" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;331,019 &lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztypRWgxaSSg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;1,342,713 &lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zoNOa3bY0JQ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;2,200,217 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Accounts payable to selling shareholders&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2FpJZ9DRzZ7" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;126,307 &lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2Mq143BlYX3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;131,446 &lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGwmVXkw2aU3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;185,821 &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2w3RgNl0xs5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;502,355 &lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zUSnIFNlp12h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;945,929 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvDmmPQnN9fb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;736,818 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zwyNtX3MoPBe" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,839,704 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgXMgQ64ffSe" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,990,573 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z4Pv9XYrLA68" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,845,068 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znoWOLTGKGG7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;6,412,163 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Less than 1 year&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;1 to 3 years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;3 to 5 years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;More than 5 years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="color: #222222"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Trade payables&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zK67vmK9kYWg" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;128,080 &lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z3GYF1pkIKs7" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3882"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zHxblqQ7dHB3" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3884"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgaXtjjdLgp5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3886"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zHr12gbM9Ejf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;128,080 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zYPHdM6YwmQ8" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;526,659 &lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjaUH06nPRTl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;1,494,287 &lt;/td&gt;
    &lt;td id="xdx_985_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z24hWxMtpVKh" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;617,818 &lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z6MrqSHuPOPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;75,526 &lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGHnFZjWePXh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;2,714,290 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zSmfkiuF7NG5" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;158,746 &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zpbidtQS0Fp5" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;303,211 &lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zCpTp9UABDul" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;293,178 &lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zA0ILEgs1OY9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;1,360,107 &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zaFH7tK4Aav1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;2,115,242 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Accounts payable to selling shareholders&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zAvtxN2ym6Uc" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;205,322 &lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zLsuZQxTUlvi" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;150,565 &lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z26HD8qrCuul" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;99,100 &lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zt61WVDLJHB8" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;373,498 &lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVzHZ5fuAol5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;828,485 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z78KMxuHMQCb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,018,807 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmmRjyOUb2Kc" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,948,063 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zzG4uph8O9W5" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,010,096 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zlTL7c9tc2w" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,809,131 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zuVCIo9EUJnf" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;5,786,097 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zYAT2NduYAmg" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;b&gt;12.5&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Changes in liabilities arising from financing activities&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock_z8kQs7hpzSya" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 11)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span id="xdx_8B7_zZMIgodaQ9w4" style="display: none"&gt;Schedule of changes in liabilities arising from financing activities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.55pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.85pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.85pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.55pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;January 1, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Payments of principal&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Payments of interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Additions and remeasurements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zNA3f0cYJtea" style="padding-right: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;2,195,161&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zBOHFfbu0WLk" style="padding-right: 2.55pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(1,624,911)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zoM0dpID9092" style="padding-right: 2.85pt; text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;(274,265)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zfy41l2ZmVW7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;1,494,881&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zL6iIrp0H5K" style="text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;252,870&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zZv3GviSRJm7" style="text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;10,531&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbF8AF1o1TZg" style="padding-right: 5.55pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;2,054,267&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zu009vAZvI8k" style="padding-right: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;978,336&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zEWih0Bgtcic" style="padding-right: 2.55pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(49,411)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zymGryeACWE8" style="padding-right: 2.85pt; text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;(121,475)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z0GSRMmdqvKl" style="padding-right: 3.85pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;136,714&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_ziiUPemjPDy7" style="text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;123,067&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zLUKEqMy2PCh" style="text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;(1,485)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zs5KiVN6Aop" style="padding-right: 5.55pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;1,065,746&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -0.1pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zkdrSnZEsdeg" style="border-bottom: Black 1pt solid; padding-right: -2.45pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(146,813)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zIzXu7nINfsa" style="border-bottom: Black 1pt solid; padding-right: 2.85pt; text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3964"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zSKFp8AK9nof" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;147,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -1.15pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zfGZctHTOnVk" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;192&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231_z2WFPiVmqtNg" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,173,497&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zW2OqeMp5wTj" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(1,821,135)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231_zyK9JtYRGFM7" style="border-bottom: Black 1.5pt double; padding-right: 2.85pt; text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(395,740)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zLboev8UMJL5" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,778,600&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zc6UOhD4NaZ8" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;375,937&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zic6RnozFOs4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;9,046&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231_zsWujkEPTGf7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,120,205&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;January 1, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Payments of principal&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Payments of interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Additions and remeasurements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Business combination&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zKLN9ka4wkFa" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;1,800,775&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zpd5ABoY3Ux8" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(128,696)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zWkWQ3p4CjV5" style="text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;(177,192)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbKqCmIGWnCi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;491,593&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIt7RnMFRZs2" style="padding-right: 5.65pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;201,472&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znWYrJAD8V98" style="text-align: right" title="Business combination"&gt;&lt;span style="font-size: 7.5pt"&gt;4,377&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zgrkIU4AjEdc" style="padding-right: 5.65pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;2,832&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIa2SyBR9xF1" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;2,195,161&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zrJRlVf7rEZ2" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;874,569&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJdqASoXhjH9" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(41,221)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zWU57RmUQDsi" style="text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;(111,605)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zWW85cX3A2Wd" style="padding-right: 5.65pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;117,897&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zAk44Z8kjpG8" style="padding-right: 5.65pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;111,966&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxVzCn18NZsi" style="text-align: right" title="Business combination"&gt;&lt;span style="font-size: 7.5pt"&gt;28,989&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zwRNvkPWEvc2" style="padding-right: 5.65pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;(2,259)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zyna1kzChKhf" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;978,336&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zKUpL8DtHOc6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(18,289)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ztZphFGnuay5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;18,289&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231_zTqseykaZ2Q" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;2,675,344&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z0g21NsOOJQe" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(188,206)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231_zWZQUxdK7b7d" style="border-bottom: Black 1.5pt double; text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(288,797)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zRV633tmfSy4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;627,779&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zFAZPF3WKB9e" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;313,438&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z1u2drMUfPgb" style="border-bottom: Black 1.5pt double; text-align: right" title="Business combination"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;33,366&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z33QO5joSqkl" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;573&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231_zeXUegstGWO9" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,173,497&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Payments of principal&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Payments of interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Additions and remeasurements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Business combination&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zAbvHkGuABqk" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;1,882,901&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zep7lXZTg8Lk" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(112,630)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzIM7vMREBXk" style="text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;(175,889)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z6oaoM6rGxYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;5,288&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z1Se6OcaDRl1" style="padding-right: 5.65pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;197,678&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.65pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zEnAymCsmtjl" style="padding-right: 5.65pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;3,427&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_ztYE4ee2JSN1" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;1,800,775&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zfZOL2E5IoR" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;769,525&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zCjCw1AzLStf" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(31,473)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zhNowFen9q4i" style="text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;(103,911)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_za0sgkcc3XC3" style="padding-right: 5.65pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;77,715&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zOIVXQn4FXFg" style="padding-right: 5.65pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;100,849&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zdefxndxLZu4" style="padding-right: 5.65pt; text-align: right" title="Business combination"&gt;&lt;span style="font-size: 7.5pt"&gt;65,408&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvUshu3gYp11" style="padding-right: 5.65pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;(3,544)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxmeQ7tHH9j1" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;874,569&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ztWQV1suQKy2" style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(18,750)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zuw744fAB3b5" style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;18,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231_zGstjq78Ltrk" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;2,652,426&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z3dzHL0Ons9f" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(162,853)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231_zwhQDlB760Mc" style="border-bottom: Black 1.5pt double; text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(279,800)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zggXI22NMHrb" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions and remeasurements"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;101,753&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zqJhwB3cVi18" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;298,527&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z33wsgDVjiD8" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;65,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zJYub1gEgp12" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(117)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231_z2j0PmtDGP03" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;2,675,344&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AB_zS9e2JhB8DGd" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The changes in equity arising from financing activities are disclosed in the consolidated
statement of changes in equity.&lt;/p&gt;

</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <afya:ScheduleOfFinancialAssetsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003273">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfFinancialAssetsTableTextBlock_zfCKk7BKGG9e" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BD_zEgMmICCUAD4" style="display: none"&gt;Schedule of financial assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;At amortized cost&lt;/b&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Cash and cash equivalents&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zFSR0GqK3u9g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;1,125,381 &lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashAndCashEquivalents_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zwNWrmprW5Kh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;911,015&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Trade receivables&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeReceivables_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zyEySZtNuMuc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables"&gt;752,358 &lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeReceivables_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_ziiNiLIaENTi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade receivables"&gt;631,846 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Other FIES credits - Other assets&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--OtherAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zuf7UVBO9Rdl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other FIES credits - Other assets"&gt;6,866 &lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--OtherAssets_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zhBXyUUyRXNl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other FIES credits - Other assets"&gt;8,982&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Dividends receivable - Other assets&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DividendReceivable_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zJPLRk7cOif4" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends receivable - Other assets"&gt;6,287 &lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DividendReceivable_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zFPdpbw2cdj5" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends receivable"&gt;1,628&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zB3YEGMg3UCb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;1,890,892 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRXN40G1V4e9" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;1,553,471 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentFinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zkOY8WERLiRh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;1,849,041 &lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CurrentFinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z06VAwl2Pyd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;1,508,541 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_znY5z8ZwboC5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;41,851 &lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentFinancialAssets_pn3n3_c20241231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zuMfYWo0Dwfh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;44,930 &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</afya:ScheduleOfFinancialAssetsTableTextBlock>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003275"
      unitRef="BRL">1125381000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003277"
      unitRef="BRL">911015000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003279"
      unitRef="BRL">752358000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003281"
      unitRef="BRL">631846000</ifrs-full:TradeReceivables>
    <ifrs-full:OtherAssets
      contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003283"
      unitRef="BRL">6866000</ifrs-full:OtherAssets>
    <ifrs-full:OtherAssets
      contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003285"
      unitRef="BRL">8982000</ifrs-full:OtherAssets>
    <afya:DividendReceivable
      contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003287"
      unitRef="BRL">6287000</afya:DividendReceivable>
    <afya:DividendReceivable
      contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003289"
      unitRef="BRL">1628000</afya:DividendReceivable>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003291"
      unitRef="BRL">1890892000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003293"
      unitRef="BRL">1553471000</ifrs-full:FinancialAssets>
    <ifrs-full:CurrentFinancialAssets
      contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003295"
      unitRef="BRL">1849041000</ifrs-full:CurrentFinancialAssets>
    <ifrs-full:CurrentFinancialAssets
      contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003297"
      unitRef="BRL">1508541000</ifrs-full:CurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="AsOf2025-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003299"
      unitRef="BRL">41851000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="AsOf2024-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      id="Fact003301"
      unitRef="BRL">44930000</ifrs-full:NoncurrentFinancialAssets>
    <afya:ScheduleOfFinancialLiabilitiesTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003304">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfFinancialLiabilitiesTableTextBlock_zApM0bo416tj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B9_zwid6Khlho16" style="display: none"&gt;Schedule of financial liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;At amortized cost&lt;/b&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Trade payables&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z967f8uR7pzf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables"&gt;123,581 &lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5iEBvLxnhBl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Trade payables"&gt;128,080 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zlsu6fnkPwag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing"&gt;2,054,267 &lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFCAXvaqZ7Zd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Loans and financing"&gt;2,195,161 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zWKhVwB4p6I5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities"&gt;1,065,746 &lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LeaseLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zPkwp9NZMQci" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities"&gt;978,336 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Accounts payable to selling shareholders&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zt0iPGHBgy48" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Accounts payable to selling shareholders"&gt;115,447 &lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z0ZirexSHOb6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Accounts payable to selling shareholders"&gt;215,819 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Dividends payable&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--DividendsPayable_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFlWtsR8A402" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends payable"&gt;192 &lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--DividendsPayable_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z80SeiiXaPI" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Dividends payable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3324"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z2yumoKcDxu1" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;3,359,233 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zzvYvHDyFZr7" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;3,517,396 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z4xsAyUzUA2g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;326,432 &lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentFinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z1xpBTbijuV" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;690,395&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zTpj8mv5vIpk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;3,032,801 &lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentFinancialLiabilities_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zYLJIetDc5I1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;2,827,001&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfFinancialLiabilitiesTableTextBlock>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003306"
      unitRef="BRL">123581000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003308"
      unitRef="BRL">128080000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003310"
      unitRef="BRL">2054267000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003312"
      unitRef="BRL">2195161000</afya:LoansAndFinancing>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003314"
      unitRef="BRL">1065746000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003316"
      unitRef="BRL">978336000</ifrs-full:LeaseLiabilities>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003318"
      unitRef="BRL">115447000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003320"
      unitRef="BRL">215819000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:DividendsPayable
      contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003322"
      unitRef="BRL">192000</ifrs-full:DividendsPayable>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003326"
      unitRef="BRL">3359233000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003328"
      unitRef="BRL">3517396000</ifrs-full:FinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003330"
      unitRef="BRL">326432000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003332"
      unitRef="BRL">690395000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003334"
      unitRef="BRL">3032801000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      id="Fact003336"
      unitRef="BRL">2827001000</ifrs-full:NoncurrentFinancialLiabilities>
    <afya:ScheduleOfFairValuesTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003338">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfFairValuesTableTextBlock_zmQJkcK0fO4j" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 2)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B7_zZmKFkpt9Eh3" style="display: none"&gt;Schedule of fair value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;At fair value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Accounts payable to selling shareholders (earn-outs)&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersEarnOutsMember_zDvLTTDZJfg1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"&gt;3,337 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersEarnOutsMember_z6W34HKHufi8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"&gt;20,067 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Accounts payable to selling shareholders (Unidom)&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersUnidomMember_zdCzDsMpiktj" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"&gt;321,813 &lt;/td&gt;
    &lt;td id="xdx_988_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersUnidomMember_zeSjmCcRFI0a" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"&gt;294,886 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20251231_zcdPTjJeT4jh" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"&gt;&lt;b&gt;325,150 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--FinancialLiabilitiesAtFairValues_iI_pn3n3_c20241231_z1yq3E0XKkfb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Financial liabilities, at fair value"&gt;&lt;b&gt;314,953 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20251231_z5gzvupBWZx7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;24,421 &lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20241231_zeCC9zpsD9y7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Current"&gt;32,137&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20251231_z3QiGJ9fRsZ7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;300,729 &lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss_iI_pn3n3_c20241231_zZsxNtpJh8he" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Non-current"&gt;282,816&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfFairValuesTableTextBlock>
    <afya:FinancialLiabilitiesAtFairValues
      contextRef="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersEarnOutsMember"
      decimals="-3"
      id="Fact003340"
      unitRef="BRL">3337000</afya:FinancialLiabilitiesAtFairValues>
    <afya:FinancialLiabilitiesAtFairValues
      contextRef="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersEarnOutsMember"
      decimals="-3"
      id="Fact003342"
      unitRef="BRL">20067000</afya:FinancialLiabilitiesAtFairValues>
    <afya:FinancialLiabilitiesAtFairValues
      contextRef="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersUnidomMember"
      decimals="-3"
      id="Fact003344"
      unitRef="BRL">321813000</afya:FinancialLiabilitiesAtFairValues>
    <afya:FinancialLiabilitiesAtFairValues
      contextRef="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersUnidomMember"
      decimals="-3"
      id="Fact003346"
      unitRef="BRL">294886000</afya:FinancialLiabilitiesAtFairValues>
    <afya:FinancialLiabilitiesAtFairValues
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003348"
      unitRef="BRL">325150000</afya:FinancialLiabilitiesAtFairValues>
    <afya:FinancialLiabilitiesAtFairValues
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003350"
      unitRef="BRL">314953000</afya:FinancialLiabilitiesAtFairValues>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003352"
      unitRef="BRL">24421000</ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003354"
      unitRef="BRL">32137000</ifrs-full:CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003356"
      unitRef="BRL">300729000</ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003358"
      unitRef="BRL">282816000</ifrs-full:NoncurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss>
    <afya:ScheduleOfLoansAndFinancingTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003360">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfLoansAndFinancingTableTextBlock_zM8pNdh4cIHf" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 3)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B2_z0Kd946A2336" style="display: none"&gt;Schedule of loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Financial institution&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Interest rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;&#160;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_90E_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zsk6mgQ1aqZg" title="Financial institution"&gt;Banco Ita&#xfa; Unibanco S.A.&lt;/span&gt; (a)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_905_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zghIEF7NWizh" title="Interest rate"&gt;CDI + 1.90% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_902_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zfmdRINOXAp" title="Maturity"&gt;October 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zIzv4cTdu8u1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3368"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyFiveMember_zZA230XVHKq" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;309,496 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_90A_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zho5Ub0wj0d4" title="Financial institution"&gt;FINEP&lt;/span&gt; (b)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90F_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zR4R7MHSOWSj" title="Interest rate"&gt;TJLP p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90A_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zQMduyFSaulk" title="Maturity"&gt;July 2027&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_zzMGfB6ps923" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;5,262&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--JulyTwentyTwentySevenMember_z3PJqmXxSVUf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;8,209 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_900_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zOXOwdIGAdL6" title="Financial institution"&gt;Softbank&lt;/span&gt; (c)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_908_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zmWpM8AvbL52" title="Interest rate"&gt;6.5% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_z7BL1PKorwS" title="Maturity"&gt;April 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zt8EyJj7OKag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3388"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--AprilTwentyTwentySixMember_zIk4zqzRAgAc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;845,492 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_900_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z9IeoQSgiGX5" title="Financial institution"&gt;Debentures&lt;/span&gt; (d)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_zuZ0u6OuNYi4" title="Interest rate"&gt;CDI + 1.80% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90F_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z896fjA34ps4" title="Maturity"&gt;January 2028&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_z1HLbfMnmsk3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3398"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--JanuaryTwentyTwentyEightMember_zGBKe5Dsv8I4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;526,946 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_903_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zw9svEiE6aj4" title="Financial institution"&gt;IFC&lt;/span&gt; (e)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90E_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zaVgDULurkU7" title="Interest rate"&gt;CDI + 1.05% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_znlDd5q6YYb9" title="Maturity"&gt;April 2030&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zzCiOfkv4la6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;510,672 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--AprilTwentyThirtyMember_zaHAYXiw4Rp" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;505,018 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_905_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zQCcBN51G4sl" title="Financial institution"&gt;Commercial notes&lt;/span&gt; (f)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_901_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zpGzhbR5Aszj" title="Interest rate"&gt;CDI + 0.70% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90C_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_z5CyciXkyRyb" title="Maturity"&gt;October 2028&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_ztPSc6KChh1l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;512,678 &lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyTwentyEightMember_zzxIKkmOKrk6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3420"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_904_ecustom--FinancialInstitution_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zJbJTQxnQ0R7" title="Financial institution"&gt;Commercial notes&lt;/span&gt; (f)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;Brazilian real&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_907_eifrs-full--BorrowingsInterestRateBasis_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zFXhJCDdwyha" title="Interest rate"&gt;CDI + 0.85% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_90D_eifrs-full--BorrowingsMaturity_c20250101__20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zEBeVDWTnoL9" title="Maturity"&gt;October 2030&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zWski1IdqoVc" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;1,025,655 &lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancing_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__custom--OctoberTwentyThirtyMember_zqAzcJDkTw5k" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3430"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20251231_zLHiAOy5g2N8" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;b&gt;2,054,267 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LoansAndFinancing_pn3n3_c20241231_zX7ix0nhzp2" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;b&gt;2,195,161 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Current&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LoansAndFinancingCurrent_iI_pn3n3_c20251231_zbQpxAy2G1ug" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;60,668 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LoansAndFinancingCurrent_iI_pn3n3_c20241231_zlokdgluSQRc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;363,554 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Non-current&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LoansAndFinancingNonCurrent_iI_pn3n3_c20251231_zdtKQQANyR8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;1,993,599 &lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LoansAndFinancingNonCurrent_iI_pn3n3_c20241231_zc3HX6s9BtS8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;1,831,607 &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfLoansAndFinancingTableTextBlock>
    <afya:FinancialInstitution
      contextRef="From2025-01-012025-12-31_custom_OctoberTwentyTwentyFiveMember"
      id="Fact003362">Banco Ita&#xfa; Unibanco S.A.</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2025-01-012025-12-31_custom_OctoberTwentyTwentyFiveMember"
      id="Fact003364">CDI + 1.90% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2025-01-012025-12-31_custom_OctoberTwentyTwentyFiveMember"
      id="Fact003366">October 2025</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_custom_OctoberTwentyTwentyFiveMember"
      decimals="-3"
      id="Fact003370"
      unitRef="BRL">309496000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2025-01-012025-12-31_custom_JulyTwentyTwentySevenMember"
      id="Fact003372">FINEP</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2025-01-012025-12-31_custom_JulyTwentyTwentySevenMember"
      id="Fact003374">TJLP p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2025-01-012025-12-31_custom_JulyTwentyTwentySevenMember"
      id="Fact003376">July 2027</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_custom_JulyTwentyTwentySevenMember"
      decimals="-3"
      id="Fact003378"
      unitRef="BRL">5262000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_custom_JulyTwentyTwentySevenMember"
      decimals="-3"
      id="Fact003380"
      unitRef="BRL">8209000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2025-01-012025-12-31_custom_AprilTwentyTwentySixMember"
      id="Fact003382">Softbank</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2025-01-012025-12-31_custom_AprilTwentyTwentySixMember"
      id="Fact003384">6.5% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2025-01-012025-12-31_custom_AprilTwentyTwentySixMember"
      id="Fact003386">April 2026</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_custom_AprilTwentyTwentySixMember"
      decimals="-3"
      id="Fact003390"
      unitRef="BRL">845492000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2025-01-012025-12-31_custom_JanuaryTwentyTwentyEightMember"
      id="Fact003392">Debentures</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2025-01-012025-12-31_custom_JanuaryTwentyTwentyEightMember"
      id="Fact003394">CDI + 1.80% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2025-01-012025-12-31_custom_JanuaryTwentyTwentyEightMember"
      id="Fact003396">January 2028</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_custom_JanuaryTwentyTwentyEightMember"
      decimals="-3"
      id="Fact003400"
      unitRef="BRL">526946000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2025-01-012025-12-31_custom_AprilTwentyThirtyMember"
      id="Fact003402">IFC</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2025-01-012025-12-31_custom_AprilTwentyThirtyMember"
      id="Fact003404">CDI + 1.05% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2025-01-012025-12-31_custom_AprilTwentyThirtyMember"
      id="Fact003406">April 2030</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_custom_AprilTwentyThirtyMember"
      decimals="-3"
      id="Fact003408"
      unitRef="BRL">510672000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_custom_AprilTwentyThirtyMember"
      decimals="-3"
      id="Fact003410"
      unitRef="BRL">505018000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2025-01-012025-12-31_custom_OctoberTwentyTwentyEightMember"
      id="Fact003412">Commercial notes</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2025-01-012025-12-31_custom_OctoberTwentyTwentyEightMember"
      id="Fact003414">CDI + 0.70% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2025-01-012025-12-31_custom_OctoberTwentyTwentyEightMember"
      id="Fact003416">October 2028</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_custom_OctoberTwentyTwentyEightMember"
      decimals="-3"
      id="Fact003418"
      unitRef="BRL">512678000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2025-01-012025-12-31_custom_OctoberTwentyThirtyMember"
      id="Fact003422">Commercial notes</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2025-01-012025-12-31_custom_OctoberTwentyThirtyMember"
      id="Fact003424">CDI + 0.85% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2025-01-012025-12-31_custom_OctoberTwentyThirtyMember"
      id="Fact003426">October 2030</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_custom_OctoberTwentyThirtyMember"
      decimals="-3"
      id="Fact003428"
      unitRef="BRL">1025655000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003432"
      unitRef="BRL">2054267000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003434"
      unitRef="BRL">2195161000</afya:LoansAndFinancing>
    <afya:LoansAndFinancingCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003436"
      unitRef="BRL">60668000</afya:LoansAndFinancingCurrent>
    <afya:LoansAndFinancingCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003438"
      unitRef="BRL">363554000</afya:LoansAndFinancingCurrent>
    <afya:LoansAndFinancingNonCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003440"
      unitRef="BRL">1993599000</afya:LoansAndFinancingNonCurrent>
    <afya:LoansAndFinancingNonCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003442"
      unitRef="BRL">1831607000</afya:LoansAndFinancingNonCurrent>
    <afya:LoanAndFinancing
      contextRef="AsOf2024-08-07_custom_InternationalFinanceCorporationMember"
      decimals="-3"
      id="Fact003444"
      unitRef="BRL">500000000</afya:LoanAndFinancing>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2024-08-012024-08-07_custom_InternationalFinanceCorporationMember"
      id="Fact003446">CDI rate plus 1.20%</ifrs-full:BorrowingsInterestRateBasis>
    <afya:LoanAndFinancing
      contextRef="AsOf2025-10-15_custom_TwoSeriesMember"
      decimals="-3"
      id="Fact003448"
      unitRef="BRL">1500000000</afya:LoanAndFinancing>
    <afya:LoanAndFinancing
      contextRef="AsOf2025-10-15_custom_FirstSeriesMember"
      decimals="-3"
      id="Fact003450"
      unitRef="BRL">500000000</afya:LoanAndFinancing>
    <afya:LoanAndFinancing
      contextRef="AsOf2025-10-15_custom_SecondSeriesMember"
      decimals="-3"
      id="Fact003452"
      unitRef="BRL">1000000000</afya:LoanAndFinancing>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2025-10-012025-10-15_custom_InternationalFinanceCorporationMember"
      id="Fact003454">CDI rate plus a spread of 0.70% and 0.85%</ifrs-full:BorrowingsInterestRateBasis>
    <afya:TransactionCosts
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact003456"
      unitRef="BRL">5163</afya:TransactionCosts>
    <afya:ContractualLeaseTerm
      contextRef="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember"
      id="Fact003458">P5Y</afya:ContractualLeaseTerm>
    <afya:ContractualLeaseTerm
      contextRef="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember"
      id="Fact003460">P30Y</afya:ContractualLeaseTerm>
    <afya:ScheduleOfLeasesTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003462">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfLeasesTableTextBlock_zD88JZhGdIE8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities  (Details 4)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BE_ziS5UYKrVDNc" style="display: none"&gt;Schedule of right-of-use assets and lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;Right-of-use assets&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;Lease liabilities&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Opening balance&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--RightofuseAssets_iS_pn3n3_c20250101__20251231_zrmYjJND5XH8" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;b&gt;842,219 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--RightofuseAssets_iS_pn3n3_c20240101__20241231_zdSaOneFkP58" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;b&gt;767,609 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--RightofuseAssets_iS_pn3n3_c20230101__20231231_zwtgdi1UNSs3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;b&gt;690,073&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LeaseLiabilities_iS_pn3n3_c20250101__20251231_z7hftFWQstSe" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;b&gt;978,336 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LeaseLiabilities_iS_pn3n3_c20240101__20241231_z56wJ6XHjch4" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;b&gt;874,569 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LeaseLiabilities_iS_pn3n3_c20230101__20231231_z16LqXKtL3Me" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;b&gt;769,525&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Additions&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20250101__20251231_zG5RCJMJlqpe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, additions"&gt;37,727 &lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20240101__20241231_znlvQUfbfdu5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, additions"&gt;37,671 &lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsToRightofuseAssets_pn3n3_c20230101__20231231_zqK893yBmtB5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, additions"&gt;7,328&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20250101__20251231_z9wOqaXwpX02" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, additions"&gt;37,727 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20240101__20241231_zD25qWIes559" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, additions"&gt;37,671 &lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AdditionsToLeaseLiabilities_pn3n3_c20230101__20231231_zru1mqAVVLrd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, additions"&gt;7,328&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Remeasurement&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20250101__20251231_zNyoJkpHTtI2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;98,987 &lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20240101__20241231_z7etiMsyHe4h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;80,226 &lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--RightofuseAssetsRemeasurement_pn3n3_c20230101__20231231_zUFlVmu95bDb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;70,387&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20250101__20251231_zbSBWQuxdI15" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, remeasurement"&gt;98,987 &lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20240101__20241231_zljZVWVsx6Lb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, remeasurement"&gt;80,226 &lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LeaseLiabilitiesRemeasurement_pn3n3_c20230101__20231231_zdxRNFVcXfG9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, remeasurement"&gt;70,387&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Business combinations&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20250101__20251231_z5EfWXvMwSHj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, business combinations"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3500"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20240101__20241231_zpMS5SSoieSi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, business combinations"&gt;28,989 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RightofuseAssetsBusinessCombinations_pn3n3_c20230101__20231231_zhg0bwUH5Rp9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, business combinations"&gt;65,408&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20250101__20251231_zYuL6NwOy2I3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, business combinations"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3506"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20240101__20241231_zzd6GS6LA7jj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, business combinations"&gt;28,989 &lt;/td&gt;
    &lt;td id="xdx_981_ecustom--BusinessCombinationsLeaseLiabilities_pn3n3_c20230101__20231231_z1svd6hJRjnc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, business combinations"&gt;65,408&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Depreciation expense&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20250101__20251231_zaLcw6anITY" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;(80,864)&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20240101__20241231_zCCby1j6NoAl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;(70,294)&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--DepreciationRightofuseAssets_iN_pn3n3_di_c20230101__20231231_zPzojHIgCWnk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;(63,118)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20250101__20251231_zXNifSeHaype" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3518"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20240101__20241231_z9P9X9mybrKk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3520"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--DepreciationExpenseLeaseLiabilities_pn3n3_c20230101__20231231_zik12oLFw6nk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3522"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Interest expense&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20250101__20251231_zcK8vh0zYxM5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3524"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20240101__20241231_zRWQMeouzGka" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3526"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RightofuseAssetsInterestExpense_pn3n3_c20230101__20231231_zRmqwqrHVgYj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3528"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20250101__20251231_z3WyXUMZlpye" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, interest expense"&gt;123,067 &lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20240101__20241231_zRKcL939U0ya" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, interest expense"&gt;111,966 &lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_c20230101__20231231_zpSz7Nt2nZM9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, interest expense"&gt;100,849&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Payments of principal&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20250101__20251231_zwD9zYJ3nvig" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right of use assets, payments of principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3536"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20240101__20241231_zvzRrODrMld1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right of use assets, payments of principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3538"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RightofuseAssetsPaymentsOfPrincipal_pn3n3_c20230101__20231231_zYluA0Wjjtz7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right of use assets, payments of principal"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3540"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20250101__20251231_zRdowUBn6c43" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of principal"&gt;(49,411)&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20240101__20241231_zPepJ0SWODm9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of principal"&gt;(41,221)&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LeaseLiabilitiesPaymentsOfPrincipal_pn3n3_c20230101__20231231_zNgzvuS7z2Dj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of principal"&gt;(31,473)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Payments of interest&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20250101__20251231_ztdg2YuJlDn8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, payments of interest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3548"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20240101__20241231_zaDc92cMtB1h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, payments of interest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3550"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsPaymentsOfInterest_pn3n3_c20230101__20231231_zBYFRjGs86n1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, payments of interest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3552"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20250101__20251231_z8n47pb78YV" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of interest"&gt;(121,475)&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20240101__20241231_ziYeoCmUxY8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of interest"&gt;(111,605)&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PaymentsOfInterestLeaseLiabilities_pn3n3_c20230101__20231231_zUykcHnsOZw2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, payments of interest"&gt;(103,911)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Write-off (i)&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightofuseAssetsWriteoff_pn3n3_c20250101__20251231_zLYEa3sEOuJ3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, Write-off"&gt;(1,311)&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsWriteoff_pn3n3_c20240101__20241231_zR6omVt1EKL9" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, Write-off"&gt;(1,982)&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RightofuseAssetsWriteoff_pn3n3_c20230101__20231231_zP3Z43ppyj7h" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, Write-off"&gt;(2,469)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20250101__20251231_zb8SmeLgEXli" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, Write-off"&gt;(1,485)&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20240101__20241231_zoINMVKtH2Oa" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, Write-off"&gt;(2,259)&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LeaseLiabilitiesWriteoff_pn3n3_c20230101__20231231_zSQ18FdrODXf" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, Write-off"&gt;(3,544)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Closing balance&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--RightofuseAssets_iE_pn3n3_c20250101__20251231_z83FsUeGPdD1" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;b&gt;896,758 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--RightofuseAssets_iE_pn3n3_c20240101__20241231_zIJlhrQ8DRN4" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;b&gt;842,219 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--RightofuseAssets_iE_pn3n3_c20230101__20231231_zigy42ysc84h" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;b&gt;767,609&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LeaseLiabilities_iE_pn3n3_c20250101__20251231_zj6U64o61w0f" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;b&gt;1,065,746 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LeaseLiabilities_iE_pn3n3_c20240101__20241231_zDOvzCg0E3rg" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;b&gt;978,336 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iE_pn3n3_c20230101__20231231_z18Kd8AYjSZ9" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;b&gt;874,569&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="width: 33%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Balances:&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Current&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20251231_zVQBU8Kzgxhj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3584"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20241231_zKmXCVBS5Yg1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3586"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RightofuseAssetsCurrent_iI_pn3n3_c20231231_zq92Mxs84Og5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3588"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20251231_zWRjzez5qT8j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, current"&gt;55,772 &lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CurrentLeaseLiabilities_pn3n3_c20241231_zF7bmEAkbuZ4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, current"&gt;45,580&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20231231_zplwbGBHes59" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, current"&gt;36,898&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Non-current&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20251231_zjWfNlJTche9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, non-current"&gt;896,758&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20241231_zzWw057iipp5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, non-current"&gt;842,219 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RightofuseAssetsNonCurrent_iI_pn3n3_c20231231_zvT3AFPGNFm9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Right-of-use assets, non-current"&gt;767,609&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20251231_zUBh0pMUPeM6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, non-current"&gt;1,009,974 &lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentLeaseLiabilities_pn3n3_c20241231_zmuTAq8dkLw6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, non-current"&gt;932,756&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20231231_z5hwXbmG3bb9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities, non-current"&gt;837,671&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Refers to early termination of lease contracts.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfLeasesTableTextBlock>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003464"
      unitRef="BRL">842219000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003466"
      unitRef="BRL">767609000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003468"
      unitRef="BRL">690073000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003470"
      unitRef="BRL">978336000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003472"
      unitRef="BRL">874569000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003474"
      unitRef="BRL">769525000</ifrs-full:LeaseLiabilities>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003476"
      unitRef="BRL">37727000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003478"
      unitRef="BRL">37671000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003480"
      unitRef="BRL">7328000</ifrs-full:AdditionsToRightofuseAssets>
    <afya:AdditionsToLeaseLiabilities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003482"
      unitRef="BRL">37727000</afya:AdditionsToLeaseLiabilities>
    <afya:AdditionsToLeaseLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003484"
      unitRef="BRL">37671000</afya:AdditionsToLeaseLiabilities>
    <afya:AdditionsToLeaseLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003486"
      unitRef="BRL">7328000</afya:AdditionsToLeaseLiabilities>
    <afya:RightofuseAssetsRemeasurement
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003488"
      unitRef="BRL">98987000</afya:RightofuseAssetsRemeasurement>
    <afya:RightofuseAssetsRemeasurement
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003490"
      unitRef="BRL">80226000</afya:RightofuseAssetsRemeasurement>
    <afya:RightofuseAssetsRemeasurement
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003492"
      unitRef="BRL">70387000</afya:RightofuseAssetsRemeasurement>
    <afya:LeaseLiabilitiesRemeasurement
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003494"
      unitRef="BRL">98987000</afya:LeaseLiabilitiesRemeasurement>
    <afya:LeaseLiabilitiesRemeasurement
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003496"
      unitRef="BRL">80226000</afya:LeaseLiabilitiesRemeasurement>
    <afya:LeaseLiabilitiesRemeasurement
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003498"
      unitRef="BRL">70387000</afya:LeaseLiabilitiesRemeasurement>
    <afya:RightofuseAssetsBusinessCombinations
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003502"
      unitRef="BRL">28989000</afya:RightofuseAssetsBusinessCombinations>
    <afya:RightofuseAssetsBusinessCombinations
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003504"
      unitRef="BRL">65408000</afya:RightofuseAssetsBusinessCombinations>
    <afya:BusinessCombinationsLeaseLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003508"
      unitRef="BRL">28989000</afya:BusinessCombinationsLeaseLiabilities>
    <afya:BusinessCombinationsLeaseLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003510"
      unitRef="BRL">65408000</afya:BusinessCombinationsLeaseLiabilities>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003512"
      unitRef="BRL">80864000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003514"
      unitRef="BRL">70294000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003516"
      unitRef="BRL">63118000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003530"
      unitRef="BRL">123067000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003532"
      unitRef="BRL">111966000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003534"
      unitRef="BRL">100849000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <afya:LeaseLiabilitiesPaymentsOfPrincipal
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003542"
      unitRef="BRL">-49411000</afya:LeaseLiabilitiesPaymentsOfPrincipal>
    <afya:LeaseLiabilitiesPaymentsOfPrincipal
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003544"
      unitRef="BRL">-41221000</afya:LeaseLiabilitiesPaymentsOfPrincipal>
    <afya:LeaseLiabilitiesPaymentsOfPrincipal
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003546"
      unitRef="BRL">-31473000</afya:LeaseLiabilitiesPaymentsOfPrincipal>
    <afya:PaymentsOfInterestLeaseLiabilities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003554"
      unitRef="BRL">-121475000</afya:PaymentsOfInterestLeaseLiabilities>
    <afya:PaymentsOfInterestLeaseLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003556"
      unitRef="BRL">-111605000</afya:PaymentsOfInterestLeaseLiabilities>
    <afya:PaymentsOfInterestLeaseLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003558"
      unitRef="BRL">-103911000</afya:PaymentsOfInterestLeaseLiabilities>
    <afya:RightofuseAssetsWriteoff
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003560"
      unitRef="BRL">-1311000</afya:RightofuseAssetsWriteoff>
    <afya:RightofuseAssetsWriteoff
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003562"
      unitRef="BRL">-1982000</afya:RightofuseAssetsWriteoff>
    <afya:RightofuseAssetsWriteoff
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003564"
      unitRef="BRL">-2469000</afya:RightofuseAssetsWriteoff>
    <afya:LeaseLiabilitiesWriteoff
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003566"
      unitRef="BRL">-1485000</afya:LeaseLiabilitiesWriteoff>
    <afya:LeaseLiabilitiesWriteoff
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003568"
      unitRef="BRL">-2259000</afya:LeaseLiabilitiesWriteoff>
    <afya:LeaseLiabilitiesWriteoff
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003570"
      unitRef="BRL">-3544000</afya:LeaseLiabilitiesWriteoff>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003572"
      unitRef="BRL">896758000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003574"
      unitRef="BRL">842219000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003576"
      unitRef="BRL">767609000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003578"
      unitRef="BRL">1065746000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003580"
      unitRef="BRL">978336000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003582"
      unitRef="BRL">874569000</ifrs-full:LeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003590"
      unitRef="BRL">55772000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003592"
      unitRef="BRL">45580000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003594"
      unitRef="BRL">36898000</ifrs-full:CurrentLeaseLiabilities>
    <afya:RightofuseAssetsNonCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003596"
      unitRef="BRL">896758000</afya:RightofuseAssetsNonCurrent>
    <afya:RightofuseAssetsNonCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003598"
      unitRef="BRL">842219000</afya:RightofuseAssetsNonCurrent>
    <afya:RightofuseAssetsNonCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003600"
      unitRef="BRL">767609000</afya:RightofuseAssetsNonCurrent>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003602"
      unitRef="BRL">1009974000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003604"
      unitRef="BRL">932756000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003606"
      unitRef="BRL">837671000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003608"
      unitRef="BRL">12617000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact003610"
      unitRef="BRL">11207000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003612"
      unitRef="BRL">10871000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <afya:ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003614">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock_zcVBNn7CbKga" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 5)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"&gt;&lt;span id="xdx_8B1_z8jHkXAu4UE4" style="display: none"&gt;Schedule of accounts payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; text-align: center"&gt;&lt;b&gt;Interest rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Accounts payable at amortized cost (deferred consideration)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Unigranrio (a)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_908_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zJC5b0b1LD4g" title="Interest rate"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zHlARej95FEj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3618"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zPDRzaJR4GJ2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;90,543 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;DelRey (b)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_907_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zlCk9dBjP4Fj" title="Interest rate"&gt;Selic&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zWPWg3dXB525" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;71,604 &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--DelReyMember_zDjUbjyGWY5i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;125,276 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;FUNIC (c)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_90A_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zFSiFuNVQ34d" title="Interest rate"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zDKnG57YjhT4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;43,843 &lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FUNICMember_zgXtCo5MQmFc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3632"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Accounts payable at fair value (contingent consideration)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Shosp (d)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;-&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zJsnNpdxVcsi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;454 &lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zBolMYi8Pky2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;454 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Al&#xe9;m da Medicina (e)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;-&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zpNHiASUYtR7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3638"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AlemDaMedicinaMember_zGRd88fogiBi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;9,600 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;CardioPapers (f)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;-&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zoa3WyA6Hpvk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;2,883 &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CardiPapersMember_zYVvQmhCETv2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;10,013 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Unidom (g)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span id="xdx_90D_ecustom--AccountsPayableAamortizedCostInterestRateBasis_c20250101__20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zsGBJFbvzyud" title="Interest rate"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_za0n4IlLlAD5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;321,813 &lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnidomMember_zIGd8gh76783" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;294,886 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231_ziCyVAdc5JXk" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opening balance"&gt;&lt;b&gt;440,597 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20241231_z5hhiKLHZf66" style="border-top: Black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable"&gt;&lt;b&gt;530,772 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Current&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_pn3n3_c20251231_zoRMpepDJVVk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;110,640 &lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersCurrent_pn3n3_c20241231_z8RKSErz3t02" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;185,318 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Non-current&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_pn3n3_c20251231_zwBpujq7o7lk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;329,957 &lt;/td&gt;
    &lt;td id="xdx_986_ecustom--AccountsPayableToSellingShareholdersNonCurrent_pn3n3_c20241231_zSuXbKLI69R1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;345,454 &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAccountsPayableToSellingShareholdersTableTextBlock>
    <afya:AccountsPayableAamortizedCostInterestRateBasis
      contextRef="From2025-01-012025-12-31_custom_UnigranrioMember"
      id="Fact003616">CDI</afya:AccountsPayableAamortizedCostInterestRateBasis>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003620"
      unitRef="BRL">90543000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:AccountsPayableAamortizedCostInterestRateBasis
      contextRef="From2025-01-012025-12-31_custom_DelReyMember"
      id="Fact003622">Selic</afya:AccountsPayableAamortizedCostInterestRateBasis>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_custom_DelReyMember"
      decimals="-3"
      id="Fact003624"
      unitRef="BRL">71604000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_custom_DelReyMember"
      decimals="-3"
      id="Fact003626"
      unitRef="BRL">125276000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:AccountsPayableAamortizedCostInterestRateBasis
      contextRef="From2025-01-012025-12-31_custom_FUNICMember"
      id="Fact003628">CDI</afya:AccountsPayableAamortizedCostInterestRateBasis>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_custom_FUNICMember"
      decimals="-3"
      id="Fact003630"
      unitRef="BRL">43843000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_custom_ShospMember"
      decimals="-3"
      id="Fact003634"
      unitRef="BRL">454000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_custom_ShospMember"
      decimals="-3"
      id="Fact003636"
      unitRef="BRL">454000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_custom_AlemDaMedicinaMember"
      decimals="-3"
      id="Fact003640"
      unitRef="BRL">9600000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_custom_CardiPapersMember"
      decimals="-3"
      id="Fact003642"
      unitRef="BRL">2883000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_custom_CardiPapersMember"
      decimals="-3"
      id="Fact003644"
      unitRef="BRL">10013000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:AccountsPayableAamortizedCostInterestRateBasis
      contextRef="From2025-01-012025-12-31_custom_UnidomMember"
      id="Fact003646">CDI</afya:AccountsPayableAamortizedCostInterestRateBasis>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_custom_UnidomMember"
      decimals="-3"
      id="Fact003648"
      unitRef="BRL">321813000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_custom_UnidomMember"
      decimals="-3"
      id="Fact003650"
      unitRef="BRL">294886000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003652"
      unitRef="BRL">440597000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003654"
      unitRef="BRL">530772000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:AccountsPayableToSellingShareholdersCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003656"
      unitRef="BRL">110640000</afya:AccountsPayableToSellingShareholdersCurrent>
    <afya:AccountsPayableToSellingShareholdersCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003658"
      unitRef="BRL">185318000</afya:AccountsPayableToSellingShareholdersCurrent>
    <afya:AccountsPayableToSellingShareholdersNonCurrent
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003660"
      unitRef="BRL">329957000</afya:AccountsPayableToSellingShareholdersNonCurrent>
    <afya:AccountsPayableToSellingShareholdersNonCurrent
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003662"
      unitRef="BRL">345454000</afya:AccountsPayableToSellingShareholdersNonCurrent>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-08-032021-08-04_custom_UnigranrioMember"
      decimals="INF"
      id="Fact003664"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NoncurrentPayablesForPurchaseOfEnergy
      contextRef="AsOf2021-08-04_custom_UnigranrioMember"
      decimals="-3"
      id="Fact003666"
      unitRef="BRL">618956000</ifrs-full:NoncurrentPayablesForPurchaseOfEnergy>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-12-292023-01-02_custom_DelReyMember"
      decimals="INF"
      id="Fact003668"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact003670"
      unitRef="BRL">234000000</afya:ConsiderationToBeTransferred>
    <afya:FirstAnnualInstallmentsPayable
      contextRef="From2022-12-292023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact003672"
      unitRef="BRL">134000000</afya:FirstAnnualInstallmentsPayable>
    <afya:SecondAnnualInstallmentsPayable
      contextRef="From2022-12-292023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact003674"
      unitRef="BRL">50000000</afya:SecondAnnualInstallmentsPayable>
    <afya:ThirdAnnualInstallmentsPayable
      contextRef="From2022-12-292023-01-02_custom_DelReyMember"
      decimals="-3"
      id="Fact003676"
      unitRef="BRL">50000000</afya:ThirdAnnualInstallmentsPayable>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2025-05-052025-05-07_custom_FUNICMember"
      decimals="INF"
      id="Fact003678"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NoncurrentPayablesForPurchaseOfEnergy
      contextRef="AsOf2025-05-07_custom_FUNICMember"
      decimals="-3"
      id="Fact003680"
      unitRef="BRL">100000000</ifrs-full:NoncurrentPayablesForPurchaseOfEnergy>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-05-122021-05-13_custom_ShospMember"
      decimals="INF"
      id="Fact003682"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-05-13_custom_ShospMember"
      decimals="-3"
      id="Fact003684"
      unitRef="BRL">513000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="AsOf2021-05-13_custom_ShospMember"
      decimals="-3"
      id="Fact003686"
      unitRef="BRL">454000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-03-032022-03-04_custom_AlemDaMedicinaMember"
      decimals="INF"
      id="Fact003688"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember"
      decimals="-3"
      id="Fact003690"
      unitRef="BRL">19200000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="AsOf2022-03-04_custom_AlemDaMedicinaMember"
      decimals="-3"
      id="Fact003692"
      unitRef="BRL">9600000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2022-04-042022-04-05_custom_CardioPapersMember"
      decimals="INF"
      id="Fact003694"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact003696"
      unitRef="BRL">15000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="AsOf2022-04-05_custom_CardioPapersMember"
      decimals="-3"
      id="Fact003698"
      unitRef="BRL">2883000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2024-06-302024-07-01_custom_UnidomMember"
      decimals="INF"
      id="Fact003700"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="AsOf2024-07-01_custom_UnidomMember"
      decimals="-3"
      id="Fact003702"
      unitRef="BRL">279989000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <afya:AccountsPayableToSellingShareholders1Explanatory contextRef="From2025-01-01to2025-12-31" id="Fact003704">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--AccountsPayableToSellingShareholders1Explanatory_ztrVH9uKlFoe" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 6)"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B5_zXqp6kpCmX4k" style="display: none"&gt;Schedule of
    accounts payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 49%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 17%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Opening balance&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zOtVHYMr1kHi" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Opening balance"&gt;&lt;b&gt;530,772&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zaejO9yWZyWh" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Opening balance"&gt;&lt;b&gt;566,867&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z462xqz8zDK1" style="border-bottom: Black 1pt solid; text-align: right" title="Opening balance"&gt;&lt;b&gt;528,678&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Additions&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zn8ME7H7tCCi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Additions consideration to be transferred on business combinations"&gt;40,000 &lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zigz5mARamFd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Additions consideration to be transferred on business combinations"&gt;279,989&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwCowbXQKk3l" style="text-align: right" title="Additions consideration to be transferred on business combinations"&gt;234,000&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Payments of principal&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z4TQgHqWmWac" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payments of principal"&gt;(144,076)&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zFzyY9CIJ1e5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payments of principal"&gt;(290,067)&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaymentsOfPrincipal_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z5bIiixptDSj" style="text-align: right" title="Payments of principal"&gt;(225,460)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Payments of interest&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zS2GT9Rsb8Vc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payment of interest"&gt;(49,608)&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zeYlP5wmZlH1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Payment of interest"&gt;(78,931)&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoFgKldgXHAa" style="text-align: right" title="Payment of interest"&gt;(55,989)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Interest&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--InterestExpense_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zdvB85FYxhK5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Interest"&gt;19,979 &lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--InterestExpense_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zrE7rcRWEn2h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Interest"&gt;37,276&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--InterestExpense_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zk1A2shaDQo9" style="text-align: right" title="Interest"&gt;85,069&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Remeasurement of contingent consideration&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RemeasurementOfEarnouts_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zjz7TBASLwof" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Remeasurement of contingent consideration"&gt;43,530 &lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RemeasurementOfEarnouts_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zwQGJEL7x3G4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Remeasurement of contingent consideration"&gt;15,638&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--RemeasurementOfEarnouts_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zoTZdqyxh2l2" style="text-align: right" title="Remeasurement of contingent consideration"&gt;2,556&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;Other&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zdoHM8oQRhsl" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3742"&gt;-&lt;/span&gt; &lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zR8s1QU08UAg" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3744"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zkOu8uRedqKd" style="border-bottom: Black 1pt solid; text-align: right" title="Other"&gt;(1,987)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Closing balance&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zTJGcfhg39xf" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Closing balance"&gt;&lt;b&gt;440,597&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20240101__20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zEt4JXbwsDbc" style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Closing balance"&gt;&lt;b&gt;530,772&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iE_pn3n3_c20230101__20231231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ztC8TeVwHVP" style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right" title="Closing balance"&gt;&lt;b&gt;566,867&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:AccountsPayableToSellingShareholders1Explanatory>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003706"
      unitRef="BRL">530772000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003708"
      unitRef="BRL">566867000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003710"
      unitRef="BRL">528678000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:AccountsPayableToSellingShareholdersBusinessCombinations
      contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003712"
      unitRef="BRL">40000000</afya:AccountsPayableToSellingShareholdersBusinessCombinations>
    <afya:AccountsPayableToSellingShareholdersBusinessCombinations
      contextRef="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003714"
      unitRef="BRL">279989000</afya:AccountsPayableToSellingShareholdersBusinessCombinations>
    <afya:AccountsPayableToSellingShareholdersBusinessCombinations
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003716"
      unitRef="BRL">234000000</afya:AccountsPayableToSellingShareholdersBusinessCombinations>
    <afya:PaymentsOfPrincipal
      contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003718"
      unitRef="BRL">144076000</afya:PaymentsOfPrincipal>
    <afya:PaymentsOfPrincipal
      contextRef="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003720"
      unitRef="BRL">290067000</afya:PaymentsOfPrincipal>
    <afya:PaymentsOfPrincipal
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003722"
      unitRef="BRL">225460000</afya:PaymentsOfPrincipal>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003724"
      unitRef="BRL">49608000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003726"
      unitRef="BRL">78931000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003728"
      unitRef="BRL">55989000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestExpense
      contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003730"
      unitRef="BRL">19979000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003732"
      unitRef="BRL">37276000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003734"
      unitRef="BRL">85069000</ifrs-full:InterestExpense>
    <afya:RemeasurementOfEarnouts
      contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003736"
      unitRef="BRL">43530000</afya:RemeasurementOfEarnouts>
    <afya:RemeasurementOfEarnouts
      contextRef="From2024-01-012024-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003738"
      unitRef="BRL">15638000</afya:RemeasurementOfEarnouts>
    <afya:RemeasurementOfEarnouts
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003740"
      unitRef="BRL">2556000</afya:RemeasurementOfEarnouts>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2023-01-012023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003746"
      unitRef="BRL">-1987000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003748"
      unitRef="BRL">440597000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003750"
      unitRef="BRL">530772000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2023-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      id="Fact003752"
      unitRef="BRL">566867000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:ScheduleOfFairValuesFinancialInstrumentstTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003754">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfFairValuesFinancialInstrumentstTableTextBlock_zaWsNnNt4Wo8" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 7)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B3_zvCQCh6mSFh8" style="display: none"&gt;Schedule of fair values of the company's financial instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt; &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 36%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 15%; text-align: right"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; text-align: right"&gt;&lt;b&gt;Carrying amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Financial liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z6mwy2GWAmLa" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at carrying amount"&gt;2,054,267 &lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zkwwMXOc6eRl" style="border-bottom: Black 1pt solid; text-align: right" title="Financial liabilities, at fair value"&gt;2,056,492 &lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zZgXKeQVxdd2" style="text-align: right" title="Financial liabilities, at carrying amount"&gt;2,195,161 &lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20241231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zy6HppqWQO7c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at fair value"&gt;2,196,152&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialLiabilities_pn3n3_c20251231_zxgafQbwzMQ7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at carrying amount"&gt;&lt;b&gt;2,054,267 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialLiabilitiesAtFairValue_pn3n3_c20251231_zTXrOYytLgt" style="border-bottom: Black 1.5pt double; text-align: right" title="Financial liabilities, at fair value"&gt;&lt;b&gt;2,056,492 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20241231_zsZax9Uj0Q5l" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; text-align: right" title="Financial liabilities, at carrying amount"&gt;&lt;b&gt;2,195,161 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilitiesAtFairValue_iI_pn3n3_c20241231_z2K7rU9FZfN9" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities, at fair value"&gt;&lt;b&gt;2,196,152&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfFairValuesFinancialInstrumentstTableTextBlock>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003756"
      unitRef="BRL">2054267000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2025-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003758"
      unitRef="BRL">2056492000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003760"
      unitRef="BRL">2195161000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2024-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003762"
      unitRef="BRL">2196152000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003764"
      unitRef="BRL">2054267000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003766"
      unitRef="BRL">2056492000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003768"
      unitRef="BRL">2195161000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003770"
      unitRef="BRL">2196152000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003772">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_zf2q7oBUugg4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 8)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BE_zNPHtsgVSAVd" style="display: none"&gt;Schedule of income before income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;Index&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;Base rate&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Cash equivalents&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zrA15uDD1pni" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;1,086,489 &lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span id="xdx_900_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zbbsq91S658k" title="Index - % per year"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zdQMczYG49Qg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;163,781 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zmZVsDbj9s5e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;(2,049,005)&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span id="xdx_904_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zVMagY5M7RPg" title="Index - % per year"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zzwxjja3r20l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;(323,480)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zbv8b2feDyzk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;(5,262)&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span id="xdx_909_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zQntQr53qNPi" title="Index - % per year"&gt;TJLP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zeCJDTfiKAWb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;(477)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Accounts payable to selling shareholders&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z6speULioNpj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;(365,656)&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span id="xdx_90F_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zkFk7JmS4N2j" title="Index - % per year"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zjLQcDfzLzH3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;(54,483)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Accounts payable to selling shareholders&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialAssets_iI_pn3n3_c20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zDc056qLG1Y7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;(71,604)&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span id="xdx_901_ecustom--IndexRatePerYear_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zmeiYYfhn45j" title="Index - % per year"&gt;Selic&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--BaseRate_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersTwoMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zTFiBj48wHSj" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;(10,669)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Net exposure&lt;/b&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--BaseRate_pn3n3_c20250101__20251231_zxkYdR3fXnsi" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;b&gt;(225,328)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;b&gt;Increase in basis points&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;+75&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;+150&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Net effect on profit before tax&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zU05K3J0Pjdj" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax"&gt;(10,538)&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_pn3n3_c20250101__20251231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z6mnSGiXUo5g" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Effect on profit before tax"&gt;(21,076)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact003774"
      unitRef="BRL">1086489000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear
      contextRef="From2025-01-012025-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      id="Fact003776">CDI</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2025-01-012025-12-31_custom_CashEquivalents1Member_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact003778"
      unitRef="BRL">163781000</afya:BaseRate>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact003780"
      unitRef="BRL">-2049005000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear
      contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      id="Fact003782">CDI</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact003784"
      unitRef="BRL">-323480000</afya:BaseRate>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact003786"
      unitRef="BRL">-5262000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear
      contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      id="Fact003788">TJLP</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact003790"
      unitRef="BRL">-477000</afya:BaseRate>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact003792"
      unitRef="BRL">-365656000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear
      contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      id="Fact003794">CDI</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact003796"
      unitRef="BRL">-54483000</afya:BaseRate>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2025-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact003798"
      unitRef="BRL">-71604000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear
      contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      id="Fact003800">Selic</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2025-01-012025-12-31_custom_AccountsPayableToSellingShareholdersTwoMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact003802"
      unitRef="BRL">-10669000</afya:BaseRate>
    <afya:BaseRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003804"
      unitRef="BRL">-225328000</afya:BaseRate>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2025-01-012025-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact003806"
      unitRef="BRL">-10538000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2025-01-012025-12-31_custom_CashEquivalents1Member_custom_IncreaseBasisPointsOneMember_ifrs-full_FloatingInterestRateMember_ifrs-full_InterestRateRiskMember"
      decimals="-3"
      id="Fact003808"
      unitRef="BRL">-21076000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <afya:CreditExposures
      contextRef="AsOf2025-12-31_ifrs-full_CurrencyRiskMember"
      decimals="-3"
      id="Fact003810"
      unitRef="BRL">23422000</afya:CreditExposures>
    <afya:CreditExposures
      contextRef="AsOf2024-12-31_ifrs-full_CurrencyRiskMember"
      decimals="-3"
      id="Fact003812"
      unitRef="BRL">21610000</afya:CreditExposures>
    <afya:SensitivityChangeInTheEuroExchangeRate
      contextRef="From2025-01-012025-12-31_ifrs-full_CurrencyRiskMember"
      decimals="INF"
      id="Fact003814"
      unitRef="Pure">0.10</afya:SensitivityChangeInTheEuroExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="AsOf2025-12-31_ifrs-full_CurrencyRiskMember"
      decimals="INF"
      id="Fact003816"
      unitRef="N">5.5018</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="AsOf2025-12-31_currency_EUR_ifrs-full_CurrencyRiskMember"
      decimals="INF"
      id="Fact003818"
      unitRef="N">1.00</ifrs-full:ClosingForeignExchangeRate>
    <afya:SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003820">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_zb2oG5xFCrXf" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 9)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8BC_zcdunEBlLHa9" style="display: none"&gt;Schedule of sensitivity foreign currency&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 49%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;Exposure&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;+10%&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;-10%&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Cash equivalents&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zrjBauUu3ul3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;23,422 &lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zAEuZErKtdkc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;2,342 &lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_pn3n3_c20250101__20251231__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_z3gubqkXuT0k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;(2,342)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2025-01-012025-12-31_custom_ForeignCurrencyExposuresMember_ifrs-full_CurrencyRiskMember"
      decimals="-3"
      id="Fact003822"
      unitRef="BRL">23422000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2025-01-012025-12-31_custom_IncreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember"
      decimals="-3"
      id="Fact003824"
      unitRef="BRL">2342000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2025-01-012025-12-31_custom_DecreaseForeignCurrencyMember_ifrs-full_CurrencyRiskMember"
      decimals="-3"
      id="Fact003826"
      unitRef="BRL">-2342000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <afya:SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003828">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_zlPRrzpky833" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 10)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BB_zvmS6iwPiNRl" style="display: none"&gt;Schedule of maturity profile of financial liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;As of December 31, 2025 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Less than 1 year&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;1 to 3 years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;3 to 5 years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;More than 5 years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="color: #222222"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Trade payables&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zFNRL9fH6a25" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;123,581 &lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zqzNeDCGV9T" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3832"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z7WfLovmFZbe" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3834"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztQJUTZkLyFk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3836"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zSLHywHPJ24l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;123,581 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z4d53RHtL1Wl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;308,292 &lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmk3Yp8XSZUl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;1,360,411 &lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcGC5AiqwmP9" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;1,473,733 &lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zb2ovbIa8IMh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3846"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LoansAndFinancing_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_za9LadJEq9db" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;3,142,436 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z75BJ7Wxsg3g" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;178,638 &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeWz7OcSCtTb" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;347,847 &lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2ydSLgnAhRa" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;331,019 &lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_ztypRWgxaSSg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;1,342,713 &lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LeaseLiabilities_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zoNOa3bY0JQ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;2,200,217 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Accounts payable to selling shareholders&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2FpJZ9DRzZ7" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;126,307 &lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2Mq143BlYX3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;131,446 &lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGwmVXkw2aU3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;185,821 &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z2w3RgNl0xs5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;502,355 &lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zUSnIFNlp12h" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;945,929 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvDmmPQnN9fb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;736,818 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zwyNtX3MoPBe" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,839,704 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgXMgQ64ffSe" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,990,573 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z4Pv9XYrLA68" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,845,068 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_pn3n3_c20251231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_znoWOLTGKGG7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;6,412,163 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;As of December 31, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Less than 1 year&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;1 to 3 years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;3 to 5 years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;More than 5 years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="color: #222222"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Trade payables&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zK67vmK9kYWg" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;128,080 &lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z3GYF1pkIKs7" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3882"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zHxblqQ7dHB3" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3884"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zgaXtjjdLgp5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3886"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zHr12gbM9Ejf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;128,080 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Loans and financing&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zYPHdM6YwmQ8" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;526,659 &lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zjaUH06nPRTl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;1,494,287 &lt;/td&gt;
    &lt;td id="xdx_985_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z24hWxMtpVKh" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;617,818 &lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z6MrqSHuPOPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;75,526 &lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zGHnFZjWePXh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;2,714,290 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zSmfkiuF7NG5" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;158,746 &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zpbidtQS0Fp5" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;303,211 &lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zCpTp9UABDul" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;293,178 &lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zA0ILEgs1OY9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;1,360,107 &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zaFH7tK4Aav1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;2,115,242 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Accounts payable to selling shareholders&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zAvtxN2ym6Uc" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;205,322 &lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zLsuZQxTUlvi" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;150,565 &lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z26HD8qrCuul" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;99,100 &lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zt61WVDLJHB8" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;373,498 &lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zVzHZ5fuAol5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;828,485 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_z78KMxuHMQCb" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,018,807 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zmmRjyOUb2Kc" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,948,063 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zzG4uph8O9W5" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,010,096 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zlTL7c9tc2w" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;1,809,131 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_pn3n3_c20241231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zuVCIo9EUJnf" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;b&gt;5,786,097 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</afya:SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003830"
      unitRef="BRL">123581000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003838"
      unitRef="BRL">123581000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003840"
      unitRef="BRL">308292000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003842"
      unitRef="BRL">1360411000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003844"
      unitRef="BRL">1473733000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003848"
      unitRef="BRL">3142436000</afya:LoansAndFinancing>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003850"
      unitRef="BRL">178638000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003852"
      unitRef="BRL">347847000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003854"
      unitRef="BRL">331019000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003856"
      unitRef="BRL">1342713000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003858"
      unitRef="BRL">2200217000</ifrs-full:LeaseLiabilities>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003860"
      unitRef="BRL">126307000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003862"
      unitRef="BRL">131446000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003864"
      unitRef="BRL">185821000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003866"
      unitRef="BRL">502355000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003868"
      unitRef="BRL">945929000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003870"
      unitRef="BRL">736818000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003872"
      unitRef="BRL">1839704000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003874"
      unitRef="BRL">1990573000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003876"
      unitRef="BRL">1845068000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2025-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003878"
      unitRef="BRL">6412163000</afya:FinancialLiabilitiesContractualUndiscounted>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003880"
      unitRef="BRL">128080000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003888"
      unitRef="BRL">128080000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003890"
      unitRef="BRL">526659000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003892"
      unitRef="BRL">1494287000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003894"
      unitRef="BRL">617818000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003896"
      unitRef="BRL">75526000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003898"
      unitRef="BRL">2714290000</afya:LoansAndFinancing>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003900"
      unitRef="BRL">158746000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003902"
      unitRef="BRL">303211000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003904"
      unitRef="BRL">293178000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003906"
      unitRef="BRL">1360107000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003908"
      unitRef="BRL">2115242000</ifrs-full:LeaseLiabilities>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003910"
      unitRef="BRL">205322000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003912"
      unitRef="BRL">150565000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003914"
      unitRef="BRL">99100000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003916"
      unitRef="BRL">373498000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003918"
      unitRef="BRL">828485000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003920"
      unitRef="BRL">1018807000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003922"
      unitRef="BRL">1948063000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003924"
      unitRef="BRL">1010096000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2024-12-31_ifrs-full_LaterThanFiveYearsMember_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003926"
      unitRef="BRL">1809131000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2024-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      id="Fact003928"
      unitRef="BRL">5786097000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact003932">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock_z8kQs7hpzSya" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Financial assets and liabilities (Details 11)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span id="xdx_8B7_zZMIgodaQ9w4" style="display: none"&gt;Schedule of changes in liabilities arising from financing activities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.55pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.85pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.85pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.55pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;January 1, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Payments of principal&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Payments of interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Additions and remeasurements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zNA3f0cYJtea" style="padding-right: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;2,195,161&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zBOHFfbu0WLk" style="padding-right: 2.55pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(1,624,911)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zoM0dpID9092" style="padding-right: 2.85pt; text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;(274,265)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zfy41l2ZmVW7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;1,494,881&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zL6iIrp0H5K" style="text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;252,870&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zZv3GviSRJm7" style="text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;10,531&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbF8AF1o1TZg" style="padding-right: 5.55pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;2,054,267&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zu009vAZvI8k" style="padding-right: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;978,336&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zEWih0Bgtcic" style="padding-right: 2.55pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(49,411)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zymGryeACWE8" style="padding-right: 2.85pt; text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;(121,475)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z0GSRMmdqvKl" style="padding-right: 3.85pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;136,714&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_ziiUPemjPDy7" style="text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;123,067&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zLUKEqMy2PCh" style="text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;(1,485)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zs5KiVN6Aop" style="padding-right: 5.55pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;1,065,746&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -0.1pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zkdrSnZEsdeg" style="border-bottom: Black 1pt solid; padding-right: -2.45pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(146,813)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zIzXu7nINfsa" style="border-bottom: Black 1pt solid; padding-right: 2.85pt; text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3964"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zSKFp8AK9nof" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;147,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -1.15pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zfGZctHTOnVk" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;192&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20250101__20251231_z2WFPiVmqtNg" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,173,497&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zW2OqeMp5wTj" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(1,821,135)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20250101__20251231_zyK9JtYRGFM7" style="border-bottom: Black 1.5pt double; padding-right: 2.85pt; text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(395,740)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zLboev8UMJL5" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;1,778,600&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zc6UOhD4NaZ8" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;375,937&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20250101__20251231_zic6RnozFOs4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;9,046&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20250101__20251231_zsWujkEPTGf7" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,120,205&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;January 1, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Payments of principal&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Payments of interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Additions and remeasurements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Business combination&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zKLN9ka4wkFa" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;1,800,775&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zpd5ABoY3Ux8" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(128,696)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zWkWQ3p4CjV5" style="text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;(177,192)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbKqCmIGWnCi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;491,593&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIt7RnMFRZs2" style="padding-right: 5.65pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;201,472&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znWYrJAD8V98" style="text-align: right" title="Business combination"&gt;&lt;span style="font-size: 7.5pt"&gt;4,377&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zgrkIU4AjEdc" style="padding-right: 5.65pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;2,832&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIa2SyBR9xF1" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;2,195,161&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zrJRlVf7rEZ2" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;874,569&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJdqASoXhjH9" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(41,221)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zWU57RmUQDsi" style="text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;(111,605)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zWW85cX3A2Wd" style="padding-right: 5.65pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;117,897&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zAk44Z8kjpG8" style="padding-right: 5.65pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;111,966&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxVzCn18NZsi" style="text-align: right" title="Business combination"&gt;&lt;span style="font-size: 7.5pt"&gt;28,989&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zwRNvkPWEvc2" style="padding-right: 5.65pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;(2,259)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zyna1kzChKhf" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;978,336&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zKUpL8DtHOc6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(18,289)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ztZphFGnuay5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;18,289&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.65pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20240101__20241231_zTqseykaZ2Q" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;2,675,344&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z0g21NsOOJQe" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(188,206)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20240101__20241231_zWZQUxdK7b7d" style="border-bottom: Black 1.5pt double; text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(288,797)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zRV633tmfSy4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;627,779&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_zFAZPF3WKB9e" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;313,438&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z1u2drMUfPgb" style="border-bottom: Black 1.5pt double; text-align: right" title="Business combination"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;33,366&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20240101__20241231_z33QO5joSqkl" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;573&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20240101__20241231_zeXUegstGWO9" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;3,173,497&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Payments of principal&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Payments of interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Additions and remeasurements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Business combination&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zAbvHkGuABqk" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;1,882,901&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zep7lXZTg8Lk" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(112,630)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzIM7vMREBXk" style="text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;(175,889)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z6oaoM6rGxYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;5,288&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z1Se6OcaDRl1" style="padding-right: 5.65pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;197,678&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.65pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zEnAymCsmtjl" style="padding-right: 5.65pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;3,427&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_ztYE4ee2JSN1" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;1,800,775&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zfZOL2E5IoR" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;769,525&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zCjCw1AzLStf" style="padding-right: 5.65pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(31,473)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zhNowFen9q4i" style="text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;(103,911)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_za0sgkcc3XC3" style="padding-right: 5.65pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;77,715&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zOIVXQn4FXFg" style="padding-right: 5.65pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;100,849&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zdefxndxLZu4" style="padding-right: 5.65pt; text-align: right" title="Business combination"&gt;&lt;span style="font-size: 7.5pt"&gt;65,408&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zvUshu3gYp11" style="padding-right: 5.65pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;(3,544)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zxmeQ7tHH9j1" style="padding-right: 5.65pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;874,569&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-size: 7.5pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ztWQV1suQKy2" style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;(18,750)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zuw744fAB3b5" style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right" title="Addition"&gt;&lt;span style="font-size: 7.5pt"&gt;18,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.65pt; text-align: right"&gt;&lt;span style="font-size: 7.5pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_pn3n3_c20230101__20231231_zGstjq78Ltrk" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;2,652,426&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z3dzHL0Ons9f" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments of principal"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(162,853)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InterestPaidClassifiedAsFinancingActivities_iN_pn3n3_di_c20230101__20231231_zwhQDlB760Mc" style="border-bottom: Black 1.5pt double; text-align: right" title="Payments of interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(279,800)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zggXI22NMHrb" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions and remeasurements"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;101,753&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zqJhwB3cVi18" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;298,527&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_z33wsgDVjiD8" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;65,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_pn3n3_c20230101__20231231_zJYub1gEgp12" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;(117)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_pn3n3_c20230101__20231231_z2j0PmtDGP03" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-size: 7.5pt"&gt;&lt;b&gt;2,675,344&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesTableTextBlock>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2024-12-31_custom_LoansAndFinancingMember197490421"
      decimals="-3"
      id="Fact003934"
      unitRef="BRL">2195161000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003936"
      unitRef="BRL">-1624911000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003938"
      unitRef="BRL">274265000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003940"
      unitRef="BRL">1494881000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003942"
      unitRef="BRL">252870000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003944"
      unitRef="BRL">10531000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2025-12-31_custom_LoansAndFinancingMember197490453"
      decimals="-3"
      id="Fact003946"
      unitRef="BRL">2054267000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003948"
      unitRef="BRL">978336000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003950"
      unitRef="BRL">-49411000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003952"
      unitRef="BRL">121475000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003954"
      unitRef="BRL">136714000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003956"
      unitRef="BRL">123067000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003958"
      unitRef="BRL">-1485000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2025-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact003960"
      unitRef="BRL">1065746000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact003962"
      unitRef="BRL">-146813000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-012025-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact003966"
      unitRef="BRL">147005000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2025-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact003968"
      unitRef="BRL">192000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact003970"
      unitRef="BRL">3173497000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003972"
      unitRef="BRL">-1821135000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003974"
      unitRef="BRL">395740000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003976"
      unitRef="BRL">1778600000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003978"
      unitRef="BRL">375937000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact003980"
      unitRef="BRL">9046000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact003982"
      unitRef="BRL">3120205000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003984"
      unitRef="BRL">1800775000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003986"
      unitRef="BRL">-128696000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003988"
      unitRef="BRL">177192000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003990"
      unitRef="BRL">491593000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003992"
      unitRef="BRL">201472000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003994"
      unitRef="BRL">4377000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact003996"
      unitRef="BRL">2832000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2024-12-31_custom_LoansAndFinancingMember197490421"
      decimals="-3"
      id="Fact003998"
      unitRef="BRL">2195161000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004000"
      unitRef="BRL">874569000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004002"
      unitRef="BRL">-41221000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004004"
      unitRef="BRL">111605000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004006"
      unitRef="BRL">117897000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004008"
      unitRef="BRL">111966000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004010"
      unitRef="BRL">28989000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004012"
      unitRef="BRL">-2259000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2024-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004014"
      unitRef="BRL">978336000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact004016"
      unitRef="BRL">-18289000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact004018"
      unitRef="BRL">18289000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004020"
      unitRef="BRL">2675344000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004022"
      unitRef="BRL">-188206000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004024"
      unitRef="BRL">288797000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004026"
      unitRef="BRL">627779000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004028"
      unitRef="BRL">313438000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004030"
      unitRef="BRL">33366000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004032"
      unitRef="BRL">573000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact004034"
      unitRef="BRL">3173497000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2022-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004036"
      unitRef="BRL">1882901000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004038"
      unitRef="BRL">-112630000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004040"
      unitRef="BRL">175889000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004042"
      unitRef="BRL">5288000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004044"
      unitRef="BRL">197678000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004046"
      unitRef="BRL">3427000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      id="Fact004048"
      unitRef="BRL">1800775000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2022-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004050"
      unitRef="BRL">769525000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004052"
      unitRef="BRL">-31473000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004054"
      unitRef="BRL">103911000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004056"
      unitRef="BRL">77715000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004058"
      unitRef="BRL">100849000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004060"
      unitRef="BRL">65408000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004062"
      unitRef="BRL">-3544000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      id="Fact004064"
      unitRef="BRL">874569000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact004066"
      unitRef="BRL">-18750000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31_custom_DividendsPayableMember"
      decimals="-3"
      id="Fact004068"
      unitRef="BRL">18750000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004070"
      unitRef="BRL">2652426000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004072"
      unitRef="BRL">-162853000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004074"
      unitRef="BRL">279800000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004076"
      unitRef="BRL">101753000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004078"
      unitRef="BRL">298527000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004080"
      unitRef="BRL">65408000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004082"
      unitRef="BRL">-117000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004084"
      unitRef="BRL">2675344000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <afya:CapitalManagementExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004086">&lt;p id="xdx_803_ecustom--CapitalManagementExplanatory_zzLvrfn0psv7" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;13&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_829_zeL97GfOrAR"&gt;Capital management&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;For the purposes of the Company&#x2019;s capital management, capital
considers total equity. The primary objective of the Company&#x2019;s capital management is to maximize shareholder value.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;In order to achieve its overall objective, the Company&#x2019;s
capital management, among other things, aims to ensure that it meets financial and non-financial covenants under the debentures and other
loans and financing. Breaches in meeting the financial covenants would permit the bank to immediately call loans and financing. There
have been no breaches of the financial and non-financial covenants of any loans and financing in the current and previous years.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;No changes were made in the objectives, policies or processes
for managing capital during the year ended December 31, 2025.&lt;/p&gt;

</afya:CapitalManagementExplanatory>
    <afya:LaborAndSocialObligationsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004088">&lt;p id="xdx_806_ecustom--LaborAndSocialObligationsExplanatory_z9oHMjVdS73f" style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;14&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_829_zb3Ygm8zrTj2"&gt;Labor and social obligations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;a) Variable compensation (bonuses)&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;span style="font-weight: normal"&gt;The bonuses related to variable compensation of employees
and management of R$&lt;span id="xdx_907_ecustom--ShareBasedCompensationOfEmployees_pn3n3_c20250101__20251231_zdgwUTT1k7nd" title="Compensation of employees"&gt;56,581&lt;/span&gt;, R$&lt;span id="xdx_90E_ecustom--ShareBasedCompensationOfEmployees_c20240101__20241231_pn3n3" title="Compensation of employees"&gt;35,857&lt;/span&gt; and R$&lt;span id="xdx_90C_ecustom--ShareBasedCompensationOfEmployees_c20230101__20231231_pn3n3" title="Compensation of employees"&gt;22,185&lt;/span&gt; are recognized in cost of services and selling, general and administrative expenses
in the consolidated statement of income and other comprehensive income for the years ended December 31, 2025, 2024 and 2023, respectively.&lt;br/&gt;
&lt;/span&gt;&lt;/p&gt;






&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;b) Afya Limited share-based compensation plans&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;b&gt;b.1) Stock options plan&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;span style="font-weight: normal"&gt;The stock options plan was approved on August 30, 2019
and granted to senior executives and other employees of the Company from that date, with subsequent changes in the exercise price, as
approved, on July 29, 2020, July 8, 2022 and July 31, 2023. Such changes were assessed as modifications by the Company and were accounted
in accordance with IFRS 2.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;During the years ended December 31, 2025, 2024 and 2023 the Company had the following grants
of stock options to its executives:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfFairValueOfStockOptionsGrantsExplanatory_zvhZDc74HnA6" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B3_zGgNPB2SqyUj" style="display: none"&gt;Schedule of grants
of stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z6T0fZrOvqI5" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zK235Tb9bNp2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zNZa1lSl2609" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zNvkL1rYPUsa" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zs3ztMRbK1Bc" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHa3XnkjJA68" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3OIbkyhLU5h" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zfs4Xs9Cb3H4" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;November&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;April&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;October&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;December&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;October&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;August&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;April&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;February&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement_pn3n3_zWqzUVBwknDh" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Amount&lt;/td&gt;
    &lt;td style="text-align: right"&gt;692,000&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;60,000 &lt;/td&gt;
    &lt;td style="text-align: right"&gt;113,900&lt;/td&gt;
    &lt;td style="text-align: right"&gt;232,000&lt;/td&gt;
    &lt;td style="text-align: right"&gt;37,000&lt;/td&gt;
    &lt;td style="text-align: right"&gt;153,000&lt;/td&gt;
    &lt;td style="text-align: right"&gt;30,000&lt;/td&gt;
    &lt;td style="text-align: right"&gt;15,000&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--SharePriceFairValueAtMeasurementDate_pip0_zt6sMhDJPCK6" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Exercise price at the measurement date&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$62.57&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$79.91&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$73.75&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$60&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$59&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$59&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$57&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$56&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pip0_dp_zaQHGtSd4vK6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Dividend yield (%)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0.0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0.0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0.0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0.0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0.0%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Expected volatility (%)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z3a2zokWHkni" title="Expected volatility"&gt;24&lt;/span&gt;-&lt;span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zhYY03hXbIyk" title="Expected volatility"&gt;41&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zmkAxaOJEPd2" title="Expected volatility"&gt;35&lt;/span&gt;-&lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTPzINAqPsrj" title="Expected volatility"&gt;44&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zRDwFMzwknRb" title="Expected volatility"&gt;32&lt;/span&gt;-&lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTaePcHfivNe" title="Expected volatility"&gt;45&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zsLUc0A16E82" title="Expected volatility"&gt;34&lt;/span&gt;-&lt;span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvQqfh9Pafxb" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zdJiyIN9wYk6" title="Expected volatility"&gt;44&lt;/span&gt;-&lt;span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zD39cWsDcLQ1" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOSZrXlcyZD3" title="Expected volatility"&gt;47&lt;/span&gt;-&lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0TpV4isUZ76" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zzLnpWvuvqO2" title="Expected volatility"&gt;48&lt;/span&gt;-&lt;span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zeEOMDZRaeG8" title="Expected volatility"&gt;55&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDvwBftIf02h" title="Expected volatility"&gt;46&lt;/span&gt;-&lt;span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zbgyNuZPYWqg" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Risk-free interest rate (%)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zXhzqbtNwI24" title="Risk-free interest rate"&gt;13&lt;/span&gt;-&lt;span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zK64lbUpWev2" title="Risk-free interest rate"&gt;15&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zL4FuMa3ygfe" title="Risk-free interest rate"&gt;14&lt;/span&gt;-&lt;span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zpQqpMVYktCe" title="Risk-free interest rate"&gt;15&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8UuU76vuby2" title="Risk-free interest rate"&gt;11&lt;/span&gt;-&lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZNJzCKOJZ7g" title="Risk-free interest rate"&gt;13&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zWqmaTXFX4I1" title="Risk-free interest rate"&gt;10&lt;/span&gt;-&lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z3zFmkt2PGP4" title="Risk-free interest rate"&gt;11&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zSg6N5dHPT0l" title="Risk-free interest rate"&gt;11&lt;/span&gt;-&lt;span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zmZaF4bP4NKg" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zUFWKlQGKDx3" title="Risk-free interest rate"&gt;10&lt;/span&gt;-&lt;span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z4JquBKNxWlc" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLYSuS7KNh63" title="Risk-free interest rate"&gt;11&lt;/span&gt;-&lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zI0vJM6gywRj" title="Risk-free interest rate"&gt;13&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zAJASHq0BBGh" title="Risk-free interest rate"&gt;13&lt;/span&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Expected life of stock options (years)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0jLLW2lU6J3" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_90A_ecustom--ExpectedLifeOfStockOptions_dtY_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zcXSWBKRKiVi" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zJ5SPoXZEyX6" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_90C_ecustom--ExpectedLifeOfStockOptions_dtY_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z9CG5kRjj7C" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ExpectedLifeOfStockOptions_dtY_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo1yo9kxDfY5" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zpwNuy5S3Tsf" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ExpectedLifeOfStockOptions_dtY_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zUUeOhGyCg0i" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_908_ecustom--ExpectedLifeOfStockOptions_dtY_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zKlUUVd2lpKh" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ExpectedLifeOfStockOptions_dtY_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLCObi1GJ524" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zp9XJ1CqRkm7" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCcJKVef1vV9" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_znWUS3p2NLj" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zXgdDziYvER" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zh9QH7khRfM8" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0NENZi2yMJ4" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z7FWqTwEwbs" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_pip0_zhSqRAp2Tre1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Share price at the measurement date&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$79.36&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$107.33&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$92.78&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$100.97&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$79.12&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$76.45&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$62.51&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$70.69&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_i" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Valuation model&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_pip0_z80Gu2ZEmFnh" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt"&gt;Weighted average fair value at the measurement date&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$33.27&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$45.95&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$39.71&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$54.25&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$38.67&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$37.04&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$32.04&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$29.54&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zOZCJZH2NT0c" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;The table below presents the number and movements in stock options
for the years ended December 31, 2025, 2024 and 2023:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfSharebasedCompensationPlanExplanatory_pn3n3_zFzoezmEhTV9" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span id="xdx_8B0_zLGkJU0tLkH5" style="display: none"&gt;Schedule of movements in stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td rowspan="2" style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;Weighted average exercise price&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;(in Brazilian Reais)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;
    &lt;p style="border-bottom: Black 1pt solid; font: 8.5pt Nunito Sans; margin: 0; text-align: center"&gt;&lt;b&gt;Number of stock options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 39%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 28%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 11%; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Outstanding at January 1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zraIJSzFCkke" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Outstanding at the beginning"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;67.31&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zO4kayTsCld6" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;1,610,679&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z5Q8ZFRA9Wtf" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;1,696,064&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHZagAo9RIX5" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;3,729,287&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zD1ZddyRkMke" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Granted"&gt;&lt;span style="font-size: 8.5pt"&gt;63.95&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zarVmL6ef2xg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-size: 8.5pt"&gt;752,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z1kiz2uCbBz6" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-size: 8.5pt"&gt;113,900&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3IAUYRtt7q7" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-size: 8.5pt"&gt;467,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zpu4iEOMKoS1" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercised"&gt;&lt;span style="font-size: 8.5pt"&gt;63.62&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zxT2Mq5vrGY2" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-size: 8.5pt"&gt;(404,478)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGKd39zZRU7l" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-size: 8.5pt"&gt;(147,955)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z9ZGh8Sebarh" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-size: 8.5pt"&gt;(164,214)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Stock options exchanged to RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_iI_pip0_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHdtqCer9AEf" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercised"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4273"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zhsjUI4JlqAh" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, stock option exchanged"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4275"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmV62YvwqcVd" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, stock option exchanged"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4277"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGxPS01O5x75" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, stock option exchanged"&gt;&lt;span style="font-size: 8.5pt"&gt;(1,751,599)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zaKvtHUKDlW8" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Forfeited"&gt;&lt;span style="font-size: 8.5pt"&gt;72.42&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_ze6ykiFid7Kg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-size: 8.5pt"&gt;(57,152)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zsidkfnTT7h4" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-size: 8.5pt"&gt;(16,182)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zMsaiNPv6mCi" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-size: 8.5pt"&gt;(333,111)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Expired&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z8mHAL7v4bZe" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Expired"&gt;&lt;span style="font-size: 8.5pt"&gt;68.54&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zPcEiMVVab3c" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"&gt;&lt;span style="font-size: 8.5pt"&gt;(57,680)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z91sTDJENHc4" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Expired"&gt;&lt;span style="font-size: 8.5pt"&gt;(35,148)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zQJsLxD7amw3" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"&gt;&lt;span style="font-size: 8.5pt"&gt;(251,299)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zATYUtVrdlh7" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Outstanding at the ending"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;65.91&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z2mW4KaitVZd" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;1,843,369&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGitrYnMUbB8" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;1,610,679&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zV27MvxAdFne" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;1,696,064&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pip0_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmDdNrIKSON5" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercisable"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;71.33&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zLVpGQ22dOC4" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;340,219&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zsJMf5UO94M6" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;427,202&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zK2nhsM4tARb" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;242,235&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zi6sz3L98kml" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;The share-based compensation expense recognized in selling, general
and administrative expenses in the consolidated statement of income and other comprehensive income for the year ended December 31, 2025
was R$&lt;span id="xdx_90B_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_z4t4P7XGUVG1" title="Share-based compensation expense"&gt;4,809&lt;/span&gt; (R$&lt;span id="xdx_90A_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zhR2rKvMLxCl" title="Share-based compensation expense"&gt;17,394&lt;/span&gt; and R$&lt;span id="xdx_909_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_z7LpqbyqduNc" title="Share-based compensation expense"&gt;20,850&lt;/span&gt; in 2024 and 2023, respectively).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white; color: #C00000"&gt;&lt;b&gt;b.2) Restricted Stock Units (RSU) Program&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;On July 8, 2022, the Company approved the Restricted Stock Units
program for its employees. The participant's right to effectively receive ownership of the restricted stock units will be conditioned
on the participant's continuance as an employee or director in the business group from the grant date until vesting. The executives will
be entitled to these shares in a proportion of &lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pip0_dp_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z8GSA5kB6JC9" title="Proportion percentage"&gt;10&lt;/span&gt;%, &lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pip0_dp_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits1Member_zS5bG2c1d0lb" title="Proportion percentage"&gt;20&lt;/span&gt;%, &lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pip0_dp_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits2Member_z7jjDJ0jHrY" title="Proportion percentage"&gt;30&lt;/span&gt;%, &lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pip0_dp_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnits3Member_ztL7nW4Klxq1" title="Proportion percentage"&gt;40&lt;/span&gt;% each year.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company accounts for the RSU plan as an equity-settled plan, except for the portion
of labor and social securities obligations.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;During the years ended December 31, 2025, 2024 and 2023 the Company
had the following grants of RSUs to its executives:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfGrantsRestrictedStockUnitsTableTextBlock_zV48BfBx6yL5" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details 2)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt"&gt;&lt;span id="xdx_8BC_zuLxXAoP3M1" style="display: none"&gt;Schedule of grants
of RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;November&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;April&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;October&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;December&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;October&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;August&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;April&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;February&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Amount&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_zICCFZgsdfx2" style="text-align: right" title="Granted"&gt;346,000&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_z6wKGwWz9FZk" style="text-align: right" title="Granted"&gt;35,000&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zMXEDJuS1bJj" style="text-align: right" title="Granted"&gt;44,500&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_ztVtzmnIuLG6" style="text-align: right" title="Granted"&gt;76,600&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zpal9jAuBLck" style="text-align: right" title="Granted"&gt;63,000&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zE0O4ptKVl31" style="text-align: right" title="Granted"&gt;153,490&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zhqa0iPvtezk" style="text-align: right" title="Granted"&gt;16,000&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_z9yQzaTS6Xni" style="text-align: right" title="Granted"&gt;8,000&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="background-color: White"&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt"&gt;Weighted average fair value at the measurement date&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_zWCPmhNdYxJ5" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$79.36&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_zYJr10Oa09M7" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$107.33&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zJGGHwdVffZ6" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$92.78&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zNvnzT4Y0cn7" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$100.97&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zNMqQFYVlTlj" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$79.12&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zieMWlWClbXe" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$76.45&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zACW5bG8T6c5" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$62.51&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zHw7SUIVdxTg" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$70.69&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Vesting period (years)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_znAcmh3mMXpd" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_90A_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_z8OXOynCf8J1" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_zPILF04KSlvk" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_z3MS7RGKoXof" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--GrantedVestingPeriod_dtY_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zphrbhAzCoq8" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_905_ecustom--GrantedVestingPeriod_dtY_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_z7dAnJ3MghPc" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zaLtoQSJ7M5a" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_904_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zVKrezoWsjae" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zYwjdE4YIn46" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_905_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_z02xbUIzr3Gj" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zqm69NMWJsNb" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_90A_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zqGjtgM78qVf" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zKkh2qfBvsD" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_90E_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_znKKKNNMnb5l" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zBt1kX2xCEok" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zjJb7xEFaRql" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AB_zGQ4BkuzLlCb" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The table below presents the number and movements in RSUs for the years ended December
31, 2025, 2024 and 2023:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfStockOptionTableTextBlock_pn3n3_zcaFvNJVhna3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details 3)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;&lt;span id="xdx_8B7_zcQK8v9WNAh7" style="display: none"&gt;Schedule of stock option&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 49%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;&lt;b&gt;Outstanding at January 1&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zKQADaIQ2OK3" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;b&gt;656,634&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zva28bMgxnV3" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;b&gt;854,431&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zCE4lHvJhfBj" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;b&gt;447,224&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;Granted&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zXCsaRfq2Moj" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Granted"&gt;381,000&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zIySk7IVqJo7" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Granted"&gt;44,500&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zYh56vwbBwEi" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Granted"&gt;317,090&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;Stock options exchanged to RSUs&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zIXJzIvwsL02" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4409"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z4ggG1ljDdj5" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4411"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z46Le5Md8Qi1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;215,797&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;Exercised&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z64yoxIWwf72" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Exercised"&gt;(224,070)&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zP2UEEmgRBZg" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Exercised"&gt;(222,910)&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z5CCL3T5mK66" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Exercised"&gt;(99,576)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;Expired&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zylOPFGb2J18" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Forfeited"&gt;(93,846)&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zaMTLE4Mao49" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Forfeited"&gt;(19,387)&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z0wLJ1wZxyMk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Forfeited"&gt;(26,104)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zb2Uk8Lq4n7k" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;b&gt;719,718&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zNE4wQnNJZ65" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;b&gt;656,634&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zXzCqgWBYC7" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;b&gt;854,431&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A4_zsNMEv2rjU5c" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Total RSU expenses recognized in selling, general and administrative expenses in the consolidated
statement of income and other comprehensive income for the year ended December 31, 2025 were R$&lt;span id="xdx_903_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z7iqg38g1MBh" title="Share-based compensation expense"&gt;10,509&lt;/span&gt; (R$&lt;span id="xdx_90C_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z9hV6vWmtrv7" title="Share-based compensation expense"&gt;15,030&lt;/span&gt; and R$&lt;span id="xdx_908_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zLUEh3KzsXV5" title="Share-based compensation expense"&gt;10,685&lt;/span&gt; in 2024 and
2023, respectively). Labor and social obligations expenses were R$&lt;span id="xdx_908_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20251231_zN29wCxaLLnh" title="Social obligations liabilities"&gt;2,660&lt;/span&gt;, R$&lt;span id="xdx_90C_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20241231_znQzFlSoSb19" title="Social obligations liabilities"&gt;8,988&lt;/span&gt; and R$&lt;span id="xdx_904_ecustom--SocialObligationsLiabilities_iI_pn3n3_c20231231_zpMY7vO1TUbj" title="Social obligations liabilities"&gt;7,177&lt;/span&gt; for the years ended December 31, 2025, 2024
and 2023, respectively.&lt;/p&gt;

</afya:LaborAndSocialObligationsExplanatory>
    <afya:ShareBasedCompensationOfEmployees
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004090"
      unitRef="BRL">56581000</afya:ShareBasedCompensationOfEmployees>
    <afya:ShareBasedCompensationOfEmployees
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004092"
      unitRef="BRL">35857000</afya:ShareBasedCompensationOfEmployees>
    <afya:ShareBasedCompensationOfEmployees
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004094"
      unitRef="BRL">22185000</afya:ShareBasedCompensationOfEmployees>
    <afya:ScheduleOfFairValueOfStockOptionsGrantsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004097">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfFairValueOfStockOptionsGrantsExplanatory_zvhZDc74HnA6" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B3_zGgNPB2SqyUj" style="display: none"&gt;Schedule of grants
of stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z6T0fZrOvqI5" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_493_20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zK235Tb9bNp2" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zNZa1lSl2609" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zNvkL1rYPUsa" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zs3ztMRbK1Bc" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49B_20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHa3XnkjJA68" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3OIbkyhLU5h" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zfs4Xs9Cb3H4" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;November&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;April&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;October&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;December&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;October&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;August&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;April&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;February&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement_pn3n3_zWqzUVBwknDh" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Amount&lt;/td&gt;
    &lt;td style="text-align: right"&gt;692,000&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;60,000 &lt;/td&gt;
    &lt;td style="text-align: right"&gt;113,900&lt;/td&gt;
    &lt;td style="text-align: right"&gt;232,000&lt;/td&gt;
    &lt;td style="text-align: right"&gt;37,000&lt;/td&gt;
    &lt;td style="text-align: right"&gt;153,000&lt;/td&gt;
    &lt;td style="text-align: right"&gt;30,000&lt;/td&gt;
    &lt;td style="text-align: right"&gt;15,000&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--SharePriceFairValueAtMeasurementDate_pip0_zt6sMhDJPCK6" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Exercise price at the measurement date&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$62.57&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$79.91&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$73.75&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$60&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$59&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$59&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$57&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$56&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pip0_dp_zaQHGtSd4vK6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Dividend yield (%)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0.0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0.0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0.0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0.0%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;0.0%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Expected volatility (%)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z3a2zokWHkni" title="Expected volatility"&gt;24&lt;/span&gt;-&lt;span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zhYY03hXbIyk" title="Expected volatility"&gt;41&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zmkAxaOJEPd2" title="Expected volatility"&gt;35&lt;/span&gt;-&lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTPzINAqPsrj" title="Expected volatility"&gt;44&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zRDwFMzwknRb" title="Expected volatility"&gt;32&lt;/span&gt;-&lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTaePcHfivNe" title="Expected volatility"&gt;45&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zsLUc0A16E82" title="Expected volatility"&gt;34&lt;/span&gt;-&lt;span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvQqfh9Pafxb" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zdJiyIN9wYk6" title="Expected volatility"&gt;44&lt;/span&gt;-&lt;span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zD39cWsDcLQ1" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOSZrXlcyZD3" title="Expected volatility"&gt;47&lt;/span&gt;-&lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0TpV4isUZ76" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zzLnpWvuvqO2" title="Expected volatility"&gt;48&lt;/span&gt;-&lt;span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zeEOMDZRaeG8" title="Expected volatility"&gt;55&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zDvwBftIf02h" title="Expected volatility"&gt;46&lt;/span&gt;-&lt;span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zbgyNuZPYWqg" title="Expected volatility"&gt;56&lt;/span&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Risk-free interest rate (%)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zXhzqbtNwI24" title="Risk-free interest rate"&gt;13&lt;/span&gt;-&lt;span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zK64lbUpWev2" title="Risk-free interest rate"&gt;15&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zL4FuMa3ygfe" title="Risk-free interest rate"&gt;14&lt;/span&gt;-&lt;span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zpQqpMVYktCe" title="Risk-free interest rate"&gt;15&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8UuU76vuby2" title="Risk-free interest rate"&gt;11&lt;/span&gt;-&lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zZNJzCKOJZ7g" title="Risk-free interest rate"&gt;13&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zWqmaTXFX4I1" title="Risk-free interest rate"&gt;10&lt;/span&gt;-&lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z3zFmkt2PGP4" title="Risk-free interest rate"&gt;11&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zSg6N5dHPT0l" title="Risk-free interest rate"&gt;11&lt;/span&gt;-&lt;span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zmZaF4bP4NKg" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zUFWKlQGKDx3" title="Risk-free interest rate"&gt;10&lt;/span&gt;-&lt;span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z4JquBKNxWlc" title="Risk-free interest rate"&gt;12&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLYSuS7KNh63" title="Risk-free interest rate"&gt;11&lt;/span&gt;-&lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zI0vJM6gywRj" title="Risk-free interest rate"&gt;13&lt;/span&gt;%&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pip0_dp_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zAJASHq0BBGh" title="Risk-free interest rate"&gt;13&lt;/span&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Expected life of stock options (years)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ExpectedLifeOfStockOptions_dtY_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0jLLW2lU6J3" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_90A_ecustom--ExpectedLifeOfStockOptions_dtY_c20251101__20251130__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zcXSWBKRKiVi" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zJ5SPoXZEyX6" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_90C_ecustom--ExpectedLifeOfStockOptions_dtY_c20250401__20250430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z9CG5kRjj7C" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ExpectedLifeOfStockOptions_dtY_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo1yo9kxDfY5" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20241001__20241031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zpwNuy5S3Tsf" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ExpectedLifeOfStockOptions_dtY_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zUUeOhGyCg0i" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_908_ecustom--ExpectedLifeOfStockOptions_dtY_c20231201__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zKlUUVd2lpKh" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ExpectedLifeOfStockOptions_dtY_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLCObi1GJ524" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20231001__20231031__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zp9XJ1CqRkm7" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCcJKVef1vV9" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_903_ecustom--ExpectedLifeOfStockOptions_dtY_c20230801__20230831__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_znWUS3p2NLj" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230401__20230430__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zXgdDziYvER" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zh9QH7khRfM8" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0NENZi2yMJ4" title="Expected life of stock options"&gt;1&lt;/span&gt;-&lt;span id="xdx_90E_ecustom--ExpectedLifeOfStockOptions_dtY_c20230201__20230228__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z7FWqTwEwbs" title="Expected life of stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_pip0_zhSqRAp2Tre1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Share price at the measurement date&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$79.36&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$107.33&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$92.78&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$100.97&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$79.12&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$76.45&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$62.51&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$70.69&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_i" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Valuation model&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;
    &lt;td style="text-align: right"&gt;Binomial&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_pip0_z80Gu2ZEmFnh" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt"&gt;Weighted average fair value at the measurement date&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$33.27&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$45.95&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$39.71&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$54.25&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$38.67&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$37.04&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$32.04&lt;/td&gt;
    &lt;td style="text-align: right"&gt;R$29.54&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</afya:ScheduleOfFairValueOfStockOptionsGrantsExplanatory>
    <afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement
      contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004099"
      unitRef="BRL">692000000</afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement>
    <afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement
      contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004100"
      unitRef="BRL">60000000</afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement>
    <afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement
      contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004101"
      unitRef="BRL">113900000</afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement>
    <afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement
      contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004102"
      unitRef="BRL">232000000</afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement>
    <afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement
      contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004103"
      unitRef="BRL">37000000</afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement>
    <afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement
      contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004104"
      unitRef="BRL">153000000</afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement>
    <afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement
      contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004105"
      unitRef="BRL">30000000</afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement>
    <afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement
      contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember"
      decimals="-3"
      id="Fact004106"
      unitRef="BRL">15000000</afya:NumberOfShareOptionsGrantedInValueSharebasedPaymentArrangement>
    <afya:SharePriceFairValueAtMeasurementDate
      contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004108"
      unitRef="BRLPShares">62.57</afya:SharePriceFairValueAtMeasurementDate>
    <afya:SharePriceFairValueAtMeasurementDate
      contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004109"
      unitRef="BRLPShares">79.91</afya:SharePriceFairValueAtMeasurementDate>
    <afya:SharePriceFairValueAtMeasurementDate
      contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004110"
      unitRef="BRLPShares">73.75</afya:SharePriceFairValueAtMeasurementDate>
    <afya:SharePriceFairValueAtMeasurementDate
      contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004111"
      unitRef="BRLPShares">60</afya:SharePriceFairValueAtMeasurementDate>
    <afya:SharePriceFairValueAtMeasurementDate
      contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004112"
      unitRef="BRLPShares">59</afya:SharePriceFairValueAtMeasurementDate>
    <afya:SharePriceFairValueAtMeasurementDate
      contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004113"
      unitRef="BRLPShares">59</afya:SharePriceFairValueAtMeasurementDate>
    <afya:SharePriceFairValueAtMeasurementDate
      contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004114"
      unitRef="BRLPShares">57</afya:SharePriceFairValueAtMeasurementDate>
    <afya:SharePriceFairValueAtMeasurementDate
      contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004115"
      unitRef="BRLPShares">56</afya:SharePriceFairValueAtMeasurementDate>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004117"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004118"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004119"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004120"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004121"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004122"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004123"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004124"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004126"
      unitRef="Pure">0.24</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004128"
      unitRef="Pure">0.41</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004130"
      unitRef="Pure">0.35</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004132"
      unitRef="Pure">0.44</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004134"
      unitRef="Pure">0.32</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004136"
      unitRef="Pure">0.45</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004138"
      unitRef="Pure">0.34</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004140"
      unitRef="Pure">0.56</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004142"
      unitRef="Pure">0.44</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004144"
      unitRef="Pure">0.56</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004146"
      unitRef="Pure">0.47</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004148"
      unitRef="Pure">0.56</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004150"
      unitRef="Pure">0.48</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004152"
      unitRef="Pure">0.55</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004154"
      unitRef="Pure">0.46</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004156"
      unitRef="Pure">0.56</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004158"
      unitRef="Pure">0.13</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004160"
      unitRef="Pure">0.15</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004162"
      unitRef="Pure">0.14</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004164"
      unitRef="Pure">0.15</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004166"
      unitRef="Pure">0.11</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004168"
      unitRef="Pure">0.13</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004170"
      unitRef="Pure">0.10</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004172"
      unitRef="Pure">0.11</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004174"
      unitRef="Pure">0.11</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004176"
      unitRef="Pure">0.12</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004178"
      unitRef="Pure">0.10</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004180"
      unitRef="Pure">0.12</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      id="Fact004182"
      unitRef="Pure">0.11</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      id="Fact004184"
      unitRef="Pure">0.13</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004186"
      unitRef="Pure">0.13</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      id="Fact004188">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      id="Fact004190">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      id="Fact004192">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      id="Fact004194">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      id="Fact004196">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      id="Fact004198">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      id="Fact004200">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      id="Fact004202">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      id="Fact004204">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      id="Fact004206">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      id="Fact004208">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      id="Fact004210">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      id="Fact004212">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      id="Fact004214">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_BottomOfRangeMember"
      id="Fact004216">P1Y</afya:ExpectedLifeOfStockOptions>
    <afya:ExpectedLifeOfStockOptions
      contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember_ifrs-full_TopOfRangeMember"
      id="Fact004218">P5Y</afya:ExpectedLifeOfStockOptions>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004220"
      unitRef="BRLPShares">79.36</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004221"
      unitRef="BRLPShares">107.33</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004222"
      unitRef="BRLPShares">92.78</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004223"
      unitRef="BRLPShares">100.97</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004224"
      unitRef="BRLPShares">79.12</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004225"
      unitRef="BRLPShares">76.45</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004226"
      unitRef="BRLPShares">62.51</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004227"
      unitRef="BRLPShares">70.69</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember"
      id="Fact004229">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember"
      id="Fact004230">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember"
      id="Fact004231">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember"
      id="Fact004232">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember"
      id="Fact004233">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember"
      id="Fact004234">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember"
      id="Fact004235">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted
      contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember"
      id="Fact004236">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="From2025-11-012025-11-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004238"
      unitRef="BRLPShares">33.27</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="From2025-04-012025-04-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004239"
      unitRef="BRLPShares">45.95</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="From2024-10-012024-10-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004240"
      unitRef="BRLPShares">39.71</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="From2023-12-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004241"
      unitRef="BRLPShares">54.25</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="From2023-10-012023-10-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004242"
      unitRef="BRLPShares">38.67</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="From2023-08-012023-08-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004243"
      unitRef="BRLPShares">37.04</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="From2023-04-012023-04-30_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004244"
      unitRef="BRLPShares">32.04</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="From2023-02-012023-02-28_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004245"
      unitRef="BRLPShares">29.54</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:ScheduleOfSharebasedCompensationPlanExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004247">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfSharebasedCompensationPlanExplanatory_pn3n3_zFzoezmEhTV9" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span id="xdx_8B0_zLGkJU0tLkH5" style="display: none"&gt;Schedule of movements in stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td rowspan="2" style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: center; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;Weighted average exercise price&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;(in Brazilian Reais)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 2.9pt; padding-left: 2.9pt"&gt;
    &lt;p style="border-bottom: Black 1pt solid; font: 8.5pt Nunito Sans; margin: 0; text-align: center"&gt;&lt;b&gt;Number of stock options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 39%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 28%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; width: 11%; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Outstanding at January 1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zraIJSzFCkke" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Outstanding at the beginning"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;67.31&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zO4kayTsCld6" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;1,610,679&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z5Q8ZFRA9Wtf" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;1,696,064&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHZagAo9RIX5" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;3,729,287&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zD1ZddyRkMke" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Granted"&gt;&lt;span style="font-size: 8.5pt"&gt;63.95&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zarVmL6ef2xg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-size: 8.5pt"&gt;752,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z1kiz2uCbBz6" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-size: 8.5pt"&gt;113,900&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z3IAUYRtt7q7" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Granted"&gt;&lt;span style="font-size: 8.5pt"&gt;467,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zpu4iEOMKoS1" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercised"&gt;&lt;span style="font-size: 8.5pt"&gt;63.62&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zxT2Mq5vrGY2" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-size: 8.5pt"&gt;(404,478)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGKd39zZRU7l" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-size: 8.5pt"&gt;(147,955)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z9ZGh8Sebarh" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercised"&gt;&lt;span style="font-size: 8.5pt"&gt;(164,214)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Stock options exchanged to RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--WeightedAverageExercisePriceOfShareOptionsExchangedInSharebasedPaymentArrangement2019_iI_pip0_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zHdtqCer9AEf" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercised"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4273"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zhsjUI4JlqAh" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, stock option exchanged"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4275"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmV62YvwqcVd" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, stock option exchanged"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4277"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGxPS01O5x75" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, stock option exchanged"&gt;&lt;span style="font-size: 8.5pt"&gt;(1,751,599)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zaKvtHUKDlW8" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Forfeited"&gt;&lt;span style="font-size: 8.5pt"&gt;72.42&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_ze6ykiFid7Kg" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-size: 8.5pt"&gt;(57,152)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zsidkfnTT7h4" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-size: 8.5pt"&gt;(16,182)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zMsaiNPv6mCi" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Forfeited"&gt;&lt;span style="font-size: 8.5pt"&gt;(333,111)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Expired&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z8mHAL7v4bZe" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Expired"&gt;&lt;span style="font-size: 8.5pt"&gt;68.54&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zPcEiMVVab3c" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"&gt;&lt;span style="font-size: 8.5pt"&gt;(57,680)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z91sTDJENHc4" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Expired"&gt;&lt;span style="font-size: 8.5pt"&gt;(35,148)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zQJsLxD7amw3" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Expired"&gt;&lt;span style="font-size: 8.5pt"&gt;(251,299)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zATYUtVrdlh7" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Outstanding at the ending"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;65.91&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_z2mW4KaitVZd" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;1,843,369&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zGitrYnMUbB8" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;1,610,679&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zV27MvxAdFne" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;1,696,064&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pip0_c20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zmDdNrIKSON5" style="vertical-align: bottom; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Weighted average exercise price, Exercisable"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;71.33&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20250101__20251231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zLVpGQ22dOC4" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;340,219&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20240101__20241231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zsJMf5UO94M6" style="white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;427,202&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NumberOfStockOptionsExercisable_iE_pip0_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__ifrs-full--ShareOptionsMember_zK2nhsM4tARb" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of stock options, Exercisable"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;242,235&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfSharebasedCompensationPlanExplanatory>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2024-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004249"
      unitRef="BRLPShares">67.31</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004251"
      unitRef="N">1610679</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004253"
      unitRef="N">1696064</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004255"
      unitRef="N">3729287</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004257"
      unitRef="BRLPShares">63.95</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004259"
      unitRef="N">752000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004261"
      unitRef="N">113900</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004263"
      unitRef="N">467000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004265"
      unitRef="BRLPShares">63.62</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004267"
      unitRef="N">404478</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004269"
      unitRef="N">147955</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004271"
      unitRef="N">164214</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004279"
      unitRef="N">1751599</afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004281"
      unitRef="BRLPShares">72.42</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004283"
      unitRef="N">57152</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004285"
      unitRef="N">16182</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004287"
      unitRef="N">333111</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019
      contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004289"
      unitRef="BRLPShares">68.54</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004291"
      unitRef="N">57680</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004293"
      unitRef="N">35148</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004295"
      unitRef="N">251299</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2025-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004297"
      unitRef="BRLPShares">65.91</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004299"
      unitRef="N">1843369</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004301"
      unitRef="N">1610679</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004303"
      unitRef="N">1696064</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="AsOf2025-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004305"
      unitRef="BRLPShares">71.33</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <afya:NumberOfStockOptionsExercisable
      contextRef="AsOf2025-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004307"
      unitRef="Shares">340219</afya:NumberOfStockOptionsExercisable>
    <afya:NumberOfStockOptionsExercisable
      contextRef="AsOf2024-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004309"
      unitRef="Shares">427202</afya:NumberOfStockOptionsExercisable>
    <afya:NumberOfStockOptionsExercisable
      contextRef="AsOf2023-12-31_ifrs-full_ShareOptionsMember"
      decimals="INF"
      id="Fact004311"
      unitRef="Shares">242235</afya:NumberOfStockOptionsExercisable>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2025-01-012025-12-31_custom_ShareBasedCompensationPlansMember"
      decimals="-3"
      id="Fact004313"
      unitRef="BRL">4809000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2024-01-012024-12-31_custom_ShareBasedCompensationPlansMember"
      decimals="-3"
      id="Fact004315"
      unitRef="BRL">17394000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2023-01-012023-12-31_custom_ShareBasedCompensationPlansMember"
      decimals="-3"
      id="Fact004317"
      unitRef="BRL">20850000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004319"
      unitRef="Pure">0.10</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnits1Member"
      decimals="INF"
      id="Fact004321"
      unitRef="Pure">0.20</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnits2Member"
      decimals="INF"
      id="Fact004323"
      unitRef="Pure">0.30</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnits3Member"
      decimals="INF"
      id="Fact004325"
      unitRef="Pure">0.40</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <afya:ScheduleOfGrantsRestrictedStockUnitsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact004327">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfGrantsRestrictedStockUnitsTableTextBlock_zV48BfBx6yL5" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details 2)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt"&gt;&lt;span id="xdx_8BC_zuLxXAoP3M1" style="display: none"&gt;Schedule of grants
of RSUs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;November&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;April&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;October&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;December&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;October&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;August&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;April&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%"&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;February&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 8.5pt Nunito Sans; margin: 0; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Amount&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_zICCFZgsdfx2" style="text-align: right" title="Granted"&gt;346,000&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_z6wKGwWz9FZk" style="text-align: right" title="Granted"&gt;35,000&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zMXEDJuS1bJj" style="text-align: right" title="Granted"&gt;44,500&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_ztVtzmnIuLG6" style="text-align: right" title="Granted"&gt;76,600&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zpal9jAuBLck" style="text-align: right" title="Granted"&gt;63,000&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zE0O4ptKVl31" style="text-align: right" title="Granted"&gt;153,490&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zhqa0iPvtezk" style="text-align: right" title="Granted"&gt;16,000&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement_pn3n3_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_z9yQzaTS6Xni" style="text-align: right" title="Granted"&gt;8,000&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="background-color: White"&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 8.7pt; text-indent: -8.7pt"&gt;Weighted average fair value at the measurement date&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_zWCPmhNdYxJ5" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$79.36&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_zYJr10Oa09M7" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$107.33&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zJGGHwdVffZ6" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$92.78&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pip0_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zNvnzT4Y0cn7" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$100.97&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zNMqQFYVlTlj" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$79.12&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zieMWlWClbXe" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$76.45&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zACW5bG8T6c5" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$62.51&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zHw7SUIVdxTg" style="width: 9%; text-align: right" title="Fair values at grant date"&gt;R$70.69&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Vesting period (years)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_znAcmh3mMXpd" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_90A_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--November2025Member_z8OXOynCf8J1" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_zPILF04KSlvk" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20250101__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2025Member_z3MS7RGKoXof" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--GrantedVestingPeriod_dtY_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_zphrbhAzCoq8" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_905_ecustom--GrantedVestingPeriod_dtY_c20240101__20241231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2024Member_z7dAnJ3MghPc" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zaLtoQSJ7M5a" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_904_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--December2023Member_zVKrezoWsjae" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_zYwjdE4YIn46" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_905_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--October2023Member_z02xbUIzr3Gj" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zqm69NMWJsNb" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_90A_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--August2023Member_zqGjtgM78qVf" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_zKkh2qfBvsD" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_90E_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--April2023Member_znKKKNNMnb5l" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zBt1kX2xCEok" title="Vesting period"&gt;1&lt;/span&gt;-&lt;span id="xdx_907_ecustom--GrantedVestingPeriod_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--DefinedBenefitPlansAxis__custom--February2023Member_zjJb7xEFaRql" title="Vesting period"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfGrantsRestrictedStockUnitsTableTextBlock>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_November2025Member"
      decimals="-3"
      id="Fact004329"
      unitRef="BRL">346000000</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_April2025Member"
      decimals="-3"
      id="Fact004331"
      unitRef="BRL">35000000</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_October2024Member"
      decimals="-3"
      id="Fact004333"
      unitRef="BRL">44500000</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_December2023Member"
      decimals="-3"
      id="Fact004335"
      unitRef="BRL">76600000</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_October2023Member"
      decimals="-3"
      id="Fact004337"
      unitRef="BRL">63000000</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_August2023Member"
      decimals="-3"
      id="Fact004339"
      unitRef="BRL">153490000</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_April2023Member"
      decimals="-3"
      id="Fact004341"
      unitRef="BRL">16000000</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_February2023Member"
      decimals="-3"
      id="Fact004343"
      unitRef="BRL">8000000</afya:NumberOfRestrictedStockUnitsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_November2025Member"
      decimals="INF"
      id="Fact004345"
      unitRef="BRLPShares">79.36</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2025-01-012025-12-31_custom_April2025Member"
      decimals="INF"
      id="Fact004347"
      unitRef="BRLPShares">107.33</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2024-01-012024-12-31_custom_October2024Member"
      decimals="INF"
      id="Fact004349"
      unitRef="BRLPShares">92.78</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-01-012023-12-31_custom_December2023Member"
      decimals="INF"
      id="Fact004351"
      unitRef="BRLPShares">100.97</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-01-012023-12-31_custom_October2023Member"
      decimals="INF"
      id="Fact004353"
      unitRef="BRLPShares">79.12</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-01-012023-12-31_custom_August2023Member"
      decimals="INF"
      id="Fact004355"
      unitRef="BRLPShares">76.45</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-01-012023-12-31_custom_April2023Member"
      decimals="INF"
      id="Fact004357"
      unitRef="BRLPShares">62.51</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="From2023-01-012023-12-31_custom_February2023Member"
      decimals="INF"
      id="Fact004359"
      unitRef="BRLPShares">70.69</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <afya:GrantedVestingPeriod
      contextRef="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember_custom_November2025Member"
      id="Fact004361">P1Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember_custom_November2025Member"
      id="Fact004363">P4Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember_custom_April2025Member"
      id="Fact004365">P1Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2025-01-012025-12-31_ifrs-full_TopOfRangeMember_custom_April2025Member"
      id="Fact004367">P4Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2024-01-012024-12-31_ifrs-full_BottomOfRangeMember_custom_October2024Member"
      id="Fact004369">P1Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2024-01-012024-12-31_ifrs-full_TopOfRangeMember_custom_October2024Member"
      id="Fact004371">P4Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_December2023Member"
      id="Fact004373">P1Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_December2023Member"
      id="Fact004375">P4Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_October2023Member"
      id="Fact004377">P1Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_October2023Member"
      id="Fact004379">P4Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_August2023Member"
      id="Fact004381">P1Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_August2023Member"
      id="Fact004383">P4Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_April2023Member"
      id="Fact004385">P1Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_April2023Member"
      id="Fact004387">P4Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember_custom_February2023Member"
      id="Fact004389">P1Y</afya:GrantedVestingPeriod>
    <afya:GrantedVestingPeriod
      contextRef="From2023-01-012023-12-31_ifrs-full_TopOfRangeMember_custom_February2023Member"
      id="Fact004391">P4Y</afya:GrantedVestingPeriod>
    <afya:ScheduleOfStockOptionTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact004395">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfStockOptionTableTextBlock_pn3n3_zcaFvNJVhna3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Labor and social obligations (Details 3)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;&lt;span id="xdx_8B7_zcQK8v9WNAh7" style="display: none"&gt;Schedule of stock option&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 49%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;&lt;b&gt;Outstanding at January 1&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zKQADaIQ2OK3" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;b&gt;656,634&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zva28bMgxnV3" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;b&gt;854,431&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zCE4lHvJhfBj" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the beginning"&gt;&lt;b&gt;447,224&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;Granted&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zXCsaRfq2Moj" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Granted"&gt;381,000&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zIySk7IVqJo7" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Granted"&gt;44,500&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zYh56vwbBwEi" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Granted"&gt;317,090&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;Stock options exchanged to RSUs&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zIXJzIvwsL02" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4409"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z4ggG1ljDdj5" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4411"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NumberOfShareOptionsExchangedInSharebasedPaymentArrangement_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z46Le5Md8Qi1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Stock options exchanged"&gt;215,797&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;Exercised&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z64yoxIWwf72" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Exercised"&gt;(224,070)&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zP2UEEmgRBZg" style="padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Exercised"&gt;(222,910)&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z5CCL3T5mK66" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Exercised"&gt;(99,576)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;Expired&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zylOPFGb2J18" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Forfeited"&gt;(93,846)&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zaMTLE4Mao49" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Forfeited"&gt;(19,387)&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pip0_di_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_z0wLJ1wZxyMk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Forfeited"&gt;(26,104)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-indent: -9.35pt"&gt;&lt;b&gt;Outstanding at December 31&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20250101__20251231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zb2Uk8Lq4n7k" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;b&gt;719,718&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20240101__20241231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zNE4wQnNJZ65" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;b&gt;656,634&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iE_pip0_uN_c20230101__20231231__ifrs-full--DefinedBenefitPlansAxis__custom--RestrictedStockUnitsMember_zXzCqgWBYC7" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; text-align: right" title="Number of stock options, Outstanding at the ending"&gt;&lt;b&gt;854,431&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfStockOptionTableTextBlock>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004397"
      unitRef="N">656634</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004399"
      unitRef="N">854431</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2022-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004401"
      unitRef="N">447224</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004403"
      unitRef="N">381000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004405"
      unitRef="N">44500</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004407"
      unitRef="N">317090</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004413"
      unitRef="N">215797</afya:NumberOfShareOptionsExchangedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004415"
      unitRef="N">224070</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004417"
      unitRef="N">222910</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004419"
      unitRef="N">99576</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004421"
      unitRef="N">93846</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2024-01-012024-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004423"
      unitRef="N">19387</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004425"
      unitRef="N">26104</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004427"
      unitRef="N">719718</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2024-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004429"
      unitRef="N">656634</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2023-12-31_custom_RestrictedStockUnitsMember"
      decimals="INF"
      id="Fact004431"
      unitRef="N">854431</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2025-01-012025-12-31_custom_RestrictedStockUnitsMember"
      decimals="-3"
      id="Fact004433"
      unitRef="BRL">10509000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2024-01-012024-12-31_custom_RestrictedStockUnitsMember"
      decimals="-3"
      id="Fact004435"
      unitRef="BRL">15030000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2023-01-012023-12-31_custom_RestrictedStockUnitsMember"
      decimals="-3"
      id="Fact004437"
      unitRef="BRL">10685000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <afya:SocialObligationsLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact004439"
      unitRef="BRL">2660000</afya:SocialObligationsLiabilities>
    <afya:SocialObligationsLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact004441"
      unitRef="BRL">8988000</afya:SocialObligationsLiabilities>
    <afya:SocialObligationsLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004443"
      unitRef="BRL">7177000</afya:SocialObligationsLiabilities>
    <afya:DisclosureOfEquityExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004445">&lt;p id="xdx_80F_ecustom--DisclosureOfEquityExplanatory_z56SPHAr04A1" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;15&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_824_zwT67diaK6p2"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;span style="text-decoration: underline"&gt;Share capital&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 7pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;As of December 31, 2025, the Company&#x2019;s share capital was R$&lt;span id="xdx_902_eifrs-full--IssuedCapital_iI_pn3n3_c20251231_zEir0WlgBYHl" title="Share capital"&gt;17&lt;/span&gt; represented by &lt;span id="xdx_90F_ecustom--NumberOfSharesIssued1_iI_pip0_c20251231_z1Nnei9eWG52" title="Total number of shares"&gt;93,722,831&lt;/span&gt; shares comprised by
&lt;span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pip0_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_z53a3OjaTXEf" title="Total number of shares"&gt;55,148,697&lt;/span&gt; class A common shares and &lt;span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_pip0_c20251231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zDJjXbp0Qr45" title="Total number of shares"&gt;38,574,134&lt;/span&gt; class B common shares. As of December 31, 2024, the Company&#x2019;s share capital was R$&lt;span id="xdx_900_eifrs-full--IssuedCapital_iI_pn3n3_c20241231_z472mbs5CMyc" title="Share capital"&gt;17&lt;/span&gt; represented
by &lt;span id="xdx_90D_ecustom--NumberOfSharesIssued1_iI_pip0_c20241231_zCeLCeakWEGd" title="Total number of shares"&gt;93,722,831&lt;/span&gt; shares comprised by &lt;span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pip0_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zGveERBlzulh" title="Total number of shares"&gt;49,920,068&lt;/span&gt; class A common shares and &lt;span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pip0_c20241231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zv6uj5zbFZM6" title="Total number of shares"&gt;43,802,763&lt;/span&gt; class B common shares. As of December 31, 2025 and 2024,
the Company&#x2019;s authorized capital was US$&lt;span id="xdx_900_ecustom--IssuedCapitals_c20251231_pn3n3" title="Authorized capital"&gt;&lt;span id="xdx_907_ecustom--IssuedCapitals_iI_pn3n3_c20241231_zRwGtSAcHKRc" title="Authorized capital"&gt;50&lt;/span&gt;&lt;/span&gt; thousand divided into &lt;span id="xdx_90E_ecustom--CapitalUnitsAuthorizedShares_iI_pn3n3_c20251231_zFQu5rexiDNi" title="Authorized capital units"&gt;1,000,000,000&lt;/span&gt; shares of a nominal value of US$&lt;span id="xdx_90E_eifrs-full--ParValuePerShare_iI_c20251231_z12HwBjrisaa" title="Nominal value per share"&gt;0.00005&lt;/span&gt; each.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white; color: #C00000"&gt;&lt;span style="text-decoration: underline"&gt;Dividends&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 7pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;In the year ended December 31, 2025, CCSI and IESVAP approved the payment of dividends
of R$&lt;span id="xdx_900_ecustom--PaymentOfDividends_pn3n3_c20250101__20251231_zEb8bjx8NFg5" title="Payment of dividends"&gt;76,862&lt;/span&gt;, which R$&lt;span id="xdx_909_ecustom--DividendDistributed_pn3n3_c20250101__20251231_zxEnf2ZO3Bmb" title="Dividend distributed"&gt;59,641&lt;/span&gt; was distributed to the Company and R$&lt;span id="xdx_900_eifrs-full--DividendsPaidToNoncontrollingInterests_c20250101__20251231_pn3n3" title="Dividends paid to non-controlling interests"&gt;17,221&lt;/span&gt; to non-controlling shareholders (December 31 2024: R$&lt;span id="xdx_90D_ecustom--PaymentOfDividends_c20240101__20241231_pn3n3" title="Payment of dividends"&gt;79,701&lt;/span&gt;, which
R$&lt;span id="xdx_908_ecustom--DividendDistributed_c20240101__20241231_pn3n3" title="Dividend distributed"&gt;61,412&lt;/span&gt; was distributed to the Company and R$&lt;span id="xdx_902_eifrs-full--DividendsPaidToNoncontrollingInterests_c20240101__20241231_pn3n3" title="Dividends paid to non-controlling interests"&gt;18,289&lt;/span&gt; to non-controlling shareholders and December 31, 2023: R$&lt;span id="xdx_90F_ecustom--PaymentOfDividends_c20230101__20231231_pn3n3" title="Payment of dividends"&gt;65,539&lt;/span&gt;, which R$&lt;span id="xdx_90A_ecustom--DividendDistributed_c20230101__20231231_pn3n3" title="Dividend distributed"&gt;46,788&lt;/span&gt; was
distributed to the Company and R$&lt;span id="xdx_90C_eifrs-full--DividendsPaidToNoncontrollingInterests_c20230101__20231231_pn3n3" title="Dividends paid to non-controlling interests"&gt;18,750&lt;/span&gt; to non-controlling shareholders).&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On March 12, 2025, the Company&#x2019;s Board of Directors approved the first dividend distribution
in the amount of R$&lt;span id="xdx_902_ecustom--FirstDividendDistributionInAmount_pn3n3_c20250311__20250312_zelXdXu8E3N5" title="First dividend distribution in amount"&gt;129,784&lt;/span&gt;, representing &lt;span id="xdx_90C_ecustom--PercentageOfDividendDistribution_pip0_dp_c20250311__20250312_zazk5TCNlOlf" title="Percentage of dividend distribution"&gt;20&lt;/span&gt;% of the Company&#x2019;s consolidated net income for the year ended December 31, 2024 and a
dividend per share of R$&lt;span id="xdx_90B_eifrs-full--DividendsPaidOtherSharesPerShare_c20250403__20250404_zGDni4S6dZUg" title="Dividends per share"&gt;1.348923&lt;/span&gt;, to the shareholders on record as of the close of business on March 26, 2025, paid in U.S. dollars on
April 4, 2025, at the exchange rate (PTAX) published by the Brazilian Central Bank on March 13, 2025.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white; color: #C00000"&gt;&lt;span style="text-decoration: underline"&gt;Treasury shares&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On August 13, 2025, the Company&#x2019;s board of directors approved a new share repurchase
program. Under the share repurchase program, Afya may repurchase up to &lt;span id="xdx_90B_ecustom--RepurchaseOfOrdinaryShares_iI_c20250813__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zzo6DK7blnfc" title="Repurchase of ordinary shares"&gt;4,000,000&lt;/span&gt; of its outstanding Class A common shares, in the open
market, based on prevailing market prices, or in privately negotiated transactions, beginning from August 15, 2025 until the earlier of
the completion of the repurchase or December 31, 2026, depending upon market conditions. During the year ended December 31, 2025, the
Company&#x2019;s cash outflow was R$&lt;span id="xdx_90A_ecustom--CashOutflow_pn3n3_c20250101__20251231_zuA1Vm3RslE9" title="Cash outflow"&gt;77,002&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The table below illustrates the number and movements in treasury shares during the years
ended December 31, 2025, 2024 and 2023:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;







&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfTreasurySharesMovementExplanatory_pn3n3_zFqys31Z6pmf" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Equity (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span id="xdx_8B7_z1lKQEh9mEhe" style="display: none"&gt;Schedule
    of number and movements in treasury shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 48%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Number of treasury shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 29%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Average price (in Brazilian Reais)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Outstanding at January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20230101__20231231_zLIRN8DzrJs6" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;3,786,285&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20230101__20231231_zp4RN1pSehDc" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;80.54&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Repurchased&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NumberOfSharesRepurchased_pip0_c20230101__20231231_zIFiSsp7ZrU6" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"&gt;&lt;span style="font-size: 8.5pt"&gt;216,339&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AveragePriceRepurchased_pip0_c20230101__20231231_zKgY03FRrdij" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"&gt;&lt;span style="font-size: 8.5pt"&gt;57.17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Delivered under the share-based compensation plans&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20230101__20231231_zBTy8AECDH69" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"&gt;&lt;span style="font-size: 8.5pt"&gt;(229,146)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20230101__20231231_z3ymjGJWvvn4" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"&gt;&lt;span style="font-size: 8.5pt"&gt;79.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="background-color: White"&gt;
    &lt;td style="width: 48%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Outstanding at December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20240101__20241231_zQzjgrbWJZt" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;3,773,478&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20240101__20241231_zN8rACYg7P9c" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 29%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;79.28&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Delivered under the share-based compensation plans&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20240101__20241231_zWarKk2kBdBc" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"&gt;&lt;span style="font-size: 8.5pt"&gt;(317,940)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20240101__20241231_ze05wOtMOcog" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"&gt;&lt;span style="font-size: 8.5pt"&gt;79.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Outstanding at December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20250101__20251231_zjJrbHUyw2Da" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;3,455,538&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20250101__20251231_znhjjQqlaLG8" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;79.28&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Repurchased&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NumberOfSharesRepurchased_pip0_c20250101__20251231_zpFkaLnJResk" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"&gt;&lt;span style="font-size: 8.5pt"&gt;966,541 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AveragePriceRepurchased_pip0_c20250101__20251231_zD2WH79RwTml" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"&gt;&lt;span style="font-size: 8.5pt"&gt;80.24&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Delivered under the share-based compensation plans&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20250101__20251231_zdMXbpddoxZ9" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"&gt;&lt;span style="font-size: 8.5pt"&gt;(566,929)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20250101__20251231_zFTLvkjxLdK2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"&gt;&lt;span style="font-size: 8.5pt"&gt;79.28 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Outstanding
at December 31, 2025 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iE_pip0_c20250101__20251231_znR8iogO0UV9" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at ending balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;3,855,150 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20250101__20251231_zF8D1o4cTSIj" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at ending balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;79.52 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&lt;/p&gt;

</afya:DisclosureOfEquityExplanatory>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact004447"
      unitRef="BRL">17000</ifrs-full:IssuedCapital>
    <afya:NumberOfSharesIssued1
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact004449"
      unitRef="Shares">93722831</afya:NumberOfSharesIssued1>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact004451"
      unitRef="Shares">55148697</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact004453"
      unitRef="Shares">38574134</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact004455"
      unitRef="BRL">17000</ifrs-full:IssuedCapital>
    <afya:NumberOfSharesIssued1
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact004457"
      unitRef="Shares">93722831</afya:NumberOfSharesIssued1>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact004459"
      unitRef="Shares">49920068</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      id="Fact004461"
      unitRef="Shares">43802763</ifrs-full:NumberOfSharesIssued>
    <afya:IssuedCapitals
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact004463"
      unitRef="BRL">50000</afya:IssuedCapitals>
    <afya:IssuedCapitals
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact004465"
      unitRef="BRL">50000</afya:IssuedCapitals>
    <afya:CapitalUnitsAuthorizedShares
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact004467"
      unitRef="Shares">1000000000000</afya:CapitalUnitsAuthorizedShares>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact004469"
      unitRef="BRLPShares">0.00005</ifrs-full:ParValuePerShare>
    <afya:PaymentOfDividends
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004471"
      unitRef="BRL">76862000</afya:PaymentOfDividends>
    <afya:DividendDistributed
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004473"
      unitRef="BRL">59641000</afya:DividendDistributed>
    <ifrs-full:DividendsPaidToNoncontrollingInterests
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004475"
      unitRef="BRL">17221000</ifrs-full:DividendsPaidToNoncontrollingInterests>
    <afya:PaymentOfDividends
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004477"
      unitRef="BRL">79701000</afya:PaymentOfDividends>
    <afya:DividendDistributed
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004479"
      unitRef="BRL">61412000</afya:DividendDistributed>
    <ifrs-full:DividendsPaidToNoncontrollingInterests
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004481"
      unitRef="BRL">18289000</ifrs-full:DividendsPaidToNoncontrollingInterests>
    <afya:PaymentOfDividends
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004483"
      unitRef="BRL">65539000</afya:PaymentOfDividends>
    <afya:DividendDistributed
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004485"
      unitRef="BRL">46788000</afya:DividendDistributed>
    <ifrs-full:DividendsPaidToNoncontrollingInterests
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004487"
      unitRef="BRL">18750000</ifrs-full:DividendsPaidToNoncontrollingInterests>
    <afya:FirstDividendDistributionInAmount
      contextRef="From2025-03-112025-03-12"
      decimals="-3"
      id="Fact004489"
      unitRef="BRL">129784000</afya:FirstDividendDistributionInAmount>
    <afya:PercentageOfDividendDistribution
      contextRef="From2025-03-112025-03-12"
      decimals="INF"
      id="Fact004491"
      unitRef="Pure">0.20</afya:PercentageOfDividendDistribution>
    <ifrs-full:DividendsPaidOtherSharesPerShare
      contextRef="From2025-04-032025-04-04"
      decimals="INF"
      id="Fact004493"
      unitRef="BRLPShares">1.348923</ifrs-full:DividendsPaidOtherSharesPerShare>
    <afya:RepurchaseOfOrdinaryShares
      contextRef="AsOf2025-08-13_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      id="Fact004495"
      unitRef="Shares">4000000</afya:RepurchaseOfOrdinaryShares>
    <afya:CashOutflow
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004497"
      unitRef="BRL">77002000</afya:CashOutflow>
    <afya:ScheduleOfTreasurySharesMovementExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004501">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfTreasurySharesMovementExplanatory_pn3n3_zFqys31Z6pmf" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Equity (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span id="xdx_8B7_z1lKQEh9mEhe" style="display: none"&gt;Schedule
    of number and movements in treasury shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 48%; padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Number of treasury shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 29%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Average price (in Brazilian Reais)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; text-align: right; font-size: 10pt; text-indent: -9.35pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Outstanding at January 1, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20230101__20231231_zLIRN8DzrJs6" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;3,786,285&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20230101__20231231_zp4RN1pSehDc" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;80.54&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Repurchased&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NumberOfSharesRepurchased_pip0_c20230101__20231231_zIFiSsp7ZrU6" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"&gt;&lt;span style="font-size: 8.5pt"&gt;216,339&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AveragePriceRepurchased_pip0_c20230101__20231231_zKgY03FRrdij" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"&gt;&lt;span style="font-size: 8.5pt"&gt;57.17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Delivered under the share-based compensation plans&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20230101__20231231_zBTy8AECDH69" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"&gt;&lt;span style="font-size: 8.5pt"&gt;(229,146)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20230101__20231231_z3ymjGJWvvn4" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"&gt;&lt;span style="font-size: 8.5pt"&gt;79.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="background-color: White"&gt;
    &lt;td style="width: 48%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Outstanding at December 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20240101__20241231_zQzjgrbWJZt" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 23%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;3,773,478&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20240101__20241231_zN8rACYg7P9c" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 29%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;79.28&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Delivered under the share-based compensation plans&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20240101__20241231_zWarKk2kBdBc" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"&gt;&lt;span style="font-size: 8.5pt"&gt;(317,940)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20240101__20241231_ze05wOtMOcog" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"&gt;&lt;span style="font-size: 8.5pt"&gt;79.28&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Outstanding at December 31, 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NumberOfSharesOutstanding_iS_pip0_c20250101__20251231_zjJrbHUyw2Da" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at beginning balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;3,455,538&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20250101__20251231_znhjjQqlaLG8" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at beginning balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;79.28&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Repurchased&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NumberOfSharesRepurchased_pip0_c20250101__20251231_zpFkaLnJResk" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Repurchased"&gt;&lt;span style="font-size: 8.5pt"&gt;966,541 &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AveragePriceRepurchased_pip0_c20250101__20251231_zD2WH79RwTml" style="padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price repurchased"&gt;&lt;span style="font-size: 8.5pt"&gt;80.24&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;Delivered under the share-based compensation plans&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan_pip0_c20250101__20251231_zdMXbpddoxZ9" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of treasury shares, delivered under the share-based compensation plan"&gt;&lt;span style="font-size: 8.5pt"&gt;(566,929)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AveragePriceDeliveredUnderSharebasedCompensationPlan_pip0_c20250101__20251231_zFTLvkjxLdK2" style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, delivered under the share-based compensation plan"&gt;&lt;span style="font-size: 8.5pt"&gt;79.28 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;Outstanding
at December 31, 2025 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iE_pip0_c20250101__20251231_znR8iogO0UV9" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Number of shares, Outstanding, at ending balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;3,855,150 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20250101__20251231_zF8D1o4cTSIj" style="border-bottom: Black 1.5pt double; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price, at ending balance"&gt;&lt;span style="font-size: 8.5pt"&gt;&lt;b&gt;79.52 &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&lt;/p&gt;

</afya:ScheduleOfTreasurySharesMovementExplanatory>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004503"
      unitRef="Shares">3786285</ifrs-full:NumberOfSharesOutstanding>
    <afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004505"
      unitRef="BRLPShares">80.54</afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019>
    <afya:NumberOfSharesRepurchased
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004507"
      unitRef="Shares">216339</afya:NumberOfSharesRepurchased>
    <afya:AveragePriceRepurchased
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004509"
      unitRef="BRLPShares">57.17</afya:AveragePriceRepurchased>
    <afya:NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004511"
      unitRef="Shares">-229146</afya:NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan>
    <afya:AveragePriceDeliveredUnderSharebasedCompensationPlan
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004513"
      unitRef="BRLPShares">79.28</afya:AveragePriceDeliveredUnderSharebasedCompensationPlan>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004515"
      unitRef="Shares">3773478</ifrs-full:NumberOfSharesOutstanding>
    <afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004517"
      unitRef="BRLPShares">79.28</afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019>
    <afya:NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact004519"
      unitRef="Shares">-317940</afya:NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan>
    <afya:AveragePriceDeliveredUnderSharebasedCompensationPlan
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact004521"
      unitRef="BRLPShares">79.28</afya:AveragePriceDeliveredUnderSharebasedCompensationPlan>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact004523"
      unitRef="Shares">3455538</ifrs-full:NumberOfSharesOutstanding>
    <afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact004525"
      unitRef="BRLPShares">79.28</afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019>
    <afya:NumberOfSharesRepurchased
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact004527"
      unitRef="Shares">966541</afya:NumberOfSharesRepurchased>
    <afya:AveragePriceRepurchased
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact004529"
      unitRef="BRLPShares">80.24</afya:AveragePriceRepurchased>
    <afya:NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact004531"
      unitRef="Shares">-566929</afya:NumberOfTreasurySharesDeliveredUnderSharebasedCompensationPlan>
    <afya:AveragePriceDeliveredUnderSharebasedCompensationPlan
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact004533"
      unitRef="BRLPShares">79.28</afya:AveragePriceDeliveredUnderSharebasedCompensationPlan>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact004535"
      unitRef="Shares">3855150</ifrs-full:NumberOfSharesOutstanding>
    <afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact004537"
      unitRef="BRLPShares">79.52</afya:WeightedAverageExercisePriceOfSharesOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004539">&lt;p id="xdx_80D_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zH11XJlrXg58" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;16&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_822_zH5jfAacIaUb"&gt;Earnings per share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; background-color: white"&gt;The table below presents the basic and diluted earnings per share
calculations:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--ScheduleOfEarningsPerShareTableExplanatory_pn3n3_zh6rgpEuBgn5" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Earnings per share (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt"&gt;&lt;span id="xdx_8B9_zodizhWBFyXc" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20250101_20251231" style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20240101_20241231" style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20230101_20231231" style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 67%; padding-right: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NumeratorAbstract_iB_z0RC0JVRVHcj"&gt;
    &lt;td style="padding-right: 5.4pt"&gt;&lt;b&gt;Numerator&lt;/b&gt;&lt;/td&gt;

    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_pn3n3_zNvLq2og6BKi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt"&gt;Net income attributable to the owners of the Company&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;752,461&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;631,510&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;386,324&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DenominatorAbstract_iB_zPDlgkbW8LBa" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt"&gt;&lt;b&gt;Denominator&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--WeightedAverageShares_pip0_zkwRAE4k6qQ1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt"&gt;Weighted average number of outstanding shares&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;90,475,878&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;90,122,429&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;89,830,351&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pip0_zd5BBGZokSp5" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt"&gt;Effects of dilution from stock options and restricted stock units&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;791,733&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;1,032,207&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;706,492&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--AdjustedWeightedAverageShares_pip0_uShares_znBfrJta8Odd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt"&gt;Weighted average number of outstanding shares adjusted for the effect of dilution&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;91,267,611&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;91,154,636&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;90,536,843&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--BasicEarningsLossPerShare_pip0_zvR340v2rBd4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Basic earnings per share (R$)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;8.32&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;7.01&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;4.30&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--DilutedEarningsLossPerShare_pip0_z1dVhWo7H7Ze" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Diluted earnings per share (R$)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;8.24&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;6.93&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;4.27&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;





</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <afya:ScheduleOfEarningsPerShareTableExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004541">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--ScheduleOfEarningsPerShareTableExplanatory_pn3n3_zh6rgpEuBgn5" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Earnings per share (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt"&gt;&lt;span id="xdx_8B9_zodizhWBFyXc" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20250101_20251231" style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20240101_20241231" style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20230101_20231231" style="padding-right: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 67%; padding-right: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NumeratorAbstract_iB_z0RC0JVRVHcj"&gt;
    &lt;td style="padding-right: 5.4pt"&gt;&lt;b&gt;Numerator&lt;/b&gt;&lt;/td&gt;

    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_pn3n3_zNvLq2og6BKi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt"&gt;Net income attributable to the owners of the Company&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;752,461&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;631,510&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;386,324&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DenominatorAbstract_iB_zPDlgkbW8LBa" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt"&gt;&lt;b&gt;Denominator&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--WeightedAverageShares_pip0_zkwRAE4k6qQ1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt"&gt;Weighted average number of outstanding shares&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;90,475,878&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;90,122,429&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;89,830,351&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pip0_zd5BBGZokSp5" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt"&gt;Effects of dilution from stock options and restricted stock units&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;791,733&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;1,032,207&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;706,492&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--AdjustedWeightedAverageShares_pip0_uShares_znBfrJta8Odd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 7.1pt; text-indent: -7.1pt"&gt;Weighted average number of outstanding shares adjusted for the effect of dilution&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;91,267,611&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;91,154,636&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;90,536,843&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--BasicEarningsLossPerShare_pip0_zvR340v2rBd4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Basic earnings per share (R$)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;8.32&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;7.01&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;4.30&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--DilutedEarningsLossPerShare_pip0_z1dVhWo7H7Ze" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;Diluted earnings per share (R$)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;8.24&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;6.93&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;4.27&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfEarningsPerShareTableExplanatory>
    <ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004547"
      unitRef="BRL">752461000</ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends>
    <ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004548"
      unitRef="BRL">631510000</ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends>
    <ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004549"
      unitRef="BRL">386324000</ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends>
    <ifrs-full:WeightedAverageShares
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact004555"
      unitRef="Shares">90475878</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact004556"
      unitRef="Shares">90122429</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004557"
      unitRef="Shares">89830351</ifrs-full:WeightedAverageShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact004559"
      unitRef="Shares">791733</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact004560"
      unitRef="Shares">1032207</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004561"
      unitRef="Shares">706492</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact004563"
      unitRef="Shares">91267611</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact004564"
      unitRef="Shares">91154636</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004565"
      unitRef="Shares">90536843</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact004567"
      unitRef="BRLPShares">8.32</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact004568"
      unitRef="BRLPShares">7.01</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004569"
      unitRef="BRLPShares">4.30</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact004571"
      unitRef="BRLPShares">8.24</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact004572"
      unitRef="BRLPShares">6.93</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004573"
      unitRef="BRLPShares">4.27</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DisclosureOfRevenueExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004576">&lt;p id="xdx_80C_eifrs-full--DisclosureOfRevenueExplanatory_zjXsL3NXZAja" style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;17&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_827_zJ2ZIj7ya1wl"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfNetSalesRevenueExplanatory_pn3n3_zCw9eshgzik3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Revenue (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;&lt;span id="xdx_8BA_zPRZBJnC7Fod" style="display: none"&gt;Schedule of net sales revenue&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20251231_z0k2DkE3dr21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20240101__20241231_zTfpTc16bgq8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20230101__20231231_zHaKiN8J6dZ3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 67%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;

    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProfessionalFeesExpenses_pn3n3_zyjYbgSzo7D4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;Tuition fees&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;4,684,322 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;4,052,379 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,505,250&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--OtherRevenue1_pn3n3_zK2rOdtULspa" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;Other&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;331,934 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;305,527 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;263,937&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeductionAbstract_iB_zmierXsa5567" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;&lt;b&gt;Deductions&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeductionOfGrantedDiscounts_pn3n3_zmSi6w4vfHif" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt"&gt;Discount and scholarships&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(685,219)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(515,311)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(435,368)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeductionOfReturnsOfNetRevenue_pn3n3_zyxMaG0JrtEd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt"&gt;Returns&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(31,665)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(25,312)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(27,743)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DeductionOfTaxes_pn3n3_ztUq5OcAl3ye" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt"&gt;Taxes&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(194,477)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(170,628)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(142,825)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DeductionOfProuni_pn3n3_zMQegXTjKfub" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt"&gt;PROUNI&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(407,640)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(342,326)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(287,338)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--RevenueFromContractsWithCustomers_pn3n3_zENpZA0g604i" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b style="display: none"&gt;Revenue from contracts with customers&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;3,697,255 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;3,304,329 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--TimingOfRevenueRecognition_iB_zmLCzlqisHAi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--TransferredOverTime_pn3n3_znL7OQZVEgVg" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;Transferred over time&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,618,234 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,242,035 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;2,821,251&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TransferredAtPointInTime_pn3n3_zJDK3Rvkhymh" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;Transferred at a point in time&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;79,021 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;62,294 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;54,662&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A9_zKRbFzCyyky" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;span style="font-weight: normal"&gt;The Company&#x2019;s revenue from contracts with customers
are all in Brazil. The Company is not subject to the payment of the contributions Social Integration Program (&lt;i&gt;Programa de Integra&#xe7;&#xe3;o
Social&lt;/i&gt;, or PIS) and the Social Contribution on Revenue (&lt;i&gt;Contribui&#xe7;&#xe3;o para o Financiamento da Seguridade Social&lt;/i&gt;,
or COFINS) on the revenue from under graduation degrees under the PROUNI program.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;span style="font-weight: normal"&gt;The tables below present the revenue for the Company&#x2019;s
operating segments for the years ended December 31, 2025, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfRevenueBySegmentTableTextBlock_pn3n3_zkBZ5wNRCs13" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Revenue (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_8BA_zmVU54gwzEyj" style="display: none"&gt;Schedule of revenue by
    segment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -5.55pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zDQtF0xJChc1" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;3,255,426 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z1ZBu6QWj095" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;284,471 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zvdxvb73LEEh" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;171,323 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zd9whSpsZVi9" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;(13,965)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231_zSOGH5Xnb3pe" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;3,697,255 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Tuition fees&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zxTj7MtzKt5d" style="text-align: right" title="Tuition fees"&gt;3,239,729 &lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zew0tg46xSEe" style="text-align: right" title="Tuition fees"&gt;187,707 &lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zqPYhTs7AE04" style="text-align: right" title="Tuition fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4640"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zSa4HZ6N1R8c" style="text-align: right" title="Tuition fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4642"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231_z2zUfl474Gf9" style="text-align: right" title="Tuition fees"&gt;3,427,436 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Other&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zr5a9NuReNjl" style="text-align: right" title="Other"&gt;15,697 &lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zMZj6PRwKhUl" style="text-align: right" title="Other"&gt;96,764 &lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z2y6DeN77sPj" style="text-align: right" title="Other"&gt;171,323 &lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z9JjdkDCSW9l" style="text-align: right" title="Other"&gt;(13,965)&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231_zIR2Ku5Qv4pc" style="text-align: right" title="Other"&gt;269,819 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TimingRevenueRecognition_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z9z7x0eRjU47" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;3,255,426 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLNQK7yhLHA6" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;284,471 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--TimingRevenueRecognition_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;171,323 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--TimingRevenueRecognition_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;(13,965)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TimingRevenueRecognition_c20250101__20251231_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;3,697,255 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Transferred over time&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjMafsieeqX9" style="text-align: right" title="Transferred over time"&gt;3,239,729 &lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zKc0tSs6qB0a" style="text-align: right" title="Transferred over time"&gt;223,774 &lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zlzJtCMPRm29" style="text-align: right" title="Transferred over time"&gt;168,696 &lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z6s05TJfK2F4" style="text-align: right" title="Transferred over time"&gt;(13,965)&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231_zRSIzEW3h2ii" style="text-align: right" title="Transferred over time"&gt;3,618,234 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Transferred at a point in time&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zLuuUHMjM7jg" style="text-align: right" title="Transferred at a point in time"&gt;15,697 &lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;60,697 &lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;2,627 &lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4682"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;79,021 &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z61D4ieGN1Q5" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;2,895,692&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsearJYQim93" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;255,438&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zZQZ6vbN1941" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;161,787&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zn8hHwScifS3" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;(8,588)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231_znjkGmFJR3K6" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;3,304,329&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Tuition fees&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zHCrZk6cnSFb" style="text-align: right" title="Tuition fees"&gt;2,877,731&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvaF2I7AKls" style="text-align: right" title="Tuition fees"&gt;122,391&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zixdSE6vsQe4" style="text-align: right" title="Tuition fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4700"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zs3LypPBHb69" style="text-align: right" title="Tuition fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4702"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231_znq0h0wEsSjk" style="text-align: right" title="Tuition fees"&gt;3,000,122&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Other&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zF42nkGGAJY7" style="text-align: right" title="Other"&gt;17,961&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSoGowoPnyC3" style="text-align: right" title="Other"&gt;133,047&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zWrG05yAV7me" style="text-align: right" title="Other"&gt;161,787&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zFovuHVYo7Ah" style="text-align: right" title="Other"&gt;(8,588)&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231_zM1MLMyzaWA1" style="text-align: right" title="Other"&gt;304,207&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TimingRevenueRecognition_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zid68DJq1ZUh" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;2,895,692&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zM1wOFLICcwg" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;255,438&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--TimingRevenueRecognition_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;161,787&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--TimingRevenueRecognition_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;(8,588)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TimingRevenueRecognition_c20240101__20241231_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;3,304,329&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Transferred over time&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zOD21ltPW7m6" style="text-align: right" title="Transferred over time"&gt;2,877,731&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdJcmR8TcIMe" style="text-align: right" title="Transferred over time"&gt;218,573&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z2oKNgmjiOn9" style="text-align: right" title="Transferred over time"&gt;154,319&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zjnVkS5xFLbd" style="text-align: right" title="Transferred over time"&gt;(8,588)&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231_zUfbeLioV3A9" style="text-align: right" title="Transferred over time"&gt;3,242,035&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Transferred at a point in time&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z64dbGHZABl2" style="text-align: right" title="Transferred at a point in time"&gt;17,961&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;36,865&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zJORSYj10usj" style="text-align: right" title="Transferred at a point in time"&gt;7,468&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4742"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;62,294&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zjhX9wnJre25" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;2,511,018&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRM8QS6uSIK9" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;235,830&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z55qWKfUG7Ng" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;140,282&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zm2MyO4OJAk" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231_zld4rMWWtk1e" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Tuition fees&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXnykqmuOb69" style="text-align: right" title="Tuition fees"&gt;2,494,121&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zw7rBSOvZ6T4" style="text-align: right" title="Tuition fees"&gt;146,477&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zmLHQC59KzQ8" style="text-align: right" title="Tuition fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4762"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_ztpdXN4ZDpNg" style="text-align: right" title="Tuition fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4764"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231_zT5GwOoPWnhb" style="text-align: right" title="Tuition fees"&gt;2,640,598&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Other&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zSfGsU9WK1V3" style="text-align: right" title="Other"&gt;16,897&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z8MJnsPKy61d" style="text-align: right" title="Other"&gt;89,353&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLgl9PjD0rf1" style="text-align: right" title="Other"&gt;140,282&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zsfYdgiqpKu2" style="text-align: right" title="Other"&gt;(11,217)&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231_zx3Tmn32k685" style="text-align: right" title="Other"&gt;235,315&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;2,511,018&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;235,830&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;140,282&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TimingRevenueRecognition_c20230101__20231231_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Transferred over time&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zeYsuWApdDMd" style="text-align: right" title="Transferred over time"&gt;2,494,121&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zDYgQqqNhTW6" style="text-align: right" title="Transferred over time"&gt;206,098&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z7ou3VsSQmAj" style="text-align: right" title="Transferred over time"&gt;132,249&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zkn5kwaV5YV9" style="text-align: right" title="Transferred over time"&gt;(11,217)&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231_zyfOVLAEXie3" style="text-align: right" title="Transferred over time"&gt;2,821,251&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Transferred at a point in time&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;16,897&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;29,732&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;8,033&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4804"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;54,662&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_z1g7ib5Ccuuh" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
</ifrs-full:DisclosureOfRevenueExplanatory>
    <afya:ScheduleOfNetSalesRevenueExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004578">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfNetSalesRevenueExplanatory_pn3n3_zCw9eshgzik3" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Revenue (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;&lt;span id="xdx_8BA_zPRZBJnC7Fod" style="display: none"&gt;Schedule of net sales revenue&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49B_20250101__20251231_z0k2DkE3dr21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20240101__20241231_zTfpTc16bgq8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49A_20230101__20231231_zHaKiN8J6dZ3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 67%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;

    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProfessionalFeesExpenses_pn3n3_zyjYbgSzo7D4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;Tuition fees&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;4,684,322 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;4,052,379 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,505,250&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--OtherRevenue1_pn3n3_zK2rOdtULspa" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;Other&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;331,934 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;305,527 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;263,937&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeductionAbstract_iB_zmierXsa5567" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;&lt;b&gt;Deductions&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeductionOfGrantedDiscounts_pn3n3_zmSi6w4vfHif" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt"&gt;Discount and scholarships&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(685,219)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(515,311)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(435,368)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeductionOfReturnsOfNetRevenue_pn3n3_zyxMaG0JrtEd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt"&gt;Returns&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(31,665)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(25,312)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(27,743)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DeductionOfTaxes_pn3n3_ztUq5OcAl3ye" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt"&gt;Taxes&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(194,477)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(170,628)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(142,825)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DeductionOfProuni_pn3n3_zMQegXTjKfub" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt; text-indent: 7pt"&gt;PROUNI&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(407,640)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(342,326)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(287,338)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--RevenueFromContractsWithCustomers_pn3n3_zENpZA0g604i" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b style="display: none"&gt;Revenue from contracts with customers&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;3,697,255 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;3,304,329 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--TimingOfRevenueRecognition_iB_zmLCzlqisHAi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--TransferredOverTime_pn3n3_znL7OQZVEgVg" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;Transferred over time&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,618,234 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,242,035 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;2,821,251&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TransferredAtPointInTime_pn3n3_zJDK3Rvkhymh" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 1.7pt"&gt;Transferred at a point in time&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;79,021 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;62,294 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;54,662&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfNetSalesRevenueExplanatory>
    <afya:ProfessionalFeesExpenses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004580"
      unitRef="BRL">4684322000</afya:ProfessionalFeesExpenses>
    <afya:ProfessionalFeesExpenses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004581"
      unitRef="BRL">4052379000</afya:ProfessionalFeesExpenses>
    <afya:ProfessionalFeesExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004582"
      unitRef="BRL">3505250000</afya:ProfessionalFeesExpenses>
    <afya:OtherRevenue1
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004584"
      unitRef="BRL">331934000</afya:OtherRevenue1>
    <afya:OtherRevenue1
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004585"
      unitRef="BRL">305527000</afya:OtherRevenue1>
    <afya:OtherRevenue1
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004586"
      unitRef="BRL">263937000</afya:OtherRevenue1>
    <afya:DeductionOfGrantedDiscounts
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004592"
      unitRef="BRL">-685219000</afya:DeductionOfGrantedDiscounts>
    <afya:DeductionOfGrantedDiscounts
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004593"
      unitRef="BRL">-515311000</afya:DeductionOfGrantedDiscounts>
    <afya:DeductionOfGrantedDiscounts
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004594"
      unitRef="BRL">-435368000</afya:DeductionOfGrantedDiscounts>
    <afya:DeductionOfReturnsOfNetRevenue
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004596"
      unitRef="BRL">-31665000</afya:DeductionOfReturnsOfNetRevenue>
    <afya:DeductionOfReturnsOfNetRevenue
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004597"
      unitRef="BRL">-25312000</afya:DeductionOfReturnsOfNetRevenue>
    <afya:DeductionOfReturnsOfNetRevenue
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004598"
      unitRef="BRL">-27743000</afya:DeductionOfReturnsOfNetRevenue>
    <afya:DeductionOfTaxes
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004600"
      unitRef="BRL">-194477000</afya:DeductionOfTaxes>
    <afya:DeductionOfTaxes
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004601"
      unitRef="BRL">-170628000</afya:DeductionOfTaxes>
    <afya:DeductionOfTaxes
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004602"
      unitRef="BRL">-142825000</afya:DeductionOfTaxes>
    <afya:DeductionOfProuni
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004604"
      unitRef="BRL">-407640000</afya:DeductionOfProuni>
    <afya:DeductionOfProuni
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004605"
      unitRef="BRL">-342326000</afya:DeductionOfProuni>
    <afya:DeductionOfProuni
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004606"
      unitRef="BRL">-287338000</afya:DeductionOfProuni>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004608"
      unitRef="BRL">3697255000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004609"
      unitRef="BRL">3304329000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004610"
      unitRef="BRL">2875913000</ifrs-full:RevenueFromContractsWithCustomers>
    <afya:TransferredOverTime
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004616"
      unitRef="BRL">3618234000</afya:TransferredOverTime>
    <afya:TransferredOverTime
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004617"
      unitRef="BRL">3242035000</afya:TransferredOverTime>
    <afya:TransferredOverTime
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004618"
      unitRef="BRL">2821251000</afya:TransferredOverTime>
    <afya:TransferredAtPointInTime
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004620"
      unitRef="BRL">79021000</afya:TransferredAtPointInTime>
    <afya:TransferredAtPointInTime
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004621"
      unitRef="BRL">62294000</afya:TransferredAtPointInTime>
    <afya:TransferredAtPointInTime
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004622"
      unitRef="BRL">54662000</afya:TransferredAtPointInTime>
    <afya:ScheduleOfRevenueBySegmentTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact004624">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfRevenueBySegmentTableTextBlock_pn3n3_zkBZ5wNRCs13" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Revenue (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span id="xdx_8BA_zmVU54gwzEyj" style="display: none"&gt;Schedule of revenue by
    segment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -5.55pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zDQtF0xJChc1" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;3,255,426 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z1ZBu6QWj095" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;284,471 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zvdxvb73LEEh" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;171,323 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zd9whSpsZVi9" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;(13,965)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20250101__20251231_zSOGH5Xnb3pe" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;3,697,255 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Tuition fees&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zxTj7MtzKt5d" style="text-align: right" title="Tuition fees"&gt;3,239,729 &lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zew0tg46xSEe" style="text-align: right" title="Tuition fees"&gt;187,707 &lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zqPYhTs7AE04" style="text-align: right" title="Tuition fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4640"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zSa4HZ6N1R8c" style="text-align: right" title="Tuition fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4642"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20250101__20251231_z2zUfl474Gf9" style="text-align: right" title="Tuition fees"&gt;3,427,436 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Other&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zr5a9NuReNjl" style="text-align: right" title="Other"&gt;15,697 &lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zMZj6PRwKhUl" style="text-align: right" title="Other"&gt;96,764 &lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z2y6DeN77sPj" style="text-align: right" title="Other"&gt;171,323 &lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z9JjdkDCSW9l" style="text-align: right" title="Other"&gt;(13,965)&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20250101__20251231_zIR2Ku5Qv4pc" style="text-align: right" title="Other"&gt;269,819 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TimingRevenueRecognition_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z9z7x0eRjU47" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;3,255,426 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLNQK7yhLHA6" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;284,471 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--TimingRevenueRecognition_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;171,323 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--TimingRevenueRecognition_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;(13,965)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TimingRevenueRecognition_c20250101__20251231_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;3,697,255 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Transferred over time&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zjMafsieeqX9" style="text-align: right" title="Transferred over time"&gt;3,239,729 &lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zKc0tSs6qB0a" style="text-align: right" title="Transferred over time"&gt;223,774 &lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zlzJtCMPRm29" style="text-align: right" title="Transferred over time"&gt;168,696 &lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_z6s05TJfK2F4" style="text-align: right" title="Transferred over time"&gt;(13,965)&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20250101__20251231_zRSIzEW3h2ii" style="text-align: right" title="Transferred over time"&gt;3,618,234 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Transferred at a point in time&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20250101__20251231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zLuuUHMjM7jg" style="text-align: right" title="Transferred at a point in time"&gt;15,697 &lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;60,697 &lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;2,627 &lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4682"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetRevenueOtherTransferredPoint_c20250101__20251231_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;79,021 &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z61D4ieGN1Q5" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;2,895,692&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zsearJYQim93" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;255,438&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zZQZ6vbN1941" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;161,787&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zn8hHwScifS3" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;(8,588)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20240101__20241231_znjkGmFJR3K6" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;3,304,329&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Tuition fees&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zHCrZk6cnSFb" style="text-align: right" title="Tuition fees"&gt;2,877,731&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvaF2I7AKls" style="text-align: right" title="Tuition fees"&gt;122,391&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zixdSE6vsQe4" style="text-align: right" title="Tuition fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4700"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zs3LypPBHb69" style="text-align: right" title="Tuition fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4702"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--ProfessionalFeesExpense_pn3n3_c20240101__20241231_znq0h0wEsSjk" style="text-align: right" title="Tuition fees"&gt;3,000,122&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Other&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zF42nkGGAJY7" style="text-align: right" title="Other"&gt;17,961&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSoGowoPnyC3" style="text-align: right" title="Other"&gt;133,047&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zWrG05yAV7me" style="text-align: right" title="Other"&gt;161,787&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zFovuHVYo7Ah" style="text-align: right" title="Other"&gt;(8,588)&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--OtherRevenue_pn3n3_c20240101__20241231_zM1MLMyzaWA1" style="text-align: right" title="Other"&gt;304,207&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TimingRevenueRecognition_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zid68DJq1ZUh" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;2,895,692&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zM1wOFLICcwg" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;255,438&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--TimingRevenueRecognition_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;161,787&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--TimingRevenueRecognition_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;(8,588)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TimingRevenueRecognition_c20240101__20241231_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;3,304,329&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Transferred over time&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_zOD21ltPW7m6" style="text-align: right" title="Transferred over time"&gt;2,877,731&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdJcmR8TcIMe" style="text-align: right" title="Transferred over time"&gt;218,573&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z2oKNgmjiOn9" style="text-align: right" title="Transferred over time"&gt;154,319&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zjnVkS5xFLbd" style="text-align: right" title="Transferred over time"&gt;(8,588)&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20240101__20241231_zUfbeLioV3A9" style="text-align: right" title="Transferred over time"&gt;3,242,035&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Transferred at a point in time&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--UndergraduateMember_z64dbGHZABl2" style="text-align: right" title="Transferred at a point in time"&gt;17,961&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;36,865&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20240101__20241231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zJORSYj10usj" style="text-align: right" title="Transferred at a point in time"&gt;7,468&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4742"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NetRevenueOtherTransferredPoint_c20240101__20241231_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;62,294&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;







&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Undergraduate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Continuing education&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Medical practice solutions&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;Elimination (inter-segment transactions)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: -0.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zjhX9wnJre25" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;2,511,018&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRM8QS6uSIK9" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;235,830&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z55qWKfUG7Ng" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;140,282&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zm2MyO4OJAk" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20230101__20231231_zld4rMWWtk1e" style="text-align: right" title="Types of services or goods"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Tuition fees&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXnykqmuOb69" style="text-align: right" title="Tuition fees"&gt;2,494,121&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zw7rBSOvZ6T4" style="text-align: right" title="Tuition fees"&gt;146,477&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zmLHQC59KzQ8" style="text-align: right" title="Tuition fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4762"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_ztpdXN4ZDpNg" style="text-align: right" title="Tuition fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4764"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20230101__20231231_zT5GwOoPWnhb" style="text-align: right" title="Tuition fees"&gt;2,640,598&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Other&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zSfGsU9WK1V3" style="text-align: right" title="Other"&gt;16,897&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z8MJnsPKy61d" style="text-align: right" title="Other"&gt;89,353&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_zLgl9PjD0rf1" style="text-align: right" title="Other"&gt;140,282&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zsfYdgiqpKu2" style="text-align: right" title="Other"&gt;(11,217)&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherRevenue_pn3n3_c20230101__20231231_zx3Tmn32k685" style="text-align: right" title="Other"&gt;235,315&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;2,511,018&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;235,830&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;140,282&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TimingRevenueRecognition_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;(11,217)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TimingRevenueRecognition_c20230101__20231231_pn3n3" style="text-align: right" title="Timing of revenue recognition"&gt;&lt;b&gt;2,875,913&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Transferred over time&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_zeYsuWApdDMd" style="text-align: right" title="Transferred over time"&gt;2,494,121&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zDYgQqqNhTW6" style="text-align: right" title="Transferred over time"&gt;206,098&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_z7ou3VsSQmAj" style="text-align: right" title="Transferred over time"&gt;132,249&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_zkn5kwaV5YV9" style="text-align: right" title="Transferred over time"&gt;(11,217)&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20230101__20231231_zyfOVLAEXie3" style="text-align: right" title="Transferred over time"&gt;2,821,251&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;Transferred at a point in time&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UndergradMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;16,897&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;29,732&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--MedicalPracticeSolutionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;8,033&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231__ifrs-full--SegmentsAxis__custom--EliminationInterSegmentTransactionsMember_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4804"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NetRevenueOtherTransferredPoint_c20230101__20231231_pn3n3" style="text-align: right" title="Transferred at a point in time"&gt;54,662&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</afya:ScheduleOfRevenueBySegmentTableTextBlock>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2025-01-012025-12-31_custom_UndergraduateMember"
      decimals="-3"
      id="Fact004626"
      unitRef="BRL">3255426000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2025-01-012025-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004628"
      unitRef="BRL">284471000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004630"
      unitRef="BRL">171323000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact004632"
      unitRef="BRL">-13965000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004634"
      unitRef="BRL">3697255000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2025-01-012025-12-31_custom_UndergraduateMember"
      decimals="-3"
      id="Fact004636"
      unitRef="BRL">3239729000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2025-01-012025-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004638"
      unitRef="BRL">187707000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004644"
      unitRef="BRL">3427436000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:OtherRevenue
      contextRef="From2025-01-012025-12-31_custom_UndergraduateMember"
      decimals="-3"
      id="Fact004646"
      unitRef="BRL">15697000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2025-01-012025-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004648"
      unitRef="BRL">96764000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004650"
      unitRef="BRL">171323000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact004652"
      unitRef="BRL">-13965000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004654"
      unitRef="BRL">269819000</ifrs-full:OtherRevenue>
    <afya:TimingRevenueRecognition
      contextRef="From2025-01-012025-12-31_custom_UndergraduateMember"
      decimals="-3"
      id="Fact004656"
      unitRef="BRL">3255426000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2025-01-012025-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004658"
      unitRef="BRL">284471000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004660"
      unitRef="BRL">171323000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact004662"
      unitRef="BRL">-13965000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004664"
      unitRef="BRL">3697255000</afya:TimingRevenueRecognition>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2025-01-012025-12-31_custom_UndergraduateMember"
      decimals="-3"
      id="Fact004666"
      unitRef="BRL">3239729000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2025-01-012025-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004668"
      unitRef="BRL">223774000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004670"
      unitRef="BRL">168696000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2025-01-012025-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact004672"
      unitRef="BRL">-13965000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004674"
      unitRef="BRL">3618234000</ifrs-full:FeeAndCommissionIncome>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2025-01-012025-12-31_custom_UndergraduateMember"
      decimals="-3"
      id="Fact004676"
      unitRef="BRL">15697000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2025-01-012025-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004678"
      unitRef="BRL">60697000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2025-01-012025-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004680"
      unitRef="BRL">2627000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004684"
      unitRef="BRL">79021000</afya:NetRevenueOtherTransferredPoint>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2024-01-012024-12-31_custom_UndergraduateMember"
      decimals="-3"
      id="Fact004686"
      unitRef="BRL">2895692000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2024-01-012024-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004688"
      unitRef="BRL">255438000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004690"
      unitRef="BRL">161787000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact004692"
      unitRef="BRL">-8588000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004694"
      unitRef="BRL">3304329000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2024-01-012024-12-31_custom_UndergraduateMember"
      decimals="-3"
      id="Fact004696"
      unitRef="BRL">2877731000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2024-01-012024-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004698"
      unitRef="BRL">122391000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004704"
      unitRef="BRL">3000122000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:OtherRevenue
      contextRef="From2024-01-012024-12-31_custom_UndergraduateMember"
      decimals="-3"
      id="Fact004706"
      unitRef="BRL">17961000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2024-01-012024-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004708"
      unitRef="BRL">133047000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004710"
      unitRef="BRL">161787000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact004712"
      unitRef="BRL">-8588000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004714"
      unitRef="BRL">304207000</ifrs-full:OtherRevenue>
    <afya:TimingRevenueRecognition
      contextRef="From2024-01-012024-12-31_custom_UndergraduateMember"
      decimals="-3"
      id="Fact004716"
      unitRef="BRL">2895692000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2024-01-012024-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004718"
      unitRef="BRL">255438000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004720"
      unitRef="BRL">161787000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact004722"
      unitRef="BRL">-8588000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004724"
      unitRef="BRL">3304329000</afya:TimingRevenueRecognition>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2024-01-012024-12-31_custom_UndergraduateMember"
      decimals="-3"
      id="Fact004726"
      unitRef="BRL">2877731000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2024-01-012024-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004728"
      unitRef="BRL">218573000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004730"
      unitRef="BRL">154319000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2024-01-012024-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact004732"
      unitRef="BRL">-8588000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004734"
      unitRef="BRL">3242035000</ifrs-full:FeeAndCommissionIncome>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2024-01-012024-12-31_custom_UndergraduateMember"
      decimals="-3"
      id="Fact004736"
      unitRef="BRL">17961000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2024-01-012024-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004738"
      unitRef="BRL">36865000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2024-01-012024-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004740"
      unitRef="BRL">7468000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004744"
      unitRef="BRL">62294000</afya:NetRevenueOtherTransferredPoint>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2023-01-012023-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact004748"
      unitRef="BRL">2511018000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004750"
      unitRef="BRL">235830000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004752"
      unitRef="BRL">140282000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact004754"
      unitRef="BRL">-11217000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004756"
      unitRef="BRL">2875913000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2023-01-012023-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact004758"
      unitRef="BRL">2494121000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004760"
      unitRef="BRL">146477000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004766"
      unitRef="BRL">2640598000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:OtherRevenue
      contextRef="From2023-01-012023-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact004768"
      unitRef="BRL">16897000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004770"
      unitRef="BRL">89353000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004772"
      unitRef="BRL">140282000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact004774"
      unitRef="BRL">-11217000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004776"
      unitRef="BRL">235315000</ifrs-full:OtherRevenue>
    <afya:TimingRevenueRecognition
      contextRef="From2023-01-012023-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact004778"
      unitRef="BRL">2511018000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004780"
      unitRef="BRL">235830000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004782"
      unitRef="BRL">140282000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact004784"
      unitRef="BRL">-11217000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004786"
      unitRef="BRL">2875913000</afya:TimingRevenueRecognition>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2023-01-012023-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact004788"
      unitRef="BRL">2494121000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004790"
      unitRef="BRL">206098000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004792"
      unitRef="BRL">132249000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2023-01-012023-12-31_custom_EliminationInterSegmentTransactionsMember"
      decimals="-3"
      id="Fact004794"
      unitRef="BRL">-11217000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004796"
      unitRef="BRL">2821251000</ifrs-full:FeeAndCommissionIncome>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2023-01-012023-12-31_custom_UndergradMember"
      decimals="-3"
      id="Fact004798"
      unitRef="BRL">16897000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2023-01-012023-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact004800"
      unitRef="BRL">29732000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2023-01-012023-12-31_custom_MedicalPracticeSolutionsMember"
      decimals="-3"
      id="Fact004802"
      unitRef="BRL">8033000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004806"
      unitRef="BRL">54662000</afya:NetRevenueOtherTransferredPoint>
    <ifrs-full:DisclosureOfExpensesByNatureExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004808">&lt;p id="xdx_80F_eifrs-full--DisclosureOfExpensesByNatureExplanatory_znzh8xseTR83" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;18&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_82A_zlCXbF7UWPbd"&gt;Costs and expenses by nature&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--ScheduleOfExpensesByNatureTableTextBlock_pn3n3_z8n8gPs6GOn7" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Costs and expenses by nature (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B7_zSWywQzRhBog" style="display: none"&gt;Schedule of expenses by nature&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_491_20250101__20251231_ztmpjTt7nWO4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20240101__20241231_zIbN2xqQL1Ch" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20230101__20231231_zPl01Wd7Pyw1" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 67%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--Payroll_pn3n3_zhzXb4JCmU65" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Payroll (i)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,370,361)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,236,666)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,149,225)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--HospitalAndMedicalAgreements_pn3n3_zP5AfY4TrlNb" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Hospital and medical agreements&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(80,449)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(94,583)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(86,151)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--DepreciationExpense_iN_pn3n3_di_zp1OnaJxg55c" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Depreciation and amortization&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(373,344)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(333,341)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(289,511)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--LeaseExpenses_pn3n3_zlDGpVvRi4M7" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Lease expenses&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(12,617)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(11,207)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(10,871)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--UtilitiesExpense_pn3n3_za8Rpqn1pGif" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Utilities&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(24,722)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(22,730)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(20,403)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--RepairsAndMaintenanceExpense_iN_pn3n3_di_zPtLi7zS7u5h" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Maintenance&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(134,156)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(127,777)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(105,919)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--SharesBasedCompensation_pn3n3_zqyPtLzbQrta" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Share-based compensation&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(15,318)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(32,424)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(31,535)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--TaxExpenses_pn3n3_zRxtcxX9pDva" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Tax expenses&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(12,091)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(12,105)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(14,447)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--SalesAndMarketingExpense_iN_pn3n3_di_zqVVQzAKi2Ai" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Sales and marketing&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(114,803)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(85,469)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(74,140)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AllowanceForExpectedCreditLosses_iN_pn3n3_di_zf0JeQaGosQ" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Allowance for expected credit losses&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(57,090)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(60,894)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(74,552)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--TravelExpense_iN_pn3n3_di_zSD3f0OT7H1a" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Travel expenses&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(26,144)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(20,345)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(16,098)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ConsultingFees_pn3n3_zgPQU4AwbE6f" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Consulting fees&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(32,645)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(46,022)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(62,630)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--CostExpensesOther_pn3n3_zHLtud2AJk6c" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Other&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(230,310)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(201,361)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(189,015)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--ExpenseByNature_pn3n3_zzBi1VnZmmo3" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(2,484,050)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(2,284,924)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(2,124,497)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--CostOfServices_iN_pn3n3_di_zBaib3z8pSK8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Cost of services&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,313,895)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,215,603)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,109,813)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--SellingGeneralAndAdministrativeExpenses_pn3n3_zEh8NUxuJNRa" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Selling, general and administrative expenses&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,113,065)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,008,427)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(940,132)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AllowanceForExpectedCreditLosses_iN_pn3n3_di_zDLa9JtSQi3c" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Allowance for expected credit losses&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(57,090)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(60,894)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(74,552)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Includes the costs of pedagogical services related to the practicing physician who provides
practical training and supervision to medical students (preceptors).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ifrs-full:DisclosureOfExpensesByNatureExplanatory>
    <afya:ScheduleOfExpensesByNatureTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact004810">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--ScheduleOfExpensesByNatureTableTextBlock_pn3n3_z8n8gPs6GOn7" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Costs and expenses by nature (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B7_zSWywQzRhBog" style="display: none"&gt;Schedule of expenses by nature&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_491_20250101__20251231_ztmpjTt7nWO4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20240101__20241231_zIbN2xqQL1Ch" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20230101__20231231_zPl01Wd7Pyw1" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 67%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--Payroll_pn3n3_zhzXb4JCmU65" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Payroll (i)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,370,361)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,236,666)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,149,225)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--HospitalAndMedicalAgreements_pn3n3_zP5AfY4TrlNb" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Hospital and medical agreements&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(80,449)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(94,583)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(86,151)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--DepreciationExpense_iN_pn3n3_di_zp1OnaJxg55c" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Depreciation and amortization&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(373,344)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(333,341)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(289,511)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--LeaseExpenses_pn3n3_zlDGpVvRi4M7" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Lease expenses&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(12,617)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(11,207)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(10,871)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--UtilitiesExpense_pn3n3_za8Rpqn1pGif" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Utilities&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(24,722)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(22,730)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(20,403)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--RepairsAndMaintenanceExpense_iN_pn3n3_di_zPtLi7zS7u5h" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Maintenance&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(134,156)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(127,777)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(105,919)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--SharesBasedCompensation_pn3n3_zqyPtLzbQrta" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Share-based compensation&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(15,318)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(32,424)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(31,535)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--TaxExpenses_pn3n3_zRxtcxX9pDva" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Tax expenses&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(12,091)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(12,105)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(14,447)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--SalesAndMarketingExpense_iN_pn3n3_di_zqVVQzAKi2Ai" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Sales and marketing&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(114,803)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(85,469)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(74,140)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AllowanceForExpectedCreditLosses_iN_pn3n3_di_zf0JeQaGosQ" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Allowance for expected credit losses&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(57,090)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(60,894)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(74,552)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--TravelExpense_iN_pn3n3_di_zSD3f0OT7H1a" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Travel expenses&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(26,144)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(20,345)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(16,098)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ConsultingFees_pn3n3_zgPQU4AwbE6f" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Consulting fees&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(32,645)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(46,022)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(62,630)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--CostExpensesOther_pn3n3_zHLtud2AJk6c" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Other&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(230,310)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(201,361)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(189,015)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--ExpenseByNature_pn3n3_zzBi1VnZmmo3" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(2,484,050)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(2,284,924)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;(2,124,497)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--CostOfServices_iN_pn3n3_di_zBaib3z8pSK8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Cost of services&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,313,895)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,215,603)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,109,813)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--SellingGeneralAndAdministrativeExpenses_pn3n3_zEh8NUxuJNRa" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Selling, general and administrative expenses&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,113,065)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(1,008,427)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(940,132)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AllowanceForExpectedCreditLosses_iN_pn3n3_di_zDLa9JtSQi3c" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Allowance for expected credit losses&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(57,090)&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(60,894)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;(74,552)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfExpensesByNatureTableTextBlock>
    <afya:Payroll
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004812"
      unitRef="BRL">-1370361000</afya:Payroll>
    <afya:Payroll
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004813"
      unitRef="BRL">-1236666000</afya:Payroll>
    <afya:Payroll
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004814"
      unitRef="BRL">-1149225000</afya:Payroll>
    <afya:HospitalAndMedicalAgreements
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004816"
      unitRef="BRL">-80449000</afya:HospitalAndMedicalAgreements>
    <afya:HospitalAndMedicalAgreements
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004817"
      unitRef="BRL">-94583000</afya:HospitalAndMedicalAgreements>
    <afya:HospitalAndMedicalAgreements
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004818"
      unitRef="BRL">-86151000</afya:HospitalAndMedicalAgreements>
    <ifrs-full:DepreciationExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004820"
      unitRef="BRL">373344000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004821"
      unitRef="BRL">333341000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004822"
      unitRef="BRL">289511000</ifrs-full:DepreciationExpense>
    <afya:LeaseExpenses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004824"
      unitRef="BRL">-12617000</afya:LeaseExpenses>
    <afya:LeaseExpenses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004825"
      unitRef="BRL">-11207000</afya:LeaseExpenses>
    <afya:LeaseExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004826"
      unitRef="BRL">-10871000</afya:LeaseExpenses>
    <ifrs-full:UtilitiesExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004828"
      unitRef="BRL">-24722000</ifrs-full:UtilitiesExpense>
    <ifrs-full:UtilitiesExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004829"
      unitRef="BRL">-22730000</ifrs-full:UtilitiesExpense>
    <ifrs-full:UtilitiesExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004830"
      unitRef="BRL">-20403000</ifrs-full:UtilitiesExpense>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004832"
      unitRef="BRL">134156000</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004833"
      unitRef="BRL">127777000</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004834"
      unitRef="BRL">105919000</ifrs-full:RepairsAndMaintenanceExpense>
    <afya:SharesBasedCompensation
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004836"
      unitRef="BRL">-15318000</afya:SharesBasedCompensation>
    <afya:SharesBasedCompensation
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004837"
      unitRef="BRL">-32424000</afya:SharesBasedCompensation>
    <afya:SharesBasedCompensation
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004838"
      unitRef="BRL">-31535000</afya:SharesBasedCompensation>
    <afya:TaxExpenses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004840"
      unitRef="BRL">-12091000</afya:TaxExpenses>
    <afya:TaxExpenses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004841"
      unitRef="BRL">-12105000</afya:TaxExpenses>
    <afya:TaxExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004842"
      unitRef="BRL">-14447000</afya:TaxExpenses>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004844"
      unitRef="BRL">114803000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004845"
      unitRef="BRL">85469000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004846"
      unitRef="BRL">74140000</ifrs-full:SalesAndMarketingExpense>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004848"
      unitRef="BRL">57090000</afya:AllowanceForExpectedCreditLosses>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004849"
      unitRef="BRL">60894000</afya:AllowanceForExpectedCreditLosses>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004850"
      unitRef="BRL">74552000</afya:AllowanceForExpectedCreditLosses>
    <ifrs-full:TravelExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004852"
      unitRef="BRL">26144000</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004853"
      unitRef="BRL">20345000</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004854"
      unitRef="BRL">16098000</ifrs-full:TravelExpense>
    <afya:ConsultingFees
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004856"
      unitRef="BRL">-32645000</afya:ConsultingFees>
    <afya:ConsultingFees
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004857"
      unitRef="BRL">-46022000</afya:ConsultingFees>
    <afya:ConsultingFees
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004858"
      unitRef="BRL">-62630000</afya:ConsultingFees>
    <afya:CostExpensesOther
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004860"
      unitRef="BRL">-230310000</afya:CostExpensesOther>
    <afya:CostExpensesOther
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004861"
      unitRef="BRL">-201361000</afya:CostExpensesOther>
    <afya:CostExpensesOther
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004862"
      unitRef="BRL">-189015000</afya:CostExpensesOther>
    <ifrs-full:ExpenseByNature
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004864"
      unitRef="BRL">-2484050000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004865"
      unitRef="BRL">-2284924000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004866"
      unitRef="BRL">-2124497000</ifrs-full:ExpenseByNature>
    <afya:CostOfServices
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004868"
      unitRef="BRL">1313895000</afya:CostOfServices>
    <afya:CostOfServices
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004869"
      unitRef="BRL">1215603000</afya:CostOfServices>
    <afya:CostOfServices
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004870"
      unitRef="BRL">1109813000</afya:CostOfServices>
    <afya:SellingGeneralAndAdministrativeExpenses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004872"
      unitRef="BRL">-1113065000</afya:SellingGeneralAndAdministrativeExpenses>
    <afya:SellingGeneralAndAdministrativeExpenses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004873"
      unitRef="BRL">-1008427000</afya:SellingGeneralAndAdministrativeExpenses>
    <afya:SellingGeneralAndAdministrativeExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004874"
      unitRef="BRL">-940132000</afya:SellingGeneralAndAdministrativeExpenses>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004876"
      unitRef="BRL">57090000</afya:AllowanceForExpectedCreditLosses>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004877"
      unitRef="BRL">60894000</afya:AllowanceForExpectedCreditLosses>
    <afya:AllowanceForExpectedCreditLosses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004878"
      unitRef="BRL">74552000</afya:AllowanceForExpectedCreditLosses>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004880">&lt;p id="xdx_808_eifrs-full--DisclosureOfFinanceIncomeExpenseExplanatory_zfqcymkjYyh6" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;19&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_826_zVneMG4DwHB"&gt;Finance result&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfFinanceResultTableTextBlock_pn3n3_zmguLDbLBLwe" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Finance result (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BC_zQxOLJJVwUF6" style="display: none"&gt;Schedule of finance result&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_490_20250101__20251231_z5XTmwejGJF" style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20240101__20241231_z7TM4d819HD9" style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20230101__20231231_zboKnwVvvkTl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 67%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--FinancialIncomeFromCashEquivalents_pn3n3_zp9TewKkqima" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Financial income from cash equivalents&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;138,456 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;59,381 &lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;73,672&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--InterestEarned_pn3n3_zdzzJBRVS35i" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Interest earned&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;49,527 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;43,417 &lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;33,450&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--OtherFinanceIncome_pn3n3_zmOsmHpFjVXe" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Other&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;6,960 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;8,485 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,520&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--FinanceIncome_pn3n3_zttyz74oPGP5" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Finance income&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;194,943 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;111,283 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;110,642&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--InterestExpense1_pn3n3_zTiLXuBq4Qy8" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Interest expense&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(316,379)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(254,386)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(285,447)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--InterestExpenseOnLeaseLiabilities1_pn3n3_zQxZ5WvUitK5" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Interest expense on lease liabilities&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(123,067)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(111,966)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(100,849)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--FinancialDiscountsGrantedExpenses_pn3n3_zyXc0MxQd62e" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Financial discounts&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(54,254)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(33,240)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(30,891)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CreditCardCharges_pn3n3_zZe32h7X88cf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Credit card charges&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(6,901)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(5,824)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(4,096)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--BankAndSimilarCharges_iN_pn3n3_di_zGHj6RIWz7ce" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Bank fees&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(3,882)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(4,436)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(7,163)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ExchangeVariance_pn3n3_zT8vAy3GhiG" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Exchange variance&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(3,095)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(8,944) &lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(681)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--OtherFinanceCost_iN_pn3n3_di_zwooNXSZn4A1" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Other&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(53,446)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(39,946)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(28,489)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--FinanceCosts_iN_pn3n3_di_z37ZFntzkeef" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Finance expenses&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;(561,024)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;(458,742)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;(457,616)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--FinanceResult_pn3n3_zqXa2TCxRASg" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Net finance result&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;(366,081)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;(347,459)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;(346,974)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <afya:ScheduleOfFinanceResultTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact004882">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfFinanceResultTableTextBlock_pn3n3_zmguLDbLBLwe" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Finance result (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BC_zQxOLJJVwUF6" style="display: none"&gt;Schedule of finance result&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_490_20250101__20251231_z5XTmwejGJF" style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20240101__20241231_z7TM4d819HD9" style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_494_20230101__20231231_zboKnwVvvkTl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 67%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--FinancialIncomeFromCashEquivalents_pn3n3_zp9TewKkqima" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Financial income from cash equivalents&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;138,456 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;59,381 &lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;73,672&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--InterestEarned_pn3n3_zdzzJBRVS35i" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Interest earned&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;49,527 &lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;43,417 &lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;33,450&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--OtherFinanceIncome_pn3n3_zmOsmHpFjVXe" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Other&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;6,960 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;8,485 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;3,520&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--FinanceIncome_pn3n3_zttyz74oPGP5" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Finance income&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;194,943 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;111,283 &lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;110,642&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--InterestExpense1_pn3n3_zTiLXuBq4Qy8" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Interest expense&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(316,379)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(254,386)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(285,447)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--InterestExpenseOnLeaseLiabilities1_pn3n3_zQxZ5WvUitK5" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Interest expense on lease liabilities&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(123,067)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(111,966)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(100,849)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--FinancialDiscountsGrantedExpenses_pn3n3_zyXc0MxQd62e" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Financial discounts&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(54,254)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(33,240)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(30,891)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CreditCardCharges_pn3n3_zZe32h7X88cf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Credit card charges&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(6,901)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(5,824)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(4,096)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--BankAndSimilarCharges_iN_pn3n3_di_zGHj6RIWz7ce" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Bank fees&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(3,882)&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(4,436)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(7,163)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ExchangeVariance_pn3n3_zT8vAy3GhiG" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Exchange variance&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(3,095)&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(8,944) &lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(681)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--OtherFinanceCost_iN_pn3n3_di_zwooNXSZn4A1" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Other&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(53,446)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(39,946)&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;(28,489)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--FinanceCosts_iN_pn3n3_di_z37ZFntzkeef" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Finance expenses&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;(561,024)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;(458,742)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;(457,616)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--FinanceResult_pn3n3_zqXa2TCxRASg" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Net finance result&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;(366,081)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;(347,459)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;(346,974)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</afya:ScheduleOfFinanceResultTableTextBlock>
    <afya:FinancialIncomeFromCashEquivalents
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004884"
      unitRef="BRL">138456000</afya:FinancialIncomeFromCashEquivalents>
    <afya:FinancialIncomeFromCashEquivalents
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004885"
      unitRef="BRL">59381000</afya:FinancialIncomeFromCashEquivalents>
    <afya:FinancialIncomeFromCashEquivalents
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004886"
      unitRef="BRL">73672000</afya:FinancialIncomeFromCashEquivalents>
    <afya:InterestEarned
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004888"
      unitRef="BRL">49527000</afya:InterestEarned>
    <afya:InterestEarned
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004889"
      unitRef="BRL">43417000</afya:InterestEarned>
    <afya:InterestEarned
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004890"
      unitRef="BRL">33450000</afya:InterestEarned>
    <ifrs-full:OtherFinanceIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004892"
      unitRef="BRL">6960000</ifrs-full:OtherFinanceIncome>
    <ifrs-full:OtherFinanceIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004893"
      unitRef="BRL">8485000</ifrs-full:OtherFinanceIncome>
    <ifrs-full:OtherFinanceIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004894"
      unitRef="BRL">3520000</ifrs-full:OtherFinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004896"
      unitRef="BRL">194943000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004897"
      unitRef="BRL">111283000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004898"
      unitRef="BRL">110642000</ifrs-full:FinanceIncome>
    <afya:InterestExpense1
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004900"
      unitRef="BRL">-316379000</afya:InterestExpense1>
    <afya:InterestExpense1
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004901"
      unitRef="BRL">-254386000</afya:InterestExpense1>
    <afya:InterestExpense1
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004902"
      unitRef="BRL">-285447000</afya:InterestExpense1>
    <afya:InterestExpenseOnLeaseLiabilities1
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004904"
      unitRef="BRL">-123067000</afya:InterestExpenseOnLeaseLiabilities1>
    <afya:InterestExpenseOnLeaseLiabilities1
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004905"
      unitRef="BRL">-111966000</afya:InterestExpenseOnLeaseLiabilities1>
    <afya:InterestExpenseOnLeaseLiabilities1
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004906"
      unitRef="BRL">-100849000</afya:InterestExpenseOnLeaseLiabilities1>
    <afya:FinancialDiscountsGrantedExpenses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004908"
      unitRef="BRL">-54254000</afya:FinancialDiscountsGrantedExpenses>
    <afya:FinancialDiscountsGrantedExpenses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004909"
      unitRef="BRL">-33240000</afya:FinancialDiscountsGrantedExpenses>
    <afya:FinancialDiscountsGrantedExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004910"
      unitRef="BRL">-30891000</afya:FinancialDiscountsGrantedExpenses>
    <afya:CreditCardCharges
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004912"
      unitRef="BRL">-6901000</afya:CreditCardCharges>
    <afya:CreditCardCharges
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004913"
      unitRef="BRL">-5824000</afya:CreditCardCharges>
    <afya:CreditCardCharges
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004914"
      unitRef="BRL">-4096000</afya:CreditCardCharges>
    <ifrs-full:BankAndSimilarCharges
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004916"
      unitRef="BRL">3882000</ifrs-full:BankAndSimilarCharges>
    <ifrs-full:BankAndSimilarCharges
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004917"
      unitRef="BRL">4436000</ifrs-full:BankAndSimilarCharges>
    <ifrs-full:BankAndSimilarCharges
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004918"
      unitRef="BRL">7163000</ifrs-full:BankAndSimilarCharges>
    <afya:ExchangeVariance
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004920"
      unitRef="BRL">-3095000</afya:ExchangeVariance>
    <afya:ExchangeVariance
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004921"
      unitRef="BRL">-8944000</afya:ExchangeVariance>
    <afya:ExchangeVariance
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004922"
      unitRef="BRL">-681000</afya:ExchangeVariance>
    <ifrs-full:OtherFinanceCost
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004924"
      unitRef="BRL">53446000</ifrs-full:OtherFinanceCost>
    <ifrs-full:OtherFinanceCost
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004925"
      unitRef="BRL">39946000</ifrs-full:OtherFinanceCost>
    <ifrs-full:OtherFinanceCost
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004926"
      unitRef="BRL">28489000</ifrs-full:OtherFinanceCost>
    <ifrs-full:FinanceCosts
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004928"
      unitRef="BRL">561024000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004929"
      unitRef="BRL">458742000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004930"
      unitRef="BRL">457616000</ifrs-full:FinanceCosts>
    <afya:FinanceResult
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004932"
      unitRef="BRL">-366081000</afya:FinanceResult>
    <afya:FinanceResult
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004933"
      unitRef="BRL">-347459000</afya:FinanceResult>
    <afya:FinanceResult
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004934"
      unitRef="BRL">-346974000</afya:FinanceResult>
    <afya:DisclosureOfIncomeTaxesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004936">&lt;p id="xdx_805_ecustom--DisclosureOfIncomeTaxesExplanatory_z0lvxiPEEwFd" style="font: 10.5pt/107% Nunito Sans; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;20&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_826_zze3F8tGkhJi"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Income taxes are comprised of taxation over operations in Brazil, related to Corporate
Income Tax (IRPJ) and Social Contribution on Net Profit (CSLL). According to Brazilian tax legislation, income taxes and social contribution
are assessed and paid by legal entity and not on a consolidated basis, except by the requirements of the Pillar Two global minimum tax.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;Income taxes expenses&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The Company calculates the income taxes expenses using the tax rate that would be applicable
to the expected total annual earnings, including the effects of the OECD&#x2019;s Pillar Two global minimum tax, which is applicable for
the fiscal year ended December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;The table below presents the reconciliation
of income tax expense for the years ended December 31, 2025, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10.5pt Nunito Sans; margin: 0; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_pn3n3_zOxwNd11tMSj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Income taxes (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span id="xdx_8BB_znVL8y7kXDX1" style="display: none"&gt;Schedule of reconciliation of income tax expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20250101__20251231_znOokTZwOfY" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20240101__20241231_zxnR448aq4pd" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20230101__20231231_zXGdEcLS8i1h" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 67%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zdA3kZpuMZQ1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;Income before income taxes&lt;/td&gt;
    &lt;td style="text-align: right"&gt;860,945 &lt;/td&gt;
    &lt;td style="text-align: right"&gt;676,391 &lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;429,582&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--ApplicableTaxRate_pip0_dp_zaV7iIeDH041" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;Statutory income taxes rate&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;34%&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;34%&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;34%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TaxExpensesIncomeAtApplicableTaxRate_z5Pa0PaAdwo1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;b&gt;Income taxes at statutory rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;b&gt;(292,721)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;b&gt;(229,973)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;b&gt;(146,058)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ReconciliationAdjustmentsAbstract_iB_zDs3502i5SCl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;b&gt;Reconciliation adjustments:&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pn3n3_zjUOl0PuFLEc" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Tax effect on loss from entities not subject to taxation&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(20,042)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(37,007)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;(32,274)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pn3n3_z3A1YRZV4sVk" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;PROUNI - Fiscal incentive (i)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;454,380 &lt;/td&gt;
    &lt;td style="text-align: right"&gt;379,747 &lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;309,952&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--UnrecognizedDeferredTaxesAssetsOnTaxLosses_pn3n3_zyyE9Npa9aek" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Unrecognized deferred taxes assets on tax losses&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(161,215)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(130,074)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;(154,062)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RecognisedDeferredTaxAssets_pn3n3_zyYpSoQ1tHI9" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Recognized deferred taxes&lt;/td&gt;
    &lt;td style="text-align: right"&gt;40,826 &lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4969"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;3,233&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_iN_pn3n3_di_zbIKRq0QB2n7" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Presumed profit income tax regime effect (ii)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(372)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;338 &lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;(8,787)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--PermanentAdjustmentsAbstract_iB_zb7VvPCHDIq4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;&lt;b&gt;Permanent adjustments:&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--PermanentAdjustmentsManagementBonuses_pn3n3_zz0hgbw2jKu" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 14.2pt"&gt;Management bonuses&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(9,146)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(6,533)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4982"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--PermanentAdjustmentsGifts_pn3n3_zPofg9EGKgjl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 14.2pt"&gt;Gifts&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(1,742)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(1,655)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(1,552)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--PermanentAdjustmentsSponsorship_pn3n3_zv71dBpa4083" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 14.2pt"&gt;Sponsorship&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(953)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(521)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(470)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_iN_pn3n3_di_z4ogpR4zSypl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 14.2pt"&gt;Other&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(1,744)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(4,744)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(2,665)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--PermanentAdjustmentsPillarTwo_pn3n3_zqxktTkAVWMc" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Pillar Two - See Note 2.3(q)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(109,458)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4997"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4998"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--OtherTaxExpenseBenefits_pn3n3_z9EZ70QrzWOj" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Other&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;9,685 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,951 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;8,517&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncomeTaxesExpense_pn3n3_zDJiK0RZG8Vj" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;b&gt;Income taxes expense&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; text-align: right"&gt;&lt;b&gt;(92,502)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; text-align: right"&gt;&lt;b&gt;(27,471)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right"&gt;&lt;b&gt;(24,166)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CurrentTaxExpenseIncome_pn3n3_zsYynNP0wjLc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Current&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(133,328)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(24,238)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;(27,399)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--DeferredTaxExpenseIncome_pn3n3_z14lYFfKVhS4" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Deferred&lt;/td&gt;
    &lt;td style="text-align: right"&gt;40,826 &lt;/td&gt;
    &lt;td style="text-align: right"&gt;(3,233)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;3,233&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--TaxRateEffectFromChangeInTaxRate_pip0_dp_zhguVaETO6md" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;b&gt;Effective rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;b&gt;10.70%&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;b&gt;4.10%&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;b&gt;5.62%&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company adhered to PROUNI, established by Law 11,096/2005, which is a federal program
that exempts companies of paying income taxes and social contribution upon compliance with certain requirements required by this Law.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Brazilian tax law establishes that companies that generate gross revenues of up to R$78,000
in the prior fiscal year may calculate income taxes as a percentage of gross revenue, using the presumed profit tax regime. The effect
of the presumed profit of certain subsidiaries represents the difference between the taxation based on this method and the amount that
would be due based on the statutory rate applied to the taxable profit of the subsidiaries.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A3_zT9hzx2NWvv5" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;






&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;Deferred income taxes&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The table below shows the balances of deferred tax assets and liabilities as of December
31, 2025 and 2024:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock_pn3n3_zfFtZthYcMk4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Income taxes (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B3_zj5ZHZtS9Kt7" style="display: none"&gt;Schedule of deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20240101__20241231_zdlB1ItzZvsi" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20250101__20251231_zmzgE2DdbQe1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 55%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; text-align: right"&gt;&lt;b&gt;Additions&lt;/b&gt; (i)&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxAssetsAbstract_iB_z2A1zPu07Ssl"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Deferred tax assets&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Tax losses carry forward&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--DeferredTaxAssetsLossCarryforwards_pn3n3_c20240101__20241231_zQf72oyl0Bg9" style="text-align: right" title="Tax losses carry forward"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5026"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--AdditionsTaxLossesCarryForward_pn3n3_c20250101__20251231_zNQ0PLM4Yza" style="text-align: right" title="Additions tax losses carry forward"&gt;1,703&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DeferredTaxAssetsLossCarryforwards_pn3n3_c20250101__20251231_zKy7a730nLul" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Tax losses carry forward"&gt;1,703&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_iB_zivqGYh3Ocnh" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Temporary differences:&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt"&gt;Allowance for expected credit losses&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--AllowanceForExpectedCreditLoss_pn3n3_c20240101__20241231_zufIhGscHNr6" style="text-align: right" title="Allowance for expected credit losses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5035"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AdditionsAllowanceForExpectedCreditLosses_pn3n3_c20250101__20251231_z2SzqGTOcXg4" style="text-align: right" title="Additions allowance for expected credit losses"&gt;1,196&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AllowanceForExpectedCreditLoss_pn3n3_c20250101__20251231_zRev5MrA0GJi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Allowance for expected credit losses"&gt;1,196&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--LeaseLiabilitiesAbstract_iB_zOJPMIyjjFU3" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt"&gt;IFRS 16 - Leases:&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 24.85pt"&gt;Right-of-use assets&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightofuseAsset_iI_pn3n3_c20241231_zgEf2c29clF1" style="text-align: right" title="Allowance for expected credit losses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5044"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AdditionsToRightofuseAsset_pn3n3_c20250101__20251231_zDm3UPMssZGg" style="text-align: right" title="Allowance for expected credit losses"&gt;56,180&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RightofuseAsset_iI_pn3n3_c20251231_zN9ZySY92IMk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Allowance for expected credit losses"&gt;56,180&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 24.85pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LeaseLiability_iI_pn3n3_c20241231_zqmfSlIdAqSd" style="text-align: right" title="Lease liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5050"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AdditionsLeaseLiability_iI_pn3n3_c20250101__20251231_ztDMXrnrPQO" style="text-align: right" title="Additions lease liabilities"&gt;(47,232)&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LeaseLiability_iI_pn3n3_c20251231_z86EaaLu7bml" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities"&gt;(47,232)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt"&gt;Provision for profit sharing&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ProvisionForProfitSharing_pn3n3_c20240101__20241231_zue9J4DB7cEe" style="text-align: right" title="Provision for profit sharing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5056"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AdditionsProvisionForProfitSharing_pn3n3_c20250101__20251231_zEXXPT4n0Ldk" style="text-align: right" title="Additions provision for profit sharing"&gt;2,047&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ProvisionForProfitSharing_pn3n3_c20250101__20251231_zHd2fuXaaHQj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Provision for profit sharing"&gt;2,047&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt"&gt;Provision for legal proceedings and contingencies&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LegalProceedingsProvision_iI_pn3n3_c20241231_zu7zw2l8fDcb" style="text-align: right" title="Provision for legal proceedings and contingencies"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5062"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AdditionsProvisionForLegalProceedingsAndContingencies_pn3n3_c20250101__20251231_zo5tj6wuCZoc" style="text-align: right" title="Additions provision for legal proceedings and contingencies"&gt;7,672&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LegalProceedingsProvision_iI_pn3n3_c20251231_zPD1UwP8Ekke" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Provision for legal proceedings and contingencies"&gt;7,672&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt"&gt;Amortization of intangible assets&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AmortizationOfIntangibleAsset_pn3n3_c20240101__20241231_zirgQCZHvRVc" style="text-align: right" title="Amortization of intangible assets"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5068"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdditionsAmortizationOfIntangibleAssets_pn3n3_c20250101__20251231_zKdHXBVf9hSf" style="text-align: right" title="Additions amortization of intangible assets"&gt;44,486&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AmortizationOfIntangibleAsset_pn3n3_c20250101__20251231_zej0kGux9YQ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Amortization of intangible assets"&gt;44,486&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt"&gt;Other&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Other_pn3n3_c20240101__20241231_z5dhx1ucZPI2" style="border-bottom: Black 1pt solid; text-align: right" title="Other"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5074"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231_zO01zfb4gnf" style="border-bottom: Black 1pt solid; text-align: right" title="Additions other"&gt;67&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--Other_pn3n3_c20250101__20251231_zDVSNUxezidg" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other"&gt;67&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DeferredTaxAsset_iI_pn3n3_c20241231_zVbOrBCNJBej" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5080"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AdditionsDeferredTaxAssets_pn3n3_c20250101__20251231_zmYwrhLUYtS3" style="border-bottom: Black 1pt solid; text-align: right" title="Additions deferred tax assets"&gt;&lt;b&gt;66,119&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DeferredTaxAsset_iI_pn3n3_c20251231_zCqyen7f1v7j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;66,119&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_zx3rdIzhLSX2" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Deferred tax liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Tax benefit from tax deductible goodwill&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20240101__20241231_zKjOpLVQgxVb" style="text-align: right" title="Tax benefit from tax deductible goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5089"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AdditionsTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20250101__20251231_z1WjRxB58sei" style="text-align: right" title="Additions tax benefit from tax deductible goodwill"&gt;(25,293)&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20250101__20251231_z57iuwhO0ehk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;(25,293)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Fair value remeasurements on business combinations&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FairValueRemeasurementsOnBusinessCombinations_pn3n3_c20240101__20241231_zYLa81w0NGKb" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value remeasurements on business combinations"&gt;(28,274)&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AdditionsFairValueRemeasurementsOnBusinessCombinations_pn3n3_c20250101__20251231_zd1xNcN8ogDf" style="border-bottom: Black 1pt solid; text-align: right" title="Additions fair value remeasurements on business combinations"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5097"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--FairValueRemeasurementsOnBusinessCombinations_pn3n3_c20250101__20251231_zTpwaZ9tKL6i" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Fair value remeasurements on business combinations"&gt;(28,274)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DeferredsTaxLiabilities_iI_pn3n3_c20241231_zMdUQudxXY1h" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;&lt;b&gt;(28,274)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AdditionsDeferredTaxLiabilities_pn3n3_c20250101__20251231_zC2ZsLiBNeJ5" style="border-bottom: Black 1pt solid; text-align: right" title="Additions deferred tax liabilities"&gt;&lt;b&gt;(25,293)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DeferredsTaxLiabilities_iI_pn3n3_c20251231_zuudVW0DIoLk" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;(53,567)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Deferred tax assets (liabilities), net&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20241231_zlozLnAGLtRl" style="border-bottom: Black 1.5pt double; text-align: right" title="Deferred tax assets (liabilities), net"&gt;&lt;b&gt;(28,274)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AdditionsDeferredTaxAssetsLiabilitiesNet_pn3n3_c20250101__20251231_zRwXswmPwuF2" style="border-bottom: Black 1.5pt double; text-align: right" title="Additions deferred tax assets (liabilities), net"&gt;&lt;b&gt;40,826&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20251231_zJdRABafBoXl" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Deferred tax assets (liabilities), net"&gt;&lt;b&gt;12,552&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recognized in the consolidated statement of income and other comprehensive income.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AF_zt7hVLjK22Ad" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The deferred tax assets were limited to the expected amount to be recovered, with the corresponding
impact recognized in the consolidated statement of income and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;As of December 31, 2025, the Company had accumulated unrecognized deferred income tax assets
on temporary differences and tax losses in the amount of R$&lt;span id="xdx_905_ecustom--DeferredTaxExpenseIncomes_pn3n3_c20250101__20251231_z8Sbr3bq2tFj" title="Unrecognized deferred income tax assets"&gt;1,603,167&lt;/span&gt; of tax-basis (December 31, 2024: R$&lt;span id="xdx_909_ecustom--DeferredTaxExpenseIncomes_c20240101__20241231_pn3n3" title="Unrecognized deferred income tax assets"&gt;1,266,126&lt;/span&gt;) which does not have
expectations of future taxable income that could support the recognition as deferred tax assets, except for R$&lt;span id="xdx_901_ecustom--RecognizedDeferredTaxAssets_pn3n3_c20250101__20251231_z3B1fcYc0Eo3" title="Recognized deferred tax assets"&gt;392,391&lt;/span&gt; of tax basis from
temporary differences recognized as deferred tax assets as result of expected future taxable income.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&lt;br/&gt;
&lt;/p&gt;




</afya:DisclosureOfIncomeTaxesExplanatory>
    <afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact004938">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_pn3n3_zOxwNd11tMSj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Income taxes (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span id="xdx_8BB_znVL8y7kXDX1" style="display: none"&gt;Schedule of reconciliation of income tax expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20250101__20251231_znOokTZwOfY" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20240101__20241231_zxnR448aq4pd" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20230101__20231231_zXGdEcLS8i1h" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 67%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ProfitLossBeforeTax_pn3n3_zdA3kZpuMZQ1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;Income before income taxes&lt;/td&gt;
    &lt;td style="text-align: right"&gt;860,945 &lt;/td&gt;
    &lt;td style="text-align: right"&gt;676,391 &lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;429,582&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--ApplicableTaxRate_pip0_dp_zaV7iIeDH041" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;Statutory income taxes rate&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;34%&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;34%&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;34%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TaxExpensesIncomeAtApplicableTaxRate_z5Pa0PaAdwo1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;b&gt;Income taxes at statutory rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;b&gt;(292,721)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;b&gt;(229,973)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;b&gt;(146,058)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ReconciliationAdjustmentsAbstract_iB_zDs3502i5SCl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;b&gt;Reconciliation adjustments:&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pn3n3_zjUOl0PuFLEc" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Tax effect on loss from entities not subject to taxation&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(20,042)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(37,007)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;(32,274)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pn3n3_z3A1YRZV4sVk" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;PROUNI - Fiscal incentive (i)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;454,380 &lt;/td&gt;
    &lt;td style="text-align: right"&gt;379,747 &lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;309,952&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--UnrecognizedDeferredTaxesAssetsOnTaxLosses_pn3n3_zyyE9Npa9aek" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Unrecognized deferred taxes assets on tax losses&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(161,215)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(130,074)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;(154,062)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RecognisedDeferredTaxAssets_pn3n3_zyYpSoQ1tHI9" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Recognized deferred taxes&lt;/td&gt;
    &lt;td style="text-align: right"&gt;40,826 &lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4969"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;3,233&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_iN_pn3n3_di_zbIKRq0QB2n7" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Presumed profit income tax regime effect (ii)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(372)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;338 &lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;(8,787)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--PermanentAdjustmentsAbstract_iB_zb7VvPCHDIq4" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;&lt;b&gt;Permanent adjustments:&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--PermanentAdjustmentsManagementBonuses_pn3n3_zz0hgbw2jKu" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 14.2pt"&gt;Management bonuses&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(9,146)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(6,533)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4982"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--PermanentAdjustmentsGifts_pn3n3_zPofg9EGKgjl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 14.2pt"&gt;Gifts&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(1,742)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(1,655)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(1,552)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--PermanentAdjustmentsSponsorship_pn3n3_zv71dBpa4083" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 14.2pt"&gt;Sponsorship&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(953)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(521)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(470)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_iN_pn3n3_di_z4ogpR4zSypl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 14.2pt"&gt;Other&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(1,744)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(4,744)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;(2,665)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--PermanentAdjustmentsPillarTwo_pn3n3_zqxktTkAVWMc" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Pillar Two - See Note 2.3(q)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(109,458)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4997"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4998"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--OtherTaxExpenseBenefits_pn3n3_z9EZ70QrzWOj" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Other&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;9,685 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,951 &lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;8,517&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncomeTaxesExpense_pn3n3_zDJiK0RZG8Vj" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;b&gt;Income taxes expense&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; text-align: right"&gt;&lt;b&gt;(92,502)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; text-align: right"&gt;&lt;b&gt;(27,471)&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right"&gt;&lt;b&gt;(24,166)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--CurrentTaxExpenseIncome_pn3n3_zsYynNP0wjLc" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Current&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(133,328)&lt;/td&gt;
    &lt;td style="text-align: right"&gt;(24,238)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;(27,399)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--DeferredTaxExpenseIncome_pn3n3_z14lYFfKVhS4" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; text-indent: 7.1pt"&gt;Deferred&lt;/td&gt;
    &lt;td style="text-align: right"&gt;40,826 &lt;/td&gt;
    &lt;td style="text-align: right"&gt;(3,233)&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;3,233&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--TaxRateEffectFromChangeInTaxRate_pip0_dp_zhguVaETO6md" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;b&gt;Effective rate&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;b&gt;10.70%&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;b&gt;4.10%&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;b&gt;5.62%&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company adhered to PROUNI, established by Law 11,096/2005, which is a federal program
that exempts companies of paying income taxes and social contribution upon compliance with certain requirements required by this Law.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(ii)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Brazilian tax law establishes that companies that generate gross revenues of up to R$78,000
in the prior fiscal year may calculate income taxes as a percentage of gross revenue, using the presumed profit tax regime. The effect
of the presumed profit of certain subsidiaries represents the difference between the taxation based on this method and the amount that
would be due based on the statutory rate applied to the taxable profit of the subsidiaries.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004940"
      unitRef="BRL">860945000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004941"
      unitRef="BRL">676391000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004942"
      unitRef="BRL">429582000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact004944"
      unitRef="Pure">0.34</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact004945"
      unitRef="Pure">0.34</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004946"
      unitRef="Pure">0.34</ifrs-full:ApplicableTaxRate>
    <afya:TaxExpensesIncomeAtApplicableTaxRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004948"
      unitRef="BRL">-292721000</afya:TaxExpensesIncomeAtApplicableTaxRate>
    <afya:TaxExpensesIncomeAtApplicableTaxRate
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004949"
      unitRef="BRL">-229973000</afya:TaxExpensesIncomeAtApplicableTaxRate>
    <afya:TaxExpensesIncomeAtApplicableTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004950"
      unitRef="BRL">-146058000</afya:TaxExpensesIncomeAtApplicableTaxRate>
    <afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004956"
      unitRef="BRL">-20042000</afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation>
    <afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004957"
      unitRef="BRL">-37007000</afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation>
    <afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004958"
      unitRef="BRL">-32274000</afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation>
    <afya:ProgramaUniversidadeParaTodosFiscalIncentive
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004960"
      unitRef="BRL">454380000</afya:ProgramaUniversidadeParaTodosFiscalIncentive>
    <afya:ProgramaUniversidadeParaTodosFiscalIncentive
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004961"
      unitRef="BRL">379747000</afya:ProgramaUniversidadeParaTodosFiscalIncentive>
    <afya:ProgramaUniversidadeParaTodosFiscalIncentive
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004962"
      unitRef="BRL">309952000</afya:ProgramaUniversidadeParaTodosFiscalIncentive>
    <afya:UnrecognizedDeferredTaxesAssetsOnTaxLosses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004964"
      unitRef="BRL">-161215000</afya:UnrecognizedDeferredTaxesAssetsOnTaxLosses>
    <afya:UnrecognizedDeferredTaxesAssetsOnTaxLosses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004965"
      unitRef="BRL">-130074000</afya:UnrecognizedDeferredTaxesAssetsOnTaxLosses>
    <afya:UnrecognizedDeferredTaxesAssetsOnTaxLosses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004966"
      unitRef="BRL">-154062000</afya:UnrecognizedDeferredTaxesAssetsOnTaxLosses>
    <afya:RecognisedDeferredTaxAssets
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004968"
      unitRef="BRL">40826000</afya:RecognisedDeferredTaxAssets>
    <afya:RecognisedDeferredTaxAssets
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004970"
      unitRef="BRL">3233000</afya:RecognisedDeferredTaxAssets>
    <afya:TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004972"
      unitRef="BRL">372000</afya:TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <afya:TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004973"
      unitRef="BRL">-338000</afya:TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <afya:TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004974"
      unitRef="BRL">8787000</afya:TaxEffectOfExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <afya:PermanentAdjustmentsManagementBonuses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004980"
      unitRef="BRL">-9146000</afya:PermanentAdjustmentsManagementBonuses>
    <afya:PermanentAdjustmentsManagementBonuses
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004981"
      unitRef="BRL">-6533000</afya:PermanentAdjustmentsManagementBonuses>
    <afya:PermanentAdjustmentsGifts
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004984"
      unitRef="BRL">-1742000</afya:PermanentAdjustmentsGifts>
    <afya:PermanentAdjustmentsGifts
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004985"
      unitRef="BRL">-1655000</afya:PermanentAdjustmentsGifts>
    <afya:PermanentAdjustmentsGifts
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004986"
      unitRef="BRL">-1552000</afya:PermanentAdjustmentsGifts>
    <afya:PermanentAdjustmentsSponsorship
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004988"
      unitRef="BRL">-953000</afya:PermanentAdjustmentsSponsorship>
    <afya:PermanentAdjustmentsSponsorship
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004989"
      unitRef="BRL">-521000</afya:PermanentAdjustmentsSponsorship>
    <afya:PermanentAdjustmentsSponsorship
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004990"
      unitRef="BRL">-470000</afya:PermanentAdjustmentsSponsorship>
    <ifrs-full:TaxExpenseOtherThanIncomeTaxExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004992"
      unitRef="BRL">1744000</ifrs-full:TaxExpenseOtherThanIncomeTaxExpense>
    <ifrs-full:TaxExpenseOtherThanIncomeTaxExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact004993"
      unitRef="BRL">4744000</ifrs-full:TaxExpenseOtherThanIncomeTaxExpense>
    <ifrs-full:TaxExpenseOtherThanIncomeTaxExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004994"
      unitRef="BRL">2665000</ifrs-full:TaxExpenseOtherThanIncomeTaxExpense>
    <afya:PermanentAdjustmentsPillarTwo
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact004996"
      unitRef="BRL">-109458000</afya:PermanentAdjustmentsPillarTwo>
    <afya:OtherTaxExpenseBenefits
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005000"
      unitRef="BRL">9685000</afya:OtherTaxExpenseBenefits>
    <afya:OtherTaxExpenseBenefits
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact005001"
      unitRef="BRL">2951000</afya:OtherTaxExpenseBenefits>
    <afya:OtherTaxExpenseBenefits
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact005002"
      unitRef="BRL">8517000</afya:OtherTaxExpenseBenefits>
    <afya:IncomeTaxesExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005004"
      unitRef="BRL">-92502000</afya:IncomeTaxesExpense>
    <afya:IncomeTaxesExpense
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact005005"
      unitRef="BRL">-27471000</afya:IncomeTaxesExpense>
    <afya:IncomeTaxesExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact005006"
      unitRef="BRL">-24166000</afya:IncomeTaxesExpense>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005008"
      unitRef="BRL">-133328000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact005009"
      unitRef="BRL">-24238000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact005010"
      unitRef="BRL">-27399000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005012"
      unitRef="BRL">40826000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact005013"
      unitRef="BRL">-3233000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact005014"
      unitRef="BRL">3233000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact005016"
      unitRef="Pure">0.1070</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact005017"
      unitRef="Pure">0.0410</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact005018"
      unitRef="Pure">0.0562</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <afya:ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact005021">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock_pn3n3_zfFtZthYcMk4" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Income taxes (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span id="xdx_8B3_zj5ZHZtS9Kt7" style="display: none"&gt;Schedule of deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20240101__20241231_zdlB1ItzZvsi" style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20250101__20251231_zmzgE2DdbQe1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 55%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 14%; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; text-align: right"&gt;&lt;b&gt;Additions&lt;/b&gt; (i)&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxAssetsAbstract_iB_z2A1zPu07Ssl"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Deferred tax assets&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Tax losses carry forward&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--DeferredTaxAssetsLossCarryforwards_pn3n3_c20240101__20241231_zQf72oyl0Bg9" style="text-align: right" title="Tax losses carry forward"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5026"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--AdditionsTaxLossesCarryForward_pn3n3_c20250101__20251231_zNQ0PLM4Yza" style="text-align: right" title="Additions tax losses carry forward"&gt;1,703&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DeferredTaxAssetsLossCarryforwards_pn3n3_c20250101__20251231_zKy7a730nLul" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Tax losses carry forward"&gt;1,703&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_iB_zivqGYh3Ocnh" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Temporary differences:&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt"&gt;Allowance for expected credit losses&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--AllowanceForExpectedCreditLoss_pn3n3_c20240101__20241231_zufIhGscHNr6" style="text-align: right" title="Allowance for expected credit losses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5035"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AdditionsAllowanceForExpectedCreditLosses_pn3n3_c20250101__20251231_z2SzqGTOcXg4" style="text-align: right" title="Additions allowance for expected credit losses"&gt;1,196&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AllowanceForExpectedCreditLoss_pn3n3_c20250101__20251231_zRev5MrA0GJi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Allowance for expected credit losses"&gt;1,196&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--LeaseLiabilitiesAbstract_iB_zOJPMIyjjFU3" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt"&gt;IFRS 16 - Leases:&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 24.85pt"&gt;Right-of-use assets&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightofuseAsset_iI_pn3n3_c20241231_zgEf2c29clF1" style="text-align: right" title="Allowance for expected credit losses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5044"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AdditionsToRightofuseAsset_pn3n3_c20250101__20251231_zDm3UPMssZGg" style="text-align: right" title="Allowance for expected credit losses"&gt;56,180&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RightofuseAsset_iI_pn3n3_c20251231_zN9ZySY92IMk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Allowance for expected credit losses"&gt;56,180&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 24.85pt"&gt;Lease liabilities&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LeaseLiability_iI_pn3n3_c20241231_zqmfSlIdAqSd" style="text-align: right" title="Lease liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5050"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AdditionsLeaseLiability_iI_pn3n3_c20250101__20251231_ztDMXrnrPQO" style="text-align: right" title="Additions lease liabilities"&gt;(47,232)&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LeaseLiability_iI_pn3n3_c20251231_z86EaaLu7bml" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Lease liabilities"&gt;(47,232)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt"&gt;Provision for profit sharing&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ProvisionForProfitSharing_pn3n3_c20240101__20241231_zue9J4DB7cEe" style="text-align: right" title="Provision for profit sharing"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5056"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AdditionsProvisionForProfitSharing_pn3n3_c20250101__20251231_zEXXPT4n0Ldk" style="text-align: right" title="Additions provision for profit sharing"&gt;2,047&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ProvisionForProfitSharing_pn3n3_c20250101__20251231_zHd2fuXaaHQj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Provision for profit sharing"&gt;2,047&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt"&gt;Provision for legal proceedings and contingencies&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LegalProceedingsProvision_iI_pn3n3_c20241231_zu7zw2l8fDcb" style="text-align: right" title="Provision for legal proceedings and contingencies"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5062"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AdditionsProvisionForLegalProceedingsAndContingencies_pn3n3_c20250101__20251231_zo5tj6wuCZoc" style="text-align: right" title="Additions provision for legal proceedings and contingencies"&gt;7,672&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LegalProceedingsProvision_iI_pn3n3_c20251231_zPD1UwP8Ekke" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Provision for legal proceedings and contingencies"&gt;7,672&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt"&gt;Amortization of intangible assets&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AmortizationOfIntangibleAsset_pn3n3_c20240101__20241231_zirgQCZHvRVc" style="text-align: right" title="Amortization of intangible assets"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5068"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdditionsAmortizationOfIntangibleAssets_pn3n3_c20250101__20251231_zKdHXBVf9hSf" style="text-align: right" title="Additions amortization of intangible assets"&gt;44,486&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AmortizationOfIntangibleAsset_pn3n3_c20250101__20251231_zej0kGux9YQ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Amortization of intangible assets"&gt;44,486&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-indent: 10.7pt"&gt;Other&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Other_pn3n3_c20240101__20241231_z5dhx1ucZPI2" style="border-bottom: Black 1pt solid; text-align: right" title="Other"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5074"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231_zO01zfb4gnf" style="border-bottom: Black 1pt solid; text-align: right" title="Additions other"&gt;67&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--Other_pn3n3_c20250101__20251231_zDVSNUxezidg" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Other"&gt;67&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DeferredTaxAsset_iI_pn3n3_c20241231_zVbOrBCNJBej" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5080"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AdditionsDeferredTaxAssets_pn3n3_c20250101__20251231_zmYwrhLUYtS3" style="border-bottom: Black 1pt solid; text-align: right" title="Additions deferred tax assets"&gt;&lt;b&gt;66,119&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DeferredTaxAsset_iI_pn3n3_c20251231_zCqyen7f1v7j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;66,119&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_zx3rdIzhLSX2" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Deferred tax liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Tax benefit from tax deductible goodwill&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20240101__20241231_zKjOpLVQgxVb" style="text-align: right" title="Tax benefit from tax deductible goodwill"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5089"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AdditionsTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20250101__20251231_z1WjRxB58sei" style="text-align: right" title="Additions tax benefit from tax deductible goodwill"&gt;(25,293)&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill_pn3n3_c20250101__20251231_z57iuwhO0ehk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;(25,293)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;Fair value remeasurements on business combinations&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FairValueRemeasurementsOnBusinessCombinations_pn3n3_c20240101__20241231_zYLa81w0NGKb" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value remeasurements on business combinations"&gt;(28,274)&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AdditionsFairValueRemeasurementsOnBusinessCombinations_pn3n3_c20250101__20251231_zd1xNcN8ogDf" style="border-bottom: Black 1pt solid; text-align: right" title="Additions fair value remeasurements on business combinations"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5097"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--FairValueRemeasurementsOnBusinessCombinations_pn3n3_c20250101__20251231_zTpwaZ9tKL6i" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Fair value remeasurements on business combinations"&gt;(28,274)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DeferredsTaxLiabilities_iI_pn3n3_c20241231_zMdUQudxXY1h" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;&lt;b&gt;(28,274)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AdditionsDeferredTaxLiabilities_pn3n3_c20250101__20251231_zC2ZsLiBNeJ5" style="border-bottom: Black 1pt solid; text-align: right" title="Additions deferred tax liabilities"&gt;&lt;b&gt;(25,293)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DeferredsTaxLiabilities_iI_pn3n3_c20251231_zuudVW0DIoLk" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Total"&gt;&lt;b&gt;(53,567)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;b&gt;Deferred tax assets (liabilities), net&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20241231_zlozLnAGLtRl" style="border-bottom: Black 1.5pt double; text-align: right" title="Deferred tax assets (liabilities), net"&gt;&lt;b&gt;(28,274)&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AdditionsDeferredTaxAssetsLiabilitiesNet_pn3n3_c20250101__20251231_zRwXswmPwuF2" style="border-bottom: Black 1.5pt double; text-align: right" title="Additions deferred tax assets (liabilities), net"&gt;&lt;b&gt;40,826&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NetDeferredTaxLiabilities_iI_pn3n3_c20251231_zJdRABafBoXl" style="border-bottom: Black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Deferred tax assets (liabilities), net"&gt;&lt;b&gt;12,552&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recognized in the consolidated statement of income and other comprehensive income.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfBalanceDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <afya:AdditionsTaxLossesCarryForward
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005028"
      unitRef="BRL">1703000</afya:AdditionsTaxLossesCarryForward>
    <afya:DeferredTaxAssetsLossCarryforwards
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005030"
      unitRef="BRL">1703000</afya:DeferredTaxAssetsLossCarryforwards>
    <afya:AdditionsAllowanceForExpectedCreditLosses
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005037"
      unitRef="BRL">1196000</afya:AdditionsAllowanceForExpectedCreditLosses>
    <afya:AllowanceForExpectedCreditLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005039"
      unitRef="BRL">1196000</afya:AllowanceForExpectedCreditLoss>
    <afya:AdditionsToRightofuseAsset
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005046"
      unitRef="BRL">56180000</afya:AdditionsToRightofuseAsset>
    <afya:RightofuseAsset
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact005048"
      unitRef="BRL">56180000</afya:RightofuseAsset>
    <afya:AdditionsLeaseLiability
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005052"
      unitRef="BRL">-47232000</afya:AdditionsLeaseLiability>
    <afya:LeaseLiability
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact005054"
      unitRef="BRL">-47232000</afya:LeaseLiability>
    <afya:AdditionsProvisionForProfitSharing
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005058"
      unitRef="BRL">2047000</afya:AdditionsProvisionForProfitSharing>
    <afya:ProvisionForProfitSharing
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005060"
      unitRef="BRL">2047000</afya:ProvisionForProfitSharing>
    <afya:AdditionsProvisionForLegalProceedingsAndContingencies
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005064"
      unitRef="BRL">7672000</afya:AdditionsProvisionForLegalProceedingsAndContingencies>
    <ifrs-full:LegalProceedingsProvision
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact005066"
      unitRef="BRL">7672000</ifrs-full:LegalProceedingsProvision>
    <afya:AdditionsAmortizationOfIntangibleAssets
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005070"
      unitRef="BRL">44486000</afya:AdditionsAmortizationOfIntangibleAssets>
    <afya:AmortizationOfIntangibleAsset
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005072"
      unitRef="BRL">44486000</afya:AmortizationOfIntangibleAsset>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005076"
      unitRef="BRL">67000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <afya:Other
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005078"
      unitRef="BRL">67000</afya:Other>
    <afya:AdditionsDeferredTaxAssets
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005082"
      unitRef="BRL">66119000</afya:AdditionsDeferredTaxAssets>
    <afya:DeferredTaxAsset
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact005084"
      unitRef="BRL">66119000</afya:DeferredTaxAsset>
    <afya:AdditionsTaxBenefitFromTaxDeductibleGoodwill
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005091"
      unitRef="BRL">-25293000</afya:AdditionsTaxBenefitFromTaxDeductibleGoodwill>
    <afya:DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005093"
      unitRef="BRL">-25293000</afya:DeferredTaxLiabilitiesTaxBenefitFromTaxDeductibleGoodwill>
    <afya:FairValueRemeasurementsOnBusinessCombinations
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact005095"
      unitRef="BRL">-28274000</afya:FairValueRemeasurementsOnBusinessCombinations>
    <afya:FairValueRemeasurementsOnBusinessCombinations
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005099"
      unitRef="BRL">-28274000</afya:FairValueRemeasurementsOnBusinessCombinations>
    <afya:DeferredsTaxLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact005101"
      unitRef="BRL">-28274000</afya:DeferredsTaxLiabilities>
    <afya:AdditionsDeferredTaxLiabilities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005103"
      unitRef="BRL">-25293000</afya:AdditionsDeferredTaxLiabilities>
    <afya:DeferredsTaxLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact005105"
      unitRef="BRL">-53567000</afya:DeferredsTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact005107"
      unitRef="BRL">-28274000</ifrs-full:NetDeferredTaxLiabilities>
    <afya:AdditionsDeferredTaxAssetsLiabilitiesNet
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005109"
      unitRef="BRL">40826000</afya:AdditionsDeferredTaxAssetsLiabilitiesNet>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact005111"
      unitRef="BRL">12552000</ifrs-full:NetDeferredTaxLiabilities>
    <afya:DeferredTaxExpenseIncomes
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005113"
      unitRef="BRL">1603167000</afya:DeferredTaxExpenseIncomes>
    <afya:DeferredTaxExpenseIncomes
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact005115"
      unitRef="BRL">1266126000</afya:DeferredTaxExpenseIncomes>
    <afya:RecognizedDeferredTaxAssets
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005117"
      unitRef="BRL">392391000</afya:RecognizedDeferredTaxAssets>
    <afya:DisclosureOfLegalProceedingsAndContingenciesExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact005119">&lt;p id="xdx_80D_ecustom--DisclosureOfLegalProceedingsAndContingenciesExplanatory_zCkrE07RpKP4" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;21&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_820_zMzaADaC9fhh"&gt;Legal proceedings and contingencies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The provisions related to labor, civil and taxes proceedings whose likelihood of loss is
assessed as probable are as follows:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfLegalProceedingsAndContingenciesTableTextBlock_pn3n3_zaYbuU3OiGJa" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Legal proceedings and contingencies (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8B5_zDvFQ6ogRu47"&gt;Schedule of legal proceedings and contingencies&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;Labor&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;Civil&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;Taxes&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Balances as of January 1, 2023&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zMPUP7yWvkUb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;22,484&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zEYXVMcMtOkk" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;24,664&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zuu0D4NWBW0j" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;148,706&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zXqE2w0Mescd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;195,854&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Business combination&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zOoi9r7FFo69" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;64&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zOLSjJ1M4Ad8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;88&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z3JldT5t38Fe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5135"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zMVgJlvFgrod" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;152&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Additions&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgGziB3HeHK9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;3,424&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zFMR9KOHFhEe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;5,875&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zhsTvUnQdBB4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;9,037&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zvLYMG4PIzPc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;18,336&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Payments&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zjxxbOccj9J9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(800)&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zpuVDmtiHAsk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(1,051)&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zRKwKO8cpVN2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(14,930)&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zAC4DaVzVIvb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(16,781)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Reversals (i)&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z6cVO1tkih71" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(2,451)&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuOr9hVKrDZa" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(8,276)&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zgiqgZBARFP1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(82,473)&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zcIC70dbufw7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(93,200)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Balances as of December 31, 2023&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zYGZ7TphNIf7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;22,721&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zXX9pWkVPrIa" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;21,300&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zsmhGeIdVD0d" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;60,340&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z9TSm2VZtvDf" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;104,361&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Business combination&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zlv1R9GFD8D3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;721&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zE2bkbXCJjki" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;481&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zFk0iSvPaDC3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;6,044&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zUlatOTIfMPc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;7,246&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Additions&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zMSz11wrKDag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;22,744&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zqEviugHnGVe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;10,006&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zLuLjOavQExb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;26,119&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z8jB2u7M0RCe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;58,869&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Payments&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zyWRp0WxL6If" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(1,638)&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znDgL82bSSwa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(2,977)&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zZ01OUmmexFf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(22)&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_ztl8tE8LPyk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(4,637)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Reversals (i)&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zea77tSXO6Qd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(13,093)&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z3dlA0d39UJ7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(3,670)&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHyjD3uhGW8k" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(35,555)&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zERfPJT1sXI6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(52,318)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Balances as of December 31, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zxtLF9S2niG7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;31,455&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z1ybsx7j7OA5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;25,140&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zmrwueKMDQX4" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;56,926&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zFdAPi3qGX2i" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;113,521&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Additions&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zGpxODUfcVke" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;20,014 &lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zrD9pb3ds7K5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;9,568 &lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_znPPLGCPOtg6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;6,799 &lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zyozkNUxBwT5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;36,381 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Payments&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ziYWFzlHD8Q7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(3,354)&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zaesi0QDNK5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(3,519)&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zkYXs0ORPb59" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5223"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhgVR9gLLcdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(6,873)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Reversals (i)&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zVqpOJ3uoaXe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(4,386)&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z6SZbaazXNqb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(3,145)&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_znoRZ1BA8sGe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(7,278)&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhxibWomxBd1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(14,809)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Balances as of December 31, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zinbUzDsoAv4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;b&gt;43,729 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_ztO98Jsm2Gyg" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;b&gt;28,044 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zE2jpyEYuiZd" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;b&gt;56,447 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zquJoqn2NcEk" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;b&gt;128,220 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Includes the reversals of provision for legal proceedings with corresponding indemnification
asset.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A8_zu1fx0pPg5v3" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The major labor proceedings to which the Company is a party were filed by former employees
or outsourced service providers seeking enforcement of labor rights allegedly not provided by the Company. The judicial proceedings relate
to employment bonds (judicial proceedings filed by former service providers), overtime, premiums for hazardous workplace conditions, statutory
severance, fines for severance payment delays, and compensation for workplace-related accidents.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The civil claims to which the Company is a party generally relate to consumer claims, including
those related to student complaints.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;The tax claims to which the Company is party are mostly tax foreclosures filed by the Brazilian
federal and municipal tax authorities.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;There are other civil, labor and taxes proceedings assessed by Management and its legal
counsels as possible risk of loss, for which no provisions are recognized, as follows:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock_pn3n3_z6TQ0Q7CUK2g" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Legal proceedings and contingencies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B5_zFCR4MkyXfv9" style="display: none"&gt;Schedule of social
    security proceedings assessed by management&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 66%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Labor&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;36,818 &lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;38,097 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Civil&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;59,145 &lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;50,667 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Taxes&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;30,530 &lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;17,498 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--OtherProvisions_c20251231_pn3n3" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;b&gt;126,493 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--OtherProvisions_c20241231_pn3n3" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;b&gt;106,262 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A8_zp1xsNRWFYV2" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Under the terms of the Share Purchase and Sale Agreements ("Agreements") between
the Company and the selling shareholders of the subsidiaries acquired, the Company assesses that the selling shareholders are exclusively
responsible for any provisions (including labor, tax and civil), which are or will be the subject of a claim by any third party, arising
from the act or fact occurred, by action or omission, prior to or on the closing dates of the acquisitions.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;Considering that the provisions for legal proceedings recorded by the Company that result
from causes arising from events occurring prior to the closing dates of the acquisitions, any liability for the amounts to be disbursed,
in case of their effective materialization in loss, belongs exclusively to the selling shareholders. In this context, the Agreements state
that the Company and its subsidiaries are indemnified and therefore exempt from any liability related to said contingent liabilities and,
therefore, the provision amounts related to such contingencies are presented in the non-current liabilities and the correspondent amount
of R$&lt;span id="xdx_90C_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20251231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zcHoDUmliTwe" title="Contingencies correspondent amount"&gt;80,379&lt;/span&gt; (December 31, 2024: R$&lt;span id="xdx_905_ecustom--ContingenciesCorrespondentAmount_c20241231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_pn3n3" title="Contingencies correspondent amount"&gt;78,701&lt;/span&gt;) is presented in non-current other assets.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;



</afya:DisclosureOfLegalProceedingsAndContingenciesExplanatory>
    <afya:ScheduleOfLegalProceedingsAndContingenciesTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact005121">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfLegalProceedingsAndContingenciesTableTextBlock_pn3n3_zaYbuU3OiGJa" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Legal proceedings and contingencies (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8B5_zDvFQ6ogRu47"&gt;Schedule of legal proceedings and contingencies&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;Labor&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;Civil&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;Taxes&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Balances as of January 1, 2023&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zMPUP7yWvkUb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;22,484&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zEYXVMcMtOkk" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;24,664&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zuu0D4NWBW0j" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;148,706&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zXqE2w0Mescd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;195,854&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Business combination&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zOoi9r7FFo69" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;64&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zOLSjJ1M4Ad8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;88&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z3JldT5t38Fe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5135"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zMVgJlvFgrod" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;152&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Additions&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zgGziB3HeHK9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;3,424&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zFMR9KOHFhEe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;5,875&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zhsTvUnQdBB4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;9,037&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zvLYMG4PIzPc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;18,336&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Payments&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zjxxbOccj9J9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(800)&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zpuVDmtiHAsk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(1,051)&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zRKwKO8cpVN2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(14,930)&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zAC4DaVzVIvb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(16,781)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Reversals (i)&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z6cVO1tkih71" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(2,451)&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuOr9hVKrDZa" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(8,276)&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zgiqgZBARFP1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(82,473)&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zcIC70dbufw7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(93,200)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Balances as of December 31, 2023&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zYGZ7TphNIf7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;22,721&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zXX9pWkVPrIa" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;21,300&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zsmhGeIdVD0d" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;60,340&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z9TSm2VZtvDf" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;104,361&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Business combination&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zlv1R9GFD8D3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;721&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zE2bkbXCJjki" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;481&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zFk0iSvPaDC3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;6,044&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zUlatOTIfMPc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;7,246&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Additions&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zMSz11wrKDag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;22,744&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zqEviugHnGVe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;10,006&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zLuLjOavQExb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;26,119&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z8jB2u7M0RCe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;58,869&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Payments&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zyWRp0WxL6If" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(1,638)&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znDgL82bSSwa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(2,977)&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zZ01OUmmexFf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(22)&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_ztl8tE8LPyk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(4,637)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Reversals (i)&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zea77tSXO6Qd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(13,093)&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z3dlA0d39UJ7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(3,670)&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHyjD3uhGW8k" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(35,555)&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20240101__20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zERfPJT1sXI6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(52,318)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Balances as of December 31, 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zxtLF9S2niG7" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;31,455&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z1ybsx7j7OA5" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;25,140&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zmrwueKMDQX4" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;56,926&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Provisions_iS_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zFdAPi3qGX2i" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;b&gt;113,521&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Additions&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zGpxODUfcVke" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;20,014 &lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zrD9pb3ds7K5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;9,568 &lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_znPPLGCPOtg6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;6,799 &lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zyozkNUxBwT5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;36,381 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Payments&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ziYWFzlHD8Q7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(3,354)&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zaesi0QDNK5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(3,519)&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zkYXs0ORPb59" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5223"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ProvisionUsedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhgVR9gLLcdf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;(6,873)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Reversals (i)&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zVqpOJ3uoaXe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(4,386)&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z6SZbaazXNqb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(3,145)&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_znoRZ1BA8sGe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(7,278)&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_iN_pn3n3_di_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zhxibWomxBd1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;(14,809)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;b&gt;Balances as of December 31, 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zinbUzDsoAv4" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;b&gt;43,729 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_ztO98Jsm2Gyg" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;b&gt;28,044 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zE2jpyEYuiZd" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;b&gt;56,447 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Provisions_iE_pn3n3_c20250101__20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zquJoqn2NcEk" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;b&gt;128,220 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;(i)&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Includes the reversals of provision for legal proceedings with corresponding indemnification
asset.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfLegalProceedingsAndContingenciesTableTextBlock>
    <ifrs-full:Provisions
      contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005123"
      unitRef="BRL">22484000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005125"
      unitRef="BRL">24664000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005127"
      unitRef="BRL">148706000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2022-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005129"
      unitRef="BRL">195854000</ifrs-full:Provisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005131"
      unitRef="BRL">64000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005133"
      unitRef="BRL">88000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005137"
      unitRef="BRL">152000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005139"
      unitRef="BRL">3424000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005141"
      unitRef="BRL">5875000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005143"
      unitRef="BRL">9037000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005145"
      unitRef="BRL">18336000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005147"
      unitRef="BRL">800000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005149"
      unitRef="BRL">1051000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005151"
      unitRef="BRL">14930000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005153"
      unitRef="BRL">16781000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005155"
      unitRef="BRL">2451000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005157"
      unitRef="BRL">8276000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005159"
      unitRef="BRL">82473000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2023-01-012023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005161"
      unitRef="BRL">93200000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:Provisions
      contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005163"
      unitRef="BRL">22721000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005165"
      unitRef="BRL">21300000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005167"
      unitRef="BRL">60340000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2023-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005169"
      unitRef="BRL">104361000</ifrs-full:Provisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005171"
      unitRef="BRL">721000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005173"
      unitRef="BRL">481000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005175"
      unitRef="BRL">6044000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005177"
      unitRef="BRL">7246000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005179"
      unitRef="BRL">22744000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005181"
      unitRef="BRL">10006000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005183"
      unitRef="BRL">26119000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005185"
      unitRef="BRL">58869000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005187"
      unitRef="BRL">1638000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005189"
      unitRef="BRL">2977000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005191"
      unitRef="BRL">22000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005193"
      unitRef="BRL">4637000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005195"
      unitRef="BRL">13093000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005197"
      unitRef="BRL">3670000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005199"
      unitRef="BRL">35555000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2024-01-012024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005201"
      unitRef="BRL">52318000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:Provisions
      contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005203"
      unitRef="BRL">31455000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005205"
      unitRef="BRL">25140000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005207"
      unitRef="BRL">56926000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005209"
      unitRef="BRL">113521000</ifrs-full:Provisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005211"
      unitRef="BRL">20014000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005213"
      unitRef="BRL">9568000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005215"
      unitRef="BRL">6799000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005217"
      unitRef="BRL">36381000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005219"
      unitRef="BRL">3354000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005221"
      unitRef="BRL">3519000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005225"
      unitRef="BRL">6873000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005227"
      unitRef="BRL">4386000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005229"
      unitRef="BRL">3145000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005231"
      unitRef="BRL">7278000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2025-01-012025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005233"
      unitRef="BRL">14809000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:Provisions
      contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005235"
      unitRef="BRL">43729000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      id="Fact005237"
      unitRef="BRL">28044000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      id="Fact005239"
      unitRef="BRL">56447000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      id="Fact005241"
      unitRef="BRL">128220000</ifrs-full:Provisions>
    <afya:ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact005243">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock_pn3n3_z6TQ0Q7CUK2g" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Legal proceedings and contingencies (Details 1)"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B5_zFCR4MkyXfv9" style="display: none"&gt;Schedule of social
    security proceedings assessed by management&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 66%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Labor&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;36,818 &lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;38,097 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Civil&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;59,145 &lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;50,667 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;Taxes&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--OtherProvisions_c20251231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;30,530 &lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherProvisions_c20241231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_pn3n3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;17,498 &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--OtherProvisions_c20251231_pn3n3" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;b&gt;126,493 &lt;/b&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--OtherProvisions_c20241231_pn3n3" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;b&gt;106,262 &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfSocialSecurityProceedingsAssessedByManagementTableTextBlock>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember"
      decimals="-3"
      id="Fact005245"
      unitRef="BRL">36818000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember"
      decimals="-3"
      id="Fact005247"
      unitRef="BRL">38097000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember"
      decimals="-3"
      id="Fact005249"
      unitRef="BRL">59145000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember"
      decimals="-3"
      id="Fact005251"
      unitRef="BRL">50667000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2025-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember"
      decimals="-3"
      id="Fact005253"
      unitRef="BRL">30530000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2024-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesAndSocialSecurityMember_custom_TypesOfRiskMember"
      decimals="-3"
      id="Fact005255"
      unitRef="BRL">17498000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2025-12-31"
      decimals="-3"
      id="Fact005257"
      unitRef="BRL">126493000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2024-12-31"
      decimals="-3"
      id="Fact005259"
      unitRef="BRL">106262000</ifrs-full:OtherProvisions>
    <afya:ContingenciesCorrespondentAmount
      contextRef="AsOf2025-12-31_custom_OtherAssetsNonCurrentMember"
      decimals="-3"
      id="Fact005261"
      unitRef="BRL">80379000</afya:ContingenciesCorrespondentAmount>
    <afya:ContingenciesCorrespondentAmount
      contextRef="AsOf2024-12-31_custom_OtherAssetsNonCurrentMember"
      decimals="-3"
      id="Fact005263"
      unitRef="BRL">78701000</afya:ContingenciesCorrespondentAmount>
    <afya:DisclosureNoncashTransactionsExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact005265">&lt;p id="xdx_80E_ecustom--DisclosureNoncashTransactionsExplanatory_zfgnVQ6OBHo5" style="font: 8.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;22&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_823_z9oJPQJUUDT6"&gt;Non-cash transactions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 8.5pt Nunito Sans; margin: 0"&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;During the years ended December 31, 2025, 2024 and 2023, the Company carried out non-cash
transactions which are not reflected in the consolidated statement of cash flows. The main non-cash transactions are as follows:&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfNonCashTransactionsTableTextBlock_pn3n3_zRQwgNhvuOoj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Non-cash transactions (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-left: 8.7pt; text-indent: -8.7pt"&gt;&lt;span id="xdx_8B2_zUoIiDVrKut8" style="display: none"&gt;Schedule
    of non-cash transactions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 67%; padding-left: 8.7pt; text-align: right; text-indent: -8.7pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-left: 8.7pt; text-indent: -8.7pt"&gt;Remeasurement of earn-out of Al&#xe9;m da Medicina, CardioPapers and Glic&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RemeasurementOfEarnOut_pn3n3_c20250101__20251231_z4T31wLxjcN7" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5269"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RemeasurementOfEarnOut_pn3n3_c20240101__20241231_zcNmgAioEoOh" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5271"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RemeasurementOfEarnOut_pn3n3_c20230101__20231231_zliFR7QG0O0f" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic"&gt;2,556&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-left: 8.7pt; text-indent: -8.7pt"&gt;Additions and remeasurements of right-of-use assets and lease liabilities&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_c20250101__20251231_pn3n3" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"&gt;136,714&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20240101__20241231_zWdWTUeEC3P6" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"&gt;117,897&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_c20230101__20231231_pn3n3" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"&gt;77,715&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-left: 8.7pt; text-indent: -8.7pt"&gt;Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_pn3n3_c20250101__20251231_zwMZpoTQkXf" style="text-align: right" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net"&gt;1,678&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_pn3n3_c20240101__20241231_zvLocT5FP47b" style="text-align: right" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net"&gt;(3,154)&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_c20230101__20231231_pn3n3" style="text-align: right" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net"&gt;20,000&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-left: 8.7pt; text-indent: -8.7pt"&gt;Additions to intangibles and goodwill through accounts payable to selling shareholders.&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_c20250101__20251231_pn3n3" style="text-align: right" title="Additions to intangibles and goodwill through accounts payable to selling shareholders"&gt;40,000&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_pn3n3_c20240101__20241231_zFZYBv0WO1Ma" style="text-align: right" title="Additions to intangibles and goodwill through accounts payable to selling shareholders"&gt;279,989&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_c20230101__20231231_pn3n3" style="text-align: right" title="Additions to intangibles and goodwill through accounts payable to selling shareholders"&gt;234,000&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-left: 8.7pt; text-indent: -8.7pt"&gt;Dividends payable&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DividendsPayables_iI_pn3n3_c20250101__20251231_z5a5QsGtgHBd" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt" title="Dividends payable"&gt;192&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--DividendsPayables_pn3n3_c20240101__20241231_zFRspycj9nD6" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt" title="Dividends payable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5295"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DividendsPayables_pn3n3_c20230101__20231231_z85Q9IaTl1L1" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt" title="Dividends payable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5297"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:DisclosureNoncashTransactionsExplanatory>
    <afya:ScheduleOfNonCashTransactionsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact005267">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleOfNonCashTransactionsTableTextBlock_pn3n3_zRQwgNhvuOoj" style="font: 8.5pt Nunito Sans; width: 97%; border-collapse: collapse; margin-left: 3%" summary="xdx: Disclosure - Non-cash transactions (Details)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-left: 8.7pt; text-indent: -8.7pt"&gt;&lt;span id="xdx_8B2_zUoIiDVrKut8" style="display: none"&gt;Schedule
    of non-cash transactions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 67%; padding-left: 8.7pt; text-align: right; text-indent: -8.7pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-left: 8.7pt; text-indent: -8.7pt"&gt;Remeasurement of earn-out of Al&#xe9;m da Medicina, CardioPapers and Glic&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RemeasurementOfEarnOut_pn3n3_c20250101__20251231_z4T31wLxjcN7" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5269"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RemeasurementOfEarnOut_pn3n3_c20240101__20241231_zcNmgAioEoOh" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5271"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RemeasurementOfEarnOut_pn3n3_c20230101__20231231_zliFR7QG0O0f" style="text-align: right" title="Remeasurement of earn-out of Alem da Medicina, CardioPapers and Glic"&gt;2,556&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-left: 8.7pt; text-indent: -8.7pt"&gt;Additions and remeasurements of right-of-use assets and lease liabilities&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_c20250101__20251231_pn3n3" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"&gt;136,714&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_pn3n3_c20240101__20241231_zWdWTUeEC3P6" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"&gt;117,897&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities_c20230101__20231231_pn3n3" style="text-align: right" title="Additions and remeasurements of right-of-use assets and lease liabilities"&gt;77,715&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-left: 8.7pt; text-indent: -8.7pt"&gt;Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_pn3n3_c20250101__20251231_zwMZpoTQkXf" style="text-align: right" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net"&gt;1,678&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_pn3n3_c20240101__20241231_zvLocT5FP47b" style="text-align: right" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net"&gt;(3,154)&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet_c20230101__20231231_pn3n3" style="text-align: right" title="Additions (reversals) of provision for legal proceedings with corresponding indemnification asset, net"&gt;20,000&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-left: 8.7pt; text-indent: -8.7pt"&gt;Additions to intangibles and goodwill through accounts payable to selling shareholders.&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_c20250101__20251231_pn3n3" style="text-align: right" title="Additions to intangibles and goodwill through accounts payable to selling shareholders"&gt;40,000&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_pn3n3_c20240101__20241231_zFZYBv0WO1Ma" style="text-align: right" title="Additions to intangibles and goodwill through accounts payable to selling shareholders"&gt;279,989&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders_c20230101__20231231_pn3n3" style="text-align: right" title="Additions to intangibles and goodwill through accounts payable to selling shareholders"&gt;234,000&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-left: 8.7pt; text-indent: -8.7pt"&gt;Dividends payable&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DividendsPayables_iI_pn3n3_c20250101__20251231_z5a5QsGtgHBd" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt" title="Dividends payable"&gt;192&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--DividendsPayables_pn3n3_c20240101__20241231_zFRspycj9nD6" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt" title="Dividends payable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5295"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DividendsPayables_pn3n3_c20230101__20231231_z85Q9IaTl1L1" style="padding-left: 8.7pt; text-align: right; text-indent: -8.7pt" title="Dividends payable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5297"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfNonCashTransactionsTableTextBlock>
    <afya:RemeasurementOfEarnOut
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact005273"
      unitRef="BRL">2556000</afya:RemeasurementOfEarnOut>
    <afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005275"
      unitRef="BRL">136714000</afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities>
    <afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact005277"
      unitRef="BRL">117897000</afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities>
    <afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact005279"
      unitRef="BRL">77715000</afya:AdditionsAndRemeasurementsOfRightofuseAssetsAndLeaseLiabilities>
    <afya:AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005281"
      unitRef="BRL">1678000</afya:AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet>
    <afya:AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact005283"
      unitRef="BRL">-3154000</afya:AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet>
    <afya:AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact005285"
      unitRef="BRL">20000000</afya:AdditionsReversalsOfProvisionForLegalProceedingsWithCorrespondingIndemnificationAssetNet>
    <afya:AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005287"
      unitRef="BRL">40000000</afya:AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders>
    <afya:AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders
      contextRef="From2024-01-012024-12-31"
      decimals="-3"
      id="Fact005289"
      unitRef="BRL">279989000</afya:AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders>
    <afya:AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact005291"
      unitRef="BRL">234000000</afya:AdditionsToIntangiblesAndGoodwillThroughAccountsPayableToSellingShareholders>
    <afya:DividendsPayables
      contextRef="From2025-01-01to2025-12-31"
      decimals="-3"
      id="Fact005293"
      unitRef="BRL">192000</afya:DividendsPayables>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="From2025-01-01to2025-12-31" id="Fact005299">&lt;p id="xdx_808_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zVblsUeamGP2" style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10.5pt Nunito Sans; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 3%"&gt;&lt;b&gt;23&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;span id="xdx_828_zr0h6L49cs99"&gt;Subsequent events&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Medical school seats increase in ITPAC Porto&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On February 6, 2026, MEC authorized the increase of 63 medical school seats of ITPAC Porto
located in the city of Abaetetuba, State of Par&#xe1;. With this authorization, Afya reached 113 medical school seats on this campus.&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%; color: #C00000"&gt;&lt;i&gt;Dividend distribution&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10.5pt Nunito Sans; margin: 0 0 0 3%"&gt;On March 12, 2026, the Company&#x2019;s Board of Directors approved a dividend distribution
in the amount of R$&lt;span id="xdx_90E_ecustom--FirstDividendDistributionInAmount_pn5n6_c20260311__20260312__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z8hARqnokK42" title="First dividend distribution in amount"&gt;307.4&lt;/span&gt; million, representing &lt;span id="xdx_90B_ecustom--PercentageOfDividendDistribution_pip0_dp_c20260311__20260312__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zlcYv0mJTj69" title="Percentage of dividend distribution"&gt;40&lt;/span&gt;% of the Company&#x2019;s consolidated net income for the year ended December 31, 2025
and a dividend per share of R$&lt;span id="xdx_908_eifrs-full--DividendsPaidOtherSharesPerShare_c20260405__20260406__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zAqHnAsvO6n4" title="Dividends per share"&gt;3.446838&lt;/span&gt;, payable in U.S. dollars on April 6, 2026, to the shareholders on record as of the close of business
on March 25, 2026. The payment will be made at the exchange rate (PTAX) published by the Brazilian Central Bank on March 13, 2026.&lt;/p&gt;

</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <afya:FirstDividendDistributionInAmount
      contextRef="From2026-03-112026-03-12_custom_NonadjustingEventMember"
      decimals="-5"
      id="Fact005301"
      unitRef="BRL">307400000</afya:FirstDividendDistributionInAmount>
    <afya:PercentageOfDividendDistribution
      contextRef="From2026-03-112026-03-12_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact005303"
      unitRef="Pure">0.40</afya:PercentageOfDividendDistribution>
    <ifrs-full:DividendsPaidOtherSharesPerShare
      contextRef="From2026-04-052026-04-06_custom_NonadjustingEventMember"
      decimals="INF"
      id="Fact005305"
      unitRef="BRLPShares">3.446838</ifrs-full:DividendsPaidOtherSharesPerShare>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
